{"meta":{"query_hash":"897c1e66c133","filters":{"venue":"Blood"},"cohort_total":10018,"direct_labels_cover":11,"predictions_cover":10018,"exported":10018,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/897c1e66c133","api":"https://metacan.xera.ac/api/v1/cohort?venue=Blood"},"results":[{"id":"W1019948147","doi":"10.1182/blood.v124.21.5995.5995","title":"Retrospective Observational Study on Multiple Myeloma Cases Admitted to Kfsh – Dammam Between 1st of June 2006 till the End of December 2013","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Multiple myeloma; Population; Autologous stem-cell transplantation; Retrospective cohort study; Transplantation; Observational study; Surgery; Internal medicine; Pediatrics","score_opus":0.07513266327263778,"score_gpt":0.33595189247673685,"score_spread":0.26081922920409906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1019948147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965264,0.00004026469,0.000015122389,0.0006150222,0.00004841901,0.0013679344,0.00028269127,0.000021724993,0.0010824164],"genre_scores_gemma":[0.99828994,0.000004225159,0.00037179363,0.000066348,0.00017911186,0.00008865479,0.00010423844,0.000024258676,0.00087144074],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99818426,0.00013816851,0.00036475863,0.0003019509,0.0007341138,0.00027672827],"domain_scores_gemma":[0.9979289,0.0008445352,0.00013892513,0.00053804123,0.00035779036,0.00019178704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029651108,0.00017724332,0.0004462625,0.0001241601,0.0000801828,0.000008332144,0.00015627246,0.000059222726,0.0001390856],"category_scores_gemma":[0.0016875375,0.00011535694,0.000095476506,0.00031962158,0.00009512512,0.000043427146,0.00008402595,0.00014995816,0.000056494482],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003613359,0.0026769699,0.99142325,0.000023982839,0.00057676114,0.000033227112,0.00029620578,0.000005308385,0.002491529,0.000043980643,0.0011700554,0.0008973837],"study_design_scores_gemma":[0.006997293,0.0027250107,0.9694809,0.00006257217,0.00024228347,0.000008873716,0.00013680766,0.000030115561,0.019464705,0.000031888267,0.000730218,0.00008936217],"about_ca_topic_score_codex":0.00096436596,"about_ca_topic_score_gemma":0.001121532,"teacher_disagreement_score":0.021942388,"about_ca_system_score_codex":0.000042549847,"about_ca_system_score_gemma":0.00008495552,"threshold_uncertainty_score":0.47041196},"labels":[],"label_agreement":null},{"id":"W1020248866","doi":"10.1182/blood.v95.2.461","title":"Identification of the soluble granulocyte-macrophage colony stimulating factor receptor protein in vivo","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Biology; In vivo; Haematopoiesis; Cell culture; Progenitor cell; HL60; U937 cell; Molecular biology; Myeloid; Stem cell; Interleukin 3; Granulocyte macrophage colony-stimulating factor; Immunology; Cytokine; Leukemia; Cell biology; T cell; Immune system; Interleukin 21","score_opus":0.008591200631204329,"score_gpt":0.22134148910179316,"score_spread":0.21275028847058883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1020248866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99706453,0.00020182611,0.000009593524,0.000059849317,0.0008801046,0.00039895455,0.0000069990033,0.000026431047,0.0013517311],"genre_scores_gemma":[0.94728607,0.000010793955,0.000010770445,0.000026369033,0.000013179568,0.00003195465,0.000010951127,0.000008275627,0.052601613],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991834,0.00015458447,0.0003358363,0.00015009817,0.00003064789,0.00014541626],"domain_scores_gemma":[0.9995773,0.00003244719,0.00013076654,0.00021474472,0.000039045015,0.000005687196],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001309106,0.00008303974,0.00012302236,0.000045558605,0.000110884575,0.0000095829955,0.00012830652,0.00012252846,0.007947322],"category_scores_gemma":[0.00006191059,0.00006535037,0.00006400453,0.00014191431,0.00005843211,0.00009103741,0.000019456571,0.00019528366,0.00039658093],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008944388,0.00025030714,0.002133893,0.000011298273,0.000029346456,1.7493394e-7,0.00027591697,0.00001961077,0.99561083,0.000024407891,0.0006142688,0.00094047864],"study_design_scores_gemma":[0.001276842,0.00006918783,0.007985222,0.00003594795,0.000014590718,0.000004500425,0.000055494354,0.000019512496,0.9767646,0.000010582402,0.0136950165,0.000068476256],"about_ca_topic_score_codex":0.00012517138,"about_ca_topic_score_gemma":0.000023187797,"teacher_disagreement_score":0.051249884,"about_ca_system_score_codex":0.000022976223,"about_ca_system_score_gemma":0.000021725746,"threshold_uncertainty_score":0.99295956},"labels":[],"label_agreement":null},{"id":"W1028049183","doi":"10.1182/blood.v124.21.2365.2365","title":"Diagnosis of Blastic Plasmacytoid Dendritic Cell Neoplasm By Using 10-Colour Flow Cytometry and Achievement of Remission By Hypercvad Therapy","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Leukemia & Lymphoma Society of Canada","funders":"","keywords":"Medicine; CD33; CD34; Internal medicine; Leukemia; Pathology; Gastroenterology; Biology; Stem cell","score_opus":0.0154406370213579,"score_gpt":0.27294797218226546,"score_spread":0.25750733516090757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1028049183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961857,0.0025866248,0.00016335711,0.00014951905,0.000027588012,0.00047834162,0.0000637862,0.00001743201,0.0003276182],"genre_scores_gemma":[0.9972254,0.0011850656,0.0009855302,0.0000851198,0.000027795495,0.0000248775,0.000030082454,0.000040179744,0.00039594507],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99832463,0.00012825632,0.0003717716,0.00032666334,0.000532738,0.00031593943],"domain_scores_gemma":[0.9987715,0.000471322,0.000116213465,0.00027327123,0.00017426616,0.00019342883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024410282,0.00020423312,0.00048256406,0.00017599281,0.00007633532,0.00001310834,0.00011435971,0.00012482116,0.0002109304],"category_scores_gemma":[0.0003724855,0.00017601032,0.00007772989,0.0002648264,0.00015045314,0.000039994204,0.00007043449,0.00014470112,0.00000583095],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000343578,0.0024192359,0.1496655,0.00038601027,0.00011481666,0.000012328544,0.00022008318,0.000010328789,0.84110403,0.0000011114495,0.0013200741,0.0044029],"study_design_scores_gemma":[0.008528133,0.0017044715,0.0019629507,0.00024246496,0.00016075898,0.00013965947,0.00017141797,0.0032494357,0.9825567,0.00001535344,0.0010834741,0.00018515653],"about_ca_topic_score_codex":0.00007948864,"about_ca_topic_score_gemma":0.000004760095,"teacher_disagreement_score":0.14770256,"about_ca_system_score_codex":0.000044146742,"about_ca_system_score_gemma":0.00010552171,"threshold_uncertainty_score":0.71774924},"labels":[],"label_agreement":null},{"id":"W1040989942","doi":"10.1182/blood.v124.21.621.621","title":"Overall Survival in Older Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) with >30% Bone Marrow Blasts Treated with Azacitidine By Cytogenetic Risk Status: Results of the AZA-AML-001 Study","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre; CancerCare Manitoba","funders":"","keywords":"Medicine; Azacitidine; Internal medicine; Myeloid leukemia; Oncology; Bone marrow; Cytogenetics; Decitabine; Leukemia; Surgery","score_opus":0.006703207031544652,"score_gpt":0.22732603675827773,"score_spread":0.22062282972673308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1040989942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99454933,0.00008044118,0.000025552068,0.00012655098,0.000032823842,0.0036671138,0.00063428865,0.00008643892,0.0007974817],"genre_scores_gemma":[0.9975583,0.00012190797,0.0004655324,0.00010024524,0.00008211474,0.0002002902,0.00044216873,0.00017715724,0.0008522996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942327,0.0007231831,0.00085232616,0.0010768613,0.0019434812,0.0011714512],"domain_scores_gemma":[0.9963248,0.00046970925,0.00058506377,0.0015571442,0.0006035973,0.000459688],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007183164,0.00070481293,0.0011595684,0.00030622145,0.00016140772,0.000054844924,0.0004613942,0.0002065498,0.000059228805],"category_scores_gemma":[0.00032092418,0.00039651335,0.00008896109,0.0011670813,0.0003957087,0.00016777826,0.00020634072,0.0008862199,0.000021177288],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011013583,0.0056798668,0.9751929,0.00008212676,0.0012491422,0.0002743965,0.0010343689,0.00018765098,0.0033464115,0.000002420092,0.0011447956,0.00079231994],"study_design_scores_gemma":[0.15891708,0.009738335,0.81958735,0.00037083778,0.0012453264,0.000027347003,0.00032031108,0.00013630406,0.00891248,0.0000023972648,0.00027203973,0.0004701673],"about_ca_topic_score_codex":0.0043522646,"about_ca_topic_score_gemma":0.0034118798,"teacher_disagreement_score":0.15560555,"about_ca_system_score_codex":0.00051772076,"about_ca_system_score_gemma":0.0008261307,"threshold_uncertainty_score":0.99984866},"labels":[],"label_agreement":null},{"id":"W110982080","doi":"10.1182/blood.v122.21.768.768","title":"Efficacy Of a Pharmacokinetics-Directed IV Busulfan (Bu), Plus Cyclophosphamide (Cy) and Etoposide (E) Preparative Regimen With Autologous Hematopoietic Stem Cell Transplantation For Lymphoma: Final Report Of a Multi-Center Phase 2 Study In North America","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Regimen; Transplantation; Busulfan; Surgery; International Prognostic Index; Hematopoietic stem cell transplantation; Etoposide; Autologous stem-cell transplantation; Oncology; Single Center; Cyclophosphamide; Gastroenterology; Chemotherapy","score_opus":0.017542218795791722,"score_gpt":0.2864364714355683,"score_spread":0.26889425263977657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W110982080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995133,0.0004340859,0.000075205004,0.00004717982,0.00002043919,0.004110155,0.000060564587,0.000043005355,0.00007641028],"genre_scores_gemma":[0.9967202,0.00012318027,0.0021512064,0.000021540023,0.000010664925,0.00075793976,0.000108027416,0.000025607906,0.000081628335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843633,0.00006615896,0.00061884604,0.0004247409,0.00022012339,0.00023379964],"domain_scores_gemma":[0.9988649,0.00017628449,0.00040666087,0.00026532798,0.00017419235,0.000112662114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000066045446,0.00024855405,0.0006686238,0.000119941345,0.000033807057,0.000009476389,0.000060066093,0.00004889994,0.000007606837],"category_scores_gemma":[0.000013075704,0.00018673608,0.000072991555,0.00023979413,0.00009645111,0.00006271878,0.000016519341,0.000043641416,0.0000013128441],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012063766,0.13039395,0.78946376,0.0014933357,0.0018222933,0.004264486,0.04131235,0.00017185912,0.0053145555,0.0000020697648,0.0001344984,0.013563096],"study_design_scores_gemma":[0.194619,0.0057484116,0.7297948,0.00024055119,0.0017168574,0.0006951732,0.00091159024,0.00085950573,0.0651801,0.0000010671213,0.000024262652,0.00020867641],"about_ca_topic_score_codex":0.00062676,"about_ca_topic_score_gemma":0.000137763,"teacher_disagreement_score":0.18255523,"about_ca_system_score_codex":0.000063178195,"about_ca_system_score_gemma":0.00017412618,"threshold_uncertainty_score":0.76148766},"labels":[],"label_agreement":null},{"id":"W112559982","doi":"10.1182/blood.v122.21.92.92","title":"ENESTnd Update: Nilotinib (NIL) Vs Imatinib (IM) In Patients (pts) With Newly Diagnosed Chronic Myeloid Leukemia In Chronic Phase (CML-CP) and The Impact Of Early Molecular Response (EMR) and Sokal Risk At Diagnosis On Long-Term Outcomes","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Nilotinib; Discontinuation; Internal medicine; Imatinib mesylate; Imatinib; Myeloid leukemia; Gastroenterology; Oncology","score_opus":0.008635732933922944,"score_gpt":0.2706753204529666,"score_spread":0.26203958751904366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W112559982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99422675,0.001997608,0.0000023283603,0.00017166388,0.00003392581,0.003386222,0.000105194085,0.000042388598,0.000033903794],"genre_scores_gemma":[0.99761546,0.0011917786,0.00009605363,0.000100178804,0.00004165296,0.0007028108,0.00009599196,0.00010131129,0.000054752803],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964321,0.00056443195,0.0008409701,0.0007923679,0.0005831528,0.00078694336],"domain_scores_gemma":[0.9969607,0.0011854622,0.0004914869,0.00094763417,0.00009739195,0.00031730058],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005460545,0.00066962733,0.0011942057,0.00037719385,0.00012139258,0.00006413595,0.00024073894,0.00023254017,0.00020733498],"category_scores_gemma":[0.00051247835,0.00041880083,0.00020111192,0.00041659301,0.00051618606,0.0002500221,0.00020540308,0.00052901614,0.00004252789],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009824982,0.0017905238,0.97856987,0.00014987473,0.0005789409,0.0003428791,0.0009753854,0.00015248466,0.0011607198,0.0000049260816,0.000047090318,0.0064023505],"study_design_scores_gemma":[0.16874434,0.008290455,0.8157186,0.0005874836,0.00042594585,0.00003444218,0.000021829532,0.00021116408,0.005624371,0.000015032461,0.000003875464,0.00032247315],"about_ca_topic_score_codex":0.0060482025,"about_ca_topic_score_gemma":0.0010718,"teacher_disagreement_score":0.16285126,"about_ca_system_score_codex":0.004470751,"about_ca_system_score_gemma":0.0014393274,"threshold_uncertainty_score":0.9998264},"labels":[],"label_agreement":null},{"id":"W114597356","doi":"10.1182/blood.v122.21.408.408","title":"Final Analysis, Cytogenetics, Long-Term Treatment, and Long-Term Survival In MM-003, A Phase 3 Study Comparing Pomalidomide + Low-Dose Dexamethasone (POM + LoDEX) Vs High-Dose Dexamethasone (HiDEX) In Relapsed/Refractory Multiple Myeloma (RRMM)","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Princess Margaret Cancer Centre; Vancouver General Hospital","funders":"","keywords":"Pomalidomide; Medicine; Lenalidomide; Internal medicine; Tolerability; Clinical endpoint; Dexamethasone; Neutropenia; Phases of clinical research; Population; Bortezomib; Ixazomib; Oncology; Multiple myeloma; Surgery; Adverse effect; Randomized controlled trial; Clinical trial; Toxicity; Carfilzomib","score_opus":0.05765599266490275,"score_gpt":0.33625866345399785,"score_spread":0.2786026707890951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W114597356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919756,0.0025951932,0.000099014534,0.000086777734,0.00013095216,0.004831339,0.00010142559,0.00012744656,0.000052239622],"genre_scores_gemma":[0.9957194,0.0007105799,0.0015493965,0.000041768155,0.00019465006,0.0007497181,0.0005590717,0.00014476482,0.00033066614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9929721,0.0010234215,0.0015197375,0.0017875789,0.0010023495,0.0016948555],"domain_scores_gemma":[0.9955748,0.0011283509,0.0004196071,0.0015357793,0.00022772244,0.001113796],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00083615136,0.0010974647,0.002551616,0.001809831,0.00021957369,0.00022277496,0.0004334611,0.00035958877,0.0003441322],"category_scores_gemma":[0.00062685396,0.0009706222,0.00040218435,0.0017079624,0.00033293598,0.00035521464,0.00035577637,0.0007977216,0.00012442522],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005222779,0.039384246,0.91899395,0.00017939923,0.004008117,0.005895711,0.00087900274,0.00006950071,0.008839643,0.0000018096284,0.000004690218,0.01652113],"study_design_scores_gemma":[0.14499725,0.0047434447,0.8394787,0.00026176352,0.0022567955,0.00010522822,0.00022992623,0.0011277605,0.0061329277,0.0000074997274,0.0000023823743,0.00065637694],"about_ca_topic_score_codex":0.009662566,"about_ca_topic_score_gemma":0.030364525,"teacher_disagreement_score":0.13977447,"about_ca_system_score_codex":0.00062285573,"about_ca_system_score_gemma":0.0003418085,"threshold_uncertainty_score":0.99927443},"labels":[],"label_agreement":null},{"id":"W116679998","doi":"10.1182/blood.v122.21.1738.1738","title":"Patients’ Knowledge Of Anticoagulation and Its Association With Clinical Characteristics, INR Control and Warfarin-Related Adverse Events","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Jewish General Hospital; McGill University; University of British Columbia","funders":"","keywords":"Medicine; Warfarin; Adverse effect; Thrombosis; Test (biology); Internal medicine; Pediatrics; Emergency medicine; Atrial fibrillation","score_opus":0.025601152898799415,"score_gpt":0.2971644947190613,"score_spread":0.27156334182026187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W116679998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99871916,0.00005974656,0.000013154715,0.00027241325,0.000089158326,0.0006015531,0.000004575459,0.000018929328,0.00022132313],"genre_scores_gemma":[0.99914485,0.000048289505,0.00006363482,0.00003560702,0.00008494727,0.0000016725329,0.00003404033,0.000008071885,0.00057888153],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992731,0.000051753457,0.00035378736,0.00012246295,0.000112846734,0.00008600222],"domain_scores_gemma":[0.9992735,0.00012682307,0.00026915382,0.000064262014,0.00020852449,0.000057767396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019544094,0.0000752924,0.0002663033,0.000051952593,0.000028267146,0.0000042175916,0.000014844734,0.00008528554,0.000029084069],"category_scores_gemma":[0.0003216807,0.00005852748,0.00003359426,0.00006418814,0.000015760055,0.00012243623,0.000020200647,0.00005878858,0.00002144166],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006338096,0.00007913127,0.9977637,0.000046642497,0.00022976003,2.587558e-7,0.00007521429,1.9302524e-7,0.0001553765,0.00008086663,0.000014745954,0.0014907417],"study_design_scores_gemma":[0.010389614,0.00024910466,0.9878141,0.00004611214,0.00057910423,4.7109629e-7,0.000012497406,0.00065211655,0.000046193305,0.000020083595,0.00012938603,0.00006119946],"about_ca_topic_score_codex":0.000006765582,"about_ca_topic_score_gemma":0.0000012102257,"teacher_disagreement_score":0.010326233,"about_ca_system_score_codex":0.00001051053,"about_ca_system_score_gemma":0.000012669987,"threshold_uncertainty_score":0.23866813},"labels":[],"label_agreement":null},{"id":"W117179347","doi":"10.1182/blood.v106.11.1620.1620","title":"Rates of Clinically Apparent Venous Thromboembolism and Death Resulting from Pulmonary Embolism among Unselected Hospitalized Acutely Ill Medical Patients Versus Rates Predicted from Clinical Studies.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Hamilton General Hospital","funders":"","keywords":"Medicine; Pulmonary embolism; Incidence (geometry); Autopsy; Prospective cohort study; Cause of death; Cohort study; Internal medicine; Venous thromboembolism; Observational study; Emergency medicine; Pediatrics; Intensive care medicine; Thrombosis; Disease","score_opus":0.04678484862400923,"score_gpt":0.36418676600826444,"score_spread":0.3174019173842552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W117179347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99141157,0.0045205173,0.000014327745,0.0006776762,0.0009914357,0.0013692137,0.0003200715,0.00021589818,0.00047928296],"genre_scores_gemma":[0.9810977,0.013447426,0.002015921,0.00080887304,0.0013195999,0.00010199508,0.0010924884,0.000094003204,0.000022014929],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9937504,0.00040589357,0.0026907716,0.0012024632,0.0012262092,0.00072428974],"domain_scores_gemma":[0.994886,0.0019111366,0.00094397855,0.0007838183,0.00078647386,0.0006885952],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009371562,0.0005900522,0.0026648722,0.00016009319,0.0002003097,0.000045942445,0.00042999556,0.0005827472,0.00017617935],"category_scores_gemma":[0.004681955,0.0004974847,0.0003427943,0.00032595717,0.00051482674,0.00020937363,0.0005215912,0.00070171687,0.000021022095],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020477904,0.022297049,0.9339559,0.00014747155,0.008475797,0.00024964125,0.0025184033,0.000004050382,0.00016844107,0.00006646655,0.0024493022,0.027619705],"study_design_scores_gemma":[0.024551002,0.0023877644,0.9655487,0.00086561474,0.0035812834,0.000003510859,0.00047636835,0.00040850355,0.00063451694,0.00016694561,0.00091259857,0.00046319122],"about_ca_topic_score_codex":0.00095448387,"about_ca_topic_score_gemma":0.00013003049,"teacher_disagreement_score":0.03159282,"about_ca_system_score_codex":0.00006648164,"about_ca_system_score_gemma":0.00023790236,"threshold_uncertainty_score":0.9997477},"labels":[],"label_agreement":null},{"id":"W1178910548","doi":"10.1182/blood.v124.21.4297.4297","title":"Prophylactic Rh and Kell Antigen Matching Significantly Decreases Rates of Alloimmunization in Transfusion Dependent MDS Patients","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Blood transfusion; Antigen; Isoantibodies; Internal medicine; Rh blood group system; Red blood cell; Immunology; Surgery; Antibody","score_opus":0.007355377033725366,"score_gpt":0.22505965529104058,"score_spread":0.2177042782573152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1178910548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984387,0.00025979706,0.0004761798,0.000035775913,0.00003428345,0.0004727258,0.0000032506405,0.000019075778,0.00026018798],"genre_scores_gemma":[0.99915904,0.00028042862,0.00042616247,0.000041667972,0.000021801778,0.000007284468,0.0000332746,0.000019559027,0.000010782379],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990964,0.000071055576,0.00027929404,0.00020302126,0.00020793153,0.00014233365],"domain_scores_gemma":[0.99958766,0.000054740914,0.00006556115,0.00015182878,0.00007017469,0.00007003947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001839485,0.000119218326,0.00024383467,0.00011645238,0.000048432095,0.000011056152,0.00004642065,0.000076883516,0.000019390172],"category_scores_gemma":[0.000043218795,0.00009888611,0.00003472107,0.00014452585,0.000029696872,0.00008416993,0.000015133461,0.0001095099,0.0000018659239],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017653697,0.0020368132,0.82020146,0.0003473576,0.000027483948,0.000008150425,0.00075032754,0.00000741931,0.17016137,0.00007758753,4.3706424e-7,0.006205063],"study_design_scores_gemma":[0.0064394386,0.0007157661,0.85481364,0.00020036253,0.0001686225,0.000009771895,0.00011668034,0.00008643417,0.13717298,0.00015910364,0.000009733928,0.00010749275],"about_ca_topic_score_codex":0.00069671596,"about_ca_topic_score_gemma":0.00017375112,"teacher_disagreement_score":0.034612164,"about_ca_system_score_codex":0.000006371322,"about_ca_system_score_gemma":0.000024571962,"threshold_uncertainty_score":0.40324584},"labels":[],"label_agreement":null},{"id":"W1179256465","doi":"10.1182/blood.v124.21.1316.1316","title":"Bone Marrow Core Biopsy Adequacy and Variability in the United Stated and Canada: A Multicenter Retrospective Study","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hematological disorders and diagnostics","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Jewish General Hospital; McGill University; Royal Victoria Hospital","funders":"","keywords":"Medicine; Biopsy; Cohort; Surgery; Radiology; Internal medicine","score_opus":0.016825192164627478,"score_gpt":0.2558448629445848,"score_spread":0.23901967077995734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1179256465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980673,0.000045391982,0.00002240762,0.00089927367,0.00001515522,0.0006011419,0.0000148907775,0.000012266054,0.0003221538],"genre_scores_gemma":[0.9991903,0.0000126228715,0.000090531095,0.0006506243,0.000010719022,0.000018172448,0.000013694673,0.000005246466,0.000008147497],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99918693,0.00015674897,0.00016422335,0.00019719392,0.00014429742,0.00015062637],"domain_scores_gemma":[0.9992298,0.00042444348,0.00003351424,0.00017419428,0.00005819075,0.00007984756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044307168,0.00009323064,0.00022275475,0.000033842665,0.000044442942,0.00001222163,0.000035582576,0.00004297088,0.000016104439],"category_scores_gemma":[0.0026217732,0.000056027086,0.00000943741,0.00016490306,0.000081828395,0.000014320716,0.000032188575,0.00015744082,4.7249515e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006615118,0.0014016973,0.99706405,0.000030493236,0.000022853685,0.00012488486,0.0006398942,1.4061035e-7,0.000045486562,0.00042487553,0.000120977274,0.000058480862],"study_design_scores_gemma":[0.005109515,0.00042188133,0.99180806,0.000024375962,0.00010562439,0.000033407414,0.0015434847,0.00038204933,0.000011482057,0.00039091695,0.00010059628,0.000068583795],"about_ca_topic_score_codex":0.12970592,"about_ca_topic_score_gemma":0.1351184,"teacher_disagreement_score":0.0054124673,"about_ca_system_score_codex":0.00001682744,"about_ca_system_score_gemma":0.00004558656,"threshold_uncertainty_score":0.88066345},"labels":[],"label_agreement":null},{"id":"W118211895","doi":"10.1182/blood.v104.11.1762.1762","title":"The International Medical Prevention Registry on Venous Thromboembolism (IMPROVE): Venous Thromboembolism Prophylaxis Practices in Acutely Ill Medical Patients.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Medicine; Venous thromboembolism; Incidence (geometry); Prospective cohort study; Emergency medicine; Surgery; Thrombosis","score_opus":0.016498602131881642,"score_gpt":0.30010799959991924,"score_spread":0.2836093974680376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W118211895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9650366,0.0005953268,0.000024577732,0.015089442,0.0022036484,0.0017016741,0.00001918769,0.0001574302,0.015172168],"genre_scores_gemma":[0.99096036,0.0027979794,0.00024303756,0.0037734606,0.0014094113,0.00032304483,0.00012618318,0.00008320129,0.00028329476],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99396247,0.00015844862,0.0009568838,0.00086608366,0.0032652172,0.00079088524],"domain_scores_gemma":[0.9972854,0.00028364809,0.00073401426,0.00090832176,0.00030815846,0.00048043483],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014327578,0.0004411759,0.00096924015,0.00022484265,0.0003430071,0.00015343478,0.0010402394,0.0005376024,0.00035409458],"category_scores_gemma":[0.0045698956,0.0003192198,0.00025590908,0.00037125027,0.0003206632,0.0002726684,0.0003868449,0.0011974456,0.0002035547],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001715075,0.3087809,0.022065775,0.0013385159,0.0073812692,0.006082102,0.007890494,0.00009063423,0.0011397955,0.05380683,0.01825223,0.5714564],"study_design_scores_gemma":[0.044731017,0.01957672,0.7973598,0.003986996,0.0017942692,0.0005716706,0.0015535463,0.00012545128,0.005025799,0.011604408,0.111961916,0.0017083907],"about_ca_topic_score_codex":0.0006174502,"about_ca_topic_score_gemma":0.00055438926,"teacher_disagreement_score":0.77529407,"about_ca_system_score_codex":0.00032143923,"about_ca_system_score_gemma":0.0010771288,"threshold_uncertainty_score":0.999926},"labels":[],"label_agreement":null},{"id":"W118410573","doi":"10.1182/blood.v114.22.262.262","title":"Elevated Systolic Blood Pressure and Low Fetal Hemoglobin Are Risk Factors for Silent Cerebral Infarcts in Children with Sickle Cell Anemia.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Fetal hemoglobin; Sickle cell anemia; Internal medicine; Blood pressure; Anemia; Cohort; Odds ratio; Pediatrics; Cardiology; Pregnancy; Disease; Fetus","score_opus":0.0036902037454402065,"score_gpt":0.19405175128935698,"score_spread":0.19036154754391676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W118410573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99370986,0.0040474357,0.000007069253,0.00017987537,0.000030884086,0.0015816535,0.00013073297,0.00010878727,0.00020372304],"genre_scores_gemma":[0.99889946,0.00028635314,0.00020079888,0.00016102724,0.00006375443,0.000023384313,0.00012981614,0.000040128136,0.0001952707],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836725,0.00004744953,0.0003240615,0.00048026213,0.00024460923,0.0005363917],"domain_scores_gemma":[0.99914205,0.00004224483,0.00018650688,0.00031319406,0.0000679501,0.00024805174],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010452175,0.00034419924,0.0005121261,0.00014865024,0.00011623319,0.000031820742,0.000105258376,0.00030837258,0.000019664398],"category_scores_gemma":[0.000067360575,0.0002521641,0.000092203576,0.0002913848,0.00007218986,0.00008690957,0.000027851911,0.00043768954,0.000003844954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002688827,0.0029408515,0.99082637,0.00033095264,0.0005185648,0.00005180174,0.0006562303,0.00021662349,0.003471065,0.000015498354,0.00024224079,0.00046092202],"study_design_scores_gemma":[0.029672757,0.0023551404,0.9307493,0.00045500108,0.0038634068,0.0003174662,0.00063320063,0.00033651767,0.030926554,0.000032431803,0.0001203179,0.00053788634],"about_ca_topic_score_codex":0.00032044042,"about_ca_topic_score_gemma":0.00003557235,"teacher_disagreement_score":0.060077045,"about_ca_system_score_codex":0.000012545649,"about_ca_system_score_gemma":0.00009449993,"threshold_uncertainty_score":0.9999931},"labels":[],"label_agreement":null},{"id":"W1193538218","doi":"10.1182/blood.v122.21.3044.3044","title":"A Phase II Study Of Cyclophosphamide, Etoposide, Vincristine and Prednisone (CEOP) Alternating With Pralatrexate (P) As Front Line Therapy For Patients With Peripheral T-Cell Lymphoma (PTCL): Preliminary Results From The T- Cell Consortium Trial","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Vincristine; Etoposide; Internal medicine; CHOP; Gastroenterology; Cyclophosphamide; Epirubicin; Prednisone; Peripheral T-cell lymphoma; Chemotherapy; Surgery; Oncology; Immunology; T cell","score_opus":0.009784853628099706,"score_gpt":0.2432115664098138,"score_spread":0.23342671278171412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1193538218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888212,0.001163182,0.0000064030355,0.0002668907,0.00008732701,0.00900386,0.0003188471,0.000049058883,0.00028325184],"genre_scores_gemma":[0.99581444,0.0001446213,0.0018522817,0.00015800216,0.00018385497,0.0011608396,0.0002684184,0.00006645722,0.00035108867],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99768156,0.00009835541,0.0007162906,0.0006560293,0.0004878102,0.0003599785],"domain_scores_gemma":[0.9977951,0.00047123551,0.0006288106,0.0005998022,0.00031989327,0.00018515617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014936173,0.00042572507,0.0006753117,0.000043474738,0.00025073567,0.00005786086,0.00015380516,0.00008628135,0.000035761903],"category_scores_gemma":[0.00006634436,0.00022821434,0.000086641536,0.00009568018,0.00010829452,0.00013028244,0.00008928985,0.00008319182,0.0000031241193],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.45581403,0.25079843,0.2607716,0.00008402999,0.0018921824,0.0001333044,0.010125086,0.000019318102,0.000785677,0.0000022594488,0.00075554097,0.018818518],"study_design_scores_gemma":[0.6783352,0.20091224,0.104638405,0.00016850981,0.001110927,0.00001274428,0.0007817312,0.00018098624,0.013465555,0.00001023922,0.00013328758,0.00025017076],"about_ca_topic_score_codex":0.004849246,"about_ca_topic_score_gemma":0.00009763433,"teacher_disagreement_score":0.22252116,"about_ca_system_score_codex":0.00005383057,"about_ca_system_score_gemma":0.00016915772,"threshold_uncertainty_score":0.93063104},"labels":[],"label_agreement":null},{"id":"W1198940312","doi":"10.1182/blood.v124.21.3703.3703","title":"Initial Results from a Phase 2 Study of Blinatumomab in Pediatric Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Blinatumomab; Medicine; Internal medicine; Refractory (planetary science); Minimal residual disease; Acute lymphocytic leukemia; Hematopoietic stem cell transplantation; Oncology; Salvage therapy; Phases of clinical research; Gastroenterology; Tumor lysis syndrome; Transplantation; Bone marrow; Leukemia; Chemotherapy; Lymphoblastic Leukemia","score_opus":0.009971044166260056,"score_gpt":0.26724872774041286,"score_spread":0.2572776835741528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1198940312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995991,0.000053832755,0.000059452635,0.000017660597,0.00013597484,0.0014695403,0.00027902567,0.00006914583,0.001924385],"genre_scores_gemma":[0.9984829,0.000016894528,0.00047821345,0.00004711989,0.00033642811,0.00007603827,0.00030619718,0.00008450718,0.0001717453],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99610883,0.00027478664,0.0009304304,0.0008047953,0.0012777568,0.0006034031],"domain_scores_gemma":[0.9969962,0.0010020182,0.00042046144,0.00088928663,0.00035797598,0.00033404893],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003810332,0.00038650905,0.000794568,0.0005882418,0.00006026066,0.000022866267,0.00036073022,0.00023684173,0.000036048008],"category_scores_gemma":[0.00094610034,0.0003083461,0.00007970057,0.00086075545,0.000108865235,0.00017433165,0.00018203005,0.000535516,0.000069111564],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09785002,0.21411805,0.6568772,0.0007837569,0.0016128839,0.0030659214,0.012907848,0.00015119642,0.003351977,0.000012177662,0.003129116,0.0061398176],"study_design_scores_gemma":[0.6726449,0.04058826,0.2752949,0.00028491823,0.003081201,0.00002290449,0.0003718461,0.0014956703,0.0054033333,0.000030250383,0.00014406316,0.0006377235],"about_ca_topic_score_codex":0.0003894078,"about_ca_topic_score_gemma":0.00008291771,"teacher_disagreement_score":0.5747949,"about_ca_system_score_codex":0.00055972487,"about_ca_system_score_gemma":0.0014383234,"threshold_uncertainty_score":0.9999369},"labels":[],"label_agreement":null},{"id":"W1219679791","doi":"10.1182/blood.v124.21.2592.2592","title":"Risk Factors for Poor Survival after Hematopoietic Stem Cell Transplantation in Inherited Bone Marrow Failure Syndromes","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Janeway Children's Health and Rehabilitation Centre; London Health Sciences Centre; McMaster University; University of Alberta; Centre hospitalier universitaire de Québec; Centre Hospitalier Universitaire de Sherbrooke; University of Saskatchewan; Hospital for Sick Children; Université de Montréal; CancerCare Manitoba; Princess Margaret Cancer Centre; Kingston General Hospital; University of Manitoba; Alberta Children's Hospital; Izaak Walton Killam Health Centre; Genome Canada; Children's Hospital of Eastern Ontario; BC Children's Hospital; Montreal Children's Hospital; University of Toronto; SickKids Foundation; Dalhousie University","funders":"","keywords":"Medicine; Cytopenia; Hematopoietic stem cell transplantation; Transplantation; Univariate analysis; Population; Pediatrics; Internal medicine; Proportional hazards model; Surgery; Bone marrow; Multivariate analysis","score_opus":0.013914643467913204,"score_gpt":0.24856435683270112,"score_spread":0.2346497133647879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1219679791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99752194,0.00017003919,0.0006477646,0.000398272,0.00006273628,0.0008244831,0.000100644735,0.00006711322,0.00020699928],"genre_scores_gemma":[0.99788016,0.00006744695,0.000971635,0.000059380513,0.00007283642,0.00014338919,0.00011392091,0.00005548624,0.0006357217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984506,0.00014772476,0.00032200565,0.00033614007,0.00033179662,0.00041177173],"domain_scores_gemma":[0.9990876,0.0003401829,0.000073618925,0.00026719432,0.000072476396,0.00015894482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041051512,0.00020255311,0.000415728,0.00021583501,0.000044639015,0.00002455987,0.00010083232,0.00018674467,0.000078181736],"category_scores_gemma":[0.00005664282,0.00017108694,0.00011765162,0.00025162645,0.000045620993,0.00008431547,0.000018949277,0.00031318655,0.00003753877],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001974536,0.0017605064,0.9289498,0.004601614,0.0003050855,0.00063732686,0.0075124865,0.00001806896,0.05204656,0.000093726754,0.0007299883,0.0013703511],"study_design_scores_gemma":[0.0464149,0.0020511753,0.7732046,0.00067455193,0.0014475087,0.0004852946,0.0035475998,0.0011393941,0.16674434,0.0002289017,0.003031992,0.0010297073],"about_ca_topic_score_codex":0.0001193491,"about_ca_topic_score_gemma":0.00018214404,"teacher_disagreement_score":0.1557451,"about_ca_system_score_codex":0.000069351794,"about_ca_system_score_gemma":0.000084328385,"threshold_uncertainty_score":0.69767225},"labels":[],"label_agreement":null},{"id":"W1223036000","doi":"10.1182/blood.v122.21.3546.3546","title":"Utility Of The Immature Platelet Fraction In Predicting Recovery With Or Without Treatment In Pediatric Immune Thrombocytopenia","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario; Hospital for Sick Children","funders":"","keywords":"Medicine; Internal medicine; Platelet; Hematology; Population; Pediatrics","score_opus":0.011491313879725257,"score_gpt":0.24125728436987454,"score_spread":0.22976597049014927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1223036000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99701536,0.00041614816,0.0000011770237,0.00013475222,0.000041667645,0.0011534625,0.000008131185,0.000016660753,0.0012126289],"genre_scores_gemma":[0.99913985,0.00029414933,0.00018733673,0.000023711611,0.00002559545,0.00007600401,0.000014708398,0.000014693437,0.0002239319],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991285,0.000044064953,0.00027424868,0.0002042666,0.0001554151,0.00019350779],"domain_scores_gemma":[0.99947304,0.000053173197,0.00013695947,0.00027199794,0.000030160363,0.000034691726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006951736,0.00015171383,0.00045766696,0.000081553495,0.000032802913,0.000009514828,0.00005681956,0.000103551385,0.0001073239],"category_scores_gemma":[0.000032956385,0.00007572743,0.000053867767,0.00032613848,0.000024046016,0.00013621959,0.000020914063,0.00016845558,0.000008480458],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006653111,0.0018512986,0.9945835,0.000053523025,0.000092072565,0.00008330143,0.00026770125,0.0000036123377,0.00042308675,4.3503627e-7,0.000012730056,0.0019634168],"study_design_scores_gemma":[0.0100352075,0.0006787411,0.9828368,0.00010011347,0.00018225743,0.00010825625,0.00022226454,0.000111388064,0.005600341,0.00003487277,0.000018145078,0.00007164009],"about_ca_topic_score_codex":0.0025079402,"about_ca_topic_score_gemma":0.0015490233,"teacher_disagreement_score":0.011746738,"about_ca_system_score_codex":0.00004764005,"about_ca_system_score_gemma":0.00013927007,"threshold_uncertainty_score":0.3791272},"labels":[],"label_agreement":null},{"id":"W1230104293","doi":"10.1182/blood.v96.9.3231","title":"Nonopsonic monocyte/macrophage phagocytosis of Plasmodium falciparum–parasitized erythrocytes: a role for CD36 in malarial clearance","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Malaria Research and Control","field":"Medicine","cited_by":260,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"CD36; Biology; Phagocytosis; MAPK/ERK pathway; Monocyte; Tyrosine phosphorylation; Cell biology; Scavenger receptor; Kinase; Immunology; Receptor; Biochemistry","score_opus":0.01303257456739245,"score_gpt":0.27681636229146384,"score_spread":0.2637837877240714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1230104293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914076,0.0015888041,0.00012575374,0.0008152934,0.00005229698,0.00167729,0.00009739024,0.00005748171,0.0041781114],"genre_scores_gemma":[0.9959475,0.00023971051,0.0013712987,0.00016995636,0.0002586329,0.00041651903,0.000025569745,0.000042541946,0.0015282977],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979072,0.000083288396,0.0005102719,0.00042890033,0.00036915226,0.0007011748],"domain_scores_gemma":[0.99897593,0.00016981515,0.0000893738,0.00043393893,0.00010064524,0.00023027697],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003654037,0.00023002441,0.0007010412,0.00017146526,0.000064637534,0.000026185096,0.00023293498,0.00019163171,0.0010034279],"category_scores_gemma":[0.00016585641,0.00021676048,0.0002552275,0.00030008363,0.00009262733,0.000111411515,0.000030263747,0.00028946245,0.00008953587],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18453641,0.019103816,0.025026636,0.0022944696,0.0028870478,0.00097473717,0.002621848,0.0005946804,0.6196972,0.004249817,0.0016237216,0.13638957],"study_design_scores_gemma":[0.26466084,0.0065543107,0.1557737,0.00080024975,0.0012453123,0.0002384823,0.00041319962,0.020221,0.5360142,0.0011011905,0.011877055,0.0011004852],"about_ca_topic_score_codex":0.00022630907,"about_ca_topic_score_gemma":0.00008258462,"teacher_disagreement_score":0.13528909,"about_ca_system_score_codex":0.00005511094,"about_ca_system_score_gemma":0.0002918678,"threshold_uncertainty_score":0.9999098},"labels":[],"label_agreement":null},{"id":"W129265093","doi":"10.1182/blood.v122.21.4025.4025","title":"Bosutinib As Therapy For Chronic Phase Chronic Myeloid Leukemia Following Failure With Imatinib Plus Dasatinib and/Or Nilotinib: 36-Month Update","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Bosutinib; Nilotinib; Dasatinib; Medicine; Internal medicine; Imatinib; Gastroenterology; Imatinib mesylate; Myeloid leukemia; Tyrosine-kinase inhibitor; Cancer","score_opus":0.014754208368096456,"score_gpt":0.2843805241773604,"score_spread":0.269626315809264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W129265093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857772,0.0045015,0.00024020115,0.0012080483,0.00018018064,0.0062559056,0.00007165917,0.0004282586,0.0013370367],"genre_scores_gemma":[0.9822891,0.0007658426,0.009703229,0.0007890338,0.00096833607,0.0021573424,0.0005108469,0.00028523017,0.0025310703],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99592954,0.00008727435,0.0008312164,0.0011811316,0.00066240795,0.001308458],"domain_scores_gemma":[0.9973436,0.00031977994,0.00040625024,0.0011758036,0.00017489826,0.0005796867],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034396126,0.00086883834,0.0012323787,0.00020182924,0.00039124535,0.00017498781,0.00035011265,0.0003318743,0.0014945763],"category_scores_gemma":[0.00016343378,0.0006083212,0.0003450972,0.00039391848,0.00020922272,0.00048331547,0.000116809606,0.0005064086,0.00037775908],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027380059,0.01576765,0.017505415,0.0072233747,0.028710946,0.0039078984,0.012724538,0.00026270893,0.2319655,0.0016700838,0.048317473,0.60456437],"study_design_scores_gemma":[0.7010741,0.049553085,0.0073265377,0.0032935485,0.0047466517,0.0030401882,0.00168376,0.007575487,0.11424727,0.00047903802,0.10364019,0.0033401456],"about_ca_topic_score_codex":0.00040737653,"about_ca_topic_score_gemma":0.00027375942,"teacher_disagreement_score":0.673694,"about_ca_system_score_codex":0.0022029395,"about_ca_system_score_gemma":0.0053332304,"threshold_uncertainty_score":0.9996368},"labels":[],"label_agreement":null},{"id":"W133568355","doi":"10.1182/blood-2010-10-305698","title":"Refractory anemia with ring sideroblasts masked by iron deficiency anemia","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Porphyrin Metabolism and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Anemia; Medicine; Sideroblastic anemia; Iron-deficiency anemia; Iron deficiency; Refractory anemia; Internal medicine; Myelodysplastic syndromes; Bone marrow","score_opus":0.0069992180484907416,"score_gpt":0.19540313560725658,"score_spread":0.18840391755876584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W133568355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97751397,0.0025284032,0.00025896102,0.000007846664,0.000046589725,0.00009634454,0.000012318437,0.00002673232,0.019508831],"genre_scores_gemma":[0.99775136,0.00019894511,0.0013467972,0.00013413634,0.000056825877,0.000012937983,0.000056918227,0.000026731022,0.00041537732],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990732,0.000027767483,0.00013876184,0.00034434046,0.00011906909,0.00029684478],"domain_scores_gemma":[0.99944055,0.0000038546273,0.00007374929,0.0003555021,0.000029218183,0.000097151365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007383556,0.00016768803,0.00011435305,0.000026467314,0.000067730696,0.000012672849,0.0001870527,0.00012578894,0.000056406414],"category_scores_gemma":[0.000022430308,0.00014364552,0.000039360326,0.000065031294,0.000079982434,0.000006318216,0.00006285603,0.00008424965,0.000022512037],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009677619,0.0005491139,0.01696977,0.000062515406,0.000010928492,0.000015874255,0.00017501821,0.0000035843902,0.9795447,0.000071837305,0.0016247525,0.0008751413],"study_design_scores_gemma":[0.00370123,0.0007794037,0.031320475,0.0000219613,0.00014601737,0.00007206703,0.0003118032,0.0000012147776,0.9541952,0.00009910239,0.008691934,0.0006595688],"about_ca_topic_score_codex":0.000054856115,"about_ca_topic_score_gemma":0.000023818086,"teacher_disagreement_score":0.025349466,"about_ca_system_score_codex":0.0000028039003,"about_ca_system_score_gemma":0.00004690249,"threshold_uncertainty_score":0.5857694},"labels":[],"label_agreement":null},{"id":"W135063420","doi":"10.1182/blood.v124.21.529.529","title":"First Clinical Results of a Randomized Phase 2 Dose-Response Study of SGI-110, a Novel Subcutaneous (SC) Hypomethylating Agent (HMA), in 102 Patients with Intermediate (Int) or High Risk (HR) Myelodysplastic Syndromes (MDS) or Chronic Myelomonocytic Leukemia (CMML)","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Decitabine; Medicine; Hypomethylating agent; Pharmacodynamics; Internal medicine; Adverse effect; Myelodysplastic syndromes; Phases of clinical research; Neutropenia; Pharmacokinetics; Clinical trial; Gastroenterology; Azacitidine; Febrile neutropenia; Oncology; Bone marrow; Chemotherapy; DNA methylation; Chemistry","score_opus":0.028520101506330022,"score_gpt":0.3203481299052177,"score_spread":0.2918280283988877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W135063420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934945,0.00012017841,0.00020566341,0.000059787617,0.00021730216,0.005561838,0.00021366347,0.000087546476,0.00003953124],"genre_scores_gemma":[0.99723095,0.00034561646,0.0013404188,0.000030253144,0.00017857064,0.00033158896,0.0000692622,0.00014669361,0.00032664466],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9898678,0.0024555111,0.003844493,0.0012325444,0.0015613281,0.0010382988],"domain_scores_gemma":[0.9770605,0.018461803,0.0019304372,0.0014291579,0.00057808857,0.0005399925],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.007043893,0.0007330202,0.0036734445,0.0010398994,0.00013714905,0.000039933104,0.0006853435,0.0003740376,0.00012341957],"category_scores_gemma":[0.038233384,0.00046411197,0.00038318217,0.00141815,0.0007968277,0.00015456225,0.00045941188,0.0013696317,0.00003514173],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95579994,0.01593166,0.011060407,0.00069471204,0.0023210126,0.0016415281,0.0033723295,0.00059042795,0.00066564087,0.0000024229398,0.00006897147,0.007850939],"study_design_scores_gemma":[0.8442381,0.0625397,0.07231345,0.0017995844,0.0025181016,0.0002523522,0.0004946368,0.014487131,0.0007585549,0.000007666842,0.000050516952,0.00054017286],"about_ca_topic_score_codex":0.0016196484,"about_ca_topic_score_gemma":0.0018389485,"teacher_disagreement_score":0.11156182,"about_ca_system_score_codex":0.0012249922,"about_ca_system_score_gemma":0.0026653865,"threshold_uncertainty_score":0.9997811},"labels":[],"label_agreement":null},{"id":"W137786602","doi":"10.1182/blood.v124.21.5567.5567","title":"Safety and Efficacy of Ruxolitinib Retreatment after Treatment Interruption in Patients Enrolled in an Open-Label, Multicenter, Expanded-Access Study in Myelofibrosis","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; St. Paul's Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Ruxolitinib; Medicine; Myelofibrosis; Tolerability; Adverse effect; Internal medicine; Discontinuation; Placebo; Phases of clinical research; Anemia; Surgery; Clinical trial; Gastroenterology; Bone marrow; Pathology","score_opus":0.04587728601097647,"score_gpt":0.3566049150287874,"score_spread":0.3107276290178109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W137786602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99539304,0.00008597604,0.0000011505144,0.00005932735,0.000043184373,0.0041534114,0.000024866258,0.000009915568,0.00022912447],"genre_scores_gemma":[0.99840164,0.00016172523,0.0002642366,0.000055425873,0.000019386673,0.0009597297,0.000080124286,0.00002624336,0.000031512664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977984,0.0003340942,0.00075249636,0.00059292075,0.000223954,0.00029816537],"domain_scores_gemma":[0.9990986,0.00015487679,0.00015069258,0.00039054002,0.00006263394,0.00014266685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002467246,0.00031880048,0.00084829505,0.00031429416,0.000029335752,0.00005225102,0.00011323393,0.000085837535,0.000061051454],"category_scores_gemma":[0.000070612135,0.00024027479,0.000033101518,0.00022963718,0.0000360817,0.000243034,0.00015670682,0.00009350219,0.000004788058],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071577774,0.088805586,0.89102226,0.000034204077,0.00013023084,0.00004574269,0.0030772055,0.000003265929,0.00009837315,0.0000073799406,4.964534e-7,0.009617469],"study_design_scores_gemma":[0.15522636,0.01480555,0.82739407,0.00037236884,0.00016075144,0.000001360513,0.00020034554,0.00006278227,0.0016193263,0.00000476212,0.000007705641,0.00014461663],"about_ca_topic_score_codex":0.0013080307,"about_ca_topic_score_gemma":0.006865361,"teacher_disagreement_score":0.14806859,"about_ca_system_score_codex":0.0002879758,"about_ca_system_score_gemma":0.000040765437,"threshold_uncertainty_score":0.9798122},"labels":[],"label_agreement":null},{"id":"W1433367056","doi":"10.1182/blood.v124.21.2292.2292","title":"Phase 1/2 Study in Pediatric Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Receiving Blinatumomab Treatment","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Blinatumomab; Medicine; Refractory (planetary science); Internal medicine; Cytokine release syndrome; Dosing; Hematopoietic stem cell transplantation; Clinical endpoint; Acute lymphocytic leukemia; Phases of clinical research; Bone marrow; Salvage therapy; Gastroenterology; Adverse effect; Transplantation; Toxicity; Oncology; Leukemia; Clinical trial; Chemotherapy; Lymphoblastic Leukemia; Immunotherapy; Cancer","score_opus":0.010931518863608592,"score_gpt":0.26903338613567696,"score_spread":0.25810186727206835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1433367056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99488026,0.0001438589,0.000070347494,0.00004131843,0.00016436547,0.0024241873,0.000028142931,0.00015733184,0.0020901905],"genre_scores_gemma":[0.99699104,0.000102003374,0.000628541,0.00008407223,0.0003278489,0.0002958332,0.00010832224,0.0001425912,0.0013197633],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.995849,0.00029816624,0.00069187686,0.0010060453,0.0011558925,0.0009989782],"domain_scores_gemma":[0.99734306,0.00064756547,0.0002708488,0.00096233306,0.00024778006,0.00052841834],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040784918,0.0005907162,0.00083344115,0.0006828795,0.00012082834,0.00005916844,0.00033354014,0.00023485342,0.00006368202],"category_scores_gemma":[0.00037412977,0.0004399415,0.00012319116,0.0008834136,0.00008716385,0.00022493045,0.0001452396,0.00045862835,0.0002251779],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059223236,0.1081183,0.8680808,0.0003316638,0.00091318204,0.0015702302,0.0027559944,0.00004569725,0.000809661,0.0000059271442,0.00074555585,0.010700683],"study_design_scores_gemma":[0.4777679,0.06928308,0.44119912,0.000237064,0.0052255457,0.000100974954,0.0002669705,0.0016334082,0.002472828,0.00001742963,0.00078267284,0.001012989],"about_ca_topic_score_codex":0.00012818462,"about_ca_topic_score_gemma":0.00007777558,"teacher_disagreement_score":0.4718456,"about_ca_system_score_codex":0.0027866627,"about_ca_system_score_gemma":0.0016501135,"threshold_uncertainty_score":0.9998052},"labels":[],"label_agreement":null},{"id":"W1440956116","doi":"10.1182/blood.v122.21.371.371","title":"A Phase III Study Of Enzastaurin In Patients With High-Risk Diffuse Large B Cell Lymphoma Following Response To Primary Treatment: The Prelude Trial","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Clinical endpoint; Diffuse large B-cell lymphoma; Rituximab; International Prognostic Index; Prednisone; Vincristine; Placebo; Surrogate endpoint; Phases of clinical research; Oncology; Cyclophosphamide; Lymphoma; Surgery; Clinical trial; Chemotherapy; Pathology","score_opus":0.007121130264520015,"score_gpt":0.23569982298567893,"score_spread":0.2285786927211589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1440956116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99298054,0.00009743372,8.115189e-7,0.000066525194,0.00006999871,0.0066160103,0.00005127817,0.000028568558,0.00008882452],"genre_scores_gemma":[0.9981964,0.000009326747,0.00009535366,0.00008300208,0.000041991632,0.0013537963,0.000029578308,0.000033064287,0.00015746079],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9981691,0.00027953403,0.00042261512,0.0003680294,0.00042266332,0.0003380106],"domain_scores_gemma":[0.99871904,0.00028212738,0.0001585635,0.0006301433,0.00004993534,0.0001602233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021535018,0.00026503086,0.000558183,0.00014907376,0.000092057424,0.000025446838,0.00011033205,0.000055165063,0.000021148144],"category_scores_gemma":[0.000053734766,0.0001424213,0.00012323036,0.00026425652,0.000016012964,0.00007936871,0.00006548073,0.00004328281,0.000023685154],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10224705,0.4366467,0.45126122,0.000010612339,0.00063053553,0.00013832463,0.0047937557,9.347149e-7,0.00016007407,0.0000012275311,0.000042681033,0.004066893],"study_design_scores_gemma":[0.5123239,0.031139756,0.4534957,0.000037439044,0.00074128,7.585077e-7,0.0003542578,0.000001001899,0.0017715391,0.0000012000013,0.000052000574,0.000081128455],"about_ca_topic_score_codex":0.001965461,"about_ca_topic_score_gemma":0.00014986061,"teacher_disagreement_score":0.4100769,"about_ca_system_score_codex":0.00022455274,"about_ca_system_score_gemma":0.00014394458,"threshold_uncertainty_score":0.58077717},"labels":[],"label_agreement":null},{"id":"W14419551","doi":"10.1182/blood.v122.21.1804.1804","title":"The Use Of GDP (Gemcitabine, Dexamethasone and Cisplatin) in The Primary Therapy Of Peripheral T-Cell Lymphomas","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; CHOP; Gemcitabine; Oncology; Chemotherapy regimen; Anaplastic large-cell lymphoma; Population; Lymphoma; Chemotherapy; Gastroenterology","score_opus":0.025607020485965522,"score_gpt":0.22883328315955528,"score_spread":0.20322626267358976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W14419551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99232006,0.005355841,0.000001316477,0.00059601775,0.000021282254,0.00061773026,0.0000071576837,0.0000052992323,0.0010753103],"genre_scores_gemma":[0.9954043,0.0029384033,0.0009977367,0.00033248254,0.000025040836,0.00009748752,0.000005511517,0.000010893409,0.00018813535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991857,0.0000781444,0.00025093427,0.00013086553,0.00020255503,0.00015181203],"domain_scores_gemma":[0.9989456,0.0005308347,0.000099880664,0.00033015365,0.00005635472,0.00003720832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015018944,0.00011457744,0.0002418428,0.000030178793,0.000041560656,0.000023864535,0.000081379534,0.00004736895,0.000037182825],"category_scores_gemma":[0.000039461833,0.000053345724,0.000066804074,0.00012124485,0.00011838377,0.00006959004,0.000024629438,0.000044351393,0.0000025582542],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015684581,0.0040567773,0.9289181,0.00006684817,0.00019623728,0.000022192717,0.0015463929,0.0000020549342,0.018716514,0.00025048523,0.0011758936,0.044891655],"study_design_scores_gemma":[0.009470174,0.0005294819,0.9704884,0.000044329252,0.00007491196,0.00003626823,0.0001702804,0.000028959743,0.016793208,0.00006536343,0.0022380978,0.00006048731],"about_ca_topic_score_codex":0.0008650238,"about_ca_topic_score_gemma":0.00003643787,"teacher_disagreement_score":0.044831168,"about_ca_system_score_codex":0.000019429703,"about_ca_system_score_gemma":0.00006065759,"threshold_uncertainty_score":0.21753755},"labels":[],"label_agreement":null},{"id":"W144797469","doi":"10.1182/blood.v122.21.1810.1810","title":"Safety Profile and Clinical Response To MEDI-551, a Humanized Monoclonal Anti-CD19, In a Phase 1/2 Study In Adults With Relapsed Or Refractory Advanced B-Cell Malignancies","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Neutropenia; Internal medicine; Adverse effect; Refractory (planetary science); Toxicity; Phases of clinical research; Gastroenterology; Oncology","score_opus":0.02333358448421981,"score_gpt":0.3469080447660509,"score_spread":0.3235744602818311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W144797469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99396557,0.00020636964,0.000003645536,0.00037455617,0.000044317436,0.0051714075,0.000015775788,0.00005889345,0.00015946548],"genre_scores_gemma":[0.99530697,0.00011311973,0.002451346,0.00018201518,0.000069080634,0.0005570101,0.000015201596,0.000057598794,0.0012476479],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99634033,0.000566695,0.00096011354,0.0008084999,0.0006832188,0.0006411244],"domain_scores_gemma":[0.9974113,0.0011532771,0.00013973375,0.00066752,0.00020274604,0.00042544169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017557933,0.00029673142,0.0008464825,0.00036715783,0.00006113449,0.000028578386,0.00020874175,0.00017546375,0.00025765324],"category_scores_gemma":[0.0019634701,0.00020848855,0.000052339787,0.0006686355,0.00017858452,0.00018893443,0.00019320592,0.00056183944,0.000083595274],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.60345,0.09703947,0.16900648,0.001161891,0.00047806776,0.01858774,0.022258397,0.000010614001,0.07339534,0.00000798765,0.0011408621,0.013463145],"study_design_scores_gemma":[0.66986066,0.022088047,0.2964875,0.0013929704,0.00012492936,0.00023039742,0.0049997997,0.00091981277,0.0030327146,0.000004422742,0.00041927918,0.0004394748],"about_ca_topic_score_codex":0.00090797583,"about_ca_topic_score_gemma":0.0012442421,"teacher_disagreement_score":0.12748103,"about_ca_system_score_codex":0.0014399706,"about_ca_system_score_gemma":0.0047947927,"threshold_uncertainty_score":0.8505757},"labels":[],"label_agreement":null},{"id":"W1448065076","doi":"10.1182/blood.v122.21.498.498","title":"Phase 1b Study Of The MDM2 Antagonist RG7112 In Combination With 2 Doses/Schedules Of Cytarabine","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pharmacodynamics; Cytarabine; Internal medicine; Rash; Phases of clinical research; Pharmacokinetics; Refractory (planetary science); Pharmacology; Gastroenterology; Clinical trial; Oncology; Leukemia; Biology","score_opus":0.009994532846563625,"score_gpt":0.25194599873574547,"score_spread":0.24195146588918184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1448065076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977992,0.00016808984,0.00002478785,0.00019507483,0.00005380064,0.0011879212,0.000006079114,0.000013592153,0.0005514264],"genre_scores_gemma":[0.9996665,0.00000976571,0.00015863392,0.000029617098,0.000014190097,0.000048062135,0.000008896376,0.000016702406,0.000047620255],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991352,0.000053254273,0.00026743155,0.00014864342,0.0002796343,0.00011582965],"domain_scores_gemma":[0.9992875,0.000021139078,0.00015203953,0.00037323716,0.00012869289,0.000037415408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010232883,0.00009864811,0.0002459464,0.000083767605,0.000022427677,0.000004899373,0.00009440008,0.000047862362,0.000034554498],"category_scores_gemma":[0.00004387857,0.00006476501,0.000037916045,0.0003253362,0.00007695185,0.00004260831,0.00003324914,0.00014692968,0.000004178177],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007119994,0.121346876,0.16736206,0.0003206046,0.00058516243,0.00007747323,0.003580314,0.00004924673,0.7018059,0.0006830186,0.00015178887,0.0033255464],"study_design_scores_gemma":[0.14196984,0.0113031035,0.22037259,0.00045304184,0.0006956694,0.00005664678,0.0022844041,0.00026027832,0.6221894,0.00013101553,0.000089883586,0.00019411248],"about_ca_topic_score_codex":0.0005236201,"about_ca_topic_score_gemma":0.00022276433,"teacher_disagreement_score":0.14125784,"about_ca_system_score_codex":0.000023804854,"about_ca_system_score_gemma":0.00008819828,"threshold_uncertainty_score":0.26410404},"labels":[],"label_agreement":null},{"id":"W1453424702","doi":"10.1182/blood.v124.21.1681.1681","title":"CD28 Mutations in Peripheral T-Cell Lymphomagenesis and Progression","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Cancer research; RHOA; Biology; Lymphoma; Mutation; T-cell lymphoma; T cell; Molecular biology; Genetics; Immunology; Gene; Signal transduction; Immune system","score_opus":0.007615652848479673,"score_gpt":0.2514435641624953,"score_spread":0.24382791131401563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1453424702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934165,0.00080851896,0.0000058282953,0.00031644155,0.00002331736,0.0001858663,0.0000015458855,0.000025540225,0.005216454],"genre_scores_gemma":[0.99795645,0.00006257796,0.0015227256,0.00011691986,0.00004390571,0.00007283264,0.000013809189,0.000009110879,0.00020168557],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995305,0.000022107608,0.00009908392,0.00014764287,0.000087117085,0.00011355224],"domain_scores_gemma":[0.9997484,0.000030141433,0.00002259528,0.00010994549,0.000015793632,0.00007313934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000049728253,0.000074586795,0.00012319376,0.000043795397,0.000037083188,0.000013483514,0.000017516195,0.000037636197,0.000029707093],"category_scores_gemma":[0.000018341381,0.000055942586,0.000026188129,0.00006963448,0.00002412847,0.000028113409,0.000014898007,0.000017710632,0.000014259465],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017614899,0.0020460924,0.9618015,0.00003558136,0.00001849282,0.000060961484,0.00024887337,8.909861e-7,0.002679637,0.000082125,0.000054996446,0.032953218],"study_design_scores_gemma":[0.009871355,0.0003300445,0.96098727,0.000071821065,0.00013391602,0.00006252507,0.00004500662,0.0001309502,0.027153429,0.00005202005,0.0010883318,0.0000733377],"about_ca_topic_score_codex":0.000039987597,"about_ca_topic_score_gemma":0.000016152815,"teacher_disagreement_score":0.032879878,"about_ca_system_score_codex":0.000025670988,"about_ca_system_score_gemma":0.000031193853,"threshold_uncertainty_score":0.22812724},"labels":[],"label_agreement":null},{"id":"W1483128131","doi":"10.1182/blood-2010-10-311589","title":"Ischemic neurons prevent vascular regeneration of neural tissue by secreting semaphorin 3A","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Axon Guidance and Neuronal Signaling","field":"Neuroscience","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital; Hôpital Maisonneuve-Rosemont; Université de Montréal; McGill University; Centre Hospitalier Universitaire Sainte-Justine","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Eye Institute; Canadian Institutes of Health Research","keywords":"Semaphorin; Regeneration (biology); Neuroscience; Anatomy; Medicine; Biology; Cell biology; Internal medicine; Receptor","score_opus":0.03435868705684566,"score_gpt":0.24239795028343972,"score_spread":0.20803926322659405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1483128131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99661094,0.00031566093,0.0003275905,0.00003813526,0.00016137816,0.00019136202,0.000008107158,0.000056339122,0.0022904607],"genre_scores_gemma":[0.9990761,0.00008037448,0.00021158479,0.00021549477,0.0001091153,0.000016344258,0.0000033773533,0.00002359652,0.00026399197],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99871755,0.00012589314,0.00028659386,0.00036645035,0.00026457084,0.00023894632],"domain_scores_gemma":[0.99944115,0.000058645062,0.00015026273,0.00025762565,0.000021490609,0.00007083026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012817813,0.00013768957,0.00015400458,0.000038699633,0.00009536318,0.000012345568,0.00022815986,0.000051221,0.00009268413],"category_scores_gemma":[0.0001553523,0.00013415769,0.00007318434,0.00017334086,0.00005134487,0.00014303059,0.00007025353,0.00014641607,0.000020497579],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000076095444,0.00020718176,0.00031563177,0.00001964644,0.000004368102,0.000013705945,0.00020050314,0.000016740087,0.998221,0.00009973905,0.0004600301,0.00043383974],"study_design_scores_gemma":[0.00033601362,0.00015483449,0.0001456676,0.000020045534,0.000036626134,0.000019629906,0.0000132052,0.00020790483,0.9970162,0.000031156564,0.0018922661,0.00012648538],"about_ca_topic_score_codex":0.000029616884,"about_ca_topic_score_gemma":0.0000015379744,"teacher_disagreement_score":0.0024651545,"about_ca_system_score_codex":0.000005703109,"about_ca_system_score_gemma":0.000019421652,"threshold_uncertainty_score":0.54707915},"labels":[],"label_agreement":null},{"id":"W1485363977","doi":"10.1182/blood.v96.4.1215","title":"A ligand-receptor signaling threshold model of stem cell differentiation control: a biologically conserved mechanism applicable to hematopoiesis","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Heart, Lung, and Blood Institute","keywords":"Stem cell; Biology; Haematopoiesis; Cell biology; Stem cell factor; Cytokine receptor; Receptor; Cellular differentiation; Hematopoietic stem cell; Signal transduction; Genetics","score_opus":0.022822231727038473,"score_gpt":0.2298372486206451,"score_spread":0.20701501689360663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1485363977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98708683,0.000073485215,0.01051772,0.00024138672,0.00002875745,0.0005905721,0.000090644826,0.00009353342,0.0012770831],"genre_scores_gemma":[0.99657255,0.000017286793,0.0020696355,0.00046550462,0.00006269617,0.00010111005,0.000023474959,0.000022432412,0.0006653241],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988846,0.000021578382,0.0004072141,0.0002792635,0.00018464899,0.00022269278],"domain_scores_gemma":[0.99931896,0.00006920387,0.00010408874,0.0002465361,0.000119904355,0.00014130784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001272106,0.00016690679,0.00043476114,0.0000824727,0.00007238182,0.00001957667,0.000094763695,0.000108940636,0.0006654276],"category_scores_gemma":[0.000008371903,0.00013332262,0.00017375978,0.0001400565,0.000019321309,0.000039730872,0.000018914561,0.00012547414,0.000077921555],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024155452,0.0008987631,0.00030137214,0.00006358123,0.00009021896,0.000001997365,0.00020129242,0.0008279893,0.99647146,0.0006319677,0.00011783982,0.00015196452],"study_design_scores_gemma":[0.0031298138,0.0005291233,0.00005287376,0.00013728115,0.00026343678,0.000009240468,0.00008810907,0.010002506,0.98516583,0.00036856713,0.00011036761,0.00014282379],"about_ca_topic_score_codex":0.000025684663,"about_ca_topic_score_gemma":0.0000023093764,"teacher_disagreement_score":0.011305602,"about_ca_system_score_codex":0.000016669755,"about_ca_system_score_gemma":0.000050321258,"threshold_uncertainty_score":0.72859657},"labels":[],"label_agreement":null},{"id":"W1494739393","doi":"10.1182/blood.v96.12.3991","title":"Polyclonal hematopoiesis with variable telomere shortening in human long-term allogeneic marrow graft recipients","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Biology; Haematopoiesis; Fluorescence in situ hybridization; Variable number tandem repeat; Polyclonal antibodies; Transplantation; Immunology; Molecular biology; Telomere; Bone marrow; Hematopoietic stem cell transplantation; Granulocyte; Stem cell; Pathology; Andrology; Internal medicine; Genetics; Chromosome; Antibody; Medicine; DNA; Genotype; Gene","score_opus":0.011656022124765372,"score_gpt":0.245932902442782,"score_spread":0.2342768803180166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1494739393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99319303,0.0007050551,0.000022602382,0.00010226368,0.000061989245,0.00040091752,0.000012522721,0.0001288131,0.0053727846],"genre_scores_gemma":[0.9933573,0.00007616645,0.0024635743,0.0003498562,0.00017686034,0.000048487094,0.00008265469,0.00006490629,0.003380214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976807,0.00005633814,0.00046198105,0.00060499733,0.00051406934,0.0006819006],"domain_scores_gemma":[0.9989821,0.000041551946,0.000081024424,0.0005489821,0.00006324379,0.00028311927],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020010196,0.0003404089,0.0005548419,0.00025568844,0.00016862675,0.000041970772,0.00022715717,0.00016979591,0.002295768],"category_scores_gemma":[0.00001503873,0.00028986094,0.00008992244,0.00063738116,0.00012926623,0.00015167128,0.000039053186,0.00032960417,0.000068732035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002549413,0.0012942217,0.96526664,0.00012096508,0.00017349703,0.0011076337,0.00028280608,0.0000073308915,0.02675045,0.000082767154,0.000088047644,0.0045707207],"study_design_scores_gemma":[0.0060955933,0.00054006657,0.97063756,0.00074042485,0.00034655258,0.0012759471,0.00006854396,0.000013705904,0.01921456,0.00005937104,0.00046206103,0.0005456188],"about_ca_topic_score_codex":0.00024138423,"about_ca_topic_score_gemma":0.00024492372,"teacher_disagreement_score":0.0075358893,"about_ca_system_score_codex":0.000057746944,"about_ca_system_score_gemma":0.00011876547,"threshold_uncertainty_score":0.99995536},"labels":[],"label_agreement":null},{"id":"W1496335343","doi":"10.1182/blood.v96.3.966","title":"Induction of monocyte tissue factor expression by homocysteine: a possible mechanism for thrombosis","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Homocysteine; Tissue factor; Monocyte; Methionine; Cysteine; Chemistry; Biochemistry; Internal medicine; Endocrinology; Biology; Immunology; Medicine; Enzyme; Amino acid; Coagulation","score_opus":0.03315290073987471,"score_gpt":0.31976667652455465,"score_spread":0.28661377578467995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1496335343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976253,0.00037344245,0.00016234304,0.00014654729,0.000037802554,0.0005515262,0.00006912146,0.0000378386,0.0009961103],"genre_scores_gemma":[0.99283785,0.00031004226,0.001376612,0.000032656648,0.000097742835,0.00005549095,0.00004685939,0.000022850882,0.005219909],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99914855,0.00001939141,0.00018641041,0.00019784128,0.00023848175,0.00020932977],"domain_scores_gemma":[0.9995112,0.000025164618,0.000039432503,0.00023171927,0.00010066411,0.00009186351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000064506195,0.000101557336,0.00022838298,0.00007810487,0.00005706293,0.000010771798,0.00007401327,0.00012874855,0.00058241637],"category_scores_gemma":[0.000025073949,0.00008005244,0.00006404343,0.00014503414,0.000024348254,0.000092969654,0.000016367017,0.00009845635,0.000035991787],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000101496924,0.0005654247,0.00022319233,0.00012646415,0.000060324182,0.0000024450535,0.00016226165,1.4739466e-7,0.9852644,0.000031046053,0.0011452954,0.012317476],"study_design_scores_gemma":[0.0032359336,0.0011980404,0.0010071142,0.0001056725,0.00008322085,0.000015223235,0.00006760768,0.000038468806,0.9924656,0.00013402,0.0015671615,0.00008190765],"about_ca_topic_score_codex":0.000114726536,"about_ca_topic_score_gemma":0.0000029209527,"teacher_disagreement_score":0.012235568,"about_ca_system_score_codex":0.000015884756,"about_ca_system_score_gemma":0.0000411063,"threshold_uncertainty_score":0.6377051},"labels":[],"label_agreement":null},{"id":"W149751534","doi":"10.1182/blood.v122.21.1809.1809","title":"Three-Year Survival Results From An Ongoing Phase 2 Study Of Brentuximab Vedotin In Patients With Relapsed Or Refractory Systemic Anaplastic Large Cell Lymphoma","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Brentuximab vedotin; Medicine; Internal medicine; Anaplastic large-cell lymphoma; Oncology; Population; Phases of clinical research; Antibody-drug conjugate; Refractory (planetary science); CD30; Lymphoma; Surgery; Clinical trial; Immunology; Antibody","score_opus":0.011728922263416437,"score_gpt":0.24269242626078552,"score_spread":0.2309635039973691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W149751534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977923,0.00007848407,0.0000024117815,0.000009769935,0.00011304003,0.0015800998,0.00022464285,0.000043873526,0.00015535705],"genre_scores_gemma":[0.999332,0.0000073890733,0.00012851394,0.000015760634,0.000057250058,0.000094739604,0.0003005575,0.000041207033,0.000022546785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794954,0.00011420183,0.0005983559,0.0005095225,0.0005004155,0.0003279931],"domain_scores_gemma":[0.99850494,0.0002471433,0.00028818563,0.000634421,0.00014451017,0.00018083052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014735824,0.00025735094,0.000595114,0.00014496589,0.00005053797,0.000023824734,0.00011943773,0.00009077024,0.000054403245],"category_scores_gemma":[0.000089886475,0.00017203673,0.000045744673,0.00023208349,0.000022389948,0.00015208338,0.00004774845,0.00007837012,0.000048227117],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049138097,0.14142808,0.8505549,0.00006067159,0.00023992555,0.00018127813,0.0013250917,0.0000019677425,0.00013520647,0.0000016003613,0.00004925778,0.0011082387],"study_design_scores_gemma":[0.27544987,0.013687498,0.70829344,0.00035219692,0.0003853167,0.0000025889267,0.0012104308,0.00005973186,0.0004067046,0.000001401633,0.0000073245005,0.00014351324],"about_ca_topic_score_codex":0.003383907,"about_ca_topic_score_gemma":0.0021508147,"teacher_disagreement_score":0.27053604,"about_ca_system_score_codex":0.00013581413,"about_ca_system_score_gemma":0.00015610932,"threshold_uncertainty_score":0.7015454},"labels":[],"label_agreement":null},{"id":"W1504351773","doi":"10.1182/blood.v95.3.943.003k34_943_951","title":"Proteolytic processing of human coagulation factor IX by plasmin","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Plasmin; Factor IXa; Factor IX; Chemistry; Biochemistry; Fibrin; Molecular biology; Thrombin; Proteolysis; Gel electrophoresis; Activator (genetics); Enzyme; Factor X; Biology; Platelet; Immunology","score_opus":0.024431540695204857,"score_gpt":0.28127228463298043,"score_spread":0.25684074393777556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1504351773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99494743,0.00014332942,0.00010951217,0.000105827145,0.000015590542,0.00043360103,0.0000086550235,0.00007899227,0.004157053],"genre_scores_gemma":[0.997482,0.00000384614,0.00049099594,0.00008803755,0.0000375661,0.000018207726,0.00003856711,0.00002041431,0.001820338],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99915147,0.000019675232,0.00026198686,0.00017398817,0.00025075502,0.00014215278],"domain_scores_gemma":[0.9996179,0.00000860839,0.00008941748,0.00016398722,0.000057306937,0.000062827356],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00005965458,0.0001082195,0.00023107698,0.000054867687,0.000067893954,0.0000121315825,0.000049585527,0.000088450106,0.0013679995],"category_scores_gemma":[0.00001162562,0.000098415236,0.000051137366,0.00014245002,0.000033066226,0.000077280834,0.000007281783,0.000084078594,0.000036657973],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037866343,0.0013483978,0.005682007,0.0002200177,0.00006848404,0.000003242945,0.00046503654,0.0000024698236,0.9671892,0.00025780645,0.00011920921,0.024606267],"study_design_scores_gemma":[0.0046086013,0.0005345975,0.038653985,0.00023286269,0.00024093369,0.000021526306,0.000041787007,0.00037663605,0.9540765,0.00033396552,0.00071224244,0.00016635109],"about_ca_topic_score_codex":0.000013461054,"about_ca_topic_score_gemma":0.0000016984527,"teacher_disagreement_score":0.03297198,"about_ca_system_score_codex":0.000010116043,"about_ca_system_score_gemma":0.000040794454,"threshold_uncertainty_score":0.99954486},"labels":[],"label_agreement":null},{"id":"W1510734879","doi":"10.1182/blood.v96.8.2803","title":"A partial deficiency of interleukin-7Rα is sufficient to abrogate T-cell development and cause severe combined immunodeficiency","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":174,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Severe combined immunodeficiency; Biology; T cell; Missense mutation; Lymphopoiesis; Immunology; CD8; Immunodeficiency; Phenotype; Cell biology; Progenitor cell; Immune system; Stem cell; Genetics; In vivo; Gene","score_opus":0.007364937601120065,"score_gpt":0.20652808685563065,"score_spread":0.1991631492545106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1510734879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9795826,0.014440605,0.00003619322,0.0000904958,0.00024761143,0.00041007844,0.000032115826,0.00007969731,0.005080606],"genre_scores_gemma":[0.9963192,0.0001228546,0.0001021993,0.00024990996,0.0000018137739,0.000038808077,0.000031294298,0.00002580507,0.0031081638],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977812,0.00010474486,0.0007439763,0.00055533386,0.00009819333,0.00071654184],"domain_scores_gemma":[0.99917245,0.00006011342,0.00015064362,0.0005061458,0.00008556818,0.000025102201],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00032148167,0.00034832733,0.00046036782,0.00018540803,0.00039356996,0.000030409563,0.0004698271,0.00020091783,0.00137889],"category_scores_gemma":[0.000027420425,0.00032390337,0.00011409816,0.00041545113,0.00028115013,0.00009524933,0.00017064059,0.00026538048,0.00079258275],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014055497,0.016287496,0.009887207,0.0003408605,0.0005578246,0.000035996003,0.09000373,0.00020406925,0.8032138,0.0013615886,0.0006049792,0.07609695],"study_design_scores_gemma":[0.012296723,0.0018575741,0.026317302,0.00024286288,0.0003127461,0.0002184099,0.0042971675,0.000019697482,0.88743275,0.000050831557,0.065617315,0.00133661],"about_ca_topic_score_codex":0.00013443174,"about_ca_topic_score_gemma":0.0000036168876,"teacher_disagreement_score":0.08570656,"about_ca_system_score_codex":0.000026279784,"about_ca_system_score_gemma":0.00016393761,"threshold_uncertainty_score":0.9999854},"labels":[],"label_agreement":null},{"id":"W1510842546","doi":"10.1182/blood.v96.13.4142","title":"Stromal-derived factor 1 and thrombopoietin regulate distinct aspects of human megakaryopoiesis","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Alberta","funders":"National Heart, Lung, and Blood Institute","keywords":"Cell biology; MAPK/ERK pathway; Biology; Matrigel; Protein kinase B; Thrombopoietin; Stromal cell; Angiogenesis; Signal transduction; Chemistry; Cancer research; Stem cell; Haematopoiesis","score_opus":0.013051069098412218,"score_gpt":0.24986517615116782,"score_spread":0.2368141070527556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1510842546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810219,0.00036628236,4.729791e-7,0.00012102031,0.000011521556,0.00020563339,0.00004224937,0.00004497979,0.018185968],"genre_scores_gemma":[0.99888057,0.00007135446,0.00016793383,0.000024002084,0.000024127761,0.0000056291387,0.00004173644,0.000018778774,0.0007658988],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99925303,0.00001758334,0.00018418553,0.00021419898,0.0001482027,0.00018280518],"domain_scores_gemma":[0.9995911,0.00002142172,0.00005387973,0.00021280306,0.000023400033,0.00009736405],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000025317211,0.00014531995,0.0003664928,0.000038360035,0.00007102138,0.000009102073,0.00004309734,0.00006266217,0.0011303347],"category_scores_gemma":[0.000011837865,0.000116834926,0.00006469434,0.00007400378,0.00008981028,0.00004300139,0.000016519078,0.00006266682,0.000017639157],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055659324,0.0088453395,0.4139604,0.00055212405,0.0029518495,0.0022250884,0.0023897395,7.612897e-7,0.5444461,0.00077247125,0.0005220858,0.022777421],"study_design_scores_gemma":[0.0065016425,0.00076156843,0.9261041,0.00008746422,0.00039460915,0.00011452091,0.00004958157,0.000003305617,0.06498038,0.00075029174,0.0001206261,0.00013188651],"about_ca_topic_score_codex":0.00010285141,"about_ca_topic_score_gemma":0.000034525234,"teacher_disagreement_score":0.51214373,"about_ca_system_score_codex":0.000008115321,"about_ca_system_score_gemma":0.000019896679,"threshold_uncertainty_score":0.99978274},"labels":[],"label_agreement":null},{"id":"W1513801843","doi":"10.1182/blood.v106.11.5252.5252","title":"A Novel Suicide Gene Therapy Approach for Reduction of GvHD Using Lentiviral Delivery of a Modified Human Thymidylate Monophosphate Kinase.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Suicide gene; Thymidine kinase; Genetic enhancement; Ganciclovir; Viral vector; Biology; Human cytomegalovirus; Virology; Gene delivery; Cancer research; Immunology; Herpes simplex virus; Virus; Gene; Genetics","score_opus":0.057855833018277375,"score_gpt":0.31061725057627515,"score_spread":0.25276141755799775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1513801843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915315,0.003332413,0.004416584,0.00001313054,0.00002596959,0.0005166498,0.00006040478,0.000008137719,0.0000952383],"genre_scores_gemma":[0.98785824,0.00029104407,0.011363627,0.000022386881,0.00018211719,0.00004406224,0.000115510506,0.000038762777,0.00008423401],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988935,0.00004520559,0.00030014318,0.00032809225,0.00016252958,0.00027053157],"domain_scores_gemma":[0.9992419,0.000006889047,0.0001675516,0.00037124183,0.00016673454,0.00004566511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028201056,0.0001584031,0.00021567936,0.00008028264,0.00007453381,0.000009442869,0.00020635543,0.00013236167,0.0000071399218],"category_scores_gemma":[0.000009990835,0.00015776325,0.00016928755,0.000104829625,0.0001042584,0.0000077286195,0.000051302064,0.00006410742,2.77706e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015575318,0.001024497,0.000108578046,0.000032891367,0.00023098492,2.3814393e-7,0.000066001165,0.004170434,0.9882877,0.000012490202,0.000008456682,0.004500191],"study_design_scores_gemma":[0.004350846,0.0016140279,0.0001922551,0.0000067928654,0.000041171083,0.0000066104003,0.00003104286,0.0015803186,0.9919681,0.000024597843,0.000031425687,0.00015279622],"about_ca_topic_score_codex":0.00009011382,"about_ca_topic_score_gemma":0.000011849537,"teacher_disagreement_score":0.0069470434,"about_ca_system_score_codex":0.000013510832,"about_ca_system_score_gemma":0.000091823276,"threshold_uncertainty_score":0.6433399},"labels":[],"label_agreement":null},{"id":"W151976266","doi":"10.1182/blood.v122.21.798.798","title":"UM171 Is a Novel and Potent Agonist Of Human Hematopoietic Stem Cell Renewal","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hôpital Maisonneuve-Rosemont; Université de Montréal","funders":"","keywords":"Haematopoiesis; Stem cell; Ex vivo; Cord blood; CD38; CD34; Cell biology; Population; Hematopoietic stem cell; Chemistry; In vivo; Biology; Pharmacology; Molecular biology; In vitro; Immunology; Biochemistry; Medicine; Genetics","score_opus":0.01777123086595692,"score_gpt":0.2412776138372342,"score_spread":0.22350638297127728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W151976266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99008965,0.00026493077,0.00020357208,0.00031684787,0.00003324076,0.00046664462,0.000013247718,0.00003523892,0.008576619],"genre_scores_gemma":[0.9971506,0.000032834505,0.0012830166,0.00014757241,0.000035740246,0.000026004427,0.000012781636,0.00002423392,0.0012872169],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989683,0.000014881353,0.0003472168,0.00022881021,0.0002520944,0.00018866877],"domain_scores_gemma":[0.99936235,0.000037826336,0.00010009152,0.00027864872,0.000079615915,0.00014147005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000088076435,0.0001393832,0.0003026073,0.00006810206,0.000050384497,0.00001743534,0.00006018051,0.000091205635,0.00016973556],"category_scores_gemma":[0.0000024726605,0.00012218166,0.000064995314,0.00008822332,0.00007122669,0.00004017789,0.000019806965,0.000083684594,0.0000541805],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012195152,0.0008607857,0.011198648,0.0015788348,0.000067662746,0.000018535227,0.0031359126,1.3533366e-7,0.9824383,0.00031605284,0.0002046418,0.00016826195],"study_design_scores_gemma":[0.0055899858,0.00040356666,0.021201158,0.0003895465,0.0004611445,0.00036417932,0.0008680408,0.000022485532,0.9702718,0.00019075308,0.000062539395,0.00017477335],"about_ca_topic_score_codex":0.00016466928,"about_ca_topic_score_gemma":0.000004120936,"teacher_disagreement_score":0.012166507,"about_ca_system_score_codex":0.000009472937,"about_ca_system_score_gemma":0.000037137943,"threshold_uncertainty_score":0.49824235},"labels":[],"label_agreement":null},{"id":"W1520664789","doi":"10.1182/blood.v95.8.2645","title":"Abundance of cyclin B1 regulates γ-radiation–induced apoptosis","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":144,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Hamilton Regional Laboratory Medicine Program; McMaster University Medical Centre","funders":"","keywords":"Cyclin A; Cyclin A2; Cyclin B1; Cyclin B; Cyclin D; Cell biology; Biology; Cyclin; Cyclin E; Cell cycle; Apoptosis; DNA damage; Cyclin-dependent kinase; Cancer research; Molecular biology; Cyclin-dependent kinase 1; Biochemistry; DNA","score_opus":0.009681910381166746,"score_gpt":0.23823523375574007,"score_spread":0.22855332337457332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1520664789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877706,0.0010434804,0.00001171458,0.00036546707,0.000083585364,0.00025066227,0.000010769502,0.00007519486,0.010388525],"genre_scores_gemma":[0.99771345,0.00023492334,0.0006988328,0.00016507681,0.0001346168,0.000016380076,0.00002295899,0.000029120982,0.00098462],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99906117,0.000024034156,0.0002776383,0.0002221571,0.0002268534,0.0001881593],"domain_scores_gemma":[0.99934536,0.000026562362,0.000080930426,0.0003974068,0.000054678803,0.000095087715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008420505,0.00011644954,0.00024921243,0.0000745078,0.00003461901,0.0000062639774,0.00007697396,0.00011782174,0.0007300678],"category_scores_gemma":[0.000056638793,0.000116446085,0.000112077505,0.0002684243,0.000040080784,0.000040555773,0.000010055912,0.00013624581,0.000114442075],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015249955,0.00094042777,0.0024846797,0.000104676736,0.00031296024,0.000019229214,0.00045327473,0.00006535682,0.93060124,0.00018068256,0.0009474573,0.06373753],"study_design_scores_gemma":[0.003545148,0.00027515157,0.020810654,0.00014553692,0.00028282581,0.000038833092,0.000014304771,0.00006737173,0.9702752,0.000093865005,0.004321614,0.00012948817],"about_ca_topic_score_codex":0.00005955765,"about_ca_topic_score_gemma":0.000004765607,"teacher_disagreement_score":0.063608035,"about_ca_system_score_codex":0.000029050934,"about_ca_system_score_gemma":0.00009315241,"threshold_uncertainty_score":0.79937303},"labels":[],"label_agreement":null},{"id":"W152238779","doi":"10.1182/blood.v122.21.2133.2133","title":"Global Hematopoietic Stem Cell Transplantation (HSCT) At One Million: An Achievement Of Pioneers and Foreseeable Challenges For The Next Decade. A Report From The Worldwide Network For Blood and Marrow Transplantation (WBMT)","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Transplantation; Medicine; Hematopoietic stem cell transplantation; Bone marrow; Immunology; Internal medicine","score_opus":0.03264808570895784,"score_gpt":0.25056010293203657,"score_spread":0.21791201722307874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W152238779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96769387,0.009578045,0.015347425,0.0026785964,0.00011009608,0.00409964,0.00027590853,0.000046110992,0.00017033017],"genre_scores_gemma":[0.98326117,0.008406369,0.0063654366,0.00016792769,0.00018171604,0.0008132392,0.00066060567,0.000041521365,0.00010199791],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99800104,0.00008848812,0.00066103885,0.0004846799,0.00039048318,0.00037424767],"domain_scores_gemma":[0.997919,0.001102885,0.00026967181,0.00040272484,0.00014767931,0.0001579983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058652734,0.00027533615,0.0004279858,0.000038040936,0.0002742068,0.000051574643,0.00013723712,0.00015809281,0.000018915534],"category_scores_gemma":[0.000011205673,0.00018839452,0.00011517006,0.00014133501,0.000117283205,0.00019284482,0.00001188469,0.000092562,0.0000014939114],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015238168,0.008710592,0.47913516,0.05360624,0.008395343,0.0005565764,0.10028131,0.0016290911,0.2794881,0.011350131,0.0020885223,0.039520774],"study_design_scores_gemma":[0.057375267,0.0039020448,0.699767,0.0038382616,0.02732866,0.004210454,0.011425687,0.0039834157,0.1776342,0.008079005,0.0010860272,0.001370019],"about_ca_topic_score_codex":0.0002300605,"about_ca_topic_score_gemma":0.0006836184,"teacher_disagreement_score":0.22063181,"about_ca_system_score_codex":0.000024546316,"about_ca_system_score_gemma":0.000056317,"threshold_uncertainty_score":0.7682506},"labels":[],"label_agreement":null},{"id":"W152497440","doi":"10.1182/blood.v124.21.394.394","title":"Validation of a Prognostic Model to Assess the Risk of CNS Disease in Patients with Aggressive B-Cell Lymphoma","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Rituximab; Internal medicine; Lymphoma; Diffuse large B-cell lymphoma; Oncology; International Prognostic Index; Cohort","score_opus":0.011265567238791428,"score_gpt":0.2318434422299434,"score_spread":0.22057787499115197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W152497440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988134,0.00005668149,0.00011709675,0.000057451325,0.000011881356,0.0007247915,0.00005052165,0.0000064662277,0.00016173828],"genre_scores_gemma":[0.9993751,0.000011643124,0.0004064183,0.0000290527,0.000010559616,0.00011191748,0.000032178395,0.000012206089,0.00001089667],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99927175,0.000050738512,0.00017609022,0.00014506762,0.00025214694,0.00010417811],"domain_scores_gemma":[0.9991822,0.00012927208,0.00020800927,0.00027420645,0.00011915686,0.00008712269],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000079153724,0.00009278837,0.00019283286,0.00005927668,0.000019534298,0.000004583338,0.000054983273,0.000021215206,0.0000032027087],"category_scores_gemma":[0.0002223762,0.000052491767,0.000045615958,0.00013414574,0.000026617627,0.000024346915,0.000025448027,0.000019828914,0.0000029280013],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002476069,0.0082917195,0.9877962,0.000061189145,0.000067503155,0.000004783578,0.00020792492,0.00104769,0.000039178223,0.00003753516,0.000010566934,0.002188087],"study_design_scores_gemma":[0.011359774,0.0006356532,0.97586316,0.00029305153,0.0007806525,3.4161727e-7,0.000017485805,0.0012804619,0.009657495,0.00005337086,0.0000031570753,0.000055412944],"about_ca_topic_score_codex":0.00006496829,"about_ca_topic_score_gemma":0.0000087132685,"teacher_disagreement_score":0.011933072,"about_ca_system_score_codex":0.000023218585,"about_ca_system_score_gemma":0.00008729261,"threshold_uncertainty_score":0.21405521},"labels":[],"label_agreement":null},{"id":"W152581345","doi":"10.1182/blood.v122.21.1173.1173","title":"The Zinc Finger Transcription Factor (Growth Factor Independence 1b) Gfi1b Regulates Megakaryocyte Proliferation and Their Ability To Produce and Release Platelets","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Thrombopoiesis; Megakaryocyte; Haematopoiesis; Biology; Thrombopoietin; Platelet; Bone marrow; Transgene; Erythropoiesis; Endocrinology; Internal medicine; Cell biology; Stem cell; Cancer research; Immunology; Gene; Medicine; Genetics; Anemia","score_opus":0.006787003233245657,"score_gpt":0.20195534358432163,"score_spread":0.19516834035107597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W152581345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962922,0.0021270078,0.00003723939,0.00066975923,0.000039032555,0.00075034983,0.000031059804,0.0000154641,0.00003792219],"genre_scores_gemma":[0.99913806,0.0003270399,0.00010386409,0.00010540959,0.00005433042,0.00011030958,0.000028267747,0.000014898353,0.00011782207],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99909246,0.00005283787,0.00015143321,0.00040922195,0.00009436366,0.00019969385],"domain_scores_gemma":[0.9994828,0.00001699162,0.000045706234,0.00025195492,0.000097138676,0.000105400264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006743624,0.00017564,0.00011390285,0.000016882084,0.00020106076,0.00010480165,0.000081694496,0.00012348696,0.000006572647],"category_scores_gemma":[0.00007805208,0.00011221635,0.000032877953,0.000044614142,0.00006282903,0.000020004876,0.000046156583,0.000072215225,0.0000041915614],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010908631,0.00044845854,0.043969646,0.00004674906,0.00013895445,0.0000013577855,0.0005570141,0.0000013773337,0.93407756,0.000029504006,0.000103222854,0.020517083],"study_design_scores_gemma":[0.0013284568,0.0004000761,0.16452406,0.0000111359395,0.00003253895,0.000017153516,0.000059319504,0.000023366458,0.83259827,0.00040179197,0.0004178195,0.00018598739],"about_ca_topic_score_codex":0.00008239177,"about_ca_topic_score_gemma":0.00011504944,"teacher_disagreement_score":0.12055442,"about_ca_system_score_codex":0.0000043266446,"about_ca_system_score_gemma":0.000030214818,"threshold_uncertainty_score":0.457605},"labels":[],"label_agreement":null},{"id":"W1526236730","doi":"10.1182/blood.v95.3.1047.003k43_1047_1055","title":"Regulation of drug sensitivity by ribosomal protein S3a","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Advanced biosensing and bioanalysis techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Acute myeloblastic leukemia; Clonogenic assay; Biology; Medicine; Leukemia; Cell culture; Immunology; Internal medicine; Cancer research; Genetics","score_opus":0.0031955233891813734,"score_gpt":0.2159063851085149,"score_spread":0.2127108617193335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1526236730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99839765,0.000105355575,0.00025282832,0.00006861611,0.0000043962677,0.0001013162,0.00002766878,0.000025740399,0.0010164423],"genre_scores_gemma":[0.99448746,0.000030144109,0.0032065767,0.000033375534,0.000061158455,0.0000030968224,0.000119635246,0.000008866579,0.0020496724],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994147,0.00005785477,0.00013282507,0.00019878914,0.000087561515,0.00010831469],"domain_scores_gemma":[0.9996459,0.0000033729577,0.00005919517,0.00021677546,0.000046911926,0.000027876576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000115230854,0.00008713372,0.000105638275,0.000015931197,0.000034791723,0.000005148522,0.00004059623,0.000080697944,0.000007917726],"category_scores_gemma":[0.000017387025,0.00007884835,0.00006747784,0.0000681638,0.00006290919,0.0000023694859,0.000017233062,0.000037679893,0.0000020702207],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026724394,0.00014779287,0.0003474435,0.0000056933736,0.00002821366,0.000001016311,0.000004827897,0.0000019799634,0.99426246,0.0000072057683,0.0005043291,0.004662331],"study_design_scores_gemma":[0.00026813985,0.00007338299,0.00090654654,0.000012205246,0.00002920811,0.000008939181,0.0000045998963,0.000019885443,0.99464166,0.00006435026,0.0038707862,0.00010031053],"about_ca_topic_score_codex":0.000020165158,"about_ca_topic_score_gemma":0.000015287678,"teacher_disagreement_score":0.004562021,"about_ca_system_score_codex":0.0000024995545,"about_ca_system_score_gemma":0.000011733373,"threshold_uncertainty_score":0.32153428},"labels":[],"label_agreement":null},{"id":"W1527288042","doi":"10.1182/blood.v100.6.2216","title":"Aberrant regulation of superantigen responses during T-cell reconstitution and graft-versus-host disease in immunodeficient mice","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Superantigen; Adoptive cell transfer; Immunology; Biology; T cell; T-cell receptor; Graft-versus-host disease; Clonal deletion; Severe combined immunodeficiency; Transplantation; In vivo; Immune system; Stem cell; Cell biology; Medicine; Internal medicine","score_opus":0.020716751892494983,"score_gpt":0.23318331493976702,"score_spread":0.21246656304727204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1527288042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99656516,0.0017856511,0.000031608095,0.00013087624,0.000073724346,0.0003416597,0.000016326669,0.000023865432,0.0010311385],"genre_scores_gemma":[0.99887437,0.0005308013,0.0003299435,0.000007547077,0.000014474275,0.000009838286,0.000016625921,0.000010108229,0.00020630915],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999135,0.00005658439,0.0002991908,0.00019417357,0.00017529452,0.00013975662],"domain_scores_gemma":[0.9995815,0.00008322221,0.0000567187,0.00017063801,0.00003927925,0.000068642425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014898143,0.00009686917,0.00017194966,0.00016338624,0.000044491087,0.000007127594,0.000030013569,0.000051624393,0.00008170228],"category_scores_gemma":[0.00004951873,0.00009580105,0.00003827185,0.00015479134,0.00007059951,0.00007501379,0.000007934748,0.00006706892,0.000012678567],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014943324,0.0007100957,0.12723738,0.00075519,0.000025738043,0.00007188679,0.001903636,0.000021287055,0.86760736,0.00008777217,0.0000033811161,0.0000819327],"study_design_scores_gemma":[0.010808946,0.00010975222,0.73435014,0.0005498198,0.00025967494,0.00006495809,0.00019667992,0.00048048774,0.2530144,0.000007709575,0.000028676332,0.00012880868],"about_ca_topic_score_codex":0.000052816584,"about_ca_topic_score_gemma":0.000011706027,"teacher_disagreement_score":0.61459297,"about_ca_system_score_codex":0.000023176075,"about_ca_system_score_gemma":0.000029038029,"threshold_uncertainty_score":0.39066535},"labels":[],"label_agreement":null},{"id":"W1531238400","doi":"10.1182/blood.v116.21.188.188","title":"The Ultra-Low-Molecular-Weight Heparin Semuloparin for Prevention of Venous Thromboembolism In Patients Undergoing Major Abdominal Surgery","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McGill University Health Centre","funders":"","keywords":"Medicine; Surgery; Low molecular weight heparin; Creatinine; Renal function; Abdominal surgery; Anesthesia; Heparin; Internal medicine","score_opus":0.007558567068313928,"score_gpt":0.2447759838155984,"score_spread":0.23721741674728447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1531238400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963069,0.0001620752,0.00013745294,0.00024158652,0.0005254257,0.0013861759,0.000008011214,0.00002830064,0.0012040865],"genre_scores_gemma":[0.99864674,0.00015039693,0.0006053335,0.000116111034,0.0001215895,0.00019664047,0.000047832982,0.00003971226,0.0000756527],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983554,0.00005494415,0.00055114995,0.0003053424,0.00031698286,0.00041620652],"domain_scores_gemma":[0.99873686,0.00038274346,0.00023419913,0.00043586394,0.000120053875,0.00009026525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053313206,0.00019030945,0.000624373,0.00014011878,0.00012855737,0.000028854989,0.00015419867,0.00011492215,0.000022512475],"category_scores_gemma":[0.0003258973,0.0001512994,0.0002421805,0.0001862118,0.00009570608,0.00007270763,0.000050244984,0.00020183869,0.0000074066875],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012456959,0.062317643,0.69485253,0.0037564225,0.0027090556,0.00010994277,0.0016403724,0.00003071187,0.11152144,0.023435267,0.0056571825,0.09272372],"study_design_scores_gemma":[0.0071534608,0.0007432883,0.9022186,0.00042152873,0.00075986644,0.000008139501,0.00008893418,0.000024330293,0.08546869,0.0019629183,0.0008904412,0.0002598338],"about_ca_topic_score_codex":0.000066963876,"about_ca_topic_score_gemma":0.00044174894,"teacher_disagreement_score":0.20736602,"about_ca_system_score_codex":0.000027261296,"about_ca_system_score_gemma":0.00013182608,"threshold_uncertainty_score":0.6169811},"labels":[],"label_agreement":null},{"id":"W1546577360","doi":"10.1182/blood.v95.3.992.003k29_992_998","title":"Ectopic expression of fibroblast growth factor receptor 3 promotes myeloma cell proliferation and prevents apoptosis","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":166,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Fibroblast growth factor receptor 3; Biology; Ectopic expression; MAPK/ERK pathway; Fibroblast growth factor receptor 4; Signal transduction; Cell biology; Cancer research; Cell growth; STAT3; Fibroblast growth factor receptor; Cytokine; Molecular biology; Fibroblast growth factor; Cell culture; Receptor; Immunology; Genetics","score_opus":0.011215729037292007,"score_gpt":0.2323340098747285,"score_spread":0.22111828083743648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1546577360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978373,0.000054498065,0.000025501799,0.000085751184,0.000030722098,0.0003399211,0.000027184968,0.00003368566,0.0015654599],"genre_scores_gemma":[0.9973609,0.000038764603,0.0012943767,0.000021441816,0.00012470386,0.000022463151,0.00002929231,0.000013545922,0.001094518],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993672,0.000025660594,0.00020240077,0.00016934866,0.00013020451,0.00010523121],"domain_scores_gemma":[0.9996697,0.000019940608,0.000064247324,0.00012215346,0.00005611018,0.000067868576],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000029886904,0.000097882454,0.00016091016,0.000056147936,0.00005043502,0.000012802905,0.000031872947,0.000059760434,0.0017778481],"category_scores_gemma":[0.000030713803,0.00007848556,0.000049602877,0.000075097785,0.000019059731,0.00009312345,0.0000125735705,0.00008617281,0.000016748936],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049580573,0.0006177911,0.006621664,0.00018428903,0.000016679616,4.5818362e-7,0.00044629388,3.181838e-7,0.98941445,0.000003259177,0.00021795332,0.0024272876],"study_design_scores_gemma":[0.0013124138,0.0006044444,0.012021951,0.0003272068,0.000048471975,0.000009850504,0.00002275867,0.00001695612,0.9852177,0.00001615174,0.00033061366,0.00007150303],"about_ca_topic_score_codex":0.000013974005,"about_ca_topic_score_gemma":7.6204765e-7,"teacher_disagreement_score":0.005400288,"about_ca_system_score_codex":0.000007642739,"about_ca_system_score_gemma":0.000026986212,"threshold_uncertainty_score":0.99913466},"labels":[],"label_agreement":null},{"id":"W1548088036","doi":"10.1182/blood.v96.12.3734.h8003734_3734_3742","title":"Differential stimulation of c-Kit mutants by membrane-bound and soluble Steel Factor correlates with leukemic potential","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Stimulation; Receptor; Biology; Molecular biology; Mutant; Cell culture; Cell biology; Endocrinology; Internal medicine; Biochemistry; Medicine; Gene; Genetics","score_opus":0.004750098800799955,"score_gpt":0.18087529569265418,"score_spread":0.1761251968918542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1548088036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99797577,0.00096261944,0.000041729225,0.000009374564,0.00013705167,0.00014074451,0.000094455696,0.000026126952,0.00061211665],"genre_scores_gemma":[0.98917276,0.00010296737,0.000017570364,0.0000081826365,0.000015570744,0.0000028059499,0.00016769102,0.00001342019,0.010499029],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993539,0.00003454704,0.00018449099,0.00019875629,0.00003627726,0.00019204237],"domain_scores_gemma":[0.99972975,0.000026723383,0.00007474467,0.00012295405,0.000025778581,0.000020037956],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000019823065,0.00013301945,0.00021821374,0.00003564203,0.00010551532,0.000013524898,0.00007088731,0.00014987559,0.0060545104],"category_scores_gemma":[0.0000024864635,0.00010708873,0.000030177956,0.000041292402,0.000158903,0.000058570302,0.000018451452,0.00011933385,0.000044732747],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003260924,0.00032510422,0.0039156596,0.000030968054,0.00017140555,0.0000034685704,0.00019426197,0.000018875111,0.99300516,0.000021332353,0.00015075451,0.0018369477],"study_design_scores_gemma":[0.023301205,0.0013803516,0.075205885,0.000095796546,0.0007085886,0.00024775288,0.00010829998,0.00024215276,0.89331967,0.000042385782,0.0047524134,0.000595512],"about_ca_topic_score_codex":0.00012662787,"about_ca_topic_score_gemma":0.000020806816,"teacher_disagreement_score":0.099685475,"about_ca_system_score_codex":0.000006346462,"about_ca_system_score_gemma":0.000023621522,"threshold_uncertainty_score":0.9948541},"labels":[],"label_agreement":null},{"id":"W1551703232","doi":"10.1182/blood.v122.21.626.626","title":"A Meta-Analysis Of Hodgkin Lymphoma Reveals 19p13.3 (TCF3) As a Novel Susceptibility Loc","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University and Génome Québec Innovation Centre","funders":"","keywords":"Genome-wide association study; SNP; Population stratification; Meta-analysis; Nodular sclerosis; Imputation (statistics); Genetic association; Expression quantitative trait loci; Oncology; Biology; Single-nucleotide polymorphism; Genetics; Case-control study; Linkage disequilibrium; Population; Heritability; Medicine; Internal medicine; Genotype; Lymphoma; Gene; Hodgkin lymphoma; Missing data","score_opus":0.0625893641432492,"score_gpt":0.2937914286735529,"score_spread":0.2312020645303037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1551703232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928026,0.0017844163,0.000019061663,0.00088866096,0.000023150042,0.0007434141,0.000081676735,0.000046510424,0.0036105015],"genre_scores_gemma":[0.9957338,0.000039686303,0.0018614371,0.00063110614,0.000035167468,0.0002753417,0.000056468736,0.000019808354,0.0013472049],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.9980835,0.00006736916,0.00059274764,0.00049286353,0.00046097586,0.00030255085],"domain_scores_gemma":[0.998073,0.0002112137,0.00023155723,0.0009913369,0.0002637733,0.00022910879],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002918316,0.00025972733,0.0016048816,0.0002488997,0.00004358784,0.000025050142,0.00012765908,0.00011645747,0.003864824],"category_scores_gemma":[0.00014701985,0.00017436962,0.0016701639,0.0007671828,0.00008527589,0.000078330784,0.00006680833,0.000039660757,0.000294533],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007014807,0.02122166,0.40723476,0.0001365357,0.5478832,0.000085827356,0.0004881574,0.0000074289615,0.018879255,0.0007877969,0.001291194,0.0019140494],"study_design_scores_gemma":[0.0047672093,0.00042568013,0.5411299,0.000008877538,0.4371754,0.00003532312,0.000066549044,0.000034748984,0.015825704,0.00015348652,0.00022825444,0.0001488788],"about_ca_topic_score_codex":0.003729861,"about_ca_topic_score_gemma":0.00013598804,"teacher_disagreement_score":0.13389514,"about_ca_system_score_codex":0.00007570362,"about_ca_system_score_gemma":0.00011378356,"threshold_uncertainty_score":0.99704576},"labels":[],"label_agreement":null},{"id":"W1551724453","doi":"10.1182/blood.v96.13.4335","title":"An adherent condition is required for formation of multinuclear osteoclasts in the presence of macrophage colony-stimulating factor and receptor activator of nuclear factor κB ligand","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Bone Metabolism and Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research & Development Corporation","funders":"","keywords":"Osteoclast; RANKL; RANK Ligand; Precursor cell; Cell biology; Cellular differentiation; Stromal cell; Biology; Macrophage colony-stimulating factor; Cell culture; Integrin; Activator (genetics); Receptor; Cell; Macrophage; Biochemistry; In vitro; Cancer research","score_opus":0.01282236084050966,"score_gpt":0.2632190555581752,"score_spread":0.25039669471766557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1551724453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986297,0.00018016505,0.000013560815,0.000014679113,0.000014366313,0.0004131486,0.00070099736,0.0000031024547,0.000030271216],"genre_scores_gemma":[0.99939346,0.00006135324,0.00038467816,0.000030056384,0.000027585213,0.000011595175,0.00006963745,0.000010547517,0.00001106341],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999374,0.00005771092,0.00023772608,0.00013877657,0.000095394345,0.00009641152],"domain_scores_gemma":[0.9995491,0.00003524695,0.00015480776,0.00017112342,0.000056438934,0.000033301338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006206048,0.00008270579,0.00014898673,0.000022184902,0.000030231242,0.000008152513,0.0000938452,0.00007859507,0.000054207427],"category_scores_gemma":[0.000076367716,0.000066304485,0.00004714434,0.000044471755,0.00006502658,0.000021912378,0.000017337326,0.000027516766,5.042229e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033494184,0.00028195523,0.002529051,0.00012561967,0.000014262873,1.3547638e-7,0.0010402607,0.000007284568,0.99296916,0.0000068423215,0.00006437417,0.0026260994],"study_design_scores_gemma":[0.0019738972,0.00063387136,0.04206023,0.00003752768,0.000030452195,9.999122e-7,0.0003356773,0.00026461598,0.9540912,0.000011027408,0.0004831461,0.00007736772],"about_ca_topic_score_codex":0.000022162301,"about_ca_topic_score_gemma":0.0000044769095,"teacher_disagreement_score":0.03953118,"about_ca_system_score_codex":0.0000018082858,"about_ca_system_score_gemma":0.000016040613,"threshold_uncertainty_score":0.27038184},"labels":[],"label_agreement":null},{"id":"W156354182","doi":"10.1182/blood.v122.21.1677.1677","title":"Cost-Effectiveness Of Arsenic Trioxide + All-Trans Retinoic Acid Compared With All-Trans Retinoic Acid + Idarubicin In The Treatment Of Newly Diagnosed Acute Promyelocytic Leukemia In Canada","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Acute promyelocytic leukemia; Idarubicin; Medicine; Internal medicine; Arsenic trioxide; Chemotherapy; Tretinoin; Coagulopathy; Retinoic acid; Gastroenterology; Cytarabine; Oncology; Surgery; Biology","score_opus":0.014555602415168428,"score_gpt":0.24229698927920276,"score_spread":0.22774138686403433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W156354182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954245,0.0018530353,0.00012837602,0.000078032426,0.000044836044,0.0021489856,0.000053330295,0.000008697568,0.0002601729],"genre_scores_gemma":[0.9975694,0.0010918058,0.00025531917,0.00007601415,0.00003552692,0.0006787161,0.00022520118,0.000042320156,0.000025691565],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974615,0.000463038,0.00062285166,0.0005607603,0.00035683007,0.0005350321],"domain_scores_gemma":[0.99871564,0.00014455339,0.0002420857,0.0006690838,0.00012784687,0.00010077975],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003063379,0.0004105162,0.00065885345,0.000085281106,0.000037334914,0.00001940998,0.00051400857,0.0001968736,0.00001758166],"category_scores_gemma":[0.000040722465,0.00029107722,0.000135139,0.00033817993,0.00018389948,0.000013138126,0.000025558664,0.00019440713,0.0000012110776],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061794306,0.0005781221,0.024925413,0.00030687463,0.0004192993,0.00014076216,0.0009522632,0.00052316586,0.9709189,0.000005495249,0.00004136475,0.0005704169],"study_design_scores_gemma":[0.00978396,0.0014707951,0.0306101,0.00019605328,0.0003296758,0.000058806196,0.00070739735,0.000069447575,0.95603067,0.000021092708,0.00039409817,0.00032792677],"about_ca_topic_score_codex":0.13042219,"about_ca_topic_score_gemma":0.21618125,"teacher_disagreement_score":0.085759066,"about_ca_system_score_codex":0.00040713736,"about_ca_system_score_gemma":0.002174706,"threshold_uncertainty_score":0.99995416},"labels":[],"label_agreement":null},{"id":"W1571014830","doi":"10.1182/blood.v95.5.1788.005k15_1788_1796","title":"FGFR1 is fused to the centrosome-associated proteinCEP110 in the 8p12 stem cell myeloproliferative disorder with t(8;9)(p12;q33)","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":143,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Medical Advances Without Animals Trust","keywords":"Fusion protein; Biology; Leucine zipper; Fibroblast growth factor receptor 1; Centrosome; Stem cell; Protein kinase domain; Gene; Molecular biology; Cell biology; Genetics; Fibroblast growth factor; Cell cycle; Peptide sequence; Receptor","score_opus":0.006688867732666154,"score_gpt":0.20804371220572762,"score_spread":0.20135484447306146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1571014830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96584016,0.00065076974,0.000009157801,0.016111279,0.000021607388,0.0024143558,0.000028720673,0.00004979529,0.014874136],"genre_scores_gemma":[0.98647994,0.00009579415,0.000063277075,0.0052611763,0.000065491586,0.00030562817,0.000019014411,0.00003636707,0.007673306],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99813,0.00017141888,0.00029460536,0.00037543787,0.0005428146,0.00048572556],"domain_scores_gemma":[0.99913824,0.00007372362,0.00007335947,0.00054080994,0.00007160678,0.00010224428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030841687,0.0002616437,0.00037003335,0.00006296555,0.00020412455,0.00006919205,0.00030119944,0.0001014529,0.00053560495],"category_scores_gemma":[0.000018674255,0.00012850716,0.000085085405,0.0006660015,0.00008197101,0.00007137136,0.000027392933,0.0003510787,0.00018415126],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026675914,0.033145152,0.6119853,0.0004911541,0.0016923762,0.00097449473,0.24233043,0.00040406897,0.0020202785,0.0012463976,0.025366807,0.07767591],"study_design_scores_gemma":[0.043044414,0.0070709167,0.7317612,0.0008327796,0.0009700286,0.00023308294,0.021779282,0.00027021044,0.004652173,0.00042424616,0.18747379,0.0014878854],"about_ca_topic_score_codex":0.00020273509,"about_ca_topic_score_gemma":0.0006008488,"teacher_disagreement_score":0.22055115,"about_ca_system_score_codex":0.000029725346,"about_ca_system_score_gemma":0.00012021993,"threshold_uncertainty_score":0.58644986},"labels":[],"label_agreement":null},{"id":"W157430056","doi":"10.1182/blood.v122.21.396.396","title":"Long-Term Outcomes Of Ruxolitinib Therapy In Patients With Myelofibrosis: 3-Year Update From COMFORT-I","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Ruxolitinib; Medicine; Myelofibrosis; Clinical endpoint; Internal medicine; Placebo; Population; Phases of clinical research; Intention-to-treat analysis; Randomized controlled trial; Surgery; Clinical trial; Gastroenterology; Bone marrow; Pathology","score_opus":0.012721526456808198,"score_gpt":0.24306618042054037,"score_spread":0.2303446539637322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W157430056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980539,0.00014635916,0.0000019375523,0.00026515056,0.00003609432,0.0010011381,0.00007274159,0.000024266377,0.00039842058],"genre_scores_gemma":[0.99815774,0.00012426729,0.0008205078,0.00037511185,0.000027614642,0.00019051963,0.00022595291,0.000026614576,0.000051661926],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888074,0.000032771648,0.00031218774,0.00025744387,0.00028712818,0.00022975238],"domain_scores_gemma":[0.9992583,0.00007446209,0.00011763671,0.00032653872,0.00011424938,0.0001088156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000035073615,0.00020302836,0.0004960003,0.00007961495,0.00002506651,0.000017423261,0.0000733995,0.00006658037,0.0007549244],"category_scores_gemma":[0.000014556286,0.00012612995,0.000071778864,0.000099519544,0.000050299383,0.00009401417,0.000024586601,0.00008911286,0.000077012366],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001681617,0.0037212237,0.99274653,0.000016496146,0.00040512197,0.000009650736,0.00017089047,2.300793e-7,0.000060767863,0.00006435524,0.000063512845,0.0025730347],"study_design_scores_gemma":[0.01890054,0.0011664266,0.9701978,0.00017542228,0.000111264424,6.847166e-7,0.000024870873,7.2063926e-7,0.009236184,0.00004363101,0.000019853533,0.00012258628],"about_ca_topic_score_codex":0.0002765381,"about_ca_topic_score_gemma":0.00005021346,"teacher_disagreement_score":0.022548739,"about_ca_system_score_codex":0.000019909108,"about_ca_system_score_gemma":0.000037312802,"threshold_uncertainty_score":0.8265893},"labels":[],"label_agreement":null},{"id":"W1578836214","doi":"10.1182/blood-2014-09-598029","title":"Dengue virus binding and replication by platelets","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Mosquito-borne diseases and control","field":"Medicine","cited_by":174,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services","funders":"Canadian Institutes of Health Research","keywords":"Platelet; Dengue virus; Heparan sulfate; Virology; Dengue fever; Biology; Virus; Antibody-dependent enhancement; Receptor; Immunology; Genetics; Cell","score_opus":0.018101491870566016,"score_gpt":0.26906862870893494,"score_spread":0.2509671368383689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1578836214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944978,0.0034895716,0.000032210337,0.0004237006,0.00003028707,0.0001595743,0.000016134845,0.000041530002,0.0013091904],"genre_scores_gemma":[0.99886703,0.00006556268,0.00007134951,0.00028719625,0.000109410095,0.00001947144,0.00004277636,0.000009601687,0.0005275695],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995216,0.000009675033,0.00008744701,0.00017791879,0.00010189721,0.00010142242],"domain_scores_gemma":[0.9995077,0.00001152461,0.00003053177,0.00023750191,0.000033715976,0.00017899703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009062956,0.000056166144,0.00009926587,0.000022025459,0.000024669092,0.000014389718,0.000028624596,0.000037628368,0.000018965331],"category_scores_gemma":[0.00009869445,0.000048400718,0.000020573581,0.00004524784,0.000012123901,0.000032621858,0.000014595372,0.00004445911,0.000033667635],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005174842,0.0023553388,0.21103947,0.00018443693,0.00048193228,0.0002971467,0.0007813726,9.936907e-7,0.58659196,0.0012769727,0.081475176,0.11499773],"study_design_scores_gemma":[0.06728033,0.0020166459,0.1589258,0.00035678694,0.0034653055,0.0010557304,0.0011121671,0.0015054897,0.3623555,0.000885767,0.39987245,0.0011680286],"about_ca_topic_score_codex":0.000039673825,"about_ca_topic_score_gemma":0.0000025447423,"teacher_disagreement_score":0.31839728,"about_ca_system_score_codex":0.000008376514,"about_ca_system_score_gemma":0.00002950179,"threshold_uncertainty_score":0.1973724},"labels":[],"label_agreement":null},{"id":"W1581631118","doi":"10.1182/blood.v95.9.2954.009k28_2954_2959","title":"Importance of L-selectin–dependent leukocyte–leukocyte interactions in human whole blood","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Medical Research Council; Fondation pour la Recherche Médicale","keywords":"Whole blood; L-selectin; Immunology; Molecular biology; Red blood cell; Granulocyte; Antibody; Blood cell; Selectin; Chemistry; Biology; Andrology; Inflammation; Medicine; Cell adhesion molecule","score_opus":0.02366052567245839,"score_gpt":0.32291921400033213,"score_spread":0.2992586883278737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1581631118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97247744,0.00039004837,0.0000037733869,0.00026469177,0.000026482256,0.00040593618,0.000005446572,0.000051370218,0.026374813],"genre_scores_gemma":[0.98239404,0.00011756752,0.00030423648,0.00014711525,0.00009856498,0.000045113655,0.00003246154,0.00003892238,0.016822005],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980076,0.00007555869,0.00056019815,0.0004103338,0.00052834454,0.0004179702],"domain_scores_gemma":[0.9989818,0.00006940414,0.00009730887,0.0005619509,0.000109860564,0.00017968946],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024757974,0.00018002202,0.0003836459,0.00029381935,0.000071354545,0.000018360255,0.00019972464,0.0000687095,0.0033456157],"category_scores_gemma":[0.00009065534,0.00017678783,0.0001316779,0.0005140037,0.00007776975,0.000087441455,0.000060886374,0.00054802466,0.00018277956],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019174026,0.0038362164,0.09674146,0.00012337929,0.00015566203,0.0007207062,0.0002641152,0.000023119543,0.8943356,0.000044295943,0.00065477623,0.0029088785],"study_design_scores_gemma":[0.007969747,0.0006240446,0.105771154,0.00020205791,0.00020523547,0.00045945568,0.0000952689,0.000059759786,0.8781698,0.00008933027,0.006126055,0.000228086],"about_ca_topic_score_codex":0.00037853315,"about_ca_topic_score_gemma":0.000747341,"teacher_disagreement_score":0.016165847,"about_ca_system_score_codex":0.000075885706,"about_ca_system_score_gemma":0.00017154492,"threshold_uncertainty_score":0.99756545},"labels":[],"label_agreement":null},{"id":"W1583529973","doi":"10.1182/blood-2010-07-298851","title":"Regulation of S100A10 by the PML-RAR-α oncoprotein","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Canadian Institutes of Health Research; Dalhousie University","keywords":"Plasmin; Acute promyelocytic leukemia; Retinoic acid; Fibrinolysis; Leukemia; Cancer research; Promyelocytic leukemia protein; Tretinoin; Retinoic acid receptor; Biology; Immunology; Medicine; Cell culture; Internal medicine; Biochemistry; Enzyme","score_opus":0.009394667529218083,"score_gpt":0.20168415373368906,"score_spread":0.19228948620447098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1583529973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9790227,0.001586799,0.0007102457,0.000024464734,0.000040843424,0.00011068307,0.000005554919,0.000006881421,0.018491874],"genre_scores_gemma":[0.9969922,0.00007641072,0.00078144483,0.000048133872,0.00006739955,0.000015206718,0.000034467586,0.000010802449,0.0019739526],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99950564,0.00003270203,0.00013035665,0.0001444642,0.00008644308,0.00010042372],"domain_scores_gemma":[0.9995583,0.0000042580095,0.00008057299,0.0002845239,0.000050253653,0.00002208471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000116623945,0.00007304117,0.00006668398,0.000008559632,0.000039329687,0.000004769604,0.00018289508,0.00009469203,0.00005688013],"category_scores_gemma":[0.00003781754,0.000051857347,0.00004652939,0.000050358758,0.000084295556,0.0000019352087,0.00004503643,0.000045681452,0.0000066013004],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019374918,0.000102290855,0.0013389376,0.000018188008,0.000029281622,4.1733549e-7,0.00007840743,6.159092e-7,0.99542236,0.00013889492,0.0018548957,0.0009963615],"study_design_scores_gemma":[0.0003820525,0.00015107557,0.0011608414,0.0000071093828,0.00002563225,0.00000914391,0.000038818198,0.0000027966903,0.9903563,0.00044185255,0.0073542953,0.00007006667],"about_ca_topic_score_codex":0.000019550369,"about_ca_topic_score_gemma":0.0000022630704,"teacher_disagreement_score":0.017969528,"about_ca_system_score_codex":0.000002034438,"about_ca_system_score_gemma":0.000039306822,"threshold_uncertainty_score":0.21146813},"labels":[],"label_agreement":null},{"id":"W1584288147","doi":"10.1182/blood.v95.1.256","title":"Nuclear factor-κB activation by the photochemotherapeutic agent verteporfin","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital","funders":"","keywords":"Verteporfin; Apoptosis; Molecular biology; Biology; Survivin; Transfection; Programmed cell death; IκBα; NF-κB; Cancer research; Biochemistry; Gene","score_opus":0.019143233487684572,"score_gpt":0.28473971249412944,"score_spread":0.26559647900644484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1584288147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916882,0.00031681723,0.0000038938892,0.0020941435,0.000019278616,0.0005956224,0.000012296456,0.0000831993,0.0051865526],"genre_scores_gemma":[0.99335366,0.00045788818,0.00002478249,0.0017732293,0.00006158154,0.000037264876,0.000011521609,0.000030805862,0.0042492794],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990414,0.000044100423,0.00013645542,0.00018928219,0.00033266903,0.0002561397],"domain_scores_gemma":[0.9994815,0.00005924268,0.00003082349,0.00032446274,0.000032854252,0.00007110443],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000088651825,0.00012708131,0.00016275865,0.000027664099,0.00014252175,0.000021923002,0.00012798853,0.00005171739,0.0026810258],"category_scores_gemma":[0.000026775293,0.00008124487,0.00007200544,0.0001418633,0.00008989011,0.00004661797,0.000018525017,0.00019977237,0.00015489104],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027831428,0.00082921056,0.0005428227,0.000026881873,0.0005427522,0.000010948237,0.0015389316,4.6702525e-7,0.9446679,0.000011632031,0.0057311715,0.045819003],"study_design_scores_gemma":[0.009596773,0.000947787,0.047397308,0.00013117204,0.00021025629,0.00010827438,0.0005342538,0.00028823456,0.6436243,0.000188605,0.29658732,0.00038570957],"about_ca_topic_score_codex":0.000077656456,"about_ca_topic_score_gemma":0.000002909891,"teacher_disagreement_score":0.30104357,"about_ca_system_score_codex":0.000053757954,"about_ca_system_score_gemma":0.00003532503,"threshold_uncertainty_score":0.99823064},"labels":[],"label_agreement":null},{"id":"W1589551152","doi":"10.1182/blood.v95.6.1883","title":"Prognostic implications of differences in telomere length between normal and malignant cells from patients with chronic myeloid leukemia measured by flow cytometry","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":205,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Institute of Allergy and Infectious Diseases; National Institute of General Medical Sciences","keywords":"Telomere; Myeloid leukemia; Flow cytometry; Telomerase; Leukemia; Myeloid; Biology; Fluorescence in situ hybridization; Bone marrow; Immunology; Pathology; Internal medicine; Medicine; Chromosome; Genetics; DNA; Gene","score_opus":0.01006663972602593,"score_gpt":0.2066605018886881,"score_spread":0.19659386216266217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1589551152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973887,0.0012608072,0.000018537481,0.00006538688,0.000018346458,0.0005976818,0.0004572364,0.000040375984,0.00015292375],"genre_scores_gemma":[0.99862117,0.0003690158,0.0005522013,0.00003072434,0.00007286114,0.000038453272,0.00021785777,0.000026633274,0.000071107075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99838394,0.0000524577,0.00041437277,0.0004230086,0.0003635654,0.0003626745],"domain_scores_gemma":[0.9990869,0.0001763304,0.00011544169,0.00034524538,0.000085493484,0.0001905668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008152212,0.00023999777,0.00051780354,0.00015203735,0.00006730557,0.00001782644,0.00015444799,0.00012584709,0.00015711709],"category_scores_gemma":[0.00003897432,0.0001844463,0.00004180379,0.00044693195,0.00015736921,0.00010790393,0.00002704476,0.00020576087,0.000012736673],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007764899,0.00048499936,0.96226597,0.00010687605,0.00011204645,0.0000053056056,0.000256834,0.0000010108225,0.01118722,0.0000010972036,0.00004236934,0.025458595],"study_design_scores_gemma":[0.00463903,0.0006429594,0.9657031,0.00033357032,0.00027909718,0.0000036477788,0.000036253296,0.00001710748,0.028045928,0.00001213892,0.000071966206,0.00021514876],"about_ca_topic_score_codex":0.000412904,"about_ca_topic_score_gemma":0.00018375486,"teacher_disagreement_score":0.025243446,"about_ca_system_score_codex":0.00007489066,"about_ca_system_score_gemma":0.00026496398,"threshold_uncertainty_score":0.7521502},"labels":[],"label_agreement":null},{"id":"W159135986","doi":"10.1182/blood.v96.5.1827.h8001827_1827_1835","title":"LSP1 modulates leukocyte populations in resting and inflamed peritoneum","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Peritoneum; Ovalbumin; Chemokine; Biology; Chemotaxis; Immunology; Macrophage; Inflammation; Antigen; In vitro; Receptor; Biochemistry","score_opus":0.04065337034305626,"score_gpt":0.3192088803125665,"score_spread":0.27855550996951023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W159135986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99352276,0.00042688224,0.0000012897209,0.0005405862,0.000009257323,0.00020204538,8.9181714e-7,0.000036913254,0.005259394],"genre_scores_gemma":[0.99610907,0.00009941812,0.001462923,0.0000690057,0.000052328494,0.000013455222,0.0000109711655,0.000015895726,0.0021669115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99920917,0.00003448473,0.00017457792,0.00018801894,0.00018752058,0.00020625112],"domain_scores_gemma":[0.99962986,0.000041176452,0.000014707577,0.00018044306,0.000026850495,0.00010695775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010797791,0.000075532065,0.00013673246,0.0001231472,0.000052828702,0.00001886937,0.000040926494,0.000055405853,0.00031084364],"category_scores_gemma":[0.0001587544,0.00007116379,0.00002290009,0.00021127143,0.000044345914,0.000042775227,0.000030792,0.000180057,0.000042758165],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014791338,0.0005487923,0.680731,0.00012698247,0.000027489785,0.00062553503,0.00068897073,0.0001689959,0.27804106,0.00010875171,0.00011605835,0.038668476],"study_design_scores_gemma":[0.0030989908,0.00014025619,0.96886224,0.00013978218,0.000034619836,0.00017660607,0.00006170727,0.0032767672,0.022536207,0.00022308825,0.0013223622,0.00012740529],"about_ca_topic_score_codex":0.0001990574,"about_ca_topic_score_gemma":0.000073099975,"teacher_disagreement_score":0.28813124,"about_ca_system_score_codex":0.000017873417,"about_ca_system_score_gemma":0.000041231393,"threshold_uncertainty_score":0.34035197},"labels":[],"label_agreement":null},{"id":"W1592515282","doi":"10.1182/blood-2015-01-622084","title":"Salvage chemotherapy and autologous stem cell transplantation for transformed indolent lymphoma: a subset analysis of NCIC CTG LY12","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Queen's University; Hôpital Notre-Dame; Saskatchewan Cancer Agency; CancerCare Manitoba; Health Sciences Centre; Sunnybrook Health Science Centre; Juravinski Cancer Centre; Queen Elizabeth II Health Sciences Centre; Kingston General Hospital; Princess Margaret Cancer Centre","funders":"National Cancer Institute; Canadian Cancer Society Research Institute; Eli Lilly Canada; Cancer Research Institute","keywords":"Medicine; Transplantation; Stem cell; Chemotherapy; Chemotherapy regimen; Autologous stem-cell transplantation; Oncology; Internal medicine; Lymphoma; Surgery; Biology","score_opus":0.019692023321322076,"score_gpt":0.25990329448557936,"score_spread":0.24021127116425728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1592515282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969685,0.0013780633,0.00027636034,0.00017769498,0.000027266706,0.0006225918,0.00016713295,0.00003102184,0.0003513891],"genre_scores_gemma":[0.99836934,0.0005615783,0.0005441628,0.00012858145,0.00002014008,0.00011453188,0.00019620363,0.00001526339,0.00005022868],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914056,0.000022474705,0.0002646827,0.00021670025,0.00018320895,0.00017238548],"domain_scores_gemma":[0.99947435,0.00007557186,0.000084441555,0.00015571475,0.00006970512,0.00014020315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012876412,0.00014429454,0.00047162178,0.00017889545,0.000025778165,0.000008446237,0.00003812582,0.00008809004,0.000008353468],"category_scores_gemma":[0.0000029277228,0.00011214107,0.00017877144,0.00025726028,0.00003419661,0.000038948136,0.0000024190483,0.000017142635,0.0000013401062],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047725416,0.017413104,0.74484575,0.0017726901,0.012683407,0.00029942885,0.025840005,0.00004073399,0.01507335,0.00026519902,0.00045473504,0.17653903],"study_design_scores_gemma":[0.04359676,0.00137224,0.71305627,0.00005357073,0.01284363,0.000059535563,0.00040626616,0.0002535421,0.22787867,0.00002276552,0.00029674722,0.00016002197],"about_ca_topic_score_codex":0.000078124576,"about_ca_topic_score_gemma":0.000055640525,"teacher_disagreement_score":0.21280533,"about_ca_system_score_codex":0.000053301163,"about_ca_system_score_gemma":0.00011262629,"threshold_uncertainty_score":0.457298},"labels":[],"label_agreement":null},{"id":"W1592800848","doi":"10.1182/blood.v96.1.139","title":"Sphingosine-1-phosphate and lysophosphatidic acid trigger invasion of primitive hematopoietic cells into stromal cell layers","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"","keywords":"Lysophosphatidic acid; Stromal cell; Haematopoiesis; Sphingosine; Biology; Cell biology; Sphingosine-1-phosphate; Receptor; Cell culture; Cell; Stem cell; Cancer research; Biochemistry","score_opus":0.004454798118171216,"score_gpt":0.19770126341477826,"score_spread":0.19324646529660705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1592800848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889467,0.00989173,0.00007564314,0.000027307418,0.00008072745,0.00018490941,0.000012390343,0.000013502908,0.0007671213],"genre_scores_gemma":[0.99612,0.0017873129,0.0014047913,0.00013358571,0.00013141498,0.0000107153555,0.000029631645,0.000029346995,0.00035319966],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988544,0.000045711506,0.00029884223,0.00038341078,0.00016262458,0.00025500736],"domain_scores_gemma":[0.999411,0.00001538309,0.00011272077,0.00028634796,0.000053949392,0.00012060399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017321057,0.00020478538,0.00027051623,0.00004061192,0.000080331076,0.000023028982,0.00015831995,0.00015173735,0.000113978895],"category_scores_gemma":[0.00002085791,0.000192455,0.00009901535,0.00010768611,0.000099789344,0.0000095262485,0.00007132645,0.000087180924,0.000011350452],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009137958,0.00021390124,0.00095480104,0.00008062605,0.00004337094,0.000006174643,0.00035132872,0.000018336106,0.9969597,0.000025217394,0.0001037309,0.0011514315],"study_design_scores_gemma":[0.002349965,0.00022239558,0.0009745262,0.000035798097,0.000114539485,0.000012778447,0.000103228114,0.0000103382245,0.99398154,0.00004963523,0.0019396979,0.00020555951],"about_ca_topic_score_codex":0.000051881634,"about_ca_topic_score_gemma":0.000003157183,"teacher_disagreement_score":0.008104417,"about_ca_system_score_codex":0.000003570807,"about_ca_system_score_gemma":0.00006026546,"threshold_uncertainty_score":0.78480875},"labels":[],"label_agreement":null},{"id":"W1600365609","doi":"10.1182/blood-2015-01-621664","title":"International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton; Princess Margaret Cancer Centre; CancerCare Manitoba","funders":"","keywords":"Azacitidine; Medicine; Internal medicine; Hypomethylating agent; Phases of clinical research; Complete remission; Oncology; Clinical trial; Chemotherapy","score_opus":0.01641405087413181,"score_gpt":0.2939353942663254,"score_spread":0.2775213433921936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1600365609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99688816,0.000028800385,0.000018963361,0.00015195899,0.000044612923,0.0011747357,0.00016242299,0.00002465885,0.0015057075],"genre_scores_gemma":[0.9981484,0.0000029625642,0.00060935033,0.00005822153,0.000094776995,0.0001237099,0.00061533967,0.00003300754,0.00031427835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99802595,0.00006498583,0.0002826683,0.0003227404,0.001056536,0.0002471099],"domain_scores_gemma":[0.9984392,0.00007580867,0.00012425183,0.00028860752,0.0008639288,0.00020819629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012616522,0.00016941027,0.00031416913,0.0002525866,0.000022757356,0.000013149765,0.00016283413,0.000056001852,0.000526542],"category_scores_gemma":[0.00014130214,0.00012480558,0.000030117062,0.0002836834,0.00009718516,0.000108648834,0.00007820658,0.00023230354,0.000021654958],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033498518,0.016133394,0.9712701,0.00006164056,0.00045709673,0.00067509117,0.004045264,0.00002779384,0.000097375116,0.00001641992,0.003370305,0.00049565884],"study_design_scores_gemma":[0.28852716,0.013700557,0.6884015,0.00042027913,0.00024601756,0.000039312075,0.005803185,0.0000792838,0.0008877475,0.0000032089843,0.0016539397,0.00023777783],"about_ca_topic_score_codex":0.0001375865,"about_ca_topic_score_gemma":0.00014615148,"teacher_disagreement_score":0.28517732,"about_ca_system_score_codex":0.0002004985,"about_ca_system_score_gemma":0.000449096,"threshold_uncertainty_score":0.5765266},"labels":[],"label_agreement":null},{"id":"W1603680605","doi":"10.1182/blood.v96.10.3499","title":"A subset of human monocyte-derived dendritic cells expresses high levels of interleukin-12 in response to combined CD40 ligand and interferon-γ treatment","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":136,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research & Development Corporation","funders":"National Center for Research Resources; National Cancer Institute","keywords":"CD40; CD80; Biology; Dendritic cell; CD86; Cell biology; CD154; Antigen presentation; Antigen-presenting cell; Antigen; Interleukin 12; T cell; Interleukin 4; Follicular dendritic cells; Cytokine; Immunology; Immune system; In vitro; Cytotoxic T cell; Biochemistry","score_opus":0.01700082294599789,"score_gpt":0.24569508282878577,"score_spread":0.22869425988278788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1603680605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962702,0.003023621,0.000003378713,0.000060486615,0.00008389839,0.00037627318,0.00010255701,0.000021217531,0.000058359685],"genre_scores_gemma":[0.997566,0.00030173516,0.000054648437,0.000035274905,0.000004513168,0.000040499606,0.000013777832,0.000022259996,0.0019613204],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983946,0.0005054029,0.0005205722,0.00026351967,0.00003071006,0.0002851882],"domain_scores_gemma":[0.99909544,0.00038530488,0.000100318815,0.00036305303,0.000034376237,0.000021504504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021098409,0.0002297135,0.0005595687,0.00024726836,0.000061956736,0.000010410108,0.0002039668,0.00016405297,0.00054125924],"category_scores_gemma":[0.000033058088,0.0002052345,0.00008206653,0.00011023005,0.0002289968,0.000067709654,0.000052552234,0.00010631547,0.000029538678],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01450355,0.0012636934,0.0006375282,0.00002833935,0.00027551883,0.000013107887,0.0045398483,0.0000023330083,0.97620153,0.000016289561,0.00002238188,0.0024958514],"study_design_scores_gemma":[0.0098853875,0.005823961,0.042383224,0.00022916301,0.00006334571,0.000028066755,0.00037861033,1.5998882e-7,0.94051576,0.00003438561,0.00048520084,0.00017274884],"about_ca_topic_score_codex":0.00044833415,"about_ca_topic_score_gemma":0.00010196523,"teacher_disagreement_score":0.041745696,"about_ca_system_score_codex":0.000030327688,"about_ca_system_score_gemma":0.00005231717,"threshold_uncertainty_score":0.836922},"labels":[],"label_agreement":null},{"id":"W1606013393","doi":"10.1182/blood-2015-03-635417","title":"CD8+ T cells are predominantly protective and required for effective steroid therapy in murine models of immune thrombocytopenia","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Canadian Blood Services; St. Michael's Hospital","funders":"Canadian Institutes of Health Research; China Scholarship Council; University of Toronto; Canadian Blood Services; Heart and Stroke Foundation of Canada","keywords":"Immune system; Immunology; Medicine; CD8","score_opus":0.027828354821316948,"score_gpt":0.2698441869820113,"score_spread":0.24201583216069433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1606013393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99340224,0.002072699,0.00013106402,0.000062243846,0.000029077935,0.0038907786,0.000039279428,0.000014436806,0.00035819487],"genre_scores_gemma":[0.99858797,0.00014968966,0.00067730795,0.000015233168,0.000014348039,0.00045220135,0.000010725814,0.000021786804,0.00007073203],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99922585,0.000040004947,0.0002115866,0.00023329158,0.0001129983,0.00017627886],"domain_scores_gemma":[0.99946564,0.00006296623,0.00012255217,0.00017880212,0.000104317856,0.000065721826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001600594,0.00014869065,0.00057631324,0.00007270156,0.000024060175,0.000006283688,0.000045960267,0.00007649673,0.0000017177045],"category_scores_gemma":[0.000038491227,0.00011243649,0.000057020006,0.00009108033,0.00005090657,0.000107324704,0.000028257373,0.00006411681,0.0000012562218],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03159006,0.024188003,0.037667345,0.0016789801,0.0035686959,0.0010412207,0.01977165,0.00015429153,0.8470598,0.00028049102,0.00014197246,0.03285752],"study_design_scores_gemma":[0.089421906,0.008002101,0.039239913,0.0005119075,0.00024748998,0.00007996746,0.0006681577,0.0005239629,0.8549396,0.0060999272,0.000029942288,0.00023516102],"about_ca_topic_score_codex":0.00015533637,"about_ca_topic_score_gemma":0.0000618367,"teacher_disagreement_score":0.057831846,"about_ca_system_score_codex":0.000028119002,"about_ca_system_score_gemma":0.00004805892,"threshold_uncertainty_score":0.45850274},"labels":[],"label_agreement":null},{"id":"W1610042796","doi":"10.1182/blood.v122.21.2153.2153","title":"The Modified Pre-Transplant EBMT Risk Score Is Superior To The HCT-CI Score In Predicting Overall Survival and Non-Relapse Mortality After Allogeneic Hematopoietic Cell Transplantation In Patients With Acute Myeloid Leukemia","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Transplantation; Univariate analysis; Hematopoietic stem cell transplantation; Hematopoietic cell; Single Center; Gastroenterology; Surgery; Multivariate analysis; Haematopoiesis; Stem cell","score_opus":0.009088373344935492,"score_gpt":0.23278313764684783,"score_spread":0.22369476430191235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1610042796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957335,0.00018761143,0.00008864244,0.0003358632,0.000060856135,0.003189424,0.00023740396,0.000032228163,0.00013446661],"genre_scores_gemma":[0.99806654,0.00067613984,0.00012838044,0.00022555323,0.00006322141,0.000584895,0.00008849469,0.000058581325,0.000108172884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971373,0.00021040149,0.0005591049,0.00060743315,0.0007760641,0.00070969475],"domain_scores_gemma":[0.9986893,0.00020562287,0.00010510676,0.00062958547,0.00012508353,0.0002453272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005962312,0.00036207712,0.00044840292,0.00014622403,0.0001872713,0.000104106504,0.0003046852,0.00018589344,0.00002980098],"category_scores_gemma":[0.00003075654,0.00020700581,0.000077053104,0.0003802134,0.00015817281,0.00020224541,0.0000756295,0.0007591067,0.000022947082],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001675972,0.00024344081,0.9890087,0.00022573714,0.00017593977,0.00013924131,0.006659383,0.00012054723,0.0014307947,0.000002448139,0.000031116386,0.00028666243],"study_design_scores_gemma":[0.010049325,0.00046164042,0.9840758,0.00037228156,0.00042624032,0.00003397746,0.00021700557,0.00075528433,0.0033410643,0.000019653224,0.000005584689,0.00024217254],"about_ca_topic_score_codex":0.0039679967,"about_ca_topic_score_gemma":0.0027469678,"teacher_disagreement_score":0.008373354,"about_ca_system_score_codex":0.00020484273,"about_ca_system_score_gemma":0.00032541784,"threshold_uncertainty_score":0.84414524},"labels":[],"label_agreement":null},{"id":"W1611329979","doi":"10.1182/blood-2015-06-646695","title":"Pharmacologic control of chromatin looping","year":2015,"lang":"en","type":"letter","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Chromatin; Medicine; Chemistry; Biology; Genetics; DNA","score_opus":0.016542538102861135,"score_gpt":0.26071799448205923,"score_spread":0.2441754563791981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1611329979","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06545482,0.02195927,0.00010027241,0.8650504,0.001303373,0.0020764729,0.00015596041,0.00029590225,0.043603547],"genre_scores_gemma":[0.13591479,0.0005375092,0.00030531557,0.85584843,0.0034004184,0.000048453578,0.00029487535,0.00009758426,0.0035526275],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986997,0.000064721324,0.00036698964,0.00022970057,0.00033938675,0.00029949422],"domain_scores_gemma":[0.9992468,0.000057772664,0.00022283652,0.00024890015,0.00014673462,0.00007695417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015653108,0.00022154632,0.00066392455,0.000112317306,0.00002437399,0.0000058333926,0.00011892847,0.000849982,0.00030333517],"category_scores_gemma":[0.00008871642,0.00016691707,0.0001788673,0.00012112779,0.00009382783,0.000017305969,0.000026931353,0.0011682545,0.000089691835],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028157527,0.0002690676,0.0003169501,0.00085901126,0.00063548336,0.0011182621,0.000067237415,0.0000023535092,0.0038058604,0.0000020142327,0.9924372,0.00045839875],"study_design_scores_gemma":[0.018172959,0.0006823002,0.00007693422,0.00075242994,0.0034171443,0.00036939405,0.000051739127,0.00007607872,0.0026183284,0.000065090455,0.9733892,0.00032838542],"about_ca_topic_score_codex":0.000020693415,"about_ca_topic_score_gemma":2.0841382e-7,"teacher_disagreement_score":0.07045996,"about_ca_system_score_codex":0.000026088572,"about_ca_system_score_gemma":0.00026008426,"threshold_uncertainty_score":0.68066806},"labels":[],"label_agreement":null},{"id":"W1627630471","doi":"10.1182/blood.v120.21.2088.2088","title":"Elevated Hematocrit Concentration and the Risk of Mortality and Vascular Events in Patients Undergoing Major Surgery.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Hematocrit; Pulmonary embolism; Perioperative; Odds ratio; Deep vein; Myocardial infarction; Surgery; Thrombosis; Anemia; Internal medicine; Anesthesia","score_opus":0.014014336628560995,"score_gpt":0.23753669393453103,"score_spread":0.22352235730597003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1627630471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99857634,0.0005590672,0.000032325996,0.000092421986,0.00004175315,0.0005585266,0.000002476986,0.000008801334,0.00012827202],"genre_scores_gemma":[0.9990598,0.00077100215,0.000038548023,0.00008259756,0.000012327528,0.000012149975,0.000009540726,0.000005473979,0.000008568798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99932855,0.00009689033,0.00020176367,0.00009011719,0.00016075195,0.00012189846],"domain_scores_gemma":[0.99964213,0.00009658617,0.00006257655,0.00012156497,0.00002486769,0.00005224619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052674743,0.0000652189,0.00019543755,0.000022445623,0.000029740457,0.0000028107931,0.000016287244,0.00002927149,0.000012383812],"category_scores_gemma":[0.00010179652,0.000043852953,0.00003850026,0.00008027541,0.000042550695,0.00005749627,0.000018614328,0.000058284342,7.6437647e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004867824,0.0005700911,0.9981144,0.00014632609,0.00020347389,4.0469547e-7,0.0002745073,1.1927702e-7,0.000053813157,0.00038215396,0.0000124649205,0.00019354484],"study_design_scores_gemma":[0.011122268,0.000028803135,0.9868002,0.00008405658,0.0005964232,9.9304e-7,0.000078617595,0.000016051248,0.001114466,0.00008626289,0.00002917477,0.000042671672],"about_ca_topic_score_codex":0.00018775467,"about_ca_topic_score_gemma":0.000056578996,"teacher_disagreement_score":0.0113142105,"about_ca_system_score_codex":0.0000046019763,"about_ca_system_score_gemma":0.000011850891,"threshold_uncertainty_score":0.17882717},"labels":[],"label_agreement":null},{"id":"W1641003942","doi":"10.1182/blood.v122.21.2961.2961","title":"Development, Establishment Of the Psychometric Properties and Usability Testing Of a Novel Multi-Dimensional Web Based Diary For Children With Sickle Cell Disease","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Physical therapy; Pain assessment; Chronic pain; Recall bias; Usability; Brief Pain Inventory; Pain management","score_opus":0.023816031303538737,"score_gpt":0.21619790561811028,"score_spread":0.19238187431457154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1641003942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99783915,0.0005639708,0.0000736695,0.00015606143,0.000016603193,0.0012807893,0.00001799273,0.00001744284,0.00003431906],"genre_scores_gemma":[0.9736407,0.0000034103987,0.026140975,0.00008147844,0.0000067848846,0.00007026317,0.000005332752,0.000014613396,0.000036434045],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992528,0.000015601501,0.00022617851,0.00017648998,0.0001863507,0.00014259253],"domain_scores_gemma":[0.9993735,0.00007870946,0.00010748977,0.00017927059,0.00016042001,0.000100639714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015019391,0.00010591132,0.00017325113,0.00006923937,0.0000674544,0.0000062090226,0.00005752952,0.00003868424,0.000007953828],"category_scores_gemma":[0.0003072511,0.0000547137,0.000038665905,0.00031659112,0.0001370245,0.00003986561,0.000036087007,0.00007136243,4.6763842e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000924448,0.0039095394,0.96005934,0.00045332027,0.00007116,1.5894253e-7,0.000116844596,0.000072017785,0.03360314,9.967981e-7,0.000041911037,0.0015791408],"study_design_scores_gemma":[0.010004391,0.00018445795,0.9599717,0.00030466667,0.00022297917,0.000003897391,0.00007943354,0.004093517,0.025007922,0.0000017435925,0.00002382989,0.00010140526],"about_ca_topic_score_codex":0.00006209908,"about_ca_topic_score_gemma":0.0000036638555,"teacher_disagreement_score":0.026067305,"about_ca_system_score_codex":0.000008957232,"about_ca_system_score_gemma":0.0003227976,"threshold_uncertainty_score":0.22311598},"labels":[],"label_agreement":null},{"id":"W1660256439","doi":"10.1182/blood-2015-01-622787","title":"Warfarin-induced venous limb ischemia/gangrene complicating cancer: a novel and clinically distinct syndrome","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; McMaster University","funders":"","keywords":"Medicine; Warfarin; Gangrene; Heparin; Limb ischemia; Cancer; Venous thrombosis; Ischemia; Surgery; Anesthesia; Internal medicine; Cardiology; Thrombosis","score_opus":0.06963541281402771,"score_gpt":0.325434063199551,"score_spread":0.2557986503855233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1660256439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932632,0.0008077852,0.000049053186,0.0013770253,0.00013961612,0.0005008683,0.000014543492,0.00011737457,0.0037305534],"genre_scores_gemma":[0.99678886,0.00012427087,0.0019227334,0.0006619146,0.00020366053,0.00011417889,0.000020757034,0.00003843941,0.00012517185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985731,0.000016655682,0.00039416435,0.00041309826,0.00026960185,0.00033334948],"domain_scores_gemma":[0.99888766,0.00007406038,0.00015393108,0.00041252878,0.00010919755,0.0003626311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030629596,0.0001918566,0.0005984418,0.000054141896,0.00008626738,0.000034453857,0.00013223135,0.00009639485,0.000023924442],"category_scores_gemma":[0.00020564625,0.00016996062,0.00007371314,0.00013865756,0.00005602684,0.00004484507,0.00020642765,0.00020208638,0.00003438006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075505266,0.06947301,0.6845969,0.002615751,0.0053966925,0.00176947,0.0071069617,0.000023114051,0.1346303,0.0030799077,0.009457634,0.081095226],"study_design_scores_gemma":[0.014264701,0.005251115,0.9597554,0.00068704656,0.0022493035,0.0010380447,0.00038867287,0.00021970764,0.004451152,0.00016263584,0.010849403,0.00068278116],"about_ca_topic_score_codex":0.0005519467,"about_ca_topic_score_gemma":0.000047272984,"teacher_disagreement_score":0.27515855,"about_ca_system_score_codex":0.000044326986,"about_ca_system_score_gemma":0.00013094398,"threshold_uncertainty_score":0.6930793},"labels":[],"label_agreement":null},{"id":"W166239273","doi":"10.1182/blood.v122.21.73.73","title":"Determining Cell-Of-Origin Subtypes In Diffuse Large B-Cell Lymphoma Using Gene Expression Profiling On Formalin-Fixed Paraffin-Embedded Tissue – An L.L.M.P.P. Project","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Tissue microarray; Gene expression profiling; Immunohistochemistry; Cancer research; Germinal center; Cancer; Lymphoma; Medicine; Pathology; Biology; Oncology; Gene expression; B cell; Internal medicine; Gene; Immunology; Genetics; Antibody","score_opus":0.016284722274274376,"score_gpt":0.2898255399554587,"score_spread":0.2735408176811843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W166239273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938512,0.00019176259,0.004927282,0.0000058232004,0.000025671821,0.0007101988,0.000021221687,0.000031354997,0.0002355011],"genre_scores_gemma":[0.94560266,0.000042408366,0.053731147,0.00006588919,0.000064095766,0.00020463791,0.00020176204,0.00003393668,0.000053451513],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99870616,0.000090083086,0.00033966638,0.00043273295,0.00009392595,0.000337441],"domain_scores_gemma":[0.9991967,0.000010428629,0.00018429103,0.0004888543,0.00005585598,0.000063843814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001480786,0.0002050846,0.00020689417,0.000088952875,0.00008110858,0.00002003974,0.00024091816,0.00026743519,0.0000055174883],"category_scores_gemma":[0.000016474609,0.000186157,0.00006160665,0.000113107686,0.00003659756,0.000009980985,0.000116148025,0.00007901892,0.00000486122],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021406035,0.0025993509,0.0040556863,0.00002864338,0.000006685488,0.000003964211,0.00006279877,0.000011509336,0.992651,0.000032802815,0.000020188281,0.00050596875],"study_design_scores_gemma":[0.0029507927,0.00042538933,0.00028431797,0.000027206699,0.000020356261,0.000009388019,0.00006529823,0.0006446218,0.9949604,0.00002879969,0.00035439557,0.00022903508],"about_ca_topic_score_codex":0.000037982365,"about_ca_topic_score_gemma":0.000008891536,"teacher_disagreement_score":0.048803866,"about_ca_system_score_codex":0.000009167376,"about_ca_system_score_gemma":0.00007945083,"threshold_uncertainty_score":0.75912625},"labels":[],"label_agreement":null},{"id":"W1668902290","doi":"10.1182/blood.v124.21.4559.4559","title":"Bosutinib As Third-Line Therapy in Patients (Pts) with Chronic Phase Chronic Myeloid Leukemia (CP CML) Following Failure with Imatinib Plus Dasatinib and/or Nilotinib: 48-Month Update of a Phase 1/2 Study","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Bosutinib; Nilotinib; Dasatinib; Medicine; Internal medicine; Imatinib; Gastroenterology; Imatinib mesylate; Myeloid leukemia","score_opus":0.012911871954017174,"score_gpt":0.2859074742347657,"score_spread":0.27299560228074854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1668902290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99306065,0.00077869516,0.00006396757,0.00013794765,0.00009981774,0.005070016,0.00006611158,0.00020139496,0.0005214029],"genre_scores_gemma":[0.99669677,0.00015419273,0.001468481,0.0001849715,0.0002683802,0.00042761432,0.00033857123,0.00021636221,0.00024468405],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99484414,0.0003011382,0.0012608102,0.0013015317,0.001212618,0.0010797861],"domain_scores_gemma":[0.9969591,0.0002375105,0.00074926217,0.0014168599,0.00019442577,0.0004428269],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007251057,0.0009805466,0.0018129543,0.00039238093,0.00020285482,0.00006517506,0.00040343378,0.00024972935,0.00025133294],"category_scores_gemma":[0.00019964353,0.0006586304,0.0001859123,0.0008577083,0.0002501116,0.00036233437,0.00015222021,0.0007267572,0.000047747704],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08544714,0.11581515,0.532602,0.0026873637,0.013720892,0.0034595602,0.020209935,0.00048718965,0.015187825,0.00016964073,0.0008334852,0.20937979],"study_design_scores_gemma":[0.8122565,0.13708866,0.022611456,0.0022282582,0.0023209865,0.00022400872,0.0010333786,0.0020908285,0.01713099,0.000019821391,0.001710356,0.0012847455],"about_ca_topic_score_codex":0.0006300498,"about_ca_topic_score_gemma":0.0016298539,"teacher_disagreement_score":0.7268094,"about_ca_system_score_codex":0.001840642,"about_ca_system_score_gemma":0.0035798817,"threshold_uncertainty_score":0.9995865},"labels":[],"label_agreement":null},{"id":"W1683783668","doi":"10.1182/blood-2014-10-608471","title":"Reflections on the FranceCoag report on inhibitory antibodies to factor VIII in patients with severe hemophilia A","year":2015,"lang":"en","type":"letter","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Antibody; Immunology","score_opus":0.04745577021314558,"score_gpt":0.32617936917892226,"score_spread":0.2787235989657767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1683783668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75786525,0.00003657225,1.3693041e-7,0.21836376,0.0002701178,0.0016410035,0.00009323751,0.000058380476,0.021671534],"genre_scores_gemma":[0.6843542,0.000034168683,0.00014868162,0.25110438,0.005379067,0.0004450491,0.001041818,0.00023082088,0.057261832],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973602,0.000096445896,0.00031541026,0.00059352675,0.0011638289,0.00047058295],"domain_scores_gemma":[0.99851525,0.00013175652,0.000104848135,0.00085468794,0.0002545112,0.00013892249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016182363,0.0003748956,0.0005129976,0.0003908881,0.00013194726,0.00003041961,0.00014817885,0.00044661382,0.00010055101],"category_scores_gemma":[0.00022722305,0.00019805382,0.00010575302,0.00036401403,0.000084077736,0.000035483616,0.000055099525,0.0017674512,0.00026855653],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005116356,0.0017073496,0.15284058,0.00014684525,0.00039257176,0.0046477546,0.0005245843,0.0000012741805,0.000039593197,0.0000033210624,0.83890486,0.00027959183],"study_design_scores_gemma":[0.00992802,0.007565118,0.23545231,0.0026698797,0.00031668105,0.00021950692,0.00007611649,3.9825554e-7,0.0014758958,0.0000691559,0.7414604,0.0007665425],"about_ca_topic_score_codex":0.000048149115,"about_ca_topic_score_gemma":0.000034875648,"teacher_disagreement_score":0.09744451,"about_ca_system_score_codex":0.00020932163,"about_ca_system_score_gemma":0.00032754836,"threshold_uncertainty_score":0.80764},"labels":[],"label_agreement":null},{"id":"W1715550511","doi":"10.1182/blood-2015-01-620872","title":"A systematic review of transfusion-associated graft-versus-host disease","year":2015,"lang":"en","type":"review","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":200,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Graft-versus-host disease; Medicine; Host (biology); Disease; Intensive care medicine; Biology; Internal medicine","score_opus":0.04320297862630995,"score_gpt":0.32735473634325146,"score_spread":0.2841517577169415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1715550511","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000016186576,0.9880741,0.0000054169977,0.00015097151,0.0002802918,0.008420192,0.00016213207,0.000117986245,0.0027872957],"genre_scores_gemma":[0.000002910641,0.99739814,0.00003216429,0.00030888314,0.000058586207,0.0006428089,0.00041049323,0.00008641054,0.0010595983],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99633586,0.00038524295,0.0015942133,0.0004673874,0.0009123293,0.00030498137],"domain_scores_gemma":[0.9974321,0.00014509365,0.0006152371,0.0010045405,0.0002840098,0.00051902013],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009969387,0.00053720264,0.0052669286,0.00023386502,0.00003947608,0.000010779366,0.00029810044,0.00021776844,0.00023279518],"category_scores_gemma":[0.0006903586,0.00037074072,0.0015413688,0.000719239,0.00005105244,0.00003509215,0.000059322865,0.00033903273,0.00013134698],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023141863,0.0015519432,5.9665444e-7,0.9897988,0.002503845,0.00014423115,0.000021508986,1.7785939e-9,1.2576045e-7,0.000085807544,0.0013088315,0.004561161],"study_design_scores_gemma":[0.0028164485,0.00017216883,0.0000011424175,0.6916918,0.10502933,0.00001611353,0.0000096738195,1.6701114e-7,2.2593635e-7,0.000002245596,0.20004007,0.00022060351],"about_ca_topic_score_codex":0.000015620555,"about_ca_topic_score_gemma":0.00000808092,"teacher_disagreement_score":0.298107,"about_ca_system_score_codex":0.00007635845,"about_ca_system_score_gemma":0.0006489641,"threshold_uncertainty_score":0.9998745},"labels":[],"label_agreement":null},{"id":"W172066064","doi":"10.1182/blood.v122.21.5093.5093","title":"Rituximab Improves Overall Survival In Patients Treated With CODOX-M/IVAC For Burkitt Lymphoma (BL) and B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and BL: A Single Center Experience and Review Of The Literature","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; Queen's University; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Rituximab; Medicine; Lymphoma; Diffuse large B-cell lymphoma; Burkitt's lymphoma; Internal medicine; Regimen; Oncology","score_opus":0.006194568633169314,"score_gpt":0.20625558912471148,"score_spread":0.20006102049154217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W172066064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98235554,0.014644125,0.0000010345142,0.00016298739,0.000039160645,0.0022772325,0.00028976882,0.00002785433,0.0002022807],"genre_scores_gemma":[0.9946809,0.0037442234,0.00024943874,0.00046077438,0.000044179502,0.00035566036,0.00017386445,0.0000577919,0.00023315768],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99793136,0.00009473588,0.00044823857,0.0006611743,0.00035728054,0.0005072032],"domain_scores_gemma":[0.9985847,0.00016916083,0.00029961407,0.0004789376,0.0002206037,0.00024697845],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001027386,0.0005077673,0.0009427608,0.00010729147,0.00011804764,0.00011912589,0.00014299227,0.000167373,0.0000041938742],"category_scores_gemma":[0.000047998376,0.00027698957,0.00008983681,0.00025465625,0.00023352532,0.00025855078,0.00016095597,0.000060554707,8.082512e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005781091,0.021856867,0.965347,0.0031522573,0.00020103471,0.00003037931,0.0012352093,8.181069e-9,0.0005076224,0.000011898296,0.00020877608,0.0068708514],"study_design_scores_gemma":[0.15099674,0.0022184402,0.83108336,0.006410517,0.0005650016,0.000053537005,0.00013969683,0.0000069719263,0.0076606357,0.0000100644065,0.00054032414,0.00031469998],"about_ca_topic_score_codex":0.00024604073,"about_ca_topic_score_gemma":0.000047240097,"teacher_disagreement_score":0.15041862,"about_ca_system_score_codex":0.000108168824,"about_ca_system_score_gemma":0.00009436229,"threshold_uncertainty_score":0.99996823},"labels":[],"label_agreement":null},{"id":"W1726552965","doi":"10.1182/blood.v106.11.585.585","title":"Determinants of Health-Related Quality of Life after Deep Venous Thrombosis: Two-Year Results from a Canadian Multicenter Prospective Cohort Study (The VETO Study).","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; McGill University; Université de Montréal; McMaster University; Jewish General Hospital","funders":"","keywords":"Medicine; Quality of life (healthcare); Cohort; Prospective cohort study; Venous thrombosis; Deep vein; Post-thrombotic syndrome; Physical therapy; Thrombosis; Cohort study; Internal medicine; Incidence (geometry)","score_opus":0.025241990575440538,"score_gpt":0.31212705174744343,"score_spread":0.2868850611720029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1726552965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99264157,0.00042558069,4.879151e-7,0.0004177978,0.00012272135,0.0056879213,0.000109100256,0.000029389705,0.00056540704],"genre_scores_gemma":[0.9989867,0.00003806865,0.000099182675,0.0003648435,0.00009755054,0.00033830968,0.000016380289,0.00003611574,0.000022800992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966574,0.00036807248,0.0014566627,0.0005277588,0.0005587379,0.0004313775],"domain_scores_gemma":[0.9979431,0.000108752385,0.0005700185,0.0009074714,0.00020378946,0.00026687537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015054964,0.00024297497,0.0012963508,0.00013733965,0.0001266141,0.000015392228,0.00022228927,0.00006636429,0.00010889961],"category_scores_gemma":[0.00026745943,0.00018532059,0.00013297758,0.0002454034,0.00009095767,0.00006658198,0.00010235004,0.00020480204,0.000039760125],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003586807,0.022942517,0.9482821,0.000043446704,0.0017092635,0.000023591901,0.026100298,0.000011197065,0.000016467613,0.000005716948,0.00007671351,0.00043000895],"study_design_scores_gemma":[0.014927989,0.00208861,0.9705933,0.0001223167,0.0011200061,7.818964e-7,0.010812287,0.000024409535,0.000120032615,0.000008370105,0.000027690554,0.00015424477],"about_ca_topic_score_codex":0.4093747,"about_ca_topic_score_gemma":0.52798265,"teacher_disagreement_score":0.11860797,"about_ca_system_score_codex":0.00016808811,"about_ca_system_score_gemma":0.0003022749,"threshold_uncertainty_score":0.7557154},"labels":[],"label_agreement":null},{"id":"W1732618877","doi":"10.1182/blood-2015-03-635805","title":"Inflammation rapidly reorganizes mouse bone marrow B cells and their environment in conjunction with early IgM responses","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Granulopoiesis; Bone marrow; Inflammation; Haematopoiesis; Immunology; Biology; Cell biology; Medicine; Stem cell","score_opus":0.008656914779433247,"score_gpt":0.17498570538114971,"score_spread":0.16632879060171646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1732618877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99665576,0.0024002343,0.00003551909,0.00025953798,0.00012923358,0.00023172556,0.000012537463,0.000055494704,0.00021997305],"genre_scores_gemma":[0.9947194,0.0002795034,0.00008975274,0.000037427326,0.000023258164,0.000020897742,0.000037734877,0.000018687126,0.004773327],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989654,0.00027554002,0.0002257157,0.00026219958,0.000027766582,0.0002433735],"domain_scores_gemma":[0.9995293,0.00008505071,0.00010516019,0.00022984207,0.000025522586,0.000025136147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002706741,0.0001745877,0.00023106794,0.00012632762,0.00007264338,0.000015684662,0.0000805959,0.00022156387,0.00008145083],"category_scores_gemma":[0.000026149366,0.00013054338,0.000020549378,0.00007297037,0.0002289945,0.00011079868,0.000062408006,0.0002113192,0.0002730578],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087724096,0.0002276258,0.005019469,0.000006761648,0.00008008358,0.000011642487,0.0013064366,0.00000288554,0.9913492,0.000050692903,0.0001383545,0.000929594],"study_design_scores_gemma":[0.0058326754,0.0008337052,0.0029733982,0.000013483755,0.000036894875,0.000114509545,0.00066145015,6.0554754e-7,0.9786502,0.00009890622,0.010611019,0.00017313976],"about_ca_topic_score_codex":0.00012541804,"about_ca_topic_score_gemma":0.000052461055,"teacher_disagreement_score":0.012699001,"about_ca_system_score_codex":0.00002505224,"about_ca_system_score_gemma":0.0000406292,"threshold_uncertainty_score":0.53234047},"labels":[],"label_agreement":null},{"id":"W1739197012","doi":"10.1182/blood.v114.22.788.788","title":"Results From a Randomized Trial of Salvage Chemotherapy Followed by Lestaurtinib for FLT3 Mutant AML Patients in First Relapse.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Tolerability; Chemotherapy; Cytarabine; Oncology; Randomized controlled trial; Chemotherapy regimen; Surgery; Adverse effect","score_opus":0.012123361364622977,"score_gpt":0.27660090809294163,"score_spread":0.26447754672831864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1739197012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990846,0.00012647595,0.00006610866,0.0024489134,0.0001103664,0.005047706,0.0004331048,0.000044349108,0.00087701716],"genre_scores_gemma":[0.99605536,0.0002681471,0.0018773588,0.00036910264,0.00020268084,0.00016491352,0.0006297242,0.00004149037,0.00039123461],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99744505,0.00015217566,0.0010321031,0.000446078,0.000509697,0.0004149134],"domain_scores_gemma":[0.9976988,0.0012101596,0.00030220745,0.0005097133,0.00013480788,0.00014432803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010688711,0.0002258127,0.0011748169,0.00016166159,0.000041993248,0.00001379496,0.00020480747,0.00022395884,0.00003127456],"category_scores_gemma":[0.0033796453,0.00018034056,0.00032836772,0.0002789521,0.00008906554,0.000060538783,0.000024520998,0.00027505207,0.000006801807],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9719023,0.0034895146,0.0004431728,0.000023591074,0.00020938131,0.000023022194,0.000856519,5.408504e-7,0.013502955,0.000011275243,0.007579465,0.0019582708],"study_design_scores_gemma":[0.95474887,0.0022417922,0.0018509257,0.00015721735,0.00020010222,0.0000011340942,0.000036528632,0.00015545066,0.038650658,0.00017394993,0.0016258165,0.00015757326],"about_ca_topic_score_codex":0.00041468907,"about_ca_topic_score_gemma":0.000047609636,"teacher_disagreement_score":0.025147703,"about_ca_system_score_codex":0.0001151269,"about_ca_system_score_gemma":0.0001998256,"threshold_uncertainty_score":0.7354075},"labels":[],"label_agreement":null},{"id":"W174443042","doi":"10.1182/blood.v122.21.3636.3636","title":"A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial Demonstrating Reversal Of Rivaroxaban-Induced Anticoagulation In Healthy Subjects By Andexanet Alfa (PRT064445), An Antidote For Fxa Inhibitors","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute; McMaster University","funders":"","keywords":"Rivaroxaban; Medicine; Placebo; Pharmacokinetics; Pharmacodynamics; Antidote; Pharmacology; Cohort; Anesthesia; Clinical trial; Randomized controlled trial; Anticoagulant; Internal medicine; Urology; Warfarin; Toxicity; Pathology","score_opus":0.05869333450192348,"score_gpt":0.3568677968344952,"score_spread":0.2981744623325717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W174443042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793466,0.00011916388,0.00037467794,0.000868688,0.00035520337,0.018513015,0.000009832231,0.000065240514,0.000347591],"genre_scores_gemma":[0.9970102,0.000024006193,0.0013284823,0.0000833055,0.0009180926,0.00022705196,0.00024792406,0.000033909033,0.00012705819],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99728,0.0002784516,0.0013176657,0.0003832192,0.00037446467,0.00036618492],"domain_scores_gemma":[0.99804395,0.0007396676,0.0006511785,0.00025889557,0.00014379292,0.00016251026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015646796,0.00026818636,0.0014844312,0.0003490831,0.000094955,0.000052576073,0.00008395893,0.0002013844,0.00005943537],"category_scores_gemma":[0.0006135269,0.00022334754,0.00034461106,0.00030814132,0.000056487166,0.00038614112,0.00002346812,0.00014794142,0.0000060596026],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9687551,0.00060792686,0.003956965,0.000116436735,0.00027498134,0.0000028066531,0.00018584517,0.000012475476,0.025033066,0.00011322166,0.00013717648,0.0008040014],"study_design_scores_gemma":[0.98097193,0.0027289027,0.000096647986,0.0000728141,0.0007581738,0.0000034602488,0.00013276299,0.004570147,0.010326715,0.00009421551,0.00003743973,0.00020680629],"about_ca_topic_score_codex":0.00031519437,"about_ca_topic_score_gemma":0.000037334485,"teacher_disagreement_score":0.018285964,"about_ca_system_score_codex":0.000028535524,"about_ca_system_score_gemma":0.00013407096,"threshold_uncertainty_score":0.91078484},"labels":[],"label_agreement":null},{"id":"W1744607539","doi":"10.1182/blood-2015-01-620377","title":"Sirolimus plus prednisone for Erdheim-Chester disease: an open-label trial","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Workers Compensation Board of British Columbia","funders":"","keywords":"Erdheim–Chester disease; Prednisone; Sirolimus; Medicine; Histiocyte; PI3K/AKT/mTOR pathway; Histiocytosis; Internal medicine; Disease; Pathology; Chemistry; Signal transduction","score_opus":0.13821077496856682,"score_gpt":0.3699909789274466,"score_spread":0.23178020395887977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1744607539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98828727,0.00091168005,0.00016980211,0.000610261,0.0003250228,0.0031495483,0.00011551281,0.00007960061,0.0063512814],"genre_scores_gemma":[0.9870098,0.000011243728,0.002839371,0.0004510035,0.0004037291,0.00053594675,0.00031172053,0.00004924687,0.008387923],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990315,0.000023916122,0.00019369292,0.00030131912,0.00020800623,0.00024158481],"domain_scores_gemma":[0.9988911,0.000026679882,0.0000553464,0.00039985665,0.000086961765,0.0005400539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012804213,0.0001484478,0.00029950365,0.00003550392,0.000067655,0.00005848605,0.0001506597,0.000062662206,0.000032029016],"category_scores_gemma":[0.00014966202,0.00012001182,0.000040344712,0.00006572144,0.00003779484,0.00013848447,0.000059165253,0.000048290876,0.00006312925],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.66537577,0.18431477,0.012281358,0.0008252965,0.004139196,0.0017181737,0.005337884,0.000025654312,0.000549058,0.004727819,0.059566293,0.061138738],"study_design_scores_gemma":[0.9367578,0.00951827,0.0012420106,0.00006979235,0.0021777549,0.000024403624,0.00013597195,0.00056828675,0.00011319448,0.0014707559,0.047644205,0.0002775229],"about_ca_topic_score_codex":0.00004202509,"about_ca_topic_score_gemma":0.0000132198675,"teacher_disagreement_score":0.2713821,"about_ca_system_score_codex":0.000054430915,"about_ca_system_score_gemma":0.0004899297,"threshold_uncertainty_score":0.489394},"labels":[],"label_agreement":null},{"id":"W1764703361","doi":"10.1182/blood.v124.21.629.629","title":"Brentuximab Vedotin Monotherapy in DLBCL Patients with Undetectable CD30: Preliminary Results from a Phase 2 Study","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Brentuximab vedotin; Medicine; CD30; Internal medicine; Oncology; Rituximab; Diffuse large B-cell lymphoma; Chemotherapy regimen; Lymphoma; Chemotherapy","score_opus":0.008682233837594403,"score_gpt":0.24453516561794775,"score_spread":0.23585293178035335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1764703361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99767953,0.00014983237,0.00000821373,0.00011760199,0.00004669905,0.0011082502,0.000081745784,0.000051854408,0.0007562475],"genre_scores_gemma":[0.99895436,0.0000137828565,0.00040998074,0.00013862299,0.00006808404,0.00014254548,0.00017220445,0.000030176217,0.00007024429],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866915,0.00007453037,0.00029770957,0.00042664417,0.0002856181,0.00024635743],"domain_scores_gemma":[0.9991414,0.00013620913,0.00009804171,0.00046653827,0.000046811747,0.00011098417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010973315,0.00019815858,0.0003498612,0.000086353575,0.000047020105,0.000022817481,0.000076276476,0.000053682983,0.000037168087],"category_scores_gemma":[0.000048316582,0.00013998973,0.000044637094,0.00015700584,0.000021317996,0.00006007446,0.000027333474,0.00007734463,0.00003479152],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009445738,0.10973359,0.8592574,0.000009430874,0.00033237063,0.00013124666,0.0013538556,0.0000054136876,0.000059129845,0.0000026128043,0.0001311062,0.019538086],"study_design_scores_gemma":[0.2743812,0.017417224,0.70457834,0.00012507288,0.00030315222,0.0000026741916,0.00015359705,0.00008538692,0.0024364314,0.000017223185,0.00035932584,0.00014037032],"about_ca_topic_score_codex":0.0010312499,"about_ca_topic_score_gemma":0.00013397452,"teacher_disagreement_score":0.26493543,"about_ca_system_score_codex":0.000066276356,"about_ca_system_score_gemma":0.000052465606,"threshold_uncertainty_score":0.5708615},"labels":[],"label_agreement":null},{"id":"W176478158","doi":"10.1182/blood.v122.21.2186.2186","title":"Time To Hematologic and Renal Improvements In Atypical Hemolytic Uremic Syndrome Patients With Long Disease Duration and Chronic Kidney Disease (CKD) Treated With Eculizumab","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Eculizumab; Medicine; Atypical hemolytic uremic syndrome; Thrombotic microangiopathy; Kidney disease; Internal medicine; Renal function; Gastroenterology; End stage renal disease; Creatinine; Hemodialysis; Disease; Immunology; Antibody","score_opus":0.003663707144035134,"score_gpt":0.18510109054438204,"score_spread":0.1814373834003469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W176478158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99719095,0.0006035641,0.0000077712375,0.00016134155,0.00001589981,0.0018027322,0.00014534054,0.000058561407,0.0000138593905],"genre_scores_gemma":[0.9986363,0.0000036958074,0.000019672603,0.00012005436,0.0000063117445,0.00031601163,0.00067052507,0.000021092708,0.00020630656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865466,0.00010782768,0.00031053592,0.00048511132,0.00007569951,0.00036616338],"domain_scores_gemma":[0.99923867,0.000036946014,0.000108094835,0.0002813495,0.00005738183,0.0002775738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000042084303,0.00025501833,0.0002914378,0.00012076061,0.0001060727,0.00003799008,0.000108100576,0.00006172578,0.0005893234],"category_scores_gemma":[0.00006280873,0.00018437495,0.000023542485,0.00013397905,0.00014059289,0.00016752136,0.00010395479,0.00009116099,0.0002301355],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014003265,0.0011115291,0.9907094,0.00020666614,0.00021069885,0.00012216435,0.000036645404,0.000005040985,0.0056269597,0.000009326939,0.00039514218,0.00016605298],"study_design_scores_gemma":[0.010421015,0.00089660386,0.9868392,0.00043508288,0.00027690825,0.000052434607,0.000010535073,0.000039326776,0.0006923287,0.00001928734,0.000028803845,0.0002884776],"about_ca_topic_score_codex":0.000039159793,"about_ca_topic_score_gemma":0.00002170144,"teacher_disagreement_score":0.009020689,"about_ca_system_score_codex":0.00007112421,"about_ca_system_score_gemma":0.0001177342,"threshold_uncertainty_score":0.75185925},"labels":[],"label_agreement":null},{"id":"W1770147359","doi":"10.1182/blood-2002-09-2731","title":"Central venous line–related thrombosis in children: association with central venous line location and insertion technique","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Central Venous Catheters and Hemodialysis","field":"Health Professions","cited_by":242,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bayer (Canada); McMaster Children's Hospital; Hospital for Sick Children","funders":"","keywords":"Medicine; Venography; Venous thrombosis; Internal jugular vein; Prospective cohort study; Subclavian vein; Percutaneous; Radiology; Confidence interval; Thrombosis; Odds ratio; Internal medicine; Surgery","score_opus":0.013341187663290783,"score_gpt":0.2782958038453452,"score_spread":0.2649546161820544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1770147359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965992,0.00031255293,0.00072593783,0.00028248364,0.00013128665,0.0014128074,0.000021941329,0.00011248793,0.0004012771],"genre_scores_gemma":[0.9983114,0.00050882134,0.00049110985,0.00017970132,0.00011548757,0.00012108152,0.00013952606,0.000038557635,0.00009430587],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99768955,0.00037618895,0.00051473203,0.0003523817,0.00024749726,0.00081963843],"domain_scores_gemma":[0.9990957,0.0000808418,0.00032596593,0.00021707792,0.00012585321,0.0001545577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004915802,0.00020841931,0.00038139394,0.00014841063,0.00038942788,0.00001908452,0.00008032464,0.000410494,0.00007308313],"category_scores_gemma":[0.00014265541,0.0001902383,0.000055675802,0.0005263688,0.000028333092,0.00013624078,0.000021113705,0.0006133882,0.000016808319],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047490536,0.0030015402,0.98869514,0.0000835685,0.00018774727,0.000004878354,0.004481554,0.00016495361,0.0023641032,0.00036045577,0.00004193319,0.0005666412],"study_design_scores_gemma":[0.00407351,0.00083162874,0.98865616,0.00029588366,0.00037501904,0.000018245459,0.00032724696,0.0001641096,0.0044549736,0.00029398839,0.00017137421,0.0003378411],"about_ca_topic_score_codex":0.000683223,"about_ca_topic_score_gemma":0.000535592,"teacher_disagreement_score":0.004154307,"about_ca_system_score_codex":0.00046693295,"about_ca_system_score_gemma":0.00028959103,"threshold_uncertainty_score":0.77576923},"labels":[],"label_agreement":null},{"id":"W1775596629","doi":"10.1182/blood.v118.21.606.606","title":"Complete Molecular Response (CMR) Rate with Nilotinib in Patients (pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) without CMR After ≥ 2 Years on Imatinib: Preliminary Results From the Randomized ENESTcmr Trial of Nilotinib 400 Mg Twice Daily (BID) Vs Imatinib","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; McMaster University Medical Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Nilotinib; Medicine; Imatinib; Internal medicine; Imatinib mesylate; Clinical endpoint; Myeloid leukemia; Oncology; Gastroenterology; Randomized controlled trial","score_opus":0.017162198750396762,"score_gpt":0.2530342717225034,"score_spread":0.23587207297210666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1775596629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98921686,0.0005470257,0.000032119948,0.0001265351,0.00014883556,0.008494045,0.000590157,0.0001218376,0.00072259904],"genre_scores_gemma":[0.99509585,0.000084271654,0.002032717,0.0002891492,0.00019639365,0.0012646455,0.0006435031,0.00024262207,0.00015084304],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9915462,0.0024574208,0.0022045905,0.0014529678,0.0012312672,0.0011075372],"domain_scores_gemma":[0.9937038,0.0022903413,0.0013123049,0.0021541256,0.000227437,0.00031202077],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0026020596,0.00102079,0.0024732822,0.00045705927,0.00009252766,0.00004603694,0.00064705405,0.0003482231,0.00018405268],"category_scores_gemma":[0.0011668232,0.0006909915,0.00034584675,0.0008319159,0.0007249902,0.00025339358,0.00020909627,0.0010233494,0.00008934498],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9813762,0.00408448,0.0032875233,0.00014954172,0.00090109336,0.0009961523,0.004073662,0.00019560101,0.003810445,0.0000125902425,0.00003935699,0.0010733609],"study_design_scores_gemma":[0.8874999,0.036622982,0.060079366,0.0029008107,0.0014329101,0.000039803268,0.00011109424,0.00092072575,0.009559194,0.000027098435,0.0001259435,0.0006801417],"about_ca_topic_score_codex":0.0028923561,"about_ca_topic_score_gemma":0.00073650345,"teacher_disagreement_score":0.093876265,"about_ca_system_score_codex":0.0025599254,"about_ca_system_score_gemma":0.0038289104,"threshold_uncertainty_score":0.9995541},"labels":[],"label_agreement":null},{"id":"W1790270491","doi":"10.1182/blood.v122.21.4345.4345","title":"Gemcitabine, Dexamethasone, and Cisplatin (GDP) As Secondary Chemotherapy In Relapsed/Refractory Peripheral T-Cell Lymphoma","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and Retrovirus Studies","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital; Leukemia & Lymphoma Society of Canada; BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Gemcitabine; Oncology; Chemotherapy regimen; Regimen; Salvage therapy; Population; Chemotherapy; Gastroenterology; Surgery","score_opus":0.004989144829180052,"score_gpt":0.1962026945221698,"score_spread":0.19121354969298973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1790270491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9641104,0.017289316,0.0000023907824,0.00021557187,0.0002982594,0.0002830623,0.000011909055,0.00006108277,0.017728012],"genre_scores_gemma":[0.9849094,0.0008143719,0.0002040197,0.0004959147,0.000046476514,0.000054736098,0.00001612488,0.0000310868,0.013427881],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987331,0.000117659394,0.0002906654,0.0003813414,0.000037068246,0.00044014628],"domain_scores_gemma":[0.9994641,0.00013411051,0.0000953462,0.00023254301,0.000038154278,0.000035750807],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001241514,0.00025832464,0.00036845566,0.00010287283,0.00016176091,0.000023637545,0.00015010175,0.00032804447,0.001750782],"category_scores_gemma":[0.00003182471,0.00021263695,0.000071922295,0.000113918024,0.00025905503,0.00010141827,0.00009096857,0.00029886028,0.0006427685],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013832808,0.0016738545,0.057812147,0.000060251736,0.00024270237,0.000023230104,0.0022737873,3.7922473e-7,0.8945999,0.00011044206,0.004084522,0.03898043],"study_design_scores_gemma":[0.057050098,0.0016963332,0.5646989,0.00008957025,0.00014249067,0.00033724928,0.0026291392,0.0000057443062,0.2788082,0.0009922086,0.09230091,0.0012491741],"about_ca_topic_score_codex":0.00097482954,"about_ca_topic_score_gemma":0.00011294049,"teacher_disagreement_score":0.61579174,"about_ca_system_score_codex":0.000026437327,"about_ca_system_score_gemma":0.000066585424,"threshold_uncertainty_score":0.9991618},"labels":[],"label_agreement":null},{"id":"W1791608341","doi":"10.1182/blood.v122.21.789.789","title":"A Murine Model Of Hemorrhagic Shock/Resuscitation Demonstrates Transfusion Related Acute Lung Injury (TRALI) Induced By Stored Platelet Transfusions","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Transfusion-related acute lung injury; Medicine; Platelet; Platelet transfusion; Lung; Immunology; Shock (circulatory); Resuscitation; In vivo; Ex vivo; Sepsis; Anesthesia; Pulmonary edema; Internal medicine; Biology","score_opus":0.01097828903930725,"score_gpt":0.24136416101798794,"score_spread":0.23038587197868068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1791608341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902502,0.0001790214,0.0014802935,0.0026726206,0.00012724524,0.002115226,0.00009232857,0.00021833145,0.0028647678],"genre_scores_gemma":[0.9957424,0.000835064,0.0020985499,0.00030859013,0.000022961372,0.00015318375,0.00018064764,0.000059221635,0.00059939554],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977661,0.00006923478,0.0007580879,0.0004980873,0.000486169,0.00042236943],"domain_scores_gemma":[0.9989686,0.000042489777,0.00012331124,0.00041856125,0.00015476487,0.00029224795],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019204128,0.00034505205,0.0005621879,0.00029746312,0.00014081654,0.000024299308,0.00017118324,0.00029067637,0.00038286936],"category_scores_gemma":[0.000016848968,0.00030535407,0.00023821833,0.00053766434,0.00008491503,0.00025626092,0.00002519398,0.00041465025,0.00002566461],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024979137,0.0021720529,0.00063724595,0.00024377285,0.000604629,0.000020129459,0.0011490204,0.00004356059,0.98725635,0.00030959543,0.0017858811,0.0055279797],"study_design_scores_gemma":[0.028580142,0.0018561992,0.008638527,0.0005245734,0.004079658,0.000098592114,0.0008347573,0.036175903,0.917257,0.0009270909,0.00012049833,0.00090705726],"about_ca_topic_score_codex":0.00033005758,"about_ca_topic_score_gemma":0.000033605484,"teacher_disagreement_score":0.06999934,"about_ca_system_score_codex":0.000030368215,"about_ca_system_score_gemma":0.000099394754,"threshold_uncertainty_score":0.99993986},"labels":[],"label_agreement":null},{"id":"W1795150761","doi":"10.1182/blood-2015-06-649319","title":"Prophylactic transfusion for pregnant women with sickle cell disease: a systematic review and meta-analysis","year":2015,"lang":"en","type":"review","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Mount Sinai Hospital","funders":"Canadian Institutes of Health Research; Health Canada; Canadian Blood Services; Society For Maternal-Fetal Medicine","keywords":"Medicine; Acute chest syndrome; Pregnancy; Sickle cell anemia; Obstetrics; Disease; Exchange transfusion; Prophylactic treatment; Pediatrics; Intensive care medicine; Surgery; Internal medicine","score_opus":0.03622067770793845,"score_gpt":0.2911538537027433,"score_spread":0.25493317599480486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1795150761","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00000345871,0.9858266,0.00003585668,0.00011275546,0.000009499955,0.013680049,0.00015166434,0.000042674452,0.00013740342],"genre_scores_gemma":[0.00002504387,0.9918214,0.00011535968,0.000121395904,0.0000134621205,0.0049971994,0.00012725053,0.00007419754,0.0027046797],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99770296,0.0002269209,0.00082085317,0.00056662736,0.00033933244,0.0003432816],"domain_scores_gemma":[0.99803966,0.00008303597,0.00048038037,0.000735232,0.00017098407,0.0004907009],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006011007,0.0005411265,0.00861024,0.00019337184,0.00006799637,0.000028034898,0.00012315821,0.0001944531,0.00007918692],"category_scores_gemma":[0.00008080375,0.00024814822,0.0014866295,0.0007233602,0.000050573308,0.000039004786,0.000023551564,0.00024912914,0.000012665847],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018622799,0.00047199626,1.6754862e-7,0.9073252,0.091112584,0.000045353157,0.000071434486,1.2820797e-7,4.6834224e-8,0.000002355484,0.000025397865,0.0009267234],"study_design_scores_gemma":[0.0008639249,0.0004935334,5.4571355e-8,0.08354424,0.88786614,0.00006668408,0.000036486534,0.0000014897255,1.2746922e-7,0.0000043871582,0.026843771,0.00027913952],"about_ca_topic_score_codex":0.0000044615826,"about_ca_topic_score_gemma":0.0000018950698,"teacher_disagreement_score":0.82378095,"about_ca_system_score_codex":0.00005479121,"about_ca_system_score_gemma":0.0005013949,"threshold_uncertainty_score":0.9999971},"labels":[],"label_agreement":null},{"id":"W1797900320","doi":"10.1182/blood-2015-05-644039","title":"Prediction of high- and low-risk multiple myeloma based on gene expression and the International Staging System","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Janssen Pharmaceuticals; Bundesministerium für Bildung und Forschung; Medical Research Council; Center for Translational Molecular Medicine; Stem Cell Network; SkylineDx; European Hematology Association","keywords":"Multiple myeloma; Oncology; Internal medicine; Medicine; Gene expression profiling; Gene expression; Computational biology; Gene; Bioinformatics; Biology; Genetics","score_opus":0.023125850120937947,"score_gpt":0.24890553924254932,"score_spread":0.22577968912161137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1797900320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984759,0.00016820642,0.00029167676,0.00014997397,0.00007352084,0.00036278536,0.0001034078,0.000027649456,0.00034684877],"genre_scores_gemma":[0.99859995,0.000032138756,0.0011309175,0.000018027991,0.00008676333,0.00003295515,0.000048974678,0.0000088225415,0.00004143933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991796,0.000073558156,0.00013408743,0.00015359618,0.00036122662,0.000097926815],"domain_scores_gemma":[0.99940294,0.0001562744,0.00006741181,0.00016336156,0.00008705382,0.00012295789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028753048,0.00007552145,0.0001419977,0.00007139131,0.000050672974,0.000015086808,0.00004280852,0.00003374696,0.000004132828],"category_scores_gemma":[0.00026658247,0.00004398777,0.000022340573,0.000039103037,0.00006594845,0.00003834948,0.00004229097,0.000078746314,0.0000021030971],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003275773,0.00056194677,0.96882993,0.00015646692,0.00021256684,0.00005917214,0.00035929235,0.000056934103,0.022819875,0.0000681816,0.0001198673,0.0034799792],"study_design_scores_gemma":[0.09159778,0.0007065433,0.5773373,0.00068410084,0.00022915287,0.000054952674,0.0005290449,0.11195621,0.21672407,0.000032707892,0.00006260289,0.00008551557],"about_ca_topic_score_codex":0.00018799471,"about_ca_topic_score_gemma":0.0000036782617,"teacher_disagreement_score":0.39149264,"about_ca_system_score_codex":0.000028911762,"about_ca_system_score_gemma":0.00003954493,"threshold_uncertainty_score":0.17937692},"labels":[],"label_agreement":null},{"id":"W183222656","doi":"10.1182/blood.v124.21.4032.4032","title":"Iron Deficiency As a Common Treatable Cause of Chronic Normocytic Anemia","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; McMaster University","funders":"","keywords":"Medicine; Anemia; Microcytic anemia; Macrocytic anemia; Iron deficiency; Anemia of chronic disease; Iron-deficiency anemia; Internal medicine; Gastroenterology; Pediatrics; Serum iron","score_opus":0.008572669731582917,"score_gpt":0.2483793917031567,"score_spread":0.2398067219715738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W183222656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95458686,0.0030324815,0.00003459893,0.000077414676,0.000059395898,0.00017212865,0.000004182834,0.000038746362,0.041994166],"genre_scores_gemma":[0.99836487,0.0001568203,0.00014500247,0.00014018088,0.000093836235,0.000007644888,0.000021923355,0.000017381235,0.0010523524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999156,0.000029306513,0.00019803282,0.00017386225,0.00019413394,0.00024869433],"domain_scores_gemma":[0.9993607,0.000035711182,0.00006619881,0.0004107683,0.000030097839,0.00009654106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011850948,0.000117121876,0.00027704562,0.00007436609,0.000043840373,0.0000058106534,0.00008753941,0.00006945228,0.00019868862],"category_scores_gemma":[0.00007551069,0.000096905016,0.000060215563,0.0001478564,0.00007178984,0.0000461475,0.000027764729,0.00009213318,0.00014678024],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010247562,0.021076249,0.5593434,0.011543679,0.00013679129,0.0003470952,0.004240911,0.00023701668,0.2708439,0.043246754,0.0077270134,0.08023243],"study_design_scores_gemma":[0.093554005,0.011797009,0.50039536,0.000691096,0.009169565,0.0012104905,0.0011199643,0.00063153834,0.35544688,0.0025770608,0.021626515,0.0017805415],"about_ca_topic_score_codex":0.00048005758,"about_ca_topic_score_gemma":0.00007239837,"teacher_disagreement_score":0.092529245,"about_ca_system_score_codex":0.000020311656,"about_ca_system_score_gemma":0.00013596323,"threshold_uncertainty_score":0.3951672},"labels":[],"label_agreement":null},{"id":"W1836083640","doi":"10.1182/blood-2015-06-649905","title":"Cell of origin of transformed follicular lymphoma","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Follicular lymphoma; Lymphoma; Medicine; Cancer research; Biology; Immunology","score_opus":0.02427362276669239,"score_gpt":0.2581502085533498,"score_spread":0.2338765857866574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1836083640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850522,0.001632302,0.000009106142,0.00009646191,0.000039194685,0.00020456998,0.000012461876,0.00001314775,0.012940523],"genre_scores_gemma":[0.9989047,0.00007990614,0.00073964515,0.00003477828,0.000027575286,0.00001638379,0.000012574407,0.000008991208,0.00017545368],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99937874,0.000010915529,0.00019392786,0.00009900341,0.00020971935,0.0001076945],"domain_scores_gemma":[0.9995419,0.000020619407,0.00005581665,0.00018695749,0.000078201665,0.000116503266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006618965,0.00007988802,0.00026445987,0.00004377238,0.0000065190275,0.0000014788691,0.000039887775,0.00004681249,0.000023961331],"category_scores_gemma":[0.000013135175,0.000057900117,0.00011086458,0.000099198805,0.00002905276,0.000021087044,0.000006389436,0.000010971169,0.000014853657],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005076346,0.030831465,0.9094436,0.0007324211,0.0010942088,0.00046425444,0.0024785316,0.000005636212,0.03452625,0.0017256085,0.003808831,0.014381532],"study_design_scores_gemma":[0.029311009,0.0011003511,0.06221422,0.00008292135,0.00077982096,0.000047854828,0.00014165817,0.000006554027,0.8994309,0.00008380769,0.0067240424,0.00007688212],"about_ca_topic_score_codex":0.00014351607,"about_ca_topic_score_gemma":0.000003583518,"teacher_disagreement_score":0.86490464,"about_ca_system_score_codex":0.000027589356,"about_ca_system_score_gemma":0.00019075694,"threshold_uncertainty_score":0.23610982},"labels":[],"label_agreement":null},{"id":"W1845618153","doi":"10.1182/blood-2014-02-558940","title":"Characterization of mice harboring a variant of EPCR with impaired ability to bind protein C: novel role of EPCR in hematopoiesis","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Haematopoiesis; Immunology; Biology; Endothelial protein C receptor; Medicine; Stem cell; Cell biology","score_opus":0.02319703399754084,"score_gpt":0.23955011417901445,"score_spread":0.21635308018147362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1845618153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977,0.000015416626,0.0010654725,0.00016811071,0.000018390474,0.00084985676,0.000023348195,0.000016903736,0.0001425309],"genre_scores_gemma":[0.99330825,6.1671864e-7,0.006569109,0.00002149913,0.000017296583,0.0000412712,0.000012107778,0.000016113176,0.000013734274],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989041,0.00003541344,0.00044721598,0.00019034487,0.000292388,0.00013053245],"domain_scores_gemma":[0.999081,0.000015469273,0.0002428368,0.0002962594,0.00025667704,0.00010774885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036940377,0.000110462985,0.000439054,0.00015957629,0.000008698869,0.0000032293497,0.00007264552,0.0000728285,0.000017653978],"category_scores_gemma":[0.00011972659,0.000094769675,0.0000401876,0.00043187084,0.000029542323,0.000074643096,0.000036382546,0.000059066067,0.0000014722882],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023846365,0.0019396119,0.010330646,0.00026554085,0.000052802654,0.0000018749447,0.0014314717,0.0000056396593,0.98460126,0.0010163076,2.0004757e-7,0.00011617565],"study_design_scores_gemma":[0.0038760304,0.0006334407,0.1101252,0.00044004768,0.00010916966,0.000010050828,0.00027098134,0.00014037202,0.8842111,0.00009888619,0.0000057583443,0.0000789391],"about_ca_topic_score_codex":0.00019749788,"about_ca_topic_score_gemma":0.0000331461,"teacher_disagreement_score":0.10039014,"about_ca_system_score_codex":0.000019769357,"about_ca_system_score_gemma":0.00016299293,"threshold_uncertainty_score":0.3864595},"labels":[],"label_agreement":null},{"id":"W184623876","doi":"10.1182/blood.v122.21.1076.1076","title":"CD8+ T Cells Are Predominantly Protective In a Murine Model Of ITP and Is Required For Effective Steroid Therapy","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Autoantibody; Immunology; Medicine; Platelet; Cytotoxic T cell; Antibody; CD8; Bone marrow; Immune system; Biology; In vitro","score_opus":0.014308354704176162,"score_gpt":0.24521819088879698,"score_spread":0.23090983618462083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W184623876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99435675,0.00054175965,0.00013013685,0.00013937055,0.000010106172,0.004591386,0.00004966337,0.000010862139,0.00016995671],"genre_scores_gemma":[0.9976404,0.00012163916,0.0008635159,0.00006505689,0.0000094971265,0.0011036805,0.0000044022736,0.000017611452,0.00017425003],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993865,0.00001761172,0.00014559174,0.00021360042,0.00007814176,0.00015858107],"domain_scores_gemma":[0.9996062,0.00005583231,0.00008356348,0.00013634066,0.000072085684,0.00004596944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000051088788,0.00012544339,0.0003480649,0.00006745996,0.000023641442,0.000005680141,0.00003044677,0.000067647146,0.0000075968246],"category_scores_gemma":[0.000021378337,0.00009300618,0.000050455583,0.000062173865,0.000035414498,0.00007190929,0.000015778964,0.000051205636,0.000002842034],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004374556,0.0114072645,0.045115765,0.0012187067,0.001513901,0.00011493303,0.008873014,0.000032308166,0.8947312,0.00003456345,0.0003106997,0.03227305],"study_design_scores_gemma":[0.049872264,0.0034009914,0.04539722,0.00040174558,0.0001768059,0.000025085681,0.0002922964,0.0044348687,0.8921634,0.0036195323,0.000016344044,0.00019947531],"about_ca_topic_score_codex":0.00014653394,"about_ca_topic_score_gemma":0.000030998675,"teacher_disagreement_score":0.045497708,"about_ca_system_score_codex":0.000013830346,"about_ca_system_score_gemma":0.000021765476,"threshold_uncertainty_score":0.37926817},"labels":[],"label_agreement":null},{"id":"W1848034928","doi":"10.1182/blood-2014-11-612903","title":"Eradication of B-ALL using chimeric antigen receptor–expressing T cells targeting the TSLPR oncoprotein","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"National Center for Research Resources; National Cancer Institute","keywords":"Chimeric antigen receptor; Antigen; Receptor; Adoptive cell transfer; Genetically engineered; Molecular biology; Cell biology; Chemistry; Biology; Virology; Immunology; T cell; Immune system; Gene; Biochemistry","score_opus":0.0622499523900424,"score_gpt":0.3304704845190863,"score_spread":0.2682205321290439,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1848034928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99352986,0.0017810484,0.00026974926,0.00033598434,0.000120710996,0.0005580291,0.0000031233994,0.00003810403,0.0033634154],"genre_scores_gemma":[0.9861238,0.00010800403,0.012373703,0.00010465554,0.00048957486,0.000012073204,0.000018132176,0.00004373521,0.0007263309],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985569,0.00014947691,0.00028583602,0.00020996043,0.00052290293,0.00027491842],"domain_scores_gemma":[0.9990642,0.0000642934,0.00016522635,0.00039726513,0.00016954832,0.00013944416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008468543,0.00011708695,0.00023109767,0.000087840504,0.00007542905,0.000024911367,0.00017048519,0.000075835735,0.00039284828],"category_scores_gemma":[0.00015037421,0.000085618536,0.000078109384,0.00030541344,0.00011675173,0.000070184185,0.00006502399,0.00024197082,0.000030824227],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008264243,0.00022488882,0.0024223358,0.000037304635,0.000085257874,0.0000044793615,0.0012258056,0.00003048749,0.99082685,0.0000051505226,0.00048383826,0.004570951],"study_design_scores_gemma":[0.0019006289,0.00016950027,0.0003811417,0.00011566665,0.00007767933,0.00001983846,0.0003122764,0.00087128434,0.9828095,0.000038583927,0.013206174,0.00009773842],"about_ca_topic_score_codex":0.00028349675,"about_ca_topic_score_gemma":0.0000020038085,"teacher_disagreement_score":0.012722335,"about_ca_system_score_codex":0.00005985359,"about_ca_system_score_gemma":0.00024204089,"threshold_uncertainty_score":0.4301413},"labels":[],"label_agreement":null},{"id":"W1858218633","doi":"10.1182/blood.v96.3.878","title":"In vivo generation of human dendritic cell subsets by Flt3 ligand","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":397,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research & Development Corporation","funders":"","keywords":"CD11c; Dendritic cell; In vivo; Immune system; Immunology; In vitro; Biology; Immunotherapy; Cell biology; Phenotype; Gene","score_opus":0.01019832240241072,"score_gpt":0.22767075361093053,"score_spread":0.2174724312085198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1858218633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98352176,0.014427445,0.0000017243232,0.000038719292,0.00010790571,0.000106763364,0.000022593074,0.000014658348,0.0017584303],"genre_scores_gemma":[0.9818196,0.00038861952,0.000009873046,0.00008868729,0.000016437862,0.000010590198,0.000043321455,0.000011702483,0.017611155],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992308,0.0001495955,0.00025800135,0.0001426485,0.000022060105,0.0001968974],"domain_scores_gemma":[0.99971336,0.000037037364,0.000046146757,0.00018107466,0.000016221873,0.0000061554706],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012154577,0.000103949766,0.00018161119,0.00006754348,0.00008230017,0.000007409992,0.00013071815,0.00015742265,0.0033190523],"category_scores_gemma":[0.0000062642207,0.00010211647,0.00004924082,0.000083283434,0.00008307688,0.000077866396,0.000009641183,0.00011574676,0.00017592487],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007411995,0.00062322745,0.0005553061,0.000008984099,0.00003677178,0.0000033812546,0.0003671093,7.281884e-7,0.99473786,0.000025541582,0.0030634583,0.0005034841],"study_design_scores_gemma":[0.0029988033,0.00021573501,0.0006900625,0.000015108328,0.000022165319,0.000024425577,0.000028161941,4.1533573e-7,0.975153,0.000017637532,0.02072728,0.00010717064],"about_ca_topic_score_codex":0.00014183336,"about_ca_topic_score_gemma":0.000024319386,"teacher_disagreement_score":0.019584853,"about_ca_system_score_codex":0.000007084733,"about_ca_system_score_gemma":0.00002120203,"threshold_uncertainty_score":0.99759203},"labels":[],"label_agreement":null},{"id":"W1860085984","doi":"10.1182/blood-2015-06-651539","title":"Improving evidence on anticoagulant therapies for venous thromboembolism in children: key challenges and opportunities","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stollery Children's Hospital; University of Alberta","funders":"American Society of Hematology","keywords":"Medicine; Apixaban; Dabigatran; Rivaroxaban; Edoxaban; Intensive care medicine; Randomized controlled trial; Clinical trial; Anticoagulant; Off-label use; Venous thromboembolism; Observational study; Warfarin; Surgery; Pharmacology; Internal medicine; Atrial fibrillation; Thrombosis","score_opus":0.12509507756814323,"score_gpt":0.299428866763094,"score_spread":0.17433378919495077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1860085984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9535526,0.04140131,0.00001687504,0.002915754,0.00010191602,0.0010046937,0.000006143949,0.000063233114,0.00093744515],"genre_scores_gemma":[0.9773119,0.021092148,0.0003815691,0.0007915341,0.00021800696,0.00012728898,0.000007690005,0.000031912252,0.00003791826],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99889404,0.000038817918,0.00021510999,0.00032192565,0.0002234169,0.0003067008],"domain_scores_gemma":[0.9993367,0.00009338087,0.00007730506,0.0002831982,0.000064838285,0.00014455128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044547577,0.00018618235,0.0005543385,0.00015106618,0.000053980333,0.000032592303,0.00009321129,0.000073016476,0.000003881993],"category_scores_gemma":[0.00012897572,0.00015477368,0.0000511081,0.000036895886,0.00006785737,0.000117844174,0.00006530564,0.0000992349,0.0000039509096],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006950863,0.026254471,0.04496493,0.003081905,0.0029731293,0.00047341466,0.06389998,0.000021395765,0.005457346,0.13297732,0.0027465133,0.7164545],"study_design_scores_gemma":[0.009079118,0.0066988016,0.9677017,0.001682211,0.000955925,0.00015946993,0.0056452695,0.00008798391,0.003190029,0.0023394788,0.0018777774,0.00058223866],"about_ca_topic_score_codex":0.00012453205,"about_ca_topic_score_gemma":0.000027827266,"teacher_disagreement_score":0.92273676,"about_ca_system_score_codex":0.000024608025,"about_ca_system_score_gemma":0.00007940631,"threshold_uncertainty_score":0.63114876},"labels":[],"label_agreement":null},{"id":"W187016892","doi":"10.1182/blood.v124.21.1493.1493","title":"Impact of Exercise on Hemostasis in Boys with Hemophilia a (HA) and B (HB): Principal Findings of the Sickkids Hemophilia Exercise Study","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Thromboelastography; Hemostasis; Internal medicine; Cohort; Platelet; Physical therapy","score_opus":0.017645850384766203,"score_gpt":0.29670334462013526,"score_spread":0.2790574942353691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W187016892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99696475,0.00015448817,2.6406732e-7,0.0002509112,0.000021025577,0.00182006,0.000016814352,0.000019895439,0.0007517697],"genre_scores_gemma":[0.9990523,0.00008500219,0.00009437385,0.000011809712,0.000028147086,0.000046772097,0.000005318278,0.000038020167,0.00063827174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979484,0.00008868294,0.00040897873,0.0004202386,0.00072124536,0.00041241775],"domain_scores_gemma":[0.9986831,0.00011776853,0.00011617386,0.00076181453,0.00011738143,0.00020374579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050259655,0.00029865085,0.00077399996,0.00026755006,0.00006912815,0.000013541867,0.00021386992,0.00010044143,0.0000456777],"category_scores_gemma":[0.00012509218,0.00016086764,0.0001706976,0.00060903525,0.00024127937,0.000060422124,0.00014069413,0.00030088378,0.0000068380714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016099393,0.0062259673,0.9853859,0.00027697912,0.0001865323,0.0000686491,0.001475653,0.000008704977,0.0021867102,0.000017066697,0.000043880347,0.002514039],"study_design_scores_gemma":[0.013569624,0.0061439904,0.943228,0.0011632136,0.00051639916,0.000036341487,0.00030216033,0.00006865021,0.034725662,0.000056831534,0.000009984036,0.00017913274],"about_ca_topic_score_codex":0.00023579718,"about_ca_topic_score_gemma":0.00003281697,"teacher_disagreement_score":0.042157866,"about_ca_system_score_codex":0.000057851736,"about_ca_system_score_gemma":0.00017469378,"threshold_uncertainty_score":0.6559992},"labels":[],"label_agreement":null},{"id":"W1892579436","doi":"10.1182/blood.v96.5.1703","title":"Impact of the patient population on the risk for heparin-induced thrombocytopenia","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":912,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"","keywords":"Medicine; Heparin; Heparin-induced thrombocytopenia; Orthopedic surgery; Internal medicine; Odds ratio; Population; Immunology; Antigen; Cardiac surgery; Gastroenterology; Surgery","score_opus":0.02958309133572942,"score_gpt":0.29524573535032167,"score_spread":0.2656626440145923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1892579436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99189925,0.000020131309,0.0000015640587,0.00046521332,0.00011777528,0.0017350734,0.000059529255,0.0000400114,0.0056614564],"genre_scores_gemma":[0.99927,0.000030595176,0.00008644807,0.00020902338,0.00011657587,0.00008777249,0.000020012896,0.000040305637,0.00013926366],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984385,0.00014587703,0.00042463889,0.0003148663,0.000334129,0.0003419947],"domain_scores_gemma":[0.9984555,0.00022248532,0.00021385933,0.0009111502,0.000091319765,0.000105673425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024922515,0.00024614861,0.000508354,0.000048284805,0.00029496106,0.000025116815,0.00024408809,0.00013778222,0.000659113],"category_scores_gemma":[0.00020775168,0.000120792545,0.00053806155,0.00029269015,0.000054687298,0.00006735019,0.000045946214,0.00028540657,0.000063293846],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008212387,0.003920348,0.8600919,0.00006974426,0.0018099194,0.000004377899,0.0015142304,0.00010401422,0.09423605,0.0018217942,0.0010217027,0.034584645],"study_design_scores_gemma":[0.0024296604,0.0015887308,0.9436866,0.00009340931,0.00058668264,0.000018016082,0.000033922635,0.00008405905,0.05057079,0.00048307073,0.0002756296,0.0001494006],"about_ca_topic_score_codex":0.0013632522,"about_ca_topic_score_gemma":0.00007829112,"teacher_disagreement_score":0.083594695,"about_ca_system_score_codex":0.000089906214,"about_ca_system_score_gemma":0.0001250568,"threshold_uncertainty_score":0.7216825},"labels":[],"label_agreement":null},{"id":"W190208491","doi":"10.1182/blood.v122.21.1788.1788","title":"Outcome Of Patients With Double-Hit Lymphomas Treated With CODOX-M/IVAC + R Followed By Hematopoietic Stem Cell Transplantation In British Columbia","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital; Leukemia & Lymphoma Society of Canada; BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Lymphoma; Rituximab; Hematopoietic stem cell transplantation; Internal medicine; Transplantation; Total body irradiation; Oncology; Chemotherapy regimen; Surgery; Chemotherapy; Cyclophosphamide","score_opus":0.006118569060031915,"score_gpt":0.19070869772260665,"score_spread":0.18459012866257474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W190208491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973846,0.00017117891,0.0000033998824,0.000027354537,0.000013965286,0.0013938706,0.000106573614,0.00004064931,0.000858379],"genre_scores_gemma":[0.99842614,0.000038099013,0.00014997955,0.000049952756,0.0000053642116,0.00026194708,0.0002989628,0.00003512661,0.00073445454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871176,0.000026152382,0.00037888496,0.00029518423,0.0003371808,0.00025083928],"domain_scores_gemma":[0.99936235,0.000038374346,0.00013840455,0.00022031723,0.00011268138,0.00012785994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000035016554,0.00015942138,0.00047523994,0.000045249813,0.000038833015,0.00006042844,0.00006172762,0.0000851524,0.00015827145],"category_scores_gemma":[9.919629e-7,0.00015660586,0.00005876696,0.00022345736,0.00004455832,0.00010668797,0.000007298739,0.000043574317,0.000017702812],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022089218,0.0055455803,0.9925429,0.00026230665,0.00014417457,0.00016035348,0.0002090853,7.029202e-7,0.00013640565,0.0000012099713,0.00029914582,0.00047723606],"study_design_scores_gemma":[0.06806275,0.0012339067,0.92162514,0.0003394441,0.0006506609,0.00005189392,0.000119179655,0.0000023239854,0.007719415,0.0000016003233,0.000020784497,0.00017287808],"about_ca_topic_score_codex":0.020979337,"about_ca_topic_score_gemma":0.008720138,"teacher_disagreement_score":0.07091774,"about_ca_system_score_codex":0.00007888381,"about_ca_system_score_gemma":0.000054007014,"threshold_uncertainty_score":0.98554003},"labels":[],"label_agreement":null},{"id":"W190699452","doi":"10.1182/blood.v124.21.813.813","title":"The Risk of Relapse in CML Patients Who Discontinued imatinib Can Be Predicted Based on Patients Age and the Results of dPCR Analysis","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Imatinib; Discontinuation; Medicine; Imatinib mesylate; Internal medicine; Minimal residual disease; Digital polymerase chain reaction; Oncology; Myeloid leukemia; Population; Gastroenterology; Surgery; Immunology; Leukemia; Polymerase chain reaction; Biology","score_opus":0.00492055600604591,"score_gpt":0.21244616561744578,"score_spread":0.20752560961139987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W190699452","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970593,0.00003121944,0.0000037240973,0.00021371894,0.000032977365,0.0007862058,0.0006011809,0.00001070546,0.0012609567],"genre_scores_gemma":[0.9992197,0.000052629184,0.00010252981,0.00006003936,0.000016383216,0.00003692425,0.00036794913,0.000015996484,0.00012785877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997938,0.0004247436,0.00066053413,0.0002726193,0.00049217936,0.00021196147],"domain_scores_gemma":[0.9974708,0.0010120912,0.00055613654,0.00076610205,0.00012184964,0.00007303117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006199531,0.00017400322,0.0005581261,0.00015037437,0.000073532996,0.000009797939,0.0001450698,0.00007535237,0.0000053325616],"category_scores_gemma":[0.002478663,0.000089748784,0.00015353585,0.00048590975,0.00024596023,0.000023940467,0.000052474454,0.00018715189,3.976231e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023726772,0.0013892382,0.99134207,0.00004231617,0.00086731947,0.0000036039771,0.0015366204,0.000062180494,0.000012825911,0.000020848605,0.00015234959,0.0021979406],"study_design_scores_gemma":[0.073658474,0.0007377245,0.91743326,0.00018708504,0.0024036434,1.2889468e-7,0.00005395002,0.004588323,0.00076140754,0.000025718611,0.000079136196,0.000071142655],"about_ca_topic_score_codex":0.0017703162,"about_ca_topic_score_gemma":0.0014533803,"teacher_disagreement_score":0.07390881,"about_ca_system_score_codex":0.000077739554,"about_ca_system_score_gemma":0.000069494236,"threshold_uncertainty_score":0.36598492},"labels":[],"label_agreement":null},{"id":"W1912448446","doi":"10.1182/blood.v122.21.2647.2647","title":"Early Mortality In Hyperleukocytosis In Patients With Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis","year":2013,"lang":"en","type":"review","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Medicine; Leukapheresis; Population; Induction chemotherapy; Chemotherapy regimen; Leukemia; Randomized controlled trial; Chemotherapy; Internal medicine; Pediatrics; Surgery","score_opus":0.05904027087799214,"score_gpt":0.3314646582679944,"score_spread":0.2724243873900023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1912448446","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0068633216,0.98049355,0.0000014984439,0.000042200485,0.0000066123275,0.012219123,0.00015862074,0.000036857953,0.000178203],"genre_scores_gemma":[0.0003273391,0.9936293,0.0003068059,0.00023600462,0.000015608259,0.0043766247,0.00031564225,0.000115728275,0.00067699805],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9936522,0.0010544123,0.002252082,0.0011768413,0.0011355557,0.0007288577],"domain_scores_gemma":[0.9963177,0.00031445583,0.00086775183,0.001866888,0.000275108,0.00035809647],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0014110362,0.0009840075,0.018078871,0.0013494118,0.000042183266,0.00007798717,0.0005100227,0.0005342886,0.0002039462],"category_scores_gemma":[0.0003283965,0.0005605046,0.0017976923,0.0035918741,0.00012490767,0.00020171415,0.0002643097,0.001453966,0.00012292339],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000075792077,0.00032878335,0.002285567,0.7408225,0.2558032,0.0002584381,0.000032200533,6.716197e-8,3.1503223e-8,0.0000033709587,0.000031592033,0.00042664915],"study_design_scores_gemma":[0.0019496381,0.00021648855,0.0027021177,0.055217706,0.9387927,0.000067445064,0.000005210154,0.0000013184608,2.725316e-7,0.0000014586016,0.00056002446,0.00048561592],"about_ca_topic_score_codex":0.0010138714,"about_ca_topic_score_gemma":0.0001645735,"teacher_disagreement_score":0.6856048,"about_ca_system_score_codex":0.0009654009,"about_ca_system_score_gemma":0.0010482892,"threshold_uncertainty_score":0.99968463},"labels":[],"label_agreement":null},{"id":"W1920982543","doi":"10.1182/blood.v95.10.3199","title":"RasGRP links T-cell receptor signaling to Ras","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":314,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Diacylglycerol kinase; Jurkat cells; Cell biology; Signal transduction; Biology; T-cell receptor; Phospholipase C; Second messenger system; Tyrosine kinase; Activator (genetics); Protein kinase C; MAPK/ERK pathway; T cell; Molecular biology; Receptor; Biochemistry; Immunology","score_opus":0.008663501921926466,"score_gpt":0.20507016909358639,"score_spread":0.19640666717165992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1920982543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97692585,0.0034998846,0.000026817634,0.00044928616,0.00067322,0.00025948285,0.000021805417,0.00020380056,0.017939834],"genre_scores_gemma":[0.93500626,0.00016507512,0.00040756105,0.0009315136,0.00012785236,0.000032879365,0.000087783126,0.000034558438,0.063206516],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983802,0.00017278509,0.0003462884,0.00045356626,0.00003503059,0.00061214966],"domain_scores_gemma":[0.9993103,0.00011203641,0.00006153611,0.00041964668,0.000046269077,0.000050207214],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00017941551,0.00025200067,0.00033540677,0.00010554835,0.00023867804,0.000020646432,0.000391139,0.00066751085,0.019411564],"category_scores_gemma":[0.0000246029,0.00023164325,0.00013120956,0.00019689131,0.00011682479,0.000055941033,0.00007424286,0.000642845,0.033358067],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000116521216,0.0007202324,0.00040637705,0.000009500005,0.00012273372,0.000010331495,0.00036480502,0.000009190006,0.9836102,0.00004880313,0.00827018,0.006311126],"study_design_scores_gemma":[0.002194478,0.00027015386,0.000047331952,0.000015896063,0.000057721456,0.000038795657,0.00006233957,1.602639e-7,0.6771022,0.000035262852,0.3199584,0.00021726081],"about_ca_topic_score_codex":0.00007857859,"about_ca_topic_score_gemma":0.0000066693888,"teacher_disagreement_score":0.3116882,"about_ca_system_score_codex":0.000015713416,"about_ca_system_score_gemma":0.000052288273,"threshold_uncertainty_score":0.98148483},"labels":[],"label_agreement":null},{"id":"W1932537262","doi":"10.1182/blood.v120.21.2122.2122","title":"Cardiopulmonary and Laboratory Profiling of Patients with Thalassemia At Risk for Pulmonary Hypertension: Report From the Thalassemia Clinical Research Network.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Thalassemia; Internal medicine; Cardiology; Pulmonary hypertension; Pulmonary embolism","score_opus":0.030272134294686975,"score_gpt":0.30086435242043574,"score_spread":0.27059221812574874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1932537262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98629826,0.011300518,0.000007335404,0.00021841114,0.00025791195,0.0010737443,0.00010006991,0.000029407991,0.00071435666],"genre_scores_gemma":[0.99662787,0.0010152631,0.001178162,0.00009343126,0.00071148487,0.00005239864,0.00019009269,0.000044473258,0.000086821965],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977441,0.0002984085,0.00052117783,0.00037201043,0.00051539013,0.0005489561],"domain_scores_gemma":[0.9974302,0.0010208773,0.00022894201,0.00060161646,0.0004836225,0.00023476343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022530234,0.00017102233,0.00046468544,0.000032673368,0.00032479412,0.000008110517,0.00009651699,0.00030401527,0.000008237722],"category_scores_gemma":[0.0006243807,0.00009595572,0.00011837734,0.00026042436,0.00030126577,0.00008375516,0.00017555137,0.00061885384,0.0000038104856],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065770006,0.00076174777,0.9930859,0.000056262696,0.00034534236,0.00015339185,0.000074890006,0.0000031397649,0.00023691598,0.000005842698,0.0036139356,0.0010049108],"study_design_scores_gemma":[0.0027682753,0.0003628808,0.9885983,0.00022182576,0.0007746795,0.00016236417,0.0003877196,0.000061476254,0.00045282245,0.00003322441,0.006043549,0.00013286708],"about_ca_topic_score_codex":0.00005367816,"about_ca_topic_score_gemma":0.0000039663473,"teacher_disagreement_score":0.010329627,"about_ca_system_score_codex":0.000024839426,"about_ca_system_score_gemma":0.00016797763,"threshold_uncertainty_score":0.3912961},"labels":[],"label_agreement":null},{"id":"W1943561089","doi":"10.1182/blood.v122.21.1136.1136","title":"Influence Of Concomitant NSAID Or ASA On The Efficacy and Safety Of Dabigatran Versus Warfarin For The Treatment Of Acute Venous Thromboembolism: A Pooled Analysis From RE-Cover and RE-Cover II","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Warfarin; Dabigatran; Concomitant; Discontinuation; Placebo; Randomization; Anesthesia; Randomized controlled trial; Internal medicine; Surgery; Atrial fibrillation","score_opus":0.022327560263878197,"score_gpt":0.27532494126528534,"score_spread":0.2529973810014071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1943561089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953137,0.0009270895,0.000012848065,0.0010178725,0.000045512435,0.0021071502,0.0002277615,0.00001228466,0.00033576952],"genre_scores_gemma":[0.9954,0.0038622885,0.00019836728,0.00022812308,0.000048175134,0.00013217333,0.000026343327,0.00002132324,0.00008319608],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.99855494,0.00006039211,0.00052179175,0.00033679305,0.00029113935,0.00023492382],"domain_scores_gemma":[0.9974416,0.001327993,0.0003233614,0.0007054198,0.000121843565,0.00007982184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018670771,0.00024471938,0.0011731418,0.000091809066,0.00013482211,0.0000157815,0.00016578587,0.00008926514,0.00020327193],"category_scores_gemma":[0.000096893506,0.00012348244,0.00021586845,0.00027038157,0.00025133844,0.000059599133,0.00007662102,0.000075184784,0.0000034656487],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.046381492,0.09243183,0.062814206,0.0017216867,0.44683316,0.00012299113,0.10047592,0.008937123,0.1864932,0.0073439437,0.007051486,0.039392952],"study_design_scores_gemma":[0.021598045,0.011577969,0.8859875,0.00020581424,0.047030795,0.0000020181758,0.0006744708,0.0003911392,0.030822573,0.00011496327,0.0013840412,0.00021064343],"about_ca_topic_score_codex":0.0020373308,"about_ca_topic_score_gemma":0.00011171864,"teacher_disagreement_score":0.82317334,"about_ca_system_score_codex":0.000031608084,"about_ca_system_score_gemma":0.00005713622,"threshold_uncertainty_score":0.50354683},"labels":[],"label_agreement":null},{"id":"W1947838475","doi":"10.1182/blood-2015-06-648667","title":"Pediatric chronic myeloid leukemia is a unique disease that requires a different approach","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":216,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; BC Children's Hospital","funders":"National Cancer Institute; Ariad Pharmaceuticals; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Chronic myelogenous leukemia; Disease; Pediatrics; Transplantation; Myeloid leukemia; Hematopoietic stem cell transplantation; Dasatinib; Leukemia; Intensive care medicine; Immunology; Imatinib; Internal medicine","score_opus":0.03734855655750234,"score_gpt":0.2647348544438029,"score_spread":0.22738629788630055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1947838475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98472613,0.008084486,0.00012186049,0.00037088498,0.00014756584,0.0009865335,0.00004360704,0.00027397525,0.0052449396],"genre_scores_gemma":[0.9936429,0.0008028603,0.0005804737,0.00036365844,0.0010728621,0.0002441849,0.0001789206,0.0000841449,0.0030299444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99756914,0.00008306873,0.00033220032,0.0006729222,0.00071736635,0.00062532286],"domain_scores_gemma":[0.9976447,0.000051442625,0.00014335464,0.0009899393,0.00008822912,0.001082333],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014913725,0.00042801004,0.0005228023,0.00018686506,0.0000781404,0.00003997513,0.00023434292,0.00017085577,0.0001461804],"category_scores_gemma":[0.00011587851,0.00033170494,0.0002239317,0.00029419028,0.00008194905,0.00012962932,0.00017296112,0.00033067196,0.00018568935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001012833,0.0068718786,0.9456397,0.0022485945,0.0012846682,0.0017592127,0.0027148526,0.00004278695,0.00090956944,0.00056695833,0.03263945,0.004309481],"study_design_scores_gemma":[0.14740908,0.0044594887,0.77573645,0.00077771547,0.01477371,0.0014082036,0.000758926,0.0046745846,0.024376918,0.0019395882,0.020603124,0.0030822337],"about_ca_topic_score_codex":0.000129257,"about_ca_topic_score_gemma":0.000010040982,"teacher_disagreement_score":0.1699033,"about_ca_system_score_codex":0.0027855018,"about_ca_system_score_gemma":0.0033307378,"threshold_uncertainty_score":0.9999135},"labels":[],"label_agreement":null},{"id":"W1949173307","doi":"10.1182/blood-2010-10-311001","title":"Gene profiling of Graffi murine leukemia virus-induced lymphoid leukemias: identification of leukemia markers and Fmn2 as a potential oncogene","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"Canadian Institutes of Health Research","keywords":"Leukemia; Lymphoid leukemia; Cancer research; Biology; Immunology","score_opus":0.008502538049344838,"score_gpt":0.2626518914834963,"score_spread":0.25414935343415146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1949173307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985011,0.000612457,0.00006201801,0.000018374334,0.00013598046,0.00041608466,0.00006694262,0.000017362167,0.00016967942],"genre_scores_gemma":[0.99798197,0.0004367892,0.0009021651,0.00003359462,0.00023405332,0.00004213001,0.00016212596,0.000051641873,0.00015555715],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980957,0.00010628062,0.000556978,0.0005361505,0.00036347183,0.0003414225],"domain_scores_gemma":[0.9985544,0.00001894672,0.00030723243,0.00071182154,0.00026092862,0.00014664557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065675395,0.00023697097,0.00028763048,0.00014101541,0.000093448514,0.000023779698,0.0003678401,0.00030899077,0.00003383431],"category_scores_gemma":[0.00016275495,0.0002450759,0.00013808101,0.00019141025,0.00020376814,0.000010483384,0.00018770492,0.00020003744,0.0000069362018],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013285175,0.00016014608,0.0007522132,0.00007541328,0.00021459421,0.000008209825,0.000038631053,0.00006392082,0.9929229,0.000010351247,0.00002499507,0.004400133],"study_design_scores_gemma":[0.0031078137,0.0013060761,0.0011514103,0.000013416289,0.00009419668,0.000103676335,0.000053463853,0.00020350087,0.99363583,0.00004668015,0.000054361513,0.0002295799],"about_ca_topic_score_codex":0.0002046721,"about_ca_topic_score_gemma":0.00017986714,"teacher_disagreement_score":0.0041705533,"about_ca_system_score_codex":0.00005598993,"about_ca_system_score_gemma":0.0010145388,"threshold_uncertainty_score":0.9993905},"labels":[],"label_agreement":null},{"id":"W1950612017","doi":"10.1182/blood-2015-02-629204","title":"Heterogeneous cytogenetic subgroups and outcomes in childhood acute megakaryoblastic leukemia: a retrospective international study","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute","keywords":"Acute megakaryoblastic leukemia; Cytarabine; Internal medicine; Karyotype; Retrospective cohort study; Medicine; Gastroenterology; Leukemia; Cytogenetics; Down syndrome; Pediatrics; Chromosome; Biology; Genetics; Gene","score_opus":0.016625725144221584,"score_gpt":0.2908076055371023,"score_spread":0.2741818803928807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1950612017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99720484,0.00021440932,0.000016799826,0.00039166666,0.0001277824,0.0009837501,0.000023379363,0.0000668411,0.00097055326],"genre_scores_gemma":[0.9986913,0.000049986345,0.00041413915,0.00017162263,0.00014614534,0.0000939716,0.000017817938,0.00004424722,0.00037075992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797666,0.00008624443,0.00034024758,0.0005204991,0.0006876235,0.0003887048],"domain_scores_gemma":[0.999009,0.00007379315,0.000065920845,0.0003715599,0.00016450876,0.00031521753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033582808,0.00024152645,0.0004956225,0.00033169804,0.00004117109,0.000046726753,0.00022322919,0.00011358441,0.00003141184],"category_scores_gemma":[0.00041062193,0.00020368441,0.00006596105,0.00027803992,0.000087097695,0.00009045696,0.00029408405,0.00046568146,0.000048511254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020882425,0.0017635582,0.99247354,0.000007643012,0.00084759283,0.0019010636,0.0018286908,0.000013634418,0.00062142755,0.000018101144,0.000068771114,0.00024717933],"study_design_scores_gemma":[0.020372758,0.002001529,0.9737774,0.000029542083,0.0003351801,0.001124534,0.0005741881,0.00022555886,0.0011597791,0.00017287816,0.000028946344,0.0001976902],"about_ca_topic_score_codex":0.00017479557,"about_ca_topic_score_gemma":0.00018950409,"teacher_disagreement_score":0.020163933,"about_ca_system_score_codex":0.00072710094,"about_ca_system_score_gemma":0.00042379633,"threshold_uncertainty_score":0.8306009},"labels":[],"label_agreement":null},{"id":"W1963522404","doi":"10.1182/blood-2011-10-384388","title":"B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor–transduced T cells","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1445,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Institutes of Health","keywords":"CD19; Medicine; Chimeric antigen receptor; Cytokine; Cytokine release syndrome; Adoptive cell transfer; Immunology; Cell therapy; T cell; Ex vivo; Antigen; Cancer research; In vivo; Cell; Immune system; Biology","score_opus":0.05428349638532947,"score_gpt":0.3184524654414508,"score_spread":0.2641689690561213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963522404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973534,0.00015119476,0.000022225684,0.000031040287,0.00007785418,0.000991026,0.000023316075,0.000023965007,0.0013260115],"genre_scores_gemma":[0.9979069,0.00086590525,0.00087389,0.000019153593,0.000055415563,0.000013273108,0.00001769719,0.000032907854,0.00021480522],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99786305,0.00027667085,0.0008085643,0.00034609818,0.00040732752,0.00029828405],"domain_scores_gemma":[0.9988495,0.00019132782,0.00028922618,0.00035297163,0.00014346495,0.00017349726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000983645,0.0001687097,0.0007398141,0.0001682093,0.000026617976,0.0000037827924,0.00011981694,0.00021364393,0.00045632807],"category_scores_gemma":[0.0001687316,0.00013644292,0.00015251333,0.00044660823,0.00017728301,0.000044704273,0.000035844805,0.00032026425,0.000003148085],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010457441,0.0061210277,0.15947329,0.0000796713,0.00014173341,0.000028064243,0.00052722933,2.1283742e-7,0.8225816,0.0000037700295,0.00002590406,0.000560056],"study_design_scores_gemma":[0.07727594,0.0034224687,0.18115906,0.00025451602,0.0001467954,0.000007841009,0.000065461034,0.000010292756,0.7374966,0.0000071854165,0.00003373436,0.00012010952],"about_ca_topic_score_codex":0.00051696086,"about_ca_topic_score_gemma":0.00007298506,"teacher_disagreement_score":0.08508501,"about_ca_system_score_codex":0.000016495298,"about_ca_system_score_gemma":0.00021899235,"threshold_uncertainty_score":0.5563981},"labels":[],"label_agreement":null},{"id":"W1963752281","doi":"10.1182/blood-2005-05-2048","title":"Predictive value of persistent versus transient antiphospholipid antibody subtypes for the risk of thrombotic events in pediatric patients with systemic lupus erythematosus","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster Children's Hospital","funders":"","keywords":"Medicine; Antiphospholipid syndrome; Predictive value; Immunology; Lupus anticoagulant; Antibody; Catastrophic antiphospholipid syndrome; Internal medicine; Gastroenterology","score_opus":0.012027001937288364,"score_gpt":0.26027283483760844,"score_spread":0.24824583290032007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963752281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921406,0.0036683842,0.00017564272,0.000043924752,0.00032983825,0.0033488101,0.00011944008,0.00002357842,0.00014978168],"genre_scores_gemma":[0.99873716,0.00061764347,0.00026713542,0.0000038353483,0.00013181227,0.00010977098,0.000026979618,0.00005047126,0.00005522433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99735045,0.00014658703,0.00072634127,0.00038424289,0.00094888627,0.00044346976],"domain_scores_gemma":[0.9977162,0.0007219991,0.00042668238,0.00058979704,0.00043407432,0.000111265224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066963956,0.00025324503,0.0007420338,0.00025199217,0.00006589947,0.000004464195,0.00027385753,0.00012339232,0.00001003406],"category_scores_gemma":[0.00027213665,0.00015537892,0.00035606974,0.0005189943,0.00011792572,0.00007756314,0.00004474303,0.00021498879,0.0000052857004],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033590018,0.0020824883,0.98645455,0.0023632692,0.0010427409,0.000002851285,0.0031969086,0.0011887106,0.00021094333,0.000026035152,0.000028755821,0.00004373199],"study_design_scores_gemma":[0.102279395,0.007825894,0.86223096,0.0033150765,0.008427885,0.0011715664,0.005929069,0.0050374772,0.003288561,0.000009836166,0.000024786077,0.00045947623],"about_ca_topic_score_codex":0.00006812462,"about_ca_topic_score_gemma":0.000022076914,"teacher_disagreement_score":0.12422358,"about_ca_system_score_codex":0.00012728364,"about_ca_system_score_gemma":0.00024827005,"threshold_uncertainty_score":0.6336168},"labels":[],"label_agreement":null},{"id":"W1963764926","doi":"10.1182/blood-2008-03-139964","title":"Impaired negative regulation of homeostatically proliferating T cells","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Cancer Institute; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Ontario Institute for Cancer Research; Canadian Diabetes Association; U.S. Department of Defense","keywords":"FOXP3; Immune system; Cell biology; Biology; Antigen; T cell; Inhibitory postsynaptic potential; Homeostasis; Immunology; Cancer research; Chemistry; Endocrinology","score_opus":0.012203171484507008,"score_gpt":0.21228147904628206,"score_spread":0.20007830756177505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963764926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99509096,0.00014323933,0.00032453256,0.000042008334,0.00062498025,0.00015817114,0.0000024006486,0.000046344765,0.0035673687],"genre_scores_gemma":[0.9930019,0.00002040372,0.0003973389,0.000044108863,0.000019973224,0.00000838466,0.000034438614,0.000007668809,0.006465813],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994003,0.00009217818,0.00024578138,0.00011538084,0.00002505513,0.000121307196],"domain_scores_gemma":[0.99955475,0.000085762455,0.00012523038,0.0001168232,0.00010908415,0.0000083582145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000070843584,0.000077018456,0.00013695314,0.000057817997,0.0001201276,0.0000029464957,0.000047268288,0.000088922905,0.00078666105],"category_scores_gemma":[0.00008428957,0.00006919823,0.000054669654,0.00008168342,0.00009183648,0.00008975422,0.000016117308,0.00011303079,0.000250217],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008973618,0.00025326826,0.0007550511,0.0000087340095,0.00009138201,9.615383e-7,0.00093983073,0.0000072912844,0.99527717,0.00014202762,0.0022296517,0.00020488887],"study_design_scores_gemma":[0.0014372221,0.00024940184,0.012661577,0.000016432929,0.00003329438,0.00007545495,0.00014654963,0.000018212597,0.9842291,0.00004657409,0.0010139835,0.00007220991],"about_ca_topic_score_codex":0.000024716976,"about_ca_topic_score_gemma":0.0000014772629,"teacher_disagreement_score":0.011906526,"about_ca_system_score_codex":0.000008791891,"about_ca_system_score_gemma":0.00003580472,"threshold_uncertainty_score":0.8613387},"labels":[],"label_agreement":null},{"id":"W1963783366","doi":"10.1182/blood-2002-02-0608","title":"Overexpression of the myeloma-associated oncogene fibroblast growth factor receptor 3 confers dexamethasone resistance","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Fibroblast growth factor receptor 3; Cancer research; Multiple myeloma; Biology; Dexamethasone; Cell culture; Fibroblast growth factor; Molecular biology; Receptor; Internal medicine; Endocrinology; Medicine; Immunology","score_opus":0.030370515430819752,"score_gpt":0.26194596787865154,"score_spread":0.2315754524478318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963783366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914409,0.00035656057,0.0000045188754,0.00046690783,0.00004137847,0.0005127919,0.00021135974,0.000044943834,0.006920673],"genre_scores_gemma":[0.99179167,0.000113149894,0.00070886343,0.000053117266,0.00005159279,0.000022950411,0.000025607711,0.000027310993,0.007205768],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983764,0.00015368985,0.0002637203,0.00026510473,0.0005936028,0.00034746772],"domain_scores_gemma":[0.99888283,0.00015850127,0.00016344001,0.00041403022,0.00018814433,0.00019307208],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008946599,0.00017224603,0.00031713353,0.000060480274,0.0001097434,0.000012497666,0.00016684271,0.00012231202,0.0011583044],"category_scores_gemma":[0.0009192899,0.00011013864,0.00016344928,0.00028804605,0.00011797425,0.00005746258,0.000074622454,0.00019081858,0.0000657836],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034929658,0.0027465853,0.12098799,0.0001951508,0.0005991405,0.00002924727,0.00039611355,2.2295359e-7,0.86764216,0.00006141353,0.005838359,0.0011542955],"study_design_scores_gemma":[0.010031131,0.00042714123,0.27830577,0.00094903575,0.000110178924,0.0000072130115,0.00004471111,0.000028913599,0.7088303,0.000027672922,0.0010930583,0.00014485941],"about_ca_topic_score_codex":0.00004656963,"about_ca_topic_score_gemma":0.000029784556,"teacher_disagreement_score":0.15881188,"about_ca_system_score_codex":0.0000814817,"about_ca_system_score_gemma":0.000059629383,"threshold_uncertainty_score":0.9997548},"labels":[],"label_agreement":null},{"id":"W1963797562","doi":"10.1182/blood-2012-08-450775","title":"Robust T-cell stimulation by Epstein-Barr virus–transformed B cells after antigen targeting to DEC-205","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"Vontobel-Stiftung; EMDO Stiftung; Roman, Marga und Mareille Sobek Stiftung; Baugarten Stiftung; National Cancer Institute; National Science Foundation; Croucher Foundation; Fondation Acteria; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"Antigen; Virology; Stimulation; Virus; Epstein–Barr virus; B cell; Biology; Immunology; Medicine; Antibody; Internal medicine","score_opus":0.016530688972539193,"score_gpt":0.25636154040352516,"score_spread":0.23983085143098595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963797562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913066,0.00080634013,0.0006954149,0.000531348,0.000082872735,0.0013667365,0.000050716844,0.000088836954,0.005071137],"genre_scores_gemma":[0.992544,0.00013068052,0.002796889,0.00080572965,0.00025654453,0.00015089898,0.00006246294,0.00006757724,0.003185201],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99789834,0.000047960526,0.00040268718,0.00043492328,0.0005472598,0.000668836],"domain_scores_gemma":[0.9988277,0.00007580233,0.000049064864,0.0003386039,0.00019724423,0.0005115609],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0002673012,0.00024308162,0.0003401031,0.00018424014,0.00012489907,0.00010505838,0.00015012462,0.00017096913,0.0045691878],"category_scores_gemma":[0.000043595574,0.00021215533,0.00012894235,0.0003307435,0.000042031363,0.00018480094,0.00005632222,0.00025984555,0.0022310645],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018424167,0.0008790749,0.01734555,0.0001443799,0.00005689483,0.000037214042,0.0005127741,0.000081552644,0.9505872,0.0000023127163,0.027519502,0.0026493073],"study_design_scores_gemma":[0.0049071084,0.00053232437,0.018160826,0.00008778125,0.00012118013,0.0000070073843,0.00012546698,0.0008817334,0.877646,0.00002038412,0.097063944,0.00044618838],"about_ca_topic_score_codex":0.001053139,"about_ca_topic_score_gemma":0.00011328398,"teacher_disagreement_score":0.07294114,"about_ca_system_score_codex":0.000057480505,"about_ca_system_score_gemma":0.00010342297,"threshold_uncertainty_score":0.9985458},"labels":[],"label_agreement":null},{"id":"W1964225651","doi":"10.1182/blood-2010-08-304048","title":"Elevated circulating t(14;18) translocation levels prior to diagnosis of follicular lymphoma","year":2010,"lang":"en","type":"letter","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Chromosomal translocation; Follicular lymphoma; Peripheral blood; Follicular phase; Lymphoma; Immunology; Medicine; Biology; Pathology; Internal medicine; Genetics; Gene","score_opus":0.028706695071479292,"score_gpt":0.2685993858829945,"score_spread":0.23989269081151518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964225651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86734056,0.0009932127,0.00003343602,0.12856974,0.0003178981,0.0018761733,0.00019748705,0.000116722826,0.00055478717],"genre_scores_gemma":[0.8442836,0.00012827372,0.003152093,0.1478476,0.0019094895,0.00124292,0.00084214215,0.00017326143,0.00042063964],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99734277,0.00006240739,0.0007285724,0.00067530206,0.00070973596,0.0004812442],"domain_scores_gemma":[0.9981439,0.00020783891,0.0003131078,0.0008592477,0.00030143154,0.0001744812],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00016409245,0.0004939749,0.0009978736,0.00029272464,0.00008686895,0.000033440534,0.00019751544,0.0014118125,0.00033487863],"category_scores_gemma":[0.00019253253,0.00042878924,0.0004454403,0.0003753653,0.00004686882,0.00005305642,0.00003799037,0.0005014809,0.00009140352],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016861716,0.014077888,0.19614567,0.0041930247,0.008767561,0.00885056,0.002972482,0.000011454437,0.050674725,0.000060935614,0.4604223,0.25365478],"study_design_scores_gemma":[0.019484295,0.00089216145,0.16476668,0.0025838304,0.005368224,0.00047606538,0.000019404579,0.000012160882,0.41026825,0.000050904473,0.39513505,0.000943001],"about_ca_topic_score_codex":0.0003720126,"about_ca_topic_score_gemma":0.00002294229,"teacher_disagreement_score":0.3595935,"about_ca_system_score_codex":0.00020760624,"about_ca_system_score_gemma":0.00051490415,"threshold_uncertainty_score":0.99988455},"labels":[],"label_agreement":null},{"id":"W1964499785","doi":"10.1182/blood-2009-11-253120","title":"Mutation-specific hemostatic variability in mice expressing common type 2B von Willebrand disease substitutions","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Canadian Institutes of Health Research; Queen's University; Cancer Research Institute","keywords":"Von Willebrand disease; Von Willebrand factor; Platelet; Coagulation; Chemistry; Bleeding time; Mutation; Thrombus; Mutant; Molecular biology; Coagulopathy; Immunology; Phenotype; Internal medicine; Endocrinology; Medicine; Biology; Biochemistry; Gene; Platelet aggregation","score_opus":0.012700405182519095,"score_gpt":0.2625143864851927,"score_spread":0.24981398130267363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964499785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99729913,0.00030063072,0.000051098683,0.0003411248,0.00014517074,0.00030776934,0.000020338037,0.000036495738,0.0014982331],"genre_scores_gemma":[0.9986071,0.000030079571,0.0010317867,0.00008162571,0.000026220741,0.000017951706,0.0001407041,0.00001081821,0.000053695992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99931455,0.000038225513,0.00017280044,0.00020080547,0.000116424446,0.00015719519],"domain_scores_gemma":[0.999448,0.00011444202,0.000037049445,0.00022625715,0.00004214413,0.00013213366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011677449,0.00010200325,0.00018014867,0.000057066853,0.000086594,0.000021046022,0.000042945154,0.000050636267,0.00010774317],"category_scores_gemma":[0.0001334697,0.000089901725,0.0000352257,0.0001793027,0.00006919834,0.000089255955,0.000012319541,0.00016904532,0.00003728151],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058232824,0.008652034,0.93460983,0.00018463552,0.00014179137,0.0028988156,0.0010923031,0.000028764793,0.042556528,0.0014719449,0.00034009674,0.0074409298],"study_design_scores_gemma":[0.016485058,0.00015901032,0.96047753,0.00024850565,0.00049704814,0.00023636776,0.00015178825,0.0006833376,0.010593976,0.0068120146,0.0032684095,0.00038693866],"about_ca_topic_score_codex":0.000054215365,"about_ca_topic_score_gemma":0.00009688389,"teacher_disagreement_score":0.031962555,"about_ca_system_score_codex":0.000016996493,"about_ca_system_score_gemma":0.00008477534,"threshold_uncertainty_score":0.3666086},"labels":[],"label_agreement":null},{"id":"W1964522660","doi":"10.1182/blood-2008-10-184226","title":"Induction of angiogenesis by normal and malignant plasma cells","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Universität Heidelberg; Stem Cell Network","keywords":"Angiogenesis; Cancer research; Medicine; Pathology; Internal medicine","score_opus":0.01437517581320826,"score_gpt":0.25424823677407676,"score_spread":0.2398730609608685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964522660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99832755,0.000458401,0.000004867158,0.00014060548,0.000014154668,0.00014489406,0.00002151887,0.000011788907,0.00087624457],"genre_scores_gemma":[0.99880314,0.00014690608,0.00058280636,0.0000238806,0.000030733103,0.0000033589968,0.000019676527,0.0000044322746,0.00038508305],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99951917,0.000012117273,0.00009044183,0.00010653303,0.00013843151,0.00013328507],"domain_scores_gemma":[0.99973637,0.00001122373,0.000024829187,0.00009607952,0.000027789589,0.00010368112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000038939124,0.000058934864,0.00011431194,0.0000517085,0.000023142527,0.0000040273776,0.000019947014,0.00003938198,0.00003204681],"category_scores_gemma":[0.000011304512,0.000045488203,0.000030833973,0.000068961,0.000021897127,0.000031130836,0.000008455114,0.000030624473,0.000008866703],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016970445,0.0010869345,0.049428172,0.0000345441,0.00012942962,0.00007027765,0.000069264526,2.0565815e-7,0.918591,0.000012408655,0.00067470066,0.029733343],"study_design_scores_gemma":[0.0037248842,0.0006789133,0.12933663,0.000021905458,0.0000942932,0.000052984087,0.000020341857,0.000016729997,0.86572665,0.000007801719,0.00027946677,0.0000394377],"about_ca_topic_score_codex":0.00004692695,"about_ca_topic_score_gemma":0.0000019408174,"teacher_disagreement_score":0.079908445,"about_ca_system_score_codex":0.000005925951,"about_ca_system_score_gemma":0.000018040364,"threshold_uncertainty_score":0.18549551},"labels":[],"label_agreement":null},{"id":"W1964632606","doi":"10.1182/blood.v97.8.2420","title":"The combination of chemotherapy and systemic immunotherapy with soluble B7–immunoglobulin G leads to cure of murine leukemia and lymphoma and demonstration of tumor-specific memory responses","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Immunotherapy; Lymphoma; Medicine; Immunology; Chemotherapy; Immune system; Antigen; Cancer research; Cytotoxic T cell; Leukemia; T cell; Biology; Internal medicine; In vitro","score_opus":0.007086963470742943,"score_gpt":0.213099924869166,"score_spread":0.20601296139842307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964632606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92361283,0.07551965,0.00007717936,0.00015234032,0.00007556797,0.00045277996,0.000010508428,0.00001797605,0.00008117128],"genre_scores_gemma":[0.984015,0.015132685,0.00013409792,0.000030782816,0.000006791458,0.000021929183,0.000008189379,0.00002339264,0.00062715355],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99864316,0.00031410204,0.00052489876,0.00022785016,0.00007224972,0.00021773686],"domain_scores_gemma":[0.99870956,0.00041192007,0.00035833527,0.00034962705,0.00015542691,0.000015104976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056699355,0.00020998636,0.00044399267,0.00014727701,0.00020785058,0.000018707799,0.00016130692,0.00013778181,0.00001758801],"category_scores_gemma":[0.000026248365,0.00015191418,0.000044372424,0.00020441554,0.00066834025,0.000108814194,0.000037590227,0.00009833312,0.0000012314761],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009891848,0.00024926907,0.013811472,0.00006966413,0.00029522885,0.0000026777564,0.0012632915,0.0000022667462,0.9570017,0.0004792135,0.000032507793,0.016900903],"study_design_scores_gemma":[0.011418389,0.0020567216,0.14296341,0.00031045527,0.000054806813,0.0012031972,0.0011228836,0.0000026999808,0.8389929,0.000050118626,0.0016302076,0.00019420404],"about_ca_topic_score_codex":0.00012468419,"about_ca_topic_score_gemma":0.0000150854485,"teacher_disagreement_score":0.12915194,"about_ca_system_score_codex":0.000022769053,"about_ca_system_score_gemma":0.00010886812,"threshold_uncertainty_score":0.61948806},"labels":[],"label_agreement":null},{"id":"W1964824076","doi":"10.1182/blood-2013-04-495374","title":"Preclinical and clinical efficacy of XPO1/CRM1 inhibition by the karyopherin inhibitor KPT-330 in Ph+ leukemias","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":146,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"National Cancer Institute; National Institute for Health and Care Research","keywords":"Karyopherin; Cytarabine; Internal medicine; Medicine; Cancer research; Pharmacology; Leukemia; Cell nucleus; Nuclear transport","score_opus":0.01031255958674991,"score_gpt":0.261727777448571,"score_spread":0.2514152178618211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964824076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984568,0.0004279494,0.000017655582,0.0001845435,0.00014341091,0.00022703223,0.0000060605716,0.000006665096,0.0005298899],"genre_scores_gemma":[0.9989274,0.00016983379,0.00016241813,0.00020268119,0.00035367464,0.000008361018,0.000036221452,0.00001343846,0.00012594208],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990982,0.00009863077,0.00034383446,0.00025201534,0.00007962873,0.00012772063],"domain_scores_gemma":[0.9995391,0.000058073816,0.00009072681,0.00022699189,0.000034819917,0.000050292787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020652193,0.00009776746,0.00013921363,0.000013324332,0.000029560837,0.000015089911,0.00007037066,0.0002218988,0.000033247426],"category_scores_gemma":[0.00014759065,0.00007116381,0.00007179688,0.00005300366,0.00013890197,0.0000055637734,0.00008345339,0.00016434336,0.000010810997],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002607099,0.0008058773,0.11240697,0.00003319967,0.000117595744,0.0000027350488,0.00008216025,0.0000024476747,0.83390343,0.000047805283,0.023504272,0.028832797],"study_design_scores_gemma":[0.0096553145,0.0021061576,0.66751486,0.000058809757,0.00012870344,0.000049566246,0.00013275798,0.00005651881,0.29968187,0.00030065194,0.019945927,0.00036887647],"about_ca_topic_score_codex":0.000055950983,"about_ca_topic_score_gemma":0.000024607718,"teacher_disagreement_score":0.5551079,"about_ca_system_score_codex":0.0000037257435,"about_ca_system_score_gemma":0.000027465034,"threshold_uncertainty_score":0.2901976},"labels":[],"label_agreement":null},{"id":"W1964837213","doi":"10.1182/blood-2006-06-031948","title":"Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph)","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":185,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Lymphoma; Internal medicine; Odds ratio; Medicine; Non-Hodgkin's lymphoma; Epidemiology; First-degree relatives; Oncology; Relative risk; Leukemia; Family history; Confidence interval","score_opus":0.015563212331046359,"score_gpt":0.24558472384319488,"score_spread":0.23002151151214853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964837213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9782401,0.02020204,0.000025108358,0.00024183476,0.00008684336,0.00027522657,0.0005215777,0.000012351391,0.00039491913],"genre_scores_gemma":[0.99805117,0.0009110909,0.00040256832,0.00025606633,0.000047587553,0.00004740722,0.00009248712,0.000014469471,0.00017717908],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981509,0.00017646517,0.0008997671,0.00034994038,0.00022676316,0.00019617759],"domain_scores_gemma":[0.9958404,0.002717643,0.00077359803,0.00039518598,0.00019841289,0.00007480906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003746195,0.00022799744,0.0012444602,0.00020497484,0.000029487583,0.000005080882,0.00013144506,0.000117284246,0.00008641215],"category_scores_gemma":[0.0005281505,0.00015525454,0.00031603657,0.00014689885,0.0005565932,0.000040744948,0.00007697819,0.00002257362,0.000001411359],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034790547,0.0017049373,0.97806686,0.00004879581,0.0063407556,0.00008054414,0.00037780774,0.000006284762,0.009532213,0.0003566732,0.0015244804,0.0016127347],"study_design_scores_gemma":[0.010671292,0.000423638,0.9650091,0.0001592349,0.014062907,0.000121271354,0.0002960653,0.00042056394,0.008044463,0.00011764801,0.0005566514,0.00011718596],"about_ca_topic_score_codex":0.024144102,"about_ca_topic_score_gemma":0.0010213214,"teacher_disagreement_score":0.02312278,"about_ca_system_score_codex":0.00014040947,"about_ca_system_score_gemma":0.0002068273,"threshold_uncertainty_score":0.9823542},"labels":[],"label_agreement":null},{"id":"W1964843845","doi":"10.1182/blood-2011-01-333179","title":"AF1q/MLLT11 regulates the emergence of human prothymocytes through cooperative interaction with the Notch signaling pathway","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; Ligue Contre le Cancer; University of Toronto; Institut National de la Santé et de la Recherche Médicale; Sunnybrook Research Institute; Association pour la Recherche sur le Cancer","keywords":"Notch signaling pathway; Lymphopoiesis; Cell biology; Biology; Progenitor cell; Gene silencing; Cellular differentiation; Transcriptome; Stem cell; Myogenesis; Signal transduction; Gene expression; Genetics; Gene; Myocyte","score_opus":0.052714381523233766,"score_gpt":0.30118578887335845,"score_spread":0.24847140735012468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964843845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891174,0.00022438659,0.00013141333,0.0007591244,0.00003194444,0.0010480317,0.0000043994924,0.00003700488,0.0086463215],"genre_scores_gemma":[0.998184,0.000021906482,0.00062069425,0.0001511047,0.00013368938,0.00014082166,0.000007045735,0.000026349022,0.00071433675],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988323,0.00013638794,0.00023341781,0.00022355991,0.0003382908,0.00023605749],"domain_scores_gemma":[0.9989153,0.00012771488,0.00013296762,0.00045266608,0.00033049332,0.000040866846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033419876,0.00015091032,0.000212548,0.000035148296,0.0002414084,0.00001582109,0.00025311834,0.000057044646,0.00048741593],"category_scores_gemma":[0.00008602762,0.00006731049,0.000050570055,0.00030400822,0.0003259757,0.00015505335,0.000079262754,0.00039040658,0.000020445537],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052350684,0.00062292453,0.0035125548,0.000105657025,0.0005080776,0.000047994767,0.032356486,0.000012926107,0.9584601,0.0021809996,0.0011634548,0.0005053025],"study_design_scores_gemma":[0.0012251423,0.0011645658,0.0020688118,0.00015940878,0.00013727073,0.00007202114,0.0066125495,0.00004431613,0.98794556,0.00012014034,0.0003558304,0.0000943636],"about_ca_topic_score_codex":0.0003709794,"about_ca_topic_score_gemma":0.000071006,"teacher_disagreement_score":0.029485462,"about_ca_system_score_codex":0.000024652507,"about_ca_system_score_gemma":0.000162657,"threshold_uncertainty_score":0.5336863},"labels":[],"label_agreement":null},{"id":"W1964908644","doi":"10.1182/blood-2005-06-009761","title":"Relative efficacy of intravenous immunoglobulin G in ameliorating thrombocytopenia induced by antiplatelet GPIIbIIIa versus GPIbα antibodies","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services","funders":"","keywords":"Antibody; Platelet; Immunology; Monoclonal antibody; Thrombocytopenic purpura; Medicine","score_opus":0.016057197641854756,"score_gpt":0.27260396207858434,"score_spread":0.2565467644367296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964908644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99141914,0.0015455774,0.000004620771,0.00008497093,0.00008302831,0.0004580622,0.00003243107,0.00004368638,0.0063284836],"genre_scores_gemma":[0.99895686,0.00010009501,0.000621947,0.000017786733,0.000034174776,0.000007438099,0.0001711057,0.000027673164,0.000062942454],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998615,0.00004650883,0.00047456846,0.00030505954,0.0002237085,0.0003351019],"domain_scores_gemma":[0.9993119,0.00014246027,0.00019106093,0.00024658095,0.00006107489,0.000046907327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000108659464,0.00023232466,0.0006833652,0.0001318878,0.000069024034,0.000015965374,0.00009089855,0.00015676214,0.000039619903],"category_scores_gemma":[0.00009214582,0.00020693407,0.00009281753,0.00037099063,0.00007762511,0.00012634075,0.00004513092,0.00024324011,0.000031820033],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029873517,0.018542526,0.18329023,0.00020544404,0.0018637103,0.003125558,0.0026011963,0.000023034112,0.7679403,0.00082515436,0.00054466753,0.018050816],"study_design_scores_gemma":[0.08473825,0.0031563123,0.5976208,0.000593796,0.0007740067,0.00015023233,0.0005172923,0.000049091585,0.31118697,0.00045571916,0.00016843023,0.00058912626],"about_ca_topic_score_codex":0.0014501098,"about_ca_topic_score_gemma":0.00012847294,"teacher_disagreement_score":0.45675334,"about_ca_system_score_codex":0.0000440458,"about_ca_system_score_gemma":0.00007637389,"threshold_uncertainty_score":0.84385264},"labels":[],"label_agreement":null},{"id":"W1964974230","doi":"10.1182/blood-2012-05-433508","title":"Differential effects of γc cytokines on postselection differentiation of CD8 thymocytes","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Canadian Institutes of Health Research","keywords":"Biology; Thymocyte; CD8; Cell biology; Immunology; Cellular differentiation; T cell; MAPK/ERK pathway; Cancer research; Signal transduction; Antigen; Immune system; Biochemistry","score_opus":0.006312031844102612,"score_gpt":0.2028964637036893,"score_spread":0.19658443185958668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964974230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99629277,0.0017532477,0.0000816504,0.00001656589,0.0013268295,0.00018391422,0.000009769794,0.00004316923,0.00029208485],"genre_scores_gemma":[0.99922454,0.00010221155,0.000012480605,0.0000105561585,0.00007796204,0.00001407446,0.00008599655,0.000014064112,0.00045811996],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99907506,0.00016753245,0.00027581962,0.00015215171,0.00003793208,0.00029153132],"domain_scores_gemma":[0.9993086,0.00020125002,0.00021144787,0.00020725493,0.000057345824,0.000014137291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000044598644,0.00016131089,0.00031770274,0.00013944169,0.000069916714,0.0000028007773,0.00012307423,0.00026002497,0.00029882393],"category_scores_gemma":[0.00006005229,0.0001292139,0.00011473115,0.00010082848,0.0001167148,0.00006355794,0.00004843573,0.00016447526,0.00011046851],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017084839,0.0022129978,0.025476836,0.00009121079,0.0003236298,3.3664898e-7,0.00023163676,2.0891326e-7,0.9696194,0.0008138493,0.00008495356,0.0009740777],"study_design_scores_gemma":[0.0025858395,0.00069701264,0.08309371,0.000043585547,0.00022328594,0.000017000602,0.000020358042,3.8509302e-7,0.91298026,0.000055094974,0.0001752413,0.00010825058],"about_ca_topic_score_codex":0.000052636075,"about_ca_topic_score_gemma":0.000004555512,"teacher_disagreement_score":0.05761687,"about_ca_system_score_codex":0.000009335813,"about_ca_system_score_gemma":0.000012338899,"threshold_uncertainty_score":0.526919},"labels":[],"label_agreement":null},{"id":"W1965174970","doi":"10.1182/blood-2014-09-599159","title":"CD24hiCD27+ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":164,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Apheresis Group","funders":"Institut National Du Cancer; Société Française de Dermatologie et de Pathologie Sexuellement Transmissible; Institut National de la Santé et de la Recherche Médicale; University College London","keywords":"Graft-versus-host disease; Host (biology); Disease; Regulatory B cells; Medicine; Immunology; Biology; Pathology; B cell; Genetics; Antibody","score_opus":0.02197338233129793,"score_gpt":0.25942648718261024,"score_spread":0.23745310485131232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965174970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99605393,0.000691472,0.000016844237,0.00014155603,0.00021303985,0.0003787789,0.000014597952,0.00006350152,0.0024262604],"genre_scores_gemma":[0.9988783,0.000054256743,0.00017471003,0.00007164336,0.00013196415,0.000023395281,0.000036350644,0.000029941555,0.00059940986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881285,0.000046244466,0.0002472432,0.00029615624,0.00029903726,0.00029849264],"domain_scores_gemma":[0.99906504,0.000057582296,0.000049093804,0.00029652583,0.000041269785,0.00049049925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023793268,0.0001561726,0.00023033854,0.00012090665,0.000037250742,0.000015192743,0.000060798902,0.00008619879,0.00004792076],"category_scores_gemma":[0.00002547161,0.00015296639,0.000039613384,0.00013170327,0.00008697521,0.000074631156,0.000022729093,0.00014511825,0.00005928895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042699757,0.0046421625,0.5122384,0.005737966,0.0006247629,0.004817228,0.007815781,0.00011774815,0.4519908,0.0030495084,0.0038541504,0.0008414956],"study_design_scores_gemma":[0.119336314,0.002481032,0.6225024,0.0022467885,0.0022359446,0.00026618372,0.0010308049,0.0005518081,0.23874973,0.00038221126,0.0089503545,0.0012664191],"about_ca_topic_score_codex":0.00003492648,"about_ca_topic_score_gemma":0.00010703448,"teacher_disagreement_score":0.21324109,"about_ca_system_score_codex":0.00008922928,"about_ca_system_score_gemma":0.000258858,"threshold_uncertainty_score":0.6237788},"labels":[],"label_agreement":null},{"id":"W1965206528","doi":"10.1182/blood-2002-01-0306","title":"Lack of progressive hepatic fibrosis during long-term therapy with deferiprone in subjects with transfusion-dependent beta-thalassemia","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":175,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Deferiprone; Medicine; Beta thalassemia; Thalassemia; Chelation therapy; Blood transfusion; Internal medicine; Gastroenterology; Deferasirox; Pediatrics","score_opus":0.014915712589694322,"score_gpt":0.23635008925787537,"score_spread":0.22143437666818105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965206528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99324995,0.0047431597,0.000005750815,0.00020783827,0.000014909113,0.00093137316,0.0000040466166,0.000045076653,0.0007978717],"genre_scores_gemma":[0.9972278,0.0022164974,0.00022671375,0.00003462463,0.000021309212,0.00006541976,0.000007995176,0.000042016218,0.00015764614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998718,0.00003689652,0.0002765945,0.00029526086,0.00035406227,0.00031913797],"domain_scores_gemma":[0.9994226,0.000022595663,0.00010664816,0.00027457695,0.00006390857,0.00010968076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000056907145,0.00021462001,0.0004135207,0.00012217594,0.000050805633,0.00001114402,0.000076727105,0.00013432407,0.0001942402],"category_scores_gemma":[0.0000059835993,0.00013463672,0.00006174111,0.00037034746,0.00010359815,0.00006540282,0.0000118210255,0.00024670057,0.000006843367],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007744674,0.0024300152,0.97322375,0.00049436284,0.00028963914,0.00079052337,0.0016762011,0.000015493675,0.019089598,0.000003308512,0.000002914515,0.0012097154],"study_design_scores_gemma":[0.027655827,0.0036727744,0.76958483,0.002366479,0.00042188686,0.0006612406,0.00051638624,0.00003618523,0.19473891,0.000003135429,0.000004089921,0.00033825432],"about_ca_topic_score_codex":0.000060479033,"about_ca_topic_score_gemma":0.00013584869,"teacher_disagreement_score":0.20363894,"about_ca_system_score_codex":0.000034116787,"about_ca_system_score_gemma":0.000044459943,"threshold_uncertainty_score":0.5490326},"labels":[],"label_agreement":null},{"id":"W1965495682","doi":"10.1182/blood-2010-06-291062","title":"Targeted deletion of the tachykinin 4 gene (TAC4−/−) influences the early stages of B lymphocyte development","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"Canadian Institutes of Health Research","keywords":"Haematopoiesis; Stem cell; Bone marrow; Biology; CD19; Cell biology; B cell; Molecular biology; Lymphopoiesis; Immune system; Stem cell factor; Lymphocyte; Immunology; Antibody","score_opus":0.007197210321469265,"score_gpt":0.20576418165417573,"score_spread":0.19856697133270645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965495682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99701566,0.00067647157,0.000017455346,0.00006277996,0.0016270267,0.00013131287,0.0000027266071,0.000014255165,0.00045234238],"genre_scores_gemma":[0.9982407,0.00003337518,0.00008105941,0.00006518984,0.00001508289,0.000012305859,0.0000151199865,0.000005601651,0.0015315489],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99936247,0.00010175243,0.0002768338,0.00010113186,0.00004143107,0.00011639559],"domain_scores_gemma":[0.99937636,0.000059371374,0.00022523104,0.0002302419,0.000103939965,0.000004881703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001978221,0.00008205676,0.00011307515,0.00003827087,0.00014422675,0.000005983467,0.00022007024,0.0001143779,0.0003826195],"category_scores_gemma":[0.000069762566,0.000045894994,0.000061329025,0.00009943567,0.00016418424,0.00005803897,0.00005676897,0.00019446689,0.00006750664],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048358736,0.0001173943,0.01756728,0.000005418949,0.0001356286,1.10466445e-7,0.00063545554,0.000001994129,0.9799833,0.00011130781,0.00016503659,0.0012287023],"study_design_scores_gemma":[0.00060824375,0.000046443707,0.18606591,0.000009087214,0.00003386053,0.00001419812,0.00009176609,3.5268084e-7,0.7949073,0.000008235283,0.018170482,0.000044150584],"about_ca_topic_score_codex":0.00014572237,"about_ca_topic_score_gemma":0.00003326249,"teacher_disagreement_score":0.18507604,"about_ca_system_score_codex":0.000007546065,"about_ca_system_score_gemma":0.00009072866,"threshold_uncertainty_score":0.41894153},"labels":[],"label_agreement":null},{"id":"W1965507670","doi":"10.1182/blood-2014-09-603357","title":"B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethality","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"National Center for Advancing Translational Sciences; National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Immunology; Graft-versus-host disease; Cytokine; Transplantation; Immune system; Spleen; Biology; Donor lymphocyte infusion; Medicine; Cancer research; Internal medicine","score_opus":0.017339401329167125,"score_gpt":0.24462160312700246,"score_spread":0.22728220179783534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965507670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855655,0.012643096,0.000012492857,0.00033083203,0.00072228024,0.00034375107,0.00013004712,0.00006641044,0.00018558223],"genre_scores_gemma":[0.9961903,0.0009311445,0.00014862564,0.00016465898,0.000030349098,0.000033859847,0.00004855201,0.000029894098,0.002422577],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99815804,0.00057162886,0.00034197446,0.00042258232,0.000058094785,0.0004476611],"domain_scores_gemma":[0.998997,0.0002870844,0.00014342737,0.00042873184,0.000065963635,0.00007779895],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036147825,0.00028880395,0.0003640055,0.00013178117,0.00016119097,0.00003880675,0.0002535432,0.0002522519,0.000106592255],"category_scores_gemma":[0.00008543208,0.00024610216,0.00009086501,0.00015758553,0.0003616463,0.00024084626,0.0001671252,0.00027235624,0.00012979803],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054386817,0.0005734861,0.0020860683,0.000017892806,0.00019127018,0.000036656103,0.0011450413,9.79843e-7,0.9887707,0.000024643337,0.0014801963,0.00023438744],"study_design_scores_gemma":[0.010482427,0.00035664276,0.027074581,0.00008628906,0.000116361225,0.000013240816,0.00041474984,9.3026466e-7,0.9447039,0.00006056057,0.016375573,0.0003147632],"about_ca_topic_score_codex":0.00015924961,"about_ca_topic_score_gemma":0.000017695902,"teacher_disagreement_score":0.044066817,"about_ca_system_score_codex":0.000029999552,"about_ca_system_score_gemma":0.000092467395,"threshold_uncertainty_score":0.9999991},"labels":[],"label_agreement":null},{"id":"W1965785075","doi":"10.1182/blood-2003-08-2968","title":"Membrane type 1–matrix metalloproteinase (MT1-MMP) cooperates with sphingosine 1–phosphate to induce endothelial cell migration and morphogenic differentiation","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Angiogenesis; Cell biology; Sphingosine-1-phosphate; Biology; Endothelial stem cell; Matrigel; Matrix metalloproteinase; S1PR1; Cell migration; Cellular differentiation; Sphingosine; Receptor; Vascular endothelial growth factor; Vascular endothelial growth factor A; Biochemistry; Cell; Cancer research; In vitro","score_opus":0.005346734642354411,"score_gpt":0.2008669033564282,"score_spread":0.1955201687140738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965785075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975102,0.0011579423,0.00061942847,0.000043039217,0.000072860326,0.000441993,0.00001658566,0.000016181517,0.00012176626],"genre_scores_gemma":[0.9970602,0.00015056672,0.0018553622,0.00012568303,0.00009631108,0.000047656064,0.0000894049,0.000026085263,0.0005487315],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99919975,0.000052140145,0.00013707278,0.00031578526,0.00011108114,0.0001841661],"domain_scores_gemma":[0.99954236,0.00000384118,0.000058450245,0.00020106781,0.000093271796,0.0001009993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010206865,0.00016802046,0.00013011228,0.000036123674,0.000083124214,0.000044669006,0.00006337784,0.0000978037,0.000030360909],"category_scores_gemma":[0.000049389993,0.00013903636,0.000028989045,0.00012029357,0.000015314208,0.000009434363,0.000028285953,0.000060129154,0.0000140073635],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010599669,0.00016489458,0.00021864772,0.000019792576,0.00004564375,0.0000049046303,0.000030972642,0.000014295179,0.9992125,0.00011404138,0.000027927557,0.000040358267],"study_design_scores_gemma":[0.0014916124,0.0008496692,0.000065661225,0.000013258804,0.00009356096,0.000025872865,0.000015994805,0.000012862788,0.99560714,0.000019899811,0.0016058356,0.00019862445],"about_ca_topic_score_codex":0.000046295798,"about_ca_topic_score_gemma":0.00005977608,"teacher_disagreement_score":0.003605378,"about_ca_system_score_codex":0.0000048954735,"about_ca_system_score_gemma":0.000057171415,"threshold_uncertainty_score":0.5669738},"labels":[],"label_agreement":null},{"id":"W1965824800","doi":"10.1182/blood-2013-01-479170","title":"A mechanistic role for DNA methylation in endothelial cell (EC)-enriched gene expression: relationship with DNA replication timing","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; University of Toronto","keywords":"DNA methylation; Biology; DNA replication; DNA; Genetics; Gene; Molecular biology; Gene expression; Cell biology","score_opus":0.01640615848154123,"score_gpt":0.24554647096744905,"score_spread":0.22914031248590783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965824800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94105834,0.00051209517,0.056948382,0.000054554945,0.00003583907,0.00070312334,0.000013067208,0.000016164366,0.0006584511],"genre_scores_gemma":[0.9742553,0.000033747194,0.02445919,0.000025190946,0.00016723441,0.00040797077,0.0003169405,0.000031041956,0.0003033323],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989322,0.00007260004,0.00026008417,0.00042462436,0.00011922811,0.00019125962],"domain_scores_gemma":[0.9991574,0.000065816625,0.00015582851,0.00043959272,0.00012156162,0.000059753533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028049195,0.0001368407,0.00011891932,0.00006888218,0.00009416039,0.000034307268,0.00010514146,0.00016318398,0.000013609774],"category_scores_gemma":[0.00019955751,0.00012625306,0.000045106688,0.000107520485,0.000016307513,0.000010986079,0.0000319815,0.00006459921,0.000009516959],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036326426,0.00012751912,0.0050034565,0.000016491183,0.0000085709025,2.591935e-7,0.00008023597,0.00014931547,0.9937878,0.00009553601,0.000010093275,0.00068435114],"study_design_scores_gemma":[0.0015107996,0.00025363578,0.011686473,0.000010560798,0.000036789133,0.0000014400813,0.00005050493,0.0004657736,0.98244005,0.0030109575,0.00036216798,0.0001708702],"about_ca_topic_score_codex":0.000018359518,"about_ca_topic_score_gemma":0.00001781798,"teacher_disagreement_score":0.033197027,"about_ca_system_score_codex":0.000012421384,"about_ca_system_score_gemma":0.000048958078,"threshold_uncertainty_score":0.514845},"labels":[],"label_agreement":null},{"id":"W1966070464","doi":"10.1182/blood-2003-12-4402","title":"Paxillin selectively associates with constitutive and chemoattractant-induced high-affinity α4β1 integrins: implications for integrin signaling","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"Medical Research Council; Promotion and Mutual Aid Corporation for Private Schools of Japan; University of Toronto; Multiple Sclerosis Society; Multiple Sclerosis Society of Canada","keywords":"Integrin; Paxillin; Cell biology; Biology; Molecular biology; Cell adhesion molecule; Receptor; Biochemistry","score_opus":0.03288770479033839,"score_gpt":0.2991989032542417,"score_spread":0.26631119846390333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966070464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99405587,0.000118251286,0.0019219663,0.0017214424,0.000016584248,0.0010846003,0.000044568922,0.00008914225,0.0009476042],"genre_scores_gemma":[0.99124634,0.000046804846,0.008125293,0.0001661256,0.00007898466,0.00018245338,0.000045462984,0.000031598873,0.00007693242],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99875623,0.00003160139,0.00023407396,0.00041020045,0.00020506498,0.00036282468],"domain_scores_gemma":[0.99864423,0.0003407884,0.00010356039,0.00020015992,0.00050835893,0.00020290399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026300494,0.00019566317,0.0003388259,0.00012706718,0.00018754195,0.00004534323,0.00010032492,0.00014257031,0.000014415661],"category_scores_gemma":[0.00073605863,0.00015266327,0.000063827305,0.00031859524,0.00014421355,0.000079239435,0.00004861484,0.00044855778,0.0000096514605],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030037243,0.0013927004,0.019796487,0.000093378956,0.00040662874,0.00003066729,0.00043809813,0.000006756968,0.96781576,0.007445244,0.000025391768,0.0022485068],"study_design_scores_gemma":[0.008684859,0.0012916279,0.082695566,0.00022275223,0.00029194375,0.00013388901,0.0004302938,0.00000715701,0.90349126,0.0023714225,0.00013788205,0.0002413375],"about_ca_topic_score_codex":0.0001581985,"about_ca_topic_score_gemma":0.000109032444,"teacher_disagreement_score":0.0643245,"about_ca_system_score_codex":0.00016623546,"about_ca_system_score_gemma":0.00061761774,"threshold_uncertainty_score":0.62254274},"labels":[],"label_agreement":null},{"id":"W1966086401","doi":"10.1182/blood-2007-03-079392","title":"Histone H2B as a functionally important plasminogen receptor on macrophages","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"S100 Proteins and Annexins","field":"Biochemistry, Genetics and Molecular Biology","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; Dalhousie University; National Institutes of Health; Cleveland Clinic","keywords":"Plasmin; Macrophage; Receptor; Molecular biology; Monocyte; Annexin; Chemistry; Cell biology; Biology; Immunology; Flow cytometry; Biochemistry; In vitro","score_opus":0.006525835883996214,"score_gpt":0.24694185341067407,"score_spread":0.24041601752667785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966086401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98917335,0.0010738779,0.000100007725,0.000094868505,0.00018325119,0.00012765745,0.00002517656,0.000021353208,0.009200479],"genre_scores_gemma":[0.99093515,0.0001041517,0.00073913817,0.000693522,0.0006271178,0.000014897478,0.000114231385,0.000026216792,0.0067455946],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991252,0.000011931955,0.00018576543,0.00029518158,0.00014377182,0.00023814083],"domain_scores_gemma":[0.99953985,0.000007980674,0.000068378846,0.00024042717,0.000046627563,0.000096721604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017616774,0.00013372107,0.00009358426,0.000038044072,0.000078550445,0.000012407652,0.00011211384,0.00012732286,0.00026709615],"category_scores_gemma":[0.000055352466,0.000120830926,0.00008737197,0.000056247354,0.00004071527,0.0000016335132,0.000042503154,0.000074774835,0.00014605894],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018892114,0.0003713222,0.0019388507,0.0000060906114,0.00007401625,0.000038936174,0.000014350295,0.0000011993019,0.9924229,0.00034719525,0.0031708835,0.0014253536],"study_design_scores_gemma":[0.00086451124,0.00078661117,0.0037637155,0.000008435147,0.0000193784,0.00004124803,0.000026871818,4.0991293e-7,0.84740424,0.000047433165,0.14687745,0.00015968831],"about_ca_topic_score_codex":0.000020177473,"about_ca_topic_score_gemma":0.000026822061,"teacher_disagreement_score":0.14501864,"about_ca_system_score_codex":0.00000967477,"about_ca_system_score_gemma":0.00005849763,"threshold_uncertainty_score":0.49273422},"labels":[],"label_agreement":null},{"id":"W1966177375","doi":"10.1182/blood-2002-06-1918","title":"Hematopoietic stem cell and progenitor defects in Sca-1/Ly-6A–null mice","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":187,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Mount Sinai Hospital; University of Toronto; Ontario Institute for Cancer Research","funders":"National Institutes of Health; Canadian Institutes of Health Research; Terry Fox Foundation; Leukemia and Lymphoma Society","keywords":"Haematopoiesis; Bone marrow; Stem cell; Biology; Megakaryocyte; Progenitor cell; Immunology; Molecular biology; Cell biology","score_opus":0.015707731938445987,"score_gpt":0.22273949379186667,"score_spread":0.20703176185342068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966177375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883731,0.0025738843,0.00002643001,0.00016599735,0.00007381353,0.0006653727,0.000004937002,0.00007699606,0.008039483],"genre_scores_gemma":[0.9978559,0.00018355316,0.0008473634,0.00011529401,0.00007252402,0.000049439965,0.0000057772468,0.00003552266,0.0008345968],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987565,0.000052865045,0.00031033004,0.000324056,0.00024996666,0.00030628158],"domain_scores_gemma":[0.9993989,0.000105994215,0.000059804108,0.0002297471,0.0000349649,0.00017062246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001364592,0.00017940011,0.0003036679,0.00012903147,0.00003778088,0.000020503643,0.000063815525,0.00012981283,0.00011838818],"category_scores_gemma":[0.000008911039,0.00016891216,0.000054600336,0.0002208447,0.000043144813,0.000059602095,0.000015930544,0.00016109932,0.00022839759],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017872958,0.005880188,0.5636515,0.010195537,0.0001865605,0.0027673964,0.018866329,0.000004251933,0.39383212,0.0003750838,0.00094206043,0.0031202727],"study_design_scores_gemma":[0.01822571,0.0006379745,0.03214895,0.0012491811,0.00086609356,0.002987248,0.0012274832,0.00034127454,0.94073033,0.00007735357,0.00089223206,0.0006161381],"about_ca_topic_score_codex":0.0000122919855,"about_ca_topic_score_gemma":0.000010506385,"teacher_disagreement_score":0.54689825,"about_ca_system_score_codex":0.000021127715,"about_ca_system_score_gemma":0.000023309787,"threshold_uncertainty_score":0.68880373},"labels":[],"label_agreement":null},{"id":"W1966179961","doi":"10.1182/blood-2007-07-101535","title":"Does angiotensin-II link arteries and monocytes?","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Macrophage Migration Inhibitory Factor","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Angiotensin II; Medicine; Internal medicine; Cardiology; Receptor","score_opus":0.007613273613152887,"score_gpt":0.21671900738400196,"score_spread":0.20910573377084907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966179961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965786,0.0015291059,0.00014378164,0.00042288064,0.0006332959,0.000100596364,0.00001641979,0.00009084178,0.00048453317],"genre_scores_gemma":[0.9948497,0.000022983082,0.00030304893,0.00019675944,0.0001462905,0.0000028158145,0.00002156152,0.0000100538455,0.0044468096],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99938756,0.000029044753,0.00016710591,0.00018508523,0.000016841319,0.0002143429],"domain_scores_gemma":[0.99966097,0.000063180785,0.000052124204,0.00016216203,0.000040319177,0.00002122557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001204442,0.00010810185,0.00012781663,0.000057366036,0.00020037948,0.000014318497,0.000056485107,0.00015773659,0.00029471394],"category_scores_gemma":[0.000039676223,0.0000697517,0.000035752513,0.000047454156,0.00015014282,0.000060458868,0.000057106918,0.00011712225,0.00012608884],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004794875,0.000108008404,0.014051776,0.000007669183,0.00008517428,0.000021232341,0.0010801685,4.667486e-8,0.97727364,0.00029397334,0.0018374679,0.0051928656],"study_design_scores_gemma":[0.0011682552,0.00013348465,0.039879728,0.000009178442,0.00004019144,0.000067208835,0.00012650086,1.873374e-7,0.82351756,0.00009784534,0.13482693,0.00013290979],"about_ca_topic_score_codex":0.000016623762,"about_ca_topic_score_gemma":0.00005844914,"teacher_disagreement_score":0.15375608,"about_ca_system_score_codex":0.0000047582935,"about_ca_system_score_gemma":0.000011689768,"threshold_uncertainty_score":0.3226911},"labels":[],"label_agreement":null},{"id":"W1966203378","doi":"10.1182/blood-2006-07-035279","title":"Altered activation of AKT is required for the suppressive function of human CD4+CD25+ T regulatory cells","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":229,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health","funders":"Michael Smith Health Research BC","keywords":"IL-2 receptor; Protein kinase B; Cell biology; Biology; Phosphorylation; T-cell receptor; Signal transduction; Regulatory T cell; T cell; PI3K/AKT/mTOR pathway; Immune system; Cancer research; Immunology","score_opus":0.013244257228654192,"score_gpt":0.21940157222765316,"score_spread":0.20615731499899898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966203378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99661493,0.0012583985,0.00021114718,0.00011214593,0.0005132271,0.00039027346,0.00006001552,0.00002836741,0.0008114841],"genre_scores_gemma":[0.9954235,0.000012871282,0.000031624517,0.000050859242,0.0000811281,0.000036335725,0.00014626933,0.000015337098,0.0042020907],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999069,0.00009252645,0.00038148675,0.00020984272,0.000033192984,0.00021398852],"domain_scores_gemma":[0.9989088,0.00019593588,0.00037868076,0.00038042763,0.00013060683,0.000005509352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013632976,0.00013372207,0.00025737024,0.000074342395,0.0001713185,0.0000038739804,0.00019060067,0.0002647694,0.0002582296],"category_scores_gemma":[0.00001291145,0.00010063777,0.00013781282,0.00007125265,0.00028798738,0.00006437025,0.00004563847,0.00011740583,0.00002380906],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022572241,0.0004820677,0.00023945079,0.000038474005,0.00028085933,1.3933635e-7,0.00018680975,0.0000055220753,0.9893906,0.0014301862,0.007129968,0.000590173],"study_design_scores_gemma":[0.0032235584,0.00048268947,0.0027376767,0.000022465052,0.00023296224,0.0000038230214,0.00013786883,0.0000012851001,0.9832579,0.001108091,0.008691825,0.000099890545],"about_ca_topic_score_codex":0.00019304542,"about_ca_topic_score_gemma":0.000012370208,"teacher_disagreement_score":0.006132763,"about_ca_system_score_codex":0.000009642753,"about_ca_system_score_gemma":0.000030646017,"threshold_uncertainty_score":0.41038892},"labels":[],"label_agreement":null},{"id":"W1966263926","doi":"10.1182/blood-2011-12-398040","title":"Tyrosine phosphorylation of DEP-1/CD148 as a mechanism controlling Src kinase activation, endothelial cell permeability, invasion, and capillary formation","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Proto-oncogene tyrosine-protein kinase Src; Cell biology; Phosphorylation; Cortactin; Tyrosine-protein kinase CSK; Tyrosine phosphorylation; Biology; Tyrosine kinase; LYN; Protein tyrosine phosphatase; FYN; SH2 domain; Chemistry; Signal transduction; Cancer research; Cell; Biochemistry; Cytoskeleton","score_opus":0.008577204961348252,"score_gpt":0.2158292514709917,"score_spread":0.20725204650964343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966263926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98871887,0.0068345056,0.003705017,0.000052045983,0.000058940594,0.00043141382,0.000055076438,0.000014506954,0.00012962408],"genre_scores_gemma":[0.99762344,0.00031497204,0.0014561182,0.0001112469,0.00016185356,0.000037757938,0.00025349943,0.0000189442,0.000022191196],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99913126,0.00005736294,0.00026455647,0.00019228618,0.00015146444,0.00020305997],"domain_scores_gemma":[0.9993247,0.000025437672,0.00018458591,0.000245267,0.0001352112,0.00008482211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002657547,0.00014368621,0.00014872536,0.000039111277,0.00008384331,0.000016017208,0.000082773244,0.00012490465,0.000017079192],"category_scores_gemma":[0.00025462365,0.00014043612,0.00004849794,0.00006274911,0.000044992987,0.000035259483,0.00008857467,0.000056126086,0.000004360714],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011513836,0.00025403334,0.0025781402,0.00007235809,0.0000192542,3.6246198e-7,0.00012673736,0.000005965293,0.9947654,0.0017170782,0.000047343994,0.00029817905],"study_design_scores_gemma":[0.0021215847,0.00023106502,0.001437973,0.000022842982,0.000058786314,0.000016087186,0.000057972702,0.000039204533,0.9947153,0.00075521384,0.00039753798,0.00014647857],"about_ca_topic_score_codex":0.00007330548,"about_ca_topic_score_gemma":0.0000064998176,"teacher_disagreement_score":0.008904547,"about_ca_system_score_codex":0.00001090507,"about_ca_system_score_gemma":0.000047625308,"threshold_uncertainty_score":0.5726819},"labels":[],"label_agreement":null},{"id":"W1966346386","doi":"10.1182/blood-2014-07-588145","title":"MERIT40 deficiency expands hematopoietic stem cell pools by regulating thrombopoietin receptor signaling","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Cancer Institute; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Cancer Research Society; Leukemia and Lymphoma Society; American Heart Association","keywords":"Thrombopoietin; Haematopoiesis; Cell biology; Biology; Stem cell; Hematopoietic stem cell; Signal transduction; Receptor; Immunology; Biochemistry","score_opus":0.023814712890301574,"score_gpt":0.2452693860544054,"score_spread":0.22145467316410383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966346386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96995753,0.002927991,0.00021765473,0.00026308701,0.00018668204,0.0002390563,0.000008410774,0.00018509338,0.026014503],"genre_scores_gemma":[0.9932185,0.00001182258,0.0024217616,0.0003167015,0.00015449463,0.000025280227,0.000036363035,0.00003553399,0.003779532],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984861,0.000062163745,0.00036261583,0.0003174473,0.00041939665,0.00035227442],"domain_scores_gemma":[0.9989956,0.000110198685,0.00012696612,0.00031993934,0.00011966672,0.0003276022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037718404,0.00019216156,0.00038675993,0.000062876694,0.000088778776,0.00003634684,0.00008872316,0.00011006976,0.00031570756],"category_scores_gemma":[0.00011175503,0.0001651633,0.00009229777,0.00024898408,0.000055326815,0.00007771112,0.000037427428,0.00014725298,0.00024360031],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006481114,0.0011069839,0.019311275,0.00027551132,0.000061485815,0.0000098904475,0.0022251566,0.00001237642,0.94785625,0.00012447362,0.02820244,0.0007493233],"study_design_scores_gemma":[0.0058820876,0.00060683355,0.00017083119,0.0002520709,0.000317502,0.000041078958,0.004705751,0.00010798194,0.9846677,0.000114032366,0.0028339147,0.00030017793],"about_ca_topic_score_codex":0.000012840781,"about_ca_topic_score_gemma":1.2069712e-7,"teacher_disagreement_score":0.036811467,"about_ca_system_score_codex":0.000036230485,"about_ca_system_score_gemma":0.00011906877,"threshold_uncertainty_score":0.6735164},"labels":[],"label_agreement":null},{"id":"W1966493000","doi":"10.1182/blood-2005-11-4407","title":"Mortality rates and causes of death among all HIV-positive individuals with hemophilia in Canada over 21 years of follow-up","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Hemophilia Society","funders":"McMaster University","keywords":"Medicine; Seroconversion; Cohort; Hepatitis C; Confidence interval; Survival analysis; Mortality rate; Liver disease; Viral disease; Internal medicine; Cause of death; Population; Immunology; Demography; Human immunodeficiency virus (HIV); Disease; Environmental health","score_opus":0.014510368480687418,"score_gpt":0.28118420917992004,"score_spread":0.2666738406992326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966493000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977451,0.0002462008,0.000002531895,0.000037104433,0.0000051724396,0.00021011107,0.00023711119,0.0000031410937,0.0015135593],"genre_scores_gemma":[0.9987564,0.000020542166,0.00006962359,0.00001373172,0.000012199069,0.000008995056,0.00005577966,0.000007725082,0.001055006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991984,0.000038726277,0.00021207932,0.00012317314,0.00026631574,0.00016133134],"domain_scores_gemma":[0.9996095,0.00006139154,0.00006508713,0.00012648084,0.00006393767,0.000073623414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000103182465,0.00006949816,0.00022987914,0.0000794637,0.0000102889035,0.000004700306,0.000043385364,0.000027102255,0.00005801797],"category_scores_gemma":[0.00006967165,0.00005881857,0.0000359395,0.00012268031,0.000077102726,0.000053040218,0.000026042468,0.00008580942,4.2830024e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028707398,0.00024680025,0.9964913,0.00007044166,0.00019450483,0.00007970942,0.000098220975,0.0000011880129,0.0016057072,0.000070923,0.0010473506,0.000065141416],"study_design_scores_gemma":[0.0026305455,0.00042318332,0.9656302,0.0002597696,0.00012882982,0.0000066069874,0.00011857001,0.000012872491,0.030649481,0.000047218444,0.000039927167,0.00005284388],"about_ca_topic_score_codex":0.80953485,"about_ca_topic_score_gemma":0.8585435,"teacher_disagreement_score":0.04900866,"about_ca_system_score_codex":0.0000337328,"about_ca_system_score_gemma":0.00030569168,"threshold_uncertainty_score":0.23985517},"labels":[],"label_agreement":null},{"id":"W1966569531","doi":"10.1182/blood-2012-03-378927","title":"Clotting factor concentrate switching and inhibitor development in hemophilia A","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Clotting factor; Medicine; Postmarketing surveillance; Immunogenicity; Tissue factor pathway inhibitor; Risk factor; Internal medicine; Adverse effect; Pediatrics; Intensive care medicine; Coagulation; Immunology; Antibody; Tissue factor","score_opus":0.03233686049360772,"score_gpt":0.2950582746664821,"score_spread":0.26272141417287437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966569531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971717,0.0013089547,0.0000029184257,0.00027037636,0.000057526588,0.0002768936,9.097413e-7,0.00002892758,0.0008817826],"genre_scores_gemma":[0.9982826,0.000051018902,0.0010787759,0.00005998514,0.00020738687,0.000015107951,0.000004892132,0.000013541813,0.00028670792],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990677,0.000023980763,0.00017758207,0.0001416982,0.00018372234,0.00040529392],"domain_scores_gemma":[0.9996065,0.000044488857,0.00002407715,0.000084979074,0.000020265787,0.00021968846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018675845,0.000106437816,0.00017111789,0.00007759468,0.00006145583,0.000014923256,0.000027098224,0.00006154002,0.00004100431],"category_scores_gemma":[0.000061026632,0.000079606136,0.000020889294,0.000104166116,0.000020074518,0.000088790555,0.000044126875,0.0001609948,0.000047505946],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025875208,0.00048777318,0.9372518,0.00007948849,0.0000442287,0.000056468765,0.002345255,1.9484991e-8,0.049846746,0.00003410901,0.000013463451,0.009814777],"study_design_scores_gemma":[0.006385105,0.00008300661,0.6943616,0.0002842711,0.000043072076,0.00009955807,0.00029129413,0.000016893422,0.2954747,0.000013648454,0.0027590492,0.00018777618],"about_ca_topic_score_codex":0.000010191194,"about_ca_topic_score_gemma":0.0000044422027,"teacher_disagreement_score":0.24562797,"about_ca_system_score_codex":0.00004466565,"about_ca_system_score_gemma":0.00008718985,"threshold_uncertainty_score":0.3246244},"labels":[],"label_agreement":null},{"id":"W1966573951","doi":"10.1182/blood-2014-09-599399","title":"Five hematologic tests and treatments to question","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Asymptomatic; Hematology; Internal medicine; Intensive care medicine","score_opus":0.009924104605089417,"score_gpt":0.2723087679682143,"score_spread":0.2623846633631249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966573951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99336034,0.000114887975,0.000055409804,0.0007905202,0.00003754307,0.00031724025,9.3308154e-7,0.000051376457,0.005271742],"genre_scores_gemma":[0.9972672,0.00005916353,0.0013739245,0.0007946032,0.000051283612,0.000046839912,0.0000054571524,0.0000072934486,0.00039421962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99956805,0.000016317403,0.00007637856,0.00015188898,0.00007462856,0.00011275986],"domain_scores_gemma":[0.9997122,0.00002267131,0.000019301597,0.00013300551,0.000018341489,0.00009443447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000068080524,0.0000709173,0.0001974216,0.000042565203,0.000033188302,0.00000951689,0.000021956914,0.000028260245,0.000020711484],"category_scores_gemma":[0.00007012841,0.0000544405,0.000018827941,0.00004818635,0.000010752071,0.000018331664,0.00003018404,0.000023800476,0.00009019293],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009020861,0.015143791,0.82698214,0.00077844417,0.0011775094,0.00028973233,0.0026693614,0.000014364801,0.010412961,0.0600444,0.012592037,0.069805056],"study_design_scores_gemma":[0.0022503426,0.0012377577,0.9878361,0.0001240453,0.0005050585,0.000035149686,0.000056150126,0.000019641428,0.0036614418,0.0007044308,0.0034702895,0.00009954855],"about_ca_topic_score_codex":0.00005299685,"about_ca_topic_score_gemma":0.000015999487,"teacher_disagreement_score":0.16085401,"about_ca_system_score_codex":0.000009485927,"about_ca_system_score_gemma":0.0000046145337,"threshold_uncertainty_score":0.22200193},"labels":[],"label_agreement":null},{"id":"W1966657674","doi":"10.1182/blood-2008-02-142430","title":"A unique three-dimensional model for evaluating the impact of therapy on multiple myeloma","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; Alberta Heritage Foundation for Medical Research; Fondation pour la Recherche Médicale","keywords":"clone (Java method); Melphalan; Stromal cell; Bone marrow; Multiple myeloma; Bortezomib; Stem cell; Haematopoiesis; Cancer research; Biology; Immunology; Molecular biology; Cell biology","score_opus":0.1386837415988641,"score_gpt":0.3978047145033722,"score_spread":0.2591209729045081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966657674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977219,0.00023360888,0.0002936257,0.00013635447,0.000009469432,0.0013557741,0.00006157058,0.000023994586,0.00016371564],"genre_scores_gemma":[0.9955824,0.000027522268,0.003820298,0.0000646113,0.000047995847,0.00017644347,0.00003961846,0.000024004989,0.00021712943],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9989421,0.000044247343,0.00017888832,0.00018587922,0.00038283312,0.0002660831],"domain_scores_gemma":[0.9987635,0.00054624456,0.000067646186,0.00032557404,0.00018759276,0.00010941642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023086733,0.00013857271,0.0002233264,0.000060902952,0.00015829381,0.0000037883487,0.00008550446,0.000053964002,0.0000334251],"category_scores_gemma":[0.00039972784,0.000071398266,0.00024080329,0.00009380679,0.00007637888,0.000027757465,0.000021115045,0.00011432363,0.000006663227],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017455801,0.011173148,0.66270304,0.00008280215,0.0033036931,0.00013705045,0.001674991,0.016253399,0.24854672,0.00015168072,0.0010224996,0.03749519],"study_design_scores_gemma":[0.016831117,0.004416277,0.34493563,0.000051263214,0.000043470234,0.00007186129,0.000004432995,0.60733855,0.025955008,0.00027426862,0.0000027979304,0.00007533247],"about_ca_topic_score_codex":0.00026074,"about_ca_topic_score_gemma":0.000024447389,"teacher_disagreement_score":0.59108514,"about_ca_system_score_codex":0.000036205438,"about_ca_system_score_gemma":0.0003794214,"threshold_uncertainty_score":0.29115367},"labels":[],"label_agreement":null},{"id":"W1966792207","doi":"10.1182/blood-2004-02-0731","title":"Molecular and cellular mechanisms underlying iron transport deficiency in microcytic anemia","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Hospital for Sick Children; Montreal Children's Hospital","funders":"","keywords":"Microcytic anemia; DMT1; Iron deficiency; Mutant; Transferrin receptor; Endosome; Endoplasmic reticulum; Wild type; Chemistry; Mutation; Hereditary hemochromatosis; Cell biology; Transferrin; Transport protein; Biochemistry; Biology; Transporter; Anemia; Hemochromatosis; Cell; Internal medicine; Genetics; Medicine; Gene; Hemoglobin","score_opus":0.010444616060773102,"score_gpt":0.22813909615852793,"score_spread":0.21769448009775483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966792207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878218,0.0040495703,0.006212741,0.00013634562,0.000031589192,0.00022593667,0.0000015223281,0.000031937885,0.001488524],"genre_scores_gemma":[0.99751455,0.00006208211,0.002062809,0.00029037663,0.00000549954,0.0000061587157,0.000011310056,0.000018546616,0.00002864492],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999205,0.0000099614,0.00016422951,0.00023145076,0.00014923626,0.00024015673],"domain_scores_gemma":[0.9997198,0.000004836454,0.000024060118,0.00015432423,0.000010778828,0.000086178356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000900729,0.000121079414,0.0001819622,0.00010255881,0.000034622703,0.0000062601357,0.00004719881,0.000083189814,0.000015531636],"category_scores_gemma":[0.0000082508595,0.000116127034,0.00003995158,0.00014784507,0.000037926937,0.000039638304,0.000008790299,0.000117877156,0.000009081573],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030396348,0.00051644305,0.0025835482,0.00030817045,0.0000035719263,0.0006052172,0.00066508015,0.00012379684,0.987238,0.0075552836,7.553055e-7,0.0003697695],"study_design_scores_gemma":[0.039144408,0.0006700487,0.080154754,0.000285885,0.0011094827,0.00041023784,0.0022050967,0.000020308105,0.8568704,0.01824419,0.00009829549,0.0007868636],"about_ca_topic_score_codex":0.000110383946,"about_ca_topic_score_gemma":0.000025143176,"teacher_disagreement_score":0.13036753,"about_ca_system_score_codex":0.000016362832,"about_ca_system_score_gemma":0.00008244337,"threshold_uncertainty_score":0.47355232},"labels":[],"label_agreement":null},{"id":"W1966820455","doi":"10.1182/blood-2002-12-3702","title":"Identification of an autoantigen on the surface of apoptotic human T cells as a new protein interacting with inflammatory group IIA phospholipase A2","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec","funders":"Huntington Medical Research Institutes; University of Washington","keywords":"Vimentin; Apoptosis; Chemistry; Cell biology; Plasma protein binding; Binding site; Phosphatidylserine; Biology; Molecular biology; Biochemistry; Membrane; Immunology; Phospholipid","score_opus":0.016688737165552865,"score_gpt":0.2834454218697302,"score_spread":0.26675668470417735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966820455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978481,0.000044010565,0.000037891652,0.000085028536,0.00001950474,0.0010001622,0.0000016317905,0.000022272017,0.00094141986],"genre_scores_gemma":[0.9978076,0.0000033842666,0.00054292154,0.00002856423,0.000018471474,0.000013831116,0.000006300395,0.00003103366,0.0015478643],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984547,0.00018094771,0.0003931405,0.00024566994,0.0005314319,0.00019413196],"domain_scores_gemma":[0.9987165,0.0001047452,0.00027566808,0.0006107513,0.00013674401,0.00015561363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059969106,0.00012733886,0.00021225319,0.000086238084,0.00006831752,0.000020590225,0.0001665539,0.00005538074,0.00021956384],"category_scores_gemma":[0.00041615334,0.00008820107,0.00005746226,0.00024827418,0.00008316632,0.00006768957,0.000030827385,0.00024837005,0.000041351614],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013250853,0.00075511815,0.0012116758,0.00015589985,0.00006571182,0.000028890367,0.00057230215,0.000027345943,0.9961845,0.0006953053,0.000042258802,0.00012846096],"study_design_scores_gemma":[0.0015209168,0.0008188833,0.0028565694,0.0003176118,0.00007475787,0.0000162815,0.00043240347,0.00006440572,0.9936312,0.00006262063,0.000121200246,0.00008314504],"about_ca_topic_score_codex":0.00016704484,"about_ca_topic_score_gemma":0.000024330591,"teacher_disagreement_score":0.002553318,"about_ca_system_score_codex":0.000025031124,"about_ca_system_score_gemma":0.00022128076,"threshold_uncertainty_score":0.35967353},"labels":[],"label_agreement":null},{"id":"W1967169606","doi":"10.1182/blood-2010-12-321539","title":"Inhibition of cellular senescence by developmentally regulated FGF receptors in mesenchymal stem cells","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Mesenchymal stem cell; Cell biology; Senescence; Stem cell; Biology; Receptor; Fibroblast growth factor; Biochemistry","score_opus":0.0297041558816068,"score_gpt":0.23759027256770401,"score_spread":0.20788611668609722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967169606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888087,0.00029582423,0.00013199978,0.00003074217,0.000082949744,0.0005874363,0.000006075711,0.00004028924,0.010015977],"genre_scores_gemma":[0.9949927,0.000074102885,0.0013967056,0.000023832996,0.000022222514,0.000018935143,0.000030728377,0.000030289466,0.003410505],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99791783,0.00013084324,0.0005451944,0.0003758991,0.0006112925,0.0004189257],"domain_scores_gemma":[0.9991711,0.00004414788,0.0001310107,0.00030492875,0.00014224513,0.00020660233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056173105,0.00018461375,0.00034692427,0.0002159081,0.000034675504,0.0000069218277,0.00012940342,0.00018075104,0.0007610337],"category_scores_gemma":[0.000028814567,0.00017149081,0.000064043496,0.00058462634,0.00011280782,0.00008914036,0.00009274138,0.00024598313,0.00010049326],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013046598,0.00089606084,0.040330954,0.000202571,0.00003808795,0.00016040938,0.0012523774,1.519801e-7,0.95509577,0.000022710372,0.00051472196,0.0013557253],"study_design_scores_gemma":[0.00231244,0.0003543126,0.0056307456,0.00031873345,0.000032866872,0.00002314872,0.00036130278,0.000020880296,0.99042445,0.000016750653,0.00034434878,0.00016001574],"about_ca_topic_score_codex":0.00024676387,"about_ca_topic_score_gemma":0.000020275802,"teacher_disagreement_score":0.03532869,"about_ca_system_score_codex":0.00007940397,"about_ca_system_score_gemma":0.00019003915,"threshold_uncertainty_score":0.8332785},"labels":[],"label_agreement":null},{"id":"W1967353717","doi":"10.1182/blood-2014-06-578955","title":"FVIII stabilization: VWF D′D3 will do","year":2014,"lang":"en","type":"letter","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Heart, Lung, and Blood Institute","keywords":"Von Willebrand factor; Bleeding diathesis; Von Willebrand disease; Proteolysis; Internal medicine; Endocrinology; Endogeny; Chemistry; Platelet; Immunology; Molecular biology; Medicine; Biology; Biochemistry; Enzyme","score_opus":0.012950994902686966,"score_gpt":0.23958283773344005,"score_spread":0.22663184283075308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967353717","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04017777,0.0025769242,0.000063396095,0.8102169,0.0006209645,0.0013433375,0.00012836869,0.00030764504,0.14456467],"genre_scores_gemma":[0.03584229,0.0007109796,0.0006052824,0.9389165,0.004676229,0.00010543233,0.0038200447,0.00019019465,0.015133037],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987113,0.000028463472,0.00023049863,0.00038137072,0.0003334068,0.00031498814],"domain_scores_gemma":[0.9991942,0.00004412602,0.000107080516,0.0005079787,0.00007557409,0.00007101071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000044688044,0.00027945742,0.00054158166,0.00023529994,0.00006033618,0.000030030003,0.00010014942,0.00056146766,0.00054668053],"category_scores_gemma":[0.000034548168,0.00022795296,0.00015323961,0.00022088445,0.00004427329,0.00004612739,0.000028682722,0.00052270066,0.00031444905],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001253092,0.00039414936,0.0022880582,0.0002756996,0.00045851732,0.003320605,0.000046034653,2.1457113e-7,0.000018390072,0.00007169621,0.99267894,0.0004351342],"study_design_scores_gemma":[0.003984744,0.00025283895,0.00019696474,0.00015800819,0.0008811244,0.0004628741,0.0000049372193,0.0000016608097,0.00012966723,0.00028764587,0.9934259,0.0002136459],"about_ca_topic_score_codex":0.000025864632,"about_ca_topic_score_gemma":0.000006669007,"teacher_disagreement_score":0.12943164,"about_ca_system_score_codex":0.000018167466,"about_ca_system_score_gemma":0.0000910518,"threshold_uncertainty_score":0.9295652},"labels":[],"label_agreement":null},{"id":"W1967490336","doi":"10.1182/blood.v97.10.3011","title":"Shwachman-Diamond syndrome marrow cells show abnormally increased apoptosis mediated through the Fas pathway","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Bone marrow; CD34; Apoptosis; Haematopoiesis; Bone marrow failure; Immunology; Pathogenesis; CD38; Leukemia; Myeloid; Progenitor cell; Biology; Cancer research; Medicine; Stem cell; Cell biology","score_opus":0.007093159212006001,"score_gpt":0.2028888238596961,"score_spread":0.19579566464769008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967490336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888559,0.0017980449,0.000054996413,0.00025504504,0.00011852696,0.00033512522,0.000098863165,0.000036891706,0.008446611],"genre_scores_gemma":[0.9967417,0.00087801093,0.00023578608,0.0008054449,0.00009568237,0.00008279566,0.000421474,0.000042372027,0.00069674506],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986056,0.00009232909,0.00023355694,0.00042979245,0.00020890372,0.0004298153],"domain_scores_gemma":[0.9991194,0.000028700733,0.0000985548,0.0005866427,0.000054858123,0.00011186259],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010610857,0.0002832941,0.00021325861,0.000029500994,0.00018746278,0.000051913757,0.00034986035,0.00021575514,0.00012016047],"category_scores_gemma":[0.000030906012,0.00020542972,0.00016450457,0.00018416552,0.000098726094,0.000010026309,0.00012565356,0.00011421708,0.000096036805],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032494054,0.0073508495,0.07801021,0.00007662648,0.0030040855,0.00053487765,0.00052861526,0.00005327878,0.8974359,0.0002213877,0.009238311,0.0032209214],"study_design_scores_gemma":[0.0071072713,0.0009888954,0.005663711,0.000025150845,0.0004531366,0.0002935353,0.00025935064,0.00001386618,0.92157876,0.00022878342,0.06270387,0.0006836829],"about_ca_topic_score_codex":0.00029687287,"about_ca_topic_score_gemma":0.00017925263,"teacher_disagreement_score":0.07234649,"about_ca_system_score_codex":0.000006416771,"about_ca_system_score_gemma":0.0000739054,"threshold_uncertainty_score":0.83771807},"labels":[],"label_agreement":null},{"id":"W1967551291","doi":"10.1182/blood-2014-05-574111","title":"p53 mediates loss of hematopoietic stem cell function and lymphopenia in Mysm1 deficiency","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"Canadian Institutes of Health Research; Wellcome Trust; McGill University","keywords":"Stem cell; Haematopoiesis; Hematopoietic stem cell; Biology; Function (biology); Hematopoietic stem cell transplantation; Cancer research; Immunology; Cell biology","score_opus":0.012693486616021541,"score_gpt":0.21141768004872757,"score_spread":0.19872419343270603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967551291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99284536,0.004523297,0.000050524697,0.000017782824,0.000051520517,0.0001105876,0.000007847883,0.000005250035,0.0023878624],"genre_scores_gemma":[0.9995759,0.0000944621,0.000105649924,0.000033473218,0.000038375834,0.000012336209,0.000014015421,0.00000882933,0.00011696701],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99943423,0.000036604815,0.00014291683,0.00017313319,0.0000860349,0.00012708515],"domain_scores_gemma":[0.99969125,0.0000071434833,0.000053833573,0.0001454896,0.000038347775,0.000063949774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018564734,0.00008016374,0.00010319967,0.00002985554,0.000013963261,0.000007446164,0.000073848765,0.00008833088,0.0000052200107],"category_scores_gemma":[0.000014749324,0.000073779825,0.000022066513,0.0000651521,0.000044625373,0.0000027183683,0.00006542165,0.00003170286,0.0000071452378],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010609389,0.00052504503,0.10509336,0.00018082766,0.000014816595,0.000008704275,0.00059512287,0.000009753738,0.89205885,0.00025843733,0.00014255165,0.0010064598],"study_design_scores_gemma":[0.0022476441,0.00044247153,0.0032726815,0.000017025232,0.000023944633,0.000026303893,0.00033757425,0.000007662537,0.99252546,0.00039438624,0.0005789369,0.00012591579],"about_ca_topic_score_codex":0.00001469037,"about_ca_topic_score_gemma":0.000012001287,"teacher_disagreement_score":0.10182068,"about_ca_system_score_codex":0.000003404308,"about_ca_system_score_gemma":0.00006326206,"threshold_uncertainty_score":0.3008654},"labels":[],"label_agreement":null},{"id":"W1967615841","doi":"10.1182/blood-2013-10-534693","title":"SATB1 overexpression promotes malignant T-cell proliferation in cutaneous CD30+ lymphoproliferative disease by repressing p21","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"CD30; Cancer research; Lymphoma; Lymphoproliferative disease; T-cell lymphoma; Lymphoproliferative disorders; Cell growth; Biology; Immunology; Genetics","score_opus":0.010281117307346805,"score_gpt":0.26467638912380637,"score_spread":0.25439527181645955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967615841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99063927,0.0010216895,0.00038038896,0.00090732943,0.000052154905,0.0021610665,0.00004778306,0.00015921028,0.0046311263],"genre_scores_gemma":[0.9950997,0.00010575987,0.0006484601,0.0005257824,0.0002087234,0.00029133356,0.00022666248,0.00009999573,0.0027935666],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99604404,0.00044438933,0.0006692403,0.0010534094,0.0009884704,0.000800465],"domain_scores_gemma":[0.9979694,0.00020866524,0.000191285,0.0007903174,0.00028848584,0.0005518625],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042163892,0.00046685734,0.00062021555,0.00030023747,0.00025771713,0.0001666313,0.00021919297,0.00022195336,0.00019497889],"category_scores_gemma":[0.001120458,0.00040087206,0.00015300894,0.00042990447,0.00016255284,0.00022890605,0.00015053898,0.00037476257,0.00008169069],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023011111,0.006438207,0.35302833,0.0007365805,0.00009301998,0.0009676776,0.0019070999,0.00006474336,0.628704,0.00014985044,0.0020019438,0.0036074494],"study_design_scores_gemma":[0.024312343,0.0023063787,0.007955561,0.0026521708,0.00036406622,0.0028837118,0.00047676289,0.02950324,0.9236684,0.0023912846,0.0019656855,0.0015204282],"about_ca_topic_score_codex":0.00009534118,"about_ca_topic_score_gemma":0.000022602717,"teacher_disagreement_score":0.34507278,"about_ca_system_score_codex":0.00020745164,"about_ca_system_score_gemma":0.00051627116,"threshold_uncertainty_score":0.9998443},"labels":[],"label_agreement":null},{"id":"W1967835097","doi":"10.1182/blood-2005-05-1867","title":"Yin and yang in transfusion medicine","year":2005,"lang":"id","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Transfusion medicine; Blood transfusion; Intensive care medicine; Internal medicine","score_opus":0.011022511827652614,"score_gpt":0.24198848198450787,"score_spread":0.23096597015685524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967835097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9460262,0.028437844,0.000042881762,0.011892368,0.00022120262,0.0005782554,0.000006696768,0.000046942965,0.012747603],"genre_scores_gemma":[0.9726616,0.023593226,0.00023412814,0.0007927702,0.0011657621,0.000012706126,0.00001883628,0.000043604818,0.001477331],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805117,0.000080292986,0.00053829985,0.00050249975,0.00036571172,0.00046204487],"domain_scores_gemma":[0.99923134,0.00009907303,0.000054356817,0.00029514058,0.000039888324,0.00028018057],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00046649028,0.0003044537,0.0005883483,0.00025450226,0.00009429403,0.000013068984,0.00009079921,0.00028419637,0.000944626],"category_scores_gemma":[0.000044246495,0.00025072772,0.000070896436,0.00035696017,0.00017106211,0.000121170575,0.000027291475,0.00051644543,0.000092405455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001057689,0.010985163,0.36825344,0.001997079,0.0005048026,0.0012997891,0.023700735,0.0000038455387,0.32511604,0.0016415322,0.0014518064,0.26398805],"study_design_scores_gemma":[0.11320515,0.0048930626,0.7570856,0.0073943995,0.0040152697,0.0009648838,0.0021877228,0.0004756597,0.0470976,0.0002469431,0.06126126,0.001172448],"about_ca_topic_score_codex":0.0008307162,"about_ca_topic_score_gemma":0.0021617173,"teacher_disagreement_score":0.38883215,"about_ca_system_score_codex":0.000024064693,"about_ca_system_score_gemma":0.000051098985,"threshold_uncertainty_score":0.9999945},"labels":[],"label_agreement":null},{"id":"W1967992739","doi":"10.1182/blood-2011-10-383448","title":"The endothelial protein C receptor (PROCR) Ser219Gly variant and risk of common thrombotic disorders: a HuGE review and meta-analysis of evidence from observational studies","year":2012,"lang":"en","type":"review","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Human Genome Research Institute; Canadian Institutes of Health Research","keywords":"Observational study; Meta-analysis; Medicine; Internal medicine; Bioinformatics; Biology","score_opus":0.3844413775880534,"score_gpt":0.4093810593290078,"score_spread":0.0249396817409544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967992739","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004233633,0.9958005,0.00002743461,0.00047412896,0.000036947815,0.0025925273,0.0006180948,0.000015942429,0.00001108878],"genre_scores_gemma":[0.0007330686,0.9966607,0.0018607504,0.00006482794,0.000047700873,0.00041072,0.00009370312,0.00003232455,0.000096222095],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9967542,0.00082016224,0.0012873531,0.00043261916,0.0005071735,0.00019843891],"domain_scores_gemma":[0.9958012,0.0015639793,0.0015987261,0.00069503166,0.00024365359,0.00009738055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014974369,0.00042688166,0.0060321814,0.00012961717,0.00012930394,0.000016977265,0.00019783058,0.00016702224,0.00017967017],"category_scores_gemma":[0.0007791429,0.0002126333,0.0011300872,0.0006418729,0.0002103186,0.00010879444,0.00017067885,0.00028844064,0.0000034099169],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026162199,0.0011347568,0.0005937258,0.076828174,0.8690272,0.0000016258208,0.00043152377,2.309727e-7,0.00006410303,0.0022818667,0.000057983998,0.04955267],"study_design_scores_gemma":[0.0003982927,0.00017771503,0.00063634786,0.006680415,0.9724207,0.000005932541,0.000035153098,0.0000030367023,0.000035851066,0.00038579974,0.01901668,0.00020407552],"about_ca_topic_score_codex":0.00015659898,"about_ca_topic_score_gemma":0.00018545767,"teacher_disagreement_score":0.103393525,"about_ca_system_score_codex":0.00001465612,"about_ca_system_score_gemma":0.00012272937,"threshold_uncertainty_score":0.86709344},"labels":[],"label_agreement":null},{"id":"W1968117566","doi":"10.1182/blood-2007-02-072082","title":"Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAILreceptor-2, predict for poor survival in diffuse large B-cell lymphoma","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Diffuse large B-cell lymphoma; Biology; Lymphoma; Cancer research; DNA; Genetics; Molecular biology; Immunology","score_opus":0.015433812543418864,"score_gpt":0.25343110858945483,"score_spread":0.23799729604603598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968117566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99786377,0.000102929625,0.000036015674,0.000113156086,0.000030130364,0.00092584343,0.0003333383,0.000016231405,0.000578604],"genre_scores_gemma":[0.9991997,0.000011088481,0.00026641297,0.00003277175,0.000021260134,0.00012285428,0.0002978368,0.000020803589,0.000027304379],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868447,0.00008907798,0.00040598155,0.00019754624,0.00033172814,0.0002912201],"domain_scores_gemma":[0.9983859,0.0009647935,0.00025255795,0.00019144788,0.00012880022,0.00007652075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006255236,0.00014823588,0.00038770464,0.000172807,0.000049209164,0.0000066467783,0.000093481074,0.00010932053,0.000009203705],"category_scores_gemma":[0.00040227943,0.00009543374,0.00008230938,0.00047610953,0.00003525546,0.000045098233,0.0000140618495,0.000050536542,6.845526e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044721473,0.05585267,0.9300486,0.00010252623,0.00011347211,0.000059261296,0.0018145656,0.0000016565493,0.01123389,0.00006187979,0.00007330812,0.00019099234],"study_design_scores_gemma":[0.07595515,0.00053583836,0.7505268,0.00067331345,0.00033511908,0.000005500571,0.0026902154,0.000029815365,0.16912773,0.00001135384,0.000024453037,0.00008470685],"about_ca_topic_score_codex":0.000105603525,"about_ca_topic_score_gemma":0.0023847963,"teacher_disagreement_score":0.17952177,"about_ca_system_score_codex":0.00008984561,"about_ca_system_score_gemma":0.00015087785,"threshold_uncertainty_score":0.3891675},"labels":[],"label_agreement":null},{"id":"W1968151924","doi":"10.1182/blood-2007-02-070342","title":"Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":310,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre","funders":"National Cancer Institute","keywords":"Medicine; Lymphoblastic Leukemia; Pediatrics; Internal medicine; Oncology; Acute lymphocytic leukemia; Leukemia","score_opus":0.011737113363389421,"score_gpt":0.26449815975070917,"score_spread":0.2527610463873198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968151924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933653,0.0004190847,0.002762677,0.0010980509,0.00038047787,0.0017366093,0.00009934375,0.00012527789,0.0000131779625],"genre_scores_gemma":[0.995674,0.00023343033,0.0013736384,0.0007103308,0.0014466319,0.000043618715,0.00043939112,0.00006196618,0.00001696157],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99789244,0.00012260376,0.0005523259,0.0006593522,0.0004019832,0.00037132087],"domain_scores_gemma":[0.99815893,0.00029996812,0.00054219755,0.0005987934,0.00022952641,0.00017060657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010154773,0.00028858532,0.00048177427,0.00007711596,0.0002231088,0.000043325064,0.00015269096,0.0002237415,0.0000027243664],"category_scores_gemma":[0.00030391442,0.0001969148,0.000098134115,0.00018687439,0.00020843952,0.00012006714,0.000045597142,0.0003639909,0.000003276721],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003755748,0.0011092274,0.9632807,0.000018538321,0.0016665305,0.00004199623,0.0017540663,6.148187e-7,0.008613205,0.000040314273,0.00020975784,0.01950935],"study_design_scores_gemma":[0.013217346,0.0021257077,0.978688,0.0001454499,0.0010968875,0.000874294,0.00023824416,0.0000026580392,0.003213157,0.00012656419,0.00004419828,0.0002275109],"about_ca_topic_score_codex":0.011033255,"about_ca_topic_score_gemma":0.0010255337,"teacher_disagreement_score":0.01928184,"about_ca_system_score_codex":0.0001456233,"about_ca_system_score_gemma":0.00023974862,"threshold_uncertainty_score":0.99555236},"labels":[],"label_agreement":null},{"id":"W1968181528","doi":"10.1182/blood-2005-01-0433","title":"Soluble factor cross-talk between human bone marrow-derived hematopoietic and mesenchymal cells enhances in vitro CFU-F and CFU-O growth and reveals heterogeneity in the mesenchymal progenitor cell compartment","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Natural Sciences and Engineering Research Council of Canada; University of Toronto","keywords":"Mesenchymal stem cell; Bone marrow; Haematopoiesis; In vitro; CFU-GM; Progenitor cell; Compartment (ship); Biology; Immunology; Chemistry; Molecular biology; Stem cell; Cell biology; Biochemistry","score_opus":0.022232911017787113,"score_gpt":0.2858532981900178,"score_spread":0.2636203871722307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968181528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99619627,0.0016826475,0.000012439849,0.00033700615,0.000039324954,0.0014064579,0.000045692766,0.00003455208,0.00024561578],"genre_scores_gemma":[0.99823743,0.00021707336,0.0010878036,0.000092567054,0.00014253671,0.00010159056,0.000051726915,0.00003129279,0.000037953414],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975578,0.0002130483,0.0006938816,0.0005766188,0.0004373941,0.0005212574],"domain_scores_gemma":[0.9990598,0.00025061742,0.00015574337,0.00027476152,0.000041177977,0.0002179068],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005055734,0.00034777581,0.00068469066,0.00015552001,0.00015641343,0.000107066044,0.000121526005,0.00017413408,0.000021566897],"category_scores_gemma":[0.000017857488,0.0002742807,0.000062546,0.00017253285,0.00025208347,0.00020151511,0.00006109949,0.00028816392,0.0000047492945],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000068425084,0.00045195554,0.27561945,0.0007540961,0.00003477377,0.00008156361,0.0028302209,2.6111155e-7,0.7200635,0.000009641887,0.000005674268,0.00008046422],"study_design_scores_gemma":[0.0047142203,0.00021036029,0.23114635,0.0001314699,0.00014171694,0.00016710286,0.00029993014,0.000013657211,0.76289254,0.000040522922,0.000021709466,0.00022043896],"about_ca_topic_score_codex":0.00008548951,"about_ca_topic_score_gemma":0.00009666189,"teacher_disagreement_score":0.04447309,"about_ca_system_score_codex":0.000029945695,"about_ca_system_score_gemma":0.00004205277,"threshold_uncertainty_score":0.9999709},"labels":[],"label_agreement":null},{"id":"W1968501325","doi":"10.1182/blood-2010-04-280305","title":"Evidence that Growth factor independence 1b regulates dormancy and peripheral blood mobilization of hematopoietic stem cells","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; NHLBI Division of Intramural Research; National Institutes of Health; Division of Intramural Research, National Institute of Allergy and Infectious Diseases","keywords":"Haematopoiesis; Stem cell; Biology; Bone marrow; Cell biology; Transplantation; Immunology; Cancer research; Internal medicine; Medicine","score_opus":0.02270770092705798,"score_gpt":0.24851448891513425,"score_spread":0.22580678798807627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968501325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99763995,0.00083200674,0.00042944902,0.00007016489,0.00016150957,0.0005533987,0.000011982048,0.000070364404,0.0002311948],"genre_scores_gemma":[0.9979085,0.00052713533,0.0012289434,0.000031846146,0.00005237072,0.000021931854,0.0000059440986,0.000030390202,0.00019297875],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984901,0.000045163004,0.00037950408,0.00035424726,0.0004984413,0.00023256829],"domain_scores_gemma":[0.99890643,0.00018532446,0.00021457161,0.00036281982,0.0001759964,0.00015486385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020509618,0.00020452586,0.00035300083,0.00009961629,0.00005511968,0.00002791501,0.00012276573,0.00021353066,0.00019253825],"category_scores_gemma":[0.000041415482,0.00017754185,0.0000647853,0.0001694011,0.00012855859,0.00024005429,0.000029673476,0.00024922425,0.000009398467],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043330692,0.00045735622,0.23752327,0.0018119032,0.000075960896,0.000038390575,0.0026009723,0.0000010010751,0.75685287,0.00026650162,0.000005126808,0.00032330913],"study_design_scores_gemma":[0.0023011346,0.0002402794,0.059784025,0.00090584514,0.0004719644,0.0005365845,0.00024093415,0.000062000516,0.935193,0.00008790098,0.0000047081517,0.00017161202],"about_ca_topic_score_codex":0.000034122862,"about_ca_topic_score_gemma":0.000017288676,"teacher_disagreement_score":0.17834014,"about_ca_system_score_codex":0.000006544502,"about_ca_system_score_gemma":0.000088046014,"threshold_uncertainty_score":0.7239947},"labels":[],"label_agreement":null},{"id":"W1968663928","doi":"10.1182/blood-2002-10-3093","title":"Cell type–specific regulation of von Willebrand factor expression by the E4BP4 transcriptional repressor","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Chromatin immunoprecipitation; Molecular biology; Repressor; Biology; Transcription factor; Promoter; Transcription (linguistics); Transcriptional regulation; Chromatin; Cell biology; Gene expression; Gene; Genetics","score_opus":0.01393763625896525,"score_gpt":0.2268180910794466,"score_spread":0.21288045482048135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968663928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99458003,0.0028307477,0.00007411338,0.00028304313,0.00006135225,0.00024487215,0.00003673037,0.000018907074,0.0018702263],"genre_scores_gemma":[0.9986698,0.00018753023,0.00023579704,0.00003601202,0.000031327996,0.0000068495797,0.00010086884,0.000011258921,0.0007205575],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99939775,0.000014222806,0.0001458628,0.00014822463,0.00019559386,0.0000983182],"domain_scores_gemma":[0.99965805,0.000016671884,0.00005703501,0.00018958565,0.000040209605,0.000038441874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000030568714,0.000085136606,0.00014312816,0.000024332747,0.000054399385,0.000006095701,0.000043147895,0.00006162801,0.00019070524],"category_scores_gemma":[0.0000064450437,0.000053074415,0.00005861938,0.00007404356,0.000035112036,0.00005162444,0.0000057348325,0.000063197826,0.000015591417],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021169487,0.0012093388,0.0028330479,0.000027624672,0.00004733621,0.000011911612,0.00040827497,0.000014430637,0.9932317,0.00006617294,0.0015160186,0.00042243945],"study_design_scores_gemma":[0.01067043,0.00028654851,0.062326502,0.00009614327,0.00012167072,0.000039692328,0.000059273505,0.000003383878,0.91962767,0.0006114566,0.0060678194,0.00008940882],"about_ca_topic_score_codex":0.000013962015,"about_ca_topic_score_gemma":0.0000010295307,"teacher_disagreement_score":0.07360404,"about_ca_system_score_codex":0.000011776177,"about_ca_system_score_gemma":0.00002311738,"threshold_uncertainty_score":0.21643119},"labels":[],"label_agreement":null},{"id":"W1968747503","doi":"10.1182/blood-2013-05-501569","title":"European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013","year":2013,"lang":"en","type":"review","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1989,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Institute for Health and Care Research","keywords":"Medicine; Myeloid leukemia; Internal medicine; Intensive care medicine","score_opus":0.05498044835877869,"score_gpt":0.32031545548990364,"score_spread":0.26533500713112496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968747503","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000092152195,0.98470247,0.00010691771,0.00030388645,0.00039248235,0.0063425587,0.00026459224,0.00009427352,0.0077836094],"genre_scores_gemma":[0.000008552712,0.97978634,0.0033311066,0.000057264166,0.0006996775,0.0015869165,0.001406245,0.00020227184,0.012921633],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971624,0.00015948183,0.0011350277,0.00065168133,0.00033318013,0.000558229],"domain_scores_gemma":[0.9969982,0.00038915157,0.00074803864,0.0015888286,0.00011206692,0.00016371079],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044292657,0.0006597318,0.0016646205,0.00017379742,0.00016870149,0.000036635043,0.00062682194,0.00025030295,0.0006903856],"category_scores_gemma":[0.000021394915,0.00041727908,0.00087587454,0.00033352128,0.00012081277,0.00006647246,0.00027965105,0.0005335509,0.0008798081],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000048082325,0.00029446295,0.0000010043389,0.031723697,0.004581503,0.000035376936,0.000025837444,0.0000014780857,7.959319e-7,0.0001786351,0.049975615,0.9131768],"study_design_scores_gemma":[0.004696822,0.00030465415,0.000012695401,0.017135575,0.018643562,0.0001768339,0.000034828925,0.000017854063,0.000008790918,0.000010114312,0.9586474,0.0003109274],"about_ca_topic_score_codex":0.000119031254,"about_ca_topic_score_gemma":0.0000111378395,"teacher_disagreement_score":0.9128659,"about_ca_system_score_codex":0.0025097136,"about_ca_system_score_gemma":0.0014078422,"threshold_uncertainty_score":0.99989814},"labels":[],"label_agreement":null},{"id":"W1968969270","doi":"10.1182/blood-2006-04-020305","title":"Autocrine release of interleukin-9 promotes Jak3-dependent survival of ALK+ anaplastic large-cell lymphoma cells","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Center for Research Resources; National Institute of Allergy and Infectious Diseases; National Cancer Institute","keywords":"Anaplastic lymphoma kinase; Autocrine signalling; Anaplastic large-cell lymphoma; Cancer research; Cell culture; Interleukin 15; Biology; Signal transduction; Lymphoma; Chemistry; Cytokine; Interleukin; Cell biology; Immunology; Internal medicine; Medicine","score_opus":0.0062844117786149505,"score_gpt":0.2197124589867445,"score_spread":0.21342804720812955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968969270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951264,0.00055950135,0.0007055335,0.000053177046,0.0002427738,0.00033794297,0.00008127481,0.000039148737,0.0028542262],"genre_scores_gemma":[0.9975162,0.0000424581,0.0005463866,0.00003291617,0.0001596077,0.00001142619,0.000024248258,0.000033196924,0.0016335666],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99876183,0.000029294364,0.0004029199,0.00023319965,0.00032238654,0.00025039417],"domain_scores_gemma":[0.9992448,0.000047510766,0.00018194967,0.00032735182,0.00011572234,0.00008263268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014161022,0.00016222877,0.0004222695,0.00010789661,0.000021500591,0.0000057705984,0.00010246334,0.00006715327,0.0002789501],"category_scores_gemma":[0.000014180145,0.0001413475,0.00013562803,0.00014732435,0.000036902842,0.00003007627,0.00004302694,0.000068992675,0.000013801349],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078757945,0.012301872,0.0026153075,0.0006882391,0.0001962597,0.00021650223,0.00022534319,0.000012227531,0.978538,0.002132117,0.00036552726,0.0019210724],"study_design_scores_gemma":[0.016880725,0.001579325,0.0032921073,0.00015022229,0.00024358269,0.000032069565,0.000080426675,0.00014001252,0.97542995,0.00043675365,0.0015943594,0.00014044844],"about_ca_topic_score_codex":0.000453289,"about_ca_topic_score_gemma":0.00019569043,"teacher_disagreement_score":0.016093144,"about_ca_system_score_codex":0.000028117609,"about_ca_system_score_gemma":0.00012511434,"threshold_uncertainty_score":0.5763984},"labels":[],"label_agreement":null},{"id":"W1969267175","doi":"10.1182/blood-2005-04-1565","title":"Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL)","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":456,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; International Prognostic Index; Follicular lymphoma; Internal medicine; Gastroenterology; CD68; Lymphoma; Vincristine; Rituximab; Prednisone; Chemotherapy; Cyclophosphamide; Oncology; Immunohistochemistry","score_opus":0.03216766737090314,"score_gpt":0.2545637908689651,"score_spread":0.22239612349806193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969267175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996854,0.0014180795,0.0000071420004,0.00012920158,0.000079236284,0.0006547627,0.0005081397,0.000045159653,0.00030427144],"genre_scores_gemma":[0.998873,0.0001874803,0.0002173795,0.00013107582,0.000035584046,0.00007690178,0.00030003034,0.000036158937,0.00014240402],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971458,0.00016759428,0.00082547235,0.0005552114,0.0008642283,0.00044173293],"domain_scores_gemma":[0.99826634,0.00016625995,0.00042960513,0.00067386124,0.00019329734,0.00027062942],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004512601,0.00034257502,0.0012618481,0.0006042096,0.00004377951,0.00001731427,0.00020418382,0.0002545027,0.0002541402],"category_scores_gemma":[0.00012677991,0.00028700917,0.00063473574,0.0009303023,0.00010002796,0.00012649411,0.000080905294,0.000041567084,0.0000059480494],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035906263,0.016287582,0.95579314,0.00004379789,0.010725864,0.00022043704,0.0009121864,0.000024836023,0.008163022,0.000014015034,0.000025394691,0.007430641],"study_design_scores_gemma":[0.031490833,0.00045987047,0.84975266,0.00009894903,0.0056172456,0.000010293211,0.0005096168,0.0019138793,0.10986941,0.0000019391089,0.00008119495,0.00019409727],"about_ca_topic_score_codex":0.0032739697,"about_ca_topic_score_gemma":0.0038027822,"teacher_disagreement_score":0.10604049,"about_ca_system_score_codex":0.00042359982,"about_ca_system_score_gemma":0.00018460823,"threshold_uncertainty_score":0.9999582},"labels":[],"label_agreement":null},{"id":"W1969269682","doi":"10.1182/blood-2005-02-0593","title":"A novel molecular basis for β thalassemia intermedia poses new questions about its pathophysiology","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Wellcome Trust","keywords":"Thalassemia; Intermedia; Genotyping; Genetics; Biology; Beta thalassemia; Gene; Genotype; Medicine","score_opus":0.009119887111742293,"score_gpt":0.2583463043277937,"score_spread":0.2492264172160514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969269682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812118,0.0051121525,0.003552846,0.006636869,0.00023161848,0.00065703184,0.000052674302,0.00014362612,0.0024014194],"genre_scores_gemma":[0.98423225,0.00064377935,0.010653903,0.0024742095,0.00040956927,0.000060622428,0.00005114808,0.000042269632,0.0014322302],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99911577,0.000013674904,0.00022145324,0.00024980988,0.000100061014,0.00029923778],"domain_scores_gemma":[0.9993796,0.00006249193,0.00005636821,0.00021751728,0.0000859589,0.00019806996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005173849,0.00015370805,0.00025173533,0.00008190096,0.000057348032,0.000010443167,0.00008579474,0.00020878794,0.000080132115],"category_scores_gemma":[0.00033809847,0.0001273613,0.00016409668,0.00012699448,0.0000425997,0.000045600915,0.000031626383,0.00017519193,0.00006678722],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010493283,0.0014733417,0.0003655525,0.00011924948,0.0003007853,0.00006131944,0.00059254916,0.00004822225,0.96758825,0.0016559683,0.0044322214,0.023257613],"study_design_scores_gemma":[0.071058765,0.0067212917,0.066716805,0.0038939856,0.0075774062,0.0019075021,0.0018182168,0.004442767,0.5881426,0.0032935538,0.24163273,0.0027944033],"about_ca_topic_score_codex":0.000024935169,"about_ca_topic_score_gemma":0.000011704159,"teacher_disagreement_score":0.37944567,"about_ca_system_score_codex":0.000023220648,"about_ca_system_score_gemma":0.00019008412,"threshold_uncertainty_score":0.5193643},"labels":[],"label_agreement":null},{"id":"W1969576610","doi":"10.1182/blood-2009-10-250639","title":"Oncogenic epidermal growth factor receptor up-regulates multiple elements of the tissue factor signaling pathway in human glioma cells","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Children's Hospital","funders":"Canadian Institutes of Health Research","keywords":"Tissue factor; Epidermal growth factor receptor; Cancer research; Biology; Angiogenesis; Epidermal growth factor; Growth factor; Growth factor receptor inhibitor; Glioma; Signal transduction; Growth factor receptor; Ectopic expression; Factor VII; Cell biology; Receptor; Cell culture; Coagulation; Medicine; Internal medicine; Genetics","score_opus":0.024635502127059308,"score_gpt":0.26968672437204927,"score_spread":0.24505122224498996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969576610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99831486,0.00003282923,0.000015614332,0.000118184245,0.0006300941,0.0006528829,0.00007623058,0.000052193955,0.00010712606],"genre_scores_gemma":[0.99835896,0.000001717409,0.00096259505,0.000074646785,0.00015677343,0.000020745942,0.00002571024,0.000041292365,0.0003575339],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99827224,0.00009266857,0.00059436646,0.00031296816,0.0003979865,0.00032977303],"domain_scores_gemma":[0.9989608,0.00009752547,0.00026082978,0.00042534407,0.000118965356,0.00013656907],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018523876,0.00022545435,0.00041177718,0.00014486433,0.00010536606,0.000017343778,0.00023319773,0.00019589646,0.0014216665],"category_scores_gemma":[0.00012480968,0.0001694705,0.00015575891,0.00028674223,0.0000644398,0.00008233063,0.000093006136,0.00033904205,0.00004396319],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016615712,0.000676724,0.033586424,0.00005642541,0.00008350887,0.0000039986235,0.00039335337,5.6842464e-7,0.9644679,0.00023825261,0.000022541344,0.00045368762],"study_design_scores_gemma":[0.0044484157,0.00018794696,0.028559556,0.00008214491,0.00006493532,0.000008269526,0.00007574512,0.000020484287,0.9659672,0.00014052623,0.00027542264,0.0001693734],"about_ca_topic_score_codex":0.00009624945,"about_ca_topic_score_gemma":0.000086594286,"teacher_disagreement_score":0.005026866,"about_ca_system_score_codex":0.000018804163,"about_ca_system_score_gemma":0.00007648066,"threshold_uncertainty_score":0.99949116},"labels":[],"label_agreement":null},{"id":"W1969762073","doi":"10.1182/blood-2002-03-0894","title":"Monoglycerides induce apoptosis in human leukemic cells while sparing normal peripheral blood mononuclear cells","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Centre Hospitalier de l’Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"Peripheral blood mononuclear cell; Apoptosis; Leukemia; Cytotoxic T cell; Chronic lymphocytic leukemia; Cancer research; Cancer cell; K562 cells; Immunology; Programmed cell death; Biology; Medicine; Cancer; In vitro; Biochemistry; Internal medicine","score_opus":0.012533553430984879,"score_gpt":0.20098603744280755,"score_spread":0.18845248401182266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969762073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958492,0.00045487078,0.00008579692,0.000016485923,0.0001279696,0.00018301865,0.000006452394,0.000024434117,0.0032517677],"genre_scores_gemma":[0.995987,0.0003699927,0.0010141185,0.00006248324,0.0002877891,0.000015108331,0.000031750445,0.00004409462,0.002187678],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987819,0.00003858568,0.00027346524,0.0004199727,0.00012597528,0.00036009622],"domain_scores_gemma":[0.9994575,0.0000040594023,0.00008628971,0.0003337891,0.000028648843,0.00008972928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009382482,0.00021072096,0.00018093598,0.00007036018,0.00012424558,0.000050535877,0.00019148033,0.00024331543,0.00019865668],"category_scores_gemma":[0.000003900179,0.00022199219,0.00010326506,0.0001063223,0.00003648247,0.00001086861,0.0001210376,0.00014518716,0.000022652666],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010538161,0.00036246204,0.0006018306,0.00001848186,0.000040117982,0.000005842836,0.00014642753,0.0010175215,0.99692166,0.000029634728,0.00019817057,0.0006473411],"study_design_scores_gemma":[0.0016953907,0.0002526117,0.00073060073,0.000019703208,0.000054560514,0.000011518802,0.000060480786,0.0005330774,0.9946579,0.000021869118,0.0016705875,0.00029172102],"about_ca_topic_score_codex":0.000115914925,"about_ca_topic_score_gemma":0.000047707497,"teacher_disagreement_score":0.0022637525,"about_ca_system_score_codex":0.00001653507,"about_ca_system_score_gemma":0.00001722769,"threshold_uncertainty_score":0.9052579},"labels":[],"label_agreement":null},{"id":"W1969869573","doi":"10.1182/blood-2014-12-616565","title":"Sample conditions determine the ability of thrombin generation parameters to identify bleeding phenotype in FXI deficiency","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"University of Manchester","keywords":"Thrombin generation; Thrombin; Phenotype; Platelet; Medicine; Immunology; Internal medicine; Biology; Biochemistry; Gene","score_opus":0.08333932926647819,"score_gpt":0.33755683378968765,"score_spread":0.25421750452320946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969869573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977913,0.00030243295,0.00055733364,0.0004839103,0.00017383214,0.00039520315,0.000020691888,0.000025619178,0.00024967495],"genre_scores_gemma":[0.99797744,0.0000066203847,0.001635383,0.00018103376,0.00009077081,0.000026045956,0.000052511063,0.000010330019,0.000019894964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990215,0.00004513792,0.0003337396,0.0001967406,0.00022989283,0.00017301975],"domain_scores_gemma":[0.9992585,0.00016346817,0.00008052728,0.00027244474,0.00012582153,0.000099203695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044374482,0.00009525565,0.0001997873,0.00008910789,0.00006194627,0.000019367466,0.000085876156,0.00004888274,0.000044181976],"category_scores_gemma":[0.00068968034,0.000074513184,0.00006044092,0.0003275027,0.000072159266,0.000092215996,0.000032639742,0.00006573753,0.000012458374],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048218128,0.001233409,0.6308075,0.00007685732,0.000056119483,0.000006761009,0.005697203,0.000637159,0.35600054,0.002505399,0.000991249,0.001939552],"study_design_scores_gemma":[0.0023180218,0.0003769243,0.90073955,0.00007604539,0.00020113713,0.000022541608,0.0006188712,0.00195821,0.090193585,0.0032414943,0.000091654816,0.00016197328],"about_ca_topic_score_codex":0.0007968814,"about_ca_topic_score_gemma":0.0002183787,"teacher_disagreement_score":0.26993203,"about_ca_system_score_codex":0.000036446276,"about_ca_system_score_gemma":0.000098359415,"threshold_uncertainty_score":0.30385596},"labels":[],"label_agreement":null},{"id":"W1969915666","doi":"10.1182/blood-2010-10-313940","title":"Constitutive activation of metalloproteinase ADAM10 in mantle cell lymphoma promotes cell growth and activates the TNFα/NFκB pathway","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Terry Fox Foundation; Cancer Research Institute","keywords":"ADAM10; Cyclin D1; Cell growth; Cancer research; Cell cycle; Cell biology; Biology; Cell culture; Mantle cell lymphoma; Disintegrin; Chemistry; Cell; Metalloproteinase; Immunology; Matrix metalloproteinase; Lymphoma; Biochemistry","score_opus":0.032896522401532104,"score_gpt":0.25513160406285285,"score_spread":0.22223508166132075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969915666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96920645,0.00038117895,0.00001997166,0.00015396447,0.000026368221,0.0009941518,0.000013771176,0.000020827676,0.029183332],"genre_scores_gemma":[0.99874884,0.00009178746,0.00076789985,0.00004519818,0.000037074286,0.000102621714,0.000005329663,0.000020620077,0.00018063399],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988406,0.000103437866,0.00023097376,0.00026341053,0.00030318898,0.00025844734],"domain_scores_gemma":[0.99927604,0.00014438579,0.00010673945,0.00027935032,0.000105025414,0.00008843517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003235845,0.0001469042,0.00025792798,0.00012654126,0.000053987053,0.000010960142,0.00013217318,0.00009438154,0.00009691633],"category_scores_gemma":[0.00018747943,0.00010050226,0.00004487118,0.00027242198,0.00029237347,0.00011441244,0.00008742617,0.00017968903,0.000008881904],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037769205,0.0029557473,0.028464004,0.0007839875,0.00008454258,0.000107081236,0.0038020113,1.2347539e-7,0.9595621,0.00085588923,0.000036641155,0.0029701358],"study_design_scores_gemma":[0.0036973413,0.000458996,0.019891404,0.0001641391,0.000054191092,0.000018431165,0.00066579133,0.000010034524,0.974362,0.00042124043,0.00015547968,0.000100923295],"about_ca_topic_score_codex":0.0010141777,"about_ca_topic_score_gemma":0.000025732117,"teacher_disagreement_score":0.0295424,"about_ca_system_score_codex":0.000033874483,"about_ca_system_score_gemma":0.00033169662,"threshold_uncertainty_score":0.4098363},"labels":[],"label_agreement":null},{"id":"W1969923830","doi":"10.1182/blood-2013-04-499491","title":"Abnormal megakaryocyte development and platelet function in Nbeal2−/− mice","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; University Health Network; Thrombosis and Atherosclerosis Research Institute; Hospital for Sick Children; McMaster University","funders":"Canadian Institutes of Health Research; National Heart, Lung, and Blood Institute; University of California, Davis","keywords":"Megakaryocyte; Platelet; Thrombopoietin; Function (biology); Chemistry; Medicine; Immunology; Biology; Internal medicine; Cell biology; Haematopoiesis; Stem cell","score_opus":0.009045264057004418,"score_gpt":0.2096593254125018,"score_spread":0.20061406135549736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969923830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99536675,0.0006314152,0.000008182793,0.00015462996,0.000038286453,0.00029108956,8.891518e-7,0.000027754822,0.0034810205],"genre_scores_gemma":[0.99811596,0.000058443948,0.0009843176,0.00024133972,0.00001973549,0.000048122365,0.000029576231,0.000009843272,0.00049264723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994203,0.00000798028,0.00014401544,0.00015340625,0.000094199066,0.0001800943],"domain_scores_gemma":[0.999791,0.000013858238,0.000025497735,0.0000721705,0.000018644409,0.00007878426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000044128734,0.000097954144,0.00016364202,0.00007300402,0.000036595717,0.000013490131,0.000019742287,0.000057843594,0.00009351591],"category_scores_gemma":[0.000007263688,0.000080146536,0.000015431995,0.00007718677,0.00001408715,0.00009794225,0.000018572096,0.00007652422,0.00015108708],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058322086,0.0048167952,0.75892764,0.00027868428,0.0009432092,0.0024805327,0.0021901422,0.0000039039037,0.010826748,0.00018532778,0.0018048858,0.2169589],"study_design_scores_gemma":[0.01288816,0.00028084125,0.9633612,0.00006788799,0.000090966765,0.0004475678,0.00014166176,0.00004348658,0.015849542,0.0001419006,0.0065173795,0.00016939704],"about_ca_topic_score_codex":0.00016810656,"about_ca_topic_score_gemma":0.00006876954,"teacher_disagreement_score":0.2167895,"about_ca_system_score_codex":0.000016816726,"about_ca_system_score_gemma":0.000035923305,"threshold_uncertainty_score":0.3268281},"labels":[],"label_agreement":null},{"id":"W1970081233","doi":"10.1182/blood-2006-06-030031","title":"Gfi1b:green fluorescent protein knock-in mice reveal a dynamic expression pattern of Gfi1b during hematopoiesis that is largely complementary to Gfi1","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Deutsche Forschungsgemeinschaft","keywords":"Haematopoiesis; Biology; Green fluorescent protein; Zinc finger; Lymphopoiesis; Molecular biology; Gene expression; Gene; Repressor; Progenitor cell; Regulation of gene expression; Stem cell; Cell biology; Genetics; Transcription factor","score_opus":0.005700054540485526,"score_gpt":0.2210270406339675,"score_spread":0.21532698609348197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970081233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99769634,0.00096660055,0.0000765785,0.000247534,0.000023507884,0.00063491304,0.00019958292,0.00001205949,0.00014286896],"genre_scores_gemma":[0.9982963,0.000018992083,0.000855884,0.00012762392,0.00004085277,0.00009976151,0.00024249377,0.000032589523,0.0002854586],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986442,0.0000505988,0.00031279286,0.0004497148,0.00019464568,0.0003480494],"domain_scores_gemma":[0.9994289,0.0000041091785,0.00011451603,0.00034810003,0.000033117336,0.00007122263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006385675,0.00022095912,0.00024684824,0.00007713672,0.00006517988,0.000012972816,0.00020037015,0.000106412896,0.00003494822],"category_scores_gemma":[0.0000036866916,0.00021689697,0.00010986315,0.000096332005,0.00002488034,0.000006252057,0.00022000774,0.00006328909,0.000009056563],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079706435,0.001421741,0.09950979,0.00015546345,0.00008917029,0.000024087645,0.00009922366,0.0000045617135,0.8975832,0.0000011419551,0.00026093732,0.000770985],"study_design_scores_gemma":[0.0035355403,0.00018638524,0.054481514,0.00017448788,0.000056470133,0.000009950163,0.00010401659,0.0000049493606,0.9409559,0.00005151907,0.00021959597,0.0002196929],"about_ca_topic_score_codex":0.0024413094,"about_ca_topic_score_gemma":0.0023090348,"teacher_disagreement_score":0.045028273,"about_ca_system_score_codex":0.00001583991,"about_ca_system_score_gemma":0.000023485585,"threshold_uncertainty_score":0.8844802},"labels":[],"label_agreement":null},{"id":"W1970196001","doi":"10.1182/blood-2010-08-297648","title":"Complement halts angiogenesis gone wild","year":2010,"lang":"en","type":"letter","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Complement (music); Complement system; Angiogenesis; Neovascularization; Immunology; Alternative complement pathway; Matrigel; Medicine; Biology; Cell biology; Cancer research; Phenotype; Immune system; Genetics","score_opus":0.019456739764992462,"score_gpt":0.23931754830080257,"score_spread":0.2198608085358101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970196001","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14734624,0.033483908,0.000063890024,0.7762312,0.01512734,0.0049698693,0.010280318,0.001415272,0.011081926],"genre_scores_gemma":[0.13796869,0.00012719154,0.00050767214,0.78883535,0.007840031,0.0010329646,0.031816654,0.00039388295,0.031477563],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99762744,0.00028473197,0.0005707927,0.0006650091,0.00010434182,0.00074766245],"domain_scores_gemma":[0.9982605,0.00021102485,0.00032360098,0.0010867672,0.00008951382,0.000028621924],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00016811918,0.0004875549,0.00065268826,0.00021125651,0.00022794075,0.000034652832,0.0007506781,0.0015133858,0.009525452],"category_scores_gemma":[0.000037980542,0.00046635306,0.00037264617,0.000100748824,0.00015585338,0.000034319928,0.00030631578,0.0016383242,0.003588639],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009784855,0.00028521786,0.0026540651,0.00014391838,0.0010193132,0.00012364415,0.000029701217,5.4559273e-8,0.018264733,0.000025220685,0.9772089,0.00023542262],"study_design_scores_gemma":[0.002032486,0.00009536071,0.0018456161,0.00010780487,0.00079152716,0.00015162196,0.0000135496375,4.672772e-8,0.009835371,0.000045354103,0.98459154,0.0004897184],"about_ca_topic_score_codex":0.00022483153,"about_ca_topic_score_gemma":0.000092473965,"teacher_disagreement_score":0.03335672,"about_ca_system_score_codex":0.00002989314,"about_ca_system_score_gemma":0.000096891155,"threshold_uncertainty_score":0.99978286},"labels":[],"label_agreement":null},{"id":"W1970379368","doi":"10.1182/blood-2007-03-078543","title":"Effect of single nucleotide polymorphisms on expression of the gene encoding thrombin-activatable fibrinolysis inhibitor: a functional analysis","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Single-nucleotide polymorphism; Untranslated region; Molecular biology; Biology; Fibrinolysis; Coding region; Gene; Genetics; Population; 5' flanking region; Messenger RNA; Gene expression; Promoter; Genotype; Medicine; Internal medicine","score_opus":0.019680136135986997,"score_gpt":0.2526980187626208,"score_spread":0.23301788262663384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970379368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967595,0.0000962685,0.0005555743,0.00004974498,0.00018762621,0.00024572053,0.000009280756,0.000034830853,0.0020614772],"genre_scores_gemma":[0.99925774,0.0000036195217,0.0003854725,0.000059975373,0.00013005678,0.0000047358885,0.000015000162,0.000019704416,0.00012368076],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984868,0.00009236276,0.0003955808,0.00025496713,0.0005629659,0.00020731273],"domain_scores_gemma":[0.99884117,0.00022681296,0.00028703304,0.00048347437,0.000078124525,0.0000834113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047914387,0.00016426393,0.00051135884,0.00029448114,0.00009443529,0.000006749758,0.00009198472,0.00010355338,0.00021264602],"category_scores_gemma":[0.00008435956,0.00011032656,0.0004147443,0.0009416519,0.00006019236,0.0000461493,0.00006937836,0.000120698736,0.0000053867802],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023241143,0.00082040665,0.02774565,0.000044186112,0.00055727357,0.0000026668647,0.00007708888,0.000057455152,0.9699281,0.00009121858,0.000024073237,0.00041945768],"study_design_scores_gemma":[0.0021593566,0.0008323105,0.06725899,0.00015412926,0.0021424657,0.000009738312,0.000032308304,0.000034600038,0.9272527,0.00002194492,0.000016135546,0.00008529175],"about_ca_topic_score_codex":0.00003655325,"about_ca_topic_score_gemma":0.0000045350753,"teacher_disagreement_score":0.042675387,"about_ca_system_score_codex":0.000031474676,"about_ca_system_score_gemma":0.000029037894,"threshold_uncertainty_score":0.44989866},"labels":[],"label_agreement":null},{"id":"W1970521173","doi":"10.1182/blood-2014-05-578732","title":"The Tao of myeloma","year":2014,"lang":"en","type":"review","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute","keywords":"Multiple myeloma; Plasma cell; Proteasome; Malignancy; Hematologic malignancy; Cancer research; Carfilzomib; Proteasome inhibitor; Disease; Lenalidomide; Plasma cell neoplasm; Cancer; Biology; Medicine; Computational biology; Immunology; Internal medicine; Cell biology; Plasmacytoma","score_opus":0.051527146080962635,"score_gpt":0.3698060043597938,"score_spread":0.3182788582788312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970521173","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000028721715,0.9900979,0.0000015856509,0.000026376072,0.000052185074,0.00078268105,0.000022956248,0.000017884913,0.008969724],"genre_scores_gemma":[0.00007582486,0.9964545,0.00011604045,0.0000064710775,0.00019396255,0.00010820646,0.00007145704,0.000033239696,0.0029403155],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987422,0.00011145752,0.00035751404,0.00019104463,0.00032869753,0.00026908913],"domain_scores_gemma":[0.9986176,0.00038114164,0.00017426714,0.0006189049,0.00006595145,0.00014214705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022583995,0.00019756892,0.0011050199,0.00007078781,0.00006820272,0.000011445726,0.00018890294,0.00013583532,0.000050786097],"category_scores_gemma":[0.00029774907,0.00009360157,0.000447977,0.00014233007,0.00009014847,0.000008588025,0.00006725909,0.00022278426,0.00026192045],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000089850455,0.00022508355,0.00009876308,0.010031272,0.00086523336,0.000055714758,0.000003635793,6.4874767e-10,4.6457038e-7,0.00010967762,0.000474137,0.98812705],"study_design_scores_gemma":[0.0011677913,0.0002118997,0.00018693565,0.005379437,0.001668966,0.00012905395,0.0000017101279,3.503633e-7,0.00001366104,0.000008838841,0.9911627,0.00006862126],"about_ca_topic_score_codex":0.0000140790935,"about_ca_topic_score_gemma":0.0000045575116,"teacher_disagreement_score":0.9906886,"about_ca_system_score_codex":0.000019594927,"about_ca_system_score_gemma":0.0002623684,"threshold_uncertainty_score":0.38169613},"labels":[],"label_agreement":null},{"id":"W1970587048","doi":"10.1182/blood-2014-04-571745","title":"Nodular sclerosis Hodgkin lymphoma with classic Reed-Sternberg cells","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Medical Imaging and Pathology Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Reed–Sternberg cell; Nodular sclerosis; Lymphoma; Medicine; Classical Hodgkin lymphoma; Hodgkin lymphoma; Pathology","score_opus":0.01969134912851232,"score_gpt":0.22494988976090835,"score_spread":0.20525854063239604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970587048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98138267,0.00042358483,0.00072342204,0.0022938573,0.00017318195,0.00013094321,0.0000030539359,0.00013019147,0.014739084],"genre_scores_gemma":[0.99037796,0.00007560453,0.0034129631,0.003058708,0.00033875636,0.000018791081,0.0000070273463,0.00002683956,0.0026833618],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989372,0.000066901455,0.00016400812,0.0002933666,0.00025233816,0.000286171],"domain_scores_gemma":[0.9992579,0.00008690802,0.00005617125,0.0003704317,0.000058431,0.00017014235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023841344,0.0001553181,0.00032875792,0.000055982087,0.00008845908,0.000011392001,0.00008391404,0.00008399021,0.000044802568],"category_scores_gemma":[0.00009701089,0.00010582786,0.00005757708,0.00011986196,0.000252784,0.000024825931,0.00004255764,0.00012093251,0.00019238984],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035104644,0.0034144123,0.73680216,0.0005375536,0.0011425206,0.0009081326,0.0016839183,0.0000027615142,0.13091758,0.00035180303,0.037376642,0.086511455],"study_design_scores_gemma":[0.033667605,0.003537311,0.6500921,0.0017357348,0.0027921428,0.0010495777,0.0003334654,0.00030804673,0.18384749,0.00017391324,0.12157237,0.0008901933],"about_ca_topic_score_codex":0.000022363452,"about_ca_topic_score_gemma":0.0000069286602,"teacher_disagreement_score":0.08671003,"about_ca_system_score_codex":0.000009694222,"about_ca_system_score_gemma":0.000032975397,"threshold_uncertainty_score":0.43155348},"labels":[],"label_agreement":null},{"id":"W1970907086","doi":"10.1182/blood.v100.1.289","title":"Transferrin receptor hyperexpression in primary erythroblasts is lost on transformation by avian erythroblastosis virus","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Transferrin receptor; Cell biology; Messenger RNA; Biology; Erythropoiesis; Transferrin; Endosome; Receptor; Molecular biology; Intracellular; Gene; Biochemistry; Internal medicine; Anemia","score_opus":0.009418514194600663,"score_gpt":0.20664399666447292,"score_spread":0.19722548246987226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970907086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9663389,0.0009940873,0.00006791372,0.004170321,0.00012678801,0.00060476287,0.00008349684,0.00008480524,0.027528964],"genre_scores_gemma":[0.9929291,0.003549542,0.00014042592,0.0020833851,0.000055493023,0.000027207414,0.00008748417,0.00004832065,0.0010790423],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984502,0.000051422274,0.00043108253,0.00033556425,0.00035446402,0.00037722127],"domain_scores_gemma":[0.99947137,0.00002981411,0.000046150795,0.00024979326,0.000028136315,0.000174738],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009203986,0.00025208518,0.0003478719,0.00017416615,0.00008207748,0.000017177734,0.000087396234,0.00032310447,0.0018493381],"category_scores_gemma":[0.000012476529,0.00021313947,0.00013677227,0.00032183688,0.000062755265,0.00015950283,0.000008793368,0.0004368062,0.00074182596],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068583206,0.010321859,0.0024462517,0.00064985594,0.00019336744,0.000054956585,0.01135425,0.000029178984,0.8781494,0.000052601757,0.048683,0.04737943],"study_design_scores_gemma":[0.038208675,0.0040063164,0.005592434,0.0037194754,0.00046019966,0.0001395659,0.0011974836,0.000697943,0.83986974,0.0000612708,0.10478999,0.0012569417],"about_ca_topic_score_codex":0.0000500607,"about_ca_topic_score_gemma":0.00001215782,"teacher_disagreement_score":0.05610699,"about_ca_system_score_codex":0.00007719265,"about_ca_system_score_gemma":0.000022273633,"threshold_uncertainty_score":0.99906313},"labels":[],"label_agreement":null},{"id":"W1970981666","doi":"10.1182/blood-2003-11-4077","title":"Bleeding risks associated with inheritance of the Quebec platelet disorder","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Odds ratio; Internal medicine; Plasminogen activator; Confidence interval; Urokinase; Platelet; Gastroenterology; Family history","score_opus":0.03008327695568363,"score_gpt":0.2881896917619354,"score_spread":0.25810641480625174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970981666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958248,0.00036986376,0.0000031166323,0.0012512335,0.000024728455,0.0002496865,0.000004417211,0.000022919266,0.0022491943],"genre_scores_gemma":[0.99821734,0.000041349795,0.000068672576,0.00003235109,0.000041312658,0.000009594909,0.000004954548,0.000012366708,0.0015720406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993535,0.00001559113,0.00009796229,0.000104599254,0.00025943675,0.0001688773],"domain_scores_gemma":[0.9996627,0.000030992614,0.000042899257,0.00015703822,0.00006175527,0.000044601213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000081319035,0.00007324111,0.00014651117,0.00002556498,0.00006164116,0.000005891995,0.000066052766,0.000057738773,0.000023079889],"category_scores_gemma":[0.000082348175,0.000037219677,0.000045063527,0.00024441243,0.00009141257,0.000028231136,0.00002179475,0.00014130716,0.0000062345503],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000090108915,0.0018884576,0.98620486,0.000054202665,0.0005316476,0.00009494148,0.0007040762,0.00002842302,0.009034819,0.0001643968,0.000075922224,0.001128171],"study_design_scores_gemma":[0.015107797,0.00054413895,0.87337774,0.0007257478,0.0002718903,0.00003499798,0.00028363738,0.0000067961087,0.10895039,0.00016063324,0.00041243114,0.00012382974],"about_ca_topic_score_codex":0.0011674045,"about_ca_topic_score_gemma":0.0020856773,"teacher_disagreement_score":0.11282712,"about_ca_system_score_codex":0.000041428797,"about_ca_system_score_gemma":0.00014942489,"threshold_uncertainty_score":0.1764774},"labels":[],"label_agreement":null},{"id":"W1971120339","doi":"10.1182/blood-2014-08-592329","title":"Inherited macrothrombocytopenias on the rise","year":2014,"lang":"en","type":"letter","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine","score_opus":0.028087262168222455,"score_gpt":0.25926002917801466,"score_spread":0.2311727670097922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971120339","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15912893,0.00045949375,0.0000012780486,0.803356,0.00014676628,0.0008409694,0.000041336938,0.00009077152,0.035934478],"genre_scores_gemma":[0.028341688,0.000099057645,0.000057174424,0.95975584,0.0014722005,0.000104452,0.0003057456,0.00009252683,0.009771345],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988302,0.00006967303,0.00017264385,0.00031763565,0.00030775936,0.00030207713],"domain_scores_gemma":[0.99907535,0.00011887339,0.00009241758,0.0006337376,0.00003363123,0.000045962726],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00006940517,0.00029031714,0.0005117939,0.00006380715,0.0000848341,0.000032917018,0.00015844936,0.0004524983,0.0006178755],"category_scores_gemma":[0.0000435187,0.00016464248,0.00016789684,0.000091775466,0.000064195985,0.0000123877435,0.000030814736,0.0010167264,0.0013239301],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022109154,0.00032433544,0.00038647832,0.000058765876,0.0004972985,0.005495201,0.000028642091,2.9582075e-8,0.000036683385,0.000013346798,0.9928327,0.0003044136],"study_design_scores_gemma":[0.0032089294,0.00036298585,0.0007159331,0.0001922671,0.0006880842,0.00043210268,0.0000039390316,0.00000248978,0.000459828,0.00013680928,0.99362093,0.00017572008],"about_ca_topic_score_codex":0.000048989958,"about_ca_topic_score_gemma":0.0000037177083,"teacher_disagreement_score":0.15639985,"about_ca_system_score_codex":0.0000205799,"about_ca_system_score_gemma":0.00004456367,"threshold_uncertainty_score":0.99945366},"labels":[],"label_agreement":null},{"id":"W1971131900","doi":"10.1182/blood-2006-02-001073","title":"Initiation of plasminogen activation on the surface of monocytes expressing the type II transmembrane serine protease matriptase","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Plasmin; Urokinase receptor; Serine protease; Plasminogen activator; Protease; U937 cell; Molecular biology; Urokinase; Cell biology; Chemistry; Cell culture; Receptor; Biology; Biochemistry; Enzyme; Endocrinology","score_opus":0.012908099357875147,"score_gpt":0.21924630468864,"score_spread":0.20633820533076486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971131900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99859416,0.00021192705,0.00018784445,0.00015025972,0.000023665423,0.00033494856,0.000022911736,0.000005033959,0.00046925587],"genre_scores_gemma":[0.9995078,0.000017318935,0.00020475539,0.000045150322,0.00008587008,0.000014218556,0.000055898385,0.000009256526,0.000059734135],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995085,0.00005515209,0.00014949779,0.00010714429,0.000100912286,0.0000787812],"domain_scores_gemma":[0.9995903,0.000014567464,0.000116390576,0.00020808184,0.00005932999,0.000011356703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012688476,0.0000759198,0.00007013713,0.000011714717,0.00007525537,0.000005569862,0.00009547673,0.000058670223,0.000015104525],"category_scores_gemma":[0.000036121113,0.000047035082,0.000041993535,0.00006551881,0.00002978555,0.0000049439864,0.000024322013,0.000045252353,7.376098e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001261401,0.00018327855,0.00005671054,0.000022842753,0.00001858648,2.960169e-7,0.000032223485,0.00020577281,0.99889445,0.0002439948,0.000121166995,0.00009454342],"study_design_scores_gemma":[0.0004994713,0.00031215049,0.0001850153,0.000032380227,0.000026169928,0.000001662687,0.00002738313,0.000056543162,0.9982663,0.00019611465,0.0003422281,0.00005460556],"about_ca_topic_score_codex":0.00003234409,"about_ca_topic_score_gemma":0.0000016341172,"teacher_disagreement_score":0.00091364444,"about_ca_system_score_codex":0.0000023202003,"about_ca_system_score_gemma":0.000034734163,"threshold_uncertainty_score":0.1918035},"labels":[],"label_agreement":null},{"id":"W1971251879","doi":"10.1182/blood-2002-09-2725","title":"Synergy between all-trans retinoic acid and tumor necrosis factor pathways in acute leukemia cells","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Tumor necrosis factor alpha; Acute promyelocytic leukemia; Retinoic acid; Cancer research; Tretinoin; Biology; Leukemia; Molecular biology; Cell culture; Immunology; Genetics","score_opus":0.01002806697089148,"score_gpt":0.21756724072984587,"score_spread":0.2075391737589544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971251879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99641347,0.0012566014,0.00025333912,0.000018767298,0.00006980846,0.00014511791,0.00006753105,0.000019941897,0.0017554436],"genre_scores_gemma":[0.9977974,0.00073175126,0.0007694568,0.00015207629,0.000088332454,0.000026396248,0.00008834892,0.00003885864,0.0003073464],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985753,0.00008986798,0.00028220325,0.0005109319,0.00013744026,0.00040424446],"domain_scores_gemma":[0.9994012,0.00001860512,0.00008084384,0.0003277467,0.000037333048,0.00013425728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013836318,0.00025283196,0.00025242768,0.00004929676,0.00006281556,0.00004372929,0.00020609528,0.00023479782,0.000025583005],"category_scores_gemma":[0.000051864554,0.00024310246,0.00008342197,0.00011454228,0.000095064126,0.0000067853657,0.0000579059,0.00017420275,0.00000678545],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001355983,0.000057751397,0.0144426385,0.000048782756,0.00009484486,0.000036630714,0.000107763735,0.0000024432065,0.984795,0.000044435736,0.00009814618,0.00025803666],"study_design_scores_gemma":[0.0013760261,0.00020479897,0.002282185,0.00002140956,0.0000962955,0.00003578783,0.000043202348,0.0000020514326,0.9878006,0.00012206869,0.007705067,0.0003104926],"about_ca_topic_score_codex":0.000018901716,"about_ca_topic_score_gemma":0.000011956739,"teacher_disagreement_score":0.012160454,"about_ca_system_score_codex":0.000022549586,"about_ca_system_score_gemma":0.00017427812,"threshold_uncertainty_score":0.9913431},"labels":[],"label_agreement":null},{"id":"W1971273692","doi":"10.1182/blood-2009-03-206524","title":"Comprehensive genomic screens identify a role for PLZF-RARα as a positive regulator of cell proliferation via direct regulation of c-MYC","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto General Hospital","funders":"National Cancer Institute; National Institutes of Health","keywords":"Biology; Acute promyelocytic leukemia; Retinoic acid; Psychological repression; Chromatin immunoprecipitation; Cancer research; Regulation of gene expression; Repressor; Tretinoin; Cell biology; Molecular biology; Transcription factor; Gene expression; Promoter; Genetics; Cell culture; Gene","score_opus":0.005183958026414228,"score_gpt":0.23284420005115575,"score_spread":0.22766024202474153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971273692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940159,0.0012794537,0.0023573933,0.000022597189,0.000028516153,0.00049712585,0.000039097133,0.000008952259,0.001750963],"genre_scores_gemma":[0.9968685,0.000053583706,0.00222231,0.00005773983,0.00013629421,0.000019752677,0.0002864614,0.0000165416,0.0003388309],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999106,0.000045889974,0.0002962483,0.00027886423,0.00012600138,0.00014701663],"domain_scores_gemma":[0.9991142,0.000016325028,0.00024778795,0.0002541645,0.00032764784,0.000039854738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008869284,0.00013564211,0.00020589922,0.000047761863,0.000051522657,0.000011265981,0.0001230703,0.00015960188,0.0000053926187],"category_scores_gemma":[0.00003496097,0.00013780416,0.0001228579,0.00007734666,0.0000534851,0.0000073303972,0.000028185736,0.00003955254,0.0000015904765],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022496314,0.00021870238,0.0005399829,0.0000872283,0.00005885399,4.9615545e-7,0.000121381956,0.00007343496,0.9978164,0.00007027206,0.00005553424,0.00073278043],"study_design_scores_gemma":[0.00134336,0.001002763,0.013487264,0.000028958188,0.00011206852,0.000011523314,0.000057082303,0.00014481808,0.9826784,0.0007274266,0.00026771936,0.00013859969],"about_ca_topic_score_codex":0.000010247438,"about_ca_topic_score_gemma":0.0000018924837,"teacher_disagreement_score":0.015137953,"about_ca_system_score_codex":0.000009476607,"about_ca_system_score_gemma":0.00009818889,"threshold_uncertainty_score":0.5619491},"labels":[],"label_agreement":null},{"id":"W1971434385","doi":"10.1182/blood-2008-02-078014","title":"Heparin-induced thrombocytopenia: a historical perspective","year":2008,"lang":"en","type":"review","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":183,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Heart and Stroke Foundation of Canada","keywords":"Heparin-induced thrombocytopenia; Heparin; Medicine; Anticoagulant; Partial thromboplastin time; Intensive care medicine; Surgery; Platelet; Internal medicine","score_opus":0.1104055194920486,"score_gpt":0.3609989090461278,"score_spread":0.25059338955407917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971434385","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007074252,0.94651717,0.0000038089295,0.00019151511,0.0007922937,0.0024516662,0.000028638862,0.0004212468,0.04888624],"genre_scores_gemma":[0.0010697636,0.993453,0.00051337143,0.00013202894,0.0013862308,0.00038443806,0.00010621216,0.00034491636,0.0026100301],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99450874,0.00031798866,0.001436615,0.0017780868,0.00082842243,0.0011301452],"domain_scores_gemma":[0.996091,0.00027064126,0.00059521507,0.0018327397,0.00037001906,0.0008403487],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00020509514,0.0014340493,0.008039281,0.00064296514,0.00035564735,0.000065579145,0.0006883978,0.0015076295,0.0004051064],"category_scores_gemma":[0.00041421052,0.0011810976,0.0024419625,0.0011997898,0.00013391343,0.00017417426,0.00040742202,0.0022101474,0.001999755],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017137271,0.024867367,0.00046737897,0.03581358,0.02434505,0.012404552,0.002690217,5.80477e-8,0.00058234285,0.008195376,0.025296018,0.86516666],"study_design_scores_gemma":[0.002735168,0.0007958085,0.00017369285,0.0060744737,0.009511437,0.007891387,0.000052822175,3.1770603e-7,0.0000846572,0.000062491636,0.97142386,0.0011938673],"about_ca_topic_score_codex":0.0008225022,"about_ca_topic_score_gemma":0.00004262067,"teacher_disagreement_score":0.94612783,"about_ca_system_score_codex":0.0036385618,"about_ca_system_score_gemma":0.0028178387,"threshold_uncertainty_score":0.9998409},"labels":[],"label_agreement":null},{"id":"W1971439170","doi":"10.1182/blood-2007-12-128918","title":"Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; Office of Naval Research; Takeda Oncology; Astellas Pharma; CellGenix; American Society for Blood and Marrow Transplantation; Kiadis Pharma; Therakos; WellPoint; Teva Pharmaceutical Industries; HistoGenetics; Medical College of Wisconsin; StemCyte; Enzon Pharmaceuticals; U.S. Navy; Osiris Therapeutics; Celgene; American International Group; Pfizer; Baxter International; GlaxoSmithKline; U.S. Department of Health and Human Services; Astellas Pharma US; Health Resources and Services Administration; Viropharma; Amgen; Blue Cross and Blue Shield Association; Cerus Corporation; Bristol-Myers Squibb; Bayer HealthCare; U.S. Department of Defense","keywords":"Medicine; Internal medicine; Gastroenterology; Transplantation; White blood cell; Leukemia; Acute lymphocytic leukemia; Surgery; Acute leukemia; Lymphoblastic Leukemia","score_opus":0.016795734649688147,"score_gpt":0.243223031356176,"score_spread":0.22642729670648787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971439170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99618644,0.00011714422,0.0001463228,0.00070549746,0.000040528936,0.0009971985,0.00007198547,0.00010108503,0.001633775],"genre_scores_gemma":[0.99765986,0.0005806077,0.0010092016,0.00017001135,0.000075386015,0.00008388045,0.000109110275,0.00007213603,0.00023982841],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99704665,0.000095596064,0.00060653064,0.0006929524,0.00074889185,0.00080936955],"domain_scores_gemma":[0.9984452,0.00049648,0.00011686352,0.00044490022,0.00012687333,0.00036965136],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017542382,0.0003943864,0.0006905348,0.0005124997,0.00013069573,0.000011125547,0.00025964915,0.0003014471,0.000113141316],"category_scores_gemma":[0.00018416006,0.00030653697,0.00007803821,0.0012017462,0.0002968465,0.0001625233,0.000062180814,0.00063131395,0.00010133468],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08789582,0.008461902,0.64284146,0.0035337468,0.0027284482,0.16037951,0.047855504,0.0044856817,0.036825757,0.00012787512,0.0039832504,0.0008810264],"study_design_scores_gemma":[0.2550902,0.0042621773,0.64396477,0.015233402,0.0007480829,0.016355762,0.00063902716,0.044398602,0.017266812,0.000097155484,0.0004624727,0.0014815134],"about_ca_topic_score_codex":0.0012176513,"about_ca_topic_score_gemma":0.00076812436,"teacher_disagreement_score":0.16719438,"about_ca_system_score_codex":0.0017476083,"about_ca_system_score_gemma":0.001791525,"threshold_uncertainty_score":0.99993867},"labels":[],"label_agreement":null},{"id":"W1971680848","doi":"10.1182/blood-2008-04-152934","title":"Heme oxygenase-1 expression enhances vascular endothelial resistance to complement-mediated injury through induction of decay-accelerating factor: a role for increased bilirubin and ferritin","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Heme Oxygenase-1 and Carbon Monoxide","field":"Biochemistry, Genetics and Molecular Biology","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Versus Arthritis; McGill University","keywords":"HMOX1; Heme oxygenase; Decay-accelerating factor; Hemin; Biliverdin; Heme; Chemistry; Molecular biology; Ferritin; Cytoprotection; Endothelial stem cell; Complement system; Cell biology; Biology; Biochemistry; Oxidative stress; Immunology; Antibody; In vitro; Enzyme","score_opus":0.021143287698024826,"score_gpt":0.2569876083803682,"score_spread":0.2358443206823434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971680848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99742466,0.000978006,0.00048391963,0.00003239601,0.000048951,0.0005010141,0.00036453683,0.000019564162,0.00014694783],"genre_scores_gemma":[0.99298877,0.0002264446,0.006038949,0.00011914874,0.0002058194,0.00014569897,0.00019952713,0.000028025075,0.00004761605],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987128,0.000078535675,0.0003472447,0.00041971717,0.00017517405,0.00026657595],"domain_scores_gemma":[0.9993538,0.0000310475,0.00012816825,0.0002741079,0.000105246785,0.00010760551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013370338,0.00018897162,0.0002400924,0.000042319756,0.00015056855,0.000013917767,0.00012767497,0.00012665063,0.000015472218],"category_scores_gemma":[0.00016141991,0.00018236192,0.00009182641,0.000091104404,0.00006428027,0.000012584258,0.00007753265,0.00006066604,0.0000010907565],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001916342,0.00016505935,0.0014998699,0.00004492299,0.00006313238,0.0000014233269,0.00022272211,0.0000010406438,0.9973247,0.000013566705,0.00036168,0.000110231216],"study_design_scores_gemma":[0.0017555127,0.00032393416,0.0017552596,0.000044412307,0.00002276322,0.0000039311203,0.00021128225,0.000005194563,0.98500293,0.000023644843,0.010642113,0.00020903633],"about_ca_topic_score_codex":0.00008477526,"about_ca_topic_score_gemma":0.0001284161,"teacher_disagreement_score":0.012321801,"about_ca_system_score_codex":0.000009255118,"about_ca_system_score_gemma":0.000078644676,"threshold_uncertainty_score":0.7436503},"labels":[],"label_agreement":null},{"id":"W1971818445","doi":"10.1182/blood-2013-02-485425","title":"Identification in CLL of circulating intraclonal subgroups with varying B-cell receptor expression and function","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"Cancer Research UK","keywords":"Biology; Identification (biology); Function (biology); Receptor; Genetics; Immunology; Cancer research; Cell biology","score_opus":0.011037443969455099,"score_gpt":0.2382314724415858,"score_spread":0.2271940284721307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971818445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99859715,0.0002064902,0.00025676115,0.000043665797,0.00002443917,0.0003925182,7.904182e-7,0.00001734227,0.00046085985],"genre_scores_gemma":[0.9987481,0.000022591223,0.0009851849,0.000015907452,0.00005977398,0.000042056694,0.000016053336,0.000014477063,0.00009584777],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99908745,0.000035383968,0.00023898897,0.00020394207,0.00027689777,0.00015735043],"domain_scores_gemma":[0.9994924,0.00008048411,0.00008978533,0.00017734304,0.00009354075,0.00006641218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020804517,0.00007426964,0.0001403937,0.00010591078,0.000029717114,0.000016979047,0.000037767044,0.00006646392,0.000105980245],"category_scores_gemma":[0.000065933236,0.00005939863,0.00001631502,0.00017110896,0.000048766284,0.00015176294,0.000032249583,0.00012838675,0.000017348277],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010496724,0.00035435622,0.026168264,0.00029703768,0.00001334209,0.000006963338,0.0002997229,0.000011677259,0.97090024,0.00001237733,0.000033457316,0.001797626],"study_design_scores_gemma":[0.035566736,0.0003351087,0.10305765,0.00064632954,0.00008436837,0.00013668105,0.000324794,0.007632615,0.8519441,0.0000980164,0.000021559305,0.00015202515],"about_ca_topic_score_codex":0.0003824534,"about_ca_topic_score_gemma":0.0000073217884,"teacher_disagreement_score":0.11895609,"about_ca_system_score_codex":0.00037724955,"about_ca_system_score_gemma":0.0003729267,"threshold_uncertainty_score":0.24222058},"labels":[],"label_agreement":null},{"id":"W1971846400","doi":"10.1182/blood-2007-09-084913","title":"Telomeres, stem cells, and hematology","year":2008,"lang":"en","type":"review","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Telomere; Telomerase; Biology; Somatic cell; Stem cell; Senescence; Telomerase RNA component; Telomere-binding protein; Genome instability; Cell biology; Cell division; Telomerase reverse transcriptase; Genetics; Cancer research; DNA damage; Cell; DNA; Gene","score_opus":0.0443806060949318,"score_gpt":0.29315761896504544,"score_spread":0.24877701287011364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971846400","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003385687,0.99713266,0.0000026174569,0.000030190153,0.00026224466,0.00080927054,0.00005270947,0.00014988484,0.0012218626],"genre_scores_gemma":[0.000043197535,0.99667084,0.0003163041,0.00011435575,0.00030545983,0.000058674632,0.00005992925,0.0001003759,0.0023308776],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99764407,0.00011940064,0.000716191,0.0007204525,0.00028864024,0.0005112427],"domain_scores_gemma":[0.99841523,0.00019109322,0.00028182875,0.0007047727,0.000059342376,0.000347713],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008547152,0.00059163396,0.002855416,0.00030981327,0.000111732654,0.000019015893,0.00020435898,0.0005931019,0.000071910516],"category_scores_gemma":[0.000025631129,0.00045655522,0.00038644767,0.00034010372,0.0002151775,0.000040006795,0.000115096605,0.0006044456,0.0002785428],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000091703505,0.00049918314,0.00013905385,0.026095117,0.00045557533,0.0020858115,0.00008418229,3.2763e-9,0.0000061946193,0.00015254362,0.004041736,0.96643144],"study_design_scores_gemma":[0.0009904349,0.00014636325,0.000017894685,0.0069211028,0.0015280241,0.015048656,0.000020592393,2.2191641e-7,0.00011270362,0.0000038948215,0.97480154,0.00040854994],"about_ca_topic_score_codex":0.000023429124,"about_ca_topic_score_gemma":0.0000052259065,"teacher_disagreement_score":0.9707598,"about_ca_system_score_codex":0.000029932036,"about_ca_system_score_gemma":0.00042943197,"threshold_uncertainty_score":0.99978864},"labels":[],"label_agreement":null},{"id":"W1971880154","doi":"10.1182/blood-2010-06-291641","title":"Establishment of the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":158,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Philadelphia chromosome; Chronic myelogenous leukemia; ABL; Medicine; Biology; Leukemia; Immunology; Internal medicine; Genetics; Chromosomal translocation; Gene; Tyrosine kinase","score_opus":0.028175711886128364,"score_gpt":0.28298799367047694,"score_spread":0.25481228178434856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971880154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967553,0.00007732601,0.0002126515,0.0015726686,0.00030191272,0.00055593724,0.00003969959,0.000013402598,0.00047112026],"genre_scores_gemma":[0.9928087,0.000044015313,0.00652069,0.00011997551,0.00006650055,0.000017237919,0.000088411114,0.000013498372,0.00032097602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99926805,0.000010719071,0.00027806356,0.00013018327,0.00021669091,0.000096310796],"domain_scores_gemma":[0.99915093,0.000068618145,0.0002478984,0.00024977888,0.00024789406,0.000034898025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009970389,0.00006950487,0.00014169556,0.00006798468,0.00004074313,0.000005824419,0.00011973435,0.000035066987,0.000113688904],"category_scores_gemma":[0.000254809,0.000051477968,0.00003256537,0.00021267684,0.00003497668,0.00003566694,0.000032034935,0.00007755531,0.000003050719],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012566628,0.0025955993,0.91843855,0.00080315664,0.00040714204,0.0000018819987,0.0015868371,0.00008605814,0.058554374,0.005884725,0.002159631,0.009356349],"study_design_scores_gemma":[0.0067111365,0.0003137383,0.8950218,0.00024182381,0.00019941335,0.00002131849,0.00007543534,0.0003508326,0.09168604,0.000195957,0.005099687,0.00008284522],"about_ca_topic_score_codex":0.00022376026,"about_ca_topic_score_gemma":0.00081343553,"teacher_disagreement_score":0.03313167,"about_ca_system_score_codex":0.00009574693,"about_ca_system_score_gemma":0.00036610346,"threshold_uncertainty_score":0.20992106},"labels":[],"label_agreement":null},{"id":"W1972066252","doi":"10.1182/blood-2014-03-559757","title":"Factors that predict thrombosis in relatives of patients with venous thromboembolism","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; McMaster University; Ottawa Hospital; McGill University; Thrombosis and Atherosclerosis Research Institute","funders":"Jewish General Hospital; Institut National de la Santé et de la Recherche Médicale; McMaster University; Hamilton Health Sciences; Heart and Stroke Foundation of Canada","keywords":"Venous thromboembolism; Medicine; Factor V Leiden; Thrombosis; Internal medicine; Venous thrombosis; Thrombophilia; Risk factor; Surgery","score_opus":0.019297515062980854,"score_gpt":0.2357021500939426,"score_spread":0.21640463503096175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972066252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912336,0.000077839715,0.00003623825,0.000077830926,0.000089970476,0.00066675793,0.000016730033,0.00005342971,0.00774763],"genre_scores_gemma":[0.9993999,0.000064760396,0.00026219076,0.00009091915,0.000035399844,0.00002792515,0.000051234747,0.00003854648,0.00002912973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858207,0.000060787243,0.00029129375,0.00031714365,0.00043608146,0.00031262296],"domain_scores_gemma":[0.9991508,0.00009668411,0.00017070399,0.00040458897,0.00007216541,0.00010502161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015180426,0.0002267431,0.0008630791,0.00018592222,0.000047566802,0.000010355978,0.00012604758,0.00009551636,0.00009895761],"category_scores_gemma":[0.000070713395,0.00015831014,0.000088351015,0.00022861862,0.000112076494,0.00012087422,0.000065406086,0.00015759452,0.000007881649],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022999931,0.0066018254,0.9895772,0.00015564151,0.0003355603,0.0000020650841,0.0018901292,0.00000858068,0.00009320405,0.0008291601,0.00012367564,0.0003599823],"study_design_scores_gemma":[0.0041545876,0.0016176084,0.9902717,0.0002847711,0.00052367256,3.3905403e-7,0.00028586248,0.000006988773,0.0021845796,0.00016516806,0.00034266151,0.00016206557],"about_ca_topic_score_codex":0.00013601282,"about_ca_topic_score_gemma":0.000040753268,"teacher_disagreement_score":0.008166321,"about_ca_system_score_codex":0.000027924198,"about_ca_system_score_gemma":0.00003366356,"threshold_uncertainty_score":0.64557},"labels":[],"label_agreement":null},{"id":"W1972151064","doi":"10.1182/blood-2009-08-234351","title":"Interim positron emission tomography scans in diffuse large B-cell lymphoma: an independent expert nuclear medicine evaluation of the Eastern Cooperative Oncology Group E3404 study","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Medicine; Interim; Positron emission tomography; Nuclear medicine; Diffuse large B-cell lymphoma; Rituximab; Medical physics; Lymphoma; Concordance; Vincristine; Prednisone; Clinical trial; Internal medicine; Cyclophosphamide; Chemotherapy","score_opus":0.02720674554937162,"score_gpt":0.3272892630740647,"score_spread":0.30008251752469306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972151064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99541724,0.00087643915,0.000002654386,0.0006277417,0.00011529117,0.0014906959,0.000003928756,0.000023206616,0.0014428059],"genre_scores_gemma":[0.99908376,0.00005915813,0.000030138472,0.0006052001,0.00008442738,0.00007254591,0.000023860006,0.000017450677,0.000023458195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977674,0.00051084993,0.0004270863,0.0003703824,0.00068938825,0.00023490898],"domain_scores_gemma":[0.9990465,0.00004076654,0.00016366731,0.00044594862,0.00016865079,0.00013448433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006047923,0.0002149879,0.0004552461,0.00016637403,0.00008193937,0.00001045925,0.00016149358,0.000114820126,0.000053138872],"category_scores_gemma":[0.000047595247,0.00012769306,0.00008959718,0.00028871096,0.00005595479,0.00008849351,0.00006358501,0.000089912166,0.000003461509],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010080043,0.37339735,0.52709806,0.000019974952,0.00029598788,0.00014911087,0.03710601,0.00000321249,0.032989018,0.00006522908,0.00022953044,0.02763849],"study_design_scores_gemma":[0.16673961,0.020086735,0.7900438,0.00034650238,0.00096770487,0.000046864883,0.0119988695,0.0007633627,0.008625889,0.000031140327,0.00018000556,0.00016955119],"about_ca_topic_score_codex":0.00043506673,"about_ca_topic_score_gemma":0.00041624976,"teacher_disagreement_score":0.3533106,"about_ca_system_score_codex":0.00028029914,"about_ca_system_score_gemma":0.00014104514,"threshold_uncertainty_score":0.5207172},"labels":[],"label_agreement":null},{"id":"W1972168709","doi":"10.1182/blood-2002-01-0099","title":"The role of cytokines in classical Hodgkin lymphoma","year":2002,"lang":"en","type":"review","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":508,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Cytokine; Chemokine; Immune system; Biology; Immunology; Tumor necrosis factor alpha; Cancer research; Lymphoma; T cell; Cell biology","score_opus":0.02666551994444972,"score_gpt":0.2915230698729212,"score_spread":0.2648575499284715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972168709","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005327842,0.99195826,3.204543e-8,0.00006767978,0.00005975159,0.0005942652,0.000022478323,0.000016903432,0.006747838],"genre_scores_gemma":[0.0013541601,0.9977258,0.000040528175,0.00001421881,0.00017791506,0.00024802444,0.00002744185,0.00003232409,0.00037957297],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986405,0.00008421725,0.00053504953,0.0002590718,0.00024009477,0.00024109031],"domain_scores_gemma":[0.9988698,0.00035152683,0.00020036777,0.0004718049,0.00002881886,0.00007769111],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009994322,0.00027546348,0.0013275604,0.000099032804,0.000034946715,0.000014069154,0.00014976638,0.00022282194,0.000033454737],"category_scores_gemma":[0.000072384806,0.00014184054,0.00047477358,0.00024480862,0.00007252401,0.000013287275,0.000056131772,0.00008443073,0.000085980275],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000054275915,0.0022406874,0.0011004863,0.0012745095,0.00032483504,0.00014282297,0.000015642216,6.1140493e-9,3.2454878e-7,0.00045022267,0.00023801855,0.994207],"study_design_scores_gemma":[0.0024689403,0.00017902211,0.0010598628,0.00642325,0.0020944052,0.00023876705,0.000009779646,0.0000012384742,0.00004557049,0.000038574442,0.98732346,0.00011710106],"about_ca_topic_score_codex":0.000034723398,"about_ca_topic_score_gemma":0.000019452473,"teacher_disagreement_score":0.9940899,"about_ca_system_score_codex":0.000102129605,"about_ca_system_score_gemma":0.00019350648,"threshold_uncertainty_score":0.5784089},"labels":[],"label_agreement":null},{"id":"W1972342014","doi":"10.1182/blood-2013-12-541078","title":"Advanced-stage nodular lymphocyte predominant Hodgkin lymphoma compared with classical Hodgkin lymphoma: a matched pair outcome analysis","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"ABVD; Stage (stratigraphy); Lymphoma; Medicine; Vinblastine; Chemotherapy; Hodgkin lymphoma; Oncology; Internal medicine; Pathology; Vincristine; Cyclophosphamide; Biology","score_opus":0.013906570616635564,"score_gpt":0.2567452202686415,"score_spread":0.24283864965200594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972342014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939147,0.00076277903,0.0011468078,0.00089759607,0.00012665734,0.0010069651,0.000098045246,0.00036786814,0.0016785745],"genre_scores_gemma":[0.9883345,0.00007309847,0.008254556,0.0007783771,0.00020549913,0.000426347,0.000261002,0.000112660215,0.0015539865],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955266,0.00023357314,0.0009821035,0.0012595367,0.0009928741,0.0010053045],"domain_scores_gemma":[0.9966985,0.0003152677,0.00043974753,0.0016455827,0.00021325627,0.00068762136],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042045352,0.0008117564,0.002112905,0.0004613321,0.00024182192,0.00011065824,0.00034563435,0.00027457176,0.00023011466],"category_scores_gemma":[0.00012566149,0.0005793755,0.00078197557,0.0012367873,0.00024808574,0.00016430061,0.00015731069,0.000088208515,0.00025026264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002244681,0.01391509,0.94198465,0.00026018644,0.0076403646,0.0018045558,0.00046517086,0.00033414896,0.0013076768,0.0006788477,0.00038005668,0.028984545],"study_design_scores_gemma":[0.09789158,0.0021554164,0.8281367,0.00024644428,0.0140353255,0.0004313693,0.00031070376,0.0055891867,0.024267608,0.00003376318,0.025852798,0.0010491161],"about_ca_topic_score_codex":0.00036853945,"about_ca_topic_score_gemma":0.00023827895,"teacher_disagreement_score":0.11384799,"about_ca_system_score_codex":0.00069328083,"about_ca_system_score_gemma":0.0003642116,"threshold_uncertainty_score":0.9996658},"labels":[],"label_agreement":null},{"id":"W1972426790","doi":"10.1182/blood-2013-06-507152","title":"An RCOR1 loss–associated gene expression signature identifies a prognostically significant DLBCL subgroup","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; McGill University; University of British Columbia; BC Cancer Agency","funders":"Michael Smith Health Research BC","keywords":"Transcriptome; Gene expression profiling; Biology; Gene signature; Diffuse large B-cell lymphoma; Gene expression; Gene; Computational biology; Genetics; Cancer research; Lymphoma; Immunology","score_opus":0.008156474930750095,"score_gpt":0.24005901108896271,"score_spread":0.23190253615821263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972426790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976152,0.00040058003,0.00020610791,0.00036497868,0.00012878377,0.0005690359,0.000031603002,0.00020904373,0.00047467387],"genre_scores_gemma":[0.9974695,0.000055697517,0.0013082239,0.00028017323,0.00025645937,0.00013113255,0.0002839849,0.000046377703,0.00016849361],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982864,0.00010982541,0.00030473163,0.0004856887,0.00043195716,0.0003813875],"domain_scores_gemma":[0.99874216,0.00018112916,0.00011402942,0.00050183083,0.00014981552,0.00031105048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023044554,0.00025176126,0.00039738437,0.00008530609,0.00012906225,0.00007494842,0.00013390962,0.00021676066,0.00012118445],"category_scores_gemma":[0.00036494056,0.00018854383,0.00014686742,0.00016803984,0.000073354466,0.000093261675,0.000045776243,0.00015205046,0.000079660975],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015729546,0.018608492,0.34055978,0.000073918265,0.00034694374,0.0006537945,0.00031565482,0.000004109243,0.6330278,0.0002428078,0.0013516292,0.004657775],"study_design_scores_gemma":[0.00724882,0.001127339,0.5183073,0.0002612933,0.00063902896,0.00005687159,0.00004381972,0.000100704965,0.471394,0.00022969865,0.00035073247,0.00024033528],"about_ca_topic_score_codex":0.000043324828,"about_ca_topic_score_gemma":0.000018042312,"teacher_disagreement_score":0.17774758,"about_ca_system_score_codex":0.000055596396,"about_ca_system_score_gemma":0.00007280648,"threshold_uncertainty_score":0.7688594},"labels":[],"label_agreement":null},{"id":"W1972459469","doi":"10.1182/blood-2011-01-331850","title":"Acute nonlymphocytic leukemia presenting with pancytopenia","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Pancytopenia; Medicine; Population; Bone marrow; Leukemia; Pathology; Acute leukemia; Cytarabine; CD33; Immunology; Basophilic; Myeloid; Gastroenterology; Biology; CD34; Genetics","score_opus":0.01726833773703098,"score_gpt":0.28039639199500405,"score_spread":0.2631280542579731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972459469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97343165,0.00043898236,0.00009071606,0.00025981694,0.000057661622,0.00047924923,0.0000057764837,0.00012930998,0.025106866],"genre_scores_gemma":[0.9872415,0.000057083023,0.004988054,0.00036578366,0.00061190245,0.00005515209,0.000024291703,0.000062666964,0.0065935357],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99820435,0.000041178286,0.0001973276,0.00025813252,0.0004852505,0.0008137424],"domain_scores_gemma":[0.9988804,0.000071642935,0.00006158957,0.00052280026,0.00010187593,0.00036172863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024014253,0.00019251653,0.00031387166,0.000110037385,0.000104825136,0.000031158856,0.00017251274,0.000106622174,0.00017965004],"category_scores_gemma":[0.000075795084,0.00013958095,0.000070664675,0.0003313659,0.00009184209,0.00024427343,0.00013394176,0.0003335008,0.0005371057],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000986196,0.0012990874,0.86859787,0.0004438633,0.0024706197,0.001938932,0.0019383118,0.000003747939,0.10939708,0.00048632844,0.009727977,0.0027099985],"study_design_scores_gemma":[0.050340068,0.0011845046,0.31985727,0.0003946497,0.0041593467,0.01284305,0.0004742489,0.00077915576,0.57373106,0.000038634942,0.035034418,0.0011635751],"about_ca_topic_score_codex":0.000060866972,"about_ca_topic_score_gemma":0.000004709184,"teacher_disagreement_score":0.54874057,"about_ca_system_score_codex":0.0004394174,"about_ca_system_score_gemma":0.00082860555,"threshold_uncertainty_score":0.6903587},"labels":[],"label_agreement":null},{"id":"W1972591005","doi":"10.1182/blood-2004-12-4600","title":"Iron is still hot: hepcidin keeps it ablaze","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Hepcidin; Chemistry; Medicine; Internal medicine; Anemia","score_opus":0.011963623866238737,"score_gpt":0.2530013312302924,"score_spread":0.24103770736405367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972591005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94622815,0.0034822829,0.000036403268,0.0055256844,0.00011589986,0.00021163431,0.000013960905,0.00008996098,0.04429602],"genre_scores_gemma":[0.9765289,0.00045704088,0.0017243064,0.0089136865,0.00060513185,0.000010954745,0.00001728004,0.000029447301,0.011713246],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99904567,0.000015689795,0.00018032006,0.00023146076,0.00024267507,0.0002841546],"domain_scores_gemma":[0.9994243,0.00001700284,0.00003938225,0.000335423,0.000034177032,0.0001497279],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00009963846,0.00013691491,0.00022187961,0.00006451752,0.00003775463,0.000012749637,0.00008419882,0.0000908244,0.0017644378],"category_scores_gemma":[0.000051262923,0.000119081305,0.00008551049,0.000110344925,0.000041393705,0.00007356358,0.00002741248,0.00012842464,0.0010227972],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009064663,0.011745476,0.1019498,0.0010752546,0.00029689423,0.0003428731,0.017213749,0.00003854465,0.07317385,0.004645771,0.64450294,0.14410836],"study_design_scores_gemma":[0.01013748,0.00020454983,0.062238336,0.000047880207,0.0006119794,0.00007638587,0.00042040797,0.00003253295,0.0399723,0.000087722525,0.88583666,0.00033373447],"about_ca_topic_score_codex":0.00005436019,"about_ca_topic_score_gemma":0.000025644773,"teacher_disagreement_score":0.24133372,"about_ca_system_score_codex":0.000009489835,"about_ca_system_score_gemma":0.000047621557,"threshold_uncertainty_score":0.999755},"labels":[],"label_agreement":null},{"id":"W1972651627","doi":"10.1182/blood-2011-04-347328","title":"Tolvaptan inhibition of desmopressin effects on coagulation factors in a patient with decreased von Willebrand factor and polycystic kidney disease","year":2011,"lang":"en","type":"letter","venue":"Blood","topic":"Renal Diseases and Glomerulopathies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital du Sacré-Cœur de Montréal","funders":"National Center for Research Resources","keywords":"Desmopressin; Medicine; Tolvaptan; Von Willebrand factor; Coagulation; Von Willebrand disease; Polycystic kidney disease; Kidney disease; Urology; Internal medicine; Surgery; Kidney; Vasopressin; Platelet","score_opus":0.009026741315877008,"score_gpt":0.2118760066337509,"score_spread":0.2028492653178739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972651627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947909,0.0007732018,0.000008040889,0.0029341953,0.000057729314,0.0009920042,0.00031894664,0.000030119394,0.00009483237],"genre_scores_gemma":[0.9837025,0.00004650843,0.000032311218,0.014792564,0.00015946884,0.000056295747,0.0011291556,0.000051057355,0.000030145786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848086,0.00011021954,0.00032352508,0.00040149412,0.00043019417,0.00025373505],"domain_scores_gemma":[0.9989182,0.00012102951,0.00024364881,0.0002920572,0.000059430626,0.0003656414],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000027363907,0.00036921463,0.00056785374,0.000330288,0.000036684673,0.000018532412,0.000034166558,0.00026751123,0.000029306779],"category_scores_gemma":[0.00022179092,0.00025814818,0.00010759406,0.00013595443,0.00009252673,0.00007503785,0.000020696902,0.000383714,0.0000017319287],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012806151,0.0033512989,0.9213869,0.018559843,0.00071647356,0.0105301505,0.0015415448,0.0000028044235,0.0066483184,0.000016637663,0.021366592,0.0030732688],"study_design_scores_gemma":[0.007994552,0.0024918013,0.952268,0.011780539,0.0016153422,0.000031702006,0.00002103118,0.000014331013,0.022247374,0.0001052119,0.0009391436,0.0004909812],"about_ca_topic_score_codex":0.00014228762,"about_ca_topic_score_gemma":0.0000065293207,"teacher_disagreement_score":0.030881075,"about_ca_system_score_codex":0.000033619115,"about_ca_system_score_gemma":0.00017196857,"threshold_uncertainty_score":0.99998707},"labels":[],"label_agreement":null},{"id":"W1972944880","doi":"10.1182/blood-2013-08-523514","title":"Value of the peripheral blood film: megakaryocytic fragments misidentified by automated counter","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; Polycythemia vera; Peripheral blood; Polycythemia rubra vera; Respiratory system; Internal medicine; Gastroenterology; Anesthesia","score_opus":0.006422099441546095,"score_gpt":0.23366418439696635,"score_spread":0.22724208495542025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972944880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99493515,0.0005605466,0.0000027088147,0.000832666,0.00015175134,0.0009894657,0.000052317726,0.00010311794,0.002372278],"genre_scores_gemma":[0.99544036,0.000051108214,0.0002529632,0.00075854984,0.0000540391,0.00021876048,0.00004515359,0.000029007748,0.0031500538],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99856687,0.00007464587,0.00036271583,0.000290504,0.00043043713,0.00027485157],"domain_scores_gemma":[0.9990727,0.00006482027,0.00013616962,0.0004505177,0.00015281586,0.00012300059],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000075754775,0.00022161803,0.00036790277,0.0000363158,0.000098327575,0.000042078,0.00014451865,0.00009975756,0.0012192449],"category_scores_gemma":[0.000058265377,0.00013552648,0.00016183754,0.00014425928,0.00008378091,0.00008220746,0.000061154955,0.00012712138,0.00011350865],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008356328,0.011663642,0.7571778,0.0003308934,0.0038466905,0.000088195964,0.0013626305,0.000031372223,0.105858326,0.00032588324,0.118964426,0.0002665726],"study_design_scores_gemma":[0.017173776,0.00074371067,0.52903306,0.00043294093,0.0019958343,0.00015467755,0.0001463169,0.0022525142,0.4463922,0.00010393596,0.0012661477,0.00030483972],"about_ca_topic_score_codex":0.00033096317,"about_ca_topic_score_gemma":0.000011241046,"teacher_disagreement_score":0.34053388,"about_ca_system_score_codex":0.000039471764,"about_ca_system_score_gemma":0.00009202996,"threshold_uncertainty_score":0.99969375},"labels":[],"label_agreement":null},{"id":"W1972960063","doi":"10.1182/blood-2013-10-535104","title":"PI3K p110δ uniquely promotes gain-of-function Shp2-induced GM-CSF hypersensitivity in a model of JMML","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Idelalisib; Juvenile myelomonocytic leukemia; PI3K/AKT/mTOR pathway; MAPK/ERK pathway; Cancer research; Protein kinase B; Biology; Signal transduction; Haematopoiesis; Leukemia; Immunology; Cell biology; Stem cell; Chronic lymphocytic leukemia","score_opus":0.03552750516043019,"score_gpt":0.28006651919053577,"score_spread":0.24453901403010558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972960063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885077,0.000024620422,0.0012255427,0.00043206813,0.000027565566,0.0005102591,0.0000073830056,0.000043484717,0.009221371],"genre_scores_gemma":[0.99723935,0.00001094399,0.0022288328,0.00012336687,0.00005469879,0.000019623287,0.000013136014,0.000031369724,0.00027868993],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99849963,0.00016818815,0.0003370977,0.0002902874,0.00039912903,0.00030564994],"domain_scores_gemma":[0.9988883,0.00016728533,0.000115164396,0.0004577347,0.00025643763,0.000115037335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008252017,0.0001522955,0.00045193327,0.00026663893,0.000025394667,0.0000051021407,0.00009677569,0.00017626658,0.000013727618],"category_scores_gemma":[0.0007514295,0.0001362697,0.00009286584,0.0003496938,0.0000880922,0.00008585942,0.00007892827,0.00037780017,0.0000138321375],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003689741,0.0010597528,0.0059825527,0.0003009168,0.00009028389,0.000023121656,0.0004708459,0.00009631232,0.98447007,0.0010443584,0.000078895195,0.0060139447],"study_design_scores_gemma":[0.008350654,0.0016559035,0.022933748,0.00033238227,0.00023946217,0.000060862814,0.00017828972,0.12064795,0.8437858,0.0015430404,0.0000418054,0.00023004944],"about_ca_topic_score_codex":0.0003550209,"about_ca_topic_score_gemma":0.00007170798,"teacher_disagreement_score":0.14068419,"about_ca_system_score_codex":0.00008145879,"about_ca_system_score_gemma":0.00037618168,"threshold_uncertainty_score":0.55569166},"labels":[],"label_agreement":null},{"id":"W1972984893","doi":"10.1182/blood-2005-07-2797","title":"Expression of rearranged TCRγ genes in natural killer cells suggests a minor thymus-dependent pathway of lineage commitment","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Michael Smith Health Research BC","keywords":"Biology; T-cell receptor; Gene rearrangement; Natural killer cell; Interleukin 21; Cell biology; T cell; Molecular biology; Immunology; Gene; Cytotoxic T cell; Genetics; In vitro; Immune system","score_opus":0.009295263676464202,"score_gpt":0.21972846575199803,"score_spread":0.21043320207553384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972984893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98916316,0.007199914,0.000008100495,0.000048693008,0.0021771316,0.0002160875,0.0000047491353,0.000019939629,0.0011622151],"genre_scores_gemma":[0.9884101,0.0002703399,0.000124439,0.000050825874,0.000035776797,0.000014491021,0.000057215773,0.000010293448,0.011026507],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990703,0.00015441088,0.00039600203,0.0001682514,0.000044584565,0.00016648653],"domain_scores_gemma":[0.9994466,0.00006582137,0.00018514271,0.0002295787,0.00006249024,0.0000103915345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014640235,0.00012355461,0.00024360626,0.00012474389,0.00003458325,0.0000031041568,0.00011664666,0.00016093424,0.00081515865],"category_scores_gemma":[0.000019017012,0.00010174415,0.00009110962,0.00006487772,0.00005021778,0.00007376809,0.00005290801,0.00021650318,0.00010845178],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024611573,0.0010663947,0.0008039414,0.000023403289,0.000056620007,0.0000019336944,0.00056457147,0.000011880256,0.9931325,0.00001004827,0.0014613669,0.0026212803],"study_design_scores_gemma":[0.002925786,0.0001761164,0.002669028,0.000080388694,0.00002669232,0.00001393362,0.0002471299,0.000003952633,0.961473,8.470602e-7,0.03228886,0.00009428979],"about_ca_topic_score_codex":0.000098342156,"about_ca_topic_score_gemma":0.000074508855,"teacher_disagreement_score":0.03165947,"about_ca_system_score_codex":0.00001985515,"about_ca_system_score_gemma":0.000021279493,"threshold_uncertainty_score":0.8925415},"labels":[],"label_agreement":null},{"id":"W1973163555","doi":"10.1182/blood-2013-11-536755","title":"Peripheral blood monocyte-derived chemokine blockade prevents murine transfusion-related acute lung injury (TRALI)","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Canadian Blood Services; St. Michael's Hospital","funders":"","keywords":"Transfusion-related acute lung injury; Immunology; Monocyte; Chemokine; Medicine; Chemokine receptor; CCR2; Lung; Inflammation; Pulmonary edema; Internal medicine","score_opus":0.006833574260852277,"score_gpt":0.24327430123116006,"score_spread":0.2364407269703078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973163555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837141,0.00027235676,0.00037673698,0.0032525235,0.000368102,0.001467422,0.000026809996,0.0004966872,0.010025258],"genre_scores_gemma":[0.9895606,0.0010622237,0.0017610205,0.0011713388,0.00030852188,0.00012466044,0.00012714388,0.00010978508,0.005774711],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972192,0.00010683719,0.000708279,0.0007327513,0.0005699704,0.00066296145],"domain_scores_gemma":[0.9985597,0.000028711063,0.00012512667,0.00076438754,0.00008489639,0.00043714314],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031151884,0.00048975454,0.00071915385,0.00020893494,0.00018747113,0.00003963411,0.00028317113,0.00027670406,0.0013455299],"category_scores_gemma":[0.000028745953,0.00043939866,0.00037028905,0.00042648872,0.00009753196,0.00012400036,0.00009690789,0.0005049285,0.000058150497],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011558998,0.013228653,0.011810255,0.0008308015,0.007344955,0.00050609733,0.0016861266,0.000025046793,0.9379813,0.00076856493,0.003055493,0.021606795],"study_design_scores_gemma":[0.08437509,0.0034742376,0.05938219,0.00081189297,0.019014303,0.00077276304,0.0001386611,0.0014979668,0.7978309,0.00034629955,0.030658744,0.0016969799],"about_ca_topic_score_codex":0.000080961116,"about_ca_topic_score_gemma":0.000017965902,"teacher_disagreement_score":0.14015044,"about_ca_system_score_codex":0.00003095898,"about_ca_system_score_gemma":0.000058831087,"threshold_uncertainty_score":0.9998058},"labels":[],"label_agreement":null},{"id":"W1973223786","doi":"10.1182/blood-2003-02-0575","title":"Heparin-induced thrombocytopenia in medical patients","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Heparin-induced thrombocytopenia; Heparin; Medicine; Internal medicine","score_opus":0.024264938157316656,"score_gpt":0.2890987591885726,"score_spread":0.2648338210312559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973223786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9231455,0.000052260875,0.000004279646,0.0003340579,0.000299556,0.00060043053,0.0000030432636,0.00009442831,0.07546645],"genre_scores_gemma":[0.9982527,0.000056667875,0.00040802534,0.00086886977,0.00008591225,0.000052581392,0.000025606247,0.000057591526,0.00019202696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99713975,0.00017080508,0.00062177225,0.0005899802,0.00079060625,0.0006871094],"domain_scores_gemma":[0.9985089,0.000094170995,0.00009162757,0.0006209462,0.00011351322,0.0005708584],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00050426595,0.00032396923,0.000863642,0.0002198344,0.00009030345,0.00003114834,0.00023938634,0.00039203098,0.0017575182],"category_scores_gemma":[0.0009058211,0.00028941742,0.00015492747,0.00058429845,0.000071914495,0.00015483133,0.00009547597,0.0006034858,0.00058802194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048770653,0.0052510942,0.9747862,0.00006999387,0.00019038243,0.0003367039,0.00029215636,1.4070288e-7,0.01299243,0.003496358,0.00020212859,0.0023335896],"study_design_scores_gemma":[0.01737922,0.0006412616,0.91024524,0.00022734731,0.00022191119,0.00017624955,0.00007809327,0.000010254255,0.06575978,0.00035739708,0.0044439407,0.00045928283],"about_ca_topic_score_codex":0.00017895743,"about_ca_topic_score_gemma":0.00020861131,"teacher_disagreement_score":0.07527442,"about_ca_system_score_codex":0.00010615869,"about_ca_system_score_gemma":0.00051379466,"threshold_uncertainty_score":0.9999558},"labels":[],"label_agreement":null},{"id":"W1973595070","doi":"10.1182/blood-2013-12-544015","title":"Deep molecular responses achieved in patients with CML-CP who are switched to nilotinib after long-term imatinib","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Nilotinib; Imatinib; Medicine; Dasatinib; Internal medicine; Imatinib mesylate; Oncology; Myeloid leukemia","score_opus":0.006477699996470823,"score_gpt":0.2363842598865341,"score_spread":0.22990655989006328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973595070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976848,0.00012421166,0.00018231708,0.0003407168,0.0000447718,0.0011504106,0.000013057944,0.00007803478,0.00038168087],"genre_scores_gemma":[0.9959586,0.0000032270977,0.0021320751,0.0011887988,0.000060320846,0.00020264961,0.000059493854,0.00007880823,0.00031597368],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979976,0.00013101118,0.000364083,0.00053435785,0.00048173507,0.00049121573],"domain_scores_gemma":[0.99860984,0.000093344875,0.0001278536,0.0007738588,0.00011116458,0.00028393124],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016386513,0.0003315414,0.0005507936,0.00019670812,0.000035747395,0.000026615802,0.00014818348,0.00012312984,0.00012365587],"category_scores_gemma":[0.00031264246,0.00026356097,0.000077614575,0.00028946146,0.00004174073,0.000073309704,0.0000933802,0.00021276028,0.00015570696],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030635486,0.0015033197,0.99202985,0.00011466893,0.00016690645,0.00034411726,0.00045117133,0.0000057966918,0.00079992105,0.000004228501,0.000023448862,0.0014929987],"study_design_scores_gemma":[0.02535532,0.0013740287,0.96400446,0.0007465152,0.00027246022,0.000018684808,0.000018667333,0.000015298794,0.007862055,0.000007332893,0.000053035626,0.00027216374],"about_ca_topic_score_codex":0.000030842966,"about_ca_topic_score_gemma":0.00015233795,"teacher_disagreement_score":0.028025435,"about_ca_system_score_codex":0.00023371709,"about_ca_system_score_gemma":0.0001302022,"threshold_uncertainty_score":0.99998164},"labels":[],"label_agreement":null},{"id":"W1973911102","doi":"10.1182/blood-2009-06-225573","title":"Linkage of the potent leukemogenic activity of Meis1 to cell-cycle entry and transcriptional regulation of cyclin D3","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Biology; Cyclin A; Cell cycle; Cancer research; Cyclin D1; Cyclin A2; Hox gene; Retinoblastoma protein; Cell growth; Cyclin E; Progenitor cell; Cell biology; Molecular biology; Stem cell; Transcription factor; Genetics; Cell; Gene","score_opus":0.009435480159513076,"score_gpt":0.24848418930992097,"score_spread":0.2390487091504079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973911102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974418,0.000085211665,0.0000805927,0.0007250182,0.000058656067,0.00039326292,0.000039529175,0.000006740551,0.0011691331],"genre_scores_gemma":[0.9983827,0.00002460296,0.0010247233,0.000033094253,0.0000692859,0.0000055839914,0.0000053435842,0.000011595727,0.0004430611],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990506,0.0000506047,0.0002292462,0.00015191581,0.00038708316,0.00013055517],"domain_scores_gemma":[0.99928516,0.000068555535,0.00010367772,0.0003388858,0.0001199116,0.000083779545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002822762,0.000079175035,0.00021750585,0.00007660928,0.000027674598,0.0000022626177,0.00011149108,0.000109333094,0.00008164253],"category_scores_gemma":[0.000094528266,0.000058040467,0.000099456614,0.00016914477,0.00012747564,0.00003854327,0.000055827993,0.0002621386,0.0000020411765],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015761744,0.0004479872,0.008717547,0.00016393069,0.00005410331,8.692312e-7,0.00033770013,0.000012849169,0.98810834,0.00015775165,0.000055022385,0.0017862638],"study_design_scores_gemma":[0.0017461273,0.000101807105,0.3909777,0.00003059846,0.00009383991,0.000010740424,0.000023599454,0.00013484321,0.6067158,0.00006725264,0.000067860696,0.000029793862],"about_ca_topic_score_codex":0.00012999709,"about_ca_topic_score_gemma":0.000032275508,"teacher_disagreement_score":0.38226017,"about_ca_system_score_codex":0.000023518201,"about_ca_system_score_gemma":0.00021686836,"threshold_uncertainty_score":0.23668216},"labels":[],"label_agreement":null},{"id":"W1974018802","doi":"10.1182/blood.v99.2.590","title":"Adoptive transfer of simian immunodeficiency virus (SIV) naıve autologous CD4+ cells to macaques chronically infected with SIV is sufficient to induce long-term nonprogressor status","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"U.S. Public Health Service; National Institutes of Health; Gilead Sciences","keywords":"Simian immunodeficiency virus; Adoptive cell transfer; Immunology; Virology; Peripheral blood mononuclear cell; Immune system; Biology; T cell; Cytotoxic T cell; CD8; Immunotherapy; In vitro","score_opus":0.013926090384408856,"score_gpt":0.24952590741030534,"score_spread":0.23559981702589647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974018802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99333584,0.003155152,0.00017879475,0.0002420669,0.00009183973,0.0013101759,0.00071064953,0.00009902771,0.00087645167],"genre_scores_gemma":[0.9984945,0.00023747637,0.00023826514,0.0001905712,0.000012154927,0.0001560709,0.00009697021,0.00003664504,0.0005373154],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99742895,0.00019763348,0.00043952832,0.0006322731,0.00016492856,0.0011367043],"domain_scores_gemma":[0.9987947,0.00012826736,0.00007098946,0.0005564162,0.0002671893,0.00018243669],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000110786794,0.00037236596,0.00053203385,0.0002467005,0.00019442293,0.000029980469,0.00036965005,0.00027187413,0.001553149],"category_scores_gemma":[0.000046637047,0.00028441727,0.00012858698,0.0005310324,0.00037710054,0.000070271395,0.000117206124,0.00040022194,0.0017267581],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010210933,0.010864284,0.016902931,0.0000896434,0.0013451566,0.0003703207,0.011445286,0.000048933416,0.9462187,0.000057799953,0.0005627653,0.011073082],"study_design_scores_gemma":[0.00553937,0.009972541,0.068366475,0.00013527024,0.00022017275,0.00007549624,0.00018788328,0.0000020802047,0.91348773,0.000001210922,0.0015874045,0.0004243642],"about_ca_topic_score_codex":0.00031645497,"about_ca_topic_score_gemma":0.00032929122,"teacher_disagreement_score":0.051463544,"about_ca_system_score_codex":0.000113768954,"about_ca_system_score_gemma":0.00018095924,"threshold_uncertainty_score":0.9999608},"labels":[],"label_agreement":null},{"id":"W1974074916","doi":"10.1182/blood-2008-11-187757","title":"Expression of the leukemia oncogene Lmo2 is controlled by an array of tissue-specific elements dispersed over 100 kb and bound by Tal1/Lmo2, Ets, and Gata factors","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Christie (Canada)","funders":"Canadian Institutes of Health Research; Kay Kendall Leukaemia Fund; National Science Foundation; University of Cambridge; Cancer Research UK; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"Biology; Haematopoiesis; Enhancer; GATA2; Ectopic expression; Chromatin immunoprecipitation; Cancer research; Transactivation; Transcription factor; Molecular biology; Stem cell; Cell biology; Promoter; Gene expression; Gene; Genetics","score_opus":0.011635494020175082,"score_gpt":0.2793569684929445,"score_spread":0.2677214744727694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974074916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99287546,0.0061958786,0.000017960027,0.000048854927,0.00002234877,0.00041989566,0.00028131908,0.0000039638126,0.00013430358],"genre_scores_gemma":[0.99824667,0.0010559781,0.000041229978,0.00009753931,0.000038679806,0.000007949457,0.00013374281,0.000019260344,0.0003589557],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987327,0.00012483435,0.00027894723,0.00035891926,0.00027076158,0.0002338806],"domain_scores_gemma":[0.99918455,0.000016779524,0.00015453252,0.00048492532,0.000051558905,0.00010762669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018253387,0.0001857925,0.0002797611,0.000028189463,0.00008679441,0.000025482264,0.00023599355,0.0001443388,0.00008194058],"category_scores_gemma":[0.000021010052,0.00013128207,0.000055654727,0.0000665943,0.0001576203,0.000008234246,0.0000628059,0.00008648389,3.8591037e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009995537,0.00034136235,0.0028351275,0.000010992835,0.00006971347,4.6184724e-7,0.000117724754,7.469603e-7,0.9924174,9.3700675e-7,0.0022971346,0.00090883556],"study_design_scores_gemma":[0.00713542,0.0023809467,0.0015660427,0.000017541923,0.000030189378,0.000001547444,0.00007631571,0.000005355515,0.9840176,0.00001569192,0.004612606,0.0001407083],"about_ca_topic_score_codex":0.000027613345,"about_ca_topic_score_gemma":0.000018826062,"teacher_disagreement_score":0.008399775,"about_ca_system_score_codex":0.000012222361,"about_ca_system_score_gemma":0.00006184942,"threshold_uncertainty_score":0.53535277},"labels":[],"label_agreement":null},{"id":"W1974131186","doi":"10.1182/blood-2005-05-2010","title":"“Cubam” goes to the dogs","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine","score_opus":0.01537645059468807,"score_gpt":0.2579214639969631,"score_spread":0.24254501340227502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974131186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9511972,0.00030522476,0.00006929435,0.02166459,0.00023014718,0.00017881143,0.0000025906143,0.00007298845,0.026279163],"genre_scores_gemma":[0.97210133,0.000033403136,0.0008759422,0.016014118,0.0013612055,0.000015633519,0.000005486288,0.000008568007,0.009584284],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99962765,0.000016012224,0.00007425786,0.000102105376,0.00006856682,0.000111394445],"domain_scores_gemma":[0.9996723,0.000024613566,0.000012699199,0.00019925213,0.00002473348,0.00006640668],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000054659202,0.000051774336,0.00008611219,0.000023118559,0.000046415422,0.0000041893845,0.00004490385,0.000034655095,0.0005337064],"category_scores_gemma":[0.00003980039,0.000029781542,0.000040298528,0.000081152466,0.000016720498,0.000013983808,0.000019636653,0.00008017208,0.0018472451],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061538635,0.0028346728,0.029327286,0.00009099667,0.0003807152,0.000096238764,0.0038195834,0.00009174701,0.30263895,0.0044777007,0.5394356,0.11619109],"study_design_scores_gemma":[0.0012811759,0.00030863367,0.038986832,0.0000121856065,0.000071798764,0.00010111302,0.00005846924,0.000013565693,0.0092608305,0.00003043525,0.94981617,0.00005881149],"about_ca_topic_score_codex":0.000010051111,"about_ca_topic_score_gemma":0.00003508924,"teacher_disagreement_score":0.4103805,"about_ca_system_score_codex":0.00000569512,"about_ca_system_score_gemma":0.00001945325,"threshold_uncertainty_score":0.9989299},"labels":[],"label_agreement":null},{"id":"W1974377953","doi":"10.1182/blood-2011-05-353482","title":"Regulation of fibrinolysis by S100A10 in vivo","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"S100 Proteins and Annexins","field":"Biochemistry, Genetics and Molecular Biology","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Dalhousie University; Heart and Stroke Foundation of Canada","keywords":"Plasmin; Angiogenesis; Fibrinolysis; Plasminogen activator; Endothelial stem cell; Matrigel; Cell biology; Tissue plasminogen activator; Immunology; Neovascularization; Biology; In vivo; Cancer research; Medicine; Internal medicine; Endocrinology; In vitro; Biochemistry","score_opus":0.00892205298552876,"score_gpt":0.1983061889854996,"score_spread":0.18938413599997084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974377953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927698,0.00028998146,0.00009163502,0.0000066641774,0.00001228811,0.00005459744,0.000010785692,0.0000033589806,0.0067609157],"genre_scores_gemma":[0.99886715,0.000032500746,0.00048123638,0.000017818344,0.000028897417,0.000006128329,0.000014498933,0.000006311558,0.00054545107],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996476,0.000012375972,0.000102267266,0.00011681359,0.000040402767,0.00008049606],"domain_scores_gemma":[0.99977356,0.0000011585669,0.000038288712,0.00015119507,0.000018183957,0.000017628168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000041640124,0.00004877564,0.000063200605,0.000021905207,0.000008981112,0.0000017662018,0.000061921244,0.00006373743,0.00009548362],"category_scores_gemma":[0.000010549038,0.000047277714,0.000035198867,0.000051721647,0.000020353038,0.0000014769674,0.000027445429,0.000019095884,0.0000021071558],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013465611,0.0001501285,0.014542174,0.0000056722542,0.000014647879,4.7662132e-7,0.000036762613,6.150855e-7,0.98440194,0.000064364394,0.00034148537,0.0004282458],"study_design_scores_gemma":[0.00042258066,0.00011679023,0.015887406,0.000006338569,0.000008848748,0.0000016197329,0.000016928894,0.0000033340264,0.9812917,0.00006685766,0.0021201398,0.000057419435],"about_ca_topic_score_codex":0.00008564466,"about_ca_topic_score_gemma":0.000029895104,"teacher_disagreement_score":0.006215465,"about_ca_system_score_codex":0.0000011111333,"about_ca_system_score_gemma":0.000009754629,"threshold_uncertainty_score":0.19279292},"labels":[],"label_agreement":null},{"id":"W1974514343","doi":"10.1182/blood-2004-03-0781","title":"Rac1 is the small GTPase responsible for regulating the neutrophil chemotaxis compass","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Cellular Mechanics and Interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":198,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Chemotaxis; RAC1; Biology; Cell biology; Chemokinesis; Conditional gene knockout; Signal transduction; Genetics; Receptor; Gene; Phenotype","score_opus":0.016574255502644956,"score_gpt":0.24114984984473956,"score_spread":0.2245755943420946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974514343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835868,0.0005746136,0.003962388,0.010519211,0.0001847839,0.0003958521,0.00003348695,0.00001281976,0.0007300763],"genre_scores_gemma":[0.9955001,0.00004828874,0.0015463611,0.0013344459,0.00036400554,0.00006453832,0.00004384872,0.000022502956,0.0010758967],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99935347,0.000029609235,0.00014766041,0.00021643336,0.000066066204,0.0001867859],"domain_scores_gemma":[0.99930257,0.00003298796,0.00007366914,0.0004893212,0.00006595657,0.000035516885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020481023,0.000106781066,0.00007878464,0.000014219854,0.0003148442,0.000045910925,0.00023112824,0.00006960445,0.000016984859],"category_scores_gemma":[0.00008143014,0.00006719574,0.00015078144,0.000067998495,0.00003568982,0.0000020616894,0.0000884073,0.00009405536,0.0000081020935],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000068222995,0.00014526237,0.000016018548,0.000007670815,0.000081106744,0.00000109778,0.000106705906,0.00007527002,0.99292517,0.0047309846,0.0014657622,0.00037675226],"study_design_scores_gemma":[0.0011134096,0.00018673114,0.00010325309,0.0000106829075,0.000058313282,0.000037775284,0.00010494301,0.00015508501,0.89310604,0.0019248204,0.1030953,0.00010365418],"about_ca_topic_score_codex":0.00003755728,"about_ca_topic_score_gemma":0.0000632674,"teacher_disagreement_score":0.10162954,"about_ca_system_score_codex":0.00000739987,"about_ca_system_score_gemma":0.000073058756,"threshold_uncertainty_score":0.27401626},"labels":[],"label_agreement":null},{"id":"W1974537911","doi":"10.1182/blood.v97.7.1960","title":"Human homologues of Delta-1 and Delta-4 function as mitogenic regulators of primitive human hematopoietic cells","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":165,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Amgen","keywords":"Biology; Haematopoiesis; Cell biology; Stromal cell; Delta; Induced pluripotent stem cell; Progenitor cell; Immunology; Stem cell; Cancer research; Embryonic stem cell; Genetics","score_opus":0.010548643163577665,"score_gpt":0.24811424916511868,"score_spread":0.237565606001541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974537911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99618953,0.0025058726,0.0002109441,0.000007969558,0.00004049777,0.00014298467,0.000013109662,0.000006526167,0.0008825859],"genre_scores_gemma":[0.9990864,0.00025278635,0.00025803418,0.000011435336,0.00006832412,0.0000071466898,0.00009486567,0.000017211993,0.00020381784],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991574,0.00005393507,0.00028733152,0.0002468702,0.00011328814,0.00014113242],"domain_scores_gemma":[0.9993779,0.000009006641,0.00018243969,0.00025595137,0.000121970974,0.00005272506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014277313,0.0001238183,0.00018153251,0.000057280155,0.00006949753,0.0000065022336,0.0000804183,0.00015755478,0.000016375883],"category_scores_gemma":[0.000020477768,0.00012417694,0.00008084001,0.00007697681,0.00012586679,0.0000031418035,0.00006258991,0.00004578986,0.000001158739],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017878616,0.00019594641,0.014537898,0.000034500743,0.00008873116,0.0000015741178,0.000068971116,0.000011693577,0.9845007,0.00027639495,0.000017062865,0.00024861345],"study_design_scores_gemma":[0.0007684299,0.00084113894,0.027973138,0.00001729298,0.00014114795,0.000008021678,0.00007451776,0.0000016631892,0.9685071,0.0011693013,0.0003756406,0.00012262275],"about_ca_topic_score_codex":0.00006636581,"about_ca_topic_score_gemma":0.000050136194,"teacher_disagreement_score":0.015993651,"about_ca_system_score_codex":0.0000032843068,"about_ca_system_score_gemma":0.000023119905,"threshold_uncertainty_score":0.5063788},"labels":[],"label_agreement":null},{"id":"W1974674483","doi":"10.1182/blood-2006-04-015560","title":"A phase 2 trial of the FLT3 inhibitor lestaurtinib (CEP701) as first-line treatment for older patients with acute myeloid leukemia not considered fit for intensive chemotherapy","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":413,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Myeloid leukemia; Medicine; Internal medicine; Fms-Like Tyrosine Kinase 3; Tyrosine-kinase inhibitor; Chemotherapy; Adverse effect; Oncology; Pharmacology; Leukemia; Chemotherapy regimen; Cancer; Biology; Mutation","score_opus":0.026505635100703077,"score_gpt":0.3123375602894287,"score_spread":0.28583192518872563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974674483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854622,0.000049826915,0.00022503115,0.0031161106,0.00016182553,0.010070531,0.0007184701,0.00005165278,0.00014437063],"genre_scores_gemma":[0.9914669,0.000040262923,0.0024587042,0.0009980884,0.0007864646,0.001303474,0.00038592954,0.000119384094,0.0024407883],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.997756,0.00004250314,0.0006323559,0.0005161437,0.00050439424,0.00054858025],"domain_scores_gemma":[0.9972055,0.0004922966,0.00035691075,0.0006421154,0.0011559129,0.00014724322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016465878,0.0003854419,0.0007682107,0.0001225066,0.00017551836,0.000025921088,0.00018359369,0.00019971536,0.000053111067],"category_scores_gemma":[0.00039631597,0.00022960058,0.00038129432,0.00023263799,0.00024592958,0.00007011835,0.00004837281,0.0001779111,0.000007677048],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.81795603,0.03682878,0.0038653917,0.00068160833,0.0068153804,0.00013828234,0.002889372,0.00004092909,0.048574418,0.0002661219,0.05009153,0.03185216],"study_design_scores_gemma":[0.62789315,0.01660444,0.0009397722,0.00016896892,0.0012335266,0.000035434598,0.00013037099,0.00017597123,0.3447972,0.00009453986,0.007683102,0.00024351977],"about_ca_topic_score_codex":0.00024834764,"about_ca_topic_score_gemma":0.00009894035,"teacher_disagreement_score":0.29622278,"about_ca_system_score_codex":0.0004957649,"about_ca_system_score_gemma":0.0012342079,"threshold_uncertainty_score":0.936284},"labels":[],"label_agreement":null},{"id":"W1974810176","doi":"10.1182/blood.v97.3.585","title":"Telomerase and T-cell function","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute","funders":"","keywords":"Telomerase; Telomere; Medicine; Cancer research; Biology; Genetics; DNA","score_opus":0.010993481266767453,"score_gpt":0.22150159514927523,"score_spread":0.21050811388250779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974810176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855848,0.0017383101,0.00007560779,0.00035560748,0.00011485303,0.00015488388,0.0000021880921,0.00010655913,0.011867179],"genre_scores_gemma":[0.99407846,0.0007041255,0.00036992048,0.00075267156,0.00024619835,0.000007622109,0.000012322495,0.0000174856,0.0038111832],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992409,0.000015626607,0.00014331732,0.00023218858,0.0001573286,0.00021065399],"domain_scores_gemma":[0.9995051,0.000027877624,0.000033715518,0.0002154855,0.00004229086,0.00017552535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007725693,0.00011696328,0.00016833917,0.0000875862,0.000072798095,0.000016470005,0.000034228757,0.00006920453,0.00022861293],"category_scores_gemma":[0.000031729047,0.000101190795,0.000039627146,0.00018246779,0.000048821097,0.00006760561,0.000019179708,0.000120111894,0.00011585245],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005172275,0.0024089203,0.66908365,0.00023519593,0.00012030679,0.00083948014,0.00045847232,6.824884e-7,0.25992113,0.00024194988,0.003667202,0.06250576],"study_design_scores_gemma":[0.015696222,0.001531191,0.72303057,0.00014476404,0.00088674366,0.0019528496,0.0005458885,0.00007168791,0.07677402,0.00030246555,0.17845039,0.000613186],"about_ca_topic_score_codex":0.000040338484,"about_ca_topic_score_gemma":0.000009184281,"teacher_disagreement_score":0.18314712,"about_ca_system_score_codex":0.000007887447,"about_ca_system_score_gemma":0.000033863816,"threshold_uncertainty_score":0.4126441},"labels":[],"label_agreement":null},{"id":"W1974829928","doi":"10.1182/blood-2012-12-466375","title":"Bleeding manifestations and management of children with persistent and chronic immune thrombocytopenia: data from the Intercontinental Cooperative ITP Study Group (ICIS)","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Immune thrombocytopenia; Medicine; Pediatrics; Immunology; Internal medicine; Platelet","score_opus":0.021984498556270122,"score_gpt":0.25363958554197985,"score_spread":0.23165508698570972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974829928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956727,0.0022463542,0.000008648287,0.00024055023,0.000011926245,0.0014654502,0.00006720435,0.000009683947,0.00027746067],"genre_scores_gemma":[0.99875695,0.00057160493,0.0002497956,0.000023240911,0.000014901458,0.000044049157,0.00027598624,0.000010599535,0.000052858322],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99937063,0.00001961456,0.00014604494,0.00024407754,0.00011344238,0.000106172454],"domain_scores_gemma":[0.99957174,0.000023857687,0.00005355362,0.0002911456,0.000024263845,0.000035414738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000051575124,0.000115286326,0.00023078594,0.000018509962,0.00010065348,0.00003758104,0.00010408596,0.00001584693,0.000063047766],"category_scores_gemma":[0.00000236183,0.00006610328,0.000017007627,0.000052183863,0.00007514167,0.00015134233,0.00022323422,0.00006545752,0.000005190929],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000112845155,0.0050101993,0.9719455,0.00006854282,0.012877776,0.00024163716,0.0044544945,0.0000013896098,0.0021579897,0.00008207905,0.00019054353,0.0028569815],"study_design_scores_gemma":[0.009859915,0.001319938,0.97542256,0.00016971896,0.0021335161,0.00014524873,0.010636508,0.000101481695,0.0001226092,0.0000048272145,0.000005130331,0.000078523546],"about_ca_topic_score_codex":0.0011562146,"about_ca_topic_score_gemma":0.00047115094,"teacher_disagreement_score":0.010744261,"about_ca_system_score_codex":0.000011559475,"about_ca_system_score_gemma":0.000008882571,"threshold_uncertainty_score":0.26956135},"labels":[],"label_agreement":null},{"id":"W1974942455","doi":"10.1182/blood-2010-04-278887","title":"Esterified eicosanoids are acutely generated by 5-lipoxygenase in primary human neutrophils and in human and murine infection","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Wellcome Trust","keywords":"Biochemistry; Extracellular; Lipopolysaccharide; Syk; Phospholipase A2; Arachidonate 5-lipoxygenase; Phosphatidylethanolamine; Biology; Zymosan; Phosphatidylcholine; Chemistry; Molecular biology; Arachidonic acid; Immunology; Phospholipid; Signal transduction; Enzyme; Tyrosine kinase","score_opus":0.00911945408773826,"score_gpt":0.225525486606792,"score_spread":0.21640603251905374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974942455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986615,0.0005340309,0.0000037427053,0.000120724646,0.0001474441,0.00030771876,0.000035229918,0.0000511408,0.0001384267],"genre_scores_gemma":[0.9990306,0.00011692338,0.000040266706,0.00022131776,0.000043088887,0.00004703047,0.0002449335,0.000024965622,0.00023087265],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99874353,0.00015554945,0.0003101333,0.00044083706,0.000027877539,0.0003220405],"domain_scores_gemma":[0.99958533,0.000022520237,0.00010352986,0.00021935614,0.000030121082,0.000039171424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017213191,0.00024190386,0.00034862614,0.00023331714,0.00017027235,0.000032766602,0.000090635454,0.00031109957,0.000073459094],"category_scores_gemma":[0.000011738602,0.0002290914,0.00002668157,0.00016767225,0.00015284948,0.00014745556,0.00011500398,0.0005696629,0.000011965904],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050468938,0.00049366365,0.031976774,0.000026897174,0.000039205806,0.00005091656,0.00009397818,2.525777e-7,0.9665977,0.0002651378,0.00008477172,0.0003202672],"study_design_scores_gemma":[0.004193872,0.00021783315,0.30073592,0.000025095225,0.000026326314,0.00007524571,0.000013292612,2.694282e-7,0.6938388,0.00015772202,0.00051433645,0.00020130108],"about_ca_topic_score_codex":0.00026447893,"about_ca_topic_score_gemma":0.0009103358,"teacher_disagreement_score":0.2727589,"about_ca_system_score_codex":0.000014327474,"about_ca_system_score_gemma":0.000016683438,"threshold_uncertainty_score":0.9342076},"labels":[],"label_agreement":null},{"id":"W1975136159","doi":"10.1182/blood-2009-11-252072","title":"Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":254,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Institutes of Health","keywords":"Medicine; Monoclonal gammopathy of undetermined significance; Venous thrombosis; Thrombosis; Hazard ratio; Internal medicine; Gastroenterology; Multiple myeloma; Population; Macroglobulinemia; Confidence interval; Monoclonal; Immunology; Monoclonal antibody; Antibody","score_opus":0.021975873521951683,"score_gpt":0.2930616481460501,"score_spread":0.27108577462409844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975136159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99899423,0.00003588721,0.0000023323341,0.00004347693,0.000038324182,0.0008119741,0.000035464436,0.000014487816,0.000023794799],"genre_scores_gemma":[0.9989347,0.0000032861187,0.00091029814,0.000009556761,0.000047789526,0.00004563269,0.000030220517,0.000012604367,0.0000059420177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914783,0.000041522107,0.00020489795,0.00023749191,0.00019125051,0.0001770205],"domain_scores_gemma":[0.99945784,0.00014479081,0.00005456743,0.0001839233,0.000036483172,0.00012239747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001155747,0.0001126491,0.00028528692,0.00011310503,0.00004006011,0.000013216148,0.000036793535,0.00005339041,0.00001799625],"category_scores_gemma":[0.00015905157,0.00009605025,0.000024305697,0.00009512584,0.00004886264,0.00003894816,0.000022857776,0.00011797429,9.396785e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003800947,0.003405413,0.9206408,0.000049341932,0.000054322423,0.000080534344,0.00022059897,6.1959827e-7,0.0738854,0.0000025742486,5.493488e-7,0.001279742],"study_design_scores_gemma":[0.016181307,0.0011473043,0.9752971,0.000027252794,0.00007674778,0.00001049244,0.00006653404,0.0006513126,0.006448141,0.000018390947,0.0000019629365,0.00007348996],"about_ca_topic_score_codex":0.0009479196,"about_ca_topic_score_gemma":0.0014482083,"teacher_disagreement_score":0.06743727,"about_ca_system_score_codex":0.000010937379,"about_ca_system_score_gemma":0.000065333246,"threshold_uncertainty_score":0.39168155},"labels":[],"label_agreement":null},{"id":"W1975166737","doi":"10.1182/blood-2007-10-120204","title":"Characterization of primitive hematopoietic cells from patients with dyskeratosis congenita","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health; National Cancer Institute; National Institute for Health and Care Research","keywords":"Dyskeratosis congenita; CD34; Haematopoiesis; Telomerase; Biology; Clonogenic assay; Bone marrow; Telomere; Stem cell; Immunology; Bone marrow failure; Molecular biology; Cancer research; Genetics; In vitro; Gene","score_opus":0.008894802524139328,"score_gpt":0.18866592214874547,"score_spread":0.17977111962460615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975166737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990524,0.00004554038,0.00007131002,0.000031800915,0.000055725726,0.00033891128,0.00011539353,0.00003644776,0.00025245472],"genre_scores_gemma":[0.9988404,0.00006710459,0.00050383154,0.00014098304,0.00004943592,0.000010216705,0.00025862097,0.000020713556,0.00010867879],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991326,0.000023456498,0.0002185853,0.00020815445,0.00027070596,0.00014650088],"domain_scores_gemma":[0.99932384,0.000032825184,0.00011947721,0.00023289853,0.00019615008,0.00009478058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000020082343,0.0001275445,0.00028409055,0.000059016496,0.000049513208,0.0000043684154,0.000056596524,0.00006141074,0.00010981282],"category_scores_gemma":[0.00001800045,0.000101981495,0.000040293973,0.0001572725,0.00009699217,0.00007485638,0.000015921903,0.0000751706,0.000027007947],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012857304,0.0011637085,0.4546073,0.00004417515,0.000113110465,0.000033398952,0.0012733503,5.7304927e-8,0.542389,0.000007847206,0.00001730155,0.00022220529],"study_design_scores_gemma":[0.0022796176,0.00019433694,0.5134977,0.00007036406,0.0001239175,0.0000066434604,0.000030615098,0.0000016904914,0.483664,0.0000014511725,0.000054545853,0.0000751301],"about_ca_topic_score_codex":0.00003590847,"about_ca_topic_score_gemma":0.0000037577272,"teacher_disagreement_score":0.05889038,"about_ca_system_score_codex":0.000009882627,"about_ca_system_score_gemma":0.0000695798,"threshold_uncertainty_score":0.41586846},"labels":[],"label_agreement":null},{"id":"W1975205173","doi":"10.1182/blood-2006-11-060103","title":"Leukocyte PI3Kγ and PI3Kδ have temporally distinct roles for leukocyte recruitment in vivo","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research; Alberta Heritage Foundation for Medical Research; Fondation pour la Recherche Médicale; Heart and Stroke Foundation of Canada","keywords":"PI3K/AKT/mTOR pathway; Intravital microscopy; CXCL1; Chemokine; CXCL2; Immunology; Biology; Leukocyte Trafficking; CXC chemokine receptors; In vivo; Cell biology; Inflammation; Chemokine receptor; Signal transduction","score_opus":0.058990696329966126,"score_gpt":0.3467727978099338,"score_spread":0.2877821014799677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975205173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99169844,0.0012017867,0.00044168305,0.0007155498,0.000038817052,0.0018691374,0.000015481399,0.000051527655,0.0039675585],"genre_scores_gemma":[0.99141407,0.0001571179,0.003679491,0.00034349403,0.00017310366,0.00016862636,0.00003455143,0.00005301596,0.003976524],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998166,0.00003877527,0.00040463448,0.00044049678,0.00040519482,0.00054489897],"domain_scores_gemma":[0.99896365,0.00023431936,0.00007281839,0.00033597296,0.00009983885,0.00029342106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078059867,0.00020211122,0.00035270475,0.00024603956,0.00007980462,0.000031817046,0.000115840776,0.00012476824,0.0000734654],"category_scores_gemma":[0.00024075307,0.00017590885,0.000090809786,0.00016090045,0.000096005344,0.000048131027,0.00008832269,0.0002266395,0.000013941425],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039613945,0.0032027555,0.35282657,0.0008895103,0.00027688022,0.0024037585,0.0011208607,0.0000032804676,0.5818863,0.00033138768,0.0076661184,0.045431197],"study_design_scores_gemma":[0.01633818,0.001699437,0.13808438,0.00027928638,0.00015692205,0.0001443847,0.00047408452,0.00017556381,0.7339955,0.00026517385,0.108000554,0.00038649942],"about_ca_topic_score_codex":0.00009985432,"about_ca_topic_score_gemma":0.0009856283,"teacher_disagreement_score":0.21474217,"about_ca_system_score_codex":0.000120177,"about_ca_system_score_gemma":0.00012275735,"threshold_uncertainty_score":0.71733546},"labels":[],"label_agreement":null},{"id":"W1975255631","doi":"10.1182/blood-2005-03-1081","title":"Human short-term repopulating stem cells are efficiently detected following intrafemoral transplantation into NOD/SCID recipients depleted of CD122+ cells","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":145,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Nod; Severe combined immunodeficiency; Stem cell; Xenotransplantation; Biology; Transplantation; Immunology; Haematopoiesis; Hematopoietic stem cell transplantation; Cancer research; Medicine; Cell biology; Internal medicine; In vivo","score_opus":0.03223495299473983,"score_gpt":0.30503650529350723,"score_spread":0.2728015522987674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975255631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99754333,0.00014214267,0.00016492246,0.00003220617,0.00020793822,0.00094920624,0.000012246424,0.00012498416,0.00082301925],"genre_scores_gemma":[0.9969967,0.000008730412,0.0022840758,0.000023763454,0.00018551548,0.00002518387,0.000051329163,0.000065138236,0.0003595352],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99657434,0.00017963702,0.0009701357,0.00059247663,0.001083789,0.000599633],"domain_scores_gemma":[0.99859816,0.00010584915,0.00025870293,0.00054345146,0.00019467495,0.0002991764],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00060546165,0.00029120065,0.00058479584,0.00032900376,0.00021433811,0.000040424322,0.0002460804,0.00020966034,0.00007337557],"category_scores_gemma":[0.000047266036,0.0002777524,0.0002481726,0.0005644836,0.000063337124,0.00012614213,0.00006345678,0.00039740652,0.00003429465],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000104870654,0.00060123036,0.1117677,0.0004602324,0.000117673044,0.0003295694,0.0012190591,0.00007325679,0.8819844,0.0000022049471,0.00001677933,0.003323004],"study_design_scores_gemma":[0.0036600514,0.00041862487,0.07820595,0.000775418,0.00038233085,0.000048137765,0.00021200387,0.0007438676,0.9152846,0.0000029079931,0.0000191486,0.00024698157],"about_ca_topic_score_codex":0.00009561831,"about_ca_topic_score_gemma":0.00018049411,"teacher_disagreement_score":0.03356175,"about_ca_system_score_codex":0.00013321872,"about_ca_system_score_gemma":0.00006592291,"threshold_uncertainty_score":0.99996746},"labels":[],"label_agreement":null},{"id":"W1975300821","doi":"10.1182/blood-2003-03-0869","title":"Hfe deficiency increases susceptibility to cardiotoxicity and exacerbates changes in iron metabolism induced by doxorubicin","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":168,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Saint-Luc; Hôpital Notre-Dame","funders":"Canadian Institutes of Health Research","keywords":"Cardiotoxicity; Doxorubicin; Anthracycline; Endocrinology; Cardiomyopathy; Hereditary hemochromatosis; Hemochromatosis; Internal medicine; Toxicity; Chemistry; Pharmacology; Medicine; Heart failure; Cancer; Chemotherapy","score_opus":0.011915474918678472,"score_gpt":0.2471634753834342,"score_spread":0.23524800046475572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975300821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878356,0.008418559,0.000009148796,0.0002826275,0.00007219161,0.0006671707,0.000026277841,0.000052368436,0.0026360753],"genre_scores_gemma":[0.9982971,0.00036329543,0.00039896145,0.00070591585,0.00005106238,0.00004565077,0.000012377763,0.000023055782,0.000102558],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99837005,0.0001822301,0.00024416592,0.0004949033,0.00027202364,0.0004366136],"domain_scores_gemma":[0.99918574,0.0000688273,0.000046605262,0.00038111318,0.00004722167,0.000270519],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054270675,0.00023715917,0.00051477016,0.0001770292,0.00006985077,0.000022347824,0.000079648715,0.00013322406,0.000085111635],"category_scores_gemma":[0.0006644275,0.00020595368,0.000052583087,0.00040416053,0.000070380025,0.00007282832,0.000049409533,0.00017261252,0.000013838352],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001278473,0.002209887,0.28914323,0.0002513205,0.000019720628,0.000020136877,0.0011572159,0.0000018955359,0.7029924,0.00071823096,0.00045953077,0.0028985776],"study_design_scores_gemma":[0.007093725,0.0003624644,0.63272434,0.0000472678,0.00036215957,0.00003416337,0.001510675,0.0000014000535,0.35413826,0.00017928486,0.0030968445,0.00044940138],"about_ca_topic_score_codex":0.0015292647,"about_ca_topic_score_gemma":0.00080055045,"teacher_disagreement_score":0.34885412,"about_ca_system_score_codex":0.000018931969,"about_ca_system_score_gemma":0.00007085146,"threshold_uncertainty_score":0.8398548},"labels":[],"label_agreement":null},{"id":"W1975459435","doi":"10.1182/blood-2009-10-250225","title":"End-of-life experience of children undergoing stem cell transplantation for malignancy: parent and provider perspectives and patterns of care","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Medicine; Transplantation; Cancer; Quality of life (healthcare); Childhood cancer; Malignancy; Pediatrics; Intensive care medicine; Family medicine; Internal medicine; Nursing","score_opus":0.01668995039300007,"score_gpt":0.2819699852210871,"score_spread":0.26528003482808704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975459435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962841,0.0025281464,0.0002755893,0.000099520796,0.00004177265,0.00054939213,0.00016725359,0.000010468201,0.000043718686],"genre_scores_gemma":[0.99871886,0.00031953253,0.00082858227,0.000023079054,0.000050026498,0.000022909979,0.000016756758,0.000013318922,0.0000069434514],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992036,0.000023960549,0.00028722547,0.00021034467,0.00017363524,0.000101228245],"domain_scores_gemma":[0.99937016,0.0001312843,0.00018061922,0.00015245784,0.000096140124,0.000069349386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000082944534,0.00009933263,0.0002898252,0.000048394668,0.000025679594,0.000004363714,0.000045415414,0.000052535506,0.000007857902],"category_scores_gemma":[0.000025668216,0.000091949194,0.000048600203,0.000035806723,0.000089146975,0.000058421723,0.000013776025,0.00006531286,4.0211724e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001494865,0.00025842313,0.8126525,0.0040514832,0.00007429823,7.989304e-7,0.1618007,4.9455e-7,0.020002168,0.00020891607,0.0000013775857,0.00079929904],"study_design_scores_gemma":[0.004769341,0.0005985041,0.6612518,0.00058921566,0.0002511023,0.000017507124,0.051847123,0.000002348577,0.28054076,0.000016808344,0.0000037305467,0.000111783615],"about_ca_topic_score_codex":0.00035042682,"about_ca_topic_score_gemma":0.0006413467,"teacher_disagreement_score":0.26053858,"about_ca_system_score_codex":0.0000045543457,"about_ca_system_score_gemma":0.00011915028,"threshold_uncertainty_score":0.37495792},"labels":[],"label_agreement":null},{"id":"W1975556282","doi":"10.1182/blood-2012-11-462903","title":"Acute promyelocytic leukemia presenting as a mass in the external ear","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Acute promyelocytic leukemia; Arsenic trioxide; Medicine; Leukemia; Tretinoin; Hematopoietic stem cell transplantation; Complete remission; Acute leukemia; Chemotherapy; Transplantation; Internal medicine; Retinoic acid; Arsenic; Biology; Chemistry","score_opus":0.011007683364207098,"score_gpt":0.25500680706866163,"score_spread":0.24399912370445453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975556282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99241483,0.00028928326,0.000002830049,0.0009313444,0.000029141407,0.0007234204,0.0000011175371,0.00002297034,0.00558508],"genre_scores_gemma":[0.99786353,0.000046360194,0.0005572912,0.00035401242,0.000118718,0.00035692067,0.000004020226,0.000012591763,0.000686532],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99922013,0.000029671191,0.00014935312,0.00016446887,0.00021773654,0.0002186587],"domain_scores_gemma":[0.9995663,0.000058616617,0.000037539958,0.0002558525,0.000023963255,0.00005771135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007759807,0.000100146994,0.00014442978,0.000043259653,0.000040026913,0.000051691768,0.00009375355,0.000039663166,0.0001974279],"category_scores_gemma":[0.000030913183,0.000059214683,0.000067468805,0.00010418913,0.00002208805,0.0000580566,0.000028033439,0.00008873,0.00042992245],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004421801,0.0022616396,0.94976944,0.000088723486,0.00051959965,0.0035112966,0.0022198139,0.0000030657845,0.019836236,0.0004936279,0.0016041194,0.019648202],"study_design_scores_gemma":[0.005650179,0.00022823442,0.974029,0.00015103353,0.00038491536,0.00071641756,0.00020247683,0.00016389559,0.01719447,0.000627932,0.00055464654,0.000096787386],"about_ca_topic_score_codex":0.0005994257,"about_ca_topic_score_gemma":0.0000111078825,"teacher_disagreement_score":0.024259552,"about_ca_system_score_codex":0.00007375184,"about_ca_system_score_gemma":0.0000997795,"threshold_uncertainty_score":0.5525927},"labels":[],"label_agreement":null},{"id":"W1975897275","doi":"10.1182/blood-2011-10-378950","title":"How I treat with anticoagulants in 2012: new and old anticoagulants, and when and how to switch","year":2012,"lang":"en","type":"review","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":247,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Rivaroxaban; Dabigatran; Medicine; Warfarin; Intensive care medicine; Drug; Anticoagulant; Pharmacology; Surgery; Atrial fibrillation; Internal medicine","score_opus":0.1104744454588444,"score_gpt":0.33001583953472613,"score_spread":0.21954139407588175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975897275","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012354454,0.9836012,0.000026025258,0.0022004386,0.00006177699,0.0015246844,0.000012611547,0.00003744615,0.00018135773],"genre_scores_gemma":[0.0023578194,0.97916335,0.000994281,0.000072901574,0.0007873157,0.000005504191,0.000041087867,0.00006047287,0.016517274],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986643,0.00005597855,0.0002238582,0.00046660393,0.00023005423,0.00035916767],"domain_scores_gemma":[0.99905276,0.00011152759,0.00015310783,0.00030072988,0.000020929527,0.0003609209],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017408095,0.00043715158,0.0018281509,0.000351598,0.00004464539,0.00016930634,0.00006339824,0.00021040802,0.000014537675],"category_scores_gemma":[0.000051771385,0.00028945963,0.000074328105,0.00020049168,0.000044408745,0.0002192764,0.00012910954,0.00015875004,0.0000059598797],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050275863,0.000029467097,0.21816126,0.009031422,0.0004405149,0.000088618115,0.00016404218,9.2846495e-9,0.000006877241,0.000115113835,0.0007788203,0.7711336],"study_design_scores_gemma":[0.004664918,0.0002938611,0.03714106,0.006334173,0.0068815686,0.0003645072,0.000048042595,0.0000011319261,0.000005867159,0.000018200144,0.9437272,0.0005194899],"about_ca_topic_score_codex":0.00004986802,"about_ca_topic_score_gemma":0.00006188207,"teacher_disagreement_score":0.94294834,"about_ca_system_score_codex":0.000013977605,"about_ca_system_score_gemma":0.000052984913,"threshold_uncertainty_score":0.9999558},"labels":[],"label_agreement":null},{"id":"W1975959396","doi":"10.1182/blood-2013-01-476614","title":"Effectiveness of supportive care measures to reduce infections in pediatric AML: a report from the Children’s Oncology Group","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Medicine; Internal medicine; Oncology; Pediatric oncology; Hematologic Neoplasms; Chemotherapy regimen; Pediatrics; Intensive care medicine; Cancer","score_opus":0.011158937066189697,"score_gpt":0.2855691205541328,"score_spread":0.2744101834879431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975959396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99495417,0.00039748813,0.00003734963,0.00027802738,0.000243674,0.0014059441,0.0000213449,0.000039390845,0.0026226025],"genre_scores_gemma":[0.9986722,0.000062721236,0.00006279835,0.000078635974,0.0002926279,0.00074838626,0.000042972704,0.000017695524,0.000021985155],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988736,0.00020069614,0.00029897058,0.000279128,0.00016482272,0.00018277564],"domain_scores_gemma":[0.99895066,0.00027575984,0.0001118893,0.0003511455,0.0002140457,0.00009652353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021526046,0.00011909012,0.000307211,0.00012461703,0.00006709716,0.00000979784,0.00008223012,0.000089594614,0.00009447234],"category_scores_gemma":[0.0002557445,0.00008667488,0.00010097734,0.00046912016,0.000045281617,0.00006120773,0.00004940713,0.0002376602,0.00003795208],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058093417,0.0007689093,0.98520434,0.000039006252,0.00010496305,0.00003812855,0.00070402556,0.000009197663,0.011412733,0.0000226113,0.0004599218,0.0011780909],"study_design_scores_gemma":[0.002066906,0.0007200982,0.9824432,0.0000625347,0.00043198277,0.00030186932,0.00024695208,8.2143174e-8,0.013243949,0.00006471362,0.00033130476,0.00008640423],"about_ca_topic_score_codex":0.010015791,"about_ca_topic_score_gemma":0.0015218365,"teacher_disagreement_score":0.008493955,"about_ca_system_score_codex":0.000113175476,"about_ca_system_score_gemma":0.0002750366,"threshold_uncertainty_score":0.9965766},"labels":[],"label_agreement":null},{"id":"W1976158989","doi":"10.1182/blood-2010-06-288001","title":"Eradication of neutralizing antibodies to factor VIII in canine hemophilia A after liver gene therapy","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":156,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; U.S. Public Health Service; National Institutes of Health","keywords":"Medicine; Antibody; Clotting factor; Genetic enhancement; Factor IX; Titer; Antigen; Immunology; Internal medicine; Gastroenterology; Gene; Biology","score_opus":0.01550498052386678,"score_gpt":0.28415282289132354,"score_spread":0.26864784236745676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976158989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99845266,0.0010135828,0.0000123990585,0.00015139072,0.000042377473,0.00023666967,0.00003186249,0.0000058976516,0.00005317506],"genre_scores_gemma":[0.9984222,0.0004869802,0.0005871751,0.0001964893,0.00012893527,0.00004001281,0.000023814859,0.000020464848,0.00009389338],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999252,0.00003891457,0.00015082787,0.00023851372,0.0001170054,0.00020271061],"domain_scores_gemma":[0.9994863,0.0000064857836,0.000035228735,0.00033644887,0.00006696012,0.00006857145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000113235685,0.00010773631,0.00011672355,0.000084130465,0.000021060809,0.000009562534,0.00017192117,0.00009845341,0.00007862363],"category_scores_gemma":[0.00002143377,0.00010008331,0.00004765992,0.00011195071,0.000047705595,0.0000032208725,0.000047596783,0.00010195421,0.000007812759],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054231915,0.00019401143,0.028910058,0.00000802279,0.000032492528,0.0000046954106,0.00017526462,0.000005109589,0.96806043,0.0000035894284,0.000021628148,0.0020423874],"study_design_scores_gemma":[0.0008542251,0.0007374075,0.09840955,0.0000055077003,0.0000034389384,0.0000043112777,0.000005463696,0.000005085702,0.8992913,0.000008349905,0.00057360437,0.000101789265],"about_ca_topic_score_codex":0.0001067305,"about_ca_topic_score_gemma":0.0013594334,"teacher_disagreement_score":0.06949949,"about_ca_system_score_codex":0.000004063258,"about_ca_system_score_gemma":0.000060236114,"threshold_uncertainty_score":0.4081279},"labels":[],"label_agreement":null},{"id":"W1976292850","doi":"10.1182/blood-2011-11-391532","title":"Asthma and coagulation","year":2012,"lang":"en","type":"review","venue":"Blood","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":160,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Asthma; Medicine; Pathophysiology of asthma; Immunology; Fibrinolysis; Coagulation; Inflammation; Internal medicine","score_opus":0.046933620710753084,"score_gpt":0.3276966314711013,"score_spread":0.2807630107603482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976292850","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001360164,0.9978948,0.000002559534,0.000004371512,0.00006276999,0.0003305086,0.0000132686855,0.000034143006,0.0015215526],"genre_scores_gemma":[0.00013800144,0.9985743,0.000052219475,0.00003295184,0.0006189243,0.000021745978,0.00007522467,0.000027417902,0.00045920105],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99941677,0.00003553303,0.00017643561,0.00014268319,0.000104500905,0.00012407862],"domain_scores_gemma":[0.99954003,0.000025334904,0.0000863544,0.000164893,0.000017609842,0.00016579671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000529674,0.00015559168,0.00062524574,0.00006675279,0.000030719522,0.0000079672855,0.000025356807,0.00015907423,0.000100527795],"category_scores_gemma":[0.000016805176,0.000104281,0.00015115335,0.00006549061,0.000032175103,0.00002611294,0.000024162933,0.000107814565,0.00010528079],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000001357473,0.00014790558,0.00024751126,0.010425306,0.00006530002,0.000017256663,0.000004996533,1.2211556e-9,3.168289e-7,0.000025217552,0.000079006626,0.98898584],"study_design_scores_gemma":[0.00034556937,0.00005328837,0.00079823873,0.0035044448,0.0028228434,0.00021555675,0.0000026798753,8.702194e-8,6.301101e-7,0.0000016736717,0.99215156,0.00010340167],"about_ca_topic_score_codex":7.783597e-7,"about_ca_topic_score_gemma":2.6344986e-7,"teacher_disagreement_score":0.9920726,"about_ca_system_score_codex":0.000007201694,"about_ca_system_score_gemma":0.00009896775,"threshold_uncertainty_score":0.4252456},"labels":[],"label_agreement":null},{"id":"W1976335329","doi":"10.1182/blood-2008-03-144063","title":"Targeting LSCs: powering an old tool","year":2008,"lang":"en","type":"letter","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Institute of Allergy and Infectious Diseases","keywords":"In silico; Computational biology; Medicine; Biology; Bioinformatics; Cancer research; Gene; Genetics","score_opus":0.021650785209127547,"score_gpt":0.27770298500170093,"score_spread":0.2560521997925734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976335329","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3727183,0.0029803433,0.00013188328,0.5885398,0.0010244823,0.002719883,0.00015302088,0.0012604776,0.030471845],"genre_scores_gemma":[0.004670663,0.0009196687,0.008002915,0.9097986,0.033071067,0.00013848481,0.0023283947,0.00052117,0.040549036],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99689245,0.00009874962,0.00043766902,0.000723142,0.00091451366,0.000933497],"domain_scores_gemma":[0.99846596,0.00011845741,0.00012736858,0.0009524703,0.00016788309,0.00016786688],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00026898843,0.0004234554,0.00067209045,0.00030616377,0.00014229972,0.00005138636,0.00040867686,0.0010361854,0.0005422998],"category_scores_gemma":[0.00033295856,0.00038772624,0.00019653983,0.00023398941,0.000107021486,0.00012715795,0.00018864273,0.004022016,0.0005154226],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002449276,0.00014110813,0.0009509735,0.00035589578,0.00024284674,0.015308079,0.00019910844,0.0000010176251,0.004347212,0.0000025858135,0.9780297,0.0003969694],"study_design_scores_gemma":[0.0029719688,0.00034635662,0.0003634604,0.00026227563,0.00025540424,0.0017567613,0.000032993947,0.000069261725,0.0020942055,0.000009180876,0.99134177,0.00049639033],"about_ca_topic_score_codex":0.000118507174,"about_ca_topic_score_gemma":8.371514e-7,"teacher_disagreement_score":0.36804762,"about_ca_system_score_codex":0.00022697226,"about_ca_system_score_gemma":0.00052571076,"threshold_uncertainty_score":0.9998575},"labels":[],"label_agreement":null},{"id":"W1976646672","doi":"10.1182/blood-2011-08-367466","title":"Publication bias is present in blood and marrow transplantation: an analysis of abstracts at an international meeting","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"U.S. National Library of Medicine; American Society for Blood and Marrow Transplantation","keywords":"Publication bias; Medicine; Transplantation; Impact factor; Bone marrow transplantation; Family medicine; Meta-analysis; Internal medicine; Political science; Law","score_opus":0.6256391021217169,"score_gpt":0.45966241184923834,"score_spread":0.16597669027247858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976646672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886574,0.00012644408,0.000120527686,0.00014603692,0.000033991193,0.0001995809,0.000046126417,0.0000034123593,0.010666478],"genre_scores_gemma":[0.9961299,0.00006681376,0.0031265565,0.00005525941,0.000026029746,0.000016642127,0.000068961584,0.000004895279,0.00050499255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9916105,0.0015438868,0.0041558947,0.00062999997,0.0019382875,0.00012139015],"domain_scores_gemma":[0.9950683,0.0004897577,0.0024141404,0.0012592274,0.00064712774,0.00012141343],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.024192521,0.00013717487,0.001056437,0.0009041255,0.000046889094,0.00026140496,0.0008053699,0.00006233228,0.005563072],"category_scores_gemma":[0.002123466,0.00008369375,0.0003855593,0.0012748328,0.00003385871,0.0006557536,0.000041073934,0.000053258584,0.000045934416],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008832505,0.00047413606,0.99153155,0.000019705098,0.00080248655,0.000005155052,0.0046170196,0.000057127487,0.0007715604,0.00023416016,0.00007058751,0.0014076836],"study_design_scores_gemma":[0.00040127448,0.00004090188,0.98811907,0.000013965567,0.0024212848,0.000010970434,0.00040078655,0.004153834,0.003725584,0.00027002048,0.00034045507,0.00010185779],"about_ca_topic_score_codex":0.00022975818,"about_ca_topic_score_gemma":0.00093091413,"teacher_disagreement_score":0.022069054,"about_ca_system_score_codex":0.0000070976,"about_ca_system_score_gemma":0.00001851515,"threshold_uncertainty_score":0.99534595},"labels":[],"label_agreement":null},{"id":"W1976799894","doi":"10.1182/blood-2010-11-319152","title":"Risk factors and mortality associated with an elevated tricuspid regurgitant jet velocity measured by Doppler-echocardiography in thalassemia: a Thalassemia Clinical Research Network report","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"National Center for Research Resources; National Heart, Lung, and Blood Institute; U.S. Food and Drug Administration; Translational Cancer Research Network","keywords":"Medicine; Thalassemia; Splenectomy; Internal medicine; Pediatrics; Gastroenterology; Cardiology; Surgery","score_opus":0.06591889962619871,"score_gpt":0.32678197921235447,"score_spread":0.26086307958615573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976799894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99547994,0.0009556518,0.000017688166,0.00006283386,0.00013014133,0.0010588412,0.00006049186,0.0001970341,0.002037371],"genre_scores_gemma":[0.99775094,0.0015059275,0.0002189545,0.000038863174,0.00008680488,0.000050451832,0.00023574126,0.00006717049,0.0000451523],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99413484,0.0014292562,0.0011498256,0.0010455229,0.0011209587,0.0011195976],"domain_scores_gemma":[0.9970048,0.0004414758,0.00047322604,0.0009377142,0.0004998284,0.00064297445],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.007957897,0.00043399012,0.0011489999,0.0002811199,0.0002994332,0.000045760185,0.00021298438,0.0010129748,0.000025167417],"category_scores_gemma":[0.0021043958,0.00029495766,0.0002653033,0.0023366313,0.0005125769,0.00016746056,0.00009957572,0.0023286878,0.000002470325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000439635,0.00244628,0.99127805,0.000023674576,0.0013794719,0.001350352,0.000346821,0.0000020503126,0.00011010968,0.000007223947,0.0024477649,0.0001685657],"study_design_scores_gemma":[0.0065759066,0.0016738232,0.98847044,0.00025074196,0.0008875628,0.00015577763,0.0006211507,0.00007868515,0.00055247196,0.00022662067,0.00014796431,0.000358843],"about_ca_topic_score_codex":0.0026283055,"about_ca_topic_score_gemma":0.00051856023,"teacher_disagreement_score":0.0061362716,"about_ca_system_score_codex":0.000085023894,"about_ca_system_score_gemma":0.00033855173,"threshold_uncertainty_score":0.999973},"labels":[],"label_agreement":null},{"id":"W1976887335","doi":"10.1182/blood-2010-07-295436","title":"Cutaneous GVHD is associated with the expansion of tissue-localized Th1 and not Th17 cells","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia; Child and Family Research Institute; Vancouver Coastal Health","funders":"Canadian Institutes of Health Research","keywords":"Proinflammatory cytokine; Interleukin 17; Immunology; Graft-versus-host disease; Medicine; Interferon; Disease; Inflammation; Pathology","score_opus":0.006457106602583032,"score_gpt":0.20032332396540672,"score_spread":0.1938662173628237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976887335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965226,0.00088051544,0.000009380165,0.00040225365,0.0003727406,0.00022220759,0.00004015745,0.000052544416,0.0014976108],"genre_scores_gemma":[0.993926,0.000089965455,0.000048229937,0.0002812266,0.000015893818,0.000009472365,0.000025966501,0.00001854703,0.005584714],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99908966,0.00013452767,0.00020518978,0.00022691522,0.000041618336,0.00030211863],"domain_scores_gemma":[0.99910235,0.00026852643,0.00016831739,0.00036836328,0.0000752178,0.000017211469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001433899,0.00018115353,0.00032399737,0.000043701042,0.0001885772,0.000010864514,0.00023921723,0.0003848823,0.0008549503],"category_scores_gemma":[0.000038544997,0.000108083754,0.00004646504,0.00009446117,0.00056888413,0.000029335477,0.00009611271,0.0004611586,0.00011988601],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000121458375,0.00024638497,0.00046146236,0.0000074518975,0.0002722832,0.000019977973,0.0008360141,1.8430977e-7,0.9952182,0.000103479426,0.0011212882,0.001591795],"study_design_scores_gemma":[0.0028938425,0.00045684414,0.00048187564,0.00001103226,0.00020284469,0.000346068,0.00020328899,7.508586e-7,0.9760198,0.00004279298,0.019190144,0.00015070026],"about_ca_topic_score_codex":0.00013401637,"about_ca_topic_score_gemma":0.00009326399,"teacher_disagreement_score":0.019198403,"about_ca_system_score_codex":0.0000034984544,"about_ca_system_score_gemma":0.000043710566,"threshold_uncertainty_score":0.9361106},"labels":[],"label_agreement":null},{"id":"W1977036406","doi":"10.1182/blood-2007-05-088666","title":"A chemical biology screen identifies glucocorticoids that regulate c-maf expression by increasing its proteasomal degradation through up-regulation of ubiquitin","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Ubiquitin; Transactivation; Biology; Ectopic expression; Cyclin D1; Cell culture; Cell cycle; Cell biology; Cyclin; Protein degradation; Cyclin D; Mdm2; Ubiquitin ligase; Molecular biology; Cell; Gene expression; Biochemistry; Genetics; Gene","score_opus":0.03408757011683462,"score_gpt":0.31812853618380676,"score_spread":0.28404096606697216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977036406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99629253,0.0005680675,0.0014919464,0.00011201564,0.000038407157,0.00092754903,0.00003396838,0.000063494525,0.00047202207],"genre_scores_gemma":[0.9937805,0.000028765917,0.0049760775,0.000017806173,0.00009692262,0.000037198726,0.0006500918,0.000023895072,0.00038876486],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983828,0.00011280434,0.0003817346,0.00032858498,0.00040558598,0.00038847057],"domain_scores_gemma":[0.99908876,0.00013598312,0.00019511962,0.0002761415,0.00015671577,0.00014727775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043689643,0.00017233669,0.00030108372,0.00010487786,0.00008359233,0.000017594139,0.000091449794,0.00018169309,0.00008905665],"category_scores_gemma":[0.00041144184,0.00014016715,0.00008691396,0.00018015788,0.000118271164,0.00023318508,0.000081496044,0.00013587126,0.000012306723],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000996408,0.00051830214,0.061210956,0.00008969976,0.00010214654,0.000012743162,0.00012305463,1.2846637e-7,0.9316922,0.00013114828,0.000067882895,0.005055319],"study_design_scores_gemma":[0.005135496,0.00016939742,0.105944015,0.00023135784,0.00010341301,0.00006411304,0.000065206565,0.00004912111,0.88776344,0.000309008,0.00006492263,0.000100533274],"about_ca_topic_score_codex":0.00029584047,"about_ca_topic_score_gemma":0.000009538189,"teacher_disagreement_score":0.04473306,"about_ca_system_score_codex":0.00004858582,"about_ca_system_score_gemma":0.000055817065,"threshold_uncertainty_score":0.571585},"labels":[],"label_agreement":null},{"id":"W1977102146","doi":"10.1182/blood-2008-09-177287","title":"CXCR4 is a key regulator of neutrophil release from the bone marrow under basal and stress granulopoiesis conditions","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":311,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; National Heart, Lung, and Blood Institute; York University","keywords":"Granulopoiesis; Granulocyte; Bone marrow; Biology; Immunology; Haematopoiesis; CXCR4; Cell biology; Homeostasis; Myelopoiesis; Inflammation; Stem cell; Chemokine","score_opus":0.009431182119009401,"score_gpt":0.23148520710651904,"score_spread":0.22205402498750965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977102146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98886645,0.0014577273,0.00001566784,0.008883888,0.000030020268,0.00014602448,0.0002429073,0.000023154265,0.00033414603],"genre_scores_gemma":[0.9977779,0.00012788399,0.00027256433,0.0012963314,0.00023619372,0.0000036482757,0.00007082692,0.000012378836,0.0002022653],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999278,0.000024012983,0.00020124631,0.00017757046,0.00018380389,0.0001353655],"domain_scores_gemma":[0.9994053,0.00009728281,0.00007197934,0.00026354863,0.000060443974,0.00010141418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000054669254,0.000112066744,0.0002444198,0.00003327933,0.00007836018,0.000013513316,0.000050724186,0.00006927553,0.00036032384],"category_scores_gemma":[0.000033849592,0.00007876345,0.00008708965,0.00011271029,0.000083905434,0.000033676268,0.000017707061,0.00011712278,0.0000033083813],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061894476,0.0036675986,0.115564,0.00021616145,0.00095629535,0.00015433512,0.0034579937,0.000020081252,0.8266727,0.0035727227,0.042666998,0.00243221],"study_design_scores_gemma":[0.010170777,0.00049088063,0.5000904,0.0005890125,0.0016490332,0.0000627057,0.0009537572,0.000108957516,0.47549212,0.008705614,0.0013502777,0.00033645076],"about_ca_topic_score_codex":0.00012588473,"about_ca_topic_score_gemma":0.000011764742,"teacher_disagreement_score":0.3845264,"about_ca_system_score_codex":0.000008266039,"about_ca_system_score_gemma":0.000040392002,"threshold_uncertainty_score":0.39452934},"labels":[],"label_agreement":null},{"id":"W1977103074","doi":"10.1182/blood-2012-09-456566","title":"Enhanced normal short-term human myelopoiesis in mice engineered to express human-specific myeloid growth factors","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency","keywords":"Myelopoiesis; Myeloid; Haematopoiesis; Biology; Myeloid cells; Peripheral blood; clone (Java method); Immunology; Term (time); Cell biology; Stem cell; Cancer research; Genetics; Gene","score_opus":0.024850063068572716,"score_gpt":0.2667550131797115,"score_spread":0.2419049501111388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977103074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936141,0.00013592407,0.0008938546,0.000034531706,0.0001841431,0.0006287801,0.000017181212,0.0001276607,0.0043638684],"genre_scores_gemma":[0.9981358,0.000028799142,0.00096871844,0.000043749704,0.00030102697,0.00008743494,0.00013568734,0.000060328774,0.00023843975],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981124,0.00004791163,0.00050752156,0.00033447513,0.00037837087,0.00061935623],"domain_scores_gemma":[0.9991358,0.00008623767,0.000048083934,0.0003219162,0.00006964624,0.0003383172],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020535367,0.00029079715,0.00043450203,0.000311487,0.00008745982,0.000022775159,0.00017082493,0.00016423682,0.00028647852],"category_scores_gemma":[0.0000208939,0.00028495563,0.00009535704,0.0003094852,0.000032979984,0.00019159527,0.00003150866,0.00022101217,0.000088711284],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030442661,0.000554097,0.111540034,0.0002464195,0.0000484456,0.000018970884,0.0074983877,0.000001127472,0.8797186,0.00023307101,0.000052676358,0.00005775608],"study_design_scores_gemma":[0.0013439476,0.000085897154,0.37332746,0.00017981738,0.000078269484,0.00001637335,0.00034343387,2.362173e-7,0.6243375,0.000003638442,0.00007405852,0.00020933586],"about_ca_topic_score_codex":0.000038709684,"about_ca_topic_score_gemma":0.000024014706,"teacher_disagreement_score":0.26178744,"about_ca_system_score_codex":0.00006610539,"about_ca_system_score_gemma":0.000019827952,"threshold_uncertainty_score":0.99996024},"labels":[],"label_agreement":null},{"id":"W1977231563","doi":"10.1182/blood-2005-06-2314","title":"Human neutrophil peptides induce interleukin-8 production through the P2Y6 signaling pathway","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":122,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"Canadian Institutes of Health Research; Canadian Lung Association","keywords":"Cell biology; Innate immune system; Biology; Purinergic receptor; Chemokine; Receptor; Chemotaxis; Signal transduction; Immune system; Molecular biology; Immunology; Extracellular; Biochemistry","score_opus":0.016562351947154004,"score_gpt":0.24790351298263089,"score_spread":0.2313411610354769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977231563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949362,0.0022233375,0.00011804961,0.00073349266,0.000104896746,0.00013369447,0.00000250173,0.000025873358,0.0017219345],"genre_scores_gemma":[0.99453706,0.000031254593,0.0004888808,0.00043590093,0.003104524,0.000022410279,0.0000313839,0.00002494228,0.0013236328],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99911064,0.000054653778,0.000197752,0.0003135339,0.000112836016,0.00021057212],"domain_scores_gemma":[0.9994828,0.0000065331847,0.000085339336,0.00033354032,0.000060547587,0.000031230073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013344448,0.00014825522,0.00009865629,0.0000180442,0.00021454974,0.00003218332,0.00021222717,0.00009527996,0.000023315451],"category_scores_gemma":[0.00003514944,0.00010954796,0.00008323884,0.0000787042,0.00006213932,0.000009165062,0.00008674145,0.0001432264,0.000014181271],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009483298,0.00015082781,0.00027529913,0.000008009682,0.000061210456,0.000003170005,0.00030145264,0.00053920224,0.993723,0.00021192347,0.0042930543,0.00042341038],"study_design_scores_gemma":[0.00040654268,0.00014752673,0.0001760541,0.000020074416,0.000041401225,0.000057714053,0.00018868559,0.0000025525248,0.94869596,0.00014204161,0.049956363,0.0001651159],"about_ca_topic_score_codex":0.000032187734,"about_ca_topic_score_gemma":0.000012641596,"teacher_disagreement_score":0.04566331,"about_ca_system_score_codex":0.0000066139914,"about_ca_system_score_gemma":0.000031437914,"threshold_uncertainty_score":0.4467236},"labels":[],"label_agreement":null},{"id":"W1977261138","doi":"10.1182/blood-2012-12-473439","title":"A transgenic mouse model demonstrating the oncogenic role of mutations in the polycomb-group gene EZH2 in lymphomagenesis","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Canada's Michael Smith Genome Sciences Centre; University of British Columbia; BC Cancer Agency","funders":"Hessisches Ministerium für Wissenschaft und Kunst; Terry Fox Foundation; Canada's Michael Smith Genome Sciences Centre; Leukemia and Lymphoma Society of Canada","keywords":"EZH2; Biology; Epigenome; Cancer research; Gene; Transgene; Polycomb-group proteins; Genetics; Mutation; Genetically modified mouse; Carcinogenesis; Gene expression; Repressor; DNA methylation","score_opus":0.008092114578953834,"score_gpt":0.22571800597986708,"score_spread":0.21762589140091324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977261138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950757,0.0013886133,0.002743539,0.000082643885,0.000010833924,0.00018806507,0.00001281659,0.000003239637,0.0004945287],"genre_scores_gemma":[0.99793124,0.00016909002,0.0016705735,0.0000717707,0.00004242848,0.000044922,0.000036889727,0.000013757145,0.000019308442],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990835,0.00017940524,0.00027308904,0.0001837643,0.00011696541,0.00016325567],"domain_scores_gemma":[0.9995212,0.0000476548,0.00007575659,0.00030953978,0.000024104504,0.00002177571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004939106,0.000100666686,0.000104960214,0.00004369528,0.000058609683,0.000013784989,0.00023231392,0.00009283704,0.0000013850864],"category_scores_gemma":[0.000053856118,0.00007152952,0.00008203483,0.00014402834,0.00005195944,0.0000030168555,0.00002419623,0.00006128811,7.8129955e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009417783,0.00020012488,0.005370063,0.000004907227,0.000016102398,1.5833969e-7,0.00041205998,0.0059322515,0.98553777,0.00017258663,5.3958297e-7,0.0023440365],"study_design_scores_gemma":[0.0009854101,0.00011371954,0.008553237,0.000004749449,0.00004295743,0.0000017274165,0.00026539518,0.010435912,0.9786091,0.00083136954,0.000054781573,0.00010163404],"about_ca_topic_score_codex":0.000100596175,"about_ca_topic_score_gemma":0.0006712911,"teacher_disagreement_score":0.006928645,"about_ca_system_score_codex":0.000004972166,"about_ca_system_score_gemma":0.000053702963,"threshold_uncertainty_score":0.29168892},"labels":[],"label_agreement":null},{"id":"W1977403686","doi":"10.1182/blood.v97.8.2257","title":"Resolution of pluripotential intermediates in murine hematopoietic differentiation by global complementary DNA amplification from single cells: confirmation of assignments by expression profiling of cytokine receptor transcripts","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Haematopoiesis; Biology; Gene expression profiling; Molecular biology; Cytokine receptor; Cytokine; DNA; Receptor; Cancer research; Gene expression; Cell biology; Chemistry; Stem cell; Immunology; Genetics; Gene","score_opus":0.011745384486604454,"score_gpt":0.21837778644156056,"score_spread":0.2066324019549561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977403686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802398,0.00035258397,0.018114217,0.000019415178,0.00015117331,0.000274542,0.0008176994,0.0000061249843,0.000024407509],"genre_scores_gemma":[0.9938113,0.00014425302,0.0011378278,0.000008432743,0.000034949782,0.000011558843,0.004834996,0.000010877342,0.000005817073],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998781,0.000088025416,0.00057731505,0.00022997514,0.00019172892,0.00013194322],"domain_scores_gemma":[0.99940324,0.00001071601,0.0003173422,0.00016485635,0.00007023692,0.000033587854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008902164,0.0001293243,0.00021260159,0.00003599205,0.000021322388,0.000006043794,0.00012513988,0.00011473294,0.00003209184],"category_scores_gemma":[0.000013137815,0.00013463416,0.00006446437,0.000083849874,0.00006076256,0.000013118531,0.00002298321,0.00004401598,4.0438258e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003011779,0.0015079924,0.024252634,0.00008587603,0.00004023884,1.4242652e-7,0.000110468136,0.000018475741,0.9732262,0.0000031630748,0.0001711522,0.00028249482],"study_design_scores_gemma":[0.0028699494,0.00029537638,0.0029781768,0.00012334432,0.000053851487,5.647966e-7,0.00011674771,0.00021126239,0.99310505,0.000034742687,0.00010424552,0.00010668746],"about_ca_topic_score_codex":0.00024019732,"about_ca_topic_score_gemma":0.000043272998,"teacher_disagreement_score":0.021274457,"about_ca_system_score_codex":0.00002125528,"about_ca_system_score_gemma":0.000015160827,"threshold_uncertainty_score":0.54902214},"labels":[],"label_agreement":null},{"id":"W1978086164","doi":"10.1182/blood-2008-11-187419","title":"Enrichment of Sca1+ hematopoietic progenitors in polycythemic mice inhibits leukemogenesis","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Haematopoiesis; Progenitor cell; Polycythemia vera; Biology; Erythropoietin receptor; Cancer research; Erythropoietin; CD34; Leukemia; Immunology; Stem cell; Molecular biology; Cell biology; Endocrinology","score_opus":0.010184806966759595,"score_gpt":0.2534026142587871,"score_spread":0.24321780729202747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978086164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995331,0.0018545361,0.000002841175,0.00067232683,0.00003918764,0.00064315053,0.0000057278107,0.00002909088,0.0014221251],"genre_scores_gemma":[0.99843234,0.00016343764,0.0008763033,0.0002297069,0.00007598969,0.00007078642,0.000011853852,0.0000141894525,0.00012538044],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99880576,0.000031289495,0.00037309257,0.00027403008,0.0002651105,0.0002506878],"domain_scores_gemma":[0.9994603,0.000045730398,0.00009489937,0.00022662453,0.000058189613,0.00011429907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000095539166,0.0001854998,0.00040186004,0.00015641242,0.00002702092,0.000006546063,0.000059220733,0.00007787815,0.00004729649],"category_scores_gemma":[0.000034657794,0.00015009058,0.000106650725,0.00028599298,0.000029156294,0.000035162713,0.000018149834,0.000081079896,0.00002663356],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002515451,0.0109097855,0.7541829,0.00020335786,0.0002865313,0.00026281294,0.001448574,0.0000052876235,0.22531724,0.0005963936,0.00028380723,0.006251777],"study_design_scores_gemma":[0.004955179,0.000781493,0.124754995,0.00024646756,0.00021968313,0.00014978743,0.000083173705,0.0000044848757,0.8684938,0.000093258495,0.00009701868,0.00012064147],"about_ca_topic_score_codex":0.000029965151,"about_ca_topic_score_gemma":0.000010913974,"teacher_disagreement_score":0.64317656,"about_ca_system_score_codex":0.00007423156,"about_ca_system_score_gemma":0.00011978362,"threshold_uncertainty_score":0.6120516},"labels":[],"label_agreement":null},{"id":"W1978093544","doi":"10.1182/blood-2012-07-443051","title":"Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis","year":2012,"lang":"en","type":"review","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":478,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Heart, Lung, and Blood Institute","keywords":"Heparin-induced thrombocytopenia; Medicine; Meta-analysis; Predictive value; Pre- and post-test probability; Population; Internal medicine; Predictive value of tests; Heparin","score_opus":0.14708543827613177,"score_gpt":0.3578725171429642,"score_spread":0.21078707886683243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978093544","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012599374,0.9804402,0.00003659494,0.000058778383,0.00017426732,0.017992146,0.00034485274,0.00009099543,0.00073617767],"genre_scores_gemma":[0.028438052,0.96605456,0.0002831759,0.00010127618,0.000137139,0.0045054215,0.000071186194,0.00017328106,0.00023588867],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9935855,0.0010660411,0.002788287,0.001035037,0.0008095354,0.000715567],"domain_scores_gemma":[0.99350977,0.00072055456,0.0024097955,0.002557268,0.00042607362,0.0003765373],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0023224035,0.0011438238,0.02592362,0.0003987825,0.00024242567,0.000054744338,0.0007660541,0.00067533116,0.000044056913],"category_scores_gemma":[0.000481657,0.00061502523,0.0075773974,0.0017063464,0.00011882097,0.00016400276,0.00047504224,0.00071916386,0.000024183366],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000028353156,0.00022089804,0.000014799378,0.70326054,0.29587254,0.0000032887592,0.000057440328,6.376257e-8,0.000009858219,0.0004506168,0.0000046541218,0.000102440055],"study_design_scores_gemma":[0.00059948314,0.00015677452,0.00004615604,0.12229761,0.8748368,0.00032739673,0.000038886174,0.0000029301398,0.00012513691,0.0000044867224,0.001126472,0.00043788404],"about_ca_topic_score_codex":0.00010109127,"about_ca_topic_score_gemma":0.000019276593,"teacher_disagreement_score":0.58096296,"about_ca_system_score_codex":0.00023098681,"about_ca_system_score_gemma":0.0005591045,"threshold_uncertainty_score":0.9996301},"labels":[],"label_agreement":null},{"id":"W1978380394","doi":"10.1182/blood-2013-01-480889","title":"Elucidating the role of interleukin-17F in cutaneous T-cell lymphoma","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McGill University Health Centre","funders":"National Cancer Institute; Novo Nordisk Fonden; Canadian Dermatology Foundation; Harvard University; Dermatology Foundation","keywords":"Lymphoma; Medicine; Interleukin; Immunology; Cancer research; Cytokine","score_opus":0.0070756304764506995,"score_gpt":0.2419420300020273,"score_spread":0.23486639952557659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978380394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96285504,0.0008294516,0.0000071348236,0.0003029766,0.000018823133,0.0007007548,0.0000032507853,0.000023949005,0.03525863],"genre_scores_gemma":[0.9985023,0.000045708348,0.0002270419,0.0001582493,0.000047948466,0.00007361747,0.0000069157836,0.000027776063,0.00091040664],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986886,0.00007972503,0.0003242914,0.0002249859,0.00034613264,0.00033625998],"domain_scores_gemma":[0.9990977,0.00019276995,0.00007606929,0.0003939917,0.0001588922,0.000080599224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013593546,0.00013690023,0.00026325116,0.0001282677,0.00004635048,0.000025914176,0.0002124372,0.00007166176,0.0004907587],"category_scores_gemma":[0.00024656506,0.000094923416,0.00008019516,0.00027665065,0.00011862085,0.000046995276,0.00010652868,0.0001400441,0.000193828],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019296765,0.0041800775,0.31563634,0.00018932899,0.00014072792,0.00036096576,0.0046401885,0.000010197179,0.6087922,0.00019541357,0.0003282796,0.065333314],"study_design_scores_gemma":[0.010660691,0.0012278261,0.015790021,0.00027399944,0.0001192311,0.0055472325,0.010515878,0.0037933919,0.9480507,0.0018013507,0.0018621966,0.00035748526],"about_ca_topic_score_codex":0.0010855659,"about_ca_topic_score_gemma":0.000114289236,"teacher_disagreement_score":0.3392585,"about_ca_system_score_codex":0.00005407083,"about_ca_system_score_gemma":0.00016358902,"threshold_uncertainty_score":0.5373463},"labels":[],"label_agreement":null},{"id":"W1978390872","doi":"10.1182/blood-2004-07-2699","title":"Hemojuvelin and hepcidin: the keys to JH?","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Hepcidin; Medicine; Biology; Internal medicine; Anemia","score_opus":0.008880107547498123,"score_gpt":0.2385356622712129,"score_spread":0.22965555472371477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978390872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9804378,0.0018669242,0.00014106899,0.009740745,0.000067931374,0.00020552271,0.000001982849,0.000029282068,0.0075087096],"genre_scores_gemma":[0.993223,0.0000957389,0.0011675002,0.004730233,0.00015262593,0.000009130906,0.0000021701285,0.0000095311925,0.00061004556],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995689,0.000007913641,0.000077176286,0.00011529938,0.00009996369,0.00013079535],"domain_scores_gemma":[0.9996914,0.000012060143,0.000011241176,0.0001761704,0.000016609134,0.00009247816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000081035556,0.00006456876,0.00009966023,0.000025266667,0.000054388216,0.000012184376,0.00004461484,0.000029046183,0.00004761459],"category_scores_gemma":[0.00006148187,0.000040221283,0.000024493798,0.00008401135,0.000031259893,0.000021266223,0.000027426237,0.00006235321,0.00011284684],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001439777,0.011504092,0.3213577,0.0013603095,0.0005896022,0.0009557558,0.043879732,0.0002467116,0.19769043,0.15614668,0.06713289,0.19769633],"study_design_scores_gemma":[0.038653754,0.0010585005,0.6344311,0.00015926656,0.0012000493,0.0005462037,0.0040811473,0.0000045250304,0.109495394,0.0083452,0.20129973,0.00072511914],"about_ca_topic_score_codex":0.00007289896,"about_ca_topic_score_gemma":0.00001798991,"teacher_disagreement_score":0.31307343,"about_ca_system_score_codex":0.0000030850863,"about_ca_system_score_gemma":0.000036788275,"threshold_uncertainty_score":0.16401763},"labels":[],"label_agreement":null},{"id":"W1978660935","doi":"10.1182/blood-2011-12-396879","title":"Outcome of hematopoietic stem cell transplantation for adenosine deaminase–deficient severe combined immunodeficiency","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":170,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Severe combined immunodeficiency; Adenosine deaminase; Adenosine deaminase deficiency; Hematopoietic stem cell transplantation; Transplantation; Medicine; Hematopoietic cell; Internal medicine; Immunology; Immune system; T cell; Stem cell; Oncology; Haematopoiesis; Biology; Adenosine; In vivo","score_opus":0.01243386737892236,"score_gpt":0.228370369655786,"score_spread":0.21593650227686365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978660935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94983864,0.046157315,0.0011968046,0.000032938977,0.0007116416,0.0005734573,0.00012460726,0.00007215419,0.0012924386],"genre_scores_gemma":[0.9983728,0.00010294313,0.00006340588,0.000045206052,0.000003423249,0.00006972856,0.00021564797,0.000028848968,0.0010979766],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99826753,0.000097708624,0.000683423,0.00024802383,0.00006357694,0.0006397511],"domain_scores_gemma":[0.99909306,0.00017168855,0.0002602502,0.0003742304,0.0000892128,0.000011545348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041999196,0.00025795004,0.00043206997,0.00013198491,0.00026203317,0.0000097534175,0.00031889044,0.00022036924,0.00011810407],"category_scores_gemma":[0.00001368817,0.00023596303,0.0002320092,0.00021613097,0.00016322253,0.00015087935,0.000038152968,0.00017793453,0.00012709462],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051066966,0.008505676,0.02438677,0.0012057965,0.00020142004,0.0000017164679,0.010291142,0.00006355076,0.944502,0.006683236,0.00007762022,0.003570436],"study_design_scores_gemma":[0.013624865,0.0009183787,0.043494936,0.000121057186,0.0008361348,0.0002107752,0.0048705535,0.0000077829145,0.9316541,0.00009838455,0.0034088937,0.0007541359],"about_ca_topic_score_codex":0.00003153558,"about_ca_topic_score_gemma":4.88997e-7,"teacher_disagreement_score":0.048534177,"about_ca_system_score_codex":0.000016519298,"about_ca_system_score_gemma":0.000036020683,"threshold_uncertainty_score":0.9622293},"labels":[],"label_agreement":null},{"id":"W1978674283","doi":"10.1182/blood-2012-11-465625","title":"Interleukin-7 promotes HIV persistence during antiretroviral therapy","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":249,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre","funders":"National Institute on Drug Abuse; National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; National Institutes of Health; Cycle for Survival","keywords":"Virology; Persistence (discontinuity); Immunology; Antiretroviral therapy; Viral load; Biology; Lentivirus; Viral replication; Virus latency; Medicine; Human immunodeficiency virus (HIV); Viral disease; Virus","score_opus":0.016080937853243472,"score_gpt":0.22653827690201261,"score_spread":0.21045733904876915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978674283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994894,0.0021073192,0.000001700661,0.00021747264,0.00006111109,0.000269559,0.000015378557,0.00006380957,0.0023696132],"genre_scores_gemma":[0.992707,0.000091795824,0.000058025904,0.000021549597,0.000020097708,0.000065522305,0.000045076296,0.0000093537565,0.0069815684],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992727,0.00006529494,0.000100397905,0.00019440212,0.000027184202,0.00033999005],"domain_scores_gemma":[0.9996941,0.000025250614,0.000025812104,0.00019229543,0.00003584986,0.000026709202],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000038291575,0.00010664567,0.00012019979,0.000051046576,0.00013668495,0.000024652145,0.00015653112,0.000071879345,0.0017917771],"category_scores_gemma":[0.0000188695,0.000077333185,0.00006854756,0.00005535827,0.000111684174,0.00009006317,0.000049100974,0.0001369965,0.008091773],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003328171,0.00068449427,0.13585837,0.000011015277,0.00031969606,0.000025001655,0.00050296343,2.7410147e-8,0.8569524,0.000025864554,0.00068472367,0.0049021216],"study_design_scores_gemma":[0.0053990916,0.0009184054,0.20488997,0.000027610953,0.000020575366,0.0001425192,0.0002717835,4.663353e-7,0.78584754,0.00003485003,0.0022801592,0.0001670181],"about_ca_topic_score_codex":0.00009344164,"about_ca_topic_score_gemma":0.00000329238,"teacher_disagreement_score":0.071104884,"about_ca_system_score_codex":0.000013270158,"about_ca_system_score_gemma":0.00002322273,"threshold_uncertainty_score":0.9991207},"labels":[],"label_agreement":null},{"id":"W1978906002","doi":"10.1182/blood-2006-04-018184","title":"Timing of neutrophil tissue repopulation predicts restoration of innate immune protection in a murine bone marrow transplantation model","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Canadian Institutes of Health Research","funders":"Canadian Institutes of Health Research; University of Toronto","keywords":"Bone marrow; Immunology; Innate immune system; Biology; Transplantation; Neutrophil extracellular traps; Repopulation; Immune system; Absolute neutrophil count; In vivo; Medicine; Stem cell; Inflammation; Haematopoiesis; Neutropenia; Cell biology; Internal medicine; Chemotherapy","score_opus":0.02104284467827976,"score_gpt":0.2593125339441922,"score_spread":0.2382696892659124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978906002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951426,0.00013354665,0.0028850364,0.00015028256,0.00004984536,0.0006251224,0.000009532801,0.000033480028,0.000970568],"genre_scores_gemma":[0.99872875,0.000046230565,0.00081446697,0.0000048904453,0.00006768288,0.000073538904,0.000094228926,0.000014380315,0.00015581827],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99904734,0.000032805245,0.0005014246,0.00014665633,0.00017744282,0.00009430729],"domain_scores_gemma":[0.99948263,0.000006343352,0.00023014292,0.00015443233,0.000107635475,0.000018784518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000132552,0.00008329043,0.00020899661,0.00022762326,0.00002980496,0.0000036896924,0.000021670054,0.00007397901,0.000008981172],"category_scores_gemma":[0.0000135396685,0.00008556741,0.00003890966,0.00031427722,0.000023608925,0.00014436446,0.000005097189,0.00010370121,8.322776e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003344873,0.0004964483,0.00873088,0.00038301828,0.000012635099,0.000013994854,0.0001851805,0.014174819,0.9747519,0.0002284404,0.000006717127,0.0006814611],"study_design_scores_gemma":[0.0044789547,0.00047578485,0.23303722,0.0003527899,0.00023506802,0.00013161307,0.000013719831,0.0085052615,0.75215554,0.0005029506,0.00001733727,0.00009375],"about_ca_topic_score_codex":0.0013798289,"about_ca_topic_score_gemma":0.00031549975,"teacher_disagreement_score":0.22430634,"about_ca_system_score_codex":0.00003860644,"about_ca_system_score_gemma":0.000054556953,"threshold_uncertainty_score":0.34893376},"labels":[],"label_agreement":null},{"id":"W1979204126","doi":"10.1182/blood-2006-02-003236","title":"Promoter SNPs in G1/S checkpoint regulators and their impact on the susceptibility to childhood leukemia","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"CDKN2B; CDKN2A; Single-nucleotide polymorphism; Biology; Cell cycle; Genetics; Carcinogenesis; Cancer research; Gene; Genotype","score_opus":0.005575511257710254,"score_gpt":0.2241915195673287,"score_spread":0.21861600830961844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979204126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981945,0.00044070312,0.00004179204,0.0002067158,0.000022426062,0.00031208532,0.000013127649,0.000006348673,0.0007622626],"genre_scores_gemma":[0.99954194,0.000025700543,0.000102869126,0.000068413385,0.0001432843,0.00001542441,0.000027751976,0.000014679516,0.000059950245],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992172,0.00006491149,0.0001671882,0.00029523764,0.000069790396,0.00018565221],"domain_scores_gemma":[0.99950826,0.000016605203,0.000040301413,0.0003590604,0.00002556185,0.000050210394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031898322,0.00014706828,0.00011242159,0.000031617128,0.000047600162,0.00002614977,0.000094252915,0.00010120121,0.0000096510585],"category_scores_gemma":[0.000055817713,0.00008518928,0.00006579074,0.00008273129,0.00003433808,0.0000017072928,0.000062682324,0.00007905263,0.0000035043452],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029247405,0.00025338933,0.07410298,0.000005168246,0.00002242297,8.306045e-7,0.00014043144,0.00020403172,0.9237007,0.000052004954,0.00007070491,0.0014180971],"study_design_scores_gemma":[0.00031288268,0.00023220062,0.4467702,0.0000070769943,0.000004251946,0.0000012499147,0.000015158347,0.000012357931,0.5515118,0.00075749547,0.00029353215,0.00008177123],"about_ca_topic_score_codex":0.00012143484,"about_ca_topic_score_gemma":0.00022962569,"teacher_disagreement_score":0.37266722,"about_ca_system_score_codex":0.000020633512,"about_ca_system_score_gemma":0.00004773236,"threshold_uncertainty_score":0.34739178},"labels":[],"label_agreement":null},{"id":"W1979211157","doi":"10.1182/blood-2009-01-201384","title":"Scl regulates the quiescence and the long-term competence of hematopoietic stem cells","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Ontario Institute for Cancer Research; Institute for Research in Immunology and Cancer","funders":"Canadian Institutes of Health Research","keywords":"Haematopoiesis; Biology; Stem cell; Transplantation; Progenitor cell; Cell biology; Hematopoietic stem cell; Cell cycle; Immunology; Cancer research; Molecular biology; Cell; Genetics; Internal medicine; Medicine","score_opus":0.01205644549855182,"score_gpt":0.23427085632243522,"score_spread":0.2222144108238834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979211157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948747,0.0015667111,0.00019730523,0.0015789097,0.00004498668,0.00053073076,0.0000026547762,0.000028803048,0.0011751585],"genre_scores_gemma":[0.998944,0.00031505726,0.0001934067,0.00025579525,0.000030580104,0.000006525276,0.0000016074266,0.000008027571,0.0002450112],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99906224,0.000071563925,0.0002809209,0.0001647282,0.000262753,0.0001578201],"domain_scores_gemma":[0.9991101,0.0002970888,0.00010333992,0.00038132878,0.0000564255,0.000051722884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031412262,0.00011567292,0.00026655186,0.000025773083,0.00007527083,0.000017516813,0.00014351525,0.00004762563,0.000019072255],"category_scores_gemma":[0.000009401525,0.000059625436,0.000059887247,0.00012943268,0.00033670603,0.00003297829,0.000014527897,0.00010807484,0.0000103847415],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001344586,0.0022035926,0.16005158,0.004780796,0.0005852011,0.00038894996,0.039831597,0.000019622497,0.73864275,0.04030046,0.0001972114,0.01165365],"study_design_scores_gemma":[0.0065748678,0.00024175314,0.18287212,0.0011275323,0.0006760168,0.0009788433,0.0005689572,0.00010279161,0.80629796,0.00040689833,0.000010467003,0.00014177534],"about_ca_topic_score_codex":0.0000050976637,"about_ca_topic_score_gemma":0.0000022983697,"teacher_disagreement_score":0.06765523,"about_ca_system_score_codex":0.0000044510048,"about_ca_system_score_gemma":0.00003144729,"threshold_uncertainty_score":0.24314548},"labels":[],"label_agreement":null},{"id":"W197938950","doi":"10.1182/blood.v122.21.3629.3629","title":"Tranexamic Acid is a Weak Provoking Factor For Thromboembolic Events: A Systematic Review Of The Literature","year":2013,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute; Queen's University","funders":"","keywords":"Tranexamic acid; Medicine; Randomized controlled trial; Fibrinolysis; Dosing; Antifibrinolytic; Surgery; Anesthesia; Internal medicine; Blood loss","score_opus":0.03309998197204963,"score_gpt":0.31648167462456595,"score_spread":0.28338169265251634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W197938950","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000015573993,0.96939874,0.0000078959,0.00017936155,0.00026238724,0.029409857,0.00034591553,0.000047470312,0.0003328062],"genre_scores_gemma":[0.000038151025,0.99210477,0.00015480671,0.0009690744,0.00020047568,0.0057272697,0.00009688555,0.00012742021,0.0005811276],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9965591,0.0002591808,0.0016023297,0.00056586444,0.00057208224,0.00044147766],"domain_scores_gemma":[0.9966783,0.00012114546,0.0013337224,0.0014995615,0.0002504793,0.00011682537],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004216898,0.0006952715,0.006885639,0.00016746766,0.000091202935,0.00004199736,0.00064093614,0.0003500305,0.00017398807],"category_scores_gemma":[0.00038372775,0.00035987198,0.0022440301,0.00056923117,0.000040453324,0.00008183789,0.00013292278,0.00041983748,0.000045571644],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[6.2136075e-7,0.0007663611,7.324702e-7,0.980002,0.0019015152,0.0000019782592,0.00031300512,1.986189e-9,0.0000047615285,0.00010934328,0.0017230336,0.015176681],"study_design_scores_gemma":[0.00061020494,0.00015519302,0.00001485271,0.8152099,0.035117034,0.00007995697,0.000018378436,2.4782318e-7,0.00002003725,0.00001998392,0.14848799,0.00026618954],"about_ca_topic_score_codex":0.0000056871527,"about_ca_topic_score_gemma":0.000001067896,"teacher_disagreement_score":0.16479203,"about_ca_system_score_codex":0.000079805235,"about_ca_system_score_gemma":0.00028248652,"threshold_uncertainty_score":0.9998853},"labels":[],"label_agreement":null},{"id":"W1979426291","doi":"10.1182/blood-2003-06-1794","title":"Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":228,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Methylenetetrahydrofolate reductase; Acute lymphocytic leukemia; Lymphoblastic Leukemia; Medicine; Genetics; Hematologic Neoplasms; Leukemia; Immunology; Oncology; Cancer research; Biology; Internal medicine; Genotype; Gene; Cancer","score_opus":0.008584111073397396,"score_gpt":0.2521648021081477,"score_spread":0.24358069103475027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979426291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99438864,0.0005754985,0.000008891594,0.0001408094,0.000020242713,0.0005007876,0.000008391173,0.00001260163,0.0043441644],"genre_scores_gemma":[0.99892646,0.00004638778,0.00048805893,0.00027229104,0.000042512995,0.000024655516,0.0000042692595,0.000015212891,0.00018017238],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99868,0.00011059283,0.000253571,0.0002470899,0.00037774333,0.00033101274],"domain_scores_gemma":[0.99918824,0.0000810675,0.000029862435,0.0005303582,0.000053332784,0.00011710972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003204984,0.00011953896,0.00024133449,0.00013390188,0.000035386107,0.000010781976,0.00018604644,0.0000764929,0.00013844039],"category_scores_gemma":[0.00021123352,0.00008015365,0.00007900711,0.00050152186,0.00006029297,0.000024906858,0.000036350684,0.0001597748,0.000091284914],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017376571,0.004002585,0.39813194,0.00006933615,0.0002969669,0.00023479176,0.0042559747,0.000027186143,0.586013,0.00039022326,0.00040780613,0.0059964303],"study_design_scores_gemma":[0.002903783,0.0009017053,0.9194517,0.000046927864,0.00015546392,0.00021825598,0.0002881776,0.000021301943,0.075255774,0.00023352771,0.000422348,0.0001010152],"about_ca_topic_score_codex":0.00017513387,"about_ca_topic_score_gemma":0.00010764235,"teacher_disagreement_score":0.5213198,"about_ca_system_score_codex":0.00006003276,"about_ca_system_score_gemma":0.0003283614,"threshold_uncertainty_score":0.3268571},"labels":[],"label_agreement":null},{"id":"W1979446605","doi":"10.1182/blood-2012-04-427047","title":"The BAF53a subunit of SWI/SNF-like BAF complexes is essential for hemopoietic stem cell function","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":134,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"National Cancer Institute; National Institute of Neurological Disorders and Stroke; Howard Hughes Medical Institute","keywords":"Haematopoiesis; Stem cell; Biology; Progenitor cell; Cell biology; Embryonic stem cell; Induced pluripotent stem cell; Chromatin remodeling; Chromatin; Genetics; DNA","score_opus":0.010901856135105829,"score_gpt":0.23509373763683755,"score_spread":0.22419188150173172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979446605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914909,0.0043066056,0.003073804,0.000048210386,0.0003348616,0.00015605231,0.000032208423,0.000008769958,0.00054857053],"genre_scores_gemma":[0.9978325,0.00014485462,0.00023707803,0.00010207959,0.00040795407,0.00002143486,0.00004536168,0.000017369963,0.0011913709],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993807,0.000024311275,0.00016181938,0.00013368925,0.00009322208,0.00020626835],"domain_scores_gemma":[0.9995147,0.000020673568,0.00008399315,0.00025953373,0.000077005185,0.000044098208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014442396,0.00009363589,0.000093356604,0.000010234569,0.000117474745,0.000013427241,0.00011416658,0.00008041256,0.000017102127],"category_scores_gemma":[0.0000048513716,0.000072254086,0.0001046302,0.000035296027,0.000045959918,0.000002664472,0.00004160827,0.000037347476,0.0000057144375],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000092288814,0.00023241452,0.0009853982,0.0001018207,0.00008769412,5.6152945e-8,0.00011799266,0.000023076642,0.99050677,0.00005996646,0.00533149,0.002461033],"study_design_scores_gemma":[0.0010627371,0.0001855023,0.00035745057,0.000009599939,0.0001327427,0.0000035838984,0.00020449438,0.00015427404,0.95825773,0.000059482092,0.039456367,0.00011603983],"about_ca_topic_score_codex":0.000014103182,"about_ca_topic_score_gemma":0.000009436499,"teacher_disagreement_score":0.034124877,"about_ca_system_score_codex":0.0000036872057,"about_ca_system_score_gemma":0.000033895987,"threshold_uncertainty_score":0.2946436},"labels":[],"label_agreement":null},{"id":"W1979541272","doi":"10.1182/blood-2006-11-059899","title":"IgM and IgA anti-erythrocyte autoantibodies induce anemia in a mouse model through multivalency-dependent hemagglutination but not through complement activation","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Autoantibody; Immunology; Complement system; Immunoglobulin M; Antibody; Hemagglutination; Biology; Complement receptor; Immunoglobulin A; Alternative complement pathway; Isotype; Immunoglobulin G; Autoimmune hemolytic anemia; Monoclonal antibody","score_opus":0.036421375378012814,"score_gpt":0.2991718066461392,"score_spread":0.26275043126812636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979541272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98534733,0.00024133969,0.0111281695,0.0007642383,0.00005872258,0.0008551488,0.000034697583,0.00011143195,0.0014589236],"genre_scores_gemma":[0.9883211,0.0006793362,0.010137174,0.00045026964,0.00009988055,0.000019737925,0.00007044482,0.000038038368,0.00018399581],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979674,0.00003345852,0.00053982827,0.00050880224,0.00050872314,0.0004417595],"domain_scores_gemma":[0.99928963,0.000077572004,0.0001447891,0.00028593524,0.000120227356,0.00008186493],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039977732,0.0002795612,0.00041898972,0.00013639808,0.00016158161,0.00002813755,0.00008173873,0.00018998276,0.000020114987],"category_scores_gemma":[0.000050941886,0.00025642425,0.000065868764,0.00019950821,0.000081655126,0.0004339328,0.000073146686,0.00035781483,0.000005245722],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004251541,0.0033473407,0.03559102,0.0005502056,0.000118549026,0.000082108934,0.005859893,0.00012712652,0.9472496,0.0035466445,0.000031249336,0.0030711407],"study_design_scores_gemma":[0.010549277,0.000272413,0.12051856,0.0002800413,0.00017254574,0.00006399028,0.000710522,0.0012341476,0.8653043,0.00053402246,0.00006259308,0.00029761426],"about_ca_topic_score_codex":0.0007861667,"about_ca_topic_score_gemma":0.0002454847,"teacher_disagreement_score":0.08492754,"about_ca_system_score_codex":0.00007793799,"about_ca_system_score_gemma":0.00006871316,"threshold_uncertainty_score":0.9999888},"labels":[],"label_agreement":null},{"id":"W1979610606","doi":"10.1182/blood-2004-02-0479","title":"IgE-induced signaling: only the weak survive","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Signal transduction; Biology; Immunology; Cell biology","score_opus":0.013016144603639479,"score_gpt":0.21326179466283296,"score_spread":0.20024565005919348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979610606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9735247,0.0014715092,0.00004920329,0.00069971115,0.00044897967,0.00013908558,0.000013313763,0.000057492238,0.023595998],"genre_scores_gemma":[0.99455297,0.000020093714,0.000029941524,0.00017546257,0.00006284561,0.000006304924,0.000033756245,0.000011064081,0.005107587],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993794,0.0000570593,0.00013919504,0.00016769709,0.0000234886,0.00023317654],"domain_scores_gemma":[0.99960834,0.000053981763,0.000053589007,0.00023633006,0.000033889744,0.000013848609],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013262343,0.00010645879,0.0001327118,0.000027462624,0.0002036493,0.000011856597,0.00019570593,0.00012274622,0.00082625897],"category_scores_gemma":[0.000022237436,0.00007084498,0.000065417174,0.000076323384,0.00008424413,0.000022032884,0.000043890897,0.0002038369,0.0009955885],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029269522,0.0005603457,0.00065494794,0.00000870702,0.00019625267,0.000012716917,0.00076144835,0.000007340626,0.97919446,0.016956175,0.0005875939,0.0010307445],"study_design_scores_gemma":[0.0062407725,0.00042955056,0.0049941135,0.00003130278,0.00018890288,0.00022950518,0.0007216839,1.7416508e-7,0.75231415,0.0011963634,0.23332873,0.00032474883],"about_ca_topic_score_codex":0.00037731224,"about_ca_topic_score_gemma":0.0003215731,"teacher_disagreement_score":0.23274113,"about_ca_system_score_codex":0.000009289689,"about_ca_system_score_gemma":0.000079158344,"threshold_uncertainty_score":0.99978226},"labels":[],"label_agreement":null},{"id":"W1979754115","doi":"10.1182/blood-2011-11-393272","title":"Asymmetric segregation and self-renewal of hematopoietic stem and progenitor cells with endocytic Ap2a2","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; University of Toronto; Ontario Institute for Cancer Research; Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Canadian Institutes of Health Research","keywords":"Cytokinesis; Biology; Stem cell; Cell biology; Asymmetric cell division; Progenitor cell; Cell division; Haematopoiesis; Cell fate determination; Hematopoietic stem cell; Cell; Genetics; Gene; Transcription factor","score_opus":0.01536480160844839,"score_gpt":0.20913399452451242,"score_spread":0.19376919291606404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979754115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99650586,0.0005228784,0.00019042596,0.000010363513,0.000030118608,0.0005810338,0.000005098102,0.0000572136,0.0020970039],"genre_scores_gemma":[0.99118245,0.00011485123,0.0085522,0.000011250104,0.00002125652,0.000024055767,0.0000042236065,0.000022556555,0.00006715149],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991075,0.000033014763,0.0002461915,0.00022327887,0.00023218883,0.0001578658],"domain_scores_gemma":[0.99944776,0.000074557924,0.00010600343,0.00016761223,0.00007669036,0.00012737865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011723224,0.00013908684,0.00027077598,0.00015743203,0.000029388795,0.000008157683,0.000034652076,0.0000730641,0.000012186228],"category_scores_gemma":[0.000005842241,0.000108590466,0.00002426,0.00024274697,0.000061019793,0.00005667718,0.000011365595,0.00006745696,0.0000056232916],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010200532,0.006395885,0.75725603,0.01782879,0.0019209344,0.0008034473,0.03760489,9.287862e-7,0.16560219,0.0036292232,0.00003087408,0.00790677],"study_design_scores_gemma":[0.0061511267,0.0010098472,0.018639226,0.00032713718,0.0013288868,0.0015351265,0.00053339935,0.000039466246,0.97015893,0.00010014568,0.000011803945,0.00016488535],"about_ca_topic_score_codex":0.000022445063,"about_ca_topic_score_gemma":0.000003486925,"teacher_disagreement_score":0.8045568,"about_ca_system_score_codex":0.000010615532,"about_ca_system_score_gemma":0.000066387496,"threshold_uncertainty_score":0.44281906},"labels":[],"label_agreement":null},{"id":"W1979798449","doi":"10.1182/blood.v99.1.121","title":"Overexpression of the myeloid leukemia–associatedHoxa9 gene in bone marrow cells induces stem cell expansion","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Genomics and Chromatin Dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":347,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Institutes of Health","keywords":"Haematopoiesis; Biology; Stem cell; Bone marrow; Cancer research; Myeloid; Lymphopoiesis; Granulopoiesis; Leukemia; Myeloid leukemia; Hematopoietic stem cell; Immunology; Transplantation; Cell biology; Medicine; Internal medicine","score_opus":0.006432352547087879,"score_gpt":0.1779619210943225,"score_spread":0.1715295685472346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979798449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99778706,0.0010519632,0.000004060956,0.00002330821,0.000085563355,0.00013267383,0.000029691311,0.0000045277825,0.00088113354],"genre_scores_gemma":[0.9983145,0.000469107,0.00020148097,0.000055468583,0.000050613864,0.000006821795,0.000014718019,0.000019432751,0.0008678685],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991586,0.000058363956,0.00024377638,0.00022199708,0.00012997177,0.00018726695],"domain_scores_gemma":[0.9994012,0.000008170536,0.00017194838,0.0003525411,0.000030517522,0.00003561029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009845299,0.00012539269,0.00013992348,0.000024868417,0.000047142177,0.000010386205,0.00022127724,0.0001982781,0.000015410487],"category_scores_gemma":[0.000005969646,0.00009923414,0.000083897095,0.00008657214,0.000030383973,0.0000024423348,0.00017281299,0.000101915,0.0000048227976],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000048927604,0.00020589659,0.0014129638,0.00002212719,0.000010215509,0.000001299566,0.000121401725,0.0001748481,0.99741703,0.000002225413,0.00029150394,0.00033557197],"study_design_scores_gemma":[0.0009774806,0.00006835965,0.0031921223,0.000035118344,0.0000150622545,0.000003723276,0.00008762366,0.00024945664,0.9949296,0.000016179678,0.00030179907,0.00012343428],"about_ca_topic_score_codex":0.000023376293,"about_ca_topic_score_gemma":0.0000147104065,"teacher_disagreement_score":0.0024874131,"about_ca_system_score_codex":0.000023625995,"about_ca_system_score_gemma":0.000036240926,"threshold_uncertainty_score":0.40466508},"labels":[],"label_agreement":null},{"id":"W1979838866","doi":"10.1182/blood.v99.11.4039","title":"Translocation of the tetraspanin CD63 in association with human eosinophil mediator release","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Alberta","funders":"","keywords":"CD63; Eosinophil peroxidase; Cell biology; Tetraspanin; Intracellular; Biology; Eosinophil cationic protein; Eosinophil; Eosinophil Granule Proteins; Immunology; Microvesicles; Cell; Biochemistry","score_opus":0.009093024458580927,"score_gpt":0.21420158355613858,"score_spread":0.20510855909755765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979838866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978164,0.00055295776,0.000002749839,0.0005885363,0.000021775302,0.00019312344,0.0000055800083,0.000015877802,0.0008030262],"genre_scores_gemma":[0.99944127,0.000019054816,0.00001832419,0.00013238768,0.000075459095,0.000010958391,0.0000037226098,0.0000095464475,0.00028930092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99935675,0.000043225773,0.00015564811,0.00009559546,0.00025180206,0.00009698988],"domain_scores_gemma":[0.9996443,0.000023978339,0.000090882946,0.00014433463,0.000047206675,0.000049342598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007106857,0.0000620377,0.00012188442,0.000045553534,0.000035780326,0.0000030720544,0.000046349796,0.000057805682,0.000084293555],"category_scores_gemma":[0.000071565526,0.000038399987,0.000041734143,0.00019683184,0.000030589188,0.000041176525,0.0000037521966,0.00009245296,0.000006803014],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021138234,0.0012424237,0.97005767,0.000058014706,0.000033550536,0.000012682091,0.00044676478,0.0000058495534,0.02650686,0.000045647408,0.0003072274,0.0012621521],"study_design_scores_gemma":[0.004354044,0.00026888415,0.92600596,0.00018184767,0.00019431413,0.0000053756535,0.00013230041,0.000029017654,0.06831292,0.000018358543,0.0004190864,0.00007791525],"about_ca_topic_score_codex":0.000017376267,"about_ca_topic_score_gemma":0.00004781473,"teacher_disagreement_score":0.04405175,"about_ca_system_score_codex":0.000029866389,"about_ca_system_score_gemma":0.00003673788,"threshold_uncertainty_score":0.1565906},"labels":[],"label_agreement":null},{"id":"W1980014109","doi":"10.1182/blood-2009-07-228106","title":"The AC133+CD38−, but not the rhodamine-low, phenotype tracks LTC-IC and SRC function in human cord blood ex vivo expansion cultures","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heart and Stroke Foundation; University Health Network; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"Canadian Institutes of Health Research; Hospital for Sick Children","keywords":"Ex vivo; Biology; Haematopoiesis; CD38; Cord blood; Stem cell; Molecular biology; Cell culture; Progenitor cell; Immunology; Cell biology; In vivo; CD34; Genetics","score_opus":0.013454281989046798,"score_gpt":0.2649464794631659,"score_spread":0.2514921974741191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980014109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938781,0.00077185035,0.00010279559,0.0011582078,0.00014315697,0.00069982914,0.0000063704847,0.00007799743,0.003161669],"genre_scores_gemma":[0.99784887,0.00034099407,0.00009475811,0.0006173035,0.00024514535,0.000026348112,0.000027282633,0.000023238845,0.0007760485],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984374,0.00011044753,0.00040678488,0.00033729963,0.0003897744,0.0003182771],"domain_scores_gemma":[0.99912316,0.00020526627,0.00010612651,0.00039809858,0.00007260413,0.000094770665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004053952,0.00022866775,0.00026853365,0.000069390735,0.00029591747,0.00006030273,0.00013325587,0.000161364,0.000048495378],"category_scores_gemma":[0.00006309739,0.00013255901,0.00007076716,0.0002072411,0.00009515169,0.00008464289,0.000014054771,0.00030579156,0.000017199784],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004796947,0.0008084836,0.0029706657,0.00013116773,0.00008864174,0.000075081836,0.0023860517,0.0000026717184,0.98674136,0.0007506562,0.00029577277,0.0052697216],"study_design_scores_gemma":[0.012656967,0.0021638947,0.32789123,0.000602749,0.0014887091,0.0004895547,0.0023071165,0.00006292171,0.64989007,0.0009730166,0.001044362,0.00042941613],"about_ca_topic_score_codex":0.00006030667,"about_ca_topic_score_gemma":0.00012865654,"teacher_disagreement_score":0.33685133,"about_ca_system_score_codex":0.000015738739,"about_ca_system_score_gemma":0.000040253366,"threshold_uncertainty_score":0.54056},"labels":[],"label_agreement":null},{"id":"W1980118603","doi":"10.1182/blood-2011-07-367532","title":"Caspase-8 is essential for maintaining chromosomal stability and suppressing B-cell lymphomagenesis","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Tech University; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Queen's University; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Necroptosis; Cytokinesis; Caspase 8; Cancer research; Biology; NLRP1; Caspase; B cell; Apoptosis; Immune system; Caspase 2; Caspase 1; Caspase 3; Function (biology); Programmed cell death; Cell; Immunology; Cell biology; Genetics; Cell division; Antibody","score_opus":0.010467292999095996,"score_gpt":0.23033870754043143,"score_spread":0.21987141454133544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980118603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99296135,0.0016179511,0.0048347632,0.000024708663,0.000118082615,0.00016623289,0.000029408107,0.000009066291,0.00023844052],"genre_scores_gemma":[0.9960648,0.00005267484,0.0031378423,0.00005136069,0.00045199445,0.000018574185,0.00007980516,0.000018188337,0.00012479047],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99935657,0.000023741099,0.00011118069,0.00021002366,0.000060712766,0.00023778739],"domain_scores_gemma":[0.9996658,0.000010166699,0.000046218465,0.00016331796,0.000032153403,0.00008237509],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015227971,0.00010141976,0.00008786269,0.00001470258,0.00012061331,0.000023996137,0.00004406203,0.00011172938,0.000034796798],"category_scores_gemma":[0.000013323878,0.000096454234,0.000058252324,0.000022546219,0.000033389977,0.0000060855245,0.000064109874,0.000018753442,0.0000010351041],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026696674,0.00018262096,0.0047419653,0.000033192675,0.000021936083,5.4937965e-7,0.00012412749,0.0000013624455,0.99355954,0.000041325955,0.000056846304,0.0012098668],"study_design_scores_gemma":[0.0013119297,0.00009675178,0.0030929816,0.000004613748,0.00008031209,0.000022704602,0.000094981595,0.00012275386,0.99306834,0.000038631762,0.0019324305,0.00013355653],"about_ca_topic_score_codex":0.000007830441,"about_ca_topic_score_gemma":0.0000031635102,"teacher_disagreement_score":0.003103423,"about_ca_system_score_codex":0.0000048775673,"about_ca_system_score_gemma":0.000024753142,"threshold_uncertainty_score":0.39332893},"labels":[],"label_agreement":null},{"id":"W1980124235","doi":"10.1182/blood-2009-07-230805","title":"Single-agent arsenic trioxide in the treatment of children with newly diagnosed acute promyelocytic leukemia","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":116,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto; University of Oklahoma","keywords":"Arsenic trioxide; Acute promyelocytic leukemia; Medicine; Leukocytosis; Internal medicine; Chemotherapy; Neutropenia; Complete remission; Surgery; Gastroenterology; Arsenic","score_opus":0.00771807102475839,"score_gpt":0.22020034923917886,"score_spread":0.21248227821442048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980124235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99680513,0.001990166,0.000070200236,0.000065984284,0.000014603363,0.00041949342,0.0000064673113,0.000008352413,0.0006196049],"genre_scores_gemma":[0.9980665,0.000906308,0.00054284016,0.00011230083,0.00010256631,0.00004119091,0.00007236914,0.000012823469,0.00014314034],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991034,0.000054005657,0.00020171206,0.00027727816,0.0001442781,0.00021931904],"domain_scores_gemma":[0.99944156,0.000013303487,0.000093972485,0.00038435633,0.000029511468,0.0000372876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006845466,0.00017740086,0.00018614004,0.00003286997,0.000035656838,0.000017961036,0.00022127274,0.000097510885,0.0000031246973],"category_scores_gemma":[0.000015166042,0.00010864033,0.00008264871,0.0001396536,0.000060914146,0.0000031586671,0.000010309391,0.000054579723,0.000002066691],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028811122,0.0032561813,0.02256921,0.000019589363,0.00044975712,0.0001414154,0.0007962428,0.00015560392,0.9532278,0.000038843806,0.00012676146,0.01893046],"study_design_scores_gemma":[0.0056707845,0.005044541,0.019282974,0.000023547798,0.00025107467,0.00014239278,0.000074656105,0.0000048132288,0.9680843,0.000037542643,0.0011987669,0.00018465339],"about_ca_topic_score_codex":0.000022903703,"about_ca_topic_score_gemma":0.000025614314,"teacher_disagreement_score":0.018745806,"about_ca_system_score_codex":0.00004317073,"about_ca_system_score_gemma":0.00018737048,"threshold_uncertainty_score":0.4430224},"labels":[],"label_agreement":null},{"id":"W1980178355","doi":"10.1182/blood-2012-06-438606","title":"A prospective study of circulating adipokine levels and risk of multiple myeloma","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"National Institutes of Health","keywords":"Adipokine; Adiponectin; Medicine; Internal medicine; Endocrinology; Leptin; Prospective cohort study; Odds ratio; Adipose tissue; Obesity; Insulin resistance","score_opus":0.022487108606997788,"score_gpt":0.26594445139311085,"score_spread":0.24345734278611306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980178355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986396,0.00061770255,0.000028487286,0.0000032701528,0.000023836987,0.00039963363,0.000008534628,0.000012479078,0.00026647173],"genre_scores_gemma":[0.9991342,0.0000059244976,0.0006898713,0.0000022811992,0.00012839423,0.00000811337,0.0000012421402,0.000012205063,0.000017760352],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993661,0.000025593034,0.00022269083,0.000108267835,0.00015134548,0.00012602583],"domain_scores_gemma":[0.9994967,0.000087708846,0.00014531701,0.00012599287,0.00007871805,0.00006559196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021683438,0.00007867676,0.00028197482,0.000047493908,0.000027440057,0.0000018251841,0.000022192336,0.000034513883,0.000030346468],"category_scores_gemma":[0.00024049624,0.000063521526,0.000039391147,0.00011120721,0.000025421235,0.0000382398,0.00003223904,0.000087170854,4.8242913e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028292536,0.001634635,0.9025846,0.00007303453,0.00028795883,0.0000016069,0.0044391593,0.0000013902677,0.089863054,0.0000061578185,0.0000014954694,0.0010786041],"study_design_scores_gemma":[0.00486612,0.00038265772,0.8245903,0.00006633783,0.00052722346,0.00002220691,0.001197744,0.000063762636,0.16821727,0.0000080720365,0.0000052483265,0.000053035234],"about_ca_topic_score_codex":0.0001376487,"about_ca_topic_score_gemma":0.00001022217,"teacher_disagreement_score":0.07835422,"about_ca_system_score_codex":0.0000074902664,"about_ca_system_score_gemma":0.000013143803,"threshold_uncertainty_score":0.25903326},"labels":[],"label_agreement":null},{"id":"W1980296375","doi":"10.1182/blood-2011-01-329656","title":"A CCR4 antagonist combined with vaccines induces antigen-specific CD8+ T cells and tumor immunity against self antigens","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":157,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Labex Immuno-Oncology; Institut National Du Cancer; Université Pierre et Marie Curie; Université Paris Descartes; Ligue Contre le Cancer; Agence Nationale de la Recherche; Association pour la Recherche sur le Cancer","keywords":"CCR4; Immunology; Antigen; FOXP3; Population; CD8; Cytotoxic T cell; CCL17; Immune tolerance; Cancer research; Biology; Immune system; Medicine; Chemokine; Chemokine receptor","score_opus":0.014520642807363501,"score_gpt":0.19393442700151797,"score_spread":0.17941378419415446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980296375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98923707,0.005954322,0.000006432499,0.000042610875,0.0005644493,0.00038384632,0.000041958352,0.0002631904,0.0035061256],"genre_scores_gemma":[0.9957865,0.0029510916,0.00042576765,0.00014063239,0.000037996502,0.000020828262,0.000086521104,0.000046102447,0.0005045531],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980939,0.0002554859,0.0004054773,0.0005363362,0.000044079683,0.00066471694],"domain_scores_gemma":[0.99891084,0.00008294945,0.00022767908,0.0006113258,0.00011379942,0.000053413547],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020115297,0.00042414985,0.0005709253,0.00017003715,0.00059339317,0.000039529925,0.00042868138,0.00030384524,0.0003052982],"category_scores_gemma":[0.000008024842,0.00033211155,0.00008416986,0.00023445164,0.00044765868,0.00014048736,0.00021225527,0.0005476361,0.00038415586],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039973579,0.0021010777,0.0157975,0.000024717834,0.00054746115,0.0001150968,0.0017391187,5.7145343e-8,0.97832835,0.00021972759,0.00040253712,0.00032462043],"study_design_scores_gemma":[0.0062866043,0.0012354698,0.024512252,0.000040364102,0.00009507375,0.00036667212,0.00085885567,2.539925e-7,0.95045465,0.00005019854,0.015619476,0.00048009816],"about_ca_topic_score_codex":0.00019988389,"about_ca_topic_score_gemma":0.00005533378,"teacher_disagreement_score":0.027873669,"about_ca_system_score_codex":0.000011705088,"about_ca_system_score_gemma":0.00008033214,"threshold_uncertainty_score":0.9999131},"labels":[],"label_agreement":null},{"id":"W1980311491","doi":"10.1182/blood-2002-02-0504","title":"The death-promoting activity of p53 can be inhibited by distinct signaling pathways","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Signal transduction; Apoptosis; Cancer research; Biology; Medicine; Chemistry; Cell biology; Genetics","score_opus":0.02527690377714492,"score_gpt":0.22838913774156586,"score_spread":0.20311223396442094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980311491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943207,0.0014351028,0.00012407468,0.0006648848,0.00007347595,0.00035979526,0.000070949194,0.00009293508,0.002858096],"genre_scores_gemma":[0.9994293,0.000051105337,0.00012470421,0.00008971493,0.000089301604,0.00002078442,0.000019981091,0.000042238946,0.00013287822],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99864084,0.0000767425,0.0002849915,0.00027997486,0.00036888514,0.0003485797],"domain_scores_gemma":[0.9990201,0.00014799857,0.00018835116,0.0004126238,0.00009375229,0.00013718233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025017743,0.0001789578,0.00027552765,0.000047108508,0.00018489499,0.000019916008,0.00011634201,0.00011663719,0.000060748083],"category_scores_gemma":[0.00036410202,0.00013865327,0.00013330698,0.0002447634,0.00008439416,0.000031708,0.00006227608,0.00034270468,0.000006289039],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002947467,0.00055016874,0.0023659766,0.000060789716,0.0001422483,0.00006729461,0.00063052285,0.0000023106743,0.9894563,0.000057677924,0.0003299976,0.006307219],"study_design_scores_gemma":[0.0026742434,0.00033191007,0.0011880118,0.00020171104,0.00030602078,0.00008458701,0.00005934011,0.00068983325,0.9930773,0.000036770773,0.0011870883,0.000163201],"about_ca_topic_score_codex":0.00015861343,"about_ca_topic_score_gemma":0.00004080795,"teacher_disagreement_score":0.006144018,"about_ca_system_score_codex":0.000058196423,"about_ca_system_score_gemma":0.000059468854,"threshold_uncertainty_score":0.5654116},"labels":[],"label_agreement":null},{"id":"W1980489286","doi":"10.1182/blood-2008-08-173278","title":"A novel deletion mutation is recurrent in von Willebrand disease types 1 and 3","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Medical College of Wisconsin","keywords":"Von Willebrand disease; Haplotype; Von Willebrand factor; Mutation; Genetics; Genotype; Exon; Biology; genomic DNA; Compound heterozygosity; Point mutation; Molecular biology; Gene; Immunology; Platelet","score_opus":0.009970800784052537,"score_gpt":0.2527903187680623,"score_spread":0.24281951798400975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980489286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996845,0.0014616186,0.000024242712,0.0011187602,0.000019150224,0.0001596272,0.00000850269,0.000011810385,0.00035127276],"genre_scores_gemma":[0.99919903,0.00018820552,0.00019465915,0.0002930992,0.000021851858,0.0000049216274,0.00004273691,0.0000032723087,0.000052201187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996841,0.0000040315585,0.000068602,0.00010683962,0.00006450945,0.00007191143],"domain_scores_gemma":[0.9998583,0.000005587798,0.00001663184,0.000050733484,0.000012152432,0.00005659703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000020243597,0.000053320473,0.00008677399,0.00004541778,0.00001595708,0.00000620504,0.000008339841,0.000021923957,0.000012382747],"category_scores_gemma":[0.000017065398,0.000044317796,0.000015387359,0.000059643815,0.000007020725,0.000036603044,0.000002599255,0.00003163878,0.0000062442973],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028207072,0.020912204,0.5086748,0.00029932585,0.00033703074,0.0028068935,0.0031127906,0.000012192631,0.013231107,0.0006394417,0.0015254137,0.4456281],"study_design_scores_gemma":[0.012248693,0.00050001603,0.9839178,0.00015433828,0.00024738608,0.00009260585,0.000025476109,0.0003561955,0.00091689744,0.0008995312,0.0005399871,0.00010108386],"about_ca_topic_score_codex":0.000011497881,"about_ca_topic_score_gemma":0.000009740738,"teacher_disagreement_score":0.475243,"about_ca_system_score_codex":0.000007668384,"about_ca_system_score_gemma":0.000014358932,"threshold_uncertainty_score":0.18072273},"labels":[],"label_agreement":null},{"id":"W1980521997","doi":"10.1182/blood-2012-01-404699","title":"Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":203,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Institute of General Medical Sciences; National Cancer Institute","keywords":"Progenitor cell; Stem cell; Biology; Haematopoiesis; Cancer research; CD34; Myeloid leukemia; Immunology; Myeloid; Medicine; Internal medicine; Cell biology","score_opus":0.0276494854823044,"score_gpt":0.2961478709077594,"score_spread":0.268498385425455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980521997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998002,0.000723384,0.0000036454187,0.00008640744,0.000025139305,0.00096790254,0.000011395868,0.000009841786,0.00017029318],"genre_scores_gemma":[0.9985886,0.000051881805,0.00083301624,0.000014280928,0.000060889393,0.00004938832,0.0000050537806,0.000014726472,0.00038213405],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990991,0.00008340676,0.00025601842,0.00016675485,0.00018483722,0.00020992223],"domain_scores_gemma":[0.99958336,0.00007114385,0.000072949,0.00012378303,0.000028987202,0.00011976276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039617004,0.000096635034,0.0002318598,0.00016041845,0.000018003144,0.00000952877,0.000036019417,0.00012990137,0.000015114586],"category_scores_gemma":[0.00007807614,0.00007886208,0.000011452292,0.00013227362,0.000065002045,0.00019524718,0.00010176479,0.00023278785,0.0000027414671],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013806717,0.00018665114,0.6581621,0.0002875413,0.00000784139,0.0000029539651,0.00057034096,8.012804e-8,0.3386748,0.0000150048645,0.000026407863,0.0019281628],"study_design_scores_gemma":[0.007268068,0.00023100986,0.62796646,0.00049960543,0.00002990287,0.000020898819,0.00039616262,0.00014457459,0.3630413,0.000011094955,0.00027037092,0.0001205165],"about_ca_topic_score_codex":0.000060882605,"about_ca_topic_score_gemma":0.000005797034,"teacher_disagreement_score":0.03019564,"about_ca_system_score_codex":0.000045045337,"about_ca_system_score_gemma":0.000044505898,"threshold_uncertainty_score":0.32159024},"labels":[],"label_agreement":null},{"id":"W1980835313","doi":"10.1182/blood-2013-01-480665","title":"Innate immune control of EBV-infected B cells by invariant natural killer T cells","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; BC Children's Hospital; University of British Columbia","funders":"","keywords":"CD1D; Natural killer T cell; Immune system; Immunology; Innate immune system; Biology; Antigen; Downregulation and upregulation; T cell; Gene","score_opus":0.003224376114441645,"score_gpt":0.17774518863127348,"score_spread":0.17452081251683182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980835313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97616625,0.004699773,0.00027481315,0.0002420159,0.01367033,0.0006803157,0.00001212769,0.00013405088,0.004120339],"genre_scores_gemma":[0.96340734,0.0000897216,0.000019700248,0.0003059462,0.00002283869,0.000029156061,0.00012136098,0.000018470571,0.03598548],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998845,0.00018248272,0.00043045048,0.00021228044,0.00003503616,0.00029474238],"domain_scores_gemma":[0.99918884,0.00011195187,0.00022674682,0.0002734317,0.00018074151,0.00001828552],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00011029147,0.00018495647,0.00031558675,0.00009631984,0.0000912408,0.0000188617,0.00016139577,0.0002300218,0.0065948893],"category_scores_gemma":[0.00003717995,0.0001545445,0.00013255244,0.00011298092,0.00009975624,0.00016817603,0.00004411879,0.00037475937,0.003413995],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007482942,0.00044856494,0.00008892975,0.0000109816065,0.00036592782,7.976062e-7,0.00010251246,0.0000014850784,0.938838,0.00004544814,0.059766464,0.00025605247],"study_design_scores_gemma":[0.0045807683,0.00019942177,0.0012432999,0.000019947336,0.0001006671,0.000020896612,0.00006622857,0.000018657134,0.94239277,0.000009445587,0.05117914,0.00016878675],"about_ca_topic_score_codex":0.0005174782,"about_ca_topic_score_gemma":0.0000024505869,"teacher_disagreement_score":0.031865142,"about_ca_system_score_codex":0.0000149318475,"about_ca_system_score_gemma":0.000025172618,"threshold_uncertainty_score":0.99736196},"labels":[],"label_agreement":null},{"id":"W1981046216","doi":"10.1182/blood.v97.8.2230","title":"A common epitope is shared by activated signal transducer and activator of transcription-5 (STAT5) and the phosphorylated erythropoietin receptor: implications for the docking model of STAT activation","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; Ontario Institute for Cancer Research","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"SH2 domain; Tyrosine phosphorylation; STAT protein; STAT5; Erythropoietin receptor; Tyrosine; Protein tyrosine phosphatase; Phosphorylation; Molecular biology; Biology; Receptor tyrosine kinase; Cell biology; Cancer research; Signal transduction; STAT3; Biochemistry","score_opus":0.028609113728196967,"score_gpt":0.2778431712020344,"score_spread":0.24923405747383742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981046216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98260933,0.00054098375,0.0068813832,0.008273702,0.000024115543,0.0010321665,0.00052995916,0.000025654157,0.00008271047],"genre_scores_gemma":[0.99831396,0.0008160692,0.00034351097,0.00020398588,0.000029781844,0.00012086284,0.00009631345,0.0000252768,0.000050258786],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99908763,0.000042743977,0.0003758088,0.00020833209,0.0001331067,0.00015236398],"domain_scores_gemma":[0.9988757,0.0004489263,0.00020548588,0.00022081457,0.00019440202,0.00005466934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019580338,0.00014691975,0.0003055387,0.00005390147,0.0002185777,0.00002221569,0.00007821742,0.000077615674,0.00013521264],"category_scores_gemma":[0.000042952193,0.000092351605,0.0001120043,0.0001955498,0.00020261269,0.00014927107,0.000011124983,0.00018053337,2.0012115e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013554493,0.00037947044,0.0005061718,0.000058223173,0.0002884277,4.4976e-8,0.0033001115,0.000058316324,0.9885906,0.00024423358,0.001048899,0.0041700583],"study_design_scores_gemma":[0.0067842756,0.00026456726,0.0013047624,0.00016052953,0.0004819937,0.000013201239,0.00073076336,0.0063873003,0.9814428,0.00041336787,0.0019056946,0.000110755136],"about_ca_topic_score_codex":0.000276679,"about_ca_topic_score_gemma":0.000010017456,"teacher_disagreement_score":0.015704615,"about_ca_system_score_codex":0.000018798004,"about_ca_system_score_gemma":0.00005873799,"threshold_uncertainty_score":0.3765989},"labels":[],"label_agreement":null},{"id":"W1981093010","doi":"10.1182/blood-2014-08-591370","title":"Mutations in TRNT1 cause congenital sideroblastic anemia with immunodeficiency, fevers, and developmental delay (SIFD)","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Porphyrin Metabolism and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":180,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; SickKids Foundation; University of Toronto; Newborn Screening Ontario; Children's Hospital of Eastern Ontario; Hospital for Sick Children; University of Ottawa","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Natural Sciences and Engineering Research Council of Canada; National Institutes of Health; University of Ottawa; National Institute for Social Care and Health Research; University of Washington; Canadian Institutes of Health Research; Cancer Research Society; Ohio State University","keywords":"Sideroblastic anemia; Immunodeficiency; Primary immunodeficiency; Mutation; Anemia; Medicine; Severe combined immunodeficiency; Immunology; Pediatrics; Biology; Genetics; Internal medicine; Gene; Immune system","score_opus":0.0045794797796212166,"score_gpt":0.19645233210629012,"score_spread":0.1918728523266689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981093010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972047,0.00068744546,0.00048122252,0.000016001413,0.0000256416,0.000091118716,0.000009654567,0.000008055839,0.0014761484],"genre_scores_gemma":[0.9980467,0.000048063237,0.0016227786,0.0000887429,0.000016918451,0.000014739506,0.00006468073,0.000011939342,0.0000854152],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99938107,0.000027640739,0.0001198509,0.000218617,0.00007317683,0.00017965316],"domain_scores_gemma":[0.9997795,0.000015186012,0.000030456857,0.000105535284,0.000021032925,0.000048275415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007015599,0.00011263274,0.00009397512,0.000039839277,0.0000617452,0.000020290856,0.0000729519,0.00006236384,0.000009346787],"category_scores_gemma":[0.00005758467,0.00009998364,0.000015850885,0.000072849296,0.00010358138,0.000005726643,0.000045199187,0.0000502904,0.000007075854],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024457884,0.001155558,0.25707877,0.00007813863,0.00024970336,0.00010484003,0.0012946473,0.00032693558,0.73504955,0.0010101249,0.00029807474,0.0031090635],"study_design_scores_gemma":[0.027467556,0.0013732748,0.7308656,0.00007344636,0.00055267836,0.0018297493,0.004139958,0.00024596837,0.22274177,0.00067439367,0.007925534,0.0021101106],"about_ca_topic_score_codex":0.000044296106,"about_ca_topic_score_gemma":0.00029201276,"teacher_disagreement_score":0.5123078,"about_ca_system_score_codex":0.0000031298678,"about_ca_system_score_gemma":0.00006985505,"threshold_uncertainty_score":0.40772146},"labels":[],"label_agreement":null},{"id":"W1981120003","doi":"10.1182/blood-2014-04-567065","title":"HIF-1α can act as a tumor suppressor gene in murine acute myeloid leukemia","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Barncancerfonden; Université de Montréal; Cancerfonden","keywords":"Myeloid leukemia; Cancer research; Leukemia; Tumor suppressor gene; Gene; Suppressor; Biology; Medicine; Immunology; Genetics; Carcinogenesis","score_opus":0.0046542595214056175,"score_gpt":0.2198385196104203,"score_spread":0.2151842600890147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981120003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995141,0.0016910805,0.000025313197,0.00014437316,0.00047623733,0.00017093308,0.00005214008,0.000018749695,0.0022801233],"genre_scores_gemma":[0.9940716,0.0006611396,0.0004853688,0.0007812808,0.0020170254,0.000052059877,0.00014005636,0.00003861225,0.0017528591],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988235,0.00005323355,0.00020583367,0.00041128232,0.00013043037,0.00037569078],"domain_scores_gemma":[0.9992768,0.00000803035,0.00007062157,0.00046834536,0.00004077641,0.0001353832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013772259,0.00019629537,0.00024905495,0.000055606888,0.000047653313,0.000023417382,0.0002476644,0.00012253918,0.000048764563],"category_scores_gemma":[0.00007233123,0.00019098133,0.0001038218,0.000097534976,0.000049032213,0.000003422438,0.00012803044,0.00012299845,0.000024677742],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006933701,0.00011102451,0.00065459555,0.000013729197,0.00008328463,0.0000116172005,0.000052003583,0.0000093939825,0.9957216,0.0000364905,0.0015946594,0.0016423027],"study_design_scores_gemma":[0.0025647448,0.00015345434,0.0074435077,0.0000083091645,0.00008320131,0.00009532223,0.000009270506,0.0000090869735,0.7645623,0.000061766696,0.22479126,0.00021777702],"about_ca_topic_score_codex":0.00029522573,"about_ca_topic_score_gemma":0.00047744636,"teacher_disagreement_score":0.23115925,"about_ca_system_score_codex":0.000019104782,"about_ca_system_score_gemma":0.00020067772,"threshold_uncertainty_score":0.7787993},"labels":[],"label_agreement":null},{"id":"W1981242581","doi":"10.1182/blood-2013-06-504647","title":"Auer rod-like inclusions in κ light chain myeloma","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Steatosis; Multiple myeloma; Complete blood count; Proteinuria; Pathology; Internal medicine; Gastroenterology; Kidney","score_opus":0.006051015131027768,"score_gpt":0.23092840070032558,"score_spread":0.22487738556929782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981242581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992751,0.0013446308,0.000012898786,0.0018668291,0.0001127409,0.0003464118,0.000010643426,0.00002567587,0.0035291451],"genre_scores_gemma":[0.9953861,0.0002843796,0.00053439726,0.0009799764,0.00011811193,0.00027533557,0.00006378573,0.00003154892,0.0023263227],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989303,0.000054320022,0.00021037414,0.00036703626,0.000113305025,0.00032466496],"domain_scores_gemma":[0.9993254,0.00001810453,0.000060077742,0.00044992336,0.000039241662,0.00010728698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007282649,0.00019180447,0.0001739643,0.00007115281,0.000078114586,0.000023520397,0.00021435766,0.00018022773,0.00019564481],"category_scores_gemma":[0.000067770256,0.00016749103,0.00009584895,0.00012141924,0.0000354583,0.000005806055,0.00030526682,0.00008056665,0.00026020515],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012060039,0.0018555598,0.45879292,0.00001915834,0.00022644227,0.000037045334,0.00030474248,0.0000078468365,0.5204263,0.00016782906,0.014384753,0.0037653495],"study_design_scores_gemma":[0.0035316276,0.00032076347,0.39067632,0.000041977673,0.000085191285,0.000019014908,0.00019298785,0.00001062141,0.5519689,0.00014391735,0.052513655,0.0004950269],"about_ca_topic_score_codex":0.00013903262,"about_ca_topic_score_gemma":0.00024002272,"teacher_disagreement_score":0.0681166,"about_ca_system_score_codex":0.00001715694,"about_ca_system_score_gemma":0.000044511904,"threshold_uncertainty_score":0.6830086},"labels":[],"label_agreement":null},{"id":"W1981280653","doi":"10.1182/blood-2004-04-1622","title":"The expression and the regulatory role of OX40 and 4-1BB heterodimer in activated human T cells","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Western University","funders":"Amgen","keywords":"Cell biology; Biology; Molecular biology; Chemistry; Cancer research","score_opus":0.004850022267538967,"score_gpt":0.1946969824619835,"score_spread":0.18984696019444453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981280653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98579353,0.013146866,2.5953042e-7,0.00021940608,0.00006746063,0.00015739903,0.0000025523655,0.000014644834,0.0005979008],"genre_scores_gemma":[0.9985655,0.0003063035,0.000009680418,0.00004291915,0.000016142849,0.000012045109,0.0000045099205,0.000008224352,0.0010346918],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99912983,0.00026631713,0.00021369486,0.00016997101,0.000019524072,0.00020064435],"domain_scores_gemma":[0.9994214,0.00019613064,0.00009925291,0.000258565,0.000016073553,0.0000085647225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024733384,0.00010944969,0.00018894816,0.000037891194,0.00023024723,0.000008552824,0.00014799877,0.00017493294,0.000039803144],"category_scores_gemma":[0.000012471108,0.000058361667,0.00003199052,0.000043025164,0.00076341635,0.000041961743,0.00012397917,0.00023597456,0.000011724191],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001482112,0.00015213761,0.000919253,0.0000038197372,0.0000562016,4.3422583e-7,0.0006004398,5.9008914e-7,0.9957755,0.0005305088,0.00012823977,0.0016846472],"study_design_scores_gemma":[0.004638755,0.0000624339,0.0027747066,0.00001599651,0.000029278597,0.00001681073,0.00023939292,5.340383e-7,0.97769237,0.00023864207,0.014219267,0.00007181172],"about_ca_topic_score_codex":0.00006439914,"about_ca_topic_score_gemma":0.00004972839,"teacher_disagreement_score":0.018083146,"about_ca_system_score_codex":0.000004231981,"about_ca_system_score_gemma":0.000009458964,"threshold_uncertainty_score":0.28128394},"labels":[],"label_agreement":null},{"id":"W1981415835","doi":"10.1182/blood-2004-04-1406","title":"Role of selectins in the triggering, growth, and dissemination of T-lymphoma cells: implication of L-selectin in the growth of thymic lymphoma","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique","funders":"Deutsches Elektronen-Synchrotron","keywords":"Selectin; Lymphoma; L-selectin; Cancer research; Immunology; Biology; Cell adhesion molecule; Cell adhesion; Cell; Genetics","score_opus":0.006916420514870149,"score_gpt":0.2668227027615756,"score_spread":0.2599062822467055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981415835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99703467,0.0006628273,0.000007070337,0.00023710626,0.0000034339048,0.00050083303,0.000005321685,0.0000040786817,0.0015446753],"genre_scores_gemma":[0.99942595,0.0003172453,0.00015835991,0.000015953041,0.000018649182,0.000029732333,0.000005885135,0.000011834229,0.000016367265],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986111,0.00017205,0.0004728259,0.00016498867,0.00042064133,0.0001584051],"domain_scores_gemma":[0.9987959,0.00054085406,0.00022263378,0.0002663797,0.00015035443,0.000023848504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069075683,0.00009548505,0.0002614484,0.0002861351,0.000017589051,0.0000040858713,0.00021737881,0.00007482525,0.000009416086],"category_scores_gemma":[0.00043621295,0.000063773616,0.000055712226,0.0008842268,0.000093305614,0.000044357334,0.000035275185,0.00008296733,5.829528e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012039824,0.0017479094,0.03422274,0.00024852552,0.000018263328,0.0000014361254,0.0036482133,9.0401244e-7,0.9509405,0.0003286315,0.0000268141,0.008695664],"study_design_scores_gemma":[0.00126475,0.00027077345,0.33393285,0.00009122603,0.00003441689,0.000026921563,0.0006894565,0.00010885231,0.66344696,0.000088374174,0.000011799432,0.000033610384],"about_ca_topic_score_codex":0.00041213588,"about_ca_topic_score_gemma":0.00011011136,"teacher_disagreement_score":0.2997101,"about_ca_system_score_codex":0.000026490876,"about_ca_system_score_gemma":0.000096698954,"threshold_uncertainty_score":0.26006126},"labels":[],"label_agreement":null},{"id":"W1981652399","doi":"10.1182/blood-2009-10-245175","title":"Response: MRP4 gene polymorphisms and treatment response in adult ALL","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Gene; Genetics; Biology; Internal medicine","score_opus":0.017342578618062546,"score_gpt":0.28897178964011594,"score_spread":0.2716292110220534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981652399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868128,0.0003579657,0.000015250927,0.011960378,0.00001692066,0.00046206874,0.000016332711,0.00005465602,0.00030363718],"genre_scores_gemma":[0.9947507,0.00014128965,0.0015286717,0.001256881,0.000095366115,0.00002695242,0.000012685221,0.000022177986,0.0021653268],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99835575,0.00027772743,0.00025274308,0.00035306078,0.00033108777,0.00042961838],"domain_scores_gemma":[0.998726,0.0004956112,0.000037367492,0.00040253098,0.00005553911,0.00028297034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052046415,0.0001868806,0.0003176032,0.00028342998,0.000037348556,0.000018475697,0.00008302407,0.00013881533,0.000038254308],"category_scores_gemma":[0.0006596923,0.00014757726,0.0000515471,0.0002406504,0.000072736,0.00004579725,0.000032542383,0.00013226387,0.000060673137],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09753205,0.002807945,0.024938557,0.000014193598,0.00027046617,0.008544422,0.0023426153,0.000002208931,0.8433139,0.00008507028,0.0010709543,0.019077672],"study_design_scores_gemma":[0.039613865,0.009439271,0.79158676,0.000110472196,0.00021551807,0.0012818394,0.00008030781,0.00015576677,0.1537971,0.00007461753,0.003388578,0.00025592025],"about_ca_topic_score_codex":0.000103381106,"about_ca_topic_score_gemma":0.0000089379055,"teacher_disagreement_score":0.7666482,"about_ca_system_score_codex":0.0004852101,"about_ca_system_score_gemma":0.000558044,"threshold_uncertainty_score":0.60180265},"labels":[],"label_agreement":null},{"id":"W1981670631","doi":"10.1182/blood-2007-11-126029","title":"FcγR-stimulated activation of the NADPH oxidase: phosphoinositide-binding protein p40phox regulates NADPH oxidase activity after enzyme assembly on the phagosome","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institute of General Medical Sciences; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Phagosome; NADPH oxidase; Internalization; Cell biology; Superoxide; Phagocytosis; Chemistry; Oxidase test; Immunoprecipitation; Wortmannin; Phosphatidylinositol; Biology; Biochemistry; Signal transduction; Receptor; Reactive oxygen species; Enzyme","score_opus":0.015628387040202585,"score_gpt":0.20980659408131422,"score_spread":0.19417820704111163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981670631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969107,0.00023854297,0.000040345134,0.0008484461,0.00024228971,0.0012873664,0.000092441674,0.00010617929,0.00023370156],"genre_scores_gemma":[0.99712825,0.00001886468,0.000045975456,0.00034386883,0.000057878402,0.00021137274,0.000038800492,0.000057367062,0.0020976262],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99743325,0.0006877756,0.00045779886,0.00060055923,0.00019772546,0.0006229101],"domain_scores_gemma":[0.9980657,0.00037443038,0.0004241511,0.0009170482,0.00016989396,0.0000487901],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036930648,0.0004798934,0.0004984918,0.0001425083,0.0007365158,0.000027227286,0.0005675653,0.00038877706,0.00046896198],"category_scores_gemma":[0.0001955992,0.00029744953,0.00027777912,0.0005352562,0.00034499896,0.00027396376,0.00022311909,0.0007358394,0.00023658782],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005838273,0.000880244,0.00042154905,0.000027631155,0.00033061704,0.00003671871,0.0003060977,0.000008337035,0.99591064,0.0010487154,0.00024070963,0.00020493333],"study_design_scores_gemma":[0.0025626053,0.00040261252,0.014367497,0.00028535607,0.00010761821,0.00008880951,0.000050968545,0.000004990947,0.98121,0.00017604318,0.00039403388,0.0003494693],"about_ca_topic_score_codex":0.00017730647,"about_ca_topic_score_gemma":0.0000135745495,"teacher_disagreement_score":0.014700624,"about_ca_system_score_codex":0.00007829589,"about_ca_system_score_gemma":0.00014059019,"threshold_uncertainty_score":0.9999478},"labels":[],"label_agreement":null},{"id":"W1981728331","doi":"10.1182/blood-2011-04-346528","title":"Noninvasive bioluminescent imaging of primary patient acute lymphoblastic leukemia: a strategy for preclinical modeling","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"bioluminescence and chemiluminescence research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; University of British Columbia","funders":"National Cancer Institute","keywords":"Leukemia; Medicine; Limiting; Clinical endpoint; Minimal residual disease; Cancer research; Immunology; Oncology; Clinical trial; Pathology","score_opus":0.04004296023512451,"score_gpt":0.28196191220613454,"score_spread":0.24191895197101002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981728331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947987,0.00090591947,0.0028951557,0.000014715005,0.000075236196,0.0004414101,0.00006289496,0.000015245925,0.00079072523],"genre_scores_gemma":[0.9970504,0.0003573328,0.0019851935,0.00007134751,0.00016109506,0.00010324457,0.00016734682,0.000032976266,0.00007106301],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983794,0.000028964905,0.00045450535,0.00049998035,0.0001857575,0.00045141106],"domain_scores_gemma":[0.99897313,0.000023056964,0.00013826686,0.00040092118,0.00032812124,0.0001364804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015617361,0.00021435958,0.00027700188,0.000052028776,0.00006414693,0.000013011897,0.00031158965,0.0001843324,0.0000097692555],"category_scores_gemma":[0.000098588804,0.00019576905,0.00020274235,0.00010669851,0.000159568,0.000011393164,0.00017721124,0.00009757528,0.0000034265067],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037318352,0.0007895995,0.008175667,0.00019284905,0.00020724686,0.000019676816,0.00011491731,0.000031332966,0.9864621,0.0000206727,0.00018041908,0.0034323048],"study_design_scores_gemma":[0.0019590186,0.0008604227,0.00031811476,0.00009830817,0.0001652913,0.00007542689,0.00021255323,0.0019159284,0.99397093,0.000050220267,0.000081773156,0.00029202402],"about_ca_topic_score_codex":0.000047772457,"about_ca_topic_score_gemma":0.0000075644957,"teacher_disagreement_score":0.007857552,"about_ca_system_score_codex":0.000029385572,"about_ca_system_score_gemma":0.000472961,"threshold_uncertainty_score":0.79832304},"labels":[],"label_agreement":null},{"id":"W1981787650","doi":"10.1182/blood-2012-11-468678","title":"Gas6 gains entry into the coagulation cascade","year":2013,"lang":"en","type":"letter","venue":"Blood","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Coagulation; Platelet; GAS6; Coagulation cascade; Thrombosis; Endothelium; Medicine; Platelet activation; Internal medicine; Immunology; Receptor; Thrombin; Receptor tyrosine kinase","score_opus":0.01631473411676731,"score_gpt":0.23582188312462532,"score_spread":0.219507149007858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981787650","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30567572,0.04008501,0.000095224634,0.6389531,0.0041935905,0.001839432,0.000067984445,0.0003335342,0.008756399],"genre_scores_gemma":[0.5161183,0.0010299071,0.000066941495,0.3974816,0.0041897898,0.00033167726,0.0069735083,0.00016675833,0.073641546],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99853796,0.00031775612,0.00035450968,0.00033627937,0.000065233486,0.00038828212],"domain_scores_gemma":[0.99891335,0.00015609927,0.00025626688,0.0005940048,0.00007141568,0.000008891913],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014209637,0.00029474968,0.0003329497,0.00009294519,0.0003024662,0.000047552276,0.00037366472,0.0013021596,0.0008515532],"category_scores_gemma":[0.00003881982,0.0001990719,0.00018556081,0.00009239264,0.00017993264,0.00009877002,0.00010440278,0.0012917077,0.00202119],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004617752,0.00008565345,0.00013648864,0.000029187659,0.0003644399,0.000006385558,0.00042073758,0.0000016322944,0.0540176,0.000054345714,0.942863,0.0020159509],"study_design_scores_gemma":[0.0008671224,0.000053778702,0.0024366311,0.000055193865,0.00029109468,0.00009592029,0.000033309232,0.0000042335364,0.056352656,0.0002251311,0.9393236,0.0002613069],"about_ca_topic_score_codex":0.00032771024,"about_ca_topic_score_gemma":0.000008400488,"teacher_disagreement_score":0.24147151,"about_ca_system_score_codex":0.000039142848,"about_ca_system_score_gemma":0.00005793008,"threshold_uncertainty_score":0.99999434},"labels":[],"label_agreement":null},{"id":"W1981811866","doi":"10.1182/blood-2008-08-174037","title":"Identification of tyrosine kinase, HCK, and tumor suppressor, BIN1, as potential mediators of AHI-1 oncogene in primary and transformed CTCL cells","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Biology; Cancer research; Gene knockdown; Oncogene; Molecular biology; Cell culture; Gene; Cell cycle","score_opus":0.004190354572752902,"score_gpt":0.21986978035813312,"score_spread":0.2156794257853802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981811866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99564457,0.0032210646,0.00000361084,0.00040826976,0.00003931478,0.00039254388,0.000047659134,0.000009330283,0.00023361559],"genre_scores_gemma":[0.9987173,0.00092803134,0.00013965702,0.0000817064,0.000026854685,0.0000139428785,0.000041109393,0.000008542798,0.000042819694],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99906594,0.00002132093,0.00038251284,0.00019529261,0.00020512028,0.00012979275],"domain_scores_gemma":[0.99957687,0.000033175354,0.00011446582,0.00014886298,0.00004059517,0.0000860111],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000107274835,0.000114827446,0.000327166,0.00012803722,0.000016502167,0.0000068181844,0.000035727615,0.00005851102,0.000015305965],"category_scores_gemma":[0.000017659735,0.00009563282,0.000047189493,0.00012419884,0.000050539813,0.000060887658,0.000009942949,0.000037024314,0.0000013238896],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002287873,0.0030563995,0.022911131,0.00021162808,0.0000724481,0.00009554672,0.00032138388,0.000001054517,0.9670979,0.000061785446,0.000053861804,0.0058880677],"study_design_scores_gemma":[0.006904451,0.00044433394,0.33572635,0.00007386558,0.00027807956,0.00003462404,0.00002512571,0.000008213493,0.65638137,0.000047896505,0.00002277479,0.00005293699],"about_ca_topic_score_codex":0.000082408216,"about_ca_topic_score_gemma":0.000011543492,"teacher_disagreement_score":0.31281522,"about_ca_system_score_codex":0.000033968314,"about_ca_system_score_gemma":0.00006816808,"threshold_uncertainty_score":0.38997933},"labels":[],"label_agreement":null},{"id":"W1982041993","doi":"10.1182/blood-2014-07-590323","title":"The impact of bleeding complications in patients receiving target-specific oral anticoagulants: a systematic review and meta-analysis","year":2014,"lang":"en","type":"review","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":329,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; McMaster University","funders":"","keywords":"Medicine; Gastrointestinal bleeding; Rivaroxaban; Major bleeding; Meta-analysis; Warfarin; Surgery; Internal medicine; Atrial fibrillation","score_opus":0.17264690415396125,"score_gpt":0.409953871938795,"score_spread":0.23730696778483376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982041993","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000020287884,0.99633723,0.00003291722,0.00008120713,0.000013520129,0.003285276,0.000025976582,0.000014328808,0.00018927299],"genre_scores_gemma":[0.0011962741,0.9982317,0.00018004868,0.000017251707,0.000026854093,0.00004669788,0.0001298535,0.000022812543,0.0001485087],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99739575,0.0003969551,0.0014861142,0.00027491356,0.00026772317,0.00017855068],"domain_scores_gemma":[0.997425,0.00060811127,0.0011450456,0.000636074,0.00012469129,0.00006104077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012264241,0.00030032906,0.007405528,0.0003532459,0.00007509221,0.00003931647,0.00016981208,0.0000808927,0.000044383683],"category_scores_gemma":[0.0004370396,0.00014484824,0.0024583898,0.0010731483,0.00003692387,0.000044223718,0.00007498782,0.00013165448,0.000011423573],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000025486695,0.000056296303,0.009705302,0.7767391,0.21198696,8.1585335e-7,0.000019921663,0.0000014583214,4.5171305e-8,0.00012990905,0.00013442621,0.0012231831],"study_design_scores_gemma":[0.00038234206,0.000049155973,0.0043491665,0.026924826,0.96239185,0.0000028042882,0.0000042895686,0.000008423904,3.1971314e-8,0.000008900131,0.005722411,0.00015580477],"about_ca_topic_score_codex":0.000015668416,"about_ca_topic_score_gemma":0.0000030130577,"teacher_disagreement_score":0.7504049,"about_ca_system_score_codex":0.000039309456,"about_ca_system_score_gemma":0.000030020448,"threshold_uncertainty_score":0.590674},"labels":[],"label_agreement":null},{"id":"W1982056010","doi":"10.1182/blood-2014-06-581082","title":"Selective inhibition of EZH2 and EZH1 enzymatic activity by a small molecule suppresses MLL-rearranged leukemia","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":230,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Structural Genomics Consortium; University of Toronto","funders":"National Cancer Institute; University of North Carolina at Chapel Hill; National Institutes of Health; National Institute of General Medical Sciences; Wellcome Trust","keywords":"EZH2; PRC2; Biology; Enhancer; Histone H3; Cancer research; Histone methyltransferase; Methyltransferase; Acetylation; Cell biology; Chemistry; Histone; Genetics; Gene expression; Methylation; Gene","score_opus":0.005984001887186583,"score_gpt":0.20962916953148444,"score_spread":0.20364516764429785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982056010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99473065,0.00081901194,0.0030743,0.000028726365,0.000018363027,0.00013927135,0.000020586867,0.000007868791,0.0011612028],"genre_scores_gemma":[0.9991767,0.00014758525,0.00043462237,0.000022444907,0.000050992916,0.000015944335,0.00006164031,0.000015225813,0.00007486518],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993291,0.00010246153,0.00012799191,0.00022847344,0.00008073383,0.00013122777],"domain_scores_gemma":[0.9995796,0.000027518829,0.00009677388,0.0001723893,0.00007293507,0.000050796574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014971287,0.00010971138,0.00014060509,0.000027781934,0.000043314474,0.000013481529,0.00004675083,0.00012529895,0.000003369748],"category_scores_gemma":[0.00013529492,0.000109780594,0.0000382418,0.0000581506,0.000051152914,0.0000033009978,0.000044259174,0.00005848254,0.0000010197309],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025882886,0.00010974781,0.0017776203,0.000050997274,0.00003535115,2.7239525e-7,0.000050956027,0.0000085865095,0.9970043,0.0000128582915,0.00008123025,0.00084221974],"study_design_scores_gemma":[0.00093378435,0.000334007,0.007063596,0.00001596752,0.0000465807,0.0000014398705,0.000009292444,0.00009238902,0.99075437,0.00018433527,0.0004436214,0.00012059325],"about_ca_topic_score_codex":0.000062751016,"about_ca_topic_score_gemma":0.00005013261,"teacher_disagreement_score":0.0062498846,"about_ca_system_score_codex":0.000006060194,"about_ca_system_score_gemma":0.000033992186,"threshold_uncertainty_score":0.44767228},"labels":[],"label_agreement":null},{"id":"W1982358201","doi":"10.1182/blood-2012-02-385898","title":"Beyond Hox: the role of ParaHox genes in normal and malignant hematopoiesis","year":2012,"lang":"en","type":"review","venue":"Blood","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Bundesministerium für Bildung und Forschung","keywords":"Hox gene; Homeobox; Biology; CDX2; HNF1B; Gene cluster; Gene; Genetics; Regulation of gene expression; Homeobox A1; Cancer research; Gene expression","score_opus":0.010302143932704524,"score_gpt":0.2469820035027208,"score_spread":0.23667985957001625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982358201","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009988783,0.9891833,0.0000028361474,0.0000068211193,0.00006196266,0.00032030296,0.000035479217,0.0000030149554,0.00039747954],"genre_scores_gemma":[0.009402051,0.9899809,0.0000743284,0.00000501285,0.00024241414,0.00006301437,0.000118570584,0.000028337192,0.000085367144],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990707,0.00008307907,0.00033025257,0.00023228758,0.000092575196,0.00019108223],"domain_scores_gemma":[0.9993462,0.00001625543,0.00021790541,0.00035774184,0.000024280873,0.00003763287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017398903,0.00020102074,0.00045108292,0.00005200777,0.000028437653,0.000008701453,0.00015015298,0.00032250755,0.000011594711],"category_scores_gemma":[0.000008118296,0.00014124792,0.00015059578,0.000105008796,0.00006640751,0.0000023453708,0.0001252768,0.000086610955,0.0000031382015],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011301292,0.00017372506,0.000500373,0.002959164,0.00039826336,0.000001585662,0.00006176274,0.0000034964303,0.0077162804,0.00019356434,0.00004674452,0.98793375],"study_design_scores_gemma":[0.00031813502,0.0000561695,0.00011170135,0.00067504734,0.0009161684,0.00013155825,0.000021313053,0.0000013781805,0.026712345,0.00006022935,0.970747,0.00024895003],"about_ca_topic_score_codex":0.000021868676,"about_ca_topic_score_gemma":0.000051896503,"teacher_disagreement_score":0.9876848,"about_ca_system_score_codex":0.000007348079,"about_ca_system_score_gemma":0.00009188783,"threshold_uncertainty_score":0.5759923},"labels":[],"label_agreement":null},{"id":"W1982418521","doi":"10.1182/blood-2014-04-572453","title":"Hemophagocytosis due to bone marrow ALCL, ALK–","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Hemophagocytosis; Medicine; Sputum; Thorax (insect anatomy); Bone marrow; Urine; Intensive care unit; Internal medicine; Pathology; Pancytopenia; Tuberculosis","score_opus":0.013676138536201145,"score_gpt":0.2674422231367924,"score_spread":0.25376608460059125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982418521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9296963,0.00062908075,0.00024235442,0.0027792484,0.0000622666,0.00036526957,0.0000025437453,0.000112459034,0.06611045],"genre_scores_gemma":[0.9899186,0.000030143252,0.000831191,0.0017886498,0.00018319982,0.00004924507,0.000012725447,0.000033777404,0.0071524815],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987883,0.000042954438,0.000237604,0.00024056397,0.00033355312,0.00035705257],"domain_scores_gemma":[0.99915874,0.000038981925,0.00003346086,0.00047239938,0.000080018486,0.00021637241],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003000854,0.00012716524,0.0003376565,0.00013220975,0.000084038715,0.000021265976,0.00011966443,0.0000831174,0.0006130547],"category_scores_gemma":[0.00024267899,0.000111639245,0.000095129195,0.00022225491,0.000040184954,0.00005596803,0.00008928324,0.00016755241,0.0015339329],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079227885,0.004331863,0.06989321,0.0009021471,0.00065499154,0.0011620282,0.001420681,0.000011119309,0.5585258,0.004162507,0.1287561,0.22938724],"study_design_scores_gemma":[0.011707443,0.0017377991,0.094282776,0.00024589334,0.00025876993,0.0005160934,0.00021614779,0.00019966855,0.27079606,0.00040259707,0.6190783,0.0005584714],"about_ca_topic_score_codex":0.000026083251,"about_ca_topic_score_gemma":0.000005014667,"teacher_disagreement_score":0.49032217,"about_ca_system_score_codex":0.000012280672,"about_ca_system_score_gemma":0.00006689722,"threshold_uncertainty_score":0.9992435},"labels":[],"label_agreement":null},{"id":"W1982544596","doi":"10.1182/blood.v100.10.3578","title":"Furin gene (fur) regulation in differentiating human megakaryoblastic Dami cells: involvement of the proximal GATA recognition motif in the P1 promoter and impact on the maturation of furin substrates","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Genetics and Neurodevelopmental Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Canadian Institutes of Health Research","keywords":"Furin; Motif (music); Biology; Cell biology; Gene; Genetics; Biochemistry; Enzyme","score_opus":0.01943720826644713,"score_gpt":0.21275597327042167,"score_spread":0.19331876500397455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982544596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99926966,0.0001056392,0.0000033435315,0.00008775349,0.000016051064,0.00043542718,0.000012894831,0.0000012752886,0.000067978945],"genre_scores_gemma":[0.99977773,0.000057548434,0.00003588483,0.000030248668,0.000009342509,0.000024348412,0.000048821636,0.000007954539,0.0000081316875],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99927473,0.00011406458,0.0002253373,0.00016152539,0.000119676726,0.000104672414],"domain_scores_gemma":[0.999656,0.000016041651,0.000119876284,0.00017886462,0.000019326328,0.00000986868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014869461,0.00010017638,0.00007525141,0.000031213276,0.00004728923,0.000015244593,0.00011742953,0.000047577272,0.000011128526],"category_scores_gemma":[0.000016966149,0.000054949756,0.00003354194,0.00008813498,0.0000342796,0.0000039883616,0.000047598518,0.00006872653,3.2319565e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018405946,0.00032690095,0.008948732,0.000031014144,0.000013713666,2.8819832e-7,0.00041748365,0.00004277686,0.9899359,0.000010132532,0.000008982036,0.00024568645],"study_design_scores_gemma":[0.00035886033,0.00014674815,0.450321,0.000029345141,0.000009540249,0.0000012959605,0.00009064506,0.00018040375,0.54868644,0.00013480915,5.8431795e-7,0.000040341994],"about_ca_topic_score_codex":0.000020313333,"about_ca_topic_score_gemma":0.00012986863,"teacher_disagreement_score":0.44137228,"about_ca_system_score_codex":0.0000049139326,"about_ca_system_score_gemma":0.0000076137194,"threshold_uncertainty_score":0.22407861},"labels":[],"label_agreement":null},{"id":"W1982645386","doi":"10.1182/blood-2002-07-1992","title":"Rosmarinic acid inhibits Ca2+-dependent pathways of T-cell antigen receptor-mediated signaling by inhibiting the PLC-γ1 and Itk activity","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Polysaccharides and Plant Cell Walls","field":"Agricultural and Biological Sciences","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Biotechnology Research Institute","funders":"","keywords":"Phosphorylation; Tyrosine phosphorylation; Signal transduction; Cell biology; T-cell receptor; Biology; Phosphorylation cascade; Tyrosine kinase; Tyrosine; T cell; Protein phosphorylation; Biochemistry; Protein kinase A; Immunology","score_opus":0.014648087372795982,"score_gpt":0.1773758696843821,"score_spread":0.1627277823115861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982645386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99785703,0.0007992819,6.938319e-7,0.00006548322,0.00004286472,0.00017339288,0.00013856885,0.000020253601,0.0009024135],"genre_scores_gemma":[0.9994007,0.00039670573,0.000020277577,0.000056140052,0.000035780453,0.0000055138926,0.00002833809,0.0000014325835,0.00005514103],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998894,0.00014268584,0.00022916151,0.0002584313,0.00018053576,0.00029520394],"domain_scores_gemma":[0.9993637,0.0003425087,0.0001522029,0.000045105935,0.000022574513,0.00007386803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005212926,0.00014098568,0.00019317385,0.000010535821,0.00012753118,0.00004062426,0.00013318638,0.000108114866,0.000106263455],"category_scores_gemma":[0.00007583758,0.00005449257,0.000049207934,0.00020484354,0.000040535317,0.00008409186,0.000058064597,0.00017951053,0.0000089253235],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007906304,0.000222189,0.012814838,0.000008301194,0.0000074094746,0.000002987153,0.000114593975,7.549888e-7,0.9850402,0.000014902446,0.00002612518,0.001739815],"study_design_scores_gemma":[0.0003533071,0.00009771284,0.0042541833,0.000030936073,0.000008882647,0.0000062010554,0.00021089452,0.000010435773,0.9945068,0.000043774595,0.00033765213,0.00013924143],"about_ca_topic_score_codex":0.0005072423,"about_ca_topic_score_gemma":0.0003232532,"teacher_disagreement_score":0.009466602,"about_ca_system_score_codex":0.000007049204,"about_ca_system_score_gemma":0.000013183596,"threshold_uncertainty_score":0.22221427},"labels":[],"label_agreement":null},{"id":"W1982694110","doi":"10.1182/blood-2007-07-100990","title":"Toward distinguishing LSCs from HSCs","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Population; Biology; Stem cell; Medicine; Cell biology; Environmental health","score_opus":0.027464495307856322,"score_gpt":0.2775396428704698,"score_spread":0.25007514756261345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982694110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9647543,0.0007265074,0.00028303647,0.00018463326,0.00019826951,0.00016801884,0.000013813809,0.00014728002,0.033524174],"genre_scores_gemma":[0.9923661,0.000018732495,0.005597277,0.00028890144,0.00080951804,0.000004014116,0.000083874766,0.000027336162,0.00080425007],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897903,0.000009393882,0.00020957862,0.00024750954,0.00025146612,0.0003030439],"domain_scores_gemma":[0.9992854,0.0001311875,0.00005661868,0.00031708274,0.000038785387,0.00017090718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015006331,0.00013126817,0.00021022596,0.00004138794,0.00004512953,0.000016185188,0.00008069061,0.00008857161,0.00024383735],"category_scores_gemma":[0.00031852518,0.00011464541,0.00007374187,0.0001075216,0.000028297583,0.000037331498,0.000047455276,0.0001670094,0.00018667265],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030388375,0.0028686225,0.89517176,0.00017153168,0.0012298748,0.007154693,0.003838902,0.0000013803973,0.02687797,0.0005640439,0.003423372,0.058393974],"study_design_scores_gemma":[0.03129624,0.00051027385,0.7726455,0.0005500986,0.0017949705,0.0005116761,0.00062952866,0.0000555109,0.14361483,0.00074982265,0.047058698,0.0005828887],"about_ca_topic_score_codex":0.0005893314,"about_ca_topic_score_gemma":0.000056605146,"teacher_disagreement_score":0.12252629,"about_ca_system_score_codex":0.00021111009,"about_ca_system_score_gemma":0.00012028439,"threshold_uncertainty_score":0.4675104},"labels":[],"label_agreement":null},{"id":"W1982866386","doi":"10.1182/blood-2004-05-1976","title":"Population dynamics and clonal dominance in tumors?","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Biology; Population; Evolutionary biology; Genetics; Demography","score_opus":0.01193816177904058,"score_gpt":0.2834473483126253,"score_spread":0.27150918653358475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982866386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99881536,0.00018175392,0.000022067536,0.00026678666,0.0000085475685,0.0001644178,0.000005627368,0.000010276461,0.0005251651],"genre_scores_gemma":[0.99826586,0.00003255154,0.0014740878,0.000023540877,0.000023659737,0.000010687768,0.000051787672,0.0000053174654,0.00011251838],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995869,0.000006924179,0.000077238125,0.00010350301,0.00010387241,0.00012160463],"domain_scores_gemma":[0.99983203,0.000010357373,0.000013599524,0.000070806294,0.000011107364,0.00006211271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004165874,0.000046921094,0.00009416929,0.00005063759,0.000019077634,0.000005592948,0.000014605981,0.00002456008,0.000007210552],"category_scores_gemma":[0.000043207107,0.000039450533,0.000013317674,0.000069698224,0.000016153663,0.000034035846,0.000012236188,0.00006018337,0.000008479894],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008965952,0.00043783992,0.9919972,0.00002729516,0.000014038078,0.00033372128,0.000035768997,0.000004038463,0.00025438334,0.0012882682,0.0000010065421,0.005516791],"study_design_scores_gemma":[0.008590041,0.00012519062,0.9894212,0.00007107871,0.00001238563,0.00010333883,0.000011284236,0.00026064657,0.0007200109,0.00064728945,0.0000037684138,0.00003377615],"about_ca_topic_score_codex":0.00055849494,"about_ca_topic_score_gemma":0.0005580083,"teacher_disagreement_score":0.008500381,"about_ca_system_score_codex":0.00005336508,"about_ca_system_score_gemma":0.00002687187,"threshold_uncertainty_score":0.1608746},"labels":[],"label_agreement":null},{"id":"W1982914579","doi":"10.1182/blood-2007-08-106286","title":"Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Graft-versus-host disease; Internal medicine; Biomarker; Oncology; Transplantation; Concomitant; Immunology; Cancer; Gastroenterology","score_opus":0.011996611417100391,"score_gpt":0.2735584062938819,"score_spread":0.2615617948767815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982914579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926267,0.0031956632,0.0002731454,0.0011823867,0.00047213226,0.0011049623,0.000047641202,0.00008495372,0.0010123996],"genre_scores_gemma":[0.99676335,0.00074515096,0.0006042195,0.00033855322,0.00095488474,0.000051419705,0.00047678835,0.000039165538,0.000026440055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979877,0.000096457494,0.0005713172,0.00049070106,0.0004023778,0.0004514862],"domain_scores_gemma":[0.997541,0.0013714522,0.00019761513,0.0005431635,0.00007423293,0.00027251936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058313267,0.00022235513,0.0003502765,0.00013569402,0.0000733996,0.000014090064,0.00015077354,0.00016940496,0.00010732969],"category_scores_gemma":[0.00043199825,0.00017177437,0.00013870264,0.00044085167,0.00009727578,0.00006122753,0.00003120101,0.0002731109,0.000062660874],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012083597,0.0009807263,0.9772365,0.00006898388,0.0003987531,0.01563429,0.0006336145,0.0000013107597,0.0017792056,0.00004588865,0.00083232846,0.0011800061],"study_design_scores_gemma":[0.01642453,0.00031597094,0.9797503,0.00009941592,0.0013361535,0.0003436614,0.00024237226,0.0000061213814,0.00059705554,0.000026607919,0.00067255046,0.00018530524],"about_ca_topic_score_codex":0.00087873236,"about_ca_topic_score_gemma":0.0012203609,"teacher_disagreement_score":0.015290629,"about_ca_system_score_codex":0.00017857927,"about_ca_system_score_gemma":0.00041551498,"threshold_uncertainty_score":0.7004756},"labels":[],"label_agreement":null},{"id":"W1983084203","doi":"10.1182/blood-2010-09-310342","title":"Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":429,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Peripheral T-cell lymphoma; Lymphoma; Internal medicine; International Prognostic Index; Anthracycline; Not Otherwise Specified; B symptoms; Stage (stratigraphy); T-cell lymphoma; Multivariate analysis; Oncology; Chemotherapy; Disease; Survival analysis; Gastroenterology; Cancer; Diffuse large B-cell lymphoma; T cell; Immunology; Breast cancer; Immune system","score_opus":0.04157237539381178,"score_gpt":0.2569832007150762,"score_spread":0.2154108253212644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983084203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.949072,0.0010588908,0.0000066500365,0.00027261986,0.0004235076,0.00063737127,0.00015840628,0.000069417554,0.048301134],"genre_scores_gemma":[0.99303406,0.00020059438,0.0021723206,0.0005790586,0.0005637767,0.0001493264,0.0001224139,0.00005774071,0.0031207025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99785745,0.0000619811,0.0006065071,0.0005511022,0.0005856825,0.00033729634],"domain_scores_gemma":[0.9984116,0.00014316173,0.00034138758,0.0008141621,0.00016032971,0.00012933693],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016443146,0.00034664813,0.0004766325,0.0000693034,0.00009863408,0.000045044464,0.0003314961,0.00013157254,0.0011478447],"category_scores_gemma":[0.000068970854,0.00022863327,0.00035152535,0.00015183043,0.00014935617,0.00010086983,0.00011694974,0.00005642678,0.000050723494],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033624205,0.058786474,0.84609663,0.00013572695,0.0022233513,0.024165753,0.0129907215,0.0000012964236,0.022613954,0.00027026463,0.01274733,0.016606096],"study_design_scores_gemma":[0.04885441,0.0014538434,0.4792354,0.00019902179,0.0014042176,0.004528923,0.0023860482,0.00005695318,0.42274082,0.00006287587,0.038485978,0.0005915052],"about_ca_topic_score_codex":0.008273018,"about_ca_topic_score_gemma":0.00030514947,"teacher_disagreement_score":0.40012687,"about_ca_system_score_codex":0.0002237492,"about_ca_system_score_gemma":0.00052773114,"threshold_uncertainty_score":0.9997652},"labels":[],"label_agreement":null},{"id":"W1983263255","doi":"10.1182/blood-2006-10-052787","title":"Serotonin provides an accessory signal to enhance T-cell activation by signaling through the 5-HT7 receptor","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":351,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Robarts Clinical Trials","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Autocrine signalling; Receptor; Signal transduction; Cell biology; Biology; 5-HT receptor; Serotonin; Immune receptor; Biochemistry","score_opus":0.017783765664830826,"score_gpt":0.2671376262674251,"score_spread":0.24935386060259426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983263255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99267673,0.00005651024,0.0020081075,0.00077874004,0.0000737821,0.0005974143,0.0000159528,0.00013763104,0.0036551098],"genre_scores_gemma":[0.9964123,0.000005353883,0.0005266239,0.0018357943,0.00016544765,0.00011368624,0.000008869077,0.000027347425,0.00090462837],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99855727,0.00015517796,0.00019864418,0.00047277322,0.00029967102,0.00031645913],"domain_scores_gemma":[0.99929464,0.0002636503,0.0001052297,0.00025851573,0.000027422004,0.000050545303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011407319,0.00016562933,0.000110536144,0.000030654344,0.00028280308,0.0001678176,0.00045584465,0.00006367702,0.00016857187],"category_scores_gemma":[0.00010803015,0.00012653686,0.00004452378,0.00033890657,0.000072922696,0.00053838507,0.000053447533,0.00015275067,0.00010661423],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025657715,0.0005156981,0.00006410062,0.00001226714,0.0000016608623,8.258937e-7,0.0003550948,0.00015172176,0.9951543,0.00026351475,0.002608417,0.0008467498],"study_design_scores_gemma":[0.00038091643,0.00013781889,0.000093699826,0.000016814669,0.0000053522617,0.0000010058548,0.00014088664,0.000022338516,0.98975295,0.00096292945,0.008300406,0.00018488916],"about_ca_topic_score_codex":0.00009717782,"about_ca_topic_score_gemma":0.000009879632,"teacher_disagreement_score":0.005691989,"about_ca_system_score_codex":0.000016205691,"about_ca_system_score_gemma":0.000041541316,"threshold_uncertainty_score":0.51600236},"labels":[],"label_agreement":null},{"id":"W1983279908","doi":"10.1182/blood-2009-07-230656","title":"Oral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children's Oncology Group CCG-1952 clinical trial","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"National Cancer Institute","keywords":"Medicine; Internal medicine; Acute lymphocytic leukemia; Lymphoblastic Leukemia; Leukemia; Mercaptopurine; Clinical trial; Oncology; Pediatrics","score_opus":0.014270289018594633,"score_gpt":0.3198881195477934,"score_spread":0.3056178305291988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983279908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961962,0.00009930927,0.00005984759,0.00044369473,0.0007295561,0.002078925,0.00020277803,0.000051895597,0.00013778203],"genre_scores_gemma":[0.9965796,0.00021795943,0.0018550118,0.00010960496,0.00087479013,0.00006136028,0.00013366944,0.00007970098,0.00008830705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957348,0.00043040366,0.0012050916,0.00083392806,0.0010876919,0.0007080694],"domain_scores_gemma":[0.99649864,0.0006779419,0.00071169017,0.0011224183,0.00029863752,0.00069065],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016904265,0.00042940266,0.0011888235,0.00022734667,0.00019699465,0.000038726823,0.0004764462,0.00044744895,0.00007827095],"category_scores_gemma":[0.0034802589,0.00027598662,0.00026846415,0.00056325283,0.0012664328,0.00013724517,0.0005652781,0.0018020672,0.0000076125393],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16326928,0.0025222,0.824682,0.00002894967,0.002057508,0.0027795632,0.00016991119,0.000012299869,0.00022081393,0.00013468317,0.00047931445,0.0036434822],"study_design_scores_gemma":[0.34125772,0.010828794,0.6395849,0.00007350628,0.0030666098,0.004165979,0.000032128046,0.00010034482,0.00020576423,0.00008238112,0.00032259765,0.00027928164],"about_ca_topic_score_codex":0.0006858357,"about_ca_topic_score_gemma":0.00045598086,"teacher_disagreement_score":0.18509711,"about_ca_system_score_codex":0.0007108749,"about_ca_system_score_gemma":0.005762787,"threshold_uncertainty_score":0.99996924},"labels":[],"label_agreement":null},{"id":"W1983396968","doi":"10.1182/blood-2011-07-363333","title":"Lack of clarity in the definition of treatment-related mortality: pediatric acute leukemia and adult acute promyelocytic leukemia as examples","year":2011,"lang":"en","type":"review","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Acute promyelocytic leukemia; Acute leukemia; Leukemia; Myeloid leukemia; Acute lymphocytic leukemia; Disease; Intensive care medicine; Pediatrics; Immunology; Internal medicine; Lymphoblastic Leukemia","score_opus":0.10611909622791058,"score_gpt":0.36005899343097353,"score_spread":0.253939897203063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983396968","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28902593,0.7036275,0.0000027203982,0.000015939491,0.000052172774,0.003331764,0.0004070422,0.00004764035,0.003489283],"genre_scores_gemma":[0.008470341,0.98961884,0.00043152538,0.000031978914,0.00012287924,0.000339484,0.00071718503,0.00009115777,0.00017659621],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99595785,0.00051743933,0.0015709893,0.0007253667,0.0006500574,0.0005782868],"domain_scores_gemma":[0.99688596,0.00066837005,0.00090469356,0.0010855214,0.00026217045,0.00019329751],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006375805,0.00069181906,0.00284077,0.0005858529,0.00006199422,0.000021663165,0.00045693395,0.00096386316,0.00006608213],"category_scores_gemma":[0.0003496108,0.00043181225,0.00053411396,0.0011274391,0.00037770957,0.00010477788,0.00017847105,0.0008492821,0.00004693265],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021846488,0.011724827,0.038853947,0.322893,0.069171935,0.012024552,0.015123992,0.0000014716161,0.0002312673,0.031432938,0.0022453878,0.49411204],"study_design_scores_gemma":[0.14036211,0.029587617,0.036744405,0.058394093,0.6111311,0.029985141,0.0011965848,0.0002049782,0.00079145853,0.012971234,0.07280855,0.0058227545],"about_ca_topic_score_codex":0.0024642409,"about_ca_topic_score_gemma":0.000079005054,"teacher_disagreement_score":0.54195917,"about_ca_system_score_codex":0.0018867392,"about_ca_system_score_gemma":0.009131258,"threshold_uncertainty_score":0.9998134},"labels":[],"label_agreement":null},{"id":"W1983653170","doi":"10.1182/blood-2012-06-435347","title":"Endothelial endoglin is involved in inflammation: role in leukocyte adhesion and transmigration","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":157,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Hospital for Sick Children; Maine Medical Center Research Institute","keywords":"Inflammation; Immunology; Adhesion; Endoglin; Medicine; Biology; Chemistry; Cell biology","score_opus":0.02025095305070102,"score_gpt":0.2713220310903203,"score_spread":0.2510710780396193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983653170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99644107,0.0013515133,0.000016382919,0.0004915781,0.000021075602,0.00043224575,0.0000024717008,0.000019507072,0.0012241384],"genre_scores_gemma":[0.9986171,0.0003090214,0.0005011782,0.000107160165,0.00015993789,0.000042220094,0.000017772569,0.00001578728,0.00022980398],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99891216,0.000081149476,0.00026854457,0.0001728023,0.00028547648,0.00027989532],"domain_scores_gemma":[0.9995874,0.00006237317,0.00003197735,0.00015654996,0.000030461384,0.00013121241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034063455,0.000104287814,0.00018020067,0.00026742383,0.000022742212,0.0000133391395,0.00004573184,0.00010395781,0.00014398515],"category_scores_gemma":[0.000082228384,0.00009614297,0.00003394075,0.00023127586,0.000029883791,0.00015461273,0.000026010766,0.00021481692,0.00005009745],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018375122,0.00032624116,0.28803432,0.000073859424,0.000007856083,0.000028994578,0.0023280708,7.569406e-7,0.7006899,0.00006589648,0.000023738186,0.008236614],"study_design_scores_gemma":[0.006199868,0.0001373551,0.17966112,0.00008595316,0.000021609361,0.000021304531,0.00027445526,0.00032585286,0.81108403,0.00007854268,0.0020130128,0.00009690454],"about_ca_topic_score_codex":0.00016624367,"about_ca_topic_score_gemma":0.000360029,"teacher_disagreement_score":0.11039413,"about_ca_system_score_codex":0.000043608252,"about_ca_system_score_gemma":0.000063391955,"threshold_uncertainty_score":0.39205965},"labels":[],"label_agreement":null},{"id":"W1984008787","doi":"10.1182/blood-2011-03-341081","title":"Identification and characterization of Hoxa9 binding sites in hematopoietic cells","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Genomics and Chromatin Dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":212,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; University of Michigan","keywords":"Enhancer; Biology; Transcription factor; Hox gene; Histone; Genetics; Epigenetics; Binding site; Cell biology; Gene","score_opus":0.00784164382496769,"score_gpt":0.19289079687809582,"score_spread":0.18504915305312813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984008787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99961704,0.00004158705,0.00015072511,0.0000035957817,0.000021377353,0.000060323742,0.000010331325,0.0000017100718,0.000093319504],"genre_scores_gemma":[0.999467,0.000106870335,0.00025373013,0.0000054903776,0.000010975108,0.0000036856018,0.00006638411,0.0000057268057,0.000080109035],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996833,0.000009402866,0.0001251601,0.00010164968,0.00002483113,0.000055639182],"domain_scores_gemma":[0.9998006,0.0000013350815,0.000069032445,0.000099647725,0.000015677539,0.00001367069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000058613172,0.000042166725,0.000052382766,0.000028353315,0.000011234008,0.0000054470174,0.000044499782,0.000046475445,0.0000053383674],"category_scores_gemma":[0.000004756915,0.00004514018,0.000012680565,0.000034384928,0.000017251454,0.000001858178,0.00002790703,0.000015480606,0.0000021229941],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000027004899,0.00007390006,0.023760831,0.000024973673,0.0000061873934,2.6815883e-7,0.00017994846,2.7370305e-7,0.97585326,0.0000498035,9.056524e-7,0.000046970716],"study_design_scores_gemma":[0.00021545433,0.000030514995,0.07340242,0.000006789213,0.000009367878,0.0000026796006,0.000035320976,0.000052744446,0.9261369,0.000050634273,0.000009599712,0.000047574278],"about_ca_topic_score_codex":0.000002836603,"about_ca_topic_score_gemma":0.0000063559114,"teacher_disagreement_score":0.04971633,"about_ca_system_score_codex":0.0000012909712,"about_ca_system_score_gemma":0.000006810282,"threshold_uncertainty_score":0.18407631},"labels":[],"label_agreement":null},{"id":"W1984073642","doi":"10.1182/blood-2008-07-162503","title":"Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":2660,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto; McMaster University","funders":"European Hematology Association; GlaxoSmithKline; Amgen","keywords":"Medicine; Clinical trial; Terminology; Thrombocytopenic purpura; Comparability; Romiplostim; MEDLINE; Standardization; Intensive care medicine; Thrombopoietin; Immunology; Internal medicine; Immune system; Computer science","score_opus":0.03552023364804125,"score_gpt":0.2983182661003306,"score_spread":0.26279803245228933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984073642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99876004,0.00053956965,0.000043265765,0.00006305113,0.000036649577,0.00016585259,0.00007952178,0.000008615293,0.00030340996],"genre_scores_gemma":[0.99734735,0.0006345544,0.0014870715,0.000015870999,0.0000126203295,0.000006142577,0.0004865349,0.0000067741466,0.0000030576482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99935544,0.000014699047,0.00032048553,0.00015269867,0.00008890868,0.00006776551],"domain_scores_gemma":[0.99967444,0.000018268873,0.00012356299,0.00012615608,0.000032061598,0.000025523677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000046785073,0.00007020093,0.00027628324,0.00008681741,0.000024947276,0.000003997676,0.000031116768,0.000051955816,0.000021035527],"category_scores_gemma":[0.00004034258,0.00006371416,0.000022257043,0.00005461815,0.000081088176,0.00009121105,0.000029437717,0.000049674472,1.9456547e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000995626,0.0005806607,0.99530107,0.000008160633,0.00011804412,0.00036551908,0.00031894664,2.2743505e-7,0.0022324498,0.00004453978,0.0000011239574,0.0009297157],"study_design_scores_gemma":[0.005581188,0.00017220891,0.9908695,0.000113754686,0.00008691844,0.0012263737,0.00005174141,0.000010205875,0.0016360626,0.00019806581,0.0000058824958,0.00004809197],"about_ca_topic_score_codex":0.00031364555,"about_ca_topic_score_gemma":0.000077216755,"teacher_disagreement_score":0.0054816254,"about_ca_system_score_codex":0.0000075846297,"about_ca_system_score_gemma":0.000015999347,"threshold_uncertainty_score":0.2598188},"labels":[],"label_agreement":null},{"id":"W1984311005","doi":"10.1182/blood-2011-12-395319","title":"HES1 opposes a PTEN-dependent check on survival, differentiation, and proliferation of TCRβ-selected mouse thymocytes","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University Health Network; Ontario Institute for Cancer Research; Sunnybrook Hospital; University of Toronto","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"HES1; PTEN; Tensin; PI3K/AKT/mTOR pathway; Notch signaling pathway; Biology; T-cell receptor; Cell biology; Cancer research; Protein kinase B; Cellular differentiation; Signal transduction; T cell; Immunology; Genetics; Gene","score_opus":0.014066049425978819,"score_gpt":0.24175513516620273,"score_spread":0.2276890857402239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984311005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977577,0.0014300002,0.00022355258,0.000039751463,0.000113935035,0.00017980178,0.000027715178,0.00001694555,0.00021061231],"genre_scores_gemma":[0.9988486,0.00018672559,0.00015481457,0.000049437265,0.0002990306,0.000031883646,0.00010720125,0.00002120577,0.00030105983],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992215,0.00006450597,0.00016054028,0.00020277308,0.00015983802,0.00019083961],"domain_scores_gemma":[0.9994735,0.000016473397,0.00010004578,0.00021294554,0.00012874111,0.00006825661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012627183,0.00012996845,0.00013445728,0.000034086584,0.000048303056,0.000018218238,0.000085475986,0.0001170096,0.000016931373],"category_scores_gemma":[0.000119017706,0.00011712211,0.000033304685,0.00005839058,0.000034778015,0.000006779392,0.00004200749,0.00005838191,0.000002812492],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006409492,0.00039253914,0.07202199,0.0000300139,0.00010343188,2.0712983e-7,0.00006968362,0.000006977612,0.9268849,0.00009525294,0.00019003436,0.00014089522],"study_design_scores_gemma":[0.0009814419,0.00027059304,0.023579642,0.000013255201,0.000056949157,0.000004669119,0.000017917127,0.000012112963,0.97457594,0.000015137796,0.00033840584,0.00013393753],"about_ca_topic_score_codex":0.00001018581,"about_ca_topic_score_gemma":0.000018400435,"teacher_disagreement_score":0.048442353,"about_ca_system_score_codex":0.000008455035,"about_ca_system_score_gemma":0.000046904115,"threshold_uncertainty_score":0.4776101},"labels":[],"label_agreement":null},{"id":"W1984341697","doi":"10.1182/blood-2009-09-241851","title":"The new oral anticoagulants","year":2009,"lang":"en","type":"review","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":282,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine","score_opus":0.15252717512877012,"score_gpt":0.41082837194997474,"score_spread":0.2583011968212046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984341697","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000019308907,0.99344414,0.000008186308,0.0005919733,0.00021378382,0.00063228654,0.0000014739803,0.00006089174,0.005045334],"genre_scores_gemma":[0.000001758804,0.96799594,0.0001820681,0.00006660215,0.0018699408,7.70122e-7,0.000041162104,0.000020112198,0.029821621],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990987,0.000041935702,0.00032179977,0.00016120149,0.00019604054,0.00018030398],"domain_scores_gemma":[0.9993138,0.00011140059,0.00014520409,0.00033084708,0.000014844137,0.00008392062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014755575,0.00018931447,0.0009733751,0.00006071442,0.00007938901,0.000045858702,0.00011942188,0.000115699004,0.000049866325],"category_scores_gemma":[0.00009717044,0.00009798574,0.00044960144,0.00017885772,0.00001585676,0.000019486823,0.000037744474,0.00012969875,0.00034836843],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000030866915,0.0000054669913,0.000098506105,0.00079036487,0.00027949712,0.000018981467,0.000002488674,8.768434e-9,3.968896e-8,0.00040287292,0.008217233,0.99018145],"study_design_scores_gemma":[0.0006371508,0.000044840446,0.00019271918,0.0016888104,0.0043408647,0.000033979413,0.0000014391479,2.1742967e-7,3.6241252e-7,0.00006640842,0.992889,0.000104223946],"about_ca_topic_score_codex":0.000004252493,"about_ca_topic_score_gemma":0.0000021373783,"teacher_disagreement_score":0.99007726,"about_ca_system_score_codex":0.000010990605,"about_ca_system_score_gemma":0.00014806313,"threshold_uncertainty_score":0.44776875},"labels":[],"label_agreement":null},{"id":"W1984362058","doi":"10.1182/blood.v98.9.2791","title":"Persistent preswitch clonotypic myeloma cells correlate with decreased survival: evidence for isotype switching within the myeloma clone","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"Isotype; Immunology; Peripheral blood mononuclear cell; Antibody; clone (Java method); Biology; Bone marrow; Molecular biology; Medicine; Monoclonal antibody; Gene","score_opus":0.055722715834416986,"score_gpt":0.30931302988990567,"score_spread":0.2535903140554887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984362058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912064,0.0025581399,0.0010494732,0.0012968604,0.00020753218,0.0025331306,0.00001573906,0.00014157168,0.000991118],"genre_scores_gemma":[0.9937412,0.00027963438,0.0029903678,0.00024064977,0.00025605012,0.00030212136,0.000037550242,0.000083086255,0.0020693433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99726635,0.00015376169,0.00041538046,0.00064141466,0.00076780276,0.00075526256],"domain_scores_gemma":[0.99728173,0.0008572132,0.00019795225,0.0008707854,0.00030183647,0.0004904608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066649937,0.0003822728,0.00048455037,0.00011912084,0.00043109918,0.00009806139,0.00032972504,0.00013923293,0.00006841794],"category_scores_gemma":[0.0005048724,0.00022657849,0.00027638205,0.0003955361,0.00011752017,0.00017672258,0.000088767854,0.0004011314,0.00010472129],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04449249,0.007084044,0.7898067,0.0011050515,0.009430254,0.0031072432,0.003823909,0.00038763322,0.103104144,0.0005719482,0.0010002339,0.036086354],"study_design_scores_gemma":[0.054209284,0.010924463,0.8557988,0.0027043326,0.006423889,0.0019826838,0.002002614,0.013239252,0.047656905,0.00024420605,0.0034912005,0.0013224031],"about_ca_topic_score_codex":0.00041174632,"about_ca_topic_score_gemma":0.00026629193,"teacher_disagreement_score":0.06599207,"about_ca_system_score_codex":0.00009688752,"about_ca_system_score_gemma":0.00038758584,"threshold_uncertainty_score":0.9239602},"labels":[],"label_agreement":null},{"id":"W1984378291","doi":"10.1182/blood-2010-02-258558","title":"Nomenclature of monocytes and dendritic cells in blood","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":2425,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Nomenclature; Immunology; Biology; Dendritic cell; Immune system; Flow cytometry; Cell type; Myeloid; Plasmacytoid dendritic cell; Cell biology; Cell; Genetics; Zoology","score_opus":0.005502815312807768,"score_gpt":0.21057156837965293,"score_spread":0.20506875306684516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984378291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98698276,0.012095755,0.0000015494263,0.000037518912,0.00027982137,0.00010670675,0.0000130601775,0.000016964503,0.00046588745],"genre_scores_gemma":[0.9982167,0.00055487204,0.0002012629,0.000038281014,0.000010489466,0.00000819162,0.0000062065105,0.000010369784,0.0009536511],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993552,0.00007427598,0.00020168742,0.00014953666,0.000015528578,0.00020377545],"domain_scores_gemma":[0.9995504,0.00015532367,0.000056370187,0.0002083164,0.000021023161,0.000008541832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013913623,0.00010988622,0.00020848152,0.00011451437,0.000046192486,0.000006603841,0.00013072895,0.00023957461,0.00022138053],"category_scores_gemma":[0.000039826267,0.00009795569,0.00004037542,0.00009023575,0.00018820436,0.000054532073,0.00004057487,0.00036013522,0.000027763379],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009493751,0.0004495889,0.008373815,0.000017758877,0.000099995006,0.000006063413,0.0004353549,6.218839e-8,0.9891616,0.0005314889,0.000019383797,0.0008099367],"study_design_scores_gemma":[0.0032444748,0.00016982963,0.03062202,0.000024618193,0.000050675906,0.00012090353,0.00007793776,1.2954854e-7,0.9623938,0.00015809653,0.003030619,0.00010688324],"about_ca_topic_score_codex":0.000062589206,"about_ca_topic_score_gemma":0.000031764048,"teacher_disagreement_score":0.026767803,"about_ca_system_score_codex":0.0000013662707,"about_ca_system_score_gemma":0.0000306906,"threshold_uncertainty_score":0.3994517},"labels":[],"label_agreement":null},{"id":"W1984408225","doi":"10.1182/blood-2012-12-471649","title":"Notch-HES1 signaling axis controls hemato-endothelial fate decisions of human embryonic and induced pluripotent stem cells","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Zebrafish Biomedical Research Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Induced pluripotent stem cell; Embryonic stem cell; HES1; Stem cell; Notch signaling pathway; Cell biology; Haematopoiesis; Biology; Signal transduction; Immunology; Genetics","score_opus":0.019654955257365447,"score_gpt":0.27138689948571504,"score_spread":0.2517319442283496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984408225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978585,0.00036743298,0.00067945203,0.00025132773,0.000020865875,0.00056452496,0.0000582178,0.000012467746,0.00018716925],"genre_scores_gemma":[0.9988295,0.00008234768,0.0004730453,0.000092466544,0.000094685,0.00015464603,0.000025257637,0.00002140484,0.0002266579],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987369,0.00006105321,0.00029836595,0.00033913224,0.00025707408,0.00030743302],"domain_scores_gemma":[0.9989946,0.000090179776,0.00010604859,0.00040186977,0.0001562405,0.0002510556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018460749,0.00013810127,0.00020909829,0.000059959184,0.000105283994,0.00003907048,0.0002686544,0.0001527058,0.000056154495],"category_scores_gemma":[0.000111773894,0.00011985317,0.00008508592,0.00009940752,0.00013576692,0.0000053141293,0.000196754,0.0001246686,0.000038222694],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009982624,0.00021891909,0.00015066452,0.00001532234,0.00009054243,0.0000015157543,0.000019897963,8.492146e-7,0.9973777,0.000099087454,0.00025557893,0.0017599169],"study_design_scores_gemma":[0.0017500992,0.00032107698,0.0005454545,0.000029912471,0.000035529793,0.000006359042,0.00007098729,0.000024271209,0.9959924,0.0002818771,0.0008161023,0.00012591504],"about_ca_topic_score_codex":0.00008258056,"about_ca_topic_score_gemma":0.000020293002,"teacher_disagreement_score":0.0017401166,"about_ca_system_score_codex":0.000007444866,"about_ca_system_score_gemma":0.00007793358,"threshold_uncertainty_score":0.48874703},"labels":[],"label_agreement":null},{"id":"W1984433766","doi":"10.1182/blood-2012-02-412080","title":"Thrombin generates previously unidentified C5 products that support the terminal complement activation pathway","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":199,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of British Columbia","funders":"Canadian Institutes of Health Research; CSL Behring; Canadian Blood Services; Heart and Stroke Foundation of British Columbia and Yukon; University of British Columbia; Heart and Stroke Foundation of Canada","keywords":"Thrombin; Complement component 5; Complement system; Complement membrane attack complex; Anaphylatoxin; C3-convertase; Biochemistry; Proteolysis; Cell biology; Chemistry; Coagulation; Fibrin; Complement control protein; Alternative complement pathway; Biology; Immunology; Enzyme; Platelet; Immune system; Medicine; Internal medicine","score_opus":0.06973897967794182,"score_gpt":0.29033561108895634,"score_spread":0.22059663141101452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984433766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99435097,0.00017980591,0.00015070816,0.0020471432,0.00039113802,0.0009674449,0.0000054058405,0.00009909532,0.001808268],"genre_scores_gemma":[0.9964657,0.000024493991,0.00067889737,0.00081115065,0.00051053305,0.000073646195,0.00015140575,0.000027675094,0.0012565042],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99866223,0.0000903622,0.00024858819,0.00023297404,0.00039626987,0.00036956577],"domain_scores_gemma":[0.9991379,0.00003067674,0.0001415346,0.00045914357,0.000107105465,0.00012363316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005303264,0.00017105052,0.00022810198,0.00005678121,0.00018497139,0.00004695295,0.00011395163,0.0000625604,0.00051208946],"category_scores_gemma":[0.00004512594,0.00011535865,0.00006581223,0.000170616,0.000043612432,0.00019190708,0.00006224955,0.00013793781,0.00011035635],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047481524,0.0033288088,0.026589334,0.00019981567,0.0004063565,0.000013113428,0.0027589346,9.611168e-7,0.945224,0.0121895885,0.00550824,0.003733372],"study_design_scores_gemma":[0.0017760823,0.0002127699,0.072093956,0.00005362004,0.00030988778,0.00016923879,0.0002641451,0.000009183783,0.91799176,0.00017841381,0.006797563,0.0001433992],"about_ca_topic_score_codex":0.00001671553,"about_ca_topic_score_gemma":0.0000054164852,"teacher_disagreement_score":0.045504622,"about_ca_system_score_codex":0.000025939104,"about_ca_system_score_gemma":0.00009756443,"threshold_uncertainty_score":0.5607021},"labels":[],"label_agreement":null},{"id":"W1984490937","doi":"10.1182/blood-2009-10-246967","title":"The transcription factor Gfi1 regulates G-CSF signaling and neutrophil development through the Ras activator RasGRP1","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institutes of Health","keywords":"Transcription factor; Signal transduction; Activator (genetics); Biology; Cancer research; Alternative complement pathway; Cell biology; Genetics; Immunology; Receptor; Gene; Complement system","score_opus":0.008085688747101317,"score_gpt":0.214949097803184,"score_spread":0.2068634090560827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984490937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972971,0.0016089123,0.000057266672,0.00047403484,0.000116382034,0.00020000734,0.000006481621,0.000011521857,0.00022826875],"genre_scores_gemma":[0.9988559,0.00022591726,0.00035798535,0.00013545406,0.00011802058,0.0000371709,0.000023970379,0.000016920196,0.00022866303],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99933463,0.000030131258,0.0001281158,0.00022379684,0.00009184863,0.00019145077],"domain_scores_gemma":[0.99961966,0.000019710747,0.000050873878,0.00023792249,0.000032946326,0.000038863578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006231289,0.00014104735,0.00008103271,0.000006596308,0.00042536418,0.000069843256,0.00013543747,0.00010416758,0.000009042178],"category_scores_gemma":[0.000017672739,0.00007813062,0.00004948986,0.00003612689,0.00009520364,0.000006615968,0.000038570957,0.00010638232,0.0000031358954],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003374095,0.00016552737,0.0022235643,0.0000052173345,0.00019674849,0.0000011154676,0.00030382985,0.0000010726907,0.9913783,0.0001349155,0.00009822158,0.005457767],"study_design_scores_gemma":[0.0012155616,0.0000783428,0.0068939487,0.000004583747,0.00005734172,0.0000127845,0.00012533915,0.0000014732002,0.95039636,0.00029846941,0.040793203,0.00012262158],"about_ca_topic_score_codex":0.000016596534,"about_ca_topic_score_gemma":0.00007428685,"teacher_disagreement_score":0.04098195,"about_ca_system_score_codex":0.0000020913546,"about_ca_system_score_gemma":0.00004352284,"threshold_uncertainty_score":0.32716003},"labels":[],"label_agreement":null},{"id":"W1984609493","doi":"10.1182/blood-2012-11-468868","title":"The adaptor molecule SAP plays essential roles during invariant NKT cell cytotoxicity and lytic synapse formation","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Immunological synapse; Lytic cycle; Cell biology; Signal transducing adaptor protein; Cell; Cytotoxicity; Biology; T-cell receptor; T cell; Immunology; Immune system; Signal transduction; Biochemistry; In vitro; Virus","score_opus":0.004173510079712206,"score_gpt":0.1764254414108405,"score_spread":0.1722519313311283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984609493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99734414,0.00072894123,0.00014465458,0.00018462609,0.000112873146,0.00023823876,0.0000021717751,0.000045917837,0.0011984337],"genre_scores_gemma":[0.9972369,0.0001414539,0.000011066834,0.00006375991,0.00003327354,0.000039213915,0.000029599625,0.000009012515,0.00243573],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99933505,0.00009849376,0.000200553,0.00013716752,0.000025266887,0.00020345782],"domain_scores_gemma":[0.99961984,0.00006153809,0.00009953234,0.00015747074,0.00004598929,0.000015628235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008475815,0.00010765591,0.000098566445,0.00004159629,0.00042447832,0.000063518695,0.00008711525,0.000115558716,0.00031154824],"category_scores_gemma":[0.000035348403,0.00007866006,0.000042305088,0.000040026982,0.00006404642,0.0002553332,0.000062318904,0.00018636991,0.000550142],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005379869,0.00010720152,0.00008016645,0.0000141136525,0.000055544468,9.4658554e-7,0.00019461497,0.0000014471573,0.99846554,0.000112364556,0.00091115927,0.000003111707],"study_design_scores_gemma":[0.0012729478,0.000080757505,0.0035507672,0.000013144448,0.00004770035,0.000108902736,0.00043247646,0.0000627573,0.9942668,0.000011473926,0.000054622746,0.00009762533],"about_ca_topic_score_codex":0.000081170285,"about_ca_topic_score_gemma":0.00002168565,"teacher_disagreement_score":0.0041987067,"about_ca_system_score_codex":0.00001574755,"about_ca_system_score_gemma":0.0000136318495,"threshold_uncertainty_score":0.70711464},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"bench_or_experimental","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"bench_or_experimental","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"agree"},{"id":"W1984901196","doi":"10.1182/blood-2008-04-150342","title":"HTLV-1 uses HSPG and neuropilin-1 for entry by molecular mimicry of VEGF165","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and Retrovirus Studies","field":"Immunology and Microbiology","cited_by":154,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"National Cancer Institute; National Institutes of Health","keywords":"Neuropilin 1; Internalization; Receptor; Biology; Cell biology; Neuropilin; Vasculogenic mimicry; Human T-lymphotropic virus 1; Plasma protein binding; Molecular biology; Virus; Virology; Biochemistry; Genetics; VEGF receptors; Cancer research; Vascular endothelial growth factor","score_opus":0.005358827125288726,"score_gpt":0.20458501208430332,"score_spread":0.1992261849590146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984901196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96761566,0.030761939,0.00004405509,0.00026465292,0.00014442408,0.00014381275,0.00006739879,0.000026320464,0.00093172037],"genre_scores_gemma":[0.9976602,0.00067908975,0.0001155536,0.0002711029,0.000016353233,0.0000052447117,0.000018821554,0.0000072661087,0.0012263433],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99945885,0.000031988096,0.0001428568,0.00016814056,0.000013911248,0.00018424216],"domain_scores_gemma":[0.9997364,0.000054954664,0.00005444166,0.00011441015,0.000028368313,0.000011378841],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000035793775,0.000103873375,0.00019498251,0.000028758292,0.00007652348,0.0000035542648,0.000076252385,0.00010151808,0.000012976915],"category_scores_gemma":[0.00003476268,0.00008465054,0.000059373953,0.00003213264,0.000117295465,0.00001724517,0.00003140499,0.00007632793,0.000010663045],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047283476,0.00032206438,0.0014603715,0.000023419007,0.00010496229,0.0000027447566,0.00009447657,1.9699947e-7,0.9922772,0.00022262195,0.0043163444,0.0011283024],"study_design_scores_gemma":[0.0021081762,0.0005362334,0.0019542412,0.000014183259,0.00013068596,0.000021918062,0.0000504115,1.4943102e-7,0.9587912,0.00020379649,0.036083393,0.00010562334],"about_ca_topic_score_codex":0.000009783844,"about_ca_topic_score_gemma":8.992368e-7,"teacher_disagreement_score":0.033486024,"about_ca_system_score_codex":0.0000016900538,"about_ca_system_score_gemma":0.000010105079,"threshold_uncertainty_score":0.3451949},"labels":[],"label_agreement":null},{"id":"W1984912112","doi":"10.1182/blood.v98.13.3823","title":"Characterization of the iron transporter DMT1 (NRAMP2/DCT1) in red blood cells of normal and anemic mk/mkmice","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":169,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"National Institute of Allergy and Infectious Diseases","keywords":"DMT1; Transferrin receptor; Transferrin; Iron-binding proteins; Ferritin; Reticulocyte; Biology; Endosome; Biochemistry; Hemoglobin; Chemistry; Molecular biology; Transporter; Cell biology; Receptor; Messenger RNA","score_opus":0.005078612707567902,"score_gpt":0.19460545403257942,"score_spread":0.18952684132501152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984912112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99828136,0.00023368774,0.000009118326,0.0001816093,0.000061340776,0.0002704419,0.000018830973,0.000008664084,0.0009349443],"genre_scores_gemma":[0.9989526,0.0004881218,0.00007166801,0.00014896382,0.00004055233,0.0000041746907,0.00003073598,0.000012285437,0.0002508579],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9992488,0.000029606052,0.00029076895,0.00013736114,0.00015024887,0.00014323504],"domain_scores_gemma":[0.99960035,0.000010804317,0.000113173555,0.00020774508,0.000029506298,0.000038415452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010209238,0.00009607659,0.00022833588,0.00007175634,0.000016324531,0.0000025705128,0.000067736786,0.00008070147,0.00007193251],"category_scores_gemma":[0.000010234415,0.00007273324,0.000047564732,0.00018708363,0.000068181704,0.00006536698,0.00001183281,0.000093432325,0.0000011077129],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000101512436,0.0005505938,0.22520374,0.00016912962,0.000008203024,0.000006801394,0.00069746235,9.781991e-7,0.77288985,0.000021130041,0.000004363731,0.00034621108],"study_design_scores_gemma":[0.004846249,0.000084418956,0.7093048,0.00006242348,0.00030525695,0.000024535304,0.00008968668,0.0000061748065,0.28497586,0.000007685317,0.00022716967,0.00006576757],"about_ca_topic_score_codex":0.000068157206,"about_ca_topic_score_gemma":0.00002643526,"teacher_disagreement_score":0.48791403,"about_ca_system_score_codex":0.0000019212512,"about_ca_system_score_gemma":0.000032900265,"threshold_uncertainty_score":0.29659754},"labels":[],"label_agreement":null},{"id":"W1984965357","doi":"10.1182/blood-2008-02-140616","title":"Genome-wide profiling of follicular lymphoma by array comparative genomic hybridization reveals prognostically significant DNA copy number imbalances","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"University of British Columbia","keywords":"Comparative genomic hybridization; Follicular lymphoma; Biology; Genome; Oncology; Internal medicine; Survival analysis; Multivariate analysis; Proportional hazards model; Computational biology; Gene dosage; Lymphoma; Genetics; Gene; Medicine; Immunology","score_opus":0.01849612188139503,"score_gpt":0.2535839149867676,"score_spread":0.23508779310537253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984965357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99484664,0.0010858381,0.00028337774,0.00012677311,0.00004195315,0.0011808143,0.00007842225,0.000057503014,0.0022986806],"genre_scores_gemma":[0.99371576,0.00038450398,0.0050642635,0.00013143547,0.00008199752,0.00017450542,0.0003028243,0.000025903288,0.000118777396],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99837935,0.00007013307,0.00051825814,0.0003896515,0.00033888733,0.00030370383],"domain_scores_gemma":[0.9989503,0.00017444084,0.00023619508,0.00027951124,0.000191133,0.00016843445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000115858966,0.00023976315,0.0006189752,0.000044349046,0.00010885078,0.0000131521565,0.0000947185,0.00007451482,0.000058015234],"category_scores_gemma":[0.00008398026,0.00019183982,0.000138806,0.0001827852,0.00014297558,0.00006196656,0.000021874477,0.000042294538,0.00008540817],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008513896,0.002767397,0.7674217,0.00006936096,0.00041112836,0.00013494029,0.00029844797,0.0000047555563,0.22832452,0.000067344045,0.0003710092,0.000044245055],"study_design_scores_gemma":[0.0045740493,0.0003246399,0.43345004,0.00007944967,0.00035284093,0.00011835483,0.00006295217,0.000007455101,0.5604708,0.000030506593,0.00037956078,0.00014936099],"about_ca_topic_score_codex":0.00002796063,"about_ca_topic_score_gemma":8.8786385e-7,"teacher_disagreement_score":0.33397168,"about_ca_system_score_codex":0.000100604644,"about_ca_system_score_gemma":0.0002218729,"threshold_uncertainty_score":0.78230006},"labels":[],"label_agreement":null},{"id":"W1985138828","doi":"10.1182/blood-2011-06-362830","title":"Increased incidence of non-Hodgkin lymphoma, leukemia, and myeloma in patients with diabetes mellitus type 2: a meta-analysis of observational studies","year":2012,"lang":"en","type":"review","venue":"Blood","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":213,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Center for Research Resources","keywords":"Medicine; Internal medicine; Multiple myeloma; Lymphoma; Odds ratio; Leukemia; Oncology; Diabetes mellitus; Gastroenterology; Endocrinology","score_opus":0.06594696122857649,"score_gpt":0.31083078411366805,"score_spread":0.24488382288509156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985138828","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31936923,0.68021774,7.0244334e-7,2.5368306e-7,0.000020869637,0.00020899797,0.00017190352,0.000001247516,0.0000090247195],"genre_scores_gemma":[0.03834298,0.9605899,0.0003288501,0.000029762003,0.000043159587,0.000097807875,0.0005321618,0.000023601026,0.0000118066],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99834156,0.00017428045,0.0006240332,0.00037531878,0.0002653833,0.00021940857],"domain_scores_gemma":[0.9984665,0.00009823185,0.0006246638,0.0004223437,0.00032744103,0.000060828603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037862652,0.00031549312,0.0026240805,0.00019970491,0.000019409536,0.00000601522,0.00020309073,0.00020544782,0.000020771973],"category_scores_gemma":[0.00012976966,0.00022262303,0.0004840678,0.0006013856,0.00013598819,0.000007729947,0.00012615137,0.000057716727,6.185505e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000750694,0.000978394,0.118308924,0.010739078,0.33624178,0.0000012651997,0.00013596448,0.000010381813,0.00010148664,0.000031078034,0.000051205483,0.5333254],"study_design_scores_gemma":[0.00241433,0.00052678556,0.10214781,0.00081367034,0.74885374,4.7529616e-7,0.000023140556,0.0000035480512,0.0023565039,0.00001605883,0.14197418,0.0008697336],"about_ca_topic_score_codex":0.000037489248,"about_ca_topic_score_gemma":0.00008262669,"teacher_disagreement_score":0.5324556,"about_ca_system_score_codex":0.000020734737,"about_ca_system_score_gemma":0.00030600003,"threshold_uncertainty_score":0.90783036},"labels":[],"label_agreement":null},{"id":"W1985318238","doi":"10.1182/blood-2003-01-0116","title":"Factor V New Brunswick: Ala221Val associated with FV deficiency reproduced in vitro and functionally characterized","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"In vitro; Biology; Internal medicine; Molecular biology; Chemistry; Medicine; Genetics","score_opus":0.023672403905911524,"score_gpt":0.23851323596862023,"score_spread":0.2148408320627087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985318238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99717873,0.00015589675,0.000101590886,0.00040151447,0.00009380741,0.00033776785,0.0000035518503,0.0000834196,0.0016436977],"genre_scores_gemma":[0.99723727,0.0000124815015,0.00090370065,0.00039824197,0.000045664132,0.0000056041604,0.00003598933,0.000024202234,0.001336871],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99879813,0.000064018466,0.0002365575,0.00038920718,0.000271984,0.00024007274],"domain_scores_gemma":[0.9993962,0.000042055435,0.00010095213,0.00023559487,0.000071190625,0.0001539959],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020362153,0.0001587755,0.00031540915,0.00011257397,0.000054206732,0.000023555564,0.000036167483,0.00010025512,0.00018887795],"category_scores_gemma":[0.0003158164,0.0001315466,0.000040492592,0.00029756702,0.00002545415,0.000082775085,0.000012174958,0.0001610502,0.000013988623],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028616775,0.0015021382,0.080528125,0.000021627005,0.00016006046,0.000036442543,0.00031103697,4.072683e-7,0.9144137,0.0019226983,0.000020298055,0.0007973136],"study_design_scores_gemma":[0.011736985,0.0003869365,0.8042052,0.00006811915,0.00021970608,0.0000923916,0.00004401351,0.00001219121,0.18265559,0.00015781757,0.0002284474,0.00019262901],"about_ca_topic_score_codex":0.000046795543,"about_ca_topic_score_gemma":0.00006363767,"teacher_disagreement_score":0.7317581,"about_ca_system_score_codex":0.000021836504,"about_ca_system_score_gemma":0.0004814857,"threshold_uncertainty_score":0.5364315},"labels":[],"label_agreement":null},{"id":"W1985410833","doi":"10.1182/blood-2008-01-128686","title":"Is allergic disease curable or transferable with allogeneic hematopoietic cell transplantation?","year":2008,"lang":"en","type":"review","venue":"Blood","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Fondation pour la Recherche Médicale","keywords":"Immunology; Medicine; Transplantation; Disease; Allergy; Hematopoietic stem cell transplantation; Pathology; Internal medicine","score_opus":0.033608583852066096,"score_gpt":0.27968959862970766,"score_spread":0.24608101477764155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985410833","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004464989,0.9937722,0.0002374709,0.000105274215,0.00005904435,0.0013810484,0.00013409452,0.00010360166,0.0037607832],"genre_scores_gemma":[0.00048564075,0.9906255,0.00043538972,0.00027301133,0.00015248504,0.00012522447,0.0010443007,0.00013260765,0.0067258556],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978634,0.00008888889,0.0006046659,0.00059316395,0.0004698822,0.00037998336],"domain_scores_gemma":[0.99881613,0.000079132784,0.00015192971,0.000473205,0.00010263658,0.00037697778],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00005082195,0.0005464427,0.0015249347,0.00015409254,0.00016265301,0.000029385765,0.00012852481,0.00025119729,0.0007567887],"category_scores_gemma":[0.000006549923,0.00034955656,0.00043134255,0.000357027,0.00006745606,0.00007490708,0.0000064045025,0.0003073475,0.00014683051],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033815377,0.018186161,0.00084685406,0.6244563,0.009783453,0.113490015,0.009029287,0.00011111331,0.000028678349,0.00052820425,0.023250954,0.19690745],"study_design_scores_gemma":[0.0056496817,0.0005348586,0.000049482715,0.018975815,0.009372944,0.009103316,0.000034288307,0.000009853216,0.000053050837,0.000014217814,0.9553481,0.0008543899],"about_ca_topic_score_codex":0.000012416417,"about_ca_topic_score_gemma":0.000010131044,"teacher_disagreement_score":0.93209714,"about_ca_system_score_codex":0.000031817828,"about_ca_system_score_gemma":0.0010017302,"threshold_uncertainty_score":0.99989563},"labels":[],"label_agreement":null},{"id":"W1985469556","doi":"10.1182/blood-2003-01-0288","title":"Bacterial lipopolysaccharide directly induces angiogenesis through TRAF6-mediated activation of NF-κB and c-Jun N-terminal kinase","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Angiogenesis; Tumor necrosis factor alpha; Cell biology; NF-κB; Signal transduction; Lipopolysaccharide; Basic fibroblast growth factor; Cancer research; Kinase; Cytokine; Biology; Chemistry; Receptor; Immunology; Growth factor; Biochemistry","score_opus":0.012092498646502267,"score_gpt":0.22365073887441606,"score_spread":0.21155824022791378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985469556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980061,0.0010634894,0.000020823534,0.00005010877,0.00026430032,0.00015634549,0.0000137285815,0.00003582221,0.0003892623],"genre_scores_gemma":[0.9993945,0.00016699356,0.00010362265,0.000027726062,0.000032696084,0.000016264657,0.00009693738,0.000012301472,0.00014898009],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990466,0.00024954698,0.00028934664,0.00018360499,0.000033789547,0.00019709243],"domain_scores_gemma":[0.9994679,0.00014404579,0.0001658531,0.00015564023,0.00005410448,0.000012448701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018414245,0.00014026529,0.00022828454,0.00009633416,0.00010382606,0.000012154719,0.00007424843,0.00022619017,0.00023950501],"category_scores_gemma":[0.00022073058,0.00012853119,0.0000745657,0.00010719994,0.00010216512,0.00022905286,0.000019702087,0.00008920218,0.000035545134],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023744523,0.00019609193,0.0004204138,0.000018942603,0.00017222256,0.000003868603,0.0007019045,1.5657172e-7,0.9959782,0.00025354078,0.000046109944,0.001971134],"study_design_scores_gemma":[0.0020290355,0.00017701255,0.003143561,0.00003424166,0.00011851879,0.000068024405,0.00016891798,2.0663094e-7,0.99092644,0.00004929285,0.003148574,0.00013615604],"about_ca_topic_score_codex":0.00009635299,"about_ca_topic_score_gemma":0.000004809277,"teacher_disagreement_score":0.005051711,"about_ca_system_score_codex":0.000008755529,"about_ca_system_score_gemma":0.000067329005,"threshold_uncertainty_score":0.52413493},"labels":[],"label_agreement":null},{"id":"W1985479322","doi":"10.1182/blood-2008-04-152710","title":"HES1 is a novel interactor of the Fanconi anemia core complex","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval","funders":"Canadian Institutes of Health Research; Hospital for Sick Children","keywords":"Fanconi anemia; Biology; Interactor; HES1; Genetics; Computational biology; Evolutionary biology; DNA repair; DNA; Gene; Notch signaling pathway","score_opus":0.031044257727089,"score_gpt":0.25012018250770707,"score_spread":0.21907592478061808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985479322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99824935,0.00008597507,0.00012346184,0.000060015744,0.00009637212,0.000108321234,0.0000525209,0.00000837364,0.0012155863],"genre_scores_gemma":[0.9972637,0.0000146061975,0.0013402158,0.0004671459,0.00007741008,0.000005897041,0.000018296165,0.000013431999,0.00079929654],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994733,0.000010497279,0.0001297068,0.00017095453,0.00009553002,0.00012004386],"domain_scores_gemma":[0.9994459,0.0000054948514,0.000075244236,0.0003913583,0.000049971488,0.00003201895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000031546548,0.000088466026,0.000097790726,0.0000105286235,0.000042397452,0.000002894108,0.00022784574,0.00007627708,0.00006168524],"category_scores_gemma":[0.000032356136,0.000065772474,0.00010136295,0.000048432183,0.000070860886,0.000001175513,0.00013392136,0.000053306827,0.0000072491985],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000116860265,0.00017409075,0.0044932035,0.00001010774,0.000033001626,0.0000016405762,0.000101195255,5.791401e-7,0.9931746,0.000057213023,0.0018955069,0.000047143254],"study_design_scores_gemma":[0.00078891276,0.00011930655,0.010209117,0.000010385501,0.000019898514,0.000100206285,0.000025417725,0.000016322045,0.9774674,0.000023655442,0.011133402,0.000085982574],"about_ca_topic_score_codex":0.000015859614,"about_ca_topic_score_gemma":0.000010869908,"teacher_disagreement_score":0.015707238,"about_ca_system_score_codex":0.000003156526,"about_ca_system_score_gemma":0.00004761706,"threshold_uncertainty_score":0.26821238},"labels":[],"label_agreement":null},{"id":"W1985577080","doi":"10.1182/blood-2012-06-435875","title":"Methemoglobinemia and ascorbate deficiency in hemoglobin E β thalassemia: metabolic and clinical implications","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Heme Oxygenase-1 and Carbon Monoxide","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Medical Research Council; Wellcome Trust; March of Dimes Foundation","keywords":"Methemoglobin; Thalassemia; Methemoglobinemia; Hemoglobin; Haptoglobin; Medicine; Internal medicine; Ascorbic acid; Endocrinology; Population; Anemia; Hemolytic anemia; Oxygen–haemoglobin dissociation curve; Hemoglobinopathy; Immunology; Chemistry","score_opus":0.014635569154630176,"score_gpt":0.29222665583391744,"score_spread":0.2775910866792873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985577080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98605436,0.011578646,0.000065364795,0.0001755941,0.00005071584,0.00013604597,0.000012796222,0.000010603376,0.0019158755],"genre_scores_gemma":[0.99657744,0.0017772575,0.0010816244,0.00022432572,0.00015622929,0.000024978335,0.000018753235,0.000015238668,0.00012415765],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989989,0.000082038525,0.00025822027,0.0002950447,0.000058610527,0.0003072163],"domain_scores_gemma":[0.9994347,0.000027330976,0.000055879307,0.00028436707,0.000023035534,0.00017466534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004522935,0.00013316389,0.00018066297,0.000036859255,0.000042575593,0.000016201782,0.00009768343,0.0001757023,0.000003988795],"category_scores_gemma":[0.00011083633,0.000121401405,0.000053385756,0.00010481528,0.00008232324,0.0000073018186,0.00012716914,0.00011664309,0.00000460352],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009994065,0.0003501108,0.6603983,0.000010889803,0.00003804934,0.0000012731082,0.00003129223,2.7104164e-7,0.33393312,0.0011131427,0.00024197563,0.0038715794],"study_design_scores_gemma":[0.0017769953,0.0001120322,0.8515716,0.000008625288,0.00013628605,0.00010617151,0.00006290872,0.000006228862,0.13420053,0.00022703159,0.011505145,0.00028643236],"about_ca_topic_score_codex":0.000021014184,"about_ca_topic_score_gemma":0.000035896188,"teacher_disagreement_score":0.19973257,"about_ca_system_score_codex":0.0000030350702,"about_ca_system_score_gemma":0.000040682506,"threshold_uncertainty_score":0.49506056},"labels":[],"label_agreement":null},{"id":"W1985705917","doi":"10.1182/blood-2010-05-284919","title":"Animal model of fetal and neonatal immune thrombocytopenia: role of neonatal Fc receptor in the pathogenesis and therapy","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Canadian Blood Services; St. Michael's Hospital","funders":"Canadian Institutes of Health Research","keywords":"Pathogenesis; Immunology; Medicine; Fetus; Immune system; Immune thrombocytopenia; Receptor; Antibody; Pregnancy; Biology; Internal medicine","score_opus":0.009872125663004168,"score_gpt":0.2312062529045542,"score_spread":0.22133412724155005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985705917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935599,0.0058121015,0.0000027284023,0.00012184819,0.000012358028,0.00025548757,0.00007934546,0.0000050362937,0.00015121484],"genre_scores_gemma":[0.9980467,0.0008326495,0.0010278488,0.000024124733,0.000012110665,0.000010494099,0.000023164213,0.000010576246,0.000012351408],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9994332,0.000016409425,0.00016677627,0.00014154558,0.0001281398,0.00011390371],"domain_scores_gemma":[0.999695,0.00003240937,0.000056716777,0.0001598495,0.000024238014,0.000031775926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000102748454,0.000103765015,0.00030539202,0.000040691022,0.00002749651,0.0000053409753,0.00006295602,0.000073097865,0.000023129793],"category_scores_gemma":[0.000012124654,0.000066766464,0.000041620726,0.000066059176,0.00012668266,0.000057009747,0.00003159292,0.00010950412,8.743084e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005291363,0.000780014,0.05753907,0.000027602147,0.0001284623,0.00004296007,0.0018758605,5.771936e-7,0.8830889,0.00014553382,0.0000038055712,0.05583809],"study_design_scores_gemma":[0.02900881,0.0027220764,0.5358202,0.00007630243,0.00036091055,0.00078942644,0.0024525248,0.0016307173,0.42571005,0.00082004524,0.00029648974,0.00031244484],"about_ca_topic_score_codex":0.00010056243,"about_ca_topic_score_gemma":0.000050179377,"teacher_disagreement_score":0.4782811,"about_ca_system_score_codex":0.0000013253489,"about_ca_system_score_gemma":0.00003270093,"threshold_uncertainty_score":0.27226573},"labels":[],"label_agreement":null},{"id":"W1985950461","doi":"10.1182/blood-2005-12-4795","title":"Natural history of cerebral vein thrombosis: a systematic review","year":2006,"lang":"en","type":"review","venue":"Blood","topic":"Cerebral Venous Sinus Thrombosis","field":"Medicine","cited_by":244,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"Heart and Stroke Foundation of Canada","keywords":"Medicine; Natural history; Thrombosis; Deep vein; Mortality rate; Incidence (geometry); Disease; Pediatrics; MEDLINE; Surgery; Internal medicine","score_opus":0.0397837303069701,"score_gpt":0.3023351622077394,"score_spread":0.26255143190076935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985950461","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000057550324,0.9890114,5.738531e-7,0.00002609762,0.0005381737,0.00527829,0.000051604886,0.00014750949,0.0049406085],"genre_scores_gemma":[0.00001434229,0.9937757,0.00025151076,0.00024248798,0.0002495711,0.0003896161,0.0003386911,0.00017581198,0.0045622573],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9954038,0.00039169064,0.0023042308,0.0006446672,0.0007625728,0.00049299287],"domain_scores_gemma":[0.9962519,0.00018325396,0.0016540152,0.0015435725,0.0002071138,0.00016017209],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005181247,0.0007723398,0.010081692,0.00032558036,0.00002944403,0.000008723913,0.00047741248,0.00044468627,0.00024606322],"category_scores_gemma":[0.0004174643,0.0005882942,0.0022005306,0.0004682813,0.00015697621,0.000072259456,0.00013153568,0.00078072585,0.00026187193],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[9.780213e-7,0.0008945902,0.0000030020483,0.97982776,0.00152769,0.00002917438,0.000029644272,2.0413533e-9,0.0000019392844,0.000042131058,0.014895956,0.0027471592],"study_design_scores_gemma":[0.00053979084,0.00016976982,0.000009300389,0.75260854,0.06283124,0.0005335175,0.0000031627535,2.3171648e-7,0.0000012526831,0.0000024914993,0.18291493,0.00038577168],"about_ca_topic_score_codex":0.00012875242,"about_ca_topic_score_gemma":0.000017978113,"teacher_disagreement_score":0.22721918,"about_ca_system_score_codex":0.0010855091,"about_ca_system_score_gemma":0.0014656874,"threshold_uncertainty_score":0.99965686},"labels":[],"label_agreement":null},{"id":"W1985991486","doi":"10.1182/blood-2007-07-098236","title":"Quantitative expression profiling guided by common retroviral insertion sites reveals novel and cell type–specific cancer genes in leukemia","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont; McGill University; Institute for Research in Immunology and Cancer","funders":"Canadian Institutes of Health Research","keywords":"Insertional mutagenesis; Biology; Gene; Genetics; Gene expression profiling; Leukemia; Mutagenesis; Gene expression; Mutant","score_opus":0.02995792967573525,"score_gpt":0.3009106487291447,"score_spread":0.27095271905340945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985991486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855445,0.013317109,0.00056465116,0.000024743962,0.00004538496,0.00014451708,0.00002443011,0.0000065264294,0.00032812232],"genre_scores_gemma":[0.99481916,0.0018826236,0.002694847,0.000072994466,0.00006817647,0.000019663525,0.00012828014,0.0000137894385,0.0003004637],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99931633,0.000022661241,0.00019288858,0.00024726766,0.000070732975,0.00015009593],"domain_scores_gemma":[0.99965274,0.000010169938,0.00008023426,0.0001590439,0.00006057948,0.000037252517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017575003,0.000094421724,0.00009866669,0.000035178484,0.000054595774,0.000015879288,0.00006986977,0.000108271364,0.0000059187296],"category_scores_gemma":[0.000013577173,0.00008859953,0.000019089195,0.000094914,0.00003438654,0.0000067845294,0.00003444007,0.00006343325,0.0000015533374],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007124816,0.00008146789,0.038796883,0.000014582605,0.0000060417237,6.657308e-7,0.00004173111,0.000020674557,0.95952266,0.000033589145,0.0009901518,0.00042030093],"study_design_scores_gemma":[0.00079818576,0.00012018458,0.014934387,0.000022756714,0.000008391319,0.0000016520852,0.000114042086,0.000027616727,0.9815093,0.000015914764,0.0023267397,0.000120820594],"about_ca_topic_score_codex":0.0000884486,"about_ca_topic_score_gemma":0.000067474735,"teacher_disagreement_score":0.023862498,"about_ca_system_score_codex":0.000027017648,"about_ca_system_score_gemma":0.00003704102,"threshold_uncertainty_score":0.3612984},"labels":[],"label_agreement":null},{"id":"W1985995339","doi":"10.1182/blood-2006-05-025197","title":"Plasminogen activator inhibitor type 1 is protective during severe Gram-negative pneumonia","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Pneumonia; Klebsiella pneumoniae; Immunology; Klebsiella pneumonia; Sepsis; Plasminogen activator inhibitor-1; Biology; Plasminogen activator; Microbiology; Lung; Pathogen; Bacterial pneumonia; Respiratory disease; In vivo; Medicine; Pseudomonas aeruginosa; Internal medicine; Bacteria; Antibiotics; Gene; Escherichia coli; Endocrinology","score_opus":0.00570157995823776,"score_gpt":0.2037846075243299,"score_spread":0.19808302756609214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985995339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976683,0.00021083407,0.00003706811,0.00005298021,0.00012775841,0.00049282605,0.000059481576,0.00003770225,0.0013130335],"genre_scores_gemma":[0.99744064,0.000011700888,0.00047000794,0.000090428104,0.00082095363,0.0000927708,0.00003607749,0.000038099402,0.0009993038],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99888974,0.000042829695,0.00017096986,0.00043577072,0.00015798063,0.0003027097],"domain_scores_gemma":[0.9994334,0.000005630986,0.00009422077,0.0002872664,0.00010497235,0.000074530144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000053426316,0.00021265984,0.00014668761,0.00003838385,0.00014527813,0.00002871425,0.00013804893,0.00020882933,0.000039182516],"category_scores_gemma":[0.000048117174,0.00020467183,0.00009055253,0.00011915918,0.000039115483,0.0000098137,0.00011768517,0.00013439858,0.000052613283],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011623668,0.00021577667,0.0004997094,0.0000199993,0.00007264131,0.000012798124,0.000042675314,0.0000021143248,0.99832255,0.000030952473,0.0006082474,0.000056288496],"study_design_scores_gemma":[0.0013803234,0.00037845323,0.0013128853,0.000026773032,0.00003466165,0.00004857059,0.000036885293,0.0000021594637,0.9943,0.0007463912,0.0014468866,0.00028602523],"about_ca_topic_score_codex":0.000070076414,"about_ca_topic_score_gemma":0.000015719419,"teacher_disagreement_score":0.0040225754,"about_ca_system_score_codex":0.000018667028,"about_ca_system_score_gemma":0.000082144354,"threshold_uncertainty_score":0.8346275},"labels":[],"label_agreement":null},{"id":"W1985999015","doi":"10.1182/blood-2011-06-361626","title":"Ionizing radiation–induced expression of INK4a/ARF in murine bone marrow–derived stromal cell populations interferes with bone marrow homeostasis","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer; Centre Hospitalier Universitaire Sainte-Justine","funders":"Canadian Institutes of Health Research","keywords":"Stromal cell; Bone marrow; Haematopoiesis; Lymphopoiesis; Cancer research; Biology; Senescence; Stem cell; Cell biology; Immunology","score_opus":0.041131821414773104,"score_gpt":0.2483351379391451,"score_spread":0.20720331652437202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985999015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99734277,0.0010297229,0.00007796841,0.00012716565,0.00009321127,0.00044422736,0.000023223387,0.00007528543,0.00078645855],"genre_scores_gemma":[0.99270904,0.00010105343,0.006788933,0.000049575632,0.00008364073,0.000031256954,0.00007590904,0.00004498834,0.00011562206],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982463,0.00008671708,0.00057955267,0.0003857746,0.00033987456,0.00036179606],"domain_scores_gemma":[0.99891764,0.000043449734,0.0002698872,0.00046604604,0.0001175711,0.00018543033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015673247,0.0002563022,0.0005165386,0.00045193982,0.00008192899,0.000013797544,0.00012611557,0.00013688124,0.00028036095],"category_scores_gemma":[0.000073388284,0.00021926475,0.00008302402,0.0004357836,0.00007350203,0.00020495002,0.000069727546,0.00026843013,0.000010726726],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060842175,0.0015587368,0.22080955,0.0001910697,0.000032613363,0.0001778071,0.002440275,0.0000027522487,0.77085507,0.000038116978,0.00005524029,0.0032303317],"study_design_scores_gemma":[0.004628003,0.000570463,0.39448276,0.00040417965,0.00011748307,0.000062360086,0.00078847265,0.000025186178,0.5986674,0.000028765397,0.000023416698,0.00020154273],"about_ca_topic_score_codex":0.00056306506,"about_ca_topic_score_gemma":0.00021080123,"teacher_disagreement_score":0.17367321,"about_ca_system_score_codex":0.00004214045,"about_ca_system_score_gemma":0.00010231889,"threshold_uncertainty_score":0.8941357},"labels":[],"label_agreement":null},{"id":"W1986076068","doi":"10.1182/blood-2006-03-007732","title":"HBZ, a new important player in the mystery of adult T-cell leukemia","year":2006,"lang":"en","type":"review","venue":"Blood","topic":"T-cell and Retrovirus Studies","field":"Immunology and Microbiology","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"Centre National de la Recherche Scientifique; Fondation de France; Ligue Contre le Cancer","keywords":"Biology; T-cell leukemia; Leukemia; Viral replication; Virology; Mechanism (biology); Function (biology); Human T-lymphotropic virus 1; Immunology; Cell biology; Virus","score_opus":0.019245601990149956,"score_gpt":0.25018365709344453,"score_spread":0.23093805510329457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986076068","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007987354,0.9919693,0.000001026844,0.000011429558,0.0003714815,0.00048609948,0.00009009509,0.000020491516,0.0062513244],"genre_scores_gemma":[0.0005676003,0.9926889,0.000018182394,0.000049353832,0.00011322417,0.00004819594,0.00014931169,0.000028887061,0.0063363397],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980944,0.00024034079,0.000899095,0.0003364644,0.00004882817,0.00038088104],"domain_scores_gemma":[0.99877256,0.00022013296,0.0005206188,0.00044512504,0.000029821873,0.000011757558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001758221,0.00039583913,0.0015395918,0.00014100294,0.00006959723,0.000008023769,0.0004892345,0.00062184624,0.00005480295],"category_scores_gemma":[0.000029383902,0.00021319393,0.00047989129,0.00021325568,0.00013648959,0.000018477991,0.00011638029,0.0006410678,0.00021739585],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015066644,0.005864662,0.0040830807,0.06236101,0.0064974795,0.00075736374,0.004283327,0.0000017397699,0.0050544767,0.0017333982,0.22801183,0.681201],"study_design_scores_gemma":[0.0013764956,0.000107938875,0.000027717017,0.0021787167,0.0012617675,0.00016046253,0.00008550433,1.3649039e-8,0.00031925537,0.000021770184,0.9941932,0.00026716068],"about_ca_topic_score_codex":0.0011278965,"about_ca_topic_score_gemma":0.00028908456,"teacher_disagreement_score":0.76618135,"about_ca_system_score_codex":0.00003430997,"about_ca_system_score_gemma":0.00041604709,"threshold_uncertainty_score":0.8693796},"labels":[],"label_agreement":null},{"id":"W1986150666","doi":"10.1182/blood-2014-11-610857","title":"Enoxaparin for prevention of unexplained recurrent miscarriage: a multicenter randomized double-blind placebo-controlled trial","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":127,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Institut National de la Santé et de la Recherche Médicale; Sanofi","keywords":"Medicine; Recurrent miscarriage; Miscarriage; Placebo; Heparin; Low molecular weight heparin; Randomized controlled trial; Live birth; Clinical trial; Obstetrics; Pregnancy; Surgery; Internal medicine; Alternative medicine","score_opus":0.07788519094619138,"score_gpt":0.34463721645443907,"score_spread":0.26675202550824767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986150666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9677906,0.00031613105,0.004824191,0.0005530298,0.0011780227,0.023121513,0.000010725526,0.000083483945,0.0021222797],"genre_scores_gemma":[0.9916657,0.000011802731,0.0038545039,0.000059447895,0.00039853484,0.0023397175,0.00009621083,0.000030328707,0.0015437066],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99799484,0.0002473697,0.00086014206,0.00028798886,0.0003818866,0.00022774373],"domain_scores_gemma":[0.99845153,0.00027934517,0.00043418963,0.0002983788,0.0003304308,0.00020609624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016110723,0.00020573106,0.001313676,0.00015903631,0.000041091946,0.000020290734,0.000090327274,0.00015576776,0.00008936673],"category_scores_gemma":[0.00069842715,0.00015783495,0.00058841816,0.0001190155,0.000045197146,0.00006887008,0.00002980803,0.0001109656,0.000011616604],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9895749,0.003376904,0.000008799204,0.00008328163,0.00095088396,0.0000014097515,0.0003728814,0.000004017997,0.003385197,0.0016595271,0.0002218831,0.00036031083],"study_design_scores_gemma":[0.9580763,0.0018024353,0.000004206862,0.00013306542,0.0032896718,0.0000035975356,0.00009492804,0.0011401146,0.03428906,0.0007969712,0.0002318934,0.00013776426],"about_ca_topic_score_codex":0.000015326294,"about_ca_topic_score_gemma":0.000013930375,"teacher_disagreement_score":0.03149861,"about_ca_system_score_codex":0.000024263545,"about_ca_system_score_gemma":0.00015862481,"threshold_uncertainty_score":0.64363223},"labels":[],"label_agreement":null},{"id":"W1986246195","doi":"10.1182/blood-2011-09-336933","title":"Transporters in human platelets: physiologic function and impact for pharmacotherapy","year":2012,"lang":"en","type":"review","venue":"Blood","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bundesministerium für Bildung und Forschung; Deutsche Forschungsgemeinschaft; McMaster University","keywords":"Platelet; Transporter; Serotonin transporter; ATP-binding cassette transporter; Platelet activation; Cell biology; Solute carrier family; Intracellular; Serotonin Plasma Membrane Transport Proteins; Chemistry; Platelet factor 4; Biochemistry; Pharmacology; Biology; Serotonin; Receptor; Immunology","score_opus":0.058337004809952804,"score_gpt":0.36201934591982865,"score_spread":0.30368234110987585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986246195","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011548272,0.98646474,0.000094567804,0.000005591008,0.00016150982,0.0015338077,0.000072005096,0.000045222794,0.000074270516],"genre_scores_gemma":[0.012702448,0.98576164,0.0000648659,0.000042498254,0.00042105108,0.00020425687,0.00058102945,0.00006395857,0.00015824032],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99886715,0.000022001295,0.00038403668,0.00029952038,0.0000990437,0.00032824997],"domain_scores_gemma":[0.9995553,0.000023660574,0.00013540739,0.00015301765,0.000014231663,0.00011840378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016898608,0.0003450656,0.0013004597,0.00017232687,0.00004500993,0.000006573027,0.000058789163,0.0002688692,0.00009974093],"category_scores_gemma":[7.635919e-7,0.0002235802,0.00046805336,0.000128424,0.00003180613,0.000047559468,0.0000019474705,0.00024122055,0.0000025142224],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031119102,0.0020090358,0.00026305445,0.04130633,0.0012784259,0.00006445407,0.00012295836,2.7952774e-7,0.005217878,0.00008967853,0.000049493072,0.94928724],"study_design_scores_gemma":[0.015223481,0.0016551651,0.0010717167,0.012978355,0.016060406,0.00009770548,0.000045291865,0.0000015175966,0.00039995252,0.00029027788,0.95124775,0.00092838577],"about_ca_topic_score_codex":0.000006410405,"about_ca_topic_score_gemma":0.0000060721454,"teacher_disagreement_score":0.9511983,"about_ca_system_score_codex":0.00003078078,"about_ca_system_score_gemma":0.000057963753,"threshold_uncertainty_score":0.91173357},"labels":[],"label_agreement":null},{"id":"W1986692435","doi":"10.1182/blood-2004-03-0881","title":"Smad7 alters cell fate decisions of human hematopoietic repopulating cells","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"George Washington University","keywords":"Haematopoiesis; Myeloid; Biology; Cell biology; Lymphopoiesis; SMAD; Myelopoiesis; Progenitor cell; Stem cell; Signal transduction; Bone marrow; Immunology; Cell fate determination; Cancer research; Transcription factor; Genetics; Gene","score_opus":0.01469999287819056,"score_gpt":0.2584636608002336,"score_spread":0.24376366792204301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986692435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99801457,0.00054771424,0.00052228675,0.000008166017,0.000056130626,0.000100344725,0.000010986088,0.00001740284,0.0007223896],"genre_scores_gemma":[0.99645895,0.000009361749,0.0032103483,0.000040864237,0.000075083146,0.000007654767,0.00004679794,0.00002518353,0.00012574339],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990804,0.000023466228,0.00030842892,0.00027285836,0.0001256185,0.0001892294],"domain_scores_gemma":[0.99926937,0.000013528449,0.00014706644,0.00043669026,0.00004822388,0.000085105836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007916553,0.00012322502,0.00013706592,0.000034847773,0.00008669391,0.000012746074,0.00019197684,0.00008338149,0.000014052442],"category_scores_gemma":[0.00006389047,0.0001239245,0.0001135516,0.00006225961,0.00005360904,0.0000018734904,0.00009933219,0.000050694027,0.000010589457],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004727472,0.00036004084,0.0022450218,0.000029709781,0.000025469035,0.00001047049,0.00008047687,0.000679832,0.9964362,0.000027230853,0.000056937413,0.00004390014],"study_design_scores_gemma":[0.0010059583,0.00011993848,0.00065022364,0.00006136436,0.000056735236,0.000008159951,0.00005968432,0.0000011868713,0.9974667,0.00030559668,0.00012472767,0.00013971353],"about_ca_topic_score_codex":0.000023596896,"about_ca_topic_score_gemma":0.0000079070705,"teacher_disagreement_score":0.0026880614,"about_ca_system_score_codex":0.000005136005,"about_ca_system_score_gemma":0.00005432855,"threshold_uncertainty_score":0.50534946},"labels":[],"label_agreement":null},{"id":"W1986870465","doi":"10.1182/blood-2014-03-563668","title":"A rare cause of lymphocytosis","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"William Osler Health System","funders":"","keywords":"Lymphocytosis; Asymptomatic; Medicine; Pathology; Immunology; Platelet","score_opus":0.011279223280209987,"score_gpt":0.22845127681439933,"score_spread":0.21717205353418934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986870465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99282724,0.00019941646,0.000100227015,0.00018417234,0.00003753499,0.00009229951,0.0000035017433,0.00003016449,0.0065254327],"genre_scores_gemma":[0.9989468,0.00004834534,0.0005753461,0.0001815843,0.00008384434,0.000004280237,0.000005797851,0.00001041532,0.00014361911],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99956614,0.000012351171,0.00011290083,0.000100751255,0.000115275936,0.000092572875],"domain_scores_gemma":[0.99966145,0.000021480271,0.000023995704,0.00019514434,0.0000358079,0.00006211676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000060614424,0.000057412355,0.00016196299,0.000036806414,0.000018364552,0.0000022220822,0.000032732816,0.000048397127,0.000081419596],"category_scores_gemma":[0.00002324984,0.000045109005,0.00006004925,0.00008363728,0.00002102196,0.000017104878,0.000010123354,0.00003933527,0.00001953889],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030968085,0.004381704,0.6798704,0.0008377319,0.00056975964,0.00011858979,0.00094640686,0.0000013744232,0.28219742,0.003836014,0.0007900595,0.026140822],"study_design_scores_gemma":[0.021233043,0.0012788412,0.26931328,0.00033904423,0.00167193,0.00032147666,0.000054669843,0.000069108995,0.69934154,0.00023783697,0.0059402804,0.00019893958],"about_ca_topic_score_codex":0.000047786983,"about_ca_topic_score_gemma":0.000009520223,"teacher_disagreement_score":0.41714415,"about_ca_system_score_codex":0.0000034886655,"about_ca_system_score_gemma":0.000023193095,"threshold_uncertainty_score":0.18394919},"labels":[],"label_agreement":null},{"id":"W1986895359","doi":"10.1182/blood-2003-03-0940","title":"Universal prestorage leukoreduction in Canada decreases platelet alloimmunization and refractoriness","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":158,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"BC Cancer Agency; Canadian Blood Services","keywords":"Leukoreduction; Medicine; Platelet; Platelet transfusion; Internal medicine; Surgery; Immunology; Gastroenterology","score_opus":0.007136779557662425,"score_gpt":0.19345178479076394,"score_spread":0.18631500523310152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986895359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960484,0.0002500457,0.000039239996,0.0001647098,0.00010606393,0.00019967197,0.0000011019324,0.000017084276,0.0031736775],"genre_scores_gemma":[0.99899423,0.00031898552,0.00018497705,0.00009633251,0.000015715481,0.000004587755,0.00001560136,0.000008415122,0.00036115976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99955064,0.000026573802,0.00009623487,0.00012074865,0.000106716194,0.0000990786],"domain_scores_gemma":[0.99976957,0.000012124536,0.000020580059,0.00010929732,0.000022880891,0.00006556211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000049878723,0.00006629472,0.000100771096,0.000059863993,0.000026980719,0.000005745444,0.000021101805,0.000025438349,0.00006419463],"category_scores_gemma":[0.00003164929,0.000064383225,0.000008766539,0.00013369725,0.000010973272,0.000057279452,0.000008011592,0.00006786114,7.5945457e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058952963,0.00431435,0.9127469,0.00076939916,0.00061270356,0.0025103355,0.0014685667,0.00028275597,0.029987128,0.01792606,0.003028786,0.025763491],"study_design_scores_gemma":[0.019946445,0.00026353935,0.78442353,0.00022933925,0.00044590677,0.0004017472,0.0028047524,0.0000868253,0.04777769,0.000092183946,0.14311397,0.00041409468],"about_ca_topic_score_codex":0.4425247,"about_ca_topic_score_gemma":0.44069242,"teacher_disagreement_score":0.14008519,"about_ca_system_score_codex":0.00007548447,"about_ca_system_score_gemma":0.00029863336,"threshold_uncertainty_score":0.5695135},"labels":[],"label_agreement":null},{"id":"W1987100029","doi":"10.1182/blood-2010-02-270561","title":"Endothelial LSP1 is involved in endothelial dome formation, minimizing vascular permeability changes during neutrophil transmigration in vivo","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Institute of Infection and Immunity","funders":"","keywords":"In vivo; Vascular permeability; Endothelium; Permeability (electromagnetism); Endothelial stem cell; Immunology; Medicine; Chemistry; Biology; Pathology; Internal medicine; In vitro; Biochemistry; Biotechnology","score_opus":0.015471801223990406,"score_gpt":0.25663554702899005,"score_spread":0.24116374580499964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987100029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99732393,0.00010797417,0.000023237744,0.0011945554,0.00008493136,0.0008862996,0.00003252776,0.000049622373,0.0002969463],"genre_scores_gemma":[0.9983988,0.00022150797,0.0006610576,0.00015712423,0.00025902854,0.00013329998,0.000017199729,0.000034784713,0.00011724434],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980034,0.00011877088,0.00044815356,0.00040864237,0.0005587135,0.00046228606],"domain_scores_gemma":[0.9991385,0.00007902731,0.00006590257,0.00045585743,0.00010756946,0.00015315069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051612145,0.0002043768,0.0003523493,0.0004880382,0.00007374722,0.000035701356,0.00016206806,0.00019114352,0.000405256],"category_scores_gemma":[0.00021735975,0.00019355872,0.00013014357,0.0003989207,0.000082476035,0.00017823518,0.00004785559,0.00060290296,0.000026531801],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021188075,0.0006216176,0.028858485,0.00029388367,0.000017018556,0.00007763066,0.003142082,0.0000037194918,0.9662648,0.000015888694,0.000009120287,0.00048389644],"study_design_scores_gemma":[0.011044954,0.00016442506,0.07453727,0.00009740517,0.00004290362,0.00004179822,0.00033951818,0.00049525243,0.9119228,0.000070296715,0.0010494122,0.0001939607],"about_ca_topic_score_codex":0.00033834553,"about_ca_topic_score_gemma":0.0050044986,"teacher_disagreement_score":0.054341972,"about_ca_system_score_codex":0.00007876052,"about_ca_system_score_gemma":0.00010964131,"threshold_uncertainty_score":0.7893095},"labels":[],"label_agreement":null},{"id":"W1987102104","doi":"10.1182/blood-2007-01-066837","title":"Functional analysis of fibrin γ-chain cross-linking by activated factor XIII: determination of a cross-linking pattern that maximizes clot stiffness","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Blood properties and coagulation","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Fibrin; Chemistry; Factor XIII; Factor XIIIa; Tissue transglutaminase; Thrombin; Biophysics; Biochemistry; Immunology; Biology; Platelet; Enzyme","score_opus":0.03774647024733141,"score_gpt":0.2967512045201092,"score_spread":0.2590047342727778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987102104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98436236,0.00026363172,0.0147729125,0.000032871616,0.00011069388,0.00023812016,0.00007188818,0.000049561284,0.00009797474],"genre_scores_gemma":[0.99891585,0.00001269865,0.00029337907,0.00005622863,0.000102034646,0.000007334497,0.00037031499,0.000028560251,0.00021361854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981762,0.000039453258,0.0006129313,0.00032210597,0.00057902763,0.00027025762],"domain_scores_gemma":[0.9986399,0.00015772143,0.00045441228,0.00028908046,0.0003791537,0.00007975558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037118566,0.00019637126,0.00051819504,0.00036287884,0.00010325751,0.000048123784,0.00009930534,0.0001976149,0.00020713446],"category_scores_gemma":[0.00006824249,0.00017199722,0.0002487643,0.0005860589,0.000115278905,0.0002094366,0.000056310044,0.00016206662,0.0000018102386],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044278605,0.00041307366,0.6618585,0.00019874125,0.0007198101,0.0000062194117,0.0003773957,0.000098783916,0.2997656,0.0000073231176,0.0000022769736,0.036109485],"study_design_scores_gemma":[0.0021522217,0.000099779725,0.5804212,0.0001247214,0.0008192144,0.000006241583,0.000057177956,0.0013295005,0.41484484,0.000015774374,0.000019672036,0.000109677116],"about_ca_topic_score_codex":0.00022860621,"about_ca_topic_score_gemma":0.000051681065,"teacher_disagreement_score":0.115079254,"about_ca_system_score_codex":0.000038437815,"about_ca_system_score_gemma":0.000048034854,"threshold_uncertainty_score":0.7013843},"labels":[],"label_agreement":null},{"id":"W1987277594","doi":"10.1182/blood.v100.1.268","title":"Expression and subcellular localization of NRAMP1 in human neutrophil granules","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Trace Elements in Health","field":"Nursing","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Institut National de la Recherche Scientifique; Ontario Institute for Cancer Research","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Biology; Subcellular localization; Azurophilic granule; Gelatinase; Molecular biology; Polyclonal antibodies; Immunogold labelling; Exocytosis; Population; Granule (geology); Granulocyte; Cell biology; Antibody; Biochemistry; Cytoplasm; Inflammation; Enzyme; Immunology; Secretion","score_opus":0.021344357756244922,"score_gpt":0.2622150363854017,"score_spread":0.2408706786291568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987277594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99805367,0.0011913443,0.00013436482,0.0001148314,0.000090903995,0.00017033011,0.0000028279542,0.000028527786,0.00021322555],"genre_scores_gemma":[0.99937403,0.00004447049,0.0004511548,0.000043749336,0.000044100736,0.000004888873,0.0000064469054,0.0000145487065,0.000016583203],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99925536,0.000071725255,0.00023773014,0.00015327593,0.00013264784,0.00014926169],"domain_scores_gemma":[0.9996903,0.000024821189,0.00007612075,0.00015590941,0.00001662576,0.000036231428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001005324,0.00007233242,0.00011902269,0.00009108376,0.00006298823,0.000008559497,0.00005905267,0.000058232188,0.000049298844],"category_scores_gemma":[0.000018945308,0.00007313796,0.000013994513,0.000108810294,0.000039763723,0.00007198101,0.000018557264,0.0000783245,0.0000022771876],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046018118,0.0020853295,0.5479456,0.00054388813,0.000009495272,0.000018562934,0.0038452605,0.00029269236,0.43774632,0.0005598613,0.00046295652,0.0064440337],"study_design_scores_gemma":[0.007892391,0.00072731386,0.08272646,0.0006076106,0.00007361844,0.000012500959,0.0002604084,0.0022986778,0.90101177,0.0021330158,0.001905747,0.00035046405],"about_ca_topic_score_codex":0.00008480668,"about_ca_topic_score_gemma":0.00004243931,"teacher_disagreement_score":0.46521914,"about_ca_system_score_codex":0.000013718745,"about_ca_system_score_gemma":0.000001557117,"threshold_uncertainty_score":0.29824796},"labels":[],"label_agreement":null},{"id":"W1987331822","doi":"10.1182/blood.v98.8.2544","title":"Bifurcation of osteoclasts and dendritic cells from common progenitors","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Bone Metabolism and Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":276,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research & Development Corporation","funders":"","keywords":"Follicular dendritic cells; Biology; Cell biology; RANKL; Dendritic cell; Osteoclast; Cellular differentiation; Macrophage colony-stimulating factor; Precursor cell; Progenitor cell; CD11c; Granulocyte macrophage colony-stimulating factor; Molecular biology; Antigen-presenting cell; Immunology; Macrophage; Cytokine; Activator (genetics); Stem cell; T cell; Receptor; Cell; Antigen; Biochemistry; In vitro; Immune system; Phenotype","score_opus":0.0054021439133241644,"score_gpt":0.21278095116295212,"score_spread":0.20737880724962796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987331822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955539,0.003965912,0.000021874752,0.0000142754525,0.000056362067,0.00007121919,0.000039944283,0.000005026922,0.00027149325],"genre_scores_gemma":[0.99919546,0.00027315554,0.00022415446,0.00003509673,0.0001268764,0.0000061024507,0.00007507504,0.0000069687494,0.000057131678],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999636,0.000022517459,0.00009095139,0.0001259125,0.00004996672,0.000074683274],"domain_scores_gemma":[0.99974793,0.0000063274492,0.00003351568,0.00014139387,0.000023155415,0.000047690533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000021408561,0.000058292222,0.000075980526,0.000014715163,0.000019234347,0.000006871475,0.000046842208,0.00004981766,0.000008300083],"category_scores_gemma":[0.000012463507,0.000055966037,0.000027046133,0.00003227699,0.000037036876,0.0000019233219,0.00003321712,0.000016345804,0.000003006613],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023254179,0.00018421873,0.07927978,0.00000970616,0.000023385814,0.0000023543262,0.000017229566,5.8712834e-7,0.91855764,0.000014062859,0.00007798664,0.001809814],"study_design_scores_gemma":[0.00073593383,0.00006305176,0.056841142,0.000006853126,0.00008508035,0.000005498568,0.00003450471,0.0000022951804,0.93941975,0.000085280386,0.0026495098,0.00007113366],"about_ca_topic_score_codex":0.000047380534,"about_ca_topic_score_gemma":0.000022987751,"teacher_disagreement_score":0.022438642,"about_ca_system_score_codex":5.2635295e-7,"about_ca_system_score_gemma":0.000016452832,"threshold_uncertainty_score":0.22822288},"labels":[],"label_agreement":null},{"id":"W1987480239","doi":"10.1182/blood-2006-03-013599","title":"Short-term repopulating cells with myeloid potential in human mobilized peripheral blood do not have a side population (SP) phenotype","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; Deutsche Forschungsgemeinschaft; National Institutes of Health; Stem Cell Network","keywords":"Myeloid; Biology; Haematopoiesis; Immunology; Stem cell; Side population; Population; Transplantation; Phenotype; Severe combined immunodeficiency; Nod; Cancer research; Cell biology; Medicine; Internal medicine; Endocrinology; Diabetes mellitus; Cancer stem cell; Genetics; Gene","score_opus":0.011978904720991904,"score_gpt":0.2549384008614528,"score_spread":0.24295949614046092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987480239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960972,0.00006220934,0.0002753872,0.000038736973,0.00007338584,0.00087445974,0.000008173049,0.00012328888,0.0024471495],"genre_scores_gemma":[0.9946813,0.000004172539,0.004354584,0.000033836255,0.00027088108,0.000052471587,0.00027174308,0.00006964181,0.0002613593],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9977226,0.00008279136,0.000743438,0.0005236882,0.00052293483,0.00040455122],"domain_scores_gemma":[0.9992391,0.00003375865,0.00015987891,0.00039178738,0.00007625931,0.00009924297],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021848003,0.00028565727,0.00047307633,0.0001658944,0.00011698531,0.00005577756,0.00008176571,0.00017255596,0.00007210004],"category_scores_gemma":[0.0000113095875,0.0002598859,0.00010207325,0.00019117155,0.00004420386,0.00012066092,0.000016937105,0.0002434862,0.0000056399163],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025803855,0.00094819994,0.4624545,0.00026733865,0.000054202264,0.0007045443,0.0005317227,0.00065232324,0.53378797,0.00008754056,0.000002057686,0.00025156207],"study_design_scores_gemma":[0.012662976,0.00043852345,0.8282177,0.00047983916,0.0008982155,0.00043299352,0.00018089301,0.00043519287,0.15573964,0.00011194065,0.0000035756018,0.00039854195],"about_ca_topic_score_codex":0.0013383703,"about_ca_topic_score_gemma":0.000769904,"teacher_disagreement_score":0.37804833,"about_ca_system_score_codex":0.000057535253,"about_ca_system_score_gemma":0.000038184047,"threshold_uncertainty_score":0.99998534},"labels":[],"label_agreement":null},{"id":"W1987558337","doi":"10.1182/blood-2011-12-398818","title":"Zebrafish screen identifies novel compound with selective toxicity against leukemia","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Zebrafish Biomedical Research Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":157,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"National Cancer Institute","keywords":"Zebrafish; Leukemia; Biology; Cancer research; Chronic myelogenous leukemia; Cancer; PI3K/AKT/mTOR pathway; Lymphoblast; Cell culture; Immunology; Cell biology; Signal transduction; Genetics","score_opus":0.013367322446607531,"score_gpt":0.2650263775990144,"score_spread":0.25165905515240683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987558337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876576,0.00024468373,0.00402823,0.00015914289,0.000025828587,0.0002913044,0.00008092381,0.000031007876,0.007481301],"genre_scores_gemma":[0.996767,0.000033303317,0.0015921592,0.0004063985,0.00039805457,0.00007801727,0.00027710712,0.000025733018,0.00042226192],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99875903,0.00003398793,0.00014385175,0.0002941715,0.00029731504,0.00047167024],"domain_scores_gemma":[0.9991214,0.00002853125,0.000057810677,0.00036472466,0.00013376317,0.00029376056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022796655,0.00014439425,0.0001310028,0.000043687534,0.00014020017,0.00004310643,0.00027662606,0.00013279707,0.000017216724],"category_scores_gemma":[0.00015783777,0.00012352593,0.000051379353,0.00021530053,0.00023702015,0.000011861756,0.00016404138,0.00015655154,0.000039830436],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003629048,0.0005441847,0.0058957487,0.000010330586,0.00016583643,0.0000014684908,0.00003134162,0.00000173875,0.98721015,0.00014792864,0.005650883,0.00030407085],"study_design_scores_gemma":[0.0015166262,0.00019764814,0.03774704,0.0000144868,0.00004005362,0.000031785894,0.0000593938,0.000010944071,0.93870264,0.000031793643,0.021412024,0.00023558247],"about_ca_topic_score_codex":0.000045648867,"about_ca_topic_score_gemma":0.000112707115,"teacher_disagreement_score":0.048507556,"about_ca_system_score_codex":0.000033676275,"about_ca_system_score_gemma":0.00018064652,"threshold_uncertainty_score":0.50372416},"labels":[],"label_agreement":null},{"id":"W1987646940","doi":"10.1182/blood-2011-07-319749","title":"Is heparin a placental anticoagulant in high-risk pregnancies?","year":2011,"lang":"en","type":"review","venue":"Blood","topic":"Pregnancy and preeclampsia studies","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"Molly Towell Perinatal Research Foundation","keywords":"Heparin; Thrombophilia; Preeclampsia; Pregnancy; Trophoblast; Placenta; Medicine; Anticoagulant; Obstetrics; Intrauterine growth restriction; Fetus; Internal medicine; Biology; Thrombosis","score_opus":0.05786850061760634,"score_gpt":0.3083201105100696,"score_spread":0.25045160989246323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987646940","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00066489796,0.9919738,0.0000023053278,0.000014308884,0.000227318,0.0013234054,0.00016733143,0.00008174896,0.00554487],"genre_scores_gemma":[0.0005730325,0.9976183,0.0003073547,0.0000485638,0.00022358062,0.00022210205,0.00007983175,0.000063876505,0.0008633508],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978952,0.00014976253,0.0006606143,0.0005866306,0.0002134984,0.00049433904],"domain_scores_gemma":[0.9987351,0.000113077585,0.00032693913,0.0006788621,0.000025582487,0.00012044019],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020240364,0.0005299013,0.0024452852,0.00021982664,0.00006981321,0.00001300864,0.00023398068,0.00041507403,0.00013048913],"category_scores_gemma":[0.000093728704,0.00039431348,0.0004927514,0.00029815076,0.00009651615,0.000050273284,0.00022668221,0.0007503115,0.00026342724],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053132033,0.0015191576,0.03346754,0.048634596,0.0020559495,0.00082709116,0.0011079388,1.2656e-8,3.391545e-7,0.00038634962,0.001353209,0.9105947],"study_design_scores_gemma":[0.0033413176,0.00028647104,0.0049342597,0.114893146,0.00667988,0.000507099,0.0000212139,4.772277e-7,0.000020555732,0.000108290944,0.868651,0.0005563044],"about_ca_topic_score_codex":0.00036194475,"about_ca_topic_score_gemma":0.00011020051,"teacher_disagreement_score":0.91003835,"about_ca_system_score_codex":0.000052695563,"about_ca_system_score_gemma":0.00024319052,"threshold_uncertainty_score":0.99985087},"labels":[],"label_agreement":null},{"id":"W1987701504","doi":"10.1182/blood-2009-03-202267","title":"A murine model for induction of long-term immunologic tolerance to factor VIII does not require persistent detectable levels of plasma factor VIII and involves contributions from Foxp3+ T regulatory cells","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"FOXP3; Immunology; Immune tolerance; Immune system; Adoptive cell transfer; Population; IL-2 receptor; Peripheral tolerance; Transgene; Antibody; Biology; Medicine; T cell; Gene; Genetics","score_opus":0.02983635519972816,"score_gpt":0.2616778388381947,"score_spread":0.23184148363846652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987701504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951442,0.0007879465,0.0004748803,0.00018852502,0.00006866097,0.00085272826,0.002440807,0.000030750918,0.000011496427],"genre_scores_gemma":[0.9983642,0.000088797504,0.001111502,0.000059671456,0.000027395126,0.000033226584,0.00004429211,0.000013029563,0.00025788817],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99894273,0.000016070171,0.00033767876,0.00030303796,0.00015906854,0.00024141418],"domain_scores_gemma":[0.99926287,0.00005339863,0.00016743448,0.0002613026,0.00015544733,0.00009953625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000037747788,0.00019489971,0.00053757144,0.00009581785,0.000083173945,0.0000094971665,0.000072183146,0.00015188333,0.000023361768],"category_scores_gemma":[0.00004763643,0.00014535832,0.00014744264,0.00008196357,0.00006455997,0.00013682542,0.00002751751,0.00008278661,0.0000010722675],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061996543,0.0011897788,0.00445066,0.000095057156,0.00041187234,0.0000120215645,0.0007601531,0.000070389164,0.9883743,0.000016618804,0.0000043790387,0.0039947946],"study_design_scores_gemma":[0.007770659,0.0012821794,0.15038697,0.0001912273,0.00032981142,0.000012162452,0.00010292134,0.00089427055,0.83873034,0.00013838407,0.000005746872,0.00015529597],"about_ca_topic_score_codex":0.00004164845,"about_ca_topic_score_gemma":0.000037575217,"teacher_disagreement_score":0.14964394,"about_ca_system_score_codex":0.000048344617,"about_ca_system_score_gemma":0.000060689516,"threshold_uncertainty_score":0.59275407},"labels":[],"label_agreement":null},{"id":"W1988009626","doi":"10.1182/blood-2002-08-2382","title":"Effects of combined chelation treatment with pyridoxal isonicotinoyl hydrazone analogs and deferoxamine in hypertransfused rats and in iron-loaded rat heart cells","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Deferoxamine; Deferiprone; Chelation; Pharmacology; Chemistry; In vivo; Chelation therapy; Antidote; Deferasirox; Medicine; Biochemistry; Thalassemia; Internal medicine; Toxicity; Biology","score_opus":0.0045247921063720845,"score_gpt":0.19326424120382724,"score_spread":0.18873944909745516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988009626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958375,0.002947389,0.000006118127,0.00017069928,0.00002593856,0.0007867678,0.000001221239,0.000014101466,0.00021026337],"genre_scores_gemma":[0.9987921,0.0008552942,0.0001923387,0.00005595921,0.000004871268,0.00001975789,0.000007910638,0.000016735374,0.00005500541],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999155,0.0000732037,0.00022840702,0.0002349921,0.00010548345,0.00020292468],"domain_scores_gemma":[0.9996485,0.000096351905,0.000039836304,0.0001095285,0.000016458947,0.00008931955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000091408256,0.00016640221,0.00040566147,0.00014067895,0.000024041077,0.000006002781,0.000014874093,0.00013199695,0.0000054325155],"category_scores_gemma":[0.00002018553,0.00012216912,0.000026406848,0.00024361881,0.000079258185,0.000040396604,0.000004732204,0.00012476607,0.0000010716911],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006543444,0.0029265091,0.19833575,0.0003339893,0.0000756559,0.000109080895,0.00094592187,0.00004151766,0.7960594,0.00002682492,0.0000043021987,0.00048667897],"study_design_scores_gemma":[0.048623275,0.0036689057,0.11322749,0.00031379948,0.00033376637,0.0000777864,0.0002147166,0.00016827366,0.83311564,0.000017429313,0.000060140068,0.00017876436],"about_ca_topic_score_codex":0.00015453392,"about_ca_topic_score_gemma":0.00014454455,"teacher_disagreement_score":0.08510826,"about_ca_system_score_codex":0.000025935302,"about_ca_system_score_gemma":0.0000525921,"threshold_uncertainty_score":0.4981912},"labels":[],"label_agreement":null},{"id":"W1988026694","doi":"10.1182/blood-2002-02-0502","title":"Emergence of muscle and neural hematopoiesis in humans","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Zebrafish Biomedical Research Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute","funders":"Amgen","keywords":"Haematopoiesis; Biology; Bone marrow; Cell biology; Erythropoiesis; Immunology; Erythropoietin; Extramedullary hematopoiesis; Stem cell; Neuroscience; Genetics; Internal medicine; Anemia; Medicine","score_opus":0.01671353777995725,"score_gpt":0.26924118949456005,"score_spread":0.2525276517146028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988026694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974381,0.0008454694,0.000048342095,0.00027361183,0.0000056578547,0.00007228696,0.0000073359824,0.0000028540705,0.0013063413],"genre_scores_gemma":[0.9992744,0.00029765404,0.00023297589,0.00003947321,0.000021581207,0.000020281293,0.000005955524,0.000004388249,0.00010329842],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995658,0.000014513736,0.00009793097,0.00013188882,0.00007892073,0.00011095373],"domain_scores_gemma":[0.9997485,0.000007878747,0.000018098013,0.00015406344,0.000018387193,0.000053061165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000057146222,0.000039288025,0.00005387237,0.000025724168,0.000016712595,0.0000029840432,0.00009313416,0.000041238356,0.00014942426],"category_scores_gemma":[0.00009628357,0.000037837137,0.000017132892,0.000090795074,0.00008978015,0.0000013080779,0.00006490633,0.00003535174,0.0000032414491],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000020378159,0.00030010674,0.009225101,0.000022518794,0.000010001387,0.000002133,0.000047808255,3.800377e-7,0.9856468,0.00012658112,0.002122307,0.0024942465],"study_design_scores_gemma":[0.002329919,0.00046193824,0.1469073,0.000026674763,0.000024186776,0.000012383458,0.0002870341,0.00051408645,0.83801526,0.0005090896,0.01061468,0.00029743867],"about_ca_topic_score_codex":0.000017529073,"about_ca_topic_score_gemma":0.000047195044,"teacher_disagreement_score":0.14763151,"about_ca_system_score_codex":5.4645227e-7,"about_ca_system_score_gemma":0.0000049375535,"threshold_uncertainty_score":0.16360909},"labels":[],"label_agreement":null},{"id":"W1988055260","doi":"10.1182/blood-2003-11-3989","title":"ABC transporter activities of murine hematopoietic stem cells vary according to their developmental and activation status","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Zebrafish Biomedical Research Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Heart, Lung, and Blood Institute; Canadian Liver Foundation; Canadian Institutes of Health Research; University of British Columbia; National Cancer Institute; National Institutes of Health; Stem Cell Network","keywords":"Haematopoiesis; Efflux; Side population; Rhodamine 123; Stem cell; Biology; Population; Cell biology; Immunology; Fetus; In vivo; Molecular biology; Andrology; Biochemistry; Genetics; Cancer stem cell; Medicine","score_opus":0.01087577742939245,"score_gpt":0.23972011690843642,"score_spread":0.22884433947904398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988055260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965642,0.000054631586,0.0027127583,0.00016385481,0.000009266587,0.00021759924,0.00003814501,0.000008308861,0.00023124169],"genre_scores_gemma":[0.99791485,0.00007692961,0.0017604299,0.000082412895,0.000030138353,0.000047295744,0.000036702448,0.000012291233,0.00003893285],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993488,0.00001066762,0.00013224706,0.00019384215,0.0001244244,0.00018997982],"domain_scores_gemma":[0.9996805,0.000013565968,0.000032595155,0.00012060328,0.000025546038,0.0001271462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000067422494,0.000085960564,0.000095123934,0.000045983998,0.000043238637,0.000010061259,0.000086175896,0.00005948373,0.000008056056],"category_scores_gemma":[0.000008381559,0.00007705525,0.000025919293,0.00009383591,0.00007936416,0.000005916731,0.000059037495,0.000050329098,0.0000021290143],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002540286,0.00017319656,0.0008763433,0.0000375127,0.000041732208,8.571732e-7,0.00024243434,0.0000018326508,0.99568987,0.000053206684,0.000021269207,0.0028363403],"study_design_scores_gemma":[0.0007289811,0.00012284472,0.0034634115,0.00002597164,0.000007515395,0.000006010284,0.0007991848,3.7438593e-7,0.99375683,0.00011413737,0.0008899786,0.00008478141],"about_ca_topic_score_codex":0.000018317009,"about_ca_topic_score_gemma":0.000010097226,"teacher_disagreement_score":0.002751559,"about_ca_system_score_codex":0.000013593529,"about_ca_system_score_gemma":0.00011147519,"threshold_uncertainty_score":0.3142222},"labels":[],"label_agreement":null},{"id":"W1988367968","doi":"10.1182/blood-2012-02-408773","title":"A phase 1 study of obinutuzumab induction followed by 2 years of maintenance in patients with relapsed CD20-positive B-cell malignancies","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":147,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; University of British Columbia; London Health Sciences Centre; Jewish General Hospital; Princess Margaret Cancer Centre; BC Cancer Agency","funders":"Genentech; F. Hoffmann-La Roche","keywords":"Obinutuzumab; Medicine; Neutropenia; Internal medicine; Maintenance therapy; Tolerability; Regimen; Rituximab; Phases of clinical research; Population; CD20; Gastroenterology; Surgery; Lymphoma; Oncology; Clinical trial; Chemotherapy; Adverse effect","score_opus":0.009608775374167903,"score_gpt":0.25755991999633626,"score_spread":0.24795114462216836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988367968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99835956,0.00015538542,0.0000047255908,0.0000050126673,0.00004547143,0.0010712773,0.00002550051,0.000010979162,0.0003220671],"genre_scores_gemma":[0.9994683,0.0000071155955,0.00013434907,0.0000100934385,0.000020656658,0.000039128907,0.000028113614,0.000023339348,0.00026886095],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99855316,0.000072150404,0.0003184425,0.00019313939,0.0005357585,0.00032733343],"domain_scores_gemma":[0.99920696,0.000060404458,0.00016165484,0.0003103655,0.00016570043,0.00009492869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023193478,0.00011731575,0.00034652295,0.0001358336,0.000014793622,0.000002903146,0.00008683192,0.00007193446,0.000015815413],"category_scores_gemma":[0.000099126926,0.00009773839,0.00003849101,0.00038909484,0.000088717905,0.00011338724,0.000045757188,0.00014803495,0.0000051387988],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018699827,0.2412132,0.5834898,0.00089851965,0.0010958106,0.00025102298,0.040719025,0.000016520817,0.1073544,0.000041622086,0.0026258812,0.0035943622],"study_design_scores_gemma":[0.6436188,0.016505376,0.19742161,0.0005866786,0.00047413047,0.000025046467,0.0041555203,0.000039967726,0.13682976,0.0000038253384,0.000069615555,0.00026964067],"about_ca_topic_score_codex":0.00071578124,"about_ca_topic_score_gemma":0.000018815002,"teacher_disagreement_score":0.624919,"about_ca_system_score_codex":0.0017450447,"about_ca_system_score_gemma":0.0009865001,"threshold_uncertainty_score":0.45632312},"labels":[],"label_agreement":null},{"id":"W1988467643","doi":"10.1182/blood-2013-08-523308","title":"Allogeneic platelet transfusions prevent murine T-cell–mediated immune thrombocytopenia","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Megakaryocyte; Medicine; Platelet; Immunology; Bone marrow; Immune system; Biology; Stem cell; Haematopoiesis","score_opus":0.009542625181144277,"score_gpt":0.22737442405088085,"score_spread":0.21783179886973658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988467643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885733,0.0016650949,0.000015701284,0.00079106144,0.0000777435,0.0010909814,0.000024758694,0.00010747035,0.0076538566],"genre_scores_gemma":[0.99591744,0.00089775154,0.00054631656,0.00024555085,0.00004150747,0.00014471576,0.00020392232,0.00003828338,0.0019645425],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988021,0.000026961727,0.00029831973,0.00029466648,0.00020826478,0.0003696508],"domain_scores_gemma":[0.9993077,0.000034947163,0.000056418998,0.00035207657,0.00004531877,0.00020354343],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000051938325,0.00022384503,0.000488251,0.00007438338,0.000097066724,0.000019413366,0.00010513301,0.0001210527,0.0018833868],"category_scores_gemma":[0.0000121577295,0.00017266418,0.00014725271,0.00016721392,0.00004103555,0.000082046936,0.000035551904,0.0001611765,0.0011146665],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012870296,0.019668117,0.01964162,0.00019640989,0.0014602807,0.0021936358,0.0006392558,0.0000038816634,0.9424478,0.00004898744,0.0035023899,0.010068933],"study_design_scores_gemma":[0.046507027,0.0022260044,0.28332892,0.00022203391,0.0014733181,0.001336948,0.00020945328,0.00007676392,0.65126824,0.00040019443,0.012125265,0.00082584785],"about_ca_topic_score_codex":0.00034105126,"about_ca_topic_score_gemma":0.000027556507,"teacher_disagreement_score":0.29117954,"about_ca_system_score_codex":0.000019709832,"about_ca_system_score_gemma":0.00006840507,"threshold_uncertainty_score":0.99966305},"labels":[],"label_agreement":null},{"id":"W1988789324","doi":"10.1182/blood-2009-05-199208","title":"Coagulation and innate immune responses: can we view them separately?","year":2009,"lang":"en","type":"review","venue":"Blood","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":312,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Horseshoe crab; Innate immune system; Living fossil; Biology; Immunology; Coagulation; Immune system; Evolutionary biology; Ecology; Zoology; Medicine","score_opus":0.05301788714955964,"score_gpt":0.30113478889188017,"score_spread":0.24811690174232054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988789324","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015374392,0.9965,0.00000663092,0.00010454786,0.00026169966,0.0007995811,0.0001576172,0.00009523395,0.00053724804],"genre_scores_gemma":[0.0010074694,0.994064,0.00006713178,0.000100953526,0.00006115928,0.00007819194,0.00051256473,0.000054814394,0.004053724],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99735016,0.0008988593,0.00068011944,0.0005952646,0.000045654477,0.0004299641],"domain_scores_gemma":[0.99877846,0.00019969154,0.00040246747,0.0005178075,0.00006367764,0.000037920774],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035847127,0.0005874019,0.0017516136,0.00020165199,0.00022735911,0.000039720107,0.0003102497,0.00068257743,0.00027419408],"category_scores_gemma":[0.00003959549,0.00044711214,0.0002772701,0.000283685,0.00013382344,0.00006898997,0.00013091331,0.0005949974,0.00078799675],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004804485,0.0002416677,0.0000012690441,0.002104229,0.0006390875,0.00006515241,0.0001343908,2.395018e-8,0.0070479224,0.00254238,0.00017342079,0.98700243],"study_design_scores_gemma":[0.0010434133,0.0002302198,0.000013364785,0.0040725996,0.0013924496,0.000682873,0.000014513512,2.3896252e-8,0.007127327,0.0005182997,0.9844086,0.00049632834],"about_ca_topic_score_codex":0.000015853318,"about_ca_topic_score_gemma":0.0000062245217,"teacher_disagreement_score":0.9865061,"about_ca_system_score_codex":0.000032818545,"about_ca_system_score_gemma":0.00019255753,"threshold_uncertainty_score":0.99999},"labels":[],"label_agreement":null},{"id":"W1988858610","doi":"10.1182/blood.v99.9.3454","title":"Ex vivo treatment of proliferating human cord blood stem cells with stroma-derived factor–1 enhances their ability to engraft NOD/SCID mice","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; U.S. Public Health Service; Amgen","keywords":"Nod; Ex vivo; Stem cell; Stroma; Cord blood; Biology; Immunology; In vivo; Pathology; Medicine; Cell biology; Immunohistochemistry","score_opus":0.029288324116109307,"score_gpt":0.2508738472791169,"score_spread":0.22158552316300756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988858610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979637,0.0003542932,0.000031162792,0.00006808787,0.00005402758,0.0009070507,0.000045949102,0.00007529342,0.00050040154],"genre_scores_gemma":[0.9978543,0.00003128795,0.0012956818,0.000027712838,0.00022950194,0.00004557618,0.0000076637025,0.00003597623,0.00047228893],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99844086,0.000053176307,0.00042696405,0.00044962714,0.00029177297,0.00033759518],"domain_scores_gemma":[0.9990171,0.00009486926,0.00017155608,0.00037859564,0.00013242553,0.00020541291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007893114,0.00031072964,0.000616848,0.000067044624,0.000110386725,0.000026750564,0.00010178802,0.00008301949,0.0005398539],"category_scores_gemma":[0.000009558464,0.00020954855,0.00013929183,0.00017022526,0.00006056645,0.00004968514,0.000025647867,0.00010373225,0.000011244671],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000078585996,0.0027095128,0.022176836,0.00014927586,0.00024513702,0.00001596164,0.003046231,0.0000042722713,0.97035396,0.0000017031525,0.000016014354,0.0012025259],"study_design_scores_gemma":[0.0041534523,0.004863746,0.0012047602,0.00018265465,0.00033930928,0.000027480244,0.00058562506,0.000031285068,0.9882454,0.0000016568416,0.00015637373,0.0002082214],"about_ca_topic_score_codex":0.00007222744,"about_ca_topic_score_gemma":0.000058661088,"teacher_disagreement_score":0.020972077,"about_ca_system_score_codex":0.000046899106,"about_ca_system_score_gemma":0.00003712278,"threshold_uncertainty_score":0.85451424},"labels":[],"label_agreement":null},{"id":"W1988866904","doi":"10.1182/blood-2010-03-273862","title":"A mutant allele of the Swi/Snf member BAF250a determines the pool size of fetal liver hemopoietic stem cell populations","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Haematopoiesis; Biology; Stem cell; Bone marrow; Mutant; Mutation; Progenitor cell; Cell biology; Genetics; Molecular biology; Cancer research; Immunology; Gene","score_opus":0.007348958552054043,"score_gpt":0.20887205964787928,"score_spread":0.20152310109582525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988866904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99754494,0.00054106,0.0000059091412,0.00012921903,0.00017115954,0.00014443023,0.000017548302,0.0000027077347,0.0014430017],"genre_scores_gemma":[0.9983201,0.00008474838,0.000078310506,0.000038925893,0.00008630582,0.000007551281,0.000004120933,0.000010214984,0.0013697012],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99946356,0.00002934448,0.00016317455,0.00012931277,0.00010451673,0.00011008304],"domain_scores_gemma":[0.999327,0.000014073014,0.000150181,0.00042403414,0.00005729709,0.000027413891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006342368,0.00008841156,0.000099746365,0.000006929845,0.00008863191,0.0000073061487,0.00027260368,0.00011944917,0.000026491745],"category_scores_gemma":[0.000021833233,0.00004607711,0.0001450419,0.00004069441,0.00014525974,0.000001994709,0.00009277995,0.00010903189,0.0000020532607],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014396091,0.00009832229,0.0023504274,0.000027141208,0.000058220412,0.0000016862788,0.00007314691,0.00003643007,0.9966309,0.000022515387,0.00013059004,0.00055621646],"study_design_scores_gemma":[0.0005392427,0.000067189,0.0075826054,0.0000130257495,0.0001304614,0.000031123756,0.000050500796,0.000054549982,0.9896913,0.0000348183,0.001728583,0.00007658536],"about_ca_topic_score_codex":0.00006962209,"about_ca_topic_score_gemma":0.00016751493,"teacher_disagreement_score":0.006939593,"about_ca_system_score_codex":0.0000014578711,"about_ca_system_score_gemma":0.00005101881,"threshold_uncertainty_score":0.187897},"labels":[],"label_agreement":null},{"id":"W1988910124","doi":"10.1182/blood-2013-09-524272","title":"Herpes simplex virus lymphadenitis","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Bendamustine; Herpes simplex virus; Chronic lymphocytic leukemia; Virology; Medicine; Rituximab; Virus; Leukemia; Immunology; Lymphoma","score_opus":0.011860611531287618,"score_gpt":0.2603832011053389,"score_spread":0.2485225895740513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988910124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94241256,0.00010356223,0.00015266353,0.00012123437,0.00008248449,0.000115926145,0.000007539324,0.00011940088,0.056884643],"genre_scores_gemma":[0.99762046,0.000033534317,0.0005803231,0.0003979049,0.00022205299,0.000020890851,0.000012329195,0.000017396866,0.0010951102],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994673,0.000022243285,0.00010736433,0.00014041492,0.00010132746,0.00016132102],"domain_scores_gemma":[0.99960274,0.000031647236,0.000022691791,0.00020948329,0.000028640585,0.00010479149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000045335295,0.00008907682,0.00014286605,0.000047209705,0.00007241067,0.000013595732,0.000028388597,0.00005624093,0.000504871],"category_scores_gemma":[0.000041129402,0.00007288627,0.00006696355,0.000090985166,0.000026116482,0.000033151482,0.000014514226,0.00003312146,0.0006933631],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023285305,0.0026784595,0.035259616,0.000027912052,0.0003761358,0.00013386658,0.00008879327,5.917566e-7,0.0009242326,0.00075172255,0.0011404117,0.958595],"study_design_scores_gemma":[0.0066581117,0.00031061049,0.054439187,0.000040244428,0.00041399075,0.00028968698,0.000012113986,0.000022594715,0.038953744,0.00035091446,0.8983679,0.0001409293],"about_ca_topic_score_codex":0.00021303227,"about_ca_topic_score_gemma":0.00003700397,"teacher_disagreement_score":0.9584541,"about_ca_system_score_codex":0.000015803667,"about_ca_system_score_gemma":0.000025001362,"threshold_uncertainty_score":0.8912011},"labels":[],"label_agreement":null},{"id":"W1989199615","doi":"10.1182/blood-2013-07-514091","title":"Pinning down myeloma with Pim2 inhibitors!","year":2013,"lang":"en","type":"letter","venue":"Blood","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Multiple myeloma; Cancer research; Biology; Suppressor; Immunology; Genetics; Cancer","score_opus":0.00922889441527449,"score_gpt":0.21714377167130722,"score_spread":0.20791487725603272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989199615","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.040287532,0.00310629,0.000251277,0.9375505,0.0011194176,0.0017384213,0.00004374799,0.0004399811,0.015462856],"genre_scores_gemma":[0.0047357087,0.000115710674,0.0021451975,0.9549701,0.02069752,0.00020177355,0.00026422483,0.00021244264,0.016657278],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985025,0.000019186826,0.00022319634,0.0004205741,0.00043548393,0.00039906014],"domain_scores_gemma":[0.9991302,0.000023273251,0.00014232332,0.0005151231,0.000099520315,0.00008959516],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000056307923,0.0003361806,0.00051983766,0.00013886153,0.000059776452,0.000050603943,0.00011153111,0.00052004703,0.001201995],"category_scores_gemma":[0.0000055174983,0.00024041459,0.00012805461,0.00013504537,0.000046575566,0.000048770635,0.000030389268,0.0012076666,0.00022194772],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003641896,0.000098629396,0.000131092,0.00022705752,0.00039549466,0.0012995269,0.00009486983,1.5708883e-7,0.0020819677,0.000032348093,0.99328893,0.002313475],"study_design_scores_gemma":[0.0037209366,0.00083510356,0.00022024545,0.00076721905,0.00044079588,0.00040911438,0.000013205509,0.0000022431082,0.007861146,0.000116411895,0.9852626,0.00035098448],"about_ca_topic_score_codex":0.00020049297,"about_ca_topic_score_gemma":0.0000069420307,"teacher_disagreement_score":0.035551824,"about_ca_system_score_codex":0.000039076793,"about_ca_system_score_gemma":0.00016293397,"threshold_uncertainty_score":0.99971104},"labels":[],"label_agreement":null},{"id":"W1989256483","doi":"10.1182/blood-2002-07-2205","title":"The mechanism of action of high-dose IgG in idiopathic thrombocytopenic purpura","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Thrombocytopenic purpura; Medicine; Immunology; Pediatrics; Platelet","score_opus":0.02681703533839138,"score_gpt":0.25656565393952907,"score_spread":0.22974861860113768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989256483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99694705,0.001391989,0.000005572538,0.00027002374,0.000059593687,0.00023154273,0.0000033581523,0.00000931345,0.0010815534],"genre_scores_gemma":[0.9987468,0.0009659892,0.000051045543,0.000021471531,0.000012925526,0.000012141181,0.0000026770244,0.000008273171,0.00017868287],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994144,0.000024268282,0.0002000852,0.000099184945,0.00014449394,0.00011759353],"domain_scores_gemma":[0.9996365,0.000024059183,0.00008873755,0.00019884702,0.000027138014,0.000024759203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000094292875,0.00007042413,0.0002505755,0.00004529981,0.000028088507,0.0000030345677,0.000054965418,0.000054404278,0.000049272934],"category_scores_gemma":[0.000031230094,0.000046147456,0.000049024187,0.00013199956,0.000029751429,0.000037322963,0.000016245516,0.00008047094,0.000017043438],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011705115,0.02841569,0.039690387,0.0010349496,0.0024003433,0.00209788,0.0038743226,0.00001384589,0.7359057,0.049937297,0.00053028576,0.13492876],"study_design_scores_gemma":[0.033681665,0.0026749938,0.10789665,0.000550817,0.00088461745,0.0004536908,0.0006569367,0.00031496055,0.83752036,0.014821261,0.00027826426,0.0002657738],"about_ca_topic_score_codex":0.00015998547,"about_ca_topic_score_gemma":0.000089284316,"teacher_disagreement_score":0.13466299,"about_ca_system_score_codex":0.000012415154,"about_ca_system_score_gemma":0.00001590332,"threshold_uncertainty_score":0.18818387},"labels":[],"label_agreement":null},{"id":"W1989284061","doi":"10.1182/blood-2002-03-0851","title":"Felic (CIP4b), a novel binding partner with the Src kinase Lyn and Cdc42, localizes to the phagocytic cup","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"Cancer Institute, University of Pittsburgh","keywords":"LYN; Proto-oncogene tyrosine-protein kinase Src; Kinase; CDC42; Cell biology; Src family kinase; Tyrosine-protein kinase CSK; Biology; Immunology; Chemistry; Medicine; Cancer research; SH3 domain","score_opus":0.028961444694868006,"score_gpt":0.2943987175526853,"score_spread":0.2654372728578173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989284061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893452,0.00094975415,0.00044362774,0.004645779,0.000026840977,0.0007992745,0.0000044094404,0.00003329591,0.0037518486],"genre_scores_gemma":[0.99380267,0.00006315361,0.0005337313,0.0014559355,0.00008275318,0.00008162627,0.000003009542,0.000036991118,0.003940123],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985603,0.00008876273,0.00014157164,0.00030558716,0.00050186535,0.00040191252],"domain_scores_gemma":[0.99895287,0.00018726818,0.000033266577,0.0005150013,0.000080690705,0.00023088924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041761252,0.00016461036,0.00019020152,0.00008389685,0.00021711533,0.00006972788,0.00015463382,0.000049378978,0.00012881203],"category_scores_gemma":[0.0002696564,0.00007632932,0.000046312998,0.00045996913,0.0001475671,0.000029838446,0.00008482014,0.00025922223,0.00014975411],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012260405,0.0038322378,0.031126086,0.00048023034,0.0010133304,0.0013994438,0.004939586,0.00008279251,0.9150194,0.005630288,0.024168069,0.01108253],"study_design_scores_gemma":[0.01867448,0.002239737,0.014260461,0.0003842475,0.0007805206,0.0017442574,0.0026354527,0.00037381676,0.365891,0.00004837914,0.5923284,0.0006391696],"about_ca_topic_score_codex":0.000044419412,"about_ca_topic_score_gemma":0.000069051166,"teacher_disagreement_score":0.5681604,"about_ca_system_score_codex":0.000028991572,"about_ca_system_score_gemma":0.00014305413,"threshold_uncertainty_score":0.31126192},"labels":[],"label_agreement":null},{"id":"W1989292065","doi":"10.1182/blood-2011-02-334532","title":"The metabolic cost of childhood ALL","year":2011,"lang":"en","type":"letter","venue":"Blood","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Childhood leukemia; Medicine; Leukemia; Cohort; Pediatrics; Population; Metabolic syndrome; Gerontology; Internal medicine; Obesity; Environmental health; Lymphoblastic Leukemia","score_opus":0.033909303485824806,"score_gpt":0.2843132685581086,"score_spread":0.2504039650722838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989292065","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007835479,0.022437608,0.000009472045,0.94733554,0.0013010651,0.0020060546,0.00034025183,0.00019072254,0.018543802],"genre_scores_gemma":[0.006685497,0.0030456549,0.00037213185,0.97508943,0.010178363,0.00014602064,0.0004575304,0.00021371324,0.0038116772],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99694556,0.00023423745,0.00081137556,0.0005014824,0.0009147219,0.0005926071],"domain_scores_gemma":[0.9971277,0.000373006,0.0005708926,0.0016181519,0.00017477335,0.00013545394],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00058600714,0.00045136336,0.0011159139,0.00013142763,0.00009426414,0.000026094416,0.0006224786,0.000673782,0.00019192089],"category_scores_gemma":[0.00031526163,0.00031475167,0.00052814255,0.00018270471,0.00025508666,0.000032051776,0.00014837676,0.001974034,0.00011656456],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000292486,0.0006298862,0.0007183798,0.0003056517,0.0024702898,0.00012888128,0.0018966396,2.7086369e-8,0.000027172475,0.00017875321,0.99149925,0.0021158408],"study_design_scores_gemma":[0.002678189,0.00018229918,0.010423975,0.00030122406,0.002399174,0.00017443424,0.000051404997,1.136441e-7,0.0020145425,0.00031504192,0.9811488,0.000310851],"about_ca_topic_score_codex":0.00047762657,"about_ca_topic_score_gemma":0.00009707825,"teacher_disagreement_score":0.027753867,"about_ca_system_score_codex":0.000016640604,"about_ca_system_score_gemma":0.00037249504,"threshold_uncertainty_score":0.99993044},"labels":[],"label_agreement":null},{"id":"W1989382032","doi":"10.1182/blood-2014-05-573915","title":"Thrombocytopenia impairs host defense in gram-negative pneumonia–derived sepsis in mice","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Sepsis Diagnosis and Treatment","field":"Medicine","cited_by":213,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Landsteiner Foundation for Blood Transfusion Research","keywords":"Sepsis; Immunology; Pneumonia; Gram-negative bacteria; Microbiology; Gram; Medicine; Biology; Bacteria; Internal medicine; Genetics; Escherichia coli","score_opus":0.035225712992079945,"score_gpt":0.2980617872608457,"score_spread":0.26283607426876576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989382032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941229,0.0002588528,0.0000022974907,0.0013965241,0.000061338505,0.0005556879,0.000006679158,0.00004425941,0.0035514499],"genre_scores_gemma":[0.99804235,0.0001444094,0.0007424688,0.0007834396,0.000051401446,0.00013821943,0.000015186821,0.000030273035,0.000052261697],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986337,0.000111976486,0.0003181513,0.00038549735,0.0001955649,0.00035511216],"domain_scores_gemma":[0.9991551,0.00029430847,0.00007668661,0.00029556037,0.000044437642,0.00013389961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020242769,0.00022013688,0.00053838233,0.00017163357,0.000036381392,0.000020728688,0.00008779674,0.00010906144,0.00008217414],"category_scores_gemma":[0.00024766978,0.00018325122,0.00011072941,0.00032526653,0.00005472192,0.00006785892,0.000047092173,0.00018433231,0.00012041516],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009370219,0.004309945,0.9658925,0.000048463244,0.00017298221,0.0003025911,0.002245209,0.000007117919,0.025586732,0.00018335416,0.00013250025,0.001024925],"study_design_scores_gemma":[0.009892185,0.0005821283,0.92827815,0.00023032396,0.00019155983,0.00003092679,0.00041699014,0.000056856337,0.05975826,0.00020279946,0.00017668147,0.00018311513],"about_ca_topic_score_codex":0.0009613972,"about_ca_topic_score_gemma":0.0018076291,"teacher_disagreement_score":0.03761431,"about_ca_system_score_codex":0.000101110934,"about_ca_system_score_gemma":0.00005535112,"threshold_uncertainty_score":0.7472768},"labels":[],"label_agreement":null},{"id":"W1989740305","doi":"10.1182/blood-2009-05-219485","title":"Cell adhesion molecule 1: a novel risk factor for venous thrombosis","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Heart, Lung, and Blood Institute; National Institutes of Health; Fondation Leducq","keywords":"Haplotype; Biology; Single-nucleotide polymorphism; Genetics; Gene; Cell adhesion molecule; Phenotype; Cell adhesion; Molecular biology; Cell; Allele; Genotype","score_opus":0.03365104908839529,"score_gpt":0.27878695839173295,"score_spread":0.24513590930333767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989740305","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863394,0.0002856316,0.009662787,0.00037720424,0.00013190939,0.00079324504,0.00011018568,0.00017931577,0.0021203186],"genre_scores_gemma":[0.9889387,0.000063444124,0.009753775,0.00085424405,0.00014511716,0.00001930352,0.000021554926,0.00002708881,0.00017678397],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990266,0.000015380656,0.00020961053,0.0002804072,0.00020963803,0.0002583525],"domain_scores_gemma":[0.9993195,0.00003820723,0.00010635773,0.00029981378,0.00008775715,0.00014838668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000073077776,0.00016190652,0.00030218152,0.00007690021,0.000114605726,0.000019245861,0.00007823217,0.00012947831,0.000108534514],"category_scores_gemma":[0.000046276215,0.00014427437,0.00017105958,0.00013319361,0.000012106525,0.000047867637,0.000013605865,0.00011864856,0.000045025292],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044398468,0.0052401763,0.0003964143,0.000041666113,0.00007915173,0.0000027936458,0.00028598928,0.0000014831106,0.9890685,0.00055161456,0.00018647275,0.0041013425],"study_design_scores_gemma":[0.007202138,0.0028894248,0.0644702,0.000049179867,0.0006334838,0.000011476373,0.000044364628,0.00016875456,0.9231888,0.0004685656,0.00067838765,0.0001951979],"about_ca_topic_score_codex":0.0000066508546,"about_ca_topic_score_gemma":0.0000013500617,"teacher_disagreement_score":0.06587967,"about_ca_system_score_codex":0.000016179269,"about_ca_system_score_gemma":0.00004171797,"threshold_uncertainty_score":0.5883338},"labels":[],"label_agreement":null},{"id":"W1989783209","doi":"10.1182/blood-2013-12-541318","title":"EPCR: holy grail of malaria cytoadhesion?","year":2014,"lang":"en","type":"letter","venue":"Blood","topic":"Malaria Research and Control","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Malaria; Virology; Holy Grail; Immunology; Biology; Medicine","score_opus":0.018207874176244816,"score_gpt":0.2606596350833259,"score_spread":0.2424517609070811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989783209","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002405333,0.00079239585,0.000082916034,0.9746518,0.00017841157,0.0008757894,0.00007873314,0.00007655174,0.020858066],"genre_scores_gemma":[0.16720498,0.00015837737,0.0009035546,0.78041685,0.011505699,0.00018026722,0.00082913245,0.00017506267,0.038626112],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99769497,0.00014135434,0.00039249257,0.00039722116,0.0008434582,0.00053049996],"domain_scores_gemma":[0.99839705,0.00016780038,0.0001769541,0.000879265,0.00021612398,0.0001628279],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032859738,0.0002774959,0.0008126939,0.00023126106,0.00003761271,0.000021864473,0.00030255626,0.00080183893,0.0013738167],"category_scores_gemma":[0.00031237025,0.00021892173,0.0003348736,0.00013073899,0.000098425895,0.000026096786,0.0000744525,0.0016779489,0.0003092689],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013021,0.00026079387,0.00077908934,0.00082661625,0.0004681305,0.0014018735,0.000013696695,2.5137068e-8,0.005667986,0.00030967212,0.98958564,0.0005562429],"study_design_scores_gemma":[0.008274768,0.001007755,0.006435652,0.00040155542,0.0010447187,0.0002823203,0.0000042541474,0.000013207101,0.003057872,0.0003070011,0.97888535,0.0002855467],"about_ca_topic_score_codex":0.00007613461,"about_ca_topic_score_gemma":0.0000018907299,"teacher_disagreement_score":0.19423498,"about_ca_system_score_codex":0.000015938153,"about_ca_system_score_gemma":0.00027412674,"threshold_uncertainty_score":0.9995391},"labels":[],"label_agreement":null},{"id":"W1989841268","doi":"10.1182/blood-2014-04-570879","title":"Functional characterization of the human dendritic cell immunodeficiency associated with the IRF8K108E mutation","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University and Génome Québec Innovation Centre; McGill University","funders":"National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; Wellcome Trust; Howard Hughes Medical Institute","keywords":"IRF8; Biology; Immunology; Myeloid; Mutation; Severe combined immunodeficiency; Genetics; Transcription factor; In vivo; Gene","score_opus":0.006544744895435384,"score_gpt":0.18174169537837592,"score_spread":0.17519695048294054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989841268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954868,0.00006676274,0.00061418244,0.00017641431,0.00090495567,0.00014736113,0.0000037585905,0.000030821677,0.0025689278],"genre_scores_gemma":[0.99037373,0.0000024460953,0.000001110428,0.000157578,0.000020479478,0.000015434314,0.0002765829,0.000009747027,0.009142907],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99927145,0.00024457506,0.00018309896,0.0001209621,0.00005265877,0.00012725206],"domain_scores_gemma":[0.9993558,0.00008078143,0.00023079694,0.00019993697,0.0001287042,0.0000040159634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019365072,0.000090650756,0.000097610646,0.000036832753,0.00039258174,0.000013700874,0.0001244875,0.000089379115,0.00042609658],"category_scores_gemma":[0.00005023921,0.000051110936,0.000061128434,0.0001456873,0.000120649725,0.000083510306,0.000023928505,0.00018973018,0.00008776231],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018313363,0.0002871639,0.0013537602,0.0000047252947,0.00006226092,7.4914965e-8,0.00019580762,0.000007526715,0.99719554,0.00046199732,0.00031918482,0.000093622446],"study_design_scores_gemma":[0.0017789275,0.000222074,0.2885313,0.000031886655,0.00017380004,0.00002812009,0.00016904016,0.0000134239635,0.7055147,0.000023331218,0.0034162332,0.00009714859],"about_ca_topic_score_codex":0.00001674029,"about_ca_topic_score_gemma":0.000008028668,"teacher_disagreement_score":0.29168084,"about_ca_system_score_codex":0.000015593689,"about_ca_system_score_gemma":0.000021743672,"threshold_uncertainty_score":0.46654588},"labels":[],"label_agreement":null},{"id":"W1989883128","doi":"10.1182/blood-2013-12-540872","title":"Selective depletion of factor XI or factor XII with antisense oligonucleotides attenuates catheter thrombosis in rabbits","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":171,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Clotting factor; Factor XII; Thrombosis; Oligonucleotide; Catheter; Internal medicine; Endocrinology; Medicine; Biology; Pharmacology; Chemistry; Immunology; Biochemistry; Surgery; Gene; Coagulation","score_opus":0.022420970771189475,"score_gpt":0.2607319783897639,"score_spread":0.23831100761857443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989883128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988014,0.00015320082,0.0000934374,0.0001841013,0.00004455065,0.00036495307,0.000028859331,0.00006544792,0.0002640286],"genre_scores_gemma":[0.99873173,0.00006032807,0.0007322877,0.00012485635,0.0001106317,0.000013222017,0.00002161286,0.00004071002,0.00016459933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879223,0.0000610155,0.00031843357,0.00030740869,0.00024218686,0.0002787464],"domain_scores_gemma":[0.99917597,0.00018527616,0.00015542655,0.00023929455,0.00014485349,0.00009918415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000087583205,0.00020950074,0.00047131543,0.00015677148,0.00005050936,0.00001484011,0.000067152694,0.000100717014,0.00012777331],"category_scores_gemma":[0.0001298153,0.00014610357,0.000090635054,0.00029429243,0.00008565714,0.0001412108,0.000021288986,0.00010927922,0.000018264409],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023264976,0.0007796516,0.9490244,0.000128128,0.00017045079,0.000007636001,0.0020805148,0.0000035286505,0.045660302,0.00004440305,0.00005505346,0.0018132813],"study_design_scores_gemma":[0.003209882,0.00085490546,0.787316,0.00025541632,0.0001168604,0.000025035946,0.00008585798,0.000081373175,0.20773338,0.000032674205,0.00012287372,0.00016571925],"about_ca_topic_score_codex":0.00032928746,"about_ca_topic_score_gemma":0.00044195366,"teacher_disagreement_score":0.16207308,"about_ca_system_score_codex":0.000025509265,"about_ca_system_score_gemma":0.00007404988,"threshold_uncertainty_score":0.5957931},"labels":[],"label_agreement":null},{"id":"W1990088161","doi":"10.1182/blood-2002-06-1720","title":"Stem cell factor increases the expression of FLIP that inhibits IFNγ-induced apoptosis in human erythroid progenitor cells","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; Merck Canada","keywords":"Apoptosis; Progenitor cell; Flip; Cell biology; Stem cell; Biology; Cancer research; Molecular biology; Genetics","score_opus":0.0321755669533617,"score_gpt":0.25196634666070994,"score_spread":0.21979077970734823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990088161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973553,0.00028665666,0.0000033724152,0.000030896015,0.0001933568,0.000572597,0.000013341298,0.000041088013,0.0015033886],"genre_scores_gemma":[0.99905604,0.000047341175,0.00011322802,0.0001536843,0.000118606455,0.00004669172,0.000011945244,0.000027002989,0.00042544032],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986691,0.0002434327,0.0003166431,0.000284959,0.0002317241,0.00025415537],"domain_scores_gemma":[0.9991432,0.00012465264,0.00016805586,0.00039424948,0.000065000146,0.000104831124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013403414,0.00019185385,0.00036267034,0.00011109128,0.00008762578,0.000008159514,0.000093474904,0.00017045013,0.00020182943],"category_scores_gemma":[0.000022928452,0.00012710354,0.00012063475,0.00020027357,0.00005926284,0.000054764838,0.000039202874,0.00023987531,0.000028305756],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006441915,0.001235084,0.01281812,0.00010316355,0.00001756091,0.00000518648,0.00047748734,6.9648206e-7,0.9848959,0.000014914092,0.0002211782,0.00014628032],"study_design_scores_gemma":[0.0031678125,0.00051698793,0.005634989,0.00013431044,0.00007244903,0.00001331419,0.00072764675,6.5796297e-7,0.9890196,0.000011058072,0.00057404,0.00012715899],"about_ca_topic_score_codex":0.000051181312,"about_ca_topic_score_gemma":0.000009362808,"teacher_disagreement_score":0.0071831318,"about_ca_system_score_codex":0.00002129226,"about_ca_system_score_gemma":0.000084413965,"threshold_uncertainty_score":0.5183132},"labels":[],"label_agreement":null},{"id":"W1990134290","doi":"10.1182/blood-2007-10-120543","title":"Bleeding risk and the management of bleeding complications in patients undergoing anticoagulant therapy: focus on new anticoagulant agents","year":2008,"lang":"en","type":"review","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":313,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Fondaparinux; Medicine; Anticoagulant; Antithrombin; Heparin; Thrombosis; Discovery and development of direct thrombin inhibitors; Intensive care medicine; Warfarin; Surgery; Thrombin; Internal medicine; Venous thromboembolism; Atrial fibrillation","score_opus":0.08095837150399347,"score_gpt":0.3272146566233249,"score_spread":0.2462562851193314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990134290","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.114147976,0.8758486,0.000026348327,0.00014130861,0.00019675969,0.0044958033,0.000035996345,0.000060524733,0.0050466917],"genre_scores_gemma":[0.13374206,0.86561966,0.00033062825,0.000036733036,0.000070172784,0.000056943536,0.000042136733,0.00006702119,0.000034635166],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9973843,0.00017490322,0.0009766733,0.0005922553,0.00044903348,0.0004228097],"domain_scores_gemma":[0.998145,0.00034683087,0.00062021933,0.00067063916,0.000051684303,0.00016564166],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029598508,0.00050563464,0.0022337853,0.0003646086,0.00020291723,0.00003815921,0.00030291238,0.00021325388,0.000012902167],"category_scores_gemma":[0.000042168285,0.0003275723,0.00036492824,0.00054731005,0.00013965687,0.000058284153,0.00020149666,0.0005139017,0.000022688495],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014786565,0.0035794815,0.046639383,0.010927201,0.007341943,0.00009077007,0.00091312994,0.0000022126055,0.000009209834,0.0049691726,0.00015502718,0.9252246],"study_design_scores_gemma":[0.12322241,0.0027692823,0.50215685,0.22884288,0.03154979,0.0004959466,0.0005031568,0.000105033614,0.00030524327,0.001621103,0.10543803,0.0029902887],"about_ca_topic_score_codex":0.00024909232,"about_ca_topic_score_gemma":0.000010088117,"teacher_disagreement_score":0.9222343,"about_ca_system_score_codex":0.000088614885,"about_ca_system_score_gemma":0.00015970631,"threshold_uncertainty_score":0.9999176},"labels":[],"label_agreement":null},{"id":"W1990196345","doi":"10.1182/blood-2009-03-208629","title":"Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":327,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Lymphocytopenia; Immunology; Biology; Medicine; Pathology; Lymphocyte","score_opus":0.005842538039069603,"score_gpt":0.205842252593772,"score_spread":0.1999997145547024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990196345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98173326,0.016933605,0.000019402349,0.00022270347,0.000116600866,0.00036795335,0.00002066561,0.000069067566,0.0005167251],"genre_scores_gemma":[0.99878,0.00021125082,0.0001345014,0.0002928007,0.0000048621123,0.000011452628,0.000028940833,0.000013381619,0.0005228123],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987116,0.00007877887,0.00025841303,0.0004731301,0.0000367962,0.00044128782],"domain_scores_gemma":[0.99948007,0.000039182625,0.00007492735,0.00035025156,0.00003109339,0.000024474044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019088677,0.00025597983,0.0003588348,0.00008295952,0.00027860634,0.000043237465,0.00016148228,0.00016413676,0.00009624489],"category_scores_gemma":[0.000023843833,0.00020259194,0.000035475616,0.00014775734,0.0002218202,0.00013948497,0.000070140755,0.00019721774,0.000079848534],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060940953,0.0005159158,0.01595142,0.000018815083,0.00009009935,0.000027500731,0.001263029,8.64178e-7,0.95094407,0.0006304705,0.00004112241,0.029907314],"study_design_scores_gemma":[0.0053459825,0.0016139401,0.8716023,0.000070227405,0.00015138621,0.00042846805,0.00049738446,0.0000010186583,0.107895166,0.00016275799,0.011771843,0.00045954259],"about_ca_topic_score_codex":0.00013288856,"about_ca_topic_score_gemma":0.000024472656,"teacher_disagreement_score":0.85565084,"about_ca_system_score_codex":0.000010784024,"about_ca_system_score_gemma":0.00004860529,"threshold_uncertainty_score":0.82614595},"labels":[],"label_agreement":null},{"id":"W1990213501","doi":"10.1182/blood-2010-12-328070","title":"Responsiveness of HIV-specific CD4 T cells to PD-1 blockade","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":161,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AIDS Vancouver; Simon Fraser University","funders":"National Institute of Allergy and Infectious Diseases; National Heart, Lung, and Blood Institute","keywords":"Blockade; Medicine; Human immunodeficiency virus (HIV); Aldesleukin; Immunology; Internal medicine; Interleukin 2; Immune system; Receptor","score_opus":0.028213206124919267,"score_gpt":0.2414815988145337,"score_spread":0.21326839268961445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990213501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99182534,0.0014975172,0.000038222006,0.00007018794,0.00014150095,0.00024869342,0.0001607716,0.000027904385,0.005989884],"genre_scores_gemma":[0.9946126,0.00007675597,0.00045595263,0.000020594061,0.000014327542,0.000030593746,0.00003965694,0.000010927899,0.004738588],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991683,0.00013156266,0.0001588009,0.00020371862,0.000033263597,0.00030438017],"domain_scores_gemma":[0.9994559,0.000071352144,0.000035419052,0.00032655214,0.00006470174,0.00004606903],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000114801514,0.00010217242,0.00018074221,0.00011442554,0.000060255385,0.0000029294833,0.00019368855,0.000098313154,0.0017768128],"category_scores_gemma":[0.00002152953,0.00008443582,0.00006258058,0.00012062686,0.00009514426,0.00002065064,0.000077605815,0.00010045504,0.00725427],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005400403,0.0010997419,0.003335131,0.000009655536,0.00021177194,0.00006195541,0.0009637861,2.333433e-7,0.98886955,0.00018555399,0.003616882,0.0011056961],"study_design_scores_gemma":[0.0017191875,0.00049386336,0.017495604,0.00001503179,0.000027846118,0.000021107831,0.00010620435,9.217823e-9,0.9225899,0.000035674017,0.05741585,0.0000797243],"about_ca_topic_score_codex":0.000047130947,"about_ca_topic_score_gemma":0.000008783868,"teacher_disagreement_score":0.06627966,"about_ca_system_score_codex":0.000009400557,"about_ca_system_score_gemma":0.00005042599,"threshold_uncertainty_score":0.9991357},"labels":[],"label_agreement":null},{"id":"W1990220334","doi":"10.1182/blood-2014-04-568329","title":"Long-term follow-up from a phase 1/2 study of single-agent bortezomib in relapsed systemic AL amyloidosis","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Comprehensive Cancer Network","keywords":"Bortezomib; Medicine; AL amyloidosis; Amyloidosis; Internal medicine; Multiple myeloma; Primary systemic amyloidosis; Surgery; Phases of clinical research; Gastroenterology; Progression-free survival; Clinical trial; Immunoglobulin light chain; Chemotherapy; Immunology; Systemic disease; Immunopathology","score_opus":0.016017425256245776,"score_gpt":0.27025690673229846,"score_spread":0.2542394814760527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990220334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975834,0.0010730511,0.00006912341,0.00005268426,0.0002554168,0.0007642497,0.000077716875,0.000027817498,0.00009654352],"genre_scores_gemma":[0.9989588,0.00010294513,0.00010467609,0.00016262397,0.00010733393,0.0002130642,0.00019779426,0.000053453983,0.000099256526],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99788976,0.00023404608,0.0006008136,0.00067153014,0.00025446396,0.00034939425],"domain_scores_gemma":[0.9986246,0.00006935575,0.000287192,0.00083136116,0.00006381948,0.00012364467],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019370807,0.00032956022,0.00052825164,0.00011025083,0.000050437295,0.000024677289,0.00033250387,0.00018739034,0.000030229667],"category_scores_gemma":[0.0001511183,0.00031207697,0.00018824948,0.00015204457,0.000048746842,0.000005429215,0.00016127847,0.000097698896,0.000017318473],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018589327,0.008250232,0.61875236,0.000023953924,0.0004873423,0.000028147117,0.00030805435,0.0000075323183,0.3708069,0.0000018330549,0.00014934664,0.0009983998],"study_design_scores_gemma":[0.067196965,0.006389068,0.27952397,0.00023459247,0.0010925685,0.000024051524,0.0007403723,0.000018484681,0.643829,0.000009193646,0.0002374199,0.00070430775],"about_ca_topic_score_codex":0.00030630326,"about_ca_topic_score_gemma":0.0006316947,"teacher_disagreement_score":0.33922836,"about_ca_system_score_codex":0.00004099169,"about_ca_system_score_gemma":0.000043545773,"threshold_uncertainty_score":0.9999331},"labels":[],"label_agreement":null},{"id":"W1990293394","doi":"10.1182/blood.v98.13.3635","title":"Expression and function of CD105 during the onset of hematopoiesis from Flk1+ precursors","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Ontario Institute for Cancer Research","funders":"","keywords":"Endoglin; Mesoderm; Biology; Haematopoiesis; Myelopoiesis; Lymphopoiesis; Cell biology; Transforming growth factor; Erythropoiesis; Immunology; Embryonic stem cell; Stem cell; Genetics; Internal medicine; Medicine; CD34","score_opus":0.0054054515185066754,"score_gpt":0.20551107480962297,"score_spread":0.20010562329111628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990293394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99730766,0.0024180429,0.00006192397,0.000009181455,0.000026204052,0.00006422787,0.000028826313,0.000005450008,0.00007845782],"genre_scores_gemma":[0.99959826,0.00006736506,0.00016198576,0.000009593689,0.00005402521,0.000007424247,0.000024931049,0.0000078752155,0.00006855546],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995736,0.00003227322,0.00012108833,0.0001300229,0.00007403181,0.0000689707],"domain_scores_gemma":[0.9996384,0.000016472432,0.00007884051,0.00021487179,0.000026863374,0.000024575584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000040273404,0.000062639614,0.00007761436,0.000013787811,0.00003687598,0.0000041090584,0.00007625429,0.00005465648,0.000026454152],"category_scores_gemma":[0.0000479489,0.000046912213,0.000036644487,0.000030378813,0.000054185173,0.0000019861768,0.000060454928,0.000023509456,6.27501e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011271214,0.00012586122,0.050927687,0.000028922545,0.000047323272,8.597538e-7,0.000070566835,0.000011302134,0.94847536,0.000001384005,0.000064678745,0.00013333994],"study_design_scores_gemma":[0.0005053433,0.00005482732,0.089440264,0.000042170203,0.000053201762,0.0000044044236,0.000099358935,0.0000015423872,0.90934116,0.00004355548,0.00036548136,0.00004867995],"about_ca_topic_score_codex":0.000012903728,"about_ca_topic_score_gemma":0.00000633208,"teacher_disagreement_score":0.039134186,"about_ca_system_score_codex":0.0000010253159,"about_ca_system_score_gemma":0.00001424622,"threshold_uncertainty_score":0.19130245},"labels":[],"label_agreement":null},{"id":"W1990385611","doi":"10.1182/blood-2005-02-0629","title":"Contribution of Hfe expression in macrophages to the regulation of hepatic hepcidin levels and iron loading","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Hôpital Notre-Dame","funders":"Canadian Institutes of Health Research","keywords":"Hepcidin; Hemochromatosis; Hereditary hemochromatosis; Endocrinology; Internal medicine; Spleen; Bone marrow; Ferroportin; Chemistry; Biology; Anemia; Medicine","score_opus":0.010437118713450197,"score_gpt":0.25656806948015115,"score_spread":0.24613095076670094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990385611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969931,0.00178311,0.0002886687,0.00051677803,0.00001924503,0.00025907665,0.0000051345232,0.000005303187,0.00012955574],"genre_scores_gemma":[0.99903715,0.000045835895,0.00074695155,0.000064013235,0.00004070595,0.0000053457898,0.0000051401735,0.000004571213,0.000050274888],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99948895,0.000037463236,0.00018649243,0.000084087755,0.000118641874,0.00008433595],"domain_scores_gemma":[0.9997229,0.000034873567,0.00006391893,0.00011434507,0.0000362876,0.000027674316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019996548,0.00005126907,0.00014776137,0.00006262081,0.000018856683,0.0000023797488,0.00002743207,0.000036376612,0.000026852784],"category_scores_gemma":[0.00014973058,0.00003559056,0.000018048466,0.00009759538,0.00002375196,0.000044418684,0.00001802041,0.00003751404,0.0000020223538],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000081915634,0.00017349531,0.052213654,0.00008281585,0.0000029692437,5.3150603e-7,0.0008620512,0.0000617953,0.942195,0.00020377654,0.000060679893,0.004061317],"study_design_scores_gemma":[0.0018531954,0.000049359507,0.48446786,0.00009536438,0.000040016395,0.0000021906044,0.000092939474,0.00006753805,0.51316994,0.000045859313,0.000088853805,0.000026868653],"about_ca_topic_score_codex":0.000029382023,"about_ca_topic_score_gemma":0.000023791863,"teacher_disagreement_score":0.43225423,"about_ca_system_score_codex":0.0000064116343,"about_ca_system_score_gemma":0.000012039312,"threshold_uncertainty_score":0.14513409},"labels":[],"label_agreement":null},{"id":"W1990568114","doi":"10.1182/blood-2002-04-1050","title":"E26 leukemia virus converts primitive erythroid cells into cycling multilineage progenitors","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; European Molecular Biology Laboratory","keywords":"Biology; Haematopoiesis; Progenitor cell; Leukemia; Cell biology; Virus; Cellular differentiation; Yolk sac; Stem cell; Virology; Immunology; Embryo; Genetics; Gene","score_opus":0.011582675116120553,"score_gpt":0.2737956396844734,"score_spread":0.26221296456835286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990568114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99692833,0.0012987505,0.00013538703,0.000014993068,0.00017705034,0.0004510394,0.000018814135,0.000032161828,0.0009434619],"genre_scores_gemma":[0.9971823,0.00028954286,0.0013128084,0.00020919002,0.00026420568,0.000059612055,0.000064971566,0.00006228217,0.000555064],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982884,0.00019952244,0.00026057576,0.0005469679,0.00024021954,0.00046430097],"domain_scores_gemma":[0.99907947,0.000024189547,0.00007936615,0.0005079861,0.00013198673,0.00017698892],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032939474,0.00024626395,0.00019645803,0.00006042991,0.00014441174,0.000035127036,0.00024973234,0.00022732632,0.00007961827],"category_scores_gemma":[0.00009717301,0.00024570912,0.00014024979,0.00012968606,0.0001432861,0.0000052825717,0.00008535778,0.00019295352,0.000089458896],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026847573,0.00027411352,0.00087973214,0.000018895033,0.0001488474,0.000023420462,0.00012032862,0.000040300492,0.9971053,0.0000072637417,0.00021292853,0.00090041454],"study_design_scores_gemma":[0.0021624886,0.0010814252,0.000094355855,0.000009127866,0.00003586007,0.000015361427,0.000087581495,0.00003244889,0.989577,0.000024083469,0.00659218,0.00028807975],"about_ca_topic_score_codex":0.00003826261,"about_ca_topic_score_gemma":0.00012884932,"teacher_disagreement_score":0.0075282725,"about_ca_system_score_codex":0.000044101922,"about_ca_system_score_gemma":0.00036760682,"threshold_uncertainty_score":0.9999995},"labels":[],"label_agreement":null},{"id":"W1990834285","doi":"10.1182/blood-2003-02-0660","title":"Protection from endotoxemia by adenoviral-mediated gene transfer of human bactericidal/permeability-increasing protein","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"","keywords":"Lipopolysaccharide; In vivo; Tumor necrosis factor alpha; Proinflammatory cytokine; Cytokine; Genetic enhancement; Transgene; Biology; Sepsis; Immunology; Pharmacology; Inflammation; Gene; Biochemistry","score_opus":0.008647960250619499,"score_gpt":0.19936721974511476,"score_spread":0.19071925949449525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990834285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99760973,0.0008100354,0.00023951472,0.000032154472,0.000075003765,0.00076918857,0.000037116537,0.00007427285,0.00035300464],"genre_scores_gemma":[0.99913824,0.000010780177,0.00006593308,0.000013778208,0.000015268253,0.00011222193,0.0003569122,0.000020490015,0.00026639976],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982438,0.0007898631,0.00042619917,0.00025101198,0.000044628283,0.00024451714],"domain_scores_gemma":[0.999499,0.00006339586,0.00009111833,0.00026896506,0.00006179679,0.00001569027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003775099,0.00016610487,0.00026818473,0.000078337536,0.000141706,0.000010308253,0.0001068344,0.0002930005,0.00061315607],"category_scores_gemma":[0.00019002904,0.00015734014,0.00008700577,0.00012994595,0.00011053829,0.00012528378,0.000011567012,0.00023467485,0.0000969664],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022890238,0.00036028758,0.00079940393,0.000021579828,0.00013827729,0.0000013319406,0.00031593136,1.5949443e-7,0.9976884,0.000056724195,0.000015692822,0.00037328375],"study_design_scores_gemma":[0.0027811707,0.00030769693,0.004686312,0.00003888383,0.00006939482,0.000020790834,0.000056835237,4.060957e-7,0.9893927,0.00006650846,0.0024193798,0.00015992192],"about_ca_topic_score_codex":0.000550601,"about_ca_topic_score_gemma":0.00000904618,"teacher_disagreement_score":0.008295726,"about_ca_system_score_codex":0.00002594577,"about_ca_system_score_gemma":0.000054474218,"threshold_uncertainty_score":0.67136294},"labels":[],"label_agreement":null},{"id":"W1990868266","doi":"10.1182/blood-2003-01-0023","title":"IVIg-mediated amelioration of murine ITP via FcγRIIB is independent of SHIP1, SHP-1, and Btk activity","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Bruton's tyrosine kinase; Fc receptor; Cell biology; Receptor; Signal transduction; Protein tyrosine phosphatase; Monocyte; Chemistry; Immunology; Syk; Tyrosine kinase; Immune system; Biology; Biochemistry","score_opus":0.011260623558698614,"score_gpt":0.24420514540554425,"score_spread":0.23294452184684564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990868266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975213,0.00037691824,0.000034259472,0.000092494556,0.00002872783,0.00026350835,0.000026723683,0.0000130605,0.001643017],"genre_scores_gemma":[0.99947315,0.00015790698,0.00016574263,0.00004885755,0.000009106088,0.0000075930475,0.000023912813,0.000011030764,0.00010271601],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99929714,0.000030329062,0.00017718192,0.00016502,0.00020492905,0.00012542191],"domain_scores_gemma":[0.99954504,0.000034413668,0.00011472553,0.00016797848,0.000065073946,0.000072775874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009174283,0.00011006165,0.00031141425,0.00008185901,0.000021268217,0.0000031740585,0.000025306877,0.00008477562,0.00010053983],"category_scores_gemma":[0.00006207886,0.000093155824,0.0000457439,0.0001501195,0.000043893455,0.000060714385,0.0000144392825,0.000077038785,0.000006841658],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035738575,0.007925661,0.69254774,0.00035856199,0.0008826493,0.00023442418,0.00083010725,0.0000010641802,0.29095387,0.00014252313,0.00013975488,0.0056262664],"study_design_scores_gemma":[0.011755311,0.00085226796,0.32987022,0.00007485993,0.00048390572,0.0001045832,0.00009518708,0.000039179908,0.65602857,0.00034608605,0.00021313176,0.00013667384],"about_ca_topic_score_codex":0.00009782874,"about_ca_topic_score_gemma":0.0000420661,"teacher_disagreement_score":0.36507472,"about_ca_system_score_codex":0.00000999883,"about_ca_system_score_gemma":0.000046445824,"threshold_uncertainty_score":0.3798784},"labels":[],"label_agreement":null},{"id":"W1991168856","doi":"10.1182/blood.v98.7.2275","title":"Distinct regulatory elements are required for faithful expression of human CD4 in T cells, macrophages, and dendritic cells of transgenic mice","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University","funders":"","keywords":"Biology; Cell biology; Transgene; Enhancer; Regulation of gene expression; Gene expression; Molecular biology; Regulatory sequence; CD8; Immune system; Gene; Genetics","score_opus":0.013080659898707676,"score_gpt":0.24191649375486662,"score_spread":0.22883583385615894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991168856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854043,0.013888548,0.000025274008,0.00001068043,0.00014900751,0.00037558933,0.0000897556,0.000013579725,0.000043242544],"genre_scores_gemma":[0.9982418,0.00041108258,0.00011783478,0.000013467281,0.00001046961,0.000027741313,0.00004105228,0.000021448426,0.0011151492],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987335,0.00020110318,0.00052158174,0.00023064182,0.000035493093,0.00027766873],"domain_scores_gemma":[0.9993189,0.00013417758,0.00023496966,0.0002558405,0.000043892862,0.000012220649],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023434602,0.00016240313,0.00037724795,0.00012501588,0.00009333957,0.000004123414,0.00017707315,0.00018554261,0.000117056494],"category_scores_gemma":[0.00001722241,0.00015355927,0.0000970378,0.00009012013,0.00019809672,0.000063339714,0.00003195063,0.000107305474,0.0000035499354],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081739476,0.00068204367,0.0036367164,0.00016254015,0.0000908398,0.0000033411854,0.0004677491,2.756367e-7,0.99353224,0.000017342329,0.00008731479,0.0005022052],"study_design_scores_gemma":[0.006914818,0.0004335317,0.028810514,0.00023664765,0.00007590585,0.00001420932,0.0003192673,2.6151224e-7,0.96168244,0.000044944278,0.0013251154,0.00014235587],"about_ca_topic_score_codex":0.00004253182,"about_ca_topic_score_gemma":0.000026319829,"teacher_disagreement_score":0.03184981,"about_ca_system_score_codex":0.00001016121,"about_ca_system_score_gemma":0.000025037958,"threshold_uncertainty_score":0.62619656},"labels":[],"label_agreement":null},{"id":"W1991304993","doi":"10.1182/blood-2013-03-492454","title":"IRP1 regulates erythropoiesis and systemic iron homeostasis by controlling HIF2α mRNA translation","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Erythropoiesis; Iron homeostasis; Translation (biology); Homeostasis; Biology; Messenger RNA; Cell biology; Medicine; Endocrinology; Internal medicine; Anemia; Genetics; Gene; Metabolism","score_opus":0.0077250578559058284,"score_gpt":0.21512771770328204,"score_spread":0.20740265984737621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991304993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9536309,0.043318685,0.00014100525,0.0012501697,0.000068169895,0.000520201,0.000013065714,0.00007191147,0.00098588],"genre_scores_gemma":[0.9969971,0.001668575,0.0006883033,0.00016762513,0.00010223807,0.000029897941,0.000036040405,0.000023381532,0.00028683216],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991383,0.00003556366,0.00023105684,0.00021342385,0.00016842385,0.00021323506],"domain_scores_gemma":[0.9995465,0.00005290804,0.0000648091,0.00017971886,0.00004655696,0.000109469074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009927024,0.00014044793,0.00030407446,0.00007035852,0.000080039084,0.00003738509,0.000038667433,0.00009760773,0.00015474115],"category_scores_gemma":[0.000030370078,0.00011706737,0.00005541275,0.00008189627,0.0000663824,0.00013709419,0.000007680625,0.00007659788,0.00004713863],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035884237,0.0013865257,0.059135094,0.0027696944,0.00035241182,0.000026800099,0.0044210185,0.000017338793,0.7105572,0.00055377744,0.0130043905,0.20741686],"study_design_scores_gemma":[0.21067268,0.0027633326,0.38501444,0.0026721957,0.016184302,0.0016066363,0.023332642,0.0032969902,0.3210717,0.0044512376,0.024203982,0.0047298465],"about_ca_topic_score_codex":0.00019672826,"about_ca_topic_score_gemma":0.0000037757873,"teacher_disagreement_score":0.3894855,"about_ca_system_score_codex":0.0000068244303,"about_ca_system_score_gemma":0.000017161137,"threshold_uncertainty_score":0.47738686},"labels":[],"label_agreement":null},{"id":"W1991361673","doi":"10.1182/blood-2009-07-235598","title":"The architectural pattern of FOXP3-positive T cells in follicular lymphoma is an independent predictor of survival and histologic transformation","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":201,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"BC Cancer Agency; Canadian Institutes of Health Research","keywords":"FOXP3; International Prognostic Index; Follicular lymphoma; Internal medicine; Tissue microarray; Follicular phase; Medicine; CD8; Lymphoma; Oncology; Survival analysis; Pathology; Gastroenterology; Immunohistochemistry; Diffuse large B-cell lymphoma; Immunology; Immune system","score_opus":0.009620876395095606,"score_gpt":0.22815448081537282,"score_spread":0.21853360442027722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991361673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981213,0.0006829162,0.000026959913,0.00037312138,0.000028701535,0.00037613546,0.00003896824,0.0000073589094,0.000344502],"genre_scores_gemma":[0.99971664,0.00011986052,0.0000401777,0.00007007037,0.000014351501,0.000011907943,0.000016729804,0.000003931932,0.0000063467864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992606,0.000052227955,0.0002478145,0.00012331385,0.00019445173,0.00012159417],"domain_scores_gemma":[0.999642,0.000054713928,0.00008068539,0.00013787906,0.000034304165,0.00005038311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010713734,0.00009593586,0.00022829839,0.00005036057,0.00002802621,0.0000055596597,0.00004777754,0.000052647836,0.0000042176],"category_scores_gemma":[0.0000054980064,0.000058694313,0.000060735016,0.000059474216,0.000046654844,0.000038901067,0.000007041207,0.000029509916,5.00776e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061284506,0.006993599,0.5567984,0.0001458197,0.00039922967,0.00013668509,0.01728526,0.000010095949,0.018429874,0.00032352828,0.000014249085,0.3988504],"study_design_scores_gemma":[0.007073104,0.0013396867,0.85442775,0.000063663734,0.00016327285,0.000037979808,0.0002622952,0.0000823956,0.13637227,0.00010770139,0.000017978124,0.000051912968],"about_ca_topic_score_codex":0.00026796662,"about_ca_topic_score_gemma":0.000097555734,"teacher_disagreement_score":0.3987985,"about_ca_system_score_codex":0.000035895115,"about_ca_system_score_gemma":0.000031945285,"threshold_uncertainty_score":0.23934846},"labels":[],"label_agreement":null},{"id":"W1991437102","doi":"10.1182/blood-2010-08-302984","title":"The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia","year":2011,"lang":"en","type":"review","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1859,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Hematology; Guideline; Immune thrombocytopenia; Medicine; Internal medicine; Intensive care medicine; Immunology; Pathology; Platelet","score_opus":0.10049769585471488,"score_gpt":0.3990161564361879,"score_spread":0.298518460581473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991437102","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000028469773,0.99632734,0.00016287284,0.0011249778,0.00008326589,0.0018981607,0.0000530426,0.000027286464,0.0002945677],"genre_scores_gemma":[0.000019039762,0.9835711,0.015111519,0.00049960834,0.00006193317,0.00032505373,0.00014761837,0.000058912963,0.00020518385],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979941,0.00013250335,0.0010070365,0.00035852217,0.00017490525,0.00033288717],"domain_scores_gemma":[0.9956675,0.0015934876,0.0015899898,0.0007430156,0.00033138812,0.000074598145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000603851,0.0003613466,0.0028572718,0.00004246314,0.00012034903,0.000010778206,0.00028376165,0.00017207864,0.000045452212],"category_scores_gemma":[0.0004923086,0.00020327159,0.0011034595,0.00016743301,0.0002655968,0.00006523047,0.000060704875,0.00023171342,0.00005104661],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003465315,0.0026786907,0.000031538842,0.013694869,0.0064267074,0.00009807904,0.00004917613,3.5763485e-8,0.000009320124,0.0003763493,0.036902674,0.939386],"study_design_scores_gemma":[0.0018464838,0.0009001235,0.000006149221,0.005002798,0.011325558,0.0004413708,0.00004101737,0.0000028207373,0.000069232796,0.00003550081,0.9801599,0.00016909064],"about_ca_topic_score_codex":0.00027937297,"about_ca_topic_score_gemma":0.000009330208,"teacher_disagreement_score":0.94325715,"about_ca_system_score_codex":0.00003299894,"about_ca_system_score_gemma":0.0007771782,"threshold_uncertainty_score":0.8289175},"labels":[],"label_agreement":null},{"id":"W1991469355","doi":"10.1182/blood-2014-02-556142","title":"The mouse NKR-P1B:Clr-b recognition system is a negative regulator of innate immune responses","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; University of Toronto; Sunnybrook Health Science Centre; University of Ottawa","funders":"Biotechnology and Biological Sciences Research Council; Canadian Institutes of Health Research","keywords":"Immune system; Innate immune system; Biology; Regulator; Immunology; B cell; Cell biology; Antibody; Gene; Genetics","score_opus":0.02322526022923228,"score_gpt":0.23184684950171383,"score_spread":0.20862158927248156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991469355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915139,0.0022165554,0.000018272001,0.0002579981,0.0017242471,0.00024969995,0.000022325288,0.00009416658,0.0039028157],"genre_scores_gemma":[0.9694465,0.000076713164,0.000026638236,0.00006922809,0.000033050546,0.000033039127,0.00005552541,0.000015536654,0.030243786],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99878687,0.00042572172,0.00038528536,0.00016726633,0.000046744215,0.00018809114],"domain_scores_gemma":[0.99884516,0.00020225265,0.0002756093,0.00031576114,0.000343596,0.000017610042],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00048292335,0.00012672655,0.00019822503,0.00008585194,0.00019615206,0.000018780474,0.00013825228,0.00016256225,0.00013403302],"category_scores_gemma":[0.0003414371,0.00009128149,0.000096599804,0.000133663,0.00014560833,0.00012169155,0.000048701153,0.00020581888,0.00085529115],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024297251,0.0002579314,0.00011680633,0.000027511103,0.0005234003,0.0000019428867,0.001925011,4.3237307e-7,0.974979,0.0002877169,0.017305722,0.0021447975],"study_design_scores_gemma":[0.0025694282,0.00038104353,0.0005626665,0.000059432296,0.00010069592,0.00009878572,0.003905144,0.0000032404914,0.9635206,0.00006455458,0.028624969,0.000109466724],"about_ca_topic_score_codex":0.00016040934,"about_ca_topic_score_gemma":0.0000064637497,"teacher_disagreement_score":0.02634097,"about_ca_system_score_codex":0.00004269081,"about_ca_system_score_gemma":0.00007057137,"threshold_uncertainty_score":0.99992263},"labels":[],"label_agreement":null},{"id":"W1991548013","doi":"10.1182/blood-2014-05-574293","title":"Distinguishing CML LSCs from HSCs using CD26","year":2014,"lang":"en","type":"letter","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Cancer research; Immunology","score_opus":0.03662174043846369,"score_gpt":0.27509064071148187,"score_spread":0.23846890027301818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991548013","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.67167294,0.0050229793,0.0004938466,0.27989388,0.0035922749,0.0022276607,0.0006249003,0.0010962263,0.03537529],"genre_scores_gemma":[0.05887803,0.00008547578,0.024326054,0.8456897,0.05522507,0.000065110464,0.0073607564,0.0006852151,0.0076845894],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972791,0.00009121158,0.0004892752,0.0008055606,0.0006809198,0.00065392494],"domain_scores_gemma":[0.9979639,0.0003152893,0.00034250887,0.0011392237,0.00009410763,0.00014498748],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012075115,0.00056755013,0.00096463354,0.0001296564,0.00012046097,0.00008197655,0.00027851583,0.0010613293,0.00043110206],"category_scores_gemma":[0.00042706708,0.00051652256,0.0002894866,0.00012776454,0.00007610035,0.00004999185,0.00014148885,0.0018713757,0.00022768487],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027298354,0.00035272856,0.013764418,0.0007073039,0.001884101,0.010427064,0.0002799389,0.0000033143403,0.0012075485,0.0000037492903,0.97025347,0.0010890702],"study_design_scores_gemma":[0.008217668,0.00014454014,0.0009698802,0.0020021645,0.004978732,0.000661713,0.000011426435,0.00027012522,0.00082199817,0.00013173779,0.98112243,0.0006675758],"about_ca_topic_score_codex":0.0019166489,"about_ca_topic_score_gemma":0.000017792001,"teacher_disagreement_score":0.61279494,"about_ca_system_score_codex":0.00074114563,"about_ca_system_score_gemma":0.0005232787,"threshold_uncertainty_score":0.9997286},"labels":[],"label_agreement":null},{"id":"W1991569711","doi":"10.1182/blood.v97.5.1330","title":"Autosomal dominant macrothrombocytopenia in Italy is most frequently a type of heterozygous Bernard-Soulier syndrome","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":173,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Missense mutation; Bernard–Soulier syndrome; Platelet Glycoprotein GPIb-IX Complex; Compound heterozygosity; Platelet membrane glycoprotein; Von Willebrand factor; Platelet; Megakaryocyte; Medicine; Von Willebrand disease; Platelet disorder; Mutation; Internal medicine; Genetics; Pathology; Biology; Gene","score_opus":0.017813981076343993,"score_gpt":0.27239617108210773,"score_spread":0.25458219000576376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991569711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99462914,0.0007800942,0.000001884916,0.00034839028,0.00007063315,0.00040487293,0.000029630097,0.000022630424,0.0037127167],"genre_scores_gemma":[0.99790514,0.0002433198,0.00032958682,0.00028876183,0.000015198858,0.000016620696,0.000027536093,0.00002891596,0.0011448978],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998878,0.000017148988,0.00030697233,0.00026769514,0.000218897,0.0003112901],"domain_scores_gemma":[0.9994542,0.000016696671,0.00008228913,0.00029782526,0.000046703484,0.000102278704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000052674633,0.00017937532,0.0005319556,0.000117272335,0.00002884219,0.00001003928,0.000094569536,0.000108705775,0.00035878515],"category_scores_gemma":[0.000021987162,0.00014976875,0.0000850965,0.00031863115,0.000052770294,0.000070972994,0.000040029707,0.000119820135,0.00015938158],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000985502,0.009028674,0.8661784,0.00019502545,0.0011249084,0.06234943,0.0011380077,0.0000038011729,0.05577477,0.00005685534,0.0008594252,0.0023051794],"study_design_scores_gemma":[0.044799015,0.0043204403,0.8635586,0.0007331552,0.0010257785,0.02395349,0.00016952853,0.00009359979,0.05476147,0.00052167027,0.005398282,0.0006649541],"about_ca_topic_score_codex":0.00048316337,"about_ca_topic_score_gemma":0.00009709047,"teacher_disagreement_score":0.04381351,"about_ca_system_score_codex":0.0000356498,"about_ca_system_score_gemma":0.00007694528,"threshold_uncertainty_score":0.61073923},"labels":[],"label_agreement":null},{"id":"W1991590387","doi":"10.1182/blood-2007-03-077628","title":"Essential role for Rap1 GTPase and its guanine exchange factor CalDAG-GEFI in LFA-1 but not VLA-4 integrin–mediated human T-cell adhesion","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":127,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Alberta; Massachusetts Institute of Technology; McGovern Institute for Brain Research, Massachusetts Institute of Technology; National Institutes of Health; National Heart, Lung, and Blood Institute; Brigham and Women's Hospital","keywords":"Rap1; Guanine nucleotide exchange factor; Cell adhesion; Integrin; Cell biology; Cell adhesion molecule; Jurkat cells; Intercellular Adhesion Molecule-1; Biology; T cell; Signal transduction; Receptor; Immunology; Cell; Biochemistry","score_opus":0.02758942954860961,"score_gpt":0.3115660283833283,"score_spread":0.2839765988347187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991590387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996145,0.0011701804,0.00008708345,0.00023085464,0.0000751749,0.0013132644,0.00008365442,0.000073238654,0.00082153606],"genre_scores_gemma":[0.99598294,0.0001907457,0.00028584065,0.00021036304,0.0003035864,0.00006255589,0.0002037871,0.000070879876,0.002689318],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976418,0.00006474896,0.0004897391,0.0005533974,0.0005496279,0.0007007031],"domain_scores_gemma":[0.998601,0.00032702574,0.000100260055,0.0003289794,0.00020407987,0.00043866033],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004964508,0.00028219295,0.0004440897,0.00048290947,0.00010210697,0.000029801682,0.00016883633,0.000274847,0.00048759018],"category_scores_gemma":[0.00048882404,0.00025260757,0.000112164045,0.00032839325,0.00006455521,0.00007610573,0.00017827124,0.00047218302,0.00007958236],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006459238,0.0012846467,0.004892987,0.00038678435,0.000029150835,0.00036408243,0.00038246982,1.3682143e-7,0.9902027,0.000022327748,0.00021334074,0.0015754097],"study_design_scores_gemma":[0.013186185,0.0010592662,0.025621643,0.00011642189,0.00008435537,0.000035809484,0.00024860693,0.0002255444,0.9558911,0.000013501963,0.0032520732,0.00026552225],"about_ca_topic_score_codex":0.00024706143,"about_ca_topic_score_gemma":0.00038153148,"teacher_disagreement_score":0.03431167,"about_ca_system_score_codex":0.0000866862,"about_ca_system_score_gemma":0.000080171296,"threshold_uncertainty_score":0.9999926},"labels":[],"label_agreement":null},{"id":"W1991661989","doi":"10.1182/blood-2003-07-2617","title":"A novel SHP-1/Grb2–dependent mechanism of negative regulation of cytokine-receptor signaling: contribution of SHP-1 C-terminal tyrosines in cytokine signaling","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; Ontario Institute for Cancer Research","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Cell biology; Proto-oncogene tyrosine-protein kinase Src; GRB2; Biology; Cytokine receptor; Suppressor of cytokine signaling 1; Receptor tyrosine kinase; SH2 domain; Signal transduction; Protein tyrosine phosphatase; SOCS3; ROR1; Tyrosine kinase; SOCS2; Immunoreceptor tyrosine-based activation motif; Janus kinase 2; Receptor; Platelet-derived growth factor receptor; Biochemistry; STAT3; Growth factor","score_opus":0.020486050505375348,"score_gpt":0.263049696937156,"score_spread":0.24256364643178066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991661989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867923,0.0001479308,0.011596517,0.00006190088,0.00019084393,0.0006426172,0.00023064938,0.000027862969,0.0003093516],"genre_scores_gemma":[0.99503815,0.00001581438,0.004587978,0.000022794828,0.00011037096,0.000029815765,0.00010220165,0.000034146873,0.00005874413],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974973,0.00010340811,0.0012129412,0.00035946976,0.0005336755,0.00029321152],"domain_scores_gemma":[0.99768716,0.0002489757,0.00080375024,0.0003074504,0.0008549484,0.00009770664],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00060446205,0.00027055835,0.0008091822,0.00045277533,0.000049396895,0.00000911732,0.00010925527,0.00018494835,0.00036066075],"category_scores_gemma":[0.0007551696,0.0002569265,0.00024819016,0.00055903284,0.00010295742,0.00015625918,0.00003274315,0.00024880594,0.0000033824635],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046595934,0.0020490296,0.002500697,0.00018634486,0.0001641158,0.000008157647,0.00050950306,0.000405012,0.9850396,0.008582524,0.00001058692,0.00007848218],"study_design_scores_gemma":[0.0080099525,0.001017304,0.0019759126,0.0013187564,0.00038956196,0.00010587031,0.00032401623,0.0005046505,0.9854311,0.0006720826,0.000052488445,0.00019832655],"about_ca_topic_score_codex":0.0002726758,"about_ca_topic_score_gemma":0.000039399656,"teacher_disagreement_score":0.008245806,"about_ca_system_score_codex":0.000079809746,"about_ca_system_score_gemma":0.00021293151,"threshold_uncertainty_score":0.9999883},"labels":[],"label_agreement":null},{"id":"W1991682939","doi":"10.1182/blood-2010-05-286062","title":"Combination of HOXB4 and Delta-1 ligand improves expansion of cord blood cells","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute","keywords":"Biology; Haematopoiesis; CD34; Transplantation; Progenitor cell; Cancer research; CD19; Immunology; Xenotransplantation; Cord blood; Stem cell; Molecular biology; Flow cytometry; Cell biology; Medicine; Internal medicine","score_opus":0.008734217475759379,"score_gpt":0.2391955358508006,"score_spread":0.23046131837504125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991682939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985581,0.00010039451,0.00008278594,0.000049964226,0.00010836273,0.0002987452,0.000013746253,0.000017950335,0.0007699598],"genre_scores_gemma":[0.99730265,0.000096619064,0.002446829,0.00001916902,0.0000244209,0.0000054744833,0.000019771698,0.000013124425,0.00007195613],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99926686,0.000014079887,0.00028600835,0.0001415836,0.00019365094,0.00009784266],"domain_scores_gemma":[0.9994081,0.000090950845,0.00012907782,0.00018492415,0.000121607365,0.00006533539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015480163,0.00008818819,0.00023979665,0.00008060636,0.000018683502,0.0000039655365,0.000039522416,0.00010481852,0.000017132124],"category_scores_gemma":[0.000034372617,0.00007772726,0.000037216607,0.000088002525,0.000076605575,0.000042754855,0.000010951328,0.00010388932,0.0000019937497],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006148774,0.00054452673,0.010398394,0.0006171648,0.000046522913,0.000007275261,0.0004808438,5.083906e-8,0.9864847,0.0002482839,0.00000939288,0.0011013286],"study_design_scores_gemma":[0.0048342855,0.0006480278,0.03551314,0.00014376541,0.0005061055,0.00008247859,0.000090963025,0.000026804311,0.9579643,0.00011049844,0.000015770476,0.00006386681],"about_ca_topic_score_codex":0.000037644128,"about_ca_topic_score_gemma":0.000009657663,"teacher_disagreement_score":0.028520433,"about_ca_system_score_codex":0.0000012854715,"about_ca_system_score_gemma":0.000043636854,"threshold_uncertainty_score":0.31696257},"labels":[],"label_agreement":null},{"id":"W1991727971","doi":"10.1182/blood-2005-09-3610","title":"De novo synthesis of early growth response factor-1 is required for the full responsiveness of mast cells to produce TNF and IL-13 by IgE and antigen stimulation","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Canadian Institutes of Health Research; Killam Trusts; Nova Scotia Health Research Foundation","keywords":"Immunoglobulin E; Cytokine; Mast cell; Tumor necrosis factor alpha; Biology; Stem cell factor; Stimulation; Bone marrow; Cell biology; Inflammation; Immunology; Molecular biology; Chemistry; Antibody; Haematopoiesis; Endocrinology; Stem cell","score_opus":0.011243043768870333,"score_gpt":0.22556314240096897,"score_spread":0.21432009863209864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991727971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99662405,0.0014671878,0.00023138602,0.0006159251,0.00003687599,0.0004282233,0.0005666284,0.000008606159,0.000021113461],"genre_scores_gemma":[0.9984482,0.0000885128,0.00038548946,0.000046934143,0.000015551579,0.000020815174,0.0000061531523,0.00001287679,0.00097544544],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992057,0.00015101077,0.00022207928,0.00021454445,0.000029845776,0.00017678327],"domain_scores_gemma":[0.998792,0.0007631887,0.00011326077,0.00020281984,0.00010725489,0.00002147218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039066997,0.000108619606,0.00021687234,0.000074381715,0.00009583072,0.0000089697705,0.00010148565,0.000112231675,0.00005597064],"category_scores_gemma":[0.000218146,0.000085238775,0.000034340417,0.00007511515,0.00013394223,0.000046140904,0.00004530625,0.00005007471,0.0000040424147],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043033087,0.00014873722,0.0028108528,0.00005953516,0.00009192695,4.67983e-7,0.0015980914,0.0000020572156,0.98832107,0.000026528474,0.000343915,0.002293504],"study_design_scores_gemma":[0.0010435818,0.0004753618,0.06454534,0.000031225056,0.00008367914,0.000009430659,0.000090079666,0.000004528718,0.92517805,0.000009572508,0.008435914,0.00009323453],"about_ca_topic_score_codex":0.000083934574,"about_ca_topic_score_gemma":0.000020998988,"teacher_disagreement_score":0.06314303,"about_ca_system_score_codex":0.0000071899317,"about_ca_system_score_gemma":0.000039619645,"threshold_uncertainty_score":0.34759364},"labels":[],"label_agreement":null},{"id":"W1992000579","doi":"10.1182/blood-2009-12-258095","title":"The human stem cell hierarchy is defined by a functional dependence on Mcl-1 for self-renewal capacity","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre; McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Stem cell; Biology; Cell biology; Progenitor cell; Haematopoiesis; Hematopoietic stem cell; Induced pluripotent stem cell; Adult stem cell; Cancer research; Endothelial stem cell; Embryonic stem cell; Genetics; In vitro","score_opus":0.015166312053223153,"score_gpt":0.23801436956206432,"score_spread":0.22284805750884115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992000579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99641436,0.0001551873,0.0001432661,0.00025599374,0.0001572833,0.00031836377,0.00012441179,0.000018754186,0.0024123932],"genre_scores_gemma":[0.99408317,0.00003480691,0.0003567822,0.00016819169,0.00023360702,0.00011239695,0.000087535685,0.000023025554,0.004900464],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987791,0.0000491472,0.00014847275,0.00038344433,0.00027606045,0.00036376333],"domain_scores_gemma":[0.99922067,0.00007029565,0.000054361906,0.000433422,0.00010906624,0.000112212074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028666214,0.00014461695,0.00008874314,0.000022773133,0.00041844195,0.000052618365,0.00033308822,0.00017204,0.000021504446],"category_scores_gemma":[0.00002526303,0.0001107051,0.00010519152,0.000048385973,0.00008307624,0.000002744524,0.00009663082,0.00021999923,0.000029424895],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004375753,0.0003920503,0.0008672208,0.000018101178,0.00005623996,7.703566e-7,0.000017764272,0.000001042626,0.9890586,0.00019922592,0.00918185,0.00016336689],"study_design_scores_gemma":[0.0012992716,0.00041802268,0.00026457268,0.0000023947714,0.000022820343,0.000009785999,0.0000111480285,0.000013443146,0.94502985,0.00020263025,0.05258605,0.00013997957],"about_ca_topic_score_codex":0.00002125781,"about_ca_topic_score_gemma":0.00009447495,"teacher_disagreement_score":0.04402873,"about_ca_system_score_codex":0.000008266592,"about_ca_system_score_gemma":0.00008100249,"threshold_uncertainty_score":0.4514423},"labels":[],"label_agreement":null},{"id":"W1992086889","doi":"10.1182/blood-2004-08-3212","title":"Iron and cell proliferation: another piece of the puzzle","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cell growth; Suppressor; Biology; Cancer research; Organism; Gene; Cell biology; Genetics","score_opus":0.0035898373562093314,"score_gpt":0.18888532848973735,"score_spread":0.18529549113352803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992086889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99755555,0.0008741172,0.0001702701,0.00025550768,0.00004104109,0.00011404244,0.00000304807,0.0000028360696,0.0009835655],"genre_scores_gemma":[0.99908394,0.00004224736,0.00017330913,0.000050735776,0.000094116076,0.0000048500874,0.000005780775,0.0000067985106,0.00053822366],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997322,0.000009824725,0.00006370853,0.00009537794,0.000048062728,0.000050801653],"domain_scores_gemma":[0.9997855,9.551726e-7,0.000037255955,0.00014642715,0.0000197863,0.000010074578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00002742902,0.000041781725,0.000034439097,0.0000065843615,0.000030538526,0.0000045074535,0.000041297004,0.000059388043,0.0000049073815],"category_scores_gemma":[0.0000053593812,0.000032239586,0.000020749267,0.0000351821,0.000030737396,0.0000011948837,0.000025242027,0.000021332371,9.892156e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009443969,0.00006918694,0.002789043,0.000012422511,0.000008928682,7.885893e-8,0.000048601574,0.00034295776,0.99632514,0.00003402603,0.0001022646,0.0002579012],"study_design_scores_gemma":[0.0008725865,0.000060220653,0.00813198,0.0000061301357,0.000019140458,0.0000064585106,0.0000063020407,0.0000041323474,0.987894,0.000060476697,0.0028965396,0.00004201835],"about_ca_topic_score_codex":0.0000069240255,"about_ca_topic_score_gemma":0.00003478395,"teacher_disagreement_score":0.00843113,"about_ca_system_score_codex":0.0000032114347,"about_ca_system_score_gemma":0.000030599935,"threshold_uncertainty_score":0.13146922},"labels":[],"label_agreement":null},{"id":"W1992119621","doi":"10.1182/blood.v97.12.3882","title":"Hoechst 33342 efflux identifies a subpopulation of cytogenetically normal CD34+CD38− progenitor cells from patients with acute myeloid leukemia","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; BC Cancer Agency","funders":"National Cancer Institute; Deutsche Krebshilfe","keywords":"CD34; Immunophenotyping; Biology; CD38; Haematopoiesis; Molecular biology; Myeloid leukemia; Leukemia; Progenitor cell; Myeloid; Population; Immunology; Bone marrow; Stem cell; Flow cytometry; Medicine; Cell biology","score_opus":0.008115062086858657,"score_gpt":0.2236687288058252,"score_spread":0.21555366671896653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992119621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997342,0.000047975023,0.0008526705,0.000028216928,0.00013795537,0.0008378881,0.00010672498,0.000066975386,0.00057959347],"genre_scores_gemma":[0.9947427,0.00004914083,0.0042685256,0.000036627604,0.00013567213,0.000037617836,0.00049646193,0.000043683125,0.00018957298],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99823076,0.000044830187,0.0004898179,0.00033289156,0.00061851845,0.00028320658],"domain_scores_gemma":[0.9990205,0.00007254125,0.00017590226,0.00034670986,0.0002325016,0.0001518337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008605979,0.00021897008,0.0003801642,0.000109791355,0.000055050645,0.000022191974,0.00011093109,0.00014795268,0.00015485783],"category_scores_gemma":[0.000016339973,0.00018441952,0.00008930847,0.00023035017,0.00007637837,0.000112234346,0.000020391928,0.00012395551,0.00007831758],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055043463,0.00058619835,0.738529,0.000158862,0.00038241755,0.00008462423,0.00046625774,0.000009593301,0.2587858,0.000007509409,0.00003188365,0.0004073663],"study_design_scores_gemma":[0.0053042597,0.00035125238,0.472763,0.0001806899,0.0011013376,0.00003885559,0.000033167333,0.000024966237,0.52000225,0.000017922715,0.00003777256,0.0001445095],"about_ca_topic_score_codex":0.00017416695,"about_ca_topic_score_gemma":0.00007098351,"teacher_disagreement_score":0.26576602,"about_ca_system_score_codex":0.000049052902,"about_ca_system_score_gemma":0.00014737879,"threshold_uncertainty_score":0.752041},"labels":[],"label_agreement":null},{"id":"W1992131118","doi":"10.1182/blood-2002-08-2608","title":"Induction of heme oxygenase-1 and stimulation of cGMP production by hemin in aortic tissues from hypertensive rats","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Heme Oxygenase-1 and Carbon Monoxide","field":"Biochemistry, Genetics and Molecular Biology","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"Canadian Institutes of Health Research","keywords":"Hemin; Heme oxygenase; Internal medicine; Endocrinology; Zinc protoporphyrin; Heme; Medicine; Blood pressure; Aorta; Chemistry; Biochemistry; Enzyme","score_opus":0.008491734949206922,"score_gpt":0.22184121576453253,"score_spread":0.21334948081532562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992131118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975502,0.0020547183,0.00003287541,0.000028737944,0.000058997157,0.00014944622,0.000015438343,0.000003850793,0.000105749525],"genre_scores_gemma":[0.99911886,0.00019581344,0.0004195854,0.000019037345,0.000046337438,0.000008770788,0.00008089176,0.000010997477,0.00009972505],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992925,0.00005069263,0.00022812925,0.00024330971,0.00008524574,0.00010014467],"domain_scores_gemma":[0.9996084,0.0000068833906,0.00010019978,0.00017383536,0.00007773921,0.00003294368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000949839,0.0000928451,0.00015493136,0.000037330632,0.000013615724,0.000003362453,0.000033547505,0.00010985579,0.000009424549],"category_scores_gemma":[0.00014723928,0.00009437426,0.000025685655,0.0000843252,0.00004389176,0.000005948572,0.000013774198,0.0000430737,7.113572e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026544445,0.00017242538,0.007934271,0.0000176445,0.000030983552,7.49921e-7,0.000072556744,0.000017969218,0.9906934,0.000005676885,0.0001847283,0.0008430373],"study_design_scores_gemma":[0.00064440136,0.00012975455,0.007020551,0.000019691966,0.000034326633,0.0000046578357,0.00015056526,0.000017303482,0.9914598,0.00006890375,0.00035646808,0.00009361564],"about_ca_topic_score_codex":0.00009664361,"about_ca_topic_score_gemma":0.000023016655,"teacher_disagreement_score":0.0018589048,"about_ca_system_score_codex":0.000004384885,"about_ca_system_score_gemma":0.000028463875,"threshold_uncertainty_score":0.38484707},"labels":[],"label_agreement":null},{"id":"W1992318396","doi":"10.1182/blood-2010-07-294819","title":"Deficiency of SATB1 expression in Sézary cells causes apoptosis resistance by regulating FasL/CD95L transcription","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Vancouver Coastal Health; Vancouver Coastal Health Research Institute; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Cancer research; Biology; Apoptosis; Fas ligand; Programmed cell death","score_opus":0.029863233685570225,"score_gpt":0.2664902543057755,"score_spread":0.23662702062020527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992318396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99049443,0.0019148401,0.0001328035,0.000045480734,0.000031819047,0.0004581105,0.0000219214,0.000034078508,0.006866503],"genre_scores_gemma":[0.9970303,0.00022459663,0.0018775188,0.00003540677,0.00001590512,0.00003331158,0.00001615321,0.000027172668,0.00073959416],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984075,0.00010429738,0.00040123786,0.00032682752,0.0004407061,0.00031944155],"domain_scores_gemma":[0.99933577,0.000055835746,0.000096676966,0.00031057373,0.00011205874,0.000089074856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022526627,0.00015018963,0.00030011855,0.00018031675,0.00006113158,0.0000072095672,0.000121078796,0.00011354934,0.00017756953],"category_scores_gemma":[0.000109979745,0.00013720665,0.00007623338,0.00034835268,0.00011777648,0.0000914411,0.000027049755,0.0001588447,0.000007867653],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033782845,0.0012462393,0.037301827,0.00027427677,0.000014866783,0.000015958884,0.0030002436,0.0000010553464,0.956922,0.000026687427,0.00038937858,0.00046962907],"study_design_scores_gemma":[0.0024431658,0.0002987578,0.0064628953,0.000406643,0.00004597483,0.000019141558,0.00082134525,0.00001627159,0.989161,0.00013201704,0.00006557136,0.00012719427],"about_ca_topic_score_codex":0.00017343042,"about_ca_topic_score_gemma":0.000118226446,"teacher_disagreement_score":0.032239016,"about_ca_system_score_codex":0.000045561585,"about_ca_system_score_gemma":0.00009290239,"threshold_uncertainty_score":0.5595125},"labels":[],"label_agreement":null},{"id":"W1992838550","doi":"10.1182/blood-2003-03-0832","title":"Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":597,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Robarts Research Institute; Natural Sciences and Engineering Research Council of Canada","keywords":"Embryoid body; Haematopoiesis; Biology; Embryonic stem cell; Hemangioblast; Cell biology; Stem cell; Progenitor cell; Immunology; Mesoderm; Cellular differentiation; Hematopoietic stem cell; Adult stem cell; Genetics","score_opus":0.011773024685265582,"score_gpt":0.24366848722830955,"score_spread":0.23189546254304397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992838550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99810666,0.00083112187,0.00008764265,0.000014957405,0.000029074583,0.00019680773,0.0000071377267,0.000006351953,0.00072024635],"genre_scores_gemma":[0.9983335,0.00011644619,0.00009601148,0.000006600452,0.000024308461,0.000010771369,0.00001513058,0.000015392689,0.0013818315],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99922454,0.000073563206,0.00015023812,0.00023604464,0.00013813343,0.00017745038],"domain_scores_gemma":[0.99956626,0.0000058536684,0.000068273424,0.0002490697,0.00005420244,0.000056370605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012817257,0.000102200465,0.00012813605,0.000037574704,0.000051453426,0.000014585395,0.00009475758,0.000089547764,0.000013037704],"category_scores_gemma":[0.0000096238455,0.00009401053,0.000045144654,0.00005597658,0.000050375773,0.0000022755269,0.000062096275,0.00005017923,0.00000439169],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004896426,0.00018463991,0.0035662523,0.00012728381,0.000042072934,0.000001988382,0.000029649156,0.0000010817315,0.9957881,0.00013278371,0.00004406365,0.000077194425],"study_design_scores_gemma":[0.00087292044,0.00021430259,0.0017619311,0.000018785777,0.000031114196,0.000016131264,0.00002465478,0.000005434671,0.99635863,0.00006785907,0.000530185,0.00009807366],"about_ca_topic_score_codex":0.0000029078187,"about_ca_topic_score_gemma":0.0000058331816,"teacher_disagreement_score":0.0018043213,"about_ca_system_score_codex":0.0000030660342,"about_ca_system_score_gemma":0.00002561892,"threshold_uncertainty_score":0.38336384},"labels":[],"label_agreement":null},{"id":"W1992915563","doi":"10.1182/blood-2013-04-496893","title":"EZH2 mutations are frequent and represent an early event in follicular lymphoma","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":323,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Blood Cancer UK; National Cancer Institute; National Institute for Health and Care Research; Cancer Research UK","keywords":"EZH2; Follicular lymphoma; Biology; Mutation; Germinal center; Cancer research; Lymphoma; Genetics; Immunology; Methylation; Gene; Antibody; B cell","score_opus":0.008555894592890726,"score_gpt":0.24289399322611457,"score_spread":0.23433809863322386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992915563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972841,0.0018601771,0.00026169696,0.000102393475,0.000030596675,0.0002122043,0.00000510585,0.000006074784,0.00023765485],"genre_scores_gemma":[0.998808,0.0001681026,0.000677799,0.000034323137,0.000064962,0.000062283216,0.000054411947,0.000011741361,0.00011835339],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9993341,0.000052175517,0.00014992742,0.00024960976,0.00008015456,0.00013404238],"domain_scores_gemma":[0.9995663,0.0000056413787,0.000051816944,0.00024740704,0.000050443276,0.000078395075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000082087354,0.00008296065,0.00007732267,0.000035241344,0.0000381942,0.000033999822,0.00006280715,0.000084846375,0.000011328375],"category_scores_gemma":[0.000037950544,0.00008090915,0.00003075802,0.000050371487,0.000024745492,0.0000055413316,0.000042182804,0.000025332418,0.0000072423522],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000044339663,0.0003902817,0.26178634,0.000008759851,0.000031353782,0.000007542996,0.000117147065,0.00011493962,0.73334277,0.000055037028,0.000015580494,0.004125795],"study_design_scores_gemma":[0.00092972186,0.00017449394,0.67953575,0.0000088850275,0.000015950762,0.000002674243,0.00007520906,0.00009524051,0.3177111,0.0008488909,0.00048016242,0.00012189123],"about_ca_topic_score_codex":0.0003798077,"about_ca_topic_score_gemma":0.00014998374,"teacher_disagreement_score":0.41774943,"about_ca_system_score_codex":0.0000054238435,"about_ca_system_score_gemma":0.000018674082,"threshold_uncertainty_score":0.32993793},"labels":[],"label_agreement":null},{"id":"W1992936543","doi":"10.1182/blood-2008-08-175216","title":"Quebec platelet disorder is linked to the urokinase plasminogen activator gene (PLAU) and increases expression of the linked allele in megakaryocytes","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Hospital for Sick Children; University of Toronto; McMaster University","funders":"","keywords":"Plasminogen activator; Biology; Allele; Gene; Molecular biology; Cancer research; Urokinase; Fibrinolysis; Genetics; Medicine; Internal medicine","score_opus":0.012912127474457216,"score_gpt":0.2307960144642991,"score_spread":0.21788388698984187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992936543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99635905,0.0015486563,0.0000025643956,0.0011188927,0.000025917687,0.0007435084,0.00006083335,0.000021178515,0.0001194109],"genre_scores_gemma":[0.9982624,0.0003991973,0.00020388183,0.00052257226,0.000043333705,0.00006364998,0.000030206109,0.000024205858,0.0004505212],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989041,0.000061699306,0.00025650076,0.00027966185,0.00025582046,0.00024219781],"domain_scores_gemma":[0.9992234,0.00013095379,0.00009062172,0.00040405302,0.000037302183,0.0001136757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006950011,0.00020101872,0.00035270437,0.00007424392,0.00015360964,0.000009302334,0.00015172255,0.00011312282,0.000059898364],"category_scores_gemma":[0.00012076033,0.00010865027,0.00008150314,0.000221978,0.000093084964,0.000068327434,0.00013305704,0.00016217517,0.000010623775],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018319968,0.007557443,0.78117365,0.00013830156,0.00058901653,0.0012326994,0.0075584054,0.000033778073,0.18932578,0.00002294347,0.005909242,0.0046267714],"study_design_scores_gemma":[0.009814538,0.00031340765,0.6819221,0.0001611872,0.0001587927,0.000358668,0.00026259662,0.000033777866,0.3015674,0.000036190362,0.00517535,0.00019600861],"about_ca_topic_score_codex":0.0050127166,"about_ca_topic_score_gemma":0.0022616566,"teacher_disagreement_score":0.11224161,"about_ca_system_score_codex":0.000019944333,"about_ca_system_score_gemma":0.00011335324,"threshold_uncertainty_score":0.75777614},"labels":[],"label_agreement":null},{"id":"W1993007017","doi":"10.1182/blood-2014-05-572875","title":"Platelets: crossroads of immunity and hemostasis","year":2014,"lang":"en","type":"letter","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Platelet; Immunology; Virus; Adoptive cell transfer; Immunity; Biology; Hemostasis; Platelet activation; Virology; TLR7; Receptor; Toll-like receptor; Innate immune system; Immune system; Medicine; Internal medicine; T cell; Genetics","score_opus":0.01371625274369685,"score_gpt":0.22461929925458887,"score_spread":0.21090304651089203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993007017","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6833003,0.030460732,0.00018198715,0.21740896,0.018816248,0.0012515299,0.0001725084,0.00050220574,0.047905494],"genre_scores_gemma":[0.25238797,0.0015010097,0.00011089743,0.6150065,0.0012334002,0.00005931031,0.0051758443,0.00017713575,0.124347895],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989498,0.00020237776,0.0003406905,0.00023568943,0.000030865034,0.00024057772],"domain_scores_gemma":[0.99909896,0.00015950584,0.0002641629,0.00038485692,0.00008554972,0.000006971464],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013978648,0.00022481917,0.00041931053,0.00012696274,0.0001266853,0.00001654031,0.000160466,0.0010691558,0.0014206015],"category_scores_gemma":[0.00006082495,0.00020640642,0.00011988803,0.000053797477,0.00021835708,0.000053542055,0.000077768855,0.00145464,0.0003510652],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046661615,0.0000960196,0.00011776514,0.00011737498,0.0005048128,0.000009197818,0.0000974437,5.317708e-8,0.0753594,0.000009714719,0.92278695,0.000854611],"study_design_scores_gemma":[0.0011909833,0.00018571402,0.0001651139,0.000060142258,0.00019375379,0.00032386373,0.000025204557,1.5594634e-7,0.14909323,0.00001588047,0.8485743,0.00017170445],"about_ca_topic_score_codex":0.00018019951,"about_ca_topic_score_gemma":0.0000017291902,"teacher_disagreement_score":0.43091235,"about_ca_system_score_codex":0.00001084584,"about_ca_system_score_gemma":0.000026662194,"threshold_uncertainty_score":0.9994922},"labels":[],"label_agreement":null},{"id":"W1993215319","doi":"10.1182/blood-2014-11-611319","title":"Arterial thrombosis is accelerated in mice deficient in histidine-rich glycoprotein","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Heart and Stroke Foundation of Canada","keywords":"Hemostasis; Thrombosis; Coagulation; In vivo; Glycoprotein; Chemistry; Medicine; Biochemistry; Immunology; Biology; Cell biology; Internal medicine; Genetics","score_opus":0.062384958440057973,"score_gpt":0.2950313846084641,"score_spread":0.23264642616840614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993215319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954911,0.0009030933,0.000010046253,0.00082182104,0.00025214205,0.00044828546,0.0000096445165,0.0000585457,0.0020053515],"genre_scores_gemma":[0.9984937,0.000023499926,0.0003992014,0.00039512798,0.00021540643,0.00003924276,0.00004241636,0.000024376854,0.00036706295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986226,0.00004096062,0.0004048847,0.0003247332,0.00028020656,0.0003266299],"domain_scores_gemma":[0.9994219,0.000029044362,0.00007818458,0.00022464343,0.00009691496,0.00014929846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000248631,0.00017408679,0.0003548153,0.0002005312,0.000028155513,0.000027871401,0.00009531621,0.00012722981,0.00020322176],"category_scores_gemma":[0.00012787095,0.0001643844,0.000052733765,0.00056535,0.000037219084,0.00009296332,0.000040916424,0.00012744547,0.00009501878],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009403066,0.006198716,0.8378759,0.00018503763,0.00013728174,0.00029510492,0.012106574,0.000049210725,0.12920405,0.0005023463,0.00942659,0.0030788877],"study_design_scores_gemma":[0.029896978,0.0007373983,0.776142,0.0004166207,0.00021686452,0.00008364963,0.0007817553,0.00090408756,0.1846468,0.0004929386,0.0050698505,0.00061105983],"about_ca_topic_score_codex":0.0011812467,"about_ca_topic_score_gemma":0.0003703776,"teacher_disagreement_score":0.06173391,"about_ca_system_score_codex":0.000100581026,"about_ca_system_score_gemma":0.00020749617,"threshold_uncertainty_score":0.6703401},"labels":[],"label_agreement":null},{"id":"W1993380096","doi":"10.1182/blood-2013-08-521138","title":"STAT3 mutations and persistence of autoimmunity","year":2013,"lang":"en","type":"letter","venue":"Blood","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Autoimmunity; STAT3; Immunology; Cytotoxic T cell; Biology; STAT protein; Leukemia; Cancer research; Genetics; Signal transduction; Immune system","score_opus":0.014810335877045146,"score_gpt":0.2042550728802882,"score_spread":0.18944473700324307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993380096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6464346,0.22960095,0.00005065204,0.10554885,0.0017027096,0.0012301293,0.0006461583,0.00027147552,0.014514474],"genre_scores_gemma":[0.91710514,0.0007504588,0.000102669415,0.059355095,0.00002628789,0.00009834496,0.0024447658,0.000073995194,0.020043243],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987392,0.00019594112,0.00037486848,0.00027966758,0.000046053978,0.00036428348],"domain_scores_gemma":[0.9989779,0.00018991496,0.00025931478,0.00046052464,0.00010924725,0.0000030827011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012051582,0.0002585613,0.0004363274,0.0001498356,0.00024090933,0.000017834585,0.00035408657,0.0007573586,0.00067030365],"category_scores_gemma":[0.00007242949,0.00024145943,0.00013579805,0.000117197145,0.0008128674,0.00008442544,0.00011745176,0.0012931778,0.0002484111],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058818692,0.0028712049,0.0011474274,0.00221154,0.0048964834,0.000118494965,0.01521603,0.000008587774,0.36831328,0.00082974194,0.5757926,0.02853578],"study_design_scores_gemma":[0.0026100746,0.00028977852,0.0061558047,0.00021794761,0.0007078997,0.00020862509,0.0014557237,0.000002133228,0.0123596275,0.0004597404,0.97485834,0.00067428703],"about_ca_topic_score_codex":0.0003969974,"about_ca_topic_score_gemma":8.4486675e-7,"teacher_disagreement_score":0.39906573,"about_ca_system_score_codex":0.000007720546,"about_ca_system_score_gemma":0.000097483666,"threshold_uncertainty_score":0.984643},"labels":[],"label_agreement":null},{"id":"W1993779367","doi":"10.1182/blood-2011-04-350553","title":"Wnt4 regulates thymic cellularity through the expansion of thymic epithelial cells and early thymic progenitors","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Canadian Institutes of Health Research; Novo Nordisk Fonden","keywords":"Biology; Progenitor cell; Progenitor; Cancer research; Cell biology; Immunology; Pathology; Medicine; Stem cell","score_opus":0.009260737021440413,"score_gpt":0.19761127749579652,"score_spread":0.1883505404743561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993779367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947042,0.0038572259,0.000042593863,0.000032844695,0.00020406103,0.00024045489,0.00001853502,0.000012525989,0.0008875585],"genre_scores_gemma":[0.9977641,0.0013669902,0.000324722,0.000045423894,0.00015453114,0.000013035053,0.000009841772,0.000021609614,0.00029970787],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99905974,0.0000690834,0.00022266772,0.00030116833,0.0001247188,0.00022262128],"domain_scores_gemma":[0.9994212,0.000009007942,0.00012720338,0.00034185042,0.000050671744,0.00005008848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010797346,0.0001699827,0.00016071385,0.000019274992,0.00010092303,0.000011939095,0.00021812391,0.00022584766,0.000011117157],"category_scores_gemma":[0.0000072356584,0.00010737108,0.00011552353,0.000076624485,0.00025147188,0.000006798058,0.000105661085,0.00013737417,0.0000064011074],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008665747,0.00010174425,0.0021296162,0.000029226776,0.000149149,0.000004033337,0.0007286479,0.0000037930567,0.99626046,0.0000602063,0.000076284145,0.00037016452],"study_design_scores_gemma":[0.0007559162,0.00037443143,0.003352142,0.000027395165,0.0001423878,0.0000234504,0.00013027966,0.0000033218953,0.9935773,0.0005763682,0.0008829387,0.0001540721],"about_ca_topic_score_codex":0.0003083243,"about_ca_topic_score_gemma":0.000008219406,"teacher_disagreement_score":0.0030599383,"about_ca_system_score_codex":0.000003903554,"about_ca_system_score_gemma":0.00005829228,"threshold_uncertainty_score":0.43784657},"labels":[],"label_agreement":null},{"id":"W1993819398","doi":"10.1182/blood-2009-02-203323","title":"Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute on Minority Health and Health Disparities; National Heart, Lung, and Blood Institute; Hospital for Sick Children; New England Research Institutes; University of South Carolina; Johns Hopkins University; National Institutes of Health; Children's Mercy Hospital; Emory University; Morehouse School of Medicine; Children's Hospital of Philadelphia","keywords":"Medicine; Gastroenterology; Internal medicine; Alanine transaminase; Ferritin; Serum ferritin; Liver disease; Anemia; Surgery","score_opus":0.006136441585571279,"score_gpt":0.19673140234231357,"score_spread":0.1905949607567423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993819398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928321,0.0047758226,7.511742e-7,0.0013131497,0.000007980184,0.00067776005,0.00016724037,0.000057590267,0.00016760083],"genre_scores_gemma":[0.995673,0.0035347724,0.000036923615,0.00042063027,0.000057711823,0.00000958029,0.00005591783,0.000030610496,0.00018087261],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988447,0.000040113635,0.00013431523,0.00038979077,0.00026632735,0.0003247564],"domain_scores_gemma":[0.99945235,0.000015465617,0.000084752435,0.00017342712,0.000045458648,0.00022856996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000081110105,0.0002510226,0.0003159056,0.00009655008,0.00009558674,0.00001971169,0.000044453434,0.00014498303,0.000018012366],"category_scores_gemma":[0.000019452871,0.00017876973,0.000026148917,0.00019768953,0.00007946326,0.000049743536,0.000014231961,0.00034390885,0.0000021994153],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001225253,0.006225088,0.9807867,0.00031905217,0.00019476606,0.0007608085,0.00077984616,0.000022403086,0.0022484811,0.000003065335,0.000055552504,0.0073789777],"study_design_scores_gemma":[0.016231986,0.004414013,0.97286963,0.0017334364,0.00075781485,0.00006361337,0.00025625885,0.0000880092,0.0032665269,0.0000033423823,0.000021533087,0.00029382162],"about_ca_topic_score_codex":0.000077234436,"about_ca_topic_score_gemma":0.001127369,"teacher_disagreement_score":0.015006733,"about_ca_system_score_codex":0.00004172657,"about_ca_system_score_gemma":0.000113032496,"threshold_uncertainty_score":0.72900176},"labels":[],"label_agreement":null},{"id":"W1993850674","doi":"10.1182/blood-2002-08-2598","title":"Autoimmune complexes in human serum in presence of therapeutic amounts of intravenous immunoglobulins","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Héma-Québec","funders":"","keywords":"Intravenous Immunoglobulins; Medicine; Antibody; Immunology; Autoimmune disease; Autoimmunity","score_opus":0.016188638594707476,"score_gpt":0.2690978102725785,"score_spread":0.252909171677871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993850674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952948,0.0021700403,0.0000023079663,0.000026804759,0.000019510244,0.00028414858,0.000010160398,0.000007633314,0.0021845694],"genre_scores_gemma":[0.99966305,0.00010141413,0.0001157963,0.00001991748,0.0000020941463,0.000008153891,0.000009222563,0.000009886523,0.00007048411],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99920213,0.00004467495,0.00032210792,0.00012521191,0.00012764258,0.00017821346],"domain_scores_gemma":[0.99961966,0.000029628181,0.000085244494,0.0002190221,0.00002616416,0.000020256837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000102453116,0.0000979955,0.0003881305,0.00011136962,0.000015232473,0.0000022998895,0.00007273058,0.000056077126,0.0000536076],"category_scores_gemma":[0.000022197955,0.00008576535,0.000041770163,0.0002146186,0.00006781969,0.000030251504,0.000014172793,0.00009482521,0.0000025333861],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010368057,0.010163097,0.78878665,0.0002049394,0.00026984667,0.00035775412,0.0020136242,0.00002247521,0.19378462,0.0020869372,0.0000030362803,0.00220336],"study_design_scores_gemma":[0.007743399,0.00047844247,0.93667626,0.00020093849,0.000065431515,0.00005000975,0.00020773086,0.00001388958,0.053368304,0.0010837694,0.00003844325,0.000073356365],"about_ca_topic_score_codex":0.000818265,"about_ca_topic_score_gemma":0.00030939322,"teacher_disagreement_score":0.14788966,"about_ca_system_score_codex":0.000017304805,"about_ca_system_score_gemma":0.00005280837,"threshold_uncertainty_score":0.34974095},"labels":[],"label_agreement":null},{"id":"W1993923451","doi":"10.1182/blood-2013-02-483495","title":"Essential role of BRG, the ATPase subunit of BAF chromatin remodeling complexes, in leukemia maintenance","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":125,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"National Cancer Institute","keywords":"Chromatin remodeling; ATPase; Protein subunit; Cell biology; Leukemia; Chromatin; Biology; Chemistry; Cancer research; Biochemistry; Genetics; Enzyme; DNA","score_opus":0.0047349628948020325,"score_gpt":0.21516526881183587,"score_spread":0.21043030591703385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993923451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99670297,0.00080188725,0.001353822,0.000029378087,0.000032030628,0.00008612363,0.000013438493,0.0000055515375,0.0009748046],"genre_scores_gemma":[0.99861085,0.00008759568,0.0010327187,0.000045366814,0.000112644506,0.0000058480477,0.000029280605,0.000014466593,0.00006123909],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99918234,0.00006441247,0.0003004835,0.00017745448,0.000117366995,0.0001579635],"domain_scores_gemma":[0.9993784,0.000018400688,0.00013986451,0.00036267383,0.0000755009,0.00002518794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027121385,0.00009755879,0.0001672644,0.00002321881,0.000029803794,0.0000055204328,0.0002195969,0.00007840639,0.0000109314715],"category_scores_gemma":[0.00007659026,0.000077241624,0.00007360465,0.00007578456,0.000082996594,0.0000020361067,0.00007537655,0.00007343731,0.0000013977213],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002916661,0.000072205716,0.0008562587,0.000049289294,0.00002003719,2.7189427e-7,0.00008223863,0.0036639338,0.9935273,0.00016385275,0.000084944295,0.0014505069],"study_design_scores_gemma":[0.0015808698,0.00011014273,0.0013041849,0.00013405147,0.00003237919,0.000011817662,0.00013895973,0.029012436,0.9658699,0.00048550343,0.0011874057,0.00013235457],"about_ca_topic_score_codex":0.00041159018,"about_ca_topic_score_gemma":0.00020437397,"teacher_disagreement_score":0.027657399,"about_ca_system_score_codex":0.000009241752,"about_ca_system_score_gemma":0.000085204265,"threshold_uncertainty_score":0.3149822},"labels":[],"label_agreement":null},{"id":"W1993959174","doi":"10.1182/blood-2004-04-1425","title":"Quebec platelet syndrome: from the bench to the family","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Platelet; Internal medicine","score_opus":0.00929206201086894,"score_gpt":0.2174134825793148,"score_spread":0.20812142056844588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993959174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849741,0.008900351,0.00032167547,0.0045710336,0.00012848357,0.00043851783,0.00003702686,0.00006475982,0.000564092],"genre_scores_gemma":[0.9925347,0.00024326751,0.00015250995,0.00641709,0.00030823622,0.000033819622,0.00003591004,0.000020603278,0.00025384108],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.999069,0.000046140587,0.00013438506,0.0002123505,0.0003270836,0.00021105834],"domain_scores_gemma":[0.99915916,0.00005639951,0.000023106531,0.00062001136,0.0000322629,0.00010907389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015581839,0.0001317187,0.00021162385,0.00001755365,0.0001612463,0.000035788515,0.00021828349,0.000059738577,0.000096824726],"category_scores_gemma":[0.00003566368,0.0000666969,0.00026982388,0.00017845376,0.000057265224,0.000035664394,0.00004305714,0.00015474737,0.00039062114],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037068143,0.0136950305,0.085690096,0.000316904,0.050541256,0.030124208,0.030413397,0.0037110623,0.04891352,0.01663877,0.12560552,0.5906434],"study_design_scores_gemma":[0.008586349,0.00031999525,0.7487355,0.00019136003,0.0012629603,0.0008901047,0.0012485601,0.0000015276903,0.006966644,0.0005898718,0.2309143,0.00029286175],"about_ca_topic_score_codex":0.004619539,"about_ca_topic_score_gemma":0.00066734257,"teacher_disagreement_score":0.6630454,"about_ca_system_score_codex":0.000019055218,"about_ca_system_score_gemma":0.00013287694,"threshold_uncertainty_score":0.69833916},"labels":[],"label_agreement":null},{"id":"W1994331630","doi":"10.1182/blood-2007-11-125039","title":"CCL5-mediated T-cell chemotaxis involves the initiation of mRNA translation through mTOR/4E-BP1","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"National Cancer Institute; Natural Sciences and Engineering Research Council of Canada; National Institutes of Health; Canadian Institutes of Health Research; U.S. Department of Veterans Affairs","keywords":"EIF4E; CCL5; PI3K/AKT/mTOR pathway; Cell biology; P70-S6 Kinase 1; Chemotaxis; Biology; Ribosomal protein s6; mTORC1; Chemokine; Molecular biology; Translation (biology); T cell; Messenger RNA; Signal transduction; Receptor; Biochemistry; Immunology; IL-2 receptor","score_opus":0.02652208873692353,"score_gpt":0.23973800446821145,"score_spread":0.21321591573128792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994331630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992349,0.0032184706,0.00063240214,0.00013750042,0.00012647423,0.00017447991,0.000035609966,0.000017911912,0.0033081253],"genre_scores_gemma":[0.9976675,0.0007283515,0.00077111134,0.00023968857,0.00028567348,0.000019794206,0.00018184225,0.00002159977,0.000084476924],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99914104,0.000058326517,0.00023802684,0.00022225517,0.00017947626,0.00016085702],"domain_scores_gemma":[0.9993977,0.000038602957,0.00013806947,0.00029729406,0.00009818678,0.000030180592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011684272,0.00012674565,0.00012423757,0.000018860754,0.00008258495,0.00000661324,0.00018169149,0.00016165638,0.00003166368],"category_scores_gemma":[0.00005986565,0.000104619976,0.000090721485,0.00012609741,0.00012431422,0.000007736999,0.000025118547,0.00008999373,0.000009030796],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003623853,0.00021246554,0.0035953308,0.000026874592,0.00005587478,0.0000018907182,0.00055627024,0.000035098565,0.9944083,0.000011160506,0.00084200676,0.00021846822],"study_design_scores_gemma":[0.0014529666,0.00019578317,0.0018850659,0.0000131743855,0.00004706559,0.000010285462,0.000043327087,0.0000301827,0.9876893,0.00007332874,0.008425715,0.00013376474],"about_ca_topic_score_codex":0.00003917591,"about_ca_topic_score_gemma":0.000016714039,"teacher_disagreement_score":0.007583709,"about_ca_system_score_codex":0.0000075136722,"about_ca_system_score_gemma":0.00010368598,"threshold_uncertainty_score":0.42662787},"labels":[],"label_agreement":null},{"id":"W1994443789","doi":"10.1182/blood-2010-05-284448","title":"Antithrombin-heparin covalent complex reduces microemboli during cardiopulmonary bypass in a pig model","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Cardiac and Coronary Surgery Techniques","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Heart and Stroke Foundation of Canada","keywords":"Heparin; Cardiopulmonary bypass; Protamine sulfate; Medicine; Anesthesia; Antithrombin; Activated clotting time; Protamine; Anticoagulant; Cardiology; Internal medicine","score_opus":0.01621011353431938,"score_gpt":0.26226622790692306,"score_spread":0.24605611437260366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994443789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882286,0.00034641777,0.00001468228,0.0003160309,0.00016176097,0.00037924398,0.000024991405,0.00022558362,0.0103026405],"genre_scores_gemma":[0.99714816,0.00020566251,0.0018164063,0.00012003624,0.00017809388,0.000057978494,0.000037777925,0.000039235998,0.00039667438],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986444,0.000037765592,0.00032235385,0.00037852078,0.00025166888,0.00036525683],"domain_scores_gemma":[0.9992669,0.000022175462,0.000059571656,0.00045797997,0.00005478339,0.00013854832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022031796,0.00020839268,0.00054727076,0.00018410366,0.00006797621,0.000017867804,0.00011486222,0.0001403689,0.000058312093],"category_scores_gemma":[0.000020671792,0.00020678193,0.0002414827,0.0001797235,0.00009452502,0.00009104955,0.00010749144,0.0004178567,0.00001889931],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011793669,0.0008025872,0.1586459,0.000074383526,0.00009838918,0.00047179963,0.0001093568,0.000010802214,0.83730197,0.00009707841,0.00072188146,0.0015478805],"study_design_scores_gemma":[0.0018229929,0.00007401727,0.7929623,0.000111025845,0.00016522582,0.0010105473,0.00006158326,0.00035963082,0.20164037,0.00018433442,0.0013104727,0.00029747834],"about_ca_topic_score_codex":0.00019397704,"about_ca_topic_score_gemma":0.000036877642,"teacher_disagreement_score":0.63566166,"about_ca_system_score_codex":0.000029098808,"about_ca_system_score_gemma":0.000107989996,"threshold_uncertainty_score":0.8432322},"labels":[],"label_agreement":null},{"id":"W1994590672","doi":"10.1182/blood-2004-01-0225","title":"Severe hypochromic microcytic anemia caused by a congenital defect of the iron transport pathway in erythroid cells","year":2004,"lang":"en","type":"letter","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Microcytic anemia; Hemosiderosis; Hypochromic anemia; Thalassemia; Anemia; Hemoglobin; Medicine; Red Cell; Red blood cell; Internal medicine","score_opus":0.004635940964095918,"score_gpt":0.18408845354679074,"score_spread":0.17945251258269482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994590672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97278637,0.004615994,8.327029e-7,0.019481663,0.00028449908,0.0011215266,0.00040371393,0.000042473832,0.0012629449],"genre_scores_gemma":[0.9342953,0.0004181098,0.00002615567,0.06206077,0.00029704487,0.000030000841,0.00050389825,0.00013994699,0.0022287988],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979078,0.000071539835,0.00059685245,0.00048826047,0.00040061257,0.00053492206],"domain_scores_gemma":[0.9990272,0.000053759475,0.00021917885,0.00057969155,0.000045012323,0.00007518142],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0000998712,0.0004567342,0.00078577665,0.00012691961,0.000049724596,0.0000075269277,0.0002536644,0.001460444,0.000117810116],"category_scores_gemma":[0.000014218879,0.00032601025,0.0005256948,0.00027732627,0.00023272498,0.000027888338,0.000028908049,0.002144215,0.00003496419],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023324315,0.002602844,0.0060938513,0.0073615345,0.0013260415,0.0083556045,0.0029895362,0.00008667714,0.6118024,0.0000024056005,0.35883296,0.00031290148],"study_design_scores_gemma":[0.10182979,0.0025556474,0.008070852,0.008310162,0.011369425,0.004644613,0.0008781307,0.00000803661,0.551005,0.0001328581,0.3070947,0.004100802],"about_ca_topic_score_codex":0.0004448378,"about_ca_topic_score_gemma":0.00009017799,"teacher_disagreement_score":0.10159655,"about_ca_system_score_codex":0.0001723402,"about_ca_system_score_gemma":0.0008078986,"threshold_uncertainty_score":0.9999192},"labels":[],"label_agreement":null},{"id":"W1994592508","doi":"10.1182/blood-2008-03-138487","title":"Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":190,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Center for Research Resources; National Cancer Institute","keywords":"Thrombocytopenic purpura; Medicine; Immune system; Purpura (gastropod); Thrombotic thrombocytopenic purpura; Splenectomy; Immunology; Pediatrics; Platelet; Spleen","score_opus":0.009076515080064018,"score_gpt":0.21883247541965697,"score_spread":0.20975596033959296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994592508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99458647,0.0012081921,0.0000026692626,0.0001661122,0.000015410198,0.0005698266,0.000009376425,0.000052995827,0.0033889604],"genre_scores_gemma":[0.9980307,0.0002484753,0.00079230714,0.000174681,0.000028065846,0.00003693731,0.00009291794,0.000026892636,0.00056898425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914163,0.000014687016,0.0001649109,0.00023929571,0.00017078042,0.00026870967],"domain_scores_gemma":[0.999555,0.000016151926,0.00004483711,0.0002831496,0.000018808245,0.00008208219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000029669465,0.00016705132,0.00038245373,0.00006900701,0.00006489635,0.000007695213,0.00007743123,0.00006720021,0.00013190658],"category_scores_gemma":[0.000013915244,0.0001227892,0.00005677262,0.0002180705,0.000047846243,0.00008544691,0.00002612584,0.00014748241,0.000106358435],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000094924486,0.0022366426,0.9874912,0.000011521734,0.00026835696,0.007730476,0.0001907228,0.0000036749875,0.00043121146,0.0000070397496,0.00008065084,0.0014535754],"study_design_scores_gemma":[0.025389124,0.0004573822,0.9627325,0.00004550599,0.00018077585,0.008808939,0.000034551995,0.0000055843384,0.002132406,0.00001699547,0.000035470894,0.000160771],"about_ca_topic_score_codex":0.00040059173,"about_ca_topic_score_gemma":0.00007302187,"teacher_disagreement_score":0.0252942,"about_ca_system_score_codex":0.000023305765,"about_ca_system_score_gemma":0.000088699424,"threshold_uncertainty_score":0.50071985},"labels":[],"label_agreement":null},{"id":"W1994600783","doi":"10.1182/blood-2009-03-209221","title":"ADA-deficient SCID is associated with a specific microenvironment and bone phenotype characterized by RANKL/OPG imbalance and osteoblast insufficiency","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"RANKL; Osteoprotegerin; Bone remodeling; Osteoblast; Internal medicine; Bone marrow; Endocrinology; Transplantation; Haematopoiesis; Cancer research; Stem cell; Biology; Medicine; Activator (genetics); Receptor; Cell biology; In vitro; Biochemistry","score_opus":0.0059121721767814136,"score_gpt":0.20993854193181544,"score_spread":0.20402636975503402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994600783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895683,0.009559889,0.000040315572,0.00022989386,0.000011823289,0.00035580338,0.000085531465,0.000012395531,0.0001360463],"genre_scores_gemma":[0.99679124,0.0021883384,0.00008965311,0.00047531136,0.000046501846,0.000017475735,0.000093400995,0.000021300733,0.00027675778],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99870354,0.000060228398,0.00016462064,0.0004887338,0.00022502693,0.00035788034],"domain_scores_gemma":[0.99947745,0.000007673376,0.000082741084,0.00028041945,0.000032781074,0.00011894444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018965547,0.00019595805,0.00020006174,0.000037663754,0.000119809905,0.000050606828,0.00011776319,0.00009525825,0.00002724953],"category_scores_gemma":[0.0000093730405,0.00017143683,0.00002939875,0.00010635953,0.00015541588,0.000004697299,0.000062396415,0.00010573759,0.000006034684],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089176145,0.00083636434,0.0011771882,0.000006228828,0.000045691326,0.00000904337,0.00007818188,6.2873033e-7,0.9946109,0.0000013473158,0.00018596339,0.0021566711],"study_design_scores_gemma":[0.007455262,0.010177657,0.032082554,0.000039838553,0.000041369618,0.00004130084,0.000043186377,0.000010883729,0.94201803,0.000008100946,0.0076779267,0.00040388244],"about_ca_topic_score_codex":0.000002100964,"about_ca_topic_score_gemma":0.0000071020463,"teacher_disagreement_score":0.052592892,"about_ca_system_score_codex":0.00001485859,"about_ca_system_score_gemma":0.00003256403,"threshold_uncertainty_score":0.69909906},"labels":[],"label_agreement":null},{"id":"W1994622828","doi":"10.1182/blood-2009-03-205096","title":"Platelet-associated complement factor H in healthy persons and patients with atypical HUS","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Platelet; Complement system; Immunology; Platelet factor 4; Autoantibody; Factor H; Alternative complement pathway; Chemistry; Biology; Antibody","score_opus":0.014388914673927557,"score_gpt":0.2442489669747833,"score_spread":0.22986005230085574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994622828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99806213,0.0009085562,0.0000013474471,0.00022933862,0.00006975489,0.00042027424,0.0001946754,0.000043354215,0.000070553644],"genre_scores_gemma":[0.99945873,0.000005890897,0.000022719696,0.0002385708,0.0000067454307,0.000013234648,0.00020357517,0.0000063349576,0.000044186258],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999084,0.00012807948,0.00022037824,0.00022227463,0.00004148972,0.0003038025],"domain_scores_gemma":[0.999648,0.000077537865,0.0000800636,0.00012834992,0.00003412609,0.000031968095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005700676,0.00012670635,0.00023829413,0.000067886256,0.000088154244,0.00000775298,0.0000809527,0.00006591772,0.0002645875],"category_scores_gemma":[0.000035235873,0.00010310824,0.000023525014,0.00007663322,0.000045636025,0.00003568956,0.000028146456,0.00010964813,0.000036557925],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060998276,0.0020865034,0.9929955,0.00001862885,0.00019475319,0.000009331792,0.00055775326,3.7944704e-7,0.00089622795,0.000113776856,0.0015838965,0.000933268],"study_design_scores_gemma":[0.010844619,0.0012631253,0.9859169,0.000062534185,0.000028156046,0.000004782426,0.00015536984,4.5824615e-7,0.00035418055,0.000026882248,0.0012111135,0.0001318755],"about_ca_topic_score_codex":0.000023938359,"about_ca_topic_score_gemma":0.00012318534,"teacher_disagreement_score":0.010234636,"about_ca_system_score_codex":0.000044349174,"about_ca_system_score_gemma":0.000028420973,"threshold_uncertainty_score":0.42046323},"labels":[],"label_agreement":null},{"id":"W1994736776","doi":"10.1182/blood-2007-07-099309","title":"Guanine exchange factor RalGDS mediates exocytosis of Weibel-Palade bodies from endothelial cells","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Cellular transport and secretion","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Exocytosis; Exocyst; Cell biology; Guanine nucleotide exchange factor; Calmodulin; Chemistry; Signal transduction; Biology; Biochemistry; Secretion","score_opus":0.013834835023995596,"score_gpt":0.2014085997867253,"score_spread":0.1875737647627297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994736776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957247,0.0027487439,0.0003992784,0.000027444974,0.00014586824,0.0001018892,0.00047061342,0.000015297861,0.00036616292],"genre_scores_gemma":[0.99398184,0.002665238,0.00044250934,0.000037747363,0.00041248018,0.000010072276,0.0019500395,0.000021480546,0.00047857908],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99921656,0.000023818917,0.00020328615,0.00024039528,0.00014044097,0.00017550972],"domain_scores_gemma":[0.9995774,0.000009814203,0.00007856209,0.00022917644,0.000042325777,0.00006269454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000032590742,0.00014740597,0.00018955159,0.000032172928,0.000050910818,0.000003991639,0.00013233528,0.00015078619,0.00022972822],"category_scores_gemma":[0.000010429323,0.00013742033,0.00012709071,0.000032252632,0.00008746147,0.0000031249285,0.00003287199,0.000056156197,0.000012489109],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057259866,0.00015567345,0.013114593,0.000018101688,0.000089200956,0.000012005181,0.00049158937,0.0000012300919,0.9859009,0.0000018698832,0.00007647743,0.00008112919],"study_design_scores_gemma":[0.0013494869,0.0001976107,0.008447627,0.000008960632,0.00006198501,0.0000045612073,0.000033429827,0.0000035098687,0.976123,0.000012870922,0.013604703,0.00015229385],"about_ca_topic_score_codex":0.00010889622,"about_ca_topic_score_gemma":0.00009019169,"teacher_disagreement_score":0.013528226,"about_ca_system_score_codex":0.0000027310175,"about_ca_system_score_gemma":0.000029947683,"threshold_uncertainty_score":0.5603838},"labels":[],"label_agreement":null},{"id":"W1994749115","doi":"10.1182/blood-2011-01-328906","title":"Alternative activation of macrophages by IL-4 enhances the proteolytic capacity of their phagosomes through synergistic mechanisms","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Wound Healing and Treatments","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Phagosome; Cathepsin; Phagolysosome; Cell biology; Chemistry; Macrophage; NADPH oxidase; Phagocytosis; Cathepsin B; Proteolytic enzymes; Biochemistry; Biology; Reactive oxygen species; Enzyme; In vitro","score_opus":0.04230892950336326,"score_gpt":0.26973993532079,"score_spread":0.22743100581742673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994749115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99568045,0.0001700271,0.002044034,0.000063702835,0.000053020427,0.00043075657,0.000048575534,0.000018603248,0.0014908226],"genre_scores_gemma":[0.99796355,0.000060026025,0.0016853695,0.00003577054,0.00003097237,0.000048177753,0.000008571862,0.0000109454995,0.00015659236],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993271,0.000045335677,0.00019640653,0.00013686088,0.00017510766,0.000119153796],"domain_scores_gemma":[0.99940777,0.000081519596,0.00019425672,0.00020422986,0.000086425454,0.000025813248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000917892,0.00010994827,0.00023110257,0.000022820903,0.000051506275,0.0000026782432,0.00008218172,0.000042972966,0.0000466595],"category_scores_gemma":[0.000051295472,0.00006137504,0.000057382582,0.0000824497,0.00011636414,0.00005224056,0.000014961948,0.00007745611,0.0000036433385],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014623461,0.0022686876,0.00088220777,0.00025645414,0.0007939867,0.000005972854,0.008928378,8.1267035e-7,0.97980654,0.006408817,0.000028248387,0.00047365553],"study_design_scores_gemma":[0.0012486061,0.00057536305,0.0015196186,0.00015509476,0.00022451917,0.000005703397,0.00032860666,0.000010564041,0.9795405,0.016334167,0.000008716214,0.00004853192],"about_ca_topic_score_codex":0.00093291485,"about_ca_topic_score_gemma":0.000004961429,"teacher_disagreement_score":0.00992535,"about_ca_system_score_codex":0.000013712929,"about_ca_system_score_gemma":0.000034371387,"threshold_uncertainty_score":0.25028014},"labels":[],"label_agreement":null},{"id":"W1995099111","doi":"10.1182/blood-2002-04-1182","title":"Iron transporter Nramp2/DMT-1 is associated with the membrane of phagosomes in macrophages and Sertoli cells","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"U.S. Public Health Service","keywords":"DMT1; Phagosome; Endosome; LAMP1; Cell biology; Phagocytosis; Transferrin; Endocytosis; Biology; Chemistry; Biochemistry; Intracellular; Transporter","score_opus":0.007817071419337103,"score_gpt":0.19983283910028746,"score_spread":0.19201576768095036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995099111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99284977,0.0037096862,0.000001911867,0.0010783237,0.000019935947,0.00022051507,0.00002094957,0.000015858603,0.0020830308],"genre_scores_gemma":[0.9968647,0.00071411295,0.000044045202,0.0005985252,0.000019774248,0.0000063162615,0.0000060868997,0.000016258178,0.0017302305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992974,0.00002906369,0.00015461793,0.0001526072,0.00018572615,0.00018059136],"domain_scores_gemma":[0.9996688,0.00003852114,0.00005756579,0.0001638053,0.000023198052,0.000048133206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008189424,0.00011751449,0.0002694346,0.00005611221,0.000026706171,0.0000062547497,0.00005481095,0.00006526133,0.0003856108],"category_scores_gemma":[0.0000089078685,0.00007063739,0.000037823836,0.00016668862,0.0001057355,0.000042447555,0.0000059257936,0.00010878603,0.0000058855653],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008622803,0.011651434,0.46139938,0.0017591694,0.0006804314,0.0010078275,0.060341943,0.000033564782,0.44397384,0.00020424071,0.005655989,0.012429898],"study_design_scores_gemma":[0.033479333,0.0006239518,0.61365485,0.00023523155,0.0016729458,0.000058692927,0.002124294,0.000070440416,0.34575653,0.00003298408,0.0018640467,0.00042672135],"about_ca_topic_score_codex":0.000058917005,"about_ca_topic_score_gemma":0.00008204518,"teacher_disagreement_score":0.15225546,"about_ca_system_score_codex":0.0000028697063,"about_ca_system_score_gemma":0.000010287508,"threshold_uncertainty_score":0.42221677},"labels":[],"label_agreement":null},{"id":"W1995224842","doi":"10.1182/blood-2015-02-626457","title":"Recurrent pregnancy loss: drop the heparin needles…","year":2015,"lang":"en","type":"letter","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Pregnancy; Heparin; Medicine; Blood loss; Live birth; Low molecular weight heparin; Obstetrics; Surgery; Biology","score_opus":0.048526054285523236,"score_gpt":0.2822846008551279,"score_spread":0.23375854656960468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995224842","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022282964,0.011334515,0.00012204446,0.9212928,0.003115991,0.0024324348,0.00008679781,0.0004889438,0.058898173],"genre_scores_gemma":[0.03983107,0.00076628337,0.000768225,0.902757,0.0137647865,0.00039332727,0.0013744043,0.0003261316,0.04001877],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99770284,0.00013297706,0.0004157039,0.00048072365,0.0008228789,0.00044486535],"domain_scores_gemma":[0.99829,0.00006017707,0.000229048,0.00106313,0.00022010341,0.0001375212],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020124945,0.00040055093,0.00061213586,0.00012383834,0.00009806136,0.00005712107,0.00033387536,0.000727356,0.0003668364],"category_scores_gemma":[0.00007929626,0.0002638028,0.0002580213,0.00023005597,0.00008951387,0.00004343951,0.00012886718,0.001715,0.00060451636],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011782539,0.00043266494,0.00022071697,0.00025866082,0.00041387678,0.00041704942,0.00029833405,1.028863e-7,0.00008221405,0.00025609724,0.99481195,0.0027965193],"study_design_scores_gemma":[0.0033266407,0.0004665653,0.00030800593,0.0014910968,0.0018602974,0.0003809998,0.000047023117,0.00001937594,0.00092598173,0.0015987006,0.9891792,0.00039611792],"about_ca_topic_score_codex":0.000022164842,"about_ca_topic_score_gemma":0.000004652298,"teacher_disagreement_score":0.03760277,"about_ca_system_score_codex":0.000047950016,"about_ca_system_score_gemma":0.0002820577,"threshold_uncertainty_score":0.9999814},"labels":[],"label_agreement":null},{"id":"W1995246972","doi":"10.1182/blood-2008-08-172338","title":"Increased expression of urokinase plasminogen activator in Quebec platelet disorder is linked to megakaryocyte differentiation","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; McMaster University","funders":"","keywords":"Megakaryocyte; Plasminogen activator; Plasmin; Molecular biology; Biology; Colocalization; Platelet; Progenitor cell; Cell biology; Chemistry; Immunology; Stem cell; Endocrinology","score_opus":0.012524189483212761,"score_gpt":0.23762126859396734,"score_spread":0.22509707911075458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995246972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99873745,0.00016890101,0.000024897354,0.00014983768,0.00003146055,0.00053725805,0.000042357377,0.000033079337,0.00027476638],"genre_scores_gemma":[0.9988449,0.00007574839,0.0003280971,0.00017402491,0.00002501304,0.000049016588,0.00012436025,0.000024597939,0.00035423425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892014,0.00003351935,0.00028949344,0.00027498088,0.000256573,0.00022531145],"domain_scores_gemma":[0.9994052,0.000048437967,0.00009260121,0.0002629471,0.000041413117,0.0001494169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000034468172,0.00018131918,0.00040297673,0.00019740906,0.00005242363,0.000005226849,0.00007067992,0.00012159935,0.0001296558],"category_scores_gemma":[0.000059581937,0.00015034806,0.000081018916,0.00022873514,0.000026298949,0.00010082516,0.0000418101,0.00010704558,0.00002713396],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001620385,0.007411438,0.6207212,0.00011999323,0.0002211596,0.0011564484,0.0028095641,0.000007135745,0.36281532,0.0000080112495,0.0006357821,0.0024735676],"study_design_scores_gemma":[0.0115517555,0.00027195294,0.5353713,0.00014472882,0.00008268207,0.00005005166,0.00006569695,0.000034682882,0.451819,0.000018827903,0.00044663716,0.00014267578],"about_ca_topic_score_codex":0.0057166326,"about_ca_topic_score_gemma":0.0008710715,"teacher_disagreement_score":0.08900369,"about_ca_system_score_codex":0.000038983013,"about_ca_system_score_gemma":0.00009107277,"threshold_uncertainty_score":0.86418766},"labels":[],"label_agreement":null},{"id":"W1995375592","doi":"10.1182/blood-2013-11-537019","title":"Superficial venous thrombosis: recognizing the risk","year":2013,"lang":"en","type":"letter","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Venous thrombosis; Thrombosis; Internal medicine; Surgery","score_opus":0.024625291296135114,"score_gpt":0.24726181905069228,"score_spread":0.22263652775455717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995375592","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15111563,0.0035100605,0.000013643699,0.80831516,0.0021810206,0.0033472818,0.00010323675,0.00037508336,0.031038878],"genre_scores_gemma":[0.026695127,0.005027001,0.00040787717,0.9412536,0.022907637,0.0006694961,0.00037465774,0.0002671053,0.0023974874],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974596,0.00016997517,0.00045237952,0.00060336664,0.00061166583,0.0007030258],"domain_scores_gemma":[0.9983009,0.00019018869,0.00025907753,0.0010374344,0.0001291387,0.00008327411],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00032331317,0.00046718793,0.0010249541,0.00014254438,0.00034122544,0.00013392665,0.0004063064,0.0006654668,0.0010381448],"category_scores_gemma":[0.00013824845,0.0003041308,0.0004040591,0.00018481226,0.00011542636,0.00006200633,0.00018379536,0.0022457507,0.0016287464],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000025499771,0.00097457133,0.00063984626,0.00024813932,0.0014840639,0.00021509334,0.00040590327,4.590558e-7,0.000030874482,0.000019453593,0.9932647,0.0027143913],"study_design_scores_gemma":[0.0012768378,0.00059624546,0.016894218,0.00043770496,0.007511521,0.000060985192,0.0001532482,0.000005469383,0.00020708618,0.000275659,0.97214514,0.0004359081],"about_ca_topic_score_codex":0.0010297638,"about_ca_topic_score_gemma":0.000028178065,"teacher_disagreement_score":0.13293844,"about_ca_system_score_codex":0.000054998076,"about_ca_system_score_gemma":0.00012253152,"threshold_uncertainty_score":0.99994105},"labels":[],"label_agreement":null},{"id":"W1995535600","doi":"10.1182/blood-2004-09-3652","title":"Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":127,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Heart, Lung, and Blood Institute; Durham University","keywords":"Progenitor cell; CD34; Biology; Haematopoiesis; Stem cell; Myeloid; Cell biology; Immunology; Cord blood; Molecular biology","score_opus":0.014742890632427544,"score_gpt":0.257956749665442,"score_spread":0.24321385903301448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995535600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970468,0.001462129,0.00016360027,0.00036008953,0.000024881823,0.00061071006,0.000050083367,0.000053729244,0.00022796783],"genre_scores_gemma":[0.99866873,0.000031552834,0.0008749184,0.00009408689,0.00007157106,0.000048020218,0.00008298705,0.000022418379,0.000105723],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988953,0.000054756754,0.000361097,0.0002118408,0.0002905081,0.0001865228],"domain_scores_gemma":[0.9993174,0.00008459669,0.0001393198,0.0002654335,0.00006468635,0.00012857284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012951867,0.00015388892,0.00027470494,0.00003253061,0.00007280616,0.000010209589,0.00007597674,0.0000694274,0.00005740445],"category_scores_gemma":[0.000030043338,0.00010094725,0.00005517478,0.000102089856,0.00008289761,0.0000402605,0.000021119742,0.0000927684,0.00002048811],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022510707,0.002559285,0.20567255,0.0010100247,0.00021480826,0.00007172148,0.0013462468,0.0000043925365,0.78533345,0.000023385428,0.0025913431,0.00094766985],"study_design_scores_gemma":[0.0040942854,0.00009845367,0.0071530757,0.00039799896,0.00041842603,0.00031480324,0.00015597994,0.00027223004,0.9860395,0.000007387652,0.000935171,0.000112645226],"about_ca_topic_score_codex":0.000008578622,"about_ca_topic_score_gemma":0.0000062211047,"teacher_disagreement_score":0.20070608,"about_ca_system_score_codex":0.000011351116,"about_ca_system_score_gemma":0.000025998346,"threshold_uncertainty_score":0.41165093},"labels":[],"label_agreement":null},{"id":"W1995560549","doi":"10.1182/blood-2006-10-047951","title":"Preclinical studies of the pan-Bcl inhibitor obatoclax (GX015-070) in multiple myeloma","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":217,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cancer Care Ontario; Eli Lilly and Company","keywords":"Bortezomib; Melphalan; Bone marrow; Multiple myeloma; Cytotoxicity; Cancer research; Dexamethasone; Pharmacology; Medicine; Biology; Immunology; Internal medicine; In vitro; Genetics","score_opus":0.0854462178360637,"score_gpt":0.3807883635765643,"score_spread":0.2953421457405006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995560549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955198,0.0019698674,0.000003674404,0.0003839785,0.00013951526,0.00083955564,0.000014583243,0.00002797571,0.0011010492],"genre_scores_gemma":[0.9983102,0.00015391823,0.0006907055,0.00008075588,0.0001832,0.000037920356,0.0000061929827,0.000018775645,0.0005183364],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982232,0.00008892811,0.00051213166,0.00027132648,0.00048644573,0.00041795734],"domain_scores_gemma":[0.9983869,0.0007785817,0.000100886515,0.00045029557,0.00014132474,0.0001420084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006386078,0.00015550968,0.0003973851,0.000104669736,0.000064858,0.0000055111914,0.00014449912,0.00011197171,0.00002456033],"category_scores_gemma":[0.002467741,0.00009382432,0.00015496988,0.00031559556,0.00024473827,0.000042925563,0.00015966428,0.0002779285,0.000036956084],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004864823,0.0019179444,0.97493285,0.00011311874,0.00031512917,0.00018422863,0.0004398322,4.3473284e-7,0.0077137016,0.00002841166,0.0002195827,0.0136482855],"study_design_scores_gemma":[0.011184006,0.00041944342,0.9033827,0.00027706168,0.00009679581,0.000028520453,0.00041653635,0.000021685824,0.083586924,0.00006936255,0.00043513626,0.00008178453],"about_ca_topic_score_codex":0.00009804952,"about_ca_topic_score_gemma":0.0006265955,"teacher_disagreement_score":0.075873226,"about_ca_system_score_codex":0.000065215594,"about_ca_system_score_gemma":0.00012790093,"threshold_uncertainty_score":0.38260445},"labels":[],"label_agreement":null},{"id":"W1995831651","doi":"10.1182/blood-2004-04-1537","title":"CD1d-unrestricted human NKT cells release chemokines upon Fas engagement","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique","funders":"","keywords":"Natural killer T cell; Biology; CD1D; Chemokine; Immunology; Cell biology; Fas ligand; Chemotaxis; Cytotoxic T cell; CXCL16; Interleukin 21; Innate immune system; CD8; Immune system; Apoptosis; Receptor; In vitro; Programmed cell death; Chemokine receptor","score_opus":0.014239857744146548,"score_gpt":0.23088303584199915,"score_spread":0.2166431780978526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995831651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885112,0.0005367817,0.000098630204,0.00016668696,0.0022588728,0.00020518717,0.0000032561568,0.00019351511,0.0080258865],"genre_scores_gemma":[0.9854769,0.00007643655,0.00004099519,0.00025462732,0.000081567865,0.000021707847,0.00018339333,0.000018986559,0.013845363],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99908566,0.00009934839,0.0002623177,0.00025199528,0.000034379995,0.0002663181],"domain_scores_gemma":[0.99951136,0.000029656136,0.00010563029,0.00027645298,0.000056072724,0.000020853407],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000105194165,0.00016578498,0.0001624976,0.000113969225,0.00029518845,0.000020902484,0.00013455472,0.00017419716,0.002009846],"category_scores_gemma":[0.000041317257,0.00015519393,0.0000981309,0.0001278291,0.00004213642,0.00009641695,0.00005378535,0.0003600111,0.0022495238],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000521614,0.00080972514,0.00009739725,0.000010529002,0.00015666633,0.000009615279,0.0001636112,0.000019210922,0.9921478,0.0004995389,0.0057188617,0.00031486186],"study_design_scores_gemma":[0.0037959649,0.00024843717,0.0018233403,0.000023584287,0.00010594304,0.00003685415,0.00013937372,3.1274072e-7,0.89419764,0.000054004566,0.09941193,0.000162607],"about_ca_topic_score_codex":0.00018237629,"about_ca_topic_score_gemma":0.000013281995,"teacher_disagreement_score":0.09795017,"about_ca_system_score_codex":0.000042466767,"about_ca_system_score_gemma":0.000032736556,"threshold_uncertainty_score":0.99890244},"labels":[],"label_agreement":null},{"id":"W1995874272","doi":"10.1182/blood-2006-09-046466","title":"It's hepcidin again, but is it the only master?","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Hepcidin; Medicine; Internal medicine; Anemia","score_opus":0.01690786665441277,"score_gpt":0.2453630808876719,"score_spread":0.22845521423325912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995874272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8083575,0.0021645532,0.00005354051,0.022574395,0.00015126044,0.0002475461,0.000015430209,0.00004574544,0.16639008],"genre_scores_gemma":[0.94325906,0.00011723207,0.0002961107,0.019492228,0.00057687133,0.000010896111,0.000022334854,0.00002414359,0.036201123],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99912107,0.000028300297,0.00018206231,0.00018184431,0.00023657257,0.000250152],"domain_scores_gemma":[0.99946296,0.00003135965,0.00004346887,0.00036608076,0.000038708546,0.000057439094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012640591,0.00012378163,0.00016958734,0.00003911199,0.00007979951,0.000023059045,0.00011147399,0.00006619406,0.00065272907],"category_scores_gemma":[0.000033014996,0.00008006402,0.00009233425,0.0001119194,0.000060529343,0.00003998042,0.000032633838,0.00012290289,0.00047359164],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000144512,0.002087025,0.08112608,0.00019436075,0.000098793185,0.00019022831,0.0021848092,0.000004321033,0.013279902,0.0038643575,0.8880744,0.008751222],"study_design_scores_gemma":[0.010780792,0.00020298254,0.13468136,0.00007141108,0.00092211756,0.00020410704,0.002848924,0.000019056957,0.02308615,0.00080582,0.8259883,0.0003889808],"about_ca_topic_score_codex":0.0002494686,"about_ca_topic_score_gemma":0.00008201975,"teacher_disagreement_score":0.1349016,"about_ca_system_score_codex":0.000004758883,"about_ca_system_score_gemma":0.00007070033,"threshold_uncertainty_score":0.71469253},"labels":[],"label_agreement":null},{"id":"W1995945086","doi":"10.1182/blood-2011-04-350868","title":"Next-generation leukemia immunotherapy","year":2011,"lang":"en","type":"review","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Canada Research Chairs","keywords":"Immunotherapy; Adoptive immunotherapy; Immunology; Leukemia; Transplantation; Hematopoietic stem cell transplantation; Cancer immunotherapy; Hematopoietic cell; T cell; Medicine; Cancer; Haematopoiesis; Adoptive cell transfer; Immune system; Cancer research; Biology; Stem cell; Internal medicine","score_opus":0.07254235144666173,"score_gpt":0.2803267289678025,"score_spread":0.20778437752114076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995945086","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001772342,0.98493475,0.000032086864,0.0000019540648,0.006518118,0.00037608758,0.0000053682243,0.000119491044,0.007994446],"genre_scores_gemma":[0.0000121924,0.9596072,0.000021834612,0.00006707108,0.00023348244,0.00010738607,0.0011937147,0.000058378933,0.038698748],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985336,0.00028751369,0.0005406828,0.00035667772,0.000019744219,0.00026179128],"domain_scores_gemma":[0.9990883,0.0000440234,0.0003443515,0.0004594077,0.000051726067,0.0000122189285],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00013937184,0.00036833854,0.00084327994,0.00018627262,0.00016614287,0.000036676287,0.0002450473,0.0007616059,0.006625037],"category_scores_gemma":[0.000021277663,0.00029942658,0.00048853183,0.00012178437,0.00005480989,0.00014588749,0.00003873666,0.00061023113,0.0094430335],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012339141,0.00020250626,3.6366004e-7,0.0005390453,0.0011431051,0.0000020069235,0.00007170783,2.0082828e-8,0.008171046,0.00032163935,0.02211309,0.96742314],"study_design_scores_gemma":[0.0006321692,0.000121930345,6.2482223e-7,0.0007572053,0.00075405807,0.00026986375,0.000008531549,1.0259119e-7,0.0017590637,0.000003834561,0.9953914,0.00030121085],"about_ca_topic_score_codex":0.00005891607,"about_ca_topic_score_gemma":0.0000033554409,"teacher_disagreement_score":0.97327834,"about_ca_system_score_codex":0.00009337211,"about_ca_system_score_gemma":0.00020451257,"threshold_uncertainty_score":0.99994576},"labels":[],"label_agreement":null},{"id":"W1996032846","doi":"10.1182/blood-2011-11-392951","title":"Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Galectins and Cancer Biology","field":"Immunology and Microbiology","cited_by":509,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of Allergy and Infectious Diseases; University of California, San Francisco; Center for AIDS Research, University of Washington; National Institutes of Health; Cancer Research Institute","keywords":"Interleukin 21; CD16; Lymphokine-activated killer cell; Interleukin 12; Biology; Janus kinase 3; NK-92; CD49b; NKG2D; Cell biology; Natural killer cell; Cytotoxic T cell; Cytotoxicity; Immunology; Molecular biology; T cell; Immune system; CD3; CD8; In vitro; Biochemistry","score_opus":0.005801116320952233,"score_gpt":0.21060824682092136,"score_spread":0.20480713049996913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996032846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860973,0.008507395,0.0000032980515,0.00005808093,0.0008993334,0.00014131403,0.000016268572,0.000055429125,0.00422162],"genre_scores_gemma":[0.9961639,0.000106354055,0.000036588375,0.00014264618,0.00010654895,0.000016791091,0.00027123798,0.000011876999,0.003144065],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99917245,0.00011239592,0.00015055519,0.00018882724,0.000018765086,0.00035701445],"domain_scores_gemma":[0.99966586,0.00005976233,0.00007541998,0.00014438282,0.000025918387,0.000028638722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009653952,0.00014350568,0.00017032889,0.000045800618,0.00017819094,0.000012178545,0.00008989101,0.000264814,0.0006742704],"category_scores_gemma":[0.000013594917,0.00011722518,0.000037673675,0.000054753848,0.0001061315,0.000089314155,0.00006506571,0.00026316097,0.0001569635],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003927031,0.00028743333,0.020293687,0.000021577418,0.000039845065,9.884949e-7,0.00021718719,5.761122e-8,0.973938,0.000048092836,0.005048353,0.000065495246],"study_design_scores_gemma":[0.002062911,0.0001467885,0.13924313,0.0000057684533,0.00007197276,0.000063033105,0.00008917958,4.3727735e-7,0.8416382,0.000019889125,0.016455717,0.00020295175],"about_ca_topic_score_codex":0.000055422257,"about_ca_topic_score_gemma":0.000025074798,"teacher_disagreement_score":0.13229978,"about_ca_system_score_codex":0.00000905137,"about_ca_system_score_gemma":0.000013530815,"threshold_uncertainty_score":0.7382788},"labels":[],"label_agreement":null},{"id":"W1996100423","doi":"10.1182/blood-2007-11-122028","title":"High-resolution whole genome tiling path array CGH analysis of CD34+ cells from patients with low-risk myelodysplastic syndromes reveals cryptic copy number alterations and predicts overall and leukemia-free survival","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Comparative genomic hybridization; Biology; Myelodysplastic syndromes; Copy-number variation; Myeloid leukemia; Karyotype; Genetics; Myeloid; Genome; Cancer research; Chromosome; Gene; Bone marrow; Immunology","score_opus":0.00905751583533974,"score_gpt":0.22145495604387486,"score_spread":0.21239744020853513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996100423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966623,0.00023267703,0.0010117106,0.000036733887,0.00005248856,0.0005607363,0.0012789159,0.00004608836,0.000118326374],"genre_scores_gemma":[0.9921602,0.00042968438,0.0061616264,0.00003738236,0.00010222345,0.000025996469,0.0008238593,0.00004353722,0.00021550203],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975437,0.00016663915,0.0005222984,0.00057927595,0.0007692596,0.00041882854],"domain_scores_gemma":[0.9980426,0.00045309492,0.00026009316,0.0006399493,0.00029853868,0.00030572785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023713207,0.00029175167,0.000819789,0.0002991741,0.0002278806,0.000035776313,0.00015295485,0.00016066937,0.00008446466],"category_scores_gemma":[0.00026370838,0.00024373284,0.00008928065,0.00056915835,0.00027082535,0.00019998629,0.000116566356,0.00035492942,0.00001637675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047709528,0.00064923585,0.9482886,0.00018168708,0.0033798458,0.00013010134,0.0010861492,0.0014095419,0.044122837,0.000020176236,0.00020856234,0.000046140216],"study_design_scores_gemma":[0.011202774,0.0005735197,0.97847074,0.00019590669,0.004310328,0.000022382053,0.000052619784,0.0024781916,0.0023243993,0.00007620851,0.000024336978,0.00026858787],"about_ca_topic_score_codex":0.00088867266,"about_ca_topic_score_gemma":0.000070941045,"teacher_disagreement_score":0.04179844,"about_ca_system_score_codex":0.0001878856,"about_ca_system_score_gemma":0.00028281077,"threshold_uncertainty_score":0.9939137},"labels":[],"label_agreement":null},{"id":"W1996121298","doi":"10.1182/blood-2006-01-0028","title":"False-positive detection of recombinant human erythropoietin in urine following strenuous physical exercise","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"World Anti-Doping Agency","keywords":"Erythropoietin; Urine; Recombinant DNA; Dipstick; Monoclonal antibody; Internal medicine; Endocrinology; Medicine; Antibody; Immunology; Biology; Biochemistry","score_opus":0.0066176439496177355,"score_gpt":0.25216841905456955,"score_spread":0.24555077510495182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996121298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99733424,0.00035376253,0.000007571724,0.00015584029,0.00010478764,0.00031015062,0.0000029970145,0.000050457395,0.0016801612],"genre_scores_gemma":[0.9989255,0.000026675149,0.00027877776,0.00000785132,0.0001130118,0.000026347912,0.000035888672,0.000024323232,0.0005616314],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990198,0.000032122058,0.00027354475,0.00025226845,0.00019841746,0.00022382496],"domain_scores_gemma":[0.99960226,0.00003112104,0.00008332388,0.00019785705,0.00003455023,0.0000508743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008162165,0.00016112292,0.00040239174,0.00010398408,0.00005819579,0.00000636512,0.000041072813,0.00007101857,0.000013944152],"category_scores_gemma":[0.000011950226,0.00013955978,0.00018693077,0.00018966958,0.000055597502,0.000034970333,0.00002554495,0.00014246308,0.000012341119],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020569548,0.021218594,0.1121523,0.00027005214,0.0001949358,0.0011295989,0.00095957983,0.0000087454855,0.8498001,0.0002972961,0.00015136908,0.013611744],"study_design_scores_gemma":[0.009144117,0.0011010088,0.15083271,0.0007797399,0.00046822726,0.000044601657,0.0002713384,0.000014048008,0.83653605,0.0005788502,0.00004954044,0.00017974737],"about_ca_topic_score_codex":0.0010337667,"about_ca_topic_score_gemma":0.00013527236,"teacher_disagreement_score":0.0386804,"about_ca_system_score_codex":0.00005698803,"about_ca_system_score_gemma":0.000022367702,"threshold_uncertainty_score":0.56910825},"labels":[],"label_agreement":null},{"id":"W1996346809","doi":"10.1182/blood-2009-05-222471","title":"Properties of CD34+ CML stem/progenitor cells that correlate with different clinical responses to imatinib mesylate","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Michael Smith Health Research BC; Canadian Cancer Society Research Institute; Cancer Research Society; Bristol-Myers Squibb","keywords":"Imatinib mesylate; Progenitor cell; CD34; Stem cell; Myeloid leukemia; Haematopoiesis; Cancer research; Imatinib; ABL; Medicine; Immunology; Biology; Internal medicine; Tyrosine kinase; Receptor; Genetics","score_opus":0.04221781815748588,"score_gpt":0.2902911563868482,"score_spread":0.24807333822936234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996346809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975598,0.00020188931,0.0000057789634,0.00024422116,0.00043675004,0.001115158,0.000024492501,0.0000865406,0.0003253812],"genre_scores_gemma":[0.9946559,0.000041673542,0.0012161141,0.00010540475,0.00017376344,0.00008400458,0.0000057734846,0.00005445011,0.0036629068],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99819523,0.00010037778,0.0005215459,0.000405879,0.00043737423,0.00033957092],"domain_scores_gemma":[0.9984806,0.00014687989,0.00019944315,0.00074522314,0.00012286087,0.00030495579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025715886,0.00027640696,0.0006381912,0.00009236997,0.000053410295,0.000017742763,0.00017052,0.00017007231,0.0001090084],"category_scores_gemma":[0.00010118779,0.00016404338,0.00014923581,0.00011209681,0.0001551154,0.000049149072,0.000101609025,0.000412017,0.0001206662],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005620764,0.0038325323,0.5108142,0.0003852069,0.0012224377,0.00026587828,0.0011175582,0.0000011514434,0.47108006,0.000022502287,0.00034592437,0.0052918014],"study_design_scores_gemma":[0.012297336,0.0022676687,0.1531585,0.00050812383,0.00096512755,0.0001858239,0.00012416925,0.000031440675,0.8294956,0.000003973081,0.00072004506,0.00024218146],"about_ca_topic_score_codex":0.000043789532,"about_ca_topic_score_gemma":0.000034664376,"teacher_disagreement_score":0.35841554,"about_ca_system_score_codex":0.0000524483,"about_ca_system_score_gemma":0.0003616497,"threshold_uncertainty_score":0.6689495},"labels":[],"label_agreement":null},{"id":"W1996668420","doi":"10.1182/blood-2012-07-446260","title":"Polycythemia vera followed by hairy cell leukemia variant","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Phlebotomy; Polycythemia vera; Myelofibrosis; Medicine; Ruxolitinib; Leukemia; Internal medicine; Gastroenterology; Bone marrow","score_opus":0.008880982484944273,"score_gpt":0.23178104689425566,"score_spread":0.2229000644093114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996668420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9651288,0.0032422584,0.000046998408,0.00054680253,0.00025527383,0.000398577,0.00003414426,0.00008447451,0.0302627],"genre_scores_gemma":[0.9936905,0.0001476675,0.0013444781,0.00078401814,0.00038876373,0.00010361021,0.00007942125,0.00003579687,0.0034257614],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99883074,0.000033224205,0.00020972746,0.00023855537,0.0002484626,0.0004393168],"domain_scores_gemma":[0.99917394,0.00007781442,0.00006364226,0.00031766502,0.00003364986,0.00033330708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011492878,0.00021716452,0.0003138567,0.00004439345,0.000088841814,0.000018033896,0.00006165768,0.000115354946,0.0005185853],"category_scores_gemma":[0.000030327688,0.00016652032,0.00012652547,0.00010150932,0.000027355754,0.000087235756,0.000035051617,0.00015387534,0.00043845654],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028189618,0.010575464,0.7499939,0.00015178179,0.0008920934,0.00045717502,0.0014454323,9.019101e-7,0.08163705,0.0010925943,0.15155938,0.0019123361],"study_design_scores_gemma":[0.017791342,0.0008694303,0.06258033,0.00011126732,0.0013750724,0.0003659318,0.00010846773,0.000019486766,0.8241113,0.00002819746,0.092183866,0.00045531732],"about_ca_topic_score_codex":0.000063102714,"about_ca_topic_score_gemma":0.0000032635241,"teacher_disagreement_score":0.74247426,"about_ca_system_score_codex":0.00011728313,"about_ca_system_score_gemma":0.00012693803,"threshold_uncertainty_score":0.67905015},"labels":[],"label_agreement":null},{"id":"W1997319017","doi":"10.1182/blood-2010-08-265892","title":"Cytokine release from innate immune cells: association with diverse membrane trafficking pathways","year":2011,"lang":"en","type":"review","venue":"Blood","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":398,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Innate immune system; Cytokine; Immune system; Biology; Cell biology; Immunology; Innate lymphoid cell; CCL18; Signal transduction; Acquired immune system; Inflammation","score_opus":0.021662378557837432,"score_gpt":0.2294235831064147,"score_spread":0.20776120454857727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997319017","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01075487,0.98784715,0.000048727885,0.0000026524333,0.00014532031,0.0002837062,0.00026648308,0.000034938665,0.00061617733],"genre_scores_gemma":[0.0051748157,0.99146795,0.00029307418,0.000028202536,0.0007430704,0.000037900918,0.0017188835,0.00008338897,0.000452718],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984452,0.00013541043,0.00041686624,0.00052281277,0.00017329502,0.00030639904],"domain_scores_gemma":[0.99877924,0.00003674308,0.0005733253,0.0004404289,0.00008342839,0.00008683269],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017255826,0.00041226466,0.0007766594,0.00006280345,0.00008677569,0.000030998843,0.00030176903,0.00054176216,0.000078550154],"category_scores_gemma":[0.000043701246,0.00033117333,0.00031492906,0.00013646235,0.000023206181,0.000004641006,0.0001289635,0.00029095283,0.000045494227],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006430964,0.005832612,0.00045470952,0.02037147,0.023797756,0.0017353449,0.0016018868,0.00013824883,0.13636853,0.0001867339,0.0154308425,0.7934388],"study_design_scores_gemma":[0.0012203862,0.00021933689,0.00000371645,0.0019079873,0.002740635,0.000023247463,0.000024246074,0.0000012158961,0.03485612,0.000003365376,0.958399,0.0006007191],"about_ca_topic_score_codex":0.000105581144,"about_ca_topic_score_gemma":0.0000064475216,"teacher_disagreement_score":0.9429682,"about_ca_system_score_codex":0.000026050582,"about_ca_system_score_gemma":0.00017156647,"threshold_uncertainty_score":0.99991405},"labels":[],"label_agreement":null},{"id":"W1997397403","doi":"10.1182/blood-2008-03-147744","title":"Multidrug resistance gene (MDR1) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":233,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Imatinib; Myeloid leukemia; Genotype; Single-nucleotide polymorphism; Pharmacogenetics; Imatinib mesylate; Haplotype; Allele; Medicine; Leukemia; Internal medicine; Immunology; Oncology; Biology; Genetics; Gene","score_opus":0.01370123802848771,"score_gpt":0.24894842035048703,"score_spread":0.23524718232199932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997397403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936861,0.0031650502,0.000057161727,0.0005674498,0.000049285092,0.00132836,0.00023420871,0.00020863027,0.0007038036],"genre_scores_gemma":[0.9880315,0.00013053023,0.0055008936,0.00042612737,0.000093820134,0.00021924805,0.000116686206,0.00013084908,0.0053503523],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9966824,0.00019078943,0.00058596337,0.0007972305,0.0008998432,0.00084377965],"domain_scores_gemma":[0.99803984,0.00018395841,0.0002718111,0.00093790586,0.00018187331,0.0003845832],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030950474,0.0004913716,0.0008701339,0.00033524007,0.00017305027,0.000022127524,0.00024002492,0.00020936145,0.00011709184],"category_scores_gemma":[0.00066937384,0.00043545495,0.00013321344,0.00085110386,0.00016222984,0.00011096275,0.000094445495,0.00041685387,0.000087539374],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020182261,0.0033994012,0.25216565,0.00044799506,0.002759461,0.068148375,0.004698798,0.0005214671,0.6427685,0.00008096295,0.0037858416,0.0010412615],"study_design_scores_gemma":[0.06663539,0.0016001313,0.53871536,0.001991193,0.00058510894,0.0006936874,0.0001346765,0.00007558693,0.38745892,0.000023551365,0.0012306982,0.0008557105],"about_ca_topic_score_codex":0.0002822603,"about_ca_topic_score_gemma":0.0012539771,"teacher_disagreement_score":0.28654972,"about_ca_system_score_codex":0.0069217277,"about_ca_system_score_gemma":0.0036397865,"threshold_uncertainty_score":0.99980974},"labels":[],"label_agreement":null},{"id":"W1997429388","doi":"10.1182/blood-2012-06-434019","title":"CCR1 blockade and myeloma bone disease","year":2012,"lang":"en","type":"letter","venue":"Blood","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Multiple myeloma; Blockade; Medicine; Lenalidomide; Bone disease; Internal medicine; Osteoporosis; Receptor","score_opus":0.012874090184344563,"score_gpt":0.23101464431943783,"score_spread":0.21814055413509326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997429388","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38950557,0.027187655,0.000009497979,0.5790346,0.00047202755,0.00057619484,0.00008854143,0.00017584588,0.002950041],"genre_scores_gemma":[0.18412085,0.00087144616,0.0009453979,0.7153729,0.06673493,0.00008877899,0.0014997823,0.0003337855,0.030032074],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99875987,0.000020921703,0.00021778356,0.0003120296,0.00030925375,0.00038015365],"domain_scores_gemma":[0.99921,0.000052370277,0.00008501167,0.00033298458,0.00003814446,0.00028150989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007594597,0.00027177526,0.00046202456,0.00009610771,0.00004901033,0.000023702807,0.000055336874,0.00039381933,0.0005069477],"category_scores_gemma":[0.00005019663,0.00022606716,0.00014997816,0.000066838205,0.00005638893,0.00002909097,0.00006299161,0.0008901777,0.00005614461],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037759142,0.00031764468,0.014559029,0.0012764323,0.00028684328,0.0019670213,0.00008666225,1.9457719e-8,0.0031346169,0.0000041050525,0.976202,0.0021278847],"study_design_scores_gemma":[0.0019937055,0.000049586844,0.0028269948,0.00037195205,0.0019269821,0.00033627596,0.0000045139554,0.0000026362814,0.0030780584,0.000029816305,0.98907447,0.00030502852],"about_ca_topic_score_codex":0.0000075254543,"about_ca_topic_score_gemma":2.434835e-7,"teacher_disagreement_score":0.2053847,"about_ca_system_score_codex":0.000016136124,"about_ca_system_score_gemma":0.00007068389,"threshold_uncertainty_score":0.9218751},"labels":[],"label_agreement":null},{"id":"W1997444277","doi":"10.1182/blood-2002-09-2773","title":"Eotaxin-3 is a natural antagonist for CCR2 and exerts a repulsive effect on human monocytes","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Antagonist; CCR2; Eotaxin; Immunology; Monocyte; Medicine; Pharmacology; Receptor; Internal medicine; Inflammation; Chemokine; Chemokine receptor","score_opus":0.015848827740534664,"score_gpt":0.29678929773553975,"score_spread":0.2809404699950051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997444277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962728,0.0012426809,0.0000068922745,0.00013292188,0.00008572603,0.0005169075,0.000005635529,0.000034661323,0.0017017968],"genre_scores_gemma":[0.99811405,0.000020444393,0.00040433335,0.0003086219,0.00015958845,0.00004097431,0.000017227962,0.000023676697,0.00091108074],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992438,0.000021735583,0.00013968568,0.0002653425,0.00011255986,0.00021687809],"domain_scores_gemma":[0.9995364,0.00011930581,0.00004922585,0.0001630207,0.00003892494,0.00009315738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014933651,0.00014821962,0.00028044038,0.000036233563,0.00013302284,0.000026395895,0.000028491342,0.00006543054,0.000043168016],"category_scores_gemma":[0.00014991332,0.00011317999,0.00010521185,0.00006117894,0.000033290944,0.000022694663,0.000010857005,0.00011834203,0.000003337218],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093084754,0.0015200599,0.05727648,0.0011787999,0.00071947346,0.00017773238,0.0016672873,3.811033e-7,0.9119928,0.0014036322,0.006539547,0.016592987],"study_design_scores_gemma":[0.0074508637,0.0015907049,0.0011024034,0.00019378253,0.00026893246,0.00013907386,0.000042473825,0.000020952812,0.98121595,0.00013169786,0.0076786377,0.0001645265],"about_ca_topic_score_codex":0.000012974376,"about_ca_topic_score_gemma":0.000002581951,"teacher_disagreement_score":0.06922318,"about_ca_system_score_codex":0.000019379828,"about_ca_system_score_gemma":0.00001665537,"threshold_uncertainty_score":0.4615346},"labels":[],"label_agreement":null},{"id":"W1997766168","doi":"10.1182/blood-2010-03-276683","title":"Association between red blood cell transfusions and development of non-Hodgkin lymphoma: a meta-analysis of observational studies","year":2010,"lang":"en","type":"review","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Relative risk; Chronic lymphocytic leukemia; Incidence (geometry); Meta-analysis; Lymphoma; Publication bias; Cohort study; Observational study; Funnel plot; Non-Hodgkin's lymphoma; Leukemia; Confidence interval","score_opus":0.25617793931876187,"score_gpt":0.41429120796920377,"score_spread":0.1581132686504419,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997766168","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03134817,0.96695185,0.000013000909,0.00005022594,0.000030272726,0.0010913428,0.0003140478,0.000015853759,0.00018522414],"genre_scores_gemma":[0.0014855309,0.9888134,0.00785343,0.000009523453,0.000089862595,0.0002508867,0.0005118087,0.000050939227,0.000934636],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99598664,0.00019680664,0.001725626,0.00053195894,0.0012298251,0.00032912754],"domain_scores_gemma":[0.99572784,0.0018270443,0.0010881191,0.00054714264,0.000661781,0.00014807493],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015778049,0.00041744922,0.006270258,0.0007196171,0.00009013851,0.000009824803,0.00022996854,0.00056242937,0.00010964558],"category_scores_gemma":[0.00057219254,0.00030471932,0.0016381686,0.0013243811,0.000102933875,0.000032403943,0.00014951141,0.00031005943,0.0000040407567],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013222944,0.0018116871,0.0007861583,0.025881141,0.8990119,0.000022489305,0.001151762,6.3719267e-7,0.000095246985,0.0000059929584,0.0000920977,0.07112762],"study_design_scores_gemma":[0.008954643,0.00008926304,0.001252627,0.0006758194,0.9156613,0.000010931155,0.000042869793,0.000007297225,0.0007645,0.000004077556,0.07228833,0.0002483795],"about_ca_topic_score_codex":0.00006497849,"about_ca_topic_score_gemma":0.000121281744,"teacher_disagreement_score":0.07219623,"about_ca_system_score_codex":0.0014898167,"about_ca_system_score_gemma":0.01056111,"threshold_uncertainty_score":0.9999405},"labels":[],"label_agreement":null},{"id":"W1997909822","doi":"10.1182/blood-2009-02-205708","title":"Characterization of Gaucher disease bone marrow mesenchymal stromal cells reveals an altered inflammatory secretome","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"National Institute of Neurological Disorders and Stroke; National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health","keywords":"Glucocerebrosidase; Mesenchymal stem cell; Bone marrow; Lactosylceramide; Biology; Stromal cell; Sphingolipid; Inflammation; Glucocerebroside; Lysosome; Immunology; Cancer research; Cell biology; Pathology; Disease; Medicine; Biochemistry; Enzyme","score_opus":0.014417409905691082,"score_gpt":0.26633230251122025,"score_spread":0.2519148926055292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997909822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99823624,0.0001544346,0.000028648083,0.0003431082,0.000051493327,0.00058491994,0.000058805726,0.000067211,0.00047513616],"genre_scores_gemma":[0.9981988,0.000035374534,0.00019907567,0.00016779937,0.00028346045,0.00001554946,0.0002614032,0.000028508352,0.0008100012],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982719,0.00011310926,0.0003714889,0.00031282593,0.0005760823,0.00035462232],"domain_scores_gemma":[0.9987452,0.000015758957,0.0001309109,0.0004800168,0.00017527497,0.00045286384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021648468,0.00017275033,0.00033380327,0.00016538118,0.000046963636,0.000021454476,0.0001354951,0.0001017858,0.00047481034],"category_scores_gemma":[0.00009483859,0.00016365624,0.00010184221,0.00022863282,0.000066669396,0.0002316637,0.000034548077,0.00017803798,0.00003538125],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039289854,0.0011221147,0.04346601,0.00015578227,0.000040967978,0.00021564771,0.00021343406,7.299423e-7,0.95357746,0.000048003705,0.000048679183,0.0007182819],"study_design_scores_gemma":[0.003382551,0.0007284638,0.8458578,0.000107456064,0.00014672831,0.000022585922,0.00004665764,0.00010717563,0.14919046,0.00008771731,0.00013731624,0.0001850764],"about_ca_topic_score_codex":0.000008998108,"about_ca_topic_score_gemma":0.0000017101194,"teacher_disagreement_score":0.804387,"about_ca_system_score_codex":0.000031241125,"about_ca_system_score_gemma":0.00016025822,"threshold_uncertainty_score":0.6673708},"labels":[],"label_agreement":null},{"id":"W1997954121","doi":"10.1182/blood-2002-05-1324","title":"Primitive interleukin 3 null hematopoietic cells transduced with BCR-ABL show accelerated loss after culture of factor-independence in vitro and leukemogenic activity in vivo","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Haematopoiesis; Biology; In vitro; Cancer research; Immunology; In vivo; Interleukin 3; Virology; Molecular biology; Stem cell; Cell biology; Interleukin 21; Genetics; Cytotoxic T cell","score_opus":0.015093356074047885,"score_gpt":0.23177468367043821,"score_spread":0.21668132759639033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997954121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979612,0.00054359855,0.0000138342875,0.000055552286,0.000024564177,0.00085514394,0.000068220164,0.000031647112,0.00044618722],"genre_scores_gemma":[0.9989629,0.00017643446,0.00028621042,0.000054359567,0.000020269863,0.0000788218,0.000005744001,0.00003847413,0.00037683407],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982482,0.000091675574,0.00033149912,0.0005462076,0.00036577508,0.00041663166],"domain_scores_gemma":[0.99925554,0.00006601299,0.00011727312,0.00034670703,0.00007004439,0.0001443963],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008075767,0.00035104324,0.0006609083,0.00017800655,0.00001979014,0.000018191955,0.000115517105,0.00024853396,0.0004066285],"category_scores_gemma":[0.000018791172,0.00027550955,0.00007700304,0.00038191862,0.00012908905,0.00019813392,0.00003929985,0.0004911719,0.000009140464],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015520809,0.0022369463,0.040469795,0.00038535445,0.00022515502,0.0013720493,0.00977294,0.00000387811,0.942949,0.0000011028651,0.000010167048,0.0010215131],"study_design_scores_gemma":[0.016610071,0.0005044345,0.048943408,0.00050872535,0.00017696538,0.00026864972,0.00028909105,0.0001511851,0.9322829,0.0000042659653,0.000012304074,0.00024797305],"about_ca_topic_score_codex":0.00023929533,"about_ca_topic_score_gemma":0.00037450725,"teacher_disagreement_score":0.015057989,"about_ca_system_score_codex":0.00048649174,"about_ca_system_score_gemma":0.00017518656,"threshold_uncertainty_score":0.9999697},"labels":[],"label_agreement":null},{"id":"W1997965901","doi":"10.1182/blood-2008-10-183301","title":"Dynamic accumulation of plasmacytoid dendritic cells in lymph nodes is regulated by interferon-β","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Immunosurveillance; Biology; Plasmacytoid dendritic cell; Lymph; Interferon; Immunology; Lymphatic system; Follicular dendritic cells; Ex vivo; Antigen; In vivo; Cell biology; Dendritic cell; Antigen-presenting cell; T cell; Immune system; Medicine","score_opus":0.011984007916441263,"score_gpt":0.2600471105602104,"score_spread":0.24806310264376913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997965901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99170053,0.0075900173,0.000057296515,0.000114403476,0.00015446378,0.00013455532,0.000035126523,0.000037278776,0.00017631655],"genre_scores_gemma":[0.9976427,0.00034119515,0.000070057344,0.00015033546,0.0000024016533,0.000004114323,0.000077993565,0.000012525029,0.001698711],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989554,0.00016958751,0.0003827437,0.00019970372,0.000028827535,0.00026369083],"domain_scores_gemma":[0.99948317,0.00010655273,0.00011244867,0.0002553614,0.000034578952,0.000007900916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012949659,0.00015612584,0.00027275042,0.0001597767,0.00005284895,0.000008850257,0.00019531198,0.00022949601,0.00027949768],"category_scores_gemma":[0.000023029186,0.0001523258,0.00007546514,0.0001625519,0.0000930749,0.00010073792,0.00002111259,0.00013693211,0.00009582165],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000626004,0.00058742,0.0006925662,0.000010135178,0.00008677614,0.0000022220422,0.0004905532,0.0000068187182,0.9929201,0.000019009593,0.0001743737,0.0043840357],"study_design_scores_gemma":[0.004560564,0.0002743638,0.023732942,0.000093894916,0.00003290112,0.000034630793,0.00008374299,0.00004463177,0.97025526,0.00009881102,0.00063097954,0.00015727142],"about_ca_topic_score_codex":0.00006171348,"about_ca_topic_score_gemma":0.0000034874831,"teacher_disagreement_score":0.023040375,"about_ca_system_score_codex":0.000029114713,"about_ca_system_score_gemma":0.000036335445,"threshold_uncertainty_score":0.6211666},"labels":[],"label_agreement":null},{"id":"W1998166546","doi":"10.1182/blood-2014-05-574160","title":"No BS! Bleeding scores predict future bleeding","year":2014,"lang":"en","type":"letter","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Bleeding diathesis; Major bleeding; Surgery; Internal medicine; Myocardial infarction; Platelet","score_opus":0.012605716513176827,"score_gpt":0.23470976892192952,"score_spread":0.2221040524087527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998166546","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16410226,0.0060035856,0.000030056332,0.62160665,0.005991876,0.002912839,0.00026966276,0.0011295334,0.19795355],"genre_scores_gemma":[0.036778614,0.001298935,0.001625298,0.8370603,0.08707307,0.00023066296,0.0035724994,0.0004919844,0.031868678],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977165,0.000028520764,0.00035867133,0.0006297219,0.0005969708,0.0006696563],"domain_scores_gemma":[0.9989747,0.00007259955,0.0002020134,0.0004810542,0.00012550552,0.00014414637],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010950123,0.0005443256,0.0009211826,0.00023316692,0.00013803055,0.00006979446,0.00021050191,0.001083308,0.0003262244],"category_scores_gemma":[0.000051240426,0.0004275528,0.00029724356,0.0001497973,0.00005847613,0.000078689205,0.00007010412,0.0015112251,0.0005765969],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003243257,0.00025399073,0.0076744347,0.0006441286,0.0012423219,0.0064884056,0.000047662048,1.4327043e-7,0.00019635407,0.000008182644,0.98293024,0.00048168493],"study_design_scores_gemma":[0.0055854013,0.00051606674,0.00064982445,0.0008205893,0.0024088644,0.0011907883,0.000015479862,0.000019195135,0.00029145615,0.00006621079,0.9880127,0.000423442],"about_ca_topic_score_codex":0.000040968047,"about_ca_topic_score_gemma":0.000002509841,"teacher_disagreement_score":0.21545361,"about_ca_system_score_codex":0.00004719352,"about_ca_system_score_gemma":0.000094575225,"threshold_uncertainty_score":0.9998176},"labels":[],"label_agreement":null},{"id":"W1998190863","doi":"10.1182/blood-2013-09-521484","title":"Analysis of the role of von Willebrand factor, platelet glycoprotein VI-, and α2β1-mediated collagen binding in thrombus formation","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research","keywords":"GPVI; Von Willebrand factor; Platelet; Thrombus; Platelet membrane glycoprotein; Glycoprotein; Hemostasis; Chemistry; Molecular biology; Biochemistry; Medicine; Immunology; Internal medicine; Biology","score_opus":0.006006294734982505,"score_gpt":0.2139157042625471,"score_spread":0.2079094095275646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998190863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99874675,0.00030113797,0.0000051913676,0.00003661211,0.0000097283455,0.00030145695,0.000045136523,0.000006981897,0.0005469954],"genre_scores_gemma":[0.9998008,0.00006302173,0.00003647567,0.000013406671,0.0000038016292,0.0000054029874,0.000056131586,0.000006116836,0.000014861758],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993754,0.000033876084,0.00022678588,0.00010216558,0.00015333503,0.00010842786],"domain_scores_gemma":[0.99960524,0.000048839967,0.00013910637,0.000146363,0.00002876867,0.00003169033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008726693,0.000083599225,0.00036378673,0.00019803613,0.00002733802,0.000004659568,0.0000426007,0.00006738991,0.00002468891],"category_scores_gemma":[0.00006192841,0.000055451135,0.000063092986,0.00055422226,0.0000325206,0.000059768303,0.000020887675,0.000037840637,0.0000014524165],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001145155,0.00053241075,0.88188106,0.00008066131,0.0010923374,0.000008811937,0.0013679496,0.000018889325,0.1112088,0.000020657404,0.000004391546,0.0036695446],"study_design_scores_gemma":[0.008336228,0.00027750284,0.70755297,0.00011998053,0.0012730672,0.000013037903,0.00031331505,0.0030430679,0.27874777,0.000111384026,0.000110448476,0.000101218895],"about_ca_topic_score_codex":0.00015584694,"about_ca_topic_score_gemma":0.00022748004,"teacher_disagreement_score":0.17432804,"about_ca_system_score_codex":0.000011410346,"about_ca_system_score_gemma":0.000015648804,"threshold_uncertainty_score":0.22612317},"labels":[],"label_agreement":null},{"id":"W1998251684","doi":"10.1182/blood-2012-04-422550","title":"Profound metabolic, functional, and cytolytic differences characterize HIV-specific CD8 T cells in primary and chronic HIV infection","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Caprion (Canada); Université de Montréal","funders":"National Institute on Drug Abuse; Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Styrelsen för Internationellt Utvecklingssamarbete","keywords":"Cytotoxic T cell; Biology; CD8; Immunology; Chronic infection; T cell; Viral load; Viral replication; Virology; Immune system; Virus; In vitro; Genetics","score_opus":0.020344972844468685,"score_gpt":0.22154749637584795,"score_spread":0.20120252353137927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998251684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9749091,0.024066985,0.000016048549,0.000083630075,0.00018263415,0.00028295824,0.000059390466,0.00002617208,0.00037304303],"genre_scores_gemma":[0.99348444,0.004845039,0.00001514978,0.000017821107,0.00010511144,0.000082275925,0.00021655904,0.000008810393,0.0012247702],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99911064,0.00012097692,0.000146052,0.00021201406,0.000036343183,0.00037398675],"domain_scores_gemma":[0.9996993,0.00007785588,0.00004298088,0.00011730676,0.000015926193,0.000046664045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013373235,0.00013994826,0.0002191081,0.0001136337,0.000119825854,0.00002425338,0.00003571949,0.00011205809,0.00030005065],"category_scores_gemma":[0.000007307806,0.000109550514,0.00002615348,0.000076836266,0.00014911355,0.00017601784,0.00006059583,0.00018536735,0.0005403938],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007325555,0.0008281918,0.47763816,0.000047068355,0.00018005328,0.0000044856924,0.00021926522,3.6053493e-8,0.51664764,0.00019777169,0.00033320603,0.0038308436],"study_design_scores_gemma":[0.002913149,0.00012682391,0.94726825,0.000017912256,0.000049682792,0.000067510264,0.0000151167205,2.9393624e-7,0.028652363,0.000013520204,0.020765273,0.00011008482],"about_ca_topic_score_codex":0.000030042107,"about_ca_topic_score_gemma":0.000020288802,"teacher_disagreement_score":0.4879953,"about_ca_system_score_codex":0.000034671502,"about_ca_system_score_gemma":0.00004731236,"threshold_uncertainty_score":0.69458497},"labels":[],"label_agreement":null},{"id":"W1998294352","doi":"10.1182/blood-2006-06-032193","title":"HLA mismatching within or outside of cross-reactive groups (CREGs) is associated with similar outcomes after unrelated hematopoietic stem cell transplantation","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Health Resources and Services Administration; Office of Naval Research; National Cancer Institute; National Institutes of Health; U.S. Navy; National Institute of Diabetes and Digestive and Kidney Diseases; U.S. Department of Defense","keywords":"Human leukocyte antigen; Hematopoietic stem cell transplantation; Transplantation; Immunology; Stem cell; Internal medicine; Univariate analysis; Medicine; Antigen; Multivariate analysis; Oncology; Biology; Genetics","score_opus":0.01563943384906072,"score_gpt":0.2712416135524988,"score_spread":0.2556021797034381,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998294352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935857,0.00009664575,0.0028608586,0.000113505695,0.00009211076,0.00083907257,0.000103096376,0.00015621351,0.0021527938],"genre_scores_gemma":[0.9974309,0.000020589101,0.0012438521,0.0002839759,0.000021773258,0.000023124554,0.00011693122,0.00009126349,0.00076758186],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99729854,0.00008498963,0.00094166596,0.0004611354,0.0007609689,0.00045272234],"domain_scores_gemma":[0.99810845,0.000618123,0.00045961555,0.0003523468,0.0002517511,0.00020971398],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00066086295,0.00039231067,0.000758293,0.00021742488,0.00008659063,0.000032375585,0.000119148506,0.0003325254,0.00012787923],"category_scores_gemma":[0.00002888256,0.0002878869,0.00016751468,0.0004176608,0.00012725772,0.00021682898,0.000009717213,0.00036290116,0.000025883412],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006168991,0.00282787,0.8542451,0.0032690254,0.001597019,0.0045389477,0.08261441,0.00008690955,0.044429854,0.00008428109,0.000013492476,0.00012408894],"study_design_scores_gemma":[0.01582935,0.00058098923,0.35767007,0.0019394691,0.002623751,0.00079026516,0.0026820938,0.000072178664,0.61727995,0.000060261315,0.0000048319266,0.00046679698],"about_ca_topic_score_codex":0.0000524996,"about_ca_topic_score_gemma":0.00010690829,"teacher_disagreement_score":0.5728501,"about_ca_system_score_codex":0.00007186075,"about_ca_system_score_gemma":0.00012661115,"threshold_uncertainty_score":0.9999573},"labels":[],"label_agreement":null},{"id":"W1998321969","doi":"10.1182/blood-2002-10-3062","title":"Detection, isolation, and stimulation of quiescent primitive leukemic progenitor cells from patients with acute myeloid leukemia (AML)","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":286,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Myeloid leukemia; Progenitor cell; Biology; Leukemia; Cancer research; Myeloid; Haematopoiesis; Stem cell; Immunology; Interleukin 3; Bone marrow; Molecular biology; Cell biology; T cell; Antigen-presenting cell; Immune system","score_opus":0.0073893000109682,"score_gpt":0.22956871322963482,"score_spread":0.22217941321866663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998321969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99616474,0.0001267914,0.0020209246,0.00002032239,0.00006703396,0.0011872522,0.0000591525,0.00005241631,0.00030136495],"genre_scores_gemma":[0.9950174,0.000057128585,0.0044611082,0.000048043607,0.000081157086,0.00004149817,0.00009849663,0.000045800905,0.00014935754],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983313,0.00009713384,0.0003645878,0.00040910355,0.000501987,0.0002958517],"domain_scores_gemma":[0.9986717,0.00010821963,0.00019265071,0.0003227983,0.000523871,0.00018075717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013394642,0.00022190475,0.00033794087,0.00015977817,0.000104677034,0.00002070341,0.0000710091,0.00015461375,0.000046491146],"category_scores_gemma":[0.00010125112,0.0001841127,0.00005070708,0.00031675288,0.00013616135,0.00016992456,0.000037562004,0.00026841823,0.000015382251],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013317876,0.00069372036,0.40517512,0.00011478601,0.0009162868,0.000026157542,0.0009267845,0.00003693107,0.58683133,0.000030900937,0.000105159896,0.0038110304],"study_design_scores_gemma":[0.0116175935,0.00087594363,0.29513603,0.000090301386,0.00062365964,0.000020395715,0.000110591456,0.00035447537,0.6907268,0.000043214066,0.00020900481,0.00019197317],"about_ca_topic_score_codex":0.00014905557,"about_ca_topic_score_gemma":0.000021154305,"teacher_disagreement_score":0.110039085,"about_ca_system_score_codex":0.0004565298,"about_ca_system_score_gemma":0.00065203314,"threshold_uncertainty_score":0.7507898},"labels":[],"label_agreement":null},{"id":"W1998339219","doi":"10.1182/blood-2010-06-289488","title":"Adaptation to anemia in hemoglobin E-β thalassemia","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"National Institute for Health and Care Research; Wellcome Trust; March of Dimes Foundation","keywords":"Hemoglobin; Thalassemia; Anemia; Oxygen–haemoglobin dissociation curve; Hemoglobin E; Hemoglobin F; Medicine; Beta thalassemia; Internal medicine; Gastroenterology; Fetal hemoglobin; Biology; Genetics","score_opus":0.00758091133792401,"score_gpt":0.24056621060341815,"score_spread":0.23298529926549413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998339219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846167,0.00010259804,0.000028772314,0.0015607224,0.00019173413,0.00028786733,0.0000020267987,0.000057866484,0.013151717],"genre_scores_gemma":[0.99662936,0.0000283338,0.0021201856,0.00057539553,0.00007844278,0.000015918547,0.000012091972,0.00001587791,0.0005243689],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9992755,0.000010657179,0.00016927694,0.00018619622,0.00014253618,0.00021581411],"domain_scores_gemma":[0.9995638,0.000019633138,0.000023713474,0.00020664406,0.000036052264,0.00015015568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011536224,0.00009501529,0.00014451292,0.00011362193,0.000026823318,0.000010009834,0.00005769497,0.00017165547,0.00013669468],"category_scores_gemma":[0.00012905448,0.00008143547,0.00003931364,0.00029598718,0.00001975317,0.000036407993,0.000020680165,0.00035649128,0.00019095486],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022596233,0.0023195455,0.20139465,0.00017426022,0.00006354761,0.0006471135,0.003995488,0.00012682423,0.74414825,0.0011658142,0.0045588324,0.041179694],"study_design_scores_gemma":[0.03345266,0.001714073,0.7050676,0.0006789663,0.00054590765,0.0014825166,0.0050644954,0.0016788142,0.1669457,0.00096936105,0.08104751,0.0013524563],"about_ca_topic_score_codex":0.00012639424,"about_ca_topic_score_gemma":0.00020612389,"teacher_disagreement_score":0.57720256,"about_ca_system_score_codex":0.000012948371,"about_ca_system_score_gemma":0.00008267336,"threshold_uncertainty_score":0.3320842},"labels":[],"label_agreement":null},{"id":"W1998352493","doi":"10.1182/blood-2013-05-500595","title":"Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Follicular lymphoma; Biology; Genome; Genetics; Copy number analysis; Lymphoma; Computational biology; Comparative genomic hybridization; Copy-number variation; Gene; Immunology","score_opus":0.022727876396799122,"score_gpt":0.2684191870169629,"score_spread":0.24569131062016375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998352493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952132,0.0009398197,0.000010175043,0.00022396559,0.00002300237,0.00055940734,0.0000132701825,0.000024801933,0.0029923336],"genre_scores_gemma":[0.9987089,0.00028052964,0.00040839918,0.00019208378,0.000035072724,0.00014906735,0.000099563644,0.000014815042,0.000111578636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989404,0.000042770997,0.0004510984,0.00016133375,0.00018379613,0.00022060037],"domain_scores_gemma":[0.9994476,0.00005904509,0.00009588358,0.00022990482,0.0000774574,0.000090142814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010121865,0.00015236171,0.00038880453,0.00011450203,0.000029099605,0.000016699429,0.00006265588,0.00007840203,0.0002579505],"category_scores_gemma":[0.000018350396,0.0001219399,0.0001511924,0.00016988858,0.00004159311,0.00016323195,0.000014898901,0.00002980722,0.00013401931],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003670848,0.0014467285,0.9874179,0.00016811298,0.00036739232,0.000042541687,0.0012416922,0.00001622389,0.008294161,0.0001356154,0.00008718048,0.00074573886],"study_design_scores_gemma":[0.0077725467,0.00013650357,0.92293876,0.00007991157,0.00036431674,0.000029155273,0.0004705722,0.000025216194,0.067664385,0.00014319667,0.00026250657,0.00011293504],"about_ca_topic_score_codex":0.0017207349,"about_ca_topic_score_gemma":0.00008215101,"teacher_disagreement_score":0.06447915,"about_ca_system_score_codex":0.00010965829,"about_ca_system_score_gemma":0.000092226685,"threshold_uncertainty_score":0.49725646},"labels":[],"label_agreement":null},{"id":"W1998480851","doi":"10.1182/blood-2008-05-156745","title":"Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":240,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Calgary; Vancouver General Hospital; University of British Columbia; Calgary Laboratory Services; BC Cancer Agency","funders":"Tata Trusts; Cancer Research UK; Lady Tata Memorial Trust","keywords":"Pedigree chart; Genetics; Platelet disorder; Medicine; Mutation; Malignancy; RUNX1; Oncology; Biology; Internal medicine; Cancer research; Platelet; Haematopoiesis; Gene; Stem cell","score_opus":0.025227572264911013,"score_gpt":0.2602151961115375,"score_spread":0.23498762384662647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998480851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945457,0.000112740505,0.0006866915,0.0014551753,0.000025994494,0.0013739156,0.000021697091,0.00014807956,0.0016299973],"genre_scores_gemma":[0.97996116,0.000036354773,0.012431229,0.0004900722,0.00030423,0.000060318926,0.00008618885,0.000075432974,0.0065550143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980934,0.000044268534,0.00023403046,0.00047483708,0.00061820395,0.00053525687],"domain_scores_gemma":[0.9987005,0.00005158693,0.00006719129,0.00042693838,0.0003155267,0.00043824187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008273764,0.00026814718,0.0004084173,0.0001937406,0.00029212862,0.000029817293,0.000118595664,0.000103771235,0.0000771047],"category_scores_gemma":[0.00011274944,0.00018831558,0.00004342374,0.0008145059,0.00018112198,0.00016286467,0.000091831316,0.0003884089,0.000090514644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008281535,0.003870051,0.8517032,0.0005010294,0.0018959957,0.031750232,0.030401642,0.0010164963,0.046085853,0.00019432456,0.014938044,0.00936159],"study_design_scores_gemma":[0.032043513,0.0052728658,0.91264266,0.0007542886,0.00060961494,0.014267088,0.001687728,0.00019166105,0.02409661,0.000024700757,0.0073622814,0.0010470108],"about_ca_topic_score_codex":0.0024448188,"about_ca_topic_score_gemma":0.0014122999,"teacher_disagreement_score":0.06093943,"about_ca_system_score_codex":0.00010656016,"about_ca_system_score_gemma":0.001370542,"threshold_uncertainty_score":0.76792866},"labels":[],"label_agreement":null},{"id":"W1998599956","doi":"10.1182/blood-2014-05-573543","title":"Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammation","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":690,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; St. Michael's Hospital; Héma-Québec; Centre hospitalier universitaire de Québec","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Heart, Lung, and Blood Institute; Agence Nationale de la Recherche; British Heart Foundation; Canadian Institutes of Health Research; Université Laval","keywords":"Inflammation; Platelet; Mitochondrion; Phospholipase A2; Immunology; Chemistry; Microbiology; Medicine; Cell biology; Biology; Biochemistry; Enzyme","score_opus":0.009181310119505355,"score_gpt":0.21961816820054997,"score_spread":0.21043685808104462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998599956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953693,0.00009393101,0.0020520259,0.00031410423,0.00056987855,0.0011381052,0.00005566109,0.00016748905,0.00023948868],"genre_scores_gemma":[0.99584883,0.0000097119855,0.0019225519,0.00046822304,0.00020135475,0.00025275958,0.0005127397,0.000052982366,0.00073084],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99827164,0.0001580618,0.0004106837,0.00054267346,0.000054985663,0.000561945],"domain_scores_gemma":[0.9990819,0.00009656188,0.00017451518,0.0004207846,0.0001301488,0.00009608234],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002663369,0.00031770402,0.0003721307,0.00012945879,0.00027662865,0.00005191447,0.00029429235,0.00027746957,0.0002940231],"category_scores_gemma":[0.0001770166,0.000296254,0.0001207279,0.00019512397,0.000041828796,0.00019213154,0.00009809033,0.00022964303,0.000985256],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042879625,0.00015018035,0.00008265662,0.00004744386,0.0001331355,0.000016247852,0.00033094623,0.0000043009018,0.9932003,0.0021772853,0.00014258821,0.0032861028],"study_design_scores_gemma":[0.0044342442,0.0010476307,0.0014698015,0.000079624406,0.0001169256,0.000071315204,0.00004851739,0.000018674162,0.9706821,0.0008717017,0.02078718,0.00037232682],"about_ca_topic_score_codex":0.00007204434,"about_ca_topic_score_gemma":0.000042549233,"teacher_disagreement_score":0.022518259,"about_ca_system_score_codex":0.000024259747,"about_ca_system_score_gemma":0.000040267663,"threshold_uncertainty_score":0.999949},"labels":[],"label_agreement":null},{"id":"W1998609464","doi":"10.1182/blood-2002-09-2942","title":"Identification and functional characterization of a novel 27-bp deletion in the macroglycopeptide-coding region of the GPIBA gene resulting in platelet-type von Willebrand disease","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Von Willebrand disease; Von Willebrand factor; Ristocetin; Platelet; Chinese hamster ovary cell; Mutant; Molecular biology; Gene; Receptor; Mutation; Biology; Platelet membrane glycoprotein; Coding region; Chemistry; Genetics; Immunology","score_opus":0.01849925305957194,"score_gpt":0.23461106399635792,"score_spread":0.21611181093678597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998609464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985621,0.00014660432,0.00009609235,0.00071351964,0.000039547896,0.00039244493,0.00001204219,0.0000049258238,0.000032746044],"genre_scores_gemma":[0.9994777,0.0001699462,0.00005227134,0.00008422978,0.000034722354,0.000011335584,0.000110887144,0.000007251955,0.00005167597],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9992778,0.000036579055,0.00029042887,0.00014304002,0.00016304893,0.00008913586],"domain_scores_gemma":[0.9995865,0.000032107593,0.00016823667,0.00014420245,0.000048214453,0.00002073374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001858161,0.00007443992,0.00013063979,0.000083887055,0.000040742692,0.000008130463,0.00003894326,0.00004169318,0.0000029171463],"category_scores_gemma":[0.00008276268,0.000049440914,0.000029025838,0.0002501144,0.00003421232,0.00010325345,0.000014794511,0.00007221782,7.5317837e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074415375,0.0014381978,0.25440285,0.00009792306,0.00004131988,0.000026513697,0.00093871437,0.00007120512,0.7385556,0.00011215466,0.000013238819,0.0035580904],"study_design_scores_gemma":[0.0056498246,0.00004516591,0.953811,0.0002120613,0.00008401039,0.00007718032,0.00006852311,0.0014852273,0.03842582,0.000026553964,0.00006001388,0.000054616998],"about_ca_topic_score_codex":0.000024904928,"about_ca_topic_score_gemma":0.000032814823,"teacher_disagreement_score":0.7001298,"about_ca_system_score_codex":0.000018701197,"about_ca_system_score_gemma":0.000030613613,"threshold_uncertainty_score":0.20161419},"labels":[],"label_agreement":null},{"id":"W1998739054","doi":"10.1182/blood-2011-11-395954","title":"Redefining interferon-producing killer dendritic cells as a novel intermediate in NK-cell differentiation","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Montreal Clinical Research Institute; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"National Key Research and Development Program of China; Canadian Institutes of Health Research","keywords":"Interleukin 21; Interleukin 12; Biology; Lymphokine-activated killer cell; Janus kinase 3; Adoptive cell transfer; Cell biology; Cellular differentiation; Natural killer cell; Natural killer T cell; Immunology; T cell; Cytotoxic T cell; In vitro; Immune system; Gene; Genetics","score_opus":0.013357004964969818,"score_gpt":0.222497810046651,"score_spread":0.2091408050816812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998739054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846761,0.0010713107,0.00028711863,0.000031429823,0.008815686,0.0001483695,0.000001328277,0.000062747145,0.004905902],"genre_scores_gemma":[0.9909159,0.000064789,0.0000487026,0.00017010947,0.000099763834,0.000025500192,0.00008529012,0.000022759566,0.008567168],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988661,0.00010098918,0.00034645517,0.0002480213,0.000032130643,0.00040632722],"domain_scores_gemma":[0.9995171,0.000079132056,0.0001228217,0.0002218244,0.000035042485,0.000024078758],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0002146192,0.00016758949,0.00019608434,0.00020484609,0.00008325749,0.000021657177,0.000111962225,0.00017362641,0.0014456355],"category_scores_gemma":[0.000079232894,0.00016299041,0.00007398456,0.000102520295,0.000036608508,0.00025477842,0.00008129518,0.0003960523,0.0022806064],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000091033886,0.001019275,0.0042526727,0.000025926793,0.000059949907,8.7182445e-7,0.002149814,0.0000021457834,0.99099106,0.00007217521,0.0010018949,0.00033315463],"study_design_scores_gemma":[0.0033038994,0.00021766296,0.012863663,0.00012834667,0.00008459343,0.00006589835,0.0008906114,0.000008905793,0.97726494,0.000009784793,0.004930963,0.0002307358],"about_ca_topic_score_codex":0.000113247566,"about_ca_topic_score_gemma":0.000015217396,"teacher_disagreement_score":0.01372615,"about_ca_system_score_codex":0.000050408384,"about_ca_system_score_gemma":0.00001734075,"threshold_uncertainty_score":0.9994672},"labels":[],"label_agreement":null},{"id":"W1999103491","doi":"10.1182/blood-2003-02-0425","title":"Iron, manganese, and cobalt transport by Nramp1 (Slc11a1) and Nramp2 (Slc11a2) expressed at the plasma membrane","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":281,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Cobalt; Manganese; Chemistry; Membrane; Biochemistry; Inorganic chemistry","score_opus":0.006067508261416019,"score_gpt":0.20750827941398559,"score_spread":0.20144077115256956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999103491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791345,0.009373764,0.000017908838,0.00083199656,0.00009050444,0.00046780752,0.000059590282,0.00005596877,0.009967958],"genre_scores_gemma":[0.9901569,0.0020746074,0.00031587383,0.0009024633,0.000055947978,0.000032967426,0.00007361908,0.000041963922,0.006345662],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99864215,0.00006793115,0.0002444758,0.00038433666,0.00030127805,0.00035982934],"domain_scores_gemma":[0.99922836,0.00008445595,0.000059786038,0.00037010093,0.000033978828,0.00022331066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024310304,0.00024448393,0.00034084052,0.00004688964,0.00019582335,0.000022263592,0.00008014554,0.00013808474,0.0003359686],"category_scores_gemma":[0.00006705554,0.00016827515,0.00005880853,0.00013176078,0.000260543,0.00007266886,0.000022659358,0.00017622199,0.00002203642],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013043507,0.0040148236,0.36893633,0.0025908153,0.00043172244,0.0004773375,0.007869011,0.000012600475,0.5500504,0.0050131083,0.050439015,0.008860507],"study_design_scores_gemma":[0.044848055,0.0005438803,0.114030935,0.00012958143,0.0026816078,0.0011495765,0.0025463568,0.00002097519,0.2542571,0.0002709582,0.57835734,0.0011636539],"about_ca_topic_score_codex":0.00006457433,"about_ca_topic_score_gemma":0.00004822356,"teacher_disagreement_score":0.5279183,"about_ca_system_score_codex":0.0000064638857,"about_ca_system_score_gemma":0.00003932672,"threshold_uncertainty_score":0.68620616},"labels":[],"label_agreement":null},{"id":"W1999106286","doi":"10.1182/blood.v99.8.2819","title":"Agonist-induced aggregation of Chinese hamster ovary cells coexpressing the human receptors for fibrinogen (integrin αIIbβ3) and the platelet-activating factor: dissociation between adhesion and aggregation","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Université de Sherbrooke","keywords":"Chinese hamster ovary cell; Cell biology; Integrin; Protein kinase C; Signal transduction; Cell adhesion; MAPK/ERK pathway; Phosphorylation; Tyrosine phosphorylation; Receptor; Biology; Chemistry; Molecular biology; Biochemistry; Cell","score_opus":0.03837922042769268,"score_gpt":0.29667932982733697,"score_spread":0.2583001093996443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999106286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99717945,0.00034590272,0.000089331945,0.00058180717,0.00003461447,0.0014863359,0.000015282163,0.000026714908,0.000240565],"genre_scores_gemma":[0.9989333,0.00008687903,0.00033990838,0.00003294722,0.00019163208,0.000059942246,0.00005176009,0.00003130709,0.00027228842],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99854684,0.00019374421,0.00038716377,0.000271956,0.0003859529,0.00021431706],"domain_scores_gemma":[0.9984061,0.0008212057,0.00032571974,0.00024918054,0.00012471672,0.00007307081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004353133,0.00017587816,0.00030954852,0.000086709406,0.00039454538,0.00007712893,0.000096465505,0.0001328715,0.00004050749],"category_scores_gemma":[0.00041576382,0.00010232251,0.00009120264,0.00016583035,0.00013835439,0.00013699847,0.000083077386,0.00024658232,0.0000020368725],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011383085,0.00009899119,0.03117137,0.00017902906,0.00010096823,0.0000014615078,0.0034231374,9.905175e-7,0.8990063,0.000019019846,0.00006808314,0.06581681],"study_design_scores_gemma":[0.005761141,0.0002783667,0.08803689,0.00031198058,0.000059332808,0.000008803671,0.0002751012,0.00090839993,0.9036823,0.00019108703,0.00033929976,0.00014729162],"about_ca_topic_score_codex":0.00007255558,"about_ca_topic_score_gemma":0.000006759236,"teacher_disagreement_score":0.06566952,"about_ca_system_score_codex":0.000040439867,"about_ca_system_score_gemma":0.000016853868,"threshold_uncertainty_score":0.4172591},"labels":[],"label_agreement":null},{"id":"W1999257052","doi":"10.1182/blood-2007-05-088815","title":"Rapid and selective death of leukemia stem and progenitor cells induced by the compound 4-benzyl, 2-methyl, 1,2,4-thiadiazolidine, 3,5 dione (TDZD-8)","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"Wilmot Cancer Institute, University of Rochester Medical Center; National Cancer Institute; Leukemia and Lymphoma Society","keywords":"Haematopoiesis; Leukemia; Stem cell; Progenitor cell; Myeloid leukemia; Biology; Cancer research; Myeloid; Immunology; Cell biology","score_opus":0.019713133837099175,"score_gpt":0.2547638598019159,"score_spread":0.23505072596481674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999257052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99143744,0.005855053,0.000017288554,0.000090625304,0.00008310155,0.0010662868,0.000032577736,0.000048217367,0.0013694055],"genre_scores_gemma":[0.9985115,0.00035596787,0.0005119468,0.00011514759,0.00016300328,0.000023211524,0.000018421912,0.000041233085,0.00025959613],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983823,0.00007374797,0.00039026028,0.0004040845,0.00034699662,0.0004026492],"domain_scores_gemma":[0.998708,0.00039432224,0.00018524873,0.00035639553,0.00012170782,0.0002343235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044620852,0.000279947,0.0004782287,0.00010088969,0.00013420105,0.00002226983,0.000102178434,0.00018560483,0.000015077411],"category_scores_gemma":[0.000044560522,0.0001984735,0.00006545105,0.00024306588,0.0001403852,0.000073330564,0.00007686093,0.00032280904,0.0000059302665],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000514632,0.0009623456,0.046457715,0.00026245302,0.0013494451,0.00011242604,0.0017552011,3.6615097e-7,0.93187344,0.00016193652,0.0009621014,0.015587936],"study_design_scores_gemma":[0.011941762,0.0010115182,0.059505586,0.0000974461,0.0008125794,0.00034768964,0.00043773482,0.000028617196,0.92449117,0.000038011203,0.0010700728,0.00021778942],"about_ca_topic_score_codex":0.00039179708,"about_ca_topic_score_gemma":0.000028770522,"teacher_disagreement_score":0.015370147,"about_ca_system_score_codex":0.00034878153,"about_ca_system_score_gemma":0.0003682918,"threshold_uncertainty_score":0.80935144},"labels":[],"label_agreement":null},{"id":"W1999328539","doi":"10.1182/blood-2013-07-516807","title":"The core autophagy protein ATG4B is a potential biomarker and therapeutic target in CML stem/progenitor cells","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":199,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Progenitor cell; Autophagy; Stem cell; Gene knockdown; Cancer research; Progenitor; Biology; Cell biology; Cell culture; Apoptosis; Genetics","score_opus":0.015068472542162587,"score_gpt":0.24480314064500647,"score_spread":0.22973466810284388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999328539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948634,0.0029230977,0.000019402376,0.0005570615,0.0001188845,0.0010913893,0.000010232618,0.000047100984,0.00036945252],"genre_scores_gemma":[0.996482,0.00004323289,0.0004244681,0.00028630157,0.00014032435,0.00012717668,0.0000062604463,0.00003455281,0.0024556743],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99875975,0.0000765052,0.0002467368,0.00031780027,0.00025207354,0.00034712197],"domain_scores_gemma":[0.9993055,0.000058639722,0.00007792533,0.00041017414,0.00003573297,0.00011204735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023706658,0.00019373842,0.0002479213,0.00005550583,0.00010500951,0.000031778272,0.00010959298,0.000117058014,0.00008263613],"category_scores_gemma":[0.000015490248,0.00012549307,0.00007122844,0.0001314348,0.000093708186,0.000026178952,0.000059298098,0.00015216129,0.00006464797],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009553358,0.002435968,0.05017759,0.00044237377,0.0015296085,0.0004931198,0.0015258441,0.0000020383052,0.8495797,0.00032953144,0.0012601422,0.09126873],"study_design_scores_gemma":[0.047996257,0.0015096222,0.12169237,0.0003848991,0.00097377505,0.0004915927,0.0002654541,0.006439146,0.7784631,0.0011074183,0.040006533,0.000669782],"about_ca_topic_score_codex":0.00008989365,"about_ca_topic_score_gemma":0.000015794116,"teacher_disagreement_score":0.09059895,"about_ca_system_score_codex":0.00009965803,"about_ca_system_score_gemma":0.00015736834,"threshold_uncertainty_score":0.51174587},"labels":[],"label_agreement":null},{"id":"W1999350238","doi":"10.1182/blood-2012-09-458174","title":"TCR triggering modulates the responsiveness and homeostatic proliferation of CD4+ thymic emigrants to IL-7 therapy","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Canadian Institutes of Health Research","keywords":"T-cell receptor; Homeostasis; Immunology; Stimulation; T cell; Biology; Medicine; Cell biology; Immune system; Neuroscience","score_opus":0.010729213225014265,"score_gpt":0.2268531710433789,"score_spread":0.21612395781836463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999350238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98434544,0.014074765,0.00003455041,0.0006134914,0.00012793444,0.0007361112,0.000010806781,0.000029450592,0.000027444406],"genre_scores_gemma":[0.9977074,0.0011312496,0.000046339395,0.00022216786,0.0000114922705,0.00012008173,0.000009335195,0.000017249145,0.00073467795],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99893945,0.0003474913,0.00027061527,0.0001767036,0.00003498449,0.00023077044],"domain_scores_gemma":[0.9991724,0.00034333163,0.00009235488,0.0002903981,0.00008928208,0.000012266795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002821307,0.00014873795,0.00023660909,0.000108846245,0.00019586568,0.000028051718,0.00017607692,0.00010425804,0.00013691095],"category_scores_gemma":[0.00010356135,0.00009551156,0.000052499156,0.00014970421,0.0001358301,0.0001133548,0.000038844675,0.00012193151,0.0000829503],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007342294,0.00015150645,0.0017324295,0.000013165335,0.00020156112,5.747682e-7,0.0024864993,0.000005146269,0.9780318,0.000065470806,0.000091123446,0.01648648],"study_design_scores_gemma":[0.0025043152,0.00050919346,0.13186024,0.000056950175,0.000024761295,0.000053448726,0.0004022994,0.0000047145795,0.86126024,0.00017926945,0.0030035574,0.00014101669],"about_ca_topic_score_codex":0.00015150949,"about_ca_topic_score_gemma":0.0000045451593,"teacher_disagreement_score":0.1301278,"about_ca_system_score_codex":0.000005608533,"about_ca_system_score_gemma":0.000043898362,"threshold_uncertainty_score":0.38948482},"labels":[],"label_agreement":null},{"id":"W1999436010","doi":"10.1182/blood-2007-05-091561","title":"A high-density SNP genome-wide linkage search of 206 families identifies susceptibility loci for chronic lymphocytic leukemia","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; Cancer Research UK; McMaster University","keywords":"Genetics; Single-nucleotide polymorphism; Chronic lymphocytic leukemia; Genetic linkage; Biology; Linkage disequilibrium; Locus (genetics); SNP array; Tag SNP; SNP; Gene; Leukemia; Genotype","score_opus":0.023511494643919655,"score_gpt":0.2996658984186277,"score_spread":0.276154403774708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999436010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99357945,0.0017479119,0.0016881356,0.000053160005,0.00017583354,0.0018781368,0.000047329508,0.00016058926,0.0006694459],"genre_scores_gemma":[0.99445987,0.00038597046,0.0015346266,0.000095103205,0.0006375328,0.00004933818,0.00016446707,0.000085022366,0.0025880523],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99554014,0.00009947414,0.0009924059,0.00087008206,0.0011882326,0.0013096621],"domain_scores_gemma":[0.99600124,0.0011782186,0.0001857994,0.0014163624,0.0007935501,0.00042481732],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0026537282,0.0003927519,0.0009924273,0.00041052158,0.00020597587,0.000045813835,0.00047368484,0.0003802899,0.0002267955],"category_scores_gemma":[0.0011163553,0.00036475377,0.00040655394,0.0006656222,0.00078351615,0.00014891525,0.0003589882,0.0004155706,0.00015776591],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.009579428,0.0042371955,0.039932694,0.03488803,0.0048959847,0.0029645234,0.008033231,0.002462043,0.867936,0.0012809994,0.0049500777,0.018839775],"study_design_scores_gemma":[0.082831055,0.0015875228,0.10158589,0.00036934513,0.0008055749,0.00030603964,0.0010403001,0.003221271,0.80620456,0.00048519424,0.00093249045,0.0006307603],"about_ca_topic_score_codex":0.009237391,"about_ca_topic_score_gemma":0.0022552735,"teacher_disagreement_score":0.07325163,"about_ca_system_score_codex":0.04788532,"about_ca_system_score_gemma":0.028614078,"threshold_uncertainty_score":0.99988043},"labels":[],"label_agreement":null},{"id":"W1999505686","doi":"10.1182/blood-2010-04-280149","title":"EZH2-mediated epigenetic silencing in germinal center B cells contributes to proliferation and lymphomagenesis","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":297,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"PRC2; EZH2; Biology; Chromatin immunoprecipitation; Germinal center; Histone H3; Gene silencing; Cancer research; Epigenetics; H3K4me3; DNA methylation; Cell cycle; Chromatin; Molecular biology; Promoter; Cell biology; B cell; Cell; Gene expression; Gene; Genetics","score_opus":0.003955922946880838,"score_gpt":0.2182357438659096,"score_spread":0.21427982091902875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999505686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99818563,0.00064819236,0.00053223444,0.00009441393,0.00013516382,0.00025452464,0.000018452503,0.0000070363185,0.00012437499],"genre_scores_gemma":[0.99835664,0.00016257128,0.0010418264,0.00010872014,0.00015856454,0.00003435624,0.000062616666,0.000015219547,0.000059484744],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992096,0.000037746144,0.00019539046,0.0002800655,0.00007521327,0.00020201247],"domain_scores_gemma":[0.99961305,0.000019879437,0.000042019943,0.0001736383,0.00006424025,0.00008714574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018878367,0.00011322142,0.00010854039,0.000074591095,0.00004623285,0.000034661687,0.000070872375,0.00014187537,0.0000068304985],"category_scores_gemma":[0.00012054653,0.00011453417,0.00002481108,0.00009181224,0.000026461468,0.0000029120445,0.000056331453,0.000057086756,0.000007864423],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016844268,0.00008193907,0.121191606,0.000008470064,0.000009606141,0.000002289263,0.00004273041,0.000014779149,0.8767584,0.000006223814,0.00000801637,0.0018591033],"study_design_scores_gemma":[0.0010381214,0.0000997921,0.13725717,0.0000074405457,0.000013754534,0.0000024756705,0.000013827122,0.000064866705,0.86014175,0.000036224686,0.0012086678,0.00011587988],"about_ca_topic_score_codex":0.000022397131,"about_ca_topic_score_gemma":0.0002855788,"teacher_disagreement_score":0.016616624,"about_ca_system_score_codex":0.0000048941856,"about_ca_system_score_gemma":0.000046105706,"threshold_uncertainty_score":0.46705678},"labels":[],"label_agreement":null},{"id":"W1999588603","doi":"10.1182/blood-2010-05-285999","title":"Aberrant interferon-signaling is associated with aggressive chronic lymphocytic leukemia","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research; Hospital for Sick Children; University of Toronto","keywords":"Chronic lymphocytic leukemia; STAT3; Cancer research; Biology; Phosphorylation; Signal transduction; STAT1; STAT protein; Interferon; Tyrosine phosphorylation; Protein tyrosine phosphatase; Leukemia; Immunology; Cell biology","score_opus":0.03430936399196056,"score_gpt":0.26136207185677274,"score_spread":0.2270527078648122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999588603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98614186,0.0017743007,0.00007617939,0.00002638538,0.000094458,0.0005971223,0.000012722428,0.00022598609,0.011050979],"genre_scores_gemma":[0.99620694,0.00011838591,0.00034114215,0.00031374113,0.00021979831,0.000075141084,0.000032207918,0.000100227946,0.002592435],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972333,0.000078541954,0.00042901532,0.0006113827,0.0007471603,0.0009006125],"domain_scores_gemma":[0.99818796,0.00014823608,0.00029202717,0.0007278178,0.00027243875,0.0003715303],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031007838,0.000361119,0.0006179268,0.00019603134,0.00012857362,0.000034923294,0.00032391128,0.00024360497,0.0010927801],"category_scores_gemma":[0.00025873532,0.0002754421,0.0001583146,0.00046027612,0.00028882048,0.00012827222,0.00014590296,0.00040571683,0.00035624503],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.040143292,0.019485284,0.033454385,0.0112468675,0.07320511,0.22405416,0.16707988,0.00094851037,0.30686283,0.0023832659,0.05662831,0.06450811],"study_design_scores_gemma":[0.24970207,0.0074231117,0.003640011,0.007927519,0.0029804274,0.007408275,0.00076578953,0.017681407,0.700077,0.0002713617,0.0006547981,0.0014682155],"about_ca_topic_score_codex":0.0013902517,"about_ca_topic_score_gemma":0.00009842574,"teacher_disagreement_score":0.3932142,"about_ca_system_score_codex":0.054966837,"about_ca_system_score_gemma":0.038350612,"threshold_uncertainty_score":0.9999698},"labels":[],"label_agreement":null},{"id":"W2000298515","doi":"10.1182/blood-2014-06-581173","title":"Disruption of IKAROS activity in primitive chronic-phase CML cells mimics myeloid disease progression","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Myeloid; Medicine; Cancer research; Disease; Imatinib; Myeloid leukemia; Immunology; Biology; Internal medicine","score_opus":0.012481730666794935,"score_gpt":0.301793895850643,"score_spread":0.28931216518384806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000298515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997629,0.0003104559,0.0001516585,0.00014030305,0.000086154316,0.0009819237,0.000044872624,0.000052801995,0.00060281524],"genre_scores_gemma":[0.99876386,0.00012317195,0.00057368336,0.000032035492,0.0001654373,0.00008635939,0.00008143721,0.000032829677,0.00014119304],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99855405,0.00010190875,0.00028663984,0.0003891072,0.00034465175,0.0003236572],"domain_scores_gemma":[0.99893856,0.000087837594,0.00019147166,0.00047901197,0.00006005369,0.00024307625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018270142,0.00021754994,0.00038535075,0.000120908284,0.000039006187,0.000008446814,0.000086268985,0.00011282721,0.00005076384],"category_scores_gemma":[0.00012842895,0.00018578254,0.00011470109,0.00018781929,0.00010116834,0.00011593525,0.00006730672,0.00020740897,0.000028129762],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019351026,0.016150106,0.06289319,0.0011645535,0.00017925879,0.00021802587,0.0005159326,0.000031815354,0.78772116,0.00011318983,0.00007119423,0.12900648],"study_design_scores_gemma":[0.03856679,0.0017989816,0.1985456,0.0010940378,0.00059839,0.000017970504,0.00002665457,0.0028451432,0.75559604,0.00004546525,0.0005962989,0.00026864675],"about_ca_topic_score_codex":0.000045877903,"about_ca_topic_score_gemma":0.000027297405,"teacher_disagreement_score":0.13565241,"about_ca_system_score_codex":0.00057921605,"about_ca_system_score_gemma":0.00049631845,"threshold_uncertainty_score":0.7575992},"labels":[],"label_agreement":null},{"id":"W2000301831","doi":"10.1182/blood-2012-08-449272","title":"Megakaryocyte-specific deletion of the protein-tyrosine phosphatases Shp1 and Shp2 causes abnormal megakaryocyte development, platelet production, and function","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; British Heart Foundation","keywords":"Megakaryocyte; Protein tyrosine phosphatase; Platelet; Phosphatase; Tyrosine; Function (biology); Cell biology; Biology; Biochemistry; Immunology; Phosphorylation; Haematopoiesis; Stem cell","score_opus":0.007614366826395481,"score_gpt":0.18937418047770116,"score_spread":0.18175981365130567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000301831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96666044,0.031800732,0.00014195204,0.00016128004,0.00013005712,0.0010115436,0.000044623775,0.000024715666,0.000024681087],"genre_scores_gemma":[0.99697757,0.00073850993,0.0014175427,0.000076574026,0.00017410309,0.0002146428,0.00017465698,0.000029195326,0.00019720633],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99868745,0.000056577956,0.000334907,0.00047096427,0.00019372259,0.00025636883],"domain_scores_gemma":[0.9991432,0.000009683338,0.00019379442,0.000403862,0.00016968958,0.00007978703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016293356,0.00023856669,0.00018428694,0.000044168253,0.00022476405,0.00005401777,0.00015099322,0.00012142008,0.000029350656],"category_scores_gemma":[0.0001388053,0.00018544799,0.00003793307,0.00014436596,0.00022855258,0.00004134671,0.00022834861,0.0000994134,0.0000056417516],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024701192,0.00027457453,0.0112525,0.00014750958,0.00015220729,0.0000020654288,0.000053281972,0.0000096597505,0.97728354,0.00049139734,0.0030519234,0.0070343413],"study_design_scores_gemma":[0.00082942017,0.00022400236,0.04854189,0.00006945398,0.000039358067,0.00006848389,0.00002526169,0.0000018983803,0.9358964,0.000077066186,0.014011942,0.0002148176],"about_ca_topic_score_codex":0.00007645947,"about_ca_topic_score_gemma":0.000042208572,"teacher_disagreement_score":0.041387122,"about_ca_system_score_codex":0.000009509754,"about_ca_system_score_gemma":0.000078759054,"threshold_uncertainty_score":0.75623494},"labels":[],"label_agreement":null},{"id":"W2000323986","doi":"10.1182/blood-2009-10-249540","title":"Toll-like receptor–induced changes in glycolytic metabolism regulate dendritic cell activation","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":1232,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Occupational Cancer Research Centre","funders":"National Cancer Institute; National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; National Institutes of Health; Cancer Research Institute","keywords":"Cell biology; Signal transduction; Biology; AMPK; Inflammation; Glycolysis; Dendritic cell; Receptor; Immune system; Cytokine; Kinase; Protein kinase A; Metabolism; Immunology; Biochemistry","score_opus":0.008582653723832764,"score_gpt":0.21823159828453384,"score_spread":0.20964894456070107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000323986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99216866,0.001033804,0.0000027491837,0.00031969015,0.0038687924,0.0002981326,0.000006320254,0.00007341487,0.002228419],"genre_scores_gemma":[0.994497,0.00007560629,0.00016752795,0.00022552873,0.00011747388,0.00007479223,0.00004599529,0.000032917826,0.004763178],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99884796,0.00011656267,0.00023378286,0.00033222375,0.00004317435,0.0004262873],"domain_scores_gemma":[0.99927765,0.000103554274,0.00010902299,0.00044014366,0.000050708462,0.000018930905],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022014437,0.00019251485,0.00027419635,0.0001730512,0.000096840886,0.0000165018,0.00026739342,0.00043404583,0.0012908983],"category_scores_gemma":[0.00006060567,0.00019309361,0.000054655236,0.00019793308,0.00009082332,0.00010203586,0.000080882164,0.0006512625,0.00060197373],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058560225,0.00027388183,0.00025642425,0.000020249483,0.000044029923,0.0000031303905,0.00037415445,5.3469404e-7,0.996755,0.00014466705,0.00057389535,0.0014954465],"study_design_scores_gemma":[0.0030208093,0.00005421143,0.006011899,0.000027059183,0.000059510934,0.000027149514,0.000083384286,7.424415e-7,0.951968,0.00009542203,0.038434606,0.00021720088],"about_ca_topic_score_codex":0.000116983996,"about_ca_topic_score_gemma":0.0002873579,"teacher_disagreement_score":0.04478702,"about_ca_system_score_codex":0.000025483885,"about_ca_system_score_gemma":0.00007051377,"threshold_uncertainty_score":0.99962205},"labels":[],"label_agreement":null},{"id":"W2000389681","doi":"10.1182/blood-2005-05-1938","title":"Anti–platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":274,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Waterloo","funders":"National Institutes of Health; Heart and Stroke Foundation of Canada; National Heart, Lung, and Blood Institute; Sanofi","keywords":"Fondaparinux; Heparin; Medicine; Platelet factor 4; Heparin-induced thrombocytopenia; Low molecular weight heparin; Anticoagulant; Antithrombin; Pharmacology; Internal medicine; Thrombosis","score_opus":0.03017927534513887,"score_gpt":0.26608089305707056,"score_spread":0.2359016177119317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000389681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952004,0.00013828366,0.000009246564,0.00019567383,0.00020503883,0.0011619325,0.000019570345,0.00021986192,0.0028499714],"genre_scores_gemma":[0.99694633,0.00040816495,0.0014928703,0.00018227914,0.00024022853,0.00005506699,0.00008078802,0.00012661515,0.00046764463],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961815,0.00014535763,0.00096401176,0.00094384083,0.0006919846,0.0010733191],"domain_scores_gemma":[0.9980649,0.00028135642,0.00028246187,0.0007681752,0.00021659146,0.00038655155],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003522868,0.0006196246,0.0017378302,0.00062862784,0.00018981592,0.00009983249,0.00023743803,0.00033075115,0.0004448209],"category_scores_gemma":[0.00043202643,0.00045467616,0.00019047745,0.0010721128,0.00019470192,0.00055643026,0.0001718669,0.00069389696,0.00024170791],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026080385,0.0031786498,0.9726307,0.00031243445,0.00033732396,0.00029135693,0.00056689675,0.0000066495113,0.0037139414,0.000016383141,0.00011008152,0.018574825],"study_design_scores_gemma":[0.005658475,0.001032381,0.9704191,0.00075868715,0.00021008181,0.0001587547,0.000081310536,0.0000271872,0.019741718,0.00000518703,0.0012723645,0.0006347202],"about_ca_topic_score_codex":0.00039909733,"about_ca_topic_score_gemma":0.002123455,"teacher_disagreement_score":0.017940104,"about_ca_system_score_codex":0.0001581121,"about_ca_system_score_gemma":0.0005711533,"threshold_uncertainty_score":0.9997905},"labels":[],"label_agreement":null},{"id":"W2000427783","doi":"10.1182/blood-2003-07-2624","title":"Rac2 is critical for neutrophil primary granule exocytosis","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":166,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Institutes of Health Research","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; Fondation pour la Recherche Médicale; Canadian Lung Association; Riley Children's Foundation","keywords":"Degranulation; Exocytosis; Granule (geology); Granulocyte; Leukotriene B4; Myeloperoxidase; Chemistry; Cell biology; Immunology; Biology; Inflammation; Secretion; Biochemistry; Receptor","score_opus":0.017282686819469845,"score_gpt":0.24952770773018274,"score_spread":0.2322450209107129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000427783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873718,0.0028507258,0.0032159062,0.003419629,0.0005902406,0.0005550558,0.00024634151,0.00018252587,0.0015677827],"genre_scores_gemma":[0.9924459,0.00009374681,0.0027460717,0.0034501315,0.00015002876,0.00015305108,0.00013655917,0.000044459317,0.00078007235],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99865687,0.00006121849,0.00027078332,0.00044710274,0.000043062748,0.0005209608],"domain_scores_gemma":[0.99931055,0.00014352117,0.00005135246,0.0003401428,0.00010744815,0.000046992653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012574534,0.00023820197,0.00034780052,0.00009119822,0.00029965004,0.00002249206,0.00024814875,0.0002446294,0.00032443824],"category_scores_gemma":[0.000063328895,0.00021305191,0.00019854531,0.00011514732,0.00019776986,0.00012585474,0.00008399749,0.00022413312,0.00070813665],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012318628,0.0007819004,0.000045437435,0.00004836905,0.00014572502,0.000021140384,0.00014193275,6.8858145e-7,0.963294,0.033792946,0.0009880128,0.00061661884],"study_design_scores_gemma":[0.0061574522,0.0006119873,0.00067296316,0.00003594594,0.00020993817,0.00011123737,0.000057755067,8.163457e-8,0.96584624,0.009409649,0.016610647,0.00027607515],"about_ca_topic_score_codex":0.000019548987,"about_ca_topic_score_gemma":0.000003096669,"teacher_disagreement_score":0.024383295,"about_ca_system_score_codex":0.00003312503,"about_ca_system_score_gemma":0.00009481947,"threshold_uncertainty_score":0.91019005},"labels":[],"label_agreement":null},{"id":"W2000580405","doi":"10.1182/blood-2006-10-043299","title":"Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; Office of Naval Research; Astellas Pharma; Novo Nordisk; IC Design Education Center; Valeant Pharmaceuticals International; Edwards Lifesciences; Therakos; Celgene; Osiris Therapeutics; WellPoint; HistoGenetics; Medical College of Wisconsin; StemCyte; Enzon Pharmaceuticals; Takeda Oncology; Amgen; Pfizer; Biogen; Blue Cross and Blue Shield Association; U.S. Department of Health and Human Services; Astellas Pharma US; Abbott Laboratories","keywords":"Cytogenetics; Medicine; Internal medicine; Myeloid leukemia; Hematopoietic stem cell transplantation; Transplantation; Leukemia; Gastroenterology; Confidence interval; Oncology; Surgery; Biology; Chromosome","score_opus":0.03772353118532175,"score_gpt":0.3325197765562388,"score_spread":0.2947962453709171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000580405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971424,0.00007832206,0.0006557174,0.000052116025,0.0000342685,0.0012513398,0.00027420057,0.000027913431,0.0004837669],"genre_scores_gemma":[0.99681014,0.00015282663,0.00208423,0.00003441749,0.000031892207,0.000018463821,0.00014416945,0.000056533587,0.00066734414],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978089,0.0000435234,0.00097003323,0.00032024828,0.0003947355,0.00046256476],"domain_scores_gemma":[0.99836546,0.000562063,0.00028944798,0.00041116576,0.00016957248,0.00020227298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005864773,0.00025457097,0.00074237137,0.00037762424,0.000041508098,0.0000064003857,0.00018792163,0.0002806293,0.00015463858],"category_scores_gemma":[0.000035341185,0.00019070152,0.0002316494,0.0004639053,0.00007391572,0.00004451379,0.000026899335,0.00032857052,0.000009236739],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013138989,0.0009640746,0.17032233,0.003778465,0.00057980337,0.00039386653,0.002972003,0.00030006366,0.8066352,0.000021079002,0.00020846083,0.0006856469],"study_design_scores_gemma":[0.023508199,0.0032712966,0.2167886,0.00057151646,0.0006272025,0.0002212101,0.00026738635,0.00052854867,0.7538852,0.000022318261,0.00006155447,0.00024694498],"about_ca_topic_score_codex":0.00011584161,"about_ca_topic_score_gemma":0.00012410888,"teacher_disagreement_score":0.052749995,"about_ca_system_score_codex":0.00058603275,"about_ca_system_score_gemma":0.00048680327,"threshold_uncertainty_score":0.7776582},"labels":[],"label_agreement":null},{"id":"W2000708054","doi":"10.1182/blood.v99.3.729a","title":"Neutrophils at the crossroads of cytokine and RA receptors","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Receptor; Cytokine; Immunology; Medicine; Biology; Internal medicine","score_opus":0.009599349082399037,"score_gpt":0.19844918942300901,"score_spread":0.18884984034060998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000708054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903264,0.0075551574,0.0000016462355,0.00045882975,0.00016624134,0.000087145134,0.0000039481274,0.000015359436,0.0013852415],"genre_scores_gemma":[0.990691,0.00063795183,0.0000057563857,0.000048900885,0.00001888913,0.000005721063,0.000010224509,0.0000054908355,0.008576052],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995503,0.000070464164,0.00015164251,0.00008868334,0.000015644866,0.0001232687],"domain_scores_gemma":[0.9996524,0.000077037635,0.00006887625,0.00017356494,0.000022869619,0.000005247902],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011761733,0.00006612296,0.00010773058,0.000029616545,0.00013313764,0.0000051371935,0.00007511289,0.00009059542,0.0013012283],"category_scores_gemma":[0.000037777816,0.000043562275,0.00003611312,0.000056422952,0.000188806,0.000039621933,0.00005530651,0.00008147418,0.00026154786],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006501103,0.000073206495,0.0014121814,0.0000065786594,0.00007562246,9.3727715e-7,0.00045201986,5.994129e-7,0.9908115,0.00018227381,0.0032146072,0.0037054538],"study_design_scores_gemma":[0.0013806928,0.00012493544,0.013942529,0.000009097139,0.00004400646,0.00007740582,0.000039207043,0.0000010250311,0.889196,0.000021296957,0.0951048,0.000059038648],"about_ca_topic_score_codex":0.000014754474,"about_ca_topic_score_gemma":0.00000240464,"teacher_disagreement_score":0.10161554,"about_ca_system_score_codex":0.000004872556,"about_ca_system_score_gemma":0.0000040015566,"threshold_uncertainty_score":0.99961174},"labels":[],"label_agreement":null},{"id":"W2000717209","doi":"10.1182/blood-2014-04-569640","title":"TAILS N-terminomics of human platelets reveals pervasive metalloproteinase-dependent proteolytic processing in storage","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of British Columbia","funders":"Canadian Institutes of Health Research; Centre for Blood Research, University of British Columbia; University of British Columbia; Michael Smith Health Research BC; Canadian Blood Services","keywords":"Proteases; Proteome; Biochemistry; Biology; Proteolysis; Storage protein; Platelet; Protease; Cell biology; Chemistry; Enzyme; Immunology; Gene","score_opus":0.01489836080817084,"score_gpt":0.2601747215558813,"score_spread":0.24527636074771045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000717209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967671,0.0003864928,0.000029657785,0.00005959392,0.000017113689,0.0010843471,0.0000060692355,0.000033278608,0.00161636],"genre_scores_gemma":[0.9987486,0.000011581815,0.0005718414,0.000058051937,0.00003463562,0.000096397445,0.000021245234,0.000032479984,0.0004251417],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987533,0.00004635696,0.0003858783,0.0002984233,0.0002360147,0.00028002344],"domain_scores_gemma":[0.999358,0.000017037051,0.00019725821,0.00027149488,0.0000628247,0.00009337855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023719257,0.00019159415,0.0005712202,0.0001502812,0.000054845874,0.00001546309,0.00009813059,0.000106095664,0.000030393681],"category_scores_gemma":[0.00007849211,0.00016480628,0.000079802434,0.0001239036,0.000050199862,0.00009564813,0.00003858974,0.00015799764,0.000015861406],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004430019,0.014702159,0.12738627,0.0034305446,0.0005869123,0.007923102,0.0029254877,0.000034892128,0.81416947,0.00040189436,0.000031382162,0.027964886],"study_design_scores_gemma":[0.07296689,0.0072275074,0.2514672,0.0041494537,0.002398347,0.0027673622,0.00086309906,0.0010452651,0.6498126,0.0054860944,0.00023380316,0.0015823718],"about_ca_topic_score_codex":0.000077225006,"about_ca_topic_score_gemma":0.00004350507,"teacher_disagreement_score":0.16435686,"about_ca_system_score_codex":0.00004190963,"about_ca_system_score_gemma":0.00006961212,"threshold_uncertainty_score":0.6720605},"labels":[],"label_agreement":null},{"id":"W2000782581","doi":"10.1182/blood-2008-12-196014","title":"JAK2V617F mutation for the early diagnosis of Ph− myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis","year":2009,"lang":"en","type":"review","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":176,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Odds ratio; Confidence interval; Internal medicine; Mutation; Myeloproliferative neoplasm; Gastroenterology; Myelofibrosis; Polycythemia vera; Genetics; Bone marrow","score_opus":0.05452431246079667,"score_gpt":0.31760236844796996,"score_spread":0.26307805598717326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000782581","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010260159,0.97807956,0.00003642804,0.00015874446,0.000042719596,0.010561208,0.00073930976,0.00002802481,0.00009382337],"genre_scores_gemma":[0.019411797,0.96408594,0.0012623294,0.00015683849,0.000106855456,0.013731505,0.0010722175,0.00010239718,0.00007010063],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9965885,0.00027126045,0.001228425,0.00082534144,0.0006321981,0.00045424938],"domain_scores_gemma":[0.99598336,0.0015935516,0.000996126,0.00077030074,0.00051864266,0.00013803606],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003476402,0.0008340478,0.007277267,0.0006102144,0.00014121136,0.00005641047,0.00023848968,0.00032061207,0.000119202836],"category_scores_gemma":[0.00017149768,0.00041993754,0.0026403565,0.0015270701,0.000103656814,0.000102406644,0.000036846966,0.0003682964,0.000012122674],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005350889,0.020122139,0.026496392,0.005500911,0.74437916,0.00010543107,0.0018939936,0.000059514263,3.499682e-8,0.00057726644,0.00012729185,0.20020278],"study_design_scores_gemma":[0.0054425844,0.0067113074,0.038300116,0.0011550176,0.9325302,0.00001347157,0.000029924313,0.0000063319303,0.00004134512,0.00005618592,0.015227889,0.00048558874],"about_ca_topic_score_codex":0.00014153126,"about_ca_topic_score_gemma":0.00031742852,"teacher_disagreement_score":0.1997172,"about_ca_system_score_codex":0.000114016206,"about_ca_system_score_gemma":0.00038829193,"threshold_uncertainty_score":0.99982524},"labels":[],"label_agreement":null},{"id":"W2000809028","doi":"10.1182/blood-2010-06-290049","title":"Jagged2 acts as a Delta-like Notch ligand during early hematopoietic cell fate decisions","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Invertebrate Immune Response Mechanisms","field":"Immunology and Microbiology","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Notch signaling pathway; Haematopoiesis; Biology; Cell fate determination; Cell biology; Stem cell; Genetics; Signal transduction; Transcription factor; Gene","score_opus":0.017921312879889014,"score_gpt":0.21041363662762932,"score_spread":0.1924923237477403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000809028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99238104,0.001481303,0.000110090616,0.000028677568,0.0006736409,0.00030151862,0.000015273616,0.0001739351,0.0048345],"genre_scores_gemma":[0.9929609,0.000101488,0.00046218897,0.00014784135,0.000018511166,0.000041682015,0.000017734992,0.000056450768,0.0061932243],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99814546,0.00022071516,0.0004055396,0.0004502185,0.00007215777,0.0007059249],"domain_scores_gemma":[0.99886745,0.00014492201,0.00014865842,0.0006786416,0.000093802926,0.00006655172],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00026395792,0.00030945925,0.00037683046,0.00019980941,0.0003719706,0.000032560154,0.0004945668,0.0004157876,0.0009875848],"category_scores_gemma":[0.00012499913,0.00028296968,0.00016318358,0.00021456058,0.00011316673,0.00014761991,0.00026405227,0.00043084484,0.009543836],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030026998,0.0006472327,0.0004773757,0.000015595986,0.00016901664,0.00016041577,0.002736375,1.5721082e-7,0.99473685,0.00054954697,0.00011280632,0.00009435474],"study_design_scores_gemma":[0.0035583419,0.00036791302,0.0034735142,0.00007581646,0.0001696479,0.00064482837,0.0003058256,4.7766997e-7,0.9892955,0.0007994452,0.0009750625,0.00033362975],"about_ca_topic_score_codex":0.00021057442,"about_ca_topic_score_gemma":0.000026896792,"teacher_disagreement_score":0.008556251,"about_ca_system_score_codex":0.000020565227,"about_ca_system_score_gemma":0.00011477171,"threshold_uncertainty_score":0.9999623},"labels":[],"label_agreement":null},{"id":"W200083443","doi":"10.1182/blood.v122.21.2221.2221","title":"A North American Experience Of Hemoglobin SC Disease, Its Complications, and Management","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Cohort; Sickle cell anemia; Anemia; Hematocrit; Pediatrics; Retrospective cohort study; Observational study; Hemoglobin; Cohort study; Internal medicine; Fetal hemoglobin; Disease; Surgery; Pregnancy","score_opus":0.008204382517323128,"score_gpt":0.2354039124388285,"score_spread":0.22719952992150536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W200083443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99352384,0.0009324407,0.000023338787,0.0010956503,0.000012445508,0.0005049193,0.000006293288,0.000030376546,0.003870695],"genre_scores_gemma":[0.997356,0.0011527054,0.00070836575,0.000462666,0.000007096001,0.00009188422,0.000011556269,0.000008136398,0.00020160455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994249,0.000009596055,0.00014772503,0.00016254844,0.00012178235,0.00013347718],"domain_scores_gemma":[0.99950397,0.00000865355,0.00005527273,0.00021413915,0.000049989685,0.00016799137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000015523605,0.00007732425,0.000132734,0.000046642865,0.000042140437,0.00000783486,0.000056584086,0.000013102148,0.000027187541],"category_scores_gemma":[0.0000127865,0.00006258197,0.00002906629,0.00020896112,0.00013706488,0.00003841832,0.000046076508,0.000046602134,0.000035629804],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030331837,0.0013584418,0.9655477,0.00034846473,0.00016633363,0.000028552195,0.00066057296,0.000004100059,0.001029809,0.00075128186,0.0011076386,0.028966783],"study_design_scores_gemma":[0.0010374578,0.0000777504,0.99568313,0.00006031498,0.00010758121,0.000010588572,0.000525784,0.0000996455,0.00026419695,0.00001582969,0.0020407632,0.0000769355],"about_ca_topic_score_codex":0.00007879854,"about_ca_topic_score_gemma":0.0000067655933,"teacher_disagreement_score":0.030135462,"about_ca_system_score_codex":0.000005421351,"about_ca_system_score_gemma":0.000013507073,"threshold_uncertainty_score":0.25520185},"labels":[],"label_agreement":null},{"id":"W2000877431","doi":"10.1182/blood-2002-02-0614","title":"Response to histone deacetylase inhibition of novel PML/RARα mutants detected in retinoic acid–resistant APL cells","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Histone deacetylase; Acute promyelocytic leukemia; Cancer research; Biology; Histone; Retinoic acid; Tretinoin; Mutation; Missense mutation; Acetylation; Transcription factor; Molecular biology; Cell culture; Genetics; Gene","score_opus":0.010254781163563998,"score_gpt":0.22793516467443045,"score_spread":0.21768038351086647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000877431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99734867,0.0012406589,0.00044009442,0.000070372116,0.000062780055,0.00022960438,0.000051332772,0.00001764512,0.00053881935],"genre_scores_gemma":[0.99713135,0.00010147548,0.0018127231,0.00011161557,0.00005515968,0.00003082067,0.000025219326,0.00003075142,0.00070085796],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986062,0.00010708137,0.00038174284,0.00041467126,0.00019607344,0.0002942341],"domain_scores_gemma":[0.9992319,0.000024373549,0.00012551188,0.0004050791,0.00010684717,0.00010633382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002949879,0.00018914645,0.0002032211,0.00012082338,0.000044258893,0.0000126776085,0.00017471983,0.00021949521,0.000048318838],"category_scores_gemma":[0.0003566367,0.00019753147,0.000068421534,0.00032661483,0.00007715749,0.000004725748,0.000090240144,0.00011732824,0.000016635835],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007174644,0.000602113,0.0001044772,0.000055269786,0.000017295595,0.0000373387,0.00013215182,0.000015890648,0.99782056,0.0000049790783,0.00026134454,0.00023109253],"study_design_scores_gemma":[0.0027171979,0.00059190736,0.00060457474,0.00007162963,0.000027679303,0.00002527043,0.000053575728,0.000030246298,0.99400485,0.000007942946,0.0016312165,0.00023389263],"about_ca_topic_score_codex":0.000014548354,"about_ca_topic_score_gemma":0.000027823318,"teacher_disagreement_score":0.0038157161,"about_ca_system_score_codex":0.000032935244,"about_ca_system_score_gemma":0.00007093347,"threshold_uncertainty_score":0.8055099},"labels":[],"label_agreement":null},{"id":"W2001035186","doi":"10.1182/blood-2014-06-578997","title":"Writing guidelines without a net: ECD","year":2014,"lang":"en","type":"letter","venue":"Blood","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Erdheim–Chester disease; Medicine; Intensive care medicine; Internal medicine; Disease; Histiocytosis","score_opus":0.03932548981734094,"score_gpt":0.30784814417937284,"score_spread":0.2685226543620319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001035186","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009580928,0.0028555898,0.00015443296,0.8779259,0.00039965572,0.0007911327,0.000046303125,0.00028218678,0.10796393],"genre_scores_gemma":[0.0069279317,0.00008351887,0.004112339,0.9471361,0.007922344,0.00006782936,0.0008051713,0.00013081542,0.032813944],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985664,0.000025068044,0.00038115372,0.00037344662,0.00032663715,0.00032731297],"domain_scores_gemma":[0.99914104,0.000036819172,0.00013995155,0.00045537754,0.00015555693,0.000071230395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000087654254,0.0002887866,0.00054966356,0.00010286505,0.000065904365,0.000042395543,0.0001262687,0.00041254863,0.00023132273],"category_scores_gemma":[0.00012755093,0.00023149756,0.00016647518,0.00006986061,0.00004286463,0.000024832358,0.00003952605,0.0005214859,0.00048194238],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000620983,0.0001408535,0.0054631014,0.00022071143,0.00033831422,0.0010948434,0.000020851357,1.6465532e-7,0.0000068254058,0.000006879297,0.99058217,0.002119104],"study_design_scores_gemma":[0.0040909927,0.00016079942,0.0001699949,0.0005669169,0.0013888484,0.00038930433,0.0000074540762,0.000029424513,0.000023753832,0.000072356546,0.9928828,0.00021736076],"about_ca_topic_score_codex":0.00010592287,"about_ca_topic_score_gemma":0.0000054669063,"teacher_disagreement_score":0.07514998,"about_ca_system_score_codex":0.000026229673,"about_ca_system_score_gemma":0.00013289184,"threshold_uncertainty_score":0.9440196},"labels":[],"label_agreement":null},{"id":"W2001566685","doi":"10.1182/blood-2008-02-139212","title":"Constitutive activation of the Wnt canonical pathway in mantle cell lymphoma","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; University of Alberta","keywords":"Wnt signaling pathway; Mantle cell lymphoma; Carcinogenesis; Cancer research; Biology; Cell culture; Signal transduction; Transcription factor; Cell; Molecular biology; Cell biology; Chemistry; Lymphoma; Gene; Genetics; Immunology","score_opus":0.00953800330078286,"score_gpt":0.199307828670616,"score_spread":0.18976982536983314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001566685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99386036,0.00019174001,0.000028570395,0.000029102106,0.00006191722,0.000078850404,0.000003953416,0.0000024747103,0.005743029],"genre_scores_gemma":[0.99914694,0.000045138742,0.00011022886,0.00007134605,0.000041821997,0.000011492949,0.000010255967,0.0000049036853,0.000557873],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99957204,0.000023003495,0.00011225534,0.0001205348,0.00007902527,0.00009312587],"domain_scores_gemma":[0.9997858,0.000006680546,0.000049099934,0.00011176921,0.00003140793,0.000015267746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005019369,0.000058838137,0.000064910535,0.0000128130205,0.00003694959,0.0000017464324,0.0001073021,0.00006980122,0.000011228236],"category_scores_gemma":[0.000018805134,0.00004436123,0.000035814744,0.00006549645,0.00010016519,0.0000014984041,0.000050194805,0.000028991879,0.0000022331956],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029412631,0.00025411247,0.033012465,0.00000786231,0.00001843373,0.0000034081306,0.000121766236,0.000024540559,0.9659225,0.00008350087,0.00032862255,0.00019339159],"study_design_scores_gemma":[0.0011438682,0.000029633988,0.022606654,0.000013346181,0.0000038494595,0.000007796808,0.000023108587,0.0000011727216,0.97324497,0.000020394913,0.0028418892,0.00006329879],"about_ca_topic_score_codex":0.000038522438,"about_ca_topic_score_gemma":0.00001665563,"teacher_disagreement_score":0.01040581,"about_ca_system_score_codex":0.000009832265,"about_ca_system_score_gemma":0.00031170514,"threshold_uncertainty_score":0.18089984},"labels":[],"label_agreement":null},{"id":"W2001570896","doi":"10.1182/blood-2014-10-606491","title":"Hepcidin is suppressed by erythropoiesis in hemoglobin E β-thalassemia and β-thalassemia trait","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Medical Research Council; Haematology Society of Australia and New Zealand; Wellcome Trust; March of Dimes Foundation; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; National Health and Medical Research Council; Bill and Melinda Gates Foundation","keywords":"Hepcidin; Thalassemia; Ineffective erythropoiesis; Erythropoiesis; Internal medicine; Medicine; Beta thalassemia; Anemia; Hemoglobinopathy; Immunology; Endocrinology; Disease","score_opus":0.005153191201622607,"score_gpt":0.22631725091079458,"score_spread":0.22116405970917197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001570896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98615,0.0020996039,0.00005538151,0.0017527894,0.00008552521,0.0003001951,0.000039226754,0.00006950248,0.0094477255],"genre_scores_gemma":[0.9963062,0.00029028513,0.0006229263,0.0013369067,0.000098958524,0.000026989666,0.00004908769,0.000041197265,0.0012274476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984474,0.00007597163,0.0003200549,0.00044591643,0.00028074038,0.00042991983],"domain_scores_gemma":[0.999217,0.00009609396,0.00006653172,0.00037423958,0.00003486385,0.00021131212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024678875,0.00025106524,0.0004815063,0.00013078107,0.00005764239,0.000033198885,0.000114521776,0.00019864742,0.00036726834],"category_scores_gemma":[0.0001614593,0.00023103692,0.00007705672,0.00023122597,0.000115097144,0.00011289544,0.000051150695,0.00022170795,0.0000369373],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028321333,0.0030742623,0.52709347,0.00086916634,0.00011700368,0.00008516131,0.0025731074,0.0000012381423,0.29832134,0.0009288803,0.15627909,0.010374043],"study_design_scores_gemma":[0.040837865,0.00077657733,0.52958655,0.00029303494,0.0009808759,0.00024299239,0.001480233,0.00018483182,0.33953863,0.0010551257,0.083846234,0.0011770678],"about_ca_topic_score_codex":0.00022042265,"about_ca_topic_score_gemma":0.000035613364,"teacher_disagreement_score":0.07243286,"about_ca_system_score_codex":0.000015155894,"about_ca_system_score_gemma":0.00004813901,"threshold_uncertainty_score":0.9421412},"labels":[],"label_agreement":null},{"id":"W2001595227","doi":"10.1182/blood-2014-12-617035","title":"Idiopathic pneumonia syndrome after hematopoietic cell transplantation: evidence of occult infectious etiologies","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":179,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Etiology; Pneumonia; Occult; Medicine; Hematopoietic stem cell transplantation; Immunology; Transplantation; Pathogenic organism; Lung transplantation; Pathogen; Hematopoietic cell; Internal medicine; Haematopoiesis; Pathology; Biology; Stem cell; Microbiology","score_opus":0.02220669574616313,"score_gpt":0.264451542645841,"score_spread":0.24224484689967785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001595227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9708832,0.027856503,0.00002354744,0.0001135623,0.00009958492,0.00017448819,0.000009828218,0.00008216554,0.0007571258],"genre_scores_gemma":[0.99840385,0.0012475519,0.00005695558,0.00008364414,0.000029937351,0.000029507764,0.0000038483904,0.0000115267085,0.00013315529],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99917966,0.000046503723,0.0002410036,0.00016468327,0.00021093001,0.00015718846],"domain_scores_gemma":[0.9994331,0.000042896925,0.000073716365,0.00020358223,0.00008928673,0.000157406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012195412,0.00011625174,0.0002575923,0.00006671156,0.000021841845,0.0000074804307,0.000058917576,0.00011990929,0.000024867548],"category_scores_gemma":[0.00007812375,0.000087334614,0.00009319342,0.00013899557,0.000090384485,0.00007945712,0.000014908673,0.00012611074,0.000082670645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015264888,0.004325215,0.86958426,0.006872446,0.00043783936,0.008914797,0.0047547957,0.00010030122,0.1026889,0.000103514074,0.00018484173,0.00050660636],"study_design_scores_gemma":[0.009888059,0.004166545,0.8775988,0.005680243,0.0039440338,0.01064763,0.0004992245,0.000019480301,0.08616917,0.0007056195,0.00011591678,0.0005652822],"about_ca_topic_score_codex":0.000034422043,"about_ca_topic_score_gemma":0.000002387873,"teacher_disagreement_score":0.027520677,"about_ca_system_score_codex":0.000011896953,"about_ca_system_score_gemma":0.00015094611,"threshold_uncertainty_score":0.3561402},"labels":[],"label_agreement":null},{"id":"W2001630759","doi":"10.1182/blood-2008-03-145821","title":"Fibrinogen is required for maintenance of platelet intracellular and cell-surface P-selectin expression","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; Canadian Blood Services; University of Toronto","funders":"Canadian Institutes of Health Research; Canadian Blood Services; Heart and Stroke Foundation of Canada","keywords":"Platelet; P-selectin; Fibrinogen; Intracellular; Cell biology; Chemistry; Platelet activation; Biochemistry; Biology; Immunology","score_opus":0.01666787980258287,"score_gpt":0.27386446106719653,"score_spread":0.25719658126461364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001630759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955928,0.0014771121,0.00054379535,0.0006019904,0.000013964824,0.00061523326,0.000012172921,0.000026818485,0.0011161612],"genre_scores_gemma":[0.9842719,0.00024480346,0.012361765,0.00014814493,0.00004426738,0.0000060072807,0.000012090249,0.000019822448,0.00289124],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988833,0.000026155483,0.00024111668,0.00029266626,0.00025773724,0.000299012],"domain_scores_gemma":[0.99928993,0.00007667286,0.00008058528,0.00028649453,0.00012636633,0.00013994826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018168129,0.000121208475,0.00026593177,0.000054453652,0.000046154535,0.00001022306,0.00008640914,0.00010382955,0.00007286135],"category_scores_gemma":[0.000108041,0.00010352509,0.00006917603,0.00013945637,0.000043908058,0.000036486756,0.000039443126,0.00012231394,0.000008678904],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003189491,0.00031880604,0.0006258122,0.00016298039,0.000015169749,0.00004083583,0.00018157488,0.000002306098,0.99286973,0.000015150502,0.0036189756,0.0018296988],"study_design_scores_gemma":[0.0039383555,0.0009697532,0.0012742418,0.00012878508,0.000039903684,0.0000525723,0.00004845499,0.00024029697,0.98966473,0.0001489031,0.0033947383,0.000099286386],"about_ca_topic_score_codex":0.000006496432,"about_ca_topic_score_gemma":3.0257021e-7,"teacher_disagreement_score":0.011817969,"about_ca_system_score_codex":0.000013611843,"about_ca_system_score_gemma":0.00005576062,"threshold_uncertainty_score":0.42216307},"labels":[],"label_agreement":null},{"id":"W2001663034","doi":"10.1182/blood-2013-02-483727","title":"Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":396,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of British Columbia; Simon Fraser University; Jewish General Hospital; BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health; Canada's Michael Smith Genome Sciences Centre","keywords":"Biology; Diffuse large B-cell lymphoma; Exome sequencing; Exome; Genetics; Point mutation; Gene; Copy-number variation; Mutation; Computational biology; Genome; Cancer research","score_opus":0.014695954641379422,"score_gpt":0.24690667997788573,"score_spread":0.2322107253365063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001663034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988275,0.0006294442,0.000017594168,0.00004829882,0.000015026915,0.00016936778,0.000092199116,0.000012974505,0.00018757227],"genre_scores_gemma":[0.9981326,0.000011385178,0.001514086,0.00009266901,0.000031018397,0.000010952912,0.00014645449,0.000009136189,0.000051712435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99928284,0.000016376405,0.0001973629,0.0001751514,0.00016926958,0.00015897494],"domain_scores_gemma":[0.999546,0.000042671592,0.00008739245,0.00014793845,0.000078516525,0.000097503216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003746242,0.00010692155,0.0002899054,0.00016814709,0.000055970653,0.000019747902,0.000029114228,0.000042524058,0.0001082376],"category_scores_gemma":[0.000012605789,0.00008262396,0.00010411024,0.00025173245,0.000031495463,0.00007454545,0.000028368122,0.0000178926,0.000007161741],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001690127,0.0030499294,0.8646342,0.00009595074,0.0031412672,0.00011819434,0.0011302567,0.00006388021,0.12672623,0.00015210565,0.000007372604,0.0008636788],"study_design_scores_gemma":[0.014759961,0.000091804446,0.9649082,0.000019460062,0.004614896,0.000067665496,0.00025824178,0.006019977,0.009088308,0.000049234888,0.000021222402,0.00010107181],"about_ca_topic_score_codex":0.00040486857,"about_ca_topic_score_gemma":0.000014191544,"teacher_disagreement_score":0.11763791,"about_ca_system_score_codex":0.00007457554,"about_ca_system_score_gemma":0.00007072663,"threshold_uncertainty_score":0.33693072},"labels":[],"label_agreement":null},{"id":"W2001941307","doi":"10.1182/blood-2003-04-1242","title":"New targets for antiadhesion therapy of human multiple sclerosis","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Multiple sclerosis; Medicine; Surgery; Immunology","score_opus":0.036386120432135675,"score_gpt":0.25578768248789263,"score_spread":0.21940156205575695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001941307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964329,0.0016424779,0.0013558595,0.00000943895,0.000054603755,0.00013150746,0.000009903245,0.0000042091456,0.00035911144],"genre_scores_gemma":[0.9969592,0.00047850184,0.0020344146,0.00006219831,0.00007310662,0.00000871381,0.000035407033,0.000010904616,0.00033757024],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995609,0.00001569125,0.000111939364,0.00015543056,0.00004334404,0.000112697635],"domain_scores_gemma":[0.9996931,0.0000056854533,0.000045900848,0.00017034102,0.000050308878,0.000034644534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000057179335,0.00007377064,0.000086292275,0.00001759117,0.000038929913,0.0000057324087,0.00008733555,0.000072633906,0.000025016037],"category_scores_gemma":[0.000028854976,0.00006642898,0.00008629784,0.000025350515,0.000013930072,0.0000016784095,0.000012082347,0.000018203411,0.0000025204424],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027651213,0.00012978472,0.0055957995,0.000004667419,0.00004133841,1.3884e-7,0.000019802521,0.0000013306156,0.9909535,0.000037110698,0.0018848564,0.0013040234],"study_design_scores_gemma":[0.0016996531,0.000692743,0.0035843689,0.000010095557,0.0000091085385,0.000001001416,0.000017467055,0.0000011015793,0.98740363,0.0000865726,0.006411699,0.00008254083],"about_ca_topic_score_codex":0.000021077638,"about_ca_topic_score_gemma":0.000013277051,"teacher_disagreement_score":0.004526843,"about_ca_system_score_codex":9.444351e-7,"about_ca_system_score_gemma":0.000028904038,"threshold_uncertainty_score":0.27088952},"labels":[],"label_agreement":null},{"id":"W2001957066","doi":"10.1182/blood-2005-08-3329","title":"Recent insights into the role of Notch signaling in tumorigenesis","year":2005,"lang":"en","type":"review","venue":"Blood","topic":"Developmental Biology and Gene Regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":494,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Notch signaling pathway; Carcinogenesis; Hes3 signaling axis; Biology; Cell biology; Signal transduction; Angiogenesis; Cancer research; Notch proteins; Transmembrane protein; Cell fate determination; Receptor; Genetics; Cancer; Transcription factor","score_opus":0.012046333140420569,"score_gpt":0.26706086084855474,"score_spread":0.25501452770813415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001957066","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018788008,0.98049504,0.0000015763787,0.000009138623,0.00006498336,0.00025495188,0.000002916051,0.0000031381712,0.0003802554],"genre_scores_gemma":[0.0072910134,0.9918757,0.00018194725,0.000018189894,0.00018613653,0.00004996322,0.00029599702,0.000016714766,0.0000843434],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998998,0.00013433525,0.00038644188,0.00027493466,0.00007282869,0.0001334726],"domain_scores_gemma":[0.99949795,0.00001898576,0.000182211,0.00024396901,0.000033077216,0.000023809847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016220869,0.00019018717,0.0003975907,0.00006170554,0.000041923675,0.00000455775,0.00022774981,0.00031524248,0.000012321314],"category_scores_gemma":[0.000024102776,0.00012649549,0.00013492498,0.00016111309,0.00005101302,0.0000012814663,0.00009925003,0.00009574854,0.000010583453],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000046958075,0.000091739035,0.000073383344,0.00017845834,0.00009849737,9.115124e-7,0.00006897947,0.0000031377792,0.007572782,0.000012829919,0.0000081977605,0.9918864],"study_design_scores_gemma":[0.0001431361,0.000036921174,0.00004529974,0.00039146564,0.000120208424,0.000008427661,0.000020810721,3.587148e-7,0.04917955,0.00004595781,0.9498586,0.00014927266],"about_ca_topic_score_codex":0.000007570224,"about_ca_topic_score_gemma":0.00008270241,"teacher_disagreement_score":0.9917371,"about_ca_system_score_codex":0.000014316481,"about_ca_system_score_gemma":0.00017671338,"threshold_uncertainty_score":0.5158337},"labels":[],"label_agreement":null},{"id":"W2002059638","doi":"10.1182/blood-2012-03-417816","title":"Cerebrospinal fluid plasmacytosis","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; Plasmacytosis; Meningitis; Neutrophilia; Cerebrospinal fluid; Leukocytosis; Pathology; Immunology; Multiple myeloma","score_opus":0.011102383556396884,"score_gpt":0.25050803483212286,"score_spread":0.23940565127572597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002059638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942496,0.0022752197,0.000048055528,0.00018011194,0.00018953269,0.00013350783,0.000025788093,0.000031353247,0.002866842],"genre_scores_gemma":[0.99678195,0.0003209151,0.0011072409,0.0004290782,0.0005429262,0.000078737925,0.00007477766,0.000032130913,0.00063226325],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99905217,0.000033376185,0.0001502168,0.00024334897,0.00011787618,0.0004030049],"domain_scores_gemma":[0.99938077,0.0000128695665,0.000055579087,0.00036363088,0.000027372835,0.00015975634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007621569,0.00018126196,0.00014178971,0.000029661333,0.00008051043,0.000017421831,0.00015939926,0.00012939531,0.000111284484],"category_scores_gemma":[0.00005728618,0.000165194,0.00012645771,0.00006175429,0.000044976277,0.0000059079925,0.000113653456,0.000051629413,0.00022820341],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023345307,0.00092259416,0.7639547,0.000011548491,0.00024393453,0.000002380664,0.000043051685,0.0000012581123,0.22954969,0.00013972008,0.004504157,0.0006036123],"study_design_scores_gemma":[0.0014573691,0.00021933856,0.1298414,0.0000070949213,0.00015328515,0.00003473258,0.000037815666,6.018975e-7,0.83219165,0.000007436026,0.035824105,0.0002251876],"about_ca_topic_score_codex":0.000016352957,"about_ca_topic_score_gemma":0.0000070800243,"teacher_disagreement_score":0.6341133,"about_ca_system_score_codex":0.000011216035,"about_ca_system_score_gemma":0.000026719186,"threshold_uncertainty_score":0.67364156},"labels":[],"label_agreement":null},{"id":"W2002129385","doi":"10.1182/blood-2010-01-262675","title":"The antiparasitic agent ivermectin induces chloride-dependent membrane hyperpolarization and cell death in leukemia cells","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Parasites and Host Interactions","field":"Immunology and Microbiology","cited_by":145,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"Canadian Institutes of Health Research","keywords":"Antiparasitic; Antiparasitic agent; Ivermectin; Leukemia; Hyperpolarization (physics); Programmed cell death; Niclosamide; Chloride; Pharmacology; Membrane potential; Chemistry; Apoptosis; Biology; Medicine; Immunology; Biochemistry; Stereochemistry; Pathology","score_opus":0.00897557818338639,"score_gpt":0.23957389654864145,"score_spread":0.23059831836525505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002129385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958533,0.00059923006,0.000008434697,0.00006282631,0.00096715643,0.0001557728,0.00001318895,0.000024951309,0.002315151],"genre_scores_gemma":[0.9974552,0.00040440858,0.000020777943,0.000048362916,0.000039388808,0.0000134868205,0.000018103687,0.0000097525235,0.001990513],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993189,0.00005791056,0.00017418893,0.00019469073,0.000026159394,0.00022813445],"domain_scores_gemma":[0.9995399,0.00017175898,0.00006952493,0.00017222187,0.000026613652,0.00001994579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015044297,0.00011051417,0.00011998178,0.00006396146,0.00027515073,0.000041803683,0.00012458459,0.00015758642,0.00009695686],"category_scores_gemma":[0.000031328622,0.00008371113,0.00003106283,0.00006708324,0.000063858424,0.00007722369,0.000042235977,0.0004532176,0.00020843695],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028588098,0.00014865416,0.021791784,0.000004373248,0.000034443612,0.0000071437066,0.00022807949,0.0000027580923,0.9771624,0.00033752518,0.00003859747,0.0002156193],"study_design_scores_gemma":[0.001092963,0.000048027283,0.0801046,0.00000742931,0.00005302197,0.00009663313,0.000115440365,0.0000061733667,0.91365916,0.000049693637,0.004663322,0.00010356197],"about_ca_topic_score_codex":0.000434921,"about_ca_topic_score_gemma":0.00035903594,"teacher_disagreement_score":0.063503295,"about_ca_system_score_codex":0.000016109336,"about_ca_system_score_gemma":0.000048931557,"threshold_uncertainty_score":0.3413641},"labels":[],"label_agreement":null},{"id":"W2002302430","doi":"10.1182/blood-2005-09-3900","title":"X-inactivation–based clonality analysis and quantitative JAK2V617F assessment reveal a strong association between clonality and JAK2V617F in PV but not ET/MMM, and identifies a subset of JAK2V617F-negative ET and MMM patients with clonal hematopoiesis","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":237,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"Myelofibrosis; Essential thrombocythemia; Polycythemia vera; Biology; Allele; Granulopoiesis; Myeloid; Immunology; Genetics; Haematopoiesis; Bone marrow; Gene; Stem cell","score_opus":0.0156500770186828,"score_gpt":0.3003505325570687,"score_spread":0.28470045553838585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002302430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960992,0.0001597253,0.00030842677,0.0011613861,0.000011347394,0.00092908647,0.0011594227,0.00001887814,0.00015253457],"genre_scores_gemma":[0.9933741,0.00006842869,0.005540116,0.00013483089,0.000023165789,0.00013484534,0.0006634073,0.000021613034,0.00003950824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969814,0.00052150723,0.0007206242,0.0006965727,0.00077727466,0.00030265085],"domain_scores_gemma":[0.99651855,0.0019957009,0.000658835,0.00020375081,0.00047548112,0.0001476542],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009808795,0.00037943092,0.0010778154,0.0003461407,0.00016201478,0.000101842525,0.000044305838,0.0001608087,0.000014879866],"category_scores_gemma":[0.00031418251,0.00031478706,0.000090665795,0.0005302789,0.00022714319,0.00033337006,0.00007346323,0.0002807291,2.933663e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003790438,0.0014940072,0.9932839,0.00024756548,0.0019845273,0.000012005718,0.0005916219,0.000010604672,0.00036101043,0.0015227265,0.000022363556,0.00009056723],"study_design_scores_gemma":[0.009201522,0.0007696631,0.9763524,0.00022560077,0.0026845776,0.0000028460952,0.0003665791,0.00012382003,0.009513843,0.0004877593,0.0000048795127,0.00026650738],"about_ca_topic_score_codex":0.0029668966,"about_ca_topic_score_gemma":0.0033709535,"teacher_disagreement_score":0.016931554,"about_ca_system_score_codex":0.00018249916,"about_ca_system_score_gemma":0.00018370885,"threshold_uncertainty_score":0.99993044},"labels":[],"label_agreement":null},{"id":"W2002394482","doi":"10.1182/blood-2010-12-324186","title":"Activation of hypoxia-inducible factor-1α (Hif-1α) delays inflammation resolution by reducing neutrophil apoptosis and reverse migration in a zebrafish inflammation model","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":245,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Cancer Research UK; Wellcome Trust","keywords":"Zebrafish; Inflammation; Cell biology; Biology; Transcription factor; Hypoxia-inducible factors; Danio; In vivo; Genetic screen; Immunology; Phenotype; Genetics; Gene","score_opus":0.01703485793360652,"score_gpt":0.21574395035916374,"score_spread":0.19870909242555723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002394482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964385,0.00032974852,0.0023892543,0.00007489666,0.00011188879,0.00032101807,0.000025348243,0.000015518839,0.0002938386],"genre_scores_gemma":[0.99696267,0.0006550754,0.0016975129,0.000023118128,0.0003133502,0.00004740269,0.0002191723,0.000020946776,0.000060728424],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988586,0.000069613794,0.00038838855,0.00034503874,0.00014916387,0.00018920077],"domain_scores_gemma":[0.9992794,0.000007713753,0.0002651923,0.00026879637,0.00012246156,0.000056456563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019810731,0.00016135973,0.00017754814,0.00014055018,0.000067276,0.000017068534,0.00008281497,0.00024106892,0.000005550655],"category_scores_gemma":[0.00010373395,0.00017957155,0.000053600772,0.00017440222,0.000040440093,0.00006500882,0.00004496729,0.00010109991,9.255963e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000112419904,0.00008425849,0.00040945903,0.00004191388,0.000026614714,6.374217e-8,0.0008074553,0.00045733352,0.99504465,0.00008190136,0.0002984872,0.002635473],"study_design_scores_gemma":[0.001343972,0.00011322366,0.0053530484,0.000045623987,0.000052122752,0.0000024284784,0.00009963203,0.0021803246,0.98974645,0.0001728521,0.0007060234,0.0001842942],"about_ca_topic_score_codex":0.0005658042,"about_ca_topic_score_gemma":0.00012193409,"teacher_disagreement_score":0.005298166,"about_ca_system_score_codex":0.000023807355,"about_ca_system_score_gemma":0.0000759271,"threshold_uncertainty_score":0.7322715},"labels":[],"label_agreement":null},{"id":"W2002451568","doi":"10.1182/blood-2008-12-196584","title":"Phosphorylation of endothelial nitric oxide synthase by atypical PKCζ contributes to angiopoietin-1–dependent inhibition of VEGF-induced endothelial permeability in vitro","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Enos; Phosphorylation; Vascular permeability; Protein kinase C; Vascular endothelial growth factor; Angiopoietin; Nitric Oxide Synthase Type III; Cell biology; Vascular endothelial growth factor A; Internal medicine; Chemistry; Endothelium; Endocrinology; Nitric oxide; Nitric oxide synthase; Biology; Cancer research; Medicine; VEGF receptors","score_opus":0.007973911050723955,"score_gpt":0.23959770215639914,"score_spread":0.2316237911056752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002451568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99780256,0.0007666573,0.0004555443,0.000093078255,0.000041884854,0.00033104728,0.0003992421,0.000007172833,0.00010279003],"genre_scores_gemma":[0.99930805,0.000053797605,0.00024526718,0.0001261365,0.00009238199,0.000025890346,0.00010795304,0.00001246749,0.00002804183],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99876773,0.00007751376,0.0004206177,0.0003319,0.00017888342,0.00022333684],"domain_scores_gemma":[0.9993899,0.000027005486,0.00013761476,0.00025653228,0.00012166748,0.00006730785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025911417,0.00015356053,0.00027136106,0.00007397567,0.000027452526,0.0000069046328,0.000110300694,0.00018571164,0.000014532693],"category_scores_gemma":[0.00017150717,0.00015258722,0.0001552599,0.0001532574,0.000042233696,0.000004991646,0.000040743053,0.00006363862,0.0000025306563],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011338589,0.000799875,0.004931176,0.00001551762,0.000031955817,0.0000019551471,0.00002311856,0.000010562676,0.9913454,0.000029699528,0.000100761594,0.0015761286],"study_design_scores_gemma":[0.0023112835,0.00033179997,0.022265416,0.000024538107,0.000045557084,0.0000029385747,0.000032256565,0.000007329914,0.97454077,0.0000785067,0.00022070442,0.00013890203],"about_ca_topic_score_codex":0.00008650945,"about_ca_topic_score_gemma":0.000013291027,"teacher_disagreement_score":0.01733424,"about_ca_system_score_codex":0.000029066545,"about_ca_system_score_gemma":0.00007563696,"threshold_uncertainty_score":0.6222327},"labels":[],"label_agreement":null},{"id":"W2002605588","doi":"10.1182/blood-2008-12-193458","title":"Influence of cytogenetics in patients with relapsed or refractory multiple myeloma treated with lenalidomide plus dexamethasone: adverse effect of deletion 17p13","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":184,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; BC Cancer Agency; University of Calgary; Vancouver General Hospital","funders":"","keywords":"Lenalidomide; Internal medicine; Hazard ratio; Multiple myeloma; Dexamethasone; Medicine; Gastroenterology; Regimen; Refractory (planetary science); Adverse effect; Oncology; Surgery; Biology; Confidence interval","score_opus":0.009374690451090184,"score_gpt":0.2552826968188061,"score_spread":0.24590800636771593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002605588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984412,0.00006749751,0.000010629512,0.000009110372,0.0000036208696,0.001343298,0.000029039124,0.000025410578,0.00007015786],"genre_scores_gemma":[0.998172,0.000033894183,0.001579591,0.000015428926,0.000009056378,0.000035511057,0.00008688483,0.000024665687,0.000043010125],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982748,0.00016682429,0.0003687055,0.00029864826,0.0005685604,0.00032244943],"domain_scores_gemma":[0.9986684,0.00029050338,0.00021843729,0.0004023836,0.00025156548,0.00016875289],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016921165,0.00023927147,0.00057650165,0.00024411343,0.000028057775,0.0000031866882,0.000092467395,0.00011165847,0.000013534133],"category_scores_gemma":[0.00046166359,0.00014148011,0.000055523018,0.0004776828,0.0001140812,0.000092182294,0.00001760098,0.00017347319,0.0000042430293],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037826207,0.0018365147,0.9430672,0.0001591103,0.00023675889,0.00020847715,0.00010559608,0.0005199952,0.0125819305,5.474317e-7,0.0000022338888,0.0034554054],"study_design_scores_gemma":[0.06633096,0.017250033,0.76114297,0.0005009499,0.0002518806,0.0000115442745,0.000012117414,0.000071405186,0.1543165,5.229891e-7,0.0000045788515,0.00010656673],"about_ca_topic_score_codex":0.0002679216,"about_ca_topic_score_gemma":0.0001261394,"teacher_disagreement_score":0.18192428,"about_ca_system_score_codex":0.00010030661,"about_ca_system_score_gemma":0.00017161423,"threshold_uncertainty_score":0.57693917},"labels":[],"label_agreement":null},{"id":"W2002902588","doi":"10.1182/blood-2010-09-310680","title":"IL-7R–dependent survival and differentiation of early T-lineage progenitors is regulated by the BTB/POZ domain transcription factor Miz-1","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Biology; STAT5; Transcription factor; Cell biology; CD8; Phosphorylation; Progenitor cell; Zinc finger; Molecular biology; Stem cell; Genetics; Gene; Immune system","score_opus":0.03159812216785902,"score_gpt":0.24182761967539004,"score_spread":0.21022949750753103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002902588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983038,0.00014843997,0.0003188653,0.00012786541,0.00021234622,0.0003552423,0.00015732816,0.000038492166,0.00033766718],"genre_scores_gemma":[0.9993301,0.00002442816,0.00012004527,0.000024598834,0.00009453526,0.000015162308,0.000046162633,0.000018407109,0.00032655126],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991351,0.000056651577,0.00027452095,0.00017971052,0.00022258186,0.00013148725],"domain_scores_gemma":[0.99950755,0.00002556938,0.00011425964,0.00019355844,0.00009392809,0.000065166896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000098945835,0.00012353159,0.00019169415,0.000056191457,0.00007040107,0.000015468406,0.000057896897,0.000081681836,0.00025747728],"category_scores_gemma":[0.000016508897,0.000084022024,0.00009646696,0.00008647155,0.00004948299,0.00007284688,0.000011452085,0.00014278504,0.000005219736],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017075273,0.0007371467,0.020995319,0.0000382638,0.00021072662,0.0000025505042,0.003127449,4.3945406e-8,0.9740501,0.00008176262,0.00014012946,0.00044573337],"study_design_scores_gemma":[0.0021382223,0.0005212616,0.15916626,0.000056729474,0.00029868179,0.00002238864,0.00029324336,0.000021612454,0.83700794,0.000048983038,0.00033391005,0.00009077398],"about_ca_topic_score_codex":0.00034139893,"about_ca_topic_score_gemma":0.000022859535,"teacher_disagreement_score":0.13817094,"about_ca_system_score_codex":0.000012095019,"about_ca_system_score_gemma":0.00002151251,"threshold_uncertainty_score":0.34263188},"labels":[],"label_agreement":null},{"id":"W2002920557","doi":"10.1182/blood-2013-07-514372","title":"Diverse T-cell responses characterize the different manifestations of cutaneous graft-versus-host disease","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Graft-versus-host disease; Immunology; Disease; Medicine; Graft vs Host Reaction; Biology; Bone marrow transplantation; Pathology; Bone marrow","score_opus":0.022805413231302345,"score_gpt":0.2479453161804799,"score_spread":0.22513990294917757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002920557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972431,0.000058634498,0.000035101668,0.0007208383,0.00013379761,0.0006767065,0.00010493155,0.000043619166,0.0009832941],"genre_scores_gemma":[0.99832106,0.00010204218,0.00012715498,0.00008643571,0.000050639253,0.000064351545,0.000075821634,0.000018315075,0.0011541973],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990865,0.00007305918,0.00023883318,0.0001620078,0.00027153123,0.0001680773],"domain_scores_gemma":[0.99889946,0.00040406222,0.00009060763,0.00033911373,0.00010759882,0.00015918307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000046209385,0.00012794002,0.00016684586,0.000057124435,0.000073836745,0.000016105241,0.0000969911,0.000038103266,0.00056237925],"category_scores_gemma":[0.000080093785,0.00008436302,0.00007974037,0.00009565947,0.00008218679,0.000051067564,0.000019772786,0.00008938006,0.00017615146],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035176927,0.004902956,0.23232757,0.0017702314,0.00046571856,0.0017024452,0.005522739,0.0000027502704,0.7478341,0.0005986284,0.00067497324,0.0006802119],"study_design_scores_gemma":[0.0055738213,0.00035787627,0.9508304,0.00017766998,0.0013287722,0.0002284988,0.0011490752,0.000057686135,0.03993993,0.000041680025,0.00014524657,0.00016936555],"about_ca_topic_score_codex":0.000056595258,"about_ca_topic_score_gemma":0.000008281597,"teacher_disagreement_score":0.7185028,"about_ca_system_score_codex":0.000012371974,"about_ca_system_score_gemma":0.000063196654,"threshold_uncertainty_score":0.6157658},"labels":[],"label_agreement":null},{"id":"W2002929600","doi":"10.1182/blood-2002-01-0235","title":"Donor-lymphocyte infusion induces transplantation tolerance by activating systemic and graft-infiltrating double-negative regulatory T cells","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Transplantation; CD8; Immunology; Immune tolerance; Cytotoxic T cell; T cell; Mixed lymphocyte reaction; Medicine; Immune system; Biology; In vitro; Internal medicine","score_opus":0.011095520125311238,"score_gpt":0.19766288010080543,"score_spread":0.1865673599754942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002929600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876843,0.0100590605,0.000030683033,0.00005175374,0.00037999125,0.00031626679,0.000030373601,0.0001233996,0.0013241518],"genre_scores_gemma":[0.99704343,0.0014189972,0.00011213075,0.00007967861,0.000042385665,0.00003813759,0.000051229108,0.000023459366,0.0011905251],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99851805,0.00019411607,0.00041567636,0.00042843327,0.00004948637,0.00039423097],"domain_scores_gemma":[0.99922717,0.00020957616,0.00026769156,0.00021696606,0.00005052062,0.000028086788],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015436333,0.00026841837,0.0003415382,0.00009184677,0.00040812604,0.00003267693,0.00016481588,0.00038386404,0.00014988094],"category_scores_gemma":[0.000012198311,0.00024807188,0.000056310397,0.00014723558,0.00020326696,0.00022583413,0.000039864874,0.00034098318,0.000106164094],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000106185624,0.00017645703,0.00056866737,0.000091644026,0.00012003379,0.000007945313,0.0029685071,0.0000055004243,0.99169004,0.000048524565,0.00020834806,0.0040081637],"study_design_scores_gemma":[0.007152779,0.00017110784,0.00033761768,0.00019307072,0.00008591539,0.00037968234,0.00059670774,0.000011904864,0.9900699,0.000015960552,0.00069465267,0.0002906887],"about_ca_topic_score_codex":0.0002117783,"about_ca_topic_score_gemma":0.00001477862,"teacher_disagreement_score":0.009359137,"about_ca_system_score_codex":0.000031939046,"about_ca_system_score_gemma":0.000022643193,"threshold_uncertainty_score":0.99999714},"labels":[],"label_agreement":null},{"id":"W2003135973","doi":"10.1182/blood-2005-07-2903","title":"A novel form of immune signaling revealed by transmission of the inflammatory mediator serotonin between dendritic cells and T cells","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Receptor Mechanisms and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":221,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"National Institute of Allergy and Infectious Diseases; Amgen","keywords":"Cell biology; Immune system; T cell; Dendritic cell; Biology; Antigen-presenting cell; Inflammation; Exocytosis; Chemistry; Immunology; Biochemistry","score_opus":0.004993972683529228,"score_gpt":0.19680095964639097,"score_spread":0.19180698696286175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003135973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99608123,0.0016514063,0.0018926907,0.000027267084,0.00003413657,0.00023026638,0.00004832663,0.000003741054,0.000030955285],"genre_scores_gemma":[0.99641657,0.00016877413,0.0031713108,0.000019107836,0.00009188326,0.000008211203,0.000012857602,0.000018165065,0.000093143404],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99913967,0.000032967793,0.0003595832,0.00017241371,0.00014129688,0.00015404932],"domain_scores_gemma":[0.99952465,0.000022959408,0.000160754,0.00018503351,0.000046634905,0.0000599497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000237057,0.00011920029,0.00019644563,0.000020223444,0.0000474178,0.0000059719187,0.00016532464,0.00014564172,0.000024370687],"category_scores_gemma":[0.000010307519,0.00009161309,0.000105690175,0.000046874156,0.00005038934,0.0000043709915,0.000052780193,0.000075989396,4.6942526e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011632702,0.00007908364,0.0005907005,0.00009281544,0.000047361278,1.3659381e-7,0.00016576926,0.000012384511,0.9983203,0.0000065621944,0.000022145077,0.0006511456],"study_design_scores_gemma":[0.0011340778,0.000105978645,0.00016459913,0.000091003814,0.000076431854,0.0000021742965,0.000048828646,0.000024820303,0.99711055,0.000017878836,0.0011181511,0.000105495215],"about_ca_topic_score_codex":0.0000073317674,"about_ca_topic_score_gemma":0.0000015467297,"teacher_disagreement_score":0.0014826322,"about_ca_system_score_codex":0.000003429068,"about_ca_system_score_gemma":0.000042377833,"threshold_uncertainty_score":0.37358734},"labels":[],"label_agreement":null},{"id":"W2003264403","doi":"10.1182/blood-2014-08-595496","title":"Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":168,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Duke Clinical Research Institute","keywords":"Apixaban; Medicine; Warfarin; Odds ratio; Anticoagulant; Stroke (engine); Confidence interval; Anesthesia; Surgery; Internal medicine; Atrial fibrillation; Rivaroxaban","score_opus":0.028326876459214494,"score_gpt":0.3066733786045849,"score_spread":0.2783465021453704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003264403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946699,0.000012626041,0.00003022407,0.0004595242,0.00003282683,0.0005464264,4.7803456e-7,0.000059121627,0.004188842],"genre_scores_gemma":[0.9966853,0.0000399515,0.00089618575,0.00020998024,0.0000713254,0.000003127382,0.000014336998,0.00001588183,0.0020638842],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99910057,0.00003815208,0.0002857949,0.00023653674,0.00018127843,0.00015767067],"domain_scores_gemma":[0.99956715,0.00011149387,0.00007236309,0.00015865029,0.000021860718,0.00006847545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016232868,0.00012432148,0.00030277553,0.000120014425,0.000035549503,0.000020160427,0.000038857615,0.000047025045,0.000011855669],"category_scores_gemma":[0.00011931754,0.00008553578,0.000050867115,0.000119738776,0.00003222647,0.00005663964,0.000053565313,0.0000637988,0.000011865297],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022111833,0.00012738851,0.9970498,0.000107846645,0.00021228864,0.000008457263,0.000022479206,0.0000015874905,4.4839587e-7,0.0004681773,0.00003669409,0.0017436771],"study_design_scores_gemma":[0.01369461,0.0006373479,0.98447907,0.00008811578,0.00033272852,9.363714e-7,0.00002874334,0.000026244208,0.00001184494,0.00004781719,0.0005469265,0.00010563587],"about_ca_topic_score_codex":0.00001366472,"about_ca_topic_score_gemma":0.000075858006,"teacher_disagreement_score":0.013473492,"about_ca_system_score_codex":0.0000113443875,"about_ca_system_score_gemma":0.000010117632,"threshold_uncertainty_score":0.34880477},"labels":[],"label_agreement":null},{"id":"W2003589118","doi":"10.1182/blood-2004-10-4065","title":"Human embryonic stem cells maintained in the absence of mouse embryonic fibroblasts or conditioned media are capable of hematopoietic development","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":170,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Haematopoiesis; Embryonic stem cell; Cell biology; Biology; Embryoid body; Basic fibroblast growth factor; Stem cell; Hemangioblast; Germ layer; Immunology; Molecular biology; Adult stem cell; Growth factor; Genetics; Induced pluripotent stem cell","score_opus":0.015561452507538619,"score_gpt":0.25003053606810804,"score_spread":0.23446908356056942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003589118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998893,0.00038725784,0.00003483122,0.0000981978,0.000015804033,0.00034447006,0.000030583928,0.0000062520994,0.00018959433],"genre_scores_gemma":[0.9977198,0.000051042876,0.00042145528,0.000039886254,0.000034877783,0.00004364381,0.00004320602,0.00001926962,0.0016267942],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99851227,0.00012962363,0.00038287908,0.00028928326,0.00034868644,0.00033727018],"domain_scores_gemma":[0.9991403,0.000047266112,0.00019798221,0.0004541431,0.000098247496,0.00006203806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003994993,0.00015867864,0.00024205199,0.000085831634,0.00006200477,0.000011614476,0.0004651026,0.00012345707,0.000059134843],"category_scores_gemma":[0.000025199812,0.00011868734,0.00006594705,0.00017658935,0.0001229105,0.000005882443,0.0001362852,0.000115446295,0.000020507514],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037042137,0.0004979414,0.0009300752,0.00022218029,0.00005313757,0.000013646679,0.0003623415,0.00019604382,0.9971434,0.000045355282,0.00045773105,0.00004113981],"study_design_scores_gemma":[0.0015588378,0.00014140515,0.0034467648,0.00009347349,0.000011918604,0.000020250647,0.0007346857,0.000014294998,0.99340487,0.0000097549355,0.00042415594,0.0001396067],"about_ca_topic_score_codex":0.0000109229,"about_ca_topic_score_gemma":0.00041042815,"teacher_disagreement_score":0.0037385141,"about_ca_system_score_codex":0.000024057801,"about_ca_system_score_gemma":0.00021209802,"threshold_uncertainty_score":0.48399293},"labels":[],"label_agreement":null},{"id":"W2003714769","doi":"10.1182/blood-2004-05-2042","title":"Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":561,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Angiogenesis; Tissue factor; Cancer research; Biology; Cancer; Tumor progression; Metastasis; Colorectal cancer; Cancer cell; HIF1A; Oncogene; Immunology; Medicine; Internal medicine; Cell cycle; Coagulation; Genetics","score_opus":0.022990752661632637,"score_gpt":0.34854092732536934,"score_spread":0.3255501746637367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003714769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960737,0.0015393362,0.00007915831,0.0006684427,0.000032496835,0.0014695323,0.000063580985,0.000033710567,0.000040013714],"genre_scores_gemma":[0.99510103,0.00021256696,0.0037510053,0.00003715018,0.00006338496,0.0006076631,0.000028403654,0.000033614706,0.00016519862],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99895376,0.000027495184,0.00020707883,0.00033773444,0.0001865213,0.00028741523],"domain_scores_gemma":[0.9994541,0.000045527137,0.00006134553,0.00017959197,0.000080703045,0.00017876693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007949962,0.00012677927,0.00020068586,0.00013904674,0.00007886078,0.000010601541,0.000082164406,0.000081421065,0.000063474254],"category_scores_gemma":[0.000049307997,0.00010487174,0.000058597336,0.0002118476,0.000037023754,0.00004320644,0.00007586067,0.000084220344,0.000010474119],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016726874,0.0005407126,0.021612363,0.00009762188,0.000018133996,0.000014703898,0.00009540818,0.000004183637,0.96893513,0.000004628959,0.0000533157,0.008456554],"study_design_scores_gemma":[0.0036363646,0.0002849826,0.23306571,0.00016003825,0.00003959859,0.00002521304,0.000014923895,0.000006689675,0.7622337,0.000082584156,0.00036411887,0.00008608171],"about_ca_topic_score_codex":0.000041209147,"about_ca_topic_score_gemma":0.00003431383,"teacher_disagreement_score":0.21145335,"about_ca_system_score_codex":0.00009362461,"about_ca_system_score_gemma":0.00018111774,"threshold_uncertainty_score":0.42765453},"labels":[],"label_agreement":null},{"id":"W2003773799","doi":"10.1182/blood-2010-01-263806","title":"Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Biology; CDKN2A; Mantle cell lymphoma; Gene expression profiling; Loss of heterozygosity; Gene dosage; Comparative genomic hybridization; Copy number analysis; Cancer research; Copy-number variation; Gene; Genetics; Locus (genetics); Gene expression; Lymphoma; Genome","score_opus":0.005399649423686771,"score_gpt":0.2228407628115854,"score_spread":0.21744111338789865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003773799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988746,0.00036475508,0.000046250632,0.000032507385,0.000047189023,0.00019526595,0.000115196926,0.000014944514,0.00030926036],"genre_scores_gemma":[0.99700946,0.00011235923,0.002296487,0.000022074264,0.000019838306,0.00003599157,0.00035642873,0.000010716896,0.00013666389],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99922216,0.000026532318,0.00022609445,0.00023731164,0.00014611786,0.00014179063],"domain_scores_gemma":[0.99955386,0.00004532256,0.00008791943,0.00021082383,0.00003742604,0.000064654734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000082517865,0.00011924857,0.00032326076,0.00011620687,0.000026295149,0.0000148458685,0.00003514618,0.00009917117,0.00004355691],"category_scores_gemma":[0.000019532152,0.00008570246,0.00006893266,0.00031078604,0.000036347952,0.00007764065,0.000030343996,0.00005174061,0.0000043304035],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059420425,0.0022439293,0.5165747,0.000021247954,0.00014731154,0.000026532787,0.000055099754,0.0000020794741,0.48018053,0.000034646004,0.000059041824,0.0005954732],"study_design_scores_gemma":[0.005549141,0.00007223351,0.18699895,0.000042511547,0.00069740345,0.0000075775056,0.00004768041,0.00015593531,0.8062938,0.000011350552,0.00005347673,0.0000699817],"about_ca_topic_score_codex":0.00078915904,"about_ca_topic_score_gemma":0.00010582283,"teacher_disagreement_score":0.32957572,"about_ca_system_score_codex":0.000030554333,"about_ca_system_score_gemma":0.000058492613,"threshold_uncertainty_score":0.3494845},"labels":[],"label_agreement":null},{"id":"W2003800151","doi":"10.1182/blood-2011-08-374777","title":"A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Providence Health Care; University of Toronto; Western University; Dalhousie University; University of Waterloo; Canadian Blood Services; Sunnybrook Health Science Centre; Grand River Hospital; Queen's University; McMaster University; University Health Network; Ottawa Hospital; Health Sciences Centre","funders":"National Cancer Institute; Canadian Institutes of Health Research; Amgen; McMaster University; Sanofi; GlaxoSmithKline","keywords":"Medicine; Rituximab; Placebo; Internal medicine; Randomized controlled trial; Blinding; Clinical endpoint; Surgery; Gastroenterology; Lymphoma; Pathology","score_opus":0.01787087140716527,"score_gpt":0.2675590350979816,"score_spread":0.24968816369081637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003800151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99143034,0.000469391,0.00010269843,0.000044774675,0.00018516222,0.006955026,0.000086666405,0.00003661966,0.0006893026],"genre_scores_gemma":[0.9949976,0.000050740797,0.0035774074,0.000042481806,0.00007272744,0.0007311151,0.00018559,0.000038671093,0.0003036247],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998642,0.00008702802,0.00046351337,0.00018934057,0.0002595452,0.00035855416],"domain_scores_gemma":[0.99870384,0.0005266462,0.00024644073,0.00028174624,0.00011787995,0.00012342427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038362734,0.00022410078,0.0018193038,0.0000772872,0.000059215858,0.0000078907415,0.000072842835,0.000053906497,0.00014649275],"category_scores_gemma":[0.00038158894,0.00012380812,0.00023201974,0.000107156484,0.00008378542,0.00010295091,0.000025285526,0.000074044314,0.000016812399],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97531205,0.020054491,0.0022313553,0.000087554974,0.0013643893,0.000010581043,0.00014564351,8.844757e-8,0.00033808974,0.000031592608,0.000057850822,0.0003662848],"study_design_scores_gemma":[0.98479193,0.005426849,0.0019606992,0.000131126,0.0028800434,0.000018277537,0.000019946421,0.000008154582,0.0044949083,0.000024813029,0.000091881026,0.00015136042],"about_ca_topic_score_codex":0.00006801465,"about_ca_topic_score_gemma":0.000012277651,"teacher_disagreement_score":0.014627643,"about_ca_system_score_codex":0.000018401397,"about_ca_system_score_gemma":0.00011765928,"threshold_uncertainty_score":0.5048749},"labels":[],"label_agreement":null},{"id":"W2003893081","doi":"10.1182/blood-2007-12-129080","title":"Macrophage-specific metalloelastase (MMP-12) truncates and inactivates ELR+ CXC chemokines and generates CCL2, -7, -8, and -13 antagonists: potential role of the macrophage in terminating polymorphonuclear leukocyte influx","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":255,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; Natural Sciences and Engineering Research Council of Canada; Michael Smith Health Research BC; Canadian Institutes of Health Research; Canadian Breast Cancer Research Alliance","keywords":"Chemokine; Macrophage inflammatory protein; CXCL2; Chemistry; CXCL1; Inflammation; CXCL14; CXC chemokine receptors; Macrophage; Matrix metalloproteinase; Interleukin 8; Immunology; Monocyte; Molecular biology; Chemotaxis; Lipopolysaccharide; Biology; Receptor; CXCL10; Biochemistry; Chemokine receptor; In vitro","score_opus":0.003902297176910423,"score_gpt":0.17106231808516512,"score_spread":0.1671600209082547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003893081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98730737,0.012243301,0.000004743512,0.000038758204,0.000049333517,0.00021941743,0.00004717822,0.000008179493,0.0000817451],"genre_scores_gemma":[0.9970421,0.0021049683,0.00048529843,0.0000640258,0.00013967391,0.000015743895,0.000022948498,0.000031109055,0.000094083574],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988721,0.00007227269,0.0002716415,0.00040258875,0.00012424371,0.00025713042],"domain_scores_gemma":[0.9994993,0.000012254497,0.00013432612,0.00023875269,0.000033582695,0.00008176997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012047814,0.00023379289,0.00024191954,0.000056841815,0.00019617028,0.000041960953,0.00013153454,0.00015460928,0.000011294566],"category_scores_gemma":[0.000040323965,0.0001860467,0.000055147124,0.00008937928,0.0002685663,0.000020667201,0.00030732004,0.00013546187,6.910203e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007929535,0.00013463502,0.0048808334,0.000034686793,0.000042589523,0.00004047317,0.00013495547,0.0000020818452,0.99309224,0.000021276443,0.000026734413,0.0015101909],"study_design_scores_gemma":[0.001890202,0.0002024748,0.008681814,0.00003195246,0.000036248413,0.00035413704,0.00019121927,0.000062370025,0.98778963,0.00010536643,0.00045010747,0.00020450087],"about_ca_topic_score_codex":0.00010474831,"about_ca_topic_score_gemma":0.000020571613,"teacher_disagreement_score":0.010138332,"about_ca_system_score_codex":0.000006824754,"about_ca_system_score_gemma":0.00003467623,"threshold_uncertainty_score":0.75867647},"labels":[],"label_agreement":null},{"id":"W2003953378","doi":"10.1182/blood-2013-01-478958","title":"Meta-analysis of low-molecular-weight heparin to prevent recurrent placenta-mediated pregnancy complications","year":2013,"lang":"en","type":"review","venue":"Blood","topic":"Maternal and fetal healthcare","field":"Medicine","cited_by":155,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Pregnancy; Obstetrics; Placenta; Low molecular weight heparin; Placental abruption; Randomized controlled trial; Birth weight; Small for gestational age; Gestational age; Live birth; Heparin; Fetus; Internal medicine","score_opus":0.14371534567746538,"score_gpt":0.38851667810470875,"score_spread":0.24480133242724336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003953378","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012694614,0.99439454,0.000030684336,0.00018815181,0.00007085633,0.0033360268,0.00089491694,0.00004176167,0.0009161216],"genre_scores_gemma":[0.00022948199,0.99398863,0.0005126278,0.00012458919,0.000037149017,0.0015528889,0.0019125014,0.000051264105,0.0015908468],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9970544,0.00022645373,0.0013071296,0.0005910582,0.0004936274,0.00032732062],"domain_scores_gemma":[0.99753803,0.00010470166,0.00062365556,0.0010376519,0.000245888,0.00045006612],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013540103,0.00046000027,0.0045283637,0.0005247658,0.00003633406,0.000013210368,0.00031607578,0.00022617885,0.0009783983],"category_scores_gemma":[0.000042613738,0.00030198452,0.002882874,0.0011656708,0.00003030286,0.0000231108,0.00014386751,0.00030786122,0.00037149378],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021538648,0.0074278163,0.00010476578,0.13418135,0.5796683,0.000104238985,0.00016352908,0.0000016334781,0.000019755027,0.00045618083,0.0006504591,0.27720046],"study_design_scores_gemma":[0.0002916283,0.00019825404,0.00013584882,0.0072121215,0.7150197,0.000029907547,0.0000028789227,0.0000053683734,0.000052707343,0.000009619225,0.27674276,0.0002992042],"about_ca_topic_score_codex":0.00013442815,"about_ca_topic_score_gemma":0.00003539058,"teacher_disagreement_score":0.27690125,"about_ca_system_score_codex":0.000062412946,"about_ca_system_score_gemma":0.0002051793,"threshold_uncertainty_score":0.99994326},"labels":[],"label_agreement":null},{"id":"W2004029643","doi":"10.1182/blood-2009-07-230698","title":"Loss-of-function Additional sex combs like 1 mutations disrupt hematopoiesis but do not cause severe myelodysplasia or leukemia","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":150,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Héma-Québec; BC Cancer Agency; University of British Columbia","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Biology; Chronic myelomonocytic leukemia; Haematopoiesis; Myeloid; Leukemia; Progenitor cell; Myeloid leukemia; Phenotype; Cancer research; Myelodysplastic syndromes; Loss function; Genetics; Stem cell; Gene; Bone marrow; Immunology","score_opus":0.02249879591221831,"score_gpt":0.2886989593274928,"score_spread":0.26620016341527447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004029643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98923326,0.0000859497,0.0002732204,0.0016201445,0.00013038014,0.000755808,0.0016406762,0.00020755247,0.0060530375],"genre_scores_gemma":[0.98504126,0.000049450362,0.0023293123,0.0009088389,0.00039220322,0.00008633986,0.0015951915,0.000046433375,0.00955098],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9976642,0.00007600152,0.00050596707,0.00044973003,0.00083868677,0.0004653926],"domain_scores_gemma":[0.9981479,0.0004824041,0.00016057932,0.0005737587,0.0003339481,0.00030139723],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001955459,0.00028067856,0.0004959405,0.00028363417,0.00020009515,0.000041363874,0.00019423605,0.00024522183,0.0061311745],"category_scores_gemma":[0.0004204663,0.00023524702,0.00016955663,0.0005732598,0.00019852225,0.00021941216,0.00006499458,0.00049513986,0.00034089453],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013070416,0.013046949,0.03851234,0.0024619615,0.0069021895,0.010605406,0.005484496,0.0004428307,0.10266833,0.012408791,0.7621316,0.032264724],"study_design_scores_gemma":[0.07510298,0.01123355,0.6435667,0.0024824087,0.0071147056,0.025782792,0.00582706,0.0022669286,0.13395421,0.004562622,0.08477446,0.00333157],"about_ca_topic_score_codex":0.00004511669,"about_ca_topic_score_gemma":0.0000196284,"teacher_disagreement_score":0.67735714,"about_ca_system_score_codex":0.00037272042,"about_ca_system_score_gemma":0.0013238614,"threshold_uncertainty_score":0.9947774},"labels":[],"label_agreement":null},{"id":"W2004492241","doi":"10.1182/blood-2006-09-046839","title":"Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":372,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Dasatinib; Imatinib; Medicine; Internal medicine; Neutropenia; Myeloid leukemia; Adverse effect; Imatinib mesylate; Nilotinib; Gastroenterology; Oncology; Chemotherapy","score_opus":0.029391149409079758,"score_gpt":0.3000116606126729,"score_spread":0.27062051120359315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004492241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99731946,0.0006914541,0.000008637828,0.000047419868,0.000032136842,0.0015760952,0.000031120246,0.00007181914,0.0002218775],"genre_scores_gemma":[0.998264,0.000090296795,0.0012099036,0.00008795743,0.00003793128,0.000091228605,0.00007986511,0.00005223544,0.00008658025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971616,0.00012811653,0.00084256945,0.00067338516,0.00046116524,0.0007331516],"domain_scores_gemma":[0.9986202,0.00035803867,0.00023929971,0.00045411245,0.00009278445,0.00023558075],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00049287913,0.00042335154,0.00075740466,0.0004701993,0.00007269709,0.00003583057,0.00014579397,0.00020303129,0.00013231335],"category_scores_gemma":[0.000261179,0.0002894327,0.000041020365,0.0008098349,0.0001622827,0.00010848178,0.000067841895,0.00037666078,0.000013220283],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033040475,0.0072351703,0.81232303,0.00071701995,0.0003872999,0.006109823,0.00202588,0.000026092774,0.12381383,0.000027172055,0.000030544474,0.01426367],"study_design_scores_gemma":[0.08733264,0.005205348,0.8171641,0.0008012248,0.00019461979,0.00012191577,0.00030483067,0.00008332213,0.08833933,0.00001076127,0.00004230999,0.00039956663],"about_ca_topic_score_codex":0.00031584967,"about_ca_topic_score_gemma":0.0008100308,"teacher_disagreement_score":0.054292165,"about_ca_system_score_codex":0.0017984748,"about_ca_system_score_gemma":0.0018621661,"threshold_uncertainty_score":0.9999558},"labels":[],"label_agreement":null},{"id":"W2004507031","doi":"10.1182/blood-2013-03-489468","title":"PPARα and fatty acid oxidation mediate glucocorticoid resistance in chronic lymphocytic leukemia","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital; Ontario Institute for Cancer Research; University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research; Gilead Sciences; University of Toronto; Leukemia and Lymphoma Society; GlaxoSmithKline","keywords":"Chronic lymphocytic leukemia; Beta oxidation; Endocrinology; Internal medicine; Fatty acid; Biology; Glucocorticoid; Chemistry; Leukemia; Biochemistry; Medicine","score_opus":0.005306004316747828,"score_gpt":0.21098166712398195,"score_spread":0.20567566280723412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004507031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9761164,0.02255446,0.00009804106,0.000030345698,0.00023615631,0.00026465452,0.000005221338,0.000011051262,0.0006836397],"genre_scores_gemma":[0.99363893,0.004584021,0.00038537383,0.00013638848,0.0006022597,0.00008184049,0.000048835012,0.000017297138,0.00050504087],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991459,0.000030188256,0.00018435686,0.0003064022,0.000092812654,0.00024033492],"domain_scores_gemma":[0.99955285,0.0000066494736,0.00006622794,0.00026680855,0.00003778776,0.00006970496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000079643476,0.00012482006,0.00015160638,0.00003638349,0.000029946883,0.000027025892,0.00009767885,0.0001184808,0.000026680655],"category_scores_gemma":[0.00003800351,0.00012424108,0.000034953224,0.00007956959,0.000050172737,0.000009297874,0.00005708854,0.00005713942,0.00003418743],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018112374,0.00001276289,0.00083025725,0.00003631878,0.000019883078,8.2799517e-7,0.000037437425,0.000014866366,0.99677014,0.000031967185,0.00047164506,0.0017557564],"study_design_scores_gemma":[0.004051538,0.00008085343,0.05402624,0.00003303121,0.00004635768,0.000010434579,0.000027083135,0.00010653508,0.913185,0.00016539863,0.028010933,0.00025661913],"about_ca_topic_score_codex":0.00012486018,"about_ca_topic_score_gemma":0.0005930549,"teacher_disagreement_score":0.08358519,"about_ca_system_score_codex":0.00017027778,"about_ca_system_score_gemma":0.0005942104,"threshold_uncertainty_score":0.50664043},"labels":[],"label_agreement":null},{"id":"W2004800182","doi":"10.1182/blood-2007-10-115873","title":"Phase 1 study of the oral isotype specific histone deacetylase inhibitor MGCD0103 in leukemia","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":234,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Leukemia; Pharmacokinetics; Nausea; Internal medicine; Histone deacetylase inhibitor; Gastroenterology; Vomiting; Pharmacology; Oncology; Histone deacetylase; Histone; Chemistry","score_opus":0.02311180398526197,"score_gpt":0.2997366033922694,"score_spread":0.2766247994070074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004800182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975392,0.0010341551,0.000005757929,0.000031197458,0.00017863723,0.0005423687,0.000017379933,0.000010533321,0.0006407679],"genre_scores_gemma":[0.99835587,0.00008137282,0.00008842038,0.000027953038,0.00020242602,0.000039978167,0.000019056919,0.000034597317,0.0011503192],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982702,0.00020685158,0.00039189946,0.0004249118,0.00037852433,0.000327612],"domain_scores_gemma":[0.99892145,0.000016124694,0.00010343062,0.00076338835,0.00010368087,0.00009193816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002444773,0.00018811872,0.0002529623,0.00010263812,0.00012519649,0.0000068922477,0.00038158035,0.00014670347,0.0000330193],"category_scores_gemma":[0.000117386044,0.00015627244,0.00010810838,0.00036478613,0.00023574229,0.000005201312,0.0002250497,0.00026694918,0.000025495981],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025772987,0.006916633,0.0052584703,0.000013783381,0.000043255382,0.00010184223,0.0006184798,0.000025876107,0.9794606,0.000003976742,0.0068998523,0.00039949254],"study_design_scores_gemma":[0.012174774,0.0017029949,0.0031812459,0.000016686605,0.000018990653,0.00007235785,0.0002540211,0.00000842295,0.9720086,0.0000027631138,0.010354274,0.00020490852],"about_ca_topic_score_codex":0.00017738991,"about_ca_topic_score_gemma":0.0003776642,"teacher_disagreement_score":0.0119170435,"about_ca_system_score_codex":0.00008501054,"about_ca_system_score_gemma":0.000302224,"threshold_uncertainty_score":0.6372605},"labels":[],"label_agreement":null},{"id":"W2004805882","doi":"10.1182/blood.v99.2.618","title":"Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":286,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; BC Cancer Agency; Ontario Institute for Cancer Research","funders":"","keywords":"STAT6; STAT protein; STAT3; STAT5; Cancer research; Lymphoma; Phosphorylation; Cytokine; STAT4; Cell culture; Biology; Signal transduction; stat; Molecular biology; Immunology; Interleukin 4; Cell biology","score_opus":0.02280073837451832,"score_gpt":0.23311425709378591,"score_spread":0.2103135187192676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004805882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982207,0.00045260077,0.000057196103,0.00025168742,0.000044400014,0.00023595426,0.000064569336,0.000016494088,0.00065639085],"genre_scores_gemma":[0.99919677,0.00023305485,0.0003017288,0.000079725905,0.000041410603,0.000008283602,0.000005902702,0.000020452559,0.000112665075],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990321,0.00004156216,0.00036842717,0.00023220111,0.00017149234,0.00015423167],"domain_scores_gemma":[0.99954695,0.000055412063,0.00011269221,0.0001451295,0.000057220463,0.00008261986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000088700326,0.00014622592,0.00035399492,0.00019722171,0.000022758068,0.000008009948,0.000040804596,0.000109169545,0.00053166674],"category_scores_gemma":[0.00001136008,0.00013412976,0.00007861825,0.00019130523,0.000079698635,0.00013037269,0.000007580727,0.00011515171,0.0000016647786],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018303184,0.0010192317,0.0033468357,0.00016735384,0.0000995622,0.000012259531,0.0021344128,0.0000010012423,0.9881443,0.0000178655,0.00007571048,0.0047984784],"study_design_scores_gemma":[0.0056251567,0.00063456444,0.015521721,0.00035865675,0.00017289599,0.00006402415,0.00018146259,0.00015496214,0.9767148,0.000023852555,0.00043522878,0.000112661306],"about_ca_topic_score_codex":0.0003076779,"about_ca_topic_score_gemma":0.000021617527,"teacher_disagreement_score":0.012174886,"about_ca_system_score_codex":0.000017459732,"about_ca_system_score_gemma":0.000020913147,"threshold_uncertainty_score":0.58213776},"labels":[],"label_agreement":null},{"id":"W2004872546","doi":"10.1182/blood-2004-10-3916","title":"Phosphorylation of RasGRP3 on threonine 133 provides a mechanistic link between PKC and Ras signaling systems in B cells","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Receptor Mechanisms and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Diacylglycerol kinase; Protein kinase C; Phosphorylation; Cell biology; Biology; Signal transduction; Kinase","score_opus":0.010075031984450929,"score_gpt":0.22022899092923304,"score_spread":0.21015395894478212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004872546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946397,0.001864868,0.002983428,0.00003498084,0.000059841936,0.00027231695,0.000013851013,0.000008739455,0.0001222527],"genre_scores_gemma":[0.9980116,0.000099465185,0.0013061633,0.000020350853,0.00041380175,0.00001640665,0.000034129258,0.000019640116,0.000078434445],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991058,0.00004923193,0.00029023326,0.00026542982,0.00012230444,0.00016701329],"domain_scores_gemma":[0.99960476,0.000031270392,0.0001210263,0.00015030503,0.00004242984,0.000050194412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029632,0.00013311995,0.00020458712,0.000055811415,0.000036739893,0.000021335172,0.000081028964,0.00014608189,0.000014507844],"category_scores_gemma":[0.00003240657,0.00012464111,0.00004142831,0.00006425304,0.000018256118,0.000004108331,0.00003379086,0.00007891985,0.0000029596085],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027779262,0.0000553499,0.00084616325,0.000054643126,0.0000347065,0.0000014261008,0.000065271175,0.00083330355,0.99562275,0.0003017739,0.0000069521966,0.0021498697],"study_design_scores_gemma":[0.00097225426,0.00038866108,0.00013222422,0.000106551284,0.000041640124,0.0000022950437,0.000054132568,0.0005748151,0.99691004,0.00013121696,0.00054578227,0.00014040274],"about_ca_topic_score_codex":0.000039875114,"about_ca_topic_score_gemma":0.0000080936,"teacher_disagreement_score":0.0033718874,"about_ca_system_score_codex":0.00000843889,"about_ca_system_score_gemma":0.00003127169,"threshold_uncertainty_score":0.5082717},"labels":[],"label_agreement":null},{"id":"W2005085994","doi":"10.1182/blood-2012-11-468702","title":"Leukemia surfaceome analysis reveals new disease-associated features","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Universität Zürich; Mach-Gaensslen Foundation of Canada; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"Leukemia; Computational biology; Disease; Biology; Bioinformatics; Immunology; Medicine; Pathology","score_opus":0.013864755107328892,"score_gpt":0.2697139147235016,"score_spread":0.2558491596161727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005085994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990588,0.0011123806,0.00003336585,0.0032870944,0.000036804344,0.0006368385,0.000030117957,0.00019439784,0.0040810206],"genre_scores_gemma":[0.9367862,0.00009880445,0.0007647484,0.0007555079,0.00019485955,0.000037378446,0.0002143599,0.000042633914,0.061105505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99788594,0.00010520912,0.00030375193,0.00044283972,0.000652883,0.00060937344],"domain_scores_gemma":[0.9978358,0.00015509792,0.00009966758,0.00071031245,0.00024128746,0.0009578419],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00025306485,0.00022907951,0.0005697058,0.0003467893,0.000096055934,0.000081797654,0.000245255,0.00017432583,0.0019979144],"category_scores_gemma":[0.0008157887,0.00018786328,0.0003472528,0.0015649621,0.00006531897,0.0001352341,0.00011076909,0.0004333044,0.0008761346],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001061162,0.0005097535,0.7153489,0.000074554024,0.0056529865,0.00034606986,0.00019905313,0.00006229713,0.01688386,0.00011140453,0.25953057,0.0011744678],"study_design_scores_gemma":[0.003570889,0.00009542877,0.9902278,0.0000447348,0.003356059,0.000012865202,0.000040628805,0.00021969012,0.0009860981,0.00047679964,0.00075370487,0.00021528541],"about_ca_topic_score_codex":0.0020084865,"about_ca_topic_score_gemma":0.000080568934,"teacher_disagreement_score":0.27487895,"about_ca_system_score_codex":0.00045467252,"about_ca_system_score_gemma":0.0008783314,"threshold_uncertainty_score":0.9999018},"labels":[],"label_agreement":null},{"id":"W2005214178","doi":"10.1182/blood-2012-05-431023","title":"A novel function for FOXP3 in humans: intrinsic regulation of conventional T cells","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; University of British Columbia","funders":"Canadian Institutes of Health Research; Canadian Blood Services","keywords":"Regulator; FOXP3; Cell biology; Cytokine; Function (biology); Cell growth; Biology; Negative regulator; Immunology; Chemistry; Immune system; Signal transduction; Biochemistry; Gene","score_opus":0.017595103533516086,"score_gpt":0.23032445697513884,"score_spread":0.21272935344162275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005214178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98005825,0.001080895,0.011070654,0.000039596034,0.0054519656,0.00043748456,0.000009981348,0.000035779754,0.0018153879],"genre_scores_gemma":[0.9952096,0.000008228153,0.00015120224,0.00004500119,0.000071666356,0.00003750985,0.00019227511,0.000007678013,0.004276839],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994533,0.00003365357,0.0002465395,0.000097276636,0.000019444633,0.00014976988],"domain_scores_gemma":[0.9996555,0.00006019845,0.00011964586,0.00009210385,0.00006565683,0.0000069266443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019714233,0.00006908427,0.00011426771,0.00012192301,0.000045364573,0.0000028761976,0.000035662113,0.00012163121,0.0008200239],"category_scores_gemma":[0.000028419156,0.000069358946,0.000072514624,0.00007071876,0.000032553187,0.00015840794,0.000011820345,0.00008629322,0.00011708694],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025598955,0.0008465291,0.0026611118,0.000022225526,0.00007716051,1.1953665e-8,0.00011547694,0.000003600919,0.9896677,0.003934065,0.0018993358,0.00051680126],"study_design_scores_gemma":[0.0057436395,0.00027439735,0.12278596,0.000035127276,0.00010665803,0.000010080465,0.0001506475,0.0000049433334,0.8099763,0.00014023275,0.060660485,0.00011154192],"about_ca_topic_score_codex":0.000024684823,"about_ca_topic_score_gemma":0.0000070275796,"teacher_disagreement_score":0.1796914,"about_ca_system_score_codex":0.000017749871,"about_ca_system_score_gemma":0.000013433536,"threshold_uncertainty_score":0.89786863},"labels":[],"label_agreement":null},{"id":"W2005259908","doi":"10.1182/blood-2010-10-313791","title":"Novel associations between activating killer-cell immunoglobulin-like receptor genes and childhood leukemia","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Canadian Cancer Society Research Institute; Cancer Research Institute","keywords":"Childhood leukemia; Biology; Leukemia; Immunology; Gene; Phenotype; Acute lymphocytic leukemia; Antibody; Genetics; Lymphoblastic Leukemia","score_opus":0.01874553864851925,"score_gpt":0.21164853343547024,"score_spread":0.192902994786951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005259908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857822,0.0017610766,0.00022069177,0.000044994933,0.00231174,0.0001906458,0.000025624235,0.00013470734,0.009528343],"genre_scores_gemma":[0.99020547,0.0001787931,0.0008188382,0.0001228533,0.00010137246,0.000015861224,0.00031715765,0.000026199968,0.008213434],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990397,0.00007596307,0.0003143814,0.00026655695,0.000031840133,0.00027155655],"domain_scores_gemma":[0.999388,0.00010510841,0.00022199913,0.00020089175,0.00006161677,0.000022376536],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014928196,0.00017569818,0.00023873446,0.00008629221,0.00035333153,0.000020332624,0.00012457001,0.0002687577,0.0010244094],"category_scores_gemma":[0.000059884012,0.00017146046,0.00008238149,0.00010387388,0.000058084635,0.00017940957,0.00008107553,0.00034952597,0.0005974587],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028100383,0.00057231105,0.020563992,0.0000067415162,0.0005088069,3.2606e-7,0.0016439798,2.955759e-7,0.97036123,0.00006924502,0.002555994,0.0036889892],"study_design_scores_gemma":[0.0036474147,0.00024093411,0.24076451,0.000028054224,0.00019075951,0.000030479872,0.0005156697,4.5992905e-7,0.70791507,0.000019925468,0.04632913,0.0003175794],"about_ca_topic_score_codex":0.00030742897,"about_ca_topic_score_gemma":0.0000044802755,"teacher_disagreement_score":0.26244614,"about_ca_system_score_codex":0.00005399032,"about_ca_system_score_gemma":0.00005982075,"threshold_uncertainty_score":0.9998888},"labels":[],"label_agreement":null},{"id":"W2005279936","doi":"10.1182/blood-2011-08-335612","title":"Warfarin and acetaminophen interaction: a summary of the evidence and biologic plausibility","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Duke Clinical Research Institute; National Heart, Lung, and Blood Institute","keywords":"Warfarin; Acetaminophen; Medicine; Aspirin; Atrial fibrillation; Anesthesia; Diabetes mellitus; Internal medicine","score_opus":0.3323914774285354,"score_gpt":0.4118783597788498,"score_spread":0.07948688235031437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005279936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956217,0.0008549951,0.0000074314707,0.000157847,0.00039356752,0.00034550956,0.000010761386,0.00002727682,0.0025809025],"genre_scores_gemma":[0.99898964,0.00043567547,0.00010086337,0.0002541841,0.00004925239,0.000026342987,6.3082143e-7,0.00000451549,0.0001388976],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989804,0.00042166677,0.00018794801,0.00021546577,0.000053028507,0.00014149131],"domain_scores_gemma":[0.9993631,0.00026213287,0.00011442736,0.00016364022,0.000035866437,0.000060802555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000624683,0.00010521239,0.0001412617,0.000030449022,0.00016887322,0.0000058650285,0.00012564725,0.00021105532,0.00015275736],"category_scores_gemma":[0.00016334793,0.00007437259,0.000037537764,0.00009857423,0.0002657397,0.0001332259,0.00016161098,0.0004668322,0.0000058631217],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040569654,0.0008482983,0.7947891,0.00021754952,0.0001804173,0.00000839236,0.0036924302,0.0000017157492,0.18079612,0.00071827037,0.000079836864,0.018262185],"study_design_scores_gemma":[0.0011622591,0.0002874134,0.42229068,0.00009018949,0.00024286612,0.00010688816,0.00024234311,0.00011952708,0.5703849,0.0025812984,0.002315578,0.00017601663],"about_ca_topic_score_codex":0.0001464434,"about_ca_topic_score_gemma":0.000075446966,"teacher_disagreement_score":0.38958883,"about_ca_system_score_codex":0.0000113417145,"about_ca_system_score_gemma":0.00002594083,"threshold_uncertainty_score":0.30328262},"labels":[],"label_agreement":null},{"id":"W2005377557","doi":"10.1182/blood-2013-06-506865","title":"IL-21 signalling via STAT3 primes human naïve B cells to respond to IL-2 to enhance their differentiation into plasmablasts","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":146,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Immunology; IL-2 receptor; STAT3; Interleukin 15; Biology; Molecular biology; Immune system; Cell biology; Interleukin; Signal transduction; Cytokine; T cell","score_opus":0.005268711482799296,"score_gpt":0.2227488670362551,"score_spread":0.2174801555534558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005377557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992466,0.0011144665,0.0041534966,0.00038236668,0.00049146294,0.0009293921,0.00003290687,0.00011548714,0.0003144243],"genre_scores_gemma":[0.99455065,0.0000136117105,0.00028723458,0.0005717315,0.000012212496,0.00017480999,0.000074638294,0.000037586327,0.0042775036],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980907,0.0001779105,0.0004606457,0.00054975133,0.000072473515,0.0006485467],"domain_scores_gemma":[0.9991368,0.0001244094,0.000115504256,0.00044999644,0.00013493883,0.000038315793],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021997606,0.00032388937,0.00035945728,0.00026333175,0.00046340868,0.000071498675,0.0004978805,0.00020038863,0.0005710331],"category_scores_gemma":[0.00006178839,0.00029349065,0.0001031242,0.00032834703,0.00005991481,0.0001558661,0.0002278972,0.0002656223,0.0045059365],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000093786824,0.00042956916,0.000049450406,0.000016983195,0.00011190253,9.498162e-7,0.008127748,0.000107355416,0.9769857,0.000062793224,0.00039027276,0.013623497],"study_design_scores_gemma":[0.0006936438,0.0005976759,0.0043856017,0.00007861296,0.00003450902,0.0000029060327,0.00080835907,0.0000049071896,0.9789865,0.00027459994,0.013735761,0.00039692468],"about_ca_topic_score_codex":0.0003788156,"about_ca_topic_score_gemma":0.00003781397,"teacher_disagreement_score":0.013345488,"about_ca_system_score_codex":0.00003697895,"about_ca_system_score_gemma":0.000043857894,"threshold_uncertainty_score":0.9999517},"labels":[],"label_agreement":null},{"id":"W2005562333","doi":"10.1182/blood-2002-02-0390","title":"c-myc proto-oncogene expression in hemophilic synovitis: in vitro studies of the effects of iron and ceramide","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Heart and Stroke Foundation of Canada","keywords":"Oncogene; Cancer research; Synovitis; Synovial membrane; Pathology; Cell growth; Medicine; Immunology; Chemistry; Arthritis; Internal medicine; Cancer; Cell cycle","score_opus":0.011936165430747658,"score_gpt":0.24757395351249475,"score_spread":0.2356377880817471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005562333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98672694,0.012029633,6.763424e-8,0.00009154567,0.000020813028,0.0009562329,0.0000030505116,0.0000043871055,0.0001673467],"genre_scores_gemma":[0.9989322,0.00080894906,0.00007534909,0.000027107588,0.0000069393095,0.00009319283,0.0000010678107,0.0000069426524,0.000048279515],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994722,0.00003470161,0.00016340577,0.00011778227,0.000106956155,0.00010493469],"domain_scores_gemma":[0.9996981,0.00007547634,0.00005880196,0.00013520458,0.000012901318,0.000019517744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000041632415,0.000080914884,0.00029596087,0.000057423047,0.000013277572,0.0000011000873,0.00003214912,0.000040357416,0.0000025570694],"category_scores_gemma":[0.00011042394,0.000050364994,0.000028798664,0.00011650974,0.0000552914,0.000022974427,0.000039573122,0.000059463877,5.4573263e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000088641886,0.0019128057,0.10957304,0.0010045796,0.000061103245,0.00021899708,0.0011317563,6.435775e-7,0.8820813,0.0000014310305,0.000017446648,0.003908277],"study_design_scores_gemma":[0.007920568,0.00027928068,0.077201135,0.00095132674,0.00007423673,0.000032959182,0.00010907212,0.000009206145,0.9132809,0.00008880275,0.00000783148,0.000044667384],"about_ca_topic_score_codex":0.000027816957,"about_ca_topic_score_gemma":0.000016564463,"teacher_disagreement_score":0.032371905,"about_ca_system_score_codex":0.000012293818,"about_ca_system_score_gemma":0.000006550776,"threshold_uncertainty_score":0.20538248},"labels":[],"label_agreement":null},{"id":"W2005568493","doi":"10.1182/blood-2009-07-199174","title":"How I treat postthrombotic syndrome","year":2009,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":162,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Compression stockings; Post-thrombotic syndrome; Deep vein; Thrombosis; Complication; Quality of life (healthcare); Venous thrombosis; Surgery; Pediatrics; Internal medicine; Intensive care medicine","score_opus":0.03982241895063226,"score_gpt":0.30630332579651526,"score_spread":0.266480906845883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005568493","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000061554194,0.9880977,0.0000028624054,0.00038360417,0.00016558703,0.0017430778,0.000019637278,0.00017052499,0.009355445],"genre_scores_gemma":[0.00008015049,0.99282646,0.00023857121,0.00025835255,0.00030401212,0.00012557607,0.00021501757,0.000101604935,0.0058502653],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980819,0.00006576782,0.00041025493,0.0005952219,0.00036042221,0.000486421],"domain_scores_gemma":[0.9985811,0.00005211567,0.00022536945,0.00086190406,0.000040466573,0.00023906257],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011514136,0.0005858338,0.0037467892,0.0002948847,0.0000713235,0.000106326566,0.00023418927,0.00034350867,0.00013990728],"category_scores_gemma":[0.000047520087,0.00043387635,0.00088369776,0.00032714487,0.000042039625,0.000061208855,0.00008160319,0.00034744875,0.00040463815],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000011263297,0.0028356481,0.0000028069717,0.0261992,0.0012085176,0.0022628696,0.000016792463,1.8660025e-8,3.0284835e-7,0.00042675552,0.0063340156,0.96071196],"study_design_scores_gemma":[0.00088151277,0.00084553857,0.00029999416,0.018204257,0.023334075,0.0022159207,0.000008942086,7.89044e-8,0.0000012701283,0.00003070936,0.95378613,0.00039155158],"about_ca_topic_score_codex":0.000012663211,"about_ca_topic_score_gemma":0.0000022641589,"teacher_disagreement_score":0.9603204,"about_ca_system_score_codex":0.000085478925,"about_ca_system_score_gemma":0.00016528156,"threshold_uncertainty_score":0.9998113},"labels":[],"label_agreement":null},{"id":"W2005638084","doi":"10.1182/blood-2003-09-3237","title":"A novel role for STAT1 in regulating murine erythropoiesis: deletion of STAT1 results in overall reduction of erythroid progenitors and alters their distribution","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Erythropoiesis; Erythropoietin; Biology; Erythropoietin receptor; STAT protein; STAT5; STAT1; STAT3; Cell biology; Transferrin receptor; Cancer research; Signal transduction; Molecular biology; Endocrinology; Internal medicine; Anemia; Transferrin; Medicine","score_opus":0.017469541443168694,"score_gpt":0.2619966010503642,"score_spread":0.2445270596071955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005638084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976198,0.00013838042,0.000935475,0.00027816114,0.00005823317,0.0006191213,0.00031575267,0.000014331843,0.000020719988],"genre_scores_gemma":[0.99719304,0.000030357794,0.002344329,0.0000047957483,0.0000763397,0.000052563657,0.00027913644,0.000012588841,0.0000068791137],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99899787,0.000015801308,0.0005164103,0.00019855963,0.00011254175,0.00015882755],"domain_scores_gemma":[0.99946064,0.00003786289,0.00022206352,0.00012544949,0.00011729105,0.00003667351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023941536,0.00010146446,0.00023876225,0.00013659694,0.000027197586,0.0000052207492,0.000023853476,0.000055713317,0.000001452146],"category_scores_gemma":[0.00017127708,0.00009379982,0.000057207173,0.00017968396,0.00005529835,0.00010927148,0.000015073621,0.000096715004,7.815521e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001157988,0.0012858682,0.0028171143,0.00021262128,0.000052764142,0.0000013251932,0.0025197146,0.0010341108,0.988882,0.00026589664,0.000007195156,0.0017633719],"study_design_scores_gemma":[0.014280719,0.0010715199,0.057142947,0.00091977866,0.00008194364,0.000088612076,0.002034572,0.00048378113,0.92315185,0.00053969974,0.000087238644,0.000117355994],"about_ca_topic_score_codex":0.0007848329,"about_ca_topic_score_gemma":0.0001603384,"teacher_disagreement_score":0.0657302,"about_ca_system_score_codex":0.00014037084,"about_ca_system_score_gemma":0.00013142214,"threshold_uncertainty_score":0.38250455},"labels":[],"label_agreement":null},{"id":"W2005741975","doi":"10.1182/blood-2010-02-271957","title":"Shiga toxin B subunits induce VWF secretion by human endothelial cells and thrombotic microangiopathy in ADAMTS13-deficient mice","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Heart, Lung, and Blood Institute","keywords":"Shiga toxin; Thrombotic microangiopathy; ADAMTS13; Thrombotic thrombocytopenic purpura; Shigella dysenteriae; Von Willebrand factor; Secretion; Microbiology; Globotriaosylceramide; Biology; Clostridium difficile toxin B; Cytotoxic T cell; Molecular biology; Clostridium difficile toxin A; Chemistry; Immunology; Escherichia coli; Platelet; Biochemistry; Medicine; Internal medicine; Enzyme replacement therapy","score_opus":0.011564283245814218,"score_gpt":0.23509705306736065,"score_spread":0.22353276982154643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005741975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972543,0.00021194831,0.000010469766,0.0001813866,0.00045158065,0.0002969427,0.00003977281,0.00005070334,0.0015028585],"genre_scores_gemma":[0.9982376,0.00005381635,0.0001956228,0.0007045601,0.00023658278,0.000014148118,0.00008002336,0.000024595665,0.00045306687],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989628,0.000063832354,0.00023946195,0.00033354256,0.00013221893,0.00026813857],"domain_scores_gemma":[0.9994768,0.00004909027,0.000072623894,0.00022563153,0.000048571535,0.00012726698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016966251,0.0001641744,0.00027263074,0.00012303836,0.00008314022,0.000015422711,0.00006739373,0.0002096048,0.00012283216],"category_scores_gemma":[0.000037475293,0.00015590152,0.00004903992,0.0001631782,0.000104510276,0.000047855174,0.000041168845,0.0004728489,0.000061055645],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052239047,0.0005949599,0.0032026106,0.00003569231,0.000013880368,0.000024641104,0.00044558026,4.7202326e-7,0.99482626,0.00021201327,0.0004795351,0.0001121287],"study_design_scores_gemma":[0.008155803,0.0010748801,0.061716784,0.000077603814,0.00017584673,0.00024955723,0.00036132432,0.000030443385,0.9190757,0.000120223245,0.0086145755,0.00034722482],"about_ca_topic_score_codex":0.0001415677,"about_ca_topic_score_gemma":0.00027712117,"teacher_disagreement_score":0.075750515,"about_ca_system_score_codex":0.0000126521445,"about_ca_system_score_gemma":0.000057349745,"threshold_uncertainty_score":0.63574797},"labels":[],"label_agreement":null},{"id":"W2005807691","doi":"10.1182/blood-2009-03-211763","title":"AID constrains germinal center size by rendering B cells susceptible to apoptosis","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Germinal center; Apoptosis; Cytidine deaminase; Activation-induced (cytidine) deaminase; Bone marrow; Biology; B cell; Cell biology; Somatic hypermutation; CD38; Cancer research; Molecular biology; Immunology; Antibody; Stem cell; Genetics","score_opus":0.00827011589041825,"score_gpt":0.21409981756971222,"score_spread":0.20582970167929396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005807691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987645,0.0008752259,0.00006323642,0.000746627,0.00064411573,0.00021587498,0.00008605746,0.00015669462,0.009567195],"genre_scores_gemma":[0.9884281,0.00008457105,0.00034748562,0.0011470986,0.000050505816,0.000011206225,0.000056353238,0.000017948072,0.00985673],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998459,0.000082363214,0.00030987532,0.00043091204,0.00003623053,0.0006816465],"domain_scores_gemma":[0.9993967,0.000086410946,0.00007937492,0.00034490335,0.000038300488,0.000054326447],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000104020226,0.00025690428,0.00033284363,0.00007930842,0.00019162115,0.000023858478,0.0003147946,0.00031076733,0.001427121],"category_scores_gemma":[0.000026787407,0.00024466263,0.00012100292,0.00013932743,0.00015105715,0.000063826585,0.00008014654,0.00033035644,0.0016752417],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006479005,0.0009614039,0.00040353183,0.000006738524,0.00011758103,0.000008946449,0.00022966873,5.581097e-7,0.97256166,0.00007470302,0.0233854,0.002185022],"study_design_scores_gemma":[0.0028911254,0.0007166242,0.00013162555,0.000020133813,0.00006167976,0.000114943025,0.00015911108,8.032316e-8,0.89013624,0.000034461304,0.10546986,0.00026410585],"about_ca_topic_score_codex":0.000037631235,"about_ca_topic_score_gemma":0.000007682385,"teacher_disagreement_score":0.08242541,"about_ca_system_score_codex":0.000020597432,"about_ca_system_score_gemma":0.000037176793,"threshold_uncertainty_score":0.99948573},"labels":[],"label_agreement":null},{"id":"W2005900338","doi":"10.1182/blood-2011-08-371989","title":"Fludarabine and rituximab for relapsed or refractory hairy cell leukemia","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"BC Cancer Agency","keywords":"Cladribine; Pentostatin; Fludarabine; Rituximab; Medicine; Purine analogue; Refractory (planetary science); Internal medicine; Hairy cell leukemia; Oncology; Leukemia; Gastroenterology; Chemotherapy; Lymphoma; Purine; Cyclophosphamide; Biology","score_opus":0.028515785185283162,"score_gpt":0.3005836549119431,"score_spread":0.27206786972665997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005900338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886331,0.004790025,0.00009953466,0.00017127555,0.00019138725,0.0008442379,0.000019285202,0.00010581235,0.005145363],"genre_scores_gemma":[0.9823569,0.0002664519,0.004680583,0.00030307463,0.0008094314,0.0001065293,0.000036793717,0.000063912295,0.011376347],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998426,0.000034323086,0.0002644872,0.00029314874,0.00032941898,0.00065257464],"domain_scores_gemma":[0.9986384,0.0003395889,0.00006281644,0.00046040933,0.000093755196,0.00040504808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043892162,0.00018530565,0.0003796384,0.000100683596,0.00009606158,0.000019014673,0.00010197192,0.00019037326,0.0001555197],"category_scores_gemma":[0.00040237067,0.00013878032,0.0000837425,0.00014213669,0.00011817348,0.00015473623,0.00008988565,0.00024013354,0.00011679096],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03451584,0.06661489,0.024775496,0.024120945,0.0029679434,0.0023040685,0.011934368,0.0000058896508,0.42764977,0.0025052186,0.29163527,0.110970296],"study_design_scores_gemma":[0.5544461,0.0029078869,0.004716941,0.0003756283,0.0012576358,0.0020501707,0.00049024203,0.0018558834,0.17116436,0.0001177929,0.25982177,0.000795544],"about_ca_topic_score_codex":0.00009419919,"about_ca_topic_score_gemma":0.000011644303,"teacher_disagreement_score":0.5199303,"about_ca_system_score_codex":0.002481084,"about_ca_system_score_gemma":0.003519637,"threshold_uncertainty_score":0.6487949},"labels":[],"label_agreement":null},{"id":"W2005942970","doi":"10.1182/blood-2009-03-211029","title":"Early defects in human T-cell development severely affect distribution and maturation of thymic stromal cells: possible implications for the pathophysiology of Omenn syndrome","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":150,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institutes of Health; National Metal and Materials Technology Center; National Institute of Allergy and Infectious Diseases; Hospital for Sick Children","keywords":"Biology; FOXP3; Immunology; Central tolerance; T cell; Lymphopoiesis; Severe combined immunodeficiency; Immune system; Cell biology; Haematopoiesis; Stem cell; Genetics","score_opus":0.008460567368203187,"score_gpt":0.21785830003276524,"score_spread":0.20939773266456205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005942970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99755347,0.0014971705,0.00017184559,0.00006104903,0.00007538394,0.0004968259,0.000083129904,0.000016473117,0.00004463911],"genre_scores_gemma":[0.9993795,0.00005972887,0.00011545117,0.00001751899,0.0000053645563,0.00004981348,0.00025742594,0.000006583933,0.000108604676],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990947,0.0001036357,0.00033021715,0.00021276434,0.00001710832,0.00024153672],"domain_scores_gemma":[0.99936247,0.00017274865,0.00020082512,0.0002030743,0.000050964336,0.000009906216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015150334,0.00013328464,0.00026468167,0.00006780718,0.00015669905,0.0000052721584,0.0001557049,0.00020325971,0.000009283379],"category_scores_gemma":[0.000011693842,0.00010266357,0.000057489542,0.00011627006,0.00013483272,0.000047351856,0.000039729835,0.00014001364,0.000006154268],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000116987656,0.00056414015,0.0019381689,0.00003630793,0.00005540372,6.284154e-7,0.00021222954,0.00000387344,0.99572814,0.0008543285,0.00003220927,0.00045760957],"study_design_scores_gemma":[0.0015958447,0.0007594487,0.4171501,0.000016762995,0.000052892865,0.000019542811,0.000034490673,6.05395e-7,0.5795144,0.0007289719,0.00005091006,0.00007601408],"about_ca_topic_score_codex":0.000034310822,"about_ca_topic_score_gemma":0.000016039212,"teacher_disagreement_score":0.41621372,"about_ca_system_score_codex":0.000014473115,"about_ca_system_score_gemma":0.00004831242,"threshold_uncertainty_score":0.4186499},"labels":[],"label_agreement":null},{"id":"W2005961846","doi":"10.1182/blood-2007-12-130534","title":"Graft-versus-host disease causes failure of donor hematopoiesis and lymphopoiesis in interferon-γ receptor-deficient hosts","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Immunology; Lymphopoiesis; Biology; Graft-versus-host disease; Haematopoiesis; Major histocompatibility complex; Interferon; Progenitor cell; Stem cell; Bone marrow; Cancer research; Immune system; Cell biology","score_opus":0.012546697372517533,"score_gpt":0.20914495628889135,"score_spread":0.1965982589163738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005961846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98818386,0.01048012,0.000003809239,0.0003367162,0.00044831616,0.0002073937,0.00007334868,0.000057410907,0.00020902137],"genre_scores_gemma":[0.998179,0.00091269304,0.00006536277,0.00004969332,0.00001671882,0.000034522564,0.00005233951,0.000022288525,0.0006673459],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99854314,0.0001564344,0.00041530936,0.00041453363,0.000045271034,0.00042528173],"domain_scores_gemma":[0.9991902,0.00016922267,0.00014508558,0.00038718112,0.000060994356,0.00004730674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010105127,0.00026129925,0.00045916895,0.00022738238,0.00015517975,0.000007657514,0.00024294034,0.00025158908,0.00037872483],"category_scores_gemma":[0.00010236862,0.00023459159,0.00010715868,0.00021691016,0.00066622696,0.00009207395,0.00021718696,0.00019230119,0.00017972344],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009064891,0.0012154827,0.039219134,0.000072386414,0.00025245818,0.000042788444,0.0011194171,7.83634e-7,0.95535856,0.00025802242,0.0014641281,0.000090331516],"study_design_scores_gemma":[0.0141547,0.000769205,0.030392373,0.00016436564,0.00025577637,0.00020396942,0.0015847778,5.6498664e-7,0.9399911,0.00004159745,0.011871916,0.000569621],"about_ca_topic_score_codex":0.00032129226,"about_ca_topic_score_gemma":0.00023389467,"teacher_disagreement_score":0.015367446,"about_ca_system_score_codex":0.0000328075,"about_ca_system_score_gemma":0.00009532152,"threshold_uncertainty_score":0.9566367},"labels":[],"label_agreement":null},{"id":"W2006197755","doi":"10.1182/blood-2009-12-255877","title":"HIT: more than just heparin","year":2010,"lang":"en","type":"letter","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Heparin; Medicine; Intensive care medicine; Internal medicine","score_opus":0.03940744123462308,"score_gpt":0.2967957387516042,"score_spread":0.2573882975169811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006197755","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39201638,0.00016337524,0.000002742751,0.55923516,0.0013615546,0.00088256376,0.00009623315,0.00034923872,0.04589275],"genre_scores_gemma":[0.2183686,0.0001545998,0.0011505303,0.7375013,0.017792378,0.00016992152,0.0015491344,0.0004097355,0.02290377],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969881,0.00006195979,0.000524326,0.00089384435,0.0006518052,0.00087996887],"domain_scores_gemma":[0.99768263,0.000090937996,0.00021293519,0.0015880726,0.00014284793,0.00028254976],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0001606303,0.00067736703,0.0013643646,0.00027660184,0.00014318974,0.000077644916,0.00047629882,0.0037629462,0.0012547487],"category_scores_gemma":[0.00011330637,0.0005907067,0.0004744882,0.00025346768,0.00019212665,0.00008319117,0.00021619746,0.007746195,0.0014252652],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019159545,0.0006274476,0.011514247,0.00065163523,0.0010398951,0.0031905114,0.0002814932,2.4662027e-8,0.015015904,0.00004507814,0.9669103,0.0007043275],"study_design_scores_gemma":[0.002919537,0.00023268774,0.024951471,0.00031819835,0.0026012766,0.00087614724,0.000030172556,0.0000019209917,0.013506234,0.000062782536,0.953786,0.0007135796],"about_ca_topic_score_codex":0.00047138368,"about_ca_topic_score_gemma":0.00009387587,"teacher_disagreement_score":0.17826617,"about_ca_system_score_codex":0.000059870188,"about_ca_system_score_gemma":0.0004747005,"threshold_uncertainty_score":0.9996582},"labels":[],"label_agreement":null},{"id":"W2006256646","doi":"10.1182/blood-2014-05-572024","title":"Hemolysis is a primary ATP-release mechanism in human erythrocytes","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Hemolysis; Mechanism (biology); Primary (astronomy); Chemistry; Immunology; Medicine","score_opus":0.011695285535232067,"score_gpt":0.23944278425349733,"score_spread":0.22774749871826527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006256646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98948133,0.0001397682,0.00023835884,0.0007128275,0.000097776436,0.00018493275,0.0000038064159,0.00010633059,0.009034847],"genre_scores_gemma":[0.98887783,0.000047630507,0.00088512606,0.008034847,0.00031331685,0.000027300404,0.000058125333,0.000027063254,0.0017287607],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989529,0.000059314407,0.00024777668,0.00032526397,0.00016155781,0.00025315152],"domain_scores_gemma":[0.9993495,0.00004751463,0.0000641924,0.00036575753,0.00004555319,0.00012752815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013228813,0.00015639943,0.000381441,0.0001590511,0.000068305155,0.000007806454,0.000070398855,0.00014256655,0.000666463],"category_scores_gemma":[0.000053403546,0.00014103997,0.00012258234,0.00020014905,0.0000449178,0.000042895757,0.000046634206,0.00020371252,0.00022336713],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002441612,0.0025828932,0.012877382,0.0003599605,0.00018393641,0.00016215439,0.001090578,0.0000023159796,0.969938,0.0047215614,0.003713423,0.0041236635],"study_design_scores_gemma":[0.042600293,0.0050704004,0.15586789,0.00045960373,0.00134982,0.00070725224,0.00042236844,0.00054008403,0.71824515,0.013585407,0.059797466,0.0013542731],"about_ca_topic_score_codex":0.000051354098,"about_ca_topic_score_gemma":0.000014312192,"teacher_disagreement_score":0.25169283,"about_ca_system_score_codex":0.000029413879,"about_ca_system_score_gemma":0.000041381463,"threshold_uncertainty_score":0.7297302},"labels":[],"label_agreement":null},{"id":"W2006501593","doi":"10.1182/blood-2008-01-136473","title":"The C-type lectin surface receptor DCIR acts as a new attachment factor for HIV-1 in dendritic cells and contributes to trans- and cis-infection pathways","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":187,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval","funders":"","keywords":"C-type lectin; Biology; DC-SIGN; Virus; Virology; Transfection; Receptor; Dendritic cell; Lectin; Cell biology; Immunology; Cell culture; Immune system; Biochemistry; Genetics","score_opus":0.01796498879743402,"score_gpt":0.24517497752477896,"score_spread":0.22720998872734494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006501593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801367,0.017316284,0.00021504697,0.0008930793,0.0006525122,0.0006990473,0.000027422891,0.00003538717,0.00002450224],"genre_scores_gemma":[0.9919249,0.003905201,0.00007404264,0.00020137272,0.000016207952,0.000025156422,0.00001475416,0.00001743304,0.0038209537],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990048,0.00018085219,0.00022237281,0.00022886346,0.000023232635,0.00033988798],"domain_scores_gemma":[0.99908364,0.0006525831,0.000046142584,0.00014247127,0.000042971566,0.000032179894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018377537,0.00016326534,0.0002342087,0.000060097027,0.00040615033,0.000028193906,0.00007873344,0.0001687418,0.000045183475],"category_scores_gemma":[0.00017331143,0.00012822972,0.000046596728,0.00012199784,0.00010718789,0.000062631756,0.000021762497,0.00015618421,0.00004723328],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016599786,0.00017388332,0.0034924175,0.000012872361,0.00015816755,0.0000020068323,0.0018449469,0.0000019435322,0.9879991,0.00007029907,0.0018072528,0.0027771501],"study_design_scores_gemma":[0.005354443,0.0009952324,0.018030897,0.000043231696,0.00003301155,0.000091143665,0.00010947404,6.2583433e-7,0.7503131,0.000047769645,0.22481331,0.00016776993],"about_ca_topic_score_codex":0.0001591168,"about_ca_topic_score_gemma":0.00007480401,"teacher_disagreement_score":0.23768598,"about_ca_system_score_codex":0.000025521198,"about_ca_system_score_gemma":0.00013399358,"threshold_uncertainty_score":0.52290565},"labels":[],"label_agreement":null},{"id":"W2006682699","doi":"10.1182/blood-2004-05-1772","title":"Trolox selectively enhances arsenic-mediated oxidative stress and apoptosis in APL and other malignant cell lines","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Trolox; Arsenic trioxide; Oxidative stress; Apoptosis; Acute promyelocytic leukemia; Chemistry; Cancer research; Cancer cell; Biochemistry; Pharmacology; Biology; Medicine; Cancer; Retinoic acid; Internal medicine","score_opus":0.005441874984242787,"score_gpt":0.21526170754428992,"score_spread":0.20981983256004713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006682699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99542075,0.0037004172,0.00011378735,0.000039084567,0.00002218286,0.0001277933,0.00002279048,0.000009347526,0.00054384035],"genre_scores_gemma":[0.997883,0.001193589,0.00058016484,0.00010579056,0.000077573175,0.000027527904,0.000021205802,0.00001694833,0.00009417422],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992067,0.000037129543,0.00014658815,0.00034458085,0.00007038618,0.00019456916],"domain_scores_gemma":[0.99971706,0.000019670533,0.00006632753,0.00010574153,0.000038972248,0.000052227053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007616114,0.00015002691,0.0001436716,0.00003828899,0.00004241226,0.000023255088,0.00008288099,0.00014276536,0.000003510473],"category_scores_gemma":[0.000057296184,0.00012902744,0.000023261617,0.000090073634,0.000085873,0.0000050962144,0.000052814194,0.00007870719,0.0000018718438],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038823873,0.0002002659,0.0137864435,0.000060210656,0.000033555618,0.00000328027,0.00022637307,0.000006355303,0.9855014,0.000022152024,0.000005821972,0.000115311326],"study_design_scores_gemma":[0.0018382963,0.00027486405,0.001281951,0.000037993625,0.000028299202,0.000008560861,0.00023988412,0.0000026865964,0.9956247,0.00013924492,0.0003533396,0.00017015779],"about_ca_topic_score_codex":0.000044547596,"about_ca_topic_score_gemma":0.00005577983,"teacher_disagreement_score":0.012504492,"about_ca_system_score_codex":0.0000056271138,"about_ca_system_score_gemma":0.000068027715,"threshold_uncertainty_score":0.52615863},"labels":[],"label_agreement":null},{"id":"W2006912293","doi":"10.1182/blood-2012-06-436295","title":"High-dimensional immunomonitoring models of HIV-1–specific CD8 T-cell responses accurately identify subjects achieving spontaneous viral control","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Institute of Allergy and Infectious Diseases; National Institute on Aging; National Heart, Lung, and Blood Institute; Massachusetts General Hospital; Howard Hughes Medical Institute","keywords":"Human immunodeficiency virus (HIV); Immunology; Medicine; CD8; Virology; Immune system","score_opus":0.0273224768866521,"score_gpt":0.2705195481230549,"score_spread":0.2431970712364028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006912293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97940177,0.018821757,0.000070927126,0.00003709105,0.00063641736,0.00032607958,0.00029034392,0.00006002215,0.00035560908],"genre_scores_gemma":[0.99789035,0.00015715267,0.00023419746,0.000012225037,0.00012061783,0.00003734044,0.00015897321,0.0000294682,0.0013596799],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99798185,0.00043702623,0.00039491846,0.00028382693,0.0001184277,0.0007839249],"domain_scores_gemma":[0.99876463,0.00051020633,0.00015193931,0.00039375565,0.00010022032,0.00007924458],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042020445,0.0002512812,0.00041062947,0.00017214406,0.00024024704,0.00002422291,0.00025664552,0.00019920019,0.00025089912],"category_scores_gemma":[0.000056322064,0.0002169777,0.00015153,0.00010069093,0.00015035672,0.0002686356,0.0001119909,0.00033266554,0.001252407],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018393461,0.0016043495,0.006836088,0.000021800723,0.00046269014,0.00028371593,0.0003201982,0.00004745724,0.9875145,0.0002521524,0.00022835663,0.00058936595],"study_design_scores_gemma":[0.014613812,0.00073243823,0.035043858,0.000087453234,0.00024841196,0.0014155132,0.00018606978,0.0000038011,0.94611627,0.00008842212,0.0010549913,0.00040895055],"about_ca_topic_score_codex":0.00013934416,"about_ca_topic_score_gemma":0.000004424162,"teacher_disagreement_score":0.0413982,"about_ca_system_score_codex":0.000053587817,"about_ca_system_score_gemma":0.00009344996,"threshold_uncertainty_score":0.99952525},"labels":[],"label_agreement":null},{"id":"W2006973868","doi":"10.1182/blood-2005-12-007005","title":"The Flt3 receptor tyrosine kinase collaborates with NUP98-HOX fusions in acute myeloid leukemia","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Cancerfonden; Terry Fox Foundation; Stem Cell Network; National Cancer Institute; Genome Canada","keywords":"Hox gene; Fms-Like Tyrosine Kinase 3; Myeloid leukemia; Cancer research; Biology; Haematopoiesis; Leukemia; Myeloid; Progenitor cell; Receptor tyrosine kinase; Tyrosine kinase; CD135; Transcription factor; Immunology; Stem cell; Cell biology; Genetics; Signal transduction; Mutation; Gene","score_opus":0.007726766008522415,"score_gpt":0.24947704544714133,"score_spread":0.24175027943861893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006973868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98508584,0.00129977,0.000014316958,0.005298105,0.00008457023,0.00092807366,0.000065581866,0.00012663323,0.00709708],"genre_scores_gemma":[0.97541887,0.0010839298,0.0036198527,0.00041181457,0.00058771955,0.00025722722,0.00020732499,0.00010997608,0.018303271],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977444,0.00010648824,0.00038937558,0.0004395896,0.0005826955,0.00073745305],"domain_scores_gemma":[0.99840945,0.00026402582,0.00009819493,0.0007018288,0.0003219354,0.00020457752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039805128,0.00028134935,0.00039511197,0.00018689255,0.00031701333,0.000093059876,0.00030741302,0.00016904683,0.00016505737],"category_scores_gemma":[0.00015828469,0.00017236517,0.00006373639,0.001548184,0.00030128527,0.000110644076,0.00013514062,0.00060879986,0.0002485087],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035721143,0.0021924656,0.15662943,0.00016070138,0.0006785927,0.0027573141,0.00055371964,0.00008337264,0.6614947,0.003096285,0.16272928,0.0060520456],"study_design_scores_gemma":[0.04283257,0.0026719358,0.25453195,0.00073036406,0.00093033205,0.0007360871,0.001162081,0.0005889187,0.4248632,0.00033509333,0.26944247,0.0011750204],"about_ca_topic_score_codex":0.0007003168,"about_ca_topic_score_gemma":0.0009265259,"teacher_disagreement_score":0.2366315,"about_ca_system_score_codex":0.00054136955,"about_ca_system_score_gemma":0.0015706841,"threshold_uncertainty_score":0.7028848},"labels":[],"label_agreement":null},{"id":"W2007022304","doi":"10.1182/blood-2008-09-179879","title":"Human T-cell leukemia virus type 2 produces a spliced antisense transcript encoding a protein that lacks a classic bZIP domain but still inhibits Tax2-mediated transcription","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and Retrovirus Studies","field":"Immunology and Microbiology","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"National Heart, Lung, and Blood Institute; University of California, San Francisco; Institut National de la Santé et de la Recherche Médicale","keywords":"Biology; Leucine zipper; Molecular biology; Transcription (linguistics); Polyadenylation; Virology; Human T-lymphotropic virus 1; CREB; Long terminal repeat; RNA; Gene; T-cell leukemia; Virus; Genetics; Transcription factor; Genome","score_opus":0.018560021480535576,"score_gpt":0.22249725391355782,"score_spread":0.20393723243302225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007022304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887187,0.0061025238,0.000018294031,0.00026862152,0.00040760238,0.0011085196,0.000086951964,0.00032613557,0.002962673],"genre_scores_gemma":[0.99437803,0.00022831754,0.00010796689,0.00020582441,0.000117515265,0.00005656617,0.00011867235,0.000038649738,0.004748428],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997635,0.0002760767,0.0004793528,0.00072279025,0.00011487827,0.00077186606],"domain_scores_gemma":[0.9992348,0.000031618678,0.00021403411,0.00035892258,0.000097616066,0.00006302804],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028747463,0.0004714504,0.0005921176,0.00020934973,0.00049630087,0.0000447456,0.0002574996,0.00048817004,0.00011320923],"category_scores_gemma":[0.000036184585,0.00039248855,0.00019703682,0.0003455281,0.00027103175,0.00016547953,0.000029796407,0.00063738093,0.00029731652],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027664352,0.00089900417,0.0002416057,0.000085349326,0.00018547477,0.00005315396,0.0029011925,9.791949e-7,0.99415976,0.00013524725,0.0005604412,0.00050114223],"study_design_scores_gemma":[0.0063111223,0.0011141154,0.0017442437,0.00016212839,0.0002316285,0.000064904925,0.00058885175,7.8483623e-7,0.981779,0.00017166979,0.00732157,0.0005100165],"about_ca_topic_score_codex":0.00025622887,"about_ca_topic_score_gemma":0.0002805083,"teacher_disagreement_score":0.012380802,"about_ca_system_score_codex":0.000078898396,"about_ca_system_score_gemma":0.00012136078,"threshold_uncertainty_score":0.9998527},"labels":[],"label_agreement":null},{"id":"W2007146182","doi":"10.1182/blood-2011-03-345991","title":"The mismatch repair pathway functions normally at a non-AID target in germinal center B cells","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"Germinal center; Mutation frequency; Molecular biology; Biology; MSH2; Mutation; Mutagenesis; DNA mismatch repair; Somatic hypermutation; Reporter gene; B cell; Gene; Genetics; Antibody; Gene expression; DNA repair","score_opus":0.014843159660449943,"score_gpt":0.21600891307552442,"score_spread":0.20116575341507448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007146182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.967013,0.00024280511,0.00001307334,0.00011189364,0.0006351121,0.00039576713,0.00001875528,0.00006181378,0.031507783],"genre_scores_gemma":[0.9894069,0.000035944922,0.002209584,0.00027230463,0.00015308782,0.00009480698,0.0000086064765,0.000027618418,0.00779119],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988549,0.00003741555,0.000268971,0.0002564485,0.00022533118,0.00035694297],"domain_scores_gemma":[0.99927706,0.000052799394,0.00006111319,0.0004254814,0.000064118656,0.00011940867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019420635,0.00014958228,0.00017728952,0.00005193973,0.000110559755,0.000007828115,0.00012322176,0.000097595825,0.00073238753],"category_scores_gemma":[0.000033561108,0.000104337414,0.00012919317,0.0001419292,0.00008130829,0.000028683888,0.000098267825,0.00021523194,0.00026750885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010860227,0.002243906,0.8908949,0.00013178715,0.00021813203,0.00042099968,0.0043477425,0.0000048332113,0.07907148,0.000012101279,0.020485787,0.0010823489],"study_design_scores_gemma":[0.0074941944,0.0016113287,0.5074001,0.00014037994,0.00019557822,0.00039122588,0.00047817183,0.00011796462,0.38549933,0.00008380292,0.09618643,0.00040147785],"about_ca_topic_score_codex":0.00008967509,"about_ca_topic_score_gemma":0.00043648886,"teacher_disagreement_score":0.38349476,"about_ca_system_score_codex":0.00007591428,"about_ca_system_score_gemma":0.00012535801,"threshold_uncertainty_score":0.80191296},"labels":[],"label_agreement":null},{"id":"W2007270178","doi":"10.1182/blood.v100.7.2530","title":"Heparin acts synergistically with interleukin-11 to induce STAT3 activation and in vitro osteoclast formation","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Hamilton General Hospital","funders":"","keywords":"Heparin; Osteoclast; Chemistry; RANKL; Cell biology; Tyrosine phosphorylation; STAT protein; Cytokine; STAT3; Endocrinology; Internal medicine; Signal transduction; Activator (genetics); Biology; Receptor; Immunology; Biochemistry; Medicine","score_opus":0.023057572708047633,"score_gpt":0.24249333435587453,"score_spread":0.2194357616478269,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007270178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99472296,0.0000077478135,0.0014209725,0.00091916416,0.000024866817,0.00024740762,0.000006517559,0.000034278906,0.0026160642],"genre_scores_gemma":[0.9980068,0.0000045289275,0.0013751114,0.00033897854,0.00006105749,0.00002658869,0.000021575257,0.000013170913,0.00015219324],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99936575,0.000016172507,0.00018228656,0.00015434103,0.00013316926,0.00014830998],"domain_scores_gemma":[0.9996122,0.000052727955,0.00004696269,0.00012130832,0.000063915904,0.00010289908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005588928,0.00009681005,0.00014398732,0.00016827523,0.00003546723,0.00003121155,0.000029045339,0.000042381802,0.00006438195],"category_scores_gemma":[0.00012587321,0.00007950321,0.000016260678,0.00018457485,0.000015727393,0.00019666362,0.000021103055,0.00014252403,0.000020893809],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003444236,0.0005111081,0.0012337901,0.000048559297,0.000022440589,0.00002880565,0.0011141152,0.000019127228,0.992927,0.00010727035,0.00021887595,0.0034244813],"study_design_scores_gemma":[0.0028921983,0.00071156037,0.012978096,0.00038257538,0.00006446247,0.00019492034,0.00029546057,0.001372306,0.9774383,0.000011868565,0.0035092682,0.00014904056],"about_ca_topic_score_codex":0.00006431441,"about_ca_topic_score_gemma":0.00015085848,"teacher_disagreement_score":0.01548876,"about_ca_system_score_codex":0.000047023328,"about_ca_system_score_gemma":0.000016664182,"threshold_uncertainty_score":0.32420468},"labels":[],"label_agreement":null},{"id":"W2007298542","doi":"10.1182/blood-2012-03-417782","title":"Histoplasmosis-induced pancytopenia","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Fungal Infections and Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Pancytopenia; Hydroxychloroquine; Medicine; Histoplasmosis; Methotrexate; Rheumatoid arthritis; Antibiotics; Dry cough; Surgery; Dermatology; Internal medicine; Bone marrow; Coronavirus disease 2019 (COVID-19)","score_opus":0.03183165498282705,"score_gpt":0.27370820067089296,"score_spread":0.2418765456880659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007298542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9418902,0.0009715071,0.000004893034,0.00030736788,0.00027655598,0.00008416578,0.0000010473611,0.000054389246,0.056409884],"genre_scores_gemma":[0.9969103,0.000033024993,0.00033563148,0.00021092825,0.0002837374,0.00001747618,0.0000016810772,0.000007976448,0.002199246],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99961936,0.0000074708814,0.00007794122,0.000065730834,0.00006783571,0.00016163972],"domain_scores_gemma":[0.99974936,0.000016612808,0.000015774209,0.00012272732,0.000027209122,0.00006832929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000058084217,0.000059109996,0.0001223355,0.000028703398,0.00007287109,0.0000035834055,0.000016363007,0.00003366907,0.000113225775],"category_scores_gemma":[0.000039366343,0.00004603288,0.00004709251,0.00007348035,0.0000117787295,0.000044935707,0.000016658158,0.000074351185,0.00023836269],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021590766,0.0017599398,0.87082714,0.000048742288,0.00021229396,0.000013770972,0.0006176389,3.6251212e-8,0.11545517,0.0013486651,0.0077142357,0.0019807734],"study_design_scores_gemma":[0.0026326997,0.0003553822,0.77382636,0.00004209031,0.00048257297,0.00027075913,0.0001254044,0.0000017039373,0.10759157,0.000022827318,0.11447212,0.0001765256],"about_ca_topic_score_codex":0.000021677699,"about_ca_topic_score_gemma":0.0000043234595,"teacher_disagreement_score":0.10675789,"about_ca_system_score_codex":0.000015351403,"about_ca_system_score_gemma":0.000012373441,"threshold_uncertainty_score":0.30637497},"labels":[],"label_agreement":null},{"id":"W2007353818","doi":"10.1182/blood.v99.4.1267","title":"Functional in vivo characterization of human monoclonal anti-D in NOD-scid mice","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Héma-Québec","funders":"","keywords":"Monoclonal antibody; In vivo; Isotype; Polyclonal antibodies; Monoclonal; Nod; Molecular biology; Antibody; In vitro; Immunology; Biology; Biochemistry","score_opus":0.01893994694862592,"score_gpt":0.22061156430668222,"score_spread":0.2016716173580563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007353818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982083,0.00006140961,0.000019806386,0.00027845276,0.000051210976,0.00015716092,0.000011285168,0.00001326446,0.0011991411],"genre_scores_gemma":[0.99936754,0.000044445376,0.000068333626,0.00009642377,0.00009226459,0.000007379261,0.000054840915,0.00001030117,0.000258495],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9993204,0.000016357533,0.00023891592,0.00015201198,0.0001533503,0.000118961354],"domain_scores_gemma":[0.9997908,0.000009871565,0.00004222146,0.0000936605,0.000028740038,0.00003474124],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000075644726,0.00007573568,0.00018118415,0.00015892844,0.000019969406,0.0000034977725,0.000030911277,0.00007194432,0.00094969454],"category_scores_gemma":[0.000006010507,0.000073033094,0.00003826442,0.00022639279,0.000022023178,0.0000619735,0.000009111081,0.00011458463,0.000017480415],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001791127,0.0013418068,0.2536804,0.00004034265,0.000011452912,0.000021616463,0.00014966319,7.393758e-7,0.7444305,0.00010649957,0.00001586003,0.00018323664],"study_design_scores_gemma":[0.0046653864,0.00015127148,0.84174746,0.00010628168,0.000042310712,0.000026967708,0.000012380877,0.00011835794,0.15292273,0.000018251523,0.00012207664,0.00006652931],"about_ca_topic_score_codex":0.000066965666,"about_ca_topic_score_gemma":0.00006153957,"teacher_disagreement_score":0.59150773,"about_ca_system_score_codex":0.000008854508,"about_ca_system_score_gemma":0.000009404965,"threshold_uncertainty_score":0.9999636},"labels":[],"label_agreement":null},{"id":"W2007385256","doi":"10.1182/blood-2014-05-574491","title":"Oxidized LDL activates blood platelets through CD36/NOX2–mediated inhibition of the cGMP/protein kinase G signaling cascade","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":171,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"British Heart Foundation","keywords":"CD36; Platelet activation; NADPH oxidase; Protein kinase C; Platelet; Chemistry; Signal transduction; Cell biology; Kinase; Reactive oxygen species; Internal medicine; Endocrinology; Biochemistry; Biology; Medicine; Receptor","score_opus":0.021207337023983402,"score_gpt":0.23848051120313346,"score_spread":0.21727317417915007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007385256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927637,0.0051718624,0.00006931628,0.0003235432,0.00009066091,0.00077160477,0.00003196706,0.00012066411,0.0006567101],"genre_scores_gemma":[0.9987032,0.00016519935,0.00037041618,0.00026393755,0.0002292795,0.00004689792,0.00006128912,0.00004946569,0.000110341214],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981031,0.00020021654,0.00039366612,0.00033657555,0.0006248841,0.00034157594],"domain_scores_gemma":[0.9988456,0.0000805417,0.00019811823,0.00053856795,0.00014555687,0.00019166114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029713666,0.00026650334,0.0005371105,0.00005411977,0.00010728499,0.000019521483,0.00014241357,0.0002081198,0.00008594382],"category_scores_gemma":[0.0002912728,0.00018759213,0.0005067272,0.0003908921,0.00017845842,0.0001588424,0.000068198075,0.00028264767,0.000021696618],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006325199,0.0013781993,0.0009447561,0.00014722208,0.0013265535,0.00038514665,0.00065415725,0.000021986476,0.9937005,0.00012827774,0.00007515769,0.00060551777],"study_design_scores_gemma":[0.01534053,0.00028905604,0.00058284047,0.00046893145,0.0012075454,0.0002470328,0.00037796528,0.000011618072,0.98008025,0.00042371912,0.000751413,0.00021909091],"about_ca_topic_score_codex":0.000065460736,"about_ca_topic_score_gemma":0.0000019452448,"teacher_disagreement_score":0.0147080105,"about_ca_system_score_codex":0.000019993608,"about_ca_system_score_gemma":0.0002263589,"threshold_uncertainty_score":0.76497847},"labels":[],"label_agreement":null},{"id":"W2007395789","doi":"10.1182/blood-2002-10-3317","title":"A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura","year":2003,"lang":"en","type":"review","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":296,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"McMaster University","keywords":"Medicine; Pregnancy; Thrombocytopenic purpura; Retrospective cohort study; Platelet; Vaginal delivery; Obstetrics; Pediatrics; Surgery; Internal medicine","score_opus":0.018572669313958918,"score_gpt":0.2743404891673682,"score_spread":0.2557678198534093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007395789","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.037287306,0.95965254,0.0000017982547,0.0000014701039,0.000053180564,0.0012831191,0.00017323869,0.00002601459,0.001521313],"genre_scores_gemma":[0.047902036,0.9512037,0.00009798442,0.000011509097,0.000014462008,0.00007324777,0.00045925865,0.000066246124,0.00017157238],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99784726,0.000095893585,0.00061670854,0.000571514,0.000554367,0.00031426336],"domain_scores_gemma":[0.9983084,0.000031401847,0.0006175081,0.00068862486,0.00022549824,0.00012857172],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000097347845,0.00047705942,0.004455902,0.0008984338,0.00004817961,0.000015612048,0.0001454666,0.0002887354,0.00009546644],"category_scores_gemma":[0.00010096502,0.00030886574,0.00087350915,0.003837475,0.00006334991,0.000050721676,0.00003595257,0.00029069977,0.000037579364],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010976674,0.017944822,0.69540966,0.023155201,0.12308332,0.0018358156,0.00020741676,6.495366e-7,3.420388e-7,0.00029050064,0.00007699673,0.13788553],"study_design_scores_gemma":[0.02594591,0.004565011,0.16088183,0.02761476,0.67712265,0.00020457123,0.00005854127,0.000001476723,0.000006376356,0.00003690627,0.10194207,0.0016199204],"about_ca_topic_score_codex":0.000029473356,"about_ca_topic_score_gemma":0.000019801613,"teacher_disagreement_score":0.5540393,"about_ca_system_score_codex":0.00015455391,"about_ca_system_score_gemma":0.0003091182,"threshold_uncertainty_score":0.99993634},"labels":[],"label_agreement":null},{"id":"W2007616371","doi":"10.1182/blood-2012-11-469403","title":"Correlation between phenotype and genotype in a large unselected cohort of children with severe hemophilia A","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Phenotype; Genotype; Medicine; Correlation; Cohort; Genetics; Internal medicine; Biology; Immunology; Gene","score_opus":0.009028706794891178,"score_gpt":0.2418158853486646,"score_spread":0.23278717855377343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007616371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99766487,0.00022132667,0.000011720115,0.0001669777,0.0000048102966,0.0009412402,0.000010423427,0.000022572834,0.00095604645],"genre_scores_gemma":[0.99887854,0.000035908404,0.00030095686,0.000017145205,0.000046032677,0.00002241373,0.0001502245,0.000015736126,0.0005330169],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992159,0.000029752777,0.00015466232,0.00018096506,0.00020553457,0.00021315648],"domain_scores_gemma":[0.9995799,0.00003717262,0.00003929965,0.00015079803,0.000098949364,0.000093895665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000095128366,0.00010045198,0.00024790192,0.00011591785,0.000029662844,0.000006962068,0.000030056486,0.00008886548,0.00012468215],"category_scores_gemma":[0.00003195555,0.00007000449,0.000018813984,0.00030445642,0.000043302658,0.00005660195,0.000020609667,0.00015018925,0.000031480882],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000561341,0.0003489837,0.9976536,0.00003072035,0.00022268975,0.000008975679,0.0001481018,5.4973367e-7,0.0006558091,0.000024054112,0.000026328162,0.0008240327],"study_design_scores_gemma":[0.0053305007,0.00051306107,0.992505,0.00006331383,0.00020076979,0.000044384647,0.000010997471,0.00006466889,0.0011227311,0.00005967246,0.000008528472,0.00007638397],"about_ca_topic_score_codex":0.00023940612,"about_ca_topic_score_gemma":0.00004147071,"teacher_disagreement_score":0.0052743666,"about_ca_system_score_codex":0.00001553756,"about_ca_system_score_gemma":0.00007800936,"threshold_uncertainty_score":0.28547004},"labels":[],"label_agreement":null},{"id":"W2007660268","doi":"10.1182/blood-2011-05-349662","title":"Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Center for Research Resources; National Cancer Institute; Children’s Oncology Group; National Institutes of Health; University of Nebraska Medical Center","keywords":"Lymphoma; Germinal center; Gene expression profiling; Diffuse large B-cell lymphoma; Cancer research; Biology; B cell; Gene rearrangement; Medicine; Oncology; Pathology; Immunology; Gene; Gene expression; Genetics; Antibody","score_opus":0.010796418517869978,"score_gpt":0.24668723805357745,"score_spread":0.23589081953570748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007660268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903374,0.005120996,0.00009072407,0.00012745442,0.00016853266,0.0005122732,0.000041223528,0.000062669285,0.0035387445],"genre_scores_gemma":[0.9960404,0.00022545381,0.002393765,0.00012488088,0.0007454953,0.00010907691,0.00012812132,0.000036446057,0.0001963832],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989096,0.000024847643,0.00023366365,0.0002840308,0.00018297642,0.00036486215],"domain_scores_gemma":[0.9993012,0.000050430095,0.00008989725,0.0002982981,0.000055723383,0.00020442875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007035375,0.00020416811,0.0002787619,0.000061486935,0.000121828954,0.000033917095,0.000055210843,0.00012987596,0.000032824595],"category_scores_gemma":[0.00002372168,0.0001696541,0.00010494251,0.0001611154,0.000028873068,0.000109420755,0.000065245404,0.0000873736,0.00010294723],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015785605,0.0014928445,0.99356884,0.00013893966,0.00018302878,0.000068772715,0.00037138083,3.2798252e-7,0.0032197929,0.00036199627,0.00024789185,0.0003304021],"study_design_scores_gemma":[0.007111493,0.00014713491,0.91965055,0.000025647487,0.002754939,0.000105459396,0.00014456894,0.0000030919007,0.06948496,0.00006650038,0.0002930013,0.00021265584],"about_ca_topic_score_codex":0.00007306221,"about_ca_topic_score_gemma":0.0000012565225,"teacher_disagreement_score":0.07391829,"about_ca_system_score_codex":0.00006001756,"about_ca_system_score_gemma":0.00005704191,"threshold_uncertainty_score":0.6918294},"labels":[],"label_agreement":null},{"id":"W2007778917","doi":"10.1182/blood-2013-07-510941","title":"Transplants for the elderly in myeloma","year":2013,"lang":"en","type":"letter","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Multiple myeloma; Medicine; Lenalidomide; Internal medicine; Oncology","score_opus":0.033832379600919636,"score_gpt":0.2917235550615796,"score_spread":0.25789117546066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007778917","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.118305154,0.003932691,0.00007498314,0.86436355,0.0003443529,0.007964468,0.00066116644,0.000106318475,0.0042472933],"genre_scores_gemma":[0.29581818,0.0026398737,0.0032141302,0.5983869,0.015851766,0.010198484,0.0061794613,0.0005736234,0.06713759],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984365,0.00004380337,0.00023026584,0.00032815247,0.0003803421,0.00058094785],"domain_scores_gemma":[0.99888,0.00046961452,0.0000498856,0.0004576021,0.000060249407,0.00008259906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010072889,0.00024931107,0.00038821375,0.00013841942,0.00006484261,0.00003418428,0.0002101624,0.0004328986,0.00024161187],"category_scores_gemma":[0.00006183391,0.00014481443,0.00018647687,0.00009212635,0.000054471053,0.000032893113,0.000015651009,0.0008931512,0.00021440179],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021305976,0.0008003418,0.0100445375,0.0011036457,0.0013748587,0.0038824235,0.00016237458,1.15946364e-7,0.0002452176,0.000005014535,0.9400043,0.042164147],"study_design_scores_gemma":[0.028128954,0.0016760466,0.057845194,0.0006699785,0.0010478377,0.00036397073,0.000025010719,0.000059773756,0.0016675637,0.00012720433,0.90801394,0.0003745032],"about_ca_topic_score_codex":0.00027097642,"about_ca_topic_score_gemma":0.00006646064,"teacher_disagreement_score":0.2659767,"about_ca_system_score_codex":0.00003098327,"about_ca_system_score_gemma":0.00012665827,"threshold_uncertainty_score":0.5905361},"labels":[],"label_agreement":null},{"id":"W2007928017","doi":"10.1182/blood-2012-02-409763","title":"Reduced intensity conditioning is superior to nonmyeloablative conditioning for older chronic myelogenous leukemia patients undergoing hematopoietic cell transplant during the tyrosine kinase inhibitor era","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"National Cancer Institute; National Blood Foundation; Genentech; Astellas Pharma; Office of Naval Research; Be The Match Foundation; Eisai; CellGenix; Medical College of Wisconsin; HistoGenetics; National Heart, Lung, and Blood Institute; Blue Cross and Blue Shield Association; National Institute of Allergy and Infectious Diseases; Celgene; Biogen; Health Resources and Services Administration; Astellas Pharma US; Amgen; IC Design Education Center","keywords":"Medicine; Internal medicine; Chronic myelogenous leukemia; Imatinib; Gastroenterology; Graft-versus-host disease; Leukemia; Cohort; Tyrosine-kinase inhibitor; Hematopoietic stem cell transplantation; Transplantation; Surgery; Cancer; Myeloid leukemia","score_opus":0.009481520573364446,"score_gpt":0.232201296206451,"score_spread":0.22271977563308654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007928017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99534893,0.0006955745,0.00020512466,0.00031387171,0.00038673935,0.00244943,0.000255584,0.00012551674,0.00021920758],"genre_scores_gemma":[0.99653023,0.000035056823,0.0008146909,0.00058461487,0.0006776434,0.00039588616,0.00043696197,0.000103688304,0.00042123167],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974389,0.000058261125,0.0005640141,0.00055529963,0.0004076693,0.00097583927],"domain_scores_gemma":[0.99839866,0.00025720132,0.00019411185,0.00050739764,0.00025043474,0.0003921731],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019855879,0.00045369248,0.00058153167,0.00015212671,0.0007736985,0.000060118087,0.0001523652,0.00018167747,0.00026494492],"category_scores_gemma":[0.00010143761,0.00037184273,0.00023436228,0.00027562628,0.00011521316,0.00026436435,0.00008198172,0.00038005254,0.00011379747],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016995862,0.0049255975,0.23437378,0.0042634155,0.0022039306,0.00024340468,0.0785671,0.00022629206,0.67046106,0.00017207183,0.002006522,0.0008572634],"study_design_scores_gemma":[0.02351065,0.00085192174,0.18478204,0.0012776477,0.0011719263,0.0003105901,0.00093235297,0.00005410787,0.7864128,0.000018096887,0.0001542335,0.0005236758],"about_ca_topic_score_codex":0.000064771506,"about_ca_topic_score_gemma":0.000022827133,"teacher_disagreement_score":0.11595172,"about_ca_system_score_codex":0.002437476,"about_ca_system_score_gemma":0.00073252805,"threshold_uncertainty_score":0.99987334},"labels":[],"label_agreement":null},{"id":"W2007968891","doi":"10.1182/blood-2002-10-3035","title":"Repopulating defect of mismatch repair–deficient hematopoietic stem cells","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; University of Toronto; Amgen","keywords":"Biology; Stem cell; MSH2; Haematopoiesis; Progenitor cell; Cancer research; Bone marrow; Immunology; Molecular biology; DNA mismatch repair; Cell biology; DNA repair; Genetics","score_opus":0.020882344073851616,"score_gpt":0.25294995462632947,"score_spread":0.23206761055247785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007968891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98728144,0.0012733049,0.000047005185,0.000016217673,0.00028021206,0.0003470764,0.00000242576,0.000089116606,0.010663188],"genre_scores_gemma":[0.994016,0.000010234214,0.005226499,0.000055268825,0.00002678761,0.00001696637,0.0000010166856,0.000028248167,0.00061897683],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986383,0.00006496209,0.00041968055,0.00028975238,0.00034268826,0.00024465795],"domain_scores_gemma":[0.99907726,0.0000811695,0.00014897856,0.0005060615,0.00008918463,0.00009735595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002988593,0.00013934865,0.00033319488,0.00005853071,0.000037685728,0.000005194461,0.000057252997,0.00008978934,0.00014954232],"category_scores_gemma":[0.00010926078,0.00012295731,0.00023832625,0.0002202298,0.000044294153,0.000011767995,0.000026670385,0.00012298893,0.000021991244],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000097362354,0.002092316,0.33835977,0.002023641,0.00044963553,0.00021722101,0.0029974997,0.00024327807,0.65061754,0.00085351005,0.0013129913,0.0007352366],"study_design_scores_gemma":[0.0016020045,0.00050480146,0.002771008,0.00021919132,0.00037522276,0.00032809319,0.00044490906,0.00003545886,0.9925157,0.00008905646,0.00095633225,0.00015826857],"about_ca_topic_score_codex":0.000019378294,"about_ca_topic_score_gemma":0.000003720106,"teacher_disagreement_score":0.3418981,"about_ca_system_score_codex":0.000037879174,"about_ca_system_score_gemma":0.00009508727,"threshold_uncertainty_score":0.50140536},"labels":[],"label_agreement":null},{"id":"W2008136854","doi":"10.1182/blood-2012-10-464248","title":"Treatment outcomes following leukemic transformation in Philadelphia-negative myeloproliferative neoplasms","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Hematologic Neoplasms; Transplantation; Population; Oncology; Internal medicine; Myelofibrosis; Intensive care medicine; Immunology; Bone marrow","score_opus":0.020425017707359622,"score_gpt":0.2917525927474074,"score_spread":0.2713275750400478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008136854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866506,0.00009897485,0.000069331145,0.006220725,0.00005840374,0.0018785911,0.000008202818,0.000088322005,0.0049268515],"genre_scores_gemma":[0.9970181,0.00007671177,0.0010967766,0.0002998155,0.000056896886,0.0005711963,0.00004389526,0.000032815096,0.00080378185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99838394,0.00007965031,0.000403149,0.00030371762,0.0003648159,0.00046475002],"domain_scores_gemma":[0.9992173,0.00020701518,0.000055447123,0.00026120243,0.0000824342,0.00017662061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012207459,0.0002623371,0.0004936076,0.0002887951,0.000082799335,0.00004021725,0.000100615405,0.00014034289,0.00015599804],"category_scores_gemma":[0.00013239498,0.00019120911,0.00019253795,0.0003586334,0.000050735904,0.00041223186,0.000021925503,0.00028821226,0.00040596066],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048455276,0.0050071543,0.83185714,0.00027209488,0.003323721,0.0009612146,0.06689336,0.00012443184,0.068299785,0.0016607714,0.00069700665,0.02041874],"study_design_scores_gemma":[0.06782505,0.0027406604,0.7888274,0.00027531618,0.00061999616,0.0002442384,0.006281653,0.0049599507,0.12547635,0.0014906797,0.00045348963,0.000805236],"about_ca_topic_score_codex":0.0009199202,"about_ca_topic_score_gemma":0.000103230566,"teacher_disagreement_score":0.06734049,"about_ca_system_score_codex":0.0007426083,"about_ca_system_score_gemma":0.00039606608,"threshold_uncertainty_score":0.7797282},"labels":[],"label_agreement":null},{"id":"W2008210335","doi":"10.1182/blood-2012-01-404673","title":"Early posttransplantation donor-derived invariant natural killer T-cell recovery predicts the occurrence of acute graft-versus-host disease and overall survival","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":116,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Erasmus+; National Institutes of Health; Institut National Du Cancer; Ligue Contre le Cancer","keywords":"Graft-versus-host disease; Immunology; Disease; Medicine; Internal medicine","score_opus":0.012150835836362684,"score_gpt":0.2187958470600778,"score_spread":0.20664501122371512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008210335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98912525,0.0019781662,0.000046952926,0.00011623958,0.0078988345,0.00021361622,0.000073678595,0.0000306888,0.0005165577],"genre_scores_gemma":[0.9973979,0.00078155415,0.000011673255,0.00009991821,0.000050781437,0.000011293477,0.0003957341,0.000008050035,0.0012430735],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99916553,0.0001791093,0.00021246141,0.0001618291,0.00004551634,0.00023552972],"domain_scores_gemma":[0.99943304,0.00016899321,0.00013381238,0.00017915109,0.000051502815,0.00003349013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001399046,0.00014245008,0.00014642537,0.000051387677,0.00014111071,0.000018166244,0.000105336265,0.00009920236,0.00023103571],"category_scores_gemma":[0.00002941049,0.00010395534,0.00007662251,0.000056684046,0.000107981716,0.0003627104,0.000037997845,0.00025088072,0.000095510615],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004436554,0.0005764215,0.010479009,0.00004358379,0.000823706,0.0000030637066,0.0012143413,0.0000011003457,0.98022246,0.0002427585,0.0018495453,0.000107473505],"study_design_scores_gemma":[0.012353697,0.0007920857,0.73726845,0.00009498615,0.001993884,0.000066644076,0.00025743415,0.00000768452,0.2415867,0.000023162327,0.0051221154,0.00043314384],"about_ca_topic_score_codex":0.0001301231,"about_ca_topic_score_gemma":0.000006989514,"teacher_disagreement_score":0.7386357,"about_ca_system_score_codex":0.0000102456925,"about_ca_system_score_gemma":0.000032298998,"threshold_uncertainty_score":0.42391756},"labels":[],"label_agreement":null},{"id":"W2008312111","doi":"10.1182/blood-2005-06-2448","title":"A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":313,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"NIH Clinical Center","keywords":"Leukemia; Medicine; Trisomy; Down syndrome; Incidence (geometry); Acute leukemia; White blood cell; Aneuploidy; Internal medicine; Prospective cohort study; Gastroenterology; Pediatrics; Immunology; Biology; Chromosome","score_opus":0.006028763279400138,"score_gpt":0.23176401465875282,"score_spread":0.22573525137935269,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008312111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933098,0.00076911517,0.0000022699617,0.00006313957,0.00010291953,0.0046979557,0.000009703601,0.00003196813,0.001013104],"genre_scores_gemma":[0.9990473,0.000003260079,0.00009732155,0.000028723507,0.00004562392,0.00022144249,0.000007484273,0.00003977688,0.0005090969],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973026,0.0002650265,0.00058966555,0.0005071622,0.00092319906,0.00041236827],"domain_scores_gemma":[0.99872965,0.00018653505,0.00023449416,0.0005780582,0.00019676946,0.00007448393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036122493,0.0002709904,0.0007803856,0.00027631078,0.00004251002,0.0000043294926,0.000353212,0.0001193361,0.000027298556],"category_scores_gemma":[0.00006786788,0.00016737274,0.000096506184,0.0005960987,0.0003608337,0.000070048794,0.00012100547,0.0006004105,0.0000024199198],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022407442,0.02903787,0.94933766,0.000104955565,0.0011646347,0.0010714395,0.0122253,0.00008355637,0.004125701,0.00005688248,0.00024075847,0.00031049486],"study_design_scores_gemma":[0.04164763,0.01326561,0.94030327,0.0001237417,0.0008229425,0.00070899667,0.0024576313,0.000046110297,0.0004238275,0.000016817743,0.000025619293,0.00015779895],"about_ca_topic_score_codex":0.009008536,"about_ca_topic_score_gemma":0.0046293633,"teacher_disagreement_score":0.039406884,"about_ca_system_score_codex":0.0027737948,"about_ca_system_score_gemma":0.0018215736,"threshold_uncertainty_score":0.99759054},"labels":[],"label_agreement":null},{"id":"W2008326745","doi":"10.1182/blood-2004-06-2226","title":"Intracellular kinetics of iron in reticulocytes: evidence for endosome involvement in iron targeting to mitochondria","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Endosome; Ferrochelatase; Biochemistry; Chemistry; Bafilomycin; Mitochondrion; Endocytosis; Cell biology; Ferritin; Vesicle; Biophysics; Protoporphyrin IX; Intracellular; Heme; Biology; Autophagy; Membrane; Cell; Enzyme","score_opus":0.02445356779532205,"score_gpt":0.281827063362233,"score_spread":0.25737349556691097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008326745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913801,0.005595826,0.0007731211,0.00084627914,0.00011883759,0.0011784146,0.000004487622,0.000014168643,0.000088766355],"genre_scores_gemma":[0.9718585,0.0002588938,0.027361779,0.0002553452,0.000100558915,0.00009430349,0.000015459795,0.000020997533,0.000034143628],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99867177,0.000027331798,0.00047454215,0.00027827066,0.00023254166,0.00031556602],"domain_scores_gemma":[0.9994471,0.00008040281,0.00008069101,0.00024421804,0.000050642233,0.0000969163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002344785,0.0001425269,0.0003161127,0.00020211504,0.000011895486,0.000006503774,0.00010864526,0.00008360969,0.000019277224],"category_scores_gemma":[0.00073795096,0.00013642055,0.000059258786,0.00028454117,0.00003690261,0.00005922542,0.000042838557,0.00011482784,0.0000073940823],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027744487,0.0014744664,0.018335875,0.0009364016,0.000004990851,0.000029111394,0.0025130438,0.00075011613,0.9745515,0.00069052196,0.00005759043,0.00037894017],"study_design_scores_gemma":[0.01684005,0.0012833071,0.02410118,0.0013676299,0.00017644624,0.0000041279577,0.0016469341,0.00002051898,0.95298177,0.0007394847,0.0005563651,0.0002821955],"about_ca_topic_score_codex":0.00021572868,"about_ca_topic_score_gemma":0.0001495038,"teacher_disagreement_score":0.026588656,"about_ca_system_score_codex":0.00005659097,"about_ca_system_score_gemma":0.00006431049,"threshold_uncertainty_score":0.55630684},"labels":[],"label_agreement":null},{"id":"W2008342326","doi":"10.1182/blood-2010-07-298372","title":"Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency)","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":366,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Centre National de la Recherche Scientifique; Institut National de la Santé et de la Recherche Médicale; Fondazione Ettore e Valeria Rossi; Agence Nationale de la Recherche","keywords":"Hemophagocytic lymphohistiocytosis; Hypogammaglobulinemia; Medicine; Cytopenia; Lymphocytosis; Lymphoproliferative disorders; Immunology; Biology; Lymphoma; Internal medicine; Antibody","score_opus":0.02949412575552594,"score_gpt":0.3027363798567036,"score_spread":0.27324225410117764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008342326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951787,0.00074488134,0.0000042252864,0.00006943345,0.0002846462,0.00046431948,0.00001581405,0.00004342718,0.0031945722],"genre_scores_gemma":[0.998959,0.00027945678,0.0003367561,0.00005407197,0.00003452092,0.000011678193,0.000031134907,0.000025032137,0.00026833115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980671,0.000076789765,0.00052874873,0.0003878401,0.0005613173,0.00037823574],"domain_scores_gemma":[0.9984781,0.00023693476,0.00016704696,0.0004112332,0.0005477835,0.00015891102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027518472,0.00022449046,0.00058468943,0.00014382649,0.00015556812,0.00003107039,0.00019770318,0.00022211834,0.00021277965],"category_scores_gemma":[0.00063775724,0.00015941446,0.00006854231,0.00037188246,0.00074904965,0.00013532762,0.000110814384,0.00046273886,0.000027086959],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014983665,0.0016335734,0.993647,0.00019341009,0.00012582683,0.000027763628,0.00040768652,3.734862e-7,0.00070000155,0.00048358913,0.000065915665,0.0012164955],"study_design_scores_gemma":[0.009225345,0.005835247,0.9830136,0.00008446316,0.00022296577,0.000023852876,0.0004704712,0.000046359215,0.0005046148,0.00007147198,0.00027139272,0.00023025734],"about_ca_topic_score_codex":0.000030813942,"about_ca_topic_score_gemma":0.000026123964,"teacher_disagreement_score":0.010633439,"about_ca_system_score_codex":0.000010752215,"about_ca_system_score_gemma":0.0005225384,"threshold_uncertainty_score":0.6500733},"labels":[],"label_agreement":null},{"id":"W2008583594","doi":"10.1182/blood-2010-01-266882","title":"An adult uterine hemangioblast: evidence for extramedullary self-renewal and clonal bilineage potential","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Hemangioblast; Stem cell; Biology; Cell biology; Totipotent; Haematopoiesis; Multipotent Stem Cell; Hematopoietic stem cell; Embryonic stem cell; Cellular differentiation; Progenitor cell; Immunology; Genetics","score_opus":0.02670289418559584,"score_gpt":0.35326761301647114,"score_spread":0.3265647188308753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008583594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973543,0.00030679518,0.00038972558,0.00061770197,0.0001877703,0.000768323,0.000019842342,0.00010133697,0.00025418896],"genre_scores_gemma":[0.97557396,0.00009759414,0.022317715,0.00013625584,0.0011306364,0.00007087337,0.00002654486,0.000035879722,0.0006105156],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983976,0.00003703641,0.00025758773,0.00045104948,0.0004431388,0.0004136051],"domain_scores_gemma":[0.9985974,0.00018828585,0.00005126286,0.0004442369,0.00025864906,0.00046020932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038799804,0.00017281515,0.0002509681,0.00009757055,0.00008773267,0.00005342927,0.00016616585,0.00015887545,0.00027347144],"category_scores_gemma":[0.00043209843,0.00014442056,0.000091808346,0.00011464951,0.00010234064,0.00013996284,0.00008398787,0.00023618226,0.000018029552],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004483961,0.0012648634,0.014527047,0.0005008968,0.00008819068,0.00023301848,0.00010054407,4.369362e-7,0.9790885,0.00017404616,0.00014314111,0.0034309619],"study_design_scores_gemma":[0.019512951,0.010537411,0.08165539,0.00053313543,0.00091443595,0.0049561756,0.00016203713,0.0075994786,0.86577046,0.0004975993,0.0069184606,0.0009424674],"about_ca_topic_score_codex":0.000049851376,"about_ca_topic_score_gemma":0.00008901921,"teacher_disagreement_score":0.113317996,"about_ca_system_score_codex":0.000010274642,"about_ca_system_score_gemma":0.00013030914,"threshold_uncertainty_score":0.58892995},"labels":[],"label_agreement":null},{"id":"W2008639122","doi":"10.1182/blood-2010-01-263764","title":"A population-based study of cardiac morbidity among Hodgkin lymphoma patients with preexisting heart disease","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; McMaster University; Queen's University; Juravinski Cancer Centre; Institute for Clinical Evaluative Sciences; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Internal medicine; Population; Incidence (geometry); Heart disease; Hazard ratio; Lymphoma; Chemotherapy; Heart failure; Surgery; Confidence interval","score_opus":0.00950181075676039,"score_gpt":0.23900580891331663,"score_spread":0.22950399815655625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008639122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987476,0.000007967504,0.000006743893,0.000022936983,0.000080128906,0.00095736474,0.000024812898,0.000049857375,0.000102587765],"genre_scores_gemma":[0.9993745,1.4643301e-7,0.00028043648,0.000053786614,0.00012182447,0.00004184849,0.00009224171,0.000022191653,0.000013029975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999054,0.000047154153,0.00018219334,0.00021464075,0.0003719323,0.0001300866],"domain_scores_gemma":[0.99922866,0.00004718384,0.00010011291,0.0003491453,0.00013331624,0.0001415705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012135386,0.000116999596,0.0002672965,0.00006073179,0.0000662039,0.000010332128,0.00004141759,0.000055105796,0.000011778088],"category_scores_gemma":[0.00011812216,0.000100482815,0.000078263125,0.00014456411,0.000027925897,0.000060723924,0.0000106676325,0.00009923328,0.0000011149358],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001462396,0.0024851137,0.9869542,0.000050761468,0.00008001946,0.0000027563199,0.00015353183,0.000010656115,0.0095743,0.0000025267695,0.0000066961948,0.0005331924],"study_design_scores_gemma":[0.005724197,0.00041472723,0.9693719,0.000062492145,0.0003340677,4.1939373e-7,0.000048824255,0.000031123705,0.02389239,0.000008288601,0.000008816261,0.00010273773],"about_ca_topic_score_codex":0.0005634279,"about_ca_topic_score_gemma":0.00010848147,"teacher_disagreement_score":0.01758229,"about_ca_system_score_codex":0.000018955938,"about_ca_system_score_gemma":0.00008520581,"threshold_uncertainty_score":0.40975702},"labels":[],"label_agreement":null},{"id":"W2008699564","doi":"10.1182/blood-2011-07-370122","title":"Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Lymphoma Research Foundation","keywords":"Mantle cell lymphoma; microRNA; Biology; Gene expression profiling; Chronic lymphocytic leukemia; Cyclin D1; Cancer research; Stromal cell; Lymphoma; Leukemia; Gene; Gene expression; Genetics; Cell cycle; Immunology","score_opus":0.012841834515012971,"score_gpt":0.22725667454484264,"score_spread":0.21441484002982966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008699564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915295,0.002494033,0.000011322891,0.00014838003,0.00004085862,0.0008524757,0.0000295185,0.000051230672,0.0048426613],"genre_scores_gemma":[0.9944434,0.00005322665,0.004601993,0.00009889984,0.00014283312,0.0002324594,0.000059866932,0.00003927623,0.00032804516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987138,0.00003147365,0.0002976066,0.00024413965,0.00029127652,0.00042169605],"domain_scores_gemma":[0.9991452,0.0000915098,0.00016800876,0.00028174435,0.000080831196,0.00023269278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001514545,0.00021183288,0.00040847206,0.000072196526,0.000056687157,0.000011645516,0.00007708982,0.0000687333,0.000057850943],"category_scores_gemma":[0.000033910233,0.00014281712,0.00011422007,0.0001801738,0.000054877724,0.00007985857,0.00004198247,0.00003657952,0.00005737787],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012078765,0.0089602405,0.97827744,0.000343705,0.0002550937,0.00008176588,0.00021371186,8.968155e-8,0.011069844,0.00004360371,0.000065734275,0.00056798384],"study_design_scores_gemma":[0.0069581456,0.00056092086,0.70727056,0.00013790275,0.00081925606,0.000090999994,0.00007785912,0.0000011322749,0.28355193,0.000005828876,0.0003973772,0.00012808936],"about_ca_topic_score_codex":0.00007049829,"about_ca_topic_score_gemma":0.000005522471,"teacher_disagreement_score":0.2724821,"about_ca_system_score_codex":0.00006836219,"about_ca_system_score_gemma":0.00008176261,"threshold_uncertainty_score":0.5823913},"labels":[],"label_agreement":null},{"id":"W2008708488","doi":"10.1182/blood-2008-09-178301","title":"Surface RANKL of Toll-like receptor 4–stimulated human neutrophils activates osteoclastic bone resorption","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Bone Metabolism and Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":216,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"RANKL; Bone resorption; Cancer research; Receptor; Toll-like receptor; Osteoclast; Chemistry; Medicine; Internal medicine; Immunology; Cell biology; Biology; Innate immune system; Activator (genetics)","score_opus":0.008088950818122732,"score_gpt":0.2382896809944914,"score_spread":0.2302007301763687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008708488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99715203,0.0021365916,0.00004321407,0.00007812235,0.00008181505,0.00015578778,0.000044362958,0.000025939802,0.00028215488],"genre_scores_gemma":[0.99882185,0.0001216263,0.0003042613,0.00010139376,0.00014896246,0.000002564659,0.00022566521,0.00001557735,0.00025807958],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990943,0.00006153162,0.00023453841,0.0002824324,0.00012456077,0.00020262989],"domain_scores_gemma":[0.99938387,0.000010866759,0.0001078419,0.0003283075,0.00007742684,0.00009170402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007093299,0.0001553229,0.00021226301,0.000035995312,0.00006235245,0.000014137592,0.0001160956,0.0001319875,0.0000390647],"category_scores_gemma":[0.000051057534,0.00014700547,0.000105263214,0.00010404427,0.000051976836,0.0000058836645,0.00003646491,0.000057636687,0.0000103591565],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018814362,0.00047405198,0.0010693318,0.000015553378,0.000036185185,0.000003011154,0.00001265089,0.00008434948,0.99704415,0.00004269296,0.0007213444,0.0003085306],"study_design_scores_gemma":[0.0024616995,0.0004702922,0.024135146,0.00002218523,0.00012721722,0.000006457733,0.000011806632,0.0000054129837,0.97046447,0.00010504355,0.0020020066,0.00018827646],"about_ca_topic_score_codex":0.000016746082,"about_ca_topic_score_gemma":0.0000035575442,"teacher_disagreement_score":0.026579699,"about_ca_system_score_codex":0.000002759414,"about_ca_system_score_gemma":0.000032858774,"threshold_uncertainty_score":0.5994709},"labels":[],"label_agreement":null},{"id":"W2008770122","doi":"10.1182/blood-2013-11-536219","title":"c-Myc regulates expression of NKG2D ligands ULBP1/2/3 in AML and modulates their susceptibility to NK-mediated lysis","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer","keywords":"Cytarabine; NKG2D; Myeloid leukemia; Cancer research; Biology; Leukemia; K562 cells; Natural killer cell; Myeloid; Cell culture; Immunology; Cytotoxicity; Biochemistry; In vitro","score_opus":0.006254586654919044,"score_gpt":0.20229719602795573,"score_spread":0.1960426093730367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008770122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984516,0.00045519933,0.000042374304,0.000091622875,0.0003868549,0.00014216232,0.0000043468285,0.000040813302,0.00038505218],"genre_scores_gemma":[0.9985706,0.000067612,0.000037037946,0.00007670027,0.000017835448,0.000010468693,0.00007348002,0.00001033394,0.0011358975],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99908227,0.00012908223,0.00031151823,0.00026476145,0.000026141188,0.00018625268],"domain_scores_gemma":[0.9993595,0.000172727,0.000096325624,0.0002798244,0.00007034403,0.000021304528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030026466,0.00013441044,0.00027200606,0.00015305134,0.000060042414,0.000008402015,0.00009140608,0.00020776426,0.00033788537],"category_scores_gemma":[0.00022677981,0.00010656489,0.00005627918,0.00014854256,0.00007402996,0.00008589558,0.00007050333,0.00016429387,0.00007728384],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015550441,0.00030192168,0.021884238,0.000021151833,0.000039193106,1.8998168e-7,0.0006518623,0.000007661733,0.97542983,0.000019593928,0.00045913956,0.0010296826],"study_design_scores_gemma":[0.0014895342,0.00025991976,0.05533451,0.00007307011,0.0000246356,0.0000071589534,0.00024329095,0.000031072275,0.9396629,0.000073314644,0.0026900638,0.000110538516],"about_ca_topic_score_codex":0.00013287477,"about_ca_topic_score_gemma":0.00005101009,"teacher_disagreement_score":0.03576697,"about_ca_system_score_codex":0.000010888555,"about_ca_system_score_gemma":0.000009725512,"threshold_uncertainty_score":0.43455902},"labels":[],"label_agreement":null},{"id":"W2008865600","doi":"10.1182/blood.v95.10.3242","title":"Locus control region activity by 5′HS3 requires a functional interaction with β-globin gene regulatory elements: expression of novel β/γ-globin hybrid transgenes","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Heart, Lung, and Blood Institute","keywords":"Locus control region; Enhancer; Biology; Globin; Chromatin; Intron; Regulatory sequence; Transgene; Molecular biology; Gene; Promoter; Genetics; Gene expression","score_opus":0.007092588456811795,"score_gpt":0.23805446009911221,"score_spread":0.23096187164230042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008865600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88547224,0.000521924,0.11351234,0.000033350727,0.00005387255,0.00017458649,0.00005728178,0.000016324037,0.00015807188],"genre_scores_gemma":[0.99830633,0.00013873268,0.00090741157,0.000038016107,0.00014114536,0.00003323212,0.00010430699,0.00002391406,0.000306922],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990801,0.000029305578,0.00020826362,0.00032908111,0.00016651735,0.00018673539],"domain_scores_gemma":[0.99953276,0.000008582279,0.000084182626,0.00025940905,0.000052211133,0.000062879226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007691487,0.00017295012,0.0001593962,0.000032124273,0.000049677048,0.000010359531,0.00008692965,0.00008227327,0.000049791925],"category_scores_gemma":[0.000006290309,0.00015671902,0.00007638456,0.000052327847,0.00003864427,0.000011147598,0.000013398161,0.000069234586,0.0000013087689],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063856324,0.00048366343,0.00034126022,0.000019999121,0.00008269053,0.0000024357728,0.000014068879,0.0024493882,0.987652,0.0000013828919,0.00067304954,0.0076414933],"study_design_scores_gemma":[0.003865323,0.00033407134,0.0015226293,0.00004714507,0.000070742644,0.00009626356,0.000014568029,0.00027756163,0.99036384,0.0000019320578,0.0032241293,0.00018178918],"about_ca_topic_score_codex":0.000021561464,"about_ca_topic_score_gemma":0.000007860863,"teacher_disagreement_score":0.112834066,"about_ca_system_score_codex":0.0000113980095,"about_ca_system_score_gemma":0.00003079229,"threshold_uncertainty_score":0.6390816},"labels":[],"label_agreement":null},{"id":"W2008890638","doi":"10.1182/blood-2006-07-037671","title":"Targeting aurora kinases as therapy in multiple myeloma","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; Alberta Cancer Foundation","keywords":"Aurora inhibitor; Kinase; Mitosis; Cancer research; Aurora kinase; Apoptosis; Bortezomib; Cytokinesis; Aurora B kinase; Cell biology; Biology; Multiple myeloma; Cell cycle; Immunology; Cell; Cell division; Genetics","score_opus":0.00876887765466568,"score_gpt":0.23846090592705607,"score_spread":0.22969202827239038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008890638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970782,0.0014679104,0.0002658884,0.000021271295,0.00006394984,0.00013324026,0.0000045105203,0.000012198717,0.0009528322],"genre_scores_gemma":[0.99792707,0.00040104857,0.0008534756,0.00032482002,0.0001896245,0.0000074810328,0.00007536609,0.000019371222,0.00020176519],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992821,0.000020117588,0.00016031702,0.00022462355,0.00006033114,0.00025246246],"domain_scores_gemma":[0.9996908,0.000014548594,0.00004053944,0.0001793774,0.000028633009,0.000046141242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018340189,0.00010699569,0.00008687985,0.000039800223,0.000040542083,0.00001159457,0.00012017335,0.00011662947,0.000015013923],"category_scores_gemma":[0.000080034624,0.00010385234,0.000048978072,0.00007211762,0.00002645606,0.0000020146153,0.000047263024,0.00006695187,0.000014652552],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004957214,0.0002351623,0.05821936,0.000003945698,0.00001905661,0.000020786922,0.000037636386,0.0000084341655,0.9373368,0.000017296717,0.00015953703,0.0038924252],"study_design_scores_gemma":[0.0016383309,0.00022258372,0.016768625,0.000008156246,0.000005179954,0.00001510073,0.0000820036,0.000013751457,0.95772356,0.000021493881,0.023335287,0.00016595559],"about_ca_topic_score_codex":0.00008202505,"about_ca_topic_score_gemma":0.0002029349,"teacher_disagreement_score":0.041450735,"about_ca_system_score_codex":0.0000045116662,"about_ca_system_score_gemma":0.000028234143,"threshold_uncertainty_score":0.42349753},"labels":[],"label_agreement":null},{"id":"W2009047479","doi":"10.1182/blood-2013-08-520445","title":"Blood stem cell fate regulation by Delta-1–mediated rewiring of IL-6 paracrine signaling","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Zebrafish Biomedical Research Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; Heart and Stroke Foundation; University Health Network; University of Toronto","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research","keywords":"Cell biology; Stem cell; Progenitor cell; Biology; Paracrine signalling; Haematopoiesis; Hematopoietic stem cell; Cell fate determination; Cytokine; Immunology; Transcription factor; Receptor; Genetics","score_opus":0.008954630519489014,"score_gpt":0.23717215350993276,"score_spread":0.22821752299044373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009047479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99690366,0.00054009503,0.001332248,0.00019209868,0.000012302084,0.00034530874,0.000079017525,0.000021399324,0.0005738733],"genre_scores_gemma":[0.99763244,0.000119975135,0.0009322018,0.00006194069,0.00007919375,0.000110239765,0.00051789114,0.00002332774,0.0005227817],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987895,0.0000531099,0.00030046675,0.0003028684,0.00025959825,0.00029448335],"domain_scores_gemma":[0.99911547,0.000042569973,0.00012300762,0.00036526768,0.00017614372,0.00017751518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001833093,0.00012060495,0.00013488415,0.000045795383,0.000055255598,0.000021582942,0.00023477251,0.00013608811,0.00009247233],"category_scores_gemma":[0.00008182662,0.00011531748,0.00005853691,0.00018197332,0.00009199266,0.000006975639,0.0001197218,0.0000967435,0.000048915208],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000068286245,0.00032594136,0.0009035039,0.00003517162,0.00005361136,7.2121776e-7,0.000011366422,0.000005486299,0.99543613,0.00001181072,0.0020541367,0.0011552628],"study_design_scores_gemma":[0.0010382568,0.00017127453,0.0011766357,0.000013544895,0.00003929328,0.0000032885225,0.00002669566,0.00011252629,0.9933276,0.00007014193,0.003898058,0.00012265984],"about_ca_topic_score_codex":0.0000607635,"about_ca_topic_score_gemma":0.0000041566027,"teacher_disagreement_score":0.0021085346,"about_ca_system_score_codex":0.0000049826635,"about_ca_system_score_gemma":0.000052016097,"threshold_uncertainty_score":0.47025105},"labels":[],"label_agreement":null},{"id":"W2009059430","doi":"10.1182/blood-2002-06-1782","title":"L-selectin stimulation enhances functional expression of surface CXCR4 in lymphocytes: implications for cellular activation during adhesion and migration","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Cell biology; Internalization; Selectin; Chemokine; Cell adhesion; Biology; Cell adhesion molecule; Chemistry; Immunology; Receptor; Cell; Inflammation; Biochemistry","score_opus":0.026284946994511803,"score_gpt":0.2889491120502963,"score_spread":0.2626641650557845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009059430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939199,0.00024543126,0.0048815887,0.00011307737,0.000016736387,0.000693543,0.0000033497797,0.000019432544,0.00010694941],"genre_scores_gemma":[0.9960731,0.00007859011,0.0034889407,0.0000087780745,0.000026019647,0.00005847872,0.00006925931,0.000015742606,0.00018105672],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990512,0.00006559011,0.00027622897,0.00025813148,0.00019728242,0.00015156924],"domain_scores_gemma":[0.99929285,0.00020708733,0.00010654523,0.00015396267,0.00018163768,0.000057927045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021679353,0.00009645005,0.00015383888,0.00016231994,0.00009011379,0.0000109890025,0.000028109642,0.000091357506,0.000033013515],"category_scores_gemma":[0.00036181367,0.00009255495,0.000039073075,0.00028768225,0.000025226778,0.000118760785,0.000013462161,0.00007342093,0.0000016662938],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020259937,0.00032716413,0.07312006,0.00014328834,0.0000069711186,3.305345e-7,0.00009528422,0.00026106267,0.92558336,0.000074422445,0.000016373211,0.00016908065],"study_design_scores_gemma":[0.0027607994,0.0001366765,0.20867792,0.00010103497,0.00002027449,0.0000051210004,0.000058522983,0.0003980706,0.7875718,0.0001574552,0.000050706803,0.00006165626],"about_ca_topic_score_codex":0.00002155771,"about_ca_topic_score_gemma":0.000011625682,"teacher_disagreement_score":0.1380116,"about_ca_system_score_codex":0.000071453556,"about_ca_system_score_gemma":0.00011649771,"threshold_uncertainty_score":0.3774281},"labels":[],"label_agreement":null},{"id":"W2009331603","doi":"10.1182/blood-2007-04-084582","title":"Src-family kinase–dependent disruption of endothelial barrier function by Plasmodium falciparum merozoite proteins","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Malaria Research and Control","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Plasmodium falciparum; Biology; Tight junction; Cell biology; Endothelium; Barrier function; Immunology; Malaria","score_opus":0.011433566793572499,"score_gpt":0.25658082342749533,"score_spread":0.24514725663392284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009331603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820136,0.0005495764,0.007928211,0.00045303634,0.00019333579,0.0012547887,0.00016843408,0.000068210495,0.007370849],"genre_scores_gemma":[0.9960861,0.000032442495,0.00016257541,0.00017147843,0.00032871414,0.00007603896,0.00006618897,0.000024773011,0.003051642],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981579,0.00005384306,0.0003433289,0.00027953633,0.00070315565,0.00046219095],"domain_scores_gemma":[0.9991073,0.000048918268,0.00009912982,0.0003125364,0.00014306654,0.00028907042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005985145,0.00015768732,0.00027536228,0.00014172505,0.00006881557,0.000016691345,0.0000958007,0.00013877658,0.00027691122],"category_scores_gemma":[0.00015066496,0.00013327721,0.00012343135,0.00014030188,0.00006124588,0.00008914628,0.000036699214,0.0002556181,0.00006597417],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002682302,0.0010047582,0.0033557168,0.00009267335,0.00019892798,0.000058263606,0.000067337896,0.0000010483818,0.9858923,0.00063210813,0.0004525802,0.0055619874],"study_design_scores_gemma":[0.023063479,0.0035628467,0.07047858,0.000115238865,0.000583363,0.000051954543,0.00030139115,0.00013144535,0.88345516,0.00020327454,0.017751139,0.00030214738],"about_ca_topic_score_codex":0.0002036033,"about_ca_topic_score_gemma":0.000053803167,"teacher_disagreement_score":0.10243715,"about_ca_system_score_codex":0.000038345417,"about_ca_system_score_gemma":0.00011559588,"threshold_uncertainty_score":0.5434887},"labels":[],"label_agreement":null},{"id":"W2009347177","doi":"10.1182/blood-2012-09-455774","title":"Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":450,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Langerhans cell histiocytosis; Medicine; Histiocytosis; Chemotherapy; Immunology; Langerhans cell; Internal medicine; Antigen; Disease","score_opus":0.017451701026913423,"score_gpt":0.25041160464676115,"score_spread":0.23295990361984772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009347177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931775,0.00054182956,0.000012748328,0.0002539584,0.00005820326,0.00087525864,0.0000036771548,0.00004950972,0.0050273305],"genre_scores_gemma":[0.99647415,0.000032816857,0.00044549728,0.00014361668,0.000032891585,0.00025412117,0.000025179152,0.00001652857,0.0025752215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993413,0.000019075407,0.00020005049,0.00016647665,0.00011597273,0.00015713199],"domain_scores_gemma":[0.9996635,0.000018315179,0.000052393145,0.0001700072,0.00003699625,0.0000588336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004705056,0.00010418094,0.00019004157,0.000072299554,0.000028632785,0.000013798039,0.000038398648,0.00006356419,0.00009830601],"category_scores_gemma":[0.000017220149,0.000079075995,0.0000472956,0.000089217436,0.000015643527,0.00005745801,0.000007407935,0.00006441526,0.00025371488],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035151796,0.002804515,0.9515482,0.00013593765,0.00007688145,0.00004552335,0.00077653915,8.508875e-7,0.023706844,0.000022618362,0.00024522227,0.0206017],"study_design_scores_gemma":[0.021981368,0.00066119566,0.95787,0.000076776705,0.00013941854,0.00002058516,0.00024289565,0.00030166385,0.016877469,0.00006472855,0.0015411788,0.00022269502],"about_ca_topic_score_codex":0.0008036194,"about_ca_topic_score_gemma":0.000038917424,"teacher_disagreement_score":0.021946216,"about_ca_system_score_codex":0.00004825851,"about_ca_system_score_gemma":0.000024374205,"threshold_uncertainty_score":0.3261076},"labels":[],"label_agreement":null},{"id":"W2009686578","doi":"10.1182/blood-2013-07-514448","title":"Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":183,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba; Ottawa Hospital; University of Ottawa","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Busulfan; Total body irradiation; Medicine; Cyclophosphamide; Internal medicine; Myeloid leukemia; Gastroenterology; Leukemia; Confidence interval; Relative risk; Oncology; Surgery; Chemotherapy","score_opus":0.008932932031706396,"score_gpt":0.21623942509832028,"score_spread":0.2073064930666139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009686578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99693066,0.00007126919,0.00005306249,0.0007872749,0.00002987774,0.00074045267,0.0000014843845,0.000027667162,0.0013582702],"genre_scores_gemma":[0.99778277,0.000025002983,0.0018943751,0.00010827054,0.000013233528,0.000055270208,0.000041245512,0.000025513818,0.000054322216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987932,0.00005057304,0.00032110623,0.00028590567,0.00030075782,0.00024845693],"domain_scores_gemma":[0.9994597,0.00013526832,0.000062835694,0.00022822697,0.000029952671,0.00008404108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022278106,0.00016426432,0.00034832623,0.00017729726,0.000026147272,0.000022637607,0.00007018801,0.00009230422,0.000020512754],"category_scores_gemma":[0.000034771692,0.00013006484,0.000018180965,0.00026752334,0.00002937583,0.00016949078,0.000017400334,0.0002095822,0.0000044964013],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019536485,0.00028755734,0.9940916,0.00022841376,0.000019466477,0.00029348576,0.001534472,0.000043408705,0.003087472,0.000021730837,0.000020608364,0.00017643694],"study_design_scores_gemma":[0.027313832,0.00021263062,0.9652243,0.0019130463,0.00004806607,0.000052218827,0.0002710469,0.0005162956,0.0041317106,0.0001323855,0.000016028034,0.00016841534],"about_ca_topic_score_codex":0.0022596996,"about_ca_topic_score_gemma":0.0029867373,"teacher_disagreement_score":0.02886726,"about_ca_system_score_codex":0.0001133372,"about_ca_system_score_gemma":0.00006881914,"threshold_uncertainty_score":0.530389},"labels":[],"label_agreement":null},{"id":"W2009720281","doi":"10.1182/blood-2005-06-2562","title":"A novel murine model of fetal and neonatal alloimmune thrombocytopenia: response to intravenous IgG therapy","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; Ontario Institute for Cancer Research","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; National Institutes of Health; University of Toronto; Canadian Blood Services","keywords":"Neonatal alloimmune thrombocytopenia; Fetus; Antibody; Immunology; Medicine; Cytopenia; Platelet; Antigen; Isoantibodies; Biology; Pregnancy; Bone marrow","score_opus":0.01857506654549615,"score_gpt":0.2572698119863733,"score_spread":0.23869474544087713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009720281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996597,0.0011803051,0.00029581288,0.0012214483,0.000011785182,0.0003727845,0.000041196414,0.000023604272,0.00025604517],"genre_scores_gemma":[0.99017173,0.00021757282,0.008701145,0.0003383911,0.000023423896,0.000014132364,0.000013043697,0.000019843677,0.0005007356],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99928033,0.000010827242,0.00017555211,0.00019114623,0.00014523893,0.00019691559],"domain_scores_gemma":[0.99958146,0.00002789208,0.000036913574,0.0002108999,0.000035970206,0.000106877356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000105529005,0.00013294602,0.00034825242,0.000071388815,0.000034551394,0.0000067074966,0.000057323752,0.000056218447,0.000030539908],"category_scores_gemma":[0.000024390949,0.00010659332,0.000049263726,0.000079565085,0.00003840037,0.00005151298,0.000041267474,0.00007449588,0.000011564857],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006245083,0.004991066,0.0012085146,0.00002572179,0.0005820456,0.0002250827,0.0019591667,0.00012110373,0.92462415,0.00006422791,0.00004543784,0.0599084],"study_design_scores_gemma":[0.13659132,0.010384942,0.20557041,0.00029924524,0.00089316315,0.004410391,0.0004192608,0.006609851,0.6275527,0.00017846997,0.0061498065,0.00094046904],"about_ca_topic_score_codex":0.00006876212,"about_ca_topic_score_gemma":0.000029311963,"teacher_disagreement_score":0.2970715,"about_ca_system_score_codex":0.00001498042,"about_ca_system_score_gemma":0.000070888746,"threshold_uncertainty_score":0.43467492},"labels":[],"label_agreement":null},{"id":"W2010173117","doi":"10.1182/blood-2014-11-610592","title":"STAT3: too much may be worse than not enough!","year":2015,"lang":"en","type":"letter","venue":"Blood","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cytopenia; Autoimmunity; Gain of function; Immunology; Medicine; Immune system; Mutation; Biology; Genetics; Gene; Bone marrow","score_opus":0.022189241575479083,"score_gpt":0.235987582513534,"score_spread":0.21379834093805491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010173117","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10407892,0.12223539,0.000024538596,0.7057431,0.010597408,0.0015890239,0.0017852373,0.00094042,0.053005997],"genre_scores_gemma":[0.21312515,0.0004985135,0.00004996491,0.5656199,0.00032326768,0.00015966616,0.009244265,0.00023346677,0.2107458],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969062,0.00039436985,0.00060318515,0.00076674466,0.00014897305,0.0011805258],"domain_scores_gemma":[0.99822295,0.00016251756,0.00032187786,0.0011197118,0.00016137883,0.0000115807925],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.00042440524,0.0006708152,0.00082294655,0.00024280792,0.00033233658,0.00005819818,0.0010273095,0.002140241,0.0011912175],"category_scores_gemma":[0.000118376556,0.0006139086,0.00034964108,0.00022270056,0.0004710931,0.000121935926,0.00026121657,0.003044081,0.0032343918],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000063378495,0.0005236066,0.00004312579,0.00008142598,0.0006484783,0.00021086956,0.0012133706,7.603495e-7,0.009867712,0.0001212005,0.9857265,0.0014995973],"study_design_scores_gemma":[0.0029126815,0.00021191886,0.00013254139,0.00006590047,0.0003604914,0.00017523322,0.00036872175,1.4124751e-7,0.010428476,0.00011494614,0.98446494,0.00076397706],"about_ca_topic_score_codex":0.0004341102,"about_ca_topic_score_gemma":0.0000061329547,"teacher_disagreement_score":0.1577398,"about_ca_system_score_codex":0.000042826632,"about_ca_system_score_gemma":0.00037239943,"threshold_uncertainty_score":0.9997218},"labels":[],"label_agreement":null},{"id":"W2010186220","doi":"10.1182/blood-2001-12-0353","title":"P-glycoprotein targeting: a unique strategy to selectively eliminate immunoreactive T cells","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Glycoprotein; Molecular biology; Cell biology; Chemistry; Biology; Cancer research","score_opus":0.01156258317323771,"score_gpt":0.2090622495847863,"score_spread":0.1974996664115486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010186220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9536118,0.0017242708,0.00043515206,0.00025187555,0.0017634073,0.000760512,0.000010284906,0.00027366623,0.04116903],"genre_scores_gemma":[0.958381,0.000081169695,0.00011285704,0.00026227973,0.000043817814,0.00008110111,0.000037333728,0.000028031249,0.04097243],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99874973,0.00019174191,0.00027670414,0.00034696807,0.000036134374,0.0003987391],"domain_scores_gemma":[0.9994306,0.00006067223,0.00011535571,0.00022087416,0.00014090275,0.000031606556],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00014104694,0.00021707085,0.00022003085,0.00015433454,0.00020752632,0.000030090923,0.00016794482,0.00022032758,0.004439756],"category_scores_gemma":[0.00006363706,0.0002080946,0.00009775408,0.00024134137,0.000049202623,0.00015450621,0.0000514795,0.0004497712,0.0060477015],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013441501,0.0006105362,0.000023529266,0.000005998753,0.00020853081,0.000007401485,0.00083585613,0.000010011495,0.9763862,0.00015319607,0.01922691,0.0023974245],"study_design_scores_gemma":[0.0012796706,0.0009251048,0.0003441856,0.000020212474,0.000055241806,0.00006698961,0.00047247525,0.000007931872,0.91242343,0.000026481057,0.08414106,0.00023721633],"about_ca_topic_score_codex":0.00019589349,"about_ca_topic_score_gemma":0.000006651886,"teacher_disagreement_score":0.06491415,"about_ca_system_score_codex":0.000052795687,"about_ca_system_score_gemma":0.000021664726,"threshold_uncertainty_score":0.99647033},"labels":[],"label_agreement":null},{"id":"W2010386763","doi":"10.1182/blood-2012-06-415943","title":"How I treat anticoagulated patients undergoing an elective procedure or surgery","year":2012,"lang":"en","type":"review","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":374,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Apixaban; Rivaroxaban; Dabigatran; Warfarin; Anticoagulant; Intensive care medicine; Bleed; Heparin; Fondaparinux; Surgery; Thrombosis; Atrial fibrillation; Venous thromboembolism; Internal medicine","score_opus":0.1629927307855722,"score_gpt":0.3622595448043214,"score_spread":0.19926681401874918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010386763","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028761486,0.99424446,0.0000055223218,0.00007430085,0.00027610397,0.0018160648,0.000012962476,0.00018064158,0.00051380595],"genre_scores_gemma":[0.0032661008,0.98754585,0.00006265407,0.000027321386,0.0015242331,0.000012763243,0.00085175334,0.00010154362,0.0066077625],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984252,0.000119731456,0.0004121903,0.00037348285,0.0003004732,0.00036896416],"domain_scores_gemma":[0.9986687,0.00035330094,0.00038581088,0.0003210405,0.00009916618,0.00017199237],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014301963,0.00041662043,0.0017436885,0.00032751643,0.00008608584,0.00007292564,0.00007480034,0.00030587433,0.000069280024],"category_scores_gemma":[0.00037971637,0.0002678795,0.00050785515,0.0005251148,0.000021403312,0.00024069396,0.00004393161,0.00017353507,0.00004450957],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010070107,0.0003473076,0.12931354,0.041272294,0.0017220968,0.00004625992,0.000065613196,7.173175e-8,7.2141637e-7,0.000044974095,0.0006140457,0.8264724],"study_design_scores_gemma":[0.00257518,0.00037707543,0.006068745,0.008490643,0.020232787,0.000055247183,0.000029108533,0.0000014061459,0.000013006823,0.000007882147,0.9614879,0.00066105806],"about_ca_topic_score_codex":0.0000032756066,"about_ca_topic_score_gemma":0.000009942686,"teacher_disagreement_score":0.96087384,"about_ca_system_score_codex":0.00006773088,"about_ca_system_score_gemma":0.0003100523,"threshold_uncertainty_score":0.99997735},"labels":[],"label_agreement":null},{"id":"W2010586772","doi":"10.1182/blood-2014-04-570531","title":"Postthrombotic syndrome following upper extremity deep vein thrombosis in children","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Pathogenesis; Thrombosis; Thrombus; Deep vein; Upper limb; Lower limb; Pediatrics; Surgery; Internal medicine","score_opus":0.0084193129154193,"score_gpt":0.24136334212288324,"score_spread":0.23294402920746393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010586772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99191225,0.00035115093,0.00009284179,0.0005534422,0.0001796317,0.0006781261,0.0000020655546,0.00012578785,0.0061047208],"genre_scores_gemma":[0.9976206,0.00008941936,0.0010208008,0.00094433996,0.00010727072,0.000052925912,0.000032532753,0.000051545372,0.00008056473],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981921,0.0000785257,0.0003638948,0.00048102342,0.00036370978,0.00052080303],"domain_scores_gemma":[0.9991057,0.00005797967,0.00007114126,0.00056613545,0.000024517292,0.00017452482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040469645,0.00025433948,0.0007565945,0.00021505657,0.0000914957,0.000038730377,0.00018662216,0.00012824147,0.00025455773],"category_scores_gemma":[0.00012636217,0.00023570113,0.0002442875,0.00030597334,0.000040298608,0.00012560771,0.00012799626,0.00022340596,0.00021545251],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004343476,0.0034474137,0.99230176,0.000064678825,0.0005332388,0.00006309476,0.00029120874,0.000012251894,0.0011172354,0.00072758243,0.000268104,0.0011690923],"study_design_scores_gemma":[0.0038114472,0.00038056093,0.9935242,0.00021991535,0.00077635644,0.00009700127,0.00006662428,0.0000731989,0.00036735614,0.0002534737,0.00017235814,0.00025751418],"about_ca_topic_score_codex":0.0002855234,"about_ca_topic_score_gemma":0.000044131197,"teacher_disagreement_score":0.006024156,"about_ca_system_score_codex":0.00005842086,"about_ca_system_score_gemma":0.000029315746,"threshold_uncertainty_score":0.9611613},"labels":[],"label_agreement":null},{"id":"W2010881438","doi":"10.1182/blood-2005-09-3613","title":"Impaired class switch recombination (CSR) in Waldenstrom macroglobulinemia (WM) despite apparently normal CSR machinery","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Immunoglobulin class switching; Biology; Waldenstrom macroglobulinemia; Cytidine deaminase; B cell; Isotype; Molecular biology; Macroglobulinemia; Somatic hypermutation; Monoclonal gammopathy of undetermined significance; Immunology; Antibody; Monoclonal; Monoclonal antibody; Multiple myeloma; Lymphoma","score_opus":0.013600924212857959,"score_gpt":0.27710648628433476,"score_spread":0.2635055620714768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010881438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916699,0.0006365162,0.000046351903,0.0020763276,0.00015820943,0.0007125866,0.000015619135,0.00015847724,0.004526048],"genre_scores_gemma":[0.99464345,0.0001342463,0.0018777248,0.00038540838,0.000584343,0.000075884935,0.0001513067,0.000063402586,0.0020842387],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9970812,0.000103740254,0.00065747416,0.0005574693,0.0007601113,0.00083998387],"domain_scores_gemma":[0.9986545,0.00012723444,0.00012503836,0.00061805896,0.00015081636,0.00032435724],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00058897276,0.0003049948,0.00047241777,0.00033991077,0.000081312515,0.000053692147,0.00028281024,0.00026454087,0.00032919628],"category_scores_gemma":[0.00025145634,0.00028561027,0.00015854555,0.0005709671,0.00009130543,0.00021838148,0.00017094043,0.0005774012,0.00037910652],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060433364,0.029007979,0.35131153,0.0027947964,0.0016768592,0.008207953,0.0054727015,0.0017064055,0.1567947,0.0014525194,0.035661507,0.3998697],"study_design_scores_gemma":[0.4295128,0.0025032249,0.20602591,0.0015606757,0.0010097905,0.0075518074,0.0006186405,0.17942835,0.13729309,0.0006086902,0.03152725,0.0023597644],"about_ca_topic_score_codex":0.0007745765,"about_ca_topic_score_gemma":0.00063678675,"teacher_disagreement_score":0.42346948,"about_ca_system_score_codex":0.005469901,"about_ca_system_score_gemma":0.0026397367,"threshold_uncertainty_score":0.9999596},"labels":[],"label_agreement":null},{"id":"W2011228017","doi":"10.1182/blood-2013-10-535443","title":"Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":297,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Lymphoma; Biology; Follicular lymphoma; Phenotype; Gene rearrangement; Cancer research; B-cell lymphoma; Fluorescence in situ hybridization; Gene; Genetics; Immunology","score_opus":0.014839297019957709,"score_gpt":0.23602139221244203,"score_spread":0.22118209519248433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011228017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928158,0.002822404,0.000005198256,0.00020619165,0.00015374113,0.0006394288,0.000012602213,0.00007440703,0.003270251],"genre_scores_gemma":[0.9976509,0.00036472254,0.0008109079,0.0004188894,0.00023956221,0.00023596267,0.00013022518,0.000034863308,0.000113939655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983578,0.000045137087,0.00034774072,0.00041224298,0.0003279859,0.00050914026],"domain_scores_gemma":[0.9991742,0.0000666592,0.00014126406,0.00033928733,0.00005244989,0.00022615299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031080836,0.00023876339,0.00041662922,0.0001441088,0.00006812565,0.000031599116,0.00010904146,0.00009747991,0.000026361124],"category_scores_gemma":[0.00007115724,0.00019881169,0.000110884765,0.00016263158,0.00002194393,0.000051741303,0.00009668457,0.0000794961,0.00008050906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011810804,0.014507646,0.9615725,0.00022751429,0.000090240734,0.00024527934,0.00030993955,1.3780517e-7,0.0014466306,0.000045840065,0.0002718642,0.02116428],"study_design_scores_gemma":[0.03797961,0.00066676177,0.94958663,0.00044235584,0.00030030988,0.000049701262,0.00007766557,0.000050928185,0.0067106467,0.00002884632,0.003910688,0.00019584094],"about_ca_topic_score_codex":0.000052256742,"about_ca_topic_score_gemma":0.00007205328,"teacher_disagreement_score":0.037861504,"about_ca_system_score_codex":0.0002694791,"about_ca_system_score_gemma":0.0001236621,"threshold_uncertainty_score":0.8107305},"labels":[],"label_agreement":null},{"id":"W2011342000","doi":"10.1182/blood-2013-04-494096","title":"The effect of rituximab on vaccine responses in patients with immune thrombocytopenia","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":189,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Ottawa Hospital; University of Ottawa; Canadian Blood Services; University of Waterloo; McMaster University","funders":"Canadian Institutes of Health Research; McMaster University","keywords":"Rituximab; Medicine; Immunology; Antibody; Pneumococcal vaccine; Placebo; Vaccination; Immune system; Internal medicine; Streptococcus pneumoniae; Microbiology; Biology; Antibiotics","score_opus":0.003508973166314522,"score_gpt":0.2195779562147976,"score_spread":0.21606898304848307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011342000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979557,0.00027449164,1.1376034e-7,0.00018237004,0.000018756386,0.00078863924,0.000003701714,0.000010340705,0.00076591497],"genre_scores_gemma":[0.99968046,0.000021611726,0.00002495323,0.000026295975,0.0000049931323,0.000047525995,0.0000124636945,0.000011880342,0.00016979554],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99938196,0.000054926608,0.00014654732,0.000113845235,0.00015318641,0.00014952247],"domain_scores_gemma":[0.9994476,0.00018722632,0.000053723852,0.0002492618,0.000032235388,0.00002995822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000083605606,0.00010583525,0.0003344997,0.000045088607,0.000040461524,0.000008080192,0.000057414192,0.000032391552,0.00003867841],"category_scores_gemma":[0.0000670112,0.00004916945,0.000033325905,0.00010474201,0.000020869571,0.000037094444,0.000016593425,0.000078224366,0.00006589365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035040893,0.002050888,0.9894008,0.00002591961,0.00018799315,0.000042208576,0.000040531766,2.7885707e-7,0.00049567164,0.000008721919,0.00007987424,0.0041630464],"study_design_scores_gemma":[0.038925804,0.006016767,0.93883336,0.00010234805,0.000103759405,0.000005315561,0.000007767546,0.0000015344001,0.015893368,0.000015567295,0.000046234345,0.000048165773],"about_ca_topic_score_codex":0.00013358488,"about_ca_topic_score_gemma":0.000018729472,"teacher_disagreement_score":0.050567407,"about_ca_system_score_codex":0.000011093291,"about_ca_system_score_gemma":0.00001468748,"threshold_uncertainty_score":0.20050721},"labels":[],"label_agreement":null},{"id":"W2011473183","doi":"10.1182/blood-2009-05-220806","title":"Neutrophil-specific deletion of Syk kinase results in reduced host defense to bacterial infection","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research","keywords":"Syk; Neutrophil extracellular traps; Biology; Phagocytosis; Cell biology; Immunology; Signal transduction; Tyrosine kinase; Inflammation","score_opus":0.014588469127851597,"score_gpt":0.22982326594635555,"score_spread":0.21523479681850394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011473183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978823,0.00017859432,0.00004755235,0.00038350796,0.00052565837,0.00036059282,0.0000556199,0.000051012248,0.0005151696],"genre_scores_gemma":[0.99920017,0.00012342706,0.00017294826,0.00012514406,0.000105179985,0.000015077435,0.00014648635,0.000013054983,0.00009854367],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986219,0.00021648564,0.00044104178,0.00037505873,0.000039401195,0.0003061563],"domain_scores_gemma":[0.99939567,0.000040022227,0.00013020713,0.00031363274,0.0000872892,0.000033162167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022023029,0.00018539901,0.00030096914,0.00028376002,0.00007177265,0.000011612253,0.000118002055,0.0002075026,0.000085463034],"category_scores_gemma":[0.00006707118,0.00017882064,0.000076436474,0.00033600605,0.000042281474,0.00009129931,0.00003724769,0.00020325278,0.00022139061],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013857441,0.00064568216,0.000072791925,0.000005025573,0.000023558132,0.000022836413,0.00020199498,0.0000052537443,0.994095,0.0012238966,0.00029546957,0.0020226939],"study_design_scores_gemma":[0.004497376,0.0015115306,0.048547182,0.000062686064,0.000027047447,0.000035150504,0.000019494117,1.0622777e-7,0.9405162,0.00017007174,0.0044353786,0.00017777989],"about_ca_topic_score_codex":0.00007909717,"about_ca_topic_score_gemma":0.000034023622,"teacher_disagreement_score":0.053578857,"about_ca_system_score_codex":0.000033087064,"about_ca_system_score_gemma":0.000029476381,"threshold_uncertainty_score":0.7292094},"labels":[],"label_agreement":null},{"id":"W2011562061","doi":"10.1182/blood-2009-12-261487","title":"Elucidation of the integrin LFA-1–mediated signaling pathway of actin polarization in natural killer cells","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Lunenfeld-Tanenbaum Research Institute; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Cell biology; Vinculin; Phosphatidylinositol; Actin cytoskeleton; Wiskott–Aldrich syndrome protein; Biology; Lymphocyte function-associated antigen 1; Integrin; Actin remodeling; Actin; Cell adhesion; Signal transduction; Focal adhesion; Cytoskeleton; Cell adhesion molecule; Intercellular Adhesion Molecule-1; Receptor; Cell; Biochemistry","score_opus":0.009497295817948795,"score_gpt":0.25230525943487486,"score_spread":0.24280796361692608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011562061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987393,0.00003237559,0.000028859537,0.00017518357,0.0002322877,0.000308542,0.0000026711145,0.000009333998,0.00047146095],"genre_scores_gemma":[0.9988267,0.0000043630193,0.00044023828,0.00003311297,0.000034989895,0.0000042002744,0.000028100418,0.000013143525,0.00061518967],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99901474,0.00007485912,0.00027849723,0.00013092528,0.00036995037,0.00013105532],"domain_scores_gemma":[0.9992821,0.00013411762,0.00012367318,0.00025055863,0.0001695272,0.000040019517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003041378,0.00007324787,0.00015429629,0.0001500413,0.000017169485,0.0000046653836,0.00012442489,0.00010800953,0.00016540143],"category_scores_gemma":[0.0007001714,0.00004989054,0.00005784854,0.00042583287,0.000057747824,0.00003791871,0.00006210914,0.00051687914,0.00000869723],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004722735,0.00030258554,0.024214454,0.000051815365,0.000012848571,0.000003144458,0.00023070264,0.000003670021,0.9741127,0.000030295658,0.00002042867,0.0009701365],"study_design_scores_gemma":[0.0013667505,0.000055612858,0.055118583,0.000072557305,0.000017561471,0.0000040137425,0.00008351833,0.00032995848,0.94268954,0.000011509991,0.00020818207,0.000042212512],"about_ca_topic_score_codex":0.000118321164,"about_ca_topic_score_gemma":0.000075076,"teacher_disagreement_score":0.03142315,"about_ca_system_score_codex":0.000012568299,"about_ca_system_score_gemma":0.0001248186,"threshold_uncertainty_score":0.22456115},"labels":[],"label_agreement":null},{"id":"W2011712807","doi":"10.1182/blood-2008-12-192054","title":"Prospective isolation and molecular characterization of hematopoietic stem cells with durable self-renewal potential","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":339,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; BC Cancer Agency","funders":"Institute of Genetics; National Cancer Institute; Canadian Institutes of Health Research; Deutsche Forschungsgemeinschaft; Terry Fox Foundation; BC Cancer Agency; Austrian Science Fund; Michael Smith Health Research BC; Stem Cell Network","keywords":"Stem cell; Biology; Haematopoiesis; Cell biology; Induced pluripotent stem cell; CXCR4; Stem cell theory of aging; Immunology; Bone marrow; Genetics; Stem cell factor; Embryonic stem cell; Gene; Immune system; Chemokine","score_opus":0.003654790148121671,"score_gpt":0.19362479573001237,"score_spread":0.1899700055818907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011712807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99115855,0.00003849113,0.007396839,0.00012236547,0.000021465843,0.0005911484,0.0000059185427,0.000061792205,0.00060342654],"genre_scores_gemma":[0.9977882,0.000034006294,0.0020012723,0.000046938156,0.000022870778,0.000008959711,0.000026085434,0.00001467297,0.000057024703],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991992,0.000024556231,0.0002181276,0.00020280288,0.00022719997,0.00012811039],"domain_scores_gemma":[0.9995748,0.0000093012395,0.00011036757,0.00013830716,0.00010138274,0.000065848944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006669962,0.000117758434,0.00021969834,0.000069829926,0.000031354164,0.000012873359,0.000026387406,0.00007033101,0.00001177554],"category_scores_gemma":[0.000001272404,0.000101066726,0.000028020902,0.00014502907,0.00002115602,0.00008045122,0.0000035856206,0.000059578768,0.0000035919688],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012499317,0.00041953695,0.0078032534,0.00026168732,0.00007027372,0.000055584376,0.0010251175,0.000004395721,0.9898612,0.00028544018,5.111864e-7,0.00008798838],"study_design_scores_gemma":[0.003497504,0.00069716136,0.039098103,0.0002079435,0.0005214538,0.00035521432,0.000079971935,0.00019901615,0.95514816,0.00008531363,0.0000018025041,0.00010838525],"about_ca_topic_score_codex":0.0000030533954,"about_ca_topic_score_gemma":4.0527024e-7,"teacher_disagreement_score":0.034713086,"about_ca_system_score_codex":0.000012550619,"about_ca_system_score_gemma":0.000045309313,"threshold_uncertainty_score":0.41213816},"labels":[],"label_agreement":null},{"id":"W2012000639","doi":"10.1182/blood-2013-07-517151","title":"The evolution of cellular deficiency in GATA2 mutation","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Congenital heart defects research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":213,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute; Medical Research Council; National Institute for Health and Care Research; Wellcome Trust; World Health Organization","keywords":"Mutation; Genetics; Biology; Gene","score_opus":0.005856695852567458,"score_gpt":0.2351051309674626,"score_spread":0.22924843511489515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012000639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99550164,0.0022126473,0.00018868706,0.00003386067,0.000018758714,0.00017215191,0.0000016643486,0.0000020724779,0.0018685033],"genre_scores_gemma":[0.99959534,0.000021871896,0.000048052974,0.000003456741,0.00002090658,0.000023902654,0.0000088937495,0.000004320006,0.00027324178],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99954647,0.000040960826,0.00009411346,0.000096607364,0.00009846822,0.00012336521],"domain_scores_gemma":[0.9997204,0.000015789841,0.000018400298,0.00016214828,0.000063985186,0.000019291629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013248427,0.000035968573,0.000034546923,0.000023357645,0.000033677345,0.000010624439,0.00009487249,0.000040097217,0.000009970258],"category_scores_gemma":[0.00008392073,0.000027442476,0.00002384095,0.00009344981,0.00004483543,0.0000022054676,0.000069322705,0.000037887214,0.000028224213],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004784027,0.00007625361,0.0042353757,0.000009892099,0.000003982688,0.0000010314592,0.000016699607,0.0000041699277,0.99231315,0.000118252334,0.00005883522,0.003157578],"study_design_scores_gemma":[0.0006601391,0.00027901516,0.043942023,0.0000070711367,0.000007189534,0.000009875684,0.00020636024,0.00023040947,0.9531879,0.00085676153,0.0005323432,0.00008090599],"about_ca_topic_score_codex":0.00018894306,"about_ca_topic_score_gemma":0.00017082687,"teacher_disagreement_score":0.039706647,"about_ca_system_score_codex":0.0000080396885,"about_ca_system_score_gemma":0.000049150935,"threshold_uncertainty_score":0.11190717},"labels":[],"label_agreement":null},{"id":"W2012209116","doi":"10.1182/blood-2011-03-343293","title":"Angiopoietin-2 promotes myeloid cell infiltration in a β2-integrin–dependent manner","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital","funders":"","keywords":"Myeloid; Cell biology; Integrin; Inflammation; Integrin alpha M; Intravital microscopy; Monocyte; Angiopoietin; Angiopoietin receptor; Cell adhesion; Biology; Paracrine signalling; Endothelial stem cell; Genetically modified mouse; Immunology; Transgene; Cancer research; Cell; In vitro; Immune system; In vivo; Receptor; Angiogenesis","score_opus":0.014796972048880013,"score_gpt":0.21942628398882041,"score_spread":0.2046293119399404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012209116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876547,0.0011014768,0.00016771193,0.000031033986,0.00008211738,0.00015257593,0.000008359773,0.000011217198,0.010790839],"genre_scores_gemma":[0.99763,0.00015232681,0.00082604354,0.00013143777,0.0001799143,0.00004608359,0.00003759253,0.000018763129,0.000977851],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992616,0.000029292414,0.00016462551,0.00026706068,0.000083265426,0.00019411168],"domain_scores_gemma":[0.9996328,0.000002631489,0.000053698106,0.00022623946,0.00003897704,0.00004570569],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011503292,0.000120988254,0.00009467924,0.00003721724,0.000027257516,0.000010684017,0.00013028947,0.00013189593,0.00010408201],"category_scores_gemma":[0.000011265588,0.000108335735,0.00007976293,0.000060581464,0.00002639496,0.0000049293403,0.00005250757,0.00005557573,0.000029772345],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049911825,0.00059977424,0.047411863,0.00002339652,0.00003443387,0.00001267878,0.00023913267,0.0000027245894,0.9502608,0.00010089884,0.0004962831,0.00076808105],"study_design_scores_gemma":[0.00073855295,0.0002240322,0.018233597,0.000011669069,0.000023195727,0.000011852059,0.00008916883,0.0000037112652,0.97689694,0.000054951317,0.0035449637,0.00016734099],"about_ca_topic_score_codex":0.00009904453,"about_ca_topic_score_gemma":0.00014215104,"teacher_disagreement_score":0.029178264,"about_ca_system_score_codex":0.0000060829684,"about_ca_system_score_gemma":0.00004071701,"threshold_uncertainty_score":0.4417803},"labels":[],"label_agreement":null},{"id":"W2012245768","doi":"10.1182/blood-2002-05-1448","title":"Central venous catheters and upper-extremity deep-vein thrombosis complicating immune heparin-induced thrombocytopenia","year":2003,"lang":"en","type":"review","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":167,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; University Health Network","funders":"","keywords":"Medicine; Thrombosis; Deep vein; Venous thrombosis; Heparin-induced thrombocytopenia; Surgery; Heparin; Orthopedic surgery; Upper limb; Intensive care unit; Peripherally inserted central catheter; Catheter; Internal medicine","score_opus":0.07366539114624807,"score_gpt":0.3341895137000222,"score_spread":0.2605241225537741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012245768","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06382876,0.92235327,0.000021236754,0.00010920756,0.0006021356,0.00384146,0.00009253672,0.00036968826,0.008781714],"genre_scores_gemma":[0.04520712,0.9511285,0.001755003,0.00022544994,0.00036118418,0.0003430519,0.00039421645,0.00042824095,0.00015722105],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99241835,0.0005919531,0.0021462638,0.0021237468,0.00071784435,0.0020018262],"domain_scores_gemma":[0.99498624,0.00037199937,0.0010425028,0.0023431047,0.0001823514,0.0010738095],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0006594849,0.0018409751,0.008019323,0.00045077302,0.0006572458,0.00025998577,0.0008218232,0.0013554052,0.00031134655],"category_scores_gemma":[0.00022710049,0.001622481,0.0015881876,0.0009466346,0.00033503232,0.00026016083,0.00056191214,0.0020413164,0.00027096595],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057468125,0.011805591,0.006822371,0.04338614,0.012632781,0.00046847988,0.0019448687,3.7787842e-7,0.006537114,0.0014521109,0.00022933334,0.9146634],"study_design_scores_gemma":[0.012383657,0.0025943606,0.028903088,0.037761297,0.051253997,0.007840565,0.0004731823,0.000029145325,0.0024491968,0.00019229155,0.8492679,0.0068513183],"about_ca_topic_score_codex":0.00040763378,"about_ca_topic_score_gemma":0.00005088691,"teacher_disagreement_score":0.90781206,"about_ca_system_score_codex":0.0005405973,"about_ca_system_score_gemma":0.0010002955,"threshold_uncertainty_score":0.99994105},"labels":[],"label_agreement":null},{"id":"W2012295337","doi":"10.1182/blood-2003-01-0166","title":"Regulation of plasminogen activation: a role for melanotransferrin (p97) in cell migration","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Atherosclerosis and Cardiovascular Diseases","field":"Immunology and Microbiology","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Cell migration; Cell biology; Angiogenesis; Chemistry; Endogeny; Endothelial stem cell; Receptor; Plasminogen activator; Cell; Recombinant DNA; Tissue plasminogen activator; Biology; Biochemistry; Cancer research; In vitro; Gene","score_opus":0.009330068615890886,"score_gpt":0.19328957064542177,"score_spread":0.18395950202953087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012295337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964048,0.0015558143,0.0010385232,0.000011771121,0.000040464525,0.00025493727,0.000018998666,0.000010800527,0.0006638633],"genre_scores_gemma":[0.9995337,0.000031993608,0.0001374783,0.00001045239,0.000007619538,0.000058520494,0.00007025982,0.00000753762,0.00014241181],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99951714,0.000086006854,0.00015044301,0.00012371941,0.00002240637,0.00010026004],"domain_scores_gemma":[0.99976504,0.000034898687,0.000040049996,0.00012168207,0.000031710697,0.0000066166867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012262254,0.000065328786,0.00013070117,0.000038153932,0.000032589138,0.000003002048,0.00004124393,0.000099641,0.000066911634],"category_scores_gemma":[0.00002168468,0.000062895415,0.00011547427,0.00006332602,0.000021102804,0.000046674635,0.000003188355,0.00003259908,0.0000076110705],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037831807,0.00032737176,0.011506399,0.000019240639,0.000065828775,4.4490914e-8,0.00024505224,0.000055975543,0.9865542,0.00066538336,0.000041244282,0.0004814364],"study_design_scores_gemma":[0.0025334363,0.00006834677,0.078636914,0.000015966361,0.00007254564,0.0000013165223,0.00014400718,0.0000023624148,0.915561,0.00022470903,0.0026744998,0.000064853426],"about_ca_topic_score_codex":0.000022778255,"about_ca_topic_score_gemma":0.00002331488,"teacher_disagreement_score":0.07099315,"about_ca_system_score_codex":0.0000069606417,"about_ca_system_score_gemma":0.000026884867,"threshold_uncertainty_score":0.25648007},"labels":[],"label_agreement":null},{"id":"W2012341114","doi":"10.1182/blood-2003-04-1029","title":"Anti-D initially stimulates an Fc-dependent leukocyte oxidative burst and subsequently suppresses erythrophagocytosis via interleukin-1 receptor antagonist","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; Pediatric Oncology Group; St. Michael's Hospital","funders":"Canadian Blood Services","keywords":"Phagocytosis; Opsonin; Respiratory burst; Receptor antagonist; Superoxide; Cytokine; Granulocyte; Immune system; Fc receptor; Biology; Receptor; Immunology; Flow cytometry; Antagonist; Molecular biology; Biochemistry","score_opus":0.022062363709986172,"score_gpt":0.2706840499772693,"score_spread":0.24862168626728312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012341114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995496,0.00091214804,0.0002529308,0.00013900078,0.00049690454,0.00044211498,0.000079325844,0.00016699154,0.0020146272],"genre_scores_gemma":[0.99589205,0.00079334114,0.0016014145,0.0007019616,0.0002702478,0.000029089808,0.00023216158,0.00006080749,0.00041890825],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979378,0.00025468547,0.00043147113,0.000668636,0.00026083933,0.00044654947],"domain_scores_gemma":[0.9987724,0.00012924902,0.00015778016,0.00039171515,0.00021169202,0.0003371541],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019716966,0.0003714484,0.0006608615,0.0001691917,0.00022359804,0.0000716863,0.00011718361,0.0002268695,0.001038332],"category_scores_gemma":[0.00015260518,0.00033022833,0.00010642683,0.000214773,0.00032334556,0.0002726052,0.00006037045,0.00033991435,0.00016335737],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008317786,0.0018869104,0.012710909,0.00018038762,0.0004380018,0.00042972752,0.000800928,0.000014246505,0.9812603,0.00031862903,0.00027541677,0.0008527499],"study_design_scores_gemma":[0.010398651,0.004626966,0.014270256,0.00014998869,0.000619776,0.0015713254,0.0009481198,0.000057854755,0.96225405,0.00018658134,0.0042994926,0.0006169626],"about_ca_topic_score_codex":0.000078418954,"about_ca_topic_score_gemma":0.00003175248,"teacher_disagreement_score":0.01900629,"about_ca_system_score_codex":0.00005540534,"about_ca_system_score_gemma":0.00015611375,"threshold_uncertainty_score":0.999915},"labels":[],"label_agreement":null},{"id":"W2012451332","doi":"10.1182/blood-2007-07-101402","title":"Brain parenchyma involvement as isolated central nervous system relapse of systemic non-Hodgkin lymphoma: an International Primary CNS Lymphoma Collaborative Group report","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Primary central nervous system lymphoma; Parenchyma; Lymphoma; Internal medicine; Methotrexate; Central nervous system; Complication; Pathology; Oncology","score_opus":0.008012219955575271,"score_gpt":0.250546609742176,"score_spread":0.24253438978660075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012451332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99151796,0.00091354246,0.00021072605,0.00017874912,0.0008101293,0.0014388318,0.000111364374,0.00016847318,0.0046502156],"genre_scores_gemma":[0.9970147,0.00011553154,0.0008377013,0.00025777658,0.0003334421,0.00014588243,0.00097574975,0.00006379576,0.00025539228],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99640083,0.0001063692,0.0013223191,0.0007280349,0.00085601123,0.00058643497],"domain_scores_gemma":[0.9973973,0.00015634784,0.00071930024,0.0008001335,0.00048439123,0.00044250317],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000716288,0.00041995497,0.00081166334,0.00029846912,0.00011503595,0.000048343714,0.0002421048,0.00024546363,0.00003225515],"category_scores_gemma":[0.0000992338,0.0003705742,0.0002217674,0.0005491079,0.00009538897,0.00022146323,0.00011080504,0.00006750113,0.000027949116],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027737375,0.027284,0.8404563,0.0013202857,0.0046529267,0.04131152,0.005980094,0.00002288563,0.03341106,0.0028593766,0.0017357691,0.03819202],"study_design_scores_gemma":[0.02329083,0.0026700976,0.939248,0.0018363772,0.0009316901,0.011493992,0.004475048,0.00014640964,0.0143638775,0.000013239156,0.0010879396,0.00044249793],"about_ca_topic_score_codex":0.0011737817,"about_ca_topic_score_gemma":0.0001560813,"teacher_disagreement_score":0.098791674,"about_ca_system_score_codex":0.0014853164,"about_ca_system_score_gemma":0.0007634832,"threshold_uncertainty_score":0.9998746},"labels":[],"label_agreement":null},{"id":"W2012486455","doi":"10.1182/blood-2003-07-2231","title":"Fanconi anemia stem cells: going round and round","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Saint-François d'Assise; Centre hospitalier universitaire de Québec","funders":"","keywords":"Fanconi anemia; Stem cell; Anemia; Medicine; Biology; Genetics; Internal medicine; DNA repair; DNA","score_opus":0.008244039720840955,"score_gpt":0.21081297249790518,"score_spread":0.20256893277706423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012486455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989562,0.0016472661,0.00042860134,0.000009016227,0.0001362558,0.00011091743,0.0000052275695,0.000021081496,0.008079671],"genre_scores_gemma":[0.9939468,0.00011560957,0.0025231505,0.00011374123,0.00007973962,0.000010098346,0.0000062560025,0.00002428242,0.0031803565],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99923795,0.00004638707,0.00011841752,0.00030886396,0.00007793143,0.00021043494],"domain_scores_gemma":[0.9995737,0.000008283367,0.000043246786,0.00027310397,0.000024688177,0.00007695946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001363642,0.0001250857,0.00010147932,0.000017318493,0.00006180446,0.0000433709,0.000080928745,0.0001266708,0.000013168639],"category_scores_gemma":[0.000013490492,0.00012690069,0.000040628463,0.000040280614,0.000028452121,0.0000036498488,0.000050560073,0.000058159494,0.000017612598],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006005787,0.00007755571,0.0011712379,0.000023092427,0.000033862205,0.0000126495515,0.000028846851,0.0000022451745,0.99717665,0.0005403129,0.00019979036,0.0007277434],"study_design_scores_gemma":[0.0008341431,0.00017516766,0.00007565548,0.000008244747,0.000036692603,0.00007749788,0.00008857013,0.0000048781244,0.9685036,0.00014363039,0.029885108,0.00016682527],"about_ca_topic_score_codex":0.0000044891344,"about_ca_topic_score_gemma":0.000015105092,"teacher_disagreement_score":0.029685318,"about_ca_system_score_codex":0.0000058967644,"about_ca_system_score_gemma":0.000040526877,"threshold_uncertainty_score":0.51748604},"labels":[],"label_agreement":null},{"id":"W2012741632","doi":"10.1182/blood-2009-03-213058","title":"TAPP2 links phosphoinositide 3-kinase signaling to B-cell adhesion through interaction with the cytoskeletal protein utrophin: expression of a novel cell adhesion-promoting complex in B-cell leukemia","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Canadian Institutes of Health Research","keywords":"Cell biology; Cytoskeleton; Cell adhesion; Phosphoinositide 3-kinase; Cell adhesion molecule; Cell; Biology; Signal transduction; Chemistry; PI3K/AKT/mTOR pathway; Genetics","score_opus":0.024578615594846503,"score_gpt":0.2826943971642419,"score_spread":0.2581157815693954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012741632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99410427,0.00030243734,0.0007059254,0.0004926353,0.000033918663,0.0023999505,0.000009992562,0.00007810695,0.0018727486],"genre_scores_gemma":[0.985224,0.000019152694,0.013637621,0.00041128858,0.00020226657,0.00010620401,0.000040435392,0.0000705821,0.0002884237],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99657875,0.00015693464,0.0007473852,0.00074249523,0.0010361378,0.0007382794],"domain_scores_gemma":[0.99810463,0.00026700372,0.0003772316,0.00077153207,0.00023248921,0.00024713489],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00049257796,0.00043075747,0.00064096285,0.00021030447,0.0001831124,0.00005427195,0.00039997,0.00029706507,0.00007304647],"category_scores_gemma":[0.00012072663,0.00029798064,0.00017597926,0.00070856855,0.00009792681,0.0002450962,0.00020045429,0.0011056876,0.000038338905],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013516276,0.0033102708,0.00006839378,0.0005403518,0.0000135330765,0.0002806735,0.002298309,0.00050986547,0.99093956,0.00000964504,0.0002003309,0.00047743123],"study_design_scores_gemma":[0.037983168,0.002344749,0.00021503413,0.0021777018,0.00010139191,0.000109499066,0.0010429192,0.004220655,0.9512326,0.000014540512,0.00024377237,0.00031395405],"about_ca_topic_score_codex":0.0009831184,"about_ca_topic_score_gemma":0.000029765932,"teacher_disagreement_score":0.039706953,"about_ca_system_score_codex":0.0027122132,"about_ca_system_score_gemma":0.001718347,"threshold_uncertainty_score":0.99994725},"labels":[],"label_agreement":null},{"id":"W2012872684","doi":"10.1182/blood-2006-02-002055","title":"In vivo control of acute lymphoblastic leukemia by immunostimulatory CpG oligonucleotides","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"In vivo; Immunology; CpG Oligodeoxynucleotide; Peripheral blood mononuclear cell; CpG site; Cancer research; Nod; Leukemia; Immune system; Immunotherapy; Ex vivo; Medicine; Biology; In vitro; DNA methylation","score_opus":0.0028507041166257307,"score_gpt":0.19081486407377612,"score_spread":0.1879641599571504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012872684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99132425,0.0022738364,0.00026898025,0.000036012825,0.0013409863,0.00014938271,0.000032465665,0.000045853656,0.0045282263],"genre_scores_gemma":[0.9900095,0.000038924347,0.000008200197,0.00016549938,0.000023305007,0.000016022883,0.000042181626,0.000014617322,0.009681746],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99912703,0.000083789855,0.00036878927,0.0001701528,0.000026088132,0.00022416095],"domain_scores_gemma":[0.99952614,0.00010775747,0.00013272386,0.00017979677,0.000046026904,0.00000753564],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008680693,0.00013613599,0.00024744915,0.00011356205,0.00005305132,0.0000065942213,0.00011021988,0.0001684104,0.0017720313],"category_scores_gemma":[0.000020943147,0.00013171442,0.00008831982,0.00009339742,0.000096976364,0.00012257887,0.000020686479,0.00015057404,0.00032654926],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021622439,0.00033948096,0.001886855,0.000007601966,0.00023154025,0.000004150874,0.000026503983,0.00004409289,0.96618706,0.00028030406,0.030743495,0.000032667198],"study_design_scores_gemma":[0.0076133013,0.00019668014,0.004918557,0.00003114388,0.00019080057,0.00006506438,0.00003110961,0.000026095904,0.95570093,0.00005296555,0.031023115,0.00015021264],"about_ca_topic_score_codex":0.0006366679,"about_ca_topic_score_gemma":0.000008858181,"teacher_disagreement_score":0.01048613,"about_ca_system_score_codex":0.00006228073,"about_ca_system_score_gemma":0.000048967882,"threshold_uncertainty_score":0.9991405},"labels":[],"label_agreement":null},{"id":"W2013138837","doi":"10.1182/blood-2007-09-110593","title":"DNA variants in the dihydrofolate reductase gene and outcome in childhood ALL","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Haplotype; Dihydrofolate reductase; Biology; Thymidylate synthase; Genetics; Single-nucleotide polymorphism; Allele; Molecular biology; Genotype; Gene; Promoter; Gene expression; Cancer; Fluorouracil","score_opus":0.01940133047757741,"score_gpt":0.2998931414694946,"score_spread":0.28049181099191717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013138837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956023,0.00030041317,0.000021308684,0.0013872839,0.000039098115,0.0004464503,0.00000681689,0.00001765863,0.0021786392],"genre_scores_gemma":[0.9980308,0.000057150926,0.0005523557,0.0010685863,0.0001370064,0.000011189405,0.000013919635,0.000019745246,0.00010927586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985218,0.00006578226,0.00033550258,0.0002647723,0.00034379246,0.00046837234],"domain_scores_gemma":[0.99926156,0.00020709008,0.000037666436,0.00034634984,0.00001870719,0.00012865108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012631862,0.00012985869,0.00023194365,0.00020250103,0.000028353688,0.00001758708,0.00015823632,0.00010445717,0.000025087811],"category_scores_gemma":[0.00033539225,0.000087417706,0.000030878913,0.0003446422,0.000063139225,0.000054491087,0.00008155481,0.00033847528,0.000029516203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074749143,0.0071234163,0.8154779,0.00019704746,0.00034873406,0.020495875,0.013801555,0.0000052647706,0.13293144,0.00068242656,0.0008734775,0.0073153833],"study_design_scores_gemma":[0.01455051,0.00020904263,0.97486216,0.000057242378,0.0000899107,0.0014701772,0.0002491671,0.000114079405,0.007760374,0.000229615,0.0002716813,0.00013606434],"about_ca_topic_score_codex":0.00021796052,"about_ca_topic_score_gemma":0.00007253363,"teacher_disagreement_score":0.15938425,"about_ca_system_score_codex":0.00010017574,"about_ca_system_score_gemma":0.00013687789,"threshold_uncertainty_score":0.35647905},"labels":[],"label_agreement":null},{"id":"W2013340805","doi":"10.1182/blood-2008-06-163279","title":"Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Université de Montréal; McGill University; Ottawa Hospital; University of Ottawa; University of Toronto; University of New Brunswick; Dalhousie University; Western University; McMaster University","funders":"","keywords":"Medicine; Thrombophilia; Hazard ratio; Warfarin; Internal medicine; Gastroenterology; Factor V Leiden; Antithrombin; Risk factor; Hyperhomocysteinemia; Protein S deficiency; Surgery; Heparin; Venous thrombosis; Thrombosis; Confidence interval","score_opus":0.03490802731823626,"score_gpt":0.27101966361607244,"score_spread":0.23611163629783619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013340805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994557,0.00015171486,0.000011254735,0.00012678042,0.0003378436,0.0015877242,0.00024427474,0.000067733876,0.0029156266],"genre_scores_gemma":[0.9983898,0.0005553237,0.00048344446,0.00014935443,0.00023423697,0.000043213528,0.00007677495,0.00003029546,0.00003760521],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99720603,0.00032893647,0.0010475407,0.0004572316,0.00072268536,0.00023758461],"domain_scores_gemma":[0.9973591,0.0007472277,0.00074782973,0.0008023922,0.00020496766,0.00013849737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006084985,0.00026877015,0.0017917183,0.00017209041,0.000090993206,0.0000046096143,0.00017427343,0.00020458992,0.00006848186],"category_scores_gemma":[0.0012469924,0.00021167581,0.00038341546,0.00025598094,0.0002209722,0.00005092829,0.000046368943,0.00033614834,0.000046501365],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9531658,0.017440204,0.00027515076,0.00007169091,0.0018696273,0.000037494825,0.00386657,0.00045646916,0.018670252,0.0030602575,0.00025471882,0.0008317299],"study_design_scores_gemma":[0.8522014,0.0049714465,0.025961746,0.00048379827,0.0013129693,0.000009018291,0.000029576737,0.000078734694,0.11255141,0.0021502187,0.000052921005,0.00019675982],"about_ca_topic_score_codex":0.0003771276,"about_ca_topic_score_gemma":0.0000076368015,"teacher_disagreement_score":0.100964434,"about_ca_system_score_codex":0.000019966274,"about_ca_system_score_gemma":0.00014989416,"threshold_uncertainty_score":0.86318886},"labels":[],"label_agreement":null},{"id":"W2013502877","doi":"10.1182/blood-2006-05-019539","title":"Alert and sniffy-nosed about Mll-AF4?","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Biology","score_opus":0.010691965048473296,"score_gpt":0.26371968690008246,"score_spread":0.25302772185160916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013502877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.958017,0.0011522244,0.000019291208,0.0013429802,0.000034812536,0.00027275705,0.0000084329995,0.00008641421,0.03906609],"genre_scores_gemma":[0.9903392,0.00010699758,0.0009946452,0.00041568605,0.00046840453,0.000017179933,0.000036213278,0.000028757351,0.007592924],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897075,0.000024479246,0.00016368055,0.00024511074,0.0002744952,0.00032146892],"domain_scores_gemma":[0.9994234,0.00005929911,0.00002856851,0.00028459704,0.00006537068,0.00013875542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014115607,0.00011869736,0.00020859556,0.00009557523,0.00006153078,0.000024578932,0.00007703223,0.00009880493,0.0001742543],"category_scores_gemma":[0.00006935901,0.00009843971,0.00004419253,0.00015912502,0.00010011157,0.00004612291,0.00006033682,0.00022407837,0.00011983102],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045642018,0.0025598772,0.44639012,0.00055321964,0.00047690154,0.003754469,0.0003703504,0.0000028400727,0.4035316,0.003405486,0.124722615,0.013776074],"study_design_scores_gemma":[0.0152895525,0.00041009943,0.85993075,0.000114743685,0.00026243276,0.0007055467,0.00005210687,0.00016653448,0.05176295,0.0004357767,0.07058173,0.00028778554],"about_ca_topic_score_codex":0.00035913842,"about_ca_topic_score_gemma":0.00003207133,"teacher_disagreement_score":0.41354063,"about_ca_system_score_codex":0.000038052174,"about_ca_system_score_gemma":0.00013286625,"threshold_uncertainty_score":0.40142548},"labels":[],"label_agreement":null},{"id":"W2013534890","doi":"10.1182/blood.v98.2.255","title":"Questions from Quebec","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Antithrombotic; Platelet; Hemostasis; Lysis; Plasminogen activator; Medicine; Pharmacology; Fibrinolytic agent; Plasminogen activator inhibitor-1; Chemistry; Internal medicine; Immunology","score_opus":0.013228752612848444,"score_gpt":0.2566952784140153,"score_spread":0.24346652580116684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013534890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9575372,0.0005353218,0.00014264186,0.0024044125,0.00011295101,0.00017543462,0.0000044656576,0.00011086739,0.038976755],"genre_scores_gemma":[0.99335265,0.00039092783,0.0008510369,0.0012444506,0.00033002073,0.00002769299,0.000031289484,0.000012377093,0.0037595385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999518,0.000009806907,0.00009823697,0.00013654346,0.00010721535,0.00013024521],"domain_scores_gemma":[0.9996323,0.000017485196,0.000020092566,0.00022646441,0.000023379818,0.000080294434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000035234814,0.000065339605,0.0001591288,0.000037217764,0.00004273636,0.000014202972,0.000043250693,0.000033520682,0.0008692114],"category_scores_gemma":[0.000024097239,0.000057211924,0.000048957692,0.00007882235,0.000017736482,0.000032889748,0.00002512165,0.00005523178,0.0003878731],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010313642,0.03408137,0.57203597,0.00013914288,0.0027633596,0.002753305,0.0025263552,0.000023607965,0.021748876,0.052790835,0.20592897,0.1051051],"study_design_scores_gemma":[0.0017732388,0.00010528779,0.79309577,0.000076222146,0.0005786672,0.00001800797,0.000091563605,0.000009410558,0.0011648136,0.0005925917,0.20239362,0.000100792924],"about_ca_topic_score_codex":0.011498131,"about_ca_topic_score_gemma":0.003070553,"teacher_disagreement_score":0.22105983,"about_ca_system_score_codex":0.000015327762,"about_ca_system_score_gemma":0.00002863026,"threshold_uncertainty_score":0.9950844},"labels":[],"label_agreement":null},{"id":"W2013782945","doi":"10.1182/blood-2003-06-2156","title":"The granzyme B–serglycin complex from cytotoxic granules requires dynamin for endocytosis","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Cellular transport and secretion","field":"Biochemistry, Genetics and Molecular Biology","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Granzyme B; Granzyme; Cytotoxic T cell; Endocytic cycle; Endocytosis; Dynamin; Cell biology; Biology; Perforin; Exocytosis; Chemistry; Biochemistry; Receptor; Secretion","score_opus":0.013832070496302364,"score_gpt":0.22994726910330193,"score_spread":0.21611519860699957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013782945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9782077,0.0011194365,0.019632539,0.0002836222,0.000093941315,0.00029505708,0.00015649463,0.00002102422,0.00019019666],"genre_scores_gemma":[0.9940008,0.00027253063,0.0010536363,0.000094966825,0.0002519305,0.000069518595,0.00411593,0.000022964297,0.00011773452],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991881,0.0000195762,0.00018703812,0.0002721212,0.00010125001,0.0002318804],"domain_scores_gemma":[0.99952185,0.000019292225,0.000054775308,0.00030545625,0.000043314027,0.000055284803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000091576294,0.00013868402,0.000117491996,0.000015708072,0.0002331079,0.000036632893,0.00020401052,0.00010303325,0.000009922127],"category_scores_gemma":[0.0000206875,0.00010703349,0.00016044198,0.000037418587,0.00008700339,0.0000029047847,0.0000227378,0.000047363606,0.0000070898564],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011656335,0.00009737367,0.00096841063,0.0000077755185,0.000080281476,0.0000033774165,0.000050136612,0.00001694879,0.99770766,0.0005407771,0.000036555106,0.00037411813],"study_design_scores_gemma":[0.004034914,0.00030430398,0.009359501,0.000013145345,0.00011915024,0.000008117921,0.00007749731,0.000025732623,0.9434504,0.0026083507,0.039756957,0.00024193332],"about_ca_topic_score_codex":0.00011061304,"about_ca_topic_score_gemma":0.0009400907,"teacher_disagreement_score":0.054257285,"about_ca_system_score_codex":0.0000072310104,"about_ca_system_score_gemma":0.000034345154,"threshold_uncertainty_score":0.4364699},"labels":[],"label_agreement":null},{"id":"W2013819800","doi":"10.1182/blood-2005-12-5119","title":"HIT without (more) heparin","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Heparin; Medicine; Internal medicine","score_opus":0.016724750702900085,"score_gpt":0.2723201825858558,"score_spread":0.2555954318829557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013819800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8989606,0.00010175722,0.000023167913,0.0008136857,0.00010313788,0.00025484932,0.0000042277634,0.00017291257,0.09956569],"genre_scores_gemma":[0.9939995,0.000013316214,0.0013641419,0.0003635792,0.00044238305,0.000022805712,0.000033326447,0.00003905284,0.0037219075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882877,0.00002255597,0.000256846,0.0003055156,0.0002336222,0.00035270525],"domain_scores_gemma":[0.9993026,0.00002177086,0.000055190052,0.00041896442,0.00005617856,0.00014524719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000104208106,0.0001791511,0.00040712213,0.0000824024,0.0000814297,0.000026182503,0.00010190125,0.00012280777,0.0003126479],"category_scores_gemma":[0.000029306793,0.00015556223,0.0001159747,0.00019452184,0.0000666289,0.000068480964,0.00005225901,0.00018551365,0.0005054637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004268049,0.0018510241,0.81999534,0.00006942676,0.00021603714,0.00015698421,0.00012798057,0.0000010330062,0.17094854,0.0031910022,0.002299249,0.0011006965],"study_design_scores_gemma":[0.0049777753,0.00020155973,0.82937706,0.000071941446,0.0005477554,0.0002533195,0.000041518913,0.000019604244,0.14216389,0.00045179488,0.021615148,0.00027865544],"about_ca_topic_score_codex":0.0008220757,"about_ca_topic_score_gemma":0.000110924375,"teacher_disagreement_score":0.095843785,"about_ca_system_score_codex":0.000032936634,"about_ca_system_score_gemma":0.0001179142,"threshold_uncertainty_score":0.6496882},"labels":[],"label_agreement":null},{"id":"W2013976238","doi":"10.1182/blood-2008-09-178236","title":"A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":169,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Waterloo; McMaster University; Canadian Blood Services","funders":"","keywords":"Medicine; Randomized controlled trial; Blood product; Confidence interval; Platelet transfusion; Platelet; Surgery; Randomization; Relative risk; Blood transfusion; Clinical trial; Internal medicine","score_opus":0.015399538456236664,"score_gpt":0.25480117299979577,"score_spread":0.23940163454355912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013976238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98993784,0.00015731738,0.00027196595,0.000039188206,0.000045363053,0.008892187,0.000027372718,0.000022347649,0.00060642045],"genre_scores_gemma":[0.99871933,0.00010780545,0.0007190835,0.000030475394,0.0000185195,0.0003230252,0.000032828524,0.00001777908,0.000031119012],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9989539,0.00004109833,0.00037533193,0.00020652678,0.00024295351,0.00018022068],"domain_scores_gemma":[0.99937755,0.00017225214,0.000110865134,0.00011917125,0.00012145233,0.00009868879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015220293,0.000175329,0.0019287275,0.000078394776,0.00009079709,0.000012895896,0.00003569571,0.000055378692,0.000012044252],"category_scores_gemma":[0.00005531503,0.000107049695,0.00015022248,0.00006805722,0.00008221022,0.00007229032,0.000009698564,0.000053224412,7.377452e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9933012,0.0015573882,0.0029279757,0.00006368387,0.00075813744,0.00005310068,0.0007725045,0.000007902996,0.00033642756,0.00005010303,0.000012474615,0.00015906678],"study_design_scores_gemma":[0.99173975,0.0031191863,0.002716246,0.00012384239,0.0008994058,0.000022506005,0.0000741587,0.000044703786,0.0010644875,0.00007440705,0.000011325561,0.00010998723],"about_ca_topic_score_codex":0.00005743744,"about_ca_topic_score_gemma":0.00004335484,"teacher_disagreement_score":0.008781526,"about_ca_system_score_codex":0.000010308297,"about_ca_system_score_gemma":0.0001232366,"threshold_uncertainty_score":0.43653598},"labels":[],"label_agreement":null},{"id":"W2014067834","doi":"10.1182/blood.v97.8.2269","title":"Overexpression of suppressor of cytokine signaling-1 impairs pre-T-cell receptor–induced proliferation but not differentiation of immature thymocytes","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"SOCS2; Suppressor of cytokine signaling 1; Suppressor of cytokine signalling; Biology; SOCS3; Cytokine receptor; Cytokine; Janus kinase; Cell biology; Thymocyte; Signal transduction; T cell; Haematopoiesis; SOCS5; T-cell receptor; Immunology; Suppressor; Stem cell; STAT3; Immune system; Genetics","score_opus":0.01585955187552883,"score_gpt":0.2566747240426568,"score_spread":0.24081517216712794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014067834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983868,0.00009468683,0.00018107014,0.00007945337,0.000117026335,0.00051557185,0.00012951574,0.000036900838,0.00045898114],"genre_scores_gemma":[0.9986959,0.00004445139,0.00061873376,0.000019415535,0.00018841044,0.000021221904,0.00020164499,0.000027168999,0.0001830519],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99845415,0.00006392066,0.00068138295,0.00023051111,0.00040253217,0.00016749663],"domain_scores_gemma":[0.99851567,0.00010439144,0.00057729945,0.00032940682,0.00040044257,0.00007282342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013567593,0.00018124764,0.00046439221,0.00017716043,0.00004246791,0.000008234491,0.00009545136,0.000170879,0.0003880737],"category_scores_gemma":[0.00016390128,0.00014661103,0.00020460831,0.00019598924,0.000035077075,0.00013387644,0.000037163496,0.00019996181,0.000002420507],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00137049,0.0021085888,0.0078810025,0.0004119787,0.00010302928,0.0000013578452,0.0005592026,0.000052267776,0.9872293,0.000031226667,0.00013892593,0.00011266745],"study_design_scores_gemma":[0.0034893805,0.0011643651,0.016646037,0.000811118,0.000281917,0.000018694147,0.00011761286,0.00038830301,0.9768912,0.00001798688,0.00005754012,0.000115841365],"about_ca_topic_score_codex":0.00009589898,"about_ca_topic_score_gemma":0.0000035885544,"teacher_disagreement_score":0.010338057,"about_ca_system_score_codex":0.000019191055,"about_ca_system_score_gemma":0.00008173959,"threshold_uncertainty_score":0.59786236},"labels":[],"label_agreement":null},{"id":"W2014154667","doi":"10.1182/blood.v98.5.1489","title":"Role for lipid rafts in regulating interleukin-2 receptor signaling","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Caveolin-1 and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":116,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Lipid raft; Lipid microdomain; Cell biology; Signal transduction; Ganglioside; Receptor; Raft; Chemistry; Biology; Biochemistry; Membrane","score_opus":0.0076832965356613435,"score_gpt":0.2261923516231018,"score_spread":0.21850905508744045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014154667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967179,0.0011622085,0.0008424968,0.0000517491,0.00007015578,0.00015011414,0.000005488737,0.000012976411,0.0009869348],"genre_scores_gemma":[0.99675614,0.00007871538,0.001326702,0.00010004083,0.0005954163,0.000042155563,0.000096170705,0.000022598097,0.0009820834],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992673,0.000016049666,0.0001814489,0.0002586184,0.000058332153,0.0002182567],"domain_scores_gemma":[0.999682,0.000013684165,0.000054131728,0.0001586251,0.000049729675,0.000041805233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015230203,0.0001051774,0.0001098296,0.000034599707,0.00004308771,0.000021014881,0.00011805649,0.00010660645,0.000027716349],"category_scores_gemma":[0.00009046367,0.000108044835,0.000070213275,0.00007721645,0.000018521605,0.0000031633053,0.000049200135,0.000052420713,0.000006106206],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006913619,0.00012185614,0.0042584524,0.000025272671,0.000020345457,0.0000014132586,0.00007663862,0.000032967888,0.99229777,0.000016391916,0.00012059038,0.0029591927],"study_design_scores_gemma":[0.0013737078,0.00015570164,0.00012945231,0.00003754842,0.000016096314,0.000017966147,0.0001618165,0.0000667466,0.9632778,0.00012016403,0.034485552,0.00015746092],"about_ca_topic_score_codex":0.000010278181,"about_ca_topic_score_gemma":0.000053256437,"teacher_disagreement_score":0.03436496,"about_ca_system_score_codex":0.0000055047776,"about_ca_system_score_gemma":0.000036611724,"threshold_uncertainty_score":0.44059405},"labels":[],"label_agreement":null},{"id":"W2014207848","doi":"10.1182/blood-2008-04-154567","title":"Revascularization of ischemic limbs after transplantation of human bone marrow cells with high aldehyde dehydrogenase activity","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":160,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute; Alvin J. Siteman Cancer Center","keywords":"Progenitor cell; Bone marrow; Transplantation; Mesenchymal stem cell; Stromal cell; Stem cell; Haematopoiesis; Population; Biology; Revascularization; Medicine; Immunology; Pathology; Cell biology; Internal medicine","score_opus":0.009761877487177578,"score_gpt":0.2486884052759695,"score_spread":0.23892652778879192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014207848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974816,0.00019481822,0.00020819916,0.00008252794,0.00000801289,0.0004830629,0.000013841329,0.000018907047,0.0015090522],"genre_scores_gemma":[0.9987174,0.000095946845,0.00073683966,0.000024278868,0.000036051926,0.000013342749,0.0000478953,0.000016420425,0.00031180793],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99876285,0.00006207714,0.00024393057,0.00021936021,0.00052139733,0.00019037833],"domain_scores_gemma":[0.9992998,0.000029416278,0.000121010904,0.00031367622,0.00013284844,0.00010322876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022074314,0.00012269359,0.00031213186,0.00011866002,0.000024740672,0.0000046266573,0.00005988852,0.000096230106,0.00013214443],"category_scores_gemma":[0.000014986356,0.00010100125,0.0000785907,0.00024517256,0.000057175675,0.00007604001,0.000007639337,0.0001351739,0.000005475167],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069355126,0.0013046471,0.0040545766,0.0006412606,0.00007647843,0.00012172274,0.0001761006,0.0000062785275,0.9924096,0.000016575095,0.00001888236,0.00048036608],"study_design_scores_gemma":[0.003508571,0.0014304157,0.035601344,0.0002829593,0.00036767303,0.00004928156,0.0000083548,0.00002655583,0.95860815,0.000011557979,0.000015217856,0.00008994496],"about_ca_topic_score_codex":0.00008523962,"about_ca_topic_score_gemma":0.000023074697,"teacher_disagreement_score":0.033801436,"about_ca_system_score_codex":0.00001741963,"about_ca_system_score_gemma":0.000062758096,"threshold_uncertainty_score":0.41187117},"labels":[],"label_agreement":null},{"id":"W2014270896","doi":"10.1182/blood-2008-06-165043","title":"CEACAM1 negatively regulates platelet-collagen interactions and thrombus growth in vitro and in vivo","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; McGill University Health Centre; St. Michael's Hospital","funders":"","keywords":"GPVI; Collagen receptor; Platelet; Chemistry; Cell biology; Platelet activation; Cell adhesion molecule; Molecular biology; Biology; Integrin; Receptor; Immunology; Biochemistry","score_opus":0.013801964560745256,"score_gpt":0.24122636191038743,"score_spread":0.22742439734964218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014270896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99677545,0.00072228676,6.234557e-7,0.0003251057,0.000020851627,0.000252505,0.000010913563,0.00001910626,0.001873135],"genre_scores_gemma":[0.9985257,0.0006457999,0.00040632358,0.00008445808,0.00001391991,0.00001353884,0.000009054897,0.000012152886,0.0002891025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993809,0.00001877383,0.00015288542,0.00020529899,0.00007354502,0.0001686251],"domain_scores_gemma":[0.9997539,0.000057194924,0.000032937656,0.000072268034,0.000016812122,0.0000668766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000033859927,0.000117608106,0.0002664527,0.00014919901,0.000052562355,0.000008363184,0.000021862243,0.00005394143,0.00002264225],"category_scores_gemma":[0.000032985892,0.00010210083,0.000019473351,0.00017413424,0.00007012988,0.00010876269,0.000024447101,0.00008382508,0.0000038975163],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001430837,0.0044426112,0.69781697,0.0001507977,0.0004889491,0.011942423,0.006944873,0.0000021104595,0.27324346,0.000080890306,0.00058397854,0.0028720796],"study_design_scores_gemma":[0.015019442,0.00025952916,0.6963918,0.00013014393,0.000082892235,0.0026815152,0.0003582297,0.00008384403,0.28384292,0.00068318984,0.00026157478,0.00020489568],"about_ca_topic_score_codex":0.00032673654,"about_ca_topic_score_gemma":0.00018925201,"teacher_disagreement_score":0.013588605,"about_ca_system_score_codex":0.000019884406,"about_ca_system_score_gemma":0.000026771515,"threshold_uncertainty_score":0.41635507},"labels":[],"label_agreement":null},{"id":"W2014534001","doi":"10.1182/blood-2013-06-510222","title":"JAK2V617F homozygosity drives a phenotypic switch in myeloproliferative neoplasms, but is insufficient to sustain disease","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; National Institute for Health and Care Research; British Heart Foundation; Cancer Research UK","keywords":"Runs of Homozygosity; Phenotype; Disease gene identification; Myeloproliferative Disorders; Biology; Genetics; Disease; Polycythemia vera; Medicine; Immunology; Internal medicine; Genotype; Gene; Exome sequencing","score_opus":0.009201383433220293,"score_gpt":0.2503553068151575,"score_spread":0.2411539233819372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014534001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98930776,0.00043997297,0.0002718213,0.0063099754,0.000111180154,0.0017003923,0.00007240658,0.00009683701,0.0016896626],"genre_scores_gemma":[0.993081,0.000090494555,0.0013691767,0.0037500663,0.00023427997,0.0005397844,0.000053744512,0.000047888614,0.0008335887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99727535,0.00016436014,0.0004969214,0.00085068546,0.0005382487,0.0006744527],"domain_scores_gemma":[0.99800116,0.0002177328,0.0001025598,0.00063423323,0.00023666902,0.0008076611],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028025074,0.00045234722,0.000691565,0.00032783585,0.0001913063,0.00007262145,0.00016642168,0.000120491764,0.00021633515],"category_scores_gemma":[0.00047644586,0.0003726854,0.00016274097,0.00055824296,0.00007776376,0.00009868003,0.00014511116,0.00029029345,0.00030038023],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008515728,0.009612867,0.9702889,0.00019664523,0.00029080012,0.00048601074,0.0059912317,0.00008282861,0.0010109858,0.006395276,0.0013365851,0.0034563292],"study_design_scores_gemma":[0.010798338,0.0018226454,0.9506301,0.00037137762,0.00046057755,0.0000402924,0.0006307801,0.0006446127,0.028404722,0.0007603675,0.0048266393,0.0006095152],"about_ca_topic_score_codex":0.00015715239,"about_ca_topic_score_gemma":0.00024457742,"teacher_disagreement_score":0.027393736,"about_ca_system_score_codex":0.00018181579,"about_ca_system_score_gemma":0.00033566245,"threshold_uncertainty_score":0.9998725},"labels":[],"label_agreement":null},{"id":"W2014655794","doi":"10.1182/blood.v99.3.792","title":"Stromal-derived factor 1 inhibits the cycling of very primitive human hematopoietic cells in vitro and in NOD/SCID mice","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Heart, Lung, and Blood Institute","keywords":"Stromal cell; Haematopoiesis; Bone marrow; Biology; Homing (biology); Stromal cell-derived factor 1; Stem cell; Stem cell factor; Cell biology; Immunology; Cancer research; Myeloid; CXCR4; Chemokine; Immune system","score_opus":0.018960690261007336,"score_gpt":0.23656331160842745,"score_spread":0.21760262134742012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014655794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99862635,0.00055691757,0.000003113003,0.000107915585,0.000021921407,0.00025095325,0.000007709538,0.000010809751,0.00041428217],"genre_scores_gemma":[0.9995922,0.000052110434,0.00017521896,0.00005485135,0.000052508556,0.0000063164084,0.000004762283,0.000015064082,0.000046985715],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99915975,0.000034755998,0.00029095038,0.00018367534,0.00014621078,0.00018464905],"domain_scores_gemma":[0.99960524,0.00011735602,0.000081522776,0.00012131616,0.000026523223,0.000048039867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010382359,0.000117357806,0.00029994457,0.00008883272,0.00003074255,0.000009206422,0.00005236813,0.00006945972,0.00007907284],"category_scores_gemma":[0.00004218084,0.00008897306,0.000049652732,0.00014577364,0.000060549053,0.00003618257,0.000040210223,0.00021005592,0.000003747807],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025572295,0.00035170163,0.010248463,0.00009323135,0.000018464834,0.000017469441,0.002337058,0.0000015622322,0.9867794,0.0000025730744,0.0000069713005,0.00011752645],"study_design_scores_gemma":[0.0029160783,0.000068455935,0.011295621,0.00027455293,0.000042598625,0.000017871382,0.0005113688,0.00008034106,0.98468804,0.000010404306,0.000009455156,0.00008520814],"about_ca_topic_score_codex":0.00004127881,"about_ca_topic_score_gemma":0.00001581774,"teacher_disagreement_score":0.002890506,"about_ca_system_score_codex":0.000019803692,"about_ca_system_score_gemma":0.00001217793,"threshold_uncertainty_score":0.3628216},"labels":[],"label_agreement":null},{"id":"W2014927292","doi":"10.1182/blood-2011-08-372722","title":"VKORC1 and CYP2C9 genotype and patient characteristics explain a large proportion of the variability in warfarin dose requirement among children","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"VKORC1; Warfarin; CYP2C9; Pharmacogenetics; Dosing; Medicine; Vitamin K epoxide reductase; Pharmacogenomics; Maintenance dose; Cohort; Internal medicine; Pharmacology; Genotype; Biology; Atrial fibrillation; Genetics","score_opus":0.055999133099533804,"score_gpt":0.32894300954047917,"score_spread":0.27294387644094537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014927292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99785155,0.00048306884,0.00001381959,0.000041988576,0.0002688214,0.00073124043,0.00011893966,0.000013578846,0.00047700084],"genre_scores_gemma":[0.99909014,0.000409109,0.00014057918,0.00023802802,0.00004353227,0.00004246146,0.000011064352,0.00001262745,0.000012463438],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841017,0.00047845946,0.0004299579,0.00027364786,0.00013057514,0.00027718657],"domain_scores_gemma":[0.999351,0.000049102797,0.00022104666,0.00020368266,0.00005628544,0.00011883772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010749494,0.00015833403,0.00022554454,0.00005242539,0.00010540012,0.000006732224,0.000132691,0.00015185136,0.00014080307],"category_scores_gemma":[0.0000934949,0.00012193337,0.000037980328,0.000117555726,0.00018948743,0.00005770878,0.00023076257,0.00031976218,0.0000016704499],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001351983,0.0017282413,0.95861906,0.0000387751,0.0000963966,0.0000066802936,0.0029240842,0.0000010354888,0.024078786,0.0006546342,0.000014451587,0.011702685],"study_design_scores_gemma":[0.0023664394,0.000072239134,0.92439705,0.000011659766,0.00021100309,0.000008551794,0.00002854311,0.00016157766,0.07152963,0.000526631,0.00055274257,0.00013393855],"about_ca_topic_score_codex":0.00005980744,"about_ca_topic_score_gemma":0.000023473578,"teacher_disagreement_score":0.04745084,"about_ca_system_score_codex":0.000011753084,"about_ca_system_score_gemma":0.00004166891,"threshold_uncertainty_score":0.49722987},"labels":[],"label_agreement":null},{"id":"W2014941431","doi":"10.1182/blood-2002-12-3733","title":"Microsatellite polymorphism in heme oxygenase-1 gene promoter is associated with susceptibility to oxidant-induced apoptosis in lymphoblastoid cell lines","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Heme Oxygenase-1 and Carbon Monoxide","field":"Biochemistry, Genetics and Molecular Biology","cited_by":164,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"","keywords":"Heme oxygenase; Biology; Molecular biology; Oxidative stress; Allele; Genotype; Gene; Promoter; Apoptosis; Heme; Genetics; Haplotype; Lymphoblast; Cell culture; Gene expression; Endocrinology; Enzyme; Biochemistry","score_opus":0.00881147610329748,"score_gpt":0.21208051625001131,"score_spread":0.20326904014671382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014941431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984363,0.0004123695,0.000019013529,0.000117336465,0.000052787505,0.00050501677,0.000048372305,0.000020559868,0.00038828736],"genre_scores_gemma":[0.9975918,0.000056192297,0.00085652247,0.00069437595,0.000057289923,0.00007363741,0.000078093835,0.000059096816,0.0005329915],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976755,0.00018329678,0.0004566675,0.0008203678,0.00019998878,0.0006641777],"domain_scores_gemma":[0.99898815,0.000014286932,0.00010654174,0.0005916147,0.00009073723,0.0002086402],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040944692,0.00035787188,0.00035444886,0.00013802222,0.00004634107,0.000035387708,0.0002298627,0.00031853482,0.00003215677],"category_scores_gemma":[0.00011072185,0.00033661086,0.00010830769,0.00044396805,0.00004046582,0.000007489629,0.00007288121,0.00014431804,0.000022099654],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000084485495,0.0009982844,0.02480807,0.000017196957,0.000042782347,0.000031788826,0.00020767636,0.00000670867,0.97362703,0.0000012559158,0.00006431742,0.000110382854],"study_design_scores_gemma":[0.0032103008,0.00043540273,0.011540578,0.000040213676,0.00002549133,0.00001577162,0.00007459441,0.000003855162,0.98362577,0.000011000488,0.0005671508,0.00044984615],"about_ca_topic_score_codex":0.0001829101,"about_ca_topic_score_gemma":0.0010556051,"teacher_disagreement_score":0.013267493,"about_ca_system_score_codex":0.000063558065,"about_ca_system_score_gemma":0.00020634753,"threshold_uncertainty_score":0.99990857},"labels":[],"label_agreement":null},{"id":"W2015018636","doi":"10.1182/blood-2014-12-615757","title":"IgH-V(D)J NGS-MRD measurement pre- and early post-allotransplant defines very low- and very high-risk ALL patients","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":224,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"National Institutes of Health; National Cancer Institute; National Heart, Lung, and Blood Institute; St. Baldrick's Foundation","keywords":"Medicine; Oncology; Internal medicine; Cohort","score_opus":0.01667898044994222,"score_gpt":0.21560553882389832,"score_spread":0.19892655837395612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015018636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99575067,0.0027665112,0.0000046287805,0.00012786887,0.00019926539,0.0006637211,0.000084501946,0.00008543419,0.00031739005],"genre_scores_gemma":[0.99834466,0.00059608807,0.0004624853,0.00019448456,0.00011684981,0.000040516647,0.0000799882,0.000044246997,0.00012067886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980645,0.000062951585,0.00031960692,0.0004563494,0.0007157613,0.00038078445],"domain_scores_gemma":[0.9988036,0.00004974369,0.00011221702,0.00035184083,0.00025700865,0.00042559538],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024986645,0.00030345228,0.0004081318,0.00009632327,0.00006304536,0.00003720094,0.00007880512,0.00014070804,0.000009908802],"category_scores_gemma":[0.00015501164,0.00024714318,0.000057048146,0.000074278345,0.000075412565,0.00014300479,0.000066717985,0.00018859518,0.00003228211],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009157292,0.0016966067,0.98929596,0.000314682,0.00093789643,0.00017337092,0.0015125879,0.0000018975225,0.0023766672,0.000028218468,0.00037009595,0.0023762651],"study_design_scores_gemma":[0.02905807,0.0022167638,0.9610864,0.00038810112,0.0016276764,0.00008519724,0.000033333683,0.000007859786,0.0045170123,0.000055128145,0.0006541516,0.00027032083],"about_ca_topic_score_codex":0.002207936,"about_ca_topic_score_gemma":0.00015419106,"teacher_disagreement_score":0.028209599,"about_ca_system_score_codex":0.00024493106,"about_ca_system_score_gemma":0.00026941882,"threshold_uncertainty_score":0.9999981},"labels":[],"label_agreement":null},{"id":"W2015095236","doi":"10.1182/blood-2008-05-158139","title":"Transcriptional repression of microRNA genes by PML-RARA increases expression of key cancer proteins in acute promyelocytic leukemia","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Centre National de la Recherche Scientifique; Fonds National de la Recherche Luxembourg; Institut National de la Santé et de la Recherche Médicale","keywords":"Acute promyelocytic leukemia; Biology; microRNA; Arsenic trioxide; Cancer research; Promyelocytic leukemia protein; Myeloid leukemia; Retinoic acid; Psychological repression; Leukemia; Tretinoin; Cancer; ALCAM; Gene; Gene expression; Genetics; Apoptosis","score_opus":0.00825795758251597,"score_gpt":0.2283284882422845,"score_spread":0.22007053065976853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015095236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858724,0.013381759,0.00018092562,0.000012973782,0.000029077983,0.00026623087,0.0000834574,0.0000071979757,0.00016599685],"genre_scores_gemma":[0.9947646,0.0033882603,0.0011460781,0.000016723376,0.00006726159,0.00010562457,0.00012638707,0.000019720626,0.00036530645],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988785,0.00006487728,0.00035409004,0.00033046637,0.00019481612,0.00017725011],"domain_scores_gemma":[0.9993965,0.000008448621,0.00018019098,0.00026778277,0.000095907606,0.000051195573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008427212,0.00015679134,0.00023891535,0.0000461246,0.00004578864,0.0000033805534,0.00021336945,0.000189782,0.00002783149],"category_scores_gemma":[0.00003438215,0.00013604146,0.00008879224,0.00008843424,0.00015332541,0.000008632735,0.000058642057,0.00008948189,6.067116e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018450228,0.0003246811,0.023925295,0.00017166905,0.000043354743,0.000010557361,0.00012860296,0.000038787573,0.9746772,0.0000027065676,0.00028745527,0.0002051966],"study_design_scores_gemma":[0.0017067132,0.00018271428,0.0041841064,0.00020161238,0.000045774894,0.000044135,0.000022880467,0.000007051596,0.99243915,0.00001838399,0.0009959092,0.00015156875],"about_ca_topic_score_codex":0.00020175877,"about_ca_topic_score_gemma":0.000013808356,"teacher_disagreement_score":0.019741189,"about_ca_system_score_codex":0.000021068181,"about_ca_system_score_gemma":0.00041485464,"threshold_uncertainty_score":0.55476093},"labels":[],"label_agreement":null},{"id":"W2015114981","doi":"10.1182/blood-2010-07-294447","title":"Thrombospondin-1 is not the major activator of TGF-β1 in thrombopoietin-induced myelofibrosis","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Ligue Contre le Cancer; Institut National de la Santé et de la Recherche Médicale; Association pour la Recherche sur le Cancer","keywords":"Myelofibrosis; Thrombopoietin; Megakaryocyte; Bone marrow; Thrombospondin 1; Spleen; Platelet; Cytokine; Transforming growth factor; Thrombospondin; Fibrosis; Immunology; Activator (genetics); Internal medicine; Biology; Medicine; Cancer research; Endocrinology; Haematopoiesis; Angiogenesis; Cell biology; Receptor; Stem cell","score_opus":0.019957638218732726,"score_gpt":0.2813375255812673,"score_spread":0.2613798873625346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015114981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902302,0.00004776103,8.859137e-7,0.005278511,0.00019480023,0.00074066484,0.00004084827,0.000024276722,0.0034420646],"genre_scores_gemma":[0.99779433,0.00004130172,0.0007531228,0.0008260367,0.00016185186,0.00014230669,0.000009774732,0.00003386713,0.00023740539],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99849,0.000053353375,0.0003832246,0.000367926,0.00038507223,0.00032046804],"domain_scores_gemma":[0.9987304,0.0002715881,0.00015254042,0.0006215188,0.00010224599,0.00012169803],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002271028,0.0002523427,0.00053414545,0.00010659675,0.0000937289,0.000020788108,0.000167589,0.00017590424,0.0013054712],"category_scores_gemma":[0.00013953829,0.00015599457,0.00016983326,0.00030699227,0.000107288724,0.00007419182,0.000069789654,0.0004077855,0.00012017781],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011236487,0.002099694,0.356033,0.00004825841,0.00032171342,0.000020628848,0.0014077441,4.2276938e-8,0.637752,0.0010253727,0.0004858774,0.00069327233],"study_design_scores_gemma":[0.002976948,0.00032569954,0.43703797,0.000057050223,0.00020838658,0.00001919912,0.000117970136,0.000002235959,0.55872816,0.00005095231,0.0003838845,0.00009153106],"about_ca_topic_score_codex":0.00029946753,"about_ca_topic_score_gemma":0.00028411465,"teacher_disagreement_score":0.081004955,"about_ca_system_score_codex":0.000024542089,"about_ca_system_score_gemma":0.0001453229,"threshold_uncertainty_score":0.99960744},"labels":[],"label_agreement":null},{"id":"W2015137718","doi":"10.1182/blood-2009-08-240309","title":"Activated cryptic granulocyte-macrophage colony-stimulating factor autoantibodies in intravenous immunoglobulin preparations","year":2010,"lang":"en","type":"letter","venue":"Blood","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Héma-Québec","funders":"","keywords":"Antibody; Immunology; Granulocyte; Granulocyte macrophage colony-stimulating factor; Immunoglobulin G; Autoantibody; Macrophage; Medicine; Biology; Cytokine; Biochemistry; In vitro","score_opus":0.009980589332564993,"score_gpt":0.23708427564842224,"score_spread":0.22710368631585726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015137718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9578603,0.020051358,0.000028573299,0.014923464,0.002594608,0.0014887395,0.0003712396,0.00044698405,0.002234769],"genre_scores_gemma":[0.97612715,0.00016736143,0.000085229876,0.016141368,0.00007875056,0.00015165431,0.002698046,0.00011559578,0.0044348435],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99636257,0.0004281719,0.001026578,0.0008563706,0.000120723635,0.0012056025],"domain_scores_gemma":[0.9979665,0.00046521795,0.0005022044,0.00092661596,0.00012985013,0.000009566733],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.00024150444,0.00077085895,0.0010657862,0.00045648954,0.0006301776,0.00009961077,0.00084059127,0.0039931354,0.0012690644],"category_scores_gemma":[0.0003332115,0.00076258974,0.00031460883,0.00040864653,0.00051861414,0.00018130803,0.00020234141,0.007958266,0.0010025507],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010966741,0.0011583478,0.00055874157,0.00020642602,0.00067419186,0.0003185105,0.0029614884,0.000073058865,0.98177,0.000028401211,0.010181356,0.0019598557],"study_design_scores_gemma":[0.013379307,0.00096492254,0.027282516,0.0008475135,0.00083167606,0.0005046032,0.00048518446,0.000045821118,0.22136898,0.000347771,0.730569,0.003372688],"about_ca_topic_score_codex":0.00075519644,"about_ca_topic_score_gemma":0.000027318305,"teacher_disagreement_score":0.76040095,"about_ca_system_score_codex":0.00007713436,"about_ca_system_score_gemma":0.00031916134,"threshold_uncertainty_score":0.9997753},"labels":[],"label_agreement":null},{"id":"W2015236855","doi":"10.1182/blood-2007-04-079988","title":"Prognostic and oncogenic relevance of TLX1/HOX11 expression level in T-ALLs","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Fondation de France; Terry Fox Foundation","keywords":"Expression (computer science); Relevance (law); Medicine; Internal medicine; Political science; Computer science","score_opus":0.02703773222776286,"score_gpt":0.30269648580466607,"score_spread":0.2756587535769032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015236855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967001,0.00079498655,0.0006066427,0.00009053166,0.00002774044,0.00040866845,0.00000629979,0.000020171381,0.0013448425],"genre_scores_gemma":[0.9934732,0.00012115596,0.0058244844,0.000059151553,0.00007062552,0.000010066753,0.000004939225,0.00001933092,0.00041705527],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987595,0.000026669522,0.00030093166,0.00023125447,0.00036723315,0.00031438257],"domain_scores_gemma":[0.9989367,0.0005467081,0.000064331696,0.00023277974,0.00007972499,0.00013971486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045468472,0.00010305344,0.00024137141,0.00015379179,0.00001914829,0.000004170335,0.00008348231,0.00010917308,0.000024439341],"category_scores_gemma":[0.0011355827,0.000084502215,0.00003144372,0.00024355511,0.00010255928,0.000049967908,0.000087679204,0.00018441236,0.000013182273],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058889476,0.0010483083,0.21188653,0.0004123909,0.00004817552,0.0007866812,0.0005461217,0.0000013897267,0.77516997,0.000076706696,0.0003546379,0.00908018],"study_design_scores_gemma":[0.013354503,0.00061442883,0.4533496,0.0009266276,0.00009853318,0.00033719456,0.00015560928,0.00011381918,0.5302653,0.00015678981,0.00047790652,0.00014971262],"about_ca_topic_score_codex":0.00005192489,"about_ca_topic_score_gemma":0.000026594453,"teacher_disagreement_score":0.2449047,"about_ca_system_score_codex":0.00008712296,"about_ca_system_score_gemma":0.00025486384,"threshold_uncertainty_score":0.34459004},"labels":[],"label_agreement":null},{"id":"W2015273849","doi":"10.1182/blood-2003-10-3705","title":"Modulating erythrocyte chimerism in a mouse model of pyruvate kinase deficiency","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute","keywords":"Pyruvate kinase deficiency; Pyruvate kinase; Haematopoiesis; In vivo; Erythropoietin; Transplantation; Biology; Red blood cell; Immunology; Hemolytic anemia; Chemistry; Cancer research; Cell biology; Biochemistry; Endocrinology; Internal medicine; Medicine; Stem cell; Glycolysis; Enzyme; Genetics","score_opus":0.0224960881321028,"score_gpt":0.2516055981147032,"score_spread":0.22910950998260038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015273849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99657696,0.00016817822,0.00110912,0.00010733133,0.000050228966,0.00018502335,0.000008163543,0.00005370008,0.0017413166],"genre_scores_gemma":[0.99383646,0.000059386533,0.005491237,0.00027141636,0.00004556601,0.000012017978,0.000010711301,0.000019008061,0.00025420805],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99909276,0.000016744525,0.00030467744,0.00022704536,0.0001353244,0.0002234497],"domain_scores_gemma":[0.9995284,0.000014073159,0.00008882314,0.00024946764,0.000047848032,0.00007139474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008694781,0.000121852005,0.00029085498,0.0001405394,0.000033748423,0.0000026356754,0.0000553491,0.000095953525,0.000021592754],"category_scores_gemma":[0.00006253941,0.00011118717,0.00007897194,0.0002029435,0.00006160686,0.00005191564,0.000033695505,0.00017237764,0.000018348455],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010118979,0.0010324226,0.002534076,0.000094081915,0.000014747862,0.000021821339,0.00062136934,0.018792864,0.9757267,0.0007196442,0.000004113249,0.00033696525],"study_design_scores_gemma":[0.01960449,0.0011595897,0.013002025,0.0002611249,0.00015375989,0.00006010408,0.00032453297,0.018618684,0.94288284,0.003530141,0.000021771226,0.00038094513],"about_ca_topic_score_codex":0.000101653364,"about_ca_topic_score_gemma":0.000020114847,"teacher_disagreement_score":0.032843873,"about_ca_system_score_codex":0.00002595726,"about_ca_system_score_gemma":0.00011730614,"threshold_uncertainty_score":0.45340812},"labels":[],"label_agreement":null},{"id":"W2015387286","doi":"10.1182/blood-2013-09-526707","title":"Akt is essential to induce NADPH-dependent NETosis and to switch the neutrophil death to apoptosis","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":146,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Neutrophil extracellular traps; Sepsis; Autoimmunity; Immunology; Thrombosis; Medicine; Pneumonia; Apoptosis; Protein kinase B; Inflammation; Biology; Internal medicine; Immune system","score_opus":0.011270452090103415,"score_gpt":0.22874427501501834,"score_spread":0.21747382292491493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015387286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98902947,0.0001553112,0.0009963204,0.007954032,0.0005050566,0.0006432609,0.00003551806,0.00006619484,0.00061481725],"genre_scores_gemma":[0.98725665,0.000017005264,0.0003905278,0.010650028,0.00019621069,0.00013978039,0.000011411725,0.000038240047,0.0013001609],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998194,0.00021117047,0.00028244953,0.0006491794,0.00008902775,0.00057417725],"domain_scores_gemma":[0.99899834,0.00010253593,0.000059716647,0.00059173047,0.00009542359,0.0001522656],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002817946,0.0003110089,0.00036107018,0.00016315677,0.00039032154,0.000069370464,0.0004808265,0.00019004644,0.0002630065],"category_scores_gemma":[0.00006843171,0.00022821421,0.000080573765,0.00028037096,0.000041296284,0.00006503447,0.00046787935,0.00027273627,0.0016084283],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000095131785,0.0001799604,0.00040632786,0.0000065361796,0.00016979415,0.0000024676642,0.0010299463,0.000005266877,0.990226,0.0022578035,0.0024759078,0.003144876],"study_design_scores_gemma":[0.0011553004,0.0007344982,0.0025169007,0.000029097062,0.00015111009,0.00003254956,0.00016139119,3.017674e-7,0.96281075,0.00021598839,0.031883568,0.00030853905],"about_ca_topic_score_codex":0.0003132688,"about_ca_topic_score_gemma":0.000074891694,"teacher_disagreement_score":0.029407661,"about_ca_system_score_codex":0.000020505035,"about_ca_system_score_gemma":0.000030798885,"threshold_uncertainty_score":0.99916893},"labels":[],"label_agreement":null},{"id":"W2015401701","doi":"10.1182/blood-2003-09-3262","title":"Anemia, thrombocytopenia, leukocytosis, extramedullary hematopoiesis, and impaired progenitor function in Pten+/-SHIP-/- mice: a novel model of myelodysplasia","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"BC Cancer Agency","keywords":"PTEN; Haploinsufficiency; Biology; Haematopoiesis; Cancer research; Progenitor cell; Extramedullary hematopoiesis; Myeloid; PI3K/AKT/mTOR pathway; Bone marrow; Internal medicine; Immunology; Stem cell; Cell biology; Phenotype; Medicine; Genetics; Signal transduction","score_opus":0.015018372971412054,"score_gpt":0.23847588240075243,"score_spread":0.22345750942934037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015401701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940437,0.0031588336,0.002077236,0.00006888428,0.00009095871,0.0003539043,0.00004855825,0.000022194625,0.00013574173],"genre_scores_gemma":[0.9939171,0.00016152392,0.005486652,0.000083888764,0.00014033966,0.00007451436,0.0000554547,0.000042106367,0.000038420083],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985984,0.000026559504,0.00036900787,0.0004872475,0.00019884077,0.00031992537],"domain_scores_gemma":[0.9993089,0.000012229047,0.00014771218,0.0003489754,0.00008392204,0.00009828479],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018836076,0.00024202383,0.0003108419,0.000077438286,0.000053543343,0.000022166681,0.00019627478,0.00030789035,0.000006186202],"category_scores_gemma":[0.000049865343,0.00025113297,0.00008842923,0.00014190104,0.00012903701,0.000013499631,0.00010698346,0.00014580479,0.0000021978242],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018302533,0.0004871343,0.0029928081,0.00013857476,0.00008433735,0.0000046145046,0.0001221001,0.0013815656,0.99430305,0.00011324571,0.00004385425,0.00014571061],"study_design_scores_gemma":[0.004647048,0.00042263334,0.003297795,0.00011084794,0.00013219292,0.00010022838,0.00012275823,0.00030291706,0.990168,0.00028764695,0.00008108417,0.00032684405],"about_ca_topic_score_codex":0.00007857705,"about_ca_topic_score_gemma":0.00011699015,"teacher_disagreement_score":0.004464023,"about_ca_system_score_codex":0.000041414944,"about_ca_system_score_gemma":0.00033885162,"threshold_uncertainty_score":0.9999941},"labels":[],"label_agreement":null},{"id":"W201550175","doi":"10.1182/blood.v124.21.2884.2884","title":"Incidence and Natural History of Ivig-Induced Aseptic Meningitis: A Retrospective Review at a Single Tertiary Care Centre","year":2014,"lang":"en","type":"review","venue":"Blood","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Victoria Hospital; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Aseptic meningitis; Incidence (geometry); Nausea; Vomiting; Pediatrics; Retrospective cohort study; Meningitis; Headaches; Surgery; Pharyngitis; Internal medicine","score_opus":0.010392644509457483,"score_gpt":0.23649435438177935,"score_spread":0.22610170987232187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W201550175","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017379232,0.99576294,3.4158157e-7,0.000011389406,0.000822348,0.0007766176,0.000041614952,0.000057379824,0.00078946457],"genre_scores_gemma":[0.021409383,0.9760913,0.0000071363183,0.000085948435,0.000006672232,0.000047758156,0.00035750575,0.0000460329,0.0019482353],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976349,0.0004897507,0.00077841204,0.0006000243,0.00007382589,0.0004231102],"domain_scores_gemma":[0.9983857,0.00014886417,0.0007512368,0.0005790675,0.00012357168,0.0000115562],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022622632,0.0005084814,0.0020698975,0.00013546135,0.00012221972,0.0000058510336,0.00039710678,0.00046040563,0.00018837012],"category_scores_gemma":[0.00026136902,0.00042993884,0.0005084696,0.00014069713,0.00031283055,0.000070876435,0.00028826538,0.0006498148,0.00012072547],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021872163,0.0007467998,0.00014325601,0.15318683,0.0018279463,0.000056140172,0.0037424436,1.6370798e-8,0.010940536,0.0001024994,0.0022093891,0.82702225],"study_design_scores_gemma":[0.000832108,0.00015573562,0.00012573077,0.07329898,0.0029334787,0.0003773178,0.000084771695,4.3374516e-8,0.00026967318,0.0000038372136,0.921371,0.00054733525],"about_ca_topic_score_codex":0.00007193014,"about_ca_topic_score_gemma":0.000012238683,"teacher_disagreement_score":0.9191616,"about_ca_system_score_codex":0.00043072627,"about_ca_system_score_gemma":0.00027997862,"threshold_uncertainty_score":0.9998152},"labels":[],"label_agreement":null},{"id":"W2015831749","doi":"10.1182/blood-2002-04-1169","title":"The zebrafish mutant gene chardonnay (cdy) encodes divalent metal transporter 1 (DMT1)","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Xenon Pharmaceuticals (Canada)","funders":"National Center for Research Resources; National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"DMT1; Zebrafish; Biology; Mutant; Gene; Genetics; Erythropoiesis; Mutation; Molecular biology; Transporter; Anemia","score_opus":0.016394693107902893,"score_gpt":0.21861851894154602,"score_spread":0.20222382583364312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015831749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9760455,0.01074058,0.00007590977,0.0020638118,0.00032477433,0.00036382626,0.000028928982,0.00009380001,0.010262863],"genre_scores_gemma":[0.9935066,0.002093378,0.0002057823,0.0008709749,0.00035530084,0.00003367845,0.00001600821,0.00003181203,0.0028864546],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986686,0.00003746773,0.00027882154,0.00026129623,0.0003677161,0.00038606723],"domain_scores_gemma":[0.9992856,0.000038480608,0.0000555066,0.00042526884,0.00004135492,0.00015381574],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017810156,0.0001859814,0.00027346323,0.00004855883,0.00017550428,0.00002577829,0.00015344964,0.00007429564,0.00093380467],"category_scores_gemma":[0.000043373475,0.00011509117,0.00020731491,0.0001317178,0.000115924966,0.00006438828,0.000017510365,0.00016195387,0.00019792636],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092659995,0.020634614,0.10762631,0.0011131016,0.0029395716,0.0028628537,0.021585472,0.000017898064,0.67234904,0.009687429,0.027337572,0.13291956],"study_design_scores_gemma":[0.0314166,0.0009917268,0.21740842,0.00012670085,0.006317092,0.0007508037,0.0019139516,0.0001952859,0.36085632,0.00061176607,0.37801048,0.001400839],"about_ca_topic_score_codex":0.000016562783,"about_ca_topic_score_gemma":0.000014367876,"teacher_disagreement_score":0.35067293,"about_ca_system_score_codex":0.00000598938,"about_ca_system_score_gemma":0.00001819695,"threshold_uncertainty_score":0.9999795},"labels":[],"label_agreement":null},{"id":"W2016110271","doi":"10.1182/blood-2013-09-529784","title":"How I treat target-specific oral anticoagulant–associated bleeding","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Apixaban; Rivaroxaban; Oral anticoagulant; Warfarin; Anticoagulant; Internal medicine; Gastroenterology; Surgery; Atrial fibrillation","score_opus":0.0583387086736241,"score_gpt":0.2860273478539402,"score_spread":0.2276886391803161,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016110271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9778134,0.00024023202,0.0007769089,0.0049135434,0.0002940438,0.000292028,0.0000026941102,0.00025402175,0.015413129],"genre_scores_gemma":[0.9857869,0.000045849265,0.0010722708,0.00011413722,0.00096103566,8.853099e-7,0.000045504374,0.000021267082,0.011952146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991859,0.000033244127,0.00014432905,0.00018765371,0.00022237192,0.00022645766],"domain_scores_gemma":[0.99956465,0.00006308735,0.000073175564,0.0001699408,0.00004720642,0.00008194639],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019610651,0.00012373387,0.00029948124,0.00009621673,0.00008181037,0.00006929033,0.000053002692,0.00007105308,0.00011022632],"category_scores_gemma":[0.00016012072,0.00010081444,0.0001222677,0.00018418793,0.000023562687,0.00009132186,0.000029876206,0.000066884524,0.00007213528],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047460857,0.00007085018,0.9712538,0.000042932,0.00022711052,0.000023792622,0.00009585834,0.0000033953697,0.015920792,0.0034415955,0.0049569425,0.0039154626],"study_design_scores_gemma":[0.019276077,0.00055470574,0.6391384,0.00012188985,0.0011252225,0.000021958345,0.000240034,0.0009996186,0.02417771,0.0007838119,0.31300783,0.0005527568],"about_ca_topic_score_codex":0.000005360831,"about_ca_topic_score_gemma":0.0000015339558,"teacher_disagreement_score":0.3321154,"about_ca_system_score_codex":0.000017282866,"about_ca_system_score_gemma":0.000007739051,"threshold_uncertainty_score":0.41110933},"labels":[],"label_agreement":null},{"id":"W2016147458","doi":"10.1182/blood-2012-05-428177","title":"Myelodyspastic syndrome with complex cytogenetics","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Sepsis; Mean corpuscular volume; Oxaliplatin; Cytogenetics; Chemotherapy; Fluorouracil; Internal medicine; Gastroenterology; Hematologic Neoplasms; Colorectal cancer; Surgery; Oncology; Hemoglobin; Cancer; Biology","score_opus":0.030757309695348272,"score_gpt":0.2643453585681127,"score_spread":0.23358804887276444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016147458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933489,0.0005059429,0.000096086456,0.0003771057,0.0000455253,0.00035550262,0.000012799662,0.000051627892,0.005206494],"genre_scores_gemma":[0.9936922,0.000043805172,0.0053347214,0.00035988097,0.00013941618,0.00007523305,0.00003884143,0.00002659889,0.0002892745],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999146,0.000020047555,0.00013323218,0.00015659379,0.0002211415,0.00032298584],"domain_scores_gemma":[0.9993683,0.000055397253,0.000040559215,0.00022873114,0.00005313557,0.00025389594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000050939212,0.00015919202,0.000261568,0.0000477212,0.00006436304,0.000011426922,0.000037645063,0.00004447896,0.00041484184],"category_scores_gemma":[0.000018514169,0.00010682842,0.00004262223,0.000110763525,0.000047382942,0.000036910533,0.000021884063,0.00007601782,0.00025612506],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039315797,0.0023099089,0.99480915,0.000044120767,0.00036591614,0.00026577836,0.00015366774,0.0000020693544,0.00078571064,0.0005545572,0.0002903651,0.00037941654],"study_design_scores_gemma":[0.004054512,0.0012432938,0.97691435,0.00007400804,0.00073825766,0.0029476078,0.000037415753,0.0000068761883,0.010013541,0.000011030352,0.0038105487,0.00014856222],"about_ca_topic_score_codex":0.0000074156274,"about_ca_topic_score_gemma":0.0000060604107,"teacher_disagreement_score":0.017894827,"about_ca_system_score_codex":0.000022455384,"about_ca_system_score_gemma":0.00004194431,"threshold_uncertainty_score":0.45422274},"labels":[],"label_agreement":null},{"id":"W2016272979","doi":"10.1182/blood-2008-06-163121","title":"Proinflammatory tachykinins that signal through the neurokinin 1 receptor promote survival of dendritic cells and potent cellular immunity","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Neuropeptides and Animal Physiology","field":"Neuroscience","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; National Institutes of Health; University of Toronto","keywords":"Proinflammatory cytokine; Immune system; Dendritic cell; Cell biology; Biology; Tachykinin receptor 1; Immunology; Receptor; Substance P; Inflammation; Neuropeptide","score_opus":0.04202264659622208,"score_gpt":0.22819083786142721,"score_spread":0.18616819126520512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016272979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99842,0.00007069228,0.000010100834,0.00007017581,0.0001741918,0.0003343258,0.000023985622,0.000047287278,0.000849227],"genre_scores_gemma":[0.99920225,0.00019840141,0.00007320891,0.00020556994,0.00009343661,0.000011342691,0.0000014913762,0.000030823292,0.00018347165],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983407,0.00041508026,0.00026214286,0.00038582002,0.00027178947,0.00032441784],"domain_scores_gemma":[0.99916047,0.00023057435,0.00015993531,0.00035145614,0.000032078115,0.00006547089],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011066043,0.0001953373,0.0002569422,0.000026613723,0.00032121458,0.00001992263,0.0003807223,0.000053410462,0.00004011629],"category_scores_gemma":[0.00006978525,0.00013866552,0.00009286599,0.00014004811,0.00055174925,0.00014130396,0.00023657453,0.00032144715,0.000033063418],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035306475,0.00032096094,0.00042633223,0.000027852291,0.0000074111754,0.000114984614,0.000513536,0.0000060977777,0.9977695,0.0006463424,0.00006144167,0.00007023377],"study_design_scores_gemma":[0.00064110995,0.00046644403,0.0038007863,0.000018054514,0.000025456335,0.00011520828,0.00008544512,0.000019093794,0.9926631,0.00021432675,0.0017999364,0.00015107913],"about_ca_topic_score_codex":0.000021545815,"about_ca_topic_score_gemma":0.0000015118076,"teacher_disagreement_score":0.005106441,"about_ca_system_score_codex":0.0000041282983,"about_ca_system_score_gemma":0.00004876056,"threshold_uncertainty_score":0.5654616},"labels":[],"label_agreement":null},{"id":"W2016402433","doi":"10.1182/blood-2014-06-581983","title":"Building bridges to diagnosis and malignancy","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hematological disorders and diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; Prednisone; Rheumatoid arthritis; Methotrexate; Complete blood count; Meloxicam; Internal medicine; Gastroenterology; Malignancy; Hemoglobin","score_opus":0.017253860704409447,"score_gpt":0.2740032112729293,"score_spread":0.2567493505685199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016402433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927499,0.00061573734,0.0013807181,0.0025336258,0.000028354541,0.00015119987,0.0000023948533,0.00004452716,0.0024935105],"genre_scores_gemma":[0.9911263,0.00016993289,0.006277457,0.0022781717,0.00006335605,0.000034394576,0.0000012546633,0.000007994551,0.000041139323],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995295,0.000011280609,0.00009243791,0.00014661255,0.00007680955,0.0001433853],"domain_scores_gemma":[0.99949837,0.00019424444,0.000012926061,0.000109060195,0.000022047012,0.00016335491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006124602,0.00006672173,0.00016065023,0.000029642726,0.000032019183,0.000013075579,0.00002929889,0.000043712327,0.000041098905],"category_scores_gemma":[0.0011531605,0.000051795196,0.000024172807,0.00006252778,0.000018109517,0.000013783306,0.000036359303,0.000041326766,0.000039912382],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012440445,0.0006339701,0.9553131,0.00011376772,0.000022745122,0.00005633617,0.000063619176,0.0000011321994,0.0008854939,0.020997532,0.0034968543,0.018403016],"study_design_scores_gemma":[0.0032689972,0.0013183171,0.9161477,0.0004883968,0.00026505123,0.00012191529,0.00005103866,0.000055592667,0.02922701,0.0036929396,0.04507869,0.00028434012],"about_ca_topic_score_codex":0.00001575231,"about_ca_topic_score_gemma":0.0000029926414,"teacher_disagreement_score":0.04158184,"about_ca_system_score_codex":0.0000019713048,"about_ca_system_score_gemma":0.0000056234526,"threshold_uncertainty_score":0.21121468},"labels":[],"label_agreement":null},{"id":"W2016456457","doi":"10.1182/blood-2002-08-2484","title":"Induction of acute myeloid leukemia in mice by the human leukemia-specific fusion gene NUP98-HOXD13 in concert with Meis1","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":147,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Biology; Hox gene; Myeloid leukemia; Leukemia; Myeloid; Haematopoiesis; Fusion gene; Cancer research; Myelopoiesis; Immunology; Genetics; Stem cell; Gene; Gene expression","score_opus":0.020360188347642093,"score_gpt":0.27121115397927337,"score_spread":0.2508509656316313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016456457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99101657,0.0010573372,0.000042055268,0.000324482,0.00006662883,0.00095226127,0.000019184043,0.00004074936,0.006480764],"genre_scores_gemma":[0.9965035,0.0006794852,0.0007557522,0.00020171577,0.00011495448,0.00009679291,0.00008608807,0.000065186585,0.0014965351],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997298,0.0002717148,0.0006044871,0.00055375264,0.00068638485,0.0005856756],"domain_scores_gemma":[0.99878895,0.00011312026,0.00018672818,0.0006166505,0.00015166015,0.00014287447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078471797,0.00030221292,0.0005476804,0.000326965,0.00011510116,0.000024164254,0.00031878552,0.0002792952,0.00012677854],"category_scores_gemma":[0.00006348901,0.0002118563,0.00007787636,0.0011175076,0.00032142462,0.00015317697,0.00008067607,0.0010411069,0.000027234708],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034772765,0.00032038393,0.010369274,0.000060225968,0.00016154183,0.00020837467,0.0009787913,0.000033180902,0.98173016,0.0006646588,0.0043172725,0.0008083848],"study_design_scores_gemma":[0.01886392,0.0007701247,0.02318098,0.00027994058,0.00019278818,0.0006521198,0.00096614764,0.0000668089,0.94795746,0.00016962668,0.00654244,0.00035764743],"about_ca_topic_score_codex":0.0011304935,"about_ca_topic_score_gemma":0.00016937386,"teacher_disagreement_score":0.03377273,"about_ca_system_score_codex":0.0019479165,"about_ca_system_score_gemma":0.0011708965,"threshold_uncertainty_score":0.8639249},"labels":[],"label_agreement":null},{"id":"W2016548691","doi":"10.1182/blood.v97.12.3902","title":"MCL1 transgenic mice exhibit a high incidence of B-cell lymphoma manifested as a spectrum of histologic subtypes","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":185,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"MCL1; Lymphoma; Transgene; Carcinogenesis; Biology; Cancer research; Follicular lymphoma; Genetically modified mouse; Cancer; Immunology; Gene; Genetics; Downregulation and upregulation","score_opus":0.010035937456847643,"score_gpt":0.22788017044847092,"score_spread":0.21784423299162328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016548691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914423,0.0027558848,0.0000040612767,0.0003766347,0.00007092167,0.00033862976,0.000012175553,0.000039882525,0.004959482],"genre_scores_gemma":[0.99807703,0.00057542196,0.0004762165,0.00013274432,0.000052012234,0.000026689986,0.000014999276,0.000018051403,0.000626856],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987743,0.000037555776,0.00038622675,0.00028296397,0.00027137564,0.00024759438],"domain_scores_gemma":[0.9992001,0.00009913959,0.00017848084,0.00034848248,0.00006663869,0.000107145584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008132731,0.00018235896,0.00047608785,0.00011100085,0.000028941195,0.0000038556473,0.000121764475,0.00010685137,0.00027200207],"category_scores_gemma":[0.000032772525,0.00014717849,0.00017453363,0.00025095366,0.00008658481,0.000042256186,0.000023613038,0.00003803202,0.000077233475],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012119528,0.03291239,0.7921804,0.0006627082,0.0007598512,0.002585572,0.0009714475,0.0000039440833,0.16399774,0.0018983668,0.0003148069,0.0025008232],"study_design_scores_gemma":[0.015151463,0.001791251,0.3784858,0.00017473818,0.0010137614,0.0008673107,0.000074499876,0.000005089574,0.60160303,0.00027356204,0.00041104507,0.0001484533],"about_ca_topic_score_codex":0.0014823503,"about_ca_topic_score_gemma":0.0001210809,"teacher_disagreement_score":0.4376053,"about_ca_system_score_codex":0.00008080601,"about_ca_system_score_gemma":0.00018451145,"threshold_uncertainty_score":0.60017645},"labels":[],"label_agreement":null},{"id":"W2016783244","doi":"10.1182/blood-2013-11-536359","title":"Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":540,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; China Scholarship Council; Center for Clinical and Translational Research; University of Nebraska Medical Center; Lymphoma Research Foundation","keywords":"Lymphoma; Gene expression; Peripheral T-cell lymphoma; Biology; Gene expression profiling; Cancer research; Medicine; Gene; Pathology; Immunology; T cell; Genetics; Immune system","score_opus":0.011833157775561378,"score_gpt":0.22987988305863277,"score_spread":0.2180467252830714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016783244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959567,0.0030134022,0.000019377338,0.00013301152,0.00003670892,0.00028819355,0.0000036305264,0.000030936542,0.0005179977],"genre_scores_gemma":[0.9970676,0.00025547436,0.002180965,0.00021854643,0.00012193227,0.00006583029,0.00003613515,0.000011723305,0.000041803887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991601,0.000057378584,0.00017214991,0.0002878674,0.00010924313,0.00021324883],"domain_scores_gemma":[0.9995778,0.00009322363,0.000036045592,0.00015009129,0.000024657087,0.000118191005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000092769784,0.0001489999,0.00023767904,0.000046591435,0.000040340594,0.000017266202,0.000040489755,0.00012551682,0.000036333022],"category_scores_gemma":[0.00007455101,0.000095329895,0.00004602126,0.000065425906,0.000040266383,0.00002646148,0.00004290147,0.00004451887,0.00001146356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000103778584,0.0034410504,0.9064849,0.000029039742,0.000021002108,0.000194851,0.00010274503,0.0000028732156,0.081403874,0.000020025735,0.000057211502,0.008138667],"study_design_scores_gemma":[0.014821384,0.00086233753,0.76526934,0.000099331504,0.000088741726,0.00008823538,0.000024177933,0.00018930902,0.21788076,0.000064010885,0.00047139768,0.00014094428],"about_ca_topic_score_codex":0.000021889815,"about_ca_topic_score_gemma":0.000005971361,"teacher_disagreement_score":0.14121552,"about_ca_system_score_codex":0.000025324125,"about_ca_system_score_gemma":0.000022901855,"threshold_uncertainty_score":0.38874403},"labels":[],"label_agreement":null},{"id":"W2016830328","doi":"10.1182/blood-2013-06-509463","title":"Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":247,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Stichting Kinderen Kankervrij; Israel Cancer Association; American Lebanese Syrian Associated Charities; National Cancer Institute; Dana-Farber Cancer Institute","keywords":"Medicine; Cumulative incidence; Internal medicine; Hazard ratio; Gastroenterology; White blood cell; Regimen; Incidence (geometry); Confidence interval; Cohort","score_opus":0.005616953211833028,"score_gpt":0.23098927701394836,"score_spread":0.22537232380211533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016830328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99621034,0.00011711568,0.00023185677,0.00022646334,0.000029387353,0.002540327,0.0000834363,0.000104829836,0.00045622728],"genre_scores_gemma":[0.99837667,0.000024772933,0.00027113117,0.00021548217,0.000131489,0.00046253004,0.00011992681,0.00006674435,0.00033125078],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99647844,0.00021003716,0.00048730793,0.00090897334,0.0011729397,0.0007423045],"domain_scores_gemma":[0.99776727,0.00036743085,0.00015633427,0.0012324948,0.00019162137,0.00028484515],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031667884,0.00042328634,0.0009291461,0.00040465078,0.00016331638,0.00013831718,0.00056342443,0.00015515085,0.0004387113],"category_scores_gemma":[0.00019663597,0.00024817808,0.00019995731,0.002548011,0.00023476197,0.00022987908,0.00027673997,0.0005738028,0.00026071025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020803811,0.0011516769,0.9840576,0.000004238586,0.012219028,0.00071092614,0.00082439114,0.000037798945,0.00039720457,0.000014050505,0.00025946242,0.00011555081],"study_design_scores_gemma":[0.01839316,0.0017749042,0.96901035,0.00007258842,0.0075405464,0.00060123025,0.0006443796,0.0015404635,0.00009298034,0.000044994726,0.0000033080362,0.0002811142],"about_ca_topic_score_codex":0.02010592,"about_ca_topic_score_gemma":0.001944143,"teacher_disagreement_score":0.018185122,"about_ca_system_score_codex":0.001898227,"about_ca_system_score_gemma":0.000720036,"threshold_uncertainty_score":0.999997},"labels":[],"label_agreement":null},{"id":"W2016874927","doi":"10.1182/blood-2004-07-2722","title":"Overexpression of mitochondrial ferritin causes cytosolic iron depletion and changes cellular iron homeostasis","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":177,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Ferritin; Cytosol; Transferrin receptor; Aconitase; Deferoxamine; Intracellular; Transferrin; Mitochondrion; Biochemistry; Iron deficiency; Chemistry; Cell biology; Cellular compartment; Biology; Cell; Internal medicine; Enzyme; Anemia; Medicine","score_opus":0.012035418118812731,"score_gpt":0.23887724960701087,"score_spread":0.22684183148819814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016874927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936857,0.005018426,0.000062060884,0.00041464926,0.000104712075,0.0002857586,0.000026716403,0.000038066944,0.00036388834],"genre_scores_gemma":[0.9970462,0.001103794,0.0012558616,0.00013520518,0.0003071884,0.0000138006235,0.000051180545,0.000022904935,0.00006389875],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99915075,0.000028470111,0.00016547878,0.00022456356,0.00023313367,0.00019762084],"domain_scores_gemma":[0.9995541,0.00001769934,0.000079210055,0.00021420892,0.00003233425,0.00010243708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004761282,0.0001395821,0.0002598461,0.00010535669,0.000055247678,0.000009724429,0.00004439009,0.000117284944,0.000053349053],"category_scores_gemma":[0.0000660975,0.000121438694,0.00004750311,0.00008997633,0.00007451828,0.000055340515,0.000037991253,0.00008870502,0.0000070648766],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017657691,0.0005955088,0.0032720305,0.00043013267,0.00001040729,0.000014762157,0.00053315976,0.0000042453808,0.9934097,0.00023935441,0.00011261958,0.001201492],"study_design_scores_gemma":[0.014410661,0.0005393766,0.032820076,0.0003445824,0.0004647149,0.000038620477,0.0004963126,0.0000011836931,0.9491486,0.00022038798,0.0012984584,0.00021706025],"about_ca_topic_score_codex":0.00025184802,"about_ca_topic_score_gemma":0.00005114904,"teacher_disagreement_score":0.044261143,"about_ca_system_score_codex":0.00000936152,"about_ca_system_score_gemma":0.000038321996,"threshold_uncertainty_score":0.49521264},"labels":[],"label_agreement":null},{"id":"W2016963097","doi":"10.1182/blood-2009-12-261131","title":"Functional characterization of a 13-bp deletion (c.-1522_-1510del13) in the promoter of the von Willebrand factor gene in type 1 von Willebrand disease","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Von Willebrand factor; Von Willebrand disease; Genetics; Gene; Biology; Molecular biology; Medicine; Immunology; Platelet","score_opus":0.010051399556388693,"score_gpt":0.21705935327687625,"score_spread":0.20700795372048755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016963097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984493,0.000072825795,0.000008259909,0.00058962364,0.00013237409,0.00060256774,0.000056831366,0.0000059124095,0.00008227735],"genre_scores_gemma":[0.99947715,0.000045603418,0.000018373257,0.00012585967,0.000045458648,0.000022715903,0.00017702037,0.000011248841,0.000076557015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992224,0.000047834917,0.00023041609,0.00014951735,0.00022979997,0.00012002889],"domain_scores_gemma":[0.999547,0.000024301611,0.00010659089,0.00022615206,0.000059220056,0.00003670178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000097654745,0.000106946834,0.00019060737,0.00007714066,0.000029298255,0.0000065631684,0.000069282636,0.00007357821,0.0001027646],"category_scores_gemma":[0.0000612106,0.00006050832,0.000059788563,0.00023787408,0.000052615487,0.00007393532,0.000017099508,0.00014596741,0.0000037679806],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005371359,0.0017318353,0.66596556,0.000069040776,0.000055427972,0.000023498098,0.0004914,0.0000020315615,0.32996032,0.00002675736,0.000016962,0.0011200194],"study_design_scores_gemma":[0.004325484,0.00012382928,0.976731,0.000070093396,0.00010413072,0.000019352558,0.000014670533,0.00007519448,0.018226437,0.000097416276,0.00015421993,0.000058151996],"about_ca_topic_score_codex":0.000032862517,"about_ca_topic_score_gemma":0.00010428784,"teacher_disagreement_score":0.31173387,"about_ca_system_score_codex":0.000008452162,"about_ca_system_score_gemma":0.00007390962,"threshold_uncertainty_score":0.24674577},"labels":[],"label_agreement":null},{"id":"W2017006015","doi":"10.1182/blood-2012-03-413112","title":"CyBorD: stellar response rates in AL amyloidosis","year":2012,"lang":"en","type":"letter","venue":"Blood","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"AL amyloidosis; Bortezomib; Dexamethasone; Cyclophosphamide; Medicine; Internal medicine; Amyloidosis; Gastroenterology; Multiple myeloma; Immunology; Chemotherapy; Immunoglobulin light chain","score_opus":0.01250620776437253,"score_gpt":0.26521446777786667,"score_spread":0.2527082600134941,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017006015","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7996698,0.01149094,0.0000075981775,0.1862517,0.00058534165,0.0007893792,0.00034437035,0.00006119431,0.00079967995],"genre_scores_gemma":[0.357766,0.0038513506,0.00083373423,0.6215193,0.0044879396,0.0007247369,0.0029207796,0.000418499,0.0074776066],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99687487,0.0005248357,0.0005060205,0.0008760069,0.00032621212,0.00089207053],"domain_scores_gemma":[0.99826884,0.00019278574,0.00025375249,0.0010954005,0.00006683597,0.0001223694],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00039961256,0.0006747538,0.0006058433,0.00023129197,0.000073456686,0.000056175308,0.00053590466,0.0014279726,0.00016324982],"category_scores_gemma":[0.00024130335,0.00064677827,0.00034162911,0.00018364878,0.00009778683,0.0000069294765,0.00027752118,0.0007369239,0.00024648686],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025272465,0.0006656823,0.12188604,0.00006503366,0.0006267623,0.00036082993,0.00006510542,0.000001694953,0.034018166,0.0000015308166,0.8417855,0.00027095457],"study_design_scores_gemma":[0.00220517,0.0002931224,0.015537417,0.000058963058,0.00031122038,0.000045635377,0.00002534676,3.125486e-7,0.13495293,0.0000062283,0.8458866,0.00067707815],"about_ca_topic_score_codex":0.00007795693,"about_ca_topic_score_gemma":0.000042037325,"teacher_disagreement_score":0.44190377,"about_ca_system_score_codex":0.000060199083,"about_ca_system_score_gemma":0.00016611652,"threshold_uncertainty_score":0.9998684},"labels":[],"label_agreement":null},{"id":"W2017107901","doi":"10.1182/blood-2011-06-363960","title":"Sorafenib treatment of FLT3-ITD+ acute myeloid leukemia: favorable initial outcome and mechanisms of subsequent nonresponsiveness associated with the emergence of a D835 mutation","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":278,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"University of Hong Kong; Croucher Foundation; Lee Hysan Foundation; Lady Tata Memorial Trust; Pfizer","keywords":"Sorafenib; Myeloid leukemia; Leukemia; Cancer research; Medicine; Internal medicine; Tyrosine kinase; Biology; Oncology; Hepatocellular carcinoma; Receptor","score_opus":0.03747264596254492,"score_gpt":0.31744743224974614,"score_spread":0.27997478628720124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017107901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99718183,0.00035892168,0.0010341553,0.0002482652,0.000046832636,0.000792897,0.0001227128,0.000018008137,0.00019639147],"genre_scores_gemma":[0.998734,0.00011532446,0.0006709654,0.000029960265,0.00003700032,0.00006883314,0.00006341585,0.000030343244,0.00025014827],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99818027,0.00022445289,0.00046146807,0.00020265317,0.0005632739,0.00036789718],"domain_scores_gemma":[0.998413,0.00032011504,0.00037459168,0.00035188068,0.00040635464,0.00013402296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063843775,0.00020509926,0.0006121359,0.00014878905,0.00006528105,0.0000050655553,0.00012355042,0.00013782532,0.00006206899],"category_scores_gemma":[0.00020073219,0.0001271778,0.00009961851,0.0004127386,0.00023014896,0.000121595374,0.000055266704,0.00014297299,0.000002678421],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041899118,0.0035222827,0.08456212,0.00042692077,0.004018765,0.0002541211,0.0064439825,0.000057059555,0.8924689,0.002351659,0.00007315823,0.0016310876],"study_design_scores_gemma":[0.01041905,0.003265155,0.07730831,0.00012648747,0.0017959338,0.00015042983,0.0017067011,0.00013895384,0.90479386,0.00011055775,0.000020857296,0.00016370839],"about_ca_topic_score_codex":0.0002974762,"about_ca_topic_score_gemma":0.00005245227,"teacher_disagreement_score":0.012324929,"about_ca_system_score_codex":0.0002037457,"about_ca_system_score_gemma":0.00059079076,"threshold_uncertainty_score":0.518616},"labels":[],"label_agreement":null},{"id":"W2017265604","doi":"10.1182/blood-2006-06-027714","title":"Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":405,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Centre hospitalier universitaire de Québec; Université de Montréal","funders":"National Institutes of Health; National Cancer Institute; Dana-Farber Cancer Institute","keywords":"Medicine; Dexrazoxane; Asparaginase; Internal medicine; Chemotherapy; Surgery; Cancer; Leukemia; Pediatrics; Lymphoblastic Leukemia; Breast cancer; Anthracycline","score_opus":0.013818146066766847,"score_gpt":0.2898975574202851,"score_spread":0.27607941135351827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017265604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8892406,0.00006352795,0.00054513616,0.0011235629,0.00015444847,0.10259467,0.0007601697,0.00013305926,0.0053847954],"genre_scores_gemma":[0.8974816,0.000015133074,0.0032622744,0.0006898721,0.00093229103,0.091186546,0.00019457487,0.00014678884,0.006090922],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99744296,0.000046687925,0.000604606,0.0005317615,0.0007473537,0.0006266591],"domain_scores_gemma":[0.9982452,0.00014339229,0.00032080436,0.0008168097,0.00031365507,0.00016014492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022036649,0.00031770775,0.00050219905,0.00009048106,0.00012689379,0.000027312715,0.00040053783,0.00017825759,0.000026103542],"category_scores_gemma":[0.00018622079,0.00018669161,0.00016061236,0.00041939842,0.00052717904,0.00011532088,0.00014519544,0.00022315608,0.000009680108],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050686944,0.009394481,0.33798832,0.0030510002,0.017274205,0.0008342035,0.0009983353,0.0042333254,0.14108409,0.0039655133,0.42632848,0.004161088],"study_design_scores_gemma":[0.23497581,0.0032675553,0.32945532,0.0015998974,0.0062321657,0.002116423,0.000038265884,0.0021986293,0.3442274,0.0002927251,0.07446877,0.0011270291],"about_ca_topic_score_codex":0.0029083148,"about_ca_topic_score_gemma":0.0007354404,"teacher_disagreement_score":0.35185972,"about_ca_system_score_codex":0.0006601018,"about_ca_system_score_gemma":0.0041675135,"threshold_uncertainty_score":0.76130635},"labels":[],"label_agreement":null},{"id":"W2017426011","doi":"10.1182/blood-2013-10-532101","title":"BCGitis induced inflammatory granuloma of the bone marrow","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Bone marrow; Granuloma; BCG vaccine; Surgery; Internal medicine; Pathology; Tuberculosis","score_opus":0.005089577512006791,"score_gpt":0.18269142905991442,"score_spread":0.17760185154790764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017426011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98864305,0.0046831206,0.000007655781,0.0001262799,0.00054436375,0.000121249475,0.0000053997,0.000039349212,0.005829548],"genre_scores_gemma":[0.9990537,0.000015462028,0.0000041585345,0.000113998794,0.0000036923107,0.000010128497,0.000008954127,0.000010667092,0.0007792246],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991583,0.00017308378,0.00025806323,0.00014303316,0.00003521197,0.00023231437],"domain_scores_gemma":[0.9993398,0.000060230905,0.00013765636,0.00042238823,0.000036884194,0.000003033034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023112349,0.00011412152,0.00018924932,0.000044180393,0.00018197089,0.0000050375606,0.00030816215,0.00015996052,0.00014364597],"category_scores_gemma":[0.00010940446,0.00008253795,0.00012367587,0.0001212724,0.00020852599,0.000042955777,0.00009147135,0.00021061367,0.00014815736],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015461805,0.00023655668,0.0036596237,0.000019173951,0.00006381705,5.1684395e-7,0.00038935768,7.6875085e-7,0.98570865,0.0031406283,0.00008891799,0.0066765295],"study_design_scores_gemma":[0.003240326,0.0001218175,0.15495227,0.000058592064,0.000084253144,0.00005396679,0.00019470845,0.0000012362547,0.8115275,0.0008291496,0.028740263,0.00019590513],"about_ca_topic_score_codex":0.000058728954,"about_ca_topic_score_gemma":0.00000487366,"teacher_disagreement_score":0.17418113,"about_ca_system_score_codex":0.000003565917,"about_ca_system_score_gemma":0.0000335455,"threshold_uncertainty_score":0.33657998},"labels":[],"label_agreement":null},{"id":"W2017712465","doi":"10.1182/blood-2014-10-567461","title":"The biology and management of systemic anaplastic large cell lymphoma","year":2015,"lang":"en","type":"review","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":196,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Anaplastic large-cell lymphoma; Anaplastic lymphoma kinase; Vincristine; Brentuximab vedotin; CD30; Medicine; Internal medicine; Oncology; Lymphoma; Cancer research; Transplantation; Cyclophosphamide; Chemotherapy","score_opus":0.026585593898832968,"score_gpt":0.3112655085809483,"score_spread":0.28467991468211534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017712465","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007073914,0.99580646,0.0000011086784,0.000009393203,0.00013338668,0.0009778116,0.00007466759,0.000015684653,0.0022740725],"genre_scores_gemma":[0.0034484246,0.995774,0.00004395291,0.0000075770713,0.000059823,0.00021783142,0.00007526001,0.000023058159,0.00035011512],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989324,0.00007803507,0.00038993373,0.00025602663,0.00012224799,0.00022130928],"domain_scores_gemma":[0.99907863,0.00014691155,0.00023759861,0.00039747162,0.000041194646,0.00009819645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019985196,0.00024093858,0.0010921234,0.00005998654,0.00004828782,0.000010070463,0.00010243668,0.00014432002,0.000003622496],"category_scores_gemma":[0.000008149104,0.00012206112,0.00017771815,0.00010803049,0.00004823575,0.000007055442,0.00011339017,0.000035127643,0.000044315464],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015376983,0.0023752546,0.0004757797,0.05641181,0.0022117496,0.00028882176,0.000027255091,5.0928297e-9,1.6393463e-7,0.0028597543,0.0007345584,0.93459946],"study_design_scores_gemma":[0.006768492,0.00040044673,0.00010081903,0.014135079,0.0096291555,0.00044209193,0.000045826095,3.614649e-7,0.0000031689162,0.000014103141,0.9683467,0.00011373091],"about_ca_topic_score_codex":0.000007748929,"about_ca_topic_score_gemma":0.0000020337588,"teacher_disagreement_score":0.96761215,"about_ca_system_score_codex":0.00007614208,"about_ca_system_score_gemma":0.00014490001,"threshold_uncertainty_score":0.49775082},"labels":[],"label_agreement":null},{"id":"W2017735587","doi":"10.1182/blood-2013-07-509885","title":"Variability in DNA methylation defines novel epigenetic subgroups of DLBCL associated with different clinical outcomes","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Canada's Michael Smith Genome Sciences Centre; Simon Fraser University; BC Cancer Agency; Jewish General Hospital","funders":"National Cancer Institute","keywords":"DNA methylation; Biology; Epigenetics; HpaII; Methylation; Germinal center; Genetics; Cancer research; Computational biology; Gene; Gene expression; B cell","score_opus":0.02022458879604734,"score_gpt":0.27863764237320787,"score_spread":0.25841305357716055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017735587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845545,0.00011355999,0.014717652,0.000039477523,0.00007592954,0.00017868578,0.000013982096,0.000007917209,0.0002982574],"genre_scores_gemma":[0.99876016,0.000053571224,0.00092222856,0.000025343978,0.000054842098,0.000013726556,0.00011995773,0.000018106373,0.00003203795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99846095,0.00034331094,0.00051326695,0.00034109465,0.0001614736,0.00017987652],"domain_scores_gemma":[0.998959,0.00028379742,0.0002278893,0.0003570579,0.000113287926,0.000058969614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012948905,0.00015534845,0.0003195789,0.000045639106,0.000025937667,0.0000089055,0.000121091696,0.0002152556,0.00000475493],"category_scores_gemma":[0.0015153121,0.00012163821,0.00010547452,0.00010416304,0.00007332811,0.0000024809003,0.000055142762,0.00008808395,6.2979973e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002447181,0.0011791461,0.8315284,0.00001041397,0.000071862516,1.4071622e-7,0.000013675163,0.000051502637,0.16601104,0.00010974954,5.885705e-7,0.0009989636],"study_design_scores_gemma":[0.0022788977,0.00036939373,0.8049055,0.000012303243,0.00006461995,1.8139936e-7,0.0000034310194,0.00012225141,0.19163187,0.00043617215,0.000049439368,0.00012594406],"about_ca_topic_score_codex":0.000027504491,"about_ca_topic_score_gemma":0.00035593862,"teacher_disagreement_score":0.026622942,"about_ca_system_score_codex":0.000007613651,"about_ca_system_score_gemma":0.000035343513,"threshold_uncertainty_score":0.49602622},"labels":[],"label_agreement":null},{"id":"W2017781499","doi":"10.1182/blood-2012-03-415778","title":"Gray platelet syndrome: macrothrombocytopenia with deficient α-granules","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Otitis; Platelet; Past medical history; Bernard–Soulier syndrome; Purpura (gastropod); Pediatrics; Internal medicine; Surgery; Gastroenterology; Biology","score_opus":0.011274779285380527,"score_gpt":0.23792020866525176,"score_spread":0.22664542937987123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017781499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916563,0.0013827095,0.000022227485,0.00011995119,0.00006075704,0.00038946533,0.000017971199,0.00007703827,0.006273566],"genre_scores_gemma":[0.9980159,0.00005051138,0.0012028249,0.00017558488,0.000028737408,0.000036009485,0.000055723176,0.000029298602,0.00040542206],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901396,0.000013108459,0.00013285421,0.00018259921,0.00022870257,0.00042875423],"domain_scores_gemma":[0.999461,0.000017232971,0.0000440672,0.00024746868,0.000025769612,0.00020445145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000067679524,0.00017558488,0.0003344864,0.00006293491,0.00008368306,0.000016062526,0.000056222874,0.00006460358,0.00018884287],"category_scores_gemma":[0.0000075713224,0.00011579966,0.00005852167,0.00015132572,0.00005294406,0.000091987866,0.000022306203,0.000100622296,0.0003463638],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000417742,0.012426005,0.9660092,0.00019924657,0.0014839765,0.008016159,0.00087093475,0.0000027215824,0.0040996424,0.00084751676,0.0011602913,0.004466542],"study_design_scores_gemma":[0.03270939,0.0025826665,0.8542244,0.0003242085,0.0018026051,0.039268456,0.00034504515,0.000007716907,0.051188927,0.00013361855,0.016661821,0.0007511903],"about_ca_topic_score_codex":0.000044085016,"about_ca_topic_score_gemma":0.000013906336,"teacher_disagreement_score":0.11178487,"about_ca_system_score_codex":0.000019216171,"about_ca_system_score_gemma":0.00003314481,"threshold_uncertainty_score":0.47221732},"labels":[],"label_agreement":null},{"id":"W2017926367","doi":"10.1182/blood-2012-03-417667","title":"Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute; U.S. Public Health Service; Health Resources and Services Administration","keywords":"Medicine; Bone marrow; Donation; Toxicity; Surgery; Bone pain; Stem cell; Internal medicine; Granulocyte colony-stimulating factor; Prospective cohort study; Chemotherapy","score_opus":0.02597226028642813,"score_gpt":0.27542265614292466,"score_spread":0.24945039585649653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017926367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871614,0.0006252523,0.000016524997,0.00031503438,0.00039500569,0.0020399694,0.00046600908,0.00007146841,0.00890935],"genre_scores_gemma":[0.9958,0.000059612074,0.002689075,0.000026160515,0.0004266235,0.00018207234,0.00025714253,0.000027146874,0.00053217786],"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99789304,0.00013072121,0.000683151,0.00024232801,0.00079138007,0.00025938242],"domain_scores_gemma":[0.9984457,0.0005018684,0.0003667044,0.00022751535,0.00036406802,0.00009413905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004785188,0.00019788984,0.0004038438,0.00007206235,0.00006272351,0.0000148408035,0.00011926727,0.00017416247,0.00009680228],"category_scores_gemma":[0.00006607099,0.00014714275,0.00015904948,0.00028486844,0.00014217076,0.0001354898,0.000021697713,0.00019658984,0.000007667819],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.45221475,0.03447669,0.039679337,0.0013630715,0.011053571,0.000114114504,0.073215604,0.00003155489,0.37816477,0.0046764663,0.0021497703,0.002860287],"study_design_scores_gemma":[0.355663,0.004742415,0.017447745,0.00040543874,0.0036130918,0.00008676087,0.0020433166,0.00006950418,0.61507905,0.00013357405,0.000378312,0.00033777344],"about_ca_topic_score_codex":0.000056112705,"about_ca_topic_score_gemma":0.000019081846,"teacher_disagreement_score":0.23691429,"about_ca_system_score_codex":0.000049128434,"about_ca_system_score_gemma":0.00022716043,"threshold_uncertainty_score":0.6000307},"labels":[],"label_agreement":null},{"id":"W2017990016","doi":"10.1182/blood-2011-06-361535","title":"Safety of anticoagulants in children with arterial ischemic stroke","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary; Hospital for Sick Children; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Asymptomatic; Stroke (engine); Pediatric stroke; Cohort; Pediatrics; Clinical trial; Intracerebral hemorrhage; Complication; Cohort study; Arterial Ischemic Stroke; Surgery; Ischemic stroke; Internal medicine; Ischemia; Glasgow Coma Scale","score_opus":0.021865033522331087,"score_gpt":0.23628403577400253,"score_spread":0.21441900225167143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017990016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928394,0.000026538404,0.00008881096,0.00001594918,0.00003389816,0.0002468373,0.000012318716,0.00002626829,0.006710003],"genre_scores_gemma":[0.99754363,0.0000112479165,0.0022546363,0.000049728707,0.000045678687,0.000004359017,0.000015407655,0.0000138302,0.00006145272],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99935144,0.000015287345,0.00020094984,0.00014747656,0.00014655042,0.00013832054],"domain_scores_gemma":[0.99963284,0.0000038050434,0.00006892916,0.00020664961,0.000029646391,0.00005810835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000072100935,0.00009165345,0.00026382424,0.00007894443,0.0000125041925,0.000002197211,0.00005543758,0.00006349145,0.00024134363],"category_scores_gemma":[0.000008057246,0.000072785435,0.000034488487,0.00010111156,0.000033569035,0.000038734688,0.00001785784,0.00007733583,0.000012492295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003161259,0.0013833798,0.790338,0.000017579001,0.00024385919,0.000008111105,0.0002962213,1.517634e-7,0.20649226,0.00048645068,0.0000149457355,0.00040294396],"study_design_scores_gemma":[0.0066335383,0.00025630972,0.6729846,0.000060084116,0.00016687816,0.00006841004,0.000027305394,0.0000040744194,0.3197038,0.000020811432,0.0000103692955,0.00006381661],"about_ca_topic_score_codex":0.000048542188,"about_ca_topic_score_gemma":0.000012356789,"teacher_disagreement_score":0.11735336,"about_ca_system_score_codex":0.0000042167485,"about_ca_system_score_gemma":0.000040638497,"threshold_uncertainty_score":0.2968104},"labels":[],"label_agreement":null},{"id":"W2018357983","doi":"10.1182/blood-2002-01-0220","title":"Deregulated expression of HOXB4 enhances the primitive growth activity of human hematopoietic cells","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":132,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; University of British Columbia; BC Cancer Agency","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute","keywords":"Haematopoiesis; Biology; Stem cell; Progenitor cell; Hematopoietic stem cell; Cell biology; Myeloid; CD34; Lymphopoiesis; Immunology; Cancer research","score_opus":0.012348433650060235,"score_gpt":0.2351739133671866,"score_spread":0.22282547971712635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018357983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967642,0.0011679421,0.0003296508,0.000019661147,0.000025228584,0.000118036034,0.0000069959306,0.000003477728,0.0015648438],"genre_scores_gemma":[0.99934787,0.00028977878,0.00018112667,0.0000050680615,0.000031733143,0.000005872078,0.000006880833,0.000008862977,0.00012282837],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994179,0.00007103226,0.0001515679,0.00015177396,0.00011080759,0.000096906624],"domain_scores_gemma":[0.9994808,0.000019739507,0.0001617795,0.00022949839,0.00008488851,0.000023329005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009258625,0.00008250801,0.0001156046,0.000018372439,0.000050339153,0.000004413805,0.0001196799,0.000088580724,0.000029214181],"category_scores_gemma":[0.00002515444,0.0000602791,0.000064888496,0.00005857582,0.000090238274,0.0000022240838,0.000054361208,0.00004555813,0.0000012964567],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000656199,0.0002637454,0.00047562525,0.000033508975,0.000021828646,2.3509944e-7,0.00015031414,0.0000036356137,0.9987954,0.00002946256,0.000020333344,0.00019933126],"study_design_scores_gemma":[0.0003919511,0.0002143904,0.0046887076,0.000024207857,0.000032002237,4.997496e-7,0.00002842908,0.000006821563,0.9943465,0.0001593196,0.000038417504,0.000068775254],"about_ca_topic_score_codex":0.000010515456,"about_ca_topic_score_gemma":0.000004289476,"teacher_disagreement_score":0.0044489396,"about_ca_system_score_codex":0.0000014544408,"about_ca_system_score_gemma":0.000008399103,"threshold_uncertainty_score":0.24581105},"labels":[],"label_agreement":null},{"id":"W2018591383","doi":"10.1182/blood-2007-04-084293","title":"Outcomes in CCG-2961, a Children's Oncology Group Phase 3 Trial for untreated pediatric acute myeloid leukemia: a report from the Children's Oncology Group","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":272,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre","funders":"National Cancer Institute; National Institutes of Health","keywords":"Idarubicin; Cytarabine; Fludarabine; Medicine; Internal medicine; Transplantation; Randomized controlled trial; Oncology; Leukemia; Surgery; Chemotherapy; Cyclophosphamide","score_opus":0.018910234001831377,"score_gpt":0.3422142945803145,"score_spread":0.3233040605784831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018591383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98608655,0.00054637704,0.0005043567,0.0027621025,0.0006072361,0.007939354,0.00037808076,0.00024943656,0.0009265048],"genre_scores_gemma":[0.9837289,0.00056542305,0.0038217073,0.0018228355,0.0051790522,0.00097220036,0.0030902864,0.00018198357,0.00063764764],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9938505,0.0004335304,0.0018295342,0.0013683047,0.0008452666,0.001672854],"domain_scores_gemma":[0.99382097,0.0033319173,0.00072623807,0.0013452901,0.00022592407,0.0005496648],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0031131916,0.0006954545,0.001876829,0.00068617065,0.00029702275,0.00005092802,0.0007839797,0.0011438852,0.00014512107],"category_scores_gemma":[0.0021069138,0.0004929978,0.0006057424,0.0012068035,0.00032405512,0.00017814226,0.0003508355,0.0018686194,0.00007197551],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1262985,0.019140797,0.78552186,0.00004806162,0.00503238,0.014533627,0.001240237,0.000002205922,0.0036702068,0.00023435448,0.014436435,0.029841354],"study_design_scores_gemma":[0.5659843,0.011751285,0.40705654,0.000026383452,0.003908696,0.0034923605,0.00019278974,0.00003250163,0.0010536347,0.00020761382,0.0056736562,0.00062020967],"about_ca_topic_score_codex":0.0032127157,"about_ca_topic_score_gemma":0.0014438095,"teacher_disagreement_score":0.43968582,"about_ca_system_score_codex":0.0022042212,"about_ca_system_score_gemma":0.0023907414,"threshold_uncertainty_score":0.99975216},"labels":[],"label_agreement":null},{"id":"W2018617965","doi":"10.1182/blood-2013-11-537084","title":"TPO signal for stem cell genomic integrity","year":2014,"lang":"en","type":"letter","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Stem cell; Personal Integrity; Biology; Medicine; Computational biology; Genetics; Psychology","score_opus":0.03033702338766601,"score_gpt":0.2519735461681327,"score_spread":0.22163652278046672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018617965","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16464524,0.0022709966,0.056835845,0.67336726,0.0032736976,0.013107726,0.0013276297,0.0010702986,0.08410129],"genre_scores_gemma":[0.08930253,0.00010519552,0.011814437,0.84811103,0.018637607,0.00059233943,0.0041795094,0.0004823961,0.026774924],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983804,0.00006698669,0.00041703062,0.00045094124,0.00030515576,0.00037943554],"domain_scores_gemma":[0.9988813,0.00035229366,0.00016592149,0.0004129402,0.000101019614,0.00008656209],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024200846,0.00031399162,0.00061456853,0.00012021329,0.0000454688,0.000023584964,0.00016696486,0.0009154204,0.00018873718],"category_scores_gemma":[0.0000051135426,0.0002799614,0.0002677823,0.000050183975,0.00003721445,0.000018251214,0.000012483444,0.0012009181,0.00030747565],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007633868,0.00025122182,0.0007439467,0.010048862,0.00027811804,0.0004574171,0.0003064269,4.0795467e-7,0.014597566,0.000020911886,0.972778,0.00044078758],"study_design_scores_gemma":[0.0070912465,0.0005675966,0.00019537668,0.0007452516,0.0029070922,0.0005946556,0.000030320265,0.00005012751,0.06884568,0.000092743176,0.9183593,0.00052064285],"about_ca_topic_score_codex":0.000013217343,"about_ca_topic_score_gemma":0.0000012532693,"teacher_disagreement_score":0.17474379,"about_ca_system_score_codex":0.0000479543,"about_ca_system_score_gemma":0.00018195609,"threshold_uncertainty_score":0.99996525},"labels":[],"label_agreement":null},{"id":"W2018746774","doi":"10.1182/blood-2011-08-369835","title":"Auer rods in mature granulocytes of a patient with mixed lineage leukemia","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pancytopenia; Bone marrow; Precursor cell; Pathology; Peripheral blood; Medicine; Population; Lineage (genetic); Biopsy; Leukemia; Immunology; Biology; Cell; Genetics","score_opus":0.009756219693277874,"score_gpt":0.2529869034099073,"score_spread":0.24323068371662945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018746774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99548787,0.0011226871,0.000014203244,0.00017040572,0.000042713793,0.00040096277,0.000009680421,0.000031737076,0.002719716],"genre_scores_gemma":[0.9956971,0.000035687946,0.0035096642,0.00013574853,0.00012347064,0.000036566948,0.000025673493,0.000032374926,0.0004037052],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987119,0.000055127606,0.00024546022,0.00017395131,0.00038495113,0.0004286228],"domain_scores_gemma":[0.99922746,0.00006213515,0.00007018326,0.0003689639,0.00008993354,0.00018130265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022578069,0.00014641917,0.00033662326,0.00017683051,0.000019472223,0.0000052382115,0.00009591892,0.00013839042,0.000068847025],"category_scores_gemma":[0.00010960129,0.00010104473,0.000053879423,0.00039126017,0.00006895979,0.000084444095,0.00006530395,0.00041676738,0.000028386938],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017874239,0.003923731,0.89950305,0.0009964835,0.00047840705,0.0006872994,0.006089206,0.000025859332,0.07429231,0.00049337215,0.0050720735,0.006650794],"study_design_scores_gemma":[0.015947971,0.0014037468,0.32772022,0.0006134432,0.00029886325,0.00041110688,0.0010564894,0.00011562437,0.64593035,0.000014077105,0.0061590383,0.00032905952],"about_ca_topic_score_codex":0.00015174673,"about_ca_topic_score_gemma":0.000034282773,"teacher_disagreement_score":0.5717828,"about_ca_system_score_codex":0.00015704092,"about_ca_system_score_gemma":0.00028884324,"threshold_uncertainty_score":0.41204846},"labels":[],"label_agreement":null},{"id":"W2018857756","doi":"10.1182/blood-2003-10-3550","title":"NUP98-Topoisomerase I acute myeloid leukemia-associated fusion gene has potent leukemogenic activities independent of an engineered catalytic site mutation","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Fusion gene; Biology; Haematopoiesis; Cancer research; Molecular biology; Myeloid; Bone marrow; Stem cell; Gene; Cell biology; Genetics; Immunology","score_opus":0.00865423393322618,"score_gpt":0.21753099495779915,"score_spread":0.20887676102457298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018857756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972521,0.00065331266,0.0014417783,0.000033522887,0.00014677168,0.00022999477,0.00018373401,0.000024712182,0.000034043336],"genre_scores_gemma":[0.997628,0.00036167595,0.00052794366,0.00009789705,0.00011133401,0.000024199337,0.00109821,0.000038274822,0.00011251384],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99890745,0.000029694447,0.0002458607,0.00033084012,0.00022635714,0.00025982823],"domain_scores_gemma":[0.9993213,0.0000045243855,0.00015348352,0.00034000626,0.00007858449,0.00010211878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000117687436,0.00019982606,0.00020404575,0.000073779,0.00009230522,0.000029951665,0.00015073072,0.00019946905,0.00000790385],"category_scores_gemma":[0.000010035887,0.00020732054,0.000130679,0.00010406119,0.000042674776,0.000011653674,0.000067758025,0.00009798224,0.0000037729499],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000922802,0.00034489634,0.000017120505,0.000014067864,0.00033011162,0.000032093296,0.00030973784,0.0012721117,0.9957824,0.00002315356,0.000004132586,0.0017779154],"study_design_scores_gemma":[0.0040852013,0.0007563599,0.00047854165,0.000016957318,0.0002797224,0.00008399711,0.00012766066,0.000111646084,0.9935664,0.00014896011,0.00010534439,0.00023920894],"about_ca_topic_score_codex":0.00020802837,"about_ca_topic_score_gemma":0.00022479249,"teacher_disagreement_score":0.003992921,"about_ca_system_score_codex":0.00013931505,"about_ca_system_score_gemma":0.0003662648,"threshold_uncertainty_score":0.84542865},"labels":[],"label_agreement":null},{"id":"W2018860370","doi":"10.1182/blood-2013-04-457671","title":"NETosis: how vital is it?","year":2013,"lang":"en","type":"review","venue":"Blood","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":970,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Neutrophil extracellular traps; Bystander effect; Innate immune system; Immunology; Programmed cell death; Lytic cycle; Biology; Medicine; Immune system; Inflammation; Apoptosis; Virus; Genetics","score_opus":0.0547888204031647,"score_gpt":0.287484730112593,"score_spread":0.23269590970942833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018860370","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007832851,0.9961703,0.00001649249,0.00019197451,0.0007834888,0.0008298577,0.00022937464,0.000090162255,0.001610021],"genre_scores_gemma":[0.000046380916,0.97611153,0.00009341109,0.00040680578,0.00019426092,0.00033141873,0.0004611645,0.000083951076,0.022271086],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979524,0.00032072823,0.00041489536,0.00068091234,0.000048159018,0.0005828904],"domain_scores_gemma":[0.99879587,0.00010833824,0.00031978975,0.00066952506,0.000059816255,0.00004669052],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00011441275,0.0006596269,0.0017326188,0.00019103094,0.00016499967,0.000067437584,0.0005969705,0.00094057,0.0033942778],"category_scores_gemma":[0.000025707688,0.0004826604,0.00064692664,0.0002017846,0.00012373657,0.000121499615,0.00023623805,0.0007296816,0.014814284],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000041611765,0.0005697831,9.380287e-7,0.0038728954,0.00302249,0.000059587313,0.00014491045,2.6179043e-9,0.010463673,0.00085502147,0.089565046,0.89144146],"study_design_scores_gemma":[0.00067765854,0.0001738191,2.713778e-7,0.0025388678,0.0018328169,0.00025715173,0.000045597386,4.232653e-9,0.01584563,0.000037492726,0.97806156,0.00052911864],"about_ca_topic_score_codex":0.0000121798985,"about_ca_topic_score_gemma":0.0000015557603,"teacher_disagreement_score":0.89091235,"about_ca_system_score_codex":0.000025018793,"about_ca_system_score_gemma":0.00013707978,"threshold_uncertainty_score":0.99976254},"labels":[],"label_agreement":null},{"id":"W2018869677","doi":"10.1182/blood-2013-10-532671","title":"Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"National Institute of Allergy and Infectious Diseases; National Heart, Lung, and Blood Institute; Blue Cross and Blue Shield Association; U.S. Public Health Service; Health Resources and Services Administration; National Cancer Institute; Medical College of Wisconsin; National Institutes of Health","keywords":"Human leukocyte antigen; Hematopoietic stem cell transplantation; Hazard ratio; Transplantation; Immunology; Graft-versus-host disease; Internal medicine; Allele; Medicine; HLA-B Antigens; Antigen; Biology; Genetics; Confidence interval; Gene","score_opus":0.012284363413281292,"score_gpt":0.24602543777720925,"score_spread":0.23374107436392796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018869677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898097,0.00011184746,0.0046330276,0.00012516718,0.00005485901,0.00039931666,0.0000071892914,0.000042583946,0.004816309],"genre_scores_gemma":[0.99882454,0.000094048526,0.0004894723,0.000030469115,0.000024754961,0.00003033833,0.00003745508,0.000022239714,0.00044667645],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986327,0.000075496515,0.0005995182,0.00023357959,0.00028950872,0.0001691396],"domain_scores_gemma":[0.9993457,0.000103043705,0.00014698695,0.00026639877,0.000062292056,0.00007557608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039667723,0.000121228004,0.0002849131,0.00017251089,0.00002189836,0.000009580372,0.00007491986,0.00010500911,0.0000399226],"category_scores_gemma":[0.000007859044,0.00011962832,0.00006785975,0.00025121486,0.000029208937,0.00006633512,0.0000033453332,0.000096357755,0.00005117637],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000121128396,0.0012320064,0.063559815,0.0067316256,0.000028223658,0.00004512436,0.008958905,0.000036030848,0.9176143,0.0007075174,0.000018489469,0.00094683946],"study_design_scores_gemma":[0.0045794304,0.000119402306,0.052820943,0.00044719045,0.00030004786,0.00020551565,0.000397888,0.00047643433,0.9403389,0.00016145056,0.000026393658,0.00012641928],"about_ca_topic_score_codex":0.000019837496,"about_ca_topic_score_gemma":0.000008067386,"teacher_disagreement_score":0.02272459,"about_ca_system_score_codex":0.000014524218,"about_ca_system_score_gemma":0.00005021852,"threshold_uncertainty_score":0.48783013},"labels":[],"label_agreement":null},{"id":"W2018938254","doi":"10.1182/blood-2012-06-434365","title":"RNAi screening uncovers Dhx9 as a modifier of ABT-737 resistance in an Eμ-myc/Bcl-2 mouse model","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"RNA interference; Biology; Interference (communication); Cell biology; Cancer research; Virology; Genetics; Gene; RNA; Computer science","score_opus":0.01667407639067343,"score_gpt":0.24193770447831767,"score_spread":0.22526362808764425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018938254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928063,0.0005053058,0.0008072674,0.000061945044,0.000018418797,0.0002723437,0.00003982186,0.00001826982,0.0054703276],"genre_scores_gemma":[0.9907275,0.0000733723,0.006780153,0.00020424764,0.000066254455,0.0000631568,0.000049781698,0.0000273547,0.0020082064],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99894273,0.000058034133,0.00023876308,0.00033329293,0.00015324463,0.00027391574],"domain_scores_gemma":[0.9992776,0.0000081328135,0.00009392564,0.0004323464,0.000086180975,0.00010183129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015355714,0.00015376044,0.00016910031,0.00005090789,0.000039552164,0.000023745686,0.00023634583,0.0001726734,0.00002680368],"category_scores_gemma":[0.0000549753,0.00015359947,0.00007046719,0.0000801851,0.0000553864,0.000014082242,0.00008147553,0.00011042886,0.000014547914],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008401801,0.00025797638,0.0025839957,0.00003953635,0.000032587734,0.0000031876816,0.00018789507,0.000653568,0.99494386,0.000489332,0.00037297726,0.00035109738],"study_design_scores_gemma":[0.0016603565,0.0002123008,0.00055423094,0.000038107795,0.000017657512,0.0000028816073,0.0001254113,0.0011446662,0.99448836,0.0008990887,0.0006076773,0.00024925568],"about_ca_topic_score_codex":0.00017058758,"about_ca_topic_score_gemma":0.00022855036,"teacher_disagreement_score":0.005972886,"about_ca_system_score_codex":0.0000063014913,"about_ca_system_score_gemma":0.000078347875,"threshold_uncertainty_score":0.6263605},"labels":[],"label_agreement":null},{"id":"W2018954315","doi":"10.1182/blood-2011-03-345173","title":"Prospective evaluation of a pharmacogenetics-guided warfarin loading and maintenance dose regimen for initiation of therapy","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; University of Ottawa; Western University","funders":"Canadian Institutes of Health Research","keywords":"VKORC1; Warfarin; Pharmacogenetics; CYP2C9; Vitamin K epoxide reductase; Medicine; Regimen; Maintenance dose; Internal medicine; Pharmacology; Dosing; Therapeutic index; Atrial fibrillation; Genotype; Biology; Genetics; Drug; Cytochrome P450","score_opus":0.28632132103989605,"score_gpt":0.4536510918270174,"score_spread":0.16732977078712136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018954315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884345,0.004466161,0.0001588006,0.00003570514,0.00031195287,0.0015269592,0.000088967754,0.000018785895,0.004958173],"genre_scores_gemma":[0.9959616,0.0019965724,0.0014516853,0.00016483644,0.0001036943,0.00024340721,0.000009688518,0.000023118619,0.000045413104],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99854887,0.00029588223,0.00043550815,0.00026622383,0.00020778998,0.0002457094],"domain_scores_gemma":[0.99862784,0.00013339988,0.0003633098,0.00014078863,0.0006375095,0.000097123666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016777527,0.00016714948,0.00027816338,0.000116697316,0.000077224744,0.000004038234,0.00015119398,0.00013474852,0.00023845084],"category_scores_gemma":[0.00010948039,0.00015867414,0.00007912022,0.00015110671,0.00015255691,0.00007237505,0.000044244916,0.00014740427,0.0000018113493],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009074374,0.0017813331,0.033944078,0.00010397066,0.0006792993,0.0000018961983,0.005556831,0.00007782552,0.9268538,0.0019387355,0.00023365408,0.027921172],"study_design_scores_gemma":[0.015696835,0.0002096574,0.0280561,0.000016002681,0.0008311567,0.000008957871,0.000085245025,0.0033011572,0.9449303,0.005512351,0.0011863378,0.00016585675],"about_ca_topic_score_codex":0.000014373063,"about_ca_topic_score_gemma":0.000001599093,"teacher_disagreement_score":0.027755314,"about_ca_system_score_codex":0.00001659415,"about_ca_system_score_gemma":0.00011708342,"threshold_uncertainty_score":0.6470544},"labels":[],"label_agreement":null},{"id":"W2019081245","doi":"10.1182/blood-2002-10-3147","title":"Increased sensitivity of Fancc-deficient hematopoietic cells to nitric oxide and evidence that this species mediates growth inhibition by cytokines","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Nitric Oxide and Endothelin Effects","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Haematopoiesis; Nitric oxide; Biology; Cancer research; Immunology; Chemistry; Cell biology; Stem cell; Endocrinology","score_opus":0.015353219033422103,"score_gpt":0.22773698504341885,"score_spread":0.21238376600999676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019081245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960743,0.002365309,0.00028954272,0.00016416139,0.000039381648,0.00043671762,0.000024176188,0.000048489706,0.000557896],"genre_scores_gemma":[0.99808687,0.0005006041,0.00084771594,0.00034662,0.00004087776,0.000016355003,0.0000060437415,0.000020578764,0.00013434245],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99862254,0.00019241415,0.00024011772,0.00029965743,0.0003854522,0.0002598016],"domain_scores_gemma":[0.998367,0.00095046096,0.00013212775,0.00022935492,0.00012639597,0.00019466602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006956564,0.00019200661,0.0004113261,0.0001846614,0.00005256827,0.000016337182,0.000032617987,0.000082870305,0.000037767983],"category_scores_gemma":[0.0015879234,0.00015882087,0.0000703387,0.00041539525,0.000082900224,0.00008925259,0.000037017657,0.00011612874,0.000031765892],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056830682,0.00043021052,0.049291477,0.0004631844,0.000030443209,0.000079775775,0.00015781116,6.1467637e-7,0.948487,0.00008760583,0.0008707679,0.00004428817],"study_design_scores_gemma":[0.0016311491,0.00017496703,0.029002776,0.00053577335,0.00024957754,0.00017555655,0.0001568583,0.00000620409,0.967733,0.00010119077,0.00007697625,0.00015597043],"about_ca_topic_score_codex":0.0002588184,"about_ca_topic_score_gemma":0.0000070070128,"teacher_disagreement_score":0.020288702,"about_ca_system_score_codex":0.000023070232,"about_ca_system_score_gemma":0.00004846068,"threshold_uncertainty_score":0.6476527},"labels":[],"label_agreement":null},{"id":"W2019199359","doi":"10.1182/blood-2008-08-077941","title":"Stem cell concepts renew cancer research","year":2008,"lang":"en","type":"review","venue":"Blood","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":998,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Stem cell; Cancer stem cell; Cancer; Biology; Hematology; Somatic evolution in cancer; Cancer research; Cancer cell; Computational biology; Immunology; Genetics","score_opus":0.20729357166055815,"score_gpt":0.46612534620984053,"score_spread":0.2588317745492824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019199359","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004264532,0.9777226,7.248663e-7,0.00003332227,0.0003349055,0.0010880395,0.00013310151,0.00004445123,0.020600231],"genre_scores_gemma":[0.000007850364,0.96509016,0.00010391216,0.00005287268,0.0012279433,0.00033121128,0.00006302915,0.00009840221,0.033024646],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974629,0.0002203744,0.0004912354,0.0005814239,0.00068817724,0.0005558824],"domain_scores_gemma":[0.9984298,0.00015864334,0.000170796,0.00072596443,0.00020054307,0.00031427277],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002810282,0.00034225394,0.0018427783,0.00024645284,0.000109156375,0.00001978492,0.00022674595,0.00031654543,0.00069009373],"category_scores_gemma":[0.000010278375,0.0002565832,0.0005953857,0.0006429814,0.00014159759,0.000022328697,0.00011141921,0.0008609088,0.00035929872],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000072510834,0.00028468543,0.0000044479348,0.019972473,0.0002552711,0.00031252607,0.0000730004,2.9381134e-8,0.000007724959,0.000006634669,0.03453576,0.9445402],"study_design_scores_gemma":[0.001194681,0.00013810232,8.3161643e-7,0.012469295,0.0018708074,0.00026030993,0.000022523354,2.2226303e-8,0.00030954642,0.0000010688652,0.9835099,0.00022292521],"about_ca_topic_score_codex":0.00045355325,"about_ca_topic_score_gemma":0.000044529144,"teacher_disagreement_score":0.94897413,"about_ca_system_score_codex":0.0001811487,"about_ca_system_score_gemma":0.0023635647,"threshold_uncertainty_score":0.9999886},"labels":[],"label_agreement":null},{"id":"W2019383774","doi":"10.1182/blood-2005-12-4788","title":"Antigen receptor–mediated changes in glucose metabolism in B lymphocytes: role of phosphatidylinositol 3-kinase signaling in the glycolytic control of growth","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":375,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; U.S. Public Health Service; University of British Columbia","keywords":"Glycolysis; Pentose phosphate pathway; Carbohydrate metabolism; Biology; Glucose uptake; B-cell receptor; Signal transduction; Metabolism; Phosphatidylinositol; Anabolism; Biochemistry; Cell biology; B cell; Endocrinology; Insulin; Immunology; Antibody","score_opus":0.0047343112932764315,"score_gpt":0.18595223581850415,"score_spread":0.18121792452522772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019383774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94742507,0.051606882,0.0000024877904,0.00010475463,0.0001440461,0.00045621695,0.000045550776,0.000016343902,0.00019866326],"genre_scores_gemma":[0.99885,0.0008312621,0.00002572166,0.0000830338,0.0000265171,0.000061340514,0.00007942805,0.000015306927,0.000027388667],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981169,0.00049567653,0.000624633,0.0002701551,0.000056093315,0.00043654224],"domain_scores_gemma":[0.9989466,0.0004675387,0.00026697607,0.00024904445,0.00006061078,0.000009241665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049480284,0.0002112864,0.0006173796,0.00033501905,0.000035166802,0.0000052327164,0.00038862473,0.0003303905,0.00010322583],"category_scores_gemma":[0.00009913213,0.00016650031,0.00007801882,0.000533085,0.00022255797,0.00005652839,0.00004667771,0.00026321333,0.00003101809],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031672895,0.0017390003,0.058175385,0.00002591393,0.00007081512,0.000017681115,0.0010558617,0.000016293965,0.93783385,0.0004410936,0.000015360207,0.00029202463],"study_design_scores_gemma":[0.012460663,0.00017623135,0.023616727,0.00008231449,0.000045458095,0.000012772446,0.000808208,0.000009973029,0.9617083,0.0002500461,0.00067059434,0.00015871268],"about_ca_topic_score_codex":0.0043485705,"about_ca_topic_score_gemma":0.0011867193,"teacher_disagreement_score":0.051424947,"about_ca_system_score_codex":0.00002593023,"about_ca_system_score_gemma":0.00009060775,"threshold_uncertainty_score":0.67896855},"labels":[],"label_agreement":null},{"id":"W2019841748","doi":"10.1182/blood-2011-02-334722","title":"The human GFI136N variant induces epigenetic changes at the Hoxa9 locus and accelerates K-RAS driven myeloproliferative disorder in mice","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"Biotechnology and Biological Sciences Research Council; Medical Research Council; National Centre for the Replacement, Refinement and Reduction of Animals in Research; Cancer Research UK; Wellcome Trust; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Biology; Myeloid leukemia; Epigenetics; Gene; Genetics; Myeloid; Allele; Transcription factor; Cancer research; Leukemia; RUNX1; Haematopoiesis; IRF8; Gene expression; Stem cell","score_opus":0.011173615541467395,"score_gpt":0.24511835261415033,"score_spread":0.23394473707268293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019841748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9743849,0.024059216,0.0000032002622,0.00076282327,0.000056909095,0.00031604955,0.000013198569,0.0000054495326,0.0003982789],"genre_scores_gemma":[0.99727345,0.0017697968,0.000022424112,0.00017096056,0.00014084132,0.00013392461,0.00004184621,0.000019374002,0.00042740742],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99909884,0.000100128535,0.00012813008,0.0002416011,0.000087898035,0.00034339193],"domain_scores_gemma":[0.9995811,0.00003287909,0.00006503632,0.00023187826,0.000027659891,0.00006145075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013300095,0.00017805868,0.00012043005,0.00001904385,0.0004141505,0.000054083852,0.0001622147,0.000106353604,0.000011133129],"category_scores_gemma":[0.000023335899,0.000101138095,0.000032183358,0.00007388345,0.00014346543,0.000005643077,0.00019853236,0.00008174036,0.0000072888924],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007215598,0.0017392301,0.6419201,0.00002564747,0.00075954833,0.000010081791,0.002590063,0.000009822927,0.33863398,0.00041631717,0.00047665957,0.013346438],"study_design_scores_gemma":[0.0046949633,0.0006052084,0.36357847,0.000025823789,0.0002645797,0.00005398902,0.0014293891,0.0000050713625,0.61556697,0.00039807317,0.012838865,0.00053861126],"about_ca_topic_score_codex":0.00012608495,"about_ca_topic_score_gemma":0.0037386166,"teacher_disagreement_score":0.2783416,"about_ca_system_score_codex":0.0000058333267,"about_ca_system_score_gemma":0.000019391377,"threshold_uncertainty_score":0.41242918},"labels":[],"label_agreement":null},{"id":"W2019932049","doi":"10.1182/blood-2007-07-098913","title":"Efficacy and safety of a new-class hemostatic drug candidate, AV513, in dogs with hemophilia A","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Hemostasis and retained surgical items","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Canada Research Chairs; Heart and Stroke Foundation of Canada","keywords":"Hemostasis; Medicine; Thromboelastography; Adverse effect; Pharmacokinetics; Pharmacology; Clotting factor; Coagulation; Bleeding time; Hemostatic Agent; Internal medicine; Platelet; Platelet aggregation","score_opus":0.009810673508997914,"score_gpt":0.2567955633546308,"score_spread":0.24698488984563285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019932049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928726,0.00061284436,0.000050345054,0.0013425102,0.000020077661,0.000426968,0.000006149864,0.000021571474,0.0046469322],"genre_scores_gemma":[0.9974361,0.00009300873,0.0008438045,0.0002711042,0.000042043073,0.000002078678,0.00001456334,0.000019019544,0.001278256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884135,0.000022489174,0.00037056184,0.00022799612,0.00023731006,0.00030028448],"domain_scores_gemma":[0.9992237,0.00017045527,0.00007330764,0.00021022937,0.000044978948,0.0002773266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037831743,0.00014475962,0.00042008507,0.00011220759,0.0000269517,0.000007336866,0.000047837693,0.00006922303,0.000043477958],"category_scores_gemma":[0.00007694102,0.00009533462,0.000037455124,0.0003683614,0.00009757587,0.00003490447,0.000026876332,0.00018845519,0.000003999705],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013493004,0.0070182197,0.83375454,0.0012410707,0.00082892866,0.004781673,0.010710459,0.000020837622,0.02565453,0.0016789983,0.0024681669,0.09834958],"study_design_scores_gemma":[0.12139322,0.0022973903,0.7542222,0.00234573,0.0007281482,0.0014560038,0.0014755226,0.00020419345,0.0576732,0.00026199565,0.05703645,0.0009059167],"about_ca_topic_score_codex":0.0004858543,"about_ca_topic_score_gemma":0.00034646224,"teacher_disagreement_score":0.10790022,"about_ca_system_score_codex":0.000019874356,"about_ca_system_score_gemma":0.00012175126,"threshold_uncertainty_score":0.38876328},"labels":[],"label_agreement":null},{"id":"W2020055542","doi":"10.1182/blood-2010-05-231548","title":"Peripheral T-cell lymphoma","year":2011,"lang":"en","type":"review","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":351,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Vorinostat; Lymphoma; Medicine; Peripheral T-cell lymphoma; Brentuximab vedotin; Clinical trial; Histone deacetylase; Oncology; Bioinformatics; Internal medicine; Immunology; T cell; Biology; Histone; Hodgkin lymphoma; Gene","score_opus":0.043225392328565856,"score_gpt":0.29482984095524317,"score_spread":0.2516044486266773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020055542","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011297475,0.94273525,2.7429283e-7,0.000005739353,0.00016632288,0.0006783985,0.000027816024,0.0000751071,0.05619814],"genre_scores_gemma":[0.000071212206,0.99450326,0.000311391,0.00006842547,0.00034218153,0.0002983706,0.00015167639,0.000074206364,0.004179302],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99875027,0.00004196607,0.00036705434,0.00040285676,0.00014712689,0.00029075105],"domain_scores_gemma":[0.999009,0.000035705732,0.00015985682,0.00056277233,0.00003150946,0.00020111623],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000047759244,0.00042177102,0.0015441461,0.00008700325,0.000043055592,0.000019172945,0.00012296588,0.00029293261,0.00052556145],"category_scores_gemma":[0.00000991089,0.00027878713,0.000787488,0.0001232973,0.00003256859,0.000021648604,0.00005530086,0.000072870884,0.0010421523],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004036673,0.0054653883,0.00015214174,0.008510209,0.00059266045,0.0005646522,0.000031651045,4.376078e-10,9.038265e-8,0.00009339086,0.0011102995,0.9834755],"study_design_scores_gemma":[0.004711084,0.00029384327,0.00009647859,0.0055235815,0.008871305,0.000798237,0.0000030170131,3.2363367e-8,0.000020239922,0.000005069562,0.9794336,0.00024353537],"about_ca_topic_score_codex":0.000045918205,"about_ca_topic_score_gemma":0.0000017370043,"teacher_disagreement_score":0.98323196,"about_ca_system_score_codex":0.00013902309,"about_ca_system_score_gemma":0.0004770506,"threshold_uncertainty_score":0.99996644},"labels":[],"label_agreement":null},{"id":"W202017566","doi":"10.1182/blood.v122.21.242.242","title":"Protein Tyrosine Phosphatase Type-1 (PTPN1) Is Frequently Mutated In Primary Mediastinal B Cell Lymphoma and Hodgkin Lymphoma","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Cancer research; Lymphoma; Biology; BCL10; Cancer; Receptor tyrosine kinase; Signal transduction; Immunology; Cell biology; Genetics","score_opus":0.005619791958576021,"score_gpt":0.20017493952154777,"score_spread":0.19455514756297176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W202017566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9624329,0.035807826,0.00003046098,0.00016910287,0.00006743326,0.0009155158,0.00020327223,0.000034038865,0.00033943483],"genre_scores_gemma":[0.9940444,0.000338132,0.0032635678,0.0007604654,0.00013095987,0.00024616512,0.00083449855,0.00005789978,0.00032387456],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99822515,0.000073061376,0.000366961,0.0006301207,0.00021687153,0.00048785878],"domain_scores_gemma":[0.9990235,0.00001628961,0.0001431944,0.0004990874,0.00011833815,0.0001995784],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015344335,0.00033224633,0.00027334635,0.00007809959,0.00006777203,0.00007085009,0.000283629,0.00021241987,0.00011578494],"category_scores_gemma":[0.00011688447,0.00032588578,0.00005391136,0.00023669383,0.00015478258,0.000023621244,0.00026417445,0.00006875299,0.000101038284],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023183104,0.0015267909,0.00797755,0.00017183402,0.000065781875,0.000120350465,0.00006116251,0.0000013447202,0.97037977,0.00010413077,0.0047196182,0.014639859],"study_design_scores_gemma":[0.0065986463,0.0004958332,0.026174504,0.00006388342,0.000038081696,0.000069895745,0.000017935068,0.000017166378,0.96366876,0.0001387521,0.0023283223,0.000388195],"about_ca_topic_score_codex":0.0006287597,"about_ca_topic_score_gemma":0.00003126665,"teacher_disagreement_score":0.035469692,"about_ca_system_score_codex":0.000031644806,"about_ca_system_score_gemma":0.00021144543,"threshold_uncertainty_score":0.9999193},"labels":[],"label_agreement":null},{"id":"W2020203596","doi":"10.1182/blood-2014-01-548800","title":"PRIMA-1Met induces myeloma cell death independent of p53 by impairing the GSH/ROS balance","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer","keywords":"Multiple myeloma; Programmed cell death; Apoptosis; Cancer research; Chemistry; Immunology; Biology; Biochemistry","score_opus":0.008202246875519424,"score_gpt":0.22191088423975266,"score_spread":0.21370863736423323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020203596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881541,0.001546665,0.00056704675,0.00022060641,0.0001318169,0.0003894679,0.000019065703,0.00006214384,0.008909095],"genre_scores_gemma":[0.9986345,0.000064738015,0.00043291342,0.00030974168,0.00013758797,0.000026399526,0.000014704626,0.000037349586,0.00034201943],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99865824,0.00007346116,0.0002840032,0.00027800765,0.00041651243,0.0002897578],"domain_scores_gemma":[0.99902904,0.00006571819,0.00017012513,0.00055017596,0.000073594514,0.0001113369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034494375,0.00017140158,0.00029374546,0.000057456386,0.000059372243,0.000015372903,0.00021304595,0.00013971305,0.000053761407],"category_scores_gemma":[0.00009880635,0.00012568886,0.00011149026,0.00016482202,0.00005588385,0.000039168837,0.0000908628,0.0003420774,0.000035011315],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052552943,0.0005922335,0.014017769,0.00013904128,0.0001377207,0.000022987166,0.00045417284,0.000010447693,0.98051286,0.00016528154,0.0011372432,0.0027577004],"study_design_scores_gemma":[0.0037938815,0.00044225412,0.032384045,0.00014421146,0.00028744532,0.00008262935,0.00006538931,0.000101925994,0.958978,0.00007693245,0.0034798973,0.00016339631],"about_ca_topic_score_codex":0.00007003659,"about_ca_topic_score_gemma":0.0000070173264,"teacher_disagreement_score":0.02153486,"about_ca_system_score_codex":0.00003977506,"about_ca_system_score_gemma":0.00011089079,"threshold_uncertainty_score":0.51254433},"labels":[],"label_agreement":null},{"id":"W2020352964","doi":"10.1182/blood-2012-08-444588","title":"Response: associations between activating KIR genes and childhood leukemia","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Leukemia; Gene; Childhood leukemia; Biology; Immunology; Genetics; Lymphoblastic Leukemia; Medicine","score_opus":0.014182830734951885,"score_gpt":0.23904213662050627,"score_spread":0.2248593058855544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020352964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99497384,0.0022447298,0.00003332065,0.00016560113,0.0007913851,0.00008272933,0.000009073755,0.00007400141,0.0016253433],"genre_scores_gemma":[0.99551815,0.000034682012,0.000060872917,0.00011583938,0.00012532755,0.00000805101,0.00010162796,0.0000114220065,0.004024026],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999267,0.00020386094,0.00016405103,0.00011217786,0.000020175863,0.00023274356],"domain_scores_gemma":[0.9994656,0.00027421777,0.00010099481,0.00011081131,0.0000293719,0.000018991945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003169104,0.000092303446,0.00013608157,0.00006692986,0.00026763353,0.000014043147,0.000048356018,0.00016027875,0.00028072073],"category_scores_gemma":[0.00022689902,0.00008767741,0.000040263913,0.00006984193,0.00003086319,0.00020167326,0.000039884388,0.00021076975,0.0003075163],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005229375,0.00018440063,0.16521582,0.0000026175783,0.0003663516,1.755578e-7,0.0010937561,2.3195562e-7,0.82449067,0.00010067576,0.002933612,0.0055593983],"study_design_scores_gemma":[0.000866079,0.0000563701,0.6432022,0.0000076119068,0.00006543195,0.000021728607,0.0001857388,9.235386e-8,0.29565462,0.0000071318136,0.059840385,0.00009265554],"about_ca_topic_score_codex":0.000032614287,"about_ca_topic_score_gemma":8.7200226e-7,"teacher_disagreement_score":0.5288361,"about_ca_system_score_codex":0.000042494605,"about_ca_system_score_gemma":0.000032128595,"threshold_uncertainty_score":0.39526024},"labels":[],"label_agreement":null},{"id":"W2020466018","doi":"10.1182/blood-2006-10-041814","title":"How we diagnose and treat thrombotic manifestations of the antiphospholipid syndrome: a case-based review","year":2007,"lang":"en","type":"review","venue":"Blood","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Antiphospholipid syndrome; Intensive care medicine; Catastrophic antiphospholipid syndrome; Thrombosis; Clinical trial; Autoantibody; Antibody; Immunology; Internal medicine","score_opus":0.07979942314177078,"score_gpt":0.3667896869844781,"score_spread":0.2869902638427073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020466018","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00090987235,0.9933043,0.0000048577467,0.0006278324,0.000113420916,0.004492563,0.00011815786,0.000037050122,0.00039192857],"genre_scores_gemma":[0.00047715195,0.99772936,0.0001859956,0.000057361623,0.000068847075,0.00025634625,0.00004179392,0.00009640882,0.0010867501],"study_design_codex":"systematic_review","study_design_gemma":"case_report","domain_scores_codex":[0.99733883,0.0003469678,0.0007846997,0.00047979748,0.0006478929,0.00040182204],"domain_scores_gemma":[0.9966883,0.0011707412,0.0005063581,0.0012615498,0.00017099468,0.00020203434],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006027072,0.00043820354,0.0026167799,0.00023749114,0.00009757599,0.00003149828,0.0002624042,0.0002797836,0.000049011476],"category_scores_gemma":[0.0007664373,0.00025902822,0.0006360883,0.00088763126,0.00024213223,0.000040142426,0.00010973704,0.00049057684,0.000022959692],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000032871853,0.00060760166,0.00073856045,0.84441733,0.00053803355,0.02490792,0.000068482084,9.1756425e-9,0.0000010866127,0.000043328426,0.0019495132,0.12672487],"study_design_scores_gemma":[0.0009876051,0.00011402446,0.000017312797,0.30935556,0.0062101763,0.5055797,0.000048843784,3.8313962e-7,0.00000660072,0.0000025381794,0.17751813,0.00015914193],"about_ca_topic_score_codex":0.000038428043,"about_ca_topic_score_gemma":0.000017847682,"teacher_disagreement_score":0.5350618,"about_ca_system_score_codex":0.00008887117,"about_ca_system_score_gemma":0.0007333271,"threshold_uncertainty_score":0.9999862},"labels":[],"label_agreement":null},{"id":"W2020521632","doi":"10.1182/blood-2011-07-365932","title":"Treating limited-stage nodular lymphocyte predominant Hodgkin lymphoma similarly to classical Hodgkin lymphoma with ABVD may improve outcome","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency","keywords":"ABVD; Lymphoma; Medicine; Stage (stratigraphy); Dacarbazine; Bleomycin; Classical Hodgkin lymphoma; Vinblastine; Hodgkin lymphoma; Brentuximab vedotin; Oncology; Internal medicine; Cancer research; Pathology; Chemotherapy; Cyclophosphamide; Biology; Vincristine","score_opus":0.029673667552053813,"score_gpt":0.2598252865507503,"score_spread":0.23015161899869652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020521632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98678356,0.0006333331,0.00021013404,0.00048792036,0.00024645135,0.0018079113,0.00013648292,0.00034889948,0.009345311],"genre_scores_gemma":[0.98195714,0.00008404205,0.011588436,0.0014911322,0.00034113525,0.0006372233,0.00006652386,0.00019111965,0.0036432396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99538755,0.00012985991,0.000979996,0.0013781432,0.00087391934,0.0012505385],"domain_scores_gemma":[0.99682695,0.00017399287,0.0003553498,0.0014744458,0.00023925691,0.00093001744],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003325987,0.00091975916,0.0013059224,0.00036181696,0.00026830874,0.00019189315,0.00038429615,0.00037203336,0.00020298193],"category_scores_gemma":[0.00019579328,0.00065855804,0.000434624,0.00058802776,0.0001778808,0.00038790627,0.0002318195,0.00010881177,0.0003930825],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004728027,0.021576473,0.7628783,0.00036837126,0.0019877278,0.011926808,0.0033351015,0.0000062835197,0.010327578,0.0013427039,0.00047692427,0.1810457],"study_design_scores_gemma":[0.07191088,0.0092764,0.68344474,0.00073120295,0.0030279832,0.0012720965,0.0006744702,0.00022712293,0.21505623,0.000031468164,0.012972163,0.001375234],"about_ca_topic_score_codex":0.0008844881,"about_ca_topic_score_gemma":0.00014833655,"teacher_disagreement_score":0.20472865,"about_ca_system_score_codex":0.0008093897,"about_ca_system_score_gemma":0.00058384024,"threshold_uncertainty_score":0.9995866},"labels":[],"label_agreement":null},{"id":"W2020578800","doi":"10.1182/blood-2014-10-559211","title":"The role of rituximab in the management of patients with acquired thrombotic thrombocytopenic purpura","year":2015,"lang":"en","type":"review","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":126,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Institute of General Medical Sciences; National Institutes of Health","keywords":"Medicine; Rituximab; Thrombotic thrombocytopenic purpura; Platelet; Abdominal pain; Gastroenterology; Internal medicine; Weakness; Physical examination; Surgery; Lymphoma","score_opus":0.024976207793002046,"score_gpt":0.28050289443472765,"score_spread":0.2555266866417256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020578800","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0046790177,0.99091876,3.5534003e-7,0.000005549062,0.00013459074,0.002495941,0.00018542519,0.000011368551,0.0015689777],"genre_scores_gemma":[0.069211766,0.92974037,0.000020531465,0.000005501106,0.000013311484,0.00041696543,0.00045697117,0.000038139242,0.000096421456],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997836,0.0006462414,0.00078996446,0.00027865902,0.0001470657,0.0003020547],"domain_scores_gemma":[0.99800456,0.000220301,0.0006931797,0.0009766567,0.00009379451,0.000011501364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049297395,0.00030380572,0.0013190215,0.00007833515,0.00008302065,0.000013393585,0.0012106306,0.00013076892,0.00008026257],"category_scores_gemma":[0.000012235982,0.00014329185,0.00021749618,0.00027741442,0.0002427902,0.00003757029,0.00028306164,0.00013209373,0.0000794525],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031810938,0.021568382,0.008883418,0.041207023,0.01976549,0.000028324232,0.0013118559,9.5233895e-7,0.000013628653,0.01421658,0.0024165628,0.8902697],"study_design_scores_gemma":[0.008039796,0.00047886334,0.0054071727,0.010151755,0.006495102,0.000016586346,0.0010919403,4.616492e-8,0.000024430658,0.00035422383,0.9675736,0.00036651752],"about_ca_topic_score_codex":0.000023104574,"about_ca_topic_score_gemma":0.000020568577,"teacher_disagreement_score":0.96515703,"about_ca_system_score_codex":0.000033764565,"about_ca_system_score_gemma":0.00011885624,"threshold_uncertainty_score":0.5843272},"labels":[],"label_agreement":null},{"id":"W2020744895","doi":"10.1182/blood-2011-04-351809","title":"The PI3K pathway drives the maturation of mast cells via microphthalmia transcription factor","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; BC Cancer Agency","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Microphthalmia-associated transcription factor; Cell biology; PI3K/AKT/mTOR pathway; Phosphoinositide 3-kinase; Biology; Transcription factor; Mast cell; Stem cell factor; Signal transduction; Haematopoiesis; Stem cell; Immunology; Gene; Genetics","score_opus":0.012802120193262498,"score_gpt":0.18015605806896856,"score_spread":0.16735393787570607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020744895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99198586,0.0024754002,0.00020041742,0.000081763195,0.00068018195,0.00022874793,0.00005456228,0.000021861919,0.004271182],"genre_scores_gemma":[0.99640286,0.00011549302,0.000059988957,0.00002120556,0.000025007397,0.000009082442,0.000020911097,0.000009039105,0.0033364366],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993887,0.00010224865,0.000200872,0.000121815516,0.000024059898,0.00016228801],"domain_scores_gemma":[0.99956226,0.00004440294,0.000109486326,0.0002335471,0.00004181804,0.000008492699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000871165,0.00010041535,0.000110352026,0.000020394087,0.0002173239,0.00000887644,0.00019368016,0.00010660179,0.0006715599],"category_scores_gemma":[0.0000041577932,0.000053501157,0.00007683584,0.00004689998,0.00020693213,0.00003612209,0.000018068728,0.0001353237,0.00013939611],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007020591,0.0001711015,0.00014321429,0.000011634834,0.00006686205,0.0000011341492,0.002009231,7.1630275e-8,0.99478054,0.00061908487,0.0001310039,0.0019958965],"study_design_scores_gemma":[0.00059732876,0.00014767778,0.011676943,0.0000074993322,0.00004563879,0.000027553495,0.00024954622,6.309346e-7,0.9641262,0.00010648851,0.022942424,0.00007204974],"about_ca_topic_score_codex":0.000080933016,"about_ca_topic_score_gemma":0.000049080834,"teacher_disagreement_score":0.030654341,"about_ca_system_score_codex":0.000003856745,"about_ca_system_score_gemma":0.000014931554,"threshold_uncertainty_score":0.735311},"labels":[],"label_agreement":null},{"id":"W2020789296","doi":"10.1182/blood-2014-05-577189","title":"Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity","year":2014,"lang":"en","type":"review","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":558,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Context (archaeology); Lymphoma; Medicine; Ibrutinib; Cancer research; Internal medicine; Biology; Leukemia; Chronic lymphocytic leukemia","score_opus":0.1056111912434274,"score_gpt":0.39516675257100214,"score_spread":0.28955556132757476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020789296","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.111018136,0.88763916,9.354917e-7,0.000033169334,0.00008816643,0.0008429079,0.00006055397,0.000012984669,0.0003039754],"genre_scores_gemma":[0.15111373,0.8481392,0.00014271411,0.0002994765,0.00010074618,0.00010765744,0.00006174094,0.000019711686,0.000015012437],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974511,0.00047621765,0.0012409118,0.00041816643,0.00015569375,0.0002578866],"domain_scores_gemma":[0.997907,0.00093228754,0.00046875016,0.0005692647,0.000025795536,0.00009694772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010032762,0.00033729227,0.0028109371,0.00008020472,0.000035147674,0.000014348923,0.0001803053,0.00037136578,0.0000049749597],"category_scores_gemma":[0.00020514536,0.00016403706,0.0007115356,0.000106694584,0.000110452296,0.000014101443,0.000113346476,0.0001508205,0.00002126224],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028654269,0.04205003,0.32611755,0.012210916,0.00070940296,0.00034779764,0.00009559177,6.1467422e-9,2.147293e-7,0.00020742977,0.00009607309,0.61813635],"study_design_scores_gemma":[0.07196796,0.0012643338,0.023159381,0.006363182,0.008479162,0.00042319624,0.000095105526,0.0000033600586,0.000020596242,0.000007079179,0.8877751,0.00044153898],"about_ca_topic_score_codex":0.00003287754,"about_ca_topic_score_gemma":0.000017704157,"teacher_disagreement_score":0.88767904,"about_ca_system_score_codex":0.000023020628,"about_ca_system_score_gemma":0.00010157874,"threshold_uncertainty_score":0.66892374},"labels":[],"label_agreement":null},{"id":"W2020823643","doi":"10.1182/blood-2003-07-2427","title":"Hypoxic gene activation by lipopolysaccharide in macrophages: implication of hypoxia-inducible factor 1α","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":453,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"McKnight Foundation","keywords":"Lipopolysaccharide; Hypoxia (environmental); Hypoxia-inducible factors; Immunology; Cell biology; Biology; Gene; Microbiology; Chemistry; Molecular biology; Cancer research; Genetics; Oxygen","score_opus":0.010370286469607573,"score_gpt":0.24040075623395377,"score_spread":0.23003046976434618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020823643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955911,0.0029177763,0.0005508524,0.000027681715,0.00020849785,0.00021574696,0.00005621271,0.000009548325,0.00042258046],"genre_scores_gemma":[0.99785745,0.0007802398,0.0005483647,0.000082193954,0.00024242963,0.000044079683,0.00008280123,0.000024250936,0.0003381668],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99899745,0.000052013416,0.0002597585,0.00034436502,0.00012110634,0.00022532564],"domain_scores_gemma":[0.9993413,0.0000099308045,0.00013508093,0.00038412877,0.000066559376,0.00006300573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011556652,0.00014354603,0.00017503282,0.000067838715,0.00003253967,0.000012341269,0.00013333363,0.00016332768,0.000031813084],"category_scores_gemma":[0.000119204014,0.00015050433,0.000070310394,0.00013374553,0.000032124786,0.000009217118,0.000027458967,0.00007549877,0.000005037145],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017227707,0.00025580954,0.00089134875,0.000013741092,0.000030472782,1.6473835e-7,0.000039981613,0.0000036388274,0.9962453,0.00007098524,0.0004542699,0.0019770637],"study_design_scores_gemma":[0.0012703313,0.00007796094,0.005204593,0.0000069665416,0.00002291354,0.000007348791,0.00003077849,0.0000011196632,0.97570944,0.00006966538,0.017447095,0.00015178703],"about_ca_topic_score_codex":0.00009555634,"about_ca_topic_score_gemma":0.00001587914,"teacher_disagreement_score":0.020535856,"about_ca_system_score_codex":0.000012258834,"about_ca_system_score_gemma":0.000097538636,"threshold_uncertainty_score":0.6137389},"labels":[],"label_agreement":null},{"id":"W2020840915","doi":"10.1182/blood-2006-01-028647","title":"NPM/ALK binds and phosphorylates the RNA/DNA-binding protein PSF in anaplastic large-cell lymphoma","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; School of Medicine, Stanford University; National IT Industry Promotion Agency","keywords":"Anaplastic lymphoma kinase; Molecular biology; Anaplastic large-cell lymphoma; Biology; Nucleophosmin; Fusion protein; Cancer research; Cell biology; Chemistry; Biochemistry; Lymphoma; Recombinant DNA; Medicine","score_opus":0.007402039493538433,"score_gpt":0.22751881432940524,"score_spread":0.2201167748358668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020840915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99225855,0.0018118711,0.000003691467,0.0003205218,0.0000624697,0.00064909144,0.000009776085,0.000041294337,0.00484275],"genre_scores_gemma":[0.9986472,0.00010825645,0.000202523,0.00013963945,0.00007692333,0.00007336477,0.00001351601,0.000025423687,0.00071312924],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998721,0.000024830688,0.0002706542,0.00029913126,0.00023000377,0.0004543551],"domain_scores_gemma":[0.9993232,0.0001728379,0.00007583728,0.0002551199,0.000027830421,0.000145204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037649774,0.00020091643,0.000261092,0.00012753742,0.00012282131,0.000036713693,0.000078400386,0.00010504771,0.000044920384],"category_scores_gemma":[0.00006529357,0.00012948016,0.00006472404,0.00028173174,0.000054200562,0.00005253998,0.00005898863,0.000078532306,0.000058694724],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005910593,0.01744781,0.8984746,0.0002623231,0.00040476056,0.0030645123,0.0018024127,6.4882227e-7,0.049687512,0.0012673121,0.00049883244,0.026498254],"study_design_scores_gemma":[0.036099363,0.00091401074,0.35631853,0.00035203045,0.0003567138,0.00019154225,0.0006356655,0.000034770215,0.60170335,0.00009451308,0.0030261765,0.000273294],"about_ca_topic_score_codex":0.00009196314,"about_ca_topic_score_gemma":0.00014557502,"teacher_disagreement_score":0.55201584,"about_ca_system_score_codex":0.00009329097,"about_ca_system_score_gemma":0.000076197626,"threshold_uncertainty_score":0.52800477},"labels":[],"label_agreement":null},{"id":"W2021130630","doi":"10.1182/blood-2012-06-436725","title":"Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; U.S. Public Health Service; National Institutes of Health","keywords":"Medicine; Internal medicine; Regimen; Transplantation; Oncology; Lymphoma; Progression-free survival; Diffuse large B-cell lymphoma; Rituximab; Overall survival","score_opus":0.02898630427423769,"score_gpt":0.28469700642362356,"score_spread":0.25571070214938585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021130630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99514997,0.0005019697,0.00051192427,0.00036921125,0.0002480569,0.0015556382,0.0005408357,0.00008537965,0.0010370025],"genre_scores_gemma":[0.99267864,0.00006264002,0.003509731,0.00063661963,0.00034638323,0.0006488784,0.0005390642,0.000040413954,0.0015376087],"study_design_codex":"nonrandomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988609,0.000015430156,0.00022376099,0.00025101923,0.00012843728,0.0005204788],"domain_scores_gemma":[0.999045,0.0002793412,0.00009691415,0.0002168025,0.00014056316,0.00022138315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013913764,0.0001995165,0.00037486537,0.00006223565,0.00017663624,0.000016147767,0.00004985278,0.00010465895,0.000038783353],"category_scores_gemma":[0.000088099114,0.00014600319,0.00017571369,0.00006986439,0.00003772705,0.000116944335,0.00001644091,0.000029672807,0.00002797422],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020795168,0.42126384,0.29265666,0.0036546206,0.010641113,0.0007098076,0.025280943,0.0000013300704,0.11558192,0.018116845,0.08275246,0.008545301],"study_design_scores_gemma":[0.24567533,0.002358472,0.0775826,0.00045737126,0.004353925,0.00042339647,0.00086284796,0.000063375526,0.64585775,0.00016265879,0.021656161,0.00054611353],"about_ca_topic_score_codex":0.000011701399,"about_ca_topic_score_gemma":0.000006277865,"teacher_disagreement_score":0.5302758,"about_ca_system_score_codex":0.00008385078,"about_ca_system_score_gemma":0.00009232168,"threshold_uncertainty_score":0.5953837},"labels":[],"label_agreement":null},{"id":"W2021200400","doi":"10.1182/blood-2002-02-0599","title":"Expression of a human β-globin transgene in erythroid cells derived from retrovirally transduced transplantable human fetal liver and cord blood cells","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute","funders":"National Heart, Lung, and Blood Institute","keywords":"Biology; Haematopoiesis; Stem cell; Molecular biology; Cord blood; Viral vector; Genetic enhancement; CD34; Transgene; Transplantation; Transduction (biophysics); Cell biology; Immunology; Gene; Genetics; Medicine; Recombinant DNA","score_opus":0.018529075270389626,"score_gpt":0.2480658505446592,"score_spread":0.22953677527426958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021200400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959354,0.0031017102,0.000042091702,0.000014630263,0.000026453607,0.00039581026,0.00022667646,0.000015639785,0.00024162262],"genre_scores_gemma":[0.9975096,0.0016252109,0.00034758454,0.00004422021,0.00008229204,0.000024939549,0.00013870354,0.000049785423,0.00017768766],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981437,0.00019315977,0.00040217268,0.0005862788,0.00025251202,0.0004222143],"domain_scores_gemma":[0.99929166,0.000017128095,0.0000842018,0.00043109947,0.00004118426,0.00013472266],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016350474,0.0002768867,0.00036018365,0.000098035605,0.00010691863,0.000023297409,0.0003095925,0.0002661635,0.0003119557],"category_scores_gemma":[0.0000026410278,0.00028464224,0.00013114518,0.000120049546,0.00015690873,0.000010796281,0.000033930926,0.00020201475,0.0000050884473],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067117123,0.0011144687,0.00067278836,0.0000725945,0.000097785734,0.000049186034,0.000530719,0.000008034134,0.9964188,8.8000706e-7,0.000037174894,0.00032640694],"study_design_scores_gemma":[0.0074702795,0.0043292814,0.000977669,0.000070462636,0.00010853299,0.000007919013,0.000046210927,0.00001326964,0.9866102,0.000019052124,0.000041801155,0.00030533393],"about_ca_topic_score_codex":0.00022750598,"about_ca_topic_score_gemma":0.000984718,"teacher_disagreement_score":0.009808603,"about_ca_system_score_codex":0.000006893654,"about_ca_system_score_gemma":0.000026428279,"threshold_uncertainty_score":0.9999606},"labels":[],"label_agreement":null},{"id":"W2021225618","doi":"10.1182/blood-2004-06-2468","title":"CpG stimulation of precursor B-lineage acute lymphoblastic leukemia induces a distinct change in costimulatory molecule expression and shifts allogeneic T cells toward a Th1 response","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"CD80; CD40; CD86; Biology; CpG site; Immune system; TLR9; CpG Oligodeoxynucleotide; Cytokine; T cell; Stimulation; Priming (agriculture); Immunology; Cancer research; Cell biology; Cytotoxic T cell; Molecular biology; Gene expression; Endocrinology; In vitro; DNA methylation; Biochemistry","score_opus":0.017527797106154798,"score_gpt":0.25269466425541454,"score_spread":0.23516686714925975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021225618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974481,0.0014322359,0.00012992785,0.000043338223,0.00043519473,0.00035839638,0.000016258675,0.000041563024,0.00009499108],"genre_scores_gemma":[0.99902254,0.00007100063,0.00009106846,0.00010475612,0.000039780283,0.000065042565,0.00006573666,0.000018704699,0.00052139064],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99877536,0.00030213254,0.00036330672,0.0002880252,0.00004737637,0.00022378538],"domain_scores_gemma":[0.99936354,0.0001898691,0.00018235133,0.00018926253,0.0000499319,0.00002503233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023686483,0.00018252507,0.0002518258,0.00020617059,0.00006530333,0.000011086706,0.00009969394,0.00025203338,0.0002776291],"category_scores_gemma":[0.0000962543,0.00016738224,0.000058025784,0.00011743098,0.000079213445,0.00019948266,0.00007504461,0.00020891233,0.000081158265],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023643177,0.0003368212,0.001121563,0.000021945467,0.00007613765,0.0000050590866,0.0012494312,0.000083581974,0.9937248,0.0000048709244,0.0001543414,0.00085711293],"study_design_scores_gemma":[0.0046200776,0.0004170368,0.066569135,0.00013123073,0.00010883504,0.000022369457,0.00006200048,0.00030582893,0.9265816,0.000003015242,0.0010087636,0.00017008728],"about_ca_topic_score_codex":0.00006812107,"about_ca_topic_score_gemma":0.000015400436,"teacher_disagreement_score":0.0671432,"about_ca_system_score_codex":0.00008141548,"about_ca_system_score_gemma":0.000068743015,"threshold_uncertainty_score":0.682565},"labels":[],"label_agreement":null},{"id":"W2021312489","doi":"10.1182/blood-2013-10-534297","title":"The addition of sirolimus to tacrolimus/methotrexate GVHD prophylaxis in children with ALL: a phase 3 Children’s Oncology Group/Pediatric Blood and Marrow Transplant Consortium trial","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":127,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Children's Hospital; CancerCare Manitoba","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Tacrolimus; Sirolimus; Methotrexate; Medicine; Bone marrow transplant; Internal medicine; Bone marrow; Transplantation; Bone marrow transplantation","score_opus":0.009405294755878214,"score_gpt":0.27286768090302915,"score_spread":0.26346238614715095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021312489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99579036,0.00023349549,0.00015741929,0.00035534546,0.00005874605,0.0029080473,0.00019868143,0.000046924553,0.00025100168],"genre_scores_gemma":[0.9975059,0.00029610805,0.0009378572,0.00021491329,0.00051101437,0.00031834387,0.00013324898,0.000052367064,0.000030222904],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9971752,0.00043688723,0.00061314105,0.00055650884,0.00057686295,0.00064136623],"domain_scores_gemma":[0.9981416,0.00071698776,0.00021741448,0.00046963207,0.00010329282,0.00035105957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009851019,0.0003000207,0.00065722724,0.00033342637,0.00010366265,0.000027291566,0.00024260554,0.00023778154,0.00004505163],"category_scores_gemma":[0.00039893808,0.00019380524,0.00008862129,0.0005014558,0.0002554222,0.00006588457,0.000068016954,0.00045767974,0.00000952456],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22199488,0.028581409,0.62765026,0.0006174463,0.0042871335,0.0008032249,0.0035353827,0.00003432484,0.033403717,0.00043063564,0.0009518886,0.07770973],"study_design_scores_gemma":[0.5372353,0.04961999,0.39905363,0.000088909226,0.0027641875,0.0025042736,0.000049555718,0.000112120644,0.0076268334,0.000072479306,0.00035996592,0.00051270676],"about_ca_topic_score_codex":0.00024066093,"about_ca_topic_score_gemma":0.00011788336,"teacher_disagreement_score":0.31524047,"about_ca_system_score_codex":0.00009324685,"about_ca_system_score_gemma":0.00043612285,"threshold_uncertainty_score":0.79031485},"labels":[],"label_agreement":null},{"id":"W2021327465","doi":"10.1182/blood-2014-10-602714","title":"Genetic inactivation of TRAF3 in canine and human B-cell lymphoma","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"NF-κB Signaling Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; Simon Fraser University","funders":"Canadian Institutes of Health Research","keywords":"Lymphoma; Biology; Genetics; Cancer research; Immunology","score_opus":0.005022880885895907,"score_gpt":0.1992646998601143,"score_spread":0.19424181897421838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021327465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987286,0.00016972741,0.00014414433,0.0000073214,0.000012891457,0.00005710098,0.0000027060773,0.0000035100477,0.0008740147],"genre_scores_gemma":[0.99934286,0.000009189904,0.0004650239,0.00003055694,0.000058145997,0.000004999503,0.0000148453155,0.000010037017,0.000064366126],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995765,0.000029914798,0.00011709028,0.00014333351,0.000046763063,0.00008636327],"domain_scores_gemma":[0.999766,0.000005388936,0.000049063437,0.00013563571,0.000019761548,0.0000241653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007655004,0.00006200776,0.00007857125,0.000030564715,0.00001507047,0.0000036599517,0.000054567518,0.000065949345,0.0000027502745],"category_scores_gemma":[0.000019505886,0.000064609354,0.000015815118,0.00003770905,0.000027067372,9.2906635e-7,0.000025922369,0.000018634559,6.208363e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000572042,0.0002035075,0.01691415,0.000020513531,0.0000055504815,7.44596e-7,0.00003741336,0.000011579686,0.98216295,0.00004642175,0.000015646887,0.00057581585],"study_design_scores_gemma":[0.0019564687,0.00025522392,0.06322328,0.000009018622,0.000011083695,0.000005032084,0.000009906395,0.0000165383,0.93406564,0.00007366688,0.00030291168,0.00007120764],"about_ca_topic_score_codex":0.00013039706,"about_ca_topic_score_gemma":0.00010142247,"teacher_disagreement_score":0.048097275,"about_ca_system_score_codex":0.0000031583268,"about_ca_system_score_gemma":0.000017338192,"threshold_uncertainty_score":0.2634693},"labels":[],"label_agreement":null},{"id":"W2021663709","doi":"10.1182/blood-2012-03-362608","title":"Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel","year":2012,"lang":"en","type":"review","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":575,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Children's Hospital of Eastern Ontario","funders":"University of Calgary","keywords":"Medicine; Childhood leukemia; Myeloid leukemia; Pediatrics; Disease; Intensive care medicine; Malignancy; Leukemia; Internal medicine; Lymphoblastic Leukemia","score_opus":0.05332780296015282,"score_gpt":0.3576143848579419,"score_spread":0.30428658189778907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021663709","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020792572,0.9766136,0.0000049805935,0.00017400498,0.00009710507,0.0014825717,0.00063048344,0.000026049882,0.00017865728],"genre_scores_gemma":[0.0011782569,0.9938265,0.0019198367,0.00008904361,0.00027090972,0.00034855556,0.002238464,0.00005597669,0.00007241885],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998242,0.00012439821,0.000555965,0.000493442,0.00030006346,0.00028410254],"domain_scores_gemma":[0.9990263,0.000064297245,0.00019786818,0.00045038134,0.00004487212,0.0002162874],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022596348,0.00031491066,0.0009514756,0.00036023342,0.000033837263,0.000029607432,0.00028578888,0.0002403485,0.00012998232],"category_scores_gemma":[0.000016031458,0.0002702104,0.00010723318,0.00019770983,0.000086472595,0.0001954334,0.0004014855,0.00044693347,0.000012687359],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019687195,0.0005201991,0.030467851,0.0020916264,0.002239846,0.000036220612,0.00014119531,9.906162e-9,0.0000018638906,0.000024313036,0.00032338002,0.9641338],"study_design_scores_gemma":[0.010415243,0.00021971781,0.30159596,0.05317768,0.010399088,0.00044308786,0.00013940521,0.000009893609,0.000039874325,0.000022959617,0.6227169,0.00082021044],"about_ca_topic_score_codex":0.00047110475,"about_ca_topic_score_gemma":0.000013870875,"teacher_disagreement_score":0.9633136,"about_ca_system_score_codex":0.00038549895,"about_ca_system_score_gemma":0.00015378873,"threshold_uncertainty_score":0.999975},"labels":[],"label_agreement":null},{"id":"W2021773905","doi":"10.1182/blood-2009-01-200048","title":"The transcriptional program controlled by the stem cell leukemia gene Scl/Tal1 during early embryonic hematopoietic development","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Genomics and Chromatin Dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"BC Cancer Agency; Cancer Research UK","keywords":"Biology; Stem cell; Hematopoietic stem cell; Chromatin immunoprecipitation; Transgene; Embryonic stem cell; Haematopoiesis; Cell biology; Progenitor cell; Chromatin; Computational biology; Genetics; Gene; Gene expression; Promoter","score_opus":0.003612695026348256,"score_gpt":0.18480556663002146,"score_spread":0.1811928716036732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021773905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947618,0.0038451855,0.0000763178,0.00015218616,0.00005674467,0.00054950005,0.000010291432,0.000020382,0.0005275892],"genre_scores_gemma":[0.9959913,0.00017553549,0.0004995799,0.00008624081,0.00007248981,0.00011457313,0.000046981848,0.000018260132,0.002995064],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989721,0.00004246556,0.00026084253,0.00024498923,0.0001632748,0.00031629938],"domain_scores_gemma":[0.99948424,0.0000107449005,0.00009564081,0.00030135133,0.00004584157,0.00006216846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017407033,0.00017463793,0.00014593308,0.000010291234,0.00039242153,0.000102679456,0.00032602917,0.00010050702,0.0000040817813],"category_scores_gemma":[0.000003243945,0.00010947821,0.00012538373,0.000047024972,0.00005275235,0.0000020476218,0.000036701374,0.00010545677,0.000012803808],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008650967,0.0002584513,0.00015711384,0.000013194451,0.00011692184,0.0000026011448,0.00015607613,0.00003512097,0.99718606,0.000059748578,0.000106320775,0.0018218758],"study_design_scores_gemma":[0.014047456,0.0005617584,0.019230712,0.000022655278,0.00017120267,0.00012612529,0.0003392319,0.0002634276,0.95138955,0.00011250722,0.013144672,0.00059070997],"about_ca_topic_score_codex":0.0000019528559,"about_ca_topic_score_gemma":0.000009350185,"teacher_disagreement_score":0.045796525,"about_ca_system_score_codex":0.000027813403,"about_ca_system_score_gemma":0.00015958522,"threshold_uncertainty_score":0.4464392},"labels":[],"label_agreement":null},{"id":"W2021864751","doi":"10.1182/blood-2013-01-479865","title":"Analysis of FOXO1 mutations in diffuse large B-cell lymphoma","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":157,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; BC Cancer Agency; Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"FOXO1; Diffuse large B-cell lymphoma; Cancer research; Mutation; Lymphoma; Biology; Genetics; Oncology; Medicine; Internal medicine; Gene; Transcription factor","score_opus":0.008405575303897819,"score_gpt":0.2402173492603096,"score_spread":0.23181177395641178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021864751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953932,0.00033574336,0.0000059478925,0.00016001725,0.000013202224,0.00022097449,0.000024056082,0.000015130941,0.0038317142],"genre_scores_gemma":[0.99912006,0.000048386326,0.00025819393,0.00011769541,0.00001157782,0.000096925294,0.000078752004,0.000007190307,0.00026120283],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993712,0.000016417434,0.00020351866,0.00013772033,0.00012437432,0.00014681178],"domain_scores_gemma":[0.9995371,0.00006315229,0.000054379103,0.00022595323,0.00004862491,0.0000707663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000037930884,0.000077940815,0.00027631986,0.00026618488,0.000017480308,0.000007283037,0.000036656733,0.00004129444,0.00022184379],"category_scores_gemma":[0.000022543221,0.000060995055,0.00014257229,0.0005542741,0.000015701778,0.00003840774,0.000017376118,0.000015394133,0.00008068172],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000054118573,0.043434482,0.9530577,0.000020488029,0.00081767654,0.000045685956,0.0003627692,0.0000019406825,0.0006890138,0.00014550715,0.00011467745,0.0013046305],"study_design_scores_gemma":[0.027596088,0.00010197429,0.9594738,0.000016786913,0.002889102,0.000003273175,0.00014194266,0.00033098547,0.009210991,0.000029162693,0.00014940595,0.000056478155],"about_ca_topic_score_codex":0.00066495733,"about_ca_topic_score_gemma":0.00016134833,"teacher_disagreement_score":0.04333251,"about_ca_system_score_codex":0.000032925946,"about_ca_system_score_gemma":0.000041731793,"threshold_uncertainty_score":0.24873061},"labels":[],"label_agreement":null},{"id":"W2021985005","doi":"10.1182/blood-2007-05-088286","title":"Perforin-dependent apoptosis functionally compensates Fas deficiency in activation-induced cell death of human T lymphocytes","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"Ligue Contre le Cancer; Sixth Framework Programme; Institut National de la Santé et de la Recherche Médicale; Agence Nationale de la Recherche","keywords":"Cytotoxic T cell; Perforin; Fas receptor; Granzyme; Biology; Apoptosis; Programmed cell death; Immunology; Fas ligand; T cell; T-cell receptor; Peripheral tolerance; Antigen; Cell biology; Molecular biology; Immune system; CD8; In vitro; Biochemistry","score_opus":0.013706248597448473,"score_gpt":0.2383174784024941,"score_spread":0.2246112298050456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021985005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955907,0.00011611586,0.0007595456,0.0000062521426,0.00006798943,0.00013348063,0.0000025227646,0.0000070656024,0.0033163321],"genre_scores_gemma":[0.9990287,0.000025538027,0.00046995856,0.00001932962,0.000080728794,0.000005726,0.000080108344,0.000012706986,0.00027724396],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99919105,0.000016576583,0.00023808205,0.00022685007,0.00015554012,0.00017192247],"domain_scores_gemma":[0.9996053,0.00001331017,0.000099247,0.00016962358,0.00007511182,0.000037414087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021511504,0.00010834417,0.00010748307,0.00008241639,0.00006965984,0.000008406047,0.00009189276,0.0001245753,0.000025781042],"category_scores_gemma":[0.000010996163,0.00010317366,0.00005698516,0.000077543715,0.000014841168,0.0000042124957,0.000043878375,0.00004442562,0.0000026304365],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026138849,0.00038023462,0.019536495,0.000018963672,0.000011023198,5.5633774e-7,0.000041064653,0.000069383415,0.978916,0.00058944547,0.0000025201666,0.00040816798],"study_design_scores_gemma":[0.0011954092,0.00026692374,0.06423275,0.000010758526,0.000017777835,0.0000029192677,0.00011038745,0.000015177449,0.9338677,0.00012505676,0.000042074193,0.00011306409],"about_ca_topic_score_codex":0.0000836152,"about_ca_topic_score_gemma":0.00005162175,"teacher_disagreement_score":0.045048308,"about_ca_system_score_codex":0.000019092999,"about_ca_system_score_gemma":0.00004769124,"threshold_uncertainty_score":0.42073},"labels":[],"label_agreement":null},{"id":"W2022013393","doi":"10.1182/blood-2008-01-129783","title":"Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":192,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Gundersen Medical Foundation; University of Nebraska Medical Center; Centre International de Recherche sur le Cancer; World Health Organization; National Cancer Institute; U.S. Department of Health and Human Services","keywords":"Diffuse large B-cell lymphoma; Missense mutation; International Prognostic Index; Mutation; Cancer research; Lymphoma; Germinal center; Biology; Gene mutation; Gene; Internal medicine; Oncology; Medicine; B cell; Genetics; Antibody","score_opus":0.04009594736173656,"score_gpt":0.34755304597596004,"score_spread":0.3074570986142235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022013393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980292,0.00011260454,0.0000013278378,0.00007056738,0.0001738881,0.0009020053,0.00029139032,0.00003005879,0.00038900075],"genre_scores_gemma":[0.9984812,0.00005310124,0.00084744097,0.000054492593,0.000121584526,0.00011953278,0.00021534206,0.000014872534,0.000092436785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984755,0.000113760114,0.000629637,0.00029322164,0.0003221677,0.00016574343],"domain_scores_gemma":[0.999164,0.000110298795,0.0001623711,0.0002636142,0.00018290215,0.000116839605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001462092,0.00014699901,0.00039351374,0.00011719928,0.000059329395,0.00000852598,0.00010931641,0.00006971171,0.00003586607],"category_scores_gemma":[0.0001234405,0.000112731,0.0000842362,0.00020329538,0.00007717944,0.00011964296,0.000049213486,0.00005736452,0.000008707823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012238492,0.07186805,0.9253802,0.000009092743,0.00022814597,0.00046404233,0.0016111702,0.0000015640326,0.00006921752,0.00004063036,0.000021698897,0.00018382762],"study_design_scores_gemma":[0.07964521,0.0014019103,0.915136,0.000013024819,0.00023669204,0.000051298866,0.0009279869,0.00011021314,0.0023557602,0.000008552775,0.000027799686,0.000085583655],"about_ca_topic_score_codex":0.00008037814,"about_ca_topic_score_gemma":0.000081328544,"teacher_disagreement_score":0.07952282,"about_ca_system_score_codex":0.000065523636,"about_ca_system_score_gemma":0.00022755994,"threshold_uncertainty_score":0.45970368},"labels":[],"label_agreement":null},{"id":"W2022027523","doi":"10.1182/blood-2014-07-590844","title":"Plasma exchange to remove HIT antibodies: dissociation between enzyme-immunoassay and platelet activation test reactivities","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Pfizer Canada; LEO Pharma; McMaster University; CSL Behring; Heart and Stroke Foundation of Canada; American Society of Hematology","keywords":"Immunoassay; Antibody; Chemistry; Platelet; Enzyme; Immunology; Molecular biology; Medicine; Biochemistry; Biology","score_opus":0.022222193854959608,"score_gpt":0.2672718379207363,"score_spread":0.24504964406577667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022027523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904624,0.000021548445,0.00008901421,0.0015338665,0.00007566467,0.00043608504,0.000030822623,0.000116363626,0.0072341943],"genre_scores_gemma":[0.9980477,0.000048324702,0.00047997426,0.0002250923,0.00045067017,0.000027514845,0.00010369057,0.000039674356,0.0005773703],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99873894,0.000069074566,0.00026662086,0.0003468718,0.0002583608,0.00032009903],"domain_scores_gemma":[0.9987466,0.0005702699,0.00013450006,0.00029771714,0.00008070769,0.00017025319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003543299,0.00021397909,0.0005069945,0.00015511284,0.00020572833,0.00007579635,0.00007730467,0.0001905299,0.000037941838],"category_scores_gemma":[0.00084049697,0.00020202526,0.00005550304,0.00019975394,0.000050792114,0.00023773001,0.00007972936,0.00020918375,0.00006299722],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006525577,0.0006797515,0.3914431,0.00024703442,0.0004619601,0.000008548474,0.0053044227,3.659539e-7,0.5675398,0.00035079187,0.0007143228,0.033184614],"study_design_scores_gemma":[0.002401409,0.00050222315,0.6315063,0.00020033265,0.00022191709,0.000015028737,0.0002650676,0.000017928369,0.35738054,0.00013340946,0.007136059,0.00021973881],"about_ca_topic_score_codex":0.00026181072,"about_ca_topic_score_gemma":0.000047809783,"teacher_disagreement_score":0.24006322,"about_ca_system_score_codex":0.00008099914,"about_ca_system_score_gemma":0.00004820434,"threshold_uncertainty_score":0.82383513},"labels":[],"label_agreement":null},{"id":"W2022098505","doi":"10.1182/blood-2012-08-447359","title":"Overexpression of uridine diphospho glucuronosyltransferase 2B17 in high-risk chronic lymphocytic leukemia","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"Ministerio de Economía y Competitividad; Canadian Institutes of Health Research; European Hematology Association","keywords":"Uridine; Chronic lymphocytic leukemia; Leukemia; Glucuronosyltransferase; Cancer research; Medicine; Chemistry; Internal medicine; Biochemistry; RNA; Gene; Enzyme","score_opus":0.01021234217395131,"score_gpt":0.2600313849349879,"score_spread":0.24981904276103659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022098505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915422,0.0064616497,0.000042506912,0.000025839963,0.00016001717,0.0007024569,0.000039548322,0.00008009308,0.00094564195],"genre_scores_gemma":[0.9973259,0.0012791033,0.00036671493,0.000046283563,0.00047375317,0.00006474674,0.000050931114,0.000073691255,0.00031889207],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970067,0.00013460858,0.00065673725,0.00042781595,0.00076219277,0.001011944],"domain_scores_gemma":[0.9981193,0.0003047855,0.00014507676,0.0008896461,0.00008667682,0.00045450998],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006023519,0.0003248155,0.000708845,0.0002657188,0.000061446735,0.000012046488,0.00026627188,0.00026303183,0.00048397895],"category_scores_gemma":[0.00035448626,0.00027788724,0.00017902847,0.0005453962,0.00018387598,0.00023539885,0.00014262491,0.00043240463,0.00014871357],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0048282114,0.006210087,0.253256,0.0054983725,0.001183779,0.00080850814,0.003469812,0.0018885207,0.70337355,0.0018331938,0.0022914913,0.015358488],"study_design_scores_gemma":[0.12311627,0.0008359305,0.049627,0.0013680196,0.00045503603,0.00037184724,0.00007184748,0.0037838256,0.81878954,0.00009044569,0.0010598494,0.00043038712],"about_ca_topic_score_codex":0.0074806875,"about_ca_topic_score_gemma":0.0000759075,"teacher_disagreement_score":0.20362899,"about_ca_system_score_codex":0.035087503,"about_ca_system_score_gemma":0.016152088,"threshold_uncertainty_score":0.99996734},"labels":[],"label_agreement":null},{"id":"W2022460659","doi":"10.1182/blood-2007-05-088468","title":"Extracellular calcium sensing promotes human B-cell activation and function","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Calcium signaling and nucleotide metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Cell biology; Biology; Extracellular; Signal transduction; Calcium-sensing receptor; Protein kinase B; Calcium; Chemistry; Calcium metabolism","score_opus":0.01285395155684846,"score_gpt":0.24002568285273201,"score_spread":0.22717173129588356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022460659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97926533,0.0012366222,0.018714767,0.000020410558,0.00007202489,0.000089925605,0.0000011505919,0.000021204367,0.00057856005],"genre_scores_gemma":[0.99805,0.000008796713,0.000789884,0.00004183506,0.00041562194,7.19409e-7,0.000043855922,0.000018386067,0.00063091004],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993725,0.000023402712,0.00013151013,0.0002267273,0.00007976641,0.00016611493],"domain_scores_gemma":[0.99969006,0.000008276395,0.000054857337,0.00014465874,0.000044034394,0.000058131685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028683795,0.0000986135,0.00007803761,0.00003903332,0.00011444242,0.00002333695,0.00003172667,0.0001098653,0.000005655154],"category_scores_gemma":[0.000023506043,0.00009932112,0.000037863425,0.00005003163,0.00003312266,0.0000033319175,0.000029560708,0.000071304334,0.000002993483],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023830475,0.00009662241,0.0007800678,0.00001286284,0.000016511149,0.0000025626146,0.000029745508,0.000001239525,0.9968109,0.000059092923,0.000048742,0.0021178052],"study_design_scores_gemma":[0.00084294745,0.00013430738,0.0050179097,0.000007810185,0.0000528238,0.000014327493,0.00003857466,0.000011152644,0.9877958,0.00007837011,0.005880036,0.00012589728],"about_ca_topic_score_codex":0.000024484767,"about_ca_topic_score_gemma":0.0000064623323,"teacher_disagreement_score":0.018784657,"about_ca_system_score_codex":0.000002515855,"about_ca_system_score_gemma":0.0000097641305,"threshold_uncertainty_score":0.40501976},"labels":[],"label_agreement":null},{"id":"W2022483351","doi":"10.1182/blood-2013-02-484451","title":"EBV DNA: a Hodgkin lymphoma biomarker?","year":2013,"lang":"en","type":"letter","venue":"Blood","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Lymphoma; Biomarker; Medicine; Hodgkin lymphoma; DNA; Immunology; Virology; Cancer research; Biology; Genetics","score_opus":0.014800445721147906,"score_gpt":0.23995488405248075,"score_spread":0.22515443833133283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022483351","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06994056,0.0063307746,0.00000952347,0.83118343,0.0011725153,0.0013028621,0.00015563857,0.0004471127,0.089457564],"genre_scores_gemma":[0.013878919,0.0005007774,0.00017823275,0.9499783,0.0037907732,0.00022245827,0.0009376511,0.00020230177,0.030310616],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99794716,0.000058652477,0.0003368187,0.000520978,0.0005032642,0.000633135],"domain_scores_gemma":[0.99892914,0.00004749968,0.00021527453,0.0005816821,0.00010336098,0.00012303983],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00008983096,0.00041682937,0.0006822572,0.00019959908,0.00007537052,0.000056774265,0.00020202257,0.00126721,0.0010064221],"category_scores_gemma":[0.000073228504,0.00035985955,0.00035943164,0.00024164107,0.00008404722,0.00005290404,0.00005866599,0.0005746203,0.00081703893],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022271706,0.00023259207,0.00073615764,0.00020661177,0.00067090394,0.00077980943,0.000045981742,1.5433994e-8,0.00027156578,0.0000034959344,0.9903275,0.006703122],"study_design_scores_gemma":[0.009646921,0.00025538818,0.0023362394,0.000263259,0.0011492082,0.00015198452,0.0000372611,0.0000052040145,0.0002334803,0.00015690384,0.98531365,0.00045050398],"about_ca_topic_score_codex":0.00047385602,"about_ca_topic_score_gemma":0.000011775012,"teacher_disagreement_score":0.11879482,"about_ca_system_score_codex":0.000139275,"about_ca_system_score_gemma":0.0003430877,"threshold_uncertainty_score":0.99996096},"labels":[],"label_agreement":null},{"id":"W2022741783","doi":"10.1182/blood-2002-10-3196","title":"IVIG induces dose-dependent amelioration of ITP in rodent models","year":2003,"lang":"en","type":"letter","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Immune thrombocytopenia; Monoclonal antibody; Medicine; Immunology; Antibody; Romiplostim; Rodent model; Immune system; Platelet; Pharmacology; Internal medicine; Thrombopoietin; Biology; Haematopoiesis","score_opus":0.028476207948036007,"score_gpt":0.2592776507299259,"score_spread":0.2308014427818899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022741783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95323294,0.0016874851,0.000016712462,0.03773137,0.00017906741,0.0007482994,0.000050875176,0.000029287761,0.0063239476],"genre_scores_gemma":[0.91437584,0.0006335031,0.00030988944,0.081625946,0.0003271879,0.00009748759,0.00064594194,0.000078139026,0.0019060522],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998549,0.00005054699,0.0003791879,0.00033315388,0.00043504656,0.00025305222],"domain_scores_gemma":[0.9993799,0.00002294895,0.00018220262,0.00031814733,0.000058302965,0.00003850425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000081949285,0.0002483848,0.00060843176,0.00025990835,0.000017250415,0.000012564145,0.000083398765,0.0005349184,0.000054862965],"category_scores_gemma":[0.000015143853,0.00021248145,0.00010634621,0.0001526799,0.00002443701,0.00007414384,0.000020943786,0.00061059196,0.000030172961],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005532316,0.027145982,0.02520542,0.004277173,0.0061753327,0.07000518,0.003398621,0.0006427657,0.013420788,0.00022401565,0.83274347,0.016208006],"study_design_scores_gemma":[0.29401365,0.013201303,0.036093116,0.013684,0.025801547,0.006943505,0.0019836319,0.0011141945,0.27434066,0.046235356,0.27609533,0.010493707],"about_ca_topic_score_codex":0.00033733586,"about_ca_topic_score_gemma":0.000077175944,"teacher_disagreement_score":0.55664814,"about_ca_system_score_codex":0.000050537703,"about_ca_system_score_gemma":0.00012679996,"threshold_uncertainty_score":0.8664742},"labels":[],"label_agreement":null},{"id":"W2023158584","doi":"10.1182/blood-2014-03-563056","title":"Evolving use of new oral anticoagulants for treatment of venous thromboembolism","year":2014,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Venous thromboembolism; Medicine; Apixaban; Intensive care medicine; Rivaroxaban; Venous thrombosis; Warfarin; Thrombosis; Surgery; Internal medicine; Atrial fibrillation","score_opus":0.14198497763949786,"score_gpt":0.3752387169619204,"score_spread":0.23325373932242255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023158584","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014692292,0.9944214,0.000112117625,0.000016813554,0.0002893549,0.003275158,0.00013079135,0.00004007465,0.0002450671],"genre_scores_gemma":[0.0005506465,0.9944078,0.0037082976,0.00002859059,0.00040100154,0.00013333706,0.00022131135,0.000107736,0.00044129667],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99783856,0.00006175934,0.000977027,0.00044208363,0.00028836023,0.00039221218],"domain_scores_gemma":[0.9979152,0.00024899372,0.00074095395,0.0007893151,0.00012932181,0.00017621618],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014563544,0.00049116596,0.007129683,0.0002685614,0.000041387422,0.000019903826,0.00016693854,0.00027114086,0.000069421105],"category_scores_gemma":[0.00012474172,0.00036323987,0.0010917564,0.00018226821,0.000058587382,0.000051891377,0.00006081205,0.000060662805,0.00001923726],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015224959,0.01010507,0.00008215151,0.048615634,0.0058026942,0.000024502217,0.00027418713,9.93448e-7,0.000012568874,0.00047966986,0.0056100753,0.92897725],"study_design_scores_gemma":[0.0030020205,0.0027006771,0.0006871121,0.0152378315,0.035160754,0.000037681897,0.000010230041,0.000005783278,0.00013103879,0.0000452298,0.9426716,0.0003100293],"about_ca_topic_score_codex":0.0004981589,"about_ca_topic_score_gemma":0.00002068699,"teacher_disagreement_score":0.93706155,"about_ca_system_score_codex":0.000068758556,"about_ca_system_score_gemma":0.00040546776,"threshold_uncertainty_score":0.999882},"labels":[],"label_agreement":null},{"id":"W2023293152","doi":"10.1182/blood-2004-02-0437","title":"Lymphocyte microvilli are dynamic, actin-dependent structures that do not require Wiskott-Aldrich syndrome protein (WASp) for their morphology","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":170,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"National Center for Research Resources","keywords":"Wiskott–Aldrich syndrome protein; Cell biology; Actin; Biology; Lymphocyte; Cytoskeleton; Motility; Wiskott–Aldrich syndrome; Actin cytoskeleton; Immunology; Cell; Biochemistry; Gene","score_opus":0.023759639552938035,"score_gpt":0.28339379192163894,"score_spread":0.2596341523687009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023293152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99267215,0.0014671879,0.0005070296,0.0019568447,0.00014631911,0.0026807738,0.00015951508,0.00014511043,0.00026508846],"genre_scores_gemma":[0.9928883,0.00015918408,0.003628189,0.0004329329,0.00010149129,0.00031323882,0.00009261338,0.0001295333,0.0022545736],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971117,0.00009365388,0.00040966016,0.0008592329,0.000651324,0.0008744715],"domain_scores_gemma":[0.99816114,0.000107953114,0.00023032016,0.00095527066,0.00020647759,0.0003388581],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002949298,0.0004278076,0.0006723041,0.0002917957,0.00020135817,0.00007047292,0.00045006943,0.00036848843,0.00027157326],"category_scores_gemma":[0.00022330564,0.00034115335,0.0002729591,0.0002477593,0.00019263143,0.00011799633,0.00025251228,0.00043242532,0.00010660658],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075310626,0.0007099676,0.000718934,0.0004840652,0.00029873027,0.0020695233,0.00020464524,0.000023473409,0.9913139,0.00017630961,0.0000751898,0.0031722083],"study_design_scores_gemma":[0.015843043,0.0011940263,0.010718797,0.00026501663,0.00018300004,0.0055752853,0.0005532257,0.00002059297,0.9617796,0.0013622474,0.0020437255,0.00046142732],"about_ca_topic_score_codex":0.00010342598,"about_ca_topic_score_gemma":0.000058173042,"teacher_disagreement_score":0.029534234,"about_ca_system_score_codex":0.0004018388,"about_ca_system_score_gemma":0.00045088993,"threshold_uncertainty_score":0.99990404},"labels":[],"label_agreement":null},{"id":"W2023423074","doi":"10.1182/blood-2008-07-167734","title":"TAFI: structured for self-destruction","year":2008,"lang":"en","type":"letter","venue":"Blood","topic":"Hemoglobin structure and function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Regulator; Instability; Physics; Chemistry; Biochemistry; Mechanics","score_opus":0.006963247555293962,"score_gpt":0.20867557641827744,"score_spread":0.2017123288629835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023423074","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.634475,0.010594118,0.033595923,0.25206563,0.03341145,0.012078164,0.0047496003,0.0017249623,0.017305154],"genre_scores_gemma":[0.03802762,0.0016638733,0.05025232,0.72208565,0.13728957,0.0006769468,0.03598056,0.0007062779,0.013317204],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99864554,0.00003608862,0.00023318482,0.00057366956,0.00016623798,0.00034529957],"domain_scores_gemma":[0.9991891,0.00001048033,0.00015253822,0.0004808704,0.00012189952,0.000045105724],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00003852873,0.00032682874,0.00025069749,0.000060233808,0.00013287131,0.000025900437,0.0001928166,0.0014719212,0.000020292731],"category_scores_gemma":[0.000035373952,0.00031257592,0.00023739619,0.00006146003,0.000044230834,0.0000026394096,0.000042447544,0.00041106835,0.000008055605],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002571798,0.000022018081,0.00010711575,0.00009787995,0.00027178728,0.000020852694,0.00001596785,0.0000015813802,0.04087749,0.00000492587,0.95803005,0.00052462367],"study_design_scores_gemma":[0.0010825107,0.0002591561,0.00012727035,0.000007612212,0.0002077912,0.00044452085,0.000003255434,0.0000019635943,0.0765052,0.00017471313,0.9208414,0.00034461822],"about_ca_topic_score_codex":0.0000056149947,"about_ca_topic_score_gemma":0.0000025984334,"teacher_disagreement_score":0.5964474,"about_ca_system_score_codex":0.000015320185,"about_ca_system_score_gemma":0.00012258213,"threshold_uncertainty_score":0.99993265},"labels":[],"label_agreement":null},{"id":"W2023450315","doi":"10.1182/blood-2008-07-169110","title":"Genetic variants in the candidate genes of the apoptosis pathway and susceptibility to chronic myeloid leukemia","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Single-nucleotide polymorphism; Biology; Myeloid leukemia; Haplotype; Allele; Genetics; Immunology; SNP; Cancer research; Genotype; Gene","score_opus":0.010089940063186628,"score_gpt":0.2385421577308934,"score_spread":0.2284522176677068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023450315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959461,0.0014435612,0.0000075936514,0.00087813113,0.000050857117,0.0008809284,0.000018429047,0.000015525555,0.0007588836],"genre_scores_gemma":[0.9986312,0.00021662554,0.0003571143,0.00053884805,0.00011094119,0.000029063885,0.0000042921797,0.000012184187,0.00009977092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99862134,0.00011454687,0.00030790656,0.0003329587,0.00031330474,0.00030991272],"domain_scores_gemma":[0.9989252,0.00006506036,0.00007791047,0.0008083832,0.00003547504,0.00008793805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027768494,0.00017965912,0.00029976817,0.00005683976,0.000068708636,0.000015021563,0.00025165518,0.00008343449,0.000042035055],"category_scores_gemma":[0.00008180362,0.00010112141,0.000073349496,0.00033310198,0.00007464646,0.000029777128,0.00007058396,0.00016244604,0.000009222069],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023996978,0.0017066911,0.52652353,0.000312726,0.00028921352,0.00009009843,0.0048496784,0.00012323739,0.35161066,0.00019508312,0.00042741664,0.11363171],"study_design_scores_gemma":[0.004583905,0.0005949556,0.9300481,0.00012362543,0.00019433365,0.00007319792,0.000094134346,0.00004501512,0.06360435,0.00011180439,0.00041715012,0.00010942196],"about_ca_topic_score_codex":0.0006852781,"about_ca_topic_score_gemma":0.0008255937,"teacher_disagreement_score":0.4035246,"about_ca_system_score_codex":0.00050243706,"about_ca_system_score_gemma":0.0007281044,"threshold_uncertainty_score":0.41236115},"labels":[],"label_agreement":null},{"id":"W2023536741","doi":"10.1182/blood-2003-01-0316","title":"Changes in the lymph node microenvironment induced by oncostatin M","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Oncostatin M; Lymph node; Medicine; Cancer research; Chemistry; Immunology; Interleukin 6; Cytokine","score_opus":0.02265897974372448,"score_gpt":0.25953775325811257,"score_spread":0.23687877351438807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023536741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99062634,0.00019417783,0.0000130652425,0.0020769353,0.00005277758,0.00015860047,0.000011393808,0.00001111048,0.006855611],"genre_scores_gemma":[0.9972806,0.000052278614,0.00022626633,0.0021339657,0.00004588146,0.000035845616,0.000016837508,0.000010218155,0.00019810756],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99947643,0.00004842405,0.00010437297,0.000119813834,0.000114664304,0.00013627423],"domain_scores_gemma":[0.999715,0.00004421743,0.00003113713,0.00016958702,0.0000068582635,0.000033247514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012692,0.00007413064,0.00009621115,0.00003675218,0.000036962363,0.000010341857,0.000045488807,0.00003168759,0.00024596174],"category_scores_gemma":[0.0000462327,0.00005081825,0.000029758216,0.00008069913,0.00001295887,0.00001549324,0.0000065228173,0.0001140248,0.000047127716],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009614019,0.0010162109,0.008232389,0.0000098046185,0.000022294775,0.000020941308,0.00069874496,5.940798e-7,0.9875005,0.00009088363,0.0017733442,0.00062466646],"study_design_scores_gemma":[0.003765578,0.00028086963,0.02945438,0.00009461347,0.00010275225,0.00016884266,0.001305527,0.0000054169664,0.8646381,0.0000319578,0.100023136,0.00012885823],"about_ca_topic_score_codex":0.000065819564,"about_ca_topic_score_gemma":0.00002925721,"teacher_disagreement_score":0.12286244,"about_ca_system_score_codex":0.000027074464,"about_ca_system_score_gemma":0.00002093975,"threshold_uncertainty_score":0.26931086},"labels":[],"label_agreement":null},{"id":"W2023684144","doi":"10.1182/blood-2006-12-063941","title":"Acute thrombocytopenia caused by sensitivity to the glucuronide conjugate of acetaminophen","year":2007,"lang":"en","type":"letter","venue":"Blood","topic":"Hematological disorders and diagnostics","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute","keywords":"Acetaminophen; Medicine; Platelet; Internal medicine; Anesthesia","score_opus":0.01918916994748321,"score_gpt":0.2738023374342357,"score_spread":0.2546131674867525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023684144","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2909366,0.0007814027,0.00037285674,0.6999739,0.00024837774,0.001674499,0.00077861175,0.00009291635,0.00514088],"genre_scores_gemma":[0.10041551,0.00021027168,0.00039803586,0.89543605,0.000773543,0.000031697236,0.0005876416,0.00007603021,0.0020712388],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980162,0.00011466111,0.00042847736,0.00041643894,0.00050531904,0.0005189486],"domain_scores_gemma":[0.9980551,0.0007952683,0.00017418526,0.0006864048,0.0001488527,0.00014017338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029056784,0.0003500813,0.0010475294,0.000063335036,0.00006572407,0.000021634614,0.00018565923,0.00068719557,0.0001355143],"category_scores_gemma":[0.0005494483,0.0002185387,0.00020461525,0.00019279329,0.00016869427,0.000021481317,0.0001413406,0.0010697151,0.00023105813],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003902911,0.00029850393,0.0005927474,0.0001621951,0.00046438092,0.0029499836,0.0000843939,3.550627e-7,0.0047924374,0.000020969153,0.990495,0.00009995874],"study_design_scores_gemma":[0.0033634205,0.00083387695,0.0029659597,0.00030002068,0.002796982,0.00027853667,0.00003435608,0.000004846803,0.054691292,0.00006046098,0.93420047,0.00046975532],"about_ca_topic_score_codex":0.000089384965,"about_ca_topic_score_gemma":0.00003065362,"teacher_disagreement_score":0.19546218,"about_ca_system_score_codex":0.00002113025,"about_ca_system_score_gemma":0.000109346896,"threshold_uncertainty_score":0.891175},"labels":[],"label_agreement":null},{"id":"W2023958942","doi":"10.1182/blood-2014-12-618165","title":"Combination of 4Ts score and PF4/H-PaGIA for diagnosis and management of heparin-induced thrombocytopenia: prospective cohort study","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of British Columbia; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Heparin-induced thrombocytopenia; Medicine; Cohort; Prospective cohort study; Heparin; Internal medicine; Platelet factor 4; Platelet; Intensive care medicine; Pediatrics","score_opus":0.0625963756184353,"score_gpt":0.31944703761242965,"score_spread":0.25685066199399437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023958942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915378,0.00020436017,0.0000134364345,0.0001349048,0.00009082084,0.0056719976,0.000015482514,0.000033943907,0.0022972254],"genre_scores_gemma":[0.99815303,0.00026940685,0.0007706025,0.000021820175,0.000027850587,0.0006409723,0.000016218339,0.000034378983,0.00006569985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983655,0.000057463025,0.0004774482,0.00048571758,0.0003750001,0.0002388353],"domain_scores_gemma":[0.99875206,0.00008535684,0.00021735519,0.0003900376,0.00035854665,0.00019666196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055726344,0.00023577252,0.00094539014,0.00014127193,0.000068812704,0.000020022002,0.00010468817,0.000107839674,0.000009120778],"category_scores_gemma":[0.000091867245,0.00021227296,0.00006572818,0.0002519676,0.00011005278,0.00014549782,0.00018637432,0.000114016155,0.00000207608],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015707064,0.0039660386,0.9868727,0.00050295744,0.0013506545,0.0000152001585,0.0010014887,1.5101546e-7,0.0033461014,0.0018889941,0.000050243867,0.0008484507],"study_design_scores_gemma":[0.014234366,0.003480687,0.91975176,0.00026252266,0.0021678808,0.000017924633,0.0009538833,0.00001324389,0.058315374,0.0006014493,0.000020230602,0.00018065178],"about_ca_topic_score_codex":0.00022928578,"about_ca_topic_score_gemma":0.000075617485,"teacher_disagreement_score":0.067120865,"about_ca_system_score_codex":0.000053902073,"about_ca_system_score_gemma":0.00007235922,"threshold_uncertainty_score":0.865624},"labels":[],"label_agreement":null},{"id":"W2024303005","doi":"10.1182/blood-2007-10-117861","title":"Hematopoietic cell–derived interferon controls viral replication and virus-induced disease","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"Virology; Viral replication; Interferon; Hematopoietic cell; Virus; Biology; Haematopoiesis; Disease; Immunology; Medicine; Stem cell; Genetics","score_opus":0.014630739995514966,"score_gpt":0.23142900600602104,"score_spread":0.21679826601050606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024303005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99454623,0.003977218,0.00004951647,0.00020853923,0.00016232298,0.0002476808,0.000015267622,0.000085827094,0.0007074049],"genre_scores_gemma":[0.99718195,0.00020406519,0.00001626004,0.00025009725,0.000019966095,0.000045221903,0.000039965184,0.000017036242,0.0022254328],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99899775,0.00017062319,0.00023516412,0.00032942285,0.000024940238,0.0002420816],"domain_scores_gemma":[0.99930066,0.0000743774,0.00008277199,0.00046390848,0.000038891718,0.000039367627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009432806,0.00015912038,0.00022282999,0.00006663493,0.00018857088,0.0000122478295,0.00013693339,0.0001196595,0.00019823329],"category_scores_gemma":[0.000091486065,0.00014171671,0.00007135514,0.000038619655,0.00015713506,0.00007745345,0.00007472539,0.00017123255,0.00037953453],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008180173,0.00036900293,0.0008668154,0.000014426815,0.00006186965,0.0000147251985,0.00040074548,4.7293888e-8,0.9966261,0.00014198737,0.0003951233,0.00029115324],"study_design_scores_gemma":[0.003337246,0.00047615907,0.018450009,0.000025137437,0.00007676532,0.00018361406,0.000075871074,0.0000014797157,0.97450495,0.000042303644,0.0026515576,0.00017492674],"about_ca_topic_score_codex":0.000028715873,"about_ca_topic_score_gemma":0.0000021830588,"teacher_disagreement_score":0.022121156,"about_ca_system_score_codex":0.0000113640235,"about_ca_system_score_gemma":0.000046606394,"threshold_uncertainty_score":0.5779039},"labels":[],"label_agreement":null},{"id":"W2024503784","doi":"10.1182/blood-2007-06-095224","title":"Iron can boost hepcidin both ways","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Hepcidin; Iron homeostasis; Ferroportin; Iron status; Cell biology; Iron deficiency; Biology; Endocrinology; Internal medicine; Chemistry; Medicine; Anemia; Metabolism","score_opus":0.013152901122756858,"score_gpt":0.24467802407984918,"score_spread":0.23152512295709232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024503784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9159871,0.0016062666,0.00020599375,0.0004264528,0.0001599797,0.00016180266,0.000005840511,0.000078245175,0.08136837],"genre_scores_gemma":[0.9953049,0.00008357283,0.0009597151,0.0013704381,0.00030897444,0.0000027051703,0.000021525757,0.000020708016,0.0019274531],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992126,0.000007087635,0.0001452397,0.0001584142,0.00018171329,0.00029490874],"domain_scores_gemma":[0.99954337,0.000019144369,0.000029289844,0.00023071063,0.000018970628,0.00015851807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018768443,0.00009974699,0.00015585845,0.00006655987,0.000050327202,0.0000071873797,0.000054816886,0.00006715498,0.00022320257],"category_scores_gemma":[0.000049347524,0.00008507918,0.000054295357,0.0001040211,0.0000381383,0.000025028046,0.000018372633,0.00010357893,0.00009538257],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008711779,0.0073925625,0.5638321,0.0009098526,0.00016035157,0.0015554536,0.005352473,0.0000039757315,0.26406515,0.035336353,0.048736207,0.07178433],"study_design_scores_gemma":[0.01886942,0.00052619906,0.7039412,0.00006914219,0.00085174956,0.00021867867,0.0013686288,0.0000035083171,0.13276893,0.0005191775,0.14030267,0.0005606694],"about_ca_topic_score_codex":0.00019773202,"about_ca_topic_score_gemma":0.00015417498,"teacher_disagreement_score":0.14010909,"about_ca_system_score_codex":0.00000888005,"about_ca_system_score_gemma":0.00004831137,"threshold_uncertainty_score":0.3469428},"labels":[],"label_agreement":null},{"id":"W2024614395","doi":"10.1182/blood-2010-04-278317","title":"Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":184,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Toronto","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; European Society for Medical Oncology; National Comprehensive Cancer Network","keywords":"Internal medicine; Medicine; Gastroenterology; Myeloid leukemia; Cytogenetics; Transplantation; Hematopoietic stem cell transplantation; Oncology; Leukemia; Hazard ratio; Human leukocyte antigen; Myelodysplastic syndromes; Immunology; Confidence interval; Chromosome; Biology; Bone marrow; Antigen; Genetics","score_opus":0.02030462989051362,"score_gpt":0.2896976178591662,"score_spread":0.2693929879686526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024614395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99555105,0.00015576271,0.00035803625,0.00084138993,0.00014749294,0.0019226578,0.0001009738,0.00017402282,0.0007486375],"genre_scores_gemma":[0.9788024,0.0015291662,0.015335243,0.00019777211,0.00017489336,0.000642311,0.0004492731,0.00014532876,0.0027236126],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99709857,0.000076756936,0.00063637004,0.00071555364,0.00059106713,0.00088169635],"domain_scores_gemma":[0.99789953,0.0006664648,0.00016172808,0.0006176211,0.0002530335,0.00040160344],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006004112,0.00043296083,0.00080174406,0.00036256484,0.0002126704,0.00006858209,0.00027252405,0.00048160687,0.00052524894],"category_scores_gemma":[0.00011506416,0.00032609896,0.0001260261,0.00088522915,0.00013034699,0.00018114694,0.0000749386,0.00083049445,0.000092261515],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033751756,0.0012761021,0.7326101,0.0018401062,0.0011382173,0.0019669659,0.0029417358,0.0012736395,0.22065595,0.000020840176,0.002144075,0.00038049082],"study_design_scores_gemma":[0.06290395,0.0020914322,0.09890776,0.0016106155,0.003104005,0.00094125536,0.0005106462,0.010227406,0.8108107,0.00007913186,0.0075360523,0.0012770656],"about_ca_topic_score_codex":0.0005267763,"about_ca_topic_score_gemma":0.00576628,"teacher_disagreement_score":0.63370234,"about_ca_system_score_codex":0.0006065149,"about_ca_system_score_gemma":0.0008845852,"threshold_uncertainty_score":0.9999191},"labels":[],"label_agreement":null},{"id":"W2024639674","doi":"10.1182/blood-2007-03-078303","title":"High levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP-E2–dependent suppression of C/EBPα-driven myeloid differentiation","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"National Cancer Institute; Pfizer","keywords":"Biology; MAPK/ERK pathway; Phosphorylation; Cancer research; Progenitor cell; Chronic myelogenous leukemia; Myeloid; breakpoint cluster region; Molecular biology; K562 cells; Haematopoiesis; ABL; Cell biology; Stem cell; Leukemia; Tyrosine kinase; Signal transduction; Immunology; Receptor; Biochemistry","score_opus":0.0247668264678103,"score_gpt":0.2709574113211005,"score_spread":0.2461905848532902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024639674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99465185,0.00046548553,0.0014472955,0.0006437796,0.00036476043,0.002017394,0.00018194108,0.000031152784,0.00019635448],"genre_scores_gemma":[0.99717265,0.000038207603,0.0011214387,0.00005654122,0.00022244752,0.00008164845,0.000038492482,0.000036342433,0.0012322263],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981464,0.00006380829,0.00056748564,0.0002912537,0.00061089045,0.00032013218],"domain_scores_gemma":[0.99806345,0.00031006674,0.0005674596,0.00080062065,0.00018404631,0.00007437964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037005788,0.00021196918,0.00042402433,0.000071293594,0.00012510277,0.000008248718,0.00029185062,0.00016636391,0.00015503974],"category_scores_gemma":[0.00023949398,0.00011659841,0.00023059598,0.00017278596,0.00009996484,0.00006166986,0.00013259974,0.00017002375,0.0000057440348],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092882663,0.0021671825,0.043801516,0.0007491043,0.0010545595,0.000019442767,0.0011058347,0.000068549205,0.9340532,0.00070058357,0.0006516038,0.014699642],"study_design_scores_gemma":[0.008680732,0.00024468044,0.32056808,0.00043895154,0.0006208476,0.000013428411,0.00018034076,0.00007680885,0.6687374,0.00016296115,0.00018988298,0.0000858936],"about_ca_topic_score_codex":0.00021056848,"about_ca_topic_score_gemma":0.00013813253,"teacher_disagreement_score":0.27676657,"about_ca_system_score_codex":0.00024660976,"about_ca_system_score_gemma":0.00019688683,"threshold_uncertainty_score":0.4754745},"labels":[],"label_agreement":null},{"id":"W2024761240","doi":"10.1182/blood-2010-01-263038","title":"C4BPB/C4BPA is a new susceptibility locus for venous thrombosis with unknown protein S–independent mechanism: results from genome-wide association and gene expression analyses followed by case-control studies","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Heart, Lung, and Blood Institute; Fondation de France; National Institutes of Health; Generalitat de Catalunya; Bundesministerium für Bildung und Forschung; Fondation Leducq; Agence Nationale de la Recherche","keywords":"Single-nucleotide polymorphism; Locus (genetics); Genome-wide association study; Venous thrombosis; Genetics; Odds ratio; Protein S; Allele; Genetic association; SNP; Factor V; Thrombophilia; Protein C; Medicine; Biology; Internal medicine; Thrombosis; Gene; Genotype","score_opus":0.03793898878621989,"score_gpt":0.30356548614738615,"score_spread":0.2656264973611663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024761240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908828,0.0006291576,0.0034003065,0.0019441484,0.00014036344,0.00232459,0.0005261508,0.00012767107,0.000024825073],"genre_scores_gemma":[0.9859109,0.00004572131,0.012510293,0.0005051486,0.00023534798,0.00017295287,0.00014078537,0.00005403717,0.0004248236],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99754375,0.00010681997,0.0005633183,0.00082825363,0.00054070575,0.00041714104],"domain_scores_gemma":[0.9977499,0.0005121773,0.00047792558,0.0005838193,0.00037941028,0.0002967663],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00065217813,0.00036552717,0.00086065754,0.00010569212,0.0002744264,0.00007016706,0.00010464758,0.0003407748,0.00006750286],"category_scores_gemma":[0.0009673424,0.0002850584,0.00015912534,0.00018453933,0.00003707872,0.00014192775,0.00006101296,0.00031425743,0.0000069670064],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005645852,0.0011286894,0.0039786478,0.00005134741,0.001820833,0.000053539516,0.0010920747,0.000001727997,0.9906142,0.00003764467,0.00049619254,0.00016056333],"study_design_scores_gemma":[0.02795509,0.001779432,0.00621116,0.00013392235,0.004059968,0.00004370703,0.0004591637,0.00010140833,0.95710033,0.00147089,0.00025784294,0.00042710532],"about_ca_topic_score_codex":0.0005116775,"about_ca_topic_score_gemma":0.0010748378,"teacher_disagreement_score":0.033513844,"about_ca_system_score_codex":0.000091362395,"about_ca_system_score_gemma":0.00015731758,"threshold_uncertainty_score":0.9999602},"labels":[],"label_agreement":null},{"id":"W2024848934","doi":"10.1182/blood-2012-08-449215","title":"IL-7/anti–IL-7 mAb complexes augment cytokine potency in mice through association with IgG-Fc and by competition with IL-7R","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kellogg's (Canada)","funders":"National Institute of Allergy and Infectious Diseases; Institute for Basic Science; National Institutes of Health; Pohang University of Science and Technology","keywords":"Cytokine; Monoclonal antibody; Potency; Antibody; In vivo; Receptor; Immunology; Biology; clone (Java method); Ex vivo; In vitro; Biochemistry; Gene","score_opus":0.005508972282896297,"score_gpt":0.18612541232389077,"score_spread":0.18061644004099447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024848934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945772,0.001643733,0.00008679216,0.0011531331,0.00013460379,0.00048341445,0.00017640293,0.000081889484,0.00166282],"genre_scores_gemma":[0.9965337,0.00033632052,0.0004025558,0.00026074582,0.00002497866,0.0000690849,0.0005533417,0.000025453619,0.0017938252],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985028,0.00020019262,0.00031740134,0.00042003024,0.00006876896,0.0004908114],"domain_scores_gemma":[0.99932104,0.00010696432,0.00023342235,0.00021491063,0.00010223663,0.000021448805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013366493,0.00027187492,0.00042189707,0.000077387835,0.00019628796,0.000035329842,0.00015920655,0.00030522476,0.00044636583],"category_scores_gemma":[0.00001433854,0.00020865026,0.000033651973,0.00016189189,0.00020953397,0.00021705742,0.00007280564,0.00036747704,0.00035606654],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012865463,0.001003277,0.028970204,0.00003159549,0.00028019535,0.000008907256,0.00040194078,0.0000023258378,0.96636844,0.0005997457,0.0019463628,0.00025838404],"study_design_scores_gemma":[0.01749072,0.0026825527,0.047849953,0.00016704477,0.0003315325,0.00035924008,0.0010802912,0.000005905125,0.8954907,0.0005826213,0.033221744,0.00073768944],"about_ca_topic_score_codex":0.0022472173,"about_ca_topic_score_gemma":0.00051173684,"teacher_disagreement_score":0.07087771,"about_ca_system_score_codex":0.000064571956,"about_ca_system_score_gemma":0.00004424446,"threshold_uncertainty_score":0.85085106},"labels":[],"label_agreement":null},{"id":"W2025301637","doi":"10.1182/blood.v97.4.844","title":"Acquired activated protein C resistance is associated with lupus anticoagulants and thrombotic events in pediatric patients with systemic lupus erythematosus","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Hamilton General Hospital","funders":"","keywords":"Medicine; Activated protein C resistance; Systemic lupus erythematosus; Thrombosis; Immunology; Internal medicine; Gastroenterology; Factor V Leiden; Disease; Venous thrombosis","score_opus":0.01380490848793469,"score_gpt":0.24354703530777658,"score_spread":0.22974212681984188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025301637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946956,0.0011629864,0.00000860785,0.00008517718,0.00008983757,0.0034767739,0.00002038919,0.00014237,0.00031827376],"genre_scores_gemma":[0.9967779,0.00012714737,0.00012291488,0.000028159202,0.000056271496,0.00019154929,0.000042052492,0.000115168776,0.0025388564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99616903,0.00024326149,0.00062215846,0.00077593786,0.0013103193,0.0008792797],"domain_scores_gemma":[0.9981166,0.0001573281,0.00038355828,0.00066081056,0.00038244989,0.00029924678],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042306387,0.00045559456,0.0010359992,0.00044568806,0.00012299514,0.000035526326,0.00021852662,0.00024726102,0.000022103599],"category_scores_gemma":[0.00029427517,0.00032356934,0.000054012617,0.0014425818,0.00010147484,0.00022349037,0.00008447478,0.00027580943,0.000024094952],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013781235,0.001633173,0.99148166,0.0011906778,0.0003311285,0.0005481314,0.0015834573,8.6427116e-7,0.0017408852,0.0000038349785,0.000098935445,0.000009152984],"study_design_scores_gemma":[0.07723882,0.0014783216,0.88768816,0.012797096,0.0008483687,0.015212432,0.0010992214,0.000047817583,0.002588118,0.000053106243,0.000010910431,0.00093761226],"about_ca_topic_score_codex":0.000034015047,"about_ca_topic_score_gemma":0.00014576316,"teacher_disagreement_score":0.10379346,"about_ca_system_score_codex":0.00025414975,"about_ca_system_score_gemma":0.00026043205,"threshold_uncertainty_score":0.9999216},"labels":[],"label_agreement":null},{"id":"W2025338891","doi":"10.1182/blood-2013-01-466706","title":"A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":633,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Vancouver General Hospital","funders":"National Cancer Institute","keywords":"Gemtuzumab ozogamicin; Cytarabine; Medicine; Daunorubicin; Gastroenterology; Internal medicine; Randomization; Myeloid leukemia; Induction chemotherapy; Surgery; Randomized controlled trial; Leukemia; Chemotherapy; CD33","score_opus":0.01245108116759154,"score_gpt":0.27324175031770004,"score_spread":0.2607906691501085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025338891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976166,0.00004361597,0.0000021006701,0.00006587112,0.000020051091,0.0021057918,0.000005678402,0.000027294382,0.00011298567],"genre_scores_gemma":[0.99942863,0.0000815773,0.00014689843,0.000036210135,0.000040249117,0.00010699676,0.000034911853,0.000029751649,0.00009476729],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987311,0.00007003326,0.00029187923,0.00030095645,0.0003590623,0.0002469884],"domain_scores_gemma":[0.9992665,0.000025355677,0.00010854714,0.00028675416,0.00022289495,0.00008995048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011130122,0.000159291,0.00030739082,0.00032416717,0.0000490696,0.000020545795,0.00007154774,0.0000831551,0.0000542424],"category_scores_gemma":[0.000029181354,0.000120347126,0.00001911307,0.00033987773,0.000060464663,0.00035650912,0.000047877023,0.00027108515,0.000009067797],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034657733,0.011703493,0.69286394,0.00008982953,0.00076913845,0.000098219214,0.0046857833,0.000004474945,0.27189088,0.0000061221817,0.000031868818,0.014390473],"study_design_scores_gemma":[0.078969516,0.0059836437,0.8798008,0.0000615039,0.00011944163,0.000048986094,0.0010006592,0.000043400076,0.03383509,0.0000069202724,0.000004132793,0.00012593277],"about_ca_topic_score_codex":0.0009021282,"about_ca_topic_score_gemma":0.000021767106,"teacher_disagreement_score":0.2380558,"about_ca_system_score_codex":0.00022516894,"about_ca_system_score_gemma":0.00016800276,"threshold_uncertainty_score":0.49076134},"labels":[],"label_agreement":null},{"id":"W2025391536","doi":"10.1182/blood-2013-12-538975","title":"PTK2 expression and immunochemotherapy outcome in chronic lymphocytic leukemia","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital; Health Sciences Centre","funders":"","keywords":"Chronic lymphocytic leukemia; Medicine; Internal medicine; Fludarabine; PTK2; Oncology; Rituximab; Cyclophosphamide; Immunology; Cancer research; Leukemia; Chemotherapy; Lymphoma; Receptor","score_opus":0.016687310438296358,"score_gpt":0.2965285665735104,"score_spread":0.27984125613521404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025391536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940442,0.0022823664,0.000059255657,0.00007444507,0.000055983073,0.0003791095,0.0000011140846,0.00008184104,0.0030216912],"genre_scores_gemma":[0.99714667,0.00038649447,0.0005785778,0.000278482,0.00023123603,0.000039406703,0.000008407315,0.00004695582,0.0012837535],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982784,0.000073245166,0.0003699488,0.00040502197,0.00037751716,0.00049590203],"domain_scores_gemma":[0.9989536,0.00017007971,0.00006018774,0.00059695396,0.000038453392,0.00018076456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044225203,0.00020290217,0.0004314812,0.00017690977,0.0000548823,0.000029063352,0.00015473612,0.00017356327,0.0001166954],"category_scores_gemma":[0.00019082715,0.00016792207,0.000068166424,0.00021354048,0.00012881026,0.00007836928,0.00011297269,0.00024053836,0.00008893634],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0009886128,0.00052702473,0.03447752,0.0020215623,0.00022734079,0.00059630646,0.0014265608,0.00021414533,0.92119384,0.00056258036,0.0009488256,0.036815688],"study_design_scores_gemma":[0.41308102,0.0015168497,0.04567297,0.0016562266,0.00021231356,0.0020087878,0.00016339603,0.072664015,0.44723862,0.0006581354,0.01414272,0.0009849281],"about_ca_topic_score_codex":0.00072067074,"about_ca_topic_score_gemma":0.000030230101,"teacher_disagreement_score":0.4739552,"about_ca_system_score_codex":0.031227803,"about_ca_system_score_gemma":0.008117663,"threshold_uncertainty_score":0.99750537},"labels":[],"label_agreement":null},{"id":"W2025477540","doi":"10.1182/blood-2006-10-053256","title":"TLR3 ligand stimulates fully functional memory CD8+ T cells in the absence of CD4+ T-cell help","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Universidad Pública de Navarra; Institut National Du Cancer; Universidad de Navarra","keywords":"Cytotoxic T cell; Priming (agriculture); CD8; T cell; Biology; Cell biology; TLR7; Immunology; Toll-like receptor; Immune system; Innate immune system; Biochemistry; In vitro","score_opus":0.00864944446287636,"score_gpt":0.20812218058648582,"score_spread":0.19947273612360947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025477540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937605,0.0023059796,0.00009351642,0.00006772963,0.00026446578,0.00015159154,0.0000037119075,0.000014105026,0.0033383858],"genre_scores_gemma":[0.9980991,0.000058302157,0.000028738239,0.000085991385,0.000033936863,0.000003911716,0.000026371185,0.0000058736173,0.0016578112],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992277,0.00010747795,0.0002883477,0.00012445677,0.00004421816,0.0002078161],"domain_scores_gemma":[0.9993045,0.00034779473,0.00009976519,0.00019314095,0.000048333655,0.000006482668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007423783,0.000094188246,0.00013168273,0.00010061979,0.00007099417,0.00000600979,0.00015090221,0.00014570907,0.00015521594],"category_scores_gemma":[0.00003731106,0.00006908564,0.000055768895,0.0001327819,0.000095064046,0.000062573024,0.000027293865,0.00017805434,0.0002710016],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021736462,0.00029205676,0.00107297,0.000014630699,0.00002919603,0.0000081992985,0.00070737273,0.00003156241,0.9963238,0.000093736715,0.0005097633,0.000699343],"study_design_scores_gemma":[0.0016508194,0.00012960983,0.029011542,0.000018268393,0.000021514692,0.00003200227,0.0005420761,0.0000020044693,0.9658735,0.000064106775,0.0025755472,0.000079031815],"about_ca_topic_score_codex":0.00004469583,"about_ca_topic_score_gemma":0.0000193268,"teacher_disagreement_score":0.030450327,"about_ca_system_score_codex":0.0000068760046,"about_ca_system_score_gemma":0.00004523108,"threshold_uncertainty_score":0.34832677},"labels":[],"label_agreement":null},{"id":"W2025617710","doi":"10.1182/blood-2011-11-382614","title":"GRPling with PTEN","year":2012,"lang":"en","type":"letter","venue":"Blood","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"PTEN; Suppressor; Cancer research; Conditional gene knockout; Knockout mouse; Biology; Tumor suppressor gene; Genetics; Phenotype; Cancer; PI3K/AKT/mTOR pathway; Carcinogenesis; Gene; Apoptosis","score_opus":0.01088888989240107,"score_gpt":0.2242203570258137,"score_spread":0.2133314671334126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025617710","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5259324,0.06514387,0.0052855597,0.3176905,0.0070349704,0.0029694648,0.0010313115,0.00059714867,0.07431481],"genre_scores_gemma":[0.17140463,0.0003251803,0.004978105,0.74918395,0.053744677,0.00027453474,0.0033810881,0.000580139,0.016127666],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986899,0.000035076897,0.00015651208,0.00044669246,0.00022030002,0.0004515125],"domain_scores_gemma":[0.9991242,0.000011584953,0.00012959086,0.00060712505,0.00007023495,0.000057234018],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0000902021,0.000294855,0.00021888317,0.000038945476,0.000051684052,0.000028712444,0.0003260913,0.00079568435,0.000077111916],"category_scores_gemma":[0.000015853344,0.00025130305,0.00010200388,0.00005050215,0.00006788679,0.0000018075059,0.00009503126,0.0005843876,0.000053451702],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025768435,0.00007846076,0.002749239,0.00013234268,0.00056385767,0.000092545335,0.000022644595,0.000008506027,0.076584935,0.0000023121684,0.9193713,0.00036808074],"study_design_scores_gemma":[0.00060990476,0.00015265535,0.000046438538,0.00006143055,0.0002457717,0.000114563525,0.0000023258337,6.264705e-7,0.077460036,0.000007987134,0.92089707,0.0004011812],"about_ca_topic_score_codex":0.000016680391,"about_ca_topic_score_gemma":0.000006050321,"teacher_disagreement_score":0.43149346,"about_ca_system_score_codex":0.000011712016,"about_ca_system_score_gemma":0.00010951854,"threshold_uncertainty_score":0.9999939},"labels":[],"label_agreement":null},{"id":"W2025780824","doi":"10.1182/blood-2007-10-117150","title":"Twenty-five–year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":389,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; National Institutes of Health; U.S. Public Health Service; American Lebanese Syrian Associated Charities; St. Jude Children's Research Hospital","keywords":"Medicine; Cumulative incidence; Pediatrics; Sibling; Odds ratio; Incidence (geometry); Cancer; Population; Adverse effect; Cohort; Internal medicine","score_opus":0.016840652775009957,"score_gpt":0.2677568640335976,"score_spread":0.25091621125858765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025780824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919437,0.0014610365,0.000039630733,0.0006749531,0.00162767,0.0025905962,0.00040421088,0.00030180748,0.00095635955],"genre_scores_gemma":[0.9956024,0.0004725284,0.00018689096,0.0006513396,0.0013655834,0.00025923314,0.00017712146,0.00018890262,0.0010959943],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9931346,0.00057072996,0.0018713014,0.0013882428,0.0021187558,0.00091637106],"domain_scores_gemma":[0.99468595,0.0008534065,0.001088169,0.0024280087,0.0004383944,0.00050610024],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012106507,0.0008069073,0.0018099939,0.00021428597,0.00048584706,0.00004716908,0.0008707634,0.00033090977,0.00033279453],"category_scores_gemma":[0.0009982595,0.0006311679,0.00071588485,0.0010305762,0.0005133202,0.00026257226,0.0004121501,0.0008453676,0.00006354209],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030796215,0.0048951977,0.9593281,0.00004944185,0.0045901686,0.0009858279,0.027253143,0.000019320145,0.00018829014,0.000009407871,0.0021967462,0.00017640862],"study_design_scores_gemma":[0.020034377,0.00081220246,0.9676761,0.00040261768,0.0029133433,0.0005455412,0.004872517,0.000008066694,0.0017825757,0.000056430017,0.00026850612,0.0006277125],"about_ca_topic_score_codex":0.07761825,"about_ca_topic_score_gemma":0.026980497,"teacher_disagreement_score":0.050637748,"about_ca_system_score_codex":0.0002499947,"about_ca_system_score_gemma":0.0019507663,"threshold_uncertainty_score":0.99961394},"labels":[],"label_agreement":null},{"id":"W2025836097","doi":"10.1182/blood-2011-01-330019","title":"A small molecule screening strategy with validation on human leukemia stem cells uncovers the therapeutic efficacy of kinetin riboside","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Lunenfeld-Tanenbaum Research Institute; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"Canadian Institutes of Health Research","keywords":"Haematopoiesis; Leukemia; In vivo; Myeloid leukemia; Stem cell; Progenitor cell; Myeloid; CD34; Cancer research; Biology; Immunology; Cell biology; Genetics","score_opus":0.060345238641999824,"score_gpt":0.27290552642472926,"score_spread":0.21256028778272945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025836097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99593246,0.00010604263,0.0004031299,0.000009696807,0.000015384938,0.00029276824,0.000009551358,0.0000113764045,0.0032196168],"genre_scores_gemma":[0.99918324,0.000009147654,0.00023083946,0.000040746392,0.0000589568,0.000019632673,0.00003088542,0.000031867014,0.00039471578],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99892324,0.00015115875,0.00018776148,0.00029180985,0.00021446418,0.00023153904],"domain_scores_gemma":[0.9992611,0.00002604882,0.00011486108,0.00045748387,0.00008477234,0.000055732038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002076214,0.00015254127,0.00012247513,0.00004528423,0.00009528651,0.000016714826,0.0002594267,0.00009926691,0.000017589928],"category_scores_gemma":[0.000008519379,0.00010822328,0.00007087979,0.00011303588,0.00012614278,0.0000025797328,0.000052049836,0.0001467767,0.000008632253],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019038639,0.00022342092,0.000444128,0.000014932137,0.00011258665,0.000007832267,0.00014871059,0.0005179932,0.99762297,0.00007319181,0.000057843026,0.0005860378],"study_design_scores_gemma":[0.0016112312,0.001270221,0.001321985,0.00003240979,0.000054478372,0.000006272831,0.00009750058,0.0000113112,0.9952675,0.0000048104494,0.00018997163,0.00013227014],"about_ca_topic_score_codex":0.00019134024,"about_ca_topic_score_gemma":0.00004873225,"teacher_disagreement_score":0.0032507759,"about_ca_system_score_codex":0.000017186878,"about_ca_system_score_gemma":0.00010720294,"threshold_uncertainty_score":0.44132173},"labels":[],"label_agreement":null},{"id":"W2026003958","doi":"10.1182/blood-2013-08-523845","title":"Phase 2 study of VcR-CVAD with maintenance rituximab for untreated mantle cell lymphoma: an Eastern Cooperative Oncology Group study (E1405)","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Medicine; Mantle cell lymphoma; Vincristine; Bortezomib; Rituximab; Internal medicine; Autologous stem-cell transplantation; Progression-free survival; Surgery; Chemoimmunotherapy; Cyclophosphamide; Oncology; Lymphoma; Chemotherapy; Multiple myeloma","score_opus":0.01799034897380513,"score_gpt":0.29848352782711657,"score_spread":0.28049317885331143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026003958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949594,0.000097995755,0.00010785835,0.000052125048,0.000055963937,0.0035193919,0.00003839548,0.000053100684,0.0011157312],"genre_scores_gemma":[0.9980499,0.000008907638,0.00052786595,0.00010285586,0.000088118104,0.000729459,0.000068300564,0.000043191103,0.00038139356],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983051,0.0001788464,0.00038228402,0.0005426716,0.00024669792,0.000344422],"domain_scores_gemma":[0.9986737,0.00014891638,0.00019565853,0.0005202135,0.00027873943,0.00018280419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020725015,0.0002970498,0.0008190151,0.000091427275,0.00010785349,0.000019301759,0.00012548645,0.00007404338,0.000020852971],"category_scores_gemma":[0.000029424207,0.00019495441,0.00006410722,0.00017211692,0.0000709877,0.00008059896,0.000041660154,0.000046946483,0.00001952767],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004954995,0.7656544,0.2020648,0.00007613637,0.0012568331,0.0006109237,0.006093005,0.0000043976147,0.00068104715,0.00007388362,0.00014334137,0.018386245],"study_design_scores_gemma":[0.62226766,0.30510873,0.042883005,0.00009637492,0.0033518514,0.000105465835,0.014228538,0.00044115706,0.010256853,0.000011005511,0.0009269083,0.00032245647],"about_ca_topic_score_codex":0.0005351997,"about_ca_topic_score_gemma":0.0011085306,"teacher_disagreement_score":0.61731267,"about_ca_system_score_codex":0.00010549558,"about_ca_system_score_gemma":0.00014056332,"threshold_uncertainty_score":0.795001},"labels":[],"label_agreement":null},{"id":"W2026028836","doi":"10.1182/blood-2008-03-145011","title":"Carboxypeptidase A5 identifies a novel mast cell lineage in the zebrafish providing new insight into mast cell fate determination","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":133,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Izaak Walton Killam Health Centre","funders":"Dalhousie University","keywords":"Zebrafish; Biology; GATA1; Cell biology; Progenitor cell; Haematopoiesis; Mast cell; Morpholino; Population; Immunology; Stem cell; Genetics; Gene; Medicine","score_opus":0.013405518040097713,"score_gpt":0.20218478026579367,"score_spread":0.18877926222569597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026028836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873876,0.0016954843,0.00026051074,0.00014546179,0.0003181647,0.00039362232,0.000016556178,0.000049935705,0.009732639],"genre_scores_gemma":[0.98414564,0.00008576673,0.00035337178,0.0001766127,0.000101970756,0.000026522042,0.000098987046,0.00002375007,0.014987375],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987767,0.00010850161,0.00036438063,0.00034517865,0.000064832566,0.00034043856],"domain_scores_gemma":[0.9993519,0.000092076596,0.00015287515,0.00032783375,0.000046466066,0.000028821465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000189284,0.00021995264,0.00024332131,0.00016336041,0.00026669737,0.000042100266,0.0003332047,0.00020088306,0.00018930511],"category_scores_gemma":[0.00002996718,0.00017290622,0.00008638511,0.0002136343,0.00013042557,0.00014312718,0.000104267994,0.00034246538,0.00020675037],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035655074,0.00090651686,0.0014059376,0.00009228881,0.000017545844,0.00009034974,0.0133683635,0.000004055166,0.98263717,0.000038016446,0.0010654842,0.0003386482],"study_design_scores_gemma":[0.005628702,0.00022014459,0.0044494257,0.000052043488,0.00009353675,0.00017005758,0.00087372866,0.000031808995,0.9377772,0.00002031007,0.05032327,0.00035973173],"about_ca_topic_score_codex":0.00075924175,"about_ca_topic_score_gemma":0.0008991122,"teacher_disagreement_score":0.049257785,"about_ca_system_score_codex":0.000022045053,"about_ca_system_score_gemma":0.00008448069,"threshold_uncertainty_score":0.7050911},"labels":[],"label_agreement":null},{"id":"W2026042142","doi":"10.1182/blood-2010-06-291484","title":"DITP causation: 3 methods better than 1?","year":2010,"lang":"en","type":"letter","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Dozen; Causation; Intensive care medicine; Medicine; Philosophy; Epistemology","score_opus":0.045833402833144736,"score_gpt":0.3422457794547786,"score_spread":0.29641237662163383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026042142","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08734659,0.00017057787,0.00021889301,0.87136245,0.0024479888,0.00094871473,0.000059289403,0.00031820175,0.037127297],"genre_scores_gemma":[0.011607681,0.00006197925,0.04519881,0.90654004,0.02499037,0.00017941423,0.001152331,0.0002910252,0.009978352],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973515,0.00022927533,0.00051380624,0.0007665702,0.0004881111,0.00065070024],"domain_scores_gemma":[0.99784935,0.00024263897,0.00022039138,0.0013362529,0.0001558503,0.00019554302],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0003906201,0.00055452716,0.001171093,0.0002545508,0.0001333793,0.00007864356,0.00032448434,0.0032748107,0.0020317386],"category_scores_gemma":[0.00016336216,0.0004732469,0.00040358122,0.00023251321,0.00013341743,0.00009489406,0.00014442876,0.0065282,0.0008428986],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011089099,0.0003751318,0.006822131,0.0004666728,0.0014305403,0.0013454491,0.00022943418,1.1904053e-8,0.051997576,0.000037965674,0.9317752,0.005508777],"study_design_scores_gemma":[0.0017870542,0.00017143585,0.013818236,0.00016236363,0.0021930085,0.00046807688,0.000006488872,0.0000012703043,0.03926426,0.00033674014,0.9412672,0.0005238613],"about_ca_topic_score_codex":0.00013906904,"about_ca_topic_score_gemma":0.00002406459,"teacher_disagreement_score":0.07573891,"about_ca_system_score_codex":0.000049804126,"about_ca_system_score_gemma":0.00026214137,"threshold_uncertainty_score":0.99993503},"labels":[],"label_agreement":null},{"id":"W2026220616","doi":"10.1182/blood-2003-09-3209","title":"Differential gene expression of human stem progenitor cells derived from early stages of in utero human hematopoiesis","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Biology; Progenitor cell; Haematopoiesis; CD38; Cell biology; Stem cell; Molecular biology; CD34; GATA2","score_opus":0.02076861002673536,"score_gpt":0.2580169742585749,"score_spread":0.23724836423183954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026220616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988259,0.00010331128,0.00022079544,0.000003656917,0.00006572658,0.00051682146,0.000049674996,0.00002616933,0.00018794174],"genre_scores_gemma":[0.99765706,0.000010407187,0.0021162385,0.0000037536922,0.00003676494,0.00002889999,0.000039235143,0.000030355028,0.000077291326],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984686,0.00012198947,0.0006098907,0.0002613478,0.00034480877,0.00019339522],"domain_scores_gemma":[0.9992256,0.00006435444,0.00021205192,0.0003487321,0.000065282184,0.000083934516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000085217165,0.00017093902,0.00051453634,0.00013335573,0.000034563298,0.0000073712595,0.00009695903,0.0001346018,0.00023930639],"category_scores_gemma":[0.0000068661816,0.00015491308,0.00010010556,0.00010304093,0.00005802674,0.00004784529,0.000016397345,0.00010090689,0.0000043803348],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034224486,0.0008526764,0.14822842,0.00046748092,0.000057791764,0.00005066144,0.0018232876,2.7009608e-7,0.8484344,0.000035495566,0.0000035554592,0.000011725595],"study_design_scores_gemma":[0.0046592145,0.00022938508,0.07468712,0.00056898553,0.00021376807,0.000009033917,0.00025330472,4.187023e-7,0.9192226,0.000042643398,0.0000013168334,0.000112231406],"about_ca_topic_score_codex":0.0001091037,"about_ca_topic_score_gemma":0.000014883183,"teacher_disagreement_score":0.0735413,"about_ca_system_score_codex":0.000014080326,"about_ca_system_score_gemma":0.0000331296,"threshold_uncertainty_score":0.6317172},"labels":[],"label_agreement":null},{"id":"W2026257211","doi":"10.1182/blood-2011-11-393983","title":"Necdin, a p53 target gene, regulates the quiescence and response to genotoxic stress of hematopoietic stem/progenitor cells","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Haematopoiesis; Stem cell; Progenitor cell; Biology; Cancer research; DNA damage; Cell biology; Progenitor; Genetics; DNA","score_opus":0.0128541266638324,"score_gpt":0.241304914504418,"score_spread":0.2284507878405856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026257211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964705,0.0017718544,0.00021437166,0.0003317197,0.00013166064,0.00086226745,0.00004643445,0.000039911305,0.00013127587],"genre_scores_gemma":[0.995779,0.000053571606,0.0034516796,0.00012444424,0.0001182223,0.000054642773,0.000005536235,0.00003240306,0.0003805007],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985542,0.00014893684,0.00036568858,0.00022329636,0.00035011733,0.00035774885],"domain_scores_gemma":[0.99877024,0.0003116334,0.00010156444,0.00046306505,0.00009547553,0.00025801454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057363696,0.00018044727,0.00031401133,0.000089020556,0.00007300177,0.000016321474,0.00013378123,0.000095826144,0.0000486869],"category_scores_gemma":[0.00003836741,0.00012917689,0.00006421306,0.00021882649,0.00009498216,0.00006856079,0.000042288924,0.00009995778,0.00003729342],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004933691,0.000399721,0.032508466,0.0005567488,0.000109267174,0.000020743877,0.0089115,0.0000031240777,0.9567732,0.000050512896,0.000057302383,0.00011604106],"study_design_scores_gemma":[0.0012847689,0.00019810228,0.026828976,0.0002530967,0.00033650734,0.00029324304,0.0010037244,0.000012562541,0.96945834,0.000010725627,0.00018498108,0.00013496392],"about_ca_topic_score_codex":0.000009677676,"about_ca_topic_score_gemma":0.0000015989295,"teacher_disagreement_score":0.012685145,"about_ca_system_score_codex":0.000016514952,"about_ca_system_score_gemma":0.000072390045,"threshold_uncertainty_score":0.526768},"labels":[],"label_agreement":null},{"id":"W2026325727","doi":"10.1182/blood.v118.21.4458.4458","title":"Late Mortality After Hematopoietic Stem-Cell Transplantation for a Childhood Malignancy","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pediatric Oncology Group; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Hematopoietic stem cell transplantation; Transplantation; Pediatrics; Retrospective cohort study; Malignancy; Cohort; Population; Pediatric cancer; Cancer; Surgery; Internal medicine","score_opus":0.02164535198567099,"score_gpt":0.2593480956632991,"score_spread":0.2377027436776281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026325727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99133825,0.0002588391,0.0018451054,0.00004748422,0.0000563525,0.00093673577,0.00007105197,0.00007572412,0.005370468],"genre_scores_gemma":[0.9964987,0.00007071709,0.0018320623,0.00018833406,0.00009121384,0.00030346206,0.000034681034,0.000040710525,0.000940104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987719,0.000028410828,0.00026749333,0.0002981887,0.0002812098,0.00035281823],"domain_scores_gemma":[0.9993206,0.000050060502,0.000054160555,0.00032809874,0.00008227994,0.00016477314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016097444,0.00015526549,0.00024417043,0.00007193088,0.000042290427,0.000010632606,0.00009797165,0.00011317675,0.00020795206],"category_scores_gemma":[0.000009054702,0.00012990102,0.000128396,0.000114818686,0.000046695048,0.00007283369,0.00001800474,0.000105183775,0.00010225744],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008968775,0.0365412,0.736389,0.024650201,0.004105108,0.010343876,0.10356591,0.000004918769,0.060366232,0.003008719,0.002246859,0.00980922],"study_design_scores_gemma":[0.030823458,0.0013746705,0.6885537,0.00055841455,0.002628385,0.0007316822,0.0002466575,0.000111173504,0.27294618,0.0013755856,0.00013979853,0.0005103376],"about_ca_topic_score_codex":0.000038238795,"about_ca_topic_score_gemma":0.0000084699295,"teacher_disagreement_score":0.21257995,"about_ca_system_score_codex":0.00004206266,"about_ca_system_score_gemma":0.00021990997,"threshold_uncertainty_score":0.52972096},"labels":[],"label_agreement":null},{"id":"W2026509109","doi":"10.1182/blood-2007-02-075804","title":"AML1/ETO, a promiscuous fusion oncoprotein","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Cancer research","score_opus":0.015930705848493286,"score_gpt":0.2963118403653234,"score_spread":0.2803811345168301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026509109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.950751,0.00030711072,0.00028227124,0.0009249419,0.00005205127,0.0008447967,0.0000025129411,0.00014778781,0.046687502],"genre_scores_gemma":[0.9834562,0.00003449487,0.005959501,0.00045526546,0.0005920284,0.00003114646,0.000017277662,0.000042252977,0.009411856],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99849653,0.00002595627,0.00023049656,0.0002805863,0.00047498016,0.0004914199],"domain_scores_gemma":[0.9990826,0.000052953626,0.00004427134,0.00042712703,0.000110741516,0.00028229615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069636054,0.00013266751,0.00022479483,0.00015608233,0.000076845,0.000014761623,0.00013079279,0.00014434612,0.00042075475],"category_scores_gemma":[0.0002408105,0.000104784995,0.00008029957,0.000313145,0.0000664381,0.00004362189,0.00010367796,0.0003974526,0.0005777829],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010348046,0.002255122,0.019816723,0.00029204472,0.00021366523,0.0039840746,0.0007386337,3.8380463e-7,0.87132895,0.00041683356,0.00832539,0.09159337],"study_design_scores_gemma":[0.020208647,0.0019257179,0.08214258,0.0002891872,0.0002569995,0.0015687307,0.00031080062,0.00007435726,0.8124657,0.0002474964,0.0800938,0.00041597435],"about_ca_topic_score_codex":0.00014444657,"about_ca_topic_score_gemma":0.000035805297,"teacher_disagreement_score":0.0911774,"about_ca_system_score_codex":0.000144327,"about_ca_system_score_gemma":0.00029053842,"threshold_uncertainty_score":0.74264234},"labels":[],"label_agreement":null},{"id":"W2026749772","doi":"10.1182/blood-2013-09-527317","title":"Acute myeloid leukemia relapse first presenting in the cerebrospinal fluid","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Acute myelomonocytic leukemia; Medicine; Myeloid leukemia; Headaches; Cerebrospinal fluid; Leukemia; Chemotherapy; Internal medicine; Chemotherapy regimen; Oncology; Surgery","score_opus":0.01466600944539647,"score_gpt":0.27042637859906504,"score_spread":0.25576036915366857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026749772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97438383,0.00016214028,0.00006851316,0.003916765,0.000080723985,0.0005806811,0.000004707086,0.00008142974,0.020721227],"genre_scores_gemma":[0.99504423,0.00010307448,0.001020553,0.0009023962,0.0006432023,0.00008616473,0.000027765938,0.00004495897,0.0021276374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977781,0.000162103,0.0003543503,0.00041048633,0.0006463277,0.00064863317],"domain_scores_gemma":[0.9985698,0.00029732272,0.00007263899,0.00082680746,0.00008247238,0.00015096138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009992365,0.00021022432,0.0003208126,0.0001641883,0.00019717198,0.000065977685,0.0004959872,0.00016131756,0.000101760386],"category_scores_gemma":[0.00059339474,0.00014495311,0.00012420859,0.0005077604,0.00013082646,0.000119807824,0.00019280161,0.00078680186,0.00031550773],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015445952,0.0030634673,0.71466774,0.0013299484,0.0014287052,0.003890107,0.009790767,0.000103717066,0.13510384,0.008001206,0.11103267,0.010043214],"study_design_scores_gemma":[0.039593097,0.0021458848,0.6749687,0.0007202838,0.0013225878,0.0041746506,0.0010377672,0.00918047,0.05843436,0.0010371986,0.2062504,0.0011345783],"about_ca_topic_score_codex":0.00023369247,"about_ca_topic_score_gemma":0.00009503484,"teacher_disagreement_score":0.09521772,"about_ca_system_score_codex":0.00020816992,"about_ca_system_score_gemma":0.00027795447,"threshold_uncertainty_score":0.59110165},"labels":[],"label_agreement":null},{"id":"W2026874266","doi":"10.1182/blood-2010-07-296616","title":"Lunatic Fringe prolongs Delta/Notch-induced self-renewal of committed αβ T-cell progenitors","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"Canadian Institutes of Health Research","keywords":"Notch signaling pathway; Biology; Lunatic; Cell biology; Medicine; Signal transduction; Psychiatry","score_opus":0.009295530472957994,"score_gpt":0.24028176313997154,"score_spread":0.23098623266701354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026874266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946692,0.00019809717,0.0000035991497,0.00018229967,0.0003723534,0.0006491023,0.000015087138,0.000105579566,0.0038046886],"genre_scores_gemma":[0.99551255,0.000019499998,0.0037217692,0.00007860663,0.00031587313,0.00005542632,0.000017001368,0.000037795337,0.00024148806],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99881333,0.000024984447,0.00031512318,0.00025228693,0.00030710342,0.00028714823],"domain_scores_gemma":[0.99903667,0.00003805245,0.00014648441,0.00043563082,0.00014943672,0.00019375466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018623545,0.00017594916,0.00036659022,0.00010506232,0.000047599726,0.000011220512,0.00013599228,0.00013504214,0.00011697643],"category_scores_gemma":[0.00005084768,0.00015120798,0.00014417342,0.00023566475,0.000042077736,0.000038154976,0.000050679355,0.00032394318,0.000022644444],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007897737,0.0028194136,0.03498634,0.00046020877,0.00027153527,0.000047887974,0.00070694974,1.4553582e-7,0.95701975,0.000041579642,0.00028820604,0.0032790136],"study_design_scores_gemma":[0.005531715,0.00047422122,0.004342827,0.000042975305,0.0010257642,0.00006428228,0.000074786505,0.0000134125685,0.9842215,0.00003185569,0.004006082,0.000170531],"about_ca_topic_score_codex":0.0002859749,"about_ca_topic_score_gemma":0.00015353145,"teacher_disagreement_score":0.030643513,"about_ca_system_score_codex":0.000014583996,"about_ca_system_score_gemma":0.0001969367,"threshold_uncertainty_score":0.6166082},"labels":[],"label_agreement":null},{"id":"W2027056052","doi":"10.1182/blood-2004-06-2161","title":"Genetic variation in XPD predicts treatment outcome and risk of acute myeloid leukemia following chemotherapy","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University College London; Medical Research Council; Kay Kendall Leukaemia Fund; University of Oxford; York University","keywords":"Myeloid leukemia; Medicine; Chemotherapy regimen; Oncology; Internal medicine; Chemotherapy","score_opus":0.013370217289115669,"score_gpt":0.278721538104365,"score_spread":0.2653513208152493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027056052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99801445,0.00039361464,0.0002563752,0.00025163408,0.000039824477,0.00065211044,0.000018042032,0.000037085574,0.00033688493],"genre_scores_gemma":[0.9901789,0.0018119491,0.0075601735,0.00007395058,0.00008604422,0.00004238635,0.000011110019,0.00003228716,0.00020319158],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99872994,0.00004548264,0.0003595557,0.0002913593,0.0002911172,0.00028251528],"domain_scores_gemma":[0.999378,0.00005636281,0.000096704796,0.00031239004,0.000034007357,0.00012251499],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021134366,0.00017024482,0.00039737113,0.00018712967,0.000038668324,0.000011066062,0.00007477176,0.00013125778,0.000016977534],"category_scores_gemma":[0.0000646084,0.000139158,0.00010215481,0.00024892046,0.000042111264,0.000061973216,0.000030426683,0.00017227554,0.000008183071],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022506587,0.0005749157,0.9392476,0.00005873219,0.0012864193,0.00029821126,0.0017937614,0.000090023954,0.05161835,0.000027334774,0.0000077223285,0.0047718366],"study_design_scores_gemma":[0.028979255,0.0009348304,0.94923455,0.000069395275,0.00083992566,0.00007353008,0.000036256915,0.00021574642,0.019285085,0.00015768087,0.0000610947,0.00011264016],"about_ca_topic_score_codex":0.0010802726,"about_ca_topic_score_gemma":0.000059264923,"teacher_disagreement_score":0.032333262,"about_ca_system_score_codex":0.00067274686,"about_ca_system_score_gemma":0.00042634388,"threshold_uncertainty_score":0.56746984},"labels":[],"label_agreement":null},{"id":"W2027190304","doi":"10.1182/blood.v97.2.575","title":"Accelerated telomere shortening in hematological lineages is limited to the first year following stem cell transplantation","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Institute of Allergy and Infectious Diseases; National Institute of General Medical Sciences","keywords":"Telomere; Transplantation; Stem cell; Biology; Fluorescence in situ hybridization; Flow cytometry; Immunology; Molecular biology; Genetics; Medicine; Internal medicine; Chromosome; DNA; Gene","score_opus":0.0346040362484793,"score_gpt":0.2656342780964612,"score_spread":0.23103024184798188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027190304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957925,0.00043811247,0.00013829255,0.0019745857,0.00009429917,0.0004647581,0.0000072500416,0.000111893445,0.0009782995],"genre_scores_gemma":[0.99738413,0.0003125279,0.00057004683,0.0011987196,0.00010370571,0.000032572072,0.000022859853,0.000024666992,0.00035077834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863386,0.00004132485,0.00034858214,0.00034296466,0.00027832773,0.00035496286],"domain_scores_gemma":[0.99940926,0.000110381014,0.00004685426,0.0002619173,0.00004456095,0.00012704734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017838395,0.00018797776,0.00033016424,0.00015170928,0.00012263021,0.000040813185,0.00016178828,0.0001343126,0.00007933826],"category_scores_gemma":[0.000020027699,0.0001316605,0.00010894843,0.0007465176,0.000020921163,0.000080283746,0.00002186494,0.00025816436,0.00009305096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040901086,0.0009769908,0.97057337,0.0001986852,0.00010435733,0.0027136202,0.0064912527,0.0000437757,0.012582017,0.000024909179,0.00078894553,0.0050930483],"study_design_scores_gemma":[0.011535574,0.00080071413,0.78052,0.0010494224,0.00073617353,0.0009062534,0.005139354,0.000760255,0.18608555,0.000014668947,0.011572089,0.0008799157],"about_ca_topic_score_codex":0.00005064774,"about_ca_topic_score_gemma":0.00011459949,"teacher_disagreement_score":0.19005336,"about_ca_system_score_codex":0.000019799263,"about_ca_system_score_gemma":0.000036711604,"threshold_uncertainty_score":0.53689593},"labels":[],"label_agreement":null},{"id":"W2027367644","doi":"10.1182/blood-2004-08-3210","title":"The splenic microenvironment is a source of proangiogenesis/inflammatory mediators accelerating the expansion of murine erythroleukemic cells","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Splenocyte; Stromal cell; Cytokine; Haematopoiesis; Paracrine signalling; Tumor necrosis factor alpha; Cancer research; Biology; Progenitor cell; Tumor microenvironment; Immunology; Spleen; Stem cell; Cell biology; Receptor","score_opus":0.009437316711468437,"score_gpt":0.21379371275984188,"score_spread":0.20435639604837344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027367644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968943,0.0016115864,0.000116876006,0.00049988966,0.000045108583,0.0006060304,0.000006503847,0.000019575027,0.00020015742],"genre_scores_gemma":[0.9977417,0.0007562931,0.0009137604,0.0001168559,0.00013762922,0.000038432645,0.0000057238226,0.000029680126,0.00025993618],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99854946,0.00006519395,0.00056169,0.00018731278,0.00041771727,0.00021864787],"domain_scores_gemma":[0.99896705,0.00021841809,0.0002601985,0.00045592044,0.000036975485,0.00006144241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036721287,0.00015070457,0.00024327348,0.000044649965,0.000098932505,0.000006400312,0.00016382714,0.00007220418,0.00007998099],"category_scores_gemma":[0.000016029531,0.00008897992,0.00014747199,0.00010002531,0.00013995155,0.000032868298,0.00003633991,0.000102348255,0.000025085124],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000069238704,0.00020529101,0.010420095,0.00033779972,0.00015733363,0.000004277839,0.0045553874,0.000055623874,0.9812079,0.000013135203,0.00016122595,0.0028126757],"study_design_scores_gemma":[0.0020058113,0.00009310484,0.007908814,0.00019214478,0.00039679048,0.000058698562,0.0007354537,0.00019167551,0.98702633,0.00000374179,0.0013062374,0.000081222504],"about_ca_topic_score_codex":0.000015836313,"about_ca_topic_score_gemma":0.000008101048,"teacher_disagreement_score":0.0058183903,"about_ca_system_score_codex":0.0000325791,"about_ca_system_score_gemma":0.00009899754,"threshold_uncertainty_score":0.36284956},"labels":[],"label_agreement":null},{"id":"W2027414674","doi":"10.1182/blood-2010-07-293332","title":"RNA-seq analysis of 2 closely related leukemia clones that differ in their self-renewal capacity","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Canadian Institutes of Health Research; University of California, Santa Cruz","keywords":"Biology; Genetics; RNA; Leukemia; RNA-Seq; Computational biology; Transcriptome; Gene; Gene expression","score_opus":0.019472873156119716,"score_gpt":0.2597172290457295,"score_spread":0.2402443558896098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027414674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946696,0.00010555832,0.0000048973056,0.00038244697,0.00009421351,0.00034057832,0.00004628808,0.00010545011,0.0042509474],"genre_scores_gemma":[0.99824494,0.00011474609,0.0008583075,0.00008777078,0.0000846927,0.000024019479,0.00007432646,0.000037479225,0.0004737315],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979736,0.000124312,0.00047566046,0.0004299094,0.00051550847,0.00048098937],"domain_scores_gemma":[0.99841475,0.00024878254,0.00015348126,0.0008078372,0.00015543349,0.00021973814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060679676,0.00024909293,0.00081012916,0.0008077601,0.0000518424,0.000015832347,0.0002991752,0.00040514302,0.00032256427],"category_scores_gemma":[0.00025041195,0.00018938465,0.0003171942,0.0016739053,0.00018701272,0.00008660628,0.000120034056,0.0011240913,0.00002740508],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014882846,0.0009514122,0.6592351,0.00008962736,0.0036114457,0.00014046553,0.0020950278,0.000012894774,0.3325654,0.0003814527,0.00018679872,0.0005815189],"study_design_scores_gemma":[0.0067386734,0.00018574245,0.74479115,0.000045635097,0.002741913,0.00007385376,0.00018845013,0.0019130019,0.24234259,0.00034136983,0.00036884364,0.00026878834],"about_ca_topic_score_codex":0.0015339704,"about_ca_topic_score_gemma":0.0012926301,"teacher_disagreement_score":0.09022278,"about_ca_system_score_codex":0.00020225291,"about_ca_system_score_gemma":0.00042898578,"threshold_uncertainty_score":0.7722882},"labels":[],"label_agreement":null},{"id":"W2027627028","doi":"10.1182/blood-2007-11-121723","title":"Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Hyperglycemia and glycemic control in critically ill and hospitalized patients","field":"Medicine","cited_by":364,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Diabetes Fonds","keywords":"Hyperinsulinemia; Internal medicine; Fibrinolysis; Endocrinology; Inflammation; Medicine; Degranulation; Immunology; Insulin; Insulin resistance","score_opus":0.016123763643184946,"score_gpt":0.24965080535935152,"score_spread":0.2335270417161666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027627028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994708,0.001008212,0.000009052284,0.00024103413,0.000095365875,0.00038188917,0.000010410807,0.00015762924,0.0033883862],"genre_scores_gemma":[0.99736243,0.00051515014,0.0005004245,0.00009924849,0.00043258938,0.00005049882,0.00008493766,0.000038855353,0.00091587834],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980805,0.000040357147,0.00054839876,0.0005286302,0.00039092815,0.00041116762],"domain_scores_gemma":[0.99901664,0.000060743732,0.000114280774,0.000305519,0.00021228033,0.0002905439],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00006172608,0.00030758686,0.0005307813,0.00016081617,0.00053039484,0.000032080323,0.00008783915,0.00020840588,0.00010566022],"category_scores_gemma":[0.00010054506,0.0002804869,0.0001443335,0.00023465994,0.00022657464,0.00020235703,0.000062224346,0.00024789636,0.000020068715],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042113557,0.00041344727,0.18171836,0.00013133527,0.00014977735,0.00015670873,0.000570396,0.000007336282,0.8155091,0.00013545292,0.000039473227,0.0007474767],"study_design_scores_gemma":[0.018504508,0.0008033767,0.425477,0.00032543,0.0007236132,0.0017612564,0.00015184247,0.000087898756,0.5507569,0.00013949939,0.00065115944,0.000617556],"about_ca_topic_score_codex":0.00008507286,"about_ca_topic_score_gemma":0.000006959836,"teacher_disagreement_score":0.26475224,"about_ca_system_score_codex":0.000035151825,"about_ca_system_score_gemma":0.000071064176,"threshold_uncertainty_score":0.9999647},"labels":[],"label_agreement":null},{"id":"W2027659061","doi":"10.1182/blood-2007-05-090852","title":"Calreticulin expression in the clonal plasma cells of patients with systemic light-chain (AL-) amyloidosis is associated with response to high-dose melphalan","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"U.S. Public Health Service; University of Alberta","keywords":"Calreticulin; Melphalan; AL amyloidosis; Amyloidosis; Cancer research; Endoplasmic reticulum; Biology; Transplantation; Medicine; Pathology; Immunology; Immunoglobulin light chain; Internal medicine; Cell biology; Antibody","score_opus":0.004639681696161108,"score_gpt":0.21565274845764623,"score_spread":0.21101306676148512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027659061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99841666,0.00012165474,0.0000382863,0.00038499132,0.000044717646,0.00076609536,0.00016340161,0.000014496385,0.000049721184],"genre_scores_gemma":[0.9985557,0.000023843138,0.000488774,0.00056240906,0.000027236993,0.000105333434,0.00011499635,0.000041679457,0.00008000092],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99795705,0.0002961291,0.00039672817,0.00047619457,0.00046698426,0.00040688494],"domain_scores_gemma":[0.9987477,0.000213131,0.00026362698,0.000513052,0.00013951633,0.00012295305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061069016,0.00030072988,0.00033513104,0.0001234188,0.00007248884,0.00001901695,0.00031055632,0.00019628898,0.000013981658],"category_scores_gemma":[0.00014583637,0.00018483233,0.00007774048,0.00030716808,0.00006027632,0.0000063127272,0.000086968175,0.00011979721,0.000007968104],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044438695,0.0024399834,0.44445032,0.000024666027,0.00029159596,0.00006847421,0.0011048751,0.000057497768,0.5459724,0.0000041362996,0.0010396886,0.00010251163],"study_design_scores_gemma":[0.005911162,0.0014850457,0.2976123,0.00019319564,0.0001148979,0.000006403895,0.00029049063,0.0000011528313,0.6939275,8.892438e-7,0.00023377719,0.0002231852],"about_ca_topic_score_codex":0.000048759506,"about_ca_topic_score_gemma":0.00016274054,"teacher_disagreement_score":0.14795512,"about_ca_system_score_codex":0.000049830796,"about_ca_system_score_gemma":0.0000720389,"threshold_uncertainty_score":0.7537244},"labels":[],"label_agreement":null},{"id":"W2027736919","doi":"10.1182/blood-2008-02-142166","title":"Response: What is the appropriate surgical intervention when imaging?","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Planarian Biology and Electrostimulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Tumor necrosis factor alpha; Medicine; Endothelium; Pathology; Cancer research; Immunology; Internal medicine","score_opus":0.007743343938824674,"score_gpt":0.23399747552971129,"score_spread":0.22625413159088661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027736919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906264,0.0025647148,0.0003275189,0.0061140135,0.000091417234,0.00008933212,0.000005223165,0.000012186665,0.00016918938],"genre_scores_gemma":[0.997008,0.00031899667,0.00005335494,0.0012434131,0.00013042078,0.000009406151,0.00010346508,0.000007120523,0.0011258073],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993489,0.00015923205,0.000108633045,0.00018499458,0.000054264114,0.00014402083],"domain_scores_gemma":[0.999683,0.000020866806,0.00004204841,0.00019870047,0.000029820794,0.00002552145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027127285,0.00007677138,0.00006072594,0.000016077764,0.00013541747,0.00001929774,0.00011633445,0.00009002926,0.000032594176],"category_scores_gemma":[0.000034600063,0.000054837958,0.00007626737,0.00003249482,0.00008122034,0.0000068966433,0.00004229007,0.00007323477,0.000026170334],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006655057,0.0011345169,0.09763825,0.000020564354,0.0005502786,0.00025913902,0.001206834,0.000033840963,0.80916834,0.0002589161,0.06598412,0.017090138],"study_design_scores_gemma":[0.0050479975,0.0006101816,0.052311365,0.000032909666,0.000087490786,0.0018793317,0.00008705576,0.00020365206,0.4864317,0.0010148875,0.45190915,0.0003843027],"about_ca_topic_score_codex":0.0000061061482,"about_ca_topic_score_gemma":0.0000022642423,"teacher_disagreement_score":0.38592502,"about_ca_system_score_codex":0.0000031314396,"about_ca_system_score_gemma":0.000021695258,"threshold_uncertainty_score":0.2236227},"labels":[],"label_agreement":null},{"id":"W2027917793","doi":"10.1182/blood-2013-01-477265","title":"Light chain deposition","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"H&E stain; Stain; Pathology; Staining; Immunoglobulin light chain; Eosin; Medicine; Monoclonal; Biopsy; Creatinine; Acute tubular necrosis; Necrosis; Chemistry; Internal medicine; Monoclonal antibody; Renal function; Antibody; Immunology","score_opus":0.0050941799642459165,"score_gpt":0.21769083811154982,"score_spread":0.2125966581473039,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027917793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945796,0.0009718561,0.00011804373,0.00092423026,0.00006846685,0.00022368063,0.000004352599,0.000027129314,0.0030826374],"genre_scores_gemma":[0.99719507,0.00017665575,0.0008943518,0.0005902343,0.0001763198,0.00018289108,0.000061872954,0.000019904473,0.00070267735],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993759,0.000027467198,0.00011176103,0.0002279832,0.000072228264,0.00018469019],"domain_scores_gemma":[0.99957937,0.000006494563,0.000043868036,0.00026608087,0.00003478501,0.0000694165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000029339679,0.0001191466,0.00009074664,0.000023233284,0.000052590833,0.000026193045,0.000100995145,0.0001050348,0.000087995024],"category_scores_gemma":[0.000025049334,0.00010475339,0.00007460947,0.0000416202,0.000014224242,0.0000036666484,0.000054991524,0.00003375291,0.0002816804],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004732036,0.00049944053,0.06617472,0.000008793293,0.00015163881,0.0000061471746,0.000029156488,0.0000013490346,0.9251403,0.000073211755,0.006000177,0.0019103257],"study_design_scores_gemma":[0.00093812746,0.00017938642,0.03582667,0.000007522458,0.000057903766,0.000018475688,0.000025265063,0.0000029315459,0.9584294,0.0000458979,0.0043211384,0.00014731527],"about_ca_topic_score_codex":0.000046071495,"about_ca_topic_score_gemma":0.000017759738,"teacher_disagreement_score":0.033289064,"about_ca_system_score_codex":0.000006480237,"about_ca_system_score_gemma":0.000014636904,"threshold_uncertainty_score":0.42717192},"labels":[],"label_agreement":null},{"id":"W2027961014","doi":"10.1182/blood-2011-12-398024","title":"Distinct but phenotypically heterogeneous human cell populations produce rapid recovery of platelets and neutrophils after transplantation","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency; Canadian Institutes of Health Research","keywords":"Transplantation; Immunology; Haematopoiesis; Biology; Stem cell; Platelet; Xenotransplantation; Andrology; Medicine; Cell biology; Internal medicine","score_opus":0.020289194167797276,"score_gpt":0.24986387903841653,"score_spread":0.22957468487061924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027961014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973453,0.00065558497,0.0004348314,0.00005741075,0.00009490789,0.00047387104,0.000061258645,0.00003997305,0.0008368507],"genre_scores_gemma":[0.9974433,0.0000902986,0.001980652,0.000041508953,0.00014804049,0.000035474935,0.00015459757,0.00002773842,0.00007835176],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989499,0.000051308944,0.00036606332,0.00020837226,0.00019333734,0.0002310175],"domain_scores_gemma":[0.9994597,0.000048123205,0.000096474694,0.00020695922,0.000049231076,0.000139528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001233397,0.0001477169,0.00024859255,0.00008318216,0.00005381322,0.00000870396,0.0000365226,0.00009309391,0.00009543721],"category_scores_gemma":[0.000010354716,0.0001363265,0.00006450742,0.00007999734,0.000045554123,0.00010576305,0.0000061976443,0.00009289652,0.00001276017],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089821016,0.0021633115,0.3211943,0.003168289,0.00014512788,0.00015650633,0.0027913197,0.000009940411,0.667734,0.00014403359,0.00001327097,0.0015816642],"study_design_scores_gemma":[0.002966066,0.00035126458,0.640198,0.00018109994,0.0008683619,0.0006889986,0.00002167283,0.000005877111,0.35443205,0.00007943194,0.000028748484,0.00017844682],"about_ca_topic_score_codex":0.00001977602,"about_ca_topic_score_gemma":0.000009371486,"teacher_disagreement_score":0.3190037,"about_ca_system_score_codex":0.000010543341,"about_ca_system_score_gemma":0.000019319246,"threshold_uncertainty_score":0.55592334},"labels":[],"label_agreement":null},{"id":"W2028029079","doi":"10.1182/blood-2010-09-308742","title":"Programming of marginal zone B-cell fate by basic Krüppel-like factor (BKLF/KLF3)","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Kruppel-like factors research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"B cell; Biology; Marginal zone; Cell biology; CD19; Antigen; B-1 cell; Immunology; Antibody; Immune system; Antigen-presenting cell; T cell","score_opus":0.01873265520897554,"score_gpt":0.2430610352910911,"score_spread":0.22432838008211556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028029079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99549645,0.0008945742,0.00057824195,0.000017284272,0.00010030527,0.0003199981,0.00012407871,0.000023857616,0.002445212],"genre_scores_gemma":[0.9945516,0.00011560479,0.0018355855,0.00003872853,0.000091552836,0.000030441608,0.00014781074,0.000050104532,0.0031385631],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982684,0.000081938466,0.0002940296,0.00046421678,0.000314785,0.00057663216],"domain_scores_gemma":[0.99896246,0.000012194556,0.0001278507,0.00056553964,0.00014341538,0.00018851722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016547236,0.00023496742,0.0002338943,0.00007067505,0.000057647416,0.000021233916,0.00043158323,0.00022120266,0.00026436552],"category_scores_gemma":[0.00004277542,0.00022150112,0.00014547003,0.0001417696,0.00014969938,0.000007151696,0.00022552887,0.00018228327,0.000059521608],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000099797755,0.0011783751,0.03600277,0.0000874346,0.0001084325,0.000012175596,0.00012890236,1.4374757e-7,0.9570177,0.000006927032,0.0014231494,0.0039341506],"study_design_scores_gemma":[0.0016502467,0.0007812807,0.0044206567,0.000013879042,0.000038083355,0.000012131919,0.00008282088,0.0000025123422,0.9588863,0.000006452177,0.03384981,0.00025580422],"about_ca_topic_score_codex":0.00016436221,"about_ca_topic_score_gemma":0.00003271729,"teacher_disagreement_score":0.03242666,"about_ca_system_score_codex":0.000010344005,"about_ca_system_score_gemma":0.0001032443,"threshold_uncertainty_score":0.90325534},"labels":[],"label_agreement":null},{"id":"W2028131627","doi":"10.1182/blood-2014-08-596775","title":"HIV-1 reprograms the migration of macrophages","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Montreal Clinical Research Institute","funders":"Agence Nationale de la Recherche; Sidaction; Fondation pour la Recherche Médicale; Deutsche Forschungsgemeinschaft; Styrelsen för Internationellt Utvecklingssamarbete","keywords":"Mesenchymal stem cell; Macrophage; Podosome; Cell biology; Human immunodeficiency virus (HIV); Biology; Phagocyte; In vivo; Immunology; Phagocytosis; In vitro; Cell; Genetics","score_opus":0.00902205858517586,"score_gpt":0.23802459194659617,"score_spread":0.22900253336142032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028131627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99541765,0.00145637,0.000059076716,0.00054849236,0.000042808602,0.00012212212,0.000018153141,0.000019973952,0.0023153399],"genre_scores_gemma":[0.99780726,0.00003969419,0.00006386734,0.00002165481,0.000015124783,0.000021070044,0.00007984439,0.0000031863897,0.0019482716],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995861,0.00010790662,0.00007906547,0.00008799553,0.000018224699,0.00012067755],"domain_scores_gemma":[0.9996642,0.00006631299,0.000029669076,0.0002089832,0.000023661552,0.0000071901186],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001367002,0.00004297354,0.0000685589,0.000014838876,0.000065661865,0.0000046506543,0.00008659452,0.000040746534,0.00014764977],"category_scores_gemma":[0.000044470733,0.000024026278,0.000037228387,0.000042573243,0.00010093999,0.000012392818,0.000021754613,0.00005934261,0.0009233158],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010108052,0.0018237809,0.13953707,0.000030491794,0.0006917034,0.000007706412,0.0009044787,0.0000013224222,0.74596167,0.002533608,0.011968964,0.096438125],"study_design_scores_gemma":[0.002837654,0.00057158095,0.06443712,0.000011922733,0.00008552628,0.000040121162,0.000103527535,0.0000015899577,0.7737273,0.0002135405,0.15790072,0.000069399524],"about_ca_topic_score_codex":0.00009417905,"about_ca_topic_score_gemma":0.000034821773,"teacher_disagreement_score":0.14593177,"about_ca_system_score_codex":0.0000020052948,"about_ca_system_score_gemma":0.000008998493,"threshold_uncertainty_score":0.99985456},"labels":[],"label_agreement":null},{"id":"W2028208596","doi":"10.1182/blood-2010-12-327536","title":"Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemia","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":171,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Alemtuzumab; Fludarabine; Medicine; Cumulative incidence; Aplastic anemia; Internal medicine; Gastroenterology; Graft-versus-host disease; Hematopoietic stem cell transplantation; Cyclophosphamide; Transplantation; Incidence (geometry); Regimen; Surgery; Anemia; Chemotherapy; Bone marrow","score_opus":0.014801634234388501,"score_gpt":0.22353579305757892,"score_spread":0.20873415882319044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028208596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939821,0.0024018753,0.0015266135,0.00005805938,0.0001423977,0.001273433,0.0001573498,0.00010015861,0.0003580655],"genre_scores_gemma":[0.99589974,0.0007829559,0.0023190856,0.00004693986,0.00010725621,0.00036840327,0.000199561,0.000065711,0.00021035524],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99849284,0.000033452558,0.00033724395,0.0004926702,0.00026597214,0.00037780835],"domain_scores_gemma":[0.99909115,0.00013759297,0.00010283312,0.00025759795,0.00008224591,0.00032858376],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009926764,0.00029670057,0.00032287434,0.00010133035,0.000092180206,0.000019277477,0.00007834399,0.00010643513,0.00009803186],"category_scores_gemma":[0.000005583117,0.00024641797,0.00007659211,0.0001340166,0.00011559205,0.00013402734,0.000007335891,0.00007103295,0.000017007615],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15730461,0.0055026263,0.22672853,0.04181376,0.001940858,0.0065081473,0.023831425,0.000060028324,0.5299326,0.00041646184,0.00017374023,0.005787208],"study_design_scores_gemma":[0.040926833,0.0037298114,0.386178,0.0012273451,0.0071190344,0.00041953046,0.00035852622,0.000090606794,0.5590617,0.000032063082,0.000117407035,0.0007391393],"about_ca_topic_score_codex":0.000015518917,"about_ca_topic_score_gemma":0.000044281325,"teacher_disagreement_score":0.15944947,"about_ca_system_score_codex":0.000050448903,"about_ca_system_score_gemma":0.00023026159,"threshold_uncertainty_score":0.9999988},"labels":[],"label_agreement":null},{"id":"W2028214577","doi":"10.1182/blood-2012-05-430389","title":"A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"International Prognostic Index; Medicine; Diffuse large B-cell lymphoma; Internal medicine; Oncology; Lymphoma; Rituximab; Tissue microarray; Immunohistochemistry; Vincristine; Survival analysis; Gene expression profiling; Pathology; Hematology; Cyclophosphamide; Chemotherapy; Biology; Gene expression","score_opus":0.00818017686283699,"score_gpt":0.2167461740695784,"score_spread":0.20856599720674143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028214577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958121,0.00035700147,0.00005318458,0.000044457833,0.00006563488,0.00062098296,0.000050025817,0.000060466427,0.0029361164],"genre_scores_gemma":[0.9984337,0.000008257827,0.0007664923,0.0001673087,0.00006710731,0.00011547302,0.00022375045,0.000028031896,0.00018984104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987376,0.000026774453,0.00019728455,0.0002739254,0.00030142395,0.00046300044],"domain_scores_gemma":[0.9991792,0.0000767602,0.00007792429,0.00037340837,0.000038582577,0.00025413558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000810195,0.00024012788,0.00030458302,0.00006272056,0.000041568288,0.0000099809695,0.00007839682,0.00011872168,0.000024177278],"category_scores_gemma":[0.000057171987,0.00016220895,0.0000676393,0.00012931821,0.000021929587,0.00004693565,0.000030817373,0.00006344928,0.000031704596],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044502123,0.06293323,0.93569124,0.000054108757,0.000054049735,0.000026424947,0.00007723672,0.000009350476,0.00019756256,0.000019692878,0.000095662894,0.00039643797],"study_design_scores_gemma":[0.11187889,0.0011596315,0.8814911,0.00020035067,0.00032255406,0.0000025130932,0.000014620128,0.00056928664,0.0041046035,0.000005457753,0.000051652987,0.00019930254],"about_ca_topic_score_codex":0.000029978291,"about_ca_topic_score_gemma":0.0000020615655,"teacher_disagreement_score":0.11143387,"about_ca_system_score_codex":0.00015655682,"about_ca_system_score_gemma":0.00021490757,"threshold_uncertainty_score":0.6614689},"labels":[],"label_agreement":null},{"id":"W2028279927","doi":"10.1182/blood-2012-04-425314","title":"An analysis of the function and expression of D6 on lymphatic endothelial cells","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Versus Arthritis; British Heart Foundation; Cancer Research UK","keywords":"Lymphatic Endothelium; Lymphatic system; Cell biology; Biology; Function (biology); Endothelium; High endothelial venules; Immunology; Genetics","score_opus":0.005524931496481284,"score_gpt":0.2029469913663016,"score_spread":0.1974220598698203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028279927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99848866,0.0010509082,0.000031310843,0.00001431923,0.00014170351,0.0001258574,0.000017826604,0.000008186285,0.00012122714],"genre_scores_gemma":[0.99936444,0.000066781,0.000013473926,0.000045767574,0.000005056978,0.000008679265,0.000007854621,0.0000052996857,0.00048265667],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99934787,0.0002491272,0.00017859224,0.00010534937,0.00002588922,0.00009315754],"domain_scores_gemma":[0.999419,0.000117185715,0.00012850607,0.0002981012,0.000032069493,0.0000051917405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000094070594,0.00007486428,0.00019041209,0.000109013985,0.00006746908,0.0000044738517,0.00011351811,0.000089617846,0.0004676286],"category_scores_gemma":[0.000016272521,0.000045760935,0.00009095549,0.00013950047,0.00012256695,0.0000542639,0.00002006273,0.00004652505,0.00001642454],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022332389,0.00038163553,0.0042746114,0.0000064463675,0.00042396935,3.7830695e-8,0.00027555274,0.000010637091,0.99290454,0.000069831935,0.000021120217,0.001408309],"study_design_scores_gemma":[0.0011562571,0.00031234,0.13955194,0.000018701325,0.0003939887,0.000001261461,0.00013119071,0.000005416961,0.85817695,0.00003535357,0.00017403203,0.00004255887],"about_ca_topic_score_codex":0.00012784502,"about_ca_topic_score_gemma":0.0000022253137,"teacher_disagreement_score":0.13527733,"about_ca_system_score_codex":0.0000029602056,"about_ca_system_score_gemma":0.000014324855,"threshold_uncertainty_score":0.5120205},"labels":[],"label_agreement":null},{"id":"W2028295154","doi":"10.1182/blood-2011-11-392894","title":"Immunostimulatory conventional dendritic cells evolve into regulatory macrophage-like cells","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto General Hospital; University Health Network","funders":"David Geffen School of Medicine, University of California, Los Angeles; Canadian Institutes of Health Research; Centers for Disease Control and Prevention","keywords":"CD11c; Cell biology; Biology; Dendritic cell; Granulocyte macrophage colony-stimulating factor; MHC class II; MHC class I; Immune system; Immunology; Major histocompatibility complex; Cytokine; Phenotype; Biochemistry","score_opus":0.007471383914437343,"score_gpt":0.22166363401538156,"score_spread":0.21419225010094423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028295154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.912338,0.08208675,0.000083456594,0.0000334393,0.004258924,0.00029303535,0.000035847206,0.0001463007,0.0007242331],"genre_scores_gemma":[0.9842594,0.0003059732,0.00031295823,0.0004487348,0.00012628971,0.000036488844,0.0000931488,0.000058910322,0.014358048],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978216,0.00046339168,0.0004910705,0.00032226054,0.000091555,0.00081011566],"domain_scores_gemma":[0.9987603,0.00029657874,0.00016284328,0.0006298291,0.000093061324,0.000057382073],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005152189,0.00034443726,0.00038515325,0.00017509119,0.0004259409,0.000026605208,0.00038835994,0.0004336973,0.003805145],"category_scores_gemma":[0.00003114022,0.00034037305,0.0002973142,0.00014845417,0.00044510904,0.0002904328,0.0001335392,0.0004543639,0.005321426],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002731061,0.0011290278,0.0008623487,0.000037939975,0.00058166095,0.000008932772,0.0005674163,0.0000027397805,0.9898859,0.00038898815,0.00556539,0.00069649523],"study_design_scores_gemma":[0.0039264075,0.0001618801,0.01034753,0.00005008255,0.00016500875,0.00013888624,0.00017058507,6.7117645e-7,0.8492245,0.000054308635,0.13537993,0.00038019934],"about_ca_topic_score_codex":0.000049876682,"about_ca_topic_score_gemma":0.0000012902178,"teacher_disagreement_score":0.14066143,"about_ca_system_score_codex":0.000060211885,"about_ca_system_score_gemma":0.00012296418,"threshold_uncertainty_score":0.9999048},"labels":[],"label_agreement":null},{"id":"W2028534296","doi":"10.1182/blood-2009-08-237370","title":"HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell–mediated killing","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":159,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research","keywords":"NKG2D; Receptor; Human immunodeficiency virus (HIV); Cell biology; Biology; Chemistry; Virology; Cytotoxicity; Biochemistry; In vitro","score_opus":0.009375495002090018,"score_gpt":0.21614785411769466,"score_spread":0.20677235911560465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028534296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99595195,0.002202311,0.00021821503,0.00032649338,0.00080276164,0.00027808902,0.0000061630785,0.00004699963,0.00016704008],"genre_scores_gemma":[0.9955127,0.00019112835,0.00013496376,0.000055425615,0.000047277725,0.000016073169,0.0000982894,0.000009862574,0.0039342763],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994129,0.000028362727,0.00022010165,0.00015672384,0.000021507027,0.00016042977],"domain_scores_gemma":[0.9992592,0.00036195596,0.00016562421,0.00013468381,0.0000689022,0.000009654397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014811556,0.00010969096,0.0001516304,0.000047535133,0.00021821742,0.000012575642,0.00007903963,0.00013919876,0.00016379009],"category_scores_gemma":[0.00012741577,0.00007392441,0.00005699937,0.000061774124,0.00004882378,0.0000938087,0.000021296237,0.00015042414,0.00001967847],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019440487,0.00015421018,0.00013508799,0.000020570169,0.000040017603,4.6048473e-8,0.00058114436,0.0000013313067,0.99433935,0.000013734959,0.0022213878,0.0022987125],"study_design_scores_gemma":[0.001612051,0.00036454631,0.0003580465,0.000091360795,0.000046412704,0.000007027629,0.000563853,0.000030751395,0.9890122,0.00001960783,0.0078073065,0.00008683959],"about_ca_topic_score_codex":0.000004903767,"about_ca_topic_score_gemma":2.3133101e-7,"teacher_disagreement_score":0.0055859187,"about_ca_system_score_codex":0.0000053729955,"about_ca_system_score_gemma":0.0000128067195,"threshold_uncertainty_score":0.30145502},"labels":[],"label_agreement":null},{"id":"W2028881051","doi":"10.1182/blood-2006-07-038059","title":"The Pten/PI3K pathway governs the homeostasis of Vα14iNKT cells","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"PTEN; Cancer research; PI3K/AKT/mTOR pathway; Biology; Cytokine; Cell biology; Immunology; Signal transduction","score_opus":0.0054645451770987735,"score_gpt":0.1827349043636465,"score_spread":0.17727035918654774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028881051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89658105,0.015067346,0.00017741238,0.0013175607,0.007297354,0.00043288665,0.000041510957,0.000107153086,0.07897771],"genre_scores_gemma":[0.9587091,0.0002035488,0.0000071753775,0.00011663703,0.000059683134,0.0000118814805,0.000028029695,0.00000985719,0.040854074],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993032,0.00012576125,0.00023232646,0.0001158653,0.000034143857,0.0001886689],"domain_scores_gemma":[0.99927217,0.00021329617,0.00014337344,0.0003070811,0.000059422902,0.0000046646533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017890209,0.000095713454,0.0001093863,0.000020758505,0.00030181115,0.000016946413,0.00019333413,0.00010007972,0.00050429546],"category_scores_gemma":[0.000027808106,0.000051395393,0.00011304982,0.000082905644,0.00014710998,0.00004219456,0.000043519223,0.00019826472,0.0006379613],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007922496,0.00033068846,0.00031890132,0.0000054837733,0.000182986,7.645382e-7,0.00012469363,0.000005189722,0.9357725,0.004826119,0.054826178,0.0035273042],"study_design_scores_gemma":[0.0005400384,0.00006322636,0.002469233,0.0000050867266,0.00004293243,0.000016234815,0.00024529308,7.2786753e-7,0.5968687,0.00008939791,0.39961022,0.00004894626],"about_ca_topic_score_codex":0.00030485293,"about_ca_topic_score_gemma":0.00005977748,"teacher_disagreement_score":0.34478405,"about_ca_system_score_codex":0.000010559632,"about_ca_system_score_gemma":0.000022480803,"threshold_uncertainty_score":0.8199915},"labels":[],"label_agreement":null},{"id":"W2028991902","doi":"10.1182/blood-2010-05-280883","title":"Systematic review and meta-analysis methodology","year":2010,"lang":"en","type":"review","venue":"Blood","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":308,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Systematic review; Meta-analysis; Computer science; Process (computing); MEDLINE; Data science; Management science; Medicine; Biology; Pathology; Engineering","score_opus":0.9156491502031748,"score_gpt":0.6134030958983251,"score_spread":0.30224605430484974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028991902","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[4.2733134e-8,0.9900873,0.0019203238,0.0001718175,0.00009071954,0.0058299904,0.00015653153,0.000011397653,0.001731892],"genre_scores_gemma":[1.0701988e-7,0.9643325,0.012473209,0.0006144406,0.0000466417,0.0014363669,0.00004223215,0.000045213033,0.021009285],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.8438333,0.11194572,0.03528761,0.0029466138,0.0055057197,0.00048103268],"domain_scores_gemma":[0.91047716,0.038858354,0.03278957,0.016035145,0.0014123307,0.0004274524],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","scholarly_communication","insufficient_payload"],"consensus_categories":["metaresearch","metaepi_narrow","metaepi_broad","insufficient_payload"],"category_scores_codex":[0.35241482,0.0014350422,0.14375468,0.0018227042,0.00016151456,0.0010984213,0.0050433264,0.00070554606,0.02880291],"category_scores_gemma":[0.15093194,0.00051029434,0.05956494,0.006762287,0.0001262021,0.00014700319,0.0005103605,0.0008951505,0.0059946333],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[3.190258e-8,0.000037882397,4.0322843e-7,0.5813993,0.4138666,0.00000831757,0.000011146568,2.350143e-8,9.571728e-9,0.00043075802,0.0013528008,0.0028926788],"study_design_scores_gemma":[0.000021341823,0.000007068355,9.93652e-8,0.004553671,0.5996412,0.000138749,0.0000051588277,0.0000010155487,2.134119e-8,0.00026171526,0.39510366,0.0002662989],"about_ca_topic_score_codex":0.0000064223077,"about_ca_topic_score_gemma":0.00003620864,"teacher_disagreement_score":0.57684565,"about_ca_system_score_codex":0.000012081235,"about_ca_system_score_gemma":0.00014624996,"threshold_uncertainty_score":0.99993855},"labels":[{"model":"gemma","categories":["metaresearch"],"domain":"methods","study_design":"not_applicable","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":["metaresearch"],"domain":"methods","study_design":"systematic_review","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W2029205367","doi":"10.1182/blood.v97.6.1876","title":"Replicative stress after allogeneic bone marrow transplantation: changes in cycling of CD34+CD90+ and CD34+CD90− hematopoietic progenitors","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University Health Network","funders":"","keywords":"CD90; CD34; Haematopoiesis; Progenitor cell; Transplantation; Bone marrow; Medicine; Immunology; Stem cell; Biology; Cancer research; Internal medicine; Cell biology","score_opus":0.013310003612305176,"score_gpt":0.25611558968455617,"score_spread":0.242805586072251,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029205367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99545586,0.0019148067,0.0001321682,0.0006194232,0.00006530603,0.00092566386,0.000049995335,0.000056966037,0.0007798385],"genre_scores_gemma":[0.9960356,0.0018821842,0.0014016151,0.00008540412,0.000105856314,0.00024296984,0.000073038835,0.000043364573,0.00012999518],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998185,0.00008335856,0.0005538527,0.00048628915,0.00035189686,0.00033965003],"domain_scores_gemma":[0.9990913,0.00014248384,0.00016157715,0.00036215337,0.00008978227,0.00015268532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026633494,0.00025453765,0.00051703677,0.0002461872,0.00003807265,0.000013372506,0.000081850405,0.00017743371,0.00009754595],"category_scores_gemma":[0.000026943084,0.00024049071,0.0000760215,0.0003592991,0.00011801044,0.00007712983,0.000014389688,0.00017315676,0.000009947411],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090631,0.0011787097,0.8476086,0.0038579393,0.00021300749,0.0016826208,0.009587231,0.0000054691295,0.13333315,0.00009604844,0.00000666499,0.0015242394],"study_design_scores_gemma":[0.00989386,0.00056272413,0.21718512,0.0024494368,0.0010423899,0.0031343903,0.00131948,0.00003680555,0.76369613,0.00014351713,0.00008938765,0.00044676362],"about_ca_topic_score_codex":0.000043725177,"about_ca_topic_score_gemma":0.0002857435,"teacher_disagreement_score":0.6304235,"about_ca_system_score_codex":0.000023398441,"about_ca_system_score_gemma":0.000054791915,"threshold_uncertainty_score":0.9806926},"labels":[],"label_agreement":null},{"id":"W2029235302","doi":"10.1182/blood-2005-02-0626","title":"Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy","year":2005,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":796,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"North Carolina State University","keywords":"Medicine; Low molecular weight heparin; Pregnancy; Adverse effect; Thrombosis; Venous thrombosis; Confidence interval; Obstetrics; Thrombophilia; Internal medicine; Surgery","score_opus":0.022133266091543886,"score_gpt":0.310573702561578,"score_spread":0.28844043647003414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029235302","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00047713242,0.983619,0.0000098624705,0.000037090256,0.000057983114,0.0153163895,0.00012027883,0.000021127596,0.0003411638],"genre_scores_gemma":[0.000515904,0.9975724,0.00043486923,0.000049272436,0.000058992395,0.0011283479,0.00011141537,0.00008996091,0.000038809478],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9966552,0.00016664833,0.001867347,0.00063219183,0.00031149198,0.00036711348],"domain_scores_gemma":[0.9976818,0.00026333268,0.00096517854,0.00084681285,0.00010166143,0.00014122158],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029776985,0.0006290503,0.009833932,0.00028287564,0.000038582402,0.000011196057,0.00015539861,0.00024766612,0.000015073396],"category_scores_gemma":[0.00015808885,0.00044458773,0.0006698842,0.00031987127,0.00011912581,0.000038888727,0.00009787466,0.0001163678,0.0000024043297],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009005389,0.006528994,0.0000036392819,0.81944436,0.0018728786,0.000037855003,0.00019917123,6.181573e-8,0.0000025018355,0.0004491596,0.0000075738735,0.1714448],"study_design_scores_gemma":[0.0038187092,0.002563052,0.00024022008,0.9434047,0.031554393,0.00008775234,0.000010884262,0.0000010257775,0.000039566483,0.000015503982,0.017919732,0.00034445545],"about_ca_topic_score_codex":0.00003903835,"about_ca_topic_score_gemma":0.00001728247,"teacher_disagreement_score":0.17110035,"about_ca_system_score_codex":0.000117142525,"about_ca_system_score_gemma":0.00022358808,"threshold_uncertainty_score":0.99980056},"labels":[],"label_agreement":null},{"id":"W2029477694","doi":"10.1182/blood-2014-07-591529","title":"EVI1-rearranged acute myeloid leukemias are characterized by distinct molecular alterations","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Université de Montréal; Government of Canada; Génome Québec; Compute Canada; Genome Canada","keywords":"Transcriptome; Cancer research; Biology; Gene; Myeloid; Mutation; Alternative splicing; Myeloid leukemia; Genetics; RNA splicing; Gene expression; Exon; RNA","score_opus":0.011914150821125973,"score_gpt":0.2669286659811775,"score_spread":0.2550145151600515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029477694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848194,0.00033835293,0.0037475175,0.0029823696,0.00008595098,0.00095633,0.0001346725,0.00024311343,0.0066922978],"genre_scores_gemma":[0.9911693,0.00009250944,0.001588311,0.0015885591,0.0004978919,0.0002768424,0.0006757131,0.00009349168,0.004017389],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978044,0.00017932439,0.00036805772,0.00051612937,0.0005582288,0.0005738829],"domain_scores_gemma":[0.99838865,0.00011239515,0.00013586285,0.0007671249,0.00019589471,0.00040004542],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035282824,0.00029401033,0.0005362298,0.0001376371,0.00017929878,0.00008172367,0.00026235564,0.00018069868,0.00030027798],"category_scores_gemma":[0.00030900736,0.00025821503,0.00018148625,0.00031265078,0.00011813247,0.00012437474,0.000111844674,0.0005302508,0.0004740487],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018639733,0.0004753645,0.0037659567,0.00011823247,0.00048625216,0.0002831359,0.000106607986,3.137421e-7,0.9841133,0.0001159725,0.006901754,0.0034467161],"study_design_scores_gemma":[0.033070486,0.0011680666,0.036564324,0.000381756,0.0020428877,0.00094780046,0.00008894826,0.00093038456,0.6844541,0.0001910863,0.2390303,0.0011298631],"about_ca_topic_score_codex":0.00003722415,"about_ca_topic_score_gemma":0.0000053541307,"teacher_disagreement_score":0.2996592,"about_ca_system_score_codex":0.00016747674,"about_ca_system_score_gemma":0.0002244351,"threshold_uncertainty_score":0.999987},"labels":[],"label_agreement":null},{"id":"W2029653604","doi":"10.1182/blood-2013-07-512830","title":"Indolent T-cell lymphoproliferative disease of the gastrointestinal tract","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":192,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"University of Nebraska Medical Center","keywords":"Gastrointestinal tract; Lymphoma; Disease; Medicine; Lymphoproliferative disease; Lymphoproliferative disorders; Immunology; Pathology; Internal medicine","score_opus":0.008360033305339735,"score_gpt":0.214086726527523,"score_spread":0.20572669322218326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029653604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956944,0.00025339916,0.0000030365593,0.0008998983,0.000025514313,0.00050935196,0.000011704085,0.0000133096055,0.002589407],"genre_scores_gemma":[0.99893737,0.000010501977,0.0002989803,0.00026174713,0.00005385302,0.00010267363,0.0000047793365,0.000008231438,0.00032183703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99939394,0.000023762637,0.00014371357,0.00012656045,0.00017956844,0.00013246803],"domain_scores_gemma":[0.99943423,0.000039188475,0.00006743417,0.000245331,0.00007056985,0.00014321954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000025517726,0.00009699831,0.0001384396,0.000019187975,0.000034548993,0.00000917623,0.000057648,0.000013282284,0.00016799274],"category_scores_gemma":[0.00004401277,0.000052405227,0.000118584336,0.00006108338,0.00004757411,0.00003140287,0.000028641005,0.0000359923,0.0000716302],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026129595,0.005219835,0.991161,0.00003804313,0.0000196701,0.000041204734,0.00009033769,0.0000013567769,0.0024574082,0.000057193396,0.000452843,0.0004349988],"study_design_scores_gemma":[0.004715858,0.00026597778,0.95146656,0.00015438964,0.00024574762,0.00011643847,0.00004325723,0.000019850724,0.04282752,0.000050800627,0.00004909089,0.000044533917],"about_ca_topic_score_codex":0.00006348006,"about_ca_topic_score_gemma":0.0000012814866,"teacher_disagreement_score":0.040370114,"about_ca_system_score_codex":0.000029858507,"about_ca_system_score_gemma":0.00015312764,"threshold_uncertainty_score":0.21370232},"labels":[],"label_agreement":null},{"id":"W2029875685","doi":"10.1182/blood-2013-06-506691","title":"Platelet-derived ERp57 mediates platelet incorporation into a growing thrombus by regulation of the αIIbβ3 integrin","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Blood properties and coagulation","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor","funders":"National Heart, Lung, and Blood Institute; Soochow University; National Institute for Health and Care Research; Priority Academic Program Development of Jiangsu Higher Education Institutions; Temple University; American Heart Association","keywords":"Platelet; Thrombus; Chemistry; Platelet activation; Platelet Glycoprotein GPIIb-IIIa Complex; Integrin; Platelet adhesiveness; Thrombin; Cell biology; Clot retraction; Protein disulfide-isomerase; Hemostasis; Biochemistry; Biophysics; Receptor; Internal medicine; Biology; Medicine; Platelet aggregation; Enzyme","score_opus":0.009784187179859963,"score_gpt":0.20608436154220672,"score_spread":0.19630017436234676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029875685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99621594,0.0004506518,0.00011972338,0.001984763,0.00013466661,0.00064901373,0.000002842855,0.00006103499,0.0003813635],"genre_scores_gemma":[0.9985179,0.000031788222,0.00073593616,0.00027788986,0.00012865907,0.00003846588,0.00007637714,0.000025814363,0.00016720142],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988568,0.000062299114,0.00039563832,0.00020623117,0.00031285934,0.00016617458],"domain_scores_gemma":[0.99918854,0.000042533084,0.00022403731,0.00031305372,0.00016882009,0.000062986495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015107935,0.00015360177,0.0002623772,0.000055253124,0.00010145773,0.00002818059,0.00011572888,0.00015329494,0.0001719791],"category_scores_gemma":[0.00009620542,0.00009904334,0.00008453068,0.00022504952,0.00008481224,0.00035044664,0.00006489527,0.00017952267,0.00003151974],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048015925,0.00023759744,0.0104297735,0.00008831441,0.00011432077,9.847802e-7,0.001074313,0.00002305611,0.97403306,0.00018030523,0.001167311,0.012602969],"study_design_scores_gemma":[0.002384679,0.00024700823,0.09850244,0.00017819827,0.00013366879,0.000025939496,0.00037286864,0.0011971897,0.8942339,0.0021649753,0.0004133383,0.00014582645],"about_ca_topic_score_codex":0.0006936376,"about_ca_topic_score_gemma":0.00003159473,"teacher_disagreement_score":0.08807267,"about_ca_system_score_codex":0.000028203496,"about_ca_system_score_gemma":0.000059640333,"threshold_uncertainty_score":0.40388703},"labels":[],"label_agreement":null},{"id":"W2029886021","doi":"10.1182/blood-2007-09-109876","title":"Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":356,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Atypical hemolytic uremic syndrome; Factor H; Autoantibody; Immunology; Alternative complement pathway; Complement factor I; Complement system; Biology; Antibody","score_opus":0.010815103252729816,"score_gpt":0.23561948867749,"score_spread":0.22480438542476017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029886021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951011,0.00297582,0.000120930425,0.000041104468,0.00030499726,0.00037596276,0.00004489269,0.00012838625,0.0009067934],"genre_scores_gemma":[0.99926865,0.0000092094115,0.000064190346,0.00004922969,0.0000106449625,0.000012853317,0.00005368904,0.000019340741,0.0005122099],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998554,0.00007628184,0.0003851291,0.0003466622,0.0000659095,0.0005720055],"domain_scores_gemma":[0.9993118,0.00019760767,0.00010234326,0.00031668093,0.000034292392,0.000037242895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019247661,0.00020939102,0.00031445577,0.00018410404,0.00010406422,0.000012748301,0.0002497052,0.00015020493,0.0005631585],"category_scores_gemma":[0.000064212996,0.00016918196,0.000065380154,0.0002121857,0.00016005825,0.000065899636,0.00008426318,0.00024395758,0.00059862295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003543629,0.0013583965,0.9483536,0.00009628351,0.00017226193,0.0005025542,0.0005316958,0.0000075927746,0.047289025,0.00069147995,0.0003150257,0.00032771018],"study_design_scores_gemma":[0.0036777873,0.0003659711,0.98561126,0.00019533638,0.00010212353,0.0013422385,0.00029947306,0.0000020009843,0.0074769254,0.00007353939,0.00055723183,0.0002961208],"about_ca_topic_score_codex":0.000060519607,"about_ca_topic_score_gemma":0.00011641638,"teacher_disagreement_score":0.0398121,"about_ca_system_score_codex":0.00004457304,"about_ca_system_score_gemma":0.00006836967,"threshold_uncertainty_score":0.7694286},"labels":[],"label_agreement":null},{"id":"W2029926718","doi":"10.1182/blood-2003-01-0054","title":"Antithrombotic thrombocytes: ectopic expression of urokinase-type plasminogen activator in platelets","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute","keywords":"Platelet; Thrombus; Fibrinolysis; Urokinase; Plasminogen activator; Medicine; Thrombosis; Bleeding diathesis; Ectopic expression; Immunology; Pathology; Internal medicine; Biology; Cell culture","score_opus":0.018628409278050657,"score_gpt":0.26215259825733567,"score_spread":0.24352418897928502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029926718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947233,0.00072824553,0.000003115427,0.000017031567,0.00008373595,0.0002815554,0.000004302336,0.000023793333,0.0041348715],"genre_scores_gemma":[0.9990229,0.00014686545,0.0006320151,0.000035827416,0.000011864203,0.0000064190817,0.000013727865,0.000019425492,0.00011093705],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99912274,0.00003435098,0.00022042177,0.00022261075,0.00017171913,0.00022818129],"domain_scores_gemma":[0.99953294,0.000047921956,0.00007214219,0.00023985727,0.0000317415,0.00007542847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000054543303,0.00014651453,0.00041518325,0.000108538035,0.000027536531,0.0000048610723,0.000052638916,0.000103861836,0.00019148565],"category_scores_gemma":[0.00009746351,0.00011883393,0.00005545452,0.00022796153,0.000035129717,0.00006605017,0.000015251791,0.00010797694,0.000031353346],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014820132,0.0049302247,0.45705265,0.00018869125,0.00019396104,0.0015508,0.00037347735,0.000007596555,0.5349055,0.00018966418,0.00013671456,0.00032256488],"study_design_scores_gemma":[0.0071728025,0.00047257004,0.10212346,0.00022890374,0.000112594425,0.00016405835,0.0000793303,0.0000040135883,0.8889952,0.00016944767,0.00036219653,0.00011547416],"about_ca_topic_score_codex":0.000028194394,"about_ca_topic_score_gemma":0.0000073516258,"teacher_disagreement_score":0.35492918,"about_ca_system_score_codex":0.000021385393,"about_ca_system_score_gemma":0.000092500675,"threshold_uncertainty_score":0.4845907},"labels":[],"label_agreement":null},{"id":"W2030100501","doi":"10.1182/blood-2002-05-1338","title":"Albumin-expressing hepatocyte-like cells develop in the livers of immune-deficient mice that received transplants of highly purified human hematopoietic stem cells","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Liver physiology and pathology","field":"Medicine","cited_by":242,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; National Cancer Institute; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; York University; Kaiser Permanente","keywords":"Stem cell; Biology; CD34; Liver injury; Bone marrow; Haematopoiesis; Progenitor cell; Immunology; Transplantation; Hematopoietic stem cell; Pathology; Cancer research; Internal medicine; Endocrinology; Medicine; Cell biology","score_opus":0.028973264190123686,"score_gpt":0.23963600670178054,"score_spread":0.21066274251165684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030100501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970558,0.0007799899,0.000016122769,0.000023056282,0.00014920761,0.0004431099,0.000016606255,0.00001491586,0.0015011905],"genre_scores_gemma":[0.999236,0.00011681383,0.00033611155,0.000113850925,0.000010831578,0.000013962316,0.000011316505,0.000016584669,0.00014452673],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983291,0.0004101806,0.00047798813,0.00027954252,0.00020618377,0.0002969851],"domain_scores_gemma":[0.9990216,0.00022760162,0.00024149788,0.00039493997,0.000069662005,0.00004472157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048744396,0.00018899904,0.00052648544,0.00011892731,0.000075799675,0.0000039449274,0.00023518743,0.00019261522,0.000033212345],"category_scores_gemma":[0.000007105512,0.00014110345,0.000112807116,0.00022658853,0.00021775952,0.00003937816,0.00002057107,0.0002557741,0.000012602805],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013218087,0.0009324073,0.00638084,0.0004011549,0.00007594236,0.00012344397,0.012694164,0.000013516192,0.9790543,0.00014126232,0.000027962638,0.000022838818],"study_design_scores_gemma":[0.0032688219,0.00026488505,0.013232392,0.00033924592,0.0002453808,0.00008652657,0.0016792746,0.00000251948,0.98062414,0.00004317097,0.00008158126,0.00013209146],"about_ca_topic_score_codex":0.000058516514,"about_ca_topic_score_gemma":0.000010326622,"teacher_disagreement_score":0.01101489,"about_ca_system_score_codex":0.000013350985,"about_ca_system_score_gemma":0.000103644044,"threshold_uncertainty_score":0.57540315},"labels":[],"label_agreement":null},{"id":"W2030320042","doi":"10.1182/blood-2002-11-3517","title":"Fanconi anemia protein complex: mapping protein interactions in the yeast 2- and 3-hybrid systems","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"FANCA; FANCD2; Fanconi anemia; Biology; Genetics; Gene; DNA repair","score_opus":0.017297316427854408,"score_gpt":0.23653672101690065,"score_spread":0.21923940458904626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030320042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99548703,0.00029319164,0.0007958595,0.000051926236,0.000061660765,0.0008003471,0.0000126191835,0.000012442789,0.0024849016],"genre_scores_gemma":[0.99819815,0.0000035957432,0.0008597371,0.00005538087,0.00006170043,0.00024238002,0.000019531175,0.000013293133,0.00054623355],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99923533,0.00014614942,0.00014852741,0.00022328315,0.000080651116,0.00016607333],"domain_scores_gemma":[0.9996248,0.000004767602,0.00005463565,0.00026001918,0.000023629827,0.000032175605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022310457,0.00010445066,0.00009256266,0.00003065899,0.000057552792,0.000045677414,0.00010947626,0.00003646163,0.000007559888],"category_scores_gemma":[0.00005894062,0.000085247346,0.000029298899,0.00006248007,0.00002839404,0.0000037309637,0.00003450629,0.0000971539,0.0000064005517],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004948393,0.00010422081,0.00040474898,0.00004012542,0.000015698359,0.0000116176125,0.00006234917,0.0000027487044,0.99823904,0.0008833845,0.000104568244,0.00012652032],"study_design_scores_gemma":[0.0011590534,0.00014128881,0.00066084426,0.000101013415,0.000015519503,0.0004138321,0.0006258536,0.000041906533,0.94089276,0.0003463057,0.055377733,0.0002238833],"about_ca_topic_score_codex":0.000037997048,"about_ca_topic_score_gemma":0.00003540257,"teacher_disagreement_score":0.057346303,"about_ca_system_score_codex":0.000006054579,"about_ca_system_score_gemma":0.000030256093,"threshold_uncertainty_score":0.3476286},"labels":[],"label_agreement":null},{"id":"W2030370150","doi":"10.1182/blood-2004-01-0151","title":"In vitro–expanded human CD4+CD25+ T-regulatory cells can markedly inhibit allogeneic dendritic cell–stimulated MLR cultures","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":275,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Institute of Allergy and Infectious Diseases; National Heart, Lung, and Blood Institute","keywords":"IL-2 receptor; Mixed lymphocyte reaction; Cell biology; Biology; Immunology; Aldesleukin; CD28; T cell; Regulatory T cell; Cell culture; Molecular biology; Immune system","score_opus":0.006462400267549184,"score_gpt":0.21465688832268054,"score_spread":0.20819448805513135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030370150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918286,0.0051801475,0.0000045757347,0.00021774322,0.00077173806,0.0004397435,0.000052722713,0.00017617855,0.0013285021],"genre_scores_gemma":[0.9926226,0.00009290144,0.000119649405,0.00055492274,0.00007238623,0.000045098834,0.0002780121,0.00005941846,0.0061550136],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972295,0.00029133976,0.00067020714,0.00072906056,0.00007681784,0.001003077],"domain_scores_gemma":[0.99899375,0.00007209231,0.00018432313,0.00060345716,0.00007810159,0.000068263296],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020557051,0.0004997164,0.0006425308,0.0003038022,0.00033856853,0.000030977844,0.0005085175,0.0008784723,0.00059968233],"category_scores_gemma":[0.00001926788,0.00046883224,0.00020939569,0.00029543097,0.00045764205,0.00010382159,0.0001903599,0.00077015115,0.00072849507],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014378774,0.0017619818,0.0004960021,0.000040952305,0.00021537342,0.0002086776,0.0006137792,0.00007168536,0.9955033,0.00014279285,0.0007177234,0.00008392677],"study_design_scores_gemma":[0.012195788,0.00027703904,0.0012809735,0.000047264046,0.00017784732,0.0002201205,0.00018169968,3.084977e-7,0.98117864,0.0005144577,0.0033722066,0.00055363716],"about_ca_topic_score_codex":0.000865658,"about_ca_topic_score_gemma":0.0004743774,"teacher_disagreement_score":0.0143246595,"about_ca_system_score_codex":0.000111133224,"about_ca_system_score_gemma":0.00015881548,"threshold_uncertainty_score":0.99977636},"labels":[],"label_agreement":null},{"id":"W2030437009","doi":"10.1182/blood-2009-03-211797","title":"Treatment of myelodysplastic syndrome patients with erythropoietin with or without granulocyte colony-stimulating factor: results of a prospective randomized phase 3 trial by the Eastern Cooperative Oncology Group (E1996)","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":207,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Cancer Institute; U.S. Department of Veterans Affairs","keywords":"Granulocyte colony-stimulating factor; Erythropoietin; Medicine; Internal medicine; Myelodysplastic syndromes; Oncology; Randomized controlled trial; Anemia; Granulocyte; Chemotherapy; Bone marrow","score_opus":0.01824722101255351,"score_gpt":0.31507436125200056,"score_spread":0.29682714023944706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030437009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98838556,0.00008546012,0.00027824793,0.00021425982,0.000037770045,0.010211901,0.0002572485,0.000040700106,0.0004888377],"genre_scores_gemma":[0.9976162,0.000030401794,0.0011369038,0.00003116047,0.000060706552,0.0003762112,0.00016537464,0.00004295432,0.0005400915],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99673593,0.00059165794,0.0008772141,0.0005524728,0.0007882762,0.00045443047],"domain_scores_gemma":[0.9966152,0.0014886458,0.00068103656,0.00046450357,0.0005696671,0.0001810023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036115886,0.00042789636,0.002027625,0.00013978055,0.00013778043,0.000018589635,0.00016280895,0.00015461244,0.000032978107],"category_scores_gemma":[0.0006367552,0.00019189982,0.00014220632,0.00045993706,0.0007772501,0.00009302105,0.00003161246,0.00029386536,0.000004395991],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97255796,0.012348074,0.0070852195,0.000039740244,0.0015464113,0.00018896951,0.004019812,0.000023076074,0.00084056566,0.000006920866,0.00003108975,0.0013121606],"study_design_scores_gemma":[0.82057613,0.17181303,0.0015092556,0.00021295657,0.0013381508,0.00015059914,0.00033310815,0.00094752375,0.0028906153,0.0000030333192,0.00004239615,0.00018322268],"about_ca_topic_score_codex":0.00025327547,"about_ca_topic_score_gemma":0.00010721935,"teacher_disagreement_score":0.15946496,"about_ca_system_score_codex":0.00039742904,"about_ca_system_score_gemma":0.0008444275,"threshold_uncertainty_score":0.78254473},"labels":[],"label_agreement":null},{"id":"W2030437588","doi":"10.1182/blood-2010-06-284935","title":"X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":319,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"European Society for Immunodeficiencies; Wellcome Trust","keywords":"Hemophagocytic lymphohistiocytosis; Medicine; Hematopoietic stem cell transplantation; Immune dysregulation; Disease; Lymphoproliferative disorders; Immunodeficiency; Lymphoma; Immunology; Malignancy; Transplantation; Pediatrics; Internal medicine; Immune system","score_opus":0.021533205855280804,"score_gpt":0.3016187587247692,"score_spread":0.2800855528694884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030437588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924398,0.000082806415,0.000011743488,0.004070583,0.000056073048,0.002556692,0.000019097308,0.000017244387,0.000745957],"genre_scores_gemma":[0.99798214,0.0000072527564,0.00003978789,0.00084001815,0.000020536807,0.0002479596,0.0000030584833,0.000014482138,0.0008447631],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987863,0.000097046344,0.00026701734,0.0002270773,0.00043560387,0.00018697383],"domain_scores_gemma":[0.9989797,0.00007881009,0.000060163533,0.0006326373,0.00007840949,0.00017030977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028086783,0.00012625796,0.00016095751,0.00007468395,0.00020853464,0.000027393442,0.0001940934,0.00001875293,0.000061729166],"category_scores_gemma":[0.00030544391,0.00006588085,0.00006794838,0.00016083813,0.000110372675,0.000039055747,0.0001766171,0.00017232886,0.000032624677],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003554763,0.003023295,0.99171525,0.00011070373,0.000096143856,0.00018313216,0.001987221,0.0000037735806,0.00032740113,0.0017147465,0.00010743274,0.00037540268],"study_design_scores_gemma":[0.0027320196,0.00014159414,0.9941007,0.000043403994,0.00025046268,0.0000025837053,0.0021605073,0.000091128335,0.00009299212,0.00009592043,0.00021462797,0.000074053154],"about_ca_topic_score_codex":0.000015661237,"about_ca_topic_score_gemma":0.000019518451,"teacher_disagreement_score":0.0055423374,"about_ca_system_score_codex":0.000010872037,"about_ca_system_score_gemma":0.00006708134,"threshold_uncertainty_score":0.2686543},"labels":[],"label_agreement":null},{"id":"W2030451786","doi":"10.1182/blood-2011-08-376814","title":"Tissue factor and glycoprotein C on herpes simplex virus type 1 are protease-activated receptor 2 cofactors that enhance infection","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of British Columbia","funders":"University of Pennsylvania; University of British Columbia; Heart and Stroke Foundation of Canada","keywords":"Tissue factor; Proteases; Thrombin; Biology; Receptor; Herpes simplex virus; Protease; Glycoprotein; Coagulation; Virus; Virology; Immunology; Molecular biology; Biochemistry; Platelet; Enzyme; Medicine","score_opus":0.044930982768443456,"score_gpt":0.3036443160013445,"score_spread":0.258713333232901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030451786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977739,0.00016710005,0.00009590818,0.00017477843,0.00030961641,0.0009433857,0.000021306892,0.00019353707,0.0003204829],"genre_scores_gemma":[0.9986468,0.00006133085,0.00030045156,0.0002379552,0.00024793425,0.000055416553,0.00003353764,0.0000410805,0.00037551095],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989666,0.0000694111,0.00016558454,0.00025452618,0.0002527617,0.00029112966],"domain_scores_gemma":[0.9992676,0.000033788514,0.00014634145,0.0002409536,0.00007142339,0.00023988902],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000087786,0.00021493067,0.0002903244,0.00009040067,0.00010620238,0.000026474505,0.000035581794,0.00018190735,0.0010111408],"category_scores_gemma":[0.00011377489,0.00018228343,0.000039143677,0.00019186363,0.000032508597,0.0001832617,0.000026168855,0.0001663134,0.00020211641],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021303033,0.0014720659,0.023090852,0.00011154824,0.00015215557,0.0000031659172,0.00031027241,1.9784942e-7,0.94530517,0.00012988356,0.00018610749,0.029025573],"study_design_scores_gemma":[0.0012210156,0.00053620763,0.10602281,0.00011931014,0.000077299934,0.000010330246,0.000033272387,0.0000015001121,0.8679212,0.000022773002,0.023858737,0.00017554597],"about_ca_topic_score_codex":0.00013504033,"about_ca_topic_score_gemma":0.000014923883,"teacher_disagreement_score":0.08293196,"about_ca_system_score_codex":0.000034000903,"about_ca_system_score_gemma":0.000027677354,"threshold_uncertainty_score":0.99990207},"labels":[],"label_agreement":null},{"id":"W2030456544","doi":"10.1182/blood-2013-07-517938","title":"Leukocyte cell-derived chemotaxin 2 (LECT2)–associated amyloidosis is a frequent cause of hepatic amyloidosis in the United States","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Amyloidosis; Medicine; Pathology","score_opus":0.01045527984704323,"score_gpt":0.23486049294437394,"score_spread":0.22440521309733072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030456544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976212,0.0006277351,0.000046747715,0.00071588845,0.000054926735,0.00052602356,0.00008974727,0.000034030432,0.0002836968],"genre_scores_gemma":[0.99486476,0.0017118037,0.00026021167,0.002113322,0.00005575571,0.00021803146,0.0005594347,0.00006311519,0.00015355894],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974435,0.00045583452,0.0005964474,0.0005789057,0.00035886536,0.00056647643],"domain_scores_gemma":[0.9982824,0.00021223132,0.0004060844,0.0008337192,0.00015336557,0.00011224491],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043946924,0.00043298182,0.0005002762,0.0001886281,0.000114324306,0.000045879904,0.000557246,0.00028053878,0.000048186437],"category_scores_gemma":[0.0003481511,0.00034342593,0.00025977407,0.00059819757,0.00015580493,0.000008667707,0.00014289768,0.00018981239,0.000022744687],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010458495,0.00413504,0.4564961,0.00012486627,0.0010607111,0.000019498546,0.002518635,0.00017802576,0.5323053,0.000023931703,0.002711102,0.0003221828],"study_design_scores_gemma":[0.0046354746,0.00064603006,0.06019187,0.00006140472,0.00046225166,0.000005805861,0.00044628917,0.00019224912,0.9316202,0.000058031088,0.0012722831,0.00040814836],"about_ca_topic_score_codex":0.0019806814,"about_ca_topic_score_gemma":0.0006113901,"teacher_disagreement_score":0.39931485,"about_ca_system_score_codex":0.00006266503,"about_ca_system_score_gemma":0.00008020301,"threshold_uncertainty_score":0.9999018},"labels":[],"label_agreement":null},{"id":"W2030867589","doi":"10.1182/blood-2014-10-603738","title":"STAT1 is phosphorylated and downregulated by the oncogenic tyrosine kinase NPM-ALK in ALK-positive anaplastic large-cell lymphoma","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; China Scholarship Council","keywords":"Anaplastic lymphoma kinase; Cancer research; STAT1; Anaplastic large-cell lymphoma; Tyrosine kinase; Biology; STAT3; Phosphorylation; Molecular biology; Lymphoma; Signal transduction; Lung cancer; Cell biology; Medicine; Immunology; Oncology","score_opus":0.009253198289338556,"score_gpt":0.23017511801146578,"score_spread":0.22092191972212724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030867589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835837,0.012704153,0.000004779972,0.0011601939,0.00007344113,0.00062644266,0.00022680493,0.00005245394,0.0015680654],"genre_scores_gemma":[0.9973402,0.0003211909,0.00007358035,0.00086592324,0.000039283404,0.00006150627,0.00020629846,0.000035271732,0.0010567295],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99843234,0.00007692194,0.0003121631,0.00042130516,0.00031818546,0.0004391145],"domain_scores_gemma":[0.99897707,0.00013608063,0.00009873095,0.00035017284,0.00011980826,0.00031814788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001927455,0.00028802606,0.0003929239,0.00008230229,0.000088159024,0.000043947734,0.00008979074,0.000138073,0.00005658544],"category_scores_gemma":[0.000053896907,0.00019259781,0.0000753595,0.0003721966,0.00009185476,0.000072279465,0.000079729856,0.000086178574,0.000077162535],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008071023,0.1164196,0.5538306,0.00037315514,0.0043950747,0.009996957,0.025311919,0.0000244026,0.05950838,0.00044919847,0.17517918,0.046440493],"study_design_scores_gemma":[0.17593755,0.0043608793,0.2248272,0.0004002928,0.0022617057,0.00065640523,0.0011587744,0.00082753855,0.56390244,0.00013690027,0.024769934,0.0007603773],"about_ca_topic_score_codex":0.00066007534,"about_ca_topic_score_gemma":0.00009237411,"teacher_disagreement_score":0.50439405,"about_ca_system_score_codex":0.00025108477,"about_ca_system_score_gemma":0.0002971446,"threshold_uncertainty_score":0.7853911},"labels":[],"label_agreement":null},{"id":"W2031150801","doi":"10.1182/blood.v100.8.2950","title":"Expression of Skp2, a p27Kip1 ubiquitin ligase, in malignant lymphoma: correlation with p27Kip1 and proliferation index","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"National Cancer Institute","keywords":"SKP2; Proliferation index; Lymphoma; Biology; Germinal center; Proliferative index; Follicular lymphoma; Cancer research; Cell cycle; Cell growth; Pathology; Ubiquitin ligase; B cell; Immunohistochemistry; Cell; Ubiquitin; Medicine; Immunology; Antibody","score_opus":0.009023427951299868,"score_gpt":0.20543645146911377,"score_spread":0.1964130235178139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031150801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957929,0.001258822,0.0007705778,0.0001296288,0.000038388138,0.00063819083,0.00000556638,0.000040712108,0.0013251855],"genre_scores_gemma":[0.9988634,0.00010818221,0.00066333334,0.000075878284,0.000050479975,0.000054857803,0.000022222976,0.000026674028,0.00013498904],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988965,0.000044433375,0.00030682152,0.00027271183,0.00029576043,0.0001838195],"domain_scores_gemma":[0.99943703,0.000024130442,0.00014401406,0.00022763878,0.000079742385,0.00008743818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001215366,0.00014500011,0.00025308906,0.0001858612,0.0000355842,0.000011577093,0.000037240017,0.00015329097,0.000044293585],"category_scores_gemma":[0.000063516956,0.000120864766,0.000030615294,0.00026602377,0.000053040952,0.00009360469,0.000028924911,0.00011748953,0.0000066447365],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010750605,0.004235424,0.4411649,0.0005001957,0.00011712812,0.00056782214,0.0043363185,0.00037167122,0.53403324,0.0003095824,0.0004845748,0.0128041],"study_design_scores_gemma":[0.02807138,0.001574632,0.14752935,0.0024147541,0.0002938719,0.00072106643,0.00021362785,0.008678502,0.80983335,0.00007797109,0.00025248554,0.0003390362],"about_ca_topic_score_codex":0.00003711765,"about_ca_topic_score_gemma":0.000043088385,"teacher_disagreement_score":0.29363558,"about_ca_system_score_codex":0.00004472521,"about_ca_system_score_gemma":0.00006123911,"threshold_uncertainty_score":0.4928722},"labels":[],"label_agreement":null},{"id":"W2031280751","doi":"10.1182/blood-2014-02-557975","title":"Phosphoinositide 3-kinase β mediates microvascular endothelial repair of thrombotic microangiopathy","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Thrombotic microangiopathy; Phosphoinositide 3-kinase; Medicine; Endothelium; Internal medicine; Cell biology; Biology; Signal transduction; PI3K/AKT/mTOR pathway","score_opus":0.006817359613016385,"score_gpt":0.20673589791651462,"score_spread":0.19991853830349823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031280751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98975515,0.008481817,0.000054662913,0.000027354314,0.0004949444,0.00029777104,0.00010286489,0.00017529006,0.0006101431],"genre_scores_gemma":[0.99914914,0.00003783759,0.00029876534,0.00007964561,0.00007674186,0.000029439452,0.00010793156,0.000025552836,0.00019491359],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998549,0.0002756366,0.00043559933,0.00033265265,0.000057409492,0.0003496965],"domain_scores_gemma":[0.99890393,0.00022274672,0.00017391099,0.0005924889,0.00007463509,0.00003231471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032248147,0.00020172138,0.0004231453,0.00008961689,0.000091723574,0.000006939958,0.00029258966,0.00010867988,0.00068489497],"category_scores_gemma":[0.00017804863,0.00018684682,0.00036951678,0.0000963881,0.00018022492,0.00004359701,0.00012287033,0.00009574427,0.00046981144],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034691842,0.0006980633,0.051388215,0.000114812596,0.0005503438,0.000008183954,0.00016837075,0.0000015973151,0.9439832,0.0005961762,0.0022805936,0.00017575605],"study_design_scores_gemma":[0.0034935514,0.0002253171,0.024214374,0.000101727775,0.00046256656,0.00005951383,0.0000964876,0.0000016384588,0.9626052,0.00015800812,0.008367178,0.00021447631],"about_ca_topic_score_codex":0.00017849849,"about_ca_topic_score_gemma":0.000018743052,"teacher_disagreement_score":0.02717384,"about_ca_system_score_codex":0.000012729777,"about_ca_system_score_gemma":0.00004315983,"threshold_uncertainty_score":0.7619392},"labels":[],"label_agreement":null},{"id":"W2031322795","doi":"10.1182/blood-2011-03-345272","title":"Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":205,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute","keywords":"Diffuse large B-cell lymphoma; Germinal center; International Prognostic Index; Stromal cell; Biology; Cancer research; Tumor microenvironment; Lymphoma; Immune system; Oncology; Medicine; B cell; Immunology; Antibody","score_opus":0.0340174480951962,"score_gpt":0.23094980375719243,"score_spread":0.19693235566199624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031322795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982725,0.00034973066,0.0000045892293,0.000033864035,0.000026131296,0.00022956902,0.000022132024,0.0000064882242,0.0010549993],"genre_scores_gemma":[0.9994873,0.0000904808,0.0003011893,0.000047625872,0.000014705881,0.000029461316,0.000005629497,0.000008934644,0.000014693325],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99939364,0.000051304414,0.00018210233,0.00013684761,0.00013332748,0.00010274815],"domain_scores_gemma":[0.9995979,0.00007747895,0.0000932995,0.00018908447,0.000009529961,0.00003269799],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001356321,0.00008246239,0.00016317908,0.00004531558,0.00002589632,0.0000016400851,0.000030450263,0.000028971957,0.000027666447],"category_scores_gemma":[0.000017543236,0.000050300816,0.000038259426,0.000042542506,0.00002735935,0.00001178815,0.000025167297,0.000021974047,0.0000013491529],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020389272,0.026566114,0.823525,0.000082623716,0.000020898155,0.000028590304,0.0005397259,4.265046e-7,0.14843927,0.000017609646,0.000016163918,0.00055965106],"study_design_scores_gemma":[0.013033431,0.0003578718,0.4103401,0.00013765939,0.00006587376,0.0000033193426,0.000131278,0.000030607684,0.57583094,0.0000037285906,0.000042247044,0.000022921402],"about_ca_topic_score_codex":0.00007668135,"about_ca_topic_score_gemma":0.000006500917,"teacher_disagreement_score":0.42739168,"about_ca_system_score_codex":0.0000244673,"about_ca_system_score_gemma":0.00001558265,"threshold_uncertainty_score":0.20512077},"labels":[],"label_agreement":null},{"id":"W2031359173","doi":"10.1182/blood-2010-09-306829","title":"HLA-matched sibling bone marrow transplantation for β-thalassemia major","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Medicine; Thalassemia; Cumulative incidence; Surgery; Transplantation; Sibling; Internal medicine; Bone marrow; Gastroenterology","score_opus":0.007244031149567426,"score_gpt":0.24415602102219214,"score_spread":0.2369119898726247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031359173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99406505,0.00025468387,0.00041811366,0.0013888307,0.00029341693,0.0004905041,0.00001791875,0.00010195117,0.0029695183],"genre_scores_gemma":[0.9940417,0.00014339479,0.004379193,0.00024911747,0.00017924592,0.000043237706,0.000104181156,0.00003046288,0.00082949793],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99923795,0.000007876623,0.0002033279,0.00018642057,0.00013067476,0.00023377096],"domain_scores_gemma":[0.9995539,0.000053844782,0.00004918508,0.00016621653,0.00006251371,0.000114293245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014861637,0.00011393354,0.00019421917,0.000087605855,0.00008147706,0.000015751399,0.000045767738,0.00021668978,0.00009346904],"category_scores_gemma":[0.00006391046,0.0000953096,0.00010488219,0.0001357939,0.000030367746,0.000049709983,0.0000050421904,0.00025745665,0.0000320099],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021608932,0.00053885713,0.008769893,0.00047627682,0.00012226724,0.00008730926,0.00057619764,0.0000036371719,0.9854733,0.00026556235,0.00072859443,0.0027420272],"study_design_scores_gemma":[0.06149833,0.0013467353,0.030475397,0.0006495389,0.0048169782,0.0024127518,0.0016275907,0.0018136977,0.8671667,0.001545644,0.0255532,0.0010934331],"about_ca_topic_score_codex":0.00001916852,"about_ca_topic_score_gemma":0.000030336674,"teacher_disagreement_score":0.118306585,"about_ca_system_score_codex":0.000005033622,"about_ca_system_score_gemma":0.00005824908,"threshold_uncertainty_score":0.38866127},"labels":[],"label_agreement":null},{"id":"W2031454492","doi":"10.1182/blood-2014-09-599498","title":"Fondaparinux for the treatment of suspected heparin-induced thrombocytopenia: a propensity score–matched study","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Fondaparinux; Heparin-induced thrombocytopenia; Medicine; Propensity score matching; Heparin; Internal medicine; Intensive care medicine; Thrombosis; Venous thromboembolism","score_opus":0.09198739414112386,"score_gpt":0.30836459379716347,"score_spread":0.2163771996560396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031454492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99037415,0.00008010126,0.00009529082,0.00047705387,0.00025770636,0.0063985395,0.000010342022,0.00014672452,0.002160111],"genre_scores_gemma":[0.99811876,0.000058307873,0.00041917939,0.00008773166,0.00030959584,0.00059313705,0.000023300569,0.00007861759,0.00031139824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99739856,0.00017290984,0.0007091054,0.0007033914,0.00042592653,0.0005901413],"domain_scores_gemma":[0.9971412,0.00055240915,0.0002690479,0.001436587,0.0003651682,0.00023562684],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00051171536,0.0004680272,0.0016573443,0.00012037148,0.0003311919,0.00005531738,0.00034789584,0.00017422525,0.00009592939],"category_scores_gemma":[0.000277365,0.00028941658,0.00038561865,0.00042155915,0.00012983648,0.000100738944,0.00010541738,0.00019205103,0.00004786448],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013608268,0.036686562,0.57896656,0.00022966623,0.005231149,0.00004264786,0.006442902,0.000003203895,0.35836267,0.0016938909,0.00013078404,0.0108491415],"study_design_scores_gemma":[0.02169223,0.013316163,0.7054214,0.00006323415,0.0037212502,0.000058546706,0.00054542325,0.00011217136,0.2531245,0.00016076402,0.0014318306,0.00035247108],"about_ca_topic_score_codex":0.0010888183,"about_ca_topic_score_gemma":0.0010931478,"teacher_disagreement_score":0.12645485,"about_ca_system_score_codex":0.00012308973,"about_ca_system_score_gemma":0.0002726628,"threshold_uncertainty_score":0.9999558},"labels":[],"label_agreement":null},{"id":"W2031530131","doi":"10.1182/blood-2013-01-478834","title":"The E3 ubiquitin ligase UBR5 is recurrently mutated in mantle cell lymphoma","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":142,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Mantle cell lymphoma; Ubiquitin ligase; Biology; DNA ligase; Lymphoma; Genetics; Ubiquitin-Protein Ligases; Cancer research; Ubiquitin; Gene; Immunology","score_opus":0.008018948697593554,"score_gpt":0.22821397900998117,"score_spread":0.2201950303123876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031530131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98352784,0.0023282622,2.6196793e-7,0.0023204545,0.00009912895,0.0005732455,0.000011092001,0.00004304984,0.011096637],"genre_scores_gemma":[0.99673617,0.00060297473,0.00008444554,0.0006916747,0.000079241625,0.00023476471,0.000023374318,0.000020487421,0.0015268914],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989378,0.000036048583,0.00025463352,0.00024350922,0.00019316672,0.0003348729],"domain_scores_gemma":[0.99927676,0.000111018904,0.000064549,0.00035335522,0.00005763608,0.00013668885],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000089605695,0.00015884318,0.00020379672,0.000054480017,0.00008593484,0.000052282532,0.00009840934,0.00006819268,0.0002935787],"category_scores_gemma":[0.0000306712,0.00009871009,0.000089274115,0.00016962171,0.000042858195,0.000052012758,0.000046126635,0.00005235766,0.001213672],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029980316,0.040202565,0.4839807,0.00032796524,0.0007345916,0.002434673,0.004354241,0.0000013277241,0.010963225,0.00060430414,0.12608632,0.3300103],"study_design_scores_gemma":[0.028314888,0.00062868046,0.4112143,0.00022812073,0.00032809205,0.00015294547,0.00049558067,0.000103699844,0.5335317,0.0003541425,0.024368986,0.00027883987],"about_ca_topic_score_codex":0.0006039728,"about_ca_topic_score_gemma":0.00004048854,"teacher_disagreement_score":0.5225685,"about_ca_system_score_codex":0.000074053314,"about_ca_system_score_gemma":0.000088866575,"threshold_uncertainty_score":0.999564},"labels":[],"label_agreement":null},{"id":"W2031540132","doi":"10.1182/blood-2003-01-0175","title":"Suppressor of cytokine signaling 1 attenuates IL-15 receptor signaling in CD8+ thymocytes","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Women's College Hospital; Ontario Institute for Cancer Research","funders":"","keywords":"Suppressor of cytokine signaling 1; Biology; CD8; Cytokine; Thymocyte; Cell biology; STAT5; Signal transduction; Suppressor of cytokine signalling; Immunology; SOCS3; Immune system; STAT3; Suppressor","score_opus":0.02252484665296639,"score_gpt":0.26324880037266524,"score_spread":0.24072395371969885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031540132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99601525,0.0006475036,0.00010509227,0.00019456279,0.00018785344,0.00031091922,0.00007052186,0.00006572896,0.0024025685],"genre_scores_gemma":[0.9957262,0.000039621573,0.0035896532,0.00012519592,0.00018250528,0.000030749372,0.00004705331,0.00004562883,0.00021336821],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982695,0.00009376575,0.00063191284,0.0003440088,0.0002974103,0.0003633813],"domain_scores_gemma":[0.99889916,0.00028690786,0.00018032378,0.0003129743,0.0001947646,0.00012587626],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003864389,0.00022865417,0.00051009835,0.00027847075,0.00006503222,0.0000211155,0.000108634544,0.00011828191,0.0018771774],"category_scores_gemma":[0.00058703654,0.00020629294,0.00019187164,0.000408085,0.00006394028,0.000118256954,0.000027247557,0.0003280285,0.00006760688],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008752044,0.000926329,0.015107295,0.000104599596,0.00011476222,0.00003399334,0.0003986224,0.00012273419,0.9824063,0.00032067852,0.00026663864,0.00011047887],"study_design_scores_gemma":[0.0031742128,0.00041007277,0.000488934,0.0005849264,0.0001831698,0.00007969168,0.00044606402,0.000060403505,0.98968077,0.00012264057,0.004565351,0.00020378764],"about_ca_topic_score_codex":0.00010008496,"about_ca_topic_score_gemma":0.000011972866,"teacher_disagreement_score":0.01461836,"about_ca_system_score_codex":0.000035100682,"about_ca_system_score_gemma":0.00011772286,"threshold_uncertainty_score":0.99903524},"labels":[],"label_agreement":null},{"id":"W2031648179","doi":"10.1182/blood-2010-01-264754","title":"S100A10 regulates plasminogen-dependent macrophage invasion","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"S100 Proteins and Annexins","field":"Biochemistry, Genetics and Molecular Biology","cited_by":143,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Dalhousie University","keywords":"Macrophage; Biology; Immunology; Cancer research; Genetics","score_opus":0.005929683684966137,"score_gpt":0.2114952313816127,"score_spread":0.20556554769664656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031648179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959347,0.0003420268,0.000040877174,0.000051154955,0.00021211054,0.00012913202,0.00001509866,0.000022718079,0.0032521763],"genre_scores_gemma":[0.99558645,0.000040271178,0.00096294715,0.00012185311,0.00044079623,0.000017830518,0.000052052255,0.000023991031,0.002753782],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992119,0.000016616836,0.00014396003,0.00030003896,0.00011186725,0.00021558582],"domain_scores_gemma":[0.9994186,0.000004624168,0.00005101215,0.0003921882,0.000040700208,0.00009283113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001067542,0.0001293561,0.00009598876,0.000026556158,0.00008512291,0.000030331194,0.00019534111,0.00019670228,0.00019603473],"category_scores_gemma":[0.000058657704,0.0001148204,0.00007260272,0.000042393265,0.00005027811,0.0000026589069,0.0001304051,0.00014289594,0.00011273214],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016321801,0.0002015446,0.003040425,0.0000070009737,0.000026401058,0.000013431829,0.00001530979,0.0000021153692,0.99447495,0.00008867656,0.00045918484,0.0016546374],"study_design_scores_gemma":[0.00081587146,0.00017456131,0.0024699846,0.000004943375,0.00001836882,0.000054858843,0.000015216958,0.0000071723293,0.9752846,0.00007748437,0.02091902,0.00015791811],"about_ca_topic_score_codex":0.000012179745,"about_ca_topic_score_gemma":0.000051282434,"teacher_disagreement_score":0.020459834,"about_ca_system_score_codex":0.0000015377962,"about_ca_system_score_gemma":0.00003647696,"threshold_uncertainty_score":0.46822402},"labels":[],"label_agreement":null},{"id":"W2031684813","doi":"10.1182/blood-2011-06-361741","title":"Relapsed lymphoma preceded by cold agglutinin disease","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Cold agglutinin disease; Medicine; Vincristine; Gastroenterology; Chlorambucil; Immunology; Pathology; Internal medicine; Cyclophosphamide; Anemia; Autoimmune hemolytic anemia; Chemotherapy","score_opus":0.009057478713628577,"score_gpt":0.2268535195863148,"score_spread":0.21779604087268623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031684813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891606,0.0033955416,0.000026285905,0.00063164346,0.00018637336,0.0003410447,0.000031235715,0.00012441994,0.006102852],"genre_scores_gemma":[0.99681646,0.00009970907,0.00025939968,0.000543816,0.00028075068,0.000033071563,0.000060098937,0.000031010743,0.0018756684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990588,0.000028223716,0.00016660568,0.00017962961,0.00022098018,0.00034576515],"domain_scores_gemma":[0.99909794,0.000030760115,0.00003639767,0.00028546184,0.000027470167,0.0005219563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000120582794,0.00013323089,0.0001880331,0.000034673325,0.00007106086,0.000009551238,0.000056410216,0.000083090155,0.00018052864],"category_scores_gemma":[0.000042532316,0.000111675756,0.00009277273,0.00012318249,0.0000329659,0.000086941036,0.00002049683,0.00007610584,0.00014158712],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082397554,0.017911412,0.6954753,0.00032241055,0.00043561385,0.00009783386,0.00070290925,1.5581345e-7,0.24652085,0.0024215116,0.028069463,0.007218554],"study_design_scores_gemma":[0.032450296,0.0005503411,0.6510683,0.0002600331,0.0023035165,0.00010064238,0.00007524262,0.000016110487,0.1889546,0.0000612973,0.12366754,0.0004920872],"about_ca_topic_score_codex":0.000022993063,"about_ca_topic_score_gemma":0.0000017102053,"teacher_disagreement_score":0.09559807,"about_ca_system_score_codex":0.00001245789,"about_ca_system_score_gemma":0.00004672781,"threshold_uncertainty_score":0.45540053},"labels":[],"label_agreement":null},{"id":"W2032830379","doi":"10.1182/blood-2007-05-087718","title":"Inducing Tregs with hepatic gene therapy","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Genetic enhancement; Transgene; Immunology; Immune system; Gene transfer; Biology; Gene; Disease; Medicine; Virology; Genetics; Pathology","score_opus":0.016138666268614037,"score_gpt":0.2804185961467784,"score_spread":0.26427992987816434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032830379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996326,0.0016845906,0.00038836733,0.000047959093,0.000023015484,0.0001758123,0.000003160547,0.00001699269,0.0013340553],"genre_scores_gemma":[0.9980118,0.0002891098,0.00074258976,0.0002433148,0.0002554174,0.00001326204,0.000030657782,0.00003525437,0.00037856546],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99905384,0.000039080238,0.00012324013,0.00027382362,0.00018022906,0.00032977588],"domain_scores_gemma":[0.9994091,0.000011333218,0.00003807238,0.0003887991,0.000058909794,0.00009382053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036144923,0.00012665318,0.00009804918,0.000050869014,0.00006920358,0.00001658581,0.00017423573,0.000091917056,0.000035668214],"category_scores_gemma":[0.000013762423,0.000100632315,0.00004488991,0.00012845513,0.00005548134,0.0000019328845,0.000031570955,0.0000905238,0.000015292162],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095665926,0.00021676629,0.0071893316,0.0000036319334,0.00011322068,0.000020792424,0.00005504592,0.0000069868497,0.98221946,0.0000028765808,0.000041472384,0.009173781],"study_design_scores_gemma":[0.0022047996,0.0032870565,0.0031605638,0.0000057135267,0.000009566468,0.000029894425,0.000033092852,0.0000022503743,0.9898801,0.000012088648,0.001226202,0.00014868438],"about_ca_topic_score_codex":0.000022764129,"about_ca_topic_score_gemma":0.00021728306,"teacher_disagreement_score":0.009025096,"about_ca_system_score_codex":0.0000065661006,"about_ca_system_score_gemma":0.000081338905,"threshold_uncertainty_score":0.41036665},"labels":[],"label_agreement":null},{"id":"W2032982863","doi":"10.1182/blood-2010-06-288506","title":"Infusion of HLA-mismatched peripheral blood stem cells improves the outcome of chemotherapy for acute myeloid leukemia in elderly patients","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Key Research and Development Program of China; University of Toronto; Erasmus Universitair Medisch Centrum Rotterdam; National Natural Science Foundation of China","keywords":"Mitoxantrone; Medicine; Cytarabine; Chemotherapy; Myeloid leukemia; Internal medicine; Leukemia; Gastroenterology; Granulocyte colony-stimulating factor; Surgery; Myeloid; Haematopoiesis; Induction chemotherapy; Immunology; Stem cell; Biology","score_opus":0.009441649147372683,"score_gpt":0.2559443993642234,"score_spread":0.24650275021685072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032982863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99804276,0.000024712082,0.00008774623,0.000105021325,0.00021129174,0.0012805397,0.00004071069,0.000020493218,0.00018672392],"genre_scores_gemma":[0.9971828,0.000038948292,0.0022663723,0.00010022908,0.00004516267,0.000056032957,0.000022147453,0.000034034838,0.00025429216],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99861103,0.000027130645,0.0006477943,0.00021103608,0.00028348097,0.00021952736],"domain_scores_gemma":[0.99904865,0.00012820587,0.0002546146,0.00036450184,0.00014313353,0.000060907874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025423575,0.00017269608,0.00045170062,0.000076445525,0.000029133207,0.0000071945183,0.00016227594,0.00017585358,0.0000334538],"category_scores_gemma":[0.000014726995,0.00012069137,0.00014015444,0.00014291379,0.00007235905,0.00005204795,0.000014324015,0.00020238671,0.0000017192866],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024522346,0.0005512608,0.100971185,0.00050655473,0.00015329164,0.0000026743492,0.0027570387,8.987862e-7,0.89238024,0.000031099862,0.000010596856,0.0023899223],"study_design_scores_gemma":[0.015590382,0.00084088504,0.07616774,0.00010958535,0.00049361004,0.000011709362,0.0002383945,0.000071995484,0.90627193,0.000031790263,0.000055760054,0.000116237235],"about_ca_topic_score_codex":0.000083467094,"about_ca_topic_score_gemma":0.000048712638,"teacher_disagreement_score":0.02480344,"about_ca_system_score_codex":0.000020179157,"about_ca_system_score_gemma":0.00011945956,"threshold_uncertainty_score":0.49216512},"labels":[],"label_agreement":null},{"id":"W2033035657","doi":"10.1182/blood.v98.2.368","title":"Increased thrombogenesis and embolus formation in mice lacking glycoprotein V","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; Heart and Stroke Foundation of Canada","keywords":"Thrombus; Thrombin; Platelet; Von Willebrand factor; Intravital microscopy; Chemistry; Platelet activation; Coagulation; Internal medicine; Immunology; Endocrinology; Medicine; Microcirculation","score_opus":0.013767088427570125,"score_gpt":0.24516795008388917,"score_spread":0.23140086165631904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033035657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964713,0.0007606363,0.000016454716,0.00017212756,0.000008869764,0.00023895862,0.0000027452802,0.000026157484,0.002302753],"genre_scores_gemma":[0.9991199,0.00023546511,0.0003857185,0.00015020657,0.000015846708,0.000015877516,0.00002597696,0.000007948033,0.00004308195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995842,0.000012625511,0.000105109204,0.00010007031,0.00007518301,0.000122804],"domain_scores_gemma":[0.9998333,0.000013392265,0.000026828502,0.00006882792,0.000013069034,0.000044568944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000045465487,0.00006846197,0.00014687174,0.000063377076,0.000030014644,0.000009100695,0.000017272077,0.000042897092,0.000022386035],"category_scores_gemma":[0.000020984531,0.000059748138,0.000017687355,0.000112829155,0.000010554558,0.00008522212,0.000011393892,0.000037484453,0.000014255381],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005336124,0.0036889333,0.8279072,0.0002700973,0.00028504498,0.0052849455,0.0012450943,0.0000029626744,0.117682464,0.00013796835,0.00013048181,0.04283118],"study_design_scores_gemma":[0.037377894,0.0005930567,0.85780346,0.0003723543,0.00044710108,0.003726321,0.00049908546,0.0006886323,0.09622173,0.0008422339,0.0010643122,0.0003638152],"about_ca_topic_score_codex":0.00038695685,"about_ca_topic_score_gemma":0.0002615046,"teacher_disagreement_score":0.042467363,"about_ca_system_score_codex":0.000014433383,"about_ca_system_score_gemma":0.000011481111,"threshold_uncertainty_score":0.24364583},"labels":[],"label_agreement":null},{"id":"W2033068457","doi":"10.1182/blood-2004-10-3825","title":"Intronic splicing of hyaluronan synthase 1 (HAS1): a biologically relevant indicator of poor outcome in multiple myeloma","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Proteoglycans and glycosaminoglycans research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"RNA splicing; Hyaluronan synthase; Biology; Alternative splicing; Gene; Cell biology; Molecular biology; Cancer research; Genetics; Exon; RNA","score_opus":0.017298749049046616,"score_gpt":0.2753575482128601,"score_spread":0.2580587991638135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033068457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981332,0.00085328636,0.0001461803,0.00022374911,0.000017569306,0.00033594333,0.00007571692,0.000007417984,0.00020692903],"genre_scores_gemma":[0.9970365,0.00012234162,0.0024947268,0.00007036718,0.00008493017,0.000043043725,0.000040763058,0.000017899149,0.000089427485],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99845725,0.000087289074,0.00053270935,0.00036193803,0.00018491902,0.00037591765],"domain_scores_gemma":[0.99924403,0.000043314893,0.00016657358,0.00039666152,0.00005533028,0.00009407767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038786067,0.00016059907,0.00031254676,0.00013831144,0.000029640009,0.0000057726525,0.00035563737,0.0001956343,0.00004464799],"category_scores_gemma":[0.00035675283,0.00013386393,0.000114821385,0.00015141729,0.00016907454,0.000004307303,0.00020475783,0.00016751453,0.000008020511],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018782166,0.0006629483,0.114641584,0.000055434008,0.000050216382,0.0000071063337,0.000031018702,0.000040637744,0.8737115,0.000049126662,0.000024013076,0.010538594],"study_design_scores_gemma":[0.0030715887,0.0012712323,0.06406275,0.000041702,0.000022440678,0.000017494349,0.000047464575,0.00014573192,0.9283854,0.000019255767,0.0027188463,0.00019614252],"about_ca_topic_score_codex":0.00014951058,"about_ca_topic_score_gemma":0.00032160713,"teacher_disagreement_score":0.05467385,"about_ca_system_score_codex":0.000017854441,"about_ca_system_score_gemma":0.00013062997,"threshold_uncertainty_score":0.5458812},"labels":[],"label_agreement":null},{"id":"W2033255852","doi":"10.1182/blood-2011-06-334672","title":"The role of the annexin A2 heterotetramer in vascular fibrinolysis","year":2011,"lang":"en","type":"review","venue":"Blood","topic":"S100 Proteins and Annexins","field":"Biochemistry, Genetics and Molecular Biology","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Heterotetramer; Annexin A2; Plasmin; Fibrinolysis; Cell biology; Plasminogen activator; Receptor; Biology; Chemistry; Protein subunit; Biochemistry; Annexin; Cell; Internal medicine; Endocrinology; Medicine","score_opus":0.013087314506435426,"score_gpt":0.24184708207499767,"score_spread":0.22875976756856223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033255852","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028463854,0.9952173,0.0000022554732,0.0000039010183,0.00005911594,0.00045731678,0.000026566233,0.000003762959,0.0013833998],"genre_scores_gemma":[0.0028102961,0.9966113,0.000032689593,0.000013153126,0.00013395511,0.000105563086,0.000022409948,0.000036708963,0.00023392969],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99877983,0.00018218468,0.0003664269,0.00031303513,0.000109869485,0.00024863213],"domain_scores_gemma":[0.9987658,0.0000152525645,0.00021783439,0.000936443,0.000031506082,0.000033110715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019035101,0.00024704688,0.0004862533,0.000035751927,0.00007224625,0.000017394363,0.0006728997,0.00029305185,0.000012053603],"category_scores_gemma":[0.000053789907,0.0001297567,0.0007651854,0.00016612906,0.00011010108,0.0000013597963,0.00027124252,0.00019611935,0.000009071755],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006582768,0.00030841524,0.00021901364,0.000981969,0.0007518805,0.0000022286624,0.000033784123,5.924119e-7,0.0018328124,0.00024873836,0.00007183999,0.99554217],"study_design_scores_gemma":[0.0001752512,0.000066177825,0.000058352485,0.00073098624,0.0002900368,0.000007872393,0.00001367779,2.6103675e-7,0.0074069616,0.000059011483,0.99102205,0.00016938249],"about_ca_topic_score_codex":0.00007371076,"about_ca_topic_score_gemma":0.000060588078,"teacher_disagreement_score":0.9953728,"about_ca_system_score_codex":0.000004796756,"about_ca_system_score_gemma":0.00010214743,"threshold_uncertainty_score":0.5291325},"labels":[],"label_agreement":null},{"id":"W2033428553","doi":"10.1182/blood-2012-02-408732","title":"Impaired natural killer cell self-education and “missing-self” responses in Ly49-deficient mice","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; Université de Montréal; University of Ottawa; Institute for Research in Immunology and Cancer; McGill University","funders":"National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research","keywords":"Natural killer cell; Immunology; Aldesleukin; Biology; Medicine; Cytotoxic T cell; Immune system; Interleukin 2; In vitro","score_opus":0.007135142356569131,"score_gpt":0.22806678471774355,"score_spread":0.22093164236117444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033428553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97666943,0.014544684,0.0000034151221,0.00016096795,0.005320376,0.00013744232,5.413567e-7,0.000088464054,0.0030747075],"genre_scores_gemma":[0.98705435,0.000121331395,0.00013946077,0.00023191202,0.000048229835,0.000014212448,0.000034405322,0.00001082761,0.012345245],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99918514,0.0001922147,0.00018737068,0.00015765495,0.000021824842,0.00025581187],"domain_scores_gemma":[0.9996533,0.00008529988,0.000074922464,0.00013180278,0.000033662895,0.000021006932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021016254,0.00011649835,0.00011761342,0.00014643143,0.00011466398,0.000017190196,0.000055390698,0.00013710483,0.00026391726],"category_scores_gemma":[0.000045518886,0.00010548884,0.000038595634,0.00009810916,0.000027273587,0.00017913975,0.00003234636,0.0002235459,0.00032369935],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002971822,0.0050003924,0.020609051,0.00004303286,0.00009356511,9.0949277e-7,0.005650847,1.8534239e-7,0.9545671,0.00015513232,0.011702021,0.0018805977],"study_design_scores_gemma":[0.0041105896,0.00027470497,0.21697678,0.00006477144,0.00019337624,0.00045156904,0.0021753078,0.000012292873,0.46991456,0.00002105519,0.30538094,0.00042407817],"about_ca_topic_score_codex":0.000060333718,"about_ca_topic_score_gemma":0.0000033665535,"teacher_disagreement_score":0.48465255,"about_ca_system_score_codex":0.000042510637,"about_ca_system_score_gemma":0.000061494065,"threshold_uncertainty_score":0.430171},"labels":[],"label_agreement":null},{"id":"W2033458237","doi":"10.1182/blood-2014-05-577932","title":"Nontoxic polyphosphate inhibitors reduce thrombosis while sparing hemostasis","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; Michael Smith Health Research BC; Centre for Blood Research, University of British Columbia; National Institutes of Health; American Heart Association","keywords":"Polyphosphate; Hemostasis; Heparin; Thrombosis; Medicine; Hemostatic Agent; Pharmacology; Intensive care medicine; Chemistry; Surgery; Biochemistry; Phosphate","score_opus":0.02624264557588213,"score_gpt":0.26547586963270114,"score_spread":0.23923322405681902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033458237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98177403,0.0018878047,0.000127069,0.0014231266,0.0005102499,0.00032783634,0.000007815078,0.00029362756,0.013648427],"genre_scores_gemma":[0.9949761,0.00012268656,0.0016396643,0.00081230357,0.00094547437,0.000021670849,0.000037640348,0.000065600514,0.0013788489],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981446,0.00004092258,0.00044001781,0.0004775389,0.0003871339,0.0005097706],"domain_scores_gemma":[0.9988053,0.00009263253,0.00015106452,0.00055228424,0.00009400799,0.00030470602],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029099357,0.00028417876,0.00047729013,0.00012600835,0.00020388285,0.000057001118,0.00014033068,0.00015643328,0.00031647767],"category_scores_gemma":[0.00015048336,0.0002674993,0.00021855943,0.00034831977,0.0000857002,0.00017382832,0.00007873247,0.00017174885,0.0001955411],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019905667,0.0028590686,0.8081598,0.00045213467,0.0008675239,0.000053055024,0.0026512835,0.000036487145,0.08569187,0.0035795418,0.015522424,0.07992775],"study_design_scores_gemma":[0.0059051253,0.00048580611,0.341599,0.000493503,0.00080055825,0.000104817926,0.00018837773,0.00042490652,0.62441695,0.0004141059,0.024541283,0.0006256136],"about_ca_topic_score_codex":0.00039802643,"about_ca_topic_score_gemma":0.00003950119,"teacher_disagreement_score":0.5387251,"about_ca_system_score_codex":0.00004063065,"about_ca_system_score_gemma":0.00008315451,"threshold_uncertainty_score":0.9999777},"labels":[],"label_agreement":null},{"id":"W2033481147","doi":"10.1182/blood-2008-10-180489","title":"GATA-1 associates with and inhibits p53","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Transactivation; Biology; Cell biology; Chromatin immunoprecipitation; Erythropoiesis; Zinc finger; GATA2; DNA-binding domain; GATA1; Molecular biology; Gene; Promoter; Gene expression; Transcription factor; Haematopoiesis; Genetics; Stem cell","score_opus":0.005042134972366443,"score_gpt":0.21402476467645012,"score_spread":0.20898262970408368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033481147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99554884,0.0012864388,0.000060272658,0.000249652,0.000005341523,0.000041755717,0.0000057851275,0.000005995511,0.002795943],"genre_scores_gemma":[0.998541,0.00019835909,0.00033090945,0.0002445313,0.0000648525,0.0000047140857,0.000018253137,0.000004048566,0.0005933599],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997156,0.000006595045,0.000042581432,0.000120752586,0.00003731594,0.00007709951],"domain_scores_gemma":[0.9998366,0.0000012158915,0.000021271026,0.000087861634,0.000025073537,0.000027952436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000030280215,0.000047196212,0.000041290907,0.0000076206325,0.00003629716,0.000014356798,0.00003393442,0.000038751474,0.0000040985547],"category_scores_gemma":[0.0000072575936,0.000037468413,0.000010811852,0.000027872486,0.000016920812,0.000001328725,0.000008442509,0.000022317732,0.000002077127],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018184863,0.00017895446,0.011995907,0.000003350798,0.000046111967,0.0000013829482,0.000033232594,0.0000027253723,0.9804014,0.0003286562,0.0013013677,0.0056887576],"study_design_scores_gemma":[0.0016329086,0.00060899835,0.12519082,0.00001312407,0.000056282057,0.000029127099,0.000041709063,0.0000035350388,0.849315,0.00020694605,0.022698715,0.00020285232],"about_ca_topic_score_codex":0.0000029687271,"about_ca_topic_score_gemma":0.000007456067,"teacher_disagreement_score":0.1310864,"about_ca_system_score_codex":0.0000013715157,"about_ca_system_score_gemma":0.00001623077,"threshold_uncertainty_score":0.15279175},"labels":[],"label_agreement":null},{"id":"W2033548186","doi":"10.1182/blood-2010-02-271841","title":"Comparison of human cord blood engraftment between immunocompromised mouse strains","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":280,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"Canadian Institutes of Health Research","keywords":"Nod; Severe combined immunodeficiency; Biology; Haematopoiesis; Bone marrow; Immunology; Xenotransplantation; Stem cell; Cord blood; Transplantation; Immune system; Cancer research; Molecular biology; Medicine; Internal medicine; Cell biology; In vivo","score_opus":0.02570977176804148,"score_gpt":0.29664642560052507,"score_spread":0.2709366538324836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033548186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947749,0.0002152331,0.000019408686,0.00002698869,0.0011137658,0.00027702466,0.000015696614,0.00009581551,0.0034612021],"genre_scores_gemma":[0.9939226,0.0000063047946,0.000083511244,0.000020912837,0.00006226121,0.000020435285,0.00034076793,0.000019307721,0.0055238903],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989009,0.000090211994,0.00049390935,0.00022381879,0.000042284875,0.000248871],"domain_scores_gemma":[0.9992009,0.000053803615,0.000252055,0.00038441498,0.00008694348,0.000021906353],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014902874,0.00017517079,0.00037052928,0.00010971272,0.00019971697,0.000014261853,0.00022237841,0.0002566003,0.002099298],"category_scores_gemma":[0.000028123606,0.00016618455,0.00014026192,0.00007274347,0.0001454728,0.00007120956,0.00005697881,0.0006261112,0.00026802704],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046410147,0.0016802935,0.0152609935,0.000013352094,0.0005536419,5.7244097e-7,0.00029164596,1.9536435e-7,0.98031515,0.0003289217,0.00078831054,0.0007205216],"study_design_scores_gemma":[0.0043506185,0.0009484566,0.026276633,0.000011494237,0.00030543868,0.000013541173,0.00023371902,4.1199777e-7,0.9580951,0.000016126107,0.009587913,0.0001605703],"about_ca_topic_score_codex":0.000105602136,"about_ca_topic_score_gemma":0.000025621344,"teacher_disagreement_score":0.022220064,"about_ca_system_score_codex":0.0000069478533,"about_ca_system_score_gemma":0.000026222977,"threshold_uncertainty_score":0.9988129},"labels":[],"label_agreement":null},{"id":"W2033773507","doi":"10.1182/blood-2010-07-290551","title":"Histidine-rich glycoprotein binds factor XIIa with high affinity and inhibits contact-initiated coagulation","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Factor XII; Coagulation; Fibrinogen; Chemistry; Glycoprotein; Partial thromboplastin time; Thromboplastin; Biophysics; Internal medicine; Biochemistry; Biology; Medicine","score_opus":0.04204314758377809,"score_gpt":0.23363313429485547,"score_spread":0.19158998671107738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033773507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99666846,0.0004904723,0.00007122392,0.000117338335,0.000085288084,0.0005463589,0.000034578978,0.0001892955,0.0017969565],"genre_scores_gemma":[0.9981106,0.000026723663,0.000947457,0.00014383133,0.00014797175,0.00002634485,0.00012033397,0.00004053051,0.00043624177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998726,0.000040305065,0.0003166582,0.00035114354,0.00027211144,0.00029379554],"domain_scores_gemma":[0.99911624,0.000058576854,0.00016392308,0.0002650126,0.00017818382,0.00021804079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000104746905,0.00024987254,0.00037737747,0.00013504177,0.00013424615,0.00002585614,0.000055295288,0.00015296743,0.00044700853],"category_scores_gemma":[0.00007891862,0.00020269182,0.000046276975,0.0002516744,0.000078823105,0.00018505973,0.00003365044,0.00014506247,0.000032724758],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010449265,0.0013742744,0.9608955,0.00017763137,0.00035204372,0.00014989133,0.0026192425,6.647073e-7,0.028161043,0.0023072101,0.00019173136,0.0027258627],"study_design_scores_gemma":[0.006697827,0.0010269304,0.8215439,0.00015895683,0.00029830405,0.000104535706,0.000064514694,0.000029769431,0.16943792,0.00016808364,0.00020928892,0.00025998443],"about_ca_topic_score_codex":0.00057334197,"about_ca_topic_score_gemma":0.00015642846,"teacher_disagreement_score":0.14127688,"about_ca_system_score_codex":0.00002599014,"about_ca_system_score_gemma":0.00011263694,"threshold_uncertainty_score":0.8265532},"labels":[],"label_agreement":null},{"id":"W203384920","doi":"10.1182/blood.v122.21.1069.1069","title":"Characterization Of Von Willebrand Factor Splice Variants From Exonic &amp; Intronic Splicing Mutations","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Centre Hospitalier Universitaire Sainte-Justine; Queen's University","funders":"","keywords":"Exon; Exon skipping; splice; Splice site mutation; RNA splicing; Von Willebrand disease; Von Willebrand factor; Molecular biology; Genetics; Mutation; Alternative splicing; Exonic splicing enhancer; Biology; Gene; Immunology; Platelet; RNA","score_opus":0.011452267994180152,"score_gpt":0.23210270913732223,"score_spread":0.22065044114314208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W203384920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984745,0.00011781137,0.0002651345,0.000160808,0.000056387496,0.00044434116,0.000085445405,0.00003342185,0.00036214257],"genre_scores_gemma":[0.99835455,0.00009230976,0.0004403982,0.000072112685,0.000052871143,0.000032227075,0.0006742021,0.000017882872,0.00026343396],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9993216,0.00001587763,0.00020871458,0.00017497681,0.00012240633,0.00015643166],"domain_scores_gemma":[0.99952483,0.00003522326,0.00010524183,0.00020549928,0.000059578826,0.000069628666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000018184519,0.000110788584,0.00024731195,0.0000636674,0.000043076077,0.000011497426,0.000043201053,0.00006691861,0.00084371935],"category_scores_gemma":[0.000028231963,0.0000942099,0.00004904025,0.00011168637,0.00002030924,0.00014516346,0.000015874468,0.00006938163,0.00022681063],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026581378,0.0010056309,0.0655339,0.00003809369,0.00038969063,0.0000149461675,0.00072671985,9.611781e-7,0.9285846,0.0000262135,0.000018599032,0.003634094],"study_design_scores_gemma":[0.006333261,0.00014091168,0.9502976,0.00012320114,0.0004303554,0.000030029434,0.00005703455,0.000108445856,0.041805673,0.00030113794,0.000235063,0.00013729582],"about_ca_topic_score_codex":0.0005345203,"about_ca_topic_score_gemma":0.000052007344,"teacher_disagreement_score":0.8867789,"about_ca_system_score_codex":0.000017431015,"about_ca_system_score_gemma":0.000044747067,"threshold_uncertainty_score":0.9238135},"labels":[],"label_agreement":null},{"id":"W203401045","doi":"10.1182/blood.v122.21.543.543","title":"Multicenter Investigation Of Unrelated Donor Hematopoietic Cell Transplantation (HCT) For Thalassemia Major After a Reduced Intensity Conditioning Regimen (URTH Trial)","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; BC Children's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Fludarabine; ThioTEPA; Alemtuzumab; Melphalan; Transplantation; Internal medicine; Thalassemia; Regimen; Gastroenterology; Hematopoietic stem cell transplantation; Surgery; Oncology; Chemotherapy; Cyclophosphamide","score_opus":0.013144618907785016,"score_gpt":0.23968100677374632,"score_spread":0.2265363878659613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W203401045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99359715,0.00006724981,0.0015994406,0.0004237177,0.00016908094,0.0036012984,0.00004360641,0.00008705997,0.00041137575],"genre_scores_gemma":[0.9901749,0.000024421035,0.008059578,0.00016819278,0.00007197264,0.0006898834,0.0005100766,0.000044937802,0.00025606173],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998297,0.00008239926,0.00071086054,0.0003574277,0.00027743992,0.00027490171],"domain_scores_gemma":[0.9986346,0.0002496853,0.00029558977,0.00028080837,0.00037508353,0.00016424054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002570928,0.00022665209,0.00045709484,0.00016675203,0.00006219038,0.000027353271,0.00007188372,0.00021663457,0.00017192766],"category_scores_gemma":[0.000055020577,0.00021027461,0.0001614532,0.00018768795,0.000085874046,0.00021102422,0.000007374633,0.00016201986,0.00005711537],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015494348,0.0010149301,0.037488304,0.005589806,0.00043787074,0.00005706698,0.012176176,0.000010252164,0.92715424,0.00011421333,0.0003964122,0.000066385095],"study_design_scores_gemma":[0.07740916,0.0006338355,0.055531662,0.0010985658,0.0017608575,0.0001064258,0.00051524286,0.0002883809,0.8620236,0.0003808251,0.0000059104573,0.00024553435],"about_ca_topic_score_codex":0.00007380316,"about_ca_topic_score_gemma":0.000007374425,"teacher_disagreement_score":0.065130636,"about_ca_system_score_codex":0.000038933395,"about_ca_system_score_gemma":0.00011945738,"threshold_uncertainty_score":0.857475},"labels":[],"label_agreement":null},{"id":"W2034087089","doi":"10.1182/blood-2003-05-1558","title":"Lentivector-mediated clonal tracking reveals intrinsic heterogeneity in the human hematopoietic stem cell compartment and culture-induced stem cell impairment","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":143,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"National Cancer Institute; Stem Cell Network","keywords":"Stem cell; Haematopoiesis; Biology; Compartment (ship); Hematopoietic stem cell; Cell culture; Cell biology; Genetics","score_opus":0.028222864311547198,"score_gpt":0.28797732947126137,"score_spread":0.2597544651597142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034087089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956387,0.0032651701,0.0000053165863,0.00003404533,0.000040780764,0.0007063776,0.000019184217,0.000011934788,0.00027843736],"genre_scores_gemma":[0.9993467,0.00012579939,0.000024253057,0.00016133618,0.00005630124,0.00008398833,0.000050372822,0.000026649941,0.00012464148],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978117,0.00062985637,0.00032825183,0.0004752967,0.00031225834,0.00044269054],"domain_scores_gemma":[0.99925506,0.000027419357,0.0001094929,0.00043449452,0.00005885114,0.00011468687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007063842,0.00025231068,0.00024307234,0.00005502676,0.0001608502,0.000063717554,0.00026283012,0.00013982806,0.00001100594],"category_scores_gemma":[0.000003456566,0.0001949891,0.00009652952,0.00014509445,0.00006195176,0.0000053617473,0.0000715074,0.00021709953,0.000010519413],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009575061,0.0010886916,0.012543781,0.000068611465,0.00005658577,0.000023384295,0.0007131391,0.000005717448,0.9851264,0.000012632132,0.00014170146,0.00012363947],"study_design_scores_gemma":[0.0031077708,0.0020294315,0.005825482,0.000018517885,0.000031110554,0.000027263215,0.00047361807,0.0000016308697,0.9877697,0.000020948908,0.00046711336,0.00022741813],"about_ca_topic_score_codex":0.0000070676692,"about_ca_topic_score_gemma":0.000106656276,"teacher_disagreement_score":0.0067182994,"about_ca_system_score_codex":0.000032034233,"about_ca_system_score_gemma":0.0000638432,"threshold_uncertainty_score":0.79514253},"labels":[],"label_agreement":null},{"id":"W2034142923","doi":"10.1182/blood-2009-05-224840","title":"Evaluation of pentostatin in corticosteroid-refractory chronic graft-versus-host disease in children: a Pediatric Blood and Marrow Transplant Consortium study","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pentostatin; Graft-versus-host disease; Medicine; Refractory (planetary science); Corticosteroid; Transplantation; Immunology; Internal medicine; Lymphoma; Rituximab; Biology","score_opus":0.018934785599403776,"score_gpt":0.282821102391278,"score_spread":0.26388631679187424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034142923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946579,0.0026244647,0.0000057758007,0.00006458256,0.000048232523,0.0024306471,0.000043299264,0.000023919833,0.00010122721],"genre_scores_gemma":[0.99927044,0.00045406498,0.000038355392,0.000021808894,0.000052790736,0.00006629935,0.00007267486,0.000018333443,0.000005248865],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99751335,0.00029597498,0.0006686977,0.00039574827,0.00084911723,0.00027710988],"domain_scores_gemma":[0.99917185,0.00012267206,0.00015857337,0.00026991733,0.00010389052,0.00017309337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090687466,0.00020942683,0.00038981697,0.00036294124,0.000023530474,0.0000112753505,0.00007151843,0.00007344033,0.00006496217],"category_scores_gemma":[0.00010838979,0.0002067407,0.000049805392,0.0003531082,0.00003700394,0.00010166694,0.0000070712877,0.00019467129,0.0000042525944],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006093804,0.005557336,0.9830992,0.00020418323,0.00008734643,0.00013855407,0.0017685539,0.00001888674,0.0080403825,0.0000050819945,0.0000010539864,0.00047001027],"study_design_scores_gemma":[0.044683088,0.0018084284,0.9465382,0.00019783228,0.004426388,0.000041643576,0.00017456278,0.00018849164,0.0017580283,0.000014238975,2.0892043e-7,0.00016889515],"about_ca_topic_score_codex":0.00009474428,"about_ca_topic_score_gemma":0.00027808704,"teacher_disagreement_score":0.04407371,"about_ca_system_score_codex":0.00006556828,"about_ca_system_score_gemma":0.00040988004,"threshold_uncertainty_score":0.8430641},"labels":[],"label_agreement":null},{"id":"W2034156891","doi":"10.1182/blood-2011-04-345777","title":"Distribution, function, and prognostic value of cytotoxic T lymphocytes in follicular lymphoma: a 3-D tissue-imaging study","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National de la Santé et de la Recherche Médicale; Institut National Du Cancer; Association pour la Recherche sur le Cancer","keywords":"Cytotoxic T cell; Follicular lymphoma; Pathology; Granzyme B; CD8; CTL*; Lymph; Biology; Immunophenotyping; Cancer research; Lymphoma; Medicine; Immunology; Immune system; Flow cytometry; In vitro","score_opus":0.01257205450176963,"score_gpt":0.2355240481751352,"score_spread":0.22295199367336557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034156891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961282,0.0024677883,0.000038782277,0.000033606415,0.000044373533,0.0009549147,0.000014865263,0.000039695035,0.00027775537],"genre_scores_gemma":[0.99944246,0.000049126535,0.00018492622,0.000034395103,0.000028997552,0.00019539199,0.00003223331,0.00001547753,0.000017020202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893254,0.00005032894,0.00031639225,0.0002981725,0.00019478524,0.00020779483],"domain_scores_gemma":[0.9994355,0.000052054387,0.00008408689,0.0002502586,0.00007843507,0.000099678924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014725924,0.00016549951,0.0003272969,0.000086745575,0.000048838596,0.00001038514,0.00004592654,0.00004123571,0.000026180158],"category_scores_gemma":[0.00009645814,0.0001344607,0.000047213667,0.00024452998,0.00005808792,0.00006671524,0.000046101515,0.000023549226,0.000009897956],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009509874,0.011164459,0.98455846,0.00005542916,0.00020288963,0.000309849,0.00062221015,3.2353412e-7,0.00039255855,0.0003521591,0.000021737967,0.0022248193],"study_design_scores_gemma":[0.01775534,0.001033402,0.96519375,0.00012764712,0.00088832213,0.00015376353,0.0004671326,0.000018947872,0.013999542,0.00018096514,0.00006833993,0.000112847214],"about_ca_topic_score_codex":0.0006188955,"about_ca_topic_score_gemma":0.000026609307,"teacher_disagreement_score":0.019364716,"about_ca_system_score_codex":0.00008855666,"about_ca_system_score_gemma":0.000112031696,"threshold_uncertainty_score":0.5483148},"labels":[],"label_agreement":null},{"id":"W2034236394","doi":"10.1182/blood-2010-12-325431","title":"May-Hegglin anomaly","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Genetic Syndromes and Imprinting","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; Anomaly (physics); Dermatology; Gynecology","score_opus":0.009888508255464501,"score_gpt":0.23192826110470452,"score_spread":0.22203975284924002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034236394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904024,0.0015287981,0.00013959267,0.000038904625,0.00015625008,0.000051108866,0.000002063551,0.00000904752,0.007671807],"genre_scores_gemma":[0.9961387,0.00004113511,0.002076704,0.00012327381,0.00044985765,0.000006300779,0.000013287101,0.000013835085,0.0011368867],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99945956,0.000015503552,0.00009138185,0.00012629652,0.000054500077,0.00025275673],"domain_scores_gemma":[0.99965775,0.000002510756,0.000027882446,0.00021528015,0.000016605865,0.00007997863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009818529,0.00007585568,0.00006110753,0.000013601378,0.00003423747,0.000009808113,0.00009194072,0.00006845077,0.00005453878],"category_scores_gemma":[0.000028705508,0.00007185317,0.000050101047,0.000033076485,0.000017654746,0.0000014215932,0.00008499212,0.000031906307,0.00007302552],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000012356433,0.00017695538,0.36644888,0.0000073933493,0.00004082598,4.983828e-7,0.000029506467,9.644327e-7,0.63023293,0.000064835906,0.00054981216,0.0024461558],"study_design_scores_gemma":[0.00070251507,0.00012618654,0.3611489,0.000004852529,0.00003701173,0.00012722211,0.000054200525,0.0000023660689,0.5436796,0.000012765894,0.093914844,0.00018957064],"about_ca_topic_score_codex":0.0000082179595,"about_ca_topic_score_gemma":0.0000015709461,"teacher_disagreement_score":0.093365036,"about_ca_system_score_codex":0.0000012423512,"about_ca_system_score_gemma":0.00001276365,"threshold_uncertainty_score":0.2930087},"labels":[],"label_agreement":null},{"id":"W2034238022","doi":"10.1182/blood-2002-08-2616","title":"Gfi-1B and erythroid development","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Transcription factor; Biology; Haematopoiesis; Genetics; Computational biology; Medicine; Gene; Stem cell","score_opus":0.00848429480629806,"score_gpt":0.19095026722582917,"score_spread":0.1824659724195311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034238022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98829806,0.0057178843,0.000027683947,0.00006411572,0.000024245343,0.00006374157,0.0000025548422,0.000008457767,0.00579327],"genre_scores_gemma":[0.9974093,0.00041052405,0.0009782647,0.00014829452,0.000038092294,0.000008449935,0.000020222053,0.000009405014,0.0009774917],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995814,0.0000071309023,0.00006956511,0.00017353888,0.000045998648,0.00012237563],"domain_scores_gemma":[0.9998043,0.0000015521417,0.00001753674,0.0001171134,0.000011499046,0.00004799632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00001807191,0.00008036522,0.000058540045,0.00001171327,0.000058793885,0.000011993195,0.000041759424,0.000053480642,0.000037631813],"category_scores_gemma":[0.0000060138614,0.00007217437,0.000018865372,0.000023137038,0.000022782318,0.0000012107294,0.00004490278,0.000020538231,0.000032245323],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006118616,0.012702903,0.46253827,0.0001201579,0.0021669366,0.00012552663,0.0012127298,0.000004001609,0.20979184,0.000404931,0.021213217,0.2896583],"study_design_scores_gemma":[0.0076187244,0.00040657312,0.021979906,0.00001429335,0.000113919246,0.000104831925,0.00007242317,0.000009531421,0.75133795,0.00009620066,0.2178025,0.0004431707],"about_ca_topic_score_codex":0.000002840119,"about_ca_topic_score_gemma":0.000012674216,"teacher_disagreement_score":0.5415461,"about_ca_system_score_codex":0.0000012506845,"about_ca_system_score_gemma":0.0000073660103,"threshold_uncertainty_score":0.29431856},"labels":[],"label_agreement":null},{"id":"W2034399120","doi":"10.1182/blood-2005-11-012450","title":"Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":291,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Heparin; Odds ratio; Internal medicine; Confidence interval; Low molecular weight heparin; Heparin-induced thrombocytopenia; Risk factor; Surgery","score_opus":0.03884124057973909,"score_gpt":0.29884201649026654,"score_spread":0.26000077591052745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034399120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802194,0.00017495759,0.000019179939,0.00017529976,0.00018775796,0.00048966927,0.000032805823,0.0001127993,0.01858813],"genre_scores_gemma":[0.9983183,0.0001926872,0.0007592191,0.00009907977,0.00022361362,0.000041710802,0.000019992229,0.000045607696,0.00029975464],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824196,0.00008500156,0.0004517169,0.00053647027,0.00021670377,0.00046812967],"domain_scores_gemma":[0.9990727,0.00010143085,0.00012942127,0.000455121,0.00006406981,0.00017730538],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001384392,0.00029044805,0.00065559725,0.00020372082,0.00013244407,0.00005953926,0.000116468844,0.00012855997,0.00029210537],"category_scores_gemma":[0.000076517106,0.00026636024,0.00010354028,0.00032730072,0.00006275759,0.00023451334,0.00010292126,0.0005402554,0.00013234996],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003447003,0.0008630912,0.8351375,0.000038573715,0.00014404269,0.000064572974,0.00023791366,8.496434e-7,0.1620737,0.00044967403,0.00007316946,0.0008824692],"study_design_scores_gemma":[0.004025047,0.00011543971,0.94763947,0.00006149035,0.0002548862,0.00017429458,0.000085206826,0.000048376533,0.04600387,0.00040655205,0.00091180607,0.00027357205],"about_ca_topic_score_codex":0.0028148023,"about_ca_topic_score_gemma":0.0024200755,"teacher_disagreement_score":0.11606982,"about_ca_system_score_codex":0.00008465927,"about_ca_system_score_gemma":0.00011771416,"threshold_uncertainty_score":0.99997884},"labels":[],"label_agreement":null},{"id":"W2034462006","doi":"10.1182/blood-2009-07-233643","title":"Super factor B-gets atypical HUS","year":2009,"lang":"en","type":"letter","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Atypical hemolytic uremic syndrome; Complement factor B; Alternative complement pathway; Factor H; Complement factor I; Medicine; Immunology; Complement system; Antibody","score_opus":0.02133199336002968,"score_gpt":0.24443175919715943,"score_spread":0.22309976583712976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034462006","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28722498,0.12036945,0.000011791626,0.56719345,0.010276582,0.002713529,0.003247421,0.0013774853,0.0075853495],"genre_scores_gemma":[0.15027346,0.00024347093,0.00007915549,0.7892229,0.0057292795,0.00016873571,0.006750274,0.00016226462,0.047370467],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99804634,0.00030517866,0.00042654725,0.00054595177,0.00007248778,0.0006035062],"domain_scores_gemma":[0.9987829,0.00028128346,0.0001336074,0.0007037792,0.00007568256,0.000022779164],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000053713546,0.00040311657,0.0006241929,0.00013342609,0.00010431561,0.000022210283,0.00051134865,0.0011405307,0.006014905],"category_scores_gemma":[0.00011809047,0.00035028014,0.0002966268,0.000045175,0.000119680284,0.000040710234,0.00011394061,0.0011275039,0.00647225],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021346736,0.00018138348,0.0005612807,0.00010309436,0.0007026869,0.00034729473,0.00005845292,1.994937e-8,0.0037458423,0.0000116825995,0.9939103,0.0003566136],"study_design_scores_gemma":[0.0015202923,0.00013447291,0.0024871365,0.00014456226,0.00033969237,0.00016998377,0.000015142095,1.34270035e-8,0.004488137,0.00012537993,0.99017507,0.00040013273],"about_ca_topic_score_codex":0.0000101288115,"about_ca_topic_score_gemma":0.000005826366,"teacher_disagreement_score":0.22202948,"about_ca_system_score_codex":0.000038668466,"about_ca_system_score_gemma":0.000080886275,"threshold_uncertainty_score":0.9998949},"labels":[],"label_agreement":null},{"id":"W2034600376","doi":"10.1182/blood-2011-03-341222","title":"Thrombomodulin is a determinant of metastasis through a mechanism linked to the thrombin binding domain but not the lectin-like domain","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; National Institutes of Health; Canadian Blood Services; CSL Behring; American Physicians Fellowship for Medicine in Israel","keywords":"Thrombomodulin; Thrombin; Biology; Cancer research; Metastasis; Cell biology; Tissue factor; Immunology; Cancer; Coagulation; Medicine; Internal medicine; Platelet","score_opus":0.06442835799510847,"score_gpt":0.2830960297472803,"score_spread":0.21866767175217183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034600376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98480195,0.00013486123,0.0063336836,0.003642325,0.00079094444,0.0017583524,0.00004260497,0.000121693796,0.0023735862],"genre_scores_gemma":[0.9672161,0.00005375747,0.027572513,0.004330545,0.00015301017,0.00015891848,0.000008403554,0.00007967449,0.00042710963],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969797,0.00029703963,0.00074224966,0.0006095317,0.0007614127,0.0006100264],"domain_scores_gemma":[0.99783844,0.00016192008,0.00035104985,0.0012993161,0.00016998796,0.0001793138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011838331,0.00041962156,0.0008029563,0.0001500859,0.0004323787,0.00004227366,0.0005957435,0.00021159257,0.0007300734],"category_scores_gemma":[0.000088398876,0.00024345279,0.00040816225,0.0007625178,0.00015342275,0.00012747408,0.0002726373,0.0004039912,0.00020846404],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003006989,0.0024237821,0.00027119077,0.00013016627,0.0017036881,0.000082792816,0.04358788,7.495842e-7,0.8880924,0.06079057,0.0011941866,0.0014219191],"study_design_scores_gemma":[0.0046112575,0.0013974414,0.0041163983,0.00022059915,0.0015521433,0.00037009845,0.0051052086,0.000025386758,0.95454425,0.025830192,0.0018165552,0.00041047673],"about_ca_topic_score_codex":0.00034994472,"about_ca_topic_score_gemma":0.000115860246,"teacher_disagreement_score":0.06645186,"about_ca_system_score_codex":0.00003757463,"about_ca_system_score_gemma":0.00013790914,"threshold_uncertainty_score":0.9927717},"labels":[],"label_agreement":null},{"id":"W2034609134","doi":"10.1182/blood-2010-11-319376","title":"Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative study","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":313,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"National Institute of Allergy and Infectious Diseases; National Heart, Lung, and Blood Institute; National Institutes of Health; Manton Foundation; Wellcome Trust; Eunice Kennedy Shriver National Institute of Child Health and Human Development; Jeffrey Modell Foundation","keywords":"Wiskott–Aldrich syndrome; Transplantation; Medicine; Hematopoietic cell; Internal medicine; Hematopoietic stem cell transplantation; Retrospective cohort study; Myeloid; Donor lymphocyte infusion; Haematopoiesis; Immunology; Oncology; Stem cell; Biology; Genetics","score_opus":0.017969382251131726,"score_gpt":0.27112680447948995,"score_spread":0.25315742222835824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034609134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99762064,0.00012704839,0.000008507558,0.00003426018,0.000023253382,0.0015972686,0.000050873932,0.000018320841,0.000519846],"genre_scores_gemma":[0.9992612,0.000086344364,0.00011765347,0.00003500466,0.000010594225,0.000103188984,0.00024785186,0.000027912312,0.000110252804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982306,0.00022369898,0.0003738872,0.0003933119,0.000546372,0.00023213532],"domain_scores_gemma":[0.9993746,0.00004537149,0.00008375292,0.00027867145,0.00011719431,0.00010039856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022600491,0.00020060696,0.00029193758,0.00026511448,0.00005104063,0.00004510889,0.00019628156,0.000070202324,0.000095552154],"category_scores_gemma":[0.000012172073,0.00013616352,0.000022198776,0.00053626025,0.00007840352,0.00014524056,0.000023188783,0.00028907618,0.0000118781045],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005678998,0.007594635,0.9716842,0.000045756075,0.000041418396,0.0013157912,0.017837705,4.2373824e-7,0.00081436575,0.0000017471368,0.0000048815295,0.00009116615],"study_design_scores_gemma":[0.012168771,0.0023985493,0.981048,0.00005190257,0.0000790231,0.00010409827,0.0020671026,0.0000070861493,0.0019242929,8.623517e-7,0.000004719449,0.00014561457],"about_ca_topic_score_codex":0.000088317676,"about_ca_topic_score_gemma":0.0001847646,"teacher_disagreement_score":0.015770603,"about_ca_system_score_codex":0.00003475937,"about_ca_system_score_gemma":0.000039023114,"threshold_uncertainty_score":0.55525875},"labels":[],"label_agreement":null},{"id":"W2034988351","doi":"10.1182/blood-2008-06-166082","title":"SHIP prevents lipopolysaccharide from triggering an antiviral response in mice","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Institute of Biomedical Imaging and Bioengineering; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Ernst Schering Foundation; BC Cancer Agency; Howard Hughes Medical Institute; National Science Foundation; National Institutes of Health; Michael Smith Health Research BC","keywords":"Biology; TRIF; Lipopolysaccharide; Cytokine; Autocrine signalling; CpG Oligodeoxynucleotide; Interferon; Toll-like receptor; Receptor; Immunology; Immune system; Innate immune system; Biochemistry; Gene expression","score_opus":0.025373674294876403,"score_gpt":0.29732321622234986,"score_spread":0.27194954192747345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034988351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985497,0.000102439124,0.000028297427,0.00035411768,0.00009428007,0.00014872945,0.000016267553,0.00006568752,0.00064048957],"genre_scores_gemma":[0.9986179,0.000009102211,0.000629994,0.00031134236,0.00023073835,0.000005056272,0.000019275602,0.000012594019,0.00016403526],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991577,0.00008060119,0.00022673923,0.00022460539,0.0001281065,0.0001822084],"domain_scores_gemma":[0.99956656,0.000074998556,0.000047873003,0.00020935503,0.000020045672,0.0000811617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021120213,0.0001050097,0.00019302363,0.00013856415,0.000035447694,0.000021546686,0.00007364676,0.00006010539,0.00009519149],"category_scores_gemma":[0.00015593453,0.0000999088,0.00006729621,0.00011267058,0.000010338196,0.00014895668,0.000011679002,0.00020822516,0.00003014252],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012762202,0.0011112968,0.00435969,0.000003416244,0.000019948708,0.00012842423,0.00040800683,0.000002075071,0.99029094,0.000019614397,0.00003241949,0.002347923],"study_design_scores_gemma":[0.0034739855,0.0010877071,0.16473596,0.00025282183,0.000091577895,0.000041102016,0.000109857414,0.00016850927,0.82925266,0.00018951576,0.0004570079,0.00013929595],"about_ca_topic_score_codex":0.00027046207,"about_ca_topic_score_gemma":0.000031489544,"teacher_disagreement_score":0.16103831,"about_ca_system_score_codex":0.000025984742,"about_ca_system_score_gemma":0.000057568763,"threshold_uncertainty_score":0.40741625},"labels":[],"label_agreement":null},{"id":"W2034992259","doi":"10.1182/blood-2008-02-136374","title":"Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOP","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Diffuse large B-cell lymphoma; Internal medicine; Vincristine; Medicine; Prednisone; Oncology; Rituximab; CHOP; Cyclophosphamide; Anthracycline; Lymphoma; Chemotherapy; Cancer","score_opus":0.01674366896439497,"score_gpt":0.2244839283498904,"score_spread":0.20774025938549542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034992259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99752575,0.0002190674,0.000015386346,0.00006504917,0.000021463797,0.0006888605,0.000104755636,0.00009680198,0.0012628691],"genre_scores_gemma":[0.99784577,0.000061386425,0.0006578402,0.0005082233,0.000025580237,0.00019260612,0.00021267695,0.000047294474,0.00044865004],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836326,0.000030337946,0.0003524159,0.00041158407,0.00039150426,0.00045089],"domain_scores_gemma":[0.99909425,0.00004771099,0.00009792155,0.0004406907,0.00008005123,0.00023935428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000045420224,0.00029838108,0.000459683,0.0001530767,0.00008316349,0.000009694717,0.000083900915,0.00011912394,0.000014190556],"category_scores_gemma":[0.000023388297,0.00021024798,0.000104960105,0.0002022805,0.000043206048,0.000056772973,0.000025033067,0.00005634292,0.00006338072],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003325069,0.08784653,0.91006136,0.00003347385,0.00008009042,0.0010796444,0.00014177807,0.000078973055,0.00007710223,0.0000035082685,0.000091291666,0.00017376196],"study_design_scores_gemma":[0.2045406,0.0009335032,0.77196157,0.00006820032,0.000324109,0.000027023592,0.000006597821,0.0030774183,0.018777408,0.0000014980053,0.00007268808,0.00020937898],"about_ca_topic_score_codex":0.00010815084,"about_ca_topic_score_gemma":0.00004198628,"teacher_disagreement_score":0.20420809,"about_ca_system_score_codex":0.00015627356,"about_ca_system_score_gemma":0.00019529795,"threshold_uncertainty_score":0.8573664},"labels":[],"label_agreement":null},{"id":"W2035068694","doi":"10.1182/blood-2010-01-263624","title":"Optimizing patient selection for myeloablative allogeneic hematopoietic cell transplantation in chronic myeloid leukemia in chronic phase","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"National Institutes of Health; Medical Research Council; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research","keywords":"Medicine; Internal medicine; Myeloid leukemia; Transplantation; Hematopoietic stem cell transplantation; Oncology; Imatinib; Imatinib mesylate; Hematopoietic cell; Chronic leukemia; Univariate analysis; Leukemia; Multivariate analysis; Immunology; Haematopoiesis; Acute leukemia; Stem cell; Biology","score_opus":0.011411524826883842,"score_gpt":0.2692569028110168,"score_spread":0.25784537798413293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035068694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956032,0.00090922625,0.0005479083,0.000051150535,0.00015244428,0.002098898,0.000027362992,0.00007839886,0.0005314275],"genre_scores_gemma":[0.99435925,0.00032951383,0.004012378,0.000048612153,0.00021974643,0.00059783016,0.0002524617,0.00006723672,0.00011295119],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978631,0.00005497309,0.0005978211,0.00059286435,0.00026608177,0.0006251502],"domain_scores_gemma":[0.9991873,0.00013359533,0.00017738936,0.00028713932,0.00007170028,0.00014287642],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021369476,0.00033801366,0.0004680248,0.00035710842,0.0000823003,0.000020056126,0.000103798644,0.0002759337,0.00013706378],"category_scores_gemma":[0.00003591726,0.00033825458,0.00013423276,0.00044467315,0.000056458433,0.00016508056,0.000018740047,0.00054867816,0.000026501604],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006072432,0.001251038,0.0056829923,0.0010544229,0.00011977434,0.00015112867,0.003821648,0.0044258735,0.9740278,0.00005894795,0.000028295533,0.008770849],"study_design_scores_gemma":[0.07133543,0.0032931725,0.006202458,0.0005130505,0.00051241735,0.00031893761,0.00017441725,0.0140949385,0.9024745,0.00009212096,0.0004875349,0.0005009841],"about_ca_topic_score_codex":0.00036757332,"about_ca_topic_score_gemma":0.0035125536,"teacher_disagreement_score":0.071553245,"about_ca_system_score_codex":0.006323899,"about_ca_system_score_gemma":0.0031887745,"threshold_uncertainty_score":0.99990696},"labels":[],"label_agreement":null},{"id":"W2035185745","doi":"10.1182/blood-2009-09-244772","title":"A murine model of severe immune thrombocytopenia is induced by antibody- and CD8+ T cell–mediated responses that are differentially sensitive to therapy","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":211,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Canadian Blood Services; St. Michael's Hospital","funders":"","keywords":"Immunology; Antibody; Immune system; Cytotoxic T cell; CD8; Medicine; Biology; Genetics; In vitro","score_opus":0.022704172881673344,"score_gpt":0.2725692840219107,"score_spread":0.24986511114023738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035185745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99702185,0.0006646963,0.000017747083,0.001149663,0.000015712936,0.00055593194,0.00022535115,0.000036455498,0.00031257665],"genre_scores_gemma":[0.9974754,0.0008428792,0.00024023,0.0008547976,0.0000103091215,0.000005313042,0.00010985447,0.000021672271,0.0004395417],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990047,0.000038823688,0.00020216683,0.00029688806,0.00022186618,0.00023555696],"domain_scores_gemma":[0.9993781,0.000046539102,0.00011060686,0.00025628906,0.000077419965,0.00013107694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000051644212,0.00022873469,0.00061932136,0.000093659844,0.000055733446,0.0000148714425,0.000059949944,0.00011240345,0.000024575467],"category_scores_gemma":[0.00001982584,0.00017802049,0.00007226637,0.00012879548,0.000027258759,0.00005955313,0.000031697815,0.00010991922,0.000007159589],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001143592,0.002011353,0.006209392,0.00002048129,0.00024958156,0.00015753259,0.0009918759,8.6205597e-7,0.98817253,0.0000019118913,0.00015349846,0.000887403],"study_design_scores_gemma":[0.013655002,0.0014881663,0.21755862,0.00013830514,0.00021330891,0.00006678427,0.00019753927,0.00010796603,0.76627016,0.000058610498,0.000019661198,0.00022584808],"about_ca_topic_score_codex":0.00006633442,"about_ca_topic_score_gemma":0.0000059312947,"teacher_disagreement_score":0.22190234,"about_ca_system_score_codex":0.0000111443715,"about_ca_system_score_gemma":0.000053430962,"threshold_uncertainty_score":0.7259465},"labels":[],"label_agreement":null},{"id":"W2035191826","doi":"10.1182/blood-2003-06-2118","title":"Lipopolysaccharide initiates a TRAF6-mediated endothelial survival signal","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"NF-κB Signaling Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Cell biology; Signal transduction; PI3K/AKT/mTOR pathway; Tumor necrosis factor alpha; Kinase; Protein kinase B; Endothelial stem cell; Biology; Lipopolysaccharide; Apoptosis; Cancer research; Immunology; Biochemistry","score_opus":0.012921705596703997,"score_gpt":0.22599972641449773,"score_spread":0.21307802081779373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035191826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969944,0.00036449436,0.00080388365,0.00008714432,0.00020284583,0.0001442107,0.0001465218,0.00006568358,0.0011908124],"genre_scores_gemma":[0.9979839,0.000042919088,0.0006574565,0.00026279115,0.0007217957,0.000024324778,0.00017720323,0.000043210217,0.00008645344],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99879736,0.00004966186,0.00022680148,0.0003735731,0.00019654594,0.000356085],"domain_scores_gemma":[0.999436,0.000023098453,0.00007294428,0.0002754496,0.000063989624,0.00012851976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016822095,0.00020155888,0.00017173108,0.00004777419,0.00007791595,0.00003096543,0.00024009583,0.00017980041,0.000065693996],"category_scores_gemma":[0.00011026816,0.00019986696,0.000121977435,0.00007292288,0.00008108301,0.0000039236397,0.00007368271,0.00012722655,0.00010212416],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004728201,0.00033920523,0.0010846233,0.000008840657,0.00009533855,0.000041767424,0.00005789169,0.000053787186,0.9978727,0.00024221365,0.000035976453,0.00012033548],"study_design_scores_gemma":[0.0032096612,0.00036861096,0.00025651223,0.00001570913,0.000052383395,0.000045825298,0.000034134442,0.000002826467,0.994052,0.00032415765,0.0013816191,0.00025656784],"about_ca_topic_score_codex":0.00007175793,"about_ca_topic_score_gemma":0.00006504881,"teacher_disagreement_score":0.0038207462,"about_ca_system_score_codex":0.000009328301,"about_ca_system_score_gemma":0.00018894074,"threshold_uncertainty_score":0.8150338},"labels":[],"label_agreement":null},{"id":"W2035279824","doi":"10.1182/blood-2012-05-433037","title":"Epidermis instructs skin homing receptor expression in human T cells","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Wellcome Trust","keywords":"Biology; Homing (biology); Cell biology; Human skin; Epidermis (zoology); Lymphocyte homing receptor; Immunology; Cell; Anatomy; Cell adhesion","score_opus":0.012529539951346959,"score_gpt":0.22710455937561608,"score_spread":0.21457501942426913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035279824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99177307,0.0040017646,0.0000062993176,0.000033225733,0.0011966563,0.00016289412,0.000008283432,0.00006644094,0.0027513432],"genre_scores_gemma":[0.9962463,0.000078366,0.00032858844,0.00008286052,0.00011113489,0.000022391103,0.00005810793,0.00002377085,0.0030485084],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99843353,0.00026626396,0.0003478649,0.0002696135,0.000026676484,0.0006560636],"domain_scores_gemma":[0.9994048,0.00009242091,0.00012521159,0.00032416283,0.000020300035,0.00003311384],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0002459794,0.00020336299,0.00031237517,0.00015153471,0.0001817921,0.000008695686,0.00024507724,0.00041813886,0.0013412348],"category_scores_gemma":[0.00003230799,0.00018197637,0.00007591196,0.00012764917,0.00014630923,0.00015258734,0.00015761972,0.00040527977,0.0010803117],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002273018,0.00057290273,0.007960534,0.000014580504,0.00004025606,0.0000032024134,0.00084695074,3.8976881e-7,0.9876099,0.00011102823,0.0015708187,0.001246711],"study_design_scores_gemma":[0.0028314914,0.00007252618,0.0017622099,0.000046195142,0.000024462088,0.000045188917,0.00024200974,9.9395734e-8,0.95415545,0.000046494195,0.040558558,0.00021532635],"about_ca_topic_score_codex":0.00010733901,"about_ca_topic_score_gemma":0.000016722854,"teacher_disagreement_score":0.03898774,"about_ca_system_score_codex":0.000030342568,"about_ca_system_score_gemma":0.000025459092,"threshold_uncertainty_score":0.99969745},"labels":[],"label_agreement":null},{"id":"W2035401368","doi":"10.1182/blood-2009-07-230508","title":"Exploiting the mevalonate pathway to distinguish statin-sensitive multiple myeloma","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"Canadian Institutes of Health Research; Mayo Clinic","keywords":"Multiple myeloma; Mevalonate pathway; Statin; Medicine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lenalidomide; Mevalonic acid; Cancer research; Internal medicine; Oncology; Biology; Genetics","score_opus":0.008705884737181892,"score_gpt":0.23063512690082769,"score_spread":0.2219292421636458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035401368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991953,0.00014497945,0.00029372913,0.00016859431,0.0042620697,0.00023452625,0.000096559495,0.000025068986,0.0028214399],"genre_scores_gemma":[0.9842785,0.00002200948,0.0015165498,0.00064408686,0.012498993,0.000050618022,0.00005608024,0.000030440875,0.00090270006],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990489,0.00004651233,0.00016278308,0.00032027072,0.00013190748,0.00028961434],"domain_scores_gemma":[0.9992697,0.00003967502,0.000067479006,0.00037225068,0.00013838222,0.00011247738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002335103,0.0001456265,0.00012658293,0.000019547619,0.0001632711,0.00003736848,0.00018018176,0.000080873026,0.000011642199],"category_scores_gemma":[0.0007406221,0.00011295073,0.00008204061,0.00007075223,0.00006329099,0.000002473291,0.00013567484,0.00015376577,0.000021244006],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027258462,0.000062432875,0.0010632868,0.0000055559726,0.00003737945,6.348109e-7,0.000440225,0.000002494749,0.98738545,0.00019334398,0.002500816,0.008281101],"study_design_scores_gemma":[0.0007481171,0.00006145853,0.012154635,0.000007065645,0.000027621309,0.000020947826,0.00033893125,0.000009121575,0.5088493,0.000029552833,0.47757795,0.00017523672],"about_ca_topic_score_codex":0.00008445577,"about_ca_topic_score_gemma":0.0007204436,"teacher_disagreement_score":0.47853613,"about_ca_system_score_codex":0.0000026116259,"about_ca_system_score_gemma":0.00006573619,"threshold_uncertainty_score":0.4605997},"labels":[],"label_agreement":null},{"id":"W2035794984","doi":"10.1182/blood-2009-07-233031","title":"gp96, an endoplasmic reticulum master chaperone for integrins and Toll-like receptors, selectively regulates early T and B lymphopoiesis","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Endoplasmic Reticulum Stress and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":122,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"National Institute of Allergy and Infectious Diseases; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Lymphopoiesis; Cell biology; Biology; Myelopoiesis; Endoplasmic reticulum; Integrin; Haematopoiesis; Stem cell; Immunology; Receptor","score_opus":0.006984936368452092,"score_gpt":0.21496745010289448,"score_spread":0.20798251373444238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035794984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99764144,0.0013094316,0.00009419669,0.00017584763,0.00008077702,0.0002987296,0.000043088046,0.000024359728,0.00033209994],"genre_scores_gemma":[0.99675226,0.00051186123,0.0015588051,0.00024794668,0.0001478517,0.00003865676,0.00008745092,0.000024196022,0.0006309652],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988598,0.00003983735,0.00018550685,0.00051870424,0.00009042202,0.00030570783],"domain_scores_gemma":[0.99939173,0.000018294517,0.00006481087,0.0002442505,0.00007136758,0.0002095146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008192939,0.00022322043,0.00019774334,0.00004529897,0.000118246935,0.0000712066,0.00010133327,0.00015466647,0.000009143458],"category_scores_gemma":[0.00005719215,0.00020049466,0.000060256385,0.000050303624,0.00010488059,0.000014607338,0.00005096139,0.000054670294,0.0000012191598],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008435771,0.0008948903,0.03923088,0.000082916384,0.0002360427,0.000017593242,0.00051813596,0.0000047965336,0.9465791,0.0012435844,0.0011092187,0.009239283],"study_design_scores_gemma":[0.007984472,0.0044200947,0.108244136,0.00007959745,0.0003565512,0.0002358236,0.0003631974,0.00016690952,0.8655095,0.0008641215,0.010884932,0.0008906596],"about_ca_topic_score_codex":0.000017447437,"about_ca_topic_score_gemma":0.00002317185,"teacher_disagreement_score":0.08106958,"about_ca_system_score_codex":0.000005919391,"about_ca_system_score_gemma":0.000037319547,"threshold_uncertainty_score":0.81759346},"labels":[],"label_agreement":null},{"id":"W2035844629","doi":"10.1182/blood-2003-10-3531","title":"Hemophilia gene therapy: it's a matter of expression","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Genetic enhancement; Factor IX; Medicine; Clotting factor; Clinical trial; Gene; Internal medicine; Biology; Genetics","score_opus":0.015855329125097347,"score_gpt":0.2764092447509138,"score_spread":0.2605539156258164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035844629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99518156,0.0018452813,0.000069730166,0.00009681493,0.000033623404,0.00014434809,0.000009241601,0.0000048938937,0.0026145026],"genre_scores_gemma":[0.9970214,0.0003925016,0.000927851,0.0004604627,0.00007458165,0.000022809392,0.000020615062,0.000026716432,0.0010530583],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99917257,0.0001055297,0.00014002324,0.00023266266,0.00014730016,0.00020188767],"domain_scores_gemma":[0.99939096,0.000006212971,0.000044519194,0.00044318495,0.00005740746,0.00005772757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017347402,0.00010725808,0.00010767808,0.000032907912,0.00003489337,0.000006601787,0.00015056913,0.00009795561,0.00039378434],"category_scores_gemma":[0.000019520929,0.000092101,0.00007539852,0.000066538705,0.0000508995,0.0000016546418,0.000036665122,0.000056878358,0.000041195024],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027701864,0.000272304,0.0032065888,0.0000076257697,0.000044022658,0.0000022849197,0.00002554702,0.000006981127,0.9944157,0.000004935524,0.0014538768,0.0002830907],"study_design_scores_gemma":[0.0015145966,0.0008737762,0.00040909435,0.0000067996248,0.0000053817403,0.000011058005,0.000012082258,5.282961e-7,0.98717165,0.000044033215,0.009847115,0.000103906386],"about_ca_topic_score_codex":0.0000023944197,"about_ca_topic_score_gemma":0.0000036738747,"teacher_disagreement_score":0.008393237,"about_ca_system_score_codex":0.0000024681585,"about_ca_system_score_gemma":0.000057570724,"threshold_uncertainty_score":0.43116623},"labels":[],"label_agreement":null},{"id":"W2035943650","doi":"10.1182/blood-2002-11-3572","title":"T-cell developmental blockage by tachykinin antagonists and the role of hemokinin 1 in T lymphopoiesis","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Neuropeptides and Animal Physiology","field":"Neuroscience","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Lymphopoiesis; Paracrine signalling; CD8; Biology; Tachykinin receptor; Haematopoiesis; CD44; T cell; Autocrine signalling; Cell growth; Cell biology; Internal medicine; IL-2 receptor; Endocrinology; Immunology; Chemistry; In vitro; Stem cell; Receptor; Immune system; Neuropeptide; Biochemistry; Medicine; Substance P","score_opus":0.005902927585137296,"score_gpt":0.18888000782837103,"score_spread":0.18297708024323373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035943650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892046,0.00024954678,2.0359724e-7,0.00002655058,0.000019207153,0.00010490961,0.000012197275,0.000010057446,0.010372736],"genre_scores_gemma":[0.99927163,0.00012278723,0.00010089264,0.00032745482,0.00000632971,0.000008166368,5.6901047e-7,0.000011297348,0.0001508541],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991403,0.00014994928,0.00018224322,0.00024573458,0.00009436005,0.0001873623],"domain_scores_gemma":[0.99962926,0.00016954615,0.00006622371,0.00009667428,0.000005714854,0.000032608208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009892788,0.000101685306,0.00016321355,0.000028491257,0.00006395417,0.0000150559545,0.00014453534,0.000029643024,0.000022821883],"category_scores_gemma":[0.000104203435,0.0000724605,0.00002830328,0.00014558004,0.00022287788,0.000039403396,0.000065915214,0.00007229692,0.000010394845],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034817785,0.00023474217,0.003095339,0.000004775412,0.0000017471976,0.000010710287,0.0002248674,3.4882135e-7,0.99327743,0.0028794205,0.00009469448,0.00014110433],"study_design_scores_gemma":[0.002584386,0.000059701822,0.0008415565,0.0000051343286,0.00000656623,0.000051528143,0.00018430527,0.000005235353,0.9894829,0.0006105942,0.006081755,0.00008637509],"about_ca_topic_score_codex":0.000029874422,"about_ca_topic_score_gemma":0.0000027053618,"teacher_disagreement_score":0.010221882,"about_ca_system_score_codex":0.000005293321,"about_ca_system_score_gemma":0.000030446137,"threshold_uncertainty_score":0.29548532},"labels":[],"label_agreement":null},{"id":"W2036169078","doi":"10.1182/blood-2014-08-594176","title":"LMP1 mediates multinuclearity through downregulation of shelterin proteins and formation of telomeric aggregates","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; University of Manitoba; Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"Canadian Institutes of Health Research","keywords":"Shelterin; Downregulation and upregulation; Telomere; Biology; Cell biology; Transfection; Cell culture; Molecular biology; Cancer research; Chemistry; Genetics; DNA; DNA-binding protein; Transcription factor; Gene","score_opus":0.021846990002523197,"score_gpt":0.2594047977272767,"score_spread":0.23755780772475352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036169078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99693805,0.0011984926,0.00009659701,0.00016821196,0.000019002407,0.0003134516,0.000010113493,0.000023415318,0.0012326436],"genre_scores_gemma":[0.9976983,0.00014417748,0.0020396672,0.000029117251,0.000022391401,0.000010360708,0.000024698771,0.000008117928,0.00002318541],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994137,0.000019982546,0.00021261409,0.000085553234,0.00017459162,0.000093507704],"domain_scores_gemma":[0.9995394,0.00001414166,0.00018811667,0.00009526557,0.00011662927,0.000046482597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011727718,0.000069505884,0.00020054753,0.000040763836,0.000017447053,0.000004370689,0.000026992773,0.00006280529,0.000012805942],"category_scores_gemma":[0.00014698296,0.000058414244,0.000031725896,0.0001325215,0.00008135251,0.00016543803,0.00001967032,0.000046468595,0.00000173135],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018670758,0.0044988287,0.30530998,0.0033729614,0.0006357845,0.00001564024,0.04369673,0.00017417056,0.5464347,0.0013085731,0.0018097506,0.090875834],"study_design_scores_gemma":[0.04015586,0.0037558018,0.38782012,0.0007729235,0.0008435741,0.0000439661,0.0069107153,0.003051034,0.54853725,0.0062094075,0.001413867,0.0004854597],"about_ca_topic_score_codex":0.0002676041,"about_ca_topic_score_gemma":0.00002617362,"teacher_disagreement_score":0.09039037,"about_ca_system_score_codex":0.00001671112,"about_ca_system_score_gemma":0.000041932388,"threshold_uncertainty_score":0.23820637},"labels":[],"label_agreement":null},{"id":"W2036416375","doi":"10.1182/blood-2008-01-129221","title":"Analysis of clonotypic switch junctions reveals multiple myeloma originates from a single class switch event with ongoing mutation in the isotype-switched progeny","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Immunoglobulin class switching; Biology; Isotype; Molecular biology; Progenitor cell; Population; Antibody; Cancer research; Immunology; Genetics; B cell; Stem cell; Medicine; Monoclonal antibody","score_opus":0.028511240658133218,"score_gpt":0.2795348627438814,"score_spread":0.2510236220857482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036416375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975626,0.00039263917,0.00035481466,0.0003252043,0.000024214765,0.00096179877,0.000040293624,0.000041841628,0.00029662874],"genre_scores_gemma":[0.9970597,0.000038725215,0.002097982,0.000061776846,0.000053723907,0.00019323273,0.0003239987,0.000024527651,0.00014634247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99808204,0.00013855057,0.00042887835,0.00039046042,0.0005997742,0.00036028126],"domain_scores_gemma":[0.9986026,0.00036436727,0.00018203004,0.00051425985,0.00021441143,0.00012230338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002410063,0.00021063662,0.0005150039,0.00044589277,0.00014441699,0.000018309664,0.00014301084,0.000094170384,0.00005489457],"category_scores_gemma":[0.00026920316,0.00013413731,0.00017678786,0.0017114015,0.000084321386,0.00010350897,0.000027369133,0.0002192944,0.000021245494],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005859061,0.0032298854,0.9710194,0.000038593298,0.0025212471,0.00040891013,0.0018080991,0.00009987943,0.018420687,0.000012071165,0.000021039952,0.0018342969],"study_design_scores_gemma":[0.0073900553,0.0007599282,0.96850115,0.00009997192,0.0020307824,0.000075103875,0.0005726157,0.002970768,0.017321218,0.000042420073,0.000094956304,0.00014103524],"about_ca_topic_score_codex":0.0016117921,"about_ca_topic_score_gemma":0.0027023982,"teacher_disagreement_score":0.006804149,"about_ca_system_score_codex":0.000100221536,"about_ca_system_score_gemma":0.00018592975,"threshold_uncertainty_score":0.5469961},"labels":[],"label_agreement":null},{"id":"W2036644772","doi":"10.1182/blood-2007-11-123885","title":"A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Bone and Joint Diseases","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; National Institute of General Medical Sciences; American Lebanese Syrian Associated Charities; McGill University","keywords":"Internal medicine; Odds ratio; Medicine; Genotype; Oncology; Acute lymphocytic leukemia; Univariate analysis; Gastroenterology; Methylenetetrahydrofolate reductase; Leukemia; Lymphoblastic Leukemia; Multivariate analysis; Biology; Genetics; Gene","score_opus":0.008174495650932537,"score_gpt":0.2158116786056567,"score_spread":0.20763718295472416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036644772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99611026,0.0010867403,0.000034900822,0.0010185412,0.000065716944,0.00089602225,0.00012836815,0.00014710192,0.0005123228],"genre_scores_gemma":[0.9963647,0.0003289903,0.00046091163,0.001639769,0.00030254532,0.00013474464,0.000532356,0.000053511176,0.00018243569],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979933,0.00008525971,0.000487326,0.0005707198,0.0004018691,0.00046151076],"domain_scores_gemma":[0.9986167,0.0001370981,0.00021196515,0.0007260996,0.00005040781,0.0002577377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012931014,0.00030830593,0.000597389,0.00010501224,0.00016001325,0.000016035308,0.00017804741,0.00021082237,0.00008522051],"category_scores_gemma":[0.00014029519,0.00019845144,0.00015227056,0.0003630905,0.00028134213,0.00010845812,0.00009996333,0.0003421134,0.000043489545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038567698,0.0012195258,0.9880922,0.0000046745663,0.0010215594,0.0051103625,0.00031108837,0.0000020468708,0.0007142407,0.000009086737,0.002593896,0.0005356724],"study_design_scores_gemma":[0.012916699,0.0010682142,0.96237487,0.00013988993,0.0017140239,0.020677023,0.000037961036,0.00001055147,0.00059559935,0.00003294701,0.00020604751,0.00022614843],"about_ca_topic_score_codex":0.0049020867,"about_ca_topic_score_gemma":0.00040925853,"teacher_disagreement_score":0.025717273,"about_ca_system_score_codex":0.00015802459,"about_ca_system_score_gemma":0.00094220636,"threshold_uncertainty_score":0.80926144},"labels":[],"label_agreement":null},{"id":"W2036716852","doi":"10.1182/blood-2009-12-261636","title":"G-CSF receptor activation of the Src kinase Lyn is mediated by Gab2 recruitment of the Shp2 phosphatase","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; RIKEN; National Institutes of Health","keywords":"LYN; Dephosphorylation; Phosphorylation; Cell biology; Proto-oncogene tyrosine-protein kinase Src; Protein tyrosine phosphatase; Tyrosine-protein kinase CSK; Tyrosine kinase; Kinase; Cancer research; Phosphatase; Tyrosine phosphorylation; Src family kinase; Syk; Chemistry; Signal transduction; Biology; SH2 domain","score_opus":0.024935809415321825,"score_gpt":0.23337399031719794,"score_spread":0.2084381809018761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036716852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990203,0.0066871014,0.00003527953,0.00032640848,0.00016185801,0.00091306673,0.0013781507,0.000008617536,0.0002864707],"genre_scores_gemma":[0.99862844,0.00020109167,0.0002963854,0.0003543828,0.000034741595,0.000081446145,0.00024295435,0.000016853222,0.00014371373],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991528,0.00007606459,0.000233742,0.00021290583,0.00017825156,0.0001462773],"domain_scores_gemma":[0.9989166,0.000014153652,0.00026258169,0.00067464897,0.00009288853,0.000039071856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012988655,0.00012781439,0.00011974717,0.00001101984,0.00005112887,0.000004037422,0.00039985913,0.000103411505,0.00010945808],"category_scores_gemma":[0.0002559711,0.00008010871,0.000098615994,0.0001345431,0.00012851616,0.0000052602977,0.0002055632,0.00006473869,0.000004472536],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008843998,0.0004923645,0.0027828137,0.000025898264,0.00008877237,1.4654104e-7,0.000096398595,2.7443133e-7,0.97913045,0.00025290463,0.016225861,0.00081570336],"study_design_scores_gemma":[0.0008530059,0.00015220552,0.001979137,0.00003984784,0.000053467244,7.8809796e-7,0.000024142199,8.761463e-7,0.9822345,0.00005909107,0.014511127,0.00009184139],"about_ca_topic_score_codex":0.00015369213,"about_ca_topic_score_gemma":0.000006256382,"teacher_disagreement_score":0.008425384,"about_ca_system_score_codex":0.000007724143,"about_ca_system_score_gemma":0.00007289889,"threshold_uncertainty_score":0.3266738},"labels":[],"label_agreement":null},{"id":"W2037171637","doi":"10.1182/blood-2008-01-134247","title":"A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":486,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Institute of General Medical Sciences; National Heart, Lung, and Blood Institute; University of Washington; National Institute of Neurological Disorders and Stroke; University of Florida","keywords":"VKORC1; Warfarin; CYP2C9; Single-nucleotide polymorphism; Vitamin K epoxide reductase; Biology; Population; Genetics; Medicine; Internal medicine; Genotype; Gene","score_opus":0.06018353544277637,"score_gpt":0.3613729850026524,"score_spread":0.30118944955987603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037171637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939031,0.0011113471,0.00032758442,0.0002889729,0.00029179297,0.00098997,0.0002855226,0.00009218473,0.002709541],"genre_scores_gemma":[0.99067295,0.0009052264,0.0013525323,0.0057255896,0.00024752927,0.00028940712,0.000026178863,0.000059439175,0.0007211665],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99781007,0.00020627161,0.00037467634,0.00051706017,0.00021255473,0.0008793442],"domain_scores_gemma":[0.99863225,0.00029713867,0.00017334147,0.000378995,0.00014468424,0.00037357167],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039150778,0.00034495813,0.0003984584,0.00012129346,0.0005036813,0.000018255536,0.00045907122,0.0002099599,0.00017806092],"category_scores_gemma":[0.00007130526,0.00029582743,0.00010850521,0.00025160183,0.00019963675,0.00006844907,0.00009739017,0.0005249373,0.00011454324],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069087306,0.014914285,0.6742913,0.00037199658,0.0024353557,0.002734775,0.0050649205,0.014418964,0.26218668,0.0029229894,0.0040644454,0.009685539],"study_design_scores_gemma":[0.02278947,0.0007633373,0.69334394,0.000035082852,0.0006409984,0.00033622133,0.000033986445,0.0012830999,0.04715633,0.0005936088,0.23224933,0.00077459565],"about_ca_topic_score_codex":0.000018711647,"about_ca_topic_score_gemma":0.000030013782,"teacher_disagreement_score":0.2281849,"about_ca_system_score_codex":0.000030210613,"about_ca_system_score_gemma":0.00017487131,"threshold_uncertainty_score":0.9999494},"labels":[],"label_agreement":null},{"id":"W2037204994","doi":"10.1182/blood-2013-01-478776","title":"Gene-centric association study of acute chest syndrome and painful crisis in sickle cell disease patients","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Acute chest syndrome; Fetal hemoglobin; Medicine; Single-nucleotide polymorphism; Internal medicine; Disease; Sickle cell anemia; Thalassemia; SNP; Bioinformatics; Oncology; Genotype; Gene; Genetics; Biology; Fetus; Pregnancy","score_opus":0.0035400488036721354,"score_gpt":0.1942668695555344,"score_spread":0.19072682075186226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037204994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99846506,0.0002423549,4.1708296e-7,0.00019795561,0.000038971742,0.0008688686,0.000010754551,0.000015057862,0.00016055928],"genre_scores_gemma":[0.9995186,0.00014717605,0.000022319251,0.000093886665,0.0000072747475,0.000031850654,0.000019266812,0.000010955734,0.0001487169],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991787,0.000045577122,0.00022576713,0.00016066608,0.00021580563,0.0001734592],"domain_scores_gemma":[0.99953014,0.000025188454,0.00010091975,0.00013450097,0.000076150114,0.00013310072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008636256,0.00009041117,0.00020322064,0.000096189644,0.000026819134,0.000009106518,0.000035784393,0.00007407402,0.00003373236],"category_scores_gemma":[0.000048553407,0.000075545504,0.000032807464,0.00022040242,0.000008372149,0.000056987516,0.00003209211,0.00010044317,0.000021646536],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017735958,0.00626819,0.9920491,0.0000642352,0.00012179704,0.000045694644,0.00074288587,0.0000016696446,0.00011906811,2.3363995e-7,0.00041577592,0.0001535977],"study_design_scores_gemma":[0.008737611,0.0005878559,0.9888578,0.000022174512,0.00062110135,0.0000014185715,0.0008841699,0.000032925436,0.00014389926,0.000011306648,0.0000197633,0.00007994828],"about_ca_topic_score_codex":0.0002220957,"about_ca_topic_score_gemma":0.000005142262,"teacher_disagreement_score":0.008719875,"about_ca_system_score_codex":0.00003635239,"about_ca_system_score_gemma":0.000028345215,"threshold_uncertainty_score":0.30806562},"labels":[],"label_agreement":null},{"id":"W2037269347","doi":"10.1182/blood-2011-12-397844","title":"Posttranslational regulation of self-renewal capacity: insights from proteome and phosphoproteome analyses of stem cell leukemia","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Canadian Institutes of Health Research","keywords":"Stem cell; Proteome; Biology; Leukemia; Myeloid leukemia; Proteomics; Cell biology; Molecular biology; Cancer research; Biochemistry; Genetics; Gene","score_opus":0.03750007853129773,"score_gpt":0.27936754703710853,"score_spread":0.2418674685058108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037269347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960282,0.0017174587,0.00012552884,0.000046297322,0.000026254926,0.00066819234,0.000054552882,0.00003382693,0.001299688],"genre_scores_gemma":[0.9888976,0.0000412486,0.010671031,0.000016608526,0.00015422459,0.000024578701,0.00006909671,0.000023162704,0.00010240499],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99852335,0.00007701482,0.00040569433,0.00021346081,0.0005528094,0.0002276425],"domain_scores_gemma":[0.99900806,0.000110160145,0.00019476084,0.0002989795,0.00021077562,0.00017723507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016919662,0.00015635781,0.00041485886,0.00019585974,0.00004184962,0.0000065770623,0.00008303853,0.00016658755,0.0000777301],"category_scores_gemma":[0.000017572685,0.00013106276,0.00008212839,0.00030443526,0.00011469879,0.00018670227,0.000041347983,0.00018941073,0.000006974622],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016629648,0.00040717903,0.04270842,0.0002551489,0.00029198098,0.0000026978132,0.001694411,0.000007106293,0.9539927,0.00011656338,0.000014864977,0.0003425892],"study_design_scores_gemma":[0.0031366686,0.00018378276,0.1836434,0.00007040479,0.00038972532,0.000015222077,0.00009224018,0.00019885076,0.811932,0.00018160747,0.000055883742,0.00010018062],"about_ca_topic_score_codex":0.0007015226,"about_ca_topic_score_gemma":0.0000097485545,"teacher_disagreement_score":0.14206071,"about_ca_system_score_codex":0.00010409145,"about_ca_system_score_gemma":0.00030761212,"threshold_uncertainty_score":0.5344584},"labels":[],"label_agreement":null},{"id":"W2037417109","doi":"10.1182/blood-2013-12-545780","title":"Omental implantation of BOECs in hemophilia dogs results in circulating FVIII antigen and a complex immune response","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Canadian Institutes of Health Research","keywords":"Antigen; Immune system; Antibody; Immunology; Medicine","score_opus":0.0304310805663806,"score_gpt":0.3134988381615662,"score_spread":0.2830677575951856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037417109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99804693,0.000121482415,0.00000116589,0.0006010163,0.000015585803,0.00033124967,0.000012084968,0.000011007991,0.00085946906],"genre_scores_gemma":[0.9993962,0.000049945487,0.0003237595,0.000019889947,0.000024114117,0.0000075251587,0.00007193763,0.000009975585,0.00009664401],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888223,0.00016333147,0.0003621823,0.00018820076,0.0001993104,0.00020475025],"domain_scores_gemma":[0.99946696,0.00022287459,0.0000626542,0.00016153036,0.000026735961,0.000059237802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008869749,0.0000901908,0.0002627654,0.00025217375,0.000030813822,0.00000721186,0.000041474148,0.00006308008,0.000011068574],"category_scores_gemma":[0.00024913234,0.00007667231,0.000029854293,0.00023152982,0.000060303297,0.0000427294,0.0000389612,0.00011187501,0.000006142248],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002224602,0.0005236411,0.5474154,0.00009072735,0.000027645838,0.00013445204,0.0012806437,0.0000018335929,0.44631588,0.0000218052,0.000010082554,0.001953309],"study_design_scores_gemma":[0.013148087,0.00035519258,0.96694237,0.00018611534,0.000016972786,0.00010449649,0.00018395827,0.00035929857,0.018540446,0.00005667601,0.000038705588,0.00006769214],"about_ca_topic_score_codex":0.00031218675,"about_ca_topic_score_gemma":0.000054096625,"teacher_disagreement_score":0.42777544,"about_ca_system_score_codex":0.000032027678,"about_ca_system_score_gemma":0.000043229036,"threshold_uncertainty_score":0.3126606},"labels":[],"label_agreement":null},{"id":"W2037688286","doi":"10.1182/blood-2002-02-0568","title":"The SCL complex regulates c-kit expression in hematopoietic cells through functional interaction with Sp1","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Zebrafish Biomedical Research Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":164,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"","keywords":"Biology; Transcription factor; Chromatin immunoprecipitation; Haematopoiesis; Ectopic expression; Chromatin; Cell biology; Molecular biology; Zinc finger; Transfection; Promoter; Stem cell; Gene; Genetics; Gene expression","score_opus":0.025467727037430624,"score_gpt":0.2659358760512411,"score_spread":0.24046814901381047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037688286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894541,0.00070449425,0.0019501453,0.0021445455,0.000059550246,0.00039529917,0.000011469553,0.00002315878,0.0052572633],"genre_scores_gemma":[0.9977829,0.00022530252,0.00083890266,0.00012610356,0.00011771322,0.00008956045,0.00005871538,0.000013152938,0.00074763555],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991478,0.000044910328,0.00014239084,0.00023750888,0.00021627823,0.00021112004],"domain_scores_gemma":[0.9994897,0.000049354796,0.000046435518,0.00030380837,0.000049601378,0.00006105899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009602303,0.000088275585,0.00006748541,0.000020609046,0.0001358751,0.000035369223,0.0001595683,0.000071820024,0.00019174858],"category_scores_gemma":[0.000051044528,0.00005782846,0.000031818603,0.00013322162,0.00015860645,0.000006269827,0.000081619786,0.000117591706,0.000060443872],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041177536,0.0003288584,0.00029493583,0.000008700936,0.000020532532,0.0000024583842,0.000034416957,0.000012556618,0.982354,0.00010455208,0.016138457,0.00065939146],"study_design_scores_gemma":[0.0011189454,0.00017489259,0.0036427854,0.000034018776,0.000009158596,0.000033003533,0.00012380353,0.00015372087,0.88977116,0.00032612545,0.10449372,0.00011868642],"about_ca_topic_score_codex":0.000009432476,"about_ca_topic_score_gemma":0.000041418694,"teacher_disagreement_score":0.09258283,"about_ca_system_score_codex":0.000010329436,"about_ca_system_score_gemma":0.000018056033,"threshold_uncertainty_score":0.23581763},"labels":[],"label_agreement":null},{"id":"W2037728003","doi":"10.1182/blood-2002-07-2108","title":"Iron transport by Nramp2/DMT1: pH regulation of transport by 2 histidines in transmembrane domain 6","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"National Institute of Allergy and Infectious Diseases","keywords":"DMT1; Mutant; Biochemistry; Transmembrane domain; Major facilitator superfamily; Chemistry; Transporter; Transport protein; Membrane transport protein; ATP-binding cassette transporter; Mutagenesis; Hereditary hemochromatosis; Mutation; Yeast; Iron-binding proteins; Transmembrane protein; Cell biology; Biology; Transferrin; Genetics; Amino acid; Gene; Receptor; Hemochromatosis","score_opus":0.005531337162986927,"score_gpt":0.2108703138585418,"score_spread":0.20533897669555487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037728003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870079,0.0041247313,0.0006730723,0.0002706203,0.00007923521,0.00045684417,0.000087395856,0.000043730382,0.007256438],"genre_scores_gemma":[0.99700075,0.00036794567,0.0008924565,0.00012544762,0.00002715197,0.000021542382,0.00039393883,0.00003747755,0.0011332879],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99844795,0.000050894792,0.00053723645,0.00031630823,0.00034802806,0.00029957804],"domain_scores_gemma":[0.9994739,0.000020782221,0.000085447915,0.00026686952,0.000034667417,0.00011833102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028545829,0.00021853401,0.0004904047,0.00012016803,0.00003036127,0.000001987442,0.00007658691,0.00017432713,0.00039550842],"category_scores_gemma":[0.00001494935,0.00020665831,0.00013379235,0.00029917547,0.000099953264,0.00009289763,9.146506e-7,0.00014417077,0.000004665106],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058065733,0.0044425186,0.16051915,0.0011629175,0.000047025635,0.000041820433,0.0020938045,0.00003279665,0.82600117,0.0016141656,0.0017868632,0.0016771312],"study_design_scores_gemma":[0.0486215,0.0006319127,0.42241043,0.00026079096,0.0013711107,0.00007173141,0.0008227829,0.000007779727,0.42208993,0.0009550221,0.10183047,0.00092654943],"about_ca_topic_score_codex":0.00016644609,"about_ca_topic_score_gemma":0.00007864207,"teacher_disagreement_score":0.4039112,"about_ca_system_score_codex":0.000013272275,"about_ca_system_score_gemma":0.00007860916,"threshold_uncertainty_score":0.84272814},"labels":[],"label_agreement":null},{"id":"W2037982702","doi":"10.1182/blood.v99.4.1246","title":"Reduced tissue macrophage population in the lung by anticancer agent cyclophosphamide: restoration by local granulocyte macrophage–colony-stimulating factor gene transfer","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Neonatal Respiratory Health Research","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"","keywords":"Macrophage; Cyclophosphamide; Granulocyte; Granulocyte macrophage colony-stimulating factor; Immunology; Granulocyte macrophage colony-stimulating factor receptor; Population; Biology; Gene transfer; Medicine; Macrophage colony-stimulating factor; Gene; Chemotherapy; Cytokine; In vitro; Genetics","score_opus":0.030289232603152312,"score_gpt":0.3327777609398363,"score_spread":0.302488528336684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037982702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97937006,0.016403621,0.001015672,0.00087214634,0.00013155665,0.0018523351,0.000111869,0.00006478051,0.00017798757],"genre_scores_gemma":[0.99724436,0.0006184514,0.0001927779,0.00083742186,0.00016093682,0.00014601726,0.00015754072,0.00006116331,0.000581344],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967458,0.00034143525,0.0006534178,0.0005360254,0.0010562659,0.0006670552],"domain_scores_gemma":[0.9988979,0.00018029864,0.000074902564,0.00047538933,0.000095768984,0.0002757046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005360955,0.00027647737,0.00038168876,0.00013268285,0.0002337315,0.00005347449,0.00021165569,0.00022726032,0.00053154706],"category_scores_gemma":[0.00021151158,0.00022540895,0.000070909075,0.0006116803,0.00010780544,0.00017389016,0.000028326758,0.00065505126,0.00007269516],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063077285,0.0016621492,0.032744635,0.00093120575,0.0000849013,0.001013362,0.0017127632,0.00018363165,0.8357474,0.000031559564,0.005035426,0.12022219],"study_design_scores_gemma":[0.021533113,0.0023796465,0.29736692,0.0004511164,0.0003273586,0.00018631015,0.00017041461,0.016579391,0.629616,0.000037288104,0.030262709,0.0010897323],"about_ca_topic_score_codex":0.0006980168,"about_ca_topic_score_gemma":0.000052186828,"teacher_disagreement_score":0.26462227,"about_ca_system_score_codex":0.00034798076,"about_ca_system_score_gemma":0.00006887701,"threshold_uncertainty_score":0.919191},"labels":[],"label_agreement":null},{"id":"W2037994583","doi":"10.1182/blood-2014-08-595801","title":"Durable remissions in a pivotal phase 2 study of brentuximab vedotin in relapsed or refractory Hodgkin lymphoma","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":222,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Takeda Pharmaceuticals International; National Cancer Institute; Celgene; Sanofi; Pfizer","keywords":"Brentuximab vedotin; Medicine; Internal medicine; Oncology; Refractory (planetary science); Hodgkin lymphoma; Lymphoma; Phases of clinical research; Chemotherapy; Biology","score_opus":0.01928113197485227,"score_gpt":0.297972365067819,"score_spread":0.27869123309296673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037994583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99708295,0.00021512125,6.301418e-7,0.00014187847,0.000063348576,0.0007016107,0.0000069201596,0.000029954716,0.0017575696],"genre_scores_gemma":[0.99926496,0.00003979175,0.00016477473,0.000059638565,0.000042821288,0.00012174273,0.000013822434,0.000023241966,0.0002692198],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845153,0.0001414678,0.00051385903,0.0003448095,0.00027527218,0.00027303677],"domain_scores_gemma":[0.9990339,0.00021022432,0.00013085835,0.00045044726,0.000038144895,0.00013642556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027141735,0.00018229929,0.00052580016,0.0002348771,0.000033325676,0.00000788694,0.00008946018,0.000092447255,0.00011179219],"category_scores_gemma":[0.00035384393,0.00013237145,0.00006610523,0.00037713637,0.000027982636,0.00004323746,0.00004580109,0.00008610979,0.000017390323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002103406,0.235492,0.7202937,0.00011245009,0.00019288248,0.0014891705,0.0026329237,0.0000054918555,0.009846725,0.00003951943,0.00043852613,0.027353201],"study_design_scores_gemma":[0.19930278,0.009180764,0.7790502,0.0005421412,0.00029322095,0.000097109216,0.0011219098,0.00013856243,0.009223568,0.000022038794,0.0008364372,0.00019127592],"about_ca_topic_score_codex":0.00083917606,"about_ca_topic_score_gemma":0.00048073928,"teacher_disagreement_score":0.22631125,"about_ca_system_score_codex":0.00013252461,"about_ca_system_score_gemma":0.00019031673,"threshold_uncertainty_score":0.5397951},"labels":[],"label_agreement":null},{"id":"W2038019363","doi":"10.1182/blood-2004-04-1508","title":"Identification of cooperative genes for NUP98-HOXA9 in myeloid leukemogenesis using a mouse model","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer","funders":"","keywords":"Biology; Fusion gene; Myeloid leukemia; Myeloid; Cancer research; Leukemia; Carcinogenesis; Transgene; Genetically modified mouse; Chromosomal translocation; Fusion protein; Gene; Haematopoiesis; Stem cell; Genetics","score_opus":0.04206000187329901,"score_gpt":0.3206554688923874,"score_spread":0.2785954670190884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038019363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97674245,0.0003419607,0.021592434,0.00020405918,0.000017996723,0.0009693574,0.000059681926,0.000027725458,0.000044337405],"genre_scores_gemma":[0.98433244,0.00012209952,0.014674128,0.00007131387,0.000067921595,0.0001036635,0.000029308272,0.000041394716,0.0005577337],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99871856,0.00002890148,0.0004294574,0.00029396793,0.00025555288,0.00027354044],"domain_scores_gemma":[0.99912834,0.00004522985,0.00010217885,0.00032308322,0.00031783228,0.00008331369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032053774,0.00013505624,0.00031089172,0.0002518844,0.00005789093,0.00001419751,0.00012784233,0.00011281718,0.0000058331634],"category_scores_gemma":[0.00019023287,0.00012756133,0.00008435504,0.0003340087,0.00008225797,0.00011800123,0.000045000113,0.00011062751,0.000006889814],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018625865,0.0004999454,0.0014007139,0.0001299504,0.00007519989,0.000006005526,0.0005823503,0.02437274,0.97203845,0.00034829447,0.000012460216,0.00034762593],"study_design_scores_gemma":[0.007510698,0.00013090673,0.0007009358,0.00005893039,0.00012824684,0.000019169182,0.00019400174,0.05945485,0.93146926,0.00020309268,0.000012582713,0.00011735056],"about_ca_topic_score_codex":0.00015799588,"about_ca_topic_score_gemma":0.000048191694,"teacher_disagreement_score":0.04056922,"about_ca_system_score_codex":0.0003538838,"about_ca_system_score_gemma":0.0009818908,"threshold_uncertainty_score":0.52018},"labels":[],"label_agreement":null},{"id":"W2038260243","doi":"10.1182/blood-2009-03-209965","title":"Chelation of intracellular iron with the antifungal agent ciclopirox olamine induces cell death in leukemia and myeloma cells","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":185,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University Health Network; Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Leukemia; Cancer research; Multiple myeloma; Pharmacology; Intracellular; Medicine; Chemistry; Immunology; Biochemistry","score_opus":0.006168829699247192,"score_gpt":0.20151093093496114,"score_spread":0.19534210123571394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038260243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945432,0.002031936,0.000019167092,0.0005416817,0.000021552629,0.00030204852,0.0000015494506,0.0000144956275,0.0025243706],"genre_scores_gemma":[0.99883276,0.00048038492,0.00026143336,0.00011855572,0.0000308282,0.0000022558652,0.000008328133,0.000009551048,0.00025591836],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99929726,0.000028988034,0.00018608948,0.00016378956,0.00015994394,0.0001639259],"domain_scores_gemma":[0.9996608,0.00002273999,0.00008100164,0.00015639198,0.000026402853,0.000052668638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001344306,0.00011693985,0.0001853402,0.000065094784,0.000038630395,0.000008618285,0.000047966147,0.00012077515,0.000014096395],"category_scores_gemma":[0.00000774692,0.000070205475,0.00002584037,0.000171522,0.000052899155,0.000039044524,0.000012643887,0.0002223266,0.000002860916],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014458904,0.0007211228,0.04263476,0.00014089773,0.00003603877,0.00012970419,0.0017502796,0.00010985213,0.9493787,0.000105618055,0.00008536743,0.004763026],"study_design_scores_gemma":[0.005427204,0.0010059364,0.41735262,0.00017371215,0.00025180468,0.000051666917,0.0006790806,0.00026542795,0.57427204,0.00003170496,0.00033717047,0.00015159913],"about_ca_topic_score_codex":0.00003584944,"about_ca_topic_score_gemma":0.0000074587365,"teacher_disagreement_score":0.3751067,"about_ca_system_score_codex":0.000021420548,"about_ca_system_score_gemma":0.00006453605,"threshold_uncertainty_score":0.28628963},"labels":[],"label_agreement":null},{"id":"W2038403389","doi":"10.1182/blood-2012-02-408997","title":"Fanconi anemia proteins interact with CtBP1 and modulate the expression of the Wnt antagonist Dickkopf-1","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Kruppel-like factors research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"Canadian Blood Services; Canadian Institutes of Health Research; Fanconi Anemia Research Fund","keywords":"Wnt signaling pathway; Antagonist; Fanconi anemia; Cell biology; Biology; Medicine; Internal medicine; Signal transduction; Genetics; DNA; Receptor; DNA repair","score_opus":0.005688837994478291,"score_gpt":0.2270581464756138,"score_spread":0.2213693084811355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038403389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998352,0.00023847129,0.00003968281,0.00034989094,0.000028246252,0.000559024,0.000011626165,0.0000047181297,0.00041637538],"genre_scores_gemma":[0.9991406,0.000044687487,0.00013521289,0.000052238665,0.000057549038,0.000059856284,0.000009294434,0.000016238315,0.00048428733],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99923533,0.00007558688,0.000121292585,0.00021319998,0.00016723717,0.00018738053],"domain_scores_gemma":[0.9993239,0.000013264706,0.000073759176,0.00045902465,0.000079969825,0.000050102328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008425879,0.000112256406,0.00009445506,0.000013532444,0.000106428415,0.00004175465,0.00027893853,0.00007397145,0.000028407407],"category_scores_gemma":[0.000045256842,0.00005176457,0.000039385945,0.000056917037,0.00020669748,0.000005770654,0.0002737722,0.00013672249,0.0000042146958],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027277942,0.00008440168,0.025738547,0.000023762983,0.000022619897,9.20115e-7,0.00007865644,0.0000030474364,0.9733302,0.0000052064197,0.0002530969,0.00043225798],"study_design_scores_gemma":[0.0005773548,0.00025173265,0.037974358,0.00004312965,0.000012391325,0.000020901985,0.00008782754,0.000010751269,0.9601376,0.000028010698,0.00077657314,0.00007937311],"about_ca_topic_score_codex":0.00017666383,"about_ca_topic_score_gemma":0.000043478438,"teacher_disagreement_score":0.01319261,"about_ca_system_score_codex":0.0000040534455,"about_ca_system_score_gemma":0.000055980978,"threshold_uncertainty_score":0.2110898},"labels":[],"label_agreement":null},{"id":"W2038558584","doi":"10.1182/blood.v98.7.2000a","title":"Another SHIP on the horizon","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute","funders":"","keywords":"Phosphatidylinositol; Second messenger system; Cell biology; Pi; Signal transduction; Phospholipid; Kinase; Biology; Chemistry; Biochemistry; Membrane","score_opus":0.01791251238202053,"score_gpt":0.24380512800854115,"score_spread":0.22589261562652063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038558584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.976018,0.0005597957,0.00011528228,0.0005610364,0.00012918492,0.0000843106,0.0000049927676,0.000014468577,0.022512931],"genre_scores_gemma":[0.99637425,0.00007675351,0.000063763335,0.0012095794,0.0005969509,0.000019955085,0.0000075154508,0.000020583338,0.0016306437],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994597,0.00003469709,0.000070414266,0.0001851826,0.00009296116,0.00015708478],"domain_scores_gemma":[0.9995692,0.000014973656,0.000028873244,0.0003422264,0.000020966036,0.000023769933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010809757,0.00008683717,0.000052855845,0.000010605977,0.00005118361,0.000015470481,0.00018177924,0.00008077972,0.000146562],"category_scores_gemma":[0.000042810618,0.00006023691,0.000050265917,0.00005086087,0.000036708705,7.2326054e-7,0.000029940362,0.00006578198,0.00006910215],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006073127,0.00018165402,0.004669047,0.0000033369824,0.0000797747,0.000009700504,0.000028918912,0.000014273448,0.98186594,0.00038140587,0.010529398,0.002175795],"study_design_scores_gemma":[0.0005250009,0.0004966735,0.0008994788,0.0000108948425,0.000021025044,0.000015604599,0.000015980713,0.0000027910553,0.7667045,0.00014429977,0.2310347,0.0001290383],"about_ca_topic_score_codex":0.0000069723205,"about_ca_topic_score_gemma":0.000009034193,"teacher_disagreement_score":0.2205053,"about_ca_system_score_codex":0.000004493896,"about_ca_system_score_gemma":0.000024388104,"threshold_uncertainty_score":0.245639},"labels":[],"label_agreement":null},{"id":"W2038904195","doi":"10.1182/blood-2007-08-108449","title":"Induction of an inhibitor antibody to factor XI in a patient with severe inherited factor XI deficiency by Rh immune globulin","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Factor XI; Antibody; Medicine; Immune system; Immunology; Gamma globulin; Factor IX; Immunization; Internal medicine; Endocrinology","score_opus":0.01181791450740007,"score_gpt":0.2629392716621662,"score_spread":0.25112135715476613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038904195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979301,0.0007241599,0.00011885191,0.00010127117,0.00014257632,0.00064634695,0.000075740376,0.00006811564,0.00019281186],"genre_scores_gemma":[0.9987847,0.000014101811,0.00073062506,0.000099808276,0.00010335474,0.000007865922,0.00014508587,0.00003334225,0.00008111625],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99826384,0.000033798362,0.0005651609,0.0003559226,0.0004169745,0.00036429675],"domain_scores_gemma":[0.99911416,0.00003606887,0.0001828393,0.00030855616,0.00015106605,0.00020731031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013046623,0.00022549166,0.0003909381,0.00023593336,0.000055010496,0.000016413123,0.000086729866,0.00015332353,0.000092608716],"category_scores_gemma":[0.00007648216,0.00018954497,0.00006459354,0.0006963062,0.00005017338,0.00017902702,0.000033837612,0.0001561725,0.000009243739],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085408625,0.0041573746,0.40363485,0.00013719543,0.00007110363,0.00009316092,0.006416326,0.000013538749,0.55998224,0.000024400508,0.00007518059,0.02454058],"study_design_scores_gemma":[0.0039026248,0.0022332063,0.75638884,0.00025419163,0.00005534711,0.00011628193,0.0008645029,0.000018040111,0.23543148,0.000007458502,0.00046041564,0.0002676015],"about_ca_topic_score_codex":0.00071966683,"about_ca_topic_score_gemma":0.00018831476,"teacher_disagreement_score":0.35275403,"about_ca_system_score_codex":0.0000615089,"about_ca_system_score_gemma":0.000104134866,"threshold_uncertainty_score":0.77294195},"labels":[],"label_agreement":null},{"id":"W2039215350","doi":"10.1182/blood-2012-09-457036","title":"Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":323,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Novo Nordisk; Bayer HealthCare; CSL Behring; Pfizer","keywords":"Medicine; Hazard ratio; Internal medicine; Incidence (geometry); Gastroenterology; Confidence interval; Risk factor; Prophylactic treatment; C1-inhibitor; Surgery","score_opus":0.020511042421865612,"score_gpt":0.2571841623745122,"score_spread":0.2366731199526466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039215350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970747,0.00013956417,1.4365976e-7,0.00046857478,0.00000985008,0.0021032721,0.0000035437338,0.000014237243,0.00018607946],"genre_scores_gemma":[0.9991055,0.00002792767,0.00014464637,0.000020538717,0.000037015587,0.000107277665,0.000008110564,0.000012011795,0.0005369525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913174,0.000035901066,0.00018706813,0.00022415051,0.00021857739,0.00020258715],"domain_scores_gemma":[0.9995258,0.00003063468,0.000036285972,0.00022729815,0.00008363198,0.0000963654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000079058416,0.0001544713,0.0002933315,0.00008026354,0.00006266781,0.000013199401,0.00005321798,0.000043329237,0.000053191612],"category_scores_gemma":[0.000017258082,0.00007138575,0.000025233823,0.00014178637,0.00007434235,0.000042136628,0.000057025012,0.00010454195,0.000017849241],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008711112,0.0030219967,0.9891329,0.000011468683,0.00041858686,0.00001677313,0.0021341275,1.1711519e-7,0.0010301385,0.0000010971751,0.000018271421,0.004127445],"study_design_scores_gemma":[0.007540234,0.0016987529,0.971005,0.00004497417,0.00009663673,0.00008920632,0.0006083289,0.0000015305778,0.018808234,0.0000048897355,0.00002292225,0.00007926478],"about_ca_topic_score_codex":0.00038972797,"about_ca_topic_score_gemma":0.00013698151,"teacher_disagreement_score":0.01812784,"about_ca_system_score_codex":0.00005730642,"about_ca_system_score_gemma":0.00011390073,"threshold_uncertainty_score":0.29110265},"labels":[],"label_agreement":null},{"id":"W2039324671","doi":"10.1182/blood-2008-07-166892","title":"Mesenchymal stromal cell–derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":223,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; McGill University Health Centre; Université du Québec à Montréal","funders":"","keywords":"Mesenchymal stem cell; Chemokine; Immunology; Chemistry; Stromal cell; STAT protein; Molecular biology; Antibody; Biology; Cell biology; STAT3; Cancer research; Inflammation; Signal transduction","score_opus":0.024456117411157285,"score_gpt":0.24789967364245893,"score_spread":0.22344355623130166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039324671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945521,0.0004936662,0.00013358299,0.0003921109,0.00025761948,0.00093167135,0.0000076213364,0.000111685105,0.003119991],"genre_scores_gemma":[0.99480766,0.00051403145,0.0014232143,0.000015835616,0.00045722185,0.000057851095,0.00008858074,0.000045077457,0.0025905499],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976376,0.00015504878,0.0003912147,0.0006008357,0.0007343436,0.00048092112],"domain_scores_gemma":[0.99883574,0.0000829176,0.00016058507,0.0004176732,0.00027649343,0.00022661562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028844742,0.00026392567,0.0003468018,0.00022912287,0.00031291324,0.00003120859,0.00010284492,0.00020495646,0.00021389792],"category_scores_gemma":[0.00019708871,0.00024469092,0.00006427981,0.00038877458,0.0001901818,0.00036490054,0.0000991459,0.0004947115,0.000067212764],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040378273,0.0010038649,0.017331684,0.0002850664,0.000053771484,0.00010574033,0.00073562487,0.00001392038,0.97832686,0.000003803119,0.0004634821,0.0012723992],"study_design_scores_gemma":[0.0034061712,0.00088490197,0.08255933,0.000047334048,0.00009888963,0.0007189651,0.00045446027,0.00008517746,0.9105658,0.000019200039,0.0009476172,0.00021214287],"about_ca_topic_score_codex":0.00023291387,"about_ca_topic_score_gemma":0.000008924296,"teacher_disagreement_score":0.06776105,"about_ca_system_score_codex":0.000106668274,"about_ca_system_score_gemma":0.00023712615,"threshold_uncertainty_score":0.9978207},"labels":[],"label_agreement":null},{"id":"W2039513027","doi":"10.1182/blood-2007-07-101691","title":"NSOM/QD-based nanoscale immunofluorescence imaging of antigen-specific T-cell receptor responses during an in vivo clonal Vγ2Vδ2 T-cell expansion","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Research Resources; National Heart, Lung, and Blood Institute; National Institutes of Health; University of Toronto","keywords":"T-cell receptor; Nanoclusters; Immunofluorescence; In vivo; T cell; Antigen; Materials science; Immune system; Fluorescence-lifetime imaging microscopy; Molecular biology; Biophysics; Biology; Chemistry; Cell biology; Nanotechnology; Immunology; Fluorescence; Optics; Physics; Antibody","score_opus":0.008304027851738291,"score_gpt":0.22494534594892235,"score_spread":0.21664131809718407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039513027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9669772,0.031533737,0.00010565941,0.000036929,0.00056976464,0.00032637783,0.000051771087,0.00008889535,0.00030967468],"genre_scores_gemma":[0.9961253,0.0016927081,0.000695256,0.000066162494,0.000035703546,0.000014646925,0.00004607693,0.000057666228,0.0012664766],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970418,0.0006272063,0.0008564287,0.00055176707,0.00011937704,0.00080337515],"domain_scores_gemma":[0.99836695,0.000436109,0.00030435505,0.0007340511,0.00011975819,0.000038746417],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010735559,0.00036983023,0.00048307102,0.0005680734,0.00029727808,0.000025281222,0.000540657,0.00030533673,0.0007675615],"category_scores_gemma":[0.000052509946,0.0003706687,0.0001865992,0.00040065584,0.00040647754,0.00025118902,0.0000843427,0.00047043472,0.00011269201],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076659597,0.0024010588,0.02812286,0.00004477952,0.000031230862,0.00004268528,0.0008023174,0.0000042412917,0.95967656,0.000012123337,0.00008736209,0.0011088261],"study_design_scores_gemma":[0.00796326,0.00038090142,0.058426462,0.00016693842,0.000012841645,0.00004738078,0.0006206593,0.0000014048032,0.925507,0.000004626511,0.0064859297,0.00038256563],"about_ca_topic_score_codex":0.00017822806,"about_ca_topic_score_gemma":0.0000154794,"teacher_disagreement_score":0.03416953,"about_ca_system_score_codex":0.00005815666,"about_ca_system_score_gemma":0.00018571629,"threshold_uncertainty_score":0.99987453},"labels":[],"label_agreement":null},{"id":"W2039543070","doi":"10.1182/blood-2011-02-337709","title":"Young maybe, but surely not immature","year":2011,"lang":"en","type":"letter","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Héma-Québec","funders":"","keywords":"Stem cell; Cord blood; Immunology; Biology; Fetal hemoglobin; Fetus; Medicine; Genetics; Pregnancy","score_opus":0.017248457151313342,"score_gpt":0.22650575888061772,"score_spread":0.20925730172930437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039543070","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.36717227,0.0067013265,0.0000067147753,0.4463723,0.0020969396,0.0018680812,0.00090556283,0.0005222174,0.17435457],"genre_scores_gemma":[0.060618345,0.0006597395,0.000866434,0.80194783,0.0047849105,0.00011200973,0.003786116,0.00028889795,0.12693569],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985238,0.000024126075,0.00022920244,0.00043364603,0.00034387808,0.00044535068],"domain_scores_gemma":[0.99917454,0.00002459231,0.0001223808,0.00053071877,0.00006479719,0.000082955325],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00004205346,0.0003900954,0.00066942,0.00012050467,0.000056974888,0.000022779464,0.00014549315,0.0011361055,0.00040504598],"category_scores_gemma":[0.00002074517,0.00030364844,0.00025037062,0.00008176232,0.000042192536,0.000036870635,0.000040927855,0.0013748828,0.0007267721],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000090348636,0.0004839818,0.0021638388,0.00023440199,0.001104478,0.03621838,0.00011019033,4.246244e-9,0.0001311737,0.000006321292,0.9592659,0.00019099297],"study_design_scores_gemma":[0.0085589485,0.0004319792,0.014139351,0.00039552187,0.0037670564,0.004983892,0.000020574262,4.287801e-7,0.0027828133,0.00020528637,0.9640638,0.00065032317],"about_ca_topic_score_codex":0.00026861328,"about_ca_topic_score_gemma":0.000008543802,"teacher_disagreement_score":0.35557556,"about_ca_system_score_codex":0.00002155405,"about_ca_system_score_gemma":0.00009345724,"threshold_uncertainty_score":0.9999416},"labels":[],"label_agreement":null},{"id":"W2039591253","doi":"10.1182/blood-2002-07-2086","title":"LCR-regulated transgene expression levels depend on the Oct-1 site in the AT-rich region of β-globin intron-2","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Locus control region; Transgene; Molecular biology; Biology; Intron; Globin; Mutant; Ectopic expression; Regulatory sequence; Binding site; Transcription (linguistics); Gene; Promoter; Gene expression; Genetics","score_opus":0.012848861019465307,"score_gpt":0.25531812775685525,"score_spread":0.24246926673738994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039591253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99711484,0.0008110361,0.0009937085,0.00014423636,0.000040055715,0.00018404963,0.000006997398,0.000004294509,0.0007007702],"genre_scores_gemma":[0.9995328,0.00006122636,0.00012305772,0.000089342786,0.000039152575,0.000015359277,0.000014815073,0.000012173095,0.00011205894],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99928576,0.00010248529,0.00015568951,0.00018274452,0.00011339448,0.00015992174],"domain_scores_gemma":[0.99952793,0.000027432276,0.000037566642,0.00036603608,0.000019321376,0.000021706543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002001887,0.000111832436,0.0000924046,0.000023588125,0.00004498709,0.0000066601992,0.00015575124,0.000097193035,0.000016455899],"category_scores_gemma":[0.000043309814,0.00006844338,0.000053697637,0.00010203053,0.00002393605,0.0000011944244,0.000022322734,0.00007829983,0.0000029225223],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024450028,0.00010864188,0.0007054607,0.000008991969,0.00001585896,0.0000042604447,0.0002313753,0.00078238425,0.9975714,0.00006722386,0.000320634,0.0001593223],"study_design_scores_gemma":[0.0007665944,0.00012190456,0.004556814,0.000020683196,0.000018742414,0.00003005199,0.00006699312,0.00001845437,0.9908232,0.000026541502,0.003459794,0.00009024671],"about_ca_topic_score_codex":0.000005205832,"about_ca_topic_score_gemma":0.000037584927,"teacher_disagreement_score":0.0067482167,"about_ca_system_score_codex":0.0000046070204,"about_ca_system_score_gemma":0.000014154768,"threshold_uncertainty_score":0.27910402},"labels":[],"label_agreement":null},{"id":"W2039730578","doi":"10.1182/blood-2009-07-234690","title":"Directed differentiation of hematopoietic precursors and functional osteoclasts from human ES and iPS cells","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Bone Metabolism and Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":156,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; Versus Arthritis; National Institute of General Medical Sciences; Nuffield Foundation","keywords":"Osteoclast; Biology; Cell biology; Cathepsin K; RANKL; Induced pluripotent stem cell; Macrophage colony-stimulating factor; Stem cell; Tartrate-resistant acid phosphatase; Embryoid body; Population; Bone resorption; Embryonic stem cell; Molecular biology; Endocrinology; Macrophage; Biochemistry; Activator (genetics); Receptor; Medicine","score_opus":0.00483332912171224,"score_gpt":0.19568516249348994,"score_spread":0.1908518333717777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039730578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985909,0.0010475498,0.000017998864,0.0000092673545,0.000090113615,0.00006167069,0.000068215326,0.000009218096,0.000105064704],"genre_scores_gemma":[0.9994186,0.000039261384,0.00018066635,0.000012092784,0.00010852683,0.0000056608305,0.0001564484,0.0000071841428,0.00007151818],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99959546,0.000018620578,0.00009418264,0.00016645438,0.000058585996,0.000066711866],"domain_scores_gemma":[0.99974465,0.000010308346,0.000046450205,0.00011706214,0.000028941837,0.00005258533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000023314884,0.0000738989,0.00008934599,0.000017252189,0.000038858005,0.000012433011,0.000027181411,0.00007239262,0.000036081685],"category_scores_gemma":[0.000021878124,0.00006670732,0.000024138615,0.000018845481,0.00006377654,0.0000027707815,0.00004417052,0.000036295478,7.91908e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001701371,0.00013366736,0.036328785,0.000015769077,0.000030113844,2.288861e-7,0.0000329992,1.0033792e-7,0.9630662,0.00009591044,0.00010705556,0.00017211956],"study_design_scores_gemma":[0.0006839935,0.000031508902,0.36763644,0.000004294347,0.00007721009,0.0000016409275,0.000013535899,0.000002276214,0.6310788,0.00020856968,0.00020201865,0.00005974341],"about_ca_topic_score_codex":0.000017894865,"about_ca_topic_score_gemma":0.0000526142,"teacher_disagreement_score":0.33198747,"about_ca_system_score_codex":2.3718371e-7,"about_ca_system_score_gemma":0.000010276516,"threshold_uncertainty_score":0.27202457},"labels":[],"label_agreement":null},{"id":"W2039731055","doi":"10.1182/blood-2003-05-1550","title":"Evidence for a positive role of SHIP in the BCR-ABL–mediated transformation of primitive murine hematopoietic cells and in human chronic myeloid leukemia","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Haematopoiesis; Biology; Myeloid leukemia; CD34; Cancer research; Stem cell; Myeloid; Leukemia; Bone marrow; breakpoint cluster region; Molecular biology; Cell biology; Immunology; Receptor; Genetics","score_opus":0.02133377006430549,"score_gpt":0.27343440865023255,"score_spread":0.2521006385859271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039731055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994871,0.0025026451,0.00002224093,0.0000788461,0.000011252452,0.0016800425,0.00002722489,0.0000081059,0.00079862995],"genre_scores_gemma":[0.99926126,0.00029612114,0.00018880525,0.00003478992,0.000014588435,0.00013764465,0.000033788554,0.000014907156,0.000018095432],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99872744,0.00011588509,0.00046755176,0.00020522231,0.00021876591,0.00026515266],"domain_scores_gemma":[0.9991193,0.0004060155,0.00015124402,0.00020874347,0.0000660473,0.000048692917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000493786,0.00015575561,0.00038798613,0.00014808355,0.000027040345,0.000004857566,0.000082620754,0.000096142205,0.00002027217],"category_scores_gemma":[0.00017581879,0.00012100997,0.00006514724,0.00027054283,0.00011701717,0.00011306844,0.00001018005,0.00015344414,0.0000013184899],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060547754,0.001773719,0.026326887,0.002277471,0.00022229056,0.00004434473,0.028331606,0.000045968132,0.9373277,0.0018851095,0.00001044548,0.0011489936],"study_design_scores_gemma":[0.016448492,0.001206139,0.093734406,0.0017879608,0.0002968788,0.00006609972,0.0016148941,0.00016577732,0.88414645,0.00038616316,0.000018732238,0.00012803586],"about_ca_topic_score_codex":0.00021435066,"about_ca_topic_score_gemma":0.00025989773,"teacher_disagreement_score":0.06740752,"about_ca_system_score_codex":0.00055365457,"about_ca_system_score_gemma":0.0005512793,"threshold_uncertainty_score":0.49346432},"labels":[],"label_agreement":null},{"id":"W2039772940","doi":"10.1182/blood-2002-06-1684","title":"Intravenous immunoglobulins induce the in vitro differentiation of human B lymphocytes and the secretion of IgG","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Héma-Québec","funders":"","keywords":"Immunology; Autoantibody; Antibody; Medicine; CD154; Immunotherapy; CD40; In vitro; Biology; Immune system; Cytotoxic T cell","score_opus":0.008633756966767329,"score_gpt":0.2272231395395263,"score_spread":0.21858938257275898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039772940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976344,0.001298965,0.0000059799854,0.00007617956,0.000014741799,0.0002418796,0.0000039625907,0.00000322936,0.0007206492],"genre_scores_gemma":[0.9997146,0.00018693793,0.0000243863,0.000023301149,0.0000052891064,0.000008928734,0.000017140423,0.0000043550453,0.000015071297],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995765,0.000055480843,0.00015126019,0.00006510438,0.00008400827,0.00006766132],"domain_scores_gemma":[0.999719,0.000047328096,0.000079601494,0.00012188606,0.000021625232,0.000010518707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000113229165,0.000055515706,0.00017287361,0.000029029965,0.000035687757,0.0000035049748,0.000029482213,0.000034861565,0.000007489177],"category_scores_gemma":[0.0000414756,0.000029055387,0.000029243267,0.000077271914,0.00007770402,0.000015374839,0.00000842889,0.000045783832,4.1493226e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012528246,0.0052546496,0.10942173,0.00021461835,0.00089106295,0.00004438826,0.009146137,0.000003063883,0.85600674,0.009244897,0.000008360417,0.008511523],"study_design_scores_gemma":[0.027933354,0.00034028047,0.36620134,0.00008719565,0.0004470121,0.000085514046,0.00070111424,0.000046610206,0.60104936,0.0030236128,0.000015572294,0.000069036156],"about_ca_topic_score_codex":0.00023334935,"about_ca_topic_score_gemma":0.000024991052,"teacher_disagreement_score":0.2567796,"about_ca_system_score_codex":0.000010427409,"about_ca_system_score_gemma":0.000023503093,"threshold_uncertainty_score":0.11848443},"labels":[],"label_agreement":null},{"id":"W2040032861","doi":"10.1182/blood-2003-03-0850","title":"Control of thrombus embolization and fibronectin internalization by integrin αIIbβ3 engagement of the fibrinogen γ chain","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; Heart and Stroke Foundation of Canada","keywords":"Integrin; Fibrinogen; Fibronectin; Internalization; Thrombus; Embolization; Medicine; Pathology; Internal medicine; Surgery; Chemistry; Biochemistry; Extracellular matrix; Receptor","score_opus":0.007820363497780798,"score_gpt":0.22651128300340984,"score_spread":0.21869091950562905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040032861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99550045,0.000780964,0.0021905333,0.00006171416,0.000031644853,0.00032422438,0.000015474854,0.000006784316,0.0010882232],"genre_scores_gemma":[0.9996149,0.00008789783,0.000080469894,0.000048202815,0.000004804577,0.000004878871,0.000012264363,0.0000076102297,0.0001390032],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995016,0.00006659775,0.0001612599,0.00009209181,0.00010724504,0.0000712346],"domain_scores_gemma":[0.999703,0.000025473195,0.000099925805,0.00011432897,0.000034963512,0.000022315584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000095551295,0.00006859149,0.00017584786,0.000026237554,0.00002346519,0.0000031837656,0.000029089399,0.000033966637,0.000038769627],"category_scores_gemma":[0.00008259839,0.00004600324,0.00003452598,0.00007908451,0.000030207475,0.000024632976,0.000011758264,0.000041515046,6.3978143e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013021272,0.002155804,0.7621842,0.0003072477,0.0009595955,0.000011933647,0.001375842,0.00003326282,0.22469927,0.0047250465,0.00053478417,0.0028828108],"study_design_scores_gemma":[0.012355547,0.0005414615,0.054262906,0.00026751918,0.00057533954,0.000060955088,0.00024103858,0.000301449,0.92976207,0.0005343376,0.0009929045,0.000104478204],"about_ca_topic_score_codex":0.000054209693,"about_ca_topic_score_gemma":0.000005504112,"teacher_disagreement_score":0.70792127,"about_ca_system_score_codex":0.000008170781,"about_ca_system_score_gemma":0.000018420467,"threshold_uncertainty_score":0.18759575},"labels":[],"label_agreement":null},{"id":"W2040061251","doi":"10.1182/blood-2005-09-3581","title":"Use of CD44 by CD4+ Th1 and Th2 lymphocytes to roll and adhere","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"CD44; In vivo; Cell biology; Endothelium; Biology; In vitro; Tumor necrosis factor alpha; Lymphocyte; Immunology; Immune system; T cell; Cell adhesion molecule; Molecular biology; Biochemistry; Endocrinology; Genetics","score_opus":0.017278579795991005,"score_gpt":0.26023147342938896,"score_spread":0.24295289363339795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040061251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99530715,0.0022447114,0.0000068998343,0.00034399505,0.0000111307445,0.00024336469,0.000019317908,0.000017318574,0.0018061287],"genre_scores_gemma":[0.9912909,0.00021053728,0.0011368184,0.00018394714,0.00004078665,0.000007893159,0.000012334586,0.000018072544,0.007098696],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992372,0.00002411778,0.00014147881,0.00019620954,0.0002301092,0.00017091402],"domain_scores_gemma":[0.9994894,0.00009363403,0.000024679097,0.0001915794,0.000061400075,0.00013927104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007218356,0.00008733132,0.00018360464,0.00007047654,0.0000254686,0.000020882826,0.000039476832,0.000056526187,0.00007481129],"category_scores_gemma":[0.000095739015,0.00007189222,0.000023832827,0.000121307836,0.00005821869,0.000034528697,0.000081163846,0.000059010417,0.000015240538],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000168667,0.00049706176,0.16930272,0.00013956206,0.00004546332,0.00007623488,0.00008775759,9.806992e-7,0.8048208,0.00005966667,0.022779789,0.002021309],"study_design_scores_gemma":[0.0059789983,0.0008534014,0.14820345,0.00012103963,0.00013480797,0.00012750975,0.00007531804,0.00004631936,0.8130647,0.000089162975,0.031128267,0.00017705467],"about_ca_topic_score_codex":0.0004613617,"about_ca_topic_score_gemma":0.00004255666,"teacher_disagreement_score":0.021099262,"about_ca_system_score_codex":0.000011171369,"about_ca_system_score_gemma":0.00004214411,"threshold_uncertainty_score":0.29316795},"labels":[],"label_agreement":null},{"id":"W2040103773","doi":"10.1182/blood-2012-02-413047","title":"Platelets can enhance vascular permeability","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":230,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"Canadian Arthritis Network; Canadian Institutes of Health Research; British Heart Foundation; Arthritis Society","keywords":"Platelet; Vascular permeability; Inflammation; Immunology; Arthritis; Medicine; Serotonin; Chemistry; Cell biology; Pathology; Biology; Internal medicine; Receptor","score_opus":0.010673739294421718,"score_gpt":0.2544659220158459,"score_spread":0.24379218272142417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040103773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99257827,0.0015762964,0.00000927852,0.00018183196,0.0000773478,0.000204254,0.000007341276,0.000052014457,0.005313379],"genre_scores_gemma":[0.9989214,0.000075490025,0.0003249616,0.00019763918,0.00009136364,0.000018775363,0.000025998126,0.000013103941,0.00033130078],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99928355,0.000015654998,0.00010480022,0.00014763846,0.00014838939,0.00029994763],"domain_scores_gemma":[0.99950355,0.000015240813,0.000023035078,0.00026311754,0.000024003602,0.00017105548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008747539,0.00010452195,0.00020478774,0.000023606262,0.000047423822,0.0000049880146,0.000035805755,0.00006006373,0.0001883432],"category_scores_gemma":[0.000037766444,0.000083095285,0.000084990155,0.00006953169,0.000028291111,0.000051354888,0.000016687192,0.000081108294,0.0001418896],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054977383,0.00823077,0.9663371,0.0001357957,0.0008268472,0.00041995136,0.001108292,4.5732574e-7,0.010540456,0.00015387379,0.00047659368,0.01171488],"study_design_scores_gemma":[0.007515109,0.0003315719,0.8703832,0.000059694965,0.0008484182,0.00054064806,0.00010702778,0.0000071795826,0.10367962,0.00022371822,0.015980879,0.00032295732],"about_ca_topic_score_codex":0.000073907984,"about_ca_topic_score_gemma":0.000014113449,"teacher_disagreement_score":0.09595393,"about_ca_system_score_codex":0.000020641615,"about_ca_system_score_gemma":0.000029215515,"threshold_uncertainty_score":0.33885273},"labels":[],"label_agreement":null},{"id":"W2040146122","doi":"10.1182/blood-2009-07-231191","title":"The ubiquitin-activating enzyme E1 as a therapeutic target for the treatment of leukemia and multiple myeloma","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":169,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Institute on Aging","keywords":"Leukemia; Myeloid leukemia; Ubiquitin; Cancer research; Clonogenic assay; Programmed cell death; Cell culture; Haematopoiesis; Cell growth; Biology; Chemistry; Cell; Apoptosis; Immunology; Cell biology; Biochemistry; Stem cell","score_opus":0.013767073055002505,"score_gpt":0.2500680950477745,"score_spread":0.236301021992772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040146122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955636,0.00300173,0.00016760697,0.00017975936,0.00008776881,0.00051272794,0.000029895908,0.000007730205,0.00044915974],"genre_scores_gemma":[0.9981012,0.000351968,0.00072722125,0.00007647869,0.00027218723,0.00014294892,0.000015807203,0.000017370097,0.00029487076],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994311,0.000029503371,0.00012687867,0.00017068321,0.000060509064,0.00018133783],"domain_scores_gemma":[0.9993444,0.00021192824,0.00008172297,0.0002815832,0.00004509097,0.00003529256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015454619,0.00011480167,0.00009375655,0.000007780248,0.00025113157,0.00002613349,0.00012784707,0.00008720803,0.0000073776837],"category_scores_gemma":[0.00010126033,0.0000627018,0.00007705447,0.00002609339,0.00011004976,0.0000017695723,0.00002980619,0.000055773915,0.0000010766353],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008217121,0.00008947511,0.0010049891,0.000009068657,0.000120827695,3.5994523e-7,0.00021303445,0.0000017943593,0.97043025,0.0003333529,0.000022268476,0.027692426],"study_design_scores_gemma":[0.0012164885,0.0008415659,0.0008007026,0.0000032741111,0.000032400676,0.000013905918,0.00013741759,0.00011762813,0.88947314,0.0002672651,0.10701981,0.00007640077],"about_ca_topic_score_codex":0.000029868732,"about_ca_topic_score_gemma":0.000052651554,"teacher_disagreement_score":0.10699754,"about_ca_system_score_codex":0.0000040756036,"about_ca_system_score_gemma":0.00007111732,"threshold_uncertainty_score":0.25569054},"labels":[],"label_agreement":null},{"id":"W2040379148","doi":"10.1182/blood-2010-01-264143","title":"Vegf regulates embryonic erythroid development through Gata1 modulation","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","keywords":"GATA1; Erythropoiesis; Biology; GATA2; Cell biology; Embryonic stem cell; Transcription factor; Erythropoietin receptor; Conditional gene knockout; Vascular endothelial growth factor; Erythropoietin; Molecular biology; Phenotype; Cancer research; Haematopoiesis; Genetics; Gene; Stem cell; Internal medicine; VEGF receptors; Medicine","score_opus":0.016655274370575863,"score_gpt":0.25126275295233513,"score_spread":0.23460747858175926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040379148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99385536,0.00011312436,0.00015285212,0.00047454328,0.0006276539,0.00019011591,0.0000019729769,0.00014055481,0.004443802],"genre_scores_gemma":[0.9863162,0.000038157286,0.0101557495,0.0005863326,0.00046945486,0.00001357684,0.00011671478,0.000022521748,0.002281317],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99915963,0.000018368451,0.00019559916,0.00026196966,0.00015014264,0.00021430079],"domain_scores_gemma":[0.9994211,0.000028785493,0.00006567023,0.00032167163,0.00008194177,0.000080817525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008416224,0.00013385266,0.00020307688,0.000049541588,0.00010841058,0.000009788704,0.00005505671,0.00015890245,0.0005222532],"category_scores_gemma":[0.000052089166,0.00011492169,0.000059495516,0.00012614307,0.00006079193,0.00008103441,0.000031544387,0.00025828092,0.00032297423],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011054458,0.00072564796,0.009621443,0.000113698734,0.0001318933,0.000030882977,0.00082178524,0.00000738718,0.98095655,0.0011428411,0.0014887952,0.0048485543],"study_design_scores_gemma":[0.005488465,0.0003914458,0.44360927,0.00008557295,0.00016088485,0.00048307076,0.0001043299,0.00013280242,0.42651656,0.0010322466,0.12163846,0.00035690455],"about_ca_topic_score_codex":0.0000058777587,"about_ca_topic_score_gemma":0.000022058219,"teacher_disagreement_score":0.55443996,"about_ca_system_score_codex":0.000013628694,"about_ca_system_score_gemma":0.00013179096,"threshold_uncertainty_score":0.57183063},"labels":[],"label_agreement":null},{"id":"W2040705537","doi":"10.1182/blood-2013-08-522847","title":"An unusual cause of anemia…","year":2014,"lang":"eo","type":"article","venue":"Blood","topic":"Vascular Tumors and Angiosarcomas","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Columbian Hospital","funders":"","keywords":"Complete blood count; Vomiting; Medicine; Nausea; Blood count; White blood cell; Anemia; Gastroenterology; Absolute neutrophil count; Internal medicine; Platelet; Neutropenia; Chemotherapy","score_opus":0.011411106479706565,"score_gpt":0.25787679499395233,"score_spread":0.24646568851424577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040705537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935532,0.0016456742,0.00009445061,0.00019028703,0.00018120112,0.0001473432,0.000016835944,0.000038830272,0.0041321605],"genre_scores_gemma":[0.99776876,0.00007497069,0.00033051372,0.0001999105,0.0008999124,0.000002629708,0.000032635144,0.000036200534,0.000654496],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99873936,0.00010536185,0.00029216617,0.00026415387,0.0002982434,0.00030073582],"domain_scores_gemma":[0.9988943,0.000038726754,0.00010440158,0.00064407213,0.000079382036,0.00023913055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003166049,0.00017049439,0.00039749214,0.00008433982,0.00004457906,0.000012999629,0.00015700814,0.00012484657,0.00016050646],"category_scores_gemma":[0.00009921843,0.0001483705,0.00017415949,0.00015352163,0.000088638335,0.000053989817,0.000035861623,0.0001654766,0.000102541744],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022551835,0.018775003,0.6397798,0.0026931863,0.0015991129,0.0012489633,0.0039722566,0.000020091127,0.28661987,0.016341072,0.004326642,0.024398513],"study_design_scores_gemma":[0.03212454,0.0086314175,0.45977443,0.0015497166,0.007559526,0.00089878007,0.0010880539,0.0011879916,0.4627253,0.0006218084,0.02263035,0.0012080822],"about_ca_topic_score_codex":0.00011300259,"about_ca_topic_score_gemma":0.000016066908,"teacher_disagreement_score":0.18000534,"about_ca_system_score_codex":0.000007276995,"about_ca_system_score_gemma":0.0000741465,"threshold_uncertainty_score":0.60503733},"labels":[],"label_agreement":null},{"id":"W2040735294","doi":"10.1182/blood-2003-11-3986","title":"Subspeciality training in hematology and oncology, 2003: results of a survey of training program directors conducted by the American Society of Hematology","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Diversity and Career in Medicine","field":"Social Sciences","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Subspecialty; Medicine; Hematology; Graduation (instrument); Curriculum; Graduate medical education; Family medicine; Internal medicine; Medical education; Specialty; Psychology; Accreditation","score_opus":0.11090618325353065,"score_gpt":0.3572304483011623,"score_spread":0.24632426504763166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040735294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99614954,0.00031523526,0.0000043647974,0.0009499421,0.00007001546,0.00026446118,0.000083278166,0.000016578982,0.0021465593],"genre_scores_gemma":[0.9991876,0.00013525861,0.0005402627,0.00008249795,0.000016206674,0.0000059309086,0.000017569737,0.0000034975699,0.000011159339],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9982888,0.0006142213,0.0003960552,0.00017913421,0.0002711138,0.00025067007],"domain_scores_gemma":[0.998623,0.00055934064,0.00042715354,0.00011251372,0.00022067266,0.000057293084],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0031383797,0.00008010436,0.0005961046,0.000039032464,0.00008449603,0.0000041812586,0.0002554548,0.00011304997,0.0000062187537],"category_scores_gemma":[0.0011899469,0.00006624324,0.000046617202,0.00089427194,0.0035824857,0.000038745104,0.000046352256,0.00015938656,1.04283544e-7],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045643348,0.0022327222,0.32387102,0.00014374715,0.00041082932,0.000021802764,0.60213846,0.0000038777175,0.0018189849,0.009568292,0.0024251917,0.05690866],"study_design_scores_gemma":[0.011833582,0.0018260274,0.3628005,0.00019872854,0.00020042839,0.000035006942,0.60961854,0.00000519198,0.007929137,0.00089257007,0.0043625543,0.00029774712],"about_ca_topic_score_codex":0.042537384,"about_ca_topic_score_gemma":0.03691939,"teacher_disagreement_score":0.056610912,"about_ca_system_score_codex":0.000026577527,"about_ca_system_score_gemma":0.0005922302,"threshold_uncertainty_score":0.9991292},"labels":[],"label_agreement":null},{"id":"W2040812277","doi":"10.1182/blood-2011-04-350017","title":"Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":230,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Izaak Walton Killam Health Centre","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Organomegaly; Leukocytosis; Internal medicine; Natural history; Pediatrics; Natural history study; Prospective cohort study; Gastroenterology; Surgery; Disease","score_opus":0.025564693285829193,"score_gpt":0.29264464683577374,"score_spread":0.2670799535499445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040812277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99402744,0.0014862822,0.0000097939665,0.00059689226,0.00025724288,0.0023271556,0.000019500498,0.00004491977,0.0012307483],"genre_scores_gemma":[0.9979637,0.00011372202,0.0006912111,0.00045576273,0.00009204243,0.00026920665,0.00008152529,0.00003799995,0.00029478205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968942,0.0004934602,0.001044255,0.0006080362,0.0005510391,0.00040904403],"domain_scores_gemma":[0.99780774,0.0008190082,0.00027835992,0.0007816635,0.00016713089,0.00014607259],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011596944,0.00025339593,0.0007997716,0.00014329617,0.000042327898,0.000004537593,0.00040139223,0.0002040437,0.00028909917],"category_scores_gemma":[0.0009255402,0.00016644965,0.00017821169,0.00027193633,0.0004001743,0.00008046535,0.0001345986,0.0011184802,0.000016436059],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013403026,0.011372066,0.93525726,0.000016951351,0.0009040233,0.009335104,0.037852548,3.9674677e-7,0.0005334249,0.000011154882,0.0008518998,0.0025248686],"study_design_scores_gemma":[0.014784979,0.0037134495,0.9768828,0.00006747865,0.0003545737,0.0007166659,0.0020001621,0.000014198016,0.000030064684,0.000033786433,0.0012346746,0.00016717345],"about_ca_topic_score_codex":0.005383216,"about_ca_topic_score_gemma":0.002086558,"teacher_disagreement_score":0.041625533,"about_ca_system_score_codex":0.0005006903,"about_ca_system_score_gemma":0.0010794855,"threshold_uncertainty_score":0.8137848},"labels":[],"label_agreement":null},{"id":"W2040931699","doi":"10.1182/blood-2007-08-108050","title":"CD28 provides T-cell costimulation and enhances PI3K activity at the immune synapse independently of its capacity to interact with the p85/p110 heterodimer","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":147,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"Biotechnology and Biological Sciences Research Council; Directorate for Biological Sciences","keywords":"Immunological synapse; Cell biology; CD28; Immune system; Synapse; PI3K/AKT/mTOR pathway; T cell; Biology; Neuroscience; Chemistry; Signal transduction; Immunology; T-cell receptor","score_opus":0.010477173536793484,"score_gpt":0.2253405761339078,"score_spread":0.2148634025971143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040931699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996126,0.0010233487,0.0003316337,0.0002635278,0.0004849238,0.00046367256,0.000004755533,0.000023771321,0.0012783558],"genre_scores_gemma":[0.99615127,0.000022690201,0.000008525391,0.00015998876,0.000019240173,0.000014244647,0.000012312972,0.000011410447,0.0036003112],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991299,0.00017849386,0.00021363788,0.00021674333,0.000055767636,0.0002054574],"domain_scores_gemma":[0.99909073,0.00031854303,0.00021556694,0.0002567228,0.000104618,0.000013796702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004466716,0.0001515136,0.00017517191,0.00006179302,0.00028419396,0.00002149575,0.00013826392,0.00011536675,0.0003119978],"category_scores_gemma":[0.00006425408,0.0000830159,0.000053726424,0.0001025012,0.00014863042,0.00017822867,0.00009354192,0.00031251213,0.00015501647],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010650974,0.0002715292,0.0010671285,0.000015624006,0.00016172325,7.76467e-7,0.0010724432,0.000008538381,0.99485093,0.000017035263,0.00023983316,0.0012293198],"study_design_scores_gemma":[0.0010755928,0.00046323444,0.023245715,0.000031378248,0.00009633456,0.00007096996,0.00029293157,0.0000035014218,0.96717924,0.0000019564025,0.0074354475,0.00010371733],"about_ca_topic_score_codex":0.00020702976,"about_ca_topic_score_gemma":0.00036753836,"teacher_disagreement_score":0.02767173,"about_ca_system_score_codex":0.000028736451,"about_ca_system_score_gemma":0.0000135482505,"threshold_uncertainty_score":0.3416157},"labels":[],"label_agreement":null},{"id":"W2040939690","doi":"10.1182/blood-2010-07-298901","title":"Unique progenitors in mouse lymph node develop into CD127+ NK cells: thymus-dependent and thymus-independent pathways","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Key Research and Development Program of China; BC Cancer Agency; Deutsche Forschungsgemeinschaft; Cancer Research Institute","keywords":"Interleukin-7 receptor; Biology; Interleukin 21; Lymph node; Molecular biology; Immunology; Natural killer cell; Cell biology; T cell; Cancer research; Cytotoxic T cell; IL-2 receptor; In vitro; Immune system; Genetics","score_opus":0.015843250178027176,"score_gpt":0.2020393411770877,"score_spread":0.1861960909990605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040939690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99040943,0.0025590966,0.00013258026,0.000026219624,0.0018995652,0.0003461065,0.000005377585,0.0001368556,0.0044847694],"genre_scores_gemma":[0.99382144,0.00072863576,0.00031198945,0.00019396722,0.000034858233,0.000081883576,0.000050518818,0.000036034948,0.0047406945],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984605,0.00022936435,0.00043343217,0.00043253336,0.00005648302,0.0003877001],"domain_scores_gemma":[0.9993613,0.000043800843,0.00014232157,0.00031008234,0.00010147767,0.000041018022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030102642,0.00026593063,0.00026758586,0.0002245572,0.00016012763,0.00002453378,0.00020751181,0.00038359797,0.00066763983],"category_scores_gemma":[0.000048149577,0.0002450286,0.00006329683,0.0001446898,0.00009334553,0.00019603713,0.00015788239,0.00039086785,0.0006317841],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025118454,0.0010386147,0.010008411,0.00003995772,0.0002027885,0.00003305164,0.005070481,8.9956256e-7,0.9794393,0.0003643198,0.00018538424,0.0033656177],"study_design_scores_gemma":[0.002901456,0.00015538695,0.005428381,0.00003858276,0.000054616412,0.00014469087,0.0013758487,0.0000023507355,0.983789,0.000103627244,0.005693778,0.00031223815],"about_ca_topic_score_codex":0.00084160676,"about_ca_topic_score_gemma":0.00017400294,"teacher_disagreement_score":0.0055083935,"about_ca_system_score_codex":0.00008129261,"about_ca_system_score_gemma":0.0001230561,"threshold_uncertainty_score":0.99919766},"labels":[],"label_agreement":null},{"id":"W2041243813","doi":"10.1182/blood-2006-10-053850","title":"Retroviral insertional activation of the Fli-3 locus in erythroleukemias encoding a cluster of microRNAs that convert Epo-induced differentiation to proliferation","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Biology; microRNA; Ectopic expression; Insertional mutagenesis; Haematopoiesis; Gene; Cancer research; Gene silencing; Transcription factor; Stem cell; Genetics; Molecular biology","score_opus":0.011740950675631426,"score_gpt":0.23557754412519674,"score_spread":0.2238365934495653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041243813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970873,0.000020566305,0.0022307707,0.00012623807,0.00006925838,0.0003662043,0.000005833751,0.0000037131101,0.00009008867],"genre_scores_gemma":[0.9995289,0.0000024973813,0.00018134115,0.0000873998,0.00009754063,0.000011134456,0.000059023154,0.000010739047,0.000021439888],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991385,0.000058362126,0.00029004653,0.0001809805,0.00020805343,0.00012407772],"domain_scores_gemma":[0.9994492,0.000015411579,0.00019763017,0.00020702311,0.00010146118,0.000029292385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023083537,0.00009327318,0.00010222892,0.000080802245,0.00002819032,0.000007264657,0.00010094329,0.00012938252,0.000004860046],"category_scores_gemma":[0.00013417633,0.000080356825,0.000063111154,0.00013929962,0.000022961509,0.000010913439,0.000060838694,0.000056866826,6.4082565e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001769077,0.00011557318,0.07241094,0.000028859331,0.000023156488,1.3663288e-7,0.0001619338,0.000089059315,0.92665493,0.000031713385,0.000013720869,0.00029306812],"study_design_scores_gemma":[0.0008399007,0.00005368601,0.29952177,0.00004017135,0.00001468782,0.0000020662271,0.000026737922,0.00007070639,0.69932985,0.000026484133,0.000016277107,0.000057633722],"about_ca_topic_score_codex":0.000016330529,"about_ca_topic_score_gemma":0.000040809868,"teacher_disagreement_score":0.22732507,"about_ca_system_score_codex":0.000044409,"about_ca_system_score_gemma":0.00008671185,"threshold_uncertainty_score":0.32768562},"labels":[],"label_agreement":null},{"id":"W2041301500","doi":"10.1182/blood-2011-02-329979","title":"Perioperative management of patients who are receiving warfarin therapy: an evidence-based and practical approach","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Medicine; Atrial fibrillation; Warfarin; Perioperative; Coronary artery disease; Cardiology; Anesthesia; Internal medicine; Surgery","score_opus":0.20783999487256058,"score_gpt":0.34942086798690797,"score_spread":0.1415808731143474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041301500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937227,0.00021057387,0.00038907,0.00025484883,0.000032137068,0.0006751703,0.0000014407152,0.000027712684,0.0046863584],"genre_scores_gemma":[0.98449224,0.00025946184,0.014676173,0.000120944955,0.000058784575,0.000006887523,0.000008836591,0.000012428765,0.0003642434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99921024,0.00007024371,0.00018964765,0.00020835387,0.00021109867,0.00011040638],"domain_scores_gemma":[0.9995083,0.000041374766,0.00010960224,0.00019533902,0.00008030952,0.000065052925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019726183,0.00010343185,0.00022405545,0.00006130432,0.000049261413,0.000014818001,0.000034893907,0.0000405602,0.00008717162],"category_scores_gemma":[0.00005771198,0.000078515994,0.000044807468,0.0001042174,0.000046591747,0.00022028695,0.000040224364,0.000056850506,0.0000026347493],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004590254,0.00028752847,0.9918882,0.00017829561,0.00018162155,0.000010032033,0.0009219214,0.000001333077,0.000052108735,0.0008223421,0.000018554858,0.0051790234],"study_design_scores_gemma":[0.0037563697,0.0004954027,0.99273837,0.0001993044,0.00022057231,9.519736e-7,0.0006988435,0.00017675081,0.0012237286,0.000015038306,0.00038107543,0.000093573195],"about_ca_topic_score_codex":0.000013990309,"about_ca_topic_score_gemma":0.0000010257318,"teacher_disagreement_score":0.014287104,"about_ca_system_score_codex":0.000008705776,"about_ca_system_score_gemma":0.000014730584,"threshold_uncertainty_score":0.32017893},"labels":[],"label_agreement":null},{"id":"W2041375407","doi":"10.1182/blood-2009-08-237230","title":"Alterations of the systemic environment are the primary cause of impaired B and T lymphopoiesis in telomere-dysfunctional mice","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Connaught Fund","keywords":"Lymphopoiesis; Telomere; Telomerase; Biology; Senescence; Immunology; Stem cell; Internal medicine; Haematopoiesis; Medicine; Cell biology; Genetics; Gene","score_opus":0.010392728904572969,"score_gpt":0.20425383128145225,"score_spread":0.19386110237687929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041375407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99625814,0.0019926287,0.000009662097,0.001145876,0.000043742413,0.00035331276,0.000025310817,0.000009021321,0.00016227746],"genre_scores_gemma":[0.9990418,0.00031686813,0.000097641576,0.0003447642,0.00004582173,0.000012277524,0.000005488488,0.0000066905877,0.00012867895],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999086,0.00006766729,0.00031807736,0.00015501118,0.00024800882,0.00012520626],"domain_scores_gemma":[0.99936765,0.00009536738,0.00015144642,0.0003163441,0.00002879711,0.000040369858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014822329,0.00010396282,0.00023826903,0.00006326911,0.000064416905,0.0000050198137,0.00009230108,0.000050056948,0.000015671432],"category_scores_gemma":[0.000049072947,0.000061414736,0.00006202242,0.00015917016,0.00012493924,0.00003950589,0.000029707136,0.00008314964,0.0000019035409],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016558127,0.0014440682,0.72667634,0.00036860505,0.00017227995,0.000021888834,0.0019954052,0.00006492914,0.26647586,0.00028215442,0.0002804377,0.002052414],"study_design_scores_gemma":[0.0017370007,0.00011072899,0.9792172,0.00026142312,0.00018287657,0.0002083271,0.0005703695,0.000028319779,0.017512208,0.000041000683,0.00006330767,0.00006725669],"about_ca_topic_score_codex":0.000060666734,"about_ca_topic_score_gemma":0.000018468498,"teacher_disagreement_score":0.2525408,"about_ca_system_score_codex":0.000042569984,"about_ca_system_score_gemma":0.000088008615,"threshold_uncertainty_score":0.25044203},"labels":[],"label_agreement":null},{"id":"W2041607260","doi":"10.1182/blood-2013-04-497354","title":"Robust ZFN-mediated genome editing in adult hemophilic mice","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":173,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; Howard Hughes Medical Institute","keywords":"Zinc finger nuclease; Genome editing; Biology; Zinc finger; Genetic enhancement; Genome; Gene; Computational biology; Transcription activator-like effector nuclease; DNA; Genetics; Cell biology; Virology; Transcription factor","score_opus":0.005392661695598176,"score_gpt":0.2157135006048714,"score_spread":0.21032083890927322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041607260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975386,0.000645767,0.0004892784,0.00013167634,0.00008692387,0.00014430041,0.0000069542834,0.000017298058,0.0009391555],"genre_scores_gemma":[0.997933,0.00009291204,0.0010570093,0.00020078679,0.00042623378,0.00003583624,0.0000900916,0.000020560126,0.00014359456],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992994,0.000012123287,0.00015331435,0.00022309365,0.00006637186,0.0002456906],"domain_scores_gemma":[0.9996721,0.0000074921236,0.000025649459,0.00017734036,0.00005078863,0.00006663109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000051278264,0.00011022581,0.000091948365,0.000039119506,0.00002204967,0.000016814796,0.00011993645,0.000102522135,0.000040434013],"category_scores_gemma":[0.00008843781,0.00011483434,0.0000371063,0.00008515095,0.00001661145,0.0000025348945,0.000059776576,0.00007955058,0.000059154638],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000018925381,0.00007440791,0.0037066909,0.000019608766,0.00001812675,0.0000041971807,0.000044244767,0.0007219663,0.9949499,0.0000031208888,0.00023482346,0.00022107168],"study_design_scores_gemma":[0.0037432727,0.00025438395,0.09514868,0.000049826376,0.000043396576,0.00007532131,0.00038672902,0.001430361,0.89258623,0.000033762484,0.0055355057,0.00071252545],"about_ca_topic_score_codex":0.00006286087,"about_ca_topic_score_gemma":0.00005202418,"teacher_disagreement_score":0.102363616,"about_ca_system_score_codex":0.0000043714554,"about_ca_system_score_gemma":0.000014463661,"threshold_uncertainty_score":0.46828085},"labels":[],"label_agreement":null},{"id":"W2041958591","doi":"10.1182/blood-2013-06-511139","title":"Somatic activating ARAF mutations in Langerhans cell histiocytosis","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":173,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Leids Universitair Medisch Centrum; Histiocytosis Association","keywords":"Vemurafenib; Langerhans cell histiocytosis; Cancer research; Somatic cell; Mutation; Exome sequencing; Biology; Exome; Genetics; Medicine; Internal medicine; Melanoma; Gene","score_opus":0.009873138923125727,"score_gpt":0.2357646111329434,"score_spread":0.22589147220981767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041958591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9561225,0.00007056565,0.00018703553,0.00017003022,0.000028296774,0.00015455676,0.0000027832596,0.00003957401,0.043224636],"genre_scores_gemma":[0.9966486,0.000005628578,0.0020360583,0.000090290836,0.000031128875,0.000036724807,0.00003010492,0.0000129063465,0.0011085207],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99948406,0.000019091269,0.00013556362,0.00012475018,0.00010150199,0.0001350211],"domain_scores_gemma":[0.9996844,0.00006588272,0.000040399515,0.00013874329,0.000016967497,0.000053608906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000052415806,0.00007669952,0.00014777928,0.00007813695,0.000043530996,0.000007665651,0.000029287326,0.00003639067,0.00007471863],"category_scores_gemma":[0.00007452034,0.00006842364,0.000035370544,0.000121635385,0.000016446595,0.000029797999,0.0000057421867,0.00006190525,0.0001104911],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000098126504,0.020115696,0.83864725,0.001334783,0.00048283083,0.0003916935,0.01389547,0.00015220414,0.04708228,0.001187199,0.0009059348,0.07570656],"study_design_scores_gemma":[0.08272963,0.0022250407,0.73805034,0.0016256652,0.002456114,0.00020921757,0.0032370728,0.009212838,0.13886267,0.004961224,0.015028653,0.0014015094],"about_ca_topic_score_codex":0.000098965276,"about_ca_topic_score_gemma":0.00004570422,"teacher_disagreement_score":0.10059686,"about_ca_system_score_codex":0.00003767306,"about_ca_system_score_gemma":0.00002833893,"threshold_uncertainty_score":0.2790235},"labels":[],"label_agreement":null},{"id":"W2041989116","doi":"10.1182/blood-2009-10-250217","title":"The inositol phosphatase SHIP-1 is negatively regulated by Fli-1 and its loss accelerates leukemogenesis","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Ontario Institute for Cancer Research; University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research","keywords":"Kinase; Biology; Cell biology; MAPK/ERK pathway; Signal transduction; Proto-oncogene tyrosine-protein kinase Src; Transcription factor; Molecular biology; Biochemistry","score_opus":0.007458652677038832,"score_gpt":0.23631089031109573,"score_spread":0.2288522376340569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041989116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872497,0.011635941,0.0000073844158,0.00043439164,0.00019050462,0.00017051713,0.00018979952,0.00001919524,0.00010259853],"genre_scores_gemma":[0.9977979,0.0006378117,0.00012263625,0.00041313213,0.00022908073,0.000036706966,0.000083826206,0.000031097275,0.000647783],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989839,0.000040056573,0.0001755095,0.0003841248,0.00013301437,0.00028335777],"domain_scores_gemma":[0.9992946,0.00003733361,0.00009173311,0.0003529632,0.000114268856,0.000109145665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014888005,0.00018907168,0.00012720007,0.00001419575,0.00024646652,0.00008972169,0.00030042676,0.00020725808,0.000041079777],"category_scores_gemma":[0.00008962321,0.00014732251,0.000050032555,0.000093063274,0.00013927362,0.000007251649,0.00012490439,0.00014524191,0.000012413938],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053176576,0.00006375967,0.002221721,0.000009577964,0.000115076946,0.000004064181,0.00005103868,7.0503023e-7,0.98754805,0.000052761385,0.008814132,0.0010659477],"study_design_scores_gemma":[0.0009114241,0.00010554197,0.0011836978,0.000007484733,0.00005071447,0.000022309681,0.000011550606,0.000026253769,0.93674946,0.000047032343,0.060688965,0.0001955887],"about_ca_topic_score_codex":0.000027619983,"about_ca_topic_score_gemma":0.000027144819,"teacher_disagreement_score":0.05187483,"about_ca_system_score_codex":0.000005795075,"about_ca_system_score_gemma":0.00008520976,"threshold_uncertainty_score":0.6007638},"labels":[],"label_agreement":null},{"id":"W2042072123","doi":"10.1182/blood-2009-12-256644","title":"Hedgehog regulates distinct vascular patterning events through VEGF-dependent and -independent mechanisms","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; SickKids Foundation; University of Toronto; Toronto Centre for Phenogenomics; Hospital for Sick Children","funders":"National Cancer Institute; Canadian Institutes of Health Research; Terry Fox Foundation","keywords":"Hedgehog; Notch signaling pathway; Biology; Vascular endothelial growth factor; Hedgehog signaling pathway; Cell biology; Vascular endothelial growth factor A; Regulator; Signal transduction; Phenotype; Endocrinology; Cancer research; Genetics; VEGF receptors; Gene","score_opus":0.008618579166983104,"score_gpt":0.22603196488452337,"score_spread":0.21741338571754026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042072123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944493,0.00085520104,0.0036815214,0.000055017892,0.00033245698,0.00019706014,0.0000201201,0.000039498067,0.00036978273],"genre_scores_gemma":[0.9972077,0.00010101345,0.0019408773,0.00010252271,0.00027704722,0.00003683634,0.00004921651,0.000044131226,0.00024064978],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99852914,0.00006002879,0.0002324645,0.00057190267,0.00025709058,0.00034937807],"domain_scores_gemma":[0.9992551,0.000017218887,0.000094530595,0.00045823492,0.000075723954,0.00009919891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029477803,0.00025492278,0.00021797101,0.000028264374,0.00019554254,0.000035108835,0.00021773082,0.00020081652,0.000026064145],"category_scores_gemma":[0.00011824002,0.00023556949,0.000103765575,0.000048836697,0.000063780826,0.0000062271974,0.00033939336,0.00020883308,0.000018648216],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010235582,0.00018118358,0.017134272,0.000035318284,0.00023996408,0.000020661966,0.00019449048,0.0000034874147,0.9813702,0.00013764677,0.000034030047,0.00063851546],"study_design_scores_gemma":[0.0018033799,0.00020875545,0.033338554,0.000035272024,0.00015779912,0.00008742367,0.00012861729,0.00001070758,0.96035665,0.0013356273,0.0021030083,0.00043423017],"about_ca_topic_score_codex":0.000034642762,"about_ca_topic_score_gemma":0.00009805858,"teacher_disagreement_score":0.021013571,"about_ca_system_score_codex":0.0000050346907,"about_ca_system_score_gemma":0.00003003523,"threshold_uncertainty_score":0.96062446},"labels":[],"label_agreement":null},{"id":"W2042153187","doi":"10.1182/blood-2011-09-378737","title":"Peripheral blood candidiasis","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Parasitic Diseases Research and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; Gastroenterology; Sepsis; Platelet; Creatinine; Parenteral nutrition; Internal medicine; Peripheral blood; Hemoglobin","score_opus":0.019899917547772733,"score_gpt":0.31474629951310346,"score_spread":0.29484638196533075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042153187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96537477,0.003601792,0.0000053372155,0.00018326743,0.000047387977,0.00018367213,0.00001647997,0.000047818892,0.03053949],"genre_scores_gemma":[0.99737275,0.000082020735,0.000370839,0.00016959122,0.0003185623,0.000049253737,0.000029639854,0.000012865865,0.0015944992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991339,0.000020928843,0.0000823428,0.00010744146,0.00023233861,0.00042306317],"domain_scores_gemma":[0.99914443,0.000019921672,0.000013220216,0.0002028029,0.000027821616,0.00059179903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000052246578,0.00008998124,0.00013574943,0.00003938285,0.000047982834,0.000014387187,0.00003723528,0.000031774252,0.00089236506],"category_scores_gemma":[0.000053092008,0.00006890663,0.00008813701,0.000080867336,0.000034613135,0.00008089185,0.000018525716,0.000062754574,0.00024391327],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007968841,0.006848593,0.9859833,0.00004111906,0.0007640621,0.0003469349,0.00017299403,8.0295514e-8,0.0018977454,0.00027350007,0.00073070684,0.002861274],"study_design_scores_gemma":[0.010239497,0.00060377945,0.95585835,0.00003998776,0.0016245969,0.00049809314,0.00012410895,0.0000036935203,0.025044918,0.0000297247,0.005772598,0.00016065204],"about_ca_topic_score_codex":0.000072592375,"about_ca_topic_score_gemma":0.0000037665668,"teacher_disagreement_score":0.031997975,"about_ca_system_score_codex":0.000021885611,"about_ca_system_score_gemma":0.000092532835,"threshold_uncertainty_score":0.9770772},"labels":[],"label_agreement":null},{"id":"W2042236044","doi":"10.1182/blood-2014-08-594408","title":"AML cells have low spare reserve capacity in their respiratory chain that renders them susceptible to oxidative metabolic stress","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":342,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"National Cancer Institute; Fondation Brain Canada","keywords":"Oxidative stress; Respiratory chain; Respiratory system; Oxidative phosphorylation; Mitochondrial respiratory chain; Spare part; Mitochondrion; Biology; Cell biology; Internal medicine; Medicine; Biochemistry; Business","score_opus":0.08575692885709743,"score_gpt":0.2581335913968057,"score_spread":0.17237666253970826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042236044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99561816,0.00033544668,0.00027451388,0.000115526906,0.00036917801,0.00032365433,0.0001453131,0.000017611472,0.002800607],"genre_scores_gemma":[0.9975339,0.000041119463,0.0004793411,0.000749606,0.00034897355,0.000054055767,0.000076711825,0.000023208995,0.00069307466],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985105,0.0003269181,0.00019678546,0.00047899777,0.00015111068,0.00033568917],"domain_scores_gemma":[0.999053,0.00001958271,0.00008206185,0.0005284489,0.00010518558,0.00021171215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037802084,0.00020805249,0.00024221478,0.00008150159,0.000045924833,0.000022850794,0.00025408308,0.0002338326,0.00004248771],"category_scores_gemma":[0.00016120475,0.00018098582,0.000080459016,0.0001345802,0.0000730911,0.000006750602,0.00014603822,0.00016813056,0.00005189653],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002522667,0.00033975331,0.02737477,0.000016838274,0.00007032259,0.000021306601,0.0016274276,0.00022432877,0.9644696,0.00018310454,0.00524319,0.00017709302],"study_design_scores_gemma":[0.0015795907,0.00036079294,0.00083454914,0.00001684729,0.000016511738,0.0000060382745,0.0020098265,0.00000810133,0.96495074,0.00007544745,0.029918725,0.00022282412],"about_ca_topic_score_codex":0.00018478282,"about_ca_topic_score_gemma":0.0029908046,"teacher_disagreement_score":0.026540222,"about_ca_system_score_codex":0.000014801329,"about_ca_system_score_gemma":0.00009832062,"threshold_uncertainty_score":0.7380388},"labels":[],"label_agreement":null},{"id":"W2042425638","doi":"10.1182/blood.v97.1.264","title":"Combined effect of all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia cells in vitro and in vivo","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":205,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Arsenic trioxide; Acute promyelocytic leukemia; In vivo; Retinoic acid; Tretinoin; Cancer research; Differentiation therapy; In vitro; Apoptosis; Leukemia; Biology; Immunology; Chemistry; Molecular biology; Cell culture; Pharmacology; Biochemistry","score_opus":0.003852916223989303,"score_gpt":0.21530928162096516,"score_spread":0.21145636539697585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042425638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997473,0.0017748664,0.000011418119,0.000025226038,0.000023930985,0.00035762822,0.0000072819125,0.0000057211737,0.00032094365],"genre_scores_gemma":[0.9974412,0.0021602218,0.00015550769,0.000032688447,0.000018478235,0.000038094862,0.000018133236,0.0000192833,0.00011640009],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99880975,0.00012404169,0.00032004158,0.0003720519,0.0000936274,0.00028049518],"domain_scores_gemma":[0.9996154,0.0000380581,0.00007153255,0.0002041751,0.00001497262,0.00005586256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031288184,0.00019255665,0.0003297562,0.00010820434,0.000013364084,0.0000118666685,0.00012685875,0.00021809565,0.0000037728273],"category_scores_gemma":[0.00004959982,0.00017972129,0.00004121566,0.00018484452,0.00010301549,0.0000062975523,0.00006158024,0.00016460143,4.416486e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008001313,0.000088282286,0.025029156,0.0001738578,0.000033358923,0.00010693073,0.00009450314,0.000008401057,0.9732848,0.0000011744456,0.000008239117,0.00037116665],"study_design_scores_gemma":[0.0073402217,0.0005472562,0.0031965761,0.000068569876,0.00005906203,0.000058329504,0.000023906761,0.000067614266,0.9882815,0.00002928585,0.00014623435,0.00018147305],"about_ca_topic_score_codex":0.000052791813,"about_ca_topic_score_gemma":0.00007146163,"teacher_disagreement_score":0.021832582,"about_ca_system_score_codex":0.000027065542,"about_ca_system_score_gemma":0.00009371647,"threshold_uncertainty_score":0.73288214},"labels":[],"label_agreement":null},{"id":"W2042503324","doi":"10.1182/blood-2012-06-438234","title":"Galectin-3 binds to CD45 on diffuse large B-cell lymphoma cells to regulate susceptibility to cell death","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Galectins and Cancer Biology","field":"Immunology and Microbiology","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Jonsson Comprehensive Cancer Center; National Institutes of Health; Terry Fox Foundation","keywords":"Diffuse large B-cell lymphoma; Galectin-1; Protein tyrosine phosphatase; Cancer research; Lymphoma; Galectin; Biology; Chemistry; Molecular biology; Cell biology; Signal transduction; Immunology","score_opus":0.010329792360670687,"score_gpt":0.2301955605798392,"score_spread":0.2198657682191685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042503324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893012,0.00042977286,0.00006628472,0.00022429416,0.0017559241,0.0006388202,0.000102617894,0.00012041289,0.007360689],"genre_scores_gemma":[0.9837337,0.000014676224,0.00025485374,0.0024943398,0.00019707195,0.00008176158,0.00003065991,0.000043837033,0.013149103],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99741435,0.00023797413,0.00033957462,0.0006815112,0.000057238987,0.0012693668],"domain_scores_gemma":[0.9986855,0.00009633444,0.00008017904,0.0008002436,0.00007722228,0.0002605572],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040368552,0.00035428736,0.000423999,0.00019845169,0.00023964305,0.00001917248,0.00039094978,0.00037957096,0.0006175997],"category_scores_gemma":[0.000045430428,0.0003147846,0.00014554213,0.00034944445,0.00003448709,0.000044075172,0.0002621469,0.00020389831,0.0064456644],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034671347,0.007968429,0.02164401,0.00002014943,0.00005408785,0.0000038710746,0.0009828552,0.000002071765,0.9556119,0.00008640333,0.01244171,0.00083780586],"study_design_scores_gemma":[0.005868555,0.0015394122,0.04509928,0.000013805404,0.000065708206,0.000016414167,0.000102445316,1.0488435e-7,0.8232907,0.00001215322,0.12361391,0.00037748547],"about_ca_topic_score_codex":0.00019222283,"about_ca_topic_score_gemma":0.00023566121,"teacher_disagreement_score":0.13232116,"about_ca_system_score_codex":0.0000992618,"about_ca_system_score_gemma":0.000062688145,"threshold_uncertainty_score":0.99993044},"labels":[],"label_agreement":null},{"id":"W2042636123","doi":"10.1182/blood.v99.10.3813","title":"Erythroid differentiation and protoporphyrin IX down-regulate frataxin expression in Friend cells: characterization of frataxin expression compared to molecules involved in iron metabolism and hemoglobinization","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Frataxin; Ferroportin; Biochemistry; Biology; Transferrin receptor; Mitochondrion; Heme; Ferrochelatase; Molecular biology; Chemistry; Cell biology; Metabolism; Transferrin; Aconitase; Enzyme","score_opus":0.017358262129373175,"score_gpt":0.22042697657352828,"score_spread":0.2030687144441551,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042636123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99750817,0.00012393636,0.00066551595,0.00005961328,0.00006812513,0.001441239,0.0000890895,0.000029415785,0.000014883766],"genre_scores_gemma":[0.9987004,0.00014752326,0.00076701824,0.00007010979,0.000025197836,0.00019048451,0.000052268704,0.000026397664,0.00002061382],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979484,0.00036086031,0.00047612155,0.00066472276,0.00031085388,0.00023904137],"domain_scores_gemma":[0.9992743,0.000046013178,0.00023347318,0.00028235573,0.000045576642,0.00011824589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000083651576,0.00024326768,0.00032005514,0.0003029255,0.00007619657,0.00006618862,0.00014102532,0.00008735879,0.000037127276],"category_scores_gemma":[0.0001455293,0.00023405957,0.000023644567,0.00042903656,0.000073676434,0.00030604465,0.00016229575,0.0001023115,0.000003235491],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052458505,0.0005779622,0.021324433,0.00007317534,0.0000010270702,0.000004564815,0.0010339918,0.00014050164,0.9765244,0.000026854115,0.000006848246,0.00023376668],"study_design_scores_gemma":[0.0015700452,0.000047257243,0.24251555,0.00011983266,0.000010292105,9.780431e-7,0.000046404268,0.0020363163,0.75342685,0.000051127387,0.000011483259,0.00016386496],"about_ca_topic_score_codex":0.000012485903,"about_ca_topic_score_gemma":0.000017376298,"teacher_disagreement_score":0.22309758,"about_ca_system_score_codex":0.000012150367,"about_ca_system_score_gemma":0.000013486808,"threshold_uncertainty_score":0.95446724},"labels":[],"label_agreement":null},{"id":"W2042662562","doi":"10.1182/blood-2010-08-299396","title":"Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination on the basis of hTERT and survivin after ASCT for myeloma","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":163,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"U.S. Public Health Service; National Cancer Institute; National Heart, Lung, and Blood Institute; Abramson Cancer Center; University of Calgary","keywords":"Multiple myeloma; Medicine; Immunotherapy; Vaccination; Adoptive cell transfer; Antigen; Cancer research; Immunology; Oncology; T cell; Immune system","score_opus":0.018650406776871246,"score_gpt":0.2757860889345335,"score_spread":0.25713568215766225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042662562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99829954,0.00016803503,0.00018796686,0.00023393559,0.00002604467,0.00087579695,0.000034992383,0.000007224402,0.000166449],"genre_scores_gemma":[0.999102,0.000066767185,0.00062734896,0.000058314516,0.000021882692,0.000054855976,0.000014449135,0.000015367159,0.000039016344],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9994295,0.00004137516,0.00011463027,0.00014271942,0.00014646076,0.00012530206],"domain_scores_gemma":[0.9995447,0.00015570226,0.00002558548,0.0001292445,0.00009970813,0.000045051333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021022448,0.00009249993,0.00014258566,0.000073191666,0.000066035784,0.000016441783,0.000030254383,0.00004089806,0.000058710644],"category_scores_gemma":[0.000035235065,0.000060301743,0.000039921975,0.000059458045,0.000034612283,0.000051931976,0.0000076100937,0.00008451614,7.0301957e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00204317,0.002036127,0.3812644,0.00017011292,0.0003372745,0.000011554909,0.0010524312,1.5433659e-7,0.5864259,0.00030359582,0.000010397735,0.0263449],"study_design_scores_gemma":[0.006992121,0.0005978928,0.65882444,0.000028024748,0.000058851198,0.0000110376795,0.000049231076,0.00043432857,0.3328621,0.000057912122,0.000033883323,0.00005015562],"about_ca_topic_score_codex":0.000054714637,"about_ca_topic_score_gemma":0.000038990784,"teacher_disagreement_score":0.27756006,"about_ca_system_score_codex":0.000007766093,"about_ca_system_score_gemma":0.000027388209,"threshold_uncertainty_score":0.24590337},"labels":[],"label_agreement":null},{"id":"W2042790564","doi":"10.1182/blood-2014-07-537480","title":"Risk assessment in the management of newly diagnosed classical Hodgkin lymphoma","year":2015,"lang":"en","type":"review","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency","keywords":"Medicine; Lymphoma; Intensive care medicine; Malignancy; Risk assessment; Disease; Hodgkin lymphoma; Oncology; Internal medicine; Computer science","score_opus":0.04405258293351854,"score_gpt":0.35222294588632413,"score_spread":0.3081703629528056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042790564","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011448468,0.9844537,0.0000027789856,0.00014290302,0.00012527601,0.0024505688,0.00008441485,0.000025358311,0.011570198],"genre_scores_gemma":[0.0012847614,0.99570787,0.0012335654,0.000063882595,0.00014894088,0.0011902328,0.0001806843,0.000044379594,0.00014570208],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972621,0.00038552156,0.0008022653,0.00047507187,0.0007416481,0.00033337137],"domain_scores_gemma":[0.9980854,0.00033404576,0.00044898357,0.0009355846,0.000057387602,0.00013861171],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007022199,0.00045707697,0.00190394,0.00017115907,0.000036164703,0.00003098397,0.00033482633,0.00024348393,0.00003268373],"category_scores_gemma":[0.000024667394,0.00024851866,0.00060440955,0.00044130377,0.000066847584,0.000029560882,0.00013226047,0.0002100153,0.00006698435],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009374189,0.008512838,0.0020255854,0.0063355095,0.0017645424,0.0022281548,0.00006923956,1.3684648e-7,1.0489375e-8,0.0008526444,0.0020592967,0.97614264],"study_design_scores_gemma":[0.011606126,0.0005467163,0.02052815,0.011804528,0.015729576,0.00015448412,0.000117636795,0.0000016322334,9.1087657e-7,0.00006635614,0.9392115,0.0002323868],"about_ca_topic_score_codex":0.00010756113,"about_ca_topic_score_gemma":0.000016108237,"teacher_disagreement_score":0.9759103,"about_ca_system_score_codex":0.0003579768,"about_ca_system_score_gemma":0.00054456055,"threshold_uncertainty_score":0.9999967},"labels":[],"label_agreement":null},{"id":"W2042918108","doi":"10.1182/blood-2009-04-214437","title":"ATG-induced expression of FOXP3 in human CD4+ T cells in vitro is associated with T-cell activation and not the induction of FOXP3+ T regulatory cells","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health","funders":"","keywords":"FOXP3; IL-2 receptor; Peripheral blood mononuclear cell; Immunology; In vitro; Population; Regulatory T cell; Medicine; T cell; Biology; Immune system","score_opus":0.011012107622296555,"score_gpt":0.20609343581324824,"score_spread":0.1950813281909517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042918108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99886215,0.0002537351,0.0000033882195,0.00009596218,0.00009476219,0.00032728506,0.000012610974,0.000018691842,0.00033141684],"genre_scores_gemma":[0.99939615,0.0000322542,0.000025162179,0.00008104793,0.000011336555,0.000009449694,0.00003994142,0.000013539719,0.00039110167],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99860775,0.00030705915,0.00044452402,0.00030204936,0.00006153342,0.0002770812],"domain_scores_gemma":[0.9990814,0.00012188143,0.00041390106,0.00030676334,0.000064065745,0.000012028646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030976033,0.00019106292,0.00039366953,0.00020995745,0.00009119943,0.0000052557243,0.00017442286,0.0004548876,0.000028038558],"category_scores_gemma":[0.000018010114,0.00014198343,0.000049845243,0.00024860547,0.00017400582,0.00010428014,0.000048737107,0.0004201151,0.0000037883296],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030802673,0.0010842488,0.00067081844,0.000016756747,0.000038657978,0.0000020148282,0.0012458836,0.000004027953,0.9960612,0.000019347506,0.00006938911,0.00047961596],"study_design_scores_gemma":[0.0051625473,0.0005366007,0.014743666,0.00010344239,0.00004657086,0.0000050108724,0.0003372996,0.0000010476302,0.97877663,0.00009411658,0.00004378776,0.00014930297],"about_ca_topic_score_codex":0.00018900979,"about_ca_topic_score_gemma":0.000024527084,"teacher_disagreement_score":0.017284606,"about_ca_system_score_codex":0.000031075942,"about_ca_system_score_gemma":0.000042998912,"threshold_uncertainty_score":0.57899165},"labels":[],"label_agreement":null},{"id":"W2043012323","doi":"10.1182/blood-2008-02-137711","title":"Requirement of TLR2-mediated signaling for the induction of IL-15 gene expression in human monocytic cells by HSV-1","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Canadian Institutes of Health Research","keywords":"TLR2; Signal transducing adaptor protein; Biology; Cell biology; Small interfering RNA; Signal transduction; Herpes simplex virus; Gene silencing; Molecular biology; Regulation of gene expression; Transcription factor; TLR4; Gene; Transfection; Virology; Virus; Genetics","score_opus":0.02847772291655322,"score_gpt":0.2435197529390981,"score_spread":0.2150420300225449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043012323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968771,0.001390223,0.00055572874,0.000027063174,0.0007418576,0.0002927196,0.000010470854,0.000013046472,0.000091834336],"genre_scores_gemma":[0.9984982,0.00016599994,0.00006042376,0.00002453723,0.000020156453,0.000031890035,0.00012370644,0.000008924801,0.0010661634],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99927986,0.00007987006,0.00035512718,0.0001288445,0.00003010592,0.00012619862],"domain_scores_gemma":[0.99945974,0.00010577158,0.00021057662,0.00015210507,0.00006598424,0.0000058370374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016848157,0.00008286344,0.00015663057,0.000078069235,0.00010970886,0.0000016784325,0.00008753303,0.00012459257,0.00021770534],"category_scores_gemma":[0.000032055053,0.00006346916,0.00006285844,0.00007847937,0.000076722805,0.000060348106,0.000021905253,0.0001251446,0.0000118271655],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012637815,0.00038255527,0.00024779345,0.000015898308,0.00006460482,2.3120289e-7,0.00041881306,0.00003165159,0.99509466,0.0000048279417,0.0035294944,0.00008309485],"study_design_scores_gemma":[0.0022398834,0.00028312238,0.00034635156,0.000037937058,0.0000431145,0.000007589959,0.00030331744,0.000009797641,0.99305975,0.00000791137,0.00359982,0.00006141495],"about_ca_topic_score_codex":0.00008325743,"about_ca_topic_score_gemma":0.0000022624913,"teacher_disagreement_score":0.0021135053,"about_ca_system_score_codex":0.000020129333,"about_ca_system_score_gemma":0.000019455894,"threshold_uncertainty_score":0.25881973},"labels":[],"label_agreement":null},{"id":"W2043081908","doi":"10.1182/blood-2001-11-0084","title":"Tumor necrosis factor-alpha expressed constitutively in erythroid cells or induced by erythropoietin has negative and stimulatory roles in normal erythropoiesis and erythroleukemia","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research","funders":"National Institute of Allergy and Infectious Diseases; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute; University of Illinois at Chicago","keywords":"Autocrine signalling; Erythropoiesis; Erythropoietin receptor; Erythropoietin; Tumor necrosis factor alpha; Biology; Signal transduction; Cell biology; Cell culture; Cytokine; Cancer research; Endocrinology; Internal medicine; Immunology; Medicine; Anemia","score_opus":0.028724234864216353,"score_gpt":0.24267339829885168,"score_spread":0.21394916343463533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043081908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960733,0.0013305176,0.000015030967,0.0005920148,0.00018010588,0.0007744614,0.00016865732,0.00010568628,0.000760249],"genre_scores_gemma":[0.9966675,0.00099578,0.0006374019,0.0010300913,0.000108861765,0.00007555676,0.000021192582,0.000059061837,0.00040456562],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99710894,0.0002192634,0.000733436,0.00091947784,0.00031442236,0.0007044804],"domain_scores_gemma":[0.99849623,0.00045557017,0.00023247633,0.00037244815,0.00009930801,0.00034394916],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001808044,0.0005609935,0.0010344592,0.00040227268,0.00021698388,0.00007446682,0.00012076689,0.00037528275,0.0006812382],"category_scores_gemma":[0.00026385929,0.0004959253,0.000093250994,0.0005064759,0.0010886415,0.0003437237,0.00015184612,0.00071910134,0.000046010322],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017804061,0.0028469013,0.04915405,0.0004055573,0.00023615234,0.0006613314,0.008858272,0.000017001817,0.92934674,0.000044987144,0.0035094214,0.0031391727],"study_design_scores_gemma":[0.07599238,0.0054466124,0.3080222,0.0014573867,0.0005407272,0.00074095477,0.0062600966,0.0014663362,0.5900194,0.00021093753,0.0073729972,0.0024699543],"about_ca_topic_score_codex":0.00058320933,"about_ca_topic_score_gemma":0.00049483374,"teacher_disagreement_score":0.33932734,"about_ca_system_score_codex":0.00017644778,"about_ca_system_score_gemma":0.00029810294,"threshold_uncertainty_score":0.99974924},"labels":[],"label_agreement":null},{"id":"W2043126484","doi":"10.1182/blood-2003-11-4070","title":"“Complex” receptor for vitamin B12-intrinsic factor","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Megaloblastic anemia; Vitamin B12; Intrinsic factor; Anemia; Medicine; OMIM : Online Mendelian Inheritance in Man; Internal medicine; Endocrinology; Gastroenterology; Biology; Biochemistry; Gene; Phenotype","score_opus":0.04695348742191123,"score_gpt":0.3182373534565435,"score_spread":0.2712838660346323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043126484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951545,0.00014411654,0.0001861353,0.0017364853,0.00013780227,0.00069385866,0.00006456783,0.000090860725,0.001791681],"genre_scores_gemma":[0.9910313,0.00005148665,0.0046814205,0.00033287762,0.0004438031,0.000058786994,0.00008665652,0.000034845052,0.0032788503],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989271,0.00001151385,0.0001766777,0.0002553503,0.00025453613,0.0003748006],"domain_scores_gemma":[0.9993321,0.000054703614,0.000028207278,0.00028492475,0.00011762889,0.00018247431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009338246,0.00012665657,0.00023148618,0.000114861534,0.00007864204,0.000022095197,0.00010360641,0.00009441394,0.00043847956],"category_scores_gemma":[0.00014964165,0.00010267846,0.00012801065,0.00017875264,0.00004875143,0.000057119887,0.00003635837,0.00014411687,0.00044465315],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000645399,0.0046462193,0.009630444,0.000615333,0.0006576215,0.00014957615,0.0007632482,0.000001754995,0.9157971,0.0017167806,0.015973702,0.0494028],"study_design_scores_gemma":[0.039576255,0.004865827,0.12787762,0.00023059724,0.0003172948,0.00019187327,0.00024179259,0.000016353986,0.5514951,0.00064601674,0.27394918,0.00059214287],"about_ca_topic_score_codex":0.000042789714,"about_ca_topic_score_gemma":0.000014714242,"teacher_disagreement_score":0.36430207,"about_ca_system_score_codex":0.000053642,"about_ca_system_score_gemma":0.00014286181,"threshold_uncertainty_score":0.5715265},"labels":[],"label_agreement":null},{"id":"W2043395973","doi":"10.1182/blood-2002-09-2888","title":"Combined carrier status of prothrombin 20210A and factor XIII-A Leu34 alleles as a strong risk factor for myocardial infarction: evidence of a gene-gene interaction","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Allele; Penetrance; Risk factor; Internal medicine; Population; Gastroenterology; Biology; Factor V Leiden; Allele frequency; Genetics; Medicine; Gene; Thrombosis; Venous thrombosis","score_opus":0.04623471223346648,"score_gpt":0.31319786255997234,"score_spread":0.26696315032650586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043395973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961025,0.0006529884,0.001145486,0.00005242276,0.00025552558,0.0014108351,0.00023643136,0.000032462503,0.000111332585],"genre_scores_gemma":[0.99648625,0.00035559857,0.0028436654,0.000035391917,0.00006424554,0.000098112985,0.00002003365,0.00003004164,0.00006664719],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985139,0.00012593443,0.0004632448,0.0003110687,0.00031529184,0.000270599],"domain_scores_gemma":[0.99872977,0.00015202236,0.00034823394,0.00028704348,0.0002967771,0.00018613438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015659528,0.00019773624,0.00052069273,0.00012911517,0.00007206726,0.000017083474,0.000050243616,0.00013648767,0.00024195277],"category_scores_gemma":[0.00054171745,0.00018384418,0.00015882969,0.00014751383,0.000070171714,0.0001779309,0.000021835795,0.00014967748,0.00000203959],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093413616,0.0010288436,0.10384617,0.00042142504,0.001408779,0.0000025275303,0.0019624159,0.000014780305,0.8860511,0.0012656962,0.000028465354,0.003035664],"study_design_scores_gemma":[0.008070106,0.0030048648,0.12040728,0.0002205036,0.00074318104,0.000027526132,0.0005858236,0.00009308491,0.8659558,0.00028953532,0.0004005396,0.00020174359],"about_ca_topic_score_codex":0.0001475135,"about_ca_topic_score_gemma":0.0000235924,"teacher_disagreement_score":0.02009529,"about_ca_system_score_codex":0.00003747812,"about_ca_system_score_gemma":0.00024136291,"threshold_uncertainty_score":0.7496948},"labels":[],"label_agreement":null},{"id":"W2043622833","doi":"10.1182/blood-2014-05-578963","title":"Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":466,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Transplantation; BCL6; Retrospective cohort study; Autologous stem-cell transplantation; Regimen; Leukocytosis; Oncology; Surgery; Immunology; B cell","score_opus":0.011427774036542587,"score_gpt":0.26646992987857604,"score_spread":0.25504215584203344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043622833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99860823,0.000038729748,0.000009253872,0.000058847672,0.000017625254,0.0002576061,0.0000127485655,0.000012056805,0.0009849037],"genre_scores_gemma":[0.99969846,0.00006930498,0.00006436532,0.000016225738,0.000015245905,0.000024216288,0.000024403977,0.0000076192014,0.000080159305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99932164,0.000033136002,0.00018512839,0.00020395806,0.00014674601,0.000109397275],"domain_scores_gemma":[0.99961454,0.00004571073,0.000093743656,0.00015669502,0.00003473965,0.000054551736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000083380335,0.00011407901,0.00035637012,0.00024176456,0.000017931101,0.000007956558,0.000020240597,0.00005923682,0.000009713451],"category_scores_gemma":[0.000003569072,0.00007923047,0.00014084863,0.00022745944,0.000017319782,0.000047692414,0.0000046514265,0.00002860773,0.0000031652783],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004019311,0.0028246327,0.9930818,0.000033014898,0.0008556633,0.000015410928,0.00089207623,0.000015445752,0.00047847518,0.00004043029,0.000002867696,0.0013582493],"study_design_scores_gemma":[0.023877544,0.0008555186,0.958932,0.000039445385,0.0020250576,0.000006236394,0.00005411042,0.00007231206,0.01406738,0.000006216302,0.0000013680789,0.000062832776],"about_ca_topic_score_codex":0.0006962503,"about_ca_topic_score_gemma":0.00009306048,"teacher_disagreement_score":0.034149826,"about_ca_system_score_codex":0.000136088,"about_ca_system_score_gemma":0.000019820636,"threshold_uncertainty_score":0.32309246},"labels":[],"label_agreement":null},{"id":"W2043640405","doi":"10.1182/blood.v97.1.250","title":"Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":196,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada); Ontario Institute for Cancer Research; University of Toronto; BC Cancer Agency","funders":"","keywords":"Reed–Sternberg cell; Lymphoma; Autocrine signalling; Histiocyte; Pathology; In situ hybridization; Anaplastic large-cell lymphoma; CD30; Lymphocyte; Interleukin 2; Biology; Cancer research; Medicine; Receptor; Hodgkin lymphoma; Immunology; Cytokine; Internal medicine; Gene expression; Gene","score_opus":0.009382057275340796,"score_gpt":0.22156422464930117,"score_spread":0.21218216737396037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043640405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930318,0.004112638,0.00001485924,0.0006180427,0.00015866368,0.00051738566,0.0001550235,0.00006605087,0.0013255415],"genre_scores_gemma":[0.9955713,0.0020830347,0.00062774355,0.0003556915,0.00012408527,0.000089095614,0.00006336382,0.000052683474,0.0010330094],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99811006,0.00008711681,0.00052598043,0.00059319043,0.00030094926,0.000382696],"domain_scores_gemma":[0.9987061,0.00015021174,0.0002720662,0.00048949727,0.00008856876,0.00029352456],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015033633,0.00037446656,0.00068561645,0.00015057865,0.000059415823,0.000057389723,0.00014003964,0.00018969,0.00020263334],"category_scores_gemma":[0.000050888375,0.00031102414,0.00012284327,0.00016065498,0.00016987137,0.00013056071,0.00013744892,0.00008762081,0.000031824304],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096084236,0.0065553547,0.5961653,0.0004529519,0.0010460173,0.0006954485,0.0019907872,4.8736166e-7,0.3241438,0.000060589653,0.02397539,0.04395305],"study_design_scores_gemma":[0.031645007,0.0024579228,0.12347456,0.001571222,0.0008429794,0.00046799093,0.00095576607,0.000029477309,0.8117212,0.0000957038,0.026151879,0.0005862849],"about_ca_topic_score_codex":0.000784077,"about_ca_topic_score_gemma":0.00015609762,"teacher_disagreement_score":0.4875774,"about_ca_system_score_codex":0.000095584415,"about_ca_system_score_gemma":0.000051809442,"threshold_uncertainty_score":0.9999342},"labels":[],"label_agreement":null},{"id":"W2043721723","doi":"10.1182/blood-2010-01-264358","title":"Dissolution of arterial platelet thrombi in vivo with a bifunctional platelet GPIIIa49-66 ligand which specifically targets the platelet thrombus","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute on Drug Abuse; National Institute on Aging; National Institutes of Health; York University","keywords":"Platelet; Thrombus; Antithrombotic; Platelet activation; In vivo; Pharmacology; Platelet Glycoprotein GPIIb-IIIa Complex; Chemistry; Fibrin; Medicine; Immunology; Internal medicine; Biology","score_opus":0.009322492610085711,"score_gpt":0.2248086091434113,"score_spread":0.21548611653332558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043721723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946056,0.00014339254,0.000031951742,0.00079043827,0.00042274638,0.0008025018,0.00013475816,0.00005976325,0.0030088178],"genre_scores_gemma":[0.99857354,0.000085190426,0.00057767105,0.00010321751,0.0002828982,0.000043293534,0.00014267996,0.000047138205,0.00014435794],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979072,0.000040691193,0.0005049718,0.0004910617,0.00054322067,0.0005128405],"domain_scores_gemma":[0.99888664,0.000119939294,0.00020296953,0.0004847032,0.0001542896,0.00015145759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023184414,0.00035664087,0.00067351083,0.0001496255,0.00014952196,0.000039755425,0.00017452666,0.00027680604,0.00056129065],"category_scores_gemma":[0.00007461446,0.00022490366,0.00010855762,0.00047142516,0.00021851153,0.00012467566,0.000047878006,0.00056733016,0.000046036817],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009343524,0.01710267,0.06589518,0.0002629462,0.002846471,0.0042284746,0.002538125,0.00009482989,0.88761777,0.002145832,0.0040137973,0.0039103916],"study_design_scores_gemma":[0.061739653,0.0038473732,0.41675994,0.00041399032,0.000552269,0.005288765,0.0004277588,0.00038892013,0.49483877,0.0020326667,0.012688338,0.0010215726],"about_ca_topic_score_codex":0.0001646051,"about_ca_topic_score_gemma":0.0014072842,"teacher_disagreement_score":0.392779,"about_ca_system_score_codex":0.000028147213,"about_ca_system_score_gemma":0.00020561242,"threshold_uncertainty_score":0.91713053},"labels":[],"label_agreement":null},{"id":"W2043831614","doi":"10.1182/blood-2008-09-177329","title":"Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":147,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"National Cancer Institute","keywords":"Medicine; Fludarabine; Rituximab; Waldenstrom macroglobulinemia; Internal medicine; Macroglobulinemia; Neutropenia; Gastroenterology; Surgery; Lymphoma; Chemotherapy; Cyclophosphamide; Multiple myeloma","score_opus":0.029377076162113058,"score_gpt":0.3144924683044922,"score_spread":0.28511539214237913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043831614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964069,0.0006811259,0.000010991785,0.0011735652,0.000053130607,0.0005223626,0.0000073781175,0.00006156311,0.0010829695],"genre_scores_gemma":[0.99570274,0.0001925143,0.0010570368,0.0005599287,0.000115162475,0.000034451874,0.000013110812,0.000030119623,0.002294903],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99838823,0.000025895884,0.0003017132,0.0003834288,0.0004189388,0.00048177727],"domain_scores_gemma":[0.9990694,0.00008784674,0.000027234011,0.0004251737,0.00006336636,0.00032700325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014522012,0.0001833972,0.00045362365,0.00019299034,0.000055332297,0.000014206604,0.000126843,0.00011122254,0.00010662176],"category_scores_gemma":[0.00024207312,0.00015333344,0.000060835777,0.00029431898,0.00012346325,0.000051750354,0.0001667586,0.00022579516,0.00022802713],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002776735,0.0031471527,0.9765149,0.00024749938,0.000110709836,0.011159967,0.0005762586,0.0000014075912,0.0021948207,0.000032105563,0.0007896823,0.004947821],"study_design_scores_gemma":[0.122461274,0.0002748585,0.8635204,0.00016145594,0.00007116188,0.0057708067,0.000021867723,0.00009808323,0.007071713,0.000014895551,0.00030795825,0.00022554665],"about_ca_topic_score_codex":0.000312665,"about_ca_topic_score_gemma":0.00015874406,"teacher_disagreement_score":0.1221836,"about_ca_system_score_codex":0.001150276,"about_ca_system_score_gemma":0.0012985016,"threshold_uncertainty_score":0.6252756},"labels":[],"label_agreement":null},{"id":"W2043872317","doi":"10.1182/blood-2005-02-0655","title":"Hematopoietic stem cells do not engraft with absolute efficiencies","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health; National Cancer Institute; Leukemia and Lymphoma Society; Canadian Institutes of Health Research; Michael Smith Health Research BC","keywords":"Haematopoiesis; Stem cell; Biology; Immunophenotyping; Population; Side population; Bone marrow; Cell biology; Hematopoietic stem cell; Phenotype; Homogeneous; Molecular biology; Immunology; Flow cytometry; Cancer stem cell; Genetics; Medicine; Gene","score_opus":0.01349885106668965,"score_gpt":0.22961909910683817,"score_spread":0.2161202480401485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043872317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99014986,0.00029582676,0.0008764434,0.0006705673,0.00005854322,0.00047510842,0.000010027291,0.00017666277,0.007286942],"genre_scores_gemma":[0.993727,0.000047016736,0.003969667,0.00041674267,0.00013745645,0.00002790029,0.0000052224773,0.000039217877,0.0016297202],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99850017,0.00002728071,0.00030405645,0.00032420526,0.00048891,0.00035537407],"domain_scores_gemma":[0.99917793,0.00010693034,0.000075274125,0.00038576973,0.00007742119,0.00017666888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019054611,0.00020308794,0.00031440402,0.000097499076,0.00007381025,0.0000326439,0.000107671825,0.00009306283,0.00016703464],"category_scores_gemma":[0.0000039752967,0.00015479016,0.00007510248,0.00021264446,0.00008306465,0.000069168396,0.000013433856,0.00015612434,0.00050200114],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009821912,0.0072036586,0.013445886,0.004550039,0.0009855464,0.0018037562,0.031314243,0.00065307406,0.9234788,0.003960894,0.0021234576,0.00949847],"study_design_scores_gemma":[0.005956426,0.00042941747,0.0031394304,0.000471217,0.00061560696,0.0012775665,0.0005737149,0.0001421049,0.98291755,0.000005890472,0.0041674245,0.00030364023],"about_ca_topic_score_codex":0.00000766739,"about_ca_topic_score_gemma":0.000007964948,"teacher_disagreement_score":0.059438772,"about_ca_system_score_codex":0.000026932901,"about_ca_system_score_gemma":0.000093310366,"threshold_uncertainty_score":0.6452376},"labels":[],"label_agreement":null},{"id":"W2043874839","doi":"10.1182/blood-2007-03-080523","title":"MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AML","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":148,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Terry Fox Foundation; Deutsche Forschungsgemeinschaft; Michael Smith Health Research BC","keywords":"Myeloid leukemia; Cancer research; Biology; Haematopoiesis; Tretinoin; Leukemia; Myeloid; Retinoic acid; Stem cell; Bone marrow; Immunology; Cell culture; Genetics","score_opus":0.008264420068514402,"score_gpt":0.24980049431693735,"score_spread":0.24153607424842294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043874839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946724,0.0003235995,0.00000978805,0.000118558855,0.000022796032,0.000680879,0.00001774137,0.000037645194,0.004116592],"genre_scores_gemma":[0.9970324,0.000100500656,0.0020145027,0.00016999652,0.00007496961,0.000018476258,0.000041456777,0.000036399622,0.00051132275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99800146,0.000052236814,0.00034864765,0.00045589567,0.0005842795,0.0005575036],"domain_scores_gemma":[0.99917674,0.00012692838,0.000089554174,0.0002981795,0.000089959125,0.00021862851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044369927,0.00020675588,0.00032863842,0.00033048075,0.000048042682,0.0000203841,0.00014723041,0.00020254076,0.000015106412],"category_scores_gemma":[0.00012683304,0.00016334013,0.000022846367,0.000535325,0.000117310796,0.0002065429,0.000108362015,0.0006252656,0.0000075345724],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039959224,0.0005690683,0.9496237,0.00021184712,0.00009457099,0.00059604074,0.0014758435,0.0000015856482,0.041651506,0.000051386043,0.00048924045,0.001239295],"study_design_scores_gemma":[0.01785555,0.0004125823,0.95278746,0.0009416415,0.000053399443,0.000014252484,0.000099067736,0.000007684267,0.027264057,0.000041611063,0.00034535668,0.0001773476],"about_ca_topic_score_codex":0.00017794258,"about_ca_topic_score_gemma":0.00046220605,"teacher_disagreement_score":0.01438745,"about_ca_system_score_codex":0.0005221559,"about_ca_system_score_gemma":0.00038994302,"threshold_uncertainty_score":0.6660817},"labels":[],"label_agreement":null},{"id":"W2043946604","doi":"10.1182/blood-2006-09-047308","title":"Slow disease progression and robust therapy-mediated CD4+ T-cell recovery are associated with efficient thymopoiesis during HIV-1 infection","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; Hôpital Saint-Luc; McGill University Health Centre; Université de Montréal; Royal Victoria Regional Health Centre; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Immunology; Viremia; T cell; CD8; Naive T cell; Antiretroviral therapy; Biology; Disease; Cytotoxic T cell; Cell; Viral load; Medicine; Human immunodeficiency virus (HIV); Immune system; Internal medicine; T-cell receptor; In vitro","score_opus":0.006425869834576581,"score_gpt":0.1983156219927748,"score_spread":0.19188975215819823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043946604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99481434,0.0039415727,0.000009616731,0.00008693197,0.00005040569,0.00041296924,0.0001788006,0.000117568205,0.00038781395],"genre_scores_gemma":[0.9973301,0.000273922,0.000015056767,0.000008536881,0.000020314945,0.00008645527,0.0008303951,0.000018779936,0.001416381],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989901,0.00016446617,0.00013490632,0.00028821162,0.0000655395,0.00035676197],"domain_scores_gemma":[0.9995456,0.00008701485,0.00010279993,0.00015405165,0.000058200436,0.000052385505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009210143,0.00016881329,0.00017036994,0.000099587,0.00029822858,0.000029998384,0.000047412883,0.00011990351,0.00008024418],"category_scores_gemma":[0.00004731206,0.00011753019,0.0000471963,0.00015389992,0.000104556224,0.000048567952,0.00003528654,0.00015601056,0.00016201523],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011394692,0.0072874674,0.9198083,0.000052261606,0.0004427,0.00017813005,0.00007552261,0.00041479353,0.06912618,0.000002578526,0.0007814521,0.0006911137],"study_design_scores_gemma":[0.009589811,0.00040073093,0.9462263,0.000130387,0.000094463205,0.0000133403355,0.00001901977,0.000007630209,0.04308143,0.00000486669,0.00025761,0.00017439986],"about_ca_topic_score_codex":0.00007214951,"about_ca_topic_score_gemma":0.00006637725,"teacher_disagreement_score":0.026417984,"about_ca_system_score_codex":0.000044443415,"about_ca_system_score_gemma":0.00004925715,"threshold_uncertainty_score":0.47927418},"labels":[],"label_agreement":null},{"id":"W2044021970","doi":"10.1182/blood-2003-07-2342","title":"Good-bye to GVHD","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Graft-versus-host disease; Immunology; Intensive care medicine; Internal medicine; Transplantation","score_opus":0.01606410641390955,"score_gpt":0.2607814652405325,"score_spread":0.24471735882662293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044021970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7245241,0.000101437414,0.0010264653,0.00030469222,0.00012266051,0.0002912228,0.0000029973712,0.00006705472,0.27355942],"genre_scores_gemma":[0.99052554,0.000009613476,0.006510078,0.00052416476,0.000040784966,0.00001636145,0.0000057768552,0.0000151248405,0.002352553],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999428,0.000019336328,0.00012140455,0.00013475344,0.00014952198,0.00014703197],"domain_scores_gemma":[0.99961,0.000032828044,0.0000134715965,0.00017801124,0.00002802551,0.00013764444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000100394114,0.000067493405,0.00011815859,0.000045327903,0.000020990276,0.0000059213635,0.000028749591,0.00004353412,0.0006609607],"category_scores_gemma":[0.000052835847,0.00006067169,0.0000337098,0.00012911177,0.000007749015,0.0000156574,0.0000026536104,0.00005257347,0.0007354913],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015254441,0.0048380895,0.6008079,0.001680644,0.0006309038,0.001774927,0.0074152467,0.000014692229,0.29561648,0.068606995,0.006693412,0.011768143],"study_design_scores_gemma":[0.0066669774,0.00043916196,0.10603526,0.00013913693,0.00048476193,0.0009058228,0.00023952249,0.0000025664535,0.819202,0.00026041077,0.06535916,0.00026519387],"about_ca_topic_score_codex":0.0000047367816,"about_ca_topic_score_gemma":0.0000022348886,"teacher_disagreement_score":0.52358556,"about_ca_system_score_codex":0.000008425938,"about_ca_system_score_gemma":0.00004141806,"threshold_uncertainty_score":0.94534975},"labels":[],"label_agreement":null},{"id":"W2044035285","doi":"10.1182/blood-2002-11-3622","title":"A novel missense mutation in the γ-glutamylcysteine synthetase catalytic subunit gene causes both decreased enzymatic activity and glutathione production","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Biology; Biochemistry; Missense mutation; Glutathione; Cysteine; Molecular biology; Mutation; Protein subunit; Amino acid; Enzyme; Mutant; Gene","score_opus":0.028323259584274698,"score_gpt":0.28031810245488786,"score_spread":0.2519948428706132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044035285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99755305,0.00061599707,0.00006761726,0.000615295,0.000028830753,0.0008745832,0.000009552434,0.000026614753,0.0002084633],"genre_scores_gemma":[0.9990147,0.00007597874,0.00043026326,0.0000729299,0.000050089544,0.000058890055,0.000026854148,0.000017806437,0.00025252101],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987221,0.00017811787,0.00021107263,0.00028206568,0.00035370776,0.00025295527],"domain_scores_gemma":[0.9992081,0.00020002607,0.00006496148,0.0003483609,0.00007356513,0.00010501772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008414978,0.00015073903,0.00026506666,0.00019714856,0.000099955185,0.000034514836,0.000050694576,0.000067719106,0.000015579652],"category_scores_gemma":[0.001399057,0.00010215758,0.000043632757,0.00044699138,0.00008398102,0.00012207487,0.0000123684395,0.00021058093,0.000011572093],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003734062,0.00371726,0.0017693521,0.000388537,0.00017683886,0.00086652965,0.001896558,0.000014529168,0.9894057,0.000057282286,0.000049152168,0.0012848551],"study_design_scores_gemma":[0.013583047,0.0009155928,0.086041905,0.0004079302,0.0010545115,0.014960445,0.0015744455,0.0010080897,0.8797947,0.00009908746,0.00016634248,0.00039389642],"about_ca_topic_score_codex":0.00043367312,"about_ca_topic_score_gemma":0.00027099953,"teacher_disagreement_score":0.10961099,"about_ca_system_score_codex":0.000034761088,"about_ca_system_score_gemma":0.0001673357,"threshold_uncertainty_score":0.41658652},"labels":[],"label_agreement":null},{"id":"W2044142836","doi":"10.1182/blood-2006-06-030270","title":"Low rhodamine 123 retention identifies long-term human hematopoietic stem cells within the Lin−CD34+CD38− population","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"CD38; Haematopoiesis; Stem cell; Side population; CD34; Biology; Population; Transplantation; Cell biology; Immunology; Hematopoietic stem cell; Molecular biology; Internal medicine; Medicine; Cancer stem cell","score_opus":0.017932961767690846,"score_gpt":0.2561907321217204,"score_spread":0.23825777035402954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044142836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963963,0.00023934999,0.0008611161,0.00019604691,0.00039248768,0.00091742264,0.00001179417,0.0001914536,0.0007940112],"genre_scores_gemma":[0.9954126,0.000016648026,0.00019029509,0.00006239539,0.00034648215,0.000049972907,0.00034272752,0.000057415575,0.0035214664],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977684,0.000116477044,0.00078178715,0.0004179865,0.0006080197,0.0003073445],"domain_scores_gemma":[0.9988315,0.000089711575,0.00030287562,0.0005734974,0.00011732148,0.00008507777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046410746,0.0002678522,0.00036774197,0.00013914715,0.0002510734,0.00009700566,0.00015462941,0.00018160928,0.00007330144],"category_scores_gemma":[0.000008785472,0.00020510668,0.00017358102,0.00026618503,0.00007212921,0.00014193844,0.000024689167,0.0002295056,0.0001957565],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000085245025,0.0014552064,0.35015088,0.002777724,0.00019969547,0.00031599062,0.0013520671,0.00007306249,0.6413832,0.0016882893,0.000275003,0.00024364593],"study_design_scores_gemma":[0.0030072618,0.00015282698,0.39745757,0.00089323457,0.0008532858,0.00030566173,0.00022658227,0.00006805735,0.5962185,0.00055211416,0.000005528603,0.00025935096],"about_ca_topic_score_codex":0.00014313572,"about_ca_topic_score_gemma":0.00019505345,"teacher_disagreement_score":0.04730667,"about_ca_system_score_codex":0.000047095262,"about_ca_system_score_gemma":0.00003044954,"threshold_uncertainty_score":0.8364008},"labels":[],"label_agreement":null},{"id":"W2044293078","doi":"10.1182/blood-2012-01-405795","title":"Impact of immune modulation with in vivo T-cell depletion and myleoablative total body irradiation conditioning on outcomes after unrelated donor transplantation for childhood acute lymphoblastic leukemia","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute","keywords":"Alemtuzumab; Total body irradiation; Medicine; Transplantation; Acute lymphocytic leukemia; Immunology; Leukemia; Internal medicine; In vivo; Gastroenterology; Oncology; Biology; Chemotherapy; Lymphoblastic Leukemia; Cyclophosphamide","score_opus":0.005350200207028285,"score_gpt":0.23912791851347706,"score_spread":0.23377771830644878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044293078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99499863,0.00007264456,0.0034821532,0.000016891689,0.000041142288,0.0010683496,0.00012999368,0.00003133232,0.0001588669],"genre_scores_gemma":[0.9982839,0.00003533429,0.0010066695,0.000013747475,0.000030980555,0.00012884034,0.000445069,0.000032543994,0.00002286885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99889046,0.00004933599,0.000414034,0.00020449459,0.00020390129,0.00023779388],"domain_scores_gemma":[0.99930716,0.00022533388,0.00019684236,0.00011548368,0.000069628164,0.000085581225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015898424,0.00020148746,0.00034116395,0.00024369589,0.000050358412,0.000011077944,0.000020644467,0.000133205,0.000031698397],"category_scores_gemma":[0.000018863875,0.000163771,0.00008927839,0.00017453336,0.000031530726,0.0003032067,0.00000231399,0.000091893664,0.0000028119075],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021448643,0.0009277752,0.9175493,0.00037828513,0.0004105813,0.000011702891,0.005843682,0.001120221,0.07139102,0.00006828736,0.0000012052257,0.00015306372],"study_design_scores_gemma":[0.014124098,0.0009781254,0.94106835,0.00037882107,0.0009209531,0.00013974111,0.00007548658,0.0017641856,0.04037209,0.000019977695,1.2036429e-7,0.00015805234],"about_ca_topic_score_codex":0.00008517081,"about_ca_topic_score_gemma":0.000008243559,"teacher_disagreement_score":0.031018933,"about_ca_system_score_codex":0.00015673714,"about_ca_system_score_gemma":0.00009266384,"threshold_uncertainty_score":0.6678387},"labels":[],"label_agreement":null},{"id":"W2044295326","doi":"10.1182/blood-2007-02-076539","title":"CD44-mediated phagocytosis induces inside-out activation of complement receptor-3 in murine macrophages","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Toronto General Hospital; University Health Network; University of Toronto","funders":"National Institutes of Health; Hospital for Sick Children","keywords":"Phagocytosis; Cell biology; Integrin alpha M; Biology; Receptor; Complement receptor; Phagosome; Integrin; Complement system; Biochemistry; Immunology; Antibody","score_opus":0.04032846893543764,"score_gpt":0.3314446045570722,"score_spread":0.2911161356216346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044295326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965249,0.00014037498,0.000066891494,0.0003382601,0.000040986808,0.00048188734,0.000009124642,0.000031296415,0.0023662914],"genre_scores_gemma":[0.9983145,0.000098062905,0.0009859506,0.00012816559,0.00007676164,0.00001459714,0.000101865524,0.00002309729,0.00025697506],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983016,0.00005920565,0.00046686226,0.00024079678,0.0005748493,0.00035664122],"domain_scores_gemma":[0.99912506,0.00021962829,0.00011465288,0.00025357344,0.00015336265,0.00013374772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005839267,0.00013008507,0.0002894041,0.00043120625,0.0000296284,0.0000072499506,0.00010611032,0.00009007023,0.00074845646],"category_scores_gemma":[0.00035259878,0.00011865113,0.000053696134,0.00049824454,0.000062658175,0.000052455016,0.00010376296,0.00024711562,0.000069852096],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022448017,0.0012242994,0.042662133,0.000111373876,0.000054813583,0.000055782348,0.00036444227,8.996726e-7,0.9510391,0.000016116363,0.00025010007,0.0039965003],"study_design_scores_gemma":[0.004278003,0.0003398055,0.14830716,0.00010980791,0.000021992171,0.000005068952,0.0002795697,0.000006422546,0.84543675,0.000009603999,0.0011234441,0.00008236898],"about_ca_topic_score_codex":0.00018362435,"about_ca_topic_score_gemma":0.000079943646,"teacher_disagreement_score":0.10564502,"about_ca_system_score_codex":0.00008080615,"about_ca_system_score_gemma":0.00009229336,"threshold_uncertainty_score":0.81950736},"labels":[],"label_agreement":null},{"id":"W2044764720","doi":"10.1182/blood-2006-04-017434","title":"Loss of SHP1 enhances JAK3/STAT3 signaling and decreases proteosome degradation of JAK3 and NPM-ALK in ALK+ anaplastic large-cell lymphoma","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":176,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Anaplastic large-cell lymphoma; Anaplastic lymphoma kinase; Cancer research; Chemistry; Cell culture; Transfection; MG132; Proteasome inhibitor; Molecular biology; Apoptosis; Biology; Lymphoma; Internal medicine; Biochemistry; Medicine; Immunology","score_opus":0.008221777847802248,"score_gpt":0.23193010643595838,"score_spread":0.22370832858815612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044764720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99748456,0.0010788125,0.0004262994,0.000034817556,0.000029611718,0.00029199335,0.00003106599,0.000014190853,0.0006086662],"genre_scores_gemma":[0.9984079,0.00008217834,0.0012776922,0.000016517173,0.00006038943,0.000017785991,0.000042090654,0.000013988291,0.00008145294],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99904454,0.000032074648,0.0003872445,0.00020506208,0.00016592069,0.00016514203],"domain_scores_gemma":[0.99940366,0.00016098494,0.00017044651,0.00011207117,0.00009311028,0.000059716553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013065398,0.00012613446,0.00029799683,0.00018590363,0.00003989747,0.00001199102,0.000035176876,0.000057454763,0.000034792636],"category_scores_gemma":[0.00010614252,0.00011270677,0.000043300937,0.00018171716,0.00006968944,0.00010419321,0.000023744018,0.00006315006,0.0000010069805],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019659924,0.0022470541,0.09620128,0.00037980828,0.000038483966,0.000032056418,0.00018153357,0.00001412807,0.8998326,0.00019787668,0.000022790056,0.00065580604],"study_design_scores_gemma":[0.0059504434,0.00063553156,0.03863768,0.0005466462,0.0001617956,0.00007438821,0.0002563978,0.00029492553,0.9529655,0.0001528436,0.0002099308,0.0001138978],"about_ca_topic_score_codex":0.0006306979,"about_ca_topic_score_gemma":0.00034301853,"teacher_disagreement_score":0.0575636,"about_ca_system_score_codex":0.000012628725,"about_ca_system_score_gemma":0.000076388795,"threshold_uncertainty_score":0.45960486},"labels":[],"label_agreement":null},{"id":"W2044865769","doi":"10.1182/blood-2011-05-352666","title":"The critical role of histone H2A-deubiquitinase Mysm1 in hematopoiesis and lymphocyte differentiation","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Institute of Genetics; Wellcome Trust","keywords":"Biology; Chromatin; Cell biology; Haematopoiesis; Stem cell; Histone; Deubiquitinating enzyme; Progenitor cell; Cellular differentiation; Lymphopoiesis; Ubiquitin; Genetics; Gene","score_opus":0.009526891300671489,"score_gpt":0.25976080338941065,"score_spread":0.2502339120887392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044865769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888672,0.00961204,0.00014146749,0.000022228554,0.000027886172,0.0000590967,0.00000400298,0.0000026376213,0.0012634388],"genre_scores_gemma":[0.9988842,0.0006540879,0.0003684633,0.000008656155,0.000027499484,0.000010174728,0.000009250527,0.0000073057595,0.00003033646],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99951446,0.00004130651,0.00015418864,0.00012615521,0.000060040118,0.00010383064],"domain_scores_gemma":[0.99971014,0.000024309425,0.000042256204,0.00015224109,0.000040477822,0.00003057434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012638344,0.00006103574,0.00007342366,0.000020252342,0.00004424061,0.0000066264283,0.000058950198,0.00006474738,0.0000061036003],"category_scores_gemma":[0.00011644935,0.000049288716,0.000025452404,0.000032022825,0.000078181234,0.0000019275847,0.000048528964,0.000024518233,7.047601e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042662385,0.00019413498,0.010611347,0.000019211797,0.000015343927,0.0000010276393,0.00022953632,3.6096313e-7,0.9840874,0.0019607614,0.00000212168,0.0028360717],"study_design_scores_gemma":[0.0004905498,0.000108980516,0.03853494,0.000007736431,0.000021899765,0.0000020101515,0.00009055548,0.000025885221,0.9575151,0.0028240955,0.00031714354,0.000061092396],"about_ca_topic_score_codex":0.000043881308,"about_ca_topic_score_gemma":0.00007369219,"teacher_disagreement_score":0.02792359,"about_ca_system_score_codex":0.0000039298634,"about_ca_system_score_gemma":0.00001879013,"threshold_uncertainty_score":0.20099355},"labels":[],"label_agreement":null},{"id":"W2045254759","doi":"10.1182/blood-2011-06-364265","title":"Risk factors for acute GVHD and survival after hematopoietic cell transplantation","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":697,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; U.S. Department of Defense; National Heart, Lung, and Blood Institute; Blue Cross and Blue Shield Association; U.S. Public Health Service","keywords":"Medicine; Internal medicine; Cumulative incidence; Total body irradiation; Transplantation; Cohort; Hematopoietic stem cell transplantation; Confidence interval; Gastroenterology; Surgery; Cyclophosphamide; Chemotherapy","score_opus":0.019059324211983072,"score_gpt":0.24841358621536297,"score_spread":0.22935426200337988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045254759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98924965,0.00012877397,0.0062496867,0.000017917868,0.00013799818,0.00063156866,0.00015799676,0.000068885434,0.0033575012],"genre_scores_gemma":[0.9942639,0.00036470182,0.0049226754,0.000030453122,0.00003585972,0.00008007475,0.000080826685,0.00003514857,0.0001863524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990692,0.00003315628,0.00024596014,0.00026420807,0.00016508337,0.00022239452],"domain_scores_gemma":[0.99943835,0.00013664413,0.00006919691,0.000169071,0.000048416514,0.00013834813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012580393,0.00017074343,0.00026287205,0.000073228985,0.0000535867,0.000010804988,0.00004226232,0.0001141414,0.00019741971],"category_scores_gemma":[0.000009652736,0.0001445121,0.00008857,0.000068398265,0.000042026,0.000070660564,0.0000043028954,0.00009261114,0.000018035766],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009885854,0.0009718312,0.95827115,0.0021451272,0.000534509,0.0002606583,0.026151925,2.495927e-7,0.010061486,0.00021348166,0.000019569336,0.0003814165],"study_design_scores_gemma":[0.006707677,0.0004515293,0.68167543,0.00007114098,0.004742031,0.00019054083,0.00052374956,0.000008823858,0.3050695,0.0002804049,0.000034474913,0.00024464895],"about_ca_topic_score_codex":0.000039168717,"about_ca_topic_score_gemma":0.000010907603,"teacher_disagreement_score":0.29500803,"about_ca_system_score_codex":0.0000068060576,"about_ca_system_score_gemma":0.000026730158,"threshold_uncertainty_score":0.58930326},"labels":[],"label_agreement":null},{"id":"W2045271912","doi":"10.1182/blood-2014-01-548651","title":"UBAP2L is a novel BMI1-interacting protein essential for hematopoietic stem cell activity","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; Université Laval; Hôpital de l'Enfant-Jésus; Centre hospitalier universitaire de Québec; Institute for Research in Immunology and Cancer","funders":"Canadian Institutes of Health Research","keywords":"BMI1; Haematopoiesis; Stem cell; Progenitor cell; Biology; Gene knockdown; Cell biology; Polycomb-group proteins; Hematopoietic stem cell; Cancer research; Cell culture; Genetics; Gene; Repressor; Gene expression","score_opus":0.010926198968353597,"score_gpt":0.24944050048068891,"score_spread":0.23851430151233532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045271912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92678267,0.00015785245,0.071885034,0.00007703866,0.000101107624,0.00034674452,0.00001981459,0.0000116099045,0.0006181421],"genre_scores_gemma":[0.99633163,0.000007630893,0.0023826375,0.00003602784,0.00033318417,0.000069595226,0.000025017915,0.000028079905,0.0007861923],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991817,0.000032707183,0.00015452976,0.0003245303,0.00009783203,0.00020873903],"domain_scores_gemma":[0.9994339,0.000026558197,0.00012788095,0.00027925798,0.00007242986,0.000059982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001998443,0.00013285459,0.00012774207,0.000023661332,0.000086983346,0.000038044927,0.00011298241,0.00012611528,0.0000066276816],"category_scores_gemma":[0.00003704916,0.00013359732,0.00010943157,0.000037705093,0.00001843999,0.000003783307,0.00006490451,0.00006212314,0.0000061536384],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032023072,0.00028404265,0.00020388652,0.000075484095,0.000024394278,1.4596455e-7,0.000075983226,0.000008163795,0.99750924,0.000026672402,0.000029450095,0.0017305153],"study_design_scores_gemma":[0.0012600747,0.00025213062,0.00016037126,0.00001809375,0.000039699855,0.0000016526633,0.000020987833,0.00035446868,0.9909127,0.00006478751,0.0067470763,0.00016796238],"about_ca_topic_score_codex":0.0000117604195,"about_ca_topic_score_gemma":0.000009066124,"teacher_disagreement_score":0.06954898,"about_ca_system_score_codex":0.0000041733965,"about_ca_system_score_gemma":0.000030999207,"threshold_uncertainty_score":0.5447941},"labels":[],"label_agreement":null},{"id":"W2045308986","doi":"10.1182/blood-2011-01-328682","title":"Irgm1 protects hematopoietic stem cells by negative regulation of IFN signaling","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; National Institute of General Medical Sciences; Dan L. Duncan Cancer Center, Baylor College of Medicine; National Cancer Institute; National Institutes of Health; National Institute of Biomedical Imaging and Bioengineering; York University; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute","keywords":"Cell biology; Autophagy; Biology; Haematopoiesis; Signal transduction; Stem cell; Knockout mouse; Biochemistry; Receptor; Apoptosis","score_opus":0.01603118587299542,"score_gpt":0.20108991531438047,"score_spread":0.18505872944138504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045308986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924341,0.0029121968,0.00029056633,0.000011078218,0.00040221232,0.00047306917,0.000017018383,0.000056475485,0.0034032972],"genre_scores_gemma":[0.9968906,0.000013670806,0.00038232972,0.000021671123,0.00001084834,0.0000363879,0.00000801136,0.000019093284,0.0026173613],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99913925,0.00013138796,0.0002775499,0.00020332329,0.00003358558,0.00021491063],"domain_scores_gemma":[0.9993681,0.00006991151,0.0002141748,0.00026404153,0.00007365501,0.000010167098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001527091,0.00012877343,0.00021945992,0.00004705272,0.000066318215,0.000003148048,0.0001692208,0.0001955864,0.0007929035],"category_scores_gemma":[0.000009953556,0.00012098933,0.00006087649,0.00010066373,0.00015788159,0.000058040434,0.00005111667,0.00016570359,0.00020165837],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005396608,0.00024160431,0.00011239888,0.00005942354,0.00013126011,9.816813e-7,0.0027546796,0.0000019385054,0.99536616,0.0001479256,0.00068237795,0.00044726217],"study_design_scores_gemma":[0.0013513323,0.0001672774,0.00020532306,0.00007560094,0.000066403896,0.000012492722,0.00029511793,6.156036e-7,0.99671394,0.00043660248,0.00054619287,0.00012912255],"about_ca_topic_score_codex":0.00006329536,"about_ca_topic_score_gemma":0.0000016621357,"teacher_disagreement_score":0.00445654,"about_ca_system_score_codex":0.000014893772,"about_ca_system_score_gemma":0.00003648805,"threshold_uncertainty_score":0.8681737},"labels":[],"label_agreement":null},{"id":"W2045378618","doi":"10.1182/blood-2007-10-119974","title":"Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":624,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Medicine; Lymphoma; Immunology; Hodgkin lymphoma; Oncology; Internal medicine","score_opus":0.0065473991619259715,"score_gpt":0.2263341170731123,"score_spread":0.2197867179111863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045378618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996012,0.0024630183,0.000037625934,0.00024763003,0.000044259796,0.00030739966,0.000023270646,0.000030931682,0.0008338696],"genre_scores_gemma":[0.99753535,0.0017685436,0.0003246761,0.00008762526,0.000020755007,0.00004922825,0.000018448376,0.000015278876,0.00018010494],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989161,0.000072713454,0.0003646591,0.0002600839,0.00021209,0.00017436598],"domain_scores_gemma":[0.998998,0.00016263704,0.00023194721,0.0004686661,0.000057570574,0.00008120587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016920682,0.00017830117,0.0004983523,0.00014601927,0.00013207652,0.000010700825,0.000091413676,0.00006919276,0.000039351766],"category_scores_gemma":[0.000084485524,0.000107206695,0.0002468904,0.00046825194,0.0002615175,0.000037131947,0.000048600752,0.0000456995,0.000010688939],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012608223,0.0017678624,0.98411757,0.000020672342,0.007545515,0.000057970774,0.0017274152,0.000011112763,0.00027908987,0.000057366582,0.000054105963,0.00423521],"study_design_scores_gemma":[0.008457598,0.00043148262,0.9736021,0.00003900586,0.012186746,0.00010797018,0.00037831205,0.0006003533,0.003952484,0.00003576493,0.00009898691,0.00010920821],"about_ca_topic_score_codex":0.0022280924,"about_ca_topic_score_gemma":0.00033909339,"teacher_disagreement_score":0.010515509,"about_ca_system_score_codex":0.000030926924,"about_ca_system_score_gemma":0.00012604984,"threshold_uncertainty_score":0.4371762},"labels":[],"label_agreement":null},{"id":"W2045459197","doi":"10.1182/blood-2007-01-067785","title":"Relapse in children with acute lymphoblastic leukemia involving selection of a preexisting drug-resistant subclone","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Medical Research Council; University of New South Wales; Cancer Council NSW; National Health and Medical Research Council; Anthony Rothe Memorial Trust","keywords":"clone (Java method); Acute lymphocytic leukemia; Somatic evolution in cancer; Drug resistance; Chemotherapy; Polymerase chain reaction; Immunology; Biology; Oncology; Leukemia; Internal medicine; Gene; Medicine; Lymphoblastic Leukemia; Genetics","score_opus":0.008057760214449221,"score_gpt":0.24765457592073717,"score_spread":0.23959681570628794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045459197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99694395,0.00022280605,0.0007786356,0.000031699663,0.00002414259,0.00066792965,0.000008565843,0.00009231057,0.0012299668],"genre_scores_gemma":[0.9938949,0.000036776994,0.005376102,0.000042380503,0.00013894176,0.00002209208,0.000027682545,0.00006408202,0.0003970933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974643,0.000057862584,0.00058891374,0.00045732694,0.0007473453,0.00068424415],"domain_scores_gemma":[0.99871385,0.00029192638,0.00020879494,0.00034057908,0.00021823296,0.00022661607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079564366,0.00025309532,0.00047193674,0.0004927675,0.00008211018,0.000017436167,0.00016930637,0.00015016526,0.000027684473],"category_scores_gemma":[0.0003910604,0.00021199734,0.00007114949,0.0012008334,0.0001609846,0.00012254064,0.00009359651,0.00037405087,0.000012328669],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033253925,0.0008464991,0.80992067,0.00022863163,0.0007954457,0.00066840975,0.0006340342,0.000061679966,0.18258096,0.00022766393,0.00011796537,0.00059266103],"study_design_scores_gemma":[0.025523994,0.001730494,0.7817628,0.0010834036,0.000903039,0.002786385,0.00024679495,0.0015265794,0.1839705,0.000060929564,0.000014532646,0.0003905597],"about_ca_topic_score_codex":0.001377464,"about_ca_topic_score_gemma":0.0007289798,"teacher_disagreement_score":0.028157862,"about_ca_system_score_codex":0.0013061741,"about_ca_system_score_gemma":0.0015177921,"threshold_uncertainty_score":0.86450005},"labels":[],"label_agreement":null},{"id":"W2045574294","doi":"10.1182/blood-2013-12-543223","title":"Factor XIII-A transglutaminase acts as a switch between preadipocyte proliferation and differentiation","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Blood properties and coagulation","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research; McGill University","keywords":"Tissue transglutaminase; Factor XIII; Cell biology; Internal medicine; Cancer research; Biology; Chemistry; Medicine; Biochemistry; Enzyme","score_opus":0.016705910590768102,"score_gpt":0.23796032913854023,"score_spread":0.22125441854777214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045574294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966531,0.00014602856,0.0009542769,0.00057161035,0.000034164455,0.00044334,0.0000049020514,0.0000698838,0.0011227241],"genre_scores_gemma":[0.9987481,0.000020898942,0.0001724039,0.00013508213,0.00030833358,0.000025637079,0.00006746576,0.000018768542,0.00050326734],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99923795,0.000043197095,0.00018047962,0.00020578635,0.00018456306,0.00014800398],"domain_scores_gemma":[0.9995893,0.000028180784,0.00005516958,0.00015698353,0.000053984484,0.000116346804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007641771,0.00012144948,0.00019885771,0.000052075065,0.00007988257,0.00003999708,0.000029324385,0.000102363054,0.000038728547],"category_scores_gemma":[0.00005409556,0.00009575968,0.000037366113,0.00006151576,0.000017933326,0.00012239025,0.0000110442315,0.00009600884,0.00001931365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030708624,0.0007981379,0.7228567,0.0005121769,0.00035953685,0.000004857145,0.0022205422,0.0000021287908,0.12600763,0.0006861287,0.00003391127,0.14621118],"study_design_scores_gemma":[0.003941295,0.00078134896,0.8329162,0.00008675693,0.00060789427,0.0000234718,0.000020506171,0.0005509477,0.15972362,0.0001608527,0.001039432,0.00014764632],"about_ca_topic_score_codex":0.00001665171,"about_ca_topic_score_gemma":0.000010202804,"teacher_disagreement_score":0.14606354,"about_ca_system_score_codex":0.000009244154,"about_ca_system_score_gemma":0.00002656225,"threshold_uncertainty_score":0.39049664},"labels":[],"label_agreement":null},{"id":"W2045785524","doi":"10.1182/blood-2014-09-601443","title":"Auer rods in a patient with chronic myelomonocytic leukemia type 2","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Medical Imaging and Pathology Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Monocytosis; Leukocytosis; Medicine; Chronic myelomonocytic leukemia; White blood cell; Anemia; Thrombocytosis; Hemoglobin; Platelet; Pathology; Gastroenterology; Internal medicine; Bone marrow; Myelodysplastic syndromes","score_opus":0.012122729440061297,"score_gpt":0.25350850784053097,"score_spread":0.24138577840046968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045785524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98570955,0.0009841226,0.000061567705,0.00055433705,0.000084672814,0.00011757966,3.4382694e-7,0.000041958054,0.012445877],"genre_scores_gemma":[0.99788994,0.00004457827,0.0006929358,0.00072699797,0.000105062674,0.000014484199,0.0000040824925,0.000010906151,0.0005110236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993619,0.000036750393,0.00011777211,0.00016793932,0.00011876795,0.00019692733],"domain_scores_gemma":[0.9996365,0.000046658653,0.000026544934,0.0001840892,0.000031950818,0.000074278956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000117880656,0.00008713095,0.00020217574,0.000050826144,0.000026676085,0.000003030881,0.00003389907,0.00004643477,0.000036503745],"category_scores_gemma":[0.00016032717,0.000057816233,0.000017761324,0.00013011959,0.000100713565,0.000013355269,0.00002336498,0.00018401766,0.00007183355],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003868578,0.0013791135,0.8471372,0.00061366113,0.00045104654,0.0028971035,0.0041952278,0.000060111717,0.004267987,0.0004683407,0.0057634367,0.13237992],"study_design_scores_gemma":[0.04146283,0.015267363,0.8183669,0.0028992428,0.0015135194,0.0025727623,0.00045284518,0.0030093298,0.013887594,0.000481422,0.09903307,0.0010531109],"about_ca_topic_score_codex":0.000044673947,"about_ca_topic_score_gemma":0.000050395596,"teacher_disagreement_score":0.13132681,"about_ca_system_score_codex":0.000060134324,"about_ca_system_score_gemma":0.00014710268,"threshold_uncertainty_score":0.23576775},"labels":[],"label_agreement":null},{"id":"W2045886098","doi":"10.1182/blood-2011-07-360594","title":"Population pharmacokinetics of recombinant factor VIII: the relationships of pharmacokinetics to age and body weight","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":204,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Baxter Healthcare Corporation","keywords":"Pharmacokinetics; Medicine; Blood sampling; Population; Body weight; Coagulation; Internal medicine; Pharmacology","score_opus":0.08224362465762455,"score_gpt":0.32745763208254786,"score_spread":0.2452140074249233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045886098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970591,0.0002898491,0.000014457046,0.00041253585,0.000093651666,0.00050257845,0.000011391283,0.000012581307,0.0016038652],"genre_scores_gemma":[0.9978926,0.00034869305,0.0009503724,0.000024499532,0.000052289466,0.000010117829,0.000016333048,0.000013749018,0.0006912985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991921,0.000071772265,0.0002538897,0.00012429325,0.00021987825,0.00013802503],"domain_scores_gemma":[0.99946225,0.00008752143,0.000070015536,0.00018782617,0.00008631327,0.00010607993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015721029,0.00009097062,0.00018881734,0.00010364383,0.000052156705,0.000003232025,0.00006897327,0.000050992523,0.00014049251],"category_scores_gemma":[0.00007744122,0.00005578231,0.000044214026,0.00018710997,0.000060607355,0.000026092135,0.00004222838,0.00014594098,0.0000062883287],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002335333,0.0014860595,0.841578,0.00019095205,0.00027570536,0.000054738735,0.0024263347,4.8880605e-7,0.14924961,0.00042042145,0.00045931508,0.003624852],"study_design_scores_gemma":[0.002722975,0.00045705077,0.8142893,0.00006663014,0.00040174584,0.000016503747,0.000049690352,0.00007050724,0.18077852,0.00020654914,0.0008725407,0.00006802013],"about_ca_topic_score_codex":0.000052525775,"about_ca_topic_score_gemma":0.0000037879538,"teacher_disagreement_score":0.031528912,"about_ca_system_score_codex":0.000008564289,"about_ca_system_score_gemma":0.000020202044,"threshold_uncertainty_score":0.22747366},"labels":[],"label_agreement":null},{"id":"W2045959749","doi":"10.1182/blood-2013-05-501445","title":"Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":249,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Center for Advancing Translational Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Institutes of Health; Alexion Pharmaceuticals","keywords":"Thrombotic microangiopathy; Pathogenesis; Microangiopathic hemolytic anemia; Alternative complement pathway; Complement system; Immunology; Medicine; Atypical hemolytic uremic syndrome; Thrombotic thrombocytopenic purpura; Microangiopathy; Hematopoietic stem cell transplantation; Autoantibody; Transplantation; Pathology; Platelet; Immune system; Internal medicine; Diabetes mellitus; Disease; Antibody","score_opus":0.010774430970667192,"score_gpt":0.19979078762949065,"score_spread":0.18901635665882346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045959749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99686253,0.0013776479,0.0000061263313,0.000047155023,0.000039143033,0.0010811063,0.00022317331,0.000017985309,0.00034512434],"genre_scores_gemma":[0.999558,0.000014697022,0.0000071981763,0.000047493973,0.0000056349413,0.00015840043,0.00014494354,0.000011999704,0.0000516387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984818,0.00046706895,0.00044058848,0.00020219744,0.0000735775,0.00033473532],"domain_scores_gemma":[0.9993729,0.00014943253,0.0001829843,0.00024661378,0.000036420268,0.0000116323035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024621177,0.00017599874,0.00033662526,0.00010571395,0.00004879608,0.000012952144,0.00036118558,0.000053615324,0.00028212022],"category_scores_gemma":[0.000002309913,0.000118728494,0.000063568375,0.00014307338,0.00010657127,0.00006328815,0.000037332986,0.0001320706,0.000055603814],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002385757,0.0020926693,0.9658823,0.00007818044,0.00030944226,0.0000091550555,0.014140717,0.00001626452,0.016840704,0.00044622825,0.00012475853,0.00003570923],"study_design_scores_gemma":[0.0069912905,0.0003973023,0.91191196,0.00031997377,0.00012531047,0.00007536789,0.0077929148,0.0000020760365,0.0719855,0.00015179867,0.000013653051,0.00023282487],"about_ca_topic_score_codex":0.0017537625,"about_ca_topic_score_gemma":0.00054623437,"teacher_disagreement_score":0.055144798,"about_ca_system_score_codex":0.000024305064,"about_ca_system_score_gemma":0.000037052174,"threshold_uncertainty_score":0.48416075},"labels":[],"label_agreement":null},{"id":"W2045970616","doi":"10.1182/blood.v97.11.3552","title":"p53 abnormalities in splenic lymphoma with villous lymphocytes","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Pathology; Lymphoma; Immunocytochemistry; Splenic marginal zone lymphoma; Biology; BCL10; Chromosome abnormality; Medicine; Spleen; Immunology; Splenectomy; Chromosome; Karyotype; Gene","score_opus":0.00931315153146382,"score_gpt":0.22351798256583733,"score_spread":0.21420483103437352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045970616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9772869,0.002511241,0.0000014907156,0.0002947682,0.00003878676,0.00026752191,0.000006266284,0.00008135747,0.019511689],"genre_scores_gemma":[0.99718285,0.0007893058,0.00034211975,0.00044041712,0.00010166566,0.00010625219,0.000022547994,0.000024887162,0.0009899681],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893516,0.000021257492,0.00020870905,0.00025465226,0.00023438469,0.00034581436],"domain_scores_gemma":[0.99942815,0.000059986458,0.00004693402,0.00030033372,0.000039610764,0.00012495452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000649829,0.00018916695,0.00030817545,0.00011892608,0.000045892626,0.000023045932,0.00006368065,0.00006725626,0.00016414955],"category_scores_gemma":[0.000017084489,0.00013260407,0.00006982589,0.00023468636,0.00005563238,0.000078992285,0.0000252785,0.000027813092,0.00011073099],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027571747,0.0032203023,0.9821463,0.000040337385,0.00019202428,0.0038334017,0.00035948076,0.0000031335992,0.0000860502,0.00044367503,0.00012478119,0.009274799],"study_design_scores_gemma":[0.033255044,0.0010451161,0.9395159,0.0002663131,0.0003494707,0.004056939,0.00037849348,0.000017054514,0.011907164,0.000064153435,0.00889902,0.00024534625],"about_ca_topic_score_codex":0.00085580884,"about_ca_topic_score_gemma":0.0003098091,"teacher_disagreement_score":0.04263041,"about_ca_system_score_codex":0.00018701963,"about_ca_system_score_gemma":0.00021131244,"threshold_uncertainty_score":0.54074365},"labels":[],"label_agreement":null},{"id":"W2045981763","doi":"10.1182/blood-2008-03-143107","title":"Endoplasmic reticulum HSP90b1 (gp96, grp94) optimizes B-cell function via chaperoning integrin and TLR but not immunoglobulin","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Endoplasmic Reticulum Stress and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Institutes of Health; Leukemia and Lymphoma Society; University of Connecticut; York University","keywords":"Endoplasmic reticulum; Antibody; Cell biology; Integrin; Chemistry; Immunology; Biology; Cell; Biochemistry","score_opus":0.006110536427365303,"score_gpt":0.18727390312082767,"score_spread":0.18116336669346236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045981763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925701,0.0032428978,0.0009980041,0.00005410329,0.00019823815,0.00019681032,0.00003308081,0.00004101624,0.0026657528],"genre_scores_gemma":[0.9951721,0.0018788141,0.0012408642,0.00021679397,0.00022134994,0.00004213156,0.0001317638,0.000038217233,0.0010579956],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985492,0.000060604143,0.00028789192,0.0005465499,0.0001778755,0.00037783087],"domain_scores_gemma":[0.9992117,0.000022163455,0.000112065485,0.0003939838,0.000072869145,0.00018719763],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000090372036,0.00028301813,0.00023032639,0.00005099174,0.00021575748,0.000034237808,0.00016187986,0.0001938109,0.00005216666],"category_scores_gemma":[0.00006726554,0.0002642735,0.00012910883,0.00006886659,0.00018337338,0.000010410479,0.00016744938,0.00017304077,0.000032228756],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000387376,0.0005104091,0.009780885,0.000057257846,0.00011511353,0.00008811807,0.00009748427,0.00011957466,0.9877832,0.000051428167,0.00036343717,0.0006457404],"study_design_scores_gemma":[0.004767746,0.0006111369,0.005858605,0.000034573703,0.00017324182,0.00040153295,0.00017934023,0.00028863028,0.9850015,0.000025225916,0.002196998,0.00046143605],"about_ca_topic_score_codex":0.00007315235,"about_ca_topic_score_gemma":0.00000884922,"teacher_disagreement_score":0.0043803705,"about_ca_system_score_codex":0.0000080983755,"about_ca_system_score_gemma":0.00006858483,"threshold_uncertainty_score":0.9999809},"labels":[],"label_agreement":null},{"id":"W2046041311","doi":"10.1182/blood-2010-05-287649","title":"SMAD3 prevents graft-versus-host disease by restraining Th1 differentiation and granulocyte-mediated tissue damage","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; Centre Hospitalier de l’Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Canadian Institutes of Health Research","keywords":"Graft-versus-host disease; Immunology; Granulocyte; Medicine; Biology; Disease; Pathology","score_opus":0.019057393870816737,"score_gpt":0.31570202108806106,"score_spread":0.2966446272172443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046041311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966415,0.00022743862,0.000053975356,0.0005592592,0.00014675994,0.00047214905,0.00006591971,0.000062330684,0.0017706278],"genre_scores_gemma":[0.99750525,0.0001491227,0.00033145968,0.00007163519,0.0001577253,0.00004823613,0.00034630182,0.000021665674,0.0013686283],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988485,0.00006876801,0.00020338628,0.00028093284,0.00029249763,0.00030593906],"domain_scores_gemma":[0.99895334,0.00021004419,0.00006189298,0.00028469088,0.00005353307,0.0004364863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022153313,0.0001440639,0.00028503375,0.00007860205,0.00011970405,0.00002510408,0.000087635184,0.00013379293,0.00030690062],"category_scores_gemma":[0.0005983607,0.00012205276,0.000033871154,0.00011012351,0.00016600588,0.00007675034,0.000057780824,0.00036314066,0.0000453113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007628494,0.0011107698,0.8486048,0.00014355242,0.00021412357,0.00012098386,0.0003500272,3.854146e-8,0.14625615,0.00010743861,0.0012479738,0.0010812982],"study_design_scores_gemma":[0.014156932,0.00056900334,0.9783806,0.00007641084,0.00082735776,0.000015748852,0.00007800137,0.0004859982,0.0033493296,0.000115174786,0.0017661484,0.0001793026],"about_ca_topic_score_codex":0.00005266593,"about_ca_topic_score_gemma":0.00003750044,"teacher_disagreement_score":0.14290683,"about_ca_system_score_codex":0.000012231143,"about_ca_system_score_gemma":0.00012385538,"threshold_uncertainty_score":0.4977167},"labels":[],"label_agreement":null},{"id":"W2046635524","doi":"10.1182/blood-2008-12-193037","title":"The BCL6 transcriptional program features repression of multiple oncogenes in primary B cells and is deregulated in DLBCL","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":233,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"BCL6; Germinal center; Biology; Psychological repression; Transcription factor; B cell; Cancer research; Repressor; Gene; Molecular biology; Genetics; Gene expression","score_opus":0.008876522422026474,"score_gpt":0.24955896153853388,"score_spread":0.2406824391165074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046635524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934574,0.0047130114,1.7395053e-7,0.00093004457,0.000018202061,0.0004812816,0.0000063839534,0.000014224845,0.00037932026],"genre_scores_gemma":[0.9984941,0.0006118154,0.0005682841,0.00019403506,0.000021037515,0.000036990314,0.0000168388,0.000004699969,0.000052192034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994037,0.000020658546,0.00017112843,0.00015443265,0.00013162478,0.000118436124],"domain_scores_gemma":[0.99972516,0.000053329517,0.000037219987,0.00013272802,0.000019634781,0.000031915315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007119992,0.00008141805,0.00016124627,0.000047249625,0.000027043692,0.000008769353,0.000031995165,0.00006414819,0.0000032626542],"category_scores_gemma":[0.000010651927,0.000049082628,0.000041773696,0.00010058809,0.000034458753,0.000025952007,0.000007681503,0.00004577263,5.442937e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043084563,0.011056049,0.65444684,0.000065580934,0.000068547146,0.00010341774,0.00073479395,0.000005397205,0.12503283,0.00007653861,0.0002604893,0.20771869],"study_design_scores_gemma":[0.008108714,0.00025403217,0.8706704,0.0001517851,0.00004995117,0.000021652244,0.00003005867,0.000028168512,0.1200546,0.00006889523,0.0005198598,0.00004188385],"about_ca_topic_score_codex":0.00010756866,"about_ca_topic_score_gemma":0.00007391954,"teacher_disagreement_score":0.21622357,"about_ca_system_score_codex":0.000022873612,"about_ca_system_score_gemma":0.00003855893,"threshold_uncertainty_score":0.20015316},"labels":[],"label_agreement":null},{"id":"W2046668932","doi":"10.1182/blood-2012-04-424226","title":"Human basophils interact with memory T cells to augment Th17 responses","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"IL-33, ST2, and ILC Pathways","field":"Immunology and Microbiology","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Immunology; Cytokine; Basophil; Population; Histamine; Biology; Immunoglobulin E; Medicine; Antibody; Endocrinology","score_opus":0.017486576898704417,"score_gpt":0.24312435386617454,"score_spread":0.22563777696747012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046668932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868891,0.0006121238,0.000020960819,0.000084246,0.00064173853,0.00025960448,0.00031223852,0.000084742765,0.011095194],"genre_scores_gemma":[0.9893059,0.000009788521,0.00015992775,0.0005103053,0.00016276856,0.00003364723,0.000036583704,0.000023394443,0.00975766],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99884874,0.00017632602,0.00019134689,0.00023080899,0.000040144365,0.000512645],"domain_scores_gemma":[0.99937487,0.0000749553,0.00006718825,0.0003754492,0.000044766035,0.00006279336],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025428567,0.00019285848,0.00022961665,0.00010637891,0.00021009,0.000014113801,0.0002021257,0.00013245743,0.00050642155],"category_scores_gemma":[0.00003442823,0.00014766883,0.0000562216,0.00009283465,0.00007987498,0.00011304002,0.00009340139,0.00020461135,0.0021702503],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022350611,0.0007915151,0.0017753434,0.00001783325,0.00019816123,0.000013108311,0.0023910217,7.2531884e-7,0.9860974,0.0002481969,0.007909774,0.00033343944],"study_design_scores_gemma":[0.0016959866,0.0006571303,0.009580146,0.000051054,0.00010095519,0.00009149213,0.00035155631,1.6230194e-8,0.8655111,0.000015407195,0.12170795,0.00023715814],"about_ca_topic_score_codex":0.000050607974,"about_ca_topic_score_gemma":0.000025749865,"teacher_disagreement_score":0.12058623,"about_ca_system_score_codex":0.00002112192,"about_ca_system_score_gemma":0.000047162823,"threshold_uncertainty_score":0.9986067},"labels":[],"label_agreement":null},{"id":"W2047068621","doi":"10.1182/blood-2010-03-275966","title":"Multicenter survey on the outcome of transplantation of hematopoietic cells in patients with the complete form of DiGeorge anomaly","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Transplantation: Methods and Outcomes","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Children's Hospital; Centre Hospitalier Universitaire Sainte-Justine","funders":"National Cancer Institute","keywords":"Medicine; Transplantation; Hematopoietic stem cell transplantation; Sibling; Human leukocyte antigen; Gastroenterology; Cord blood; Surgery; DiGeorge syndrome; Internal medicine; Immunology; Graft-versus-host disease; Retrospective cohort study; Bone marrow; Antigen","score_opus":0.022305214434715396,"score_gpt":0.2674869144489646,"score_spread":0.24518170001424922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047068621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998871,0.000004217231,0.00014609916,0.00012704878,0.000050893934,0.00045518694,0.00023189369,0.0000035995804,0.00011001545],"genre_scores_gemma":[0.99884844,0.0000049716364,0.0009962972,0.00007054623,0.0000055409846,0.000004950886,0.000045029512,0.000009494705,0.00001475539],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914104,0.000092300084,0.00034137085,0.00009088145,0.00023563899,0.00009877482],"domain_scores_gemma":[0.9988444,0.00064643804,0.00017001417,0.00022671866,0.00009138727,0.000021076117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044016232,0.00008879249,0.00027245953,0.000051962284,0.00001844758,0.0000021357148,0.00009579379,0.000038031514,0.000026194231],"category_scores_gemma":[0.000026906506,0.00004175275,0.00005766926,0.000118043296,0.00008995124,0.000026044085,0.0000040560453,0.00013288805,0.0000010118588],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005186865,0.00054375245,0.98646486,0.0002483999,0.00004549706,0.0000013385488,0.001640607,0.0000014478311,0.010324665,0.00015983962,0.0000016216469,0.000049294405],"study_design_scores_gemma":[0.0045780577,0.00025533928,0.9261303,0.00008517211,0.00015576652,0.0000011125765,0.000057325607,0.00000572329,0.06867627,0.000010529492,0.0000034413586,0.000040961575],"about_ca_topic_score_codex":0.00030338997,"about_ca_topic_score_gemma":0.0010441435,"teacher_disagreement_score":0.060334545,"about_ca_system_score_codex":0.0000022262793,"about_ca_system_score_gemma":0.0000134853935,"threshold_uncertainty_score":0.17026278},"labels":[],"label_agreement":null},{"id":"W2047187548","doi":"10.1182/blood-2007-04-087577","title":"Unique subset of natural killer cells develops from progenitors in lymph node","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Biology; Interleukin-7 receptor; Interleukin 21; Progenitor cell; CD8; T-cell receptor; Cell biology; Immunology; IL-2 receptor; Molecular biology; T cell; Stem cell; Antigen; Immune system","score_opus":0.009185146660915744,"score_gpt":0.20082068034569592,"score_spread":0.19163553368478017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047187548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937993,0.0010253644,0.000012274571,0.00002519721,0.0040610083,0.00009729665,0.0000029405041,0.000031437074,0.0009451367],"genre_scores_gemma":[0.9922598,0.000105426036,0.00019096528,0.00009298488,0.000022509028,0.000009915404,0.00015806592,0.000010077587,0.0071502584],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993135,0.00009857298,0.00025084766,0.00015465583,0.000022142818,0.00016027899],"domain_scores_gemma":[0.99965614,0.000054360004,0.00008292419,0.00014252376,0.000056016932,0.000008033045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000051221687,0.000104449195,0.00016947635,0.000094242016,0.00005317453,0.000002175279,0.000098275814,0.00016841659,0.0006986035],"category_scores_gemma":[0.000026908532,0.00009452792,0.00005693836,0.00011488433,0.0000722459,0.00006857869,0.000029022329,0.00018780572,0.00039859698],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012250408,0.00036797955,0.03570694,0.0000051137345,0.0001243312,0.0000092248,0.00065044843,0.0000020206962,0.9588172,0.000015674872,0.0040324405,0.00014613975],"study_design_scores_gemma":[0.001905168,0.000027211405,0.071276754,0.000021320198,0.000020009438,0.000052884257,0.00013645546,0.0000015052111,0.9135621,0.000006848679,0.012879749,0.00010995435],"about_ca_topic_score_codex":0.0003996413,"about_ca_topic_score_gemma":0.00001808926,"teacher_disagreement_score":0.045255035,"about_ca_system_score_codex":0.000022155773,"about_ca_system_score_gemma":0.00006304604,"threshold_uncertainty_score":0.76492184},"labels":[],"label_agreement":null},{"id":"W2047457389","doi":"10.1182/blood-2013-12-546218","title":"Rapamycin relieves lentiviral vector transduction resistance in human and mouse hematopoietic stem cells","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of General Medical Sciences; National Cancer Institute; National Heart, Lung, and Blood Institute; National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research","keywords":"Transduction (biophysics); Stem cell; Viral vector; Haematopoiesis; Biology; Hematopoietic stem cell; Gene delivery; Genetic enhancement; Cancer research; Cell biology; Gene; Genetics","score_opus":0.01072544915765371,"score_gpt":0.24731066890489942,"score_spread":0.2365852197472457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047457389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980806,0.0012567242,0.000059419515,0.000090904345,0.000029267228,0.00016365644,0.0000061857295,0.000012972149,0.0003002687],"genre_scores_gemma":[0.9977114,0.00016932577,0.00009172927,0.000039677223,0.000097075994,0.000021874996,0.0000119867345,0.00002507856,0.0018318517],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990269,0.00014902491,0.00015835544,0.00032442683,0.00011956343,0.00022171081],"domain_scores_gemma":[0.99958456,0.000008475133,0.000034670527,0.00029586093,0.000023376015,0.000053053667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028020237,0.00011792304,0.00012772474,0.000051140563,0.00006254147,0.000023065099,0.00011759006,0.00009902187,0.000010151676],"category_scores_gemma":[0.000005411521,0.000120808116,0.00004025708,0.00007205598,0.00007420257,0.000003972756,0.000026387712,0.0000960591,0.0000048623538],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024673072,0.00015118452,0.00046930698,0.000044967797,0.000018275532,0.0000017059305,0.00013408758,0.000004032505,0.998524,0.000059785147,0.00011074948,0.00023515841],"study_design_scores_gemma":[0.0016337137,0.00071430445,0.0004782261,0.00001600644,0.000009795469,0.0000023758312,0.000037152397,0.0000027930944,0.9956634,0.000093144445,0.0012105589,0.00013851763],"about_ca_topic_score_codex":0.000007979688,"about_ca_topic_score_gemma":0.00053457095,"teacher_disagreement_score":0.0028606039,"about_ca_system_score_codex":0.000006444674,"about_ca_system_score_gemma":0.000019264078,"threshold_uncertainty_score":0.49264118},"labels":[],"label_agreement":null},{"id":"W2047760441","doi":"10.1182/blood-2013-05-500272","title":"Loss of Asxl1 leads to myelodysplastic syndrome–like disease in mice","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":178,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Center for Research Resources; National Institute of General Medical Sciences; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Medicine; Internal medicine; Cancer research; Biology","score_opus":0.00705108447157499,"score_gpt":0.21142802126216756,"score_spread":0.20437693679059257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047760441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977893,0.0013619001,0.000027092638,0.00015902752,0.00020781005,0.00025228117,0.000012946401,0.00001923748,0.00017039508],"genre_scores_gemma":[0.99886626,0.000015953137,0.00004029423,0.000067009125,0.000007052341,0.000041774696,0.000036454905,0.00001037824,0.00091480254],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9992517,0.00006820756,0.00025060965,0.0001775123,0.000027141612,0.00022481865],"domain_scores_gemma":[0.9996128,0.00006021558,0.00006072416,0.00019333881,0.000041520005,0.000031383363],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00006937374,0.00010538483,0.00020682198,0.00012283775,0.0000318247,0.0000064218584,0.0001446751,0.000088462046,0.0003962532],"category_scores_gemma":[0.000054869455,0.00009621796,0.000050611026,0.00015850856,0.000062543295,0.00009763985,0.000060744864,0.00008992284,0.0010735719],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006161341,0.00069500634,0.10055023,0.000045867346,0.000068669644,0.000010562132,0.00016822798,0.000047390564,0.8970271,0.00019790819,0.0005473744,0.0005800672],"study_design_scores_gemma":[0.0016742258,0.00015634007,0.9164831,0.00008476469,0.000056514975,0.000035475325,0.000019610727,0.0000062811423,0.08057257,0.000099128585,0.00067161885,0.00014038416],"about_ca_topic_score_codex":0.00014382777,"about_ca_topic_score_gemma":0.000011798204,"teacher_disagreement_score":0.8164545,"about_ca_system_score_codex":0.000012645028,"about_ca_system_score_gemma":0.000033690612,"threshold_uncertainty_score":0.9997042},"labels":[],"label_agreement":null},{"id":"W2047861432","doi":"10.1182/blood-2012-02-414441","title":"TBL1XR1/TP63: a novel recurrent gene fusion in B-cell non-Hodgkin lymphoma","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Fusion gene; Follicular lymphoma; Diffuse large B-cell lymphoma; Lymphoma; Germinal center; Biology; Cancer research; Gene; Oncology; B cell; Immunology; Medicine; Genetics; Antibody","score_opus":0.017386372069822437,"score_gpt":0.2560405399172242,"score_spread":0.23865416784740176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047861432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98904383,0.00322193,0.000016710934,0.00022443,0.00031595663,0.00045587085,0.000015682173,0.00003909391,0.006666476],"genre_scores_gemma":[0.9964311,0.0003700412,0.0021612109,0.00029301582,0.00027676247,0.0001230181,0.000054287135,0.000028070777,0.00026247496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987025,0.000020057962,0.00028082632,0.0002665199,0.00026129704,0.000468759],"domain_scores_gemma":[0.9992383,0.00004730838,0.00007323602,0.00034736397,0.000034412187,0.00025936615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016615354,0.00020944164,0.0003160417,0.00012794085,0.000045637727,0.000012884536,0.000072062685,0.0001122677,0.00010177728],"category_scores_gemma":[0.000025144942,0.00016512471,0.000121652956,0.00021039974,0.000021456857,0.00007855122,0.000073122916,0.000056005178,0.00029483458],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023058684,0.05996751,0.8143149,0.0001397486,0.00015030486,0.00022042416,0.0012598996,0.0000010499263,0.07416499,0.000121222234,0.0016545806,0.04777478],"study_design_scores_gemma":[0.026149053,0.00052519765,0.8200236,0.000169527,0.0002981342,0.0001764858,0.00006722937,0.00003569426,0.1450252,0.0000064229926,0.007313384,0.0002100751],"about_ca_topic_score_codex":0.00020074312,"about_ca_topic_score_gemma":0.00002240412,"teacher_disagreement_score":0.07086021,"about_ca_system_score_codex":0.0001665407,"about_ca_system_score_gemma":0.00009404157,"threshold_uncertainty_score":0.67335904},"labels":[],"label_agreement":null},{"id":"W2047867934","doi":"10.1182/blood-2011-05-326538","title":"The molecular pathogenesis of primary mediastinal large B-cell lymphoma","year":2011,"lang":"en","type":"review","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":209,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"STAT protein; Biology; Lymphoma; Cancer research; Crosstalk; Transcription factor; Janus kinase; Germinal center; Tumor microenvironment; Epigenome; Pathogenesis; Immune system; stat; Gene expression profiling; Signal transduction; Gene; B cell; Cell biology; Gene expression; Immunology; STAT3; Genetics; Antibody; DNA methylation","score_opus":0.02589214070933102,"score_gpt":0.2648918936415143,"score_spread":0.23899975293218326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047867934","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007666785,0.9895564,0.000002692591,0.000009514739,0.00012523611,0.000839082,0.00012905773,0.000027994065,0.008543389],"genre_scores_gemma":[0.00024803996,0.9984435,0.0003055726,0.0000562931,0.000121959514,0.00031603887,0.00017540975,0.00006858355,0.00026463083],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982123,0.00012699123,0.000607347,0.0003625012,0.00032724024,0.00036363443],"domain_scores_gemma":[0.99832696,0.00023163168,0.00041685198,0.00077792857,0.000085618856,0.00016099059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023722649,0.00040874103,0.0015663072,0.00008481277,0.00007698376,0.00001129584,0.00024400471,0.00024040428,0.00003976601],"category_scores_gemma":[0.00005016145,0.00022345198,0.00088977476,0.00018815098,0.00006933116,0.000014484384,0.00013236712,0.00007274154,0.0001082952],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001443737,0.0076425667,0.00017731625,0.010753836,0.000916596,0.00069947593,0.00002848353,1.1118693e-9,0.000009829147,0.0004373999,0.00021316294,0.9791069],"study_design_scores_gemma":[0.005732966,0.0003062865,0.0008632073,0.004823632,0.012116811,0.00040987416,0.000006816804,5.2055963e-8,0.00033285082,0.000009813847,0.9751902,0.0002074939],"about_ca_topic_score_codex":0.000015935704,"about_ca_topic_score_gemma":0.0000017938632,"teacher_disagreement_score":0.9788994,"about_ca_system_score_codex":0.00009179474,"about_ca_system_score_gemma":0.0007847055,"threshold_uncertainty_score":0.9112107},"labels":[],"label_agreement":null},{"id":"W2047907548","doi":"10.1182/blood-2002-04-1244","title":"Oncogenic interaction between BCR-ABL andNUP98-HOXA9 demonstrated by the use of an in vitro purging culture system","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Cancer research; Myeloid leukemia; Bone marrow; Leukemia; Chronic myelogenous leukemia; ABL; Biology; Philadelphia chromosome; Immunology; Stem cell; K562 cells; breakpoint cluster region; Medicine; Tyrosine kinase; Chromosomal translocation; Cell biology; Signal transduction; Receptor; Genetics; Gene","score_opus":0.03926552683287885,"score_gpt":0.2641455768159855,"score_spread":0.22488004998310665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047907548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981631,0.0005873745,0.000013449632,0.00009697732,0.000054359098,0.0004668954,0.000049082875,0.00006791725,0.0005008203],"genre_scores_gemma":[0.998815,0.00004194094,0.00039148898,0.000036481124,0.00010275904,0.000021980175,0.00012956961,0.00002158442,0.00043920096],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988372,0.00012241495,0.00035128073,0.00024214231,0.0002196168,0.00022736443],"domain_scores_gemma":[0.9992543,0.00009157536,0.00015191869,0.00036004453,0.000047836864,0.00009431641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011005985,0.00016369585,0.00033152613,0.00007445389,0.000052844738,0.00002508155,0.00009436646,0.0001295992,0.000047071313],"category_scores_gemma":[0.00004847088,0.000112409565,0.000075158154,0.00027187367,0.000040889674,0.0002052131,0.000024310515,0.00028266176,0.000029934636],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055047416,0.0042174356,0.17576884,0.00066805445,0.0018664718,0.00048049996,0.0037928459,0.00006336395,0.7667993,0.000016462867,0.0050389837,0.040737286],"study_design_scores_gemma":[0.036195148,0.0012520875,0.024342554,0.0015878896,0.0030419969,0.001535102,0.0030265443,0.011789463,0.9053739,0.000005662733,0.011230992,0.00061868236],"about_ca_topic_score_codex":0.00042427873,"about_ca_topic_score_gemma":0.000022576944,"teacher_disagreement_score":0.15142629,"about_ca_system_score_codex":0.00040317822,"about_ca_system_score_gemma":0.00005174005,"threshold_uncertainty_score":0.4583929},"labels":[],"label_agreement":null},{"id":"W2048013322","doi":"10.1182/blood-2002-04-1032","title":"Tissue distribution of target antigen has a decisive influence on the outcome of adoptive cancer immunotherapy","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Immunotherapy; Adoptive immunotherapy; Immunology; Cancer; Medicine; Adoptive cell transfer; Cancer immunotherapy; Antigen; Immune system; Internal medicine; T cell","score_opus":0.027124184959901716,"score_gpt":0.26673978460227354,"score_spread":0.23961559964237183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048013322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97195345,0.026694952,0.00010682655,0.0004030451,0.00017106686,0.00031580662,0.0002109195,0.000028926392,0.000115005976],"genre_scores_gemma":[0.9971955,0.0020059252,0.000028440962,0.00015832722,0.000009868462,0.000040634946,0.000022051963,0.000019616562,0.00051964197],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99879825,0.00026447387,0.0004507154,0.00017692825,0.00006177201,0.00024784057],"domain_scores_gemma":[0.9986716,0.00042620802,0.00031548608,0.00042456744,0.00015472062,0.000007448513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000218964,0.00017777598,0.00035469592,0.00005806665,0.0001490561,0.000008598203,0.00035405974,0.00016699526,0.0008264824],"category_scores_gemma":[0.00016404002,0.00011982284,0.00012527482,0.00020338595,0.0005388993,0.00006979382,0.000034069177,0.00021398315,0.00007688467],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071019086,0.00081749546,0.018788848,0.000012424494,0.0007272437,0.000002392477,0.0016325654,0.0000292712,0.97057277,0.00074906426,0.00057452463,0.005383199],"study_design_scores_gemma":[0.0018255924,0.00052474387,0.09718451,0.00007408342,0.0000326808,0.000012298968,0.00012804734,8.1647966e-7,0.8741331,0.00007137066,0.02588455,0.00012818565],"about_ca_topic_score_codex":0.00028248943,"about_ca_topic_score_gemma":0.0000055197474,"teacher_disagreement_score":0.09643966,"about_ca_system_score_codex":0.000019319541,"about_ca_system_score_gemma":0.00003303042,"threshold_uncertainty_score":0.9049403},"labels":[],"label_agreement":null},{"id":"W2048290687","doi":"10.1182/blood-2013-11-536581","title":"Application of CIBMTR risk score to NIH chronic GVHD at individual centers","year":2014,"lang":"en","type":"letter","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Graft-versus-host disease; Transplantation; Cohort; Internal medicine; Framingham Risk Score; Cancer; Disease","score_opus":0.01731828428152377,"score_gpt":0.24817209180693398,"score_spread":0.2308538075254102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048290687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7140634,0.0015000992,0.01900534,0.2379803,0.0013116132,0.0098714195,0.0019570237,0.0005207022,0.013790053],"genre_scores_gemma":[0.6939034,0.00032905664,0.00325862,0.28083205,0.007396172,0.00061403273,0.011141391,0.00037541497,0.0021498736],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99791473,0.00008144736,0.00050136313,0.00049899716,0.0006628391,0.00034063906],"domain_scores_gemma":[0.9986176,0.0001338823,0.00034126683,0.000706726,0.00008649626,0.0001140224],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021841345,0.00028950948,0.0005642619,0.00022576052,0.000045178804,0.000009790525,0.0002275942,0.00057701074,0.00020328937],"category_scores_gemma":[0.000030565094,0.00027476912,0.00016168738,0.00017157635,0.000057441182,0.000019520927,0.000044107495,0.0006247852,0.00040224975],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012875673,0.00050842337,0.1514376,0.0116722435,0.0014401132,0.00028315486,0.0015846104,0.000016954496,0.012582904,0.00002509436,0.8130607,0.00725945],"study_design_scores_gemma":[0.012546548,0.0015325532,0.08459174,0.0022616931,0.008673838,0.00073922804,0.00003213193,0.000043899076,0.108164504,0.00004908707,0.78028035,0.0010844194],"about_ca_topic_score_codex":0.000082182014,"about_ca_topic_score_gemma":0.00001821945,"teacher_disagreement_score":0.0955816,"about_ca_system_score_codex":0.00012183472,"about_ca_system_score_gemma":0.000110025,"threshold_uncertainty_score":0.99997044},"labels":[],"label_agreement":null},{"id":"W2048354162","doi":"10.1182/blood-2009-10-249201","title":"Genomic instability after allogeneic hematopoietic cell transplantation is frequent in oral mucosa, particularly in patients with a history of chronic graft-versus-host disease, and rare in nasal mucosa","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Oral mucosa; Transplantation; Graft-versus-host disease; Hematopoietic stem cell transplantation; Gastroenterology; Mucous membrane of nose; Internal medicine; Pathology","score_opus":0.005329064222500986,"score_gpt":0.19748301797755632,"score_spread":0.19215395375505534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048354162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99693984,0.0021835438,0.0000014456809,0.00006578075,0.000076449345,0.0005936418,0.00004831043,0.000008991071,0.00008198461],"genre_scores_gemma":[0.9995854,0.000100577265,0.00003758056,0.00009434428,0.0000090040385,0.00008935352,0.000055059816,0.00001634247,0.000012371714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989099,0.000050205206,0.00030367915,0.00029425405,0.00019333226,0.00024863883],"domain_scores_gemma":[0.99956274,0.000017427015,0.000080644684,0.00019268764,0.00003527567,0.00011121408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011074902,0.00015357538,0.0002808618,0.00013214017,0.000009628802,0.0000048135,0.00004888486,0.00010027874,0.00007271567],"category_scores_gemma":[0.000013849956,0.00013952988,0.00004596846,0.00014014902,0.00010144274,0.00009646558,0.000012038922,0.00022254807,0.0000015771975],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020976611,0.0016046634,0.99090725,0.00038588577,0.000025318508,0.000060649883,0.0022773945,0.0000047488447,0.0025150047,0.0000034579382,0.000011858959,0.00010613216],"study_design_scores_gemma":[0.027357943,0.0004786693,0.97116846,0.00009894017,0.00017234663,7.1288014e-7,0.00009058993,0.00002263557,0.00040248956,0.000020465268,0.000037685164,0.00014903558],"about_ca_topic_score_codex":0.00077637896,"about_ca_topic_score_gemma":0.0143052,"teacher_disagreement_score":0.025260283,"about_ca_system_score_codex":0.00039115653,"about_ca_system_score_gemma":0.0004760511,"threshold_uncertainty_score":0.7982637},"labels":[],"label_agreement":null},{"id":"W2048368768","doi":"10.1182/blood-2008-03-146779","title":"Retention of Plasmodium falciparum ring-infected erythrocytes in the slow, open microcirculation of the human spleen","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Malaria Research and Control","field":"Medicine","cited_by":181,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Sanofi","keywords":"Spleen; Plasmodium falciparum; Red pulp; Microcirculation; Biology; Population; Ex vivo; In vivo; Malaria; Parasite hosting; Perfusion; Parasitemia; Circulatory system; Anatomy; Immunology; Pathology; Andrology; Medicine; Internal medicine; Endocrinology","score_opus":0.03848722843214081,"score_gpt":0.2913198948711828,"score_spread":0.252832666439042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048368768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943652,0.00007675755,0.000017055727,0.00091688836,0.000017064973,0.0008446682,0.000006290646,0.000006372935,0.0037496574],"genre_scores_gemma":[0.9996221,0.000011855336,0.000043856708,0.000042928834,0.00003602544,0.00002988386,0.000016403526,0.0000065317754,0.00019043585],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99908847,0.00012914646,0.00024189736,0.00011518339,0.00027727167,0.00014804762],"domain_scores_gemma":[0.9993978,0.000055851473,0.000112273774,0.0003177718,0.00009103327,0.000025241396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033840275,0.00006564666,0.00018848375,0.000059471484,0.00008372818,0.000008990203,0.00027558676,0.00005340927,0.000042402364],"category_scores_gemma":[0.00014088066,0.00003835179,0.00007977665,0.00022448337,0.00008067962,0.000058030575,0.00008328331,0.00014587965,0.0000025687536],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016897549,0.0009341594,0.39724243,0.00011023219,0.00012761267,0.000015490936,0.00080053497,0.000008458088,0.5980351,0.002133725,0.0002852143,0.00013808713],"study_design_scores_gemma":[0.0052579143,0.00019048816,0.9133018,0.00007978942,0.00007910893,0.000035947094,0.00007691449,0.0000852225,0.08057737,0.00018303988,0.0000934287,0.00003895676],"about_ca_topic_score_codex":0.00056915847,"about_ca_topic_score_gemma":0.0001440919,"teacher_disagreement_score":0.5174577,"about_ca_system_score_codex":0.000012985777,"about_ca_system_score_gemma":0.000087601555,"threshold_uncertainty_score":0.15639405},"labels":[],"label_agreement":null},{"id":"W2048483323","doi":"10.1182/blood-2014-12-615187","title":"Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":762,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Multiple myeloma; Medicine; Internal medicine; Lenalidomide; Oncology; Intensive care medicine","score_opus":0.03792475166351981,"score_gpt":0.317462271230351,"score_spread":0.27953751956683115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048483323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98605067,0.00011542181,0.000036976744,0.00012106064,0.00034627476,0.0004968883,0.000016692466,0.000062192004,0.01275381],"genre_scores_gemma":[0.9964403,0.000052837528,0.0023735364,0.000027564623,0.00031045504,0.000073932315,0.0003952033,0.000025377605,0.00030082263],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979644,0.00010027244,0.00037908836,0.00040416338,0.00080310967,0.00034896648],"domain_scores_gemma":[0.99897444,0.00006173993,0.00010866014,0.00029426577,0.00016411596,0.0003967764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004524403,0.00018039637,0.00028123386,0.00027321695,0.000050523573,0.00007758874,0.00011642988,0.00009044287,0.000032999546],"category_scores_gemma":[0.00026561425,0.0001565745,0.000041317624,0.00019414557,0.000055103188,0.00028173465,0.00010979975,0.00019239716,0.0000054272205],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022136803,0.0017533833,0.9733465,0.000022269001,0.0001555828,0.0017970767,0.00023427044,7.55944e-7,0.00011831304,0.00012295209,0.000037232658,0.022190304],"study_design_scores_gemma":[0.012557113,0.0014355645,0.9841553,0.00007934207,0.00005899885,0.00023292315,0.00032874855,0.00016593255,0.00013578935,0.00010509878,0.0006097093,0.00013546819],"about_ca_topic_score_codex":0.0001686924,"about_ca_topic_score_gemma":0.00014818786,"teacher_disagreement_score":0.022054838,"about_ca_system_score_codex":0.00014702149,"about_ca_system_score_gemma":0.00017248355,"threshold_uncertainty_score":0.6384923},"labels":[],"label_agreement":null},{"id":"W2048506561","doi":"10.1182/blood-2010-07-296749","title":"Inhibition of the Nef regulatory protein of HIV-1 by a single-domain antibody","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University","funders":"","keywords":"Single-domain antibody; Internalization; Biology; Antibody; In vivo; Pathogenesis; Peripheral blood mononuclear cell; Cell biology; In vitro; Virus; Virology; Viral replication; Cell; Immunology; Genetics","score_opus":0.013849036089777837,"score_gpt":0.21960426951561715,"score_spread":0.20575523342583932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048506561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995261,0.00082029833,0.000016984695,0.000038859518,0.000023345867,0.00030254223,0.00013965809,0.000010184638,0.0033871063],"genre_scores_gemma":[0.9989262,0.0000038717762,0.0000989712,0.0000059588015,0.0000037736156,0.000016657894,0.000078050274,0.0000058142864,0.0008606913],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994318,0.00013690429,0.00014712778,0.00010206821,0.000033235025,0.0001488811],"domain_scores_gemma":[0.9996257,0.000013211924,0.000086068525,0.0002296106,0.000034441804,0.00001097612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009961495,0.000064501575,0.00011850529,0.000030032743,0.00004432731,0.0000010365382,0.00008818715,0.000081799306,0.00022742196],"category_scores_gemma":[0.000020225803,0.000042121726,0.000060493978,0.00006857949,0.00023963834,0.000024152514,0.00004817927,0.00007745457,0.00009130927],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000590775,0.0014586851,0.006830211,0.000019869298,0.0001223218,0.0000023518803,0.00038446955,8.813939e-9,0.9899687,0.00035981016,0.0005670853,0.00022740726],"study_design_scores_gemma":[0.0018530162,0.0003385018,0.01199048,0.000051789,0.000025828154,0.000010339671,0.00007850703,1.3074794e-8,0.98459107,0.0002512073,0.0007705188,0.000038741437],"about_ca_topic_score_codex":0.000060010512,"about_ca_topic_score_gemma":0.0000070756655,"teacher_disagreement_score":0.005377645,"about_ca_system_score_codex":0.000006953593,"about_ca_system_score_gemma":0.000035292225,"threshold_uncertainty_score":0.2490111},"labels":[],"label_agreement":null},{"id":"W2048538774","doi":"10.1182/blood-2007-02-075382","title":"Hematopoietic stem-cell behavior in nonhuman primates","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Institute of Allergy and Infectious Diseases; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Baboon; Biology; Haematopoiesis; Stem cell; Rhesus macaque; Macaque; Transgene; In vivo; Hematopoietic stem cell; Immunology; Telomere; Cell biology; Genetics; Andrology; Molecular biology; Gene; Endocrinology; Neuroscience","score_opus":0.015271740937334544,"score_gpt":0.26571828990091984,"score_spread":0.2504465489635853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048538774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931745,0.0010354972,0.000019151203,0.000067494395,0.00008974368,0.0003581098,0.0000027068547,0.00009241704,0.0051603937],"genre_scores_gemma":[0.99772143,0.000048932656,0.0004995205,0.0001901839,0.00009004388,0.000016847665,0.0000094928855,0.000027145164,0.0013963905],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987638,0.00001422859,0.00033128323,0.0002570341,0.00024463385,0.0003890484],"domain_scores_gemma":[0.9993705,0.000052572756,0.000057931466,0.00032091868,0.000039585397,0.00015847025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024280851,0.00015151351,0.00027632382,0.00017916954,0.000042065756,0.000013650663,0.00010339989,0.00009920018,0.00012441368],"category_scores_gemma":[0.000010311862,0.00013683487,0.00006712859,0.00022874532,0.000055322882,0.00005100056,0.000031044663,0.00018723375,0.00013829261],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008156848,0.004271805,0.8260446,0.00040514304,0.00001769334,0.0017936751,0.0015804034,1.6573544e-7,0.16072522,0.00017370947,0.00016867557,0.004737321],"study_design_scores_gemma":[0.004676115,0.00034593206,0.604518,0.00014691448,0.00020905337,0.00032981113,0.0007551709,0.0000026450514,0.38771135,0.00002397769,0.0010018715,0.0002791443],"about_ca_topic_score_codex":0.00005815426,"about_ca_topic_score_gemma":0.00007792511,"teacher_disagreement_score":0.22698613,"about_ca_system_score_codex":0.000030059606,"about_ca_system_score_gemma":0.000051499726,"threshold_uncertainty_score":0.55799645},"labels":[],"label_agreement":null},{"id":"W2048859754","doi":"10.1182/blood-2007-12-128074","title":"Epigenomic repression by APL oncoprotein","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"National Institute of Biomedical Innovation","keywords":"Epigenomics; Epigenetics; Biology; Psychological repression; Transcription factor; Transcription (linguistics); Chromosomal translocation; Genetics; DNA methylation; Computational biology; Gene; Cancer research; Gene expression","score_opus":0.009207016254608446,"score_gpt":0.22469751497489196,"score_spread":0.2154904987202835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048859754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894301,0.006012617,0.0010851827,0.000036843823,0.00005770887,0.00011823103,0.000010782372,0.000012092294,0.0032364377],"genre_scores_gemma":[0.99555683,0.00086746324,0.0010480179,0.000044867444,0.00018166151,0.0000151737895,0.00011780778,0.000017498927,0.002150693],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99934584,0.000035334477,0.00013414155,0.00025541658,0.00008571588,0.00014353897],"domain_scores_gemma":[0.9995507,0.0000042536167,0.000054360906,0.00029964178,0.000030290494,0.000060776427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008720613,0.00008933212,0.00007800214,0.000015889862,0.00009622854,0.0000062827003,0.000098873905,0.00011450339,0.00002316442],"category_scores_gemma":[0.000039756527,0.00008564538,0.000049564074,0.000036793066,0.00003490988,0.0000013998215,0.000053568052,0.00004797515,0.000026453714],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010743949,0.00011343625,0.005204814,0.0000029994333,0.000014501783,0.0000033490135,0.000020917383,0.0000079489855,0.99251646,0.0000037326747,0.0009913285,0.0011097711],"study_design_scores_gemma":[0.00058810593,0.00014384574,0.0028270243,0.000003846792,0.000009032177,0.0000065110976,0.0000035622218,0.0000051805587,0.94277817,0.00007621311,0.053445224,0.00011330109],"about_ca_topic_score_codex":0.000024079363,"about_ca_topic_score_gemma":0.0000034235932,"teacher_disagreement_score":0.052453894,"about_ca_system_score_codex":0.0000038141802,"about_ca_system_score_gemma":0.000033607455,"threshold_uncertainty_score":0.3492517},"labels":[],"label_agreement":null},{"id":"W2049145862","doi":"10.1182/blood-2008-02-142687","title":"Cyproheptadine displays preclinical activity in myeloma and leukemia","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Cyproheptadine; Cancer research; Leukemia; Multiple myeloma; Pharmacology; Medicine; Biology; Internal medicine; Receptor; Serotonin","score_opus":0.024740195178153537,"score_gpt":0.2763561640633495,"score_spread":0.251615968885196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049145862","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99474835,0.0007511064,0.000055132496,0.0002444159,0.00006898374,0.0002993883,0.000006276295,0.00005309586,0.0037732348],"genre_scores_gemma":[0.9986653,0.00027652687,0.00042150024,0.00012512841,0.000117185315,0.000022748165,0.00000673704,0.00002258571,0.00034234024],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990944,0.000034065615,0.0001849466,0.00030019807,0.000167301,0.00021907661],"domain_scores_gemma":[0.9994588,0.000057289773,0.000043971762,0.00026766726,0.00002208726,0.00015017463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011215814,0.00012228574,0.00028542193,0.0000753357,0.000039374114,0.0000044500557,0.00004583274,0.00015607345,0.000039075567],"category_scores_gemma":[0.00017179489,0.000114714385,0.00006070136,0.00017092793,0.000109245346,0.000050166716,0.00005285641,0.00035373963,0.000022699947],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012871689,0.002777397,0.5681832,0.00025006203,0.0003044651,0.004744045,0.0009317734,0.000016277612,0.39776987,0.00018944388,0.0014868617,0.022059444],"study_design_scores_gemma":[0.008756548,0.0004805669,0.92195725,0.00012621692,0.00013700617,0.0011481132,0.0000072243574,0.00028615716,0.065443344,0.000035634654,0.0014509702,0.00017093997],"about_ca_topic_score_codex":0.000061754676,"about_ca_topic_score_gemma":0.00006641989,"teacher_disagreement_score":0.35377407,"about_ca_system_score_codex":0.00007696202,"about_ca_system_score_gemma":0.00021561277,"threshold_uncertainty_score":0.46779168},"labels":[],"label_agreement":null},{"id":"W2049339208","doi":"10.1182/blood-2011-02-335539","title":"Deletion of genes encoding PU.1 and Spi-B in B cells impairs differentiation and induces pre-B cell acute lymphoblastic leukemia","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children’s Health Research Institute; Western University","funders":"Canadian Institutes of Health Research","keywords":"B cell; Biology; Progenitor cell; Cellular differentiation; Stem cell; Transcription factor; Haematopoiesis; Cell biology; Immunology; Molecular biology; Cancer research; Genetics; Gene; Antibody","score_opus":0.015478692901287823,"score_gpt":0.2399369563702834,"score_spread":0.22445826346899558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049339208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99811727,0.00043317417,0.0002799354,0.000013616206,0.000049694245,0.0003696359,0.000009203984,0.000024845644,0.0007026257],"genre_scores_gemma":[0.9978846,0.00072835624,0.001176258,0.000020691354,0.00005039647,0.000021393496,0.000011257407,0.000023486027,0.00008361321],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987477,0.00005384975,0.00033233067,0.00030757659,0.0002729971,0.00028554045],"domain_scores_gemma":[0.9993589,0.00011568201,0.0001247155,0.00018571038,0.00007098923,0.00014400322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018558509,0.00016943377,0.00032278756,0.00026372256,0.000040069714,0.000014938872,0.00007933003,0.00015694082,0.000034335248],"category_scores_gemma":[0.000049595787,0.0001455962,0.00003524644,0.0001923123,0.00011657064,0.00012731025,0.00011155489,0.00012907088,0.000004172756],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031093584,0.00042359313,0.09585725,0.00048336518,0.00011279972,0.000079169076,0.0025288488,0.0000029783214,0.8980337,0.000045836936,0.000027570548,0.0020939943],"study_design_scores_gemma":[0.0070666536,0.00057045126,0.2548715,0.00017980844,0.00034694237,0.00010248352,0.000224336,0.0015846036,0.7347878,0.00011236693,0.00000550033,0.00014755974],"about_ca_topic_score_codex":0.00035898172,"about_ca_topic_score_gemma":0.000026042666,"teacher_disagreement_score":0.16324586,"about_ca_system_score_codex":0.00017975643,"about_ca_system_score_gemma":0.00026812835,"threshold_uncertainty_score":0.5937241},"labels":[],"label_agreement":null},{"id":"W2049358764","doi":"10.1182/blood-2003-09-3153","title":"T-cell protein tyrosine phosphatase deletion results in progressive systemic inflammatory disease","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":169,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Protein tyrosine phosphatase; Medicine; Disease; Tyrosine; Immunology; Biology; Internal medicine; Biochemistry","score_opus":0.004808296823119844,"score_gpt":0.2111763649478611,"score_spread":0.20636806812474126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049358764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9300471,0.067750216,0.000112715185,0.00014457625,0.000053048683,0.0013624675,0.00041725446,0.00004255031,0.00007005675],"genre_scores_gemma":[0.99700713,0.000116722884,0.00079088553,0.00007710786,0.00017097904,0.00049306295,0.001227637,0.000036850528,0.000079616744],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984675,0.00006226809,0.00039297648,0.00052917167,0.00019723663,0.00035084938],"domain_scores_gemma":[0.9989615,0.0000049355026,0.00019130505,0.00058002037,0.0000808784,0.0001813704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019783305,0.00023485516,0.00016088254,0.000061706356,0.000060138373,0.000033680648,0.0002417632,0.00012937853,0.0000039707816],"category_scores_gemma":[0.00025635865,0.00023472754,0.000067803965,0.0001476124,0.000080894875,0.000012352918,0.00013579265,0.000116785224,0.000036798338],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024502948,0.0025694408,0.004608335,0.00069813913,0.00006439685,0.0013174196,0.00006592648,0.00088329444,0.9827836,0.00302606,0.0008187942,0.0007143062],"study_design_scores_gemma":[0.007364853,0.00025850744,0.0016628784,0.00036904955,0.000033578704,0.00002799561,0.000014198455,0.0000034248308,0.9890252,0.00018302917,0.00076017994,0.00029710034],"about_ca_topic_score_codex":0.0000379295,"about_ca_topic_score_gemma":0.000013732792,"teacher_disagreement_score":0.06763349,"about_ca_system_score_codex":0.000035749108,"about_ca_system_score_gemma":0.0002723914,"threshold_uncertainty_score":0.9571911},"labels":[],"label_agreement":null},{"id":"W2049360002","doi":"10.1182/blood.v99.8.2845","title":"Flt3 ligand as a vaccine adjuvant in association with HER-2/neu peptide-based vaccines in patients with HER-2/neu–overexpressing cancers","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research & Development Corporation","funders":"National Center for Research Resources; National Cancer Institute","keywords":"HER2/neu; Adjuvant; Medicine; Ex vivo; Cancer vaccine; Immunology; Peptide vaccine; In vivo; Granulocyte macrophage colony-stimulating factor; Dendritic cell; Immune system; Spleen; Internal medicine; Antigen; Immunotherapy; Cancer research; Cancer; Cytokine; Biology; Epitope; Breast cancer","score_opus":0.004956351801242701,"score_gpt":0.19254823493294695,"score_spread":0.18759188313170425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049360002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99361634,0.0050316276,0.000005746299,0.00024720462,0.00014586546,0.00048389097,0.000019298854,0.000058357873,0.00039165793],"genre_scores_gemma":[0.9977896,0.0001450406,0.00005233342,0.0003161807,0.000020084797,0.000063643354,0.000058606227,0.00004748337,0.001506978],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981373,0.000309515,0.00043289253,0.0004100609,0.00011729577,0.0005929164],"domain_scores_gemma":[0.9989979,0.0002205346,0.00031187924,0.00034022843,0.00010656961,0.00002284822],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024511173,0.00033320926,0.00051262596,0.00026991527,0.00015097711,0.000042591244,0.00022246252,0.00028477158,0.0003745],"category_scores_gemma":[0.000101604266,0.00026022366,0.00006085625,0.00042431726,0.000036157006,0.0002444898,0.000031470314,0.0004379791,0.000078628815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040592137,0.001477672,0.9498277,0.000029014402,0.00028536472,0.000023998704,0.00095756847,0.00017699221,0.040876705,0.000003545358,0.00035778896,0.0019244603],"study_design_scores_gemma":[0.042019315,0.0018758463,0.8124309,0.0006787933,0.00010312365,0.000016755737,0.00019457073,0.000014426321,0.13916616,0.0000075660882,0.0029672612,0.0005252783],"about_ca_topic_score_codex":0.0011314712,"about_ca_topic_score_gemma":0.000847507,"teacher_disagreement_score":0.13739678,"about_ca_system_score_codex":0.0002522991,"about_ca_system_score_gemma":0.00013556799,"threshold_uncertainty_score":0.999985},"labels":[],"label_agreement":null},{"id":"W2049365670","doi":"10.1182/blood-2012-07-445304","title":"Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant","year":2012,"lang":"en","type":"review","venue":"Blood","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":538,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Monoclonal gammopathy of undetermined significance; Medicine; Multiple myeloma; Monoclonal; Kidney; Transplantation; Pathology; Monoclonal antibody; Immunology; Internal medicine; Antibody","score_opus":0.052020501317534475,"score_gpt":0.3117213085165097,"score_spread":0.2597008071989752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049365670","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015779423,0.9957074,0.000028491027,0.000019774692,0.00028737722,0.0010732475,0.0006152516,0.000026326728,0.00066419516],"genre_scores_gemma":[0.0022936272,0.9912363,0.0011387068,0.00013676402,0.00088726496,0.00048347178,0.00057609944,0.00015235666,0.0030953677],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99694645,0.00021631623,0.0009764951,0.0008934918,0.00034800803,0.00061920646],"domain_scores_gemma":[0.9974976,0.00009645715,0.0008458662,0.0011460438,0.00015722102,0.0002568202],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021386355,0.00081659784,0.0017350467,0.00014083735,0.00005975075,0.000031714124,0.0006360128,0.0007616471,0.0004302465],"category_scores_gemma":[0.00012238858,0.0005996182,0.0008969971,0.00016243276,0.00018241243,0.000007997641,0.0002769594,0.0002463268,0.00021543828],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057076284,0.009027179,0.0040044505,0.028221205,0.013434466,0.00044113115,0.00046744008,9.703754e-7,0.012956431,0.000055497236,0.02218302,0.90863746],"study_design_scores_gemma":[0.0014378424,0.0007579002,0.00008035423,0.0017691614,0.004832557,0.00010625728,0.000013304594,3.4219312e-7,0.018299695,0.0000063401826,0.97182983,0.0008664087],"about_ca_topic_score_codex":0.000031732136,"about_ca_topic_score_gemma":0.000016621287,"teacher_disagreement_score":0.94964683,"about_ca_system_score_codex":0.00005390315,"about_ca_system_score_gemma":0.00065823796,"threshold_uncertainty_score":0.99964553},"labels":[],"label_agreement":null},{"id":"W2049644695","doi":"10.1182/blood-2013-05-499970","title":"Interleukin-15 enhances cellular proliferation and upregulates CNS homing molecules in pre-B acute lymphoblastic leukemia","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Wellcome Trust; Kay Kendall Leukaemia Fund; Hospital for Sick Children; Leukaemia and Lymphoma Research; National Institute for Health and Care Research","keywords":"MAPK/ERK pathway; Biology; Kinase; Cancer research; STAT protein; Signal transduction; PI3K/AKT/mTOR pathway; Cell biology; Molecular biology; Immunology; STAT3","score_opus":0.004008740799854958,"score_gpt":0.19630069383085702,"score_spread":0.19229195303100205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049644695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99557066,0.00093145244,0.001695016,0.00004574017,0.00076835824,0.00015347652,9.44696e-7,0.000053651038,0.00078072003],"genre_scores_gemma":[0.9969488,0.0000836331,0.000073580064,0.00011077155,0.000039852795,0.000028795192,0.000059269445,0.000012910898,0.0026424262],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99915105,0.00013383804,0.00024400344,0.00024440163,0.000023571243,0.00020310571],"domain_scores_gemma":[0.99965316,0.000072262475,0.00008807039,0.00013901285,0.000033915952,0.0000135894115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013318777,0.00014173127,0.00018353529,0.000114163915,0.0000973343,0.000034881512,0.00007727401,0.00015390673,0.00017963277],"category_scores_gemma":[0.0000550996,0.0001299246,0.00003882643,0.0000653815,0.00006957038,0.00016304632,0.00004351037,0.00015438575,0.000119952],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012930497,0.0000944601,0.001416178,0.00001826505,0.00010978339,0.0000014842119,0.000796001,0.000018651906,0.9953726,0.00018683143,0.00023783559,0.0016185897],"study_design_scores_gemma":[0.0017161486,0.0002680104,0.007159793,0.00006359416,0.000078670775,0.000061471605,0.00010170834,0.00042927844,0.9863926,0.00009306275,0.0034828482,0.0001528225],"about_ca_topic_score_codex":0.0000610721,"about_ca_topic_score_gemma":0.00004334532,"teacher_disagreement_score":0.008980024,"about_ca_system_score_codex":0.000031462798,"about_ca_system_score_gemma":0.000027400638,"threshold_uncertainty_score":0.52981716},"labels":[],"label_agreement":null},{"id":"W2049766622","doi":"10.1182/blood-2014-07-587600","title":"FlnA binding to PACSIN2 F-BAR domain regulates membrane tubulation in megakaryocytes and platelets","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research","keywords":"Platelet; FLNA; Cell biology; Megakaryocyte; Biology; Chemistry; Cytoskeleton; Filamin; Cell; Immunology; Biochemistry; Haematopoiesis","score_opus":0.017826595199668914,"score_gpt":0.2536879364962414,"score_spread":0.23586134129657246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049766622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99622124,0.00071459584,0.0000037006755,0.00068125856,0.000045100853,0.00036897266,0.0000064285823,0.00004823669,0.0019104404],"genre_scores_gemma":[0.99783415,0.00004223015,0.0016734436,0.00010315277,0.0000367628,0.000015371506,0.000050390907,0.000019800953,0.00022470797],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991455,0.0000229603,0.00018172554,0.00023867797,0.00017880992,0.0002323292],"domain_scores_gemma":[0.9995435,0.000036114438,0.000033771114,0.0001445134,0.000029891033,0.00021224075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015976994,0.00013992478,0.0002848004,0.00018054766,0.000035974826,0.000022786613,0.000033453518,0.00008383389,0.000016236141],"category_scores_gemma":[0.00006954937,0.0001185972,0.000024935112,0.00020346134,0.000021575237,0.00009700806,0.000029193983,0.000072206654,0.000053049986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017625743,0.0043207477,0.79381025,0.00031973966,0.00084982417,0.00940632,0.010714292,0.00015831825,0.15954663,0.0008080001,0.0014923225,0.01681097],"study_design_scores_gemma":[0.09170826,0.0034813685,0.4727531,0.0012848215,0.00083663757,0.0036476466,0.0028656533,0.00066828454,0.40821594,0.006906995,0.0062091104,0.0014221899],"about_ca_topic_score_codex":0.000081344755,"about_ca_topic_score_gemma":0.000040339728,"teacher_disagreement_score":0.32105717,"about_ca_system_score_codex":0.00003600331,"about_ca_system_score_gemma":0.00003746886,"threshold_uncertainty_score":0.48362535},"labels":[],"label_agreement":null},{"id":"W2049794466","doi":"10.1182/blood-2005-12-4898","title":"Upfront double high-dose chemotherapy with DICEP followed by BEAM and autologous stem cell transplantation for poor-prognosis aggressive non-Hodgkin lymphoma","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre","funders":"","keywords":"Medicine; Etoposide; Internal medicine; Melphalan; Vincristine; CHOP; International Prognostic Index; Autologous stem-cell transplantation; Surgery; Aggressive lymphoma; Gastroenterology; Cyclophosphamide; Transplantation; Chemotherapy; Lymphoma; Oncology; Rituximab","score_opus":0.005191703411979636,"score_gpt":0.21289705561844569,"score_spread":0.20770535220646605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049794466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947894,0.0021966174,0.00017025515,0.0005934565,0.00005969784,0.0015746943,0.00013915742,0.00008713418,0.00038957337],"genre_scores_gemma":[0.99575025,0.00045042066,0.0018429459,0.00023829305,0.00008844968,0.0007198819,0.0003816017,0.000051194827,0.00047698503],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99874645,0.000013567292,0.0002537019,0.00043756838,0.00021883442,0.00032987713],"domain_scores_gemma":[0.9993556,0.00007956549,0.00020439016,0.0001712253,0.00006780376,0.00012140672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000056950666,0.0002855505,0.00042640086,0.000064358945,0.00012452253,0.00004218126,0.00005928953,0.00013408902,0.000012017456],"category_scores_gemma":[8.566914e-7,0.00020797401,0.00009504668,0.000099286386,0.000057223,0.00007676683,0.0000069009398,0.00003246204,0.0000052926794],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015985092,0.030122744,0.7236993,0.0016528537,0.0026706306,0.0021234213,0.002536536,0.00002913961,0.0864823,0.0002409021,0.02146698,0.1129901],"study_design_scores_gemma":[0.09561872,0.002541598,0.25123227,0.00021083452,0.0016152693,0.00021780963,0.00008523051,0.00003030498,0.6474345,0.000019931256,0.0006999334,0.00029361644],"about_ca_topic_score_codex":0.0008635758,"about_ca_topic_score_gemma":0.000088727415,"teacher_disagreement_score":0.5609522,"about_ca_system_score_codex":0.00007212744,"about_ca_system_score_gemma":0.00008474007,"threshold_uncertainty_score":0.8480934},"labels":[],"label_agreement":null},{"id":"W2049946512","doi":"10.1182/blood-2013-02-485839","title":"The lupus anticoagulant: results from 2257 patients attending a high-risk pregnancy clinic","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; Pacific Centre for Reproductive Medicine; Mount Sinai Hospital","funders":"","keywords":"Medicine; Miscarriage; Recurrent miscarriage; Lupus anticoagulant; Antiphospholipid syndrome; Pregnancy; Obstetrics; Gynecology; Internal medicine; Thrombosis; Biology","score_opus":0.021785159993375193,"score_gpt":0.2778936920670875,"score_spread":0.2561085320737123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049946512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99271196,0.0014431395,0.000007358244,0.00038442932,0.0010655615,0.0015300947,0.000107172535,0.000110025074,0.0026402755],"genre_scores_gemma":[0.9930917,0.00090581557,0.00029976864,0.000040798615,0.00041966725,0.0001247956,0.000095138865,0.00005358102,0.0049687163],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971388,0.00023292702,0.0007391579,0.00050680945,0.00077415473,0.00060816854],"domain_scores_gemma":[0.9967957,0.0012171466,0.00029969166,0.0011125173,0.0003367832,0.00023812687],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042119253,0.00021912705,0.00042186942,0.00008555658,0.00029611436,0.00010057375,0.00034147323,0.00015461189,0.00016309736],"category_scores_gemma":[0.0023275304,0.00013219261,0.00013747679,0.00022680064,0.00011157022,0.00011063111,0.00018051785,0.00039559216,0.0025894537],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012060699,0.0005218573,0.98260224,0.00008108767,0.00029795576,0.000036726502,0.0007884068,9.958199e-8,0.00033070942,0.000011587874,0.010461454,0.0047472655],"study_design_scores_gemma":[0.062580965,0.0013350316,0.91567713,0.007164826,0.00095442357,0.00076382497,0.0016104175,0.00026006543,0.00435428,0.0012862268,0.0033165726,0.0006962325],"about_ca_topic_score_codex":0.0015325886,"about_ca_topic_score_gemma":0.000045191377,"teacher_disagreement_score":0.06692511,"about_ca_system_score_codex":0.00005363126,"about_ca_system_score_gemma":0.00008183397,"threshold_uncertainty_score":0.9981871},"labels":[],"label_agreement":null},{"id":"W2050127987","doi":"10.1182/blood-2003-09-3192","title":"Engraftment of NOD/SCID-β2 microglobulin null mice with multilineage neoplastic cells from patients with myelodysplastic syndrome","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Nod; Cancer research; Myelodysplastic syndromes; Beta-2 microglobulin; Biology; Medicine; Immunology; Bone marrow; In vivo; Genetics","score_opus":0.005244723828822886,"score_gpt":0.20918674837958198,"score_spread":0.2039420245507591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050127987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972924,0.00013600512,0.0007269732,0.000102587386,0.00007373988,0.0011586364,0.00027882215,0.000076945704,0.00015386516],"genre_scores_gemma":[0.9782935,0.000017232394,0.02096403,0.00012456304,0.000070561604,0.000045578083,0.00021359966,0.00008761318,0.00018334],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99739313,0.000049816717,0.00045869072,0.00062566466,0.0008687744,0.000603899],"domain_scores_gemma":[0.9982111,0.0002927977,0.00020086356,0.0005923822,0.00032826595,0.00037463088],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010340284,0.0003962353,0.00065705593,0.00020029282,0.00007682343,0.00002345795,0.0002647559,0.00015613221,0.00013489832],"category_scores_gemma":[0.00009522981,0.00027916682,0.0000845751,0.00042860632,0.00024360696,0.00009549529,0.000107287924,0.00045376577,0.00022945488],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018983131,0.036232658,0.31698272,0.002335244,0.0069820005,0.011959986,0.0044999225,0.0034096332,0.5966024,0.000050824896,0.000609742,0.0013517379],"study_design_scores_gemma":[0.08240038,0.008625615,0.31750938,0.001628317,0.0020600967,0.00039969574,0.0002535389,0.00019157484,0.5859002,0.000017405644,0.00030296308,0.0007108558],"about_ca_topic_score_codex":0.00064063305,"about_ca_topic_score_gemma":0.00011691953,"teacher_disagreement_score":0.06341725,"about_ca_system_score_codex":0.00025779745,"about_ca_system_score_gemma":0.000633224,"threshold_uncertainty_score":0.999966},"labels":[],"label_agreement":null},{"id":"W2050186600","doi":"10.1182/blood.v97.10.3075","title":"Numerous growth factors, cytokines, and chemokines are secreted by human CD34+ cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":502,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Alberta","funders":"Canadian Blood Services; National Heart, Lung, and Blood Institute; University of Pennsylvania","keywords":"Autocrine signalling; Biology; Hematopoietic growth factor; Haematopoiesis; Paracrine signalling; Hepatocyte growth factor; Interleukin 3; Growth factor; Chemokine; Stem cell factor; Cell biology; Thrombopoietin; Cancer research; Molecular biology; Immunology; Cell culture; T cell; Stem cell; Inflammation; Antigen-presenting cell; Receptor; Immune system","score_opus":0.008216117868122598,"score_gpt":0.22743492871524426,"score_spread":0.21921881084712166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050186600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968011,0.0019274205,0.000003955018,0.00034538528,0.000036240166,0.0005069993,0.00009393774,0.00012507135,0.0001598991],"genre_scores_gemma":[0.9977948,0.0009564129,0.0001558425,0.00012736597,0.000058656417,0.000029307294,0.00031957403,0.00007194876,0.00048608764],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997934,0.000046888275,0.00043728665,0.00072109845,0.00027928766,0.00058145984],"domain_scores_gemma":[0.99905497,0.000039952403,0.00015809856,0.00031202286,0.00006142736,0.00037355692],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008719185,0.00052807253,0.0008082881,0.00022163575,0.00018833265,0.000091277405,0.000093325594,0.00018995228,0.000047013924],"category_scores_gemma":[0.000018732571,0.00045203237,0.000051830873,0.00028395408,0.00017636313,0.00036941082,0.00013928906,0.00022935071,0.00000260395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003455052,0.0018719386,0.9633347,0.0004359849,0.00036281435,0.0019767669,0.00058307534,0.00000142085,0.029809931,0.00006277449,0.0006769449,0.00053813664],"study_design_scores_gemma":[0.014671589,0.00095324067,0.9469505,0.00032653508,0.00044443904,0.0021954384,0.0004364102,0.00013904463,0.032327514,0.00023938077,0.0006250296,0.0006908567],"about_ca_topic_score_codex":0.00052486896,"about_ca_topic_score_gemma":0.00066671235,"teacher_disagreement_score":0.016384184,"about_ca_system_score_codex":0.000025366162,"about_ca_system_score_gemma":0.00002034608,"threshold_uncertainty_score":0.9997932},"labels":[],"label_agreement":null},{"id":"W2050195771","doi":"10.1182/blood-2015-01-622159","title":"Response: Hemolysis is a primary and physiologically relevant ATP release mechanism in human erythrocytes","year":2015,"lang":"en","type":"letter","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Hemolysis; Adenosine triphosphate; Red blood cell; Extracellular; Centrifugation; Chemistry; Biochemistry; Medicine; Immunology","score_opus":0.02396733628303079,"score_gpt":0.2584911049485326,"score_spread":0.23452376866550181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050195771","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7188122,0.0016628562,0.000012279641,0.27692497,0.00021912307,0.0008349933,0.00009967846,0.00023125362,0.0012026116],"genre_scores_gemma":[0.021148406,0.00077478256,0.0011748169,0.96199286,0.0023354974,0.00014282188,0.0011460794,0.00014194903,0.011142777],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968484,0.00046957957,0.00061014213,0.0010321566,0.00047125344,0.0005684902],"domain_scores_gemma":[0.99824333,0.00029433964,0.00027104412,0.00080746587,0.00018594236,0.00019789352],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00044632817,0.00055643846,0.0013441975,0.00040543106,0.00010413692,0.000024079387,0.0001770995,0.0014930456,0.0003548884],"category_scores_gemma":[0.0003142657,0.00045628188,0.00024214029,0.00028486174,0.00020509055,0.000057503792,0.00020534689,0.0020353922,0.00012304702],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020057904,0.00058320194,0.000111831214,0.00059788645,0.00025938996,0.0047738743,0.00042950799,1.9442341e-7,0.22529611,0.000026035501,0.76565415,0.0002620342],"study_design_scores_gemma":[0.014899345,0.005909897,0.007869412,0.0008198807,0.001309559,0.0015510205,0.00011296443,0.000017008866,0.0087861,0.0039886083,0.9534302,0.0013060512],"about_ca_topic_score_codex":0.000039938768,"about_ca_topic_score_gemma":0.0000032785647,"teacher_disagreement_score":0.69766384,"about_ca_system_score_codex":0.00013165125,"about_ca_system_score_gemma":0.00031406456,"threshold_uncertainty_score":0.99980325},"labels":[],"label_agreement":null},{"id":"W2050231360","doi":"10.1182/blood-2009-01-198580","title":"Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":206,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Biology; Chromosomal translocation; Germinal center; Follicular lymphoma; Molecular biology; Gene; Gene duplication; Gene expression; Comparative genomic hybridization; Gene expression profiling; Immunohistochemistry; Locus (genetics); Genetics; B cell; Lymphoma; Chromosome; Antibody; Immunology","score_opus":0.010507382009862256,"score_gpt":0.23894196257930342,"score_spread":0.22843458056944116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050231360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954291,0.0033026624,0.0001140003,0.000505508,0.0000068842332,0.0004946678,0.000003913713,0.000020869704,0.00012238405],"genre_scores_gemma":[0.99321735,0.0005610136,0.005881873,0.00013953407,0.000034283938,0.00009481945,0.000026435679,0.0000090099575,0.000035672405],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99940705,0.000020020967,0.00012632333,0.00021825568,0.00011304681,0.000115286435],"domain_scores_gemma":[0.99972576,0.000010289756,0.000026341355,0.00013406915,0.000022740564,0.00008081499],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000022748929,0.00011551662,0.00016918406,0.000058160324,0.000052094212,0.000022857,0.000015485746,0.000045753484,0.000008044794],"category_scores_gemma":[0.000004944562,0.00007715084,0.000015704705,0.00006638156,0.000024763178,0.000048321202,0.000004543729,0.000024488432,0.0000010135275],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000087663815,0.0015179972,0.8928765,0.000029947032,0.00004796376,0.00009431054,0.000555477,0.000005023219,0.09630003,0.000047863334,0.00002280718,0.0084144],"study_design_scores_gemma":[0.008357245,0.00040959177,0.7451414,0.0001632094,0.00014467216,0.00022008205,0.000017516879,0.000074239804,0.24532434,0.000047289035,0.000024754849,0.00007566268],"about_ca_topic_score_codex":0.0000179817,"about_ca_topic_score_gemma":0.000012122129,"teacher_disagreement_score":0.14902432,"about_ca_system_score_codex":0.00001753859,"about_ca_system_score_gemma":0.00003356988,"threshold_uncertainty_score":0.314612},"labels":[],"label_agreement":null},{"id":"W2050239232","doi":"10.1182/blood-2012-05-433730","title":"Vascular Gas6 contributes to thrombogenesis and promotes tissue factor up-regulation after vessel injury in mice","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Thrombus; GAS6; Tissue factor; Platelet; Thrombin; Platelet activation; Endothelium; Biology; Pathology; Medicine; Immunology; Endocrinology; Receptor; Internal medicine; Coagulation; Receptor tyrosine kinase","score_opus":0.00913030057814994,"score_gpt":0.23844350866354158,"score_spread":0.22931320808539163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050239232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847134,0.014310948,0.00011070513,0.00013487665,0.00027151743,0.00037593162,0.00002819047,0.000029579805,0.000024869973],"genre_scores_gemma":[0.9994359,0.000072502065,0.00007858307,0.00006871988,0.00003488553,0.00006571625,0.000051233925,0.000014943752,0.00017750019],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99912083,0.00012247264,0.00022267284,0.00019298604,0.000028806748,0.00031224094],"domain_scores_gemma":[0.9996736,0.00004335987,0.0000526215,0.00016399128,0.000040374864,0.000026069516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001751362,0.00014456094,0.00024316824,0.00012378441,0.00006550746,0.000016564476,0.00006841351,0.00018896502,0.00015069323],"category_scores_gemma":[0.000052423486,0.00013062818,0.000036265283,0.0001421673,0.00004757861,0.0002091917,0.00006342438,0.000077217504,0.000115287454],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048587925,0.00023198233,0.10078537,0.000016382852,0.00010222263,1.5360213e-7,0.0005148678,2.8891827e-7,0.89434564,0.000087516266,0.000080583784,0.003786402],"study_design_scores_gemma":[0.00069152244,0.00004604086,0.5051294,0.000022822594,0.000043757653,0.0000037497632,0.000016371647,4.5705602e-7,0.48934186,0.00003177203,0.0045848624,0.000087397035],"about_ca_topic_score_codex":0.00006726054,"about_ca_topic_score_gemma":0.000011275874,"teacher_disagreement_score":0.40500382,"about_ca_system_score_codex":0.000021133692,"about_ca_system_score_gemma":0.000014213433,"threshold_uncertainty_score":0.53268623},"labels":[],"label_agreement":null},{"id":"W2050297365","doi":"10.1182/blood-2010-06-292300","title":"Leukemia-initiating cells in human T-lymphoblastic leukemia exhibit glucocorticoid resistance","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Hospital for Sick Children; University of Toronto","funders":"Hospital for Sick Children; University Health Network; Leukemia and Lymphoma Society","keywords":"Immunophenotyping; Leukemia; Cancer research; Biology; Nod; Severe combined immunodeficiency; Immunology; Stem cell; T cell; Acute lymphocytic leukemia; Flow cytometry; Lymphoblastic Leukemia; Immune system; Endocrinology; In vivo; Diabetes mellitus; Cell biology","score_opus":0.011792023530875325,"score_gpt":0.2656121771693385,"score_spread":0.25382015363846316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050297365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.966416,0.00010405928,0.00010576503,0.00011775907,0.00029890667,0.0008003142,0.000018707806,0.00017242116,0.03196608],"genre_scores_gemma":[0.99136615,0.00002206738,0.0028634996,0.00039661812,0.0005327304,0.0000925057,0.000036660178,0.0001182964,0.0045714923],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962193,0.000085980115,0.00085088395,0.0008250201,0.00092682475,0.0010920307],"domain_scores_gemma":[0.99755627,0.0005703503,0.00021064974,0.0010551943,0.00019572706,0.0004118178],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00057074946,0.00040809406,0.00066989596,0.0004069865,0.0001683815,0.00007880627,0.00042088606,0.00039867236,0.00046831788],"category_scores_gemma":[0.00080592994,0.00039614737,0.00016658484,0.00073409727,0.0002493375,0.0001864054,0.00021894986,0.0012650425,0.00051553734],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018811706,0.00041246307,0.013306725,0.00043645504,0.00008079735,0.0013773722,0.00034198113,0.000042618998,0.9814333,0.0008332016,0.0012373519,0.00030961845],"study_design_scores_gemma":[0.04199208,0.00067965244,0.056374367,0.0012169458,0.00043379294,0.00065185444,0.00040741585,0.003206792,0.88835824,0.0006485565,0.004837273,0.0011930639],"about_ca_topic_score_codex":0.00029128112,"about_ca_topic_score_gemma":0.00066079345,"teacher_disagreement_score":0.09307509,"about_ca_system_score_codex":0.0016654016,"about_ca_system_score_gemma":0.0031368108,"threshold_uncertainty_score":0.999849},"labels":[],"label_agreement":null},{"id":"W2050583021","doi":"10.1182/blood-2011-06-363572","title":"Transplantation in patients with SCID: mismatched related stem cells or unrelated cord blood?","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"Hospital for Sick Children; University of Toronto","keywords":"Medicine; Umbilical Cord Blood Transplantation; Transplantation; Umbilical cord; Hematopoietic stem cell transplantation; Internal medicine; Cord blood; Stem cell; Cumulative incidence; Surgery; Immunology; Gastroenterology; Biology","score_opus":0.012910007328152768,"score_gpt":0.22860631849985316,"score_spread":0.2156963111717004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050583021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973604,0.00007631166,0.00008950214,0.000059279875,0.00017336365,0.0009821568,0.000024809266,0.00012247406,0.0011116898],"genre_scores_gemma":[0.9982904,0.000052633575,0.00079858804,0.00006132804,0.000036628146,0.000028888368,0.00019203761,0.00005245782,0.0004870299],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99828345,0.000089408524,0.00050323136,0.00027008087,0.0004198931,0.000433942],"domain_scores_gemma":[0.9992231,0.00011880452,0.00013042497,0.00024550175,0.000067426525,0.0002146997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024107075,0.0002306942,0.0003566358,0.00018888815,0.00004457359,0.0000118572225,0.0000706891,0.00021879656,0.00019108668],"category_scores_gemma":[0.0000054398793,0.00017208578,0.00004553326,0.0005165277,0.000042366515,0.00018629899,0.0000046593045,0.0002443947,0.00012555208],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029019688,0.003968703,0.9746739,0.00091227604,0.00033127918,0.0002568409,0.0052591013,0.000016025993,0.011238245,0.000042261832,0.00002392046,0.00037542408],"study_design_scores_gemma":[0.05078558,0.0015069986,0.7075082,0.0013506428,0.002646407,0.0003789766,0.00031189548,0.000028687487,0.23496264,0.00000777478,0.000051746254,0.00046045086],"about_ca_topic_score_codex":0.00003579947,"about_ca_topic_score_gemma":0.0000147842875,"teacher_disagreement_score":0.26716575,"about_ca_system_score_codex":0.000030375299,"about_ca_system_score_gemma":0.00007707732,"threshold_uncertainty_score":0.70174545},"labels":[],"label_agreement":null},{"id":"W2050616143","doi":"10.1182/blood-2007-05-091942","title":"Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":226,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Canadian Institutes of Health Research; Children’s Oncology Group","keywords":"Medicine; Hazard ratio; Internal medicine; Confidence interval; Myeloid leukemia; Underweight; Incidence (geometry); Amphotericin B; Body mass index; Epidemiology; Leukemia; Mortality rate; Cumulative incidence; Immunology; Cohort; Antifungal; Overweight","score_opus":0.007390877897620644,"score_gpt":0.2621446371772377,"score_spread":0.254753759279617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050616143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99441916,0.00007729785,0.000081507205,0.000059692706,0.000055627006,0.0005040762,0.00000818261,0.00012044278,0.0046740435],"genre_scores_gemma":[0.9991126,0.00023013227,0.00010403395,0.00016027455,0.000049880597,0.000031665128,0.000045482317,0.000013797775,0.00025213417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99912316,0.000025406034,0.00024984026,0.0002740225,0.00007952919,0.00024802473],"domain_scores_gemma":[0.9995663,0.000022353572,0.0000641372,0.00018018084,0.000053490687,0.000113533046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001730977,0.0001487991,0.00022908677,0.00015870613,0.000110650864,0.000019856527,0.000028915809,0.00012386384,0.00011639185],"category_scores_gemma":[0.000013760679,0.00011338975,0.00004824876,0.0004953192,0.00011146263,0.00009381356,0.000028819803,0.00032308232,0.000018596966],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004102347,0.0004290864,0.9787717,0.0000061696096,0.00054207887,0.000034367193,0.000033177163,0.000006201546,0.019702848,0.00012391074,0.00002684114,0.00028260765],"study_design_scores_gemma":[0.0044439505,0.0005790869,0.9848203,0.000037438862,0.00056226336,0.0020404784,0.0000064062006,5.991682e-7,0.007012421,0.00004944493,0.00031209993,0.00013550722],"about_ca_topic_score_codex":0.0013738127,"about_ca_topic_score_gemma":0.0015863546,"teacher_disagreement_score":0.012690427,"about_ca_system_score_codex":0.000098835095,"about_ca_system_score_gemma":0.00011186703,"threshold_uncertainty_score":0.46239},"labels":[],"label_agreement":null},{"id":"W2050723571","doi":"10.1182/blood-2006-07-037473","title":"A GMCSF and IL-15 fusokine leads to paradoxical immunosuppression in vivo via asymmetrical JAK/STAT signaling through the IL-15 receptor complex","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research; McGill University","keywords":"Biology; Immune system; Cytokine; Immunology; Cancer research; Growth factor; Cell biology; Receptor","score_opus":0.014799135678441232,"score_gpt":0.243816904682426,"score_spread":0.22901776900398477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050723571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902746,0.0021303424,0.0011626945,0.0015442756,0.0014809191,0.00044253026,0.00003017324,0.00009093017,0.0028435476],"genre_scores_gemma":[0.9948567,0.000079524565,0.00034526686,0.0007119238,0.00012701504,0.000041061758,0.00014073914,0.000024231998,0.0036735365],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982861,0.00032283735,0.00049671484,0.00039048877,0.000075685166,0.00042812506],"domain_scores_gemma":[0.99920577,0.00030725685,0.00011619544,0.00028381962,0.00006247797,0.000024490753],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023450464,0.00024334165,0.00033520552,0.00015947521,0.0002889563,0.000048894373,0.00019785223,0.00027055136,0.0021775807],"category_scores_gemma":[0.000097438235,0.00017677325,0.00010023172,0.00039534326,0.00014135455,0.00016556513,0.00013312399,0.0005691394,0.0005466703],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004246066,0.0006295507,0.0011324397,0.000009251621,0.000059055765,0.000004744194,0.00030150366,0.00001756858,0.95405763,0.0003025027,0.042129736,0.00093139993],"study_design_scores_gemma":[0.0030793326,0.00050285755,0.005092509,0.000057198293,0.00006814155,0.00015081067,0.00029843725,0.000025839336,0.6040803,0.00015531058,0.386211,0.00027826068],"about_ca_topic_score_codex":0.00056902383,"about_ca_topic_score_gemma":0.000042412557,"teacher_disagreement_score":0.34997734,"about_ca_system_score_codex":0.000041974476,"about_ca_system_score_gemma":0.000021144591,"threshold_uncertainty_score":0.9987346},"labels":[],"label_agreement":null},{"id":"W2050899268","doi":"10.1182/blood-2006-10-051318","title":"CD4 cells can be more efficient at tumor rejection than CD8 cells","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":421,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Cytotoxic T cell; CD8; CTL*; Effector; Major histocompatibility complex; Biology; MHC class I; Immunology; Immunotherapy; Cancer research; Interleukin 21; Antigen; Immune system; In vitro; Genetics","score_opus":0.007891154768465162,"score_gpt":0.21546231900227167,"score_spread":0.2075711642338065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050899268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833311,0.00037485288,0.00012615773,0.00016397316,0.007941844,0.0002267338,0.00000985885,0.00014185006,0.0076836357],"genre_scores_gemma":[0.9501222,0.000020886459,0.000027784134,0.00067280896,0.00009038306,0.000008322493,0.00011121289,0.000023485696,0.048922915],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99885464,0.000074134165,0.00030046178,0.00031241786,0.00005087533,0.0004074842],"domain_scores_gemma":[0.9993903,0.00006951816,0.00014306698,0.0002909363,0.00007365206,0.000032527416],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000254393,0.00018507375,0.00017908138,0.00014804146,0.0002963498,0.000014291626,0.00011506383,0.00018338369,0.0015189964],"category_scores_gemma":[0.000019509289,0.00017184683,0.00012808044,0.00014627769,0.000089819456,0.000036959405,0.00006511665,0.00029918033,0.0014373132],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019305659,0.00044410233,0.00025967555,0.000009709489,0.0000948487,0.000012614059,0.00057474786,0.000025999405,0.9781531,0.000022000768,0.020096572,0.00011354513],"study_design_scores_gemma":[0.0013455058,0.00018562784,0.0015825953,0.000014579862,0.000078548794,0.00015277443,0.0005813158,0.000005017006,0.8603643,0.0000011406016,0.13552213,0.00016648095],"about_ca_topic_score_codex":0.0002901953,"about_ca_topic_score_gemma":0.00012659119,"teacher_disagreement_score":0.11778884,"about_ca_system_score_codex":0.000102519574,"about_ca_system_score_gemma":0.000026907817,"threshold_uncertainty_score":0.99939376},"labels":[],"label_agreement":null},{"id":"W2050999393","doi":"10.1182/blood-2011-11-391474","title":"Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":334,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; Canadian Institutes of Health Research; Ligue Genevoise Contre le Cancer; Terry Fox Foundation; Canada's Michael Smith Genome Sciences Centre","keywords":"Mantle cell lymphoma; Biology; Cyclin D1; Cancer research; Transcriptome; Mutation; Genetics; Indel; Gene; Lymphoma; Cell cycle; Single-nucleotide polymorphism; Genotype; Immunology","score_opus":0.04219781797124564,"score_gpt":0.2602862394829832,"score_spread":0.21808842151173755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050999393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97912204,0.00072691374,0.000039711384,0.000075910895,0.00030028442,0.00036508485,0.00001856783,0.000048982376,0.019302495],"genre_scores_gemma":[0.99535596,0.000032324107,0.003628975,0.00016384135,0.00006389542,0.00006391682,0.000014368179,0.000026621656,0.0006501051],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99896324,0.000036510024,0.0002760635,0.00025538934,0.00019668645,0.00027209404],"domain_scores_gemma":[0.9995082,0.00002749175,0.00005149646,0.00024833347,0.000053206513,0.000111286936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013182823,0.00013324036,0.00021514283,0.00013097866,0.0000322819,0.000006860488,0.00009625865,0.00008804407,0.00032033797],"category_scores_gemma":[0.000038788683,0.00012783486,0.00007026201,0.00024246122,0.00004513484,0.000043657772,0.000017289458,0.000111987436,0.00011855469],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017512252,0.002241382,0.06060748,0.00037194436,0.00006585672,0.00029729313,0.014965682,0.0000057723455,0.9153555,0.000048666134,0.0005763072,0.005288976],"study_design_scores_gemma":[0.01078782,0.0011543263,0.33623862,0.000417369,0.00036959758,0.00016424176,0.0013341309,0.0000643741,0.64623374,0.0009823721,0.0018187145,0.0004346687],"about_ca_topic_score_codex":0.00012714273,"about_ca_topic_score_gemma":0.00009029769,"teacher_disagreement_score":0.27563116,"about_ca_system_score_codex":0.00013611035,"about_ca_system_score_gemma":0.00016848688,"threshold_uncertainty_score":0.5212954},"labels":[],"label_agreement":null},{"id":"W2051008724","doi":"10.1182/blood-2003-06-1852","title":"Genetic control of myeloproliferation in BXH-2 mice","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Kruppel-like factors research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Biology","score_opus":0.007192216338878003,"score_gpt":0.24363845892698882,"score_spread":0.2364462425881108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051008724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99720395,0.000676889,0.0007957371,0.00002723992,0.000029238909,0.00017182702,0.000008333298,0.0000027392673,0.0010840357],"genre_scores_gemma":[0.9991305,0.000059558875,0.00052660925,0.000051597544,0.000040365798,0.000016599643,0.000010823023,0.000010758265,0.00015320363],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99929696,0.000094987256,0.00015846686,0.00017155695,0.00010920551,0.00016883397],"domain_scores_gemma":[0.99965984,0.000009889576,0.00003440404,0.00018925109,0.00006746951,0.00003916197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013747494,0.00007027699,0.00009558541,0.00004481525,0.000014101836,0.000006715883,0.00009134245,0.000093641465,0.000025977606],"category_scores_gemma":[0.00018215162,0.00006988806,0.000033725883,0.000079455596,0.000031172924,0.0000014350296,0.000015906438,0.00005616681,0.00000888904],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019324498,0.00015338966,0.14136359,0.000011378421,0.000019799878,0.0000026345838,0.000015542171,0.000031858242,0.8581151,0.000047205707,0.000043748274,0.00017648023],"study_design_scores_gemma":[0.0020615684,0.00017406694,0.04508132,0.000005155994,0.000009923412,0.000010914592,0.000016317517,0.000023546942,0.9507546,0.000047006495,0.0017311749,0.00008443455],"about_ca_topic_score_codex":0.000023060016,"about_ca_topic_score_gemma":0.00006404033,"teacher_disagreement_score":0.09628227,"about_ca_system_score_codex":0.0000051570764,"about_ca_system_score_gemma":0.00009261556,"threshold_uncertainty_score":0.28499523},"labels":[],"label_agreement":null},{"id":"W2051019115","doi":"10.1182/blood-2008-07-170464","title":"The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Universität Heidelberg; Stem Cell Network","keywords":"Autocrine signalling; Hepatocyte growth factor; Growth factor; Biology; Receptor; Cell culture; Internal medicine; Cancer research; Endocrinology; Medicine; Biochemistry; Genetics","score_opus":0.010729174263471728,"score_gpt":0.26284594594201427,"score_spread":0.2521167716785425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051019115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99117976,0.0059561273,0.000003956844,0.00070626003,0.000022482303,0.0015644324,0.00006961069,0.000006840595,0.00049051346],"genre_scores_gemma":[0.9983431,0.0005949468,0.00038611132,0.000019307427,0.0000464993,0.00006687451,0.0000036208785,0.000009680758,0.00052986934],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99909604,0.00007637264,0.00023908909,0.00013099631,0.00028532534,0.00017217943],"domain_scores_gemma":[0.9983951,0.00088333513,0.00017543197,0.00027279125,0.00021818574,0.00005519877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014823303,0.00010041861,0.00022642325,0.000022778531,0.00009461171,0.000006136519,0.0001583287,0.00004642286,0.000011882586],"category_scores_gemma":[0.0016514063,0.000039323095,0.000102309554,0.00010102005,0.00015088772,0.000028292814,0.0000449326,0.00008121546,0.0000014337148],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034750786,0.0012660738,0.043916136,0.00044556602,0.00015140678,0.0000018638901,0.000982735,2.3689722e-7,0.9272351,0.00050372817,0.00011955856,0.021902507],"study_design_scores_gemma":[0.0071860235,0.0007209961,0.06945408,0.00025773942,0.00011482978,0.000004274241,0.00011092923,0.000033122127,0.9211319,0.00066170184,0.00028837932,0.000035989826],"about_ca_topic_score_codex":0.0000164478,"about_ca_topic_score_gemma":0.0000047417716,"teacher_disagreement_score":0.025537945,"about_ca_system_score_codex":0.000005048404,"about_ca_system_score_gemma":0.00007188402,"threshold_uncertainty_score":0.1977007},"labels":[],"label_agreement":null},{"id":"W2051116482","doi":"10.1182/blood-2012-06-438481","title":"Delivery of viral-vectored vaccines by B cells represents a novel strategy to accelerate CD8+ T-cell recall responses","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; McMaster University; Health Sciences Centre; McMaster University Medical Centre","funders":"Canadian Institutes of Health Research","keywords":"Recall; CD8; Cytotoxic T cell; Immunology; B cell; Virology; Antigen; Viral vector; Biology; Medicine; Genetics; Gene; Psychology; Antibody; Recombinant DNA","score_opus":0.01633272655146244,"score_gpt":0.22598483034380001,"score_spread":0.20965210379233756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051116482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99381393,0.0028211027,0.00002762809,0.00018147769,0.00053001806,0.00061162014,0.00013430668,0.00010116091,0.0017787757],"genre_scores_gemma":[0.97173744,0.0002483922,0.00021407956,0.00024351045,0.000036969715,0.00007813564,0.00009119766,0.000040616975,0.027309628],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977469,0.00027504453,0.0006384983,0.0006157867,0.000060928644,0.000662884],"domain_scores_gemma":[0.998493,0.00025653475,0.00024875812,0.000704922,0.00023118954,0.00006559487],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00017437147,0.0003557871,0.00055796094,0.00019853191,0.00013909028,0.000036142872,0.0006119241,0.000467514,0.001394643],"category_scores_gemma":[0.000056469642,0.0003116922,0.00015192048,0.000239894,0.00013698387,0.00017210461,0.00027735124,0.000338832,0.0019700231],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042353725,0.0018025432,0.00087339524,0.000029011624,0.00024626288,0.0000064504175,0.00014624052,0.0000054791217,0.96471715,0.000015917909,0.031176053,0.00055793347],"study_design_scores_gemma":[0.004444075,0.0009868039,0.0013506318,0.000026685519,0.000099291276,0.000032323533,0.00014514105,0.0000016774743,0.9830227,0.000045882436,0.009505467,0.00033934662],"about_ca_topic_score_codex":0.0015886959,"about_ca_topic_score_gemma":0.000027098358,"teacher_disagreement_score":0.025530852,"about_ca_system_score_codex":0.00001661196,"about_ca_system_score_gemma":0.0000905692,"threshold_uncertainty_score":0.99993354},"labels":[],"label_agreement":null},{"id":"W2051118426","doi":"10.1182/blood-2007-03-079699","title":"Small-molecule agonists of SHIP1 inhibit the phosphoinositide 3-kinase pathway in hematopoietic cells","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":161,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Institute of Infection and Immunity; University of British Columbia; Vancouver Coastal Health Research Institute; Vancouver General Hospital","funders":"","keywords":"PI3K/AKT/mTOR pathway; Phosphoinositide 3-kinase; Kinase; Cell biology; Phosphatase; Signal transduction; Chemistry; Inositol; Phosphorylation; Allosteric regulation; MAPK/ERK pathway; Biology; Biochemistry; Receptor","score_opus":0.010496194686487423,"score_gpt":0.22617223556670407,"score_spread":0.21567604088021664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051118426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946132,0.002571071,0.00028676787,0.000057990153,0.00012542668,0.00020510149,0.000017635979,0.000010917014,0.0021119427],"genre_scores_gemma":[0.9989626,0.000044333297,0.00030315283,0.0003070842,0.00012413539,0.00001735194,0.000020130588,0.000030637457,0.00019057069],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998761,0.00005294155,0.0003452454,0.00032186415,0.00016554035,0.00035338508],"domain_scores_gemma":[0.9991978,0.00004262609,0.00012965557,0.00049363327,0.00006442835,0.00007186346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005038322,0.00017383041,0.00017519253,0.00004223556,0.000046047862,0.000014568843,0.00031183907,0.00016192123,0.000022220222],"category_scores_gemma":[0.000057782734,0.00014715036,0.000111927024,0.00016930254,0.00012708305,0.000001981882,0.0001211611,0.00014799685,0.0000101333935],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005214344,0.00026456427,0.0028462128,0.00003932852,0.00003294763,0.00005478726,0.00014084166,0.00001946952,0.9960522,0.00010178793,0.00013283058,0.00026286914],"study_design_scores_gemma":[0.0009828237,0.00018301149,0.00087435305,0.00005399005,0.000020998581,0.000023617915,0.00006816417,0.0000023792077,0.99587184,0.000065653934,0.0016745275,0.00017861903],"about_ca_topic_score_codex":0.000077051074,"about_ca_topic_score_gemma":0.00019804377,"teacher_disagreement_score":0.004349456,"about_ca_system_score_codex":0.000016130147,"about_ca_system_score_gemma":0.00011601135,"threshold_uncertainty_score":0.6000617},"labels":[],"label_agreement":null},{"id":"W2051165614","doi":"10.1182/blood-2012-06-430645","title":"Darwinian evolution and tiding clones in multiple myeloma","year":2012,"lang":"en","type":"letter","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Multiple myeloma; Darwinism; Biology; Genetics; Cancer research; Computational biology; Evolutionary biology; Immunology","score_opus":0.035603067959147125,"score_gpt":0.28251217205177775,"score_spread":0.24690910409263062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051165614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88451797,0.0071223523,0.000015031143,0.10317785,0.00028598856,0.0015481588,0.00012711094,0.00012710453,0.0030784127],"genre_scores_gemma":[0.97918886,0.00015241108,0.0008036992,0.0151344035,0.0026790113,0.00011241643,0.0006011603,0.00007172341,0.0012563077],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99823505,0.00008943761,0.00024891528,0.0003847505,0.00039438353,0.00064745545],"domain_scores_gemma":[0.9992084,0.00016038262,0.00007228284,0.00033932945,0.000045223907,0.0001743994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015350235,0.00027577215,0.0004447472,0.0003563204,0.000074715615,0.00002503176,0.00007705917,0.0005181661,0.000083601415],"category_scores_gemma":[0.00020217805,0.00023356189,0.000081223836,0.00014977393,0.000074662974,0.00009259584,0.00008250499,0.00096847815,0.00012126115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000107517124,0.00053263124,0.9444326,0.00065150816,0.00032825244,0.0029011522,0.00017264644,4.3429818e-8,0.001103626,0.000006551698,0.044666287,0.0050971904],"study_design_scores_gemma":[0.011696971,0.00027297635,0.8639056,0.0005934181,0.00037244445,0.0005344005,0.00003619762,0.00005364177,0.0008810618,0.000041042036,0.12125674,0.00035552343],"about_ca_topic_score_codex":0.00039611387,"about_ca_topic_score_gemma":0.000076982855,"teacher_disagreement_score":0.09467088,"about_ca_system_score_codex":0.00011247749,"about_ca_system_score_gemma":0.000093401606,"threshold_uncertainty_score":0.95243776},"labels":[],"label_agreement":null},{"id":"W2051341651","doi":"10.1182/blood-2013-07-505099","title":"Notch signals are required for in vitro but not in vivo maintenance of human hematopoietic stem cells and delay the appearance of multipotent progenitors","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Sunnybrook Hospital; University of Toronto","funders":"Canadian Institutes of Health Research; American Society of Hematology","keywords":"Cell biology; Stem cell; In vitro; Haematopoiesis; Multipotent Stem Cell; Biology; Progenitor cell; In vivo; Ex vivo; Immunology; Biochemistry; Genetics","score_opus":0.02086687975198192,"score_gpt":0.2495311645308795,"score_spread":0.22866428477889758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051341651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966972,0.00026096925,0.00020296747,0.0001803625,0.00003245755,0.0025327073,0.00003689866,0.000011157787,0.000045315035],"genre_scores_gemma":[0.9987633,0.000033200737,0.0007061582,0.00004471333,0.000020290501,0.00032284285,0.0000021750323,0.00002337673,0.00008393666],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99856764,0.00006208292,0.0006390944,0.00024262935,0.00023483194,0.00025370243],"domain_scores_gemma":[0.99914455,0.00016773521,0.00024696288,0.00025784445,0.00012615942,0.000056757395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003462204,0.00014900445,0.00047111654,0.00009675858,0.000024592178,0.0000067509563,0.00010661874,0.00009418192,0.0000075294074],"category_scores_gemma":[0.000020865029,0.000108747634,0.000073334915,0.0001558231,0.00011040633,0.00005193179,0.000016134101,0.00009649104,0.0000024009676],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001489834,0.00038796442,0.007750149,0.0019360853,0.000032905653,0.0000127586,0.0019332794,0.000010378058,0.98758245,0.000028169725,0.00000799463,0.00016890933],"study_design_scores_gemma":[0.005037631,0.00015513369,0.006574787,0.0013637448,0.000083758365,0.000038327624,0.0016962045,0.00028214365,0.98461777,0.00004603074,0.000003863252,0.00010060052],"about_ca_topic_score_codex":0.00015404206,"about_ca_topic_score_gemma":0.000031143896,"teacher_disagreement_score":0.0048886472,"about_ca_system_score_codex":0.000018156908,"about_ca_system_score_gemma":0.000032890162,"threshold_uncertainty_score":0.44346},"labels":[],"label_agreement":null},{"id":"W2051397980","doi":"10.1182/blood-2012-12-471029","title":"An evolutionarily conserved program of B-cell development and activation in zebrafish","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Zebrafish Biomedical Research Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":211,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute of General Medical Sciences; Howard Hughes Medical Institute","keywords":"Zebrafish; Biology; Cell biology; Conserved sequence; Haematopoiesis; Model organism; Evolutionary biology; Genetics; Stem cell; Gene; Base sequence","score_opus":0.010862726854707822,"score_gpt":0.2660729603747006,"score_spread":0.2552102335199927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051397980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987589,0.0000498431,0.00021635814,0.00014408707,0.0000033281192,0.00042862553,0.0000022156528,0.000008408505,0.00038820342],"genre_scores_gemma":[0.98955417,0.000008309729,0.00991919,0.000042373355,0.000017014818,0.00029715785,0.00011411551,0.0000062118097,0.00004144027],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994233,0.000028047574,0.00013908153,0.00016842995,0.00010850975,0.00013260898],"domain_scores_gemma":[0.99963546,0.00001100216,0.000036168472,0.00014785724,0.00007962113,0.00008986596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010240623,0.000054268326,0.000059135647,0.000039005496,0.000024328663,0.000012002879,0.00009524161,0.000077092176,0.000016545197],"category_scores_gemma":[0.00006763746,0.00005245982,0.000010546653,0.00009554778,0.00008519955,0.00000579735,0.000046308163,0.000045608624,0.0000047962],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006117707,0.0010295353,0.00699075,0.000018084327,0.000009265378,1.2410358e-7,0.000023375833,1.840895e-7,0.9867347,0.000036973983,0.00021239172,0.0049385326],"study_design_scores_gemma":[0.0008179083,0.00018872248,0.1629608,0.0000071586446,0.0000022220581,8.006287e-7,0.00004029597,0.000034560384,0.8334575,0.00009356235,0.0023351961,0.000061246705],"about_ca_topic_score_codex":0.000064884975,"about_ca_topic_score_gemma":0.000039791044,"teacher_disagreement_score":0.15597005,"about_ca_system_score_codex":0.0000057992893,"about_ca_system_score_gemma":0.0001199568,"threshold_uncertainty_score":0.21392494},"labels":[],"label_agreement":null},{"id":"W2051609624","doi":"10.1182/blood-2006-08-037770","title":"Steel factor responsiveness regulates the high self-renewal phenotype of fetal hematopoietic stem cells","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Heart, Lung, and Blood Institute","keywords":"Stem cell; Haematopoiesis; Phenotype; Stem cell factor; Biology; Immunology; Fetus; Cancer research; Cell biology; Medicine; Genetics; Pregnancy; Gene","score_opus":0.01400908848867763,"score_gpt":0.23728866188979875,"score_spread":0.22327957340112112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051609624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979522,0.00035647847,0.000044691762,0.00015244941,0.00043953137,0.00025982375,0.000011168081,0.000073948475,0.00070969306],"genre_scores_gemma":[0.99735755,0.000030178713,0.0003550319,0.00022185291,0.0002234019,0.0000039717984,0.000006873311,0.000020655472,0.001780483],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99899065,0.00008320128,0.00028767454,0.0002017779,0.00020735677,0.00022932005],"domain_scores_gemma":[0.9989599,0.0003085863,0.00012366264,0.00038682696,0.00013426093,0.00008675447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021789972,0.00013985118,0.0003071666,0.00006928994,0.00006662664,0.00000486093,0.00009783144,0.00012819908,0.00017777651],"category_scores_gemma":[0.000018908944,0.000090819834,0.00010490662,0.00018594968,0.000091055124,0.000023341307,0.000040389375,0.00014192246,0.000061941275],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010779109,0.0007806586,0.0025942724,0.00022259202,0.00024938927,0.000066093795,0.0012629207,0.000005390454,0.99184,0.0007870487,0.00017669894,0.0009370059],"study_design_scores_gemma":[0.0030357372,0.0007504547,0.05206982,0.00006823744,0.00028955445,0.00010110019,0.00056571566,0.000005725481,0.94080853,0.00015229758,0.0020158591,0.00013698613],"about_ca_topic_score_codex":0.00001999127,"about_ca_topic_score_gemma":0.000009537961,"teacher_disagreement_score":0.051031508,"about_ca_system_score_codex":0.000015999953,"about_ca_system_score_gemma":0.00008886639,"threshold_uncertainty_score":0.37035254},"labels":[],"label_agreement":null},{"id":"W2051832959","doi":"10.1182/blood-2013-06-498303","title":"von Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapy","year":2013,"lang":"en","type":"review","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":167,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research","keywords":"Von Willebrand disease; Von Willebrand factor; Desmopressin; Hemostasis; Platelet disorder; Missense mutation; Coagulopathy; Bleeding diathesis; Immunology; Medicine; Phenotype; Platelet; Genetics; Biology; Internal medicine; Gene","score_opus":0.0502404870894125,"score_gpt":0.3211771857562363,"score_spread":0.27093669866682385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051832959","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003197091,0.9948663,0.0000013025317,0.00003110891,0.000047817535,0.0014709149,0.0000482387,0.00002076306,0.00031643544],"genre_scores_gemma":[0.0006636415,0.9984057,0.000034366156,0.00003584258,0.000041885327,0.000546662,0.00013332338,0.000043363263,0.000095219904],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99896026,0.00005012157,0.00026086887,0.0003586618,0.00014301903,0.00022706033],"domain_scores_gemma":[0.9994219,0.000082790364,0.00010382318,0.00021354007,0.000008623452,0.00016932559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000042657353,0.0003201528,0.0011102754,0.00014004642,0.0000384386,0.000023249433,0.000054986438,0.00013141055,0.00007977105],"category_scores_gemma":[0.00001822445,0.00021377248,0.00014817748,0.00014135471,0.000051188727,0.0000632023,0.000020709962,0.00013379536,0.000018837167],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011749296,0.0008104851,0.017672783,0.005217987,0.00020838277,0.00062428566,0.000017362094,2.183678e-8,8.6093586e-8,0.000033059416,0.00007088662,0.9753329],"study_design_scores_gemma":[0.004406002,0.00022765252,0.0009068386,0.012147056,0.0014119002,0.000096355376,0.000013886143,3.976602e-7,7.3374633e-7,0.0005738905,0.9799336,0.0002816381],"about_ca_topic_score_codex":0.0000075461544,"about_ca_topic_score_gemma":0.000009217659,"teacher_disagreement_score":0.97986275,"about_ca_system_score_codex":0.00003766497,"about_ca_system_score_gemma":0.000090265334,"threshold_uncertainty_score":0.87173885},"labels":[],"label_agreement":null},{"id":"W2051938173","doi":"10.1182/blood-2012-11-465971","title":"Development of a novel redirected T-cell–based adoptive immunotherapy targeting human telomerase reverse transcriptase for adult T-cell leukemia","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and Retrovirus Studies","field":"Immunology and Microbiology","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Telomerase reverse transcriptase; Immunotherapy; Adoptive cell transfer; Cytotoxic T cell; CD8; Cancer research; Leukemia; Chimeric antigen receptor; Biology; T-cell leukemia; T cell; Telomerase; Immunology; Cancer immunotherapy; Virology; Antigen; In vitro; Immune system; Gene","score_opus":0.013451760122209668,"score_gpt":0.217461283128201,"score_spread":0.20400952300599134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051938173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99346274,0.0030072553,0.00088323967,0.000059296148,0.0003177674,0.0010229885,0.00014305925,0.000110692876,0.000992952],"genre_scores_gemma":[0.9686818,0.00006380256,0.02776938,0.00028223798,0.000038245835,0.00035550602,0.000305796,0.000049853425,0.0024533656],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983382,0.0000647179,0.0006380859,0.0003962384,0.000059624286,0.00050312944],"domain_scores_gemma":[0.99890065,0.00010353644,0.0002887699,0.00024193974,0.00043020942,0.0000349212],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018423275,0.00032294725,0.0005007125,0.00013169198,0.00048262495,0.000011041357,0.00023529431,0.00025857618,0.00023398636],"category_scores_gemma":[0.00004974341,0.00027086592,0.00020304811,0.0001529647,0.00019368377,0.000068638656,0.000034157078,0.00023959551,0.00006684933],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017082992,0.0017900553,0.00027486775,0.00015899973,0.00034187397,0.0000013759403,0.0025649024,0.0000035956436,0.98970807,0.000020513588,0.00430954,0.0006553896],"study_design_scores_gemma":[0.015846672,0.0003010273,0.00033490182,0.000072495364,0.0001312116,0.000002275896,0.0015274032,0.0000070594774,0.9672044,0.000006185822,0.014210299,0.00035607905],"about_ca_topic_score_codex":0.00033766002,"about_ca_topic_score_gemma":0.000028739669,"teacher_disagreement_score":0.02688614,"about_ca_system_score_codex":0.000059678358,"about_ca_system_score_gemma":0.00021463826,"threshold_uncertainty_score":0.99997437},"labels":[],"label_agreement":null},{"id":"W2052054991","doi":"10.1182/blood-2012-02-410688","title":"A randomized trial of dasatinib 100 mg versus imatinib 400 mg in newly diagnosed chronic-phase chronic myeloid leukemia","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":176,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Cancer Society Research Institute; Ariad Pharmaceuticals; National Cancer Institute; National Institutes of Health; Pfizer; Oregon Health and Science University; Bristol-Myers Squibb","keywords":"Dasatinib; Medicine; Nilotinib; Imatinib; Internal medicine; Myeloid leukemia; Imatinib mesylate; Gastroenterology; Randomized controlled trial; Tyrosine-kinase inhibitor; Immunology; Cancer","score_opus":0.028945470028785506,"score_gpt":0.3226977424825182,"score_spread":0.2937522724537327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052054991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807906,0.006998977,0.00003035962,0.0001548778,0.0010512938,0.0049005197,0.000053329284,0.00013975755,0.0058802557],"genre_scores_gemma":[0.9939719,0.0009143878,0.0011837849,0.0000615697,0.0021158145,0.0009377434,0.00025414393,0.00011114386,0.000449514],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9954041,0.0004541902,0.0015590966,0.00060436554,0.00079134176,0.0011868754],"domain_scores_gemma":[0.9959253,0.0017414805,0.00064496254,0.0011279765,0.0000971738,0.00046307777],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014369615,0.0006087847,0.002236428,0.00036146454,0.00008010469,0.000023586386,0.00031225942,0.00039350436,0.0012468348],"category_scores_gemma":[0.0017038457,0.0005222813,0.00061877735,0.00057240756,0.00032504462,0.000287436,0.00014375355,0.000587173,0.0002135838],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95901537,0.007804067,0.0006986758,0.0005848236,0.0016213305,0.00023872699,0.0017651393,0.000029219545,0.011455796,0.00029183537,0.0006282524,0.015866783],"study_design_scores_gemma":[0.9748926,0.0035043962,0.00046994345,0.0004782845,0.0017895292,0.0000541681,0.00009312493,0.00058978755,0.016061114,0.000021867492,0.0016357886,0.0004093538],"about_ca_topic_score_codex":0.0009030135,"about_ca_topic_score_gemma":0.00021744154,"teacher_disagreement_score":0.015877292,"about_ca_system_score_codex":0.0038803462,"about_ca_system_score_gemma":0.0040572113,"threshold_uncertainty_score":0.99994355},"labels":[],"label_agreement":null},{"id":"W2052344090","doi":"10.1182/blood.v98.9.2664","title":"High-level erythroid-specific gene expression in primary human and murine hematopoietic cells with self-inactivating lentiviral vectors","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Biology; Molecular biology; Viral vector; Haematopoiesis; Woodchuck hepatitis virus; Enhancer; Myeloid; Transplantation; Genetic enhancement; Virology; Stem cell; Gene expression; Gene; Virus; Cancer research; Cell biology; Genetics; Hepatitis B virus; Recombinant DNA; Medicine; Hepadnaviridae","score_opus":0.014543575039325117,"score_gpt":0.24224711039338281,"score_spread":0.22770353535405768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052344090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984414,0.0008887373,0.00009449705,0.000028683866,0.000025525844,0.00025851684,0.000007657824,0.00002413695,0.00023083533],"genre_scores_gemma":[0.99632585,0.0003962603,0.0027447036,0.00004198146,0.00016085744,0.000033518285,0.000063025574,0.000046871144,0.00018691119],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99866617,0.000093277886,0.00019831344,0.00046886795,0.0002127004,0.0003606536],"domain_scores_gemma":[0.99942416,0.000013485355,0.000071056966,0.00036942435,0.00003976861,0.00008212082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018470534,0.00020281061,0.00019701356,0.00008715007,0.00011680878,0.000033078628,0.00015803297,0.00011384542,0.000025236079],"category_scores_gemma":[0.000004280061,0.00017995872,0.00003433835,0.00014920109,0.00007018035,0.000009064769,0.00013688469,0.00015850225,0.00000416464],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000406035,0.00051445974,0.011170557,0.000034460012,0.00003723659,0.000049813163,0.00009565784,0.000020085037,0.9873086,0.0000029839246,0.000057508394,0.00030256476],"study_design_scores_gemma":[0.0032245796,0.0014188328,0.009886863,0.000043970864,0.000009949806,0.00004458108,0.000043215972,0.0000017425807,0.9848509,0.000018768975,0.00022520624,0.00023138057],"about_ca_topic_score_codex":0.00001701412,"about_ca_topic_score_gemma":0.000064287684,"teacher_disagreement_score":0.0028185446,"about_ca_system_score_codex":0.000029731511,"about_ca_system_score_gemma":0.00004914678,"threshold_uncertainty_score":0.73385036},"labels":[],"label_agreement":null},{"id":"W2052372808","doi":"10.1182/blood-2007-07-103291","title":"Loss of TLE1 and TLE4 from the del(9q) commonly deleted region in AML cooperates with AML1-ETO to affect myeloid cell proliferation and survival","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Myeloid leukemia; Biology; Myeloid; Cancer research; Gene knockdown; Haematopoiesis; Fusion gene; Haploinsufficiency; Cell growth; Leukemia; Progenitor cell; Stem cell; Cell culture; Gene; Genetics; Phenotype","score_opus":0.019289677595388816,"score_gpt":0.24994862589184258,"score_spread":0.23065894829645375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052372808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964004,0.0006073346,0.00009931177,0.0016754285,0.000011534131,0.0009120755,0.00001694584,0.000022699822,0.00025427196],"genre_scores_gemma":[0.998486,0.0003284335,0.0005019402,0.00034455597,0.00008885273,0.00003469191,0.000042961445,0.00002717413,0.00014542868],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988012,0.00017245943,0.00020935487,0.00029186072,0.00028856553,0.00023656865],"domain_scores_gemma":[0.99905986,0.0003011792,0.00005314732,0.0002995187,0.00015386949,0.00013240211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024611317,0.00015913595,0.0003304768,0.00009393556,0.00009385421,0.000018776087,0.000097500684,0.00009216778,0.000006395109],"category_scores_gemma":[0.00012552703,0.000101514146,0.000018101398,0.00035375368,0.00019698996,0.00009012715,0.00007777277,0.0002675543,0.0000047385297],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012290654,0.00033209447,0.9677955,0.00007888214,0.00007677155,0.0003138054,0.0016080282,0.000017961147,0.027286487,0.000037227095,0.000796312,0.0004278678],"study_design_scores_gemma":[0.013373861,0.0019506604,0.846838,0.0002578703,0.00014862216,0.0004959736,0.0006005394,0.0007142919,0.13494664,0.000015825288,0.00040326235,0.00025444955],"about_ca_topic_score_codex":0.0019399645,"about_ca_topic_score_gemma":0.0017301594,"teacher_disagreement_score":0.120957494,"about_ca_system_score_codex":0.000053983218,"about_ca_system_score_gemma":0.00021050984,"threshold_uncertainty_score":0.41396266},"labels":[],"label_agreement":null},{"id":"W2052522969","doi":"10.1182/blood-2007-08-105221","title":"Cytotoxic T lymphocytes overcome Bcl-2 inhibition: target cells contribute to their own demise","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; National Cancer Institute; Alberta Heritage Foundation for Medical Research; Fondation pour la Recherche Médicale","keywords":"Cytotoxic T cell; Granzyme; Cell biology; Granzyme B; Apoptosis; Biology; Programmed cell death; Mitochondrion; Perforin; Biochemistry; In vitro","score_opus":0.005662453170986241,"score_gpt":0.21224763751914164,"score_spread":0.2065851843481554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052522969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98412925,0.0011181335,0.013300674,0.00008189311,0.00020010225,0.0002963361,0.000059079302,0.000029034385,0.0007854823],"genre_scores_gemma":[0.99567103,0.00015392747,0.0019264969,0.0004967944,0.0004978841,0.000013519319,0.00018889186,0.000023979203,0.0010274866],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990003,0.000022991051,0.00022092137,0.00031421162,0.00012279474,0.00031876474],"domain_scores_gemma":[0.99938697,0.000014407524,0.00006535002,0.0002850407,0.000084819985,0.00016343441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029489398,0.00016662646,0.00014503763,0.000048957612,0.00009565924,0.000027167584,0.00009546249,0.00019710472,0.000052676165],"category_scores_gemma":[0.000025654956,0.00014192813,0.0001019945,0.00010590971,0.00002329998,0.0000041668195,0.00008722921,0.00004775695,0.0000388648],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005405078,0.0001406573,0.00024494232,0.000010335469,0.000034507684,0.000013614739,0.00003197217,0.0000404376,0.9979387,0.00013854347,0.0005503712,0.0008018696],"study_design_scores_gemma":[0.0014796113,0.00019581316,0.0011281619,0.000015709316,0.000020262447,0.00003008866,0.000025368448,0.000014762353,0.9399134,0.00025559062,0.056721587,0.00019965302],"about_ca_topic_score_codex":0.0000076138767,"about_ca_topic_score_gemma":0.000016411339,"teacher_disagreement_score":0.058025304,"about_ca_system_score_codex":0.000019981726,"about_ca_system_score_gemma":0.000044716326,"threshold_uncertainty_score":0.5787661},"labels":[],"label_agreement":null},{"id":"W2052814200","doi":"10.1182/blood-2004-04-1430","title":"Incorporation of CXCR4 into membrane lipid rafts primes homing-related responses of hematopoietic stem/progenitor cells to an SDF-1 gradient","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":248,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Alberta","funders":"National Heart, Lung, and Blood Institute","keywords":"Homing (biology); Progenitor cell; Stem cell; CXCR4; Haematopoiesis; Cell biology; Lipid raft; Biology; Immunology; Chemokine; Signal transduction; Immune system","score_opus":0.012665977378315511,"score_gpt":0.25070254152700616,"score_spread":0.23803656414869065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052814200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986363,0.0002986392,0.00009110123,0.00017114394,0.00014621958,0.00053221243,0.0000064092465,0.000044912053,0.00007306432],"genre_scores_gemma":[0.99618,0.00001750967,0.0034422218,0.000030144427,0.00012002242,0.000014536572,0.000018861776,0.000030221952,0.00014647501],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986143,0.000053559226,0.00058135286,0.00025734617,0.0003224726,0.00017098147],"domain_scores_gemma":[0.999002,0.00005517686,0.0002366849,0.0003344714,0.00018815567,0.00018353487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003154396,0.00016448382,0.00046577188,0.00020261804,0.000039392587,0.000008302555,0.000100197474,0.00011774191,0.000040199753],"category_scores_gemma":[0.000061482206,0.00014454662,0.00011640364,0.0003576736,0.000055205972,0.00006659348,0.000040227776,0.00010365922,0.000010598429],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003613408,0.0012300521,0.0031799572,0.0003614224,0.0001115981,0.000014121238,0.0036420792,0.000079415564,0.9905256,0.000110901754,0.000016781249,0.0003667005],"study_design_scores_gemma":[0.0034158381,0.001117031,0.0006578038,0.00040893446,0.00025925404,0.00004337929,0.00039813205,0.000017234324,0.9933692,0.000110011024,0.00006783279,0.00013533275],"about_ca_topic_score_codex":0.00008723329,"about_ca_topic_score_gemma":0.0000109484145,"teacher_disagreement_score":0.0033511205,"about_ca_system_score_codex":0.000045193967,"about_ca_system_score_gemma":0.00019875373,"threshold_uncertainty_score":0.589444},"labels":[],"label_agreement":null},{"id":"W2052914628","doi":"10.1182/blood-2006-04-013813","title":"Expression of interleukin-3 receptor subunits on defined subpopulations of acute myeloid leukemia blasts predicts the cytotoxicity of diphtheria toxin interleukin-3 fusion protein against malignant progenitors that engraft in immunodeficient mice","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; BC Cancer Agency","funders":"","keywords":"Myeloid leukemia; Biology; Molecular biology; Progenitor cell; CD38; Diphtheria toxin; Leukemia; Haematopoiesis; Cancer research; Interleukin 15; CD34; Interleukin; Immunology; Stem cell; Cytokine; Cell biology; Microbiology; Toxin","score_opus":0.017335440033182554,"score_gpt":0.25592899077339853,"score_spread":0.238593550740216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052914628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959932,0.00023323859,0.000038110942,0.00009030766,0.00010689467,0.0027685713,0.00013764793,0.000040987266,0.00059105165],"genre_scores_gemma":[0.9984803,0.00008270445,0.00040842599,0.000018044764,0.00007160251,0.0002026523,0.00013808944,0.000064246946,0.0005339113],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99668616,0.00038221106,0.0010413686,0.00045107774,0.0009797419,0.00045941447],"domain_scores_gemma":[0.99799657,0.00019108139,0.0005809368,0.0008274828,0.00031582793,0.000088127505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007752715,0.00034590845,0.0006808784,0.00046184068,0.00007817239,0.000016271139,0.0004481215,0.00023317196,0.00017311092],"category_scores_gemma":[0.00014350793,0.0002423708,0.00026273748,0.00075864367,0.00033078075,0.000089501875,0.0002337751,0.00046996368,0.0000053134318],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023949998,0.0019703363,0.015925782,0.00023991877,0.0001219164,0.000017065235,0.001291752,0.00009613228,0.9768234,0.000049220755,0.00005106178,0.0010184308],"study_design_scores_gemma":[0.004657941,0.0012592337,0.028728241,0.0022308077,0.0001071292,0.00002331737,0.00034811828,0.00013177854,0.96222717,0.000031300275,0.00007616388,0.00017881165],"about_ca_topic_score_codex":0.0005757251,"about_ca_topic_score_gemma":0.0001408508,"teacher_disagreement_score":0.014596227,"about_ca_system_score_codex":0.00028917374,"about_ca_system_score_gemma":0.0003166965,"threshold_uncertainty_score":0.98835945},"labels":[],"label_agreement":null},{"id":"W2053037845","doi":"10.1182/blood-2012-12-472803","title":"Human proT-cells generated in vitro facilitate hematopoietic stem cell-derived T-lymphopoiesis in vivo and restore thymic architecture","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research","keywords":"Lymphopoiesis; Stem cell; Biology; Haematopoiesis; Progenitor cell; Cell biology; Immunology; Bone marrow; Myeloid; Transplantation; CD34; Cancer research; Internal medicine; Medicine","score_opus":0.014949397646484779,"score_gpt":0.2225694244004126,"score_spread":0.20762002675392782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053037845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957369,0.0003989382,0.000043906675,0.00023327993,0.000041466054,0.0021175193,0.000023726936,0.000081700826,0.0013225882],"genre_scores_gemma":[0.99742067,0.000047408234,0.001167764,0.00011738398,0.000029417262,0.0003531614,0.000025579267,0.000048052552,0.0007905786],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979883,0.00016340958,0.00057780446,0.00051884085,0.00029351827,0.00045812706],"domain_scores_gemma":[0.999209,0.00008254285,0.000094992436,0.00037197958,0.000058166403,0.00018334974],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020851725,0.00031158465,0.00053406757,0.0003221736,0.000060246035,0.000038846087,0.00011169978,0.00020439684,0.00012025736],"category_scores_gemma":[0.00000811545,0.00027805532,0.00006219373,0.00034158578,0.0000976923,0.000079757694,0.00002917268,0.00027929596,0.00007100912],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006671785,0.0004190277,0.0053637284,0.0010788061,0.000026618949,0.00017478918,0.0069362386,0.000021394071,0.985571,0.000004652662,0.000052883755,0.0002841408],"study_design_scores_gemma":[0.008007879,0.00016206728,0.009517679,0.0004071298,0.00009034185,0.00014837385,0.001142979,0.00011147141,0.97994745,0.00010942248,0.000056086184,0.00029911697],"about_ca_topic_score_codex":0.00047329522,"about_ca_topic_score_gemma":0.000101416525,"teacher_disagreement_score":0.007941161,"about_ca_system_score_codex":0.00006601692,"about_ca_system_score_gemma":0.0000849776,"threshold_uncertainty_score":0.99996716},"labels":[],"label_agreement":null},{"id":"W2053361200","doi":"10.1182/blood-2012-09-454694","title":"Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Lymphoma; In situ hybridization; Epstein–Barr virus; Concordance; Internal medicine; Virus; Medicine; Virology; Gastroenterology; Pathology; Oncology; Immunology; Biology; Genetics","score_opus":0.009652908364685107,"score_gpt":0.25149057052573676,"score_spread":0.24183766216105165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053361200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961557,0.00022372796,0.00013471625,0.00016738994,0.00018662073,0.0013446987,0.00039636221,0.000096817545,0.0012939739],"genre_scores_gemma":[0.9977253,0.00008117529,0.00025688304,0.0006193841,0.0001222759,0.00034954425,0.0004976386,0.00003965681,0.00030815878],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975494,0.00018854605,0.0006516514,0.0005992488,0.00043534586,0.0005757758],"domain_scores_gemma":[0.9986749,0.00020031763,0.00036389072,0.00037066976,0.00013127827,0.00025893576],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013893869,0.00034605656,0.0011487833,0.00031605145,0.000108874985,0.000039680108,0.00015340284,0.00013237372,0.00039081002],"category_scores_gemma":[0.0003582757,0.0002989381,0.0003005846,0.0018958095,0.00012532849,0.00020568598,0.000058015576,0.0002690015,0.00014850593],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067431503,0.0028867854,0.98163575,0.000008594903,0.0024418875,0.00008411266,0.0018795939,0.0001876122,0.00039692273,0.00001970196,0.000326706,0.0033891713],"study_design_scores_gemma":[0.19944452,0.0021086745,0.79128516,0.000029777819,0.002137584,0.0000011353709,0.0019975675,0.002060445,0.00028634662,0.000022377491,0.0002494783,0.00037694277],"about_ca_topic_score_codex":0.007211451,"about_ca_topic_score_gemma":0.017321784,"teacher_disagreement_score":0.19270137,"about_ca_system_score_codex":0.00023147085,"about_ca_system_score_gemma":0.00015966829,"threshold_uncertainty_score":0.9999463},"labels":[],"label_agreement":null},{"id":"W2053420373","doi":"10.1182/blood-2014-05-576470","title":"Opposing regulation of BIM and BCL2 controls glucocorticoid-induced apoptosis of pediatric acute lymphoblastic leukemia cells","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"Cancer Council NSW; National Health and Medical Research Council; Medical Research Council; University of North Carolina at Chapel Hill; University of New South Wales","keywords":"Apoptosis; Lymphoblastic Leukemia; Glucocorticoid; Cancer research; Medicine; Leukemia; Acute lymphocytic leukemia; Venetoclax; Immunology; Internal medicine; Biology; Chronic lymphocytic leukemia; Genetics","score_opus":0.005710001004678429,"score_gpt":0.20361768547763687,"score_spread":0.19790768447295845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053420373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943834,0.00020106847,0.004981821,0.0000073517817,0.0000989402,0.00018447488,0.0000065234244,0.000005494299,0.00013090808],"genre_scores_gemma":[0.9985966,0.00020067155,0.00093050866,0.000014423287,0.0001436988,0.0000045832994,0.000028860188,0.000014880718,0.000065789725],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99925554,0.00003861578,0.000264919,0.0002088711,0.000110437,0.000121589954],"domain_scores_gemma":[0.99942696,0.00002395264,0.00021772493,0.00021062813,0.00007720867,0.000043504464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012085957,0.00010686383,0.00018766642,0.000058847738,0.000029197861,0.000008374424,0.000060590293,0.00014354165,0.0000043780046],"category_scores_gemma":[0.000027971428,0.00009894614,0.0000642313,0.00007669943,0.000022242375,0.000004030703,0.0000437927,0.000025068886,0.0000010381578],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003900088,0.00005541833,0.0007472765,0.000058722417,0.000057775786,8.939296e-8,0.000015510881,0.00017294225,0.9971254,0.00022516928,0.000006786995,0.0014959052],"study_design_scores_gemma":[0.0019144783,0.0003972204,0.007640964,0.000013225849,0.00032544712,0.0000037349857,0.000007661926,0.0016094496,0.987814,0.00011739812,0.000048729813,0.000107661865],"about_ca_topic_score_codex":0.000012730809,"about_ca_topic_score_gemma":0.0000013072215,"teacher_disagreement_score":0.009311374,"about_ca_system_score_codex":0.000006753934,"about_ca_system_score_gemma":0.00005031193,"threshold_uncertainty_score":0.40349066},"labels":[],"label_agreement":null},{"id":"W2053574838","doi":"10.1182/blood-2008-12-195677","title":"Skewing of X-inactivation ratios in blood cells of aging women is confirmed by independent methodologies","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"National Heart, Lung, and Blood Institute","keywords":"X-inactivation; Polymerase chain reaction; TaqMan; Biology; SNP; Skewed X-inactivation; Reverse transcription polymerase chain reaction; Single-nucleotide polymorphism; X chromosome; Molecular biology; Genetics; Immunology; Andrology; Gene; Medicine; Genotype; Messenger RNA","score_opus":0.01800633684768952,"score_gpt":0.2816039366411407,"score_spread":0.26359759979345115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053574838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988071,0.00027846915,0.00023011466,0.00010163284,0.000022663926,0.00009106539,0.000013210436,0.000005001423,0.00045079633],"genre_scores_gemma":[0.9982564,0.00015250205,0.0011922336,0.00021241595,0.00002283699,0.0000062083773,0.000010349344,0.000004232312,0.00014283643],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99916357,0.00006905701,0.00033798863,0.00017316802,0.00011488905,0.00014134754],"domain_scores_gemma":[0.99956524,0.000035439385,0.00016083644,0.0001414539,0.000065130145,0.000031871063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002296699,0.000090453046,0.00018398438,0.00003771974,0.000017452461,0.0000075114735,0.00012073464,0.00010457706,0.000033934277],"category_scores_gemma":[0.000073694035,0.000086367014,0.000049597937,0.000057493256,0.000048682443,0.0000048909683,0.000040923333,0.00005985312,3.726882e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020755218,0.00034184332,0.0045233723,0.000028294138,0.000033540273,0.0000011972885,0.0004986461,0.000012468211,0.9925841,0.000045514458,0.000015005833,0.0018952299],"study_design_scores_gemma":[0.001209818,0.000535441,0.020127226,0.000019608158,0.000019099742,0.0000019816732,0.0011922707,0.0000032344344,0.97605866,0.000696714,0.000043869735,0.000092089234],"about_ca_topic_score_codex":0.0000112727075,"about_ca_topic_score_gemma":0.00000209502,"teacher_disagreement_score":0.016525485,"about_ca_system_score_codex":0.000003555936,"about_ca_system_score_gemma":0.000031377862,"threshold_uncertainty_score":0.35219446},"labels":[],"label_agreement":null},{"id":"W2053899257","doi":"10.1182/blood-2010-01-265652","title":"A germline gain-of-function mutation in Ptpn11 (Shp-2) phosphatase induces myeloproliferative disease by aberrant activation of hematopoietic stem cells","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"PTPN11; Juvenile myelomonocytic leukemia; Biology; Cancer research; Haematopoiesis; Stem cell; Protein tyrosine phosphatase; Noonan syndrome; Mutation; Immunology; Cell biology; Signal transduction; Genetics; KRAS","score_opus":0.0072392645921468025,"score_gpt":0.22750237119019656,"score_spread":0.22026310659804976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053899257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960302,0.0023071363,0.000753413,0.000051294628,0.0000904266,0.00044835923,0.0002953694,0.0000088010775,0.000014966345],"genre_scores_gemma":[0.99871117,0.000044553144,0.0003217499,0.00004572686,0.000054824384,0.00008168804,0.00069140515,0.0000188292,0.000030058838],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998968,0.000052876774,0.0003556358,0.0002962345,0.00017158128,0.00015567952],"domain_scores_gemma":[0.9992241,0.000025162415,0.0002665665,0.00028810912,0.00011839388,0.0000776539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016666121,0.00015811968,0.00018263982,0.00005916623,0.000030558356,0.000010132081,0.00012273339,0.00012185438,0.000017748715],"category_scores_gemma":[0.00008708767,0.0001548116,0.00005553068,0.00015262,0.000080654245,0.000017133547,0.000049989547,0.000118910626,0.0000023476018],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032875716,0.00065643294,0.0014753572,0.00010236894,0.000039504153,0.0000040489463,0.000093309915,0.00003778481,0.9955758,0.00038842496,0.00017215348,0.0011260568],"study_design_scores_gemma":[0.0015861308,0.0002617689,0.002085647,0.00004972986,0.00005399116,0.0000029312598,0.000053656564,0.0000394769,0.9954101,0.00018250383,0.00012270143,0.00015137799],"about_ca_topic_score_codex":0.000050392926,"about_ca_topic_score_gemma":0.000015873593,"teacher_disagreement_score":0.0026809312,"about_ca_system_score_codex":0.000005650353,"about_ca_system_score_gemma":0.00010765593,"threshold_uncertainty_score":0.63130337},"labels":[],"label_agreement":null},{"id":"W2053957384","doi":"10.1182/blood-2003-05-1426","title":"Helper-dependent adenoviral vectors mediate therapeutic factor VIII expression for several months with minimal accompanying toxicity in a canine model of severe hemophilia A","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Queen's University","funders":"Canadian Institutes of Health Research; Canadian Blood Services; Heart and Stroke Foundation of Canada","keywords":"Factor IX; Toxicity; Medicine; Viral vector; Immunology; Internal medicine; Cancer research; Biology; Genetics; Recombinant DNA; Gene","score_opus":0.0396295790725316,"score_gpt":0.28976957171688295,"score_spread":0.2501399926443513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053957384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978063,0.00036834332,0.00009093156,0.00016526281,0.000034543285,0.0011959653,0.00007190328,0.000034127675,0.00023259463],"genre_scores_gemma":[0.9970831,0.000031402164,0.0020213753,0.000049210284,0.00005499661,0.00011945287,0.000020758313,0.00004473804,0.0005749107],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99815553,0.00007079621,0.00034321504,0.00038606924,0.0005328304,0.00051153166],"domain_scores_gemma":[0.9992252,0.000101768506,0.000091134694,0.00028382955,0.00010372543,0.00019436122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017538702,0.00026644306,0.00052679214,0.00014367363,0.000072983974,0.00001342495,0.00012102468,0.00015309153,0.00005995045],"category_scores_gemma":[0.00006745131,0.00018020658,0.00011674061,0.0001963711,0.00006580992,0.00011133811,0.0000359826,0.00023594417,0.000002500604],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037929406,0.005607312,0.27285525,0.00062920543,0.00048351302,0.00017155956,0.0043298146,0.0013648133,0.709252,0.00004875467,0.000028944232,0.0014358725],"study_design_scores_gemma":[0.04158941,0.0025404824,0.053371318,0.00062882,0.0003748609,0.0001359154,0.0007945887,0.008082662,0.89169043,0.00017414577,0.000026251377,0.0005911382],"about_ca_topic_score_codex":0.00005884481,"about_ca_topic_score_gemma":0.000116268886,"teacher_disagreement_score":0.21948394,"about_ca_system_score_codex":0.00010152109,"about_ca_system_score_gemma":0.00031412052,"threshold_uncertainty_score":0.73486114},"labels":[],"label_agreement":null},{"id":"W2054087543","doi":"10.1182/blood-2010-01-261958","title":"Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of British Columbia; Alberta Children's Hospital","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute; U.S. Public Health Service; National Institutes of Health","keywords":"Medicine; Internal medicine; Human leukocyte antigen; Myeloid leukemia; Transplantation; Leukemia; Bone marrow; Immunology; Sibling; Oncology; Myelodysplastic syndromes; Graft-versus-host disease; Gastroenterology; Antigen","score_opus":0.019452000052071036,"score_gpt":0.27530311336929053,"score_spread":0.2558511133172195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054087543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965744,0.00010375279,0.001202724,0.00021030853,0.00031057675,0.0012077898,0.00006535503,0.00013296542,0.00019215255],"genre_scores_gemma":[0.9720727,0.00036338146,0.026788505,0.000044123462,0.00011336808,0.000040798932,0.00015705518,0.0000799792,0.00034009526],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979363,0.000043436215,0.0009164138,0.00041456055,0.00032669233,0.00036257796],"domain_scores_gemma":[0.99853855,0.0004438588,0.0003523917,0.00030858934,0.00015723312,0.00019938295],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046230794,0.00031661798,0.0007564706,0.0003715035,0.00009058039,0.000022598444,0.00009142713,0.00047966168,0.00010772008],"category_scores_gemma":[0.00011714405,0.00026474532,0.0001506832,0.00045320342,0.00008105558,0.00014047808,0.000010094005,0.00034344732,0.000008336959],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001046826,0.0003779447,0.274207,0.003686561,0.00043698266,0.00015994252,0.0040540835,0.00002778697,0.71568084,0.00014882305,0.000024276364,0.00014892514],"study_design_scores_gemma":[0.064246014,0.0008756082,0.34039867,0.00065335754,0.015876442,0.004835217,0.0014796392,0.0038108397,0.56569594,0.00086872984,0.00003954021,0.0012199784],"about_ca_topic_score_codex":0.000103674785,"about_ca_topic_score_gemma":0.000045381814,"teacher_disagreement_score":0.14998488,"about_ca_system_score_codex":0.000030569587,"about_ca_system_score_gemma":0.00027669815,"threshold_uncertainty_score":0.99998045},"labels":[],"label_agreement":null},{"id":"W2054216490","doi":"10.1182/blood-2010-04-277806","title":"NUP98-MLL fusion in human acute myeloblastic leukemia","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institut National Du Cancer; Institute of Cancer Research; Institut National de la Santé et de la Recherche Médicale","keywords":"Biology; Fusion protein; Chromatin; Homeobox; Histone; PHD finger; Cancer research; Myeloid leukemia; Fusion gene; Histone H3; Genetics; Gene; Molecular biology; Cell biology; Transcription factor; Zinc finger","score_opus":0.011260707043239377,"score_gpt":0.2915121533797395,"score_spread":0.2802514463365001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054216490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97514963,0.00003832624,0.000013412887,0.00053891935,0.00014238323,0.00042858513,0.0000071643203,0.00010830065,0.02357329],"genre_scores_gemma":[0.9936734,0.000030363974,0.00088445406,0.0003016281,0.00043523998,0.00003995696,0.000043925935,0.000049222384,0.0045418083],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982859,0.00002809133,0.00030770537,0.00039479675,0.00043449498,0.000549028],"domain_scores_gemma":[0.9989076,0.00008165995,0.00005366911,0.00059745595,0.00009072033,0.00026885362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003169263,0.00019573965,0.0003437244,0.00030333773,0.00010000426,0.000027442626,0.00025279852,0.00025548172,0.00073663116],"category_scores_gemma":[0.00020629665,0.00016973968,0.00008613554,0.0004036377,0.0001296852,0.00008983388,0.00018244729,0.0012619488,0.00044136442],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010286114,0.0004289189,0.020253228,0.000062468156,0.000086324144,0.0015915048,0.00028572843,9.968632e-7,0.9710765,0.0005322505,0.0029750045,0.0026042452],"study_design_scores_gemma":[0.03615072,0.0016193636,0.5658871,0.00038232107,0.0007334868,0.0019016879,0.00023400817,0.00088760833,0.36282223,0.0011725313,0.027283508,0.00092544674],"about_ca_topic_score_codex":0.0002505109,"about_ca_topic_score_gemma":0.00030359154,"teacher_disagreement_score":0.60825425,"about_ca_system_score_codex":0.00020030534,"about_ca_system_score_gemma":0.00049542106,"threshold_uncertainty_score":0.8065595},"labels":[],"label_agreement":null},{"id":"W2054742296","doi":"10.1182/blood-2005-02-0556","title":"Providing research results to study participants: support versus practice of researchers presenting at the American Society of Hematology annual meeting","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Psychological intervention; Family medicine; Medicine; Institutional review board; Psychology; Medical education; Nursing; Psychiatry","score_opus":0.658938684927355,"score_gpt":0.6440661496712589,"score_spread":0.014872535256096109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054742296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9587987,0.000114039125,0.0000023479645,0.032063816,0.00003301001,0.001537981,0.000025778842,0.000026421334,0.007397911],"genre_scores_gemma":[0.992981,0.00012758498,0.0049817697,0.00022167996,0.0002081299,0.000108190965,0.0000037302789,0.000037862552,0.0013300583],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.99059963,0.0022641022,0.0013242151,0.00072685553,0.0038424393,0.0012427703],"domain_scores_gemma":[0.9191872,0.07457835,0.0005911168,0.001453005,0.0037244442,0.0004658672],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.053194232,0.00014823467,0.00058299483,0.00015949554,0.0003450461,0.000023792949,0.0006557113,0.00015437613,0.000038818504],"category_scores_gemma":[0.22466628,0.00010982429,0.0001641084,0.0014530387,0.0014683357,0.0001314223,0.0017398653,0.0024508086,0.00004042807],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06954481,0.04582351,0.46364355,0.002871348,0.008509821,0.0006300771,0.26693445,0.00027888134,0.078141406,0.0023648134,0.04298858,0.01826877],"study_design_scores_gemma":[0.03686001,0.032625485,0.042377654,0.0009998182,0.001204325,0.00009228856,0.490605,0.0004719963,0.37505543,0.00028977892,0.018838186,0.0005800278],"about_ca_topic_score_codex":0.000778149,"about_ca_topic_score_gemma":0.0005749104,"teacher_disagreement_score":0.4212659,"about_ca_system_score_codex":0.00013910633,"about_ca_system_score_gemma":0.0009104445,"threshold_uncertainty_score":0.9998506},"labels":[],"label_agreement":null},{"id":"W2054830906","doi":"10.1182/blood-2008-08-174953","title":"Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformation","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Cancer Research UK","keywords":"Follicular lymphoma; Transformation (genetics); Medicine; Uniparental disomy; Lymphoma; Survival analysis; Oncology; Biology; Internal medicine; Genetics; Gene","score_opus":0.011204330696069529,"score_gpt":0.2225724274465951,"score_spread":0.2113680967505256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054830906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980757,0.00079733675,0.000007474047,0.0001668085,0.000012101467,0.00035484563,0.00020273101,0.000015072573,0.00036789532],"genre_scores_gemma":[0.9983732,0.0013758678,0.00006243848,0.000014339731,0.000008421777,0.000022298223,0.000119609016,0.000009136638,0.00001468017],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991068,0.000052576666,0.0003019141,0.00013845625,0.00027156537,0.00012868455],"domain_scores_gemma":[0.9992379,0.000100294375,0.00033465776,0.00017639076,0.000076443626,0.000074311254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007657248,0.0001338396,0.0004539036,0.00006341307,0.000040311883,0.0000030800873,0.000037156926,0.00007083976,0.000009614533],"category_scores_gemma":[0.000039419825,0.000097340475,0.0001184939,0.00013651626,0.00006945303,0.0000677371,0.000009740662,0.000012092151,2.826327e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022009375,0.004822975,0.9917163,0.00005950032,0.00081192405,0.000018573091,0.00059229514,0.0000050465806,0.0005136198,0.00029170085,0.00004364186,0.0009042813],"study_design_scores_gemma":[0.016414516,0.0012197386,0.9243068,0.0004389478,0.0016983063,0.0000133303865,0.00019154727,0.000018284534,0.055545244,0.000048598937,0.000022856753,0.000081822414],"about_ca_topic_score_codex":0.00027806655,"about_ca_topic_score_gemma":0.00019750377,"teacher_disagreement_score":0.067409545,"about_ca_system_score_codex":0.000062449806,"about_ca_system_score_gemma":0.000038102524,"threshold_uncertainty_score":0.39694294},"labels":[],"label_agreement":null},{"id":"W2054911279","doi":"10.1182/blood-2006-08-039628","title":"Forced expression of Nanog in hematopoietic stem cells results in a γδT-cell disorder","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Foundation for Biomedical Research and Innovation; University of Toronto","keywords":"Homeobox protein NANOG; Stem cell; Biology; Haematopoiesis; Rex1; CD44; IL-2 receptor; Cell biology; Embryonic stem cell; Cancer research; Immunology; T cell; Induced pluripotent stem cell; Cell; Immune system","score_opus":0.008006178726216501,"score_gpt":0.21079439275850745,"score_spread":0.20278821403229094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054911279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913006,0.0047963047,0.000035724188,0.000036050504,0.00031369887,0.00030296497,0.000015502783,0.000033728655,0.0031654635],"genre_scores_gemma":[0.9957987,0.00014869362,0.00007615872,0.000028934777,0.000009023532,0.000013102107,0.000025858079,0.000019676554,0.0038798463],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981095,0.0001685411,0.00075869414,0.0003769574,0.000041075753,0.0005451895],"domain_scores_gemma":[0.99908286,0.0002487138,0.00021350214,0.00040406224,0.00003178128,0.000019095709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050329504,0.00020620853,0.00042257653,0.00028139306,0.00004652885,0.000003818647,0.00028479367,0.00046313027,0.00008416304],"category_scores_gemma":[0.000017390397,0.00018050909,0.00008557886,0.0002820334,0.00014932736,0.000054611846,0.00013446083,0.00036589857,0.00016720369],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048833713,0.0017055356,0.0034846968,0.000058434976,0.00001590863,0.000035890662,0.0015395489,0.000005748537,0.99188215,0.000059751874,0.00016320556,0.0005608197],"study_design_scores_gemma":[0.011635339,0.00025939324,0.0009137864,0.00012653002,0.000018491783,0.00002472331,0.0010531318,6.5026484e-7,0.98258036,0.00006133995,0.003133883,0.00019235961],"about_ca_topic_score_codex":0.0002164779,"about_ca_topic_score_gemma":0.0002929218,"teacher_disagreement_score":0.011147002,"about_ca_system_score_codex":0.000018442928,"about_ca_system_score_gemma":0.000040517807,"threshold_uncertainty_score":0.73609465},"labels":[],"label_agreement":null},{"id":"W2054991963","doi":"10.1182/blood-2002-05-1404","title":"Mouse T cells receive costimulatory signals from LIGHT, a TNF family member","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"T-cell receptor; Biology; CD28; Cell biology; Tumor necrosis factor alpha; T cell; Lymphokine; Molecular biology; CD3; Receptor; Immunology; Antigen; CD8; Immune system; Biochemistry","score_opus":0.016668616214025492,"score_gpt":0.20983022012728555,"score_spread":0.19316160391326007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054991963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98267525,0.007938936,0.000022813723,0.00013692875,0.00037944072,0.00020351745,0.000033071516,0.00011704145,0.008493006],"genre_scores_gemma":[0.98462814,0.00035871187,0.000065675005,0.00035937762,0.0000664428,0.000014503747,0.000074505835,0.000023952793,0.0144086685],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998881,0.00024028681,0.0002981738,0.00025203952,0.000039947805,0.00028854996],"domain_scores_gemma":[0.99928343,0.00018309614,0.00011010707,0.00034252118,0.0000590198,0.000021818389],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00012501563,0.00017385565,0.00024265407,0.00008389152,0.00013333296,0.000018614815,0.00017731792,0.00029854715,0.0038757105],"category_scores_gemma":[0.00004479067,0.00015864128,0.00010247839,0.00008473441,0.000057654164,0.00012656004,0.000047600475,0.00022568901,0.010412142],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006891403,0.00027433416,0.0000674329,0.000003598974,0.00024088235,0.000011210428,0.00063036307,0.000008843222,0.97548544,0.000021236583,0.021867497,0.0013202382],"study_design_scores_gemma":[0.0020963135,0.00009795477,0.00048222856,0.000020200845,0.00009702693,0.0000075783455,0.00007758653,0.000011081813,0.88538074,0.000035941393,0.1115098,0.00018356735],"about_ca_topic_score_codex":0.000068552275,"about_ca_topic_score_gemma":0.0000037235313,"teacher_disagreement_score":0.09010473,"about_ca_system_score_codex":0.000016496526,"about_ca_system_score_gemma":0.00001750209,"threshold_uncertainty_score":0.9970349},"labels":[],"label_agreement":null},{"id":"W2055017279","doi":"10.1182/blood-2011-07-364141","title":"Mechanism of catheter thrombosis: comparison of the antithrombotic activities of fondaparinux, enoxaparin, and heparin in vitro and in vivo","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Fondaparinux; Heparin; Medicine; Bivalirudin; Activated clotting time; Thrombosis; Catheter; Anticoagulant; Anesthesia; Pharmacology; Surgery; Percutaneous coronary intervention; Internal medicine; Myocardial infarction","score_opus":0.06818948562095706,"score_gpt":0.30223552149631544,"score_spread":0.23404603587535838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055017279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981479,0.00018406921,0.000012542396,0.00003918202,0.000036324407,0.00028908777,0.0000027589354,0.0000046846976,0.0012834239],"genre_scores_gemma":[0.9993652,0.000050074716,0.00051081687,0.000010894914,0.000011850802,0.0000014704367,4.8717493e-7,0.000007369891,0.000041795694],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992938,0.000039135506,0.0003313557,0.00011473518,0.00012582957,0.00009512633],"domain_scores_gemma":[0.9995691,0.000063679865,0.00016759156,0.00016475935,0.000016139838,0.00001869956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014479265,0.00008541542,0.00047189614,0.00012453318,0.000011396732,0.000002146036,0.000052301333,0.000050958617,0.000017617976],"category_scores_gemma":[0.000035460034,0.00006233345,0.000049364993,0.0001269384,0.00010934647,0.00005711503,0.00009811105,0.00006219874,1.0834643e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011222889,0.00015957018,0.86491233,0.00021023552,0.00006812609,4.2735502e-7,0.0029125654,0.0000010142834,0.12972979,0.0017987475,0.000002622205,0.000092352755],"study_design_scores_gemma":[0.001300345,0.00011759677,0.54002005,0.000097416996,0.00013260735,9.62027e-7,0.00060250907,0.00007235577,0.45723075,0.0003801185,0.0000041631265,0.000041139618],"about_ca_topic_score_codex":0.00046537985,"about_ca_topic_score_gemma":0.00020355178,"teacher_disagreement_score":0.32750097,"about_ca_system_score_codex":0.0000053472336,"about_ca_system_score_gemma":0.000016212101,"threshold_uncertainty_score":0.25418842},"labels":[],"label_agreement":null},{"id":"W2055085510","doi":"10.1182/blood-2007-03-077602","title":"The ABO blood group system and Plasmodium falciparum malaria","year":2007,"lang":"en","type":"review","venue":"Blood","topic":"Malaria Research and Control","field":"Medicine","cited_by":316,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"ABO blood group system; Malaria; Plasmodium falciparum; Immunology; Biology; Virology; Medicine","score_opus":0.03291280048494673,"score_gpt":0.31429331432804275,"score_spread":0.28138051384309604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055085510","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000022490536,0.98657,0.000024605813,0.00026607802,0.00024857416,0.0023517497,0.00005924374,0.00011452962,0.0103427],"genre_scores_gemma":[0.00048748511,0.99523395,0.000099195066,0.00004230881,0.0009619795,0.00036068723,0.00007380415,0.00008728379,0.0026532966],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968646,0.0002559098,0.00073098944,0.000572441,0.0006766978,0.0008993315],"domain_scores_gemma":[0.99764824,0.00061798596,0.0002496787,0.00087954674,0.000101861035,0.0005026596],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013696587,0.0005057386,0.0017621639,0.00019864338,0.00029501435,0.00016301882,0.00038964298,0.0005408686,0.00003731198],"category_scores_gemma":[0.0002183923,0.0002878291,0.00046692352,0.00029388804,0.00014254994,0.00003919164,0.00018182839,0.0010263757,0.00013767644],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021789096,0.00092430686,0.00006484335,0.073031686,0.005394785,0.0025177929,0.00002988208,9.859017e-9,0.000009590702,0.06033951,0.001164337,0.85630536],"study_design_scores_gemma":[0.0039395276,0.00041316432,0.000087497014,0.008910322,0.007302317,0.002387763,0.000039580384,0.000004889234,0.0000035361238,0.000010836107,0.9766227,0.0002778402],"about_ca_topic_score_codex":0.00004032172,"about_ca_topic_score_gemma":0.000025449499,"teacher_disagreement_score":0.9754584,"about_ca_system_score_codex":0.000046490495,"about_ca_system_score_gemma":0.00037850795,"threshold_uncertainty_score":0.9999574},"labels":[],"label_agreement":null},{"id":"W2055264579","doi":"10.1182/blood-2007-01-070300","title":"Concordant but not discordant bone marrow involvement in diffuse large B-cell lymphoma predicts a poor clinical outcome independent of the International Prognostic Index","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":143,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"International Prognostic Index; Internal medicine; Diffuse large B-cell lymphoma; Medicine; Proportional hazards model; Lymphoma; Bone marrow; Concordance; Lactate dehydrogenase; B symptoms; Oncology; Gastroenterology; Biology","score_opus":0.025528312612662724,"score_gpt":0.29390138224688483,"score_spread":0.26837306963422214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055264579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99629885,0.00022822815,0.00003846651,0.00087471865,0.0006041545,0.0012323214,0.00010587886,0.00003028735,0.0005871243],"genre_scores_gemma":[0.997745,0.00008281299,0.00018050882,0.0012835718,0.0001779044,0.00010651746,0.00004105509,0.000029129349,0.00035350173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996763,0.00007489971,0.0013097934,0.00044812038,0.000945617,0.0004585574],"domain_scores_gemma":[0.9984502,0.000330529,0.00039422626,0.00049096113,0.0001079692,0.0002260967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010200429,0.0002662631,0.0005706442,0.0001562207,0.00004889235,0.000022572283,0.00029497166,0.0001195186,0.00003506736],"category_scores_gemma":[0.00035176674,0.000168842,0.0003063603,0.00018954188,0.000115765775,0.000060997674,0.00035513737,0.00018332918,0.000018225846],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046246644,0.06085584,0.9342614,0.00007812214,0.000238909,0.0010025394,0.00016952246,3.7778977e-7,0.001726887,0.00020078341,0.00009076767,0.0009123959],"study_design_scores_gemma":[0.078490146,0.00055275497,0.89427364,0.00025561987,0.00034128776,0.00010880715,0.00030390464,0.00009224104,0.024963075,0.000024501356,0.0004463569,0.00014766806],"about_ca_topic_score_codex":0.0003784992,"about_ca_topic_score_gemma":0.0010064419,"teacher_disagreement_score":0.07802768,"about_ca_system_score_codex":0.00024231499,"about_ca_system_score_gemma":0.00029218386,"threshold_uncertainty_score":0.6885177},"labels":[],"label_agreement":null},{"id":"W2055306584","doi":"10.1182/blood-2009-05-222729","title":"Deferasirox pharmacokinetics in patients with adequate versus inadequate response","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Heart, Lung, and Blood Institute; National Center for Research Resources; Harvard Catalyst","keywords":"Deferasirox; Medicine; Internal medicine; Gastroenterology; Pharmacokinetics; Cmax; Deferoxamine; Dosing; Thalassemia; Pharmacology","score_opus":0.009536608685923839,"score_gpt":0.24541176337004708,"score_spread":0.23587515468412323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055306584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958681,0.00029120062,0.0000066607645,0.0009422424,0.00010390098,0.00035210073,0.0000039841984,0.000055553788,0.0023762984],"genre_scores_gemma":[0.9989804,0.000055175322,0.00022358606,0.00046597284,0.000025413352,0.0000056509566,0.000017880084,0.000018539948,0.00020735168],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989479,0.00005895552,0.00020575876,0.00021676098,0.00024745334,0.00032317895],"domain_scores_gemma":[0.99949604,0.000045574685,0.000048006197,0.00020889167,0.000058123103,0.00014336317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012601742,0.00015461243,0.00019904907,0.00013744687,0.000036942758,0.000010206143,0.0000649186,0.00010339724,0.00005532304],"category_scores_gemma":[0.00007443283,0.00011768124,0.000039853487,0.00033872997,0.000036426376,0.000045687306,0.00001252325,0.0002696442,0.000048884045],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2305837,0.024066674,0.57911134,0.00014436398,0.0009454543,0.0025928223,0.004250162,0.0003067337,0.005096426,0.0005422659,0.0016426252,0.15071742],"study_design_scores_gemma":[0.07773275,0.0056410283,0.91189045,0.000141156,0.00036916923,0.000011874134,0.00014101372,0.000043006876,0.00201125,0.00002882548,0.001712535,0.00027696943],"about_ca_topic_score_codex":0.000009217647,"about_ca_topic_score_gemma":0.0000021922433,"teacher_disagreement_score":0.33277908,"about_ca_system_score_codex":0.000033030246,"about_ca_system_score_gemma":0.000068164176,"threshold_uncertainty_score":0.47989017},"labels":[],"label_agreement":null},{"id":"W2055389755","doi":"10.1182/blood-2014-05-577825","title":"Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":426,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"National Institute of Allergy and Infectious Diseases; National Institute of General Medical Sciences; National Cancer Institute; National Institutes of Health; Dan L. Duncan Cancer Center, Baylor College of Medicine; Lester and Sue Smith Foundation; National Human Genome Research Institute; Texas Children's Hospital; Deutsche Forschungsgemeinschaft; Howard Hughes Medical Institute","keywords":"MAPK/ERK pathway; Somatic cell; Kinase; Mutation; Mutant; Cancer research; Phosphorylation; Biology; Protein kinase A; Cell biology; Genetics; Gene","score_opus":0.008187265647701976,"score_gpt":0.2352227689866391,"score_spread":0.22703550333893713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055389755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984519,0.0002870117,0.0002989043,0.00019639592,0.00013580787,0.00037686148,0.000019515965,0.000018098212,0.00021553066],"genre_scores_gemma":[0.99914825,0.000021809623,0.00016717312,0.00009322112,0.0000140858465,0.00010257257,0.00014017384,0.000010966968,0.0003017607],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999083,0.00018694915,0.0002551446,0.00018254717,0.000017964103,0.0002744273],"domain_scores_gemma":[0.999552,0.00023444928,0.00006937547,0.00010967073,0.000020830157,0.000013650998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015804039,0.00010913967,0.00018425504,0.00016166526,0.000063465865,0.000011538921,0.00007519246,0.00012464613,0.00008270669],"category_scores_gemma":[0.00017694155,0.00010525368,0.000039861654,0.00007045027,0.000045185483,0.000073271185,0.00003496226,0.00010074962,0.000023245766],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004700582,0.00072078157,0.010268542,0.000057706304,0.00006016154,0.0000017681649,0.004374718,0.0000039941806,0.9667825,0.00081912085,0.00008575875,0.016354874],"study_design_scores_gemma":[0.009468527,0.0011547578,0.38421172,0.0001671212,0.00008257933,0.000065054235,0.0022166732,0.00009916297,0.5975731,0.0010728603,0.0035498664,0.0003385753],"about_ca_topic_score_codex":0.000026410507,"about_ca_topic_score_gemma":0.000098001125,"teacher_disagreement_score":0.37394318,"about_ca_system_score_codex":0.000019685349,"about_ca_system_score_gemma":0.00005418959,"threshold_uncertainty_score":0.42921203},"labels":[],"label_agreement":null},{"id":"W2055421409","doi":"10.1182/blood-2012-09-454348","title":"Antibodies against neutrophil LY6G do not inhibit leukocyte recruitment in mice in vivo","year":2013,"lang":"en","type":"letter","venue":"Blood","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"In vivo; Immunology; Antibody; Medicine; Molecular biology; Biology; Genetics","score_opus":0.033416053068762816,"score_gpt":0.246057785961192,"score_spread":0.21264173289242916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055421409","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9043457,0.0040148827,0.0000023564726,0.08581758,0.0012610793,0.0020178757,0.00023879383,0.000119864526,0.0021818548],"genre_scores_gemma":[0.25640398,0.0056582815,0.0003483136,0.7174645,0.0017892307,0.0015861827,0.0018186279,0.0003606023,0.014570269],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958311,0.0006717239,0.0009562799,0.0012045879,0.00012140613,0.0012149477],"domain_scores_gemma":[0.9985789,0.00020826636,0.00036749803,0.0007138774,0.00009709584,0.000034366],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00029807753,0.0008757928,0.001275375,0.000841723,0.00013067914,0.00007022998,0.00069333916,0.0018984872,0.0006215778],"category_scores_gemma":[0.00004060665,0.0007972537,0.00024880303,0.00034397043,0.0002472469,0.00019378112,0.00038245972,0.0031152407,0.0016456232],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006540072,0.00040317202,0.0002737536,0.00013268086,0.0002552606,0.0014521384,0.00030809693,0.0000022366578,0.7724536,0.00008843051,0.22395198,0.00061321637],"study_design_scores_gemma":[0.0038247337,0.00018864522,0.0004438047,0.00047435478,0.00008731748,0.00007201255,0.00006476512,2.0740872e-7,0.598409,0.0001308763,0.395611,0.0006932993],"about_ca_topic_score_codex":0.000317777,"about_ca_topic_score_gemma":0.00010799252,"teacher_disagreement_score":0.6479417,"about_ca_system_score_codex":0.00017420875,"about_ca_system_score_gemma":0.00011917926,"threshold_uncertainty_score":0.9994478},"labels":[],"label_agreement":null},{"id":"W2055450998","doi":"10.1182/blood-2005-11-025536","title":"Minimally differentiated acute myeloid leukemia (FAB AML-M0) is associated with an adverse outcome in children: a report from the Children's Oncology Group, studies CCG-2891 and CCG-2961","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; BC Children's Hospital","funders":"National Cancer Institute","keywords":"Myeloid leukemia; Internal medicine; White blood cell; Gastroenterology; Medicine; Leukemia; Trisomy; Incidence (geometry); Biology","score_opus":0.017075726083339123,"score_gpt":0.2920350298965719,"score_spread":0.27495930381323275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055450998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947873,0.0009786917,0.000004542255,0.0015085401,0.0000684128,0.0017567043,0.00027494144,0.00021117007,0.00040973283],"genre_scores_gemma":[0.99486667,0.0003273109,0.0006922684,0.0010401717,0.0003906645,0.00015313769,0.0016107772,0.00011596186,0.0008030511],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954425,0.0004139895,0.0010813656,0.0011872977,0.0008839017,0.0009909254],"domain_scores_gemma":[0.9973926,0.00047054543,0.00053720264,0.0010349334,0.00028528355,0.00027942503],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00077577104,0.00064705755,0.0014130083,0.00028186443,0.00029461406,0.00005982661,0.00045016382,0.0004768145,0.00006904431],"category_scores_gemma":[0.00048431434,0.00042736816,0.00017492936,0.0007326661,0.0006611193,0.00024220766,0.00038315807,0.0012526637,0.000022279366],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007324825,0.0015456317,0.98557293,0.000013160298,0.0037369106,0.002596908,0.0008841293,0.0000017110079,0.0024930544,0.000011508047,0.0019521584,0.00045940946],"study_design_scores_gemma":[0.024733193,0.0015166801,0.9678291,0.00015363938,0.0020285316,0.0015319181,0.00051729655,0.00005973622,0.0009747529,0.000072537354,0.00011053829,0.00047206154],"about_ca_topic_score_codex":0.0049029887,"about_ca_topic_score_gemma":0.003401453,"teacher_disagreement_score":0.024000712,"about_ca_system_score_codex":0.0010298659,"about_ca_system_score_gemma":0.00067130383,"threshold_uncertainty_score":0.9998178},"labels":[],"label_agreement":null},{"id":"W2055884944","doi":"10.1182/blood-2013-12-540971","title":"Phase 2 trial of CPX-351, a fixed 5:1 molar ratio of cytarabine/daunorubicin, vs cytarabine/daunorubicin in older adults with untreated AML","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":336,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Celator Pharmaceuticals","keywords":"Daunorubicin; Cytarabine; Medicine; Internal medicine; Leukemia; Oncology; Gastroenterology","score_opus":0.008712615199877411,"score_gpt":0.268214824499536,"score_spread":0.25950220929965856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055884944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941513,0.0002021686,0.0003339314,0.00064184534,0.00007716498,0.003051094,0.000070430804,0.00008437615,0.0013877004],"genre_scores_gemma":[0.99697435,0.000099435594,0.0012929579,0.00018442518,0.000282208,0.00016317534,0.00025348522,0.00010115141,0.000648797],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99575305,0.00039804625,0.0012623298,0.0007557084,0.0010514437,0.0007793996],"domain_scores_gemma":[0.9970293,0.0004016994,0.0004665153,0.0011596351,0.0006102259,0.00033263743],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009577667,0.00050529087,0.0015298451,0.0007359299,0.000060234415,0.000017291644,0.00039037917,0.0003399307,0.00032403364],"category_scores_gemma":[0.0008751726,0.00039220092,0.000213194,0.001327402,0.00033407554,0.0001795989,0.000108921755,0.0006907537,0.00003701594],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.51378816,0.039057042,0.037016034,0.0022964287,0.0015716645,0.0008839256,0.005277124,0.00017820316,0.3881347,0.00040764644,0.0035175367,0.007871539],"study_design_scores_gemma":[0.63310987,0.018820297,0.009557768,0.0012126486,0.0006170558,0.00011520412,0.00033001901,0.0032155118,0.33217236,0.00002246691,0.0003777319,0.00044908962],"about_ca_topic_score_codex":0.0016029011,"about_ca_topic_score_gemma":0.0002962342,"teacher_disagreement_score":0.1193217,"about_ca_system_score_codex":0.00016047762,"about_ca_system_score_gemma":0.0007479514,"threshold_uncertainty_score":0.999853},"labels":[],"label_agreement":null},{"id":"W2056144642","doi":"10.1182/blood-2010-10-314518","title":"The genome of self-complementary adeno-associated viral vectors increases Toll-like receptor 9–dependent innate immune responses in the liver","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":233,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institute of Allergy and Infectious Diseases; National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; National Institutes of Health; Fondation pour la Recherche Médicale; Howard Hughes Medical Institute","keywords":"TLR9; Biology; Innate immune system; Adeno-associated virus; Capsid; Immune system; Transgene; Immunology; Genetic enhancement; Virology; Vector (molecular biology); Gene expression; Gene; Virus; Recombinant DNA; Genetics","score_opus":0.019804210731342947,"score_gpt":0.2593872018511552,"score_spread":0.23958299111981227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056144642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942913,0.004922699,6.0907956e-7,0.00007082309,0.000048897833,0.0003914147,0.00009962094,0.000012008451,0.0001626057],"genre_scores_gemma":[0.9979157,0.0014907662,0.000049929855,0.00014905358,0.000061534935,0.000062987085,0.00009888433,0.00002392665,0.0001472466],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979501,0.0008220856,0.0003205527,0.00025194272,0.0002947826,0.0003605486],"domain_scores_gemma":[0.999117,0.00009228317,0.00012725664,0.0005384794,0.000081612125,0.000043365435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011948796,0.00016149446,0.00015858375,0.000063123334,0.00015669566,0.000020390371,0.0007100944,0.00009483573,0.00009551049],"category_scores_gemma":[0.000102496,0.00010667445,0.00010282975,0.00015050957,0.00012364592,0.0000050624813,0.00020791625,0.00016359135,0.000013771713],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003470887,0.0014115808,0.008572349,0.000011712614,0.0004773813,0.000024211467,0.0010945101,0.0000012471767,0.9843733,0.00002523721,0.00017634509,0.00036126352],"study_design_scores_gemma":[0.0028987064,0.0041127093,0.08042894,0.000015007452,0.00007592677,0.000015807314,0.00076813257,0.0000035812159,0.9086976,0.000046493595,0.002692939,0.00024416033],"about_ca_topic_score_codex":0.0007753593,"about_ca_topic_score_gemma":0.0014432796,"teacher_disagreement_score":0.07567568,"about_ca_system_score_codex":0.000024897814,"about_ca_system_score_gemma":0.00013349213,"threshold_uncertainty_score":0.43500578},"labels":[],"label_agreement":null},{"id":"W2056372782","doi":"10.1182/blood-2010-03-277012","title":"Genome-wide identification of human microRNAs located in leukemia-associated genomic alterations","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research; Michael Smith Health Research BC; Genome Canada","keywords":"Biology; microRNA; Myeloid leukemia; Leukemia; Genetics; Small RNA; Cancer research; Computational biology; Gene","score_opus":0.006946018875263175,"score_gpt":0.23331549341436392,"score_spread":0.22636947453910075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056372782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993513,0.000111440226,0.000116397125,0.000017327853,0.000054131542,0.00020921144,0.0000412337,0.000010636516,0.0000883156],"genre_scores_gemma":[0.99857897,0.000012685446,0.00009455463,0.000017303444,0.000058256162,0.000019428311,0.0010664711,0.00001878027,0.00013353254],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99915916,0.000042121403,0.0003593922,0.0002317017,0.000068570924,0.00013902824],"domain_scores_gemma":[0.9993253,0.000006529242,0.00018955776,0.00033403016,0.00010449743,0.000040119623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018319693,0.000095743846,0.0001038856,0.00008125802,0.000052625535,0.000017939006,0.00015566916,0.00014835222,0.000023089027],"category_scores_gemma":[0.00009726765,0.00011257349,0.000055323093,0.0001086439,0.00004672453,0.0000045365405,0.00004278039,0.000086324275,0.000008638525],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000055643754,0.00019837577,0.048533753,0.00001161174,0.000038982867,7.8366554e-7,0.00003829136,0.00007226487,0.9510335,0.00002832311,0.000021201437,0.000017346783],"study_design_scores_gemma":[0.00053175923,0.000018916853,0.43489856,0.000003712055,0.000022052725,0.0000014260002,0.0000064589876,0.000016437965,0.56431633,0.000040843388,0.00007568753,0.000067814515],"about_ca_topic_score_codex":0.000040566913,"about_ca_topic_score_gemma":0.0004403789,"teacher_disagreement_score":0.38671717,"about_ca_system_score_codex":0.000028143286,"about_ca_system_score_gemma":0.00010743119,"threshold_uncertainty_score":0.45906138},"labels":[],"label_agreement":null},{"id":"W2056376654","doi":"10.1182/blood-2010-03-272765","title":"Effect of FCGR2A and FCGR3A variants on CLL outcome","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of Alberta","funders":"","keywords":"Hazard ratio; Rituximab; Medicine; Antibody-dependent cell-mediated cytotoxicity; Chronic lymphocytic leukemia; Internal medicine; Fludarabine; Cyclophosphamide; Progression-free survival; Immunology; Monoclonal antibody; Regimen; Monoclonal; Antibody; Gastroenterology; Leukemia; Confidence interval; Chemotherapy","score_opus":0.011319256124485802,"score_gpt":0.3242386685967386,"score_spread":0.3129194124722528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056376654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910484,0.00007337095,0.0000014837661,0.00013001551,0.000130928,0.0003392746,0.0000054351085,0.0000288383,0.00824224],"genre_scores_gemma":[0.99870455,0.00001184242,0.00014060315,0.000089265246,0.00014027419,0.000011457004,0.0000036918407,0.000019961637,0.0008783311],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99900544,0.000045764482,0.00018691897,0.000207874,0.00032281803,0.00023119904],"domain_scores_gemma":[0.998913,0.00041953317,0.000039945775,0.00042978517,0.000042598,0.00015514552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052455615,0.00011303317,0.00030507435,0.00008441216,0.000028722938,0.00000851828,0.00008849359,0.00011846551,0.00013107117],"category_scores_gemma":[0.0007955646,0.000079354184,0.000056068973,0.00010051875,0.000115017116,0.000025467445,0.000065543216,0.0002973007,0.00008114132],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041861366,0.0044259015,0.29035452,0.0051554726,0.0010274481,0.0021861824,0.00076853705,0.0000016367873,0.62598497,0.0045833425,0.0023077838,0.05901808],"study_design_scores_gemma":[0.19074365,0.007904858,0.13168609,0.00032384138,0.00081407314,0.0016578643,0.000019546462,0.0010381141,0.66245663,0.0001440179,0.0028291482,0.0003821398],"about_ca_topic_score_codex":0.00015698263,"about_ca_topic_score_gemma":0.000014008093,"teacher_disagreement_score":0.18655753,"about_ca_system_score_codex":0.00015380107,"about_ca_system_score_gemma":0.0006215459,"threshold_uncertainty_score":0.32359695},"labels":[],"label_agreement":null},{"id":"W2056394634","doi":"10.1182/blood-2012-04-422527","title":"SOCS3 is an endogenous inhibitor of pathologic angiogenesis","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute; National Eye Institute; Canadian Institutes of Health Research","keywords":"Angiogenesis; Angiogenesis inhibitor; Endogeny; Medicine; Internal medicine; Cancer research","score_opus":0.07641123709606995,"score_gpt":0.28526879247821374,"score_spread":0.2088575553821438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056394634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953186,0.00082831475,0.000022840775,0.00006323164,0.00015746751,0.00011405761,0.000040096733,0.000044031833,0.0034113885],"genre_scores_gemma":[0.9980593,0.0000235751,0.001061848,0.00026241274,0.00045825474,0.00001021186,0.000018047522,0.000014836412,0.000091555354],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993984,0.000021568803,0.00016922966,0.00010895675,0.0001153589,0.00018648106],"domain_scores_gemma":[0.9995013,0.000021333153,0.00006184658,0.0002293394,0.00006800154,0.00011821097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010584991,0.00008233983,0.00017218167,0.00006866999,0.000041188792,0.000003931033,0.000041296775,0.000058620953,0.0006031124],"category_scores_gemma":[0.000037413563,0.000066905246,0.00012552817,0.00009744044,0.00002717512,0.00007693359,0.000018468363,0.000060590846,0.000068075606],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016723845,0.0016298268,0.042775303,0.000023705532,0.00005260711,0.000020358857,0.000928764,1.3350697e-7,0.9532865,0.000050396673,0.00026149512,0.0009541782],"study_design_scores_gemma":[0.0008444848,0.00047131575,0.014338895,0.000026764554,0.00027114133,0.0005800879,0.000202374,0.000002275561,0.980229,0.000013097964,0.0029446625,0.00007590778],"about_ca_topic_score_codex":0.00004421431,"about_ca_topic_score_gemma":0.0000012458481,"teacher_disagreement_score":0.02843641,"about_ca_system_score_codex":0.00000860475,"about_ca_system_score_gemma":0.000028064429,"threshold_uncertainty_score":0.66036576},"labels":[],"label_agreement":null},{"id":"W2056441411","doi":"10.1182/blood-2005-03-0916","title":"Platelets express functional Toll-like receptor-4","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Sepsis Diagnosis and Treatment","field":"Medicine","cited_by":480,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Research Centre of Canada; University of Calgary; University of British Columbia","funders":"Canadian Institutes of Health Research; Michael Smith Health Research BC; Canadian Association of Gastroenterology; Fondation pour la Recherche Médicale; AstraZeneca","keywords":"Platelet; TLR4; Immunology; Platelet activation; Lipopolysaccharide; Receptor; P-selectin; Biology; Sepsis; Toll-like receptor; Protease-activated receptor; Chemistry; Internal medicine; Endocrinology; Inflammation; Innate immune system; Thrombin; Medicine; Immune system","score_opus":0.0583398034036459,"score_gpt":0.28885408186818606,"score_spread":0.23051427846454017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056441411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883094,0.0011495134,0.000013188041,0.0019100335,0.00020304059,0.0001687669,0.000007889895,0.00007730907,0.008160899],"genre_scores_gemma":[0.99409914,0.00011722854,0.0013051915,0.0013145414,0.0006508532,0.00006664423,0.000058712576,0.000016451091,0.002371248],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993021,0.000010127554,0.00013244739,0.00019252545,0.0001994917,0.00016331735],"domain_scores_gemma":[0.99959,0.000042155163,0.000028117185,0.00019275944,0.000034483768,0.00011248244],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000041187497,0.000103480015,0.00015350034,0.000041486186,0.000048434653,0.000011267026,0.000031074764,0.000059988637,0.0025138764],"category_scores_gemma":[0.00001526895,0.000082093226,0.00008275063,0.00005365801,0.000016877719,0.00004700867,0.000016458811,0.00006934119,0.0008811921],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004063549,0.02264561,0.40226403,0.00008284321,0.0019098474,0.00039939402,0.0006133907,0.000056514906,0.032043733,0.0012798321,0.46304157,0.075256884],"study_design_scores_gemma":[0.0108765755,0.00045735238,0.15613416,0.00009478712,0.00041945485,0.00028332727,0.000046132613,0.000012285744,0.12611477,0.00003646696,0.70530933,0.00021535915],"about_ca_topic_score_codex":0.000007878238,"about_ca_topic_score_gemma":0.0000042220754,"teacher_disagreement_score":0.24612986,"about_ca_system_score_codex":0.000031341446,"about_ca_system_score_gemma":0.000030351091,"threshold_uncertainty_score":0.99989676},"labels":[],"label_agreement":null},{"id":"W2056572822","doi":"10.1182/blood-2012-06-430678","title":"Thrombophilia screening: whom to test?","year":2012,"lang":"en","type":"letter","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Thrombophilia; Medicine; Test (biology); Internal medicine; Biology; Thrombosis","score_opus":0.02736229991124532,"score_gpt":0.26755418619128163,"score_spread":0.24019188628003632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056572822","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0120396195,0.0014483355,0.00009958269,0.9548688,0.0010028118,0.0021957408,0.00009110687,0.00036968602,0.027884332],"genre_scores_gemma":[0.01338519,0.00013044328,0.0030983193,0.95743424,0.01686569,0.00022843637,0.00040495268,0.0001999223,0.008252806],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974842,0.000032836862,0.00038171315,0.00058795494,0.0006568454,0.00085642526],"domain_scores_gemma":[0.9983562,0.00011826079,0.00013238547,0.0010160931,0.000097107055,0.00027995455],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00018906737,0.00047127518,0.0010730076,0.00026953817,0.00013194875,0.00008892258,0.00030050156,0.00061455194,0.0010648996],"category_scores_gemma":[0.00013710627,0.0004177614,0.00027856414,0.00022987797,0.0000508049,0.00006110324,0.00025313854,0.0010903114,0.00181451],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000031645118,0.0015750795,0.0030515804,0.00038473684,0.0005290306,0.00052936084,0.00017857867,3.0488093e-7,0.00013452393,0.000024753868,0.99257135,0.0010175252],"study_design_scores_gemma":[0.0011396261,0.0006359535,0.03242523,0.00052154524,0.0024972602,0.000059519294,0.00001587931,5.3264597e-7,0.00034018065,0.000037381204,0.9618884,0.0004385183],"about_ca_topic_score_codex":0.000101861515,"about_ca_topic_score_gemma":0.0000071917243,"teacher_disagreement_score":0.030682987,"about_ca_system_score_codex":0.00004088644,"about_ca_system_score_gemma":0.000079686346,"threshold_uncertainty_score":0.99984825},"labels":[],"label_agreement":null},{"id":"W2056641238","doi":"10.1182/blood-2012-10-460063","title":"MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":679,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Biology; Cancer research; Gene expression; Gene; Genetics; Immunology","score_opus":0.0068453526359068375,"score_gpt":0.22946402255005457,"score_spread":0.22261866991414775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056641238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940375,0.0016778787,0.0000274383,0.00074366044,0.00013425066,0.0028766138,0.00034553462,0.000053880165,0.00010321354],"genre_scores_gemma":[0.9972544,0.00018796943,0.0013440972,0.000102059,0.00008944783,0.0006919459,0.00021645566,0.000028041442,0.000085632484],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99806803,0.00016242398,0.00060035684,0.00041464227,0.00047267188,0.00028184103],"domain_scores_gemma":[0.99778646,0.0005421713,0.0005579333,0.0005798787,0.00039354502,0.0001399948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002763383,0.00027450017,0.0005166254,0.00006277388,0.00013664509,0.000068001864,0.00024536272,0.00018018471,0.000054332228],"category_scores_gemma":[0.00042537382,0.00014217991,0.000121900135,0.00016479891,0.0001379455,0.00009578681,0.00021860073,0.00013587305,0.000009389967],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037843717,0.02340232,0.31983504,0.000036327765,0.00029120405,0.000045798097,0.00019956104,6.048053e-7,0.6538397,0.000016380995,0.00076328166,0.0011913227],"study_design_scores_gemma":[0.028926408,0.00031753138,0.27514133,0.0002925795,0.00030044964,0.000010565962,0.00020796111,0.0000278216,0.6939664,0.00004772293,0.0006563097,0.00010493525],"about_ca_topic_score_codex":0.0017837905,"about_ca_topic_score_gemma":0.00006714857,"teacher_disagreement_score":0.044693716,"about_ca_system_score_codex":0.000037477505,"about_ca_system_score_gemma":0.00016935598,"threshold_uncertainty_score":0.5797928},"labels":[],"label_agreement":null},{"id":"W2056733949","doi":"10.1182/blood-2010-09-310383","title":"Rac regulates PtdInsP3 signaling and the chemotactic compass through a redox-mediated feedback loop","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Cell biology; Chemotaxis; Intracellular; NADPH oxidase; Phosphatidylinositol; Chemistry; Biology; Phosphorylation; Reactive oxygen species; Biochemistry; Receptor","score_opus":0.022224177016026938,"score_gpt":0.2130247909108649,"score_spread":0.19080061389483796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056733949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99362886,0.0029082804,0.00016703055,0.00039624242,0.00023739788,0.00035902805,0.000018606717,0.00010697475,0.0021775607],"genre_scores_gemma":[0.9977634,0.00017395659,0.0005988413,0.00051311974,0.000045867735,0.000031587722,0.000045555724,0.000027311591,0.000800391],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99872315,0.00021484595,0.00028935593,0.00035488975,0.000041453666,0.00037632507],"domain_scores_gemma":[0.99912554,0.000276835,0.00015693768,0.00034148686,0.000072803276,0.000026394086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029249053,0.0002419394,0.000388551,0.000043382333,0.00030070933,0.000022977312,0.00025384684,0.0001922215,0.00054079463],"category_scores_gemma":[0.000083102226,0.00015678721,0.000088203284,0.00015776155,0.0005242008,0.00014296781,0.0001330712,0.00032540565,0.00035489502],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038048573,0.0003376288,0.00021836397,0.000017908551,0.0004570022,0.000014816874,0.0021345268,2.1190303e-7,0.98717165,0.008880926,0.0002237614,0.00016269414],"study_design_scores_gemma":[0.009221784,0.00016212945,0.0011831158,0.000050747185,0.000268551,0.00016952233,0.00056122075,0.0000026497335,0.9836238,0.0027380288,0.0017896087,0.00022885835],"about_ca_topic_score_codex":0.000112544905,"about_ca_topic_score_gemma":0.0000069817934,"teacher_disagreement_score":0.008841298,"about_ca_system_score_codex":0.000008282731,"about_ca_system_score_gemma":0.00002699254,"threshold_uncertainty_score":0.63935965},"labels":[],"label_agreement":null},{"id":"W2056809624","doi":"10.1182/blood-2014-10-609271","title":"Thymic expression of a T-cell receptor targeting a tumor-associated antigen coexpressed in the thymus induces T-ALL","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"National Cancer Institute; National Institutes of Health","keywords":"T-cell receptor; Thymocyte; Biology; Cancer research; Receptor; Transgene; Signal transduction; Immunology; Survivin; Antigen; T cell; Cell biology; Molecular biology; Cancer; Gene; Genetics; CD8; Immune system","score_opus":0.04458352362943507,"score_gpt":0.3033461817699167,"score_spread":0.2587626581404816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056809624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912375,0.001619263,0.0000015477085,0.0002431961,0.00006828893,0.00065970316,0.000011723886,0.00004031293,0.0061184242],"genre_scores_gemma":[0.99852157,0.00017112448,0.00040538874,0.00019201548,0.00012318342,0.00004302729,0.000046519795,0.000033404896,0.00046375644],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99784094,0.0003914138,0.00036672078,0.00026424264,0.0007482341,0.00038845447],"domain_scores_gemma":[0.99890333,0.00023910498,0.00017318068,0.00037977588,0.00017378197,0.00013081092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015288357,0.00015930794,0.00035623138,0.00014686916,0.000037221278,0.000023656938,0.00031900077,0.00011771147,0.00031921105],"category_scores_gemma":[0.00062030856,0.000107788874,0.00009063286,0.00042111185,0.00007049772,0.000068025394,0.000091026086,0.0004202075,0.000028751727],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025294034,0.0015380345,0.01103369,0.00004569674,0.000034696837,0.000049318143,0.0054608416,0.0000017502344,0.979107,0.0000034094096,0.0023427086,0.00012987832],"study_design_scores_gemma":[0.0076989625,0.0005431081,0.0028289668,0.00024344059,0.000040984458,0.000010674281,0.0026168628,0.000026401878,0.98325,0.000087355475,0.0025187067,0.00013454069],"about_ca_topic_score_codex":0.00024372665,"about_ca_topic_score_gemma":0.000011746769,"teacher_disagreement_score":0.008204723,"about_ca_system_score_codex":0.00005153596,"about_ca_system_score_gemma":0.00022771324,"threshold_uncertainty_score":0.43955028},"labels":[],"label_agreement":null},{"id":"W2056892179","doi":"10.1182/blood-2014-09-599969","title":"HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Human leukocyte antigen; Hematopoietic stem cell transplantation; Transplantation; Immunology; Histocompatibility Testing; Stem cell; Hematopoietic cell; Medicine; Histocompatibility; Haematopoiesis; Oncology; Biology; Internal medicine; Antigen; Genetics","score_opus":0.020223349210717865,"score_gpt":0.2521304809495504,"score_spread":0.2319071317388325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056892179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797959,0.00019557876,0.0043292977,0.0002699141,0.00007100575,0.0003984881,0.000010304728,0.000102490514,0.014827063],"genre_scores_gemma":[0.9940733,0.00008191961,0.005013479,0.00014364034,0.000067314744,0.000040599625,0.000068645364,0.000039118728,0.00047199382],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99848807,0.00008757401,0.000441898,0.00034218002,0.00033465933,0.00030559712],"domain_scores_gemma":[0.9992623,0.00016670302,0.000081401544,0.00029410445,0.00004138541,0.00015415526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030842988,0.00020411398,0.00035260135,0.0001714811,0.000050298233,0.00001806096,0.00008977332,0.0001631676,0.00021376504],"category_scores_gemma":[0.000028110628,0.0001841092,0.00008188137,0.0002088897,0.000031920503,0.00009265083,0.0000072300204,0.00017666716,0.00013639004],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013504953,0.0011073658,0.050608844,0.0034569646,0.000016355469,0.00017987395,0.004815332,0.000039366198,0.938898,0.0002218871,0.000078354315,0.00044256536],"study_design_scores_gemma":[0.0073481505,0.00015596356,0.0627716,0.0009789319,0.00021412031,0.00043147267,0.0002222602,0.00016271774,0.92710084,0.00023158955,0.00015885998,0.000223517],"about_ca_topic_score_codex":0.000022736342,"about_ca_topic_score_gemma":0.000011108382,"teacher_disagreement_score":0.014355069,"about_ca_system_score_codex":0.000019170646,"about_ca_system_score_gemma":0.00006020762,"threshold_uncertainty_score":0.7507755},"labels":[],"label_agreement":null},{"id":"W2056920544","doi":"10.1182/blood-2011-06-363911","title":"Bortezomib-induced “BRCAness” sensitizes multiple myeloma cells to PARP inhibitors","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":156,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"National Cancer Institute; Geoffrey Beene Cancer Research Center; Multiple Myeloma Research Foundation","keywords":"Bortezomib; RAD51; Poly ADP ribose polymerase; Genome instability; PARP1; DNA repair; DNA damage; Homologous recombination; Biology; Proteasome inhibitor; Proteasome; Synthetic lethality; Molecular biology; Cancer research; Ubiquitin; PARP inhibitor; Multiple myeloma; DNA; Cell biology; Polymerase; Genetics; Immunology; Gene","score_opus":0.014261510396584538,"score_gpt":0.2086126622192225,"score_spread":0.19435115182263796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056920544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968777,0.000051702988,0.0001509518,0.000024783409,0.0003825305,0.00028258332,0.000017852759,0.00006205707,0.002149838],"genre_scores_gemma":[0.99361396,0.000007824517,0.005190519,0.00032308302,0.00031320896,0.00003422594,0.000026366386,0.00004607182,0.00044473252],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99880034,0.000050352195,0.00020651237,0.0004571537,0.00013775568,0.00034788088],"domain_scores_gemma":[0.9991329,0.000008526514,0.000062305466,0.00052393205,0.000075557946,0.00019681586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012869095,0.00020369669,0.00016763588,0.0000486957,0.00006123438,0.000015996597,0.00018919643,0.00018999248,0.0000310688],"category_scores_gemma":[0.00006393122,0.00020459111,0.00010678332,0.00009232213,0.000022537015,0.0000032902124,0.00017017275,0.00007195079,0.00013522992],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004660014,0.00020773565,0.00094207755,0.000008782579,0.000059970538,0.000040891267,0.00018606092,0.0000013400596,0.99703306,0.000020748897,0.00064497045,0.000807756],"study_design_scores_gemma":[0.0008862235,0.00039799378,0.0013333424,0.000011526074,0.000041709372,0.000028829141,0.00015098503,0.000006678032,0.9941683,0.000029910887,0.0026613346,0.00028321415],"about_ca_topic_score_codex":0.00007095129,"about_ca_topic_score_gemma":0.00007448557,"teacher_disagreement_score":0.0050395676,"about_ca_system_score_codex":0.0000066916577,"about_ca_system_score_gemma":0.000052113548,"threshold_uncertainty_score":0.8342984},"labels":[],"label_agreement":null},{"id":"W2057186028","doi":"10.1182/blood-2010-05-283861","title":"In pediatric patients, age has more impact on dosing of vitamin K antagonists than VKORC1 or CYP2C9 genotypes","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stollery Children's Hospital; University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"VKORC1; CYP2C9; Dosing; Vitamin K epoxide reductase; Medicine; Warfarin; Phenprocoumon; Internal medicine; Genotype; Gastroenterology; Biology; Genetics; Cytochrome P450; Atrial fibrillation","score_opus":0.055102093488590756,"score_gpt":0.40129211118856173,"score_spread":0.346190017699971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057186028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961515,0.0003369056,0.0000018088718,0.00018725739,0.0015404298,0.0003831127,0.00023029314,0.000031673568,0.0011370232],"genre_scores_gemma":[0.9979072,0.00042983677,0.0001861329,0.0005862082,0.0006385192,0.000021172702,0.000039904637,0.000039684175,0.00015131195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99826115,0.00019995097,0.00044943974,0.00034316187,0.00022404273,0.0005222411],"domain_scores_gemma":[0.99893725,0.0002511358,0.00021073624,0.0002661969,0.00007797106,0.00025668944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044121762,0.00030148827,0.00038909077,0.00028665102,0.00013902492,0.000026882546,0.00035294463,0.0003283439,0.0006417521],"category_scores_gemma":[0.000097571174,0.0002347282,0.00014471826,0.00037933124,0.00016635071,0.00008860085,0.00009594042,0.00092014426,0.000055143144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011855098,0.0063427705,0.61593705,0.00013284649,0.00021729777,0.00029423524,0.0017547932,0.00028804713,0.36668983,0.00019482343,0.0018564197,0.005106383],"study_design_scores_gemma":[0.010462072,0.0003960904,0.56334215,0.000010705677,0.00059280684,0.000014993454,0.000023561244,0.00020701445,0.40833637,0.00014507578,0.01598136,0.00048777353],"about_ca_topic_score_codex":0.00005415546,"about_ca_topic_score_gemma":0.000059374837,"teacher_disagreement_score":0.05259487,"about_ca_system_score_codex":0.000017257766,"about_ca_system_score_gemma":0.0001666754,"threshold_uncertainty_score":0.9571938},"labels":[],"label_agreement":null},{"id":"W2057239580","doi":"10.1182/blood-2009-05-220095","title":"MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":667,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Terry Fox Foundation","keywords":"Diffuse large B-cell lymphoma; Hazard ratio; Vincristine; Internal medicine; Rituximab; Oncology; Medicine; Population; Cyclophosphamide; Lymphoma; CHOP; Chemotherapy; Confidence interval; Cancer research","score_opus":0.007187967582575832,"score_gpt":0.20952294597654375,"score_spread":0.2023349783939679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057239580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969672,0.00020342227,6.2406014e-7,0.00035384577,0.0000109360635,0.0013168202,0.000070730595,0.00011424873,0.00096218835],"genre_scores_gemma":[0.9978239,0.00010885394,0.00019892052,0.0010038833,0.000027863336,0.00020796062,0.00026858633,0.000049826518,0.00031018455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824697,0.000047935333,0.00027117532,0.0004701707,0.00045445721,0.00050930143],"domain_scores_gemma":[0.99918026,0.000026841975,0.00020085054,0.00026461235,0.00014322606,0.00018420348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000699271,0.00034606527,0.00050844526,0.00014734559,0.000073524134,0.00003380978,0.00008360087,0.00012561947,0.00002558116],"category_scores_gemma":[0.000021369215,0.00022747948,0.0000772325,0.00048692385,0.000024619583,0.00008003745,0.00001239361,0.00005958597,0.000017782999],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007168523,0.12883608,0.86663574,0.000016082256,0.00039965753,0.0005307788,0.00021267628,1.14959704e-7,0.00027952623,0.0000011463416,0.00021096448,0.0021603773],"study_design_scores_gemma":[0.18828078,0.0033064974,0.7838655,0.00035772377,0.00045675196,0.000012076359,0.000036272308,0.000007840178,0.023355184,0.0000015951695,0.0001050978,0.00021468278],"about_ca_topic_score_codex":0.00008179563,"about_ca_topic_score_gemma":0.00010705624,"teacher_disagreement_score":0.18756393,"about_ca_system_score_codex":0.00024393084,"about_ca_system_score_gemma":0.00006904811,"threshold_uncertainty_score":0.9276344},"labels":[],"label_agreement":null},{"id":"W2057862856","doi":"10.1182/blood-2010-05-285320","title":"DNA methylation signatures define molecular subtypes of diffuse large B-cell lymphoma","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Canadian Institutes of Health Research; Terry Fox Foundation; Michael Smith Health Research BC","keywords":"DNA methylation; Biology; Epigenetics; Diffuse large B-cell lymphoma; Gene expression profiling; Methylation; CpG site; Promoter; Gene; Cancer research; Genetics; Gene expression; Computational biology","score_opus":0.005171165776245504,"score_gpt":0.22737425126074026,"score_spread":0.22220308548449474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057862856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99497616,0.0015955116,0.000016607572,0.0001597604,0.00008828881,0.00021502622,0.000022667316,0.00003836729,0.0028876157],"genre_scores_gemma":[0.99836856,0.000051777413,0.001156371,0.00016041112,0.0000565939,0.000022122125,0.000059806876,0.000019148774,0.00010523287],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992388,0.000019678555,0.0001780791,0.00018589682,0.0002064968,0.00017107312],"domain_scores_gemma":[0.9993827,0.00006106485,0.00008209361,0.00030898213,0.00007387309,0.000091284775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008513105,0.00012860395,0.00023117173,0.00007334978,0.000030797575,0.000007948342,0.00005644732,0.00012338733,0.000066569184],"category_scores_gemma":[0.0000649065,0.000098090044,0.000118958225,0.000110218774,0.000026709577,0.000030431343,0.000027596374,0.000056454683,0.000024928224],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007138831,0.026811656,0.065253496,0.00008431244,0.00021597196,0.00017439123,0.0001269904,4.0511043e-7,0.9004768,0.0035740775,0.00024528604,0.0029652345],"study_design_scores_gemma":[0.021816112,0.0002290908,0.13967231,0.000019368397,0.00045951494,0.0000174549,0.000010894179,0.00001188972,0.83595484,0.000155539,0.001568532,0.000084437524],"about_ca_topic_score_codex":0.000035146928,"about_ca_topic_score_gemma":0.000022148313,"teacher_disagreement_score":0.07441882,"about_ca_system_score_codex":0.000011472917,"about_ca_system_score_gemma":0.000059337777,"threshold_uncertainty_score":0.3999996},"labels":[],"label_agreement":null},{"id":"W2057893105","doi":"10.1182/blood-2010-03-272336","title":"CD8+ T-cell expansion and maintenance after recombinant adenovirus immunization rely upon cooperation between hematopoietic and nonhematopoietic antigen-presenting cells","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Christie (Canada); McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Antigen; Biology; Immunology; Antigen presentation; Antigen-presenting cell; Cytotoxic T cell; Population; Haematopoiesis; CD8; T cell; Hematopoietic stem cell; Stem cell; Cell biology; Immune system; Medicine","score_opus":0.012551380640342715,"score_gpt":0.2585916342091094,"score_spread":0.2460402535687667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057893105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99695206,0.00076977554,0.00014827239,0.00027489045,0.00016645102,0.0007608487,0.0000047940193,0.000061969404,0.00086095114],"genre_scores_gemma":[0.99529076,0.0011960949,0.0010650661,0.00005710642,0.00014394871,0.00003620488,0.000029454362,0.00006261504,0.0021187342],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99833274,0.000086730615,0.00038467505,0.0004573872,0.000335902,0.00040256683],"domain_scores_gemma":[0.99886465,0.00014512276,0.00010064732,0.0005006987,0.0001875884,0.00020128243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048973423,0.00022503635,0.000368318,0.00016043882,0.00019376657,0.00010971793,0.000101067446,0.00020719765,0.00028365158],"category_scores_gemma":[0.0001113449,0.00019946214,0.000052269548,0.0002520553,0.00011955264,0.00015986655,0.00015330913,0.00050005555,0.00003833366],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009771817,0.00025998554,0.06351164,0.00028958046,0.00003107791,0.000065699045,0.00088753237,3.4797287e-7,0.93347025,0.00003355805,0.00005275296,0.0012998295],"study_design_scores_gemma":[0.0054035983,0.00034513118,0.051187877,0.0003217091,0.00016959163,0.00032722316,0.00017679123,0.00024869273,0.939966,0.00016250934,0.0013507168,0.0003401604],"about_ca_topic_score_codex":0.00005761944,"about_ca_topic_score_gemma":0.000039395516,"teacher_disagreement_score":0.012323766,"about_ca_system_score_codex":0.00001634304,"about_ca_system_score_gemma":0.00006938942,"threshold_uncertainty_score":0.81338304},"labels":[],"label_agreement":null},{"id":"W2057895084","doi":"10.1182/blood-2011-08-375873","title":"Role of SHP2 phosphatase in KIT-induced transformation: identification of SHP2 as a druggable target in diseases involving oncogenic KIT","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute; School of Medicine, Indiana University","keywords":"Druggability; Cancer research; Protein tyrosine phosphatase; Kinase; Phosphatase; Biology; Leukemia; Tyrosine kinase; Oncogene; Signal transduction; Phosphorylation; Cell biology; Cancer; Immunology; Genetics; Gene; Cell cycle","score_opus":0.0067412092966278245,"score_gpt":0.21505932812605416,"score_spread":0.20831811882942633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057895084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9763909,0.022386052,0.0000070704255,0.000026379517,0.00011198368,0.00023623921,0.00012653091,0.000012138178,0.0007027193],"genre_scores_gemma":[0.9992041,0.00012440041,0.00002600129,0.000015491176,0.000014558459,0.00003173035,0.00038339852,0.0000090835265,0.0001912225],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99894875,0.000086309745,0.00053616124,0.00013611096,0.000043447857,0.00024923708],"domain_scores_gemma":[0.9995052,0.000046725298,0.00018079196,0.00020243232,0.00003864531,0.000026180825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027178306,0.000107141284,0.0002587407,0.00016331155,0.0000353519,0.00000449658,0.00013923363,0.00012352111,0.0005792111],"category_scores_gemma":[0.000045134275,0.00010872128,0.000062287254,0.00021206398,0.000053899916,0.00024029579,0.000025230753,0.00011376695,0.00006958847],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009732117,0.001665435,0.023110325,0.00013028031,0.00004800888,0.0000012648613,0.003943632,0.000007168261,0.9670083,0.0029932575,0.000036095113,0.00095890847],"study_design_scores_gemma":[0.0026308713,0.00007746282,0.0383548,0.000051693678,0.000074592455,0.0000072108883,0.0013462843,0.00001422669,0.9549522,0.0002759863,0.0020856508,0.00012905379],"about_ca_topic_score_codex":0.0007407854,"about_ca_topic_score_gemma":0.00016415375,"teacher_disagreement_score":0.022813227,"about_ca_system_score_codex":0.00002135094,"about_ca_system_score_gemma":0.0000632984,"threshold_uncertainty_score":0.63419557},"labels":[],"label_agreement":null},{"id":"W2058102240","doi":"10.1182/blood-2005-07-2793","title":"Interferon-γ-stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cell","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":294,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Ovalbumin; Antigen; Immunology; Mesenchymal stem cell; Cytotoxic T cell; Immune system; CD8; Antigen presentation; Major histocompatibility complex; Bone marrow; T cell; Biology; Stromal cell; Antigen-presenting cell; Cancer research; In vitro; Cell biology","score_opus":0.03868291522401509,"score_gpt":0.3119828911749385,"score_spread":0.2732999759509234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058102240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97339624,0.0009640441,0.000059063306,0.00017001861,0.00008953015,0.00041054556,0.0000027975473,0.000058762394,0.024848975],"genre_scores_gemma":[0.9838771,0.00006273097,0.0041572023,0.00003505277,0.00026762063,0.000002418011,0.000010547378,0.0000425577,0.011544731],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981498,0.000049697795,0.00043773736,0.00032785014,0.00054920505,0.00048569252],"domain_scores_gemma":[0.9987835,0.000102756385,0.00011644915,0.0004884765,0.00017738137,0.0003313933],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025034478,0.00018410641,0.00039849943,0.00016174445,0.000041230414,0.000020675665,0.0002322088,0.00013038346,0.0016739476],"category_scores_gemma":[0.000106829364,0.00016558533,0.00011834734,0.00038600023,0.00005852015,0.00006672094,0.00017023568,0.0003023068,0.0005053999],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020439501,0.0009950608,0.02722174,0.00040905655,0.00010766422,0.00012685466,0.0004619349,0.00004835181,0.9670495,0.000016035216,0.0026502812,0.00070917286],"study_design_scores_gemma":[0.0042611477,0.00072802574,0.003622783,0.00021083912,0.0001397905,0.0000756963,0.00011201327,0.00177216,0.9860282,0.000013118437,0.00285882,0.00017743495],"about_ca_topic_score_codex":0.00010145648,"about_ca_topic_score_gemma":0.00001015432,"teacher_disagreement_score":0.023598956,"about_ca_system_score_codex":0.00002789331,"about_ca_system_score_gemma":0.00023173036,"threshold_uncertainty_score":0.99923867},"labels":[],"label_agreement":null},{"id":"W2058319182","doi":"10.1182/blood-2011-09-378687","title":"The miR-17-92 cluster expands multipotent hematopoietic progenitors whereas imbalanced expression of its individual oncogenic miRNAs promotes leukemia in mice","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research","keywords":"Biology; microRNA; Haematopoiesis; Cancer research; Progenitor cell; Myeloid; Phenotype; Stem cell; Leukemia; Immunology; Gene; Cell biology; Genetics","score_opus":0.01037556515097984,"score_gpt":0.24494564167025085,"score_spread":0.234570076519271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058319182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99153256,0.0075439652,0.000023311979,0.000028561204,0.00010596728,0.000658125,0.000020448131,0.000011322178,0.00007575282],"genre_scores_gemma":[0.9987834,0.000083605795,0.000506821,0.000020171796,0.00022712509,0.00013096828,0.000076516386,0.000028659566,0.00014273211],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986594,0.00012962396,0.00035335845,0.00025609427,0.00022599494,0.00037556418],"domain_scores_gemma":[0.99925023,0.00002842555,0.00019891221,0.00033489123,0.00007512346,0.0001124064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003067087,0.00018647811,0.00016194451,0.000038494385,0.00007443193,0.000019863564,0.00025884205,0.00019815813,0.000009310052],"category_scores_gemma":[0.00010139655,0.0001408083,0.00011356173,0.00009509147,0.00006476685,0.000012055473,0.00017815726,0.00009255028,0.0000060866937],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009234624,0.00031213972,0.017771337,0.00007180851,0.000059750524,7.866207e-7,0.000292896,0.000013959244,0.9807834,0.0000027158696,0.00030911696,0.00028972173],"study_design_scores_gemma":[0.0018258214,0.00007669541,0.026227541,0.00009371379,0.00006641116,0.00002435672,0.00009855258,0.00002000145,0.9704073,0.000007518001,0.0009811253,0.00017094825],"about_ca_topic_score_codex":0.000008027488,"about_ca_topic_score_gemma":0.00001543091,"teacher_disagreement_score":0.010376107,"about_ca_system_score_codex":0.000036456142,"about_ca_system_score_gemma":0.00012005097,"threshold_uncertainty_score":0.57419956},"labels":[],"label_agreement":null},{"id":"W2058464136","doi":"10.1182/blood-2013-04-496257","title":"Antiphospholipid antibodies and the risk of recurrence after a first episode of venous thromboembolism: a systematic review","year":2013,"lang":"en","type":"review","venue":"Blood","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Antiphospholipid syndrome; Thrombosis; Venous thromboembolism; Intensive care medicine; Antibody; Venous thrombosis; Internal medicine; Immunology","score_opus":0.02472622682653949,"score_gpt":0.31108814933740103,"score_spread":0.28636192251086157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058464136","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009339558,0.9876808,0.000002229818,0.000032381995,0.00010989993,0.010845856,0.00013500736,0.000020131874,0.00023974571],"genre_scores_gemma":[0.00052723463,0.99741787,0.000109152956,0.000018835226,0.00007560089,0.0016392311,0.000013538758,0.00006902494,0.00012950253],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9952345,0.0010187023,0.0021250634,0.00046467807,0.0007793317,0.00037771306],"domain_scores_gemma":[0.99421483,0.0016571062,0.0019707861,0.0016469781,0.00038710373,0.00012320271],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023164134,0.00050554535,0.009858199,0.00018605533,0.000060863083,0.00001997507,0.00048525282,0.00025713778,0.000052060175],"category_scores_gemma":[0.0030305504,0.00025255835,0.00090078305,0.00050941325,0.0006558082,0.000049347098,0.00027516577,0.00052950025,0.00007290489],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013760686,0.00028609895,0.00062440196,0.9928601,0.001603801,0.000018739733,0.00041065278,2.760889e-9,1.3617537e-7,0.000034467605,0.00025811302,0.003889743],"study_design_scores_gemma":[0.0013425106,0.00013686737,0.000027393955,0.96009004,0.027532179,0.0061260634,0.000050926024,0.0000019278127,0.000004146387,0.000020260512,0.004466174,0.00020149139],"about_ca_topic_score_codex":0.00019936377,"about_ca_topic_score_gemma":0.000012875357,"teacher_disagreement_score":0.032770023,"about_ca_system_score_codex":0.00003173393,"about_ca_system_score_gemma":0.00023863571,"threshold_uncertainty_score":0.99999267},"labels":[],"label_agreement":null},{"id":"W2058767673","doi":"10.1182/blood-2008-01-134270","title":"ALK− anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":854,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Anaplastic large-cell lymphoma; Anaplastic lymphoma kinase; Medicine; Lymphoma; Not Otherwise Specified; Peripheral T-cell lymphoma; Internal medicine; T-cell lymphoma; Pathology; Oncology; Gastroenterology; T cell; Immunology; Immune system","score_opus":0.023526446734610056,"score_gpt":0.27384685565886197,"score_spread":0.2503204089242519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058767673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984357,0.0035975196,0.00024915897,0.0010217397,0.0004072906,0.0014433907,0.0006932216,0.00014071752,0.008089947],"genre_scores_gemma":[0.98569506,0.002732487,0.00191468,0.0026657374,0.0008971363,0.0001361505,0.0005030506,0.0001939562,0.005261743],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9938013,0.00033854772,0.0014447077,0.0017479388,0.0016273552,0.00104015],"domain_scores_gemma":[0.9964024,0.0009319088,0.00048855686,0.0013159759,0.00036730978,0.0004938535],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041928736,0.00089715014,0.0011754915,0.00015799305,0.00060508127,0.00031871657,0.0007612496,0.0004552047,0.001448339],"category_scores_gemma":[0.0003304082,0.0006745565,0.00041275984,0.0002541874,0.0008532071,0.00018757806,0.0006276382,0.00034081363,0.000062433],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023949401,0.045346323,0.77015823,0.00022953072,0.0027770896,0.011783405,0.016497241,0.0000034753973,0.10060907,0.00006390849,0.01330444,0.015277903],"study_design_scores_gemma":[0.21716602,0.004755029,0.68094504,0.00041910555,0.0016778479,0.009351658,0.0041985265,0.0083061475,0.029115515,0.00045946558,0.04074449,0.002861152],"about_ca_topic_score_codex":0.0019072562,"about_ca_topic_score_gemma":0.00034003358,"teacher_disagreement_score":0.19321662,"about_ca_system_score_codex":0.00037747694,"about_ca_system_score_gemma":0.0011425412,"threshold_uncertainty_score":0.99957055},"labels":[],"label_agreement":null},{"id":"W2058914749","doi":"10.1182/blood-2006-04-017087","title":"MIP-1α (CCL3) is a downstream target of FGFR3 and RAS-MAPK signaling in multiple myeloma","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Fibroblast growth factor receptor 3; Biology; Cancer research; MAPK/ERK pathway; Fibroblast growth factor; Molecular biology; Signal transduction; Fibroblast growth factor receptor; Cell biology; Receptor; Genetics","score_opus":0.007613318904306558,"score_gpt":0.22457558963852323,"score_spread":0.21696227073421667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058914749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983701,0.00075731653,0.000045141853,0.00004149478,0.000016565502,0.00016552061,0.000056602796,0.000007078226,0.0005401664],"genre_scores_gemma":[0.9978406,0.00002218349,0.0017742643,0.000023223858,0.0000821321,0.00001313628,0.00006968076,0.000019518855,0.00015526243],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99900717,0.00004629679,0.00021978709,0.00030325446,0.0001475884,0.00027589913],"domain_scores_gemma":[0.99958074,0.000031932916,0.00005506296,0.00022446759,0.000052599942,0.00005521809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012133682,0.00013022737,0.00015956331,0.00007909768,0.00003100453,0.0000146929515,0.00012968031,0.00013897153,0.000034950583],"category_scores_gemma":[0.0000771971,0.00012797106,0.000054313903,0.0001179119,0.00009228354,0.000004041738,0.00011679943,0.00009122216,0.000004858488],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041249783,0.00018869038,0.18499762,0.00004838973,0.00002211694,0.0000072794564,0.000031697546,0.000014987657,0.8142614,0.00000726363,0.00024896066,0.00013033663],"study_design_scores_gemma":[0.0017711344,0.00019000049,0.050178744,0.000030436842,0.000008352744,0.000009316682,0.000031163756,0.000046700203,0.94632465,0.000070033406,0.0012075531,0.00013188804],"about_ca_topic_score_codex":0.00033682285,"about_ca_topic_score_gemma":0.00012514871,"teacher_disagreement_score":0.13481888,"about_ca_system_score_codex":0.000005255456,"about_ca_system_score_gemma":0.000046463043,"threshold_uncertainty_score":0.5218508},"labels":[],"label_agreement":null},{"id":"W2058931657","doi":"10.1182/blood-2012-04-420661","title":"Bacteria differentially induce degradation of Bcl-xL, a survival protein, by human platelets","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Center for Advancing Translational Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases; State Government of Victoria; Pfizer; National Heart, Lung, and Blood Institute; National Institute on Aging; ARUP Institute for Clinical and Experimental Pathology; National Medical Research Council; National Institutes of Health; National Health and Medical Research Council; Deutsche Gesellschaft für Kardiologie-Herz und Kreislaufforschung.; Canadian Institutes of Health Research; National Institute for Health and Care Research","keywords":"Platelet; Bacteria; Biology; Degradation (telecommunications); Immunology; Microbiology; Cell biology; Genetics","score_opus":0.02578452415827229,"score_gpt":0.28574035711354157,"score_spread":0.25995583295526925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058931657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979775,0.00018022455,0.00012726044,0.00009309299,0.000144316,0.00033227698,0.000017794602,0.000029860457,0.0010977075],"genre_scores_gemma":[0.99832046,0.000016662067,0.00035634532,0.000025481022,0.000233009,0.0000030964318,0.00015268064,0.000024914818,0.0008673748],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99914706,0.00003144611,0.00024336795,0.00012926813,0.00020948883,0.00023937196],"domain_scores_gemma":[0.99949265,0.000012512624,0.00011022931,0.00017899775,0.000063989384,0.00014161033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012921021,0.00012249193,0.00022698892,0.000048839192,0.00004194109,0.000010773937,0.00007745642,0.00008270764,0.00021198037],"category_scores_gemma":[0.000026856344,0.000106243555,0.000053735865,0.00007951056,0.000038463008,0.00005536227,0.000043987722,0.00012705797,0.000018799095],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003632072,0.0023092285,0.013592778,0.000087428874,0.00010031217,0.0000028974446,0.000078872705,3.3415855e-8,0.98204756,0.00031838208,0.00042976715,0.0009964202],"study_design_scores_gemma":[0.003562263,0.0002508184,0.12136871,0.00007782445,0.0002539331,0.00001235088,0.000016303382,0.00000785188,0.8724797,0.000010708997,0.0018239297,0.00013561509],"about_ca_topic_score_codex":0.00002536815,"about_ca_topic_score_gemma":0.0000014560086,"teacher_disagreement_score":0.10956787,"about_ca_system_score_codex":0.000007531479,"about_ca_system_score_gemma":0.000021658363,"threshold_uncertainty_score":0.43324864},"labels":[],"label_agreement":null},{"id":"W2058950982","doi":"10.1182/blood-2009-01-196303","title":"Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium Study ONC0313","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; CancerCare Manitoba","funders":"Otsuka Pharmaceutical","keywords":"Medicine; Transplantation; Hematologic Neoplasms; Bone marrow transplantation; Internal medicine; Pediatrics","score_opus":0.017296500039677476,"score_gpt":0.256383180485288,"score_spread":0.23908668044561054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058950982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959251,0.00029126272,0.00003631477,0.00021315218,0.00010992693,0.0029625434,0.00018628304,0.000033471548,0.0002419042],"genre_scores_gemma":[0.9977767,0.0015443318,0.00027638086,0.0001126628,0.000097722055,0.000054371452,0.00009031818,0.000021374757,0.000026177557],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979683,0.00012954677,0.0007840769,0.00044020006,0.0003868378,0.00029104942],"domain_scores_gemma":[0.99892026,0.00023507024,0.00025492164,0.00027832913,0.00021867793,0.000092763636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004402443,0.0002481445,0.00047798277,0.00025142092,0.00007460349,0.0000104410165,0.00012008291,0.00013526012,0.0000025579525],"category_scores_gemma":[0.00006396984,0.00018371378,0.000107993044,0.0005076969,0.00003774353,0.00007573586,0.0000055808823,0.00017799447,9.0233164e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025709302,0.0037389647,0.97535557,0.00034283553,0.000084470485,0.000030863455,0.00711235,0.000009542359,0.010570025,0.000010106189,0.000018089704,0.00015627],"study_design_scores_gemma":[0.031881824,0.0018725501,0.91625553,0.00007960512,0.0017691724,0.000056566652,0.00018119847,0.000011058991,0.04765394,0.000058909103,0.0000017503131,0.00017790853],"about_ca_topic_score_codex":0.000042694774,"about_ca_topic_score_gemma":0.000036533278,"teacher_disagreement_score":0.05910004,"about_ca_system_score_codex":0.000014597612,"about_ca_system_score_gemma":0.0001254002,"threshold_uncertainty_score":0.74916303},"labels":[],"label_agreement":null},{"id":"W2059190713","doi":"10.1182/blood-2009-06-225565","title":"International consensus report on the investigation and management of primary immune thrombocytopenia","year":2009,"lang":"en","type":"review","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":2267,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Immune thrombocytopenia; Medicine; Intensive care medicine; Clinical trial; Consensus conference; MEDLINE; Pediatrics; Immunology; Pathology; Internal medicine; Political science","score_opus":0.04974759383829321,"score_gpt":0.31011341733882786,"score_spread":0.26036582350053467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059190713","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0057356036,0.9572639,2.4990356e-7,0.0004388505,0.00006740827,0.0009586464,0.000015471413,0.000013328143,0.035506554],"genre_scores_gemma":[0.0002544584,0.99807096,0.0003808478,0.000078111174,0.00002313921,0.000031080286,0.00033928503,0.000012642509,0.000809481],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999129,0.000028607132,0.00037523333,0.00019417999,0.00019796612,0.000074995034],"domain_scores_gemma":[0.99932396,0.000049537975,0.00029662155,0.00027326186,0.000027304739,0.00002930447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013599267,0.00015927324,0.0008163086,0.00005789426,0.000026790467,0.00000901796,0.00006832267,0.00007479333,0.000018812747],"category_scores_gemma":[0.000015967096,0.000092788956,0.0001173407,0.000071894574,0.000057483303,0.000009318261,0.000038752336,0.00010865765,0.00000892231],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022636968,0.0007890429,0.000108029795,0.007387937,0.0035219404,0.0054818736,0.000024660128,3.1814967e-8,0.0000061263227,0.0011758999,0.0008829452,0.98059887],"study_design_scores_gemma":[0.002770068,0.0002835278,0.0052458653,0.02282449,0.0066794246,0.004655245,0.000014102344,4.50421e-7,0.000041124506,0.00033647296,0.95695376,0.0001954754],"about_ca_topic_score_codex":0.000007041011,"about_ca_topic_score_gemma":3.3574446e-7,"teacher_disagreement_score":0.9804034,"about_ca_system_score_codex":0.000029256897,"about_ca_system_score_gemma":0.00006249901,"threshold_uncertainty_score":0.37838238},"labels":[],"label_agreement":null},{"id":"W2059372258","doi":"10.1182/blood-2004-01-0023","title":"Combination of retinoic acid and tumor necrosis factor overcomes the maturation block in a variety of retinoic acid-resistant acute promyelocytic leukemia cells","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Retinoic acid; Acute promyelocytic leukemia; Tumor necrosis factor alpha; CD14; Cancer research; U937 cell; Cell culture; Biology; Leukemia; Cellular differentiation; Tretinoin; Monocyte; Molecular biology; Immunology; Flow cytometry; Biochemistry; Gene","score_opus":0.0047455248477834425,"score_gpt":0.20731191307851618,"score_spread":0.20256638823073272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059372258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981567,0.0010385009,0.00009118651,0.000077628356,0.00005472809,0.00036708268,0.000037346625,0.0000093777135,0.00016740503],"genre_scores_gemma":[0.9988265,0.000351117,0.0005834712,0.00004284653,0.000028592642,0.000030228362,0.000046952107,0.000020500409,0.00006981495],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987516,0.00007541392,0.00042265127,0.00032413116,0.00021799632,0.00020822693],"domain_scores_gemma":[0.9991617,0.000020902002,0.00029392482,0.0003498915,0.00013111442,0.00004244901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019722956,0.00019504614,0.000259884,0.00005085088,0.00006597586,0.000027878386,0.00022600086,0.00017337836,0.0000050961635],"category_scores_gemma":[0.00009783627,0.000151276,0.00008382011,0.00019656247,0.00019070842,0.000011989822,0.00010354278,0.00014729242,8.5308704e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016431854,0.00014948865,0.0012181194,0.00022492645,0.000068647925,0.0000049249875,0.00034020314,0.000019741476,0.9975857,0.00013359,0.00001660426,0.00007370339],"study_design_scores_gemma":[0.0022897893,0.00043732094,0.011666916,0.000088327724,0.00010727566,0.000024644012,0.000107324224,0.00002331651,0.98464096,0.00038213175,0.000066404,0.00016558587],"about_ca_topic_score_codex":0.00005453569,"about_ca_topic_score_gemma":0.000021074153,"teacher_disagreement_score":0.012944768,"about_ca_system_score_codex":0.000051802057,"about_ca_system_score_gemma":0.00029766408,"threshold_uncertainty_score":0.61688566},"labels":[],"label_agreement":null},{"id":"W2059715308","doi":"10.1182/blood-2006-03-011353","title":"Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":306,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Research Resources; National Cancer Institute; National Institutes of Health; National Institute of Allergy and Infectious Diseases; Fondation de l'Hôpital Général de Montréal; Damon Runyon Cancer Research Foundation; Deutsches Krebsforschungszentrum; Eli Lilly and Company; Dana Foundation","keywords":"FOXP3; CD86; CD80; Immunology; Dendritic cell; IL-2 receptor; Immune system; Immune tolerance; Cytokine; Antigen-presenting cell; Biology; Interleukin 10; T cell; CD40; Cancer research; Cytotoxic T cell; In vitro","score_opus":0.002942851926528248,"score_gpt":0.17970814088700432,"score_spread":0.17676528896047608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059715308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99685717,0.0023676762,0.000002235869,0.0000059296885,0.0002852325,0.00025620684,0.000070963644,0.000017954426,0.00013665618],"genre_scores_gemma":[0.99925417,0.00003920244,0.000042089447,0.0000222777,0.000012325053,0.000020603014,0.00014715242,0.000019125986,0.00044308102],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99854815,0.0001994333,0.00057784835,0.00031343973,0.000049325183,0.00031181672],"domain_scores_gemma":[0.99943024,0.00005807733,0.00019794842,0.00024672077,0.000054785145,0.000012216991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012294188,0.00019756454,0.00041708583,0.00026913028,0.000041896514,0.000004053825,0.00011965171,0.0004657487,0.000046829064],"category_scores_gemma":[0.0000072764374,0.00019350342,0.00006171661,0.00016745557,0.00023871698,0.00007426876,0.00008137725,0.00026500484,0.000011954094],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030871658,0.0013499726,0.019092085,0.0000716844,0.000031567222,0.0000067124697,0.00020640896,0.0000023868852,0.9783818,0.000013530702,0.00032228683,0.00021282856],"study_design_scores_gemma":[0.005116509,0.00034096595,0.071012616,0.000067375404,0.00004282433,0.000010633814,0.00005905426,5.2004924e-7,0.922843,0.00009270007,0.0002516735,0.00016213735],"about_ca_topic_score_codex":0.00053701556,"about_ca_topic_score_gemma":0.00018060424,"teacher_disagreement_score":0.055538826,"about_ca_system_score_codex":0.000024152221,"about_ca_system_score_gemma":0.000020198377,"threshold_uncertainty_score":0.7890841},"labels":[],"label_agreement":null},{"id":"W2059880890","doi":"10.1182/blood-2012-11-467803","title":"A new way of trapping bugs: neutrophil microvesicles","year":2013,"lang":"en","type":"letter","venue":"Blood","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Microvesicles; Neutrophil extracellular traps; Extracellular vesicles; Cell biology; Extracellular; Biology; Immunology; Microbiology; Inflammation; microRNA; Biochemistry","score_opus":0.013707712819550704,"score_gpt":0.202935525601466,"score_spread":0.18922781278191528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059880890","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4432493,0.040279157,0.001086553,0.4959247,0.0054225894,0.0034339628,0.00089417223,0.00074740726,0.008962165],"genre_scores_gemma":[0.08276486,0.00182087,0.005085831,0.77364767,0.009103381,0.00030045066,0.0038197224,0.0007626965,0.12269451],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99768555,0.00024515594,0.0006215164,0.0006704522,0.000076795855,0.0007005123],"domain_scores_gemma":[0.9985533,0.0001529346,0.00043106487,0.00070954,0.00011743165,0.000035776866],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00009393444,0.00057392614,0.00095530937,0.0002914637,0.00011371281,0.000029081553,0.00068791496,0.00144114,0.002251088],"category_scores_gemma":[0.000021648928,0.0004974834,0.0003703795,0.00017927398,0.00017726418,0.000106204294,0.00016464932,0.0016394729,0.0016142237],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010005036,0.00007401186,0.0000049096557,0.00008352873,0.00047728888,0.000058204474,0.000084165484,6.311336e-8,0.55832857,0.00013436456,0.43952477,0.0012201362],"study_design_scores_gemma":[0.0015730427,0.00020974966,0.00005668285,0.00014963327,0.00028970971,0.00010158862,0.000021158328,2.3234312e-8,0.5830787,0.0004671237,0.41370964,0.0003429474],"about_ca_topic_score_codex":0.00028623478,"about_ca_topic_score_gemma":0.0000038378266,"teacher_disagreement_score":0.36048442,"about_ca_system_score_codex":0.000019602125,"about_ca_system_score_gemma":0.00014944831,"threshold_uncertainty_score":0.9998552},"labels":[],"label_agreement":null},{"id":"W2060013642","doi":"10.1182/blood-2012-04-415034","title":"Chopped and diced: Dicer1 deletion generates myeloid dysplasia","year":2012,"lang":"en","type":"letter","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Myeloid; Cancer research","score_opus":0.01913930568128071,"score_gpt":0.2655508589859952,"score_spread":0.24641155330471445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060013642","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30741456,0.010096106,0.000060835588,0.6701012,0.0005837191,0.0017192123,0.00014431655,0.0003571754,0.009522885],"genre_scores_gemma":[0.054436713,0.005138348,0.0038320723,0.8441579,0.04925934,0.00038845785,0.005208143,0.00064349856,0.03693557],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970832,0.00014078082,0.00039390413,0.00065781985,0.0007749746,0.0009493452],"domain_scores_gemma":[0.9984926,0.00017559057,0.00016178584,0.00068577426,0.00017398533,0.0003102871],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00032645365,0.0005002027,0.0007164586,0.0003628991,0.00014510099,0.000080990314,0.00022119067,0.001352468,0.0004982304],"category_scores_gemma":[0.0001550707,0.00042396455,0.00013761954,0.00023177925,0.00019469837,0.00012671073,0.0001989293,0.0029021138,0.00048473538],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006112773,0.0001573149,0.006134613,0.0008038359,0.0005434181,0.001133046,0.00011658486,6.954452e-8,0.01197039,0.000009910015,0.9766437,0.0024260122],"study_design_scores_gemma":[0.004753618,0.00027738375,0.006023416,0.00023921621,0.0013360434,0.0016517409,0.000018080003,0.000029229745,0.005980141,0.000023995195,0.9791497,0.00051743136],"about_ca_topic_score_codex":0.00010654307,"about_ca_topic_score_gemma":0.0000062592626,"teacher_disagreement_score":0.25297785,"about_ca_system_score_codex":0.00018930394,"about_ca_system_score_gemma":0.00033434544,"threshold_uncertainty_score":0.999944},"labels":[],"label_agreement":null},{"id":"W2060057084","doi":"10.1182/blood-2011-04-351239","title":"Targeting survivin overcomes drug resistance in acute lymphoblastic leukemia","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Survivin; Cancer research; Chemotherapy; Drug resistance; Leukemia; Medicine; Minimal residual disease; Acute lymphocytic leukemia; Cytarabine; Drug; Inhibitor of apoptosis; Apoptosis; Biology; Pharmacology; Immunology; Lymphoblastic Leukemia; Internal medicine; Cancer; Programmed cell death","score_opus":0.01538796614368169,"score_gpt":0.2512861769358303,"score_spread":0.2358982107921486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060057084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9737509,0.00075762765,0.0002494029,0.00016058913,0.00014793084,0.00043828192,0.00001457482,0.00014230993,0.024338398],"genre_scores_gemma":[0.98442376,0.00017978945,0.0080669215,0.00022486622,0.00013874436,0.000054132066,0.000023123355,0.00007044259,0.006818246],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99744844,0.00011940465,0.00049969624,0.00053180184,0.0006227339,0.0007779262],"domain_scores_gemma":[0.99865067,0.0003170121,0.000104661056,0.00053801923,0.00012161787,0.0002680265],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005674765,0.00027595786,0.00051671633,0.0002811144,0.00007840065,0.000022569158,0.00031287552,0.00014722411,0.00036960575],"category_scores_gemma":[0.00055738166,0.0002459468,0.00010298871,0.0006027516,0.00015151897,0.00015725408,0.0001807757,0.00034688812,0.0002689277],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005742847,0.005435034,0.8009795,0.0018945036,0.00231257,0.016076721,0.019610858,0.000021828457,0.08905306,0.0058799083,0.051752716,0.0012404699],"study_design_scores_gemma":[0.09277635,0.000879465,0.7310152,0.0030046715,0.0020400453,0.0010890843,0.0019475985,0.0031245074,0.14684466,0.00449956,0.009940115,0.00283872],"about_ca_topic_score_codex":0.0005280061,"about_ca_topic_score_gemma":0.00031319135,"teacher_disagreement_score":0.0870335,"about_ca_system_score_codex":0.00096116046,"about_ca_system_score_gemma":0.0012217031,"threshold_uncertainty_score":0.9999993},"labels":[],"label_agreement":null},{"id":"W2060073480","doi":"10.1182/blood-2012-08-447367","title":"High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":208,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"","keywords":"Myeloid leukemia; Neutropenia; Medicine; Myeloid; Congenital Neutropenia; GATA2; Leukemia; Internal medicine; Transcription factor; Cancer research; Immunology; Genetics; Biology; Gene; Chemotherapy","score_opus":0.003470949122264223,"score_gpt":0.19828711313916403,"score_spread":0.1948161640168998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060073480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998011,0.0013700033,0.000020616342,0.000016854076,0.00003471712,0.00031583058,0.00006703743,0.000005274591,0.00015867157],"genre_scores_gemma":[0.9978585,0.000046819183,0.0017323152,0.000031664673,0.000022655804,0.000048207905,0.00020175801,0.000021627713,0.000036404985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99923235,0.000020264146,0.00016834262,0.000229301,0.00008603763,0.00026372154],"domain_scores_gemma":[0.99955994,0.000005295959,0.000065840155,0.00022165632,0.000041780615,0.0001054875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000033017615,0.00014937004,0.00017298698,0.000060291924,0.000045019762,0.000010810939,0.0000911232,0.000077789824,0.000009981739],"category_scores_gemma":[0.000008008929,0.00013129892,0.000025453865,0.000117259246,0.000037999307,0.000015702504,0.00006701761,0.000050517396,0.0000057855636],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035224817,0.00058252976,0.98339915,0.000023105307,0.000288143,0.0000057113807,0.00007351836,0.000022174932,0.014939737,0.000034703553,0.000028988448,0.000566989],"study_design_scores_gemma":[0.004498005,0.0007973731,0.959627,0.000033595432,0.00018740463,0.000011954329,0.0000179244,0.0000013612364,0.03460604,0.000016824706,0.000028986458,0.00017353344],"about_ca_topic_score_codex":0.00022328984,"about_ca_topic_score_gemma":0.00022385777,"teacher_disagreement_score":0.023772178,"about_ca_system_score_codex":0.000025134863,"about_ca_system_score_gemma":0.00007353177,"threshold_uncertainty_score":0.5354215},"labels":[],"label_agreement":null},{"id":"W2060388290","doi":"10.1182/blood-2013-09-526392","title":"Asparaginase unveils glutamine-addicted AML","year":2013,"lang":"en","type":"letter","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute","funders":"","keywords":"Medicine; Glutamine; Asparaginase; Internal medicine; Leukemia; Chemistry; Lymphoblastic Leukemia; Biochemistry","score_opus":0.01608417308666537,"score_gpt":0.25924512308245984,"score_spread":0.24316094999579446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060388290","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04599678,0.0013026056,0.00014785072,0.90151525,0.00079439144,0.0029709893,0.00038549307,0.0008051331,0.046081513],"genre_scores_gemma":[0.005570193,0.00017212317,0.0018613806,0.849823,0.015557195,0.00048321843,0.003464741,0.00042795847,0.12264018],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957313,0.00013370719,0.0005547613,0.0008917012,0.0014564239,0.0012320906],"domain_scores_gemma":[0.99712825,0.00039472763,0.00020152582,0.0014855824,0.0004105864,0.00037931657],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.00015591618,0.0006481953,0.0010156841,0.00048183388,0.000085793145,0.00009700053,0.00054943864,0.0016602499,0.0033183708],"category_scores_gemma":[0.0004892335,0.0005340627,0.00029255898,0.00046148058,0.00028465077,0.00009661926,0.00025429585,0.0032100182,0.006127555],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031310134,0.00028793843,0.0001880316,0.0005315101,0.0006512144,0.012895763,0.000041495896,1.264714e-7,0.0009972312,0.0000059145077,0.98378915,0.00058029185],"study_design_scores_gemma":[0.009660398,0.00051342143,0.00079136767,0.00045176965,0.0011762088,0.0022492998,0.000010453929,0.00012535873,0.0029822567,0.0000518863,0.98141605,0.000571532],"about_ca_topic_score_codex":0.0002984548,"about_ca_topic_score_gemma":0.0000022411116,"teacher_disagreement_score":0.076558664,"about_ca_system_score_codex":0.00048070803,"about_ca_system_score_gemma":0.0015163167,"threshold_uncertainty_score":0.9997111},"labels":[],"label_agreement":null},{"id":"W2060443143","doi":"10.1182/blood-2009-07-233965","title":"Persons with Quebec platelet disorder have a tandem duplication of PLAU, the urokinase plasminogen activator gene","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Hospital for Sick Children; McMaster University; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Gene duplication; Tandem exon duplication; Platelet; Activator (genetics); Gene; Genetics; Medicine; Urokinase; Biology; Internal medicine","score_opus":0.005652357495187258,"score_gpt":0.20598383923418243,"score_spread":0.20033148173899518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060443143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99770766,0.00044509192,0.0008845786,0.0002994036,0.0000138125415,0.00026885778,0.000030475729,0.000009668279,0.00034047072],"genre_scores_gemma":[0.998803,0.000030525032,0.00034038103,0.00021270996,0.00012444983,0.00003363692,0.000067572524,0.000012164807,0.00037552873],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99937856,0.000025993617,0.00011121938,0.00021931353,0.0001116077,0.00015332174],"domain_scores_gemma":[0.9994989,0.0000059397275,0.00008765728,0.0003214486,0.000039086877,0.000046950237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006096278,0.000119326076,0.00009874499,0.000017317809,0.00007979754,0.000011919479,0.00014226024,0.00009788153,0.000009696752],"category_scores_gemma":[0.000017605042,0.00007978241,0.000053259828,0.00004926926,0.00004045402,0.0000045416814,0.000024948593,0.00006475872,0.000002367257],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000082857514,0.00025296496,0.00044580596,0.000003541078,0.000058777907,0.0000034962904,0.00008254917,0.0000064020887,0.9976735,0.00010794833,0.00031887516,0.0009632846],"study_design_scores_gemma":[0.0010699094,0.00048714815,0.0012043209,0.000009649641,0.00004558351,0.000029884623,0.000096191034,0.000015583984,0.9928571,0.00004879606,0.0040164283,0.000119431745],"about_ca_topic_score_codex":0.00010239736,"about_ca_topic_score_gemma":0.00016201918,"teacher_disagreement_score":0.004816424,"about_ca_system_score_codex":0.000005141094,"about_ca_system_score_gemma":0.00007709015,"threshold_uncertainty_score":0.32534325},"labels":[],"label_agreement":null},{"id":"W2060445806","doi":"10.1182/blood-2003-09-3311","title":"Do thymically and strictly extrathymically developing T cells generate similar immune responses?","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Immune system; Biology; Immunology; Medicine","score_opus":0.014550854568647523,"score_gpt":0.22579965232460925,"score_spread":0.21124879775596173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060445806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837684,0.0074773915,0.0010461187,0.00016875888,0.0018768229,0.00020377997,0.000004617881,0.00010109255,0.005353014],"genre_scores_gemma":[0.98472697,0.001067358,0.0018240379,0.00070485246,0.00003498383,0.000019834135,0.00003537708,0.000031804724,0.011554769],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985177,0.0003749233,0.0003831373,0.00034474474,0.00003736025,0.00034211922],"domain_scores_gemma":[0.99934834,0.00014921137,0.00011743858,0.00026101634,0.00009647569,0.000027528708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003351468,0.00020955956,0.00023828527,0.000121142686,0.000253553,0.000056755394,0.00011699703,0.00025597707,0.00082309096],"category_scores_gemma":[0.00017414504,0.000191706,0.00007679898,0.00014436406,0.00009200449,0.00012484728,0.000044880613,0.00033823051,0.00047870498],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014662054,0.00016024636,0.00026481412,0.000008044555,0.000158082,0.000009007126,0.000112229485,0.0000013896594,0.9949132,0.002524613,0.0012708065,0.000430926],"study_design_scores_gemma":[0.001983895,0.00017450441,0.0017812909,0.00002348963,0.00007213525,0.00021219363,0.000120929755,0.0000013324889,0.8564841,0.000105442276,0.13879551,0.00024517436],"about_ca_topic_score_codex":0.000009086811,"about_ca_topic_score_gemma":0.0000015603703,"teacher_disagreement_score":0.13842912,"about_ca_system_score_codex":0.00002401559,"about_ca_system_score_gemma":0.00010520455,"threshold_uncertainty_score":0.9012269},"labels":[],"label_agreement":null},{"id":"W2060453837","doi":"10.1182/blood.v100.3.1055","title":"γ-Globulins prepared from sera of multiparous women bind anti-HLA antibodies and inhibit an established in vivo human alloimmune response","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services","funders":"","keywords":"In vivo; Antibody; Immunology; Isoantibodies; Human leukocyte antigen; Medicine; Chemistry; Biology; Antigen; Genetics","score_opus":0.02612640312839593,"score_gpt":0.28921059664980936,"score_spread":0.26308419352141343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060453837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99680096,0.0012832853,5.352266e-7,0.0003867375,0.000033095363,0.00043172645,0.00018716259,0.00004535183,0.00083112885],"genre_scores_gemma":[0.9958075,0.0005109462,0.00052677206,0.00009729343,0.00008810964,0.000022580307,0.00004444534,0.000031124626,0.0028712116],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99780935,0.00022716931,0.00053327985,0.0004714501,0.00044021284,0.00051855174],"domain_scores_gemma":[0.9988315,0.00023316791,0.00011233861,0.00044941492,0.000112212256,0.00026136922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048212425,0.00024950068,0.0006654593,0.00031158942,0.00011305592,0.000043414726,0.00017600966,0.00015084348,0.00071038865],"category_scores_gemma":[0.00020749916,0.00021544931,0.000069628935,0.00030283036,0.00027120544,0.00019977883,0.00017199434,0.00028433552,0.000012980213],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018019975,0.002211156,0.32157823,0.00011964307,0.00016223767,0.00041286027,0.0070580067,0.000003135416,0.6658572,0.000012946096,0.00021715749,0.00056541205],"study_design_scores_gemma":[0.010129074,0.0017814086,0.86579907,0.00034875798,0.00008424253,0.00009944843,0.0011708022,0.00042810524,0.11636124,0.00007551284,0.0033586512,0.00036371636],"about_ca_topic_score_codex":0.0019544594,"about_ca_topic_score_gemma":0.0002615761,"teacher_disagreement_score":0.549496,"about_ca_system_score_codex":0.000034285575,"about_ca_system_score_gemma":0.00004711475,"threshold_uncertainty_score":0.87857676},"labels":[],"label_agreement":null},{"id":"W2060562046","doi":"10.1182/blood-2014-10-602060","title":"Premature changes in trabecular and cortical microarchitecture result in decreased bone strength in hemophilia","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"University of Calgary","keywords":"Medicine; Arthropathy; Internal medicine; Pathology; Osteoarthritis","score_opus":0.022458094415775145,"score_gpt":0.2838691007018443,"score_spread":0.26141100628606917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060562046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99217135,0.0029647783,2.3568835e-7,0.0036967143,0.000015839149,0.0005710633,0.000009667566,0.000018698713,0.0005516597],"genre_scores_gemma":[0.99864817,0.00015831382,0.00069681177,0.0001048212,0.00006575567,0.00003583506,0.00004294183,0.000017286344,0.00023009515],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870193,0.000121711906,0.00021554016,0.0003089446,0.00027863152,0.00037326306],"domain_scores_gemma":[0.9993777,0.00008174116,0.000020808235,0.00021094366,0.000031316147,0.0002774633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003771358,0.00015571844,0.0003561575,0.00033654,0.000013769137,0.000012635831,0.00005634054,0.00020684411,0.000015998146],"category_scores_gemma":[0.0004341586,0.000116361596,0.000025893509,0.00039107638,0.00008742888,0.000024655548,0.000041410553,0.0005315927,0.0000063391612],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024054819,0.0062912954,0.8872949,0.00045467503,0.00008829708,0.010612414,0.0054308753,0.0000049811483,0.07867634,0.00005784384,0.00023300649,0.008449916],"study_design_scores_gemma":[0.059439536,0.0013139128,0.87796086,0.001291494,0.00014751709,0.0006466119,0.00094154046,0.0004116529,0.05596311,0.0004655949,0.00097339664,0.00044475365],"about_ca_topic_score_codex":0.00017253839,"about_ca_topic_score_gemma":0.0026911795,"teacher_disagreement_score":0.057034057,"about_ca_system_score_codex":0.00005488682,"about_ca_system_score_gemma":0.0001439015,"threshold_uncertainty_score":0.47450882},"labels":[],"label_agreement":null},{"id":"W2060562486","doi":"10.1182/blood-2013-03-490334","title":"Effect of body mass in children with hematologic malignancies undergoing allogeneic bone marrow transplantation","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute; U.S. Public Health Service; National Institutes of Health","keywords":"Medicine; Bone marrow transplantation; Hematologic Neoplasms; Bone marrow; Transplantation; Leukemia; Internal medicine","score_opus":0.007270310701317516,"score_gpt":0.24699344649109153,"score_spread":0.23972313578977403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060562486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99778455,0.00042416857,0.0004598798,0.00030000348,0.000030855812,0.00052140397,0.000007667402,0.000061319224,0.00041013118],"genre_scores_gemma":[0.9986481,0.00008368839,0.00091383955,0.00016741763,0.000058673955,0.000028545533,0.000048872793,0.000025214142,0.000025633293],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985632,0.00025649887,0.00034996786,0.00027366172,0.00031757436,0.00023911662],"domain_scores_gemma":[0.9991828,0.00030052828,0.00014858422,0.00026910173,0.000027091464,0.00007185309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007241299,0.00018391087,0.00054859696,0.00012742734,0.000028487755,0.0000073943584,0.00008197145,0.00009330173,0.00001609175],"category_scores_gemma":[0.000113474816,0.00014282524,0.00007487105,0.00019071947,0.00006786919,0.00005546374,0.000009855137,0.00012721751,0.0000069686153],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035203987,0.00022551979,0.96243244,0.0011265007,0.00015185855,0.00002741937,0.00031123732,0.000019758152,0.035052348,0.0001725939,0.000010038381,0.000118244374],"study_design_scores_gemma":[0.012749457,0.0027174712,0.66676956,0.0010158762,0.0006032825,0.0006935451,0.00004510434,0.000016320953,0.3150583,0.000105484505,0.0000060657376,0.00021956123],"about_ca_topic_score_codex":0.00015640164,"about_ca_topic_score_gemma":0.00033806814,"teacher_disagreement_score":0.2956629,"about_ca_system_score_codex":0.000018074072,"about_ca_system_score_gemma":0.000062187326,"threshold_uncertainty_score":0.58242446},"labels":[],"label_agreement":null},{"id":"W2060621228","doi":"10.1182/blood-2012-01-402156","title":"Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":201,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Tissue factor; Thromboplastin; Cancer research; Thrombosis; Medicine; Thrombomodulin; Coagulation; Pathology; Inferior vena cava; Cancer; Thrombus; Pancreatic cancer; Venous thrombosis; Thrombin; Internal medicine; Platelet","score_opus":0.04109267808630075,"score_gpt":0.317849649766488,"score_spread":0.27675697168018726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060621228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99827087,0.0007833786,0.000035221055,0.000080678525,0.00002670235,0.00046755763,0.000015266587,0.000027841244,0.0002924553],"genre_scores_gemma":[0.9986897,0.000524116,0.00042150734,0.00007756474,0.000056704896,0.00010203721,0.000008995992,0.000019568468,0.00009981317],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992095,0.00002328362,0.00022447555,0.00015587766,0.00015486425,0.00023197832],"domain_scores_gemma":[0.9996005,0.000024527975,0.000106817475,0.0001546232,0.00003119408,0.00008228735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000771428,0.00013107386,0.00044342838,0.00010373997,0.000043046224,0.000009194125,0.000043119606,0.000043710956,0.000102852086],"category_scores_gemma":[0.000017603135,0.00011295054,0.000030616993,0.00008945815,0.000051004965,0.00015050123,0.00003944256,0.00006384715,0.0000026893608],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008685286,0.0012529214,0.14685942,0.00024314216,0.00012870587,5.98025e-7,0.0022268838,0.00001812186,0.84880173,0.00011922825,0.00003543968,0.00030510052],"study_design_scores_gemma":[0.00095527206,0.000117966985,0.41931632,0.00012854324,0.00021174809,5.3996075e-7,0.00020335105,0.000105396175,0.5788224,0.00004049949,0.000011845765,0.000086159314],"about_ca_topic_score_codex":0.0008377729,"about_ca_topic_score_gemma":0.00013422722,"teacher_disagreement_score":0.27245688,"about_ca_system_score_codex":0.000024382934,"about_ca_system_score_gemma":0.000018917899,"threshold_uncertainty_score":0.46059895},"labels":[],"label_agreement":null},{"id":"W2060647240","doi":"10.1182/blood-2011-10-386045","title":"Recombinant factor XIII: a safe and novel treatment for congenital factor XIII deficiency","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Blood properties and coagulation","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Novo Nordisk","keywords":"Medicine; Factor XIII deficiency; Cryoprecipitate; Factor XIII; Surgery; Gastroenterology; Internal medicine; Pediatrics","score_opus":0.06093002334434895,"score_gpt":0.2768266552964394,"score_spread":0.21589663195209047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060647240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99510914,0.0026447263,0.0002490413,0.00023874773,0.00025245675,0.0007458008,0.00007387859,0.000039748556,0.00064646604],"genre_scores_gemma":[0.9971755,0.0000661176,0.0011281957,0.000084281324,0.00018810776,0.00007481618,0.00002616588,0.000022988788,0.001233831],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991839,0.000008536631,0.00018747455,0.00018637479,0.000115297335,0.00031844352],"domain_scores_gemma":[0.999517,0.000038332055,0.000054372482,0.0001685539,0.00005248615,0.00016924358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000043545766,0.00016033278,0.00023970664,0.000041524105,0.00010254941,0.000019493455,0.00003202708,0.00008558348,0.00008792631],"category_scores_gemma":[0.00003494421,0.00010876143,0.00008439691,0.000049960447,0.00002990665,0.00010780881,0.000020220168,0.000047258418,0.000016003389],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013267534,0.018918356,0.5440823,0.00050589204,0.0012167974,0.00001078544,0.008181467,6.0802313e-7,0.22019471,0.0033379882,0.00031680329,0.20190756],"study_design_scores_gemma":[0.03682821,0.00767647,0.8090806,0.00012049738,0.001994323,0.00035837214,0.0007130736,0.00019796827,0.09940504,0.0000944145,0.042776566,0.0007544752],"about_ca_topic_score_codex":0.000066390865,"about_ca_topic_score_gemma":0.0000111616455,"teacher_disagreement_score":0.2649983,"about_ca_system_score_codex":0.000033596523,"about_ca_system_score_gemma":0.00004793654,"threshold_uncertainty_score":0.44351625},"labels":[],"label_agreement":null},{"id":"W2060753739","doi":"10.1182/blood-2011-05-349621","title":"Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":215,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Medicine; Blood pressure; Internal medicine; Sickle cell anemia; Stroke (engine); Logistic regression; Anemia; Neurology; Cardiology","score_opus":0.008683176199110035,"score_gpt":0.20451862858950653,"score_spread":0.1958354523903965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060753739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941644,0.0026727037,0.000045827946,0.000104039755,0.00013163225,0.0013169771,0.00028632535,0.00012136979,0.0011567078],"genre_scores_gemma":[0.9974557,0.0003641312,0.00059507333,0.00013460488,0.00005754408,0.000051770527,0.00016809284,0.000060986324,0.0011120719],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99796313,0.00016920228,0.00050924654,0.00053020124,0.00025128204,0.0005769552],"domain_scores_gemma":[0.99874145,0.00027377947,0.00027024053,0.0003174965,0.00012541946,0.00027161505],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040729583,0.0003622244,0.0006360738,0.00016988862,0.00013646545,0.000015937236,0.00011069922,0.0005805369,0.00010550954],"category_scores_gemma":[0.0005601075,0.00029565688,0.00013912514,0.0003028882,0.0001042293,0.0001266799,0.00007248975,0.0006506528,0.000008939096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052486116,0.011003508,0.96574384,0.0014818301,0.0019923127,0.0002600627,0.013827973,0.00013804453,0.0029371795,0.00029132213,0.0013728308,0.0004262283],"study_design_scores_gemma":[0.12309991,0.0075640148,0.6610768,0.002123789,0.024294643,0.0002001674,0.0079113655,0.0036324998,0.16446562,0.0016354305,0.0013184784,0.002677299],"about_ca_topic_score_codex":0.0018386716,"about_ca_topic_score_gemma":0.00011416084,"teacher_disagreement_score":0.30466706,"about_ca_system_score_codex":0.000029080535,"about_ca_system_score_gemma":0.00012250905,"threshold_uncertainty_score":0.9999496},"labels":[],"label_agreement":null},{"id":"W2060824604","doi":"10.1182/blood-2009-09-245951","title":"Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; McMaster University","funders":"National Cancer Institute","keywords":"Asparaginase; Medicine; Gastroenterology; Dosing; Internal medicine; Pancreatitis; PEG ratio; Lymphoblastic Leukemia; Leukemia; Pharmacology","score_opus":0.00534999375547334,"score_gpt":0.23195978560267336,"score_spread":0.2266097918472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060824604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99853766,0.00019052405,0.00008152239,0.00022028874,0.000027303824,0.00071202416,0.0000052766973,0.00009656203,0.00012882176],"genre_scores_gemma":[0.99863124,0.00023663971,0.00057780923,0.00015110799,0.00021036809,0.000017129212,0.000028421186,0.000039339313,0.00010796517],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99801993,0.000054107826,0.00029793626,0.00054958905,0.00051137386,0.0005670525],"domain_scores_gemma":[0.9990721,0.000027320753,0.000087994165,0.0003650076,0.00007386683,0.0003737534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012727137,0.00028217022,0.0003965405,0.00031606955,0.00010713443,0.000042229665,0.00012667652,0.00018743951,0.000011296103],"category_scores_gemma":[0.00012377724,0.00022834423,0.000036260153,0.0004604837,0.00009683955,0.0001639501,0.000060819963,0.00041058645,0.000016842445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058372556,0.003771351,0.78428453,0.00037161683,0.00043613883,0.00867957,0.0014903398,0.00019195577,0.17396994,0.0000240255,0.0002708481,0.020672439],"study_design_scores_gemma":[0.03116246,0.0010555834,0.93849725,0.0012316428,0.00028403368,0.0053736637,0.000045310426,0.0002444855,0.021832073,0.00002182102,0.0000041057306,0.00024756542],"about_ca_topic_score_codex":0.00020466406,"about_ca_topic_score_gemma":0.000012092222,"teacher_disagreement_score":0.15421274,"about_ca_system_score_codex":0.00081168156,"about_ca_system_score_gemma":0.0006423774,"threshold_uncertainty_score":0.93116075},"labels":[],"label_agreement":null},{"id":"W2060944287","doi":"10.1182/blood-2004-01-0150","title":"Self-reactive memory-phenotype CD8 T cells exhibit both MHC-restricted and non-MHC-restricted cytotoxicity: a role for the T-cell receptor and natural killer cell receptors","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cytotoxic T cell; NKG2D; Natural killer T cell; Biology; Interleukin 21; IL-2 receptor; CD8; Cell biology; Antigen-presenting cell; ZAP70; T-cell receptor; T cell; Major histocompatibility complex; Interleukin 12; Immunology; Molecular biology; Immune system; In vitro; Biochemistry","score_opus":0.004344197012567905,"score_gpt":0.19153518664574895,"score_spread":0.18719098963318104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060944287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864843,0.005134708,0.0001359922,0.00028270108,0.004576429,0.0013980463,0.000018946672,0.00018805637,0.0017808451],"genre_scores_gemma":[0.9879389,0.0007120362,0.00041542147,0.000331165,0.0001396949,0.000116916555,0.0001576366,0.000055897846,0.010132343],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983469,0.0001359685,0.00038964106,0.00055314624,0.00007083711,0.00050348416],"domain_scores_gemma":[0.99875635,0.00042957102,0.00027510524,0.0003432503,0.00013695448,0.000058760474],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012863685,0.00038770548,0.00036663038,0.0001683832,0.0005570371,0.00007524537,0.00020655536,0.0004161157,0.0003000809],"category_scores_gemma":[0.00006895235,0.00029653482,0.00013239353,0.00027202486,0.00015476487,0.00023769544,0.000110415225,0.0006644475,0.00022174689],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005749515,0.0008146341,0.00007190404,0.000039451956,0.00032616392,0.0000014923809,0.001252642,0.0000079772235,0.9901777,0.000022588287,0.0063874843,0.00032299408],"study_design_scores_gemma":[0.008543942,0.00078512507,0.00094241835,0.000032209933,0.00040634113,0.000031410123,0.001347951,0.00002728738,0.9319696,0.000026941672,0.055491537,0.00039523692],"about_ca_topic_score_codex":0.00030419548,"about_ca_topic_score_gemma":0.000022863069,"teacher_disagreement_score":0.058208115,"about_ca_system_score_codex":0.00007876918,"about_ca_system_score_gemma":0.000110147696,"threshold_uncertainty_score":0.9999487},"labels":[],"label_agreement":null},{"id":"W2061049714","doi":"10.1182/blood-2003-05-1412","title":"JNK activation is a mediator of arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cells","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Arsenic trioxide; Acute promyelocytic leukemia; Apoptosis; Kinase; Cancer research; Buthionine sulfoximine; Chemistry; Glutathione; Cell biology; Cell culture; Biology; Retinoic acid; Biochemistry; Enzyme","score_opus":0.007226696624707599,"score_gpt":0.2278253692895262,"score_spread":0.2205986726648186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061049714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988634,0.00016824335,0.00018745004,0.00007104,0.00006979074,0.000245514,0.0000079838455,0.000011593122,0.00037498432],"genre_scores_gemma":[0.99851745,0.00024400535,0.00081119774,0.00009888844,0.00010203392,0.000045384713,0.000036308233,0.000025323065,0.00011939655],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99888104,0.000030722385,0.00032051673,0.00034752494,0.00018029427,0.00023991725],"domain_scores_gemma":[0.99937415,0.000011319,0.00015667689,0.0003231893,0.00007306767,0.00006160539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012272554,0.00017191787,0.00021167277,0.000077342476,0.000029001325,0.00001169129,0.00021578828,0.00025288496,0.000011431582],"category_scores_gemma":[0.00006458579,0.00016657874,0.00009809974,0.00022425003,0.000045630135,0.0000078641015,0.00006192609,0.0001270826,0.000009009488],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004974133,0.00015970228,0.0005015639,0.000070525326,0.00008244817,0.0000032589537,0.00020014247,0.000025750247,0.9985232,0.000014715112,0.000039724084,0.00032926278],"study_design_scores_gemma":[0.0029641758,0.0002687796,0.00030613982,0.00005416511,0.00007518133,0.000007848416,0.00008082364,0.000004218463,0.99570197,0.00014488978,0.00020612012,0.00018569203],"about_ca_topic_score_codex":0.000040583564,"about_ca_topic_score_gemma":0.000006246638,"teacher_disagreement_score":0.0029144343,"about_ca_system_score_codex":0.0000721838,"about_ca_system_score_gemma":0.00062025455,"threshold_uncertainty_score":0.6792884},"labels":[],"label_agreement":null},{"id":"W2061053923","doi":"10.1182/blood-2006-05-020917","title":"ATM deficiency disrupts Tcra locus integrity and the maturation of CD4+CD8+ thymocytes","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; McMaster University; University of Toronto","funders":"Hospital for Sick Children","keywords":"T-cell receptor; Thymocyte; Biology; Ataxia-telangiectasia; CD8; Cell biology; Molecular biology; T cell; DNA damage; Cancer research; Genetics; Immune system; DNA","score_opus":0.004538586454458702,"score_gpt":0.20987285444919707,"score_spread":0.20533426799473836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061053923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99514425,0.0020423287,0.0005798985,0.00012050565,0.000048394784,0.00013841278,0.000009128947,0.000010141165,0.001906966],"genre_scores_gemma":[0.9988835,0.00006674845,0.00070428115,0.000038192404,0.000075665186,0.000009868416,0.00002616899,0.000007511971,0.00018808233],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994608,0.000046539022,0.00013583794,0.00016345942,0.00008789167,0.00010547611],"domain_scores_gemma":[0.9996427,0.000015263437,0.00006400171,0.00021710615,0.000044494376,0.000016425767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016451611,0.000081532555,0.00009084562,0.000011780276,0.000046347068,0.000015867317,0.00009953451,0.000083256185,0.0000058532796],"category_scores_gemma":[0.000056489025,0.00005338439,0.000049379614,0.00004457294,0.00011001547,0.0000027290218,0.000068978436,0.00006395581,0.0000025798872],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000074543466,0.00015599099,0.0012706697,0.000019364152,0.000016616903,0.0000015045423,0.00003627615,0.000003961803,0.98874277,0.008977835,0.00012321156,0.00057725306],"study_design_scores_gemma":[0.0012643344,0.00011701723,0.0034504216,0.000007911449,0.000047527195,0.000029405197,0.000055369695,0.000041653533,0.99139196,0.0031330145,0.0003757772,0.00008558935],"about_ca_topic_score_codex":0.00008491927,"about_ca_topic_score_gemma":0.000052947977,"teacher_disagreement_score":0.0058448208,"about_ca_system_score_codex":0.0000021940625,"about_ca_system_score_gemma":0.000021817636,"threshold_uncertainty_score":0.2176952},"labels":[],"label_agreement":null},{"id":"W2061196972","doi":"10.1182/blood-2005-01-0033","title":"Immunohistochemistry accurately predicts FGFR3 aberrant expression and t(4;14) in multiple myeloma","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Immunohistochemistry; Multiple myeloma; Immunocytochemistry; Isotype; Pathology; Fibroblast growth factor receptor 3; Biology; Chromosomal translocation; Immunoglobulin A; Fluorescence in situ hybridization; Antibody; Medicine; Internal medicine; Fibroblast growth factor; Monoclonal antibody; Receptor; Immunology; Immunoglobulin G","score_opus":0.03258036829058847,"score_gpt":0.3066833460329813,"score_spread":0.27410297774239284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061196972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934442,0.0030364261,0.00000637241,0.00026549207,0.000025803216,0.00045456315,0.000019985586,0.00006112822,0.0026860514],"genre_scores_gemma":[0.99646163,0.00028845394,0.001902711,0.000055410466,0.00012766183,0.000088832225,0.00006738027,0.000022936485,0.0009849955],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986901,0.000031020605,0.00025238417,0.0003368853,0.00030298976,0.00038658705],"domain_scores_gemma":[0.9992299,0.00008568923,0.000050329025,0.0003242673,0.000049400784,0.00026039215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011366306,0.00017946176,0.0002583346,0.000093410235,0.00007925844,0.000020947045,0.00008351221,0.00012393024,0.0001282683],"category_scores_gemma":[0.00026425623,0.00014559977,0.000050176033,0.000113030015,0.00007498069,0.00011610469,0.00008256384,0.0002399577,0.000050030165],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006060709,0.0016280292,0.19099492,0.00013228925,0.0000826893,0.0004157594,0.00036009596,0.0000019437193,0.78583014,0.000001925367,0.00044364773,0.019502517],"study_design_scores_gemma":[0.025924647,0.00026585074,0.42475602,0.00044895196,0.00006344253,0.0002576194,0.00008532104,0.0005239634,0.545789,0.000011307117,0.001680106,0.00019373983],"about_ca_topic_score_codex":0.00005938695,"about_ca_topic_score_gemma":0.00002042833,"teacher_disagreement_score":0.24004109,"about_ca_system_score_codex":0.000061869476,"about_ca_system_score_gemma":0.000080889884,"threshold_uncertainty_score":0.5937386},"labels":[],"label_agreement":null},{"id":"W2061432565","doi":"10.1182/blood-2014-03-562579","title":"Bodies of evidence? Lymphoglandular bodies in aspirate smears of bone marrow involved by aggressive large B-cell lymphoma","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hematological disorders and diagnostics","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"European Hematology Association","keywords":"Medicine; Lymphoma; Pathology; Bone marrow; Mediastinal mass; Mediastinal lymphadenopathy; Radiology; Computed tomography; Bone marrow aspirate","score_opus":0.030897639305064853,"score_gpt":0.2665613242770185,"score_spread":0.23566368497195367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061432565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98248464,0.015469707,0.000044525765,0.000287993,0.000037776477,0.00024603674,0.000037562182,0.00002261238,0.0013691518],"genre_scores_gemma":[0.9971129,0.0018989855,0.0003690755,0.00036077303,0.000020463847,0.000021014188,0.000023473422,0.000016392207,0.00017696685],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998512,0.00009567548,0.00053106504,0.0002554595,0.0002932045,0.00031257633],"domain_scores_gemma":[0.9986362,0.00046995303,0.0003316594,0.0003093347,0.0001430984,0.00010978971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036183366,0.00017881501,0.00073019153,0.00010909077,0.00002876121,0.0000067596784,0.00010248572,0.00016620767,0.000051662202],"category_scores_gemma":[0.0030168956,0.0001271309,0.00011893219,0.00011772601,0.00015223242,0.000057485046,0.00008105073,0.000069302725,0.000015913145],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033730885,0.008237799,0.96021533,0.0016444596,0.00010452914,0.0002442429,0.0008324279,0.0000024925794,0.022564577,0.0006144839,0.003856765,0.0013456027],"study_design_scores_gemma":[0.09460641,0.006336388,0.26886687,0.010192116,0.0013114843,0.00009479409,0.0021560271,0.00093038345,0.60054916,0.0061528757,0.007571538,0.0012319677],"about_ca_topic_score_codex":0.0001362164,"about_ca_topic_score_gemma":0.000088309695,"teacher_disagreement_score":0.69134843,"about_ca_system_score_codex":0.000012603697,"about_ca_system_score_gemma":0.000075918644,"threshold_uncertainty_score":0.51842475},"labels":[],"label_agreement":null},{"id":"W2061458797","doi":"10.1182/blood-2011-04-350249","title":"Sclerotic-type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of disease","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"National Institutes of Health; Pfizer","keywords":"Medicine; Total body irradiation; Internal medicine; Gastroenterology; Chemotherapy","score_opus":0.031072755153350232,"score_gpt":0.25962708029894205,"score_spread":0.22855432514559182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061458797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986989,0.011875285,6.151635e-7,0.000025987516,0.00028371258,0.00032108687,0.00007824044,0.000016529646,0.00040950117],"genre_scores_gemma":[0.9972893,0.0024169376,0.000034802684,0.000019639114,0.00015131255,0.0000028478173,0.000004324265,0.000016210886,0.000064605396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886596,0.00016653558,0.00043202727,0.00019361654,0.00021041022,0.00013143921],"domain_scores_gemma":[0.9988003,0.000109703695,0.00026959568,0.00046921696,0.00013214114,0.00021906872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025526443,0.00011358819,0.00031342788,0.000034442353,0.000039285882,0.0000029766913,0.000114627306,0.000114458424,0.00024333537],"category_scores_gemma":[0.00045104467,0.000065915105,0.0001545629,0.00016809956,0.00026746717,0.000027352913,0.000068093956,0.00014794085,0.000004605243],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019801063,0.0005795895,0.99632645,0.00020605988,0.00038492325,0.0000032269334,0.00025520302,6.503384e-7,0.0008091963,0.000025638938,0.0005053632,0.00070567307],"study_design_scores_gemma":[0.002436843,0.0003386224,0.9917591,0.00058491924,0.001450985,0.0000012027859,0.0002525765,0.00001188019,0.0029591485,0.000014384164,0.00011820229,0.00007212614],"about_ca_topic_score_codex":0.00014040813,"about_ca_topic_score_gemma":0.0000017396418,"teacher_disagreement_score":0.010300278,"about_ca_system_score_codex":0.000010118653,"about_ca_system_score_gemma":0.0002938007,"threshold_uncertainty_score":0.268794},"labels":[],"label_agreement":null},{"id":"W2061514779","doi":"10.1182/blood-2005-06-2202","title":"Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-α production in vivo","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":475,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; St. Michael's Hospital","funders":"Canadian Institutes of Health Research; Canadian Blood Services","keywords":"Innate immune system; TLR4; TLR2; TLR9; Platelet; Biology; Lipopolysaccharide; Tumor necrosis factor alpha; Toll-like receptor; Immunology; In vivo; Receptor; Cytokine; Immune system; Gene expression; Biochemistry","score_opus":0.012299519627697666,"score_gpt":0.22901763306449824,"score_spread":0.21671811343680059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061514779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997848,0.0007892998,0.000002644027,0.000367352,0.00046534897,0.00035787243,0.000007857922,0.00008169893,0.000079967744],"genre_scores_gemma":[0.9987288,0.00014016296,0.00012526647,0.000055863155,0.000081850805,0.000039603492,0.00002468637,0.000019758483,0.00078398903],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987846,0.00015850611,0.0003515141,0.00035880125,0.000042385564,0.0003041715],"domain_scores_gemma":[0.9995083,0.000048730843,0.00012681299,0.00025859452,0.000037427653,0.000020084308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018256507,0.00019477252,0.00029312773,0.00015956414,0.0001634167,0.000029985193,0.00011970519,0.00021303736,0.0004761355],"category_scores_gemma":[0.00008525727,0.00017237157,0.000044987104,0.0000937971,0.000052264746,0.00042441816,0.000074571624,0.00024019534,0.00019982237],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020523486,0.00019610485,0.00143132,0.000013280929,0.00003864675,0.000002140167,0.00088727195,0.000004165013,0.992077,0.000015772868,0.00041391558,0.0047151693],"study_design_scores_gemma":[0.0018912655,0.00011917913,0.0059784777,0.00007457266,0.000017913771,0.00007939111,0.00012448145,0.0000065790427,0.987457,0.000016941936,0.0040265587,0.0002076563],"about_ca_topic_score_codex":0.00009797856,"about_ca_topic_score_gemma":0.00004546057,"teacher_disagreement_score":0.004619995,"about_ca_system_score_codex":0.000033758388,"about_ca_system_score_gemma":0.00003229145,"threshold_uncertainty_score":0.70291084},"labels":[],"label_agreement":null},{"id":"W2061673064","doi":"10.1182/blood-2010-12-322990","title":"Homozygosity mapping with SNP arrays confirms 3p21 as a recessive locus for gray platelet syndrome and narrows the interval significantly","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; National Institutes of Health; Heart and Stroke Foundation of Canada","keywords":"Locus (genetics); SNP; SNP array; Genetics; Disease gene identification; Runs of Homozygosity; Biology; Odds ratio; Single-nucleotide polymorphism; Medicine; Cartography; Internal medicine; Genotype; Gene; Geography; Phenotype","score_opus":0.02945422669380047,"score_gpt":0.24156150462148254,"score_spread":0.21210727792768208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061673064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953656,0.00043555305,0.00029212865,0.00034843324,0.000052188134,0.0010140083,0.000037501377,0.000049390863,0.00240519],"genre_scores_gemma":[0.9982316,0.00005089855,0.0009545709,0.0002562742,0.000023640694,0.00012439476,0.000029667604,0.000027674154,0.0003012708],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990299,0.000026285185,0.0001828103,0.00031752046,0.00014518142,0.00029834124],"domain_scores_gemma":[0.9993795,0.000067391135,0.00011119918,0.00024670418,0.000066135486,0.00012902565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011774703,0.00021093464,0.00039151337,0.000055879333,0.00017075446,0.000026739712,0.00010037459,0.00008506984,0.00006376265],"category_scores_gemma":[0.000031627515,0.00012031309,0.00007115215,0.000110508496,0.0001458929,0.00007323571,0.000028055756,0.00014987137,0.00001904928],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023534423,0.035402425,0.4884133,0.0042768046,0.038637046,0.12664223,0.14752537,0.0000075063913,0.056823377,0.005491889,0.006106313,0.06713933],"study_design_scores_gemma":[0.1894165,0.051112972,0.26033646,0.0052644475,0.010881565,0.1261781,0.040985513,0.00030812284,0.27480432,0.021746473,0.014492445,0.0044730674],"about_ca_topic_score_codex":0.0002518776,"about_ca_topic_score_gemma":0.00009434044,"teacher_disagreement_score":0.22807685,"about_ca_system_score_codex":0.000012001509,"about_ca_system_score_gemma":0.00005675572,"threshold_uncertainty_score":0.49062252},"labels":[],"label_agreement":null},{"id":"W2061718990","doi":"10.1182/blood-2008-08-175323","title":"Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":269,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; Office of Naval Research; Takeda Oncology; National Institutes of Health; Otsuka Pharmaceutical; Astellas Pharma; Therakos; Kiadis Pharma; Association of Medical Microbiology and Infectious Disease Canada; American Society for Blood and Marrow Transplantation; Teva Pharmaceutical Industries; WellPoint; HistoGenetics; CellGenix; Medical College of Wisconsin; Enzon Pharmaceuticals; U.S. Navy; Centers for Disease Control and Prevention; Celgene; Osiris Therapeutics; Pfizer; Baxter International; Health Resources and Services Administration; Viropharma; Amgen; Blue Cross and Blue Shield Association; U.S. Department of Health and Human Services; Astellas Pharma US; Bayer HealthCare; U.S. Department of Defense","keywords":"Medicine; Filgrastim; Adverse effect; Nausea; Internal medicine; Surgery; Apheresis; Granulocyte colony-stimulating factor; Bone marrow; Odds ratio; Donation; Chemotherapy; Platelet","score_opus":0.016495048168283698,"score_gpt":0.26252347818426736,"score_spread":0.24602843001598365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061718990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944645,0.00007282665,0.000012394115,0.00015025845,0.00013165336,0.0026898296,0.00021035569,0.00006649213,0.0022016892],"genre_scores_gemma":[0.99799514,0.000030957108,0.0013293703,0.000032929576,0.0001525358,0.00007816964,0.000104701256,0.000018370878,0.00025779833],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978925,0.00013164128,0.00075277174,0.0003296153,0.0006845933,0.00020886486],"domain_scores_gemma":[0.9987715,0.00021600423,0.00038727152,0.00024813443,0.00028916477,0.000087960405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003911123,0.00019313497,0.00040513027,0.0000684882,0.000049150516,0.0000051221355,0.00013744262,0.00016816868,0.00004190866],"category_scores_gemma":[0.00007067064,0.00014045958,0.00018991133,0.00031480924,0.00009963032,0.000080502046,0.000011775019,0.0002090613,0.000005234578],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18342803,0.05053564,0.4957985,0.0009190232,0.0071596494,0.00027936266,0.041731786,0.00034215476,0.21355674,0.00070965174,0.00080870895,0.0047307652],"study_design_scores_gemma":[0.29089102,0.005264473,0.36342576,0.0012034497,0.0025410864,0.000040487932,0.000958675,0.00024019837,0.33468142,0.00037735762,0.000052065836,0.00032398367],"about_ca_topic_score_codex":0.00017644276,"about_ca_topic_score_gemma":0.000037561356,"teacher_disagreement_score":0.13237274,"about_ca_system_score_codex":0.000037146463,"about_ca_system_score_gemma":0.00018580664,"threshold_uncertainty_score":0.57277757},"labels":[],"label_agreement":null},{"id":"W2061846271","doi":"10.1182/blood-2010-11-321208","title":"Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":597,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; Ontario Institute for Cancer Research; University of Toronto; BC Cancer Agency","funders":"Canadian Institutes of Health Research; Knut och Alice Wallenbergs Stiftelse; Karolinska Institutet; Stiftelsen för Strategisk Forskning; Ontario Genomics; Terry Fox Foundation; GlaxoSmithKline; Ontario Innovation Trust; Deutsche Forschungsgemeinschaft; Ontario Genomics Institute; BC Cancer Foundation; Wellcome Trust; Leukemia and Lymphoma Society; Genome Canada; Pfizer","keywords":"EZH2; Biology; Histone H3; Histone methyltransferase; Molecular biology; PRC2; Methyltransferase; Histone; Methylation; Histone methylation; Mutation; Cancer research; DNA methylation; Genetics; Gene expression; Gene","score_opus":0.01067644703807115,"score_gpt":0.2680245912378236,"score_spread":0.25734814419975244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061846271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99124146,0.000093404444,0.0070230495,0.00006510516,0.00013553268,0.0005220332,0.000050874376,0.000015812597,0.00085272535],"genre_scores_gemma":[0.99435616,0.00002706065,0.0050302795,0.000022208338,0.0001458899,0.00005504809,0.00013495435,0.00003228534,0.00019610584],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99885297,0.00009034283,0.0002732449,0.00037045358,0.00018599727,0.00022698396],"domain_scores_gemma":[0.9990786,0.00006234776,0.00020156743,0.0004044948,0.00014609285,0.00010692652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026030096,0.00018231837,0.00021571474,0.00008118915,0.00011799956,0.000020159354,0.00015712308,0.00018970798,0.000019909483],"category_scores_gemma":[0.000365074,0.00018288131,0.00010300075,0.00017863067,0.000043721717,0.00001257987,0.0001243506,0.00011044003,0.000018757075],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006803522,0.0003530628,0.0012892283,0.000027435066,0.00007680139,0.0000010768911,0.00027043713,0.00002402918,0.9967928,0.00013285373,0.000010028939,0.0009542438],"study_design_scores_gemma":[0.0013067996,0.00040043466,0.011305569,0.000010433963,0.00011054299,0.0000080947575,0.000017252547,0.0001221407,0.98422897,0.0020051347,0.00028237887,0.00020222862],"about_ca_topic_score_codex":0.00021364818,"about_ca_topic_score_gemma":0.00037086452,"teacher_disagreement_score":0.012563778,"about_ca_system_score_codex":0.000016102831,"about_ca_system_score_gemma":0.00014182502,"threshold_uncertainty_score":0.7457683},"labels":[],"label_agreement":null},{"id":"W2061918976","doi":"10.1182/blood-2006-11-051672","title":"Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph)","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":389,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Lymphoma; Epidemiology; Medicine; Working Formulation; Pathology; Etiology; Oncology; Non-Hodgkin's lymphoma","score_opus":0.14767376877730368,"score_gpt":0.3773571086854142,"score_spread":0.22968333990811055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061918976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98999876,0.0012221911,0.0008119713,0.005248476,0.00048773593,0.0010795407,0.00005628123,0.000019832429,0.0010752338],"genre_scores_gemma":[0.99533695,0.00015942981,0.003223179,0.0007129244,0.0002691218,0.00012583358,0.000090952104,0.00001656262,0.000065036926],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997325,0.0006212694,0.00095139525,0.0004116023,0.0002784036,0.00041232124],"domain_scores_gemma":[0.98714143,0.011294363,0.0005566711,0.00063168764,0.00030648505,0.000069363814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051214686,0.0001587056,0.00053965085,0.00009476172,0.0001312211,0.00000514487,0.00045859267,0.00022262646,0.00002880272],"category_scores_gemma":[0.005032457,0.000081996106,0.0002861881,0.00021869213,0.00063925504,0.000025510662,0.00014074905,0.00009554188,0.0000062004005],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058840733,0.001553133,0.93170595,0.000022085222,0.00029257056,0.000012194715,0.00027203225,0.0000013115613,0.027670944,0.014422345,0.0006313398,0.022827685],"study_design_scores_gemma":[0.006643882,0.0005470345,0.94673526,0.00017808858,0.00022858586,0.00013863292,0.00048315624,0.0001730991,0.037863426,0.004870737,0.0020646714,0.00007339564],"about_ca_topic_score_codex":0.0004249816,"about_ca_topic_score_gemma":0.00018045037,"teacher_disagreement_score":0.02275429,"about_ca_system_score_codex":0.00019325338,"about_ca_system_score_gemma":0.00019761363,"threshold_uncertainty_score":0.60246843},"labels":[],"label_agreement":null},{"id":"W2061928989","doi":"10.1182/blood-2003-08-2887","title":"Inappropriately low reticulocytosis in severe malarial anemia correlates with suppression in the development of late erythroid precursors","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Malaria Research and Control","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Reticulocytosis; Erythropoiesis; Plasmodium chabaudi; Transferrin receptor; Biology; Immunology; Erythropoietin; Erythropoietin receptor; Population; Erythroblast; Haematopoiesis; Anemia; Stem cell; Malaria; Internal medicine; Endocrinology; Cell biology; Medicine; Parasitemia; Plasmodium falciparum; Transferrin","score_opus":0.00942089603859498,"score_gpt":0.23578876842314267,"score_spread":0.2263678723845477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061928989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99661016,0.00014000676,0.000028554492,0.001360502,0.000024212362,0.0008500252,0.0000031069442,0.000013016896,0.0009703918],"genre_scores_gemma":[0.9980078,0.000020708541,0.0017171184,0.00004903814,0.000032393385,0.000082104336,0.000018703202,0.000013242985,0.000058934584],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986078,0.0000900771,0.00032321448,0.00021737395,0.00044542758,0.0003161109],"domain_scores_gemma":[0.9994903,0.00006380323,0.00007420228,0.00023827264,0.00006036097,0.000073015304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047161058,0.00013608937,0.00026953084,0.00012312071,0.000037437094,0.000014424908,0.00015501305,0.00012423367,0.000056906523],"category_scores_gemma":[0.00013124025,0.00007908605,0.000033325116,0.00032229096,0.00006343875,0.000059710204,0.00004318432,0.00038533445,0.00000841186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026633548,0.018176852,0.69216627,0.0027433275,0.00082120026,0.002776848,0.068521544,0.0022901404,0.16985399,0.0029453845,0.00019186553,0.012879015],"study_design_scores_gemma":[0.052293967,0.0014442384,0.8156959,0.0020913663,0.00017306271,0.0001920171,0.0012502981,0.00010623627,0.12580065,0.0005613855,0.000072399846,0.0003185148],"about_ca_topic_score_codex":0.000100456724,"about_ca_topic_score_gemma":0.00035201485,"teacher_disagreement_score":0.12352957,"about_ca_system_score_codex":0.0000526361,"about_ca_system_score_gemma":0.00048062773,"threshold_uncertainty_score":0.32250357},"labels":[],"label_agreement":null},{"id":"W2062266319","doi":"10.1182/blood-2009-05-224188","title":"Specific iron chelators determine the route of ferritin degradation","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":172,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health; McGill University","keywords":"Ferritin; Deferoxamine; Cytosol; Autophagy; Proteasome; Degradation (telecommunications); Protein degradation; Chemistry; Biochemistry; Incubation; Apoptosis; Enzyme","score_opus":0.014291525274042857,"score_gpt":0.23997090684413425,"score_spread":0.22567938157009138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062266319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986784,0.001814772,0.000054165943,0.0007870546,0.000056916706,0.00016267749,0.0000035537546,0.000022423035,0.010314478],"genre_scores_gemma":[0.9981862,0.00017919853,0.0005746613,0.00029101237,0.00012588516,0.000002103772,0.0000191913,0.000006704201,0.00061505433],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9994513,0.00001786626,0.00016056573,0.00010237284,0.00015286528,0.00011506221],"domain_scores_gemma":[0.9996379,0.000016397067,0.000053366064,0.00022826987,0.000025317013,0.000038739418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009690437,0.000073318006,0.00013396992,0.00003905917,0.000032927845,0.0000058649453,0.00006182382,0.000040623152,0.00007142897],"category_scores_gemma":[0.00003142395,0.000048502956,0.000055722587,0.00010797858,0.00003419763,0.000037219346,0.0000069470707,0.00007163405,0.000016958007],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000581998,0.005444541,0.17129427,0.00031890633,0.00007789472,0.00009541016,0.002486006,0.000015371472,0.38724294,0.018482268,0.008125888,0.40583447],"study_design_scores_gemma":[0.0054182317,0.00031410827,0.88285065,0.00004363937,0.00032496467,0.00005173559,0.00027567465,0.000014962709,0.10004447,0.00040805343,0.0101101305,0.00014340207],"about_ca_topic_score_codex":0.000012466717,"about_ca_topic_score_gemma":0.0000027018673,"teacher_disagreement_score":0.7115564,"about_ca_system_score_codex":0.000004065697,"about_ca_system_score_gemma":0.000020855052,"threshold_uncertainty_score":0.19778931},"labels":[],"label_agreement":null},{"id":"W2062323121","doi":"10.1182/blood-2013-04-496281","title":"RNAi screen identifies Jarid1b as a major regulator of mouse HSC activity","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; BC Cancer Agency; Université de Montréal; University of British Columbia; Institute for Research in Immunology and Cancer; Centre Hospitalier Universitaire Sainte-Justine","funders":"National Health and Medical Research Council; Medical Research Council; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research","keywords":"Biology; Regulator; Gene knockdown; RNA interference; Cell biology; Stem cell; Histone; Small hairpin RNA; Hematopoietic stem cell; Haematopoiesis; Cancer research; Molecular biology; RNA; Gene; Genetics","score_opus":0.006867039398812862,"score_gpt":0.2320574165946143,"score_spread":0.22519037719580143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062323121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972159,0.000688581,0.00026855242,0.00007583642,0.00004792288,0.00018542355,0.000016342596,0.000009118386,0.0014923196],"genre_scores_gemma":[0.9958391,0.00010862226,0.00061107567,0.000026965345,0.00010403344,0.00001847353,0.000033835044,0.000017291106,0.0032405925],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993117,0.00004125535,0.00015299133,0.00021948865,0.00012650901,0.00014805689],"domain_scores_gemma":[0.99934745,0.0000092202945,0.000103366845,0.0003627389,0.00011265539,0.00006455638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010426707,0.00010379431,0.00012112144,0.000032813958,0.00004265735,0.00002649601,0.00013017256,0.00012805323,0.00007245417],"category_scores_gemma":[0.00008097463,0.00009921776,0.00007892986,0.000052627878,0.000054554646,0.0000060049792,0.000091084876,0.000046625762,0.00003992385],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013030388,0.00015382959,0.004301138,0.000014154333,0.00006320482,4.5444304e-7,0.000016166628,0.000004129708,0.99414223,0.000033332526,0.00018765022,0.0010706852],"study_design_scores_gemma":[0.0005624041,0.00015605029,0.02731976,0.0000052035607,0.000034734014,0.0000014060928,0.0000150942,0.000010736921,0.97065365,0.00033943538,0.0007886863,0.000112842725],"about_ca_topic_score_codex":0.00043095156,"about_ca_topic_score_gemma":0.00004835477,"teacher_disagreement_score":0.023488577,"about_ca_system_score_codex":0.0000027555602,"about_ca_system_score_gemma":0.00003599504,"threshold_uncertainty_score":0.4045983},"labels":[],"label_agreement":null},{"id":"W2062476040","doi":"10.1182/blood-2002-01-0316","title":"Oxidized omega-3 fatty acids in fish oil inhibit leukocyte-endothelial interactions through activation of PPARα","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Peroxisome Proliferator-Activated Receptors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":162,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; Heart and Stroke Foundation of Canada; American Heart Association; Brigham and Women's Hospital; American Diabetes Association","keywords":"Eicosapentaenoic acid; Fish oil; Polyunsaturated fatty acid; Peroxisome proliferator-activated receptor; Peroxisome proliferator-activated receptor alpha; Lipopolysaccharide; Docosahexaenoic acid; Receptor; Chemistry; Nitric oxide; Biochemistry; Peroxisome; Fatty acid; Pharmacology; Biology; Nuclear receptor; Endocrinology; Transcription factor; Fish <Actinopterygii>","score_opus":0.017327469205322313,"score_gpt":0.24609721733372728,"score_spread":0.22876974812840495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062476040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957723,0.00010061285,0.00011362083,0.00018288962,0.00015328734,0.00010111782,0.00003497267,0.000023811432,0.00351736],"genre_scores_gemma":[0.99786454,0.00035059088,0.00069662766,0.00018354059,0.0002097624,0.00005215602,0.00007665255,0.000029831159,0.0005363109],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988396,0.000085679996,0.0003375251,0.0003369898,0.00015046148,0.00024975115],"domain_scores_gemma":[0.99940073,0.000022388997,0.00014809046,0.00030031416,0.00007726424,0.00005121616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000077016215,0.00018581527,0.00021822455,0.00008549136,0.000053795622,0.000018987337,0.00016700393,0.00019269543,0.00013796664],"category_scores_gemma":[0.00015928954,0.00018836033,0.00010334795,0.00023280998,0.00007149924,0.000028465603,0.00008376935,0.0002053189,0.000016513904],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010775621,0.00064613187,0.004301991,0.000021035006,0.00007815939,0.000001615011,0.00018428995,0.000019701993,0.9935287,0.000014516448,0.00046115942,0.00063490355],"study_design_scores_gemma":[0.0029978182,0.00013405799,0.00039129623,0.000041938136,0.000019605264,0.000013177786,0.000076138924,0.000021467496,0.983738,0.000018081504,0.012359265,0.0001891232],"about_ca_topic_score_codex":0.00003544751,"about_ca_topic_score_gemma":0.00004790422,"teacher_disagreement_score":0.011898106,"about_ca_system_score_codex":0.000032377633,"about_ca_system_score_gemma":0.000039453465,"threshold_uncertainty_score":0.7681111},"labels":[],"label_agreement":null},{"id":"W2062604372","doi":"10.1182/blood.v98.12.3301","title":"Proliferation of primitive myeloid progenitors can be reversibly induced by HOXA10","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; Haematopoiesis; Progenitor cell; Myeloid; Transgene; Transactivation; Molecular biology; Bone marrow; Cell biology; Cancer research; Gene expression; Stem cell; Immunology; Gene; Genetics","score_opus":0.008590997401967414,"score_gpt":0.22706475519283495,"score_spread":0.21847375779086753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062604372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984611,0.0002987382,0.00006334352,0.00022725244,0.00007733276,0.00032456606,0.000028668084,0.000011386925,0.0005075681],"genre_scores_gemma":[0.99871755,0.000092594615,0.00015608632,0.000056682922,0.00020647432,0.000026542342,0.0003026612,0.000016306944,0.00042512416],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993265,0.00003483564,0.00016087781,0.00021853202,0.00012357763,0.00013563815],"domain_scores_gemma":[0.99954474,0.0000031696154,0.000106454616,0.00018323107,0.00011576339,0.000046627618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006442375,0.000099684905,0.000094170166,0.000034709046,0.000040097002,0.0000075732005,0.00007267932,0.00016855143,0.000008139424],"category_scores_gemma":[0.00003443079,0.000106455715,0.000049884085,0.0001238476,0.000029491326,0.0000037543816,0.000028085387,0.00005421797,0.0000012282811],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050799114,0.00012519034,0.004353571,0.00000857671,0.00007556207,5.03365e-7,0.00006316451,0.0000096276035,0.9933886,0.000008055674,0.0007575743,0.0011587652],"study_design_scores_gemma":[0.00097498234,0.0003066683,0.0045412295,0.000010389067,0.00005698455,0.0000135504415,0.000031690593,0.000008457547,0.989266,0.0000074851305,0.004662771,0.00011979895],"about_ca_topic_score_codex":0.000031191194,"about_ca_topic_score_gemma":0.0000599986,"teacher_disagreement_score":0.0041226177,"about_ca_system_score_codex":0.000015737021,"about_ca_system_score_gemma":0.00011767389,"threshold_uncertainty_score":0.4341138},"labels":[],"label_agreement":null},{"id":"W2062717261","doi":"10.1182/blood.v99.8.2913","title":"Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":226,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"CD86; CD80; Human cytomegalovirus; CD40; Biology; Cytotoxic T cell; Dendritic cell; Major histocompatibility complex; MHC class I; Immunology; Antigen presentation; Cytokine; T cell; MHC class II; Antigen; Immune system; Virus; In vitro","score_opus":0.029192723663481357,"score_gpt":0.27242381580804553,"score_spread":0.24323109214456418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062717261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935055,0.001306105,0.000025216563,0.00012469216,0.00005179864,0.00038349742,0.00001257028,0.000060200047,0.004530432],"genre_scores_gemma":[0.9981,0.0002508139,0.00017024174,0.000095515614,0.0001426097,0.000017930452,0.000010639988,0.000028572367,0.001183671],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99879813,0.00004099827,0.00031469556,0.0002640017,0.00031278524,0.00026939114],"domain_scores_gemma":[0.99935454,0.00003321174,0.00007928902,0.00024615348,0.00011623657,0.00017058823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014138754,0.0001497434,0.00029833542,0.00023208532,0.000117731055,0.000036865582,0.000052252602,0.0001292365,0.00055398396],"category_scores_gemma":[0.000028272485,0.00013777074,0.00007910157,0.00023396095,0.00010564235,0.00013934301,0.000047173642,0.00022260458,0.0001093493],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013104538,0.0006076461,0.0023161615,0.00021556357,0.00009964881,0.0000318765,0.0003104696,0.0000013661675,0.9919204,0.00012528742,0.0007780582,0.0034624378],"study_design_scores_gemma":[0.007937084,0.0014192372,0.06878413,0.00016003217,0.00037109255,0.00011190204,0.00018422952,0.00037973427,0.9175215,0.00013990566,0.00271641,0.00027478178],"about_ca_topic_score_codex":0.00008904796,"about_ca_topic_score_gemma":0.000045547615,"teacher_disagreement_score":0.07439899,"about_ca_system_score_codex":0.000030546482,"about_ca_system_score_gemma":0.000021889811,"threshold_uncertainty_score":0.6065736},"labels":[],"label_agreement":null},{"id":"W2063153017","doi":"10.1182/blood.v98.7.2210","title":"Expression of scinderin in megakaryoblastic leukemia cells induces differentiation, maturation, and apoptosis with release of plateletlike particles and inhibits proliferation and tumorigenesis","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Canadian Institutes of Health Research; Consejo Nacional de Investigaciones Científicas y Técnicas","keywords":"Cell biology; Gelsolin; Biology; Cellular differentiation; Cell growth; Apoptosis; Cell culture; Molecular biology; Chemistry; Actin; Biochemistry","score_opus":0.007970999841579165,"score_gpt":0.20700041782897924,"score_spread":0.19902941798740006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063153017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992431,0.00036723676,0.000025306375,0.00005322142,0.0000066061257,0.00028020176,0.00000443502,0.000008033311,0.000011870197],"genre_scores_gemma":[0.99912894,0.0004412536,0.0003671667,0.000009964694,0.0000075027788,0.00001586674,0.000012073021,0.0000084208405,0.000008823354],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99938923,0.000021785092,0.00021176338,0.0001643401,0.000120340716,0.000092516326],"domain_scores_gemma":[0.9996873,0.000034442593,0.00010205259,0.00006984323,0.000048239315,0.000058109894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000042855827,0.00009893231,0.00022688054,0.00009620779,0.00003616152,0.0000116217325,0.000012168146,0.000049605394,0.0000032315456],"category_scores_gemma":[0.000021118567,0.0000718113,0.000008093712,0.00012280725,0.000052222284,0.00012017287,0.000014694065,0.00004070421,1.4353984e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048303045,0.00042867323,0.36180222,0.00019725744,0.000038871305,0.000018697181,0.0006495893,0.000013837568,0.6354606,0.000012116715,0.0000039003235,0.000891165],"study_design_scores_gemma":[0.0034731198,0.00025538806,0.32297385,0.00020771609,0.00009379558,0.000042327458,0.00012262308,0.00014913139,0.67257077,0.000059621925,6.3564227e-7,0.000051044914],"about_ca_topic_score_codex":0.000047141715,"about_ca_topic_score_gemma":0.000052277628,"teacher_disagreement_score":0.03882837,"about_ca_system_score_codex":0.000008495378,"about_ca_system_score_gemma":0.000036170182,"threshold_uncertainty_score":0.292838},"labels":[],"label_agreement":null},{"id":"W2063259008","doi":"10.1182/blood-2013-05-505511","title":"Genetic sequence analysis of inherited bleeding diseases","year":2013,"lang":"en","type":"review","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research","keywords":"Platelet disorder; Disease; Blood Platelet Disorders; Genetics; Medicine; Genetic testing; Gene; Bioinformatics; Von Willebrand disease; Mutation; Phenotype; Biology; Immunology; Von Willebrand factor; Pathology; Platelet","score_opus":0.11968315612483556,"score_gpt":0.3932095152577708,"score_spread":0.27352635913293527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063259008","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0060653198,0.9926946,0.0000010211515,0.000012523806,0.000019728468,0.000726291,0.00009309382,0.00002934535,0.00035808852],"genre_scores_gemma":[0.0005452983,0.99767953,0.00030854644,0.0000062154927,0.000122408,0.00011551837,0.00029796571,0.000030321049,0.00089417933],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99859,0.000069984184,0.0004352036,0.00030529534,0.00035540995,0.00024410886],"domain_scores_gemma":[0.9989645,0.000121540834,0.00015748681,0.00043648577,0.00011240192,0.00020761327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000059074482,0.00023926137,0.0018990898,0.0007243845,0.000029791332,0.000015075729,0.00014565037,0.00017711797,0.0005483287],"category_scores_gemma":[0.00008295622,0.00015173566,0.0008232026,0.0016412385,0.00008612536,0.000021838288,0.000061280814,0.00017019619,0.000078079116],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000042788015,0.0010443645,0.012275711,0.030346187,0.022412341,0.00034620074,0.000025996274,3.3216378e-7,0.00007205536,0.000007069956,0.00019233926,0.93327314],"study_design_scores_gemma":[0.0019712911,0.00054513075,0.0084149735,0.025608696,0.46316987,0.00013206687,0.000027383825,0.000097827186,0.00004947307,0.000010995888,0.49928966,0.000682641],"about_ca_topic_score_codex":0.00004135242,"about_ca_topic_score_gemma":0.000001120342,"teacher_disagreement_score":0.9325905,"about_ca_system_score_codex":0.000039377075,"about_ca_system_score_gemma":0.00027966304,"threshold_uncertainty_score":0.61876005},"labels":[],"label_agreement":null},{"id":"W2063420113","doi":"10.1182/blood-2010-12-325365","title":"Polycythemia vera with pancytopenia and red cell fragmentation","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Pancytopenia; Polycythemia vera; Medicine; Platelet; Gastroenterology; Hemoglobin; Red Cell; Internal medicine; Immunology; Bone marrow","score_opus":0.016699529047031727,"score_gpt":0.21394869158590726,"score_spread":0.19724916253887553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063420113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799179,0.00024192326,0.000014947007,0.00018868384,0.000017389495,0.00030526923,0.000004756621,0.000024944511,0.019284181],"genre_scores_gemma":[0.9943048,0.00011574121,0.004785036,0.0001990195,0.0000358105,0.000064132946,0.00001571827,0.000013326404,0.00046646627],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995099,0.000012049986,0.00009126876,0.00017280254,0.000102406964,0.00011158211],"domain_scores_gemma":[0.99970764,0.00001562262,0.000037234226,0.00012446023,0.000028545184,0.0000864873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00002751608,0.00010036892,0.00014502107,0.000021825645,0.00004501749,0.000008617892,0.0000182821,0.000033601267,0.00024390029],"category_scores_gemma":[0.0000038837884,0.00006813107,0.000018004463,0.00004780845,0.000024040952,0.000043623182,0.000010360118,0.000051843872,0.00002480458],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004140013,0.0016482983,0.9851651,0.0000563049,0.00018991993,0.00021125165,0.001909809,6.906161e-8,0.008338752,0.00025392705,0.00029022153,0.0015223272],"study_design_scores_gemma":[0.008263826,0.0013590466,0.53065526,0.000066314446,0.00039579067,0.00009813699,0.00012176516,0.0000025336583,0.45837727,0.00005512749,0.0005022192,0.000102707636],"about_ca_topic_score_codex":0.000039274564,"about_ca_topic_score_gemma":0.000013607635,"teacher_disagreement_score":0.45450985,"about_ca_system_score_codex":0.000010639416,"about_ca_system_score_gemma":0.000029701785,"threshold_uncertainty_score":0.27783045},"labels":[],"label_agreement":null},{"id":"W2063582896","doi":"10.1182/blood-2009-04-214593","title":"Wild-type FOXP3 is selectively active in CD4+CD25hi regulatory T cells of healthy female carriers of different FOXP3 mutations","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"FOXP3; Biology; X-inactivation; Regulatory T cell; Mutation; Immunology; Immune system; Cell biology; Genetics; X chromosome; Molecular biology; T cell; Gene; IL-2 receptor","score_opus":0.00993274843979748,"score_gpt":0.2391115823460308,"score_spread":0.22917883390623334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063582896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99654543,0.0006131333,0.000021472766,0.000119257464,0.00081353297,0.00025361683,0.000013930934,0.000023259257,0.0015963624],"genre_scores_gemma":[0.9979005,0.00007820317,0.000027759103,0.0002177092,0.000014005049,0.000007188471,0.000053962485,0.000010460385,0.00169023],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989304,0.00016529494,0.00040320802,0.00022872526,0.000045232726,0.00022712181],"domain_scores_gemma":[0.999273,0.00008116166,0.00026009153,0.00020740263,0.00015766144,0.000020689038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008759148,0.0001490888,0.00033244444,0.00022467288,0.00007353588,0.0000030203523,0.00010099942,0.00020001942,0.00048232058],"category_scores_gemma":[0.000041814434,0.00014399395,0.00010622729,0.00024956718,0.00009977971,0.00009685576,0.000017101404,0.00027460887,0.00003577156],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007432866,0.0011179037,0.0033387302,0.000024527684,0.00021578373,8.8187767e-7,0.002998533,0.000011786855,0.9887565,0.00015162949,0.0013736222,0.001266819],"study_design_scores_gemma":[0.0021846828,0.0012415799,0.096421055,0.00004135626,0.00008342259,0.000009873225,0.0012372661,0.0000036956142,0.89760894,0.00008783344,0.0009634151,0.000116872354],"about_ca_topic_score_codex":0.00012820789,"about_ca_topic_score_gemma":0.000031633692,"teacher_disagreement_score":0.09308233,"about_ca_system_score_codex":0.000052561543,"about_ca_system_score_gemma":0.000097886536,"threshold_uncertainty_score":0.5871903},"labels":[],"label_agreement":null},{"id":"W2063676577","doi":"10.1182/blood-2008-04-151191","title":"A novel in vivo siRNA delivery system specifically targeting dendritic cells and silencing CD40 genes for immunomodulation","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; London Health Sciences Centre; Western University","funders":"Heart and Stroke Foundation of Canada","keywords":"Gene silencing; In vivo; Small interfering RNA; Immune system; Dendritic cell; CD40; RNA interference; Cell biology; Biology; In vitro; Chemistry; Immunology; RNA; Gene; Cytotoxic T cell; Biochemistry","score_opus":0.009926413132230853,"score_gpt":0.2131201188410189,"score_spread":0.20319370570878803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063676577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99373657,0.0018076359,0.003950451,0.000017610908,0.00009291778,0.00020499575,0.000022907881,0.0000110655365,0.00015587198],"genre_scores_gemma":[0.996123,0.00016351188,0.0033139144,0.000065286964,0.00022367109,0.000012912189,0.000024984898,0.000011191287,0.00006149178],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991829,0.0000171489,0.00023892295,0.00028966053,0.00006366438,0.00020774647],"domain_scores_gemma":[0.99967384,0.000015180397,0.000060211896,0.00013796662,0.000074149495,0.00003862993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013130759,0.0001226596,0.0001329048,0.00004742437,0.000058713325,0.000034699642,0.000094456314,0.00010756795,0.0000022259815],"category_scores_gemma":[0.000019953524,0.00012636358,0.000056628134,0.000042991593,0.00001554192,0.0000074576033,0.000028020257,0.000043758468,0.0000017693452],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046657267,0.00008922009,0.0004248625,0.00003545821,0.000017773365,0.0000040133514,0.000045710836,0.000118697324,0.9978514,0.000029961551,0.000049691207,0.0012865915],"study_design_scores_gemma":[0.0010641802,0.0003342843,0.0029867038,0.00007746315,0.000027664202,0.000025915777,0.00030962736,0.00085989834,0.993894,0.00001371267,0.0002276915,0.00017885117],"about_ca_topic_score_codex":0.000024377821,"about_ca_topic_score_gemma":0.000017590011,"teacher_disagreement_score":0.0039573554,"about_ca_system_score_codex":0.00001186687,"about_ca_system_score_gemma":0.000026729876,"threshold_uncertainty_score":0.5152957},"labels":[],"label_agreement":null},{"id":"W2063686290","doi":"10.1182/blood-2003-11-4026","title":"Deregulated expression in Ph+ human leukemias of AHI-1, a gene activated by insertional mutagenesis in mouse models of leukemia","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; Myeloid leukemia; Leukemia; Myeloid; Haematopoiesis; CD34; Gene isoform; Cancer research; ABL; Insertional mutagenesis; Stem cell; Gene; Molecular biology; Immunology; Genetics; Receptor; Tyrosine kinase","score_opus":0.010195362822109724,"score_gpt":0.22465966550783206,"score_spread":0.21446430268572234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063686290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99896085,0.000359227,0.000326686,0.000013022781,0.000010672682,0.00017120499,0.000030199712,0.0000074411737,0.000120699005],"genre_scores_gemma":[0.9988145,0.00006016713,0.00068515365,0.000025981068,0.000014252086,0.000022050803,0.00025716436,0.000016528831,0.000104185],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990751,0.00004749781,0.00035883757,0.0002339416,0.00013959939,0.0001450341],"domain_scores_gemma":[0.99955755,0.0000037572129,0.0001345138,0.00021502779,0.000049069742,0.000040057927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009142254,0.0001210758,0.0001752538,0.00010611529,0.000020210438,0.0000035860933,0.00013405159,0.00020201188,0.000010289695],"category_scores_gemma":[0.000022373455,0.00012219885,0.000052421477,0.00016086336,0.00005183141,0.000011469621,0.000060006496,0.00007694323,4.083109e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000072102994,0.00040527876,0.00063689577,0.000020903539,0.000016666709,0.0000017720807,0.000059973852,0.0025589126,0.9960654,0.000027305763,0.000043053362,0.00009173018],"study_design_scores_gemma":[0.0039018549,0.00011411181,0.0010813688,0.000057933685,0.0000057907555,0.0000027006784,0.000025210256,0.000050119215,0.9944303,0.0001833923,0.000024703215,0.00012248414],"about_ca_topic_score_codex":0.00026507175,"about_ca_topic_score_gemma":0.00006297984,"teacher_disagreement_score":0.0038297519,"about_ca_system_score_codex":0.000052929165,"about_ca_system_score_gemma":0.00017889844,"threshold_uncertainty_score":0.49831247},"labels":[],"label_agreement":null},{"id":"W2063691874","doi":"10.1182/blood-2013-09-524108","title":"An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":953,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Rituximab; International Prognostic Index; Diffuse large B-cell lymphoma; Medicine; Internal medicine; Lymphoma; Oncology","score_opus":0.0047602183113819715,"score_gpt":0.222502393562567,"score_spread":0.21774217525118506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063691874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967666,0.000045590303,0.000029248806,0.00027793893,0.00004683879,0.001960547,0.000057866,0.00003724509,0.0007781098],"genre_scores_gemma":[0.9971492,0.000011433733,0.00029368926,0.0004660735,0.00006916648,0.001472165,0.00044445216,0.000024024477,0.00006973897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989384,0.00003364592,0.00019941309,0.00027731727,0.0002768979,0.000274339],"domain_scores_gemma":[0.9992958,0.00011017101,0.0000758344,0.00027842587,0.00015418134,0.00008560363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000055627374,0.00017749827,0.00021344157,0.000081121776,0.00005902942,0.000059423342,0.00014302497,0.000064211315,0.000062627565],"category_scores_gemma":[0.000036471076,0.000099895755,0.00005671456,0.00011991067,0.000024800787,0.00013712254,0.000017016957,0.000042483614,0.000043616015],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020279567,0.10893485,0.8869172,0.000021822752,0.00011559437,0.000020848835,0.00041072385,2.2868574e-7,0.00008884571,0.000032874585,0.00015407577,0.0031001908],"study_design_scores_gemma":[0.12780161,0.0014734721,0.86701494,0.00006369475,0.00018327952,0.0000076628485,0.00008586376,0.00015965886,0.0028773407,0.000026125097,0.00019125249,0.00011510225],"about_ca_topic_score_codex":0.00013537533,"about_ca_topic_score_gemma":0.00007130669,"teacher_disagreement_score":0.12759882,"about_ca_system_score_codex":0.000066955035,"about_ca_system_score_gemma":0.000051414296,"threshold_uncertainty_score":0.4073631},"labels":[],"label_agreement":null},{"id":"W2063756127","doi":"10.1182/blood-2014-02-554634","title":"Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":428,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"National Cancer Institute; MPN Stichting; Leukemia and Lymphoma Society; American Society of Hematology","keywords":"Myeloproliferative neoplasm; stat; Pathogenesis; Cancer research; Allele; Gene expression profiling; Biology; JAK-STAT signaling pathway; Janus kinase 2; Genetics; Myeloproliferative Disorders; Gene; Signal transduction; Myelofibrosis; Gene expression; Immunology; STAT3; Tyrosine kinase; Bone marrow","score_opus":0.008681461745573745,"score_gpt":0.21954389572178853,"score_spread":0.2108624339762148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063756127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99746376,0.00014949558,0.0002034323,0.00042655654,0.000030096018,0.00063363515,0.00005007202,0.00002819054,0.0010147642],"genre_scores_gemma":[0.99858946,0.000095757125,0.0006309243,0.00016172322,0.00007948695,0.00015223355,0.00019353314,0.000022915685,0.00007394339],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982686,0.00023972543,0.0004905217,0.00038102933,0.00026962085,0.00035048643],"domain_scores_gemma":[0.9988493,0.0002838324,0.00020663746,0.00035331666,0.00018960415,0.000117327174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026008155,0.00027349326,0.0006161394,0.00027230836,0.00009302248,0.000029258275,0.00010912847,0.000119034514,0.000103213046],"category_scores_gemma":[0.00016067932,0.00017118931,0.00021349535,0.00090412964,0.00008551633,0.00007655155,0.000031954292,0.00017561117,0.00001180047],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016191813,0.0013712051,0.88289934,0.000026081534,0.001417566,0.000008864107,0.0021794643,0.00036528707,0.1030844,0.0011616689,0.000010227518,0.0073139966],"study_design_scores_gemma":[0.0022578437,0.00030569607,0.7091942,0.000051761785,0.00088774646,0.00000638925,0.00084327854,0.0014997451,0.2844107,0.00013945879,0.00026728964,0.00013589079],"about_ca_topic_score_codex":0.00039330902,"about_ca_topic_score_gemma":0.00090819184,"teacher_disagreement_score":0.18132629,"about_ca_system_score_codex":0.000091507274,"about_ca_system_score_gemma":0.00018925901,"threshold_uncertainty_score":0.6980898},"labels":[],"label_agreement":null},{"id":"W2063882823","doi":"10.1182/blood-2010-01-264275","title":"Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":188,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Oncosuisse; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"Biology; Genome; Marginal zone; Gene expression profiling; Lymphoma; Immunology; Computational biology; Cancer research; Genetics; Gene; Gene expression; B cell; Antibody","score_opus":0.05815297952425725,"score_gpt":0.33543914595410745,"score_spread":0.2772861664298502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063882823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975059,0.00016501822,0.0000070216606,0.00057220546,0.00014483878,0.000524043,0.0000274753,0.00004103968,0.0010124615],"genre_scores_gemma":[0.9983632,0.0000752576,0.0008891593,0.00013176037,0.0002279056,0.00004334514,0.000041052288,0.00002956209,0.00019875081],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985532,0.00006937223,0.0004472713,0.0003208825,0.00033707128,0.00027219698],"domain_scores_gemma":[0.9983374,0.00043133207,0.00017502018,0.0007541359,0.000106227606,0.00019590219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046586528,0.00020917824,0.00043021294,0.00007530329,0.000121308476,0.000035034704,0.00015458716,0.00010337464,0.00025492074],"category_scores_gemma":[0.00010348855,0.000101240876,0.00021381724,0.00014270702,0.0001899423,0.00006179521,0.000037110196,0.00019797959,0.00007402802],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044169676,0.0040584425,0.98757035,0.000018879218,0.00030020167,0.00015528382,0.000086445085,0.0000012161837,0.005936843,0.0007092324,0.0000655009,0.0006559376],"study_design_scores_gemma":[0.0048308927,0.0016825441,0.9634771,0.000048195467,0.00035927325,0.00010319663,0.00012234392,0.000003838541,0.028847447,0.000043740638,0.0003662695,0.00011518146],"about_ca_topic_score_codex":0.00004915673,"about_ca_topic_score_gemma":0.000061678176,"teacher_disagreement_score":0.024093244,"about_ca_system_score_codex":0.00003358463,"about_ca_system_score_gemma":0.00018794814,"threshold_uncertainty_score":0.41284832},"labels":[],"label_agreement":null},{"id":"W2064036251","doi":"10.1182/blood-2010-02-271460","title":"Nfe2l3 (Nrf3) deficiency predisposes mice to T-cell lymphoblastic lymphoma","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Lymphoma; Lymphoblastic lymphoma; Immunology; Cancer research; T cell; Immune system","score_opus":0.005750635402697611,"score_gpt":0.22178083353004982,"score_spread":0.21603019812735222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064036251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.959854,0.00040832677,0.000046713572,0.0006524791,0.00038802676,0.0003372447,0.000013372819,0.000118030635,0.038181785],"genre_scores_gemma":[0.9942581,0.000022880642,0.0014811845,0.0007182628,0.00016643183,0.000028593855,0.000011003752,0.000034938937,0.003278603],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986787,0.000013194317,0.00024576788,0.00037004924,0.00030029673,0.0003920304],"domain_scores_gemma":[0.9990508,0.00006738972,0.000047985137,0.00044577618,0.0000854028,0.00030265044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000112431604,0.00019515755,0.00027706777,0.00012993044,0.00009508157,0.00003499078,0.00019202012,0.00012159078,0.00026048036],"category_scores_gemma":[0.00019057553,0.00016544058,0.00010209075,0.0002704174,0.00006791848,0.000058510446,0.00006840956,0.00009896057,0.0005279949],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021001422,0.01431785,0.08058999,0.0006001928,0.00012571934,0.00047757576,0.0019866663,0.00000675095,0.87188196,0.0030052958,0.009262405,0.01753559],"study_design_scores_gemma":[0.031143757,0.0047127623,0.7004467,0.00040006306,0.0016181866,0.0032703064,0.0010756227,0.00020262644,0.19069408,0.001320477,0.06337821,0.0017371874],"about_ca_topic_score_codex":0.000059605867,"about_ca_topic_score_gemma":0.000042151645,"teacher_disagreement_score":0.68118787,"about_ca_system_score_codex":0.000012968644,"about_ca_system_score_gemma":0.00019249487,"threshold_uncertainty_score":0.67864823},"labels":[],"label_agreement":null},{"id":"W2064070223","doi":"10.1182/blood-2005-04-1546","title":"Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis","year":2005,"lang":"en","type":"review","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":874,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Heparin-induced thrombocytopenia; Odds ratio; Heparin; Low molecular weight heparin; Confidence interval; Internal medicine; Randomized controlled trial; Meta-analysis; Prospective cohort study; Surgery","score_opus":0.0813725350598562,"score_gpt":0.3511729431253982,"score_spread":0.269800408065542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064070223","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011499833,0.9773777,0.0002376356,0.00016759304,0.00015238993,0.007187925,0.00062281254,0.00037408673,0.0023800398],"genre_scores_gemma":[0.03645878,0.9530912,0.0051697297,0.00021339789,0.0004283206,0.0023584135,0.0011636824,0.0004935014,0.0006229521],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99206704,0.00059609185,0.0021109716,0.0028037233,0.0010629274,0.0013592459],"domain_scores_gemma":[0.993646,0.0006508272,0.0017170975,0.0024898318,0.0005859712,0.0009102412],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0009108885,0.0022103263,0.015369628,0.0013682107,0.00052980473,0.0003043169,0.0006734122,0.0014175553,0.000710239],"category_scores_gemma":[0.0002339358,0.001521877,0.0058906223,0.0030082425,0.0002651437,0.00036239883,0.00034095315,0.0017339617,0.00017462518],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017898831,0.003278761,0.00029484593,0.009247577,0.87735564,0.00032687603,0.00012307486,0.0000037326276,0.00034489617,0.0006064792,0.00010039361,0.10813871],"study_design_scores_gemma":[0.003953157,0.0010766166,0.00061691715,0.0007464986,0.8040754,0.00053465867,0.000021480453,0.000020977172,0.0006022367,0.000060128823,0.18669477,0.00159716],"about_ca_topic_score_codex":0.00048833387,"about_ca_topic_score_gemma":0.00047511648,"teacher_disagreement_score":0.18659438,"about_ca_system_score_codex":0.0003000559,"about_ca_system_score_gemma":0.0012888969,"threshold_uncertainty_score":0.9998788},"labels":[],"label_agreement":null},{"id":"W2064220369","doi":"10.1182/blood-2010-05-284570","title":"Recipient T lymphocytes modulate the severity of antibody-mediated transfusion-related acute lung injury","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Canadian Blood Services; St. Michael's Hospital","funders":"Canadian Institutes of Health Research","keywords":"Transfusion-related acute lung injury; Medicine; Immunology; Antibody; Blood transfusion; Lung; Internal medicine; Pulmonary edema","score_opus":0.005247995589620565,"score_gpt":0.2524530646259624,"score_spread":0.24720506903634185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064220369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930394,0.00015989579,0.000068465204,0.0019106014,0.000577395,0.0008873272,0.000044914425,0.00013216818,0.003179779],"genre_scores_gemma":[0.99744284,0.001097396,0.00029393597,0.00050270837,0.000058305868,0.000023203655,0.00007302491,0.000029807878,0.00047874692],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985377,0.00004887912,0.00043342938,0.0003067283,0.00039229248,0.00028094507],"domain_scores_gemma":[0.9989836,0.00005839598,0.00009569937,0.0005996169,0.000114004804,0.00014863309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003537446,0.00020087585,0.00035344192,0.00011873557,0.00012026132,0.000012686422,0.00019983771,0.00017546631,0.0005804136],"category_scores_gemma":[0.00004328679,0.00013285816,0.00019270914,0.00042932844,0.00015209618,0.00006116987,0.000057485497,0.00039550048,0.000038303064],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003997245,0.0024408405,0.020768033,0.00016605602,0.0014510163,0.00009269797,0.0011607421,0.000002623664,0.9630452,0.00082912046,0.0008152875,0.008828705],"study_design_scores_gemma":[0.02638265,0.0010276424,0.44991994,0.00036777285,0.006279751,0.00041385446,0.00023631005,0.0024526305,0.50062436,0.00035778628,0.011240881,0.0006964374],"about_ca_topic_score_codex":0.00014342558,"about_ca_topic_score_gemma":0.00004076819,"teacher_disagreement_score":0.46242082,"about_ca_system_score_codex":0.000011638476,"about_ca_system_score_gemma":0.00009101915,"threshold_uncertainty_score":0.63551223},"labels":[],"label_agreement":null},{"id":"W2064338630","doi":"10.1182/blood-2014-06-581611","title":"Oral therapy for multiple myeloma: ixazomib arriving soon","year":2014,"lang":"en","type":"letter","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Ixazomib; Multiple myeloma; Medicine; Internal medicine; Oncology; Intensive care medicine; Lenalidomide; Carfilzomib","score_opus":0.05015570316181866,"score_gpt":0.31302725835172684,"score_spread":0.2628715551899082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064338630","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24562846,0.004554886,0.0014280499,0.72368145,0.0014094934,0.014621588,0.0008540366,0.0009986229,0.0068234163],"genre_scores_gemma":[0.28354025,0.000559,0.014961469,0.64831316,0.021721294,0.0027394153,0.007504358,0.00071026455,0.019950803],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99726784,0.000104533174,0.00036247107,0.0007024558,0.00060641835,0.0009562539],"domain_scores_gemma":[0.9981017,0.00054490485,0.0001578083,0.00078501296,0.00018664557,0.00022394514],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024076788,0.0005054231,0.00086058583,0.00023781162,0.00016766321,0.000067830755,0.0002559227,0.00074510474,0.00018835005],"category_scores_gemma":[0.00037419173,0.00038701246,0.0004711825,0.00010657481,0.000083286985,0.000053204683,0.000056180837,0.0010048705,0.00020299798],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006017424,0.00096602086,0.028613381,0.0007118432,0.001992261,0.0013173984,0.000074379524,2.396338e-7,0.0018591582,0.000004031202,0.93870205,0.025157504],"study_design_scores_gemma":[0.030739442,0.0013550959,0.007847062,0.00025895544,0.0003901447,0.00016655726,0.0000065668864,0.00016929948,0.0060304073,0.00007329639,0.9525296,0.0004335494],"about_ca_topic_score_codex":0.000106421685,"about_ca_topic_score_gemma":0.000021559643,"teacher_disagreement_score":0.0753683,"about_ca_system_score_codex":0.00007172003,"about_ca_system_score_gemma":0.00019382167,"threshold_uncertainty_score":0.9998582},"labels":[],"label_agreement":null},{"id":"W2064412759","doi":"10.1182/blood-2005-07-2970","title":"The hematopoietic stem compartment consists of a limited number of discrete stem cell subsets","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":243,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institute on Aging; U.S. Public Health Service","keywords":"Stem cell; Haematopoiesis; Biology; Transplantation; Immunology; Hematopoietic stem cell; Bone marrow; Population; Homogeneous; Repopulation; Cell biology; Genetics; Internal medicine; Medicine; Combinatorics","score_opus":0.017835108701340936,"score_gpt":0.26579556998433274,"score_spread":0.2479604612829918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064412759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99045193,0.0006600679,0.000102283186,0.0003696905,0.00005442067,0.00055846607,0.000029034887,0.000033506003,0.007740583],"genre_scores_gemma":[0.9984272,0.00011078064,0.00066831335,0.000046219753,0.00003067404,0.00002460283,0.00001631751,0.000022938058,0.00065295317],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99844265,0.000083344115,0.0006353026,0.00018516617,0.00042371103,0.00022981715],"domain_scores_gemma":[0.99875796,0.00032905996,0.000242776,0.00044099565,0.00011991987,0.00010928851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024401088,0.00015748592,0.000423811,0.000036933623,0.000049338683,0.000008154094,0.00011226473,0.000072785944,0.00006745567],"category_scores_gemma":[0.0000041190415,0.00010928626,0.00013080653,0.00015516828,0.00013169397,0.000030888063,0.00001901328,0.00009904309,0.00008249128],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019305575,0.011356611,0.64817524,0.014466632,0.0026356324,0.0003237191,0.030882243,0.00008442507,0.26653588,0.014689237,0.0030268,0.00589301],"study_design_scores_gemma":[0.0069414168,0.00018597805,0.0134115415,0.0006317071,0.00090447714,0.00039661257,0.0013008182,0.00014801792,0.97466296,0.000030620376,0.0012067237,0.00017915461],"about_ca_topic_score_codex":0.00000787813,"about_ca_topic_score_gemma":0.000011482973,"teacher_disagreement_score":0.7081271,"about_ca_system_score_codex":0.000019631114,"about_ca_system_score_gemma":0.00007581578,"threshold_uncertainty_score":0.44565645},"labels":[],"label_agreement":null},{"id":"W2064418887","doi":"10.1182/blood-2013-03-491589","title":"Analysis of risk factors influencing outcomes after cord blood transplantation in children with juvenile myelomonocytic leukemia: a EUROCORD, EBMT, EWOG-MDS, CIBMTR study","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"National Cancer Institute","keywords":"Transplantation; Juvenile myelomonocytic leukemia; Medicine; Cumulative incidence; Umbilical Cord Blood Transplantation; Hazard ratio; Internal medicine; Leukemia; Monosomy; Gastroenterology; Umbilical cord; Surgery; Hematopoietic stem cell transplantation; Immunology; Biology; Confidence interval; Karyotype; Stem cell; Haematopoiesis","score_opus":0.010444806798033151,"score_gpt":0.26005862940927016,"score_spread":0.24961382261123702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064418887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975767,0.00009123614,0.000037338166,0.000022227383,0.000014873196,0.0019802304,0.000102148246,0.000071577546,0.00010363086],"genre_scores_gemma":[0.9988732,0.000092881965,0.00044252933,0.00005916363,0.000029820623,0.00024825914,0.000117577336,0.00006126263,0.00007535287],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99700886,0.00023116033,0.00079574314,0.0006365021,0.00077107456,0.00055667316],"domain_scores_gemma":[0.99827266,0.00028013665,0.00028787018,0.00071980775,0.00020909247,0.00023042041],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003472345,0.0003975955,0.0011327197,0.0013023755,0.00006935895,0.000042513908,0.00027235958,0.00016008553,0.00021883646],"category_scores_gemma":[0.00015819824,0.00029340704,0.00023253035,0.002030471,0.00010797424,0.0002650327,0.000067536566,0.0006916087,0.000027850538],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033941003,0.0012290654,0.98769414,0.000058362242,0.005150074,0.00013845142,0.004206566,0.00018268578,0.00058053364,8.463908e-7,0.000004726208,0.00041515718],"study_design_scores_gemma":[0.012851978,0.0010835861,0.96838146,0.000066259,0.013628577,0.0000435328,0.0016285774,0.00022942678,0.0018022716,0.000004640786,8.3327376e-7,0.00027887328],"about_ca_topic_score_codex":0.016026698,"about_ca_topic_score_gemma":0.0023437412,"teacher_disagreement_score":0.019312678,"about_ca_system_score_codex":0.00024039365,"about_ca_system_score_gemma":0.00041680058,"threshold_uncertainty_score":0.9999518},"labels":[],"label_agreement":null},{"id":"W2064454765","doi":"10.1182/blood-2003-10-3552","title":"IgG antiplatelet immunity is dependent on an early innate natural killer cell–derived interferon-γ response that is regulated by CD8+ T cells","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services","funders":"Canadian Institutes of Health Research; Canadian Blood Services","keywords":"Immunology; CD8; Cytotoxic T cell; Antibody; Immunity; Humoral immunity; Biology; Immune system; Medicine","score_opus":0.009764559161901137,"score_gpt":0.2178087098183215,"score_spread":0.20804415065642037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064454765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991416,0.0011163265,0.000015086845,0.00018077639,0.005190798,0.0002800564,0.000020216645,0.00013412008,0.0016466709],"genre_scores_gemma":[0.92756623,0.00013410939,0.000017273002,0.0013217037,0.00001206154,0.000011393189,0.00016651342,0.00004309938,0.07072761],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974006,0.0011307293,0.00038445898,0.0005080107,0.000082764265,0.00049346016],"domain_scores_gemma":[0.9988116,0.0001299781,0.00021464247,0.00069419283,0.00010255342,0.000047032103],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0004128577,0.00036688868,0.0003355563,0.00019784068,0.00035097584,0.000070268194,0.0002926692,0.0004586141,0.0043955953],"category_scores_gemma":[0.00004084618,0.0003345215,0.00015132826,0.00015318705,0.00011691398,0.00029122274,0.00006690563,0.00094721327,0.002076776],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036604947,0.00094489823,0.00017143722,0.0000068178024,0.00030024638,0.000010023184,0.0014766222,8.829919e-7,0.9646113,0.000009358737,0.028646963,0.00016098774],"study_design_scores_gemma":[0.0042508715,0.0012775265,0.0016471678,0.000034106757,0.000087691005,0.00006987292,0.00043103134,0.000002881544,0.93628633,0.0000085025795,0.05554425,0.0003597404],"about_ca_topic_score_codex":0.00018264314,"about_ca_topic_score_gemma":0.000004869998,"teacher_disagreement_score":0.06908094,"about_ca_system_score_codex":0.000060341987,"about_ca_system_score_gemma":0.00004309239,"threshold_uncertainty_score":0.99991065},"labels":[],"label_agreement":null},{"id":"W2064589139","doi":"10.1182/blood-2010-09-309831","title":"Functional interactions between Lmo2, the Arf tumor suppressor, and Notch1 in murine T-cell malignancies","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and Retrovirus Studies","field":"Immunology and Microbiology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; National Cancer Institute; National Institutes of Health; Sunnybrook Research Institute; American Lebanese Syrian Associated Charities; Harvard University; Assisi Foundation of Memphis; Howard Hughes Medical Institute","keywords":"Cancer research; Suppressor; Biology; Medicine; Cancer; Genetics","score_opus":0.026125317128595962,"score_gpt":0.20683897683801586,"score_spread":0.18071365970941988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064589139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98915434,0.0028431942,0.000007548734,0.00018313402,0.000523768,0.000111344074,0.000037490427,0.0000307664,0.0071084443],"genre_scores_gemma":[0.9927549,0.000070326576,0.000025971374,0.00008126875,0.000060384697,0.000028283393,0.000017082612,0.000008023865,0.0069537526],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99935204,0.000064812746,0.0001687568,0.00017749499,0.000020406847,0.00021649127],"domain_scores_gemma":[0.99963975,0.00012995867,0.00005459492,0.00013848588,0.000025601263,0.000011596736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008765246,0.00011797213,0.00016284507,0.00005973921,0.0002064759,0.0000068829813,0.000098917706,0.00005731599,0.00042028815],"category_scores_gemma":[0.000021821465,0.00007493787,0.00004497148,0.00006623404,0.00022570103,0.00005168403,0.00012691264,0.00024106585,0.00022435519],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013832875,0.0011710888,0.47538888,0.000046134213,0.00045084464,0.000025959893,0.0039744135,7.055432e-7,0.51002485,0.00080401375,0.007555836,0.0004189402],"study_design_scores_gemma":[0.0025155854,0.0001640194,0.59715444,0.000027828844,0.00016929585,0.000097422664,0.0010349883,2.1566473e-7,0.36732042,0.0003520686,0.030970301,0.00019341218],"about_ca_topic_score_codex":0.00027986706,"about_ca_topic_score_gemma":0.00017850693,"teacher_disagreement_score":0.14270441,"about_ca_system_score_codex":0.0000055058563,"about_ca_system_score_gemma":0.00001475142,"threshold_uncertainty_score":0.46018606},"labels":[],"label_agreement":null},{"id":"W2064633465","doi":"10.1182/blood-2010-10-313643","title":"Toso regulates the balance between apoptotic and nonapoptotic death receptor signaling by facilitating RIP1 ubiquitination","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"FADD; Apoptosis; Programmed cell death; Chemistry; Signal transduction; Cancer research; Immune system; Cell biology; Kinase; Signal transducing adaptor protein; Immunology; Biology; Biochemistry; Caspase","score_opus":0.015131049278754385,"score_gpt":0.214085299352102,"score_spread":0.1989542500733476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064633465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99748814,0.00096970756,0.0009539888,0.000038815924,0.000036531976,0.0001715484,0.000012570903,0.000009984446,0.0003186982],"genre_scores_gemma":[0.9972332,0.00007831334,0.002211317,0.000029043797,0.00008661543,0.000013749698,0.000101245816,0.000012518685,0.0002339863],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992717,0.00005518258,0.00017481062,0.00024343513,0.00008488945,0.00017000503],"domain_scores_gemma":[0.99968916,0.000027442415,0.000068222995,0.00014520173,0.0000333648,0.000036598074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024282819,0.000108888045,0.00009859846,0.000022121234,0.000091519345,0.000017868026,0.000087340995,0.000100407946,0.000016300888],"category_scores_gemma":[0.00004698268,0.000084844236,0.000030878913,0.000054966007,0.00003558963,0.0000058802093,0.000045027387,0.00006111606,0.0000027947124],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010118119,0.00005264835,0.014844329,0.000023447876,0.00003061799,4.0828303e-7,0.0003689276,0.000009273258,0.9812167,0.00018936442,0.000027813387,0.0032263438],"study_design_scores_gemma":[0.00080187485,0.00022384543,0.0323062,0.00004228591,0.000053742482,0.0000054155344,0.00023229641,0.00018184919,0.964723,0.00077807065,0.00044782774,0.0002035877],"about_ca_topic_score_codex":0.00003095356,"about_ca_topic_score_gemma":0.000005156678,"teacher_disagreement_score":0.017461874,"about_ca_system_score_codex":0.000005182164,"about_ca_system_score_gemma":0.000011223514,"threshold_uncertainty_score":0.34598476},"labels":[],"label_agreement":null},{"id":"W2064827510","doi":"10.1182/blood-2014-02-557132","title":"Acquired von Willebrand syndrome: von Willebrand factor propeptide to von Willebrand factor antigen ratio predicts remission status","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Calgary Laboratory Services; University of Calgary","funders":"National Heart, Lung, and Blood Institute; Calgary Laboratory Services","keywords":"Von Willebrand factor; Medicine; Von Willebrand disease; Antigen; Internal medicine; Immunology; Platelet","score_opus":0.011510846338617093,"score_gpt":0.24109192897921317,"score_spread":0.22958108264059607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064827510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923963,0.0010667038,0.00018475186,0.0005726791,0.00037033545,0.0024346965,0.00027743226,0.000297466,0.002399619],"genre_scores_gemma":[0.99411225,0.0005308776,0.00060199585,0.00044076037,0.00020089748,0.000089165376,0.0004115232,0.00013854813,0.0034739855],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99605805,0.00015189516,0.0007402592,0.0010474275,0.00090198906,0.0011004028],"domain_scores_gemma":[0.9975152,0.00012171667,0.00025504778,0.00085544324,0.00017957532,0.0010729983],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000188457,0.0007234222,0.001210134,0.00031452114,0.00035383808,0.00013617646,0.00024213706,0.00038234788,0.0005435665],"category_scores_gemma":[0.0003930649,0.0005478068,0.0002445521,0.000438844,0.00010527076,0.00042698285,0.00012417896,0.00025714168,0.00024531406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030066639,0.004428888,0.76752424,0.0008209929,0.0019643542,0.0017167671,0.004001343,0.00002605763,0.18189013,0.00003261453,0.007597606,0.026990315],"study_design_scores_gemma":[0.05653103,0.007029624,0.71885264,0.0020888634,0.0012097019,0.0010662129,0.0002346245,0.00035586517,0.117478944,0.00016917686,0.0931229,0.0018604354],"about_ca_topic_score_codex":0.000108182445,"about_ca_topic_score_gemma":0.00005222857,"teacher_disagreement_score":0.08552529,"about_ca_system_score_codex":0.0001059929,"about_ca_system_score_gemma":0.00022950153,"threshold_uncertainty_score":0.9996973},"labels":[],"label_agreement":null},{"id":"W2064850490","doi":"10.1182/blood-2012-10-460691","title":"Anti–protamine-heparin antibodies: incidence, clinical relevance, and pathogenesis","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Bundesministerium für Bildung und Forschung","keywords":"Pathogenesis; Protamine; Antibody; Heparin; Immunology; Medicine; Incidence (geometry); Internal medicine","score_opus":0.03340927270434114,"score_gpt":0.31682369660281345,"score_spread":0.2834144238984723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064850490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99059004,0.00041702046,0.000016905471,0.00052942603,0.00019290597,0.0008728357,0.00000712383,0.00014005188,0.007233723],"genre_scores_gemma":[0.9926531,0.0021946086,0.0035029987,0.0005518523,0.00032142957,0.000064177824,0.000013214905,0.0000459168,0.0006527249],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99789214,0.000101452526,0.00065833307,0.00061048067,0.00027677015,0.00046081175],"domain_scores_gemma":[0.99842745,0.00024316483,0.00013888873,0.00061011163,0.00018120698,0.0003991671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039967307,0.00027489598,0.0008701052,0.000121893456,0.00013730887,0.00006333027,0.00015157058,0.0002585963,0.0002553293],"category_scores_gemma":[0.0005642164,0.00022786856,0.00015330163,0.0002863592,0.00023145924,0.00024844854,0.00018656804,0.000319397,0.0005736071],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014411085,0.0007253484,0.8961934,0.00010896617,0.000198365,0.00007415578,0.000096875636,5.8663076e-8,0.09358087,0.00018348511,0.00069268944,0.00813141],"study_design_scores_gemma":[0.002810584,0.0004079158,0.98135674,0.00016338538,0.00037510562,0.00020506524,0.00010264211,0.000028932664,0.0117671685,0.00019992203,0.0023049924,0.00027756268],"about_ca_topic_score_codex":0.0002175299,"about_ca_topic_score_gemma":0.000020385187,"teacher_disagreement_score":0.08516336,"about_ca_system_score_codex":0.00001549124,"about_ca_system_score_gemma":0.00012321216,"threshold_uncertainty_score":0.929221},"labels":[],"label_agreement":null},{"id":"W2064865448","doi":"10.1182/blood-2008-08-174839","title":"Transformation of follicular lymphoma to diffuse large B-cell lymphoma may occur by divergent evolution from a common progenitor cell or by direct evolution from the follicular lymphoma clone","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Cancer Research UK","keywords":"Follicular lymphoma; Somatic hypermutation; Biology; Germinal center; Lymphoma; clone (Java method); Somatic evolution in cancer; Immunoglobulin heavy chain; Transplantation; Progenitor cell; Cell of origin; Lymph node; B cell; Immunology; Pathology; Antibody; Genetics; Stem cell; Gene; Medicine; Internal medicine","score_opus":0.007387720383040668,"score_gpt":0.22400863516151445,"score_spread":0.21662091477847378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064865448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97603345,0.01602592,0.0005476889,0.00091594225,0.00023262082,0.002516273,0.0032277894,0.00018065312,0.00031964484],"genre_scores_gemma":[0.9952097,0.0007299813,0.00041880467,0.0005822775,0.00023926905,0.0003524894,0.0022328869,0.00006313118,0.00017148902],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99609053,0.00028286377,0.0009798992,0.0008054921,0.0010858076,0.00075543125],"domain_scores_gemma":[0.99775547,0.00020395084,0.00039825487,0.0010042957,0.0001804583,0.00045758818],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002610968,0.0006638056,0.0009564969,0.00012948929,0.00036168177,0.000071478586,0.00038057438,0.00036538029,0.00006908771],"category_scores_gemma":[0.000051162613,0.00046127048,0.0005613281,0.0005949003,0.00006015194,0.00027963816,0.00007754822,0.000064135085,0.00013374712],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006470588,0.2619146,0.25177708,0.00030444542,0.0031239162,0.0004893684,0.00576808,0.00001627664,0.3509168,0.00024352898,0.074894615,0.044080693],"study_design_scores_gemma":[0.105493374,0.002413838,0.25925502,0.00035277664,0.0037025497,0.000036046997,0.00063554686,0.0004169836,0.60466737,0.000095697564,0.02214304,0.0007877654],"about_ca_topic_score_codex":0.00500996,"about_ca_topic_score_gemma":0.00016488631,"teacher_disagreement_score":0.25950077,"about_ca_system_score_codex":0.0010123525,"about_ca_system_score_gemma":0.00027775124,"threshold_uncertainty_score":0.9997839},"labels":[],"label_agreement":null},{"id":"W2064889896","doi":"10.1182/blood-2008-01-133801","title":"Differences in lymphocyte developmental potential between human embryonic stem cell and umbilical cord blood–derived hematopoietic progenitor cells","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"National Heart, Lung, and Blood Institute; University of California, Los Angeles","keywords":"Biology; Embryonic stem cell; Cell biology; Haematopoiesis; Stem cell; Progenitor cell; CD34; Immunology; Cord blood; Adult stem cell; Molecular biology; Genetics; Gene","score_opus":0.019282006184492242,"score_gpt":0.23700877391959513,"score_spread":0.21772676773510288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064889896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99813807,0.0010526228,0.000014604183,0.000018872715,0.000045277047,0.00043527083,0.000022645874,0.000020156129,0.0002525073],"genre_scores_gemma":[0.9980748,0.0004301327,0.00033419952,0.00001554647,0.00014249241,0.00005030384,0.000071646195,0.000033615597,0.0008472528],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99804956,0.00013374804,0.0003386884,0.00062592485,0.00032422357,0.00052786793],"domain_scores_gemma":[0.9994011,0.000018858964,0.00008013686,0.00024681547,0.000043841268,0.00020928046],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013498987,0.00026206893,0.00032083475,0.00008501924,0.00019854058,0.00003628416,0.00032149802,0.00023556875,0.000016363028],"category_scores_gemma":[0.0000056235085,0.00025618522,0.000083026236,0.00011807899,0.0002349888,0.000007767796,0.00035747213,0.00015964196,0.000021356154],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044094377,0.000442256,0.085728765,0.00007640096,0.00007477741,0.00013543108,0.000087060835,3.5636702e-7,0.9132314,9.758335e-7,0.000027868986,0.00015062201],"study_design_scores_gemma":[0.003405787,0.00041978696,0.054414753,0.000021080119,0.00005139396,0.00023986762,0.000103000784,0.0000049844953,0.9409047,0.000004226504,0.00012248935,0.00030794097],"about_ca_topic_score_codex":0.000030073066,"about_ca_topic_score_gemma":0.00001944948,"teacher_disagreement_score":0.03131401,"about_ca_system_score_codex":0.000024186882,"about_ca_system_score_gemma":0.0002204595,"threshold_uncertainty_score":0.99998903},"labels":[],"label_agreement":null},{"id":"W2064910904","doi":"10.1182/blood-2011-02-335190","title":"The ribosome-related protein, SBDS, is critical for normal erythropoiesis","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research; Hospital for Sick Children","keywords":"Gene knockdown; Biology; Erythropoiesis; Ineffective erythropoiesis; K562 cells; Cell biology; Haematopoiesis; Stem cell; Diamond–Blackfan anemia; Cellular differentiation; Cancer research; Molecular biology; Apoptosis; Leukemia; Immunology; Internal medicine; Anemia; Medicine; Biochemistry; Ribosome; Gene; RNA","score_opus":0.011427317571845345,"score_gpt":0.23686732654725803,"score_spread":0.2254400089754127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064910904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985744,0.0036284134,0.00023658565,0.0006813048,0.00011900203,0.0006066663,0.00007358331,0.00002389872,0.008886576],"genre_scores_gemma":[0.9970542,0.00008996681,0.0010569919,0.00016369004,0.00006460037,0.00018648975,0.00003403262,0.000022485901,0.0013274964],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99924946,0.000021316198,0.0001473441,0.00023270604,0.00007103276,0.00027816603],"domain_scores_gemma":[0.9995254,0.000012871866,0.00003365413,0.00028952543,0.00007536921,0.00006316008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000067127476,0.00012458875,0.00008838316,0.000010842287,0.00025090433,0.0000192578,0.00015013349,0.00012884107,0.00004803858],"category_scores_gemma":[0.00007764623,0.000087982546,0.00011562634,0.000041498093,0.00017941922,0.0000032374328,0.0000591126,0.00004488032,0.000023672137],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033751926,0.03434027,0.1074294,0.0006368802,0.013803498,0.00015569974,0.003804246,0.0000017509213,0.6123394,0.07290485,0.08407158,0.06713724],"study_design_scores_gemma":[0.0033712944,0.0010923953,0.0016539218,0.0000118111175,0.0002557874,0.000020977408,0.00022573245,0.0000035999687,0.9680223,0.0037591867,0.021330783,0.00025219747],"about_ca_topic_score_codex":0.000021302001,"about_ca_topic_score_gemma":0.000024987976,"teacher_disagreement_score":0.3556829,"about_ca_system_score_codex":0.00000187955,"about_ca_system_score_gemma":0.00003527715,"threshold_uncertainty_score":0.3587824},"labels":[],"label_agreement":null},{"id":"W2064997579","doi":"10.1182/blood.v97.4.1138","title":"Expression of the DMT1 (NRAMP2/DCT1) iron transporter in mice with genetic iron overload disorders","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital","funders":"National Institute of Allergy and Infectious Diseases; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute","keywords":"DMT1; Hemochromatosis; Hereditary hemochromatosis; Transporter; Knockout mouse; Iron deficiency; Biology; Ferroportin; Ferrous; Hepcidin; Pathogenesis; Endocrinology; Internal medicine; Cell biology; Biochemistry; Anemia; Immunology; Inflammation; Chemistry; Medicine; Genetics; Gene","score_opus":0.004753886800531694,"score_gpt":0.20653392489739714,"score_spread":0.20178003809686545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064997579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938543,0.0015544856,0.00005895923,0.0003048363,0.00006159767,0.00040639102,0.0000049815794,0.000018610921,0.0037358343],"genre_scores_gemma":[0.9982799,0.00050269644,0.0004222626,0.0002291794,0.00004245685,0.000016793181,0.000007752493,0.00002448129,0.00047444616],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896353,0.000039279934,0.00023655502,0.00023029905,0.00028399835,0.00024633482],"domain_scores_gemma":[0.99948275,0.000017076305,0.00007754696,0.00034285508,0.000016740327,0.000063042826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006270132,0.0001543925,0.0002320205,0.00006749149,0.000034744702,0.0000044098256,0.00012543783,0.000086168904,0.00012811199],"category_scores_gemma":[0.000011351501,0.00009455476,0.00007570661,0.00022459014,0.000100210214,0.000052142557,0.000015462998,0.00015042999,0.000005936326],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005289083,0.001712226,0.90956485,0.00025354984,0.000009140241,0.000026710946,0.0016502816,0.00010047677,0.08251512,0.000034346915,0.0001281371,0.0034762481],"study_design_scores_gemma":[0.008555672,0.00020104837,0.9751278,0.00018213913,0.00023818134,0.000024100042,0.0005036207,0.0000085602815,0.013205481,0.000052500054,0.0017458748,0.00015497707],"about_ca_topic_score_codex":0.00025769332,"about_ca_topic_score_gemma":0.00038792042,"teacher_disagreement_score":0.06930964,"about_ca_system_score_codex":0.000006627784,"about_ca_system_score_gemma":0.000051114424,"threshold_uncertainty_score":0.3855831},"labels":[],"label_agreement":null},{"id":"W2065145765","doi":"10.1182/blood-2012-01-403386","title":"CCR2 recruits an inflammatory macrophage subpopulation critical for angiogenesis in tissue repair","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Wound Healing and Treatments","field":"Medicine","cited_by":515,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"Universiteit Gent; Deutsche Forschungsgemeinschaft; European Commission","keywords":"Macrophage; CCR2; Biology; Monocyte; Angiogenesis; Wound healing; Immunology; Cell biology; Context (archaeology); Inflammation; Cancer research; Chemokine; Chemokine receptor; Genetics","score_opus":0.050409646018552766,"score_gpt":0.3721363427556872,"score_spread":0.32172669673713444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065145765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99763906,0.0012092667,0.00003230759,0.00013585748,0.00014475624,0.00042650886,0.000010492981,0.00010740346,0.00029433868],"genre_scores_gemma":[0.9949974,0.000011082732,0.0040250593,0.000078710276,0.0004183213,0.00009726092,0.00007402821,0.000023303572,0.0002748316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992323,0.00003985098,0.00018899357,0.00015120282,0.00010860156,0.00027904985],"domain_scores_gemma":[0.9994959,0.00006461796,0.000021766376,0.00019766772,0.00004020797,0.00017979958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023565197,0.00009092528,0.00015932866,0.00007994615,0.000056403067,0.000006105165,0.000023013637,0.000104413564,0.000033851924],"category_scores_gemma":[0.00015478702,0.00008371092,0.000056812478,0.00007678961,0.000018040613,0.00010461221,0.000008026164,0.000048012284,0.00004133064],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010679017,0.0019215544,0.98946345,0.00020549915,0.000046741658,0.0000628586,0.00044027364,0.0000013559032,0.003311167,0.0005655507,0.0001172628,0.0037574926],"study_design_scores_gemma":[0.0035527726,0.0004424415,0.9733438,0.00009068194,0.0003384908,0.00007536435,0.00005785912,0.00005231072,0.018549168,0.00017315696,0.0031967,0.00012724473],"about_ca_topic_score_codex":0.00007079629,"about_ca_topic_score_gemma":0.00004374353,"teacher_disagreement_score":0.016119644,"about_ca_system_score_codex":0.00003845057,"about_ca_system_score_gemma":0.000030407435,"threshold_uncertainty_score":0.34136322},"labels":[],"label_agreement":null},{"id":"W2065430663","doi":"10.1182/blood-2011-01-329797","title":"A genome-wide association study identifies novel loci associated with susceptibility to chronic myeloid leukemia","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Myeloid leukemia; Cohort; Genome-wide association study; Medicine; Internal medicine; Locus (genetics); Candidate gene; Genetic association; Oncology; Genetics; Biology; Gene; Genotype; Single-nucleotide polymorphism","score_opus":0.023632263912175405,"score_gpt":0.2481965590923387,"score_spread":0.2245642951801633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065430663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99442416,0.00012270676,0.000064228,0.00011184388,0.00009760984,0.0022014112,0.00003726589,0.000267774,0.0026730173],"genre_scores_gemma":[0.9942942,0.000010198238,0.00032985036,0.00022190438,0.00015778949,0.00019232542,0.00011839084,0.00007277845,0.0046025147],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970173,0.00010545555,0.00052091427,0.0007621967,0.0008946716,0.00069943815],"domain_scores_gemma":[0.9979904,0.00021243498,0.00031673847,0.0008179175,0.00036026232,0.0003022398],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007990016,0.00038108663,0.0006662497,0.00016566382,0.00016326399,0.00004793006,0.00024432666,0.00020175627,0.00048823247],"category_scores_gemma":[0.0011840534,0.00032627652,0.00013314188,0.0005801536,0.000049446342,0.00015841897,0.00014152899,0.00035373378,0.0003069541],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018868339,0.0048549166,0.9815591,0.0000460942,0.0019393013,0.00012441396,0.003753715,0.0000073662836,0.0071820724,0.0000027809813,0.00025412728,0.000087420114],"study_design_scores_gemma":[0.01720492,0.0028820795,0.9712632,0.000094923074,0.0015404229,0.000010695738,0.0006255818,0.0000070935334,0.00589387,0.00001552859,0.0001423295,0.00031940304],"about_ca_topic_score_codex":0.00094826357,"about_ca_topic_score_gemma":0.005473472,"teacher_disagreement_score":0.017016236,"about_ca_system_score_codex":0.010350785,"about_ca_system_score_gemma":0.0013742942,"threshold_uncertainty_score":0.99991894},"labels":[],"label_agreement":null},{"id":"W2065458063","doi":"10.1182/blood-2013-12-512681","title":"Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism","year":2014,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":277,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"Bayer Canada; Heart and Stroke Foundation of Canada","keywords":"Medicine; Deep vein; Pulmonary embolism; Thrombosis; Anticoagulant therapy; Surgery; Warfarin; Anticoagulant; Internal medicine; Anesthesia; Cardiology; Atrial fibrillation","score_opus":0.055601633709865095,"score_gpt":0.34579952460429086,"score_spread":0.29019789089442577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065458063","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009419256,0.9950288,0.00018370032,0.00011345635,0.0001553505,0.002803925,0.000028592762,0.000036865076,0.00070740964],"genre_scores_gemma":[0.0012984236,0.99686337,0.000625905,0.00012545055,0.0003635139,0.00037595426,0.000222658,0.00007087447,0.00005384226],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984532,0.00006343685,0.0006524809,0.00039108828,0.00020101342,0.00023878674],"domain_scores_gemma":[0.9988671,0.00013821608,0.00041005216,0.00041843628,0.00007786052,0.00008835175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029880487,0.00033157543,0.0025416694,0.0001802285,0.000062191175,0.00002132988,0.00011451224,0.00023349577,0.000028261618],"category_scores_gemma":[0.000043255055,0.0002443596,0.0003983119,0.00012038955,0.000057351615,0.000038474805,0.00005429406,0.00011050306,0.000006809278],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009403379,0.002342732,0.00007098612,0.044447407,0.0015222925,0.0000067251995,0.00009933868,8.927482e-8,0.000049148992,0.002005332,0.0006476569,0.9487989],"study_design_scores_gemma":[0.0015690173,0.00066891697,0.0023652862,0.008288289,0.0069176364,0.000038343347,0.00001890742,0.000019967229,0.00006688225,0.000121320016,0.9796154,0.00031006435],"about_ca_topic_score_codex":0.000020963975,"about_ca_topic_score_gemma":0.000002632374,"teacher_disagreement_score":0.9789677,"about_ca_system_score_codex":0.000014418039,"about_ca_system_score_gemma":0.00007000647,"threshold_uncertainty_score":0.99646956},"labels":[],"label_agreement":null},{"id":"W2065497789","doi":"10.1182/blood.v97.1.95","title":"Lymphocytic vasculitis in X-linked lymphoproliferative disease","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of Calgary","funders":"","keywords":"Medicine; Pathology; Vasculitis; Immunology; Necrotizing Vasculitis; Disease","score_opus":0.01805757623326457,"score_gpt":0.2787105054624986,"score_spread":0.260652929229234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065497789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840048,0.002438435,0.000020734884,0.00058430724,0.000030380199,0.00043695554,0.000003068725,0.00006256006,0.012418757],"genre_scores_gemma":[0.9955881,0.00089363044,0.00005342812,0.0004506505,0.00008364989,0.0000902649,0.000026623477,0.000021899998,0.0027917584],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876773,0.000056083278,0.0002714379,0.0002448857,0.00030584802,0.00035400677],"domain_scores_gemma":[0.9993234,0.00003160163,0.000030861083,0.00033718866,0.00006656887,0.00021033862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016259566,0.00012950474,0.00027440157,0.00015908713,0.00005855047,0.000018768109,0.00009236097,0.000063674925,0.0005229006],"category_scores_gemma":[0.0002016014,0.00011459022,0.00010132417,0.00033526833,0.0000745446,0.00010517042,0.00004465626,0.00012181295,0.00031837285],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088892627,0.0019236254,0.9760827,0.00020460108,0.00020571671,0.00502937,0.000993176,0.00002920021,0.0016587423,0.00073012273,0.00054705696,0.011706801],"study_design_scores_gemma":[0.02422428,0.00022373744,0.957253,0.00021175528,0.00012739493,0.00020308381,0.00035483993,0.0011658622,0.0007200155,0.00054728385,0.014701919,0.0002668796],"about_ca_topic_score_codex":0.00009217625,"about_ca_topic_score_gemma":0.000016079304,"teacher_disagreement_score":0.023335353,"about_ca_system_score_codex":0.00014714042,"about_ca_system_score_gemma":0.0008167821,"threshold_uncertainty_score":0.5725395},"labels":[],"label_agreement":null},{"id":"W2065753733","doi":"10.1182/blood-2004-12-4782","title":"The influence of high-altitude living on body iron","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nutrition International","funders":"","keywords":"Iron status; Soluble transferrin receptor; Serum ferritin; Ferritin; Population; Iron deficiency; Medicine; Effects of high altitude on humans; Demography; Altitude (triangle); Transferrin receptor; Body weight; Physiology; Animal science; Transferrin; Biology; Anemia; Endocrinology; Internal medicine; Environmental health; Mathematics","score_opus":0.005000142069266446,"score_gpt":0.2366889273910189,"score_spread":0.23168878532175247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065753733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99409765,0.00084024924,0.000003660723,0.0006646624,0.0000390011,0.00010569344,0.0000013194189,0.000021427715,0.0042263153],"genre_scores_gemma":[0.9982065,0.00025449131,0.00023868566,0.0005194738,0.00014202278,0.000004983523,9.4352714e-7,0.0000081884655,0.00062471704],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99944395,0.00001844006,0.00013025319,0.00009551464,0.00017308015,0.0001387928],"domain_scores_gemma":[0.9995443,0.00009230239,0.000044425,0.0002489119,0.000027015254,0.000043030217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012423474,0.00006419583,0.00010863244,0.000026786905,0.000058225545,0.0000060156117,0.000079653895,0.000032444244,0.00003490851],"category_scores_gemma":[0.00019441976,0.000041047937,0.00003273424,0.00005921288,0.000052212068,0.000034414632,0.000021865297,0.00008271279,0.00006863093],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008662965,0.014622342,0.4491588,0.0011163162,0.00031244036,0.00006805446,0.006318761,0.0052021393,0.3007188,0.11544948,0.009054508,0.09711206],"study_design_scores_gemma":[0.0016619022,0.00018624935,0.9804866,0.000087733235,0.0001387771,0.0000062913205,0.000087542634,0.0000059625454,0.009912128,0.0000615132,0.0072897174,0.00007560964],"about_ca_topic_score_codex":0.000059145725,"about_ca_topic_score_gemma":0.000019667963,"teacher_disagreement_score":0.5313278,"about_ca_system_score_codex":0.000004073409,"about_ca_system_score_gemma":0.000029756937,"threshold_uncertainty_score":0.16738863},"labels":[],"label_agreement":null},{"id":"W2065900855","doi":"10.1182/blood.v99.9.3256","title":"Alanine-170 and proline-172 are critical determinants for extracellular CD20 epitopes; heterogeneity in the fine specificity of CD20 monoclonal antibodies is defined by additional requirements imposed by both amino acid sequence and quaternary structure","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":156,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Epitope; Monoclonal antibody; Biology; Molecular biology; Antibody; Antigen; Epitope mapping; Peptide sequence; CD20; Virology; Biochemistry; Genetics; Gene","score_opus":0.05697412030067603,"score_gpt":0.32208068683973756,"score_spread":0.2651065665390615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065900855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9790706,0.0061233975,0.00002017043,0.0019326598,0.000034261444,0.0006569591,0.012114209,0.000012917666,0.00003484868],"genre_scores_gemma":[0.9965537,0.00064369553,0.0014119928,0.00032695217,0.00015880939,0.000053785177,0.00057566905,0.000024474532,0.00025091454],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977338,0.000111190515,0.0005356694,0.00053059857,0.0005917278,0.00049703853],"domain_scores_gemma":[0.9989012,0.00038429323,0.0001443466,0.00025559808,0.00013136904,0.0001832236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022385459,0.00031858758,0.00053057465,0.000083211155,0.00017075498,0.0000426036,0.00020643769,0.00015839608,0.00045329865],"category_scores_gemma":[0.00022001735,0.00022553155,0.000099545265,0.00011482692,0.00046934193,0.00013279002,0.000102673876,0.0002875853,0.0000025442102],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065906823,0.0012887978,0.55326635,0.0007992783,0.00014223432,0.00029409386,0.00034893322,1.7882009e-7,0.42603254,0.00006584022,0.015066144,0.0020365056],"study_design_scores_gemma":[0.010048995,0.002841748,0.39299834,0.0008043588,0.00037932265,0.0018093903,0.00017378457,0.004271585,0.5776663,0.0012407221,0.0068697454,0.00089572265],"about_ca_topic_score_codex":0.00008325821,"about_ca_topic_score_gemma":0.00006641395,"teacher_disagreement_score":0.16026802,"about_ca_system_score_codex":0.000017965547,"about_ca_system_score_gemma":0.000030786858,"threshold_uncertainty_score":0.9196909},"labels":[],"label_agreement":null},{"id":"W2066235768","doi":"10.1182/blood-2008-06-162263","title":"Loss of Mll5 results in pleiotropic hematopoietic defects, reduced neutrophil immune function, and extreme sensitivity to DNA demethylation","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Biology; DNA demethylation; Chromatin; Haematopoiesis; Myeloid; Hematopoietic stem cell; DNA methylation; Stem cell; Genetics; Cell biology; Immunology; Cancer research; Gene; Gene expression","score_opus":0.027270030575987567,"score_gpt":0.258535515493873,"score_spread":0.23126548491788543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066235768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99729806,0.00051852263,0.00013567,0.0010743997,0.000045317447,0.0005445996,0.000008341884,0.000040013852,0.00033504787],"genre_scores_gemma":[0.998707,0.00015505256,0.0007310002,0.000082003906,0.0001058619,0.000015594454,0.00002598147,0.000025132027,0.00015235461],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983724,0.0001732928,0.0004440901,0.00036187732,0.00034385332,0.00030453483],"domain_scores_gemma":[0.9989575,0.00018900313,0.00009473639,0.00042041973,0.00017975862,0.00015854793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004651736,0.00015432738,0.0004051307,0.00029736105,0.00006994666,0.0000067533174,0.000050416435,0.0001243514,0.000010380806],"category_scores_gemma":[0.00062928617,0.00014622306,0.000058741687,0.00058051985,0.00011309092,0.0000920721,0.00008601732,0.00027526307,0.00001921233],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011627389,0.00045346923,0.06162693,0.00015142423,0.00006757349,0.0004024561,0.0006686131,0.00002337519,0.9346922,0.00008416579,0.00016285603,0.0005042139],"study_design_scores_gemma":[0.0073396596,0.00051652984,0.85056925,0.000120734316,0.00008131334,0.00048944977,0.000060570987,0.000078673074,0.14047383,0.000078465775,0.00007191065,0.00011963508],"about_ca_topic_score_codex":0.00026370393,"about_ca_topic_score_gemma":0.00004297849,"teacher_disagreement_score":0.79421836,"about_ca_system_score_codex":0.000096328346,"about_ca_system_score_gemma":0.00019965456,"threshold_uncertainty_score":0.59628034},"labels":[],"label_agreement":null},{"id":"W2066492659","doi":"10.1182/blood-2012-07-442558","title":"Comparison of primary human cytotoxic T-cell and natural killer cell responses reveal similar molecular requirements for lytic granule exocytosis but differences in cytokine production","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":146,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"University of Chicago","keywords":"Exocytosis; Lytic cycle; Cytotoxic T cell; Cytokine; Cell biology; Biology; Natural killer cell; Granule (geology); Granzyme; Immunology; Chemistry; Perforin; Secretion; Biochemistry; In vitro; Virus","score_opus":0.0261306360820179,"score_gpt":0.26505309858846,"score_spread":0.23892246250644208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066492659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99600285,0.0018990992,0.000022212114,0.00010699179,0.0009108648,0.00073930336,0.0000038426133,0.000027666416,0.0002871696],"genre_scores_gemma":[0.9906032,0.00005676857,0.000117374104,0.000055728262,0.000019974026,0.00010389043,0.00011692699,0.000015499494,0.008910658],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987873,0.00018186649,0.0004399125,0.00030885325,0.000048556303,0.00023351],"domain_scores_gemma":[0.9994046,0.00007777493,0.00021624996,0.00020061519,0.000086059714,0.000014703101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015929843,0.0001733702,0.0003591181,0.00018089543,0.00012652094,0.000015542853,0.000102210695,0.0001479108,0.00011187272],"category_scores_gemma":[0.000056811474,0.00015514679,0.00007078787,0.00008774449,0.000108414126,0.000163389,0.000047570462,0.0002095129,0.000026236105],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003050257,0.0008992771,0.016197173,0.00015219249,0.000054672913,5.269928e-7,0.00024512576,8.273383e-7,0.9805712,0.000007851396,0.0014572415,0.00010886186],"study_design_scores_gemma":[0.0028058898,0.00060020876,0.05192523,0.000057148485,0.00009302333,0.0000087974595,0.00028692742,0.000006051863,0.9436588,0.000039584305,0.0003613362,0.00015699815],"about_ca_topic_score_codex":0.00009486219,"about_ca_topic_score_gemma":0.000007398554,"teacher_disagreement_score":0.03691242,"about_ca_system_score_codex":0.000035255518,"about_ca_system_score_gemma":0.000022271006,"threshold_uncertainty_score":0.6326702},"labels":[],"label_agreement":null},{"id":"W2066519436","doi":"10.1182/blood-2009-03-211441","title":"TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":164,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Services and Policy Research","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Hematopoietic cell; Graft-versus-host disease; Transplantation; Hematopoietic stem cell transplantation; Conditioning; Medicine; Immunology; Disease; Haematopoiesis; Internal medicine; Biology; Stem cell; Genetics","score_opus":0.005143209693781117,"score_gpt":0.21017163659312363,"score_spread":0.2050284268993425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066519436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99730057,0.0008364295,0.0004545873,0.00017593733,0.000041782558,0.00051353907,0.00023137462,0.00008141925,0.00036437542],"genre_scores_gemma":[0.9963181,0.0020307642,0.0010819653,0.00003796086,0.000017490065,0.000018284833,0.00041497912,0.000027604992,0.00005284632],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986849,0.00008336531,0.00041973882,0.0003742116,0.00023854086,0.00019928713],"domain_scores_gemma":[0.99907345,0.00018433115,0.0001970586,0.00023098994,0.00007579385,0.00023836347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000115320705,0.00021679139,0.0003249935,0.00014087783,0.0001043357,0.000020916752,0.0000350389,0.0001245182,0.00006743605],"category_scores_gemma":[0.000023442459,0.000191258,0.000057856054,0.00022299353,0.00013719797,0.00014567007,0.000003987888,0.00020983344,0.0000070134324],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005817165,0.0014602308,0.8733504,0.0017385653,0.0007896026,0.0016808466,0.005848778,0.00009037481,0.10879597,0.00029959108,0.000009267546,0.00011924065],"study_design_scores_gemma":[0.0134430835,0.0005536028,0.93714654,0.0012109957,0.0048788707,0.00024853734,0.00030627762,0.0001201558,0.041610707,0.00021030962,0.0000059337003,0.000264998],"about_ca_topic_score_codex":0.00009963811,"about_ca_topic_score_gemma":0.00003647184,"teacher_disagreement_score":0.06718526,"about_ca_system_score_codex":0.000015321499,"about_ca_system_score_gemma":0.00006590345,"threshold_uncertainty_score":0.7799275},"labels":[],"label_agreement":null},{"id":"W2066554543","doi":"10.1182/blood.v100.1.120","title":"Engraftment potential of human fetal hematopoietic cells in NOD/SCID mice is not restricted to mitotically quiescent cells","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Haematopoiesis; Biology; Stem cell; CD34; Bone marrow; Immunology; Cord blood; Cell biology; Cell cycle; Progenitor cell; Hematopoietic stem cell; Cancer research; Cell; Genetics","score_opus":0.016009454173259774,"score_gpt":0.24370802017737836,"score_spread":0.22769856600411859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066554543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99626154,0.000086656975,0.00024632885,0.0008787249,0.00017309349,0.00097268337,0.00004207016,0.000052927775,0.0012859482],"genre_scores_gemma":[0.9955765,0.00005902834,0.0031220934,0.00044110554,0.000084397136,0.000027034082,0.000020895508,0.00004059402,0.0006283296],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99756247,0.0000769253,0.0007866203,0.00044970744,0.0006794579,0.00044482038],"domain_scores_gemma":[0.9989953,0.00007605637,0.00011797814,0.0004278649,0.00010555514,0.0002772372],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000120371595,0.00025647544,0.00052096834,0.00027979707,0.000047887035,0.00001696126,0.00016940062,0.00017170247,0.00075279863],"category_scores_gemma":[0.000020953601,0.00025225375,0.00015205482,0.00042206945,0.00006351696,0.000037567752,0.00004010376,0.00022483115,0.00045423253],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000081891034,0.00241873,0.00071037404,0.0006134438,0.00007274261,0.0003391427,0.002420051,0.000011179077,0.99276006,0.000039544364,0.00046245934,0.00007036865],"study_design_scores_gemma":[0.0055934754,0.00061469176,0.00686286,0.00050911674,0.00040043858,0.00009568642,0.00021038235,0.00012545563,0.9852201,0.000011250045,0.00012641234,0.00023016972],"about_ca_topic_score_codex":0.00008143144,"about_ca_topic_score_gemma":0.00001500963,"teacher_disagreement_score":0.0075400127,"about_ca_system_score_codex":0.000056967423,"about_ca_system_score_gemma":0.00003936687,"threshold_uncertainty_score":0.99999297},"labels":[],"label_agreement":null},{"id":"W2066796374","doi":"10.1182/blood-2008-06-165233","title":"The Montreal platelet syndrome kindred has type 2B von Willebrand disease with the VWF V1316M mutation","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; University of Toronto; Université Laval; Hôpital de l'Enfant-Jésus; Calgary Laboratory Services; University of Calgary; Alberta Health Services","funders":"","keywords":"Von Willebrand disease; Von Willebrand factor; Platelet; Ristocetin; Coagulopathy; Internal medicine; Mutation; Bleeding time; Endocrinology; Immunology; Medicine; Chemistry; Platelet aggregation; Biochemistry; Gene","score_opus":0.011466151092999673,"score_gpt":0.2110352577396955,"score_spread":0.19956910664669583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066796374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939707,0.0013431847,0.000004780463,0.0027376802,0.00004633385,0.0004718598,0.000016688651,0.000047161506,0.0013616058],"genre_scores_gemma":[0.9983177,0.00021876236,0.000025501393,0.00020267654,0.000035648332,0.000032349675,0.00009339776,0.000022440614,0.001051506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991956,0.000029094783,0.000114233815,0.00018330745,0.0002544824,0.00022330049],"domain_scores_gemma":[0.9994152,0.00007169892,0.000057053465,0.000282608,0.00005048844,0.00012294517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000046557536,0.00014106373,0.00017830635,0.000025942549,0.0004916144,0.000031115287,0.000078343284,0.00004121531,0.000020874495],"category_scores_gemma":[0.000027808914,0.000067367786,0.000051539686,0.00015566031,0.0001554992,0.00005715174,0.000013984219,0.000106262225,0.000063394495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028852157,0.019711098,0.47081062,0.00040413457,0.014341675,0.34919482,0.015619307,0.0004596209,0.0010405843,0.0013940203,0.048344597,0.049827367],"study_design_scores_gemma":[0.02404886,0.0017717851,0.94954675,0.00010561183,0.0013774991,0.010096226,0.00030243545,0.00023264265,0.0005580266,0.0003838507,0.011241991,0.00033432795],"about_ca_topic_score_codex":0.00012514158,"about_ca_topic_score_gemma":0.00019636341,"teacher_disagreement_score":0.47873613,"about_ca_system_score_codex":0.000011347046,"about_ca_system_score_gemma":0.00014349625,"threshold_uncertainty_score":0.378115},"labels":[],"label_agreement":null},{"id":"W2066882388","doi":"10.1182/blood.v98.6.1942","title":"Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":329,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Prostaglandin D2; Receptor; Prostaglandin; Agonist; Endocrinology; Internal medicine; Adenylyl cyclase; Receptor antagonist; Thromboxane receptor; Prostaglandin E2 receptor; Eosinophil; Chemistry; Adenosine receptor; Biology; Biochemistry; Antagonist; Medicine","score_opus":0.03607173645121633,"score_gpt":0.28737405553144246,"score_spread":0.25130231908022616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066882388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939019,0.0004967025,0.00052500033,0.0027037475,0.00010968021,0.0011898357,0.000087604974,0.00010233344,0.00088318076],"genre_scores_gemma":[0.9945802,0.000027971657,0.0004498423,0.0014608055,0.00058458856,0.000119877164,0.000077671,0.000045561785,0.0026534721],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988017,0.0000100814505,0.00018421098,0.00033890485,0.00028136285,0.00038370848],"domain_scores_gemma":[0.9991703,0.000024871631,0.0001088,0.00030449984,0.00009177266,0.00029973243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009213163,0.00021142347,0.00030878643,0.00007917416,0.00015758428,0.000037440892,0.00009210427,0.00012631912,0.00015609624],"category_scores_gemma":[0.000047156966,0.00015954419,0.00019305196,0.00011124464,0.000055731514,0.00008259568,0.000028804001,0.00011553665,0.000030081961],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056417857,0.005575925,0.046580955,0.0003553247,0.0002458712,0.0001475527,0.00051693234,1.999196e-7,0.9333061,0.00007474113,0.0051104454,0.007521799],"study_design_scores_gemma":[0.023556836,0.0024426382,0.09138167,0.00050011027,0.0009245709,0.00041553762,0.00032152433,0.000023775636,0.48140422,0.00014941985,0.3981974,0.0006822778],"about_ca_topic_score_codex":0.0000067389037,"about_ca_topic_score_gemma":0.0000036187055,"teacher_disagreement_score":0.45190185,"about_ca_system_score_codex":0.000033306955,"about_ca_system_score_gemma":0.00009225485,"threshold_uncertainty_score":0.65060234},"labels":[],"label_agreement":null},{"id":"W2067065681","doi":"10.1182/blood-2004-01-0204","title":"Constitutively active Notch4 promotes early human hematopoietic progenitor cell maintenance while inhibiting differentiation and causes lymphoid abnormalities in vivo","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Developmental Biology and Gene Regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Hospital and Health Sciences Centre; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Biology; Haematopoiesis; Stem cell; Progenitor cell; Notch signaling pathway; CD34; Myeloid; Cell biology; Bone marrow; Hematopoietic stem cell; Immunology; Cancer research; Signal transduction","score_opus":0.006849514844114698,"score_gpt":0.20818901635090048,"score_spread":0.20133950150678578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067065681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99894845,0.00019368198,0.000052109557,0.00002571737,0.000035142184,0.00024630447,0.000026190586,0.000012339416,0.00046003234],"genre_scores_gemma":[0.99938023,0.000023585066,0.00027220254,0.000026843398,0.000050287148,0.00004062254,0.00007056642,0.000008635146,0.00012703758],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993128,0.000030480944,0.00016470959,0.00025007018,0.000056694535,0.00018521694],"domain_scores_gemma":[0.9997478,0.00000600601,0.000101539124,0.000072289105,0.000037974558,0.000034385866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006272142,0.00012762188,0.00011012815,0.000039124356,0.00011121873,0.000019267341,0.00004856526,0.00012042497,0.0000040271075],"category_scores_gemma":[0.000019024745,0.00012191509,0.00002549616,0.000049522903,0.00013411045,0.000011926135,0.00005815072,0.000045959612,0.000001926817],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024557885,0.00016072298,0.110043176,0.00003615975,0.000024765195,0.0000047103176,0.0004933504,0.0000025804723,0.8889087,0.00023895301,0.00000318545,0.00005913732],"study_design_scores_gemma":[0.0015104661,0.000120624834,0.088222034,0.000051709085,0.000014615866,0.00004582677,0.00017910969,4.789972e-7,0.9093743,0.00031028196,0.00002331033,0.0001472223],"about_ca_topic_score_codex":0.000041371528,"about_ca_topic_score_gemma":0.000118057185,"teacher_disagreement_score":0.021821136,"about_ca_system_score_codex":0.00001868506,"about_ca_system_score_gemma":0.00006630433,"threshold_uncertainty_score":0.4971553},"labels":[],"label_agreement":null},{"id":"W2067079282","doi":"10.1182/blood-2014-04-564666","title":"Modeling de novo leukemogenesis from human cord blood with MN1 and NUP98HOXD13","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency","keywords":"Cord blood; Haematopoiesis; Biology; Immunology; CD34; Leukemia; Cell biology; Stem cell; Medicine; Cancer research","score_opus":0.020307337593836673,"score_gpt":0.2718908760961658,"score_spread":0.2515835385023291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067079282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99440986,0.0003599873,0.002271115,0.0002955324,0.000015573536,0.00027287123,0.000012587812,0.00011642821,0.0022460725],"genre_scores_gemma":[0.9880082,0.00006683474,0.010481955,0.0004431598,0.00042260002,0.00002888455,0.000037323123,0.000068637455,0.00044242406],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983991,0.00007330144,0.00022735927,0.00045149928,0.0003694635,0.0004793037],"domain_scores_gemma":[0.9988948,0.000099686,0.000043144904,0.00051820127,0.0001122044,0.0003319678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003007545,0.00021460798,0.00037038355,0.00011977964,0.00016367491,0.000045537687,0.00016195286,0.00015682774,0.00007679323],"category_scores_gemma":[0.00011518424,0.00017381363,0.000050392227,0.00015808252,0.00010218012,0.00006977713,0.00010605126,0.00034609594,0.000029469033],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012716979,0.0020100623,0.3365369,0.00040809473,0.0020543982,0.0011948887,0.0014805765,0.00037216127,0.6415438,0.0011253443,0.00038445805,0.011617612],"study_design_scores_gemma":[0.16124585,0.012781602,0.13232364,0.00200254,0.012136413,0.0066402173,0.001816176,0.17438805,0.48503923,0.0035875752,0.0046033873,0.0034352953],"about_ca_topic_score_codex":0.00114398,"about_ca_topic_score_gemma":0.00017798465,"teacher_disagreement_score":0.20421328,"about_ca_system_score_codex":0.00006928647,"about_ca_system_score_gemma":0.00023447101,"threshold_uncertainty_score":0.70879143},"labels":[],"label_agreement":null},{"id":"W2067194066","doi":"10.1182/blood.v99.5.1683","title":"Cell surface antigen CD109 is a novel member of the α2 macroglobulin/C3, C4, C5 family of thioester-containing proteins","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":192,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Thioester; Antigen; Macroglobulin; Molecular biology; Immunology; Chemistry; Biology; Biochemistry; Enzyme","score_opus":0.04198874089758194,"score_gpt":0.27383146295189403,"score_spread":0.23184272205431208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067194066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9774554,0.0011952152,0.00011678322,0.0005455373,0.00004749415,0.0010266451,0.000037666065,0.000025480089,0.019549804],"genre_scores_gemma":[0.98885405,0.00013326887,0.004028404,0.00033499146,0.000044403052,0.000011642753,0.0000027911121,0.00004291659,0.006547536],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979008,0.000073615534,0.0004644805,0.000330023,0.00084132125,0.00038978297],"domain_scores_gemma":[0.99852556,0.00007990051,0.00020524567,0.0007980415,0.00025525846,0.00013600731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029102957,0.00019274872,0.00042096243,0.00007301044,0.00006329246,0.000013346243,0.00034895664,0.0001412557,0.0005412493],"category_scores_gemma":[0.00011091222,0.00013686418,0.00021836253,0.0004220874,0.00014906915,0.000042080686,0.0002484715,0.00033754107,0.00007847026],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006954438,0.0014942043,0.0379751,0.00026598564,0.00009413198,0.000029984463,0.0012365244,0.0000055985993,0.95774215,0.000015832988,0.0007750383,0.00029588985],"study_design_scores_gemma":[0.004680871,0.00052839576,0.035873108,0.00023960012,0.00013093094,0.000038663944,0.0003742151,0.00034015547,0.95510733,0.000012747771,0.0025221496,0.00015181821],"about_ca_topic_score_codex":0.0002638396,"about_ca_topic_score_gemma":0.000011489598,"teacher_disagreement_score":0.013002268,"about_ca_system_score_codex":0.000023449807,"about_ca_system_score_gemma":0.000116355826,"threshold_uncertainty_score":0.59263},"labels":[],"label_agreement":null},{"id":"W2067201516","doi":"10.1182/blood-2013-04-491787","title":"Jump-starting the T cells in CLL","year":2013,"lang":"en","type":"letter","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Chronic lymphocytic leukemia; Lenalidomide; Immune system; Lymphocytosis; Immunology; Medicine; Leukemia; Cancer research; Multiple myeloma","score_opus":0.02225573793311002,"score_gpt":0.2693427936704702,"score_spread":0.24708705573736017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067201516","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.184984,0.0017017381,0.0000030809952,0.7838426,0.00050692906,0.0022076096,0.000022800772,0.0001167465,0.026614489],"genre_scores_gemma":[0.019810928,0.00021051987,0.00030881766,0.91818434,0.010217484,0.00027777313,0.00014120508,0.000193883,0.050655033],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99743277,0.00012612931,0.00040791617,0.00042775265,0.00083013123,0.0007752936],"domain_scores_gemma":[0.9983065,0.0004644033,0.000111811336,0.0009574599,0.00008317399,0.00007661162],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043170503,0.00026322986,0.0004498269,0.00017079893,0.000051261104,0.000062796986,0.00044050848,0.0006391443,0.00069161225],"category_scores_gemma":[0.00018431555,0.00016655667,0.00015354838,0.00025360906,0.00013697792,0.00003802419,0.0002102963,0.0026215445,0.0018131422],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008100875,0.00010831729,0.00005980613,0.00042475824,0.000089157635,0.0025895936,0.00018750624,0.0000010432981,0.00049544,0.0000022837648,0.9956075,0.0004264909],"study_design_scores_gemma":[0.0184707,0.00009451036,0.00009514785,0.00051879225,0.0002350432,0.000269125,0.00005090535,0.0005351833,0.0056976657,0.000113631824,0.9736468,0.0002724564],"about_ca_topic_score_codex":0.0018572315,"about_ca_topic_score_gemma":0.00003709,"teacher_disagreement_score":0.16517307,"about_ca_system_score_codex":0.002708672,"about_ca_system_score_gemma":0.0037747296,"threshold_uncertainty_score":0.99967945},"labels":[],"label_agreement":null},{"id":"W2067394538","doi":"10.1182/blood-2006-01-029199","title":"Phospholipase C, calcium, and calmodulin are critical for α4β1 integrin affinity up-regulation and monocyte arrest triggered by chemoattractants","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Monocyte; Calmodulin; Calcium; Integrin; Chemotaxis; Cell biology; Immunology; Chemistry; Receptor; Internal medicine; Medicine; Endocrinology; Biology","score_opus":0.03130219160038489,"score_gpt":0.3191470580660539,"score_spread":0.28784486646566904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067394538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956011,0.0015414355,0.0005380293,0.0011789718,0.00006295706,0.00063077203,0.000114308845,0.000046791632,0.00028563477],"genre_scores_gemma":[0.99732566,0.00005734417,0.0011521413,0.0000953423,0.0001556805,0.00005993151,0.0001059385,0.00003407554,0.0010138813],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99860775,0.0000427994,0.00029220368,0.00041519303,0.00029016874,0.00035190914],"domain_scores_gemma":[0.9989505,0.0003337987,0.00005505784,0.00023438557,0.00015593004,0.00027033428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023152109,0.0001826174,0.00033777676,0.00008232144,0.00010997336,0.000052713025,0.000058719503,0.00017323853,0.00007665089],"category_scores_gemma":[0.00072930974,0.00016492527,0.00005957636,0.00012683903,0.00016947078,0.00006920834,0.00005819384,0.0002520258,0.000009468748],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023353824,0.003245707,0.033455033,0.0009457854,0.00011119962,0.00018989718,0.00015761213,0.0000019495321,0.9319077,0.00042346388,0.01594639,0.011279891],"study_design_scores_gemma":[0.013204357,0.00040088594,0.18279475,0.0001561493,0.00028430074,0.00012755608,0.00013883623,0.0019148225,0.79600257,0.00064367114,0.0040096347,0.00032244797],"about_ca_topic_score_codex":0.00019838299,"about_ca_topic_score_gemma":0.00003916367,"teacher_disagreement_score":0.14933972,"about_ca_system_score_codex":0.000033704076,"about_ca_system_score_gemma":0.00006374212,"threshold_uncertainty_score":0.6725457},"labels":[],"label_agreement":null},{"id":"W2067493438","doi":"10.1182/blood.v99.9.3197","title":"Modulation of p210BCR-ABL activity in transduced primary human hematopoietic cells controls lineage programming","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Haematopoiesis; Biology; Progenitor cell; CD34; Stem cell; Cell biology; Cancer research; Tyrosine kinase; Cord blood; Molecular biology; Immunology; Signal transduction","score_opus":0.027258975885427236,"score_gpt":0.28055444059181184,"score_spread":0.2532954647063846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067493438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965255,0.0003111267,0.00014655627,0.00008748408,0.000026536112,0.0010376314,0.0000038059218,0.000055401102,0.0018059226],"genre_scores_gemma":[0.99864376,0.00002597484,0.00071782374,0.000030287778,0.0000864187,0.000056833906,0.000010509881,0.000030511319,0.00039786904],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99837124,0.00008231463,0.00038997352,0.00029709804,0.0004790797,0.00038028212],"domain_scores_gemma":[0.9991811,0.00012748103,0.00010192748,0.00040168615,0.00007023317,0.00011757505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034714496,0.00015408036,0.0004842605,0.00016555219,0.000037907386,0.000013905016,0.00011069988,0.00014175299,0.00012318803],"category_scores_gemma":[0.000057009882,0.00014442154,0.00011881166,0.00030920506,0.000094460374,0.00009538545,0.000029617768,0.00024892052,0.000018310073],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011704702,0.0037236416,0.0009835578,0.0010309425,0.00009779373,0.00017136274,0.00092778186,0.000048497626,0.9844514,0.000032454238,0.000023745893,0.008391782],"study_design_scores_gemma":[0.08395956,0.00063219067,0.012963006,0.00045349193,0.00024607775,0.00011183366,0.000052873143,0.019657517,0.88142294,0.00003387484,0.00019831532,0.0002683077],"about_ca_topic_score_codex":0.00020823366,"about_ca_topic_score_gemma":0.00002746968,"teacher_disagreement_score":0.10302844,"about_ca_system_score_codex":0.001107492,"about_ca_system_score_gemma":0.00039325733,"threshold_uncertainty_score":0.588934},"labels":[],"label_agreement":null},{"id":"W2067578715","doi":"10.1182/blood-2008-09-177469","title":"Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survival","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":163,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Canada's Michael Smith Genome Sciences Centre; Terry Fox Research Institute; BC Cancer Agency","funders":"National Cancer Institute; Terry Fox Foundation","keywords":"CD20; Diffuse large B-cell lymphoma; Lymphoma; CHOP; Rituximab; Immunohistochemistry; International Prognostic Index; Pathology; Vincristine; Immunophenotyping; Medicine; Biology; Cancer research; Antigen; Internal medicine; Immunology; Cyclophosphamide; Chemotherapy","score_opus":0.018510790643641098,"score_gpt":0.24336470975438856,"score_spread":0.22485391911074748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067578715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99622935,0.00026063508,0.0000024577566,0.00012896575,0.00007163843,0.00032420256,0.00005427251,0.00014719543,0.0027812785],"genre_scores_gemma":[0.99793535,0.000119477554,0.00025251711,0.00034000224,0.00010754758,0.00006499914,0.00015803064,0.00004398303,0.0009780762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857694,0.000066013796,0.00021263518,0.0003730789,0.0003976416,0.0003737129],"domain_scores_gemma":[0.9990083,0.000061180894,0.0001084572,0.00044365713,0.00009828325,0.00028010437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008197359,0.00023723498,0.00040401574,0.00006286761,0.00019103487,0.000018107276,0.000080568105,0.00013509762,0.00009647753],"category_scores_gemma":[0.000047323447,0.00016404397,0.00009469708,0.00016991062,0.000043960463,0.00010628461,0.000041630967,0.00005641208,0.00005663171],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045144014,0.13084525,0.8358791,0.000035325644,0.0004116216,0.0026652876,0.0020059552,1.3625049e-7,0.025322398,0.000020983087,0.0019232824,0.0004392653],"study_design_scores_gemma":[0.097517475,0.0014291278,0.6399099,0.00015846973,0.00044745638,0.0001663064,0.00011400018,0.000012361241,0.2591213,0.000004757318,0.00086607004,0.0002527629],"about_ca_topic_score_codex":0.0000786616,"about_ca_topic_score_gemma":0.000023240633,"teacher_disagreement_score":0.23379889,"about_ca_system_score_codex":0.00009172579,"about_ca_system_score_gemma":0.00019438993,"threshold_uncertainty_score":0.66895187},"labels":[],"label_agreement":null},{"id":"W2067613860","doi":"10.1182/blood-2011-05-354076","title":"C-terminal domain of MEIS1 converts PKNOX1 (PREP1) into a HOXA9-collaborating oncoprotein","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Genomics and Chromatin Dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Canadian Institutes of Health Research","keywords":"Hox gene; Biology; Homeobox; Chromatin; Ectopic expression; Fusion protein; DNA-binding domain; Gene; Cancer research; Genetics; Cell cycle; Cell biology; Transcription factor","score_opus":0.006611523252327958,"score_gpt":0.2064900315988299,"score_spread":0.19987850834650195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067613860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965857,0.00027458597,0.00042492975,0.00001331166,0.00006985973,0.00018210076,0.00001696148,0.000008692341,0.0024238324],"genre_scores_gemma":[0.9761165,0.000026324873,0.023510234,0.000048392685,0.000083799445,0.00002244314,0.000044977925,0.000021547448,0.00012579732],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99918044,0.0000369149,0.00026346397,0.0002501608,0.0000920797,0.00017695052],"domain_scores_gemma":[0.9993181,0.000004433596,0.00015981992,0.000355006,0.00009924696,0.000063400024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015201473,0.00013454507,0.00016011571,0.000028956938,0.000050909282,0.000010498841,0.00020798547,0.00013219449,0.000030830823],"category_scores_gemma":[0.00003217095,0.00013494065,0.00006819091,0.00007498394,0.00006859287,0.0000026335408,0.00013020456,0.000053871754,0.000007920616],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044131928,0.00029006085,0.007119356,0.00006731696,0.00009034133,0.000015151677,0.0008266113,0.000002280486,0.9904123,0.00036977875,0.000067153735,0.0006954976],"study_design_scores_gemma":[0.0017142626,0.0006799846,0.004479136,0.000038457212,0.00005925012,0.00005096573,0.00047323466,0.00007244369,0.98954046,0.0015315178,0.0010653409,0.00029497306],"about_ca_topic_score_codex":0.00007549134,"about_ca_topic_score_gemma":0.00010983638,"teacher_disagreement_score":0.023085305,"about_ca_system_score_codex":0.0000069311845,"about_ca_system_score_gemma":0.000112390204,"threshold_uncertainty_score":0.55027205},"labels":[],"label_agreement":null},{"id":"W2067637255","doi":"10.1182/blood-2007-09-111948","title":"Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-κB pathways in subtypes of diffuse large B-cell lymphoma","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":354,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Autocrine signalling; STAT3; Cancer research; Signal transduction; Biology; STAT protein; Diffuse large B-cell lymphoma; Germinal center; Transcription factor; Janus kinase; stat; PIM1; B cell; Lymphoma; Cell biology; Phosphorylation; Cell culture; Immunology; Genetics; Gene","score_opus":0.01675344155575692,"score_gpt":0.23422661037823644,"score_spread":0.21747316882247952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067637255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99776274,0.0014413518,0.000037017053,0.00007155854,0.000014185793,0.00030513632,0.000055733915,0.00000909412,0.00030319576],"genre_scores_gemma":[0.99944043,0.00029428344,0.00013727271,0.00007551027,0.00002072772,0.0000055196115,0.0000055207747,0.000014325782,0.0000064005258],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992584,0.000036891935,0.00023887635,0.00016477845,0.00014437694,0.00015665132],"domain_scores_gemma":[0.999622,0.00012696792,0.00006518137,0.00009636457,0.000041121544,0.000048401766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000114022856,0.00012451899,0.000271265,0.000040135452,0.00004574296,0.0000074204163,0.000031210322,0.00007342155,0.000034378318],"category_scores_gemma":[0.000008116596,0.000079212994,0.00005128285,0.00009715077,0.00008078809,0.00007786353,0.0000082635515,0.000045508852,5.5857294e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005154879,0.011387527,0.047924478,0.00017981196,0.00017893064,0.000047598016,0.026743487,5.060761e-7,0.9098493,0.00093230867,0.0000047811195,0.0022357858],"study_design_scores_gemma":[0.02492078,0.00061710406,0.15239717,0.00012998235,0.00020477106,0.000016431875,0.0024297563,0.000013012905,0.8189981,0.000031889896,0.00015545372,0.00008557941],"about_ca_topic_score_codex":0.00013692588,"about_ca_topic_score_gemma":0.000038277834,"teacher_disagreement_score":0.10447269,"about_ca_system_score_codex":0.000020543433,"about_ca_system_score_gemma":0.000036251273,"threshold_uncertainty_score":0.3230212},"labels":[],"label_agreement":null},{"id":"W2067687662","doi":"10.1182/blood-2008-09-174649","title":"Recombinant and plasma-derived factor VIII products induce distinct splenic cytokine microenvironments in hemophilia A mice","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Recombinant DNA; Cytokine; Antibody; Titer; Immunology; Proinflammatory cytokine; Antibody titer; Von Willebrand factor; Medicine; Cell biology; Chemistry; Biology; Gene; Inflammation; Biochemistry; Platelet","score_opus":0.022330839423389166,"score_gpt":0.26230850751978096,"score_spread":0.2399776680963918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067687662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946518,0.00043806928,2.6798875e-7,0.0036256616,0.000058272948,0.0007784373,0.000015764812,0.00003498346,0.00039672607],"genre_scores_gemma":[0.99729514,0.0003465249,0.00035448206,0.0000869163,0.000093840245,0.000018408848,0.00004648786,0.000022051176,0.0017361518],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99848527,0.000050652012,0.00026621058,0.00048828125,0.00026223832,0.0004473789],"domain_scores_gemma":[0.99938685,0.000038027894,0.00005268344,0.00030491807,0.000024462506,0.00019306388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011362531,0.00022830987,0.00035964363,0.00014798882,0.000070109774,0.000019274987,0.00009280887,0.00011146185,0.00006413778],"category_scores_gemma":[0.000126904,0.00017615918,0.000044908214,0.00022530787,0.00007879078,0.00007540114,0.000058594276,0.00028579368,0.00008253151],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031222313,0.0033577809,0.15666673,0.000105454186,0.00008374663,0.0006570603,0.00039393373,6.861032e-8,0.8296994,0.0000057241123,0.00013397868,0.008583929],"study_design_scores_gemma":[0.008516247,0.000765952,0.70088285,0.00014482898,0.000085378204,0.00021572744,0.000028881928,0.000008868662,0.28831366,0.000050390085,0.00080823526,0.00017895419],"about_ca_topic_score_codex":0.00002396781,"about_ca_topic_score_gemma":0.000010871648,"teacher_disagreement_score":0.54421616,"about_ca_system_score_codex":0.00007428254,"about_ca_system_score_gemma":0.00006925817,"threshold_uncertainty_score":0.7183563},"labels":[],"label_agreement":null},{"id":"W2067752807","doi":"10.1182/blood-2011-01-331819","title":"Genetic interaction between Kit and Scl","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont; Institute for Research in Immunology and Cancer","funders":"Canadian Institutes of Health Research; National Institutes of Health","keywords":"Progenitor cell; Haematopoiesis; Biology; Stem cell; Immunology; Cell biology","score_opus":0.0174303245410309,"score_gpt":0.2792806921129268,"score_spread":0.2618503675718959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067752807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995067,0.00011121495,0.00016247678,0.0006260383,0.000029254645,0.00024908068,0.0000014989345,0.000034889552,0.003718516],"genre_scores_gemma":[0.9968669,0.000030342107,0.0017541929,0.00013645127,0.00030665443,0.000022389113,0.000005054535,0.000014246448,0.00086376397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99939334,0.000016769269,0.000110888184,0.00014600178,0.00016545922,0.00016755474],"domain_scores_gemma":[0.99953634,0.00008532681,0.00002116361,0.00015367976,0.000057582638,0.00014589811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000042986027,0.00006629343,0.00011965242,0.000064364765,0.000029414812,0.000025553161,0.00004144264,0.000055368593,0.00035468463],"category_scores_gemma":[0.00008643755,0.000053292195,0.000020115835,0.00007237905,0.000044060787,0.0000640716,0.0000535448,0.00011560486,0.00054916146],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039974402,0.00035899534,0.8555996,0.00021658782,0.00037315747,0.000115328745,0.0003828246,6.714564e-7,0.047907062,0.000036744706,0.010612155,0.084356904],"study_design_scores_gemma":[0.0043215966,0.0003146214,0.98183244,0.00007045833,0.00018777697,0.0003013157,0.000084340594,0.00035121903,0.00966011,0.0001620131,0.0026175694,0.000096544594],"about_ca_topic_score_codex":0.0002050196,"about_ca_topic_score_gemma":0.0000017023034,"teacher_disagreement_score":0.12623285,"about_ca_system_score_codex":0.000049892365,"about_ca_system_score_gemma":0.00006943963,"threshold_uncertainty_score":0.7058543},"labels":[],"label_agreement":null},{"id":"W2067796529","doi":"10.1182/blood-2005-09-012807","title":"Hepatocyte growth factor mediates angiopoietin-induced smooth muscle cell recruitment","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Ontario Institute for Cancer Research","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute; Vanderbilt University Medical Center","keywords":"Angiopoietin receptor; Mural cell; Hepatocyte growth factor; Angiopoietin; Cell biology; Biology; Western blot; Endothelial stem cell; Vascular smooth muscle; Motility; Vascular endothelial growth factor B; Growth factor; Cell migration; Receptor; Molecular biology; Vascular endothelial growth factor A; Chemistry; Vascular endothelial growth factor; Cancer research; Cell; Angiogenesis; Endocrinology; Biochemistry; In vitro; Gene","score_opus":0.02328046245747612,"score_gpt":0.24750517888305187,"score_spread":0.22422471642557576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067796529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992991,0.0029415423,0.00006471631,0.00007547134,0.00016190571,0.00026215686,0.000049039187,0.000026857646,0.0034273383],"genre_scores_gemma":[0.99754584,0.00031126142,0.00041102254,0.00017270746,0.0007416573,0.000094984236,0.00012759582,0.00003660138,0.00055833336],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989655,0.000034880995,0.0001925092,0.00036363408,0.00014354415,0.0002999004],"domain_scores_gemma":[0.99948055,0.000009093956,0.00008303822,0.0002834762,0.0000662383,0.00007761312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000682666,0.00018617937,0.00014182721,0.000029686247,0.000075130825,0.000023169297,0.00016963936,0.0001567274,0.00007518907],"category_scores_gemma":[0.000010271406,0.00016712095,0.00016907844,0.000074565854,0.000028954002,0.0000029278715,0.00007560481,0.000046856345,0.000033862707],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012817277,0.00030737295,0.016525058,0.000015323996,0.000029713963,0.000006361952,0.000017451495,0.0000013870908,0.9798612,0.00002739947,0.0023745713,0.00082137313],"study_design_scores_gemma":[0.00095857837,0.00019382153,0.035599537,0.000006394614,0.000042809515,0.0000020650705,0.000016889257,0.0000023575271,0.92091864,0.000042185082,0.041979466,0.0002372687],"about_ca_topic_score_codex":0.00017011164,"about_ca_topic_score_gemma":0.00005733137,"teacher_disagreement_score":0.058942545,"about_ca_system_score_codex":0.0000121541525,"about_ca_system_score_gemma":0.000057125282,"threshold_uncertainty_score":0.6814994},"labels":[],"label_agreement":null},{"id":"W2067915257","doi":"10.1182/blood-2013-10-535278","title":"Treatment of NLPHL","year":2013,"lang":"en","type":"letter","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Hodgkin lymphoma; Intensive care medicine; Lymphoma; Internal medicine; Pathology","score_opus":0.019768587025680035,"score_gpt":0.2479634362136167,"score_spread":0.22819484918793664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067915257","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22309373,0.0074146055,5.3878546e-7,0.73176134,0.00038884563,0.0018538925,0.00017354586,0.00010268505,0.03521082],"genre_scores_gemma":[0.19192769,0.0062664063,0.0024751334,0.69102734,0.015022317,0.0022007104,0.0036834117,0.0003117791,0.087085195],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99904,0.000019891295,0.00024740348,0.00025364535,0.0002293878,0.0002096925],"domain_scores_gemma":[0.9991961,0.0000780613,0.00012879934,0.00048537433,0.000055417895,0.00005626091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000009444716,0.00025105945,0.0006779402,0.00008082168,0.000015618016,0.000008453489,0.000047098805,0.0003648598,0.0005291099],"category_scores_gemma":[0.000007463404,0.00016041855,0.00030199112,0.00004655649,0.00003479669,0.000013004229,0.0000117473155,0.00009044633,0.00041912743],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008812197,0.0039938996,0.020308565,0.00022070632,0.0016675405,0.0026469398,0.00007587478,1.6920486e-8,0.0000696622,0.000015107595,0.9648443,0.0061485777],"study_design_scores_gemma":[0.008193401,0.0021876679,0.012363851,0.00013728399,0.002712919,0.00027154956,0.000004108387,4.39111e-7,0.010521065,0.00002026454,0.9634444,0.00014303258],"about_ca_topic_score_codex":0.0003087125,"about_ca_topic_score_gemma":0.0000011812286,"teacher_disagreement_score":0.051874377,"about_ca_system_score_codex":0.00009639383,"about_ca_system_score_gemma":0.00010604455,"threshold_uncertainty_score":0.6541679},"labels":[],"label_agreement":null},{"id":"W2067977262","doi":"10.1182/blood-2010-06-287243","title":"Human neutrophils interact with both 6-sulfo LacNAc+ DC and NK cells to amplify NK-derived IFNγ: role of CD18, ICAM-1, and ICAM-3","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Cell biology; Interleukin 12; Innate immune system; Biology; Cytokine; Interferon; Immune system; Immunology; Cytotoxic T cell; In vitro","score_opus":0.005244876392706821,"score_gpt":0.21030823108601054,"score_spread":0.20506335469330372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067977262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99579966,0.000399599,0.000017462171,0.00011346772,0.00062943535,0.00027749292,0.000009964853,0.000048950093,0.0027039398],"genre_scores_gemma":[0.9968477,0.00006316338,0.00012490018,0.00025351837,0.000050372695,0.000018767987,0.000036862806,0.00002418288,0.002580561],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99901307,0.000078738834,0.0002785411,0.00033937703,0.000035519493,0.00025477458],"domain_scores_gemma":[0.99935085,0.000066318404,0.00014973323,0.000312073,0.0000723827,0.000048654023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011343512,0.0002028996,0.00030714564,0.00012890922,0.00016318014,0.000032667398,0.00012253613,0.00021367779,0.00074209593],"category_scores_gemma":[0.000024581861,0.00016786203,0.000043629665,0.00007658889,0.00017631301,0.00012792757,0.00009468723,0.00048966834,0.000111760695],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020853856,0.00029341702,0.0023215916,0.000019831856,0.00018541311,0.0000020895238,0.0004630282,4.788164e-7,0.9946685,0.0002669457,0.0010489736,0.00052121904],"study_design_scores_gemma":[0.0023531995,0.0009579118,0.03201862,0.00004981586,0.00013964891,0.00014472399,0.00040384178,9.735987e-7,0.9299601,0.000038000562,0.033706803,0.00022641319],"about_ca_topic_score_codex":0.00020912958,"about_ca_topic_score_gemma":0.00010840698,"teacher_disagreement_score":0.06470843,"about_ca_system_score_codex":0.0000068371346,"about_ca_system_score_gemma":0.000017716598,"threshold_uncertainty_score":0.812543},"labels":[],"label_agreement":null},{"id":"W2068343048","doi":"10.1182/blood-2013-11-536433","title":"Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":617,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Concordance; Lymphoma; Diffuse large B-cell lymphoma; Gene expression profiling; Germinal center; Pathology; Cancer research; Medicine; Computational biology; Biology; Molecular biology; B cell; Gene expression; Gene; Immunology; Internal medicine; Antibody; Genetics","score_opus":0.025362049045606384,"score_gpt":0.3065655540313091,"score_spread":0.2812035049857027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068343048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99711525,0.00046919225,0.00070790655,0.000008383644,0.00007669683,0.00037457954,0.0000081165235,0.000028805702,0.0012110625],"genre_scores_gemma":[0.9890652,0.000056652596,0.010116849,0.000026200212,0.00011958447,0.000012488142,0.000016486276,0.00005033995,0.0005362013],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99811375,0.00013771575,0.0005536761,0.00029017834,0.00044432105,0.00046038465],"domain_scores_gemma":[0.99883837,0.0001816282,0.00022467076,0.0005211393,0.00009338899,0.00014083229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055097404,0.00019285113,0.000558424,0.00027180515,0.000042084732,0.0000106718835,0.00018647479,0.00016571776,0.00018000072],"category_scores_gemma":[0.00008235472,0.00017430392,0.00009902279,0.0002734518,0.00005626727,0.000080129816,0.00011511203,0.0001409885,0.000010044118],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025011614,0.003947221,0.035582077,0.0003124327,0.000017072365,0.00003751345,0.0009667765,0.0000125170955,0.9558092,0.0000075949415,0.000009089887,0.0030484023],"study_design_scores_gemma":[0.023478674,0.00044098852,0.00235774,0.00022035956,0.00007435823,0.000022827095,0.00011450331,0.0026086671,0.97002035,0.000017326945,0.0004886932,0.00015553788],"about_ca_topic_score_codex":0.000048558526,"about_ca_topic_score_gemma":0.000014801995,"teacher_disagreement_score":0.033224337,"about_ca_system_score_codex":0.000037054007,"about_ca_system_score_gemma":0.00013040102,"threshold_uncertainty_score":0.71079075},"labels":[],"label_agreement":null},{"id":"W2068475193","doi":"10.1182/blood-2014-10-601518","title":"Cautious enthusiasm about GWAS findings","year":2014,"lang":"en","type":"letter","venue":"Blood","topic":"Diabetes and associated disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Enthusiasm; Medicine; Genome-wide association study; Psychology; Biology; Genetics; Single-nucleotide polymorphism","score_opus":0.004816995666833173,"score_gpt":0.2037970801296787,"score_spread":0.19898008446284554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068475193","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.46304345,0.0103301555,0.00015202415,0.44551373,0.002101706,0.0010714794,0.00059304555,0.00023572688,0.07695867],"genre_scores_gemma":[0.12634777,0.0004789879,0.00009548146,0.8481573,0.0052620373,0.000064065745,0.0043991227,0.0001533897,0.015041855],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99852407,0.00005326623,0.00021155021,0.0005001774,0.00019686682,0.00051409664],"domain_scores_gemma":[0.9993144,0.000013033086,0.0001251239,0.00043892846,0.000055153992,0.000053305175],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000095327465,0.00031377157,0.00027875695,0.000050711882,0.00008243333,0.00006054841,0.00033604112,0.0011685101,0.000064261745],"category_scores_gemma":[0.00006369045,0.0003138142,0.00024841705,0.000057575213,0.00006321989,0.0000012225582,0.000104163795,0.00050404924,0.00012715394],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000017901586,0.00007046933,0.0005474232,0.000049949194,0.00026885103,0.00002785718,0.000014993809,0.0000011927679,0.0043832245,0.000005993948,0.99447846,0.00014981983],"study_design_scores_gemma":[0.0008966231,0.00012604849,0.00015235087,0.000037368183,0.00017892047,0.000009617528,0.0000039807373,0.0000013155853,0.0073464923,0.000031678977,0.9908019,0.00041372812],"about_ca_topic_score_codex":0.000021722735,"about_ca_topic_score_gemma":0.00001145216,"teacher_disagreement_score":0.40264356,"about_ca_system_score_codex":0.000008917019,"about_ca_system_score_gemma":0.00006494772,"threshold_uncertainty_score":0.9999314},"labels":[],"label_agreement":null},{"id":"W2068531455","doi":"10.1182/blood-2012-10-462085","title":"Alloantibodies in von Willebrand disease","year":2013,"lang":"en","type":"review","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research","keywords":"Von Willebrand disease; Von Willebrand factor; Medicine; Complication; Immunology; Coagulopathy; Disease; Internal medicine; Platelet","score_opus":0.0302768097092774,"score_gpt":0.3142282495574759,"score_spread":0.28395143984819854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068531455","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002319852,0.9939488,1.1924197e-7,0.00003313342,0.00005608118,0.0010181931,0.000038159265,0.000029738116,0.0025559168],"genre_scores_gemma":[0.00013802316,0.9974443,0.000048609567,0.00003563895,0.00005640014,0.00015609867,0.00035278895,0.00003902166,0.0017291668],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990418,0.000030438481,0.00028534382,0.0002822752,0.00013321516,0.00022693147],"domain_scores_gemma":[0.99942917,0.000035332112,0.000083980914,0.00027569523,0.000014590138,0.00016122306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000033589455,0.00029027442,0.0013754206,0.00015180925,0.000021382222,0.00001617222,0.00006785183,0.00013295219,0.00014711704],"category_scores_gemma":[0.000037254515,0.0001919662,0.00028592013,0.000120877965,0.000027692071,0.000038718754,0.000033014483,0.00016837269,0.0004350034],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014522756,0.0021302148,0.0038413883,0.02371623,0.0008973441,0.005086351,0.000025306032,1.6640007e-8,1.8109465e-7,0.000029200262,0.0010943586,0.96316487],"study_design_scores_gemma":[0.0023806058,0.0000580153,0.0004255291,0.013465519,0.0036416142,0.00011882027,0.0000030731517,3.4492484e-7,3.4781922e-7,0.000052844163,0.97965276,0.00020051276],"about_ca_topic_score_codex":0.000025980296,"about_ca_topic_score_gemma":0.0000073630667,"teacher_disagreement_score":0.9785584,"about_ca_system_score_codex":0.000020178953,"about_ca_system_score_gemma":0.00014842501,"threshold_uncertainty_score":0.78281546},"labels":[],"label_agreement":null},{"id":"W2068558726","doi":"10.1182/blood.v99.6.2138","title":"A novel costimulatory signaling in human T lymphocytes by a splice variant of CD28","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Connaught Fund","keywords":"CD28; Gene isoform; Transmembrane domain; Molecular biology; Transmembrane protein; Biology; splice; Alternative splicing; Tyrosine kinase; Signal transduction; T cell; Jurkat cells; Exon; Cell biology; Receptor; Gene; Biochemistry; Immunology; Immune system","score_opus":0.014746158033687406,"score_gpt":0.21161705377365725,"score_spread":0.19687089573996985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068558726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98453814,0.013099307,0.00006281882,0.000033593333,0.00014744069,0.0001525644,0.00003310124,0.000046721438,0.0018863428],"genre_scores_gemma":[0.99809325,0.00008346098,0.00009918142,0.000102999315,0.00001583937,0.000014369365,0.00003522005,0.000018043045,0.0015376252],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99884945,0.00008796868,0.00038846847,0.0002859136,0.000028151428,0.00036004226],"domain_scores_gemma":[0.9993996,0.00013793354,0.00013883528,0.0002727436,0.000034890727,0.00001596465],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014412953,0.00017336238,0.00034378062,0.00012302968,0.00009366649,0.0000041737553,0.0002507693,0.00030363415,0.0009912007],"category_scores_gemma":[0.00003064221,0.00016694966,0.00007564124,0.00015076423,0.00019211943,0.000047580725,0.00007936822,0.00022501909,0.00020542652],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026537806,0.001974558,0.0010044978,0.000018679511,0.00015239732,0.000015137053,0.00041569045,0.00001325356,0.995244,0.00025132854,0.00067909394,0.00020480856],"study_design_scores_gemma":[0.0082419,0.0002458316,0.0002107084,0.00005030381,0.000075456395,0.0001640184,0.00010494242,0.000010711102,0.986814,0.000051394636,0.0038268412,0.00020384054],"about_ca_topic_score_codex":0.00039072693,"about_ca_topic_score_gemma":0.000020444231,"teacher_disagreement_score":0.013555151,"about_ca_system_score_codex":0.000025202316,"about_ca_system_score_gemma":0.000021805205,"threshold_uncertainty_score":0.99992204},"labels":[],"label_agreement":null},{"id":"W2068655274","doi":"10.1182/blood-2010-07-295758","title":"Patient-derived C-terminal mutation of FANCI causes protein mislocalization and reveals putative EDGE motif function in DNA repair","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of General Medical Sciences; National Cancer Institute; National Institutes of Health; School of Medicine, New York University; York University","keywords":"Biology; DNA repair; FANCD2; Ubiquitin ligase; Cell biology; DNA damage; Genetics; Ubiquitin; Fanconi anemia; DNA; Gene","score_opus":0.005586399444372255,"score_gpt":0.21900542609188206,"score_spread":0.2134190266475098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068655274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983327,0.00006744244,0.0010163919,0.00000934434,0.00007131144,0.0004152457,0.000013218024,0.000019956977,0.000054436423],"genre_scores_gemma":[0.99793005,0.00000490078,0.0018067746,0.000026299345,0.000040094554,0.000057994992,0.00008139794,0.000014556038,0.000037907088],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992595,0.00006666556,0.00021758421,0.00025032015,0.0000924959,0.00011343626],"domain_scores_gemma":[0.9995647,0.0000069550806,0.00013293646,0.00015903033,0.00009988335,0.000036479298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012254206,0.0001003481,0.00010852453,0.00005196324,0.000026757138,0.0000074841328,0.000034908895,0.0001347705,0.000006377715],"category_scores_gemma":[0.0001793479,0.00010250868,0.000035553887,0.00007527055,0.000047576326,0.000008770103,0.000037062833,0.00006335085,0.0000010720926],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058498405,0.00015609433,0.003393365,0.000048583275,0.000022356631,0.000006805769,0.00021259754,0.0000067002334,0.9948014,0.00007023882,0.0000075574276,0.0012157781],"study_design_scores_gemma":[0.0008121511,0.00061930885,0.00920168,0.000025458981,0.000030554096,0.000023798366,0.00012320101,0.00010356064,0.98848575,0.0004187872,0.000052063155,0.00010365586],"about_ca_topic_score_codex":0.00001798257,"about_ca_topic_score_gemma":0.000066118824,"teacher_disagreement_score":0.0063156444,"about_ca_system_score_codex":0.000003972072,"about_ca_system_score_gemma":0.000034179422,"threshold_uncertainty_score":0.41801828},"labels":[],"label_agreement":null},{"id":"W2068688235","doi":"10.1182/blood-2003-12-4260","title":"Puromycin-insensitive leucyl-specific aminopeptidase (PILSAP) binds and catalyzes PDK1, allowing VEGF-stimulated activation of S6K for endothelial cell proliferation and angiogenesis","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"","keywords":"Angiogenesis; P70-S6 Kinase 1; Biology; Protein kinase B; Cell biology; Kinase; PI3K/AKT/mTOR pathway; Molecular biology; Phosphatidylinositol; Phosphorylation; Signal transduction; Biochemistry; Chemistry; Cancer research","score_opus":0.013699433918189433,"score_gpt":0.23385032510637607,"score_spread":0.22015089118818665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068688235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99754274,0.00012798555,0.0012379297,0.00029005576,0.000011462324,0.00050250185,0.00008520885,0.00004288387,0.00015920948],"genre_scores_gemma":[0.997643,0.000042090076,0.0016249163,0.00011817868,0.00013142587,0.000025174133,0.0002826429,0.000023823339,0.000108736596],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990237,0.000026788071,0.00028992764,0.00030774795,0.00017915778,0.00017270549],"domain_scores_gemma":[0.9993773,0.00006593029,0.00012227285,0.0001455245,0.0001772223,0.000111732305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012410729,0.00016808808,0.00030769198,0.00024796405,0.000114028204,0.000029925852,0.00002366004,0.00009889146,0.00001323319],"category_scores_gemma":[0.000056973287,0.00015614011,0.00010791443,0.00021555011,0.00007150786,0.00014859214,0.000018450346,0.00006403969,0.0000026310552],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023166303,0.0004871312,0.0018921816,0.00014129441,0.00013085434,0.000019711104,0.0006612146,0.000047641413,0.9949736,0.000065439526,0.000023053597,0.0013262348],"study_design_scores_gemma":[0.0088653695,0.00037763297,0.009946812,0.00026545557,0.0003626279,0.000040112598,0.00020205078,0.0003098556,0.9793573,0.00004394975,0.00006829963,0.00016054492],"about_ca_topic_score_codex":0.000066361434,"about_ca_topic_score_gemma":0.000011653846,"teacher_disagreement_score":0.015616291,"about_ca_system_score_codex":0.000029901074,"about_ca_system_score_gemma":0.00006028069,"threshold_uncertainty_score":0.63672096},"labels":[],"label_agreement":null},{"id":"W2068693591","doi":"10.1182/blood-2012-04-421057","title":"Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":208,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Sunnybrook Hospital; BC Cancer Agency","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Tissue microarray; Medicine; CD68; Internal medicine; Oncology; CD163; Immunohistochemistry; Proportional hazards model; Cohort; Pathology; Biology; Macrophage","score_opus":0.019099619487802047,"score_gpt":0.27656627245462784,"score_spread":0.2574666529668258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068693591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99531084,0.00088625157,0.0000014866118,0.00033092548,0.0006879414,0.002163856,0.000090641406,0.00008522773,0.00044279936],"genre_scores_gemma":[0.99841106,0.000020441486,0.00003469214,0.0003558817,0.00030798576,0.00057821,0.000051628802,0.000033602533,0.00020651743],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979932,0.00033179246,0.0005047584,0.0003163435,0.00040399784,0.0004499277],"domain_scores_gemma":[0.99829197,0.0008833227,0.00020449351,0.00041785403,0.000043734362,0.0001586288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036741226,0.00030828814,0.000694106,0.000080636484,0.00009640963,0.000042464824,0.00015685082,0.000102996964,0.00011826981],"category_scores_gemma":[0.0005647999,0.00017966129,0.0001983712,0.0002503726,0.00007094938,0.00012973853,0.00013128718,0.00014846971,0.00010362563],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020403313,0.03167978,0.9590448,0.000003133718,0.0012204053,0.00023415721,0.003978279,1.8787962e-7,0.000022750059,0.000016803513,0.0003423822,0.0014169652],"study_design_scores_gemma":[0.17906433,0.0018067373,0.816088,0.0000852532,0.0010434759,0.000010318096,0.0014169003,0.000009802695,0.00022620446,0.000018035056,0.000095343756,0.00013559066],"about_ca_topic_score_codex":0.0014309804,"about_ca_topic_score_gemma":0.00050838344,"teacher_disagreement_score":0.177024,"about_ca_system_score_codex":0.00031102847,"about_ca_system_score_gemma":0.00012293068,"threshold_uncertainty_score":0.73263747},"labels":[],"label_agreement":null},{"id":"W2069332674","doi":"10.1182/blood-2014-12-570200","title":"Hematopoietic stem cells: concepts, definitions, and the new reality","year":2015,"lang":"en","type":"review","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":538,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Stem cell; Haematopoiesis; Biology; Cell biology","score_opus":0.1090314005075445,"score_gpt":0.3439442648283102,"score_spread":0.2349128643207657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069332674","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000067944084,0.98995644,0.00011671601,0.00025065002,0.00014852216,0.0017286487,0.00008279437,0.000087059416,0.007622369],"genre_scores_gemma":[0.000038377748,0.9979846,0.0003416099,0.0001002819,0.00022795929,0.00011587583,0.00014670327,0.00005970386,0.0009848727],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977908,0.00037652865,0.0007619309,0.00040634105,0.0004105302,0.00025385545],"domain_scores_gemma":[0.9980619,0.00061625976,0.00029482556,0.00064507074,0.00007814286,0.000303823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007881395,0.00038169848,0.0019120222,0.00007421347,0.00007314565,0.000043263415,0.00015500058,0.0003297575,0.00006415714],"category_scores_gemma":[0.000028637194,0.0002288471,0.00031618078,0.00021705746,0.00023103443,0.00003138404,0.000038891638,0.00040220396,0.0002267392],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014196515,0.0008410042,0.000014962473,0.23004746,0.002263806,0.00062503206,0.0047200383,1.310135e-7,0.0000035213184,0.035956327,0.034818254,0.6905675],"study_design_scores_gemma":[0.005916228,0.000062903375,6.538722e-7,0.014715214,0.011611264,0.0033794711,0.00015841273,6.580298e-7,0.00003870947,0.0005987355,0.9632493,0.00026844026],"about_ca_topic_score_codex":0.000032001237,"about_ca_topic_score_gemma":0.0000032564512,"teacher_disagreement_score":0.92843103,"about_ca_system_score_codex":0.00003807162,"about_ca_system_score_gemma":0.0008337535,"threshold_uncertainty_score":0.9332114},"labels":[],"label_agreement":null},{"id":"W2069457631","doi":"10.1182/blood-2009-06-227603","title":"Modeling the functional heterogeneity of leukemia stem cells: role of STAT5 in leukemia stem cell self-renewal","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"China Scholarship Council","keywords":"Leukemia; Cancer research; Stem cell; Myeloid leukemia; Oncogene; Biology; Myeloid; STAT5; Cancer stem cell; Immunology; Cancer; Signal transduction; Cell cycle; Cell biology; Genetics","score_opus":0.02054020114975398,"score_gpt":0.24900982127370838,"score_spread":0.2284696201239544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069457631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958457,0.0013263153,0.0002041595,0.00007544036,0.000051400806,0.0005295659,0.000030908333,0.000053914613,0.001882603],"genre_scores_gemma":[0.9986047,0.00017876725,0.0006550589,0.00010673034,0.00013272882,0.000017850924,0.000014506766,0.000032846656,0.00025678638],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974003,0.0001619044,0.000717639,0.00040659495,0.0008183285,0.00049525395],"domain_scores_gemma":[0.9986349,0.00013729562,0.00016956724,0.00065783976,0.00023767586,0.00016274718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006764944,0.00025110872,0.0005308204,0.00021710811,0.00006541225,0.000013229879,0.00032343104,0.00020556197,0.000027714696],"category_scores_gemma":[0.000009555735,0.00019080732,0.00019147675,0.00044016604,0.00007386172,0.00009345751,0.00011025765,0.00056098687,0.000017506643],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011861378,0.0018096761,0.019636644,0.0005305209,0.00040625816,0.00009674298,0.0023713624,0.062495068,0.9037578,0.00026444203,0.0003713198,0.007074025],"study_design_scores_gemma":[0.007931266,0.00072920445,0.0037654913,0.00013394076,0.00026715716,0.000056590638,0.0014766003,0.08667462,0.898435,0.00014044743,0.00015309264,0.00023661602],"about_ca_topic_score_codex":0.00039893712,"about_ca_topic_score_gemma":0.000060503702,"teacher_disagreement_score":0.024179557,"about_ca_system_score_codex":0.00078401074,"about_ca_system_score_gemma":0.0017054033,"threshold_uncertainty_score":0.77808964},"labels":[],"label_agreement":null},{"id":"W2069648201","doi":"10.1182/blood-2008-05-154849","title":"Lnk adaptor protein down-regulates specific Kit-induced signaling pathways in primary mast cells","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"Institut National de la Santé et de la Recherche Médicale","keywords":"Stem cell factor; Cell biology; Signal transducing adaptor protein; Signal transduction; Haematopoiesis; Progenitor cell; Biology; MAPK/ERK pathway; Tyrosine phosphorylation; Mast cell; Tyrosine kinase; Phosphorylation; Proto-oncogene tyrosine-protein kinase Src; Stem cell; Chemistry; Immunology","score_opus":0.017570305440278537,"score_gpt":0.17531447738934897,"score_spread":0.15774417194907042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069648201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99161553,0.002312965,0.000009505006,0.000041011263,0.00023596076,0.00044408216,0.000038239043,0.000079841135,0.005222869],"genre_scores_gemma":[0.99508977,0.00006782277,0.0004849521,0.00004787518,0.00009125688,0.000041098974,0.00010153027,0.000029894247,0.0040457714],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985765,0.000107859,0.00039113808,0.00040111202,0.000053295,0.00047006714],"domain_scores_gemma":[0.9994383,0.000046699406,0.00011675656,0.00032545565,0.000038203794,0.00003459744],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016576693,0.00023614921,0.0003653023,0.00014146429,0.00017658428,0.000011917233,0.00022310804,0.00026768018,0.0009405665],"category_scores_gemma":[0.0000079287065,0.00021895292,0.0000918432,0.00016362373,0.00012707913,0.0000658845,0.00007980463,0.00033104728,0.0005687474],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007373142,0.0006876661,0.0003773127,0.00003863729,0.00004199232,0.0001116382,0.00048089854,0.0000026962023,0.99691904,0.00019113833,0.00044569318,0.00062953174],"study_design_scores_gemma":[0.0029803847,0.00018978081,0.004087412,0.00006552478,0.000016735603,0.000074378186,0.00008760196,7.738819e-7,0.97469807,0.000034018616,0.017485594,0.0002797162],"about_ca_topic_score_codex":0.00007636061,"about_ca_topic_score_gemma":0.000017532391,"teacher_disagreement_score":0.022220986,"about_ca_system_score_codex":0.000035561636,"about_ca_system_score_gemma":0.00008273759,"threshold_uncertainty_score":0.9999727},"labels":[],"label_agreement":null},{"id":"W2069674599","doi":"10.1182/blood-2008-04-151597","title":"Anti-CD3 prevents factor VIII inhibitor development in hemophilia A mice by a regulatory CD4+CD25+-dependent mechanism and by shifting cytokine production to favor a Th1 response","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"FOXP3; IL-2 receptor; Cytokine; Immunology; CD3; Immune system; Spleen; Immune tolerance; Biology; Antibody; Splenocyte; Interleukin 10; Molecular biology; T cell; CD8","score_opus":0.01130936260169654,"score_gpt":0.2283674368766816,"score_spread":0.21705807427498505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069674599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973603,0.00051221094,0.000017956141,0.00066792377,0.00009869765,0.0012008058,0.000054098924,0.00006742464,0.000020618541],"genre_scores_gemma":[0.9962831,0.000075551055,0.0010995523,0.00018990452,0.00004443385,0.000107696826,0.000052171486,0.000042476753,0.0021051234],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998111,0.000083653584,0.0003975166,0.0006081061,0.00041086346,0.00038882444],"domain_scores_gemma":[0.999378,0.000029828787,0.000104197694,0.00022557621,0.000045494762,0.00021687442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026299918,0.00028038386,0.0004374923,0.00018566365,0.00015289898,0.000015065809,0.000070803915,0.00012928498,0.000012453446],"category_scores_gemma":[0.00014354476,0.00023705419,0.00004030779,0.00023166687,0.00002766226,0.00011718212,0.00008092605,0.0001644348,0.000027234448],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012124403,0.0032470988,0.018038893,0.00009614899,0.00021058787,0.00068606925,0.0034361528,5.347671e-7,0.9703324,0.0000021936066,0.0011256805,0.001611803],"study_design_scores_gemma":[0.008961136,0.00047820513,0.06311422,0.00033178064,0.00009479633,0.0006867822,0.00015309024,0.000003962663,0.9240489,0.000031991676,0.0017277419,0.00036737198],"about_ca_topic_score_codex":0.000053087526,"about_ca_topic_score_gemma":0.000027269007,"teacher_disagreement_score":0.046283472,"about_ca_system_score_codex":0.00014135426,"about_ca_system_score_gemma":0.00016156853,"threshold_uncertainty_score":0.966679},"labels":[],"label_agreement":null},{"id":"W2069827448","doi":"10.1182/blood-2004-04-1363","title":"p53 gene deletion detected by fluorescence in situ hybridization is an adverse prognostic factor for patients with multiple myeloma following autologous stem cell transplantation","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":202,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Multiple myeloma; Fluorescence in situ hybridization; Autologous stem-cell transplantation; Transplantation; Biology; Internal medicine; Beta-2 microglobulin; Chemotherapy; Stem cell; Oncology; Cancer research; Pathology; Immunology; Medicine; Gastroenterology; Gene","score_opus":0.011639351976677976,"score_gpt":0.23818833088007194,"score_spread":0.22654897890339395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069827448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940432,0.000043204316,0.003163438,0.0000203458,0.000029416675,0.002353738,0.00025685268,0.00008341248,0.0000064482074],"genre_scores_gemma":[0.9914687,0.000018428775,0.0067355293,0.000016590344,0.000015939413,0.00020222906,0.0014949623,0.00003459068,0.00001302129],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863863,0.000043853808,0.00023729562,0.00037650767,0.00034641815,0.00035731256],"domain_scores_gemma":[0.9993902,0.00006438704,0.000077890036,0.00016518153,0.00012962817,0.00017270354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000047455724,0.00018756719,0.00020775832,0.00013321938,0.00009632645,0.000015834774,0.00006262548,0.00008757815,0.0000041453004],"category_scores_gemma":[0.000043956537,0.00015856355,0.000058029527,0.0002053097,0.000020997079,0.00021425022,0.0000063658035,0.00009053889,0.000007161948],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001185894,0.00272701,0.827612,0.00019649278,0.0000902558,0.00015667359,0.0009578956,0.000035899797,0.15898466,3.6145155e-7,0.0000016271758,0.008051255],"study_design_scores_gemma":[0.023071384,0.0015097267,0.6343979,0.000104268336,0.00014742935,0.0000080990285,0.000035039917,0.00029514224,0.34030494,0.0000018193264,0.0000021670148,0.000122057994],"about_ca_topic_score_codex":0.000085111096,"about_ca_topic_score_gemma":0.00014763084,"teacher_disagreement_score":0.19321404,"about_ca_system_score_codex":0.000113011156,"about_ca_system_score_gemma":0.00010846826,"threshold_uncertainty_score":0.6466034},"labels":[],"label_agreement":null},{"id":"W2069937776","doi":"10.1182/blood-2011-08-339465","title":"Novel treatment concepts for graft-versus-host disease","year":2011,"lang":"en","type":"review","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Deutsche Krebshilfe; University of British Columbia; Deutsche Forschungsgemeinschaft","keywords":"Graft-versus-host disease; Medicine; Clinical trial; Disease; Refractory (planetary science); Intensive care medicine; Transplantation; Immune system; Immunology; Randomized controlled trial; Internal medicine; Biology","score_opus":0.1223066445191159,"score_gpt":0.37717622570490106,"score_spread":0.2548695811857852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069937776","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000015678443,0.9928859,0.0004083961,0.000013434145,0.00039427806,0.0033509291,0.0007392843,0.00008201452,0.0021101227],"genre_scores_gemma":[0.000022614848,0.99413687,0.0017504033,0.000020643225,0.0003379681,0.0010360547,0.0012336689,0.00009411893,0.0013676649],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99864054,0.000027990995,0.00045715566,0.00043991746,0.00015155155,0.00028281883],"domain_scores_gemma":[0.99867475,0.00028374512,0.00018167795,0.00046620006,0.000057987203,0.00033562107],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000071472525,0.00041880505,0.0013053775,0.00009702843,0.00004592803,0.000011089432,0.000098776676,0.00020763844,0.0001466739],"category_scores_gemma":[0.000043525262,0.0003045466,0.00071201,0.000098985256,0.00004804827,0.000024907838,0.000009175677,0.00008849747,0.00017458713],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010452738,0.008054261,0.00006838312,0.21511027,0.006030111,0.00043194008,0.0008083568,3.618196e-8,0.0000310403,0.0035898476,0.000440652,0.7643898],"study_design_scores_gemma":[0.010649218,0.00059894106,0.000019787285,0.01140194,0.027337348,0.00010290198,0.0000112505795,4.7621634e-7,0.0000425861,0.0000043544537,0.94954264,0.00028855767],"about_ca_topic_score_codex":0.000013943339,"about_ca_topic_score_gemma":0.0000043277346,"teacher_disagreement_score":0.949102,"about_ca_system_score_codex":0.0000844649,"about_ca_system_score_gemma":0.0005335596,"threshold_uncertainty_score":0.9999407},"labels":[],"label_agreement":null},{"id":"W2070177642","doi":"10.1182/blood-2008-10-184556","title":"CEACAM1+ myeloid cells control angiogenesis in inflammation","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Angiogenesis; Inflammation; Myeloid; Cancer research; Medicine; Neovascularization; Immunology; Biology","score_opus":0.005023158556730383,"score_gpt":0.21553328635867885,"score_spread":0.21051012780194847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070177642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960063,0.0019461202,0.00045604235,0.00018978406,0.00006074813,0.00013698637,0.000011120296,0.000011027514,0.0011818581],"genre_scores_gemma":[0.99843997,0.00024315852,0.00026847218,0.00040303636,0.00039035914,0.000014686155,0.000029399973,0.000010485243,0.00020043008],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99932003,0.00003037373,0.00016669069,0.00021457487,0.000080265854,0.00018805533],"domain_scores_gemma":[0.99966776,0.0000048340985,0.000049964183,0.00019874435,0.00003427463,0.000044429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010610944,0.000107184525,0.00011014621,0.000043674114,0.000029468936,0.000012851727,0.000106031104,0.000121107456,0.000020581601],"category_scores_gemma":[0.000012122251,0.000104340295,0.00009519798,0.00008440076,0.000015717076,0.0000030814285,0.000012841098,0.000027529435,0.000016947322],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003146925,0.00008826221,0.0080215875,0.0000035828373,0.000023473533,0.000004184608,0.000015015993,0.00009409295,0.9857899,0.000039015427,0.0004096667,0.0054797553],"study_design_scores_gemma":[0.0016351481,0.00016485543,0.045859724,0.000008167495,0.00003240938,0.0000051807983,0.000012527242,0.000021735048,0.94225633,0.00004114965,0.0097996285,0.00016316859],"about_ca_topic_score_codex":0.000010732815,"about_ca_topic_score_gemma":0.00002301463,"teacher_disagreement_score":0.04353359,"about_ca_system_score_codex":0.000007131939,"about_ca_system_score_gemma":0.000032915694,"threshold_uncertainty_score":0.42548737},"labels":[],"label_agreement":null},{"id":"W2070285748","doi":"10.1182/blood-2012-05-427989","title":"PRRC2A and BCL2L11 gene variants influence risk of non-Hodgkin lymphoma: results from the InterLymph consortium","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"National Institute of Environmental Health Sciences; Canadian Institutes of Health Research; National Institutes of Health; National Cancer Institute; José Carreras Leukämie-Stiftung; Bundesministerium für Bildung und Forschung","keywords":"Lymphoma; Genotyping; Odds ratio; Biology; Immunology; B cell; Allele; Oncology; Single-nucleotide polymorphism; Genotype; Genetics; Internal medicine; Gene; Medicine; Antibody","score_opus":0.01033931200351582,"score_gpt":0.24070536401281206,"score_spread":0.23036605200929625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070285748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954674,0.0025086144,0.000008924442,0.000286136,0.00012310134,0.00035152485,0.0003546981,0.000023529505,0.00087602844],"genre_scores_gemma":[0.99772495,0.0006046725,0.0010396228,0.0003041508,0.00018933191,0.000036950372,0.000037460817,0.000016679349,0.000046165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881357,0.000069611895,0.00038046393,0.00025321485,0.0002114965,0.0002716208],"domain_scores_gemma":[0.9985435,0.00045927882,0.00022685499,0.0005287472,0.000073339754,0.00016826572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026785437,0.00017610523,0.00031908596,0.000033487147,0.000073467716,0.000017361539,0.000103299055,0.000089751586,0.000020422684],"category_scores_gemma":[0.00031890947,0.00010701916,0.00007576747,0.000105639,0.00013057173,0.00010188029,0.00008816788,0.000046203455,0.000037185557],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032349926,0.0025040307,0.97909427,0.000015946272,0.0006896824,0.00004343883,0.0024415455,7.679553e-7,0.004750575,0.000043777018,0.00035332725,0.009739134],"study_design_scores_gemma":[0.015179663,0.00024587856,0.9359749,0.00012691373,0.0010318045,0.000089880654,0.00011334872,0.000018023013,0.046497446,0.000029172657,0.00059165445,0.00010129532],"about_ca_topic_score_codex":0.0025090347,"about_ca_topic_score_gemma":0.000022724438,"teacher_disagreement_score":0.043119356,"about_ca_system_score_codex":0.000035271656,"about_ca_system_score_gemma":0.000087547494,"threshold_uncertainty_score":0.43641147},"labels":[],"label_agreement":null},{"id":"W2070330288","doi":"10.1182/blood-2010-01-266320","title":"A CK2-dependent mechanism for activation of the JAK-STAT signaling pathway","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Army Research Office; National Center for Complementary and Integrative Health; Mayo Clinic; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Tampereen Yliopisto; National Center for Research Resources; National Institute of Neurological Disorders and Stroke; National Institute of General Medical Sciences; National Cancer Institute; Canadian Cancer Society Research Institute; National Institutes of Health; Peking University; National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"JAK-STAT signaling pathway; Suppressor of cytokine signaling 1; Janus kinase; stat; SOCS3; Cancer research; Tyrosine kinase 2; Signal transduction; Cytokine; Janus kinase 2; Myeloproliferative Disorders; Tyrosine kinase; Biology; Janus kinase 1; Cell biology; Polycythemia vera; Autophosphorylation; Phosphorylation; Immunology; STAT3; Platelet-derived growth factor receptor; Suppressor; Receptor; Protein kinase A; Growth factor; Biochemistry; Gene","score_opus":0.04027488913000221,"score_gpt":0.24918625933252792,"score_spread":0.2089113702025257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070330288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99597466,0.000031356147,0.0012191829,0.00023254889,0.00007620724,0.0008828908,0.00002437036,0.000018102759,0.0015407059],"genre_scores_gemma":[0.99679154,0.000009476327,0.0024872147,0.00021392992,0.00005840224,0.00021326417,0.000008136555,0.000014894696,0.00020311262],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993602,0.000023203103,0.00017279525,0.00015051989,0.00017011895,0.00012315389],"domain_scores_gemma":[0.9994616,0.000068481335,0.00010408589,0.00018613914,0.00013669857,0.000042991345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009297724,0.00009753052,0.0001705035,0.000030516743,0.00006360371,0.000004405128,0.000051615032,0.00004935132,0.000088865665],"category_scores_gemma":[0.000079025056,0.00005858443,0.00010228432,0.000056112378,0.000015222203,0.00003163995,0.000021047743,0.000052021584,0.000004477943],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066019007,0.009895261,0.11022976,0.00044632165,0.0015601142,0.000029834748,0.008434009,0.000005310858,0.6888321,0.17516382,0.0002417615,0.0045015193],"study_design_scores_gemma":[0.0030852896,0.0005025799,0.0053932974,0.00011121155,0.00022541793,0.000009008832,0.00015611276,0.000016814598,0.9871997,0.0031779076,0.00006563158,0.000056983168],"about_ca_topic_score_codex":0.00003077132,"about_ca_topic_score_gemma":0.000010808577,"teacher_disagreement_score":0.29836765,"about_ca_system_score_codex":0.000019495641,"about_ca_system_score_gemma":0.0000662344,"threshold_uncertainty_score":0.23890036},"labels":[],"label_agreement":null},{"id":"W2070414796","doi":"10.1182/blood-2014-05-576041","title":"Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":280,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; BC Children's Hospital; University of British Columbia; Princess Margaret Cancer Centre","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; Office of Naval Research; National Heart, Lung, and Blood Institute; Genentech; Health Resources and Services Administration; National Institutes of Health; Medac; Swedish Orphan Biovitrum; Otsuka America; Incyte; Allos Therapeutics; Ariad Pharmaceuticals; Actinium Pharmaceuticals; Blue Cross and Blue Shield Association; Kiadis Pharma; Therakos; Sigma-Tau Pharmaceuticals; Chimerix; Medical College of Wisconsin; Tarix Pharmaceuticals; StemCyte; Takeda Oncology; University of Minnesota; Teva Pharmaceutical Industries; HistoGenetics; WellPoint; U.S. Navy; Osiris Therapeutics; Celgene; Amgen; Onyx Pharmaceuticals; U.S. Department of Defense; Sanofi; Leukemia and Lymphoma Society; Be The Match Foundation; U.S. Department of Health and Human Services; GlaxoSmithKline","keywords":"Human leukocyte antigen; Immunology; Leukemia; Transplantation; Chronic myelogenous leukemia; Hematopoietic stem cell transplantation; Medicine; Histocompatibility; Acute lymphocytic leukemia; Bone marrow; Internal medicine; Antigen; Lymphoblastic Leukemia","score_opus":0.01122745418755452,"score_gpt":0.24762555429870997,"score_spread":0.23639810011115545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070414796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98669815,0.00030209078,0.0029632698,0.00014740291,0.000089952766,0.0007637243,0.00006326769,0.0001871204,0.008785015],"genre_scores_gemma":[0.9969333,0.0001883456,0.0014701874,0.00036496835,0.00011527924,0.000121186284,0.00032029944,0.00006348917,0.0004229554],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976892,0.00022188529,0.0006016922,0.00054323056,0.0005202186,0.000423783],"domain_scores_gemma":[0.9985907,0.00029042384,0.00016655793,0.00046320364,0.00016414338,0.0003249899],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032963188,0.0003632393,0.0005378015,0.0001418089,0.00009386925,0.000028211338,0.00011716177,0.00027127477,0.0005120328],"category_scores_gemma":[0.000051556006,0.00033012268,0.0001873052,0.0002821578,0.00010478105,0.00012418433,0.000012647687,0.00024477733,0.00027557372],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010905864,0.0040444965,0.8069792,0.0060813706,0.0009526845,0.0019016952,0.0110444175,0.00006407636,0.16676293,0.00041902348,0.00013592036,0.00052362314],"study_design_scores_gemma":[0.009428063,0.0004243562,0.58292603,0.0008036489,0.0036198103,0.0010926601,0.00031355157,0.00016415477,0.40002516,0.0004511573,0.00015446525,0.000596914],"about_ca_topic_score_codex":0.00015436404,"about_ca_topic_score_gemma":0.00003255099,"teacher_disagreement_score":0.23326223,"about_ca_system_score_codex":0.00003457977,"about_ca_system_score_gemma":0.000116773896,"threshold_uncertainty_score":0.99991506},"labels":[],"label_agreement":null},{"id":"W2070479212","doi":"10.1182/blood.v99.9.3360","title":"Identification of an HLA  A*0201–restricted CD8+T-cell epitope for the glycoprotein B homolog of human herpesvirus 8","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research & Development Corporation","funders":"Graduate School of Public Health, University of Pittsburgh; National Institutes of Health; National Cancer Institute; University of Pittsburgh","keywords":"Epitope; Virology; Human leukocyte antigen; Biology; Identification (biology); CD8; Cytotoxic T cell; Glycoprotein; HLA-B Antigens; HLA-B; Human herpesvirus; Molecular biology; Virus; Immunology; Genetics; Antibody; Antigen","score_opus":0.01829640472899737,"score_gpt":0.2624625697773446,"score_spread":0.24416616504834723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070479212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953544,0.0024488966,0.00008470211,0.0002967608,0.00006330299,0.00077707024,0.000037861984,0.000027613489,0.0009093694],"genre_scores_gemma":[0.99867076,0.000187395,0.000110849855,0.00006630802,0.00006651014,0.00007758282,0.00002258252,0.000018030747,0.0007799652],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991115,0.000035284298,0.0003488471,0.00016749387,0.00017968586,0.00015721734],"domain_scores_gemma":[0.99913144,0.000046157467,0.00028329197,0.00036588285,0.00012785371,0.000045359397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014897663,0.00009309053,0.00022286699,0.000057657635,0.00008514851,0.000007997825,0.00014260302,0.00010364536,0.00010563313],"category_scores_gemma":[0.00008800225,0.00007058096,0.000104290586,0.00020533081,0.000082551844,0.000048713006,0.000013103648,0.00008934121,0.0000065029367],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015711646,0.0032492261,0.002485705,0.00022544693,0.000213845,0.000005543188,0.0008138145,0.000021424066,0.97314286,0.00029681972,0.0022763591,0.017111821],"study_design_scores_gemma":[0.017922154,0.0027981722,0.017809588,0.000073887815,0.0011640902,0.000007793405,0.0009545907,0.00092845375,0.95539355,0.0011381375,0.0015591045,0.00025045898],"about_ca_topic_score_codex":0.0003083292,"about_ca_topic_score_gemma":0.000043535023,"teacher_disagreement_score":0.017765038,"about_ca_system_score_codex":0.000017091972,"about_ca_system_score_gemma":0.00002844473,"threshold_uncertainty_score":0.2878208},"labels":[],"label_agreement":null},{"id":"W2070677464","doi":"10.1182/blood-2009-03-212746","title":"An upstream insulator regulates DLK1 imprinting in AML","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Genetic Syndromes and Imprinting","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Genomic imprinting; Biology; Methylation; Imprinting (psychology); Molecular biology; Allele; Epigenetics; DNA methylation; Myeloid leukemia; Uniparental disomy; Cancer research; Genetics; Gene; Gene expression; Chromosome","score_opus":0.004282711526569268,"score_gpt":0.22481929011371826,"score_spread":0.220536578587149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070677464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99880666,0.00007434774,0.000022586033,0.00002766899,0.00014146596,0.0000923763,0.0000022748966,0.000016021586,0.0008165838],"genre_scores_gemma":[0.99647593,0.000013438087,0.0030979624,0.000045007375,0.00022556957,0.0000090263675,0.00001920372,0.000023467037,0.000090373156],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991356,0.000021002972,0.00018785766,0.00031937298,0.00007030061,0.00026583488],"domain_scores_gemma":[0.9993773,0.000004835603,0.000056091405,0.00044740338,0.000032296713,0.00008203304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017382641,0.00012236547,0.00010797985,0.000042479296,0.000044120403,0.00003358184,0.00020611162,0.00015422494,0.000031088384],"category_scores_gemma":[0.000071243296,0.00012064735,0.000048773498,0.0000727445,0.00003589835,0.0000034566103,0.000098883516,0.00013249778,0.000010005715],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000012989068,0.00013474183,0.21191977,0.0000049262276,0.000009986864,0.0000014151784,0.000029461175,0.0000061852797,0.78369,0.00003611965,0.000004468526,0.00416162],"study_design_scores_gemma":[0.0006552672,0.00011035576,0.35388115,0.0000062007957,0.000008443325,0.00005186846,0.000049185743,0.00005790522,0.64395493,0.00007859335,0.0010033477,0.00014277475],"about_ca_topic_score_codex":0.000056381636,"about_ca_topic_score_gemma":0.000097419615,"teacher_disagreement_score":0.14196137,"about_ca_system_score_codex":0.0000016232875,"about_ca_system_score_gemma":0.000032508153,"threshold_uncertainty_score":0.49198565},"labels":[],"label_agreement":null},{"id":"W2071006115","doi":"10.1182/blood-2012-02-412593","title":"MHC I–associated peptides preferentially derive from transcripts bearing miRNA response elements","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Canadian Institutes of Health Research; Canada Research Chairs; Pfizer","keywords":"Biology; Transcriptome; microRNA; Biogenesis; Major histocompatibility complex; Human leukocyte antigen; Computational biology; Cell biology; Gene; Genetics; Gene expression; Antigen","score_opus":0.019923075341288565,"score_gpt":0.23828621059135588,"score_spread":0.21836313525006731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071006115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848952,0.0132728815,0.000038549268,0.00007096803,0.00081146037,0.00025036873,0.00011090758,0.00014472553,0.00040488475],"genre_scores_gemma":[0.995593,0.00020085908,0.00012171848,0.00016154075,0.000036930356,0.00003656716,0.0002219634,0.00004093329,0.0035864583],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99759364,0.0009459366,0.00042511447,0.00025678132,0.00006352335,0.0007150293],"domain_scores_gemma":[0.9990625,0.00033296333,0.0001644642,0.00034899238,0.0000557168,0.000035409237],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00058800593,0.00026645022,0.0003337323,0.00011487631,0.0003114093,0.000032137745,0.0003071294,0.00031601483,0.0012324502],"category_scores_gemma":[0.00021936081,0.0002515086,0.00017364568,0.000118346754,0.000118576114,0.00025899883,0.00006301535,0.00032213144,0.0006158432],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003195877,0.0011807755,0.023386432,0.000004223133,0.001386783,0.0000023123102,0.002936313,1.6130791e-7,0.96605897,0.00002789272,0.00033611717,0.0014841176],"study_design_scores_gemma":[0.005122984,0.00023460516,0.31805602,0.00005905083,0.00021147616,0.000011073449,0.00028253658,1.3486437e-7,0.6561612,0.00003148043,0.019570995,0.00025843832],"about_ca_topic_score_codex":0.00022196709,"about_ca_topic_score_gemma":0.000028677096,"teacher_disagreement_score":0.30989778,"about_ca_system_score_codex":0.00003817796,"about_ca_system_score_gemma":0.00007141823,"threshold_uncertainty_score":0.99999374},"labels":[],"label_agreement":null},{"id":"W2071035298","doi":"10.1182/blood.v100.10.3832","title":"Polymorphism G80A in the reduced folate carrier gene and its relationship to methotrexate plasma levels and outcome of childhood acute lymphoblastic leukemia","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":216,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Methotrexate; Genotype; Pharmacogenetics; Lymphoblastic Leukemia; Oncology; Internal medicine; Drug resistance; Leukemia; Childhood leukemia; Acute lymphocytic leukemia; Medicine; Immunology; Biology; Pharmacology; Gene; Genetics","score_opus":0.044367774456427686,"score_gpt":0.2947404738922528,"score_spread":0.2503726994358251,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071035298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99604416,0.00083984283,0.000048348003,0.0013108383,0.000051208117,0.000824904,0.00009336051,0.000031314594,0.00075600034],"genre_scores_gemma":[0.99709857,0.000073731506,0.0013590489,0.00040520955,0.00007846409,0.00005575339,0.000007300539,0.000046610086,0.00087532133],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99770814,0.00020523844,0.000575912,0.00047195161,0.00054573314,0.00049304287],"domain_scores_gemma":[0.9981921,0.00082860445,0.00012284574,0.0004634289,0.000089902795,0.00030313066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059914583,0.0002752427,0.0005429571,0.00036560517,0.000118756325,0.0000327155,0.00022111299,0.0001952717,0.00006129958],"category_scores_gemma":[0.0011877395,0.00020118851,0.00007121477,0.00065415987,0.000106838794,0.00011579005,0.00015803387,0.0003422263,0.000031544532],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011505651,0.0021293764,0.41776857,0.0007782185,0.0027260883,0.0031138612,0.044070784,0.00011789179,0.5159531,0.003163341,0.0013962634,0.00763193],"study_design_scores_gemma":[0.019450499,0.0009057627,0.9197072,0.00023777004,0.0011711273,0.0031635906,0.00024289476,0.0036124128,0.050751768,0.00023560553,0.00009399202,0.00042738952],"about_ca_topic_score_codex":0.00007915095,"about_ca_topic_score_gemma":0.000012986436,"teacher_disagreement_score":0.50193864,"about_ca_system_score_codex":0.00021961487,"about_ca_system_score_gemma":0.00021366718,"threshold_uncertainty_score":0.82042295},"labels":[],"label_agreement":null},{"id":"W2071046100","doi":"10.1182/blood-2002-10-3195","title":"Membrane cholesterol regulates LFA-1 function and lipid raft heterogeneity","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Lipid raft; Filipin; Ganglioside; Cholesterol; Cell biology; Biology; Raft; NPC1; Chemistry; Biochemistry; Receptor; Endosome","score_opus":0.01821410125738215,"score_gpt":0.26630417275394763,"score_spread":0.24809007149656548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071046100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960694,0.0004435159,0.000079581485,0.00024715826,0.000061965016,0.00029091456,0.000001620389,0.000055198798,0.002750699],"genre_scores_gemma":[0.9975537,0.00012213933,0.00033285888,0.0002842478,0.00009050028,0.00001566686,0.000015006033,0.000024910405,0.0015609397],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99893093,0.00008504321,0.00016097474,0.00029421927,0.0002844816,0.0002443226],"domain_scores_gemma":[0.99933267,0.00003850207,0.000031328425,0.00032683386,0.00006364227,0.00020702345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000218556,0.00012246997,0.00018922988,0.00009304712,0.000067899724,0.000028479022,0.00004236719,0.000094044175,0.00022892273],"category_scores_gemma":[0.00012823795,0.00010527766,0.000056411485,0.00014035811,0.00006372338,0.00004826854,0.000035543468,0.00016320667,0.00008957384],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000112582784,0.00052408664,0.05948095,0.00014542726,0.000100405945,0.000033322478,0.000033043005,0.0000012965287,0.93753856,0.00007772859,0.00017564764,0.0017769503],"study_design_scores_gemma":[0.0055976263,0.0005226928,0.15430208,0.00004589043,0.00017204226,0.00032784298,0.000024407305,0.00002925964,0.82404673,0.00004687445,0.014748807,0.0001357551],"about_ca_topic_score_codex":0.000008761834,"about_ca_topic_score_gemma":0.000008318178,"teacher_disagreement_score":0.11349183,"about_ca_system_score_codex":0.000012948737,"about_ca_system_score_gemma":0.000036649468,"threshold_uncertainty_score":0.42930984},"labels":[],"label_agreement":null},{"id":"W2071072641","doi":"10.1182/blood-2006-08-043067","title":"Tickle my innards","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Neonatal Respiratory Health Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine","score_opus":0.029310638645436985,"score_gpt":0.34847143447838674,"score_spread":0.31916079583294976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071072641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92981184,0.0027780677,0.000021014494,0.001042364,0.000051758354,0.0002884379,0.0000053718895,0.00008504295,0.065916106],"genre_scores_gemma":[0.9909052,0.00002988852,0.000603613,0.0008697323,0.00047089314,0.000024856845,0.000009824469,0.000022633774,0.007063362],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990261,0.000023297349,0.00014785187,0.00015065614,0.00036834358,0.00028375772],"domain_scores_gemma":[0.9994644,0.00004212423,0.000019424304,0.00024630845,0.00008034583,0.00014738365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018854135,0.00006472613,0.0001239119,0.00007979471,0.000045455705,0.000008395448,0.00006104878,0.000056863457,0.00030345665],"category_scores_gemma":[0.00012454677,0.000055450157,0.000035704266,0.0001808958,0.000045057994,0.000029400639,0.000033552336,0.00017486485,0.0006034262],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010707269,0.009615349,0.39455208,0.0042791185,0.00024560143,0.0061180834,0.0002357696,0.0000047337735,0.26764917,0.016603312,0.06350105,0.23612499],"study_design_scores_gemma":[0.0050910003,0.00054530514,0.121741734,0.00006551398,0.00004925094,0.0001392363,0.000016630094,0.00001761757,0.06750367,0.00048260996,0.80422235,0.00012507066],"about_ca_topic_score_codex":0.00012745208,"about_ca_topic_score_gemma":0.000018186953,"teacher_disagreement_score":0.7407213,"about_ca_system_score_codex":0.00002823395,"about_ca_system_score_gemma":0.00024705776,"threshold_uncertainty_score":0.77560246},"labels":[],"label_agreement":null},{"id":"W2071185625","doi":"10.1182/blood-2009-12-256826","title":"Bone marrow as a site for pancreatic islet transplantation","year":2010,"lang":"en","type":"letter","venue":"Blood","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; Alberta Children's Hospital; University of Alberta; University of Calgary","funders":"","keywords":"Islet; Medicine; Bone marrow; Transplantation; Bone marrow transplantation; Femur; Diabetes mellitus; Pancreatic islets; Bone marrow transplant; Internal medicine; Surgery; Endocrinology","score_opus":0.011231623420193265,"score_gpt":0.23694497291321312,"score_spread":0.22571334949301985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071185625","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5361767,0.0008843119,0.00025369003,0.43715084,0.0009647069,0.0022107107,0.0005636673,0.00032672728,0.021468693],"genre_scores_gemma":[0.0059617776,0.00021424312,0.0044000824,0.9277742,0.008113119,0.00057704176,0.008235959,0.00014992288,0.04457368],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99867517,0.000027914266,0.00030245827,0.00036295428,0.00029191596,0.00033959298],"domain_scores_gemma":[0.9990801,0.00023746137,0.0001322512,0.00037441798,0.0000986192,0.00007710165],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012012545,0.00028559423,0.0006028244,0.00017179253,0.000064105596,0.000029613273,0.000059165777,0.0011389618,0.0007010497],"category_scores_gemma":[0.00017729956,0.0002462353,0.00025032662,0.00009072798,0.000045934332,0.000040874802,0.000005641858,0.0011701875,0.00038097732],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017165123,0.00017645341,0.00092537166,0.0024454612,0.00034007526,0.0005015755,0.00013913926,5.1001557e-8,0.034938477,0.000015035043,0.95999014,0.00035657964],"study_design_scores_gemma":[0.008329887,0.00057935074,0.00048855826,0.00048033343,0.005633391,0.0006648695,0.000009273635,0.000021895417,0.015419553,0.00022739434,0.96778935,0.0003561643],"about_ca_topic_score_codex":0.000040622614,"about_ca_topic_score_gemma":0.0000031610846,"teacher_disagreement_score":0.5302149,"about_ca_system_score_codex":0.000015003536,"about_ca_system_score_gemma":0.00010603666,"threshold_uncertainty_score":0.999999},"labels":[],"label_agreement":null},{"id":"W2071260613","doi":"10.1182/blood-2008-06-159335","title":"“Spare-spleen-uximab” for chronic ITP","year":2008,"lang":"en","type":"letter","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Splenectomy; Rituximab; Medicine; Thrombocytopenic purpura; Observational study; Internal medicine; Pediatrics; Spleen; Immunology; Immune system; Lymphoma","score_opus":0.02182526365863139,"score_gpt":0.2569899490924022,"score_spread":0.2351646854337708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071260613","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05257852,0.026636425,0.00015046245,0.8880562,0.0012653677,0.0051913382,0.0011670479,0.0004997359,0.024454886],"genre_scores_gemma":[0.011599321,0.0040722922,0.0025011313,0.9021064,0.01521222,0.0010549875,0.011227237,0.00044618986,0.05178019],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99846286,0.0000128511665,0.0002477519,0.00046434952,0.00027715942,0.0005350043],"domain_scores_gemma":[0.99920774,0.000066226145,0.00011367976,0.00047372148,0.0000627136,0.00007595024],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000027306389,0.0003631378,0.0007260947,0.00011533859,0.00009686994,0.000014490931,0.00012522668,0.0006637961,0.00014881269],"category_scores_gemma":[0.000026546388,0.0003038855,0.00031807236,0.00008045233,0.00005260104,0.00003071286,0.000028011094,0.0006052764,0.00022862978],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027594962,0.00048295318,0.0002471106,0.0003984744,0.00082339003,0.0071115876,0.000024630177,1.5079492e-7,0.000020101208,0.00000326164,0.98980737,0.0010534077],"study_design_scores_gemma":[0.010896322,0.00077804655,0.0001784043,0.0001751451,0.0012398821,0.0012423228,0.0000017490107,0.000007473171,0.00038375167,0.00009073297,0.984726,0.00028013784],"about_ca_topic_score_codex":0.000035350826,"about_ca_topic_score_gemma":0.000010486565,"teacher_disagreement_score":0.0409792,"about_ca_system_score_codex":0.00009215804,"about_ca_system_score_gemma":0.0002834626,"threshold_uncertainty_score":0.99994135},"labels":[],"label_agreement":null},{"id":"W2071370702","doi":"10.1182/blood-2013-03-491571","title":"Mutant IDH1 promotes leukemogenesis in vivo and can be specifically targeted in human AML","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":208,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; University of British Columbia","funders":"","keywords":"IDH1; Mutant; In vivo; Cancer research; Bone marrow; Biology; CD34; Cell biology; Immunology; Stem cell; Genetics; Gene","score_opus":0.02048177892487313,"score_gpt":0.26649814917300285,"score_spread":0.24601637024812972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071370702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994234,0.00021690635,0.0000016556114,0.0025485305,0.000016625985,0.0009768907,0.00001371009,0.00004494584,0.0019466843],"genre_scores_gemma":[0.99805295,0.00007415083,0.00074695534,0.00026059308,0.00010508696,0.00010415076,0.00001608461,0.000039429688,0.00060058763],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983283,0.000081123246,0.00036171218,0.00040079208,0.00032196433,0.000506085],"domain_scores_gemma":[0.9992383,0.00006870256,0.000044352506,0.0003394281,0.00007924831,0.00022996137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027291104,0.00018273717,0.00037466086,0.0003249534,0.000047353198,0.00003688002,0.0001438839,0.0001471678,0.000689996],"category_scores_gemma":[0.00018525281,0.00015679178,0.00003859009,0.00041649787,0.00012525741,0.00006086422,0.00010645221,0.00035688246,0.000023723598],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031229378,0.0003962028,0.10487692,0.000079640675,0.000036553032,0.00047288687,0.00057854276,4.6563937e-7,0.89209837,0.00010228911,0.0005197481,0.0008071518],"study_design_scores_gemma":[0.009550127,0.0005007038,0.3944123,0.00014776037,0.000049054015,0.00015888519,0.00046418823,0.00024335571,0.59313995,0.00027222864,0.00076682406,0.0002946231],"about_ca_topic_score_codex":0.0034593025,"about_ca_topic_score_gemma":0.0015355209,"teacher_disagreement_score":0.29895842,"about_ca_system_score_codex":0.00021803768,"about_ca_system_score_gemma":0.00024121902,"threshold_uncertainty_score":0.7554972},"labels":[],"label_agreement":null},{"id":"W2071582678","doi":"10.1182/blood-2009-12-257345","title":"Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":174,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Biology; Comparative genomic hybridization; Cancer research; ABCC1; Gene silencing; Gene dosage; Chromosome; Genetics; Gene; Gene expression; ATP-binding cassette transporter","score_opus":0.015229363559561237,"score_gpt":0.2854469116598305,"score_spread":0.27021754810026927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071582678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99658567,0.00012370192,0.000037034824,0.0003484551,0.00020376589,0.00050902733,0.000116183335,0.00003655041,0.0020396262],"genre_scores_gemma":[0.99644226,0.0000815511,0.0014931872,0.00007727101,0.00006139781,0.00014073605,0.0001327135,0.000017214676,0.0015536976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987311,0.000023422896,0.00039737066,0.0003374226,0.0002901832,0.00022052639],"domain_scores_gemma":[0.9988576,0.00014344741,0.00016416663,0.0005231368,0.00012037309,0.00019123068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007756126,0.00021475984,0.0006056849,0.00020797728,0.00006526361,0.000028627708,0.000082391845,0.000065486245,0.00040881365],"category_scores_gemma":[0.00002511172,0.00014166147,0.00024262985,0.00055801205,0.000054502052,0.00004848911,0.000027830929,0.0000644813,0.00014699873],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008629154,0.002647983,0.99041194,0.000017703309,0.003266036,0.000055379005,0.0005053245,0.00003932118,0.0023990183,0.00004405198,0.000069869,0.00045708608],"study_design_scores_gemma":[0.0034084802,0.00067297847,0.95517874,0.000033597793,0.008988915,0.000014467163,0.00009272319,0.000014306499,0.029404491,0.0000064829323,0.0020379934,0.00014681555],"about_ca_topic_score_codex":0.00037399985,"about_ca_topic_score_gemma":0.0019012144,"teacher_disagreement_score":0.03523319,"about_ca_system_score_codex":0.00007008905,"about_ca_system_score_gemma":0.00006293534,"threshold_uncertainty_score":0.5776787},"labels":[],"label_agreement":null},{"id":"W2071831134","doi":"10.1182/blood-2003-08-2974","title":"Direct evidence of leukocyte adhesion in arterioles by angiotensin II","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":177,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Cell adhesion molecule; Intravital microscopy; Intercellular Adhesion Molecule-1; Cell adhesion; Selectin; Neural cell adhesion molecule; Addressin; Angiotensin II; Venule; Integrin; Soluble cell adhesion molecules; VCAM-1; Endothelium; Intercellular adhesion molecule; Immunology; Chemistry; Adhesion; Microcirculation; Pathology; Biology; Medicine; ICAM-1; Internal medicine; Cell; Biochemistry; Receptor","score_opus":0.02539535092415768,"score_gpt":0.2989542754677631,"score_spread":0.2735589245436054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071831134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936613,0.0043783374,0.000015753025,0.0008251429,0.000018132394,0.00024925167,0.000002013142,0.00002593313,0.0008241321],"genre_scores_gemma":[0.99794793,0.00058343064,0.0008392577,0.000111838875,0.000028826596,0.0000072693615,0.000005418223,0.000016788104,0.00045926325],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988553,0.000043650194,0.000247936,0.00024145716,0.00037741128,0.00023424588],"domain_scores_gemma":[0.9993931,0.00006670355,0.000048137208,0.00030984325,0.00007545594,0.00010674107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021390448,0.00010338118,0.00026895397,0.00014954664,0.00002605204,0.0000057256425,0.000098063225,0.00007795309,0.000056593904],"category_scores_gemma":[0.00029398268,0.00008932533,0.0000774061,0.0003053806,0.00007217274,0.000053403197,0.000091373324,0.0001438101,0.000036423095],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015338293,0.0006283967,0.0057154973,0.00007536302,0.000015023085,0.00012912619,0.00014271194,0.000004001036,0.9914388,0.0000071806935,0.00042371752,0.0012667854],"study_design_scores_gemma":[0.0025948095,0.00084352616,0.029644929,0.0010654241,0.00003349136,0.000039692826,0.000024849136,0.000008133614,0.9649805,0.000025770989,0.0006557797,0.000083122366],"about_ca_topic_score_codex":0.00021437225,"about_ca_topic_score_gemma":0.000033299602,"teacher_disagreement_score":0.026458343,"about_ca_system_score_codex":0.0000534119,"about_ca_system_score_gemma":0.00014573561,"threshold_uncertainty_score":0.3642581},"labels":[],"label_agreement":null},{"id":"W2071961135","doi":"10.1182/blood-2008-08-173062","title":"The temporal profile of the anti-PF4/heparin immune response","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Heparin; Heparin-induced thrombocytopenia; Immune system; Medicine; Antibody; Immunology; Platelet factor 4; Thrombosis; Immunoglobulin G; Gastroenterology; Internal medicine","score_opus":0.02869732587588809,"score_gpt":0.267070154100544,"score_spread":0.23837282822465594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071961135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99077487,0.00028469771,0.0000015496364,0.0022608032,0.00018919032,0.0005420642,0.000008892284,0.00004443219,0.0058934726],"genre_scores_gemma":[0.9971853,0.00008210128,0.0001664796,0.00010455851,0.000079973295,0.000028876659,0.000004266478,0.000026145415,0.0023223206],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99858785,0.00020829313,0.00038507493,0.00020472064,0.00031423784,0.0002998216],"domain_scores_gemma":[0.9985971,0.00018699358,0.00014850013,0.00089140236,0.0000944094,0.00008158839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052536355,0.00015293335,0.0003796809,0.000040724837,0.00039484072,0.000010836607,0.0003106796,0.000100046986,0.000082529215],"category_scores_gemma":[0.00034899588,0.00008092843,0.00020018905,0.00033066326,0.000322884,0.000049324055,0.00015849472,0.00026886273,0.000080580474],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050310226,0.00092572276,0.3091175,0.000036557165,0.0003094733,0.000058819798,0.0007392398,3.163661e-7,0.68660724,0.00038440185,0.00093273533,0.0003848622],"study_design_scores_gemma":[0.0016961293,0.00017267166,0.7039278,0.00004502215,0.000117614836,0.00020120127,0.000085261585,0.0000059644703,0.28908995,0.000026767313,0.0045532556,0.00007832653],"about_ca_topic_score_codex":0.00019104389,"about_ca_topic_score_gemma":0.0000149592015,"teacher_disagreement_score":0.39751732,"about_ca_system_score_codex":0.000021869015,"about_ca_system_score_gemma":0.00035084228,"threshold_uncertainty_score":0.33001658},"labels":[],"label_agreement":null},{"id":"W2071985445","doi":"10.1182/blood-2012-07-444281","title":"Evaluation of participants with suspected heritable platelet function disorders including recommendation and validation of a streamlined agonist panel","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; British Heart Foundation; Wellcome Trust","keywords":"Platelet; Receptor; Medicine; Genotyping; Thromboxane; Agonist; Phenotype; Bioinformatics; Platelet disorder; Pharmacology; Internal medicine; Biology; Genetics; Genotype","score_opus":0.07986472002168114,"score_gpt":0.31211467902112716,"score_spread":0.232249958999446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071985445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983381,0.00022828912,0.000118739496,0.00008402883,0.000035740126,0.0004450281,0.00001369806,0.00001953008,0.0007168508],"genre_scores_gemma":[0.9992189,0.00006092318,0.00033086367,0.000006843547,0.000019430945,0.000032375927,0.0003058801,0.000012714262,0.0000120594],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991212,0.0000727465,0.00022333421,0.00012328275,0.00028397804,0.00017549547],"domain_scores_gemma":[0.9994347,0.000037400216,0.00018249646,0.00010208196,0.00018090142,0.00006238124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048842095,0.00009865537,0.00022064158,0.0000756592,0.000054521784,0.0000058289556,0.000014444759,0.00005078956,0.00008443849],"category_scores_gemma":[0.000098694756,0.000080277874,0.000021406304,0.00017111708,0.000031991633,0.00019524379,0.000012336397,0.000043500375,0.0000014829374],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095117005,0.0050102295,0.9045179,0.0002011834,0.0012159297,0.0000019955414,0.001353193,0.000062943014,0.030881248,0.00006677489,0.000026035137,0.05571141],"study_design_scores_gemma":[0.032306947,0.0023497927,0.7668883,0.0002611064,0.006782838,0.00004686637,0.0016032931,0.002595419,0.18611117,0.00066333637,0.00010713889,0.00028377835],"about_ca_topic_score_codex":0.00015724817,"about_ca_topic_score_gemma":0.000078215395,"teacher_disagreement_score":0.15522991,"about_ca_system_score_codex":0.000029366634,"about_ca_system_score_gemma":0.00005649957,"threshold_uncertainty_score":0.32736367},"labels":[],"label_agreement":null},{"id":"W2072009397","doi":"10.1182/blood-2011-09-381905","title":"FOXO1 is a tumor suppressor in classical Hodgkin lymphoma","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"FOXO transcription factor regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":167,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Deutsche Krebshilfe; China Scholarship Council; Cancer Research Society","keywords":"Mantle cell lymphoma; Cancer research; Lymphoma; Chronic lymphocytic leukemia; MAPK/ERK pathway; FOXO1; Biology; Protein kinase B; Follicular lymphoma; Germinal center; PI3K/AKT/mTOR pathway; Cell cycle; Cell growth; Cell culture; Kinase; Leukemia; B cell; Apoptosis; Signal transduction; Immunology; Cell biology; Antibody; Genetics","score_opus":0.0116065888259105,"score_gpt":0.2361457028383178,"score_spread":0.22453911401240728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072009397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981369,0.00042072026,0.000111717774,0.00016672551,0.00011800732,0.00010718073,0.000019173118,0.000013229296,0.000906375],"genre_scores_gemma":[0.99883235,0.0000054876036,0.00036088884,0.00025355682,0.0002134697,0.000020041425,0.000054617107,0.000016332016,0.00024326408],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99929726,0.000040549847,0.00013702853,0.0001760625,0.00010136429,0.00024772275],"domain_scores_gemma":[0.9996589,0.0000047828735,0.0000303283,0.00020838832,0.000018352537,0.00007925735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000082116676,0.000099806995,0.00008837189,0.00003627656,0.000021430082,0.000011598698,0.00009025037,0.00009901112,0.00006389412],"category_scores_gemma":[0.000023287123,0.00009892657,0.00006149103,0.000062962594,0.000035814788,0.0000067562264,0.000027098478,0.000035592286,0.000043076667],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036304307,0.0005076971,0.033053916,0.000009344504,0.0000209715,0.0000019427985,0.00009802722,9.388169e-7,0.9643976,0.00014868584,0.0013539528,0.00037060367],"study_design_scores_gemma":[0.0018062491,0.00007693958,0.21250115,0.0000064257033,0.00001839217,0.000024438583,0.000017114175,0.0000124398175,0.7393629,0.000030452875,0.04600612,0.00013737436],"about_ca_topic_score_codex":0.000010048218,"about_ca_topic_score_gemma":0.000015910127,"teacher_disagreement_score":0.22503471,"about_ca_system_score_codex":0.000008846189,"about_ca_system_score_gemma":0.000022461152,"threshold_uncertainty_score":0.40341085},"labels":[],"label_agreement":null},{"id":"W2072037914","doi":"10.1182/blood-2008-10-182626","title":"Leukemogenic Ptpn11 causes fatal myeloproliferative disorder via cell-autonomous effects on multiple stages of hematopoiesis","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Haematopoiesis; Myelofibrosis; Myeloproliferative Disorders; Immunology; Leukemia; Ruxolitinib; Cancer research; Preleukemia; Polycythemia vera; Medicine; Bone marrow; Biology; Stem cell; Genetics","score_opus":0.009768974421783826,"score_gpt":0.260517977871734,"score_spread":0.25074900344995016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072037914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955516,0.00086147286,0.00017121356,0.00060401676,0.000051017938,0.001067314,0.000034452492,0.00012170239,0.001537253],"genre_scores_gemma":[0.9971145,0.00008340819,0.001040029,0.00042380876,0.00017284391,0.000055144297,0.000049543218,0.000048329523,0.0010124404],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979495,0.0001093637,0.00038382947,0.0004712039,0.00054949056,0.00053662714],"domain_scores_gemma":[0.99835837,0.00049980386,0.00013078909,0.0006216462,0.00016040176,0.00022899121],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017571021,0.00032853486,0.000639673,0.0002447478,0.000113512695,0.000019849676,0.00021428568,0.00017706885,0.00007733581],"category_scores_gemma":[0.00043256074,0.00027091725,0.00019003169,0.00034055547,0.000110924295,0.00009867679,0.00007650999,0.00040910687,0.000114224626],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014338506,0.0062841373,0.12663682,0.0014106393,0.000938812,0.0012662117,0.003360831,0.00007562625,0.8412025,0.00024866773,0.0020717867,0.015070121],"study_design_scores_gemma":[0.009282799,0.0024625603,0.061263308,0.00013254008,0.00024318349,0.000091975875,0.00016887541,0.00014641746,0.9255643,0.00007028813,0.00030679937,0.0002669648],"about_ca_topic_score_codex":0.000103006176,"about_ca_topic_score_gemma":0.000027821896,"teacher_disagreement_score":0.08436179,"about_ca_system_score_codex":0.00016377843,"about_ca_system_score_gemma":0.00036500438,"threshold_uncertainty_score":0.9999743},"labels":[],"label_agreement":null},{"id":"W2072193332","doi":"10.1182/blood-2010-08-303537","title":"The replication rate of human hematopoietic stem cells in vivo","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":252,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"National Center for Research Resources; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Haematopoiesis; Stem cell; In vivo; Biology; Replication (statistics); Hematopoietic stem cell transplantation; Immunology; Medicine; Cancer research; Virology; Cell biology; Genetics","score_opus":0.03310387633083537,"score_gpt":0.26422157125637263,"score_spread":0.23111769492553727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072193332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987005,0.00009590266,0.00006446629,0.000064869986,0.000039109505,0.00039441884,0.0000029876549,0.000026431178,0.012306807],"genre_scores_gemma":[0.99902356,0.00005310081,0.00017975314,0.00003261836,0.000014942279,0.000032771717,0.000001946162,0.000014021579,0.0006472734],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991649,0.000057666046,0.00035429522,0.00017702181,0.00011207655,0.00013405904],"domain_scores_gemma":[0.999182,0.000081897924,0.000108323,0.0005378086,0.000047533467,0.000042458316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045585507,0.000077226236,0.00016515152,0.000049872837,0.000039349143,0.0000040613613,0.0000913515,0.000054886408,0.00006507223],"category_scores_gemma":[0.00000802658,0.000056080255,0.000042987365,0.00013816454,0.000051685973,0.000025341404,0.000008931582,0.00007367556,0.000024531731],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006225,0.0005863707,0.02403518,0.00043535177,0.000045445227,0.000032294218,0.005277957,2.458039e-7,0.9637816,0.0053977445,0.000093332485,0.00025222206],"study_design_scores_gemma":[0.0014367014,0.0001214963,0.012651988,0.00016267484,0.000096781245,0.000035919606,0.00039728993,0.000006489583,0.9845503,0.0003965949,0.000089195746,0.000054588156],"about_ca_topic_score_codex":0.00005720114,"about_ca_topic_score_gemma":0.000024681583,"teacher_disagreement_score":0.020768672,"about_ca_system_score_codex":0.000009677338,"about_ca_system_score_gemma":0.00003086869,"threshold_uncertainty_score":0.22868864},"labels":[],"label_agreement":null},{"id":"W2072324099","doi":"10.1182/blood-2012-08-439083","title":"A novel syndrome of congenital sideroblastic anemia, B-cell immunodeficiency, periodic fevers, and developmental delay (SIFD)","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Porphyrin Metabolism and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"National Center for Advancing Translational Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; Imperial College London","keywords":"Sideroblastic anemia; Immunodeficiency; Medicine; Primary immunodeficiency; Immunology; Bone marrow; Anemia; Severe combined immunodeficiency; Pediatrics; Biology; Internal medicine; Immune system; In vivo; Genetics","score_opus":0.004387514179577141,"score_gpt":0.17812292666897955,"score_spread":0.1737354124894024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072324099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945545,0.0034942448,0.00023890361,0.000008387877,0.00004538686,0.0001644876,0.000027555694,0.000007619574,0.0014588835],"genre_scores_gemma":[0.9965539,0.00011291343,0.0029489808,0.00006088695,0.000010775145,0.000019212452,0.000040104467,0.000014748187,0.00023846523],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992195,0.000012593946,0.00019517104,0.00024696146,0.00010578473,0.00022000854],"domain_scores_gemma":[0.9996631,0.000009406317,0.000063970605,0.00014840679,0.00004526364,0.000069841575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000054068478,0.00014683876,0.00015243547,0.000037318114,0.00006375206,0.000023837656,0.00013466082,0.00009915859,0.00007127867],"category_scores_gemma":[0.000035324265,0.00013980761,0.0000488309,0.000060591694,0.0001593012,0.000008081454,0.00012742463,0.00005241238,0.00002766862],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008766923,0.0003460108,0.0041352673,0.000035004217,0.00003707257,0.000006267213,0.00009985966,0.000002708831,0.99504066,0.000015454989,0.00009483507,0.00017807563],"study_design_scores_gemma":[0.014985336,0.0010683661,0.21853375,0.00004741204,0.00037568374,0.0037901846,0.0033236833,0.000055586977,0.753783,0.0001340045,0.002462433,0.001440584],"about_ca_topic_score_codex":0.00011759972,"about_ca_topic_score_gemma":0.000009458561,"teacher_disagreement_score":0.24125771,"about_ca_system_score_codex":0.000002600933,"about_ca_system_score_gemma":0.00009135931,"threshold_uncertainty_score":0.5701189},"labels":[],"label_agreement":null},{"id":"W2072351874","doi":"10.1182/blood-2006-08-038257","title":"The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1484,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"International Prognostic Index; Diffuse large B-cell lymphoma; Internal medicine; Rituximab; Medicine; CHOP; Oncology; Lymphoma; Progression-free survival; Chemotherapy","score_opus":0.005419418758643413,"score_gpt":0.21613464835556098,"score_spread":0.21071522959691757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072351874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958372,0.00017205988,0.00003431138,0.0009828304,0.000045583824,0.0018759415,0.0006307796,0.000034532968,0.00038673342],"genre_scores_gemma":[0.9983429,0.000021211992,0.00015807038,0.00028765158,0.00011008551,0.0004675754,0.00017839778,0.000036521593,0.00039762942],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985465,0.000030601288,0.00033648856,0.00025905826,0.0005473513,0.00027999817],"domain_scores_gemma":[0.9988038,0.00024289064,0.00022510298,0.00037215813,0.00029185734,0.0000641852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008734888,0.00022535406,0.00030103666,0.00004708639,0.00014164344,0.000047318194,0.00015406522,0.000056307137,0.00001785756],"category_scores_gemma":[0.00003290474,0.00009299769,0.0001159779,0.0001232819,0.000091093614,0.000051403407,0.00003355066,0.00004398543,0.0000031154818],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014957441,0.010029045,0.98649514,0.00005479325,0.00051803736,0.000014686706,0.00009783753,2.2156414e-7,0.000006183735,0.00004346119,0.0007307156,0.0005141198],"study_design_scores_gemma":[0.086941056,0.001713722,0.90428656,0.00015872446,0.0008694925,0.000007117479,0.000030607167,0.000027949112,0.0011753389,0.000015249479,0.004665524,0.00010866554],"about_ca_topic_score_codex":0.00006890323,"about_ca_topic_score_gemma":0.00005014957,"teacher_disagreement_score":0.085445315,"about_ca_system_score_codex":0.00008189346,"about_ca_system_score_gemma":0.00007796001,"threshold_uncertainty_score":0.37923357},"labels":[],"label_agreement":null},{"id":"W2072361473","doi":"10.1182/blood.v97.2.376","title":"Recombinant human granulocyte colony-stimulating factor therapy for patients with neutropenia and/or neutrophil dysfunction secondary to glycogen storage disease type 1b","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Neutropenia; Granulocyte colony-stimulating factor; Granulocyte; Medicine; Glycogen storage disease type I; Immunology; Glycogen storage disease; Recombinant DNA; Internal medicine; Disease; Chemotherapy; Biology","score_opus":0.011056842466197111,"score_gpt":0.23931388788384084,"score_spread":0.22825704541764372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072361473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981079,0.000562789,0.0000603709,0.000049462138,0.000101874844,0.0009566436,0.00008110302,0.000017490773,0.0000623778],"genre_scores_gemma":[0.99834526,0.00014465985,0.00021094474,0.00023707104,0.000071672126,0.00010072312,0.0004544994,0.000041150834,0.0003940261],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991225,0.000026067924,0.0001378112,0.0003941404,0.00008532586,0.00023412748],"domain_scores_gemma":[0.9994302,0.000008629536,0.00006552894,0.00023475605,0.00009773939,0.00016316996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000026424119,0.00019625874,0.00015987456,0.00003317792,0.00021301293,0.000036115383,0.00007943014,0.00006778995,0.000023476117],"category_scores_gemma":[0.000014649184,0.00014390028,0.000046688267,0.00007726375,0.000023704746,0.000008834585,0.00004219751,0.00004503999,0.0000030412477],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014097732,0.0057427716,0.92604274,0.00006597281,0.0006457783,0.000048473485,0.000117020674,0.00008189771,0.027894696,0.000019508829,0.0005488605,0.024694555],"study_design_scores_gemma":[0.048310347,0.023399133,0.8919017,0.000049969272,0.00033749087,0.000010495977,0.000028141487,0.000027544094,0.008117196,0.000085667256,0.026941143,0.00079121976],"about_ca_topic_score_codex":0.000027978253,"about_ca_topic_score_gemma":0.00006870251,"teacher_disagreement_score":0.034212615,"about_ca_system_score_codex":0.000008231303,"about_ca_system_score_gemma":0.000050574297,"threshold_uncertainty_score":0.5868083},"labels":[],"label_agreement":null},{"id":"W2072559448","doi":"10.1182/blood-2008-10-184077","title":"Differentiation stage–specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":249,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Biology; Germinal center; microRNA; Diffuse large B-cell lymphoma; IRF4; BCL6; Cellular differentiation; B cell; Cell; Cancer research; Cell biology; Lymphoma; Genetics; Transcription factor; Gene; Immunology; Antibody","score_opus":0.0077506661234204325,"score_gpt":0.20360943462652947,"score_spread":0.19585876850310904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072559448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952344,0.0042522983,0.00018488665,0.000003989508,0.0000273331,0.0001292353,0.00003495726,0.0000068096133,0.00012609323],"genre_scores_gemma":[0.99829143,0.0009777314,0.00035600286,0.000010892336,0.00004337162,0.0000087703465,0.00013630962,0.00001566521,0.00015985193],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992971,0.00004583726,0.00019137208,0.0002345598,0.000087817985,0.00014332094],"domain_scores_gemma":[0.9995875,0.000008041745,0.00010157901,0.00022420284,0.000032786833,0.000045940204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000050163184,0.000107665626,0.00011458153,0.00005688973,0.0000420939,0.000006240908,0.0000733657,0.00010492465,0.000015176878],"category_scores_gemma":[0.000014178035,0.00010593261,0.0000413833,0.00005705552,0.000043391887,0.0000049351806,0.00007939543,0.000023505176,0.0000018345457],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005069773,0.0012258535,0.0602626,0.000036982183,0.0000068437575,0.0000041526355,0.00008709248,0.0000023190748,0.9381779,0.000011501204,0.00009043688,0.00004363654],"study_design_scores_gemma":[0.006524168,0.000038433136,0.1373188,0.000019407766,0.000008673032,0.000008180456,0.000024252198,0.000013733139,0.85508984,0.0000092552245,0.0008474555,0.00009781395],"about_ca_topic_score_codex":0.000006991089,"about_ca_topic_score_gemma":0.0000061824826,"teacher_disagreement_score":0.083088055,"about_ca_system_score_codex":0.000011908689,"about_ca_system_score_gemma":0.000036816553,"threshold_uncertainty_score":0.43198064},"labels":[],"label_agreement":null},{"id":"W2072675839","doi":"10.1182/blood-2011-10-385989","title":"The zebrafish reveals dependence of the mast cell lineage on Notch signaling in vivo","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Izaak Walton Killam Health Centre","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Zebrafish; Notch signaling pathway; Biology; Mast cell; Cell biology; Gene knockdown; Progenitor cell; Stem cell; Signal transduction; Immunology; Cell culture; Genetics","score_opus":0.008990343498382269,"score_gpt":0.20174288862658168,"score_spread":0.19275254512819942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072675839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98736614,0.0022669095,0.0000044920457,0.00010400097,0.00038870727,0.00014479084,0.000017288055,0.000008503746,0.009699139],"genre_scores_gemma":[0.9924048,0.000042424155,0.000023052102,0.00011504689,0.000049438957,0.000007094181,0.000002028994,0.000008196363,0.007347926],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992303,0.00013613269,0.00021895673,0.00010791202,0.000035068868,0.0002716097],"domain_scores_gemma":[0.999342,0.00022567115,0.00011438145,0.0002848892,0.00002133541,0.000011686325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039634432,0.000088816705,0.00013088484,0.000022894059,0.00013436824,0.0000059034364,0.00027263444,0.00010738368,0.00033253056],"category_scores_gemma":[0.000045484394,0.000050216095,0.000058570888,0.000088758825,0.000098909564,0.00002650631,0.000074499505,0.00022904295,0.000077105615],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025547151,0.00035839216,0.013273524,0.000017233004,0.000016775008,8.23539e-7,0.00036905168,0.000003699088,0.9845955,0.0005680312,0.00066743133,0.000104009],"study_design_scores_gemma":[0.00080474134,0.00005161591,0.0063658785,0.000037565445,0.00002593057,0.000007294894,0.00013343785,4.7533658e-7,0.97077733,0.00001960638,0.021706568,0.000069527065],"about_ca_topic_score_codex":0.00005912208,"about_ca_topic_score_gemma":0.00007352973,"teacher_disagreement_score":0.021039136,"about_ca_system_score_codex":0.000006354806,"about_ca_system_score_gemma":0.000015857959,"threshold_uncertainty_score":0.36409763},"labels":[],"label_agreement":null},{"id":"W2072728217","doi":"10.1182/blood.v98.4.1078","title":"Antiapoptotic mechanism of HIV protease inhibitors: preventing mitochondrial transmembrane potential loss","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Ontario HIV Treatment Network","keywords":"Nelfinavir; Apoptosis; Caspase; Saquinavir; Protease; Ritonavir; Cell biology; Caspase-9; Mitochondrion; Biology; Caspase 3; Chemistry; Pharmacology; Biochemistry; Programmed cell death; Enzyme; Human immunodeficiency virus (HIV); Virology","score_opus":0.007867603037829704,"score_gpt":0.2255433754639587,"score_spread":0.21767577242612898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072728217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99502814,0.0001475002,0.001218988,0.0010237853,0.0002341063,0.0011779804,0.000010946344,0.00008886951,0.0010696915],"genre_scores_gemma":[0.98635805,0.000050280123,0.0062956437,0.000023363054,0.0004918867,0.00005424181,0.00006526797,0.000035388897,0.0066258716],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984244,0.000046527424,0.0004552246,0.00032154165,0.00041418467,0.0003381361],"domain_scores_gemma":[0.9993689,0.000017563234,0.00012571915,0.00024753032,0.00007851998,0.00016173325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011499414,0.00022182445,0.00039682028,0.00014793637,0.00007511313,0.000014363736,0.000085433385,0.000112362584,0.00027762973],"category_scores_gemma":[0.00003432217,0.00018952844,0.00021155541,0.00022834713,0.00004635818,0.000090743735,0.000028361344,0.00013780012,0.00006721064],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018361739,0.017464656,0.039566725,0.0015384235,0.0026624664,0.0054991837,0.003152738,0.00001644074,0.920934,0.0011803844,0.00108849,0.0050602956],"study_design_scores_gemma":[0.02554646,0.00040395372,0.0014863934,0.0008148974,0.0019067845,0.0008337861,0.00015967363,0.00012800233,0.96666116,0.00045368474,0.0012047195,0.0004004861],"about_ca_topic_score_codex":0.0000095861,"about_ca_topic_score_gemma":0.0000022339086,"teacher_disagreement_score":0.045727134,"about_ca_system_score_codex":0.000019956255,"about_ca_system_score_gemma":0.00013600421,"threshold_uncertainty_score":0.77287453},"labels":[],"label_agreement":null},{"id":"W2072760298","doi":"10.1182/blood-2011-11-391284","title":"HIT: treatment easier, prevention harder","year":2012,"lang":"en","type":"letter","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Intensive care medicine","score_opus":0.06580164004388879,"score_gpt":0.3108043627482737,"score_spread":0.24500272270438495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072760298","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2784917,0.003720576,0.000032095682,0.60754144,0.002918145,0.0040574064,0.00015891618,0.0006611241,0.10241857],"genre_scores_gemma":[0.2628517,0.0014907038,0.0026990843,0.4798125,0.040025678,0.0010176565,0.005218502,0.00070556015,0.20617865],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978882,0.000104411534,0.00039636108,0.00053774,0.00038647334,0.00068681146],"domain_scores_gemma":[0.99865174,0.000045081608,0.00017512175,0.0008505926,0.000076484976,0.00020100195],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00010332822,0.0005130126,0.0009817762,0.00017631226,0.0000925506,0.000037504335,0.00013839953,0.0010918969,0.0020117774],"category_scores_gemma":[0.000026902837,0.00041491608,0.00048498574,0.00013444932,0.00005215859,0.00009288017,0.00005608653,0.00087525055,0.0018470016],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004157683,0.0045739897,0.012248593,0.0007133095,0.004946745,0.0010764009,0.00043113355,4.5971774e-8,0.005251432,0.0000415473,0.9598523,0.010822925],"study_design_scores_gemma":[0.0043960945,0.0007366199,0.010575032,0.00027982236,0.0052124406,0.0003415613,0.00000943754,3.815905e-7,0.00753293,0.00006992847,0.97042614,0.0004195874],"about_ca_topic_score_codex":0.00010849526,"about_ca_topic_score_gemma":0.000010187939,"teacher_disagreement_score":0.12772897,"about_ca_system_score_codex":0.00020686821,"about_ca_system_score_gemma":0.00027644873,"threshold_uncertainty_score":0.99983025},"labels":[],"label_agreement":null},{"id":"W2072888813","doi":"10.1182/blood-2009-06-225706","title":"A linked donor-recipient study to evaluate parvovirus B19 transmission by blood component transfusion","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Parvovirus B19 Infection Studies","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Heart, Lung, and Blood Institute","keywords":"Parvovirus; Blood transfusion; Medicine; Transmission (telecommunications); Blood donor; Blood component; Parvoviridae; Virology; Immunology; Intensive care medicine; Virus; Computer science","score_opus":0.029563788484641095,"score_gpt":0.3169985504926547,"score_spread":0.2874347620080136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072888813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900772,0.0012930601,0.0006769184,0.0019967025,0.00020825812,0.002683588,0.000020320445,0.00033948294,0.0027044825],"genre_scores_gemma":[0.9968204,0.00043746943,0.0005060303,0.0012745335,0.00018717161,0.00012992042,0.00002291146,0.000039481834,0.0005820848],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9969443,0.0002090794,0.0006809279,0.0007163192,0.00090587896,0.0005434977],"domain_scores_gemma":[0.99860525,0.00007866188,0.000097387965,0.00052577327,0.00018641533,0.0005064942],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00062462233,0.00042711283,0.0007441564,0.00025769672,0.00030845514,0.00003607313,0.00015657724,0.00011367613,0.00025313676],"category_scores_gemma":[0.00006107929,0.0003514397,0.00023096296,0.00055069104,0.000039513878,0.00008303814,0.000037366368,0.00036094704,0.00053559005],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017092141,0.051575,0.041621227,0.00006420553,0.0010660292,0.00024486292,0.008114955,0.00005014934,0.84055364,0.000011663059,0.008755031,0.046234023],"study_design_scores_gemma":[0.08361234,0.017440194,0.5096978,0.00065386057,0.008951952,0.00041035222,0.0011281727,0.00014592285,0.28852358,0.000108253764,0.08753781,0.0017897756],"about_ca_topic_score_codex":0.00015745747,"about_ca_topic_score_gemma":0.000030039379,"teacher_disagreement_score":0.55203,"about_ca_system_score_codex":0.000067321125,"about_ca_system_score_gemma":0.00006903363,"threshold_uncertainty_score":0.9998938},"labels":[],"label_agreement":null},{"id":"W2072972595","doi":"10.1182/blood-2008-03-143396","title":"The human Pk histo-blood group antigen provides protection against HIV-1 infection","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Héma-Québec; Hospital for Sick Children; University of Toronto; University Health Network; Canadian Blood Services","funders":"Lunds Universitet","keywords":"Human immunodeficiency virus (HIV); Antigen; Medicine; Immunology; Blood group antigens; Virology","score_opus":0.014063110892145894,"score_gpt":0.24326903544055237,"score_spread":0.22920592454840646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072972595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922129,0.0020861402,0.00004804814,0.00043968201,0.00012811495,0.0007398015,0.000014302211,0.00015279306,0.004178197],"genre_scores_gemma":[0.99672365,0.0002705062,0.000018945655,0.0000429051,0.000066738074,0.00012336497,0.00017075201,0.000009905329,0.002573249],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989693,0.00018592051,0.00017824757,0.0002423322,0.000047531903,0.00037664757],"domain_scores_gemma":[0.9995589,0.000028748904,0.00007249236,0.0002664395,0.000045600977,0.000027794387],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020413776,0.00014131836,0.00012808004,0.00007113608,0.0009691138,0.0000411691,0.0001191081,0.00013801378,0.000042662617],"category_scores_gemma":[0.00005158012,0.00009554894,0.00008534308,0.0001118811,0.000116961965,0.00008617457,0.000026892687,0.00026246966,0.00079045584],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000061960025,0.0020241642,0.01766939,0.000011769704,0.00039540144,0.000023725475,0.00017731542,7.925649e-7,0.9394327,0.000600095,0.0018187131,0.037783984],"study_design_scores_gemma":[0.010445062,0.003850926,0.30294177,0.00006808381,0.00024565932,0.00021116347,0.00006928221,0.0000017636635,0.4469261,0.0009182216,0.23388045,0.00044152778],"about_ca_topic_score_codex":0.00019494606,"about_ca_topic_score_gemma":0.00023540009,"teacher_disagreement_score":0.4925066,"about_ca_system_score_codex":0.00003801721,"about_ca_system_score_gemma":0.00003486917,"threshold_uncertainty_score":0.99998754},"labels":[],"label_agreement":null},{"id":"W2073151803","doi":"10.1182/blood-2011-01-328096","title":"Loss of the wild-type allele contributes to myeloid expansion and disease aggressiveness in FLT3/ITD knockin mice","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; AGE-WELL","keywords":"Allele; Biology; Genetics; Wild type; Myeloid; Immunology; Medicine; Gene; Mutant","score_opus":0.01940632800509075,"score_gpt":0.26534982991946454,"score_spread":0.24594350191437378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073151803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952983,0.0021271918,0.00002133157,0.001448447,0.000057233487,0.0007347322,0.000019347299,0.00001731543,0.00027608586],"genre_scores_gemma":[0.99877447,0.00017687143,0.00021652474,0.00042573316,0.000047624268,0.00003411387,0.000010342757,0.00002209621,0.00029225028],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988146,0.000111683534,0.0002398014,0.00027211566,0.00026647944,0.00029531203],"domain_scores_gemma":[0.99895066,0.000091697984,0.00007180355,0.0004353557,0.00018392764,0.00026652965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025446803,0.0001367903,0.00029116176,0.00012678659,0.000050292863,0.0000077063,0.00021727575,0.000081292885,0.000046738583],"category_scores_gemma":[0.0008875066,0.000092772956,0.000049936825,0.0004298323,0.00014625171,0.00005246181,0.00025024824,0.00020278782,0.000015429752],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021954495,0.0010298954,0.9212668,0.00029192027,0.0001583626,0.0004008672,0.0014372477,0.0000035897706,0.06904386,0.00031173008,0.0013592748,0.0025010284],"study_design_scores_gemma":[0.006670771,0.00024602338,0.8769669,0.0006698508,0.00021657548,0.00003625886,0.00021381387,0.000053378404,0.11290485,0.00040203406,0.0014642985,0.00015527762],"about_ca_topic_score_codex":0.0003211286,"about_ca_topic_score_gemma":0.000060849732,"teacher_disagreement_score":0.044299904,"about_ca_system_score_codex":0.00005274486,"about_ca_system_score_gemma":0.00038656077,"threshold_uncertainty_score":0.37831715},"labels":[],"label_agreement":null},{"id":"W2073251313","doi":"10.1182/blood-2010-02-269902","title":"Genetic variation in hyaluronan metabolism loci is associated with plasma plasminogen activator inhibitor-1 concentration","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute; Western University","funders":"Canadian Institutes of Health Research","keywords":"Plasminogen activator inhibitor-1; Single-nucleotide polymorphism; Fibrinolysis; Biology; Plasminogen activator; Genetics; Population; Locus (genetics); Internal medicine; Genotype; Endocrinology; Gene; Medicine","score_opus":0.005112303696891133,"score_gpt":0.1959452400561887,"score_spread":0.19083293635929757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073251313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989149,0.00008134619,0.00013847426,0.0000412544,0.00016626694,0.00030443826,0.000036542784,0.000018315226,0.00029848976],"genre_scores_gemma":[0.9983664,0.000010267062,0.0008155227,0.00017053829,0.00036701746,0.00005510596,0.000104116836,0.000026852937,0.000084149164],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99896187,0.000054297274,0.0001976374,0.00035018966,0.00018114698,0.00025485584],"domain_scores_gemma":[0.9994755,0.000008703268,0.00012238596,0.00023877026,0.00007313572,0.000081549806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011855388,0.0001682223,0.00014418342,0.000033193952,0.000061704595,0.000031863026,0.000116270574,0.00027182687,0.000040160838],"category_scores_gemma":[0.00008697703,0.00015611171,0.00004302096,0.00010956959,0.00003323227,0.000011976162,0.000037195547,0.00017116535,0.000009919569],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050640552,0.00024851007,0.0020593794,0.0000035231058,0.00006379509,0.000006882155,0.00009714553,0.0000049107875,0.9969695,0.00008788543,0.00011574372,0.00029205516],"study_design_scores_gemma":[0.0026897264,0.00028125723,0.017285364,0.000011525198,0.00005814997,0.000013130036,0.0000108914855,0.000112363865,0.9779833,0.00009669506,0.0012431038,0.00021452553],"about_ca_topic_score_codex":0.00002889017,"about_ca_topic_score_gemma":0.000114118746,"teacher_disagreement_score":0.01898626,"about_ca_system_score_codex":0.00000985043,"about_ca_system_score_gemma":0.00013281769,"threshold_uncertainty_score":0.6366051},"labels":[],"label_agreement":null},{"id":"W2073308951","doi":"10.1182/blood-2011-11-393587","title":"Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding","year":2012,"lang":"en","type":"letter","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":208,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"","keywords":"Dabigatran; Medicine; Recombinant factor VIIa; Direct thrombin inhibitor; Prothrombin complex concentrate; Warfarin; Atrial fibrillation; Factor VIIa; Surgery; Anesthesia; Stroke (engine); Hemodialysis; Coagulation; Internal medicine; Tissue factor","score_opus":0.05491133183256853,"score_gpt":0.2829563544042748,"score_spread":0.22804502257170628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073308951","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47999394,0.0011019666,0.000031437576,0.51076823,0.0031343296,0.001776964,0.00016184215,0.00034788362,0.0026833843],"genre_scores_gemma":[0.64397496,0.0014037836,0.00078959286,0.28692156,0.028637575,0.000060248753,0.003581002,0.0005302666,0.034100994],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972003,0.0001454154,0.0006317077,0.0006216168,0.00064693496,0.00075401843],"domain_scores_gemma":[0.99811345,0.00066117983,0.00037344903,0.00047107955,0.0001249472,0.00025590585],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004411319,0.0005316072,0.0015607529,0.0007092048,0.00015132422,0.00010786536,0.00012325236,0.0007525985,0.00026915592],"category_scores_gemma":[0.00042421476,0.00048040957,0.00075256726,0.0004910219,0.000041781608,0.00015408313,0.00017727003,0.0006737137,0.00015549877],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008370136,0.00005502486,0.4124736,0.00077283976,0.0045627034,0.00079980434,0.0004712319,7.436162e-7,0.0008272704,0.000013509016,0.5749649,0.0049747126],"study_design_scores_gemma":[0.0029488506,0.00014095378,0.24453296,0.00060303917,0.008815584,0.000028251035,0.00009538565,0.0000056244453,0.0006509897,0.00006632678,0.7409493,0.0011627738],"about_ca_topic_score_codex":0.00006568559,"about_ca_topic_score_gemma":0.0000046710647,"teacher_disagreement_score":0.2238467,"about_ca_system_score_codex":0.000106813226,"about_ca_system_score_gemma":0.00004249539,"threshold_uncertainty_score":0.99976474},"labels":[],"label_agreement":null},{"id":"W2073409515","doi":"10.1182/blood.v98.9.2651","title":"Prognostic significance of minimal residual disease detection and PML/RAR-α isoform type: long-term follow-up in acute promyelocytic leukemia","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"National Cancer Institute; Medical Research Council; Medical Research Council Canada; National Institutes of Health; American Cancer Society","keywords":"Acute promyelocytic leukemia; Minimal residual disease; Medicine; Leukemia; Internal medicine; Oncology; Immunology; Biology; Retinoic acid; Genetics; Gene","score_opus":0.008032645607492459,"score_gpt":0.23321902832752778,"score_spread":0.22518638272003533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073409515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970741,0.0021459209,0.00014188701,0.000015556352,0.00007904264,0.0003423684,0.000008234223,0.000012592206,0.00018029603],"genre_scores_gemma":[0.9982359,0.0007236727,0.00016655237,0.000019611141,0.000098427976,0.000055322525,0.00005098465,0.000021820006,0.00062775705],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99898416,0.00003633762,0.00024056622,0.0003601568,0.00013403554,0.0002447233],"domain_scores_gemma":[0.9994825,0.000015579311,0.00009651496,0.0002326499,0.00007720644,0.000095526586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010365326,0.00016102166,0.00016508531,0.00005047681,0.000045658395,0.000019379517,0.0001383229,0.00013433653,0.0000074553864],"category_scores_gemma":[0.00015162156,0.00015419934,0.000043576867,0.0001660771,0.00011338342,0.000009756472,0.000070485235,0.000097951706,0.0000026188884],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006883827,0.00014426533,0.3071402,0.00023144855,0.00007411347,0.000104789855,0.000056946177,0.000006269122,0.6893106,0.000004672129,0.000016383141,0.0022219343],"study_design_scores_gemma":[0.0026938927,0.000724885,0.25407514,0.000085751315,0.00023262836,0.00008466075,0.000032994205,0.00003965784,0.74156195,0.000057949335,0.00014226793,0.00026820743],"about_ca_topic_score_codex":0.000010695203,"about_ca_topic_score_gemma":0.000047332032,"teacher_disagreement_score":0.053065073,"about_ca_system_score_codex":0.000025183203,"about_ca_system_score_gemma":0.000305317,"threshold_uncertainty_score":0.62880665},"labels":[],"label_agreement":null},{"id":"W2073512501","doi":"10.1182/blood-2011-05-355560","title":"ATF5 polymorphisms influence ATF function and response to treatment in children with childhood acute lymphoblastic leukemia","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Canadian Institutes of Health Research; National Cancer Institute; Dana-Farber Cancer Institute","keywords":"Haplotype; Asparaginase; Biology; Allele; Immunology; Leukemia; Genetics; Molecular biology; Gene; Lymphoblastic Leukemia","score_opus":0.00934359052263933,"score_gpt":0.23001919385522834,"score_spread":0.220675603332589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073512501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99788994,0.00013254637,0.00010266113,0.00012760801,0.000022288328,0.0012106583,0.000019003903,0.00009600917,0.00039927295],"genre_scores_gemma":[0.99739325,0.00004307116,0.0014230924,0.0003901426,0.00008472518,0.00018124309,0.000016111526,0.000058707774,0.00040965143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99799615,0.00009403992,0.0002974966,0.00061391585,0.00042123377,0.0005771545],"domain_scores_gemma":[0.99873966,0.00011250144,0.00006658732,0.000536089,0.00007508081,0.00047005518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020710766,0.00033257552,0.00042013192,0.00041697494,0.00008724043,0.000026198866,0.00013619084,0.00014692206,0.000064159096],"category_scores_gemma":[0.0001366089,0.0002450715,0.00004962303,0.00056660635,0.00013969697,0.00014970281,0.00010464377,0.00015902372,0.00013978503],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015120511,0.0016875615,0.95281845,0.000012596254,0.0010880515,0.0006148863,0.0028593955,0.000020470865,0.02149865,0.000045779343,0.000039350212,0.004194297],"study_design_scores_gemma":[0.02082087,0.0072051557,0.9595801,0.0001422463,0.00064500317,0.0020403524,0.000063392916,0.000027519307,0.00915251,0.000033372504,0.000036931306,0.00025251048],"about_ca_topic_score_codex":0.001134782,"about_ca_topic_score_gemma":0.000085514876,"teacher_disagreement_score":0.012346141,"about_ca_system_score_codex":0.0011302754,"about_ca_system_score_gemma":0.001474945,"threshold_uncertainty_score":0.9993726},"labels":[],"label_agreement":null},{"id":"W2073708673","doi":"10.1182/blood-2003-02-0378","title":"Generation and role of angiostatin in human platelets","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Angiostatin; Platelet; Angiogenesis; Chemistry; Umbilical vein; Thrombin; Molecular biology; Biochemistry; Immunology; Cell biology; Biology; In vitro; Cancer research","score_opus":0.014947965398460957,"score_gpt":0.2559885601274503,"score_spread":0.24104059472898934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073708673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99506706,0.0009990846,0.0000016666569,0.000015152013,0.000005628847,0.00009491919,0.000002133441,0.000004356391,0.0038099997],"genre_scores_gemma":[0.99950254,0.000033196866,0.00035094135,0.000020591078,0.0000054975762,0.0000038217863,0.000017322827,0.0000042696915,0.00006183262],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99973714,0.000009583517,0.00008035516,0.00006906524,0.000043098866,0.00006076938],"domain_scores_gemma":[0.99989694,0.0000047357507,0.000018880997,0.00004909467,0.00000866349,0.000021682596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000030302921,0.000038940227,0.00010010657,0.000039089948,0.000012742635,0.00000211888,0.0000065062377,0.000025156602,0.000020408916],"category_scores_gemma":[0.0000109784605,0.000034075456,0.000010896896,0.00004322996,0.000009366008,0.000017673307,0.0000024202275,0.000022790633,0.0000014133801],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020195603,0.0030104893,0.49140692,0.000040692405,0.00012402597,0.00044144958,0.0008979274,0.0000036861516,0.49435082,0.0027194729,0.000082098784,0.006902237],"study_design_scores_gemma":[0.017779067,0.00078815065,0.1716113,0.000064217995,0.00017344696,0.00030944418,0.00027951846,0.00013322805,0.80593634,0.0018715478,0.00089937536,0.00015439083],"about_ca_topic_score_codex":0.000036485882,"about_ca_topic_score_gemma":0.00004184998,"teacher_disagreement_score":0.3197956,"about_ca_system_score_codex":0.0000030318436,"about_ca_system_score_gemma":0.000009160339,"threshold_uncertainty_score":0.13895568},"labels":[],"label_agreement":null},{"id":"W2073886406","doi":"10.1182/blood-2007-02-077099","title":"The spectrum of mutations in the PCFT gene, coding for an intestinal folate transporter, that are the basis for hereditary folate malabsorption","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute","keywords":"Solute carrier family; Exon; Gene; Mutation; Genetics; Biology; Malabsorption; Transporter; Loss function; Membrane transport protein; Phenotype; Endocrinology","score_opus":0.05605802457824592,"score_gpt":0.32071068489030286,"score_spread":0.2646526603120569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073886406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925528,0.00042579471,0.002958708,0.0022834272,0.00008410011,0.00143539,0.000064816995,0.000017837403,0.0001770841],"genre_scores_gemma":[0.9985538,0.00009683862,0.0006659787,0.00013680418,0.00023998498,0.00011948539,0.000063827785,0.000022373777,0.00010091013],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988086,0.00005225501,0.00030294317,0.00018595438,0.00027704414,0.00037320037],"domain_scores_gemma":[0.99851185,0.0009115854,0.000102067344,0.00031848295,0.00010297416,0.000053036092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016871861,0.00012047239,0.00016946036,0.00009642182,0.0002695294,0.000029816283,0.00024383343,0.0000661424,0.000007745667],"category_scores_gemma":[0.00013605464,0.000060976217,0.00014388311,0.0002476128,0.000103954924,0.00009726672,0.000011360804,0.0002086813,0.0000014297881],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007897794,0.0073057576,0.6495999,0.0018596144,0.0018754179,0.0006086544,0.023232728,0.00008924033,0.21491206,0.009238976,0.0018091045,0.081570745],"study_design_scores_gemma":[0.008574573,0.0045855176,0.85750777,0.00038586993,0.0009438269,0.00048179014,0.017003218,0.0030460244,0.101450086,0.00444686,0.0012857626,0.0002887133],"about_ca_topic_score_codex":0.00012861818,"about_ca_topic_score_gemma":0.002061753,"teacher_disagreement_score":0.20790786,"about_ca_system_score_codex":0.00002155688,"about_ca_system_score_gemma":0.000060879607,"threshold_uncertainty_score":0.2486538},"labels":[],"label_agreement":null},{"id":"W2073895665","doi":"10.1182/blood-2010-08-303727","title":"Pathologic mechanisms of type 1 VWD mutations R1205H and Y1584C through in vitro and in vivo mouse models","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada; National Institutes of Health; Cancer Research Institute","keywords":"Von Willebrand disease; In vivo; Wild type; In vitro; Recombinant DNA; Knockout mouse; Molecular biology; Chemistry; Von Willebrand factor; Phenotype; Antigen; Coagulation; Mutation; Mutant; Immunology; Biology; Internal medicine; Gene; Medicine; Platelet; Biochemistry; Genetics","score_opus":0.037726605480611484,"score_gpt":0.2521413928272557,"score_spread":0.21441478734664418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073895665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971978,0.000412814,0.00009897488,0.000021497346,0.000008739594,0.00017954661,0.000015626712,0.000009814679,0.0020551903],"genre_scores_gemma":[0.99396646,0.00021145248,0.005676722,0.00005890117,0.0000016803695,0.000010851092,0.0000075786506,0.000006955672,0.00005938524],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99960375,0.000012937403,0.000114124916,0.00012412432,0.000047825975,0.00009724663],"domain_scores_gemma":[0.99984,0.000013105338,0.000026888212,0.00007965465,0.000014993092,0.000025346315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003953433,0.000067857036,0.00018259115,0.000055889657,0.000011043244,0.0000020209316,0.00001739147,0.00005434758,0.000015563115],"category_scores_gemma":[0.000013602081,0.000054905144,0.000011251833,0.00008652873,0.000029371993,0.00006246242,0.000017030969,0.00004792173,0.0000011440479],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017779993,0.01339715,0.060340993,0.00035409516,0.0003741619,0.006794428,0.029568097,0.000034799203,0.87560076,0.00898328,0.00003143184,0.002742819],"study_design_scores_gemma":[0.021709573,0.0013434042,0.021793561,0.00011985062,0.0003802338,0.0005056702,0.002029559,0.0011670702,0.75451785,0.19612506,0.0000075886196,0.00030058986],"about_ca_topic_score_codex":0.00021173547,"about_ca_topic_score_gemma":0.000056531673,"teacher_disagreement_score":0.18714179,"about_ca_system_score_codex":0.000004415047,"about_ca_system_score_gemma":0.0000135543505,"threshold_uncertainty_score":0.22389668},"labels":[],"label_agreement":null},{"id":"W2074105102","doi":"10.1182/blood-2010-01-263012","title":"Validation of a predictive model for identifying an increased risk for thromboembolism in children with acute lymphoblastic leukemia: results of a multicenter cohort study","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stollery Children's Hospital","funders":"","keywords":"Medicine; Asparaginase; Internal medicine; Hazard ratio; Low molecular weight heparin; Thrombosis; Confidence interval; Risk assessment; Multivariate analysis; Concomitant; Leukemia; Pediatrics; Lymphoblastic Leukemia","score_opus":0.013261772026788552,"score_gpt":0.278920298686419,"score_spread":0.2656585266596304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074105102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98644894,0.000007554601,0.005452198,0.000007052461,0.00004753336,0.00742753,0.0005290257,0.00002926529,0.000050887003],"genre_scores_gemma":[0.9927426,0.0000203867,0.005947778,0.000019108777,0.000064594875,0.00091900694,0.00023957406,0.00004010633,0.0000068426875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843174,0.000044339133,0.00055118534,0.00043068774,0.00030215163,0.00023987869],"domain_scores_gemma":[0.99866676,0.00011336174,0.00040915623,0.00045086042,0.0002718351,0.000088035275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068462314,0.00018799021,0.00070983084,0.00020818163,0.000058517024,0.000013736707,0.00011832932,0.000094293384,0.0000022542324],"category_scores_gemma":[0.00022607246,0.00015492484,0.000090682915,0.00014191134,0.000060382805,0.0001610799,0.000048820584,0.00012640853,2.9701604e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028207218,0.014033765,0.95999676,0.00020157953,0.0033476907,0.0000040077252,0.004383638,0.0018421089,0.013106212,0.00007588191,0.00004294454,0.00014471178],"study_design_scores_gemma":[0.035119884,0.0024716968,0.8949473,0.00012963213,0.006215377,0.0000056643926,0.00032367537,0.043980245,0.01655829,0.00011546856,4.000904e-7,0.00013240185],"about_ca_topic_score_codex":0.0013446953,"about_ca_topic_score_gemma":0.00046153352,"teacher_disagreement_score":0.06504947,"about_ca_system_score_codex":0.00004618555,"about_ca_system_score_gemma":0.00017251706,"threshold_uncertainty_score":0.6317652},"labels":[],"label_agreement":null},{"id":"W2074347542","doi":"10.1182/blood-2009-09-243055","title":"The antihelmintic flubendazole inhibits microtubule function through a mechanism distinct from Vinca alkaloids and displays preclinical activity in leukemia and myeloma","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"Terry Fox Foundation","keywords":"Vinblastine; Pharmacology; Leukemia; Multiple myeloma; In vivo; Vincristine; Cancer research; Biology; Medicine; Immunology; Chemotherapy; Internal medicine; Cyclophosphamide","score_opus":0.008514685347485281,"score_gpt":0.24512206050865687,"score_spread":0.23660737516117158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074347542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99756294,0.0007964671,0.00083298807,0.0001136194,0.0002874109,0.00021243862,0.000047263064,0.000009904678,0.00013694973],"genre_scores_gemma":[0.9985116,0.00066247914,0.00030697786,0.0001241676,0.00022787508,0.00003064244,0.000030461844,0.000021416608,0.000084353014],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99907035,0.000044409684,0.00016719922,0.00040627347,0.000087120134,0.00022467918],"domain_scores_gemma":[0.99950135,0.000048695907,0.000069057976,0.00029151348,0.00002467099,0.00006469542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019516805,0.00016125281,0.00015196168,0.000013921148,0.00016284846,0.00006389292,0.00010232418,0.00021197353,0.000008150386],"category_scores_gemma":[0.000036851612,0.00012807596,0.000044420176,0.000046203855,0.00010745503,0.00000879012,0.0001764177,0.00023658664,0.0000018459077],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016219779,0.000090785674,0.0014844683,0.000009882889,0.000050404036,0.0000021079418,0.00005508927,1.1342964e-7,0.9893723,0.0006804219,0.000014846499,0.0080773635],"study_design_scores_gemma":[0.001986012,0.00033857525,0.025460795,0.000019915302,0.00008299644,0.000022899509,0.00003432611,0.000096479795,0.9593039,0.0055126776,0.006937905,0.00020351226],"about_ca_topic_score_codex":0.0001849472,"about_ca_topic_score_gemma":0.0023915607,"teacher_disagreement_score":0.030068412,"about_ca_system_score_codex":0.000007890342,"about_ca_system_score_gemma":0.000067043504,"threshold_uncertainty_score":0.5222786},"labels":[],"label_agreement":null},{"id":"W2074470232","doi":"10.1182/blood-2005-04-1422","title":"Optimal biologic dose of metronomic chemotherapy regimens is associated with maximum antiangiogenic activity","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":256,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Medicine; Chemotherapy; Pharmacology; Oncology; Toxicity; Pharmacodynamics; Internal medicine; Pharmacokinetics","score_opus":0.010641206957814677,"score_gpt":0.23885811561235254,"score_spread":0.22821690865453786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074470232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973503,0.0016974396,0.00020956129,0.00016196926,0.000021170496,0.000117093776,0.0000525511,0.0000125601455,0.00037737298],"genre_scores_gemma":[0.99758804,0.00034372197,0.0012660264,0.00022285398,0.00015336633,0.000011648521,0.00003602375,0.000024264778,0.00035404356],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992237,0.000033621654,0.00013190944,0.00030196962,0.00007765013,0.00023112007],"domain_scores_gemma":[0.9994509,0.000008306017,0.00014869068,0.0002917381,0.000052851537,0.00004748791],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011322235,0.00015649202,0.00020284388,0.000033904857,0.000040515275,0.0000073589545,0.0001504149,0.00015888392,0.00009371205],"category_scores_gemma":[0.000009548418,0.00012632804,0.00016924398,0.00009593883,0.00008514238,0.000003890885,0.000040685,0.000040911946,0.0000061130872],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024313053,0.00068519585,0.01779481,0.000005668462,0.00087804924,0.0000017214519,0.00003554358,0.00008947617,0.9759534,0.000005418393,0.0010194562,0.0032881314],"study_design_scores_gemma":[0.0027804482,0.00056427025,0.021658383,0.000010201016,0.00010681516,0.000008378466,0.000013730507,0.000031771346,0.9699269,0.000003263908,0.0046925927,0.00020325537],"about_ca_topic_score_codex":0.000013643073,"about_ca_topic_score_gemma":0.000019206984,"teacher_disagreement_score":0.006026509,"about_ca_system_score_codex":0.000015759832,"about_ca_system_score_gemma":0.00006719562,"threshold_uncertainty_score":0.5151508},"labels":[],"label_agreement":null},{"id":"W2074584895","doi":"10.1182/blood-2010-03-275420","title":"Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":304,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"National Cancer Institute; Amgen","keywords":"Alemtuzumab; Fludarabine; Medicine; Transplantation; Internal medicine; Chronic lymphocytic leukemia; Minimal residual disease; Oncology; Leukemia; Immunology; Cyclophosphamide; Chemotherapy","score_opus":0.016884207317919685,"score_gpt":0.30618732176142066,"score_spread":0.289303114443501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074584895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99370307,0.0006730763,0.000008023466,0.00007664529,0.0003388054,0.0049836673,0.00010282159,0.00004438063,0.00006953938],"genre_scores_gemma":[0.99832106,0.00060606305,0.00001739974,0.00006317782,0.0004634966,0.00019493073,0.000029066105,0.00004741481,0.00025741875],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9960058,0.00068169803,0.0012816712,0.0007287038,0.0007507028,0.000551448],"domain_scores_gemma":[0.99732226,0.00087845325,0.00037924078,0.0009488284,0.00010282728,0.00036839512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020204505,0.00030242914,0.0007099499,0.00014782013,0.00012109483,0.000042149783,0.00036543273,0.00026774558,0.000013313819],"category_scores_gemma":[0.0002909197,0.00021088753,0.00022647294,0.00028526215,0.00042687677,0.00012681996,0.00009146001,0.0007793345,0.000010837076],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21534681,0.008979539,0.739154,0.0031080842,0.00081713416,0.0026480863,0.0023735017,0.00013603571,0.019890532,0.000027602833,0.00013713038,0.007381551],"study_design_scores_gemma":[0.6079865,0.0020763534,0.38269436,0.00019138287,0.001397192,0.000101371596,0.000058211743,0.0029883387,0.0022730038,0.000017277092,0.000018295877,0.00019772873],"about_ca_topic_score_codex":0.0014230582,"about_ca_topic_score_gemma":0.003836281,"teacher_disagreement_score":0.39263967,"about_ca_system_score_codex":0.0034840265,"about_ca_system_score_gemma":0.015123071,"threshold_uncertainty_score":0.9904603},"labels":[],"label_agreement":null},{"id":"W2074637790","doi":"10.1182/blood-2012-08-453860","title":"Who is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer?","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Cancer Institute; U.S. Public Health Service","keywords":"Sibling; Volunteer; Medicine; Hematopoietic cell; Gerontology; Psychology; Haematopoiesis; Biology; Developmental psychology; Genetics; Stem cell","score_opus":0.019126366247252467,"score_gpt":0.2641697415595082,"score_spread":0.2450433753122557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074637790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866846,0.00014779785,0.005791732,0.0030324953,0.00026103275,0.00340179,0.0000682802,0.00020286658,0.0004093737],"genre_scores_gemma":[0.9906783,0.00008078132,0.0031911803,0.0023855458,0.0002013724,0.0006808239,0.000188308,0.00011650333,0.002477188],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974686,0.00010642577,0.00072486,0.0005953895,0.00047798717,0.00062677247],"domain_scores_gemma":[0.99836797,0.00028081264,0.00016069904,0.0007210359,0.00020861161,0.00026086238],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041917776,0.00038685123,0.00057874125,0.0001689913,0.00022299419,0.000114250295,0.00027499342,0.00029435192,0.0014980597],"category_scores_gemma":[0.000033085453,0.00024612335,0.00022287661,0.00038690437,0.00008697209,0.00025402335,0.000014655484,0.00033952366,0.00021704947],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023850617,0.008664149,0.460322,0.007834219,0.0041228537,0.0005921299,0.3261868,0.00001333429,0.16401912,0.00032982632,0.021428732,0.0041017635],"study_design_scores_gemma":[0.08015432,0.0026219322,0.5659755,0.010139381,0.010486505,0.0052036275,0.010026949,0.005239289,0.30528507,0.0010726049,0.0011903298,0.002604474],"about_ca_topic_score_codex":0.00016273359,"about_ca_topic_score_gemma":0.0000668051,"teacher_disagreement_score":0.31615984,"about_ca_system_score_codex":0.000035771372,"about_ca_system_score_gemma":0.00008948522,"threshold_uncertainty_score":0.9999991},"labels":[],"label_agreement":null},{"id":"W2074678620","doi":"10.1182/blood-2012-02-408542","title":"Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":492,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Institut National Du Cancer; Ligue Contre le Cancer; Institute of Cancer Research; Fondation pour la Recherche Médicale","keywords":"Angioimmunoblastic T-cell lymphoma; Lymphoma; Peripheral T-cell lymphoma; Medicine; Anaplastic large-cell lymphoma; Internal medicine; Not Otherwise Specified; T cell; Gastroenterology; Oncology; Cancer research; Immunology; Immune system","score_opus":0.01871058031353838,"score_gpt":0.2828336209555949,"score_spread":0.2641230406420565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074678620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99365413,0.0035433264,0.0000021262413,0.00019054707,0.00022818123,0.00036316607,0.000009184864,0.000030444187,0.001978865],"genre_scores_gemma":[0.99679863,0.0003437605,0.0021475006,0.00022127971,0.00006749977,0.000071712355,0.00003758748,0.000017440947,0.00029459316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990361,0.000059417685,0.00024119043,0.00023106593,0.00015085313,0.00028141926],"domain_scores_gemma":[0.99932927,0.00013788401,0.00007026024,0.00018903427,0.000024630752,0.00024894264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012911548,0.0001613183,0.00027397697,0.000058800088,0.000048106165,0.000011912634,0.0000319349,0.000094648014,0.00002967898],"category_scores_gemma":[0.0000330564,0.00011192709,0.00007491191,0.00010918351,0.00010008667,0.00008418214,0.000022995791,0.000113703405,0.00002259517],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020358106,0.0048575457,0.9872574,0.000025607791,0.00013362133,0.00014817688,0.0007137806,0.0000031325314,0.000020376161,0.00004037963,0.00023763215,0.006358766],"study_design_scores_gemma":[0.01714163,0.00086317543,0.9788474,0.00011348574,0.0006028719,0.00033974278,0.0003536308,0.000018793971,0.00043163967,0.000011064911,0.0011314014,0.00014515957],"about_ca_topic_score_codex":0.000087375396,"about_ca_topic_score_gemma":0.00005802362,"teacher_disagreement_score":0.01693805,"about_ca_system_score_codex":0.00006290609,"about_ca_system_score_gemma":0.00008281811,"threshold_uncertainty_score":0.45642543},"labels":[],"label_agreement":null},{"id":"W2075175917","doi":"10.1182/blood-2002-06-1675","title":"In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":384,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"Chromosomal translocation; Multiple myeloma; Monoclonal gammopathy of undetermined significance; Fibroblast growth factor receptor 3; Biology; Bone marrow; Hazard ratio; Breakpoint; Internal medicine; Exon; Medicine; Molecular biology; Gastroenterology; Pathology; Immunology; Antibody; Monoclonal; Monoclonal antibody; Receptor; Fibroblast growth factor; Genetics; Gene","score_opus":0.038379939079467,"score_gpt":0.31034755893236465,"score_spread":0.27196761985289764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075175917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967003,0.00026064683,0.000022279248,0.000043056545,0.000056993165,0.0010124837,0.00007166217,0.000035776324,0.0017968361],"genre_scores_gemma":[0.99677026,0.000029695684,0.0024402726,0.000048300753,0.000041694228,0.00009014439,0.000027425122,0.0000302361,0.0005219683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824417,0.00015068612,0.00030482045,0.00040999133,0.00046503975,0.00042530306],"domain_scores_gemma":[0.99883753,0.0001801074,0.00009031439,0.00043646025,0.0001418083,0.0003137598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012059795,0.00020770727,0.0003685641,0.00023776207,0.000058205664,0.000007777892,0.00009884446,0.000118380536,0.0006965213],"category_scores_gemma":[0.0009733635,0.00016478951,0.00010352015,0.0002860654,0.00008271669,0.00019349104,0.000037428734,0.0002114498,0.00007920923],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044553785,0.004541153,0.909397,0.00009737612,0.00012644188,0.00047671018,0.0015597185,0.0000012431672,0.082316436,0.000026887517,0.00010972242,0.0009017557],"study_design_scores_gemma":[0.012880121,0.0008311071,0.5779034,0.0001606493,0.00006282578,0.00003260157,0.00039628329,0.00005593686,0.40705493,0.00007155816,0.00041641647,0.0001342003],"about_ca_topic_score_codex":0.00017781435,"about_ca_topic_score_gemma":0.00008936556,"teacher_disagreement_score":0.33149365,"about_ca_system_score_codex":0.00006148838,"about_ca_system_score_gemma":0.00016240167,"threshold_uncertainty_score":0.762642},"labels":[],"label_agreement":null},{"id":"W2075284809","doi":"10.1182/blood-2011-11-392308","title":"Solulin increases clot stability in whole blood from humans and dogs with hemophilia","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Heart, Lung, and Blood Institute","keywords":"Thromboelastography; Fibrinolysis; Fibrin; Thrombomodulin; In vivo; Thrombin; Ex vivo; Antifibrinolytic; Medicine; Pharmacology; Whole blood; Chemistry; Tissue plasminogen activator; Immunology; Coagulation; Internal medicine; In vitro; Surgery; Biochemistry; Platelet; Tranexamic acid; Biology; Blood loss","score_opus":0.030318632871567656,"score_gpt":0.28063259193224865,"score_spread":0.250313959060681,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075284809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951452,0.0024258734,0.0000010014137,0.00063469453,0.000019034744,0.00045997588,0.00004471355,0.000048468653,0.0012210243],"genre_scores_gemma":[0.9985588,0.000081363716,0.0005563494,0.00006838922,0.00024901555,0.00003868521,0.00007834343,0.000023678,0.0003453744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865276,0.000081632505,0.00020105095,0.00030239864,0.0003068904,0.0004552416],"domain_scores_gemma":[0.99909264,0.00014280248,0.000031920343,0.00036119562,0.00004479938,0.00032664303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002924613,0.00017693918,0.00033128067,0.00009274729,0.000074523574,0.000019199531,0.00006574059,0.00010367923,0.00025576216],"category_scores_gemma":[0.0000874441,0.00012132488,0.000042278083,0.00017327123,0.00016432085,0.00013019987,0.00007005233,0.0002315244,0.00004354005],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018552018,0.0046386807,0.9807339,0.00006384815,0.00014696737,0.000112183356,0.00058891205,3.7225526e-8,0.013110649,0.00002651092,0.000042419677,0.00035041507],"study_design_scores_gemma":[0.010782751,0.00066340284,0.9509152,0.00013217656,0.0004248619,0.00005094606,0.00025751925,0.000004228239,0.036000147,0.00012493404,0.0004680801,0.00017573033],"about_ca_topic_score_codex":0.0016269338,"about_ca_topic_score_gemma":0.0005212227,"teacher_disagreement_score":0.029818635,"about_ca_system_score_codex":0.000022902697,"about_ca_system_score_gemma":0.000082302104,"threshold_uncertainty_score":0.4947485},"labels":[],"label_agreement":null},{"id":"W2075376229","doi":"10.1182/blood-2014-09-600858","title":"Microtubule sliding drives proplatelet elongation and is dependent on cytoplasmic dynein","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Division of Materials Research; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Materials Research Science and Engineering Center, Harvard University; Deutsche Forschungsgemeinschaft; National Science Foundation; National Institutes of Health; Department of Physics, Harvard University; Harvard University","keywords":"Microtubule; Cell biology; Cytoplasm; Differential interference contrast microscopy; Tubulin; Dynein; Platelet; Cytoskeleton; Biophysics; Biology; Fluorescence microscope; Elongation; Chemistry; Biochemistry; Fluorescence; Cell; Microscopy; Immunology; Materials science; Medicine; Pathology; Physics","score_opus":0.007649152559041442,"score_gpt":0.22735055637781493,"score_spread":0.21970140381877348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075376229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968229,0.00015740814,0.0000372844,0.00045057715,0.000037534883,0.00025929642,0.000005796745,0.000040147366,0.0021890362],"genre_scores_gemma":[0.9985312,0.000088995956,0.00038978056,0.00045113367,0.000039994397,0.000014666903,0.000025298394,0.000015211315,0.00044371875],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993671,0.000017393542,0.00011145645,0.00022162072,0.00012347903,0.00015891487],"domain_scores_gemma":[0.9997039,0.00002766776,0.00004091082,0.0001345977,0.000019136882,0.00007379729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006335812,0.00011641022,0.00018315832,0.00006214644,0.00008091881,0.000021662174,0.00002701251,0.00006298234,0.00003640615],"category_scores_gemma":[0.000024323479,0.000093041686,0.00003132993,0.00004570318,0.000015174155,0.000042692725,0.000015683203,0.00008094362,0.00008477834],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073501526,0.006809604,0.52269036,0.0006136896,0.0014032741,0.0018039158,0.0049044997,0.000008264223,0.37236762,0.0019746874,0.0030039707,0.08368512],"study_design_scores_gemma":[0.01954149,0.0021525687,0.07266648,0.00037185746,0.00055343565,0.0011346845,0.00016670665,0.0005447989,0.8966584,0.0010180569,0.0047736256,0.00041785996],"about_ca_topic_score_codex":0.000014969505,"about_ca_topic_score_gemma":0.0000087708,"teacher_disagreement_score":0.5242908,"about_ca_system_score_codex":0.0000128772745,"about_ca_system_score_gemma":0.000014283402,"threshold_uncertainty_score":0.379413},"labels":[],"label_agreement":null},{"id":"W2075402290","doi":"10.1182/blood-2003-06-1816","title":"Neutrophils and the protein C pathway","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Sepsis Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Chemistry; Biology; Medicine","score_opus":0.03530702221533962,"score_gpt":0.2644533095660162,"score_spread":0.22914628735067658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075402290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837634,0.0024648635,0.0000012370491,0.0019583148,0.000017138997,0.00048287766,9.763727e-7,0.000016010805,0.011295198],"genre_scores_gemma":[0.9987299,0.000073998905,0.00022417707,0.00048762176,0.00003338615,0.00012683967,9.4215505e-7,0.0000065436866,0.0003165924],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99964815,0.000033547818,0.00006608262,0.000094925934,0.00007167223,0.00008562427],"domain_scores_gemma":[0.9997412,0.000035580215,0.00001706088,0.00014858703,0.000013651984,0.00004390148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008842228,0.00005644637,0.00010969724,0.000011603979,0.000041216193,0.000010222243,0.000015004232,0.00002106206,0.00005169558],"category_scores_gemma":[0.000058656435,0.000028140732,0.00003624289,0.00003911209,0.00004484082,0.000010062995,0.0000059756926,0.00004146307,0.000020755793],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046732527,0.01272589,0.3327374,0.00021866112,0.0018921233,0.0009575152,0.0019314213,9.0486645e-7,0.027199034,0.60011315,0.0018632121,0.01989339],"study_design_scores_gemma":[0.08924263,0.0015123998,0.22148027,0.00026523505,0.0013677011,0.00074417325,0.00031222205,0.000006330887,0.5947215,0.0086020455,0.08140467,0.00034084692],"about_ca_topic_score_codex":0.000011531257,"about_ca_topic_score_gemma":0.0000016730731,"teacher_disagreement_score":0.59151113,"about_ca_system_score_codex":0.000003830313,"about_ca_system_score_gemma":0.000018548,"threshold_uncertainty_score":0.11475458},"labels":[],"label_agreement":null},{"id":"W2075520012","doi":"10.1182/blood-2008-09-178350","title":"Inhibition of aurora kinases for tailored risk-adapted treatment of multiple myeloma","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Deutsche Krebshilfe; Universität Heidelberg; Stem Cell Network","keywords":"Aurora inhibitor; Multiple myeloma; Cancer research; Aurora kinase; Chromosome instability; Biology; Fluorescence in situ hybridization; Gene expression profiling; Tissue microarray; Cell cycle; Medicine; Internal medicine; Cancer; Gene expression; Immunology; Genetics; Gene","score_opus":0.033893588809122834,"score_gpt":0.3000409426158555,"score_spread":0.26614735380673266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075520012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974726,0.00046057208,0.00010307547,0.00010951645,0.000016138765,0.0011872855,0.00023074236,0.00003451524,0.00038556423],"genre_scores_gemma":[0.9948635,0.0001607648,0.004432313,0.000010871016,0.0000579945,0.00007092688,0.00026094852,0.000013710072,0.0001289826],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99900943,0.000033324195,0.00029113726,0.0002025711,0.00022890161,0.00023466333],"domain_scores_gemma":[0.99911654,0.00014498293,0.00016138087,0.00026836738,0.00017678096,0.00013197317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000055027223,0.00014531195,0.00038205486,0.00013817333,0.000045666555,0.0000038554904,0.000033162472,0.00006604346,0.000031668176],"category_scores_gemma":[0.00025751386,0.00011004898,0.00018687181,0.00014326068,0.000047899553,0.000041893614,0.00000706525,0.00003381681,0.000005387391],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0079204235,0.027906643,0.26198533,0.00029301943,0.0013216228,0.0002165329,0.00080321863,0.000011785442,0.498888,0.00016264652,0.00018719293,0.20030358],"study_design_scores_gemma":[0.027393285,0.0088194,0.28199694,0.00008215788,0.00039895315,0.000012113607,0.000070545306,0.0002833,0.68053526,0.00013195956,0.00020211266,0.00007396597],"about_ca_topic_score_codex":0.00017311789,"about_ca_topic_score_gemma":0.00003633326,"teacher_disagreement_score":0.20022961,"about_ca_system_score_codex":0.000039940238,"about_ca_system_score_gemma":0.000071659015,"threshold_uncertainty_score":0.44876674},"labels":[],"label_agreement":null},{"id":"W2075548587","doi":"10.1182/blood.v97.3.720","title":"Primitive quiescent leukemic cells from patients with chronic myeloid leukemia spontaneously initiate factor-independent growth in vitro in association with up-regulation of expression of interleukin-3","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":150,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency","keywords":"Biology; Myeloid leukemia; CD38; Interleukin 3; Progenitor cell; CD34; Leukemia; Cancer research; Population; Myeloid; Molecular biology; Growth factor; ABL; Immunology; Stem cell; Cell biology; T cell; Interleukin 21; Signal transduction; Immune system; Tyrosine kinase; Medicine; Receptor; Genetics","score_opus":0.006904935077660119,"score_gpt":0.20762307441750769,"score_spread":0.20071813933984756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075548587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982541,0.00010615364,0.0000489549,0.000010773372,0.00007855275,0.0011506709,0.00011408639,0.00003076319,0.00020591075],"genre_scores_gemma":[0.99887717,0.00009888486,0.00034489436,0.000018923543,0.00004931047,0.000046181747,0.00042915906,0.000054419175,0.00008103267],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972375,0.00014197045,0.0007563778,0.0005106286,0.0009215679,0.00043195434],"domain_scores_gemma":[0.99833655,0.00018765133,0.0007781984,0.00034941637,0.0002432073,0.00010495016],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001414366,0.00035512753,0.00074083824,0.00035442584,0.000024667634,0.000010218623,0.00014272968,0.0002458018,0.000093607174],"category_scores_gemma":[0.00006111819,0.00028580747,0.00007952153,0.00038795083,0.00005906272,0.00022326344,0.00006647455,0.0003755505,0.000007067269],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003675319,0.0010876865,0.65014344,0.00011552729,0.00016762123,0.00013566711,0.0015504599,0.0000963778,0.34224188,0.0000016962276,0.0000046140494,0.000779718],"study_design_scores_gemma":[0.020659862,0.00068619597,0.48607865,0.0009987284,0.00013036822,0.00001299825,0.00008894511,0.000053325577,0.4911367,0.000009569485,0.0000028547977,0.00014181103],"about_ca_topic_score_codex":0.003885922,"about_ca_topic_score_gemma":0.0014688749,"teacher_disagreement_score":0.1640648,"about_ca_system_score_codex":0.009409653,"about_ca_system_score_gemma":0.0011515495,"threshold_uncertainty_score":0.9999594},"labels":[],"label_agreement":null},{"id":"W2075603023","doi":"10.1182/blood-2010-03-273193","title":"Photodepletion differentially affects CD4+ Tregs versus CD4+ effector T cells from patients with chronic graft-versus-host disease","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Leukemia & Lymphoma Society of Canada; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Fonds de Recherche du Québec - Santé; Kiadis Pharma","keywords":"Effector; Graft-versus-host disease; Immunology; Biology; Disease; Host (biology); Medicine; Internal medicine; Genetics","score_opus":0.006384240672000273,"score_gpt":0.21638302982019472,"score_spread":0.20999878914819445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075603023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99557775,0.000072288436,0.00017246728,0.00005066455,0.001780889,0.0013915364,0.00025364774,0.00017809292,0.00052264036],"genre_scores_gemma":[0.99766546,0.00002523513,0.00038126184,0.000026346868,0.00041974132,0.00010198996,0.0012297464,0.00008122353,0.0000690085],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980619,0.00007759253,0.00024030055,0.00055590743,0.0006486187,0.00041567898],"domain_scores_gemma":[0.99832845,0.0003835423,0.00013251699,0.0005997864,0.00008886855,0.0004668323],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00007268473,0.0003578395,0.00039219024,0.000104840554,0.0000993947,0.000044940105,0.0001429823,0.0001700927,0.0006231314],"category_scores_gemma":[0.000053597898,0.00029036085,0.00014077431,0.00016287275,0.000092776936,0.000110793466,0.000024299712,0.00033833494,0.0002864782],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018188603,0.003920409,0.15396911,0.0011247244,0.0009196865,0.0002806236,0.00046279,0.0000034612005,0.8199246,0.00005075936,0.00022646223,0.00092880643],"study_design_scores_gemma":[0.080608346,0.002306107,0.6090997,0.00048561493,0.00323115,0.000002791513,0.000015801477,0.00008317045,0.30334532,0.0000049037135,0.0003264753,0.00049059786],"about_ca_topic_score_codex":0.0001057294,"about_ca_topic_score_gemma":0.0004981098,"teacher_disagreement_score":0.5165792,"about_ca_system_score_codex":0.00006624274,"about_ca_system_score_gemma":0.00017891426,"threshold_uncertainty_score":0.9999549},"labels":[],"label_agreement":null},{"id":"W2075902082","doi":"10.1182/blood-2007-10-118547","title":"Human mast cell activation with virus-associated stimuli leads to the selective chemotaxis of natural killer cells by a CXCL8-dependent mechanism","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":127,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Chemokine; Interleukin 8; Biology; Immunology; CXCL10; Chemotaxis; NK-92; Proinflammatory cytokine; Mast cell; Lymphokine-activated killer cell; Inflammation; Interleukin 21; Immune system; T cell; Receptor","score_opus":0.0070792404863869495,"score_gpt":0.19511579735094037,"score_spread":0.18803655686455342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075902082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971883,0.00018195719,0.000089710375,0.000097314216,0.00019665711,0.00037700112,0.000044997014,0.000039722498,0.0017842968],"genre_scores_gemma":[0.97419006,0.000016264414,0.000047697475,0.00014844003,0.000018065402,0.000021455888,0.0000847917,0.000022387043,0.025450872],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990557,0.00009732189,0.00020768146,0.0002712747,0.000078058634,0.00028996594],"domain_scores_gemma":[0.99940807,0.00004326774,0.00017653288,0.00021916247,0.00013054792,0.000022407534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010340278,0.00018830055,0.0002557618,0.000059303653,0.00031716152,0.000006414249,0.00020278442,0.00016437564,0.0003358527],"category_scores_gemma":[0.000011387864,0.00013110854,0.00005714202,0.00017782037,0.000094543066,0.000043043594,0.00005953642,0.00031312284,0.00009495093],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009185979,0.0008292247,0.00016616941,0.0000092008995,0.0001524884,0.0000027674444,0.0012313867,0.000007926464,0.9895165,0.000045033503,0.00790501,0.00004242156],"study_design_scores_gemma":[0.002697833,0.00063859177,0.0013632339,0.000015522968,0.00007352826,0.000012973251,0.00013531487,0.0000015638896,0.99161667,0.000009258152,0.0032617985,0.00017372388],"about_ca_topic_score_codex":0.00046408013,"about_ca_topic_score_gemma":0.00026906678,"teacher_disagreement_score":0.023666576,"about_ca_system_score_codex":0.000040214712,"about_ca_system_score_gemma":0.000039309634,"threshold_uncertainty_score":0.5346451},"labels":[],"label_agreement":null},{"id":"W2075944172","doi":"10.1182/blood-2012-05-428672","title":"Regulating type 1 IFN effects in CD8 T cells during viral infections: changing STAT4 and STAT1 expression for function","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; National Center for Research Resources; School of Medicine, Indiana University","keywords":"CD8; Biology; Expression (computer science); Function (biology); Virology; Immunology; Cancer research; Cell biology; Immune system; Computer science","score_opus":0.013075616599091571,"score_gpt":0.26180159957471044,"score_spread":0.24872598297561888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075944172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973298,0.00036516014,0.0012266628,0.000016470962,0.00044473066,0.00038491227,0.0000035964715,0.000054018143,0.00017466384],"genre_scores_gemma":[0.99822605,0.000013057347,0.0010083814,0.00003183588,0.0004266673,0.000053246684,0.000015456633,0.000020362799,0.00020494782],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99938214,0.000019698413,0.00014700902,0.00013033148,0.00007254212,0.0002482895],"domain_scores_gemma":[0.99963427,0.00010957818,0.000055632867,0.00009264172,0.00003791457,0.00006998544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001482257,0.000090376234,0.00013183046,0.00019494619,0.00012653145,0.000014922698,0.000011902765,0.000049145634,0.000017951656],"category_scores_gemma":[0.00011007175,0.00008229845,0.000035049365,0.00013844072,0.0000095315145,0.00019082509,0.00002391162,0.00011426158,0.0000043463647],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010390906,0.00028597531,0.016666345,0.00022878856,0.000019693463,0.0000014309584,0.0007391792,0.000022574675,0.9810195,0.000042067888,0.000029746468,0.0008408096],"study_design_scores_gemma":[0.0030861937,0.00052451075,0.027744878,0.0005865803,0.00011770446,0.000034547786,0.00024294673,0.00028355236,0.96626586,0.000051368097,0.00094708777,0.000114795395],"about_ca_topic_score_codex":0.000018562012,"about_ca_topic_score_gemma":0.0000038716844,"teacher_disagreement_score":0.014753645,"about_ca_system_score_codex":0.000040111507,"about_ca_system_score_gemma":0.000018976685,"threshold_uncertainty_score":0.33560336},"labels":[],"label_agreement":null},{"id":"W2076027168","doi":"10.1182/blood-2010-12-322727","title":"Increased HIV-specific CD8+ T-cell cytotoxic potential in HIV elite controllers is associated with T-bet expression","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":172,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Center for Research Resources; National Institute of Allergy and Infectious Diseases; Center for AIDS Research, University of Washington; amfAR, The Foundation for AIDS Research","keywords":"Granulysin; Perforin; Granzyme; Granzyme B; Cytotoxic T cell; Granzyme A; Biology; CD8; Effector; T cell; Immunology; Cell biology; Immune system; In vitro; Biochemistry","score_opus":0.012202880227163595,"score_gpt":0.20334096136037944,"score_spread":0.19113808113321584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076027168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908547,0.0017328516,0.000033289034,0.000049198625,0.00005328958,0.0004848935,0.00031677505,0.000065781955,0.0064092274],"genre_scores_gemma":[0.99656963,0.00016509168,0.000107413005,0.00005998035,0.0000148838335,0.00008434737,0.00053654186,0.000023471433,0.002438665],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99837244,0.0003434078,0.00024762025,0.00037683995,0.0000788137,0.0005808808],"domain_scores_gemma":[0.9993804,0.000077805686,0.000102192986,0.0003122817,0.00005655847,0.00007077096],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00018319691,0.00022009514,0.00034073179,0.00016351047,0.00013465722,0.000015233498,0.00019925105,0.00024085422,0.0018993184],"category_scores_gemma":[0.000024612407,0.00016323778,0.00008856728,0.0001516133,0.0001373121,0.00007701883,0.00005859402,0.00030357286,0.001832914],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017295616,0.0040929895,0.051225465,0.000008140086,0.0004212244,0.0005167074,0.0008901816,7.991534e-7,0.9356297,0.000016205395,0.0052684234,0.00020055166],"study_design_scores_gemma":[0.05971669,0.00083463767,0.0922558,0.00016389905,0.0001407537,0.00004328221,0.00032677842,0.000002973793,0.84257585,0.000046535057,0.0034857397,0.00040703738],"about_ca_topic_score_codex":0.00013919549,"about_ca_topic_score_gemma":0.000044358203,"teacher_disagreement_score":0.093053885,"about_ca_system_score_codex":0.00004606147,"about_ca_system_score_gemma":0.00008175122,"threshold_uncertainty_score":0.99901307},"labels":[],"label_agreement":null},{"id":"W2076043109","doi":"10.1182/blood-2012-07-440776","title":"IgM+IgD+CD27+ B cells are markedly reduced in IRAK-4–, MyD88-, and TIRAP- but not UNC-93B–deficient patients","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Hospital for Sick Children; University of Toronto","funders":"National Center for Advancing Translational Sciences; National Institute of Allergy and Infectious Diseases; North Carolina State University","keywords":"TRIF; Immunoglobulin D; Somatic hypermutation; TLR3; B cell; Biology; Signal transducing adaptor protein; TLR9; Immunology; Molecular biology; Cell biology; Antibody; Toll-like receptor; Signal transduction; Immune system; Innate immune system; Gene; Genetics; Gene expression","score_opus":0.009829338867714763,"score_gpt":0.20241811326214745,"score_spread":0.1925887743944327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076043109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990501,0.001328579,0.0000062245367,0.000077193414,0.0042063394,0.0002486176,0.000013418553,0.000049693215,0.0035689252],"genre_scores_gemma":[0.9884175,0.00010295245,0.000022706534,0.0003866924,0.000052637406,0.000022400158,0.00009998185,0.000020314395,0.010874835],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987175,0.00017551516,0.0003336919,0.00027223694,0.000048521582,0.0004525271],"domain_scores_gemma":[0.99942034,0.0000684444,0.00016128938,0.00024488565,0.00006770586,0.000037352685],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022496616,0.00019663654,0.00023733599,0.00016800908,0.00012816288,0.000020252715,0.00010393739,0.0002454224,0.00076327653],"category_scores_gemma":[0.00005690141,0.00018172679,0.00006719083,0.00012716877,0.00007427934,0.00019279576,0.000066907895,0.00033205783,0.0010004933],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039697354,0.0023047389,0.062375158,0.000035521593,0.00012778888,0.0000024369313,0.0009707769,0.0000012713356,0.9188942,0.00008700048,0.01326234,0.0015418101],"study_design_scores_gemma":[0.0045088846,0.00024978945,0.28970066,0.00006019075,0.00009048321,0.000031115036,0.0006172434,0.0000021306196,0.6383224,0.0000056127265,0.06609974,0.00031176084],"about_ca_topic_score_codex":0.00009036154,"about_ca_topic_score_gemma":0.000010403028,"teacher_disagreement_score":0.2805718,"about_ca_system_score_codex":0.000041375246,"about_ca_system_score_gemma":0.00001622012,"threshold_uncertainty_score":0.9997773},"labels":[],"label_agreement":null},{"id":"W2076102211","doi":"10.1182/blood-2014-11-611046","title":"Endothelial cells suppress monocyte activation through secretion of extracellular vesicles containing antiinflammatory microRNAs","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":272,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heart and Stroke Foundation; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Secretion; Proinflammatory cytokine; Cell biology; Extracellular; Microvesicles; Monocyte; Extracellular vesicles; Chemistry; Vesicle; Inflammation; Biology; microRNA; Biochemistry; Immunology; Gene","score_opus":0.01861830793910014,"score_gpt":0.24521836031851604,"score_spread":0.2266000523794159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076102211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925868,0.0020095333,0.0041493555,0.000020475672,0.00014423938,0.00023689927,0.000048498427,0.00002572418,0.0007785092],"genre_scores_gemma":[0.9962909,0.000066059525,0.002887484,0.000034110442,0.0003023999,0.00001468451,0.00014855753,0.00004072755,0.0002150731],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99876696,0.000119983706,0.00033168966,0.00033641828,0.000206503,0.00023842859],"domain_scores_gemma":[0.9990516,0.000017988916,0.00023563529,0.00043635076,0.00014523214,0.00011323235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025485977,0.0001821778,0.00017828589,0.00003521522,0.000047025715,0.000025350058,0.00024848618,0.00017828356,0.000010112538],"category_scores_gemma":[0.00009450573,0.00019823636,0.00010804149,0.00006337459,0.000117797565,0.000022653863,0.0001091253,0.000091059876,0.0000113361875],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026004013,0.0002491757,0.0011959736,0.00004219212,0.0000784379,0.0000138701635,0.0003016398,0.00010396522,0.9971134,0.00013629065,0.00026702916,0.00023798787],"study_design_scores_gemma":[0.0023627868,0.00022409714,0.00026493508,0.000029316609,0.000072185794,0.000010590589,0.00034396342,0.000069912836,0.9894476,0.00020249152,0.006760083,0.00021205729],"about_ca_topic_score_codex":0.000022247374,"about_ca_topic_score_gemma":0.0000020441512,"teacher_disagreement_score":0.007665818,"about_ca_system_score_codex":0.000012589553,"about_ca_system_score_gemma":0.0001442372,"threshold_uncertainty_score":0.8083844},"labels":[],"label_agreement":null},{"id":"W2076190156","doi":"10.1182/blood-2004-10-4077","title":"Podocalyxin is a CD34-related marker of murine hematopoietic stem cells and embryonic erythroid cells","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":127,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Podocalyxin; Haematopoiesis; Stem cell; Biology; Bone marrow; CD34; Embryonic stem cell; Immunology; Progenitor cell; Myeloid; Population; Yolk sac; Cancer research; Cell biology; Molecular biology; Medicine; Embryo; Endocrinology; Genetics","score_opus":0.009147833589389491,"score_gpt":0.22679307068808183,"score_spread":0.21764523709869232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076190156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99253386,0.0014247792,0.00009675152,0.0007270462,0.00009144974,0.000576155,0.000034238456,0.000081226885,0.0044344654],"genre_scores_gemma":[0.99297583,0.00049463054,0.0016521795,0.00025284875,0.000056769124,0.000013990641,0.000011305683,0.000052373958,0.0044900835],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982199,0.00006120368,0.00060752564,0.0003924548,0.00037740113,0.00034150973],"domain_scores_gemma":[0.99897337,0.00013492782,0.00016695302,0.00043318042,0.000083077,0.00020847694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026465263,0.0002537472,0.0005505167,0.00014874215,0.00004163051,0.000013367166,0.00009292894,0.00019510572,0.0006853248],"category_scores_gemma":[0.000004863713,0.00023125927,0.00013206837,0.0002534847,0.00011276019,0.00007266167,0.00003243702,0.00020442724,0.00023977963],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023705402,0.0022033153,0.009235686,0.0037421319,0.00070771127,0.000263105,0.0062415125,0.000014711913,0.97260046,0.00026000495,0.001776975,0.0027173408],"study_design_scores_gemma":[0.0073864725,0.00026286222,0.0037305015,0.0006263618,0.00087948516,0.00076492975,0.00032094072,0.00029273023,0.9840259,0.00004052837,0.0014117432,0.00025752693],"about_ca_topic_score_codex":0.000013508803,"about_ca_topic_score_gemma":0.0000043089753,"teacher_disagreement_score":0.011425465,"about_ca_system_score_codex":0.00002447482,"about_ca_system_score_gemma":0.00007920848,"threshold_uncertainty_score":0.94304794},"labels":[],"label_agreement":null},{"id":"W2076220047","doi":"10.1182/blood-2010-09-308858","title":"Improving academic leadership and oversight in large industry-sponsored clinical trials: the ARO-CRO model","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Clinical trial; Stakeholder; Process (computing); Diversification (marketing strategy); Data monitoring committee; Public relations; Business; Institutional review board; Stakeholder engagement; Process management; Accounting; Medicine; Political science; Computer science; Marketing","score_opus":0.3393740713216744,"score_gpt":0.40507151576369416,"score_spread":0.06569744444201975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076220047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98768246,0.0013897757,0.00011398021,0.0058327275,0.00038519528,0.00027672967,0.00019972556,0.000020518599,0.004098866],"genre_scores_gemma":[0.9945002,0.00033377996,0.00015126854,0.004011037,0.00049171457,0.00001931013,0.0000030164229,0.000021942145,0.0004677018],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9978634,0.000100697944,0.0011497549,0.00040895108,0.000023577139,0.00045360965],"domain_scores_gemma":[0.9983025,0.0007880216,0.0004091355,0.00030474595,0.00000839237,0.00018716817],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0071364343,0.00015655802,0.00055018667,0.00014156211,0.00009478231,0.000073681476,0.00032976843,0.0006785794,0.0002005233],"category_scores_gemma":[0.0023048355,0.00014097622,0.00014777377,0.00012496322,0.0001138149,0.0001860944,0.00012272102,0.0024475893,0.00008213019],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015975325,0.00069502025,0.46750364,0.000063115425,0.0001844028,0.000008630138,0.0010068372,0.000074983844,0.0008846305,0.52245355,0.0029049937,0.0040604235],"study_design_scores_gemma":[0.029948018,0.00019406741,0.124321446,0.00005869907,0.00019839504,0.00004158613,0.0005817175,0.5315567,0.001962652,0.16005315,0.14929985,0.0017836966],"about_ca_topic_score_codex":0.00004782669,"about_ca_topic_score_gemma":0.00006094965,"teacher_disagreement_score":0.53148174,"about_ca_system_score_codex":0.000016552107,"about_ca_system_score_gemma":0.00004874343,"threshold_uncertainty_score":0.9998538},"labels":[],"label_agreement":null},{"id":"W2076249236","doi":"10.1182/blood-2008-07-169003","title":"Genetic elimination of prothrombin in adult mice is not compatible with survival and results in spontaneous hemorrhagic events in both heart and brain","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Heart, Lung, and Blood Institute","keywords":"Biology; Hemostasis; Immunology; Thrombin; Coagulation; Allele; Prothrombin time; Thromboplastin; Null allele; Internal medicine; Platelet; Endocrinology; Medicine; Genetics","score_opus":0.02001707026503771,"score_gpt":0.24982624851520976,"score_spread":0.22980917825017205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076249236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99783754,0.000066308385,0.0000075622706,0.0012142751,0.000015872216,0.00069960323,0.0000073704823,0.00001032806,0.00014115841],"genre_scores_gemma":[0.99709237,0.000044914865,0.002475565,0.00027803914,0.00000962397,0.00001829934,0.000009439628,0.000014386384,0.000057340312],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99887115,0.000089171466,0.0003853216,0.00026605575,0.00022855385,0.00015973879],"domain_scores_gemma":[0.99960154,0.00007155351,0.00008738396,0.00013594163,0.00004637798,0.000057215002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023254538,0.000119127624,0.00034610918,0.000223156,0.00001897113,0.0000026853827,0.000032297474,0.00007436226,0.0000066714592],"category_scores_gemma":[0.000073749085,0.00011183405,0.000013232436,0.000280184,0.00004456083,0.000046165816,0.000019694826,0.00011833072,0.0000012194877],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019840884,0.003698524,0.81016076,0.00046069076,0.000042439828,0.0006983536,0.006563025,0.000031030417,0.17537116,0.00023289265,0.000022835788,0.00073419523],"study_design_scores_gemma":[0.015896106,0.00080401136,0.95404017,0.0003330618,0.000024130484,0.0008520289,0.00019918762,0.0009149584,0.026761895,0.000057982772,0.000004154126,0.00011228847],"about_ca_topic_score_codex":0.00074035994,"about_ca_topic_score_gemma":0.002090234,"teacher_disagreement_score":0.14860927,"about_ca_system_score_codex":0.000019013847,"about_ca_system_score_gemma":0.000055779346,"threshold_uncertainty_score":0.45604604},"labels":[],"label_agreement":null},{"id":"W2076533444","doi":"10.1182/blood-2006-06-028902","title":"The risk of dialysis access thrombosis is related to the transforming growth factor–β1 production haplotype and is modified by polymorphisms in the plasminogen activator inhibitor–type 1 gene","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Central Venous Catheters and Hemodialysis","field":"Health Professions","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Children's Hospital of Eastern Ontario","funders":"","keywords":"Haplotype; Plasminogen activator inhibitor-1; Thrombosis; Odds ratio; Internal medicine; Hemodialysis; Plasminogen activator; Gastroenterology; Medicine; Genotype; Immunology; Biology; Genetics; Gene","score_opus":0.03037280719888878,"score_gpt":0.305172980045287,"score_spread":0.2748001728463982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076533444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901231,0.0006751577,0.000021244567,0.0072490512,0.0002499114,0.0012757878,0.00018061583,0.00002996352,0.00019515454],"genre_scores_gemma":[0.99774176,0.0013185287,0.000022455904,0.0003723013,0.00019129277,0.00010947177,0.00002230613,0.000033147717,0.00018874736],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975906,0.00047850105,0.0006423886,0.00039636297,0.00039144783,0.000500707],"domain_scores_gemma":[0.9985509,0.00043916897,0.00031801505,0.00050361507,0.00012076264,0.00006756867],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.00076498813,0.00022893133,0.00035815258,0.000102384445,0.001325979,0.000050237435,0.00044676257,0.00020250588,0.00005186093],"category_scores_gemma":[0.00012234977,0.000118316624,0.00014824365,0.0008637243,0.00009637291,0.00018453992,0.0000818454,0.00049776357,0.000012292527],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005277532,0.001726728,0.68669856,0.00013428912,0.0012378283,0.0000025558784,0.12699911,0.00007614936,0.16078536,0.00025635678,0.016849771,0.00470553],"study_design_scores_gemma":[0.0034133715,0.0004013558,0.5533183,0.00016739912,0.0020833772,0.000005332492,0.00419406,0.00016402228,0.42868108,0.002369816,0.004481366,0.00072048686],"about_ca_topic_score_codex":0.0056510316,"about_ca_topic_score_gemma":0.0010570639,"teacher_disagreement_score":0.2678957,"about_ca_system_score_codex":0.000059070677,"about_ca_system_score_gemma":0.00009197496,"threshold_uncertainty_score":0.99997413},"labels":[],"label_agreement":null},{"id":"W2076557803","doi":"10.1182/blood-2003-06-2099","title":"Mobilization studies in mice deficient in either C3 or C3a receptor (C3aR) reveal a novel role for complement in retention of hematopoietic stem/progenitor cells in bone marrow","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":174,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Alberta","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health; National Cancer Institute; National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; Canadian Blood Services","keywords":"Progenitor cell; Haematopoiesis; Bone marrow; Complement system; iC3b; Anaphylatoxin; Granulocyte colony-stimulating factor; Mobilization; Stromal cell; Stem cell; Homing (biology); Immunology; Cell biology; Biology; Chemistry; Cancer research; Internal medicine; Medicine; Immune system","score_opus":0.0534705643872653,"score_gpt":0.2913751801326894,"score_spread":0.23790461574542413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076557803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921943,0.0051498194,0.000033849836,0.000026811966,0.00025205064,0.0021498334,0.00015043907,0.000012755034,0.000030168485],"genre_scores_gemma":[0.998493,0.000043860608,0.00045966613,0.000015359648,0.000006840124,0.0006897499,0.00006882735,0.000018889159,0.00020376685],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979312,0.00034137623,0.0009539036,0.00036027073,0.00006369726,0.0003495403],"domain_scores_gemma":[0.9992809,0.00017160224,0.0002454051,0.0002095424,0.00007888077,0.000013657286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007743247,0.00017933807,0.0004772559,0.00033483136,0.000030290972,0.00000504706,0.00012551584,0.00010384118,0.000109109744],"category_scores_gemma":[0.000105007195,0.00016768546,0.00006462662,0.00038360595,0.00005910734,0.000050659633,0.000060033173,0.000091091424,0.000013306997],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003855304,0.003649462,0.098148435,0.000688198,0.000073215204,0.0000036144313,0.0023596233,0.000090627735,0.8938681,0.00038546784,0.0002633061,0.000084450876],"study_design_scores_gemma":[0.029523317,0.00093027856,0.020253336,0.0021175435,0.00013757336,0.00002988031,0.03037988,0.000042867556,0.91381454,0.00025473855,0.0019267409,0.0005893229],"about_ca_topic_score_codex":0.00013345774,"about_ca_topic_score_gemma":0.0024032132,"teacher_disagreement_score":0.0778951,"about_ca_system_score_codex":0.00015170094,"about_ca_system_score_gemma":0.00006855904,"threshold_uncertainty_score":0.6838015},"labels":[],"label_agreement":null},{"id":"W2076596744","doi":"10.1182/blood-2006-08-044370","title":"TC-PTP–deficient bone marrow stromal cells fail to support normal B lymphopoiesis due to abnormal secretion of interferon-γ","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Bone marrow; Stromal cell; Lymphopoiesis; Biology; Cancer research; Cytokine; Tyrosine phosphorylation; Protein tyrosine phosphatase; Cell biology; Chemistry; Signal transduction; Immunology; Internal medicine; Haematopoiesis; Stem cell; Medicine","score_opus":0.005761424982093795,"score_gpt":0.22175596350946797,"score_spread":0.21599453852737419,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076596744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99189436,0.00061996176,0.006031221,0.0000760938,0.0002046447,0.00038876932,0.00026868712,0.00001997869,0.00049630675],"genre_scores_gemma":[0.9956245,0.000009690204,0.0032708955,0.0003076937,0.00018621034,0.000029873174,0.00026371196,0.00003090031,0.0002765276],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99836403,0.000029135534,0.00042277068,0.0004199545,0.0002613276,0.00050278846],"domain_scores_gemma":[0.9990189,0.000011715108,0.00011242395,0.00047635275,0.0001271529,0.00025345472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040275496,0.00022340067,0.00023871027,0.00011232302,0.000055684457,0.000022242151,0.00028793767,0.0001430281,0.0001226991],"category_scores_gemma":[0.00006755808,0.0002339195,0.000112423375,0.00017753546,0.000053538148,0.000008382145,0.0003729928,0.000063007115,0.00007531979],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049585174,0.00028900767,0.0011948127,0.00003997697,0.00004277878,0.000049293736,0.00008698496,0.00006515458,0.99400437,0.00007650156,0.0022232516,0.0014320404],"study_design_scores_gemma":[0.0009840067,0.0023006974,0.0034964073,0.0000237085,0.000045999102,0.000086634514,0.000100528174,0.0000033065442,0.98815906,0.000003339334,0.0045355037,0.0002608084],"about_ca_topic_score_codex":0.00011342243,"about_ca_topic_score_gemma":0.00011931668,"teacher_disagreement_score":0.005845285,"about_ca_system_score_codex":0.000024966143,"about_ca_system_score_gemma":0.00008758742,"threshold_uncertainty_score":0.95389605},"labels":[],"label_agreement":null},{"id":"W2076646108","doi":"10.1182/blood-2008-02-141770","title":"Inherited and acquired variations in the hyaluronan synthase 1 (HAS1) gene may contribute to disease progression in multiple myeloma and Waldenstrom macroglobulinemia","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; Alberta Heritage Foundation for Medical Research; Cancer Research Institute","keywords":"Waldenstrom macroglobulinemia; RNA splicing; Biology; Intron; Macroglobulinemia; Exon; Hyaluronan synthase; Cancer research; Somatic cell; Molecular biology; Bone marrow; Multiple myeloma; Gene; Genetics; Immunology; Lymphoma; RNA","score_opus":0.015890976571391144,"score_gpt":0.273867113036514,"score_spread":0.25797613646512285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076646108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99712485,0.0007798557,0.00012551605,0.0011471995,0.0000132902705,0.0006820338,0.00009163611,0.0000075682256,0.000028031327],"genre_scores_gemma":[0.99796337,0.00011668455,0.0012707066,0.00020968556,0.000049676255,0.00014665742,0.00016404068,0.000010664984,0.00006849311],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990062,0.00012978021,0.00017581624,0.00029658273,0.00015789218,0.00023369613],"domain_scores_gemma":[0.9995124,0.000029215991,0.000031358577,0.00022866635,0.000048947077,0.0001494666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019576702,0.00011358838,0.000105868785,0.00007168505,0.00011867378,0.000030221328,0.000111238594,0.000081915176,0.0000078363255],"category_scores_gemma":[0.00034901447,0.00008977334,0.000021627704,0.00017868924,0.00007703313,0.000005698801,0.00011392897,0.000068711495,0.0000028639163],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006946066,0.0008692442,0.49603626,0.000033156903,0.000030115298,0.00037991573,0.00040917157,0.000029090426,0.49130434,0.000047177236,0.0002610327,0.009905896],"study_design_scores_gemma":[0.0049618925,0.00032720208,0.9546136,0.000038488914,0.000014280696,0.000085105596,0.000049930066,0.000802432,0.035034813,0.000021787673,0.0038594173,0.00019100934],"about_ca_topic_score_codex":0.00007390509,"about_ca_topic_score_gemma":0.0002427657,"teacher_disagreement_score":0.45857736,"about_ca_system_score_codex":0.0000074520385,"about_ca_system_score_gemma":0.00006414005,"threshold_uncertainty_score":0.36608505},"labels":[],"label_agreement":null},{"id":"W2076684617","doi":"10.1182/blood-2013-07-515726","title":"Polyphosphate suppresses complement via the terminal pathway","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; Howard Hughes Medical Institute","keywords":"Polyphosphate; Complement system; Lysis; Biochemistry; Innate immune system; Alternative complement pathway; Complement membrane attack complex; Chemistry; Classical complement pathway; Biology; Cell biology; Biophysics; Phosphate; Immune system; Immunology; Receptor","score_opus":0.015294156154986915,"score_gpt":0.24303309952759877,"score_spread":0.22773894337261186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076684617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98843396,0.0026736264,0.00012946872,0.0035257468,0.00025449868,0.0008016053,0.0000170919,0.00012962167,0.0040343753],"genre_scores_gemma":[0.9951121,0.00004115634,0.00046197473,0.0011908564,0.00040000697,0.0000855408,0.00004641726,0.000026763262,0.002635177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987571,0.000032631957,0.00030677038,0.00024114676,0.00030031477,0.0003620411],"domain_scores_gemma":[0.99913555,0.00009179509,0.00009165448,0.0004323788,0.00009640894,0.00015221669],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000121913254,0.00018377138,0.00023637689,0.000042604228,0.00019043464,0.00006135544,0.0001599761,0.000053312342,0.0025261429],"category_scores_gemma":[0.000029661933,0.000117960415,0.00012623596,0.00012246592,0.00009958232,0.00011341663,0.00007131901,0.00010987803,0.00039990107],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022972666,0.0054296004,0.6166731,0.0005136202,0.0013578966,0.000518851,0.005563544,0.000011472731,0.09389033,0.00857815,0.0626167,0.20461698],"study_design_scores_gemma":[0.005447032,0.0005682705,0.73709685,0.00015401699,0.00045874534,0.00065062795,0.00038531274,0.000501032,0.17724697,0.0017268035,0.075339586,0.00042473554],"about_ca_topic_score_codex":0.0006275197,"about_ca_topic_score_gemma":0.000030515897,"teacher_disagreement_score":0.20419224,"about_ca_system_score_codex":0.000012846806,"about_ca_system_score_gemma":0.00006356524,"threshold_uncertainty_score":0.99838567},"labels":[],"label_agreement":null},{"id":"W2077152576","doi":"10.1182/blood-2007-03-080044","title":"Mutations in the SBDS gene in acquired aplastic anemia","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; SickKids Foundation; Hospital for Sick Children; Terry Fox Research Institute; University of Toronto","funders":"National Institutes of Health","keywords":"Loss of heterozygosity; Telomerase; Biology; Telomere; Bone marrow failure; Mutation; Aplastic anemia; Allele; Cancer research; Molecular biology; Gene; Genetics; Bone marrow; Immunology; Haematopoiesis; Stem cell","score_opus":0.00700296651986524,"score_gpt":0.24104088557951367,"score_spread":0.23403791905964844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077152576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971675,0.0007856186,0.00012738109,0.000064746535,0.000028086155,0.00012195848,0.000005751859,0.000003295605,0.0016956449],"genre_scores_gemma":[0.999363,0.000033481436,0.00022633214,0.00016291188,0.00004081396,0.000017035225,0.00009249332,0.0000069672647,0.000056936446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994884,0.000022101804,0.00011600968,0.00014463448,0.000060726004,0.00016813101],"domain_scores_gemma":[0.9997778,0.000016821636,0.00002122484,0.0001529479,0.000010126283,0.000021090691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011890488,0.00007160818,0.000056669756,0.000037648875,0.000028149505,0.00000900457,0.00009734215,0.00006939429,0.0000060042753],"category_scores_gemma":[0.000027684524,0.0000550984,0.000026297233,0.00012484804,0.000025828744,0.0000015246193,0.000019297519,0.00003060543,0.000007614837],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015805525,0.0060137506,0.62677234,0.000030203726,0.00014393381,0.00047546602,0.0012284607,0.00020842075,0.3552642,0.00038954514,0.00039818004,0.0089174695],"study_design_scores_gemma":[0.010597783,0.000565158,0.5858267,0.00001820803,0.00012282861,0.0001145658,0.00083328306,0.00001890614,0.3989532,0.0007328453,0.0018646334,0.00035187817],"about_ca_topic_score_codex":0.000049675466,"about_ca_topic_score_gemma":0.00092654105,"teacher_disagreement_score":0.04368899,"about_ca_system_score_codex":0.0000034599357,"about_ca_system_score_gemma":0.000023132392,"threshold_uncertainty_score":0.22468476},"labels":[],"label_agreement":null},{"id":"W2077236416","doi":"10.1182/blood-2007-11-122408","title":"Targeting dendritic cell signaling to regulate the response to immunization","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"University College London; Cancer Research UK","keywords":"Immune system; MAPK/ERK pathway; IRF3; Biology; Antigen; Signal transduction; Cell biology; Interferon; Interferon regulatory factors; Immunology; Dendritic cell; Protein kinase A; Immune tolerance; Cancer research; Kinase; Innate immune system","score_opus":0.00954760932157126,"score_gpt":0.21463727763801516,"score_spread":0.2050896683164439,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077236416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99161404,0.005904922,0.00066993345,0.00084274536,0.0003368675,0.00037076094,0.000006540498,0.000091366,0.00016281205],"genre_scores_gemma":[0.98970324,0.00009098593,0.0004118229,0.0009115113,0.000032718333,0.000037768255,0.000017691762,0.00003245715,0.008761786],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99819267,0.0008099102,0.00030994377,0.0002330589,0.000047511145,0.00040692603],"domain_scores_gemma":[0.9989012,0.00048927235,0.00006625476,0.00042840344,0.00009163713,0.000023229451],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000689212,0.00017126762,0.0001902454,0.00014220769,0.0008144741,0.000021333231,0.00037658878,0.00012905714,0.00026303367],"category_scores_gemma":[0.00038118532,0.00013313038,0.000077213066,0.00035495026,0.00009098778,0.00006867957,0.00010640109,0.00021163443,0.001191629],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016994986,0.0001531343,0.0002192555,0.0000038119263,0.000066624016,0.000012365474,0.0036936004,0.00019288075,0.99264497,0.000018927009,0.0010584433,0.0002364893],"study_design_scores_gemma":[0.0014381433,0.00035487983,0.005295285,0.000035421846,0.000032470274,0.00017179889,0.00045158414,0.0000012470955,0.9413444,0.0000099477065,0.050658308,0.00020654424],"about_ca_topic_score_codex":0.000038413942,"about_ca_topic_score_gemma":8.5864997e-7,"teacher_disagreement_score":0.0513006,"about_ca_system_score_codex":0.000020981577,"about_ca_system_score_gemma":0.00008108573,"threshold_uncertainty_score":0.99958605},"labels":[],"label_agreement":null},{"id":"W2077694466","doi":"10.1182/blood-2005-03-1004","title":"Allogeneic marrow stromal cells are immune rejected by MHC class I– and class II–mismatched recipient mice","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":554,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Immunology; Bone marrow; CD8; Immune system; Major histocompatibility complex; MHC class I; Stromal cell; Mesenchymal stem cell; Splenocyte; Transplantation; Medicine; Biology; Cancer research; Pathology; Internal medicine","score_opus":0.013655311797070016,"score_gpt":0.25097036789721033,"score_spread":0.2373150561001403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077694466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849508,0.0041407277,0.000008070525,0.0035393918,0.000109565895,0.00074694,0.000045518696,0.00010897796,0.0063500535],"genre_scores_gemma":[0.9780719,0.0004169601,0.0011580477,0.0002896654,0.00029746536,0.00004607892,0.00007280231,0.000063475825,0.019583547],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99723047,0.00016122719,0.00050266035,0.00062087923,0.0007298189,0.00075491925],"domain_scores_gemma":[0.9984307,0.00013595665,0.0001634967,0.00060548494,0.00017986259,0.00048449796],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048830634,0.00030638947,0.00054647546,0.00013646345,0.00018268454,0.000043726715,0.00023756089,0.0002811442,0.00058515253],"category_scores_gemma":[0.0001404611,0.00027353704,0.00011605516,0.00031706682,0.00013143082,0.00008024219,0.00025004533,0.0005274328,0.00016732657],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023072014,0.0009703483,0.007222012,0.00013449634,0.0001723013,0.00011895839,0.00020688129,0.0000023717591,0.9786818,0.000011312066,0.0109177595,0.0013310396],"study_design_scores_gemma":[0.008455734,0.00097460987,0.023428341,0.00021708445,0.0002796185,0.000226351,0.00033792708,0.00028178075,0.8849179,0.000008001975,0.08047185,0.00040080526],"about_ca_topic_score_codex":0.00009814889,"about_ca_topic_score_gemma":0.00006310354,"teacher_disagreement_score":0.0937639,"about_ca_system_score_codex":0.0001137978,"about_ca_system_score_gemma":0.00012414837,"threshold_uncertainty_score":0.9999717},"labels":[],"label_agreement":null},{"id":"W2077716817","doi":"10.1182/blood-2014-06-583351","title":"Randomized phase 2 study of GMI-1070 in SCD: reduction in time to resolution of vaso-occlusive events and decreased opioid use","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":206,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Children's Hospital of Pittsburgh; University of Colorado Denver; University of Illinois at Urbana-Champaign; Hospital for Sick Children; Leonard M. Miller School of Medicine; Children's National Hospital; University of Cincinnati; Johns Hopkins University; Harvard University; Cincinnati Children's Hospital Medical Center; Emory University; University of Miami; Children's Hospital of Philadelphia; Virginia Commonwealth University; University of California","keywords":"Medicine; Internal medicine; Surrogate endpoint; Opioid; Randomized controlled trial; Reduction (mathematics); Anesthesia; Cardiology; Mathematics","score_opus":0.04003207888325372,"score_gpt":0.3151541970754425,"score_spread":0.2751221181921888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077716817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978569,0.00006774399,0.00004558781,0.00007526667,0.00004635491,0.0018142042,0.000004969793,0.000013339159,0.00007561084],"genre_scores_gemma":[0.9990596,0.000009371473,0.0007275392,0.000028220677,0.00002284735,0.000046246667,0.000018312967,0.000011302014,0.00007651778],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99860585,0.00028025213,0.0004840959,0.00020149078,0.00031216987,0.00011614989],"domain_scores_gemma":[0.9993086,0.00006671974,0.0001508023,0.00020074741,0.00013852777,0.00013459737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008978226,0.0001032528,0.0005901283,0.00035671098,0.000012048395,0.0000044339445,0.000046452125,0.0000682067,0.000029014647],"category_scores_gemma":[0.00056554703,0.000094948104,0.000039360675,0.00035922148,0.000026063237,0.00009604445,0.00004471885,0.00008004831,0.0000053916015],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.30247077,0.10183953,0.07950313,0.000307754,0.0010996268,0.00007124364,0.035907608,0.00029008926,0.4756796,0.0005284171,0.00034101465,0.0019612017],"study_design_scores_gemma":[0.920995,0.0024630742,0.028330147,0.00036513357,0.0005932059,0.000018909772,0.0013150622,0.00081127166,0.04453942,0.00041021602,0.00001363035,0.00014490887],"about_ca_topic_score_codex":0.00053694827,"about_ca_topic_score_gemma":0.000043940618,"teacher_disagreement_score":0.61852425,"about_ca_system_score_codex":0.000030000745,"about_ca_system_score_gemma":0.00008618775,"threshold_uncertainty_score":0.38718715},"labels":[],"label_agreement":null},{"id":"W2078104401","doi":"10.1182/blood-2008-05-159434","title":"Role of activated protein C and its receptor in inhibition of tumor metastasis","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Endothelial protein C receptor; Metastasis; Cancer research; Protein C; Endothelium; Receptor; Cell adhesion molecule; Biology; Immunology; Medicine; Internal medicine; Cancer; Endocrinology; Thrombin","score_opus":0.01631414254467596,"score_gpt":0.24974019694149296,"score_spread":0.23342605439681702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078104401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99869573,0.00024303196,0.0000036094477,0.00020169208,0.0000054003385,0.00036575313,0.0000068035793,0.00001515091,0.00046281924],"genre_scores_gemma":[0.9987507,0.000007987682,0.0011382311,0.000050038947,0.000010883679,0.000008052277,0.000008668758,0.0000055573796,0.000019922967],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994617,0.000029727707,0.00020516728,0.00010420317,0.000122983,0.00007620735],"domain_scores_gemma":[0.9997165,0.000007479122,0.00009548248,0.00008206475,0.000059030954,0.000039403585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010622277,0.00006301461,0.00022425293,0.0001138745,0.00000827148,0.0000017512574,0.000016253032,0.000039075432,0.00006976749],"category_scores_gemma":[0.000049858998,0.00005708969,0.000027348418,0.00020240087,0.000010036916,0.000050994266,0.000008091138,0.000057770838,0.000002037224],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057579076,0.00078267016,0.00023516269,0.000045408382,0.000023781882,0.0000013077031,0.00013484285,2.2679605e-7,0.99513537,0.0020373762,0.0000022118136,0.0015440496],"study_design_scores_gemma":[0.0026261301,0.0004918591,0.015734624,0.00021408159,0.00006847339,0.0000047835724,0.00008268618,0.000016571294,0.97993404,0.00076072174,0.000020254876,0.00004575139],"about_ca_topic_score_codex":0.000008189442,"about_ca_topic_score_gemma":0.0000021943554,"teacher_disagreement_score":0.015499462,"about_ca_system_score_codex":0.0000047314056,"about_ca_system_score_gemma":0.000022873583,"threshold_uncertainty_score":0.232805},"labels":[],"label_agreement":null},{"id":"W2078277354","doi":"10.1182/blood-2013-04-496760","title":"Heme oxygenase 1 is expressed in murine erythroid cells where it controls the level of regulatory heme","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Heme Oxygenase-1 and Carbon Monoxide","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Heme oxygenase; Heme; Oxygenase; Chemistry; Molecular biology; Biology; Cell biology; Biochemistry; Enzyme","score_opus":0.016473391713010446,"score_gpt":0.2291938900025561,"score_spread":0.21272049828954565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078277354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99568194,0.0011935554,0.0001488731,0.0005840763,0.000066691835,0.0002399696,0.00009789921,0.000009101892,0.001977899],"genre_scores_gemma":[0.99656427,0.00018798333,0.0002745397,0.0010537397,0.00022596095,0.000039080693,0.000022794211,0.000031328884,0.0016002852],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99865776,0.00011293584,0.00036234502,0.00036752626,0.00018829697,0.00031111375],"domain_scores_gemma":[0.9988899,0.0000301863,0.0001310783,0.0007868303,0.00007202858,0.00008996049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036337617,0.00020178194,0.00026137236,0.000034861947,0.000041156658,0.000014512837,0.00032828463,0.00017306386,0.0000673404],"category_scores_gemma":[0.000057751942,0.00016008761,0.0001468374,0.000082150014,0.0001020441,0.0000041190824,0.00011359527,0.00011132214,0.00001423651],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052077852,0.00023247674,0.0006229229,0.00004115263,0.00006237485,0.000003797106,0.00007532626,0.000014896435,0.9902987,0.0000601525,0.00830482,0.00023129015],"study_design_scores_gemma":[0.0026692115,0.00015137762,0.001975175,0.000029758032,0.000031775307,0.000004837732,0.00009335472,0.00003940347,0.9393238,0.00006935961,0.05542031,0.00019166505],"about_ca_topic_score_codex":0.00007729184,"about_ca_topic_score_gemma":0.00016240937,"teacher_disagreement_score":0.05097494,"about_ca_system_score_codex":0.0000060063835,"about_ca_system_score_gemma":0.00006564572,"threshold_uncertainty_score":0.6528183},"labels":[],"label_agreement":null},{"id":"W2078349955","doi":"10.1182/blood-2012-02-413526","title":"Thymic retention of CD4+CD25+FoxP3+ T regulatory cells is associated with their peripheral deficiency and thrombocytopenia in a murine model of immune thrombocytopenia","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Canadian Blood Services; St. Michael's Hospital","funders":"Canadian Blood Services","keywords":"FOXP3; Platelet; Splenocyte; Immunology; Medicine; Spleen; Immune system; IL-2 receptor; Bone marrow; Antibody; Adoptive cell transfer; Internal medicine; Endocrinology; T cell","score_opus":0.01858813647176059,"score_gpt":0.22802316566322992,"score_spread":0.20943502919146934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078349955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959494,0.002371998,0.000014540907,0.00003656369,0.000024567826,0.00045958944,0.00005030681,0.000018177854,0.0010748677],"genre_scores_gemma":[0.999044,0.00021988746,0.00042349464,0.000032126496,0.000007709731,0.000012834859,0.000035386398,0.000027515021,0.00019702637],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987773,0.000040322015,0.00039971253,0.00022485919,0.00023892931,0.0003189199],"domain_scores_gemma":[0.9992917,0.000024364805,0.00023962367,0.0002957591,0.00007161268,0.00007694058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023464917,0.0002062996,0.0007781648,0.00009838259,0.000040775976,0.0000059723793,0.00007747922,0.00012174972,0.000053365522],"category_scores_gemma":[0.000014903944,0.0001499706,0.00008567096,0.00020065717,0.00013171206,0.00017931651,0.000051120398,0.00012485977,0.0000015009268],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004607737,0.006824465,0.3198856,0.00027162716,0.0005960699,0.000039708888,0.0045835623,0.00005406261,0.66652817,0.00018368986,0.00003778451,0.0005344776],"study_design_scores_gemma":[0.014973263,0.0009788903,0.71837467,0.0004771782,0.00060646376,0.00007821168,0.00045554742,0.0012614455,0.26228994,0.00024018041,0.000004287504,0.00025989828],"about_ca_topic_score_codex":0.00012817472,"about_ca_topic_score_gemma":0.000047221856,"teacher_disagreement_score":0.4042382,"about_ca_system_score_codex":0.000044782428,"about_ca_system_score_gemma":0.000080214646,"threshold_uncertainty_score":0.6115624},"labels":[],"label_agreement":null},{"id":"W2078380089","doi":"10.1182/blood-2005-11-026823","title":"Enhanced natural-killer cell and erythropoietic activities in VEGF-A–overexpressing mice delay F-MuLV–induced erythroleukemia","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Health Sciences Centre; Mount Sinai Hospital; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Bone marrow; Haematopoiesis; Biology; Erythropoiesis; Progenitor cell; Spleen; Erythropoietin; CD34; Leukemia; Immunology; Cancer research; Stem cell; Internal medicine; Endocrinology; Anemia; Medicine; Cell biology","score_opus":0.00497764807534196,"score_gpt":0.2037764782996262,"score_spread":0.19879883022428424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078380089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847477,0.0037286258,0.000045667322,0.000060037557,0.0022874232,0.0001459828,0.0000011220554,0.00006987226,0.0089135645],"genre_scores_gemma":[0.9858595,0.00010364416,0.000046529192,0.0001272987,0.0000604046,0.000017507722,0.000053805907,0.00002189707,0.0137094185],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988879,0.0001263672,0.0002838179,0.00032625304,0.00003736846,0.00033827097],"domain_scores_gemma":[0.9995512,0.00011065061,0.00012354825,0.00017531832,0.000027151425,0.000012139529],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008603792,0.00020934935,0.00024116693,0.00014395315,0.00017190518,0.000040308594,0.00008683712,0.0002471062,0.0004122519],"category_scores_gemma":[0.000016286167,0.0001978915,0.00006329855,0.0001074722,0.000099044504,0.0002664995,0.0000574996,0.00047227397,0.00013869401],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011424333,0.0003010649,0.00022976272,0.000022115411,0.000038213133,0.0000049401965,0.00034976864,0.000006506599,0.99666256,0.000043476928,0.0017082571,0.00051912066],"study_design_scores_gemma":[0.0035729115,0.000117376854,0.0038328378,0.00007426297,0.00004558505,0.00009131542,0.00055622467,0.00001197101,0.9857425,0.000039487746,0.005662331,0.00025318077],"about_ca_topic_score_codex":0.00042870155,"about_ca_topic_score_gemma":0.00007787871,"teacher_disagreement_score":0.010920015,"about_ca_system_score_codex":0.000060131028,"about_ca_system_score_gemma":0.000039079678,"threshold_uncertainty_score":0.8069781},"labels":[],"label_agreement":null},{"id":"W2078397642","doi":"10.1182/blood-2009-06-222448","title":"Combination immunosuppressant therapy for patients with chronic refractory immune thrombocytopenic purpura","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Canadian Blood Services","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Refractory (planetary science); Thrombocytopenic purpura; Azathioprine; Splenectomy; Adverse effect; Internal medicine; Gastroenterology; Surgery; Platelet; Spleen","score_opus":0.00817681686371439,"score_gpt":0.24352797457977457,"score_spread":0.2353511577160602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078397642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99430037,0.0031311414,0.000016327711,0.00025482773,0.000053269232,0.0013600761,0.000015276637,0.000052258776,0.00081642956],"genre_scores_gemma":[0.9984939,0.0004895736,0.00019414861,0.00013020054,0.00002733929,0.00006685559,0.00039691784,0.000021240232,0.00017982924],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99919343,0.000012812626,0.00017524196,0.00020512476,0.00018300475,0.00023036459],"domain_scores_gemma":[0.9994597,0.000023112781,0.00009224309,0.00027520105,0.00010306006,0.00004670452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000041533407,0.00015848094,0.0003038689,0.00005116175,0.00009696826,0.000019095625,0.00007368664,0.00006726067,0.000050476363],"category_scores_gemma":[0.000010117279,0.00010939495,0.00007714928,0.00008405263,0.000025364376,0.00012514656,0.000007175114,0.000083632265,0.000013017057],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012984305,0.15639894,0.24640906,0.00032682336,0.0061217775,0.00047957487,0.0014118544,0.0000064753017,0.107600845,0.001782944,0.0021818117,0.4642956],"study_design_scores_gemma":[0.06377131,0.014809415,0.90428317,0.000103745355,0.0002548981,0.00002276068,0.000011695732,0.000011150314,0.01360228,0.000351915,0.0025787083,0.00019893196],"about_ca_topic_score_codex":0.0000127784515,"about_ca_topic_score_gemma":0.0000020481366,"teacher_disagreement_score":0.65787417,"about_ca_system_score_codex":0.000056685425,"about_ca_system_score_gemma":0.000075728865,"threshold_uncertainty_score":0.44609964},"labels":[],"label_agreement":null},{"id":"W2078406257","doi":"10.1182/blood.v98.6.1842","title":"Decreased von Willebrand factor protease activity associated with thrombocytopenic disorders","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":178,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"","keywords":"Von Willebrand factor; Medicine; Thrombotic thrombocytopenic purpura; Internal medicine; Von Willebrand disease; Factor IX; Protease; Immunology; Platelet; Biology; Biochemistry; Enzyme","score_opus":0.015040101025285068,"score_gpt":0.23772212416663807,"score_spread":0.222682023141353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078406257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968491,0.0004472466,0.00004910525,0.000115664116,0.000099155266,0.00096988055,0.00012811105,0.00018282693,0.0011589023],"genre_scores_gemma":[0.99891794,0.0000207154,0.000008484402,0.00003948318,0.000015319365,0.00013052228,0.00013777438,0.000024878436,0.00070489733],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987184,0.00028837819,0.00019032849,0.0003391422,0.00006493608,0.00039882556],"domain_scores_gemma":[0.99924165,0.0001529964,0.00016287276,0.0003481754,0.000043439275,0.00005088169],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00010268851,0.00022091116,0.00031282805,0.00006380356,0.0002165003,0.000022962457,0.00020668862,0.000118677075,0.0021519552],"category_scores_gemma":[0.00017641354,0.00017617655,0.00009087298,0.00016942168,0.000115963405,0.00012814475,0.000058109632,0.00014857958,0.0001745142],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005950703,0.003329339,0.8860612,0.00002584075,0.0011201445,0.000022903172,0.00014961822,0.0000016521368,0.10642245,0.00003455593,0.00068355043,0.0015536941],"study_design_scores_gemma":[0.013639565,0.0005672716,0.943621,0.00013404146,0.000365106,0.00003901072,0.00009157262,0.0000023410198,0.035918422,0.00008104866,0.0050764326,0.0004642197],"about_ca_topic_score_codex":0.00019571288,"about_ca_topic_score_gemma":0.00065941596,"teacher_disagreement_score":0.070504025,"about_ca_system_score_codex":0.00003853153,"about_ca_system_score_gemma":0.0001033039,"threshold_uncertainty_score":0.9987602},"labels":[],"label_agreement":null},{"id":"W2078460274","doi":"10.1182/blood-2010-10-311415","title":"A microRNA expression signature of osteoclastogenesis","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Bone Metabolism and Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":274,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"microRNA; Gene expression profiling; Expression (computer science); Biology; Gene expression; Medicine; Computational biology; Genetics; Computer science; Gene","score_opus":0.010098223270633387,"score_gpt":0.20176924772279706,"score_spread":0.19167102445216366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078460274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99203527,0.0055021523,0.000083365434,0.0000034280345,0.00004937856,0.000054136282,0.00003192105,0.000006329021,0.0022340063],"genre_scores_gemma":[0.99798006,0.00008367929,0.0015907278,0.00005461585,0.00007788564,0.0000061925475,0.00002308522,0.000009983938,0.00017379168],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995943,0.000021727157,0.000091129936,0.00014598502,0.000052771167,0.00009410045],"domain_scores_gemma":[0.99964744,0.0000020436073,0.00004691355,0.0002175476,0.000035700865,0.000050364135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00002861347,0.00007263966,0.000082335886,0.000017892367,0.000018245342,0.000002012907,0.00010313501,0.000087321,0.000047683716],"category_scores_gemma":[0.000022064285,0.00006113687,0.0000703167,0.00003521015,0.00003243231,0.0000013561563,0.00006160054,0.000021866974,0.0000042804095],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006159616,0.00025744428,0.00487365,0.000014004779,0.00001886142,0.000002116532,0.00004624804,1.3699314e-7,0.993868,0.000017764156,0.00050864596,0.0003315193],"study_design_scores_gemma":[0.0005949322,0.000075782795,0.011781835,0.000008494795,0.000052735555,0.000004228726,0.000032245447,6.902225e-8,0.9842301,0.00003314554,0.0031108048,0.00007563392],"about_ca_topic_score_codex":0.000007635875,"about_ca_topic_score_gemma":0.0000016958841,"teacher_disagreement_score":0.00963792,"about_ca_system_score_codex":3.3264737e-7,"about_ca_system_score_gemma":0.00002534067,"threshold_uncertainty_score":0.2493089},"labels":[],"label_agreement":null},{"id":"W2078526803","doi":"10.1182/blood-2013-03-492801","title":"Activated platelets can deliver mRNA regulatory Ago2•microRNA complexes to endothelial cells via microparticles","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":434,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec","funders":"Canadian Institutes of Health Research","keywords":"microRNA; Cell biology; Platelet; Endogeny; Gene silencing; Gene expression; Biology; Regulation of gene expression; Chemistry; Molecular biology; Gene; Immunology; Biochemistry","score_opus":0.006768637729867742,"score_gpt":0.20564151202377368,"score_spread":0.19887287429390593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078526803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987132,0.00020939928,0.00011458481,0.00015220915,0.000098702905,0.00048643458,0.000086418804,0.00003941625,0.000099652825],"genre_scores_gemma":[0.9976317,0.000013208735,0.0012875409,0.00040485713,0.00024102653,0.000042197094,0.00010508763,0.00004687804,0.00022750434],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99874556,0.000064084685,0.0002499368,0.00042313698,0.0001390235,0.00037826484],"domain_scores_gemma":[0.99907833,0.000009659407,0.00009300473,0.0004575154,0.00013087389,0.0002306409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006162428,0.00022184134,0.00016596282,0.00005708038,0.000097784876,0.00005041303,0.00023391916,0.00013920713,0.00017040381],"category_scores_gemma":[0.000018079474,0.00022387507,0.000094215284,0.00009292018,0.000076261764,0.000007829908,0.00013979804,0.0000680897,0.00024576735],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043216427,0.00019682357,0.00068472285,0.000014544447,0.000104612416,0.0000054112097,0.00005710054,0.00004880581,0.9939841,0.0000050215967,0.0038307863,0.0010248296],"study_design_scores_gemma":[0.0010543829,0.000098477474,0.019519038,0.000014490857,0.000043809407,0.000026015754,0.000017329454,0.000014818438,0.9743089,0.00003815839,0.0045817173,0.000282825],"about_ca_topic_score_codex":0.00019808285,"about_ca_topic_score_gemma":0.00004885529,"teacher_disagreement_score":0.01967519,"about_ca_system_score_codex":0.00002302217,"about_ca_system_score_gemma":0.000050454953,"threshold_uncertainty_score":0.91293603},"labels":[],"label_agreement":null},{"id":"W2078736354","doi":"10.1182/blood-2012-05-431205","title":"The VPS33B-binding protein VPS16B is required in megakaryocyte and platelet α-granule biogenesis","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Eye Institute; Canadian Institutes of Health Research; National Science Foundation","keywords":"Megakaryocyte; Biogenesis; Cell biology; Chemistry; Platelet; Biology; Plasma protein binding; Molecular biology; Biochemistry; Immunology; Haematopoiesis; Gene; Stem cell","score_opus":0.017227469230169483,"score_gpt":0.2506366938267291,"score_spread":0.2334092245965596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078736354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929513,0.004502118,0.0000010796535,0.0006969045,0.000045892,0.0005329461,0.00001718127,0.000031389995,0.001221191],"genre_scores_gemma":[0.9980902,0.00043111024,0.00032911802,0.000112149486,0.000053380667,0.00007276392,0.000017622173,0.000021550048,0.0008720773],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990533,0.000024692972,0.00018376908,0.00017822123,0.00015533264,0.0004046729],"domain_scores_gemma":[0.99955684,0.000040761737,0.000050996645,0.00021217512,0.000014544553,0.00012467061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019537457,0.00014738058,0.0002308576,0.00006424232,0.0001447289,0.000023883134,0.000055338252,0.00008355551,0.000021337626],"category_scores_gemma":[0.000028453147,0.00009644782,0.000059955997,0.00018203717,0.000054470653,0.00011101257,0.00003851433,0.00008477766,0.00004556654],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007770695,0.0040385923,0.7827119,0.00023409564,0.0013051523,0.0009814575,0.003407108,1.5771914e-7,0.15842862,0.00047699385,0.0016355318,0.04600328],"study_design_scores_gemma":[0.031560134,0.0006318514,0.116970256,0.00043694125,0.0006713933,0.0011141836,0.0009022341,0.00005263402,0.81341624,0.0004869781,0.033063237,0.0006939413],"about_ca_topic_score_codex":0.00012201247,"about_ca_topic_score_gemma":0.000033222885,"teacher_disagreement_score":0.6657417,"about_ca_system_score_codex":0.000020703472,"about_ca_system_score_gemma":0.000024508594,"threshold_uncertainty_score":0.3933028},"labels":[],"label_agreement":null},{"id":"W2078786399","doi":"10.1182/blood-2011-05-352039","title":"Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trial","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":198,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut Gustave-Roussy; Institut National Du Cancer; Association pour la Recherche sur le Cancer","keywords":"Decitabine; Chronic myelomonocytic leukemia; Medicine; Internal medicine; Oncology; Neuroblastoma RAS viral oncogene homolog; Azacitidine; KRAS; Hypomethylating agent; Leukemia; Phases of clinical research; Myelodysplastic syndromes; Clinical trial; Bone marrow; Biology; Cancer; Gene; DNA methylation; Gene expression","score_opus":0.023853825533364036,"score_gpt":0.31250658665482584,"score_spread":0.2886527611214618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078786399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996014,0.00043364472,0.00015474783,0.00013651901,0.00010250614,0.0019420375,0.000016809747,0.00005688407,0.0011428581],"genre_scores_gemma":[0.99716073,0.000039286486,0.0020492622,0.000096605116,0.00012581804,0.0002159422,0.000010921234,0.000052152755,0.00024926354],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978131,0.00019496927,0.00056692155,0.0004239673,0.000470002,0.0005310253],"domain_scores_gemma":[0.99855316,0.00016806572,0.000094385214,0.0007123108,0.00012765378,0.00034440865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007888985,0.00021347725,0.00054337125,0.00055982504,0.00002235341,0.0000049773143,0.00026938392,0.00016646986,0.00014965219],"category_scores_gemma":[0.0015786341,0.00019675567,0.00012883663,0.00081780116,0.000101050166,0.00008051953,0.0001377147,0.00039216995,0.000053127933],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3395718,0.0023831434,0.0011855534,0.0001335119,0.00022401186,0.0017502671,0.0015875674,0.00003220235,0.6488001,0.000046967798,0.00015468543,0.0041301837],"study_design_scores_gemma":[0.42457354,0.016272511,0.007379274,0.00027774184,0.00024141074,0.00008613432,0.0001871036,0.0001736481,0.5497392,0.000045069723,0.0007770643,0.00024731224],"about_ca_topic_score_codex":0.00010814208,"about_ca_topic_score_gemma":0.000022677514,"teacher_disagreement_score":0.0990609,"about_ca_system_score_codex":0.0010189195,"about_ca_system_score_gemma":0.0022379244,"threshold_uncertainty_score":0.80234635},"labels":[],"label_agreement":null},{"id":"W2079013883","doi":"10.1182/blood-2004-06-2125","title":"Inhibition of Akt increases p27Kip1 levels and induces cell cycle arrest in anaplastic large cell lymphoma","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"Anaplastic large-cell lymphoma; Protein kinase B; Anaplastic lymphoma kinase; Cancer research; Cell cycle; Lymphoma; PI3K/AKT/mTOR pathway; Kinase; Cell cycle checkpoint; Chemistry; Biology; Signal transduction; Medicine; Apoptosis; Pathology; Immunology; Cell biology; Biochemistry","score_opus":0.010442712795126296,"score_gpt":0.22817432091634735,"score_spread":0.21773160812122105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079013883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99643177,0.0012308909,0.000002947321,0.0000623795,0.000033461332,0.000236381,0.00006936687,0.000020762696,0.0019120455],"genre_scores_gemma":[0.99945116,0.000085785854,0.00023073776,0.000096328455,0.000045254426,0.000027464837,0.000032996606,0.000013896253,0.000016384482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991578,0.000022456223,0.00023403356,0.00021966464,0.00016061025,0.00020543487],"domain_scores_gemma":[0.9995545,0.00007446042,0.00008198995,0.00014747588,0.00003011935,0.00011141225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007058416,0.00014047622,0.00026384537,0.00012516488,0.000036212412,0.000011277773,0.000027874841,0.00008200888,0.00001842744],"category_scores_gemma":[0.000034563804,0.00011930015,0.00004486115,0.00015706403,0.000040046292,0.00007295039,0.000037496888,0.00003516573,0.000016491384],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003223674,0.08194723,0.8185832,0.0009294849,0.00016220206,0.0018180414,0.0015898091,0.000025169391,0.091890365,0.00066403975,0.00009862966,0.0019694667],"study_design_scores_gemma":[0.031220667,0.00057819847,0.50579554,0.00028126602,0.00017656485,0.00003417838,0.00020686034,0.0000026421055,0.46132565,0.00025752274,0.000016444703,0.000104502324],"about_ca_topic_score_codex":0.0008644957,"about_ca_topic_score_gemma":0.00024819584,"teacher_disagreement_score":0.36943528,"about_ca_system_score_codex":0.00007076377,"about_ca_system_score_gemma":0.00012610904,"threshold_uncertainty_score":0.48649192},"labels":[],"label_agreement":null},{"id":"W2079075712","doi":"10.1182/blood-2007-01-068148","title":"Direct interorganellar transfer of iron from endosome to mitochondrion","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":262,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; National Institutes of Health; Rural Development Administration","keywords":"Mitochondrion; Endosome; Chemistry; Biochemistry; Receptor","score_opus":0.007874663300981055,"score_gpt":0.23433695488930942,"score_spread":0.22646229158832837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079075712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98982394,0.00096028013,0.0015880244,0.00014321778,0.00020068735,0.0002234785,0.000018925666,0.000035484376,0.007005948],"genre_scores_gemma":[0.9977815,0.00004929221,0.0012113657,0.00039451837,0.00017155081,0.000002568275,0.00002102209,0.000018576051,0.00034957804],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992543,0.000013157994,0.00020627993,0.00017160173,0.00017708827,0.00017760755],"domain_scores_gemma":[0.9995686,0.000038777336,0.000014472127,0.00022201006,0.000028925779,0.00012725662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008805263,0.000098209326,0.00023457,0.00009379124,0.000014022485,0.0000031512648,0.000064319756,0.000066766675,0.00021506059],"category_scores_gemma":[0.000046177483,0.000084348045,0.00007334877,0.00012941202,0.000019198456,0.00002580756,0.000012391449,0.000068350055,0.000069990405],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033434923,0.0007753214,0.01847265,0.00006248456,0.000032591808,0.000038550617,0.0018216632,0.0000013569604,0.9753553,0.00009176195,0.00031860603,0.0026953523],"study_design_scores_gemma":[0.0042293896,0.0002513906,0.09477783,0.000054239983,0.00032022296,0.000005950603,0.00029908627,4.3434432e-7,0.89236164,0.000021306967,0.00756745,0.00011104398],"about_ca_topic_score_codex":0.00014469774,"about_ca_topic_score_gemma":0.00004935644,"teacher_disagreement_score":0.08299366,"about_ca_system_score_codex":0.0000051764605,"about_ca_system_score_gemma":0.000017003182,"threshold_uncertainty_score":0.34396136},"labels":[],"label_agreement":null},{"id":"W2079309051","doi":"10.1182/blood-2009-10-247536","title":"ITP has elevated BAFF expression","year":2009,"lang":"en","type":"letter","venue":"Blood","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"B-cell activating factor; Immunology; Medicine; Autoimmunity; B cell; Antibody","score_opus":0.01280824022645272,"score_gpt":0.20614979708338235,"score_spread":0.19334155685692964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079309051","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04878748,0.27897438,0.00010481716,0.6286766,0.0068741348,0.0017140568,0.00032127593,0.0016899554,0.032857303],"genre_scores_gemma":[0.26534113,0.0006060769,0.00006745576,0.65378714,0.0003197174,0.00010585607,0.009864472,0.00020289051,0.06970526],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977554,0.0002682131,0.00047663896,0.0006035264,0.00007756349,0.0008186215],"domain_scores_gemma":[0.99877363,0.00009505905,0.00026303108,0.0007947907,0.00006890197,0.0000045984093],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.00014962124,0.0005069519,0.0005890285,0.00019986923,0.0004650505,0.000056488796,0.0007095774,0.0022332924,0.0014922012],"category_scores_gemma":[0.00006178458,0.0004470245,0.0002866031,0.00017739585,0.00027740575,0.000083180974,0.000104480976,0.002602325,0.0026138953],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020210073,0.00035231176,0.000007957409,0.000035845154,0.000153436,0.00009873666,0.00016047865,5.9190575e-7,0.3068764,0.000008119617,0.68985033,0.0024356078],"study_design_scores_gemma":[0.002029804,0.00013899979,0.00020102896,0.00017123333,0.00017047614,0.000104730054,0.000027434759,1.4888205e-7,0.12718001,0.000121987396,0.86935776,0.00049637875],"about_ca_topic_score_codex":0.00004726882,"about_ca_topic_score_gemma":3.8855154e-7,"teacher_disagreement_score":0.2783683,"about_ca_system_score_codex":0.000017330605,"about_ca_system_score_gemma":0.00012830786,"threshold_uncertainty_score":0.9997982},"labels":[],"label_agreement":null},{"id":"W2079406524","doi":"10.1182/blood-2010-05-280115","title":"Amelioration of murine immune thrombocytopenia by CD44 antibodies: a potential therapy for ITP?","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Canadian Blood Services; St. Michael's Hospital","funders":"Canadian Institutes of Health Research; Canadian Blood Services","keywords":"Monoclonal antibody; Antibody; Immunology; Immune system; Medicine; CD44; Biology; In vitro","score_opus":0.008474854510115266,"score_gpt":0.26780630446829196,"score_spread":0.2593314499581767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079406524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976074,0.00077605736,0.00008682387,0.00029469363,0.00011954022,0.0005961823,0.000060083872,0.000025251771,0.0004339817],"genre_scores_gemma":[0.9977834,0.0003433463,0.0012232665,0.00006615591,0.000060011407,0.000030006815,0.00022790185,0.000017657734,0.000248211],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994095,0.0000065498334,0.00018496635,0.00014662438,0.00011236277,0.00013999706],"domain_scores_gemma":[0.99958825,0.000015728667,0.00008367491,0.00019506486,0.00007789978,0.000039399103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000060760758,0.000105839776,0.00031913267,0.00003978193,0.00004976916,0.000009507009,0.000053116517,0.00007483602,0.00010253236],"category_scores_gemma":[0.00001969519,0.00008122067,0.000094771625,0.00006431519,0.000041767973,0.00005737956,0.00001130115,0.000073979245,0.000008652557],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029019985,0.00228243,0.004115202,0.000034909,0.0002903469,0.000024050105,0.00010993055,2.4672485e-7,0.988503,0.000058303584,0.0006547024,0.0036367176],"study_design_scores_gemma":[0.026477033,0.0016440902,0.029720623,0.000036584308,0.00033846413,0.000096229334,0.00007162808,0.000054987435,0.9372476,0.00039699327,0.0037527578,0.00016302329],"about_ca_topic_score_codex":0.00007753208,"about_ca_topic_score_gemma":0.000014323579,"teacher_disagreement_score":0.051255375,"about_ca_system_score_codex":0.000002946523,"about_ca_system_score_gemma":0.00003552826,"threshold_uncertainty_score":0.3312083},"labels":[],"label_agreement":null},{"id":"W2079475300","doi":"10.1182/blood-2010-11-319186","title":"Differences in clinical outcomes after 2009 influenza A/H1N1 and seasonal influenza among hematopoietic cell transplant recipients","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":137,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Hematopoietic cell; Hematopoietic stem cell transplantation; Medicine; Immunology; Influenza A virus; Seasonal influenza; Transplantation; Virology; Internal medicine; Haematopoiesis; Biology; Coronavirus disease 2019 (COVID-19); Stem cell; Virus; Disease; Genetics; Infectious disease (medical specialty)","score_opus":0.10083397348693486,"score_gpt":0.35587760526457657,"score_spread":0.2550436317776417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079475300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950886,0.00219105,0.0000025455347,0.00003678419,0.00009174578,0.0005523987,0.000045298013,0.000055824104,0.0019357555],"genre_scores_gemma":[0.99757063,0.00035219477,0.00038418363,0.0013034643,0.00006211339,0.00012799437,0.0000023186647,0.000029830742,0.00016727948],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972304,0.00017052235,0.00084176706,0.0005289414,0.0005785596,0.0006497993],"domain_scores_gemma":[0.99874985,0.00027421748,0.000116196046,0.00038587453,0.00010551795,0.00036833802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006161883,0.00033245707,0.00080039114,0.00021813856,0.00007658638,0.00002727451,0.00018280296,0.00022850533,0.00020926053],"category_scores_gemma":[0.00027457293,0.00024508737,0.0001794592,0.0002096574,0.0004945996,0.0001713156,0.00014523299,0.00061108364,0.000085212894],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006572626,0.0013511509,0.99393034,0.00015258124,0.00018986005,0.0003468918,0.0030440572,3.97892e-8,0.00003141319,0.000015141308,0.000044088498,0.00023717899],"study_design_scores_gemma":[0.0074124127,0.0003751796,0.99054587,0.0003331995,0.00022026834,0.000017464135,0.00014760598,0.0000058576115,0.00044589653,0.000087676046,0.00015119993,0.00025739457],"about_ca_topic_score_codex":0.00024608636,"about_ca_topic_score_gemma":0.00018260203,"teacher_disagreement_score":0.00675515,"about_ca_system_score_codex":0.000022540293,"about_ca_system_score_gemma":0.000091426205,"threshold_uncertainty_score":0.99943733},"labels":[],"label_agreement":null},{"id":"W2079513879","doi":"10.1182/blood-2010-06-292243","title":"Integrin β7-mediated regulation of multiple myeloma cell adhesion, migration, and invasion","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":162,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"National Cancer Institute; Terry Fox Foundation; Alberta Cancer Foundation; Multiple Myeloma Research Foundation; Georgia Cancer Coalition","keywords":"Integrin; Bortezomib; Homing (biology); Focal adhesion; Cell biology; Fibronectin; Cancer research; Cell adhesion; Cell adhesion molecule; Cell migration; Biology; Gene silencing; Transplantation; Cell; Chemistry; Immunology; Signal transduction; Multiple myeloma; Extracellular matrix; Medicine; Internal medicine","score_opus":0.03439741748884629,"score_gpt":0.2509290326101518,"score_spread":0.21653161512130553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079513879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976616,0.00029191628,0.000033480293,0.00005706857,0.000021285176,0.0004042651,0.0000128874135,0.00003473484,0.0014827916],"genre_scores_gemma":[0.9961381,0.00014472292,0.0031696088,0.000019254465,0.00002816698,0.00002074601,0.00013109791,0.000014127749,0.0003341728],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914247,0.00004630676,0.00023138296,0.00019749007,0.00022450527,0.00015785269],"domain_scores_gemma":[0.99928564,0.000087633256,0.000082849016,0.00022316349,0.00016037773,0.00016031988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010747769,0.00010762844,0.00018398654,0.00013109336,0.00004320383,0.000004976763,0.00004327797,0.00008487624,0.00015471061],"category_scores_gemma":[0.0003004224,0.000081964026,0.000041977553,0.0001458595,0.000058715592,0.000079736186,0.000035958514,0.00008432203,0.000039516686],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032213953,0.0009911032,0.72908634,0.000102294245,0.000054401462,0.000023940336,0.0006836428,6.381234e-8,0.26616246,0.00001710731,0.0001395256,0.0024169993],"study_design_scores_gemma":[0.004008015,0.0003580172,0.58868533,0.00005404737,0.00005228183,0.000012419376,0.00007564645,0.00015594595,0.40641907,0.000043140608,0.00009174912,0.00004434506],"about_ca_topic_score_codex":0.0004882745,"about_ca_topic_score_gemma":0.00021981752,"teacher_disagreement_score":0.14040099,"about_ca_system_score_codex":0.000012873509,"about_ca_system_score_gemma":0.0000444305,"threshold_uncertainty_score":0.3342396},"labels":[],"label_agreement":null},{"id":"W2079560936","doi":"10.1182/blood-2014-01-549741","title":"Spontaneous heparin-induced thrombocytopenia syndrome: 2 new cases and a proposal for defining this disorder","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":157,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Heparin; Heparin-induced thrombocytopenia; Medicine; Platelet; Spontaneous remission; Bernard–Soulier syndrome; Immunology; Internal medicine; Gastroenterology; Pathology","score_opus":0.023061135595033793,"score_gpt":0.27681812538211226,"score_spread":0.25375698978707845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079560936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919197,0.00025227532,0.00010129519,0.0012916959,0.00021812618,0.0014255277,0.0000220356,0.00021484942,0.0045544994],"genre_scores_gemma":[0.9884819,0.00005350902,0.009470298,0.00041340862,0.00019638365,0.00010211914,0.000066139226,0.0001095697,0.0011066821],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99766046,0.00007894877,0.00048728808,0.0007613297,0.00030644712,0.0007055337],"domain_scores_gemma":[0.9980981,0.0005042882,0.00014328367,0.0006132387,0.00010571227,0.0005353728],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033015423,0.00044590907,0.0011030304,0.00015384635,0.0003133415,0.00010991514,0.00019235117,0.0002786859,0.00033156696],"category_scores_gemma":[0.00076620164,0.00038854784,0.00018594673,0.00023778474,0.00009129581,0.00017533975,0.00015787237,0.00032048312,0.00015401766],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029170734,0.0096614985,0.3165951,0.0034408667,0.0059049088,0.015852353,0.0065549714,0.000003968101,0.38088807,0.10212592,0.006710918,0.14934434],"study_design_scores_gemma":[0.07472077,0.026822811,0.43115443,0.0020113054,0.010680331,0.29587886,0.00094340567,0.0006290486,0.08559981,0.009696405,0.05705302,0.0048098112],"about_ca_topic_score_codex":0.00092490733,"about_ca_topic_score_gemma":0.00067361176,"teacher_disagreement_score":0.29528826,"about_ca_system_score_codex":0.000050698778,"about_ca_system_score_gemma":0.00055334426,"threshold_uncertainty_score":0.99985665},"labels":[],"label_agreement":null},{"id":"W2079597091","doi":"10.1182/blood-2012-04-422253","title":"Mutations in the mechanotransduction protein PIEZO1 are associated with hereditary xerocytosis","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":453,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; American Society of Hematology","keywords":"PIEZO1; Mechanotransduction; Genetics; Mutation; Biology; Medicine; Gene","score_opus":0.02242564394016159,"score_gpt":0.2381817491143769,"score_spread":0.2157561051742153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079597091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997167,0.0001402309,0.00016905517,0.0011056551,0.00010980847,0.000451061,0.000007919886,0.000055775523,0.00079351244],"genre_scores_gemma":[0.99855393,0.000005443351,0.00019592736,0.00053802703,0.00029132015,0.00013899615,0.000082045175,0.000012254535,0.00018208315],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99932086,0.00010757191,0.000118128206,0.00011094789,0.00014989421,0.00019257091],"domain_scores_gemma":[0.9996671,0.000046405643,0.000057554324,0.00013399562,0.000047340378,0.000047571633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000170505,0.00008817382,0.0001403785,0.000060893035,0.00007055005,0.0000043679697,0.000037177324,0.00008566766,0.00009836157],"category_scores_gemma":[0.00007131429,0.000055396624,0.000037938687,0.0002787139,0.000034046698,0.00008297584,0.000004255292,0.00019429158,0.000030747684],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021150506,0.030279357,0.46308988,0.0005811324,0.0016895807,0.0005952844,0.029021565,0.00007934883,0.45973682,0.004019808,0.004679612,0.0041125324],"study_design_scores_gemma":[0.009719723,0.0015475445,0.9362604,0.00041655253,0.00077131356,0.0005557553,0.006492972,0.00003950907,0.04216044,0.00031751682,0.0013873754,0.00033087758],"about_ca_topic_score_codex":0.000024110846,"about_ca_topic_score_gemma":0.000088949215,"teacher_disagreement_score":0.47317052,"about_ca_system_score_codex":0.000021452432,"about_ca_system_score_gemma":0.000028416835,"threshold_uncertainty_score":0.22590087},"labels":[],"label_agreement":null},{"id":"W2079698153","doi":"10.1182/blood-2011-08-374223","title":"The neonatal Fc receptor (FcRn) is not required for IVIg or anti-CD44 monoclonal antibody–mediated amelioration of murine immune thrombocytopenia","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"Canadian Institutes of Health Research","keywords":"Neonatal Fc receptor; Monoclonal antibody; Antibody; Immunology; Immune system; Receptor; Monoclonal; Isoantibodies; Medicine; Immunoglobulin G; Biology; Internal medicine","score_opus":0.03905946280576969,"score_gpt":0.29111978602271776,"score_spread":0.25206032321694805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079698153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968811,0.0006883234,0.000057500063,0.00049819436,0.00018949159,0.0009203589,0.00033155075,0.000046711335,0.00038674093],"genre_scores_gemma":[0.99573815,0.0007018639,0.0019928608,0.00012827116,0.00007623257,0.000058461403,0.00073886476,0.00003635145,0.0005289515],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987107,0.000027338689,0.0004411668,0.00027591822,0.00023856277,0.00030634564],"domain_scores_gemma":[0.9990659,0.00011565641,0.00022466626,0.00037247303,0.00013699723,0.00008433848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001491444,0.00020486652,0.0005190938,0.00006630044,0.00015636189,0.000016134356,0.00015201642,0.000117019044,0.00022918698],"category_scores_gemma":[0.00011614587,0.00012679465,0.00014743446,0.00021280744,0.0001167335,0.00013818489,0.000049249615,0.00009528005,0.00006550185],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014482965,0.0075110183,0.0377238,0.00042121942,0.0036213407,0.000479446,0.0043937676,6.2950323e-7,0.9063773,0.0003561957,0.004442375,0.020189902],"study_design_scores_gemma":[0.023571385,0.0034842317,0.066742085,0.00017490952,0.0007984362,0.00015229943,0.00034187618,0.00015083983,0.8963498,0.0001412076,0.0077647334,0.00032817887],"about_ca_topic_score_codex":0.00012260111,"about_ca_topic_score_gemma":0.00003427452,"teacher_disagreement_score":0.029018287,"about_ca_system_score_codex":0.00001343285,"about_ca_system_score_gemma":0.00013143376,"threshold_uncertainty_score":0.51705354},"labels":[],"label_agreement":null},{"id":"W2080006818","doi":"10.1182/blood.v100.2.427","title":"Acute myeloid leukemia and myelodysplastic syndrome in children treated for cancer: comparison with primary presentation","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Myeloid leukemia; Cancer; Myelodysplastic syndromes; Leukemia; Presentation (obstetrics); Pediatrics; Oncology; Internal medicine; Bone marrow; Surgery","score_opus":0.015664000661924266,"score_gpt":0.27331925464448975,"score_spread":0.2576552539825655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080006818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99608487,0.0010805518,0.00007674367,0.00038407728,0.000013918526,0.0016572324,0.00006569087,0.00007446442,0.0005624526],"genre_scores_gemma":[0.9958467,0.0006055893,0.0014047209,0.00011029749,0.00007518825,0.0003649133,0.0001940685,0.000051476327,0.0013470714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985319,0.00003758688,0.00028279383,0.00041560445,0.0003037493,0.00042837788],"domain_scores_gemma":[0.9993076,0.00012300065,0.000083814186,0.00023360821,0.000076593875,0.00017541823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000093200484,0.00021433318,0.00047099064,0.00024042062,0.00007641135,0.000031585452,0.00010206827,0.000121297315,0.000058628717],"category_scores_gemma":[0.000032384625,0.00017398392,0.000038027516,0.00037659492,0.000109122404,0.00013585229,0.000043751694,0.00028963602,0.000013356895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076305354,0.0005134347,0.9839883,0.0002161609,0.0007680282,0.00019462129,0.00031282988,0.00005623628,0.0062252115,0.000016019067,0.001286862,0.0056592296],"study_design_scores_gemma":[0.022893284,0.0014212452,0.9626041,0.0002141178,0.00084543973,0.0014875334,0.00003983904,0.004702827,0.0053605395,0.000008569815,0.00016917742,0.00025335012],"about_ca_topic_score_codex":0.0003621992,"about_ca_topic_score_gemma":0.000079436984,"teacher_disagreement_score":0.02213023,"about_ca_system_score_codex":0.0003749584,"about_ca_system_score_gemma":0.00016242139,"threshold_uncertainty_score":0.7094858},"labels":[],"label_agreement":null},{"id":"W2080125373","doi":"10.1182/blood-2006-09-047266","title":"Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":609,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Dasatinib; Imatinib; Medicine; Myeloid leukemia; Internal medicine; Imatinib mesylate; Adverse effect; Nilotinib; Oncology; Pharmacology; Gastroenterology; Immunology","score_opus":0.017234787570403184,"score_gpt":0.2844798465666158,"score_spread":0.2672450589962126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080125373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9766186,0.021695662,0.000005520323,0.0001821093,0.00003207509,0.00092881016,0.000045458513,0.000064023974,0.00042777642],"genre_scores_gemma":[0.99675024,0.0007576428,0.0015517967,0.0000655658,0.00017515488,0.00023507222,0.00005543488,0.000052322033,0.00035679396],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977732,0.00012273203,0.00068118854,0.0005451856,0.00033511233,0.0005425903],"domain_scores_gemma":[0.9988078,0.0002025252,0.00023064147,0.00058509415,0.000063911415,0.00011003044],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002336463,0.00037747753,0.00073625834,0.00026023664,0.00005491332,0.00002344902,0.00014062275,0.00025456442,0.00034260194],"category_scores_gemma":[0.000069300666,0.00031115036,0.00010618724,0.00036520662,0.00022031457,0.00011123443,0.00007863292,0.00028018327,0.000023773342],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019184138,0.0024291875,0.12914611,0.0009313326,0.0003478155,0.0009938875,0.00062874646,0.00005500995,0.8540903,0.00011201405,0.00026801357,0.009079174],"study_design_scores_gemma":[0.062906355,0.0030388923,0.2171823,0.0007672953,0.00027532352,0.0007217343,0.000110120316,0.00015851503,0.7129069,0.00019585273,0.0012688484,0.00046788284],"about_ca_topic_score_codex":0.00053959887,"about_ca_topic_score_gemma":0.00055404654,"teacher_disagreement_score":0.1411834,"about_ca_system_score_codex":0.001118945,"about_ca_system_score_gemma":0.0018599789,"threshold_uncertainty_score":0.9999341},"labels":[],"label_agreement":null},{"id":"W2080142157","doi":"10.1182/blood-2014-01-549725","title":"Protein superglue that holds VWF together","year":2014,"lang":"en","type":"letter","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Von Willebrand factor; Platelet; Platelet adhesion; Von Willebrand disease; D-dimer; Medicine; Chemistry; Internal medicine","score_opus":0.02112454373585022,"score_gpt":0.2397376332877608,"score_spread":0.21861308955191058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080142157","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.37691838,0.0012227762,0.000011889121,0.55721664,0.00022867096,0.0017711483,0.00006420728,0.00022473569,0.06234156],"genre_scores_gemma":[0.13423069,0.00006577703,0.00047827244,0.81132126,0.0029440068,0.00031570325,0.0011770227,0.0002218105,0.04924547],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985552,0.000044537137,0.00017423212,0.00043017286,0.00037592946,0.0004199275],"domain_scores_gemma":[0.9992056,0.000024339502,0.00007839074,0.00057729887,0.000036383895,0.00007797269],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000058356865,0.00035596418,0.0006341587,0.000102470454,0.000051501273,0.00002859713,0.00013491914,0.00083090615,0.0003994517],"category_scores_gemma":[0.0000185608,0.0002746372,0.00021576714,0.00006503556,0.000049565246,0.000032767144,0.000034594104,0.00082464254,0.0006678391],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030541585,0.00069787045,0.0039234646,0.00042659184,0.001028136,0.013047011,0.00006614475,3.2767666e-8,0.00041229327,0.00002785926,0.9797044,0.0006356848],"study_design_scores_gemma":[0.004614219,0.00033308554,0.00033080878,0.0003071706,0.0007446442,0.00058036967,0.0000052636788,6.697774e-7,0.0029471342,0.00017570985,0.9896591,0.00030183856],"about_ca_topic_score_codex":0.0000982095,"about_ca_topic_score_gemma":0.000010142114,"teacher_disagreement_score":0.2541046,"about_ca_system_score_codex":0.00001909998,"about_ca_system_score_gemma":0.00008948915,"threshold_uncertainty_score":0.99997056},"labels":[],"label_agreement":null},{"id":"W2080218560","doi":"10.1182/blood-2012-07-440495","title":"Lack of association between KIR genes and acute lymphoblastic leukemia in children","year":2012,"lang":"en","type":"letter","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lymphoblastic Leukemia; Gene; Acute lymphocytic leukemia; Immunology; Antibody; Medicine; Leukemia; Childhood leukemia; Biology; Genetics","score_opus":0.011489682179475989,"score_gpt":0.22444779078961483,"score_spread":0.21295810861013884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080218560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866213,0.0045368266,0.000009481008,0.0056276415,0.0019313903,0.0003056623,0.000086294895,0.00004652117,0.00083489175],"genre_scores_gemma":[0.83965147,0.0024812152,0.000053443873,0.06440889,0.0035274783,0.000076770295,0.010681983,0.00015411056,0.07896461],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99894255,0.00017390186,0.00035006728,0.00020864363,0.000040349005,0.0002845031],"domain_scores_gemma":[0.9992636,0.00015566158,0.0003634926,0.00016298213,0.000046729216,0.0000075251733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014287618,0.00019205234,0.00040269818,0.00018643517,0.000042479664,0.000009239908,0.00010215073,0.00120275,0.00032712636],"category_scores_gemma":[0.000038897055,0.00018541486,0.00008147104,0.00007211027,0.000041864416,0.00008586296,0.000054168573,0.0007678314,0.0002967247],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003235747,0.00008669362,0.43425912,0.00006261941,0.0033035506,0.0000028991158,0.00013689297,4.393485e-7,0.053996373,0.000003623301,0.50730795,0.0008074817],"study_design_scores_gemma":[0.005188871,0.00022991563,0.3991759,0.00014578765,0.0025655956,0.00014576795,0.000015923111,4.3833134e-7,0.091616996,0.000019105779,0.500394,0.00050169294],"about_ca_topic_score_codex":0.00020699098,"about_ca_topic_score_gemma":0.0000033377871,"teacher_disagreement_score":0.1469698,"about_ca_system_score_codex":0.00019580683,"about_ca_system_score_gemma":0.00006506418,"threshold_uncertainty_score":0.92767096},"labels":[],"label_agreement":null},{"id":"W2080480765","doi":"10.1182/blood-2004-05-1886","title":"Monoclonal antibodies that mimic the action of anti-D in the amelioration of murine ITP act by a mechanism distinct from that of IVIg","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services","funders":"","keywords":"Monoclonal antibody; Antibody; Polyclonal antibodies; Immunology; Receptor; Mononuclear phagocyte system; Mechanism of action; Fc receptor; Monoclonal; Immunoglobulin G; Immune system; Medicine; Chemistry; In vitro; Internal medicine","score_opus":0.02712572260692907,"score_gpt":0.2692326712368654,"score_spread":0.2421069486299363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080480765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983828,0.00048911484,0.00008133875,0.00048004577,0.000032470332,0.00029681897,0.000095165226,0.0000064515193,0.00013579249],"genre_scores_gemma":[0.99930274,0.0003716473,0.00013137129,0.00003413656,0.000014408493,0.0000083534505,0.00012096755,0.000007824089,0.000008545493],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993365,0.00003590008,0.00017937503,0.00011693837,0.00023502356,0.00009626682],"domain_scores_gemma":[0.9995101,0.00006647462,0.0001853197,0.00019781769,0.000026220816,0.000014070542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009797265,0.00010228581,0.00027101912,0.000047226808,0.000028760669,0.00000450122,0.00008227873,0.000049902083,0.00001504042],"category_scores_gemma":[0.000020173167,0.000055931843,0.000072329945,0.00010847118,0.0000575531,0.000060213122,0.000017398837,0.00007726983,0.0000013529842],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004067072,0.0064477734,0.41341415,0.00018122747,0.0007298186,0.000092674374,0.0037907015,0.00001956324,0.57188016,0.00036404922,0.00009032926,0.0025828478],"study_design_scores_gemma":[0.004217607,0.00027131435,0.35327065,0.00013575477,0.00029962452,0.000022036418,0.0008387164,0.000022342563,0.6383875,0.0024678535,0.00001403426,0.000052560983],"about_ca_topic_score_codex":0.0017827419,"about_ca_topic_score_gemma":0.0003282137,"teacher_disagreement_score":0.06650736,"about_ca_system_score_codex":0.000010531865,"about_ca_system_score_gemma":0.000032658103,"threshold_uncertainty_score":0.26949844},"labels":[],"label_agreement":null},{"id":"W2080495049","doi":"10.1182/blood-2012-04-417436","title":"Response: hematopoietic defects in 12/15-lipoxygenase–deficient mice","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Canadian Institutes of Health Research; Wellcome Trust; Heart and Stroke Foundation of Canada","keywords":"Haematopoiesis; Arachidonate 5-lipoxygenase; Lipoxygenase; Immunology; Medicine; Biology; Cell biology; Biochemistry; Stem cell; Enzyme; Arachidonic acid","score_opus":0.011584784845287757,"score_gpt":0.2274749322167748,"score_spread":0.21589014737148704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080495049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98661566,0.0060104034,0.000029604333,0.00013131561,0.0027273453,0.00014960174,0.0000015223823,0.00006430742,0.0042702253],"genre_scores_gemma":[0.9900958,0.00002878774,0.000017626588,0.00034547938,0.00003031837,0.000024454288,0.000028898008,0.000014151042,0.009414506],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988738,0.00031019782,0.00022932983,0.00016513173,0.00002890104,0.0003926829],"domain_scores_gemma":[0.9995238,0.00014676033,0.00006787226,0.00021585663,0.000023202398,0.000022461283],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00044508564,0.00012804323,0.0001557872,0.00015179033,0.00009622596,0.000008845094,0.000093862946,0.00016913643,0.001503737],"category_scores_gemma":[0.0001331397,0.000119053526,0.00007473555,0.00012424483,0.000045826004,0.00011914487,0.00004341499,0.00025166976,0.0041600135],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005184918,0.0010098106,0.007324637,0.000012120919,0.000050041104,0.000003433257,0.00085614104,0.0000017520427,0.9789336,0.00023051912,0.0109556215,0.00010388183],"study_design_scores_gemma":[0.0023749548,0.00018109356,0.045092426,0.000039450813,0.00005237995,0.00030704148,0.0004388915,7.148141e-7,0.71428984,0.000009722626,0.2370235,0.00018994624],"about_ca_topic_score_codex":0.000031816588,"about_ca_topic_score_gemma":0.000010215699,"teacher_disagreement_score":0.26464367,"about_ca_system_score_codex":0.000035470537,"about_ca_system_score_gemma":0.000025208945,"threshold_uncertainty_score":0.999409},"labels":[],"label_agreement":null},{"id":"W2080500939","doi":"10.1182/blood-2010-05-284810","title":"A small-molecule inhibitor of D-cyclin transactivation displays preclinical efficacy in myeloma and leukemia via phosphoinositide 3-kinase pathway","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; SickKids Foundation; Hospital for Sick Children; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Phosphoinositide 3-kinase; Kinase; Transactivation; Cyclin; Cancer research; Biology; Leukemia; Cell cycle; Chemistry; Molecular biology; Biochemistry; Signal transduction; PI3K/AKT/mTOR pathway; Apoptosis; Immunology","score_opus":0.012351736184800111,"score_gpt":0.24737120300803783,"score_spread":0.2350194668232377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080500939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975252,0.00030747408,0.0006188241,0.00015345821,0.000168944,0.00069219456,0.000020349864,0.00005144652,0.00046211333],"genre_scores_gemma":[0.9980828,0.00003482593,0.0014899641,0.00010914449,0.00012107415,0.000041456522,0.000036967427,0.000047038302,0.00003671565],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983927,0.000058207173,0.0005816054,0.00044006563,0.000244628,0.0002827638],"domain_scores_gemma":[0.99898374,0.00018672993,0.00015351585,0.00040457744,0.00007293675,0.00019851782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002841733,0.00021660123,0.00043358348,0.00014819768,0.00003474294,0.0000114331615,0.000088249464,0.00033541856,0.000039469047],"category_scores_gemma":[0.00034111828,0.00021387897,0.00013448962,0.00028328088,0.00013973232,0.00005804775,0.000032378426,0.00073658925,0.000007101293],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005072935,0.001312236,0.004932499,0.000115783696,0.00006288272,0.00018044222,0.0003603166,0.000005558034,0.98140496,0.000056843066,0.000011398147,0.0110497605],"study_design_scores_gemma":[0.011168705,0.0005815009,0.09249099,0.0002956236,0.0001752019,0.00012334669,0.0000176495,0.00026609207,0.8945347,0.000028630766,0.00012536159,0.00019219187],"about_ca_topic_score_codex":0.00013816608,"about_ca_topic_score_gemma":0.00027665953,"teacher_disagreement_score":0.08755849,"about_ca_system_score_codex":0.000050403105,"about_ca_system_score_gemma":0.0003117382,"threshold_uncertainty_score":0.87217313},"labels":[],"label_agreement":null},{"id":"W2080724300","doi":"10.1182/blood-2014-08-545152","title":"Evidence-based focused review of the role of radiation therapy in the treatment of early-stage Hodgkin lymphoma","year":2015,"lang":"en","type":"review","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Grand River Hospital; Cancer Care Ontario; McMaster University; Juravinski Cancer Centre; Northeast Cancer Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Thorax (insect anatomy); Radiology; Stage (stratigraphy); Biopsy; Mediastinum; Supraclavicular lymph nodes; Mediastinal mass; Lymphoma; Radiation therapy; Axilla; Pathology; Metastasis; Internal medicine; Anatomy; Cancer","score_opus":0.09113541500845695,"score_gpt":0.3409795814210709,"score_spread":0.24984416641261392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080724300","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009572092,0.98616385,1.07955294e-7,0.00011771082,0.000051632596,0.0037898791,0.0000887888,0.0000060100983,0.00020992187],"genre_scores_gemma":[0.007215499,0.99186134,0.00003223517,0.00007693402,0.00006356887,0.0006489862,0.000047429963,0.000027021186,0.000026962221],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974522,0.00062062783,0.0009299785,0.00025584633,0.00057957595,0.00016174889],"domain_scores_gemma":[0.9972192,0.00047720972,0.0010327203,0.0010574104,0.00016519258,0.00004824649],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057717477,0.00033950678,0.0020564068,0.00011462534,0.000017886541,0.000005312913,0.00028313804,0.0001510636,0.000032574666],"category_scores_gemma":[0.0001433541,0.00014386959,0.0009363818,0.0005370736,0.00006617622,0.00003249731,0.000014151531,0.00004487578,0.0000043789155],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035890538,0.0049952143,0.005948655,0.015332432,0.00043487345,0.0000088183,0.00019701583,9.211413e-8,0.0000015633489,0.000029480138,0.000053375814,0.9729626],"study_design_scores_gemma":[0.009304132,0.004197154,0.009081736,0.19891304,0.005989815,0.000012519374,0.0000216337,8.448065e-7,0.0023589672,0.000013471457,0.7699368,0.00016988681],"about_ca_topic_score_codex":0.00050377427,"about_ca_topic_score_gemma":0.000011163639,"teacher_disagreement_score":0.9727927,"about_ca_system_score_codex":0.00023301452,"about_ca_system_score_gemma":0.0012337421,"threshold_uncertainty_score":0.5866832},"labels":[],"label_agreement":null},{"id":"W2081128157","doi":"10.1182/blood-2006-04-018341","title":"In vivo tumor growth is inhibited by cytosolic iron deprivation caused by the expression of mitochondrial ferritin","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"McGill University; Mayo Clinic","keywords":"Cytosol; Ferritin; Mitochondrion; Transferrin receptor; Frataxin; Intracellular; Biology; Heme; Cell biology; Aconitase; Transferrin; Chemistry; Biochemistry; Enzyme","score_opus":0.005487020425139519,"score_gpt":0.22021638812388133,"score_spread":0.21472936769874182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081128157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99658316,0.00075699476,0.000062603125,0.0007917444,0.000073556344,0.00038091428,0.000059269216,0.000023199507,0.0012685718],"genre_scores_gemma":[0.99820125,0.000027997212,0.00017723482,0.0007619569,0.0001830543,0.000029656956,0.00007636308,0.000020629372,0.0005218357],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989582,0.000058406084,0.0003134938,0.00020179951,0.00027340834,0.0001946967],"domain_scores_gemma":[0.9995536,0.000039568025,0.00010911366,0.00021840369,0.00003989812,0.000039397837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007502557,0.0001276652,0.0002145648,0.00007858315,0.0000422459,0.00000937435,0.00008329295,0.000081193364,0.00013347024],"category_scores_gemma":[0.00007983306,0.000093331284,0.00005173469,0.0002267827,0.00005623522,0.00008169564,0.00002629413,0.00012263184,0.0000065345616],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007731274,0.00062836456,0.01232427,0.00005153849,0.0000021218254,0.0000040147565,0.00018946428,4.6936478e-7,0.90590423,0.00005829017,0.0807423,0.000017610679],"study_design_scores_gemma":[0.008312504,0.000058025882,0.0083374325,0.000055891975,0.00007263032,0.0000055139712,0.00010811053,0.000005180173,0.9807856,0.00016022717,0.0019977156,0.000101161575],"about_ca_topic_score_codex":0.0010445429,"about_ca_topic_score_gemma":0.00003703881,"teacher_disagreement_score":0.07874458,"about_ca_system_score_codex":0.000009690775,"about_ca_system_score_gemma":0.00003119423,"threshold_uncertainty_score":0.38059393},"labels":[],"label_agreement":null},{"id":"W2081440424","doi":"10.1182/blood-2010-11-318048","title":"Leukemic transformation of anaplastic large-cell lymphoma","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Anaplastic large-cell lymphoma; Lymphoma; Transformation (genetics); Medicine; Cancer research; Internal medicine; Biology; Genetics","score_opus":0.016355442677598087,"score_gpt":0.21831896625209174,"score_spread":0.20196352357449365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081440424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96897244,0.00033565916,0.00006300106,0.000017057606,0.000040908853,0.00016688,0.000014621016,0.00002710123,0.030362302],"genre_scores_gemma":[0.99929553,0.000088374705,0.00039404165,0.000055893528,0.000020082836,0.000018588873,0.000022436969,0.000008359402,0.00009668024],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99948215,0.000009129163,0.00017324822,0.000091719594,0.00011325197,0.00013049481],"domain_scores_gemma":[0.9996985,0.000017911838,0.000047823014,0.00013911359,0.000033330056,0.0000633231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000041642248,0.00007896517,0.0001568596,0.000054912693,0.000020810709,0.0000020204131,0.000032783766,0.00004596828,0.00013259046],"category_scores_gemma":[0.000007072343,0.00006129207,0.00007377869,0.00007553029,0.000015483938,0.0000471163,0.000006018633,0.000014997769,0.00007475636],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016872007,0.12226528,0.7605897,0.0019181615,0.0015884067,0.0006580867,0.023059698,0.0000018410072,0.029414168,0.011692957,0.0016253048,0.045499183],"study_design_scores_gemma":[0.037624504,0.0013498546,0.43292454,0.00010197396,0.00080728595,0.00010108318,0.00022784203,0.000048720885,0.52579814,0.00009226312,0.0008129096,0.000110896006],"about_ca_topic_score_codex":0.000056706307,"about_ca_topic_score_gemma":0.000008424841,"teacher_disagreement_score":0.49638397,"about_ca_system_score_codex":0.00003149325,"about_ca_system_score_gemma":0.0000712703,"threshold_uncertainty_score":0.2499418},"labels":[],"label_agreement":null},{"id":"W2081794739","doi":"10.1182/blood-2005-05-1970","title":"Deletion of the selection cassette, but not cis-acting elements, in targeted Flk1-lacZ allele reveals Flk1 expression in multipotent mesodermal progenitors","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":291,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Biology; Vasculogenesis; Mesoderm; Primitive streak; Progenitor cell; Cell biology; Hemangioblast; Molecular biology; Genetics; Haematopoiesis; Embryonic stem cell; Stem cell; Gene","score_opus":0.011306712771683415,"score_gpt":0.25003077202595464,"score_spread":0.23872405925427123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081794739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985936,0.0006329266,0.00018081948,0.000095316806,0.000060443414,0.00035277373,0.000012256897,0.0000065395543,0.00006527598],"genre_scores_gemma":[0.9975199,0.00010645424,0.0017713691,0.00010972442,0.0002484363,0.00008236964,0.000043790387,0.000018729586,0.00009922168],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99884766,0.00010896796,0.0003692881,0.00027538376,0.0001608768,0.00023784215],"domain_scores_gemma":[0.9995495,0.000007676809,0.00017118477,0.0001797825,0.00006071094,0.000031111114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024409099,0.00013114234,0.00013705945,0.000049064434,0.000059060963,0.000007898811,0.0001279583,0.0001528152,0.000016179596],"category_scores_gemma":[0.000053083495,0.00010693217,0.00009136016,0.0001388736,0.000020358093,0.00000821549,0.000076718075,0.00009155054,0.0000012523006],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006442936,0.00022114119,0.10107017,0.000015714673,0.0000211589,8.321168e-7,0.00005129143,0.0004395142,0.8957562,0.0000011249435,0.00021472773,0.0021437318],"study_design_scores_gemma":[0.0011583818,0.00006871929,0.046672735,0.00003756059,0.000016434753,0.0000060905077,0.00007093027,0.00029257234,0.94919485,0.0000017501516,0.0023578072,0.0001221748],"about_ca_topic_score_codex":0.000087207794,"about_ca_topic_score_gemma":0.0003662809,"teacher_disagreement_score":0.054397438,"about_ca_system_score_codex":0.000036200923,"about_ca_system_score_gemma":0.000049514474,"threshold_uncertainty_score":0.43605673},"labels":[],"label_agreement":null},{"id":"W2081830302","doi":"10.1182/blood-2014-09-603803","title":"Podoplanin and CLEC-2 drive cerebrovascular patterning and integrity during development","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"British Heart Foundation; Wellcome Trust","keywords":"Podoplanin; Structural integrity; Platelet; Personal Integrity; Medicine; Internal medicine; Pathology; Psychology; Lymphatic system","score_opus":0.02528911013160292,"score_gpt":0.24160351946555125,"score_spread":0.21631440933394833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081830302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99769825,0.0013613128,0.000041773386,0.000055849832,0.00003544385,0.00013798918,0.000001458902,0.000038923477,0.00062901614],"genre_scores_gemma":[0.9986813,0.000012428547,0.0010090828,0.0000811406,0.00007909005,0.00000881224,0.000007306737,0.000009253976,0.0001115925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99940073,0.000024909845,0.00013143143,0.00016316104,0.00015746322,0.00012230682],"domain_scores_gemma":[0.9995618,0.000018691839,0.000030342613,0.00010401742,0.00004162956,0.00024353703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012159191,0.000087678985,0.00016737192,0.000039113205,0.000045106073,0.000021638856,0.000022707267,0.000039459283,0.000010605638],"category_scores_gemma":[0.00009216826,0.000069371396,0.000017708342,0.000033495104,0.000023654902,0.000041739637,0.00005318927,0.000021529915,0.000012403677],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016560434,0.00010807233,0.9968151,0.00018700058,0.0000971873,0.00006228952,0.0014366284,5.8740692e-8,0.0004603269,0.000007523851,0.000057764522,0.0007514776],"study_design_scores_gemma":[0.0062275496,0.00005151277,0.9823091,0.0002944927,0.00017582909,0.00055147515,0.0011801482,0.0000076127035,0.008775003,0.00001742024,0.00029807523,0.00011177894],"about_ca_topic_score_codex":0.000038869362,"about_ca_topic_score_gemma":0.000007135409,"teacher_disagreement_score":0.014506008,"about_ca_system_score_codex":0.000021606906,"about_ca_system_score_gemma":0.0001030505,"threshold_uncertainty_score":0.28288835},"labels":[],"label_agreement":null},{"id":"W2081833219","doi":"10.1182/blood-2011-02-332759","title":"Salivary microvesicles clot blood","year":2011,"lang":"de","type":"letter","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Saliva; Clot retraction; Medicine; Tissue factor; Microvesicles; Clot formation; Coagulation; Internal medicine; Pathology; Immunology; Chemistry; Platelet; Biochemistry; Thrombin","score_opus":0.01705012742740851,"score_gpt":0.22766344677322162,"score_spread":0.21061331934581312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081833219","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8124464,0.12544718,0.0000063307593,0.025214303,0.0023726537,0.001899207,0.0009035145,0.00034871112,0.03136168],"genre_scores_gemma":[0.29340118,0.043257523,0.0044222507,0.5520745,0.03074874,0.0005248416,0.014975237,0.001814703,0.05878105],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99597764,0.00014292912,0.00080693414,0.0012032797,0.0005700126,0.0012992258],"domain_scores_gemma":[0.9977044,0.0001504248,0.0004188033,0.0012729904,0.000113757604,0.00033964883],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00014217445,0.0011056788,0.0016082852,0.00031130583,0.00020245533,0.00007618301,0.00050273933,0.0014590478,0.0021397443],"category_scores_gemma":[0.000055560395,0.0009765242,0.00062376086,0.00024343646,0.0002325349,0.000100413425,0.00019308942,0.0016199205,0.0088427225],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030687355,0.020028984,0.03769797,0.0017750183,0.027872253,0.12399846,0.0010160769,4.1125794e-8,0.008668978,0.00009173613,0.77537113,0.00317248],"study_design_scores_gemma":[0.039122622,0.0028515838,0.008944573,0.002134634,0.05565052,0.0027138735,0.00007348063,9.147926e-7,0.059728913,0.0010967939,0.825397,0.0022850554],"about_ca_topic_score_codex":0.0005020935,"about_ca_topic_score_gemma":0.000016677066,"teacher_disagreement_score":0.5268602,"about_ca_system_score_codex":0.000035580357,"about_ca_system_score_gemma":0.00027709774,"threshold_uncertainty_score":0.9998373},"labels":[],"label_agreement":null},{"id":"W2081988140","doi":"10.1182/blood-2011-01-329078","title":"Identification of T-lymphocytic leukemia–initiating stem cells residing in a small subset of patients with acute myeloid leukemic disease","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; McMaster University","funders":"","keywords":"Severe combined immunodeficiency; Leukemia; Biology; Stem cell; Myeloid leukemia; Cancer research; Nod; CD34; Myeloid; Immunology; Transplantation; In vivo; Haematopoiesis; Medicine; Internal medicine; Cell biology; Genetics","score_opus":0.025634963787461336,"score_gpt":0.2402346682524661,"score_spread":0.21459970446500476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081988140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984057,0.00013557401,0.00009163255,0.0000071583163,0.0000350211,0.0008430136,0.00010559763,0.000038251463,0.00033805906],"genre_scores_gemma":[0.99867207,0.00008024321,0.00084257877,0.000027788443,0.000026578371,0.000052383013,0.00006273727,0.000054065375,0.00018156477],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99777424,0.00011661315,0.00081808836,0.0004099654,0.00047398513,0.0004071183],"domain_scores_gemma":[0.99821305,0.00011831436,0.00046861576,0.00063702103,0.00034427087,0.0002187246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045060212,0.0002161407,0.00047456016,0.0004134609,0.000042258904,0.000009541519,0.0002717637,0.00010627261,0.000025768848],"category_scores_gemma":[0.000099939134,0.00018888955,0.00008891925,0.00060499227,0.00014440759,0.00015282762,0.00010846713,0.00025196385,0.000015367936],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004540439,0.0011586512,0.74315816,0.0017694354,0.0005757647,0.00044522525,0.0040888437,0.00006098661,0.24273525,0.00014970767,0.000052436626,0.0012650839],"study_design_scores_gemma":[0.012654794,0.00045867,0.44221088,0.0006285073,0.00064591225,0.000011270879,0.0003847884,0.000812854,0.5419193,0.000050060426,0.000003019651,0.0002199746],"about_ca_topic_score_codex":0.0003649765,"about_ca_topic_score_gemma":0.000032837368,"teacher_disagreement_score":0.3009473,"about_ca_system_score_codex":0.0011825501,"about_ca_system_score_gemma":0.0023070413,"threshold_uncertainty_score":0.7702693},"labels":[],"label_agreement":null},{"id":"W2082050404","doi":"10.1182/blood-2006-01-010363","title":"Rac1 links leading edge and uropod events through Rho and myosin activation during chemotaxis","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Cellular Mechanics and Interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of General Medical Sciences","keywords":"Chemotaxis; RAC1; Myosin; Cell biology; Motility; Biology; Actin; Chemistry; Signal transduction; Biochemistry; Receptor","score_opus":0.005875782603451759,"score_gpt":0.21930573960413097,"score_spread":0.2134299570006792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082050404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997255,0.00052080513,0.00082631357,0.000118597876,0.000059944363,0.000084032596,0.0000047077674,0.000009485159,0.0011211013],"genre_scores_gemma":[0.997969,0.00020969806,0.0004602863,0.00005335203,0.00023130911,0.000006182566,0.0000575789,0.000015272295,0.0009973495],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994822,0.000013827663,0.000107878834,0.00022261695,0.000050098628,0.00012334781],"domain_scores_gemma":[0.9997713,0.000004757293,0.000048937032,0.00012275059,0.000026140138,0.000026130228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003918876,0.00009240055,0.00007489795,0.000019836887,0.00011303637,0.000024033712,0.000037226964,0.00012647301,0.000009469478],"category_scores_gemma":[0.000020735437,0.000096390955,0.000029450355,0.00003615757,0.000014902082,0.00000934024,0.00006436737,0.00009797832,0.0000027257668],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001046369,0.00009350302,0.0011931898,0.000015013696,0.000023299483,0.0000010487224,0.000025497035,0.0000013276892,0.9981098,0.00013362251,0.00009797254,0.00029524864],"study_design_scores_gemma":[0.0007912859,0.00006595383,0.0048734494,0.000021170863,0.000024776475,0.0000389077,0.000027861075,0.000030428972,0.98617554,0.00023605788,0.0075950683,0.00011948157],"about_ca_topic_score_codex":0.000039653023,"about_ca_topic_score_gemma":0.000011489621,"teacher_disagreement_score":0.011934255,"about_ca_system_score_codex":0.000005375834,"about_ca_system_score_gemma":0.0000091820575,"threshold_uncertainty_score":0.3930709},"labels":[],"label_agreement":null},{"id":"W2082084049","doi":"10.1182/blood-2006-03-009720","title":"Cytotoxic CD4+ T cells use granulysin to kill Cryptococcus neoformans, and activation of this pathway is defective in HIV patients","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Fungal Infections and Studies","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research; Canadian Foundation for AIDS Research","keywords":"Granulysin; Perforin; Cytotoxic T cell; Cryptococcus neoformans; Biology; Degranulation; CD8; Interleukin 21; Immunology; Effector; Microbiology; Immune system; In vitro; Receptor","score_opus":0.00862211803470153,"score_gpt":0.21693501653730993,"score_spread":0.2083128985026084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082084049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978475,0.000029850515,0.000058467398,0.00005836255,0.000036042886,0.00056779466,0.000044851608,0.000017249164,0.0013399135],"genre_scores_gemma":[0.99915284,0.000018863559,0.00034584187,0.00013620759,0.000030024097,0.000021870088,0.000016218759,0.00001007106,0.0002680351],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993447,0.000020618381,0.00020669855,0.00016090328,0.00012065062,0.00014639564],"domain_scores_gemma":[0.9996148,0.000057698282,0.000057771424,0.00011932503,0.00011129314,0.000039113856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005791135,0.0001069412,0.00021179397,0.00017115306,0.0000545193,0.000009689793,0.00001929814,0.000048416132,0.00002265457],"category_scores_gemma":[0.000044447464,0.0000895837,0.000045034743,0.00022252835,0.000027919556,0.00010924261,0.000029111967,0.00008364638,0.00001331761],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012239862,0.0019483411,0.8703145,0.000091323964,0.00006788029,0.0000053674635,0.0019147245,0.000016311491,0.122411944,0.000101369216,0.0023697983,0.00063608645],"study_design_scores_gemma":[0.002484967,0.00045282373,0.6315858,0.00010180083,0.00005316853,0.0000014603103,0.00006965373,0.000014755143,0.3641946,0.0000698198,0.0008757004,0.00009545734],"about_ca_topic_score_codex":0.00064603856,"about_ca_topic_score_gemma":0.00007472702,"teacher_disagreement_score":0.24178265,"about_ca_system_score_codex":0.000033353972,"about_ca_system_score_gemma":0.000015670545,"threshold_uncertainty_score":0.36531174},"labels":[],"label_agreement":null},{"id":"W2082756994","doi":"10.1182/blood-2010-06-291237","title":"Functional roles of aspartate residues of the proton-coupled folate transporter (PCFT-SLC46A1); a D156Y mutation causing hereditary folate malabsorption","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Children's Hospital","funders":"National Cancer Institute","keywords":"Mutation; Folic acid; Genetics; Transporter; Malabsorption; Methylenetetrahydrofolate reductase; Medicine; Biology; Chemistry; Biochemistry; Internal medicine; Gene; Allele","score_opus":0.017570598942892576,"score_gpt":0.2619058766662548,"score_spread":0.24433527772336222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082756994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978828,0.00014722486,0.000055234083,0.00037169797,0.00017368153,0.001006389,0.000022440901,0.000032515083,0.00030804193],"genre_scores_gemma":[0.9988268,0.000026470878,0.00029068673,0.000032482767,0.00018831735,0.00006114825,0.00006219082,0.000029222587,0.000482674],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99842167,0.000049922208,0.00045217745,0.00024284329,0.0005811764,0.000252185],"domain_scores_gemma":[0.99902636,0.000052660907,0.00017813312,0.00035343753,0.0003115137,0.00007790782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040725255,0.00015524027,0.00028874387,0.00014828856,0.00008670241,0.000011210822,0.00009001955,0.00015389566,0.0002430433],"category_scores_gemma":[0.000062119274,0.000107028936,0.00017300498,0.00028619883,0.00014883306,0.00016304605,0.000025879055,0.00037991963,0.000010809522],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006154598,0.0006160533,0.07871737,0.00040327775,0.00026926736,0.00006857993,0.0005891219,0.0000194981,0.9175118,0.000064929685,0.000056747755,0.0010678748],"study_design_scores_gemma":[0.0036470846,0.00060122064,0.5224579,0.00020915229,0.00036658946,0.00019461165,0.00009015868,0.0008255421,0.47104692,0.00036339197,0.00008252211,0.000114892624],"about_ca_topic_score_codex":0.00024388955,"about_ca_topic_score_gemma":0.00064451614,"teacher_disagreement_score":0.4464649,"about_ca_system_score_codex":0.000011148821,"about_ca_system_score_gemma":0.00017627538,"threshold_uncertainty_score":0.43645132},"labels":[],"label_agreement":null},{"id":"W2082812004","doi":"10.1182/blood-2003-05-1540","title":"Developmental stage–specific epigenetic control of human β-globin gene expression is potentiated in hematopoietic progenitor cells prior to their transcriptional activation","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"National Cancer Institute; Canadian Institutes of Health Research; Terry Fox Foundation; Cancer Research Society","keywords":"Locus control region; Biology; Epigenetics; Histone; Chromatin; Acetylation; Molecular biology; Promoter; Haematopoiesis; Transgene; Regulation of gene expression; Gene expression; Gene; Cell biology; Genetics; Stem cell","score_opus":0.013480815429866,"score_gpt":0.2316800398865188,"score_spread":0.2181992244566528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082812004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98405504,0.0006559679,0.0144762155,0.00001817691,0.0000511262,0.0005671664,0.00006214809,0.000007021459,0.00010714308],"genre_scores_gemma":[0.99326044,0.00006184737,0.006310276,0.000040990166,0.000040595896,0.000058514877,0.00008575909,0.000026173784,0.00011538298],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987081,0.00011373118,0.00039874215,0.00036931198,0.00018637344,0.00022370393],"domain_scores_gemma":[0.99952966,0.000009688486,0.00011304296,0.00017011006,0.000094319104,0.00008319866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020561212,0.00017689177,0.0001817981,0.00009546634,0.00007323645,0.000016553071,0.000120592405,0.00015065915,0.00007580244],"category_scores_gemma":[0.000014712959,0.0001730767,0.00007877194,0.00014574162,0.000024541656,0.0000052028263,0.00002058355,0.00006345051,0.000004310841],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004455475,0.00043535876,0.004108655,0.000021756052,0.000030807892,0.0000010369579,0.00027286584,0.00014995271,0.9946805,0.000023194056,0.000011180095,0.00022014251],"study_design_scores_gemma":[0.0021809943,0.00020574784,0.012127681,0.000029934019,0.000012346487,0.0000017916442,0.00011254295,0.0000062429162,0.98378676,0.0000636586,0.0012804066,0.00019187591],"about_ca_topic_score_codex":0.000006673328,"about_ca_topic_score_gemma":0.0000068846525,"teacher_disagreement_score":0.010893717,"about_ca_system_score_codex":0.000020838243,"about_ca_system_score_gemma":0.00008193489,"threshold_uncertainty_score":0.7057863},"labels":[],"label_agreement":null},{"id":"W2082829565","doi":"10.1182/blood-2009-08-239822","title":"A variant allele of Growth Factor Independence 1 (GFI1) is associated with acute myeloid leukemia","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"Cancer Research Society; National Cancer Institute; Stichting Vanderes","keywords":"Myeloid leukemia; RUNX1; Biology; Repressor; Myeloid; Allele; Genetics; Cancer research; Leukemia; Transcription factor; Fusion protein; Gene","score_opus":0.004699754665229582,"score_gpt":0.20601165651762507,"score_spread":0.20131190185239548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082829565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980845,0.00012273843,0.00006606421,0.000037735375,0.000036291905,0.00013530483,0.00019081644,0.000011580625,0.0013149548],"genre_scores_gemma":[0.99878573,0.00006882576,0.00046051483,0.000120283694,0.000031936404,0.000016559463,0.00016044595,0.00002083113,0.0003348388],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991864,0.000017262555,0.00013507473,0.0002838697,0.00016984149,0.00020755605],"domain_scores_gemma":[0.99941003,0.000007277539,0.00011287203,0.00028010955,0.00011665649,0.00007306811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004583292,0.00015496035,0.00017108233,0.00002348731,0.000048787464,0.000013770163,0.00017554885,0.0002239632,0.0000655564],"category_scores_gemma":[0.00003889153,0.00012242977,0.00006488172,0.00008097057,0.000058629103,0.000004601179,0.00006407708,0.00013231483,0.000005957764],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013273091,0.0016045555,0.07681316,0.000015797566,0.0027272697,0.00012948345,0.00019226932,8.5945345e-7,0.9168154,0.0001658701,0.00072210055,0.0006804738],"study_design_scores_gemma":[0.004720257,0.00078920415,0.028206926,0.000011985044,0.0003316701,0.000084037034,0.00002211131,0.000005666836,0.96493906,0.00015357096,0.00048084062,0.00025465293],"about_ca_topic_score_codex":0.00012955995,"about_ca_topic_score_gemma":0.00030361934,"teacher_disagreement_score":0.04860624,"about_ca_system_score_codex":0.000004666646,"about_ca_system_score_gemma":0.00017966237,"threshold_uncertainty_score":0.49925417},"labels":[],"label_agreement":null},{"id":"W2082870113","doi":"10.1182/blood-2013-05-501510","title":"Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Diabetes and associated disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Amino acid substitution; Substitution (logic); Peptide; Human leukocyte antigen; Amino acid; Medicine; Immunology; Chemistry; Biochemistry; Antigen; Mutation; Gene","score_opus":0.005239744502309111,"score_gpt":0.2110733592835902,"score_spread":0.2058336147812811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082870113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977095,0.0008583655,0.000010115674,0.000009084139,0.000022856573,0.00014146387,0.00021803829,0.0000069682596,0.0010235653],"genre_scores_gemma":[0.9989271,0.0005764111,0.00015447734,0.000021556796,0.00001745158,0.00001109982,0.0001894108,0.000010342709,0.00009216215],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999261,0.000053235344,0.00019678437,0.00020887222,0.00010742959,0.0001726813],"domain_scores_gemma":[0.99945194,0.000012035227,0.00020543039,0.00019084921,0.00007950436,0.0000602378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000088759734,0.00012183961,0.0001776694,0.000026566417,0.00005536222,0.00001056612,0.00008864721,0.00012976004,0.000028290953],"category_scores_gemma":[0.000085610445,0.000114002265,0.0000854111,0.000056050518,0.00011073317,0.000007401107,0.000112905356,0.00004552955,0.0000036328079],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007734221,0.00017398671,0.45833695,0.000027786555,0.0003645387,8.9835083e-7,0.000016987713,0.0000051841444,0.54054695,0.000025513747,0.0001508241,0.00034266937],"study_design_scores_gemma":[0.00094692345,0.00012690012,0.43154606,0.000014038077,0.00028144356,0.000003457371,0.000061024326,0.000009687227,0.5667101,0.00008758621,0.00008548921,0.00012728172],"about_ca_topic_score_codex":0.00025823014,"about_ca_topic_score_gemma":0.000060220125,"teacher_disagreement_score":0.026790876,"about_ca_system_score_codex":0.0000058281234,"about_ca_system_score_gemma":0.000025259385,"threshold_uncertainty_score":0.46488774},"labels":[],"label_agreement":null},{"id":"W2082876325","doi":"10.1182/blood-2013-06-508432","title":"Analysis of the clonal growth and differentiation dynamics of primitive barcoded human cord blood cells in NSG mice","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency; Canadian Institutes of Health Research","keywords":"Biology; Cord blood; Haematopoiesis; Myeloid; Stem cell; Immunology; CD34; Somatic evolution in cancer; Transplantation; Cell biology; Genetics; Gene; Medicine; Internal medicine","score_opus":0.0059097666450168874,"score_gpt":0.2018750139701451,"score_spread":0.1959652473251282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082876325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987812,0.0001083137,0.00004159867,0.000042474385,0.00022397848,0.00015814426,0.00001452455,0.0000063679186,0.00062341685],"genre_scores_gemma":[0.9991313,0.000033797554,0.000012381288,0.00002953012,0.0000038864973,0.0000087335575,0.00012775382,0.0000048737375,0.00064770115],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99931663,0.00014093253,0.00028188413,0.00013180664,0.000027868138,0.00010088108],"domain_scores_gemma":[0.9995049,0.000072147835,0.00020885446,0.00012483285,0.00008313182,0.000006090145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006002651,0.00008305912,0.00021541861,0.00017848948,0.000052031526,0.0000054949624,0.00008797948,0.000106507774,0.00037113516],"category_scores_gemma":[0.000023720619,0.00006382636,0.00009605594,0.00023475068,0.000097242126,0.00006700774,0.00004750369,0.00014503811,0.000006111345],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028987211,0.00047568398,0.0680915,0.000015016613,0.0008867084,7.978112e-8,0.00021597996,0.0000021873893,0.92958236,0.00059938006,0.000028406606,0.000073721785],"study_design_scores_gemma":[0.0009783828,0.00009812749,0.4517524,0.0000132438145,0.00082828366,0.0000020737255,0.00018562718,0.0000741521,0.5459775,0.00003722972,0.000005201328,0.00004784349],"about_ca_topic_score_codex":0.0006202781,"about_ca_topic_score_gemma":0.00019945037,"teacher_disagreement_score":0.38366088,"about_ca_system_score_codex":0.0000086647005,"about_ca_system_score_gemma":0.00001002054,"threshold_uncertainty_score":0.40636697},"labels":[],"label_agreement":null},{"id":"W2083067420","doi":"10.1182/blood-2002-12-3939","title":"Homeostasis and regeneration of the hematopoietic stem cell pool are altered in SHIP-deficient mice","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Canadian Institutes of Health Research; Terry Fox Foundation","keywords":"Haematopoiesis; Biology; Stem cell; Cell biology; Progenitor cell; Multipotent Stem Cell; Immunology; Regeneration (biology); Myeloid; Cytokine; Homeostasis; Hematopoietic stem cell","score_opus":0.01677174269441728,"score_gpt":0.22773141859398457,"score_spread":0.2109596758995673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083067420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99650586,0.0015516864,0.0001424902,0.0002185598,0.00007407848,0.0004364282,0.000009284499,0.000011442327,0.0010501569],"genre_scores_gemma":[0.9993556,0.00011420825,0.000284884,0.00007660215,0.000012479881,0.000015455564,0.00000409116,0.000013695768,0.00012298241],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990612,0.00010454165,0.000292863,0.00018446693,0.00021756551,0.00013933444],"domain_scores_gemma":[0.99949634,0.000061510495,0.000111778565,0.00023827629,0.000043089458,0.00004901426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021256045,0.00010066589,0.00020805061,0.00006351484,0.00003210034,0.0000085121455,0.000045876077,0.000067778245,0.000017380464],"category_scores_gemma":[0.000017279104,0.000075400625,0.000041989406,0.00021597533,0.000034516746,0.000025410234,0.000008246833,0.00008771195,0.000004847792],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013411125,0.0029479377,0.2998331,0.0057306043,0.000104376515,0.00009454599,0.015179905,0.000120313336,0.6714735,0.0031545423,0.00017244654,0.0010546283],"study_design_scores_gemma":[0.0029935976,0.00006820699,0.03422227,0.00039806237,0.00018080625,0.00018003346,0.0014768286,0.000043035077,0.9602461,0.000049263734,0.000051974996,0.00008982415],"about_ca_topic_score_codex":0.00001283535,"about_ca_topic_score_gemma":0.000025685718,"teacher_disagreement_score":0.2887726,"about_ca_system_score_codex":0.000016793772,"about_ca_system_score_gemma":0.000049697126,"threshold_uncertainty_score":0.30747482},"labels":[],"label_agreement":null},{"id":"W2083131489","doi":"10.1182/blood-2013-02-485524","title":"Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Münster AML-study group","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"National Cancer Institute; Stichting Kinder Oncologisch Centrum Rotterdam","keywords":"Medicine; Cohort; Myeloid leukemia; Leukemia; Internal medicine; Myeloid; Immunophenotyping; Pediatrics; Oncology; Immunology; Flow cytometry","score_opus":0.02079256657621617,"score_gpt":0.30876192464696384,"score_spread":0.28796935807074764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083131489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99171996,0.00034373175,0.00005510076,0.001534604,0.00016610097,0.0047520883,0.00008748183,0.00010607396,0.0012348634],"genre_scores_gemma":[0.99584055,0.0003232759,0.00030316648,0.00064266473,0.00073065294,0.00076169474,0.0000810391,0.000051984025,0.0012649652],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961522,0.00058788905,0.00076508545,0.0009748093,0.0009576173,0.0005623637],"domain_scores_gemma":[0.9974073,0.0007384707,0.00023562681,0.000707153,0.00053156127,0.00037987795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012881667,0.00042748335,0.00074623193,0.00016037193,0.00027429315,0.00026254324,0.0006171175,0.00020292487,0.00039057815],"category_scores_gemma":[0.0005063223,0.00023193815,0.00011227043,0.00076507597,0.000489797,0.00023194382,0.00062166614,0.0010373617,0.00019814914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006482575,0.0047426703,0.978165,0.000013610959,0.0016092875,0.0002986797,0.0011162071,8.0699365e-8,0.00022145019,0.000013726535,0.011617811,0.0015532243],"study_design_scores_gemma":[0.025784053,0.008926089,0.9535075,0.00001969702,0.0015397493,0.0002173221,0.0063763205,0.00006693335,0.000058707512,0.00004368383,0.0030771906,0.00038274887],"about_ca_topic_score_codex":0.00066069886,"about_ca_topic_score_gemma":0.0005023182,"teacher_disagreement_score":0.025135795,"about_ca_system_score_codex":0.00023440781,"about_ca_system_score_gemma":0.0004641887,"threshold_uncertainty_score":0.9458163},"labels":[],"label_agreement":null},{"id":"W2083225404","doi":"10.1182/blood-2007-08-110338","title":"Angiopoietin-1 promotes endothelial cell proliferation and migration through AP-1–dependent autocrine production of interleukin-8","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Christie (Canada)","funders":"Heart and Stroke Foundation of Canada","keywords":"Autocrine signalling; Angiopoietin 2; Cell growth; Angiopoietin; Cell biology; Cancer research; Immunology; Chemistry; Biology; Medicine; Internal medicine; Vascular endothelial growth factor; Biochemistry; VEGF receptors; Receptor","score_opus":0.011763072110770921,"score_gpt":0.23043586704370111,"score_spread":0.21867279493293018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083225404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975708,0.0011550006,0.00047553243,0.00012305312,0.00011848168,0.00026306356,0.000011084318,0.000010450748,0.0002725112],"genre_scores_gemma":[0.99654996,0.0006516791,0.0011881386,0.00003194052,0.0004158293,0.000039618873,0.000056348632,0.000013418141,0.0010530449],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993539,0.00002758964,0.0001693577,0.0002462243,0.00010032865,0.0001026406],"domain_scores_gemma":[0.9996424,0.0000024415515,0.00009142548,0.00015664948,0.00008545096,0.000021641321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000065209955,0.00009880781,0.000097240496,0.000020784351,0.000062185914,0.000006776378,0.000050400224,0.00006815627,0.000008484489],"category_scores_gemma":[0.000023367742,0.00008818,0.000049972143,0.00004169805,0.0000579551,0.000007871277,0.00003508915,0.000029977253,0.0000016754094],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052685165,0.0002538027,0.017367046,0.000041269803,0.000030784147,0.0000014044244,0.0003469947,0.000007926375,0.98109704,0.000015402813,0.00045736658,0.00032828512],"study_design_scores_gemma":[0.0005859493,0.0003623937,0.002959109,0.000010588296,0.000034613924,0.00006790446,0.000038659804,0.000009993277,0.99337053,0.000023290442,0.0024390488,0.00009791513],"about_ca_topic_score_codex":0.000035622114,"about_ca_topic_score_gemma":0.000042496562,"teacher_disagreement_score":0.014407938,"about_ca_system_score_codex":0.000004492128,"about_ca_system_score_gemma":0.0000449147,"threshold_uncertainty_score":0.3595876},"labels":[],"label_agreement":null},{"id":"W2083278995","doi":"10.1182/blood-2003-07-2343","title":"Activated Fps/Fes partially rescues the in vivo developmental potential of Flk1-deficient vascular progenitor cells","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Mount Sinai Hospital","funders":"","keywords":"Hemangioblast; Cell biology; Progenitor cell; Biology; Embryonic stem cell; Vasculogenesis; Stem cell; Biochemistry","score_opus":0.0075316025707899085,"score_gpt":0.215707697714468,"score_spread":0.20817609514367807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083278995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99762416,0.0014402186,0.00008188856,0.000016941196,0.00012391925,0.00019978627,0.000012118384,0.000005033851,0.0004959557],"genre_scores_gemma":[0.99882287,0.00021914177,0.00061283086,0.000046386886,0.00007941382,0.000036209905,0.000008370235,0.000015936988,0.00015884906],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991203,0.000082549224,0.00020878346,0.00022978845,0.0001505809,0.0002079922],"domain_scores_gemma":[0.9996541,0.0000053204008,0.00006324331,0.00019018825,0.000052947606,0.000034187713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018974273,0.00011873886,0.000118575765,0.00002480732,0.000058005975,0.000011736411,0.00014679383,0.00009737084,0.000051487827],"category_scores_gemma":[0.000023261995,0.0000869509,0.00011689546,0.00010293186,0.00006387079,0.0000023036484,0.00005140746,0.000042029347,0.0000034392033],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026665086,0.0002751528,0.0031379766,0.000010371723,0.00010243866,0.0000032163189,0.000057435827,0.00006810731,0.9958852,0.000025654208,0.00020461416,0.00020314487],"study_design_scores_gemma":[0.0007086533,0.00007912853,0.002510087,0.000011111603,0.00003942027,0.000007554724,0.00017611872,0.000002518457,0.98010767,0.0000064792043,0.016231788,0.00011949134],"about_ca_topic_score_codex":0.000023492219,"about_ca_topic_score_gemma":0.00003966571,"teacher_disagreement_score":0.016027175,"about_ca_system_score_codex":0.000009312484,"about_ca_system_score_gemma":0.00013912133,"threshold_uncertainty_score":0.35457548},"labels":[],"label_agreement":null},{"id":"W2083365324","doi":"10.1182/blood-2012-03-414359","title":"An open-label, single-arm, phase 2 (PX-171-004) study of single-agent carfilzomib in bortezomib-naive patients with relapsed and/or refractory multiple myeloma","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":254,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; University of Alberta; University of Calgary; University of Toronto","funders":"National Cancer Institute","keywords":"Carfilzomib; Bortezomib; Medicine; Multiple myeloma; Nausea; Proteasome inhibitor; Refractory (planetary science); Internal medicine; Adverse effect; Cohort; Clinical endpoint; Oncology; Surgery; Gastroenterology; Clinical trial","score_opus":0.06713614919153943,"score_gpt":0.33827399089045646,"score_spread":0.271137841698917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083365324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99559236,0.00030909848,0.0000051799875,0.00002215845,0.00007948281,0.0034594727,0.00010030206,0.000048609938,0.0003833255],"genre_scores_gemma":[0.99777806,0.000019610326,0.0014414883,0.000051890576,0.00007754861,0.0002001538,0.00022136125,0.00007817519,0.00013170441],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970594,0.0002790746,0.0005874318,0.0005917274,0.00072726497,0.00075508264],"domain_scores_gemma":[0.997807,0.00019323285,0.00026013592,0.00077117764,0.00024615283,0.0007222699],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003257446,0.0003874175,0.00074954255,0.0003065002,0.00012495324,0.000052562253,0.00027346707,0.00013023734,0.000090237016],"category_scores_gemma":[0.00034140746,0.00027391152,0.000029180035,0.0004056817,0.00012305017,0.0005911626,0.00020879535,0.0002902472,0.000011625928],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009041026,0.25638416,0.7029325,0.00007519215,0.00045938208,0.00028855458,0.0026091048,4.367743e-7,0.017051937,0.0000020380955,0.000034076547,0.011121628],"study_design_scores_gemma":[0.22559416,0.074341185,0.6876617,0.00024624442,0.00047833277,0.000028783283,0.0018274627,0.00006850564,0.009176645,0.0000018394109,0.00022162384,0.0003535286],"about_ca_topic_score_codex":0.0008272829,"about_ca_topic_score_gemma":0.00059652363,"teacher_disagreement_score":0.21655314,"about_ca_system_score_codex":0.00017306168,"about_ca_system_score_gemma":0.0001397571,"threshold_uncertainty_score":0.99997133},"labels":[],"label_agreement":null},{"id":"W2083398319","doi":"10.1182/blood-2012-12-475863","title":"NrasG12D/+ promotes leukemogenesis by aberrantly regulating hematopoietic stem cell functions","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"National Cancer Institute; Canadian Institutes of Health Research; University of Wisconsin Carbone Cancer Center; Greater Milwaukee Foundation; University of Wisconsin-Madison; American Society of Hematology; V Foundation for Cancer Research","keywords":"Neuroblastoma RAS viral oncogene homolog; Cancer research; Myeloid; Haematopoiesis; Biology; Progenitor cell; Stem cell; MAPK/ERK pathway; Immunology; Signal transduction; Cell biology; Mutation; Genetics; KRAS; Gene","score_opus":0.014754856163675209,"score_gpt":0.23780090715364857,"score_spread":0.22304605098997338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083398319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810367,0.0010084402,0.00020947645,0.0010219172,0.000067274756,0.0010155437,0.000014293836,0.00022695548,0.015399393],"genre_scores_gemma":[0.9638247,0.000028951426,0.0012863649,0.0002059872,0.00018470109,0.00020461186,0.000044555178,0.00007733558,0.034142796],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99801743,0.0000739726,0.00037637143,0.000450219,0.0004951868,0.00058681006],"domain_scores_gemma":[0.99859595,0.00014153103,0.00009648938,0.0006327871,0.00020890553,0.0003243337],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00021365791,0.00024085856,0.00036652992,0.00013224492,0.00020372384,0.000067412766,0.00017995185,0.00017043187,0.0009801198],"category_scores_gemma":[0.00003691661,0.00020458797,0.00013365666,0.0004059544,0.00009793214,0.00015463431,0.0001049965,0.0003265369,0.0016765422],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035363206,0.0012158599,0.013541874,0.0006099764,0.00026249888,0.000053595075,0.00086135365,0.000003553405,0.9080536,0.00003443383,0.06426696,0.011060947],"study_design_scores_gemma":[0.010445044,0.00088255695,0.009404515,0.00029874122,0.00076281966,0.0007855627,0.0025925133,0.0014322869,0.96433914,0.00015116968,0.008168225,0.0007374317],"about_ca_topic_score_codex":0.0002715068,"about_ca_topic_score_gemma":0.0000045600636,"teacher_disagreement_score":0.056285545,"about_ca_system_score_codex":0.00014290669,"about_ca_system_score_gemma":0.00026398493,"threshold_uncertainty_score":0.9999331},"labels":[],"label_agreement":null},{"id":"W2083420643","doi":"10.1182/blood-2013-11-540021","title":"Patient-reported outcomes for the myelodysplastic syndromes: a new MDS-specific measure of quality of life","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Laurentian University; Children's Hospital of Eastern Ontario","funders":"","keywords":"Myelodysplastic syndromes; Medicine; Quality of life (healthcare); Intensive care medicine; Gerontology; Pediatrics; Internal medicine; Bone marrow","score_opus":0.06565081009864157,"score_gpt":0.3199981261636594,"score_spread":0.2543473160650178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083420643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911397,0.00072076183,0.0043492615,0.0017371047,0.00013994159,0.0011524749,0.00002925104,0.000041932533,0.000689563],"genre_scores_gemma":[0.99754274,0.000037494192,0.001591596,0.00018675387,0.00010565111,0.000045333847,0.00001452886,0.00003287275,0.00044302558],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976943,0.00012427208,0.0008307155,0.00026886657,0.0007782502,0.00030357525],"domain_scores_gemma":[0.9962598,0.0018427063,0.00040426175,0.0008404946,0.0004320299,0.00022070798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096376764,0.00017293898,0.0007363569,0.00010981341,0.000056106128,0.000008370861,0.0002154933,0.00011754886,0.00008671356],"category_scores_gemma":[0.0055066096,0.00010569547,0.0002565705,0.00027137448,0.00015155172,0.000037602847,0.00007197809,0.00021267687,0.000011407673],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054196035,0.0070546027,0.76183283,0.004163625,0.009694668,0.00005099413,0.0050909845,0.000071510476,0.11024571,0.008845871,0.040874105,0.046655502],"study_design_scores_gemma":[0.034055214,0.00304577,0.92482483,0.00040288985,0.0013376367,0.00011019334,0.0009950256,0.00033502685,0.020066103,0.0006652575,0.0137376515,0.00042439357],"about_ca_topic_score_codex":0.00021602106,"about_ca_topic_score_gemma":0.000018195957,"teacher_disagreement_score":0.16299202,"about_ca_system_score_codex":0.00003894651,"about_ca_system_score_gemma":0.00058910204,"threshold_uncertainty_score":0.6592324},"labels":[],"label_agreement":null},{"id":"W2083642109","doi":"10.1182/blood-2013-07-515536","title":"Influenza virus H1N1 activates platelets through FcγRIIA signaling and thrombin generation","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":206,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"Canadian Institutes of Health Research","keywords":"Platelet; Immunology; Influenza A virus; Coagulation; Virus; Thrombin; Immune system; Immune thrombocytopenia; Thrombin generation; Virology; Biology; Medicine; Internal medicine","score_opus":0.09686560206371164,"score_gpt":0.3586433668731288,"score_spread":0.26177776480941717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083642109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953307,0.0016909279,0.00014844057,0.00023650835,0.000049880695,0.000326646,0.000006232223,0.00009389821,0.0021167712],"genre_scores_gemma":[0.995422,0.00030238976,0.0021143758,0.0015101071,0.0004754483,0.000036354755,0.000008982047,0.00003151532,0.00009880538],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99864507,0.00007857052,0.00024727974,0.0003183458,0.00035157247,0.00035915576],"domain_scores_gemma":[0.99929947,0.00014788168,0.000067814144,0.00025479216,0.00012919812,0.00010082945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029981992,0.0001880165,0.0003232686,0.00007342524,0.00024558097,0.000053918502,0.000067609515,0.00010836993,0.00006513373],"category_scores_gemma":[0.0005095141,0.00015480061,0.000048765472,0.00013739303,0.00012947692,0.00021409056,0.00010190522,0.00024019375,0.00006922165],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079483456,0.00021989735,0.008422284,0.000077576835,0.00024879084,0.000017244283,0.0011552643,0.000015517273,0.9865404,0.000750158,0.00045505812,0.002018326],"study_design_scores_gemma":[0.0041711265,0.00043062042,0.008593317,0.00008240735,0.000133173,0.00004304302,0.00007569036,0.0002749067,0.9779833,0.00069753185,0.007317547,0.00019736073],"about_ca_topic_score_codex":0.00022120301,"about_ca_topic_score_gemma":0.000021693453,"teacher_disagreement_score":0.008557124,"about_ca_system_score_codex":0.00002631684,"about_ca_system_score_gemma":0.00003801669,"threshold_uncertainty_score":0.63125855},"labels":[],"label_agreement":null},{"id":"W2083730819","doi":"10.1182/blood-2013-02-481507","title":"NOTCH2 and FLT3 gene mis-splicings are common events in patients with acute myeloid leukemia (AML): new potential targets in AML","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Montreal Clinical Research Institute","funders":"U.S. National Library of Medicine; National Cancer Institute; University of Alberta; American Society of Hematology; American Association for Cancer Research","keywords":"Biology; Myeloid leukemia; Alternative splicing; Cancer research; Gene; splice; Exon; Myeloid; RNA splicing; Leukemia; Bone marrow; Genetics; Immunology; RNA","score_opus":0.0034958236695060746,"score_gpt":0.20916577175925447,"score_spread":0.2056699480897484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083730819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99915844,0.00017663749,0.00019627296,0.00010504454,0.000026765338,0.00024334344,0.000011336036,0.0000063030357,0.00007587989],"genre_scores_gemma":[0.9986651,0.00007312627,0.0004422715,0.00016952581,0.000089559246,0.000010684572,0.00012622635,0.000024200463,0.00039931503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881107,0.0000600443,0.00018992291,0.0003630575,0.00019266522,0.00038321526],"domain_scores_gemma":[0.99946755,0.0000064845985,0.00007227238,0.00025543378,0.000037793863,0.00016044952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001276476,0.00016733157,0.00020298194,0.000075170625,0.000048438716,0.000017458204,0.00016778146,0.00013195409,0.0000035675503],"category_scores_gemma":[0.000029200335,0.00014691656,0.00003264246,0.00009202873,0.00003202256,0.000008244311,0.000108076034,0.000154644,0.000004077764],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033289893,0.0001762111,0.62481004,0.00001833809,0.000056886467,0.00001907293,0.000037214995,0.000051311574,0.3726875,0.0000020911962,0.00013696305,0.0016714701],"study_design_scores_gemma":[0.008099594,0.0006233685,0.81980604,0.00005866288,0.000026976415,0.00001070991,0.00001611591,0.00014776287,0.17066774,0.000034497574,0.00026409898,0.0002444574],"about_ca_topic_score_codex":0.00063237693,"about_ca_topic_score_gemma":0.00072075904,"teacher_disagreement_score":0.20201974,"about_ca_system_score_codex":0.000023474578,"about_ca_system_score_gemma":0.000069582,"threshold_uncertainty_score":0.59910834},"labels":[],"label_agreement":null},{"id":"W2083773813","doi":"10.1182/blood-2014-10-606665","title":"New checkpoint of the coagulant phenotype","year":2014,"lang":"en","type":"letter","venue":"Blood","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Phenotype; Allele; Biology; Cancer research; Genetics; Mutation; Gene","score_opus":0.009852852164655623,"score_gpt":0.21692533865701086,"score_spread":0.20707248649235524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083773813","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12794197,0.10400899,0.0036647173,0.6659025,0.036464937,0.0036306197,0.0008815458,0.00014866759,0.057356052],"genre_scores_gemma":[0.022080513,0.0024916537,0.0017731737,0.77358603,0.14084703,0.000054309956,0.0009876767,0.00026890764,0.05791071],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989775,0.00005621702,0.00022485749,0.0003125383,0.00019341275,0.00023550943],"domain_scores_gemma":[0.99889606,0.0000071613663,0.00020100428,0.000794907,0.000058459857,0.000042423297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000083853585,0.00021059363,0.00028823575,0.000021590202,0.000032560798,0.000011168944,0.0004380211,0.00054465135,0.000051231746],"category_scores_gemma":[0.000042966025,0.00015018672,0.00027655758,0.000049486625,0.00006224623,6.1708414e-7,0.00014660618,0.00035197067,0.000013317807],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007755496,0.000021405807,0.000030876887,0.00005699462,0.00012045772,9.73399e-7,0.000013316704,7.506213e-7,0.12776099,0.000011214255,0.8712086,0.0007666308],"study_design_scores_gemma":[0.00064829964,0.000047666967,0.00022874984,0.000027553348,0.00020917144,0.000020530493,0.0000013953924,2.6711112e-7,0.15029564,0.00006274054,0.84829473,0.00016324059],"about_ca_topic_score_codex":0.00011103538,"about_ca_topic_score_gemma":0.00002363112,"teacher_disagreement_score":0.10768352,"about_ca_system_score_codex":0.0000034458726,"about_ca_system_score_gemma":0.00023959446,"threshold_uncertainty_score":0.6124437},"labels":[],"label_agreement":null},{"id":"W2084072374","doi":"10.1182/blood-2002-10-3078","title":"Monoclonal IgG can ameliorate immune thrombocytopenia in a murine model of ITP: an alternative to IVIG","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services","funders":"","keywords":"Immunology; Medicine; Antibody; Monoclonal antibody; Thrombocytopenic purpura; Immune system; Antigen; Immunoglobulin G","score_opus":0.02877785747962651,"score_gpt":0.28472889609609553,"score_spread":0.255951038616469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084072374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99671227,0.0001699702,0.00003522817,0.00016794093,0.000024780553,0.00037398032,0.000045407214,0.000013797292,0.002456638],"genre_scores_gemma":[0.9967196,0.000049278216,0.0027130153,0.00015342442,0.000011052498,0.000030923657,0.000028501256,0.000019524046,0.00027469257],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991209,0.000029930377,0.00023578717,0.00022995325,0.00016131524,0.00022214718],"domain_scores_gemma":[0.9995075,0.000010792328,0.00005990528,0.00024298429,0.000055965073,0.00012289066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008573561,0.00014308248,0.00043901004,0.00012054013,0.000021389522,0.00000634697,0.00007491021,0.00004374136,0.00004435855],"category_scores_gemma":[0.000029573623,0.00012299599,0.000047641985,0.00019956783,0.000024484088,0.000058135203,0.000023943905,0.000092090835,0.000013013407],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002170969,0.04352176,0.27728763,0.00030706648,0.0024854746,0.0067391805,0.017083436,0.01046936,0.6249036,0.0074262214,0.00019841379,0.007406846],"study_design_scores_gemma":[0.04643245,0.004069192,0.11140097,0.0004100541,0.00061758526,0.0003583959,0.0008241716,0.007574895,0.8204883,0.0069015105,0.00015879654,0.0007637124],"about_ca_topic_score_codex":0.000883039,"about_ca_topic_score_gemma":0.0005119257,"teacher_disagreement_score":0.19558464,"about_ca_system_score_codex":0.00003052293,"about_ca_system_score_gemma":0.000108171844,"threshold_uncertainty_score":0.50156313},"labels":[],"label_agreement":null},{"id":"W2084080793","doi":"10.1182/blood-2008-08-174987","title":"Quantitation of anti–factor VIII antibodies in human plasma","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"Bayer Canada; National Heart, Lung, and Blood Institute; University of Notre Dame Australia; National Hemophilia Foundation","keywords":"Antibody; Recombinant DNA; Titer; Immunoassay; Chemistry; Molecular biology; Human plasma; Multiplex; Factor IX; Immunology; Medicine; Chromatography; Biology; Biochemistry","score_opus":0.044861349117982736,"score_gpt":0.3529673487492719,"score_spread":0.30810599963128915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084080793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99547535,0.00015304475,9.9697e-7,0.0004138088,0.0000144865935,0.00016613663,0.0000034865836,0.000017252976,0.0037554395],"genre_scores_gemma":[0.9992522,0.00007560082,0.00022427193,0.000014714246,0.000034647655,0.0000013160262,0.000017773558,0.000004768383,0.00037469677],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99943084,0.00001705237,0.00014979478,0.000102089354,0.00016740803,0.00013284075],"domain_scores_gemma":[0.9997598,0.000024578916,0.000026926436,0.00011025107,0.00004000287,0.0000384441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006181725,0.00006121953,0.00017790293,0.00015791101,0.000025192114,0.000004402511,0.000033804885,0.000048528826,0.000047638237],"category_scores_gemma":[0.00004216168,0.00004637265,0.00004021333,0.00013440358,0.000031556123,0.000040160485,0.0000065599625,0.0000697444,0.00001492139],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031730164,0.0012911838,0.50086886,0.000055236684,0.000035158486,0.00008085345,0.0003781573,6.378231e-7,0.4953413,0.00052856165,0.000046850277,0.0013414979],"study_design_scores_gemma":[0.0027197725,0.00057577423,0.712626,0.000087732915,0.000026549516,0.0000067494852,0.00005779101,0.000017963415,0.2837051,0.00009676148,0.000039442435,0.00004041053],"about_ca_topic_score_codex":0.000021900381,"about_ca_topic_score_gemma":0.000011180916,"teacher_disagreement_score":0.21175714,"about_ca_system_score_codex":0.000008775096,"about_ca_system_score_gemma":0.00002834667,"threshold_uncertainty_score":0.18910217},"labels":[],"label_agreement":null},{"id":"W2084116711","doi":"10.1182/blood-2014-09-603043","title":"Nongenetic stochastic expansion of JAK2V617F-homozygous subclones in polycythemia vera?","year":2014,"lang":"en","type":"letter","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; National Institute for Health and Care Research; Cancer Research UK; Wellcome Trust","keywords":"Polycythemia vera; Medicine; Genetics; Biology; Internal medicine","score_opus":0.01569287129768855,"score_gpt":0.2487397605156014,"score_spread":0.23304688921791283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084116711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8969681,0.0032561256,0.00009464983,0.09591681,0.0004357343,0.0018218927,0.0000797036,0.00007188501,0.0013550913],"genre_scores_gemma":[0.9172372,0.00020659092,0.0005739142,0.078191526,0.0020535225,0.0003599187,0.00047232248,0.0001372269,0.00076776545],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976903,0.00009904515,0.0005979596,0.00059787085,0.00055886386,0.00045593575],"domain_scores_gemma":[0.99856883,0.00031216384,0.00024920772,0.0006579832,0.000111005495,0.00010083499],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000115699,0.00049010257,0.0011458838,0.00033623463,0.000037663653,0.000014123584,0.00014653623,0.00066204194,0.00022995243],"category_scores_gemma":[0.00008611709,0.00039777116,0.00022459812,0.0001839032,0.000089457324,0.000021804593,0.00005503333,0.0008120499,0.00009823999],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012160438,0.009541632,0.11037677,0.006852208,0.003794802,0.02579964,0.0026094806,0.00013584219,0.00986968,0.00011161838,0.820258,0.009434279],"study_design_scores_gemma":[0.1486274,0.02706759,0.189959,0.02993388,0.022250341,0.012142786,0.0002506469,0.000653347,0.2760906,0.0014017056,0.283642,0.007980747],"about_ca_topic_score_codex":0.0001465472,"about_ca_topic_score_gemma":0.000042900712,"teacher_disagreement_score":0.536616,"about_ca_system_score_codex":0.000073907824,"about_ca_system_score_gemma":0.00021885145,"threshold_uncertainty_score":0.9998474},"labels":[],"label_agreement":null},{"id":"W2084224647","doi":"10.1182/blood-2012-03-419721","title":"Formation of a PKCζ/β-catenin complex in endothelial cells promotes angiopoietin-1–induced collective directional migration and angiogenic sprouting","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; Institut de Recherche Clinique De Montréal","keywords":"Adherens junction; Cell biology; Cell migration; Endothelial stem cell; Angiogenesis; Biology; CDC42; Sprouting angiogenesis; Zebrafish; Cell; Actin; Cadherin; Cancer research; In vitro; Neovascularization","score_opus":0.021462044010493037,"score_gpt":0.24764849128628552,"score_spread":0.22618644727579248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084224647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984453,0.00060681923,0.00016283734,0.000027518117,0.000054717086,0.00020605832,0.000039945637,0.0000053765734,0.0004514795],"genre_scores_gemma":[0.99868554,0.00005078909,0.00087898114,0.000023452398,0.00019542666,0.000032413034,0.0000650656,0.00001071753,0.000057634334],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993962,0.000046280933,0.00017956104,0.00013429624,0.000077818426,0.00016586024],"domain_scores_gemma":[0.99972814,0.000011927278,0.00010058466,0.0000709781,0.000052868418,0.00003551437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016249718,0.000091701615,0.00010749406,0.00005286812,0.00004702666,0.000007589035,0.00004036419,0.00008262435,0.000010441122],"category_scores_gemma":[0.000021807575,0.0000883709,0.00006592636,0.000103569095,0.000026545704,0.000010488418,0.000032708158,0.000027109701,0.0000012225529],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039662737,0.00016277534,0.041848183,0.000014167128,0.000029709034,1.5232172e-7,0.00031406333,0.0000021713251,0.9570634,0.00001339151,0.000061785046,0.0004505885],"study_design_scores_gemma":[0.0007900088,0.00013172979,0.03441993,0.0000110350475,0.000026307072,0.000013186013,0.00009172667,0.00005860011,0.9638577,0.000011716808,0.000487622,0.00010043094],"about_ca_topic_score_codex":0.00006687583,"about_ca_topic_score_gemma":0.00010440271,"teacher_disagreement_score":0.0074282517,"about_ca_system_score_codex":0.000014174431,"about_ca_system_score_gemma":0.00003768191,"threshold_uncertainty_score":0.36036608},"labels":[],"label_agreement":null},{"id":"W2084259712","doi":"10.1182/blood-2014-10-609370","title":"Leukemia stem cells in T-ALL require active Hif1α and Wnt signaling","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Canadian Institutes of Health Research; Terry Fox Foundation; University of Pennsylvania","keywords":"Wnt signaling pathway; Stem cell; Leukemia; Cancer research; Biology; Cell biology; Chemistry; Signal transduction; Immunology","score_opus":0.020492433261785275,"score_gpt":0.24468256962590212,"score_spread":0.22419013636411686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084259712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979846,0.0012481152,0.00006954137,0.000046385358,0.00008232934,0.00011824283,0.0000071967406,0.000008077107,0.0004355417],"genre_scores_gemma":[0.99918246,0.00007046616,0.0001647848,0.000038427333,0.00015243991,0.000007766335,0.000021841079,0.000013966948,0.00034784642],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994014,0.00003348883,0.0001223712,0.00022643385,0.000078509904,0.00013779437],"domain_scores_gemma":[0.99970144,0.0000051819657,0.000052488955,0.00013331976,0.000037881466,0.00006966971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000106412364,0.00008774282,0.000087251334,0.000030203128,0.000014497244,0.0000116806095,0.000054408643,0.00014199484,0.0000025665097],"category_scores_gemma":[0.000007955772,0.00009153269,0.000022789356,0.000054292123,0.000025579788,0.0000050700105,0.000052761305,0.00006126743,0.0000042954503],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000611923,0.00003364133,0.0004310119,0.000009476985,0.000037718262,0.000004391129,0.00019752941,0.00080123486,0.99491227,0.000013865657,0.00019430176,0.0033033958],"study_design_scores_gemma":[0.0015636489,0.00014040148,0.0004990741,0.000017714356,0.00002547657,0.000012151025,0.00014316024,0.00010188263,0.9929067,0.00007738324,0.0043859934,0.0001264171],"about_ca_topic_score_codex":0.0000349464,"about_ca_topic_score_gemma":0.00005368707,"teacher_disagreement_score":0.0041916915,"about_ca_system_score_codex":0.0000515775,"about_ca_system_score_gemma":0.00011683484,"threshold_uncertainty_score":0.37325945},"labels":[],"label_agreement":null},{"id":"W2084319477","doi":"10.1182/blood-2009-10-249326","title":"Engraftment of human hematopoietic stem cells is more efficient in female NOD/SCID/IL-2Rgc-null recipients","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"Canadian Institutes of Health Research","keywords":"Haematopoiesis; Stem cell; Biology; Nod; CD90; CD34; Transplantation; Andrology; Immunology; CD38; Bone marrow; Internal medicine; Medicine; Endocrinology; Cell biology","score_opus":0.016549582774986554,"score_gpt":0.2707152500046434,"score_spread":0.25416566722965683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084319477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961391,0.000073250114,0.000035395056,0.00015456951,0.0002960215,0.0008802726,0.000038154936,0.000050838866,0.0023324173],"genre_scores_gemma":[0.9984111,0.000013172584,0.0007585564,0.00011292897,0.000056132874,0.000047697107,0.00002173699,0.000042501728,0.00053615123],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978345,0.000044275363,0.0006819737,0.00043927087,0.00061506656,0.00038492176],"domain_scores_gemma":[0.99882483,0.00008329423,0.00017448529,0.0006272227,0.00009672328,0.00019344702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037145652,0.00024616395,0.000509337,0.00023568916,0.000056053846,0.000013225128,0.00017473007,0.00019286851,0.00030649066],"category_scores_gemma":[0.000009101813,0.0002253393,0.00013987898,0.00028765312,0.00010230663,0.00002982488,0.00003803266,0.0003269907,0.000121352285],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006364192,0.0035979536,0.068275236,0.0011058048,0.00009155729,0.00018658147,0.010584853,0.000011264831,0.91550094,0.0002436838,0.00010458466,0.00023388855],"study_design_scores_gemma":[0.0054564597,0.00027587093,0.02940159,0.000555155,0.00024375583,0.00009805233,0.00067342643,0.0000729582,0.962885,0.000017792301,0.00011894294,0.00020094858],"about_ca_topic_score_codex":0.00006085187,"about_ca_topic_score_gemma":0.00003024547,"teacher_disagreement_score":0.047384102,"about_ca_system_score_codex":0.000035810845,"about_ca_system_score_gemma":0.0000720701,"threshold_uncertainty_score":0.918907},"labels":[],"label_agreement":null},{"id":"W2084379028","doi":"10.1182/blood-2006-12-062448","title":"CD34 facilitates the development of allergic asthma","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"CD34; Eosinophil; Immunology; Mast cell; Bone marrow; Cytokine; Asthma; Medicine; Interleukin 5; Stem cell; Biology; Interleukin; Cell biology","score_opus":0.015730202061370838,"score_gpt":0.262584882743902,"score_spread":0.2468546806825312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084379028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933808,0.0012360155,0.00014323668,0.00009375479,0.000031966494,0.00012657179,0.000002313473,0.00002260916,0.004962759],"genre_scores_gemma":[0.9981213,0.000004409548,0.0010711438,0.00014173432,0.000057098576,0.000004134633,0.0000041436338,0.0000062988365,0.00058969454],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99936604,0.000011115356,0.00020712428,0.00009157455,0.00018271642,0.00014140445],"domain_scores_gemma":[0.99963194,0.000049487222,0.00003931661,0.00014933363,0.00004931649,0.00008059173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021672905,0.00006858467,0.00011075654,0.00003393602,0.00005724576,0.0000024301926,0.000060472543,0.00003107704,0.000105120525],"category_scores_gemma":[0.000042496224,0.000038488874,0.00005646103,0.000080748294,0.00006431048,0.000013308172,0.00002355118,0.000052489642,0.000050772273],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082226325,0.007081986,0.40935186,0.0008312192,0.0011657435,0.00042597295,0.01826332,0.000010981373,0.14883472,0.00069076143,0.0029304982,0.40959066],"study_design_scores_gemma":[0.0018574216,0.0001888233,0.7379933,0.0000672307,0.000059066406,0.000021989088,0.001956615,0.0000017010605,0.11653232,0.00002656693,0.14119467,0.00010030248],"about_ca_topic_score_codex":0.0000015703795,"about_ca_topic_score_gemma":0.000010089392,"teacher_disagreement_score":0.40949038,"about_ca_system_score_codex":0.0000060333946,"about_ca_system_score_gemma":0.00011218216,"threshold_uncertainty_score":0.15695307},"labels":[],"label_agreement":null},{"id":"W2084382618","doi":"10.1182/blood-2003-07-2272","title":"VEGF-mediated endothelial P-selectin translocation: role of VEGF receptors and endogenous PAF synthesis","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute; Montreal Children's Hospital","funders":"","keywords":"Vascular endothelial growth factor; Vascular endothelial growth factor A; Kinase insert domain receptor; Endothelial stem cell; Cell biology; Chemistry; Receptor; Umbilical vein; Internal medicine; Biology; Endocrinology; Cancer research; Medicine; VEGF receptors; Biochemistry","score_opus":0.008871665299339603,"score_gpt":0.20528535902769643,"score_spread":0.19641369372835682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084382618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868848,0.011921282,0.00008619416,0.000053169682,0.00006383009,0.00011879014,0.000050250594,0.000012455324,0.0008092748],"genre_scores_gemma":[0.996489,0.0027000224,0.0004255153,0.000048932317,0.00021834509,0.000038689996,0.000029138308,0.00002230678,0.000028090395],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992925,0.000027701795,0.00017605413,0.00023874085,0.00009359602,0.00017144051],"domain_scores_gemma":[0.99963003,0.000016810083,0.00006778641,0.00017159671,0.00005410308,0.000059699025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008474497,0.00012149823,0.00014829542,0.00003006508,0.00005502466,0.0000075422317,0.000097903874,0.00012603172,0.00003048946],"category_scores_gemma":[0.000048044203,0.00011668564,0.00007883459,0.00008243305,0.000068264955,0.0000024953608,0.000019141753,0.00003638258,0.0000053877757],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004703904,0.00019254099,0.0016714936,0.000016343243,0.000108343665,0.0000014389003,0.00015631692,0.000011039558,0.9901745,0.00004374535,0.00002083045,0.007556404],"study_design_scores_gemma":[0.0009706617,0.00020236321,0.00055197807,0.000019333762,0.0000661793,0.00003306033,0.00010038998,9.2656984e-7,0.9905325,0.00004659971,0.007341876,0.00013412748],"about_ca_topic_score_codex":0.0000745523,"about_ca_topic_score_gemma":0.000038561586,"teacher_disagreement_score":0.009604206,"about_ca_system_score_codex":0.000007102462,"about_ca_system_score_gemma":0.00010298146,"threshold_uncertainty_score":0.47583023},"labels":[],"label_agreement":null},{"id":"W2084452268","doi":"10.1182/blood-2003-09-3032","title":"Imatinib mesylate (STI571) for treatment of children with Philadelphia chromosome-positive leukemia: results from a Children's Oncology Group phase 1 study","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":238,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Imatinib mesylate; Imatinib; Nausea; Pharmacokinetics; Internal medicine; Gastroenterology; Vomiting; Myeloid leukemia; Philadelphia chromosome; Chromosomal translocation","score_opus":0.01754745499324663,"score_gpt":0.2983391117999296,"score_spread":0.280791656806683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084452268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989036,0.0005872685,0.00008191389,0.00044040082,0.00006290327,0.0065286825,0.002881037,0.00013164034,0.00025012053],"genre_scores_gemma":[0.98969656,0.00012504005,0.005547055,0.00006568339,0.00036452519,0.00055422593,0.0035082453,0.00009485279,0.000043802833],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9971316,0.00008222337,0.00082006614,0.0009770942,0.00042383306,0.0005652003],"domain_scores_gemma":[0.9979454,0.00024120773,0.00052254886,0.0008629623,0.00014291613,0.0002849368],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013502891,0.0005818872,0.0012958763,0.00017281131,0.00014524523,0.000016364851,0.00017907345,0.00023123274,0.000037315505],"category_scores_gemma":[0.00007300369,0.00042785995,0.0002473291,0.00028656633,0.00017765533,0.000108585795,0.000050442264,0.00015799952,0.000020411886],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.095302165,0.4750116,0.1803747,0.00019179563,0.09228245,0.0042465827,0.04953761,0.00079387176,0.042812537,0.00025282943,0.0005005338,0.058693327],"study_design_scores_gemma":[0.5771782,0.103172556,0.25106198,0.00032231034,0.009355553,0.0006817995,0.0003839389,0.000024851897,0.05713467,0.000093384,0.000056387085,0.00053438457],"about_ca_topic_score_codex":0.0035172212,"about_ca_topic_score_gemma":0.00034948776,"teacher_disagreement_score":0.48187605,"about_ca_system_score_codex":0.0024182135,"about_ca_system_score_gemma":0.0012967665,"threshold_uncertainty_score":0.9998173},"labels":[],"label_agreement":null},{"id":"W2084454068","doi":"10.1182/blood-2010-05-282574","title":"Sbds is required for Rac2-mediated monocyte migration and signaling downstream of RANK during osteoclastogenesis","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Osteoclast; Biology; RANKL; RHOA; Cell biology; RANK Ligand; Cancer research; Internal medicine; Activator (genetics); Endocrinology; Signal transduction; Receptor; Medicine; Biochemistry","score_opus":0.006543120697450019,"score_gpt":0.22146820417048604,"score_spread":0.21492508347303602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084454068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99866194,0.0007400062,0.000089043315,0.00005721132,0.00004678146,0.00024299101,0.00008006885,0.000008446022,0.00007354002],"genre_scores_gemma":[0.9981454,0.00014869912,0.0013152037,0.000028517898,0.00006735324,0.00004346674,0.00014719018,0.000016711849,0.00008744124],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993978,0.0000106177395,0.00015800667,0.00023664295,0.00005762313,0.0001392861],"domain_scores_gemma":[0.99960387,0.000013140834,0.00008516129,0.0001821819,0.00006605271,0.000049604332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000051777613,0.00011459605,0.00012852445,0.00003259942,0.000065573404,0.000011923936,0.00005651041,0.00013357337,0.000008050529],"category_scores_gemma":[0.00004284304,0.000107249754,0.00006876523,0.000045129193,0.000048382564,0.000005082213,0.000029493185,0.00002968013,0.0000010521698],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011179428,0.00020225027,0.017460603,0.000035987032,0.00014642326,8.0551786e-7,0.0000712939,0.00000198687,0.9806952,0.000003320917,0.000024045377,0.0012463245],"study_design_scores_gemma":[0.004357059,0.0002263087,0.0029424408,0.0000082858905,0.00014764047,0.000008041343,0.00004868096,0.000037277317,0.9917284,0.000031041578,0.00035385662,0.000110940884],"about_ca_topic_score_codex":0.000038145346,"about_ca_topic_score_gemma":0.0001287558,"teacher_disagreement_score":0.014518161,"about_ca_system_score_codex":0.0000012062284,"about_ca_system_score_gemma":0.000024986606,"threshold_uncertainty_score":0.43735182},"labels":[],"label_agreement":null},{"id":"W2084509256","doi":"10.1182/blood.v97.6.1835","title":"Involvement of caspase-2 long isoform in Fas-mediated cell death of human leukemic cells","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"FADD; Death domain; Fas receptor; Caspase 8; Cell biology; Apoptosis; Transfection; Programmed cell death; Biology; Molecular biology; Caspase; Caspase 10; Fas ligand; Chemistry; Cell culture; Biochemistry","score_opus":0.011147649146496862,"score_gpt":0.22375236987867447,"score_spread":0.21260472073217762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084509256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980341,0.0005595005,0.00025681054,0.000004157371,0.000039203525,0.00015566673,0.000009359714,0.0000037233674,0.0009374451],"genre_scores_gemma":[0.9985295,0.0004403917,0.00026832338,0.000017493994,0.000041026597,0.00000590334,0.0001608469,0.000012229109,0.0005243073],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99930257,0.000017158654,0.00026194792,0.00016928508,0.00009941901,0.00014962787],"domain_scores_gemma":[0.99959034,0.00000449188,0.00012148513,0.00020401133,0.00004383819,0.000035816207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010512402,0.0000960966,0.0001368324,0.000061080435,0.000018374558,0.0000027484516,0.00009240948,0.00012099839,0.000026674792],"category_scores_gemma":[0.000003856112,0.00009064776,0.000059616646,0.00007496114,0.00002307775,0.0000021042893,0.00005082918,0.000040935458,0.0000015352834],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015022322,0.00036867306,0.0148351155,0.000047751077,0.000016611926,0.0000068789996,0.000057222787,0.000077975026,0.98434275,0.00003943985,0.000018146984,0.00017443088],"study_design_scores_gemma":[0.0016137584,0.00034617906,0.0151667055,0.000021124575,0.00002653684,0.000003152914,0.00005717927,0.00007189912,0.9823439,0.00004672182,0.00020468445,0.00009811689],"about_ca_topic_score_codex":0.00021130547,"about_ca_topic_score_gemma":0.00019416727,"teacher_disagreement_score":0.00199879,"about_ca_system_score_codex":0.000011091588,"about_ca_system_score_gemma":0.000035634373,"threshold_uncertainty_score":0.3696508},"labels":[],"label_agreement":null},{"id":"W2084542540","doi":"10.1182/blood-2009-06-229658","title":"Bortezomib and high-dose melphalan as conditioning regimen before autologous stem cell transplantation in patients with de novo multiple myeloma: a phase 2 study of the Intergroupe Francophone du Myélome (IFM)","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":171,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Melphalan; Bortezomib; Multiple myeloma; Regimen; Autologous stem-cell transplantation; Internal medicine; Transplantation; Surgery; Oncology","score_opus":0.006386028454849118,"score_gpt":0.2424116482619217,"score_spread":0.23602561980707257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084542540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99815035,0.00005807828,0.000013449999,0.00007605369,0.000028732447,0.0015203058,0.00005476545,0.000027832455,0.000070455244],"genre_scores_gemma":[0.9995433,0.000009242916,0.00017187564,0.000041865882,0.000023833027,0.000058134217,0.000099937264,0.000017382657,0.000034427743],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99872285,0.00010633977,0.0002803913,0.00027229617,0.0003393991,0.00027870238],"domain_scores_gemma":[0.9993667,0.00006043773,0.00012012887,0.00024352902,0.00007797298,0.00013121156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011045441,0.00017606994,0.0003228289,0.00013494508,0.00009200683,0.00001386912,0.000090234134,0.000065044536,0.0000121355515],"category_scores_gemma":[0.000020237196,0.00011593191,0.000034004723,0.00025293118,0.000056228553,0.00009274642,0.000017911574,0.00017190755,0.0000026224363],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033404585,0.011964553,0.9673577,0.00008310564,0.00017543913,0.00058463326,0.008135957,0.00000845201,0.0017100921,0.000003253475,0.0000037883747,0.0066325595],"study_design_scores_gemma":[0.094990775,0.008131882,0.889341,0.0001479412,0.00017821057,0.000056989888,0.0009441911,0.0000910312,0.006018123,0.000013377653,9.896662e-7,0.000085471765],"about_ca_topic_score_codex":0.00037712842,"about_ca_topic_score_gemma":0.000377707,"teacher_disagreement_score":0.09165032,"about_ca_system_score_codex":0.000051617022,"about_ca_system_score_gemma":0.00007538003,"threshold_uncertainty_score":0.4727566},"labels":[],"label_agreement":null},{"id":"W2084661091","doi":"10.1182/blood-2006-06-028522","title":"AKTion on mantle cell lymphoma","year":2006,"lang":"als","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Blastoid; Mantle cell lymphoma; Cancer research; Lymphoma; Protein kinase B; Medicine; Signal transduction; Biology; Cell biology; Immunology","score_opus":0.007577001102124336,"score_gpt":0.2174372150310166,"score_spread":0.20986021392889226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084661091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86618674,0.004872697,0.000002805967,0.00059455266,0.00042653922,0.0004020203,0.00005725464,0.00006982361,0.12738758],"genre_scores_gemma":[0.9867508,0.0005149225,0.00010469089,0.00040582445,0.001112579,0.000055385666,0.00012685651,0.00004145196,0.010887513],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983514,0.000054895136,0.00034107995,0.00043825546,0.0003781757,0.00043617084],"domain_scores_gemma":[0.9990988,0.00010680537,0.0001306009,0.000471023,0.000050477614,0.00014230298],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009870175,0.0003005556,0.0003609044,0.00010385663,0.000122032056,0.00004863955,0.000083519866,0.00017888704,0.000452039],"category_scores_gemma":[0.0000135673945,0.0002503556,0.0001961106,0.00015502579,0.000041535557,0.000042934364,0.000030687974,0.00005009329,0.004694539],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070766645,0.25492463,0.50253075,0.0010840693,0.0014185017,0.00744829,0.00056464435,0.000045553526,0.017917968,0.015752902,0.13110137,0.06650367],"study_design_scores_gemma":[0.03714814,0.0018184691,0.53140026,0.00047283378,0.0018030751,0.00009298318,0.00007651345,0.000032261374,0.39845678,0.00024868982,0.028076671,0.00037329618],"about_ca_topic_score_codex":0.00077430287,"about_ca_topic_score_gemma":0.000022569047,"teacher_disagreement_score":0.38053882,"about_ca_system_score_codex":0.00017943286,"about_ca_system_score_gemma":0.00011546886,"threshold_uncertainty_score":0.9999949},"labels":[],"label_agreement":null},{"id":"W2084663053","doi":"10.1182/blood.v98.3.541","title":"HIV-1 glycoprotein 120 induces the MMP-9 cytopathogenic factor production that is abolished by inhibition of the p38 mitogen-activated protein kinase signaling pathway","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique","funders":"National Institutes of Health; Sidaction; Styrelsen för Internationellt Utvecklingssamarbete","keywords":"Cell biology; Biology; Chemokine; Signal transduction; p38 mitogen-activated protein kinases; Protein kinase A; MAPK/ERK pathway; Kinase; Immune system; Immunology","score_opus":0.017977355411908463,"score_gpt":0.22498066408306214,"score_spread":0.20700330867115369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084663053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99404985,0.0024212655,0.000009772304,0.0011212607,0.00018726627,0.0016411353,0.00042851115,0.00005138431,0.00008957192],"genre_scores_gemma":[0.99713385,0.000048857553,0.00001359209,0.00004523711,0.00006400114,0.00030117927,0.00019502136,0.000021870112,0.0021764138],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983457,0.00046397134,0.00026577542,0.00037973127,0.00013386966,0.00041099428],"domain_scores_gemma":[0.99912953,0.000042170974,0.00020954052,0.00047909157,0.00010712081,0.00003256216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021084749,0.0002231592,0.00022408162,0.00006264387,0.0003889271,0.000027803757,0.00023803639,0.00020344544,0.0004688671],"category_scores_gemma":[0.00012882067,0.00012593553,0.00014074273,0.00030841675,0.00022658976,0.00013716088,0.00008665201,0.00037083475,0.0001977888],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019892525,0.00066462473,0.0021290048,0.000019723526,0.00023294137,0.000007795968,0.0007773603,5.2235544e-7,0.99308485,0.000008440869,0.00056885986,0.0023069263],"study_design_scores_gemma":[0.0019846708,0.00019489072,0.0021082251,0.000084021834,0.000059468217,0.00004819037,0.00024604867,9.07527e-8,0.9895652,0.000048350055,0.0055252276,0.00013560145],"about_ca_topic_score_codex":0.00018904288,"about_ca_topic_score_gemma":0.000017616137,"teacher_disagreement_score":0.004956368,"about_ca_system_score_codex":0.000038702063,"about_ca_system_score_gemma":0.00011853105,"threshold_uncertainty_score":0.5135502},"labels":[],"label_agreement":null},{"id":"W2084749640","doi":"10.1182/blood-2006-11-060350","title":"Cell adhesion induces p27Kip1-associated cell-cycle arrest through down-regulation of the SCFSkp2 ubiquitin ligase pathway in mantle-cell and other non-Hodgkin B-cell lymphomas","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"SKP2; Ubiquitin ligase; Cell cycle; Biology; Mantle cell lymphoma; Cell biology; Cell growth; Cancer research; Cell adhesion; Cell; Ubiquitin; Lymphoma; Immunology; Biochemistry","score_opus":0.00966253945219786,"score_gpt":0.22654937366977518,"score_spread":0.21688683421757732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084749640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9748017,0.0018577495,0.000043827495,0.00008474335,0.0002532843,0.00091282185,0.000043461372,0.000056332883,0.021946086],"genre_scores_gemma":[0.9984191,0.0000778997,0.00036812297,0.00031359555,0.00011869894,0.00001838066,0.000028546094,0.000087372515,0.0005682934],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976023,0.00013118876,0.00067504565,0.00051894895,0.00054244546,0.00053010136],"domain_scores_gemma":[0.9985705,0.00013715698,0.00047674918,0.0005734297,0.00010020249,0.00014195906],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006099311,0.00034141645,0.0004614514,0.00017521885,0.00011224053,0.000024424016,0.00019885595,0.00044480598,0.00007345262],"category_scores_gemma":[0.00005971613,0.00028354794,0.00016432747,0.0006204721,0.00013492882,0.00009791562,0.0001328479,0.00037995903,0.000030881223],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001632773,0.002678902,0.009756749,0.00023020549,0.00003013859,0.000067467256,0.001886652,0.000037515925,0.98456186,0.000018625455,0.00024590583,0.0003226914],"study_design_scores_gemma":[0.012245022,0.00035991502,0.031711895,0.00044903392,0.0002046761,0.000014396505,0.00040117773,0.00008920998,0.95360214,0.000107724045,0.0005341022,0.00028073182],"about_ca_topic_score_codex":0.0007075917,"about_ca_topic_score_gemma":0.00028520537,"teacher_disagreement_score":0.030959755,"about_ca_system_score_codex":0.0001511336,"about_ca_system_score_gemma":0.00020680639,"threshold_uncertainty_score":0.9999617},"labels":[],"label_agreement":null},{"id":"W2085194212","doi":"10.1182/blood-2009-07-231498","title":"A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40phox and selective defects in neutrophil NADPH oxidase activity","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":415,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"National Heart, Lung, and Blood Institute; Emory University; National Cancer Institute; National Institutes of Health; National Institute of Allergy and Infectious Diseases; Riley Children's Foundation; School of Medicine, Indiana University; Montana State University; Lilly Endowment; Eli Lilly and Company; Jeffrey Modell Foundation; American Heart Association","keywords":"Chronic granulomatous disease; NADPH oxidase; Superoxide; Biology; Compound heterozygosity; Phagocyte; Molecular biology; Phagocytosis; P22phox; Mutation; Immunology; Reactive oxygen species; Biochemistry; Gene","score_opus":0.00555266280984642,"score_gpt":0.21118084265087642,"score_spread":0.20562817984103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085194212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963807,0.0026263807,0.00014062939,0.00013698457,0.000039022085,0.0005392191,0.000025966388,0.000037071582,0.00007405496],"genre_scores_gemma":[0.9994017,0.0001092743,0.00027598286,0.000058164987,0.000021098107,0.000040495514,0.000025038562,0.000018633305,0.000049608065],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985813,0.00025178696,0.00024916785,0.00045776332,0.00005237198,0.0004076485],"domain_scores_gemma":[0.9994069,0.00009431201,0.00014520713,0.00022552241,0.00004930109,0.000078776175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006639094,0.00025960678,0.00040117907,0.0002816778,0.000084081206,0.0000121209305,0.00013147935,0.00013831772,0.000029237262],"category_scores_gemma":[0.000033253385,0.00022878798,0.000050318446,0.0004956131,0.0001276603,0.00014899034,0.000036676298,0.00031484797,0.000010878208],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074616366,0.0012256907,0.014260224,0.00004248176,0.000080565274,0.0003602774,0.00065863255,0.000071221504,0.9782915,0.0005223318,0.000009584408,0.003731335],"study_design_scores_gemma":[0.006855199,0.0012991884,0.5643944,0.0001323267,0.000111941845,0.00008926651,0.00004771476,0.000009503109,0.42546117,0.0013566901,0.000010155648,0.00023238988],"about_ca_topic_score_codex":0.00029579943,"about_ca_topic_score_gemma":0.00089191867,"teacher_disagreement_score":0.55283034,"about_ca_system_score_codex":0.00006430047,"about_ca_system_score_gemma":0.00034849107,"threshold_uncertainty_score":0.9329703},"labels":[],"label_agreement":null},{"id":"W2085298326","doi":"10.1182/blood-2011-12-393637","title":"Infectivity in chimpanzees (Pan troglodytes) of plasma collected before HCV RNA detectability by FDA-licensed assays: implications for transfusion safety and HCV infection outcomes","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Hepatitis C virus research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Center for Research Resources; National Heart, Lung, and Blood Institute","keywords":"Infectivity; Virology; Biology; Immunology; Medicine; Blood transfusion; Virus","score_opus":0.019684452526861965,"score_gpt":0.3094925702307836,"score_spread":0.2898081177039216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085298326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99533266,0.00006780678,0.0006241367,0.00044346033,0.000040985706,0.0022335013,0.000325854,0.00007744129,0.0008541321],"genre_scores_gemma":[0.99895984,0.00016417568,0.00037493245,0.000026486063,0.000042414656,0.0002864426,0.00007827819,0.000031544096,0.000035867703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99828416,0.0001943341,0.0005033114,0.00031019762,0.00023783729,0.00047015236],"domain_scores_gemma":[0.9985575,0.0005670767,0.000111601636,0.00035342,0.00018731075,0.00022309305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007787571,0.00020330871,0.0005538489,0.00023732016,0.00015140131,0.000013286352,0.00006358229,0.00022476139,0.00003444961],"category_scores_gemma":[0.0014678427,0.00018102609,0.00012927222,0.00058775546,0.0001224936,0.0002084974,0.00003993706,0.00028117496,0.0000021643214],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024718934,0.0016871542,0.8973465,0.00019995999,0.00008740112,2.1061162e-7,0.00057256554,4.4625273e-7,0.059315577,0.00003658152,0.000026048012,0.04048037],"study_design_scores_gemma":[0.0069758333,0.00066988886,0.94556564,0.000042203552,0.0001394978,0.0000060735824,0.00002050827,0.00013734848,0.04550161,0.000058860558,0.00075051567,0.00013198996],"about_ca_topic_score_codex":0.002360429,"about_ca_topic_score_gemma":0.008698986,"teacher_disagreement_score":0.048219178,"about_ca_system_score_codex":0.00015851682,"about_ca_system_score_gemma":0.00014113121,"threshold_uncertainty_score":0.7382029},"labels":[],"label_agreement":null},{"id":"W2085346499","doi":"10.1182/blood-2013-11-531327","title":"Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":638,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Dalhousie University; University of Ottawa","funders":"National Cancer Institute; Teva Pharmaceutical Industries","keywords":"Bendamustine; Rituximab; Medicine; CHOP; Internal medicine; Oncology; Lymphoma","score_opus":0.033397176635848715,"score_gpt":0.30563597359123723,"score_spread":0.2722387969553885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085346499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926395,0.00047938267,0.000004994025,0.00076937745,0.00016736062,0.0054416475,0.000024866533,0.000022363698,0.00045051565],"genre_scores_gemma":[0.9976661,0.00055114174,0.00012732869,0.00005485913,0.0002457296,0.00089956546,0.00001690924,0.000023953842,0.00041438572],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99775386,0.00031572732,0.00094835163,0.00032362132,0.00040757496,0.00025084426],"domain_scores_gemma":[0.99745315,0.0014439776,0.0003145689,0.00060671836,0.0000887529,0.00009280299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006192997,0.0002845795,0.0016443798,0.00013629286,0.000052355655,0.0000100203515,0.00012009518,0.000081792896,0.00022825437],"category_scores_gemma":[0.00050703296,0.00011933853,0.00032503944,0.00024513778,0.00011425985,0.000027290856,0.000040375468,0.00005719174,0.000010439496],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.85929006,0.10820132,0.01858292,0.00008890235,0.0014459377,0.00014485886,0.0022227382,0.000008490075,0.000030146548,0.00005420492,0.00007018659,0.009860264],"study_design_scores_gemma":[0.9631204,0.014369595,0.012025389,0.00017015066,0.002640802,0.000027813814,0.0001941792,0.000060495862,0.0063558538,0.000022034668,0.0008985866,0.000114687726],"about_ca_topic_score_codex":0.0011672506,"about_ca_topic_score_gemma":0.0012162814,"teacher_disagreement_score":0.103830375,"about_ca_system_score_codex":0.00008311031,"about_ca_system_score_gemma":0.0001721062,"threshold_uncertainty_score":0.4866484},"labels":[],"label_agreement":null},{"id":"W2085418826","doi":"10.1182/blood-2003-01-0335","title":"Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":305,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; University of British Columbia","funders":"","keywords":"Dyskeratosis congenita; Telomerase RNA component; Bone marrow failure; Telomerase; Telomere; Aplastic anemia; Myelodysplastic syndromes; Paroxysmal nocturnal hemoglobinuria; Cancer research; Mutation; Biology; Gene mutation; Bone marrow; Genetics; Gene; Telomerase reverse transcriptase; Immunology; Haematopoiesis; Stem cell","score_opus":0.011495122767526718,"score_gpt":0.23685404305961644,"score_spread":0.22535892029208973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085418826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99833095,0.00044901576,0.00002060536,0.00007990531,0.000097671116,0.0003020399,0.000012711024,0.00002464463,0.00068248046],"genre_scores_gemma":[0.99911755,0.000036400023,0.00042941316,0.00008538918,0.00002181295,0.000016961856,0.000008729771,0.00002094391,0.0002627698],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988287,0.00007307986,0.0003511604,0.0002567945,0.00023213797,0.00025809516],"domain_scores_gemma":[0.9992632,0.00015512532,0.00009119463,0.00031859626,0.000049942697,0.00012193242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013243817,0.0001625205,0.0003055375,0.0001728289,0.00010293793,0.000011569775,0.0000950108,0.00008291308,0.00009027714],"category_scores_gemma":[0.000321444,0.00012309443,0.00005411687,0.0004284497,0.0001934991,0.00005143931,0.000028243547,0.00020790887,0.000010529566],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052037583,0.0018409786,0.5187749,0.0006566386,0.00013066191,0.0009057627,0.0018341701,0.00004668758,0.47354296,0.0014330688,0.000056837336,0.00072524894],"study_design_scores_gemma":[0.0040972265,0.0002576948,0.9174013,0.0002746152,0.00029545082,0.0016363399,0.00022658837,0.000021794558,0.07519229,0.0002867794,0.000111169036,0.000198755],"about_ca_topic_score_codex":0.00005901251,"about_ca_topic_score_gemma":0.000059996357,"teacher_disagreement_score":0.39862636,"about_ca_system_score_codex":0.000021773792,"about_ca_system_score_gemma":0.000107513304,"threshold_uncertainty_score":0.50196457},"labels":[],"label_agreement":null},{"id":"W2085608364","doi":"10.1182/blood-2010-01-266528","title":"TIMP-3 recruits quiescent hematopoietic stem cells into active cell cycle and expands multipotent progenitor pool","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Stem cell; Haematopoiesis; Progenitor cell; Biology; Multipotent Stem Cell; Cell biology; Immunology","score_opus":0.01102535924324409,"score_gpt":0.2452141989243213,"score_spread":0.23418883968107723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085608364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99643576,0.00016289203,0.00023526196,0.00017111667,0.0003538329,0.0014338922,0.00001536032,0.00012392447,0.0010679848],"genre_scores_gemma":[0.9942869,0.000061121376,0.0047273664,0.00008222912,0.00018663847,0.00014128549,0.000015036332,0.00005509123,0.00044435685],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99839133,0.00004905807,0.0003732022,0.0004513579,0.00037857756,0.00035645987],"domain_scores_gemma":[0.9989279,0.00010191046,0.00011661022,0.00039797238,0.00010314106,0.000352486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017519947,0.00026549518,0.00037520702,0.000100268575,0.000106423264,0.000034578796,0.000101058984,0.00021573756,0.00010132293],"category_scores_gemma":[0.000011671868,0.00023308862,0.00009162063,0.0001327583,0.00008916908,0.00008909681,0.00004124739,0.00035766826,0.00013771531],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001505188,0.0012354989,0.005931608,0.001109918,0.00009618662,0.00013999843,0.007187604,9.704945e-7,0.9789706,0.000025214104,0.00004928165,0.0051026074],"study_design_scores_gemma":[0.005036672,0.00026735643,0.003136174,0.00018460638,0.00036763528,0.00034552283,0.0010936833,0.00011621357,0.9888272,0.000034710334,0.00034446627,0.00024571942],"about_ca_topic_score_codex":0.000029291483,"about_ca_topic_score_gemma":0.000012345528,"teacher_disagreement_score":0.009856646,"about_ca_system_score_codex":0.00002677191,"about_ca_system_score_gemma":0.00010329003,"threshold_uncertainty_score":0.9505078},"labels":[],"label_agreement":null},{"id":"W2085653932","doi":"10.1182/blood-2008-11-191098","title":"Polymorphisms in multidrug resistance-associated protein gene 4 is associated with outcome in childhood acute lymphoblastic leukemia","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Fondation Charles-Bruneau; Centre hospitalier universitaire Sainte-Justine; Genome Canada","keywords":"Gene; Multiple drug resistance; Medicine; Lymphoblastic Leukemia; Cancer research; Leukemia; Acute lymphocytic leukemia; Genetics; Oncology; Immunology; Biology; Drug resistance; Internal medicine","score_opus":0.010762585953357376,"score_gpt":0.25135103763176664,"score_spread":0.24058845167840925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085653932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99483716,0.00021192506,0.00002654671,0.0013652708,0.000034775087,0.0017727624,0.00010171062,0.00019185487,0.0014579813],"genre_scores_gemma":[0.9933919,0.000025101746,0.0010151332,0.0011298038,0.000069824186,0.00013738924,0.0001465041,0.000098746255,0.00398562],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995263,0.00020784014,0.0009997819,0.0008935741,0.0012704589,0.0013653473],"domain_scores_gemma":[0.998188,0.00022348811,0.0003168479,0.000697771,0.00019405819,0.0003798205],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006494533,0.00055863685,0.001175958,0.0006859983,0.00010623733,0.00005369308,0.00040510195,0.00048150012,0.00007296312],"category_scores_gemma":[0.0012665705,0.00047674563,0.0001550442,0.0019965128,0.00014156225,0.0001975926,0.000089012276,0.000805383,0.000064900654],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060939165,0.02638012,0.765764,0.00018152004,0.0036214546,0.052559134,0.008262868,0.00015725226,0.13265193,0.00021655926,0.0023915758,0.0017196552],"study_design_scores_gemma":[0.06556115,0.0011276022,0.90673363,0.0015362289,0.00043482918,0.00025117668,0.0000726185,0.0011043586,0.022239637,0.00019844127,0.000027141108,0.0007132024],"about_ca_topic_score_codex":0.00044613983,"about_ca_topic_score_gemma":0.0009949714,"teacher_disagreement_score":0.1409696,"about_ca_system_score_codex":0.0045837634,"about_ca_system_score_gemma":0.0020673284,"threshold_uncertainty_score":0.99976844},"labels":[],"label_agreement":null},{"id":"W2085656861","doi":"10.1182/blood-2010-01-264077","title":"The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome–negative acute lymphoblastic leukemia in first and second complete remission","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":205,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Alberta Children's Hospital","funders":"National Cancer Institute; U.S. Public Health Service; Centers for Disease Control and Prevention; Astellas Pharma; IC Design Education Center; American Society for Blood and Marrow Transplantation; Bayer HealthCare; CellGenix; Medical College of Wisconsin; BioMarin Pharmaceutical; National Heart, Lung, and Blood Institute; Blue Cross and Blue Shield Association; National Institute of Allergy and Infectious Diseases; Biogen; Celgene; Baxter International; Health Resources and Services Administration; Astellas Pharma US; Amgen; Office of Naval Research; Be The Match Foundation","keywords":"Medicine; Melphalan; Conditioning; Transplantation; Internal medicine; Busulfan; Total body irradiation; Acute leukemia; Acute lymphocytic leukemia; Gastroenterology; Surgery; Hematopoietic stem cell transplantation; Leukemia; Lymphoblastic Leukemia; Chemotherapy; Cyclophosphamide","score_opus":0.014582904224499036,"score_gpt":0.24639264772302752,"score_spread":0.23180974349852848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085656861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985538,0.000029856477,0.00010158027,0.00043530375,0.00006624814,0.00066283974,0.000054773365,0.000030982796,0.000064593536],"genre_scores_gemma":[0.9986457,0.00018262208,0.00096604857,0.00004987031,0.000019703373,0.000018608014,0.00008157025,0.000021564309,0.000014304329],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986115,0.000042252068,0.00056650734,0.0003401761,0.00020503072,0.00023452422],"domain_scores_gemma":[0.99877274,0.00056305004,0.00020594339,0.00017789457,0.00016684677,0.00011349832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030247946,0.00020686444,0.0004974285,0.00017785779,0.00013204882,0.000021912823,0.00005821545,0.00016489025,0.000026690428],"category_scores_gemma":[0.00011258378,0.00013977576,0.000028376999,0.00031992374,0.00022308806,0.00012322153,0.00001432496,0.00039479544,0.0000013719138],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016931493,0.00024101001,0.26533428,0.0028262837,0.00029929882,0.0009792717,0.01666095,0.000060901428,0.69651335,0.000070478,0.000007991384,0.000074696385],"study_design_scores_gemma":[0.023889236,0.0006208739,0.85399336,0.004101873,0.00057951023,0.005182247,0.001964081,0.004808101,0.10448181,0.00008711395,0.0000028819807,0.00028891192],"about_ca_topic_score_codex":0.0002238619,"about_ca_topic_score_gemma":0.0036510935,"teacher_disagreement_score":0.59203154,"about_ca_system_score_codex":0.000064784,"about_ca_system_score_gemma":0.00013070581,"threshold_uncertainty_score":0.56998897},"labels":[],"label_agreement":null},{"id":"W2085947800","doi":"10.1182/blood-2014-07-587329","title":"Myxoma virus suppresses proliferation of activated T lymphocytes yet permits oncolytic virus transfer to cancer cells","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; University of Manitoba; University of Florida","keywords":"Oncolytic virus; Myxoma virus; Virus; Secretion; Virology; Biology; Immunology; Cancer research","score_opus":0.026898777912334915,"score_gpt":0.3046962839111134,"score_spread":0.2777975059987785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085947800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977298,0.001066128,0.000035425994,0.00010621309,0.00009924349,0.0004948031,0.00017490429,0.000017890761,0.00027563874],"genre_scores_gemma":[0.99856913,0.00028638027,0.00007139956,0.00022303396,0.0001767437,0.00014215516,0.000059553746,0.00004106295,0.00043054196],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99873084,0.00011200018,0.00022020655,0.000342732,0.00029612394,0.00029812357],"domain_scores_gemma":[0.9991375,0.00001582505,0.000025251373,0.00035596098,0.0002618636,0.00020358671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017329761,0.00017742658,0.00020075848,0.000073729556,0.000043553428,0.000024386582,0.0002457622,0.000148669,0.000069236456],"category_scores_gemma":[0.000057973277,0.00016654449,0.00006729292,0.00018097294,0.000053788077,0.000007675909,0.000052974294,0.00006697607,0.00002426449],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021300605,0.00044621524,0.00032701803,0.000029480283,0.00012541225,0.000004330009,0.0002700982,0.00043551755,0.99413496,0.0000018538384,0.001310397,0.0007846352],"study_design_scores_gemma":[0.002529068,0.0025286765,0.00017492409,0.00002174519,0.000044047454,0.000004611376,0.0000335994,0.000021234137,0.99080074,0.000006499846,0.0036400054,0.00019485124],"about_ca_topic_score_codex":0.0002072227,"about_ca_topic_score_gemma":0.0010371062,"teacher_disagreement_score":0.0033342445,"about_ca_system_score_codex":0.000041930227,"about_ca_system_score_gemma":0.0006355095,"threshold_uncertainty_score":0.6791487},"labels":[],"label_agreement":null},{"id":"W2086046468","doi":"10.1182/blood-2010-11-320812","title":"G-CSF supplementation with chemotherapy can promote revascularization and subsequent tumor regrowth: prevention by a CXCR4 antagonist","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Israel Science Foundation","keywords":"Angiogenesis; Chemotherapy; CXCR4 antagonist; Medicine; Bone marrow; Granulocyte colony-stimulating factor; Haematopoiesis; Cancer research; Paclitaxel; Hematopoietic growth factor; CXCR4; Pharmacology; Internal medicine; Immunology; Receptor; Biology; Stem cell; Chemokine","score_opus":0.010975733612716825,"score_gpt":0.23289241946569159,"score_spread":0.22191668585297475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086046468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962553,0.00073304435,0.002203468,0.00009629964,0.000023234608,0.00033858776,0.000036753554,0.000011225142,0.00030211842],"genre_scores_gemma":[0.9958274,0.0005547239,0.002325539,0.00017945812,0.00007394038,0.00006866206,0.0005329633,0.00002571014,0.00041160497],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993476,0.000030429974,0.00012519765,0.00026964198,0.00009220376,0.00013489471],"domain_scores_gemma":[0.999628,0.0000010124602,0.00010990172,0.00016130954,0.000053189957,0.000046573503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009117374,0.00011426514,0.00008631128,0.000017365885,0.00007059629,0.00002082384,0.000056198573,0.00005163362,0.00004166442],"category_scores_gemma":[0.0000051252473,0.000098389915,0.00003896171,0.000054626198,0.000043814558,0.000005860544,0.00001713917,0.000024572522,7.574206e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018725471,0.00044195226,0.05473156,0.0000575604,0.00024301164,0.0000045907173,0.00027921217,4.1633777e-7,0.9405259,0.000115583454,0.0010158825,0.0023970732],"study_design_scores_gemma":[0.002159389,0.0007173858,0.009868982,0.000026601478,0.00009753183,0.00003559143,0.000055495817,0.000006055458,0.98341393,0.00006050571,0.0033791035,0.00017943172],"about_ca_topic_score_codex":0.000094497955,"about_ca_topic_score_gemma":0.00010529865,"teacher_disagreement_score":0.044862576,"about_ca_system_score_codex":0.000008496364,"about_ca_system_score_gemma":0.00004423987,"threshold_uncertainty_score":0.40122244},"labels":[],"label_agreement":null},{"id":"W2086167068","doi":"10.1182/blood-2006-02-003103","title":"NK4, an antagonist of hepatocyte growth factor (HGF), inhibits growth of multiple myeloma cells: molecular targeting of angiogenic growth factor","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Liver physiology and pathology","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"","keywords":"Hepatocyte growth factor; Cancer research; Multiple myeloma; Growth factor; Growth factor receptor inhibitor; Hepatocyte; Angiogenesis; Biology; Internal medicine; Immunology; Medicine; Receptor; In vitro; Genetics","score_opus":0.010774585293141034,"score_gpt":0.22583612338351303,"score_spread":0.21506153809037198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086167068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978391,0.0006651472,0.00011564893,0.000026825423,0.00011105878,0.00041940052,0.00042092148,0.000051601808,0.00035032435],"genre_scores_gemma":[0.99756753,0.000046241406,0.001893261,0.000059710244,0.00013865974,0.000010553943,0.00021610355,0.000048011083,0.000019935876],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99789244,0.00021086943,0.0007539738,0.0004487453,0.00028388438,0.00041007219],"domain_scores_gemma":[0.9984369,0.00014628835,0.0004921806,0.0003774822,0.00041797114,0.00012912315],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014515729,0.00030914528,0.0008488875,0.00021883134,0.000059892864,0.0000036238619,0.00023006505,0.0003080489,0.000062050036],"category_scores_gemma":[0.00013560458,0.00028055254,0.00032782703,0.00031822122,0.0003452836,0.0001224223,0.00009901548,0.00022112206,0.000008001392],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020075824,0.0010631429,0.29186067,0.00040670077,0.00015906336,0.000068216264,0.00030200358,0.0000010290701,0.7056122,0.0002762859,0.000034075154,0.000015896747],"study_design_scores_gemma":[0.0030159145,0.00089910405,0.2206005,0.000066474146,0.00023778215,0.000030174257,0.000044435146,0.000023386396,0.7746291,0.00026842993,0.0000045944594,0.00018011953],"about_ca_topic_score_codex":0.00070787617,"about_ca_topic_score_gemma":0.00001539565,"teacher_disagreement_score":0.07126018,"about_ca_system_score_codex":0.000016433814,"about_ca_system_score_gemma":0.00012078229,"threshold_uncertainty_score":0.99996465},"labels":[],"label_agreement":null},{"id":"W2086232358","doi":"10.1182/blood-2010-10-265603","title":"Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia: myths, controversies, and unknowns","year":2010,"lang":"en","type":"review","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":173,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Transplantation; Medicine; Myeloid leukemia; Oncology; Hematopoietic stem cell transplantation; Clinical trial; Hematopoietic cell; Internal medicine; Leukemia; Risk stratification; Intensive care medicine; Immunology; Stem cell; Haematopoiesis; Biology","score_opus":0.013622806329370279,"score_gpt":0.2795107550460868,"score_spread":0.2658879487167165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086232358","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019198619,0.9906366,0.00026476727,0.000110613306,0.00010185012,0.0050255326,0.0007198159,0.000106983854,0.0011140117],"genre_scores_gemma":[0.00018692961,0.9914825,0.003576535,0.000121298384,0.00036406406,0.0006977422,0.001666476,0.00018611204,0.0017183324],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973124,0.00008247892,0.0005896423,0.00085706805,0.0004612635,0.0006971251],"domain_scores_gemma":[0.9977584,0.0006833062,0.00031868345,0.0006297497,0.00020999812,0.00039987502],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027506167,0.00069108984,0.0021271443,0.0002981562,0.00014967588,0.000054421558,0.0002803773,0.00090985186,0.000033514967],"category_scores_gemma":[0.000070744754,0.0004931428,0.00037608756,0.00027923568,0.00021047733,0.000091445654,0.000052065014,0.0012263962,0.00003886577],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027626194,0.0010076688,0.00007203671,0.2912065,0.0051473365,0.0034049426,0.0015423299,3.271946e-7,0.00067196327,0.00027268557,0.0038346439,0.69007695],"study_design_scores_gemma":[0.01891202,0.0014126117,0.000016718575,0.0111040715,0.022993537,0.0071129766,0.00010672047,0.0000052476807,0.00067678443,0.000010828162,0.9369344,0.00071404764],"about_ca_topic_score_codex":0.000032691696,"about_ca_topic_score_gemma":0.00005294337,"teacher_disagreement_score":0.9330998,"about_ca_system_score_codex":0.00026456465,"about_ca_system_score_gemma":0.0025000288,"threshold_uncertainty_score":0.99975204},"labels":[],"label_agreement":null},{"id":"W2086280521","doi":"10.1182/blood-2009-02-207795","title":"Mesenchymal stromal cells cross-present soluble exogenous antigens as part of their antigen-presenting cell properties","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":147,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McMaster University; Jewish General Hospital","funders":"","keywords":"Antigen presentation; Cross-presentation; Antigen processing; Antigen; Mesenchymal stem cell; Biology; MHC class I; Immune system; Immunology; T cell; CD8; Major histocompatibility complex; Cytotoxic T cell; Antigen-presenting cell; Cell biology; In vitro; Biochemistry","score_opus":0.018640064319715013,"score_gpt":0.23618319833540374,"score_spread":0.21754313401568873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086280521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97407174,0.020868778,0.0000068565223,0.0000691792,0.0007448002,0.0003963094,0.000025065903,0.000103018436,0.0037142565],"genre_scores_gemma":[0.9902392,0.00073800865,0.000052887703,0.00007538286,0.00008645551,0.000010489094,0.000026089272,0.00003135936,0.008740099],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977853,0.000280774,0.0006149158,0.00041041293,0.000094581956,0.00081402954],"domain_scores_gemma":[0.9987839,0.000093578994,0.00027214503,0.00066753844,0.00015121404,0.000031628322],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034210386,0.00034474168,0.000518254,0.00013845066,0.00045332263,0.000059784223,0.0005632015,0.00030385688,0.0005248807],"category_scores_gemma":[0.000035554265,0.00027571557,0.00028859676,0.00016994352,0.00030034358,0.000192493,0.00013773431,0.0003263212,0.00028760635],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047503278,0.001498016,0.0029652056,0.000029143495,0.00028256027,0.000021481099,0.0016138593,0.000009840691,0.9918903,0.000044362445,0.00031283702,0.00085734355],"study_design_scores_gemma":[0.0024738268,0.000968506,0.0076168976,0.000050237242,0.000047604073,0.00011902532,0.00046162642,0.0000026133632,0.9704055,0.000045043176,0.017500745,0.00030838256],"about_ca_topic_score_codex":0.00018935058,"about_ca_topic_score_gemma":0.0000030657163,"teacher_disagreement_score":0.021484826,"about_ca_system_score_codex":0.000011221318,"about_ca_system_score_gemma":0.00016822203,"threshold_uncertainty_score":0.9999695},"labels":[],"label_agreement":null},{"id":"W2086293577","doi":"10.1182/blood-2007-01-065573","title":"Radioiodide imaging and radiovirotherapy of multiple myeloma using VSV(Δ51)-NIS, an attenuated vesicular stomatitis virus encoding the sodium iodide symporter gene","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Sodium-iodide symporter; Vesicular stomatitis virus; Symporter; Virology; Sodium iodide; Iodide; Cancer research; Multiple myeloma; Medicine; Gene; Virus; Internal medicine; Biology; Chemistry; Genetics","score_opus":0.014480226327060633,"score_gpt":0.27312886430905076,"score_spread":0.2586486379819901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086293577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922491,0.0057712663,0.0012961937,0.000080064805,0.00006946238,0.00040929287,0.00003947113,0.00002500878,0.00006016267],"genre_scores_gemma":[0.9969946,0.0006133033,0.0015918579,0.00034115164,0.0002996466,0.000013119138,0.000059861395,0.000063729014,0.000022709315],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99810094,0.00019811194,0.00039947624,0.000481357,0.00030539357,0.000514728],"domain_scores_gemma":[0.99885267,0.000048376332,0.00016600039,0.00067209004,0.00010626896,0.00015457548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010209291,0.00025971574,0.00025989278,0.00011205707,0.0002446805,0.000058793263,0.0003380348,0.00012347948,0.000018262122],"category_scores_gemma":[0.00004674805,0.0002203849,0.000112226466,0.00016735103,0.00027867142,0.000017484277,0.000090953465,0.00015049383,0.0000020899133],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040301308,0.00015811963,0.024022873,0.000016817314,0.0001895761,0.000043566055,0.00021728834,0.000041675048,0.9687746,0.0000025150925,0.000027323247,0.006102623],"study_design_scores_gemma":[0.0024510338,0.00048994075,0.012006431,0.000020925549,0.000060935217,0.00019552198,0.00012865895,0.0009022224,0.9829372,0.000012633641,0.00052494527,0.00026950586],"about_ca_topic_score_codex":0.00019392687,"about_ca_topic_score_gemma":0.00022163731,"teacher_disagreement_score":0.014162636,"about_ca_system_score_codex":0.000021630663,"about_ca_system_score_gemma":0.00009792404,"threshold_uncertainty_score":0.8987035},"labels":[],"label_agreement":null},{"id":"W2086509049","doi":"10.1182/blood-2010-10-312462","title":"Epigenetic control of IRF1 responses in HIV-exposed seronegative versus HIV-susceptible individuals","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada; University of Manitoba","funders":"National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research","keywords":"IRF1; Biology; Immunology; Interferon regulatory factors; Interferon; Epigenetics; Immunity; Peripheral blood mononuclear cell; Virology; Immune system; Transcription factor; Innate immune system; Genetics; In vitro; Gene","score_opus":0.040683793256015746,"score_gpt":0.2653430696027122,"score_spread":0.22465927634669647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086509049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99315935,0.0021932698,0.000031501684,0.000061911705,0.00008778927,0.0004097622,0.00048040718,0.000025343239,0.0035506748],"genre_scores_gemma":[0.99817425,0.00007587242,0.00028297072,0.000014672772,0.000008152315,0.00007249247,0.00009526386,0.000012442206,0.0012639064],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99855024,0.00047494317,0.00027237594,0.00023867216,0.00005181076,0.00041197197],"domain_scores_gemma":[0.9991517,0.0003968116,0.00009058594,0.0002701587,0.00005347616,0.00003726322],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00025092514,0.00014888328,0.00030607398,0.00019445867,0.000058325597,0.00000399423,0.00019947592,0.00015172032,0.0013108456],"category_scores_gemma":[0.00018366057,0.00012687141,0.00006881022,0.00014990936,0.00023318629,0.000045758818,0.000053275657,0.0001764267,0.0016455585],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064416532,0.00425916,0.5022484,0.00003275381,0.0017198314,0.0001127365,0.0060118707,0.0000016682026,0.47656024,0.0004733539,0.00067191606,0.0014664101],"study_design_scores_gemma":[0.035243258,0.0027994993,0.2528368,0.000038113027,0.00014314627,0.000010286977,0.0006622429,2.7737576e-7,0.70708,0.00011812391,0.0009025916,0.00016567452],"about_ca_topic_score_codex":0.0001398283,"about_ca_topic_score_gemma":0.00010862907,"teacher_disagreement_score":0.24941161,"about_ca_system_score_codex":0.000021690938,"about_ca_system_score_gemma":0.00012759567,"threshold_uncertainty_score":0.9996021},"labels":[],"label_agreement":null},{"id":"W2086642580","doi":"10.1182/blood-2006-12-062695","title":"Platelet-bound lipopolysaccharide enhances Fc receptor–mediated phagocytosis of IgG-opsonized platelets","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":142,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group; Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"Canadian Blood Services","keywords":"Phagocytosis; Platelet; Antibody opsonization; Opsonin; Lipopolysaccharide; Fc receptor; Immunology; Autoantibody; Antibody; Chemistry; Microbiology; Biology","score_opus":0.012256481496990178,"score_gpt":0.2627631856082055,"score_spread":0.25050670411121534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086642580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927392,0.0022906386,0.000045650293,0.00014027166,0.00025682888,0.0005088413,0.00006801415,0.0001422566,0.0038082965],"genre_scores_gemma":[0.99684334,0.0007549513,0.0012780272,0.00018387138,0.0001353264,0.000019426909,0.00019199836,0.000049643033,0.0005434043],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99785155,0.000027178856,0.0006229098,0.00042475533,0.00047647694,0.00059715786],"domain_scores_gemma":[0.99873376,0.00023000159,0.00025965087,0.00037359705,0.0001312163,0.0002717756],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000313441,0.00032030814,0.00078278343,0.0002329435,0.00010173892,0.000019390884,0.00015343672,0.00024192472,0.000601842],"category_scores_gemma":[0.00016985497,0.0002730853,0.0001953958,0.00035299727,0.00012692594,0.0001304938,0.000043313772,0.00022847073,0.00030723494],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026107323,0.0066344636,0.022538725,0.00026057527,0.0025433747,0.002682279,0.00096651615,7.381405e-7,0.93344903,0.0001224261,0.0009960611,0.027195068],"study_design_scores_gemma":[0.013950916,0.000855504,0.0032360496,0.00014879956,0.00035310336,0.00027309326,0.00019016089,0.0000075956846,0.9773211,0.00007382562,0.0033194944,0.0002703908],"about_ca_topic_score_codex":0.00022752001,"about_ca_topic_score_gemma":0.00010849213,"teacher_disagreement_score":0.04387203,"about_ca_system_score_codex":0.000047008554,"about_ca_system_score_gemma":0.000119832286,"threshold_uncertainty_score":0.9999721},"labels":[],"label_agreement":null},{"id":"W2086664962","doi":"10.1182/blood.v97.8.2286","title":"Overexpression of HOXA10 perturbs human lymphomyelopoiesis in vitro and in vivo","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Developmental Biology and Gene Regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Biology; Haematopoiesis; Myelopoiesis; Progenitor cell; Myeloid; Cell biology; CD34; Cellular differentiation; Stem cell; Molecular biology; Immunology; Genetics; Gene","score_opus":0.005323143783721748,"score_gpt":0.22310897011926578,"score_spread":0.21778582633554402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086664962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99858165,0.00042195152,0.0000028374272,0.00002605312,0.0000123391565,0.000058810892,0.0000035925275,0.0000020127522,0.000890741],"genre_scores_gemma":[0.9992942,0.00014298767,0.00021622085,0.000035460303,0.000018882081,0.000005851698,0.000036503756,0.00000413213,0.00024573502],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99957126,0.00002797819,0.00012377475,0.00014975194,0.00003327045,0.000093989845],"domain_scores_gemma":[0.9998532,0.000004867219,0.000032176365,0.00008301057,0.000009032639,0.000017696731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007299562,0.00006264387,0.00008395375,0.000045820263,0.000018766768,0.0000021723906,0.000044096032,0.000112056674,0.00001169734],"category_scores_gemma":[0.0000136452945,0.000058454338,0.000015365798,0.00005623073,0.000039177008,0.0000022604734,0.000050643634,0.000022462234,4.227055e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007728962,0.0000958312,0.15244544,0.0000062848876,0.0000060750967,0.0000017564116,0.000033090433,0.0000012172868,0.8465487,0.0000036557853,0.000021856644,0.00075884216],"study_design_scores_gemma":[0.0008933529,0.000030716168,0.26726234,0.000015545864,0.0000022113456,0.0000101055275,0.000021547405,0.0000020790887,0.7310904,0.000049825958,0.0005659877,0.000055853736],"about_ca_topic_score_codex":0.000023993143,"about_ca_topic_score_gemma":0.00006361995,"teacher_disagreement_score":0.11545823,"about_ca_system_score_codex":0.000004526976,"about_ca_system_score_gemma":0.000014825643,"threshold_uncertainty_score":0.23836988},"labels":[],"label_agreement":null},{"id":"W2086776394","doi":"10.1182/blood-2002-11-3621","title":"Integration of DAG signaling systems mediated by PKC-dependent phosphorylation of RasGRP3","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Protein Kinase Regulation and GTPase Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; Canadian Institutes of Health Research; Fondation pour la Recherche Médicale","keywords":"Diacylglycerol kinase; Protein kinase C; Phosphorylation; Cell biology; Signal transduction; Biology; MAPK/ERK pathway; Kinase; HEK 293 cells; Molecular biology; Receptor; Biochemistry","score_opus":0.009111347885947085,"score_gpt":0.2230659179274431,"score_spread":0.213954570041496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086776394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9739652,0.0039846916,0.021193614,0.0000057351594,0.00006638305,0.000213716,0.00003317581,0.000008256157,0.000529183],"genre_scores_gemma":[0.99909836,0.000057089455,0.00045202722,0.00000938284,0.000026567232,0.000012414201,0.00022966844,0.0000115120565,0.00010300762],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991827,0.00008979692,0.00031307447,0.0001591685,0.00015964685,0.00009560423],"domain_scores_gemma":[0.99943393,0.000013280754,0.00021629847,0.00016280504,0.00013657217,0.000037086644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002960592,0.00009149218,0.00013607393,0.000037474845,0.0000254261,0.0000071711074,0.00006022489,0.000117771924,0.000022298556],"category_scores_gemma":[0.00014968247,0.00008764787,0.000051794395,0.000085964595,0.00002844455,0.000003848769,0.000011561356,0.00003996148,0.0000014888942],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018712524,0.00012009481,0.0005268363,0.000034497385,0.000041268217,4.1960504e-7,0.00002888629,0.00038663187,0.9982698,0.0003910889,0.000047946723,0.00013383116],"study_design_scores_gemma":[0.0008697365,0.00010301894,0.000071503884,0.000046283214,0.000034008008,0.000004000408,0.00008576143,0.00020958696,0.9978407,0.000031734748,0.0006151931,0.000088450244],"about_ca_topic_score_codex":0.00002776478,"about_ca_topic_score_gemma":0.0000027068195,"teacher_disagreement_score":0.025133085,"about_ca_system_score_codex":0.000005672946,"about_ca_system_score_gemma":0.00004548989,"threshold_uncertainty_score":0.35741764},"labels":[],"label_agreement":null},{"id":"W2087002320","doi":"10.1182/blood-2014-04-571232","title":"Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials","year":2014,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":841,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Medicine; Venous thromboembolism; Vitamin k; Internal medicine; Intensive care medicine; Major bleeding; Vitamin K antagonist; Clinical trial; Warfarin; Thrombosis; Atrial fibrillation","score_opus":0.13269748416873234,"score_gpt":0.43037458604911566,"score_spread":0.2976771018803833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087002320","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030211948,0.9843312,0.0005447754,0.00009537054,0.0007363134,0.008634867,0.0020564718,0.00024980292,0.0003300177],"genre_scores_gemma":[0.0018898454,0.98889637,0.003478434,0.00022329052,0.0013524039,0.0012776786,0.0024925636,0.0002453262,0.00014408362],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946389,0.00061370735,0.0017853356,0.0013581621,0.0007139773,0.00088990084],"domain_scores_gemma":[0.99475026,0.0017841945,0.001418964,0.0014428073,0.00020053146,0.00040322042],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0016415915,0.001125464,0.017083125,0.00031142356,0.00023585808,0.00019447408,0.00060226757,0.0004373105,0.00013960322],"category_scores_gemma":[0.0005508628,0.00076466694,0.0013071363,0.000363813,0.00015832618,0.00013884967,0.00016692556,0.00036494448,0.00012497319],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094671454,0.02846788,0.00006114998,0.05284986,0.059918292,0.0013326193,0.00058427063,0.0000014893413,0.00023813514,0.000119679535,0.032286946,0.82319295],"study_design_scores_gemma":[0.012718085,0.0036972442,0.00015066753,0.05547133,0.15477039,0.0001426689,0.000020616111,0.000012978239,0.00039721298,0.00001726783,0.7715649,0.0010366164],"about_ca_topic_score_codex":0.00028698432,"about_ca_topic_score_gemma":0.000053437412,"teacher_disagreement_score":0.82215637,"about_ca_system_score_codex":0.000113877264,"about_ca_system_score_gemma":0.00056177244,"threshold_uncertainty_score":0.9994804},"labels":[],"label_agreement":null},{"id":"W2087235653","doi":"10.1182/blood.v98.2.257","title":"Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase-type plasminogen activator","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Plasminogen activator; Platelet; Plasmin; Urokinase; Molecular biology; Endocrinology; Proteases; Serine protease; Chemistry; Zymography; Internal medicine; Biology; Protease; Immunology; Medicine; Biochemistry; Matrix metalloproteinase; Enzyme","score_opus":0.005583808554962187,"score_gpt":0.20271132308744721,"score_spread":0.19712751453248503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087235653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980973,0.0005026484,0.000006065379,0.0001596189,0.000040178125,0.00057646655,0.000117416355,0.000030146382,0.00047014852],"genre_scores_gemma":[0.99901044,0.000098651646,0.00008174901,0.00017443481,0.000031518804,0.000015853248,0.00027649206,0.00003359453,0.00027728855],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988621,0.000033705244,0.00020957655,0.00029009543,0.00030488014,0.00029967053],"domain_scores_gemma":[0.9992498,0.00010702096,0.0001398134,0.00028477702,0.00009000816,0.00012854443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000045617184,0.00024599276,0.00041124492,0.00005469272,0.00010506177,0.000020733267,0.00009346341,0.000111167115,0.000121485726],"category_scores_gemma":[0.000025493096,0.0001480139,0.000046260488,0.00016248242,0.000121682155,0.00013056165,0.00004584846,0.00015176334,0.000014366112],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024352483,0.0013822211,0.9879682,0.000026772817,0.0010172534,0.00066622545,0.00056206976,0.0000034203842,0.0013290294,0.000018381079,0.00020989706,0.0043812464],"study_design_scores_gemma":[0.024744049,0.0013103512,0.95799816,0.00009327612,0.0005364386,0.0001103577,0.00022896106,0.000036148103,0.008690317,0.000033842924,0.0059521007,0.0002660094],"about_ca_topic_score_codex":0.0032284618,"about_ca_topic_score_gemma":0.0018752554,"teacher_disagreement_score":0.029970087,"about_ca_system_score_codex":0.000020812597,"about_ca_system_score_gemma":0.00007653437,"threshold_uncertainty_score":0.60358316},"labels":[],"label_agreement":null},{"id":"W2087316845","doi":"10.1182/blood-2009-02-207928","title":"Outcomes and predictors of very stable INR control during chronic anticoagulation therapy","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Logistic regression; Warfarin; Internal medicine; Retrospective cohort study; Diabetes mellitus; Cohort; Confidence interval; Proportional hazards model; Multivariate analysis; Atrial fibrillation","score_opus":0.021986890111420767,"score_gpt":0.27933400426389693,"score_spread":0.2573471141524762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087316845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99767953,0.00080703566,0.00004432351,0.0006780539,0.00006118617,0.00033056276,0.0000015308004,0.00004455864,0.00035320714],"genre_scores_gemma":[0.99897295,0.00022546893,0.000060115515,0.000063371495,0.0002452052,5.390311e-7,0.000005375679,0.0000062619756,0.00042069217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99944824,0.000014271846,0.00018829234,0.00010086533,0.00014254416,0.00010581334],"domain_scores_gemma":[0.9997118,0.00003588751,0.00007461374,0.0001164059,0.000026512555,0.000034754426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007991674,0.00007795168,0.00024078165,0.0000798999,0.000034872413,0.000008490419,0.000022073451,0.000037362017,0.00003116544],"category_scores_gemma":[0.000031504627,0.00006071057,0.000056790974,0.0000771832,0.000018355571,0.00009066603,0.0000070120923,0.00003286219,0.000001815155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010604109,0.000024645635,0.97867966,0.000027265327,0.00013005186,0.0000020388961,0.00004697384,0.000021537116,0.020004416,0.00013968293,0.000010212683,0.00080745615],"study_design_scores_gemma":[0.010841579,0.00023576734,0.9800063,0.000022811442,0.00013958845,0.0000018724083,0.00001101382,0.00006424395,0.0083367955,0.00004745849,0.00023914452,0.000053468462],"about_ca_topic_score_codex":0.0000057576485,"about_ca_topic_score_gemma":9.5251795e-7,"teacher_disagreement_score":0.011667619,"about_ca_system_score_codex":0.000011018613,"about_ca_system_score_gemma":0.000017909977,"threshold_uncertainty_score":0.2475705},"labels":[],"label_agreement":null},{"id":"W2087733469","doi":"10.1182/blood-2004-04-1653","title":"Molecular interactions involved in HOXB4-induced activation of HSC self-renewal","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Developmental Biology and Gene Regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer","funders":"National Heart, Lung, and Blood Institute","keywords":"Haematopoiesis; Biology; In vivo; Stem cell; In vitro; Cancer research; Bone marrow; Leukemia; Transplantation; Cell biology; Molecular biology; Immunology; Genetics; Medicine","score_opus":0.007791241079497072,"score_gpt":0.2376182624954039,"score_spread":0.22982702141590683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087733469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99894094,0.000059339975,0.00019993204,0.00009548645,0.000060033417,0.00010628591,0.000001825485,0.000009123162,0.00052702724],"genre_scores_gemma":[0.9985652,0.000015959988,0.001161297,0.000060767565,0.000030938183,0.000014050118,0.00012868775,0.000006958239,0.000016168628],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995066,0.000026659172,0.0001526141,0.00016441906,0.0000498604,0.00009986472],"domain_scores_gemma":[0.99975556,0.0000036678641,0.00006140487,0.00012294426,0.00003350397,0.000022935932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000060498707,0.00007760296,0.00007729594,0.000057410114,0.000021843272,0.0000031323298,0.000063945976,0.000107991786,0.000004001366],"category_scores_gemma":[0.000023414317,0.00008045008,0.000037445883,0.00010004789,0.000017127042,0.0000045260863,0.00003499371,0.000048646685,0.0000034442714],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024443481,0.00028137414,0.008945787,0.0000073543238,0.00004512034,0.0000012815153,0.0000607815,0.00011041692,0.99000293,0.000115078896,0.0000031059026,0.0004023219],"study_design_scores_gemma":[0.0011888343,0.00010650943,0.022542296,0.000014523286,0.000012105782,0.000004798667,0.000040142077,0.0000021832964,0.97550064,0.0003732289,0.00012787968,0.000086842716],"about_ca_topic_score_codex":0.000032381955,"about_ca_topic_score_gemma":0.00010592327,"teacher_disagreement_score":0.014502278,"about_ca_system_score_codex":0.000015081638,"about_ca_system_score_gemma":0.000074838696,"threshold_uncertainty_score":0.32806593},"labels":[],"label_agreement":null},{"id":"W2087879951","doi":"10.1182/blood-2013-04-460162","title":"Treatment of cancer-associated thrombosis","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":181,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Gynecology; Low molecular weight heparin; Apixaban; Thrombosis; Cancer; Vitamin K antagonist; Surgery; Internal medicine; Warfarin; Rivaroxaban; Atrial fibrillation","score_opus":0.022164647171794928,"score_gpt":0.2889528506659054,"score_spread":0.2667882034941105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087879951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98929423,0.0010678477,0.0000010051797,0.0009082589,0.00007175329,0.00054996746,0.000007853359,0.00004361904,0.00805549],"genre_scores_gemma":[0.996201,0.0026199906,0.00012819727,0.00015129117,0.000058180234,0.00023045123,0.000011377243,0.000013923152,0.0005856328],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99939823,0.000011408482,0.00016127422,0.0001312492,0.00013143367,0.00016639211],"domain_scores_gemma":[0.99958485,0.000018042669,0.000070948765,0.0001879794,0.00006938261,0.00006881811],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000019178566,0.00009540879,0.00036823266,0.000044465793,0.000027237633,0.0000069845123,0.000037158134,0.00004187799,0.0010628161],"category_scores_gemma":[0.000009872928,0.00007108357,0.0000960714,0.00010195109,0.000024633615,0.00003000595,0.000014169506,0.00001987642,0.00007763835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011862661,0.04230824,0.82991904,0.0002105472,0.005315551,0.000022488148,0.0018108423,0.000006566167,0.05739673,0.0011377756,0.013487908,0.04837243],"study_design_scores_gemma":[0.0033692296,0.001170466,0.9532817,0.000061412175,0.001123209,9.609499e-7,0.0000961297,0.000014306096,0.038726002,0.00007042631,0.002006278,0.000079909696],"about_ca_topic_score_codex":0.004595516,"about_ca_topic_score_gemma":0.00010224614,"teacher_disagreement_score":0.12336261,"about_ca_system_score_codex":0.000051279025,"about_ca_system_score_gemma":0.000031979973,"threshold_uncertainty_score":0.99985033},"labels":[],"label_agreement":null},{"id":"W2087967932","doi":"10.1182/blood-2010-08-302737","title":"NK-cell enteropathy: a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma: clinicopathologic features and follow-up in a unique case series","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":178,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Calgary Laboratory Services","funders":"National Cancer Institute; National Institutes of Health","keywords":"Lymphoma; Pathology; Medicine; T-cell lymphoma; Lymphoproliferative disorders; Gastroenterology","score_opus":0.009124193935060955,"score_gpt":0.22727670234670305,"score_spread":0.2181525084116421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087967932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938276,0.002093047,0.000030565905,0.00010684775,0.0023669084,0.00038309005,0.000016300033,0.00010510939,0.001070551],"genre_scores_gemma":[0.9922424,0.00020258492,0.00018428866,0.00035715636,0.000064294065,0.00008175651,0.000095538315,0.000029565861,0.0067424336],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998241,0.00036584327,0.00043602518,0.0005327524,0.00003756107,0.00038678534],"domain_scores_gemma":[0.99911404,0.00017994494,0.00020353826,0.0003283463,0.000107382126,0.000066733635],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032527425,0.0003254797,0.00034187012,0.00020614325,0.00028172534,0.000067701876,0.00014640205,0.0003060076,0.00021057126],"category_scores_gemma":[0.0002858565,0.0002922833,0.000118942684,0.00013020934,0.00022657154,0.00027898367,0.0001411152,0.0005595113,0.00010031852],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021433497,0.0021449635,0.05157164,0.000102920065,0.000059534093,0.002802637,0.0027565865,0.0000016013834,0.93633085,0.00021017782,0.00096148654,0.00091427483],"study_design_scores_gemma":[0.028581962,0.0018820742,0.020127473,0.00023732022,0.0004713638,0.059205998,0.005044705,0.00003116491,0.87765956,0.00033095205,0.00535272,0.0010747318],"about_ca_topic_score_codex":0.00017351528,"about_ca_topic_score_gemma":0.00034766516,"teacher_disagreement_score":0.058671296,"about_ca_system_score_codex":0.000031892538,"about_ca_system_score_gemma":0.00013069701,"threshold_uncertainty_score":0.9999529},"labels":[],"label_agreement":null},{"id":"W2088044493","doi":"10.1182/blood-2010-11-319517","title":"Essential role for Ptpn11 in survival of hematopoietic stem and progenitor cells","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"National Center for Research Resources; National Cancer Institute","keywords":"Haematopoiesis; Stem cell; Progenitor cell; Cancer research; Biology; Immunology; Cell biology","score_opus":0.01621679725761539,"score_gpt":0.22140276660861036,"score_spread":0.20518596935099498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088044493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99813706,0.0006266996,0.00011105072,0.0000036043286,0.000060251074,0.00028774867,0.000029264658,0.000004204283,0.0007401446],"genre_scores_gemma":[0.9988196,0.000023918354,0.0008984504,0.000007176206,0.00007879812,0.00004961953,0.000009361148,0.000012064403,0.000100995036],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994988,0.000025565907,0.00013385725,0.00016434902,0.000046017303,0.0001314453],"domain_scores_gemma":[0.9997519,0.000006333875,0.000046758654,0.00012838816,0.000029629435,0.000036993515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011401279,0.00007484934,0.00011035995,0.000019890696,0.000015420545,0.0000040881796,0.000077092314,0.000083736224,0.000008191005],"category_scores_gemma":[0.0000069518974,0.00007246457,0.00004138012,0.0000270552,0.000036134454,0.0000014446919,0.000048490903,0.000026816439,0.0000012568361],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006825378,0.00023429655,0.0066294204,0.000094085844,0.00002671243,0.0000013709023,0.0002808948,9.909859e-8,0.99213284,0.00018734536,0.000009860511,0.00033481108],"study_design_scores_gemma":[0.0010618105,0.000249128,0.00057182054,0.000011221288,0.000022081995,0.000005600759,0.00015262647,0.0000034505254,0.997295,0.0001634309,0.00037797797,0.00008581685],"about_ca_topic_score_codex":0.00001178246,"about_ca_topic_score_gemma":0.000017499724,"teacher_disagreement_score":0.0060575996,"about_ca_system_score_codex":8.975719e-7,"about_ca_system_score_gemma":0.00002685174,"threshold_uncertainty_score":0.29550195},"labels":[],"label_agreement":null},{"id":"W2088123597","doi":"10.1182/blood-2004-10-3913","title":"CHIR-258, a novel, multitargeted tyrosine kinase inhibitor for the potential treatment of t(4;14) multiple myeloma","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":289,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cancer research; MAPK/ERK pathway; Fibroblast growth factor receptor 3; Tyrosine kinase; Receptor tyrosine kinase; Tyrosine-kinase inhibitor; Biology; Cytotoxic T cell; Kinase; Molecular biology; Fibroblast growth factor; Cell biology; Signal transduction; Receptor; In vitro; Cancer; Biochemistry","score_opus":0.024645446219068407,"score_gpt":0.28353234773862024,"score_spread":0.25888690151955185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088123597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99232936,0.0020072344,0.0013642296,0.00086971576,0.00018265663,0.0026496886,0.00045254987,0.000069948284,0.00007462578],"genre_scores_gemma":[0.9870285,0.00018101695,0.011168884,0.000045568817,0.00040836787,0.00041167912,0.00023087044,0.000046380243,0.00047874253],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99835443,0.00001661868,0.00036083366,0.00036459925,0.00041836378,0.00048515433],"domain_scores_gemma":[0.9987045,0.00020606138,0.00010640483,0.00050227455,0.00023766472,0.00024312598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010186387,0.0002705146,0.00040910675,0.00011652107,0.00019160625,0.000020074756,0.000117876385,0.00011601519,0.000041337968],"category_scores_gemma":[0.00030473922,0.00016350619,0.0003240846,0.00019846292,0.00013098476,0.00006077689,0.000039149087,0.00009144216,0.000024718169],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055928114,0.03156974,0.025075195,0.00030292387,0.002966481,0.00040551496,0.00075756374,0.00021778651,0.9111145,0.0002066795,0.00015661599,0.021634165],"study_design_scores_gemma":[0.11698185,0.0055264733,0.14381474,0.00014958448,0.0010602636,0.00012952673,0.00015761673,0.0010887509,0.7284619,0.00005597202,0.0023314932,0.00024181444],"about_ca_topic_score_codex":0.0005312993,"about_ca_topic_score_gemma":0.00018303344,"teacher_disagreement_score":0.18265261,"about_ca_system_score_codex":0.00011733319,"about_ca_system_score_gemma":0.00021752164,"threshold_uncertainty_score":0.6667589},"labels":[],"label_agreement":null},{"id":"W2088126954","doi":"10.1182/blood-2009-04-211417","title":"Apolipoprotein-mediated lipid antigen presentation in B cells provides a pathway for innate help by NKT cells","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; Child and Family Research Institute; University of British Columbia","funders":"","keywords":"Natural killer T cell; Antigen; Antigen presentation; CD1; Biology; Antigen-presenting cell; CD1D; Cell biology; Apolipoprotein B; Cross-presentation; CD40; Immunology; T cell; Cytotoxic T cell; Immune system; Biochemistry; CD8; Cholesterol; In vitro","score_opus":0.008083865804594028,"score_gpt":0.22033458682137444,"score_spread":0.2122507210167804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088126954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99141085,0.0018349465,0.00040900466,0.000578773,0.0023503478,0.001725222,0.000059917787,0.00015598988,0.0014749507],"genre_scores_gemma":[0.987033,0.00022886466,0.00014090049,0.00051001913,0.000082774444,0.00011408223,0.0006163758,0.000019700288,0.011254266],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99887156,0.00012248695,0.00034834936,0.00028893782,0.000034094828,0.0003345406],"domain_scores_gemma":[0.999446,0.00008412353,0.0001495007,0.00022788753,0.00007354411,0.00001895975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016888136,0.00016844703,0.0002070652,0.00014557062,0.000097830416,0.000026867578,0.0001537405,0.00023375334,0.00018435075],"category_scores_gemma":[0.000059230624,0.00016030461,0.000080638965,0.00014350984,0.00004512567,0.00018282581,0.000022884124,0.00020915498,0.00042431513],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022699317,0.0006901695,0.00014971776,0.000018080009,0.0000498914,0.0000011379025,0.00028438508,0.0000016951356,0.9748637,0.000025037214,0.020450683,0.003238478],"study_design_scores_gemma":[0.0029080252,0.00050287956,0.00037268086,0.000025983227,0.00001982467,0.0000058486876,0.000120172175,0.00002382715,0.8693605,0.000036927522,0.12646611,0.00015723493],"about_ca_topic_score_codex":0.00014357733,"about_ca_topic_score_gemma":0.000018827755,"teacher_disagreement_score":0.10601544,"about_ca_system_score_codex":0.000026243235,"about_ca_system_score_gemma":0.000041888532,"threshold_uncertainty_score":0.6537032},"labels":[],"label_agreement":null},{"id":"W2088431383","doi":"10.1182/blood-2015-01-623777","title":"A roadmap for discovery and translation in lymphoma","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; Allos Therapeutics; Leonard M. Miller School of Medicine; Weill Cornell Medical College; Pharmacyclics; Genentech; Five Prime Therapeutics; National Institutes of Health; Helsinn; BC Cancer Agency; Bristol-Myers Squibb; University of Miami; Celgene; Teva Pharmaceutical Industries; Kite Pharma; Gilead Sciences; Sanofi; University of Washington; GlaxoSmithKline; Takeda Oncology; Amgen","keywords":"Chronic lymphocytic leukemia; Immunophenotyping; Lymphoma; Hodgkin lymphoma; Medicine; Leukemia; Pathology; Biology; Immunology; Flow cytometry","score_opus":0.04222863533692403,"score_gpt":0.28163556231727804,"score_spread":0.239406926980354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088431383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961417,0.001756051,0.00004020398,0.00064944813,0.000027351376,0.00031458947,0.0000075325806,0.000010958726,0.0010522205],"genre_scores_gemma":[0.9986647,0.00003877942,0.00094729656,0.00009751093,0.00004682251,0.000082545754,0.000019654837,0.0000058197397,0.00009690595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996771,0.0000058773367,0.000078328296,0.00010004206,0.0000598547,0.00007877711],"domain_scores_gemma":[0.9998165,0.000036366288,0.000012910493,0.00006409721,0.000012666729,0.000057471698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005381676,0.000050162304,0.00010465168,0.000032634984,0.000008975005,0.000011689816,0.000009728576,0.000028750323,0.0000010412995],"category_scores_gemma":[0.000022337168,0.00003823149,0.000024385858,0.00003773678,0.000009422713,0.000065008935,0.0000035936391,0.0000066351836,0.0000023220762],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042723326,0.0041490872,0.8787122,0.00008882656,0.000128098,0.00009900791,0.0016524427,0.0000018220929,0.00060403,0.0010419631,0.00047199964,0.1126233],"study_design_scores_gemma":[0.07479754,0.0011334697,0.90160364,0.00013177806,0.00039168497,0.00012641601,0.00029774816,0.00020994255,0.012911511,0.0011148001,0.0071332757,0.00014817539],"about_ca_topic_score_codex":0.0000620431,"about_ca_topic_score_gemma":0.00004556715,"teacher_disagreement_score":0.11247512,"about_ca_system_score_codex":0.00002543599,"about_ca_system_score_gemma":0.00005674222,"threshold_uncertainty_score":0.15590349},"labels":[],"label_agreement":null},{"id":"W2088473598","doi":"10.1182/blood-2011-11-391896","title":"A critical role for endoglin in the emergence of blood during embryonic development","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Zebrafish Biomedical Research Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Biology; Hemangioblast; Embryonic stem cell; Cell biology; Haematopoiesis; Mesoderm; Progenitor cell; GATA2; Stem cell; Bone morphogenetic protein; Endoglin; Immunology; Genetics; CD34; Gene","score_opus":0.015383431269893237,"score_gpt":0.30468766501985545,"score_spread":0.2893042337499622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088473598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971098,0.0015002162,0.0003941329,0.00026760198,0.000016229089,0.0002701614,0.000013315206,0.0000033678325,0.00042519358],"genre_scores_gemma":[0.9968641,0.000047480124,0.0024879738,0.00004516896,0.00011957273,0.00036880645,0.000024325529,0.000007724838,0.00003488288],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991954,0.000035129684,0.00015957208,0.00013759929,0.00015650813,0.00031581373],"domain_scores_gemma":[0.9995724,0.000056120276,0.00002274401,0.00021535846,0.000050396786,0.000082962375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003661684,0.000062757485,0.000068296176,0.000027223408,0.00005192524,0.000005486764,0.00024986072,0.00006314635,0.000021556145],"category_scores_gemma":[0.0006401185,0.000048699105,0.000039291463,0.00010075976,0.00007565463,0.0000030400406,0.00008310924,0.00006313468,0.0000049065175],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001386695,0.0009067137,0.006259493,0.00004780259,0.000033403932,5.0956373e-7,0.00013691615,1.8591048e-7,0.991345,0.00070417934,0.00010331345,0.0004486208],"study_design_scores_gemma":[0.0007453695,0.00006753257,0.029301792,0.000009422102,0.000023366838,0.000010828563,0.00017026534,0.0000026447053,0.9637753,0.00010390726,0.0057167388,0.00007283618],"about_ca_topic_score_codex":0.0000037085538,"about_ca_topic_score_gemma":0.000019754307,"teacher_disagreement_score":0.0275697,"about_ca_system_score_codex":0.0000020116286,"about_ca_system_score_gemma":0.000081935796,"threshold_uncertainty_score":0.19858919},"labels":[],"label_agreement":null},{"id":"W2088510119","doi":"10.1182/blood-2003-02-0518","title":"In human B cells, IL-12 triggers a cascade of molecular events similar to Th1 commitment","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"","keywords":"STAT4; Biology; STAT1; Cytokine; Interleukin 12; Cell biology; STAT protein; Transcription factor; Molecular biology; Phosphorylation; Signal transduction; stat; Immunology; STAT3; In vitro; Genetics; Gene; Cytotoxic T cell","score_opus":0.01036945267378918,"score_gpt":0.23763007280843224,"score_spread":0.22726062013464304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088510119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99280465,0.00042301058,0.000062166466,0.00009094087,0.0010486282,0.0002732139,0.0000042254196,0.000015955844,0.005277212],"genre_scores_gemma":[0.99425894,0.000019543177,0.000050716502,0.00043650478,0.0000051767074,0.000021748741,0.000017877535,0.000011320558,0.0051781647],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99914366,0.00019472845,0.0002655164,0.00016870917,0.00002953117,0.00019785407],"domain_scores_gemma":[0.99965644,0.000020552487,0.00007198028,0.0002090136,0.000025669828,0.000016373106],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014745118,0.00011269324,0.00018739176,0.00013883553,0.000051261955,0.0000027464616,0.00009278106,0.0001252668,0.0009481159],"category_scores_gemma":[0.000027471477,0.000110353925,0.000080274025,0.00010270477,0.000022763326,0.000041619696,0.0000218403,0.00017150458,0.00023076704],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044452023,0.0007038319,0.00038164965,0.000008903039,0.00011485377,0.0000067793226,0.00031814672,0.000019536421,0.99374026,0.00029904192,0.0043268306,0.000035725934],"study_design_scores_gemma":[0.0023038995,0.00027323954,0.00044464512,0.000021102896,0.000044041062,0.0000165688,0.0001814686,1.7975321e-7,0.9098046,0.000036873018,0.08677523,0.00009819793],"about_ca_topic_score_codex":0.000092800314,"about_ca_topic_score_gemma":0.00001307366,"teacher_disagreement_score":0.08393569,"about_ca_system_score_codex":0.00003075132,"about_ca_system_score_gemma":0.000018642384,"threshold_uncertainty_score":0.99996513},"labels":[],"label_agreement":null},{"id":"W2088550884","doi":"10.1182/blood-2002-06-1725","title":"Recombinant PfEMP1 peptide inhibits and reverses cytoadherence of clinical Plasmodium falciparum isolates in vivo","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Malaria Research and Control","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Alberta","funders":"Health Research Board","keywords":"CD36; In vivo; Plasmodium falciparum; Molecular biology; Intercellular Adhesion Molecule-1; Tumor necrosis factor alpha; Chemistry; Biology; Cell adhesion molecule; Receptor; Biochemistry; Cell biology; Immunology","score_opus":0.05030896351211146,"score_gpt":0.3176230391666255,"score_spread":0.26731407565451404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088550884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98721564,0.00063984864,0.0000037215864,0.0014026484,0.00006387263,0.0003721176,0.000009157057,0.000017721763,0.010275278],"genre_scores_gemma":[0.994584,0.0007446175,0.0002761569,0.00010584692,0.000058977817,0.000021042568,9.617917e-7,0.000010182653,0.0041981824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986685,0.000093903276,0.0004909832,0.00026050096,0.00018649858,0.00029960115],"domain_scores_gemma":[0.9991825,0.00023789183,0.00009314081,0.00022593683,0.00006681337,0.00019368711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039386883,0.000111576315,0.00044620852,0.000091927664,0.00002723779,0.000011467496,0.00008466676,0.00011776683,0.000525973],"category_scores_gemma":[0.0006649275,0.000090309186,0.00007558972,0.00014077217,0.00011368198,0.00006512231,0.0000606903,0.00028750402,0.000024691066],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014676744,0.005749819,0.9018394,0.00052756944,0.0002884643,0.00051787274,0.0005944528,0.0000012788036,0.069441274,0.0009870495,0.011935571,0.0066496083],"study_design_scores_gemma":[0.118746735,0.014281617,0.54810095,0.0029717223,0.0007376301,0.00070133695,0.0011809263,0.006838558,0.28200212,0.0013605518,0.021915069,0.0011627577],"about_ca_topic_score_codex":0.00014380371,"about_ca_topic_score_gemma":0.00008774542,"teacher_disagreement_score":0.3537384,"about_ca_system_score_codex":0.000006438122,"about_ca_system_score_gemma":0.000056216868,"threshold_uncertainty_score":0.57590353},"labels":[],"label_agreement":null},{"id":"W2088686519","doi":"10.1182/blood-2003-09-3078","title":"Effect of Mthfr genotype on diet-induced hyperhomocysteinemia and vascular function in mice","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Children's Hospital","funders":"National Institute of Neurological Disorders and Stroke; National Heart, Lung, and Blood Institute","keywords":"Methylenetetrahydrofolate reductase; Hyperhomocysteinemia; Internal medicine; Endocrinology; Homocysteine; Methionine; Medicine; Chemistry; Biology; Genotype; Biochemistry; Gene","score_opus":0.010777861529936775,"score_gpt":0.2618603554230198,"score_spread":0.251082493893083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088686519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954963,0.000860182,0.0000016191183,0.000019417217,0.00003977569,0.00028689238,6.651199e-7,0.000011185555,0.0032839815],"genre_scores_gemma":[0.9996619,0.00008861359,0.00003179171,0.000022554717,0.000026699523,0.00001036104,0.0000040182667,0.00001228152,0.00014178072],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992604,0.00010767157,0.000119749195,0.00016357136,0.00019451109,0.00015408482],"domain_scores_gemma":[0.9996493,0.00007908957,0.00001974063,0.00016071078,0.000031239484,0.000059922037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040716177,0.000086438515,0.00020692764,0.00009269506,0.000019258472,0.000004123962,0.00002583785,0.00008855629,0.00003117281],"category_scores_gemma":[0.000121381345,0.00006483434,0.000042034062,0.00018885598,0.000017840455,0.000024090126,0.00001085731,0.00015721677,0.000024216508],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011872449,0.0006449478,0.061150625,0.0008691536,0.00022389508,0.000091169866,0.00010188001,0.0000014446534,0.92811304,0.00012268499,0.00002319001,0.007470713],"study_design_scores_gemma":[0.014587103,0.017090539,0.16313894,0.00036882487,0.00036859876,0.000029712046,0.000042759144,0.000033623095,0.8035735,0.0000141474,0.00061266345,0.00013957004],"about_ca_topic_score_codex":0.00005704536,"about_ca_topic_score_gemma":0.000009168531,"teacher_disagreement_score":0.12453954,"about_ca_system_score_codex":0.000013657351,"about_ca_system_score_gemma":0.000029307135,"threshold_uncertainty_score":0.26438677},"labels":[],"label_agreement":null},{"id":"W2088903681","doi":"10.1182/blood-2004-12-4844","title":"Hepcidin in iron overload disorders","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":444,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Xenon Pharmaceuticals (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Hepcidin; Ferroportin; Hemochromatosis; Hereditary hemochromatosis; HAMP; Internal medicine; Endocrinology; Anemia; Medicine","score_opus":0.005901175611781687,"score_gpt":0.2373502710488831,"score_spread":0.2314490954371014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088903681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9550573,0.0026439808,0.000012624643,0.001715508,0.00006113931,0.00017609647,0.0000021643637,0.000045542703,0.0402856],"genre_scores_gemma":[0.9964624,0.00045727563,0.0007329319,0.0008179718,0.00015435561,0.000011254285,0.000010003795,0.000015384561,0.0013383967],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992937,0.000016543217,0.00014900284,0.00016800844,0.00014495771,0.00022779201],"domain_scores_gemma":[0.9996885,0.000013676805,0.000022368504,0.00019336354,0.000007656052,0.00007440045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008116576,0.00009729733,0.0001586995,0.000091096525,0.000021094367,0.0000061351143,0.00005271729,0.000062104424,0.00030721133],"category_scores_gemma":[0.00004386398,0.000088038265,0.000052060186,0.00013775191,0.000030499587,0.000069765716,0.000018099272,0.0001131069,0.00020026136],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002808904,0.006629695,0.81108046,0.00026016255,0.00002872688,0.000053294618,0.002014794,0.00008100116,0.014114147,0.004108446,0.0062021744,0.15514618],"study_design_scores_gemma":[0.022892365,0.0002239653,0.83299834,0.00005900363,0.00021731065,0.000029342995,0.0005695574,0.000057809586,0.0057926173,0.00044322934,0.1363215,0.0003949555],"about_ca_topic_score_codex":0.00012719279,"about_ca_topic_score_gemma":0.00043395138,"teacher_disagreement_score":0.15475123,"about_ca_system_score_codex":0.000010551227,"about_ca_system_score_gemma":0.000034429442,"threshold_uncertainty_score":0.35900962},"labels":[],"label_agreement":null},{"id":"W2088940681","doi":"10.1182/blood-2010-08-300541","title":"American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer","year":2010,"lang":"en","type":"review","venue":"Blood","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":205,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"American Society of Clinical Oncology","keywords":"Medicine; Internal medicine; Adverse effect; Guideline; Darbepoetin alfa; Hematology; Clinical trial; Intensive care medicine; Anemia; Cancer; MEDLINE; Randomized controlled trial; Oncology; Pathology","score_opus":0.11453086506511478,"score_gpt":0.4644086960681308,"score_spread":0.349877831003016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088940681","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31291342,0.64611447,0.000028803059,0.031947184,0.00054272526,0.006723579,0.0010483701,0.00006884711,0.00061262975],"genre_scores_gemma":[0.0005605519,0.9305843,0.065031305,0.0033649956,0.00014913778,0.00007977255,0.00013852866,0.000057975645,0.000033435237],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939388,0.0009993493,0.0035737623,0.00068402843,0.0004783896,0.00032565236],"domain_scores_gemma":[0.98763293,0.004957096,0.0056805327,0.0008003515,0.00075153884,0.00017755658],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0017435547,0.00046287684,0.004867943,0.000048828304,0.00003531116,0.0000045890865,0.00021334339,0.0005492316,0.00003747226],"category_scores_gemma":[0.0020261754,0.00025218082,0.001013585,0.00043869918,0.003180591,0.00003447601,0.00016247637,0.0017170567,0.0000022771274],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005560914,0.011904204,0.09599478,0.0034015907,0.0023658385,0.000020601774,0.00016724951,2.201255e-7,0.0000011368759,0.0000575634,0.021039244,0.86449146],"study_design_scores_gemma":[0.00629779,0.005110386,0.003775813,0.00614297,0.005182993,0.00005120572,0.00043635213,0.00000766062,0.000013641855,0.000001162397,0.97273964,0.00024040935],"about_ca_topic_score_codex":0.0012569085,"about_ca_topic_score_gemma":0.00015903235,"teacher_disagreement_score":0.9517004,"about_ca_system_score_codex":0.000047797268,"about_ca_system_score_gemma":0.0013444343,"threshold_uncertainty_score":0.999993},"labels":[],"label_agreement":null},{"id":"W2088941703","doi":"10.1182/blood-2005-05-2090","title":"Delta-like1-induced Notch1 signaling regulates the human plasmacytoid dendritic cell versus T-cell lineage decision through control of GATA-3 and Spi-B","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Leids Universitair Medisch Centrum; University of Toronto; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Universiteit Leiden; Landsteiner Foundation for Blood Transfusion Research","keywords":"JAG1; Biology; Cell biology; Progenitor cell; Notch signaling pathway; Ectopic expression; Transcription factor; Plasmacytoid dendritic cell; Stromal cell; T cell; Lineage (genetic); B cell; Dendritic cell; Immunology; Stem cell; Signal transduction; Cancer research; Genetics; Cell culture; Immune system; Gene","score_opus":0.015350503602575784,"score_gpt":0.24727491738307708,"score_spread":0.2319244137805013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088941703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.968658,0.029956514,0.00015503743,0.00011548646,0.00032587,0.0003294847,0.0000318725,0.00004658228,0.00038119647],"genre_scores_gemma":[0.9984181,0.0004325968,0.0003331934,0.00015431365,0.000069982525,0.000017015296,0.000030272273,0.000034477955,0.0005100421],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983212,0.00031023918,0.0005520008,0.0003228084,0.000070857655,0.00042289725],"domain_scores_gemma":[0.99781096,0.001359728,0.00023597898,0.00049025286,0.000085098625,0.00001800443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039055262,0.00028033045,0.00043193286,0.000081070684,0.0004695909,0.00003206013,0.00037594355,0.0002885036,0.00020970711],"category_scores_gemma":[0.0000884149,0.00020706559,0.00016009345,0.000121127516,0.0002725259,0.00015392572,0.000081659375,0.0003649692,0.00009064923],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014937876,0.0005171123,0.00016247251,0.000017853776,0.00022310771,0.0000049150653,0.0008125237,0.000023190858,0.9950582,0.00010572665,0.00013583811,0.0014453116],"study_design_scores_gemma":[0.018844735,0.0007269986,0.00052644307,0.000053514123,0.00026992685,0.00004650636,0.0003356764,0.000009379453,0.97175086,0.000045131183,0.0071552643,0.0002355899],"about_ca_topic_score_codex":0.00008591469,"about_ca_topic_score_gemma":0.000021305474,"teacher_disagreement_score":0.029760148,"about_ca_system_score_codex":0.000015803007,"about_ca_system_score_gemma":0.00005558655,"threshold_uncertainty_score":0.84438896},"labels":[],"label_agreement":null},{"id":"W2089078614","doi":"10.1182/blood-2003-07-2563","title":"VEGF-A165 augments erythropoietic development from human embryonic stem cells","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Zebrafish Biomedical Research Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":154,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Embryoid body; Biology; Stem cell factor; Cell biology; Haematopoiesis; Erythropoiesis; Embryonic stem cell; Stem cell; Immunology; Adult stem cell; Internal medicine; Genetics; Medicine","score_opus":0.01498270082851006,"score_gpt":0.2687999403417383,"score_spread":0.25381723951322827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089078614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953905,0.00061659864,0.00068187976,0.00008815798,0.0000610314,0.00025257494,0.000022853577,0.000020889573,0.0028655347],"genre_scores_gemma":[0.9947642,0.0000687732,0.0021079811,0.00015436157,0.000088601424,0.00011445223,0.00015533764,0.00002758464,0.0025187102],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986481,0.00006847913,0.00021179242,0.00041784442,0.00029098048,0.0003627875],"domain_scores_gemma":[0.99917793,0.0000140374,0.000055189703,0.00046390574,0.000054288503,0.00023466277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017044254,0.000143072,0.000116312745,0.00003382607,0.00016063482,0.000032361757,0.0002891246,0.00013870283,0.00019779889],"category_scores_gemma":[0.00002897564,0.00013971658,0.000053418356,0.000110543486,0.000107313776,0.0000021941582,0.00012220338,0.00010965293,0.00028293068],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000035824494,0.0004795083,0.0007566252,0.000010467398,0.00011298661,0.0000047584845,0.000030485224,3.7395418e-7,0.9940024,0.00011859317,0.0033613855,0.0011188154],"study_design_scores_gemma":[0.00096181943,0.00008396599,0.0014605201,0.000010297714,0.000018164355,0.0000023363657,0.00003773094,6.1126593e-7,0.82364655,0.00011542928,0.17351417,0.00014842405],"about_ca_topic_score_codex":0.000012136536,"about_ca_topic_score_gemma":0.000027075303,"teacher_disagreement_score":0.1703559,"about_ca_system_score_codex":0.00002349792,"about_ca_system_score_gemma":0.00022434344,"threshold_uncertainty_score":0.5697477},"labels":[],"label_agreement":null},{"id":"W2089154194","doi":"10.1182/blood-2009-05-219550","title":"BMS-214662 induces mitochondrial apoptosis in chronic myeloid leukemia (CML) stem/progenitor cells, including CD34+38− cells, through activation of protein kinase Cβ","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Progenitor cell; Stem cell; Biology; Cell biology; Cancer research; Myeloid leukemia; Haematopoiesis; Apoptosis; CD34; Chemistry; Biochemistry","score_opus":0.027113385441561593,"score_gpt":0.2699501453277935,"score_spread":0.2428367598862319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089154194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99458563,0.00093224016,0.000038088438,0.0002462903,0.0003344974,0.002658342,0.000027624812,0.00013798833,0.0010392832],"genre_scores_gemma":[0.9943275,0.000182145,0.0035418116,0.000083940795,0.0010756911,0.00021934381,0.000078907215,0.00007683461,0.00041384174],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964902,0.00014637886,0.0009777382,0.0008322964,0.0007895313,0.00076389255],"domain_scores_gemma":[0.9982352,0.00009726321,0.000510089,0.0008188203,0.0001436696,0.00019491298],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020020352,0.00055860955,0.0008854564,0.00031854038,0.00013885346,0.00003828854,0.0003301216,0.00047368006,0.00010779229],"category_scores_gemma":[0.000076079785,0.0005315651,0.00024448737,0.0008159193,0.000095788346,0.0004261936,0.00012390941,0.0006240593,0.0000521509],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003929978,0.0013640821,0.00027229334,0.00037645252,0.00020538962,0.00004789577,0.0008985788,0.000060940423,0.99099433,0.000058839203,0.00020351016,0.005124677],"study_design_scores_gemma":[0.017359806,0.0013760395,0.0009024504,0.0011206727,0.00030702894,0.00001604579,0.00028316662,0.00007173507,0.9770925,0.00010092281,0.0009519471,0.00041765408],"about_ca_topic_score_codex":0.0007902741,"about_ca_topic_score_gemma":0.00004178565,"teacher_disagreement_score":0.016966809,"about_ca_system_score_codex":0.0042563616,"about_ca_system_score_gemma":0.0022026717,"threshold_uncertainty_score":0.9997136},"labels":[],"label_agreement":null},{"id":"W2089158135","doi":"10.1182/blood-2010-09-288373","title":"How I treat relapsed and refractory Hodgkin lymphoma","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":143,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Comprehensive Cancer Network; Memorial Sloan-Kettering Cancer Center","keywords":"Medicine; Salvage therapy; Context (archaeology); Radiation therapy; Oncology; Refractory (planetary science); Chemotherapy; Lymphoma; Internal medicine; Chemotherapy regimen; Regimen; Disease; Clinical trial; Transplantation; Autologous stem-cell transplantation; Surgery","score_opus":0.025612686941002293,"score_gpt":0.22196040425727537,"score_spread":0.19634771731627307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089158135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9746346,0.002167053,0.0000018286387,0.00035475596,0.000049904116,0.00018283342,0.0000059126924,0.000066629145,0.022536518],"genre_scores_gemma":[0.9959309,0.00045313773,0.00087249454,0.00019416543,0.00008023259,0.000039273415,0.000010212064,0.00001844868,0.0024011005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993701,0.00001892185,0.000093768365,0.00022870282,0.00011690539,0.00017157465],"domain_scores_gemma":[0.99947685,0.000031991538,0.00004105402,0.0002698097,0.000026208247,0.00015408544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000039140697,0.00013474817,0.00020754196,0.00005314347,0.00004608764,0.000018623135,0.00003317637,0.00008093175,0.00006593393],"category_scores_gemma":[0.00003136582,0.00009732711,0.00006145535,0.00005767165,0.00004781745,0.00006681674,0.000023661472,0.000026496813,0.000034619068],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003322158,0.010814486,0.80943173,0.00010502959,0.00063076016,0.0022598724,0.0016818877,3.6212615e-9,0.0046170074,0.001562165,0.0030882768,0.16547655],"study_design_scores_gemma":[0.018467821,0.0013659268,0.90063715,0.000071068665,0.0007942949,0.0004525655,0.00014601913,0.0000012031293,0.065252624,0.00013401094,0.012515215,0.00016212817],"about_ca_topic_score_codex":0.00010930335,"about_ca_topic_score_gemma":0.000009296254,"teacher_disagreement_score":0.16531442,"about_ca_system_score_codex":0.000035260546,"about_ca_system_score_gemma":0.00004194372,"threshold_uncertainty_score":0.39688843},"labels":[],"label_agreement":null},{"id":"W2089274280","doi":"10.1182/blood-2008-10-187013","title":"Characterization in vitro and engraftment potential in vivo of human progenitor T cells generated from hematopoietic stem cells","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":137,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Health Sciences Centre; Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"Krembil Foundation; Women's College Hospital; Canadian Institutes of Health Research; Terry Fox Foundation; Ontario HIV Treatment Network","keywords":"CD38; Progenitor cell; Biology; CD34; Stem cell; Haematopoiesis; Cell biology; Immunology; Cord blood","score_opus":0.006650089216957004,"score_gpt":0.1930751935327666,"score_spread":0.18642510431580958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089274280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981907,0.001040464,0.000010837324,0.00003538341,0.0002457967,0.00033474562,0.0000863055,0.00002632577,0.000029468601],"genre_scores_gemma":[0.999243,0.00008720405,0.00004231812,0.00003997452,0.000025970687,0.000015096189,0.00016511623,0.000010925573,0.0003703978],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99880964,0.00017769333,0.0004178457,0.0002956962,0.000028493225,0.00027063882],"domain_scores_gemma":[0.9996183,0.000018284105,0.00014108869,0.00018031796,0.000026657264,0.000015342373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000080458216,0.00017175317,0.00034974667,0.0001456575,0.000050260132,0.00001026797,0.00012211283,0.00027506126,0.00010723167],"category_scores_gemma":[0.000001177427,0.00016457123,0.000042468724,0.00011897481,0.00007795536,0.00004987833,0.000041129475,0.00017765826,0.000026277012],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011446867,0.0012669667,0.00040255763,0.000012584247,0.000055042932,0.000024746394,0.000577933,0.0000011554172,0.9969938,0.000015819667,0.00000993598,0.0005249989],"study_design_scores_gemma":[0.0039791767,0.00025123873,0.0016817884,0.00002636377,0.000050314597,0.000011180069,0.00009667542,0.000003824601,0.9935697,0.000033791763,0.0001433236,0.00015265105],"about_ca_topic_score_codex":0.00011161047,"about_ca_topic_score_gemma":0.000018362227,"teacher_disagreement_score":0.0038647081,"about_ca_system_score_codex":0.000015590307,"about_ca_system_score_gemma":0.000022504999,"threshold_uncertainty_score":0.67110205},"labels":[],"label_agreement":null},{"id":"W2089311432","doi":"10.1182/blood-2012-05-425934","title":"A phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myeloma","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":655,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Calgary; University of Toronto","funders":"National Cancer Institute; Jewish General Hospital; Onyx Pharmaceuticals; University of Alberta; Wake Forest University","keywords":"Carfilzomib; Multiple myeloma; Refractory (planetary science); Medicine; Pomalidomide; Lenalidomide; Oncology; Internal medicine; Materials science","score_opus":0.02848352810245834,"score_gpt":0.2876643652637208,"score_spread":0.25918083716126245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089311432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99778324,0.00032956636,0.0000016293106,0.000013856846,0.00003781768,0.0015086812,0.000027895754,0.00002418741,0.00027310022],"genre_scores_gemma":[0.9993278,0.000010550824,0.00035717714,0.000016584952,0.000042606458,0.000071817136,0.00005913069,0.000031216314,0.00008311165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983955,0.00010611775,0.00030147188,0.00027023623,0.00049185945,0.0004348309],"domain_scores_gemma":[0.9990034,0.00009617886,0.000105724284,0.00036390763,0.00009086614,0.00033993475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015879769,0.00019546972,0.00038811192,0.00019218794,0.00004892073,0.0000089095,0.000060915605,0.00006577609,0.000033416894],"category_scores_gemma":[0.00018637809,0.00014037188,0.00003349422,0.00020800094,0.00006127597,0.00013921887,0.0000633877,0.00016666057,0.000008485644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025849496,0.07736052,0.9093176,0.000064017135,0.00030630542,0.00008857243,0.002005789,1.9012164e-7,0.0029652927,6.982081e-7,0.000020563655,0.005285488],"study_design_scores_gemma":[0.12359687,0.0112273805,0.86002165,0.00008932954,0.00020147479,0.0000073566766,0.0005779993,0.000009177719,0.004022155,6.271312e-7,0.00012666837,0.00011930115],"about_ca_topic_score_codex":0.0002396821,"about_ca_topic_score_gemma":0.00012521412,"teacher_disagreement_score":0.12101192,"about_ca_system_score_codex":0.00006708079,"about_ca_system_score_gemma":0.000043895587,"threshold_uncertainty_score":0.57241994},"labels":[],"label_agreement":null},{"id":"W2089425361","doi":"10.1182/blood-2012-12-476200","title":"Erk1 and Erk2 are required for maintenance of hematopoietic stem cells and adult hematopoiesis","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Haematopoiesis; Stem cell; Biology; Immunology; Cell biology","score_opus":0.015457546402777151,"score_gpt":0.2494663806990245,"score_spread":0.23400883429624733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089425361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950811,0.00076694635,0.00014097175,0.0023642655,0.000023085684,0.0011551286,0.000034393954,0.000035567846,0.0003985367],"genre_scores_gemma":[0.99378794,0.00020499286,0.0034699072,0.00025809417,0.0000508436,0.00015806334,0.000003988833,0.000035580193,0.0020306066],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988157,0.000025258616,0.00029451965,0.00030959304,0.00021531046,0.0003396269],"domain_scores_gemma":[0.99879956,0.00018216894,0.00012243296,0.0003560978,0.0003422819,0.00019745958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016457785,0.00015393418,0.00045092832,0.0000845339,0.00005221617,0.000022185663,0.00009040044,0.00011124502,0.00003663848],"category_scores_gemma":[0.00011768629,0.000121633806,0.000059706144,0.00011905754,0.00018975932,0.00009102509,0.000093976094,0.00011670093,0.000015540189],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087626633,0.0018607025,0.059059173,0.020463644,0.0012518386,0.00024701332,0.0053086183,8.492341e-7,0.8065016,0.009475124,0.08632649,0.008628632],"study_design_scores_gemma":[0.022988493,0.0012322488,0.016811991,0.0014372234,0.00062636763,0.00087020884,0.007011045,0.00079654675,0.94366956,0.0020173746,0.001988434,0.00055052736],"about_ca_topic_score_codex":0.00004878236,"about_ca_topic_score_gemma":0.0000066570783,"teacher_disagreement_score":0.13716789,"about_ca_system_score_codex":0.00002745987,"about_ca_system_score_gemma":0.00006736893,"threshold_uncertainty_score":0.49600828},"labels":[],"label_agreement":null},{"id":"W2089471154","doi":"10.1182/blood-2009-07-231084","title":"The impact of prophylactic fresh-frozen plasma and cryoprecipitate on the incidence of central nervous system thrombosis and hemorrhage in children with acute lymphoblastic leukemia receiving asparaginase","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia; Izaak Walton Killam Health Centre; Dalhousie University","funders":"National Cancer Institute; Center for Nanoscale Science and Technology; Killam Trusts; Dalhousie University","keywords":"Medicine; Cryoprecipitate; Fresh frozen plasma; Thrombosis; Incidence (geometry); Asparaginase; Surgery; Pediatrics; Anesthesia; Internal medicine; Fibrinogen; Leukemia; Lymphoblastic Leukemia; Platelet","score_opus":0.009481825846907708,"score_gpt":0.254794214871814,"score_spread":0.24531238902490626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089471154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99820614,0.00020291861,0.000025202286,0.0002301347,0.000015906668,0.0009862599,0.000024805531,0.000024408548,0.00028424777],"genre_scores_gemma":[0.9994784,0.00012899385,0.00024791833,0.000025466014,0.000042771713,0.000023254273,0.0000036390984,0.000026675718,0.000022851633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99799985,0.00016639839,0.000400018,0.00035613973,0.00054626324,0.0005313588],"domain_scores_gemma":[0.998203,0.0007416626,0.00024289903,0.00052532373,0.00010304495,0.00018408104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043564092,0.00027358404,0.00050101045,0.0001222935,0.00013360343,0.000047629812,0.0002551504,0.00009596755,0.00000524846],"category_scores_gemma":[0.00033460883,0.00013331583,0.00006571184,0.0004009471,0.00038253466,0.000106037674,0.00009030305,0.0003068918,0.0000018459114],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056905965,0.0013652728,0.92045,0.0007908076,0.0025688037,0.00089014316,0.004523533,0.0012953328,0.052887022,0.00049196713,0.00024559392,0.008800941],"study_design_scores_gemma":[0.005717641,0.0030121224,0.969493,0.00067739526,0.00043422324,0.0017251814,0.00029302566,0.008963747,0.009497661,0.000037820348,1.6312107e-7,0.0001480533],"about_ca_topic_score_codex":0.00096704613,"about_ca_topic_score_gemma":0.000041060095,"teacher_disagreement_score":0.049042977,"about_ca_system_score_codex":0.00059079163,"about_ca_system_score_gemma":0.000882919,"threshold_uncertainty_score":0.5436462},"labels":[],"label_agreement":null},{"id":"W2089536721","doi":"10.1182/blood-2005-03-1307","title":"Aminoglycoside suppression of nonsense mutations in severe hemophilia","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Calgary","funders":"Canadian Hemophilia Society; Heart and Stroke Foundation of Canada","keywords":"Aminoglycoside; Medicine; Gentamicin; Factor IX; Nonsense mutation; Partial thromboplastin time; Antibiotics; Internal medicine; Gastroenterology; Coagulation; Surgery; Mutation; Microbiology; Chemistry; Biology","score_opus":0.022834217755233758,"score_gpt":0.3054459119873108,"score_spread":0.28261169423207705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089536721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913437,0.0002257237,0.0000015189571,0.0020172074,0.000018520153,0.00026506482,0.000009833473,0.000020050837,0.006098374],"genre_scores_gemma":[0.99502516,0.000050813585,0.0015048977,0.000048670077,0.00008092342,0.00001293338,0.00003179183,0.000010999733,0.003233802],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99923307,0.000030391026,0.00019582298,0.00014142589,0.00021648068,0.00018279726],"domain_scores_gemma":[0.9995499,0.00008023198,0.000027658054,0.00020179238,0.00005118922,0.00008918995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009033397,0.00007883405,0.00017512491,0.00015543087,0.000027002437,0.0000034212896,0.000043571807,0.00007002083,0.000213131],"category_scores_gemma":[0.00008570172,0.000060227707,0.000056528017,0.00019427712,0.000052364347,0.000044263623,0.000024876334,0.000121900084,0.00007827785],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004263962,0.007422463,0.64223987,0.00028638414,0.00017416525,0.00087785197,0.001890669,0.000059588438,0.32498848,0.00015858293,0.0019222207,0.019553306],"study_design_scores_gemma":[0.013311508,0.00047559745,0.32613134,0.00038221813,0.00018540863,0.00040497843,0.00021550224,0.00032486822,0.6564762,0.00018040455,0.0017439782,0.0001680033],"about_ca_topic_score_codex":0.000029506098,"about_ca_topic_score_gemma":0.000035877038,"teacher_disagreement_score":0.3314877,"about_ca_system_score_codex":0.00002444888,"about_ca_system_score_gemma":0.00008685731,"threshold_uncertainty_score":0.24560146},"labels":[],"label_agreement":null},{"id":"W2089621615","doi":"10.1182/blood-2012-02-411397","title":"Structural basis of CBP/p300 recruitment in leukemia induction by E2A-PBX1","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research; Queen's University","funders":"Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Queen's University","keywords":"Transcription factor; Gene silencing; Biology; Cell biology; Coactivator; Molecular biology; Genetics; Gene","score_opus":0.058289341079211625,"score_gpt":0.3263323527270245,"score_spread":0.26804301164781286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089621615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955896,0.0008440555,0.0000045187367,0.0004665657,0.00013701206,0.00064782845,0.0000166722,0.000029419187,0.002264312],"genre_scores_gemma":[0.99760544,0.00008658838,0.000922926,0.00010664307,0.00026998398,0.0000677899,0.000057557158,0.00002576205,0.0008572961],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985508,0.00008296412,0.00032120605,0.00019999765,0.0004009333,0.00044413688],"domain_scores_gemma":[0.99927676,0.000052126717,0.00008375808,0.00033038572,0.000068408575,0.00018857927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037608188,0.000142291,0.0003006074,0.00019539538,0.000030901316,0.0000062420104,0.0001104832,0.00016018412,0.00032233575],"category_scores_gemma":[0.00014258602,0.00011958141,0.000063959385,0.00036916067,0.000072474584,0.00015953455,0.00007078401,0.00038094184,0.000044615863],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003466818,0.000724736,0.6083323,0.00029843565,0.00028958186,0.000032565702,0.0016983513,0.0000033894025,0.33934873,0.00020833888,0.0127833765,0.03593352],"study_design_scores_gemma":[0.008579766,0.00042780148,0.43388516,0.00013033512,0.00019885473,0.00019700728,0.00044418062,0.00008292312,0.5507109,0.00004956346,0.005051218,0.00024229912],"about_ca_topic_score_codex":0.00045643363,"about_ca_topic_score_gemma":0.000014167598,"teacher_disagreement_score":0.21136215,"about_ca_system_score_codex":0.00058571505,"about_ca_system_score_gemma":0.00024227817,"threshold_uncertainty_score":0.48763886},"labels":[],"label_agreement":null},{"id":"W2089702550","doi":"10.1182/blood-2010-05-282723","title":"Enhancing research in regenerative medicine","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Regenerative medicine; Medicine; Intensive care medicine; Stem cell; Biology; Genetics","score_opus":0.07725916729101003,"score_gpt":0.41306132949743857,"score_spread":0.33580216220642856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089702550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9429678,0.0002747762,0.000058323072,0.043528613,0.00023965021,0.00019337916,4.753102e-7,0.000020339836,0.01271665],"genre_scores_gemma":[0.9970099,0.00003855291,0.0010147041,0.00022134898,0.0007758029,0.000009431348,0.000009873632,0.000007926556,0.0009124854],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989993,0.000053432508,0.00017035558,0.0001607118,0.00043391093,0.00018226849],"domain_scores_gemma":[0.999414,0.00012568435,0.000019474404,0.00017789903,0.00014444672,0.00011846162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015537681,0.000050657593,0.00013246929,0.00019703395,0.00005541789,0.0000041685944,0.000047140395,0.00019300786,0.0002100101],"category_scores_gemma":[0.00026500708,0.00003370422,0.000016164295,0.00040682586,0.00061558303,0.000020936017,0.000026244306,0.0009448953,0.000021381407],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017840392,0.0002300138,0.001487265,0.000049495306,0.0000115182975,0.00005858202,0.0010538562,6.26994e-8,0.9754528,0.016879555,0.00023445212,0.004524578],"study_design_scores_gemma":[0.011947533,0.0012171097,0.11819,0.0011249713,0.00007918988,0.0002305881,0.00096965506,0.00033861352,0.8071953,0.031785816,0.026681336,0.00023990446],"about_ca_topic_score_codex":0.00013358281,"about_ca_topic_score_gemma":0.0006532093,"teacher_disagreement_score":0.16825749,"about_ca_system_score_codex":0.0000098869,"about_ca_system_score_gemma":0.00012098909,"threshold_uncertainty_score":0.41051525},"labels":[],"label_agreement":null},{"id":"W2089743461","doi":"10.1182/blood-2014-04-566778","title":"Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Gene expression profiling; microRNA; Lymphoma; Biology; Cancer research; Medicine; Computational biology; Gene expression; Immunology; Genetics; Gene","score_opus":0.009375312588064186,"score_gpt":0.24673417560656252,"score_spread":0.23735886301849835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089743461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99623686,0.0008320038,0.00013892046,0.00027328354,0.000043048192,0.0009846257,0.000019535491,0.000027410464,0.0014443275],"genre_scores_gemma":[0.99217755,0.00007767404,0.007116122,0.00013359876,0.00003251021,0.0003737374,0.000058171587,0.000014039532,0.000016605914],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991165,0.000037758095,0.00018459605,0.0003272417,0.00013286265,0.00020105427],"domain_scores_gemma":[0.9994942,0.00006368154,0.00013987168,0.00015286342,0.000049873513,0.0000995305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001052633,0.00014244163,0.00020050147,0.000047663983,0.000044120523,0.00002258145,0.000042223004,0.00009371256,0.0000022044096],"category_scores_gemma":[0.000097589254,0.00011688339,0.000066509405,0.0001050331,0.00003120523,0.000045305736,0.00002544946,0.000019160232,0.0000031367588],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033659444,0.0028759872,0.90724456,0.00023230893,0.00006960084,0.00006817488,0.00006030846,0.0000020603554,0.0731387,0.00031417562,0.00022119768,0.015436305],"study_design_scores_gemma":[0.029126897,0.0006749071,0.35745275,0.00051369396,0.0003595068,0.000060544084,0.00016486674,0.000412975,0.6103353,0.00020554732,0.0005028186,0.0001902247],"about_ca_topic_score_codex":0.000023805145,"about_ca_topic_score_gemma":0.000004130549,"teacher_disagreement_score":0.5497919,"about_ca_system_score_codex":0.00011270194,"about_ca_system_score_gemma":0.000067542176,"threshold_uncertainty_score":0.47663665},"labels":[],"label_agreement":null},{"id":"W2089988981","doi":"10.1182/blood-2010-02-269621","title":"Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":399,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Medicine; Acute promyelocytic leukemia; Cytarabine; Regimen; Internal medicine; Mercaptopurine; Surgery; Daunorubicin; Leukemia; Gastroenterology; Retinoic acid","score_opus":0.0035731154756143187,"score_gpt":0.21911186792795606,"score_spread":0.21553875245234175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089988981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979487,0.00017545313,0.00041058267,0.000032969994,0.00016196264,0.001061375,0.000046839275,0.00003928611,0.00012282422],"genre_scores_gemma":[0.99674374,0.00014798777,0.0016995838,0.0000710538,0.0003704239,0.00028488188,0.00012125197,0.00006936555,0.0004917163],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981542,0.000049585586,0.00033344235,0.0007843188,0.00021869027,0.00045975368],"domain_scores_gemma":[0.9985996,0.000038073853,0.00022912254,0.0008072997,0.00015706957,0.00016883969],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018215811,0.00037457584,0.0003786466,0.000052272168,0.00013599041,0.00007469113,0.0005155326,0.00013918996,0.0000024678156],"category_scores_gemma":[0.00015796957,0.00030332172,0.000106211184,0.00013535784,0.0002517033,0.0000149122325,0.0002663063,0.00032852998,0.0000016462999],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024160494,0.0009833276,0.05819183,0.00029002034,0.0013374834,0.00009397607,0.0006429817,0.000010935126,0.9285809,0.0000383148,0.00032961427,0.0070846057],"study_design_scores_gemma":[0.045545883,0.021407403,0.08516005,0.00010032893,0.0017871478,0.0005697046,0.0022744362,0.00024120908,0.83604825,0.00017650341,0.0044262377,0.002262855],"about_ca_topic_score_codex":0.0001378052,"about_ca_topic_score_gemma":0.0027603104,"teacher_disagreement_score":0.09253262,"about_ca_system_score_codex":0.00004249879,"about_ca_system_score_gemma":0.0005710918,"threshold_uncertainty_score":0.9999419},"labels":[],"label_agreement":null},{"id":"W2090079954","doi":"10.1182/blood-2001-11-0007","title":"Short-term granulocyte colony-stimulating factor and erythropoietin treatment enhances hematopoiesis and survival in the mitomycin C–conditioned Fancc−/− mouse model, while long-term treatment is ineffective","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Saint-François d'Assise","funders":"Hospital for Sick Children","keywords":"Erythropoietin; Haematopoiesis; Granulocyte colony-stimulating factor; Granulocyte; Medicine; Mitomycin C; Internal medicine; Cancer research; Term (time); Myelofibrosis; Immunology; Oncology; Biology; Chemotherapy; Bone marrow; Stem cell; Surgery","score_opus":0.037991385515118714,"score_gpt":0.287059260682043,"score_spread":0.2490678751669243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090079954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963057,0.0007864839,0.00020709341,0.00030775098,0.00004041773,0.001708523,0.0001602966,0.000064041975,0.00041969985],"genre_scores_gemma":[0.99766546,0.0011774346,0.00036419244,0.000055265766,0.00006505,0.00032670496,0.000078201774,0.000037195405,0.00023046427],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982306,0.000153289,0.00041863,0.00053387164,0.00031559155,0.00034801682],"domain_scores_gemma":[0.9989501,0.00045968074,0.00009126258,0.00032048643,0.000045977642,0.00013245796],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010717792,0.00039384005,0.0006232665,0.00013250946,0.0001841592,0.00006289685,0.000063499305,0.00014179909,0.000105276],"category_scores_gemma":[0.00001614712,0.00027221147,0.00009861058,0.00015338854,0.0001334511,0.00013098979,0.000015329702,0.00011010185,0.000011139379],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024040144,0.0032073706,0.88931733,0.00063215726,0.00057964405,0.00033561137,0.03636772,0.00003400116,0.06677932,0.00003570804,0.000015978403,0.0024547547],"study_design_scores_gemma":[0.016224641,0.002648501,0.61894614,0.0005074823,0.0013676916,0.00041830682,0.0009809686,0.0030293902,0.35527414,0.000034855286,0.0000060726256,0.0005618209],"about_ca_topic_score_codex":0.00010373193,"about_ca_topic_score_gemma":0.00030818945,"teacher_disagreement_score":0.28849483,"about_ca_system_score_codex":0.00012099308,"about_ca_system_score_gemma":0.000024181669,"threshold_uncertainty_score":0.999973},"labels":[],"label_agreement":null},{"id":"W2090186172","doi":"10.1182/blood-2009-05-223081","title":"BTG1 regulates glucocorticoid receptor autoinduction in acute lymphoblastic leukemia","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"Radboud Universitair Medisch Centrum","keywords":"Coactivator; Glucocorticoid receptor; Biology; Cancer research; Gene; Leukemia; Gene expression; Gene silencing; Regulation of gene expression; Genetics; Transcription factor","score_opus":0.003670474388566341,"score_gpt":0.21159860512394918,"score_spread":0.20792813073538283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090186172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982386,0.00020823501,0.000065429784,0.00010015162,0.00081531395,0.00022343332,0.000008293704,0.000029121871,0.0003114068],"genre_scores_gemma":[0.99738055,0.00008627728,0.00071290816,0.00002988333,0.00044975095,0.000028760256,0.00016448817,0.000031730277,0.0011156495],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99900466,0.000026479676,0.00023523597,0.00037625385,0.000118671334,0.00023872653],"domain_scores_gemma":[0.99939936,0.000007973358,0.00009527873,0.00038586356,0.00005294919,0.000058546735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009947391,0.0001500365,0.00013572529,0.00007445431,0.000040713054,0.000021481997,0.00011950907,0.00032419869,0.0000688722],"category_scores_gemma":[0.000057859314,0.00015875643,0.000067946996,0.00016876224,0.000053211075,0.0000073518513,0.0000547983,0.00015010747,0.00006597747],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052487765,0.00007048723,0.0022625932,0.00000865063,0.000060158964,0.0000015149803,0.000024464081,0.00035668843,0.99437207,0.000032889035,0.00038626816,0.0023717312],"study_design_scores_gemma":[0.0018285012,0.00015301592,0.028286893,0.00001805496,0.000065520086,0.00007088783,0.000013140392,0.00040307932,0.96166086,0.000062486135,0.0072158654,0.00022172037],"about_ca_topic_score_codex":0.00003370448,"about_ca_topic_score_gemma":0.00013600546,"teacher_disagreement_score":0.03271123,"about_ca_system_score_codex":0.00005089683,"about_ca_system_score_gemma":0.00022053295,"threshold_uncertainty_score":0.64738995},"labels":[],"label_agreement":null},{"id":"W2090845094","doi":"10.1182/blood-2012-07-445098","title":"Allogeneic, but not autologous, hematopoietic cell transplantation improves survival only among younger adults with acute lymphoblastic leukemia in first remission: an individual patient data meta-analysis","year":2012,"lang":"en","type":"review","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Medical Research Council; Cancer Research UK","keywords":"Medicine; Hematopoietic cell; Transplantation; Lymphoblastic Leukemia; Meta-analysis; Hematopoietic stem cell transplantation; Acute lymphocytic leukemia; Oncology; Leukemia; Haematopoiesis; Internal medicine; Immunology; Stem cell; Biology; Genetics","score_opus":0.06475710079478887,"score_gpt":0.30908500310750536,"score_spread":0.2443279023127165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090845094","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.048761323,0.94348615,0.00023184961,0.000039166993,0.00016006605,0.0030933365,0.003898473,0.00015344755,0.00017616336],"genre_scores_gemma":[0.04433297,0.92259365,0.0032505388,0.000096382195,0.00029163007,0.0005416629,0.028149305,0.00032104697,0.00042282784],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9913727,0.00084298395,0.0019495847,0.002236353,0.0022748695,0.0013235321],"domain_scores_gemma":[0.9935709,0.00089735107,0.0010324465,0.0033025567,0.00028773397,0.0009090137],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0010712292,0.0013695705,0.0063166497,0.0010129651,0.00017991575,0.00014228372,0.0014861664,0.0011221959,0.00031191754],"category_scores_gemma":[0.0001243636,0.00091165246,0.0012888425,0.0018259357,0.0002918292,0.0005819408,0.00053293497,0.0010476669,0.000047265163],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027919877,0.008995712,0.002611428,0.104118936,0.7487038,0.026664598,0.0055068936,0.00009503273,0.00012735065,0.000022329918,0.0002920465,0.100069925],"study_design_scores_gemma":[0.0060204873,0.0009153988,0.0016532077,0.0023944115,0.97629106,0.0035739797,0.00021780608,0.00022199658,0.00020991542,7.119166e-7,0.0072470815,0.0012539293],"about_ca_topic_score_codex":0.0012325314,"about_ca_topic_score_gemma":0.0019609618,"teacher_disagreement_score":0.22758731,"about_ca_system_score_codex":0.001031106,"about_ca_system_score_gemma":0.0071037808,"threshold_uncertainty_score":0.9999055},"labels":[],"label_agreement":null},{"id":"W2090883050","doi":"10.1182/blood-2003-12-4244","title":"Notch4-induced inhibition of endothelial sprouting requires the ankyrin repeats and involves signaling through RBP-Jκ","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Developmental Biology and Gene Regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Universität Ulm","keywords":"Ankyrin repeat; Biology; Cell biology; Sprouting; Sprouting angiogenesis; Notch signaling pathway; Ankyrin; Angiogenesis; Signal transduction; Transcription factor; Fibroblast growth factor; Receptor; Molecular biology; Genetics; Gene; Neovascularization","score_opus":0.01493115197945137,"score_gpt":0.23956972435760282,"score_spread":0.22463857237815144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090883050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988894,0.00039343373,0.00016826185,0.000085362,0.000055606113,0.00012302636,0.0000076151173,0.000008031714,0.00026929416],"genre_scores_gemma":[0.9986267,0.000055277662,0.0009779716,0.00010818737,0.000136869,0.000007414104,0.000058107264,0.000007328292,0.000022151502],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99942046,0.000036489197,0.0001708186,0.00019455382,0.000060754504,0.00011693137],"domain_scores_gemma":[0.9997307,0.000010097123,0.000091067894,0.00012479135,0.000027007158,0.000016311156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015785468,0.00008480188,0.000083481085,0.00001373878,0.00008828215,0.000008496647,0.000050754014,0.00010971801,0.0000021049648],"category_scores_gemma":[0.00004208834,0.0000664133,0.000034852554,0.00003593372,0.00008558503,0.0000061517776,0.00006637339,0.000046067278,0.0000010542794],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028966202,0.000047316276,0.004253403,0.000011049558,0.00003708148,0.0000019107522,0.0002930611,0.000017761507,0.99406016,0.000288582,0.0000030766798,0.00095760997],"study_design_scores_gemma":[0.00090437813,0.00014222016,0.012770453,0.000034368983,0.000021062688,0.000021990954,0.00015401897,7.39204e-7,0.98454463,0.0011967582,0.00012316524,0.00008621798],"about_ca_topic_score_codex":0.000030225836,"about_ca_topic_score_gemma":0.00003108165,"teacher_disagreement_score":0.009515555,"about_ca_system_score_codex":0.000004339026,"about_ca_system_score_gemma":0.0000375142,"threshold_uncertainty_score":0.27082556},"labels":[],"label_agreement":null},{"id":"W2091192696","doi":"10.1182/blood-2009-01-197608","title":"The VWD2B saga continues to Montreal","year":2009,"lang":"en","type":"letter","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Platelet; Blood Platelet Disorders; Family medicine; Intensive care medicine; Immunology; Platelet aggregation","score_opus":0.010384563761373908,"score_gpt":0.2356259350639294,"score_spread":0.2252413713025555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091192696","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04496539,0.003397583,0.0000016586508,0.8829838,0.00021418005,0.0008548181,0.0000619297,0.00010846711,0.067412175],"genre_scores_gemma":[0.007119971,0.0005378969,0.00017077134,0.9095569,0.0028046148,0.00007751446,0.00043021148,0.0000679046,0.079234205],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99885124,0.000023749177,0.00018326027,0.00027913932,0.0002727678,0.00038986278],"domain_scores_gemma":[0.9993034,0.000077558216,0.0000630534,0.00042981657,0.00004643638,0.000079738944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000045873472,0.00024610804,0.0004277065,0.00005385339,0.00010549955,0.000047736397,0.00013716515,0.00031880528,0.000029446841],"category_scores_gemma":[0.00004049528,0.00014682581,0.00015265781,0.00007581712,0.00002745114,0.000014931251,0.000024390223,0.00052115327,0.00030320874],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028524137,0.00019761235,0.00032006024,0.000014288819,0.00035609087,0.006442711,0.000049820475,2.6133735e-8,0.000013016393,0.0000021466828,0.9773903,0.015185409],"study_design_scores_gemma":[0.0024600811,0.00038461588,0.0051254923,0.000099299585,0.00064030004,0.00026464785,0.000008608327,3.2093814e-7,0.0001103765,0.00022771987,0.99052876,0.00014979525],"about_ca_topic_score_codex":0.00018235933,"about_ca_topic_score_gemma":0.0001152241,"teacher_disagreement_score":0.03784542,"about_ca_system_score_codex":0.000019313053,"about_ca_system_score_gemma":0.000049517006,"threshold_uncertainty_score":0.5987383},"labels":[],"label_agreement":null},{"id":"W2091428457","doi":"10.1182/blood-2004-10-4144","title":"Telomere loss, senescence, and genetic instability in CD4+ T lymphocytes overexpressing hTERT","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia Hospital","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Telomerase reverse transcriptase; Telomere; Telomerase; Biology; Senescence; Molecular biology; Population; Transfection; Green fluorescent protein; Cancer research; Cell culture; Cell biology; Gene; Genetics; Medicine","score_opus":0.010261056731498843,"score_gpt":0.2395696486117373,"score_spread":0.22930859188023844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091428457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99331105,0.0045014354,0.000018224504,0.00040295604,0.000059190625,0.00031262526,0.000009362729,0.000092708804,0.0012924768],"genre_scores_gemma":[0.99344015,0.00072027836,0.00488775,0.0005102757,0.0002545668,0.000015925669,0.0000070680567,0.000029674533,0.0001343145],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982216,0.00005739547,0.0004292835,0.00053378777,0.0002990002,0.00045896377],"domain_scores_gemma":[0.99909604,0.00007767922,0.00007798338,0.00046006663,0.00005903478,0.00022922535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014094383,0.0002570037,0.00042189786,0.0001714322,0.00009048027,0.000044550754,0.00011782847,0.00014691714,0.000099471035],"category_scores_gemma":[0.00012447812,0.00023305003,0.00006425657,0.00031877277,0.00021588158,0.00018701986,0.000084082945,0.00019903206,0.000028898226],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010330243,0.0008052038,0.9078834,0.00022268847,0.00002707841,0.0002478619,0.0005988674,0.0000046829578,0.048426285,0.000031870863,0.00005219393,0.041596547],"study_design_scores_gemma":[0.005204146,0.00011284371,0.9364697,0.00037850183,0.00008137454,0.0006713729,0.00014032862,0.00024643674,0.052852046,0.0000732312,0.0034414122,0.0003286165],"about_ca_topic_score_codex":0.00015814125,"about_ca_topic_score_gemma":0.00013541832,"teacher_disagreement_score":0.04126793,"about_ca_system_score_codex":0.00008970304,"about_ca_system_score_gemma":0.00019408543,"threshold_uncertainty_score":0.9503504},"labels":[],"label_agreement":null},{"id":"W2091637866","doi":"10.1182/blood-2007-12-077917","title":"The phagocytes: neutrophils and monocytes","year":2008,"lang":"en","type":"review","venue":"Blood","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":730,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Phagocyte; Immunology; Biology; Haematopoiesis; Chemokine; Macrophage; Chronic granulomatous disease; Myeloperoxidase; NADPH oxidase; Inflammation; Phagocytosis; Cell biology; Stem cell; In vitro; Biochemistry; Reactive oxygen species","score_opus":0.033118761560739535,"score_gpt":0.27540490288033653,"score_spread":0.242286141319597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091637866","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026367276,0.99789256,0.000003984565,0.00003153318,0.0004557405,0.00063850137,0.00006682719,0.00008939701,0.00055779354],"genre_scores_gemma":[0.000050942373,0.9973817,0.000027946773,0.00005908319,0.00014648981,0.00017008779,0.00010826577,0.000065205444,0.0019902983],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99794936,0.00042145507,0.0005075566,0.00055377965,0.000040802643,0.0005270542],"domain_scores_gemma":[0.9984622,0.0005813136,0.00028589397,0.0005852416,0.000046013105,0.000039360766],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012528461,0.00056076073,0.0012753943,0.00011056631,0.0007400769,0.000049148133,0.00050915836,0.0005032903,0.00005035084],"category_scores_gemma":[0.00005130149,0.00032299352,0.00036205203,0.00017515286,0.000419424,0.00006075338,0.0002494529,0.0006754924,0.00080317206],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012225533,0.00018322641,0.0000015368447,0.0008113945,0.0012942618,0.000093633054,0.000058594786,1.14133485e-8,0.00086135784,0.0027546878,0.0015353187,0.99239373],"study_design_scores_gemma":[0.0007634701,0.00015791085,0.0000025931606,0.00096716336,0.0007671774,0.0014838602,0.000017396324,1.1945589e-8,0.0029826788,0.00009878949,0.9924027,0.0003562986],"about_ca_topic_score_codex":0.000009387864,"about_ca_topic_score_gemma":0.0000029365815,"teacher_disagreement_score":0.9920375,"about_ca_system_score_codex":0.000020068512,"about_ca_system_score_gemma":0.00014582882,"threshold_uncertainty_score":0.99997485},"labels":[],"label_agreement":null},{"id":"W2091646547","doi":"10.1182/blood-2006-06-026997","title":"Involvement of the fractalkine pathway in the pathogenesis of childhood hemolytic uremic syndrome","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"CX3CR1; Thrombotic microangiopathy; Pathogenesis; Immunology; CD16; Peripheral blood mononuclear cell; Shiga toxin; Biology; Chemokine; CX3CL1; Chemokine receptor; Medicine; Inflammation; Immune system; Pathology; Disease","score_opus":0.00550842918250232,"score_gpt":0.17985217390562247,"score_spread":0.17434374472312014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091646547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99640876,0.001543605,0.0000056234835,0.0001251607,0.00050795474,0.00021931795,0.0000075262237,0.00000822092,0.0011738184],"genre_scores_gemma":[0.999093,0.000017392123,0.000005488998,0.00014762294,0.000011197742,0.000014818807,0.000037654143,0.0000066554658,0.00066619687],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999245,0.00015802919,0.00031710934,0.00010965812,0.000043812834,0.00012641556],"domain_scores_gemma":[0.9994306,0.00006456475,0.0001756643,0.00029373562,0.000032834756,0.0000025804914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019329601,0.00008975779,0.00015377675,0.000059428134,0.000051581115,0.0000028899246,0.00020454219,0.00009368341,0.0002192166],"category_scores_gemma":[0.000027072387,0.00005209818,0.0001066319,0.00017134934,0.00006994267,0.00003402053,0.000037970338,0.0001607646,0.000028164024],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002315265,0.0014177216,0.00879367,0.000017248583,0.000064228436,0.0000021423045,0.0003182598,0.00000784746,0.9883056,0.00026340593,0.0005408587,0.00024585822],"study_design_scores_gemma":[0.0013089936,0.00014586965,0.4482565,0.00005372728,0.000051693893,0.00015171386,0.00030870794,5.971411e-7,0.5465119,0.00008716036,0.003061725,0.000061460625],"about_ca_topic_score_codex":0.00029688643,"about_ca_topic_score_gemma":0.000046730325,"teacher_disagreement_score":0.44179374,"about_ca_system_score_codex":0.0000106624475,"about_ca_system_score_gemma":0.000029882021,"threshold_uncertainty_score":0.2400268},"labels":[],"label_agreement":null},{"id":"W2091705814","doi":"10.1182/blood-2012-07-443713","title":"Novel interferon-based pre-transplantation conditioning in the treatment of a congenital metabolic disorder","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Metabolism and Genetic Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University Health Network; University of Connecticut","keywords":"Transplantation; Medicine; Conditioning; Immunology; Internal medicine; Intensive care medicine","score_opus":0.006374596953886336,"score_gpt":0.22902697050053702,"score_spread":0.22265237354665068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091705814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99480975,0.002176365,0.0021982018,0.000048502465,0.000036166235,0.0003357849,0.000041422463,0.0000028836705,0.00035091926],"genre_scores_gemma":[0.9986311,0.0003887055,0.000430625,0.00008218413,0.000033138065,0.00015670613,0.0002237469,0.0000075320663,0.000046244244],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9994886,0.00003864666,0.00014849145,0.00014005094,0.000071148555,0.00011304823],"domain_scores_gemma":[0.9997272,0.000014892156,0.000043219767,0.0001670196,0.00002908194,0.00001858441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000043541604,0.000092496244,0.0001004591,0.000031034648,0.000022798797,0.000013602407,0.00009472541,0.00004645943,0.0000440896],"category_scores_gemma":[0.0000074781324,0.000064841166,0.000056387045,0.000057629262,0.000048200873,0.0000029094394,0.0000041317644,0.000018839293,0.00000436538],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012784699,0.004652074,0.080019295,0.000048771017,0.00026363417,0.0000017982135,0.0021975967,0.0005761216,0.9040056,0.00027441102,0.00006655073,0.0077662873],"study_design_scores_gemma":[0.009360934,0.0010585261,0.5352256,0.00001317699,0.00028991335,0.000012270753,0.0006031715,0.00016859992,0.4486829,0.00007592076,0.0042667566,0.00024225938],"about_ca_topic_score_codex":0.00031262246,"about_ca_topic_score_gemma":0.000295964,"teacher_disagreement_score":0.4553227,"about_ca_system_score_codex":5.744254e-7,"about_ca_system_score_gemma":0.000026290527,"threshold_uncertainty_score":0.2644146},"labels":[],"label_agreement":null},{"id":"W2091773528","doi":"10.1182/blood-2013-11-538835","title":"Pomalidomide alone or in combination with low-dose dexamethasone in relapsed and refractory multiple myeloma: a randomized phase 2 study","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":384,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of Alberta; University of Calgary; Royal Victoria Hospital; Princess Margaret Cancer Centre","funders":"National Cancer Institute; Celgene","keywords":"Medicine; Pomalidomide; Lenalidomide; Neutropenia; Multiple myeloma; Internal medicine; Bortezomib; Population; Dexamethasone; Surgery; Febrile neutropenia; Thalidomide; Randomized controlled trial; Phases of clinical research; Chemotherapy","score_opus":0.01876082933216229,"score_gpt":0.3065881242718411,"score_spread":0.28782729493967885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091773528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99566394,0.00021240603,0.000052583182,0.00016846371,0.000019599836,0.0036654428,0.000004936363,0.00004284851,0.00016980055],"genre_scores_gemma":[0.99734753,0.000046648256,0.0017510189,0.000052306474,0.000027837015,0.0004844825,0.000042084026,0.000034193683,0.00021391218],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99754924,0.00076076784,0.0004686818,0.0004292591,0.00042410873,0.00036793866],"domain_scores_gemma":[0.99777126,0.0014693638,0.00012277639,0.00033878806,0.000078870886,0.00021896146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014560091,0.00023163263,0.0009338212,0.00041271353,0.000050334493,0.000024794404,0.000069067755,0.000086871354,0.000033003616],"category_scores_gemma":[0.0029212008,0.00015159446,0.000046485577,0.00038751535,0.00012335756,0.000100291705,0.000044082342,0.0002845214,0.000010740534],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5040025,0.047234014,0.4265726,0.00014968644,0.00049432076,0.0025187782,0.0018645684,0.0000033313033,0.004959366,0.000014928509,0.000009935663,0.012175966],"study_design_scores_gemma":[0.7993569,0.0041204374,0.19184946,0.00020142425,0.00018498595,0.000056392255,0.00031921637,0.0019832284,0.001753527,0.000022613156,0.000011406148,0.0001404074],"about_ca_topic_score_codex":0.0008289237,"about_ca_topic_score_gemma":0.0018425074,"teacher_disagreement_score":0.2953544,"about_ca_system_score_codex":0.00006978695,"about_ca_system_score_gemma":0.00010280065,"threshold_uncertainty_score":0.61818427},"labels":[],"label_agreement":null},{"id":"W2091872525","doi":"10.1182/blood-2011-01-329359","title":"Myeloid dysplasia and bone marrow hypocellularity in adenosine deaminase-deficient severe combined immune deficiency","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Dalhousie University","funders":"National Institutes of Health","keywords":"Medicine; Bone marrow; Adenosine deaminase; Adenosine deaminase deficiency; Immune system; Dysplasia; Myeloid; Pathology; Immunology; Internal medicine; Adenosine","score_opus":0.015686328056262962,"score_gpt":0.23161804409851725,"score_spread":0.21593171604225428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091872525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902513,0.0076811695,0.000022278215,0.000054689757,0.00003981476,0.00030201636,0.000017240987,0.000017521457,0.001613955],"genre_scores_gemma":[0.99873847,0.00038496958,0.0003400227,0.00006269412,0.000029901863,0.000031771815,0.00005542687,0.000032845084,0.00032392555],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99853045,0.00011248374,0.0002737322,0.00046347803,0.00017552618,0.00044436185],"domain_scores_gemma":[0.9992614,0.00001112557,0.00006492406,0.00048113588,0.00006617068,0.00011527183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041275372,0.00020413689,0.00020772991,0.000102456135,0.00009097493,0.000021127065,0.00024294728,0.00017317364,0.00007104983],"category_scores_gemma":[0.00005591849,0.00020464182,0.000059095382,0.00019804147,0.00014617584,0.000005073489,0.00020249725,0.00017723585,0.000020969146],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012946189,0.0011951365,0.02248887,0.00003939105,0.000028941899,0.000052274416,0.00014156802,0.0000027773704,0.9737947,0.00006206421,0.00004295726,0.00085672515],"study_design_scores_gemma":[0.0041000973,0.00421941,0.039187454,0.000020021032,0.00003039001,0.00011335866,0.000095059884,0.000031319214,0.9515622,0.00014742414,0.00016976603,0.00032345208],"about_ca_topic_score_codex":0.00007159185,"about_ca_topic_score_gemma":0.00019165677,"teacher_disagreement_score":0.022232428,"about_ca_system_score_codex":0.00001342665,"about_ca_system_score_gemma":0.00008818314,"threshold_uncertainty_score":0.83450514},"labels":[],"label_agreement":null},{"id":"W2091969887","doi":"10.1182/blood-2009-05-220665","title":"Granules and thrombus formation","year":2009,"lang":"en","type":"letter","venue":"Blood","topic":"Cellular transport and secretion","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Takeda Oncology","keywords":"Thrombus; Platelet; Secretion; In vivo; Granule (geology); Platelet activation; Chemistry; Cell biology; Medicine; Pathology; Immunology; Internal medicine; Biology","score_opus":0.007111306660449116,"score_gpt":0.19327601109034653,"score_spread":0.1861647044298974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091969887","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8004634,0.0171027,0.010589742,0.16209036,0.0004199728,0.0009016976,0.00018205325,0.000100513156,0.008149608],"genre_scores_gemma":[0.22345877,0.008381934,0.0013338896,0.5675686,0.01199155,0.000033612523,0.18294732,0.00014791581,0.004136438],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99943537,0.000016358446,0.00012004256,0.00020297852,0.000088407345,0.00013684767],"domain_scores_gemma":[0.99972737,0.0000018412269,0.00005258405,0.00017483602,0.0000235582,0.000019829755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000039202867,0.00013996448,0.00011611792,0.000029142713,0.000041589195,0.00002122196,0.00006773307,0.00050647114,0.00000932186],"category_scores_gemma":[0.0000031306301,0.00013465107,0.00006590479,0.000019638343,0.000027823051,0.0000022310883,0.000010745456,0.0001975495,0.000005142773],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020528476,0.00009358085,0.0005423798,0.0002688555,0.00012710907,0.000135152,0.00008531508,5.9490685e-7,0.7171106,0.000016946156,0.2795324,0.0020666022],"study_design_scores_gemma":[0.0005121258,0.00013588894,0.0007539877,0.00002146213,0.0001158822,0.00006662892,0.000003502462,0.0000019921727,0.046928644,0.00012657003,0.9511252,0.00020810132],"about_ca_topic_score_codex":0.0000046944315,"about_ca_topic_score_gemma":0.000010641448,"teacher_disagreement_score":0.67159283,"about_ca_system_score_codex":0.0000018066221,"about_ca_system_score_gemma":0.000012561307,"threshold_uncertainty_score":0.5490911},"labels":[],"label_agreement":null},{"id":"W2091973627","doi":"10.1182/blood-2013-10-533083","title":"Serological investigation of patients with a previous history of heparin-induced thrombocytopenia who are reexposed to heparin","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Hamilton Health Sciences","keywords":"Heparin; Heparin-induced thrombocytopenia; Platelet factor 4; Medicine; Platelet; Serology; Immunology; Antibody; Internal medicine","score_opus":0.029661483724267745,"score_gpt":0.23622671406711376,"score_spread":0.20656523034284602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091973627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945456,0.00003951043,0.000031193867,0.00019432961,0.000121115685,0.0012276864,0.0000120117165,0.00007989676,0.0037487026],"genre_scores_gemma":[0.9973793,0.000010046031,0.00163481,0.0005168592,0.0000694783,0.00005983572,0.000043308908,0.000052990992,0.00023337438],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99746925,0.00020523142,0.00075051305,0.00058698567,0.0005845017,0.00040352443],"domain_scores_gemma":[0.99766624,0.00010824608,0.000511238,0.0008682911,0.00044539294,0.00040056795],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036542615,0.00034886014,0.0014635868,0.00020933607,0.000046225734,0.0000087638755,0.0002837798,0.00026171887,0.000100944475],"category_scores_gemma":[0.00034270322,0.0002781672,0.00014338933,0.00035765395,0.00017801947,0.0001362439,0.00015469296,0.0002865741,0.000033505865],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000491527,0.0012271474,0.8814599,0.0003134682,0.0002934018,0.0000064805463,0.0010393608,0.000002804664,0.113839716,0.0003452552,0.00036736147,0.0006135977],"study_design_scores_gemma":[0.0063318294,0.0040154476,0.91247386,0.00048006256,0.0005528561,0.0000071977965,0.000030433312,0.00001961355,0.075072885,0.00006868542,0.00066380383,0.00028334386],"about_ca_topic_score_codex":0.00026706737,"about_ca_topic_score_gemma":0.00016467721,"teacher_disagreement_score":0.038766827,"about_ca_system_score_codex":0.00019610145,"about_ca_system_score_gemma":0.00034604722,"threshold_uncertainty_score":0.99996704},"labels":[],"label_agreement":null},{"id":"W2092021753","doi":"10.1182/blood-2011-04-350066","title":"Ontogeny stage-independent and high-level clonal expansion in vitro of mouse hematopoietic stem cells stimulated by an engineered NUP98-HOX fusion transcription factor","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Heart, Lung, and Blood Institute; BC Cancer Agency; Canadian Institutes of Health Research","keywords":"Biology; Haematopoiesis; Hox gene; Stem cell; Transcription factor; Cell biology; In vitro; Genetics; Immunology; Gene","score_opus":0.03476668479318263,"score_gpt":0.23652746588263854,"score_spread":0.20176078108945592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092021753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99509573,0.0002031701,0.0033096976,0.000013192304,0.00009807777,0.00079586235,0.0003690544,0.000077194694,0.000038034806],"genre_scores_gemma":[0.9970791,0.00010558664,0.002232531,0.00002254098,0.000016641416,0.000020679225,0.00017722868,0.000051613715,0.00029409069],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980548,0.0000995516,0.00062936614,0.00042096668,0.00048989616,0.0003054079],"domain_scores_gemma":[0.99918145,0.000050338476,0.00012610988,0.00032182602,0.00008512192,0.00023515824],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019848962,0.00027535082,0.00050276564,0.00020825125,0.000032846583,0.000010425284,0.00009647058,0.00025883102,0.00019848063],"category_scores_gemma":[0.0000044853464,0.00025803817,0.00006984095,0.00015559858,0.000041771018,0.00016219549,0.000013045294,0.00020836531,0.000008625014],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007564525,0.0015873438,0.00199838,0.00065006997,0.000056600406,0.00007795186,0.006175493,0.00001362372,0.9881592,0.000022193033,0.0000042384795,0.00049846864],"study_design_scores_gemma":[0.008783067,0.00051387097,0.015201129,0.0002053583,0.00019571274,0.000058342543,0.00063104834,0.00059339183,0.9735749,0.000009922646,0.0000046821465,0.00022862082],"about_ca_topic_score_codex":0.00037137524,"about_ca_topic_score_gemma":0.00003730975,"teacher_disagreement_score":0.014584332,"about_ca_system_score_codex":0.00004366883,"about_ca_system_score_gemma":0.00006458094,"threshold_uncertainty_score":0.9999872},"labels":[],"label_agreement":null},{"id":"W2092224500","doi":"10.1182/blood-2004-10-3856","title":"Iron trafficking in the mitochondrion: novel pathways revealed by disease","year":2004,"lang":"en","type":"review","venue":"Blood","topic":"Porphyrin Metabolism and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":281,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Mitochondrion; Frataxin; Ferritin; Sideroblastic anemia; Heme; Iron-binding proteins; Mitochondrial disease; Iron–sulfur cluster; Biology; Organelle; Cell biology; Biochemistry; Mitochondrial DNA; Chemistry; Genetics; Aconitase; Gene","score_opus":0.01833794804996627,"score_gpt":0.26217063481193553,"score_spread":0.24383268676196926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092224500","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00084499957,0.9977293,0.00005918122,0.000024621368,0.0001297515,0.0006162745,0.00022862792,0.0000110097835,0.00035625385],"genre_scores_gemma":[0.0007552982,0.9970816,0.00011221055,0.00019687702,0.00029813824,0.00018328485,0.0012319426,0.000044433196,0.00009623717],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998521,0.00011733159,0.0003609309,0.0005101101,0.00017917152,0.0003115029],"domain_scores_gemma":[0.99908614,0.000017296335,0.00016347351,0.0006221981,0.000014121966,0.00009679306],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018110531,0.000356959,0.00052170875,0.000048028793,0.00006175482,0.000037760696,0.0005452191,0.0002750369,0.0000064842857],"category_scores_gemma":[0.00008327766,0.00024960647,0.00038117502,0.00016457944,0.00005407847,0.0000025118497,0.000075391,0.0002225888,0.000013263418],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011791683,0.012061688,0.00019110467,0.04189851,0.00066853495,0.0003528406,0.0005317336,0.00005855664,0.0062074037,0.0013457976,0.022484168,0.91408175],"study_design_scores_gemma":[0.0010727535,0.00003531585,0.000030452196,0.0013029965,0.00050239393,0.000023153898,0.000019255429,1.2421602e-7,0.000018147446,0.000019321897,0.99663335,0.00034274353],"about_ca_topic_score_codex":0.000008092236,"about_ca_topic_score_gemma":0.000007746925,"teacher_disagreement_score":0.97414917,"about_ca_system_score_codex":0.0000081700855,"about_ca_system_score_gemma":0.0003083461,"threshold_uncertainty_score":0.9999956},"labels":[],"label_agreement":null},{"id":"W2092283128","doi":"10.1182/blood-2008-10-186064","title":"Studies of the immune response in heparin-induced thrombocytopenia","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":179,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; McMaster University","funders":"Hamilton Health Sciences; Sanofi","keywords":"Antibody; Heparin; Heparin-induced thrombocytopenia; Immunology; Platelet factor 4; Medicine; Immunoglobulin M; Immunoglobulin G; Immune system; Platelet; Immunoglobulin A; Internal medicine","score_opus":0.057315423960832154,"score_gpt":0.3355682941187228,"score_spread":0.27825287015789063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092283128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99119425,0.00088295987,5.2219036e-7,0.0033750203,0.00018586873,0.0006810599,0.0000031469717,0.00004951906,0.003627684],"genre_scores_gemma":[0.99892926,0.00012230787,0.00020408179,0.00038566542,0.000058844154,0.000018287432,0.0000017125012,0.000023035513,0.00025677792],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99794525,0.00026499943,0.00067004556,0.00035971572,0.00035054606,0.0004094466],"domain_scores_gemma":[0.99843967,0.00020184502,0.00018117431,0.0009419696,0.00013930863,0.00009601668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079509866,0.00025991493,0.0010227705,0.00016539016,0.00010570362,0.000012981081,0.00033132362,0.00015760308,0.000043645923],"category_scores_gemma":[0.0007440959,0.00017689714,0.00023361086,0.00072419125,0.00012956449,0.00010716274,0.00015441069,0.00038870063,0.000036740872],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071642554,0.0012828294,0.024434777,0.000044667122,0.00025060785,0.000050482467,0.0013980942,0.0000010830757,0.97033083,0.00072726136,0.000033789915,0.00072914246],"study_design_scores_gemma":[0.0031929188,0.0006749568,0.58571655,0.0002327505,0.00018527484,0.000055616216,0.00030618385,0.000002346209,0.40911767,0.000298561,0.00009695393,0.000120205914],"about_ca_topic_score_codex":0.00007517461,"about_ca_topic_score_gemma":0.000040858962,"teacher_disagreement_score":0.5612818,"about_ca_system_score_codex":0.00009333847,"about_ca_system_score_gemma":0.00026607033,"threshold_uncertainty_score":0.7213656},"labels":[],"label_agreement":null},{"id":"W2092538118","doi":"10.1182/blood-2013-10-535716","title":"Transplantation for children with acute myeloid leukemia: a comparison of outcomes with reduced intensity and myeloablative regimens","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute; Health Resources and Services Administration","keywords":"Medicine; Transplantation; Myeloid leukemia; Internal medicine; Leukemia; Oncology; Hematopoietic stem cell transplantation; Myeloid; Chemotherapy regimen; Immunology; Chemotherapy","score_opus":0.013424199207760298,"score_gpt":0.2647577879311147,"score_spread":0.25133358872335443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092538118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852428,0.000020975664,0.013143394,0.00023371268,0.000014314626,0.0008904943,0.000036581776,0.000041857613,0.0003759013],"genre_scores_gemma":[0.98526603,0.000023063129,0.014366895,0.000061175844,0.000020843603,0.00003528041,0.00014612163,0.000023299048,0.000057303278],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991274,0.00002624914,0.0002451207,0.0002460032,0.00019811894,0.00015709539],"domain_scores_gemma":[0.99931765,0.00013523553,0.00015103439,0.00016826279,0.00014741468,0.00008039845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012193576,0.00016184992,0.00050848135,0.00007371293,0.000052239444,0.0000071568984,0.0000381201,0.00007746275,0.0000025821055],"category_scores_gemma":[0.000013788327,0.00011011931,0.00003765064,0.00009577612,0.00010186695,0.00005856743,0.0000034595514,0.00010268441,9.2902036e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033227436,0.0003642391,0.945543,0.0006727973,0.001659405,0.000013610602,0.0084131975,0.00001622469,0.03880608,0.00039488115,0.000032533164,0.0007612933],"study_design_scores_gemma":[0.011318964,0.0017594293,0.71058726,0.00032634143,0.0028406573,0.0005885584,0.00025781785,0.00013435756,0.27200562,0.00003338565,0.000004183898,0.00014340534],"about_ca_topic_score_codex":0.000044257682,"about_ca_topic_score_gemma":0.000039736395,"teacher_disagreement_score":0.2349557,"about_ca_system_score_codex":0.000016928896,"about_ca_system_score_gemma":0.00007123121,"threshold_uncertainty_score":0.44905353},"labels":[],"label_agreement":null},{"id":"W2092632463","doi":"10.1182/blood.v98.10.3143","title":"Platelet-derived microparticles bind to hematopoietic stem/progenitor cells and enhance their engraftment","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":349,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Alberta","funders":"National Heart, Lung, and Blood Institute","keywords":"Homing (biology); CD34; Progenitor cell; Haematopoiesis; Stem cell; Bone marrow; Immunology; Transplantation; Stem cell factor; Biology; Molecular biology; Cell biology; Chemistry; Cancer research; Medicine; Internal medicine","score_opus":0.011659770713467098,"score_gpt":0.23590703688360973,"score_spread":0.22424726617014262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092632463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968307,0.0017401266,0.000017466606,0.00048390045,0.000054112275,0.0006027589,0.000015222032,0.00005658104,0.00019914906],"genre_scores_gemma":[0.9982929,0.000340072,0.00058185065,0.00031398714,0.000043526426,0.000056668432,0.0000062787303,0.000024586947,0.00034011347],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990576,0.000017639424,0.00018520065,0.00029859523,0.00012366608,0.00031729456],"domain_scores_gemma":[0.99943763,0.000029584391,0.000038195685,0.00022688333,0.000030956413,0.00023674699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004775526,0.00018776738,0.00029910463,0.000054561926,0.00007881254,0.000028234494,0.00005365037,0.000058177862,0.00004900853],"category_scores_gemma":[0.000004591299,0.00014235819,0.000053442895,0.00012656032,0.00003241667,0.00003708309,0.000042376134,0.00006560413,0.00016421292],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015119623,0.0016252374,0.008375172,0.00005283014,0.00029325325,0.0011975026,0.0011227684,4.917456e-7,0.97583926,0.0000064626056,0.00016367683,0.011172149],"study_design_scores_gemma":[0.0034056744,0.00043311925,0.0027318492,0.000063162784,0.00012930649,0.0005706223,0.0003220276,0.0000051136863,0.9894438,0.000039593302,0.0027069848,0.0001487566],"about_ca_topic_score_codex":0.00001547493,"about_ca_topic_score_gemma":0.000011690784,"teacher_disagreement_score":0.013604529,"about_ca_system_score_codex":0.000016726006,"about_ca_system_score_gemma":0.00002466869,"threshold_uncertainty_score":0.5805198},"labels":[],"label_agreement":null},{"id":"W2092925278","doi":"10.1182/blood-2006-01-024729","title":"Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":476,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Internal medicine; Concordance; Oncology; Minimal residual disease; Cog; Cancer; Acute lymphocytic leukemia; White blood cell; Hematology; Leukemia; Pediatrics; Lymphoblastic Leukemia","score_opus":0.006805720420293499,"score_gpt":0.248935339241957,"score_spread":0.24212961882166348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092925278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99527115,0.0015425786,0.0005460263,0.00042429141,0.000041726507,0.0012935647,0.00077916996,0.00004585004,0.000055645636],"genre_scores_gemma":[0.9975603,0.00058856315,0.0010114849,0.000078093595,0.00014583542,0.0001923808,0.00035994253,0.00004416855,0.000019192023],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969811,0.0006234102,0.0007324377,0.0006267992,0.0006192476,0.00041699695],"domain_scores_gemma":[0.9943034,0.004077738,0.0006593468,0.0005800395,0.00019998972,0.0001795101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076760777,0.0003151099,0.0008926633,0.00058346667,0.0001393247,0.000024290746,0.00025011448,0.00030101193,0.000051232397],"category_scores_gemma":[0.0008772807,0.00023149046,0.00019599513,0.0016377209,0.0005168514,0.00006820944,0.00011936489,0.00032853935,0.0000019754514],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005407532,0.0013854116,0.9822913,0.00006341892,0.003349026,0.000025046618,0.00022765918,0.00005532354,0.005352352,0.000048809594,0.00027136298,0.0015227986],"study_design_scores_gemma":[0.017438795,0.001737025,0.9467509,0.00006315815,0.025785638,0.000025915795,0.000083744206,0.007444602,0.00040693965,0.00006696893,0.000009098148,0.00018724619],"about_ca_topic_score_codex":0.0037940315,"about_ca_topic_score_gemma":0.00053465104,"teacher_disagreement_score":0.03554039,"about_ca_system_score_codex":0.00048101737,"about_ca_system_score_gemma":0.0013326133,"threshold_uncertainty_score":0.9439907},"labels":[],"label_agreement":null},{"id":"W2093076684","doi":"10.1182/blood-2007-11-121590","title":"Analysis of the linker for activation of T cells and the linker for activation of B cells in natural killer cells reveals a novel signaling cassette, dual usage in ITAM signaling, and influence on development of the Ly49 repertoire","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Linker; Dual (grammatical number); Cell biology; Signal transduction; Biology; Chemistry; Computer science; Philosophy","score_opus":0.014144178997828964,"score_gpt":0.22515765429337317,"score_spread":0.2110134752955442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093076684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985059,0.000109190674,0.00020833481,0.00007765033,0.0002888107,0.00077735283,0.0000123160025,0.0000030331776,0.00001740418],"genre_scores_gemma":[0.9989921,0.000025235173,0.00022246552,0.000127876,0.000008202533,0.000040834635,0.000019970263,0.000009300604,0.0005540128],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99869967,0.00016627737,0.0007040219,0.00021017148,0.000076839635,0.00014299736],"domain_scores_gemma":[0.99799544,0.0008746457,0.000689846,0.0002126898,0.00022104439,0.000006320166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056280085,0.00014112768,0.00038551973,0.0002073192,0.00013260175,0.0000045572847,0.000118573575,0.0001824344,0.000012037503],"category_scores_gemma":[0.00021963628,0.000083352454,0.00014161228,0.00038773598,0.00020429185,0.00010572808,0.000051731866,0.00022272154,2.0491474e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006590148,0.0002828782,0.0032086128,0.00007126755,0.0003806476,4.595531e-8,0.003590336,0.0013333005,0.99025375,0.000024673178,0.00005642694,0.00013906686],"study_design_scores_gemma":[0.003141006,0.000085629625,0.038717832,0.00021776618,0.00019286499,0.0000015349756,0.00043796032,0.00023618242,0.9566329,0.000008878283,0.00024269879,0.00008473892],"about_ca_topic_score_codex":0.00012565071,"about_ca_topic_score_gemma":0.000034496465,"teacher_disagreement_score":0.03550922,"about_ca_system_score_codex":0.000028385559,"about_ca_system_score_gemma":0.000070941234,"threshold_uncertainty_score":0.33990145},"labels":[],"label_agreement":null},{"id":"W2093126196","doi":"10.1182/blood-2008-02-138131","title":"The cytoplasmic tail of CD45 is released from activated phagocytes and can act as an inhibitory messenger for T cells","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Austrian Science Fund","keywords":"Cell biology; Biology; Intracellular; Molecular biology; Protein tyrosine phosphatase; T cell; Cytoplasm; Signal transduction; Immune system; Immunology","score_opus":0.010409400838693836,"score_gpt":0.20913648057386888,"score_spread":0.19872707973517506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093126196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99368906,0.005050139,0.0000016486443,0.00022785178,0.00035655728,0.00028065805,0.00014103785,0.000052445725,0.00020058009],"genre_scores_gemma":[0.99608475,0.0007448264,0.000054596196,0.00016193399,0.00004931025,0.000029505298,0.000105133135,0.000025525984,0.002744432],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988053,0.00016513563,0.00028318109,0.00033552173,0.000031853957,0.00037899765],"domain_scores_gemma":[0.9988394,0.00050077774,0.00017609498,0.00037167515,0.000080698635,0.00003137105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010280753,0.00020634467,0.00032200888,0.000055100343,0.00041789975,0.000009082273,0.00023312302,0.0003374013,0.00015565644],"category_scores_gemma":[0.000048023143,0.0001505423,0.000088116336,0.000071629256,0.00054680917,0.00006792001,0.000062582294,0.00024950318,0.000053698648],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041317285,0.00044135994,0.0007341442,0.000009653262,0.0003326154,0.0000068705776,0.0010730895,1.4855972e-7,0.9945625,0.000034565295,0.0019241046,0.0004677926],"study_design_scores_gemma":[0.004564154,0.00047575298,0.0008132662,0.000012423845,0.00012821831,0.00006115826,0.00034354033,0.0000010876583,0.96958405,0.00017390156,0.023666365,0.00017606808],"about_ca_topic_score_codex":0.0006343039,"about_ca_topic_score_gemma":0.000110221124,"teacher_disagreement_score":0.02497842,"about_ca_system_score_codex":0.000012287388,"about_ca_system_score_gemma":0.00017473368,"threshold_uncertainty_score":0.6138937},"labels":[],"label_agreement":null},{"id":"W2093164294","doi":"10.1182/blood-2014-04-572545","title":"MPD-RC 101 prospective study of reduced-intensity allogeneic hematopoietic stem cell transplantation in patients with myelofibrosis","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Myelofibrosis; Hematopoietic stem cell transplantation; Medicine; Transplantation; Stem cell; Internal medicine; Regimen; Surgery; Gastroenterology; Oncology; Bone marrow; Biology","score_opus":0.00766578970528299,"score_gpt":0.21279811109286942,"score_spread":0.20513232138758644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093164294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99752885,0.000024810426,0.000012482756,0.000032222335,0.00003009752,0.0016887678,0.000012047555,0.000019780991,0.0006509444],"genre_scores_gemma":[0.99946964,0.000013147187,0.00020594259,0.00003337413,0.000018401826,0.00016432186,0.000024919174,0.000021805114,0.00004844202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99872565,0.00007524537,0.00031068502,0.00036099087,0.00033859408,0.0001888123],"domain_scores_gemma":[0.99926424,0.000054912234,0.0001302551,0.00025393398,0.0002131837,0.000083458865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009836759,0.00019882622,0.00048326165,0.00010609008,0.000044134064,0.000008082498,0.000049127877,0.00005608547,0.000018925708],"category_scores_gemma":[0.000006774257,0.0001428973,0.00004726677,0.0001933273,0.000030395373,0.000047753998,0.000012466264,0.0000965504,0.00001200041],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080157205,0.01343331,0.9799608,0.00016851422,0.00016134712,0.000020544665,0.004193341,0.000009294208,0.00095443125,0.000020157817,0.0000062899003,0.00027039798],"study_design_scores_gemma":[0.015699219,0.006198498,0.8514078,0.00017794601,0.0005322363,0.000007714101,0.00042317595,0.0000034377904,0.12542494,0.00000835981,0.0000013006588,0.00011535935],"about_ca_topic_score_codex":0.000081467064,"about_ca_topic_score_gemma":0.00018836386,"teacher_disagreement_score":0.12855299,"about_ca_system_score_codex":0.000043819327,"about_ca_system_score_gemma":0.000033271852,"threshold_uncertainty_score":0.58271825},"labels":[],"label_agreement":null},{"id":"W2093200886","doi":"10.1182/blood-2011-10-386094","title":"GFI1 and GFI1B control the loss of endothelial identity of hemogenic endothelium during hematopoietic commitment","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Zebrafish Biomedical Research Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":173,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"Biotechnology and Biological Sciences Research Council; National Centre for the Replacement, Refinement and Reduction of Animals in Research; Cancer Research UK; Wellcome Trust","keywords":"RUNX1; Biology; Haematopoiesis; Hemangioblast; Cell biology; Embryonic stem cell; Progenitor cell; Stem cell; Yolk sac; Transcription factor; Endothelium; Cancer research; Embryo; Genetics; Gene","score_opus":0.007903860758171483,"score_gpt":0.26053883275807904,"score_spread":0.2526349719999076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093200886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968221,0.0017325068,0.00051354384,0.0002518554,0.000025495441,0.00031353012,0.0001350125,0.0000042310585,0.00020168147],"genre_scores_gemma":[0.9993195,0.00024111493,0.000118428004,0.000049460996,0.00013233918,0.00005909851,0.000009801326,0.000010627789,0.00005962647],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991246,0.00006602684,0.00020889196,0.00013184005,0.00023007566,0.00023856379],"domain_scores_gemma":[0.9993241,0.00004850908,0.000092502705,0.00036377925,0.000056730165,0.00011436699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031999778,0.000084026804,0.0001369809,0.000024014858,0.000049279577,0.000007035306,0.00023514024,0.000064077,0.000026489828],"category_scores_gemma":[0.00014729118,0.00006166505,0.00007193623,0.00006890299,0.00032368777,0.0000056000035,0.00015993047,0.00006775669,0.0000046576147],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032125256,0.0003812482,0.02371709,0.000065720335,0.0001197171,5.0687333e-7,0.00006018128,2.0512053e-7,0.97466207,0.0008427918,0.00003271737,0.00008565284],"study_design_scores_gemma":[0.001967095,0.000087931905,0.024684502,0.000009875306,0.00006289863,0.000035972444,0.000046528443,0.0000017878803,0.97151184,0.00017320376,0.0013538838,0.00006446061],"about_ca_topic_score_codex":0.000027407925,"about_ca_topic_score_gemma":0.000015271195,"teacher_disagreement_score":0.0031501832,"about_ca_system_score_codex":0.0000044370736,"about_ca_system_score_gemma":0.000034818615,"threshold_uncertainty_score":0.2514628},"labels":[],"label_agreement":null},{"id":"W2093580866","doi":"10.1182/blood-2014-03-558478","title":"Genetic polymorphisms of vein wall remodeling in chronic venous disease: a narrative and systematic review","year":2014,"lang":"en","type":"review","venue":"Blood","topic":"Diagnosis and Treatment of Venous Diseases","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Western University","funders":"","keywords":"Chronic venous insufficiency; Medicine; Varicose veins; Disease; Bioinformatics; Genetic predisposition; Pathology; Internal medicine; Surgery; Biology","score_opus":0.023966428537760445,"score_gpt":0.3094582812978571,"score_spread":0.28549185276009664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093580866","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00051593524,0.9952427,0.0000013122461,0.00004479348,0.000023536386,0.0040542088,0.00004045033,0.000023584902,0.000053446463],"genre_scores_gemma":[0.0024220026,0.99641144,0.00005820514,0.00008329124,0.00006851517,0.0007415278,0.00009718008,0.00006406694,0.000053796386],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9976576,0.0002476149,0.0010820308,0.00044532717,0.00030655443,0.00026086305],"domain_scores_gemma":[0.99833715,0.00017643384,0.00057157135,0.0006145087,0.000057960195,0.00024237155],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002084096,0.0004172721,0.004285908,0.00019035858,0.00003388141,0.000013385238,0.00013351813,0.00011098875,0.0000252103],"category_scores_gemma":[0.00025648947,0.0003049842,0.00049815275,0.0002103113,0.0000549918,0.00002553959,0.000046369358,0.00014491823,0.000018542467],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000042202537,0.0049725,0.000018278457,0.9746242,0.0005830663,0.00021364531,0.00005191247,3.946962e-7,1.0280536e-7,0.000014648985,0.000015946154,0.019501047],"study_design_scores_gemma":[0.0010121204,0.0014372193,0.000061023173,0.9601214,0.033679083,0.00012604655,0.000005561829,0.000012254332,2.2683199e-7,0.0000148857,0.0032943792,0.00023578231],"about_ca_topic_score_codex":0.000029400047,"about_ca_topic_score_gemma":0.000008373255,"teacher_disagreement_score":0.033096015,"about_ca_system_score_codex":0.00015665527,"about_ca_system_score_gemma":0.00077401916,"threshold_uncertainty_score":0.9999402},"labels":[],"label_agreement":null},{"id":"W2093724620","doi":"10.1182/blood-2012-05-399048","title":"Allogeneic hematopoietic cell transplantation for myelofibrosis in the era of JAK inhibitors","year":2012,"lang":"en","type":"review","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Transplantation; Internal medicine; Oncology; Constitutional symptoms; Hematopoietic stem cell transplantation; Hematopoietic cell; Regimen; Stem cell; Haematopoiesis; Bone marrow; Disease","score_opus":0.03791316878432824,"score_gpt":0.3062783403199888,"score_spread":0.26836517153566053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093724620","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0046107885,0.9916682,0.000010558519,0.00008172969,0.00008913257,0.00298245,0.0001550669,0.000010692452,0.0003913309],"genre_scores_gemma":[0.012885569,0.98405623,0.0006218278,0.000052120427,0.00019773905,0.0016298566,0.00047797905,0.000044136577,0.00003451608],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984605,0.00013063946,0.00063999783,0.00027067415,0.00024053335,0.00025768604],"domain_scores_gemma":[0.9988487,0.00047343125,0.0002698661,0.0002951284,0.000046852794,0.00006604459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027850922,0.0003350456,0.0012635425,0.000111836554,0.00004011732,0.000010508441,0.00011095673,0.0002318101,0.000034430777],"category_scores_gemma":[0.0000142987865,0.00019211882,0.00051397894,0.000214708,0.000033833934,0.000030722942,0.00000926385,0.00021363236,0.000018017558],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010261383,0.010748098,0.011322226,0.22308515,0.0012764905,0.00009782396,0.0042948895,6.294632e-7,0.00008185211,0.0006466271,0.00042399994,0.7479196],"study_design_scores_gemma":[0.012340482,0.002418156,0.0054483535,0.05259305,0.05306942,0.00085821556,0.00024788952,5.599737e-7,0.013170366,0.00008183761,0.85872495,0.0010467204],"about_ca_topic_score_codex":0.000016315647,"about_ca_topic_score_gemma":0.000018320812,"teacher_disagreement_score":0.8583009,"about_ca_system_score_codex":0.000032106895,"about_ca_system_score_gemma":0.00015557128,"threshold_uncertainty_score":0.78343785},"labels":[],"label_agreement":null},{"id":"W2093785176","doi":"10.1182/blood-2009-04-216085","title":"Evidence for a cross-talk between human neutrophils and Th17 cells","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":761,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Università degli Studi di Verona; Fondazione Cassa di Risparmio di Verona Vicenza Belluno e Ancona; Associazione Italiana per la Ricerca sul Cancro","keywords":"CCL20; C-C chemokine receptor type 6; Chemokine; Interleukin 17; Immunology; Chemotaxis; Tumor necrosis factor alpha; Biology; CCR2; CXCL16; Chemokine receptor; Cell biology; Cytokine; Inflammation; Receptor","score_opus":0.05511394460269681,"score_gpt":0.308155979884125,"score_spread":0.2530420352814282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093785176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99148375,0.007559636,0.000014974056,0.0001121189,0.00012290377,0.00028228856,0.000067370995,0.0000544542,0.00030248784],"genre_scores_gemma":[0.99815506,0.0001776003,0.00013629175,0.00007062485,0.00012629342,0.00002395359,0.00006491515,0.000008710539,0.0012365448],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992515,0.000046414734,0.00015995612,0.00026404034,0.000016828393,0.00026130446],"domain_scores_gemma":[0.9995196,0.00016878148,0.000062330946,0.00019618006,0.000029457631,0.000023665883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011522286,0.00014154092,0.00021281408,0.00004385844,0.00025369038,0.000027724975,0.0001237001,0.00016866905,0.000042985397],"category_scores_gemma":[0.000021618964,0.0001215554,0.000082919076,0.000047183912,0.00007424139,0.000103257844,0.000021463633,0.00006144271,0.000044163942],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079085214,0.00023553666,0.030394053,0.000017371434,0.00022282744,0.000008874374,0.00017699519,2.1493776e-7,0.9541185,0.00029397022,0.00027042252,0.014182152],"study_design_scores_gemma":[0.004061205,0.000855617,0.34717596,0.00005074032,0.00047189198,0.000022571177,0.00001092844,5.8351098e-8,0.6434155,0.00070764025,0.003036717,0.00019117026],"about_ca_topic_score_codex":0.0000138724845,"about_ca_topic_score_gemma":0.0000035909768,"teacher_disagreement_score":0.3167819,"about_ca_system_score_codex":0.0000061998066,"about_ca_system_score_gemma":0.000013973556,"threshold_uncertainty_score":0.49568853},"labels":[],"label_agreement":null},{"id":"W2093952640","doi":"10.1182/blood-2006-11-057315","title":"Involvement of Fyn kinase in Kit and integrin-mediated Rac activation, cytoskeletal reorganization, and chemotaxis of mast cells","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Heart, Lung, and Blood Institute","keywords":"FYN; Cell biology; LYN; Degranulation; Stem cell factor; RAC1; Mast cell; Chemotaxis; Biology; Lamellipodium; Kinase; Cell migration; Chemistry; Cancer research; Proto-oncogene tyrosine-protein kinase Src; Signal transduction; Receptor; Stem cell; Cell; Immunology; Haematopoiesis; Biochemistry","score_opus":0.004716300057663153,"score_gpt":0.18864882998386512,"score_spread":0.18393252992620196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093952640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986414,0.00053708366,0.00017057064,0.000047242313,0.00004599771,0.00013633809,0.000015429508,0.000007930827,0.00039803743],"genre_scores_gemma":[0.99925584,0.00012809334,0.00020312793,0.000027938591,0.000008539146,0.0000014327331,0.000066591856,0.000007982713,0.0003004536],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993675,0.000027414484,0.0003052443,0.00014702548,0.000025396184,0.00012745],"domain_scores_gemma":[0.99957556,0.00007643236,0.00013723828,0.00010630764,0.0000878974,0.000016584992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022212196,0.00008861614,0.00018965482,0.00012331079,0.00002545172,0.0000023454427,0.000050546805,0.00011529796,0.00017941548],"category_scores_gemma":[0.00006519515,0.000083085986,0.000013671726,0.00017194942,0.00014953673,0.00003611818,0.00005225211,0.00009631626,0.0000036092442],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005160451,0.00033919117,0.034303956,0.00009571096,0.00003831968,0.0000016494408,0.00071043015,3.7715174e-7,0.9633879,0.0003106779,0.00006402695,0.0006961208],"study_design_scores_gemma":[0.0023764782,0.0001372155,0.061333403,0.000037977632,0.000021728598,0.00000411368,0.0003442668,8.6219404e-7,0.9334946,0.000028080074,0.0021473109,0.00007393351],"about_ca_topic_score_codex":0.00020396142,"about_ca_topic_score_gemma":0.00012759017,"teacher_disagreement_score":0.029893305,"about_ca_system_score_codex":0.000008140619,"about_ca_system_score_gemma":0.000020702893,"threshold_uncertainty_score":0.33881482},"labels":[],"label_agreement":null},{"id":"W2093953371","doi":"10.1182/blood-2002-08-2508","title":"Reovirus oncolysis as a novel purging strategy for autologous stem cell transplantation","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"University of Calgary","keywords":"Ex vivo; Transplantation; Biology; Cancer research; Stem cell; Lymphoma; Chronic lymphocytic leukemia; Oncolytic virus; Leukemia; In vivo; Immunology; Medicine; Internal medicine","score_opus":0.025363915891939218,"score_gpt":0.2980198845739803,"score_spread":0.2726559686820411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093953371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923847,0.00083075045,0.0027403142,0.00003134678,0.000043376727,0.00040403297,0.00005736022,0.000019835912,0.0034883337],"genre_scores_gemma":[0.99732935,0.00023811958,0.0007219474,0.000108652515,0.00007125722,0.000116726704,0.00008803736,0.000033840126,0.001292073],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99894553,0.00007099017,0.00017601317,0.00034570546,0.00013909985,0.00032266014],"domain_scores_gemma":[0.99948865,0.000024602703,0.000058539452,0.00027062657,0.00007352171,0.00008403197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002691706,0.00014194132,0.00013469938,0.000054221815,0.00010640177,0.000028575372,0.00014888246,0.00014722226,0.000026821715],"category_scores_gemma":[0.000013042995,0.00014498031,0.00011025119,0.00010305979,0.00003192833,0.0000035907217,0.000009399318,0.000075047275,0.000016236674],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005999296,0.00031806022,0.000109054025,0.000049593396,0.000084357394,0.000009630812,0.000059440074,0.00027702274,0.9945575,0.00008408892,0.00004574735,0.0038055922],"study_design_scores_gemma":[0.0030551408,0.0023416711,0.0000657461,0.0000057339957,0.00007790359,0.000049026035,0.00009201318,0.00002768898,0.990782,0.000052505173,0.0032711704,0.00017937126],"about_ca_topic_score_codex":0.000013522541,"about_ca_topic_score_gemma":0.0000833492,"teacher_disagreement_score":0.004944697,"about_ca_system_score_codex":0.000011437902,"about_ca_system_score_gemma":0.0002266246,"threshold_uncertainty_score":0.5912125},"labels":[],"label_agreement":null},{"id":"W2094124990","doi":"10.1182/blood-2012-02-410928","title":"Development of myeloproliferative disease in 12/15-lipoxygenase deficiency","year":2012,"lang":"en","type":"letter","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Wellcome Trust","keywords":"Lipoxygenase; Arachidonate 5-lipoxygenase; Polycythemia vera; Disease; Medicine; Immunology; Chemistry; Internal medicine; Biochemistry; Arachidonic acid; Enzyme","score_opus":0.016515796854657365,"score_gpt":0.22352752676144858,"score_spread":0.2070117299067912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094124990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80404776,0.051169217,0.0004420931,0.0731049,0.03332835,0.00385222,0.00019778796,0.00044240558,0.033415254],"genre_scores_gemma":[0.71152544,0.00031031715,0.0009223181,0.17976834,0.0016360596,0.000595599,0.008666375,0.00021407714,0.09636145],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998478,0.0001705444,0.0005678701,0.0003068989,0.00006065756,0.0004160229],"domain_scores_gemma":[0.99929434,0.00005853446,0.00026392343,0.00029478784,0.000068835245,0.000019564599],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00015866401,0.00027937102,0.0003616352,0.000280756,0.000101628626,0.00000805367,0.0001877236,0.0005816032,0.0020728852],"category_scores_gemma":[0.000059327544,0.00025196502,0.000114517425,0.00010072622,0.00008905508,0.000095816795,0.000073298266,0.0010972929,0.0011243862],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035228833,0.002168724,0.004568757,0.00045171616,0.0005789088,0.00007900702,0.003701964,0.0000013681663,0.12367529,0.000056114168,0.86199933,0.0023665424],"study_design_scores_gemma":[0.0012714246,0.00004781354,0.005145927,0.00012348835,0.00013403279,0.000018433742,0.000070328635,2.1897974e-7,0.06264699,0.0000076173164,0.93023133,0.0003023706],"about_ca_topic_score_codex":0.000024384162,"about_ca_topic_score_gemma":0.000014338584,"teacher_disagreement_score":0.10666344,"about_ca_system_score_codex":0.000056415804,"about_ca_system_score_gemma":0.00024937908,"threshold_uncertainty_score":0.99999326},"labels":[],"label_agreement":null},{"id":"W2094301460","doi":"10.1182/blood-2004-12-4886","title":"T-cell generation by lymph node resident progenitor cells","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Université de Montréal; Hôpital Maisonneuve-Rosemont; Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Progenitor cell; Biology; Wnt signaling pathway; Cell biology; Stromal cell; Lymphopoiesis; Progenitor; T cell; Stem cell; HES1; Immunology; Molecular biology; Cancer research; Signal transduction; Notch signaling pathway; Immune system","score_opus":0.004977814329573485,"score_gpt":0.20745920462364886,"score_spread":0.2024813902940754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094301460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949583,0.0032083348,0.0005966423,0.0001813807,0.00016069706,0.00016687003,0.00001906119,0.000018292407,0.00069044135],"genre_scores_gemma":[0.9920516,0.00022378645,0.001366296,0.00012179202,0.001692598,0.000029816243,0.00028981495,0.000025852605,0.0041984534],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99926054,0.000030261486,0.00015731314,0.00027043928,0.00012002415,0.00016143025],"domain_scores_gemma":[0.99957824,0.0000018856167,0.00006444841,0.00025026733,0.000048594437,0.00005656165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000064481144,0.00010801195,0.00006685142,0.000020597656,0.000056296885,0.000023505358,0.0000846982,0.00015206766,0.00003210729],"category_scores_gemma":[0.0000058782557,0.00011592862,0.000053664557,0.00004807638,0.000017869374,0.0000035786618,0.000032214837,0.000034121535,0.000058975696],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010460977,0.0001245552,0.00034353803,0.000005256486,0.000023133178,3.5719506e-7,0.000017034694,0.00052685343,0.96571404,0.0000016206122,0.032295156,0.0009380178],"study_design_scores_gemma":[0.0010662748,0.00004379011,0.00017632463,0.000002814675,0.000039655577,0.000006166231,0.0000046866694,0.00028849853,0.9431491,0.0000015831062,0.055085104,0.00013599604],"about_ca_topic_score_codex":0.000012569011,"about_ca_topic_score_gemma":0.000015610414,"teacher_disagreement_score":0.022789944,"about_ca_system_score_codex":0.000024106725,"about_ca_system_score_gemma":0.00006415503,"threshold_uncertainty_score":0.47274318},"labels":[],"label_agreement":null},{"id":"W2094352563","doi":"10.1182/blood-2003-09-3300","title":"Contributions of β2-microglobulin–dependent molecules and lymphocytes to iron regulation: insights from HfeRag1-/- and β2mRag1-/- double knock-out mice","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Beta-2 microglobulin; Hereditary hemochromatosis; Gene knockin; Biology; Phenotype; Knockout mouse; Major histocompatibility complex; Hemochromatosis; Gene; Haploinsufficiency; Genetics; Immunology","score_opus":0.007419220380817878,"score_gpt":0.2360756214964788,"score_spread":0.2286564011156609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094352563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98060995,0.0157674,0.00036051657,0.00029817765,0.00014127661,0.00041730131,0.000075293545,0.000030982163,0.0022991144],"genre_scores_gemma":[0.9965797,0.00039284024,0.0019949724,0.00030979555,0.0000730738,0.000015985152,0.00005832674,0.000016703027,0.0005586234],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989598,0.00004963389,0.00028342276,0.00031680914,0.00019397809,0.0001963807],"domain_scores_gemma":[0.9992884,0.000057210567,0.000078007804,0.00025319468,0.0001203601,0.00020282577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000073370546,0.00017143592,0.00034129305,0.00009819467,0.00009515541,0.000026596916,0.000049567432,0.00012399518,0.00006162166],"category_scores_gemma":[0.00009374097,0.00015427686,0.00004300596,0.00011486404,0.00008631973,0.00007188265,0.000041862142,0.00007439947,0.000016251459],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010078984,0.001802878,0.033148192,0.00030521362,0.00024122107,0.00006101087,0.0037532998,0.000039841576,0.92326874,0.034095287,0.0010962205,0.0011802289],"study_design_scores_gemma":[0.02501182,0.00024890227,0.06313381,0.00011917835,0.00088505365,0.00007106619,0.00077194266,0.0000158859,0.8995706,0.0018941761,0.007918841,0.00035872572],"about_ca_topic_score_codex":0.00024673232,"about_ca_topic_score_gemma":0.000076774224,"teacher_disagreement_score":0.03220111,"about_ca_system_score_codex":0.000018864506,"about_ca_system_score_gemma":0.000100986676,"threshold_uncertainty_score":0.6291228},"labels":[],"label_agreement":null},{"id":"W2094502152","doi":"10.1182/blood-2006-11-059469","title":"Rapid infusion rituximab in combination with corticosteroid-containing chemotherapy or as maintenance therapy is well tolerated and can safely be delivered in the community setting","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency","keywords":"Medicine; Rituximab; Maintenance therapy; Chemotherapy regimen; Corticosteroid; Chemotherapy; Internal medicine; Oncology; Surgery; Lymphoma","score_opus":0.020805593284187976,"score_gpt":0.2641695825640168,"score_spread":0.24336398927982883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094502152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945045,0.00042445297,0.0000037814298,0.0032911988,0.000012539061,0.00076415774,0.000004142606,0.000019955953,0.00097523397],"genre_scores_gemma":[0.9911117,0.00076288544,0.00025978958,0.0077360827,0.000012002081,0.000034984434,0.00003294837,0.000015865775,0.00003372274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898565,0.00014306935,0.00026963837,0.00016433756,0.00018970945,0.00024760122],"domain_scores_gemma":[0.9992594,0.00028050246,0.00010510222,0.00023416658,0.000068879825,0.000051963503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006435865,0.00016024815,0.00025765089,0.000087645014,0.00013479876,0.00003387717,0.00007765349,0.000070709684,0.00004432724],"category_scores_gemma":[0.000034929937,0.0000928972,0.00002225456,0.00024788527,0.000053346015,0.00005004635,0.000018652812,0.00021298049,0.0000018574907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005606689,0.01188522,0.8321028,0.000045407567,0.00015509824,0.000676392,0.035143994,6.958447e-7,0.003114974,0.00005830898,0.00011344035,0.11109704],"study_design_scores_gemma":[0.08267623,0.0036244325,0.88620025,0.00039848304,0.00004560266,0.00023868892,0.0049418,0.00009393741,0.02110229,0.000031862546,0.0005000753,0.00014635205],"about_ca_topic_score_codex":0.0039404826,"about_ca_topic_score_gemma":0.0035082141,"teacher_disagreement_score":0.110950686,"about_ca_system_score_codex":0.00010244691,"about_ca_system_score_gemma":0.000078496974,"threshold_uncertainty_score":0.5956857},"labels":[],"label_agreement":null},{"id":"W2094611598","doi":"10.1182/blood-2014-03-559963","title":"The novel AKT inhibitor afuresertib shows favorable safety, pharmacokinetics, and clinical activity in multiple myeloma","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"GlaxoSmithKline","keywords":"Multiple myeloma; Pharmacokinetics; Medicine; Lenalidomide; Safety profile; Protein kinase B; Cancer research; Pharmacology; Oncology; Internal medicine; Adverse effect; Chemistry; Signal transduction","score_opus":0.04141649061552355,"score_gpt":0.33802430690756835,"score_spread":0.2966078162920448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094611598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957197,0.00029524567,0.000097985765,0.0013923752,0.00013551679,0.0007069454,0.000026418304,0.000040984334,0.0015848748],"genre_scores_gemma":[0.9977163,0.00038305728,0.0006523323,0.00012081368,0.00034551974,0.00003669054,0.000012623845,0.000026993042,0.0007056489],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981966,0.0001875466,0.0003503457,0.00039016549,0.00036954653,0.0005057713],"domain_scores_gemma":[0.9980114,0.0010886189,0.00007078149,0.0004027007,0.00007501849,0.000351458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008987093,0.00018606668,0.0003437204,0.00007063116,0.00019366652,0.00004830946,0.0001363735,0.000117192394,0.00002808461],"category_scores_gemma":[0.0014314905,0.00012204554,0.0000933994,0.00014587861,0.00021036465,0.00007897394,0.00017022008,0.0004385284,0.000033815697],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019438615,0.0035151278,0.85362935,0.00006196655,0.00027993266,0.00006846604,0.000053568212,0.0000016542067,0.04057223,0.000046577734,0.00036879128,0.09945849],"study_design_scores_gemma":[0.031964585,0.0007638189,0.9072706,0.0000759196,0.00013004235,0.00003734619,0.000029436273,0.0057227863,0.04192781,0.000039081493,0.011871073,0.00016750857],"about_ca_topic_score_codex":0.00024920664,"about_ca_topic_score_gemma":0.00092733966,"teacher_disagreement_score":0.09929099,"about_ca_system_score_codex":0.000034479257,"about_ca_system_score_gemma":0.00009041684,"threshold_uncertainty_score":0.49768725},"labels":[],"label_agreement":null},{"id":"W2094800640","doi":"10.1182/blood-2006-02-004945","title":"Eosinophils are a major intravascular location for tissue factor storage and exposure","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":240,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Deutsche Forschungsgemeinschaft","keywords":"Tissue factor; Eosinophil; Eosinophil cationic protein; Granulocyte; Biology; Thromboplastin; Monocyte; Immunology; Progenitor cell; Platelet-activating factor; Immunoelectron microscopy; Cell biology; Molecular biology; Coagulation; Stem cell; Antibody; Internal medicine; Medicine","score_opus":0.008447263613658943,"score_gpt":0.229159721793797,"score_spread":0.22071245818013807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094800640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990345,0.00668617,0.00097232667,0.0008761968,0.000058930458,0.00065785385,0.000030387577,0.00005542468,0.0003176881],"genre_scores_gemma":[0.9973445,0.000040791176,0.0009435021,0.00012678007,0.00020173642,0.00005257777,0.00005710076,0.000024171326,0.0012088285],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992668,0.000013135776,0.00017066042,0.00022983954,0.00014165553,0.00017789031],"domain_scores_gemma":[0.9995513,0.000025006777,0.000058252182,0.00020806189,0.00008862929,0.00006873433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006368367,0.00012767868,0.00024401427,0.00006253977,0.00006721636,0.00002692804,0.000041204872,0.00009805841,0.00003931116],"category_scores_gemma":[0.000042413307,0.000110678244,0.000045317876,0.00008963712,0.000041606483,0.000055478886,0.0000122828,0.00006181434,0.0000076286888],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006480456,0.01427774,0.5602936,0.008821157,0.0020226133,0.0008194963,0.003508918,0.00004932241,0.27572602,0.009492595,0.024450976,0.09988947],"study_design_scores_gemma":[0.0154560795,0.0016808852,0.92714703,0.00032941534,0.0008373927,0.00035200763,0.00037267437,0.00007541856,0.023181597,0.0023249015,0.027723864,0.00051872217],"about_ca_topic_score_codex":0.000064735024,"about_ca_topic_score_gemma":0.00003551403,"teacher_disagreement_score":0.36685342,"about_ca_system_score_codex":0.000009925163,"about_ca_system_score_gemma":0.00002974021,"threshold_uncertainty_score":0.45133278},"labels":[],"label_agreement":null},{"id":"W2094859089","doi":"10.1182/blood-2012-05-423236","title":"Point/counterpoint: early-stage Hodgkin lymphoma and the role of radiation therapy","year":2012,"lang":"en","type":"review","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Ontario Institute for Cancer Research","funders":"","keywords":"Hematologist; Medicine; Radiation therapy; Hodgkin lymphoma; Radiation oncologist; Stage (stratigraphy); Lymphoma; Clinical trial; Protocol (science); Counterpoint; Oncology; Medical physics; Internal medicine; Pathology; Disease; Psychology; Alternative medicine; Biology","score_opus":0.019638987593020973,"score_gpt":0.2778677943432261,"score_spread":0.25822880675020515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094859089","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006334789,0.99045306,4.284508e-7,0.000050890743,0.00007545101,0.0013258215,0.000057080655,0.000021691507,0.001680766],"genre_scores_gemma":[0.01867941,0.9804052,0.000029648467,0.00006514281,0.00024805608,0.00026329025,0.000069017966,0.000043314547,0.00019689494],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99873585,0.00014999717,0.00043431605,0.00023910619,0.00022972932,0.00021100423],"domain_scores_gemma":[0.99880946,0.00022293939,0.00037357592,0.00046689637,0.000032911405,0.00009421222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002943709,0.0003154518,0.0013104578,0.000095016025,0.000048219612,0.000024345743,0.00010012528,0.00018077347,0.00006625207],"category_scores_gemma":[0.000022714186,0.00016086781,0.0004307607,0.00012006206,0.000092260896,0.000054051354,0.000041487147,0.00006898003,0.000041526822],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047408575,0.0008760778,0.0026828244,0.001131364,0.00095233665,0.00001004129,0.00023434348,2.1227031e-9,4.7928995e-7,0.00092410215,0.000019250323,0.99312174],"study_design_scores_gemma":[0.012367999,0.00024100333,0.0055173077,0.0021263605,0.004439628,0.000183044,0.000026449166,6.88931e-7,0.0001659662,0.000049160208,0.9747188,0.00016358467],"about_ca_topic_score_codex":0.00026657368,"about_ca_topic_score_gemma":0.0000035196424,"teacher_disagreement_score":0.9929582,"about_ca_system_score_codex":0.000058931815,"about_ca_system_score_gemma":0.00013780725,"threshold_uncertainty_score":0.6559999},"labels":[],"label_agreement":null},{"id":"W2095163452","doi":"10.1182/blood-2007-03-078824","title":"Thrombin-thrombomodulin connects coagulation and fibrinolysis: more than an in vitro phenomenon","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; National Institutes of Health; National Institute of General Medical Sciences; Heart and Stroke Foundation of Canada","keywords":"Thrombomodulin; Thrombin; Plasmin; Fibrinolysis; Fibrin; Protein C; Coagulation; Chemistry; Immunology; Medicine; Pharmacology; Biochemistry; Internal medicine; Platelet; Enzyme","score_opus":0.02312998433334616,"score_gpt":0.28346127763637585,"score_spread":0.2603312933030297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095163452","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99702936,0.0002630905,0.0003961395,0.00030349413,0.00008713578,0.00043926638,0.00000514831,0.00012137429,0.0013550041],"genre_scores_gemma":[0.99694383,0.000026235366,0.002320921,0.00037700214,0.00014291429,0.000009030508,0.000092704824,0.000034852743,0.000052483203],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99854976,0.00004397933,0.00035957192,0.0004081465,0.00028774518,0.0003507926],"domain_scores_gemma":[0.99922335,0.000049453625,0.000098244964,0.00034155478,0.00006263789,0.00022475641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042137736,0.00019974798,0.00041595742,0.00024400723,0.000075979595,0.000029107632,0.00006429172,0.00015807322,0.000058792088],"category_scores_gemma":[0.00003275624,0.00019682477,0.000052152798,0.00031541864,0.000060935177,0.00018366429,0.000038845497,0.00016081143,0.000015039148],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016430972,0.0012187001,0.01795129,0.00005704249,0.00010130426,0.000048412825,0.0013874162,0.0000062461368,0.9740802,0.0018863538,0.000004274575,0.0030944387],"study_design_scores_gemma":[0.005660604,0.00039715535,0.45023268,0.00006393993,0.00021032512,0.00008664484,0.0007689743,0.00037629087,0.5406925,0.0012702643,0.00002985659,0.00021075079],"about_ca_topic_score_codex":0.000085886124,"about_ca_topic_score_gemma":0.000092573704,"teacher_disagreement_score":0.4333877,"about_ca_system_score_codex":0.000030711413,"about_ca_system_score_gemma":0.000037481397,"threshold_uncertainty_score":0.80262816},"labels":[],"label_agreement":null},{"id":"W2095203753","doi":"10.1182/blood-2009-06-225417","title":"Indirect inhibition of in vivo and in vitro T-cell responses by intravenous immunoglobulins due to impaired antigen presentation","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Héma-Québec","funders":"Université Laval","keywords":"Antigen; In vivo; Immunology; Antibody; Antigen presentation; Antigen-presenting cell; Polyclonal antibodies; In vitro; T cell; Medicine; Biology; Immune system; Biochemistry","score_opus":0.013646245469966728,"score_gpt":0.2823683123299617,"score_spread":0.26872206685999495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095203753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99686515,0.00093282206,0.0000047242074,0.0010024849,0.000011668982,0.00044209472,0.00006213163,0.00001108188,0.00066783075],"genre_scores_gemma":[0.99868387,0.00030793546,0.0004109873,0.00016822017,0.00002914746,0.0000094565185,0.000037505193,0.000007212409,0.0003456945],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99900824,0.000092748494,0.0002744432,0.0001828019,0.00022076412,0.00022099256],"domain_scores_gemma":[0.9996433,0.000082794526,0.000042807125,0.00010342713,0.000039378916,0.00008828681],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023342435,0.00009859602,0.00026790716,0.00027970265,0.000023903862,0.000009527379,0.00004222251,0.00006713879,0.000021618504],"category_scores_gemma":[0.00007959857,0.00008959322,0.00003109823,0.0003199629,0.000036677193,0.00005133662,0.000026713724,0.0001303513,0.0000039045226],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033648612,0.001104426,0.026124712,0.000059529157,0.000011358751,0.00020662673,0.0008541653,0.0000011825759,0.9648488,0.0000029545783,0.00018993503,0.0032314225],"study_design_scores_gemma":[0.0018569685,0.0006043064,0.32007846,0.00007622701,0.000008513255,0.000047541744,0.000075213284,0.000016041384,0.677016,0.000048586648,0.000111477624,0.000060660896],"about_ca_topic_score_codex":0.0006425123,"about_ca_topic_score_gemma":0.00006468531,"teacher_disagreement_score":0.29395375,"about_ca_system_score_codex":0.000022874989,"about_ca_system_score_gemma":0.00006651289,"threshold_uncertainty_score":0.36535054},"labels":[],"label_agreement":null},{"id":"W2095255852","doi":"10.1182/blood-2008-07-166439","title":"Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":272,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; St. Michael's Hospital","funders":"","keywords":"Medicine; Syk; Cytopenia; Refractory (planetary science); Thrombocytopenic purpura; Internal medicine; Platelet; Gastroenterology; Toxicity; Autoimmune hemolytic anemia; Immunology; Anemia","score_opus":0.06270308419405138,"score_gpt":0.3229006111517533,"score_spread":0.26019752695770193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095255852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955674,0.001799646,0.0000016498833,0.00004337517,0.000017387403,0.002180805,0.00014229552,0.000008643664,0.00023883185],"genre_scores_gemma":[0.9985144,0.0003850143,0.0006712466,0.00000870685,0.000011083141,0.00009374412,0.000098538985,0.000021710392,0.00019555316],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990653,0.000032733293,0.00038061268,0.00023954891,0.00013857296,0.0001432702],"domain_scores_gemma":[0.999306,0.000033360735,0.00018135963,0.00031561314,0.00008244968,0.000081222446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006161036,0.00015681637,0.0007773438,0.000048481295,0.000052084055,0.000004748094,0.00010387008,0.000033596123,0.000011130735],"category_scores_gemma":[0.000009818028,0.00011894408,0.000026387099,0.00008538928,0.000076968085,0.0001317761,0.000037465532,0.000019559911,4.618006e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002274189,0.19282773,0.03359056,0.0001197704,0.0014641916,0.00008728336,0.0021995767,1.6038217e-7,0.7652818,0.00002555727,0.000100661906,0.0020285014],"study_design_scores_gemma":[0.11709506,0.21737239,0.05539893,0.00006584969,0.0016067883,0.00013344514,0.0014652157,0.000021619904,0.6065378,0.00004598631,0.00006935782,0.00018753082],"about_ca_topic_score_codex":0.0009072525,"about_ca_topic_score_gemma":0.000059957245,"teacher_disagreement_score":0.15874399,"about_ca_system_score_codex":0.000015556296,"about_ca_system_score_gemma":0.00006707541,"threshold_uncertainty_score":0.48503986},"labels":[],"label_agreement":null},{"id":"W2095286549","doi":"10.1182/blood-2011-12-399683","title":"Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":239,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health; Leukemia and Lymphoma Research; U.S. Public Health Service; New York State Stem Cell Science; National Heart, Lung, and Blood Institute; U.S. Department of Defense","keywords":"Biology; Progenitor cell; Stem cell; Myelodysplastic syndromes; Myeloid; Epigenetics; Cancer research; Haematopoiesis; CD34; CD90; Immunology; Genetics; Bone marrow; Gene","score_opus":0.027211408439502576,"score_gpt":0.26049681042555756,"score_spread":0.233285401986055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095286549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98242605,0.016285775,0.00009905201,0.0001670102,0.00008134217,0.0008464435,0.000023218794,0.000028005075,0.000043107088],"genre_scores_gemma":[0.99359226,0.0028259144,0.00280623,0.00003560544,0.0001590042,0.00008702552,0.0000057532316,0.00003818199,0.00045003678],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985659,0.00008878323,0.0002750129,0.00035169616,0.00025373464,0.00046485907],"domain_scores_gemma":[0.99912655,0.0001593913,0.000043774406,0.00025188908,0.000046131598,0.00037225374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002115777,0.00019762665,0.000304989,0.00021245744,0.00009949839,0.000059848284,0.00005314204,0.0001083092,0.00004042457],"category_scores_gemma":[0.00002239847,0.0001694126,0.000020828105,0.00016759262,0.00014757576,0.00011460577,0.00009729267,0.00023170191,0.000016425083],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016695056,0.00088785414,0.40572178,0.00083336706,0.00015117065,0.00038701316,0.0028687818,0.000006579885,0.577389,0.00008920237,0.00023574696,0.01126258],"study_design_scores_gemma":[0.0074985153,0.00069857144,0.91127735,0.00027260184,0.00024304815,0.0007366357,0.00066005514,0.0009488023,0.07503754,0.000011518918,0.0022200642,0.0003952646],"about_ca_topic_score_codex":0.000016865491,"about_ca_topic_score_gemma":0.000009360907,"teacher_disagreement_score":0.5055556,"about_ca_system_score_codex":0.000048064383,"about_ca_system_score_gemma":0.00009553342,"threshold_uncertainty_score":0.6908445},"labels":[],"label_agreement":null},{"id":"W2095750011","doi":"10.1182/blood-2002-07-2287","title":"Discrimination of polycythemias and thrombocytoses by novel, simple, accurate clonality assays and comparison with PRV-1 expression and BFU-E response to erythropoietin","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"National Heart, Lung, and Blood Institute","keywords":"Polycythemia vera; Essential thrombocythemia; Erythropoiesis; Thrombocytosis; Biology; Haematopoiesis; Erythropoietin; Myelofibrosis; Immunology; Molecular biology; Bone marrow; Internal medicine; Stem cell; Genetics; Anemia; Medicine; Platelet","score_opus":0.024726970735725735,"score_gpt":0.3036710571190307,"score_spread":0.278944086383305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095750011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99705344,0.0010023374,0.00024278843,0.0008361535,0.000009910427,0.00053264725,0.00007550707,0.000015146368,0.00023206629],"genre_scores_gemma":[0.996268,0.00016527635,0.003305712,0.00010021379,0.000011073994,0.000046057936,0.000027681865,0.000015411502,0.000060572223],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99895215,0.000119188626,0.00023415538,0.0003229,0.00021382917,0.00015778533],"domain_scores_gemma":[0.9991726,0.00031034302,0.00011387505,0.00016075058,0.00007650204,0.00016587887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002714148,0.00018142533,0.00038784108,0.00005187852,0.000097878336,0.000027310296,0.000021417329,0.00006388656,0.000020324556],"category_scores_gemma":[0.00023769477,0.00012305091,0.000016603813,0.000090938534,0.000121083496,0.00007769128,0.00003504346,0.00007965904,5.6332726e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002136468,0.0023046776,0.56660926,0.00018801176,0.00014197244,0.00001314737,0.001983067,0.000001262989,0.42483687,0.00034226192,0.00092465413,0.00051832164],"study_design_scores_gemma":[0.0060809604,0.0018398435,0.36338118,0.000245691,0.0002423492,0.00008785887,0.00070020783,0.000011056711,0.6264152,0.000037782436,0.0008195334,0.00013833871],"about_ca_topic_score_codex":0.000041541603,"about_ca_topic_score_gemma":0.000036772235,"teacher_disagreement_score":0.20322812,"about_ca_system_score_codex":0.000016410702,"about_ca_system_score_gemma":0.000045699817,"threshold_uncertainty_score":0.501787},"labels":[],"label_agreement":null},{"id":"W2095961092","doi":"10.1182/blood-2014-05-571778","title":"Evidence of an oncogenic role of aberrant TOX activation in cutaneous T-cell lymphoma","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health; BC Cancer Agency","funders":"Canadian Institutes of Health Research; University of British Columbia; Mayo Clinic","keywords":"Cancer research; Gene knockdown; Lymphoma; Apoptosis; Biology; Cell growth; Cutaneous T-cell lymphoma; Carcinogenesis; Immunology; Cancer; Mycosis fungoides; Genetics","score_opus":0.020477796051345514,"score_gpt":0.29103862763063043,"score_spread":0.2705608315792849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095961092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996244,0.00050198,0.000032655927,0.00007492478,0.000012216922,0.0004101576,0.0000024418816,0.00001613883,0.0027054516],"genre_scores_gemma":[0.9992175,0.000086517066,0.00041984284,0.00004581409,0.000036049638,0.000016022504,0.000008025797,0.000021613883,0.0001486088],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985754,0.00013150835,0.00035487823,0.00025069644,0.00046067958,0.00022681903],"domain_scores_gemma":[0.9989445,0.00023442305,0.00012353851,0.00040006833,0.00020401999,0.00009345619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026373513,0.000120054734,0.00034909416,0.00019386142,0.000020613754,0.000005649187,0.00014678808,0.000093454684,0.000076676544],"category_scores_gemma":[0.00051970076,0.000111671914,0.00007070717,0.00029514448,0.000083989515,0.00008745227,0.000039347167,0.00007936312,0.000011144914],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007232298,0.0028650756,0.029113514,0.00023540785,0.000030535615,0.000026560965,0.0009095932,0.000022432363,0.94702613,0.000038718386,0.000005520027,0.01900327],"study_design_scores_gemma":[0.0044242376,0.0021461993,0.007614046,0.0004027479,0.000057247096,0.00042346862,0.00041177616,0.002267206,0.9818308,0.00026261114,0.000046887795,0.00011278293],"about_ca_topic_score_codex":0.00049423845,"about_ca_topic_score_gemma":0.0001340618,"teacher_disagreement_score":0.034804646,"about_ca_system_score_codex":0.000061797175,"about_ca_system_score_gemma":0.00026628512,"threshold_uncertainty_score":0.45538485},"labels":[],"label_agreement":null},{"id":"W2096000317","doi":"10.1182/blood-2011-02-336842","title":"Posttranscriptional deregulation of MYC via PTEN constitutes a major alternative pathway of MYC activation in T-cell acute lymphoblastic leukemia","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer","keywords":"PTEN; Carcinogenesis; Cancer research; PI3K/AKT/mTOR pathway; Biology; Effector; Context (archaeology); Protein kinase B; Leukemia; Signal transduction; Cancer; Cell biology; Genetics","score_opus":0.021285100350222456,"score_gpt":0.2458000022812814,"score_spread":0.22451490193105894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096000317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98335475,0.0000579114,0.010825443,0.000047478483,0.00007368071,0.0006027519,0.00007391719,0.000028320372,0.004935731],"genre_scores_gemma":[0.995048,0.000018519717,0.004453016,0.00005492108,0.00006709187,0.00003878906,0.00011147446,0.000029253131,0.00017896893],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99806327,0.000078142155,0.0006052351,0.00032913196,0.00061459857,0.00030963036],"domain_scores_gemma":[0.998718,0.00021280097,0.000275187,0.0002912973,0.000379255,0.000123434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022676033,0.00021221339,0.00045059543,0.00041103447,0.000033919518,0.000005576406,0.00017818037,0.00017586922,0.00022659742],"category_scores_gemma":[0.00014744487,0.0001928736,0.00011379736,0.0003954018,0.00029289647,0.00022308089,0.000054489865,0.00016891237,0.000020454068],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013667962,0.0014025378,0.013111602,0.0003157818,0.00040477634,0.00007648344,0.001999512,0.00004111745,0.97891015,0.0015120091,0.000048659993,0.00081056345],"study_design_scores_gemma":[0.01552626,0.0005875532,0.04880274,0.0003707377,0.00030660466,0.00010562457,0.000128248,0.0032515933,0.9296463,0.0010900499,0.000011800407,0.00017245921],"about_ca_topic_score_codex":0.00085965754,"about_ca_topic_score_gemma":0.000022497352,"teacher_disagreement_score":0.049263835,"about_ca_system_score_codex":0.00047559856,"about_ca_system_score_gemma":0.0013800736,"threshold_uncertainty_score":0.7865157},"labels":[],"label_agreement":null},{"id":"W2096480091","doi":"10.1182/blood-2006-05-021105","title":"The mutational spectrum of type 1 von Willebrand disease: results from a Canadian cohort study","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":351,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Queen's University","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada; CSL Behring Foundation for Research and Advancement of Patient Health","keywords":"Von Willebrand disease; Missense mutation; Genetics; Nonsense mutation; Von Willebrand factor; Biology; Mutation; Gene; Point mutation; Genotype; Immunology","score_opus":0.0054302067295300205,"score_gpt":0.2215359803572556,"score_spread":0.2161057736277256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096480091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933346,0.0005203909,1.955458e-7,0.0007104092,0.000050248564,0.00041504277,0.0002493763,0.000008672007,0.0047110897],"genre_scores_gemma":[0.9987448,0.00001513773,0.000015316407,0.000029273444,0.00005514169,0.000008816069,0.00040725997,0.0000071886934,0.00071705185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994238,0.000015118521,0.00014043896,0.00013007993,0.00016819852,0.00012237171],"domain_scores_gemma":[0.9996018,0.00005396088,0.000048561862,0.00016747095,0.000031976586,0.00009626852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000054532138,0.00006426436,0.000120047094,0.000030702406,0.000081689635,0.000008906853,0.000037442616,0.0000182712,0.00003380246],"category_scores_gemma":[0.000056768342,0.000042521384,0.000027314914,0.00008810019,0.000025622136,0.000014571429,0.000005336672,0.000037356982,0.000018042987],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028863334,0.0008400948,0.9968307,0.0000017083922,0.0002657633,0.0006104452,0.000055371867,0.0000049470505,0.0000128943375,0.000048254864,0.00095952675,0.00008166762],"study_design_scores_gemma":[0.005345083,0.00013779043,0.99249166,0.000010669113,0.00035080488,0.0000061505457,0.000047940044,0.000019085663,0.000067362416,0.00068163924,0.0008011204,0.00004068385],"about_ca_topic_score_codex":0.124533154,"about_ca_topic_score_gemma":0.1781807,"teacher_disagreement_score":0.053647544,"about_ca_system_score_codex":0.0000189128,"about_ca_system_score_gemma":0.00020245413,"threshold_uncertainty_score":0.88129663},"labels":[],"label_agreement":null},{"id":"W2096513091","doi":"10.1182/blood-2010-10-312454","title":"Comprehensive analysis of mammalian miRNA* species and their role in myeloid cells","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"","keywords":"microRNA; Myeloid leukemia; Biology; Myeloid; Stem cell; Cancer research; Gene; Cell biology; Genetics; Computational biology","score_opus":0.01233292309589133,"score_gpt":0.20251331995637928,"score_spread":0.19018039686048796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096513091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979942,0.0010834375,0.000032951273,0.000004141485,0.000010734416,0.00006394129,0.000037946298,0.0000023294556,0.00077031046],"genre_scores_gemma":[0.9994525,0.0000673032,0.0003114138,0.00001756685,0.000017210903,0.0000028219206,0.0000485141,0.0000057870334,0.000076930904],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999586,0.000027344791,0.000120054894,0.00014917669,0.000033053424,0.00008440536],"domain_scores_gemma":[0.9997024,0.000003887762,0.000046541612,0.00017926873,0.000036995087,0.000030894396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000030267283,0.00007199737,0.00012633919,0.00008257509,0.000010576105,0.0000035371108,0.00006446162,0.000055949073,0.00004046722],"category_scores_gemma":[0.000004141635,0.00006494188,0.00006234172,0.0001283564,0.000052005216,0.0000015015233,0.00004838847,0.000019785859,0.0000010132758],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019507755,0.000110438465,0.034399692,0.000011334824,0.00024650904,0.0000010521707,0.00023770046,0.000014974083,0.96480626,0.000016247279,0.0000121544335,0.00012412775],"study_design_scores_gemma":[0.00023296324,0.00002708136,0.35502306,0.00000258656,0.000105417086,7.131486e-7,0.00014816737,0.000022147631,0.6439257,0.00001973426,0.00044324205,0.000049136244],"about_ca_topic_score_codex":0.000056299672,"about_ca_topic_score_gemma":0.000119577446,"teacher_disagreement_score":0.3208805,"about_ca_system_score_codex":0.0000020530852,"about_ca_system_score_gemma":0.000010225059,"threshold_uncertainty_score":0.2648253},"labels":[],"label_agreement":null},{"id":"W2097160518","doi":"10.1182/blood-2009-08-238360","title":"Myeloid-specific inactivation of p15Ink4b results in monocytosis and predisposition to myeloid leukemia","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"National Cancer Institute; National Institutes of Health","keywords":"Myeloid leukemia; Monocytosis; Leukemia; Myeloid; Cancer research; Chronic myelomonocytic leukemia; RUNX1T1; Immunology; Biology; IRF8; Bone marrow; Medicine; Myelodysplastic syndromes; Gene; Genetics; Chromosomal translocation; Gene expression","score_opus":0.016485117287437068,"score_gpt":0.27291041167528896,"score_spread":0.2564252943878519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097160518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938171,0.000070341426,0.000076752556,0.0013603328,0.00007372267,0.0007425834,0.00003659973,0.000045712288,0.003776855],"genre_scores_gemma":[0.9948897,0.00015199483,0.0042028944,0.00011020542,0.00021294135,0.000059181766,0.00006797944,0.000030131234,0.00027496976],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99838984,0.000048620906,0.00045208476,0.00042052605,0.00037417654,0.000314729],"domain_scores_gemma":[0.9989004,0.00015090694,0.00010106429,0.00046484178,0.00017070002,0.0002120705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050763844,0.00016455518,0.00033586,0.00047297758,0.000049883693,0.000022457247,0.00012747703,0.00021648622,0.000028651932],"category_scores_gemma":[0.00040827252,0.00015653508,0.000043972526,0.00062026875,0.000092578346,0.00016688387,0.00010686485,0.00056929904,0.000023928804],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012799929,0.0002855656,0.010576392,0.00008778323,0.000035225825,0.00003183129,0.00096488034,0.0000061148635,0.97292566,0.00032546648,0.00082939136,0.012651709],"study_design_scores_gemma":[0.0071876384,0.00052277895,0.44181165,0.00014549494,0.00004108295,0.00006896388,0.00020021392,0.00016102096,0.54734224,0.000111685265,0.0022539177,0.0001532923],"about_ca_topic_score_codex":0.00029527943,"about_ca_topic_score_gemma":0.00011350167,"teacher_disagreement_score":0.43123525,"about_ca_system_score_codex":0.00024638756,"about_ca_system_score_gemma":0.00025125252,"threshold_uncertainty_score":0.63833153},"labels":[],"label_agreement":null},{"id":"W2097408234","doi":"10.1182/blood.v99.1.245","title":"Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":179,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"AGE-WELL","keywords":"Peripheral blood mononuclear cell; Medicine; Myeloid leukemia; Drug; Lymphoblastic Leukemia; Peripheral blood; Immunology; Myeloid; Leukemia; Pharmacology; In vitro; Biology","score_opus":0.00571626148610074,"score_gpt":0.20601559138740946,"score_spread":0.20029932990130872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097408234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982794,0.0005379808,0.000006543244,0.0001071385,0.000008981676,0.00079798937,0.00006915753,0.00004079679,0.00015201597],"genre_scores_gemma":[0.9978128,0.00085915945,0.0008206154,0.000050302915,0.000041814135,0.000021115016,0.000012337151,0.000052257972,0.00032960612],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982529,0.000113344926,0.0002874107,0.00051857834,0.0003581364,0.000469598],"domain_scores_gemma":[0.9992009,0.00006792656,0.00009548354,0.0002895647,0.000054826764,0.00029129925],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018010492,0.00032846615,0.0006636988,0.00019054094,0.000084433785,0.000043115975,0.00006675641,0.00012817075,0.000038894228],"category_scores_gemma":[0.00002045502,0.00024718212,0.000036214806,0.00017895405,0.00044080568,0.00014878552,0.00019066273,0.00037442637,0.0000030502476],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004281743,0.0006666774,0.93641436,0.00027218802,0.0009312849,0.0005070398,0.0014642536,0.0000057622333,0.058088355,0.000010526235,0.000040032,0.0011713735],"study_design_scores_gemma":[0.01521601,0.0010610488,0.94251615,0.00024383004,0.0008922523,0.008696879,0.000098401855,0.0022536903,0.02871849,0.000004737079,0.000003520746,0.00029501884],"about_ca_topic_score_codex":0.00038718997,"about_ca_topic_score_gemma":0.00006508191,"teacher_disagreement_score":0.029369865,"about_ca_system_score_codex":0.00008781215,"about_ca_system_score_gemma":0.00008913844,"threshold_uncertainty_score":0.99999803},"labels":[],"label_agreement":null},{"id":"W2097688270","doi":"10.1182/blood-2009-10-251124","title":"Enumeration of human antigen–specific naive CD8+ T cells reveals conserved precursor frequencies","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":171,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer; Ligue Contre le Cancer","keywords":"Epitope; Biology; Priming (agriculture); Antigen; Virology; CD8; Cytotoxic T cell; T cell; Streptamer; Immune system; Immunology; Molecular biology; Interleukin 21; Genetics","score_opus":0.015421595748173731,"score_gpt":0.23822243470430873,"score_spread":0.222800838956135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097688270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912307,0.006556336,0.000014615984,0.00007490887,0.0007924968,0.00028874277,0.000047969286,0.000057798305,0.0009364225],"genre_scores_gemma":[0.9953129,0.0003435646,0.00019414644,0.000052349955,0.000035971447,0.00001946854,0.00007174066,0.000020101592,0.0039497106],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987847,0.0002589927,0.00041105467,0.00022994826,0.000039209306,0.0002760488],"domain_scores_gemma":[0.9990397,0.00014725671,0.00022776864,0.0004432539,0.0001291529,0.000012866437],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032688765,0.00017830191,0.0003148309,0.000109314016,0.00024619856,0.000019021862,0.00026582283,0.00030049757,0.0011642082],"category_scores_gemma":[0.000053996093,0.00016353284,0.00012659146,0.00010702732,0.00033116096,0.00010878632,0.00003362844,0.00033946786,0.0002867272],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012561432,0.00039601966,0.0022675397,0.000013309707,0.00019638575,0.000002506751,0.00091215345,1.01782504e-7,0.9931042,0.001152283,0.0014745854,0.00035527014],"study_design_scores_gemma":[0.0018791304,0.0003248546,0.013092884,0.00003153808,0.000027121594,0.00003824421,0.0001566968,5.080788e-8,0.96411943,0.00022236444,0.019933084,0.00017461779],"about_ca_topic_score_codex":0.00008522924,"about_ca_topic_score_gemma":0.0000199652,"teacher_disagreement_score":0.028984817,"about_ca_system_score_codex":0.0000056413105,"about_ca_system_score_gemma":0.00006085339,"threshold_uncertainty_score":0.9997489},"labels":[],"label_agreement":null},{"id":"W2098230120","doi":"10.1182/blood-2007-03-079848","title":"Epitope specificity and isotype of monoclonal anti-D antibodies dictate their ability to inhibit phagocytosis of opsonized platelets","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hydrogenics (Canada); St. Michael's Hospital; University of Toronto; Canadian Blood Services","funders":"","keywords":"Phagocytosis; Antibody opsonization; Opsonin; Thrombocytopenic purpura; Antibody; Epitope; Isotype; Monoclonal antibody; Immune system; Immunology; Platelet; Biology; Molecular biology","score_opus":0.014423842266007954,"score_gpt":0.2530292199051111,"score_spread":0.23860537763910317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098230120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968776,0.0012929948,0.0001634903,0.00021851926,0.0000658852,0.0004239126,0.00006120743,0.000027942695,0.0008684306],"genre_scores_gemma":[0.99709266,0.0005551672,0.0021790387,0.00006192519,0.000070891794,0.0000018427348,0.000009561508,0.000016666725,0.000012214694],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99874884,0.000026042551,0.00046712015,0.0002893643,0.0002276523,0.00024099917],"domain_scores_gemma":[0.99921095,0.00012113702,0.00009861601,0.00026654272,0.0001500399,0.0001527035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047937882,0.00016877444,0.0005740532,0.00011877393,0.0000469484,0.0000055085725,0.00006866659,0.00010004479,0.000046042365],"category_scores_gemma":[0.000053210202,0.00013018797,0.00010411286,0.00024162878,0.00014395673,0.000053047137,0.000056050994,0.0001374674,0.0000028319098],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006918524,0.0013687932,0.35774973,0.00025731584,0.00013525155,0.000034833087,0.0009543197,7.94996e-7,0.62872756,0.000098903336,0.0000136250765,0.009967042],"study_design_scores_gemma":[0.002657109,0.00039282208,0.444318,0.0000941724,0.0001265475,0.000030012166,0.00009993281,0.000005190158,0.55201733,0.000094992465,0.00008665288,0.000077262266],"about_ca_topic_score_codex":0.00016820082,"about_ca_topic_score_gemma":0.000047701185,"teacher_disagreement_score":0.08656827,"about_ca_system_score_codex":0.0000071395707,"about_ca_system_score_gemma":0.00003124426,"threshold_uncertainty_score":0.5308911},"labels":[],"label_agreement":null},{"id":"W2099023168","doi":"10.1182/blood-2003-03-0971","title":"Fanconi anemia type C and p53 cooperate in apoptosis and tumorigenesis","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; University of Toronto","keywords":"Fanconi anemia; Carcinogenesis; Biology; Cancer research; Apoptosis; Haematopoiesis; Bone marrow failure; Bone marrow; Mutant; Myeloid; DNA damage; Myeloid leukemia; DNA repair; Immunology; Cancer; Cell biology; Stem cell; Genetics; Gene; DNA","score_opus":0.006169058428043523,"score_gpt":0.21328530397200673,"score_spread":0.2071162455439632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099023168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971127,0.0016355336,0.000013769615,0.000015197337,0.0000564609,0.00008422008,0.0000030801764,0.000007625714,0.001071424],"genre_scores_gemma":[0.99789643,0.0005716693,0.0010168381,0.000102815226,0.000023529441,0.000008544031,0.000007975259,0.000013333553,0.0003588601],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99946415,0.000037292102,0.000087508364,0.00023353014,0.00003826328,0.00013926734],"domain_scores_gemma":[0.9997504,0.0000044914677,0.000018794304,0.00014123638,0.000032768457,0.00005234515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010030088,0.00008929503,0.00009051247,0.000022575921,0.000027287924,0.000015318048,0.000038328635,0.000081950624,0.000010970886],"category_scores_gemma":[0.00007068976,0.0000874876,0.000010355072,0.00008305771,0.000026266334,0.0000019722906,0.00003387321,0.00003492432,0.0000034263883],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000111316485,0.000055424185,0.011711617,0.000013934351,0.0000130243925,0.0000045110046,0.00002189007,0.0000012126741,0.98756325,0.0002152179,0.00005844875,0.00033032516],"study_design_scores_gemma":[0.0007904268,0.00016836308,0.0018299716,0.0000063328926,0.000017961784,0.000033224125,0.000036501584,0.0000030025988,0.994371,0.000058287995,0.0025629501,0.00012195101],"about_ca_topic_score_codex":0.000011546328,"about_ca_topic_score_gemma":0.00002116585,"teacher_disagreement_score":0.009881645,"about_ca_system_score_codex":0.000002356082,"about_ca_system_score_gemma":0.000035322497,"threshold_uncertainty_score":0.35676408},"labels":[],"label_agreement":null},{"id":"W2099348828","doi":"10.1182/blood-2011-06-361972","title":"MicroRNA profiles of t(14;18)–negative follicular lymphoma support a late germinal center B-cell phenotype","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Circular RNAs in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Germinal center; microRNA; Biology; Phenotype; Follicular lymphoma; B cell; Molecular biology; Cell cycle; Gene expression; Lymphoma; Cancer research; Cell; Gene; Immunology; Genetics; Antibody","score_opus":0.012678555649485,"score_gpt":0.22519913648074108,"score_spread":0.21252058083125608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099348828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988778,0.00067817146,0.000054560245,0.0000062156582,0.00008453289,0.00023590362,0.0001293268,0.000014925546,0.010018366],"genre_scores_gemma":[0.9975273,0.00005894182,0.0014473574,0.00010238532,0.00009652171,0.000027477414,0.00012220748,0.000036240257,0.0005815545],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99893296,0.00005322531,0.00024373777,0.00035856257,0.00014359197,0.0002679459],"domain_scores_gemma":[0.9991616,0.000005853827,0.00015190248,0.00045155635,0.0001247932,0.0001043075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000788263,0.00019058598,0.00018783199,0.00004022565,0.00003903627,0.00000869194,0.00027082264,0.0001314221,0.00024949005],"category_scores_gemma":[0.0000485259,0.00018500198,0.00019745418,0.00007124964,0.000128181,0.0000047705817,0.00015045593,0.000040987514,0.000039777176],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001756939,0.00230411,0.0314045,0.00009686963,0.00026803004,0.00008058809,0.00023605715,5.026918e-7,0.9637588,0.00002953225,0.0011027759,0.0005425129],"study_design_scores_gemma":[0.002709668,0.00030145483,0.019174065,0.000019837478,0.00016090446,0.000034459863,0.000045632,0.0000012919427,0.97476286,0.00010758853,0.0024586779,0.00022359115],"about_ca_topic_score_codex":0.000027875785,"about_ca_topic_score_gemma":0.000006526123,"teacher_disagreement_score":0.012230434,"about_ca_system_score_codex":0.000006860003,"about_ca_system_score_gemma":0.0001206716,"threshold_uncertainty_score":0.75441617},"labels":[],"label_agreement":null},{"id":"W2099417620","doi":"10.1182/blood-2011-08-374363","title":"Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":278,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"National Institute of General Medical Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; University of Washington","keywords":"Haploinsufficiency; Lymphedema; Germline mutation; Frameshift mutation; GATA2; Germline; Biology; Cancer research; Mutation; Missense mutation; Genetics; Phenotype; Cancer; Haematopoiesis; Breast cancer; Gene; Stem cell","score_opus":0.01343896097475104,"score_gpt":0.22141934388863366,"score_spread":0.20798038291388263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099417620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971103,0.00075443974,0.000051043287,0.000037391557,0.000035756446,0.0015065809,0.000050274484,0.000018216047,0.00043598734],"genre_scores_gemma":[0.99830645,0.000008517784,0.0009481211,0.00019619525,0.000033993078,0.00023494329,0.00018835603,0.00002174694,0.00006168575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998857,0.000069642585,0.00037732592,0.00024933188,0.0002484812,0.00019818249],"domain_scores_gemma":[0.9992203,0.00015387134,0.00013860439,0.00031492242,0.00008939685,0.00008287303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021302655,0.00016052721,0.0003720657,0.00014144254,0.000043544907,0.000012188068,0.00008524405,0.00008175898,0.000024123941],"category_scores_gemma":[0.00012584715,0.000094019466,0.00005949558,0.00027399487,0.0000678979,0.00014940255,0.000020781228,0.000013032672,0.0000027189817],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001644492,0.0025415143,0.9919297,0.00085921725,0.00015898938,0.000069479815,0.0019778837,0.0000027077328,0.00002595022,0.00009419559,0.00003175942,0.0006640896],"study_design_scores_gemma":[0.01719467,0.0009738274,0.97947484,0.0004959643,0.00066881656,0.00014819036,0.00046370618,0.000037614103,0.00005439117,0.00035337152,0.000013811258,0.0001208094],"about_ca_topic_score_codex":0.00013341913,"about_ca_topic_score_gemma":0.000045075732,"teacher_disagreement_score":0.015550177,"about_ca_system_score_codex":0.000042448373,"about_ca_system_score_gemma":0.00020662419,"threshold_uncertainty_score":0.38340026},"labels":[],"label_agreement":null},{"id":"W2099568190","doi":"10.1182/blood-2004-06-2283","title":"The safety and efficacy of recombinant human blood coagulation factor IX in previously untreated patients with severe or moderately severe hemophilia B","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"City of Hope; Aflac","keywords":"Factor IX; Medicine; Coagulation; Coagulopathy; Blood coagulation factors; Recombinant DNA; Internal medicine; Gastroenterology; Surgery; Chemistry","score_opus":0.020644089489484003,"score_gpt":0.2739274084879788,"score_spread":0.2532833189984948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099568190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99771804,0.00021418052,0.0000010231932,0.00030274663,0.000020756619,0.0014018218,0.000016108826,0.000028887454,0.00029645546],"genre_scores_gemma":[0.9984719,0.0001994542,0.00008430547,0.000012264803,0.000015829808,0.00001567538,0.000097025244,0.000026274323,0.0010772679],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986215,0.0000642501,0.00034985782,0.00028874568,0.00035233868,0.00032328683],"domain_scores_gemma":[0.9992362,0.00011213204,0.00009851324,0.00029568106,0.0001489101,0.00010856621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012137792,0.0001991539,0.00035570684,0.00008823362,0.00019528756,0.000023709832,0.00007909087,0.000111068744,0.00003132535],"category_scores_gemma":[0.00007814448,0.000101711776,0.000042571854,0.0002684337,0.00010779975,0.000079040175,0.000040233517,0.0001806798,0.000003875623],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060814656,0.007139965,0.9756097,0.00027129403,0.0006067137,0.00017974754,0.0015043876,0.00008436045,0.00078811846,0.00013841395,0.000009856995,0.0075859847],"study_design_scores_gemma":[0.050695457,0.0028938209,0.94130653,0.0004916235,0.00027806955,0.000068473375,0.000045515826,0.000016748767,0.0038768542,0.00012333495,0.000037621598,0.0001659521],"about_ca_topic_score_codex":0.0001408506,"about_ca_topic_score_gemma":0.00021005933,"teacher_disagreement_score":0.04461399,"about_ca_system_score_codex":0.00006065463,"about_ca_system_score_gemma":0.00017094267,"threshold_uncertainty_score":0.41476858},"labels":[],"label_agreement":null},{"id":"W2100129763","doi":"10.1182/blood-2011-03-341909","title":"A pilot study of subcutaneous decitabine in β-thalassemia intermedia","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Decitabine; Thalassemia; Erythropoiesis; Molecular biology; DNA methyltransferase; Hemolysis; Hemoglobin; Fetal hemoglobin; Pharmacology; Biology; Internal medicine; Immunology; Medicine; Chemistry; Anemia; Methyltransferase; Genetics; DNA methylation; DNA; Fetus; Methylation; Gene; Gene expression","score_opus":0.023121007527275462,"score_gpt":0.24121563996557419,"score_spread":0.2180946324382987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100129763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98933464,0.00028444213,0.0000016801308,0.000027728765,0.00011061884,0.00041672512,0.0000013182283,0.000031077445,0.009791778],"genre_scores_gemma":[0.99959964,0.00006875184,0.000117489726,0.00004031634,0.000018994035,0.000013945493,0.0000023728956,0.000017769478,0.00012070006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913937,0.00002994035,0.00031430478,0.0001738998,0.00015110496,0.00019135898],"domain_scores_gemma":[0.99953675,0.000031359483,0.000059613038,0.0002461328,0.00004254231,0.00008361492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000098965385,0.00010905429,0.00027730624,0.00014236283,0.000012566111,0.0000019666056,0.0000860903,0.000044123142,0.00014582288],"category_scores_gemma":[0.00007766969,0.000086511944,0.000032959095,0.00023413954,0.00004442312,0.00002228536,0.000041031108,0.00020060438,0.00002202528],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012717689,0.038188603,0.9259736,0.00010900759,0.00025162217,0.0036329278,0.011672108,8.269759e-7,0.017291283,0.00004548908,0.00016362181,0.0013991195],"study_design_scores_gemma":[0.040879365,0.05988122,0.86641026,0.0006448934,0.000957324,0.0017790004,0.018341947,0.000044808774,0.0102713145,0.00023080426,0.00010361862,0.00045544325],"about_ca_topic_score_codex":0.00053098117,"about_ca_topic_score_gemma":0.0002500973,"teacher_disagreement_score":0.059563365,"about_ca_system_score_codex":0.000012377319,"about_ca_system_score_gemma":0.00004348432,"threshold_uncertainty_score":0.35278547},"labels":[],"label_agreement":null},{"id":"W2100222319","doi":"10.1182/blood-2008-10-167643","title":"Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention","year":2009,"lang":"en","type":"review","venue":"Blood","topic":"Blood donation and transfusion practices","field":"Business, Management and Accounting","cited_by":621,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Canadian Blood Services","funders":"","keywords":"Medicine; Blood transfusion; Intensive care medicine; Transfusion reaction; Internal medicine","score_opus":0.09924980783555508,"score_gpt":0.3261835176572381,"score_spread":0.22693370982168298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100222319","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004694631,0.9809835,0.00020286923,0.00047183177,0.0002508109,0.004002651,0.00003652809,0.0001189066,0.009238303],"genre_scores_gemma":[0.0056883553,0.9929562,0.00005767951,0.00019323788,0.00031342922,0.0003118773,0.00013333015,0.000065442626,0.00028042318],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973401,0.00021042295,0.0011450492,0.00057391514,0.0004016475,0.00032887424],"domain_scores_gemma":[0.9975329,0.0007227399,0.0009953638,0.00053284393,0.00019735043,0.000018802708],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023032092,0.0005452883,0.0012677854,0.00023895601,0.0006604585,0.0005035928,0.00056072883,0.00036976117,0.00033744556],"category_scores_gemma":[0.000091216556,0.00028570744,0.0008521003,0.00063473755,0.00023300394,0.0008851595,0.000057785717,0.00049770024,0.000023960352],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000113245085,0.0015888179,0.000065920154,0.015580263,0.002994409,0.0000056822237,0.0004512088,0.000010212856,0.00004481707,0.05419239,0.00019055774,0.9247625],"study_design_scores_gemma":[0.009244587,0.00009714292,0.00010102665,0.004779347,0.03179676,0.00004951365,0.000743448,0.00012822621,0.000034507204,0.014304803,0.9380323,0.0006883078],"about_ca_topic_score_codex":0.0005470242,"about_ca_topic_score_gemma":0.00052616076,"teacher_disagreement_score":0.9378418,"about_ca_system_score_codex":0.000005122862,"about_ca_system_score_gemma":0.00018264452,"threshold_uncertainty_score":0.9999595},"labels":[],"label_agreement":null},{"id":"W2100394072","doi":"10.1182/blood-2003-10-3583","title":"Expression of SMRTβ promotes ligand-induced activation of mutated and wild-type retinoid receptors","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Corepressor; Nuclear receptor; Biology; Transcription factor; Retinoid X receptor; Cell biology; Retinoid X receptor alpha; Retinoid X receptor gamma; Receptor; Gene isoform; Molecular biology; Cancer research; Biochemistry; Gene","score_opus":0.008302450941122516,"score_gpt":0.2276617420859426,"score_spread":0.21935929114482006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100394072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989992,0.00042955342,0.000091618494,0.000021825706,0.000043818516,0.000120618315,0.000001738743,0.0000084004405,0.00028324127],"genre_scores_gemma":[0.99869287,0.00022432653,0.0009207556,0.000010752601,0.000050181883,0.0000043336204,0.000046207082,0.000013409786,0.000037160535],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993825,0.000025326706,0.00019157006,0.00019983554,0.000100415156,0.000100343495],"domain_scores_gemma":[0.99951065,0.000007872715,0.00015057516,0.00017242818,0.00012490309,0.000033554792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009151444,0.00009824673,0.00012939924,0.000030090037,0.000029870826,0.0000051421107,0.00008498789,0.00015325882,0.000004215718],"category_scores_gemma":[0.00017563494,0.00008623133,0.00003111449,0.00010438152,0.000058154583,0.0000051356865,0.00004883391,0.000056122226,4.6902124e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000064095235,0.00014054368,0.00211211,0.000097544136,0.000021276583,5.7999e-7,0.00012848731,0.00000745937,0.99698865,0.000011836339,0.000014854163,0.0004125639],"study_design_scores_gemma":[0.0010705324,0.0005376905,0.0005113402,0.00011337737,0.000025895324,0.0000070068204,0.00007186441,8.499454e-7,0.9973271,0.00014711279,0.00009158508,0.000095655836],"about_ca_topic_score_codex":0.000013748901,"about_ca_topic_score_gemma":6.0153695e-7,"teacher_disagreement_score":0.0016007697,"about_ca_system_score_codex":0.0000038334147,"about_ca_system_score_gemma":0.00008587205,"threshold_uncertainty_score":0.35164118},"labels":[],"label_agreement":null},{"id":"W2100411523","doi":"10.1182/blood-2013-08-519009","title":"Prospective cohort study comparing intravenous busulfan to total body irradiation in hematopoietic cell transplantation","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Otsuka Pharmaceutical Development and Commercialization; National Institutes of Health; National Cancer Institute; National Heart, Lung, and Blood Institute; Fonds National de la Recherche Luxembourg","keywords":"Medicine; Total body irradiation; Busulfan; Internal medicine; Cumulative incidence; Transplantation; Gastroenterology; Prospective cohort study; Cohort; Surgery; Hematopoietic stem cell transplantation; Confidence interval; Chemotherapy; Cyclophosphamide","score_opus":0.008377339142267367,"score_gpt":0.2355232198843737,"score_spread":0.22714588074210632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100411523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884648,0.000025195593,0.00054933905,0.00009598571,0.00009115695,0.005291912,0.0000041935336,0.0000978877,0.0053795474],"genre_scores_gemma":[0.9982743,0.000011369254,0.00078048994,0.00005085892,0.00006377729,0.0006208537,0.000058258967,0.000036757596,0.00010332427],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982373,0.00007450142,0.00050950056,0.00043815584,0.00041450336,0.00032601517],"domain_scores_gemma":[0.9993156,0.00006521698,0.0000770124,0.00026000774,0.00009976576,0.00018236907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024801667,0.00021249213,0.0004335214,0.0002505735,0.00005821646,0.00004374103,0.00007615873,0.00008669274,0.0001173795],"category_scores_gemma":[0.000017404423,0.00021335801,0.000048548434,0.00038725592,0.000018009981,0.0001415672,0.000009210565,0.00019816012,0.00033967986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007732723,0.002484056,0.961959,0.0003073424,0.00005911679,0.000118279335,0.01221345,0.000079092795,0.022572128,0.000031765132,0.000008272979,0.000090146175],"study_design_scores_gemma":[0.0056507452,0.0006567537,0.96953285,0.000145065,0.00034856668,0.00024316616,0.00137004,0.00020321255,0.021600911,0.000040801307,7.193524e-7,0.00020717358],"about_ca_topic_score_codex":0.00081280683,"about_ca_topic_score_gemma":0.00012195146,"teacher_disagreement_score":0.01084341,"about_ca_system_score_codex":0.000096855874,"about_ca_system_score_gemma":0.00006035604,"threshold_uncertainty_score":0.8700487},"labels":[],"label_agreement":null},{"id":"W2100895205","doi":"10.1182/blood-2002-10-3176","title":"IgE alone stimulates mast cell adhesion to fibronectin via pathways similar to those used by IgE + antigen but distinct from those used by Steel factor","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"University of California, San Diego; National Institute of General Medical Sciences; University of British Columbia","keywords":"Immunoglobulin E; Cell biology; Mast cell; Immunology; Chemistry; Biology; Antibody","score_opus":0.016507719820222796,"score_gpt":0.21804576024412423,"score_spread":0.20153804042390144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100895205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988872,0.0042218487,0.00071764324,0.00009602671,0.00043946388,0.00082350307,0.003964411,0.00016220186,0.0007029095],"genre_scores_gemma":[0.9908069,0.000053263473,0.00072101696,0.00017467164,0.0000456495,0.000036881578,0.0012515611,0.000085199084,0.0068249074],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973095,0.0003087887,0.00056217436,0.0008837059,0.000119062846,0.0008167634],"domain_scores_gemma":[0.99853384,0.00031103738,0.0001836559,0.000703032,0.00006509481,0.00020333726],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00017441482,0.0005408068,0.00071377977,0.00011149859,0.00033881076,0.00005612939,0.00039081846,0.00044835397,0.0029648703],"category_scores_gemma":[0.00009728322,0.0004955821,0.00016674562,0.00021156414,0.00007615699,0.00009126002,0.00015761607,0.00034287915,0.0014968299],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016903131,0.001429026,0.007610313,0.00003056717,0.000119544864,0.000024195517,0.0017096568,0.0000050196245,0.98144245,0.00000776442,0.0070418506,0.00041056614],"study_design_scores_gemma":[0.004008215,0.00076103094,0.004403675,0.00005608662,0.00009918977,0.000005357964,0.00029194506,0.0000036707036,0.8934552,0.00001880793,0.09628767,0.00060913403],"about_ca_topic_score_codex":0.0010842287,"about_ca_topic_score_gemma":0.00021938099,"teacher_disagreement_score":0.08924582,"about_ca_system_score_codex":0.000044178683,"about_ca_system_score_gemma":0.000051917854,"threshold_uncertainty_score":0.9997496},"labels":[],"label_agreement":null},{"id":"W210102231","doi":"10.1182/blood.v96.6.2233","title":"Ligand-inducible interaction of the DRIP/TRAP coactivator complex with retinoid receptors in retinoic acid–sensitive and –resistant acute promyelocytic leukemia cells","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Retinoid X receptor; Promyelocytic leukemia protein; Transcription factor; Biology; Nuclear receptor; Retinoic acid; Acute promyelocytic leukemia; Cell biology; Coactivator; Retinoid; Fusion protein; Retinoic acid receptor; Biochemistry; Molecular biology; Gene; Recombinant DNA","score_opus":0.006812133623443235,"score_gpt":0.21323546549415942,"score_spread":0.20642333187071618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W210102231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967961,0.00019382707,0.000011973133,0.00005841008,0.00006170066,0.00032812188,0.000014020631,0.000011309345,0.0025245708],"genre_scores_gemma":[0.99843407,0.00033893285,0.00035797467,0.00007075201,0.00007465104,0.000022362723,0.00003201046,0.00002856995,0.0006406732],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987298,0.00011273586,0.0002868453,0.0004409667,0.00017874302,0.00025086533],"domain_scores_gemma":[0.999308,0.000019621113,0.00016160072,0.0003701553,0.00008050279,0.00006010274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015342711,0.00021624113,0.00023635518,0.000041002295,0.000090190675,0.000027095846,0.00018321833,0.00017154332,0.000028760773],"category_scores_gemma":[0.000027549355,0.00015569785,0.000061885316,0.00021343376,0.0002224569,0.000010966538,0.000061809784,0.00021622075,0.0000029164448],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047543374,0.00009983745,0.0016569657,0.00006585642,0.00009548048,0.000010863896,0.00025015924,0.000018239998,0.9965629,0.000007304607,0.00014302462,0.0006139622],"study_design_scores_gemma":[0.0014390595,0.00046585084,0.0026355262,0.00013724752,0.000099017816,0.00007755355,0.0002828966,0.000017904737,0.9925398,0.000015402868,0.0020816054,0.00020813965],"about_ca_topic_score_codex":0.00005040159,"about_ca_topic_score_gemma":0.000034674515,"teacher_disagreement_score":0.0040230765,"about_ca_system_score_codex":0.00004665664,"about_ca_system_score_gemma":0.00022919795,"threshold_uncertainty_score":0.6349174},"labels":[],"label_agreement":null},{"id":"W2101141932","doi":"10.1182/blood-2012-03-417253","title":"Prediagnosis biomarkers of insulin-like growth factor-1, insulin, and interleukin-6 dysregulation and multiple myeloma risk in the Multiple Myeloma Cohort Consortium","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; National Cancer Institute; National Heart, Lung, and Blood Institute; National Institutes of Health; American Cancer Society","keywords":"Multiple myeloma; Medicine; Monoclonal gammopathy of undetermined significance; Internal medicine; Biomarker; Odds ratio; Cohort; Immunology; Oncology; Gastroenterology; Monoclonal; Antibody; Biology; Monoclonal antibody","score_opus":0.01878017910811322,"score_gpt":0.26407504714871344,"score_spread":0.24529486804060022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101141932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948776,0.002726012,0.000017299439,0.00015050174,0.000096819305,0.0016856433,0.00021384997,0.000043346416,0.00018892332],"genre_scores_gemma":[0.997209,0.001471767,0.0008508516,0.00006493991,0.000102498954,0.00013422717,0.00011630662,0.00003520664,0.000015199219],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99767137,0.00032140367,0.0005406654,0.00041199,0.00050499797,0.0005495539],"domain_scores_gemma":[0.99764407,0.0012399044,0.00022488847,0.00041957616,0.00014653643,0.00032500413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006025901,0.0003083485,0.00048734233,0.00030478032,0.0001243762,0.000035728346,0.00013870896,0.00018492177,0.000025821477],"category_scores_gemma":[0.001575873,0.0002192079,0.000090619855,0.00035873934,0.00033049608,0.00026750498,0.00012986103,0.00027946796,0.000007842532],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006382668,0.0015492241,0.9810341,0.00015715837,0.00057906966,0.000034490637,0.0020371834,3.4897653e-7,0.0036649478,0.000012856406,0.00006441912,0.010227926],"study_design_scores_gemma":[0.012946682,0.00050893245,0.968681,0.00011772634,0.00030640082,0.00009246066,0.0005793488,0.00060186663,0.01583834,0.000024143299,0.00011761481,0.00018551484],"about_ca_topic_score_codex":0.0011330735,"about_ca_topic_score_gemma":0.0003583018,"teacher_disagreement_score":0.012353139,"about_ca_system_score_codex":0.000052720356,"about_ca_system_score_gemma":0.00005840409,"threshold_uncertainty_score":0.8939039},"labels":[],"label_agreement":null},{"id":"W2101413395","doi":"10.1182/blood-2005-02-0802","title":"Cellular prion protein is released on exosomes from activated platelets","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Prion Diseases and Protein Misfolding","field":"Biochemistry, Genetics and Molecular Biology","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Canadian Science Centre for Human and Animal Health","funders":"","keywords":"Microvesicles; Platelet; Cell biology; Biology; Transmissible spongiform encephalopathy; Immunology; microRNA; Prion protein; Scrapie; Disease; Medicine; Biochemistry; Gene; Pathology","score_opus":0.005230966054719632,"score_gpt":0.19796327198952438,"score_spread":0.19273230593480475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101413395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948527,0.0039469423,0.00009077078,0.00013760624,0.000034991022,0.00032043245,0.00006540941,0.000033728636,0.0005173919],"genre_scores_gemma":[0.99822134,0.00012691645,0.00037442383,0.00019669709,0.00033799378,0.000039859926,0.00033949592,0.000027705848,0.00033556984],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990686,0.000044054632,0.000154678,0.0003748325,0.00014401041,0.00021379274],"domain_scores_gemma":[0.9994668,0.00000688074,0.00007866711,0.00034685511,0.00003002512,0.000070775175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004303615,0.00016138064,0.000115276576,0.000029528965,0.00007979522,0.000031297062,0.00014429033,0.00016001615,0.00012948543],"category_scores_gemma":[0.00002729641,0.00015413319,0.000098316654,0.0000621246,0.000021770888,0.0000033483846,0.000050496845,0.00007902675,0.00004519303],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011661773,0.00028212956,0.0005547562,0.000009503734,0.000046399975,0.000019308556,0.0000056779536,0.000004387249,0.9949294,0.00003847846,0.00067222246,0.0033211568],"study_design_scores_gemma":[0.0013837912,0.0001630218,0.0016393987,0.000039302984,0.000025787856,0.0000012007719,0.0000052111495,0.0000071706827,0.9699528,0.0003534471,0.026226625,0.00020220781],"about_ca_topic_score_codex":0.00015897515,"about_ca_topic_score_gemma":0.0000044937756,"teacher_disagreement_score":0.025554402,"about_ca_system_score_codex":0.000007083875,"about_ca_system_score_gemma":0.00004012899,"threshold_uncertainty_score":0.62853694},"labels":[],"label_agreement":null},{"id":"W2101642059","doi":"10.1182/blood.v96.9.3029","title":"Generation of murine dendritic cells from flt3-ligand–supplemented bone marrow cultures","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":437,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research & Development Corporation","funders":"","keywords":"Biology; CD40; Bone marrow; CD11c; CD86; Dendritic cell; CD80; CD8; Immunology; MHC class II; Population; Follicular dendritic cells; Major histocompatibility complex; Antigen; Myeloid; Cytotoxic T cell; Antigen-presenting cell; T cell; Immune system; In vitro; Phenotype; Medicine","score_opus":0.01248712909344847,"score_gpt":0.23355049083647103,"score_spread":0.22106336174302255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101642059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826996,0.016049111,0.000013352039,0.000104047176,0.00027708,0.00017260613,0.00024077043,0.00004318398,0.00040029045],"genre_scores_gemma":[0.9901485,0.0011856948,0.00019873239,0.00013657984,0.000066187386,0.000018096283,0.0010078931,0.000017721353,0.00722062],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99897856,0.00018246088,0.000350946,0.00020525142,0.00004118528,0.00024162342],"domain_scores_gemma":[0.99953216,0.00006175043,0.000080085665,0.0002801301,0.000034736066,0.000011140974],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000102276295,0.00016012223,0.00026340713,0.000056871784,0.00012761122,0.000013458183,0.00016108007,0.00016650742,0.0110807065],"category_scores_gemma":[0.000011602393,0.00013978909,0.00008227323,0.00007777342,0.00010524926,0.000072543844,0.000021867803,0.00013400525,0.0004333054],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029644073,0.0005269007,0.00017827541,0.000007470531,0.0003145618,0.000006282879,0.00032472206,0.0000036649574,0.9907747,0.000031732976,0.004199575,0.003335685],"study_design_scores_gemma":[0.003818589,0.00020022644,0.0012194391,0.000022072367,0.000106673804,0.00003068182,0.000059533308,0.0000018882376,0.9124429,0.000021131369,0.08193425,0.0001426081],"about_ca_topic_score_codex":0.00037794802,"about_ca_topic_score_gemma":0.000039265364,"teacher_disagreement_score":0.07833178,"about_ca_system_score_codex":0.0000074795785,"about_ca_system_score_gemma":0.000028648015,"threshold_uncertainty_score":0.9898233},"labels":[],"label_agreement":null},{"id":"W2101725260","doi":"10.1182/blood-2014-03-560557","title":"Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":229,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cytarabine; Hazard ratio; Internal medicine; Adverse effect; Myeloid leukemia; Confidence interval; Surgery; Oncology","score_opus":0.030154932912024094,"score_gpt":0.32413933032379777,"score_spread":0.2939843974117737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101725260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938821,0.000025484891,0.00030730825,0.00021438561,0.00009892357,0.005262757,0.000016869342,0.000027940152,0.00016422091],"genre_scores_gemma":[0.99693227,0.000056685523,0.0010914825,0.00014182742,0.00029424968,0.00057112536,0.0000880773,0.0000460073,0.00077827007],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998211,0.00021276952,0.0004914525,0.00030157843,0.00043695502,0.00034620828],"domain_scores_gemma":[0.9986404,0.00040969052,0.00018611479,0.00035482677,0.00028819952,0.00012077834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012902955,0.00018597781,0.00089895475,0.0002286395,0.000039981504,0.0000119430415,0.00011527535,0.00013033459,0.000060138773],"category_scores_gemma":[0.0011696962,0.00011155688,0.000108782915,0.00029708003,0.00012618976,0.000121781,0.000021778558,0.00023885249,0.0000055274527],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9745785,0.0052041765,0.0031743147,0.00011724603,0.00018918513,0.000004272568,0.0002649832,0.0000032092244,0.011090571,0.00001304485,0.00013576687,0.0052247043],"study_design_scores_gemma":[0.9099881,0.009139423,0.000576076,0.00012488558,0.00014773036,0.0000063932403,0.000033929256,0.0009096797,0.07860799,0.000016469712,0.0003268542,0.00012244281],"about_ca_topic_score_codex":0.00022277691,"about_ca_topic_score_gemma":0.00004970959,"teacher_disagreement_score":0.06751742,"about_ca_system_score_codex":0.00007167898,"about_ca_system_score_gemma":0.0003265843,"threshold_uncertainty_score":0.45491576},"labels":[],"label_agreement":null},{"id":"W2102016263","doi":"10.1182/blood.v97.1.107","title":"Systemic delivery of an adenoviral vector encoding canine factor VIII results in short-term phenotypic correction, inhibitor development, and biphasic liver toxicity in hemophilia A dogs","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Genetic enhancement; Viral vector; Vector (molecular biology); Toxicity; Factor IX; Medicine; Antibody; Coagulation; Immunology; In vivo; Internal medicine; Pharmacology; Biology; Recombinant DNA; Gene; Biochemistry","score_opus":0.020253987706931025,"score_gpt":0.2641029640979544,"score_spread":0.2438489763910234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102016263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983157,0.0011764412,0.000007397007,0.000008433511,0.00009629707,0.00030735543,0.000029321269,0.000011356759,0.00004770246],"genre_scores_gemma":[0.99929076,0.00028964772,0.0000758213,0.000019329196,0.00012945328,0.000025427313,0.00006443269,0.000022957687,0.000082188795],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985397,0.00012846285,0.00040791833,0.00043531455,0.00017453871,0.00031407556],"domain_scores_gemma":[0.9995004,0.000020467118,0.000059130336,0.0002475782,0.00007515626,0.00009726541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027459176,0.00018161177,0.00022560928,0.0001871714,0.00005013617,0.000017733335,0.0001653394,0.00016493862,0.000010154566],"category_scores_gemma":[0.0000583234,0.0001860926,0.00003120673,0.0002528729,0.000060374492,0.000014914658,0.000089434456,0.00015124293,0.0000024153132],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017954963,0.0002803702,0.08338724,0.000042617008,0.00003170597,0.000047413458,0.00057301373,0.00002076523,0.9091851,4.331508e-7,0.000009784522,0.0046260217],"study_design_scores_gemma":[0.0028387967,0.0010001726,0.09774686,0.00011373701,0.00000881918,0.00007722604,0.000090808164,0.00008757418,0.8977823,9.2395527e-7,0.0000316268,0.00022113287],"about_ca_topic_score_codex":0.00023060579,"about_ca_topic_score_gemma":0.008502907,"teacher_disagreement_score":0.014359612,"about_ca_system_score_codex":0.00006267168,"about_ca_system_score_gemma":0.0002036339,"threshold_uncertainty_score":0.75886357},"labels":[],"label_agreement":null},{"id":"W2102243498","doi":"10.1182/blood.v100.7.2522","title":"Biphasic transmittance waveform in the APTT coagulation assay is due to the formation of a Ca++-dependent complex of C-reactive protein with very-low–density lipoprotein and is a novel marker of impending disseminated intravascular coagulation","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; National Institutes of Health; Heart and Stroke Foundation of Canada","keywords":"Very low-density lipoprotein; Internal medicine; Lipoprotein; C-reactive protein; Chemistry; Endocrinology; Disseminated intravascular coagulation; Cholesterol; Medicine; Inflammation","score_opus":0.021315459340221284,"score_gpt":0.23754717959788274,"score_spread":0.21623172025766146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102243498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98343503,0.000066684894,0.01283275,0.0010431941,0.000011874059,0.00240296,0.000041422718,0.000011703095,0.00015436663],"genre_scores_gemma":[0.99872726,0.0000066678554,0.0009959182,0.000119924,0.00001550697,0.00007209202,0.00002944212,0.000016881648,0.000016328397],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983516,0.00010959547,0.000527748,0.00022447755,0.0006141465,0.00017245261],"domain_scores_gemma":[0.9989338,0.00007218342,0.000362629,0.0003562772,0.00022491287,0.000050207476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007402911,0.00018220505,0.00044124242,0.00017640484,0.000071485774,0.000013604376,0.00010921525,0.00010315677,0.0000615528],"category_scores_gemma":[0.0000510194,0.000115361065,0.000074523035,0.00051855977,0.00007298019,0.00019073662,0.000022063474,0.00015393537,0.0000014076759],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059608696,0.0015442251,0.0043122303,0.00063766044,0.0003161039,0.000008191054,0.024350155,0.000058620128,0.95925725,0.001183427,0.000015152668,0.0077209286],"study_design_scores_gemma":[0.004397824,0.00053126254,0.28033456,0.0006679275,0.00032642693,0.00010748293,0.0013300854,0.022747304,0.6892385,0.0001673814,0.000007965011,0.00014328094],"about_ca_topic_score_codex":0.00043152165,"about_ca_topic_score_gemma":0.00027686195,"teacher_disagreement_score":0.27602232,"about_ca_system_score_codex":0.00003606062,"about_ca_system_score_gemma":0.000020914948,"threshold_uncertainty_score":0.47042876},"labels":[],"label_agreement":null},{"id":"W2102750142","doi":"10.1182/blood-2002-01-0008","title":"A molecular compendium of genes expressed in multiple myeloma","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":186,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Biology; Gene; Expressed sequence tag; Microarray; Genetics; Computational biology; Complementary DNA; Gene expression","score_opus":0.03476847430627687,"score_gpt":0.2740630524604476,"score_spread":0.2392945781541707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102750142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99490494,0.0016313284,0.000016666276,0.000120274686,0.000014855029,0.0003623887,0.000020250125,0.000023355193,0.0029059537],"genre_scores_gemma":[0.9981617,0.0001061525,0.0014510523,0.000030935556,0.000021161492,0.000040469793,0.000018653374,0.000015729562,0.00015417338],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990785,0.000039809962,0.0001903544,0.0001814339,0.00025972186,0.00025019457],"domain_scores_gemma":[0.9994555,0.00005812574,0.000036688063,0.00028110447,0.000042844935,0.00012573038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004965527,0.000102176535,0.00024169408,0.00013689656,0.00001820306,0.000004973893,0.00007758975,0.0000504917,0.00027130992],"category_scores_gemma":[0.0000916609,0.00008729283,0.00007022508,0.00015840406,0.00004704451,0.00003008682,0.000038754162,0.00008270682,0.00006568582],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012593345,0.0033129726,0.54764575,0.00012294011,0.00016643241,0.0013767981,0.00018574686,0.000007081555,0.44041768,0.00003194728,0.00007225115,0.006534455],"study_design_scores_gemma":[0.016816169,0.00033239071,0.26555714,0.00009758784,0.000059094054,0.000047302932,0.000046441768,0.0018436152,0.71458757,0.000019718507,0.00049284153,0.000100152836],"about_ca_topic_score_codex":0.00011920452,"about_ca_topic_score_gemma":0.000024905545,"teacher_disagreement_score":0.2820886,"about_ca_system_score_codex":0.000013589812,"about_ca_system_score_gemma":0.000016186068,"threshold_uncertainty_score":0.35596982},"labels":[],"label_agreement":null},{"id":"W2102838512","doi":"10.1182/blood-2014-01-512723","title":"Role of phenotypic and genetic testing in managing clopidogrel therapy","year":2014,"lang":"en","type":"review","venue":"Blood","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; McMaster University; Population Health Research Institute","funders":"","keywords":"Prasugrel; Clopidogrel; Ticagrelor; P2Y12; Medicine; CYP2C19; Loading dose; Intensive care medicine; Internal medicine; Pharmacology; Aspirin","score_opus":0.024679709816329835,"score_gpt":0.27450379482731974,"score_spread":0.2498240850109899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102838512","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0116186375,0.98721206,0.00001083962,0.0000025196691,0.000019164896,0.000487072,0.0000030790075,0.000023641494,0.00062300643],"genre_scores_gemma":[0.0029127432,0.99627626,0.0005093824,0.000025673586,0.00017031227,0.00003047632,0.000012747529,0.000044881835,0.000017547802],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989451,0.00010960129,0.0003575787,0.00026653337,0.00014856328,0.00017263464],"domain_scores_gemma":[0.999358,0.00009462824,0.0001401149,0.0003183739,0.000025725643,0.000063145606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014964199,0.0002236111,0.0013795878,0.00014818137,0.000020919111,0.000007601632,0.000082578365,0.00013313933,0.000011038552],"category_scores_gemma":[0.00003628428,0.00017458634,0.00034905007,0.00021296334,0.00004882129,0.000013534266,0.000028720475,0.00016495219,0.0000051018105],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008354272,0.00012045899,0.0021641625,0.007307062,0.00053568126,0.000041673142,0.000021497151,3.5864e-7,0.000007960529,0.000012517672,0.000001230743,0.98977906],"study_design_scores_gemma":[0.007395084,0.0004791929,0.013465177,0.04506084,0.0068747927,0.0011466849,0.00004666397,0.000026520887,0.000033031632,0.00041170447,0.9243601,0.0007001851],"about_ca_topic_score_codex":0.000014938677,"about_ca_topic_score_gemma":8.8624535e-7,"teacher_disagreement_score":0.9890789,"about_ca_system_score_codex":0.0000071389272,"about_ca_system_score_gemma":0.00008179569,"threshold_uncertainty_score":0.71194243},"labels":[],"label_agreement":null},{"id":"W2103651203","doi":"10.1182/blood-2012-06-439570","title":"Gene expression profiling of microdissected Hodgkin Reed-Sternberg cells correlates with treatment outcome in classical Hodgkin lymphoma","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Defense Advanced Research Projects Agency; Canadian Institutes of Health Research; Pennsylvania State University; National Science Foundation","keywords":"Reed–Sternberg cell; CD68; Gene expression profiling; Biology; In situ hybridization; Gene signature; Lymphoma; Cancer research; Phenotype; Immunohistochemistry; Gene expression; Pathology; Comparative genomic hybridization; Internal medicine; Gene; Oncology; Immunology; Medicine; Hodgkin lymphoma; Genetics","score_opus":0.02070070896423385,"score_gpt":0.26157096943076646,"score_spread":0.24087026046653262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103651203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971749,0.0013309965,0.000011227728,0.00009072825,0.00011954271,0.0007399758,0.000026382102,0.000051532552,0.0004546979],"genre_scores_gemma":[0.99276984,0.000092375645,0.006459857,0.000037829508,0.000112545524,0.00014941946,0.0000733894,0.0000408186,0.00026391432],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99838847,0.00007102223,0.00048460826,0.0003384437,0.0002636168,0.0004538235],"domain_scores_gemma":[0.9990125,0.0001225168,0.00017842789,0.0004136814,0.000050034905,0.00022286986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010545094,0.00030918172,0.00061169674,0.00014692335,0.00003969107,0.000011390773,0.00007241097,0.00015831314,0.000044587134],"category_scores_gemma":[0.000019993653,0.00019445956,0.00013001275,0.00020701159,0.0000614874,0.00008567434,0.00004221931,0.00006031848,0.000039527324],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033458855,0.008428746,0.72663456,0.000048176666,0.00015289363,0.00015873734,0.00037672787,0.0000027092237,0.26225278,0.0000162526,0.000021348205,0.0015724746],"study_design_scores_gemma":[0.012393648,0.00088153046,0.34864968,0.00020121936,0.00035597023,0.00011768769,0.00008167625,0.000009525681,0.63710916,0.0000018367497,0.00006748408,0.00013054152],"about_ca_topic_score_codex":0.0001166065,"about_ca_topic_score_gemma":0.00002099216,"teacher_disagreement_score":0.37798488,"about_ca_system_score_codex":0.00022270164,"about_ca_system_score_gemma":0.00009452243,"threshold_uncertainty_score":0.79298306},"labels":[],"label_agreement":null},{"id":"W2104436383","doi":"10.1182/blood-2005-10-4160","title":"Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":184,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; National Institutes of Health","keywords":"Lymphoma; Immunology; Hodgkin lymphoma; Cytokine; Medicine; Cancer research","score_opus":0.011478907154585688,"score_gpt":0.24652678848835388,"score_spread":0.2350478813337682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104436383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98955923,0.00015247836,0.00009134683,0.0019518697,0.0000876738,0.00043249244,0.00003492364,0.000040261788,0.0076497225],"genre_scores_gemma":[0.99779415,0.0000059415515,0.00044209685,0.0009950773,0.00037646163,0.0000412024,0.000025622056,0.00001840173,0.0003010301],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99887615,0.000047792728,0.00029442966,0.00030734422,0.00021418632,0.00026007852],"domain_scores_gemma":[0.9993186,0.00010023433,0.000047302143,0.0004017652,0.00005034341,0.000081762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032455742,0.00015691397,0.00023423803,0.00012494408,0.00008460044,0.00003805672,0.00010230323,0.000067774636,0.00011308103],"category_scores_gemma":[0.00007437823,0.00010744485,0.000080958016,0.00030488975,0.000049139682,0.00005531014,0.000043897806,0.00013249055,0.000039960345],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018915585,0.002990869,0.11621763,0.000037208898,0.000038330338,0.0002482014,0.0010027955,0.000009289708,0.86913514,0.0008984773,0.00330731,0.005925608],"study_design_scores_gemma":[0.0044268644,0.000833451,0.8119523,0.0001273515,0.000092823706,0.00044873974,0.00025830866,0.00006123884,0.16638067,0.0003148195,0.014893836,0.00020958869],"about_ca_topic_score_codex":0.001646777,"about_ca_topic_score_gemma":0.0007752596,"teacher_disagreement_score":0.70275444,"about_ca_system_score_codex":0.000033213288,"about_ca_system_score_gemma":0.000065373795,"threshold_uncertainty_score":0.43814737},"labels":[],"label_agreement":null},{"id":"W2104441503","doi":"10.1182/blood.v98.4.1003","title":"Defective hematopoiesis and hepatic steatosis in mice with combined deficiencies of the genes encoding Fancc and Cu/Zn superoxide dismutase","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Hospital for Sick Children","funders":"National Cancer Institute; Cancer Research Society","keywords":"SOD1; Biology; Superoxide dismutase; Fanconi anemia; Haematopoiesis; Progenitor cell; Bone marrow; SOD2; Molecular biology; Myeloid; Immunology; Cancer research; Oxidative stress; Stem cell; Cell biology; Endocrinology; DNA repair; Genetics; Gene","score_opus":0.007063531847221747,"score_gpt":0.2061238987260164,"score_spread":0.19906036687879466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104441503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99514574,0.0037032368,0.000010185141,0.0002963277,0.000014554664,0.00031084797,0.0000043331843,0.000014028309,0.00050074287],"genre_scores_gemma":[0.99872166,0.001023581,0.00012453871,0.00007437218,0.0000043883015,0.000012536852,0.000001228598,0.000010897943,0.000026787842],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993108,0.00004104683,0.00017034475,0.00017120979,0.00013615377,0.00017046169],"domain_scores_gemma":[0.99962646,0.000100123696,0.000050171635,0.00013251259,0.000034923873,0.00005583862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010550562,0.000117348,0.00025101678,0.000068230875,0.00008218846,0.000009592451,0.000043820655,0.000062089886,0.0000044630606],"category_scores_gemma":[0.00007249068,0.00006878843,0.00003213773,0.00030253272,0.00019990483,0.000047086458,0.000045897283,0.000103031736,4.4264715e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009425851,0.00037526575,0.9678425,0.00017892254,0.00007044838,0.000036323574,0.0027439063,0.00000694775,0.02821803,0.00013343582,0.0000034976713,0.0002964555],"study_design_scores_gemma":[0.016168498,0.0013380414,0.77847546,0.0016664175,0.001437525,0.0012794154,0.032475073,0.0004770054,0.16584127,0.0003193869,0.000057848774,0.00046404285],"about_ca_topic_score_codex":0.00039615316,"about_ca_topic_score_gemma":0.00027725968,"teacher_disagreement_score":0.18936703,"about_ca_system_score_codex":0.000011518035,"about_ca_system_score_gemma":0.00003898089,"threshold_uncertainty_score":0.28051108},"labels":[],"label_agreement":null},{"id":"W2104690247","doi":"10.1182/blood-2008-12-192344","title":"Spatiotemporal regulation of intracellular trafficking of Toll-like receptor 9 by an inhibitory receptor, Ly49Q","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Nitric Oxide and Endothelin Effects","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Receptor; Inhibitory postsynaptic potential; Intracellular; Toll-like receptor; Cell biology; Biology; Neuroscience; Genetics; Innate immune system","score_opus":0.009085732192484045,"score_gpt":0.2340414487469234,"score_spread":0.22495571655443936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104690247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99765915,0.000886901,0.00019555588,0.00020831403,0.00016372344,0.00030410298,0.000012029238,0.00006111372,0.000509093],"genre_scores_gemma":[0.9954391,0.000055080433,0.0036457584,0.000078207806,0.00028468348,0.000003163685,0.0001915207,0.000020376616,0.00028212593],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99878824,0.00008004689,0.00043025616,0.0002163171,0.00030813343,0.00017699956],"domain_scores_gemma":[0.9992154,0.000049105587,0.00022431798,0.00030122467,0.00010223929,0.00010769242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031960508,0.00014000284,0.0003580656,0.00012192888,0.000028015813,0.0000049721175,0.00007245824,0.00015414806,0.00012545458],"category_scores_gemma":[0.00007617811,0.00013252241,0.00009126934,0.00020767392,0.0000496444,0.00012146399,0.000008405232,0.00013304448,0.000010829974],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017234372,0.0011311219,0.0034153052,0.000100892285,0.00003996089,0.0000031232917,0.00037642076,0.000012242958,0.97464854,0.000043976677,0.0020173457,0.018038701],"study_design_scores_gemma":[0.0032417455,0.001426712,0.0047690105,0.0002161926,0.00014111576,0.0000111303325,0.00009174144,0.00012724152,0.98757404,0.000059480226,0.0022059763,0.00013559576],"about_ca_topic_score_codex":0.000026604328,"about_ca_topic_score_gemma":0.0000021892229,"teacher_disagreement_score":0.017903106,"about_ca_system_score_codex":0.000022222424,"about_ca_system_score_gemma":0.00007415339,"threshold_uncertainty_score":0.5404107},"labels":[],"label_agreement":null},{"id":"W2106788103","doi":"10.1182/blood-2004-09-3523","title":"Heat shock protein 90 inhibition sensitizes acute myelogenous leukemia cells to cytarabine","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Université Laval; Mayo Clinic","keywords":"Cytarabine; CHEK1; Leukemia; Kinase; Cancer research; Biology; Chemistry; Apoptosis; Cell cycle; Immunology; Cell cycle checkpoint; Cell biology; Biochemistry","score_opus":0.004731784519304806,"score_gpt":0.20404455983931385,"score_spread":0.19931277532000904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106788103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972992,0.00011468571,0.00069869007,0.00030903812,0.00007445652,0.0005492853,0.00004133862,0.000063844105,0.0008494701],"genre_scores_gemma":[0.985632,0.000025568861,0.010856401,0.0008893117,0.0005399803,0.00006738405,0.00011272483,0.000041519605,0.0018351106],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99884623,0.000044514956,0.00019622881,0.0004278509,0.00015006872,0.00033507973],"domain_scores_gemma":[0.99935335,0.0000030663793,0.000024022609,0.00040653517,0.000069427166,0.0001436274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001148824,0.00019595757,0.00015748147,0.000044924127,0.000072942894,0.000024964782,0.000107259395,0.00018004935,0.00003107838],"category_scores_gemma":[0.00001607368,0.00019894546,0.00009293111,0.00008514098,0.000023049515,0.000004357461,0.00012972014,0.00008252117,0.00019133044],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055354365,0.00013129112,0.0000061452433,0.000009726455,0.0000694121,0.000037820304,0.000043254076,0.0001256867,0.9976597,0.00001755283,0.0009344976,0.0009096011],"study_design_scores_gemma":[0.0009943126,0.00055478094,0.000024278286,0.000018811088,0.000058012232,0.000106230684,0.000016796077,0.000038644528,0.98939526,0.000027801238,0.0085143875,0.00025065753],"about_ca_topic_score_codex":0.000019741747,"about_ca_topic_score_gemma":0.000050106257,"teacher_disagreement_score":0.011667193,"about_ca_system_score_codex":0.000042044932,"about_ca_system_score_gemma":0.000086604516,"threshold_uncertainty_score":0.8112761},"labels":[],"label_agreement":null},{"id":"W2106838577","doi":"10.1182/blood-2005-10-4179","title":"The inhibitory anti-FGFR3 antibody, PRO-001, is cytotoxic to t(4;14) multiple myeloma cells","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cytotoxic T cell; Multiple myeloma; Antibody; Cancer research; Medicine; Immunology; Chemistry; In vitro; Biochemistry","score_opus":0.009389533767043632,"score_gpt":0.25150082652777334,"score_spread":0.2421112927607297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106838577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902226,0.0008944741,0.000013282163,0.00089541107,0.00035178463,0.0014356982,0.000050776678,0.00018523236,0.0059507485],"genre_scores_gemma":[0.9856407,0.00008005665,0.0009046894,0.0005954031,0.00085367146,0.000097234806,0.000081031234,0.00007404984,0.011673137],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977813,0.00005356136,0.0004317972,0.0005352244,0.000529448,0.0006686908],"domain_scores_gemma":[0.9985284,0.00015923515,0.00011555585,0.0008595333,0.0001156727,0.00022158434],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020222455,0.0003302774,0.00038881117,0.00010671672,0.00028304575,0.00005809587,0.000220322,0.00016087391,0.00013768565],"category_scores_gemma":[0.000072926334,0.00023381025,0.0001573386,0.00031800364,0.000109722554,0.000071856644,0.00013204764,0.00024892308,0.0012004882],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000110126944,0.002296496,0.065849185,0.00011422035,0.00025949194,0.00042644975,0.00028816095,0.000008616473,0.8814219,0.000046823563,0.04711205,0.0020664574],"study_design_scores_gemma":[0.012050667,0.00041095377,0.0843583,0.00016231126,0.00030562366,0.00015552681,0.000059585047,0.000071023576,0.8048942,0.000032365653,0.09717296,0.000326448],"about_ca_topic_score_codex":0.00043117054,"about_ca_topic_score_gemma":0.00010524249,"teacher_disagreement_score":0.076527685,"about_ca_system_score_codex":0.00027973208,"about_ca_system_score_gemma":0.00031345282,"threshold_uncertainty_score":0.99957716},"labels":[],"label_agreement":null},{"id":"W2106843173","doi":"10.1182/blood-2006-06-032524","title":"Adenovirus-induced thrombocytopenia: the role of von Willebrand factor and P-selectin in mediating accelerated platelet clearance","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":219,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Platelet; Von Willebrand factor; Platelet activation; Immunology; Fibronectin; P-selectin; Adenoviridae; Flow cytometry; Chemistry; Medicine; Cell; Genetic enhancement","score_opus":0.013857457961764663,"score_gpt":0.24607747138452646,"score_spread":0.2322200134227618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106843173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99610424,0.0016411681,3.1789054e-7,0.0001262766,0.000019300005,0.00036886657,0.000012720241,0.000021764921,0.001705366],"genre_scores_gemma":[0.9996959,0.00009314934,0.00004774026,0.000046357,0.000038256167,0.000012963603,0.0000160119,0.000017569206,0.000032027325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99915785,0.00003207523,0.0002451558,0.00019411666,0.00015781878,0.00021297937],"domain_scores_gemma":[0.9996376,0.00006981087,0.0000931097,0.0001328773,0.000031612493,0.00003499541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000072396535,0.00013498166,0.00036155197,0.000059238326,0.00006183332,0.000014976337,0.000058802107,0.00009053086,0.000030448728],"category_scores_gemma":[0.00003738865,0.00009156981,0.000032484742,0.00023929079,0.000035046007,0.00007353661,0.000022392738,0.00017148601,0.000005268743],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032350412,0.0011624569,0.57855,0.000048054095,0.00018458866,0.00020361491,0.0008796815,0.000004593136,0.40744883,0.00006375952,0.000024639332,0.011106264],"study_design_scores_gemma":[0.007824843,0.00024441865,0.59260046,0.000058071717,0.00007034927,0.0000879528,0.00016035358,0.0000835652,0.39840916,0.00022935917,0.00012399396,0.000107464075],"about_ca_topic_score_codex":0.0006687477,"about_ca_topic_score_gemma":0.0003477483,"teacher_disagreement_score":0.014050457,"about_ca_system_score_codex":0.0000129709,"about_ca_system_score_gemma":0.000042398002,"threshold_uncertainty_score":0.37341085},"labels":[],"label_agreement":null},{"id":"W2106933841","doi":"10.1182/blood-2006-08-039883","title":"Notch signals positively regulate activity of the mTOR pathway in T-cell acute lymphoblastic leukemia","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":282,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute","funders":"","keywords":"PI3K/AKT/mTOR pathway; Notch signaling pathway; Protein kinase B; Biology; Signal transduction; Cell biology; Cancer research; Cell growth; RPTOR; Biochemistry","score_opus":0.006799721205217212,"score_gpt":0.2280360984819266,"score_spread":0.2212363772767094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106933841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99734616,0.00032389644,0.00065858045,0.000026730204,0.00014945229,0.00018615766,0.00005165061,0.000008427384,0.001248961],"genre_scores_gemma":[0.99901015,0.000019611056,0.00022945873,0.00011565211,0.00014339713,0.000009293673,0.0000075252674,0.000026241793,0.00043869085],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99885464,0.00007436834,0.00023663323,0.00032461633,0.00019594486,0.00031379424],"domain_scores_gemma":[0.99924517,0.00004965025,0.00017109003,0.00039883598,0.00007602468,0.0000592611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034738152,0.00016858036,0.0001871542,0.000041431813,0.000044518034,0.000009464291,0.00030647506,0.0001993029,0.000011686795],"category_scores_gemma":[0.000051068535,0.00013791636,0.00012363192,0.00017404242,0.000102024605,0.0000041820886,0.00013624008,0.00011294065,0.0000041971352],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000158243,0.00019426663,0.0027152076,0.000019837093,0.000068738445,0.000013143059,0.000051961757,0.00009477085,0.99602866,0.00000800265,0.00007078337,0.0005763622],"study_design_scores_gemma":[0.0015223651,0.00020019452,0.023560194,0.000044872566,0.000046508838,0.000015102538,0.000008190015,0.000016540476,0.97399443,0.000031689753,0.0003965803,0.00016331053],"about_ca_topic_score_codex":0.000060415245,"about_ca_topic_score_gemma":0.00006088122,"teacher_disagreement_score":0.022034232,"about_ca_system_score_codex":0.00006710181,"about_ca_system_score_gemma":0.00030310676,"threshold_uncertainty_score":0.5624066},"labels":[],"label_agreement":null},{"id":"W2106985538","doi":"10.1182/blood.v95.5.1735.005k47_1735_1742","title":"Unique processing pathways within recipient antigen-presenting cells determine IgG immunity against donor platelet MHC antigens","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; St. Michael's Hospital","funders":"","keywords":"Immunology; Antigen; Platelet; Antibody; Immunoglobulin G; Biology","score_opus":0.0194468870494848,"score_gpt":0.2438496284362178,"score_spread":0.224402741386733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106985538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987345,0.00065619586,0.000012205288,0.00006079716,0.000095195595,0.00059753214,0.000037865924,0.00018732018,0.01100788],"genre_scores_gemma":[0.99595046,0.0007575262,0.0018746644,0.00029714557,0.00009677177,0.00002444632,0.00015884124,0.000061385916,0.0007787334],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99809796,0.000071492206,0.00049681775,0.0004554488,0.0003020354,0.00057622435],"domain_scores_gemma":[0.99897754,0.000038134665,0.00017058231,0.0004956116,0.00009087943,0.00022724546],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000230053,0.00034099803,0.00053729455,0.00012925203,0.00034795835,0.00007348729,0.00017393188,0.00017290316,0.00016436947],"category_scores_gemma":[0.00003187505,0.00029273445,0.00014326644,0.0003244284,0.0000809781,0.00017190429,0.000060276234,0.0003480241,0.00011408205],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007812174,0.013796451,0.13016589,0.0007683947,0.0013196265,0.02010528,0.009513243,0.00022304455,0.55811965,0.000022597756,0.0004568886,0.2647277],"study_design_scores_gemma":[0.013758088,0.000642254,0.03315414,0.0009167164,0.00039813947,0.0010832093,0.00046761145,0.0017867455,0.9412489,0.00015794291,0.005502244,0.000884003],"about_ca_topic_score_codex":0.00012592299,"about_ca_topic_score_gemma":0.000042457326,"teacher_disagreement_score":0.38312924,"about_ca_system_score_codex":0.000037059024,"about_ca_system_score_gemma":0.0001597364,"threshold_uncertainty_score":0.9999525},"labels":[],"label_agreement":null},{"id":"W2107027906","doi":"10.1182/blood-2014-11-610543","title":"Acute myeloid leukemia ontogeny is defined by distinct somatic mutations","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":977,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"National Institute of General Medical Sciences; National Heart, Lung, and Blood Institute; National Cancer Institute; National Institutes of Health; Lady Tata Memorial Trust; Edward P. Evans Foundation; Harvard Catalyst; Leukemia and Lymphoma Society","keywords":"Biology; Mutation; Myeloid leukemia; Genetics; Leukemia; Myeloid; Cancer research; Somatic cell; Gene","score_opus":0.012657192205586809,"score_gpt":0.2708781713231564,"score_spread":0.2582209791175696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107027906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97523385,0.00020789205,0.0015227182,0.0025974256,0.00007781798,0.0005146956,0.00010560386,0.00022213742,0.019517833],"genre_scores_gemma":[0.9850893,0.000039803166,0.0049209166,0.0012578282,0.000261286,0.00010290781,0.00033248204,0.00007139908,0.007924087],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99802,0.00008161507,0.0003731145,0.00042052002,0.00054500403,0.0005597592],"domain_scores_gemma":[0.99846035,0.00026339153,0.000096850905,0.00069286494,0.00012162766,0.00036493485],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027069607,0.00024973977,0.000413635,0.00013251274,0.00018624596,0.00004877303,0.0002550648,0.000158011,0.0006560779],"category_scores_gemma":[0.0004348141,0.00021535989,0.0001507327,0.0003023427,0.000134617,0.00009637085,0.000104354665,0.0003743097,0.0013476969],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040635237,0.0029697593,0.08036127,0.00089068344,0.003531505,0.00052528677,0.0031363906,0.000005435182,0.56698394,0.0020469108,0.31379953,0.025342956],"study_design_scores_gemma":[0.061930783,0.0033430331,0.14372303,0.00054528395,0.00719654,0.0025043415,0.00055155315,0.01176524,0.60798967,0.0051410203,0.1530156,0.0022939027],"about_ca_topic_score_codex":0.00016474011,"about_ca_topic_score_gemma":0.00002631567,"teacher_disagreement_score":0.16078392,"about_ca_system_score_codex":0.0003163073,"about_ca_system_score_gemma":0.00048561805,"threshold_uncertainty_score":0.9994299},"labels":[],"label_agreement":null},{"id":"W2108528869","doi":"10.1182/blood-2013-08-520387","title":"Characterization of multiple platelet activation pathways in patients with bleeding as a high-throughput screening option: use of 96-well Optimul assay","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; British Heart Foundation; Wellcome Trust","keywords":"Platelet; Ristocetin; Medicine; Platelet activation; Aspirin; Population; Internal medicine; Predictive value; Bleeding time; Thromboxane; Epinephrine; Thrombin; Gastroenterology; Immunology; Platelet aggregation","score_opus":0.013769538362478415,"score_gpt":0.20107176207462385,"score_spread":0.18730222371214544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108528869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98581487,0.0000140779575,0.013627943,0.000015205248,0.000027200818,0.00041475275,0.000017641747,0.000029520317,0.000038783433],"genre_scores_gemma":[0.99710053,0.000029532172,0.0022784022,0.000044368917,0.000063391366,0.000011505461,0.00043524944,0.000026415575,0.000010599525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988947,0.000082088925,0.00029812285,0.00021413028,0.00036104687,0.00014991773],"domain_scores_gemma":[0.9992447,0.0000768995,0.00021627748,0.00023340159,0.0001731836,0.000055560864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020415887,0.00013822583,0.00036806325,0.000127925,0.000034203083,0.000011336745,0.000048788406,0.00009562307,0.000024634695],"category_scores_gemma":[0.00010581902,0.00011876174,0.000097353084,0.00022212781,0.000039581286,0.00032892966,0.000020616506,0.000092708535,0.0000026705418],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021193877,0.0017276373,0.8192788,0.00024145955,0.0005931379,0.000009117569,0.00034499486,0.0007900623,0.16330694,0.0001586773,0.0000019842068,0.011427795],"study_design_scores_gemma":[0.012263821,0.0006693528,0.69530064,0.0005469278,0.00018221306,0.000004318476,0.000033867815,0.00079055777,0.28991178,0.000006728604,0.00015334807,0.00013648446],"about_ca_topic_score_codex":0.000061734114,"about_ca_topic_score_gemma":0.0000014909159,"teacher_disagreement_score":0.12660483,"about_ca_system_score_codex":0.000013512394,"about_ca_system_score_gemma":0.00002842422,"threshold_uncertainty_score":0.48429632},"labels":[],"label_agreement":null},{"id":"W2109424178","doi":"10.1182/blood-2002-04-1103","title":"Nuclear localization of cyclin B1 regulates DNA damage–induced apoptosis","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Regional Laboratory Medicine Program","funders":"Massachusetts General Hospital","keywords":"Cell biology; Cyclin D; Cyclin A; DNA damage; Apoptosis; Cyclin A2; Cyclin B; Cyclin B1; Biology; Nuclear export signal; Cyclin D2; Ectopic expression; Cyclin; Inhibitor of apoptosis domain; Molecular biology; Programmed cell death; Cell nucleus; Cytoplasm; Cell cycle; Cell culture; DNA; Biochemistry; Genetics; Caspase; Cyclin-dependent kinase 1","score_opus":0.0057834298060827315,"score_gpt":0.20121843541910395,"score_spread":0.1954350056130212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109424178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99608797,0.000055317792,0.00018452873,0.000015894204,0.00011372928,0.00006494005,0.0000025962538,0.000011553838,0.0034634809],"genre_scores_gemma":[0.9991464,0.000026119775,0.00047954769,0.000097682474,0.00007510466,0.0000012377097,0.000033628137,0.000020076122,0.00012023022],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99949706,0.00003795808,0.00012781065,0.00016833929,0.000068120404,0.000100708894],"domain_scores_gemma":[0.99962944,0.0000028607456,0.000062476065,0.00022524067,0.000047765636,0.000032236476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005994942,0.00008003262,0.000085091466,0.000024492889,0.000045355977,0.000008649615,0.00006048762,0.00012302915,0.00006467012],"category_scores_gemma":[0.000058184967,0.00007653876,0.000051670384,0.00007578641,0.000026546159,0.0000027920248,0.000019410621,0.00003590438,0.00000831684],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017946808,0.00007130609,0.0010596156,0.000011265601,0.00004215681,2.3882322e-7,0.000027944583,0.000020074805,0.9972537,0.0006149696,0.0004951104,0.00038566234],"study_design_scores_gemma":[0.0005700492,0.00018950316,0.0013634026,0.0000061660844,0.000046055597,0.0000049853525,0.000050331524,0.000020902791,0.9838208,0.00015426293,0.013678818,0.000094749856],"about_ca_topic_score_codex":0.000006001482,"about_ca_topic_score_gemma":0.0000027145252,"teacher_disagreement_score":0.013432936,"about_ca_system_score_codex":0.0000022739703,"about_ca_system_score_gemma":0.000012993465,"threshold_uncertainty_score":0.312116},"labels":[],"label_agreement":null},{"id":"W2109768043","doi":"10.1182/blood-2005-01-0247","title":"Identification and functional characterization of 2 variant alleles of the telomerase RNA template gene (TERC) in a patient with dyskeratosis congenita","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Children's Hospital; BC Cancer Agency","funders":"National Institute of Allergy and Infectious Diseases; Winship Cancer Institute; Terry Fox Foundation; Emory University; National Institutes of Health; American Cancer Society","keywords":"Dyskeratosis congenita; Telomerase; Telomerase RNA component; Telomere; Biology; Bone marrow failure; Molecular biology; Cancer research; Genetics; Telomerase reverse transcriptase; Gene; Stem cell; Haematopoiesis","score_opus":0.009103752730299494,"score_gpt":0.1972770688493117,"score_spread":0.18817331611901222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109768043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988902,0.0001408464,0.00013292028,0.00037154206,0.000037329322,0.00034079995,0.000040299186,0.000009746489,0.000036289926],"genre_scores_gemma":[0.9993304,0.00011654514,0.00028373665,0.00009390138,0.00004053662,0.000021143205,0.000046111163,0.000010910209,0.00005671787],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990808,0.000041093386,0.00036281528,0.00017882731,0.00023139767,0.00010507336],"domain_scores_gemma":[0.9993982,0.000024145578,0.00019477791,0.00021379754,0.00012448021,0.00004460896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000101424484,0.00009869619,0.00019191613,0.00010451691,0.00003883707,0.000008414218,0.00004249585,0.000048343612,0.000033999717],"category_scores_gemma":[0.000028062641,0.000067630885,0.000028648608,0.00023115127,0.00007964875,0.00009493222,0.000020939391,0.00007148311,0.0000015666734],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017697208,0.00059102755,0.039018504,0.00006546918,0.00006555568,0.000010471545,0.00073780323,0.0000064794676,0.95502037,0.000044602493,0.000006284261,0.0042564855],"study_design_scores_gemma":[0.001384484,0.00010317108,0.48761567,0.000076221455,0.000086299326,0.00010862007,0.000057165627,0.00009500985,0.510339,0.000003896135,0.00007358117,0.000056866345],"about_ca_topic_score_codex":0.00003740671,"about_ca_topic_score_gemma":0.000056451605,"teacher_disagreement_score":0.44859716,"about_ca_system_score_codex":0.000013779757,"about_ca_system_score_gemma":0.000067575995,"threshold_uncertainty_score":0.27579072},"labels":[],"label_agreement":null},{"id":"W2109841776","doi":"10.1182/blood.v100.3.998","title":"Heterozygous PU.1 mutations are associated with acute myeloid leukemia","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":239,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Myeloid leukemia; Mutation; Genetics; Medicine; Leukemia; Biology; Cancer research; Gene","score_opus":0.021889131417652963,"score_gpt":0.2607821144595538,"score_spread":0.23889298304190082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109841776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98350704,0.0002612124,0.00006110016,0.0014827057,0.00004199262,0.0005286092,0.000062190695,0.00029287173,0.013762304],"genre_scores_gemma":[0.9848897,0.000105548526,0.000830252,0.00066210184,0.00016134224,0.000088105706,0.00012172896,0.00007428675,0.0130669195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980959,0.000068688176,0.00025760412,0.00039490568,0.0005997939,0.00058305694],"domain_scores_gemma":[0.9986969,0.00012964213,0.00012881901,0.00049203384,0.00024858996,0.00030401887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001342272,0.00023539485,0.00040451484,0.00019112192,0.00018304995,0.000049244605,0.00018574038,0.00018046143,0.00060325454],"category_scores_gemma":[0.00027621136,0.00018879183,0.00010223592,0.00061742886,0.00015554925,0.00012739531,0.00006280593,0.0005605869,0.000544357],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016635305,0.016698135,0.4796046,0.0007238943,0.029579747,0.08751299,0.010996541,0.00034116552,0.13605292,0.0006426713,0.21116917,0.025014624],"study_design_scores_gemma":[0.12023055,0.008448838,0.7054582,0.0020475157,0.010697454,0.015700804,0.0020823819,0.012279656,0.09549819,0.00039307066,0.023714323,0.003449013],"about_ca_topic_score_codex":0.000044876924,"about_ca_topic_score_gemma":0.000060335886,"teacher_disagreement_score":0.2258536,"about_ca_system_score_codex":0.00050893606,"about_ca_system_score_gemma":0.00022441431,"threshold_uncertainty_score":0.76987076},"labels":[],"label_agreement":null},{"id":"W2110069072","doi":"10.1182/blood-2011-02-315283","title":"New sources of drugs for hematologic malignancies","year":2011,"lang":"en","type":"review","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Repurposing; Drug repositioning; Drug; Drug discovery; Clinical trial; Approved drug; Drug development; Investigational Drugs; Medicine; Pharmacology; Bioinformatics; Biology","score_opus":0.026863144116041408,"score_gpt":0.2741734035743715,"score_spread":0.24731025945833007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110069072","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030882473,0.9980645,0.00028280658,0.0000026032908,0.00013171915,0.0004075536,0.0001972204,0.0000054422744,0.00059933355],"genre_scores_gemma":[0.0000493156,0.9963368,0.0023246275,0.000022829987,0.0003215144,0.0000730945,0.00018307133,0.000037732352,0.0006509981],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99915147,0.000014977337,0.00032633476,0.0002843891,0.00004195121,0.00018089479],"domain_scores_gemma":[0.99920756,0.000042728705,0.00028787123,0.00035002327,0.00004892375,0.00006291028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007022202,0.00022213608,0.00069796614,0.00003768689,0.000024014285,0.000009714463,0.00027851388,0.00029126866,0.00001501257],"category_scores_gemma":[0.000081503415,0.00018567921,0.0004384192,0.000043937067,0.000037235677,5.464056e-7,0.00011645428,0.00004504854,0.000005637048],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041336272,0.00051678275,0.00006872824,0.032337036,0.0014840488,0.0000071985614,0.00016550015,7.335739e-7,0.00080681965,0.006005514,0.024793064,0.9337732],"study_design_scores_gemma":[0.0003492967,0.00018883063,7.4493414e-7,0.0007823808,0.00078594557,0.000029346691,0.0000088275165,2.7481203e-8,0.0054210434,0.00020214405,0.99201816,0.00021326709],"about_ca_topic_score_codex":0.000024599527,"about_ca_topic_score_gemma":0.000008732338,"teacher_disagreement_score":0.9672251,"about_ca_system_score_codex":0.0000038069097,"about_ca_system_score_gemma":0.00035701107,"threshold_uncertainty_score":0.7571778},"labels":[],"label_agreement":null},{"id":"W2110602039","doi":"10.1182/blood-2001-11-0067","title":"Dangerous liaisons: the role of “danger” signals in the immune response to gene therapy","year":2002,"lang":"en","type":"review","venue":"Blood","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Genetic enhancement; Innate immune system; Immune system; Context (archaeology); Immunology; Biology; Gene; Perspective (graphical); Genetics; Computer science","score_opus":0.08584906249071639,"score_gpt":0.3825945266773238,"score_spread":0.2967454641866074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110602039","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012781767,0.9829192,0.0000015129395,0.00035944415,0.000042740325,0.0027002643,0.00003429702,0.000025924111,0.0011348235],"genre_scores_gemma":[0.0006328332,0.99161613,0.00005433222,0.0062957527,0.00031283518,0.0008741976,0.000006014899,0.00007996046,0.00012793082],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962491,0.001353984,0.00072512194,0.00040891886,0.000782946,0.00047992787],"domain_scores_gemma":[0.9964068,0.0017356792,0.00021180684,0.0015006863,0.000108154185,0.000036858106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026523895,0.000385095,0.0014221328,0.00039627127,0.000076965815,0.00004100126,0.0010660754,0.00028199106,0.000041213134],"category_scores_gemma":[0.0006090148,0.00018724725,0.0005294853,0.0012348869,0.000112599526,0.000025610843,0.00012968229,0.0007540975,0.00019612754],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004571176,0.0011646524,0.00005301685,0.0010153691,0.00039655124,0.00022656878,0.0013611802,3.9055035e-8,0.007919803,0.000009914031,0.00026885298,0.98712695],"study_design_scores_gemma":[0.0011810998,0.0006530812,0.00007665864,0.002861291,0.0003820726,0.00021541292,0.00014829013,6.819746e-7,0.007008427,0.0000188293,0.98727053,0.00018360239],"about_ca_topic_score_codex":0.00018092827,"about_ca_topic_score_gemma":0.000009830419,"teacher_disagreement_score":0.9870017,"about_ca_system_score_codex":0.000056363857,"about_ca_system_score_gemma":0.0004668174,"threshold_uncertainty_score":0.7635721},"labels":[],"label_agreement":null},{"id":"W2111403445","doi":"10.1182/blood-2002-03-0958","title":"Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":612,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Center for Research Resources; National Heart, Lung, and Blood Institute","keywords":"Medicine; Transfusion-related acute lung injury; Platelet; Prospective cohort study; Immunology; Internal medicine; ARDS; Platelet activation; Gastroenterology; Pulmonary edema; Lung","score_opus":0.02194616224130689,"score_gpt":0.28409647662826704,"score_spread":0.2621503143869601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111403445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99361026,0.001044722,0.00021349287,0.0010115553,0.000043187138,0.0005552877,0.000027545286,0.00006988187,0.0034240428],"genre_scores_gemma":[0.9959932,0.002900301,0.00030205405,0.00028450167,0.000008954223,0.000021117961,0.00002475149,0.000009736789,0.0004553781],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988692,0.00009769794,0.00039105176,0.00032783803,0.0001029716,0.00021125942],"domain_scores_gemma":[0.99939865,0.00012411097,0.000090448426,0.00022344048,0.00004871313,0.00011464301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024047913,0.00014966054,0.00072351197,0.00035814592,0.000053719363,0.0000022519098,0.00005428425,0.00014512027,0.00091191294],"category_scores_gemma":[0.000086059765,0.000108239416,0.000220666,0.00077058084,0.000121175726,0.00002907071,0.00002304683,0.00016938787,0.000004212443],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008726983,0.0012859016,0.97538334,0.00006379143,0.011943665,0.000025929114,0.0016264946,0.0000053387707,0.0058544055,0.0021028018,0.00023608931,0.0013849427],"study_design_scores_gemma":[0.0036739248,0.0008135922,0.96699756,0.000031708565,0.024232652,0.000013220209,0.00019171258,0.0010505213,0.0023796696,0.00023809425,0.00022057974,0.00015678228],"about_ca_topic_score_codex":0.00007465654,"about_ca_topic_score_gemma":0.00002247576,"teacher_disagreement_score":0.012288988,"about_ca_system_score_codex":0.000010624286,"about_ca_system_score_gemma":0.0000059867966,"threshold_uncertainty_score":0.99848074},"labels":[],"label_agreement":null},{"id":"W2111733466","doi":"10.1182/blood-2005-02-0782","title":"Protection of erythrocytes from human complement–mediated lysis by membrane-targeted recombinant soluble CD59: a new approach to PNH therapy","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Inflazyme (Canada)","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; CD59; Hemolysis; Eculizumab; Complement system; Complement membrane attack complex; Decay-accelerating factor; Immunology; Complement component 5; Recombinant DNA; Hemoglobinuria; Red blood cell; Biology; Biochemistry; Immune system","score_opus":0.0326861227866076,"score_gpt":0.2537214155913008,"score_spread":0.2210352928046932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111733466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99364436,0.0028208403,0.00045927137,0.00033296787,0.00028016855,0.0015486951,0.00021105382,0.00017140247,0.0005312491],"genre_scores_gemma":[0.99522084,0.000047282425,0.0007177339,0.00011113621,0.00006928859,0.00023824404,0.0018419416,0.000031458134,0.0017220587],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99818224,0.00026528336,0.0006024684,0.00047294368,0.00008879677,0.00038824248],"domain_scores_gemma":[0.9990482,0.00007754435,0.00026311824,0.00047102946,0.00007691353,0.00006323149],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002005517,0.00024831112,0.00047908598,0.00014573998,0.0002019137,0.00001850785,0.0003412812,0.00013121571,0.0033420413],"category_scores_gemma":[0.000042215703,0.00022996416,0.0001403656,0.0002422653,0.000054159238,0.00008568244,0.00009473432,0.00012747153,0.0003197642],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014830093,0.0024234012,0.0022323641,0.00002405073,0.0010313021,3.136796e-7,0.0005632725,0.0000097752,0.94702214,0.00005621845,0.04526682,0.001222062],"study_design_scores_gemma":[0.010446456,0.00040147087,0.0032403928,0.00006390996,0.0002185725,0.000006146814,0.0003137237,0.000019369407,0.8854605,0.00007788243,0.09936357,0.00038799236],"about_ca_topic_score_codex":0.0031488547,"about_ca_topic_score_gemma":0.00019033307,"teacher_disagreement_score":0.06156161,"about_ca_system_score_codex":0.00004256479,"about_ca_system_score_gemma":0.00005638307,"threshold_uncertainty_score":0.997569},"labels":[],"label_agreement":null},{"id":"W2111978676","doi":"10.1182/blood-2004-03-1203","title":"Patients with severe sepsis vary markedly in their ability to generate activated protein C","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Sepsis Diagnosis and Treatment","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Canadian Intensive Care Foundation; McMaster University; Intensive Care Foundation; Heart and Stroke Foundation of Canada","keywords":"Protein C; Endothelial protein C receptor; Sepsis; Medicine; Thrombomodulin; Internal medicine; Immunology; Thrombin; Endothelial activation; Inflammation; Platelet","score_opus":0.02313624581022978,"score_gpt":0.2536513249402679,"score_spread":0.2305150791300381,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111978676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967775,0.000048097867,0.000002530441,0.0008658426,0.00001754783,0.0015011946,0.000024564739,0.000044109132,0.0007186594],"genre_scores_gemma":[0.9974892,0.0000038245976,0.0015310822,0.00053878425,0.000026448459,0.00030159287,0.000045832043,0.00002316924,0.000040050854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990471,0.000035688092,0.00017193572,0.0003273011,0.00018593099,0.00023203781],"domain_scores_gemma":[0.9993945,0.00002126943,0.000039193248,0.0003238038,0.00007779869,0.0001434814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007286737,0.00017328486,0.0002472087,0.00007382909,0.00003433218,0.000012192657,0.000051819097,0.00006141197,0.00009157943],"category_scores_gemma":[0.000039780465,0.00011218232,0.000045567987,0.0002902241,0.000016501854,0.000054476797,0.000028431125,0.00009542725,0.00003176431],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044183366,0.00961586,0.98085946,0.000050267055,0.00018689915,0.000064694344,0.0004251069,0.000061856044,0.0057094437,0.000011142439,0.00005405791,0.0025193945],"study_design_scores_gemma":[0.010498907,0.00090274244,0.87153345,0.00022057287,0.00007411791,0.000004348559,0.000027776074,6.75749e-7,0.11644128,0.00005537233,0.00010814689,0.0001326259],"about_ca_topic_score_codex":0.00022862836,"about_ca_topic_score_gemma":0.00008915982,"teacher_disagreement_score":0.11073183,"about_ca_system_score_codex":0.000135595,"about_ca_system_score_gemma":0.00009202411,"threshold_uncertainty_score":0.4574662},"labels":[],"label_agreement":null},{"id":"W2112519486","doi":"10.1182/blood-2009-02-205153","title":"Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":311,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; McMaster University; Hamilton Health Sciences; Université de Montréal; Institute for Research in Immunology and Cancer; McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"EIF4E; Ribavirin; Myeloid leukemia; Cancer research; Leukemia; Medicine; Myeloid; Clinical trial; Acute leukemia; Initiation factor; Translation (biology); Biology; Oncology; Immunology; Internal medicine; Messenger RNA; Gene; Genetics; Virus","score_opus":0.018673705328499574,"score_gpt":0.3086300032636587,"score_spread":0.2899562979351591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112519486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996565,0.00022813158,0.00003484509,0.0006711077,0.00005378675,0.0010284716,0.000004145172,0.00001570581,0.0013987981],"genre_scores_gemma":[0.9940372,0.00002398615,0.0050458875,0.00009341443,0.000069643575,0.000027613749,0.000015534264,0.0000150112155,0.0006717169],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99841577,0.00009798075,0.0006603044,0.00025552043,0.00034764194,0.00022280573],"domain_scores_gemma":[0.9992497,0.000052720436,0.00022422348,0.00033268728,0.00006266788,0.00007797615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045735142,0.00016055822,0.0004924133,0.00006996502,0.000027520307,0.0000042958823,0.0001395335,0.00010009887,0.000012824806],"category_scores_gemma":[0.0001312638,0.00009609116,0.0001591786,0.00031678044,0.00007048727,0.000029570794,0.00004882726,0.00020357248,0.000003427191],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06082346,0.025993897,0.7317359,0.00029417462,0.0045181187,0.0026143517,0.0031665845,0.00018425997,0.1212211,0.000987631,0.0007387442,0.04772179],"study_design_scores_gemma":[0.1521902,0.0029388473,0.045908097,0.00043776198,0.0011243267,0.000048651582,0.00006052506,0.00005666213,0.79512435,0.00010137225,0.001764612,0.00024461],"about_ca_topic_score_codex":0.000008750643,"about_ca_topic_score_gemma":0.0000102673,"teacher_disagreement_score":0.6858278,"about_ca_system_score_codex":0.000056921966,"about_ca_system_score_gemma":0.0005869697,"threshold_uncertainty_score":0.39184836},"labels":[],"label_agreement":null},{"id":"W2112582649","doi":"10.1182/blood-2003-01-0224","title":"In vitro generation of T lymphocytes from embryonic stem cell–derived prehematopoietic progenitors","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Embryonic stem cell; Biology; Cell biology; Progenitor cell; Haematopoiesis; In vitro; Stem cell; Cellular differentiation; Immunology; Cell; Genetics","score_opus":0.014453583066685689,"score_gpt":0.234496530669237,"score_spread":0.22004294760255133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112582649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959418,0.0031552745,0.00007816168,0.000014242273,0.00007758269,0.00026707648,0.000018934277,0.0000053002846,0.00044159938],"genre_scores_gemma":[0.9984462,0.00015092817,0.00076481863,0.000017250544,0.0000771517,0.000043210366,0.00007162735,0.000020122656,0.0004086842],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99893856,0.00014373117,0.00021283908,0.00030589633,0.00017295271,0.00022601972],"domain_scores_gemma":[0.9994897,0.000012851741,0.00007320405,0.00031334165,0.00005343879,0.000057463465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012315111,0.00012156551,0.0001523966,0.00005062947,0.000027156273,0.000012862085,0.00014825018,0.00013215991,0.000019530695],"category_scores_gemma":[0.000019431465,0.00012160167,0.00006576272,0.000101369864,0.000039106068,0.00000431371,0.000051887117,0.000053324362,0.000014044282],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028929822,0.0003031541,0.0013426933,0.000036557198,0.0000326262,0.000006861766,0.000046140103,0.000024391018,0.9980285,0.0000053036556,0.00007007279,0.00007475549],"study_design_scores_gemma":[0.0016751601,0.00008721439,0.0001932616,0.000007759947,0.000019137302,0.000007234723,0.000053114025,0.00005985515,0.997237,0.000013460079,0.00052727293,0.00011951406],"about_ca_topic_score_codex":0.000024791068,"about_ca_topic_score_gemma":0.000010483698,"teacher_disagreement_score":0.0030043463,"about_ca_system_score_codex":0.000017013548,"about_ca_system_score_gemma":0.00015952642,"threshold_uncertainty_score":0.4958772},"labels":[],"label_agreement":null},{"id":"W2113476651","doi":"10.1182/blood-2012-10-457507","title":"The C-type lectin receptor CLEC4M binds, internalizes, and clears von Willebrand factor and contributes to the variation in plasma von Willebrand factor levels","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Queen's University","funders":"National Center for Advancing Translational Sciences; National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research","keywords":"Von Willebrand factor; Von Willebrand disease; Allele; Molecular biology; Chemistry; Receptor; Lectin; Biology; Internal medicine; Genetics; Endocrinology; Immunology; Platelet; Gene; Medicine","score_opus":0.01208933617005748,"score_gpt":0.23827006650430466,"score_spread":0.22618073033424718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113476651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932406,0.0014798809,0.000017195613,0.0037596314,0.00027268453,0.0010521843,0.000034041204,0.000026157126,0.00011765229],"genre_scores_gemma":[0.9978995,0.0006241848,0.00007115881,0.00031865205,0.000048548256,0.000043378066,0.000012927739,0.000023343706,0.0009583231],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890846,0.000080870246,0.00025929938,0.00028402102,0.00017128348,0.00029607318],"domain_scores_gemma":[0.9992327,0.00029670016,0.00008200905,0.00019208068,0.00007940709,0.00011708121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013032656,0.00019913819,0.00030784553,0.00008637814,0.00019139242,0.00016409198,0.00008982201,0.000115222014,0.000102632475],"category_scores_gemma":[0.00029630808,0.00011132051,0.00003533966,0.00019801986,0.000060576804,0.000138641,0.000056776324,0.00018794728,0.000046376357],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017709553,0.00096713746,0.8629126,0.000087267064,0.0013913668,0.00005243165,0.0063554198,0.0000026707414,0.041171458,0.00016132898,0.0081279585,0.07699942],"study_design_scores_gemma":[0.011533435,0.0007091836,0.9614736,0.00014954485,0.00013255412,0.000053693257,0.00023939935,0.00011656681,0.0048652454,0.00029656442,0.020228252,0.00020197323],"about_ca_topic_score_codex":0.00048064187,"about_ca_topic_score_gemma":0.00048897794,"teacher_disagreement_score":0.098561004,"about_ca_system_score_codex":0.000033723805,"about_ca_system_score_gemma":0.000040430517,"threshold_uncertainty_score":0.45395187},"labels":[],"label_agreement":null},{"id":"W2113782980","doi":"10.1182/blood.v97.5.1180","title":"Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction?","year":2001,"lang":"en","type":"review","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":424,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Canadian Blood Services","funders":"","keywords":"Immunology; Antigen; Immune system; Blood transfusion; Medicine; Persistence (discontinuity); Biology; Intensive care medicine","score_opus":0.05382864349435041,"score_gpt":0.3699229662461489,"score_spread":0.3160943227517985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113782980","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015914232,0.99203753,0.00019161895,0.000042652213,0.000807716,0.0031577628,0.000024899427,0.00016235895,0.001984005],"genre_scores_gemma":[0.000683171,0.9967419,0.00016643683,0.000102924816,0.00021570355,0.00012801492,0.00022671657,0.00007767393,0.0016574627],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970747,0.00029265613,0.0014412657,0.000502525,0.00039749328,0.00029133967],"domain_scores_gemma":[0.998305,0.00042074002,0.0004139764,0.0005922003,0.000103463506,0.00016462624],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037394356,0.0004392318,0.0026211434,0.0002373558,0.000076456,0.000014671239,0.00017766048,0.0005934602,0.00045224815],"category_scores_gemma":[0.00018319875,0.00030637524,0.0012646349,0.0006091358,0.00006305741,0.000037067643,0.00003922819,0.00053977955,0.000048749633],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000070900394,0.0038428681,0.00011972904,0.019796474,0.0024969485,0.00036442358,0.00003902589,7.807792e-8,0.000003856045,0.000009321633,0.00057164417,0.97268474],"study_design_scores_gemma":[0.008043324,0.0017371805,0.0013619829,0.019463979,0.017258154,0.00021370458,0.0000076332035,0.0000020445825,0.000012371657,0.0000032757255,0.9515631,0.0003332381],"about_ca_topic_score_codex":0.000051576888,"about_ca_topic_score_gemma":0.000023514245,"teacher_disagreement_score":0.9723515,"about_ca_system_score_codex":0.00004136741,"about_ca_system_score_gemma":0.00027454167,"threshold_uncertainty_score":0.99993885},"labels":[],"label_agreement":null},{"id":"W2114277323","doi":"10.1182/blood-2005-11-4449","title":"Remarkable activity of novel agents bortezomib and thalidomide in patients not responding to donor lymphocyte infusions following nonmyeloablative allogeneic stem cell transplantation in multiple myeloma","year":2006,"lang":"en","type":"letter","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Multiple myeloma; Bortezomib; Transplantation; Medicine; Donor lymphocyte infusion; Thalidomide; Lymphocyte; Stem cell; Lenalidomide; Immunology; Graft-versus-host disease; Internal medicine; Biology","score_opus":0.03035046726206052,"score_gpt":0.27442106844006625,"score_spread":0.24407060117800572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114277323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944274,0.00007059377,0.00002993581,0.0015386663,0.00009618987,0.0025364053,0.00080988306,0.00002305681,0.00046788264],"genre_scores_gemma":[0.99379826,0.0000687794,0.00123546,0.0027445585,0.00009249043,0.00021028152,0.0008779486,0.0000857253,0.0008864791],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966427,0.0002473555,0.0007227776,0.0008111121,0.000811859,0.00076417794],"domain_scores_gemma":[0.99841994,0.00058112916,0.00028402978,0.00043200282,0.00009336469,0.00018955141],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037719824,0.0004999875,0.0010199795,0.0018724214,0.00009609694,0.000030844796,0.00017330975,0.00055967,0.000010166384],"category_scores_gemma":[0.00009778763,0.00047829852,0.00020148356,0.00086520857,0.00004542336,0.00018757912,0.00011158971,0.0006696395,0.0000074415234],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041517178,0.002920331,0.91483694,0.0010640441,0.00038787912,0.0025029057,0.0010921588,0.00005599178,0.06949808,4.042686e-7,0.0008334853,0.002656054],"study_design_scores_gemma":[0.045137823,0.00046737742,0.90508807,0.0012588217,0.000322959,0.000010977677,0.00002920847,0.00019774685,0.0465656,0.0000012950784,0.00054408435,0.00037606945],"about_ca_topic_score_codex":0.0016984435,"about_ca_topic_score_gemma":0.0009365242,"teacher_disagreement_score":0.040986106,"about_ca_system_score_codex":0.00045669905,"about_ca_system_score_gemma":0.0002688619,"threshold_uncertainty_score":0.9997669},"labels":[],"label_agreement":null},{"id":"W2114591684","doi":"10.1182/blood-2011-02-338244","title":"Occlusive thrombi arise in mammals but not birds in response to arterial injury: evolutionary insight into human cardiovascular disease","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Agriculture and Agri-Food Canada","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Platelet; In vivo; Thrombosis; Biology; Pathology; Medicine; Internal medicine","score_opus":0.018722688681285866,"score_gpt":0.25727474626062946,"score_spread":0.23855205757934358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114591684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974238,0.0007880345,0.0000041720846,0.00026348027,0.00011156627,0.0008231786,0.000052528412,0.00004683901,0.0004863454],"genre_scores_gemma":[0.9989911,0.000041404568,0.00031097495,0.00027586753,0.00007370956,0.00013870467,0.00003906741,0.000033753902,0.000095456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839234,0.0001793625,0.00032457212,0.00044851194,0.00032372086,0.0003314932],"domain_scores_gemma":[0.9990418,0.000026610267,0.000039817685,0.0005608883,0.000049489623,0.00028142665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025764355,0.00022349872,0.00052354543,0.00040718788,0.00007063585,0.000010079392,0.000112639136,0.00011369513,0.00009430824],"category_scores_gemma":[0.00015680213,0.00020796522,0.00018669855,0.00033306103,0.00006289597,0.00008485523,0.0001118293,0.00014724389,0.000116261275],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07753725,0.029032415,0.5720672,0.00034804255,0.0041331146,0.0830343,0.026831351,0.000048231464,0.20128867,0.00052162405,0.00085232564,0.00430546],"study_design_scores_gemma":[0.012443882,0.00080145476,0.9775121,0.00017402325,0.0004560747,0.000048682035,0.00015640545,0.000007597743,0.0062265685,0.00079955696,0.0010851454,0.0002884656],"about_ca_topic_score_codex":0.0016018776,"about_ca_topic_score_gemma":0.00016630489,"teacher_disagreement_score":0.40544492,"about_ca_system_score_codex":0.00012848755,"about_ca_system_score_gemma":0.00019671452,"threshold_uncertainty_score":0.84805757},"labels":[],"label_agreement":null},{"id":"W2115158250","doi":"10.1182/blood-2008-03-148502","title":"A dual role for integrin-linked kinase in platelets: regulating integrin function and α-granule secretion","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"University of Reading; British Heart Foundation; Wellcome Trust","keywords":"Integrin-linked kinase; Platelet; Integrin; Cell biology; Dense granule; Platelet Glycoprotein GPIIb-IIIa Complex; Clot retraction; Chemistry; Kinase; Phosphorylation; Platelet activation; Biology; Protein kinase A; Cell; Immunology; Biochemistry; Thrombin; Cyclin-dependent kinase 2","score_opus":0.024726469075537966,"score_gpt":0.2720016035584585,"score_spread":0.24727513448292052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115158250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972447,0.00034058493,0.00054688443,0.00024127556,0.000041641153,0.0006829773,0.000004536031,0.000054516455,0.0008428912],"genre_scores_gemma":[0.9971847,0.000061302104,0.0016339665,0.00007905541,0.00013804508,0.00008572417,0.00007869534,0.000027699303,0.000710813],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988467,0.000049362854,0.00027202914,0.00031056436,0.00024884476,0.00027250507],"domain_scores_gemma":[0.99942046,0.000117173855,0.00005111089,0.00018699752,0.000098701676,0.00012555975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028606283,0.00013141938,0.00023035,0.00023043466,0.00008514331,0.000013565122,0.000039425166,0.00013777516,0.000058835114],"category_scores_gemma":[0.00037158438,0.00011781841,0.00006067158,0.00022291864,0.000068157584,0.000067320565,0.00005325124,0.0003277078,0.00001402996],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019491742,0.0009542964,0.04526937,0.00025333476,0.00006459161,0.00026150275,0.001064332,0.000011954194,0.9291426,0.00032187492,0.00027078713,0.020436179],"study_design_scores_gemma":[0.05523409,0.0055026505,0.60051066,0.0010088533,0.00030938978,0.0021766708,0.002836801,0.01908287,0.3010209,0.0026559692,0.008819225,0.0008419028],"about_ca_topic_score_codex":0.00011033457,"about_ca_topic_score_gemma":0.000068991925,"teacher_disagreement_score":0.6281217,"about_ca_system_score_codex":0.00005109221,"about_ca_system_score_gemma":0.000075561926,"threshold_uncertainty_score":0.48044953},"labels":[],"label_agreement":null},{"id":"W2115196873","doi":"10.1182/blood-2004-01-0254","title":"Gene-trap expression screening to identify endothelial-specific genes","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Biology; Endothelial stem cell; Gene; Reporter gene; Gene expression; Cell biology; Embryonic stem cell; Molecular biology; Genetics; In vitro","score_opus":0.021125029427009355,"score_gpt":0.28402363422527765,"score_spread":0.2628986047982683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115196873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9771504,0.007289816,0.014676405,0.00008318022,0.00018278878,0.00014837789,0.000034540997,0.00002263912,0.00041185317],"genre_scores_gemma":[0.98456824,0.00098502,0.012677305,0.00033958536,0.0010026685,0.00004428013,0.00004595759,0.0000372292,0.0002996931],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990323,0.000019651403,0.00016483043,0.0003863959,0.00014303913,0.0002537677],"domain_scores_gemma":[0.9994294,0.000003394466,0.000044896973,0.0003554197,0.000051039784,0.00011583548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008813662,0.00014812297,0.00011388615,0.000041301035,0.00010964275,0.000035114128,0.00020724974,0.00011488852,0.000039020357],"category_scores_gemma":[0.000009412419,0.00013808774,0.00012882498,0.000079309284,0.000026523212,0.0000034918817,0.00011119887,0.000037895446,0.00005101402],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029204044,0.000088207074,0.0016531928,0.0000045945876,0.00003155682,0.000007809129,0.00003044422,0.00022625962,0.9932842,0.000012911006,0.0011240606,0.0035075457],"study_design_scores_gemma":[0.0008925051,0.00009802676,0.0040296223,0.000023726905,0.00001601066,0.000019279707,0.00002887752,2.0006458e-7,0.91173506,0.000017619557,0.0829589,0.00018019219],"about_ca_topic_score_codex":0.000015825583,"about_ca_topic_score_gemma":0.000008345536,"teacher_disagreement_score":0.08183484,"about_ca_system_score_codex":0.000007013668,"about_ca_system_score_gemma":0.000033993303,"threshold_uncertainty_score":0.56310546},"labels":[],"label_agreement":null},{"id":"W2115235832","doi":"10.1182/blood-2011-04-349241","title":"CD8+ T-cell reconstitution in recipients of umbilical cord blood transplantation and characteristics associated with leukemic relapse","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Héma-Québec; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"CD8; Medicine; Immunology; Umbilical Cord Blood Transplantation; Cytotoxic T cell; Umbilical cord; T cell; Transplantation; Immune system; Antigen; Internal medicine; Biology; Human leukocyte antigen","score_opus":0.022670235560346787,"score_gpt":0.2259177517225418,"score_spread":0.20324751616219502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115235832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99555326,0.00003767738,0.00017313057,0.000008802294,0.000054825636,0.00039150365,0.00004072243,0.00003219916,0.003707888],"genre_scores_gemma":[0.99829984,0.00036529542,0.0010648592,0.000018550854,0.000011611846,0.000016892238,0.0001524255,0.000015922706,0.00005462553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989469,0.000060634797,0.00041054477,0.00023060967,0.00018646911,0.00016484874],"domain_scores_gemma":[0.99944,0.000106085296,0.00015704813,0.00013933436,0.00007408665,0.00008345298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021983733,0.00012766915,0.00030098422,0.00012103984,0.000028869985,0.000004015314,0.00003943445,0.00014782099,0.000033155447],"category_scores_gemma":[0.000064204294,0.00011626473,0.000028062777,0.00017871088,0.0001051482,0.000072534414,0.0000037673674,0.00015530728,0.0000045820066],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001003324,0.0017309457,0.92544,0.00052218616,0.00008111638,0.00025717638,0.0020939796,1.7829959e-7,0.0684821,0.00011010114,0.000001552562,0.0002773106],"study_design_scores_gemma":[0.011687485,0.0010027776,0.84211403,0.0013402998,0.0010760817,0.00056491344,0.00007508823,0.000025500296,0.1419344,0.000031015847,0.0000015401353,0.0001468794],"about_ca_topic_score_codex":0.000081383514,"about_ca_topic_score_gemma":0.000104157065,"teacher_disagreement_score":0.083326004,"about_ca_system_score_codex":0.00002515749,"about_ca_system_score_gemma":0.00011387987,"threshold_uncertainty_score":0.47411382},"labels":[],"label_agreement":null},{"id":"W2115506924","doi":"10.1182/blood-2012-07-442392","title":"Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":248,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; SickKids Foundation; University of Ottawa; Hospital for Sick Children; University of Toronto","funders":"European Hematology Association; GlaxoSmithKline; Amgen","keywords":"Medicine; Standardization; Immune thrombocytopenia; Immunology; Internal medicine; Intensive care medicine; Platelet; Political science","score_opus":0.01692550861698359,"score_gpt":0.27913498248262225,"score_spread":0.26220947386563864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115506924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99025536,0.000258218,0.000600672,0.00085934653,0.00012736223,0.0002753556,0.0000047868402,0.0000110041465,0.0076078894],"genre_scores_gemma":[0.9978746,0.00007537045,0.0017452828,0.000051332412,0.00004623252,0.000024040135,0.00012669976,0.000007543279,0.000048893507],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99931127,0.000011213963,0.00024857977,0.00011937439,0.00022683182,0.00008272773],"domain_scores_gemma":[0.9996386,0.00004606097,0.00011016349,0.00014201761,0.00004608956,0.000017038195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013641611,0.00006221438,0.00019366048,0.00003114743,0.00002554924,0.000022054151,0.000068520494,0.000032563454,0.0002082375],"category_scores_gemma":[0.000033606353,0.000041617423,0.000038165024,0.000084816296,0.000016432383,0.00007442174,0.00004077579,0.000086550965,0.0000042386823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020321597,0.0007171808,0.9670883,0.0000058788114,0.00039967304,0.00031958343,0.00025143352,0.000013425409,0.027442785,0.00018336956,0.0001659335,0.0033921627],"study_design_scores_gemma":[0.0040011974,0.000057212485,0.9890992,0.000205994,0.00012513233,0.000075159995,0.00032003844,0.00015440438,0.004613852,0.00071203214,0.00058089435,0.00005489204],"about_ca_topic_score_codex":0.00082298403,"about_ca_topic_score_gemma":0.0000656063,"teacher_disagreement_score":0.022828933,"about_ca_system_score_codex":0.000040322517,"about_ca_system_score_gemma":0.00003796494,"threshold_uncertainty_score":0.22800547},"labels":[],"label_agreement":null},{"id":"W2115764984","doi":"10.1182/blood-2010-08-301887","title":"High expression levels of B lymphocyte stimulator (BLyS) by dendritic cells correlate with HIV-related B-cell disease progression in humans","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"B-cell activating factor; Immunology; B cell; Dendritic cell; Lymphocyte; Myeloid; Biology; Antibody; Medicine; Immune system","score_opus":0.005645632567402125,"score_gpt":0.2297750329433715,"score_spread":0.22412940037596937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115764984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99650526,0.0020761464,0.000013905084,0.000029792505,0.00016853676,0.0004861238,0.00047424846,0.0000452837,0.00020073213],"genre_scores_gemma":[0.9971638,0.000041314463,0.00021107006,0.0000070019423,0.0000071105837,0.0000595526,0.00033457112,0.000026298498,0.0021493346],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99865115,0.0001486835,0.00030306322,0.00036151923,0.00009244076,0.00044313626],"domain_scores_gemma":[0.9992438,0.00010047141,0.000117758354,0.00037394502,0.000055830173,0.00010821835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011447189,0.00021157396,0.00028643265,0.00011723561,0.00011338066,0.000010657819,0.00019768273,0.00023082562,0.00088615273],"category_scores_gemma":[0.000022742255,0.00015020404,0.000059476733,0.00013206589,0.00023265228,0.000080042664,0.000077170465,0.0003811105,0.0005230871],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045576482,0.0030943034,0.017886538,0.000049189664,0.000082806095,0.00013994395,0.00016969477,0.000015838345,0.9771541,0.000022618697,0.00047681457,0.00045239198],"study_design_scores_gemma":[0.019858424,0.00042997207,0.023068996,0.0002268635,0.00011879601,0.000010628319,0.000028375682,0.0000059749277,0.95551103,0.00003166772,0.00050955283,0.00019973211],"about_ca_topic_score_codex":0.000047168993,"about_ca_topic_score_gemma":0.00001796009,"teacher_disagreement_score":0.02164308,"about_ca_system_score_codex":0.000023461245,"about_ca_system_score_gemma":0.00015641119,"threshold_uncertainty_score":0.9702751},"labels":[],"label_agreement":null},{"id":"W2115925474","doi":"10.1182/blood-2003-06-1994","title":"Extending a welcome into the uterine bed...","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Reproductive System and Pregnancy","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Fetus; Pregnancy; Immune system; Immunology; Biology; Genetics","score_opus":0.012276836195303571,"score_gpt":0.24821089121921053,"score_spread":0.23593405502390696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115925474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89830387,0.061610106,0.00015219706,0.00041644985,0.0021592665,0.00034000163,0.0000043929917,0.00009626099,0.036917437],"genre_scores_gemma":[0.99187446,0.00007456578,0.00009121671,0.000050527477,0.0000615331,0.00003149977,0.000004448574,0.000009759772,0.007802006],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99917173,0.00024498368,0.00014354523,0.00022700071,0.000017739672,0.00019502387],"domain_scores_gemma":[0.99946016,0.000050022096,0.000050265986,0.00040568638,0.000024819592,0.000009016787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002999873,0.000097677585,0.000131805,0.000030249812,0.00019812824,0.000011002396,0.00015165971,0.000071576695,0.0005744651],"category_scores_gemma":[0.00008748273,0.000060794053,0.00005657177,0.00009055173,0.00008329126,0.000042201125,0.000037026723,0.00012179112,0.0007451654],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015867918,0.00041782283,0.045537107,0.00006713468,0.000522009,0.000027832377,0.0040194136,7.2327583e-7,0.8981245,0.042812183,0.0019687982,0.0064866133],"study_design_scores_gemma":[0.0015460874,0.00012813797,0.014213022,0.000054559176,0.00006111101,0.000597202,0.00034178887,2.2679043e-8,0.4693518,0.0020598574,0.51145166,0.00019472864],"about_ca_topic_score_codex":0.00003425759,"about_ca_topic_score_gemma":0.0000053705808,"teacher_disagreement_score":0.5094829,"about_ca_system_score_codex":0.0000055553314,"about_ca_system_score_gemma":0.000015756268,"threshold_uncertainty_score":0.9577842},"labels":[],"label_agreement":null},{"id":"W2116277397","doi":"10.1182/blood-2010-11-319632","title":"Prolonged self-renewal activity unmasks telomerase control of telomere homeostasis and function of mouse hematopoietic stem cells","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Heart, Lung, and Blood Institute; BC Cancer Agency; Canadian Institutes of Health Research; Terry Fox Foundation; National Institutes of Health; Stem Cell Network","keywords":"Telomere; Telomerase; Stem cell; Biology; Haematopoiesis; Cell biology; Transplantation; Hematopoietic stem cell; Immunology; Cancer research; Genetics; Internal medicine; Medicine; DNA","score_opus":0.017724326667260256,"score_gpt":0.21308242859041143,"score_spread":0.19535810192315117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116277397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99710196,0.0013457886,0.00010605925,0.00004728339,0.000103563296,0.00078183744,0.000071445545,0.00011802344,0.00032403338],"genre_scores_gemma":[0.99880207,0.0003178473,0.00053108577,0.00005849537,0.000058705416,0.000034056906,0.0000042253264,0.000042825242,0.00015070535],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981542,0.000121414014,0.00051613775,0.0004391152,0.00040228837,0.00036681598],"domain_scores_gemma":[0.9984932,0.00011752357,0.00036584795,0.0005483098,0.00021858605,0.00025656403],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028189915,0.00030564592,0.00083405623,0.00025169674,0.00006820836,0.000008398994,0.00012108625,0.00020933151,0.00008759463],"category_scores_gemma":[0.000031083346,0.00026538412,0.00015314887,0.0003248309,0.00020802792,0.00013509844,0.00004848508,0.000229831,0.000010098124],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024877142,0.0056084385,0.10955816,0.001999131,0.0010313843,0.000081590304,0.0037728834,7.0587436e-7,0.85557544,0.00015663356,0.000047448397,0.019680498],"study_design_scores_gemma":[0.0076065795,0.0013830318,0.034626585,0.00012466362,0.0011724891,0.00007012606,0.0004997087,0.000017068183,0.95415455,0.000034309945,0.00005886181,0.00025201775],"about_ca_topic_score_codex":0.00015909373,"about_ca_topic_score_gemma":0.000021642116,"teacher_disagreement_score":0.098579146,"about_ca_system_score_codex":0.000021573978,"about_ca_system_score_gemma":0.00014573487,"threshold_uncertainty_score":0.99997985},"labels":[],"label_agreement":null},{"id":"W2116818706","doi":"10.1182/blood-2004-04-1293","title":"Induction of T-cell development from human cord blood hematopoietic stem cells by Delta-like 1 in vitro","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":294,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Women's College Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Cell biology; Biology; Haematopoiesis; Cord blood; Stem cell; T cell; CD8; Cellular differentiation; T-cell receptor; Stromal cell; Cytotoxic T cell; Antigen-presenting cell; Immunology; In vitro; Antigen; Cancer research; Immune system","score_opus":0.0172576970074286,"score_gpt":0.23793130808699672,"score_spread":0.22067361107956812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116818706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978119,0.00033236574,0.00044939833,0.000040920484,0.00012746666,0.00053550664,0.000037504935,0.000058488775,0.00060642936],"genre_scores_gemma":[0.9934457,0.000029500374,0.0059721656,0.00006652228,0.000036360434,0.000040121635,0.00020129928,0.000040665225,0.00016770017],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99810207,0.00004308597,0.0007452748,0.00038220792,0.00043289384,0.00029449127],"domain_scores_gemma":[0.99924767,0.000048836122,0.00019178493,0.00031182458,0.000064092164,0.00013581812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018328741,0.00022996224,0.00046543355,0.00015859744,0.000049760805,0.000010787195,0.0001164271,0.00018767941,0.00006242295],"category_scores_gemma":[0.000002891057,0.00023191463,0.00007082616,0.00024850536,0.000049178932,0.00006319212,0.000020684562,0.00021158527,0.000050331742],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009487646,0.0023898215,0.0020845155,0.00042175868,0.000088989465,0.00008379769,0.0024281836,0.000004313972,0.99212474,0.000014740155,0.000026569794,0.00023770597],"study_design_scores_gemma":[0.010825346,0.00020812175,0.0013629986,0.00039280183,0.00037095096,0.00006636525,0.0005423949,9.596297e-7,0.9858672,0.0000668577,0.000091391914,0.00020463667],"about_ca_topic_score_codex":0.0002602857,"about_ca_topic_score_gemma":0.00003692742,"teacher_disagreement_score":0.0107304705,"about_ca_system_score_codex":0.00006693988,"about_ca_system_score_gemma":0.00017905042,"threshold_uncertainty_score":0.94572043},"labels":[],"label_agreement":null},{"id":"W2116860515","doi":"10.1182/blood-2007-12-130096","title":"NOTCH1 extracellular juxtamembrane expansion mutations in T-ALL","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":137,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"National Cancer Institute","keywords":"Biology; Extracellular; Mutant; Mutation; Signal transduction; Exon; Cell biology; Receptor; Genetics; Gene duplication; Gene; Molecular biology","score_opus":0.01426821679231553,"score_gpt":0.2382264052336143,"score_spread":0.22395818844129878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116860515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966145,0.0021422044,0.00038095718,0.0001158262,0.00009085379,0.00014570444,0.000005262701,0.000015782522,0.0004888778],"genre_scores_gemma":[0.99767417,0.00031509282,0.0005743804,0.000041813462,0.00015534219,0.000020166368,0.00021575192,0.000018610552,0.0009846969],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992965,0.000029978324,0.00017062291,0.00024038082,0.00010150116,0.00016103161],"domain_scores_gemma":[0.9996329,0.00000598072,0.000045450633,0.0002364322,0.00003395954,0.000045284887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005997253,0.000095428404,0.00008466189,0.00005655596,0.00004678906,0.000004997748,0.000074325326,0.00014577534,0.000025874582],"category_scores_gemma":[0.00002653088,0.00010558266,0.00005145276,0.00011456228,0.00004237514,0.0000036213762,0.000027091392,0.000068741116,0.000024520787],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018884935,0.00017606934,0.0019132992,0.0000064345977,0.000020982812,0.000017677425,0.00011448435,0.0012030512,0.99534243,0.000012397113,0.00023413355,0.0009401271],"study_design_scores_gemma":[0.0022322957,0.00013015559,0.021976322,0.00001649904,0.00003562878,0.00014772125,0.000031658932,0.0003004597,0.9620273,0.000044021745,0.01283698,0.0002209736],"about_ca_topic_score_codex":0.000028923158,"about_ca_topic_score_gemma":0.0000642322,"teacher_disagreement_score":0.033315174,"about_ca_system_score_codex":0.000011086615,"about_ca_system_score_gemma":0.00006845135,"threshold_uncertainty_score":0.4305536},"labels":[],"label_agreement":null},{"id":"W2116972703","doi":"10.1182/blood-2013-03-484550","title":"Loss of the F-BAR protein CIP4 reduces platelet production by impairing membrane-cytoskeleton remodeling","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"National Heart, Lung, and Blood Institute; National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; National Institute of General Medical Sciences; Northwestern University","keywords":"Cytoskeleton; Cell biology; Biogenesis; Biology; Membrane; Chemistry; Biochemistry; Cell; Gene","score_opus":0.009408586939236312,"score_gpt":0.225434437578336,"score_spread":0.21602585063909968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116972703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99580276,0.00044580293,0.000004687923,0.0015890949,0.00008196848,0.0012081943,0.000005317145,0.00005106689,0.00081107963],"genre_scores_gemma":[0.9982894,0.00005062275,0.0003753991,0.000039847648,0.00007898855,0.00007359011,0.000015413167,0.00002392567,0.0010528093],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998992,0.000031706582,0.00024950516,0.00025500602,0.00024104044,0.00023073332],"domain_scores_gemma":[0.9994158,0.000009124724,0.000119301796,0.00031079142,0.00008216227,0.00006283292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000108113796,0.00014659016,0.00025460895,0.00003975287,0.00009148172,0.000013358492,0.00009485256,0.00007965798,0.000056500012],"category_scores_gemma":[0.00007127865,0.0000946542,0.00009020706,0.00014504469,0.00005643311,0.00012254911,0.000033527613,0.00014017663,0.000031644973],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053986885,0.0010446636,0.0032647992,0.00017739843,0.00021651511,0.000020227999,0.00029603703,0.000031868163,0.98943573,0.000009851977,0.0007425297,0.0047064177],"study_design_scores_gemma":[0.0022237957,0.0001595746,0.0013659594,0.00026075478,0.00012210675,0.00016688545,0.000099474164,0.000108716216,0.99490947,0.00018901793,0.00028487865,0.0001093786],"about_ca_topic_score_codex":0.00024669353,"about_ca_topic_score_gemma":0.000004728143,"teacher_disagreement_score":0.005473754,"about_ca_system_score_codex":0.000019975258,"about_ca_system_score_gemma":0.000050407187,"threshold_uncertainty_score":0.38598862},"labels":[],"label_agreement":null},{"id":"W21183699","doi":"10.1182/blood-2010-08-304048","title":"Hegel and Deleuze: Together Again for the First Time","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Critical Theory and Philosophy","field":"Social Sciences","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Hegelianism; Philosophy; Epistemology; Computer science; Sociology","score_opus":0.01921826813102106,"score_gpt":0.27447885373524017,"score_spread":0.2552605856042191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W21183699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.541254,0.0019250492,0.0002804922,0.104419425,0.00026125167,0.001736294,0.000030888088,0.00014823615,0.34994435],"genre_scores_gemma":[0.997298,0.000020037578,0.00014538626,0.0009683887,0.0003757358,0.000052607495,4.759848e-7,0.000004998199,0.0011343606],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99963075,0.000037166097,0.00005033763,0.000078966834,0.000067004,0.00013576332],"domain_scores_gemma":[0.9992243,0.0006131812,0.000009291994,0.0000770162,0.000027353235,0.00004886464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000294964,0.000038939754,0.000049575912,0.000006025232,0.0004163763,0.000060401802,0.00010363637,0.00003910174,0.0004696012],"category_scores_gemma":[0.00015607085,0.00002595751,0.00003039528,0.00004179368,0.00018869672,0.00006107685,0.000017263088,0.00003672166,0.00015592804],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010458526,0.00015759375,0.00026438403,0.000013269695,0.00004161405,8.105099e-7,0.005220761,5.7023226e-7,0.00027044734,0.9829792,0.0040213666,0.007019537],"study_design_scores_gemma":[0.00042032948,0.0000423671,0.00021151098,0.000007820611,0.000038499318,7.316692e-7,0.0004506897,0.000056899826,0.00022400873,0.658126,0.34032393,0.00009724756],"about_ca_topic_score_codex":0.00011918125,"about_ca_topic_score_gemma":0.000028710143,"teacher_disagreement_score":0.45604402,"about_ca_system_score_codex":0.0000025431357,"about_ca_system_score_gemma":0.000007507601,"threshold_uncertainty_score":0.51418036},"labels":[],"label_agreement":null},{"id":"W2118384332","doi":"10.1182/blood-2002-03-0932","title":"Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":312,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Hospital for Sick Children; Karolinska Institutet; Cerus Corporation","keywords":"Platelet; Buffy coat; Medicine; Hemostasis; Adverse effect; Platelet transfusion; Confidence interval; Internal medicine; Plateletpheresis; Randomized controlled trial; Gastroenterology; Whole blood; Surgery; Apheresis","score_opus":0.02656172925617649,"score_gpt":0.22913528259980304,"score_spread":0.20257355334362653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118384332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931278,0.000095557196,0.00008992933,0.0006532735,0.000056182158,0.002641174,0.00002186615,0.00006269781,0.0032514683],"genre_scores_gemma":[0.998679,0.0003908287,0.00015687087,0.00017257055,0.00007171759,0.00013075552,0.000065722685,0.000022329408,0.00031024785],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989071,0.00005794711,0.00027905064,0.00025243792,0.00033329404,0.00017018132],"domain_scores_gemma":[0.9994122,0.00004651817,0.00008424306,0.0003293455,0.000048738322,0.000078974655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008109328,0.00017079698,0.00031058304,0.000055712622,0.00007397921,0.000010190304,0.00008050452,0.00007275267,0.00020282144],"category_scores_gemma":[0.000011859292,0.000100599886,0.00011004097,0.00018023587,0.000059951137,0.00004190854,0.000012925637,0.00010067471,0.00000941302],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025003046,0.010976186,0.0014314867,0.000101773905,0.00073976524,0.000095478725,0.0018908797,0.0000027089477,0.95233077,0.000064186825,0.00023344716,0.0071302936],"study_design_scores_gemma":[0.31145608,0.0052490113,0.004814871,0.00020167818,0.0021512338,0.00010519038,0.00018812352,0.0003938143,0.66542345,0.00001585892,0.009753532,0.00024714114],"about_ca_topic_score_codex":0.00008797012,"about_ca_topic_score_gemma":0.000013711308,"teacher_disagreement_score":0.28690732,"about_ca_system_score_codex":0.00002257113,"about_ca_system_score_gemma":0.0000133181,"threshold_uncertainty_score":0.41023442},"labels":[],"label_agreement":null},{"id":"W2118999711","doi":"10.1182/blood-2007-08-019729","title":"Telomere maintenance and human bone marrow failure","year":2008,"lang":"en","type":"review","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":217,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; University of British Columbia; National Institute for Health and Care Research","keywords":"Dyskeratosis congenita; Telomere; Telomerase; Bone marrow failure; Biology; Diamond–Blackfan anemia; Telomerase RNA component; Aplastic anemia; Cancer research; Stem cell; Immunology; Haematopoiesis; Genetics; Bone marrow; Telomerase reverse transcriptase; Gene","score_opus":0.02812778388340838,"score_gpt":0.29168653155727514,"score_spread":0.2635587476738668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118999711","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007742843,0.99556327,0.0000017601825,0.00012359917,0.00011477384,0.0009472532,0.000062979496,0.00017119724,0.002240859],"genre_scores_gemma":[0.000283557,0.9922352,0.0007077797,0.0001575697,0.00059185055,0.00008280987,0.00016861493,0.00013171443,0.00564091],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99729055,0.000087953966,0.0007586104,0.0008327656,0.00040535146,0.00062474195],"domain_scores_gemma":[0.99824446,0.00008490853,0.00034059933,0.0008417445,0.00009866629,0.0003896176],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012035022,0.0007087546,0.0026370173,0.0003117794,0.00021535982,0.000036734265,0.00022535352,0.0005438263,0.0001480645],"category_scores_gemma":[0.00010963122,0.00054425915,0.00049300166,0.00042836525,0.00028796037,0.000073096686,0.000120906305,0.00083730486,0.00016061203],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015061752,0.00086023635,0.0006645219,0.037938442,0.00069434993,0.0035881128,0.00017916858,5.67327e-9,0.00007148929,0.00065044494,0.021859089,0.9334791],"study_design_scores_gemma":[0.0013925271,0.00017983955,0.00022479492,0.01478059,0.0013786773,0.009643279,0.000029397492,7.931531e-8,0.000010801462,0.000015259371,0.97179574,0.00054899266],"about_ca_topic_score_codex":0.00004778732,"about_ca_topic_score_gemma":0.000035302266,"teacher_disagreement_score":0.9499367,"about_ca_system_score_codex":0.000052082825,"about_ca_system_score_gemma":0.00029714612,"threshold_uncertainty_score":0.9997009},"labels":[],"label_agreement":null},{"id":"W2119942856","doi":"10.1182/blood-2002-04-1063","title":"Comparative analysis of murine marrow–derived dendritic cells generated by Flt3L or GM-CSF/IL-4 and matured with immune stimulatory agents on the in vivo induction of antileukemia responses","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research & Development Corporation","funders":"National Cancer Institute","keywords":"In vivo; Tumor necrosis factor alpha; Immunology; Immune system; Cytokine; Granulocyte macrophage colony-stimulating factor; Dendritic cell; Bone marrow; Lipopolysaccharide; Cancer research; Biology; Medicine","score_opus":0.021325702836557908,"score_gpt":0.24264535879995888,"score_spread":0.22131965596340097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119942856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99293756,0.0063686483,0.0000040768177,0.000051139774,0.00007716516,0.0003109713,0.0001555633,0.000016482052,0.00007840321],"genre_scores_gemma":[0.99720377,0.0006360596,0.000030031677,0.00005898427,0.0000039250876,0.000017876171,0.00003823378,0.000013877408,0.0019972601],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99836135,0.00062242144,0.00045994247,0.00025402298,0.000066027336,0.00023622075],"domain_scores_gemma":[0.9988498,0.00040692763,0.00027934235,0.00036019573,0.00009152324,0.000012200766],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023213838,0.0002263737,0.0006544088,0.00039739607,0.00011533091,0.000010828087,0.00017636536,0.00019686887,0.000986642],"category_scores_gemma":[0.000043459346,0.00014572202,0.00008591976,0.00072575983,0.0003968179,0.00007391703,0.00003453664,0.00025942066,0.000007551574],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005307578,0.0008014672,0.001041078,0.000017167229,0.0025342114,0.000008523127,0.0015185412,0.00008941708,0.98817873,0.000009689409,0.00041727378,0.00007633619],"study_design_scores_gemma":[0.0041861716,0.0007874795,0.04287468,0.00008267633,0.0005517943,0.000022540966,0.00055185077,0.0000728528,0.95033866,0.0000012123846,0.0003682198,0.00016186696],"about_ca_topic_score_codex":0.00014063809,"about_ca_topic_score_gemma":0.000034231176,"teacher_disagreement_score":0.041833602,"about_ca_system_score_codex":0.000022883829,"about_ca_system_score_gemma":0.000039690094,"threshold_uncertainty_score":0.99992657},"labels":[],"label_agreement":null},{"id":"W2120037979","doi":"10.1182/blood-2010-12-325951","title":"β2-Glycoprotein I: a novel component of innate immunity","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":126,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Lunds Universitet; Medical Research Council; ZonMw","keywords":"Innate immune system; Sepsis; Lipopolysaccharide; Immunology; Biology; Immunity; Microbiology; Immune system; Monocyte; Inflammation; Tumor necrosis factor alpha; Gram-negative bacteria; Acquired immune system; Tissue factor; Bacterial outer membrane; Neutralization; Antibody; Medicine; Escherichia coli; Internal medicine; Biochemistry","score_opus":0.024442880841813976,"score_gpt":0.21247249555939096,"score_spread":0.18802961471757698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120037979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99429893,0.00092145684,0.00021359326,0.000019193258,0.00014382895,0.00016254366,0.00000773044,0.000038297974,0.004194425],"genre_scores_gemma":[0.99926776,0.00002817926,0.0002546525,0.000019856308,0.0000064771425,0.000014397593,0.000034808858,0.000008187013,0.00036566632],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993354,0.00011127278,0.0002682918,0.00009710945,0.000021342226,0.00016660117],"domain_scores_gemma":[0.99949425,0.00003153717,0.00013436963,0.00027768954,0.00005428355,0.000007839639],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023774797,0.00009348494,0.0001757453,0.000086183936,0.0000708271,0.000002075551,0.00017051838,0.00013374934,0.0004594111],"category_scores_gemma":[0.00004688086,0.00008310796,0.00006603459,0.000082987826,0.00010962657,0.000065084714,0.00007406503,0.00015575484,0.00027345965],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024735538,0.00071175786,0.00044989574,0.000013240063,0.00015544787,0.0000016534203,0.0012365135,1.1184715e-7,0.99433213,0.0017306394,0.000033981563,0.0010872951],"study_design_scores_gemma":[0.0022882342,0.00018258081,0.032873254,0.000031121228,0.000044388988,0.000043838623,0.000121176214,6.280024e-7,0.96172583,0.00011847105,0.002478597,0.00009190299],"about_ca_topic_score_codex":0.0002866153,"about_ca_topic_score_gemma":0.0000075273433,"teacher_disagreement_score":0.032606304,"about_ca_system_score_codex":0.0000056499107,"about_ca_system_score_gemma":0.000033417964,"threshold_uncertainty_score":0.50302297},"labels":[],"label_agreement":null},{"id":"W2120303261","doi":"10.1182/blood-2014-12-618363","title":"Fatal autoimmunity in mice reconstituted with human hematopoietic stem cells encoding defective FOXP3","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institute of Allergy and Infectious Diseases; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Beth Israel Deaconess Medical Center","keywords":"Autoimmunity; Nod; Immunology; Haematopoiesis; FOXP3; Immune system; Stem cell; Humanized mouse; Major histocompatibility complex; Biology; Medicine; Cell biology; Gene; Genetics","score_opus":0.024980195081340088,"score_gpt":0.2328533231229001,"score_spread":0.20787312804156002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120303261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98133075,0.0005523469,0.000108581145,0.000017726537,0.001104734,0.00022327741,0.0000026635746,0.00009583598,0.016564092],"genre_scores_gemma":[0.99592835,0.0000067444694,0.00003145139,0.00004779813,0.000013725055,0.00002250223,0.000042407715,0.000012785636,0.0038942546],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99906665,0.00021168223,0.00023933704,0.00021601433,0.000029691744,0.00023661555],"domain_scores_gemma":[0.9995293,0.00006128378,0.00010960935,0.0001948649,0.00008323527,0.000021710002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023346067,0.00015086254,0.00021756106,0.00013924197,0.0001436046,0.000019157902,0.00012341476,0.00015691007,0.00023313805],"category_scores_gemma":[0.000015753758,0.00013337085,0.00004623092,0.00015673548,0.000120749326,0.00018760179,0.000048642898,0.00042140583,0.0005520432],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021003412,0.0006586006,0.0026721896,0.000018054523,0.00018557433,0.000019692881,0.0021482822,0.000016132391,0.99216354,0.0004323327,0.0013064622,0.00016911693],"study_design_scores_gemma":[0.00540418,0.00047426045,0.0009514976,0.00011185411,0.00008758209,0.0004224316,0.0037340524,0.0000026878533,0.9830539,0.000036775305,0.005477281,0.00024345546],"about_ca_topic_score_codex":0.00038102196,"about_ca_topic_score_gemma":0.00012856832,"teacher_disagreement_score":0.014597588,"about_ca_system_score_codex":0.00007150444,"about_ca_system_score_gemma":0.00007536299,"threshold_uncertainty_score":0.70955825},"labels":[],"label_agreement":null},{"id":"W2120433588","doi":"10.1182/blood-2002-01-0154","title":"Activation of Rac-1, Rac-2, and Cdc42 by hemopoietic growth factors or cross-linking of the B-lymphocyte receptor for antigen","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Cancer Research Institute","keywords":"LY294002; Haematopoiesis; MAPK/ERK pathway; Biology; CDC42; Cell biology; p38 mitogen-activated protein kinases; Molecular biology; Kinase; Signal transduction; PI3K/AKT/mTOR pathway; Stem cell","score_opus":0.012034443421880599,"score_gpt":0.2270070833372741,"score_spread":0.2149726399153935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120433588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978909,0.0005972227,0.0010814688,0.000032037,0.00007361321,0.00023485349,0.00003206156,0.0000036808126,0.000054154447],"genre_scores_gemma":[0.99823415,0.00048823605,0.0005661537,0.000020436188,0.000052714786,0.0000063596162,0.00005980552,0.000013549975,0.0005586185],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994616,0.000019210423,0.00017251838,0.00016118694,0.0000847795,0.000100718],"domain_scores_gemma":[0.9995739,0.000020490968,0.00015502868,0.00014963672,0.000078651196,0.000022305838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007545215,0.00008754926,0.0001088584,0.000016226328,0.00007284054,0.000010081813,0.00008330017,0.00012244676,0.000023333829],"category_scores_gemma":[0.000061019375,0.00005787491,0.00006662679,0.00005748959,0.0000566649,0.000004958744,0.00004095194,0.000023654698,1.8249558e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044561788,0.00010519753,0.005030729,0.00006545777,0.00003567799,2.8587426e-8,0.00009343652,0.0000046550635,0.9933251,0.00003728504,0.0001204646,0.0011373634],"study_design_scores_gemma":[0.00133263,0.000165511,0.0035647738,0.000026201902,0.000025487561,0.0000017853263,0.000032181884,0.00008735442,0.99298924,0.00006787542,0.0016297307,0.000077225974],"about_ca_topic_score_codex":0.000010342989,"about_ca_topic_score_gemma":0.000001692947,"teacher_disagreement_score":0.0015092661,"about_ca_system_score_codex":0.0000044369613,"about_ca_system_score_gemma":0.000015673999,"threshold_uncertainty_score":0.23600702},"labels":[],"label_agreement":null},{"id":"W2120483230","doi":"10.1182/blood-2006-04-018564","title":"VCAM-1 expression on dystrophic muscle vessels has a critical role in the recruitment of human blood-derived CD133+ stem cells after intra-arterial transplantation","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Transplantation: Methods and Outcomes","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Stem cell; Transplantation; Blood vessel; Pathology; Medicine; Biology; Anatomy; Cell biology; Internal medicine","score_opus":0.04383374526127438,"score_gpt":0.30803615864873796,"score_spread":0.2642024133874636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120483230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978466,0.000143776,0.00036525997,0.00040167195,0.00013494582,0.0007289257,0.00006073731,0.000030250945,0.00028783735],"genre_scores_gemma":[0.997009,0.000037171718,0.0022944321,0.00014419892,0.0002452702,0.0001841347,0.00004510638,0.00002123662,0.000019441632],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99836135,0.0002979128,0.0004669383,0.0002767044,0.00035580352,0.00024131339],"domain_scores_gemma":[0.999329,0.0002449045,0.00007142942,0.00026021828,0.00003985148,0.00005461168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028372902,0.00018365367,0.00032322857,0.00010814608,0.00007990006,0.000032841825,0.00010135962,0.00012012677,0.00007064698],"category_scores_gemma":[0.0000060137227,0.00012758496,0.00010607996,0.00011278783,0.00009298684,0.00007300734,0.000005232227,0.0001852432,0.0000056770455],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043141507,0.0015770142,0.0025735248,0.0003055439,0.00002475924,0.00028603853,0.0025342538,0.0000051355514,0.9913563,0.00048851466,0.000008660704,0.00040880084],"study_design_scores_gemma":[0.006583188,0.0007293924,0.2184124,0.0004935333,0.0005510651,0.000044945144,0.00032254466,0.0000041536996,0.7723113,0.0003397661,0.00007222843,0.00013553309],"about_ca_topic_score_codex":0.00007630107,"about_ca_topic_score_gemma":0.000040582745,"teacher_disagreement_score":0.21904509,"about_ca_system_score_codex":0.000011858904,"about_ca_system_score_gemma":0.000038347254,"threshold_uncertainty_score":0.52027637},"labels":[],"label_agreement":null},{"id":"W2120566462","doi":"10.1182/blood-2011-11-391748","title":"IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":500,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute; Institut National Du Cancer; National Institutes of Health; Institut Universitaire de France; Terry Fox Foundation; Canadian Institutes of Health Research; Leukemia and Lymphoma Society","keywords":"IDH2; Isocitrate dehydrogenase; IDH1; Cancer research; Lymphoma; Biology; Mutation; Angioimmunoblastic T-cell lymphoma; Pathology; Medicine; T cell; Immunology; Gene; Genetics; Enzyme","score_opus":0.017626236859604884,"score_gpt":0.27175941811233933,"score_spread":0.25413318125273443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120566462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98859125,0.0017487915,0.000057985137,0.00033972174,0.00008092216,0.00029963948,0.000009629306,0.000053047217,0.008819034],"genre_scores_gemma":[0.99753636,0.000037074034,0.0009315762,0.00019576513,0.00019387652,0.00005745963,0.000031615764,0.00002899074,0.0009872534],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988726,0.000046828496,0.00020031829,0.00015208675,0.00025772065,0.00047046907],"domain_scores_gemma":[0.99930334,0.00010300012,0.00004686821,0.00030089627,0.000058103065,0.00018777545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019490754,0.00011483862,0.00019222197,0.00019956214,0.000045626635,0.000012034266,0.00010007392,0.00008811983,0.00017399152],"category_scores_gemma":[0.00017295893,0.000103404214,0.00006472496,0.00034056779,0.00005453692,0.00010043074,0.000053793694,0.00015831976,0.0006616689],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016318394,0.011997544,0.8562395,0.00039597123,0.0002453435,0.00083215476,0.003616546,0.00001633768,0.11675666,0.0005362527,0.0038371207,0.005363376],"study_design_scores_gemma":[0.018275408,0.00021953748,0.91940665,0.00019141128,0.00024413744,0.00035748296,0.0011930318,0.00012663094,0.055131946,0.00008708473,0.0044921935,0.00027446786],"about_ca_topic_score_codex":0.00012082494,"about_ca_topic_score_gemma":0.000015680891,"teacher_disagreement_score":0.06316716,"about_ca_system_score_codex":0.0002262879,"about_ca_system_score_gemma":0.00019933473,"threshold_uncertainty_score":0.85046357},"labels":[],"label_agreement":null},{"id":"W2121228422","doi":"10.1182/blood-2004-09-3473","title":"Quantitative RT-PCR analysis of activation-induced cytidine deaminase expression in tissue samples from mantle cell lymphoma and B-cell chronic lymphocytic leukemia patients","year":2005,"lang":"en","type":"letter","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Cytidine deaminase; Activation-induced (cytidine) deaminase; Somatic hypermutation; Germinal center; Mantle cell lymphoma; Chronic lymphocytic leukemia; Immunoglobulin class switching; Molecular biology; Biology; Cytidine; B cell; Antibody; Cancer research; Lymphoma; Leukemia; Immunology; Enzyme; Biochemistry","score_opus":0.02248725891153662,"score_gpt":0.2794664427859763,"score_spread":0.2569791838744397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121228422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947215,0.0017557038,0.00005902014,0.0010538342,0.00007648146,0.0011665912,0.0005498967,0.000053691318,0.0005632999],"genre_scores_gemma":[0.9826353,0.00076858635,0.0021525428,0.0050983937,0.0008915438,0.00014870579,0.006623112,0.00019775059,0.0014840561],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9949544,0.00029449325,0.0011690765,0.0013062716,0.001393854,0.00088187424],"domain_scores_gemma":[0.99608755,0.0014114769,0.00072982506,0.0012125229,0.00032857995,0.00023007017],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025679034,0.0007518906,0.0018568909,0.0016616696,0.000094534334,0.000051100986,0.00043919316,0.0011934132,0.00040030404],"category_scores_gemma":[0.00030076632,0.0006973745,0.00030078753,0.0013850811,0.00019721029,0.00020403424,0.00032483236,0.00076170574,0.00008372847],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.003884323,0.009198663,0.01174852,0.011851285,0.008632976,0.0050757197,0.0065667434,0.0016453037,0.76467854,0.000009156288,0.16419896,0.01250978],"study_design_scores_gemma":[0.12266408,0.0011472554,0.0090706665,0.0018455844,0.0054867226,0.000017206361,0.00023023863,0.011825335,0.83541226,0.00001974404,0.011228633,0.0010522797],"about_ca_topic_score_codex":0.0088343695,"about_ca_topic_score_gemma":0.0004275111,"teacher_disagreement_score":0.15297033,"about_ca_system_score_codex":0.04177103,"about_ca_system_score_gemma":0.015484459,"threshold_uncertainty_score":0.9995477},"labels":[],"label_agreement":null},{"id":"W2122021478","doi":"10.1182/blood-2005-09-3869","title":"Prospective comparison of autologous stem cell transplantation followed by dose-reduced allograft (IFM99-03 trial) with tandem autologous stem cell transplantation (IFM99-04 trial) in high-risk de novo multiple myeloma","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":370,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital","funders":"","keywords":"Medicine; Melphalan; Transplantation; Autologous stem-cell transplantation; Multiple myeloma; Surgery; Internal medicine; Regimen; Vincristine; Clinical trial; Stem cell; Cyclophosphamide; Chemotherapy; Biology","score_opus":0.015402233590398533,"score_gpt":0.26716109181650316,"score_spread":0.2517588582261046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122021478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99031657,0.00070719107,0.0005816655,0.00006367233,0.00015826109,0.0069151707,0.00048576816,0.00021856395,0.0005531241],"genre_scores_gemma":[0.9950643,0.0002600391,0.002391032,0.000012357991,0.00010225632,0.0007626742,0.0009067978,0.00009377463,0.00040673057],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9952637,0.0006440171,0.0013051252,0.00091547065,0.00091024494,0.00096143084],"domain_scores_gemma":[0.9977233,0.000633287,0.00067906664,0.00047652848,0.00019113644,0.0002967237],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005431049,0.0006132061,0.0014245913,0.00043608926,0.00020233447,0.000049244936,0.0002482867,0.00046612526,0.00001942203],"category_scores_gemma":[0.000020749672,0.000510094,0.00027202666,0.00067191274,0.00015021466,0.0001851158,0.000015643032,0.000581901,0.00001746437],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28896576,0.013297972,0.5881867,0.00072084053,0.00052770186,0.0012256334,0.0033280118,0.0003141338,0.100144915,0.000015557118,0.000070171554,0.0032026526],"study_design_scores_gemma":[0.40833226,0.0069310013,0.26568535,0.00014917548,0.0012374789,0.00009095064,0.00041411017,0.0003499952,0.3164395,0.000017715529,0.000010660283,0.00034179597],"about_ca_topic_score_codex":0.0029520239,"about_ca_topic_score_gemma":0.0030074487,"teacher_disagreement_score":0.3225013,"about_ca_system_score_codex":0.0003027277,"about_ca_system_score_gemma":0.0004771034,"threshold_uncertainty_score":0.99973506},"labels":[],"label_agreement":null},{"id":"W2122083453","doi":"10.1182/blood.v97.8.2390","title":"Regulation of nuclear factor of activated T cells by phosphotyrosyl-specific phosphatase activity: a positive effect on HIV-1 long terminal repeat–driven transcription and a possible implication of SHP-1","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Signaling Pathways in Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"Medical Research Council; Canadian Institutes of Health Research","keywords":"NFAT; Jurkat cells; Transcription factor; Phosphatase; Molecular biology; T cell; Biology; Cell biology; Long terminal repeat; Protein tyrosine phosphatase; HIV Long Terminal Repeat; Kinase; Phosphorylation; Biochemistry; Gene expression; Immunology; Immune system; Gene","score_opus":0.006633602514455158,"score_gpt":0.22047088272591503,"score_spread":0.21383728021145987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122083453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983427,0.00040054717,0.00016111374,0.000012314296,0.000023321601,0.0003481234,0.00065949373,0.000009771281,0.00004263216],"genre_scores_gemma":[0.9994272,0.00008031429,0.00010531092,0.000007992221,0.000020020454,0.000010056686,0.00030508323,0.000023119474,0.000020881082],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991081,0.00008152772,0.00021973577,0.00031593954,0.00014940773,0.00012531286],"domain_scores_gemma":[0.99925596,0.000029434448,0.00025957392,0.00031339595,0.00008104564,0.000060599366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008076113,0.00014854106,0.0002086866,0.00004415547,0.000033190747,0.000007731395,0.00009184078,0.00013134479,0.000019295867],"category_scores_gemma":[0.000021784776,0.00014965353,0.0000894263,0.00010746207,0.00009326498,0.000012128042,0.000023138262,0.000058632104,8.955604e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001762411,0.000659351,0.0033558607,0.0000777624,0.000077640456,0.0000027921012,0.00011425044,0.000015071827,0.991427,0.000009009128,0.00008706963,0.002411771],"study_design_scores_gemma":[0.001814888,0.0012889653,0.03490545,0.000099715384,0.00008708845,0.000009282645,0.000012221431,0.000030350404,0.9615883,0.0000058648234,0.000037634883,0.00012023779],"about_ca_topic_score_codex":0.000023431418,"about_ca_topic_score_gemma":8.275983e-7,"teacher_disagreement_score":0.031549588,"about_ca_system_score_codex":0.000012778913,"about_ca_system_score_gemma":0.00002224567,"threshold_uncertainty_score":0.61026937},"labels":[],"label_agreement":null},{"id":"W2123159083","doi":"10.1182/blood-2012-09-452375","title":"Pomalidomide plus low-dose dexamethasone is active and well tolerated in bortezomib and lenalidomide–refractory multiple myeloma: Intergroupe Francophone du Myélome 2009-02","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":208,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital","funders":"Agence Nationale de la Recherche; Celgene; American Society of Hematology","keywords":"Pomalidomide; Lenalidomide; Bortezomib; Multiple myeloma; Dexamethasone; Medicine; Refractory (planetary science); Thalidomide; Oncology; Salvage therapy; Internal medicine; Pharmacology; Chemotherapy; Materials science","score_opus":0.010772124904402184,"score_gpt":0.2453502164545257,"score_spread":0.23457809155012352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123159083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99449223,0.0023362976,0.000025606869,0.0005518206,0.00011230054,0.001698527,0.00006380601,0.00007634172,0.00064308353],"genre_scores_gemma":[0.9964617,0.00093725236,0.0009257738,0.00043426192,0.0001852276,0.0002568799,0.000071741255,0.000069141606,0.0006580259],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973707,0.00016979587,0.0005327208,0.00075718184,0.00041583643,0.0007537494],"domain_scores_gemma":[0.9980986,0.00045141412,0.00014501347,0.00045109622,0.00020402594,0.0006498157],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021176871,0.00045821635,0.0008515613,0.00039218055,0.00012189521,0.000090248075,0.00012965029,0.00025360662,0.00082618964],"category_scores_gemma":[0.0004236561,0.0003853039,0.00009869583,0.0004388379,0.00023800916,0.0004261525,0.00018828787,0.00051721226,0.0002895746],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008720486,0.006904829,0.72526497,0.00060515234,0.0019026623,0.0030803054,0.007192738,0.0000046153577,0.19849528,0.000008108201,0.0030129428,0.044807907],"study_design_scores_gemma":[0.06796651,0.00092011434,0.87045246,0.00035520626,0.00013314855,0.00028449923,0.0010458741,0.0027712744,0.055245947,0.000049794806,0.00034605328,0.00042909032],"about_ca_topic_score_codex":0.0037880924,"about_ca_topic_score_gemma":0.00033284945,"teacher_disagreement_score":0.14518751,"about_ca_system_score_codex":0.00014337346,"about_ca_system_score_gemma":0.00016467764,"threshold_uncertainty_score":0.99985987},"labels":[],"label_agreement":null},{"id":"W2124356384","doi":"10.1182/blood-2009-06-228791","title":"CD43 processing and nuclear translocation of CD43 cytoplasmic tail are required for cell homeostasis","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"CD43; Cell biology; Biology; Apoptosis; Molecular biology; Biochemistry; Immunology; Antigen","score_opus":0.011579684997547782,"score_gpt":0.22476481138107535,"score_spread":0.21318512638352757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124356384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9623074,0.03670242,0.00016757345,0.00026011796,0.00006142889,0.0002721127,0.000028128006,0.000046617944,0.00015421401],"genre_scores_gemma":[0.99810165,0.0009885198,0.0003250839,0.0001357276,0.000011089402,0.000009668998,0.000025428266,0.000016760196,0.00038609412],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992434,0.000072093404,0.0002601982,0.00018724745,0.000022047081,0.00021505624],"domain_scores_gemma":[0.99953514,0.000060712304,0.0001672229,0.00016142846,0.000065868066,0.000009650563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014823084,0.00013226573,0.00025450444,0.00008883325,0.00017899924,0.000014339859,0.00011281639,0.00017783487,0.000030720526],"category_scores_gemma":[0.000023344448,0.00012370615,0.00007114636,0.00009471135,0.00011032827,0.00011825339,0.0000074584464,0.00009069547,0.000011442691],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083748746,0.00043229604,0.000088010216,0.00007318653,0.0000562763,6.6290204e-7,0.0012480982,4.127467e-7,0.9388287,0.000099307224,0.000091946386,0.05824359],"study_design_scores_gemma":[0.006021908,0.00089702004,0.0037576347,0.00012133282,0.00011279597,0.000045046738,0.0007426283,0.0000041000676,0.97863454,0.00014034752,0.009335745,0.00018687897],"about_ca_topic_score_codex":0.0000065325285,"about_ca_topic_score_gemma":0.0000014491249,"teacher_disagreement_score":0.058056712,"about_ca_system_score_codex":0.0000068257395,"about_ca_system_score_gemma":0.00004188037,"threshold_uncertainty_score":0.504459},"labels":[],"label_agreement":null},{"id":"W2124789060","doi":"10.1182/blood-2011-10-385377","title":"Bilateral adrenal EBV-associated smooth muscle tumors in a child with a natural killer cell deficiency","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Natural killer cell; Medicine; Immunology; Pathology; Biology; Cancer research; Cytotoxic T cell","score_opus":0.00472027574889784,"score_gpt":0.18573158326730566,"score_spread":0.18101130751840783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124789060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872449,0.0019086971,0.000004560922,0.00006024216,0.0019406071,0.00014684463,0.0000015879215,0.00006921955,0.0086233225],"genre_scores_gemma":[0.99381626,0.00001305049,0.000014317428,0.0001642694,0.000032106786,0.000016250655,0.00009696371,0.000016881928,0.0058299173],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99898136,0.000113129194,0.00021626745,0.00018456808,0.00003690173,0.0004677854],"domain_scores_gemma":[0.9996746,0.000029565548,0.00010295704,0.00014208218,0.000029789704,0.000020960146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013810524,0.00016096557,0.00017772608,0.00014201987,0.00013227094,0.000013483241,0.00009648988,0.00013730949,0.0008511903],"category_scores_gemma":[0.000023750554,0.00012240502,0.00006333726,0.00020273356,0.000056026223,0.0002075952,0.000032745014,0.00045608255,0.00048248583],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094863324,0.012003301,0.17703709,0.000052170373,0.0003218494,0.000060505317,0.0066793067,0.00002100243,0.793234,0.00036835484,0.0077467836,0.0015270313],"study_design_scores_gemma":[0.011684181,0.00074589835,0.8439528,0.0001655202,0.00015041954,0.00050952693,0.0008626941,0.000009324179,0.11766798,0.000007770999,0.023603685,0.0006402111],"about_ca_topic_score_codex":0.00018236437,"about_ca_topic_score_gemma":0.00004719647,"teacher_disagreement_score":0.67556596,"about_ca_system_score_codex":0.00003925038,"about_ca_system_score_gemma":0.000024646299,"threshold_uncertainty_score":0.93199366},"labels":[],"label_agreement":null},{"id":"W2125028785","doi":"10.1182/blood-2006-05-023796","title":"A role for IL-1 receptor antagonist or other cytokines in the acute therapeutic effects of IVIg?","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Receptor antagonist; Immunology; Receptor; Medicine; Mechanism of action; Interleukin; Immune system; Interleukin 1 receptor antagonist; Proinflammatory cytokine; Cytokine; Biology; Antagonist; Inflammation; In vitro; Internal medicine","score_opus":0.00831932442796028,"score_gpt":0.2572748859433157,"score_spread":0.24895556151535544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125028785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99680215,0.0008282628,0.000016816715,0.00041468863,0.000032885768,0.0008128119,0.000048022255,0.000015369775,0.0010289756],"genre_scores_gemma":[0.99843633,0.00004784267,0.00028369506,0.00036974985,0.00006198571,0.00013494541,0.000029597735,0.000018038016,0.0006178094],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99947995,0.00002133047,0.00012801292,0.00011838982,0.00009695082,0.0001553866],"domain_scores_gemma":[0.99964327,0.00012410188,0.00004582071,0.00015421717,0.00001778368,0.000014822976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000056363308,0.00010042958,0.00022129857,0.0000378355,0.00003086443,0.000007995881,0.00006309994,0.000047364443,0.00001658768],"category_scores_gemma":[0.000011242616,0.000052547897,0.00006938761,0.00011285362,0.000029167213,0.00002089108,0.000005874052,0.000040917366,0.000007366923],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041602394,0.024617225,0.17268322,0.0010972001,0.0027073347,0.00083791936,0.0023211746,0.0000024248766,0.7636112,0.0016008721,0.0040201284,0.022341043],"study_design_scores_gemma":[0.07089937,0.0058710165,0.16208398,0.0005001158,0.0034482556,0.00040541074,0.0004746624,0.00007755345,0.69242746,0.0041452902,0.059165373,0.0005014908],"about_ca_topic_score_codex":0.00013888378,"about_ca_topic_score_gemma":0.00011740757,"teacher_disagreement_score":0.07118373,"about_ca_system_score_codex":0.0000066638713,"about_ca_system_score_gemma":0.00002694845,"threshold_uncertainty_score":0.21428409},"labels":[],"label_agreement":null},{"id":"W2125288397","doi":"10.1182/blood-2002-07-2231","title":"Nonmalignant late effects after allogeneic stem cell transplantation","year":2003,"lang":"en","type":"review","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":426,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Memorial University of Newfoundland","keywords":"Transplantation; Stem cell; Medicine; Oncology; Internal medicine; Biology","score_opus":0.019373764331088384,"score_gpt":0.2692597652514183,"score_spread":0.24988600092032992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125288397","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021070638,0.9916494,0.00026297465,0.0000041923654,0.00032418247,0.00235007,0.00008346946,0.00009683107,0.003121854],"genre_scores_gemma":[0.0004531267,0.99564165,0.0006170545,0.00008425148,0.000108351815,0.0005244128,0.00040106196,0.00014953944,0.0020205744],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99746317,0.00028497056,0.00078397896,0.0006148189,0.00041181402,0.00044127952],"domain_scores_gemma":[0.99875593,0.00023379127,0.0002480965,0.0004897171,0.00004731267,0.00022513936],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024355078,0.0006043891,0.0017545222,0.00023863686,0.00004277531,0.000025632198,0.0001203619,0.00057271286,0.00010768717],"category_scores_gemma":[0.0000025192485,0.00047629475,0.000597077,0.00028425994,0.000031527074,0.000045785546,0.0000069919306,0.000347307,0.00070262974],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007834817,0.0011626811,0.00023088293,0.7194974,0.0009685737,0.00781872,0.00070920127,5.067659e-7,0.00034549128,0.000025488878,0.000048854297,0.2691139],"study_design_scores_gemma":[0.009681127,0.0007701097,0.00027975652,0.12968868,0.0701812,0.0069848658,0.000016109856,0.0000013125674,0.012270138,0.000011523646,0.7682904,0.0018247843],"about_ca_topic_score_codex":0.0000032624753,"about_ca_topic_score_gemma":0.0000021591538,"teacher_disagreement_score":0.7682415,"about_ca_system_score_codex":0.000051061917,"about_ca_system_score_gemma":0.00027395145,"threshold_uncertainty_score":0.99976885},"labels":[],"label_agreement":null},{"id":"W2125397216","doi":"10.1182/blood-2011-03-342733","title":"Thrombin and diabetic nephropathy","year":2011,"lang":"en","type":"letter","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Protein C; Coagulation; Thrombin; Chemistry; Protein S; Biochemistry; Medicine; Internal medicine; Pharmacology; Endocrinology; Platelet","score_opus":0.0275114341452655,"score_gpt":0.23724570794757077,"score_spread":0.20973427380230528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125397216","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22596458,0.005814389,0.0001406987,0.703018,0.0019488516,0.0024151509,0.00007794321,0.0008926101,0.059727754],"genre_scores_gemma":[0.097000875,0.0002528536,0.0013452561,0.8936115,0.0029119134,0.000057370893,0.0002458532,0.00015400226,0.004420403],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986897,0.000052631152,0.00024619917,0.0004183361,0.00027547523,0.00031761947],"domain_scores_gemma":[0.9992066,0.00003252702,0.00011019757,0.0004857523,0.000058250178,0.00010668867],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008764242,0.00029359953,0.0005678458,0.00013810542,0.00005774188,0.000026837984,0.00009219105,0.00070750393,0.00078284467],"category_scores_gemma":[0.000022552005,0.00025820182,0.000116587406,0.00009441289,0.00008419133,0.000037061687,0.00006931466,0.0009029368,0.00022741244],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012390496,0.000721899,0.0016411978,0.00079929654,0.00077761896,0.0010676937,0.00037156738,5.507368e-9,0.008465038,0.0008278713,0.98411065,0.0012047435],"study_design_scores_gemma":[0.011691703,0.0019033226,0.021620706,0.0010522885,0.0076463283,0.0016947724,0.000043685166,0.0000104584215,0.05042421,0.009301057,0.89319426,0.0014171968],"about_ca_topic_score_codex":0.00001770657,"about_ca_topic_score_gemma":0.0000010774633,"teacher_disagreement_score":0.19059344,"about_ca_system_score_codex":0.000009155348,"about_ca_system_score_gemma":0.000061931445,"threshold_uncertainty_score":0.999987},"labels":[],"label_agreement":null},{"id":"W2126364067","doi":"10.1182/blood-2005-11-4670","title":"CD43, a novel lymphocyte ligand for E-selectin","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Selectin; CD43; Ligand (biochemistry); E-selectin; Cell adhesion molecule; L-selectin; P-selectin; Lymphocyte; Immunology; Chemistry; Cell adhesion; Cell biology; Biology; Biochemistry; Cell; Antigen; Receptor","score_opus":0.019240842993459746,"score_gpt":0.286197514431745,"score_spread":0.2669566714382853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126364067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835069,0.0006019944,0.001675862,0.0004582549,0.000040584753,0.0006229032,0.0000109594985,0.000074955584,0.013007575],"genre_scores_gemma":[0.97282493,0.000022574699,0.0077002714,0.0002608771,0.00045001524,0.00008322229,0.000040549363,0.000044796874,0.018572738],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990761,0.0000068743707,0.00015554245,0.00022080436,0.00024400273,0.0002966347],"domain_scores_gemma":[0.9994724,0.00008112352,0.000028454977,0.00021126674,0.00011479403,0.000092003975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012373057,0.000093522416,0.00016233209,0.00009330268,0.00005808372,0.00001931773,0.00006966368,0.000069928334,0.000050857518],"category_scores_gemma":[0.00012495006,0.00008204376,0.00009056775,0.0001904289,0.000028263601,0.00001783636,0.000030483456,0.00007859308,0.00008105572],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001739182,0.0010612761,0.0026195382,0.00008839898,0.00003922968,0.000037667654,0.000017829221,0.0000017368577,0.9896237,0.0002366903,0.0045957724,0.0015042066],"study_design_scores_gemma":[0.011824386,0.00038882924,0.00812497,0.00003504722,0.00010364992,0.0001753087,0.0000116922165,0.00022733556,0.9199784,0.00013445126,0.058879547,0.00011639006],"about_ca_topic_score_codex":0.00009686097,"about_ca_topic_score_gemma":0.000024866471,"teacher_disagreement_score":0.069645345,"about_ca_system_score_codex":0.000040970488,"about_ca_system_score_gemma":0.00017493936,"threshold_uncertainty_score":0.33456475},"labels":[],"label_agreement":null},{"id":"W2127016965","doi":"10.1182/blood.v97.11.3581","title":"Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":217,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Breakpoint; Haploinsufficiency; Biology; Chromosomal translocation; breakpoint cluster region; Myeloid leukemia; Leukemia; Fluorescence in situ hybridization; Comparative genomic hybridization; Genetics; Cytogenetics; Gene rearrangement; Molecular biology; Chromosome; Cancer research; Gene; Phenotype","score_opus":0.018409199722548987,"score_gpt":0.26336061842172,"score_spread":0.244951418699171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127016965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99552786,0.0013004036,0.000012167794,0.00066349376,0.000082005594,0.0012190118,0.00011420513,0.000072803545,0.0010080193],"genre_scores_gemma":[0.9957054,0.00028939883,0.0018291901,0.00074554613,0.000103348575,0.00014630145,0.00019958818,0.000046209934,0.0009349944],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983608,0.000042104217,0.00038777493,0.0004826403,0.000316389,0.0004102874],"domain_scores_gemma":[0.99897075,0.000040748666,0.00016657943,0.00042847483,0.0001590559,0.00023440328],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00006897112,0.00026327453,0.00053509924,0.00012386222,0.000083526385,0.00002003095,0.00012064752,0.00011685121,0.000109946355],"category_scores_gemma":[0.00006191656,0.00024861807,0.00008072973,0.00025961222,0.000094720366,0.00008514275,0.00009684921,0.00015288762,0.00005094111],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016787584,0.0010348499,0.5319323,0.00021610987,0.0004519444,0.00016053315,0.00027684646,0.0000010032613,0.45693272,0.000004346618,0.0071689654,0.0016525252],"study_design_scores_gemma":[0.014565106,0.0007607505,0.8374406,0.00067500013,0.000750175,0.00033637972,0.00015861061,0.0000093589215,0.14237902,0.0000104475785,0.0026398983,0.0002746305],"about_ca_topic_score_codex":0.00030384553,"about_ca_topic_score_gemma":0.00005336544,"teacher_disagreement_score":0.31455368,"about_ca_system_score_codex":0.0005617577,"about_ca_system_score_gemma":0.0002633773,"threshold_uncertainty_score":0.9999966},"labels":[],"label_agreement":null},{"id":"W2127143739","doi":"10.1182/blood.v99.3.731","title":"Comparison of 200 mg/m2 melphalan and 8 Gy total body irradiation plus 140 mg/m2 melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myelome 9502 randomized trial","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":566,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Melphalan; Total body irradiation; Medicine; Transplantation; Conditioning; Surgery; Stem cell; Peripheral Blood Stem Cells; Peripheral blood; Hematopoietic stem cell transplantation; Chemotherapy; Internal medicine; Cyclophosphamide; Biology","score_opus":0.014935343163142592,"score_gpt":0.2591304528636316,"score_spread":0.24419510970048902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127143739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952488,0.0003977203,0.00015781204,0.000055790915,0.00008570844,0.0036625946,0.00025479478,0.00002225254,0.00011453968],"genre_scores_gemma":[0.9981316,0.00008562856,0.0003668703,0.000015278058,0.00007684081,0.0003730793,0.0008097127,0.00003286228,0.00010816216],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99727064,0.00035689882,0.0009140129,0.00043037615,0.0006500242,0.00037801694],"domain_scores_gemma":[0.99792176,0.00084690936,0.00054607575,0.00030319055,0.00021510001,0.00016695732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032933868,0.00031277552,0.0014309067,0.00042103292,0.00013785629,0.000028948156,0.00012038795,0.00014564935,0.000116369396],"category_scores_gemma":[0.00016550325,0.00022395456,0.00033754547,0.00067874725,0.0001712751,0.00015742051,0.000022836986,0.00019852539,0.0000016808727],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32675385,0.0055907625,0.653945,0.00028457545,0.003394917,0.000042993004,0.0070855366,0.00043995725,0.0017613011,0.000010052708,0.000028547236,0.0006624932],"study_design_scores_gemma":[0.5838262,0.001930649,0.3884641,0.000118618955,0.0029656007,0.0000061788014,0.0003670304,0.018800236,0.0033776355,0.0000029888174,0.0000015445133,0.00013925454],"about_ca_topic_score_codex":0.000689636,"about_ca_topic_score_gemma":0.0004149266,"teacher_disagreement_score":0.26548094,"about_ca_system_score_codex":0.00008086859,"about_ca_system_score_gemma":0.000083847415,"threshold_uncertainty_score":0.91326016},"labels":[],"label_agreement":null},{"id":"W2127738098","doi":"10.1182/blood-2005-05-2003","title":"Loss of expression of the Hoxa-9 homeobox gene impairs the proliferation and repopulating ability of hematopoietic stem cells","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":229,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of British Columbia; BC Cancer Agency","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Homeobox; Haematopoiesis; Biology; Stem cell; Cell biology; Gene; Gene expression; Cancer research; Genetics","score_opus":0.013893690854224327,"score_gpt":0.24426395810208618,"score_spread":0.23037026724786186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127738098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984476,0.0002770823,0.00020246972,0.00019626597,0.00003403232,0.00068486907,0.000009892544,0.000011120604,0.00013666456],"genre_scores_gemma":[0.99856925,0.000027529139,0.0013017646,0.000014860248,0.000036510424,0.000012469723,0.0000024722426,0.000011303743,0.000023845721],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998678,0.00011216346,0.0006092167,0.00016028546,0.00033337122,0.000106954685],"domain_scores_gemma":[0.9989052,0.00014784161,0.0003588694,0.0004444714,0.00010736717,0.000036283378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004700504,0.000098964054,0.0002852197,0.000029463587,0.000046260782,0.0000036706206,0.00008063983,0.00007280627,0.000011955747],"category_scores_gemma":[0.00003373089,0.00005541062,0.00008051231,0.0001299124,0.00012805987,0.00004341732,0.000028093717,0.00008758994,5.136154e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004704068,0.00027466458,0.15713723,0.0011653218,0.000022312,0.000001064021,0.0038548093,0.000056572153,0.83716255,0.00004385487,0.000004710131,0.0002298982],"study_design_scores_gemma":[0.0012156933,0.00008735976,0.057679992,0.00045584806,0.00018272258,0.000089600326,0.00041159417,0.00018453883,0.9396013,0.000043345906,0.0000029897874,0.000045022403],"about_ca_topic_score_codex":0.000016281314,"about_ca_topic_score_gemma":0.0000047665117,"teacher_disagreement_score":0.10243877,"about_ca_system_score_codex":0.000010256996,"about_ca_system_score_gemma":0.000050444145,"threshold_uncertainty_score":0.22595794},"labels":[],"label_agreement":null},{"id":"W2128214001","doi":"10.1182/blood-2005-04-1512","title":"Platelet PECAM-1 inhibits thrombus formation in vivo","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":211,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; Biotechnology and Biological Sciences Research Council; Medical Research Council; Directorate for Biological Sciences; University of Toronto; National Institutes of Health; University of Reading; British Heart Foundation; Wellcome Trust; Amgen","keywords":"Platelet; Thrombus; Cremaster muscle; Cell biology; Platelet activation; Endothelial stem cell; Biology; In vivo; Endothelium; Chemistry; Immunology; Internal medicine; Endocrinology; In vitro; Medicine; Biochemistry","score_opus":0.019122656709231387,"score_gpt":0.2854901140581193,"score_spread":0.2663674573488879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128214001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9762871,0.00021099758,0.000028550088,0.0010261091,0.000013800783,0.00028216085,0.0000024166259,0.00004004372,0.022108817],"genre_scores_gemma":[0.9971721,0.000090064794,0.0009084674,0.00028708111,0.00011283863,0.000010389141,0.00001161542,0.000014490786,0.0013929621],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990948,0.00002408901,0.00019847738,0.00013890224,0.00031070647,0.00023304955],"domain_scores_gemma":[0.999623,0.00002688631,0.000027529566,0.00018484278,0.000044601566,0.00009312294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012443664,0.00007809848,0.00013869397,0.00016726303,0.000025168369,0.000012919274,0.000057966976,0.00006992287,0.00072168064],"category_scores_gemma":[0.00007155611,0.00006984716,0.000037351296,0.00022271673,0.000021222622,0.00011306442,0.00004342813,0.00018399234,0.00044910473],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000100220794,0.0012775017,0.0043344228,0.00012915836,0.00002373288,0.00031559818,0.00086900545,0.000018868417,0.9711639,0.00014137517,0.005754346,0.015871845],"study_design_scores_gemma":[0.0043928334,0.00015175583,0.006040806,0.000067037836,0.000013250333,0.00024943694,0.00007066509,0.00042630604,0.97181463,0.000028435994,0.016661098,0.000083723644],"about_ca_topic_score_codex":0.000015185857,"about_ca_topic_score_gemma":0.00007095411,"teacher_disagreement_score":0.020884987,"about_ca_system_score_codex":0.000050867624,"about_ca_system_score_gemma":0.00003725586,"threshold_uncertainty_score":0.79018974},"labels":[],"label_agreement":null},{"id":"W2129652709","doi":"10.1182/blood-2003-01-0013","title":"GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":325,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Acute megakaryoblastic leukemia; GATA1; Down syndrome; Trisomy; Leukemia; Medicine; Myeloid leukemia; Acute leukemia; Mutation; Haematopoiesis; Cancer research; Immunology; Genetics; Biology; Gene","score_opus":0.011725930574856092,"score_gpt":0.2629574799329259,"score_spread":0.2512315493580698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129652709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939864,0.0003927,0.00014052505,0.00018171384,0.000039470564,0.0005285885,0.000034301836,0.000035113488,0.004661167],"genre_scores_gemma":[0.9967161,0.00014930076,0.0022080638,0.00009282458,0.000015809197,0.000048107297,0.00003244196,0.000032968826,0.0007044257],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998324,0.000087569424,0.00043517677,0.00035608522,0.00038298883,0.00041422245],"domain_scores_gemma":[0.9990638,0.00019624585,0.00006686726,0.00035762414,0.00008896509,0.00022649608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029982033,0.00019052261,0.00046812155,0.00035076393,0.00005010049,0.000013228963,0.000108536675,0.00014519399,0.00013342225],"category_scores_gemma":[0.00024632175,0.00017262998,0.00007535164,0.0005886227,0.00020808987,0.000103946775,0.00003072061,0.00041236755,0.000029530029],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022439193,0.005545125,0.16216381,0.004734056,0.005473096,0.029849075,0.014862466,0.0013966465,0.74364257,0.016056558,0.0052357265,0.008796941],"study_design_scores_gemma":[0.062059365,0.0038296904,0.7442916,0.0012924543,0.0030410006,0.01993534,0.0016068157,0.0027435552,0.1554878,0.0015184222,0.0029929534,0.0012009613],"about_ca_topic_score_codex":0.00014577789,"about_ca_topic_score_gemma":0.00004286067,"teacher_disagreement_score":0.5881548,"about_ca_system_score_codex":0.00049028575,"about_ca_system_score_gemma":0.0013601916,"threshold_uncertainty_score":0.70396465},"labels":[],"label_agreement":null},{"id":"W2129783860","doi":"10.1182/blood-2008-04-150854","title":"Thalidomide and rituximab in Waldenstrom macroglobulinemia","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":143,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Thalidomide; Medicine; Rituximab; Internal medicine; Gastroenterology; Waldenstrom macroglobulinemia; Macroglobulinemia; Population; Adverse effect; Immunology; Surgery; Multiple myeloma; Lymphoma","score_opus":0.019476463062325502,"score_gpt":0.26903342529079416,"score_spread":0.24955696222846865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129783860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99331945,0.0012771128,0.0000043492805,0.00037468862,0.000028359516,0.00024723858,0.0000040528666,0.000042569773,0.0047021843],"genre_scores_gemma":[0.99686176,0.00044847996,0.0012865948,0.00017321082,0.00013344317,0.000016167704,0.000007986954,0.000019362386,0.001052975],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9988837,0.000026912305,0.0002012451,0.00026080498,0.00028689246,0.0003403931],"domain_scores_gemma":[0.9994227,0.0000794817,0.000023572822,0.0002755969,0.000036831174,0.00016176298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013743347,0.000113179995,0.00027716014,0.00009962233,0.000044005137,0.000008294868,0.000072982395,0.00009376474,0.000074541866],"category_scores_gemma":[0.00014995708,0.00009866021,0.000040577648,0.00017552523,0.00015918177,0.00004243476,0.000083394254,0.0002105602,0.0000983015],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042402404,0.035111476,0.70065266,0.002258544,0.0010178859,0.13927636,0.0075774854,0.000014261828,0.060625263,0.00158211,0.020142145,0.027501568],"study_design_scores_gemma":[0.7486917,0.00060074637,0.13107638,0.00045246177,0.00022831869,0.05153644,0.0002696922,0.0025305343,0.056933142,0.00037066452,0.006713654,0.00059626775],"about_ca_topic_score_codex":0.0005887764,"about_ca_topic_score_gemma":0.000049782793,"teacher_disagreement_score":0.74445146,"about_ca_system_score_codex":0.00083727035,"about_ca_system_score_gemma":0.0015436335,"threshold_uncertainty_score":0.40232465},"labels":[],"label_agreement":null},{"id":"W2129834424","doi":"10.1182/blood-2005-06-2317","title":"131I–anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":157,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Research Resources; National Cancer Institute; Cancer Research Society","keywords":"Busulfan; Medicine; Cyclophosphamide; Myeloid leukemia; Transplantation; Myeloid; Bone marrow; Total body irradiation; Internal medicine; Leukemia; Gastroenterology; Hazard ratio; Haematopoiesis; Hematopoietic stem cell transplantation; Immunology; Surgery; Oncology; Chemotherapy; Stem cell; Biology; Confidence interval","score_opus":0.01081085101877537,"score_gpt":0.2814298008304982,"score_spread":0.2706189498117228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129834424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956601,0.0014374709,0.0002296279,0.0007060347,0.000031890584,0.0014328022,0.00008510382,0.00004376139,0.00037319248],"genre_scores_gemma":[0.98659515,0.008142422,0.0036776722,0.000060134575,0.00013044091,0.00008611178,0.0003787107,0.00005602547,0.0008733289],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99819803,0.000031557483,0.00052836194,0.00046571513,0.0003054285,0.0004709072],"domain_scores_gemma":[0.9991132,0.000107597734,0.00013129173,0.00034831476,0.00008440253,0.00021516663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018353,0.0002878074,0.00064587203,0.00023191089,0.00010241841,0.0000140152015,0.000117351316,0.00022184184,0.000028416971],"category_scores_gemma":[0.000020184394,0.00023578486,0.00013501444,0.00026127155,0.000094747236,0.00010055428,0.000025137038,0.000114331146,0.000008295979],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036426687,0.0020274643,0.1808845,0.0032570362,0.0006803207,0.0008664045,0.010624782,0.00040770628,0.78405684,0.00009674645,0.00020454885,0.013250958],"study_design_scores_gemma":[0.04068329,0.0025265643,0.21549624,0.000548705,0.0014279025,0.00072058017,0.00024615956,0.0019161404,0.7332947,0.000055375735,0.0027014376,0.00038285635],"about_ca_topic_score_codex":0.00021182426,"about_ca_topic_score_gemma":0.00015150513,"teacher_disagreement_score":0.05076212,"about_ca_system_score_codex":0.0006832387,"about_ca_system_score_gemma":0.00052855036,"threshold_uncertainty_score":0.9615028},"labels":[],"label_agreement":null},{"id":"W2129838844","doi":"10.1182/blood.v120.21.499.499","title":"Antithrombotic Treatment of Splanchnic Vein Thrombosis: Results of an International Registry","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Fondaparinux; Internal medicine; Thrombosis; Portal vein thrombosis; Surgery; Myeloproliferative neoplasm; Aspirin; Anticoagulant; Myelofibrosis","score_opus":0.08283179449943183,"score_gpt":0.30064824866678175,"score_spread":0.2178164541673499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129838844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99319756,0.0008090145,0.0000030748915,0.00009865952,0.00014140792,0.00023000629,0.00007819335,0.000023776944,0.0054182927],"genre_scores_gemma":[0.9975154,0.0002640511,0.0015728597,0.000009122379,0.00022205789,0.000013547716,0.00022060204,0.00001332951,0.00016905284],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99918205,0.00003105949,0.00028591973,0.0001417129,0.00019762128,0.00016162806],"domain_scores_gemma":[0.99928576,0.000029847071,0.00014283664,0.0003757389,0.00005818172,0.000107642554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009959316,0.00011520859,0.0003010432,0.00007468306,0.00001554946,0.0000037679172,0.00007203275,0.00007247355,0.000070642796],"category_scores_gemma":[0.000029972382,0.000089648485,0.00011603492,0.000089273424,0.000051547082,0.000109486304,0.000012373121,0.000032070435,0.000013625888],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014043156,0.006238038,0.9722958,0.00005170275,0.0004835071,0.00002170424,0.00051985984,1.2982797e-7,0.019065024,0.00008765214,0.000042420095,0.0010536863],"study_design_scores_gemma":[0.007048834,0.001959043,0.66794676,0.00010483001,0.00086896087,0.00005802424,0.000074467695,0.000037610753,0.32091144,0.000010186254,0.00089344534,0.000086423126],"about_ca_topic_score_codex":0.0001122956,"about_ca_topic_score_gemma":0.00000529358,"teacher_disagreement_score":0.30434912,"about_ca_system_score_codex":0.000029281187,"about_ca_system_score_gemma":0.000044680717,"threshold_uncertainty_score":0.36557594},"labels":[],"label_agreement":null},{"id":"W2130141211","doi":"10.1182/blood-2006-07-035089","title":"Functional characterization of natural telomerase mutations found in patients with hematologic disorders","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Institute of Allergy and Infectious Diseases; National Institute of Diabetes and Digestive and Kidney Diseases; Center for AIDS Research, University of Washington; Emory University; American Cancer Society","keywords":"Haploinsufficiency; Telomerase; Dyskeratosis congenita; Telomere; Telomerase RNA component; Biology; Telomerase reverse transcriptase; Genetics; Mutation; Cancer research; Gene; Phenotype","score_opus":0.004525101811362834,"score_gpt":0.19113890128952404,"score_spread":0.1866137994781612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130141211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991285,0.000048980328,0.000107081854,0.00010773684,0.00007709232,0.0002958528,0.000015865471,0.000032665233,0.00018618317],"genre_scores_gemma":[0.9984259,0.0000037724637,0.0003690263,0.000056849767,0.000035409896,0.000016932883,0.0009436063,0.000011966622,0.00013653436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991791,0.000018728242,0.00024180413,0.00017480321,0.00023371824,0.00015184366],"domain_scores_gemma":[0.99956375,0.000029904328,0.00010048639,0.00012475821,0.00014764903,0.000033466666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000034006556,0.0001089976,0.00019273807,0.00016067651,0.000041237407,0.0000067652286,0.00003451308,0.00004695306,0.000047891062],"category_scores_gemma":[0.000038785838,0.00008624236,0.000027366925,0.0004943237,0.00007630233,0.00011075722,0.000008720193,0.000095011914,0.000007763293],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016718131,0.00160963,0.99232763,0.00006647096,0.000023711213,0.000007042908,0.000066674555,0.000012777983,0.0049903025,0.00018454337,0.000011540837,0.0005325076],"study_design_scores_gemma":[0.0045899944,0.0001560359,0.99271697,0.00005781923,0.000055809385,0.0000072655334,0.000021854506,0.000029966766,0.0021529803,0.000061521714,0.00005161516,0.00009816141],"about_ca_topic_score_codex":0.00008249913,"about_ca_topic_score_gemma":0.0001185392,"teacher_disagreement_score":0.004422813,"about_ca_system_score_codex":0.000017947494,"about_ca_system_score_gemma":0.00006270023,"threshold_uncertainty_score":0.35168615},"labels":[],"label_agreement":null},{"id":"W2130491242","doi":"10.1182/blood-2003-07-2365","title":"Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":349,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"University of Arizona","keywords":"Immunosurveillance; International Prognostic Index; Human leukocyte antigen; Biology; MHC class I; Diffuse large B-cell lymphoma; CD8; Lymphoma; Immunology; Major histocompatibility complex; Gene expression profiling; CIITA; Cancer research; Internal medicine; Oncology; Antigen; MHC class II; Immune system; Medicine; Gene expression; Gene; Genetics","score_opus":0.008935299649229515,"score_gpt":0.23012964310653877,"score_spread":0.22119434345730926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130491242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929566,0.002279515,0.000003604489,0.00005137594,0.000028200582,0.0044435146,0.00019543292,0.000023025757,0.000018776744],"genre_scores_gemma":[0.9990464,0.000033697408,0.00040871944,0.00006228007,0.000008050023,0.00035901755,0.00002857716,0.000044073633,0.000009177113],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980237,0.00019437842,0.000550231,0.0005479024,0.0003854497,0.0002983687],"domain_scores_gemma":[0.998958,0.00014711755,0.00025624686,0.00041803514,0.000097311546,0.00012332476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022033502,0.00032291407,0.00063954707,0.000101801714,0.000093421346,0.000023464552,0.00009446446,0.00009944758,0.0000018564593],"category_scores_gemma":[0.00018227992,0.00020864641,0.0000703421,0.0002486051,0.00008024569,0.0000509914,0.00019765394,0.000054187294,3.3778818e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009461803,0.017128203,0.85863656,0.0001317032,0.00026814025,0.00023000961,0.007216523,8.701287e-7,0.11511767,0.000010226693,0.0000017493809,0.00031216245],"study_design_scores_gemma":[0.074026465,0.0018083848,0.43151876,0.00073271553,0.00021911327,0.00001830849,0.0015094463,0.000015237902,0.48994932,0.000021422587,0.000008227804,0.00017261974],"about_ca_topic_score_codex":0.0028200105,"about_ca_topic_score_gemma":0.00014057655,"teacher_disagreement_score":0.42711782,"about_ca_system_score_codex":0.00012692952,"about_ca_system_score_gemma":0.000287484,"threshold_uncertainty_score":0.8508354},"labels":[],"label_agreement":null},{"id":"W2130606936","doi":"10.1182/blood-2002-03-0832","title":"Donor immunization with pneumococcal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell transplantation","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Medicine; Pneumococcal conjugate vaccine; Transplantation; Immunization; Immunology; Pneumococcal polysaccharide vaccine; Antibody; Conjugate vaccine; Pneumococcal vaccine; Vaccination; Virology; Streptococcus pneumoniae; Internal medicine; Biology; Antibiotics; Microbiology; Pneumococcal disease","score_opus":0.01216289288950278,"score_gpt":0.2763548898468662,"score_spread":0.2641919969573634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130606936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966405,0.0007481901,0.0006170482,0.00010575239,0.000017445098,0.0010228887,0.0000067184797,0.000048434493,0.0007930416],"genre_scores_gemma":[0.99873513,0.00024029912,0.0005667858,0.00003267756,0.000022180026,0.000059175007,0.000017727487,0.00003576818,0.0002902845],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988558,0.00014218123,0.00020722406,0.00028343446,0.00024402287,0.00026730986],"domain_scores_gemma":[0.9994506,0.00008278853,0.00005416904,0.00019420883,0.00009189198,0.0001263056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030416204,0.00016148812,0.00027575175,0.0001624994,0.00015892705,0.000049840935,0.000046626206,0.00008732489,0.000038707196],"category_scores_gemma":[0.000047441346,0.00012698265,0.000053769672,0.0002776547,0.000034359437,0.000118020675,0.00001054043,0.00020443129,0.000013596139],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012078424,0.000372233,0.30588755,0.00023778962,0.00013301456,0.0002964205,0.0010090716,0.0000020766565,0.6906056,0.00009108295,0.0000011369291,0.0001561717],"study_design_scores_gemma":[0.009997476,0.0014504814,0.5262391,0.00020997782,0.00043395604,0.00045118257,0.00019186399,0.0000061685205,0.46044338,0.000068061934,0.0002810084,0.00022738709],"about_ca_topic_score_codex":0.0001062418,"about_ca_topic_score_gemma":0.000032003725,"teacher_disagreement_score":0.23016225,"about_ca_system_score_codex":0.000018660308,"about_ca_system_score_gemma":0.00013349968,"threshold_uncertainty_score":0.51782024},"labels":[],"label_agreement":null},{"id":"W2130669032","doi":"10.1182/blood-2014-02-555607","title":"Patients with myeloid malignancies bearing PDGFRB fusion genes achieve durable long-term remissions with imatinib","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":139,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Institute for Health and Care Research","keywords":"PDGFRB; Imatinib; Medicine; Cancer research; Myeloproliferative neoplasm; Myeloid; Transplantation; Fusion gene; Myeloid leukemia; Oncology; Internal medicine; Gene; Myelofibrosis; Biology; Bone marrow; Genetics","score_opus":0.007410830029973305,"score_gpt":0.21119623837924356,"score_spread":0.20378540834927025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130669032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99249583,0.00025678644,0.00015162557,0.00037365645,0.00003947506,0.0003763539,0.000005470201,0.00008625687,0.0062145605],"genre_scores_gemma":[0.99530876,0.00005630536,0.0022552474,0.00015639752,0.000056307486,0.000023147444,0.000066367866,0.000041194387,0.0020363051],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876326,0.000028360157,0.00020822593,0.0003106892,0.00037258703,0.00031686074],"domain_scores_gemma":[0.99916947,0.00003569672,0.000105824154,0.00039367072,0.00012464929,0.00017069548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000105063395,0.00020741488,0.0003252855,0.000075927215,0.0002001244,0.000034054785,0.000101736776,0.000072619594,0.000115191804],"category_scores_gemma":[0.000041737196,0.00012802613,0.00004662163,0.00016207693,0.000081723854,0.00010401678,0.000055953602,0.00013182404,0.000022601167],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016158768,0.0009216945,0.9881762,0.00019300432,0.00007844664,0.000029069544,0.0003094038,0.0000057816733,0.0047474992,0.000070563416,0.00007449236,0.0052322485],"study_design_scores_gemma":[0.006370038,0.0017329936,0.9859591,0.0007839936,0.00027558,0.0000999965,0.0000962135,0.000020496616,0.0039091334,0.000041016883,0.0004500351,0.00026138788],"about_ca_topic_score_codex":0.000030124558,"about_ca_topic_score_gemma":0.000035690355,"teacher_disagreement_score":0.0062084505,"about_ca_system_score_codex":0.00001089825,"about_ca_system_score_gemma":0.000063779116,"threshold_uncertainty_score":0.5220754},"labels":[],"label_agreement":null},{"id":"W2130963430","doi":"10.1182/blood-2005-10-4308","title":"Impact of anemia on hospitalization and mortality in older adults","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":467,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Medicine; Anemia; Gerontology; Intensive care medicine; Pediatrics; Internal medicine","score_opus":0.005944721434493465,"score_gpt":0.26944511851509095,"score_spread":0.26350039708059747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130963430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99717635,0.00020385944,0.0000012673316,0.000048211274,0.000010333929,0.00017679392,0.0000060522266,0.000012248653,0.0023648678],"genre_scores_gemma":[0.9997163,0.0000392121,0.00007988615,0.000012705416,0.000033127286,0.0000040855066,0.00004036559,0.000006110368,0.000068238536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99959934,0.000008574827,0.00011876124,0.00010950847,0.000084933155,0.000078899924],"domain_scores_gemma":[0.99980515,0.000009654644,0.000034634308,0.00010314335,0.000019459863,0.000027929656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000030371426,0.00006619418,0.0001248982,0.00003741099,0.000008122781,0.00000233224,0.000010807094,0.000042270087,0.00003629887],"category_scores_gemma":[0.000009741259,0.00004833886,0.00003498267,0.00006960588,0.000024972378,0.000015365613,0.000005038757,0.000033939643,0.0000018437047],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031659278,0.0016486737,0.9970612,0.00006276076,0.00001558388,0.000032264623,0.000107122316,0.0000028494735,0.0006072258,0.000058226517,0.000101476166,0.00027096286],"study_design_scores_gemma":[0.0050265957,0.00054616533,0.9882409,0.00018939092,0.00005393137,0.00001122619,0.00002690375,0.000009366311,0.0058165966,0.000035077002,0.0000016614531,0.000042163974],"about_ca_topic_score_codex":0.0009617543,"about_ca_topic_score_gemma":0.000045826302,"teacher_disagreement_score":0.008820273,"about_ca_system_score_codex":0.00002005133,"about_ca_system_score_gemma":0.000019056894,"threshold_uncertainty_score":0.19712016},"labels":[],"label_agreement":null},{"id":"W2131122030","doi":"10.1182/blood-2005-05-1860","title":"CCR2 is required for CD8-induced graft-versus-host disease","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of New Brunswick","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Graft-versus-host disease; Host (biology); Medicine; Immunology; Disease; Biology; Internal medicine; Genetics","score_opus":0.03711251928198702,"score_gpt":0.2988533800773214,"score_spread":0.2617408607953344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131122030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99296623,0.00052978395,0.00009033817,0.0041380613,0.00019560046,0.00042257446,0.000029974493,0.000093041795,0.0015343615],"genre_scores_gemma":[0.99476403,0.000030733696,0.0013079216,0.00073450163,0.0015430027,0.000041774696,0.00004537742,0.00003580906,0.0014968285],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999063,0.000007858385,0.00020154801,0.00026016877,0.00019576291,0.00027167142],"domain_scores_gemma":[0.99925005,0.000062506,0.00005159081,0.00027229387,0.00007708183,0.0002864876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009377647,0.00014125793,0.00022215651,0.000052376898,0.000075909935,0.000017566294,0.00006989881,0.000069902075,0.00036225925],"category_scores_gemma":[0.0001367472,0.0001243105,0.00019411789,0.00010517579,0.000018549874,0.000066119224,0.0000251098,0.000084950334,0.0000651697],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00424797,0.0045403545,0.0138087105,0.0006205888,0.0009374474,0.00009675869,0.0014002095,0.0000037570999,0.9082468,0.0006847814,0.039716322,0.025696296],"study_design_scores_gemma":[0.0352448,0.00073489244,0.0026224225,0.00023936777,0.0016391651,0.00001829136,0.00014718228,0.00071732857,0.7917411,0.000119513636,0.16625333,0.0005226161],"about_ca_topic_score_codex":0.00000743549,"about_ca_topic_score_gemma":0.0000041196213,"teacher_disagreement_score":0.12653701,"about_ca_system_score_codex":0.000033298675,"about_ca_system_score_gemma":0.000093513896,"threshold_uncertainty_score":0.5069235},"labels":[],"label_agreement":null},{"id":"W2131339869","doi":"10.1182/blood-2005-04-1550","title":"Functional consequences of the human DMT1 (SLC11A2) mutation on protein expression and iron uptake","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"DMT1; Chinese hamster ovary cell; Exon; Mutation; Biology; Point mutation; Molecular biology; Biochemistry; Genetics; Transporter; Gene; Cell culture","score_opus":0.016925555190644075,"score_gpt":0.2516387622173834,"score_spread":0.23471320702673934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131339869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99524015,0.0003913024,0.00001046919,0.00075822475,0.00003394166,0.00027140533,0.0000036743438,0.000013626193,0.0032772296],"genre_scores_gemma":[0.998508,0.0000072312214,0.00033510104,0.0001900795,0.00010211151,0.000015390682,0.000007856699,0.0000053654844,0.00082891557],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994871,0.000026938027,0.000121468474,0.00010781983,0.00018476171,0.00007191669],"domain_scores_gemma":[0.9997594,0.000011185893,0.000060188486,0.000115455274,0.000024693521,0.000029078039],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000730206,0.000060926883,0.00008539746,0.000030845615,0.0000774222,0.0000048243833,0.000028308325,0.00004008951,0.00012294984],"category_scores_gemma":[0.00004292258,0.00003772458,0.000027921518,0.00004369596,0.00011337741,0.000038511454,0.00001143624,0.00006642741,0.0000067656165],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049721362,0.00038353735,0.005794182,0.00007143784,0.0000056226036,0.0000017599979,0.00026397503,0.000013650548,0.98732775,0.00266218,0.00036150074,0.0030646962],"study_design_scores_gemma":[0.0038380232,0.00015459799,0.31180865,0.000125921,0.000090689384,0.000019091254,0.0002631902,0.0000032664361,0.68177474,0.0004889338,0.0013636416,0.00006924852],"about_ca_topic_score_codex":0.00001367229,"about_ca_topic_score_gemma":0.0000049729165,"teacher_disagreement_score":0.30601445,"about_ca_system_score_codex":0.0000034083573,"about_ca_system_score_gemma":0.00003106145,"threshold_uncertainty_score":0.15383638},"labels":[],"label_agreement":null},{"id":"W2132017565","doi":"10.1182/blood-2004-10-4003","title":"Differential regulation of the p70 S6 kinase pathway by interferon α (IFNα) and imatinib mesylate (STI571) in chronic myelogenous leukemia cells","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"National Cancer Institute; Turun Yliopistollinen Keskussairaala","keywords":"Imatinib mesylate; Chronic myelogenous leukemia; Cancer research; Leukemia; Medicine; Interferon; Imatinib; Immunology","score_opus":0.007127805237723367,"score_gpt":0.21799944094801627,"score_spread":0.2108716357102929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132017565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99707186,0.0013988784,0.000023795994,0.00019405542,0.00009348027,0.00064518227,0.00003813322,0.000032386415,0.00050223176],"genre_scores_gemma":[0.9984592,0.0001445023,0.00020686473,0.000057166802,0.00013412825,0.000027001364,0.00004880366,0.000033771186,0.00088855467],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99856067,0.00007652435,0.0004490143,0.0003299054,0.00026661443,0.00031727797],"domain_scores_gemma":[0.9991575,0.00005530675,0.00018775031,0.00047435102,0.000035078196,0.000090024936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009963066,0.00023394635,0.0003732497,0.000079385514,0.000054744854,0.000012852845,0.00013017522,0.00014924986,0.00023653399],"category_scores_gemma":[0.000026845475,0.00016982394,0.000089681904,0.00014722972,0.00011389676,0.000086268374,0.0001108951,0.00023418764,0.000018963443],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016463698,0.00050470576,0.002688787,0.00018552008,0.00011994819,0.000013679052,0.0007097641,0.00005906633,0.97296745,0.000038602353,0.0002372298,0.02231062],"study_design_scores_gemma":[0.014939932,0.00064577145,0.061568692,0.00041406014,0.00030382202,0.00006689233,0.000036536963,0.002101612,0.91873795,0.000040804585,0.0009443246,0.00019958154],"about_ca_topic_score_codex":0.0002182631,"about_ca_topic_score_gemma":0.00019497196,"teacher_disagreement_score":0.058879904,"about_ca_system_score_codex":0.0013057287,"about_ca_system_score_gemma":0.00046592925,"threshold_uncertainty_score":0.69252187},"labels":[],"label_agreement":null},{"id":"W2132161976","doi":"10.1182/blood-2014-05-574913","title":"Platelet bioreactor-on-a-chip","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"3D Printing in Biomedical Research","field":"Engineering","cited_by":205,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Heart, Lung, and Blood Institute","keywords":"Bioreactor; Platelet; Organ-on-a-chip; Biomedical engineering; Bone marrow; Shear stress; Chemistry; Microfluidics; Materials science; Biology; Nanotechnology; Medicine; Immunology; Composite material","score_opus":0.013272055895157934,"score_gpt":0.23961557752162732,"score_spread":0.2263435216264694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132161976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9349161,0.00003296904,0.00039661166,0.000085728236,0.00018216106,0.000053275144,0.0000025852607,0.00036813904,0.06396246],"genre_scores_gemma":[0.9990125,0.00001349133,0.00055194134,0.00005077262,0.0002368079,0.0000068150794,0.0000035091252,0.000024916446,0.00009927845],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999283,0.000017525022,0.00009390126,0.0001117763,0.00023352947,0.00026022617],"domain_scores_gemma":[0.9994437,0.00018279726,0.000006600012,0.00023445154,0.000011250435,0.000121163735],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021942853,0.00008080278,0.00008522752,0.00006825029,0.000023675726,0.000022519329,0.00018466037,0.00007305606,0.00014008697],"category_scores_gemma":[0.00025290987,0.0000709351,0.000028725573,0.00011360801,0.000034700035,0.000019480958,0.000031009702,0.00021102204,0.000918515],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003748074,0.0013478552,0.023578977,0.0007498475,0.0005954359,0.00015756828,0.00055471616,0.0009778445,0.3759839,0.022236437,0.046530753,0.52724916],"study_design_scores_gemma":[0.0028841875,0.00028718438,0.03598519,0.0001239396,0.00002026828,0.00002361434,0.000009993247,0.009978198,0.566228,0.0018310684,0.38204733,0.0005810921],"about_ca_topic_score_codex":0.0000040268483,"about_ca_topic_score_gemma":7.5678776e-7,"teacher_disagreement_score":0.5266681,"about_ca_system_score_codex":0.000009386594,"about_ca_system_score_gemma":0.0000057759835,"threshold_uncertainty_score":0.9998594},"labels":[],"label_agreement":null},{"id":"W2132171352","doi":"10.1182/blood-2003-04-1165","title":"Gene expression profiling illuminates myeloma biology","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Gene expression profiling; Biology; Gene expression; Multiple myeloma; Genetics; Computational biology; Gene; Immunology","score_opus":0.026573726648077542,"score_gpt":0.3066200462234915,"score_spread":0.2800463195754139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132171352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901821,0.0010185911,0.000066544104,0.000056252306,0.000049219798,0.00032888065,0.000008538278,0.000057118978,0.008232731],"genre_scores_gemma":[0.9814616,0.00006629271,0.017578969,0.00004021866,0.00006166305,0.000051438037,0.00005820847,0.000015915997,0.0006656941],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991502,0.00006386531,0.00012475811,0.00022959769,0.00012191094,0.00030966994],"domain_scores_gemma":[0.99946636,0.000047336223,0.000028266453,0.00023079272,0.000057010162,0.00017024124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010348191,0.000106181215,0.00016746558,0.00007560963,0.00007278632,0.0000073898377,0.000046004978,0.000077742,0.00022901609],"category_scores_gemma":[0.0002806955,0.00007591329,0.000054107313,0.00009659137,0.000051867082,0.00002947567,0.000023874689,0.00009864401,0.0001520427],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004928077,0.000635608,0.26635778,0.00003223469,0.000082470215,0.00019046143,0.000038403545,9.135425e-8,0.7293659,0.00024972355,0.00004005456,0.002957995],"study_design_scores_gemma":[0.004179853,0.0003003533,0.016204018,0.00003178068,0.000045215773,0.0001349166,0.000040090083,0.000006963634,0.9778533,0.00017260984,0.00095838954,0.00007253429],"about_ca_topic_score_codex":0.000007566893,"about_ca_topic_score_gemma":7.747838e-7,"teacher_disagreement_score":0.25015375,"about_ca_system_score_codex":0.000015331141,"about_ca_system_score_gemma":0.00006391595,"threshold_uncertainty_score":0.3095654},"labels":[],"label_agreement":null},{"id":"W2132290892","doi":"10.1182/blood.v100.4.1160.h81602001160_1160_1167","title":"Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":613,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia","funders":"","keywords":"Chemokine; Gelatinase; Matrix metalloproteinase; Matrilysin; Chemotaxis; Proteases; Chemistry; Monocyte; Gelatinase A; Molecular biology; Matrix metalloproteinase inhibitor; Chemokine receptor; Collagenase; Receptor; Biology; Immunology; Biochemistry; Enzyme","score_opus":0.011316911131508022,"score_gpt":0.20323232653431753,"score_spread":0.1919154154028095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132290892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942232,0.004472189,0.000092275135,0.00007782328,0.00002602565,0.00082058,0.000015041067,0.000028331786,0.00024455533],"genre_scores_gemma":[0.9942808,0.00023079579,0.004460837,0.000033098135,0.00018420353,0.00021465628,0.000016518647,0.000050312665,0.00052878633],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99860024,0.000042519823,0.00036784922,0.00043478064,0.00021704228,0.0003375611],"domain_scores_gemma":[0.9992494,0.0000017155293,0.00021000969,0.000336948,0.00011924019,0.000082673745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016363655,0.00027404772,0.00030461844,0.00007221281,0.000074165386,0.000034471057,0.00019512519,0.00017176785,0.000036869835],"category_scores_gemma":[0.000034516983,0.00021513744,0.00007103379,0.00015530326,0.00009733517,0.000022390577,0.00007599285,0.0001260487,0.000004655674],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009985196,0.0014814845,0.00042461633,0.00026117873,0.000057413956,0.000025356363,0.00007899195,0.0000063109005,0.9971405,0.0000116258125,0.00003219516,0.00038044417],"study_design_scores_gemma":[0.003378226,0.00046640026,0.000029833143,0.00019662666,0.00004211277,0.00004491039,0.000043936765,0.00015975873,0.9941578,0.000007037874,0.001152096,0.0003212892],"about_ca_topic_score_codex":0.000016468475,"about_ca_topic_score_gemma":0.000011961382,"teacher_disagreement_score":0.0043685623,"about_ca_system_score_codex":0.000013318183,"about_ca_system_score_gemma":0.00008847262,"threshold_uncertainty_score":0.877305},"labels":[],"label_agreement":null},{"id":"W2132608570","doi":"10.1182/blood-2011-01-330795","title":"Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":291,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"AGE-WELL","keywords":"Germinal center; Chromosomal translocation; IRF4; Lymphoma; Biology; B cell; Burkitt's lymphoma; Genetics; Immunology; Cancer research; Medicine; Transcription factor; Antibody; Gene","score_opus":0.012856211195775841,"score_gpt":0.23724400742345017,"score_spread":0.22438779622767432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132608570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971037,0.00054427097,0.000016595961,0.000018572639,0.000055779466,0.0005295606,0.000026071126,0.00003787962,0.0016675815],"genre_scores_gemma":[0.9981771,0.00011307366,0.0015170375,0.000013347546,0.00004961996,0.00003804542,0.000031774165,0.000022801125,0.00003718337],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990442,0.000034263394,0.00027581496,0.00028119946,0.00014978061,0.00021474685],"domain_scores_gemma":[0.9994027,0.000050031238,0.00016075067,0.00021730154,0.00006370849,0.000105483974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008460622,0.00016452903,0.00027957134,0.00008208194,0.000094423856,0.000012231335,0.000060135913,0.00007170085,0.000023159524],"category_scores_gemma":[0.000037810467,0.00014191729,0.00009470083,0.000117226155,0.000055148455,0.0000828771,0.000029305951,0.000043836073,0.000005219597],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024501735,0.007124485,0.94358826,0.0001755584,0.0002719293,0.000053659736,0.0054913233,3.7920433e-8,0.02391812,0.00001976425,0.000009094181,0.01910276],"study_design_scores_gemma":[0.013143344,0.00036642863,0.7088276,0.0002864251,0.00034458167,0.00031265168,0.00026494617,0.0000079962165,0.27635187,0.000005271099,0.0000015366622,0.00008733853],"about_ca_topic_score_codex":0.0008580442,"about_ca_topic_score_gemma":0.000059945924,"teacher_disagreement_score":0.25243375,"about_ca_system_score_codex":0.00002592823,"about_ca_system_score_gemma":0.00006462287,"threshold_uncertainty_score":0.5787219},"labels":[],"label_agreement":null},{"id":"W2133268214","doi":"10.1182/blood-2002-01-0133","title":"Transferrin receptor 2 (TfR2) and HFE mutational analysis in non-C282Y iron overload: identification of a novel TfR2 mutation","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; Vancouver General Hospital; BC Children's Hospital; BC Cancer Agency","funders":"BC Cancer Agency","keywords":"Hereditary hemochromatosis; Hemochromatosis; Genetics; Missense mutation; Transferrin receptor; Mutation; Biology; Transferrin; Exon; Gene; Receptor; Endocrinology","score_opus":0.01171936462174646,"score_gpt":0.24556294473366966,"score_spread":0.2338435801119232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133268214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996005,0.00049602526,0.0023214892,0.00026534428,0.000037548343,0.00025890296,0.00005440968,0.000013333989,0.0005479279],"genre_scores_gemma":[0.9981579,0.00011901981,0.0010732863,0.00006416134,0.00003449834,0.000021548101,0.00017646865,0.000010473316,0.000342638],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99898183,0.000023745011,0.00038732885,0.00022897853,0.00025479402,0.00012331047],"domain_scores_gemma":[0.9996041,0.000036961817,0.000089305024,0.00014975444,0.000062984494,0.000056880937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016687636,0.0001008884,0.0002532416,0.00037649772,0.000027221373,0.000010903635,0.00004022204,0.00007534192,0.00027245577],"category_scores_gemma":[0.00006694528,0.00010141554,0.00007993265,0.00062246085,0.000050546652,0.000107874555,0.000005683351,0.000073418036,0.000012691989],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004663716,0.011745596,0.23680264,0.0012554807,0.00076343433,0.000036489662,0.020781526,0.0018315901,0.7005464,0.0017324483,0.00048509732,0.023552926],"study_design_scores_gemma":[0.011564654,0.00012589204,0.96026313,0.000033556036,0.0018215239,0.000016364733,0.00081552676,0.0063168006,0.018710667,0.000052700565,0.00008799854,0.00019117502],"about_ca_topic_score_codex":0.00012954908,"about_ca_topic_score_gemma":0.00007240342,"teacher_disagreement_score":0.7234605,"about_ca_system_score_codex":0.000010972026,"about_ca_system_score_gemma":0.000016790134,"threshold_uncertainty_score":0.41356057},"labels":[],"label_agreement":null},{"id":"W2134812077","doi":"10.1182/blood.v96.5.1740","title":"Identification of novel circulating human embryonic blood stem cells","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Prenatal Screening and Diagnostics","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Stem cell; Biology; Embryonic stem cell; Haematopoiesis; Bone marrow; Induced pluripotent stem cell; Fetus; Immunology; Adult stem cell; Amniotic epithelial cells; Cord blood; Cell biology","score_opus":0.02407391065228771,"score_gpt":0.2638412057465297,"score_spread":0.239767295094242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134812077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946485,0.00025760336,0.0001282353,0.000034257482,0.00003140099,0.00015663833,0.000020037556,0.00006487124,0.004658437],"genre_scores_gemma":[0.9979726,0.000015011385,0.0003796699,0.000034378634,0.000096674645,0.000005941973,0.000019101488,0.000015702904,0.0014609344],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99915993,0.000013666905,0.00029417087,0.0001773337,0.00020276832,0.00015213726],"domain_scores_gemma":[0.9994061,0.00006295241,0.000103467784,0.00030077997,0.000050947852,0.000075723845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001424293,0.000086580716,0.00017231844,0.00004528433,0.000059361482,0.000012359866,0.000080672995,0.00006927112,0.00009458282],"category_scores_gemma":[0.000031804844,0.00008464645,0.000067993285,0.00013102122,0.000032587322,0.00004155959,0.000016774962,0.00009998286,0.00003795528],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011501842,0.001636109,0.010744355,0.00013764441,0.00011380172,0.000026192023,0.000181552,0.00009904347,0.9830043,0.00034004953,0.00005821293,0.0036472585],"study_design_scores_gemma":[0.00566962,0.00024044336,0.053253483,0.0003114492,0.00083735347,0.00010991049,0.00007119022,0.0005061568,0.9386937,0.000033352113,0.000108921085,0.00016439831],"about_ca_topic_score_codex":0.000046324687,"about_ca_topic_score_gemma":0.000002760525,"teacher_disagreement_score":0.044310555,"about_ca_system_score_codex":0.000006521742,"about_ca_system_score_gemma":0.000027002192,"threshold_uncertainty_score":0.34517822},"labels":[],"label_agreement":null},{"id":"W2135304449","doi":"10.1182/blood-2004-09-3531","title":"Angiopoietins can directly activate endothelial cells and neutrophils to promote proinflammatory responses","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":178,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Angiopoietin receptor; Angiogenesis; Angiopoietin; Cell biology; Proinflammatory cytokine; Biology; Inflammation; Immunology; Cancer research; Vascular endothelial growth factor","score_opus":0.007770341910281947,"score_gpt":0.2291911686585401,"score_spread":0.22142082674825816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135304449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982911,0.0004908829,0.000030271096,0.00039666484,0.000078218756,0.00027834007,0.00010049823,0.00002101453,0.00031302538],"genre_scores_gemma":[0.9973748,0.00019251929,0.0011391371,0.0002955593,0.00040299317,0.000050268056,0.000009356823,0.000032204745,0.00050317094],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999164,0.000028970895,0.00012760866,0.00034077466,0.0000917636,0.00024688704],"domain_scores_gemma":[0.9995326,0.000004541515,0.00004462121,0.00024580111,0.0000383488,0.0001341073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008982369,0.00015171582,0.00012234587,0.000037424867,0.000081695674,0.000024914598,0.00010953412,0.00009217574,0.000006794886],"category_scores_gemma":[0.000023607297,0.0001385173,0.00007188233,0.000059798807,0.000045711815,0.0000025401437,0.00008786258,0.00004219244,0.000007946192],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013860158,0.00009100023,0.000804438,0.000012719883,0.00004986058,0.0000151429795,0.00010736486,0.000013035335,0.9978481,0.00003056812,0.00011378922,0.0007754006],"study_design_scores_gemma":[0.0009808257,0.0003369766,0.0037661297,0.000020345602,0.000030816143,0.000025650537,0.000014897441,1.5026956e-7,0.9601412,0.000034921588,0.03446348,0.00018463375],"about_ca_topic_score_codex":0.000043528755,"about_ca_topic_score_gemma":0.00004968134,"teacher_disagreement_score":0.037706908,"about_ca_system_score_codex":0.000011105811,"about_ca_system_score_gemma":0.00012209051,"threshold_uncertainty_score":0.5648571},"labels":[],"label_agreement":null},{"id":"W2136155663","doi":"10.1182/blood.v97.5.1343","title":"SHIP's C-terminus is essential for its hydrolysis of PIP3 and inhibition of mast cell degranulation","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Degranulation; Mast cell; Cell biology; Phosphorylation; Phosphatase; Biochemistry; Chemistry; Biology; Immunology; Receptor","score_opus":0.008356873920784174,"score_gpt":0.20594430074457018,"score_spread":0.197587426823786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136155663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970445,0.0012810511,0.00026375946,0.0000368202,0.000060889448,0.0001468474,0.00007524744,0.000007229684,0.0010836348],"genre_scores_gemma":[0.9979532,0.00008308611,0.00009478287,0.000013105529,0.000019324032,0.0000068833765,0.00011174396,0.0000065403688,0.0017113546],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99953103,0.000020572188,0.00020002142,0.00012541364,0.000018183175,0.00010478234],"domain_scores_gemma":[0.999692,0.000031378284,0.00012646751,0.00008728765,0.00005403511,0.000008812603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000064242806,0.00007031775,0.00016692586,0.00006803463,0.000042791984,0.000002593112,0.000031542782,0.00010787829,0.0003177422],"category_scores_gemma":[0.000006640659,0.000067854286,0.000055492637,0.000056625227,0.00005884686,0.000035062174,0.000017114688,0.00003680314,0.000007236827],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010049895,0.0003142523,0.0019257241,0.000110202884,0.00003969984,0.0000015682207,0.00026919722,0.0000011885273,0.99604726,0.00009760589,0.00011636152,0.00097641477],"study_design_scores_gemma":[0.002892786,0.00018207265,0.0025205065,0.000019185785,0.00018999583,0.000018514187,0.00003342237,0.000023449273,0.9917467,0.000063882915,0.0022394438,0.000070027236],"about_ca_topic_score_codex":0.000027044453,"about_ca_topic_score_gemma":0.000020586944,"teacher_disagreement_score":0.0043005724,"about_ca_system_score_codex":0.00000213254,"about_ca_system_score_gemma":0.0000091284855,"threshold_uncertainty_score":0.34790543},"labels":[],"label_agreement":null},{"id":"W213641328","doi":"10.1182/blood.v124.21.4090.4090","title":"Assessing the Effect of Short and Long-Term Hydroxyurea Treatment on Cerebral Hemodynamics in Children with Sickle Cell Anemia Using Quantitative MRI: Preliminary Findings","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Sickle cell anemia; Hemodynamics; Anemia; Cerebral blood flow; Vaso-occlusive crisis; Fetal hemoglobin; Vasodilation; Stroke (engine); Acute chest syndrome; Nitric oxide; Internal medicine; Cardiology; Anesthesia; Disease","score_opus":0.00773129731756206,"score_gpt":0.2628641475692202,"score_spread":0.25513285025165816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W213641328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983545,0.0003800877,0.000083257866,0.000057277517,0.00001664258,0.00066090154,0.0000031308264,0.000016825421,0.00042736222],"genre_scores_gemma":[0.9995292,0.000036725825,0.00031451674,0.000029403325,0.000016458642,0.00000804864,0.000024913408,0.000025401854,0.00001532797],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914795,0.00008930745,0.00017226188,0.00023515456,0.00014900714,0.00020631494],"domain_scores_gemma":[0.99952745,0.00014604609,0.000060081667,0.00019445359,0.000014273132,0.000057694357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016651662,0.0001949651,0.0003211796,0.00008378533,0.00008178808,0.00002132632,0.00004910334,0.00010866883,0.0000031546715],"category_scores_gemma":[0.000017479617,0.00010656124,0.000050457355,0.00013656286,0.00012296018,0.00006494242,0.00002315692,0.00018205064,8.35105e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023368625,0.00044075714,0.99448663,0.00011068375,0.00010951598,0.000021109097,0.00044825693,0.0005474618,0.0025547782,0.000012400975,0.0000011100137,0.0010335868],"study_design_scores_gemma":[0.0074031968,0.010396078,0.9490406,0.00056703197,0.0009610761,0.00020803134,0.00016169487,0.008221462,0.022860967,0.0000048269612,7.1148895e-7,0.00017433787],"about_ca_topic_score_codex":0.00007431659,"about_ca_topic_score_gemma":0.000011015739,"teacher_disagreement_score":0.045446068,"about_ca_system_score_codex":0.00004207486,"about_ca_system_score_gemma":0.000036881644,"threshold_uncertainty_score":0.43454412},"labels":[],"label_agreement":null},{"id":"W2136845772","doi":"10.1182/blood-2002-07-1947","title":"Gemtuzumab ozogamicin: first clinical experiences in children with relapsed/refractory acute myeloid leukemia treated on compassionate-use basis","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Gemtuzumab ozogamicin; Medicine; Mucositis; CD33; Refractory (planetary science); Myeloid leukemia; Internal medicine; Surgery; Hematopoietic stem cell transplantation; Leukemia; Hepatic veno-occlusive disease; Transplantation; Gastroenterology; Chemotherapy; Stem cell; CD34","score_opus":0.023213502618030502,"score_gpt":0.2762754834077394,"score_spread":0.2530619807897089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136845772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99666625,0.00006302006,0.00002680901,0.00008842121,0.000093483155,0.00062878703,0.000014245225,0.00009975061,0.00231922],"genre_scores_gemma":[0.9978313,0.0002899711,0.0009779929,0.00026460353,0.000046764064,0.000081129896,0.00008414111,0.00004276602,0.00038134592],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99793994,0.00016861099,0.0005859391,0.00053888385,0.0004228215,0.00034381007],"domain_scores_gemma":[0.99882144,0.00033412955,0.00013841646,0.00044019846,0.00005451572,0.00021132037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025470756,0.00027817703,0.0005306216,0.00018312394,0.00009325979,0.00002411259,0.00011409162,0.00022950313,0.00022848697],"category_scores_gemma":[0.00009454298,0.00020351763,0.000099302444,0.00034780885,0.00014048077,0.00013249769,0.000009025212,0.0003993346,0.000087155044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008276529,0.0014914871,0.99459016,0.000033686883,0.00030780735,0.00031111177,0.0013976204,0.000013040236,0.0003540646,0.00008505711,0.00023171224,0.00035658042],"study_design_scores_gemma":[0.019944714,0.0024151625,0.9460116,0.00064069655,0.00058897346,0.0006666011,0.0007087038,0.000029505607,0.027924418,0.0000052205082,0.0007170705,0.00034733553],"about_ca_topic_score_codex":0.0001306364,"about_ca_topic_score_gemma":0.00006826509,"teacher_disagreement_score":0.048578583,"about_ca_system_score_codex":0.0001326495,"about_ca_system_score_gemma":0.00023939327,"threshold_uncertainty_score":0.8299208},"labels":[],"label_agreement":null},{"id":"W2137040543","doi":"10.1182/blood-2007-03-081018","title":"Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working Group","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":234,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute","keywords":"Medicine; Multiple myeloma; Internal medicine; Transplantation; Creatinine; Multivariate analysis; Adverse effect; Stage (stratigraphy); Surgery; Young adult","score_opus":0.020908658863440212,"score_gpt":0.2568256700594882,"score_spread":0.235917011196048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137040543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987232,0.00008913809,0.0000023424936,0.000082576866,0.00005157344,0.00048785654,0.00018457457,0.000018497765,0.00036020664],"genre_scores_gemma":[0.997481,0.000029420233,0.00046703027,0.00010928379,0.00006806378,0.00003487083,0.0015127078,0.000029677409,0.0002679574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99788165,0.00011039215,0.00027102014,0.0004256681,0.0009877965,0.00032345665],"domain_scores_gemma":[0.99904406,0.00011988235,0.0001242859,0.00043061795,0.00012013953,0.00016103266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011540897,0.00020816173,0.0004113425,0.00028581455,0.000081303064,0.000041941188,0.00024835463,0.000089682595,0.00011522791],"category_scores_gemma":[0.00007215707,0.00013783015,0.000094121526,0.00042221125,0.00014604696,0.00019077514,0.00013202989,0.00020210491,0.0000037115067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008932206,0.001889856,0.9910122,0.000006863386,0.0020807397,0.0001855026,0.0010383022,0.000004452421,0.00013564706,0.0000016578672,0.000111698144,0.0026398555],"study_design_scores_gemma":[0.008361263,0.00038457537,0.990008,0.00007167335,0.00053221674,0.0000028209104,0.00011802187,0.0000843348,0.00021182175,0.0000055098403,0.000093448645,0.00012633471],"about_ca_topic_score_codex":0.001921063,"about_ca_topic_score_gemma":0.0020048895,"teacher_disagreement_score":0.0074680424,"about_ca_system_score_codex":0.000046526682,"about_ca_system_score_gemma":0.000029228868,"threshold_uncertainty_score":0.56205505},"labels":[],"label_agreement":null},{"id":"W2137230390","doi":"10.1182/blood-2005-05-2096","title":"Enhanced TNF-α–induced apoptosis in Fanconi anemia type C–deficient cells is dependent on apoptosis signal-regulating kinase 1","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; University of Toronto; Hospital for Sick Children; Riley Children's Foundation; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; University of Missouri; Fanconi Anemia Research Fund","keywords":"Apoptosis; Fanconi anemia; Cancer research; Anemia; Kinase; Signal transduction; Tumor necrosis factor alpha; Medicine; Biology; Cell biology; Immunology; Internal medicine; DNA; Genetics; DNA repair","score_opus":0.010466879942697552,"score_gpt":0.2369853487684326,"score_spread":0.22651846882573506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137230390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99693197,0.00013054766,0.00020591158,0.000084426196,0.00018875704,0.00032274987,0.000014321144,0.000038348993,0.0020829784],"genre_scores_gemma":[0.9962534,0.000035670942,0.0023164917,0.0005331836,0.00021209713,0.00004628989,0.000035168625,0.000049851016,0.0005178584],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998099,0.00007391338,0.00035754216,0.00069476094,0.0002917611,0.0004829797],"domain_scores_gemma":[0.99907947,0.000019035515,0.00013371118,0.00057012,0.00007353322,0.00012412634],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002172637,0.00029014755,0.00023809206,0.00010200809,0.000076091084,0.000037129055,0.00026557743,0.00027671034,0.00013677953],"category_scores_gemma":[0.00003867983,0.00030058293,0.00012071361,0.00018648292,0.000021928076,0.0000065957797,0.00013809929,0.0001670507,0.00011979366],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000065743014,0.0005575001,0.00006381675,0.000019012343,0.000033764612,0.0000015954744,0.00015258028,0.00042703448,0.9941007,0.000022296294,0.00012873091,0.0044272398],"study_design_scores_gemma":[0.0015199372,0.00057363353,0.000063677006,0.00004676006,0.00004319199,0.0000027380152,0.00012247369,0.000107223255,0.9968272,0.000015158594,0.00032599908,0.00035203923],"about_ca_topic_score_codex":0.000034410954,"about_ca_topic_score_gemma":0.00003861474,"teacher_disagreement_score":0.0040752008,"about_ca_system_score_codex":0.000050587016,"about_ca_system_score_gemma":0.00007244711,"threshold_uncertainty_score":0.9999446},"labels":[],"label_agreement":null},{"id":"W2137328701","doi":"10.1182/blood-2007-04-085076","title":"Histone deacetylase–mediated transcriptional activation reduces proviral loads in HTLV-1–associated myelopathy/tropical spastic paraparesis patients","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and Retrovirus Studies","field":"Immunology and Microbiology","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Hôpital Saint-Luc; Centre Hospitalier de l’Université de Montréal","funders":"Fonds De La Recherche Scientifique - FNRS; World Health Organization","keywords":"Tropical spastic paraparesis; Immunology; Biology; Myelopathy; Virology; Histone deacetylase; Virus; Viral load; Viral replication; Histone deacetylase inhibitor; Immune system; Medicine; Cancer research; Histone; Gene; Neuroscience","score_opus":0.008798970163394914,"score_gpt":0.22105345039825613,"score_spread":0.2122544802348612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137328701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974868,0.0009406278,0.00004652055,0.00012939952,0.00050714944,0.00028048284,0.000051332543,0.000088516914,0.000469133],"genre_scores_gemma":[0.9986717,0.000048624526,0.000031740565,0.00008095275,0.00005045257,0.00002839924,0.00039818816,0.000017449729,0.00067251123],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984667,0.00013726151,0.00044159938,0.00033458648,0.00009379095,0.00052606536],"domain_scores_gemma":[0.99943876,0.00018052816,0.0001444179,0.00010703622,0.00009596889,0.00003329159],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017834478,0.00021870468,0.00031853712,0.00019866636,0.0001970384,0.00000859565,0.00013382427,0.00033262448,0.00009467004],"category_scores_gemma":[0.000299327,0.00019162297,0.00009085222,0.00027595274,0.00021792858,0.000095823074,0.00003400215,0.0003535669,0.00014268534],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005072196,0.0031439513,0.2859187,0.000018552368,0.00025488157,0.000011521831,0.0010303124,0.0000020220652,0.70692486,0.00008854733,0.00045683223,0.0016426225],"study_design_scores_gemma":[0.0056709787,0.00037133385,0.8475798,0.0000468191,0.00008057815,0.000003242751,0.00018577637,7.9279187e-7,0.14473103,0.000034068547,0.0010635112,0.00023210993],"about_ca_topic_score_codex":0.00014906733,"about_ca_topic_score_gemma":0.00029451007,"teacher_disagreement_score":0.5621938,"about_ca_system_score_codex":0.00012615381,"about_ca_system_score_gemma":0.000062830215,"threshold_uncertainty_score":0.78141576},"labels":[],"label_agreement":null},{"id":"W2137698660","doi":"10.1182/blood-2004-08-3156","title":"A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":561,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Biology; Major histocompatibility complex; Cell biology; CD1; MHC class I; Receptor; Self Tolerance; Natural killer cell; Natural killer T cell; Interleukin 12; Cytotoxic T cell; Janus kinase 3; Immunology; Immune system; T cell; In vitro; Biochemistry","score_opus":0.0069410411030653655,"score_gpt":0.21153729259783394,"score_spread":0.20459625149476857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137698660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828211,0.0067338888,0.00022201423,0.00007856536,0.008413879,0.00037293223,0.000004677245,0.00019597785,0.0011569286],"genre_scores_gemma":[0.986732,0.00023113315,0.0040486692,0.00012373041,0.00022672307,0.000035091,0.00008238506,0.000031805244,0.008488472],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99895006,0.00010578509,0.00035262987,0.00027884543,0.000039858027,0.0002728285],"domain_scores_gemma":[0.9993714,0.00007754844,0.00020531948,0.00022363458,0.00010583066,0.000016254553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001226104,0.0001915564,0.00026132647,0.000102201164,0.00016105693,0.000017797738,0.00013550202,0.0001946021,0.00027774848],"category_scores_gemma":[0.000014021055,0.00017514252,0.00015226188,0.00007454826,0.00006948675,0.00019445065,0.000032612494,0.00026305646,0.00020704199],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002313009,0.0006447015,0.00029051074,0.000034133573,0.00019892758,3.343233e-7,0.00095162354,0.000010502952,0.9646857,0.000045593642,0.032093793,0.00081292266],"study_design_scores_gemma":[0.0019171488,0.00010576004,0.00024163179,0.000045904144,0.000057684196,0.000016940761,0.00016400155,0.00001922831,0.65339226,0.000002805875,0.3438958,0.00014085676],"about_ca_topic_score_codex":0.0000045397023,"about_ca_topic_score_gemma":0.000002840762,"teacher_disagreement_score":0.311802,"about_ca_system_score_codex":0.000030361605,"about_ca_system_score_gemma":0.00003017101,"threshold_uncertainty_score":0.71421045},"labels":[],"label_agreement":null},{"id":"W2137723066","doi":"10.1182/blood-2002-10-3280","title":"Safety and effectiveness of long-term therapy with the oral iron chelator deferiprone","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":319,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Apotex (Canada)","funders":"","keywords":"Deferiprone; Medicine; Discontinuation; Neutropenia; Internal medicine; Chelation therapy; Thalassemia; Gastroenterology; Deferoxamine; Absolute neutrophil count; Regimen; Pediatrics; Surgery; Chemotherapy","score_opus":0.006110720864404984,"score_gpt":0.22389833375993076,"score_spread":0.21778761289552578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137723066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99263287,0.004814771,0.0000614656,0.00010322877,0.000021637301,0.00043840552,0.0000016032075,0.00001575052,0.0019102555],"genre_scores_gemma":[0.9988981,0.00088304566,0.000057492638,0.00006251326,0.0000080661175,0.0000084610865,0.000003383238,0.000014739772,0.000064231186],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99945813,0.0000915451,0.00009058728,0.00012657917,0.00010575886,0.00012737738],"domain_scores_gemma":[0.9996658,0.000050935636,0.000037391816,0.00016476981,0.00003171125,0.000049392776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023316317,0.00009757054,0.00019570385,0.000018466337,0.000054793094,0.0000047072267,0.000030441568,0.00007436735,0.00002749718],"category_scores_gemma":[0.000014639931,0.00004851763,0.000031643503,0.00011652303,0.00013049526,0.000020348143,0.000007276,0.00011871378,0.0000020725445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002078762,0.0012287295,0.9631798,0.00043647413,0.00047749176,0.000063914405,0.00046858922,0.0000055046785,0.025020184,0.00091931294,0.000009539437,0.00611168],"study_design_scores_gemma":[0.016033815,0.0014269891,0.92742586,0.00023036075,0.00031106488,0.00026518223,0.00021774968,0.000002281382,0.053429283,0.000017971306,0.00050579244,0.00013367305],"about_ca_topic_score_codex":0.000010610745,"about_ca_topic_score_gemma":0.0000040106643,"teacher_disagreement_score":0.03575398,"about_ca_system_score_codex":0.000008815626,"about_ca_system_score_gemma":0.00004284193,"threshold_uncertainty_score":0.19784915},"labels":[],"label_agreement":null},{"id":"W2137965475","doi":"10.1182/blood-2009-12-257030","title":"EGR-1 activation by EGF inhibits MMP-9 expression and lymphoma growth","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique","funders":"National Cancer Institute; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Terry Fox Foundation; Cancer Research Society","keywords":"Cancer research; Lymphoma; Medicine; Internal medicine; Biology; Oncology","score_opus":0.003148517696893793,"score_gpt":0.19291284968567296,"score_spread":0.18976433198877918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137965475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99835855,0.000203135,0.00024627996,0.00006784172,0.00008933405,0.0001230763,0.000012753299,0.000016680271,0.0008823696],"genre_scores_gemma":[0.99850416,0.00005621431,0.0006322467,0.0001968653,0.00027015505,0.000036710433,0.00008708075,0.000015936512,0.00020063901],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999418,0.000018540944,0.00009378999,0.00024606969,0.00008480113,0.00013876372],"domain_scores_gemma":[0.9996615,0.0000039953493,0.000047084908,0.00017251416,0.000038896364,0.00007600587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006945808,0.000105278195,0.00006795673,0.000018514565,0.00007516,0.000022444028,0.00007110714,0.00018158143,0.000016571197],"category_scores_gemma":[0.000059001326,0.000095161806,0.000026867714,0.000031204887,0.000026433707,0.000008159071,0.00007825361,0.000060472135,0.000005650157],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016971915,0.0001418869,0.00048333593,0.000007869993,0.00000807504,6.380807e-7,0.0000122571255,1.1221271e-8,0.9958847,0.00010018241,0.002483397,0.0008606697],"study_design_scores_gemma":[0.0011185932,0.00013878242,0.00018725342,0.000013848334,0.0000095861205,0.000013522397,0.000008284515,0.0000016450252,0.9902033,0.00031542376,0.007860553,0.00012916359],"about_ca_topic_score_codex":0.000010554171,"about_ca_topic_score_gemma":0.0000025135582,"teacher_disagreement_score":0.0056813606,"about_ca_system_score_codex":0.0000016603449,"about_ca_system_score_gemma":0.000023072715,"threshold_uncertainty_score":0.38805857},"labels":[],"label_agreement":null},{"id":"W2139220888","doi":"10.1182/blood.v99.5.1692","title":"A tyrosine703serine polymorphism of CD109 defines the Gov platelet alloantigens","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Biology; Genotype; Allele; Single-nucleotide polymorphism; Genotyping; Molecular biology; Genetics; Complementary DNA; Variants of PCR; Polymerase chain reaction; SNP genotyping; Neonatal alloimmune thrombocytopenia; genomic DNA; Gene","score_opus":0.018438311887376758,"score_gpt":0.22215939600159576,"score_spread":0.203721084114219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139220888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9811172,0.004620591,0.0000033225074,0.0016779227,0.000053725096,0.0002237359,0.000023504563,0.00003900815,0.01224099],"genre_scores_gemma":[0.9964817,0.0007151454,0.00026560755,0.00034876206,0.000054061584,0.000012082988,0.000016451755,0.000019215884,0.0020869437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99926025,0.000012069828,0.00019190699,0.00015316313,0.00017215665,0.00021047912],"domain_scores_gemma":[0.9994976,0.000033223536,0.000068390786,0.00030127453,0.00003587161,0.0000636744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000039420538,0.00013515528,0.0002874431,0.00004466154,0.00005799198,0.0000072693633,0.00008423264,0.000056193145,0.00038127296],"category_scores_gemma":[0.00002956108,0.00008286656,0.00010308326,0.0001623849,0.00006758115,0.000030789102,0.00002886488,0.0000810313,0.00012819291],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090777886,0.03887864,0.50982463,0.0007550751,0.00847149,0.010006547,0.0045024487,0.000018131546,0.25756755,0.0066093816,0.08243858,0.08001977],"study_design_scores_gemma":[0.06573663,0.004077388,0.4016408,0.0005876162,0.0036782688,0.01138526,0.0004200063,0.0006532353,0.35526022,0.0012346039,0.15403442,0.0012915734],"about_ca_topic_score_codex":0.000107253814,"about_ca_topic_score_gemma":0.000021490214,"teacher_disagreement_score":0.108183816,"about_ca_system_score_codex":0.0000053912086,"about_ca_system_score_gemma":0.000011802678,"threshold_uncertainty_score":0.41746715},"labels":[],"label_agreement":null},{"id":"W2140196635","doi":"10.1182/blood-2002-11-3444","title":"Refractory anemia in childhood: a retrospective analysis of 67 patients with particular reference to monosomy 7","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":177,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Monosomy; Medicine; Internal medicine; Trisomy 8; Chromosome 7 (human); Anemia; Pediatrics; Retrospective cohort study; Transplantation; Gastroenterology; Trisomy; Myelodysplastic syndromes; Chromosome abnormality; Cytogenetics; Bone marrow; Karyotype; Biology; Chromosome","score_opus":0.009881563413163173,"score_gpt":0.256108841303417,"score_spread":0.2462272778902538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140196635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99488866,0.00005333212,0.00001997829,0.000051136078,0.0000059293084,0.0004950984,0.000020548143,0.0000177386,0.0044475775],"genre_scores_gemma":[0.9983335,0.000015193987,0.0013513109,0.00010949486,0.000008728704,0.000040634426,0.000038933093,0.000018695484,0.00008348813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842864,0.00008955686,0.00027700272,0.00037112154,0.00051275047,0.00032090262],"domain_scores_gemma":[0.9988899,0.000046396617,0.000083354345,0.0005287197,0.000256827,0.00019480693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020134945,0.00014229512,0.00047596698,0.0005247025,0.000026513913,0.0000070580736,0.00010283202,0.00008932997,0.00014528853],"category_scores_gemma":[0.00046547272,0.00011088056,0.00006464231,0.0020327922,0.000051787447,0.000060101887,0.000033963544,0.0003126161,0.000018396157],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012171704,0.0014729676,0.9957324,0.00001731419,0.00059690827,0.000048901853,0.00047750262,0.000025079546,0.0012279395,0.00012370563,0.000048706464,0.00010682567],"study_design_scores_gemma":[0.004329633,0.0008222682,0.9866452,0.00005776937,0.00089507893,0.0000023578684,0.00009563168,0.000009610567,0.006798252,0.000015553582,0.000209992,0.000118650096],"about_ca_topic_score_codex":0.00013288771,"about_ca_topic_score_gemma":0.000099067875,"teacher_disagreement_score":0.009087229,"about_ca_system_score_codex":0.00022551067,"about_ca_system_score_gemma":0.00023301717,"threshold_uncertainty_score":0.4521578},"labels":[],"label_agreement":null},{"id":"W2141569879","doi":"10.1182/blood-2011-03-344408","title":"Blood platelets contain tumor-derived RNA biomarkers","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":393,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"National Cancer Institute","keywords":"Platelet; Prostate cancer; Glioma; RNA; Cancer; In vivo; Medicine; Cancer research; Biology; Gene; Internal medicine; Genetics","score_opus":0.015987413160801506,"score_gpt":0.2381254497716541,"score_spread":0.22213803661085257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141569879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98171663,0.0013417967,0.001818576,0.000030803454,0.00015172946,0.0003903457,0.000028414539,0.000048656068,0.014473028],"genre_scores_gemma":[0.99740684,0.00016073066,0.0015387668,0.00024159417,0.00013529618,0.00006137795,0.000069662194,0.00006288338,0.00032286826],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99838173,0.00009647949,0.00023544299,0.0005317986,0.00023774114,0.00051680446],"domain_scores_gemma":[0.99901843,0.000007733661,0.00008342639,0.0005778171,0.00010666785,0.00020595126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021382439,0.00023129789,0.00018507124,0.00009013411,0.00009420812,0.000025381163,0.00037053993,0.0002153165,0.0001991117],"category_scores_gemma":[0.00010051691,0.00023975993,0.00014734024,0.0001512525,0.000104690705,0.0000041074813,0.00021155307,0.00017650372,0.00006550797],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016197827,0.00036392946,0.00007159416,0.000015790787,0.00053215824,0.00019003623,0.000055222772,7.502292e-7,0.99745756,0.0000912167,0.00046764195,0.00059211196],"study_design_scores_gemma":[0.0032829756,0.0006389603,0.00036067257,0.000018358627,0.0001159658,0.00020320185,0.00006139837,0.0000056375497,0.99195313,0.00011358248,0.0029469058,0.00029919145],"about_ca_topic_score_codex":0.00010324407,"about_ca_topic_score_gemma":0.000040026414,"teacher_disagreement_score":0.01569017,"about_ca_system_score_codex":0.000011055021,"about_ca_system_score_gemma":0.00015687282,"threshold_uncertainty_score":0.9777126},"labels":[],"label_agreement":null},{"id":"W2142129796","doi":"10.1182/blood-2005-11-4370","title":"The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":429,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Hospital for Sick Children","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; Amgen; National Institutes of Health; Amgen Foundation","keywords":"Medicine; Neutropenia; Cumulative incidence; Internal medicine; Sepsis; Hematopoietic stem cell transplantation; Granulocyte colony-stimulating factor; Absolute neutrophil count; Gastroenterology; Incidence (geometry); Hazard ratio; Febrile neutropenia; Transplantation; Surgery; Chemotherapy; Confidence interval","score_opus":0.004913719207666605,"score_gpt":0.2109527423784922,"score_spread":0.2060390231708256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142129796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977369,0.001847175,0.0000025460322,0.000007866734,0.000016683442,0.00018611139,0.00003755921,0.0000030573117,0.0001621476],"genre_scores_gemma":[0.9995311,0.00021996532,0.000048825856,0.000022746031,0.000020094209,0.000012512099,0.000103871804,0.0000107321985,0.00003017636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993945,0.0000341132,0.0001375258,0.00021108735,0.00009384192,0.00012893672],"domain_scores_gemma":[0.99962515,0.000014097469,0.000075408534,0.00021946638,0.000042951953,0.000022922632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000037658487,0.000110428875,0.00010992308,0.000010082363,0.000055673892,0.000021948732,0.00009618311,0.00006211611,0.0000036392487],"category_scores_gemma":[0.0000065837175,0.000073139636,0.000025763604,0.00004572396,0.00007386074,0.000006521314,0.00004930321,0.00004136486,4.877587e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000099559955,0.0002729629,0.99447733,0.000002635181,0.0001407108,0.0000034356622,0.000017920602,0.0000038565004,0.0035095527,0.000002065357,0.000010401751,0.001459585],"study_design_scores_gemma":[0.004040955,0.00021714957,0.97468895,0.000011767176,0.000046177076,0.0000011039052,0.00000949069,0.0000010030457,0.020843685,0.000036727266,0.000009479775,0.00009350397],"about_ca_topic_score_codex":0.0010471399,"about_ca_topic_score_gemma":0.0033895432,"teacher_disagreement_score":0.019788356,"about_ca_system_score_codex":0.00000569819,"about_ca_system_score_gemma":0.00003685378,"threshold_uncertainty_score":0.29825476},"labels":[],"label_agreement":null},{"id":"W2142439096","doi":"10.1182/blood-2003-01-0292","title":"Sustained phenotypic correction of canine hemophilia A using an adeno-associated viral vector","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Genetic enhancement; Vector (molecular biology); Factor IX; Clotting factor; Viral vector; Adeno-associated virus; Duchenne muscular dystrophy; Gene expression; Phenotype; Gene; Medicine; Expression cassette; Biology; Immunology; Virology; Internal medicine; Recombinant DNA; Genetics","score_opus":0.014851653184509322,"score_gpt":0.27613014854724005,"score_spread":0.26127849536273073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142439096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998879,0.000353448,0.000075278185,0.000009795026,0.00012682965,0.00016914503,0.000013742228,0.000013904699,0.0003588342],"genre_scores_gemma":[0.9991499,0.000016341468,0.0001138315,0.000038047412,0.00009638409,0.000006817392,0.00006918018,0.000029788973,0.00047966142],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99897623,0.00018813187,0.00016538659,0.0002457903,0.00015320053,0.0002712396],"domain_scores_gemma":[0.99938816,0.0000073938445,0.000080873666,0.00028052687,0.0001638953,0.00007915439],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023877218,0.00012109861,0.00014168266,0.00005276992,0.00007078187,0.000011185608,0.00011794501,0.00013155419,0.000055614353],"category_scores_gemma":[0.00018516304,0.00012728787,0.000059743044,0.00016472691,0.00005046123,0.000004011154,0.000033564098,0.000086601445,0.0000020024427],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039147574,0.0005319487,0.0016211834,0.000008737532,0.00009900715,0.0000035181265,0.000046937068,0.000279222,0.9966581,0.000014211908,0.00004398931,0.000301663],"study_design_scores_gemma":[0.0020033764,0.0027639344,0.00069383206,0.000007854751,0.00004324282,0.000009165873,0.00008735893,0.0003662923,0.9937361,0.000045852332,0.00009454542,0.00014844145],"about_ca_topic_score_codex":0.00009707414,"about_ca_topic_score_gemma":0.00036879972,"teacher_disagreement_score":0.002922003,"about_ca_system_score_codex":0.000031256135,"about_ca_system_score_gemma":0.00022988999,"threshold_uncertainty_score":0.5190649},"labels":[],"label_agreement":null},{"id":"W2142450574","doi":"10.1182/blood-2008-09-179796","title":"Identification of a potent natural triterpenoid inhibitor of proteosome chymotrypsin-like activity and NF-κB with antimyeloma activity in vitro and in vivo","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Natural Compounds in Disease Treatment","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Proteasome; Bortezomib; Proteasome inhibitor; Cancer research; Chemistry; Transcription factor; Multiple myeloma; Biology; Biochemistry; Immunology","score_opus":0.009213873991936529,"score_gpt":0.24069939305511961,"score_spread":0.2314855190631831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142450574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981432,0.0007295678,0.0000034415086,0.0001573673,0.000038769776,0.0008643498,0.00002245494,0.000015632946,0.000025232304],"genre_scores_gemma":[0.9992154,0.000052602114,0.0005694506,0.000009692685,0.000021043832,0.00003865218,0.000004830188,0.000013892177,0.00007442533],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989006,0.000071919276,0.00025729687,0.000312173,0.00028995494,0.00016807322],"domain_scores_gemma":[0.99937946,0.000047399095,0.00019027048,0.00024169352,0.00006722509,0.00007393962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001138988,0.0001682565,0.00042857963,0.00028651388,0.000030954398,0.000006646361,0.000047134694,0.00007596717,0.000001883657],"category_scores_gemma":[0.00003764914,0.00013234545,0.0000393788,0.0003549722,0.0001743751,0.0001855768,0.000050376035,0.000202462,2.1577434e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034698118,0.0021251517,0.06869674,0.00025380068,0.00006223957,0.00013971464,0.00020149605,3.7476642e-7,0.9224517,0.0000010516633,0.0000033002425,0.0025946405],"study_design_scores_gemma":[0.0047045704,0.00020782946,0.45887378,0.000114948176,0.000057391448,0.000119188066,0.00001055918,0.000059387217,0.53577715,0.0000072381763,0.000001031776,0.00006692979],"about_ca_topic_score_codex":0.00015533253,"about_ca_topic_score_gemma":0.00004921529,"teacher_disagreement_score":0.39017704,"about_ca_system_score_codex":0.00006111943,"about_ca_system_score_gemma":0.0000768244,"threshold_uncertainty_score":0.53968906},"labels":[],"label_agreement":null},{"id":"W2142814377","doi":"10.1182/blood-2011-04-345256","title":"Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":191,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Genentech; National Institute for Health and Care Research; Eli Lilly and Company","keywords":"Rituximab; International Prognostic Index; Medicine; BCL6; Diffuse large B-cell lymphoma; Internal medicine; Oncology; Lymphoma; Biomarker; Pathology; Immunology; B cell; Antibody; Biology","score_opus":0.02218879087789223,"score_gpt":0.2473049939326845,"score_spread":0.2251162030547923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142814377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99197197,0.0035381077,0.0000038349585,0.00007737683,0.00012123044,0.002066048,0.000101681515,0.000055744094,0.0020640297],"genre_scores_gemma":[0.9988016,0.000067940724,0.00026880918,0.000122057136,0.000034719564,0.0005679226,0.00004753442,0.000040821214,0.00004861063],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99773496,0.00016447097,0.00067947916,0.0005621136,0.00039326286,0.00046570128],"domain_scores_gemma":[0.99818283,0.0004744229,0.00024251435,0.000866337,0.0000827834,0.0001511238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002888155,0.00034075696,0.0005993144,0.000108125714,0.00007401832,0.000014898001,0.0002859874,0.00013650516,0.00010925946],"category_scores_gemma":[0.00017764406,0.0002290937,0.00020929701,0.00040840465,0.00021538604,0.000050004684,0.0001325067,0.00005573149,0.00003901154],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007224275,0.14697237,0.83394647,0.000035137116,0.0009837585,0.00059593155,0.0021808117,6.232254e-9,0.0131003745,0.000018565797,0.00029651285,0.0011476498],"study_design_scores_gemma":[0.082078144,0.000580698,0.8692805,0.00013886634,0.0012322423,0.000029684405,0.0013581741,0.000014795649,0.044873636,0.000031161657,0.00016280837,0.00021929131],"about_ca_topic_score_codex":0.002862183,"about_ca_topic_score_gemma":0.00009656525,"teacher_disagreement_score":0.14639167,"about_ca_system_score_codex":0.00015004835,"about_ca_system_score_gemma":0.00026334438,"threshold_uncertainty_score":0.934217},"labels":[],"label_agreement":null},{"id":"W2142821156","doi":"10.1182/blood-2003-05-1428","title":"Evidence for adequate thymic function but impaired naive T-cell survival following allogeneic hematopoietic stem cell transplantation in the absence of chronic graft-versus-host disease","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Centre Hospitalier de l’Université de Montréal; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Naive T cell; Immunology; Hematopoietic stem cell transplantation; Transplantation; Interleukin-7 receptor; T cell; Immunophenotyping; Biology; Stem cell; Graft-versus-host disease; T-cell receptor; Medicine; Flow cytometry; Internal medicine; IL-2 receptor; Immune system; Cell biology","score_opus":0.029411386728745482,"score_gpt":0.24212690232327214,"score_spread":0.21271551559452664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142821156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96879435,0.027839553,0.00079327164,0.000043004915,0.0015462238,0.000767479,0.000036924397,0.000036933667,0.00014229023],"genre_scores_gemma":[0.99838144,0.00080384937,0.000017938974,0.0000300504,0.000023421035,0.00015716968,0.000068852554,0.000023020808,0.00049427274],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99798656,0.0005631035,0.00045312478,0.0004292531,0.00007602918,0.0004919391],"domain_scores_gemma":[0.9984736,0.0008465245,0.00021115618,0.0003920551,0.00004906202,0.00002758903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054171705,0.00025803724,0.00033103835,0.0001015797,0.0001886732,0.000013720258,0.00033770647,0.00021437043,0.00005996182],"category_scores_gemma":[0.000031590513,0.0002068232,0.00026280637,0.00021341753,0.00014520067,0.00013932724,0.000020638527,0.00023266082,0.000080679194],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010493441,0.000771955,0.004073604,0.00026548517,0.00014295641,0.000026744867,0.0013427803,0.00002998121,0.991748,0.00037326606,0.000021324464,0.00015456806],"study_design_scores_gemma":[0.017125662,0.0019481486,0.008955024,0.00030803125,0.0012038784,0.000036809375,0.003769322,0.000008894052,0.9655523,0.00021480129,0.00033313187,0.0005440419],"about_ca_topic_score_codex":0.00008176267,"about_ca_topic_score_gemma":0.000083138235,"teacher_disagreement_score":0.029587105,"about_ca_system_score_codex":0.00004281075,"about_ca_system_score_gemma":0.00020403389,"threshold_uncertainty_score":0.84340054},"labels":[],"label_agreement":null},{"id":"W2142862734","doi":"10.1182/blood-2003-05-1689","title":"Characterization of DNA-binding-dependent and -independent functions of SCL/TAL1 during human erythropoiesis","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics; Institut National de la Santé et de la Recherche Médicale","keywords":"Biology; Erythropoiesis; Transactivation; Cell biology; Haematopoiesis; Transcription factor; Molecular biology; DNA-binding domain; Stem cell; Genetics; Gene","score_opus":0.013427172835860215,"score_gpt":0.2373429110932133,"score_spread":0.22391573825735306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142862734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986535,0.00003623983,0.0000984618,0.000095851094,0.00015780043,0.0002031487,0.00002788582,0.000038189508,0.0006889642],"genre_scores_gemma":[0.99867433,0.00008058688,0.00007791642,0.000028328011,0.00010526389,0.000010141152,0.00008262583,0.000016278065,0.00092453475],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991468,0.00002075961,0.0003089881,0.00020492106,0.00018169814,0.00013681795],"domain_scores_gemma":[0.9994465,0.000010530555,0.00017631815,0.00019932343,0.00009343407,0.00007390558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000069221336,0.00011224406,0.000286552,0.00017496585,0.00009750406,0.000004413082,0.000035440364,0.000100869576,0.00024503394],"category_scores_gemma":[0.00002260808,0.00010526875,0.0000700133,0.00014441148,0.00009435372,0.00006722917,0.000041474643,0.00010412717,0.000017705031],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007179592,0.00063103874,0.015060103,0.00020487663,0.00009895157,0.000011197021,0.00025080974,0.0000020277316,0.98346555,0.00015045269,0.0000023721368,0.00005083205],"study_design_scores_gemma":[0.0040407795,0.00049485906,0.37473345,0.00010838563,0.00020794955,0.00012575102,0.00020655827,4.552847e-7,0.6199338,0.00004123656,0.000026792248,0.00008003134],"about_ca_topic_score_codex":0.0000328007,"about_ca_topic_score_gemma":0.000018567142,"teacher_disagreement_score":0.36353177,"about_ca_system_score_codex":0.000026784764,"about_ca_system_score_gemma":0.00004433781,"threshold_uncertainty_score":0.4292735},"labels":[],"label_agreement":null},{"id":"W2143581598","doi":"10.1182/blood-2011-01-331363","title":"DCIR-mediated enhancement of HIV-1 infection requires the ITIM-associated signal transduction pathway","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôpital de l'Enfant-Jésus; Centre hospitalier universitaire de Québec","funders":"Canadian Institutes of Health Research","keywords":"Phosphorylation; Signal transduction; Biology; Cell biology; Kinase; Syk; FYN; LYN; Tyrosine kinase","score_opus":0.022410038749079993,"score_gpt":0.22915300819706902,"score_spread":0.20674296944798903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143581598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954926,0.0005434997,0.00017205178,0.00006874617,0.0001556677,0.00027663333,0.000117114985,0.000044418346,0.0031293014],"genre_scores_gemma":[0.9985797,0.00012870033,0.000015585232,0.000013637929,0.000014859914,0.00006402193,0.00039567964,0.0000075651956,0.0007802598],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991235,0.00022734475,0.00020261371,0.00014881922,0.00004896742,0.00024875675],"domain_scores_gemma":[0.9996084,0.000066883535,0.00008981682,0.0001453539,0.00007156298,0.000017958919],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021495404,0.00010004231,0.00013977788,0.000055004777,0.00013229593,0.0000036951708,0.00008279869,0.00011856169,0.0027367175],"category_scores_gemma":[0.00004232122,0.000066617504,0.00007687227,0.00009194976,0.00014919933,0.00005288443,0.000017120794,0.00014291127,0.0007122448],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016059322,0.0027826189,0.015173704,0.000013100745,0.0009059715,0.0000060619773,0.0016662527,3.9334589e-7,0.97515273,0.00017473688,0.0005072675,0.0034565881],"study_design_scores_gemma":[0.0026130518,0.0008252904,0.029533153,0.000020311092,0.00009612995,0.000011133924,0.000076818746,5.815104e-7,0.96480286,0.000074099575,0.0018722799,0.00007429036],"about_ca_topic_score_codex":0.00037549797,"about_ca_topic_score_gemma":0.000100632,"teacher_disagreement_score":0.014359449,"about_ca_system_score_codex":0.000024010324,"about_ca_system_score_gemma":0.000054640655,"threshold_uncertainty_score":0.9981749},"labels":[],"label_agreement":null},{"id":"W2144004068","doi":"10.1182/blood.v98.10.2887","title":"Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":250,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"John and Lucille Van Geest Foundation; North West Cancer Research; Trent University; Nottingham Trent University","keywords":"Myeloid leukemia; K562 cells; Biology; Human leukocyte antigen; Cytotoxic T cell; Fusion protein; Leukemia; Cancer research; Immunology; Antigen; In vitro; Genetics; Recombinant DNA","score_opus":0.048150746881359716,"score_gpt":0.2904851457881751,"score_spread":0.24233439890681535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144004068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841119,0.010012547,0.000011506254,0.0011600666,0.00010929283,0.0020325077,0.000016491224,0.00016442098,0.0023812356],"genre_scores_gemma":[0.97830325,0.0039016241,0.00011117398,0.00018951479,0.0003625946,0.00018943292,0.000038967748,0.000067449975,0.016835986],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969906,0.00047081927,0.00034719918,0.0005360827,0.0010021984,0.0006530622],"domain_scores_gemma":[0.99762493,0.00080645084,0.00019894583,0.0010167487,0.00017510062,0.00017784591],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00079416577,0.00029341676,0.0004454251,0.00007574853,0.00024915847,0.00009680122,0.0005111148,0.00018660384,0.0030087554],"category_scores_gemma":[0.00056436256,0.00020263196,0.0002755968,0.0004278129,0.00016026701,0.0001365461,0.00026185735,0.0005227816,0.00026540426],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055099605,0.00051606674,0.020321934,0.000019740006,0.000407145,0.00013171321,0.00057739153,0.0000035980613,0.97231126,5.9062666e-7,0.00081083237,0.0043487437],"study_design_scores_gemma":[0.0037471657,0.00038590544,0.07805884,0.00081061694,0.000299613,0.000033599215,0.00018008178,0.000084831976,0.91209644,0.000049165843,0.0040191747,0.0002345693],"about_ca_topic_score_codex":0.0038943705,"about_ca_topic_score_gemma":0.00027177038,"teacher_disagreement_score":0.060214814,"about_ca_system_score_codex":0.00025608315,"about_ca_system_score_gemma":0.00031051878,"threshold_uncertainty_score":0.99790263},"labels":[],"label_agreement":null},{"id":"W2144118333","doi":"10.1182/blood-2010-10-313908","title":"A randomized, double-blind study of romiplostim to determine its safety and efficacy in children with immune thrombocytopenia","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":220,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Amgen","keywords":"Romiplostim; Immune thrombocytopenia; Medicine; Randomized controlled trial; Pediatrics; Internal medicine; Thrombopoietin; Platelet","score_opus":0.03539263368920906,"score_gpt":0.2770057548908016,"score_spread":0.24161312120159253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144118333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943811,0.00038333584,0.0000020038874,0.000024397885,0.000008688803,0.004128995,0.0000051528987,0.000015690095,0.0010505769],"genre_scores_gemma":[0.9994614,0.000060543443,0.00028169982,0.00001938772,0.000008228895,0.00006914846,0.000011348671,0.000019951129,0.00006825229],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990398,0.000042241216,0.0003413485,0.00025390965,0.00014564184,0.00017703215],"domain_scores_gemma":[0.9994973,0.00004282777,0.000085931606,0.00024109033,0.00003784413,0.00009502014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016851122,0.00017116148,0.0009918042,0.0001289503,0.000029075898,0.00000592742,0.00006967328,0.00004527772,0.00004241855],"category_scores_gemma":[0.000028802408,0.00011297549,0.000041129082,0.00018752764,0.00003781364,0.00005212538,0.00005715455,0.00008471032,0.000009499457],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.70949864,0.020871444,0.26062053,0.000025569032,0.0020799947,0.00036029855,0.004946467,0.0000024079918,0.0005001518,0.000016924298,0.0000011616402,0.0010764266],"study_design_scores_gemma":[0.6187116,0.0016494446,0.37551495,0.00006664848,0.00073440745,0.00014076855,0.000072412935,0.0000025412082,0.0030228104,0.0000026667994,6.037941e-7,0.000081153805],"about_ca_topic_score_codex":0.0005398774,"about_ca_topic_score_gemma":0.00020394349,"teacher_disagreement_score":0.114894405,"about_ca_system_score_codex":0.000007656417,"about_ca_system_score_gemma":0.000028940718,"threshold_uncertainty_score":0.4607007},"labels":[],"label_agreement":null},{"id":"W2144353758","doi":"10.1182/blood.v95.7.2337","title":"Transgenic expression of granulocyte-macrophage colony-stimulating factor induces the differentiation and activation of a novel dendritic cell population in the lung","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Medical Research Council; Canadian Lung Association; McMaster University; Hamilton Health Sciences","keywords":"Biology; Population; Immunology; Granulocyte macrophage colony-stimulating factor; CD8; Dendritic cell; Immune system; Cytokine; Medicine","score_opus":0.013134549137735107,"score_gpt":0.24045664234879804,"score_spread":0.22732209321106295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144353758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973904,0.002054809,0.00009956988,0.000030631985,0.000037390902,0.00033256534,0.000014436659,0.000007179088,0.000033020955],"genre_scores_gemma":[0.9997153,0.00011616803,0.000023899205,0.000016815662,0.000005781731,0.000016125012,0.00003731225,0.0000072128914,0.000061374354],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99911875,0.0003135025,0.0002931225,0.00011041155,0.00004543475,0.00011875386],"domain_scores_gemma":[0.9993147,0.00038190302,0.00013310094,0.00014702929,0.000020127098,0.0000031295979],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001743659,0.000096078926,0.00015917535,0.00006195593,0.00012948422,0.000008349917,0.00011982237,0.0001232586,0.00011104501],"category_scores_gemma":[0.000029856477,0.00005905103,0.000047499117,0.00011987069,0.00007230148,0.00009965166,0.0000085632055,0.00015341402,8.0446796e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002928739,0.00038491085,0.008462766,0.000036193105,0.00002360657,8.7453515e-8,0.003828375,0.00003755728,0.98518604,0.000014714534,0.0000014917455,0.0017313956],"study_design_scores_gemma":[0.00203787,0.00008773206,0.36919782,0.000061886814,0.000029668137,0.0000033281215,0.0001898482,0.000027044642,0.6283005,0.000009395629,0.000009392579,0.000045548422],"about_ca_topic_score_codex":0.00018880045,"about_ca_topic_score_gemma":0.0000072254606,"teacher_disagreement_score":0.36073506,"about_ca_system_score_codex":0.0000067870274,"about_ca_system_score_gemma":0.000011928623,"threshold_uncertainty_score":0.24080312},"labels":[],"label_agreement":null},{"id":"W2145081035","doi":"10.1182/blood-2005-06-2245","title":"Analysis of HSC activity and compensatory Hox gene expression profile in Hoxb cluster mutant fetal liver cells","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; U.S. Public Health Service","keywords":"Hox gene; Mutant; Biology; Fetus; Gene expression; Cell biology; Gene; Regulation of gene expression; Genetics; Pregnancy","score_opus":0.007655026068384268,"score_gpt":0.23023687240207322,"score_spread":0.22258184633368894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145081035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99785984,0.0012479761,0.00053575845,0.000011503946,0.000017534363,0.00011506029,0.00002903427,0.000002773797,0.0001805459],"genre_scores_gemma":[0.99734044,0.00034735052,0.0021266127,0.000016446456,0.000053947337,0.000005945683,0.00004014395,0.000008052586,0.00006103817],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993611,0.00006602204,0.0001442875,0.0002285248,0.00008807634,0.000111973815],"domain_scores_gemma":[0.9996389,0.00001245717,0.00008095577,0.00019382752,0.00003207398,0.000041742383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014022808,0.000088151945,0.00015683915,0.000085862615,0.000022457836,0.0000071533605,0.000055653967,0.00010821561,0.000020475809],"category_scores_gemma":[0.000009413362,0.00008225575,0.00006227852,0.00010697854,0.000036441637,0.00000383289,0.000077578065,0.000047775222,0.0000014207287],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032493208,0.00022753415,0.01912628,0.000010255867,0.000083242274,0.0000013221968,0.000062244326,0.00030070657,0.9781763,5.6920095e-7,0.0000036454826,0.0019754004],"study_design_scores_gemma":[0.0006543184,0.000072879266,0.07476078,0.000005189803,0.00014005932,5.156826e-7,0.000008285704,0.0016050179,0.92244697,0.0000020007426,0.00021269164,0.00009129107],"about_ca_topic_score_codex":0.000023311672,"about_ca_topic_score_gemma":0.00012871079,"teacher_disagreement_score":0.055729333,"about_ca_system_score_codex":0.0000046866985,"about_ca_system_score_gemma":0.000017833001,"threshold_uncertainty_score":0.3354292},"labels":[],"label_agreement":null},{"id":"W2145307509","doi":"10.1182/blood-2005-09-3808","title":"CD44 is a phagocytic receptor","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Proteoglycans and glycosaminoglycans research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":161,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University Health Network; Toronto General Hospital; University of Toronto; Hospital for Sick Children; Canadian Institutes of Health Research","funders":"","keywords":"Receptor; Immunology; Biology; Medicine; Internal medicine","score_opus":0.007374078357625724,"score_gpt":0.2416140431473576,"score_spread":0.23423996478973189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145307509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873769,0.0014221673,0.00038292783,0.00025058645,0.000058860616,0.00018757007,0.000053545777,0.00001865657,0.010248728],"genre_scores_gemma":[0.98978966,0.000087780834,0.00071264786,0.00023107351,0.0005261254,0.00004701167,0.00011210468,0.000022903303,0.008470661],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990406,0.000028798535,0.00013737862,0.00030968623,0.0001653325,0.0003182168],"domain_scores_gemma":[0.99949116,0.0000046733535,0.000030203782,0.0003427856,0.000060741248,0.00007043421],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009541874,0.00012149754,0.00009784694,0.000038308237,0.00007309312,0.000031144067,0.00020084012,0.00011580074,0.00021775093],"category_scores_gemma":[0.000023545655,0.0001127833,0.000080358,0.00010304777,0.000060420763,0.000002249645,0.000084975996,0.0000799199,0.00013209788],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039906507,0.00029680046,0.0033827964,0.000015893971,0.00004241235,0.000010193061,0.000009675754,0.0000020069185,0.9668428,0.00011525894,0.02756258,0.0016796817],"study_design_scores_gemma":[0.0012165591,0.00020285674,0.00097417005,0.000005747161,0.000013716435,0.000020538506,0.0000063182893,0.0000053663866,0.81519586,0.0001457344,0.18206063,0.00015252379],"about_ca_topic_score_codex":0.00017563904,"about_ca_topic_score_gemma":0.00004258489,"teacher_disagreement_score":0.15449804,"about_ca_system_score_codex":0.0000078280445,"about_ca_system_score_gemma":0.000089165835,"threshold_uncertainty_score":0.45991695},"labels":[],"label_agreement":null},{"id":"W2145578897","doi":"10.1182/blood-2003-12-4286","title":"A novel type 2A von Willebrand factor mutation located at the last nucleotide of exon 26 (3538G&amp;gt;A) causes skipping of 2 nonadjacent exons","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University of Calgary","funders":"","keywords":"Exon; Molecular biology; Mutation; Transition (genetics); Missense mutation; Complementary DNA; Biology; Recombinant DNA; Exon skipping; Exon trapping; Point mutation; Von Willebrand disease; Genetics; Von Willebrand factor; Coding region; Chemistry; Gene; Alternative splicing; Platelet","score_opus":0.024023272958911206,"score_gpt":0.2576327679292953,"score_spread":0.23360949497038408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145578897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980275,0.00055699894,0.000099559365,0.00022775106,0.00006212921,0.00039142408,0.000054468608,0.000033192322,0.0005469732],"genre_scores_gemma":[0.9992341,0.00011445152,0.00032161505,0.00007330991,0.000020808058,0.000007033589,0.00007225462,0.00002667404,0.00012977513],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991446,0.000013297906,0.0002570576,0.00017505375,0.00023186103,0.00017808782],"domain_scores_gemma":[0.99938333,0.000050755643,0.00015476147,0.00022930921,0.00012071953,0.00006111938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000046647034,0.00014259703,0.0002958735,0.000068936875,0.00006553831,0.0000057603756,0.000056634024,0.000064406646,0.000090189154],"category_scores_gemma":[0.00006581261,0.00009830983,0.00007487601,0.00021849512,0.00008102602,0.000047848465,0.000030676456,0.000071605544,0.000034971818],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007551985,0.0076141926,0.065765075,0.00043557203,0.001647791,0.00024306399,0.004422827,0.000693972,0.91596526,0.000200023,0.00024104738,0.002015962],"study_design_scores_gemma":[0.033512175,0.0013123612,0.31943288,0.0010442281,0.0014444782,0.0005065214,0.0006534937,0.000033630102,0.6397995,0.00012990733,0.0017452154,0.0003856393],"about_ca_topic_score_codex":0.00025354,"about_ca_topic_score_gemma":0.00085204333,"teacher_disagreement_score":0.2761658,"about_ca_system_score_codex":0.000047401107,"about_ca_system_score_gemma":0.00009137595,"threshold_uncertainty_score":0.40089583},"labels":[],"label_agreement":null},{"id":"W2146006907","doi":"10.1182/blood.v122.21.2400.2400","title":"Use Of Prothrombin Complex Concentrates In Patients With Hepatic Coagulopathy: A Single Center Retrospective","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Liver transplantation; Liver disease; Retrospective cohort study; Single Center; Hepatology; Internal medicine; Coagulopathy; Population; Adverse effect; Prothrombin complex concentrate; Hemostasis; Prothrombin time; Factor IX; Medical record; Surgery; Transplantation; Gastroenterology; Warfarin","score_opus":0.018156648589749302,"score_gpt":0.20942198239719617,"score_spread":0.19126533380744687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146006907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986372,0.000010230823,0.00000718367,0.000025724727,0.000009961284,0.0010797866,0.000043724056,0.000014732263,0.00017143403],"genre_scores_gemma":[0.9994428,0.0000038524704,0.0002636187,0.00006512121,0.0000074613054,0.00003385481,0.0001630694,0.0000098882865,0.000010314098],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99943316,0.00002316535,0.00014576895,0.00012235428,0.0001583355,0.00011720163],"domain_scores_gemma":[0.999644,0.000016004697,0.000056969948,0.000098406854,0.00013305852,0.000051595885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000014347262,0.00007494983,0.0001679936,0.00003978156,0.0000116075225,0.000010899895,0.000021608243,0.000022639297,0.00009111776],"category_scores_gemma":[0.000005572411,0.000056882644,0.000020710155,0.000093207105,0.000046407782,0.00015742186,0.0000046082096,0.00004325543,0.000011942653],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015682407,0.0024594697,0.9933833,0.00010494397,0.00010575534,0.000007994766,0.000500303,4.1641658e-7,0.003221156,0.000025722291,0.000010868947,0.000023235136],"study_design_scores_gemma":[0.0078629395,0.0007805237,0.980983,0.0002345048,0.00020154353,0.0000019275287,0.0000333022,0.000027602862,0.009779575,0.000032157244,0.0000013013791,0.00006163303],"about_ca_topic_score_codex":0.00021669267,"about_ca_topic_score_gemma":0.000026632903,"teacher_disagreement_score":0.012400321,"about_ca_system_score_codex":0.00002118927,"about_ca_system_score_gemma":0.00002532361,"threshold_uncertainty_score":0.23196068},"labels":[],"label_agreement":null},{"id":"W2146050626","doi":"10.1182/blood-2002-02-0503","title":"Reovirus therapy of lymphoid malignancies","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; Calgary Laboratory Services","funders":"Calgary Laboratory Services; World Health Organization","keywords":"Lymphoma; Raji cell; Biology; Cell culture; Cancer research; Progenitor cell; Haematopoiesis; Stem cell; Virology; Immunology","score_opus":0.025529343096104218,"score_gpt":0.26552912942277546,"score_spread":0.23999978632667124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146050626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858251,0.010964958,0.000009221922,0.00006619304,0.00003102144,0.00011238743,0.000014057845,0.000010295352,0.0029667143],"genre_scores_gemma":[0.99329543,0.005049774,0.00011580613,0.00019536124,0.00012384086,0.00001703633,0.000010607442,0.000021589276,0.0011705318],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992399,0.00005433852,0.00013725602,0.00020077582,0.0001570103,0.00021067317],"domain_scores_gemma":[0.9994292,0.00000733962,0.000045260225,0.00040099944,0.0000666443,0.00005050678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012378648,0.00010031972,0.000107993816,0.000037202728,0.000038266975,0.0000073952656,0.00021782392,0.00008409699,0.0002673116],"category_scores_gemma":[0.000024327486,0.00009054278,0.000080520775,0.00009386189,0.00008374261,0.0000016164026,0.00004291658,0.000037435257,0.00003922143],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020615665,0.00031416008,0.0024666716,0.0000052022756,0.000074157455,0.0000035044966,0.000041756113,0.0000034962327,0.99092495,0.000010991485,0.0007815021,0.0051674293],"study_design_scores_gemma":[0.0016538848,0.0017803322,0.00032768332,0.000004566072,0.0000045421793,0.000015987032,0.000012541261,0.000004965727,0.9832047,0.000025466241,0.012861639,0.00010368914],"about_ca_topic_score_codex":0.000009957833,"about_ca_topic_score_gemma":0.000014560396,"teacher_disagreement_score":0.012080138,"about_ca_system_score_codex":0.0000033495385,"about_ca_system_score_gemma":0.000028240407,"threshold_uncertainty_score":0.36922273},"labels":[],"label_agreement":null},{"id":"W2147260548","doi":"10.1182/blood-2004-11-4469","title":"Quiescence and functional reprogramming of Epstein-Barr virus (EBV)-specific CD8+ T cells during persistent infection","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Reprogramming; Biology; Virology; Virus; CD8; Epstein–Barr virus; Immunology; Immune system; Genetics; Cell","score_opus":0.012492176540801946,"score_gpt":0.20157044167204183,"score_spread":0.18907826513123988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147260548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940707,0.0028946665,0.00013284235,0.000051661238,0.0015079592,0.00012953716,0.0000018461964,0.000072930816,0.0011378569],"genre_scores_gemma":[0.9938123,0.000548359,0.00009496103,0.000028443696,0.00009764064,0.000012299178,0.000024311179,0.0000114525055,0.005370208],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99915206,0.00006527134,0.0002829873,0.00026623812,0.00003980724,0.0001936394],"domain_scores_gemma":[0.9995453,0.00003490596,0.00013690707,0.00018673309,0.00007863422,0.000017521048],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012527689,0.00012702064,0.00015601811,0.00011692192,0.00020420161,0.000016948314,0.000041096926,0.00013742175,0.0009294334],"category_scores_gemma":[0.000018549623,0.00012643798,0.000118697455,0.00009208925,0.00010646106,0.00016108957,0.000041563435,0.00021659631,0.00026574827],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015265365,0.0003524636,0.0021582092,0.000024640916,0.00014345028,7.5401965e-7,0.00027045823,0.000040009683,0.9933891,0.000056121546,0.00047313038,0.0029389784],"study_design_scores_gemma":[0.0015731921,0.00020507166,0.0132782515,0.00003702122,0.00007474405,0.0001766542,0.00022343945,0.000005969637,0.9302672,0.0000019817742,0.054022934,0.00013355182],"about_ca_topic_score_codex":0.00006481844,"about_ca_topic_score_gemma":0.00001642236,"teacher_disagreement_score":0.06312194,"about_ca_system_score_codex":0.000035540063,"about_ca_system_score_gemma":0.000013554728,"threshold_uncertainty_score":0.99998385},"labels":[],"label_agreement":null},{"id":"W2147376659","doi":"10.1182/blood-2007-10-117820","title":"Steel factor coordinately regulates the molecular signature and biologic function of hematopoietic stem cells","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; BC Cancer Agency; Canadian Institutes of Health Research; Michael Smith Health Research BC; Stem Cell Network","keywords":"Haematopoiesis; Stem cell; Cell biology; Biology; Cell division; Transcription factor; Stem cell factor; Cell culture; Cellular differentiation; In vitro; In vivo; Hematopoietic stem cell; BMI1; CXCR4; Molecular biology; Immunology; Cell; Genetics; Gene; Chemokine","score_opus":0.01745226260838076,"score_gpt":0.2193808511439254,"score_spread":0.20192858853554463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147376659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961167,0.0023968322,0.00027164817,0.00015826024,0.000072750314,0.00043763765,0.000013526724,0.000046847374,0.00048581645],"genre_scores_gemma":[0.99915403,0.00018818678,0.00017669158,0.00009992168,0.000021631417,0.000011200807,0.00000887876,0.000016533473,0.00032294364],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99913424,0.000062370054,0.00024371366,0.00020709563,0.00019773773,0.00015486621],"domain_scores_gemma":[0.99939865,0.00012451509,0.000097500626,0.00024058112,0.00007589809,0.00006284763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000952124,0.00014212573,0.00026546983,0.000052807314,0.00006488591,0.0000053282884,0.00006222829,0.00014945139,0.000041740634],"category_scores_gemma":[0.000007749207,0.00008921151,0.000069159316,0.00015009483,0.00013528428,0.00002944212,0.00001441331,0.00013963484,0.000010387735],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008757397,0.00020479377,0.007813446,0.0004344564,0.0001383257,0.00009987366,0.00097077835,0.000005022203,0.9894782,0.0004307815,0.00006011073,0.00027666756],"study_design_scores_gemma":[0.0018710853,0.00038493672,0.033388477,0.00013342957,0.00031448703,0.0005104827,0.0003087085,0.000019141842,0.96271724,0.0001002609,0.00014368289,0.00010809813],"about_ca_topic_score_codex":0.000004415171,"about_ca_topic_score_gemma":4.5672925e-7,"teacher_disagreement_score":0.02676096,"about_ca_system_score_codex":0.0000065171257,"about_ca_system_score_gemma":0.00003285836,"threshold_uncertainty_score":0.363794},"labels":[],"label_agreement":null},{"id":"W2147603976","doi":"10.1182/blood.v100.3.869","title":"Functional analysis of human hematopoietic repopulating cells mobilized with granulocyte colony-stimulating factor alone versus granulocyte colony-stimulating factor in combination with stem cell factor","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; London Health Sciences Centre; Western University","funders":"","keywords":"Granulocyte colony-stimulating factor; Haematopoiesis; Stem cell; Granulocyte; Hematopoietic growth factor; Colony-stimulating factor; Biology; Immunology; Cell biology; Genetics","score_opus":0.04017045513017541,"score_gpt":0.2662199630900402,"score_spread":0.22604950795986478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147603976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953602,0.000106919164,0.0015243916,0.000026349819,0.000106236614,0.0018760712,0.00012040393,0.00018070343,0.000698724],"genre_scores_gemma":[0.99658096,0.0000098539585,0.0025413192,0.000020083922,0.000040900763,0.00010034549,0.00030622966,0.00010928811,0.0002910258],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951743,0.00024092046,0.0015654364,0.00095951534,0.0013833999,0.00067646295],"domain_scores_gemma":[0.99664587,0.0009814104,0.0010090664,0.00068244117,0.00041031887,0.00027090768],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028232354,0.00063492655,0.0016680752,0.00090789504,0.0002783341,0.000060866347,0.00016895021,0.00030432234,0.00063309795],"category_scores_gemma":[0.00005044672,0.0005553244,0.0002957201,0.0019728297,0.00015446056,0.00025764646,0.00003606857,0.00050045137,0.000016109734],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001528457,0.0021429814,0.7737793,0.001325503,0.0014123503,0.00022177126,0.005226199,0.011252095,0.20289782,0.000033113218,0.000004181853,0.00017625892],"study_design_scores_gemma":[0.066539966,0.0049954206,0.6064347,0.0013662765,0.00693924,0.00009063436,0.0013640815,0.059328046,0.25167525,0.000009731042,0.000004662139,0.0012519947],"about_ca_topic_score_codex":0.00030286642,"about_ca_topic_score_gemma":0.00037290037,"teacher_disagreement_score":0.16734457,"about_ca_system_score_codex":0.0002516583,"about_ca_system_score_gemma":0.000085938496,"threshold_uncertainty_score":0.9996898},"labels":[],"label_agreement":null},{"id":"W2147754866","doi":"10.1182/blood-2012-04-396846","title":"Eyeing central neurons in vascular growth and reparative angiogenesis","year":2012,"lang":"en","type":"review","venue":"Blood","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Canadian Institutes of Health Research","keywords":"Angiogenesis; Neuroscience; Retina; Muller glia; Biology; Central nervous system; Ischemia; Spinal cord; Anatomy; Medicine; Progenitor cell; Stem cell; Internal medicine; Cell biology; Cancer research","score_opus":0.025642972887956108,"score_gpt":0.28773536266270444,"score_spread":0.26209238977474836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147754866","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0042013144,0.99494,0.000022589724,0.0000037563698,0.00011564559,0.0003063762,0.0000446211,0.000008087586,0.00035764565],"genre_scores_gemma":[0.00363478,0.9952707,0.00015885179,0.00003458506,0.00053936645,0.00009488259,0.00015179095,0.000058106558,0.000056933615],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99852616,0.00014832856,0.00030932887,0.0005009202,0.00009624196,0.00041901565],"domain_scores_gemma":[0.9993825,0.000016554273,0.00013472344,0.00032563924,0.000021075248,0.000119540266],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012132702,0.00033454684,0.0006442125,0.00007826232,0.00005006663,0.000020249447,0.00016393342,0.0003423424,0.000010603804],"category_scores_gemma":[0.000026619746,0.0002898966,0.00044683105,0.00014422367,0.000054069165,0.0000036367833,0.000150959,0.00009276383,0.000004952041],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041473722,0.0015460693,0.014908785,0.018347772,0.0042776396,0.00013643209,0.00031290585,0.000002981618,0.005440956,0.00050354685,0.00081682863,0.9536646],"study_design_scores_gemma":[0.00037931756,0.00007587045,0.0007928585,0.0006730115,0.0014327338,0.000044433673,0.000008754481,2.6331287e-7,0.0009882441,0.0000036157217,0.99513614,0.00046474184],"about_ca_topic_score_codex":0.000026947499,"about_ca_topic_score_gemma":0.000019132105,"teacher_disagreement_score":0.9943193,"about_ca_system_score_codex":0.000011043224,"about_ca_system_score_gemma":0.000113677735,"threshold_uncertainty_score":0.9999553},"labels":[],"label_agreement":null},{"id":"W2148346685","doi":"10.1182/blood-2005-12-4995","title":"Quantitative proteomics reveals posttranslational control as a regulatory factor in primary hematopoietic stem cells","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":172,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Christie (Canada)","funders":"Directorate for Biological Sciences; Wellcome Trust","keywords":"Proteome; Biology; Stem cell; Proteomics; Haematopoiesis; Isobaric labeling; Quantitative proteomics; Transcriptome; Cell biology; Biochemistry; Computational biology; Gene expression; Gene","score_opus":0.010987654769448546,"score_gpt":0.24733490181651435,"score_spread":0.2363472470470658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148346685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835524,0.00024816988,0.009795175,0.00014170275,0.000008002131,0.0006365467,0.00028319884,0.0001337153,0.0052010673],"genre_scores_gemma":[0.9585487,0.000010357079,0.040103648,0.0000752005,0.000048126996,0.0004226135,0.000050960494,0.00003568169,0.00070469227],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99884784,0.000018180694,0.0004042725,0.0003152766,0.0001824991,0.00023195264],"domain_scores_gemma":[0.9993247,0.00009902372,0.0001716103,0.00030228813,0.00005472635,0.00004765842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008266616,0.0001757348,0.0002416918,0.00005047827,0.00006494558,0.0000219466,0.0001698337,0.00014896649,0.000095620875],"category_scores_gemma":[0.0000041931457,0.00018672466,0.00007924006,0.00011096146,0.000058963305,0.00009077433,0.000020466921,0.00021106891,0.00002580121],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004148002,0.0003453567,0.0049223443,0.00009934549,0.000014917239,0.000006703421,0.00007776867,0.00006865939,0.979709,0.014624612,0.000036951395,0.000052827043],"study_design_scores_gemma":[0.001945041,0.00003616407,0.0018248642,0.000097576165,0.000027541013,0.000018051938,0.0000373642,0.000080943995,0.97130835,0.024042051,0.00028616327,0.00029590743],"about_ca_topic_score_codex":0.000033210854,"about_ca_topic_score_gemma":0.0000073443084,"teacher_disagreement_score":0.030308474,"about_ca_system_score_codex":0.00006792939,"about_ca_system_score_gemma":0.000082433544,"threshold_uncertainty_score":0.76144105},"labels":[],"label_agreement":null},{"id":"W2148743957","doi":"10.1182/blood-2006-01-0092","title":"Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results","year":2006,"lang":"en","type":"review","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1202,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Fogarty International Center; European Commission","keywords":"Imatinib mesylate; Tyrosine kinase; Philadelphia chromosome; Fluorescence in situ hybridization; Imatinib; ABL; Myeloid leukemia; Cancer research; Medicine; breakpoint cluster region; Tyrosine-kinase inhibitor; Internal medicine; Oncology; Biology; Bioinformatics; Gene; Genetics; Cancer; Chromosomal translocation; Chromosome; Receptor","score_opus":0.18646272106561537,"score_gpt":0.40711279167258724,"score_spread":0.22065007060697187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148743957","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006484784,0.97651565,0.002977403,0.00029839738,0.0002436066,0.011749417,0.0016628228,0.000062390165,0.000005520863],"genre_scores_gemma":[0.0002407219,0.79220414,0.19940999,0.000025723051,0.00038630283,0.006220387,0.0013166316,0.00014288763,0.000053222775],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968474,0.00026242094,0.001114802,0.001066397,0.00014928212,0.0005596822],"domain_scores_gemma":[0.9958232,0.0027204845,0.0005932058,0.00035464225,0.00022067592,0.00028778028],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00078794314,0.00069645076,0.00201441,0.00061262125,0.0005675764,0.00009080307,0.000068615045,0.00019991168,6.384407e-7],"category_scores_gemma":[0.0009810688,0.0005527577,0.00024530033,0.00040599954,0.00006236872,0.0001419425,0.00004653415,0.00019511238,2.0129114e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003283917,0.00042396947,0.00008576111,0.03606408,0.00040493632,0.0000066745165,0.00059461617,1.9558131e-7,0.00013457169,0.000010181006,0.00008868429,0.9618579],"study_design_scores_gemma":[0.033128865,0.0038120477,0.000050913808,0.1654183,0.025121974,0.00015842571,0.00020058334,0.000006959165,0.0018097215,0.00006515926,0.76936907,0.0008580156],"about_ca_topic_score_codex":0.00003513545,"about_ca_topic_score_gemma":0.000019375524,"teacher_disagreement_score":0.9609999,"about_ca_system_score_codex":0.000677965,"about_ca_system_score_gemma":0.00029346475,"threshold_uncertainty_score":0.9996924},"labels":[],"label_agreement":null},{"id":"W214942746","doi":"10.1182/blood.v122.21.215.215","title":"Rivaroxaban Versus Low Molecular Weight Heparin For The Prevention Of Venous Thromboembolism After Orthopedic Surgery: A Population-Based Study","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; Western University","funders":"","keywords":"Medicine; Rivaroxaban; Apixaban; Pulmonary embolism; Dabigatran; Population; Low molecular weight heparin; Deep vein; Surgery; Thrombosis; Warfarin; Emergency medicine; Internal medicine","score_opus":0.01515278171950854,"score_gpt":0.26727645022929997,"score_spread":0.2521236685097914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W214942746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99406993,0.00048851845,0.00041705996,0.0005036724,0.00036316764,0.003952014,0.000009483786,0.000051533272,0.00014461341],"genre_scores_gemma":[0.99731153,0.000032717475,0.00038838608,0.00027177783,0.00015921897,0.0016725543,0.00006329087,0.000045324185,0.000055200097],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847287,0.00007943246,0.0004390011,0.00031272942,0.00039259464,0.00030338],"domain_scores_gemma":[0.9986626,0.0002819717,0.00018850951,0.0005871589,0.0001904054,0.00008934841],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033711127,0.00020245349,0.0006408001,0.00013433456,0.000099032746,0.000030375684,0.000121587975,0.000071039205,0.0002693353],"category_scores_gemma":[0.00014226486,0.00014721714,0.00030288505,0.00021351383,0.00003100806,0.00007680881,0.000050587165,0.00009160008,0.000023857981],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012660288,0.078605525,0.862302,0.0018253025,0.007516455,0.00013649717,0.0018610142,0.00030712195,0.0016306306,0.0011668524,0.0052225227,0.038160037],"study_design_scores_gemma":[0.005627167,0.0013021103,0.9883376,0.00014997051,0.0025984861,0.0000014735657,0.0001783204,0.00021202881,0.00091560395,0.00017961526,0.00031306993,0.00018456562],"about_ca_topic_score_codex":0.00081809243,"about_ca_topic_score_gemma":0.00012693794,"teacher_disagreement_score":0.12603557,"about_ca_system_score_codex":0.00003040312,"about_ca_system_score_gemma":0.00009280732,"threshold_uncertainty_score":0.6003341},"labels":[],"label_agreement":null},{"id":"W2149780959","doi":"10.1182/blood-2002-01-0031","title":"CXCR4–SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":303,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; U.S. Public Health Service; National Institutes of Health; Canadian Blood Services","keywords":"Biology; Matrigel; Rhabdomyosarcoma; Stromal cell; Cell biology; Cancer research; Bone marrow; Stromal cell-derived factor 1; CXCR4; Immunology; Chemokine; Pathology; Angiogenesis; Medicine; Sarcoma; Inflammation","score_opus":0.012379981269277623,"score_gpt":0.21583261685174135,"score_spread":0.20345263558246374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149780959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99668646,0.001856344,0.000011740849,0.00069574645,0.000026866408,0.00022901049,0.0000052736186,0.000030364874,0.00045819388],"genre_scores_gemma":[0.99803174,0.0004634313,0.000860506,0.00014535904,0.0001307649,0.000005337336,0.00000590478,0.000021365991,0.0003355904],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99908835,0.00002342866,0.00022107815,0.0002998966,0.00015554935,0.00021171215],"domain_scores_gemma":[0.99956197,0.00007175208,0.00006388044,0.00013539223,0.000044225242,0.00012275866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012017946,0.00015737553,0.00028880817,0.00010705382,0.00006194343,0.000023258102,0.000034562974,0.000113936214,0.0003766638],"category_scores_gemma":[0.000030243818,0.00014100102,0.000043473214,0.00016384534,0.000056266097,0.000078589874,0.00004212321,0.00017235843,0.0000073558313],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006074313,0.0007013219,0.036205757,0.00023040417,0.000073853844,0.000061581995,0.0025389686,0.0000012887253,0.9395006,0.000015864658,0.00076313864,0.019846497],"study_design_scores_gemma":[0.0037226502,0.00017223886,0.007618714,0.0003248177,0.00009778574,0.00010702862,0.00020884641,0.0005228697,0.98608667,0.00014203512,0.00082997413,0.00016634965],"about_ca_topic_score_codex":0.000034499088,"about_ca_topic_score_gemma":0.0000034650468,"teacher_disagreement_score":0.04658611,"about_ca_system_score_codex":0.000019753139,"about_ca_system_score_gemma":0.000009220023,"threshold_uncertainty_score":0.5749855},"labels":[],"label_agreement":null},{"id":"W2149787089","doi":"10.1182/blood.v99.4.1364","title":"In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":364,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Japan Society for the Promotion of Science; Ligue Genevoise Contre le Cancer; National Institute of Diabetes and Digestive and Kidney Diseases; Fonds De La Recherche Scientifique - FNRS; Australian Government; National Institutes of Health; American Cancer Society","keywords":"RUNX1; Platelet disorder; Missense mutation; Nonsense mutation; Haploinsufficiency; Frameshift mutation; Point mutation; Biology; Genetics; Leukemia; Mutation; Cancer research; Molecular biology; Gene; Immunology; Phenotype; Transcription factor","score_opus":0.02523519962083143,"score_gpt":0.3024561867370647,"score_spread":0.2772209871162333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149787089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97257185,0.00014600622,0.024267161,0.0008019949,0.000010065416,0.0014437382,0.0006955811,0.000009589569,0.000054023272],"genre_scores_gemma":[0.9770129,0.00008032023,0.022169558,0.000077117096,0.00002265719,0.00044038554,0.00011466611,0.000026677677,0.000055734024],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988067,0.000026911332,0.00040913813,0.00030393671,0.00017556734,0.0002777229],"domain_scores_gemma":[0.999195,0.00015279611,0.00010316212,0.0002714844,0.00017803088,0.00009954173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015594796,0.00014822805,0.00042918124,0.00047136343,0.000049032038,0.000005808389,0.000099352466,0.00011262916,0.000007987252],"category_scores_gemma":[0.00008436073,0.00012374735,0.000056692505,0.0006988784,0.00007549945,0.00007887712,0.000046014153,0.00011249657,0.0000010711766],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061799644,0.0009186965,0.0010224556,0.000108488704,0.00015518189,0.000017803377,0.00063569535,0.00015101266,0.9943041,0.00037501365,0.000016317732,0.001677235],"study_design_scores_gemma":[0.013002168,0.0012028583,0.05985191,0.00009671273,0.0005739954,0.00016325027,0.00035176612,0.0018511075,0.9223801,0.00033523052,0.000019406081,0.00017152313],"about_ca_topic_score_codex":0.0005132062,"about_ca_topic_score_gemma":0.0002864267,"teacher_disagreement_score":0.07192403,"about_ca_system_score_codex":0.00014087124,"about_ca_system_score_gemma":0.0001738055,"threshold_uncertainty_score":0.50462705},"labels":[],"label_agreement":null},{"id":"W2150460384","doi":"10.1182/blood-2005-05-1823","title":"Loss of Tie2 receptor compromises embryonic stem cell–derived endothelial but not hematopoietic cell survival","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Stem cell; Biology; Cell biology; Haematopoiesis; Endothelial stem cell; Progenitor cell; Embryonic stem cell; Receptor tyrosine kinase; Lymphatic Endothelium; Hematopoietic stem cell; Cancer research; Immunology; Lymphatic system; Signal transduction; Biochemistry","score_opus":0.01673142166809165,"score_gpt":0.23429810948882177,"score_spread":0.2175666878207301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150460384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98888075,0.0015152831,0.000030732288,0.00017750512,0.0002932301,0.0005169975,0.00012549134,0.000094089235,0.008365903],"genre_scores_gemma":[0.99291706,0.00006377812,0.00042091697,0.0001331842,0.00052832335,0.000028722672,0.000022885157,0.000042716296,0.005842442],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983296,0.00009544622,0.00047421764,0.00030827685,0.00046858692,0.00032388308],"domain_scores_gemma":[0.9987845,0.00017412356,0.00020870735,0.00047162035,0.00010307038,0.00025799737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014728407,0.00023168749,0.0006014293,0.0000727144,0.000055985263,0.000017085058,0.00016709304,0.00010201537,0.0004968442],"category_scores_gemma":[0.000022980592,0.00019402825,0.00021449276,0.00010510566,0.000100636345,0.000059759837,0.000053407774,0.000033398017,0.00039076488],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006590795,0.00564976,0.0315009,0.0030181517,0.00021436802,0.0000853327,0.0011875688,0.0000078398225,0.95558625,0.00011513272,0.0014558566,0.0005197608],"study_design_scores_gemma":[0.012790631,0.0002953107,0.0029370608,0.00021629091,0.00049238827,0.00005611149,0.00085923186,0.000016426211,0.98089,0.0000046472524,0.001218794,0.00022313785],"about_ca_topic_score_codex":0.000029684034,"about_ca_topic_score_gemma":0.0000042913193,"teacher_disagreement_score":0.028563837,"about_ca_system_score_codex":0.00003911871,"about_ca_system_score_gemma":0.00029776545,"threshold_uncertainty_score":0.79122424},"labels":[],"label_agreement":null},{"id":"W2150528960","doi":"10.1182/blood-2014-07-587857","title":"Dynamin 2–dependent endocytosis is required for normal megakaryocyte development in mice","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"National Heart, Lung, and Blood Institute","keywords":"Thrombopoiesis; Endocytosis; Dynamin; Megakaryocyte; Cell biology; Megakaryocytopoiesis; Bone marrow; Biology; Chemistry; Immunology; Haematopoiesis; Receptor; Biochemistry; Stem cell","score_opus":0.013755946607375053,"score_gpt":0.24813422693852935,"score_spread":0.2343782803311543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150528960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942645,0.00021353955,0.00026883598,0.00033213428,0.0000649716,0.00051728834,0.000014227892,0.000033641205,0.004290891],"genre_scores_gemma":[0.99253315,0.000030358331,0.005244756,0.0004607382,0.000035048528,0.00015513937,0.00007721127,0.000021412632,0.0014421927],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989714,0.000015121241,0.00025642518,0.00026230369,0.00017791761,0.00031681568],"domain_scores_gemma":[0.9996077,0.000050716437,0.000053891832,0.0001557847,0.000034955112,0.000096993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013747986,0.00015010877,0.00029702153,0.00010020208,0.000054946373,0.0000116166575,0.000070693226,0.00007272284,0.00003466507],"category_scores_gemma":[0.000042294483,0.00013212713,0.00006299616,0.00008636892,0.000013876629,0.000058414367,0.00003114296,0.000063832136,0.000058664762],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004866163,0.030287411,0.4535559,0.0020190678,0.004897265,0.0031396104,0.011381762,0.000026708463,0.10133704,0.0014820541,0.0042559234,0.38275108],"study_design_scores_gemma":[0.08349918,0.0016103556,0.11291638,0.00039227307,0.0008809383,0.0005212017,0.00024298741,0.0010929842,0.7551135,0.00042668433,0.04244774,0.00085582264],"about_ca_topic_score_codex":0.00006427561,"about_ca_topic_score_gemma":0.00019690834,"teacher_disagreement_score":0.6537764,"about_ca_system_score_codex":0.00006006986,"about_ca_system_score_gemma":0.00007637161,"threshold_uncertainty_score":0.53879875},"labels":[],"label_agreement":null},{"id":"W2150538954","doi":"10.1182/blood-2011-04-344507","title":"Chelation use and iron burden in North American and British thalassemia patients: a report from the Thalassemia Longitudinal Cohort","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Hospital for Sick Children; University of Toronto","funders":"National Center for Research Resources; National Heart, Lung, and Blood Institute","keywords":"Deferasirox; Deferiprone; Thalassemia; Medicine; Chelation therapy; Deferoxamine; Beta thalassemia; Internal medicine; Cohort; Gastroenterology; Pediatrics; Surgery","score_opus":0.007903978115848358,"score_gpt":0.21916273906219655,"score_spread":0.21125876094634818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150538954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99757683,0.0013740236,0.000002834584,0.00022801646,0.00006429227,0.0003814006,0.000017808166,0.000027186241,0.00032760188],"genre_scores_gemma":[0.9984529,0.0009492026,0.00012160463,0.00009803193,0.00012810499,0.000016526743,0.00015376059,0.000018734081,0.00006111664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898535,0.00004075283,0.00025528975,0.0002555443,0.00020511093,0.0002579468],"domain_scores_gemma":[0.99938077,0.00009682533,0.0001239404,0.00021375569,0.000047607413,0.00013707549],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001471575,0.0001260787,0.0002322962,0.000031363055,0.000074181036,0.000049917035,0.00003591399,0.00008203062,0.000010837707],"category_scores_gemma":[0.00024591282,0.00009978062,0.000029936764,0.00019806685,0.00013655113,0.00019909932,0.00005231621,0.00025341654,0.0000030027243],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019221512,0.00025930014,0.9960178,0.000011927262,0.0000655415,0.000104285355,0.00046848005,6.836388e-7,0.0000531319,0.0000015949779,0.00023388566,0.0027641552],"study_design_scores_gemma":[0.0016855082,0.00007665957,0.99662167,0.00008006428,0.0002828186,0.00030809792,0.00026554812,0.000019025045,0.000019960822,0.00000380179,0.0005209467,0.00011587836],"about_ca_topic_score_codex":0.0080208,"about_ca_topic_score_gemma":0.0018508139,"teacher_disagreement_score":0.006169986,"about_ca_system_score_codex":0.000024848894,"about_ca_system_score_gemma":0.000025244277,"threshold_uncertainty_score":0.99858487},"labels":[],"label_agreement":null},{"id":"W2150567223","doi":"10.1182/blood-2004-05-2010","title":"Effect of fondaparinux on platelet activation in the presence of heparin-dependent antibodies: a blinded comparative multicenter study with unfractionated heparin","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":210,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Heart and Stroke Foundation of Canada; Sanofi","keywords":"Fondaparinux; Heparin; Medicine; Heparin-induced thrombocytopenia; Platelet factor 4; Platelet; Immunology; Antibody; Platelet activation; Thrombosis; Internal medicine; Pharmacology; Gastroenterology","score_opus":0.03738411797023211,"score_gpt":0.33771182808448097,"score_spread":0.30032771011424886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150567223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99505997,0.0000070011774,0.000019232984,0.000101496546,0.000040108724,0.0026983577,0.0000049220266,0.000025804462,0.0020430917],"genre_scores_gemma":[0.9996857,0.00000759588,0.00008688794,0.00003726597,0.000023086586,0.00010689094,0.000016359214,0.000018059873,0.000018174573],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979756,0.00032454464,0.0004774233,0.00036850406,0.000605355,0.00024858717],"domain_scores_gemma":[0.9984769,0.0005509265,0.00028075368,0.00048691215,0.00014428303,0.000060194812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005579781,0.00025966528,0.0007718215,0.00021790584,0.0000658979,0.000015702139,0.00020137605,0.000096377255,0.000018709354],"category_scores_gemma":[0.00014433147,0.00015856331,0.0000754971,0.00047872803,0.000111821384,0.0001509294,0.000052164203,0.0004078676,0.000011163733],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014828685,0.032803144,0.74944115,0.00046700076,0.0020123683,0.00014205159,0.02328106,0.0013572599,0.17436793,0.00052379543,0.000012713246,0.00076282315],"study_design_scores_gemma":[0.020470671,0.0077011483,0.4404455,0.0003448195,0.0002615401,0.000014463463,0.0014084607,0.000041954117,0.5291739,0.00001501331,0.0000066676516,0.00011584047],"about_ca_topic_score_codex":0.0016147924,"about_ca_topic_score_gemma":0.00060612283,"teacher_disagreement_score":0.35480598,"about_ca_system_score_codex":0.00007701633,"about_ca_system_score_gemma":0.00014101909,"threshold_uncertainty_score":0.64660245},"labels":[],"label_agreement":null},{"id":"W2150938787","doi":"10.1182/blood.v98.9.2837","title":"Cyclin D3 is a target gene of t(6;14)(p21.1;q32.3) of mature B-cell malignancies","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health; Daiwa Anglo-Japanese Foundation; Wellcome Trust; Kay Kendall Leukaemia Fund; Lady Tata Memorial Trust; Deutsche Krebshilfe","keywords":"Cancer research; Gene; Biology; Cyclin D3; Cyclin D1; Genetics; Molecular biology; Cell cycle","score_opus":0.014746707047740448,"score_gpt":0.270093906262556,"score_spread":0.2553471992148156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150938787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98441374,0.0040361607,0.000046051497,0.00032775287,0.00007226415,0.00037579358,0.000056568188,0.000037298065,0.010634381],"genre_scores_gemma":[0.98623854,0.0006997064,0.0042179488,0.00026332896,0.00018265891,0.000015877264,0.000028372537,0.00004162762,0.008311947],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99806637,0.000039130067,0.0004665165,0.00030519508,0.0006923153,0.00043045322],"domain_scores_gemma":[0.99862444,0.000093469556,0.00016161856,0.00069535064,0.0002575321,0.0001675846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026862355,0.00018381292,0.0005237615,0.00015280774,0.000028730974,0.000006598693,0.00023316263,0.00021427275,0.00074677577],"category_scores_gemma":[0.00014111958,0.00015362777,0.00018844388,0.00041215454,0.00017108557,0.000048857855,0.00011547426,0.00021005179,0.00007467621],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010457685,0.006514816,0.016007204,0.002668799,0.0006053097,0.0014035279,0.0024873328,0.000024562842,0.94615525,0.00015325179,0.021905653,0.0010285478],"study_design_scores_gemma":[0.032369927,0.00041301645,0.0018967321,0.00023511048,0.00022643604,0.0005200923,0.0001560389,0.000287786,0.9547012,0.00018202234,0.008847992,0.00016364669],"about_ca_topic_score_codex":0.00027976398,"about_ca_topic_score_gemma":0.0000080668615,"teacher_disagreement_score":0.03132416,"about_ca_system_score_codex":0.0004583132,"about_ca_system_score_gemma":0.0021761064,"threshold_uncertainty_score":0.81766707},"labels":[],"label_agreement":null},{"id":"W2151149645","doi":"10.1182/blood-2005-06-2244","title":"Molecular dissection of Meis1 reveals 2 domains required for leukemia induction and a key role for Hoxa gene activation","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Université de Montréal; Hôpital Maisonneuve-Rosemont; McGill University Health Centre","funders":"","keywords":"Leukemia; Gene; Cancer research; Key (lock); Biology; Dissection (medical); Computational biology; Genetics; Medicine; Cell biology; Anatomy","score_opus":0.009389795798988047,"score_gpt":0.23149559600779393,"score_spread":0.22210580020880588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151149645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9804011,0.00028859638,0.01834862,0.0000371359,0.000037787824,0.00061523577,0.000059229264,0.000010784969,0.00020154164],"genre_scores_gemma":[0.99390936,0.000019935082,0.0050898925,0.000026246282,0.00026731935,0.00020617436,0.00037317735,0.000019711126,0.00008815689],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99938583,0.00002428177,0.00016986526,0.00022637835,0.000059870326,0.00013375076],"domain_scores_gemma":[0.99961,0.000011494619,0.000118133554,0.000142356,0.00009120915,0.000026828935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014529726,0.00009610625,0.00011372931,0.00003489246,0.00006709553,0.000010953587,0.00004544504,0.00013378798,8.203165e-7],"category_scores_gemma":[0.0000667883,0.00009913663,0.00006675255,0.000048547452,0.000027212503,0.000006404003,0.000019009989,0.000026580257,1.522504e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012976275,0.00007192102,0.00023771505,0.00005859777,0.00003532914,1.4057001e-7,0.000024120303,0.000025053003,0.99791336,0.0005361092,0.00007865324,0.0008892249],"study_design_scores_gemma":[0.0015584341,0.00042386923,0.0016043509,0.000015066774,0.000053050928,0.000010209702,0.000025172445,0.000037595993,0.9920616,0.0027594704,0.0013380424,0.00011310564],"about_ca_topic_score_codex":0.000027380358,"about_ca_topic_score_gemma":0.000008263325,"teacher_disagreement_score":0.013508318,"about_ca_system_score_codex":0.0000121290595,"about_ca_system_score_gemma":0.00003604596,"threshold_uncertainty_score":0.40426746},"labels":[],"label_agreement":null},{"id":"W2151347057","doi":"10.1182/blood-2002-02-0632","title":"All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":498,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Acute promyelocytic leukemia; Medicine; Cytarabine; Internal medicine; White blood cell; Gastroenterology; Tretinoin; Retinoic acid; Regimen; Maintenance therapy; Daunorubicin; Chemotherapy; Cumulative incidence; Randomized controlled trial; Oncology; Immunology; Transplantation; Biology","score_opus":0.013960332766296818,"score_gpt":0.26072575760090516,"score_spread":0.24676542483460834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151347057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99180084,0.00022509028,0.00035693657,0.00010926516,0.000019770536,0.0073433807,0.000047069912,0.00002351976,0.00007409752],"genre_scores_gemma":[0.991142,0.00011501704,0.0002370699,0.00020746967,0.000110599205,0.0079066325,0.00013703266,0.000030484067,0.000113707836],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983098,0.000115662275,0.0004112706,0.00060209236,0.00019144593,0.00036976585],"domain_scores_gemma":[0.99912244,0.00003724751,0.00017701402,0.00051411765,0.00004795591,0.000101200334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000082155006,0.00029273436,0.00035275385,0.00006883445,0.0000739398,0.00007779473,0.0004198678,0.00012290133,0.0000451742],"category_scores_gemma":[0.000086278975,0.00020987325,0.00015325898,0.00045644134,0.0002344236,0.000009108223,0.00013374681,0.00026671359,0.0000067273877],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042331725,0.00015666542,0.96828234,0.000050471546,0.0007695351,0.00005082439,0.00021681795,0.0000046603413,0.02908941,5.2031857e-7,0.000022882117,0.0013135498],"study_design_scores_gemma":[0.0018580745,0.00040171095,0.94070995,0.00002519869,0.0010398402,0.000023727393,0.00003872545,0.00010790059,0.055082086,0.000003490512,0.0003370515,0.00037222102],"about_ca_topic_score_codex":0.00007229509,"about_ca_topic_score_gemma":0.00089158415,"teacher_disagreement_score":0.02757236,"about_ca_system_score_codex":0.000035309153,"about_ca_system_score_gemma":0.000049234146,"threshold_uncertainty_score":0.8558383},"labels":[],"label_agreement":null},{"id":"W2152429066","doi":"10.1182/blood-2010-01-261875","title":"How I treat hemochromatosis","year":2010,"lang":"en","type":"review","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":189,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Phlebotomy; Hemochromatosis; Medicine; Hereditary hemochromatosis; Internal medicine; Bloodletting; Iron therapy; Intensive care medicine; Iron deficiency; Physiology; Pathology; Anemia","score_opus":0.024943685474819975,"score_gpt":0.2921914870896305,"score_spread":0.26724780161481054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152429066","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000043990844,0.9834964,0.0000028114905,0.000097867225,0.00025837775,0.00055120577,0.00003074353,0.00009339338,0.015425159],"genre_scores_gemma":[0.000002572391,0.9874478,0.000510437,0.00007580173,0.0005994509,0.000069384165,0.00017932657,0.00007628028,0.011038973],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989316,0.00003497628,0.00022384999,0.00033307608,0.0002103227,0.00026617188],"domain_scores_gemma":[0.9990022,0.000038985145,0.00012935147,0.000629006,0.000028287497,0.00017215194],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00006328449,0.00036064774,0.0016286412,0.00015066547,0.00004326014,0.000045604622,0.00014116129,0.00050069863,0.00016388779],"category_scores_gemma":[0.00009540259,0.0002465023,0.00060503616,0.00018701253,0.000055940087,0.00003708566,0.000037782364,0.00044984015,0.00024748905],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000012520647,0.00031256798,0.0000085503525,0.01909155,0.00004908348,0.000055544144,0.000009851581,1.3253214e-10,0.000004938747,0.000104776125,0.001835961,0.97852594],"study_design_scores_gemma":[0.0011983092,0.00003943782,0.0000062589515,0.002181369,0.008553942,0.00041875293,0.000008537331,1.1293482e-8,0.000027125137,0.000008520241,0.9873319,0.00022582813],"about_ca_topic_score_codex":0.0000064799924,"about_ca_topic_score_gemma":0.0000024041983,"teacher_disagreement_score":0.9854959,"about_ca_system_score_codex":0.0000066128146,"about_ca_system_score_gemma":0.00021224933,"threshold_uncertainty_score":0.99999875},"labels":[],"label_agreement":null},{"id":"W2152518936","doi":"10.1182/blood-2004-12-4689","title":"High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: long-term outcome in the first 100 patients treated in Vancouver","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Autologous stem-cell transplantation; Internal medicine; Surgery; Transplantation; Chemotherapy; Malignancy; Refractory (planetary science); Lymphoma; Chemotherapy regimen","score_opus":0.012806834983711046,"score_gpt":0.2453881516376033,"score_spread":0.23258131665389226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152518936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99766314,0.00036141087,0.000002520763,0.00031138564,0.0000707875,0.0013865902,0.000038966373,0.000032278902,0.00013291022],"genre_scores_gemma":[0.997675,0.00047221035,0.00023578817,0.0009149456,0.00004525486,0.0002873403,0.00012812471,0.000027196947,0.00021412493],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998869,0.000044639604,0.00038094356,0.00029644123,0.00017090268,0.00023807512],"domain_scores_gemma":[0.9993792,0.00022365189,0.00010721429,0.00021399852,0.000025503752,0.00005043965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011662179,0.00020772203,0.0003604888,0.000115862866,0.000052106654,0.000015400976,0.000071485745,0.00013240255,0.000015086386],"category_scores_gemma":[0.000005219879,0.00012712242,0.00006317836,0.0001343779,0.000028625764,0.000094418945,0.0000064516125,0.000053505213,0.0000045563875],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015913172,0.007823455,0.93605125,0.00023161292,0.0000534342,0.00022940332,0.001302279,0.0000017179797,0.000045766643,0.00000226133,0.00018127389,0.052486222],"study_design_scores_gemma":[0.064464,0.0010019308,0.931295,0.00010313427,0.00022985329,0.000022630747,0.00002818466,0.0000063099556,0.0023405799,0.000001917489,0.00037464028,0.00013184387],"about_ca_topic_score_codex":0.00014442168,"about_ca_topic_score_gemma":0.0020169998,"teacher_disagreement_score":0.062872685,"about_ca_system_score_codex":0.00023685968,"about_ca_system_score_gemma":0.000052841664,"threshold_uncertainty_score":0.5183902},"labels":[],"label_agreement":null},{"id":"W2152557467","doi":"10.1182/blood-2003-11-4079","title":"RHAMM expression and isoform balance predict aggressive disease and poor survival in multiple myeloma","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; National Cancer Institute; Alberta Heritage Foundation for Medical Research; Fondation pour la Recherche Médicale","keywords":"Gene isoform; Biology; Molecular biology; Immunology; Genetics; Gene","score_opus":0.015869188758726824,"score_gpt":0.2667017309133481,"score_spread":0.25083254215462125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152557467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957818,0.0028558352,0.00001656356,0.00036138642,0.000033035227,0.0005884875,0.00007071494,0.0000403489,0.00025182503],"genre_scores_gemma":[0.99811894,0.0007685707,0.0007226638,0.000049558897,0.00007968793,0.000072336414,0.00005695586,0.00001867014,0.00011261886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988351,0.000030909476,0.00016498631,0.00033394885,0.0002897232,0.00034532085],"domain_scores_gemma":[0.9991235,0.00008479744,0.000059102134,0.00019989318,0.000036198235,0.0004965209],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008646899,0.00016087046,0.00023820625,0.000098701814,0.00008375664,0.00002292488,0.00004943929,0.000061041326,0.000018228824],"category_scores_gemma":[0.00044547458,0.00012215292,0.000032632604,0.0000983286,0.00010633082,0.000117517026,0.000093243725,0.00014221302,0.000008838339],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009295068,0.00095720985,0.98230225,0.00013662208,0.00006297156,0.0018885378,0.00018384629,0.0000017690978,0.00923057,0.000017959774,0.00002041231,0.004268357],"study_design_scores_gemma":[0.025721924,0.00029828475,0.96273106,0.0005934066,0.000060036928,0.00006753894,0.00007708192,0.00020303475,0.009909335,0.00015638045,0.00006608133,0.00011582849],"about_ca_topic_score_codex":0.00012668672,"about_ca_topic_score_gemma":0.000073974385,"teacher_disagreement_score":0.024792418,"about_ca_system_score_codex":0.000033904504,"about_ca_system_score_gemma":0.00009552581,"threshold_uncertainty_score":0.49812517},"labels":[],"label_agreement":null},{"id":"W2153105560","doi":"10.1182/blood.v124.21.2090.2090","title":"Mir-29a Displays in Vitro and in Vivo Anti-Tumor Activity in Multiple Myeloma","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"microRNA; Transfection; Cancer research; Viability assay; Biology; Cell culture; Multiple myeloma; In vivo; Pathogenesis; Immunology; Gene; Genetics","score_opus":0.010345986923509205,"score_gpt":0.23928312833678947,"score_spread":0.22893714141328025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153105560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99893165,0.00014049296,0.00004762816,0.00022392797,0.00005840798,0.00025879688,0.000009136125,0.0000139878475,0.0003159841],"genre_scores_gemma":[0.99933237,0.00003205447,0.0002795606,0.00020579337,0.00006520697,0.000029333421,0.0000020243124,0.000015350492,0.000038300932],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992955,0.000037988902,0.00013687598,0.00022226214,0.000096661184,0.00021076083],"domain_scores_gemma":[0.99967664,0.00005975111,0.000033735145,0.00016105452,0.000007715678,0.00006110139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019747498,0.00010477638,0.00028629648,0.00013408336,0.0000146237135,0.000008442326,0.000039056336,0.000053714688,0.000029384508],"category_scores_gemma":[0.000043171927,0.00009579468,0.00002532982,0.00015833045,0.000021826943,0.00005607342,0.000024077806,0.00015813964,0.00000271261],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040453783,0.000642358,0.09925352,0.00004588845,0.0000073194174,0.0000846362,0.00022955265,0.0000011962051,0.8958575,0.00004998044,0.0000071773643,0.0034162928],"study_design_scores_gemma":[0.010716113,0.00013008802,0.4535009,0.00009517232,0.000010203295,0.000022584363,0.000035647394,0.0010517451,0.53356284,0.0001369772,0.0006297627,0.000107971144],"about_ca_topic_score_codex":0.0007815029,"about_ca_topic_score_gemma":0.0028521873,"teacher_disagreement_score":0.3622947,"about_ca_system_score_codex":0.000027295686,"about_ca_system_score_gemma":0.000025977462,"threshold_uncertainty_score":0.39063936},"labels":[],"label_agreement":null},{"id":"W2153722638","doi":"10.1182/blood.v124.21.2960.2960","title":"Role of Bone Marrow Biopsy in the Staging of Diffuse Large B-Cell Lymphoma in the PET/CT Era","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Lymphoma; Diffuse large B-cell lymphoma; Bone marrow; Biopsy; Radiology; Iliac crest; Positron emission tomography; Stage (stratigraphy); Cancer; Hodgkin lymphoma; Nuclear medicine; Internal medicine; Surgery","score_opus":0.005938800234037085,"score_gpt":0.2188793578069199,"score_spread":0.2129405575728828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153722638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939181,0.0009868491,7.7113054e-7,0.0005475167,0.00001590779,0.00029095568,0.000015248767,0.0000063630323,0.004218255],"genre_scores_gemma":[0.9994171,0.000070762886,0.00009947981,0.00028689086,0.00002937318,0.000046188547,0.000011675243,0.00001028093,0.0000281961],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900734,0.0001279079,0.0002712207,0.00014296951,0.00025197453,0.00019855419],"domain_scores_gemma":[0.9992209,0.0002134731,0.0000999118,0.0004191227,0.000020078327,0.000026532018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004966763,0.000110960005,0.00027266564,0.00008522229,0.000023238168,0.000008285538,0.00012833763,0.000011342006,0.000015052528],"category_scores_gemma":[0.000047013924,0.00005821533,0.00008499239,0.00019990277,0.00003445294,0.000025119165,0.000030189067,0.00005150259,0.0000072737716],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006471519,0.042301103,0.9416552,0.00014212746,0.00006095064,0.0006371035,0.0030111298,8.5556326e-7,0.007757823,0.0017135213,0.00011932916,0.0025361432],"study_design_scores_gemma":[0.039238114,0.00033533087,0.92034197,0.00017357206,0.00022256545,0.00035057927,0.0023848454,0.00012116414,0.0353642,0.00020970224,0.0011608142,0.00009717293],"about_ca_topic_score_codex":0.0004610859,"about_ca_topic_score_gemma":0.00008977703,"teacher_disagreement_score":0.041965775,"about_ca_system_score_codex":0.000020445243,"about_ca_system_score_gemma":0.000041011957,"threshold_uncertainty_score":0.23739523},"labels":[],"label_agreement":null},{"id":"W2153867928","doi":"10.1182/blood-2005-12-5115","title":"Multiyear therapeutic benefit of AAV serotypes 2, 6, and 8 delivering factor VIII to hemophilia A mice and dogs","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":200,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Bayer HealthCare","keywords":"Genetic enhancement; Factor IX; Medicine; Immunology; Antibody; Coagulation; Serotype; Therapeutic effect; Neutralizing antibody; Virology; Internal medicine; Gene; Biology","score_opus":0.011287562205769791,"score_gpt":0.2560969159999344,"score_spread":0.2448093537941646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153867928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99658054,0.0030048166,0.000028390132,0.00006220328,0.00001149117,0.00017964756,0.00002981426,0.0000068942823,0.00009622172],"genre_scores_gemma":[0.9990224,0.0001885975,0.00042031452,0.000092395094,0.000062863,0.000009416229,0.000008899051,0.000018504066,0.00017659154],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993637,0.000020428832,0.000110223125,0.00023920367,0.00009292139,0.0001734989],"domain_scores_gemma":[0.9996758,0.0000102993745,0.000026805505,0.00017458828,0.000051128456,0.000061347186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006580521,0.000105223815,0.00011104937,0.00003901839,0.00004058201,0.000014886846,0.00009069789,0.00007273804,0.000010885443],"category_scores_gemma":[0.000007822566,0.00009977331,0.000026923055,0.000054556032,0.00004614916,0.0000025137917,0.000088148096,0.000044750857,0.0000028643037],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002551725,0.00008076157,0.010384888,0.00002310561,0.000052845164,0.0000014068371,0.000049107744,0.000015804046,0.985762,0.000013445096,0.000006391518,0.0033550698],"study_design_scores_gemma":[0.0011130333,0.0010318899,0.03028652,0.000010805298,0.00001822566,0.000008098556,0.000012556368,0.000021371074,0.9666992,0.000055704222,0.00061513594,0.0001275058],"about_ca_topic_score_codex":0.00019819573,"about_ca_topic_score_gemma":0.00051495753,"teacher_disagreement_score":0.019901631,"about_ca_system_score_codex":0.0000030864906,"about_ca_system_score_gemma":0.000016677825,"threshold_uncertainty_score":0.40686375},"labels":[],"label_agreement":null},{"id":"W2153944703","doi":"10.1182/blood-2009-03-212191","title":"Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":584,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; BC Cancer Agency; Terry Fox Foundation; National Institutes of Health; Michael Smith Health Research BC","keywords":"Chromosomal translocation; Follicular lymphoma; Lymphoma; International Prognostic Index; Fluorescence in situ hybridization; Rituximab; Internal medicine; Aggressive lymphoma; Diffuse large B-cell lymphoma; Oncology; Biology; Cytogenetics; Chemotherapy; Gene rearrangement; Medicine; Cancer research; Gene; Chromosome; Genetics","score_opus":0.026946947333257434,"score_gpt":0.26977379390569606,"score_spread":0.24282684657243864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153944703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99311966,0.0011148955,0.000025904972,0.004151036,0.000030322743,0.00030009172,0.000020327037,0.00005120586,0.0011865569],"genre_scores_gemma":[0.99950576,0.000051100717,0.000039945364,0.00025184153,0.000040354666,0.00002625581,0.000037324142,0.000009874858,0.000037528636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992256,0.000039190378,0.000114594215,0.00018813414,0.00024272817,0.00018974266],"domain_scores_gemma":[0.9993524,0.00026642415,0.00002742487,0.0001555611,0.000078265584,0.000119944016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006420145,0.00014533424,0.00021174569,0.000023436083,0.00012256816,0.00003237681,0.000037869704,0.00004460486,0.000021818485],"category_scores_gemma":[0.000057053705,0.000068541245,0.00003373045,0.000121172314,0.00012700509,0.000040910727,0.0000039248625,0.00005331178,0.0000023136429],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011896735,0.008538183,0.97191834,0.000028074372,0.0008821105,0.00016614694,0.001582456,0.0000012251406,0.00014900546,0.00895712,0.00020372598,0.007454622],"study_design_scores_gemma":[0.009214694,0.0015441932,0.98480123,0.00015779833,0.0011115993,0.00005617689,0.00030546947,0.000010480492,0.002330434,0.00005577836,0.00029474805,0.00011740576],"about_ca_topic_score_codex":0.000029679672,"about_ca_topic_score_gemma":0.0000452606,"teacher_disagreement_score":0.0128828585,"about_ca_system_score_codex":0.000038796425,"about_ca_system_score_gemma":0.00010649257,"threshold_uncertainty_score":0.27950308},"labels":[],"label_agreement":null},{"id":"W2153985422","doi":"10.1182/blood-2006-04-016634","title":"Mantle cell lymphoma cells express predominantly cyclin D1a isoform and are highly sensitive to selective inhibition of CDK4 kinase activity","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":147,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Alberta","funders":"National Cancer Institute","keywords":"Cyclin D1; Cyclin D; Cyclin-dependent kinase 6; Mantle cell lymphoma; Cancer research; Cyclin A2; Cyclin A; Cell cycle; Biology; Cyclin-dependent kinase; Cyclin D3; Cyclin-dependent kinase complex; Cyclin E; Cyclin B; Cell biology; Cell; Lymphoma; Biochemistry; Immunology","score_opus":0.004454568117789684,"score_gpt":0.19993608140271568,"score_spread":0.195481513284926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153985422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945318,0.00015034554,0.0005798224,0.00010711563,0.00008065424,0.0008320608,0.00018742279,0.000049910745,0.003480886],"genre_scores_gemma":[0.99837637,0.000025619209,0.0008997545,0.00007873166,0.00011935949,0.000034480643,0.000022565227,0.000042068783,0.00040104968],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998706,0.000056888726,0.00024589745,0.00042564896,0.00026376275,0.00030182267],"domain_scores_gemma":[0.999139,0.000060575207,0.00019641395,0.00027481597,0.00019267078,0.00013651403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010705683,0.00022166374,0.00039938008,0.00016061637,0.00006416121,0.000012753,0.000035756122,0.00017556548,0.0000058935493],"category_scores_gemma":[0.0000297086,0.00022487063,0.00009276764,0.00026519416,0.00007484491,0.00008397772,0.00006896863,0.00013080594,0.000021990922],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005912677,0.0016905839,0.0003133529,0.0001580558,0.00004918009,0.0003097222,0.00041465048,0.000022661961,0.99503183,0.000014792458,0.0006528071,0.00075106905],"study_design_scores_gemma":[0.007428799,0.0006297303,0.027566671,0.000306774,0.00029938368,0.000085236745,0.0001476685,0.00006236673,0.9630224,0.000034241613,0.0002068549,0.00020983844],"about_ca_topic_score_codex":0.00043561487,"about_ca_topic_score_gemma":0.00010711523,"teacher_disagreement_score":0.03200942,"about_ca_system_score_codex":0.00011603476,"about_ca_system_score_gemma":0.00010187095,"threshold_uncertainty_score":0.91699576},"labels":[],"label_agreement":null},{"id":"W2154310260","doi":"10.1182/blood-2004-08-3168","title":"Small-molecule XIAP inhibitors derepress downstream effector caspases and induce apoptosis of acute myeloid leukemia cells","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":125,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"XIAP; Inhibitor of apoptosis; Apoptosis; Caspase; Leukemia; Cancer research; Chemistry; Biology; Programmed cell death; Immunology; Biochemistry","score_opus":0.006285867216778724,"score_gpt":0.20487481144942887,"score_spread":0.19858894423265014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154310260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983862,0.00074388896,0.00017771371,0.000024917763,0.00008451183,0.00019511495,0.000032245476,0.000012728933,0.00034268628],"genre_scores_gemma":[0.9976176,0.0004475249,0.0012211087,0.00004539209,0.00024064367,0.00001591627,0.00008241129,0.000021375245,0.00030804685],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99918175,0.000035032248,0.00019168176,0.00031503444,0.0000944087,0.00018209417],"domain_scores_gemma":[0.99949723,0.000011393316,0.000099472694,0.00026077355,0.000047974176,0.00008316945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007238909,0.0001614584,0.00016205898,0.000042860327,0.000054397828,0.000017631248,0.000090641566,0.00019448798,0.000011134912],"category_scores_gemma":[0.000010459125,0.00014547406,0.0000809261,0.000060918766,0.000053010932,0.0000042168845,0.00010270154,0.00005970783,0.0000039029323],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025150452,0.00011932389,0.0002621777,0.000031863456,0.00012835812,0.0000014054118,0.00003840687,0.000031467778,0.99447006,0.000013149592,0.00014822329,0.0047304314],"study_design_scores_gemma":[0.0010499591,0.00023316624,0.00051664095,0.000023134462,0.00018708615,0.00001911566,0.00001543762,0.000029967625,0.99670607,0.0000055196115,0.0010423248,0.00017155665],"about_ca_topic_score_codex":0.000057787394,"about_ca_topic_score_gemma":0.00001877207,"teacher_disagreement_score":0.0045588748,"about_ca_system_score_codex":0.0000093677145,"about_ca_system_score_gemma":0.000044668217,"threshold_uncertainty_score":0.593226},"labels":[],"label_agreement":null},{"id":"W2155356669","doi":"10.1182/blood-2008-08-173641","title":"Contribution of STAT3 and SMAD4 pathways to the regulation of hepcidin by opposing stimuli","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":164,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Hôpital Notre-Dame","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Hepcidin; Erythropoiesis; Erythropoietin; Ferroportin; Anemia of chronic disease; Lipopolysaccharide; Signal transduction; Inflammation; Hypoxia (environmental); Ineffective erythropoiesis; Regulator; Cell biology; Biology; Endocrinology; Internal medicine; Anemia; Chemistry; Immunology; Medicine; Biochemistry","score_opus":0.012754350814177315,"score_gpt":0.24705365609644683,"score_spread":0.23429930528226953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155356669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99538517,0.0018708769,0.0011945445,0.0009102514,0.000021296439,0.00024242162,0.000026010059,0.000009261137,0.0003401706],"genre_scores_gemma":[0.99925464,0.000047001235,0.00037607428,0.00022807912,0.000024385716,0.0000013279459,0.0000390798,0.000003235875,0.000026160375],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995514,0.00002323275,0.00014572317,0.00007668166,0.00012119147,0.000081734746],"domain_scores_gemma":[0.9996945,0.000022779914,0.000057137313,0.00011437996,0.00007116127,0.00004001032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014948538,0.00004887468,0.00013387225,0.000028246444,0.000026607126,0.000003373358,0.000024349765,0.0000306495,0.00000881545],"category_scores_gemma":[0.00011182117,0.00003458955,0.00002019849,0.00008197142,0.00002393895,0.000028343811,0.000007110711,0.000030619063,8.7779597e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020522832,0.0004248099,0.0055877403,0.00004222825,0.000014375694,7.5614304e-7,0.00094081543,0.000021318976,0.9678656,0.003734715,0.0017293319,0.0194331],"study_design_scores_gemma":[0.006159214,0.0007234511,0.41129807,0.00008083275,0.00031295422,0.000007996666,0.00034403484,0.00010676768,0.57800967,0.0009620653,0.0019008131,0.00009417031],"about_ca_topic_score_codex":0.000019798166,"about_ca_topic_score_gemma":0.0000021128076,"teacher_disagreement_score":0.4057103,"about_ca_system_score_codex":0.0000030313681,"about_ca_system_score_gemma":0.000018786664,"threshold_uncertainty_score":0.14105208},"labels":[],"label_agreement":null},{"id":"W2155477306","doi":"10.1182/blood-2011-03-278127","title":"How I treat hemophagocytic lymphohistiocytosis","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":1138,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institutes of Health; National Heart, Lung, and Blood Institute; Cincinnati Children's Hospital Medical Center; American Society of Hematology","keywords":"Hemophagocytic lymphohistiocytosis; Medicine; Disease; Macrophage activation syndrome; Immunology; Immune dysregulation; Immune system; Pediatrics; Intensive care medicine; Internal medicine","score_opus":0.0381820793013617,"score_gpt":0.2534675904848563,"score_spread":0.2152855111834946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155477306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90989,0.0017155631,0.00004692307,0.0002635522,0.00003380373,0.00021532591,0.0000023237408,0.00010700599,0.0877255],"genre_scores_gemma":[0.98552847,0.00014047058,0.00040127046,0.00014165856,0.000056818124,0.000029834024,0.000007828287,0.000023263769,0.013670386],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991977,0.000020269086,0.00013043283,0.00018177176,0.00020877444,0.0002610156],"domain_scores_gemma":[0.9994273,0.000012315946,0.000033682903,0.00034995365,0.000062392275,0.0001143099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000076246375,0.00011223848,0.00022357747,0.000093806564,0.00006962831,0.000018580206,0.00009517001,0.00007537654,0.00051321945],"category_scores_gemma":[0.00007764692,0.00009199653,0.00009875594,0.00014458342,0.00007971463,0.00009297258,0.000037242775,0.00009384626,0.00025468768],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013760914,0.010852609,0.6360527,0.0014503655,0.0014933409,0.0037991577,0.0064755315,3.1596042e-7,0.15519801,0.00538172,0.014520774,0.16339935],"study_design_scores_gemma":[0.023013778,0.0014485086,0.27648318,0.00015352224,0.0008539862,0.0007823114,0.0013453744,0.0000898704,0.6592492,0.00043104333,0.035546314,0.00060293893],"about_ca_topic_score_codex":0.00004883508,"about_ca_topic_score_gemma":0.00000194112,"teacher_disagreement_score":0.5040512,"about_ca_system_score_codex":0.00003157197,"about_ca_system_score_gemma":0.0001437858,"threshold_uncertainty_score":0.5619393},"labels":[],"label_agreement":null},{"id":"W2156134727","doi":"10.1182/blood-2007-04-060715","title":"Pathobiology of ALK+ anaplastic large-cell lymphoma","year":2007,"lang":"en","type":"review","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":264,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; National Institutes of Health; Alberta Cancer Foundation","keywords":"Anaplastic large-cell lymphoma; Anaplastic lymphoma kinase; Cancer research; CD30; Lymphoma; Biology; Immunophenotyping; Tyrosine kinase; Nucleophosmin; BCL10; Medicine; Signal transduction; Pathology; Flow cytometry; Immunology; Tumor cells; Cell biology","score_opus":0.035262052957552296,"score_gpt":0.32222109065286136,"score_spread":0.28695903769530906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156134727","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00091088936,0.99117374,0.0000046920636,0.0000042966553,0.0001903911,0.00066670903,0.00017876393,0.00003475565,0.0068357773],"genre_scores_gemma":[0.0011255017,0.9973619,0.00027614748,0.000055311877,0.00020240126,0.000082512764,0.00044148168,0.00004991902,0.00040480524],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99830973,0.00006785051,0.0006544737,0.00040277952,0.00017310135,0.00039204533],"domain_scores_gemma":[0.9985987,0.00033025088,0.00034894355,0.00050157227,0.00006201309,0.000158541],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001642363,0.0003945953,0.0021344938,0.00022081943,0.00002926093,0.0000046858104,0.000121674435,0.0004583545,0.00011712984],"category_scores_gemma":[0.000053837215,0.00026652694,0.0006642552,0.00023744836,0.00004992908,0.000011564638,0.00006959658,0.0000841748,0.00026138322],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002041681,0.013671301,0.00081828097,0.018582314,0.0009156417,0.0012638211,0.000020908019,5.920292e-9,0.0000013188524,0.00017031883,0.0006401956,0.9638955],"study_design_scores_gemma":[0.008851701,0.0008995198,0.00027056257,0.0061627263,0.007819942,0.00066485454,0.000006035201,1.4075991e-7,0.00009174801,0.000004190132,0.9750256,0.00020300216],"about_ca_topic_score_codex":0.000015394044,"about_ca_topic_score_gemma":0.0000065960717,"teacher_disagreement_score":0.9743854,"about_ca_system_score_codex":0.00009237202,"about_ca_system_score_gemma":0.00044028874,"threshold_uncertainty_score":0.9999787},"labels":[],"label_agreement":null},{"id":"W2157290593","doi":"10.1182/blood-2008-07-167700","title":"MGUS: not so benign after all","year":2008,"lang":"en","type":"letter","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; Monoclonal gammopathy of undetermined significance; Multiple myeloma; Risk factor; Internal medicine; Intensive care medicine; Immunology; Monoclonal; Antibody","score_opus":0.020264814319183682,"score_gpt":0.24556623127353405,"score_spread":0.22530141695435038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157290593","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.035762034,0.0030123983,0.0000126765535,0.9338465,0.00097014464,0.0015817749,0.0001014647,0.0003021348,0.024410926],"genre_scores_gemma":[0.014639217,0.0021234076,0.00048550795,0.96474415,0.0076969597,0.00032093647,0.00043658924,0.00014091154,0.009412325],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977506,0.000040815743,0.00037130775,0.000608539,0.0006212879,0.0006074969],"domain_scores_gemma":[0.9987878,0.00004547275,0.00012538837,0.0008556733,0.00006934227,0.00011629553],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00008363631,0.00042745014,0.0009290569,0.00019882021,0.000058213736,0.00004913954,0.00020841726,0.0006705104,0.0010839932],"category_scores_gemma":[0.000024968182,0.0003741055,0.0003620838,0.000086190215,0.00009706718,0.00004144346,0.00013507143,0.0010908705,0.0010813981],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015216543,0.000809817,0.00017325932,0.0003957577,0.000909421,0.009216584,0.00030909618,1.3604661e-7,0.000032193908,0.0000109179155,0.9877019,0.00042567952],"study_design_scores_gemma":[0.0017582477,0.0002951469,0.005333407,0.00027578327,0.0022128408,0.00019549961,0.0000069179737,6.036379e-7,0.0004025823,0.000022058843,0.9891094,0.00038748689],"about_ca_topic_score_codex":0.00011941275,"about_ca_topic_score_gemma":0.000009356795,"teacher_disagreement_score":0.0308977,"about_ca_system_score_codex":0.000046448946,"about_ca_system_score_gemma":0.00010735047,"threshold_uncertainty_score":0.9998711},"labels":[],"label_agreement":null},{"id":"W2157501125","doi":"10.1182/blood-2011-10-385658","title":"Rac2-MRC-cIII–generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitors","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":187,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Medical Research Council; Imperial Experimental Cancer Medicine Centre; University of Pennsylvania; China Scholarship Council; Cancer Institute, University of Pittsburgh; Cancer Research UK; Peking University; National Institutes of Health; Warszawski Uniwersytet Medyczny; National Cancer Institute; Uniwersytet Warszawski; Cancer Research Institute; Temple University","keywords":"Genome instability; Myeloid leukemia; Biology; Cancer research; Stem cell; Progenitor cell; Mitochondrial ROS; Haematopoiesis; Mitochondrion; Molecular biology; DNA damage; Cell biology; Genetics","score_opus":0.020180924643032,"score_gpt":0.2512487543760032,"score_spread":0.23106782973297119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157501125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923305,0.00498409,0.0000032622559,0.00003008668,0.00022173113,0.001779487,0.000049462364,0.000119143486,0.00048224427],"genre_scores_gemma":[0.99796826,0.00035738733,0.00033152528,0.000070690956,0.00047892347,0.00018536282,0.000052050953,0.00007416528,0.0004816606],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975671,0.00015901354,0.0005372715,0.0005914255,0.0002968929,0.00084829977],"domain_scores_gemma":[0.99864924,0.00009501921,0.00015569694,0.00059689605,0.000077789904,0.00042537693],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003675204,0.0004103158,0.0005878372,0.00016427125,0.000093517076,0.000027104314,0.00011557756,0.00026842565,0.00008983522],"category_scores_gemma":[0.000033022137,0.00037061799,0.000094620606,0.0003244573,0.00015562656,0.00023017665,0.00014287887,0.00042196887,0.00011870089],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026047725,0.0015214698,0.5374551,0.00048836553,0.00060222857,0.00019256346,0.002087902,0.000028830087,0.45157048,0.000033745233,0.00008243782,0.0056764153],"study_design_scores_gemma":[0.018214494,0.00046440435,0.36043984,0.0001719473,0.0006695533,0.0002386659,0.00022946336,0.00017746005,0.61774856,0.0000038457197,0.0012082288,0.00043353514],"about_ca_topic_score_codex":0.00038876632,"about_ca_topic_score_gemma":0.00021184172,"teacher_disagreement_score":0.17701527,"about_ca_system_score_codex":0.0054737525,"about_ca_system_score_gemma":0.0020596955,"threshold_uncertainty_score":0.9998746},"labels":[],"label_agreement":null},{"id":"W2158267770","doi":"10.1182/blood-2003-05-1545","title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4277,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Associazione Italiana per la Ricerca sul Cancro; U.S. Department of Health and Human Services","keywords":"Tissue microarray; Microarray; Lymphoma; Germinal center; Immunohistochemistry; Diffuse large B-cell lymphoma; Pathology; Biology; International Prognostic Index; Gene expression profiling; Microarray analysis techniques; Complementary DNA; Gene expression; Medicine; B cell; Antibody; Gene; Immunology; Genetics","score_opus":0.008936389457920729,"score_gpt":0.24885822921689454,"score_spread":0.23992183975897383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158267770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948158,0.0025459116,0.0001318389,0.000044744156,0.000029749292,0.00025255018,0.000025832034,0.000007016847,0.002146555],"genre_scores_gemma":[0.9993285,0.000026914864,0.00043217317,0.00004051315,0.0000051259626,0.000014261592,0.000028462742,0.000010640663,0.00011338431],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99935853,0.00003640391,0.00023376841,0.00011761626,0.0001524145,0.00010125728],"domain_scores_gemma":[0.9993389,0.000017283946,0.00019951948,0.00033881658,0.000073704236,0.000031743726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000637977,0.000089892135,0.0001678587,0.000018719353,0.000034070556,0.0000039019083,0.00005512738,0.000068465604,0.000020001167],"category_scores_gemma":[0.00003412242,0.00006674174,0.000075604825,0.00009717777,0.000043644257,0.00001780672,0.000010660645,0.000021775759,0.0000023726798],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012270265,0.007437288,0.0061049745,0.00009863589,0.00006194841,0.0000027407511,0.00012263423,2.0326385e-7,0.98569,0.00024927704,0.000089689245,0.00013032988],"study_design_scores_gemma":[0.012075259,0.000048546637,0.0056184926,0.00007312521,0.00033724392,0.00003267324,0.00008458525,0.000015961827,0.98048985,0.000009114753,0.0011606681,0.000054491687],"about_ca_topic_score_codex":0.000041870553,"about_ca_topic_score_gemma":2.5580172e-7,"teacher_disagreement_score":0.012062989,"about_ca_system_score_codex":0.000059478614,"about_ca_system_score_gemma":0.00009659185,"threshold_uncertainty_score":0.2721649},"labels":[],"label_agreement":null},{"id":"W2158548991","doi":"10.1182/blood-2002-02-0355","title":"Transgenic targeting with regulatory elements of the humanCD34 gene","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Biology; Molecular biology; Transgene; Progenitor cell; Gene; Fusion gene; Gene expression; Stem cell; Cell biology; Genetics","score_opus":0.014114940997270889,"score_gpt":0.24270644573403352,"score_spread":0.22859150473676262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158548991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997188,0.0020134272,0.000015239867,0.000051701165,0.000020074498,0.00016191551,0.000009111691,0.0000054336656,0.0005351023],"genre_scores_gemma":[0.9988073,0.00011926927,0.00026289892,0.00007770673,0.00009519878,0.0000140235825,0.000009184894,0.000021561935,0.0005928247],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991984,0.00006290392,0.00014553774,0.00018974303,0.00020315182,0.00020030294],"domain_scores_gemma":[0.9994511,0.0000031415636,0.000058206355,0.0004024455,0.000049538692,0.000035571382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014898794,0.00009108513,0.000081924365,0.000017533197,0.000073934076,0.0000053291074,0.00025117054,0.00005416018,0.00012110659],"category_scores_gemma":[0.000009008808,0.00006326079,0.000068439214,0.00008561039,0.0000835456,0.0000013963228,0.00003979917,0.00006636674,0.0000050328563],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009622842,0.0001628399,0.0053196317,0.000011302281,0.000113386224,7.554468e-7,0.000047643072,0.000022283395,0.99347067,0.0000025308639,0.00029961063,0.00045314658],"study_design_scores_gemma":[0.0013151701,0.00085038826,0.0023259795,0.000007484211,0.000025546351,0.000003367774,0.000013574234,0.000009484819,0.99425465,0.0000068514128,0.0011014297,0.00008610221],"about_ca_topic_score_codex":0.000002225303,"about_ca_topic_score_gemma":0.000032548778,"teacher_disagreement_score":0.0029936524,"about_ca_system_score_codex":0.0000039373685,"about_ca_system_score_gemma":0.000025907646,"threshold_uncertainty_score":0.25797004},"labels":[],"label_agreement":null},{"id":"W2158735008","doi":"10.1182/blood-2015-05-644591","title":"IDH2 R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":248,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; Agios Pharmaceuticals; University of Nebraska Medical Center","keywords":"Angioimmunoblastic T-cell lymphoma; IDH2; Biology; Mutation; Cancer research; DNA methylation; Genetics; Gene; Point mutation; Histone; Lymphoma; Gene expression; Immunology; T cell; IDH1","score_opus":0.00888982317513798,"score_gpt":0.20350926968949712,"score_spread":0.19461944651435914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158735008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993203,0.00043649133,0.00009753332,0.00007452198,0.00003417791,0.00026418272,0.000021022095,0.000034085482,0.005834997],"genre_scores_gemma":[0.9981329,0.00000792738,0.0012546474,0.000065102824,0.000012063519,0.000015722215,0.00011308555,0.000022064036,0.00037650275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992349,0.000020243555,0.0001979893,0.00014314397,0.00024742036,0.00015628767],"domain_scores_gemma":[0.99931115,0.000033893404,0.000083243955,0.00023896246,0.00021711168,0.00011565297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006442462,0.0001143553,0.00023908901,0.00009097105,0.000025952879,0.000006914755,0.00006465649,0.000051909454,0.000029291561],"category_scores_gemma":[0.00005837625,0.000086733584,0.000048856447,0.0002245987,0.00007516897,0.00004837903,0.000021390782,0.000041704192,0.000021263137],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005269088,0.018227631,0.9725711,0.0003241346,0.00039517455,0.00009831697,0.0028961485,0.000016840682,0.0011475219,0.0011280304,0.0008876464,0.001780559],"study_design_scores_gemma":[0.049388863,0.0050374693,0.9377469,0.00026621736,0.000955717,0.00008089243,0.0007060421,0.000047094833,0.0032483023,0.00093411544,0.001235935,0.00035248982],"about_ca_topic_score_codex":0.00007863213,"about_ca_topic_score_gemma":0.000017081858,"teacher_disagreement_score":0.048861954,"about_ca_system_score_codex":0.000016042923,"about_ca_system_score_gemma":0.00017671935,"threshold_uncertainty_score":0.35368928},"labels":[],"label_agreement":null},{"id":"W2159231148","doi":"10.1182/blood.v99.7.2387","title":"Early hematopoietic reconstitution after clinical stem cell transplantation: evidence for stochastic stem cell behavior and limited acceleration in telomere loss","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Canadian Institutes of Health Research; Hospital for Sick Children; Sick Kids Foundation","keywords":"CD34; Stem cell; CD90; Hematopoietic stem cell transplantation; Telomere; Progenitor cell; Transplantation; Haematopoiesis; Biology; Immunology; Internal medicine; Hematopoietic stem cell; Andrology; Medicine; Cell biology; Genetics","score_opus":0.08602067265741879,"score_gpt":0.3103322715775686,"score_spread":0.2243115989201498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159231148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993909,0.003037166,0.0011250628,0.00017257972,0.00019569602,0.001394365,0.000030759522,0.000065190216,0.00007015395],"genre_scores_gemma":[0.9975417,0.00092156033,0.0005517455,0.00012905,0.00014559184,0.00029013032,0.000014407758,0.000025820682,0.00037999317],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981182,0.00008962031,0.00070915144,0.0005189527,0.00024714143,0.0003169321],"domain_scores_gemma":[0.99889475,0.00037684554,0.0001421535,0.00027865754,0.00011150565,0.0001960654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028558046,0.00023026169,0.00041303292,0.00016586408,0.000087705506,0.000056640034,0.00008740888,0.0002238785,0.00006192345],"category_scores_gemma":[0.000019542811,0.00021947706,0.000106246516,0.0002365901,0.00013809699,0.00031947566,0.000013468089,0.0002604836,0.000040035124],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019591039,0.004815089,0.93552256,0.0031863723,0.00005967285,0.0010428859,0.006941765,0.000020439093,0.009158883,0.000069536254,0.000110537476,0.037113164],"study_design_scores_gemma":[0.018021163,0.002253856,0.94880146,0.002198693,0.0017845304,0.0007959073,0.00067566615,0.00080799806,0.023729676,0.000019677795,0.00007614374,0.0008352016],"about_ca_topic_score_codex":0.000015164837,"about_ca_topic_score_gemma":0.000031084335,"teacher_disagreement_score":0.03627796,"about_ca_system_score_codex":0.00003336517,"about_ca_system_score_gemma":0.000065319495,"threshold_uncertainty_score":0.89500153},"labels":[],"label_agreement":null},{"id":"W2159289068","doi":"10.1182/blood.v97.1.56","title":"A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission: a report from the Children's Cancer Group","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":361,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Grace (Canada)","funders":"","keywords":"Medicine; Chemotherapy; Cytarabine; Regimen; Internal medicine; Surgery; Bone marrow; Chemotherapy regimen; Transplantation; Randomization; Leukemia; Oncology; Myeloid leukemia; Randomized controlled trial","score_opus":0.0107190085006928,"score_gpt":0.2846117187186004,"score_spread":0.2738927102179076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159289068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99095213,0.005084733,0.000112767266,0.0020654025,0.000024681762,0.0014449656,0.00016358666,0.000051394574,0.00010033874],"genre_scores_gemma":[0.9818156,0.014764836,0.001721677,0.0003235175,0.00012912111,0.00017563101,0.00089248084,0.0000628282,0.00011433898],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971331,0.0001753566,0.00086469244,0.0007018869,0.0006200143,0.00050496234],"domain_scores_gemma":[0.99854934,0.00015289443,0.0004943213,0.0005105429,0.00011363739,0.00017925675],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040327015,0.00037274754,0.0008723361,0.00024167956,0.00010330142,0.00002414079,0.0002248408,0.00027274602,0.00012133271],"category_scores_gemma":[0.000040946336,0.0002630534,0.0000817645,0.0006805441,0.00028730463,0.00013023481,0.00002263138,0.0006727329,0.0000021170056],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030878154,0.00038751226,0.9562266,0.000061014653,0.000621558,0.0044482015,0.0029600859,0.00004538067,0.028651262,0.000005198302,0.0002480059,0.0032573496],"study_design_scores_gemma":[0.018923063,0.00031981932,0.94368,0.00073597545,0.0006714135,0.01881375,0.00013233087,0.00013524601,0.016229216,0.000033680735,0.0000414962,0.0002840419],"about_ca_topic_score_codex":0.005838291,"about_ca_topic_score_gemma":0.00305201,"teacher_disagreement_score":0.015835248,"about_ca_system_score_codex":0.00026471433,"about_ca_system_score_gemma":0.00074260053,"threshold_uncertainty_score":0.9999822},"labels":[],"label_agreement":null},{"id":"W2159403621","doi":"10.1182/blood-2014-05-577627","title":"The role of FDG-PET in defining prognosis of Hodgkin lymphoma for early-stage disease","year":2014,"lang":"en","type":"review","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McMaster University","keywords":"Stage (stratigraphy); Medicine; Lymphoma; Disease; Positron emission tomography; Hodgkin lymphoma; Oncology; Internal medicine; Nuclear medicine; Biology","score_opus":0.02088860018484849,"score_gpt":0.3022961687054133,"score_spread":0.2814075685205648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159403621","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013220569,0.98393065,7.091545e-7,0.000022458138,0.000046378045,0.001961239,0.00029643942,0.000014445865,0.0005071089],"genre_scores_gemma":[0.042350847,0.9552262,0.00030470488,0.000011369819,0.000061159095,0.001762528,0.00014187946,0.000054850523,0.00008649955],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982997,0.00009624528,0.00075615646,0.0003164984,0.0002480582,0.00028330047],"domain_scores_gemma":[0.99799466,0.0007479908,0.0005353901,0.0005162751,0.00007247252,0.00013321283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000301221,0.0003052317,0.0015734716,0.00012824424,0.00004404675,0.000014307177,0.00018290657,0.00010274909,0.0000076214496],"category_scores_gemma":[0.00026688675,0.00018039212,0.0007030507,0.00018955431,0.000071814684,0.000020022193,0.00006403494,0.000052164534,0.000009003557],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006759548,0.0026421372,0.053596452,0.0150316255,0.00071433384,0.000046222038,0.00004497393,9.369204e-8,3.9741712e-7,0.0016338957,0.000041092826,0.9261812],"study_design_scores_gemma":[0.00673551,0.0007028968,0.01530228,0.024053533,0.00795905,0.000022988226,0.000031130825,0.0000070889478,0.00018302789,0.00010998215,0.9446341,0.00025843704],"about_ca_topic_score_codex":0.00011795918,"about_ca_topic_score_gemma":0.0000194807,"teacher_disagreement_score":0.944593,"about_ca_system_score_codex":0.00006522145,"about_ca_system_score_gemma":0.00047148476,"threshold_uncertainty_score":0.7356177},"labels":[],"label_agreement":null},{"id":"W2159872876","doi":"10.1182/blood-2002-10-3233","title":"Functional receptor for C3a anaphylatoxin is expressed by normal hematopoietic stem/progenitor cells, and C3a enhances their homing-related responses to SDF-1","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":219,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services","funders":"National Institute of Allergy and Infectious Diseases; National Institute of General Medical Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute","keywords":"Homing (biology); Biology; Cell biology; Stem cell; Anaphylatoxin; Haematopoiesis; Progenitor cell; Bone marrow; CD34; Stromal cell; Immunology; Complement system; Cancer research; Immune system","score_opus":0.013577637442828515,"score_gpt":0.22072753435981785,"score_spread":0.20714989691698932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159872876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98830175,0.008110243,0.00012148243,0.00014280867,0.0006940443,0.0009232705,0.0015074953,0.00009270428,0.0001062155],"genre_scores_gemma":[0.99449277,0.00003948086,0.00017150096,0.000150947,0.00003517317,0.00038912875,0.00012763182,0.00003185014,0.0045615416],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99832535,0.00029108007,0.00042183927,0.0004832224,0.00005799302,0.00042050538],"domain_scores_gemma":[0.9990501,0.0003293808,0.00014280937,0.00031467463,0.00008894025,0.00007412166],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026982537,0.00026994979,0.00033361398,0.00011281092,0.00028981807,0.000035932266,0.00017684582,0.00017864472,0.0012548668],"category_scores_gemma":[0.000066475244,0.0002435601,0.00012591192,0.00013821395,0.00009399622,0.00008472408,0.00006284038,0.00010421842,0.00026038833],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037292222,0.00040016064,0.002389344,0.00007483181,0.0003467192,7.929149e-7,0.0005144058,3.0958088e-7,0.9160966,0.00010280939,0.07956556,0.00013550832],"study_design_scores_gemma":[0.0026071968,0.0002891541,0.00036829297,0.00005518614,0.000082615355,0.000021877631,0.0006302555,3.063103e-7,0.8835772,0.000036299552,0.11206842,0.00026318154],"about_ca_topic_score_codex":0.0000050424537,"about_ca_topic_score_gemma":0.000003059814,"teacher_disagreement_score":0.032519415,"about_ca_system_score_codex":0.000017936029,"about_ca_system_score_gemma":0.0000777274,"threshold_uncertainty_score":0.9996581},"labels":[],"label_agreement":null},{"id":"W2160300160","doi":"10.1182/blood-2004-09-3704","title":"Overexpression of transcripts originating from the MMSET locus characterizes all t(4;14)(p16;q32)-positive multiple myeloma patients","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":182,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; University of Alberta","keywords":"Biology; Breakpoint; Exon; Molecular biology; Alternative splicing; Nucleolus; Gene; Chromosomal translocation; Genetics; Cytoplasm","score_opus":0.018690058764591268,"score_gpt":0.27234382125712975,"score_spread":0.25365376249253846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160300160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966538,0.00030522607,0.000016797074,0.00051844225,0.00006192869,0.0008063409,0.00080247683,0.000044682907,0.00079029135],"genre_scores_gemma":[0.99720967,0.00006255902,0.0011442513,0.00025888093,0.00024521237,0.000051722473,0.00081346964,0.00003362404,0.00018058869],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99813306,0.00012167044,0.00036062562,0.00034938942,0.0006224331,0.00041281155],"domain_scores_gemma":[0.9986964,0.0003473816,0.00015580138,0.00040548996,0.00018956517,0.000205354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010983148,0.00023721247,0.00035885177,0.000062866115,0.00012546736,0.000026494848,0.00018446428,0.00010498882,0.00019060302],"category_scores_gemma":[0.00025275027,0.00015074038,0.00015705025,0.00012008348,0.00008941114,0.00018271765,0.00006052366,0.00023923923,0.000059612048],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012601365,0.0045332746,0.5322802,0.00006816305,0.0009168601,0.00006567756,0.00255583,0.0000014688312,0.41042754,0.000016470693,0.00054922525,0.04732515],"study_design_scores_gemma":[0.0150762815,0.00046329186,0.6751674,0.00040923347,0.00021248213,0.000006801646,0.00006735688,0.00017068091,0.30570483,0.000011650242,0.002570915,0.00013905924],"about_ca_topic_score_codex":0.00050063257,"about_ca_topic_score_gemma":0.00005651502,"teacher_disagreement_score":0.1428872,"about_ca_system_score_codex":0.000052669446,"about_ca_system_score_gemma":0.00005913102,"threshold_uncertainty_score":0.6147014},"labels":[],"label_agreement":null},{"id":"W2160388832","doi":"10.1182/blood-2005-06-2235","title":"Antigen-positive platelet transfusion in neonatal alloimmune thrombocytopenia (NAIT)","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"Bundesministerium für Bildung und Forschung","keywords":"Neonatal alloimmune thrombocytopenia; Platelet; Medicine; Platelet transfusion; Isoantibodies; Immunology; Complication; Antigen; Internal medicine; Pregnancy; Fetus; Biology","score_opus":0.0062139665661681675,"score_gpt":0.22772719232182617,"score_spread":0.22151322575565802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160388832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902039,0.0021335064,0.000030269179,0.00021855572,0.00004759995,0.00044422428,0.000025803181,0.00004627965,0.006849874],"genre_scores_gemma":[0.99838865,0.0006875877,0.0002803514,0.00009484573,0.000039020604,0.000013961038,0.00023941141,0.000022176668,0.0002339822],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905974,0.00001875355,0.0002200078,0.00025423872,0.0001724897,0.00027477767],"domain_scores_gemma":[0.9997137,0.000021141132,0.000033075532,0.00016064032,0.000023001312,0.00004843662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000053817468,0.00016409741,0.00036616353,0.00009418531,0.000055008448,0.000013031836,0.000057886977,0.00010285638,0.00011909429],"category_scores_gemma":[0.0000045905776,0.00014127887,0.00008124444,0.0001781336,0.00003552041,0.0000844473,0.00001758336,0.0001409897,0.00007461001],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021518634,0.016504465,0.5585174,0.00015413365,0.0011331874,0.056417376,0.0031387925,0.0000390346,0.293652,0.0017338814,0.0007575478,0.06580029],"study_design_scores_gemma":[0.025529057,0.00058547355,0.83500206,0.00018562363,0.00012361299,0.0010736847,0.00014071497,0.000034537636,0.1328871,0.0002603426,0.0038884797,0.0002893341],"about_ca_topic_score_codex":0.0013519921,"about_ca_topic_score_gemma":0.0004957454,"teacher_disagreement_score":0.2764846,"about_ca_system_score_codex":0.0000273009,"about_ca_system_score_gemma":0.0000447893,"threshold_uncertainty_score":0.57611847},"labels":[],"label_agreement":null},{"id":"W2160881152","doi":"10.1182/blood-2008-02-137372","title":"Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Rituximab; Survival analysis; Gene expression profiling; Biology; Oncology; Cancer research; Chemotherapy; Gene; Internal medicine; Medicine; Gene expression; Genetics","score_opus":0.013454216082044761,"score_gpt":0.23230082174344488,"score_spread":0.21884660566140013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160881152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962254,0.0011905262,0.0000035508654,0.000032419248,0.00003177488,0.0004650146,0.000047193233,0.00007290563,0.0019311944],"genre_scores_gemma":[0.997656,0.00066653796,0.0008140102,0.000046030123,0.000060696682,0.00007237097,0.0001017515,0.00003453174,0.00054810144],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985616,0.000058791233,0.00031914277,0.00034676178,0.00037657563,0.000337128],"domain_scores_gemma":[0.99916905,0.00007292289,0.00012220434,0.00040959453,0.00006317271,0.00016305521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006321306,0.00024455052,0.00052857905,0.000115849885,0.000051205,0.0000063766347,0.00007890522,0.00011818109,0.000046864996],"category_scores_gemma":[0.000021422069,0.00016834041,0.00008197603,0.00017473454,0.000052554977,0.000070750175,0.00004189366,0.00004587764,0.00001854208],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000752573,0.051052254,0.9200859,0.00007867471,0.00015247258,0.002300478,0.00089418056,0.0000041600465,0.024117587,0.000012531284,0.00028690943,0.000262289],"study_design_scores_gemma":[0.07942642,0.0007681212,0.43647993,0.00018796507,0.00017152521,0.00011053949,0.00003665694,0.00002135759,0.4825078,0.0000023770854,0.00016358036,0.0001237347],"about_ca_topic_score_codex":0.0002208375,"about_ca_topic_score_gemma":0.000034534096,"teacher_disagreement_score":0.48360595,"about_ca_system_score_codex":0.000059528655,"about_ca_system_score_gemma":0.000115794,"threshold_uncertainty_score":0.6864723},"labels":[],"label_agreement":null},{"id":"W2162194231","doi":"10.1182/blood-2007-02-075598","title":"Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":350,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute","funders":"National Cancer Institute; National Institutes of Health; Bernische Krebsliga; National Institute of Allergy and Infectious Diseases; Terry Fox Foundation","keywords":"Dyskeratosis congenita; Telomere; Fluorescence in situ hybridization; In situ; Dyskeratosis; In situ hybridization; Biology; Genetics; Chemistry; Hyperkeratosis; DNA; Chromosome","score_opus":0.006398810562810056,"score_gpt":0.21712560628615085,"score_spread":0.2107267957233408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162194231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99757075,0.0005192433,0.00018158795,0.00006109124,0.00016335097,0.0005551882,0.000035421624,0.00010610796,0.00080723007],"genre_scores_gemma":[0.9981491,0.000140102,0.0008874382,0.0001879577,0.00009593917,0.00001663359,0.0002695386,0.00004467781,0.00020859168],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978859,0.000038243623,0.00045748425,0.000495856,0.00060892524,0.0005135815],"domain_scores_gemma":[0.9989803,0.00008338846,0.000074906515,0.00040547477,0.00023909778,0.00021687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002578922,0.00027881665,0.00038063896,0.00025203353,0.00010625388,0.000049113856,0.00015445927,0.00012372666,0.000045583558],"category_scores_gemma":[0.00014044892,0.0002430342,0.00005665575,0.0006179533,0.00012819687,0.0002924145,0.000042465177,0.00025477284,0.0000371586],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002620986,0.0013955333,0.9309588,0.00009570229,0.00009349841,0.00015155748,0.00041884466,0.0000018129416,0.05811262,0.000009183888,0.00096862303,0.007531718],"study_design_scores_gemma":[0.003961459,0.00028330443,0.7432878,0.00022689483,0.00018089995,0.00002670948,0.00025469155,0.00003506748,0.2509106,0.000005277018,0.00046572014,0.00036155523],"about_ca_topic_score_codex":0.000066815875,"about_ca_topic_score_gemma":0.00027048335,"teacher_disagreement_score":0.19279797,"about_ca_system_score_codex":0.000064118736,"about_ca_system_score_gemma":0.00009284575,"threshold_uncertainty_score":0.99106467},"labels":[],"label_agreement":null},{"id":"W2162786541","doi":"10.1182/blood-2009-01-198374","title":"Probing the mitotic history and developmental stage of hematopoietic cells using single telomere length analysis (STELA)","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; BC Cancer Agency; National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Telomere; Biology; Haematopoiesis; Stem cell; Telomerase; CD38; CD34; Somatic cell; Cell biology; Cord blood; Molecular biology; Mitosis; Genetics; DNA; Gene","score_opus":0.027244529805451542,"score_gpt":0.23260188066854356,"score_spread":0.20535735086309204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162786541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99554914,0.0028489747,0.00008832749,0.00009444119,0.000061612714,0.00028301758,0.0000046117207,0.000040349696,0.0010295399],"genre_scores_gemma":[0.9949296,0.000057519166,0.0038900028,0.00019389328,0.000042710188,0.000002228048,0.0000045701795,0.000016113501,0.0008633479],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99869597,0.000048831702,0.0003750314,0.00029606817,0.0003095059,0.00027460212],"domain_scores_gemma":[0.9993067,0.00007701509,0.00015812037,0.00027890533,0.000064857915,0.000114437884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001841224,0.00018872273,0.00045072078,0.00023293214,0.00009784946,0.0000141705,0.000110695575,0.000074603624,0.0001042705],"category_scores_gemma":[0.000044016902,0.0001424362,0.0001247733,0.00045203912,0.00015128731,0.000076160904,0.000034538774,0.00015527569,0.00000409084],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058460668,0.0013223127,0.029782198,0.000374928,0.0007666382,0.00013153,0.006572749,0.00003378954,0.9579548,0.00009999991,0.00011060368,0.002791994],"study_design_scores_gemma":[0.005577531,0.00086353725,0.08265832,0.0006387735,0.0071673025,0.0006082835,0.008638328,0.0010468292,0.88765836,0.00005094939,0.004119679,0.00097213394],"about_ca_topic_score_codex":0.00005092242,"about_ca_topic_score_gemma":0.000016910424,"teacher_disagreement_score":0.07029647,"about_ca_system_score_codex":0.00012852676,"about_ca_system_score_gemma":0.00016353051,"threshold_uncertainty_score":0.58083797},"labels":[],"label_agreement":null},{"id":"W2163276820","doi":"10.1182/blood.v124.21.lba-2.lba-2","title":"A Randomized Trial of Long-Term Tinzaparin, a Low Molecular Weight Heparin (LMWH), Versus Warfarin for Treatment of Acute Venous Thromboembolism (VTE) in Cancer Patients - the CATCH Study","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver Coastal Health","funders":"","keywords":"Medicine; Warfarin; Pulmonary embolism; Clinical endpoint; Deep vein; Surgery; Internal medicine; Randomized controlled trial; Low molecular weight heparin; Thrombosis; Atrial fibrillation","score_opus":0.01965872591159213,"score_gpt":0.31135192050581445,"score_spread":0.2916931945942223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163276820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98764575,0.0003096494,0.00003929496,0.00018046224,0.00056668255,0.010780512,0.000029303335,0.00002138484,0.00042698937],"genre_scores_gemma":[0.99610966,0.00050899695,0.00006774292,0.00006651209,0.00015389026,0.0029417498,0.000049653576,0.00004604078,0.000055732533],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.997645,0.000252775,0.0008393475,0.00042564768,0.00044740623,0.00038980524],"domain_scores_gemma":[0.9983546,0.00032034962,0.00041977942,0.00065985933,0.00015679012,0.000088582674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005448042,0.0003197043,0.002257668,0.00014997534,0.00006040962,0.000014144455,0.00022566346,0.00009824953,0.00002784163],"category_scores_gemma":[0.0001090763,0.0002079066,0.00043041958,0.00020414314,0.00011864599,0.00003696325,0.00008921507,0.00007197645,0.000002743171],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7487676,0.17967273,0.03137023,0.00050837005,0.014827829,0.00005982141,0.009837629,0.00004568041,0.0006154922,0.00053456967,0.00014867331,0.013611359],"study_design_scores_gemma":[0.90341824,0.012431814,0.06768963,0.00012674378,0.008764631,8.4941126e-7,0.00006658295,0.000061330386,0.007146901,0.000050286326,0.000058975504,0.00018402681],"about_ca_topic_score_codex":0.0023428344,"about_ca_topic_score_gemma":0.0006297626,"teacher_disagreement_score":0.16724092,"about_ca_system_score_codex":0.00009840495,"about_ca_system_score_gemma":0.00011147759,"threshold_uncertainty_score":0.8478185},"labels":[],"label_agreement":null},{"id":"W2163320846","doi":"10.1182/blood-2005-06-2573","title":"Tandem autologous stem cell transplantation in high-risk de novo multiple myeloma: final results of the prospective and randomized IFM 99-04 protocol","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Melphalan; Medicine; Transplantation; Multiple myeloma; Regimen; Autologous stem-cell transplantation; Population; Internal medicine; Surgery; Oncology; Urology; Gastroenterology","score_opus":0.01433486973002101,"score_gpt":0.2742035298222019,"score_spread":0.2598686600921809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163320846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95326537,0.000057322206,0.000045792054,0.00016957757,0.000010568979,0.04574641,0.00008615721,0.000026635644,0.00059216825],"genre_scores_gemma":[0.97983265,0.00004613328,0.0020826175,0.000014617649,0.00004480152,0.017687062,0.000013005662,0.000014243976,0.0002648607],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984263,0.0003241703,0.00040748945,0.00026954486,0.0002848575,0.00028764262],"domain_scores_gemma":[0.99901515,0.0004335664,0.0001730677,0.00020855875,0.00007233643,0.00009732255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054461294,0.00015539162,0.00044595165,0.000089095214,0.000075806296,0.000010965897,0.00007799245,0.000100960424,0.000007644182],"category_scores_gemma":[0.00020448385,0.00009530669,0.000090412555,0.0001638457,0.00013611346,0.0000578187,0.000022255594,0.00023263693,0.0000040362215],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1521812,0.0027636155,0.82383525,0.00035608822,0.00025117415,0.00023476449,0.0029703546,0.000050731072,0.0058087916,0.000032072236,0.000017838438,0.011498137],"study_design_scores_gemma":[0.40326858,0.00027942742,0.50319415,0.00010360876,0.00016259596,0.00007520559,0.000039967377,0.0004655976,0.0922892,0.000044146756,0.00001696295,0.00006054657],"about_ca_topic_score_codex":0.00040199715,"about_ca_topic_score_gemma":0.000647711,"teacher_disagreement_score":0.32064107,"about_ca_system_score_codex":0.0000718476,"about_ca_system_score_gemma":0.00016694964,"threshold_uncertainty_score":0.38864943},"labels":[],"label_agreement":null},{"id":"W2163899134","doi":"10.1182/blood-2005-11-4570","title":"Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapy","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":253,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Chemotherapy; Oncology; Internal medicine; Cancer","score_opus":0.004992719706788912,"score_gpt":0.21355760191828127,"score_spread":0.20856488221149236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163899134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99811107,0.0007679628,0.00006193752,0.00004017739,0.00009195385,0.00015175449,0.000099609155,0.00000762841,0.00066788436],"genre_scores_gemma":[0.9990467,0.00023373977,0.0002026507,0.000052032156,0.0003194894,0.000024326619,0.000039694576,0.00002516543,0.000056202316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991377,0.000041927382,0.00020849372,0.0003199095,0.00008259612,0.00020939537],"domain_scores_gemma":[0.99966717,0.000012236681,0.00007756939,0.00016496245,0.000041754098,0.000036298592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011950627,0.00013424372,0.000141708,0.000026683998,0.00003405652,0.000016520913,0.00007866431,0.0000968729,0.000021820599],"category_scores_gemma":[0.000007661079,0.00013279261,0.00005540652,0.000058174643,0.000042990767,0.0000034523655,0.000045389905,0.000044129938,6.317919e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019135969,0.0003053726,0.73637336,0.000017008637,0.0000151139775,3.6796678e-7,0.000009835811,0.00006342828,0.26187333,0.00000160576,0.00003139769,0.0012900677],"study_design_scores_gemma":[0.0022116972,0.000064058106,0.86742854,0.000013634056,0.000023012679,0.0000023063687,0.0000106998405,0.000052965028,0.12940678,0.000015396286,0.00060179294,0.00016913953],"about_ca_topic_score_codex":0.00042549902,"about_ca_topic_score_gemma":0.00023165882,"teacher_disagreement_score":0.13246654,"about_ca_system_score_codex":0.000025796884,"about_ca_system_score_gemma":0.000031796924,"threshold_uncertainty_score":0.54151255},"labels":[],"label_agreement":null},{"id":"W2163976592","doi":"10.1182/blood-2011-02-335216","title":"Enteropathy-associated T-cell lymphoma: clinical and histological findings from the International Peripheral T-Cell Lymphoma Project","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":360,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lymphoma; Medicine; T-cell lymphoma; Peripheral T-cell lymphoma; Pathology; Enteropathy; Internal medicine; T cell; Immunology; Immune system; Disease","score_opus":0.043460758850315515,"score_gpt":0.2700865285249623,"score_spread":0.22662576967464676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163976592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881588,0.0011144173,0.00000274055,0.00038094775,0.0004305618,0.00038991077,0.00006290769,0.00007996496,0.009379752],"genre_scores_gemma":[0.99683034,0.00041097854,0.000570053,0.0011532264,0.00020075282,0.000075402124,0.00009452886,0.000023987803,0.0006406973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836034,0.00011627746,0.00044578215,0.0004941501,0.00029851592,0.00028493293],"domain_scores_gemma":[0.9991328,0.00022320737,0.00014445596,0.00029327968,0.00006934107,0.00013687664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002528546,0.00024340083,0.0003980907,0.000038044418,0.00012058377,0.00004689046,0.00022847642,0.00020200244,0.0002135029],"category_scores_gemma":[0.00014172502,0.0001502616,0.00022465493,0.00007604793,0.00019663422,0.00006186186,0.0001574747,0.00008143511,0.00006197374],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002740493,0.016960805,0.9744681,0.000006086561,0.0003228916,0.0004367256,0.0009877125,5.436911e-9,0.00027395407,0.00004092611,0.0031116533,0.003117062],"study_design_scores_gemma":[0.037034888,0.00089729886,0.95266235,0.000050631428,0.0006433174,0.0001070827,0.00023353932,0.00003325629,0.0036109122,0.000067474764,0.0044796667,0.00017960934],"about_ca_topic_score_codex":0.0008180603,"about_ca_topic_score_gemma":0.0000506729,"teacher_disagreement_score":0.03676084,"about_ca_system_score_codex":0.00015073594,"about_ca_system_score_gemma":0.00017210015,"threshold_uncertainty_score":0.61274904},"labels":[],"label_agreement":null},{"id":"W2163990748","doi":"10.1182/blood-2005-04-1399","title":"Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":382,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Diffuse large B-cell lymphoma; Comparative genomic hybridization; Biology; Gene expression profiling; Lymphoma; Gene dosage; Cancer research; Germinal center; Gene; Locus (genetics); Gene expression; Large-cell lymphoma; Chromosomal region; Genetics; B cell; Chromosome; Immunology","score_opus":0.007700153296512909,"score_gpt":0.23287804211083285,"score_spread":0.22517788881431994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163990748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969304,0.001437505,0.00007785689,0.00014659365,0.000101479876,0.00066901004,0.00034123717,0.00010633834,0.00018956764],"genre_scores_gemma":[0.99727595,0.00009920245,0.0016062915,0.00024561715,0.00024546645,0.00026083045,0.00016379592,0.000033470944,0.000069367576],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851555,0.000071529925,0.00028206786,0.00052105857,0.0002057515,0.0004040532],"domain_scores_gemma":[0.99903977,0.0001367496,0.00013531891,0.0003905154,0.000063074855,0.00023456367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010013468,0.0002773445,0.00034489395,0.00008041643,0.0001419028,0.000031668616,0.00008439357,0.00012376456,0.000028089182],"category_scores_gemma":[0.000054994376,0.0002048587,0.00009104608,0.000062561536,0.000098228535,0.00006815546,0.000070222195,0.00006083489,0.000023656961],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010986384,0.009055571,0.94555926,0.00007425121,0.00005760763,0.00009235246,0.00007238956,0.0000015567359,0.043150306,0.000010354063,0.00003376496,0.0017827415],"study_design_scores_gemma":[0.02483484,0.0004624357,0.66012055,0.000056190263,0.00025746014,0.000047133457,0.000026500504,0.00038508096,0.31323916,0.000011318268,0.0004190416,0.0001402966],"about_ca_topic_score_codex":0.000102716105,"about_ca_topic_score_gemma":0.00004183446,"teacher_disagreement_score":0.2854387,"about_ca_system_score_codex":0.000081779974,"about_ca_system_score_gemma":0.0001210549,"threshold_uncertainty_score":0.83538955},"labels":[],"label_agreement":null},{"id":"W2165207421","doi":"10.1182/blood-2008-05-154013","title":"The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Medical Research Council; National Institutes of Health; Cancer Research UK","keywords":"International Prognostic Index; Follicular lymphoma; Internal medicine; Lymphoma; Oncology; Mutation; Multivariate analysis; Medicine; Biology; Immunology; Pathology; Diffuse large B-cell lymphoma; Gene; Genetics","score_opus":0.005409346239000455,"score_gpt":0.21239328898450696,"score_spread":0.2069839427455065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165207421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99814695,0.00080240675,0.0000015084605,0.0000831291,0.000021913009,0.00080952194,0.00010603119,0.000009459107,0.000019065334],"genre_scores_gemma":[0.9991891,0.0003178711,0.0001853693,0.000010281209,0.000011830527,0.00016506878,0.00007277216,0.000013012761,0.00003469588],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884826,0.00006166891,0.00026596303,0.000206268,0.0004892716,0.00012858315],"domain_scores_gemma":[0.9990461,0.00019204256,0.00021021314,0.00026947,0.0001588261,0.0001233853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000077495366,0.00012515581,0.00028138142,0.000046411595,0.00008948211,0.0000055562173,0.00005767142,0.000031807023,0.000015425827],"category_scores_gemma":[0.00011645955,0.00007056957,0.000066843844,0.00011035498,0.00013226789,0.000054213502,0.000069558046,0.000013534194,0.0000023906857],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010112252,0.0033177487,0.99137133,0.00007849991,0.0003046561,0.000051233088,0.00024933595,0.000005084096,0.00021620184,0.000023651086,0.000071035975,0.0033000119],"study_design_scores_gemma":[0.007226294,0.0010748926,0.96706164,0.00025627718,0.00071190915,0.0000035980308,0.000012299509,0.000015713118,0.023523748,0.000022356033,0.000021828717,0.00006941783],"about_ca_topic_score_codex":0.00031577653,"about_ca_topic_score_gemma":0.000024814184,"teacher_disagreement_score":0.02430965,"about_ca_system_score_codex":0.000025602461,"about_ca_system_score_gemma":0.000038841998,"threshold_uncertainty_score":0.28777438},"labels":[],"label_agreement":null},{"id":"W2165208287","doi":"10.1182/blood-2009-04-214718","title":"Acute T-cell leukemias remain dependent on Notch signaling despite PTEN and INK4A/ARF loss","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and Retrovirus Studies","field":"Immunology and Microbiology","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; BC Cancer Agency","funders":"National Cancer Institute","keywords":"PTEN; Tensin; Cancer research; Notch signaling pathway; Biology; Signal transduction; Leukemia; PI3K/AKT/mTOR pathway; Immunology; Cell biology","score_opus":0.0076599048255737035,"score_gpt":0.21073167418295605,"score_spread":0.20307176935738233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165208287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98832333,0.0055985176,0.000033138054,0.0003038918,0.00023420963,0.00016232832,0.000022536267,0.00008610536,0.00523592],"genre_scores_gemma":[0.9939268,0.000634706,0.00011295527,0.0006735093,0.000066658715,0.0000063126754,0.000018859726,0.000014029291,0.004546167],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99885833,0.000084675514,0.00022860171,0.00036710044,0.000047361325,0.00041393936],"domain_scores_gemma":[0.9995359,0.00008824301,0.00008805744,0.00022077136,0.000034525834,0.000032500928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015803592,0.0002273977,0.0003019438,0.00008360382,0.00030839656,0.000019927114,0.00015481078,0.00024909925,0.0000469252],"category_scores_gemma":[0.000020389272,0.00017733227,0.0000771086,0.00007943801,0.00011886053,0.00004308225,0.00007992649,0.00034477725,0.00030796733],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015096052,0.0004180955,0.0019429644,0.000013182527,0.00027609122,0.00011403247,0.0005796198,0.000004900588,0.9929895,0.00025576577,0.0006847256,0.0025702107],"study_design_scores_gemma":[0.0050685266,0.00084382494,0.0026041989,0.000053587064,0.0003279269,0.00018602236,0.00016074322,8.190482e-7,0.984461,0.00039605444,0.00555099,0.00034629653],"about_ca_topic_score_codex":0.000029303734,"about_ca_topic_score_gemma":0.000015422724,"teacher_disagreement_score":0.008528441,"about_ca_system_score_codex":0.00002504122,"about_ca_system_score_gemma":0.000029719908,"threshold_uncertainty_score":0.72314},"labels":[],"label_agreement":null},{"id":"W2165410879","doi":"10.1182/blood.v99.9.3102","title":"How we diagnose and treat deep vein thrombosis","year":2002,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":178,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Medicine; Venography; Deep vein; Thrombosis; Pre- and post-test probability; Thrombophilia; Low molecular weight heparin; Venous thrombosis; Heparin; Radiology; Surgery; D-dimer; Vein; Clinical trial; Anticoagulant; Internal medicine","score_opus":0.05608509348913179,"score_gpt":0.30643798012677587,"score_spread":0.2503528866376441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165410879","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000048481783,0.99109066,0.000004161882,0.00091049285,0.00014902894,0.0015864775,0.000026679701,0.000115435316,0.006068564],"genre_scores_gemma":[0.00005905156,0.99580073,0.00024280175,0.0001663688,0.00052624353,0.0004582388,0.00007971548,0.000118703625,0.002548132],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980929,0.00008346195,0.00038926114,0.00066979195,0.00031196236,0.0004526133],"domain_scores_gemma":[0.9986065,0.00016961595,0.00021879857,0.0006994831,0.000035652745,0.00026997048],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000110736226,0.0005990629,0.0030053514,0.00025372842,0.0000995502,0.00013924736,0.00017219163,0.00034915016,0.00026900784],"category_scores_gemma":[0.00007366108,0.0004457721,0.000518313,0.00026694697,0.0000826776,0.00007929955,0.00016922875,0.00031940264,0.00015152579],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[5.9480215e-7,0.0020128982,0.000027882905,0.022537436,0.0010156792,0.0001947099,0.00010526151,9.047797e-9,3.0223154e-7,0.00022670676,0.01342938,0.96044916],"study_design_scores_gemma":[0.0011725064,0.00035639465,0.00017145935,0.012179323,0.017392337,0.00010798032,0.000037561767,7.4895524e-7,0.0000037659008,0.000021317954,0.96815664,0.00039997871],"about_ca_topic_score_codex":0.000022122495,"about_ca_topic_score_gemma":0.000013815204,"teacher_disagreement_score":0.96004915,"about_ca_system_score_codex":0.000055175184,"about_ca_system_score_gemma":0.000042257052,"threshold_uncertainty_score":0.99979943},"labels":[],"label_agreement":null},{"id":"W2165603851","doi":"10.1182/blood-2009-09-240440","title":"Deregulation of the telomerase reverse transcriptase (TERT) gene by chromosomal translocations in B-cell malignancies","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Telomerase; Biology; Chromosomal translocation; Locus (genetics); Telomerase reverse transcriptase; Mantle cell lymphoma; Chronic lymphocytic leukemia; Gene; Cancer research; Molecular biology; Genetics; Leukemia; Lymphoma; Immunology","score_opus":0.006643402430887123,"score_gpt":0.2081124994808658,"score_spread":0.20146909704997867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165603851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99719226,0.00052952784,0.00005864682,0.0010557814,0.00018229031,0.0004561273,0.00009589646,0.000032992426,0.00039649504],"genre_scores_gemma":[0.99783987,0.00006624628,0.0010893442,0.0003000626,0.0000675378,0.00002778037,0.00005334371,0.000021929663,0.00053387193],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998819,0.00004732812,0.0003804289,0.00024831112,0.0002629251,0.00024199605],"domain_scores_gemma":[0.9992158,0.00003621803,0.000087161316,0.00047814837,0.00007823775,0.00010445864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013885938,0.00016178387,0.0002498961,0.00009918564,0.000077180426,0.000008984012,0.00016273659,0.00012899052,0.00016632194],"category_scores_gemma":[0.000046944755,0.00012491722,0.0001230248,0.00040716236,0.00017107074,0.000097006225,0.000010276438,0.00026209428,0.000008301101],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003747722,0.0012071833,0.036857657,0.00011071715,0.000016720758,0.000014736922,0.0009867582,0.0000022208121,0.9594546,0.000041609113,0.0004851611,0.0007851554],"study_design_scores_gemma":[0.00359991,0.000075880445,0.091918536,0.00007373812,0.00015536844,0.00006713604,0.00013226582,0.0000420414,0.90196216,0.000027952485,0.0018086031,0.0001364093],"about_ca_topic_score_codex":0.00022917152,"about_ca_topic_score_gemma":0.00021176098,"teacher_disagreement_score":0.057492442,"about_ca_system_score_codex":0.000012069443,"about_ca_system_score_gemma":0.00015115557,"threshold_uncertainty_score":0.5093976},"labels":[],"label_agreement":null},{"id":"W2165615022","doi":"10.1182/blood-2002-03-0823","title":"Therapeutic factor VIII levels and negligible toxicity in mouse and dog models of hemophilia A following gene therapy with high-capacity adenoviral vectors","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":139,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Genetic enhancement; Medicine; Immunology; Factor IX; Antibody; Clotting factor; Proinflammatory cytokine; In vivo; Cytokine; Immune system; Pharmacology; Internal medicine; Inflammation; Biology; Gene","score_opus":0.03236398465264031,"score_gpt":0.2678900686769251,"score_spread":0.2355260840242848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165615022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964184,0.0029710424,0.00014776127,0.000022540291,0.000015666248,0.00032947332,0.00004189171,0.000009418254,0.00004378828],"genre_scores_gemma":[0.99884826,0.00042430128,0.00049882376,0.00009200443,0.000021934915,0.000020837377,0.0000061155456,0.00003425043,0.000053462958],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99874896,0.00015215506,0.00018892963,0.00039503578,0.00019696476,0.00031796462],"domain_scores_gemma":[0.9994744,0.000019186029,0.00005657822,0.0003162614,0.000041394407,0.00009218615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020826496,0.00021026548,0.00025980722,0.000080976395,0.000060307026,0.000024714232,0.00012634839,0.00014599976,0.000008553698],"category_scores_gemma":[0.000014555656,0.00017341525,0.000052675074,0.00014006911,0.00011889835,0.000013638263,0.00003783133,0.00012636301,3.1132365e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004218856,0.00027903676,0.01595652,0.000014967925,0.00017683805,0.000004492236,0.00018152404,0.00006824543,0.98246306,0.000046481135,6.7252984e-7,0.0003862948],"study_design_scores_gemma":[0.0039811553,0.0023675526,0.00491112,0.000010152296,0.0000143688985,0.000010539612,0.000026398462,0.000027171849,0.98804337,0.00038359794,0.000015293686,0.00020929286],"about_ca_topic_score_codex":0.00006046936,"about_ca_topic_score_gemma":0.00013230115,"teacher_disagreement_score":0.011045399,"about_ca_system_score_codex":0.000010588345,"about_ca_system_score_gemma":0.00008964959,"threshold_uncertainty_score":0.70716685},"labels":[],"label_agreement":null},{"id":"W2165896516","doi":"10.1182/blood-2015-05-646398","title":"MLL leukemia induction by genome editing of human CD34+ hematopoietic cells","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"National Cancer Institute; European Hematology Association","keywords":"Haematopoiesis; Leukemia; Genome editing; Biology; CD34; Genome; Human genome; Cancer research; Genetics; Gene; Computational biology; Immunology; Stem cell","score_opus":0.00969154035577284,"score_gpt":0.2603412472414822,"score_spread":0.25064970688570937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165896516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99620646,0.0010724067,0.0012543673,0.000010665108,0.00013974472,0.00006605108,0.000010189792,0.000011598543,0.0012285176],"genre_scores_gemma":[0.9988124,0.000020271813,0.00037175266,0.000016047472,0.0003714207,0.0000055155847,0.000066888904,0.000017081427,0.00031864867],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994306,0.0000121535095,0.00015582156,0.00016540806,0.00009352403,0.00014247147],"domain_scores_gemma":[0.99963194,0.0000019746997,0.000051427403,0.00019266746,0.000049029768,0.00007293217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010238338,0.000090873786,0.00009974438,0.00002243894,0.000023896602,0.000007404321,0.00009543119,0.00009641341,0.0000073537285],"category_scores_gemma":[0.000016610682,0.000096794836,0.000041077226,0.000046268735,0.000026019145,0.0000017432873,0.000051890736,0.000056033256,0.000005084161],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000001966372,0.000044250897,0.0002181467,0.000023663295,0.000022169499,0.0000011337739,0.000092315786,0.00016634646,0.99803364,0.000006854098,0.0013196105,0.00006991021],"study_design_scores_gemma":[0.00058685517,0.00016022324,0.0002189619,0.0000074985073,0.00002697428,0.000012850944,0.00014971862,0.000007543723,0.9939618,0.000026077058,0.0047362163,0.00010524802],"about_ca_topic_score_codex":0.000020551215,"about_ca_topic_score_gemma":0.0000039400575,"teacher_disagreement_score":0.0040718,"about_ca_system_score_codex":0.000008971796,"about_ca_system_score_gemma":0.000030430938,"threshold_uncertainty_score":0.3947179},"labels":[],"label_agreement":null},{"id":"W2165991538","doi":"10.1182/blood-2013-07-518423","title":"The ASH Choosing Wisely® campaign: five hematologic tests and treatments to question","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":168,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; McMaster University; University of Toronto; St. Michael's Hospital","funders":"ABIM Foundation","keywords":"Medicine; Adverse effect; Intensive care medicine; Medical physics; Family medicine; Surgery; Internal medicine","score_opus":0.0098207877275177,"score_gpt":0.26496303199758536,"score_spread":0.25514224427006765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165991538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99365187,0.0006664361,0.00001433411,0.002418994,0.00006759672,0.00095008494,0.0000010497987,0.000056722645,0.0021729306],"genre_scores_gemma":[0.99751526,0.0002918207,0.0006424823,0.00067770033,0.00006361407,0.00021160717,0.000004261072,0.000011525203,0.00058174547],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99933696,0.000027971866,0.00012595003,0.00018320863,0.000120985074,0.00020495136],"domain_scores_gemma":[0.9995244,0.00006235323,0.000038837028,0.00020188793,0.00005141245,0.000121121855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009395422,0.00010706134,0.00020799699,0.000034928387,0.0001580385,0.000058396017,0.000048331807,0.000036738023,0.000031473686],"category_scores_gemma":[0.000091515205,0.00006502488,0.000029185687,0.000078772566,0.000028418302,0.00005045411,0.000053946093,0.000047968722,0.00016621653],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009338469,0.013195758,0.711606,0.0006616175,0.0027896827,0.0003539736,0.00855869,0.000023920042,0.019675504,0.015801938,0.05936979,0.16786973],"study_design_scores_gemma":[0.001569251,0.00061085745,0.9910532,0.00016841672,0.0004448397,0.000041328818,0.00053095043,0.000018170755,0.002553258,0.0010081091,0.0018794456,0.00012217739],"about_ca_topic_score_codex":0.00024024956,"about_ca_topic_score_gemma":0.000036278292,"teacher_disagreement_score":0.27944717,"about_ca_system_score_codex":0.000023455394,"about_ca_system_score_gemma":0.000012581375,"threshold_uncertainty_score":0.26516375},"labels":[],"label_agreement":null},{"id":"W2166180289","doi":"10.1182/blood-2006-01-010199","title":"Unique effects of Stat3 on the early phase of hematopoietic stem cell regeneration","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Stem cell; Haematopoiesis; Regeneration (biology); Hematopoietic stem cell; Biology; Immunology; Cancer research; Cell biology","score_opus":0.013710951996544651,"score_gpt":0.2515819168775406,"score_spread":0.23787096488099596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166180289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962562,0.00013251026,0.00042696673,0.00015003579,0.000051742696,0.00026185872,0.000009449515,0.000014322812,0.0026969195],"genre_scores_gemma":[0.9993059,0.0000061186156,0.00008644844,0.00004257503,0.000068847636,0.000012723421,0.000009165153,0.000009712565,0.00045851726],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994971,0.000038394184,0.00019062909,0.00008025455,0.00012606637,0.000067545385],"domain_scores_gemma":[0.99947184,0.00013688146,0.00010591221,0.0001937181,0.000071776056,0.0000198801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000073848925,0.000062604864,0.00013514057,0.000045673583,0.00002549667,0.000004219239,0.000033047545,0.000029743276,0.000027963093],"category_scores_gemma":[0.000012392266,0.00004113959,0.00006477536,0.00008718274,0.000022656075,0.000018543235,0.000006010342,0.00007785757,0.0000053838758],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040701165,0.0015714553,0.00020338412,0.00015649377,0.000020459169,0.000008048597,0.00021752858,0.000014277712,0.9940321,0.0029764948,0.0006282038,0.00013085312],"study_design_scores_gemma":[0.0019838724,0.0012292669,0.0004452927,0.00019599254,0.0001155276,0.0000083278655,0.000035067722,0.00004528198,0.9955809,0.000097034455,0.00022843186,0.000035000987],"about_ca_topic_score_codex":0.00009728527,"about_ca_topic_score_gemma":0.0000043475575,"teacher_disagreement_score":0.003049698,"about_ca_system_score_codex":0.000006778289,"about_ca_system_score_gemma":0.000031448715,"threshold_uncertainty_score":0.16776237},"labels":[],"label_agreement":null},{"id":"W2167134605","doi":"10.1182/blood-2002-03-0965","title":"How we manage venous thromboembolism during pregnancy","year":2002,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Medicine; Pregnancy; Warfarin; Venous thromboembolism; Low molecular weight heparin; Heparin; Childbirth; Intensive care medicine; Thrombosis; Anticoagulant; Dosing; Obstetrics; Surgery; Internal medicine","score_opus":0.04469977087205912,"score_gpt":0.2863819156343926,"score_spread":0.24168214476233346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167134605","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000038102844,0.97833604,0.0000041407307,0.00043151077,0.00050612935,0.0029949886,0.00003991076,0.00033634555,0.017312825],"genre_scores_gemma":[0.00009665356,0.98575723,0.00024371332,0.000051898845,0.00093651976,0.0006060637,0.00009469559,0.0002656668,0.011947538],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99672997,0.00009869757,0.0006745728,0.0010116604,0.0005910124,0.00089411007],"domain_scores_gemma":[0.997674,0.000053346816,0.00046449507,0.0014423084,0.000056614175,0.00030926763],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000078125806,0.0009124048,0.0048826984,0.00047714013,0.0002059632,0.00018209078,0.00047538622,0.000511248,0.0003392892],"category_scores_gemma":[0.000048086233,0.0007547896,0.0011497069,0.00049965025,0.000079098245,0.00013427706,0.00034417937,0.0006809788,0.00056424306],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000012516342,0.0051138722,0.000002488431,0.12613615,0.0029321837,0.0029707286,0.00022093437,6.233233e-8,0.0000012257511,0.000568756,0.0026958105,0.8593565],"study_design_scores_gemma":[0.00133567,0.00025664864,0.00010495709,0.08019304,0.016465543,0.0006193211,0.00003038268,2.9038924e-7,0.000007556621,0.00003928224,0.90030384,0.0006434342],"about_ca_topic_score_codex":0.000012397048,"about_ca_topic_score_gemma":0.0000038457806,"teacher_disagreement_score":0.89760804,"about_ca_system_score_codex":0.00012710855,"about_ca_system_score_gemma":0.00007311909,"threshold_uncertainty_score":0.9994903},"labels":[],"label_agreement":null},{"id":"W2167673584","doi":"10.1182/blood-2004-03-1046","title":"Quantitative analysis of nucleoside transporter and metabolism gene expression in chronic lymphocytic leukemia (CLL): identification of fludarabine-sensitive and -insensitive populations","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"Fondation de France; Ligue Contre le Cancer; Fondation pour la Recherche Médicale; Alberta Cancer Foundation","keywords":"Chronic lymphocytic leukemia; Fludarabine; Biology; Leukemia; Gene; Gene expression; Nucleoside transporter; Genetics; Cancer research; Transporter; Chemotherapy","score_opus":0.025238310660422317,"score_gpt":0.30608211591879825,"score_spread":0.28084380525837593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167673584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970358,0.0013893148,0.0008847211,0.000044710196,0.000020388348,0.00044131998,0.000091470254,0.00001414285,0.000078137135],"genre_scores_gemma":[0.9966793,0.00040170795,0.0027053636,0.000016085536,0.00002145189,0.000014272074,0.00011284222,0.0000200465,0.000028918295],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99829185,0.00007173941,0.00064330164,0.00039989033,0.00036872612,0.00022448244],"domain_scores_gemma":[0.99877846,0.000113860544,0.00031345306,0.00038679602,0.0002995844,0.0001078367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033548032,0.00017003488,0.00069620786,0.0007073093,0.00006701317,0.000014006384,0.000063337226,0.00011997981,0.0000071731333],"category_scores_gemma":[0.00021869568,0.00015676748,0.000121052704,0.0006802566,0.00034868467,0.00016330229,0.000040468574,0.00011532967,0.0000016869644],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038974543,0.00017539057,0.0013073125,0.00022805811,0.00093611545,0.00015518416,0.0040728804,0.003767478,0.9876166,0.000998531,0.0000018491879,0.0003508745],"study_design_scores_gemma":[0.02205171,0.0001301726,0.39020747,0.00026544358,0.0027768577,0.000058562084,0.00042330634,0.021031134,0.56270844,0.0002094856,0.0000013617978,0.0001360856],"about_ca_topic_score_codex":0.00386526,"about_ca_topic_score_gemma":0.00085321843,"teacher_disagreement_score":0.42490816,"about_ca_system_score_codex":0.005120114,"about_ca_system_score_gemma":0.0040855817,"threshold_uncertainty_score":0.99869907},"labels":[],"label_agreement":null},{"id":"W2167966317","doi":"10.1182/blood-2011-10-387522","title":"Regulation of acute graft-versus-host disease by microRNA-155","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute; U.S. Public Health Service; National Institutes of Health","keywords":"miR-155; microRNA; Graft-versus-host disease; Haematopoiesis; Immunology; Downregulation and upregulation; Hematopoietic stem cell transplantation; Stem cell; Disease; Cancer research; Medicine; Biology; Internal medicine; Gene; Cell biology","score_opus":0.006960417513068713,"score_gpt":0.23462648247829668,"score_spread":0.22766606496522795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167966317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963129,0.002557473,0.00027591307,0.000060034323,0.00014812713,0.0001580264,0.0001859251,0.0000129379705,0.00028867094],"genre_scores_gemma":[0.99813664,0.00006746934,0.00039306426,0.000033144184,0.00022787666,0.000012191952,0.00079281046,0.00002250242,0.00031428554],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992739,0.000038283415,0.00017271338,0.00018522827,0.00011953023,0.00021035134],"domain_scores_gemma":[0.99930274,0.000006035069,0.000112351925,0.00035028835,0.000060634902,0.00016794656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008123042,0.000120455654,0.00009390117,0.000027602644,0.00003837525,0.000007914052,0.00011018451,0.000091379865,0.000048923197],"category_scores_gemma":[0.000030222544,0.00012458794,0.00009713128,0.0000681746,0.0000568928,0.000009112902,0.00006346696,0.000030595533,0.000016423917],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002011322,0.00031512254,0.011025603,0.00002075209,0.00016874589,4.4550455e-7,0.000013950974,0.0000015477298,0.984198,0.000065314336,0.003905672,0.000083756975],"study_design_scores_gemma":[0.0015603105,0.00005852244,0.104694754,0.000010019492,0.0003357374,0.0000034897291,0.0000056070476,0.000005226957,0.88307303,0.000016725437,0.010080963,0.00015562178],"about_ca_topic_score_codex":0.000003119952,"about_ca_topic_score_gemma":9.269335e-7,"teacher_disagreement_score":0.10112493,"about_ca_system_score_codex":0.000008513866,"about_ca_system_score_gemma":0.000036006753,"threshold_uncertainty_score":0.5080549},"labels":[],"label_agreement":null},{"id":"W2168295368","doi":"10.1182/blood-2009-08-239558","title":"Anucleate platelets generate progeny","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":184,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; Materials Research Science and Engineering Center, Harvard University; Deutsche Forschungsgemeinschaft; Division of Materials Research; ARUP Institute for Clinical and Experimental Pathology; University of Utah; American Heart Association; Pfizer; National Institutes of Health; National Science Foundation","keywords":"Thrombopoiesis; Platelet; Cell biology; Megakaryocyte; Megakaryocytopoiesis; Cell division; Biology; Nucleus; Chemistry; Cell; Immunology; Biochemistry; Stem cell; Haematopoiesis","score_opus":0.009398734786811382,"score_gpt":0.23871245485466808,"score_spread":0.2293137200678567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168295368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98913276,0.0001248997,0.0000013431896,0.0003135433,0.00012681159,0.00021971232,0.000007644724,0.00008937658,0.009983915],"genre_scores_gemma":[0.997072,0.000041889038,0.00134462,0.00027747545,0.000109001245,0.000016773492,0.000031995707,0.000022582954,0.001083686],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99939185,0.000005121787,0.00010438898,0.00017993512,0.00010843406,0.00021024232],"domain_scores_gemma":[0.9995933,0.000006004263,0.000027747277,0.00021730752,0.00003096233,0.00012467623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003822021,0.000109232315,0.00017326022,0.000039141643,0.000055478187,0.00001591522,0.000045226865,0.00008137785,0.00021756788],"category_scores_gemma":[0.000014402472,0.000084532134,0.000055591277,0.00007418577,0.000027797123,0.000038327962,0.000017835257,0.00015206313,0.00037896904],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015958346,0.0049369107,0.15181077,0.00007014742,0.0008472082,0.009421702,0.0002564726,7.0818083e-7,0.80591106,0.00065913773,0.0017285352,0.024197733],"study_design_scores_gemma":[0.022073528,0.0008891482,0.12946479,0.000046725163,0.00087840285,0.0056101624,0.000024050418,0.00014631123,0.76299745,0.0007702048,0.07657856,0.0005206584],"about_ca_topic_score_codex":0.000020017342,"about_ca_topic_score_gemma":0.0000314904,"teacher_disagreement_score":0.07485002,"about_ca_system_score_codex":0.0000032363598,"about_ca_system_score_gemma":0.0000345765,"threshold_uncertainty_score":0.4871007},"labels":[],"label_agreement":null},{"id":"W2169210165","doi":"10.1182/blood-2012-09-451872","title":"A randomized phase 3 trial of thalidomide and prednisone as maintenance therapy after ASCT in patients with MM with a quality-of-life assessment: the National Cancer Institute of Canada Clinicals Trials Group Myeloma 10 Trial","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":144,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research; Juravinski Cancer Centre; BC Cancer Agency; Dr. H. Bliss Murphy Cancer Centre; Hôpital de l'Enfant-Jésus; McGill University; Hôpital Maisonneuve-Rosemont; CancerCare Manitoba; Saint John Regional Hospital; London Health Sciences Centre; Queen Elizabeth II Health Sciences Centre","funders":"National Cancer Institute","keywords":"Medicine; Prednisone; Thalidomide; Hazard ratio; Surgery; Multiple myeloma; Internal medicine; Maintenance therapy; Transplantation; Randomized controlled trial; Autologous stem-cell transplantation; Clinical endpoint; Confidence interval; Chemotherapy","score_opus":0.06801261865729823,"score_gpt":0.4037691003261362,"score_spread":0.335756481668838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169210165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98977345,0.0002349904,0.00001418359,0.0004333643,0.000083620565,0.008994492,0.00022917092,0.0000043322075,0.00023240403],"genre_scores_gemma":[0.9967808,0.00016480732,0.00047196794,0.00012342267,0.00011590602,0.0021753858,0.000048908565,0.000016346274,0.000102436075],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9955528,0.0012160421,0.0014425684,0.00028201946,0.0012420504,0.00026452547],"domain_scores_gemma":[0.9957648,0.0023232456,0.00094835623,0.0002525659,0.00053694047,0.00017409612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003306558,0.000210697,0.0017955664,0.00010066051,0.000036447193,0.000015138934,0.00011475122,0.00007414498,0.00024307115],"category_scores_gemma":[0.0038861432,0.00009865539,0.00015654524,0.00020366971,0.00037912925,0.00012843536,0.00002823732,0.00015433051,3.340596e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9622773,0.005075852,0.028755946,0.00007294097,0.0020183264,0.0000063532916,0.00010440053,0.0000016851274,0.000080350634,0.000063365755,0.000056045443,0.0014874369],"study_design_scores_gemma":[0.91169685,0.0047480497,0.08253253,0.00023253442,0.00021296303,8.6262565e-7,0.000029369272,0.000021364198,0.00030994622,0.000064939515,0.00005700263,0.00009360505],"about_ca_topic_score_codex":0.095783696,"about_ca_topic_score_gemma":0.027970476,"teacher_disagreement_score":0.06781322,"about_ca_system_score_codex":0.00006390342,"about_ca_system_score_gemma":0.0026063065,"threshold_uncertainty_score":0.98976654},"labels":[],"label_agreement":null},{"id":"W2169259508","doi":"10.1182/blood-2005-04-1356","title":"Requirement of VPS33B, a member of the Sec1/Munc18 protein family, in megakaryocyte and platelet  -granule biogenesis","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; SickKids Foundation","funders":"","keywords":"Platelet; Granule (geology); Cell biology; Hermansky–Pudlak syndrome; Biogenesis; Biology; Thrombopoiesis; Dense granule; Endosome; Secretion; Megakaryocyte; Chemistry; Platelet activation; Intracellular; Biochemistry; Internal medicine; Immunology; Gene; Medicine","score_opus":0.023037030778425338,"score_gpt":0.2488249416995025,"score_spread":0.22578791092107717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169259508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966386,0.001001314,0.000004582244,0.0004284055,0.00004440068,0.00045490699,0.000012433924,0.000011123144,0.001404229],"genre_scores_gemma":[0.9983042,0.0001301335,0.00080770865,0.00031842344,0.00006816051,0.000026935484,0.000005099082,0.000010645668,0.00032869307],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992037,0.000053436394,0.00029630822,0.00016002195,0.00015298446,0.00013353782],"domain_scores_gemma":[0.9995236,0.000023019797,0.00010490586,0.0002606667,0.00004840731,0.000039427643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015733765,0.000099258534,0.00027964663,0.00006445761,0.000021161208,0.0000015114239,0.000056882676,0.00008224138,0.000078993755],"category_scores_gemma":[0.000027318438,0.000066184715,0.0000825617,0.00019016449,0.00010010713,0.000028502958,0.000052094154,0.00008431346,0.0000045553456],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025092746,0.0006235391,0.013961101,0.00020868612,0.00008562394,0.000005608055,0.00036522723,0.000006909843,0.98229516,0.00010355164,0.00026070286,0.001832974],"study_design_scores_gemma":[0.0058810622,0.00039734066,0.09140498,0.00023438931,0.000110683264,0.00003806753,0.00014877356,0.00006767684,0.89546555,0.000056138742,0.0060998285,0.000095512],"about_ca_topic_score_codex":0.00013878047,"about_ca_topic_score_gemma":0.00009708172,"teacher_disagreement_score":0.0868296,"about_ca_system_score_codex":0.000012790798,"about_ca_system_score_gemma":0.000054151078,"threshold_uncertainty_score":0.26989344},"labels":[],"label_agreement":null},{"id":"W2169478074","doi":"10.1182/blood-2005-10-4222","title":"Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":271,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Genentech; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"CHOP; Vincristine; Internal medicine; Rituximab; International Prognostic Index; Medicine; Lymphoma; Diffuse large B-cell lymphoma; Gastroenterology; Cyclophosphamide; Oncology; Chemotherapy","score_opus":0.009727508956446652,"score_gpt":0.24144774217015924,"score_spread":0.2317202332137126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169478074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915492,0.00021307873,0.00000934616,0.00003298858,0.000008594304,0.006613848,0.000014555906,0.000050571176,0.0015078395],"genre_scores_gemma":[0.99598426,0.0000030661724,0.00057647796,0.000006478455,0.00003398094,0.0024819914,0.000011792903,0.000025148265,0.00087679335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987073,0.00007247149,0.00030612884,0.0003926823,0.00030084632,0.00022055657],"domain_scores_gemma":[0.9993012,0.00010235233,0.00016408079,0.00024771196,0.0001234602,0.00006120085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007462024,0.00021553722,0.0004328366,0.00010717754,0.000039525494,0.000010079081,0.000051257324,0.000060964292,0.00003222941],"category_scores_gemma":[0.00007658575,0.00012429444,0.000041211533,0.00043288234,0.00006502501,0.00006564861,0.000020112346,0.000094697556,0.000008573498],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016560144,0.0355096,0.95374113,0.000054970948,0.00014476349,0.0007662411,0.000813835,0.0000063812745,0.0070172613,0.000017323815,0.000025817213,0.0002466826],"study_design_scores_gemma":[0.030765042,0.0056017307,0.8549272,0.0007789849,0.00033349876,0.00002342765,0.0005500345,0.000008563446,0.10685464,0.000021687105,0.000009107979,0.0001260914],"about_ca_topic_score_codex":0.0007348634,"about_ca_topic_score_gemma":0.0003524537,"teacher_disagreement_score":0.09983738,"about_ca_system_score_codex":0.00011603204,"about_ca_system_score_gemma":0.0001590817,"threshold_uncertainty_score":0.50685805},"labels":[],"label_agreement":null},{"id":"W2169530872","doi":"10.1182/blood-2003-03-0786","title":"ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of 6 cases","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":299,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Cancer research; Ibrutinib; Clathrin; Anaplastic lymphoma kinase; Crizotinib; Medicine; Chemistry; Molecular biology; Pathology; Biology; Leukemia; Chronic lymphocytic leukemia; Internal medicine; Lung cancer; Endocytosis; Receptor","score_opus":0.011808442146278578,"score_gpt":0.2414543560233285,"score_spread":0.2296459138770499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169530872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95979726,0.0008554975,0.0000041170147,0.00011576847,0.000046907386,0.0004638748,0.00011888098,0.000046975983,0.03855073],"genre_scores_gemma":[0.99676186,0.0001348893,0.00027941985,0.00038892508,0.00002597372,0.000060507886,0.00013130641,0.000034642148,0.0021824841],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99850225,0.000059100308,0.00034965438,0.00035930777,0.00039900927,0.00033065313],"domain_scores_gemma":[0.9988236,0.00011769083,0.00026645846,0.00044557103,0.00019559445,0.00015108129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015767346,0.00022537808,0.00045954273,0.00007372274,0.00007687176,0.000013163514,0.00004830387,0.000103611164,0.00012028576],"category_scores_gemma":[0.00017412254,0.00016642125,0.00013473185,0.00021838276,0.00004911762,0.00005708144,0.000023307271,0.000043310483,0.000023035313],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026436948,0.12073424,0.8213062,0.00009828308,0.0030519448,0.046697043,0.0011673959,1.4376462e-7,0.0016387717,0.00038188073,0.004045176,0.00061454205],"study_design_scores_gemma":[0.17024009,0.0037345083,0.39249393,0.0008685693,0.004740124,0.0064717145,0.00067164324,0.0000034989428,0.40758032,0.00004526912,0.012602254,0.0005480662],"about_ca_topic_score_codex":0.00016943796,"about_ca_topic_score_gemma":0.00004791967,"teacher_disagreement_score":0.42881227,"about_ca_system_score_codex":0.000119774326,"about_ca_system_score_gemma":0.00016972315,"threshold_uncertainty_score":0.67864615},"labels":[],"label_agreement":null},{"id":"W2169676118","doi":"10.1182/blood-2005-04-1510","title":"Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"CIITA; Biology; Diffuse large B-cell lymphoma; Locus (genetics); Gene; Major histocompatibility complex; Cancer research; Genetics; MHC class II; Lymphoma; Immunology","score_opus":0.006803894941725787,"score_gpt":0.2315509391024203,"score_spread":0.22474704416069452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169676118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964648,0.00048335848,0.00002208676,0.0013867909,0.000043767657,0.00104612,0.00020060003,0.000042983957,0.00030950675],"genre_scores_gemma":[0.997805,0.000034418023,0.001176712,0.0004199496,0.000056481527,0.00018479637,0.000074236385,0.000027143778,0.00022123971],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833643,0.000058715763,0.00052893505,0.0004668406,0.00025076102,0.0003583153],"domain_scores_gemma":[0.99889416,0.00008362075,0.00013589652,0.00056162657,0.00009945285,0.00022522322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014736566,0.00025568242,0.00060076034,0.0001648732,0.00013110427,0.000012025204,0.00010152684,0.00014727587,0.00007951141],"category_scores_gemma":[0.00003815067,0.00021643448,0.00011829005,0.00025040744,0.000060960218,0.000090277135,0.00018901742,0.00007650695,0.000039691808],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067322125,0.08101502,0.52855814,0.00030981723,0.00014044179,0.0004206935,0.0032260914,0.0000032794208,0.3820959,0.000051069448,0.0014900756,0.0020162773],"study_design_scores_gemma":[0.04335178,0.000499938,0.55125517,0.00023207245,0.00016158767,0.000041768028,0.000028066584,0.0001457283,0.40293851,0.0000035380617,0.0011860951,0.0001557401],"about_ca_topic_score_codex":0.00036170302,"about_ca_topic_score_gemma":0.0002917566,"teacher_disagreement_score":0.08051508,"about_ca_system_score_codex":0.00022319466,"about_ca_system_score_gemma":0.00008253237,"threshold_uncertainty_score":0.88259417},"labels":[],"label_agreement":null},{"id":"W2170173758","doi":"10.1182/blood-2002-01-0048","title":"A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":334,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Hospital; Queen Elizabeth II Health Sciences Centre; McMaster University; London Health Sciences Centre; Vancouver Hospital and Health Sciences Centre; University of Ottawa; Dalhousie University; Western University","funders":"","keywords":"Medicine; Busulfan; Hazard ratio; Bone marrow; Transplantation; Cumulative incidence; Cyclophosphamide; Myeloid leukemia; Internal medicine; Gastroenterology; Surgery; Graft-versus-host disease; Leukemia; Myeloid; Immunology; Chemotherapy; Confidence interval","score_opus":0.033450130894376644,"score_gpt":0.28155308183762306,"score_spread":0.24810295094324641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170173758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959604,0.0020224128,0.00036197287,0.000068953654,0.00006585873,0.0013326315,0.000036481193,0.000016078915,0.00013522222],"genre_scores_gemma":[0.99169046,0.0005597869,0.0074914056,0.000027127659,0.000018576053,0.00006479641,0.000031232586,0.000023117367,0.00009351065],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983905,0.00008791869,0.00084006815,0.00022435548,0.00022884479,0.0002283145],"domain_scores_gemma":[0.99918336,0.00029884579,0.00020317262,0.00014910202,0.000094706746,0.000070835675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040962955,0.00016273324,0.0010713862,0.00017401995,0.000020093847,0.0000055202177,0.000050682916,0.00011347719,0.00007206094],"category_scores_gemma":[0.00008598462,0.00014269292,0.00012993782,0.00014660739,0.00009906056,0.000045168425,0.0000065071026,0.00007773846,8.7894983e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027317252,0.0027938506,0.32895783,0.003375695,0.0004162339,0.000033563872,0.013352204,0.000027157106,0.6234771,0.000023683468,0.0000077265,0.00021773139],"study_design_scores_gemma":[0.48427108,0.00039377803,0.014218624,0.0017788401,0.0016375817,0.0000933868,0.00050937245,0.0033411267,0.49355277,0.000015581274,0.0000064876713,0.00018137808],"about_ca_topic_score_codex":0.00002783358,"about_ca_topic_score_gemma":0.00002385991,"teacher_disagreement_score":0.45695382,"about_ca_system_score_codex":0.0000074120094,"about_ca_system_score_gemma":0.000014980474,"threshold_uncertainty_score":0.58188486},"labels":[],"label_agreement":null},{"id":"W2170329898","doi":"10.1182/blood-2007-11-125658","title":"IGF-IR tyrosine kinase interacts with NPM-ALK oncogene to induce survival of T-cell ALK+ anaplastic large-cell lymphoma cells","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"Anaplastic lymphoma kinase; Anaplastic large-cell lymphoma; Cancer research; Crizotinib; ALK inhibitor; Tyrosine kinase; Lymphoma; Tyrosine-kinase inhibitor; Biology; Medicine; Immunology; Cancer; Oncology; Internal medicine; Signal transduction; Lung cancer; Cell biology","score_opus":0.009829024830245297,"score_gpt":0.23513762699595517,"score_spread":0.22530860216570986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170329898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878493,0.0006279397,0.000031925472,0.00035407304,0.00018780144,0.0005886101,0.000077731296,0.000058284815,0.01022434],"genre_scores_gemma":[0.996323,0.000078870406,0.0016956108,0.00078101736,0.00016871799,0.000027344746,0.00006972101,0.000043656393,0.0008120686],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980336,0.000051700696,0.00042121828,0.0005040291,0.0004702345,0.0005192639],"domain_scores_gemma":[0.9984689,0.00014750037,0.00017694684,0.00057371357,0.00017748127,0.00045548734],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012722105,0.00037271413,0.00064314995,0.00018480963,0.00006431325,0.000028493365,0.00015860138,0.00011969106,0.00008812376],"category_scores_gemma":[0.000040400475,0.0002828186,0.00013677609,0.00040881266,0.000032300093,0.000073051466,0.0000626722,0.00008003648,0.0001820239],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030486966,0.112684615,0.02694877,0.0004161729,0.00061528484,0.004334253,0.0015273594,0.00006123072,0.83507526,0.00015458514,0.0041506137,0.010983148],"study_design_scores_gemma":[0.032230128,0.0064707235,0.0396587,0.00031609094,0.00074511784,0.000077526296,0.00012353821,0.00001608082,0.9171516,0.0000058729247,0.002907837,0.0002968356],"about_ca_topic_score_codex":0.000120289,"about_ca_topic_score_gemma":0.00009880798,"teacher_disagreement_score":0.10621389,"about_ca_system_score_codex":0.00013940128,"about_ca_system_score_gemma":0.00029088176,"threshold_uncertainty_score":0.9999624},"labels":[],"label_agreement":null},{"id":"W2171034095","doi":"10.1182/blood-2003-03-0860","title":"Inhibition of acute lymphoblastic and myeloid leukemias by a novel kinase inhibitor","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Tyrosine kinase; Myeloid leukemia; Cancer research; Tyrosine-kinase inhibitor; Leukemia; Kinase; Cell growth; Pharmacology; CD135; Myeloid; Medicine; Biology; Cancer; Immunology; Internal medicine; Cell biology; Receptor; Biochemistry","score_opus":0.00928502401975881,"score_gpt":0.2302247136542342,"score_spread":0.22093968963447538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171034095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962096,0.0008010256,0.00012663854,0.00005536915,0.000055103348,0.00034943875,0.00009159973,0.00004668086,0.0022645413],"genre_scores_gemma":[0.9972443,0.0001452355,0.0016756034,0.00014279103,0.000054729255,0.000029880724,0.00006952294,0.0000328263,0.00060513907],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99885947,0.000023150997,0.00029862736,0.00031124274,0.00025125485,0.00025628402],"domain_scores_gemma":[0.99932283,0.00005874546,0.000110058754,0.00026810088,0.00006379748,0.00017647404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000093510214,0.00020019767,0.0003306322,0.00008917745,0.000044721786,0.0000097049615,0.00002951433,0.0001271403,0.00007214538],"category_scores_gemma":[0.00011201637,0.00018025479,0.000069282505,0.00018290494,0.00010157726,0.00007413224,0.000029140345,0.00010631179,0.000021305317],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013163916,0.0018414975,0.005803878,0.00020643836,0.0005018201,0.00015643089,0.00027597154,9.376243e-7,0.9889049,0.00030459408,0.0012269462,0.0006449348],"study_design_scores_gemma":[0.03430386,0.00082409626,0.0029692969,0.00033865977,0.0014163954,0.0009370653,0.00007821592,0.0000378182,0.95717824,0.00006616677,0.0016226204,0.00022756678],"about_ca_topic_score_codex":0.00004852139,"about_ca_topic_score_gemma":0.00000339404,"teacher_disagreement_score":0.03417222,"about_ca_system_score_codex":0.00029135685,"about_ca_system_score_gemma":0.00038740452,"threshold_uncertainty_score":0.7350577},"labels":[],"label_agreement":null},{"id":"W2171245941","doi":"10.1182/blood-2008-04-148361","title":"Plasma fibronectin depletion enhances platelet aggregation and thrombus formation in mice lacking fibrinogen and von Willebrand factor","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"Canadian Institutes of Health Research; Canadian Blood Services; Heart and Stroke Foundation of Canada","keywords":"Platelet; Von Willebrand factor; Thrombus; Chemistry; Fibrinogen; Intravital microscopy; Platelet adhesiveness; Fibronectin; Hemostasis; Coagulation; Platelet-rich plasma; Platelet activation; Internal medicine; Endocrinology; Molecular biology; Immunology; Medicine; Biology; Biochemistry; Microcirculation; Extracellular matrix; Platelet aggregation","score_opus":0.01562524352803183,"score_gpt":0.23437909405819143,"score_spread":0.2187538505301596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171245941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99834776,0.0009307807,0.000024861452,0.00008718474,0.000022185151,0.00029322956,0.000008597183,0.000029172852,0.0002562456],"genre_scores_gemma":[0.9980748,0.001387836,0.00038432423,0.000025350884,0.000021452395,0.000007537073,0.00005723073,0.00000958949,0.00003187381],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99941033,0.000017869666,0.00015754405,0.00016705735,0.00010785026,0.0001393605],"domain_scores_gemma":[0.9997722,0.000041912015,0.00006637839,0.00005566005,0.000017258848,0.000046590063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000031628697,0.0001090599,0.00019303522,0.00008621512,0.000088588284,0.000014628149,0.000014980013,0.00007436343,0.000010290187],"category_scores_gemma":[0.000027357108,0.000096371085,0.000017374141,0.000083386236,0.000030313488,0.00026838257,0.000012753873,0.00006457375,0.0000053034487],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065178785,0.00088597485,0.71442753,0.0005333136,0.00026635887,0.0009715218,0.008800619,0.000014858605,0.21231523,0.000028532957,0.00010283524,0.06100146],"study_design_scores_gemma":[0.012156974,0.0004689671,0.3917256,0.00026778164,0.000070998576,0.0027780028,0.00020214859,0.0006229062,0.59123677,0.00010774794,0.00015706314,0.00020501447],"about_ca_topic_score_codex":0.00007538991,"about_ca_topic_score_gemma":0.0001430088,"teacher_disagreement_score":0.37892157,"about_ca_system_score_codex":0.000017474356,"about_ca_system_score_gemma":0.000011878029,"threshold_uncertainty_score":0.39298987},"labels":[],"label_agreement":null},{"id":"W2171600086","doi":"10.1182/blood-2012-09-457747","title":"Gli3-mediated hedgehog inhibition in human pluripotent stem cells initiates and augments developmental programming of adult hematopoiesis","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Hedgehog; Stem cell; Induced pluripotent stem cell; Haematopoiesis; Biology; Cell biology; Hedgehog signaling pathway; Embryonic stem cell; Signal transduction; Genetics; Gene","score_opus":0.01085714653893083,"score_gpt":0.21339362582107504,"score_spread":0.20253647928214422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171600086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99906415,0.00036775362,0.000018627637,0.000018426617,0.00002576308,0.000363225,0.000013048826,0.000014264568,0.00011476996],"genre_scores_gemma":[0.99883753,0.000056206976,0.00081872765,0.000049089445,0.000026346766,0.00010147658,0.000058509944,0.000017590002,0.000034544904],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990399,0.00003927984,0.0003202941,0.0002623746,0.00011621626,0.00022195322],"domain_scores_gemma":[0.9996258,0.000012773449,0.00009945918,0.000099074154,0.00010635546,0.00005655562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000084820495,0.00015224009,0.00018296004,0.000066692664,0.00006196797,0.000018659162,0.00005310885,0.00010127218,0.0000069981793],"category_scores_gemma":[0.000026614734,0.00014821549,0.000034421922,0.000088625595,0.00008579601,0.0000069684256,0.00013203247,0.00005468447,0.000007335914],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000060711836,0.00027627093,0.016836666,0.000108507826,0.000071900264,0.000007659455,0.00045528673,0.0000013633638,0.9816644,0.000006321077,0.000036240242,0.0005292824],"study_design_scores_gemma":[0.0014070853,0.00015915977,0.0063882233,0.00011173029,0.0000188587,0.000009720493,0.001032702,0.0000034713873,0.9906248,0.000019314173,0.00005924448,0.00016572664],"about_ca_topic_score_codex":0.0000778013,"about_ca_topic_score_gemma":0.000054783286,"teacher_disagreement_score":0.010448443,"about_ca_system_score_codex":0.00001210489,"about_ca_system_score_gemma":0.000027681639,"threshold_uncertainty_score":0.6044052},"labels":[],"label_agreement":null},{"id":"W2171680799","doi":"10.1182/blood-2002-12-3693","title":"Founder von Willebrand factor haplotype associated with type 1 von Willebrand disease","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"Department of Medicine, University of Toronto; Canadian Institutes of Health Research; University of Toronto; Dalhousie University; University of Alberta; Queen's University; McMaster University; Université de Sherbrooke; Canadian Blood Services; McGill University; Heart and Stroke Foundation of Canada","keywords":"Von Willebrand factor; Von Willebrand disease; Haplotype; Exon; Mutation; Genotype; Molecular biology; Point mutation; Intron; Genetics; Chemistry; Internal medicine; Biology; Gene; Medicine; Platelet","score_opus":0.014651200381336382,"score_gpt":0.2362905545065006,"score_spread":0.22163935412516422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171680799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99181926,0.001193676,0.0000106106445,0.00014010876,0.00010121001,0.00040551898,0.000031013962,0.000100055455,0.006198521],"genre_scores_gemma":[0.99653345,0.00010185685,0.00008603562,0.00029221008,0.00002741132,0.000013238643,0.00012527707,0.00004924792,0.0027712565],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988912,0.00004307571,0.00015398367,0.00030206025,0.00028391954,0.0003257906],"domain_scores_gemma":[0.99924535,0.000049694976,0.00006887732,0.00025659736,0.00009534019,0.00028416657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000048377708,0.00022818636,0.00034809083,0.00006393358,0.0001093078,0.000028821729,0.000045833927,0.000094623196,0.00038291022],"category_scores_gemma":[0.00019715884,0.00016200176,0.00007221708,0.00023646884,0.000052753283,0.00009375883,0.000009483945,0.00012349023,0.000095317926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008243897,0.0034442237,0.9905534,0.00005266448,0.0014757548,0.0014762708,0.00017263369,0.0000028538693,0.0005714477,0.00015885808,0.0008883493,0.0003791909],"study_design_scores_gemma":[0.0503694,0.0024267044,0.92578286,0.00043950044,0.0031824165,0.00019042892,0.00009809348,0.000035611636,0.0027886238,0.0010241767,0.012825171,0.00083703356],"about_ca_topic_score_codex":0.000011913663,"about_ca_topic_score_gemma":0.0000370141,"teacher_disagreement_score":0.06477053,"about_ca_system_score_codex":0.000037182657,"about_ca_system_score_gemma":0.00016283192,"threshold_uncertainty_score":0.660624},"labels":[],"label_agreement":null},{"id":"W2171696638","doi":"10.1182/blood-2002-10-3236","title":"MALT1 is deregulated by both chromosomal translocation and amplification in B-cell non-Hodgkin lymphoma","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":190,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Institutes of Health; Deutsche Krebshilfe; National Cancer Institute; Kay Kendall Leukaemia Fund","keywords":"Comparative genomic hybridization; Biology; Molecular biology; Fluorescence in situ hybridization; Chromosomal translocation; Lymphoma; Immunoglobulin heavy chain; Gene rearrangement; Breakpoint; Polymerase chain reaction; BCL10; Gene; Genetics; Chromosome","score_opus":0.0070901649814802195,"score_gpt":0.22236945182885173,"score_spread":0.21527928684737152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171696638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948873,0.0024821106,0.000060297167,0.0003656606,0.00002329367,0.00041656935,0.000011872347,0.000025709758,0.001727193],"genre_scores_gemma":[0.99821943,0.00050221686,0.0006460978,0.0002645483,0.000016024831,0.00007626382,0.0000692453,0.00001779061,0.00018840884],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991704,0.000029807898,0.00021103292,0.00027835282,0.00013006754,0.00018029363],"domain_scores_gemma":[0.9996041,0.000025341069,0.000050359555,0.00019915319,0.000025067988,0.00009596937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007605415,0.00013550579,0.00019049259,0.00006434706,0.000041117528,0.00001830834,0.000028468841,0.00009759253,0.000064337175],"category_scores_gemma":[0.000008648212,0.00012187282,0.00003501156,0.00016649808,0.000027548867,0.000054982575,0.0000037705859,0.000027311306,0.000024472247],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014394821,0.017604595,0.7615402,0.000271292,0.00023074227,0.00012323594,0.0023045568,0.0000017218618,0.17228432,0.0006031072,0.0026805738,0.04221171],"study_design_scores_gemma":[0.020406518,0.00031311647,0.48148045,0.00009773015,0.00018115844,0.000103266946,0.000077316065,0.00008114723,0.4950704,0.000064578024,0.0019679826,0.00015632785],"about_ca_topic_score_codex":0.00013048926,"about_ca_topic_score_gemma":0.000017147742,"teacher_disagreement_score":0.3227861,"about_ca_system_score_codex":0.00006225052,"about_ca_system_score_gemma":0.000078114965,"threshold_uncertainty_score":0.49698296},"labels":[],"label_agreement":null},{"id":"W2172036130","doi":"10.1182/blood-2013-07-453480","title":"How I treat ALL in Down's syndrome: pathobiology and management","year":2013,"lang":"en","type":"review","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Israel Science Foundation; Israel Cancer Association","keywords":"Medicine; Intensive care medicine; Population; Blinatumomab; Internal medicine; Oncology; Immunology; Leukemia; Lymphoblastic Leukemia","score_opus":0.047808837381899796,"score_gpt":0.3254840697990191,"score_spread":0.27767523241711933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2172036130","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005767866,0.9941679,0.000004596959,0.00019910277,0.000050462768,0.0023195802,0.000025338439,0.0000379768,0.0026182507],"genre_scores_gemma":[0.000046702997,0.98968494,0.0006492012,0.00006802803,0.00007686407,0.0006227923,0.000188495,0.000061135186,0.008601824],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998148,0.0001519039,0.00034494887,0.000600486,0.00022832019,0.0005263201],"domain_scores_gemma":[0.99894446,0.00016838047,0.00010885105,0.00054639747,0.000027195236,0.000204739],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001922083,0.00040223997,0.0017136626,0.00042907696,0.00001920386,0.00004569728,0.00020407912,0.00045523865,0.00007308698],"category_scores_gemma":[0.000058945483,0.00026954644,0.00016631163,0.00024865556,0.00011158178,0.000041569016,0.0002968562,0.00040160705,0.00020181059],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000057297066,0.00035134982,0.000056742254,0.04311694,0.0006860976,0.008841473,0.000020651987,4.4982067e-9,0.0000018860301,0.00010972929,0.0023375705,0.94447184],"study_design_scores_gemma":[0.0037896372,0.00032737775,0.000113566384,0.0078081787,0.002463372,0.0075174267,0.000016218175,0.0000017404471,0.0000010391831,0.000017964296,0.97769105,0.0002524423],"about_ca_topic_score_codex":0.000042568998,"about_ca_topic_score_gemma":0.0000058720575,"teacher_disagreement_score":0.9753535,"about_ca_system_score_codex":0.00031175444,"about_ca_system_score_gemma":0.0002098375,"threshold_uncertainty_score":0.9999757},"labels":[],"label_agreement":null},{"id":"W2174444939","doi":"10.1182/blood.v122.21.211.211","title":"Edoxaban For Long-Term Treatment Of Venous Thromboembolism In Cancer Patients","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Medicine; Venous thromboembolism; Edoxaban; Cancer; Internal medicine; Intensive care medicine; Surgery; Thrombosis; Warfarin; Rivaroxaban; Atrial fibrillation","score_opus":0.02056382740148805,"score_gpt":0.29195497306837237,"score_spread":0.2713911456668843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2174444939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99549836,0.0007788207,0.0000055705495,0.0002425977,0.00019168758,0.0023962948,0.000023657482,0.000022947987,0.0008400655],"genre_scores_gemma":[0.9973697,0.000822785,0.0001634431,0.00015543427,0.00013727315,0.0011016575,0.000051824674,0.000028935638,0.0001689321],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999016,0.000012097108,0.00029137055,0.00023413455,0.00015281937,0.00029359586],"domain_scores_gemma":[0.9994434,0.000028753695,0.00009702017,0.00024272963,0.000101419064,0.000086652755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000033280423,0.00015742182,0.0006168676,0.000111867506,0.000030201192,0.000010379121,0.00006728422,0.00006287166,0.00023827913],"category_scores_gemma":[0.0000124317185,0.00012634197,0.00011780202,0.000098526085,0.000031818454,0.000059488157,0.000022579065,0.00003109359,0.000022820486],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032015552,0.04567428,0.9014228,0.0004497491,0.00060921826,0.000011588469,0.0016027351,0.000004919815,0.0013135617,0.00019763481,0.0010565476,0.04762497],"study_design_scores_gemma":[0.007481201,0.0027078872,0.9809618,0.00015267065,0.0004892128,9.988531e-7,0.000032013784,0.0000063247608,0.007620355,0.00007817938,0.00035249448,0.000116875344],"about_ca_topic_score_codex":0.0012112145,"about_ca_topic_score_gemma":0.00021918098,"teacher_disagreement_score":0.07953901,"about_ca_system_score_codex":0.00008279135,"about_ca_system_score_gemma":0.000049688264,"threshold_uncertainty_score":0.51520765},"labels":[],"label_agreement":null},{"id":"W2179600628","doi":"10.1182/blood-2015-07-659656","title":"High-dose dexamethasone vs prednisone for treatment of adult immune thrombocytopenia: a prospective multicenter randomized trial","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":215,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Key Research and Development Program of China; Independent Innovation Foundation of Shandong University; National High-tech Research and Development Program; Science and Technology Development Plan of Shandong Province; Major Research Plan; National Public Health Grand Research Foundation; Natural Science Foundation of Shandong Province; University of Toronto; School of Medicine, Stanford University; National Natural Science Foundation of China; Shandong University","keywords":"Prednisone; Medicine; Immune thrombocytopenia; Dexamethasone; Internal medicine; Randomized controlled trial; Corticosteroid; Gastroenterology; Platelet","score_opus":0.022245840594907623,"score_gpt":0.2892072427817678,"score_spread":0.26696140218686015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2179600628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879088,0.0010652986,0.00016328359,0.00028797393,0.00024414464,0.009839732,0.00008687376,0.000051366034,0.00035255917],"genre_scores_gemma":[0.98631436,0.00020046732,0.010739339,0.00003324867,0.00013619417,0.0017109949,0.00013017941,0.000038192633,0.00069704204],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99851215,0.00008719837,0.00052535575,0.00034014147,0.0002465548,0.00028857912],"domain_scores_gemma":[0.9987019,0.00024730767,0.00023791869,0.00033874944,0.00031445373,0.00015972671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018663515,0.00027257096,0.0019685635,0.00007787469,0.00004342619,0.000013364122,0.00006452552,0.0001174355,0.000027802294],"category_scores_gemma":[0.0004529199,0.00018100547,0.00041309063,0.000106701984,0.00011354503,0.00007333583,0.00002147386,0.00004134265,0.000016920889],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9747406,0.017478462,0.00093413185,0.000049249178,0.0029921704,0.000097452496,0.0013683285,0.0000017760221,0.0012441996,0.00017122261,0.00005003739,0.0008723681],"study_design_scores_gemma":[0.9316843,0.009883102,0.00056067505,0.00006674849,0.0033409577,0.00003263523,0.00015071516,0.000080933394,0.05355404,0.00045173682,0.000054924632,0.00013922268],"about_ca_topic_score_codex":0.0005237818,"about_ca_topic_score_gemma":0.000034817473,"teacher_disagreement_score":0.05230984,"about_ca_system_score_codex":0.000104614206,"about_ca_system_score_gemma":0.00016003785,"threshold_uncertainty_score":0.7381189},"labels":[],"label_agreement":null},{"id":"W218273434","doi":"10.1182/blood.v124.21.714.714","title":"Primary Analysis Results from an Open-Label Phase II Study of INCB039110, a Selective JAK1 Inhibitor, in Patients with Myelofibrosis","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of British Columbia; St. Paul's Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Myelofibrosis; Medicine; Internal medicine; Ruxolitinib; Clinical endpoint; Polycythemia vera; Gastroenterology; Constitutional symptoms; Essential thrombocythemia; Anemia; Bone pain; Phases of clinical research; Extramedullary hematopoiesis; Abdominal pain; Bone marrow; Clinical trial; Disease; Haematopoiesis","score_opus":0.016291533542011793,"score_gpt":0.29013978478780006,"score_spread":0.27384825124578827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W218273434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970253,0.000019629015,0.000006589642,0.000064183994,0.000020251337,0.0017965925,0.00025059542,0.000018805142,0.0007980569],"genre_scores_gemma":[0.9973994,0.000004657689,0.0014123211,0.000136542,0.000046445683,0.00021102576,0.00072546746,0.000027297488,0.000036853802],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977331,0.00023575913,0.0005841661,0.0007166794,0.0004963659,0.0002338888],"domain_scores_gemma":[0.99845046,0.00016957405,0.00028651554,0.0006196464,0.00029739537,0.00017642893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025574892,0.00027864988,0.00094582414,0.00033006867,0.000112091155,0.00003156621,0.0001694013,0.000082249746,0.00002478865],"category_scores_gemma":[0.000114125476,0.00020261157,0.00004101454,0.0010637258,0.000039594244,0.00020454645,0.00016578285,0.00015354148,0.0000045918537],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005944563,0.15205038,0.83289844,0.000011024299,0.0023186163,0.000015493919,0.0031233218,0.000007668915,0.00043432417,0.0000073222595,0.000045517387,0.0031433417],"study_design_scores_gemma":[0.14481229,0.052044515,0.79278886,0.00010057005,0.0030161836,3.679606e-7,0.00014544665,0.000054094085,0.006838766,0.000009167196,0.000015080456,0.00017463513],"about_ca_topic_score_codex":0.0023282615,"about_ca_topic_score_gemma":0.0032647431,"teacher_disagreement_score":0.13886772,"about_ca_system_score_codex":0.00008119691,"about_ca_system_score_gemma":0.000107728614,"threshold_uncertainty_score":0.826226},"labels":[],"label_agreement":null},{"id":"W2185048627","doi":"10.1182/blood.v124.21.3740.3740","title":"Quantitative Whole Body Autoradiography (QWBA) Analysis Reveals That CPX-351 Shifts the Exposure of Cytarabine (Cyt) and Daunorubicin (Daun) Away from Many Tissues While Providing Prolonged Exposure to Cytotoxic Drug Concentrations in the Bone Marrow Compared to Conventional Free Drug Administration","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celator Pharmaceuticals (Canada)","funders":"","keywords":"Pharmacology; Chemistry; In vivo; Context (archaeology); Therapeutic index; Toxicity; Drug; Pharmacokinetics; Cytarabine; Daunorubicin; Pharmacodynamics; Medicine; Internal medicine; Chemotherapy; Biology","score_opus":0.0226830958486664,"score_gpt":0.2858542061588398,"score_spread":0.2631711103101734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2185048627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813476,0.00094266824,0.00052806793,0.013675697,0.000046623165,0.0028710125,0.00038154263,0.000047898153,0.00015884155],"genre_scores_gemma":[0.99523014,0.000025953812,0.0029057595,0.00048082753,0.00014488654,0.00044776485,0.0005306795,0.000031805488,0.00020217393],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996249,0.00093562814,0.0007407799,0.0006506641,0.000972683,0.00045121906],"domain_scores_gemma":[0.9974111,0.00086772104,0.00029235252,0.000961792,0.0002290115,0.00023806153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018547266,0.0003239993,0.0007988413,0.00052356155,0.0002701508,0.00014478934,0.00051603705,0.000111101406,0.000059236172],"category_scores_gemma":[0.00049009843,0.00022591866,0.00020978361,0.0016637277,0.0002331183,0.00022066574,0.000122167,0.0004368474,0.000011493659],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014068751,0.0013193653,0.6885708,0.00017400854,0.0016953802,0.00007207687,0.020992087,0.000163142,0.27507916,0.0018424513,0.008563491,0.00012113098],"study_design_scores_gemma":[0.007687341,0.0018119393,0.92529786,0.0003910504,0.0018245584,0.000020197602,0.00797658,0.001964313,0.051242344,0.0005021063,0.00086582,0.00041588573],"about_ca_topic_score_codex":0.000563588,"about_ca_topic_score_gemma":0.0028425467,"teacher_disagreement_score":0.23672704,"about_ca_system_score_codex":0.00008630481,"about_ca_system_score_gemma":0.00023269469,"threshold_uncertainty_score":0.92126954},"labels":[],"label_agreement":null},{"id":"W2186931370","doi":"10.1182/blood-2015-09-670950","title":"Transfusion of fresher vs older red blood cells in hospitalized patients: a systematic review and meta-analysis","year":2015,"lang":"en","type":"review","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Schwartz/Reisman Emergency Medicine Institute; Thrombosis and Atherosclerosis Research Institute; University of Toronto; McMaster University","funders":"","keywords":"Meta-analysis; Medicine; Confidence interval; Relative risk; Adverse effect; Certainty; Randomized controlled trial; MEDLINE; Internal medicine; Intensive care medicine; Biology","score_opus":0.03843242219317449,"score_gpt":0.3009916678422033,"score_spread":0.2625592456490288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2186931370","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004610078,0.9877383,0.0000071516856,0.00013109633,0.00003570008,0.0112864915,0.00013428705,0.000035277164,0.0005855799],"genre_scores_gemma":[0.000042284853,0.9971691,0.00028524775,0.0003775262,0.000009557734,0.0009873692,0.00018959084,0.00006863105,0.0008706961],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9953508,0.00061440456,0.0022665255,0.00072151696,0.0007531303,0.00029365747],"domain_scores_gemma":[0.9976094,0.00007487531,0.00072562107,0.0011154343,0.0002468882,0.00022783315],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011478561,0.0006656574,0.014089874,0.00071976386,0.000023085508,0.000017083568,0.00024540766,0.0003115126,0.0005881698],"category_scores_gemma":[0.0000818533,0.000416305,0.0029869901,0.0015305156,0.00004824898,0.000055036326,0.00007229219,0.0003204006,0.000013049017],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005962429,0.0023651656,0.0000128723395,0.8405371,0.15629114,0.00003562895,0.00008064045,2.7653428e-8,2.8691224e-7,0.0000069268244,0.00027594974,0.00038831704],"study_design_scores_gemma":[0.0038057682,0.0002599145,0.000012142017,0.07640986,0.9007537,0.000009655616,0.000009504664,2.1416781e-7,0.0000036000326,0.0000025468785,0.018419128,0.00031396202],"about_ca_topic_score_codex":0.00008287902,"about_ca_topic_score_gemma":0.0000460716,"teacher_disagreement_score":0.7641272,"about_ca_system_score_codex":0.000022777864,"about_ca_system_score_gemma":0.00009044963,"threshold_uncertainty_score":0.9998289},"labels":[],"label_agreement":null},{"id":"W2187343514","doi":"10.1182/blood-2015-05-647172","title":"Disease evolution and outcomes in familial AML with germline CEBPA mutations","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":194,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre","funders":"Novo Nordisk Fonden; National Institute for Health and Care Research; Lundbeckfonden; Cancer Research UK","keywords":"CEBPA; Myeloid leukemia; Germline; Biology; Exome sequencing; Germline mutation; Leukemia; Mutation; Oncology; Genetics; Cancer research; Internal medicine; Medicine; Gene","score_opus":0.020404323616219588,"score_gpt":0.2953762748293807,"score_spread":0.27497195121316115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2187343514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996632,0.0002531709,0.00013848627,0.0019428278,0.000020968419,0.00032831467,0.000019218916,0.0000361684,0.00062885735],"genre_scores_gemma":[0.99782246,0.000010134625,0.00099979,0.00011551744,0.00007628822,0.000035678364,0.00004120674,0.000013947662,0.00088498666],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99923974,0.000033755645,0.00011971411,0.00017087422,0.00025247457,0.00018346103],"domain_scores_gemma":[0.9993576,0.000043876622,0.000021082622,0.00017554939,0.000091364425,0.00031053837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013346148,0.00008338477,0.00015744664,0.00013739007,0.000025919031,0.000009326552,0.00003952137,0.000036481844,0.00000914379],"category_scores_gemma":[0.00030645003,0.00006106523,0.000017837116,0.00018285698,0.00009326189,0.000074291536,0.00003415153,0.00014955926,0.000023838842],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000311577,0.00045823064,0.99756485,0.000030458537,0.000040447194,0.0003005235,0.00023757906,0.000013389122,0.00034336818,0.00020928284,0.00018379418,0.00030647538],"study_design_scores_gemma":[0.011682453,0.00027480506,0.9863822,0.00003138537,0.00013029228,0.00004730249,0.00026165854,0.0005691206,0.00009143291,0.00026051924,0.00018614653,0.000082709754],"about_ca_topic_score_codex":0.00021487533,"about_ca_topic_score_gemma":0.00012753828,"teacher_disagreement_score":0.011370875,"about_ca_system_score_codex":0.00011429328,"about_ca_system_score_gemma":0.00048244416,"threshold_uncertainty_score":0.24901678},"labels":[],"label_agreement":null},{"id":"W2187901936","doi":"10.1182/blood.v114.22.2745.2745","title":"Distinct Signaling Profiles of Gemtuzumab Ozogamicin Responsiveness and Refractoriness in Acute Myeloid Leukemia.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Click Chemistry and Applications","field":"Chemistry","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Gemtuzumab ozogamicin; Calicheamicin; Myeloid leukemia; CD33; Pharmacology; Medicine; Leukemia; Cytarabine; Cancer research; Immunology; Biology; Stem cell; CD34; Cell biology","score_opus":0.011708324129520633,"score_gpt":0.2581608253713758,"score_spread":0.24645250124185517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2187901936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99691796,0.00016204838,0.000009780642,0.00009979808,0.0000067954097,0.000062917454,0.000056467867,0.000038644786,0.0026456132],"genre_scores_gemma":[0.99902207,0.000042726082,0.00020128161,0.000012909245,0.00007837853,0.00002177572,0.00005416588,0.000010777626,0.0005559124],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991459,0.000010506021,0.00028637142,0.0002690622,0.00011403583,0.0001740906],"domain_scores_gemma":[0.9993446,0.00013422023,0.00012427835,0.00029411016,0.000048924772,0.00005385098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008660692,0.00013840725,0.00022209666,0.000032342366,0.000052112624,0.000014615175,0.00015958406,0.000110157205,0.000057709167],"category_scores_gemma":[0.00008106449,0.00013973773,0.000036975838,0.0001623633,0.000051535095,0.00005583061,0.000041693846,0.00016745653,0.000001690551],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007729935,0.00020187673,0.008187396,0.00010690821,0.000020421303,0.00001988802,0.00010574067,0.000005693266,0.9898685,0.00014204289,0.000009280129,0.0012549221],"study_design_scores_gemma":[0.0011278789,0.000017382996,0.015568914,0.00014119777,0.00006129878,0.000026849857,0.000101240745,0.000020083522,0.9819343,0.00042731277,0.00041953486,0.00015402488],"about_ca_topic_score_codex":0.000026141233,"about_ca_topic_score_gemma":0.0000040105347,"teacher_disagreement_score":0.00793425,"about_ca_system_score_codex":0.00004332885,"about_ca_system_score_gemma":0.000084497886,"threshold_uncertainty_score":0.569834},"labels":[],"label_agreement":null},{"id":"W2188151624","doi":"10.1182/blood.v118.21.1605.1605","title":"CPOP-R Versus CHOP-R As First-Line Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): A Phase 2, Randomized, Open-Label, Multicenter Study","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Internal medicine; Medicine; Gastroenterology; Clinical endpoint; CHOP; Diffuse large B-cell lymphoma; Phases of clinical research; Oncology; Lymphoma; Randomized controlled trial; Chemotherapy","score_opus":0.06869787425977714,"score_gpt":0.3452803908395079,"score_spread":0.27658251657973076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2188151624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98354924,0.0018194779,0.000028985978,0.00018928661,0.0004367927,0.009973636,0.00010906938,0.00010000152,0.0037934834],"genre_scores_gemma":[0.9925793,0.0009297574,0.0009652774,0.0007237799,0.00021105874,0.0036932272,0.000090876565,0.00008467502,0.0007220447],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99775064,0.0001258645,0.0005770045,0.00065599504,0.00031758184,0.000572896],"domain_scores_gemma":[0.9980329,0.000496602,0.0002176093,0.00077113585,0.00015526605,0.00032646983],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048581098,0.00044881497,0.0011038167,0.00010957219,0.00023230682,0.00008119639,0.0003381355,0.00012260996,0.0003228319],"category_scores_gemma":[0.00018803096,0.00030988062,0.00027711733,0.00013911485,0.00006432735,0.0001570811,0.00016057308,0.00006414955,0.00019362409],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34596014,0.6368595,0.0058196643,0.000044731318,0.0023540212,0.00043435278,0.0027207574,2.319298e-8,0.000073501535,0.000117732736,0.00053953566,0.0050760633],"study_design_scores_gemma":[0.96723485,0.012420446,0.0013436503,0.00006392202,0.002446686,0.000015944723,0.0003772399,0.00011010762,0.009759913,0.000032203057,0.0058788494,0.00031618774],"about_ca_topic_score_codex":0.00045830433,"about_ca_topic_score_gemma":0.00009505751,"teacher_disagreement_score":0.624439,"about_ca_system_score_codex":0.00008908519,"about_ca_system_score_gemma":0.00012753093,"threshold_uncertainty_score":0.9999353},"labels":[],"label_agreement":null},{"id":"W2188401913","doi":"10.1182/blood-2015-08-664656","title":"Monovalent Fc receptor blockade by an anti–Fcγ receptor/albumin fusion protein ameliorates murine ITP with abrogated toxicity","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; Canadian Blood Services; St. Michael's Hospital","funders":"Canadian Institutes of Health Research; University of Toronto","keywords":"Blockade; Antibody; Receptor; Fc receptor; Fusion protein; Albumin; Chemistry; Immunoglobulin G; Immunology; Immunoglobulin Fc Fragments; Toxicity; Medicine; Pharmacology; Biochemistry; Internal medicine; Recombinant DNA","score_opus":0.02841160782810602,"score_gpt":0.2885550253799692,"score_spread":0.26014341755186315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2188401913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932759,0.00089452043,0.000012249192,0.002945001,0.000085888576,0.001159856,0.00015985318,0.00017898032,0.0012877677],"genre_scores_gemma":[0.9824239,0.00023321326,0.004081338,0.00023059582,0.0005835074,0.00011100301,0.00066316343,0.00007621999,0.011597078],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99712557,0.00016682493,0.0004148277,0.00062991603,0.0009926772,0.00067019113],"domain_scores_gemma":[0.9978913,0.000037386315,0.00013787045,0.0004956328,0.0005583224,0.00087945367],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044645584,0.00037676474,0.00054665655,0.00015887643,0.00015738806,0.000057655427,0.0002645465,0.00019458435,0.0007400806],"category_scores_gemma":[0.00014174555,0.0002702627,0.00007973847,0.000658353,0.00021698543,0.00017512086,0.00015043694,0.0004892023,0.0004718752],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002843453,0.0040900386,0.02449243,0.00021019595,0.00022030073,0.00015748251,0.00042972207,0.000005231717,0.94520515,0.000022511793,0.01986025,0.0024632283],"study_design_scores_gemma":[0.006060737,0.0058918037,0.002600941,0.00035838873,0.00010172168,0.00012513262,0.00030289174,0.0001491214,0.90980786,0.000020553995,0.0741368,0.00044405804],"about_ca_topic_score_codex":0.00059016416,"about_ca_topic_score_gemma":0.00006558346,"teacher_disagreement_score":0.054276552,"about_ca_system_score_codex":0.00006758852,"about_ca_system_score_gemma":0.00029703378,"threshold_uncertainty_score":0.99997497},"labels":[],"label_agreement":null},{"id":"W2189160632","doi":"10.1182/blood.v122.21.1578.1578","title":"Increased Arginase 1 Expression In Human MDS, CMML and Murine Models Points To Dysregulation Of Common Immunosuppressive Signaling Networks","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Bone marrow; Immune dysregulation; Internal medicine; Immunohistochemistry; Immune system; Myeloid; Myelodysplastic syndromes; Hematology; Oncology; Immunology; Cancer research","score_opus":0.008315118943919609,"score_gpt":0.22312963687473553,"score_spread":0.2148145179308159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2189160632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950212,0.003691071,0.00033551708,0.00003892245,0.000120659235,0.0004657273,0.0000073992683,0.000025583453,0.00029387436],"genre_scores_gemma":[0.99911624,0.000033829,0.00045902826,0.00006377868,0.00001985222,0.00007372889,0.000099949946,0.00002052607,0.00011308054],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99887604,0.00020029176,0.00037516694,0.00024493836,0.000036132227,0.0002674468],"domain_scores_gemma":[0.99931973,0.00011324868,0.00015833459,0.00031851904,0.00006719458,0.000022946047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001780898,0.00016017344,0.00030319596,0.00013510496,0.00009392507,0.000012315533,0.00016769489,0.000211294,0.00031615794],"category_scores_gemma":[0.000020739377,0.00015380401,0.000036125235,0.00010703155,0.00009893704,0.00016709497,0.0001814892,0.00022071667,0.00001576111],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079628335,0.00030711145,0.0035430798,0.000026216518,0.00004354662,0.0000027406015,0.00047456907,0.002424445,0.99219036,0.00007473033,0.0002885132,0.00054503034],"study_design_scores_gemma":[0.003675103,0.00014397866,0.020551575,0.00035382048,0.000036779547,0.000012276901,0.0001229105,0.0004607735,0.9734437,0.0009563408,0.0000507694,0.00019195823],"about_ca_topic_score_codex":0.0008072778,"about_ca_topic_score_gemma":0.00001964697,"teacher_disagreement_score":0.018746674,"about_ca_system_score_codex":0.000019642113,"about_ca_system_score_gemma":0.000013818081,"threshold_uncertainty_score":0.6271946},"labels":[],"label_agreement":null},{"id":"W218989274","doi":"10.1182/blood.v124.21.5544.5544","title":"Bosutinib As Second-Line Therapy in Patients (Pts) with Chronic Phase Chronic Myeloid Leukemia (CP CML) Resistant or Intolerant to Prior Imatinib: 60-Month Update of a Phase 1/2 Study","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Bosutinib; Medicine; Internal medicine; Gastroenterology; Imatinib; Dasatinib; Imatinib mesylate; Discontinuation; Nilotinib; Myeloid leukemia","score_opus":0.0146167909784973,"score_gpt":0.29754422788039475,"score_spread":0.2829274369018975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W218989274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99253905,0.0006399107,0.000033641933,0.00013731734,0.000114412745,0.0057862317,0.00013588934,0.00013458407,0.00047894684],"genre_scores_gemma":[0.99712366,0.000106875756,0.00075895555,0.00032463082,0.0002766335,0.000514712,0.00022999081,0.00016629377,0.00049826107],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99511766,0.00026806718,0.001449799,0.0011530103,0.0010097007,0.0010017406],"domain_scores_gemma":[0.9968505,0.0001653203,0.0005875269,0.0016103458,0.00028393773,0.0005023993],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00068506395,0.000780926,0.0015378138,0.0004587254,0.00013338779,0.000042891632,0.0004560396,0.00019026228,0.0012694099],"category_scores_gemma":[0.00021941979,0.0005515756,0.00016633308,0.00087950286,0.00014278613,0.00019360575,0.0001518195,0.00052148674,0.00012977011],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16755971,0.18744609,0.050366715,0.002602298,0.006414821,0.0030524398,0.016420074,0.00025332716,0.103024594,0.00009521399,0.0011119243,0.4616528],"study_design_scores_gemma":[0.64983773,0.21133815,0.037548877,0.0017049571,0.0010665647,0.000087814085,0.00040849642,0.00091533386,0.089063905,0.000019573721,0.006904041,0.0011045603],"about_ca_topic_score_codex":0.0006099228,"about_ca_topic_score_gemma":0.0033272656,"teacher_disagreement_score":0.48227802,"about_ca_system_score_codex":0.0031330958,"about_ca_system_score_gemma":0.0036984587,"threshold_uncertainty_score":0.9996936},"labels":[],"label_agreement":null},{"id":"W2190417520","doi":"10.1182/blood.v124.21.3392.3392","title":"Bone Marrow Stromal Cells Induce Bortezomib Resistance Partly through a Transcriptome Modulation in Multiple Myeloma Cells","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Queen's University; University Health Network","funders":"","keywords":"Bortezomib; Stromal cell; Cancer research; Bone marrow; Cell culture; Tetherin; Biology; Proteasome inhibitor; Molecular biology; Multiple myeloma; Immunology; Chemistry","score_opus":0.027129184832613385,"score_gpt":0.26814926877661127,"score_spread":0.24102008394399788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2190417520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99499285,0.00029851362,0.00030881015,0.00033821896,0.000114844326,0.00090730836,0.00005816276,0.00008246907,0.0028988218],"genre_scores_gemma":[0.9925872,0.000055402976,0.0052729617,0.00011925418,0.00019713599,0.00011000158,0.00009317981,0.000049295286,0.0015155354],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99761075,0.00015940004,0.00045026792,0.0005418813,0.00057224033,0.00066543906],"domain_scores_gemma":[0.9988831,0.00013682563,0.00009823176,0.0005374659,0.00008526149,0.00025909755],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002773202,0.00027764024,0.00047966113,0.00015613488,0.00009948654,0.000036264428,0.00012864592,0.00017338496,0.00007982202],"category_scores_gemma":[0.00010748118,0.0002549809,0.0001335021,0.00034173607,0.00008167083,0.00021018706,0.00002868533,0.0003108223,0.00010549785],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010329073,0.0023873372,0.058794707,0.00024113484,0.000155884,0.00042439875,0.0007608167,0.000040549618,0.9333205,0.00010837519,0.00048984704,0.0022435086],"study_design_scores_gemma":[0.034073394,0.0007402368,0.3178837,0.00032353905,0.00017525924,0.000027260676,0.00016488628,0.0031370907,0.63851506,0.00030663644,0.0042040236,0.0004489096],"about_ca_topic_score_codex":0.00022112865,"about_ca_topic_score_gemma":0.0005666194,"teacher_disagreement_score":0.29480547,"about_ca_system_score_codex":0.00008191239,"about_ca_system_score_gemma":0.00008900243,"threshold_uncertainty_score":0.9999902},"labels":[],"label_agreement":null},{"id":"W2191808551","doi":"10.1182/blood-2015-07-657973","title":"Diagnosis of hantavirus cardiopulmonary syndrome with peripheral blood film","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Viral Infections and Vectors","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital","funders":"","keywords":"Medicine; Malaise; White blood cell; Peripheral blood; Platelet; Differential diagnosis; Peripheral; Internal medicine; Pathology","score_opus":0.022831762393106227,"score_gpt":0.2522418082675806,"score_spread":0.22941004587447436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2191808551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941405,0.0009178731,0.000010192509,0.000080497215,0.00009430644,0.00020366383,0.000020687861,0.000063459695,0.0044688405],"genre_scores_gemma":[0.99876285,0.000056209403,0.00041786,0.000058576377,0.000096743264,0.000054259635,0.000013609645,0.000024681693,0.0005152066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99922615,0.000026297841,0.00017082153,0.00017663657,0.00022163232,0.0001784722],"domain_scores_gemma":[0.99938476,0.000015022062,0.000053889933,0.0002692036,0.00009981451,0.00017731322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008801957,0.0001289267,0.00032963752,0.0000769184,0.00003697154,0.000008264019,0.00005080756,0.00006946547,0.00010975111],"category_scores_gemma":[0.000030086785,0.00009505714,0.00009980011,0.0002292827,0.00007120283,0.00007079855,0.000026497088,0.00011942018,0.000018744042],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009875642,0.0019317443,0.99383384,0.00008021673,0.0005563938,0.0012991532,0.00021184834,0.00003464156,0.0009317828,0.00003075306,0.0006115402,0.0003793424],"study_design_scores_gemma":[0.020737479,0.0144283995,0.8538537,0.0007325395,0.0053066085,0.022955665,0.00086457434,0.00007165999,0.07105678,0.000072022136,0.009173518,0.00074703165],"about_ca_topic_score_codex":0.00045602056,"about_ca_topic_score_gemma":0.000027880355,"teacher_disagreement_score":0.13998011,"about_ca_system_score_codex":0.000016117798,"about_ca_system_score_gemma":0.00009348138,"threshold_uncertainty_score":0.38763174},"labels":[],"label_agreement":null},{"id":"W2198189555","doi":"10.1182/blood.v120.21.1586.1586","title":"A 7-Gene Microrna Signature Characteristic of Mantle Cell Lymphoma Reveals Focal Adhesion and Integrin Signalling, Proteasome-Mediated Degradation, and the PI3K Signalling Cascade As Important to MCL Pathogenesis","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Alberta; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Queen's University; University of Toronto; Toronto General Hospital; University Health Network; BC Cancer Agency; Kingston General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Mantle cell lymphoma; Cancer research; Biology; Cyclin D1; microRNA; Pathogenesis; Lymphoma; Cell cycle; Immunology; Cell; Gene; Genetics","score_opus":0.009596013486732861,"score_gpt":0.22702645997411647,"score_spread":0.2174304464873836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2198189555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98527426,0.0126339905,0.000045336943,0.00045638342,0.00005254348,0.0014105738,0.000067206915,0.000029250728,0.000030443403],"genre_scores_gemma":[0.9967356,0.0010781932,0.0011980926,0.00039021717,0.00015787529,0.00020928674,0.00008192748,0.000038112084,0.00011075222],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99829394,0.000145337,0.00054330606,0.0003473395,0.0003037446,0.0003663356],"domain_scores_gemma":[0.9986854,0.00033597375,0.0002816621,0.00023306956,0.0001248449,0.0003390447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006048827,0.00029187274,0.0005498793,0.00010933178,0.00013169063,0.000029763816,0.00008803405,0.00017585763,0.00002624774],"category_scores_gemma":[0.00025684977,0.00018129287,0.00010308725,0.00019049022,0.000087115695,0.000076866665,0.00007524728,0.000108580796,0.000012891515],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052776845,0.0018941085,0.095959716,0.00023753311,0.00022844432,0.000092209215,0.0012084839,4.3890518e-7,0.8968872,0.00005326626,0.000058935348,0.0028519006],"study_design_scores_gemma":[0.01009547,0.00058372447,0.17314787,0.00038740292,0.0010373906,0.000288489,0.00022044998,0.000037729034,0.8136795,0.000044156535,0.0002422391,0.00023557348],"about_ca_topic_score_codex":0.0001540965,"about_ca_topic_score_gemma":0.000005769007,"teacher_disagreement_score":0.0832077,"about_ca_system_score_codex":0.000050160506,"about_ca_system_score_gemma":0.00009820732,"threshold_uncertainty_score":0.73929083},"labels":[],"label_agreement":null},{"id":"W2198879547","doi":"10.1182/blood.v122.21.2340.2340","title":"Regulation Of Factor VIII Clearance By Mannose-Binding Lectins","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Glycan; Mannose; Mannan-binding lectin; Recombinant DNA; Lectin; Mannose receptor; Asialoglycoprotein receptor; Chemistry; Internalization; Mannan; Biochemistry; Von Willebrand factor; Glycosylation; Molecular biology; Receptor; Biology; Glycoprotein; In vitro; Immunology; Polysaccharide; Platelet; Hepatocyte","score_opus":0.024373936196167244,"score_gpt":0.2885417514664949,"score_spread":0.2641678152703277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2198879547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99409616,0.00016415397,0.0000074073932,0.000614611,0.000026554844,0.00030639456,0.000005413278,0.00002747453,0.0047518183],"genre_scores_gemma":[0.9897387,0.000032296077,0.00019442501,0.000015956179,0.000057205234,0.000011620398,0.000018588753,0.00001108404,0.009920117],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99940956,0.000015844038,0.00011666019,0.000113279224,0.00019409865,0.00015058272],"domain_scores_gemma":[0.99967337,0.000026857371,0.000033155615,0.00013837598,0.00006136111,0.00006689275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000039257673,0.000060902843,0.00012676381,0.00005614161,0.000039534505,0.000007935405,0.00003631112,0.0000561055,0.00061270024],"category_scores_gemma":[0.000033738466,0.000045636007,0.000041637308,0.00011910052,0.00003112173,0.000061786726,0.000012690364,0.000076542594,0.00021833277],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027382988,0.0004930475,0.10868242,0.00006977786,0.00008153226,0.0000037699024,0.0001715209,1.4344776e-7,0.8825311,0.000025429908,0.002630948,0.0052829008],"study_design_scores_gemma":[0.0022832395,0.00029846624,0.3850726,0.000071084854,0.00004086828,0.000010517242,0.000042104686,0.000039905626,0.61104494,0.00004729786,0.0009886516,0.00006031639],"about_ca_topic_score_codex":0.000044474014,"about_ca_topic_score_gemma":0.0000011414975,"teacher_disagreement_score":0.27639017,"about_ca_system_score_codex":0.000015383814,"about_ca_system_score_gemma":0.00002227818,"threshold_uncertainty_score":0.6708638},"labels":[],"label_agreement":null},{"id":"W2199710607","doi":"10.1182/blood.v122.21.4277.4277","title":"Evaluation Of a Novel 3 Factor Prognostic Score (PS-3) For Patients With Advanced Hodgkin Lymphoma (HL) Treated On US Intergroup E2496","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; ABVD; Univariate analysis; Proportional hazards model; Oncology; International Prognostic Index; Survival analysis; Progression-free survival; Multivariate analysis; Surgery; Rituximab; Lymphoma; Overall survival; Chemotherapy; Vincristine; Cyclophosphamide","score_opus":0.02690904124616717,"score_gpt":0.26691789352268935,"score_spread":0.2400088522765222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2199710607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99541515,0.00009390051,0.00002232237,0.000046952173,0.000056971174,0.003964394,0.00010271826,0.000039164494,0.0002584406],"genre_scores_gemma":[0.9968788,0.0000056676763,0.0010933846,0.00006538452,0.000031941472,0.0016309968,0.00023105802,0.00003269005,0.000030094669],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986023,0.000028900857,0.00026005603,0.00030694937,0.00058235414,0.00021945355],"domain_scores_gemma":[0.99853265,0.00012774159,0.00017069404,0.0002741936,0.0007897628,0.00010497888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000759054,0.00021175794,0.00031965508,0.00009823345,0.000037573045,0.00001494802,0.000056459114,0.00006818086,0.00007139373],"category_scores_gemma":[0.00026348664,0.00013727037,0.00008866103,0.0001317496,0.000032219486,0.00009035273,0.000014857582,0.000022756714,0.000018071869],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042973796,0.021667464,0.87490225,0.000078576166,0.00056968274,0.0000023465636,0.00016351976,0.000009148518,0.0010883178,0.000019755724,0.000048509974,0.101020716],"study_design_scores_gemma":[0.059391644,0.0076326584,0.9118897,0.0005294015,0.001401701,0.000004844201,0.000022392973,0.000421036,0.018533729,0.000013717963,0.000025574465,0.00013365631],"about_ca_topic_score_codex":0.0001057162,"about_ca_topic_score_gemma":0.000024351653,"teacher_disagreement_score":0.10088706,"about_ca_system_score_codex":0.0001772589,"about_ca_system_score_gemma":0.00012687252,"threshold_uncertainty_score":0.5597723},"labels":[],"label_agreement":null},{"id":"W2202470170","doi":"10.1182/blood.v124.21.5670.5670","title":"A Phase II Study of AT7519M, a CDK Inhibitor, in Patients with Chronic Lymphocytic Leukemia: NCIC CTG Trial IND.193","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Juravinski Cancer Centre; Kingston General Hospital; Princess Margaret Cancer Centre; CancerCare Manitoba; University of Toronto","funders":"","keywords":"Medicine; Tumor lysis syndrome; Internal medicine; Chronic lymphocytic leukemia; Regimen; Gastroenterology; Cytopenia; Febrile neutropenia; Oncology; Neutropenia; Leukemia; Immunology; Chemotherapy; Bone marrow","score_opus":0.012514800442363801,"score_gpt":0.2805970150934022,"score_spread":0.2680822146510384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2202470170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953993,0.00015885275,0.0000067675496,0.000012798793,0.0001573475,0.0036272905,0.00000834997,0.000069748305,0.00055951905],"genre_scores_gemma":[0.9988465,0.000008881058,0.000058550067,0.00004691358,0.00046271298,0.00022826588,0.000034384753,0.000076783836,0.00023701332],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99605167,0.00022648221,0.000849939,0.0006879844,0.0014246221,0.00075932813],"domain_scores_gemma":[0.9979572,0.00020318203,0.00025729692,0.0010451967,0.00023916442,0.0002979187],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006901926,0.00037178304,0.0009500421,0.00045581258,0.000103421975,0.000021342945,0.00031539277,0.00023421287,0.00007626603],"category_scores_gemma":[0.00045778535,0.00029250557,0.000111306304,0.00087999215,0.00018004855,0.00013357867,0.00027434534,0.0004459723,0.00003992541],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.56530917,0.28525552,0.06255072,0.0039597107,0.0038103082,0.0018284104,0.01899506,0.00073445396,0.003953878,0.00018461836,0.001778782,0.051639374],"study_design_scores_gemma":[0.9108613,0.08005922,0.0029417155,0.00042021208,0.00043288394,0.000032780306,0.00015434003,0.0021418775,0.0024565223,0.00001305025,0.00019940951,0.0002866704],"about_ca_topic_score_codex":0.0023176798,"about_ca_topic_score_gemma":0.0006698669,"teacher_disagreement_score":0.34555215,"about_ca_system_score_codex":0.03192512,"about_ca_system_score_gemma":0.027125042,"threshold_uncertainty_score":0.99995273},"labels":[],"label_agreement":null},{"id":"W220323948","doi":"10.1182/blood.v95.5.1869.005k09_1869_1871","title":"Germline CDKN2A mutation implicated in predisposition to multiple myeloma","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"CDKN2A; Loss of heterozygosity; Cancer research; Multiple myeloma; Germline mutation; Germline; Plasmacytoma; Biology; Allele; Mutation; Genetics; Immunology; Cancer; Gene","score_opus":0.015717171284957806,"score_gpt":0.2968261956724675,"score_spread":0.2811090243875097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W220323948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962406,0.00006673579,0.000034072622,0.00063711725,0.0000124366325,0.0008879345,0.000038063565,0.000079506375,0.0020035228],"genre_scores_gemma":[0.99693465,0.000020640204,0.0014368857,0.00016327797,0.00008222263,0.00017270345,0.00037168508,0.00001895059,0.000798995],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896306,0.00003408536,0.00020820956,0.00026476887,0.0002256639,0.00030421795],"domain_scores_gemma":[0.9994258,0.000042439384,0.00001900222,0.00022595565,0.00005316167,0.00023361038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007879241,0.00011354559,0.00016899158,0.00015672248,0.00004206974,0.00001496487,0.00005274776,0.00006402615,0.0005405132],"category_scores_gemma":[0.000080457015,0.00010045307,0.000045676694,0.00033394285,0.000015985717,0.00006876452,0.000014034529,0.000100143705,0.0005675254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029020612,0.0059004324,0.5983267,0.00010843198,0.00022698776,0.0017377717,0.00071353186,0.00009211531,0.12440084,0.00001818557,0.00043795453,0.26513502],"study_design_scores_gemma":[0.01018576,0.00053223973,0.95597804,0.00006754632,0.000045353827,0.00013786677,0.000015619198,0.00097290345,0.031499065,0.000027543168,0.00044396432,0.000094106],"about_ca_topic_score_codex":0.0002486942,"about_ca_topic_score_gemma":0.00014261472,"teacher_disagreement_score":0.35765135,"about_ca_system_score_codex":0.000057248453,"about_ca_system_score_gemma":0.000041942654,"threshold_uncertainty_score":0.729458},"labels":[],"label_agreement":null},{"id":"W2205449481","doi":"10.1182/blood.v124.21.4190.4190","title":"Response to TPO-Receptor Agonists: Role of Immature Platelet Fraction and Anti-GP1b","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Platelet; Medicine; Eltrombopag; Romiplostim; Thrombopoietin; Internal medicine; Immunology; Gastroenterology; Immune thrombocytopenia; Biology; Haematopoiesis","score_opus":0.00419274032036554,"score_gpt":0.2309882685157735,"score_spread":0.22679552819540796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2205449481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974418,0.00040556316,0.000012971372,0.00077149,0.000046484685,0.0001951824,0.000022305345,0.000029449377,0.0010747231],"genre_scores_gemma":[0.9985711,0.0000512884,0.0007928773,0.00024766277,0.00004126362,0.000008327704,0.000028842282,0.000014457638,0.00024417994],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99941117,0.000036448913,0.00012621348,0.00016673736,0.00012452036,0.00013488533],"domain_scores_gemma":[0.99958134,0.000058727062,0.000050335362,0.00016777198,0.000037954745,0.00010385462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012705586,0.00010055325,0.00025939394,0.00007226898,0.000041268693,0.0000097322445,0.000030349915,0.000092743685,0.000047705325],"category_scores_gemma":[0.00011254859,0.000082537605,0.000036370697,0.000092674105,0.000019946105,0.000041169136,0.000018074265,0.0000807137,0.000057294943],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004661133,0.001738419,0.031463634,0.00007698207,0.00035324757,0.000096412674,0.0005427777,0.0000017035268,0.9438927,0.000089651505,0.0019947523,0.015088595],"study_design_scores_gemma":[0.013964772,0.0019018754,0.27400374,0.00018973486,0.0003288906,0.00034152047,0.00034896913,0.000033431777,0.51324075,0.00027892753,0.19508651,0.00028085496],"about_ca_topic_score_codex":0.000035905483,"about_ca_topic_score_gemma":0.000003914379,"teacher_disagreement_score":0.43065193,"about_ca_system_score_codex":0.000010271742,"about_ca_system_score_gemma":0.000020936151,"threshold_uncertainty_score":0.3365786},"labels":[],"label_agreement":null},{"id":"W2205757214","doi":"10.1182/blood-2015-08-665927","title":"Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":212,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Bayer HealthCare; Government of the United Kingdom; Sanofi; GlaxoSmithKline; Pfizer; Daiichi Sankyo Europe; Bristol-Myers Squibb","keywords":"Medicine; Rivaroxaban; Anticoagulant therapy; Hormone therapy; Venous thromboembolism; Anticoagulant; Estrogen; Gynecology; Surgery; Internal medicine; Thrombosis; Warfarin; Cancer; Breast cancer; Atrial fibrillation","score_opus":0.04350078813672533,"score_gpt":0.2751438381708569,"score_spread":0.23164305003413158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2205757214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99342257,0.0046157343,0.000034745015,0.0004860285,0.00009505276,0.0005452743,0.000007130831,0.000079201614,0.0007142367],"genre_scores_gemma":[0.98897433,0.008951748,0.0013429624,0.00039574745,0.00019963394,0.000028797633,0.000012445317,0.000034606055,0.000059737413],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988792,0.000021926811,0.00018815072,0.00032004676,0.00027142937,0.0003192512],"domain_scores_gemma":[0.9992889,0.00002420964,0.000070329996,0.00023834592,0.00008014845,0.00029805725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019001006,0.00021425934,0.00055983925,0.00009627587,0.00008289506,0.00009438503,0.000052817275,0.000056766374,0.000010074623],"category_scores_gemma":[0.0000190483,0.00015434367,0.000026484715,0.000105963074,0.00009814187,0.00018667385,0.000097547745,0.00012549802,0.000005370153],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005019538,0.058250695,0.5302285,0.0020641226,0.011270651,0.006552332,0.040972188,0.000032969674,0.06322684,0.014034374,0.026054904,0.24229288],"study_design_scores_gemma":[0.013830192,0.007560971,0.95782703,0.00023655342,0.0007170436,0.00090273074,0.00047730556,0.00008735939,0.0022223382,0.00011023306,0.0156204095,0.0004078469],"about_ca_topic_score_codex":0.00017512873,"about_ca_topic_score_gemma":0.0000122368865,"teacher_disagreement_score":0.4275985,"about_ca_system_score_codex":0.000015067634,"about_ca_system_score_gemma":0.00004076495,"threshold_uncertainty_score":0.62939525},"labels":[],"label_agreement":null},{"id":"W2205850292","doi":"10.1182/blood.v122.21.1154.1154","title":"The Use Of Platelet Transfusions In The Intensive Care Unit and Impact On Platelet Count: A 30,000 Patient Registry Study","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Platelet transfusion; Intensive care unit; Platelet; Cohort; Medical record; Emergency medicine; Blood transfusion; Internal medicine; Complication; Cohort study; Intensive care medicine","score_opus":0.030105865398928428,"score_gpt":0.26872592101933673,"score_spread":0.2386200556204083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2205850292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953037,0.00023662705,0.000001570447,0.0013499779,0.000043836262,0.0024288823,0.000034799392,0.000016770664,0.00058385736],"genre_scores_gemma":[0.9981962,0.00037983613,0.000009931008,0.0012205155,0.000015270854,0.00011004145,0.000009439495,0.000014608985,0.000044157565],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.99889547,0.000107861524,0.00027379394,0.00019992958,0.0003179491,0.00020502789],"domain_scores_gemma":[0.9989631,0.00022587506,0.00005954318,0.0004781681,0.00019996619,0.000073354015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000119880715,0.00016395436,0.00024383582,0.00007561176,0.00012197039,0.00004323674,0.000114755436,0.000056375615,0.000076054865],"category_scores_gemma":[0.000069324706,0.00007841569,0.000064795735,0.0001836889,0.0000864085,0.000046014546,0.000029145063,0.0002823006,0.000007841876],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003823749,0.020446178,0.32869187,0.0007308184,0.003858914,0.0024809774,0.43972588,0.00022656337,0.0032236904,0.0009770876,0.030466849,0.16534743],"study_design_scores_gemma":[0.01665387,0.007158633,0.72692144,0.00036903113,0.0006439584,0.00013625452,0.2289318,0.000056764162,0.0016327577,0.000034296325,0.017190073,0.00027115954],"about_ca_topic_score_codex":0.0020933982,"about_ca_topic_score_gemma":0.00050880155,"teacher_disagreement_score":0.39822954,"about_ca_system_score_codex":0.000012154573,"about_ca_system_score_gemma":0.000031628857,"threshold_uncertainty_score":0.3197699},"labels":[],"label_agreement":null},{"id":"W2208304134","doi":"10.1182/blood.v122.21.5378.5378","title":"Induction Therapy With Cyclophosphamide, Bortezomib, and Dexamethasone (CyBorD) For Primary Plasma Cell Leukemia (pPCL)","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Plasma cell leukemia; Bortezomib; Internal medicine; Cyclophosphamide; Gastroenterology; Dexamethasone; Median follow-up; Plasma cell dyscrasia; Melphalan; Multiple myeloma; Surgery; Chemotherapy; Immunology","score_opus":0.0133084105670059,"score_gpt":0.24151796921355104,"score_spread":0.22820955864654513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2208304134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99336296,0.0012768258,0.00013378523,0.00017603823,0.00006662073,0.0020281835,0.000008189348,0.0001005032,0.0028469053],"genre_scores_gemma":[0.9867563,0.0006936821,0.00915973,0.00038612934,0.00027224957,0.0005276251,0.000050505383,0.00008682242,0.0020669594],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983538,0.000051179642,0.00026411546,0.0004274561,0.00039971396,0.00050373573],"domain_scores_gemma":[0.99868155,0.00029413585,0.00009090485,0.00045519893,0.00020959238,0.000268631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002928573,0.00024714018,0.0003865941,0.00011347166,0.0001455662,0.00005714157,0.000116456824,0.00019470953,0.00008509364],"category_scores_gemma":[0.00008092284,0.00018283752,0.00006338241,0.00023726591,0.0001749215,0.00019802828,0.000052591502,0.00035638598,0.000041110987],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007358112,0.006116208,0.023219418,0.0034795632,0.0018340409,0.0003199422,0.0034013763,0.00004653454,0.45623773,0.00017053324,0.010983961,0.48683256],"study_design_scores_gemma":[0.28704605,0.0064650313,0.09894475,0.0003499087,0.0005407701,0.0018494854,0.0008690362,0.0021918237,0.5871111,0.0004702643,0.013204227,0.0009575219],"about_ca_topic_score_codex":0.0012809582,"about_ca_topic_score_gemma":0.000022815166,"teacher_disagreement_score":0.48587504,"about_ca_system_score_codex":0.0023926955,"about_ca_system_score_gemma":0.0038767618,"threshold_uncertainty_score":0.7455898},"labels":[],"label_agreement":null},{"id":"W2208397898","doi":"10.1182/blood.v124.21.219.219","title":"Dimethyl Fumarate Induces Cytoprotection and Inhibits Inflammation and Vaso-Occlusion in Transgenic Sickle Mice","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Heme Oxygenase-1 and Carbon Monoxide","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cytoprotection; KEAP1; Dimethyl fumarate; Oxidative stress; Heme oxygenase; Inflammation; Chemistry; Heme; Pharmacology; Ferritin; Biochemistry; Immunology; Biology; Transcription factor; Enzyme","score_opus":0.004826254898709411,"score_gpt":0.2029488627776609,"score_spread":0.19812260787895147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2208397898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99869263,0.00047965386,0.00021098394,0.00008477516,0.000027086166,0.00015388291,0.00000196054,0.000009837535,0.00033920008],"genre_scores_gemma":[0.9993103,0.00024820125,0.00018045098,0.000044237302,0.00011398701,0.000012279839,0.000019343795,0.000011028136,0.00006016849],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99934983,0.00007785426,0.00014239132,0.0002394649,0.000062519866,0.0001279604],"domain_scores_gemma":[0.9997731,0.000008510325,0.000042129926,0.00010559511,0.000020268712,0.000050414706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025257916,0.00010182518,0.00009560738,0.000046746656,0.00004992963,0.000020379606,0.000037754042,0.0001416596,0.0000023601801],"category_scores_gemma":[0.00003781534,0.00009931947,0.000020559231,0.00006496994,0.000028494424,0.000007829558,0.000040099974,0.00007500817,0.0000017880762],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023056891,0.000026473597,0.00120995,0.000022484717,0.000010293189,6.404712e-7,0.00010030562,0.0000047415365,0.9922876,0.000017210696,0.0000037128812,0.0062935734],"study_design_scores_gemma":[0.0011588638,0.00017447233,0.011212843,0.000017054404,0.000018015404,0.000012155921,0.000033811677,0.0000648068,0.98627317,0.0001204493,0.0007871217,0.00012723867],"about_ca_topic_score_codex":0.000052954943,"about_ca_topic_score_gemma":0.0002222122,"teacher_disagreement_score":0.010002892,"about_ca_system_score_codex":0.000003380251,"about_ca_system_score_gemma":0.000014884985,"threshold_uncertainty_score":0.40501302},"labels":[],"label_agreement":null},{"id":"W2209050427","doi":"10.1182/blood.v124.21.1501.1501","title":"Immunization Against Influenza but Not MMR Modulates the Anti-Factor VIII Immune Response in Hemophilia Α Mice","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Janeway Children's Health and Rehabilitation Centre; Memorial University of Newfoundland; Queen's University","funders":"","keywords":"Medicine; Immunogenicity; Immunology; Rubella; Immunization; Antibody; Immune system; Measles; Vaccination; Internal medicine","score_opus":0.022218110678570928,"score_gpt":0.2865555000595282,"score_spread":0.26433738938095724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2209050427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954076,0.0005805107,0.0000062553986,0.0027540654,0.00007092915,0.00051949953,0.000010009991,0.00006326811,0.0005878765],"genre_scores_gemma":[0.9979284,0.00014349491,0.000105122585,0.0005238816,0.00012397343,0.000024288423,0.00003268304,0.000036026584,0.0010821187],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99834025,0.00032916592,0.00035068518,0.00025838427,0.00035100925,0.0003704895],"domain_scores_gemma":[0.99871695,0.00039568354,0.000069552385,0.0006033973,0.000116343195,0.00009809102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072622247,0.00019014346,0.00031279723,0.00019884818,0.00015551354,0.000037617625,0.0002132713,0.00014641907,0.000052280637],"category_scores_gemma":[0.00062243885,0.000121738456,0.00009595437,0.00040476563,0.00011675077,0.00009150257,0.00009604461,0.00031972284,0.00020414287],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011996577,0.0008792437,0.07663488,0.00006388327,0.00013030197,0.00007030034,0.0007160927,0.00006274994,0.9182532,0.00005621596,0.000030921477,0.0019025552],"study_design_scores_gemma":[0.005897671,0.0002717421,0.6790186,0.00013466831,0.00005973201,0.000024352788,0.00011020948,0.0008550694,0.31228337,0.00002790955,0.0011670324,0.00014963839],"about_ca_topic_score_codex":0.00008236862,"about_ca_topic_score_gemma":0.0000046516425,"teacher_disagreement_score":0.60596985,"about_ca_system_score_codex":0.000050751747,"about_ca_system_score_gemma":0.00010551844,"threshold_uncertainty_score":0.49643502},"labels":[],"label_agreement":null},{"id":"W2209063367","doi":"10.1182/blood.v124.21.712.712","title":"Phase 1b Dose-Escalation Study of Sonidegib (LDE225) in Combination with Ruxolitinib (INC424) in Patients with Myelofibrosis","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ruxolitinib; Medicine; Myelofibrosis; Internal medicine; Smoothened; Oncology; Gastroenterology; Bone marrow; Hedgehog signaling pathway","score_opus":0.009788318639597818,"score_gpt":0.2545714235835682,"score_spread":0.2447831049439704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2209063367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975927,0.000010404117,0.000019012963,0.000089387024,0.000017122224,0.0016150658,0.0000069845705,0.000015469057,0.00063384813],"genre_scores_gemma":[0.99918944,0.0000034043173,0.0004074539,0.00003790442,0.00001789924,0.00021145862,0.00008429006,0.000022365914,0.00002580973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998617,0.0001118135,0.00036146757,0.00030354646,0.0004056736,0.00020051168],"domain_scores_gemma":[0.9992646,0.00009698896,0.00016483171,0.00023794326,0.000159889,0.00007575941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017142386,0.00018478924,0.00041815924,0.00022590661,0.000034647106,0.000012769824,0.000043631033,0.000055129993,0.000025354979],"category_scores_gemma":[0.00004809297,0.0001291244,0.000022783135,0.000341001,0.000033111955,0.00010852335,0.00001600977,0.00010813677,0.0000061864907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010213117,0.08492601,0.90912443,0.000045929224,0.00008140165,0.0000095415135,0.0010937314,0.000012298603,0.00004080338,0.00016712879,0.000005311852,0.003472084],"study_design_scores_gemma":[0.12876622,0.022323046,0.84575355,0.00027338087,0.0001732075,0.0000014641387,0.00018509592,0.00009183794,0.0022879427,0.000020910898,0.000011090716,0.000112222806],"about_ca_topic_score_codex":0.00024379032,"about_ca_topic_score_gemma":0.00096932444,"teacher_disagreement_score":0.12774491,"about_ca_system_score_codex":0.00005828397,"about_ca_system_score_gemma":0.000045297336,"threshold_uncertainty_score":0.526554},"labels":[],"label_agreement":null},{"id":"W2210629425","doi":"10.1182/blood.v106.11.2201.2201","title":"A Phase I Study with Long-Term Follow-Up of Autologous Stem Cell Transplantation Using Photodynamic Treatment of Marrow Grafts for Relapsed/Refractory Acute Leukemia.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Leukemia; Transplantation; Acute leukemia; Hematopoietic stem cell transplantation; Myeloid leukemia; Refractory (planetary science); Internal medicine; Oncology; Surgery; Immunology; Gastroenterology; Biology","score_opus":0.023280738203942164,"score_gpt":0.31976832847915504,"score_spread":0.2964875902752129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2210629425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995426,0.00073633925,0.0002825058,0.000015826367,0.00004284203,0.0030916038,0.00031194888,0.000046399793,0.000046515943],"genre_scores_gemma":[0.9980219,0.0005299169,0.000653053,0.000008260968,0.00003634764,0.00020570122,0.00009427215,0.000048088663,0.0004024316],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99841946,0.000072324394,0.00044572924,0.00034828382,0.0003716576,0.00034253858],"domain_scores_gemma":[0.9989886,0.00013134161,0.00025641563,0.0003653187,0.00015647493,0.000101802194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014297004,0.00027506956,0.0007372965,0.0002093998,0.00007990877,0.00000607172,0.00010500711,0.00008154902,0.000010103244],"category_scores_gemma":[0.0000041891217,0.0002036841,0.00017357599,0.00017997477,0.00011412181,0.00009135132,0.00001116932,0.00009480861,7.2009993e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016992655,0.020247106,0.013189641,0.0006744768,0.003575027,0.00040154494,0.0076844697,0.00004220976,0.9264207,0.0000011570338,0.0000043678,0.010766668],"study_design_scores_gemma":[0.19046149,0.061336577,0.026097298,0.00035873387,0.0071812524,0.00026967344,0.0009810437,0.0012009486,0.7117471,0.0000031537975,0.000016005955,0.0003467152],"about_ca_topic_score_codex":0.00012573268,"about_ca_topic_score_gemma":0.00045026635,"teacher_disagreement_score":0.21467356,"about_ca_system_score_codex":0.00033669593,"about_ca_system_score_gemma":0.00032153007,"threshold_uncertainty_score":0.83059967},"labels":[],"label_agreement":null},{"id":"W2214065438","doi":"10.1182/blood.v122.21.4292.4292","title":"Either Combined-Modality Or Radiotherapy Alone Provide Favorable Outcome In Stage I-II Mantle Cell Lymphoma: A Report Of 82 Patients From The International Lymphoma Radiation Oncology Group (ILROG)","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Vincristine; Mantle cell lymphoma; Radiation therapy; CHOP; Rituximab; Univariate analysis; Cyclophosphamide; Surgery; Internal medicine; Chemotherapy; Stage (stratigraphy); Median follow-up; Lymphoma; Prednisone; Oncology; Gastroenterology; Multivariate analysis","score_opus":0.015496779654960945,"score_gpt":0.27473944238643694,"score_spread":0.259242662731476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2214065438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99434686,0.00035903585,0.000012390783,0.0019599095,0.00030147893,0.001591102,0.000093804716,0.000035527806,0.0012998877],"genre_scores_gemma":[0.9957524,0.00014038211,0.001071308,0.0008511265,0.00011008621,0.000414316,0.0003721507,0.000032794134,0.0012554689],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99800634,0.00010541411,0.000781569,0.0003994564,0.0004400576,0.0002671681],"domain_scores_gemma":[0.99852484,0.00024949695,0.00046999796,0.0005266585,0.00012886057,0.00010012936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027727606,0.00022771658,0.000534698,0.00008637145,0.00007052847,0.000029325029,0.00021251863,0.00014487091,0.00053750514],"category_scores_gemma":[0.0001065867,0.00014134363,0.00013188641,0.00015933787,0.00006932283,0.00015961319,0.00008393117,0.000052462707,0.000030474755],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043271133,0.019856183,0.9627676,0.000029059494,0.00034876252,0.00023639559,0.00065765233,0.000002096941,0.00074713485,0.000043539236,0.0010530278,0.013825816],"study_design_scores_gemma":[0.05050353,0.0012986205,0.9321078,0.00004581928,0.00015802875,0.000033980432,0.00014498144,0.00015795059,0.006089452,0.00008142117,0.009232582,0.0001458151],"about_ca_topic_score_codex":0.012194137,"about_ca_topic_score_gemma":0.00042141948,"teacher_disagreement_score":0.05007082,"about_ca_system_score_codex":0.00057816214,"about_ca_system_score_gemma":0.00026950476,"threshold_uncertainty_score":0.99438375},"labels":[],"label_agreement":null},{"id":"W2214595745","doi":"10.1182/blood.v122.21.3637.3637","title":"Perioperative Management Of Patients On Dabigatran – a Prospective Cohort Study","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Cardiac, Anesthesia and Surgical Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; St Mary's Hospital Centre; St Joseph's Health Care; Ottawa Hospital; University of British Columbia; Montreal General Hospital; Jewish General Hospital; McMaster University","funders":"","keywords":"Medicine; Dabigatran; Perioperative; Warfarin; Prothrombin complex concentrate; Surgery; Anesthesia; Hemostasis; Internal medicine; Atrial fibrillation","score_opus":0.005881343585121265,"score_gpt":0.23521731029400963,"score_spread":0.22933596670888837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2214595745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9154151,0.000014560005,7.9432186e-7,0.00007381441,0.000030502782,0.0026657972,0.0000018892814,0.000020679629,0.081776835],"genre_scores_gemma":[0.9968027,0.0000082697925,0.000097522214,0.0000856165,0.000022332124,0.00025306162,0.0000064554956,0.000011221459,0.0027128558],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99912155,0.0000418999,0.00017495528,0.00020329746,0.00033622116,0.00012210815],"domain_scores_gemma":[0.99953747,0.000037933147,0.000034069068,0.00021565336,0.00010302653,0.000071842165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000085861364,0.00010958551,0.00041610538,0.00003821924,0.000031022482,0.000009502276,0.000041888703,0.000026597098,0.00018313114],"category_scores_gemma":[0.000014637498,0.00007467092,0.00013613576,0.000096015814,0.000033851033,0.000032370215,0.000018186616,0.000067419074,0.00007999586],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000697124,0.00383763,0.9931991,0.000030444133,0.0006564789,0.000070163434,0.00074150675,4.4541574e-7,0.00002452952,0.0008582599,0.000013745366,0.00049795763],"study_design_scores_gemma":[0.0055424003,0.0012820103,0.99097943,0.000032589345,0.00043700647,0.0000030709375,0.00073030195,0.0000010038568,0.00061080983,0.000004783775,0.00029943307,0.00007714506],"about_ca_topic_score_codex":0.000037549125,"about_ca_topic_score_gemma":0.0000013300348,"teacher_disagreement_score":0.081387535,"about_ca_system_score_codex":0.00001857412,"about_ca_system_score_gemma":0.000008989106,"threshold_uncertainty_score":0.30449915},"labels":[],"label_agreement":null},{"id":"W2215476320","doi":"10.1182/blood.v122.21.437.437","title":"Fine-Mapping and Genome Editing Reveal An Essential Erythroid Enhancer At The HbF-Associated BCL11A Locus","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Biology; Chromosome conformation capture; Enhancer; Genetics; Locus (genetics); Chromatin; Transcription activator-like effector nuclease; Genome editing; Chromatin immunoprecipitation; CRISPR; Transcription factor; Gene; Molecular biology; Promoter; Gene expression","score_opus":0.006346121305916081,"score_gpt":0.21688866628529524,"score_spread":0.21054254497937916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2215476320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915937,0.0026255539,0.000017323633,0.0023144835,0.0002349279,0.00042600554,0.000007645991,0.00007915022,0.002701194],"genre_scores_gemma":[0.99620205,0.00019055467,0.000075766286,0.0002784294,0.00053141935,0.000028346225,0.000045527348,0.000028775363,0.0026191166],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99881995,0.000055072574,0.00025919595,0.00027600137,0.00020990516,0.00037988124],"domain_scores_gemma":[0.99936086,0.000044305867,0.00010979569,0.00023887541,0.00009404575,0.00015214657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019755476,0.00016158848,0.0002376482,0.000044498473,0.0003036152,0.000046446617,0.00007805261,0.00017803055,0.00048447307],"category_scores_gemma":[0.00010266662,0.00010874652,0.00006589585,0.00016640207,0.00012416154,0.00010389369,0.00009369283,0.00028723123,0.00011530103],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000426268,0.0010437152,0.01927451,0.00018176182,0.0007151338,0.00011359552,0.0045852573,0.000019323532,0.9587024,0.000031918084,0.007104615,0.008185135],"study_design_scores_gemma":[0.06985591,0.004083572,0.6757964,0.0027467685,0.0055170404,0.002579942,0.022737682,0.0022463289,0.13382548,0.0015349694,0.07491593,0.004159994],"about_ca_topic_score_codex":0.000255042,"about_ca_topic_score_gemma":0.000095689415,"teacher_disagreement_score":0.8248769,"about_ca_system_score_codex":0.00003678326,"about_ca_system_score_gemma":0.00004542192,"threshold_uncertainty_score":0.53046405},"labels":[],"label_agreement":null},{"id":"W2215631084","doi":"10.1182/blood.v122.21.4394.4394","title":"Siltuximab Reverses Muscle Wasting In Patients With Multicentric Castleman’s Disease","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Gastroenterology; Internal medicine; Wasting","score_opus":0.006031593902683029,"score_gpt":0.19581289054301224,"score_spread":0.1897812966403292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2215631084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99834245,0.00023390538,6.0989476e-7,0.00018507086,0.0000289352,0.0006765953,0.000008363578,0.000028900933,0.0004951425],"genre_scores_gemma":[0.999033,0.000014684921,0.0005180515,0.00016065626,0.000032791828,0.00010372918,0.000030286526,0.000014772562,0.00009207043],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99923086,0.00001559557,0.0001395784,0.00020247781,0.00018997882,0.0002214969],"domain_scores_gemma":[0.99946284,0.000042248572,0.000045544388,0.00019876657,0.000066447086,0.00018413775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000021256335,0.000115748204,0.00016267307,0.0000673175,0.00003471291,0.000016925174,0.000033510012,0.000023212322,0.0001568035],"category_scores_gemma":[0.0000790526,0.000078566,0.000035277317,0.00013500193,0.000017863895,0.00009076615,0.00002559003,0.000041114024,0.00015781198],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003426675,0.0051154424,0.99082303,0.00005529139,0.000041548752,0.00014351458,0.00009140746,0.000002680356,0.000013184684,0.0000050132207,0.00014981511,0.0035247952],"study_design_scores_gemma":[0.01807295,0.00018719757,0.9808578,0.00021075233,0.00023200235,0.0000021419153,0.000055979002,0.00005023036,0.00012801784,0.0000036053711,0.000107375134,0.000091938906],"about_ca_topic_score_codex":0.00023970786,"about_ca_topic_score_gemma":0.000012681794,"teacher_disagreement_score":0.018038683,"about_ca_system_score_codex":0.00006462496,"about_ca_system_score_gemma":0.00004578234,"threshold_uncertainty_score":0.32038286},"labels":[],"label_agreement":null},{"id":"W2216659987","doi":"10.1182/blood-2015-05-647602","title":"MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA/LYSA study","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":254,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"Chugai Pharmaceutical; Sunesis; Celgene; Amgen","keywords":"Internal medicine; Oncology; Medicine; Overall survival","score_opus":0.0189819917800764,"score_gpt":0.24759458164756087,"score_spread":0.22861258986748448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2216659987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966554,0.00010956862,2.3574796e-7,0.000039410494,0.00005364902,0.0013040797,0.000038600505,0.000033892822,0.0017651469],"genre_scores_gemma":[0.9995178,0.000020195142,0.00007281848,0.000029152978,0.00002976427,0.0001304125,0.000045274188,0.000028490223,0.00012611957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865365,0.00009379007,0.00029408323,0.00027953938,0.0004710606,0.00020790196],"domain_scores_gemma":[0.9991144,0.000041984218,0.00017079746,0.00032831918,0.00021661558,0.00012789888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012875807,0.00020348893,0.00048211723,0.00012163056,0.00002102528,0.000008885024,0.000074108204,0.00005490807,0.000020895353],"category_scores_gemma":[0.000057002508,0.0001383221,0.000050905237,0.00030550102,0.000044539625,0.000057283978,0.000029905734,0.000060982962,0.000008548671],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009127121,0.029157305,0.964929,0.00001821114,0.0010369165,0.00010715908,0.0033094322,6.562691e-7,0.000055701625,0.0000011259078,0.00009309221,0.00037872232],"study_design_scores_gemma":[0.07229102,0.004809163,0.9158638,0.00017877524,0.00045505902,0.0000026754221,0.0021179016,0.0000018042657,0.004133223,0.000004278756,0.00003397591,0.00010832876],"about_ca_topic_score_codex":0.0010036167,"about_ca_topic_score_gemma":0.00023177252,"teacher_disagreement_score":0.071378306,"about_ca_system_score_codex":0.00012668494,"about_ca_system_score_gemma":0.00008819848,"threshold_uncertainty_score":0.56406116},"labels":[],"label_agreement":null},{"id":"W2218195752","doi":"10.1182/blood.v122.21.1729.1729","title":"The Impact Of a Standardized Protocol On Thromboprophylaxis, Venous Thromboembolism and Bleeding Rates In Hospitalized Patients With Hematological Malignancies","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Retrospective cohort study; Incidence (geometry); Medical record; Venous thromboembolism; Thrombosis; Cohort; Pulmonary embolism; Emergency medicine; Pediatrics; Internal medicine","score_opus":0.008816902018028719,"score_gpt":0.2738575670614732,"score_spread":0.2650406650434445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2218195752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9559331,0.00006073256,0.0000020157895,0.00012891543,0.000019372666,0.042802025,0.000007868382,0.00003324816,0.0010127099],"genre_scores_gemma":[0.9788164,0.000043258085,0.00020113739,0.000042893425,0.000021613729,0.02083306,0.0000048740426,0.000026725404,0.0000100243615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848396,0.000055832643,0.00037813222,0.00029768804,0.00038762207,0.00039679135],"domain_scores_gemma":[0.99911696,0.00010066218,0.00019012559,0.00030410095,0.00018443963,0.000103696904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020421512,0.00025285812,0.00087944866,0.00009397346,0.00012727053,0.00007041561,0.00011421244,0.000079834725,0.00007122536],"category_scores_gemma":[0.0001016732,0.00012263881,0.00009911146,0.00021858476,0.00020818776,0.00010099616,0.000079412355,0.00014667984,0.0000068688705],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088970945,0.014317805,0.97421294,0.00055593555,0.0011453389,0.000047233443,0.0012347999,0.000011359167,0.002185671,0.0023605013,0.00097187253,0.0020668462],"study_design_scores_gemma":[0.010624332,0.007060233,0.9783682,0.00040693127,0.00010396118,0.0000061675064,0.00015416736,0.000009240879,0.0024019114,0.00066111085,0.0000441341,0.00015956051],"about_ca_topic_score_codex":0.00033694156,"about_ca_topic_score_gemma":0.000008111542,"teacher_disagreement_score":0.0228833,"about_ca_system_score_codex":0.000046330984,"about_ca_system_score_gemma":0.00007182493,"threshold_uncertainty_score":0.5001066},"labels":[],"label_agreement":null},{"id":"W2219644495","doi":"10.1182/blood.v124.21.3090.3090","title":"Rituximab with High Dose Methotrexate in the Management of Primary Central Nervous System Diffuse Large B-Cell Lymphoma","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Spinal Cord Injury BC; BC Cancer Agency","funders":"","keywords":"Medicine; Primary central nervous system lymphoma; Rituximab; Methotrexate; Diffuse large B-cell lymphoma; Lymphoma; Chemotherapy; Internal medicine; Surgery; Gastroenterology","score_opus":0.006930859399352015,"score_gpt":0.20497250349756077,"score_spread":0.19804164409820876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2219644495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99004835,0.00054863346,0.0000499815,0.00017667789,0.00005101925,0.00073285896,0.000018900617,0.000042155403,0.008331411],"genre_scores_gemma":[0.9971122,0.00011191143,0.0021934614,0.00022088793,0.00005267066,0.00012928578,0.000041131425,0.00002711627,0.00011130901],"study_design_codex":"nonrandomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9985674,0.00012346703,0.0002858189,0.00028133043,0.00036622243,0.00037578144],"domain_scores_gemma":[0.99911326,0.000081610946,0.0001183621,0.0005724515,0.000027982227,0.000086316744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027979707,0.00020169705,0.000469331,0.00007494696,0.000046445282,0.000018128563,0.0001475592,0.000051687835,0.000007742232],"category_scores_gemma":[0.0000027807248,0.00011513327,0.00009695718,0.00020728141,0.000032509488,0.000033327302,0.00005537771,0.0000476045,0.000019531246],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023710022,0.42851993,0.3230128,0.012084838,0.0038978069,0.011137039,0.0039534685,0.000022260796,0.0012464023,0.040089827,0.0007530548,0.17291157],"study_design_scores_gemma":[0.09775513,0.0005608114,0.8944509,0.00052796165,0.0013831919,0.00015635595,0.00045476333,0.000041824496,0.0034332033,0.000014249768,0.0010809706,0.00014063287],"about_ca_topic_score_codex":0.00021357297,"about_ca_topic_score_gemma":0.000028059812,"teacher_disagreement_score":0.57143813,"about_ca_system_score_codex":0.00011558695,"about_ca_system_score_gemma":0.000034868255,"threshold_uncertainty_score":0.46949983},"labels":[],"label_agreement":null},{"id":"W2220411799","doi":"10.1182/blood-2015-02-626390","title":"Hoxa cluster genes determine the proliferative activity of adult mouse hematopoietic stem and progenitor cells","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Université de Genève","keywords":"Haematopoiesis; Stem cell; Biology; Progenitor cell; Ectopic expression; Gene; Hematopoietic stem cell; Cell biology; Cancer research; Genetics","score_opus":0.010514922465824885,"score_gpt":0.21738736780188192,"score_spread":0.20687244533605703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2220411799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986697,0.00034002218,0.00017671152,0.00019038584,0.00003091151,0.00042893324,0.00005322758,0.000007817257,0.000102326645],"genre_scores_gemma":[0.9986929,0.00011658013,0.00019208963,0.000070618196,0.00013778327,0.0000841313,0.0000017149082,0.000014993713,0.0006891303],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99935,0.00008747868,0.00011861946,0.0002112568,0.00008431522,0.00014831006],"domain_scores_gemma":[0.99949807,0.000026616739,0.000083948325,0.0002595798,0.00008317225,0.000048619906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008574389,0.000119199,0.00011973821,0.000012212335,0.000051053834,0.000011684067,0.00011241157,0.00008691865,0.0000050398558],"category_scores_gemma":[0.000020189118,0.0000635583,0.000049916853,0.000024934574,0.00011007044,0.0000037876703,0.00010611834,0.000034932873,0.0000038851485],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067578396,0.000116619594,0.0020243407,0.00004866862,0.000048890015,9.903281e-7,0.00013021188,9.021894e-8,0.99372107,0.00001326569,0.00004205619,0.0037862302],"study_design_scores_gemma":[0.0010080696,0.00028574423,0.00014336595,0.000020727282,0.00003137652,0.000019248842,0.000041932537,0.000003914557,0.99787074,0.000014816575,0.00045610918,0.000103949475],"about_ca_topic_score_codex":0.0000027078813,"about_ca_topic_score_gemma":0.000013129448,"teacher_disagreement_score":0.004149687,"about_ca_system_score_codex":0.0000021279457,"about_ca_system_score_gemma":0.000033341155,"threshold_uncertainty_score":0.25918323},"labels":[],"label_agreement":null},{"id":"W2224648422","doi":"10.1182/blood.v124.21.1630.1630","title":"Prognostic Impact of Extranodal Diffuse Large B-Cell Lymphoma in the Era of Immunochemotherapy and PET/CT Staging","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Stage (stratigraphy); Diffuse large B-cell lymphoma; Univariate analysis; International Prognostic Index; B symptoms; Lymphoma; Internal medicine; Proportional hazards model; Radiology; Nuclear medicine; Gastroenterology; Multivariate analysis","score_opus":0.006198984263775764,"score_gpt":0.24663351963893818,"score_spread":0.2404345353751624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2224648422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974878,0.001540344,0.0000041668245,0.00010418976,0.000011363175,0.0003448254,0.000015987223,0.000008408144,0.00048293226],"genre_scores_gemma":[0.9994287,0.00027549692,0.0001508882,0.000070539485,0.000018902669,0.00002201246,0.000009652066,0.000013470384,0.000010367116],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992529,0.000058877828,0.00021367484,0.00013630811,0.0001584063,0.00017982571],"domain_scores_gemma":[0.9993893,0.00019702676,0.00008658008,0.000259145,0.000027283724,0.000040655206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020254722,0.00012439612,0.00028334887,0.00004665582,0.000022723643,0.000008981615,0.00006727784,0.000009815321,0.000016788592],"category_scores_gemma":[0.000035089593,0.00007185474,0.000106745305,0.00010003469,0.000043479165,0.00002848331,0.000014586543,0.000042271357,0.0000014127436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008705836,0.018472347,0.9697575,0.00010829232,0.00014211178,0.00012621812,0.00080763205,2.5274238e-7,0.0064152917,0.00007987886,0.00001648312,0.0039869105],"study_design_scores_gemma":[0.041144285,0.0009015661,0.9337191,0.00015915811,0.000196476,0.00023613794,0.00013284954,0.00007223357,0.023293713,0.000037172886,0.000038300048,0.00006898544],"about_ca_topic_score_codex":0.00028585424,"about_ca_topic_score_gemma":0.000008397601,"teacher_disagreement_score":0.041057225,"about_ca_system_score_codex":0.000021657968,"about_ca_system_score_gemma":0.00006477221,"threshold_uncertainty_score":0.29301512},"labels":[],"label_agreement":null},{"id":"W2227531350","doi":"10.1182/blood.v124.21.930.930","title":"Lysosome Membrane Permeabilization Causes Cell Death in Primary Chronic Lymphocytic Leukemia Cells","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Lysosome; Chronic lymphocytic leukemia; Biology; Programmed cell death; Leukemia; Cancer research; Apoptosis; Immunology; Biochemistry","score_opus":0.01231879229911371,"score_gpt":0.24664632537343117,"score_spread":0.23432753307431747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2227531350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819473,0.0008518528,0.000064478554,0.00003589937,0.00013740329,0.00076341804,0.00000522978,0.00015798256,0.01603644],"genre_scores_gemma":[0.99517107,0.0005556123,0.0004407593,0.0003225593,0.0004518508,0.000072445946,0.00007343422,0.00009005747,0.0028221812],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99709076,0.00015462007,0.00053731404,0.00065728155,0.00075595046,0.0008041001],"domain_scores_gemma":[0.99829406,0.0003097274,0.00010683845,0.000873063,0.00011741756,0.00029889515],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005289078,0.00032118437,0.00058744865,0.00033039448,0.00007862659,0.00004298683,0.0002755999,0.00026005626,0.00023703021],"category_scores_gemma":[0.00018493357,0.00029508513,0.00013377648,0.0005318702,0.00013030971,0.00014820423,0.00015013685,0.00029453277,0.00044101002],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0005044357,0.0015524545,0.007989198,0.0070050796,0.00019597793,0.0009329982,0.0010719103,0.008181356,0.9693814,0.00040910352,0.00067647424,0.0020996488],"study_design_scores_gemma":[0.121186815,0.00087124674,0.00978838,0.00060905423,0.00042517317,0.00056192663,0.000052963635,0.077738,0.7850975,0.000111199595,0.002879502,0.0006782559],"about_ca_topic_score_codex":0.0010593133,"about_ca_topic_score_gemma":0.00012837216,"teacher_disagreement_score":0.18428388,"about_ca_system_score_codex":0.074477084,"about_ca_system_score_gemma":0.029073536,"threshold_uncertainty_score":0.9999501},"labels":[],"label_agreement":null},{"id":"W2228680004","doi":"10.1182/blood.v112.11.36.36","title":"A Pooled Analysis of Four Pivotal Studies of Rivaroxaban for the Prevention of Venous Thromboembolism after Orthopaedic Surgery: Effect on Symptomatic Venous Thromboembolism, Death, and Bleeding","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Rivaroxaban; Pulmonary embolism; Surgery; Deep vein; Thrombosis; Hemostasis; Venous thrombosis; Randomized controlled trial; Knee replacement; Anesthesia; Arthroplasty; Internal medicine; Warfarin; Atrial fibrillation","score_opus":0.03656437108191536,"score_gpt":0.29573939001625776,"score_spread":0.2591750189343424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2228680004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99233925,0.0052882386,0.000077405915,0.00011578012,0.0001870834,0.0017979335,0.00004652205,0.000039230395,0.00010855347],"genre_scores_gemma":[0.99680406,0.0023850782,0.00020053223,0.00007483902,0.00012044865,0.00032310642,0.000022042224,0.00004800767,0.000021907043],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974854,0.00015247581,0.0009285055,0.00042655846,0.0006079323,0.00039914725],"domain_scores_gemma":[0.996827,0.0015661877,0.00066432834,0.0005795447,0.0002676724,0.0000952586],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010186014,0.00035476184,0.0029994631,0.0006549553,0.00017507558,0.000008954366,0.00014959888,0.00012080735,0.0000222596],"category_scores_gemma":[0.0004304878,0.0002487501,0.00096186594,0.00077705656,0.00030452147,0.00008414867,0.00011517865,0.00013317201,0.0000011949209],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002406164,0.047256306,0.5354869,0.024049563,0.29766363,0.00036419186,0.034428827,0.00060921186,0.02854334,0.0035423425,0.0010236586,0.024625907],"study_design_scores_gemma":[0.0031224377,0.0050189667,0.9182248,0.0013283304,0.060644135,0.000047586513,0.00050379947,0.00023036095,0.010394382,0.00022352768,0.000016779919,0.00024486368],"about_ca_topic_score_codex":0.00010699322,"about_ca_topic_score_gemma":0.000030460727,"teacher_disagreement_score":0.38273796,"about_ca_system_score_codex":0.000036962636,"about_ca_system_score_gemma":0.00009168464,"threshold_uncertainty_score":0.9999965},"labels":[],"label_agreement":null},{"id":"W2230923431","doi":"10.1182/blood-2015-09-672592","title":"C-reactive protein enhances murine antibody–mediated transfusion-related acute lung injury","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Canadian Blood Services; St. Michael's Hospital","funders":"Health Canada; Canadian Blood Services","keywords":"Transfusion-related acute lung injury; Antibody; In vivo; Immunology; Medicine; Lung; C-reactive protein; Isoantibodies; Inflammation; Pulmonary edema; Biology; Internal medicine","score_opus":0.010096798379412063,"score_gpt":0.27730073295587,"score_spread":0.2672039345764579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2230923431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9760238,0.00037588147,0.00023828258,0.0021779346,0.00024750546,0.0018376745,0.000025682632,0.00034513575,0.01872812],"genre_scores_gemma":[0.99495935,0.00019629992,0.0006024432,0.00043500008,0.000110688285,0.000121545934,0.00017385247,0.000045885252,0.003354936],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982458,0.00006391977,0.00038595003,0.00042899023,0.00050544355,0.00036992534],"domain_scores_gemma":[0.99898577,0.000021485426,0.00008329577,0.00036138983,0.00016221084,0.00038585206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002748038,0.00026428813,0.0004219154,0.00020339972,0.00007496793,0.000020975123,0.00013564102,0.00016246598,0.00036200296],"category_scores_gemma":[0.000055266282,0.00021595666,0.00013379693,0.00049347326,0.00008075634,0.00014694856,0.000045725177,0.00033808814,0.0002262744],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008397451,0.0038123787,0.00399959,0.00016742588,0.0016427271,0.00058114924,0.0015406992,5.5549907e-7,0.98333806,0.00039699255,0.001698813,0.0019818756],"study_design_scores_gemma":[0.03253627,0.002582435,0.01367849,0.0006573586,0.002985575,0.00018696967,0.00072656083,0.00015395824,0.9250934,0.00029900402,0.02032176,0.0007782188],"about_ca_topic_score_codex":0.00014395888,"about_ca_topic_score_gemma":0.000020056692,"teacher_disagreement_score":0.05824465,"about_ca_system_score_codex":0.000031054144,"about_ca_system_score_gemma":0.00014538372,"threshold_uncertainty_score":0.8806457},"labels":[],"label_agreement":null},{"id":"W2231200204","doi":"10.1182/blood.v124.21.3460.3460","title":"Interpretation and Application of the International Myeloma Working Group (IMWG) Criteria: Proposal for Uniform Assessment and Reporting in Clinical Trials Based on the First Study Independent Response Adjudication Committee (IRAC) Experience","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Clinical trial; Discontinuation; Clinical endpoint; Multiple myeloma; Surrogate endpoint; Family medicine; Internal medicine; Oncology; Medical physics","score_opus":0.10680282608917449,"score_gpt":0.45167109004951544,"score_spread":0.344868263960341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2231200204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99050707,0.000009928422,0.0038658397,0.0026182262,0.000064609536,0.0028424163,0.0000038685225,0.000009629899,0.000078398414],"genre_scores_gemma":[0.9975578,0.0000038118362,0.0014016378,0.00013663074,0.000057130394,0.00081587903,0.000013713845,0.000008891413,0.000004501728],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99738675,0.0007252622,0.0011146978,0.0002740557,0.0003891184,0.000110109555],"domain_scores_gemma":[0.9960365,0.0025912027,0.00092254305,0.00031621626,0.00008735721,0.000046138866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011505197,0.0000942946,0.00028349963,0.000084802814,0.00011930854,0.00004267261,0.00012373732,0.000052682968,0.0000037177426],"category_scores_gemma":[0.007863731,0.000053691187,0.00006134683,0.00010006829,0.00008576704,0.000051081814,0.000079416975,0.0001593191,2.0339677e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002964161,0.0013939039,0.9567564,0.0000276472,0.000069478636,0.0000030445788,0.0009354476,0.000003178007,0.001729029,0.00020429706,0.0000050955696,0.03590831],"study_design_scores_gemma":[0.0060760975,0.00090157473,0.9342273,0.00016017426,0.00006479476,0.0000069739876,0.0006876935,0.056831572,0.00081562303,0.000141595,0.000042383508,0.000044229608],"about_ca_topic_score_codex":0.000037343067,"about_ca_topic_score_gemma":0.00015089088,"teacher_disagreement_score":0.056828395,"about_ca_system_score_codex":0.00005785943,"about_ca_system_score_gemma":0.0000909588,"threshold_uncertainty_score":0.9414188},"labels":[],"label_agreement":null},{"id":"W2232969484","doi":"10.1182/blood.v124.21.1624.1624","title":"Cell-of-Origin Assignment in Diffuse Large B-Cell Lymphoma Determined By Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Has Prognostic Significance Independent of IPI and MYC/BCL2 Immunohistochemistry","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Tissue microarray; Immunohistochemistry; Concordance; Lymphoma; Pathology; Gene expression profiling; Biology; Germinal center; Cancer research; Medicine; Gene expression; Gene; B cell; Bioinformatics; Immunology; Antibody; Genetics","score_opus":0.013016549360451162,"score_gpt":0.2711677360484875,"score_spread":0.2581511866880363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2232969484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996151,0.001781938,0.00043627122,0.000034042052,0.000040306688,0.0010817789,0.000028108312,0.000020854712,0.00042573374],"genre_scores_gemma":[0.99737066,0.00014201897,0.0011904569,0.000021088397,0.000045032404,0.00018711822,0.000058854566,0.00004428,0.0009404925],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99759656,0.00014736617,0.0006968245,0.00045432107,0.0006005948,0.0005043119],"domain_scores_gemma":[0.99869525,0.00023957071,0.000263917,0.00055305293,0.00007013173,0.00017807278],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00060638913,0.00027013128,0.0006129415,0.00016709036,0.000038571023,0.000018001985,0.00022619436,0.00022435699,0.00010285655],"category_scores_gemma":[0.00008693787,0.00025416634,0.000067041576,0.00021799191,0.0001235804,0.00006499668,0.00013343536,0.0002325642,0.000003616001],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006285856,0.010065679,0.02627151,0.0005801733,0.000019827823,0.000055888744,0.0006786074,0.000003188006,0.9604757,0.0000013230942,0.00007967456,0.0011398764],"study_design_scores_gemma":[0.04062291,0.00060917326,0.0040988475,0.0002858591,0.000053023814,0.000017761613,0.00010273778,0.00035356177,0.9533181,0.000014467239,0.00030733435,0.0002162162],"about_ca_topic_score_codex":0.000100911166,"about_ca_topic_score_gemma":0.000007702253,"teacher_disagreement_score":0.039994325,"about_ca_system_score_codex":0.00011984216,"about_ca_system_score_gemma":0.000187531,"threshold_uncertainty_score":0.99999106},"labels":[],"label_agreement":null},{"id":"W2233438852","doi":"10.1182/blood-2015-06-655043","title":"From cytopenia to leukemia: the role of Gfi1 and Gfi1b in blood formation","year":2015,"lang":"en","type":"review","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":117,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Montreal Clinical Research Institute","funders":"National Institute on Drug Abuse; Canadian Institutes of Health Research; Institut de Recherche Clinique De Montréal","keywords":"Cytopenia; Leukemia; Hematologic Neoplasms; Cancer research; Medicine; Biology; Genetics; Oncology; Immunology; Bone marrow; Cancer","score_opus":0.013637425400754698,"score_gpt":0.2678188156159507,"score_spread":0.25418139021519603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2233438852","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.033544086,0.9649386,0.0000023229418,0.000010689584,0.00002410766,0.00052410504,0.00014673697,0.0000032692242,0.0008060833],"genre_scores_gemma":[0.015086854,0.983958,0.00014115869,0.000026439086,0.000097958095,0.00010832293,0.00050084095,0.00002508572,0.000055357625],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991186,0.000060295486,0.0003022342,0.00026944562,0.000100121026,0.00014926541],"domain_scores_gemma":[0.9993819,0.000010387918,0.00014865493,0.0003636203,0.000034659573,0.00006078629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010419371,0.00021654535,0.0005186301,0.000045146207,0.000024696821,0.000018764355,0.00020406724,0.00025709817,0.0000036248762],"category_scores_gemma":[0.000022380595,0.0001456308,0.00010426445,0.000099926554,0.000031565032,0.0000037007487,0.00017334482,0.00009498679,0.000009147118],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025609,0.00076244015,0.00068853656,0.001003462,0.00088477664,0.000012095789,0.0003288299,0.0000014119815,0.0008280875,0.00004875526,0.00040297266,0.995013],"study_design_scores_gemma":[0.002152672,0.00032436542,0.000049348604,0.0008757501,0.0018397177,0.000036658937,0.00012440282,9.549575e-7,0.0059469077,0.00035399853,0.9880028,0.00029245744],"about_ca_topic_score_codex":0.00028093273,"about_ca_topic_score_gemma":0.0002705824,"teacher_disagreement_score":0.9947206,"about_ca_system_score_codex":0.000009280707,"about_ca_system_score_gemma":0.00015148502,"threshold_uncertainty_score":0.59386516},"labels":[],"label_agreement":null},{"id":"W2234721586","doi":"10.1182/blood.v122.21.2939.2939","title":"Pomalidomide (POM) Plus Low-Dose Dexamethasone (LoDEX) Improves Health-Related Quality Of Life (HRQoL) Vs High-Dose Dexamethasone (HiDEX) In Relapsed Refractory Multiple Myeloma (RRMM) Patients Enrolled In MM-003 Phase 3 Randomized Trial","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Vancouver General Hospital","funders":"","keywords":"Medicine; Pomalidomide; Lenalidomide; Multiple myeloma; Internal medicine; Dexamethasone; Quality of life (healthcare); Randomized controlled trial; Surgery","score_opus":0.031077756836230323,"score_gpt":0.3190235386957008,"score_spread":0.2879457818594705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2234721586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97994125,0.0019485472,0.000031915235,0.0005629649,0.0004392457,0.016634924,0.00017016694,0.00015549053,0.00011549614],"genre_scores_gemma":[0.99171257,0.00031363487,0.0041123284,0.00030262876,0.00014798163,0.002174434,0.0006767322,0.00015791148,0.00040177908],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98526645,0.0049817553,0.0049078017,0.0014116362,0.0017059356,0.0017264106],"domain_scores_gemma":[0.9885365,0.0060644927,0.0019450742,0.0015086374,0.00053989596,0.0014054298],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0053979624,0.0009655895,0.005435437,0.0012855133,0.00016256442,0.00006536823,0.00048757036,0.00070942007,0.00041629252],"category_scores_gemma":[0.02659924,0.0008016501,0.00080136687,0.0013730472,0.00051634095,0.0004246685,0.0002510561,0.0013517276,0.00012582418],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9013763,0.029908264,0.02924294,0.0005897047,0.0013666552,0.00018109976,0.0012458652,0.000021320346,0.022583663,0.000018223725,0.0001092288,0.013356703],"study_design_scores_gemma":[0.86458033,0.004324848,0.12187318,0.0004334018,0.00021942714,0.0000065873774,0.00018798193,0.0014317394,0.006241032,0.00014157788,0.000011625611,0.0005482782],"about_ca_topic_score_codex":0.035243414,"about_ca_topic_score_gemma":0.0012589758,"teacher_disagreement_score":0.09263024,"about_ca_system_score_codex":0.0007254178,"about_ca_system_score_gemma":0.0017140068,"threshold_uncertainty_score":0.9994434},"labels":[],"label_agreement":null},{"id":"W2235391695","doi":"10.1182/blood.v124.21.1179.1179","title":"Incidence of Secondary Malignancies Following Allogeneic Hematopoietic Cell Transplantation: A Single Center Experience","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Gastroenterology; Internal medicine; Transplantation; Total body irradiation; Hematopoietic stem cell transplantation; Leukemia; Aplastic anemia; Mucositis; Acute leukemia; Myeloid leukemia; Incidence (geometry); Surgery; Bone marrow; Radiation therapy; Chemotherapy; Cyclophosphamide","score_opus":0.013025615345397642,"score_gpt":0.23961573621586438,"score_spread":0.22659012087046673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2235391695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865473,0.00028561588,0.004420027,0.000057391582,0.00013861028,0.00027595015,0.000010785547,0.000059641796,0.008204684],"genre_scores_gemma":[0.99516946,0.000047304577,0.0043177283,0.00018938222,0.00004310997,0.00003186961,0.000034218865,0.00002574304,0.00014116411],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985736,0.000057760364,0.00044738277,0.00029037532,0.00037585758,0.000254998],"domain_scores_gemma":[0.999281,0.00012705693,0.00011469243,0.0003011039,0.000061719744,0.00011443073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018219007,0.00017207886,0.00034868522,0.000089250876,0.000052655694,0.000012733734,0.00012404783,0.000092299124,0.00013429967],"category_scores_gemma":[0.000024987297,0.00016240386,0.0001551004,0.00016760376,0.00007116549,0.00011385103,0.000011748622,0.000096307784,0.000029883406],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005576706,0.0007008906,0.17135844,0.0018940528,0.00004811497,0.00018532707,0.009706934,0.0000036436404,0.8156608,0.00012043148,0.000013616197,0.00025198897],"study_design_scores_gemma":[0.003809715,0.00029490126,0.024996232,0.0007835213,0.0003234617,0.0009203904,0.0005978943,0.000008973867,0.96787274,0.000060323495,0.00014051024,0.00019136193],"about_ca_topic_score_codex":0.000012548047,"about_ca_topic_score_gemma":0.0000075630173,"teacher_disagreement_score":0.15221192,"about_ca_system_score_codex":0.000013077084,"about_ca_system_score_gemma":0.00006380717,"threshold_uncertainty_score":0.6622637},"labels":[],"label_agreement":null},{"id":"W2235819850","doi":"10.1182/blood.v124.21.1489.1489","title":"Administration of Dexamethasone during Initial Exposure to Factor VIII Induces Durable and Antigen-Specific Tolerance to Factor VIII in Hemophilia Α Mice with a Humanized Major Histocompatibility Complex II Transgene","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Janeway Children's Health and Rehabilitation Centre; Queen's University; Memorial University of Newfoundland","funders":"","keywords":"Medicine; Immunology; Immune tolerance; Von Willebrand factor; Antibody; Antigen; Transgene; Immune system; Pharmacology; Internal medicine; Biology","score_opus":0.04984924654980655,"score_gpt":0.30555555056812955,"score_spread":0.255706304018323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2235819850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970563,0.00017452534,0.00005811506,0.0005383703,0.00003309288,0.0018694419,0.000068774214,0.00004139622,0.00015999957],"genre_scores_gemma":[0.99670607,0.000030171064,0.0028406028,0.000046344874,0.00011536367,0.00008608474,0.000031435004,0.0000316422,0.00011230761],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.997962,0.0001223487,0.00050081377,0.00056427444,0.00045406632,0.00039652543],"domain_scores_gemma":[0.99897444,0.00009407671,0.000089215246,0.00037814697,0.0001476066,0.0003165254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019584195,0.0002769304,0.00067065825,0.0002469437,0.0001726949,0.000027051568,0.00013483288,0.00012297157,0.00022023178],"category_scores_gemma":[0.000055100747,0.00022338745,0.000059556427,0.0003516224,0.00010220834,0.00011165008,0.00004371843,0.0002153086,0.000012374273],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026249394,0.001532827,0.12269419,0.00030599473,0.00007241876,0.000046592464,0.0032174187,0.0000027588742,0.8685621,0.0000108474,0.000008013254,0.00092189113],"study_design_scores_gemma":[0.007334337,0.0021986768,0.5764525,0.00017019866,0.000021903408,0.00002567272,0.00007687452,0.0000072646885,0.41343403,0.000005122293,0.000106894535,0.00016656281],"about_ca_topic_score_codex":0.000091786605,"about_ca_topic_score_gemma":0.0005052561,"teacher_disagreement_score":0.45512807,"about_ca_system_score_codex":0.000074044656,"about_ca_system_score_gemma":0.00010144897,"threshold_uncertainty_score":0.91094756},"labels":[],"label_agreement":null},{"id":"W2237296780","doi":"10.1182/blood.v124.21.3873.3873","title":"Non-Myeloablative Conditioning Targeting Host Immunosuppression Is Successful in Matched Sibling Donor Stem Cell Transplantation for Hemoglobinopathies in Children","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Fludarabine; Treosulfan; Alemtuzumab; Melphalan; Transplantation; Internal medicine; Hematopoietic stem cell transplantation; Mucositis; Graft-versus-host disease; Busulfan; Regimen; Immunosuppression; Surgery; Gastroenterology; Cyclophosphamide; Chemotherapy","score_opus":0.006864989201285002,"score_gpt":0.23661074564947332,"score_spread":0.22974575644818832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2237296780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935039,0.0001500118,0.0039948495,0.00010474212,0.00007036587,0.0012694614,0.00006423702,0.00005133061,0.0007910475],"genre_scores_gemma":[0.99588525,0.00012186843,0.0031213087,0.00010202816,0.00007863947,0.00014948082,0.0004570852,0.00004149717,0.000042857188],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99831975,0.00008091655,0.00061938475,0.00039162315,0.00023458959,0.00035376384],"domain_scores_gemma":[0.99921674,0.00028699244,0.00018475598,0.00016366439,0.0000780449,0.00006980399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053567777,0.00022511963,0.0004285484,0.00034369985,0.00009750094,0.000037558842,0.00009657681,0.00017291831,0.00002815457],"category_scores_gemma":[0.000018410567,0.00022339259,0.00007908183,0.00033371054,0.00003301122,0.00022792353,0.0000098303935,0.00022184361,0.00001337306],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026187635,0.00038708642,0.73377836,0.0013590504,0.000037369886,0.000018226032,0.010988191,0.00011828957,0.2526882,0.00002459494,0.000015068803,0.00032370116],"study_design_scores_gemma":[0.011128749,0.00016523957,0.33545178,0.0013543839,0.00017026033,0.000053037365,0.00143501,0.0010024611,0.64896774,0.00004715692,0.0000038762623,0.00022030568],"about_ca_topic_score_codex":0.00014372218,"about_ca_topic_score_gemma":0.000018608383,"teacher_disagreement_score":0.39832658,"about_ca_system_score_codex":0.00004455149,"about_ca_system_score_gemma":0.000056255194,"threshold_uncertainty_score":0.91096854},"labels":[],"label_agreement":null},{"id":"W2239584778","doi":"10.1182/blood.v122.21.3569.3569","title":"Myeloid-Derived Suppressor Cell (MDSC) Dynamics In FVIII-Exposed Hemophilia A Mice: Novel Therapeutic Implications","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Immunology; Immune system; Myeloid-derived Suppressor Cell; Bone marrow; Spleen; Myeloid; Internal medicine; Cancer; Suppressor","score_opus":0.012070873171322641,"score_gpt":0.22325144093994126,"score_spread":0.21118056776861863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2239584778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98808557,0.0034840598,0.00024796883,0.0014084905,0.000559297,0.000809391,0.000081298655,0.00010907231,0.0052148397],"genre_scores_gemma":[0.99452543,0.0001387491,0.00051338185,0.00056718633,0.000026951118,0.0003072087,0.00018745103,0.000046569192,0.0036870479],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985074,0.00009103226,0.00039999382,0.00041906838,0.00003428358,0.0005482172],"domain_scores_gemma":[0.99893516,0.00015896806,0.00013937076,0.0006456499,0.00009564013,0.000025232916],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000107974745,0.00025145555,0.00031049078,0.0001283091,0.00013866965,0.000028533777,0.00051826274,0.0004863499,0.0009238416],"category_scores_gemma":[0.00002234439,0.0002461661,0.000100443234,0.00022053233,0.0002031871,0.000119184304,0.00013460324,0.00055880466,0.001224702],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019539293,0.0009752919,0.0026745994,0.000024176858,0.00010130228,8.911017e-7,0.00035228804,0.000004930508,0.9941199,0.0006124338,0.0004228007,0.0006918809],"study_design_scores_gemma":[0.006550181,0.0001028408,0.06890103,0.000027605807,0.00011406916,0.000056088575,0.00041988623,0.0000501074,0.9187568,0.00060506735,0.003974949,0.00044140627],"about_ca_topic_score_codex":0.00030558457,"about_ca_topic_score_gemma":0.00011630461,"teacher_disagreement_score":0.0753631,"about_ca_system_score_codex":0.00011984729,"about_ca_system_score_gemma":0.00009677539,"threshold_uncertainty_score":0.99999905},"labels":[],"label_agreement":null},{"id":"W2240640285","doi":"10.1182/blood.v110.11.2672.2672","title":"Subpopulations with Iron Deficiency, Liver Disease, or HFE Mutations Revealed by Statistical Mixture Modeling of Transferrin Saturation and Serum Ferritin Concentration in Asians, African Americans, Hispanics, and Whites.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Transferrin saturation; Hereditary hemochromatosis; Hemochromatosis; Confidence interval; Ferritin; Internal medicine; Demography; Medicine; Transferrin; Population; Ethnic group; Endocrinology; Serum ferritin","score_opus":0.010819168362837955,"score_gpt":0.24584474100956358,"score_spread":0.23502557264672563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2240640285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95722806,0.0021540467,0.039305184,0.0004122592,0.000011411993,0.00047647938,0.00023686184,0.000019402329,0.00015629176],"genre_scores_gemma":[0.9940235,0.00032987964,0.0051676384,0.00008221595,0.000015341999,0.000009973997,0.0003244139,0.000014469959,0.000032570897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99902064,0.000044933244,0.0002959234,0.00023535738,0.00020384329,0.0001992921],"domain_scores_gemma":[0.9995651,0.00006186078,0.00005372274,0.00010008723,0.000060967086,0.000158255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001271542,0.00012602721,0.00021202599,0.00007759729,0.00006633792,0.000014780323,0.000025909014,0.000056350204,0.000017526982],"category_scores_gemma":[0.00008899793,0.000103603066,0.000014361744,0.00023995187,0.00012749781,0.000110519926,0.000005136129,0.00011643526,2.2001825e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022195643,0.0020490938,0.9602956,0.0010002318,0.000029964658,0.00011525016,0.0068976334,0.0008903448,0.0060198,0.0075646397,0.00013772714,0.012780132],"study_design_scores_gemma":[0.0052884137,0.00033293682,0.9785665,0.0001166628,0.0005487984,0.000026093103,0.0027868364,0.011812546,0.00013665973,0.0001259785,0.000028022494,0.000230529],"about_ca_topic_score_codex":0.0003900243,"about_ca_topic_score_gemma":0.0017841669,"teacher_disagreement_score":0.036795434,"about_ca_system_score_codex":0.000016451711,"about_ca_system_score_gemma":0.000106860956,"threshold_uncertainty_score":0.42248103},"labels":[],"label_agreement":null},{"id":"W2240957062","doi":"10.1182/blood.v96.10.3630","title":"o-Raffinose cross-linked hemoglobin improves the hemostatic defect associated with anemia and thrombocytopenia in rabbits","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobin structure and function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Queen's University","funders":"","keywords":"Vasoconstriction; Platelet; Medicine; Bleeding time; Thrombosis; Hemostasis; Anesthesia; Internal medicine; Pharmacology","score_opus":0.005550846795797855,"score_gpt":0.22646879847654194,"score_spread":0.2209179516807441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2240957062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975815,0.0005938843,0.000007190291,0.00009922539,0.00003477018,0.00027773328,0.000013845206,0.000017521697,0.001374354],"genre_scores_gemma":[0.9985422,0.000098386525,0.00009676607,0.00047895944,0.00006590463,0.00001936229,0.000091192014,0.000019875037,0.0005873941],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99905914,0.0000712616,0.00017144928,0.0003290951,0.000106782085,0.00026228387],"domain_scores_gemma":[0.9995661,0.000031623676,0.00005389672,0.00025736124,0.00003768277,0.000053383406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016738934,0.00017287812,0.00017071221,0.000018380617,0.00011102745,0.000063419895,0.00012172956,0.0001623207,0.000042205218],"category_scores_gemma":[0.00007849757,0.000114819035,0.00004460766,0.00014530195,0.0001258562,0.000007892795,0.000035645593,0.00013576481,0.0000063256343],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000601121,0.00040838722,0.13012055,0.00004492771,0.0002850505,0.000058066707,0.00045018806,0.0001150529,0.846999,0.000030292955,0.0009164139,0.019970953],"study_design_scores_gemma":[0.010047185,0.0012279678,0.7625937,0.00006252356,0.00019662839,0.00022635069,0.00008954342,0.000067127745,0.22025962,0.0002258232,0.0043894537,0.00061408343],"about_ca_topic_score_codex":0.00003885305,"about_ca_topic_score_gemma":0.00022783557,"teacher_disagreement_score":0.6324731,"about_ca_system_score_codex":0.000011354689,"about_ca_system_score_gemma":0.00006407256,"threshold_uncertainty_score":0.46821845},"labels":[],"label_agreement":null},{"id":"W2241182848","doi":"10.1182/blood.v110.11.645.645","title":"Interim Results of a Phase I/II Study of Ocrelizumab, a New Humanised Anti-CD20 Antibody in Patients with Relapsed/Refractory Follicular Non-Hodgkin’s Lymphoma.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Rituximab; Cohort; Internal medicine; Follicular lymphoma; Adverse effect; Interim analysis; Refractory (planetary science); Gastroenterology; Lymphoma; Progressive disease; Surgery; Oncology; Chemotherapy; Clinical trial","score_opus":0.01971437987032344,"score_gpt":0.32903012857881014,"score_spread":0.3093157487084867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2241182848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99680924,0.00017446422,0.00002297457,0.000041392308,0.000061275416,0.0012243383,0.00004164683,0.000020744825,0.00160392],"genre_scores_gemma":[0.9987965,0.000033069424,0.00031586672,0.000040341696,0.000083978346,0.0000064557626,0.00012582376,0.000039023013,0.0005589235],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970678,0.00007159253,0.0009588504,0.00046188937,0.00095833687,0.000481502],"domain_scores_gemma":[0.9984859,0.00011221278,0.00033512284,0.00055258494,0.0002903328,0.00022383075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048038104,0.0002864729,0.00080337905,0.00047573977,0.000073982264,0.000008298996,0.00025040653,0.00012031754,0.000058558926],"category_scores_gemma":[0.00011820224,0.00021404815,0.00012990154,0.00055562577,0.00013203928,0.00009733282,0.00017178144,0.00023934706,0.0000079960655],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.062397283,0.13542153,0.7046637,0.00047100818,0.0011998778,0.001269913,0.008160572,0.000004796695,0.07653002,0.000032417534,0.0005904081,0.00925848],"study_design_scores_gemma":[0.15055516,0.04460613,0.78138524,0.0005864506,0.00021758857,0.000016539807,0.00058461225,0.000015627187,0.020936027,0.000008847695,0.00084321236,0.0002445459],"about_ca_topic_score_codex":0.0020884497,"about_ca_topic_score_gemma":0.0002346421,"teacher_disagreement_score":0.090815395,"about_ca_system_score_codex":0.000045737488,"about_ca_system_score_gemma":0.00024848018,"threshold_uncertainty_score":0.872863},"labels":[],"label_agreement":null},{"id":"W2241865136","doi":"10.1182/blood.v112.11.10.10","title":"High-Dose Methotrexate Seems to Benefit Only to Standard-Risk BCP-ALL Patients with Good Early Response to Chemotherapy: Final Analysis of the FRALLE93B Study","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Idarubicin; Internal medicine; Methotrexate; Gastroenterology; Daunorubicin; Randomization; Cytarabine; Chemotherapy; Randomized controlled trial; Surgery","score_opus":0.015356063020597721,"score_gpt":0.27720923784791085,"score_spread":0.26185317482731313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2241865136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954904,0.00001511797,0.000361697,0.0010964354,0.00004451817,0.0024963608,0.00036772864,0.00004944756,0.000078343845],"genre_scores_gemma":[0.9895886,0.0000061240885,0.007094611,0.00096046756,0.000055626442,0.000093352486,0.000012306703,0.00007246363,0.0021164282],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958199,0.00036208532,0.0005301805,0.0006942263,0.0019786714,0.0006149324],"domain_scores_gemma":[0.99683255,0.00040206086,0.00017406764,0.0013642805,0.00062810344,0.00059893786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092704745,0.00034522088,0.0009134133,0.0007286457,0.00017030741,0.00002955589,0.00055263593,0.00010269152,0.0001347442],"category_scores_gemma":[0.0007091074,0.00021968418,0.00020868749,0.0032604625,0.00007411923,0.00006335864,0.00027834525,0.0003037978,0.000049675462],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0394275,0.0038708367,0.9320316,0.00001570374,0.006433587,0.00014779305,0.011805547,0.0011048192,0.0019507406,0.0000066013276,0.00055614114,0.0026491822],"study_design_scores_gemma":[0.01976677,0.009353916,0.963777,0.000058298578,0.0025908404,0.00000952409,0.00022725455,0.000022829814,0.0030853434,0.0000041103353,0.00085705234,0.00024704312],"about_ca_topic_score_codex":0.0020914432,"about_ca_topic_score_gemma":0.0007415042,"teacher_disagreement_score":0.03174547,"about_ca_system_score_codex":0.00041451427,"about_ca_system_score_gemma":0.00070693035,"threshold_uncertainty_score":0.8958461},"labels":[],"label_agreement":null},{"id":"W2242744840","doi":"10.1182/blood.v106.11.277.277","title":"Thromboprophylaxis after Orthopaedic Surgery with an Oral, Direct Factor Xa Inhibitor: Pooled Results of Two Phase Iib Clinical Trials.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Hamilton General Hospital","funders":"","keywords":"Medicine; Clinical endpoint; Pulmonary embolism; Deep vein; Surgery; Clinical trial; Venography; Thrombosis; Knee replacement; Data monitoring committee; Randomized controlled trial; Arthroplasty; Internal medicine","score_opus":0.07545296860242093,"score_gpt":0.38909795086207283,"score_spread":0.31364498225965187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2242744840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99596345,0.0006308802,0.000016091562,0.000591023,0.00036668062,0.0010855099,0.00016980508,0.00013536359,0.001041178],"genre_scores_gemma":[0.9957113,0.00057130586,0.0011693253,0.00063818233,0.0015053047,0.00009118535,0.00010274949,0.00006528844,0.00014534606],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.995842,0.000619526,0.0017908689,0.000670383,0.0006302514,0.0004469811],"domain_scores_gemma":[0.9972757,0.00069841027,0.0005779589,0.00085609197,0.00019059243,0.00040121182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033093868,0.0003429807,0.0022001516,0.0002408744,0.000059304835,0.00003542738,0.00012552855,0.00015683234,0.00031523508],"category_scores_gemma":[0.0011078585,0.0002359735,0.0005895522,0.00032415276,0.0001774109,0.00020993329,0.00007080468,0.0002717967,0.00004469988],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036226388,0.19719252,0.18393914,0.0012297581,0.010061577,0.0012661659,0.0025409872,0.000019100831,0.012833916,0.0001167182,0.049761347,0.50481236],"study_design_scores_gemma":[0.24906123,0.037272684,0.48453143,0.0024713578,0.01477947,0.00008757064,0.00040411347,0.000120787925,0.13079852,0.00006596897,0.0781382,0.0022686513],"about_ca_topic_score_codex":0.00015686564,"about_ca_topic_score_gemma":0.00024309257,"teacher_disagreement_score":0.50254375,"about_ca_system_score_codex":0.000029668312,"about_ca_system_score_gemma":0.00022945237,"threshold_uncertainty_score":0.962272},"labels":[],"label_agreement":null},{"id":"W2243751126","doi":"10.1182/blood.v122.21.sci-37.sci-37","title":"T-Cell-Mediated Suppression: From Bench to Bedside","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"FOXP3; Adoptive cell transfer; IL-2 receptor; Regulatory T cell; Immunology; T cell; Cell biology; Biology; Interleukin-7 receptor; Cancer research; Immune system","score_opus":0.006736283956892943,"score_gpt":0.20057874890674599,"score_spread":0.19384246494985305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2243751126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98111975,0.00090849417,0.00005981144,0.0005919859,0.0033033243,0.00023406152,0.00000822948,0.000111090194,0.01366328],"genre_scores_gemma":[0.9703983,0.000023350194,0.00009518502,0.0011717537,0.000064899585,0.000055533415,0.0003937455,0.000013205191,0.027784018],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999293,0.000070109716,0.0001874213,0.00021082404,0.000024189127,0.00021444762],"domain_scores_gemma":[0.99951833,0.00009824301,0.00004878721,0.00024101074,0.00006305607,0.000030550484],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000035945555,0.0001139145,0.00013287857,0.00006572741,0.00010131962,0.00002204673,0.000127333,0.0001633003,0.03169753],"category_scores_gemma":[0.000058022008,0.000096767944,0.000053244483,0.00007946064,0.000022417864,0.00011843964,0.000060447466,0.0001968058,0.043202206],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017023505,0.00019703957,0.0008296213,0.0000012496234,0.000048083402,9.162581e-7,0.00015178547,4.6632582e-7,0.7376479,0.0000051556563,0.26081783,0.0002829503],"study_design_scores_gemma":[0.001411333,0.00013377081,0.010275566,0.000013422658,0.00003866654,0.000009930262,0.0002119993,0.0000017898622,0.77002233,0.000030281954,0.2177171,0.00013382563],"about_ca_topic_score_codex":0.00073386275,"about_ca_topic_score_gemma":0.0000064573237,"teacher_disagreement_score":0.04310074,"about_ca_system_score_codex":0.000009748445,"about_ca_system_score_gemma":0.00001549888,"threshold_uncertainty_score":0.9691876},"labels":[],"label_agreement":null},{"id":"W2244397005","doi":"10.1182/blood.v122.21.709.709","title":"A Canadian Blood and Marrow Transplant Group (CBMTG) Randomised Trial Comparing G-CSF Mobilized Peripheral Blood Versus G-CSF Stimulated Bone Marrow In Recipients Of Sibling Allografts For Hematologic Malignancies","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Children's Hospital; London Health Sciences Centre; University of Ottawa; Capital District Health Authority; CancerCare Manitoba; Vancouver General Hospital; Princess Margaret Cancer Centre; University of Manitoba; BC Cancer Agency; McMaster University; Université de Montréal; Hôpital Maisonneuve-Rosemont; University of Toronto; Dalhousie University","funders":"","keywords":"Medicine; Internal medicine; Bone marrow; Transplantation; Cumulative incidence; Randomized controlled trial; Gastroenterology; Myelodysplastic syndromes; Surgery","score_opus":0.026509630942407814,"score_gpt":0.2563367088096747,"score_spread":0.22982707786726686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2244397005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924904,0.00065893575,0.00007686921,0.0001487645,0.0002862837,0.005884436,0.00006352743,0.00007975718,0.0003110125],"genre_scores_gemma":[0.99504846,0.00015918745,0.0035817882,0.000057346148,0.00005931969,0.00074750616,0.0002283632,0.00006027532,0.000057754172],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.996862,0.00016993645,0.0011867079,0.0006128064,0.00038011404,0.00078842364],"domain_scores_gemma":[0.998155,0.00062259275,0.00024994896,0.0003404484,0.00018499471,0.00044699557],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000654777,0.00042816222,0.0013929573,0.0005188601,0.00011537287,0.00005849848,0.00016434323,0.0003410013,0.00013793858],"category_scores_gemma":[0.00021799203,0.0003965912,0.000243742,0.00041045397,0.00012145256,0.0001744808,0.000016631071,0.00024780136,0.0000036040137],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17676532,0.004438212,0.20527028,0.0033458092,0.0019580182,0.00080804934,0.0045484803,0.00011567152,0.602383,0.000155338,0.00003784216,0.00017398363],"study_design_scores_gemma":[0.9402897,0.00228154,0.013726908,0.0014965107,0.0032622842,0.00045248825,0.0003973393,0.0022488611,0.03515029,0.0000975695,0.000013140925,0.0005833678],"about_ca_topic_score_codex":0.010730856,"about_ca_topic_score_gemma":0.014740416,"teacher_disagreement_score":0.7635244,"about_ca_system_score_codex":0.00005906559,"about_ca_system_score_gemma":0.00021806851,"threshold_uncertainty_score":0.9998486},"labels":[],"label_agreement":null},{"id":"W2245158690","doi":"10.1182/blood.v114.22.1514.1514","title":"A Phase I/II, Open-Label, Dose-Escalation Trial of Once-Daily Oral Chelator Deferasirox to Treat Iron Overload in HFE-Related Hereditary Hemochromatosis: Final Results of the Core Study.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital","funders":"","keywords":"Deferasirox; Medicine; Hereditary hemochromatosis; Internal medicine; Gastroenterology; Discontinuation; Adverse effect; Clinical endpoint; Transferrin saturation; Phlebotomy; Chelation therapy; Pediatrics; Anemia; Hemochromatosis; Thalassemia; Clinical trial; Iron deficiency","score_opus":0.046342962469509454,"score_gpt":0.33508981760124035,"score_spread":0.2887468551317309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2245158690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99404794,0.00039956436,6.933372e-7,0.00047918013,0.00019628786,0.002864935,0.00007491612,0.000026683234,0.0019097828],"genre_scores_gemma":[0.9988862,0.00002009096,0.00025066233,0.00016042478,0.00008374363,0.000034691646,0.00004913466,0.000018748466,0.0004962969],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99786353,0.00013904138,0.00089977885,0.00037990327,0.00044617365,0.00027158792],"domain_scores_gemma":[0.9988847,0.000045279183,0.00028061168,0.0005862037,0.00008167322,0.00012154213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042727834,0.00024001388,0.00067613204,0.00015467397,0.000078117206,0.000012244696,0.00030446242,0.0001636736,0.00004000659],"category_scores_gemma":[0.0003283499,0.0001745767,0.00009184659,0.000682313,0.0000650506,0.00014505579,0.00010458167,0.00021990402,0.0000064075625],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44774666,0.2979046,0.016121583,0.00030021934,0.00022162595,0.00019899373,0.017748851,0.00010044593,0.15712331,0.00029724333,0.009576868,0.052659582],"study_design_scores_gemma":[0.8319884,0.02486179,0.13203582,0.0002915636,0.0009413807,0.0000218716,0.00097636436,0.000059317466,0.008386588,0.00009959503,0.00008577028,0.00025154665],"about_ca_topic_score_codex":0.00039043845,"about_ca_topic_score_gemma":0.0000978712,"teacher_disagreement_score":0.38424173,"about_ca_system_score_codex":0.00003110187,"about_ca_system_score_gemma":0.0002022702,"threshold_uncertainty_score":0.7119031},"labels":[],"label_agreement":null},{"id":"W2247323713","doi":"10.1182/blood.v108.11.2176.2176","title":"In Vitro and In Vivo Activity of SKI-606, a Novel Abl/Src Inhibitor, Against Imatinib Resistant BCR-ABL+ Neoplastic Cells.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Dasatinib; Imatinib; Imatinib mesylate; Cancer research; Nilotinib; ABL; Biology; Kinase; Tyrosine kinase; Signal transduction; Cell biology; Myeloid leukemia","score_opus":0.0072796213297371135,"score_gpt":0.22424800803318024,"score_spread":0.21696838670344312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2247323713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99625176,0.00035539243,0.000011941876,0.00010337779,0.00008474211,0.00050892925,0.000092832786,0.000027009024,0.0025640307],"genre_scores_gemma":[0.99784833,0.000040297564,0.0014433739,0.000057365945,0.00010737159,0.000035020876,0.000014816268,0.000033943947,0.0004194718],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99840885,0.000041856936,0.0004576778,0.0003973464,0.00030801844,0.00038625108],"domain_scores_gemma":[0.9991545,0.00021148151,0.00016411356,0.00033667593,0.000037194048,0.00009601314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017844138,0.0002483378,0.00055675866,0.00024440614,0.00002776759,0.000013992282,0.00006917697,0.00014850024,0.00003119438],"category_scores_gemma":[0.00009615578,0.00023224414,0.000064622844,0.00034965068,0.00008953895,0.00010628604,0.00006963639,0.00025129443,0.0000067333035],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081937114,0.00304363,0.006712309,0.00031690794,0.00004390432,0.00030988696,0.00020232682,0.000024463796,0.9881004,0.00001213564,0.00016783178,0.0002468311],"study_design_scores_gemma":[0.025354125,0.00022867262,0.040075388,0.00045558802,0.00013760239,0.000043956934,0.000049027545,0.00046472822,0.932606,0.00003496972,0.0003413659,0.0002085706],"about_ca_topic_score_codex":0.0018047568,"about_ca_topic_score_gemma":0.00093820156,"teacher_disagreement_score":0.055494398,"about_ca_system_score_codex":0.0004006791,"about_ca_system_score_gemma":0.00034408504,"threshold_uncertainty_score":0.94706416},"labels":[],"label_agreement":null},{"id":"W2247796472","doi":"10.1182/blood.v124.21.4231.4231","title":"A Universal Heparin Antidote with Negligible Effect on Fibrin(ogen) and Plasma Coagulation","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Blood properties and coagulation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of British Columbia","funders":"","keywords":"Fibrin; Chemistry; Fibrinogen; Heparin; Factor XIIIa; Coagulation; Antithrombin; Pharmacology; Thrombin; Factor IX; Biochemistry; Medicine; Immunology; Platelet; Internal medicine","score_opus":0.006086029741242431,"score_gpt":0.20014355589255872,"score_spread":0.1940575261513163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2247796472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938679,0.00005324215,0.000078479636,0.00021734695,0.000027841144,0.00026231873,0.0000017150778,0.00006670276,0.0054244543],"genre_scores_gemma":[0.9988788,0.000008941455,0.00030505468,0.00010225536,0.0001126454,0.000004899059,0.000020098507,0.00001749785,0.0005498414],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99937475,0.000041508858,0.000088742876,0.00019822519,0.00015716821,0.00013961655],"domain_scores_gemma":[0.999628,0.00004846379,0.00003951498,0.00017615737,0.000029788775,0.000078096804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009510782,0.000115127805,0.00018545377,0.00005794233,0.00007020332,0.000021153966,0.000026218944,0.00006223722,0.00001819211],"category_scores_gemma":[0.00002023941,0.00008093229,0.000025795389,0.00009089318,0.00003403564,0.00006913971,0.000018075289,0.00008042778,0.000029620049],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049862503,0.0007391888,0.86568654,0.0005012047,0.0005124211,0.00006793183,0.0004042495,0.00044680058,0.05623923,0.002857784,0.0005019961,0.06705638],"study_design_scores_gemma":[0.026664387,0.018335134,0.66072077,0.0006489522,0.0012907994,0.00039812337,0.000049667065,0.016229192,0.26302847,0.00009218264,0.012039529,0.0005027965],"about_ca_topic_score_codex":0.00008049603,"about_ca_topic_score_gemma":0.000018306751,"teacher_disagreement_score":0.20678926,"about_ca_system_score_codex":0.000008732997,"about_ca_system_score_gemma":0.000018367447,"threshold_uncertainty_score":0.3300323},"labels":[],"label_agreement":null},{"id":"W2247849493","doi":"10.1182/blood.v122.21.4617.4617","title":"Recovery Of Myeloid Derived Suppressor Cell Subsets Following Allogeneic Hematopoietic Stem/Progenitor Cell Transplantation","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Immunology; Stem cell; Myeloid-derived Suppressor Cell; Myeloid; Progenitor cell; Inflammation; Haematopoiesis; Population; Biology; Immune system; Medicine; Cancer research; Cell biology; Suppressor; Internal medicine; Cancer","score_opus":0.00765504345543672,"score_gpt":0.1986534788716767,"score_spread":0.19099843541623998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2247849493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864978,0.01032997,0.00007839226,0.000039433624,0.0012439005,0.0005314862,0.000039658065,0.000059538725,0.0011797824],"genre_scores_gemma":[0.99698776,0.0004373595,0.00035928356,0.000059162438,0.00002663732,0.00011523418,0.00011759564,0.00004230745,0.0018546798],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99855083,0.00017527222,0.00046105735,0.0003326957,0.0000622715,0.00041787795],"domain_scores_gemma":[0.9991562,0.00015392694,0.00020087043,0.00039276032,0.000070952636,0.000025335443],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013133333,0.00023483665,0.00037761973,0.00009038214,0.00010367498,0.000015602314,0.00032194814,0.00042557274,0.0008000919],"category_scores_gemma":[0.0000062272175,0.00022891245,0.00023922684,0.00010651714,0.00008379284,0.00015001225,0.000045050183,0.0002585276,0.00084336696],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051909672,0.0003663991,0.0025442464,0.00026144684,0.00019383396,0.000010117586,0.0008315434,0.000007439738,0.9949975,0.0000028896864,0.0004624863,0.00027017633],"study_design_scores_gemma":[0.003149265,0.00012149798,0.003414931,0.00005235743,0.00034417983,0.000044521585,0.00025989767,3.209951e-7,0.9919063,0.000032459186,0.00042746277,0.0002468217],"about_ca_topic_score_codex":0.0000882433,"about_ca_topic_score_gemma":0.000005962174,"teacher_disagreement_score":0.010489902,"about_ca_system_score_codex":0.000020065969,"about_ca_system_score_gemma":0.000070840244,"threshold_uncertainty_score":0.9999346},"labels":[],"label_agreement":null},{"id":"W2248208340","doi":"10.1182/blood.v124.21.4204.4204","title":"Baseline Demographics and Characteristics of 466 Patients with Atypical Hemolytic Uremic Syndrome in the Global aHUS Registry","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Demographics; Medicine; Atypical hemolytic uremic syndrome; Demography; Economic history; History; Political science; Gerontology; Geography; Sociology","score_opus":0.005082933932218661,"score_gpt":0.20004946936823725,"score_spread":0.1949665354360186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2248208340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990062,0.00032247097,0.000051809617,0.00007344678,0.00006557464,0.00022886328,0.00017594184,0.000013569458,0.00006210173],"genre_scores_gemma":[0.99966985,0.000006515128,0.00003792203,0.000092993236,0.0000096158765,0.000010583616,0.00016010298,0.0000053703416,0.000007066374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991447,0.00021792969,0.0002501391,0.000167088,0.000050957606,0.00016923559],"domain_scores_gemma":[0.9993513,0.00016874175,0.00012574901,0.0002951988,0.00004280954,0.000016160693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021532891,0.00010928242,0.00021223849,0.000032286778,0.00004305221,0.0000067113865,0.00018475145,0.000081457074,0.00002704501],"category_scores_gemma":[0.00014993655,0.000073458126,0.000029521902,0.00012185274,0.00016369163,0.00002014395,0.000047270583,0.000103132435,0.0000066350954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000121844365,0.0005434296,0.99815756,0.00006215147,0.000059407197,0.0000056685562,0.000023143151,1.1902161e-7,0.00012246017,0.0005664356,0.00010284014,0.00023492432],"study_design_scores_gemma":[0.0026876174,0.00027038308,0.9960353,0.00010971806,0.0001262978,0.00012526028,0.000030013452,0.000002739828,0.000043057884,0.00009525252,0.00038658016,0.00008777319],"about_ca_topic_score_codex":0.000017499004,"about_ca_topic_score_gemma":0.00003316043,"teacher_disagreement_score":0.0025657732,"about_ca_system_score_codex":0.000007034472,"about_ca_system_score_gemma":0.000020045854,"threshold_uncertainty_score":0.29955354},"labels":[],"label_agreement":null},{"id":"W2248699119","doi":"10.1182/blood.v120.21.19.19","title":"Management and Outcomes of Major Bleeding On Dabigatran or Warfarin","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Dabigatran; Medicine; Warfarin; Prothrombin complex concentrate; Atrial fibrillation; Bleed; Rivaroxaban; Direct thrombin inhibitor; Gastrointestinal bleeding; Apixaban; Internal medicine; Anesthesia; Surgery","score_opus":0.06233431653954131,"score_gpt":0.3266004642424392,"score_spread":0.2642661477028979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2248699119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9811668,0.00014899655,0.000031674077,0.0010039248,0.00014863694,0.00033684497,0.0000015859129,0.000042425658,0.01711915],"genre_scores_gemma":[0.98980373,0.00005679872,0.0018745814,0.00014313082,0.00022196393,0.0000018864048,0.000003667011,0.000011875162,0.007882378],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993671,0.000009636774,0.00018204622,0.00010184093,0.00017790179,0.00016145942],"domain_scores_gemma":[0.9996605,0.00005510957,0.000054521723,0.00014215482,0.00001118087,0.00007653441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001498034,0.00009385451,0.00022351604,0.00010662735,0.000032270247,0.000006751311,0.000033834975,0.000031501855,0.0001246752],"category_scores_gemma":[0.00002785197,0.00006251874,0.00006055427,0.00009443349,0.000021626673,0.000065256376,0.00004796779,0.000038158716,0.000020580204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009842341,0.00006301323,0.9874694,0.00016596673,0.0003371727,0.000009457957,0.00012771682,3.9373242e-7,0.000450192,0.00750931,0.000104610896,0.0036643501],"study_design_scores_gemma":[0.0038937053,0.00013788416,0.98436946,0.000048812362,0.0007002369,0.000006472878,0.00020415828,0.0000037082527,0.0043251524,0.00005316459,0.006169387,0.000087839784],"about_ca_topic_score_codex":0.000004802992,"about_ca_topic_score_gemma":8.12276e-7,"teacher_disagreement_score":0.009236773,"about_ca_system_score_codex":0.0000064150345,"about_ca_system_score_gemma":0.0000030615672,"threshold_uncertainty_score":0.254944},"labels":[],"label_agreement":null},{"id":"W2249015683","doi":"10.1182/blood.v114.22.743.743","title":"Impact of FISH and Cytogenetics On Overall and Event Free Survival in Myeloma: An IMWG Analysis of 9,897 Patients.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital","funders":"","keywords":"Internal medicine; Multiple myeloma; Population; Univariate analysis; Multivariate analysis; Hematology; Oncology; Stage (stratigraphy); Progression-free survival; Cytogenetics; Medicine; Biology; Overall survival; Genetics; Chromosome","score_opus":0.02051526905891881,"score_gpt":0.3193394394229631,"score_spread":0.2988241703640443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2249015683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992342,0.00009255315,0.0000012306956,0.000045160134,0.000004947751,0.0002170056,0.00019098695,0.0000043455193,0.00020956788],"genre_scores_gemma":[0.99956954,0.00013550697,0.00013239712,0.000026797998,0.0000102363365,0.0000022170311,0.000105475236,0.000006059522,0.000011768455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990733,0.000052431755,0.00022249496,0.00018413152,0.0002913582,0.00017626517],"domain_scores_gemma":[0.99935275,0.00005174326,0.00006813038,0.0002902259,0.0000718064,0.00016533956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009960418,0.00010935723,0.0003871669,0.00029347814,0.00001356009,0.00000522257,0.000051277213,0.00005065021,0.000021694654],"category_scores_gemma":[0.000110568435,0.00008321746,0.000090028734,0.0002487977,0.000036673533,0.000031510335,0.00002783984,0.00006453432,2.0172511e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004113472,0.0032355257,0.9875772,0.000018393031,0.0008155093,0.000023778628,0.00013740336,0.000016758242,0.0012786576,0.000010242176,0.000013536941,0.006461676],"study_design_scores_gemma":[0.009347742,0.004505772,0.9828572,0.000029369829,0.0005419589,0.0000010575149,0.000011015127,0.00024562943,0.0023553097,0.000044577577,0.0000017886624,0.000058537356],"about_ca_topic_score_codex":0.00047999393,"about_ca_topic_score_gemma":0.00034958083,"teacher_disagreement_score":0.008936396,"about_ca_system_score_codex":0.000024622956,"about_ca_system_score_gemma":0.000036117108,"threshold_uncertainty_score":0.33935097},"labels":[],"label_agreement":null},{"id":"W2249235135","doi":"10.1182/blood.v124.21.745.745","title":"Exome Sequencing Identifies a GNPAT Variant Associated with Severe Iron Overload in HFE C282Y Homozygous Men with Extreme Phenotypes; Possible Role in Regulation of Hepcidin Expression","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Hepcidin; Phlebotomy; Hemochromatosis; Hereditary hemochromatosis; Exome sequencing; Internal medicine; Transferrin saturation; Ferritin; Serum iron; Biology; Medicine; Genetics; Endocrinology; Phenotype; Anemia; Gene; Serum ferritin","score_opus":0.009823113486811924,"score_gpt":0.2063065343508234,"score_spread":0.1964834208640115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2249235135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937881,0.00038352472,0.00013889474,0.00004123893,0.000023746486,0.00042114238,0.000007051786,0.00003912343,0.005157167],"genre_scores_gemma":[0.9981578,0.0000186295,0.00086204807,0.000039212344,0.000035771864,0.000023847166,0.000058400197,0.0000329333,0.00077137974],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982787,0.00017318704,0.00041258518,0.00034686053,0.00047980528,0.0003088879],"domain_scores_gemma":[0.99915284,0.00006757606,0.00025638027,0.00036337835,0.00008645291,0.00007336865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053431856,0.00020415845,0.0004854506,0.00024964043,0.000045946912,0.000021979185,0.00009531246,0.00013743235,0.00007143634],"category_scores_gemma":[0.0001676433,0.00015184688,0.000037821734,0.00042952015,0.00005304374,0.0002392626,0.000034586817,0.00017387165,0.0000046918894],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014813946,0.0015906059,0.3400204,0.00038910785,0.00005582038,0.00017326705,0.0076387855,0.0021044863,0.644999,0.00024070311,0.00011375143,0.0011926587],"study_design_scores_gemma":[0.019501567,0.0005794358,0.9225785,0.0016147901,0.00027411993,0.0000966651,0.0024797139,0.001722825,0.050089553,0.00065107166,0.000015690892,0.00039603314],"about_ca_topic_score_codex":0.0009291993,"about_ca_topic_score_gemma":0.0012058592,"teacher_disagreement_score":0.5949095,"about_ca_system_score_codex":0.00007497139,"about_ca_system_score_gemma":0.0001383926,"threshold_uncertainty_score":0.6192136},"labels":[],"label_agreement":null},{"id":"W2249669966","doi":"10.1182/blood.v106.11.350.350","title":"Mabthera (Rituximab) Plus CVP Chemotherapy for First-Line Treatment of Stage III/IV Follicular Non-Hodgkin’s Lymphoma (NHL): Confirmed Efficacy with Longer Follow-Up.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Rituximab; Internal medicine; Follicular lymphoma; Gastroenterology; International Prognostic Index; Surgery; Lymphoma","score_opus":0.016765597841438107,"score_gpt":0.26862097987216554,"score_spread":0.25185538203072744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2249669966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910028,0.0025743293,0.00027661567,0.0016550171,0.000104282,0.0034552405,0.00012851018,0.000107231965,0.00069594715],"genre_scores_gemma":[0.98966414,0.0010364208,0.0036240981,0.00051555276,0.00039287953,0.0009440995,0.00020394976,0.000121886194,0.0034969933],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9976878,0.000024604427,0.0005817987,0.00066468253,0.00043802508,0.0006030921],"domain_scores_gemma":[0.99821013,0.00020724797,0.0002707607,0.00082925847,0.00019107515,0.00029152696],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010463326,0.00058253965,0.0012763116,0.00013596586,0.00014027317,0.000033625536,0.00014325694,0.00019132318,0.00032639454],"category_scores_gemma":[0.00001532793,0.0003961063,0.0005281764,0.00020440521,0.000113429836,0.00008256468,0.000019137813,0.000038023576,0.000043115764],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055625908,0.27559105,0.1070316,0.0015241979,0.03378106,0.0025134408,0.017249504,0.00049862283,0.012558251,0.0011751836,0.0046859565,0.48776522],"study_design_scores_gemma":[0.60550445,0.014569877,0.04568483,0.00043083666,0.0033805133,0.00020157061,0.00019654538,0.00076289126,0.25067014,0.000013737611,0.07784032,0.00074426853],"about_ca_topic_score_codex":0.00031861832,"about_ca_topic_score_gemma":0.0002406949,"teacher_disagreement_score":0.54987854,"about_ca_system_score_codex":0.00048633135,"about_ca_system_score_gemma":0.00038257436,"threshold_uncertainty_score":0.9998491},"labels":[],"label_agreement":null},{"id":"W2253123656","doi":"10.1182/blood.v122.21.4281.4281","title":"Epidemiology Of Post-Transplant Lymphoproliferative Disorders Following Solid Organ Transplant In a Major Canadian Transplant Centre","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Cumulative incidence; Transplantation; Univariate analysis; Lymphoproliferative disorders; Incidence (geometry); Internal medicine; Organ transplantation; Epidemiology; Immunosuppression; Multivariate analysis; Lymphoma","score_opus":0.007536096912191259,"score_gpt":0.23599717508423912,"score_spread":0.22846107817204786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2253123656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921398,0.0030571553,0.000018514484,0.002624077,0.00012353827,0.0007858272,0.00049486896,0.000038595514,0.0007176121],"genre_scores_gemma":[0.9979229,0.00063385785,0.00010341647,0.00082420895,0.00004023701,0.000038195474,0.00028210494,0.000035538345,0.000119554556],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979821,0.00014240177,0.00060601934,0.00035875975,0.00015207907,0.00075866247],"domain_scores_gemma":[0.9988514,0.00016192287,0.00007949353,0.0002305533,0.000042802312,0.00063378544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016448376,0.00027887546,0.00071260467,0.00030240402,0.00007966684,0.0000034075456,0.00013209364,0.0002736538,0.00030483492],"category_scores_gemma":[0.000052506148,0.00021587366,0.00027669163,0.00021681434,0.00009277988,0.000084282496,0.0000049444607,0.00023584747,0.00004943878],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019180925,0.00076104293,0.98590857,0.00016322042,0.00056485686,0.000582142,0.00400577,0.0000129539285,0.0073188487,0.00014975696,0.000028747512,0.00031227645],"study_design_scores_gemma":[0.014548583,0.00048048442,0.96966994,0.0016149327,0.0018286747,0.0003341365,0.00083902304,0.00026508095,0.00948096,0.00030482124,0.00008929292,0.0005440772],"about_ca_topic_score_codex":0.17611462,"about_ca_topic_score_gemma":0.17483921,"teacher_disagreement_score":0.016238641,"about_ca_system_score_codex":0.00005582984,"about_ca_system_score_gemma":0.00057860767,"threshold_uncertainty_score":0.88030726},"labels":[],"label_agreement":null},{"id":"W2253719787","doi":"10.1182/blood.v122.21.1821.1821","title":"Phase I Study Of Inotuzumab Ozogamicin (InO) Combined With R-GDP For Relapsed/Refractory CD22+ B-Cell Non-Hodgkin Lymphoma (B-NHL)","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; University of Alberta","funders":"","keywords":"Tolerability; Medicine; Calicheamicin; Internal medicine; Rituximab; Refractory (planetary science); Gastroenterology; Regimen; Adverse effect; Neutropenia; Febrile neutropenia; Lymphoma; Toxicity","score_opus":0.012222366603137521,"score_gpt":0.2561606938958768,"score_spread":0.2439383272927393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2253719787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99404657,0.00023421993,0.00001952297,0.00012250945,0.000101151854,0.003953214,0.000039334478,0.00006642758,0.0014170464],"genre_scores_gemma":[0.99701256,0.00002977757,0.0008397909,0.0001689457,0.00008779919,0.00091620977,0.00006961026,0.000067007495,0.00080828764],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99815154,0.000046621997,0.00051760266,0.00048471964,0.00039593436,0.00040356023],"domain_scores_gemma":[0.9983101,0.00021507255,0.00027197166,0.00071802206,0.0002562868,0.00022854243],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001168811,0.00035360843,0.0007386013,0.00016169944,0.000097727905,0.000027058337,0.00015527966,0.000121684614,0.000104373124],"category_scores_gemma":[0.00003415879,0.00025001995,0.00014971055,0.00021658135,0.000067845445,0.00013055018,0.000052208645,0.00007060451,0.00007568809],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068334085,0.59072953,0.31447694,0.00070912373,0.0030551662,0.0005609685,0.0051157274,0.000007225827,0.029841477,0.000096179625,0.00864891,0.03992532],"study_design_scores_gemma":[0.5271458,0.11917679,0.17127639,0.00029081854,0.0031041945,0.00007787016,0.002494357,0.00015848684,0.17459284,0.000047772588,0.0010997106,0.000534948],"about_ca_topic_score_codex":0.0009660038,"about_ca_topic_score_gemma":0.000074008945,"teacher_disagreement_score":0.5203124,"about_ca_system_score_codex":0.00013797493,"about_ca_system_score_gemma":0.00023431722,"threshold_uncertainty_score":0.99999523},"labels":[],"label_agreement":null},{"id":"W2253747904","doi":"10.1182/blood.v122.21.4376.4376","title":"Final Report Of a Phase II Clinical Trial Of Lenalidomide Monotherapy For T-Cell Lymphoma","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saint John Regional Hospital; CancerCare Manitoba; University of Alberta; Queen Elizabeth II Health Sciences Centre; Ottawa Hospital; BC Cancer Agency; University of Calgary; University of New Brunswick; Dalhousie University","funders":"","keywords":"Medicine; Lenalidomide; Internal medicine; Gastroenterology; Peripheral T-cell lymphoma; Lymphoma; Anaplastic large-cell lymphoma; Phases of clinical research; T-cell lymphoma; Mycosis fungoides; Clinical endpoint; Transplantation; Oncology; Clinical trial; Surgery; T cell; Multiple myeloma; Immunology; Immune system","score_opus":0.09483648591023919,"score_gpt":0.4197087427480236,"score_spread":0.3248722568377844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2253747904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943732,0.00025306368,0.00030639998,0.00045499214,0.00008643704,0.0029513612,0.00002044212,0.000017422337,0.0015366843],"genre_scores_gemma":[0.9933216,0.000111963505,0.0027551528,0.00011233321,0.00027335266,0.0002701947,0.0000337709,0.000033006658,0.0030886196],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9979028,0.00008384765,0.0010560214,0.00030596138,0.0003931045,0.00025828],"domain_scores_gemma":[0.998143,0.00035604872,0.00034868368,0.00047809188,0.0005355446,0.00013861057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068898377,0.00014068538,0.0006784657,0.000111388385,0.00004640387,0.000007252098,0.00012827484,0.000135476,0.00027431524],"category_scores_gemma":[0.000989283,0.00011584265,0.00039771493,0.00013461873,0.00018642226,0.000041727755,0.00003987031,0.000074163545,0.000008784953],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3497879,0.1772677,0.019352965,0.00082071044,0.0016794961,0.0006488626,0.00094990985,0.0000013702379,0.33597517,0.00014602937,0.013249125,0.10012078],"study_design_scores_gemma":[0.79156125,0.029528037,0.00037884663,0.00006302612,0.0002583947,0.0008084175,0.00011522387,0.00033638426,0.17340544,0.00036442603,0.0030296526,0.00015091848],"about_ca_topic_score_codex":0.00013560872,"about_ca_topic_score_gemma":0.000005196107,"teacher_disagreement_score":0.44177336,"about_ca_system_score_codex":0.00001871698,"about_ca_system_score_gemma":0.0006413353,"threshold_uncertainty_score":0.47239262},"labels":[],"label_agreement":null},{"id":"W2254608744","doi":"10.1182/blood-2015-06-652263","title":"Factor XIIIa-dependent retention of red blood cells in clots is mediated by fibrin α-chain crosslinking","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Blood properties and coagulation","field":"Medicine","cited_by":160,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; St. Michael's Hospital","funders":"National Heart, Lung, and Blood Institute; British Heart Foundation; National Center for Advancing Translational Sciences; Canadian Blood Services; National Institutes of Health; National Science Foundation","keywords":"Factor XIIIa; Fibrin; Factor XIII; Chemistry; Pathology; Immunology; Medicine","score_opus":0.03468266257433658,"score_gpt":0.2479883374470667,"score_spread":0.2133056748727301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2254608744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997111,0.0012456196,0.000021865999,0.00044799465,0.0001376499,0.00040425497,0.000052448224,0.00005469368,0.0005244227],"genre_scores_gemma":[0.99851,0.000084555766,0.00024852552,0.00014500773,0.00008957758,0.00001274595,0.00008155817,0.000029727691,0.0007983109],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99842316,0.00006708187,0.00049814925,0.00028909204,0.00046686188,0.0002556414],"domain_scores_gemma":[0.99919754,0.000027216689,0.00018239224,0.0002930986,0.00015344509,0.00014632083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030584817,0.00015898557,0.000345873,0.00011103714,0.00002745421,0.000019042996,0.00008971116,0.00018926596,0.000095464966],"category_scores_gemma":[0.00009507107,0.00014064259,0.00007972917,0.00021523001,0.000036274007,0.00009723555,0.00005407263,0.00017390445,0.00002043389],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028109414,0.001296843,0.084674686,0.00016080863,0.00015728895,0.00003769616,0.0014821257,0.000010027948,0.9101117,0.000009018648,0.000774635,0.0010040485],"study_design_scores_gemma":[0.014125645,0.00081450527,0.03332127,0.00029778728,0.00031655113,0.00002832287,0.00030303383,0.00036979897,0.9492326,0.00012385528,0.00083184795,0.00023481814],"about_ca_topic_score_codex":0.00034835894,"about_ca_topic_score_gemma":0.0000342238,"teacher_disagreement_score":0.051353414,"about_ca_system_score_codex":0.000027054517,"about_ca_system_score_gemma":0.000087959364,"threshold_uncertainty_score":0.5735238},"labels":[],"label_agreement":null},{"id":"W2255952682","doi":"10.1182/blood.v122.21.511.511","title":"A Novel TWIST2-ID2 Axis That Modulates The Growth and Imatinib Sensitivity Of CML CD34+ Cells","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Haematopoiesis; Cancer research; Gene knockdown; Biology; CD34; Bone marrow; Imatinib mesylate; K562 cells; Molecular biology; Small hairpin RNA; Myeloid leukemia; Stem cell; Cell biology; Leukemia; Cell culture; Immunology; Imatinib; Genetics","score_opus":0.014382656658104212,"score_gpt":0.22512345701597689,"score_spread":0.21074080035787268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2255952682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968574,0.00030758773,0.000113949674,0.00059407525,0.000045296274,0.00058004627,0.000033720786,0.000036254354,0.0014316512],"genre_scores_gemma":[0.9976137,0.000058193105,0.0017508935,0.00016741751,0.000062813284,0.000025104799,0.000011852743,0.000021811964,0.0002881872],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991272,0.000045449313,0.00017896314,0.00023038416,0.00019535974,0.00022266318],"domain_scores_gemma":[0.9990766,0.0002866998,0.00010356819,0.0003746787,0.000065231085,0.00009324541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015925617,0.00017107898,0.0003081566,0.00003730794,0.000049882907,0.000016812694,0.00005356891,0.00007370812,0.00007922772],"category_scores_gemma":[0.00009004044,0.00010464181,0.00007547641,0.00008910151,0.00013962397,0.000073312105,0.000078001496,0.00012606446,0.000042037347],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030909654,0.0011844056,0.03539035,0.00030971598,0.0004979067,0.000034851688,0.0016336743,0.0000025039787,0.9577389,0.000118947726,0.00048454286,0.0025733346],"study_design_scores_gemma":[0.008413542,0.00023132705,0.17500167,0.00016116607,0.00044108616,0.00040566575,0.0002894227,0.0016848912,0.81290126,0.00020980604,0.00008169262,0.00017848412],"about_ca_topic_score_codex":0.0020110863,"about_ca_topic_score_gemma":0.000027285492,"teacher_disagreement_score":0.1448376,"about_ca_system_score_codex":0.00003920468,"about_ca_system_score_gemma":0.00007800417,"threshold_uncertainty_score":0.42671692},"labels":[],"label_agreement":null},{"id":"W2256936668","doi":"10.1182/blood.v96.9.3200","title":"Altered ligand binding and transcriptional regulation by mutations in the PML/RARα ligand-binding domain arising in retinoic acid–resistant patients with acute promyelocytic leukemia","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"National Cancer Institute","keywords":"Corepressor; Acute promyelocytic leukemia; Transcription factor; Biology; Retinoic acid; Cancer research; Coactivator; Promyelocytic leukemia protein; Leukemia; Nuclear receptor; Tretinoin; Cell biology; Genetics; Cell culture; Gene","score_opus":0.004281676916367981,"score_gpt":0.20056655372629376,"score_spread":0.19628487680992576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2256936668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99841934,0.0005919991,0.00009467962,0.00006265771,0.000021236241,0.00036692643,0.000042240856,0.000009109312,0.00039182452],"genre_scores_gemma":[0.99835324,0.00012189783,0.0005519636,0.00004341144,0.000053891003,0.00004896826,0.0006492601,0.000022041146,0.00015534797],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987451,0.00008882897,0.0002958643,0.0003801369,0.00022143203,0.0002686412],"domain_scores_gemma":[0.99964,0.00001802714,0.00008519658,0.00018055766,0.000032776225,0.000043463257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023848684,0.00018507394,0.00015538034,0.00007692005,0.00016287014,0.000087359986,0.00014744831,0.00014542235,0.000008323401],"category_scores_gemma":[0.00001802749,0.00014500204,0.000033575496,0.000243421,0.00009964233,0.000022747821,0.00001493863,0.0001657085,0.000001960501],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025533853,0.00015877893,0.018614119,0.000039829665,0.00005058177,0.00001236216,0.0010203309,0.00004301557,0.9790452,0.000035671324,0.00003470821,0.0006900647],"study_design_scores_gemma":[0.00826498,0.00058982836,0.05605667,0.00026481433,0.00015756828,0.00007582205,0.000494725,0.00006565068,0.9322103,0.0004403647,0.00086765684,0.0005115988],"about_ca_topic_score_codex":0.0000162909,"about_ca_topic_score_gemma":0.00003455655,"teacher_disagreement_score":0.04683488,"about_ca_system_score_codex":0.000052757543,"about_ca_system_score_gemma":0.00012675319,"threshold_uncertainty_score":0.59130114},"labels":[],"label_agreement":null},{"id":"W2258155620","doi":"10.1182/blood.v122.21.2636.2636","title":"Anticoagulation Prophylaxis With Enoxaparin For Patients With Acute Lymphoblastic Leukemia Receiving Asparaginase-Based Intensification Therapy","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Regimen; Cohort; Asparaginase; Surgery; Internal medicine; Low molecular weight heparin; Heparin; Leukemia; Lymphoblastic Leukemia","score_opus":0.012862128989220257,"score_gpt":0.2430710421555331,"score_spread":0.23020891316631284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2258155620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97870743,0.00002671842,0.017216813,0.00029919212,0.0000397225,0.0034101466,0.000013572205,0.00013359921,0.00015279434],"genre_scores_gemma":[0.98438257,0.000009510711,0.013974011,0.00023154588,0.00009507478,0.0007324657,0.00027374786,0.00009212712,0.000208949],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979479,0.0000504347,0.0003107807,0.0005354267,0.0006533649,0.0005021094],"domain_scores_gemma":[0.99753004,0.00028666624,0.00018270971,0.0005526647,0.0012362761,0.00021166081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013785271,0.00029815384,0.00037699044,0.00022281604,0.00014672993,0.000084475236,0.00015400881,0.00014142884,0.00005636911],"category_scores_gemma":[0.0002034459,0.00019535676,0.00005967068,0.0004378727,0.00016019442,0.0002371468,0.000022550332,0.0001639907,0.000061433886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013630905,0.005744389,0.8643165,0.0007484285,0.00229457,0.00009840755,0.0008314153,0.00054551585,0.06127379,0.0001394375,0.0017490621,0.04862753],"study_design_scores_gemma":[0.05149709,0.01144468,0.87392837,0.00047019566,0.0005373013,0.000076980126,0.0000627444,0.021542182,0.039700683,0.00006012367,0.00016025116,0.0005194111],"about_ca_topic_score_codex":0.00018558242,"about_ca_topic_score_gemma":0.0000075476096,"teacher_disagreement_score":0.04810812,"about_ca_system_score_codex":0.0006156332,"about_ca_system_score_gemma":0.0011786371,"threshold_uncertainty_score":0.7966417},"labels":[],"label_agreement":null},{"id":"W2258411679","doi":"10.1182/blood.v95.1.314","title":"Resistance of ICAM-1–deficient mice to metastasis overcome by increased aggressiveness of lymphoma cells","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Armand Frappier Museum; Institut National de la Recherche Scientifique","funders":"","keywords":"Lymphoma; Homing (biology); BCL10; Metastasis; Cancer research; Cell adhesion molecule; Immunology; Biology; Cell adhesion; Medicine; Pathology; Cancer; Cell; Internal medicine","score_opus":0.009835746044694064,"score_gpt":0.2622170535836297,"score_spread":0.2523813075389356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2258411679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929688,0.0020669138,0.000023413984,0.00015646355,0.000016564994,0.00041575325,0.00018848103,0.000017964067,0.0041456725],"genre_scores_gemma":[0.9936874,0.0002067401,0.0016162319,0.00016105056,0.000016967519,0.000021675489,0.000023565877,0.00002989202,0.0042364956],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980342,0.0001236469,0.00042378783,0.0003329458,0.0007770068,0.00030845465],"domain_scores_gemma":[0.99867153,0.00016016667,0.0001210085,0.00058500556,0.00020388018,0.00025840147],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002708966,0.00015457378,0.00047854602,0.00016532726,0.000033281045,0.0000072196563,0.0002425765,0.00007217635,0.0010834169],"category_scores_gemma":[0.00013119158,0.0001391931,0.00013927199,0.00060754095,0.000102123726,0.00002560766,0.00006830633,0.00007278112,0.000088074936],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083208317,0.0021021818,0.0006842883,0.0003305719,0.000103705686,0.00008489329,0.000110657296,0.0000061817436,0.9890702,0.000015549893,0.002752593,0.00390713],"study_design_scores_gemma":[0.0036255554,0.00028100255,0.0058831684,0.00029141703,0.00017682306,0.000012282126,0.000046825076,0.0000068490513,0.97247815,0.00000755685,0.017072208,0.00011813442],"about_ca_topic_score_codex":0.00023239948,"about_ca_topic_score_gemma":0.000012428038,"teacher_disagreement_score":0.016591987,"about_ca_system_score_codex":0.000043435222,"about_ca_system_score_gemma":0.00015091867,"threshold_uncertainty_score":0.9998297},"labels":[],"label_agreement":null},{"id":"W2259196046","doi":"10.1182/blood.v122.21.2332.2332","title":"Tissue Factor On The Herpes Simplex Virus Type 1 Surface Enhances Infection In Vivo","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Canadian Blood Services","funders":"","keywords":"Tissue factor; Herpes simplex virus; Biology; Virus; Virology; In vivo; Proteases; Thromboplastin; Virus quantification; Molecular biology; Coagulation; Medicine","score_opus":0.024700538567908943,"score_gpt":0.2939277475699846,"score_spread":0.26922720900207564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2259196046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990879,0.000071887756,0.0000062900262,0.0002683345,0.00014330941,0.00043915803,0.0000063547177,0.00005523913,0.008130405],"genre_scores_gemma":[0.99804544,0.0001535222,0.000045848166,0.00019522324,0.00007477004,0.00003450326,0.0000028123145,0.000013878166,0.0014340078],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99940777,0.000043762753,0.00012721811,0.0001487913,0.000110625224,0.00016183143],"domain_scores_gemma":[0.9995865,0.00008823124,0.000034440363,0.0001967324,0.000044164648,0.00004989952],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000049324117,0.000110456735,0.00013438931,0.00004303177,0.00007414515,0.000025389929,0.000030988398,0.000068726345,0.003315908],"category_scores_gemma":[0.000055571014,0.000067406574,0.000031164665,0.00021116,0.000026095237,0.000067739704,0.000012386266,0.000098152406,0.0012012523],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015653513,0.012748334,0.37999904,0.00012134364,0.0009817268,0.0001029467,0.0015105434,0.00006410461,0.22339001,0.000759732,0.008506553,0.37165913],"study_design_scores_gemma":[0.0012767183,0.0005105524,0.14759497,0.000053109667,0.000056395755,0.000010202287,0.000023522065,0.000016112346,0.70144,0.0001261875,0.14878097,0.00011129298],"about_ca_topic_score_codex":0.0045955256,"about_ca_topic_score_gemma":0.0008061866,"teacher_disagreement_score":0.47804996,"about_ca_system_score_codex":0.00003252863,"about_ca_system_score_gemma":0.000028999568,"threshold_uncertainty_score":0.99957645},"labels":[],"label_agreement":null},{"id":"W2260534935","doi":"10.1182/blood.v114.22.2099.2099","title":"Prothrombin Time and Bleeding Events in Patients Undergoing Total Hip or Knee Replacement Surgery Receiving 10 Mg Rivaroxaban.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Rivaroxaban; Medicine; Surgery; Knee replacement; Prothrombin time; Anesthesia; Randomized controlled trial; Atrial fibrillation; Arthroplasty; Internal medicine; Warfarin","score_opus":0.013742682582992992,"score_gpt":0.23993806868352988,"score_spread":0.22619538610053688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2260534935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99592286,0.00009774079,0.0000026617552,0.00049531885,0.00011057508,0.0012546035,0.00000203677,0.000076147066,0.0020380542],"genre_scores_gemma":[0.99766266,0.00010927255,0.00029094992,0.000325768,0.000094207986,0.000053624284,0.000028357194,0.000029008013,0.0014061439],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824685,0.000054749293,0.00045301745,0.00043469877,0.00036339465,0.00044728647],"domain_scores_gemma":[0.9992639,0.00014433797,0.00013905091,0.00026868118,0.000044266,0.00013978392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004947338,0.00022174769,0.000554191,0.00024011999,0.00009369649,0.000027395667,0.000054368735,0.000084145184,0.00035709786],"category_scores_gemma":[0.0003118008,0.00019522037,0.00007169428,0.00024209368,0.000018282677,0.00016049908,0.00008820348,0.00013418504,0.00005658862],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010920658,0.017567648,0.94589245,0.00082529796,0.0007325097,0.00019291212,0.0015518004,0.000021858055,0.0026061852,0.00014669193,0.011552587,0.017818013],"study_design_scores_gemma":[0.008152778,0.0019065989,0.9866445,0.0013899677,0.00024804607,0.00001909695,0.000077515775,0.00006814317,0.0009311958,0.00009922305,0.00017980293,0.00028313816],"about_ca_topic_score_codex":0.000033981352,"about_ca_topic_score_gemma":0.000012742812,"teacher_disagreement_score":0.04075206,"about_ca_system_score_codex":0.0001343354,"about_ca_system_score_gemma":0.00009179951,"threshold_uncertainty_score":0.79608554},"labels":[],"label_agreement":null},{"id":"W2260744446","doi":"10.1182/blood-2015-10-673681","title":"Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Heart, Lung, and Blood Institute","keywords":"Von Willebrand disease; Medicine; Cohort; Von Willebrand factor; Internal medicine; Pediatrics; Platelet","score_opus":0.010465999168993403,"score_gpt":0.270459910406167,"score_spread":0.25999391123717364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2260744446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994563,0.000032144984,9.176299e-7,0.00008657017,0.000009156885,0.00030025348,0.000027097467,0.0000040217546,0.0000835414],"genre_scores_gemma":[0.9995823,0.00018606245,0.000046882116,0.00013343044,0.0000034420166,0.000011828912,0.000027982214,0.000004064282,0.0000040461446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994322,0.00012832994,0.00016240355,0.00011234066,0.00008642793,0.0000783084],"domain_scores_gemma":[0.99936557,0.00037682307,0.00003477745,0.00013516357,0.000060969436,0.000026676154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036556443,0.00005261475,0.00017111991,0.0000392255,0.0000062253125,0.0000016334085,0.00002689361,0.000037795795,0.000009345056],"category_scores_gemma":[0.0002950333,0.000023500343,0.000008295112,0.00021625264,0.00008177556,0.000020045327,0.000009077385,0.000051565534,0.0000013522325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020001233,0.002579581,0.9963623,0.000012353402,0.00004701089,0.00008359753,0.00015395305,6.572324e-8,0.000007929088,0.000008243373,0.000022658543,0.0005222962],"study_design_scores_gemma":[0.009525703,0.00054005405,0.9894649,0.000060266557,0.000062273946,0.0000010190469,0.000043887376,0.000002671101,0.0000423899,0.00008141042,0.00014555633,0.000029876166],"about_ca_topic_score_codex":0.0001478675,"about_ca_topic_score_gemma":0.00014267457,"teacher_disagreement_score":0.009325691,"about_ca_system_score_codex":0.0000052343485,"about_ca_system_score_gemma":0.00004057715,"threshold_uncertainty_score":0.09583162},"labels":[],"label_agreement":null},{"id":"W2260934440","doi":"10.1182/blood.v124.21.2772.2772","title":"Maternal Anti-Platelet β3 Integrin Antibodies Impair Angiogenesis and Cause Intracranial Hemorrhage in Fetal and Neonatal Alloimmune Thrombocytopenia","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Neonatal alloimmune thrombocytopenia; Angiogenesis; Medicine; Immunology; Fetus; Antibody; Platelet; Hemostasis; Antigen; Integrin; Internal medicine; Biology; Pregnancy; Receptor","score_opus":0.0077525797369497555,"score_gpt":0.23452128462895533,"score_spread":0.22676870489200557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2260934440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975659,0.0015956735,0.000033287273,0.00019112678,0.00007065053,0.00028346546,0.000034277535,0.000048701735,0.00017690101],"genre_scores_gemma":[0.9978847,0.0005102738,0.0012883835,0.000094349445,0.000058474794,0.000008536786,0.000045957826,0.000029602419,0.0000797243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988768,0.00003673261,0.00026235287,0.00034112303,0.00015038277,0.00033257826],"domain_scores_gemma":[0.99955624,0.00003835452,0.00007422803,0.00018530455,0.000023349734,0.00012254331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013256862,0.0002552104,0.00059374864,0.00013217147,0.00007098329,0.000051174306,0.0000667048,0.00011960073,0.000038333514],"category_scores_gemma":[0.00003533344,0.00020567994,0.000057842084,0.00009745473,0.00010935238,0.00014343842,0.00009956087,0.00014621635,0.000017557519],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025284366,0.0006188512,0.91697663,0.00015970039,0.0003595436,0.008424592,0.00035294372,5.6627863e-7,0.017191168,0.000033947563,0.000013154389,0.05561607],"study_design_scores_gemma":[0.012047325,0.00044767943,0.95783,0.00010920425,0.0002953746,0.007924937,0.00011138969,0.00040091263,0.020398416,0.000063120475,0.000117809315,0.0002538368],"about_ca_topic_score_codex":0.0007041385,"about_ca_topic_score_gemma":0.00029958508,"teacher_disagreement_score":0.055362232,"about_ca_system_score_codex":0.000013943607,"about_ca_system_score_gemma":0.000022192407,"threshold_uncertainty_score":0.8387385},"labels":[],"label_agreement":null},{"id":"W2262784706","doi":"10.1182/blood.v122.21.4390.4390","title":"The Outcome Of Patients With Post Transplant and Immunodeficiency Associated Lymphoproliferative Disorder: The BCCA Experience","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Rituximab; Immunosuppression; Medicine; Lymphoproliferative disorders; Internal medicine; Lymphoma; Gastroenterology; Post-transplant lymphoproliferative disorder; Diffuse large B-cell lymphoma; Transplantation; Oncology; Immunology","score_opus":0.004810262188082763,"score_gpt":0.21245106925278073,"score_spread":0.20764080706469798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2262784706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99649525,0.0012019193,0.0000059697254,0.00092540943,0.000035007153,0.00059077394,0.000035749094,0.00001870174,0.0006912236],"genre_scores_gemma":[0.99923396,0.0001967945,0.0000072462153,0.0003124651,0.0000051359348,0.000082001934,0.000018615156,0.000012481237,0.00013131238],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990432,0.000043784617,0.00023442792,0.0001510893,0.00028995101,0.00023753227],"domain_scores_gemma":[0.99934304,0.000086330634,0.00013870318,0.00019589473,0.00019313103,0.00004287639],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009618461,0.00012928141,0.00020269495,0.00001899389,0.00029427305,0.000032067313,0.00011473472,0.000052268533,0.000028273644],"category_scores_gemma":[0.000089554414,0.00005797938,0.000049174694,0.00015924964,0.00023086157,0.00007864902,0.000018423698,0.00010229377,0.0000033369577],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010099759,0.00048037904,0.9935985,0.000009198211,0.00010916607,7.3662704e-7,0.0043940376,0.0000010741014,0.00018213813,0.00006609451,0.000022043696,0.0010356037],"study_design_scores_gemma":[0.005781937,0.00062572403,0.989644,0.00003600283,0.00014367676,0.0000019883644,0.0033533901,0.00002448259,0.0001776868,0.000032432963,0.00008091303,0.000097765624],"about_ca_topic_score_codex":0.0007319974,"about_ca_topic_score_gemma":0.00014881472,"teacher_disagreement_score":0.0056809396,"about_ca_system_score_codex":0.0000222271,"about_ca_system_score_gemma":0.00005510118,"threshold_uncertainty_score":0.23643306},"labels":[],"label_agreement":null},{"id":"W2262886133","doi":"10.1182/blood.v122.21.3586.3586","title":"High False Positive Rate Of An ELISA Screen For The Detection Of Anti-Factor VIII Antibodies In Congenital Hemophilia A","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Paul's Hospital; BC Children's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Antibody; Gold standard (test); Factor IX; Internal medicine; Gastroenterology; Immunology","score_opus":0.02083166862446829,"score_gpt":0.28781803348580653,"score_spread":0.26698636486133825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2262886133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99778634,0.00029127605,0.000018810682,0.000413111,0.000042150237,0.0012583258,0.0000930532,0.000010460849,0.000086471126],"genre_scores_gemma":[0.9993534,0.00007929659,0.00021218091,0.000023798677,0.00006709543,0.000044650904,0.00003065773,0.000013399646,0.0001755044],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999248,0.000053151765,0.00021083323,0.00014815139,0.00013454653,0.00020531456],"domain_scores_gemma":[0.9992474,0.00018572065,0.000055763398,0.00018913139,0.00024607166,0.000075949414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016638252,0.00010283015,0.00026435006,0.00014335335,0.00005287948,0.000009723622,0.00007263699,0.000077218814,0.00005148838],"category_scores_gemma":[0.00010791448,0.000061803476,0.00007905284,0.00014378679,0.00012043747,0.00010419769,0.000021912505,0.000086975604,0.000009328401],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027545897,0.00094698014,0.07097614,0.00008710556,0.00040875433,0.000016556347,0.00050031877,0.0000013873132,0.9198054,0.0000540808,0.000009823786,0.006917976],"study_design_scores_gemma":[0.0028213507,0.00059877057,0.46106178,0.000037613736,0.0001006813,0.000006782194,0.00015595817,0.0001334508,0.5349556,0.000077610464,0.000006623835,0.000043758264],"about_ca_topic_score_codex":0.007142946,"about_ca_topic_score_gemma":0.0009202932,"teacher_disagreement_score":0.39008564,"about_ca_system_score_codex":0.00001620725,"about_ca_system_score_gemma":0.00006345794,"threshold_uncertainty_score":0.99946856},"labels":[],"label_agreement":null},{"id":"W2264208057","doi":"10.1182/blood.v95.3.855.003k41_855_862","title":"High-resolution tracking of cell division suggests similar cell cycle kinetics of hematopoietic stem cells stimulated in vitro and in vivo","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Heart, Lung, and Blood Institute","keywords":"Haematopoiesis; In vivo; Stem cell; Biology; Stem cell factor; Population; In vitro; Molecular biology; Bone marrow; Cell biology; Flow cytometry; Andrology; Immunology; Biochemistry; Medicine; Genetics","score_opus":0.009423731329812831,"score_gpt":0.22671140220521827,"score_spread":0.21728767087540543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2264208057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983749,0.0004033763,0.00011821719,0.000024428366,0.00003272391,0.00051309844,0.00003181401,0.000021968981,0.00047948607],"genre_scores_gemma":[0.99816626,0.00019436506,0.0014957155,0.000013861499,0.00001042042,0.0000054771335,0.000014571446,0.000030400282,0.00006895217],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983049,0.00009171007,0.00073056284,0.0002853868,0.00032562896,0.00026181774],"domain_scores_gemma":[0.99928004,0.00018466929,0.00014729885,0.000249214,0.00005252484,0.00008622972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021367305,0.00018551522,0.0005216728,0.00022662392,0.000012876537,0.0000060690936,0.0000738476,0.00017757014,0.00011032264],"category_scores_gemma":[0.0000052135742,0.0001870324,0.00005381858,0.0003461198,0.000058103316,0.000059627746,0.000013880718,0.00015839534,0.000005396522],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002640564,0.0015936762,0.0059562996,0.0015552696,0.000009253166,0.00007456299,0.0014268643,0.0029195875,0.9858348,0.0000019259576,0.0000024033304,0.00036134603],"study_design_scores_gemma":[0.007506671,0.0002608597,0.018111246,0.00067892787,0.00013800437,0.000017344366,0.00013617461,0.002393514,0.97059023,0.000024479492,0.0000034153954,0.00013912912],"about_ca_topic_score_codex":0.00010550936,"about_ca_topic_score_gemma":0.000016940367,"teacher_disagreement_score":0.015244521,"about_ca_system_score_codex":0.000026273754,"about_ca_system_score_gemma":0.000026994097,"threshold_uncertainty_score":0.76269597},"labels":[],"label_agreement":null},{"id":"W2264743073","doi":"10.1182/blood.v122.21.94.94","title":"Achievement and Maintenance Of Deeper Molecular Response By Switching To Nilotinib In Patients (pts) With Chronic Myeloid Leukemia In Chronic Phase (CML-CP) With Residual Disease On Long-Term Imatinib: ENESTcmr 36-Month Follow-Up","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Princess Margaret Cancer Centre; University of Toronto; McMaster University","funders":"","keywords":"Nilotinib; Imatinib; Medicine; Discontinuation; Internal medicine; Imatinib mesylate; Oncology; Gastroenterology; Minimal residual disease; Myeloid leukemia; Leukemia","score_opus":0.006340590874513017,"score_gpt":0.24290564261922312,"score_spread":0.2365650517447101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2264743073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952281,0.000758311,0.000068125926,0.00040264605,0.000033486565,0.0033537652,0.00005556843,0.000047209887,0.00005278267],"genre_scores_gemma":[0.9979684,0.000055614255,0.0005585172,0.00034508624,0.000035054723,0.0005728338,0.00014346813,0.00011907227,0.00020197124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996485,0.00021230862,0.0007206668,0.00092888885,0.0007938303,0.00085929193],"domain_scores_gemma":[0.99803907,0.00014093998,0.00027623805,0.00089644926,0.00012141665,0.00052590255],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003458566,0.0005846357,0.00076390436,0.00036059273,0.00006619337,0.000038441995,0.00022764201,0.000105884894,0.000057410092],"category_scores_gemma":[0.00016973192,0.00044460778,0.00006630206,0.00044338845,0.00011022917,0.000211772,0.00012913697,0.00039304767,0.000024235387],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06317778,0.008046124,0.8255865,0.0011610358,0.00069056597,0.002107715,0.0016683884,0.00072150666,0.08347894,0.00003770269,0.0003014615,0.013022278],"study_design_scores_gemma":[0.14276022,0.016549757,0.8098846,0.004116098,0.00037905254,0.000025078472,0.000074372896,0.00016519931,0.025387798,0.000011743548,0.00004415242,0.0006019355],"about_ca_topic_score_codex":0.00080703944,"about_ca_topic_score_gemma":0.0010977222,"teacher_disagreement_score":0.07958244,"about_ca_system_score_codex":0.0046494897,"about_ca_system_score_gemma":0.0020880976,"threshold_uncertainty_score":0.99980056},"labels":[],"label_agreement":null},{"id":"W2265325729","doi":"10.1182/blood.v124.21.3764.3764","title":"A Phase 1 Study of Azacitidine (AZA) in Combination with Fludarabine and Cytarabine in Relapse/Refractory Childhood Leukemia: A Therapeutic Advances in Childhood Leukemia &amp; Lymphoma (TACL) Study","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cytarabine; Fludarabine; Acute myeloblastic leukemia; Leukemia; Decitabine; Internal medicine; Oncology; Childhood leukemia; Refractory (planetary science); Chemotherapy; Azacitidine; Gastroenterology; DNA methylation; Cyclophosphamide; Biology","score_opus":0.011283265791433681,"score_gpt":0.2820521748959951,"score_spread":0.2707689091045614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2265325729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930826,0.0020515204,0.000028548266,0.00013758129,0.000038022306,0.004152835,0.0000100818925,0.00006890568,0.00042993613],"genre_scores_gemma":[0.99848044,0.0005288593,0.0002039514,0.00010129626,0.00007234109,0.00040487098,0.00005871288,0.000097915945,0.000051630075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955645,0.0006474284,0.0011169239,0.0009891901,0.00097029685,0.0007116263],"domain_scores_gemma":[0.9980418,0.0003874633,0.00031792614,0.0008667414,0.00017047094,0.00021556311],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015435852,0.00054548803,0.0013252645,0.001357975,0.00008778657,0.000031040847,0.00032828076,0.00022005542,0.00002279117],"category_scores_gemma":[0.00039855007,0.00045613243,0.000059765825,0.0017741914,0.0001834196,0.00048146976,0.00016540382,0.0009319237,0.0000078468365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040948596,0.14055441,0.7636563,0.00030605527,0.00041257165,0.0006496916,0.023103494,0.0002160009,0.0041365493,0.00007842156,0.000011471508,0.06278017],"study_design_scores_gemma":[0.23064725,0.020433597,0.7416196,0.00045344495,0.00022172969,0.0001838319,0.004564328,0.00037875958,0.0008485543,0.00012947098,0.00011334195,0.00040607958],"about_ca_topic_score_codex":0.0010021776,"about_ca_topic_score_gemma":0.0044002444,"teacher_disagreement_score":0.22655238,"about_ca_system_score_codex":0.0011086821,"about_ca_system_score_gemma":0.0008860437,"threshold_uncertainty_score":0.99978906},"labels":[],"label_agreement":null},{"id":"W2266142448","doi":"10.1182/blood.v124.21.396.396","title":"The Oral Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) Demonstrates Broad and Durable Clinical Activity in Relapsed / Refractory Non Hodgkin’s Lymphoma (NHL)","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ozmosis Research (Canada); Alberta Health Services; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Neutropenia; Lymphoma; Nausea; Nuclear export signal; Medicine; Anemia; Internal medicine; Cancer research; Vomiting; Progressive disease; Cell cycle checkpoint; Gastroenterology; Cancer; Cell cycle; Oncology; Chemotherapy; Cell nucleus","score_opus":0.007075050263865582,"score_gpt":0.23929113790859027,"score_spread":0.23221608764472468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2266142448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99866,0.00014575665,0.000021715783,0.00007949085,0.00018191601,0.00014076415,0.0000045520937,0.000011273027,0.00075452996],"genre_scores_gemma":[0.99897623,0.00020743781,0.0003384197,0.00008673804,0.00026363813,0.000004667755,0.000008203637,0.000024355033,0.00009031986],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989357,0.00015736798,0.00028470988,0.00032733942,0.00009956978,0.00019532553],"domain_scores_gemma":[0.9993667,0.000056172426,0.00016204426,0.00027274803,0.00007891646,0.00006340731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045464982,0.00014280828,0.00020985382,0.000028359647,0.000101196754,0.000021038502,0.00010257214,0.000259788,0.0000035788794],"category_scores_gemma":[0.00021007407,0.000109185174,0.00007342833,0.00008691227,0.0001582175,0.000008173857,0.00006631109,0.00014881365,0.0000030113006],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096553296,0.00051184243,0.050123833,0.000024069215,0.000119993965,0.0000033741637,0.000069775924,0.0000028019851,0.9149039,0.00003610117,0.0014738393,0.031764943],"study_design_scores_gemma":[0.006390341,0.0028889927,0.6540044,0.000039807674,0.00012064782,0.00005453062,0.00018125064,0.00034552743,0.30743626,0.00016910845,0.027990984,0.00037816595],"about_ca_topic_score_codex":0.000063522086,"about_ca_topic_score_gemma":0.00014512103,"teacher_disagreement_score":0.60746765,"about_ca_system_score_codex":0.000008733979,"about_ca_system_score_gemma":0.00006910574,"threshold_uncertainty_score":0.44524422},"labels":[],"label_agreement":null},{"id":"W2266244964","doi":"10.1182/blood.v124.21.3448.3448","title":"Final Overall Survival Results of a Randomized Trial Comparing Bortezomib Plus Pegylated Liposomal Doxorubicin with Bortezomib Alone in Subjects with Relapsed or Refractory Multiple Myeloma","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Bortezomib; Multiple myeloma; Medicine; Internal medicine; Clinical endpoint; Lenalidomide; Interim analysis; Gastroenterology; Urology; Pharmacology; Oncology; Randomized controlled trial","score_opus":0.03416027449591645,"score_gpt":0.2806213074109411,"score_spread":0.24646103291502464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2266244964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931769,0.00013678134,0.000077601515,0.00013584323,0.00009592875,0.003956514,0.000042752625,0.00011538301,0.00226231],"genre_scores_gemma":[0.9960339,0.000052710937,0.0022342487,0.000030796593,0.00022064056,0.00023984583,0.00035078096,0.00008492483,0.00075214944],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9950937,0.00079562096,0.0012465849,0.00080083736,0.0011870371,0.00087619934],"domain_scores_gemma":[0.9959846,0.0018661742,0.00057529006,0.0008184853,0.0003066055,0.00044881616],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015278301,0.00053929526,0.002633333,0.00046261083,0.000106890664,0.00004239378,0.00023040904,0.00023492852,0.000042016978],"category_scores_gemma":[0.002355477,0.00033151664,0.00023304342,0.00054605823,0.00032815346,0.00018292214,0.00008467162,0.0006391891,0.000013428112],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95175886,0.0035806207,0.03751762,0.00016638251,0.0012645442,0.0012926089,0.0004944093,0.00007371801,0.0033465088,0.00001960097,0.000038714792,0.0004464209],"study_design_scores_gemma":[0.8993089,0.008488666,0.0776524,0.0007762716,0.00068468996,0.00015027066,0.00007421141,0.0049447655,0.007495129,0.000007137663,0.000063632404,0.0003538821],"about_ca_topic_score_codex":0.0035318353,"about_ca_topic_score_gemma":0.0067335884,"teacher_disagreement_score":0.052449916,"about_ca_system_score_codex":0.00015034135,"about_ca_system_score_gemma":0.0007707923,"threshold_uncertainty_score":0.9999137},"labels":[],"label_agreement":null},{"id":"W2267074358","doi":"10.1182/blood.v124.21.4447.4447","title":"Clinical Characteristics and Treatment Outcomes in Patients Diagnosed with Primary Mediastinal Large B-Cell Lymphoma at Princess Margaret Cancer Centre from 1994-2012","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Vincristine; Rituximab; CHOP; Chemotherapy regimen; Internal medicine; Prednisone; Regimen; Surgery; Oncology; Radiation therapy; Clinical trial; Cyclophosphamide; Cancer; Lymphoma; Chemotherapy","score_opus":0.010335413178426268,"score_gpt":0.24978642282110622,"score_spread":0.23945100964267996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2267074358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978519,0.0003689879,0.0000012567467,0.00020350692,0.0001670286,0.00064585573,0.00042670948,0.000034820154,0.00029992402],"genre_scores_gemma":[0.9970037,0.00083875767,0.000352256,0.0005353851,0.00018346505,0.00013124691,0.0006627332,0.000035584413,0.00025687495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822396,0.0000972855,0.00045604477,0.0005092128,0.000317637,0.0003958821],"domain_scores_gemma":[0.9986988,0.00041607747,0.00020089623,0.0003339984,0.000040714738,0.00030954063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009558917,0.00032443952,0.0007830658,0.000054120006,0.00006470521,0.000020293679,0.000068758614,0.00012819875,0.0000999325],"category_scores_gemma":[0.000037981677,0.00020794258,0.000090599635,0.00006301881,0.000066626526,0.000065466316,0.000090089714,0.000056143304,0.000021549304],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044564277,0.024027353,0.94978815,0.000039627488,0.00027771745,0.00020061109,0.00025533006,3.904939e-8,0.000004156033,0.0000047972244,0.00008607148,0.024870483],"study_design_scores_gemma":[0.07975723,0.0011548927,0.9139891,0.00017941199,0.00071651366,0.0000032723292,0.000017748249,0.000009050279,0.00019687113,0.0000017854233,0.0037717621,0.00020235403],"about_ca_topic_score_codex":0.0005660652,"about_ca_topic_score_gemma":0.0014400402,"teacher_disagreement_score":0.07931159,"about_ca_system_score_codex":0.00031570965,"about_ca_system_score_gemma":0.00011560553,"threshold_uncertainty_score":0.8479652},"labels":[],"label_agreement":null},{"id":"W2267593360","doi":"10.1182/blood.v96.13.4160","title":"During ontogeny primitive (CD34+CD38−) hematopoietic cells show altered expression of a subset of genes associated with early cytokine and differentiation responses of their adult counterparts","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; CD38; Haematopoiesis; CD34; Stem cell factor; Bone marrow; Hematopoietic growth factor; Cord blood; Stem cell; Cytokine; Growth factor; Cell biology; Immunology; Molecular biology; Receptor; Genetics","score_opus":0.010924146603458511,"score_gpt":0.21865961801003742,"score_spread":0.20773547140657891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2267593360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988438,0.0001824639,0.000042656106,0.000015271404,0.000016654709,0.0005135147,0.00024127025,0.00002405146,0.000120334815],"genre_scores_gemma":[0.9993288,0.00022144415,0.00022886273,0.000007230148,0.000015868709,0.000018483917,0.000063141364,0.00002712673,0.000089047084],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985865,0.00012701527,0.0005067072,0.00023682846,0.00036688618,0.00017610872],"domain_scores_gemma":[0.9988643,0.00024698093,0.0003303954,0.00024069933,0.0002464629,0.00007116219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013162252,0.00018539424,0.00053553184,0.00011548578,0.00003192762,0.0000061636956,0.000061445644,0.000108658365,0.00008012696],"category_scores_gemma":[0.000036477173,0.0001414656,0.000068191424,0.00013898016,0.00010755217,0.0000742823,0.000011215812,0.00007500443,7.8786223e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016497,0.00065680273,0.1449845,0.0007870988,0.00016717402,0.000011166918,0.004766336,0.0000025241006,0.8469134,0.0000049331275,0.0000016300578,0.000054739307],"study_design_scores_gemma":[0.003853812,0.0003799219,0.375531,0.0018596945,0.00028363272,0.000032874326,0.0001841312,0.000015699614,0.61777854,0.000005473093,3.5197255e-7,0.00007488758],"about_ca_topic_score_codex":0.000042944263,"about_ca_topic_score_gemma":0.000030317766,"teacher_disagreement_score":0.23054647,"about_ca_system_score_codex":0.000015825677,"about_ca_system_score_gemma":0.00005098496,"threshold_uncertainty_score":0.57688},"labels":[],"label_agreement":null},{"id":"W2268106067","doi":"10.1182/blood.v124.21.4816.4816","title":"Design, Optimization, and Pre-Clinical Evaluation of Direct, Mechanism-Based STAT3 Inhibitors for Treating Myeloid Disorders","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; York University","funders":"","keywords":"Myeloid leukemia; Cancer research; Chemistry; Myeloid; Biology; Molecular biology","score_opus":0.028509852793576748,"score_gpt":0.31641545287120076,"score_spread":0.287905600077624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2268106067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7786148,0.00026641742,0.21787372,0.00019273492,0.0001043516,0.00241695,0.0000133717895,0.000070582326,0.00044702704],"genre_scores_gemma":[0.9328225,0.00004397716,0.06661372,0.000047446178,0.00009562809,0.00019733212,0.00008702993,0.000032893673,0.000059445425],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9984927,0.00023972288,0.00044119026,0.00031042067,0.0003432114,0.00017275168],"domain_scores_gemma":[0.99859387,0.00066641025,0.00021521586,0.00024036977,0.00018757724,0.00009653822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014904073,0.00014824158,0.00032991348,0.00007809212,0.00006389418,0.0000091091415,0.00004028111,0.00010357601,0.000042866137],"category_scores_gemma":[0.0012136098,0.00012967645,0.000076540775,0.000107460866,0.00005326864,0.000048636277,0.000014727852,0.00005954115,0.0000010486738],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004141727,0.017330393,0.20724392,0.0027859488,0.0040470255,0.0000061309083,0.0036541775,0.30649787,0.020193264,0.00060423143,0.0013466262,0.43214867],"study_design_scores_gemma":[0.044690676,0.0029412315,0.0041962755,0.00025881972,0.0029502036,0.0000042283496,0.00004965251,0.86554474,0.07828334,0.0007858079,0.00007569771,0.00021935163],"about_ca_topic_score_codex":0.000041367184,"about_ca_topic_score_gemma":0.00001975323,"teacher_disagreement_score":0.55904686,"about_ca_system_score_codex":0.00009278152,"about_ca_system_score_gemma":0.00039001263,"threshold_uncertainty_score":0.52880526},"labels":[],"label_agreement":null},{"id":"W2268781386","doi":"10.1182/blood.v122.21.4301.4301","title":"Predicting Cell Of Origin In Diffuse Large B-Cell Lymphoma By High Dimensional Flow Cytometry","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lymphoma; Diffuse large B-cell lymphoma; Flow cytometry; Immunohistochemistry; Germinal center; Lymph node; Pathology; CD19; Immunophenotyping; B cell; Staining; Biology; Antibody; Medicine; Cancer research; Immunology","score_opus":0.005598824189835827,"score_gpt":0.2128075641963486,"score_spread":0.2072087400065128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2268781386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968201,0.0011876131,0.000003816878,0.00012233235,0.00009340428,0.00038866405,0.00008941789,0.000037721453,0.0012569375],"genre_scores_gemma":[0.997902,0.00006974965,0.0010204228,0.00019338206,0.00006792436,0.0000803323,0.000107424836,0.000025240235,0.0005335208],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871296,0.000030606872,0.0003350587,0.0002768447,0.00031780882,0.0003267478],"domain_scores_gemma":[0.9992865,0.00011919075,0.00010233719,0.0002766445,0.000058694473,0.0001566574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009002364,0.00017790157,0.00035254582,0.00013092904,0.000034793447,0.000011577384,0.00007148173,0.000106754065,0.00021974026],"category_scores_gemma":[0.000028210961,0.000138994,0.000089669746,0.00023167155,0.00002528144,0.00007223118,0.000060462302,0.00005693206,0.00014117951],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032617096,0.056974772,0.9192172,0.00012039005,0.0000798099,0.00010672952,0.00012511485,0.0000012587193,0.019090008,0.000017558245,0.0032571508,0.0009773638],"study_design_scores_gemma":[0.11521297,0.00065328483,0.5693272,0.00019917215,0.0003248113,0.000036577778,0.000085713364,0.0008573358,0.31222492,0.000031796986,0.0008100044,0.00023625462],"about_ca_topic_score_codex":0.0007498827,"about_ca_topic_score_gemma":0.000010297523,"teacher_disagreement_score":0.34989005,"about_ca_system_score_codex":0.00007966035,"about_ca_system_score_gemma":0.000080933416,"threshold_uncertainty_score":0.5668011},"labels":[],"label_agreement":null},{"id":"W2269258645","doi":"10.1182/blood.v122.21.5386.5386","title":"Description Of The Hematological Toxicity Of Different Regimens Using Bortezomib In Multiple Myeloma (CyborD, Vel-Dex and VMP)","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"","keywords":"Bortezomib; Melphalan; Multiple myeloma; Medicine; Dexamethasone; Internal medicine; Neutropenia; Cyclophosphamide; Gastroenterology; Prednisone; Oncology; Surgery; Chemotherapy","score_opus":0.05241896176627964,"score_gpt":0.27902178575121,"score_spread":0.22660282398493037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2269258645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99878824,0.00019307234,0.000022751541,0.00012816938,0.000020312451,0.00070034823,0.00000909372,0.0000092891805,0.00012872276],"genre_scores_gemma":[0.9990294,0.00003311275,0.00082549773,0.000017327295,0.000013418081,0.000024704827,0.0000048537368,0.000008367942,0.000043317224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990236,0.00008066706,0.00026922778,0.00017500768,0.00023848015,0.00021303062],"domain_scores_gemma":[0.9993967,0.0000901776,0.000096062424,0.00024751722,0.00007296629,0.00009660487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007791759,0.00011313143,0.00032632757,0.0000685166,0.000037858823,0.000007133931,0.00006730447,0.00008024705,0.000038992614],"category_scores_gemma":[0.00025215125,0.000064787484,0.00006531324,0.000123662,0.00014033256,0.00005344298,0.00008711313,0.00011862286,0.0000019635022],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008274181,0.0010473967,0.7779081,0.000088427325,0.00005839024,0.000011917259,0.00010694848,5.8128234e-7,0.22001036,0.000030749936,0.000009517308,0.0006448611],"study_design_scores_gemma":[0.0045501683,0.00017914169,0.8113936,0.00014189225,0.00005143159,0.00004557357,0.00009456509,0.0011934049,0.18219395,0.000108319386,0.0000023456332,0.000045604826],"about_ca_topic_score_codex":0.00048273368,"about_ca_topic_score_gemma":0.00012282663,"teacher_disagreement_score":0.037816413,"about_ca_system_score_codex":0.000029549876,"about_ca_system_score_gemma":0.00003081539,"threshold_uncertainty_score":0.26419568},"labels":[],"label_agreement":null},{"id":"W2269544826","doi":"10.1182/blood.v122.21.4175.4175","title":"An Open-Label Phase 2 Study Of Ofatumumab In Combination With a Novel AKT Inhibitor (Afuresertib) In Previously Treated Patients With Chronic Lymphocytic Leukemia (CLL)","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; CancerCare Manitoba; Princess Margaret Cancer Centre","funders":"","keywords":"Ofatumumab; Medicine; Fludarabine; Chronic lymphocytic leukemia; Internal medicine; Phases of clinical research; Oncology; Interim analysis; Refractory (planetary science); Pharmacology; Clinical trial; Leukemia; Cyclophosphamide; Chemotherapy; Biology","score_opus":0.02195042890963005,"score_gpt":0.3083522339784295,"score_spread":0.2864018050687994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2269544826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991341,0.00010656161,0.0000061067276,0.000015365726,0.000018858262,0.008255984,0.000012219393,0.000050053226,0.00019383195],"genre_scores_gemma":[0.99850494,0.000008682267,0.00021328771,0.00003057077,0.000029102606,0.00085130683,0.0001362855,0.000088218796,0.00013758658],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9966193,0.00016271578,0.00073640206,0.00072973483,0.0010579429,0.0006938993],"domain_scores_gemma":[0.99795794,0.00009710142,0.00024966453,0.00095704,0.00046032973,0.00027790442],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035641363,0.00037116432,0.000802497,0.00052069745,0.00005545082,0.00008842034,0.0005562843,0.00015387536,0.00006728525],"category_scores_gemma":[0.00011571599,0.00027196817,0.000020117677,0.0013221102,0.00014647239,0.000651282,0.00019386243,0.00031846858,0.000015558458],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.02890148,0.39690354,0.50228447,0.0022090033,0.0013631977,0.0012823889,0.012726389,0.0011249151,0.03936261,0.00006250286,0.00022883494,0.0135506345],"study_design_scores_gemma":[0.8295691,0.048758063,0.089872696,0.0011457504,0.00024609812,0.000057671343,0.00049945177,0.021689557,0.0077715763,0.0000076153324,0.000005597598,0.00037680598],"about_ca_topic_score_codex":0.03534026,"about_ca_topic_score_gemma":0.007974867,"teacher_disagreement_score":0.80066764,"about_ca_system_score_codex":0.031903837,"about_ca_system_score_gemma":0.016076295,"threshold_uncertainty_score":0.99997324},"labels":[],"label_agreement":null},{"id":"W2271533528","doi":"10.1182/blood.v95.5.1767.005k07_1767_1772","title":"MSH2-deficient murine lymphomas harbor insertion/deletion mutations in the transforming growth factor beta receptor type 2 gene and display low not high frequency microsatellite instability","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Royal University Hospital","funders":"","keywords":"Microsatellite instability; MSH2; Biology; DNA mismatch repair; Mutation frequency; Cancer research; Genome instability; Mutation; Lymphoma; MLH1; Molecular biology; Gene; Genetics; Microsatellite; DNA repair; Immunology; Allele; DNA; DNA damage","score_opus":0.011991548774196953,"score_gpt":0.23310793396173665,"score_spread":0.2211163851875397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2271533528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99700433,0.0007225605,0.000023255367,0.0008751861,0.00015427422,0.0008127432,0.00012649567,0.000043327567,0.0002378524],"genre_scores_gemma":[0.9976005,0.0005620711,0.0011710495,0.00033656336,0.00008247938,0.00007362845,0.00010916288,0.000025694417,0.00003888013],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99849623,0.00009457554,0.0004035795,0.00038916245,0.00032205685,0.00029440326],"domain_scores_gemma":[0.99933314,0.000104663675,0.00005467346,0.00029998738,0.00011252641,0.00009498828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021961232,0.00020974444,0.00024935792,0.00009228723,0.00012578165,0.000032994212,0.00012037176,0.00012917556,0.00059546635],"category_scores_gemma":[0.00007553771,0.00015583077,0.00006273512,0.0004162291,0.00014311475,0.00009541515,0.000012822504,0.0002096519,0.000032109434],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000506821,0.0017641664,0.14548352,0.00029143805,0.000079204496,0.000026639038,0.0048250197,0.000019769574,0.8379583,0.00025313688,0.00001135204,0.008780676],"study_design_scores_gemma":[0.0027774698,0.00041823083,0.7141821,0.00007297932,0.00011742701,0.000042624113,0.00006376062,0.000022843742,0.2815695,0.000116872005,0.00041698417,0.00019923151],"about_ca_topic_score_codex":0.00046451745,"about_ca_topic_score_gemma":0.00015889599,"teacher_disagreement_score":0.5686985,"about_ca_system_score_codex":0.00012793556,"about_ca_system_score_gemma":0.00014748455,"threshold_uncertainty_score":0.6519939},"labels":[],"label_agreement":null},{"id":"W2272014925","doi":"10.1182/blood.v122.21.3970.3970","title":"ODE-Adefovir As Potential Therapeutic Agent In AML","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"","keywords":"Adefovir; Pharmacology; Biology; Chemistry; Virology; Hepatitis B virus; Virus","score_opus":0.010523186428210776,"score_gpt":0.2388148631267285,"score_spread":0.22829167669851774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2272014925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98374605,0.0007377851,0.00001681755,0.0037857231,0.000087868626,0.0005311412,9.329959e-7,0.000055917466,0.011037778],"genre_scores_gemma":[0.9760351,0.00008195565,0.00050407014,0.00050621864,0.000073419564,0.00009515471,0.000021225895,0.000018095421,0.02266477],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914485,0.000023978122,0.00018175085,0.00019636945,0.00020288888,0.00025014614],"domain_scores_gemma":[0.9996403,0.0000128109905,0.000029011526,0.00018389616,0.000027581555,0.00010639501],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000057538877,0.00013269253,0.00018591569,0.00010250964,0.00003309596,0.000019840516,0.000057144298,0.00006280239,0.0012979279],"category_scores_gemma":[0.000008990741,0.00009987559,0.00006464692,0.00012495801,0.000023250313,0.000055631255,0.000027046173,0.00010210962,0.0029207354],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027501845,0.01662313,0.74146676,0.00023985811,0.002541313,0.0035825754,0.007174418,0.000011855469,0.06159344,0.0016794549,0.013149227,0.15166292],"study_design_scores_gemma":[0.029611506,0.0006739826,0.8727848,0.00024625816,0.0010194379,0.00052797876,0.00094955455,0.00021333554,0.056584187,0.0026763105,0.033956904,0.00075576245],"about_ca_topic_score_codex":0.0000931652,"about_ca_topic_score_gemma":0.0000126417435,"teacher_disagreement_score":0.15090716,"about_ca_system_score_codex":0.000038638977,"about_ca_system_score_gemma":0.0000770705,"threshold_uncertainty_score":0.999615},"labels":[],"label_agreement":null},{"id":"W2272245864","doi":"10.1182/blood-2015-05-647552","title":"Intravenous immune globulin and thromboembolic adverse events in patients with hematologic malignancy","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Chronic Disease Prevention and Health Promotion; Holden Comprehensive Cancer Center, University of Iowa; Centers for Medicare and Medicaid Services; U.S. Food and Drug Administration; Centers for Disease Control and Prevention; Hamilton Health Sciences Foundation; National Cancer Institute; U.S. Department of Health and Human Services; National Institutes of Health; National Institute of Neurological Disorders and Stroke; California Department of Public Health; University of Southern California","keywords":"Medicine; Hypogammaglobulinemia; Adverse effect; Internal medicine; Myocardial infarction; Stroke (engine); Antibody; Immunology","score_opus":0.01408671154445772,"score_gpt":0.2510201641193053,"score_spread":0.23693345257484755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2272245864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99760085,0.00057270663,0.000004169382,0.000053308206,0.000035660927,0.00064759987,0.0000037622035,0.000035717538,0.0010462245],"genre_scores_gemma":[0.9992469,0.000032887732,0.00048060445,0.000058828497,0.000027504546,0.000024727879,0.00002271664,0.00002287999,0.000082972954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859595,0.00004880358,0.00024808475,0.0002832829,0.00043836664,0.00038552273],"domain_scores_gemma":[0.9992453,0.000030214183,0.000059153554,0.00033672614,0.00010545064,0.00022314841],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019585578,0.00015516803,0.00039528927,0.00010061857,0.000024806915,0.0000033175677,0.0001008923,0.00010028702,0.00002520583],"category_scores_gemma":[0.00013661326,0.00011373615,0.000026139078,0.00024829418,0.000087744585,0.000069166534,0.000105154744,0.0001597057,0.000069867914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008139438,0.0048013884,0.99077636,0.0002906612,0.00019036683,0.00075897935,0.0011572199,0.000007642978,0.000096430675,0.00014708593,0.000054977532,0.0009049696],"study_design_scores_gemma":[0.12276646,0.0012976227,0.87308854,0.00038545553,0.00011659771,0.00040594046,0.00020453075,0.000087003806,0.0011613683,0.00024108317,0.000048720853,0.000196694],"about_ca_topic_score_codex":0.00038967395,"about_ca_topic_score_gemma":0.000033825785,"teacher_disagreement_score":0.12195252,"about_ca_system_score_codex":0.0011225708,"about_ca_system_score_gemma":0.0016047372,"threshold_uncertainty_score":0.46380255},"labels":[],"label_agreement":null},{"id":"W2274060198","doi":"10.1182/blood.v122.21.3041.3041","title":"Accrual Of Patients With Relapsed and Refractory DLBCL Onto Clinical Trials","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Clinical trial; Internal medicine; Oncology; Refractory (planetary science); Lymphoma; Progressive disease; Interim analysis; Chemotherapy regimen; Lenalidomide; Surgery; Disease; Cancer; Multiple myeloma","score_opus":0.05035598214498882,"score_gpt":0.342667363834602,"score_spread":0.2923113816896132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2274060198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99787295,0.00033417653,6.881052e-7,0.00015564132,0.000055364144,0.00059895584,0.00001220213,0.000014087354,0.0009559088],"genre_scores_gemma":[0.9989611,0.00010892404,0.00049164344,0.00015558687,0.00007349756,0.000042681506,0.000023775157,0.000010125926,0.00013268678],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898857,0.000117727985,0.0004485499,0.00016901355,0.00017193629,0.00010420089],"domain_scores_gemma":[0.99894637,0.0004263716,0.00018761696,0.00020765356,0.00009748051,0.00013452422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034134163,0.000091534144,0.00049023126,0.00002776488,0.000017692648,0.000007905212,0.00002704531,0.0000792285,0.00013318888],"category_scores_gemma":[0.00044749054,0.000052177606,0.00007597306,0.000035076948,0.00005311031,0.000055041874,0.00001956116,0.00005091019,0.000026946198],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022580322,0.0068195253,0.9768056,0.000020452384,0.00032954756,0.000007189638,0.000057360532,6.868793e-9,0.00006288706,0.000023364546,0.0011517196,0.014496531],"study_design_scores_gemma":[0.034442093,0.0022023844,0.9606387,0.00007049153,0.0005628764,0.00000242512,0.000023926286,5.5337273e-7,0.0008555835,0.000015487412,0.0011306218,0.000054836597],"about_ca_topic_score_codex":0.000101783895,"about_ca_topic_score_gemma":0.0000074674663,"teacher_disagreement_score":0.03421629,"about_ca_system_score_codex":0.000012366959,"about_ca_system_score_gemma":0.00005995721,"threshold_uncertainty_score":0.2127741},"labels":[],"label_agreement":null},{"id":"W2275402064","doi":"10.1182/blood.v124.21.4583.4583","title":"Ruxolitinib Overcomes the Adverse Prognostic Effect of Anemia in Patients with Myelofibrosis (MF)","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Ruxolitinib; Medicine; Myelofibrosis; Adverse effect; Internal medicine; Anemia; Proportional hazards model; International Prognostic Scoring System; Gastroenterology; Oncology; Bone marrow; Myelodysplastic syndromes","score_opus":0.003425780218566742,"score_gpt":0.20942185750895828,"score_spread":0.20599607729039154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2275402064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971537,0.000055586952,0.0000018978353,0.00014211488,0.000028087217,0.0010951059,0.000013989687,0.000018575376,0.0014909601],"genre_scores_gemma":[0.9994134,0.000009890974,0.0001740117,0.0001028449,0.00003860708,0.00016960387,0.00003603714,0.000017907641,0.000037703823],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895376,0.00013421808,0.0002098428,0.00020995956,0.0002829564,0.00020929101],"domain_scores_gemma":[0.99886245,0.0006290161,0.00009162957,0.0002795833,0.00006498245,0.00007233582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018177839,0.00017479622,0.00036843613,0.000061008315,0.00004009408,0.0000060562525,0.00006136132,0.00005183735,0.000053307736],"category_scores_gemma":[0.00025267966,0.00008673229,0.00006617705,0.00015829796,0.000068362904,0.00003742623,0.000025744075,0.00010118318,0.000018138706],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034248136,0.0011146906,0.9962697,0.00014901966,0.000091806214,0.0000069830626,0.00014474605,0.0000026619668,0.000042133655,0.0001346709,0.00004627686,0.0016548261],"study_design_scores_gemma":[0.013249024,0.004467668,0.96683925,0.00034678177,0.00041858002,0.000004307508,0.000012928771,0.000007215413,0.014425901,0.000010585087,0.00013215168,0.00008559821],"about_ca_topic_score_codex":0.000035777783,"about_ca_topic_score_gemma":0.000018635244,"teacher_disagreement_score":0.029430445,"about_ca_system_score_codex":0.000021414176,"about_ca_system_score_gemma":0.000031118372,"threshold_uncertainty_score":0.353684},"labels":[],"label_agreement":null},{"id":"W2275498261","doi":"10.1182/blood.v122.21.3538.3538","title":"Platelet Functional and Morphological Abnormalities In a Case Of Arthrogryposis, Renal Dysfunction and Cholestasis (ARC) Syndrome With a Novel Genetic Profile","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Metabolism and Genetic Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Failure to thrive; Medicine; Gastroenterology; Jaundice; Internal medicine; Hypotonia; Cholestasis; Pediatrics; Surgery; Pathology","score_opus":0.007386910659378503,"score_gpt":0.19078932003093096,"score_spread":0.18340240937155247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2275498261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975532,0.0016786946,0.00032786583,0.00003341366,0.00001780966,0.00025254738,0.00004538797,0.000004463196,0.00008656596],"genre_scores_gemma":[0.99696,0.00024091298,0.002516588,0.00005043952,0.000023058166,0.00008913944,0.000040833795,0.000009300129,0.00006975246],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99931085,0.000027492648,0.00016604834,0.00026197758,0.0000756667,0.00015795657],"domain_scores_gemma":[0.9997119,0.000008151597,0.000045798275,0.00013067451,0.000041165385,0.000062336025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006825155,0.00012057698,0.00014464563,0.000049373793,0.000036525726,0.000018174578,0.000032559412,0.00009408334,0.00007452895],"category_scores_gemma":[0.000014645991,0.000096247786,0.000019435192,0.00006471135,0.00016935293,0.0000063527505,0.000049497306,0.000054859192,0.0000012972945],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063618313,0.002545451,0.29878417,0.00039454782,0.0005871218,0.0012235127,0.00050603965,0.00036990616,0.6559706,0.00023342173,0.0004827383,0.038266357],"study_design_scores_gemma":[0.005907383,0.0010912763,0.93421024,0.00003118986,0.000081638274,0.02184501,0.00046760225,0.00006860306,0.035616808,0.00007326202,0.0003261933,0.0002807785],"about_ca_topic_score_codex":0.00027525335,"about_ca_topic_score_gemma":0.00014499175,"teacher_disagreement_score":0.6354261,"about_ca_system_score_codex":7.764418e-7,"about_ca_system_score_gemma":0.00002552381,"threshold_uncertainty_score":0.39248708},"labels":[],"label_agreement":null},{"id":"W2275948481","doi":"10.1182/blood-2004-03-0796","title":"Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated retrospective comparative analysis of CALGB 9712 and CALGB 9011","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":407,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital","funders":"State University of New York Upstate Medical University; University of North Carolina at Chapel Hill; University of Illinois at Urbana-Champaign; Virginia Commonwealth University; McGill University; Syracuse University; University of Pittsburgh; Memorial Sloan-Kettering Cancer Center; Johns Hopkins University; University of Rochester; University of Miami; York University; University of Missouri; Georgetown University; National Cancer Institute; Wake Forest University; University of Pennsylvania; Dartmouth College; State University of New York; University of Nebraska Medical Center; Kaiser Permanente; University of South Carolina; University of Minnesota; Massachusetts General Hospital; University of Pretoria; Ohio State University; D. Warren Brown Family Foundation; Leukemia and Lymphoma Society","keywords":"Fludarabine; Rituximab; Medicine; Internal medicine; Chronic lymphocytic leukemia; Oncology; Leukemia; Surgery; Chemotherapy; Lymphoma; Cyclophosphamide","score_opus":0.011943521884834505,"score_gpt":0.2820362234149799,"score_spread":0.2700927015301454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2275948481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971381,0.00030048192,0.000023338313,0.00003600129,0.00002120278,0.00196575,0.000306646,0.000045140216,0.00016335696],"genre_scores_gemma":[0.9982571,0.00003773211,0.00061003835,0.0000121584335,0.000030439647,0.00007735883,0.00092000206,0.00003284328,0.000022335422],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968052,0.00021015873,0.0006623557,0.0007564855,0.0010130213,0.00055276905],"domain_scores_gemma":[0.9979692,0.0000963871,0.00028638568,0.00069970265,0.0006034367,0.00034484966],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043774134,0.00036512487,0.001451317,0.00064280647,0.00006761049,0.000023411092,0.00019107378,0.00020107075,0.00005808189],"category_scores_gemma":[0.0001603472,0.00028676275,0.0000778647,0.0016827337,0.00041353458,0.00021091422,0.00018572484,0.00026428135,0.000001900991],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.019230854,0.008001764,0.94996333,0.0011554467,0.0070384163,0.00044154943,0.0058920924,0.0033737773,0.0029763859,0.00070308795,0.000067236746,0.0011560778],"study_design_scores_gemma":[0.1604648,0.0059188535,0.8203126,0.00058542,0.0020078078,0.000023024886,0.00015352598,0.004167995,0.006005715,0.00005246705,0.0000034638879,0.00030431355],"about_ca_topic_score_codex":0.0063361344,"about_ca_topic_score_gemma":0.005206979,"teacher_disagreement_score":0.14123395,"about_ca_system_score_codex":0.015866477,"about_ca_system_score_gemma":0.0064141722,"threshold_uncertainty_score":0.99995846},"labels":[],"label_agreement":null},{"id":"W2275966295","doi":"10.1182/blood.v124.21.314.314","title":"Selective Photodepletion of Recipient-Alloreactive T-Cells Enables Safe and Efficacious Haploidentical HSCT: Initial Results from a Phase 2 Trial in Patients with AML, ALL, and MDS","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Juravinski Hospital; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Hematopoietic stem cell transplantation; Graft-versus-host disease; Immunology; Leukemia; Internal medicine; CD34; Clinical trial; Phases of clinical research; Stem cell; Transplantation; Oncology; Gastroenterology; Biology","score_opus":0.011003525270896918,"score_gpt":0.257274373052014,"score_spread":0.24627084778111707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2275966295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978576,0.0000151967,0.00020388675,0.000034228477,0.00006179432,0.0011357544,0.00015871953,0.00001865234,0.00051420496],"genre_scores_gemma":[0.99874645,0.00002585047,0.0007802318,0.00003866765,0.00007097278,0.000027208,0.00028259307,0.000020621228,0.0000074256736],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9985322,0.00013159063,0.00043071862,0.00037990854,0.00033522022,0.00019041187],"domain_scores_gemma":[0.9989963,0.0004568732,0.00015603231,0.00015613274,0.00011366146,0.000121009965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026702936,0.00016451653,0.0004116081,0.00013007617,0.000027905984,0.000014669797,0.00003581779,0.00013272298,0.000008273066],"category_scores_gemma":[0.00022080884,0.00013724342,0.00002776721,0.00012091096,0.000110106026,0.000085077874,0.000014236482,0.00016367924,0.0000022892984],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7112843,0.021397011,0.04724497,0.00049176725,0.0010440687,0.00012182863,0.021376872,0.0000057992843,0.19047488,0.00013189465,0.00007150954,0.0063551003],"study_design_scores_gemma":[0.6266316,0.008331596,0.08887234,0.0006321467,0.00091535016,0.000014980601,0.00019411203,0.00017945866,0.2738123,0.00009513315,0.00006140731,0.0002595902],"about_ca_topic_score_codex":0.00023586625,"about_ca_topic_score_gemma":0.0000726476,"teacher_disagreement_score":0.08465269,"about_ca_system_score_codex":0.000024777433,"about_ca_system_score_gemma":0.000047074383,"threshold_uncertainty_score":0.5596624},"labels":[],"label_agreement":null},{"id":"W2276781572","doi":"10.1182/blood-2015-07-658401","title":"Clinical impact of molecular features in diffuse large B-cell lymphoma and follicular lymphoma","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Canada's Michael Smith Genome Sciences Centre","funders":"Canadian Institutes of Health Research","keywords":"Follicular lymphoma; Lymphoma; Diffuse large B-cell lymphoma; Cell of origin; Clinical trial; Medicine; Oncology; Biology; Cancer research; Cancer; Pathology; Internal medicine","score_opus":0.01607402377836165,"score_gpt":0.3091935196842825,"score_spread":0.29311949590592085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2276781572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904822,0.0076546976,0.000002739089,0.00008932067,0.000046955836,0.0003319124,0.000025606525,0.000024434661,0.0013421477],"genre_scores_gemma":[0.99886596,0.00032999768,0.00043315123,0.00017044596,0.00005270449,0.000025034607,0.000027428532,0.000024797522,0.00007047777],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99864423,0.00008920357,0.0003826787,0.00031858668,0.0002666756,0.0002986027],"domain_scores_gemma":[0.99898875,0.00007954161,0.000105435,0.0003910791,0.00007179598,0.00036340012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002812875,0.00020727381,0.00056026276,0.000107398744,0.000016872964,0.000014510166,0.000072875155,0.00017208925,0.000006280766],"category_scores_gemma":[0.00013779836,0.00014799967,0.0002777847,0.00016621547,0.000058923888,0.00004482508,0.00007615696,0.000040690993,0.00001196303],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022613643,0.048015013,0.94364893,0.00004117209,0.00033667154,0.0014943843,0.000200271,5.6019667e-7,0.0007161909,0.000112828864,0.00054464646,0.004663184],"study_design_scores_gemma":[0.13122676,0.0013463416,0.8534844,0.00008366849,0.00040563874,0.00019975578,0.00006358062,0.000018830135,0.012613818,0.00008288368,0.00033779946,0.00013653157],"about_ca_topic_score_codex":0.00038297768,"about_ca_topic_score_gemma":0.000027916478,"teacher_disagreement_score":0.13100062,"about_ca_system_score_codex":0.00009625795,"about_ca_system_score_gemma":0.00028184606,"threshold_uncertainty_score":0.6035251},"labels":[],"label_agreement":null},{"id":"W2277305660","doi":"10.1182/blood.v122.21.3381.3381","title":"Outcome After First Relapse Or Refractory Acute Lymphoblastic Leukemia In Children From 1996 To 2011 – Comparison Of Two Different Treatment Strategies","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Refractory (planetary science); Internal medicine; Hematopoietic stem cell transplantation; Induction chemotherapy; Transplantation; Chemotherapy; Retrospective cohort study; Surgery; Pediatrics","score_opus":0.020790229462530042,"score_gpt":0.30588824305864026,"score_spread":0.2850980135961102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2277305660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973743,0.00031199204,0.000093133705,0.00018911791,0.00009906963,0.0014889697,0.00013948158,0.00006820081,0.00023570938],"genre_scores_gemma":[0.9970236,0.00006694478,0.001164276,0.0001153414,0.00017575949,0.0004796393,0.00010735321,0.00006786956,0.0007992116],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971628,0.00008183463,0.00088631583,0.00061240816,0.00061695,0.0006396484],"domain_scores_gemma":[0.9980784,0.00039199827,0.00015839167,0.0008338074,0.00010056943,0.00043679925],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00007088942,0.0004579695,0.0010672177,0.00032383093,0.000049757837,0.000053062686,0.00028793563,0.0002003019,0.0015050161],"category_scores_gemma":[0.000081475366,0.00029973718,0.000160108,0.00021789085,0.0001244846,0.00018258877,0.00019493444,0.00025695888,0.0007833189],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012289163,0.0021592584,0.9886464,0.000059309557,0.00062821555,0.0001737523,0.0012336253,0.000063128085,0.0043702754,0.000011685525,0.00054800184,0.00087741454],"study_design_scores_gemma":[0.021281244,0.0025234623,0.9658425,0.00021261441,0.00073817617,0.000055943223,0.0002935528,0.00078966893,0.007817922,0.000054728127,0.00006642593,0.00032374728],"about_ca_topic_score_codex":0.0146632055,"about_ca_topic_score_gemma":0.0029054338,"teacher_disagreement_score":0.022803903,"about_ca_system_score_codex":0.0023162044,"about_ca_system_score_gemma":0.0009107084,"threshold_uncertainty_score":0.9999947},"labels":[],"label_agreement":null},{"id":"W2278895774","doi":"10.1182/blood.v122.21.5398.5398","title":"Lenalidomide (Revlimid), Bortezomib (Velcade) and Dexamethasone (RVD) For The Treatment Of Secondary Plasma Cell Leukaemia","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Lenalidomide; Medicine; Bortezomib; Thalidomide; Plasma cell leukemia; Dexamethasone; Multiple myeloma; Internal medicine; Gastroenterology; Melphalan; Neutropenia; Toxicity; Oncology","score_opus":0.02664593212057632,"score_gpt":0.27908132835494825,"score_spread":0.25243539623437194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2278895774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902239,0.005460282,0.000037769023,0.000589065,0.000038745737,0.002081008,0.00007412125,0.000025073487,0.001470069],"genre_scores_gemma":[0.990717,0.0024967983,0.0036465349,0.000065925866,0.00012382495,0.0005728547,0.000043355216,0.00003178186,0.002301943],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99887717,0.000036715228,0.00025568876,0.0002670234,0.0002059193,0.00035751238],"domain_scores_gemma":[0.99855477,0.00068444293,0.000086404645,0.00035453806,0.0000991804,0.00022067285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010526216,0.0001966946,0.00037642042,0.000072247836,0.000102752856,0.000021305,0.00008062951,0.000087328706,0.00024298379],"category_scores_gemma":[0.00006781952,0.00011294206,0.00014814244,0.00008020143,0.00012359206,0.000064296124,0.000025590096,0.00009268955,0.000036241494],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027480233,0.011938736,0.21117356,0.0013018177,0.0048264917,0.00018173532,0.0020837148,0.0000054516154,0.18582155,0.00011718681,0.006658549,0.5731432],"study_design_scores_gemma":[0.06154656,0.0050408295,0.20342827,0.00007255629,0.0014358422,0.00013048289,0.00046109373,0.0008900158,0.7137274,0.00014453352,0.012885598,0.00023680419],"about_ca_topic_score_codex":0.00051838707,"about_ca_topic_score_gemma":0.000038859464,"teacher_disagreement_score":0.5729064,"about_ca_system_score_codex":0.000052711996,"about_ca_system_score_gemma":0.00015160927,"threshold_uncertainty_score":0.46056437},"labels":[],"label_agreement":null},{"id":"W2279265373","doi":"10.1182/blood.v122.21.5137.5137","title":"Resistance To Vorinostat In Hematological Malignancies May Involve Cytoprotective UPR and Correlates With Increased Sensitivity To Bortezomib-Induced Cell Death","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Vorinostat; Bortezomib; Histone deacetylase inhibitor; Proteasome inhibitor; Cancer research; Autophagy; Histone deacetylase; Biology; Proteasome; Pharmacology; Medicine; Immunology; Histone; Apoptosis; Multiple myeloma; Cell biology","score_opus":0.009800577781426952,"score_gpt":0.23043192929206033,"score_spread":0.22063135151063337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2279265373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99789107,0.0001331662,0.00017983394,0.00020520268,0.000017206894,0.0009955373,0.000025496223,0.000018307333,0.00053415133],"genre_scores_gemma":[0.9963457,0.000009930134,0.0029038212,0.00018105931,0.00003976038,0.00022991086,0.000016405707,0.00002492086,0.0002484788],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984475,0.00017281472,0.00018531611,0.00057871133,0.00019776344,0.000417924],"domain_scores_gemma":[0.999138,0.000056253557,0.00004470305,0.00033267488,0.0001668819,0.0002615118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024412468,0.00021197392,0.00025519668,0.000094885,0.00008084319,0.00004031889,0.00010160485,0.00017279753,0.000006356435],"category_scores_gemma":[0.00025030525,0.00017999239,0.000032135264,0.00021116543,0.00006515712,0.000008382631,0.00017936446,0.00018305994,0.00003574021],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002170703,0.00022529396,0.03770126,0.000034045315,0.000019053827,0.00015717416,0.0002060866,0.0000048714337,0.9610552,0.000028279315,0.00028337855,0.00006823948],"study_design_scores_gemma":[0.001119051,0.00058249035,0.053277504,0.0000661954,0.000010655073,0.000052414005,0.00017578555,0.000008587736,0.9442018,0.000025702346,0.00021480783,0.00026497545],"about_ca_topic_score_codex":0.0006532592,"about_ca_topic_score_gemma":0.0017455136,"teacher_disagreement_score":0.016853416,"about_ca_system_score_codex":0.000029194476,"about_ca_system_score_gemma":0.000097435324,"threshold_uncertainty_score":0.7339877},"labels":[],"label_agreement":null},{"id":"W227971227","doi":"10.1182/blood.v95.2.519","title":"Adenosine receptor occupancy suppresses chemoattractant-induced phospholipase D activity by diminishing membrane recruitment of small GTPases","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Calcium signaling and nucleotide metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"","keywords":"Phospholipase D; Agonist; RHOA; Adenosine; Adenosine A2A receptor; Adenosine receptor; Chemistry; Receptor; Autocrine signalling; Cell biology; Biology; Pharmacology; Signal transduction; Biochemistry","score_opus":0.030913786753295546,"score_gpt":0.2621415013071439,"score_spread":0.23122771455384838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W227971227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959408,0.0025307043,0.000013764717,0.0001166708,0.0001449824,0.0003087462,0.00019594979,0.000029020988,0.0007193283],"genre_scores_gemma":[0.99688303,0.0011350388,0.00046326753,0.00011507348,0.0002464256,0.000050016883,0.00018262427,0.00003983936,0.0008846578],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986214,0.00008142162,0.00030225352,0.0004710011,0.00018406661,0.00033984534],"domain_scores_gemma":[0.999138,0.00003883828,0.00014282654,0.00047030393,0.00006823186,0.0001418039],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017738689,0.00025749067,0.00034041522,0.000029875808,0.000082379396,0.000032217216,0.00024778818,0.0001939195,0.00042784214],"category_scores_gemma":[0.00011083815,0.00025063538,0.00016183112,0.000113580434,0.00005963511,0.000008900765,0.00005880911,0.00014459487,0.000017378094],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003150055,0.0011985971,0.00052031473,0.00004816222,0.000116106574,0.0000048469296,0.00006742279,0.0000034232703,0.9865029,0.0000031740158,0.0010422172,0.010177843],"study_design_scores_gemma":[0.0018100976,0.00026043746,0.0009047353,0.000042950294,0.00014173717,0.000012150752,0.000020367357,0.0000042276824,0.9693824,0.0000032733712,0.027142042,0.00027556904],"about_ca_topic_score_codex":0.00013136659,"about_ca_topic_score_gemma":0.000010191553,"teacher_disagreement_score":0.026099825,"about_ca_system_score_codex":0.000006559017,"about_ca_system_score_gemma":0.000060460345,"threshold_uncertainty_score":0.9999946},"labels":[],"label_agreement":null},{"id":"W2279791399","doi":"10.1182/blood.v122.21.2941.2941","title":"Frontline Rituximab Monotherapy Induction Versus a Watch and Wait Approach For Asymptomatic Advanced Stage Follicular Lymphoma: A Cost-Effectiveness Analysis","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Rituximab; Follicular lymphoma; Asymptomatic; Watchful waiting; Internal medicine; Oncology; Randomized controlled trial; Quality-adjusted life year; Maintenance therapy; Cohort; Cost effectiveness; Lymphoma; Surgery; Chemotherapy; Cancer; Prostate cancer","score_opus":0.021518877538591188,"score_gpt":0.282634407681047,"score_spread":0.2611155301424558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2279791399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98948956,0.0012642436,0.0052310773,0.00017208804,0.00005989016,0.0035367282,0.000032471886,0.00008064872,0.00013327952],"genre_scores_gemma":[0.9832464,0.00016631739,0.01153792,0.000051539024,0.00006764373,0.0045471904,0.00023447323,0.00003360253,0.00011495145],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987336,0.000064695385,0.00024786484,0.00046452897,0.00020396875,0.00028536082],"domain_scores_gemma":[0.99909145,0.00017116792,0.00010649476,0.0003530468,0.00012530205,0.00015253267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014691526,0.00025230116,0.0006599226,0.00013285472,0.00010578153,0.00004964252,0.00005323704,0.00011883097,0.000033902295],"category_scores_gemma":[0.000042532425,0.00019276248,0.00024833326,0.00034435274,0.000039608858,0.00015564119,0.000021018615,0.000036131587,0.0000094119405],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008451028,0.07153305,0.3778358,0.0017950643,0.058495235,0.00011316349,0.0020648553,0.0010271916,0.020874409,0.00073808385,0.0002632209,0.4568089],"study_design_scores_gemma":[0.3251279,0.0033400117,0.57664275,0.00012918605,0.016069666,0.000049697184,0.00072922336,0.023150517,0.052394263,0.00013524429,0.0014987353,0.00073280936],"about_ca_topic_score_codex":0.000364828,"about_ca_topic_score_gemma":0.00001273961,"teacher_disagreement_score":0.4560761,"about_ca_system_score_codex":0.00016901054,"about_ca_system_score_gemma":0.00004783539,"threshold_uncertainty_score":0.7860626},"labels":[],"label_agreement":null},{"id":"W2280104852","doi":"10.1182/blood.v122.21.1119.1119","title":"The Efficacy and Safety Of Therapeutic Aheresis In Sepsis and Septic Shock: A Systematic Review and Meta-Analysis","year":2013,"lang":"en","type":"review","venue":"Blood","topic":"Sepsis Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Université Laval; McMaster University; Hôpital de l'Enfant-Jésus; George & Fay Yee Centre for Healthcare Innovation; University of Manitoba","funders":"","keywords":"Medicine; Septic shock; Sepsis; Internal medicine; Intensive care medicine; Population; Meta-analysis; Odds ratio; Randomized controlled trial; Clinical trial; Adverse effect; SOFA score","score_opus":0.15706184243513457,"score_gpt":0.38564049018564356,"score_spread":0.22857864775050898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2280104852","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010285357,0.9940849,4.06474e-7,0.00037122847,0.0000051208904,0.005319772,0.000027040272,0.000009053338,0.00007962065],"genre_scores_gemma":[0.0005860756,0.99765617,0.000057282923,0.00021416756,0.0000066463044,0.0012123884,0.000015498588,0.000032675776,0.00021908837],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99729526,0.0005626176,0.001225027,0.00046448433,0.00024542853,0.00020718224],"domain_scores_gemma":[0.9964095,0.0020548725,0.0005720684,0.00078355434,0.00006123568,0.000118781434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007653344,0.00046250262,0.008335791,0.00020551143,0.00006502945,0.000042754844,0.00010607831,0.00014771828,0.00011737075],"category_scores_gemma":[0.00021677588,0.00020473433,0.0011073377,0.00058524485,0.00009925934,0.000026627153,0.0000756559,0.00016359088,0.0000067139886],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000002474317,0.0003693874,0.00013116149,0.6919178,0.29600522,0.000010510515,0.000044968434,1.6705988e-8,4.6849852e-8,0.000037037174,0.000025031713,0.0114563815],"study_design_scores_gemma":[0.0007229463,0.00010922135,0.00037052398,0.046466496,0.9477729,0.00006416275,0.000021967846,8.903373e-7,3.70583e-7,0.0000072391726,0.004306266,0.00015699492],"about_ca_topic_score_codex":0.000053083273,"about_ca_topic_score_gemma":0.000043522818,"teacher_disagreement_score":0.65176773,"about_ca_system_score_codex":0.000026495778,"about_ca_system_score_gemma":0.00005180173,"threshold_uncertainty_score":0.8348823},"labels":[],"label_agreement":null},{"id":"W2280269954","doi":"10.1182/blood-2015-10-676700","title":"Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCL","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":185,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; CancerCare Manitoba; BC Cancer Agency","funders":"Canadian Institutes of Health Research; Terry Fox Research Institute","keywords":"Immunohistochemistry; Diffuse large B-cell lymphoma; Medicine; Oncology; Internal medicine; Lymphoma; Cancer research; Pathology","score_opus":0.006757360245682148,"score_gpt":0.25368122213541267,"score_spread":0.2469238618897305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2280269954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99798566,0.0010397049,4.4622465e-7,0.000081424376,0.000007683975,0.00012307512,0.0001033631,0.0000028247296,0.0006557978],"genre_scores_gemma":[0.99937624,0.00048680854,0.000023039476,0.0000046530504,0.00000814131,0.000011278636,0.000003972304,0.0000058640644,0.000079981626],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99950105,0.000025674153,0.00018545162,0.000096178446,0.00011640833,0.000075226504],"domain_scores_gemma":[0.99937683,0.00018152098,0.00014517014,0.00023960134,0.000025098672,0.000031788306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008860516,0.000074740536,0.00019971731,0.000022168448,0.00001061531,8.0367994e-7,0.000032138418,0.000043382264,0.000047340814],"category_scores_gemma":[0.00012506683,0.00003239332,0.00007532999,0.000039166745,0.00007084056,0.000013781455,0.000022817754,0.000033018507,0.0000010853797],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014564756,0.002036323,0.41285375,0.000021436921,0.00008480187,0.000005293495,0.00012606638,6.3361114e-8,0.5833278,0.000011471263,0.0006511392,0.00073623075],"study_design_scores_gemma":[0.005453551,0.00046328746,0.366476,0.00038788843,0.00009474436,0.0000071427485,0.00002357793,3.066737e-7,0.62704194,0.000018744611,0.000008821974,0.000024004708],"about_ca_topic_score_codex":0.00022558264,"about_ca_topic_score_gemma":6.0303336e-7,"teacher_disagreement_score":0.04637774,"about_ca_system_score_codex":0.000029830122,"about_ca_system_score_gemma":0.000040350926,"threshold_uncertainty_score":0.13209611},"labels":[],"label_agreement":null},{"id":"W2280310901","doi":"10.1182/blood.v124.21.136.136","title":"Analysis of Relapse Biopsies in Classical Hodgkin Lymphoma Reveals Correlations with Outcome after Autologous Stem Cell Transplantation","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"ABVD; Autologous stem-cell transplantation; Medicine; Oncology; Internal medicine; Transplantation; Salvage therapy; Biopsy; Lymphoma; Chemotherapy; Pathology; Cyclophosphamide; Vincristine","score_opus":0.01110529996399508,"score_gpt":0.2407113772746209,"score_spread":0.22960607731062582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2280310901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99821866,0.00015338785,0.00015475442,0.00025892848,0.000024440702,0.00021564346,0.00003844633,0.000027532249,0.0009082261],"genre_scores_gemma":[0.99875456,0.000029621304,0.00066393643,0.00008189847,0.000013482444,0.000078631354,0.00006909655,0.000011256867,0.00029753323],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989947,0.00007304456,0.0003697925,0.0002220547,0.00018950949,0.00015090783],"domain_scores_gemma":[0.9993382,0.00018820795,0.00011469966,0.00024480422,0.00004291961,0.0000711333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011334827,0.0001312163,0.00047561745,0.00032024676,0.000022450398,0.000007558677,0.000038008802,0.000096128926,0.000022930686],"category_scores_gemma":[0.000009504691,0.00009220376,0.00012974032,0.000538312,0.00005148824,0.000042492422,0.0000065248732,0.000039889965,0.000013291045],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021495266,0.0016782994,0.99489933,0.00007868092,0.0004204071,0.00015752153,0.00052478974,0.00008424449,0.00016282334,0.00013704007,0.000007722196,0.0016341567],"study_design_scores_gemma":[0.006533329,0.00042873464,0.9839141,0.00006813092,0.006455742,0.00003864129,0.000056508354,0.00042458164,0.0019456154,0.000007867795,0.000031638905,0.00009515644],"about_ca_topic_score_codex":0.000093101335,"about_ca_topic_score_gemma":0.00026488444,"teacher_disagreement_score":0.010985307,"about_ca_system_score_codex":0.000049287064,"about_ca_system_score_gemma":0.000036861024,"threshold_uncertainty_score":0.37599602},"labels":[],"label_agreement":null},{"id":"W2280981145","doi":"10.1182/blood.v122.21.5403.5403","title":"Implementing Cybord As First-Line Therapy For Transplant-Eligible Multiple Myeloma Patients : A Single-Center Preliminary Comparaison","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Multiple myeloma; Regimen; Single Center; Lenalidomide; Surgery; Autologous stem-cell transplantation; Internal medicine; Median follow-up; Chemotherapy","score_opus":0.041184436500048945,"score_gpt":0.30488826471424446,"score_spread":0.2637038282141955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2280981145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99355507,0.00030105177,0.00019067232,0.00051101623,0.00007031966,0.0041902266,0.0001839948,0.00010716932,0.00089046615],"genre_scores_gemma":[0.9950038,0.00009565753,0.0020193243,0.00025860275,0.00014791706,0.001059027,0.0010407781,0.00005972973,0.0003151567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997788,0.000038576465,0.00041450292,0.00043640565,0.00040234032,0.00092017034],"domain_scores_gemma":[0.99875087,0.00023854827,0.0001049685,0.00033855977,0.00024466738,0.000322393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000111279915,0.0002911406,0.0003942008,0.00014012288,0.00027405107,0.000061022263,0.00014787761,0.00009286366,0.0003826901],"category_scores_gemma":[0.000085655454,0.00022936074,0.00020386642,0.00013223013,0.000042206608,0.0001607009,0.00005242241,0.00012950397,0.00018836095],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023310226,0.010958147,0.94585145,0.0002018035,0.0005565138,0.0000369043,0.00047760908,8.153783e-7,0.004084674,0.000008405505,0.0009139539,0.034578692],"study_design_scores_gemma":[0.1262421,0.016523248,0.76515293,0.00040633042,0.0002865409,0.00009469219,0.0001221602,0.0017600979,0.069266714,0.000145639,0.019453632,0.00054593856],"about_ca_topic_score_codex":0.0002986164,"about_ca_topic_score_gemma":0.00010041865,"teacher_disagreement_score":0.18069854,"about_ca_system_score_codex":0.000045131503,"about_ca_system_score_gemma":0.000044388416,"threshold_uncertainty_score":0.93530595},"labels":[],"label_agreement":null},{"id":"W2282158872","doi":"10.1182/blood.v106.11.1635.1635","title":"Predictors of the Development of Post-Thrombotic Syndrome after Acute Symptomatic Deep Vein Thrombosis: Two-Year Results from a Canadian Multicenter Prospective Cohort Study (The VETO Study).","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; McGill University; Université de Montréal; McMaster University; Jewish General Hospital","funders":"","keywords":"Medicine; Post-thrombotic syndrome; Internal medicine; Prospective cohort study; Thrombophilia; Thrombosis; Deep vein; Cohort; Venous thrombosis; Univariate analysis; Multivariate analysis; Surgery; Pediatrics","score_opus":0.007422747064378921,"score_gpt":0.24244881395633777,"score_spread":0.23502606689195885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2282158872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910619,0.00006381268,0.0000014643169,0.00040318884,0.00021845287,0.007528268,0.00008734382,0.000037098638,0.00059842074],"genre_scores_gemma":[0.99845856,0.000007754813,0.00042545187,0.00020824365,0.00007585669,0.00070058875,0.00002214569,0.00004858722,0.00005278137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970011,0.0001616935,0.0010026821,0.0005401348,0.0008434928,0.00045090474],"domain_scores_gemma":[0.99805415,0.00008924245,0.00032370313,0.0010936271,0.00023908686,0.0002002193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060632004,0.0003295271,0.00087003666,0.00016531229,0.00018219023,0.000029161334,0.00044605398,0.000066975605,0.00013041771],"category_scores_gemma":[0.00010578305,0.000204405,0.00015234158,0.0003534193,0.0001248296,0.00009706796,0.00024839884,0.0002235403,0.000051596377],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010357311,0.011141257,0.9343606,0.00003897461,0.008337131,0.000035958565,0.045697216,0.00002061605,0.00013577909,0.0000059563054,0.00006588615,0.000057008143],"study_design_scores_gemma":[0.00861763,0.0010659121,0.9721343,0.00026591355,0.005787133,0.0000051938964,0.011166355,0.000028662893,0.0007068789,0.0000038345643,0.000028094672,0.00019007939],"about_ca_topic_score_codex":0.015053866,"about_ca_topic_score_gemma":0.1459725,"teacher_disagreement_score":0.13091865,"about_ca_system_score_codex":0.0002699548,"about_ca_system_score_gemma":0.00035717458,"threshold_uncertainty_score":0.99150497},"labels":[],"label_agreement":null},{"id":"W2282189730","doi":"10.1182/blood.v122.21.497.497","title":"First Clinical Results Of a Randomized Phase 2 Study Of SGI-110, a Novel Subcutaneous (SQ) Hypomethylating Agent (HMA), In Adult Patients With Acute Myeloid Leukemia (AML)","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Decitabine; Medicine; Hypomethylating agent; Pharmacodynamics; Internal medicine; Phases of clinical research; Clinical endpoint; Cytarabine; Adverse effect; Gastroenterology; Refractory (planetary science); Myeloid leukemia; Pharmacokinetics; Randomized controlled trial; Surgery; Oncology; Chemotherapy; DNA methylation; Chemistry; Biology","score_opus":0.021949113843195613,"score_gpt":0.3130125473374891,"score_spread":0.29106343349429353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2282189730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99236697,0.0000543142,0.000053787728,0.00016555219,0.0000721448,0.006454163,0.00015939298,0.00004605145,0.00062761287],"genre_scores_gemma":[0.9943178,0.000105584506,0.0047234995,0.000079246776,0.00009312279,0.00030598542,0.00008725771,0.00007414495,0.00021333387],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99405634,0.0004810602,0.002718457,0.0007658693,0.0013228623,0.0006553785],"domain_scores_gemma":[0.9941464,0.0022610333,0.0010193787,0.0009995158,0.0012081295,0.00036554728],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019155806,0.00041322227,0.0023430842,0.0004946949,0.00006834148,0.000018929357,0.00039544087,0.0002499614,0.000058871166],"category_scores_gemma":[0.0052509774,0.0002943686,0.00031007812,0.0009117584,0.00037261142,0.00015013629,0.0002524699,0.0008446589,0.000024789124],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7633891,0.084300935,0.10902936,0.00075749465,0.0077762376,0.0019469713,0.011029669,0.0001481664,0.010152989,0.00002998482,0.00080200547,0.010637058],"study_design_scores_gemma":[0.9510806,0.013083157,0.027882116,0.000544731,0.0013831652,0.00009418337,0.0011175394,0.002301868,0.0021459712,0.000012913709,0.00002354442,0.00033018034],"about_ca_topic_score_codex":0.0031962644,"about_ca_topic_score_gemma":0.00033273202,"teacher_disagreement_score":0.1876915,"about_ca_system_score_codex":0.00027153434,"about_ca_system_score_gemma":0.0006766186,"threshold_uncertainty_score":0.9999508},"labels":[],"label_agreement":null},{"id":"W2282383247","doi":"10.1182/blood-2015-06-655126","title":"CD20+ B-cell depletion therapy suppresses murine CD8+ T-cell–mediated immune thrombocytopenia","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"Health Canada; China Scholarship Council; Canadian Blood Services; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"CD20; CD8; Immunology; Cytotoxic T cell; Cell therapy; T cell; In vivo; Medicine; Immune system; Cancer research; Biology; In vitro; Cell; Antigen; Biochemistry","score_opus":0.023328496886704044,"score_gpt":0.2542055967024005,"score_spread":0.23087709981569646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2282383247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97904074,0.0066510043,0.0000098794135,0.00041201664,0.00014331855,0.0005015844,0.00001851115,0.00013245546,0.013090497],"genre_scores_gemma":[0.99597543,0.0013963818,0.0004036723,0.0002471108,0.000085585976,0.00003818134,0.0003885318,0.000044212768,0.0014209003],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988092,0.00004085591,0.00024801755,0.00028632363,0.00030023867,0.00031535217],"domain_scores_gemma":[0.9991705,0.00004385673,0.0000887521,0.000376444,0.0001108579,0.00020959112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011009068,0.00022511207,0.00046065854,0.00007628047,0.000060230657,0.000026941916,0.000111578425,0.000120754696,0.00024335958],"category_scores_gemma":[0.000037940626,0.00017419139,0.000095205774,0.00017453,0.000044608863,0.00009981431,0.000040202405,0.00014530538,0.0004750092],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001970157,0.038523678,0.15403755,0.00027358503,0.0011824047,0.004236193,0.00191372,0.000010469984,0.7781443,0.00004328607,0.016265396,0.0033992503],"study_design_scores_gemma":[0.09281157,0.003012523,0.0340259,0.00008728288,0.00061607687,0.000410156,0.00037099846,0.000051694555,0.83378273,0.00028312657,0.033974923,0.0005729984],"about_ca_topic_score_codex":0.00024560705,"about_ca_topic_score_gemma":0.000015523228,"teacher_disagreement_score":0.12001164,"about_ca_system_score_codex":0.000025251717,"about_ca_system_score_gemma":0.000122049576,"threshold_uncertainty_score":0.71033186},"labels":[],"label_agreement":null},{"id":"W2282398530","doi":"10.1182/blood.v122.21.204.204","title":"Covalent Stabilization Of Coagulation Factor Xa Enhances Its Fibrinolytic Function In Vitro and In Vivo: A Novel Cofactor-Based Thrombolytic Agent","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Canadian Blood Services; University of British Columbia","funders":"","keywords":"Plasmin; Fibrinolysis; Fibrin; Chemistry; Biochemistry; Cofactor; Proteolysis; Tissue plasminogen activator; Thrombin; Tissue factor; Plasminogen activator; Coagulation; In vivo; Heparin cofactor II; Enzyme; Platelet; Antithrombin; Biology; Heparin; Immunology; Medicine; Internal medicine; Endocrinology","score_opus":0.034860438319645866,"score_gpt":0.26178400942431007,"score_spread":0.2269235711046642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2282398530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99660397,0.00018825113,0.0018481062,0.00010971278,0.00009904927,0.0010105931,0.000019475963,0.000036605215,0.000084211206],"genre_scores_gemma":[0.9994225,0.000028202117,0.00031588992,0.00009494542,0.000019399322,0.000035835037,0.000034248318,0.000019138597,0.00002983976],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998739,0.000043726817,0.00044838554,0.00027840142,0.00029725736,0.00019321674],"domain_scores_gemma":[0.99939924,0.00007375846,0.00016132953,0.00017690145,0.00011999181,0.00006876173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010864867,0.0001619158,0.00036512647,0.00021500544,0.000024613802,0.00001851884,0.000038210554,0.0001179316,0.00033345807],"category_scores_gemma":[0.000068149595,0.00015254613,0.00004593506,0.00030101236,0.00003342612,0.00017917376,0.000019253695,0.00009433787,0.00000997158],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000094888994,0.0009713038,0.027512493,0.00023597991,0.00003013107,7.498982e-7,0.00019262538,0.00013252735,0.9703201,0.00011582533,0.000001792231,0.00039160016],"study_design_scores_gemma":[0.0038894229,0.00021122806,0.41086358,0.00013661626,0.00006946084,0.0000019561173,0.000076164855,0.008898496,0.5756983,0.000049671387,0.000009207709,0.000095898824],"about_ca_topic_score_codex":0.00009440105,"about_ca_topic_score_gemma":0.00004049259,"teacher_disagreement_score":0.3946218,"about_ca_system_score_codex":0.000056878005,"about_ca_system_score_gemma":0.000079004305,"threshold_uncertainty_score":0.622065},"labels":[],"label_agreement":null},{"id":"W2284555999","doi":"10.1182/blood.v122.21.1548.1548","title":"DNA Demethylation Activity Over Time and Safety Of 3 Different Dose-Escalation Regimens Of SGI-110, a Novel Subcutaneous (SQ) Hypomethylating Agent (HMA), In The Treatment Of Relapsed/Refractory Patients With MDS and AML","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Regimen; Decitabine; Refractory (planetary science); Hypomethylating agent; Internal medicine; Neutropenia; Phases of clinical research; Surgery; Pharmacology; Clinical trial; Oncology; Gastroenterology; Toxicity; Chemistry","score_opus":0.007305438960826543,"score_gpt":0.21161855959713885,"score_spread":0.2043131206363123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2284555999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99864817,0.00050588243,0.00016123608,0.000013566406,0.000013807544,0.0005225782,0.00004449409,0.0000021185563,0.000088175184],"genre_scores_gemma":[0.99899673,0.00037247784,0.00049703754,0.0000030256774,0.000016769593,0.00001347142,0.000071065624,0.000012529644,0.000016894552],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99909395,0.000105612125,0.00029179073,0.00021796333,0.00017475043,0.00011595539],"domain_scores_gemma":[0.9992305,0.00010202316,0.00032098583,0.00022142654,0.000090965186,0.000034084696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012957604,0.00014434943,0.00021956024,0.000059768903,0.000032434094,0.0000062613312,0.000046228855,0.00011251199,0.00000560681],"category_scores_gemma":[0.000040199517,0.000097865515,0.000040605843,0.000081814534,0.00007446307,0.000009900613,0.000026060126,0.000042857755,1.4580829e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020886958,0.0013402108,0.1363199,0.000029374876,0.000075315904,2.5380837e-7,0.00037004295,0.000044547232,0.8503698,0.000007761801,4.9798757e-7,0.01123338],"study_design_scores_gemma":[0.0024627543,0.0023133808,0.7056625,0.000021766968,0.00006911505,7.363594e-7,0.000019802143,0.00021390461,0.28908688,0.00004350781,0.000020918182,0.00008477959],"about_ca_topic_score_codex":0.000112672366,"about_ca_topic_score_gemma":0.00004854476,"teacher_disagreement_score":0.56934255,"about_ca_system_score_codex":0.000014385519,"about_ca_system_score_gemma":0.000017338383,"threshold_uncertainty_score":0.399084},"labels":[],"label_agreement":null},{"id":"W2285687880","doi":"10.1182/blood.v122.21.3293.3293","title":"Incidence, Risk Factors and Allogeneic Stem Cell Transplant Outcomes In Chronic Sclerotic Gvhd: T-Cell Depletion Is Preventive and Peripheral Blood Stem Cellis a Risk Factor, But Not HLA-Mismatch With No Adverse Impact On Transplant Outcomes","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Cumulative incidence; Graft-versus-host disease; Incidence (geometry); Internal medicine; Hematopoietic stem cell transplantation; Transplantation; Stem cell; Risk factor; Surgery","score_opus":0.010954582887661903,"score_gpt":0.2284946972713665,"score_spread":0.2175401143837046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2285687880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950172,0.00037657275,0.00026330582,0.000044410317,0.000091119546,0.002853326,0.0010978747,0.0001105504,0.00014568861],"genre_scores_gemma":[0.99655974,0.002270977,0.00031372055,0.00007773763,0.000030227322,0.00014695877,0.00006858272,0.00011013023,0.00042191934],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99619436,0.00034718172,0.00088871416,0.0009883585,0.00076797185,0.00081343454],"domain_scores_gemma":[0.997927,0.00053730235,0.00042279897,0.00052088825,0.000097098164,0.0004948925],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027391344,0.00091255276,0.0012927618,0.00032271972,0.00018078493,0.000075519754,0.00018860157,0.00037087765,0.00033721383],"category_scores_gemma":[0.000005944012,0.0006090792,0.000293015,0.0002143019,0.00014797936,0.00031357212,0.000019047067,0.0006705811,0.000050698527],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037107742,0.001192715,0.96769756,0.0011445621,0.000600047,0.00017371478,0.010614717,0.00008919703,0.017844258,0.0000011264688,0.0000032815792,0.0002677165],"study_design_scores_gemma":[0.015337752,0.0025009406,0.86496633,0.0005831153,0.0023084271,0.00011343106,0.0009379907,0.00027471324,0.11233019,0.0000034834477,0.0000032257142,0.0006403763],"about_ca_topic_score_codex":0.0032608516,"about_ca_topic_score_gemma":0.0004113276,"teacher_disagreement_score":0.102731235,"about_ca_system_score_codex":0.00018977097,"about_ca_system_score_gemma":0.00023662345,"threshold_uncertainty_score":0.99963605},"labels":[],"label_agreement":null},{"id":"W2285786982","doi":"10.1182/blood.v122.21.3961.3961","title":"A Phase I Study Of Nilotinib As a c-Kit Inhibitor Combined With Re-Induction Chemotherapy For Relapsed and Refractory c-Kit Positive Acute Myeloid Leukemia","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Alberta","funders":"","keywords":"Cytarabine; Medicine; Nilotinib; Etoposide; Mitoxantrone; Internal medicine; Gastroenterology; Myeloid leukemia; Refractory (planetary science); Chemotherapy; Phases of clinical research; Pharmacology; Imatinib","score_opus":0.012373781639105902,"score_gpt":0.27684445000487296,"score_spread":0.26447066836576705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2285786982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99375945,0.00012197139,0.000013383741,0.00043183495,0.000081657934,0.004997598,0.000027842534,0.00009238626,0.0004738593],"genre_scores_gemma":[0.9960459,0.000052571704,0.0011745706,0.00020163995,0.0001751164,0.00055306643,0.00008992449,0.000083321094,0.0016239302],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982615,0.000058865495,0.00043862118,0.00054823613,0.00036246187,0.0003303021],"domain_scores_gemma":[0.9986002,0.000110511144,0.00031183587,0.00049323414,0.00027900672,0.00020520436],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013814824,0.0003383512,0.0006663111,0.00015261483,0.00010689205,0.000024857494,0.000084682535,0.00016164171,0.000100657664],"category_scores_gemma":[0.000061690655,0.00026326394,0.00008013676,0.00022078987,0.000103339065,0.00021235502,0.000033170312,0.00023915229,0.000017223017],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048960097,0.08232764,0.01553103,0.0007053468,0.014941642,0.00048178132,0.031543,0.0000025370714,0.7619193,0.00008415636,0.0057956493,0.037707806],"study_design_scores_gemma":[0.49430004,0.1516777,0.026379433,0.0006185355,0.004216865,0.00047039802,0.0051588253,0.00010527006,0.31573358,0.00012215291,0.00056506344,0.00065212365],"about_ca_topic_score_codex":0.0005378389,"about_ca_topic_score_gemma":0.000033308817,"teacher_disagreement_score":0.4461857,"about_ca_system_score_codex":0.00046246639,"about_ca_system_score_gemma":0.00048531976,"threshold_uncertainty_score":0.99998194},"labels":[],"label_agreement":null},{"id":"W2286459480","doi":"10.1182/blood.v124.21.3246.3246","title":"Activation of Non-Canonical Immune Signalling Pathways Drives Marrow Failure in a Murine Model of MDS","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; Haploinsufficiency; Bone marrow; Cancer research; Haematopoiesis; Myeloid; Myeloid leukemia; Immunology; Leukemia; Cell biology; Phenotype; Stem cell; Genetics; Gene","score_opus":0.018425006199023295,"score_gpt":0.25886869139027896,"score_spread":0.24044368519125567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2286459480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926438,0.000034447075,0.005269462,0.00036514658,0.0000076085557,0.00028699226,0.000005174237,0.00001488389,0.0013725368],"genre_scores_gemma":[0.99031544,0.000022933902,0.009390722,0.000028775627,0.0000595202,0.000019277517,0.00001959239,0.00002356484,0.000120203134],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987494,0.00005278896,0.0004128983,0.00019948435,0.00035365112,0.00023181865],"domain_scores_gemma":[0.9992038,0.00014581565,0.0001266472,0.0003083238,0.00014152251,0.000073901865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004337113,0.00011598397,0.00041148203,0.00020544582,0.000016871527,0.0000035900414,0.00014830245,0.00013453844,0.000035941513],"category_scores_gemma":[0.0002749046,0.00010201683,0.00008676136,0.00025369774,0.000083517225,0.00007277564,0.00008640534,0.0003205032,0.0000041075946],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017563537,0.0005284028,0.0049513616,0.00024223299,0.000054513832,0.000004747447,0.0004579455,0.0010633849,0.9913347,0.00036401776,0.00002606468,0.0007970115],"study_design_scores_gemma":[0.0061968467,0.00041347928,0.009817169,0.000372628,0.00005414397,0.000006842852,0.00012483877,0.12280923,0.8598421,0.0002443065,0.000020505291,0.00009789143],"about_ca_topic_score_codex":0.000121253725,"about_ca_topic_score_gemma":0.000019058367,"teacher_disagreement_score":0.13149256,"about_ca_system_score_codex":0.000054972967,"about_ca_system_score_gemma":0.0003348011,"threshold_uncertainty_score":0.41601256},"labels":[],"label_agreement":null},{"id":"W2286812527","doi":"10.1182/blood.v122.21.3396.3396","title":"Early Relapse After Single ASCT For MM Patients Is a Major Predictor Of Survival In The Era Of Novel Agents","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Multiple myeloma; Internal medicine; Autologous stem-cell transplantation; Hazard ratio; Oncology; Proportional hazards model; Cohort; Multivariate analysis; Single Center; Median follow-up; Progression-free survival; Surgery; Overall survival; Confidence interval","score_opus":0.028791436224282343,"score_gpt":0.2744883921870438,"score_spread":0.24569695596276145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2286812527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974685,0.00006722335,0.000016124803,0.00016946036,0.00004477794,0.0015702195,0.00027138906,0.0000059374347,0.0003863799],"genre_scores_gemma":[0.9983988,0.0000051443867,0.0008985199,0.00007445906,0.000035011446,0.00028887158,0.000043097923,0.00001652622,0.00023958323],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885833,0.000036498717,0.00027348535,0.00016344384,0.00042555472,0.00024268629],"domain_scores_gemma":[0.999239,0.0001229584,0.00007998232,0.0002921266,0.00018132979,0.00008456579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012353167,0.00010555809,0.0002389223,0.00006603997,0.000017434697,0.00000920765,0.000111954905,0.00006008504,0.00014026261],"category_scores_gemma":[0.00020425432,0.000066469416,0.00010276863,0.00012543962,0.000049958504,0.00007049423,0.000036080026,0.00010063871,0.000015176251],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053822057,0.008589964,0.9848527,0.00016350932,0.00023830439,0.000008150446,0.0013718372,6.8238194e-8,0.0026093246,0.0000049375694,0.00033105406,0.0012919455],"study_design_scores_gemma":[0.020056013,0.0014990801,0.9729084,0.00013000381,0.000104968836,0.0000013979397,0.000054853983,0.000048297243,0.0050505153,0.000023519679,0.00007267141,0.000050272374],"about_ca_topic_score_codex":0.00063167553,"about_ca_topic_score_gemma":0.000031536372,"teacher_disagreement_score":0.019517792,"about_ca_system_score_codex":0.000017127468,"about_ca_system_score_gemma":0.000039776434,"threshold_uncertainty_score":0.27105442},"labels":[],"label_agreement":null},{"id":"W2286862949","doi":"10.1182/blood.v122.21.3680.3680","title":"Molecular and Functional Characterization Of The Novel Protein-Coding Gene Tihl (Translocated in Hodgkin’s Lymphoma) in Hematopoiesis","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and Retrovirus Studies","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"CIITA; Biology; Haematopoiesis; Ectopic expression; Cancer research; Gene expression; Gene; Molecular biology; Major histocompatibility complex; Stem cell; MHC class II; Cell biology; Genetics","score_opus":0.00820935143796451,"score_gpt":0.1734988776831459,"score_spread":0.1652895262451814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2286862949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998684,0.0005578142,0.000093312396,0.00018880694,0.00007691166,0.00029724985,0.000009015604,0.000009017556,0.00008389801],"genre_scores_gemma":[0.99969774,0.000023221033,0.000024481764,0.00003815628,0.000005341401,0.00005763674,0.000014774934,0.0000060292978,0.0001326414],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995109,0.000041262603,0.00016857946,0.00012700824,0.000022412114,0.00012984799],"domain_scores_gemma":[0.99980915,0.0000128385545,0.000058301,0.00008742794,0.000027309317,0.000004995154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000059106154,0.000080419646,0.00014155188,0.00006250458,0.00005050638,0.0000043355753,0.000053824133,0.000098175835,0.00003387292],"category_scores_gemma":[0.000014795655,0.000056365887,0.000026426997,0.0001268061,0.000095273805,0.000039477047,0.000043995264,0.000060127986,0.000009960203],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013407377,0.00023538472,0.012322383,0.000025003728,0.000049614624,6.543796e-7,0.00024691847,9.335528e-7,0.98664933,0.00020385908,0.00000206459,0.00025047007],"study_design_scores_gemma":[0.0014691504,0.000017152499,0.27925175,0.00003380511,0.000012294524,0.000011386703,0.000043084015,0.000002345316,0.7190447,0.00003082977,0.000033170192,0.000050377857],"about_ca_topic_score_codex":0.0001998725,"about_ca_topic_score_gemma":0.000030506579,"teacher_disagreement_score":0.26760465,"about_ca_system_score_codex":0.000008344485,"about_ca_system_score_gemma":0.000019658373,"threshold_uncertainty_score":0.22985342},"labels":[],"label_agreement":null},{"id":"W2287476653","doi":"10.1182/blood.v122.21.1656.1656","title":"Effective Expansion and Engraftment Of Nonhuman Primate CD34+Hematopoietic Stem Cells After Co-Culture With The Small Molecule UM171","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Haematopoiesis; CD34; Stem cell; Transplantation; Immunology; CD38; Biology; Cord blood; Bone marrow; Cancer research; Cell biology; Andrology; Medicine; Internal medicine","score_opus":0.008030500671443331,"score_gpt":0.24445613016682427,"score_spread":0.23642562949538093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2287476653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938001,0.00095055887,0.000029167872,0.0002115589,0.000011156221,0.0023308154,0.0000042475435,0.000022101323,0.0026402865],"genre_scores_gemma":[0.9976607,0.00005048706,0.0002074804,0.000100607824,0.000032350374,0.00040395927,0.0000034428945,0.000026504424,0.0015144463],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987285,0.0001168146,0.00017015263,0.00027967832,0.00041914085,0.00028572785],"domain_scores_gemma":[0.99913883,0.00009839098,0.00007368433,0.00037182323,0.00016383574,0.00015344752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020793278,0.00018050746,0.00029695197,0.00004806348,0.00006861928,0.000032548556,0.00009709746,0.00008127199,0.00013866597],"category_scores_gemma":[0.0000067915116,0.00009142579,0.000049176724,0.00010954651,0.00014800865,0.000039452967,0.000079801655,0.00021138103,0.000073685325],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003858227,0.0011711256,0.010845936,0.0017955896,0.00038465392,0.00020729842,0.008329497,0.0000013278492,0.97422224,0.00006591257,0.00077584083,0.0018147461],"study_design_scores_gemma":[0.0029539764,0.0014862844,0.018716395,0.0003263606,0.00019672753,0.00007335986,0.00071105134,0.000017975053,0.9751418,0.000012130049,0.00023601917,0.00012790434],"about_ca_topic_score_codex":0.00005036274,"about_ca_topic_score_gemma":0.000013303299,"teacher_disagreement_score":0.007870459,"about_ca_system_score_codex":0.000024622957,"about_ca_system_score_gemma":0.000036157187,"threshold_uncertainty_score":0.37282354},"labels":[],"label_agreement":null},{"id":"W2288737088","doi":"10.1182/blood.v122.21.2682.2682","title":"An Update On The Robust Clinical Activity Of SL-401, a Targeted Therapy Directed To The Interleukin-3 Receptor On Cancer Stem Cells and Tumor Bulk, In Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Interleukin-3 receptor; Medicine; Plasmacytoid dendritic cell; Cancer; Myeloid; Internal medicine; Leukemia; Cancer research; Oncology; Immunology; Immune system; Dendritic cell","score_opus":0.010883121309514576,"score_gpt":0.21611669611449844,"score_spread":0.20523357480498386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2288737088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976545,0.00014716618,0.0000115531675,0.00024261253,0.0005385437,0.0011941444,0.00014436679,0.00003886546,0.0000282362],"genre_scores_gemma":[0.9989155,0.00010939991,0.00007330145,0.0005077537,0.000024401028,0.00017786928,0.000013736666,0.00003494096,0.00014309133],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99811643,0.00062870135,0.00036379715,0.00043136324,0.00008022841,0.00037947975],"domain_scores_gemma":[0.9987069,0.00046390085,0.00020270336,0.0004906792,0.00008885011,0.000046989277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025507447,0.0002759625,0.00039016418,0.00008418086,0.00014877248,0.000034695062,0.00037522716,0.00015385587,0.00041315338],"category_scores_gemma":[0.000029058128,0.00014701375,0.000059703627,0.00017728018,0.00017887991,0.000086254,0.00006704395,0.00054963084,0.00018263215],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038893546,0.0064022345,0.018626824,0.000025766518,0.00042048044,0.000003587987,0.001214707,0.0002408116,0.95838916,0.00007900024,0.0011876171,0.009520467],"study_design_scores_gemma":[0.0068051997,0.004524961,0.12866475,0.00014269276,0.00004942067,0.0000018966164,0.0001944187,0.000053290678,0.8581908,0.000007962156,0.0010863108,0.00027833157],"about_ca_topic_score_codex":0.00027148193,"about_ca_topic_score_gemma":0.0002447037,"teacher_disagreement_score":0.110037915,"about_ca_system_score_codex":0.000027662329,"about_ca_system_score_gemma":0.00006259237,"threshold_uncertainty_score":0.59950465},"labels":[],"label_agreement":null},{"id":"W2288929049","doi":"10.1182/blood.v122.21.1749.1749","title":"Shelf-Life Extension Of Azacitidine: A Cancer Centre Experience On Waste and Cost Reduction In The Treatment Of Myelodysplastic Syndromes","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Vial; Azacitidine; Medicine; Dosing; Medical prescription; Myelodysplastic syndromes; Lenalidomide; Internal medicine; Pharmacology; Chemistry; Multiple myeloma; Chromatography","score_opus":0.0585988443302296,"score_gpt":0.34645775932608636,"score_spread":0.28785891499585675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2288929049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99456877,0.0027013833,4.7881423e-7,0.0019257255,0.000058889083,0.0004162765,0.0000045706834,0.0000037747743,0.00032014056],"genre_scores_gemma":[0.9936627,0.006075167,0.000023128418,0.00008252546,0.000044962893,0.000061820596,0.0000012334805,0.000003648697,0.0000448141],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99947417,0.000035243207,0.00014150537,0.000116665025,0.00012983211,0.000102614635],"domain_scores_gemma":[0.9995632,0.0001920136,0.00006454339,0.0000938092,0.000037896203,0.000048517886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000041067207,0.00007198396,0.00017256163,0.000025180412,0.000029701523,0.000004266013,0.000023652703,0.000021871396,0.00009944215],"category_scores_gemma":[0.000086116066,0.000039508563,0.000022352247,0.00008947338,0.000070810645,0.000048377824,0.000008497164,0.000043033862,0.0000023320194],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003504816,0.024983283,0.2984857,0.0015227705,0.0014437432,0.00022898887,0.07450016,0.00013025085,0.4213002,0.0005829314,0.0021971082,0.17112006],"study_design_scores_gemma":[0.019794906,0.006543722,0.6880641,0.001463797,0.0016932178,0.00034428312,0.043634266,0.0010570232,0.22349754,0.00007574701,0.013447357,0.00038401593],"about_ca_topic_score_codex":0.00042581346,"about_ca_topic_score_gemma":0.000014222556,"teacher_disagreement_score":0.38957843,"about_ca_system_score_codex":0.000014024717,"about_ca_system_score_gemma":0.000013849781,"threshold_uncertainty_score":0.16111125},"labels":[],"label_agreement":null},{"id":"W2289188465","doi":"10.1182/blood.v122.21.5603.5603","title":"Cost-Effectiveness Of Arsenic Trioxide In The Treatment Of Relapsed/Refractory Acute Promyelocytic Leukemia In Canada","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Acute promyelocytic leukemia; Medicine; Arsenic trioxide; Internal medicine; Refractory (planetary science); Leukemia; Myeloid leukemia; Chemotherapy; Oncology; Surgery; Retinoic acid","score_opus":0.011632729367525492,"score_gpt":0.23741658747404343,"score_spread":0.22578385810651794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2289188465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972831,0.0015670042,0.000010187246,0.000008748385,0.000037574202,0.000699336,0.0000091226175,0.0000014366975,0.0003834925],"genre_scores_gemma":[0.99885535,0.0007078774,0.00004885903,0.000015520041,0.000020184194,0.00025512875,0.00003232956,0.000010901187,0.000053827192],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99906105,0.00017179216,0.00026145362,0.00020043296,0.00012508275,0.00018021172],"domain_scores_gemma":[0.9994346,0.00007827696,0.00010482759,0.00030708933,0.00004851005,0.000026696427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014734185,0.00012892277,0.00022269094,0.00003514599,0.000012503072,0.000004247941,0.00019554498,0.00008791106,0.000007166636],"category_scores_gemma":[0.000037125123,0.00009042727,0.000055535373,0.00013365985,0.000052066014,0.000003912408,0.000018343027,0.00006743677,0.0000010147505],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013454819,0.0005198956,0.046490856,0.00018197313,0.00013636258,0.00003839471,0.00023349754,0.00017626715,0.9494193,0.000015424019,0.000041053434,0.0026124213],"study_design_scores_gemma":[0.0032411716,0.00062768755,0.041701976,0.000051387065,0.00005400758,0.000016500644,0.000248419,0.000019776047,0.9532303,0.00004616658,0.0006520014,0.00011059572],"about_ca_topic_score_codex":0.1822849,"about_ca_topic_score_gemma":0.09029731,"teacher_disagreement_score":0.09198759,"about_ca_system_score_codex":0.00028586524,"about_ca_system_score_gemma":0.001840917,"threshold_uncertainty_score":0.9263024},"labels":[],"label_agreement":null},{"id":"W2289506799","doi":"10.1182/blood.v122.21.4322.4322","title":"Predictors Of Delay In Diagnosis and Treatment In Diffuse Large B-Cell Lymphoma and Impact On Survival","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Hematology; Internal medicine; Rituximab; Vincristine; Diffuse large B-cell lymphoma; Prednisone; Cyclophosphamide; Population; Chemotherapy regimen; Chemotherapy; Lymphoma; Oncology; Surgery","score_opus":0.010257475342171958,"score_gpt":0.2434817534815077,"score_spread":0.23322427813933574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2289506799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99729186,0.0013840182,5.9757454e-8,0.00012148863,0.000027553584,0.00067046296,0.00004642439,0.000011355204,0.0004467531],"genre_scores_gemma":[0.997372,0.0021824078,0.000026377795,0.000037757934,0.000023757713,0.00029158095,0.000016552576,0.000015035781,0.0000345567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913,0.000043650543,0.00022310734,0.00023795465,0.00012871623,0.00023658307],"domain_scores_gemma":[0.9994024,0.00020192811,0.000050101717,0.00018120358,0.000016097936,0.00014823931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006488221,0.00018756081,0.00039283288,0.00015100114,0.000015984451,0.0000121894145,0.000024982133,0.000076061566,0.000029607396],"category_scores_gemma":[0.000021975595,0.000120177814,0.000058285077,0.00010988839,0.000031476182,0.000051012234,0.000025453279,0.000025193704,0.000007219121],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067853056,0.0400429,0.95495325,0.000026360492,0.00011632634,0.00013053209,0.0004776005,3.3751334e-7,0.000087745786,0.000015779817,0.00004426271,0.0040370435],"study_design_scores_gemma":[0.06103992,0.0020817863,0.93019843,0.00010282582,0.00014883032,0.000014455939,0.00009784171,0.000027775313,0.0061243894,0.0000106951475,0.00006769132,0.000085345826],"about_ca_topic_score_codex":0.0033908929,"about_ca_topic_score_gemma":0.00063611194,"teacher_disagreement_score":0.06097207,"about_ca_system_score_codex":0.00012847924,"about_ca_system_score_gemma":0.000047238416,"threshold_uncertainty_score":0.5126038},"labels":[],"label_agreement":null},{"id":"W2290370781","doi":"10.1182/blood.v124.21.3458.3458","title":"Impact of Response Quality on Survival Outcomes in Transplant-Ineligible Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts): Results from the First Trial","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Charles-Le Moyne; University of Calgary","funders":"","keywords":"Medicine; Internal medicine; Lenalidomide; Multiple myeloma; Progression-free survival; Melphalan; Clinical endpoint; Gastroenterology; Surgery; Randomized controlled trial; Chemotherapy","score_opus":0.04400510173070445,"score_gpt":0.3413703157451652,"score_spread":0.29736521401446075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2290370781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99558437,0.000020480356,0.0000040134364,0.0005948651,0.00015022539,0.0014829691,0.0018129349,0.000038261223,0.0003118967],"genre_scores_gemma":[0.99905753,0.000027204582,0.00007468063,0.00006926958,0.00012679525,0.0000726442,0.0004638689,0.000029615005,0.00007838992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965809,0.0008794822,0.00078690273,0.00045943612,0.00080083613,0.0004924143],"domain_scores_gemma":[0.98985535,0.008741514,0.00020822647,0.00085099076,0.00010706776,0.00023686072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001309165,0.00029706402,0.00075909874,0.00014929828,0.00009718634,0.000023355342,0.00025719972,0.00014294943,0.000035227964],"category_scores_gemma":[0.007215588,0.00017155509,0.00035690752,0.0002408427,0.00008437025,0.00006291266,0.0000420026,0.00027508667,0.000046316036],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28564167,0.005179401,0.7067604,0.000012824217,0.00029473347,0.000043864038,0.00060427596,0.000008799936,0.00022201374,0.0000029154285,0.00008673513,0.0011423819],"study_design_scores_gemma":[0.29245743,0.0030483566,0.70269525,0.000100699566,0.000069361995,4.409355e-7,0.000022916587,0.00005034115,0.0013461997,0.0000100221605,0.00008785997,0.00011114372],"about_ca_topic_score_codex":0.014649942,"about_ca_topic_score_gemma":0.004136619,"teacher_disagreement_score":0.010513322,"about_ca_system_score_codex":0.00009726698,"about_ca_system_score_gemma":0.0001628384,"threshold_uncertainty_score":0.9919116},"labels":[],"label_agreement":null},{"id":"W2290986859","doi":"10.1182/blood.v122.21.3613.3613","title":"Pharmacokinetic Characterisation Of Recombinant FXIII Across Age Groups In Patients With FXIII Subunit A Congenital Deficiency","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Pharmacokinetics; Dosing; Clinical trial; Internal medicine; Gastroenterology","score_opus":0.007920029392875273,"score_gpt":0.23071170071629676,"score_spread":0.22279167132342148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2290986859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985353,0.00007745385,0.0000020164973,0.000038496997,0.00006987639,0.0007790123,0.00001727902,0.000019120023,0.00046145226],"genre_scores_gemma":[0.99949074,0.000024200936,0.00006434717,0.000047869555,0.0000082871775,0.00005977512,0.00016424981,0.000018062821,0.00012247397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99907964,0.000020680602,0.00024935763,0.00018920565,0.0001963046,0.0002648049],"domain_scores_gemma":[0.9995613,0.000016488273,0.00010635782,0.00015512756,0.000088325665,0.00007240466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000049272396,0.0001401731,0.0002817352,0.0000725497,0.000034520817,0.000013815913,0.00005752297,0.00005091218,0.00011551542],"category_scores_gemma":[0.000014816861,0.000104420804,0.00003748639,0.00019403735,0.00005208156,0.00013774612,0.000023642964,0.00009150129,0.000047674952],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018671145,0.0056516,0.9846378,0.00006011036,0.000093264265,0.00014079202,0.0009280529,3.3042423e-7,0.0022885513,0.0000059681947,0.000016074146,0.005990742],"study_design_scores_gemma":[0.017842624,0.0010193739,0.9791712,0.000061006976,0.00012422376,0.000018336134,0.000103821556,0.000014111484,0.0014831414,0.00003207091,0.000020425892,0.00010965932],"about_ca_topic_score_codex":0.00025135017,"about_ca_topic_score_gemma":0.00003753098,"teacher_disagreement_score":0.017655913,"about_ca_system_score_codex":0.000020644286,"about_ca_system_score_gemma":0.00002234259,"threshold_uncertainty_score":0.4258157},"labels":[],"label_agreement":null},{"id":"W2292390406","doi":"10.1182/blood.v122.21.4071.4071","title":"Baseline Characteristics and Symptom Burden in RESPONSE: A Randomized, Open-Label, Phase 3 Study of Ruxolitinib In Polycythemia Vera Patients Resistant to or Intolerant of Hydroxyurea","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Phlebotomy; Medicine; Ruxolitinib; Polycythemia vera; Internal medicine; Hematocrit; Phases of clinical research; Myelofibrosis; Myeloproliferative neoplasm; Clinical trial; Gastroenterology; Surgery; Bone marrow","score_opus":0.022583394364637844,"score_gpt":0.31889456224638146,"score_spread":0.2963111678817436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2292390406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99379164,0.00009270548,0.000001967355,0.00050072774,0.00002707146,0.0053962898,0.000107226464,0.0000069353555,0.00007540983],"genre_scores_gemma":[0.9982701,0.000061856765,0.00047351152,0.00012555273,0.000025560677,0.00086575816,0.00004081136,0.000023188772,0.000113644],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99757046,0.0004742149,0.0010510847,0.0003564914,0.00030636293,0.00024136963],"domain_scores_gemma":[0.99808306,0.000939173,0.00024673686,0.00034539666,0.00021500744,0.00017063096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092315103,0.00023609828,0.0013283463,0.0002996733,0.00002549929,0.000026028825,0.0001271142,0.00006958473,0.00012328196],"category_scores_gemma":[0.001526238,0.00016216902,0.00003132978,0.00029748937,0.000056829933,0.00008148918,0.000139379,0.00012439158,0.0000052826013],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6118291,0.06571976,0.2899391,0.00023930417,0.00051400554,0.0003141235,0.013019626,0.0000010761584,0.01410771,0.000039102066,0.00009960235,0.0041774805],"study_design_scores_gemma":[0.75685126,0.010307774,0.22457863,0.0009640576,0.00032877503,0.0000075262183,0.0006917328,0.00018114997,0.005816654,0.000013940964,0.000066980305,0.00019154069],"about_ca_topic_score_codex":0.0015456096,"about_ca_topic_score_gemma":0.00017881212,"teacher_disagreement_score":0.14502212,"about_ca_system_score_codex":0.000051562154,"about_ca_system_score_gemma":0.0001423438,"threshold_uncertainty_score":0.661306},"labels":[],"label_agreement":null},{"id":"W2292463206","doi":"10.1182/blood.v122.21.3969.3969","title":"Sorafenib Treatment Following Hematopoietic Stem Cell Transplant In Pediatric FLT3/ITD+ AML","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Sorafenib; Tolerability; Internal medicine; Hematopoietic stem cell transplantation; Oncology; Retrospective cohort study; Transplantation; Context (archaeology); Pediatrics; Surgery; Adverse effect; Hepatocellular carcinoma","score_opus":0.015353110844020967,"score_gpt":0.2507643596960034,"score_spread":0.23541124885198245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2292463206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99238396,0.0014610001,0.000021780277,0.0006604282,0.00007904414,0.0010875986,0.0000069484854,0.00008933725,0.004209885],"genre_scores_gemma":[0.9950643,0.00050590903,0.00033927846,0.00008484704,0.00019667011,0.00023734142,0.000024254194,0.000051265586,0.003496088],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99815375,0.000075290154,0.00036917714,0.0003922121,0.00039931195,0.0006102745],"domain_scores_gemma":[0.9991008,0.00011843346,0.000047597186,0.0004235645,0.00003456395,0.00027504703],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016416886,0.00024891703,0.00045690974,0.00027334222,0.000054834654,0.00003314997,0.0001523824,0.00014824224,0.00019753868],"category_scores_gemma":[0.000006670268,0.00019443166,0.00020931591,0.000401434,0.000022326694,0.00010181054,0.000029719355,0.000260699,0.00087499607],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032998272,0.011783559,0.8584895,0.002159477,0.0007129152,0.011659273,0.018192168,0.000026970552,0.084328495,0.00013236565,0.003761938,0.008423328],"study_design_scores_gemma":[0.1620485,0.0070504374,0.26695028,0.0008165459,0.006125056,0.0017095433,0.00525732,0.0015060997,0.5417731,0.00040455098,0.0035619743,0.00279657],"about_ca_topic_score_codex":0.00034300724,"about_ca_topic_score_gemma":0.000030656734,"teacher_disagreement_score":0.59153926,"about_ca_system_score_codex":0.00025026884,"about_ca_system_score_gemma":0.0003000976,"threshold_uncertainty_score":0.99990296},"labels":[],"label_agreement":null},{"id":"W2292858884","doi":"10.1182/blood-2015-12-626739","title":"A meta-analysis of low-molecular-weight heparin to prevent pregnancy loss in women with inherited thrombophilia","year":2016,"lang":"en","type":"review","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pacific Centre for Reproductive Medicine; University of Toronto; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Thrombophilia; Low molecular weight heparin; Medicine; Pregnancy; Confidence interval; Obstetrics; Meta-analysis; Randomized controlled trial; Heparin; Relative risk; Gynecology; Internal medicine; Thrombosis; Biology; Genetics","score_opus":0.06476213652549179,"score_gpt":0.32717835729735584,"score_spread":0.26241622077186405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2292858884","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032509994,0.99337935,0.00015538087,0.00009176215,0.000037215577,0.0025123807,0.00012696174,0.000052259096,0.00039370442],"genre_scores_gemma":[0.011793363,0.9845149,0.0009837527,0.00020701933,0.00003668941,0.0016020808,0.00010137088,0.00013939242,0.0006214275],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9964564,0.0003152594,0.0012347121,0.00083419704,0.00067022024,0.000489253],"domain_scores_gemma":[0.9975545,0.00008037472,0.0006060642,0.0012820828,0.00015993038,0.00031706848],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035346637,0.0006433487,0.007042395,0.001156134,0.000022412449,0.000015943746,0.00032220615,0.0003486671,0.0010889919],"category_scores_gemma":[0.00004048543,0.00038375898,0.0015920647,0.0028249295,0.00005322491,0.000051166728,0.00014087664,0.0002631387,0.00005205922],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009888448,0.008439899,0.0000804077,0.021841068,0.8799042,0.0005205257,0.0006296504,0.00000375317,0.00031619228,0.0013722931,0.00001824074,0.086774886],"study_design_scores_gemma":[0.0026176393,0.0009569377,0.00039349016,0.023110306,0.94069326,0.000050896397,0.000012304139,0.0000014799195,0.0008228378,0.0001499344,0.030360715,0.0008302113],"about_ca_topic_score_codex":0.000013471068,"about_ca_topic_score_gemma":0.000030115336,"teacher_disagreement_score":0.085944675,"about_ca_system_score_codex":0.0001071508,"about_ca_system_score_gemma":0.00033627686,"threshold_uncertainty_score":0.9998614},"labels":[],"label_agreement":null},{"id":"W2293392254","doi":"10.1182/blood.v122.21.2397.2397","title":"Persistence Of Dengue Virus In Stored Platelets and Red Blood Cells","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Mosquito-borne diseases and control","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of British Columbia; Canadian Blood Services","funders":"","keywords":"Dengue fever; Dengue virus; Whole blood; Virology; Platelet; Biology; Virus; Asymptomatic; Immunology; Dengue vaccine; Medicine; Internal medicine","score_opus":0.00881320131558852,"score_gpt":0.20581552260880023,"score_spread":0.1970023212932117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2293392254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996424,0.0021962405,0.000001456751,0.00018951218,0.000033141394,0.0003694255,0.000013290827,0.000015561072,0.0007573506],"genre_scores_gemma":[0.9991863,0.00013323363,0.00018907266,0.00015573487,0.000050387054,0.000030154373,0.0000047502426,0.000011583993,0.0002388221],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9992673,0.000022432674,0.00019555273,0.00019661638,0.0001383505,0.00017975748],"domain_scores_gemma":[0.99950004,0.0000326596,0.0000577818,0.00022181543,0.000054812674,0.00013290468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005660763,0.00009878482,0.0002542472,0.000060824583,0.000017629445,0.000009732295,0.000063237996,0.00006308581,0.00019339292],"category_scores_gemma":[0.000042834898,0.000085817235,0.000061401144,0.00008408644,0.000042515912,0.000047415786,0.00002620303,0.000082459526,0.000013987308],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011757738,0.0017558503,0.057329487,0.00023107669,0.0002051713,0.00021710488,0.00054675335,0.0000023187865,0.93585116,0.00004840485,0.0004079614,0.0032871312],"study_design_scores_gemma":[0.023877677,0.0008115677,0.71362764,0.00033347713,0.0012969536,0.00010679337,0.00084673724,0.00049131707,0.25750914,0.00010283935,0.000663348,0.0003324979],"about_ca_topic_score_codex":0.00032234014,"about_ca_topic_score_gemma":0.000033413045,"teacher_disagreement_score":0.67834204,"about_ca_system_score_codex":0.0000052615856,"about_ca_system_score_gemma":0.00003927915,"threshold_uncertainty_score":0.34995252},"labels":[],"label_agreement":null},{"id":"W2293727557","doi":"10.1182/blood-2015-11-680744","title":"Thrombocytopenia is associated with a dysregulated host response in critically ill sepsis patients","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Sepsis Diagnosis and Treatment","field":"Medicine","cited_by":345,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Center for Translational Molecular Medicine; Landsteiner Foundation for Blood Transfusion Research","keywords":"Sepsis; Critically ill; Medicine; Intensive care unit; Host response; Intensive care medicine; Severity of illness; Severe sepsis; Septic shock; Internal medicine; Immunology; Immune system","score_opus":0.029428268612653914,"score_gpt":0.2905239107053398,"score_spread":0.2610956420926859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2293727557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917567,0.00006369871,0.0000016702063,0.007002958,0.000027113527,0.00044814814,0.00006365163,0.00005810678,0.00057799916],"genre_scores_gemma":[0.9961215,0.000022360435,0.00016775783,0.0031531595,0.000013012877,0.000063540145,0.00001832983,0.000032781834,0.00040751038],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865294,0.00011152587,0.00024844395,0.00033197593,0.00032428003,0.000330838],"domain_scores_gemma":[0.99863946,0.00038558073,0.000056900186,0.00031422847,0.0004514075,0.0001524463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016526417,0.00018234643,0.0003950593,0.00011376691,0.000039115293,0.000015391399,0.00006503122,0.00011485455,0.00045617291],"category_scores_gemma":[0.0012313863,0.000103463964,0.0000674335,0.0002660845,0.00006890887,0.0000708167,0.000030218038,0.0000683328,0.000110855435],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013575492,0.0063498938,0.98589677,0.0000074345935,0.0004133542,0.00032891973,0.00025917514,3.0308204e-8,0.0039224904,0.00001679776,0.0009216372,0.0005259592],"study_design_scores_gemma":[0.020707315,0.0022448408,0.9534508,0.00067154825,0.0003559526,0.000009424148,0.000027138163,0.0000014663124,0.022071036,0.000021081174,0.00028608416,0.00015333768],"about_ca_topic_score_codex":0.000036924488,"about_ca_topic_score_gemma":0.000048481696,"teacher_disagreement_score":0.032445982,"about_ca_system_score_codex":0.00014580596,"about_ca_system_score_gemma":0.00009232615,"threshold_uncertainty_score":0.49947736},"labels":[],"label_agreement":null},{"id":"W2294247703","doi":"10.1182/blood.v124.21.1859.1859","title":"Safety and Efficacy of Ruxolitinib in Patients with Low Platelets Enrolled in a Phase 3b Expanded-Access Study in Myelofibrosis (MF)","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; St. Paul's Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Ruxolitinib; Medicine; Myelofibrosis; Tolerability; Internal medicine; Adverse effect; Clinical trial; Phases of clinical research; Clinical endpoint; Discontinuation; Placebo; Surgery; Bone marrow; Pathology","score_opus":0.010353132557740239,"score_gpt":0.28359723680859583,"score_spread":0.2732441042508556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2294247703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974864,0.00005193666,0.0000022819659,0.000058117115,0.000016905733,0.002015548,0.000016836953,0.000011334677,0.00034061036],"genre_scores_gemma":[0.99956644,0.00003263072,0.00010395046,0.000053560543,0.000017459499,0.0001617492,0.000033957956,0.000020360814,0.000009878401],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983988,0.00013817646,0.00053979945,0.00038608257,0.00027093783,0.00026621384],"domain_scores_gemma":[0.99920976,0.00025974022,0.0001266308,0.00024176328,0.000055094657,0.00010699222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024146118,0.00022130119,0.00075508014,0.0002797589,0.00002447903,0.000016660631,0.00007078865,0.00006699269,0.000036326015],"category_scores_gemma":[0.00013214293,0.00016157771,0.000031407355,0.0003326221,0.000041567833,0.00009128089,0.000054196338,0.00013791514,0.000001975358],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00463455,0.030562043,0.95914507,0.00007259585,0.000097002,0.000070201495,0.0015606605,0.000011884269,0.000056121746,0.000014637448,0.0000018920077,0.0037733456],"study_design_scores_gemma":[0.16114521,0.0042854836,0.8311298,0.00040467174,0.00007603244,0.0000026704058,0.00010715071,0.0000252018,0.0026868233,0.000006065143,0.000007907318,0.00012296576],"about_ca_topic_score_codex":0.00024971846,"about_ca_topic_score_gemma":0.00070492155,"teacher_disagreement_score":0.15651067,"about_ca_system_score_codex":0.00004394802,"about_ca_system_score_gemma":0.00005577323,"threshold_uncertainty_score":0.6588948},"labels":[],"label_agreement":null},{"id":"W2294278582","doi":"10.1182/blood.v122.21.886.886","title":"A Mechanistic Role For Mir-126, a Hematopoietic Stem Cell Microrna, In Acute Leukemias","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Progenitor cell; Haematopoiesis; Stem cell; Biology; Bone marrow; CD19; Cancer research; Population; Immunology; Hematopoietic stem cell; Lymphopoiesis; Molecular biology; Cell biology; Flow cytometry; Medicine","score_opus":0.005754577983806833,"score_gpt":0.2101304245035058,"score_spread":0.20437584651969898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2294278582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99640024,0.0012891272,0.0011738301,0.000049028957,0.00004713231,0.00072169374,0.000040080282,0.000015501728,0.00026333937],"genre_scores_gemma":[0.99697727,0.000026175605,0.0016225096,0.00009944842,0.0000725582,0.00028833514,0.000115898605,0.000035339624,0.0007624411],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990668,0.000029566361,0.00021976102,0.0003289508,0.000075547534,0.00027935155],"domain_scores_gemma":[0.9994329,0.00001167472,0.00008239597,0.00032423603,0.000064282794,0.00008446373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007167908,0.00015681505,0.0001471185,0.000045968725,0.000038465958,0.000032022894,0.0001705752,0.00015518017,0.000029770803],"category_scores_gemma":[0.000008638312,0.0001610152,0.00009900008,0.000067563815,0.00002217665,0.000004384819,0.000071119975,0.000048511534,0.000060507955],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002120973,0.00020972594,0.000200537,0.00007340206,0.000044453165,0.0000031091342,0.00005375055,0.0000058524906,0.99792063,0.0000539107,0.0011983168,0.00021507301],"study_design_scores_gemma":[0.0021105553,0.00013499385,0.0007171405,0.000024068644,0.00009845233,0.00002650364,0.000087666376,0.00017107005,0.99386275,0.00056324905,0.001984783,0.00021879472],"about_ca_topic_score_codex":0.000023441646,"about_ca_topic_score_gemma":0.000014923774,"teacher_disagreement_score":0.004057937,"about_ca_system_score_codex":0.000022136535,"about_ca_system_score_gemma":0.00008079356,"threshold_uncertainty_score":0.6566009},"labels":[],"label_agreement":null},{"id":"W2295097092","doi":"10.1182/blood-2016-01-690636","title":"Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages","year":2016,"lang":"en","type":"review","venue":"Blood","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":1561,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute","keywords":"Histiocyte; Histiocytosis; Pathology; Hemophagocytic lymphohistiocytosis; Mucocutaneous zone; Medicine; Langerhans cell histiocytosis; Erdheim–Chester disease; Macrophage activation syndrome; Rosai–Dorfman disease; Phenotype; Biology; Disease","score_opus":0.028184788186195714,"score_gpt":0.29811635855317703,"score_spread":0.26993157036698134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2295097092","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011514318,0.99410087,0.0000063087973,0.000024759884,0.000084732244,0.00071281724,0.000119719065,0.000009167645,0.0037901748],"genre_scores_gemma":[0.008645372,0.98677456,0.00014354421,0.000007067705,0.000044935936,0.000036826295,0.000027619853,0.000030437026,0.004289635],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99890363,0.00007333505,0.0005029103,0.00022609207,0.00018053564,0.0001134727],"domain_scores_gemma":[0.9988064,0.0001496029,0.00046063197,0.00045309972,0.0000750458,0.000055205823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007680778,0.00020615326,0.0010249006,0.00007308428,0.00003572349,0.00000450335,0.000106586995,0.00015558972,0.000067040455],"category_scores_gemma":[0.00013036196,0.00010760011,0.0002628384,0.0001322601,0.00016706546,0.000014739993,0.000036740825,0.000099668905,0.000022868055],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017264307,0.0015284377,0.00042817404,0.06895659,0.00053694414,0.00002735172,0.000057744208,1.0445777e-8,0.00017038987,0.00029372546,0.00045237306,0.927531],"study_design_scores_gemma":[0.004855497,0.00034963284,0.0008103108,0.047964357,0.011638366,0.00013384258,0.000019373047,0.0000012849341,0.000643362,0.000034890632,0.9333134,0.00023563538],"about_ca_topic_score_codex":0.000007465528,"about_ca_topic_score_gemma":0.0000012119011,"teacher_disagreement_score":0.9328611,"about_ca_system_score_codex":0.000028615952,"about_ca_system_score_gemma":0.0002556034,"threshold_uncertainty_score":0.43878055},"labels":[],"label_agreement":null},{"id":"W2295340797","doi":"10.1182/blood.v122.21.1126.1126","title":"The Effectiveness Of 30-40 Mm Hg Compression Stockings To Treat Acute Leg Pain Associated With Proximal Deep Vein Thrombosis: Results From The Sox Randomized Controlled Trial","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St Mary's Hospital Centre; University of Toronto; Hamilton General Hospital; Centre hospitalier universitaire de Québec; St. Boniface Hospital; Université de Montréal; Hôpital Maisonneuve-Rosemont; Hôpital Notre-Dame; McMaster University; Health Sciences Centre; Hôpital du Sacré-Cœur de Montréal; St. Joseph's Hospital; Ottawa Hospital; Victoria Heart Institute Foundation; University Health Network; University of Ottawa; Dalhousie University; Thrombosis and Atherosclerosis Research Institute; University of Manitoba; Jewish General Hospital; Montreal General Hospital; Sunnybrook Health Science Centre; McGill University; London Health Sciences Centre","funders":"","keywords":"Medicine; Placebo; Randomized controlled trial; Deep vein; Compression stockings; Venous thrombosis; Thrombosis; Thrombolysis; Post-thrombotic syndrome; Surgery; Anesthesia; Internal medicine; Myocardial infarction","score_opus":0.008839375294540174,"score_gpt":0.24550792380504827,"score_spread":0.2366685485105081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2295340797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9736905,0.00032194157,0.00023985594,0.0018174516,0.00018027252,0.022053141,0.00003131101,0.00008294469,0.0015825959],"genre_scores_gemma":[0.9948431,0.00010195468,0.000097367905,0.00039786162,0.00018475129,0.004141119,0.00007153832,0.000043360982,0.00011889935],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99421626,0.0034454565,0.00082074775,0.00043718002,0.0006601899,0.00042015148],"domain_scores_gemma":[0.9861519,0.012222159,0.0005610452,0.0006420816,0.00029395527,0.0001289089],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006362018,0.00034371484,0.0023873004,0.000057592766,0.00031819817,0.000109785135,0.00031908057,0.00012997357,0.000048543185],"category_scores_gemma":[0.003911399,0.00014466497,0.00040766282,0.0002114853,0.00018850346,0.0000808789,0.00012016558,0.00022670501,0.000017420629],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9787774,0.003930098,0.00033528317,0.00004020726,0.006654463,0.000012247763,0.0013478876,0.000034608674,0.0057703797,0.00016823478,0.0021514045,0.0007777709],"study_design_scores_gemma":[0.9543973,0.002388353,0.03166882,0.001044957,0.0057823476,8.618317e-7,0.00029212248,0.00035739542,0.0035900709,0.00022803857,0.00005765824,0.00019202392],"about_ca_topic_score_codex":0.0011712438,"about_ca_topic_score_gemma":0.0000744367,"teacher_disagreement_score":0.03133354,"about_ca_system_score_codex":0.000056109384,"about_ca_system_score_gemma":0.00008087899,"threshold_uncertainty_score":0.5899266},"labels":[],"label_agreement":null},{"id":"W2295535233","doi":"10.1182/blood.v95.9.2813.009k20_2813_2820","title":"Isolation and characterization of human CD34−Lin− and CD34+Lin− hematopoietic stem cells using cell surface markers AC133 and CD7","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":317,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Amgen","keywords":"CD38; CD34; Haematopoiesis; Stem cell; Biology; Cord blood; Population; Immunology; Progenitor cell; Transplantation; Clonogenic assay; Molecular biology; Cell biology; Cell; Internal medicine; Medicine; Biochemistry","score_opus":0.014050867425322716,"score_gpt":0.23537675467233257,"score_spread":0.22132588724700986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2295535233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99803424,0.00029338597,0.0003725999,0.0000465682,0.00003590239,0.0005192515,0.000023632885,0.00003605623,0.0006383516],"genre_scores_gemma":[0.99744505,0.00048467,0.0014527466,0.000038002116,0.00003534371,0.0000029018097,0.00004535901,0.000033961507,0.00046196606],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99878496,0.000070968024,0.00042327624,0.000320977,0.00020895812,0.0001908417],"domain_scores_gemma":[0.99941635,0.00006913597,0.00014841746,0.00018394228,0.0000550895,0.00012705527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022493978,0.00018983752,0.00035417973,0.00007820117,0.000096986885,0.000031430838,0.000033719825,0.00014688208,0.00010097684],"category_scores_gemma":[0.0000020505213,0.0001911897,0.00003134202,0.00012904448,0.0000894771,0.00014085526,0.000013555032,0.0001022086,0.0000044891035],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007902706,0.00015316019,0.032188136,0.0012639664,0.0000364008,0.000013123734,0.0017686014,0.0000046116447,0.96405035,0.00001432208,0.0000017389116,0.00042657534],"study_design_scores_gemma":[0.0058904523,0.00036906137,0.066001154,0.0007785396,0.0008424834,0.0002904825,0.00050680124,0.002634276,0.9223002,0.000025136726,0.000041892963,0.00031950744],"about_ca_topic_score_codex":0.000027440532,"about_ca_topic_score_gemma":0.0000025882698,"teacher_disagreement_score":0.041750126,"about_ca_system_score_codex":0.000012482649,"about_ca_system_score_gemma":0.000029711988,"threshold_uncertainty_score":0.77964896},"labels":[],"label_agreement":null},{"id":"W2295805773","doi":"10.1182/blood-2015-10-676924","title":"Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Vascular Malformations Diagnosis and Treatment","field":"Medicine","cited_by":327,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"National Cancer Institute; Medical Research Council; European Commission","keywords":"Defibrotide; Medicine; Hepatic veno-occlusive disease; Disease; Internal medicine; Surgery; Intensive care medicine; Hematopoietic stem cell transplantation","score_opus":0.02147483339435223,"score_gpt":0.2910748467229818,"score_spread":0.26960001332862954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2295805773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995036,0.0013831647,0.00028279866,0.0011074921,0.000027038293,0.0018584514,0.00028485694,0.000008008755,0.000012169962],"genre_scores_gemma":[0.9974312,0.0007461443,0.0014002005,0.000015448613,0.000056182234,0.00026287328,0.000023262835,0.000009528267,0.000055157478],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99953246,0.000015054389,0.00017337914,0.000100254285,0.000092413604,0.00008644952],"domain_scores_gemma":[0.9993578,0.00017811873,0.00008497984,0.00023796651,0.00006685113,0.000074262825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000041148487,0.00008883546,0.00020645486,0.000031818243,0.000047117217,0.0000031429204,0.000026297988,0.000024338116,0.000018698724],"category_scores_gemma":[0.00007349364,0.000040196956,0.00015694181,0.000037862214,0.00004711433,0.000032791897,0.000009429154,0.000009269428,0.0000018673427],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10670623,0.36140853,0.12920481,0.0017816464,0.018322213,0.00011989573,0.008865041,0.000022085116,0.038039643,0.0039884853,0.0014853991,0.330056],"study_design_scores_gemma":[0.88920534,0.014647572,0.018868,0.0002747357,0.0067131873,0.000028141569,0.000250221,0.000038477036,0.06310408,0.000085308384,0.006644941,0.000139993],"about_ca_topic_score_codex":0.000013278599,"about_ca_topic_score_gemma":0.0000125387105,"teacher_disagreement_score":0.78249913,"about_ca_system_score_codex":0.000019541485,"about_ca_system_score_gemma":0.00005751993,"threshold_uncertainty_score":0.16391844},"labels":[],"label_agreement":null},{"id":"W2296163423","doi":"10.1182/blood-2016-01-687707","title":"Platelet production: new players in the field","year":2016,"lang":"en","type":"letter","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Platelet; CCL5; Platelet activation; Chemokine; Cytokine; Cell biology; Immunology; Biology; Chemistry; Inflammation; T cell; Immune system; IL-2 receptor","score_opus":0.015572503530812553,"score_gpt":0.2560486865233172,"score_spread":0.24047618299250464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2296163423","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028108768,0.00066610373,0.000002579686,0.96088195,0.000354657,0.0005534648,0.000009929308,0.000033749435,0.009388808],"genre_scores_gemma":[0.007343261,0.00032150763,0.000095266994,0.95390517,0.007888652,0.00006017438,0.0001728853,0.000043301712,0.030169796],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99892944,0.000028451877,0.00017174156,0.00031404643,0.0002637464,0.00029257752],"domain_scores_gemma":[0.9993315,0.00012484753,0.00006143059,0.00043485843,0.0000148823865,0.000032507374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000065893575,0.00020652864,0.00031792448,0.000094635216,0.00003472504,0.000016277181,0.00013804644,0.00040612867,0.0002433454],"category_scores_gemma":[0.00007754524,0.00010921251,0.000097032906,0.000106832966,0.000019959458,0.000035191963,0.000015837968,0.00073960144,0.00020812043],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027426313,0.00011861746,0.00058354664,0.000044990822,0.00016835697,0.008249969,0.00011625468,3.475455e-8,0.000009940371,0.0000037011096,0.9853417,0.0053354343],"study_design_scores_gemma":[0.0031613924,0.0002186199,0.0002866043,0.00021028589,0.00020518147,0.0011275301,0.000013205404,7.013731e-8,0.0006061893,0.00026120793,0.9937759,0.00013382168],"about_ca_topic_score_codex":0.000098296194,"about_ca_topic_score_gemma":0.00002422932,"teacher_disagreement_score":0.020780988,"about_ca_system_score_codex":0.000017356422,"about_ca_system_score_gemma":0.000113120856,"threshold_uncertainty_score":0.44535568},"labels":[],"label_agreement":null},{"id":"W2296429742","doi":"10.1182/blood.v124.21.343.343","title":"Bleeding in Patients with Atrial Fibrillation Treated with Non Vitamin K Antagonist Oral Anticoagulants: A Population-Based Study","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Rivaroxaban; Dabigatran; Medicine; Vitamin K antagonist; Atrial fibrillation; Apixaban; Population; Stroke (engine); Warfarin; Internal medicine; Edoxaban","score_opus":0.019123893910090093,"score_gpt":0.27459457037702345,"score_spread":0.25547067646693333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2296429742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981659,0.0000033123288,0.00014302992,0.00009044657,0.00004658279,0.0013204252,0.000003457788,0.000070712,0.00015614806],"genre_scores_gemma":[0.9986804,4.8283255e-7,0.0005876659,0.000022153888,0.0003614386,0.0000013529635,0.000254987,0.000028323262,0.00006321175],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987531,0.000065846696,0.00030407961,0.00028248507,0.00039406345,0.00020044748],"domain_scores_gemma":[0.9994282,0.00007598471,0.00015088997,0.00020316346,0.00007938197,0.00006237522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020040172,0.0001831792,0.0004144495,0.0002477932,0.00008581307,0.000045329754,0.00003950075,0.00005252774,0.000017740296],"category_scores_gemma":[0.000058905473,0.00012940349,0.000056972644,0.0004262132,0.000014009452,0.00012661725,0.000014045927,0.0000616073,0.0000073834062],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016786362,0.000091685164,0.99649036,0.000025745268,0.00013007782,0.000006190163,0.000053492768,0.0007986943,0.000027192278,0.000008877161,0.0000024067697,0.0006866541],"study_design_scores_gemma":[0.035287112,0.0021293184,0.9598882,0.00009200966,0.00049095624,5.486134e-7,0.000051568015,0.0017741808,0.00007612514,0.0000018334194,0.000037148777,0.00017096137],"about_ca_topic_score_codex":0.00031224286,"about_ca_topic_score_gemma":0.00015273264,"teacher_disagreement_score":0.03660211,"about_ca_system_score_codex":0.000041562624,"about_ca_system_score_gemma":0.000024833616,"threshold_uncertainty_score":0.52769214},"labels":[],"label_agreement":null},{"id":"W2298658083","doi":"10.1182/blood.v122.21.3739.3739","title":"Role Of The BTB/POZ Domain Protein Miz-1 In The Development Of c-Myc Driven B-Cell Lymphoma","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Montreal Clinical Research Institute","funders":"","keywords":"Biology; Chromatin; PAX5; Transcription factor; Chromosomal translocation; Lymphoma; Cancer research; Immunoglobulin heavy chain; Gene; B cell; Enhancer; Epigenetics; Genetics; Antibody; Immunology","score_opus":0.0029896231595522137,"score_gpt":0.18040909054577167,"score_spread":0.17741946738621947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2298658083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978694,0.00044654697,0.000023069455,0.00009260394,0.000017587328,0.00051418645,0.0000027825886,0.0000019466163,0.001031894],"genre_scores_gemma":[0.9982748,0.000005349595,0.0014443202,0.000017104352,0.000032978693,0.00008544366,0.00001133516,0.000008604588,0.00012006397],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999345,0.000067218345,0.00021782334,0.00012939845,0.0001289879,0.00011154212],"domain_scores_gemma":[0.9995247,0.0000052605214,0.000120259974,0.0002916334,0.000043977634,0.000014171712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012210346,0.00007674443,0.00008098816,0.000019383624,0.000029271834,0.0000049624855,0.00022723095,0.00009351598,0.000011808211],"category_scores_gemma":[0.00001111515,0.00004965135,0.000051165036,0.000099340716,0.000045671175,0.0000019473596,0.00007190038,0.000031117324,0.0000041170565],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009069198,0.00028681534,0.00168194,0.000014899649,0.000022419355,6.176283e-8,0.00046835854,0.000027613216,0.9948768,0.000022687376,0.00005559963,0.0025337453],"study_design_scores_gemma":[0.0012283671,0.000044854598,0.045665476,0.00002289283,0.00001051876,0.0000021831427,0.00020534177,0.000017372373,0.9503548,0.00017134976,0.0022135118,0.000063335734],"about_ca_topic_score_codex":0.000040332074,"about_ca_topic_score_gemma":0.000120704106,"teacher_disagreement_score":0.044521995,"about_ca_system_score_codex":0.000010229633,"about_ca_system_score_gemma":0.00012938639,"threshold_uncertainty_score":0.20247233},"labels":[],"label_agreement":null},{"id":"W2298992290","doi":"10.1182/blood-2016-03-703868","title":"RNA-sequencing analysis of core binding factor AML identifies recurrent ZBTB7A mutations and defines RUNX1-CBFA2T3 fusion signature","year":2016,"lang":"en","type":"letter","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Core binding factor; RUNX1; Biology; NPM1; Genetics; Fusion gene; Transcription factor; Computational biology; Gene; Molecular biology; Karyotype; Chromosome","score_opus":0.04385148627232477,"score_gpt":0.30956506967483993,"score_spread":0.26571358340251516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2298992290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9349732,0.0026382764,0.00009589067,0.05917653,0.00033269325,0.0008505855,0.001290999,0.00010208845,0.00053974026],"genre_scores_gemma":[0.89192986,0.006171981,0.003164584,0.053737048,0.008869735,0.0003476615,0.0138831325,0.00055130175,0.02134468],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969452,0.00011185346,0.0006610709,0.0007220088,0.0009813879,0.00057845854],"domain_scores_gemma":[0.9975761,0.0006453305,0.00047464302,0.00066332583,0.00049014034,0.00015044399],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026921174,0.0004467648,0.00115418,0.0020466694,0.00017406029,0.00006399163,0.00028181038,0.0009580019,0.00041480723],"category_scores_gemma":[0.00060028915,0.00032457153,0.00042553435,0.0012124635,0.00024766324,0.00012755241,0.00021919303,0.0017194053,0.000025807474],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018440218,0.00023222908,0.023287749,0.003917928,0.015335286,0.0025091649,0.002516966,0.0000046503,0.5850018,0.00005141009,0.3569109,0.010047447],"study_design_scores_gemma":[0.041570727,0.0038815371,0.105173245,0.025620135,0.17664345,0.0015924595,0.003679739,0.0018911216,0.30190882,0.0016827498,0.3279607,0.008395292],"about_ca_topic_score_codex":0.00013470314,"about_ca_topic_score_gemma":0.00005959451,"teacher_disagreement_score":0.283093,"about_ca_system_score_codex":0.0003231788,"about_ca_system_score_gemma":0.00048011323,"threshold_uncertainty_score":0.9999206},"labels":[],"label_agreement":null},{"id":"W2300062471","doi":"10.1182/blood.v124.21.4607.4607","title":"Somatic Mutations in TET2, but Not SF3B1, Are Prevalent during Normal Aging Hematopoiesis in Human","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Population; Myelodysplastic syndromes; Biology; Cancer; Epigenetics; Myeloid; Somatic cell; Genetics; Medicine; Bioinformatics; Oncology; Gene; Cancer research; Immunology; Bone marrow","score_opus":0.016573645529887868,"score_gpt":0.2851755153641487,"score_spread":0.2686018698342608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2300062471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99695385,0.000068087444,0.000022550048,0.00069878274,0.000020822392,0.0004506308,0.0000043217588,0.00006337484,0.0017176091],"genre_scores_gemma":[0.99825305,0.000008092664,0.00059961784,0.00008453817,0.00011970678,0.000102153004,0.000013381731,0.000032853884,0.0007866158],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983994,0.00010731567,0.00040245152,0.00027525533,0.00037063763,0.00044498706],"domain_scores_gemma":[0.999247,0.00013900241,0.00008155973,0.00036812946,0.000042668922,0.00012163278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041870584,0.00014827609,0.00033136044,0.00043511143,0.00009610654,0.000024972114,0.0001506445,0.00008060651,0.00012475967],"category_scores_gemma":[0.0003450089,0.00014535413,0.000060475948,0.0002856208,0.000054756823,0.00011350137,0.0001132245,0.00038450013,0.00008049432],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004822079,0.0013100896,0.7116845,0.0027457199,0.00009208407,0.00069777697,0.0030740146,0.00014415487,0.27970296,0.00015374385,0.0000405416,0.00030617963],"study_design_scores_gemma":[0.0076115406,0.00006927452,0.7907398,0.00081115944,0.00007439555,0.00014842335,0.00077106425,0.0007780077,0.19870123,0.00009426208,0.000023112834,0.00017775013],"about_ca_topic_score_codex":0.00021610541,"about_ca_topic_score_gemma":0.000322525,"teacher_disagreement_score":0.08100172,"about_ca_system_score_codex":0.00021555768,"about_ca_system_score_gemma":0.00008728298,"threshold_uncertainty_score":0.59273696},"labels":[],"label_agreement":null},{"id":"W2300489674","doi":"10.1182/blood.v122.21.332.332","title":"The Complete Type I VWD Cohort Of The Zimmerman Program For The Molecular and Clinical Biology Of VWD - Phenotypic Assignment, Mutation Frequency, and Bleeding Assessment","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Von Willebrand disease; Ristocetin; Medicine; Von Willebrand factor; Cohort; Internal medicine; Platelet; Immunology; Gastroenterology; Pediatrics","score_opus":0.026087178117382412,"score_gpt":0.3454540659402852,"score_spread":0.3193668878229028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2300489674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957792,0.0013642566,0.000116215015,0.0007607007,0.000062224695,0.0015816472,0.000008895179,0.00000616074,0.00032066577],"genre_scores_gemma":[0.99861336,0.0002683747,0.0008892407,0.00006975146,0.000014745943,0.00010700202,0.00001519052,0.0000072911052,0.000015039493],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999402,0.000052000472,0.00022885282,0.00012054159,0.000082576604,0.00011405903],"domain_scores_gemma":[0.9992887,0.00031378027,0.00013700232,0.00015779688,0.00007465462,0.000028089615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022707958,0.000073754585,0.00018579475,0.000010863161,0.00009651284,0.000010889727,0.00006148764,0.000047696663,0.000005677534],"category_scores_gemma":[0.000065700566,0.00003300986,0.000047986818,0.000052875745,0.00022117303,0.000018373465,0.000033619333,0.00007110918,4.8037293e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037349604,0.00073236064,0.94014823,0.00005349444,0.0013639632,0.0000032678358,0.000068506575,5.1290317e-7,0.01556341,0.0037182765,0.000055320565,0.038255304],"study_design_scores_gemma":[0.003958138,0.0014507257,0.98695743,0.00004697295,0.0011828985,0.000024959152,0.00015862494,0.00072449323,0.0018251719,0.0032409267,0.00036669153,0.000062978834],"about_ca_topic_score_codex":0.00010244846,"about_ca_topic_score_gemma":0.000010764313,"teacher_disagreement_score":0.04680918,"about_ca_system_score_codex":0.0000056115487,"about_ca_system_score_gemma":0.000034540983,"threshold_uncertainty_score":0.13461031},"labels":[],"label_agreement":null},{"id":"W2300531214","doi":"10.1182/blood.v116.21.2956.2956","title":"Incidence of Plasma Cell Myeloma In Ethnic Chinese In British Columbia, a 30-Year Survey From 1975–2004","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Demography; Incidence (geometry); Population; Ethnic group; Census; Cancer registry; Medicine; Plasma Cell Myeloma; Poisson regression; Multiple myeloma; Geography; Internal medicine","score_opus":0.01727314790618624,"score_gpt":0.28387087946687944,"score_spread":0.2665977315606932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2300531214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99802023,0.0003346883,6.233128e-7,0.000015246065,0.00006840647,0.0005160202,0.0002320337,0.00001721703,0.0007955554],"genre_scores_gemma":[0.99854815,0.00009605107,0.00060360954,0.000020012927,0.00005150197,0.000044539847,0.00014109611,0.000024856352,0.0004701552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983679,0.00013508489,0.00036578826,0.000351776,0.00039920537,0.00038024565],"domain_scores_gemma":[0.9988871,0.0003440145,0.00007750514,0.00039211157,0.00009021715,0.00020903113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004461369,0.00011628861,0.0004190899,0.00010773147,0.000023510533,0.000033674158,0.00018166563,0.00017024278,0.0007904169],"category_scores_gemma":[0.00094776787,0.00015247318,0.000060994153,0.0004996392,0.00009487538,0.000078529854,0.00009073055,0.0005196361,0.00008890219],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009144113,0.0018277363,0.9707741,0.000049540624,0.000034374054,0.0009546121,0.00013563692,5.19205e-7,0.022963043,1.5694464e-7,0.00006687407,0.0031019277],"study_design_scores_gemma":[0.013409915,0.00021327064,0.9815542,0.00015329232,0.000018087698,0.000030333005,0.000026848014,0.00008100846,0.004327661,0.00005811384,0.000012822015,0.00011441043],"about_ca_topic_score_codex":0.41389778,"about_ca_topic_score_gemma":0.8992146,"teacher_disagreement_score":0.48531684,"about_ca_system_score_codex":0.00003257329,"about_ca_system_score_gemma":0.00026333946,"threshold_uncertainty_score":0.8654511},"labels":[],"label_agreement":null},{"id":"W2300582939","doi":"10.1182/blood.v122.21.2595.2595","title":"Functional and Phenotypic Characterization Of Acute Myeloid Leukemia By Analysis Of Diagnostic/Relapse Paired Samples","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"CD117; Medicine; Myeloid leukemia; Internal medicine; Transplantation; CD34; Minimal residual disease; Leukemia; Oncology; Myeloid; Stem cell; Gastroenterology; Immunology; Biology","score_opus":0.014141621093510408,"score_gpt":0.23585202671424754,"score_spread":0.22171040562073713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2300582939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977336,0.00018145883,0.00092613575,0.00034343902,0.000026417438,0.0003765958,0.00025873154,0.000026873138,0.00012673852],"genre_scores_gemma":[0.99663436,0.00054561807,0.0005790084,0.00011376336,0.00005830377,0.00005385466,0.0014220574,0.00002017035,0.0005728892],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987364,0.0000562815,0.0003833525,0.00025597448,0.000360376,0.00020762875],"domain_scores_gemma":[0.9986939,0.00041912653,0.00017406224,0.00029196005,0.0002818566,0.00013908352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015447375,0.00013903949,0.00048223516,0.00032479383,0.000041014046,0.000012421314,0.00008037306,0.00011714744,0.0007379189],"category_scores_gemma":[0.00038886545,0.00011996475,0.000113810784,0.0007127246,0.00015298674,0.00013168225,0.00006780954,0.00013928574,0.000018748642],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008804348,0.0002721729,0.17306991,0.00008559626,0.0036457283,0.000004444294,0.00016355331,0.0000026058235,0.81846654,0.000082067934,0.0011821383,0.0029372117],"study_design_scores_gemma":[0.0024707692,0.00020134627,0.8963712,0.000035190005,0.004362232,0.000010436812,0.000042551466,0.0006938415,0.095493056,0.000030631316,0.00018724597,0.00010152804],"about_ca_topic_score_codex":0.00033271252,"about_ca_topic_score_gemma":0.0000056257454,"teacher_disagreement_score":0.7233013,"about_ca_system_score_codex":0.000069631344,"about_ca_system_score_gemma":0.00018347723,"threshold_uncertainty_score":0.80796945},"labels":[],"label_agreement":null},{"id":"W2300957547","doi":"10.1182/blood.v122.21.5529.5529","title":"Second Autologous Stem Cell Transplant As Salvage Therapy For Multiple Myeloma","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Saskatchewan Cancer Agency; University of Saskatchewan","funders":"","keywords":"Medicine; Salvage therapy; Lenalidomide; Multiple myeloma; Surgery; Bortezomib; Thalidomide; Transplantation; Internal medicine; Median follow-up; Chemotherapy; Oncology","score_opus":0.021871443546456665,"score_gpt":0.2687739272912105,"score_spread":0.24690248374475385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2300957547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914861,0.0009612762,0.00005981888,0.0002783309,0.00006231033,0.0023299071,0.00011365949,0.00011630109,0.004592342],"genre_scores_gemma":[0.99144393,0.00012965835,0.0011698755,0.00028463622,0.000102822494,0.0006263833,0.000114682014,0.000043086355,0.006084903],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986828,0.000039128856,0.00021398124,0.0003270794,0.00022840778,0.0005085833],"domain_scores_gemma":[0.99901044,0.00021618711,0.000047325335,0.00032993648,0.00008740839,0.00030872633],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008093216,0.00020226245,0.00031086666,0.00008419245,0.00010555414,0.00003375444,0.00011528702,0.000118298994,0.0010503656],"category_scores_gemma":[0.000013050878,0.00014722567,0.00016163505,0.0000750583,0.00004464106,0.00007799059,0.000013317661,0.00013354288,0.0005697152],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025369015,0.009193992,0.24785292,0.000879857,0.0018806253,0.0012271248,0.0026349328,0.0000011037342,0.50688493,0.00010110215,0.006068247,0.22073823],"study_design_scores_gemma":[0.042498864,0.0031086686,0.34294468,0.000060558767,0.00014497431,0.00025673784,0.00017023402,0.0004056302,0.59969765,0.00011396952,0.010297731,0.0003002946],"about_ca_topic_score_codex":0.000110855275,"about_ca_topic_score_gemma":0.000032073123,"teacher_disagreement_score":0.22043794,"about_ca_system_score_codex":0.000022261433,"about_ca_system_score_gemma":0.000098984725,"threshold_uncertainty_score":0.9998628},"labels":[],"label_agreement":null},{"id":"W2301273092","doi":"10.1182/blood.v122.21.5501.5501","title":"A Comparison Of Long-Term Outcomes Of Donor Lymphocyte Infusions and Tyrosine Kinase Inhibitors In CML Patients Relapsed After Allogeneic Hemopoietic Stem Cell Transplantation","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Nilotinib; Dasatinib; Internal medicine; Transplantation; Donor lymphocyte infusion; Imatinib; Cumulative incidence; Tyrosine-kinase inhibitor; Graft-versus-host disease; Gastroenterology; Hematopoietic stem cell transplantation; Stem cell; Oncology; Myeloid leukemia; Surgery; Cancer","score_opus":0.012373655439929127,"score_gpt":0.255595072388396,"score_spread":0.24322141694846688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2301273092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99783725,0.0010731273,0.0000028872355,0.000033679687,0.000056974106,0.0008805969,0.000031897405,0.000014415797,0.00006919791],"genre_scores_gemma":[0.99924695,0.0001903571,0.00024375276,0.00003077362,0.000009683593,0.00007999821,0.00007637042,0.000021789036,0.000100319325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987205,0.00004445736,0.0005812328,0.00022748676,0.00023374113,0.00019255134],"domain_scores_gemma":[0.99930435,0.0000745797,0.00019495506,0.0002464726,0.00007529031,0.000104355764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000047842397,0.00018466814,0.00050602155,0.00016863448,0.000017825432,0.0000055301693,0.000052921714,0.00011199592,0.00006555204],"category_scores_gemma":[0.000009210623,0.00015169135,0.00007287979,0.0001499724,0.00006796019,0.000075877324,0.000031181444,0.00008227811,0.00000952811],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019177531,0.0023257704,0.9795518,0.00060463586,0.000065313056,0.000029232922,0.0014169213,0.000004286965,0.013054456,4.7965256e-7,0.000008890364,0.0027464598],"study_design_scores_gemma":[0.020015098,0.00045032473,0.8476058,0.00033694756,0.00036919158,0.0000058187393,0.00005478395,0.000021431366,0.1310402,0.0000015982679,0.0000011739564,0.00009757739],"about_ca_topic_score_codex":0.00030652125,"about_ca_topic_score_gemma":0.00013484004,"teacher_disagreement_score":0.13194592,"about_ca_system_score_codex":0.00014310153,"about_ca_system_score_gemma":0.000106398016,"threshold_uncertainty_score":0.6185794},"labels":[],"label_agreement":null},{"id":"W2301325588","doi":"10.1182/blood.v122.21.3145.3145","title":"Abnormalities Of FAM46C, AHCYL1, CDC14A and CDKN2C Genes Located At Chromosome 1p Detected By QM-FISH Identifies Deletion Of 1p32.3 Covered CDKN2C Is An Independent Adverse Prognostic Marker In Multiple Myeloma","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Chromosome; Locus (genetics); Gene; Biology; Genetics; Molecular biology","score_opus":0.01682184609377475,"score_gpt":0.24346923579602278,"score_spread":0.22664738970224804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2301325588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99648374,0.0011887783,0.0000083978875,0.000066632114,0.00004239569,0.0017172747,0.0003487461,0.000053724332,0.00009030367],"genre_scores_gemma":[0.9978879,0.0004883825,0.00021666352,0.00004140441,0.000028620894,0.0002371329,0.000512195,0.00004414085,0.000543575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99742687,0.00018524838,0.00068646227,0.00048442264,0.0006818664,0.0005351374],"domain_scores_gemma":[0.9983674,0.00023107378,0.00025003802,0.0004447976,0.00040273814,0.0003038992],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022106277,0.000316192,0.0005941882,0.00031895284,0.00008822137,0.000029314171,0.00015110508,0.00021194399,0.0005180503],"category_scores_gemma":[0.0003841605,0.00028090706,0.00009734754,0.00031555514,0.00027181618,0.0003817378,0.00016424253,0.00017162791,0.000032139855],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006413201,0.0014240752,0.73972946,0.00056628016,0.00038208766,0.00008657036,0.0005866605,0.0000026313035,0.25461072,0.0000011988385,0.00019113928,0.001777846],"study_design_scores_gemma":[0.009777323,0.0006147588,0.6837298,0.00021133244,0.00015236894,0.0000625241,0.00054292334,0.0007656046,0.30391338,0.000015881018,0.000037316844,0.00017672508],"about_ca_topic_score_codex":0.0030164716,"about_ca_topic_score_gemma":0.0012509559,"teacher_disagreement_score":0.05599962,"about_ca_system_score_codex":0.00009383287,"about_ca_system_score_gemma":0.00011074929,"threshold_uncertainty_score":0.9999643},"labels":[],"label_agreement":null},{"id":"W2302186512","doi":"10.1182/blood.v122.21.sci-35.sci-35","title":"Lessons from the Mouse Model","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Biology; Phenotype; Allele; Genetics; Progenitor cell; Myeloid; Immunology; Gene; Cancer research; Cell biology; Stem cell","score_opus":0.01186249497255861,"score_gpt":0.2315425387528481,"score_spread":0.2196800437802895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2302186512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995872,0.00088934635,0.0002793788,0.0008140784,0.000014971387,0.00011728871,0.000048700556,0.000009106114,0.001955102],"genre_scores_gemma":[0.9970036,0.000114935814,0.00051366683,0.00061446993,0.00006393213,0.000047763428,0.0001192873,0.000011926398,0.0015103818],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996046,0.000012435632,0.000057983845,0.00015803472,0.00004863889,0.00011832502],"domain_scores_gemma":[0.9996292,0.000004468501,0.000019532816,0.00029216858,0.000020169091,0.00003447975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000014653119,0.00007624505,0.00005057197,0.00000363225,0.00006312797,0.00002430771,0.00013161694,0.000058484347,0.00003421628],"category_scores_gemma":[0.000009371062,0.0000493817,0.000046803907,0.000016544473,0.000025211084,0.0000017190124,0.00005882927,0.00003192134,0.000082719125],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019417474,0.0023209585,0.03551083,0.0000045386178,0.0008984408,0.0000026284256,0.00021141199,0.00028609432,0.90092814,0.00068525714,0.04796905,0.011163225],"study_design_scores_gemma":[0.0042053033,0.00016653049,0.006627507,0.0000047425997,0.0002235502,0.0000036322913,0.00016051487,0.0007451063,0.9766902,0.0044031604,0.006429307,0.00034044308],"about_ca_topic_score_codex":0.00025910762,"about_ca_topic_score_gemma":0.00007406493,"teacher_disagreement_score":0.075762056,"about_ca_system_score_codex":8.769491e-7,"about_ca_system_score_gemma":0.000017974382,"threshold_uncertainty_score":0.20137273},"labels":[],"label_agreement":null},{"id":"W2302206306","doi":"10.1182/blood.v122.21.3060.3060","title":"The Role Of Body Mass Index In Survival Outcome For Lymphoma Patients: US Intergroup Experience","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Underweight; Internal medicine; Body mass index; Follicular lymphoma; Overweight; International Prognostic Index; Proportional hazards model; Rituximab; Lymphoma; Log-rank test; Progression-free survival; Gastroenterology; Chemotherapy","score_opus":0.01674707414521226,"score_gpt":0.3018496370224573,"score_spread":0.28510256287724506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2302206306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997626,0.000140456,0.000046892197,0.00034564588,0.00018803835,0.0005159597,0.000003888048,0.000014554884,0.0011185562],"genre_scores_gemma":[0.99898034,0.000017081307,0.00032630714,0.00031043333,0.000052951684,0.00019302573,0.000005299617,0.000009339744,0.00010519273],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992192,0.000022178356,0.00032171598,0.000106799554,0.00013769059,0.00019243656],"domain_scores_gemma":[0.9995116,0.00009363672,0.00007309687,0.00015879227,0.0000973955,0.0000654749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012560749,0.00006358686,0.00016179078,0.0000494051,0.000045641398,0.000010121048,0.00008534935,0.000040839794,0.00003288562],"category_scores_gemma":[0.00011145917,0.00004475914,0.000040374285,0.00007809965,0.00003962495,0.000051267645,0.000021847676,0.000050327908,0.00000853316],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045944547,0.0004901788,0.9947492,0.000057963713,0.0000069943994,5.747597e-7,0.00028276906,4.528614e-8,0.00094713364,0.00035675024,0.000034262604,0.0030281695],"study_design_scores_gemma":[0.0064246687,0.00018261661,0.98304427,0.00008266417,0.000009542393,0.000001694762,0.0012914864,0.00021535206,0.002881575,0.0007232589,0.0050849854,0.000057885314],"about_ca_topic_score_codex":0.00017992714,"about_ca_topic_score_gemma":0.000025903082,"teacher_disagreement_score":0.011704943,"about_ca_system_score_codex":0.00002679978,"about_ca_system_score_gemma":0.000021386251,"threshold_uncertainty_score":0.18252248},"labels":[],"label_agreement":null},{"id":"W2302391440","doi":"10.1182/blood.v122.21.931.931","title":"Accuracy Of Adverse Event Reporting Compared To Patient Chart Abstraction On a Phase III NCI-Funded Clinical Trial For Pediatric Acute Myeloid Leukemia: A Report From The Children’s Oncology Group","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Clinical trial; Internal medicine; Common Terminology Criteria for Adverse Events; Adverse effect; Oncology; Cog; Discontinuation; Intensive care medicine; Pediatrics","score_opus":0.29767980930045657,"score_gpt":0.5481916015675767,"score_spread":0.25051179226712017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2302391440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885862,0.000040872255,0.00020833977,0.0032020214,0.0010317166,0.0064876657,0.000058908583,0.000057393638,0.00032687234],"genre_scores_gemma":[0.99309945,0.00020914212,0.0017074599,0.001099839,0.0025657075,0.0008868334,0.0002627746,0.000038559494,0.00013020688],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.992245,0.00029082323,0.004955511,0.0008433568,0.0011909909,0.00047428836],"domain_scores_gemma":[0.97002494,0.022759583,0.004543045,0.0013025054,0.00089188275,0.00047804916],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.008000269,0.00023581812,0.0010357565,0.00011220595,0.00016366653,0.000016805834,0.0003027254,0.000617675,0.0001657844],"category_scores_gemma":[0.09751331,0.00016643608,0.00062773837,0.00023833154,0.00013826859,0.00009263618,0.00021112942,0.0020798028,0.000064856074],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.40783063,0.10280303,0.26207474,0.00054279575,0.007994899,0.0031229192,0.0049022594,0.00010716086,0.015172504,0.0006160674,0.051748984,0.14308402],"study_design_scores_gemma":[0.47684294,0.04363258,0.46074668,0.00041841727,0.00413123,0.0004015832,0.0010124557,0.00027782016,0.005079318,0.0034271344,0.0033841594,0.00064568303],"about_ca_topic_score_codex":0.0010692866,"about_ca_topic_score_gemma":0.00020777044,"teacher_disagreement_score":0.19867194,"about_ca_system_score_codex":0.00027480078,"about_ca_system_score_gemma":0.0016029121,"threshold_uncertainty_score":0.9100887},"labels":[],"label_agreement":null},{"id":"W2302480850","doi":"10.1182/blood.v122.21.821.821","title":"A New Form Of Therapeutic Resistance: Drug Glucuronidation Regulated By The Sonic Hedgehog Factor Gli1","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Aegera Therapeutics (Canada); Jewish General Hospital; Hôpital Maisonneuve-Rosemont; Université de Montréal; McMaster University Medical Centre; Institute for Research in Immunology and Cancer","funders":"","keywords":"EIF4E; Biology; Cancer research; Ribavirin; Drug resistance; Initiation factor; Pharmacology; Translation (biology); Gene; Biochemistry; Genetics; Messenger RNA","score_opus":0.008563838974222146,"score_gpt":0.2203691709107074,"score_spread":0.21180533193648526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2302480850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900673,0.007934387,0.00050942245,0.0005190827,0.00006497506,0.0003272111,0.000020448619,0.000019042085,0.000538153],"genre_scores_gemma":[0.99443936,0.00015196553,0.00020432849,0.00011997991,0.0001031085,0.000028265831,0.000045911256,0.00002216645,0.004884885],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991363,0.000051503852,0.00021949166,0.00023104403,0.00014227304,0.00021935834],"domain_scores_gemma":[0.9993073,0.000023413599,0.00012280265,0.0003912143,0.00010675009,0.00004853728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009318571,0.00014495732,0.00014200936,0.00001728379,0.00009139193,0.000023036018,0.00023337093,0.000087879525,0.000054320386],"category_scores_gemma":[0.000045889683,0.000102305814,0.00008077862,0.000097803044,0.000068951216,0.0000052690602,0.000065162225,0.00006889484,0.000019216262],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018071742,0.00007132747,0.00064436387,0.000021378364,0.00017121717,1.9122085e-7,0.00043528344,0.0000011642268,0.9845029,0.0000469673,0.011580096,0.0025070042],"study_design_scores_gemma":[0.00095685164,0.00010027573,0.004687983,0.000021550508,0.000057522113,0.0000019617962,0.00015250519,0.000006428484,0.9766511,0.0005079235,0.016699681,0.00015623652],"about_ca_topic_score_codex":0.0000689989,"about_ca_topic_score_gemma":0.00007477219,"teacher_disagreement_score":0.007851855,"about_ca_system_score_codex":0.000008643078,"about_ca_system_score_gemma":0.0000835419,"threshold_uncertainty_score":0.417191},"labels":[],"label_agreement":null},{"id":"W2303174757","doi":"10.1182/blood.v122.21.2290.2290","title":"Safety and Immunogenicity Of Inactivated Varicella-Zoster Virus Vaccine In Adults With Hematologic Malignancies Receiving Treatment With Anti-CD20 Monoclonal Antibodies","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Capital District Health Authority; Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Medicine; ELISPOT; Immunogenicity; Monoclonal antibody; Immunology; Population; Regimen; Rituximab; Virology; Antibody; Varicella zoster virus; Internal medicine; Immune system; Virus; T cell","score_opus":0.007958418606168733,"score_gpt":0.22019513721189896,"score_spread":0.21223671860573023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2303174757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99767256,0.00065016723,0.000015783708,0.00007569149,0.000012320837,0.0007032065,0.000015787946,0.000038171343,0.0008163099],"genre_scores_gemma":[0.9976915,0.000891118,0.0011980777,0.000023269558,0.000009490718,0.000053562322,0.000018524805,0.000019503486,0.00009495499],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901974,0.000040353894,0.00029793015,0.0002808063,0.000119458884,0.00024172057],"domain_scores_gemma":[0.9993897,0.00006694152,0.00013285766,0.00023126924,0.000110633984,0.00006858156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000052705025,0.00023638672,0.00053716917,0.00012814646,0.00007450883,0.000013866326,0.00003260024,0.00007966331,0.000090436886],"category_scores_gemma":[0.000011395144,0.00013721558,0.000037934824,0.0002550238,0.00006128786,0.000116505245,0.000027467937,0.000085931664,0.000008667665],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010867827,0.0026156986,0.9771875,0.00011740473,0.00068744266,0.00014726451,0.0005275751,0.000004187392,0.0154977245,0.000012068909,0.0000020718549,0.0021142908],"study_design_scores_gemma":[0.014621228,0.0024503386,0.8730319,0.00064702565,0.0003180058,0.0005116611,0.00022895575,0.000032643595,0.107929155,0.00000939503,0.00005872335,0.00016093142],"about_ca_topic_score_codex":0.0043770624,"about_ca_topic_score_gemma":0.0005579802,"teacher_disagreement_score":0.104155555,"about_ca_system_score_codex":0.00006206892,"about_ca_system_score_gemma":0.000055684057,"threshold_uncertainty_score":0.66168386},"labels":[],"label_agreement":null},{"id":"W2304073669","doi":"10.1182/blood.v122.21.513.513","title":"Disruption Of Ikaros In Patients’ Chronic Phase CML Cells Induces The Features Of Accelerated Phase Disease","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Immunology; CD34; Biology; Cancer research; Myeloid; Myeloid leukemia; CD38; Stromal cell; Stem cell; Cell biology","score_opus":0.017056089418271032,"score_gpt":0.289482142458701,"score_spread":0.27242605304043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2304073669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973481,0.0008666895,0.0000013576981,0.00014808714,0.000068826506,0.0012766274,0.000078296915,0.000019403475,0.00019256346],"genre_scores_gemma":[0.99931294,0.00011370684,0.000032554617,0.00004257943,0.00006965078,0.00009637073,0.00018380591,0.000020817626,0.00012757456],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99879676,0.000061463994,0.00038110098,0.00022387717,0.00030429024,0.00023250717],"domain_scores_gemma":[0.9990454,0.000058646187,0.00020821308,0.00043539036,0.00012331406,0.00012903845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007194967,0.00017454491,0.00031107222,0.00010454564,0.000030789688,0.000010895261,0.00013193057,0.00007441604,0.00038160916],"category_scores_gemma":[0.00007079295,0.000113221024,0.00009015746,0.00026988515,0.000103246246,0.00012356324,0.000044183118,0.00016553492,0.000023653201],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020498794,0.061148003,0.14184786,0.0010872579,0.00082416437,0.000077594545,0.0020981205,0.000032379376,0.7094143,0.000069005284,0.0021370603,0.07921437],"study_design_scores_gemma":[0.08054813,0.002169721,0.40974367,0.00034313626,0.00059906393,0.0000029317366,0.00009567153,0.00011417836,0.506085,0.000038307193,0.00009296798,0.00016726064],"about_ca_topic_score_codex":0.00034676248,"about_ca_topic_score_gemma":0.000017909939,"teacher_disagreement_score":0.2678958,"about_ca_system_score_codex":0.00019146131,"about_ca_system_score_gemma":0.00032799965,"threshold_uncertainty_score":0.46170196},"labels":[],"label_agreement":null},{"id":"W2304579011","doi":"10.1182/blood.v122.21.1145.1145","title":"Rivaroxaban Versus Enoxaparin For Prevention Of Venous Thromboembolism In Elective Total Hip Replacement: A Retrospective Cohort Study","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. John’s Health Sciences Centre; Memorial University of Newfoundland","funders":"","keywords":"Rivaroxaban; Medicine; Low molecular weight heparin; Retrospective cohort study; Venous thromboembolism; Cohort; Cohort study; Surgery; Anesthesia; Thrombosis; Internal medicine; Warfarin; Atrial fibrillation","score_opus":0.016342694075339708,"score_gpt":0.2846115196583708,"score_spread":0.26826882558303106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2304579011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98510766,0.000097878925,0.000055554785,0.00008805298,0.00024815823,0.008776683,0.000008774545,0.000052443782,0.0055648065],"genre_scores_gemma":[0.9970068,0.000036778893,0.0004381201,0.000036956586,0.00012945697,0.0020044576,0.00003173563,0.00003986355,0.00027585545],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99808425,0.00007631674,0.00050209207,0.0005395873,0.00039631053,0.00040145507],"domain_scores_gemma":[0.9988528,0.00007700359,0.0002239002,0.0004692544,0.00028771284,0.00008934875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004225189,0.00022665084,0.00096935104,0.00021771995,0.00007124762,0.00002217182,0.00011304486,0.000092310926,0.00020776562],"category_scores_gemma":[0.00022940488,0.0002213116,0.00015478898,0.00030961676,0.00004738547,0.00013648008,0.000089903675,0.00016671351,0.000025304756],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013593748,0.07369802,0.8985853,0.00035542314,0.0049864044,0.000027638924,0.007335841,0.000019300387,0.005231792,0.0030191124,0.0019810859,0.0034006776],"study_design_scores_gemma":[0.015404449,0.011726466,0.9649617,0.00009691718,0.001215018,0.0000049856258,0.0015158162,0.00003904594,0.0038815713,0.00093287416,0.000029375846,0.00019176689],"about_ca_topic_score_codex":0.0013879399,"about_ca_topic_score_gemma":0.00020503339,"teacher_disagreement_score":0.06637638,"about_ca_system_score_codex":0.00021806384,"about_ca_system_score_gemma":0.00007015248,"threshold_uncertainty_score":0.9024825},"labels":[],"label_agreement":null},{"id":"W2304970776","doi":"10.1182/blood.v122.21.2907.2907","title":"Evaluation Of Afuresertib, An Oral Pan-AKT Inhibitor, In Patients With Langerhans Cell Histiocytosis","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Langerhans cell histiocytosis; Medicine; Histiocytosis; Bone marrow; Chemotherapy; Internal medicine; Histiocyte; Gastroenterology; Surgery; Pathology; Disease","score_opus":0.015783026908192915,"score_gpt":0.24843595236700208,"score_spread":0.23265292545880917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2304970776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943279,0.0001012354,0.000002896313,0.00003186164,0.000027644859,0.00069995015,0.000009230106,0.000014972152,0.004784319],"genre_scores_gemma":[0.9992049,0.0000023015307,0.00038903623,0.000028828774,0.000014617827,0.000078062105,0.00010967377,0.000015393816,0.00015723353],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891907,0.000058258698,0.00016999729,0.0001666387,0.00054491963,0.0001411156],"domain_scores_gemma":[0.999333,0.000009406443,0.000063413725,0.00021182121,0.0003126481,0.00006971254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014865199,0.00010010574,0.00018440148,0.000089004294,0.000019614929,0.000006987644,0.000039567873,0.00005283062,0.0002389143],"category_scores_gemma":[0.000039159182,0.00007451574,0.000024334471,0.00013461085,0.00002847107,0.00010138645,0.000009663126,0.000052269286,0.00003944772],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000088006476,0.008418096,0.978531,0.000042341682,0.00007909116,0.000003935037,0.0004592153,0.000007300904,0.0005890748,0.000007096126,0.00018964708,0.011585167],"study_design_scores_gemma":[0.023285123,0.0017421899,0.96862686,0.00008065811,0.00076960155,7.846905e-7,0.00011490407,0.00017920804,0.004952334,0.00007167166,0.00006666229,0.00010998428],"about_ca_topic_score_codex":0.0008675287,"about_ca_topic_score_gemma":0.000292701,"teacher_disagreement_score":0.023197116,"about_ca_system_score_codex":0.000073990275,"about_ca_system_score_gemma":0.000119836346,"threshold_uncertainty_score":0.30386636},"labels":[],"label_agreement":null},{"id":"W2305151049","doi":"10.1182/blood.v118.21.3766.3766","title":"Imatinib Long-Term Effects Study: Global Independent Assessment of Imatinib in Chronic Myeloid Leukemia: Results At 8 Years,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Imatinib; Cumulative incidence; Internal medicine; Incidence (geometry); Population; Standardized mortality ratio; Imatinib mesylate; Myeloid leukemia; Adverse effect; Mortality rate; Rate ratio; Cohort; Confidence interval","score_opus":0.02203925635593625,"score_gpt":0.3071219850640448,"score_spread":0.2850827287081086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2305151049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900011,0.0005146448,0.00000902321,0.000018555347,0.00018735962,0.0023667957,0.00006668051,0.00008811829,0.0067477454],"genre_scores_gemma":[0.9981808,0.00007616579,0.0010434729,0.000038012484,0.00011356798,0.00017794242,0.00010618747,0.000046419376,0.00021740524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99674207,0.00018342487,0.00094919355,0.00070274435,0.00081801944,0.0006045618],"domain_scores_gemma":[0.998144,0.00011964888,0.0004118905,0.0010360443,0.000062308885,0.00022616373],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005111578,0.00039301228,0.0008419442,0.0001553599,0.00004735546,0.000012799641,0.00029650013,0.00022583717,0.000198755],"category_scores_gemma":[0.00010839732,0.00036257395,0.00016665073,0.00038594735,0.000095677155,0.00010836644,0.00036431124,0.0003761927,0.00009658315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005180012,0.0050596935,0.98211473,0.000628003,0.0007326026,0.0027128006,0.0014652645,0.000008217461,0.002777492,0.000056731216,0.000107648724,0.003818806],"study_design_scores_gemma":[0.051475987,0.003016027,0.9358755,0.0005817385,0.00062229397,0.00019270649,0.00006866335,0.000048649195,0.007832102,0.000029783525,0.000009682683,0.00024687583],"about_ca_topic_score_codex":0.00095935434,"about_ca_topic_score_gemma":0.0013533946,"teacher_disagreement_score":0.050957985,"about_ca_system_score_codex":0.0070528723,"about_ca_system_score_gemma":0.001822434,"threshold_uncertainty_score":0.99988264},"labels":[],"label_agreement":null},{"id":"W2305188648","doi":"10.1182/blood-2015-08-662353","title":"Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphoma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of Ottawa","funders":"Novo Nordisk Fonden; Lundbeckfonden","keywords":"Enterotoxin; Lymphoma; Immunology; Cancer research; Biology; Medicine; Gene; Genetics","score_opus":0.012866846448203928,"score_gpt":0.2703591116709907,"score_spread":0.2574922652227868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2305188648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969575,0.0001714733,0.00034421685,0.00043511507,0.000017154694,0.0010108512,0.000040503335,0.000056344958,0.00096684357],"genre_scores_gemma":[0.9980427,0.00016369192,0.00035583097,0.00011530028,0.000050574574,0.000088006556,0.000017739683,0.000038636463,0.0011274947],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99835086,0.00009993526,0.0002749617,0.00044200497,0.00040977524,0.0004224583],"domain_scores_gemma":[0.99907506,0.00026957024,0.00006434864,0.0002875957,0.00010817873,0.00019523685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012015984,0.00020984112,0.00029410442,0.0002497626,0.00006678742,0.000032930937,0.000090122296,0.00012801851,0.00018615442],"category_scores_gemma":[0.0002277489,0.00014599421,0.000052110947,0.00017467678,0.00011772801,0.00011819037,0.00009815189,0.0000936955,0.000029348923],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010446591,0.0018454785,0.18231806,0.00009152429,0.000027804312,0.00038628568,0.00042066188,0.0000018574386,0.8029005,0.000005612025,0.0002660747,0.010691476],"study_design_scores_gemma":[0.023099897,0.0012398497,0.021125218,0.00061293197,0.000033812183,0.00073933764,0.0002927544,0.00032368393,0.95070523,0.00024095591,0.0012971283,0.00028918133],"about_ca_topic_score_codex":0.000059724636,"about_ca_topic_score_gemma":0.00003464642,"teacher_disagreement_score":0.16119283,"about_ca_system_score_codex":0.000120763856,"about_ca_system_score_gemma":0.00014679297,"threshold_uncertainty_score":0.59534717},"labels":[],"label_agreement":null},{"id":"W2305816079","doi":"10.1182/blood.v124.21.3245.3245","title":"Gfi136N As a Novel Marker and Therapeutic Target of MDS and AML","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Myeloid leukemia; Decitabine; Myelodysplastic syndromes; Leukemia; Oncology; Exome sequencing; Myeloid; Internal medicine; Population; Biology; Haematopoiesis; Medicine; Immunology; Bone marrow; Genetics; Stem cell; Mutation; DNA methylation; Gene","score_opus":0.004685979672469749,"score_gpt":0.21232387677095765,"score_spread":0.2076378970984879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2305816079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993413,0.003407714,0.00015863108,0.000056626483,0.000015580552,0.00006916663,0.000010262917,0.000003245637,0.0028657964],"genre_scores_gemma":[0.99874794,0.00016771154,0.0006271789,0.00018992572,0.000023704673,0.000006274661,0.000014325382,0.0000095908645,0.00021333764],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996211,0.000013779259,0.00007073097,0.00015963057,0.00004149092,0.00009328225],"domain_scores_gemma":[0.9997785,0.000006159226,0.00003076926,0.00012926983,0.000016791613,0.000038529815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004741668,0.00007987299,0.00009089942,0.0000125751185,0.000025361405,0.0000073303195,0.00003599389,0.0000646002,0.000008466311],"category_scores_gemma":[0.0000124249345,0.00006641764,0.000023178905,0.00001983532,0.00005222625,0.0000010103389,0.00004160646,0.000020449612,0.0000011978315],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012500783,0.0016360311,0.298985,0.00007809715,0.0007475441,0.0000023403481,0.0001160707,0.0000015182495,0.68004185,0.001116913,0.0001267957,0.01702286],"study_design_scores_gemma":[0.015909472,0.0024972407,0.19591568,0.00003437903,0.0005100685,0.00012290965,0.00010965072,0.00010632779,0.74763256,0.0037138031,0.03292215,0.00052572746],"about_ca_topic_score_codex":0.000021289534,"about_ca_topic_score_gemma":0.0000071762042,"teacher_disagreement_score":0.10306931,"about_ca_system_score_codex":3.9644652e-7,"about_ca_system_score_gemma":0.000010166747,"threshold_uncertainty_score":0.2708433},"labels":[],"label_agreement":null},{"id":"W2306855400","doi":"10.1182/blood.v122.21.989.989","title":"Characterization Of Pulmonary Compliance In Sickle Cell Patients Revealed Wide Variability","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Pulmonary hypertension; Internal medicine; Cardiology; Vascular resistance; Afterload; Ventricle; Hemodynamics; Cohort; Regurgitation (circulation)","score_opus":0.007229195989484216,"score_gpt":0.2035844417744712,"score_spread":0.19635524578498698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2306855400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99351907,0.00002834866,0.00002649867,0.00018939888,0.000051121606,0.0005518393,0.0000074532877,0.000017274895,0.005609011],"genre_scores_gemma":[0.9992856,0.000043585267,0.00014156038,0.00015171761,0.000011057649,0.000018666235,0.00008762705,0.0000094136885,0.00025077292],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99929875,0.000042029707,0.00026752165,0.00014746579,0.0001096956,0.0001345285],"domain_scores_gemma":[0.99954623,0.000028834329,0.00008634089,0.00018960176,0.0000954077,0.000053601554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008884523,0.00007540352,0.00018715186,0.000038784186,0.000015939777,0.0000029868493,0.000045914567,0.00008651551,0.00014533942],"category_scores_gemma":[0.000069662485,0.00006452592,0.00003350576,0.00016318198,0.000034427325,0.000066080414,0.000021235752,0.00010759481,0.000050253904],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022314434,0.0023437052,0.85445243,0.00025480957,0.000008446776,0.0000036623394,0.0001174075,7.15438e-7,0.14114003,0.000003944669,0.00002640112,0.0016261452],"study_design_scores_gemma":[0.0020450493,0.00008469018,0.9871108,0.00014298124,0.00003235637,0.0000017452577,0.000024412528,0.00028044448,0.010028768,0.00007805041,0.00010168049,0.000068999114],"about_ca_topic_score_codex":0.0000718296,"about_ca_topic_score_gemma":7.091035e-7,"teacher_disagreement_score":0.1326584,"about_ca_system_score_codex":0.000013206617,"about_ca_system_score_gemma":0.000026537113,"threshold_uncertainty_score":0.2631291},"labels":[],"label_agreement":null},{"id":"W2308972734","doi":"10.1182/blood.v124.21.81.81","title":"Effect of Age on Efficacy and Safety Outcomes in Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM) Receiving Lenalidomide and Low-Dose Dexamethasone (Rd): The First Trial","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Royal Victoria Hospital","funders":"","keywords":"Medicine; Internal medicine; Lenalidomide; Clinical endpoint; Thalidomide; Interim analysis; Multiple myeloma; Melphalan; Adverse effect; Gastroenterology; Prednisone; Dexamethasone; Surgery; Randomized controlled trial","score_opus":0.011535121424371865,"score_gpt":0.26795987437220153,"score_spread":0.2564247529478297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2308972734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968158,0.00007907338,0.000005468305,0.0002124051,0.00004229474,0.0026746297,0.000015787482,0.000022249684,0.0001322722],"genre_scores_gemma":[0.999395,0.00006323434,0.00021952362,0.000063122185,0.000054458465,0.00011203133,0.000025090185,0.000031139483,0.000036396945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981235,0.00038456215,0.00033353845,0.00037214492,0.000430872,0.0003553845],"domain_scores_gemma":[0.9938722,0.0053730984,0.0001262292,0.00040368756,0.000039982686,0.00018477763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007509769,0.00026597144,0.00067273306,0.00013418413,0.000118505224,0.00002772077,0.0000985109,0.00008592444,0.00000871554],"category_scores_gemma":[0.0035168685,0.00014177895,0.00006733539,0.00016267555,0.0001621782,0.00005702838,0.00007681852,0.00023422064,0.0000047791236],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09156178,0.002032052,0.8629148,0.00017890778,0.00026357506,0.00008116221,0.00030662323,0.0000065456406,0.000118596974,0.000002668213,0.000011463686,0.042521834],"study_design_scores_gemma":[0.3284364,0.007707783,0.66087574,0.00033396218,0.00013834881,0.0000032121588,0.000009408036,0.00007680816,0.0022844034,0.000001647976,0.000041579846,0.000090713016],"about_ca_topic_score_codex":0.0003393977,"about_ca_topic_score_gemma":0.00044471127,"teacher_disagreement_score":0.23687463,"about_ca_system_score_codex":0.000035727284,"about_ca_system_score_gemma":0.00002688689,"threshold_uncertainty_score":0.5781577},"labels":[],"label_agreement":null},{"id":"W2309112759","doi":"10.1182/blood-2015-11-624320","title":"The role of autologous and allogeneic stem cell transplantation in the management of indolent B-cell lymphoma","year":2016,"lang":"en","type":"review","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Transplantation; Lymphoma; Rituximab; Stem cell; Hematopoietic stem cell transplantation; Oncology; Autologous stem-cell transplantation; Disease; Internal medicine; Immunology; Biology","score_opus":0.01387089511952282,"score_gpt":0.2557726020030322,"score_spread":0.24190170688350937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2309112759","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023229571,0.9726159,7.4320775e-7,0.000021138481,0.00002930662,0.0011825005,0.00004639941,0.000005344373,0.0028690938],"genre_scores_gemma":[0.062638216,0.9369545,0.000038228725,0.000009250781,0.000015269488,0.00022957961,0.000021632704,0.000014757863,0.00007859272],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99881905,0.0001331294,0.0004709046,0.00020434789,0.00021739554,0.00015517481],"domain_scores_gemma":[0.99910694,0.00021601928,0.00028758674,0.00034166357,0.000017884398,0.000029922621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021777299,0.00020558409,0.00066927116,0.00006557498,0.000031539454,0.000006916926,0.00015208096,0.00010823619,0.0000026017765],"category_scores_gemma":[5.775049e-7,0.00008599877,0.00018807553,0.00009757978,0.00005330188,0.000010523215,0.00002616742,0.00003626642,0.000006123378],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019794497,0.0016207052,0.00050928025,0.01238379,0.00036427565,0.00011995234,0.00023477427,2.7192895e-8,0.0000049709033,0.00021713314,0.000005965608,0.9845193],"study_design_scores_gemma":[0.026724894,0.0012997702,0.01666868,0.04174671,0.023019493,0.0006425409,0.0009243871,7.507948e-7,0.0064518205,0.00009621944,0.8819664,0.00045832022],"about_ca_topic_score_codex":0.000020030973,"about_ca_topic_score_gemma":0.0000058459523,"teacher_disagreement_score":0.984061,"about_ca_system_score_codex":0.000038387203,"about_ca_system_score_gemma":0.000078827245,"threshold_uncertainty_score":0.3506928},"labels":[],"label_agreement":null},{"id":"W2310849390","doi":"10.1182/blood.v122.21.425.425","title":"Elevated Transferrin Saturation, Health-Related Quality Of Life and Telomere Length","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Transferrin saturation; Medicine; Telomere; Context (archaeology); Quality of life (healthcare); Internal medicine; Hemochromatosis; Mental health; Hereditary hemochromatosis; Gerontology; Psychiatry; Anemia; Biology; Iron deficiency; Genetics; Gene","score_opus":0.02115485122272383,"score_gpt":0.2691547542294053,"score_spread":0.24799990300668148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2310849390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918273,0.0040321546,0.000018283381,0.0025231559,0.00003962062,0.0004150329,0.0000085691345,0.000043507553,0.0010923772],"genre_scores_gemma":[0.99860823,0.00029276722,0.00028843293,0.00054126594,0.000022912434,0.000010122219,0.00003056305,0.000010711274,0.00019501615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901927,0.00008297333,0.00044917263,0.00014542672,0.00015020027,0.00015298954],"domain_scores_gemma":[0.99947786,0.000034105953,0.00008159758,0.0001636257,0.000082316044,0.00016049019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020356521,0.00009155894,0.00033642456,0.000054793283,0.00003956282,0.0000064427973,0.000031809133,0.0000755882,0.00026788536],"category_scores_gemma":[0.00014841849,0.00007448818,0.000039548246,0.0001424334,0.000059548383,0.00007065577,0.000006563616,0.00010715436,0.00002089036],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007656817,0.005694228,0.636438,0.004090052,0.00065378594,0.0000067873125,0.012028094,0.000005677754,0.24966769,0.026457043,0.008686469,0.055506453],"study_design_scores_gemma":[0.0073272106,0.00016981873,0.9879508,0.000025722464,0.00006268038,0.0000063694783,0.0005610858,0.000009280584,0.0032441523,0.00030198268,0.0002338267,0.000107062115],"about_ca_topic_score_codex":0.0012876176,"about_ca_topic_score_gemma":0.000041631447,"teacher_disagreement_score":0.35151276,"about_ca_system_score_codex":0.000003183975,"about_ca_system_score_gemma":0.00011064185,"threshold_uncertainty_score":0.303754},"labels":[],"label_agreement":null},{"id":"W2312264617","doi":"10.1182/blood-2012-03-415695","title":"Mouse background and IVIG dosage are critical in establishing the role of inhibitory Fcγ receptor for the amelioration of experimental ITP","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Canadian Blood Services","funders":"Canadian Blood Services","keywords":"Inhibitory postsynaptic potential; Receptor; Immunology; Antibody; Immune system; Fc receptor; Medicine; Biology; Pharmacology; Internal medicine","score_opus":0.023448139353552725,"score_gpt":0.29205716508868385,"score_spread":0.2686090257351311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312264617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913676,0.0078718765,0.000010138125,0.00017232548,0.000047133955,0.00031614394,0.000022868126,0.0000045873026,0.00018735437],"genre_scores_gemma":[0.999566,0.000046687423,0.00018662777,0.0000417468,0.00008064129,0.000042356518,0.000010265752,0.00000870153,0.000016984077],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99954736,0.000023826748,0.00013521391,0.0000731336,0.000100447185,0.00012002318],"domain_scores_gemma":[0.99956274,0.00022537855,0.000046560217,0.00010813521,0.000025245901,0.000031918855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014548984,0.00006283372,0.00013934873,0.000025186606,0.00004254094,0.000010560868,0.000033411987,0.0000410301,0.000013550208],"category_scores_gemma":[0.00008706368,0.000036460977,0.000030562067,0.000052733427,0.00007652499,0.00013722517,0.000021382933,0.000056763438,8.548361e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044122065,0.0059881727,0.26823768,0.00015580667,0.0002011151,0.0000063837892,0.00848488,8.549827e-7,0.71090865,0.0016577172,0.00054761313,0.0033699034],"study_design_scores_gemma":[0.005021833,0.00037720756,0.022017192,0.00012589023,0.00021114346,0.000017192671,0.024345333,0.00007950985,0.94666016,0.00012174159,0.00093112513,0.00009169142],"about_ca_topic_score_codex":0.00008057454,"about_ca_topic_score_gemma":0.000021090067,"teacher_disagreement_score":0.24622048,"about_ca_system_score_codex":0.000010253745,"about_ca_system_score_gemma":0.000012399807,"threshold_uncertainty_score":0.14868355},"labels":[],"label_agreement":null},{"id":"W2312406641","doi":"10.1182/blood-2014-02-555755","title":"Jumping translocations and high-risk myeloma","year":2014,"lang":"en","type":"letter","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Multiple myeloma; Chromosomal translocation; Mechanism (biology); Disease; Biology; Genetics; Bioinformatics; Immunology; Medicine; Gene; Internal medicine","score_opus":0.02362528862622432,"score_gpt":0.27731315877534934,"score_spread":0.253687870149125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312406641","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.178378,0.0026604165,0.0005270245,0.8106541,0.00020971613,0.0017862772,0.00031679482,0.0002696923,0.0051979837],"genre_scores_gemma":[0.6008842,0.0018845166,0.006164217,0.36795822,0.008961047,0.00042658314,0.0034832468,0.00025859696,0.00997939],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998527,0.00009122086,0.00020503548,0.00041249298,0.00036635413,0.0003979166],"domain_scores_gemma":[0.99906415,0.0001695161,0.00007496327,0.0004535258,0.00007530464,0.00016252625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000099284,0.00024819665,0.00041488983,0.0001910771,0.00013552871,0.00003718981,0.00008792861,0.0004071661,0.00011518003],"category_scores_gemma":[0.00009826901,0.00020209141,0.00010463437,0.00010046237,0.000089038294,0.00003081748,0.000024028677,0.0010138481,0.00015931272],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010014162,0.000768318,0.05997892,0.001892811,0.0035068702,0.004132637,0.0002629478,3.4311347e-7,0.0004080053,0.00004911274,0.8663691,0.06253077],"study_design_scores_gemma":[0.016620563,0.0008966265,0.12067008,0.0006480514,0.003389301,0.0007793408,0.000012823415,0.00009127438,0.001782295,0.0003018293,0.8542501,0.00055775786],"about_ca_topic_score_codex":0.00034607,"about_ca_topic_score_gemma":0.000022133889,"teacher_disagreement_score":0.4426959,"about_ca_system_score_codex":0.00002230116,"about_ca_system_score_gemma":0.00009514496,"threshold_uncertainty_score":0.82410485},"labels":[],"label_agreement":null},{"id":"W2312603476","doi":"10.1182/blood-2015-09-670802","title":"Cytokine release in patients with CLL treated with obinutuzumab and possible relationship with infusion-related reactions","year":2015,"lang":"en","type":"letter","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Cilag; National Cancer Institute; H. Lundbeck A/S; Deutsche Forschungsgemeinschaft; F. Hoffmann-La Roche; Pharmacyclics; Genentech; Celgene; Gilead Sciences; Sanofi; Pfizer; Amgen","keywords":"Obinutuzumab; Chronic lymphocytic leukemia; Medicine; Cytokine; Rituximab; CD20; Immunology; Monoclonal antibody; Cytokine release syndrome; Pathophysiology; Monoclonal; Leukemia; Internal medicine; Antibody; Immunotherapy; Immune system","score_opus":0.015864260023813706,"score_gpt":0.24273088327932188,"score_spread":0.22686662325550816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312603476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836819,0.00015624022,0.0000017064845,0.009776063,0.000022707218,0.0018631619,0.00009402645,0.00015217668,0.0042520002],"genre_scores_gemma":[0.97024834,0.000041949937,0.000774629,0.008894076,0.00038393,0.00025539164,0.0041585327,0.00032317033,0.014919983],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9965631,0.00015522224,0.0005242216,0.0008115954,0.001272311,0.0006735466],"domain_scores_gemma":[0.9975397,0.00028262477,0.00029151922,0.0009609965,0.0006076414,0.00031753667],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00021752337,0.00054272014,0.0007569423,0.00070923957,0.00013125825,0.00005966652,0.0001498172,0.00084410014,0.00006916622],"category_scores_gemma":[0.00022876952,0.0003462943,0.000043210013,0.0012530114,0.0003305021,0.00019555214,0.000075117976,0.0025046114,0.000048534916],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.01119579,0.0026995207,0.80489224,0.0017640556,0.0019499131,0.01561276,0.0009006482,0.0001605174,0.0000252471,0.000024203544,0.16036807,0.00040703506],"study_design_scores_gemma":[0.53037375,0.014027333,0.37403807,0.009528469,0.0044543357,0.0049065207,0.00016297019,0.0006056952,0.00020434146,0.000100876714,0.059446566,0.0021510883],"about_ca_topic_score_codex":0.002720639,"about_ca_topic_score_gemma":0.00030789958,"teacher_disagreement_score":0.519178,"about_ca_system_score_codex":0.007613655,"about_ca_system_score_gemma":0.011031888,"threshold_uncertainty_score":0.9998989},"labels":[],"label_agreement":null},{"id":"W2313380772","doi":"10.1182/blood-2016-01-689547","title":"Plasma cell myeloma with lymphoplasmacytic morphology and cyclin D1 expression","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Multiple myeloma; White blood cell; Hemoglobin; Cyclin D1; Exertion; Internal medicine; Pathology; Gastroenterology; Cancer; Cell cycle","score_opus":0.012824190253998221,"score_gpt":0.2519222492665129,"score_spread":0.23909805901251469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313380772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99642026,0.00017044533,0.00004608884,0.00036987828,0.00003198731,0.00030877008,0.00001628669,0.00005405083,0.0025822527],"genre_scores_gemma":[0.9943077,0.00015038908,0.0023158074,0.000054688066,0.00006066158,0.000045857072,0.000009401397,0.000025617703,0.0030298599],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989438,0.000040862444,0.0001302329,0.0003174515,0.00022300093,0.0003446466],"domain_scores_gemma":[0.9991824,0.00015561735,0.000043117383,0.00027877587,0.00004179318,0.0002982683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000059700655,0.00015109079,0.00022062297,0.00008900701,0.00006457351,0.000010204044,0.000055735993,0.00008147674,0.00018308911],"category_scores_gemma":[0.000058815374,0.00007638799,0.000030806434,0.00006786587,0.00011904187,0.000058778183,0.000058645775,0.000064259664,0.00019249368],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012158395,0.00093956926,0.36491904,0.00007298346,0.00011245149,0.0018486113,0.00007867633,1.2181084e-7,0.6171042,0.000009770034,0.0003848893,0.013313902],"study_design_scores_gemma":[0.03906006,0.0012482539,0.13294362,0.00021480853,0.0001349786,0.0012228619,0.000034582947,0.000022212987,0.823967,0.000029510866,0.0009787873,0.00014334409],"about_ca_topic_score_codex":0.00002011967,"about_ca_topic_score_gemma":0.000008391215,"teacher_disagreement_score":0.23197542,"about_ca_system_score_codex":0.000034003544,"about_ca_system_score_gemma":0.00010058601,"threshold_uncertainty_score":0.31150118},"labels":[],"label_agreement":null},{"id":"W2313445985","doi":"10.1182/blood-2015-06-653006","title":"Distinct GAB2 signaling pathways are essential for myeloid and lymphoid transformation and leukemogenesis by BCR-ABL1","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Institutes of Health; National Cancer Institute; Princess Margaret Hospital Foundation","keywords":"Myeloid; Cancer research; Signal transduction; Transformation (genetics); Biology; Immunology; Cell biology; Genetics; Gene","score_opus":0.01176830110819154,"score_gpt":0.22468968606838985,"score_spread":0.2129213849601983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313445985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994834,0.0015476727,0.001958011,0.00047204865,0.000052800096,0.0006291524,0.0002727051,0.000072958865,0.00016063434],"genre_scores_gemma":[0.9983098,0.00036635023,0.0006598375,0.000070124406,0.00015957472,0.00009666183,0.000087812645,0.000034851266,0.00021497364],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989339,0.0000223934,0.00026190365,0.00032113589,0.00017668496,0.00028398604],"domain_scores_gemma":[0.9993159,0.00014466172,0.00009957361,0.00022073029,0.000054747532,0.00016436804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012671105,0.00020287486,0.00029405399,0.000056190347,0.0001313346,0.000024518185,0.00005647013,0.00010627734,0.00004040275],"category_scores_gemma":[0.00009089767,0.00014202285,0.00006760493,0.00005787492,0.00007035257,0.00013838209,0.000026236215,0.000034805886,0.0000069468783],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047976946,0.00052185514,0.039638452,0.0007018666,0.00042899596,0.000035650733,0.00084213883,3.2348285e-7,0.9018423,0.00010221916,0.00066219264,0.054744236],"study_design_scores_gemma":[0.05028615,0.00069399195,0.02053995,0.00062697654,0.001462894,0.0005391915,0.00023617983,0.00016934486,0.92116004,0.00034078068,0.0034808046,0.00046369966],"about_ca_topic_score_codex":0.000039820185,"about_ca_topic_score_gemma":0.000016028327,"teacher_disagreement_score":0.054280534,"about_ca_system_score_codex":0.00017734867,"about_ca_system_score_gemma":0.00013829154,"threshold_uncertainty_score":0.5791524},"labels":[],"label_agreement":null},{"id":"W2316655990","doi":"10.1182/blood.v112.11.1527.1527","title":"Generation of T Cells from Human Embryonic Stem Cells.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Embryonic stem cell; Biology; Haematopoiesis; Cell biology; Population; Stem cell; Stromal cell; Immunology; Molecular biology; Cancer research; Genetics; Medicine; Gene","score_opus":0.03749878979995182,"score_gpt":0.25773425170234265,"score_spread":0.22023546190239085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316655990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99778706,0.0008677914,0.00013195636,0.000014241247,0.000084000414,0.00013051282,0.000046507867,0.000008059984,0.00092987117],"genre_scores_gemma":[0.9957288,0.00032148868,0.00031141486,0.000024718416,0.00026869774,0.000008329371,0.000132793,0.000018831111,0.0031849633],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99909604,0.000063764994,0.0001783808,0.00028223227,0.00019237044,0.00018721794],"domain_scores_gemma":[0.99941295,0.000006093094,0.000071195,0.00037783693,0.00006742987,0.00006450606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007910697,0.0001037236,0.0001245282,0.000033329936,0.00008385724,0.000007366795,0.0001978174,0.000122237,0.000040015977],"category_scores_gemma":[0.000002802596,0.00010377997,0.00007761499,0.00005587472,0.00006488602,0.0000023406712,0.00009830076,0.00006686312,0.000042137093],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006958114,0.00020228562,0.00083168695,0.000011143045,0.000052423013,0.000010897343,0.000029083943,0.00003746651,0.9964223,0.0000044526205,0.002300936,0.000090371286],"study_design_scores_gemma":[0.00081398065,0.00016064779,0.00059291767,0.000004728406,0.000018840705,0.000005236736,0.00000935163,0.000039651604,0.9948589,0.0000036166164,0.0033846388,0.000107469656],"about_ca_topic_score_codex":0.00005581851,"about_ca_topic_score_gemma":0.00002835239,"teacher_disagreement_score":0.0022550921,"about_ca_system_score_codex":0.000005632172,"about_ca_system_score_gemma":0.000059194306,"threshold_uncertainty_score":0.42320243},"labels":[],"label_agreement":null},{"id":"W2317127582","doi":"10.1182/blood-2015-10-675470","title":"A slan-based nomenclature for monocytes?","year":2015,"lang":"en","type":"letter","venue":"Blood","topic":"S100 Proteins and Annexins","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"CD16; Nomenclature; Medicine; Pathology; Immunology; Leukodystrophy; Biology; Disease; Antigen; CD8","score_opus":0.019354759878720238,"score_gpt":0.24941531750706422,"score_spread":0.230060557628344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317127582","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06829241,0.029349983,0.009798862,0.82469183,0.0047695073,0.009084937,0.007440902,0.00037030425,0.046201274],"genre_scores_gemma":[0.003889854,0.000053404256,0.009489175,0.88590837,0.064461775,0.000878726,0.01281353,0.00026733128,0.022237837],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988878,0.00002534704,0.00015304926,0.00046039312,0.00013698741,0.00033642413],"domain_scores_gemma":[0.9991874,0.0000110066785,0.00010661484,0.00050150667,0.00013519319,0.000058263777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009382581,0.00027134456,0.0002274173,0.000047253703,0.000048200574,0.000036197398,0.00028576155,0.0011021039,0.000025967225],"category_scores_gemma":[0.00005845539,0.000243982,0.00021280794,0.00004211236,0.00003587205,9.606605e-7,0.000050074745,0.00036495127,0.000016792626],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026519163,0.0000651284,0.000024550918,0.00009202106,0.000099019766,0.000026602447,0.0000047751173,0.0000012418861,0.009065005,0.0000050032972,0.9903603,0.00022981354],"study_design_scores_gemma":[0.0016078156,0.0004675075,0.0000042200427,0.00002739301,0.00009657162,0.000009217018,0.0000019126558,0.000006612503,0.040145844,0.00020369518,0.9571025,0.00032675502],"about_ca_topic_score_codex":0.0000056025406,"about_ca_topic_score_gemma":0.000005545495,"teacher_disagreement_score":0.06440256,"about_ca_system_score_codex":0.000008887055,"about_ca_system_score_gemma":0.0002485668,"threshold_uncertainty_score":0.99492973},"labels":[],"label_agreement":null},{"id":"W2321489508","doi":"10.1182/blood-2015-07-661371","title":"Dicer1-mediated miRNA processing shapes the mRNA profile and function of murine platelets","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Health and Medical Research Council; American Heart Association; Canadian Institutes of Health Research; Health Canada; National Cancer Institute; National Institutes of Health; National Heart, Lung, and Blood Institute; National Institute of Child Health and Human Development; Australian Cancer Research Foundation; National Institute of General Medical Sciences; University of Utah; Canadian Blood Services; Medical Research Council","keywords":"Platelet; microRNA; Messenger RNA; In vivo; Cell biology; Integrin; Function (biology); In vitro; Biology; Molecular biology; Immunology; Gene; Receptor; Genetics","score_opus":0.006046846098263087,"score_gpt":0.2078705212019212,"score_spread":0.20182367510365812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321489508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973598,0.0019683149,0.00017776777,0.000120095196,0.000018667492,0.00012982676,0.000017830911,0.000008967834,0.000198727],"genre_scores_gemma":[0.9995235,0.00008138585,0.0000835568,0.000026084586,0.00009704852,0.000013640505,0.000028694782,0.000009936253,0.00013614367],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99957085,0.000020322135,0.000108071996,0.00014401409,0.00006723977,0.00008949918],"domain_scores_gemma":[0.99972385,0.000009645793,0.00008183511,0.00010317983,0.00005254081,0.000028921724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006757533,0.00006712212,0.000057630863,0.000015617243,0.00004033734,0.000007367388,0.000055029202,0.000058345646,0.00002779688],"category_scores_gemma":[0.00004721263,0.000038189035,0.00002171558,0.00003916215,0.0000643205,0.000004118043,0.00004195287,0.00001867779,0.0000035631053],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047984806,0.00005837256,0.0027878825,0.000034043347,0.000032466476,5.192585e-7,0.000012333173,4.1030353e-7,0.9852576,0.000005959993,0.00012602904,0.011636362],"study_design_scores_gemma":[0.0011996166,0.00011848445,0.10797395,0.00004899061,0.000059564594,0.000011498845,0.000011965365,0.00002663438,0.88625526,0.00004494414,0.004162493,0.00008661546],"about_ca_topic_score_codex":0.000002327226,"about_ca_topic_score_gemma":0.0000036665451,"teacher_disagreement_score":0.10518607,"about_ca_system_score_codex":0.0000023330383,"about_ca_system_score_gemma":0.000030145357,"threshold_uncertainty_score":0.15573037},"labels":[],"label_agreement":null},{"id":"W2324579537","doi":"10.1182/blood-2015-07-658203","title":"The ubiquitin ligase HERC4 mediates c-Maf ubiquitination and delays the growth of multiple myeloma xenografts in nude mice","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; SickKids Foundation; Princess Margaret Cancer Centre; Hospital for Sick Children; University of Toronto","funders":"National Key Research and Development Program of China; Priority Academic Program Development of Jiangsu Higher Education Institutions; Government of Jiangsu Province; Natural Science Foundation of Jiangsu Province; National Natural Science Foundation of China","keywords":"Ubiquitin ligase; Ubiquitin; Multiple myeloma; Cancer research; Biology; Nude mouse; Molecular biology; Immunology; Genetics; Cell culture","score_opus":0.005475935038636026,"score_gpt":0.20847406037022598,"score_spread":0.20299812533158995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324579537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99671686,0.001181189,0.000067869994,0.0015332679,0.00005576636,0.0001910309,0.00001659237,0.000006531475,0.0002309181],"genre_scores_gemma":[0.9989198,0.00053402275,0.000114275324,0.00012322313,0.00013218881,0.000039180995,0.000013739041,0.000009799852,0.00011378354],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99931955,0.00008884261,0.00018990104,0.00015735207,0.000098366625,0.00014599352],"domain_scores_gemma":[0.99951947,0.0001109081,0.00009066053,0.00016993347,0.00007487062,0.000034144767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003208504,0.000086567474,0.0000711903,0.000024163619,0.0000793697,0.000015849859,0.00015356453,0.000077188284,0.0000033295667],"category_scores_gemma":[0.0005247044,0.000044494507,0.00003377474,0.000069700465,0.00013332682,0.000006350655,0.00007995905,0.00004414256,0.000002475081],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000306257,0.00006278084,0.013919444,0.00001030485,0.00001984579,8.3846976e-7,0.00009711908,1.2216621e-7,0.9807124,0.00035344705,0.00039065472,0.0044024065],"study_design_scores_gemma":[0.0010826745,0.0001065461,0.012367368,0.00002664501,0.000010076282,0.000005357926,0.00009776532,0.0000077227505,0.9836032,0.00019114287,0.0024274585,0.00007403643],"about_ca_topic_score_codex":0.000026748441,"about_ca_topic_score_gemma":0.00024282122,"teacher_disagreement_score":0.00432837,"about_ca_system_score_codex":0.0000040609484,"about_ca_system_score_gemma":0.00002728344,"threshold_uncertainty_score":0.18144333},"labels":[],"label_agreement":null},{"id":"W2325939231","doi":"10.1182/blood-2016-03-705053","title":"Chemo-genomic interrogation of CEBPA mutated AML reveals recurrent CSF3R mutations and subgroup sensitivity to JAK inhibitors","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; Institute for Research in Immunology and Cancer; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Deutsche Krebshilfe; Université de Montréal; Government of Canada; Génome Québec; Compute Canada; Canadian Cancer Society Research Institute; Genome Canada","keywords":"CEBPA; Cancer research; Gene; Biology; Mutation; Genetics; Medicine","score_opus":0.016148082189855677,"score_gpt":0.28136002797993775,"score_spread":0.26521194579008206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325939231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962912,0.00006206309,0.00028647832,0.0021818837,0.000074289,0.0006685039,0.000057223082,0.000045294797,0.0003330189],"genre_scores_gemma":[0.99821836,0.00003095865,0.0010902736,0.00009037939,0.00012743978,0.000029542667,0.000039216324,0.000024444524,0.00034936325],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99876803,0.0001153614,0.0003318681,0.00029909957,0.00023244739,0.0002531828],"domain_scores_gemma":[0.99897105,0.00023006246,0.00010236081,0.00026226882,0.0002190434,0.00021522994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048809568,0.00013443096,0.00028506122,0.000217998,0.000044144927,0.0000095030055,0.000049332968,0.00008683619,0.000043598404],"category_scores_gemma":[0.00046960026,0.000100785735,0.000056951,0.00026319065,0.00012066757,0.0000814156,0.00010429034,0.000136454,0.000067066736],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022216384,0.0002316192,0.0105553325,0.0000820191,0.00008889485,0.00004381259,0.0009712338,4.5756826e-7,0.9782412,0.000041787767,0.00050303567,0.009018442],"study_design_scores_gemma":[0.008766654,0.0007293932,0.16739134,0.0005457537,0.00022013561,0.0002372113,0.000526968,0.00006532443,0.82087064,0.00012101512,0.00032028486,0.00020528297],"about_ca_topic_score_codex":0.00008543065,"about_ca_topic_score_gemma":0.00006308794,"teacher_disagreement_score":0.15737057,"about_ca_system_score_codex":0.00022216637,"about_ca_system_score_gemma":0.00017842426,"threshold_uncertainty_score":0.4109923},"labels":[],"label_agreement":null},{"id":"W2327048936","doi":"10.1182/blood.v122.21.4369.4369","title":"Outcomes In Splenic Marginal Zone Lymphoma: Analysis Of 108 Patients Treated In British Columbia (BC)","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Splenic marginal zone lymphoma; Splenectomy; Rituximab; Chemotherapy; Internal medicine; Lymphoma; Regimen; Gastroenterology; Aggressive lymphoma; Chemotherapy regimen; Surgery; Spleen","score_opus":0.006550659157891226,"score_gpt":0.21613586765784593,"score_spread":0.2095852084999547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327048936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987621,0.00017428023,1.3958763e-7,0.00006023285,0.00002141206,0.00050048967,0.000055717337,0.000017259117,0.0004084112],"genre_scores_gemma":[0.9988032,0.000069422895,0.000100817844,0.00006327753,0.0000085913825,0.00015458305,0.00017970795,0.00001319769,0.0006071747],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875283,0.000039842664,0.00044194277,0.00027049115,0.00024019316,0.00025469856],"domain_scores_gemma":[0.9994083,0.000064489854,0.00009983552,0.0002514162,0.00008302429,0.00009294462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000556265,0.00011200973,0.0007116331,0.00025441783,0.000018111334,0.00003777138,0.00006501962,0.00008352463,0.000799436],"category_scores_gemma":[0.00004432642,0.00013566633,0.00018595839,0.0008645894,0.000035464338,0.00007038088,0.00003155555,0.000031786967,0.000033220098],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012171756,0.011456564,0.9786281,0.000022522783,0.0010023299,0.00016630076,0.000059575133,0.0000011811304,0.00001638006,8.0697646e-7,0.00023081622,0.0084032575],"study_design_scores_gemma":[0.021106359,0.00029018466,0.97654164,0.00008766323,0.0015897114,0.0000063993316,0.00003710737,0.000051168372,0.00014351332,0.000005045834,0.00003289721,0.00010831374],"about_ca_topic_score_codex":0.30367213,"about_ca_topic_score_gemma":0.1869124,"teacher_disagreement_score":0.11675975,"about_ca_system_score_codex":0.00014429247,"about_ca_system_score_gemma":0.000042970903,"threshold_uncertainty_score":0.87532634},"labels":[],"label_agreement":null},{"id":"W2328147613","doi":"10.1182/blood-2010-09-307900","title":"The “age” of understanding VKA dose","year":2010,"lang":"en","type":"letter","venue":"Blood","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Vitamin k; Intensive care medicine; Internal medicine","score_opus":0.1791364927972956,"score_gpt":0.413488375052902,"score_spread":0.23435188225560638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328147613","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.058411244,0.024032157,0.0001805675,0.7928143,0.029198699,0.002258806,0.0011439795,0.00032015546,0.09164009],"genre_scores_gemma":[0.09740222,0.007766241,0.00026282744,0.8681561,0.016426757,0.00014105762,0.00036329468,0.00024071493,0.00924083],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974959,0.00049809966,0.00055322144,0.00038896248,0.00034416307,0.00071963866],"domain_scores_gemma":[0.99781823,0.0010757684,0.00037632586,0.0005236376,0.00008897363,0.00011704784],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00088242884,0.00040484365,0.0004907746,0.0001299665,0.00047480437,0.000049333135,0.0009356851,0.0024875153,0.00056409015],"category_scores_gemma":[0.000088525405,0.00030107528,0.00029219373,0.00018145726,0.0006150084,0.000033359152,0.00020389375,0.008519609,0.00009298449],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006428545,0.00028803735,0.00028177665,0.00014555473,0.0010391533,0.0006090566,0.00027681293,0.000006413244,0.07012699,0.0013129383,0.92360115,0.0022478278],"study_design_scores_gemma":[0.002097346,0.000035167577,0.00006395105,0.000013341345,0.0011877865,0.000040257262,0.00002377004,0.000018636498,0.027239975,0.0036746077,0.9652815,0.00032367045],"about_ca_topic_score_codex":0.000011598516,"about_ca_topic_score_gemma":0.00001397938,"teacher_disagreement_score":0.082399264,"about_ca_system_score_codex":0.000026421605,"about_ca_system_score_gemma":0.00017221872,"threshold_uncertainty_score":0.99994415},"labels":[],"label_agreement":null},{"id":"W2329970613","doi":"10.1182/blood-2015-12-688838","title":"Cardiolipin-mediated procoagulant activity of mitochondria contributes to traumatic brain injury–associated coagulopathy in mice","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Traumatic Brain Injury and Neurovascular Disturbances","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"National Institute of Neurological Disorders and Stroke; National Heart, Lung, and Blood Institute; National Institutes of Health; National Natural Science Foundation of China","keywords":"Coagulopathy; Traumatic brain injury; Cardiolipin; Mitochondrion; Medicine; Internal medicine; Biology; Biochemistry; Psychiatry","score_opus":0.018820314792699695,"score_gpt":0.2663640073351832,"score_spread":0.24754369254248348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329970613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99508566,0.00023735422,0.00018939059,0.0023010971,0.00017035396,0.001407028,0.00016716143,0.00008761794,0.00035436597],"genre_scores_gemma":[0.99897295,0.000027270173,0.0001404358,0.00040726387,0.000051606075,0.0001580493,0.000013937413,0.000029322731,0.0001991713],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980016,0.00025893596,0.000548435,0.00040984803,0.00036689962,0.0004143146],"domain_scores_gemma":[0.99835724,0.000763546,0.00019406837,0.0003895497,0.00013297256,0.00016261941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056068494,0.0002451114,0.0009040146,0.00023889274,0.000037418362,0.000010757932,0.00017525074,0.00016264233,0.000023608245],"category_scores_gemma":[0.002918329,0.00017077527,0.00021000982,0.000622614,0.000106700085,0.00009354504,0.000043565004,0.0001618345,0.000041703464],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007290921,0.0021289198,0.05237331,0.00032757685,0.0005924089,0.00004935626,0.000703614,6.7211886e-7,0.93656725,0.00009733368,0.0016908434,0.0047396277],"study_design_scores_gemma":[0.010797724,0.00080386264,0.5950337,0.0015597106,0.0003154075,0.000025221394,0.00007677087,0.0000089232835,0.3902545,0.00014178909,0.0007207862,0.00026160295],"about_ca_topic_score_codex":0.000057665184,"about_ca_topic_score_gemma":0.00014641446,"teacher_disagreement_score":0.54631275,"about_ca_system_score_codex":0.00006879197,"about_ca_system_score_gemma":0.0001390101,"threshold_uncertainty_score":0.6964013},"labels":[],"label_agreement":null},{"id":"W2331195506","doi":"10.1182/blood-2010-09-305375","title":"Stage C or not stage C…?","year":2010,"lang":"en","type":"letter","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Stage (stratigraphy); Medicine; Geology; Paleontology","score_opus":0.04431605335968141,"score_gpt":0.3235188632264209,"score_spread":0.2792028098667395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331195506","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17909293,0.00064044364,0.000029416076,0.758691,0.0020931214,0.004040683,0.0013840547,0.0008504678,0.05317789],"genre_scores_gemma":[0.0012765242,0.00010443341,0.0007029073,0.45950758,0.0086763585,0.00009313626,0.0005255518,0.0002088143,0.5289047],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99618423,0.00007508737,0.0004554902,0.000781439,0.0014839644,0.0010197783],"domain_scores_gemma":[0.9972156,0.0004007982,0.00016383681,0.0017917582,0.00017627027,0.0002516888],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.000329881,0.0004746171,0.00081615295,0.00020449278,0.00008164716,0.00007936327,0.00052552245,0.0028041487,0.008225099],"category_scores_gemma":[0.0005442179,0.00034443074,0.00025870575,0.00023569696,0.00023816884,0.0000570325,0.00027501208,0.007742097,0.0015655877],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027755162,0.00031637042,0.000023764975,0.0021033545,0.00038211024,0.039084993,0.00008182103,1.0158074e-7,0.0017044116,0.0000111742,0.95550066,0.0005137053],"study_design_scores_gemma":[0.030005962,0.00028773167,0.000037103484,0.00020540718,0.00036566608,0.0008783324,0.000014090906,0.000041230935,0.010024421,0.0000030748142,0.9577636,0.00037339734],"about_ca_topic_score_codex":0.0006805174,"about_ca_topic_score_gemma":0.00010088596,"teacher_disagreement_score":0.4757268,"about_ca_system_score_codex":0.002710089,"about_ca_system_score_gemma":0.016500872,"threshold_uncertainty_score":0.99990076},"labels":[],"label_agreement":null},{"id":"W2332247966","doi":"10.1182/blood-2016-01-692053","title":"Less menorrhagia for women with VTE","year":2016,"lang":"en","type":"letter","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Obstetrics","score_opus":0.016154588201487574,"score_gpt":0.23784642717713086,"score_spread":0.2216918389756433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332247966","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024365248,0.0004092127,0.00029573796,0.9317267,0.0004808163,0.0031847758,0.00020273656,0.00021597906,0.039118826],"genre_scores_gemma":[0.005257177,0.00024683593,0.0010792846,0.91698545,0.011361503,0.0024942288,0.00023978834,0.00024215932,0.062093552],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99827987,0.000018115348,0.00021977678,0.00047863246,0.00032743881,0.00067613967],"domain_scores_gemma":[0.9990015,0.00007235466,0.00014064947,0.0005875466,0.000099390585,0.000098553726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001384546,0.00032458446,0.00080214534,0.00012804514,0.00006701729,0.0000321059,0.00017556695,0.0003341051,0.0002533194],"category_scores_gemma":[0.000013920541,0.00020187939,0.00009628643,0.00006187751,0.000054868407,0.000035206107,0.00005710478,0.0003469467,0.00008195988],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050571547,0.00031488328,0.0001033399,0.0011516277,0.0012207458,0.0003965554,0.00015201888,5.087357e-8,0.00006232528,0.00007232642,0.99080485,0.0056707226],"study_design_scores_gemma":[0.0047008004,0.0012541886,0.00065028726,0.0004793863,0.0012405096,0.000038681057,0.00007543562,2.3882913e-7,0.00028072292,0.00020353579,0.99076205,0.00031417375],"about_ca_topic_score_codex":0.00001534709,"about_ca_topic_score_gemma":0.0000049640157,"teacher_disagreement_score":0.022974728,"about_ca_system_score_codex":0.000086637854,"about_ca_system_score_gemma":0.00010920724,"threshold_uncertainty_score":0.8232403},"labels":[],"label_agreement":null},{"id":"W2333009892","doi":"10.1182/blood-2015-04-639088","title":"UV-inactivated HSV-1 potently activates NK cell killing of leukemic cells","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency; Terry Fox Foundation","keywords":"Peripheral blood mononuclear cell; Receptor; Virology; Immunology; Biology; Cancer research; In vitro","score_opus":0.007269975257167946,"score_gpt":0.19329532032456823,"score_spread":0.1860253450674003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333009892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909968,0.0006567847,0.00041769067,0.00007539224,0.0020355356,0.00012950868,0.000007468808,0.000089162706,0.0055916826],"genre_scores_gemma":[0.969753,0.00033457528,0.00004102222,0.000057935435,0.000034745986,0.0000073206606,0.000023423898,0.000021216147,0.02972675],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990432,0.000102271995,0.00030546245,0.00024090431,0.00003248001,0.00027565117],"domain_scores_gemma":[0.9992497,0.00015925082,0.00021597992,0.00025903364,0.000098555436,0.000017474502],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0000978994,0.00016301087,0.00022812813,0.000122000354,0.00009219341,0.000006431714,0.0001483902,0.0002180472,0.001938756],"category_scores_gemma":[0.00003319553,0.00011451486,0.00011847424,0.00010278144,0.00008527365,0.0001637028,0.000045711622,0.00018439602,0.0012153896],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017416554,0.00039637942,0.0005273276,0.00001929827,0.0001480385,0.0000013875836,0.0000965837,0.0000013021712,0.99452865,0.000029917053,0.0028666025,0.0012103263],"study_design_scores_gemma":[0.0026966298,0.00021947615,0.0005508138,0.000082221035,0.00007461738,0.000024037334,0.00016966884,8.0659805e-7,0.976839,0.00002210245,0.019168215,0.0001523913],"about_ca_topic_score_codex":0.00006962773,"about_ca_topic_score_gemma":8.520657e-7,"teacher_disagreement_score":0.024135066,"about_ca_system_score_codex":0.000042020547,"about_ca_system_score_gemma":0.00004169471,"threshold_uncertainty_score":0.99956226},"labels":[],"label_agreement":null},{"id":"W2333120186","doi":"10.1182/blood.v122.21.3342.3342","title":"Low CD34 Cell Dose Is Associated With Higher Non-Relapse and Overall Mortality After Reduced Intensity Conditioning Hematopoietic Cell Transplantation For Acute Myeloid Leukemia and Myelodysplastic Syndrome","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Transplantation; Fludarabine; Internal medicine; Hematopoietic stem cell transplantation; Myeloid; Gastroenterology; Myeloid leukemia; CD34; Oncology; Leukemia; Immunology; Stem cell; Chemotherapy; Cyclophosphamide; Biology","score_opus":0.008481522584461977,"score_gpt":0.22816923268800632,"score_spread":0.21968771010354435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333120186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99694705,0.00007837146,0.0006755847,0.00012162784,0.00009909125,0.0015279278,0.0001685472,0.00008299201,0.0002988167],"genre_scores_gemma":[0.9970961,0.000114773735,0.0010190348,0.00038095613,0.000031519754,0.0002871523,0.00038802664,0.00006168026,0.00062074885],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99824804,0.00004068067,0.00044098173,0.00054783217,0.00032227178,0.0004001892],"domain_scores_gemma":[0.9988821,0.00021295063,0.00018672073,0.0002405469,0.00021373508,0.00026391345],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015241811,0.0003508154,0.00059423194,0.0001092725,0.00012777404,0.00007760532,0.000055523404,0.0002455327,0.00015903532],"category_scores_gemma":[0.000011095084,0.00030699326,0.00007747037,0.00013037366,0.0001320318,0.00026424692,0.000013438127,0.00023078971,0.000022156075],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00315189,0.0023822384,0.21365525,0.013478094,0.0027411908,0.0032855074,0.015929515,0.000024542154,0.7444449,0.000050097307,0.0007638892,0.0000928998],"study_design_scores_gemma":[0.013315968,0.0007076177,0.8529809,0.0010757672,0.004079359,0.0010678025,0.000111242145,0.00024397412,0.12585217,0.00014764292,0.0000021593917,0.0004153773],"about_ca_topic_score_codex":0.00007330332,"about_ca_topic_score_gemma":0.000010035608,"teacher_disagreement_score":0.6393257,"about_ca_system_score_codex":0.00007169585,"about_ca_system_score_gemma":0.00010817845,"threshold_uncertainty_score":0.9999382},"labels":[],"label_agreement":null},{"id":"W2336221715","doi":"10.1182/blood.v122.21.2964.2964","title":"Medical Complications In Patients With Myelofibrosis By Frequency Of Blood Transfusion and Iron Chelation Therapy","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Myelofibrosis; Incidence (geometry); Blood transfusion; Anemia; Myeloproliferative neoplasm; Internal medicine; Bone marrow","score_opus":0.006211802182032017,"score_gpt":0.21705327089185594,"score_spread":0.21084146870982393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2336221715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969257,0.00047068286,0.000017840484,0.0011714881,0.0000067289416,0.0008803179,0.000018511153,0.000013137091,0.0004955951],"genre_scores_gemma":[0.99817854,0.0005596892,0.0007888755,0.00012805103,0.000009748253,0.0001877714,0.00012406678,0.000011609313,0.000011624206],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99916476,0.000030119121,0.00021999709,0.00019200082,0.00028220456,0.00011092968],"domain_scores_gemma":[0.999552,0.00005634003,0.00005673954,0.0001385668,0.0000915807,0.000104734165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000046182875,0.00011097429,0.00020530581,0.00005628676,0.000036635054,0.000006484669,0.000032305186,0.0000794191,0.000266774],"category_scores_gemma":[0.00001717886,0.000074876916,0.000022448832,0.000115813404,0.00005806315,0.000068747904,0.000006261321,0.00007793879,0.000005318055],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027903643,0.004138034,0.98445237,0.000024231225,0.00006985554,8.386393e-7,0.00023064365,1.0271112e-7,0.005018658,0.00009996805,0.000037293663,0.005900119],"study_design_scores_gemma":[0.011829333,0.001104382,0.9724967,0.00013974604,0.00010156984,0.000003427925,0.000014121674,0.000008816232,0.014169316,0.00004952078,0.000013657774,0.00006944937],"about_ca_topic_score_codex":0.00035075773,"about_ca_topic_score_gemma":0.00004405077,"teacher_disagreement_score":0.0119556915,"about_ca_system_score_codex":0.000008753124,"about_ca_system_score_gemma":0.000032194534,"threshold_uncertainty_score":0.30533922},"labels":[],"label_agreement":null},{"id":"W2336316221","doi":"10.1182/blood.v122.21.3289.3289","title":"The Risk Of BK Virus Haemorrhagic Cystitis After Allogeneic Hematopoietic Stem Cell Transplantation Is Increased With Myeloablative Conditioning, CMV Viremia and Acute Gvhd","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Hemorrhagic cystitis; BK virus; Medicine; Hematopoietic stem cell transplantation; Internal medicine; Cumulative incidence; Transplantation; Gastroenterology; Graft-versus-host disease; Busulfan; Urinalysis; Viremia; Surgery; Immunology; Kidney transplantation; Urinary system; Virus","score_opus":0.0035120038450238778,"score_gpt":0.19734498711350726,"score_spread":0.1938329832684834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2336316221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993595,0.0042274264,0.000060858412,0.00007705523,0.000025770325,0.0005218533,0.0003372034,0.00003182194,0.0011230232],"genre_scores_gemma":[0.99704605,0.0020881218,0.00014692779,0.00016914816,0.000024159692,0.000096459386,0.000043555705,0.000022497205,0.00036305308],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99907047,0.000072556,0.00023652677,0.00021131453,0.0002101105,0.00019902628],"domain_scores_gemma":[0.9992669,0.00011708168,0.00016316038,0.00020419313,0.00008641214,0.00016222971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006260961,0.00017077039,0.00024050073,0.00005232887,0.00014781178,0.000027053029,0.00005441541,0.00009940164,0.00028130165],"category_scores_gemma":[0.0000044647277,0.00010040606,0.00006951021,0.000108152926,0.00025524406,0.00009227391,0.000011626222,0.0001414329,0.000039912808],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003919567,0.0030151713,0.7734923,0.001926386,0.0076319105,0.0026631404,0.016376352,0.000029185738,0.18095188,0.00021512026,0.0016415948,0.00813742],"study_design_scores_gemma":[0.008154632,0.00077265565,0.7152809,0.00031925787,0.007569035,0.000579946,0.00061056035,0.00010806566,0.2659949,0.00022752077,0.00008221562,0.00030034877],"about_ca_topic_score_codex":0.00056215544,"about_ca_topic_score_gemma":0.000033344357,"teacher_disagreement_score":0.08504301,"about_ca_system_score_codex":0.00001121216,"about_ca_system_score_gemma":0.00007653134,"threshold_uncertainty_score":0.40944403},"labels":[],"label_agreement":null},{"id":"W2336892034","doi":"10.1182/blood-2016-02-697144","title":"End of the road for heparin thromboprophylaxis","year":2016,"lang":"en","type":"letter","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Heparin; Low molecular weight heparin; Medicine; Anticoagulant; Intensive care medicine; Surgery; Anesthesia; Pharmacology","score_opus":0.016597865956522014,"score_gpt":0.25141362619411284,"score_spread":0.23481576023759082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2336892034","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025593774,0.0010098878,0.000050638384,0.9375512,0.0015731237,0.0040848674,0.0003432441,0.000077798715,0.029715449],"genre_scores_gemma":[0.115285605,0.0006454366,0.0007557842,0.84178305,0.014646238,0.00086974836,0.00018785082,0.00024790395,0.02557837],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985248,0.00003152037,0.00033330172,0.00035280877,0.0003968586,0.00036073875],"domain_scores_gemma":[0.9986449,0.00007759369,0.00024116146,0.00089839584,0.00010281389,0.00003512255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013923933,0.0002476389,0.00076551345,0.00007776524,0.0000626651,0.000011297673,0.00030857883,0.00036655282,0.00029297575],"category_scores_gemma":[0.00006489462,0.0001333945,0.0004460827,0.00008214667,0.00013046633,0.000020468491,0.00014882538,0.0003417315,0.00003461546],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007667845,0.00037925597,0.0003616648,0.0010243268,0.0007459505,0.000023706089,0.000051181138,3.549193e-8,0.00075859897,0.0002162535,0.99002683,0.006404514],"study_design_scores_gemma":[0.001967329,0.00042711306,0.013523495,0.0005292719,0.0014426478,0.000011701692,0.000005511149,4.034833e-7,0.00693377,0.00047473825,0.9745078,0.00017621054],"about_ca_topic_score_codex":0.00011749447,"about_ca_topic_score_gemma":0.000011786728,"teacher_disagreement_score":0.09576815,"about_ca_system_score_codex":0.000030516218,"about_ca_system_score_gemma":0.0001081505,"threshold_uncertainty_score":0.543967},"labels":[],"label_agreement":null},{"id":"W2337225648","doi":"10.1182/blood.v122.21.5035.5035","title":"A Phase II Study Of Aprepitant As Anti-Emetic Prophylaxis In Patients Receiving Induction Chemotherapy For AML","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Nausea and vomiting management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Aprepitant; Medicine; Nausea; Retching; Vomiting; Antiemetic; Ondansetron; Granisetron; Chemotherapy-induced nausea and vomiting; Chemotherapy; Regimen; Cytarabine; Anesthesia; Interim analysis; Internal medicine; Clinical trial","score_opus":0.017349149670851414,"score_gpt":0.2876092231382363,"score_spread":0.27026007346738484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337225648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964363,0.0000146321545,0.000010400774,0.00013058544,0.00007073865,0.0031220855,9.896163e-7,0.000023880033,0.00019041808],"genre_scores_gemma":[0.99923855,0.0000050913645,0.0002858113,0.00005188993,0.000052411207,0.00018997595,0.0000054087404,0.000017636317,0.00015324602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99915993,0.00002652993,0.00027927652,0.00020266193,0.00018015993,0.00015145875],"domain_scores_gemma":[0.99951446,0.000016861033,0.00010951809,0.00021290353,0.00010750782,0.000038722697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001749261,0.00009142245,0.00022561576,0.00015294965,0.000039617586,0.000008135922,0.000052710217,0.00003783136,0.000038617454],"category_scores_gemma":[0.00012735502,0.00007677858,0.0000364581,0.00019282966,0.000012931781,0.00006180891,0.00002852357,0.00007036683,0.000005387411],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007484744,0.15935735,0.5484794,0.0006633143,0.0005723805,0.000009338055,0.011275173,0.0000035183175,0.060149696,0.000029425666,0.0005412903,0.21817066],"study_design_scores_gemma":[0.12206817,0.07469699,0.7605352,0.00028352812,0.00029951654,0.0000024052408,0.0024365657,0.00008256835,0.038905095,0.00020766251,0.00023232223,0.00025003086],"about_ca_topic_score_codex":0.00012905309,"about_ca_topic_score_gemma":0.0000062524596,"teacher_disagreement_score":0.21792062,"about_ca_system_score_codex":0.000021004722,"about_ca_system_score_gemma":0.00001540078,"threshold_uncertainty_score":0.313094},"labels":[],"label_agreement":null},{"id":"W2337353790","doi":"10.1182/blood.v124.21.2489.2489","title":"Circulating Angiogenic Factors As Biomarkers of Acute Gvhd Onset and Response to Therapy: Repair and Regeneration Versus Endothelial Damage and Inflammation","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Medicine; Vascular endothelial growth factor; Internal medicine; Angiogenesis; Transplantation; Inflammation; Placental growth factor; Hematopoietic stem cell transplantation; Immunology; Gastroenterology","score_opus":0.016398308901952284,"score_gpt":0.26412557659096386,"score_spread":0.24772726768901157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337353790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99891907,0.00008759799,0.0001491334,0.00020469024,0.000048500744,0.00038460034,0.000022510138,0.000043420496,0.00014045624],"genre_scores_gemma":[0.9980944,0.00007874356,0.0016798343,0.00003204994,0.00003321105,0.000008406732,0.00003786058,0.000014963707,0.000020547275],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99919045,0.0001408003,0.00021620769,0.00020050087,0.00014964664,0.00010242316],"domain_scores_gemma":[0.99932855,0.0003081081,0.00007426264,0.00015176667,0.00004180299,0.00009553386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042839313,0.00010718427,0.00017093853,0.00013049398,0.0000572629,0.000015191881,0.000018469584,0.00007306464,0.0000104753035],"category_scores_gemma":[0.00016817787,0.000096541735,0.00003303976,0.00009671245,0.000043856326,0.00006526304,0.000010743945,0.000036507237,0.0000010971498],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025553214,0.00003126479,0.063784815,0.00009604841,0.00031948337,0.000014863799,0.0034456316,0.000001186154,0.92753744,0.000047742913,0.000006735956,0.0021594877],"study_design_scores_gemma":[0.008153684,0.0010017226,0.4527318,0.00008391021,0.0004603826,0.00012272653,0.00028574787,0.00029635918,0.5366301,0.000028173707,0.00007258826,0.00013279171],"about_ca_topic_score_codex":0.000037440932,"about_ca_topic_score_gemma":0.000009339923,"teacher_disagreement_score":0.39090732,"about_ca_system_score_codex":0.000010504196,"about_ca_system_score_gemma":0.000034160985,"threshold_uncertainty_score":0.39368576},"labels":[],"label_agreement":null},{"id":"W2337430961","doi":"10.1182/blood.v124.21.588.588","title":"Assessment of Risk of Thromboprophylaxis Failure in Hospitalized Patients with Cancer (Artic Study)","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Pulmonary embolism; Cancer; Low molecular weight heparin; Retrospective cohort study; Incidence (geometry); Deep vein; Thrombosis; Surgery; Internal medicine","score_opus":0.004821269770422754,"score_gpt":0.2527640243656946,"score_spread":0.24794275459527187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337430961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99821323,0.000033621785,0.000026000753,0.00003899706,0.00004462048,0.0010073002,0.00001613259,0.000011977091,0.00060810754],"genre_scores_gemma":[0.99894387,0.00004375758,0.0008373661,0.000025249401,0.000020282712,0.00009720951,0.000007640763,0.000017762877,0.000006880982],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885774,0.00006877668,0.00031599365,0.00021137216,0.00038385604,0.00016227907],"domain_scores_gemma":[0.999229,0.00003435977,0.00021301287,0.0003436557,0.00013021723,0.000049747723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019980776,0.00012263333,0.0005918416,0.00010951279,0.000018718174,0.000004270192,0.00007835685,0.000032468102,0.000099305566],"category_scores_gemma":[0.000046714013,0.00008654729,0.000050861938,0.00023196478,0.000044250868,0.0000380077,0.000046681034,0.00008849577,0.0000014933435],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002399134,0.01251133,0.9852861,0.00015743414,0.00038377394,0.000002325485,0.00059584976,0.000033584874,0.00013354901,0.00010339511,0.000041194027,0.00072745496],"study_design_scores_gemma":[0.010605835,0.0033530432,0.98416775,0.0001813284,0.0007774934,8.536025e-8,0.00024167942,0.000019802408,0.00049882417,0.000030756968,0.000033593547,0.00008977855],"about_ca_topic_score_codex":0.0012814187,"about_ca_topic_score_gemma":0.00076593616,"teacher_disagreement_score":0.010581844,"about_ca_system_score_codex":0.00002349981,"about_ca_system_score_gemma":0.000042617423,"threshold_uncertainty_score":0.35292962},"labels":[],"label_agreement":null},{"id":"W2337486654","doi":"10.1182/blood.v122.21.5581.5581","title":"Long Term Treatment and Prevention Of Recurrent VTE In Cancer Patients: Results Of The Canadian Proact Survey","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; St. Joseph's Hospital; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Venous thromboembolism; Family medicine; Cancer; Medical prescription; Thrombosis; Intensive care medicine; Internal medicine; Nursing","score_opus":0.028837782399939945,"score_gpt":0.28276804030968744,"score_spread":0.2539302579097475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337486654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976129,0.0002806606,9.190225e-8,0.00021330407,0.000063862215,0.001232603,0.00005338958,0.000002144253,0.0005410305],"genre_scores_gemma":[0.9992972,0.0003864766,0.000012682609,0.000021725498,0.000011308909,0.00010597187,0.000035788704,0.0000057597877,0.00012308803],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993783,0.000057831156,0.00022426635,0.00012170678,0.00009781445,0.00012003187],"domain_scores_gemma":[0.9995773,0.000018456922,0.00010795692,0.0001644093,0.00007254427,0.000059335343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012839015,0.000066799235,0.00020131844,0.00006531452,0.00002216531,0.0000052239147,0.00003922189,0.000029692585,0.000021267546],"category_scores_gemma":[0.00005127077,0.000043698976,0.000031891115,0.000098774195,0.000027602951,0.000029963845,0.000019833678,0.000032466254,8.6842397e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018972674,0.0019363543,0.9613471,0.000081298684,0.00009973218,4.971792e-7,0.0004620277,9.952801e-7,0.000039142873,0.0000076088468,0.00022707345,0.03577922],"study_design_scores_gemma":[0.0032747914,0.00058325054,0.9940074,0.0002926579,0.00012847742,2.1427962e-7,0.000013071008,0.000002508713,0.0015822849,0.000010299212,0.000066513254,0.000038545677],"about_ca_topic_score_codex":0.4676634,"about_ca_topic_score_gemma":0.7781265,"teacher_disagreement_score":0.31046307,"about_ca_system_score_codex":0.00009525888,"about_ca_system_score_gemma":0.00012605461,"threshold_uncertainty_score":0.53588146},"labels":[],"label_agreement":null},{"id":"W2337697218","doi":"10.1182/blood.v122.21.3537.3537","title":"Megakaryocyte Abnormalities Occur In The Absence Of Cell-Mediated Immunity In a Murine Model Of Passive Immune Thrombocytopenia (ITP)","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Megakaryocyte; Platelet; Bone marrow; Antibody; Immunology; Spleen; Immune system; Immune thrombocytopenia; Medicine; Biology; Haematopoiesis; Stem cell","score_opus":0.015280007224459824,"score_gpt":0.23587688095308765,"score_spread":0.22059687372862782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337697218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953826,0.0007221758,0.0000031018765,0.00013621691,0.000013903724,0.00059654616,0.0000376929,0.000008803684,0.0030989235],"genre_scores_gemma":[0.9990822,0.00038128582,0.0002291434,0.00007201607,0.0000045990637,0.00006866642,0.000049072147,0.000010568574,0.000102450875],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99891216,0.00006985393,0.00044419753,0.00013094385,0.00021604315,0.0002268002],"domain_scores_gemma":[0.99922943,0.00013182033,0.00016042586,0.0003674482,0.000077122655,0.000033766803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015743307,0.00014745485,0.0005345765,0.00011891284,0.0000230256,0.000006036783,0.00019073256,0.00007432114,0.000068946356],"category_scores_gemma":[0.00005405234,0.000098677316,0.0000722149,0.00025869237,0.00010370544,0.0001266063,0.00006114461,0.00019774924,0.000014442997],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083902694,0.025508376,0.36025327,0.0014523302,0.0007422542,0.001028571,0.03551642,0.0005614675,0.57216334,0.0006569601,0.0002850221,0.0009929431],"study_design_scores_gemma":[0.019728597,0.0006972874,0.7870432,0.00038124775,0.00016621796,0.00006753199,0.0050042584,0.0036253396,0.18167524,0.0013464794,0.000008244569,0.00025635978],"about_ca_topic_score_codex":0.00567516,"about_ca_topic_score_gemma":0.00023207246,"teacher_disagreement_score":0.4267899,"about_ca_system_score_codex":0.000017013488,"about_ca_system_score_gemma":0.00010373235,"threshold_uncertainty_score":0.8579182},"labels":[],"label_agreement":null},{"id":"W2337848504","doi":"10.1182/blood-2015-11-683649","title":"GPR56 identifies primary human acute myeloid leukemia cells with high repopulating potential in vivo","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":234,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital de l'Enfant-Jésus; McGill University Health Centre; Montreal Children's Hospital; BC Cancer Agency; Centre hospitalier de l'Université Laval; Hôpital Maisonneuve-Rosemont; Université Laval; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Deutsche Krebshilfe; Université de Montréal; Vetenskapsrådet; Government of Canada; Génome Québec; Genome Canada","keywords":"Myeloid leukemia; Biology; In vivo; Leukemia; Cancer research; Myeloid; Phenotype; Immunology; Genetics; Gene","score_opus":0.010378095141719564,"score_gpt":0.25521648198375857,"score_spread":0.244838386842039,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337848504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99496317,0.000066582084,0.00011050778,0.0005297985,0.00011048822,0.00055608235,0.000022255417,0.00014661286,0.0034944965],"genre_scores_gemma":[0.98334783,0.00006582913,0.0022671102,0.00018837552,0.00042332144,0.000051496994,0.000024428078,0.00008313154,0.013548459],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972971,0.00009080155,0.00053884665,0.0006325298,0.00074532,0.00069537485],"domain_scores_gemma":[0.99866,0.00007676647,0.00017390796,0.00073784817,0.00013678246,0.00021465881],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038482025,0.0002863937,0.0005194636,0.00031752823,0.00015101917,0.000055995315,0.00026659633,0.00019001396,0.00033847755],"category_scores_gemma":[0.000057391364,0.0001864727,0.00010231916,0.0003537513,0.0001958508,0.0002642197,0.00022873869,0.00040801853,0.00009635147],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002543199,0.00019184154,0.017109554,0.00010940104,0.00024180832,0.0027863728,0.00015063815,0.0000051894776,0.9767449,0.000072402516,0.001588918,0.00074468815],"study_design_scores_gemma":[0.017225064,0.00066546455,0.10028416,0.00074589724,0.00048950146,0.00075254904,0.00013709797,0.000016064358,0.8785313,0.00025781908,0.00042384345,0.00047128592],"about_ca_topic_score_codex":0.00084406364,"about_ca_topic_score_gemma":0.00014331621,"teacher_disagreement_score":0.09821361,"about_ca_system_score_codex":0.00066410523,"about_ca_system_score_gemma":0.00048284724,"threshold_uncertainty_score":0.7604136},"labels":[],"label_agreement":null},{"id":"W2338021169","doi":"10.1182/blood-2015-07-655944","title":"Detection of septic transfusion reactions to platelet transfusions by active and passive surveillance","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":212,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Public Health Agency of Canada; School of Medicine, Case Western Reserve University","keywords":"Medicine; Sepsis; Platelet transfusion; Platelet; Intensive care medicine; Transfusion reaction; Blood transfusion; Immunology","score_opus":0.013142250179236864,"score_gpt":0.24290181247572587,"score_spread":0.229759562296489,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2338021169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98974854,0.00009285081,0.0039223563,0.0016562986,0.00012434144,0.0008383509,0.00004777412,0.000076464705,0.0034930378],"genre_scores_gemma":[0.9986158,0.00041878285,0.00028129577,0.00020637458,0.000034168734,0.0000516153,0.000013798115,0.000019783976,0.00035835928],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99902993,0.000044527984,0.00023434711,0.00027017656,0.0002494803,0.00017152962],"domain_scores_gemma":[0.99931395,0.000043067208,0.000041934723,0.00019298306,0.000106116706,0.00030197145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010020295,0.00013635519,0.0002750218,0.0001372015,0.00006995693,0.000007074242,0.000041853327,0.00008813761,0.00003161563],"category_scores_gemma":[0.000046221594,0.00012291473,0.00006445214,0.00030574127,0.00004258675,0.000062078405,0.000013695079,0.00014745035,0.000008206114],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006447176,0.0014868333,0.0006338142,0.00013250556,0.0002555263,0.0000333005,0.0027528703,0.0000061216583,0.94304925,0.00007603928,0.0009764375,0.049952608],"study_design_scores_gemma":[0.013010551,0.0021846094,0.024654806,0.00014971952,0.0004873944,0.00022643516,0.0020333459,0.000043973876,0.909198,0.000073987,0.04763382,0.0003034001],"about_ca_topic_score_codex":0.0003693251,"about_ca_topic_score_gemma":0.00035534648,"teacher_disagreement_score":0.04964921,"about_ca_system_score_codex":0.000021510998,"about_ca_system_score_gemma":0.000038753984,"threshold_uncertainty_score":0.50123173},"labels":[],"label_agreement":null},{"id":"W2338240975","doi":"10.1182/blood.v122.21.780.780","title":"Liver Iron Concentration By MRI In Chronically Transfused Children With Sickle Cell Anemia In The Twitch Trial","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Liver biopsy; Sickle cell anemia; Magnetic resonance imaging; Biopsy; Anemia; Blood sampling; Clinical trial; Transcranial Doppler; Nuclear medicine; Surgery; Radiology; Internal medicine","score_opus":0.0038397610090852483,"score_gpt":0.1946255285612804,"score_spread":0.19078576755219515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2338240975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99329925,0.0006748515,0.000017214817,0.0016477001,0.000024361287,0.0017149488,0.000002536257,0.000019157655,0.0025999995],"genre_scores_gemma":[0.99868965,0.00058336864,0.000050335017,0.00043074045,0.000056925044,0.000054393382,0.000044355576,0.000012934083,0.00007728071],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9991136,0.00006909375,0.00021170564,0.00018693772,0.00018769657,0.00023094205],"domain_scores_gemma":[0.99969524,0.000032402477,0.000038385286,0.00016503369,0.000017047088,0.000051901996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012920226,0.000112721325,0.00016731647,0.000023820361,0.000028416061,0.000019518042,0.00008328319,0.00014481657,0.00016469843],"category_scores_gemma":[0.00000831469,0.000066594504,0.00003442803,0.0001693759,0.000056823206,0.00006399067,0.0000044316075,0.0003196443,0.000034595763],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02835512,0.05462578,0.61704004,0.0008098082,0.0004885108,0.00046372844,0.047792275,0.00085346604,0.1800928,0.0002632802,0.05257126,0.016643941],"study_design_scores_gemma":[0.716564,0.008020169,0.25237554,0.00032327572,0.0007357956,0.00012487463,0.0022286363,0.0008687375,0.016001876,0.000041221483,0.0019470196,0.00076882995],"about_ca_topic_score_codex":0.0009160467,"about_ca_topic_score_gemma":0.00016692062,"teacher_disagreement_score":0.6882089,"about_ca_system_score_codex":0.000024185929,"about_ca_system_score_gemma":0.00010608748,"threshold_uncertainty_score":0.2715645},"labels":[],"label_agreement":null},{"id":"W2338251154","doi":"10.1182/blood-2015-08-664862","title":"Vitamin B12 deficiency presenting as pancytopenia with ring sideroblasts","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Pancytopenia; pernicious anemia; Lethargy; Vitamin B12; Medicine; Hemoglobin; Gastroenterology; Anemia; Macrocytosis; Mean corpuscular volume; Internal medicine; Pediatrics; Bone marrow","score_opus":0.03344530890750531,"score_gpt":0.2968277762890369,"score_spread":0.2633824673815316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2338251154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9465184,0.00031253762,0.00003769273,0.00024971913,0.000040811905,0.00027991628,0.0000011049056,0.00007610984,0.052483663],"genre_scores_gemma":[0.9929281,0.0000131771385,0.0012891791,0.000069397545,0.000121094185,0.000018065164,0.000005840031,0.000029126662,0.005526015],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985198,0.000032824646,0.00016986717,0.00027852174,0.00056933716,0.00042964297],"domain_scores_gemma":[0.9991764,0.000042838416,0.000040524574,0.0003238027,0.00016308363,0.0002533386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026077998,0.00013065626,0.00020947316,0.00011160588,0.000073105184,0.000049861126,0.000120134224,0.00006279965,0.000054304794],"category_scores_gemma":[0.0002179544,0.000094553834,0.00003954711,0.00030063753,0.00005785517,0.00014195593,0.000100398946,0.0002172699,0.00042483662],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070687983,0.004708022,0.77845323,0.0008066621,0.0005050595,0.0061562783,0.0050445953,0.000037555343,0.18841264,0.0007159006,0.0037293993,0.01072376],"study_design_scores_gemma":[0.04532497,0.008976067,0.29622945,0.0015686499,0.001174901,0.008026618,0.005215634,0.0015922661,0.617714,0.0005802269,0.012026118,0.001571089],"about_ca_topic_score_codex":0.00013946982,"about_ca_topic_score_gemma":0.000042993302,"teacher_disagreement_score":0.48222378,"about_ca_system_score_codex":0.000024050754,"about_ca_system_score_gemma":0.0002251219,"threshold_uncertainty_score":0.5460557},"labels":[],"label_agreement":null},{"id":"W2338258959","doi":"10.1182/blood.v96.1.132","title":"The Shc adaptor protein forms interdependent phosphotyrosine-mediated protein complexes in mast cells stimulated with interleukin 3","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"GRB2; Signal transducing adaptor protein; SH2 domain; Phosphotyrosine-binding domain; Phosphorylation; Cell biology; Tyrosine phosphorylation; Phosphopeptide; Chemistry; Signal transduction; Proto-oncogene tyrosine-protein kinase Src; Protein tyrosine phosphatase; Pleckstrin homology domain; Biology; Biochemistry","score_opus":0.010740936855062784,"score_gpt":0.24631045480683667,"score_spread":0.2355695179517739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2338258959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914974,0.00037463187,0.00000678151,0.0013086364,0.000018928995,0.0020867968,0.000055943365,0.00007431542,0.00457655],"genre_scores_gemma":[0.9846746,0.000049978036,0.00036444387,0.00012789528,0.00008094154,0.00020604781,0.000075320684,0.00004431533,0.014376466],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99785405,0.000103609666,0.00044654642,0.00036971428,0.00060112175,0.00062494393],"domain_scores_gemma":[0.9991806,0.000081249294,0.000072906616,0.00035214762,0.00009682394,0.00021624284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033889318,0.00028331726,0.00035732304,0.00009917599,0.00015835243,0.000077460005,0.0003053696,0.00008773578,0.00082149066],"category_scores_gemma":[0.000029770687,0.00015310795,0.00009259774,0.00033544764,0.00023198819,0.0000844761,0.00009058674,0.0005563254,0.00028641915],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017608752,0.004473829,0.011354066,0.00048233988,0.00065660424,0.0020047666,0.0012901233,0.00003973992,0.9371317,0.0004184025,0.0008729065,0.023666741],"study_design_scores_gemma":[0.01626215,0.0043237004,0.03017615,0.0020487234,0.00009144301,0.00024859648,0.00043837944,0.0015758796,0.90960735,0.00018580367,0.0343725,0.0006693148],"about_ca_topic_score_codex":0.00076740334,"about_ca_topic_score_gemma":0.0007741586,"teacher_disagreement_score":0.033499595,"about_ca_system_score_codex":0.000061295905,"about_ca_system_score_gemma":0.00012847228,"threshold_uncertainty_score":0.8994747},"labels":[],"label_agreement":null},{"id":"W2338464704","doi":"10.1182/blood.v122.21.3085.3085","title":"Bone Marrow Microenvironment Affects The Pathogenesis Of Multiple Myeloma Through Downregulation Of Alternative Splicing Factor Fox2 In Myeloma Cells","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"RNA splicing; Alternative splicing; Stromal cell; Splicing factor; Downregulation and upregulation; Cancer research; Biology; Exon; Gene expression; Cell culture; Molecular biology; Bone marrow; RNA; Gene; Immunology; Genetics","score_opus":0.018447345420321,"score_gpt":0.2535769200385018,"score_spread":0.2351295746181808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2338464704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972957,0.00046059777,0.00007890206,0.00016836503,0.000030213843,0.0016830467,0.00006278763,0.000012290666,0.00020812916],"genre_scores_gemma":[0.9970738,0.00014564247,0.0023605921,0.000030135037,0.000048042577,0.00012762436,0.00003115719,0.000027813414,0.00015519047],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984045,0.00013230383,0.00036908142,0.00029157635,0.0004572237,0.00034534055],"domain_scores_gemma":[0.99890715,0.00028035932,0.00021834538,0.00043807816,0.000060754996,0.000095311254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012185085,0.00020442379,0.00041292456,0.000111496905,0.000046141133,0.000009692111,0.00012437995,0.00007880592,0.00018122623],"category_scores_gemma":[0.00008180335,0.00013721132,0.00013212259,0.00018320123,0.00012578182,0.000114968294,0.00009198697,0.00011449149,0.000037120906],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012051398,0.0009169001,0.15784322,0.0001362856,0.00017518601,0.000037256486,0.0010433437,0.000029146222,0.8315336,0.000008553862,0.00001904608,0.008136907],"study_design_scores_gemma":[0.0033565538,0.00021349813,0.52277094,0.000100177036,0.000047146037,0.000008399611,0.00014105035,0.0003126294,0.47295344,0.000023781655,0.000013626212,0.00005877805],"about_ca_topic_score_codex":0.0010212312,"about_ca_topic_score_gemma":0.00009233775,"teacher_disagreement_score":0.3649277,"about_ca_system_score_codex":0.00007086548,"about_ca_system_score_gemma":0.000034929544,"threshold_uncertainty_score":0.5595315},"labels":[],"label_agreement":null},{"id":"W2338878406","doi":"10.1182/blood-2015-05-645069","title":"Combinatorial targeting of nuclear export and translation of RNA inhibits aggressive B-cell lymphomas","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Center for Research Resources; U.S. Public Health Service","keywords":"Cancer research; Translation (biology); EIF4E; Nuclear export signal; Lymphoma; Nuclear protein; RNA; Biology; Messenger RNA; Gene; Immunology; Genetics; Transcription factor","score_opus":0.01642435368769307,"score_gpt":0.2539120191364933,"score_spread":0.23748766544880023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2338878406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99536854,0.0014888572,0.000018000133,0.000018547782,0.000041915995,0.00015608582,0.000009264129,0.000003700857,0.002895065],"genre_scores_gemma":[0.9991407,0.00007214016,0.00064404274,0.000005184793,0.00008266488,0.0000040149625,0.00002216505,0.000014109985,0.000015001763],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99932,0.000054753353,0.00018251035,0.00014812591,0.00017536881,0.00011924576],"domain_scores_gemma":[0.9995331,0.0000074928366,0.000104835315,0.00013006931,0.00014460304,0.00007986027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023092168,0.00006756359,0.00011704067,0.000030784624,0.000019788087,0.00000449377,0.00007395772,0.00011099737,0.000005027188],"category_scores_gemma":[0.00014423025,0.00006693727,0.000031118478,0.000055082604,0.000065686305,0.0000034513107,0.00006040749,0.00004262984,0.0000010897269],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008499105,0.00021976292,0.0011720269,0.00005106215,0.000019913685,0.0000035358628,0.00020595074,0.0000015939147,0.99730134,0.000053562013,0.000101788646,0.0007844733],"study_design_scores_gemma":[0.0032314258,0.0004626162,0.00012541229,0.000019677032,0.0000129153495,0.000005181271,0.00009902581,0.000019338357,0.9948106,0.0000942606,0.0010527753,0.00006679553],"about_ca_topic_score_codex":0.000022677634,"about_ca_topic_score_gemma":9.4290266e-7,"teacher_disagreement_score":0.0037721125,"about_ca_system_score_codex":0.0000035342912,"about_ca_system_score_gemma":0.00010821312,"threshold_uncertainty_score":0.27296227},"labels":[],"label_agreement":null},{"id":"W2339034661","doi":"10.1182/blood.v124.21.527.527","title":"Loss of MiR-143 and MiR-145 Inhibits Hematopoietic Stem Cell Self-Renewal through Dysregulated TGFβ Signaling","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; Haematopoiesis; Bone marrow; Myeloid; Stem cell; Cancer research; Myelodysplastic syndromes; Hematopoietic stem cell; Progenitor cell; Myeloid leukemia; Immunology; Genetics","score_opus":0.012854694502043011,"score_gpt":0.24928771325112592,"score_spread":0.2364330187490829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339034661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941985,0.0010433948,0.000113918875,0.0004047152,0.00004904385,0.0005125567,0.000010460835,0.00013846945,0.0035289384],"genre_scores_gemma":[0.99571025,0.00006827769,0.0031112432,0.0001756285,0.00016316008,0.00001671505,0.000020655134,0.000066413806,0.00066766003],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997761,0.00014299575,0.0005147562,0.00047250008,0.0005820877,0.0005266453],"domain_scores_gemma":[0.9986528,0.00022768119,0.00016657743,0.00049631984,0.00021080708,0.00024579474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004545931,0.0002775127,0.0006292631,0.00012864417,0.00008889641,0.000026123967,0.00018094898,0.0002490973,0.000078008394],"category_scores_gemma":[0.000044647306,0.00024140814,0.00010644776,0.00037441682,0.00017710376,0.000099332115,0.00017103058,0.00035159476,0.000056224835],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028986164,0.0017932402,0.01499431,0.0028236923,0.00054170657,0.00023286029,0.0057910685,0.00001265708,0.9711274,0.0005738511,0.0010973616,0.0007219983],"study_design_scores_gemma":[0.009614119,0.0006459091,0.00071768055,0.00036197974,0.00044565517,0.00035384178,0.0003445375,0.00030051792,0.98571503,0.00029829965,0.0009255331,0.00027691014],"about_ca_topic_score_codex":0.00009202325,"about_ca_topic_score_gemma":0.000006239239,"teacher_disagreement_score":0.014587624,"about_ca_system_score_codex":0.000065052285,"about_ca_system_score_gemma":0.00019985672,"threshold_uncertainty_score":0.9844338},"labels":[],"label_agreement":null},{"id":"W2340216483","doi":"10.1182/blood.v124.21.4714.4714","title":"Bone Marrow Microenvironment Regulates Alternative Splicing Events in Myeloma Cells through Downregulation of RNA Binding Protein Fox2","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Biology; Stromal cell; Gene knockdown; Alternative splicing; Cell biology; Molecular biology; Small hairpin RNA; Cell culture; RNA splicing; Podosome; Cancer research; Cell adhesion; Cell; Exon; RNA; Cytoskeleton; Gene; Genetics","score_opus":0.01595184215941961,"score_gpt":0.2614747376178033,"score_spread":0.2455228954583837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2340216483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99776125,0.0001785154,0.00009795495,0.00013080964,0.000022695951,0.0011354659,0.000010791203,0.00001764738,0.00064488663],"genre_scores_gemma":[0.9948492,0.000050367114,0.0041791084,0.000012796312,0.00006428459,0.000069144226,0.000045963956,0.000027259719,0.00070188235],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99844444,0.000105074476,0.00035952742,0.00031921413,0.00042013868,0.00035158367],"domain_scores_gemma":[0.9993373,0.000054241977,0.000170453,0.00030820078,0.000029583449,0.00010018537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002497217,0.0001783524,0.00034222024,0.00015903647,0.000047378868,0.0000058398464,0.00008182876,0.000073087154,0.000062361934],"category_scores_gemma":[0.000058710564,0.00015279868,0.00008152834,0.00015828446,0.000054918248,0.00012560125,0.00006999445,0.00012610236,0.000043308377],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002010328,0.0008773978,0.04030564,0.00017052486,0.00011565086,0.000036154917,0.0002856854,0.000026359408,0.9533718,0.000054090262,0.0000053727385,0.0045502954],"study_design_scores_gemma":[0.0067528603,0.00035577817,0.17404436,0.0004996647,0.000053681477,0.000013176059,0.00003921357,0.0002982707,0.8175079,0.00028293717,0.00005204484,0.00010010535],"about_ca_topic_score_codex":0.0002235532,"about_ca_topic_score_gemma":0.00002896586,"teacher_disagreement_score":0.13586389,"about_ca_system_score_codex":0.00010892366,"about_ca_system_score_gemma":0.000022102455,"threshold_uncertainty_score":0.6230949},"labels":[],"label_agreement":null},{"id":"W2340502986","doi":"10.1182/blood.v122.21.3937.3937","title":"Targeting The Mitochondrial ClpP As a Novel Therapeutic Strategy For Acute Myeloid Leukemia","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Advanced biosensing and bioanalysis techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Myeloid leukemia; Viability assay; Gene knockdown; Biology; Small hairpin RNA; Molecular biology; Leukemia; Haematopoiesis; Stem cell; Cancer research; Apoptosis; Cell biology; Biochemistry; Immunology","score_opus":0.012210260966856649,"score_gpt":0.2769267248667548,"score_spread":0.26471646389989817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2340502986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9641865,0.0013237351,0.03159129,0.00068575295,0.00021596445,0.0011973731,0.000054541935,0.00011301393,0.0006318556],"genre_scores_gemma":[0.9832154,0.00019457062,0.0139221465,0.00069052237,0.0008528935,0.00011550367,0.0001603622,0.000029117076,0.0008195149],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99908644,0.000025571584,0.00019296899,0.00032081487,0.00009915025,0.00027506487],"domain_scores_gemma":[0.9993902,0.000021670423,0.00010040716,0.00031200686,0.00012909017,0.00004666894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008560626,0.00017062695,0.00014771079,0.000020964811,0.00016675032,0.000066650915,0.00021930227,0.00015864242,0.000005113516],"category_scores_gemma":[0.000046132664,0.000109867586,0.00015571457,0.000075113654,0.000084527106,0.000004819398,0.00005807502,0.00009326369,0.0000120219365],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029641269,0.00006348316,0.000023216273,0.0000034243849,0.00031633416,4.9511146e-7,0.000010248551,0.000009565048,0.99575675,0.000069899696,0.0011157265,0.0026012384],"study_design_scores_gemma":[0.00087162456,0.0003732623,0.000052804622,0.0000062560844,0.0003029413,0.000018971357,0.00008135997,0.00015226117,0.98177356,0.0009092349,0.015241884,0.00021582478],"about_ca_topic_score_codex":0.000032637003,"about_ca_topic_score_gemma":0.000006656605,"teacher_disagreement_score":0.019028893,"about_ca_system_score_codex":0.0000097544735,"about_ca_system_score_gemma":0.00007726091,"threshold_uncertainty_score":0.448027},"labels":[],"label_agreement":null},{"id":"W2341839070","doi":"10.1182/blood-2015-11-682963","title":"Risk factors predictive of occult cancer detection in patients with unprovoked venous thromboembolism","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Université de Montréal; Hôpital du Sacré-Cœur de Montréal; University of Ottawa; McGill University; Ottawa Hospital; CancerCare Manitoba; Queen Elizabeth II Health Sciences Centre; St Mary's Hospital Centre; Western University; St. Joseph’s Healthcare Hamilton; Montreal General Hospital; University of Manitoba; Dalhousie University; Jewish General Hospital","funders":"","keywords":"Medicine; Venous thromboembolism; Occult; Internal medicine; Cancer; Predictive value; Intensive care medicine; Pathology; Thrombosis","score_opus":0.005974464126956181,"score_gpt":0.21850046066234688,"score_spread":0.2125259965353907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2341839070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983016,0.00007141359,0.000090434376,0.00003853043,0.00012836666,0.0008347407,0.00008433396,0.000043377604,0.0004071682],"genre_scores_gemma":[0.9995045,0.00022461373,0.00004392104,0.000031441057,0.000052635027,0.00008100778,0.0000075909347,0.000025976422,0.000028328846],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988969,0.000038390404,0.00024053645,0.00027380523,0.00030363092,0.0002467547],"domain_scores_gemma":[0.9993168,0.000040546274,0.0001836838,0.00024856685,0.00013165345,0.00007873249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000803853,0.0001610192,0.0004944244,0.00013653867,0.000041673626,0.000004491074,0.0000681423,0.00007619548,0.00006299022],"category_scores_gemma":[0.00005730553,0.00009277746,0.000057063702,0.00019502673,0.00006938035,0.00009354433,0.000034313645,0.00009403997,0.0000055784994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019157682,0.004856884,0.98387176,0.00006341034,0.00050512946,0.000003861711,0.00089042593,0.000011677519,0.0011318058,0.000018222136,0.000042670446,0.008412558],"study_design_scores_gemma":[0.007112728,0.0020149667,0.9620681,0.0002854748,0.00066468306,3.368758e-7,0.00010557123,0.0000030464194,0.027489565,0.00003613663,0.00010032965,0.00011907342],"about_ca_topic_score_codex":0.0013554636,"about_ca_topic_score_gemma":0.00036158456,"teacher_disagreement_score":0.02635776,"about_ca_system_score_codex":0.000085340514,"about_ca_system_score_gemma":0.000050684688,"threshold_uncertainty_score":0.37833548},"labels":[],"label_agreement":null},{"id":"W2342022702","doi":"10.1182/blood.v124.21.1237.1237","title":"Development and Validation of a Prognostic Score Involving Disease Status, Patient Age and Donor Type for Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Myeloid Leukemia","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Transplantation; Internal medicine; Hematopoietic stem cell transplantation; Cumulative incidence; Myeloid leukemia; Surgery; Single Center; Gastroenterology","score_opus":0.012293326477649306,"score_gpt":0.23805801168157126,"score_spread":0.22576468520392196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342022702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984656,0.00010781232,0.000117839474,0.000013856919,0.00001129111,0.0012309201,0.0000334058,0.0000086261225,0.000010662927],"genre_scores_gemma":[0.99210596,0.000078590034,0.0073734825,0.000023216297,0.0000039766346,0.00006660642,0.00031630782,0.000019489857,0.000012396604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990039,0.000033571323,0.0003083872,0.00020978895,0.00024944622,0.00019489064],"domain_scores_gemma":[0.99937755,0.00010474648,0.00012380879,0.00012294996,0.00013951474,0.00013143501],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010663302,0.00012692116,0.0002850245,0.00013748398,0.000028046261,0.000007716495,0.00003741297,0.000040451458,0.0000021037176],"category_scores_gemma":[0.00009166801,0.000097197095,0.000017572187,0.00012255092,0.000056918696,0.000061637125,0.000024647463,0.00006514757,4.7308131e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085136475,0.00032923496,0.99232775,0.0015833954,0.000087570384,0.000013549591,0.0018246341,0.000008071629,0.001973164,0.000014487877,0.0000030021322,0.0009837743],"study_design_scores_gemma":[0.0074718636,0.0007156564,0.96536237,0.00024699367,0.0003517705,0.0000019868437,0.00006674072,0.0000415162,0.025612874,0.000016153139,0.000010555055,0.000101490245],"about_ca_topic_score_codex":0.000018548164,"about_ca_topic_score_gemma":0.000021572432,"teacher_disagreement_score":0.026965352,"about_ca_system_score_codex":0.000067910776,"about_ca_system_score_gemma":0.00030778634,"threshold_uncertainty_score":0.39635825},"labels":[],"label_agreement":null},{"id":"W2342069276","doi":"10.1182/blood-2015-07-660001","title":"Reducing the hospital burden of heparin-induced thrombocytopenia: impact of an avoid-heparin program","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Patient Safety Institute; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Heparin; Medicine; Heparin-induced thrombocytopenia; Intensive care medicine; Surgery","score_opus":0.027128954612040155,"score_gpt":0.32395968320447804,"score_spread":0.29683072859243786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342069276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920595,0.00007210938,0.0000069733646,0.0006281117,0.00018399418,0.0017042805,0.000034735433,0.00015677401,0.0051534767],"genre_scores_gemma":[0.9982296,0.00006768202,0.0009373196,0.000017996268,0.00035430797,0.0000998129,0.000016510872,0.000085672975,0.00019106164],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99698776,0.0001870317,0.00089636905,0.00064343936,0.00057814876,0.0007072271],"domain_scores_gemma":[0.99705684,0.00019667117,0.00047075952,0.0015679743,0.0003403026,0.0003674665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059429416,0.0004482882,0.0013085896,0.00017493637,0.00014250034,0.000035836994,0.0006086358,0.0002886973,0.0002938256],"category_scores_gemma":[0.0003400345,0.00023995858,0.00056607375,0.0005256945,0.00033927176,0.00035432086,0.0002506938,0.00034877812,0.000053470394],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017855673,0.0037043937,0.04276204,0.00012244502,0.001377835,0.000044715376,0.0017786141,0.0000027760561,0.9204445,0.00035331395,0.000097960765,0.02913286],"study_design_scores_gemma":[0.006586025,0.0076514403,0.437632,0.0005498897,0.0010388202,0.00018532776,0.0003204222,0.000047963644,0.5452193,0.0002211497,0.00012792514,0.00041972552],"about_ca_topic_score_codex":0.0032894625,"about_ca_topic_score_gemma":0.00006232242,"teacher_disagreement_score":0.39486995,"about_ca_system_score_codex":0.00012505165,"about_ca_system_score_gemma":0.0005996837,"threshold_uncertainty_score":0.97852266},"labels":[],"label_agreement":null},{"id":"W2342300318","doi":"10.1182/blood.v122.21.3664.3664","title":"Evaluation Of The Appropriateness Of Frozen Plasma Usage In The Era Of Prothrombin Complex Concentrates: A Retrospective Study","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Trauma, Hemostasis, Coagulopathy, Resuscitation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Joseph’s Healthcare Hamilton; St. Joseph's Hospital; McMaster University","funders":"","keywords":"Medicine; Prothrombin complex concentrate; Audit; Fresh frozen plasma; Retrospective cohort study; Pediatrics; Emergency medicine; Internal medicine; Warfarin; Platelet","score_opus":0.05483719532189284,"score_gpt":0.30865530085185683,"score_spread":0.253818105529964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342300318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99255836,0.000065844324,0.0000075208836,0.0002063869,0.000050105493,0.0063095423,0.000017265846,0.000008013487,0.0007769798],"genre_scores_gemma":[0.9994666,0.0000031690442,0.000177885,0.000017939918,0.0000195357,0.00029115882,0.00000779841,0.000011877312,0.0000040527616],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997363,0.0006575859,0.0004949527,0.00019334244,0.0011546966,0.00013643358],"domain_scores_gemma":[0.99821603,0.00010165562,0.00036838793,0.00044631277,0.0008466357,0.000020984922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017493023,0.000112536116,0.00035142514,0.000049374237,0.00003109239,0.00000811659,0.0002063883,0.000053909258,0.0000700252],"category_scores_gemma":[0.00059204997,0.00006567025,0.000061421306,0.00046270736,0.00015829409,0.00007561233,0.000034564404,0.00017704541,0.0000028404668],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013224532,0.005829071,0.8495098,0.00018594964,0.00025508294,0.0000014612128,0.029688133,0.000057451787,0.10958706,0.0002086811,0.000028597588,0.0045164726],"study_design_scores_gemma":[0.008635677,0.0006384641,0.93286306,0.00015707129,0.0004599023,0.000003238303,0.010275214,0.0011028291,0.045139335,0.00066967355,6.164459e-7,0.000054948323],"about_ca_topic_score_codex":0.0005132593,"about_ca_topic_score_gemma":0.00021758139,"teacher_disagreement_score":0.08335324,"about_ca_system_score_codex":0.000060016566,"about_ca_system_score_gemma":0.0002168065,"threshold_uncertainty_score":0.2677955},"labels":[],"label_agreement":null},{"id":"W2342410120","doi":"10.1182/blood.v122.21.1735.1735","title":"Cost-Utility Of Bortezomib In Induction Treatment Prior To Autologous Stem-Cell Transplantation (ASCT) In Previously Untreated Multiple Myeloma Patients In Canada","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Queen Elizabeth II Health Sciences Centre; Dalhousie University; Sunnybrook Health Science Centre; Juravinski Cancer Centre","funders":"","keywords":"Bortezomib; Multiple myeloma; Medicine; Autologous stem-cell transplantation; Regimen; Oncology; Internal medicine; Transplantation; Clinical trial; Progression-free survival; Surgery; Chemotherapy","score_opus":0.022281077438896686,"score_gpt":0.25776500038183753,"score_spread":0.23548392294294085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342410120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951239,0.0000782487,0.0000026463372,0.00007208502,0.000037327474,0.0044267867,0.0000842853,0.000014138557,0.0001605507],"genre_scores_gemma":[0.99876374,0.000099826,0.00020569525,0.000019509149,0.000007126037,0.0005838659,0.00024086778,0.000016637594,0.00006273765],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981757,0.00015276646,0.00054556393,0.00036258734,0.0003100568,0.00045331803],"domain_scores_gemma":[0.9992393,0.00010347815,0.00008812012,0.00025383628,0.00009690321,0.00021832927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009590556,0.00020443508,0.00044744296,0.00030661962,0.000021337451,0.0000071024724,0.000069552305,0.0000917967,0.00006082344],"category_scores_gemma":[0.000047302277,0.00017142612,0.000039460734,0.00043451914,0.000020005185,0.00009901795,0.000013898539,0.00013033104,0.000014838245],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006438666,0.003036605,0.90906096,0.00013135385,0.000040630748,0.0001833028,0.001053019,0.000024160003,0.0008570127,1.6029449e-7,0.000011543356,0.0849574],"study_design_scores_gemma":[0.023534296,0.00078474416,0.94792706,0.0001467732,0.00004834846,0.000007831571,0.00025186336,0.00044708242,0.026730109,0.0000016332158,0.00001210067,0.00010816604],"about_ca_topic_score_codex":0.91170484,"about_ca_topic_score_gemma":0.9486583,"teacher_disagreement_score":0.08484923,"about_ca_system_score_codex":0.00092241884,"about_ca_system_score_gemma":0.00078684493,"threshold_uncertainty_score":0.69905543},"labels":[],"label_agreement":null},{"id":"W2343469574","doi":"10.1182/blood.v122.21.2650.2650","title":"Duration Of Neutropenia Is Associated With Reduced Relapse Risk In Children With De Novo Acute Myeloid Leukemia: A Report From The Children’s Oncology Group","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Neutropenia; Gemtuzumab ozogamicin; Internal medicine; Induction chemotherapy; Febrile neutropenia; Mucositis; Chemotherapy; Cumulative incidence; Myeloid leukemia; Chemotherapy regimen; Randomized controlled trial; Oncology; Pediatrics; Transplantation; Stem cell","score_opus":0.0061557203115994484,"score_gpt":0.23076739588410553,"score_spread":0.22461167557250608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343469574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99677056,0.00007943644,0.000023500304,0.00094783347,0.000036685597,0.0012121588,0.00005626125,0.00005453063,0.0008190405],"genre_scores_gemma":[0.99819744,0.0001422974,0.0003918941,0.00044593378,0.00014168768,0.00024800905,0.0002102697,0.00003716061,0.00018528246],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985575,0.00014535095,0.00042660272,0.00036027256,0.00023440397,0.00027586624],"domain_scores_gemma":[0.9987086,0.000081237995,0.0004834535,0.00048902625,0.00014152894,0.00009611813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002155164,0.000191009,0.0004210349,0.00007010202,0.00011519855,0.000023748556,0.00012988865,0.00017064794,0.0001280866],"category_scores_gemma":[0.000079938014,0.00011656252,0.00006706921,0.00039423342,0.00012008193,0.00014709994,0.000036924248,0.0005537072,0.0000150044325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024369331,0.0005547204,0.9754623,0.0000017180558,0.0013101286,0.00009932945,0.0005267315,0.000008625449,0.020560922,0.000011574785,0.00084728946,0.00037292374],"study_design_scores_gemma":[0.008970541,0.0011676338,0.97226566,0.000087649016,0.0017091901,0.00264238,0.00005889527,0.00000461105,0.012864076,0.00004214271,0.00004500856,0.00014222787],"about_ca_topic_score_codex":0.011997875,"about_ca_topic_score_gemma":0.0030486104,"teacher_disagreement_score":0.008949265,"about_ca_system_score_codex":0.00029475856,"about_ca_system_score_gemma":0.00057284144,"threshold_uncertainty_score":0.99458134},"labels":[],"label_agreement":null},{"id":"W2344178087","doi":"10.1182/blood.v124.21.4261.4261","title":"Rate of Venous Thromboembolism in Obese Patients Undergoing General Surgery: A Retrospective Cohort Study","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Contraindication; Body mass index; Pulmonary embolism; Retrospective cohort study; Surgery; Regimen; Internal medicine","score_opus":0.009303096017949302,"score_gpt":0.23994494840595953,"score_spread":0.23064185238801024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344178087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99470216,0.00006954765,0.00000751977,0.0000629804,0.00024604355,0.0013533605,0.000004690474,0.000044296503,0.0035093727],"genre_scores_gemma":[0.9992168,0.00013465552,0.000085208594,0.00022639584,0.00013297376,0.00009375387,0.000022618951,0.00003820304,0.000049372113],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982153,0.0001810369,0.00048432557,0.00041451142,0.00035054632,0.00035424295],"domain_scores_gemma":[0.998974,0.0001399082,0.00018928491,0.00046077167,0.00013907468,0.00009693312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086680386,0.00020160632,0.0012027004,0.00024789912,0.00005569751,0.000015723062,0.000100843754,0.00006716118,0.000051393643],"category_scores_gemma":[0.0003717311,0.00018546486,0.00012086687,0.00033685224,0.000044046796,0.00007246847,0.00009867463,0.0001472026,0.000018590132],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002558065,0.016913803,0.98026973,0.000107080035,0.00041545788,0.000025891239,0.0007418484,0.000010723713,0.000116032345,0.0004554658,0.00043347242,0.00048491562],"study_design_scores_gemma":[0.0045230105,0.0014312112,0.9919061,0.00018115899,0.0005400714,0.0000015812885,0.00014533749,0.000026516576,0.00053665077,0.0004910551,0.000049669852,0.00016765764],"about_ca_topic_score_codex":0.0008071949,"about_ca_topic_score_gemma":0.0004960229,"teacher_disagreement_score":0.015482591,"about_ca_system_score_codex":0.0000895714,"about_ca_system_score_gemma":0.00007582142,"threshold_uncertainty_score":0.7563037},"labels":[],"label_agreement":null},{"id":"W2344421872","doi":"10.1182/blood-2016-01-635003","title":"How I treat patients with a history of heparin-induced thrombocytopenia","year":2016,"lang":"en","type":"review","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"McMaster University","keywords":"Heparin-induced thrombocytopenia; Medicine; Heparin; Intensive care medicine; Internal medicine; Surgery","score_opus":0.056421450387947894,"score_gpt":0.28485819190977696,"score_spread":0.22843674152182908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344421872","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011603823,0.9563453,0.0000029795465,0.000054126325,0.0004219941,0.0028996118,0.00012964348,0.00015347532,0.028389033],"genre_scores_gemma":[0.0062015317,0.98156404,0.00024503664,0.00004190101,0.00031877815,0.00023974708,0.00023980076,0.00025723822,0.0108918995],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99626964,0.00020518064,0.00094311364,0.0010865051,0.0007547577,0.0007408259],"domain_scores_gemma":[0.9962821,0.00018551353,0.0009907014,0.0017291179,0.00034642252,0.00046614098],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017427158,0.0011009349,0.005981381,0.0004666388,0.00005958772,0.000033058674,0.0005196163,0.0007929187,0.00031957193],"category_scores_gemma":[0.00013346117,0.00065939414,0.0009372647,0.00037174328,0.00023277265,0.00023515562,0.0002087988,0.0006138243,0.00020341412],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014380543,0.0052849995,0.0035980365,0.036881916,0.0054134633,0.00018197965,0.00020328238,1.9075654e-9,0.0004505044,0.00051609776,0.0020142545,0.94531167],"study_design_scores_gemma":[0.0075823395,0.0016506081,0.0016703594,0.022224115,0.0121156275,0.00011512026,0.00000639532,4.1239343e-8,0.00023268981,0.000007381879,0.9535097,0.00088564196],"about_ca_topic_score_codex":0.0000771512,"about_ca_topic_score_gemma":0.000022017037,"teacher_disagreement_score":0.9514954,"about_ca_system_score_codex":0.0009632778,"about_ca_system_score_gemma":0.002367449,"threshold_uncertainty_score":0.99958575},"labels":[],"label_agreement":null},{"id":"W2344579973","doi":"10.1182/blood-2016-01-688226","title":"Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":217,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Adenosine deaminase deficiency; Severe combined immunodeficiency; Genetic enhancement; Adenosine deaminase; Medicine; Adverse effect; Immunology; Internal medicine; Oncology; Virology; Gene; Biology; Adenosine; Genetics","score_opus":0.01359156115148987,"score_gpt":0.27081988474328633,"score_spread":0.2572283235917965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344579973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99440545,0.0025757027,0.0009610849,0.0012245714,0.000031133884,0.0005849028,0.00010328351,0.000007321227,0.00010653711],"genre_scores_gemma":[0.9980721,0.00096836843,0.0002253344,0.00042762113,0.00007169769,0.000042327414,0.000015453936,0.000025689062,0.00015139578],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989113,0.0000836726,0.00020209752,0.00033812,0.0001647664,0.00030000284],"domain_scores_gemma":[0.9991446,0.00008699417,0.000060773247,0.00055333955,0.0000939707,0.000060291957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004647924,0.00014361388,0.00014622007,0.000048102982,0.00012340394,0.000012969687,0.00032362947,0.00007419866,0.00002214285],"category_scores_gemma":[0.00017379755,0.00008042137,0.000077971454,0.00011525613,0.00012435084,0.0000026024811,0.0000858092,0.000045385637,0.000008979575],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004235657,0.00034898915,0.00021481246,0.000004790765,0.00003494822,0.0000012553529,0.000030038798,0.000004137651,0.9739802,0.00021350491,0.000114679184,0.020817026],"study_design_scores_gemma":[0.003451098,0.0076587247,0.0037827108,0.000013395186,0.0000115908715,0.000008375112,0.000010795869,0.0000020611021,0.98246455,0.000056770194,0.002409624,0.00013031802],"about_ca_topic_score_codex":0.000004962075,"about_ca_topic_score_gemma":0.0000054346974,"teacher_disagreement_score":0.020686708,"about_ca_system_score_codex":0.000007769719,"about_ca_system_score_gemma":0.000069462534,"threshold_uncertainty_score":0.3279488},"labels":[],"label_agreement":null},{"id":"W2344711836","doi":"10.1182/blood.v122.21.36.36","title":"Inflammation Markers and The Risk Of Post Thrombotic Syndrome: Results From The Bio-Sox Study","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Hamilton General Hospital; Centre hospitalier universitaire de Québec; St. Boniface Hospital; Université de Montréal; Hôpital Maisonneuve-Rosemont; Hôpital Notre-Dame; McMaster University; Thrombosis and Atherosclerosis Research Institute; McGill University; London Health Sciences Centre; St Mary's Hospital Centre; Hôpital du Sacré-Cœur de Montréal; St. Joseph's Hospital; Ottawa Hospital; Victoria Heart Institute Foundation; University Health Network; University of Ottawa; Dalhousie University; University of Manitoba; Jewish General Hospital; Montreal General Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Post-thrombotic syndrome; Internal medicine; Biomarker; Odds ratio; Placebo; Venous thrombosis; Thrombosis; Gastroenterology; Deep vein; Logistic regression; Randomized controlled trial; Surgery; Pathology","score_opus":0.007131060659990539,"score_gpt":0.2149903012817806,"score_spread":0.20785924062179006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344711836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917656,0.00029737985,0.0000030448903,0.0044923057,0.00007664625,0.0021343136,0.000027122143,0.000022987235,0.0011805608],"genre_scores_gemma":[0.99906915,0.0004005788,0.00008105577,0.0002008304,0.00006537499,0.00007891549,0.000018932029,0.00001235062,0.00007281126],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99889123,0.0001922156,0.00033383744,0.00019484936,0.00025224747,0.00013560832],"domain_scores_gemma":[0.99864495,0.0005117076,0.00019598611,0.0005199615,0.00008468307,0.000042687654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064561376,0.000115867835,0.00033497944,0.000033168762,0.0001229177,0.00003996303,0.00013065939,0.00003595206,0.000085510976],"category_scores_gemma":[0.00040513198,0.00005565012,0.00006210686,0.00011588466,0.00015111682,0.00006589864,0.0001087202,0.00011803502,0.00004598389],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018186375,0.01376422,0.8355027,0.0003493326,0.016909381,0.00013566152,0.06023359,0.00007444748,0.003212753,0.0025010156,0.020969009,0.044529244],"study_design_scores_gemma":[0.009342104,0.00045074624,0.9828438,0.000072917624,0.0018286475,0.000006820489,0.0047675553,0.00006182419,0.0001558129,0.00029548223,0.000110785004,0.00006349343],"about_ca_topic_score_codex":0.0067024715,"about_ca_topic_score_gemma":0.00018756109,"teacher_disagreement_score":0.1473411,"about_ca_system_score_codex":0.000007254765,"about_ca_system_score_gemma":0.000017656012,"threshold_uncertainty_score":0.99991196},"labels":[],"label_agreement":null},{"id":"W2344778610","doi":"10.1182/blood.v124.21.5336.5336","title":"A Standard, 3-Tube, 10-Color Flow Cytometry Panel for Acute Myeloid Leukemia Diagnosis Can be Used for MRD Detection at Day 30 after Induction, and Is Predictive of Early Relapse","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Leukemia & Lymphoma Society of Canada","funders":"","keywords":"Medicine; Minimal residual disease; Myeloid leukemia; Internal medicine; CD33; Induction chemotherapy; Acute leukemia; Leukemia; Immunophenotyping; Oncology; CD34; Gastroenterology; Surgery; Immunology; Flow cytometry; Chemotherapy; Stem cell; Biology","score_opus":0.01804065520445389,"score_gpt":0.2757583530413219,"score_spread":0.257717697836868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344778610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898472,0.00015072161,0.0043903966,0.000830045,0.00015971395,0.0026066513,0.0018721536,0.000086457774,0.00005667253],"genre_scores_gemma":[0.99159575,0.00016915584,0.0032094095,0.00029913412,0.00045711535,0.0027209357,0.000103141836,0.0001030865,0.0013422774],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975958,0.000100296405,0.0004804828,0.0006748261,0.0005900759,0.00055853336],"domain_scores_gemma":[0.99760544,0.0006742836,0.0001945824,0.0005147762,0.0006897501,0.00032115998],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007978055,0.00031543017,0.00066716457,0.00040760948,0.0002132297,0.00003606779,0.00014354709,0.00041124978,0.00013434222],"category_scores_gemma":[0.0010423335,0.00028086203,0.00020122867,0.00043856993,0.00022879073,0.00018051668,0.00013522804,0.00031808577,0.0000067958867],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05740077,0.0018999617,0.2798781,0.0035797236,0.011900446,0.00012032647,0.024228688,0.00003744279,0.5121248,0.000054455264,0.04672975,0.062045563],"study_design_scores_gemma":[0.03144778,0.0128531065,0.08772495,0.00024070911,0.0032991085,0.000116240415,0.00032791877,0.0021779651,0.84512305,0.00018279518,0.01598402,0.0005223835],"about_ca_topic_score_codex":0.00014113134,"about_ca_topic_score_gemma":0.0001325658,"teacher_disagreement_score":0.33299828,"about_ca_system_score_codex":0.0008846387,"about_ca_system_score_gemma":0.00042339726,"threshold_uncertainty_score":0.99996436},"labels":[],"label_agreement":null},{"id":"W23449636","doi":"10.1182/blood-2013-01-479170","title":"Nonlinear backlash compensation for speed controlled elastic systems","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Control Systems in Engineering","field":"Engineering","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research","keywords":"Backlash; Nonlinear system; Control theory (sociology); Compensation (psychology); Computer science; Mathematics; Physics; Artificial intelligence; Control (management); Psychology","score_opus":0.0068209852531457785,"score_gpt":0.19230804358224077,"score_spread":0.18548705832909498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W23449636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9429174,0.0022477603,0.034815785,0.000023898487,0.002128544,0.0029462748,0.00008266532,0.001601365,0.013236298],"genre_scores_gemma":[0.99731463,0.000017331433,0.0009767732,0.0000060077077,0.00076735986,0.00013321068,0.00002117817,0.000070340924,0.00069318607],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9989794,0.000018399014,0.00040100003,0.00015772572,0.00014603182,0.00029745768],"domain_scores_gemma":[0.99939346,0.00022781473,0.000029678871,0.00022874275,0.00004621919,0.00007407992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018561272,0.00019108132,0.00043948003,0.000073224925,0.000042476473,0.00006261901,0.00012546887,0.00009285056,0.000066429246],"category_scores_gemma":[0.000049280377,0.00019307059,0.000112285,0.000096206626,0.000009087476,0.00007781204,0.0000051564634,0.000091961796,0.00016121895],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000087859065,0.0001071492,0.00008953668,0.00039420373,0.0004541123,0.000007242751,0.000099568024,0.9745782,0.021817649,0.0003047787,0.00037356102,0.0016861531],"study_design_scores_gemma":[0.013355314,0.0000521061,0.0001210116,0.00008672736,0.00014739676,0.000024221987,0.000014685205,0.9741319,0.0006868197,0.00000906889,0.011125795,0.00024499273],"about_ca_topic_score_codex":0.000008285428,"about_ca_topic_score_gemma":0.0000047948797,"teacher_disagreement_score":0.054397203,"about_ca_system_score_codex":0.000040553427,"about_ca_system_score_gemma":0.000009729535,"threshold_uncertainty_score":0.787319},"labels":[],"label_agreement":null},{"id":"W2345149497","doi":"10.1182/blood.v120.21.97.97","title":"Functional Characterization of the Type 1 VWD Candidate VWF Gene Variants: P.M771I, p.L881R, p.P1413L, and p.Q1475X","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Von Willebrand factor; Von Willebrand disease; Molecular biology; Missense mutation; Biology; Complementary DNA; Gene; Mutation; Chemistry; Genetics; Immunology; Platelet","score_opus":0.011768438662140569,"score_gpt":0.2173973812340656,"score_spread":0.20562894257192504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345149497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99789095,0.0005251913,0.000023584898,0.00025578824,0.0002246601,0.00016828059,0.000039453982,0.000012663058,0.00085941865],"genre_scores_gemma":[0.9985772,0.00019070263,0.00006463144,0.00021382944,0.000108530694,0.000006116366,0.00014269332,0.000011004745,0.00068533374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999506,0.000016960541,0.00011590133,0.00009637779,0.00012394259,0.00014082252],"domain_scores_gemma":[0.9996688,0.000010219565,0.00006446102,0.00014748739,0.000044121523,0.000064926644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000054725228,0.00008089876,0.00014246951,0.00002808434,0.000057358102,0.0000055253145,0.0000271544,0.000051258172,0.00014889277],"category_scores_gemma":[0.000022265382,0.00005377914,0.000029213184,0.000112637776,0.00003154958,0.00008217963,0.00002719644,0.000051265484,0.000020365746],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017807061,0.0015855189,0.6165542,0.00005574572,0.00046645536,0.00001797722,0.00023130947,2.5257106e-7,0.3787765,0.00042024223,0.0003039988,0.001409727],"study_design_scores_gemma":[0.0024357704,0.00008839113,0.9687402,0.00002588578,0.0003117702,0.00017266095,0.000009151578,0.0000071592995,0.02662404,0.000032453434,0.0014936416,0.000058852314],"about_ca_topic_score_codex":0.00003753095,"about_ca_topic_score_gemma":0.000004832922,"teacher_disagreement_score":0.35218602,"about_ca_system_score_codex":0.000007146283,"about_ca_system_score_gemma":0.00004753744,"threshold_uncertainty_score":0.21930496},"labels":[],"label_agreement":null},{"id":"W2345360418","doi":"10.1182/blood.v120.21.2516.2516","title":"Pediatric Acute Myeloid Leukemia with t(8;16)(p11;p13): A Distinct Clinical and Biological Entity. Results of a Collaborative Study by the International Berlin-Frankfurt-Munster AML Study Group.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Medicine; Myeloid leukemia; Oncology; Leukemia; Internal medicine","score_opus":0.027967082771690292,"score_gpt":0.32911404966322405,"score_spread":0.30114696689153375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345360418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947141,0.0005410375,0.000030702748,0.00046854693,0.00017769069,0.0027041116,0.0003213735,0.00005013042,0.0009923492],"genre_scores_gemma":[0.99763364,0.0002651048,0.00031140918,0.00014739395,0.0008088574,0.00017279884,0.00011404904,0.000035030786,0.0005116985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99626327,0.00066628883,0.00093731115,0.00064437627,0.0009701183,0.0005186208],"domain_scores_gemma":[0.9973201,0.0009400269,0.0003524554,0.00063588354,0.00043165227,0.000319848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026438741,0.00033686994,0.0007224293,0.00015060004,0.00016434382,0.00006427956,0.0004996632,0.00017634408,0.000054962282],"category_scores_gemma":[0.000810178,0.00018527909,0.00010311527,0.0007005874,0.0005003688,0.00019489044,0.0005353168,0.0008162704,0.000024739054],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004031698,0.00891306,0.9772316,0.000016444907,0.0016103432,0.000105439954,0.0027695934,9.408981e-8,0.00024130965,0.00001472233,0.004281489,0.0007842016],"study_design_scores_gemma":[0.036908288,0.009281292,0.94355285,0.000020099607,0.0016080381,0.00012984917,0.0059779827,0.000014330233,0.00015795017,0.000007623833,0.0020946339,0.0002470542],"about_ca_topic_score_codex":0.00023637671,"about_ca_topic_score_gemma":0.00025086038,"teacher_disagreement_score":0.033678744,"about_ca_system_score_codex":0.00016413638,"about_ca_system_score_gemma":0.00037413932,"threshold_uncertainty_score":0.7555462},"labels":[],"label_agreement":null},{"id":"W2345491145","doi":"10.1182/blood.v124.21.4542.4542","title":"Efficacy and Safety of Dose-Optimized Nilotinib (NIL) in Patients (Pts) with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP): ENESTxtnd Interim Analysis","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Nilotinib; Internal medicine; Interim analysis; Adverse effect; Clinical endpoint; Anemia; Myeloid leukemia; Clinical trial; Imatinib","score_opus":0.009825242666280267,"score_gpt":0.26291835273030134,"score_spread":0.2530931100640211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345491145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967517,0.0009030422,0.000131542,0.00005620564,0.000047194015,0.0015197317,0.000030401652,0.0000605864,0.0004995754],"genre_scores_gemma":[0.99752647,0.00048737664,0.0012030887,0.00005902516,0.000108162785,0.000112316084,0.0003347033,0.000073430776,0.000095423646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99664384,0.00022923444,0.0010577682,0.0008726955,0.0005037712,0.00069269806],"domain_scores_gemma":[0.997896,0.00039974155,0.00041241868,0.00090597355,0.00010264291,0.00028319983],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042403955,0.0005324515,0.0015306157,0.000782218,0.00005239022,0.00002353867,0.00023404826,0.00023080787,0.00021434684],"category_scores_gemma":[0.00024703526,0.00044579429,0.00018423518,0.0013619527,0.00028728135,0.00015853407,0.000135668,0.00042146476,0.000016214603],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024256743,0.016825775,0.80602914,0.0014299371,0.0067751976,0.0005751703,0.0028090952,0.013349441,0.010237644,0.00008760197,0.00008564423,0.11753862],"study_design_scores_gemma":[0.43716052,0.00807463,0.5376116,0.0010648535,0.0032743998,0.00002117049,0.000060644816,0.0060136775,0.005778127,0.0000060436287,0.0003895651,0.00054479804],"about_ca_topic_score_codex":0.0018394793,"about_ca_topic_score_gemma":0.0029878991,"teacher_disagreement_score":0.41290376,"about_ca_system_score_codex":0.0042266375,"about_ca_system_score_gemma":0.0015638316,"threshold_uncertainty_score":0.9997994},"labels":[],"label_agreement":null},{"id":"W2345643455","doi":"10.1182/blood.v124.21.2444.2444","title":"NK Cell Line Killing of Leukemia Cells Is Enhanced By Reverse Antibody Dependent Cell Mediated Cytotoxicity (R-ADCC) Via NKp30 and NKp44 and Target Fcγ Receptor II (CD32)","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Antibody-dependent cell-mediated cytotoxicity; Cytotoxicity; Cytotoxic T cell; CD16; Cell culture; Biology; Molecular biology; Flow cytometry; Natural killer cell; K562 cells; Fc receptor; Antibody; Monoclonal antibody; Immunology; Cancer research; Leukemia; In vitro; Antigen; CD8; CD3","score_opus":0.004149579595745044,"score_gpt":0.198646442221791,"score_spread":0.19449686262604596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345643455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927999,0.0020564923,0.0022780385,0.000046069657,0.0011925851,0.00026519172,0.000055335528,0.00005848171,0.001247923],"genre_scores_gemma":[0.98746914,0.0017295815,0.00029537542,0.00032978255,0.000049914914,0.000008175092,0.00039294505,0.00002871214,0.009696381],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99848115,0.00019657756,0.00048403014,0.00044842198,0.00006082488,0.00032897096],"domain_scores_gemma":[0.99908954,0.00014443092,0.00033190782,0.00027288098,0.00010925886,0.000051987103],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029451205,0.00027159136,0.00042103595,0.00010706683,0.00022737258,0.000014273536,0.00012768147,0.00039766627,0.0013834084],"category_scores_gemma":[0.000040602925,0.00025812438,0.00007914847,0.00009292467,0.00013775141,0.00013745116,0.00012058827,0.00039993573,0.00021142347],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019190734,0.00042604838,0.00021599849,0.000091375536,0.00008497788,4.4633333e-7,0.00045891016,0.000003648584,0.99058485,0.000001653808,0.007833515,0.00010664028],"study_design_scores_gemma":[0.0037392909,0.00063687505,0.00005822601,0.00004320612,0.00011182382,0.000008590384,0.00016724867,0.00007892541,0.9680879,0.000008519003,0.026799247,0.00026012116],"about_ca_topic_score_codex":0.00021818244,"about_ca_topic_score_gemma":0.000005827862,"teacher_disagreement_score":0.02249695,"about_ca_system_score_codex":0.00003486343,"about_ca_system_score_gemma":0.00003753637,"threshold_uncertainty_score":0.9999871},"labels":[],"label_agreement":null},{"id":"W2345859162","doi":"10.1182/blood.v122.21.5143.5143","title":"Small Molecule PRIMA-1 met Sensitizes Waldenstrom Macroglobulinemia Cells To Apoptosis and Displays Synergistic Cytotoxicity With Bortezomib","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Bortezomib; Viability assay; Apoptosis; Waldenstrom macroglobulinemia; Cancer research; MTT assay; Bone marrow; Dexamethasone; Multiple myeloma; Chemistry; Medicine; Molecular biology; Biology; Immunology; Internal medicine; Lymphoma; Biochemistry","score_opus":0.010641687648834278,"score_gpt":0.22699745948425654,"score_spread":0.21635577183542226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345859162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99615014,0.00011579629,0.00053623354,0.00044581742,0.000035759844,0.0012853858,0.000036874444,0.00010849493,0.0012855182],"genre_scores_gemma":[0.98287624,0.000031846084,0.015025815,0.0006371338,0.00016122591,0.00012623431,0.0000291737,0.00006683827,0.0010455142],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977511,0.00006128076,0.00032199456,0.00063189433,0.00051548093,0.0007182089],"domain_scores_gemma":[0.9981599,0.0001824251,0.00007147304,0.0006509951,0.00022787279,0.0007073245],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001513053,0.0003278501,0.00053378893,0.00013136383,0.00010249781,0.00010050638,0.00016064952,0.00014369297,0.00013167657],"category_scores_gemma":[0.00015248577,0.00025030912,0.00007414106,0.00030323814,0.00018517197,0.00006380836,0.00021859004,0.00026511992,0.00023728979],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003240472,0.0007097103,0.0007739878,0.00045207268,0.0004263445,0.000653153,0.00027868478,0.000044211964,0.9928195,0.00006273106,0.0026809073,0.0007746802],"study_design_scores_gemma":[0.020499779,0.00092478545,0.001982348,0.0002554122,0.00053389865,0.0006857021,0.00013108218,0.0021461938,0.97228175,0.000015462818,0.00015142531,0.00039215214],"about_ca_topic_score_codex":0.0017036648,"about_ca_topic_score_gemma":0.00006230109,"teacher_disagreement_score":0.02053771,"about_ca_system_score_codex":0.0010176158,"about_ca_system_score_gemma":0.0012288319,"threshold_uncertainty_score":0.99999493},"labels":[],"label_agreement":null},{"id":"W2345869085","doi":"10.1182/blood.v122.21.2927.2927","title":"Transition From Pediatric To Adult Care Of High Cost Patients In a Medicaid Population With Sickle Cell Disease","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicaid; Medicine; Population; Pediatrics; Emergency medicine; Health care; Logistic regression; Emergency department; Disease; Total cost; Demography; Internal medicine; Environmental health","score_opus":0.011044402160463212,"score_gpt":0.29064751053755217,"score_spread":0.27960310837708896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345869085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964248,0.00009798821,0.00005445844,0.0007794519,0.00015037035,0.0020061529,0.00036440656,0.000032734108,0.00008962291],"genre_scores_gemma":[0.99729383,0.000051824554,0.00026605037,0.0006679338,0.0004564666,0.00019634653,0.0010283914,0.000021244554,0.000017925828],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984998,0.00021277601,0.00043395098,0.00022897334,0.00032097442,0.00030349987],"domain_scores_gemma":[0.99889004,0.00009695105,0.00015765041,0.00019098002,0.00031974932,0.0003446457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000056008772,0.00011993533,0.0002069294,0.00013519153,0.00011089296,0.0000027762424,0.00008469606,0.00012954717,0.00021118828],"category_scores_gemma":[0.00005818462,0.0001000251,0.00002600772,0.0003080891,0.0000073445353,0.00010634478,0.000020700625,0.0002525693,0.00013226876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009197689,0.0003063302,0.99199915,0.00055190094,0.0000020679227,0.000002060175,0.005905875,0.0000090334115,0.0000018017338,0.000005811163,0.00056419976,0.00055980694],"study_design_scores_gemma":[0.0038366977,0.00012118446,0.99421555,0.00015468422,0.000076601966,1.1813013e-8,0.0013856263,0.000010750226,0.0000067252745,0.000048178517,0.00002950228,0.000114480725],"about_ca_topic_score_codex":0.019301878,"about_ca_topic_score_gemma":0.002728213,"teacher_disagreement_score":0.016573664,"about_ca_system_score_codex":0.00006323551,"about_ca_system_score_gemma":0.00019338563,"threshold_uncertainty_score":0.9872287},"labels":[],"label_agreement":null},{"id":"W2346269859","doi":"10.1182/blood-2016-04-709899","title":"CSF3R mutations have a high degree of overlap with CEBPA mutations in pediatric AML","year":2016,"lang":"en","type":"letter","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"National Cancer Institute; National Institutes of Health","keywords":"CEBPA; Myeloid; Mutation; Medicine; Childhood cancer; Cancer research; Oncology; Genetics; Biology; Internal medicine; Cancer; Gene","score_opus":0.024179097875192252,"score_gpt":0.27582212293250924,"score_spread":0.251643025057317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346269859","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42034784,0.00070569565,0.00035427103,0.5550184,0.00023244404,0.0033154916,0.0012080831,0.00018106012,0.018636681],"genre_scores_gemma":[0.7277338,0.0009729056,0.017726548,0.16969003,0.021514267,0.0018306955,0.0063582747,0.0009078012,0.05326571],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9971931,0.00013114284,0.0005635877,0.00055846,0.0009018002,0.00065193436],"domain_scores_gemma":[0.99777985,0.00064218044,0.00029542012,0.0007549593,0.00039774788,0.00012984195],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019619078,0.00036368932,0.00072582316,0.0011756163,0.000057561334,0.000018758554,0.00029990936,0.00067445653,0.00029708399],"category_scores_gemma":[0.00029319487,0.0002642142,0.00014384821,0.00066405407,0.00023709271,0.000097736694,0.00008670602,0.0017863112,0.00016597704],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034053824,0.001212998,0.1844706,0.0028710943,0.0012548298,0.01392613,0.0012600229,0.000012259722,0.0008124402,0.00017267215,0.791511,0.0021554364],"study_design_scores_gemma":[0.12018908,0.0066242334,0.55615896,0.004100482,0.0159206,0.004092866,0.00094756833,0.000111136564,0.0073372056,0.002681352,0.2777251,0.0041113924],"about_ca_topic_score_codex":0.0004613829,"about_ca_topic_score_gemma":0.0001762231,"teacher_disagreement_score":0.5137859,"about_ca_system_score_codex":0.00026383245,"about_ca_system_score_gemma":0.0017032976,"threshold_uncertainty_score":0.999981},"labels":[],"label_agreement":null},{"id":"W2346498289","doi":"10.1182/blood.v122.21.4653.4653","title":"Rituximab For The Treatment Of Hepatitis C Associated IgM Mediated Cold Hemolytic Anemia – Case Report and Literature Review","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; St. Joseph's Hospital","funders":"","keywords":"Medicine; Rituximab; Internal medicine; Gastroenterology; Autoimmune hemolytic anemia; Anemia; Antibody; Immunology; Hemolytic anemia; Pediatrics","score_opus":0.00928678729400061,"score_gpt":0.24427590562862161,"score_spread":0.234989118334621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346498289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87755924,0.11781866,0.000008097308,0.0020839213,0.00005650863,0.0022441735,0.00009667571,0.000030874515,0.00010184857],"genre_scores_gemma":[0.90750164,0.09080749,0.00023732099,0.00044867137,0.00006832164,0.0002910786,0.00019882132,0.000021161668,0.00042547175],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9991741,0.000025061543,0.00031647156,0.00019547559,0.00013513431,0.00015372684],"domain_scores_gemma":[0.9990965,0.00020813242,0.00012334892,0.00027821268,0.00020371078,0.00009005654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013867566,0.0001353099,0.00043757702,0.000027067228,0.00007457542,0.000015605801,0.000027815817,0.00010327015,0.000045056328],"category_scores_gemma":[0.00011421661,0.000080508966,0.00011357449,0.00017493428,0.000039083116,0.000040969306,0.0000061336405,0.00007088434,0.0000028769075],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005558942,0.06849069,0.2780072,0.038250875,0.010003588,0.40378076,0.00801639,3.9404588e-7,0.04522638,0.0005575422,0.036741626,0.11036866],"study_design_scores_gemma":[0.17733742,0.022418736,0.15879077,0.035216834,0.046558607,0.4577677,0.00032546438,0.0009724274,0.055269036,0.00037373914,0.04315255,0.0018167284],"about_ca_topic_score_codex":0.0005334226,"about_ca_topic_score_gemma":0.00014567154,"teacher_disagreement_score":0.17678154,"about_ca_system_score_codex":0.000017336577,"about_ca_system_score_gemma":0.000037412014,"threshold_uncertainty_score":0.32830602},"labels":[],"label_agreement":null},{"id":"W2346727982","doi":"10.1182/blood-2015-03-569277","title":"HUS and the case for complement","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Canadian Blood Services; Natural Sciences and Engineering Research Council of Canada; CSL Behring","keywords":"Microangiopathic hemolytic anemia; Thrombotic microangiopathy; Complement system; Shiga toxin; Atypical hemolytic uremic syndrome; Immunology; Eculizumab; Alternative complement pathway; Hemolytic anemia; Complement (music); Coagulation; Disease; Medicine; Biology; Escherichia coli; Microbiology; Thrombotic thrombocytopenic purpura; Internal medicine; Antibody; Platelet; Phenotype; Genetics; Complementation","score_opus":0.04636097028928599,"score_gpt":0.2854771537793594,"score_spread":0.2391161834900734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346727982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99005485,0.0069269687,0.00012048057,0.0005781089,0.00029503563,0.0008377621,0.00013936512,0.000037347883,0.0010101026],"genre_scores_gemma":[0.9992672,0.000003284755,0.00007274256,0.00011442196,0.00003057816,0.00013902101,0.000035116325,0.0000046560185,0.00033294145],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995346,0.00009892893,0.00012330526,0.00010250349,0.000011037906,0.00012958913],"domain_scores_gemma":[0.99955624,0.00019302707,0.000039730683,0.00015698222,0.00003750692,0.0000164871],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027922067,0.000059497423,0.000109406705,0.000014559602,0.00011668492,0.000010557062,0.000073482246,0.000020890631,0.00011118727],"category_scores_gemma":[0.00006904671,0.00003749273,0.000032260166,0.000017858112,0.00010503073,0.00001429065,0.00006896034,0.000026814718,0.000055083085],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024192042,0.0023542887,0.041031174,0.00030084545,0.003212112,0.00047350815,0.007675363,0.000005486786,0.011215013,0.18417373,0.74068326,0.006456001],"study_design_scores_gemma":[0.1428373,0.0009251531,0.0036778955,0.000058592024,0.0014982135,0.010484061,0.012988846,0.000034294957,0.0154167935,0.011853908,0.7996548,0.0005701699],"about_ca_topic_score_codex":0.00014159358,"about_ca_topic_score_gemma":0.0000927535,"teacher_disagreement_score":0.17231983,"about_ca_system_score_codex":0.000004833329,"about_ca_system_score_gemma":0.000018121975,"threshold_uncertainty_score":0.1528909},"labels":[],"label_agreement":null},{"id":"W2346948763","doi":"10.1182/blood.v124.21.424.424","title":"Genetic Determinants of Busulfan Clearance and Outcomes in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation- Result of a Multicentric Prospective Study on Behalf of the Pediatric Disease Working Party of the European Blood and Marrow Transplantation Group","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; Hospital for Sick Children; SickKids Foundation; University of Toronto; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Busulfan; Melphalan; Hematopoietic stem cell transplantation; Internal medicine; Transplantation; Oncology; Hazard ratio; Fludarabine; Cyclophosphamide; Surgery; Gastroenterology; Chemotherapy; Confidence interval","score_opus":0.00901172426914697,"score_gpt":0.21943606529955834,"score_spread":0.21042434103041135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346948763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978709,0.00021504829,0.000027912509,0.000008101819,0.000058036236,0.0016817686,0.000048820362,0.000008121844,0.00008126902],"genre_scores_gemma":[0.9993471,0.00046804402,0.00010337391,0.000005772497,0.00001871846,0.000019895904,0.0000031659415,0.00002941627,0.000004512768],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99756616,0.0005154798,0.0008874644,0.0003279526,0.0005184253,0.00018448876],"domain_scores_gemma":[0.99837095,0.00053247035,0.0006245131,0.00031128782,0.000086617474,0.00007418143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040474578,0.00020787044,0.000461696,0.00018662082,0.000057078254,0.0000061150026,0.00014714869,0.00005166504,7.936826e-7],"category_scores_gemma":[0.000052923428,0.0001419002,0.00008948171,0.00047122032,0.00008373719,0.000047526974,0.00002019364,0.00013633938,2.4498257e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036756892,0.0023583255,0.98277503,0.0049190014,0.000031299216,0.000013091824,0.008535532,0.000034966175,0.00075198035,0.0000064436335,6.1963036e-8,0.00020668238],"study_design_scores_gemma":[0.012916176,0.000559648,0.9735529,0.00064040546,0.0026627583,0.000009899509,0.0004100331,0.00003725795,0.009081052,0.000013349666,1.3273697e-8,0.00011652854],"about_ca_topic_score_codex":0.000026642918,"about_ca_topic_score_gemma":0.000081769416,"teacher_disagreement_score":0.012548607,"about_ca_system_score_codex":0.000009029834,"about_ca_system_score_gemma":0.00004660675,"threshold_uncertainty_score":0.5786522},"labels":[],"label_agreement":null},{"id":"W2347131152","doi":"10.1182/blood.v126.23.326.326","title":"Nuclear Export Inhibitor KPT-8602 Is Highly Active Against Leukemic Blasts and Leukemia-Initiating Cells in Patient-Derived Xenograft Models of AML","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Nuclear export signal; Leukemia; Medicine; Adverse effect; Clinical trial; Internal medicine; Chemotherapy; Refractory (planetary science); Haematopoiesis; Oncology; Cancer research; Pharmacology; Stem cell; Biology; Cell nucleus","score_opus":0.010118924382143115,"score_gpt":0.19634200877313182,"score_spread":0.1862230843909887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2347131152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99794215,0.00015947114,0.000020111203,0.000015714426,0.00012496076,0.00015237792,0.000033234028,0.0000133008725,0.0015386879],"genre_scores_gemma":[0.99879694,0.000092023,0.00064061576,0.00024503478,0.00012533384,0.00000497741,0.00004076908,0.000033380933,0.000020946847],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990592,0.000037481346,0.00025389894,0.00031142365,0.00013645027,0.00020157234],"domain_scores_gemma":[0.9994511,0.000006442735,0.00014822767,0.00020791337,0.00008784703,0.0000984682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006300638,0.00016026609,0.0001832787,0.00006192623,0.00003613998,0.000014534001,0.00007884653,0.00018930218,0.00000417336],"category_scores_gemma":[0.00002220491,0.0001603924,0.000053133266,0.00007985664,0.00006545242,0.000017294984,0.000116469055,0.00011900109,0.0000034406476],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013785492,0.00006811726,0.00032081455,0.000018523499,0.000046050398,0.000007994193,0.0014157462,0.00009080058,0.9947277,0.000008986961,0.0005510638,0.0026064017],"study_design_scores_gemma":[0.0022040997,0.0005677104,0.0004889482,0.000033827015,0.000033186465,0.000012869489,0.0011302653,0.0003527786,0.99374074,0.00009319135,0.0011339011,0.00020850317],"about_ca_topic_score_codex":0.000041777676,"about_ca_topic_score_gemma":0.000012201255,"teacher_disagreement_score":0.0023978986,"about_ca_system_score_codex":0.000029960089,"about_ca_system_score_gemma":0.000094289666,"threshold_uncertainty_score":0.65406126},"labels":[],"label_agreement":null},{"id":"W2351739364","doi":"10.1182/blood.v122.21.919.919","title":"Striking Predictive Power For Relapse and Decreased Survival Associated With Detectable Minimal Residual Disease by IGH VDJ Deep Sequencing Of Bone Marrow Pre- and Post-Allogeneic Transplant In Children With B-Lineage ALL: A Subanalysis Of The COG ASCT0431/PBMTC ONC051 Study","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of Manitoba","funders":"","keywords":"Minimal residual disease; Medicine; Internal medicine; Bone marrow; Oncology; Regimen; Cohort","score_opus":0.006558864223106884,"score_gpt":0.22179664698186285,"score_spread":0.21523778275875596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2351739364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99575436,0.00042871758,0.00009718591,0.00006411604,0.000005310228,0.0030394564,0.00057879416,0.000020072612,0.0000119832885],"genre_scores_gemma":[0.999239,0.000018706078,0.00029499742,0.000029448285,0.000013701664,0.00017984753,0.00013252514,0.000050699604,0.000041030606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975318,0.00027347307,0.0004988273,0.00049786817,0.00075492874,0.0004431554],"domain_scores_gemma":[0.9981997,0.00057523325,0.00028597467,0.00035188344,0.00030530838,0.0002819116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062505755,0.00027814053,0.00069632527,0.00018530137,0.0000835406,0.0000244787,0.00014604005,0.00011436059,0.00001149121],"category_scores_gemma":[0.0005401097,0.00017528379,0.000070394155,0.00042179337,0.00025592692,0.00012323477,0.00006740959,0.00023325434,4.5447084e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048875106,0.0013953617,0.9496199,0.00009539907,0.0031884229,0.000043000295,0.001703923,0.000044267308,0.038990468,0.000001224183,0.000006993559,0.000023543216],"study_design_scores_gemma":[0.026238307,0.0038917256,0.951344,0.0003625884,0.0050140605,0.000049355695,0.0013101571,0.0016658012,0.009926224,0.0000035261437,1.9801821e-7,0.00019402427],"about_ca_topic_score_codex":0.0022302372,"about_ca_topic_score_gemma":0.001791704,"teacher_disagreement_score":0.029064244,"about_ca_system_score_codex":0.00016649415,"about_ca_system_score_gemma":0.00077100785,"threshold_uncertainty_score":0.7147865},"labels":[],"label_agreement":null},{"id":"W2352311707","doi":"10.1182/blood.v124.21.5057.5057","title":"Immune Tolerance Induction in Severe Hemophilia a Patients Using Wilate®, a Von Willebrand Factor/Factor VIII Concentrate","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Medicine; Haemophilia A; Haemophilia; Von Willebrand factor; Factor IX; Von Willebrand disease; Antibody; Coagulopathy; Immune tolerance; Immunology; Internal medicine; Immune system; Surgery; Platelet","score_opus":0.023028726511939865,"score_gpt":0.2731281934131488,"score_spread":0.25009946690120893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2352311707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981537,0.00024710302,0.0000053500216,0.00016488193,0.00020490843,0.00063338317,0.0000170643,0.00004390802,0.0005296872],"genre_scores_gemma":[0.99914885,0.00006968046,0.00013040825,0.00005647561,0.00018031294,0.000012063133,0.000040696727,0.000030241528,0.00033127636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843574,0.00008919966,0.00032474758,0.00034106086,0.00037236587,0.00043691366],"domain_scores_gemma":[0.99933124,0.000038706272,0.000082183185,0.0002788186,0.00010470387,0.00016432523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009891209,0.00021281169,0.00038963702,0.00013447794,0.00009500391,0.000027896485,0.000080192134,0.00017080067,0.00012981119],"category_scores_gemma":[0.00008314402,0.00016919736,0.00008672045,0.00028652573,0.000068553454,0.00017576004,0.000037340702,0.00029197265,0.00003743545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002868051,0.0013700038,0.9244792,0.00012397309,0.00009508834,0.00003583779,0.00069862267,0.000010727173,0.067417376,0.000008915588,0.000012477746,0.0054609706],"study_design_scores_gemma":[0.021760775,0.00082072377,0.8986505,0.0005327386,0.000098718,0.00004909232,0.000049803235,0.00084226293,0.076134145,0.000050067087,0.00067221833,0.0003389282],"about_ca_topic_score_codex":0.00008631616,"about_ca_topic_score_gemma":0.00001003635,"teacher_disagreement_score":0.02582868,"about_ca_system_score_codex":0.000105866144,"about_ca_system_score_gemma":0.00009021578,"threshold_uncertainty_score":0.6899668},"labels":[],"label_agreement":null},{"id":"W2352795241","doi":"10.1182/blood.v122.21.130.130","title":"A Transgenic Model Of Multiple Myeloma Bone Disease Shows Profound Mesenchymal Stem Cell Impairment","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Genetically modified mouse; Apposition; Osteoclast; Transgene; Bone disease; Mesenchymal stem cell; Pathology; Osteolysis; Multiple myeloma; Osteoblast; Bone mineral; Biology; Immunology; Internal medicine; Osteoporosis; Medicine; Anatomy; Surgery; In vitro; Genetics; Receptor","score_opus":0.027330745517966923,"score_gpt":0.26134452595986196,"score_spread":0.23401378044189503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2352795241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956174,0.0006720102,0.00016654024,0.0002585046,0.000023194792,0.0022631611,0.00012324622,0.000062817424,0.00081311783],"genre_scores_gemma":[0.9936051,0.00004734073,0.0018807845,0.000043986733,0.000050588777,0.00045977894,0.000055542485,0.000038676288,0.003818236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980847,0.000051973628,0.00036715355,0.00036452946,0.00059611397,0.0005354944],"domain_scores_gemma":[0.9984587,0.00005791619,0.00007779938,0.0005107865,0.00015036894,0.00074445555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010495268,0.00023504437,0.00038677442,0.0001241176,0.000068747126,0.000020586363,0.00011737119,0.000071970244,0.00029720447],"category_scores_gemma":[0.000021603428,0.00017965937,0.00023800346,0.00013192081,0.000081156206,0.0001276161,0.000053031596,0.000147601,0.00014833434],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024512364,0.026648764,0.48763153,0.0024995496,0.0011968011,0.00052659394,0.001664029,0.0002079045,0.46242753,0.00006886517,0.00088381773,0.013793393],"study_design_scores_gemma":[0.065419905,0.003210583,0.4452686,0.00035750362,0.001574135,0.000060994673,0.0005490108,0.13874231,0.3436234,0.0003054712,0.00011744149,0.00077061635],"about_ca_topic_score_codex":0.00013116059,"about_ca_topic_score_gemma":0.000022349846,"teacher_disagreement_score":0.13853441,"about_ca_system_score_codex":0.000050712224,"about_ca_system_score_gemma":0.00028949126,"threshold_uncertainty_score":0.73262966},"labels":[],"label_agreement":null},{"id":"W2361747243","doi":"10.1182/blood.v126.23.3279.3279","title":"Epidemiologic and Clinical Characteristics of Thalassemia (Thal) Intermedia (TI) in the United States","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Thalassemia; Internal medicine; Pediatrics; Gastroenterology","score_opus":0.045561600271483524,"score_gpt":0.3281417677785097,"score_spread":0.28258016750702614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2361747243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967358,0.00041061552,0.000010421956,0.0016808193,0.00009940111,0.00017435798,0.0000075995167,0.000014427413,0.0008665242],"genre_scores_gemma":[0.9967334,0.002030505,0.000118709795,0.00095077045,0.00005182918,0.00000375226,0.000074742726,0.0000071218865,0.000029114592],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99894005,0.00021697926,0.00045239428,0.00013103792,0.00010473632,0.00015478914],"domain_scores_gemma":[0.9990017,0.0005334686,0.000116204756,0.00018089752,0.000064601925,0.000103127255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011876079,0.00008903722,0.0003278034,0.00006941962,0.000012295612,0.000004468175,0.000083549676,0.00015909206,0.000007251133],"category_scores_gemma":[0.0018724836,0.000048929593,0.00004854982,0.00017644974,0.00020843555,0.000016476688,0.000040158833,0.00033879757,0.0000065403597],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006309694,0.0006178376,0.9949842,0.00004320182,0.000057685258,0.000077092314,0.0010817043,7.357926e-7,0.000033134602,0.00012990991,0.00091250945,0.0019988911],"study_design_scores_gemma":[0.0053048357,0.0011915739,0.98252237,0.00022811102,0.0002820629,0.00016661947,0.0042178296,0.0007189794,0.000056108056,0.0009282729,0.0042679203,0.00011531395],"about_ca_topic_score_codex":0.00007985053,"about_ca_topic_score_gemma":0.000007419822,"teacher_disagreement_score":0.012461827,"about_ca_system_score_codex":0.0000064354094,"about_ca_system_score_gemma":0.000049452527,"threshold_uncertainty_score":0.22416732},"labels":[],"label_agreement":null},{"id":"W2378971247","doi":"10.1182/blood.v124.21.4191.4191","title":"A Phase II Study Evaluating the Efficacy of Rituximab in the Management of Patients with Relapsed or Refractory TTP","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital; London Health Sciences Centre; McMaster University; Canadian Apheresis Group; Hamilton Health Sciences","funders":"","keywords":"Rituximab; Medicine; Refractory (planetary science); Internal medicine; Thrombotic thrombocytopenic purpura; Gastroenterology; Adverse effect; ADAMTS13; Phases of clinical research; Surgery; Clinical trial; Platelet; Lymphoma","score_opus":0.029932380112028558,"score_gpt":0.31955054555701745,"score_spread":0.2896181654449889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2378971247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979132,0.00017534304,0.0000054590864,0.000022420425,0.00006490766,0.0014913371,0.000019654935,0.000010235979,0.00029745392],"genre_scores_gemma":[0.99972695,0.0000012778437,0.000036642792,0.000020296982,0.0000067117244,0.000099517965,0.000025986577,0.000007785509,0.000074803094],"study_design_codex":"nonrandomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9984652,0.00073295727,0.00037152704,0.0001707623,0.00011112342,0.00014843167],"domain_scores_gemma":[0.9987275,0.0004040798,0.00025808855,0.0005478855,0.000056908608,0.0000055537253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083065766,0.00010495679,0.00021835983,0.0000481639,0.000116040304,0.0000036037695,0.00037247452,0.000025728461,0.00013239757],"category_scores_gemma":[0.00008898853,0.000049662984,0.00003833928,0.00014637718,0.00007894232,0.000024515783,0.0001268406,0.00009268503,0.0000095995],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016377915,0.5114328,0.37289122,0.0007623186,0.005480094,0.000019243156,0.029625408,0.000029572217,0.011013244,0.0010131029,0.0010829356,0.05027211],"study_design_scores_gemma":[0.23590155,0.042416796,0.70806533,0.00043757472,0.0017325158,0.00000299154,0.008732602,0.000008526433,0.0014222572,0.000036196998,0.0010066992,0.00023699053],"about_ca_topic_score_codex":0.000025854008,"about_ca_topic_score_gemma":0.000025022448,"teacher_disagreement_score":0.46901605,"about_ca_system_score_codex":0.000007631901,"about_ca_system_score_gemma":0.000019157558,"threshold_uncertainty_score":0.20251977},"labels":[],"label_agreement":null},{"id":"W23836559","doi":"10.1182/blood-2011-01-331819","title":"Le trasformazioni territoriali della città di Torino: il ruolo della valutazione","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Urban Planning and Valuation","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; National Institutes of Health","keywords":"Humanities; Art","score_opus":0.03201942351143661,"score_gpt":0.2182648100855926,"score_spread":0.18624538657415599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W23836559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9291781,0.000059060963,0.00033061358,0.000044946235,0.00083832897,0.00013994268,0.000009206562,0.00009637774,0.06930342],"genre_scores_gemma":[0.9967619,0.000014106072,0.0012900004,0.000047652982,0.00037684094,0.00001634936,0.000016057886,0.000016967464,0.0014601131],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988547,0.000057627116,0.0002096474,0.00027128326,0.00032048643,0.00028623387],"domain_scores_gemma":[0.99952453,0.000022392433,0.00007502394,0.00025310274,0.000008553709,0.000116416835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029713905,0.00013653826,0.00012166585,0.000026631336,0.00018723025,0.000027763333,0.00021646677,0.00009967294,0.0005806179],"category_scores_gemma":[0.00002563434,0.00013032739,0.00006053283,0.00012398083,0.00007342114,0.00018899953,0.00007718904,0.00010598959,0.00076825835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014146659,0.0031641817,0.87640786,0.000029988285,0.00016640326,0.0000633584,0.011451404,0.0003899535,0.05493965,0.0025557629,0.03596753,0.01472243],"study_design_scores_gemma":[0.0066694673,0.001128743,0.6985185,0.00006609744,0.00041794922,0.00012914109,0.0005365833,0.0013635128,0.12558198,0.0037946284,0.16035289,0.001440502],"about_ca_topic_score_codex":0.0016721847,"about_ca_topic_score_gemma":0.000108122345,"teacher_disagreement_score":0.17788936,"about_ca_system_score_codex":0.000039127186,"about_ca_system_score_gemma":0.000026032807,"threshold_uncertainty_score":0.9874663},"labels":[],"label_agreement":null},{"id":"W2389117332","doi":"10.1182/blood.v124.21.4259.4259","title":"FEIBA™ for Patients on Direct Oral Anticoagulants Requiring Urgent Surgery","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Apixaban; Dabigatran; Rivaroxaban; Surgery; Warfarin; Atrial fibrillation; Population; Edoxaban; Internal medicine","score_opus":0.08473914533738264,"score_gpt":0.3242674157043054,"score_spread":0.23952827036692276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2389117332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99457276,0.000018286511,0.00010575066,0.0004783048,0.00049865484,0.00042773708,0.000004189512,0.00008118001,0.0038131205],"genre_scores_gemma":[0.9975429,0.000012766945,0.0003275244,0.00031270785,0.00061721227,0.0000038476373,0.000059741524,0.000018682991,0.0011046277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99922454,0.000025676698,0.00020425861,0.00017146161,0.00018659855,0.00018743651],"domain_scores_gemma":[0.9993426,0.0002808793,0.00007179692,0.00016969649,0.000044128774,0.000090903144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025902063,0.00009810625,0.00031394325,0.00009807142,0.000061452934,0.000015226535,0.000030611955,0.000037801146,0.000040317325],"category_scores_gemma":[0.0007874181,0.00007941494,0.00015757034,0.00007459514,0.0000106895295,0.000040080635,0.000021035006,0.000027978966,0.000046545167],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014008161,0.000081322236,0.9894977,0.000069366106,0.00009805494,0.0000015515767,0.000014872982,0.000003186132,0.0001273664,0.0002503734,0.0025721798,0.007143914],"study_design_scores_gemma":[0.004822302,0.00038591918,0.9102598,0.0001237654,0.00038605076,8.2347486e-7,0.0000065485174,0.00017015052,0.00397976,0.000098882396,0.07956934,0.00019665124],"about_ca_topic_score_codex":0.000004540109,"about_ca_topic_score_gemma":0.0000012021321,"teacher_disagreement_score":0.07923792,"about_ca_system_score_codex":0.000010755616,"about_ca_system_score_gemma":0.000012530434,"threshold_uncertainty_score":0.32384473},"labels":[],"label_agreement":null},{"id":"W2392037591","doi":"10.1182/blood-2015-06-652636","title":"Abnormalities of follicular helper T-cell number and function in Wiskott-Aldrich syndrome","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"BCL6; Wiskott–Aldrich syndrome protein; Biology; Immunology; Germinal center; Adoptive cell transfer; T cell; Interleukin 21; B cell; Cell; Cell biology; Immune system; Antibody; Genetics; Actin cytoskeleton","score_opus":0.010693000732175655,"score_gpt":0.24619297440982213,"score_spread":0.23549997367764647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2392037591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931445,0.00045128714,0.0000552959,0.0001999022,0.000024435598,0.0001985057,0.0000035880053,0.000015777376,0.005906715],"genre_scores_gemma":[0.99282664,0.00019048787,0.00015925293,0.00005009382,0.000021381695,0.00001545687,0.0000028831878,0.000016559548,0.0067172186],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990826,0.000048819842,0.00019464889,0.0001816488,0.00029106002,0.00020120807],"domain_scores_gemma":[0.99952304,0.00007322998,0.00003424954,0.00021346791,0.00006531992,0.00009069992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019031305,0.00008809829,0.00020202383,0.000110036344,0.000015451007,0.000005420088,0.000043711843,0.00007550475,0.0005559523],"category_scores_gemma":[0.000056436875,0.000059166206,0.000044750555,0.00015862432,0.00006915506,0.00005880918,0.000055799417,0.00008246369,0.00011005321],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013577155,0.00073839986,0.5760147,0.00030853378,0.000059682923,0.00029937888,0.00014239523,2.3949738e-7,0.42043328,0.00014400706,0.00033165855,0.0013919777],"study_design_scores_gemma":[0.010872963,0.00079409516,0.6880087,0.00032803838,0.00014791968,0.0007205445,0.00023223514,0.0000068039817,0.2945094,0.0003148398,0.003866222,0.00019821005],"about_ca_topic_score_codex":0.000078819765,"about_ca_topic_score_gemma":0.000009322712,"teacher_disagreement_score":0.12592387,"about_ca_system_score_codex":0.000017075121,"about_ca_system_score_gemma":0.00004499626,"threshold_uncertainty_score":0.60872877},"labels":[],"label_agreement":null},{"id":"W2394632625","doi":"10.1182/blood.v122.21.1681.1681","title":"Systematic Review and Meta-Analysis Of Rituximab For The Treatment Of Immune Thrombocytopenia In Adults","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; St. Joseph's Hospital; McMaster University","funders":"","keywords":"Rituximab; Medicine; Internal medicine; Thrombocytopenic purpura; Placebo; Randomized controlled trial; Relative risk; Meta-analysis; Gastroenterology; Immunology; Platelet; Confidence interval; Lymphoma; Pathology","score_opus":0.029294832456956767,"score_gpt":0.28917529063624464,"score_spread":0.2598804581792879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2394632625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5640619,0.43107533,0.000004096608,0.0005315147,0.000003478123,0.00419896,0.00004932211,0.0000035157711,0.00007192442],"genre_scores_gemma":[0.9829228,0.015776228,0.00019285586,0.00006431329,0.0000011383526,0.00085115404,0.00002141568,0.000006276142,0.00016382377],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9992304,0.000029635714,0.00045897058,0.000112491274,0.00008515089,0.00008338643],"domain_scores_gemma":[0.99926585,0.00015754651,0.00018354431,0.00030959464,0.000062576444,0.00002090336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010031511,0.000102967,0.0024986141,0.0000642993,0.000013910829,0.0000029972973,0.00004207629,0.000023627721,0.000104053936],"category_scores_gemma":[0.000035632085,0.000045990226,0.0005277252,0.00020648076,0.000024794028,0.000024163432,0.000006506731,0.000013852137,0.0000030197677],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007015806,0.0120024085,0.0018828323,0.16841163,0.8160487,0.000022788552,0.0010365397,0.0000012742191,0.00022021795,0.00009750939,0.000026778085,0.00017919455],"study_design_scores_gemma":[0.0059052673,0.00056728884,0.005801883,0.0010692531,0.98569876,0.000009131081,0.00009335784,0.00005957335,0.00072171394,0.000025663116,0.0000027595015,0.00004536081],"about_ca_topic_score_codex":0.0005617804,"about_ca_topic_score_gemma":0.00009785815,"teacher_disagreement_score":0.41886094,"about_ca_system_score_codex":0.000007786712,"about_ca_system_score_gemma":0.000010094344,"threshold_uncertainty_score":0.18754269},"labels":[],"label_agreement":null},{"id":"W2395266396","doi":"10.1182/blood-2015-11-679639","title":"Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis","year":2016,"lang":"en","type":"letter","venue":"Blood","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":547,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Université de Montréal","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Cytomegalovirus; Medicine; Bone marrow transplantation; Leukemia; Transplantation; Oncology; Hematopoietic cell; Cytomegalovirus infections; Bone marrow; Internal medicine; Immunology; Human cytomegalovirus; Herpesviridae; Viral disease; Human immunodeficiency virus (HIV); Virus; Stem cell; Biology; Haematopoiesis","score_opus":0.028428325757117054,"score_gpt":0.29395086145055865,"score_spread":0.2655225356934416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2395266396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9301297,0.000381645,0.000021253329,0.06292975,0.000061782426,0.0015767358,0.0007939174,0.00012156935,0.003983635],"genre_scores_gemma":[0.9707491,0.00035382458,0.000008242251,0.023964664,0.0008881502,0.0002491986,0.0031939815,0.000106183616,0.00048668258],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994356,0.0008639142,0.00089653436,0.000942128,0.001957214,0.0009842113],"domain_scores_gemma":[0.9971434,0.0007356086,0.00046521457,0.001198938,0.0002941324,0.00016274732],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0016264612,0.00061537995,0.0013719896,0.0013898798,0.00016832615,0.00012466614,0.0004845559,0.000929064,0.0002459466],"category_scores_gemma":[0.0002283697,0.000354563,0.00056860875,0.002977831,0.00021605169,0.00017149218,0.000036905727,0.0050203805,0.00007588564],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008287796,0.0025808697,0.92488027,0.00039539998,0.018224938,0.0056637856,0.001368006,0.0000012579886,0.0013908767,0.00004054747,0.04070599,0.003919283],"study_design_scores_gemma":[0.0079446705,0.0003708725,0.9358378,0.0010311031,0.009109559,0.00004386202,0.000010012845,0.00001860227,0.00015958722,0.00006746706,0.04485044,0.00055600214],"about_ca_topic_score_codex":0.0027562564,"about_ca_topic_score_gemma":0.0029030023,"teacher_disagreement_score":0.04061936,"about_ca_system_score_codex":0.0003423427,"about_ca_system_score_gemma":0.00077260693,"threshold_uncertainty_score":0.9998906},"labels":[],"label_agreement":null},{"id":"W2395420640","doi":"10.1182/blood-2016-02-701144","title":"Acute myeloid leukemia with myelodysplasia-related changes demonstrating prominent basophilic differentiation","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pancytopenia; Bone marrow; Basophilic; Dysplasia; Myeloid leukemia; Medicine; Pathology; Leukemia; Myeloid; Preleukemia; Cytopenia; Immunology","score_opus":0.011426750208982789,"score_gpt":0.2429502136947868,"score_spread":0.23152346348580402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2395420640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98986506,0.00013514789,0.00028820246,0.005794304,0.0000647921,0.0009724085,0.000023748795,0.0002557488,0.0026006012],"genre_scores_gemma":[0.9937044,0.00021902627,0.0014779154,0.00014356633,0.00026735433,0.00016464897,0.000060565257,0.000078625744,0.0038839371],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99773437,0.00007909776,0.0003415727,0.00056300015,0.00063305954,0.0006489101],"domain_scores_gemma":[0.998651,0.00014036015,0.00017932798,0.0005292658,0.00019153777,0.00030847007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002346318,0.00032583412,0.00042498868,0.00024539788,0.00015038931,0.00003727086,0.00019296035,0.0002204009,0.000259701],"category_scores_gemma":[0.00014420194,0.0001870798,0.00008195208,0.0004043784,0.000170125,0.00015790146,0.000099336314,0.0003513099,0.00016597641],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043322105,0.0002638813,0.03841917,0.0001247374,0.0011333687,0.0004294978,0.0003175841,5.5301234e-7,0.9330993,0.0003193285,0.00037060466,0.025088737],"study_design_scores_gemma":[0.031028304,0.002913346,0.17236663,0.0013678649,0.0018820212,0.002400377,0.00015819159,0.00044285125,0.78562367,0.00019541496,0.00085020746,0.0007711133],"about_ca_topic_score_codex":0.000019001473,"about_ca_topic_score_gemma":0.000045905443,"teacher_disagreement_score":0.14747564,"about_ca_system_score_codex":0.00042678465,"about_ca_system_score_gemma":0.0005547703,"threshold_uncertainty_score":0.76288927},"labels":[],"label_agreement":null},{"id":"W2395626186","doi":"10.1182/blood.v126.23.759.759","title":"Safety and Effectiveness of Desmopressin for the Management of Delivery and Major Surgery in Patients with Mild-Moderate Von Willebrand Disease: Final Analysis of the Prodeswil Study","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Desmopressin; Medicine; Tranexamic acid; Von Willebrand disease; Tachyphylaxis; Surgery; Clinical trial; Coagulopathy; Anesthesia; Von Willebrand factor; Internal medicine; Blood loss; Platelet","score_opus":0.014358620953191228,"score_gpt":0.23922149847187174,"score_spread":0.2248628775186805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2395626186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997505,0.0010062957,0.000017662982,0.000013783353,0.000007902653,0.0013875086,0.000052278425,0.0000016207495,0.000007947235],"genre_scores_gemma":[0.99982536,0.000052517225,0.000037772,0.000003823137,0.0000011004716,0.000047622096,0.000017905613,0.0000059687013,0.000007960381],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993454,0.000077736724,0.00017599651,0.00014293815,0.00017762167,0.000080263504],"domain_scores_gemma":[0.99943876,0.00016511828,0.000104238614,0.00017606614,0.00008109351,0.000034722736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030165174,0.00008751511,0.00038814294,0.00007590851,0.000030424902,0.000003361015,0.0000340141,0.000015486768,5.892274e-7],"category_scores_gemma":[0.000015418158,0.000043284566,0.000048964223,0.00023614775,0.00006673015,0.000032106404,0.0000363282,0.000024246361,1.1023798e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008815073,0.002531277,0.98352593,0.00040661945,0.0037197517,0.00000908272,0.00017212097,0.00008175893,0.0000060050597,0.0000040634086,0.0000013741435,0.0007269629],"study_design_scores_gemma":[0.014517637,0.0003007191,0.97707367,0.0002731593,0.00719482,3.3240116e-7,0.00011993925,0.00017261089,0.0002860358,0.00001936514,8.425839e-7,0.00004085996],"about_ca_topic_score_codex":0.00007614002,"about_ca_topic_score_gemma":0.00004836943,"teacher_disagreement_score":0.0064522317,"about_ca_system_score_codex":0.0000074117675,"about_ca_system_score_gemma":0.000029895813,"threshold_uncertainty_score":0.17650934},"labels":[],"label_agreement":null},{"id":"W239630536","doi":"10.1182/blood.v122.21.1107.1107","title":"Normal Range Of Bleeding Scores For The ISTH-BAT: Adult and Pediatric Data From The Merging Project","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Queen's University","funders":"","keywords":"Medicine; Bleeding diathesis; Scoring system; Hemostasis; Thrombosis; Pediatrics; Surgery; Internal medicine; Platelet","score_opus":0.05976043108805838,"score_gpt":0.31820688314018514,"score_spread":0.25844645205212674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W239630536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99142754,0.0041120006,0.000012965587,0.0028587792,0.00004352295,0.0011245577,0.00008432323,0.000013242679,0.00032309018],"genre_scores_gemma":[0.9971765,0.0012092603,0.00040217218,0.000068425026,0.0007369057,0.000082796796,0.00005107206,0.000012330668,0.0002605269],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992965,0.000021322165,0.00013121188,0.00016645688,0.00020196542,0.00018255934],"domain_scores_gemma":[0.9988109,0.00062580936,0.000041675004,0.00039364636,0.000091060174,0.00003694251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022330883,0.000078849946,0.00013472133,0.000036864716,0.00013724415,0.000028212336,0.00021935171,0.000035655314,0.00005003323],"category_scores_gemma":[0.00026286306,0.000034113258,0.00003526478,0.000120402336,0.00006992804,0.000092715345,0.00014406261,0.000098136516,0.0000085546735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007491881,0.0002463181,0.9811137,0.00017865693,0.00031131422,0.000005902912,0.0010206809,1.3488123e-7,0.0018445391,0.00003346611,0.009187196,0.0059832036],"study_design_scores_gemma":[0.019989455,0.000917162,0.95154727,0.00029075204,0.004088945,0.000045780595,0.0036004484,0.0059070457,0.010918694,0.00016093365,0.0022232335,0.00031029977],"about_ca_topic_score_codex":0.0011953885,"about_ca_topic_score_gemma":0.00004546246,"teacher_disagreement_score":0.029566417,"about_ca_system_score_codex":0.0000035707012,"about_ca_system_score_gemma":0.00006577318,"threshold_uncertainty_score":0.18070778},"labels":[],"label_agreement":null},{"id":"W2396470450","doi":"10.1182/blood.v124.21.257.257","title":"Application of Novel Next Generation Sequencing Gene Panel Assay to Genetic and Clinical Diagnosis of Inherited Bone Marrow Failure Syndromes","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Janeway Children's Health and Rehabilitation Centre; London Health Sciences Centre; McMaster University; University of Alberta; Centre Hospitalier Universitaire de Sherbrooke; Princess Margaret Cancer Centre; Queen's University; University of Saskatchewan; Hospital for Sick Children; Université de Montréal; CancerCare Manitoba; University of Manitoba; Alberta Children's Hospital; Izaak Walton Killam Health Centre; Genome Canada; Children's Hospital of Eastern Ontario; BC Children's Hospital; SickKids Foundation; Montreal Children's Hospital; University of Toronto; Dalhousie University","funders":"","keywords":"Sanger sequencing; Genetic testing; Genetics; Diamond–Blackfan anemia; DNA sequencing; Gene; Bone marrow failure; Genetic counseling; Biology; Fanconi anemia; Bioinformatics; Genotype; Gene mutation; Mutation; Medicine; DNA repair","score_opus":0.042494683450095085,"score_gpt":0.26968505634650863,"score_spread":0.22719037289641356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2396470450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881772,0.0008492915,0.010580639,0.00008085047,0.000022041506,0.00024191366,0.000025652293,0.000005100438,0.000017301916],"genre_scores_gemma":[0.98401505,0.00022962841,0.015377095,0.00010000746,0.00008075734,0.000060910443,0.00010996753,0.00001551394,0.000011102376],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991538,0.000052566866,0.00030786113,0.00028754672,0.00008764691,0.00011058272],"domain_scores_gemma":[0.9994345,0.000019732877,0.00013263033,0.00026758917,0.00007730682,0.00006824212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015428285,0.00011025323,0.00019867197,0.00003382405,0.000028804772,0.000009494998,0.00007037534,0.00014148104,0.0000022789548],"category_scores_gemma":[0.000081687824,0.00010627268,0.000058782443,0.00007848271,0.00004227801,0.0000034971051,0.000057448397,0.00003289092,0.0000011146899],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009557963,0.00053483364,0.1437355,0.00002521441,0.00012056299,5.4688593e-7,0.000020130281,0.00004813194,0.84611523,0.000014522496,0.00004702805,0.009328766],"study_design_scores_gemma":[0.003646416,0.0010588387,0.096357144,0.000025442689,0.0003469608,0.0000377055,0.000041842315,0.0019324435,0.8956412,0.000029772953,0.00063629774,0.00024593476],"about_ca_topic_score_codex":0.00007774161,"about_ca_topic_score_gemma":0.00010662383,"teacher_disagreement_score":0.049525987,"about_ca_system_score_codex":0.0000033017939,"about_ca_system_score_gemma":0.000025211893,"threshold_uncertainty_score":0.4333674},"labels":[],"label_agreement":null},{"id":"W2397837817","doi":"10.1182/blood.v124.21.5630.5630","title":"A Link Between Hypercholesterolemia and Chronic Lymphocytic Leukemia","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Dyslipidemia; Internal medicine; Chronic lymphocytic leukemia; Statin; Hyperlipidemia; Lipid profile; Chemoimmunotherapy; Gastroenterology; Oncology; Leukemia; Cholesterol; Diabetes mellitus; Disease; Endocrinology","score_opus":0.017147439307659794,"score_gpt":0.27473195763755975,"score_spread":0.2575845183299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397837817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929792,0.0012772606,0.000102911035,0.00031637575,0.00005026253,0.00037125385,0.000004924202,0.00016623591,0.0047315303],"genre_scores_gemma":[0.99569434,0.00020925968,0.00054830225,0.00028782772,0.0020671189,0.000032723587,0.00002597715,0.000061546205,0.0010729253],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9979735,0.000082168975,0.0003319453,0.00051038596,0.0004820588,0.00061992666],"domain_scores_gemma":[0.9984245,0.00028486646,0.000059829534,0.00070164865,0.000076259246,0.00045289804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044402538,0.0002436149,0.00050624204,0.0001158667,0.00010189067,0.000054698125,0.00018758501,0.00023731546,0.000056128207],"category_scores_gemma":[0.0002746277,0.0002116406,0.00009020152,0.00021826153,0.00022320531,0.00008761732,0.00019386351,0.00033517947,0.0002991814],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00062161946,0.00033917636,0.0693704,0.006073246,0.0022078252,0.0011992335,0.0018388112,0.0001516262,0.072943114,0.0016367069,0.0028965368,0.8407217],"study_design_scores_gemma":[0.4819355,0.005554308,0.14180318,0.0025959203,0.0038034895,0.008123305,0.00013084336,0.061608747,0.12680687,0.0017387166,0.16364957,0.002249556],"about_ca_topic_score_codex":0.00029238727,"about_ca_topic_score_gemma":0.000019235282,"teacher_disagreement_score":0.8384721,"about_ca_system_score_codex":0.022231914,"about_ca_system_score_gemma":0.012711992,"threshold_uncertainty_score":0.992885},"labels":[],"label_agreement":null},{"id":"W2398298261","doi":"10.1182/blood-2015-08-664250","title":"Murine allogeneic CD19 CAR T cells harbor potent antileukemic activity but have the potential to mediate lethal GVHD","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"CD19; Immunology; Leukemia; Medicine; Cancer research; Biology; Antigen","score_opus":0.031122916195809064,"score_gpt":0.2884574029197534,"score_spread":0.2573344867239443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398298261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931175,0.0003965478,0.00009669863,0.0024415401,0.00056499295,0.0011043927,0.000054154905,0.00009213482,0.0021320211],"genre_scores_gemma":[0.9906903,0.00010275271,0.00023796334,0.00050774787,0.0011884597,0.00006612181,0.000015034922,0.00007477648,0.007116874],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971758,0.00020726943,0.00027029475,0.0005276691,0.0010913474,0.00072763267],"domain_scores_gemma":[0.9979788,0.00008644889,0.000078822515,0.0009090271,0.00025117042,0.00069573143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007925529,0.0002932919,0.0004446889,0.00015795098,0.00010391856,0.00005345938,0.0003986944,0.00016647964,0.0007601765],"category_scores_gemma":[0.00014091656,0.00020810959,0.0002159588,0.00023258192,0.00014359529,0.0000649062,0.00027991168,0.0005573553,0.00038000464],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060233823,0.0006221032,0.001600418,0.00003175984,0.0002678672,0.00078184286,0.00032857063,0.00006661882,0.9894677,0.0000036705653,0.0021109085,0.004116194],"study_design_scores_gemma":[0.0070602493,0.00087397295,0.023254795,0.00002387993,0.0003384589,0.00027394955,0.00019059223,0.00023773867,0.96020544,0.000025847085,0.0072211055,0.00029397805],"about_ca_topic_score_codex":0.0006660067,"about_ca_topic_score_gemma":0.000055965156,"teacher_disagreement_score":0.029262276,"about_ca_system_score_codex":0.00018639337,"about_ca_system_score_gemma":0.0004936171,"threshold_uncertainty_score":0.8486463},"labels":[],"label_agreement":null},{"id":"W2398646127","doi":"10.1182/blood.v122.21.3517.3517","title":"Heterogeneity Of Type 3 Von Willebrand Disease (VWD): Evidence From Patient-Derived Blood Outgrowth Endothelial Cells (BOEC)","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Von Willebrand factor; Von Willebrand disease; CD146; Immunology; CD31; Flow cytometry; Medicine; Andrology; Biology; Platelet; Cell biology; CD34; Stem cell; Immunohistochemistry","score_opus":0.014416047632422851,"score_gpt":0.23213790934031414,"score_spread":0.2177218617078913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398646127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964,0.0022733014,0.000005824659,0.00010693508,0.00014338968,0.0006580675,0.00020133084,0.000043353517,0.00016782348],"genre_scores_gemma":[0.99869263,0.00044178774,0.00046113116,0.00014409891,0.00006491956,0.00003407179,0.00006876582,0.000028150593,0.00006442654],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987553,0.000048420687,0.0002933922,0.00034312686,0.00029278375,0.00026698664],"domain_scores_gemma":[0.9989688,0.00008514497,0.00012945716,0.0004109059,0.0001149243,0.0002908089],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000029654428,0.00021506548,0.00040552116,0.000053644362,0.000049667382,0.000019421159,0.00010283258,0.00007708226,0.00038692335],"category_scores_gemma":[0.00009544296,0.00017034145,0.0001393094,0.00010040439,0.00006800366,0.00014370182,0.00005699351,0.000089934954,0.00019895224],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004633739,0.0033696515,0.32635662,0.000098946075,0.0007500902,0.00040490864,0.00032244387,0.0000023046077,0.66648173,0.0000021018343,0.00023638511,0.0015114514],"study_design_scores_gemma":[0.0088333925,0.000964908,0.11369059,0.0003049535,0.0015550253,0.000016885615,0.00003943128,0.00003978511,0.8740554,0.00017803471,0.00008963811,0.00023194487],"about_ca_topic_score_codex":0.0006234952,"about_ca_topic_score_gemma":0.000020688985,"teacher_disagreement_score":0.21266603,"about_ca_system_score_codex":0.000010230563,"about_ca_system_score_gemma":0.00008013109,"threshold_uncertainty_score":0.69463223},"labels":[],"label_agreement":null},{"id":"W2398652404","doi":"10.1182/blood.v122.21.578.578","title":"The Architecture Of Fibrin Clots Formed From Plasma With Low Platelet Levels Are Less Altered In The Presence Of Factor-Specific Anticoagulants Compared With Unfractionated Heparin","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Manitoba; Shared Health; Thrombosis and Atherosclerosis Research Institute; McMaster University Medical Centre","funders":"","keywords":"Fondaparinux; Fibrin; Platelet; Thromboelastography; Dabigatran; Rivaroxaban; Heparin; Chemistry; Pharmacology; Platelet-poor plasma; Anticoagulant; Medicine; Platelet-rich plasma; Anesthesia; Thrombosis; Surgery; Internal medicine; Immunology; Warfarin","score_opus":0.04340138917632265,"score_gpt":0.2615557776984109,"score_spread":0.21815438852208824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398652404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99774194,0.0000742371,0.000043978056,0.00038500925,0.00005098826,0.0012410858,0.000119387834,0.000026140304,0.0003172608],"genre_scores_gemma":[0.9993486,0.000041128027,0.00037138924,0.000030290286,0.000051158913,0.000057170462,0.000043927063,0.00003063338,0.000025737565],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981223,0.00015414962,0.00046790144,0.0003409611,0.0005403824,0.00037434566],"domain_scores_gemma":[0.9980033,0.0006762809,0.00035777502,0.000690075,0.00017573842,0.000096846394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012336382,0.00026948637,0.00072494196,0.000093918105,0.00010593863,0.000043740867,0.00038742268,0.000115620074,0.00006610884],"category_scores_gemma":[0.000052295887,0.0001329281,0.00006379103,0.00038088756,0.0002664694,0.00013029492,0.000057958256,0.000406949,0.0000097908905],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002161044,0.0024550513,0.7151511,0.0003165954,0.0015140758,0.0001318789,0.0056703542,0.00030918152,0.2652595,0.000108423985,0.00025524892,0.006667545],"study_design_scores_gemma":[0.005137551,0.00030781812,0.8159852,0.00054524717,0.00007368707,0.00007817479,0.0013142593,0.00014412531,0.17609718,0.00009416277,0.000072725714,0.00014989045],"about_ca_topic_score_codex":0.0018297448,"about_ca_topic_score_gemma":0.0018704792,"teacher_disagreement_score":0.10083407,"about_ca_system_score_codex":0.00002440806,"about_ca_system_score_gemma":0.00014245638,"threshold_uncertainty_score":0.542065},"labels":[],"label_agreement":null},{"id":"W2399105930","doi":"10.1182/blood.v96.7.2432","title":"Efficient retrovirus-mediated gene transfer to transplantable human bone marrow cells in the absence of fibronectin","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"U.S. Public Health Service","keywords":"Stem cell; Biology; CD34; Haematopoiesis; Interleukin 3; Bone marrow; Progenitor cell; Stem cell factor; CD38; Myeloid; Immunology; Virology; Molecular biology; Cell biology; T cell; Antigen-presenting cell; Immune system","score_opus":0.010081145027794823,"score_gpt":0.2485484326109615,"score_spread":0.23846728758316665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399105930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99828494,0.0005070527,0.000019880683,0.00010144926,0.000014422701,0.0003647406,0.00010650913,0.000007106106,0.0005938977],"genre_scores_gemma":[0.99916637,0.00018479333,0.00005435071,0.00019842366,0.00005283695,0.00003359577,0.000057878933,0.000020826523,0.0002309388],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987228,0.0001454075,0.00023750067,0.00030281174,0.00025560762,0.00033587634],"domain_scores_gemma":[0.9994554,0.000020759748,0.000011292629,0.00041585858,0.000027753103,0.000068925845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042346475,0.00013565666,0.00015533344,0.00006155272,0.000058347527,0.000011353861,0.00032207379,0.00010080209,0.0002549623],"category_scores_gemma":[0.000005920716,0.00011066275,0.0000726175,0.00025685766,0.000058766273,0.0000011835599,0.000011710227,0.00012156066,0.00003713703],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007322781,0.00042472547,0.00022556451,0.00001971054,0.000023184768,0.000014146306,0.00033668496,0.0014241291,0.99635243,0.0000013925335,0.00012639147,0.00031935395],"study_design_scores_gemma":[0.0014999516,0.001832885,0.0008998841,0.000015668847,0.000011339664,0.000009798152,0.000031208794,0.000026870763,0.99455804,0.0000023632376,0.0009777754,0.00013420472],"about_ca_topic_score_codex":0.00013010726,"about_ca_topic_score_gemma":0.00053056114,"teacher_disagreement_score":0.0017943885,"about_ca_system_score_codex":0.0000064518545,"about_ca_system_score_gemma":0.00004589777,"threshold_uncertainty_score":0.45126963},"labels":[],"label_agreement":null},{"id":"W2399992468","doi":"10.1182/blood.v122.21.982.982","title":"High Resource Utilizers From The Multicenter Compact Study Of Complications In Patients With Sickle Cell Disease and Utilization Of Iron Chelation Therapy","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Cohort; Population; Psychological intervention; Logistic regression; Anemia; Internal medicine; Blood transfusion; Emergency medicine; Pediatrics; Environmental health","score_opus":0.011500538407795542,"score_gpt":0.22414041714077443,"score_spread":0.21263987873297888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399992468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99814826,0.0002477615,0.000006875589,0.00021415872,0.0000065276204,0.0012451955,0.000015319169,0.000007515322,0.00010837311],"genre_scores_gemma":[0.9997493,0.000035998386,0.00003084474,0.000060197486,0.0000039676297,0.000010266927,0.00009184349,0.000008789061,0.000008803288],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999445,0.00005276556,0.00018108494,0.00011353326,0.00013996207,0.00006765104],"domain_scores_gemma":[0.999533,0.000052898693,0.000102830745,0.00020094895,0.00006511795,0.000045177876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003300415,0.000070389215,0.00012643862,0.000032019612,0.000031672946,0.0000044066496,0.00003945519,0.00002838716,0.000027934457],"category_scores_gemma":[0.000012140796,0.0000413126,0.00001452058,0.000110314286,0.000056630797,0.000038685557,0.000009626415,0.000064245345,0.0000013622099],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024137876,0.0045625037,0.9917746,0.00001599731,0.000038377573,1.7556336e-7,0.0022877424,0.00008824513,0.0003988541,0.0000034403718,0.00003366492,0.0005549963],"study_design_scores_gemma":[0.01261968,0.00040107017,0.98420924,0.000056507983,0.0001183527,3.378888e-8,0.0018650468,0.00040736413,0.00025363528,0.0000112298,0.00001720097,0.0000406446],"about_ca_topic_score_codex":0.0010571115,"about_ca_topic_score_gemma":0.000019651727,"teacher_disagreement_score":0.012378301,"about_ca_system_score_codex":0.0000057246175,"about_ca_system_score_gemma":0.000011904142,"threshold_uncertainty_score":0.1684679},"labels":[],"label_agreement":null},{"id":"W2400894217","doi":"10.1182/blood.v126.23.727.727","title":"Ixazomib, an Investigational Oral Proteasome Inhibitor (PI), in Combination with Lenalidomide and Dexamethasone (IRd), Significantly Extends Progression-Free Survival (PFS) for Patients (Pts) with Relapsed and/or Refractory Multiple Myeloma (RRMM): The Phase 3 Tourmaline-MM1 Study (NCT01564537)","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary","funders":"","keywords":"Ixazomib; Lenalidomide; Medicine; Multiple myeloma; Dexamethasone; Progression-free survival; Oncology; Internal medicine; Proteasome inhibitor; Pegfilgrastim; Miltefosine; Pharmacology; Febrile neutropenia; Neutropenia; Overall survival; Carfilzomib; Chemotherapy; Immunology","score_opus":0.05309745008142338,"score_gpt":0.3334005016023233,"score_spread":0.28030305152089996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2400894217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991762,0.00011910218,0.000055229077,0.00044544012,0.000046973702,0.007356996,0.00012780033,0.00006606012,0.000020393192],"genre_scores_gemma":[0.98980063,0.000008296461,0.007776378,0.00005205446,0.0001365947,0.0016808728,0.0003705455,0.000067831774,0.000106804844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966999,0.00048387342,0.0004749221,0.00067515334,0.0011731032,0.0004930294],"domain_scores_gemma":[0.99742645,0.0005328992,0.00025495482,0.00053601677,0.00059885223,0.0006508554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011996251,0.00038431986,0.0005312453,0.00023604109,0.00023019544,0.00009777791,0.00018526346,0.00011655381,0.000008435347],"category_scores_gemma":[0.0019235121,0.00020782874,0.000034549437,0.00035327292,0.0003383557,0.00045901912,0.00010742132,0.00033702553,0.0000014276192],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03847482,0.025474634,0.9138755,0.00013166934,0.00036487114,0.00024438044,0.0019222451,0.0000031324093,0.0010579089,0.000020682732,0.00008632951,0.018343836],"study_design_scores_gemma":[0.33494088,0.053600784,0.60233206,0.00039616082,0.0004056385,0.00006653415,0.0023812896,0.0020431248,0.0031309412,0.00013548207,0.00013207473,0.00043502645],"about_ca_topic_score_codex":0.0002091289,"about_ca_topic_score_gemma":0.001290431,"teacher_disagreement_score":0.31154343,"about_ca_system_score_codex":0.00010863908,"about_ca_system_score_gemma":0.00055342534,"threshold_uncertainty_score":0.847501},"labels":[],"label_agreement":null},{"id":"W2400940566","doi":"10.1182/blood-2015-09-672352","title":"Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the disease","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Institute of Environmental Health Sciences; National Cancer Institute","keywords":"Lymphoma; Computational biology; Disease; Genetic heterogeneity; Drug discovery; Diffuse large B-cell lymphoma; Cancer research; Biology; Medicine; Bioinformatics; Immunology; Genetics; Pathology; Gene; Phenotype","score_opus":0.01230967202451227,"score_gpt":0.21223435149573153,"score_spread":0.19992467947121925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2400940566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942823,0.0038892603,0.00003125099,0.00109557,0.00002960271,0.00042639038,0.00012816618,0.00001807962,0.00009938383],"genre_scores_gemma":[0.9989725,0.0002512727,0.000035895246,0.0006377238,0.00001536366,0.000058894653,0.0000056125145,0.000010524221,0.000012256729],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991981,0.000080382146,0.00014683983,0.00021422884,0.00016644922,0.00019400807],"domain_scores_gemma":[0.99925244,0.00005990561,0.00007088141,0.0004395996,0.000037139733,0.00014005628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004165628,0.00014133964,0.00017783909,0.000013631332,0.000075968244,0.000007963519,0.000092729766,0.00005996052,0.0000073007036],"category_scores_gemma":[0.000032516135,0.00004855891,0.00015534024,0.000052790696,0.00012759818,0.00002438602,0.00013065341,0.000022787559,0.0000029356347],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041744413,0.039745573,0.80234873,0.00008833742,0.0006436771,0.00037627987,0.00077009137,0.0000019266254,0.14674017,0.0019462724,0.00019378187,0.0067277187],"study_design_scores_gemma":[0.04438108,0.0004961313,0.48546296,0.00015729961,0.000988967,0.000059314923,0.00010396928,0.000051870084,0.46653765,0.0007483838,0.0007905904,0.0002217996],"about_ca_topic_score_codex":0.000018681005,"about_ca_topic_score_gemma":0.000004162306,"teacher_disagreement_score":0.3197975,"about_ca_system_score_codex":0.000017110715,"about_ca_system_score_gemma":0.00004026762,"threshold_uncertainty_score":0.1980175},"labels":[],"label_agreement":null},{"id":"W2401980287","doi":"10.1182/blood-2015-02-628867","title":"Prostaglandin E synthase is upregulated by Gas6 during cancer-induced venous thrombosis","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Heart and Stroke Foundation of Canada","keywords":"Platelet; Thrombosis; GAS6; Medicine; Platelet activation; Venous thrombosis; Endothelium; Downregulation and upregulation; Cancer; Thrombus; Cancer research; Internal medicine; Biology; Receptor; Biochemistry; Receptor tyrosine kinase","score_opus":0.014846891500326316,"score_gpt":0.2429645845828172,"score_spread":0.22811769308249089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2401980287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945891,0.0035951424,0.000009897406,0.0009072324,0.0002774367,0.00024823972,0.00016071946,0.000111897796,0.00010032283],"genre_scores_gemma":[0.997363,0.0003066474,0.0000051907205,0.00004109222,0.000036198555,0.000059453498,0.000040658757,0.000026607504,0.0021211782],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989504,0.000082794315,0.00020220331,0.00032678177,0.000041955762,0.00039583145],"domain_scores_gemma":[0.99944186,0.00003755074,0.00013080971,0.000314364,0.000048488724,0.000026949785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007511066,0.0001888846,0.0002773489,0.000059606195,0.00021281128,0.000020046891,0.00015652535,0.00023234413,0.00064539304],"category_scores_gemma":[0.000022962386,0.00013148245,0.00008606058,0.00010875552,0.00007171853,0.00015696438,0.000056790457,0.000096082214,0.00015461308],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047815167,0.00043692923,0.006120234,0.000015309308,0.0003120639,0.0000013991967,0.00015765532,5.1631986e-8,0.9881448,0.000013059218,0.0016976524,0.0030530028],"study_design_scores_gemma":[0.0039456575,0.0001591687,0.05112483,0.0001222337,0.00011555605,0.00002493126,0.000013938228,3.9393368e-7,0.9420493,0.00001676507,0.0022233517,0.00020386724],"about_ca_topic_score_codex":0.0001330308,"about_ca_topic_score_gemma":0.0000067819433,"teacher_disagreement_score":0.04609552,"about_ca_system_score_codex":0.00005337286,"about_ca_system_score_gemma":0.000040225386,"threshold_uncertainty_score":0.7066601},"labels":[],"label_agreement":null},{"id":"W2402003835","doi":"10.1182/blood-2016-03-705210","title":"Clinical efficacy of daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":404,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Janssen Research and Development","keywords":"Daratumumab; Medicine; Refractory (planetary science); Carfilzomib; Internal medicine; Multiple myeloma; Oncology; Lenalidomide; Pomalidomide; Bortezomib","score_opus":0.028289681126676833,"score_gpt":0.32043252700161345,"score_spread":0.2921428458749366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2402003835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982246,0.00009560217,0.000013081418,0.00008024874,0.00003906839,0.0011076614,0.000049394253,0.000049893915,0.000340409],"genre_scores_gemma":[0.9979445,0.000106068466,0.001161345,0.000032373224,0.000042473883,0.00003405095,0.00004636015,0.00004357381,0.00058926176],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804395,0.00016293529,0.0005450769,0.00041692864,0.00045440145,0.00037667694],"domain_scores_gemma":[0.99821216,0.00061403244,0.00015697014,0.00059182424,0.00016803243,0.00025701144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018876647,0.00020827314,0.00053199433,0.00017072895,0.0000355781,0.0000060076613,0.000119176315,0.00015310518,0.00014342465],"category_scores_gemma":[0.0007184711,0.00010257495,0.00010025455,0.00027347065,0.00015549357,0.00009692564,0.000030585423,0.00018488432,0.000042255757],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027286505,0.009637159,0.91349417,0.000028798479,0.0003774024,0.00014821358,0.000061807696,9.888685e-8,0.0009439565,0.0000017558574,0.000054937875,0.047965206],"study_design_scores_gemma":[0.13658059,0.006671669,0.8517203,0.00041845837,0.00007119969,0.000004020893,0.0000065264067,0.0000065561917,0.0041466653,0.0000020649557,0.0002591473,0.000112830305],"about_ca_topic_score_codex":0.00007386773,"about_ca_topic_score_gemma":0.00009035294,"teacher_disagreement_score":0.10929409,"about_ca_system_score_codex":0.000064568696,"about_ca_system_score_gemma":0.00019767553,"threshold_uncertainty_score":0.41828853},"labels":[],"label_agreement":null},{"id":"W2402650027","doi":"10.1182/blood.v122.21.229.229","title":"Inhibitory Receptors and Phosphatases Enable Oncogenic Tyrosine Kinase Signaling In B Cell Lineage Leukemia","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Cancer research; breakpoint cluster region; Biology; Tyrosine kinase; Signal transduction; Leukemia; Bruton's tyrosine kinase; Chronic lymphocytic leukemia; Cell biology; Receptor; Immunology; Biochemistry","score_opus":0.010380479534106842,"score_gpt":0.23540284149986268,"score_spread":0.22502236196575584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2402650027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99327534,0.004420768,0.000015652993,0.00013242898,0.00010214515,0.00062868634,0.000012488383,0.00006761196,0.001344846],"genre_scores_gemma":[0.9947134,0.00034889576,0.0019695344,0.0003265453,0.00036225727,0.000084869964,0.00006414033,0.00005215316,0.0020781648],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982253,0.00005988151,0.00038063378,0.0004214223,0.0003752134,0.0005375688],"domain_scores_gemma":[0.9988978,0.00025810555,0.00007445114,0.00032920425,0.000108931265,0.00033150485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027793768,0.00022368673,0.0003736545,0.00020652254,0.00006955749,0.00004985319,0.00012010621,0.00017555553,0.00062975625],"category_scores_gemma":[0.00025121545,0.00019550732,0.000059948234,0.00035952657,0.00013399443,0.00019123552,0.00014704054,0.00036225843,0.00029204652],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001934056,0.0011493088,0.023106322,0.0005904703,0.0000834485,0.00073579204,0.000515538,0.00003473197,0.95024854,0.0000231603,0.020499945,0.0028193274],"study_design_scores_gemma":[0.010634342,0.00040235036,0.0011619717,0.0002665742,0.00010862276,0.00008162213,0.00027094124,0.0005836022,0.9832308,0.000028558758,0.0029986266,0.00023198604],"about_ca_topic_score_codex":0.0012242584,"about_ca_topic_score_gemma":0.000014022515,"teacher_disagreement_score":0.03298225,"about_ca_system_score_codex":0.0004612051,"about_ca_system_score_gemma":0.0007225695,"threshold_uncertainty_score":0.79725575},"labels":[],"label_agreement":null},{"id":"W2403091260","doi":"10.1182/blood.v122.21.3737.3737","title":"PU.1 and Spi-B Oppose Transformation Of Pre-B Cells Through Activation Of Key Genes Involved In B Cell Receptor Signalling","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"CD19; Biology; B cell; Bone marrow; Molecular biology; Leukemia; Immunology; Flow cytometry; Antibody","score_opus":0.01907475948456927,"score_gpt":0.25289405661344355,"score_spread":0.23381929712887428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403091260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965725,0.00015533518,0.0015369498,0.00018659391,0.000018046452,0.00073312543,0.00000597041,0.000011692072,0.0007798153],"genre_scores_gemma":[0.99456435,0.00034728373,0.0048771403,0.000034407818,0.000035028865,0.00002934621,0.000023549856,0.000014422548,0.00007444868],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99901253,0.000043339995,0.00036746394,0.00013734162,0.00027917465,0.0001601534],"domain_scores_gemma":[0.99943054,0.0001254909,0.00011293427,0.0001274475,0.0001479088,0.00005566035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016219048,0.000095533665,0.00023686088,0.000109272,0.000015505071,0.000007429781,0.00006377513,0.00010758502,0.00010795687],"category_scores_gemma":[0.000039073166,0.000081949904,0.0000335058,0.0001893111,0.00006125529,0.00028625425,0.000020189802,0.0001023058,0.000008226128],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012908761,0.00039262956,0.0016328702,0.0006772023,0.000027296373,7.784838e-7,0.0035817535,0.000040671977,0.9921553,0.000024925654,0.00007892918,0.001258564],"study_design_scores_gemma":[0.0048648673,0.0003180851,0.0024670553,0.00021248605,0.000043171905,0.0000015406151,0.0005659568,0.0018035271,0.9894851,0.00010415316,0.00006661888,0.000067470224],"about_ca_topic_score_codex":0.000505093,"about_ca_topic_score_gemma":0.000007260595,"teacher_disagreement_score":0.0047357795,"about_ca_system_score_codex":0.000057520916,"about_ca_system_score_gemma":0.00016453155,"threshold_uncertainty_score":0.334182},"labels":[],"label_agreement":null},{"id":"W2403295133","doi":"10.1182/blood.v122.21.4273.4273","title":"Follicular Lymphoma In Young Adults: Clinical Characteristics and Early Treatment Outcomes","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Follicular lymphoma; Population; Cancer; Pediatrics; Young adult; Transplantation; Internal medicine; Lymphoma; Psychosocial; Surgery","score_opus":0.015357926754503013,"score_gpt":0.2767751322434405,"score_spread":0.2614172054889375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403295133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977903,0.00040549325,4.7607708e-7,0.00049817335,0.000096620446,0.00065960444,0.00001017388,0.000034635996,0.0005045398],"genre_scores_gemma":[0.9981297,0.0007378514,0.0003525985,0.00016833501,0.00008863431,0.0002373346,0.000018364823,0.000017004879,0.00025016256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998925,0.00003404305,0.00040137803,0.00028702055,0.00012911376,0.00022345183],"domain_scores_gemma":[0.9993458,0.00009783357,0.00007075771,0.00026451965,0.000038781494,0.00018230203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006192601,0.00018226096,0.0004991335,0.000058098256,0.00002997095,0.000034703382,0.000034598204,0.0001028238,0.000040656203],"category_scores_gemma":[0.000060172315,0.000120586614,0.00013089716,0.000059660255,0.000041054464,0.00006113783,0.000026292018,0.000030190695,0.00012197165],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031980217,0.0046376702,0.957704,0.000014364222,0.0002482611,0.00025667826,0.00018023221,4.300012e-9,0.000014385768,0.000037560654,0.000023955661,0.03685092],"study_design_scores_gemma":[0.021200206,0.0010725209,0.9765389,0.00008888972,0.0003132221,0.00007240659,0.000048187387,0.0000083781715,0.00022176794,0.000016853424,0.00030751023,0.00011114293],"about_ca_topic_score_codex":0.0016413211,"about_ca_topic_score_gemma":0.00006111482,"teacher_disagreement_score":0.036739778,"about_ca_system_score_codex":0.00007428109,"about_ca_system_score_gemma":0.000046066125,"threshold_uncertainty_score":0.49173793},"labels":[],"label_agreement":null},{"id":"W2404166748","doi":"10.1182/blood.v122.21.374.374","title":"Novel Intracranial Xenografts Of CNS Lymphoma Implicate a Role For Cereblon As a Mediator Of Lenalidomide Efficacy","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Lymphoma; Cancer research; Medicine; Pathology; Primary central nervous system lymphoma; Biology","score_opus":0.011811446515847212,"score_gpt":0.2558120919826345,"score_spread":0.2440006454667873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2404166748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965187,0.00062856934,0.000045190638,0.00069240265,0.00007057226,0.0014310435,0.000109325054,0.000034396344,0.00046981673],"genre_scores_gemma":[0.99622583,0.00008050807,0.0027818338,0.00013655114,0.00022670116,0.00043017327,0.000043784905,0.000037780526,0.00003685245],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986951,0.000012725186,0.0004855453,0.00027469906,0.00024132135,0.000290627],"domain_scores_gemma":[0.9987406,0.0002472041,0.00022438349,0.00039291952,0.00020471583,0.00019015683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009153259,0.00019552448,0.0005614169,0.00010959644,0.000034074783,0.000010640685,0.00011514497,0.00011094685,0.00015564421],"category_scores_gemma":[0.00012654485,0.00015383854,0.00029143193,0.00014869565,0.00007453788,0.000063468084,0.000045737954,0.0000314134,0.00004689093],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011153275,0.030695695,0.034664635,0.00045992972,0.0018993154,0.000026471693,0.000884848,0.000002054278,0.8009655,0.0012161654,0.0014784744,0.12659161],"study_design_scores_gemma":[0.041827917,0.0015462455,0.36391166,0.00016740273,0.0011119542,0.00021622484,0.00009816787,0.000037815487,0.5892382,0.00021580029,0.0014615541,0.000167021],"about_ca_topic_score_codex":0.001102931,"about_ca_topic_score_gemma":0.000026225622,"teacher_disagreement_score":0.32924703,"about_ca_system_score_codex":0.00003748738,"about_ca_system_score_gemma":0.00016950759,"threshold_uncertainty_score":0.62733537},"labels":[],"label_agreement":null},{"id":"W2404263296","doi":"10.1182/blood.v122.21.5542.5542","title":"Stem Cell Dose and Time To Engraftment Does Not Predict Outcome After Autologous Stem Cell Transplantation For Relapsed Aggressive NHL","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Autologous stem-cell transplantation; Etoposide; Filgrastim; Internal medicine; Stem cell; Transplantation; Melphalan; Oncology; Plerixafor; Hematopoietic stem cell transplantation; Surgery; Chemotherapy; Granulocyte colony-stimulating factor; Biology; CXCR4","score_opus":0.008555921466623867,"score_gpt":0.22379104754396442,"score_spread":0.21523512607734055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2404263296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99518585,0.00057489786,0.000017384089,0.00073603605,0.00009520005,0.0025666638,0.00024587748,0.00007897788,0.000499108],"genre_scores_gemma":[0.992416,0.000085683016,0.0008612085,0.0005850322,0.00006644151,0.001759402,0.00005573613,0.000030704578,0.0041397903],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998769,0.000035808163,0.00032597824,0.00038035444,0.0001986635,0.000290233],"domain_scores_gemma":[0.9991655,0.00015577827,0.00012895463,0.00024248436,0.00006889571,0.00023838815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000070461116,0.00023507976,0.00036084518,0.00007801802,0.000064219596,0.00004080929,0.000053388034,0.00011404146,0.000120891964],"category_scores_gemma":[0.0000026450036,0.0001486091,0.00010732125,0.000048503025,0.000023409737,0.000074104304,0.000019891224,0.00005128412,0.000317777],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063676056,0.020974206,0.6855541,0.0064953384,0.0019612059,0.0040395977,0.019428415,0.000025842093,0.09165545,0.00007425761,0.005196264,0.15822773],"study_design_scores_gemma":[0.026635604,0.0031703766,0.57248163,0.00026214443,0.0022450692,0.00010556265,0.00020012898,0.00008377547,0.3935448,0.000017178125,0.00088249805,0.00037123635],"about_ca_topic_score_codex":0.00003494498,"about_ca_topic_score_gemma":0.000004736299,"teacher_disagreement_score":0.30188936,"about_ca_system_score_codex":0.00006178947,"about_ca_system_score_gemma":0.0000371609,"threshold_uncertainty_score":0.6060103},"labels":[],"label_agreement":null},{"id":"W2404529007","doi":"10.1182/blood.v124.21.5441.5441","title":"Effect of Unintentional Cyclophosphamide Under-Dosing on Disease Response and Outcomes in Patients with Diffuse Large B-Cell Lymphoma","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Cyclophosphamide; Medicine; Diffuse large B-cell lymphoma; Internal medicine; Surgery; Retrospective cohort study; Gemcitabine; Chemotherapy; Cohort; Exact test; Vincristine; Oncology","score_opus":0.009471600077491872,"score_gpt":0.28701020389420545,"score_spread":0.2775386038167136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2404529007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99881166,0.00018264724,0.0000064367196,0.00046759666,0.00002937467,0.00022172298,0.000014863651,0.000010771414,0.00025490797],"genre_scores_gemma":[0.99942964,0.000021557747,0.000022992448,0.0004184358,0.000009737124,0.000007041401,0.000006895495,0.000010041144,0.00007365158],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991726,0.00019512004,0.00012557834,0.00014846465,0.00020574375,0.00015244],"domain_scores_gemma":[0.99837065,0.0013047153,0.00006149041,0.000109498316,0.000025558444,0.00012808722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035569063,0.00010594701,0.00022255449,0.00004378533,0.00004619532,0.0000067815527,0.000028990798,0.000022688766,0.000008529823],"category_scores_gemma":[0.00058746163,0.000066422566,0.00003448818,0.00006741333,0.000048917595,0.000041486986,0.000037464615,0.00006534404,0.000003246777],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020064665,0.006139966,0.9725087,0.000120839366,0.000066737426,0.000013546262,0.000024208595,6.6645094e-7,0.0001014449,0.00006606469,0.000006321722,0.0008868014],"study_design_scores_gemma":[0.0531232,0.0017824349,0.9429209,0.00011614726,0.00026319182,6.8779383e-7,0.000009244159,0.000029470586,0.0012005761,0.000016706286,0.0004690641,0.000068325186],"about_ca_topic_score_codex":0.0000111370355,"about_ca_topic_score_gemma":0.0000026615626,"teacher_disagreement_score":0.033058535,"about_ca_system_score_codex":0.000015848458,"about_ca_system_score_gemma":0.00001406659,"threshold_uncertainty_score":0.27086335},"labels":[],"label_agreement":null},{"id":"W2404824632","doi":"10.1182/blood.v124.21.4457.4457","title":"Updated Results of a Phase II Randomized Study (ROMULUS) of Polatuzumab Vedotin or Pinatuzumab Vedotin Plus Rituximab in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University; Spinal Cord Injury BC","funders":"","keywords":"Medicine; Internal medicine; Brentuximab vedotin; Cohort; Rituximab; Refractory (planetary science); Gastroenterology; Follicular lymphoma; Lymphoma; Oncology; Hodgkin lymphoma","score_opus":0.007494244142693291,"score_gpt":0.2521085767412386,"score_spread":0.24461433259854531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2404824632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952332,0.0001993862,0.00000821916,0.00006300076,0.0001089015,0.0034251204,0.000101701626,0.00005280756,0.00080766535],"genre_scores_gemma":[0.9985496,0.000030605777,0.0006495282,0.000055074426,0.000044937664,0.00019393067,0.00027256244,0.00006490177,0.00013887719],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9961205,0.00043947092,0.0014812063,0.0006859377,0.0008027529,0.00047012686],"domain_scores_gemma":[0.9971454,0.0005005476,0.00084399525,0.0009520812,0.00034861383,0.0002093451],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007858754,0.00048667015,0.0022724338,0.00043468902,0.00009455872,0.000013248174,0.00023177346,0.00019296902,0.00005045074],"category_scores_gemma":[0.00075624906,0.00031761776,0.0002323803,0.0006164761,0.00020361062,0.00012584655,0.00013692102,0.00016116432,0.000013373584],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6713828,0.26481014,0.046568114,0.00017293422,0.0018742072,0.0002520267,0.00398936,0.000012245046,0.0003398105,0.00004331081,0.00028088913,0.0102741895],"study_design_scores_gemma":[0.8467834,0.027176786,0.11820855,0.0005454162,0.001267688,0.000010619148,0.00023782226,0.00028672206,0.0050287824,0.000009987974,0.00016432072,0.00027989442],"about_ca_topic_score_codex":0.0013496542,"about_ca_topic_score_gemma":0.00019087289,"teacher_disagreement_score":0.23763336,"about_ca_system_score_codex":0.00029894063,"about_ca_system_score_gemma":0.0005948009,"threshold_uncertainty_score":0.9999276},"labels":[],"label_agreement":null},{"id":"W2405216291","doi":"10.1182/blood.v122.21.1688.1688","title":"Implementing a Computerized Care Process Management System To Determine The Feasibility Of Utilizing, and Concomitantly Validating, a Prediction Tool For The Risk Of Venous Thromboembolism In Cancer Patients","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Cancer; Risk assessment; Internal medicine; Ambulatory; Intensive care medicine; Emergency medicine","score_opus":0.023325133254752488,"score_gpt":0.29788803502215094,"score_spread":0.27456290176739845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2405216291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99173665,0.0002856668,0.00019393484,0.000076382625,0.00011161407,0.007256326,0.00013650427,0.000023085047,0.0001798347],"genre_scores_gemma":[0.99765486,0.00010731799,0.00067816617,0.00008141049,0.000047395293,0.001393906,0.00001421135,0.000018618006,0.000004128687],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852204,0.00006964458,0.00057467475,0.0002825509,0.00026142804,0.0002896289],"domain_scores_gemma":[0.9988663,0.00013323824,0.00034792072,0.0003444533,0.0002653261,0.00004273066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048719512,0.00015457984,0.00053506915,0.00006929356,0.00014877699,0.000025680498,0.00016041499,0.00003637125,0.000009500352],"category_scores_gemma":[0.000057226585,0.000094425515,0.00008006483,0.00016409621,0.000049777063,0.000057089306,0.00018187778,0.00007177158,4.0005696e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000101812686,0.0021630556,0.9346407,0.0071296864,0.0009697338,0.0000017242171,0.013741393,0.00008871331,0.0005075991,0.00025018863,0.00017498943,0.040230375],"study_design_scores_gemma":[0.005514395,0.0009186251,0.9805061,0.0008031616,0.0014062007,0.0000013290371,0.0079424,0.0013083934,0.0013651504,0.000025138383,0.00011281834,0.00009626218],"about_ca_topic_score_codex":0.0011151958,"about_ca_topic_score_gemma":0.00017086434,"teacher_disagreement_score":0.045865398,"about_ca_system_score_codex":0.000058889134,"about_ca_system_score_gemma":0.00002815337,"threshold_uncertainty_score":0.38505608},"labels":[],"label_agreement":null},{"id":"W2405613492","doi":"10.1182/blood.v122.21.454.454","title":"Platelet-Mediated Mechanical Tensile Force Influences ADAMTS13 Localization and Regulation Of Thrombus Development At The Site Of Platelet Accumulation","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"ADAMTS13; Von Willebrand factor; Thrombus; Platelet; Chemistry; Biophysics; Platelet adhesiveness; Endothelium; Platelet membrane glycoprotein; Platelet activation; Cell biology; Internal medicine; Medicine; Biology; Platelet aggregation","score_opus":0.018241857412488655,"score_gpt":0.25195598354984816,"score_spread":0.2337141261373595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2405613492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986453,0.00028599196,0.00020576533,0.000116116345,0.000020649924,0.0005907592,0.000008357304,0.00002113912,0.000105928586],"genre_scores_gemma":[0.99882126,0.000059552163,0.0005809105,0.000072914,0.0000094862735,0.00001690297,0.00030315202,0.000011583498,0.00012422577],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99905455,0.00002593729,0.00036006706,0.00016931514,0.000255556,0.00013456702],"domain_scores_gemma":[0.9993365,0.00009833803,0.00020320664,0.00015265745,0.00015754074,0.000051748655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000962513,0.000119958815,0.00026909795,0.00005910947,0.00008102408,0.000008148761,0.00003190141,0.000105912455,0.00011179551],"category_scores_gemma":[0.00007157256,0.00007869876,0.00003092304,0.0001646439,0.00006871627,0.000121002005,0.000042219875,0.00004839144,0.00002048787],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064168347,0.002032288,0.37038776,0.0005808139,0.0014779946,0.000050417133,0.0038956748,0.0017043534,0.5933282,0.00038843206,0.0008714322,0.024640972],"study_design_scores_gemma":[0.0050867903,0.00029001234,0.630293,0.00014418017,0.00016808811,0.00007856705,0.00011143306,0.006463556,0.35653475,0.00041218332,0.00028161082,0.00013583631],"about_ca_topic_score_codex":0.00014667718,"about_ca_topic_score_gemma":0.000057843245,"teacher_disagreement_score":0.25990522,"about_ca_system_score_codex":0.000018221883,"about_ca_system_score_gemma":0.000047616973,"threshold_uncertainty_score":0.32092422},"labels":[],"label_agreement":null},{"id":"W2405689756","doi":"10.1182/blood.v122.21.1648.1648","title":"Enforced Expression Of Mir-125b Promotes the in vivo expansion Of Human Linneg cord Blood Multi-Lymphoid Progenitors and Leukemia Stem Cells","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Stem cell; Biology; Progenitor cell; Myeloid leukemia; Cancer research; Leukemia; Haematopoiesis; microRNA; Population; Transplantation; Cancer stem cell; Immunology; Medicine; Cell biology; Gene; Genetics; Internal medicine","score_opus":0.013403137014959177,"score_gpt":0.2544827483998544,"score_spread":0.24107961138489523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2405689756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987599,0.0005842962,0.00001246315,0.000007756147,0.000017352228,0.00055705936,0.000008011423,0.000004826806,0.000048295373],"genre_scores_gemma":[0.9988841,0.00011033459,0.00039022445,0.000007969346,0.000036404417,0.000054616827,0.000006581301,0.000015566302,0.00049420825],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990374,0.000078927296,0.00027856274,0.00023085023,0.00015458169,0.00021967223],"domain_scores_gemma":[0.99939704,0.000021197742,0.000121068304,0.00030070601,0.000091611495,0.000068385794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016345474,0.00012435626,0.00016930555,0.00004708344,0.00005798599,0.000015237045,0.00019086995,0.00012834826,0.000011215887],"category_scores_gemma":[0.000025041296,0.000085150954,0.000052593816,0.00007260857,0.000101020676,0.000007127822,0.00015161722,0.000080318896,8.594453e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032889486,0.00017190835,0.007703428,0.0000850502,0.00002337473,0.0000016288847,0.00014527953,0.000003304926,0.99121916,0.0000022703778,0.00004171931,0.0005699838],"study_design_scores_gemma":[0.0020927715,0.0006040611,0.001122955,0.000097331416,0.000017429065,0.000007120867,0.0002828685,0.00011049033,0.9955442,0.0000044192843,0.000022477514,0.00009390579],"about_ca_topic_score_codex":0.00033290818,"about_ca_topic_score_gemma":0.000033322456,"teacher_disagreement_score":0.006580473,"about_ca_system_score_codex":0.000005518159,"about_ca_system_score_gemma":0.00007249829,"threshold_uncertainty_score":0.3472355},"labels":[],"label_agreement":null},{"id":"W2405988711","doi":"10.1182/blood.v122.21.4460.4460","title":"Expansion Culture Of Hematopoietic Stem &amp; Progenitor Cells From Frozen-Thawed, Non-Enriched Human Umbilical Cord Blood In Animal Component– &amp; Serum–Free Medium Enhances Engraftment &amp; Reduces Graft-Versus-Host-Disease","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Progenitor cell; Stem cell; Haematopoiesis; Andrology; CD34; Stromal cell; Umbilical cord; Transplantation; Biology; Population; Immunology; Cell biology; Medicine; Internal medicine; Cancer research","score_opus":0.038529693381840396,"score_gpt":0.30835104629164706,"score_spread":0.2698213529098067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2405988711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99221253,0.0026227627,0.000009395063,0.0004867947,0.0004276865,0.0036277543,0.00013536627,0.0001461605,0.00033152776],"genre_scores_gemma":[0.9927805,0.0002710011,0.0036474313,0.00005123581,0.00046551618,0.00043530963,0.00044037018,0.00010651233,0.0018020994],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99353594,0.00043564755,0.0013640253,0.0013374405,0.0022014745,0.0011254861],"domain_scores_gemma":[0.99554294,0.0004024659,0.0004301784,0.0017340336,0.0006184735,0.0012719339],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005706537,0.0007308921,0.0013412202,0.00033866693,0.00020710359,0.00011020793,0.0009384055,0.00045736763,0.0018097182],"category_scores_gemma":[0.00030464254,0.00061061775,0.00036759942,0.00075477816,0.00041087373,0.00025836247,0.0006041385,0.00088962767,0.0006671159],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017021026,0.0060718465,0.017016448,0.0006849468,0.00044511072,0.0001142682,0.0027206775,0.0000013532601,0.96850795,0.000008770489,0.0026400236,0.00008652763],"study_design_scores_gemma":[0.022689836,0.0020291558,0.07033677,0.0010769672,0.0011857796,0.00003860554,0.0019477828,0.000019494288,0.89785933,0.00015257708,0.0017099446,0.00095372915],"about_ca_topic_score_codex":0.0012800413,"about_ca_topic_score_gemma":0.00073889276,"teacher_disagreement_score":0.070648566,"about_ca_system_score_codex":0.00014110822,"about_ca_system_score_gemma":0.00039991958,"threshold_uncertainty_score":0.9996345},"labels":[],"label_agreement":null},{"id":"W2407942424","doi":"10.1182/blood.v122.21.3023.3023","title":"Aggressive Non-Hodgkin Lymphoma: Predictive Value Of Sarcopenia and Skeletal Muscle Density On Prognosis With Rituximab Containing Therapy","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Sarcopenia; Medicine; Diffuse large B-cell lymphoma; Internal medicine; Population; Skeletal muscle; International Prognostic Index; Oncology; Lymphoma","score_opus":0.014545881091587097,"score_gpt":0.26854289452876456,"score_spread":0.25399701343717745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407942424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965551,0.00056975294,0.000050191447,0.0007129507,0.00003332416,0.0011053495,0.000008223187,0.00004394383,0.0009211712],"genre_scores_gemma":[0.9961735,0.00020182905,0.0025687527,0.0007873478,0.000094645264,0.00011946909,0.000008504172,0.000022113227,0.000023861816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99902564,0.000050528517,0.00021028696,0.0002506558,0.00023565488,0.00022725057],"domain_scores_gemma":[0.9992088,0.000089658184,0.00019120221,0.00015683437,0.00019599113,0.00015751901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012947497,0.00014192822,0.00036149603,0.00008620279,0.000102978236,0.000015511088,0.000046453806,0.00007171082,0.000044409386],"category_scores_gemma":[0.000037855967,0.00010572544,0.00003837022,0.0001102019,0.00012685635,0.00008149367,0.000022967843,0.00012232164,0.00001200829],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029484113,0.013253943,0.83524114,0.0010740465,0.0008223809,0.00040337694,0.0066115144,0.0000020544069,0.019439973,0.0006756412,0.0009102365,0.11861727],"study_design_scores_gemma":[0.03323428,0.0048691956,0.9316931,0.0012838272,0.000119852135,0.00013890903,0.0005825788,0.00025029466,0.027376603,0.00013007261,0.00017083928,0.0001504624],"about_ca_topic_score_codex":0.00021913495,"about_ca_topic_score_gemma":0.0000062073877,"teacher_disagreement_score":0.1184668,"about_ca_system_score_codex":0.000024816363,"about_ca_system_score_gemma":0.000106430125,"threshold_uncertainty_score":0.43113583},"labels":[],"label_agreement":null},{"id":"W2408288427","doi":"10.1182/blood-2016-03-703231","title":"VWD diagnosis: improved","year":2016,"lang":"en","type":"letter","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Von Willebrand disease; Von Willebrand factor; Multiplex; Phenotype; Medicine; Immunology; Molecular biology; Genetics; Biology; Platelet; Gene","score_opus":0.011301414614171865,"score_gpt":0.23767740137236695,"score_spread":0.2263759867581951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2408288427","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02737752,0.0032424985,0.0000031231937,0.9502668,0.0004074691,0.0007846003,0.0002219357,0.00017531181,0.017520761],"genre_scores_gemma":[0.0053880624,0.0012921212,0.00029513513,0.9582992,0.0062299664,0.00057128695,0.00066284015,0.00014308009,0.02711826],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99890167,0.000012034859,0.00017312037,0.00035076943,0.00018568803,0.00037669906],"domain_scores_gemma":[0.9993327,0.00005859959,0.00008238567,0.00042107212,0.000038444072,0.000066774126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000025277712,0.0002671764,0.00048411143,0.00008338616,0.000033908826,0.00001476133,0.00009087346,0.0005692684,0.0004486213],"category_scores_gemma":[0.000029262008,0.00017071614,0.00018800116,0.000047782167,0.00003265095,0.000027972392,0.00003139635,0.0004728111,0.0006498632],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008490852,0.00042429098,0.002904164,0.00012628712,0.0007770764,0.010014634,0.000013183736,4.1080792e-10,0.00012453496,9.818334e-7,0.9808111,0.004795217],"study_design_scores_gemma":[0.005639673,0.00026769095,0.00042516092,0.00030248298,0.0011605623,0.000301071,0.0000019098145,1.8470651e-7,0.0011216307,0.00009725036,0.99047804,0.00020431522],"about_ca_topic_score_codex":0.000036906484,"about_ca_topic_score_gemma":0.0000034473878,"teacher_disagreement_score":0.021989457,"about_ca_system_score_codex":0.000024042196,"about_ca_system_score_gemma":0.000074246,"threshold_uncertainty_score":0.83528936},"labels":[],"label_agreement":null},{"id":"W2408400316","doi":"10.1182/blood-2016-02-698506","title":"Abnormal chromatin clumping in myeloblasts","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Ottawa","funders":"","keywords":"Pancytopenia; Mean corpuscular volume; Complete blood count; Medicine; Platelet; Hemoglobin; White blood cell; Blood count; Gastroenterology; Internal medicine; Pathology; Immunology; Bone marrow","score_opus":0.01461450845003958,"score_gpt":0.27558912918219275,"score_spread":0.26097462073215316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2408400316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874426,0.00011938328,0.00008269768,0.001993676,0.000034299766,0.00023065465,0.000003363169,0.00006665315,0.010026633],"genre_scores_gemma":[0.9965747,0.00004892533,0.0010846234,0.00022040786,0.00022278364,0.000024633071,0.0000025532668,0.000022197155,0.0017991647],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99889857,0.00003918106,0.00020612252,0.00020816318,0.00025921938,0.00038874595],"domain_scores_gemma":[0.9994214,0.00009980803,0.000030939933,0.00027427822,0.00004131205,0.00013224252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027294317,0.000098688215,0.0001900097,0.00015876332,0.000026294436,0.000008354111,0.000110365014,0.0000836002,0.0003536631],"category_scores_gemma":[0.00026236317,0.000064359745,0.000044072283,0.0002157245,0.00006005532,0.00009473446,0.00008691097,0.00016215202,0.0005844322],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021405431,0.0007450848,0.43845809,0.00017158051,0.000114047456,0.001384495,0.00045700994,5.591451e-7,0.5056907,0.00040340927,0.0024404305,0.049920574],"study_design_scores_gemma":[0.01760056,0.00040654512,0.7976747,0.00074068666,0.00004451311,0.000534718,0.00007630223,0.000081071514,0.17823903,0.0001242981,0.004244422,0.00023311254],"about_ca_topic_score_codex":0.00004704806,"about_ca_topic_score_gemma":0.000031157804,"teacher_disagreement_score":0.35921666,"about_ca_system_score_codex":0.00013248641,"about_ca_system_score_gemma":0.00020887863,"threshold_uncertainty_score":0.7511889},"labels":[],"label_agreement":null},{"id":"W2409224885","doi":"10.1182/blood.v122.21.3198.3198","title":"MM-003 Phase 3 Study Of Pomalidomide In Combination With Low-Dose Dexamethasone (POM + LoDEX) Vs High-Dose Dexamethasone (HiDEX) In Relapsed/Refractory Multiple Myeloma (RRMM): POM + Lodex Is Beneficial For Elderly Patients (&gt; 65 Years of Age)","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Vancouver General Hospital","funders":"","keywords":"Pomalidomide; Medicine; Dexamethasone; Multiple myeloma; Internal medicine; Oncology; Lenalidomide","score_opus":0.018021240543051906,"score_gpt":0.2833395327326576,"score_spread":0.2653182921896057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2409224885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99212825,0.00020856557,0.00006298741,0.000072975075,0.0001013654,0.007127438,0.00021543392,0.000045565725,0.00003742772],"genre_scores_gemma":[0.99394757,0.00004187287,0.004596498,0.00005400449,0.000054741522,0.000715594,0.0003503838,0.00012035122,0.00011896133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99536467,0.00036602092,0.0013044839,0.00087257935,0.0012234419,0.0008687965],"domain_scores_gemma":[0.9966045,0.00096900784,0.00060413446,0.00086698943,0.00058603846,0.00036934737],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000601448,0.0005250923,0.001371936,0.0009752091,0.000076182056,0.00003747296,0.0003333256,0.00030244674,0.00011206372],"category_scores_gemma":[0.0011242633,0.00048442182,0.00018022944,0.0009249869,0.00018596706,0.00033832502,0.00012521606,0.00047386164,0.000023468609],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018299773,0.10850934,0.75673056,0.0005433618,0.00092894206,0.0005019926,0.0040314007,0.00007222346,0.020559078,0.000020821797,0.000095699754,0.08970681],"study_design_scores_gemma":[0.21679772,0.021070179,0.7423052,0.00043682888,0.00030134816,0.000006924598,0.0006598416,0.0007642002,0.017165678,0.00010165961,0.000021776541,0.0003686313],"about_ca_topic_score_codex":0.007950933,"about_ca_topic_score_gemma":0.0027965168,"teacher_disagreement_score":0.19849794,"about_ca_system_score_codex":0.00023686762,"about_ca_system_score_gemma":0.0002803928,"threshold_uncertainty_score":0.99976075},"labels":[],"label_agreement":null},{"id":"W2409959614","doi":"10.1182/blood-2015-07-657916","title":"More than one way to shrink","year":2015,"lang":"en","type":"letter","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Genetics; Medicine; Biology","score_opus":0.03856776034367789,"score_gpt":0.2701618377995326,"score_spread":0.23159407745585472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2409959614","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.033559922,0.00043404294,0.00002870604,0.9310415,0.001504167,0.0006618983,0.00007176823,0.0002585671,0.03243946],"genre_scores_gemma":[0.0015092252,0.0000330541,0.00080845447,0.9335427,0.01512846,0.000052791653,0.0008446918,0.00007806317,0.048002508],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99865896,0.00004484493,0.00020692793,0.00041249316,0.00033957104,0.00033720987],"domain_scores_gemma":[0.99894464,0.000035284254,0.000066608765,0.000609888,0.00015435638,0.00018921116],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007851114,0.00024997213,0.0005546722,0.0001603214,0.000030762938,0.000009163766,0.00012319446,0.0007514029,0.00064490497],"category_scores_gemma":[0.000080584105,0.00021300401,0.0001396789,0.00013726956,0.00004336239,0.000016218213,0.000072359646,0.001130946,0.0023058034],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054962104,0.00016363079,0.00017887242,0.000156164,0.00015671227,0.0006447211,0.00013865661,1.848795e-7,0.0017559789,0.000004418543,0.9963703,0.00037538778],"study_design_scores_gemma":[0.0017888211,0.0007751266,0.0020690365,0.0001588363,0.00040282306,0.00020443753,0.00001908039,5.7905805e-7,0.0006824624,0.000047940834,0.99362016,0.00023068508],"about_ca_topic_score_codex":0.000034602723,"about_ca_topic_score_gemma":0.0000056743793,"teacher_disagreement_score":0.0320507,"about_ca_system_score_codex":0.00003354503,"about_ca_system_score_gemma":0.00011222478,"threshold_uncertainty_score":0.998471},"labels":[],"label_agreement":null},{"id":"W2412642891","doi":"10.1182/blood.v122.21.2670.2670","title":"Zebrafish Xenotransplantation and Focused Chemical Genomics: A Preclinical Therapeutic Model For T-Cell Acute Lymphoblastic Leukemia","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Zebrafish Biomedical Research Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Zebrafish; Biology; Xenotransplantation; Cancer research; PTEN; Leukemia; T cell; Molecular biology; In vivo; PI3K/AKT/mTOR pathway; Immune system; Immunology; Transplantation; Cell biology; Genetics; Signal transduction; Gene; Medicine","score_opus":0.01662689734966697,"score_gpt":0.275446637694996,"score_spread":0.258819740345329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2412642891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92698103,0.0002427596,0.071313694,0.00033983783,0.000014364485,0.00083742326,0.00009795817,0.000022144228,0.00015079362],"genre_scores_gemma":[0.98826087,0.00025507572,0.009685603,0.000466601,0.00012712703,0.00067267957,0.00028953297,0.00003341344,0.00020908476],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988711,0.00002360958,0.00023686317,0.00041489344,0.00013439861,0.00031913264],"domain_scores_gemma":[0.9992734,0.00009361331,0.000052858497,0.0002684712,0.00009010233,0.00022155145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012249962,0.00014153957,0.00014667516,0.000027787353,0.00006647556,0.00004803876,0.0002205147,0.0002224449,0.0000141101245],"category_scores_gemma":[0.00007428757,0.00013128524,0.000077664234,0.00005317528,0.00015182374,0.0000070304973,0.00006608376,0.00008910662,0.00002065322],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000065670014,0.00020553684,0.00011178634,0.000037153794,0.000100899706,3.857735e-7,0.000032773,0.000008123935,0.99651796,0.000058511967,0.0007000245,0.0021611792],"study_design_scores_gemma":[0.0075757205,0.0005043557,0.00088194426,0.000013879184,0.00028233553,0.00002161914,0.00001286735,0.055462614,0.93054414,0.0031827793,0.0011597531,0.00035799766],"about_ca_topic_score_codex":0.000009434174,"about_ca_topic_score_gemma":0.0000048743736,"teacher_disagreement_score":0.06597382,"about_ca_system_score_codex":0.000022330576,"about_ca_system_score_gemma":0.00024385702,"threshold_uncertainty_score":0.5353657},"labels":[],"label_agreement":null},{"id":"W2412828514","doi":"10.1182/blood-2016-06-724732","title":"Antigen modulation as a potential mechanism of anti-KEL immunoprophylaxis in mice","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services","funders":"National Center for Advancing Translational Sciences; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Mechanism (biology); Antigen; Immunology; Modulation (music); Biology; Epistemology; Physics; Philosophy","score_opus":0.006078035466912679,"score_gpt":0.21669011023223206,"score_spread":0.21061207476531937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2412828514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99741,0.00020598789,0.0012671007,0.00028333417,0.00009605388,0.0002585977,0.0000070022875,0.000023328603,0.00044861005],"genre_scores_gemma":[0.9989409,0.00027456912,0.0005673889,0.000030251624,0.00006291707,0.00000483475,0.0000058050405,0.000015921954,0.00009739976],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992132,0.000020936235,0.00023185273,0.00018500113,0.00019795807,0.00015102774],"domain_scores_gemma":[0.9996497,0.000011721234,0.000054470915,0.00018146497,0.00006002909,0.000042632088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001138197,0.000091693386,0.00021183662,0.000120142024,0.00002222441,0.0000034873574,0.000055140954,0.00009674174,0.00009589779],"category_scores_gemma":[0.000019149884,0.00006307333,0.00007358565,0.00014596505,0.000025159354,0.000069038346,0.000019599316,0.00006215415,0.000029225377],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000083798914,0.00068835355,0.0092942715,0.00003384541,0.00004824279,0.00004778754,0.00009277525,5.748996e-7,0.9815872,0.0010334745,0.00000150475,0.007088218],"study_design_scores_gemma":[0.007709463,0.00054037117,0.28656664,0.00021574587,0.00007198526,0.0000811041,0.000027454387,0.000059206144,0.70262825,0.001966154,0.000031644842,0.00010195165],"about_ca_topic_score_codex":0.0003255584,"about_ca_topic_score_gemma":0.000012106476,"teacher_disagreement_score":0.2789589,"about_ca_system_score_codex":0.000007787648,"about_ca_system_score_gemma":0.00003682557,"threshold_uncertainty_score":0.25720558},"labels":[],"label_agreement":null},{"id":"W2413177871","doi":"10.1182/blood-2016-02-701029","title":"XLF deficiency results in reduced N-nucleotide addition during V(D)J recombination","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Child and Family Research Institute","funders":"ZonMw","keywords":"V(D)J recombination; Recombination; Genetics; Nucleotide; DNA; Biology; Ligation; Molecular biology; Chemistry; Gene","score_opus":0.006998140042039837,"score_gpt":0.21434460017062407,"score_spread":0.20734646012858424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2413177871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968866,0.000042470474,0.00006274438,0.00017326493,0.00010444481,0.00012058592,0.00002675375,0.000026945898,0.002556156],"genre_scores_gemma":[0.9985822,0.0000555039,0.00042059028,0.000018898547,0.00006965034,0.00002246132,0.000052819974,0.000014542061,0.00076336076],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991907,0.000045449975,0.00018815148,0.0003056957,0.00008977737,0.00018023522],"domain_scores_gemma":[0.99959415,0.000008939964,0.000067422385,0.00025675815,0.000036790327,0.000035920395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017494531,0.00008401261,0.00006566145,0.000057154677,0.000034468318,0.000008445575,0.00010307218,0.00009206736,0.000017534068],"category_scores_gemma":[0.00026029555,0.00007042179,0.000037910726,0.000077508645,0.000017015864,0.000006245279,0.00005209105,0.00003300254,0.000032289223],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050577197,0.00016018027,0.0001651,0.000005185756,0.0000049082846,0.0000055054843,0.000016978747,0.000001568299,0.99788696,0.00010089827,0.00011253737,0.0014895931],"study_design_scores_gemma":[0.0026321276,0.00016297813,0.012495828,0.000040965515,0.000006831934,0.000014351732,0.000014117789,0.000002464482,0.983742,0.0004108478,0.00036057763,0.000116908675],"about_ca_topic_score_codex":0.000005780961,"about_ca_topic_score_gemma":0.000021727743,"teacher_disagreement_score":0.014144966,"about_ca_system_score_codex":0.000017429495,"about_ca_system_score_gemma":0.00002490357,"threshold_uncertainty_score":0.28717172},"labels":[],"label_agreement":null},{"id":"W2413543718","doi":"10.1182/blood.v122.21.5407.5407","title":"In Vitro Stromal Co-Culture Model For The Evaluation Of Reovirus Oncolytic Therapy For Refractory Pediatric Leukemia","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Stromal cell; Leukemia; Cancer research; Bone marrow; Oncolytic virus; Immunology; Myeloid leukemia; Plerixafor; Context (archaeology); Tumor microenvironment; Oncology; Cancer; CXCR4; Internal medicine; Biology; Chemokine; Immune system","score_opus":0.043425360546852185,"score_gpt":0.35284042268703125,"score_spread":0.30941506214017905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2413543718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99361736,0.0035839349,0.0004681461,0.00009065343,0.00003336013,0.0020559991,0.00007959413,0.000004131247,0.00006685154],"genre_scores_gemma":[0.99679506,0.00057588133,0.00053574366,0.0001555956,0.00032354673,0.001198272,0.000096901196,0.000026729864,0.00029229635],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989508,0.000089223446,0.00020587293,0.00024303661,0.00027199945,0.00023910914],"domain_scores_gemma":[0.9991169,0.000060580638,0.00009671704,0.00034523557,0.00034209192,0.000038489685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008070677,0.00011973933,0.00013418013,0.000046599096,0.00006588175,0.000015806336,0.00024736865,0.00015239345,0.00001840244],"category_scores_gemma":[0.000118446456,0.000086121014,0.00011000628,0.00007565188,0.000039449893,0.00000775055,0.000020762698,0.00008717276,0.000002768411],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00155464,0.00020154877,0.00009015346,0.00001871014,0.000060139206,6.408489e-8,0.00010504983,0.0013921802,0.9899928,0.0000029263126,0.0017502449,0.004831569],"study_design_scores_gemma":[0.0070041344,0.0021861154,0.00031109908,0.000002222967,0.00007747912,9.302166e-7,0.000046843415,0.03888508,0.95047456,0.00030315365,0.00057989877,0.00012847244],"about_ca_topic_score_codex":0.000018804101,"about_ca_topic_score_gemma":0.00003576982,"teacher_disagreement_score":0.039518204,"about_ca_system_score_codex":0.00004896226,"about_ca_system_score_gemma":0.0005501115,"threshold_uncertainty_score":0.3511913},"labels":[],"label_agreement":null},{"id":"W2414432783","doi":"10.1182/blood.v122.21.1161.1161","title":"Transfusion Related Alloimmunization In Children: Epidemiology and Effects Of Chemotherapy (TRACE-EC Study)","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hamilton Health Sciences; McMaster Children's Hospital; McMaster University","funders":"","keywords":"Medicine; Chemotherapy; Retrospective cohort study; Cancer; Internal medicine; Hematology; Cohort; Pediatrics; Malignancy","score_opus":0.005268283686074999,"score_gpt":0.233468644990574,"score_spread":0.228200361304499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2414432783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99551475,0.0019976548,0.00004861115,0.0005043875,0.000031420717,0.0017286793,4.844679e-7,0.00003098661,0.00014302428],"genre_scores_gemma":[0.99782264,0.0016325678,0.0002934496,0.00013321581,0.00001994485,0.000033057604,0.000010942286,0.00001935877,0.000034838402],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990298,0.00014179299,0.00036400417,0.00022048793,0.00008168881,0.00016223993],"domain_scores_gemma":[0.9995156,0.00013471981,0.00006186738,0.00019371015,0.00003591979,0.00005820174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028439445,0.00012157804,0.00040886406,0.00011473011,0.000029901561,0.0000023606012,0.000043224427,0.00014841145,0.000056123266],"category_scores_gemma":[0.00006148934,0.00009755405,0.00004447285,0.00021655009,0.00004856005,0.00005869003,0.000009644984,0.00018380705,0.0000042825304],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046790134,0.0027090397,0.93991286,0.00008002026,0.00013979813,0.0000043641035,0.0010367295,0.0000014120114,0.045266677,0.000053794218,0.0000073696815,0.010741152],"study_design_scores_gemma":[0.014875632,0.0012954923,0.9732768,0.00012564714,0.00018717465,0.00004168052,0.00005734798,0.000053707772,0.009813976,0.00018453151,0.000006760738,0.00008123347],"about_ca_topic_score_codex":0.0007720817,"about_ca_topic_score_gemma":0.000025784655,"teacher_disagreement_score":0.0354527,"about_ca_system_score_codex":0.000004978831,"about_ca_system_score_gemma":0.000011990514,"threshold_uncertainty_score":0.3978139},"labels":[],"label_agreement":null},{"id":"W2414703178","doi":"10.1182/blood-2015-07-655860","title":"Protective mitochondrial transfer from bone marrow stromal cells to acute myeloid leukemic cells during chemotherapy","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":454,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Cancer Research UK; National Cancer Institute; National Institutes of Health; Institut National Du Cancer; Fondation de France","keywords":"Bone marrow; Stromal cell; Mesenchymal stem cell; Cancer research; Myeloid leukemia; Leukemia; Mitochondrion; In vivo; In vitro; Myeloid; Biology; Chemistry; Cell biology; Immunology; Biochemistry","score_opus":0.008614955398169194,"score_gpt":0.23800244351882635,"score_spread":0.22938748812065715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2414703178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916777,0.00007504858,0.0022772753,0.002218987,0.00030795898,0.002510898,0.00032753465,0.00020408056,0.00040049196],"genre_scores_gemma":[0.98517555,0.00012993731,0.0055220854,0.00049741345,0.0020716954,0.0003698088,0.00001918947,0.00018385782,0.0060304753],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968454,0.000107185886,0.0004553177,0.00091252755,0.0007451906,0.0009343298],"domain_scores_gemma":[0.998281,0.0001292609,0.000051958636,0.00080053357,0.00015724321,0.0005800267],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00014221827,0.0004339689,0.0006641755,0.0002541721,0.00012656063,0.00004355934,0.000354857,0.00031335108,0.0010013226],"category_scores_gemma":[0.000043345608,0.00031457242,0.0002599312,0.00033340135,0.00012674488,0.00016855172,0.00009920141,0.0005155967,0.0008984084],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032140515,0.00037173752,0.00020025476,0.00004090442,0.0006023939,0.00042769825,0.00063638267,8.855208e-7,0.9914072,0.0000048578595,0.0011548293,0.0019388184],"study_design_scores_gemma":[0.025713472,0.00084137626,0.0045718593,0.00022539569,0.00027358573,0.000087938046,0.00006019306,0.0000051940146,0.96640635,0.000055764845,0.0013719628,0.00038694232],"about_ca_topic_score_codex":0.00025922531,"about_ca_topic_score_gemma":0.00002934936,"teacher_disagreement_score":0.025000868,"about_ca_system_score_codex":0.00058020424,"about_ca_system_score_gemma":0.00048073364,"threshold_uncertainty_score":0.9999306},"labels":[],"label_agreement":null},{"id":"W2415416350","doi":"10.1182/blood.v124.21.5008.5008","title":"The Mcmaster ITP Registry: Assessing the Prevalence, Clinical and Laboratory Features of Immune Thrombocytopenia","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Canadian Blood Services","funders":"","keywords":"Medicine; Internal medicine; Cohort; Prospective cohort study; Epidemiology; Observational study; Pediatrics; Autoantibody; Cohort study; Immune thrombocytopenia; Immunology; Platelet; Antibody","score_opus":0.016219437083219837,"score_gpt":0.31724053052834444,"score_spread":0.3010210934451246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2415416350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986382,0.005572285,0.0000029444238,0.0010009285,0.0000715813,0.00018760929,0.000006108051,0.000012219891,0.0067643197],"genre_scores_gemma":[0.9973994,0.0008304722,0.00014679933,0.00019716514,0.000072079754,0.0000065461204,0.0000022930735,0.0000097768825,0.0013355057],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992427,0.000113694354,0.00023021488,0.00014542621,0.0001401714,0.00012774761],"domain_scores_gemma":[0.99916947,0.00027808434,0.00012473094,0.00033439358,0.00005315209,0.00004015969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050069776,0.00008903642,0.0002595372,0.000009639368,0.00014491787,0.000042431202,0.00010355124,0.000067008456,0.000013877569],"category_scores_gemma":[0.0002327396,0.000041187574,0.00005601426,0.00006881608,0.00028803563,0.00004868718,0.00004868994,0.00016386759,0.000003921314],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017251805,0.0014271865,0.945514,0.00039898805,0.00094165606,0.00007402557,0.00035054865,1.7951396e-7,0.0056578037,0.001375585,0.0034143566,0.04067313],"study_design_scores_gemma":[0.0030068909,0.00020632613,0.9842528,0.000121650686,0.00043712818,0.0000623821,0.00010907557,0.000006911089,0.0021198713,0.00019595015,0.009424511,0.00005651125],"about_ca_topic_score_codex":0.000010702174,"about_ca_topic_score_gemma":0.0000058851283,"teacher_disagreement_score":0.040616617,"about_ca_system_score_codex":0.000002273832,"about_ca_system_score_gemma":0.00004537227,"threshold_uncertainty_score":0.16795805},"labels":[],"label_agreement":null},{"id":"W2415476100","doi":"10.1182/blood.v122.21.2314.2314","title":"Novel Murine Models Of Fetal and Neonatal Alloimmune Thrombocytopenia Established In αIIb Deficient and Human αIIb Transgenic Mice","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Neonatal alloimmune thrombocytopenia; Platelet; Immunology; Antigen; Fetus; Antibody; Medicine; Isoantibodies; Andrology; Biology; Pregnancy","score_opus":0.01591317115249802,"score_gpt":0.2374520532749584,"score_spread":0.2215388821224604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2415476100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964706,0.0019035746,0.00007060325,0.0001231729,0.000019192486,0.00054398057,0.000021987944,0.000015479327,0.00083145],"genre_scores_gemma":[0.9985473,0.00014119357,0.0010378979,0.00004113711,0.000008586967,0.000024754385,0.00004696738,0.000018184639,0.00013395534],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99909645,0.000010416571,0.00026419415,0.00025874175,0.00014695665,0.00022326455],"domain_scores_gemma":[0.9996367,0.000021558531,0.000052581367,0.00016621596,0.000037339698,0.000085605745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000065426546,0.00016147882,0.00043448096,0.00009953531,0.000040758947,0.000019610721,0.000057515932,0.00007403927,0.000050354578],"category_scores_gemma":[0.0000066283014,0.00013531673,0.000043710734,0.00011154227,0.00008343057,0.00018738738,0.000045492732,0.00010617026,0.0000031027253],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034092247,0.010779741,0.07210345,0.00070306397,0.00093987846,0.000285201,0.0041966047,0.000060647744,0.8982872,0.0015230662,0.00006561069,0.010714632],"study_design_scores_gemma":[0.08665312,0.0020468233,0.84490925,0.00047114713,0.0011172745,0.0013143014,0.0010491181,0.0025833833,0.057675015,0.0012908946,0.00016936805,0.0007202757],"about_ca_topic_score_codex":0.0020412155,"about_ca_topic_score_gemma":0.0003299504,"teacher_disagreement_score":0.8406122,"about_ca_system_score_codex":0.00001044637,"about_ca_system_score_gemma":0.00002548768,"threshold_uncertainty_score":0.5518056},"labels":[],"label_agreement":null},{"id":"W2416181174","doi":"10.1182/blood.v122.21.686.686","title":"Patient Outcomes By Prior Therapies and Depth Of Response: Analysis Of MM-003, a Phase 3 Study Comparing Pomalidomide + Low-Dose Dexamethasone (POM + LoDEX) Vs High-Dose Dexamethasone (HiDEX) In Relapsed/Refractory Multiple Myeloma (RRMM)","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Princess Margaret Cancer Centre; Vancouver General Hospital","funders":"","keywords":"Pomalidomide; Medicine; Lenalidomide; Tolerability; Clinical endpoint; Internal medicine; Dexamethasone; Phases of clinical research; Neutropenia; Bortezomib; Refractory (planetary science); Progressive disease; Population; Multiple myeloma; Surgery; Urology; Oncology; Randomized controlled trial; Adverse effect; Clinical trial; Toxicity; Chemotherapy","score_opus":0.025200036811512953,"score_gpt":0.3113322676816826,"score_spread":0.28613223087016965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2416181174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942428,0.0021340032,0.00003858847,0.00020046944,0.000042221174,0.003118576,0.00014299696,0.000058955662,0.00002137415],"genre_scores_gemma":[0.994941,0.000121906196,0.0042285873,0.00006964749,0.000012449135,0.00034178692,0.00009915286,0.00007249846,0.00011300489],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948796,0.0010581352,0.001406627,0.0008402526,0.0010650425,0.00075033266],"domain_scores_gemma":[0.99503595,0.002464722,0.00061057525,0.0010909506,0.0003170308,0.00048074996],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010215839,0.00057070743,0.0022490278,0.0013510168,0.00011279367,0.000046650162,0.0002622028,0.00019233298,0.00015098287],"category_scores_gemma":[0.0019065803,0.00045279998,0.00032597038,0.0013836375,0.00031443575,0.00022460091,0.00023531601,0.00043884755,0.000011653795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013261536,0.024563784,0.856949,0.00011693378,0.006565166,0.00022505793,0.0037211545,0.00002698967,0.07699059,0.0000017926635,0.000037788257,0.01754022],"study_design_scores_gemma":[0.07856643,0.004866109,0.8823212,0.00016394042,0.0018142036,0.000010200676,0.0021599662,0.0014093521,0.028336033,0.000008119588,0.000021854756,0.00032259483],"about_ca_topic_score_codex":0.007116224,"about_ca_topic_score_gemma":0.0015755307,"teacher_disagreement_score":0.0653049,"about_ca_system_score_codex":0.00014553005,"about_ca_system_score_gemma":0.00018206354,"threshold_uncertainty_score":0.9997924},"labels":[],"label_agreement":null},{"id":"W2416748499","doi":"10.1182/blood-2015-11-683003","title":"Comprehensive characterization of programmed death ligand structural rearrangements in B-cell non-Hodgkin lymphomas","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Canada's Michael Smith Genome Sciences Centre; University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency; Canadian Institutes of Health Research","keywords":"Breakpoint; Cancer research; Biology; Computational biology; Ligand (biochemistry); Genetics; Molecular biology; Chemistry; Gene; Receptor; Chromosomal translocation","score_opus":0.015206915539770723,"score_gpt":0.2533705947125114,"score_spread":0.23816367917274067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2416748499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985293,0.00010021055,0.0000051904885,0.0001628856,0.00006304736,0.00062459207,0.00002438578,0.000019650151,0.00047069712],"genre_scores_gemma":[0.99916476,0.00012018407,0.00030658298,0.00006426208,0.000047849986,0.00006584907,0.00006348507,0.000014976666,0.00015207627],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991609,0.000020310961,0.00024657056,0.00020369956,0.0001756281,0.00019291477],"domain_scores_gemma":[0.9995137,0.000028729515,0.00010791625,0.00019737039,0.00007811048,0.00007416195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000032090375,0.00013162162,0.00027250632,0.00008513519,0.000019105939,0.0000074954896,0.00004710231,0.000060480426,0.000030167528],"category_scores_gemma":[0.000009722236,0.00008161516,0.00005864524,0.00011128168,0.00002912407,0.0000603483,0.000027333099,0.000019407797,0.000015662892],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000095669275,0.0009836074,0.6207327,0.000067443325,0.000071326634,0.000057340927,0.00014796708,2.5021256e-8,0.36562282,0.000017001914,0.000006740511,0.0121973585],"study_design_scores_gemma":[0.014006202,0.0003122296,0.6355004,0.00016406747,0.000090614914,0.000014631103,0.000012703567,0.0000033618514,0.3495807,0.000012730734,0.00024224189,0.000060133363],"about_ca_topic_score_codex":0.00007460595,"about_ca_topic_score_gemma":0.0000059411327,"teacher_disagreement_score":0.016042111,"about_ca_system_score_codex":0.000059110484,"about_ca_system_score_gemma":0.00005451614,"threshold_uncertainty_score":0.33281696},"labels":[],"label_agreement":null},{"id":"W2417041000","doi":"10.1182/blood.v122.21.744.744","title":"NGS-Based Detection Of Multiple RAS-Mutated Clones In MLL-Rearranged Leukemias Suggests Strong Oncogenic Collaboration","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"CEBPA; Biology; KRAS; Exome sequencing; NPM1; Exome; Transcriptome; Mutation; Genetics; Leukemia; Cancer research; Deep sequencing; Gene; Karyotype; Genome; Gene expression","score_opus":0.015177345971364617,"score_gpt":0.27767023350638953,"score_spread":0.2624928875350249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2417041000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997365,0.00021925328,0.00028912514,0.00038163058,0.00006603085,0.0013771581,0.000015754864,0.000086753535,0.00019928304],"genre_scores_gemma":[0.9985679,0.000027361486,0.00078460656,0.00005669535,0.00009371832,0.00018646126,0.00009967551,0.000042362743,0.00014122878],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982453,0.00016239818,0.00045375148,0.00031823508,0.0004454131,0.0003749082],"domain_scores_gemma":[0.998637,0.0002211025,0.00014584475,0.00036592185,0.0004802107,0.000149922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033106402,0.00018335356,0.0003806061,0.00039189353,0.000054240823,0.000024897072,0.000113598515,0.00021768708,0.00012298783],"category_scores_gemma":[0.00064155785,0.00017168338,0.00007729762,0.0009914609,0.00009115103,0.00017662224,0.000031448137,0.00035200574,0.00010510966],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038162793,0.0004924779,0.05781299,0.00013010926,0.00007799351,0.000052780073,0.00025012527,0.0001823197,0.9368068,0.0000025858117,0.00010787527,0.0037023483],"study_design_scores_gemma":[0.016061893,0.0005422724,0.17613423,0.00010486465,0.00010078574,0.000023030676,0.00035829248,0.014778472,0.7916303,0.0000116937235,0.000096709104,0.00015740948],"about_ca_topic_score_codex":0.0029607844,"about_ca_topic_score_gemma":0.0017792913,"teacher_disagreement_score":0.14517641,"about_ca_system_score_codex":0.00044613122,"about_ca_system_score_gemma":0.0007778453,"threshold_uncertainty_score":0.70010453},"labels":[],"label_agreement":null},{"id":"W2417320515","doi":"10.1182/blood.v122.21.612.612","title":"Abnormalities Of 12p Are Associated With High-Risk Acute Myeloid Leukemia: A Children’s Oncology Group Report","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Hospital for Sick Children","funders":"","keywords":"ETV6; Internal medicine; Cytogenetics; Oncology; Myeloid leukemia; Medicine; Leukemia; NPM1; Karyotype; Biology; Chromosome; Chromosomal translocation; Genetics; Gene","score_opus":0.009385587597040094,"score_gpt":0.24708948958014904,"score_spread":0.23770390198310895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2417320515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993747,0.00023212151,0.000028936509,0.0009721191,0.00006874944,0.0010925562,0.00011603078,0.00017556938,0.0035669256],"genre_scores_gemma":[0.99239504,0.00034271218,0.0022102129,0.00036478072,0.00025607363,0.00022972483,0.0003488926,0.000077749835,0.0037748062],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970451,0.00020340204,0.00072935474,0.00052145676,0.0007897936,0.00071091723],"domain_scores_gemma":[0.9970961,0.00026619647,0.00077697076,0.0007914883,0.0007585405,0.000310679],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069458486,0.00032369225,0.0009622868,0.00024575065,0.00012793977,0.000027431961,0.00027833538,0.00042732403,0.0003690674],"category_scores_gemma":[0.0008798628,0.00024260813,0.0001545217,0.00044645587,0.00036744523,0.00020880929,0.00018056275,0.00095568725,0.00009351588],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004069139,0.0014981192,0.96187264,0.000109011125,0.0058875987,0.004032558,0.0006629701,0.0000066420407,0.0059401235,0.00019767247,0.017360618,0.0020251367],"study_design_scores_gemma":[0.011973237,0.0025577864,0.9674059,0.00024688925,0.0015852051,0.0039151525,0.00043361096,0.000023851842,0.010975387,0.00012611118,0.00044960223,0.0003072636],"about_ca_topic_score_codex":0.005981556,"about_ca_topic_score_gemma":0.0003467169,"teacher_disagreement_score":0.016911017,"about_ca_system_score_codex":0.0007943945,"about_ca_system_score_gemma":0.001114971,"threshold_uncertainty_score":0.98932725},"labels":[],"label_agreement":null},{"id":"W2417615734","doi":"10.1182/blood.v96.12.4001","title":"Signaling mechanism in the induction of apoptosis by thrombin in human tumor cells","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Apoptosis; Thrombin; Mechanism (biology); Cancer research; Signal transduction; Cell biology; Tumor cells; Thrombin generation; Biology; Chemistry; Immunology; Biochemistry; Platelet; Physics","score_opus":0.019989512833154095,"score_gpt":0.25695151628832724,"score_spread":0.23696200345517315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2417615734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99758226,0.000040476818,0.000021385431,0.00022528127,0.000043503485,0.00034805734,0.0000042252213,0.000021641936,0.0017131967],"genre_scores_gemma":[0.9991793,0.000015361382,0.00024432203,0.00036938037,0.0000381871,0.000024627949,0.000016535658,0.000015011763,0.00009725273],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99896246,0.000099143705,0.0003305546,0.00018623454,0.00025174927,0.00016986937],"domain_scores_gemma":[0.99963415,0.000026382448,0.00006991466,0.00021557116,0.000020177995,0.000033818644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000380541,0.000109284556,0.00025172535,0.00011211456,0.00003927212,0.000009855667,0.00010149513,0.000079211044,0.0006350043],"category_scores_gemma":[0.000007787859,0.00008724725,0.0000551106,0.0003438868,0.00002361906,0.00005593095,0.000009544297,0.00019122647,0.000015868718],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010157417,0.0012497208,0.0002814193,0.00002143213,0.000018643621,0.0000035646724,0.00082147226,0.0000059307476,0.99421656,0.0030437694,0.00006864287,0.00025866766],"study_design_scores_gemma":[0.0028374759,0.00025893643,0.0016106636,0.00010366724,0.0000823628,0.00001277477,0.00052413647,0.000028806022,0.9909799,0.003430568,0.000043547647,0.00008715186],"about_ca_topic_score_codex":0.00017667773,"about_ca_topic_score_gemma":0.000016443591,"teacher_disagreement_score":0.0032366698,"about_ca_system_score_codex":0.00001456115,"about_ca_system_score_gemma":0.000021094727,"threshold_uncertainty_score":0.6952852},"labels":[],"label_agreement":null},{"id":"W2417685891","doi":"10.1182/blood-2015-09-671172","title":"Activation of the thrombopoietin receptor by mutant calreticulin in CALR-mutant myeloproliferative neoplasms","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":281,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"Division of Human Resource Development; Ministry of Education, Culture, Sports, Science and Technology","keywords":"Calreticulin; Thrombopoietin; Thrombopoietin receptor; Mutant; Megakaryocyte; Cancer research; Janus kinase 2; Phosphorylation; Mutation; Receptor; Biology; Molecular biology; Cell biology; Genetics; Haematopoiesis; Gene; Stem cell","score_opus":0.00973414097659781,"score_gpt":0.23880471385706328,"score_spread":0.22907057288046548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2417685891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98935694,0.00013663265,0.000050477687,0.008453172,0.00011328896,0.0010531455,0.0001122178,0.000028015585,0.00069610204],"genre_scores_gemma":[0.9984473,0.0002664231,0.00032482127,0.0003182253,0.00007893444,0.0001981731,0.000019171908,0.000028935572,0.00031803388],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981815,0.00015933478,0.0005041776,0.00040225714,0.00043367883,0.00031903034],"domain_scores_gemma":[0.9988195,0.0003132338,0.00020861927,0.00038635862,0.00015583487,0.00011647471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020079261,0.00026375582,0.0004917415,0.0000720593,0.00007774217,0.000011059614,0.00012138553,0.00015117484,0.0005052186],"category_scores_gemma":[0.00039414334,0.00012859008,0.000129908,0.00032294585,0.00016347166,0.00008580375,0.000060263097,0.00017494839,0.000059048114],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027742618,0.0027312397,0.2247529,0.00004941712,0.0002569536,0.000015385804,0.0012202989,0.0000016585386,0.76558185,0.0014486008,0.0014143046,0.002249971],"study_design_scores_gemma":[0.0067248647,0.0005384239,0.062975295,0.0005999231,0.00011406044,0.000023277444,0.00014637211,0.000010056127,0.9271166,0.00014706049,0.0014463194,0.00015774931],"about_ca_topic_score_codex":0.00009615197,"about_ca_topic_score_gemma":0.00007002417,"teacher_disagreement_score":0.16177762,"about_ca_system_score_codex":0.00014542906,"about_ca_system_score_gemma":0.0002071749,"threshold_uncertainty_score":0.5531789},"labels":[],"label_agreement":null},{"id":"W2417723079","doi":"10.1182/blood.v124.21.1540.1540","title":"FEIBA™ for Reversal of Direct Oral Anticoagulant Associated Major Bleeding","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Rivaroxaban; Dabigatran; Apixaban; Atrial fibrillation; Vitamin K antagonist; Adverse effect; Bleeding diathesis; Prothrombin complex concentrate; Warfarin; Thrombosis; Surgery; Internal medicine","score_opus":0.053109052795613856,"score_gpt":0.31784916299335975,"score_spread":0.2647401101977459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2417723079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906742,0.000049010745,0.00048031777,0.0009046303,0.00022279423,0.00043850805,0.000008320239,0.00007899105,0.0071432428],"genre_scores_gemma":[0.99524665,0.0000062069994,0.0017275236,0.000076153585,0.00035259416,0.0000013673641,0.00002840813,0.000013116544,0.0025480092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99939924,0.000020214291,0.00019217293,0.00011252529,0.00014005785,0.00013577486],"domain_scores_gemma":[0.9995489,0.00014113006,0.000105444786,0.000102780155,0.00006294905,0.000038758422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003530391,0.00007161192,0.00030678464,0.00006395869,0.00003624116,0.0000075639928,0.000037327787,0.000048605143,0.00003155766],"category_scores_gemma":[0.0005868648,0.000059465317,0.00012562201,0.00010436412,0.000015530448,0.000034653265,0.000021306043,0.000028581739,0.0000069392077],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016743009,0.00007985206,0.96570945,0.00020886956,0.0006359324,0.000002672052,0.000097575066,0.0000045409524,0.026817622,0.0021691895,0.0027849048,0.0013219785],"study_design_scores_gemma":[0.033106953,0.0014266935,0.83954763,0.00037294364,0.0050333682,0.0000063969032,0.00013792094,0.0026668939,0.07539744,0.00070358,0.04113597,0.00046422586],"about_ca_topic_score_codex":0.000017389817,"about_ca_topic_score_gemma":0.0000045782836,"teacher_disagreement_score":0.12616181,"about_ca_system_score_codex":0.000008988669,"about_ca_system_score_gemma":0.000011470088,"threshold_uncertainty_score":0.24249253},"labels":[],"label_agreement":null},{"id":"W2418383775","doi":"10.1182/blood.v122.21.4574.4574","title":"Sulfolane (a metabolite of busulfan) Levels Could Predict Occurrence Of Hemorrhagic Cystitis In Children Receiving Busulfan Based Myeloablative Conditioning Before Hematopoietic Stem Cell Transplantation","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Hemorrhagic cystitis; Busulfan; Medicine; Mesna; Hematopoietic stem cell transplantation; Cyclophosphamide; Transplantation; Total body irradiation; Gastroenterology; Internal medicine; Cord blood; Urology; Immunology; Surgery; Chemotherapy","score_opus":0.008398761839627676,"score_gpt":0.22479188128831343,"score_spread":0.21639311944868575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2418383775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949391,0.0019433212,0.00021187903,0.000047720845,0.00005441705,0.0007758343,0.0015043888,0.000044927576,0.00047839578],"genre_scores_gemma":[0.9987381,0.00011809188,0.00038513922,0.00004113029,0.000030024115,0.000044133478,0.00056100095,0.000020093741,0.000062296334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998315,0.00008901078,0.00064801454,0.00029486333,0.0003595876,0.000293547],"domain_scores_gemma":[0.9989798,0.00011247584,0.0003343954,0.0002464149,0.00017036249,0.00015655423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015507558,0.00022143577,0.000548676,0.00025327588,0.000050117684,0.000012315175,0.00011552202,0.00015815835,0.00023699731],"category_scores_gemma":[0.000031494463,0.00019300949,0.00012539132,0.00040837858,0.000141852,0.00019238688,0.000014037005,0.0002331994,0.000013285213],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015553774,0.0018222908,0.9339028,0.0019650126,0.00035448838,0.00008232527,0.0030515273,0.00036567502,0.054549363,0.00008953252,0.000045622393,0.0036158178],"study_design_scores_gemma":[0.004945118,0.00026209318,0.8552762,0.0010423005,0.00082269486,0.00009289569,0.00019481496,0.00037634835,0.13675843,0.00006541185,0.0000018436499,0.00016182581],"about_ca_topic_score_codex":0.00039622345,"about_ca_topic_score_gemma":0.000010072751,"teacher_disagreement_score":0.082209066,"about_ca_system_score_codex":0.000020103129,"about_ca_system_score_gemma":0.00018700196,"threshold_uncertainty_score":0.78706986},"labels":[],"label_agreement":null},{"id":"W2419001201","doi":"10.1182/blood.v122.21.1647.1647","title":"Mir-126 Governs Human Leukemia Stem Cell Quiescence and Chemotherapy Resistance","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital; University of Toronto; Princess Margaret Cancer Centre; McGill University; University Health Network","funders":"","keywords":"Stem cell; Biology; Haematopoiesis; Myeloid leukemia; Leukemia; microRNA; Cancer research; Immunology; Population; Xenotransplantation; Transplantation; Cell biology; Medicine; Internal medicine; Genetics; Gene","score_opus":0.005084359775693605,"score_gpt":0.2046878897967583,"score_spread":0.1996035300210647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2419001201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99596334,0.0015841764,0.00006361591,0.000066424225,0.000019572739,0.00018404642,0.000010362839,0.000013779897,0.0020946732],"genre_scores_gemma":[0.9949361,0.000107429885,0.00045012753,0.00014173913,0.00009769489,0.000020894371,0.00002607895,0.000019386205,0.0042005377],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993676,0.00002173346,0.000116392905,0.0002597003,0.00008236929,0.00015220772],"domain_scores_gemma":[0.99953246,0.0000036713798,0.00006675925,0.00028772606,0.000041351876,0.00006802409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004046489,0.000108779735,0.00007927978,0.000011042909,0.00006345669,0.00003306733,0.00010952551,0.000091156784,0.00003816323],"category_scores_gemma":[0.0000032474795,0.00010985656,0.000034142737,0.000032940785,0.000054994354,0.0000048630636,0.000042811924,0.00003771725,0.000016841474],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000082779325,0.00005664837,0.0036195833,0.00003908013,0.00001729014,7.839312e-7,0.000029170367,6.5233985e-7,0.99286014,0.00004355884,0.003126109,0.00019872535],"study_design_scores_gemma":[0.0012280028,0.000052752042,0.07950186,0.000019302912,0.00001957304,0.0000032546423,0.000035252502,0.0000039214324,0.9065734,0.00009739315,0.012279615,0.00018568753],"about_ca_topic_score_codex":0.000017488084,"about_ca_topic_score_gemma":0.00002511566,"teacher_disagreement_score":0.08628673,"about_ca_system_score_codex":0.000016035225,"about_ca_system_score_gemma":0.00003359502,"threshold_uncertainty_score":0.44798207},"labels":[],"label_agreement":null},{"id":"W2419706633","doi":"10.1182/blood-2015-12-687665","title":"Knee replacement and HIT without heparin","year":2016,"lang":"en","type":"letter","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Heparin; Heparin-induced thrombocytopenia; Medicine; Platelet factor 4; Arthroplasty; Knee replacement; Surgery","score_opus":0.02599177324331825,"score_gpt":0.27242295399754746,"score_spread":0.2464311807542292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2419706633","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26582012,0.0005554363,0.000015680234,0.66227794,0.00066113274,0.0015466394,0.00007451994,0.00029156054,0.06875699],"genre_scores_gemma":[0.1826478,0.0006417091,0.0011743157,0.72969645,0.012400983,0.00030132112,0.0003467338,0.00035744405,0.07243324],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975853,0.00007852909,0.0004375292,0.0008130369,0.00044483226,0.00064079533],"domain_scores_gemma":[0.99847895,0.00008491866,0.00018086923,0.00097107905,0.0000810283,0.000203131],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021232034,0.00048563685,0.0010629712,0.00017992045,0.000095926065,0.00005119286,0.00014616777,0.00088323705,0.000677228],"category_scores_gemma":[0.00006918444,0.00035609482,0.00016172866,0.00009216827,0.00012550826,0.000066363675,0.0001960866,0.0010994129,0.0004816067],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000100346006,0.0002762774,0.054981653,0.0007620839,0.0018321938,0.00095358613,0.00014953004,3.6743872e-9,0.006784242,0.00008148742,0.9306346,0.003443957],"study_design_scores_gemma":[0.0057615153,0.00065187394,0.0076966104,0.0006970379,0.0016105218,0.0005151568,0.0000082089255,6.27971e-7,0.004067918,0.00012847634,0.9783642,0.00049781357],"about_ca_topic_score_codex":0.00010323113,"about_ca_topic_score_gemma":0.000012616105,"teacher_disagreement_score":0.08317233,"about_ca_system_score_codex":0.000083304825,"about_ca_system_score_gemma":0.00024276109,"threshold_uncertainty_score":0.9998891},"labels":[],"label_agreement":null},{"id":"W2421031319","doi":"10.1182/blood.v126.23.3468.3468","title":"Rivaroxaban for Treatment of Suspected or Confirmed Heparin-Induced Thrombocytopenia Study","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Joseph’s Healthcare Hamilton; St. Joseph's Hospital; Queen Elizabeth II Health Sciences Centre; University of Alberta; Ottawa Hospital; University of Manitoba; McMaster University","funders":"","keywords":"Rivaroxaban; Medicine; Cohort; Incidence (geometry); Anticoagulant; Heparin-induced thrombocytopenia; Thrombosis; Venous thrombosis; Prospective cohort study; Dosing; Anesthesia; Internal medicine; Surgery; Warfarin; Atrial fibrillation","score_opus":0.17586401729982282,"score_gpt":0.3756923628980633,"score_spread":0.19982834559824048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2421031319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899875,0.00006409244,0.00001643738,0.00029597126,0.00029879736,0.0045101373,0.000037795802,0.0001759024,0.004613395],"genre_scores_gemma":[0.9970313,0.000021130669,0.0012410142,0.00007118369,0.00027497916,0.00026743617,0.00006363608,0.00008495049,0.00094437995],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974563,0.000118355485,0.00075112877,0.00065096427,0.0004443862,0.0005788329],"domain_scores_gemma":[0.99742645,0.00019891826,0.00023927138,0.00096157077,0.00062224944,0.00055154186],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002926341,0.00045001684,0.001708406,0.00019935681,0.00010926142,0.000035175555,0.00023045235,0.0001973202,0.00018449458],"category_scores_gemma":[0.00039650768,0.00032395552,0.0002557678,0.00045453847,0.00008532972,0.00011567993,0.00007453544,0.000095013886,0.00006663317],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071250857,0.077204615,0.39298055,0.0003083287,0.008010915,0.0006448774,0.018195022,0.0000016024821,0.48851818,0.0012420764,0.0009312949,0.0048374753],"study_design_scores_gemma":[0.09762721,0.049162038,0.28832787,0.00011237231,0.0047998154,0.0002635026,0.006373485,0.00004581594,0.5490365,0.00020852141,0.0032911357,0.0007516921],"about_ca_topic_score_codex":0.00088750635,"about_ca_topic_score_gemma":0.0007052063,"teacher_disagreement_score":0.10465266,"about_ca_system_score_codex":0.0002046158,"about_ca_system_score_gemma":0.0008989781,"threshold_uncertainty_score":0.99992126},"labels":[],"label_agreement":null},{"id":"W2424323355","doi":"10.1182/blood-2015-10-678052","title":"Characterization of aberrant splicing of von Willebrand factor in von Willebrand disease: an underrecognized mechanism","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary; Health Sciences Centre; Centre Hospitalier Universitaire Sainte-Justine; Alberta Health Services; Queen's University","funders":"National Heart, Lung, and Blood Institute; Alberta Health Services; National Institutes of Health; Cancer Research Institute","keywords":"Von Willebrand disease; Von Willebrand factor; Medicine; Mechanism (biology); Genetics; Immunology; Biology; Platelet; Physics","score_opus":0.014127691424268691,"score_gpt":0.24284193704746862,"score_spread":0.22871424562319992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2424323355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987458,0.000082832186,0.00022746589,0.00019262366,0.000057710764,0.0004449241,0.00012669161,0.000020563264,0.000101415004],"genre_scores_gemma":[0.99929196,0.00030833305,0.0000711071,0.000032383934,0.000021128451,0.000012927318,0.000103092076,0.000022472592,0.00013661156],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990692,0.000035557576,0.00031380024,0.0002222836,0.0001864483,0.0001727074],"domain_scores_gemma":[0.99944293,0.000031990556,0.00015106148,0.00020925966,0.00004770956,0.00011706156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006459424,0.00014303449,0.00042087268,0.00013733648,0.000020056064,0.0000039991314,0.00004925923,0.00007207298,0.00011987473],"category_scores_gemma":[0.000033536846,0.00009526592,0.00006685407,0.0001190001,0.000029533085,0.00014902552,0.000014753478,0.00004003756,0.000004188319],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005264932,0.0014054822,0.11535008,0.00012294207,0.00012491047,0.000060294038,0.0002862864,1.07220615e-7,0.87739396,0.00006871128,9.755399e-7,0.004659784],"study_design_scores_gemma":[0.028614817,0.00059211196,0.4745294,0.0009534849,0.00039497664,0.000019843967,0.00004704597,0.000063101295,0.49357924,0.0009670365,0.00003248058,0.00020647969],"about_ca_topic_score_codex":0.000038231217,"about_ca_topic_score_gemma":0.000036884165,"teacher_disagreement_score":0.3838147,"about_ca_system_score_codex":0.000016637065,"about_ca_system_score_gemma":0.00005403654,"threshold_uncertainty_score":0.38848314},"labels":[],"label_agreement":null},{"id":"W2428539785","doi":"10.1182/blood-2016-03-707786","title":"Surface IgM expression and function are associated with clinical behavior, genetic abnormalities, and DNA methylation in CLL","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"Imperial Experimental Cancer Medicine Centre; Gilead Sciences; University of Southampton; Cancer Research UK; Bundesministerium für Bildung und Forschung; National Institute for Health and Care Research","keywords":"DNA methylation; Biology; Methylation; Immunology; Genetics; DNA; Gene expression; Cancer research; Gene","score_opus":0.03560816049409988,"score_gpt":0.3102328562786294,"score_spread":0.2746246957845295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2428539785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985071,0.00079641497,0.000051443127,0.00010180808,0.000035675705,0.0003599948,0.000008264046,0.00003368049,0.000105636485],"genre_scores_gemma":[0.9988262,0.00030128562,0.00022590336,0.00003676724,0.000055973527,0.000018438412,0.000010500647,0.000019219233,0.00050570886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871737,0.00016978654,0.00027785497,0.00029311283,0.00031410993,0.0002277492],"domain_scores_gemma":[0.9991331,0.00036423825,0.000096515665,0.00019347649,0.00007473801,0.00013795016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057062326,0.00010907087,0.00024140644,0.000057866575,0.00003926033,0.000016275644,0.000035089877,0.00016929502,0.000033697535],"category_scores_gemma":[0.0003023212,0.00006835096,0.000020974023,0.00010937369,0.00012587474,0.0000944449,0.000056222238,0.00013601605,0.000004111717],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050843775,0.0006644843,0.9700564,0.00006366282,0.00006001315,0.00018004165,0.00014304594,0.0000011651488,0.02140419,0.000007921262,0.00010346553,0.0068071294],"study_design_scores_gemma":[0.04010228,0.00050008687,0.9505877,0.0004921208,0.00018232864,0.000081864026,0.00008691895,0.00010291437,0.0076074707,0.00003320581,0.00011352108,0.00010959734],"about_ca_topic_score_codex":0.00012427384,"about_ca_topic_score_gemma":0.00016986472,"teacher_disagreement_score":0.039593842,"about_ca_system_score_codex":0.00057967025,"about_ca_system_score_gemma":0.00057254784,"threshold_uncertainty_score":0.2787271},"labels":[],"label_agreement":null},{"id":"W243187273","doi":"10.1182/blood.v122.21.1134.1134","title":"The Cost Analysis Of Aspirin Versus Low Molecular Weight Heparin For Thromboprophylaxis Following Total Hip Arthroplasty","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Capital District Health Authority; Dalhousie University","funders":"","keywords":"Medicine; Aspirin; Low molecular weight heparin; Regimen; Surgery; Deep vein; Randomization; Thrombosis; Arthroplasty; Heparin; Randomized controlled trial; Anticoagulant; Venous thrombosis; Anesthesia; Internal medicine","score_opus":0.011186207494744959,"score_gpt":0.25833373389067105,"score_spread":0.24714752639592608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W243187273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941921,0.0005140366,0.00054123485,0.00040073955,0.0004022624,0.0015405862,0.000013106944,0.000038199898,0.0023577262],"genre_scores_gemma":[0.9980494,0.00010064766,0.0009986486,0.000110256566,0.00007881025,0.00042156334,0.00004779081,0.000029041777,0.00016385593],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99855494,0.000032606316,0.0003646207,0.00031317613,0.00035390176,0.00038075968],"domain_scores_gemma":[0.9988821,0.00018784926,0.00013097444,0.0005568508,0.00012312004,0.0001191002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020896911,0.0001883168,0.00063558674,0.0001515314,0.00015255847,0.000046411915,0.00012923818,0.000073967225,0.0001382155],"category_scores_gemma":[0.000110606634,0.0001327972,0.00062385836,0.0005106187,0.00007378622,0.00006775937,0.00008974151,0.00009086533,0.000040602215],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015537589,0.031606115,0.10516432,0.0021073532,0.24866346,0.00044493141,0.0022876405,0.0022346973,0.18281417,0.03998377,0.021335017,0.36180475],"study_design_scores_gemma":[0.028835956,0.0050214073,0.8025817,0.0002917386,0.046318837,0.000007973356,0.0007893702,0.0046233693,0.092644446,0.0005145811,0.017315973,0.0010546249],"about_ca_topic_score_codex":0.00023419318,"about_ca_topic_score_gemma":0.000069353606,"teacher_disagreement_score":0.6974174,"about_ca_system_score_codex":0.000033381915,"about_ca_system_score_gemma":0.000045075773,"threshold_uncertainty_score":0.54153126},"labels":[],"label_agreement":null},{"id":"W2434582744","doi":"10.1182/blood.v122.21.1638.1638","title":"TP53 Mutation or Deletion and Efficacy with Single-Agent Lenalidomide in Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) (CC-5013-CLL-009 Study)","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"","keywords":"Lenalidomide; Medicine; Internal medicine; Neutropenia; Bendamustine; Chronic lymphocytic leukemia; Oncology; Gastroenterology; Refractory (planetary science); Febrile neutropenia; Chemotherapy; Leukemia; Multiple myeloma; Biology","score_opus":0.028865155415544973,"score_gpt":0.2854078378169268,"score_spread":0.25654268240138184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2434582744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950781,0.000749978,0.000038553517,0.00011435959,0.000079835976,0.0032502327,0.0000024787537,0.00015412754,0.0005323554],"genre_scores_gemma":[0.9966873,0.00016917173,0.00048974995,0.00017872058,0.00026396543,0.0003506421,0.000034838125,0.00010455817,0.001721067],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9964678,0.00025296575,0.0007308922,0.0008264907,0.0009403021,0.0007815435],"domain_scores_gemma":[0.9978525,0.000586416,0.00022412346,0.0007473279,0.00022402016,0.00036561402],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00054766034,0.00042067986,0.0006612049,0.00042141852,0.00013447517,0.0001174926,0.00020562959,0.00023783902,0.0003257647],"category_scores_gemma":[0.000728359,0.0002848059,0.00006637823,0.0007576746,0.00017286256,0.00024510332,0.00012449679,0.00042492893,0.00023626394],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.11299191,0.11919302,0.022450462,0.013736144,0.008788346,0.07088039,0.046274498,0.008402033,0.23582628,0.00023797313,0.0095181335,0.3517008],"study_design_scores_gemma":[0.8806182,0.021096904,0.032409035,0.0021217538,0.001331605,0.004631143,0.0029544914,0.033527225,0.018611033,0.00003970667,0.0014399681,0.0012189114],"about_ca_topic_score_codex":0.004327802,"about_ca_topic_score_gemma":0.002142305,"teacher_disagreement_score":0.76762635,"about_ca_system_score_codex":0.049828216,"about_ca_system_score_gemma":0.02084538,"threshold_uncertainty_score":0.9999604},"labels":[],"label_agreement":null},{"id":"W2435859559","doi":"10.1182/blood-2015-10-676304","title":"Modeling altered T-cell development with induced pluripotent stem cells from patients with RAG1-dependent immune deficiencies","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute; National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research","keywords":"Induced pluripotent stem cell; Recombination-activating gene; Cell biology; Immune system; Cellular differentiation; Biology; In vitro; Immunology; Genetics; Embryonic stem cell; Gene; Recombination","score_opus":0.00874103694308008,"score_gpt":0.16472701968127673,"score_spread":0.15598598273819664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2435859559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99171215,0.004787281,0.0022705176,0.000025304722,0.000361885,0.0004499993,0.000039407776,0.000116046955,0.00023739155],"genre_scores_gemma":[0.99898845,0.00003139441,0.00017215067,0.000040556948,0.0000037283073,0.000054467633,0.00006341307,0.00004360086,0.00060222304],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979464,0.000106762825,0.00051931274,0.0005841186,0.00016206845,0.00068133237],"domain_scores_gemma":[0.999036,0.000061533145,0.0002027063,0.00052717153,0.00015467922,0.000017920307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015157969,0.00039653026,0.0004046963,0.00011567221,0.00041321968,0.000033390657,0.00046148998,0.00019131074,0.000113101334],"category_scores_gemma":[0.0000051408465,0.00022996543,0.00006872928,0.00013872168,0.00012834655,0.00017736608,0.00014804288,0.00023564375,0.00037107096],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004103684,0.001967125,0.0027171113,0.000015230646,0.0003081793,0.0000053217464,0.0016557815,0.0002792804,0.9823783,0.000016371136,0.000002496467,0.010244434],"study_design_scores_gemma":[0.014242056,0.00050612993,0.003963519,0.00020836249,0.00013804136,0.000006310174,0.0013833328,0.000011958432,0.978455,0.000009706924,0.00046788485,0.0006076894],"about_ca_topic_score_codex":0.000246904,"about_ca_topic_score_gemma":0.000019958374,"teacher_disagreement_score":0.013831687,"about_ca_system_score_codex":0.000056551064,"about_ca_system_score_gemma":0.0002077405,"threshold_uncertainty_score":0.9377718},"labels":[],"label_agreement":null},{"id":"W2443551412","doi":"10.1182/blood.v122.21.4929.4929","title":"The In Vitro and In Vivo Effects Of Fermented Papaya Preparation On Radiation Exposure","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Papaya Research and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Propidium iodide; Dichlorofluorescein; Reactive oxygen species; Chemistry; Programmed cell death; Apoptosis; Molecular biology; Biology; Biochemistry","score_opus":0.005977490674171599,"score_gpt":0.27060663212346747,"score_spread":0.2646291414492959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2443551412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977318,0.00027469813,0.0000032268476,0.00053986936,0.0000066724997,0.00080715184,0.0000011243874,0.0000058016685,0.0006296637],"genre_scores_gemma":[0.9993242,0.00016185165,0.000038519596,0.000033336564,0.000015933454,0.00027654393,0.0000051974075,0.0000031115324,0.0001413095],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995961,0.00003862393,0.00010159883,0.00007718887,0.00009668178,0.00008977189],"domain_scores_gemma":[0.9996511,0.00015894136,0.000025008067,0.00011252827,0.000018685103,0.000033743767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009105307,0.000035990637,0.00006839908,0.000039586277,0.000021272961,0.000007413723,0.000024346406,0.00002587569,0.0000046025107],"category_scores_gemma":[0.00014756547,0.000024135014,0.000009723973,0.000113978924,0.000020877304,0.00003250502,0.000007370754,0.00006224847,0.000005989825],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012767821,0.0003796997,0.018529821,0.000043414195,0.000009629074,0.0000014566012,0.00014720319,0.0000011518579,0.974539,0.000079251484,0.00016774578,0.005973953],"study_design_scores_gemma":[0.0024180994,0.00022359444,0.4069952,0.000040065173,0.000006899344,0.0000012490289,0.000026409773,0.00020719462,0.5897808,0.00013618932,0.00014292863,0.000021341093],"about_ca_topic_score_codex":0.00005022087,"about_ca_topic_score_gemma":0.000025187204,"teacher_disagreement_score":0.38846537,"about_ca_system_score_codex":0.0000129070095,"about_ca_system_score_gemma":0.000020548836,"threshold_uncertainty_score":0.09841973},"labels":[],"label_agreement":null},{"id":"W2443612236","doi":"10.1182/blood.v104.11.492.492","title":"A Prospective Cohort Study of the Epidemiology of Symptomatic Venous Thromboembolism (VTE) after Isolated Leg Fractures Distal to the Knee without Thromboprophylaxis.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; University of Toronto","funders":"","keywords":"Medicine; Pulmonary embolism; Prospective cohort study; Surgery; Asymptomatic; Venography; Incidence (geometry); Deep vein; Thrombosis; Cohort; Internal medicine","score_opus":0.008651301692032754,"score_gpt":0.2729699378532248,"score_spread":0.26431863616119206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2443612236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913507,0.0005795778,0.00009628001,0.00081822043,0.00025955684,0.006133771,0.00001713208,0.000052194446,0.00069255586],"genre_scores_gemma":[0.99808973,0.00002858858,0.00017072471,0.00085531746,0.0001340013,0.0006313727,0.000003929491,0.000048175607,0.000038151655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976074,0.00022292422,0.00076888147,0.000492907,0.00047673602,0.00043112878],"domain_scores_gemma":[0.99801224,0.00013823851,0.0003906746,0.0011655788,0.00018361525,0.00010967634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006034796,0.0003235508,0.0015272317,0.00010468129,0.00014809126,0.0000091927795,0.00035766079,0.000121907244,0.00006180754],"category_scores_gemma":[0.00034289862,0.00017132633,0.00023338107,0.0004474592,0.00023334424,0.000053619176,0.00028959848,0.00031629618,0.000019433828],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017059904,0.016874382,0.96310157,0.00022542448,0.0026455806,0.000025130115,0.014790167,0.00034228057,0.0006862688,0.00082822546,0.00011310373,0.00019726441],"study_design_scores_gemma":[0.0031425422,0.0045431876,0.9862315,0.0002836453,0.0018726104,0.000028660366,0.0011697547,0.000007449346,0.0014148665,0.0010968535,0.000034258082,0.00017467602],"about_ca_topic_score_codex":0.0012324842,"about_ca_topic_score_gemma":0.00052131235,"teacher_disagreement_score":0.023129921,"about_ca_system_score_codex":0.000075882985,"about_ca_system_score_gemma":0.00011715441,"threshold_uncertainty_score":0.6986485},"labels":[],"label_agreement":null},{"id":"W2460270380","doi":"10.1182/blood-2015-09-668251","title":"Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cells","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; McMaster University; Hamilton Health Sciences; Ottawa Hospital; CancerCare Manitoba; McGill University Health Centre; University of Calgary; Princess Margaret Cancer Centre; Vancouver General Hospital; Hôpital de l'Enfant-Jésus; Hôpital Notre-Dame; BC Cancer Agency; Centre hospitalier universitaire de Québec; Centre Hospitalier de l’Université de Montréal; BC Children's Hospital; University of British Columbia","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute; Pharmacyclics; Canadian Institutes of Health Research; Genome British Columbia; University of Victoria; Cleveland Clinic","keywords":"CXCR3; CXCL10; Graft-versus-host disease; Immunology; Cohort; Medicine; Disease; Biomarker; Biology; Chemokine; Internal medicine; Immune system; Chemokine receptor; Genetics","score_opus":0.01136642747607385,"score_gpt":0.23879364081918575,"score_spread":0.2274272133431119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2460270380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99798626,0.0004011177,0.0003305767,0.00032009344,0.00008609096,0.00032623645,0.000067920686,0.000037531394,0.00044417626],"genre_scores_gemma":[0.9991205,0.0003031201,0.00030685824,0.000021494125,0.00006975727,0.000013862627,0.000014322098,0.000018598263,0.00013152043],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990591,0.000043264234,0.00019516316,0.00021927094,0.00029720226,0.00018600404],"domain_scores_gemma":[0.99922055,0.00019375126,0.0001300941,0.00020990254,0.000077205135,0.00016852128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016092275,0.00011899178,0.00020084789,0.000057528443,0.00002854008,0.0000072412445,0.000039549534,0.000070913346,0.00005504916],"category_scores_gemma":[0.000045197994,0.00007819246,0.000048284255,0.00009836661,0.000056056433,0.00007004489,0.0000105120025,0.00003892773,0.00002179295],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011268274,0.0006154828,0.46292022,0.0009519003,0.0006805911,0.00006746578,0.00014844388,2.761344e-7,0.53255415,0.000050260507,0.00008967818,0.0007947166],"study_design_scores_gemma":[0.016936148,0.0007034038,0.23293711,0.0007647842,0.0013280205,0.000018713077,0.000027180988,0.0000137717725,0.746883,0.0000107685655,0.00020912648,0.00016802635],"about_ca_topic_score_codex":0.000016709071,"about_ca_topic_score_gemma":0.000036467245,"teacher_disagreement_score":0.2299831,"about_ca_system_score_codex":0.00008240816,"about_ca_system_score_gemma":0.00011644607,"threshold_uncertainty_score":0.3188596},"labels":[],"label_agreement":null},{"id":"W2460389737","doi":"10.1182/blood.v124.21.4393.4393","title":"Eculizumab Treatment Improves Outcomes of Pregnancy in Patients with Paroxysmal Nocturnal Hemoglobinuria","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Eculizumab; Paroxysmal nocturnal hemoglobinuria; Medicine; Pregnancy; Hemoglobinuria; Thrombosis; Gestation; Pediatrics; Obstetrics; Anemia; Internal medicine; Immunology; Complement system; Antibody","score_opus":0.005889418102080642,"score_gpt":0.20847059465637,"score_spread":0.20258117655428937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2460389737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979835,0.0008234477,0.0000056556514,0.000017271865,0.00014232844,0.0004435409,0.0000510018,0.000024614306,0.0005086055],"genre_scores_gemma":[0.99954593,0.0000043595896,0.00007066466,0.000011153892,0.000007376863,0.00005157336,0.000056026853,0.000011214371,0.00024170052],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990905,0.00011512055,0.00029997874,0.00021237884,0.000043230113,0.00023882426],"domain_scores_gemma":[0.9994279,0.00006540346,0.00015568142,0.00029121307,0.00004094765,0.000018852359],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003812864,0.00016964838,0.00034372916,0.00006680735,0.000037396647,0.0000053414096,0.00014169693,0.00006324105,0.00014178018],"category_scores_gemma":[0.00002705058,0.00011230266,0.00007004289,0.000057329133,0.00006221936,0.00004715261,0.000038755443,0.000047268448,0.000034301753],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013835586,0.0019568547,0.99113184,0.00003485532,0.0002949158,0.000001368872,0.00013541349,0.0000014620539,0.0022994585,0.000088520064,0.000024290179,0.0038926876],"study_design_scores_gemma":[0.016195133,0.0013887216,0.9670749,0.00016683344,0.0001343043,0.0000032152236,0.000030935138,5.3617197e-7,0.014574863,0.000035599307,0.0002596723,0.0001353092],"about_ca_topic_score_codex":0.00010145817,"about_ca_topic_score_gemma":0.00008299974,"teacher_disagreement_score":0.024056941,"about_ca_system_score_codex":0.000030196077,"about_ca_system_score_gemma":0.00003563324,"threshold_uncertainty_score":0.45795694},"labels":[],"label_agreement":null},{"id":"W2460609230","doi":"10.1182/blood.v114.22.2314.2314","title":"High Dose Chemotherapy and Autologous Stem Cell Transplantation in the Primary Therapy of Advanced Follicular Lymphoma in Adults: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.","year":2009,"lang":"en","type":"review","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton; St. Joseph's Hospital; Sunnybrook Hospital; University Health Network; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Oncology; Autologous stem-cell transplantation; Follicular lymphoma; Transplantation; Clinical trial; Randomized controlled trial; Rituximab; Chemotherapy regimen; Interim analysis; Chemotherapy; Hematopoietic stem cell transplantation; Surgery; Lymphoma","score_opus":0.06126703303032959,"score_gpt":0.36742572454958045,"score_spread":0.30615869151925085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2460609230","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006637833,0.97956413,0.0000024100461,0.00011693282,0.000009307582,0.013557964,0.00008843138,0.000007327688,0.000015658663],"genre_scores_gemma":[0.0026846349,0.9945246,0.00024980263,0.00041335466,0.000007777714,0.0019316345,0.00016149726,0.000019963622,0.000006715707],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98743236,0.007032745,0.0045774686,0.00046377096,0.00034394732,0.00014968496],"domain_scores_gemma":[0.9906944,0.006059487,0.0025534874,0.00057470903,0.00006449225,0.000053450745],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.009783802,0.0004684971,0.027969401,0.00036689968,0.000012870642,0.000009796249,0.0001410132,0.00026567944,0.000009546315],"category_scores_gemma":[0.00020957552,0.00020591464,0.0041228402,0.0007256182,0.00008408417,0.0000330377,0.0000070350507,0.00010138739,2.9602964e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004415301,0.003801301,0.00002229196,0.68587565,0.13931923,0.00012446115,0.00034060114,2.8676155e-7,2.7336216e-7,0.00002174996,0.0000021732262,0.16607665],"study_design_scores_gemma":[0.17215236,0.00031824832,0.0004092943,0.05405579,0.7727406,0.00005907708,0.000015595491,0.000001418962,0.0000058504174,0.0000057910092,0.00009565821,0.0001402935],"about_ca_topic_score_codex":0.00005854561,"about_ca_topic_score_gemma":0.000011249769,"teacher_disagreement_score":0.6334214,"about_ca_system_score_codex":0.00003722667,"about_ca_system_score_gemma":0.0001524141,"threshold_uncertainty_score":0.9864614},"labels":[],"label_agreement":null},{"id":"W2460636042","doi":"10.1182/blood.v122.21.1176.1176","title":"Perturbation Of Gpsm2/Lgn Enhances Haematopoietic Stem Cell Function","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Biology; Stem cell; Cell biology; Haematopoiesis; Molecular biology; Mitosis","score_opus":0.008142161082640358,"score_gpt":0.21485613203749188,"score_spread":0.20671397095485153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2460636042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99214983,0.0011023546,0.000715416,0.000054978398,0.00007327537,0.00023169396,0.0000034206291,0.0000090298445,0.005659976],"genre_scores_gemma":[0.9933294,0.00013972964,0.00014778884,0.00003060617,0.000079643134,0.00003943736,0.000033228996,0.000012440321,0.006187715],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992371,0.000051367602,0.00016245325,0.00021042167,0.00017182923,0.00016679475],"domain_scores_gemma":[0.9994952,0.000011015933,0.00007187717,0.00024943208,0.000121071826,0.000051420884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009369279,0.00008729992,0.00009849545,0.000035729106,0.00003584555,0.000016547046,0.00012865126,0.000097662676,0.000103001075],"category_scores_gemma":[0.000009779755,0.0000774928,0.000057347865,0.0000666715,0.000040235453,0.000005671891,0.000060779596,0.000049805047,0.00012434124],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011809965,0.00016808353,0.0008814157,0.00007787327,0.000025475809,5.320157e-7,0.000026655833,0.0000066631915,0.9972861,0.000019498686,0.00070761266,0.0007883193],"study_design_scores_gemma":[0.0004950028,0.00030199875,0.002247935,0.0000109032535,0.000022288725,0.000004826531,0.00009040699,0.000046059842,0.99516195,0.000082371036,0.0014481768,0.00008806907],"about_ca_topic_score_codex":0.000017917251,"about_ca_topic_score_gemma":0.0000031125135,"teacher_disagreement_score":0.0021240988,"about_ca_system_score_codex":0.0000037470402,"about_ca_system_score_gemma":0.00003368163,"threshold_uncertainty_score":0.31600648},"labels":[],"label_agreement":null},{"id":"W2460697893","doi":"10.1182/blood.v122.21.3353.3353","title":"High Progression-Free Survival At 10 Years After Tandem Autologous/Nonmyeloablative Allogeneic Transplants For Multiple Myeloma In a Cohort Of 93 Patients: Impact Of Disease Remission Status At Transplant and Chronic Graft-Versus-Host Disease","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Internal medicine; Immunosuppression; Transplantation; Progression-free survival; Hematopoietic stem cell transplantation; Fludarabine; Cohort; Regimen; Multiple myeloma; Cyclophosphamide; Surgery; Proportional hazards model; Oncology; Graft-versus-host disease; Chemotherapy","score_opus":0.011905659776299784,"score_gpt":0.2801296716959936,"score_spread":0.26822401191969386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2460697893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910874,0.0016217572,0.0000043234236,0.00004213677,0.000048268146,0.0032984798,0.0038601863,0.000025754714,0.000011700705],"genre_scores_gemma":[0.99704164,0.0006804324,0.0002717406,0.000004151111,0.000028697283,0.00058433414,0.0012428407,0.00004497737,0.00010119992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976057,0.00012314176,0.0004883617,0.00051392935,0.0006007281,0.0006681333],"domain_scores_gemma":[0.9979088,0.0003340189,0.00017039473,0.00045804217,0.00016483825,0.000963914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012999166,0.0003236338,0.0006179769,0.00018046392,0.00006762347,0.000008834447,0.00012684331,0.00012226675,0.00033905072],"category_scores_gemma":[0.0002652135,0.00023571953,0.00023515304,0.00015503072,0.00020907065,0.0001252239,0.00008908945,0.000109465094,0.000006923721],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03138781,0.0020988737,0.957384,0.00052642095,0.00062344497,0.00018907891,0.00025161312,0.0000043808236,0.0052814013,9.922826e-7,0.000037119196,0.0022148897],"study_design_scores_gemma":[0.041770115,0.0021947585,0.9517674,0.0006219524,0.000539459,0.000002358976,0.000009386666,0.00032548368,0.0025338118,0.00001634466,0.000016540342,0.00020243313],"about_ca_topic_score_codex":0.0003769863,"about_ca_topic_score_gemma":0.00039416287,"teacher_disagreement_score":0.010382305,"about_ca_system_score_codex":0.0003403509,"about_ca_system_score_gemma":0.0003482421,"threshold_uncertainty_score":0.96123636},"labels":[],"label_agreement":null},{"id":"W2461079615","doi":"10.1182/blood.v126.23.3412.3412","title":"The Effects of Glutamine Supplementation on Markers of Autophagy and Apoptosis in Peripheral Blood Mononuclear Cells from Patients with Sickle Cell Disease","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Victoria","funders":"","keywords":"Biology; Programmed cell death; Glutathione; Autophagy; Glutamine; Biochemistry; Internal medicine; Immunology; Endocrinology; Apoptosis; Medicine","score_opus":0.002839816009814428,"score_gpt":0.18791780786521953,"score_spread":0.1850779918554051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2461079615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99857795,0.00045887684,0.0000016851291,0.00007126001,0.00005090894,0.00051443715,0.000035677713,0.000008167358,0.00028102752],"genre_scores_gemma":[0.99946874,0.00016069219,0.00017763065,0.00004262411,0.000010657922,0.000010649178,0.000044219603,0.000016660199,0.0000681224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992454,0.00005137501,0.00019261017,0.00014855583,0.00022445303,0.00013761941],"domain_scores_gemma":[0.99948025,0.00008756451,0.00009483453,0.00016170787,0.000047066274,0.00012860022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006314954,0.00010713356,0.00017965739,0.000041327385,0.000025602705,0.000006021934,0.000044754834,0.00004515142,0.000013136044],"category_scores_gemma":[0.000038151684,0.0000681496,0.000030305828,0.00010011371,0.0000758489,0.000032042455,0.000021795522,0.00008087524,0.0000011563014],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010864289,0.014725633,0.89284045,0.0012834229,0.00074622076,0.000062967134,0.005317461,0.00018013948,0.065370515,0.000036789912,0.0012360013,0.00733612],"study_design_scores_gemma":[0.07331603,0.009062893,0.5033933,0.00060600776,0.0016186512,6.252612e-7,0.002074391,0.0003292089,0.40907106,0.00006660748,0.00017962907,0.00028157711],"about_ca_topic_score_codex":0.00023654477,"about_ca_topic_score_gemma":0.000011586524,"teacher_disagreement_score":0.38944712,"about_ca_system_score_codex":0.000012240326,"about_ca_system_score_gemma":0.00004666851,"threshold_uncertainty_score":0.277906},"labels":[],"label_agreement":null},{"id":"W2461345736","doi":"10.1182/blood.v114.22.2872.2872","title":"Exposure to Novel Agents Increases Post Relapse Survival in Patients with High Risk Myeloma Defined by Early Relapse (&lt;12 months).","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Lenalidomide; Multiple myeloma; Thalidomide; Cohort; Internal medicine; Bortezomib; Autologous stem-cell transplantation; Oncology; Transplantation; Surgery","score_opus":0.009810796874228304,"score_gpt":0.23123278838826913,"score_spread":0.22142199151404082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2461345736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99661446,0.00014811003,0.000009173911,0.00030368424,0.000058489022,0.0014252999,0.00067777437,0.000098017255,0.0006649749],"genre_scores_gemma":[0.9962955,0.000033831995,0.0020086612,0.00026344613,0.00006468592,0.00007022624,0.00066291564,0.000057577523,0.0005431573],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970127,0.0001357554,0.00043912587,0.00064645696,0.0009960033,0.00076996617],"domain_scores_gemma":[0.9980525,0.00013618376,0.00013436789,0.00067343377,0.00023908091,0.00076446164],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020876234,0.00040177227,0.0005737828,0.00029461898,0.00013328751,0.000049295784,0.00020857809,0.00017268794,0.00009421375],"category_scores_gemma":[0.0007234975,0.0003113681,0.00009560885,0.00045779682,0.000048942526,0.0001904062,0.00007532343,0.00036079713,0.00017871463],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045434632,0.013507293,0.97588986,0.000018898056,0.00029881808,0.00034087515,0.0001930085,0.0000037482944,0.0008995814,0.000027929891,0.0006166348,0.0036598807],"study_design_scores_gemma":[0.04736507,0.009268612,0.9415732,0.00016574842,0.0002337456,0.000009666087,0.000029206309,0.000004001174,0.0009227418,0.000017666709,0.00011608104,0.00029426924],"about_ca_topic_score_codex":0.0050504236,"about_ca_topic_score_gemma":0.0008438203,"teacher_disagreement_score":0.04282161,"about_ca_system_score_codex":0.00011736612,"about_ca_system_score_gemma":0.00012117292,"threshold_uncertainty_score":0.99993384},"labels":[],"label_agreement":null},{"id":"W2461383975","doi":"10.1182/blood.v124.21.4358.4358","title":"Characterization of the Hematopoietic Supporting Activity of Osteoblasts Derived from Bone Marrow Mesenchymal Stromal Cells","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Ottawa","funders":"","keywords":"Mesenchymal stem cell; Haematopoiesis; CD34; Progenitor cell; Bone marrow; Stromal cell; Cell biology; Cord blood; Immunology; Stem cell; Andrology; Biology; Chemistry; Cancer research; Medicine","score_opus":0.013895261746926955,"score_gpt":0.25314045162123744,"score_spread":0.23924518987431048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2461383975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977932,0.000014224202,0.0002209083,0.00022266983,0.00009121863,0.0004812254,0.000030883126,0.000018368559,0.0011273065],"genre_scores_gemma":[0.9991847,0.0000044954963,0.00028858776,0.000019510378,0.000105325285,0.000009618009,0.000020225354,0.000023815468,0.00034366545],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99813277,0.00021262687,0.00043168588,0.000255923,0.0006667838,0.00030023587],"domain_scores_gemma":[0.9985962,0.00018953452,0.00041934827,0.0005277108,0.00014251757,0.00012471867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045883778,0.0001437264,0.0004492485,0.000064572814,0.00004977828,0.000009509251,0.00017200044,0.00011067189,0.00036390917],"category_scores_gemma":[0.00032533583,0.00010500344,0.00014014328,0.00021555278,0.0001239142,0.00006613987,0.0001595467,0.00020681732,0.000014618313],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000088310124,0.00037910088,0.038409673,0.00025913748,0.00005149257,0.00000648218,0.000314441,5.9345314e-7,0.9596296,0.000017540247,0.0000041151316,0.00083952636],"study_design_scores_gemma":[0.0012802228,0.00019628655,0.22684528,0.00015278049,0.00009727325,0.000012519224,0.000039583396,0.00020026084,0.7710785,0.000015843978,0.000018303353,0.00006311589],"about_ca_topic_score_codex":0.00011371138,"about_ca_topic_score_gemma":0.000015756397,"teacher_disagreement_score":0.18855105,"about_ca_system_score_codex":0.00001628791,"about_ca_system_score_gemma":0.00011610986,"threshold_uncertainty_score":0.4281916},"labels":[],"label_agreement":null},{"id":"W2461665465","doi":"10.1182/blood-2016-02-698977","title":"Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell–derived lymphomas","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":318,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; BC Cancer Agency","funders":"Direction Générale de l’offre de Soins; Fondation Medic; Institut National Du Cancer","keywords":"T-cell receptor; Gene; Biology; Cancer research; Immunology; Pathogenesis; Mutation; Signal transduction; T cell; Genetics; Immune system","score_opus":0.011199767392676023,"score_gpt":0.24024019387184237,"score_spread":0.22904042647916634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2461665465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975489,0.0012641626,0.00001777514,0.00038340985,0.00002177539,0.0003450251,0.0000044406543,0.000026113057,0.00038839597],"genre_scores_gemma":[0.9986234,0.000037168073,0.00095042866,0.00014024996,0.000015091566,0.00010496623,0.000003072254,0.000022453822,0.000103191735],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992,0.00003598185,0.00022806089,0.0002306505,0.00010468026,0.0002006479],"domain_scores_gemma":[0.9995605,0.00016937008,0.000041494535,0.00013482077,0.000021588188,0.00007225487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008251219,0.00012385691,0.00020351207,0.00015879593,0.0000361612,0.000012415819,0.000030500176,0.000064409716,0.00005666535],"category_scores_gemma":[0.00007309746,0.00008456516,0.00004123693,0.00021553332,0.000020512494,0.000048485595,0.000025352138,0.000026891548,0.000028542],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033642893,0.0008641209,0.42821115,0.000017647337,0.00008024482,0.00015915399,0.0010200448,0.000025553658,0.5619507,0.00004914888,0.0000029563178,0.007585677],"study_design_scores_gemma":[0.018855277,0.00026804034,0.40943086,0.000872976,0.00013294394,0.00006441893,0.00041176914,0.000031797965,0.5693426,0.00012092095,0.00026611684,0.00020228229],"about_ca_topic_score_codex":0.00018730147,"about_ca_topic_score_gemma":0.000034964858,"teacher_disagreement_score":0.018821634,"about_ca_system_score_codex":0.00008899091,"about_ca_system_score_gemma":0.000051606654,"threshold_uncertainty_score":0.3448467},"labels":[],"label_agreement":null},{"id":"W2461690387","doi":"10.1182/blood.v124.21.592.592","title":"Antithrombotic Treatment and Outcomes of Splanchnic Vein Thrombosis in an International Prospective Registry: Results of 2-Year Follow-up","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Medicine; Thrombosis; Prospective cohort study; Portal vein thrombosis; Clinical endpoint; Surgery; Internal medicine; Interquartile range; Clinical trial","score_opus":0.018436641687010702,"score_gpt":0.2900606447297325,"score_spread":0.2716240030427218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2461690387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935207,0.00003540285,0.000006664872,0.0003117657,0.00012845638,0.00042987533,0.000033179876,0.000017289778,0.00551666],"genre_scores_gemma":[0.9987639,0.0003049512,0.0006600618,0.000033739485,0.000045015837,0.000023054308,0.0000327089,0.000013503953,0.00012305164],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990518,0.000033020366,0.0003325069,0.00026517388,0.00018160365,0.00013587564],"domain_scores_gemma":[0.9993215,0.000051203227,0.00016304069,0.00034305287,0.00006604326,0.00005511897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018031248,0.000128302,0.00057818164,0.00012871389,0.000016051046,0.000008558467,0.00008800786,0.000052905605,0.000017900677],"category_scores_gemma":[0.00012169714,0.0001020006,0.00006453172,0.00010004087,0.000071617906,0.00007703792,0.000042500145,0.000048386006,0.000002404813],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012588663,0.0037497769,0.98788536,0.000082796345,0.00045604844,0.0000048701895,0.0009528519,0.000004260842,0.0027646322,0.0033657236,0.000085745916,0.00052202214],"study_design_scores_gemma":[0.012215117,0.0018819937,0.97743624,0.00014896953,0.00033901908,0.0000024702674,0.00020724972,0.000024758932,0.0073213973,0.00020750538,0.00013092467,0.000084337684],"about_ca_topic_score_codex":0.00045230554,"about_ca_topic_score_gemma":0.00036277762,"teacher_disagreement_score":0.01208923,"about_ca_system_score_codex":0.000039070215,"about_ca_system_score_gemma":0.000027056993,"threshold_uncertainty_score":0.41594636},"labels":[],"label_agreement":null},{"id":"W2461719129","doi":"10.1182/blood.v122.21.5248.5248","title":"Barriers To Diagnosis In Myeloproliferative Neoplasms","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Referral; Polycythemia vera; Abnormality; Demographics; Pediatrics; Internal medicine; Myelofibrosis; Essential thrombocythemia; Surgery; Family medicine; Bone marrow","score_opus":0.010305858376697664,"score_gpt":0.25086316624792243,"score_spread":0.24055730787122476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2461719129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98475087,0.0002802115,0.00000811941,0.0076911952,0.00009604644,0.001940184,0.000015094837,0.000068390764,0.0051499135],"genre_scores_gemma":[0.9884963,0.0001772701,0.002493168,0.0039278767,0.00012953472,0.0042126235,0.000015850394,0.00003603838,0.0005113465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833006,0.00006445785,0.00035483288,0.0004837906,0.00029855754,0.00046829175],"domain_scores_gemma":[0.99847454,0.00017638519,0.000048394337,0.0003314697,0.00014325426,0.00082595606],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00010756421,0.00028352733,0.0004795645,0.00023778243,0.00009407551,0.000056791643,0.00009342251,0.000111501155,0.002835133],"category_scores_gemma":[0.0004862161,0.00022492469,0.00010148917,0.00043389847,0.000040819912,0.00013662971,0.00005848758,0.00018950694,0.0013443392],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000413723,0.0008926769,0.9893553,0.000024252102,0.00016281962,0.00014916687,0.0013476342,0.000010538263,0.0006005147,0.00062916346,0.0044477195,0.0023388274],"study_design_scores_gemma":[0.007237413,0.0014269197,0.8878174,0.00024142656,0.00017496473,0.00007465565,0.0005472173,0.000047742193,0.09729237,0.00035568196,0.004394678,0.00038954173],"about_ca_topic_score_codex":0.0003398259,"about_ca_topic_score_gemma":0.00025404608,"teacher_disagreement_score":0.10153793,"about_ca_system_score_codex":0.000093255316,"about_ca_system_score_gemma":0.00018885148,"threshold_uncertainty_score":0.9994332},"labels":[],"label_agreement":null},{"id":"W2462258177","doi":"10.1182/blood.v104.11.4105.4105","title":"Transfusion-Related Acute Lung Injury (TRALI): A Retrospective Analysis of 119 Cases.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Transfusion-related acute lung injury; Etiology; Medical record; Blood product; Retrospective cohort study; Institutional review board; Pediatrics; Transfusion medicine; Epidemiology; Electronic records; Emergency medicine; Intensive care medicine; Internal medicine; Blood transfusion; Lung; Surgery; Database; Pulmonary edema","score_opus":0.007145552022742327,"score_gpt":0.26245090622887723,"score_spread":0.2553053542061349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2462258177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917193,0.00023589502,0.0003855622,0.0010795852,0.000091654045,0.0006152667,0.00007462971,0.00011611082,0.005681963],"genre_scores_gemma":[0.99787647,0.000725593,0.00049265707,0.00032810977,0.000022121947,0.000022035645,0.00006042516,0.000022253009,0.00045036498],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985823,0.000024216073,0.0004173185,0.00035267076,0.0003816353,0.00024186233],"domain_scores_gemma":[0.999238,0.00001622373,0.00008303146,0.00040805395,0.00010563798,0.0001490199],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014943609,0.00018173484,0.00060380594,0.00053485093,0.00006300828,0.000008264902,0.00009344925,0.00012320196,0.0005186522],"category_scores_gemma":[0.00001974289,0.00015797497,0.00045659073,0.0018287187,0.00007252372,0.000057606972,0.000022619657,0.00020974278,0.000013035587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024298222,0.031578586,0.42602906,0.00095200964,0.18952689,0.007531307,0.014203957,0.00048503408,0.28107896,0.035038166,0.001749794,0.0093963975],"study_design_scores_gemma":[0.026322547,0.002076481,0.7465569,0.00029096892,0.12294167,0.00021831237,0.00042024476,0.00013386364,0.099460006,0.00046805214,0.000537889,0.0005730631],"about_ca_topic_score_codex":0.0005187353,"about_ca_topic_score_gemma":0.00019249774,"teacher_disagreement_score":0.32052785,"about_ca_system_score_codex":0.000054130873,"about_ca_system_score_gemma":0.00006769167,"threshold_uncertainty_score":0.64420325},"labels":[],"label_agreement":null},{"id":"W2462678394","doi":"10.1182/blood.v120.21.2534.2534","title":"NPM1, IDH1/2 and DNAH11 Gene Mutations Can Improve a Prognostic Stratification of Acute Myeloid Leukemia Patients with Normal Karyotype but Not Harboring FLT3/ITD Mutation.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"NPM1; Myeloid leukemia; Internal medicine; Oncology; IDH1; Neuroblastoma RAS viral oncogene homolog; Biology; Sanger sequencing; Myeloid; Cancer research; Immunology; Medicine; Mutation; Karyotype; Gene; Genetics; KRAS","score_opus":0.010688706390760312,"score_gpt":0.2449127783885928,"score_spread":0.2342240719978325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2462678394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99749875,0.00011028824,0.00023965233,0.00016402324,0.000071902585,0.0012178506,0.0002283015,0.00006077153,0.00040847022],"genre_scores_gemma":[0.99195987,0.00002357222,0.0067567225,0.00006252686,0.0001830117,0.00016026844,0.00061913574,0.000051480947,0.00018338917],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981234,0.000056383084,0.0004146579,0.00033211775,0.0005744488,0.00049896503],"domain_scores_gemma":[0.99846035,0.000116707786,0.00022054692,0.0003711344,0.00050608325,0.00032515833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023046495,0.00023031697,0.00031006537,0.00021024242,0.00014273608,0.000035229616,0.000117622614,0.00012275027,0.000025761921],"category_scores_gemma":[0.00018850177,0.00019600645,0.000045436136,0.0003758161,0.00017577603,0.000353138,0.000061717765,0.00030985518,0.000015200133],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006110246,0.0011100493,0.6280882,0.00039082754,0.0010182896,0.00005215169,0.0028879542,0.000020105352,0.3606211,0.00021827997,0.000048096004,0.004933978],"study_design_scores_gemma":[0.0054937364,0.0007171678,0.6758525,0.00006753479,0.000997671,0.0000708709,0.0001700348,0.0002775328,0.31612715,0.00001038278,0.000014350551,0.00020106518],"about_ca_topic_score_codex":0.00029518703,"about_ca_topic_score_gemma":0.000030684547,"teacher_disagreement_score":0.04776435,"about_ca_system_score_codex":0.00021115635,"about_ca_system_score_gemma":0.0007305766,"threshold_uncertainty_score":0.79929113},"labels":[],"label_agreement":null},{"id":"W2463133669","doi":"10.1182/blood.v104.11.347.347","title":"MALT1 Is an Essential Regulator of Antigen Receptor Mediated NF-kappaB Activation.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"NF-κB Signaling Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"BCL10; Biology; T-cell receptor; Signal transduction; Cell biology; Cancer research; Jurkat cells; T cell; breakpoint cluster region; Molecular biology; Lymphoma; Receptor; Immunology; Immune system; Genetics","score_opus":0.009073087794691091,"score_gpt":0.22891763994530687,"score_spread":0.21984455215061577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2463133669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99854267,0.00013787839,0.00066321896,0.00011491984,0.00009091288,0.00013474641,0.00006883884,0.000023685587,0.00022313753],"genre_scores_gemma":[0.99623865,0.00003960435,0.0027778747,0.00014841897,0.00031081372,0.000008153073,0.00035039533,0.00002902093,0.000097073],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990862,0.00003300548,0.0002145645,0.00031056406,0.00016894213,0.00018672337],"domain_scores_gemma":[0.999277,0.0000057050115,0.00012526444,0.00039603875,0.000110440626,0.000085538835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000107423766,0.00013067284,0.00013902124,0.00004163239,0.00004864067,0.000011528793,0.00019216436,0.0001771024,0.000094946976],"category_scores_gemma":[0.00006616728,0.00013335682,0.00007148215,0.000109469096,0.00006747205,0.0000062922245,0.000053772503,0.000059473703,0.000020549194],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004005159,0.00034808318,0.0012173775,0.00001520147,0.00007894008,0.0000013067832,0.000110981004,0.00001925175,0.9976528,0.00009497361,0.00033701092,0.000084002124],"study_design_scores_gemma":[0.0015184006,0.000252153,0.0015213694,0.00002083439,0.00002120122,0.0000048886163,0.000028483466,0.0000023241266,0.99376833,0.00011353367,0.0025932402,0.00015525374],"about_ca_topic_score_codex":0.000036865607,"about_ca_topic_score_gemma":0.000006395092,"teacher_disagreement_score":0.0038845025,"about_ca_system_score_codex":0.0000068884565,"about_ca_system_score_gemma":0.00014152315,"threshold_uncertainty_score":0.5438133},"labels":[],"label_agreement":null},{"id":"W2463649602","doi":"10.1182/blood.v126.23.2667.2667","title":"Flow Cytometric Characterization of 129 Cases of Peripheral T Cell Lymphoma Not Otherwise Specified (PTCL NOS) and Angioimmunoblastic T Cell Lymphoma (AITL)","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Angioimmunoblastic T-cell lymphoma; Immunophenotyping; Pathology; Peripheral T-cell lymphoma; Lymphoma; CD5; Flow cytometry; T cell; Medicine; Biology; Immunology; Immune system","score_opus":0.021326999590626634,"score_gpt":0.22918984977159285,"score_spread":0.2078628501809662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2463649602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99591655,0.00159988,0.000033964916,0.000041416715,0.00014201623,0.00042589972,0.00015167183,0.00003704207,0.001651572],"genre_scores_gemma":[0.99804556,0.00035323162,0.00084928033,0.00007292808,0.0001229323,0.000030256617,0.00010870872,0.00004501422,0.00037211363],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99847096,0.000051526957,0.00047861543,0.0003270667,0.00040503184,0.00026679962],"domain_scores_gemma":[0.9987651,0.00012494171,0.0002854703,0.0003973008,0.00021198679,0.0002152131],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011769636,0.00026926355,0.0005934883,0.00031684875,0.0000401452,0.000022508968,0.00009660181,0.0001265409,0.00007726024],"category_scores_gemma":[0.00007643615,0.0002260513,0.0001416781,0.00055484555,0.00009669613,0.00010416262,0.00006108643,0.00002549633,0.000024524792],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032951757,0.04608495,0.27207553,0.0014175439,0.0008239414,0.0012918126,0.004007997,0.000025193915,0.6291023,0.00007353408,0.00026459072,0.041537438],"study_design_scores_gemma":[0.02924848,0.0015741218,0.46868646,0.00010842667,0.0006150591,0.00021757661,0.00015925353,0.0002817564,0.49840325,0.000003155344,0.0005022452,0.00020023197],"about_ca_topic_score_codex":0.00019294032,"about_ca_topic_score_gemma":0.00000565088,"teacher_disagreement_score":0.19661093,"about_ca_system_score_codex":0.00013104292,"about_ca_system_score_gemma":0.00023896473,"threshold_uncertainty_score":0.92181045},"labels":[],"label_agreement":null},{"id":"W2463764098","doi":"10.1182/blood.v126.23.3373.3373","title":"Pathophysiology and Treatment of Beta-Thalassemia: Investigations of Heme Oxygenase 1 and Its Inhibitors","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Thalassemia; Heme; Globin; Beta thalassemia; Heme oxygenase; Hemoglobin; Ineffective erythropoiesis; Medicine; Chemistry; Biochemistry; Internal medicine; Anemia; Enzyme; Erythropoiesis","score_opus":0.022384355594100017,"score_gpt":0.24610281810602064,"score_spread":0.22371846251192062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2463764098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99156106,0.007235721,4.863111e-7,0.00051478285,0.000030129575,0.00018155825,0.000014702546,0.000009610913,0.00045197987],"genre_scores_gemma":[0.9983761,0.0011838363,0.00025148664,0.000038960352,0.000027455015,0.0000073980373,0.000011474829,0.0000070948895,0.00009620943],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99953276,0.000021311478,0.00017655194,0.000114146154,0.000068358,0.00008685583],"domain_scores_gemma":[0.9996028,0.00002360878,0.00006519896,0.00009319892,0.00006586651,0.00014935885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000039056486,0.00007918602,0.00023957682,0.000051407686,0.000016675687,0.0000012395448,0.000012900323,0.000100650046,0.0000046848727],"category_scores_gemma":[0.000053710683,0.000056854537,0.000029865312,0.000086153625,0.00010422973,0.000020674823,0.000015809528,0.000040096547,0.0000016653261],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016668245,0.0039130934,0.12978387,0.0004799787,0.00071606366,0.00010933808,0.006753967,0.000014134377,0.84867674,0.0012006616,0.0010913179,0.007094117],"study_design_scores_gemma":[0.029438615,0.0099829305,0.057565838,0.00039006173,0.002094949,0.00023801741,0.0034810451,0.00026171963,0.89189374,0.0015726766,0.0027123948,0.00036799142],"about_ca_topic_score_codex":0.000034342196,"about_ca_topic_score_gemma":0.0000035830171,"teacher_disagreement_score":0.07221804,"about_ca_system_score_codex":0.00000683185,"about_ca_system_score_gemma":0.000076437806,"threshold_uncertainty_score":0.23184606},"labels":[],"label_agreement":null},{"id":"W2463828088","doi":"10.1182/blood.v122.21.108.108","title":"Update On The Long-Term Efficacy and Safety Of Momelotinib, a JAK1 and JAK2 Inhibitor, For The Treatment Of Myelofibrosis","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Myelofibrosis; Medicine; Anemia; Internal medicine; Phases of clinical research; Gastroenterology; Constitutional symptoms; Clinical trial; Surgery; Disease; Bone marrow","score_opus":0.019062296254904982,"score_gpt":0.26169491538944334,"score_spread":0.24263261913453835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2463828088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99224514,0.0016775395,0.000006884816,0.003503923,0.00003211245,0.002299445,0.00006232655,0.0000072435696,0.0001653719],"genre_scores_gemma":[0.99537975,0.0035853698,0.00021549135,0.00013502387,0.00007121481,0.00045839598,0.000015167957,0.000015647696,0.00012391634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999206,0.000033932392,0.00026423947,0.00020660284,0.00013826379,0.00015094942],"domain_scores_gemma":[0.9985741,0.0008756373,0.000114286115,0.00028458628,0.00008101735,0.00007037982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008415363,0.00017358297,0.0003470998,0.00003553478,0.000105619154,0.000016159638,0.00004214918,0.00004817409,0.0001014315],"category_scores_gemma":[0.00004374173,0.000076555574,0.0000841352,0.00006465627,0.00013646416,0.000025909794,0.00002062526,0.000037261274,0.0000069267016],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015188435,0.011828944,0.88294566,0.00031429794,0.0027094553,0.000008752771,0.0027088623,0.0000025933316,0.009231295,0.0031076306,0.0006642909,0.08495939],"study_design_scores_gemma":[0.01019258,0.0043353476,0.84404767,0.0001702753,0.00072674896,0.000013090014,0.00006177403,0.000016020986,0.1396507,0.00003442114,0.00067714084,0.00007426181],"about_ca_topic_score_codex":0.000051918814,"about_ca_topic_score_gemma":0.000022268034,"teacher_disagreement_score":0.1304194,"about_ca_system_score_codex":0.000014778549,"about_ca_system_score_gemma":0.000024898798,"threshold_uncertainty_score":0.31218457},"labels":[],"label_agreement":null},{"id":"W2464225265","doi":"10.1182/blood.v124.21.792.792","title":"Harnessing Negative B Cell Selection to Overcome Drug-Resistance in Acute Lymphoblastic Leukemia","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research","funders":"","keywords":"Syk; LYN; breakpoint cluster region; Cancer research; Bruton's tyrosine kinase; Biology; Tyrosine kinase; B-cell receptor; Leukemia; Signal transduction; Hyperactivation; Cell biology; B cell; Immunology; Receptor; Biochemistry; Antibody","score_opus":0.007641393202662552,"score_gpt":0.2526545259707253,"score_spread":0.24501313276806275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2464225265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841279,0.00006615136,0.004346218,0.00052313996,0.00011496738,0.00053688517,0.000006003644,0.00011879525,0.010159987],"genre_scores_gemma":[0.9822909,0.000012149744,0.008807974,0.0006400247,0.00023956363,0.00007479657,0.000009585332,0.00006130659,0.0078636715],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976746,0.00013270235,0.0003763065,0.0005609012,0.0005912794,0.0006642382],"domain_scores_gemma":[0.99860555,0.00044382818,0.00009060823,0.0003559655,0.00016576205,0.000338275],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035636133,0.00026402212,0.00046320542,0.00037247964,0.00011355812,0.00005704302,0.00019791943,0.00013492788,0.000070411275],"category_scores_gemma":[0.0005214234,0.00024738922,0.00007953704,0.0010259246,0.00007601212,0.00015261686,0.00011091347,0.00031639496,0.00033462665],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005429443,0.0038404223,0.09716468,0.0020152123,0.0008199868,0.0013721887,0.0132009005,0.0010842269,0.83940893,0.0016423728,0.02825796,0.0057636867],"study_design_scores_gemma":[0.06519454,0.0011803056,0.24904205,0.0022403132,0.0011308667,0.0004213417,0.00041868413,0.018616736,0.64833003,0.0018714374,0.00987947,0.0016742267],"about_ca_topic_score_codex":0.00024531086,"about_ca_topic_score_gemma":0.00028778822,"teacher_disagreement_score":0.19107889,"about_ca_system_score_codex":0.0018472099,"about_ca_system_score_gemma":0.000986882,"threshold_uncertainty_score":0.99999785},"labels":[],"label_agreement":null},{"id":"W2464464109","doi":"10.1182/blood.v126.23.3.3","title":"TCD with Transfusions Changing to Hydroxyurea (TWiTCH): Hydroxyurea Therapy As an Alternative to Transfusions for Primary Stroke Prevention in Children with Sickle Cell Anemia","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Transcranial Doppler; Clinical endpoint; Phlebotomy; Stroke (engine); Anemia; Sickle cell anemia; Pediatrics; Internal medicine; Randomized controlled trial","score_opus":0.010975612944176805,"score_gpt":0.24933901317309376,"score_spread":0.23836340022891694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2464464109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871986,0.00022157504,0.0034399042,0.0011859193,0.00004474355,0.004105343,0.00005630271,0.00010331615,0.0036442822],"genre_scores_gemma":[0.99409115,0.00016324192,0.003099399,0.00090531167,0.00011940156,0.000355341,0.00013019984,0.00008339473,0.0010525499],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99818075,0.000054546595,0.00027627137,0.0005331199,0.00040759353,0.00054774276],"domain_scores_gemma":[0.99886805,0.000025302577,0.000057752928,0.00035155594,0.000114856804,0.0005824672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022358057,0.00031395105,0.00041161606,0.0004030991,0.00014108823,0.000025569087,0.00015839735,0.00016135667,0.000027820352],"category_scores_gemma":[0.0000123367745,0.00022474493,0.000092600174,0.000622398,0.000039767594,0.00014908976,0.000017667118,0.00028696808,0.000013031236],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029178083,0.045033183,0.29740727,0.0005490576,0.0029152883,0.00053890015,0.19559799,0.019103678,0.31476536,0.00054952415,0.0008763343,0.09348533],"study_design_scores_gemma":[0.31822506,0.14996967,0.20905077,0.0042190244,0.0047980323,0.0017983164,0.035244197,0.0013338007,0.25950488,0.0010323065,0.0092916135,0.0055323183],"about_ca_topic_score_codex":0.00049508776,"about_ca_topic_score_gemma":0.0004255668,"teacher_disagreement_score":0.28904697,"about_ca_system_score_codex":0.000069838934,"about_ca_system_score_gemma":0.00032330755,"threshold_uncertainty_score":0.9164832},"labels":[],"label_agreement":null},{"id":"W2464621341","doi":"10.1182/blood.v122.21.4797.4797","title":"Association Between Inherited and Acquired Thrombophilias and The Post Thrombotic Syndrome: A Systematic Review and Metaanalysis","year":2013,"lang":"en","type":"review","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Thrombophilia; Lupus anticoagulant; Factor V Leiden; Odds ratio; Internal medicine; Antiphospholipid syndrome; Meta-analysis; Prothrombin G20210A; Risk factor; Venous thrombosis; Thrombosis","score_opus":0.03967194272769431,"score_gpt":0.3015763995726127,"score_spread":0.26190445684491837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2464621341","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006953459,0.99194,0.0000050434182,0.001029281,0.00003839392,0.0061116787,0.000039473853,0.000070107635,0.000070683804],"genre_scores_gemma":[0.0014875728,0.9966307,0.00015006361,0.0005754833,0.000052373107,0.00046498302,0.0001539879,0.00007121353,0.00041359098],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9962508,0.0010339759,0.0013205827,0.00058507605,0.00050613476,0.00030339416],"domain_scores_gemma":[0.9967711,0.00088804547,0.0012299122,0.0006760675,0.00021818792,0.00021671905],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016881968,0.00059459556,0.0073643033,0.0002119402,0.00018491193,0.00015850198,0.00015738445,0.00044502472,0.00009399368],"category_scores_gemma":[0.0009737244,0.0003364369,0.0004661148,0.00060620235,0.00014163817,0.00012793392,0.00017511945,0.00031391764,0.000043305743],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000011772033,0.00010854542,0.000099151126,0.9775711,0.01885679,0.0000095274445,0.00009852933,1.7653636e-9,0.0000022561014,0.00027936423,0.000050229854,0.0029233221],"study_design_scores_gemma":[0.0031114554,0.00020854734,0.0013356173,0.37383643,0.6180796,0.0009515654,0.00005075941,0.000005742043,0.0000012340009,0.00022412428,0.0016475797,0.0005473437],"about_ca_topic_score_codex":0.000035227466,"about_ca_topic_score_gemma":0.000004248909,"teacher_disagreement_score":0.6037347,"about_ca_system_score_codex":0.000054000626,"about_ca_system_score_gemma":0.00008285238,"threshold_uncertainty_score":0.99990875},"labels":[],"label_agreement":null},{"id":"W2464635942","doi":"10.1182/blood-2016-05-717355","title":"Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":229,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Follicular lymphoma; Medicine; Oncology; Lymphoma; Internal medicine","score_opus":0.011415217609621567,"score_gpt":0.2552736184447872,"score_spread":0.24385840083516563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2464635942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99120355,0.0072996216,0.00019124805,0.0002929703,0.00006348812,0.0006337918,0.00006203358,0.00005390224,0.00019940465],"genre_scores_gemma":[0.99308205,0.0049095037,0.0013837898,0.00006805955,0.00011916338,0.0002511937,0.000007645315,0.00003723686,0.00014134418],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865234,0.00004242228,0.00040841277,0.0003248127,0.00032189506,0.0002501215],"domain_scores_gemma":[0.9989216,0.00009143355,0.00018276303,0.0005710991,0.00010087356,0.00013224503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012905653,0.00020331745,0.00037958557,0.000065296066,0.000040983214,0.000008487491,0.00008880546,0.00013423013,0.00009782546],"category_scores_gemma":[0.000032324522,0.00011188903,0.000255046,0.0000975464,0.00007760027,0.00006438782,0.00004079682,0.000026875663,0.000037484937],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008201386,0.0056133233,0.8566529,0.00005453493,0.00060197245,0.00011439158,0.0001681992,0.0000022290856,0.0020484824,0.000017994487,0.000048984966,0.13385686],"study_design_scores_gemma":[0.035355408,0.0031553893,0.8054065,0.0010275088,0.000994356,0.000052589672,0.0000049255837,0.00007563477,0.15251842,0.00054975715,0.0006764077,0.00018308089],"about_ca_topic_score_codex":0.000047929363,"about_ca_topic_score_gemma":0.000005369765,"teacher_disagreement_score":0.15046994,"about_ca_system_score_codex":0.000042106858,"about_ca_system_score_gemma":0.00008023266,"threshold_uncertainty_score":0.45627022},"labels":[],"label_agreement":null},{"id":"W2464833189","doi":"10.1182/blood.v124.21.4674.4674","title":"Pattern of Cytokine Release in Patients with Chronic Lymphocytic Leukemia Treated with Obinutuzumab and Possible Relationship with Development of Infusion Related Reactions (IRR)","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Obinutuzumab; Medicine; Antibody-dependent cell-mediated cytotoxicity; Chronic lymphocytic leukemia; Rituximab; CD20; Immunology; Cytokine; Cytokine release syndrome; Neutropenia; Leukemia; Pharmacology; Internal medicine; Immunotherapy; Antibody; Monoclonal antibody; Chemotherapy; Immune system","score_opus":0.00836036145291262,"score_gpt":0.22179892688005476,"score_spread":0.21343856542714212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2464833189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983978,0.00006927509,0.00008973212,0.000010921347,0.0000068028407,0.0007949541,0.0000068178038,0.000044914686,0.000578747],"genre_scores_gemma":[0.99831116,0.00001210453,0.0011555951,0.000008614654,0.0000115858575,0.000045671273,0.00012235354,0.00005128798,0.0002816328],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979156,0.000084483836,0.0006159698,0.00039643116,0.0006376071,0.00034988936],"domain_scores_gemma":[0.99852586,0.00018756808,0.0003095656,0.00050985627,0.00029064392,0.00017652857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025847738,0.00024788908,0.00048713235,0.0003839309,0.00008506526,0.000009802056,0.00009401964,0.0001495622,0.000027119208],"category_scores_gemma":[0.000109521905,0.00016740464,0.000025461442,0.00083443563,0.00022501577,0.0001275327,0.000055978235,0.00025433974,0.0000059743966],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0034200307,0.0006377596,0.9864927,0.0011544537,0.000356249,0.00006377363,0.0011975614,0.0012658569,0.001504607,0.000037216094,0.000008746965,0.0038610732],"study_design_scores_gemma":[0.13500871,0.0035086884,0.8368713,0.0028600136,0.00033921146,0.00017751477,0.00007610389,0.0050959163,0.015744146,0.000011302586,0.000037399852,0.0002696992],"about_ca_topic_score_codex":0.002354097,"about_ca_topic_score_gemma":0.0008497031,"teacher_disagreement_score":0.14962137,"about_ca_system_score_codex":0.018813923,"about_ca_system_score_gemma":0.018072532,"threshold_uncertainty_score":0.9874941},"labels":[],"label_agreement":null},{"id":"W2464869795","doi":"10.1182/blood.v126.23.1701.1701","title":"Iron Chelation Is Associated with Improved Survival Adjusting for Disease and Patient Related Characteristics in Low/Int-1 Risk MDS at the Time of First Transfusion Dependence: A MDS-CAN Study","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Queen Elizabeth II Health Sciences Centre; Montreal General Hospital; Foothills Medical Centre; Health Sciences Centre; CancerCare Manitoba; Ottawa Hospital; Princess Margaret Cancer Centre; University of Alberta; University of Saskatchewan; Leukemia & Lymphoma Society of Canada; Sunnybrook Health Science Centre; McMaster University; St. Paul's Hospital; University of British Columbia; University of Toronto","funders":"","keywords":"Medicine; Interquartile range; Hazard ratio; International Prognostic Scoring System; Proportional hazards model; Internal medicine; Myelodysplastic syndromes; Comorbidity; Retrospective cohort study; Univariate analysis; Multivariate analysis; Pediatrics; Confidence interval","score_opus":0.008032530973647617,"score_gpt":0.21388518138819837,"score_spread":0.20585265041455075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2464869795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99739826,0.00032689082,0.000009581903,0.0003490904,0.00005269795,0.0016640101,0.00012489312,0.000025879988,0.000048714504],"genre_scores_gemma":[0.9995178,0.00017208939,0.000012824232,0.000028433935,0.00001227371,0.000040337683,0.00009649353,0.00002494884,0.00009480329],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987898,0.00009537477,0.00038526763,0.00024910868,0.0002769179,0.0002035292],"domain_scores_gemma":[0.99913704,0.00012985819,0.00024851027,0.0001811724,0.00015615739,0.00014725453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044244292,0.0001543029,0.00029831892,0.000054488548,0.00012461461,0.000009796005,0.000045298173,0.00013061902,0.0000142685885],"category_scores_gemma":[0.0005149615,0.00009992275,0.000046100613,0.00020936514,0.00006201967,0.00003981524,0.00003327767,0.00021940214,0.0000011964577],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019954476,0.002723436,0.9726228,0.00013622826,0.00027650912,0.000044655782,0.018658476,0.00003545667,0.0010682361,7.8544605e-7,0.000028074179,0.002409894],"study_design_scores_gemma":[0.032627165,0.0044746865,0.9239211,0.0008174515,0.0028144175,0.000014983404,0.00754729,0.026781872,0.0006210545,0.000027657505,0.000016766133,0.0003355512],"about_ca_topic_score_codex":0.00030556077,"about_ca_topic_score_gemma":0.00044852388,"teacher_disagreement_score":0.048701696,"about_ca_system_score_codex":0.00006529529,"about_ca_system_score_gemma":0.00009561036,"threshold_uncertainty_score":0.40747315},"labels":[],"label_agreement":null},{"id":"W2464971697","doi":"10.1182/blood.v112.11.262.262","title":"Confirmation of the Efficacy and Safety of Lenalidomide Oral Monotherapy in Patients with Relapsed or Refractory Mantle-Cell Lymphoma: Results of An International Study (NHL-003)","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Lenalidomide; Medicine; Mantle cell lymphoma; Internal medicine; Regimen; Chemotherapy regimen; Phases of clinical research; Lymphoma; Oncology; Surgery; Refractory (planetary science); Progressive disease; Gastroenterology; Clinical trial; Chemotherapy; Multiple myeloma","score_opus":0.01446357016416299,"score_gpt":0.24718857717597179,"score_spread":0.2327250070118088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2464971697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998775,0.000037277034,5.941029e-7,0.00003737256,0.00003226206,0.000739233,0.00004866208,0.0000046811347,0.00032491874],"genre_scores_gemma":[0.9996202,0.000070109214,0.00018366723,0.000020255638,0.000009073951,0.000010803404,0.00003439296,0.00000925708,0.000042219286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989875,0.000076750104,0.0004214549,0.00014758653,0.00029763367,0.00006906034],"domain_scores_gemma":[0.9992045,0.00009875383,0.00030300062,0.00025009026,0.000113186055,0.000030451938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012301066,0.000094981864,0.0002641341,0.00007259196,0.000021813572,0.0000019560925,0.00007322982,0.000037298767,0.000009549654],"category_scores_gemma":[0.000049641883,0.000052858763,0.000027089067,0.00011164006,0.00007274583,0.00007297628,0.000018682129,0.00002765255,3.1614567e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016117502,0.029760191,0.9492469,0.000023324184,0.00020461065,0.000016219945,0.0023283062,0.000007811209,0.0003309268,0.000006751621,0.000016186383,0.001941264],"study_design_scores_gemma":[0.1517363,0.0027573179,0.8323438,0.00009818708,0.00010161715,0.0000057083166,0.00016402133,0.000010999562,0.012698979,0.0000010279555,0.00003920713,0.00004279168],"about_ca_topic_score_codex":0.00030775854,"about_ca_topic_score_gemma":0.00006181732,"teacher_disagreement_score":0.1356188,"about_ca_system_score_codex":0.000032913314,"about_ca_system_score_gemma":0.000093734525,"threshold_uncertainty_score":0.21555178},"labels":[],"label_agreement":null},{"id":"W2465121937","doi":"10.1182/blood-2015-07-650713","title":"Coagulation factor XIIIa is inactivated by plasmin","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Blood properties and coagulation","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research","keywords":"Plasmin; Factor XIIIa; Zymogen; Coagulation; Chemistry; Fibrinolysin; Medicine; Enzyme; Biochemistry; Immunology; Internal medicine; Fibrinogen","score_opus":0.041074751318278244,"score_gpt":0.25848103208815765,"score_spread":0.2174062807698794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2465121937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950724,0.00049434806,0.000085642954,0.0008481859,0.00008245555,0.00020556753,0.000014460611,0.000087823,0.003109077],"genre_scores_gemma":[0.9969366,0.0000071700942,0.00017693955,0.00047431287,0.00008095413,0.000008760414,0.000068355934,0.000017976552,0.0022289308],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99930024,0.000018823479,0.00015052044,0.00015747022,0.00023161774,0.00014132897],"domain_scores_gemma":[0.9995464,0.000010385748,0.000051980118,0.0001705882,0.00010923101,0.000111395435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000052214695,0.00009819055,0.00015331231,0.000037332764,0.00003485807,0.00001686138,0.00003695871,0.00009723233,0.00016178579],"category_scores_gemma":[0.00004296076,0.00007940977,0.00003404795,0.00011868008,0.00001832412,0.000100554054,0.000018762606,0.00008768363,0.00010586285],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012421136,0.0036541559,0.37458107,0.00017346718,0.000703574,0.000036316764,0.0052611628,0.000012783638,0.4526323,0.00019652671,0.122023165,0.03948335],"study_design_scores_gemma":[0.012432715,0.0010737579,0.08625563,0.00009302896,0.00038295746,0.00007378202,0.00035055084,0.001161616,0.81710947,0.0002026167,0.080506176,0.00035769286],"about_ca_topic_score_codex":0.000111568675,"about_ca_topic_score_gemma":0.000002036651,"teacher_disagreement_score":0.36447716,"about_ca_system_score_codex":0.00002733372,"about_ca_system_score_gemma":0.000059449078,"threshold_uncertainty_score":0.32382366},"labels":[],"label_agreement":null},{"id":"W2465495338","doi":"10.1182/blood-2016-04-710285","title":"Corticosteroids compared with intravenous immunoglobulin for the treatment of immune thrombocytopenia in pregnancy","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Canadian Blood Services; University of Toronto; Mount Sinai Hospital; Western University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Immune thrombocytopenia; Pregnancy; Platelet; Antibody; Retrospective cohort study; Immunology; Pediatrics; Obstetrics; Internal medicine","score_opus":0.01938472900277038,"score_gpt":0.2575157516371814,"score_spread":0.238131022634411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2465495338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903171,0.0076087443,0.000095083895,0.00031867155,0.000030959545,0.0013772135,0.00003481787,0.000013607423,0.00020379275],"genre_scores_gemma":[0.99748343,0.0016369871,0.00036795624,0.000011471165,0.000010791931,0.00020023074,0.000014227004,0.000016275604,0.00025865308],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992984,0.0000119589085,0.00024782852,0.00015179723,0.00009421728,0.0001957764],"domain_scores_gemma":[0.9994231,0.00011011086,0.00008708116,0.00030879068,0.000040010706,0.00003090542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000025745518,0.00013234997,0.00044174053,0.000031840635,0.000035708435,0.00000507913,0.000064494976,0.000035623736,0.000028215434],"category_scores_gemma":[0.000008428735,0.000055105666,0.000072859104,0.00007672437,0.00006831945,0.000029387535,0.000007785935,0.000020185807,0.0000067819306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008339275,0.05028342,0.4073977,0.00026658244,0.0056495517,0.0013429101,0.004914473,0.0000065389,0.12517071,0.0002819301,0.00002972034,0.3963172],"study_design_scores_gemma":[0.10492735,0.0153765455,0.74727017,0.0014430303,0.0014626277,0.00031336385,0.00025498116,0.000017749531,0.1276653,0.00017128614,0.0008738218,0.00022376946],"about_ca_topic_score_codex":0.00013973178,"about_ca_topic_score_gemma":0.00012543985,"teacher_disagreement_score":0.39609343,"about_ca_system_score_codex":0.000043625383,"about_ca_system_score_gemma":0.0000581754,"threshold_uncertainty_score":0.22471437},"labels":[],"label_agreement":null},{"id":"W2465735492","doi":"10.1182/blood.v108.11.2654.2654","title":"A Phase I Trial of the Small Molecule Pan-Bcl-2 Family Inhibitor Obatoclax Mesylate (GX15-070) Administered by 24 Hour Infusion Every 2 Weeks to Patients with Myeloid Malignancies and Chronic Lymphocytic Leukemia (CLL).","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Adverse effect; Internal medicine; Gastroenterology; Pharmacology","score_opus":0.0055500632185013984,"score_gpt":0.19626197524866165,"score_spread":0.19071191203016025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2465735492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99771684,0.0008503213,0.00017054337,0.00001823282,0.00018173277,0.0008626873,0.00008536531,0.000012916215,0.00010135066],"genre_scores_gemma":[0.99857444,0.0000900685,0.00015654195,0.000094362105,0.00018590485,0.000048533646,0.00017291924,0.000032071297,0.0006451424],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998764,0.000057056983,0.00032050713,0.0003746623,0.00023274339,0.00025103937],"domain_scores_gemma":[0.9992845,0.000008210119,0.00019008062,0.00035206263,0.00009265923,0.0000724581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009259248,0.0002268484,0.00021571072,0.00003983193,0.00010279626,0.00003427515,0.00015441024,0.00018509633,0.0000028469642],"category_scores_gemma":[0.000017550406,0.00015841078,0.00008559214,0.00011882593,0.000064817854,0.0000061639844,0.00015747901,0.000056249683,0.0000015604274],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026015309,0.00035662315,0.00028386014,0.00004321732,0.000038863942,0.0000021553633,0.000026824433,0.000048591413,0.99500316,0.000009484922,0.00044028918,0.0011453886],"study_design_scores_gemma":[0.06795769,0.004977781,0.0029758154,0.00009318688,0.00014765188,0.000008775725,0.000017980425,0.00010527521,0.9202782,0.000018661061,0.0031074174,0.00031159335],"about_ca_topic_score_codex":0.00014535591,"about_ca_topic_score_gemma":0.00010223807,"teacher_disagreement_score":0.074725,"about_ca_system_score_codex":0.00012158667,"about_ca_system_score_gemma":0.000513475,"threshold_uncertainty_score":0.6459804},"labels":[],"label_agreement":null},{"id":"W2465907423","doi":"10.1182/blood.v126.23.4465.4465","title":"Management of Osteonecrosis By Adult and Pediatric Sickle Cell Providers","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Bone and Joint Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Toronto General Hospital; McMaster University; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Specialty; Population; Hemoglobinopathy; Pediatrics; Logistic regression; Cross-sectional study; Young adult; Family medicine; Disease; Internal medicine; Pathology","score_opus":0.00913628036089829,"score_gpt":0.21814182236579505,"score_spread":0.20900554200489677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2465907423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98985696,0.0023802442,0.000006292595,0.00029295392,0.000021270986,0.00023189567,0.000013848776,0.00002449641,0.0071720486],"genre_scores_gemma":[0.9975624,0.00034472957,0.0005823668,0.0001518693,0.000024375084,0.00001202753,0.000011495967,0.000009356387,0.0013013766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995109,0.0000080001955,0.00011606136,0.000118063275,0.00014580222,0.00010120852],"domain_scores_gemma":[0.9996247,0.00000846522,0.0000414617,0.00012567152,0.00005351036,0.00014618441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004117868,0.00006415451,0.0001261351,0.000032953634,0.000011464273,0.0000056652884,0.000023200695,0.000025443958,0.000012901698],"category_scores_gemma":[0.0000115394205,0.000054462987,0.000029774941,0.00008115943,0.000021484377,0.000035987876,0.000029979425,0.000030960546,0.000015152153],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004751371,0.0067287567,0.7510401,0.0053729205,0.00034907955,0.000315103,0.0011943233,9.050665e-7,0.0055348785,0.00017981172,0.22118801,0.0076209987],"study_design_scores_gemma":[0.15412423,0.009895541,0.4122147,0.00094670826,0.027435571,0.00014619679,0.021492446,0.00010190078,0.33518705,0.0012897083,0.03501855,0.002147389],"about_ca_topic_score_codex":0.00006421561,"about_ca_topic_score_gemma":0.0000013475823,"teacher_disagreement_score":0.33882537,"about_ca_system_score_codex":0.0000041193107,"about_ca_system_score_gemma":0.000026566173,"threshold_uncertainty_score":0.22209363},"labels":[],"label_agreement":null},{"id":"W2465951686","doi":"10.1182/blood.v124.21.1532.1532","title":"Detection of Paroxysmal Nocturnal Hemoglobinuria Clones in Patients with Idiopathic Venous Thromboembolism","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Paroxysmal nocturnal hemoglobinuria; Pulmonary embolism; Thrombosis; Population; Internal medicine; Venous thrombosis; Deep vein; Pediatrics; Surgery; Gastroenterology","score_opus":0.004352133007188247,"score_gpt":0.18734305522400316,"score_spread":0.1829909222168149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2465951686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99863476,0.00059863494,0.00004597256,0.0000076233177,0.00030464068,0.0002396745,0.000014594191,0.00002964103,0.00012446342],"genre_scores_gemma":[0.9998836,0.0000016204957,0.000013375809,0.000014428546,0.000031570446,0.000016882785,0.000017736713,0.000011422181,0.000009384079],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990828,0.00019687743,0.0002785377,0.00018092692,0.000049803788,0.00021106223],"domain_scores_gemma":[0.99952006,0.00002834878,0.0001591601,0.00021716663,0.00006028569,0.000014992164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015481836,0.00011991701,0.00031090487,0.0000830518,0.000056601453,0.0000050355743,0.00012979018,0.00009015919,0.000049995586],"category_scores_gemma":[0.000042294687,0.00009860607,0.00004131408,0.0000962909,0.00007155699,0.000047577792,0.00003827518,0.00011196826,0.00004304605],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038938643,0.0024827023,0.89039856,0.000119858254,0.00019507535,0.0000020659786,0.00034883493,0.000012610381,0.10348554,0.00016745932,0.000018790448,0.0023791138],"study_design_scores_gemma":[0.0057381624,0.00089227594,0.9267055,0.00013198024,0.00009337053,0.0000119127735,0.00003449212,0.0000011160295,0.06601651,0.00009983134,0.00015260706,0.00012228116],"about_ca_topic_score_codex":0.00009467337,"about_ca_topic_score_gemma":0.00009277796,"teacher_disagreement_score":0.037469026,"about_ca_system_score_codex":0.00001508276,"about_ca_system_score_gemma":0.000025805306,"threshold_uncertainty_score":0.40210387},"labels":[],"label_agreement":null},{"id":"W2466110078","doi":"10.1182/blood.v106.11.1572.1572","title":"Studies of the Bcl Inhibitor GX15-070 in Multiple Myeloma Demonstrate Substantial Pre-Clinical Activity.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Apoptosis; Cytotoxicity; Cytotoxic T cell; Biology; Bcl-2 family; Viability assay; Cell culture; Cancer research; Molecular biology; Programmed cell death; In vitro; Biochemistry; Genetics","score_opus":0.07985099789310943,"score_gpt":0.3775488828657138,"score_spread":0.2976978849726044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2466110078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996838,0.0010574585,0.0000026800683,0.00072824955,0.000110986075,0.00071708334,0.000022362814,0.000026250744,0.00049695955],"genre_scores_gemma":[0.99826646,0.00029879384,0.00061091885,0.000040088693,0.00030538742,0.000037951228,0.0000036525776,0.000018130666,0.00041861704],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983083,0.00019371818,0.00043578245,0.00029183773,0.00041193774,0.00035842333],"domain_scores_gemma":[0.99881876,0.00042647042,0.00012077684,0.0003937691,0.000102391044,0.00013782449],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036983937,0.00016533468,0.00045022758,0.00008208078,0.000073295865,0.000008623402,0.00013379536,0.00011257367,0.00003546502],"category_scores_gemma":[0.00092350104,0.0001043262,0.00017916157,0.00025236697,0.00031164667,0.00008864529,0.00011960116,0.0003316213,0.000030063562],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008665806,0.0035336588,0.934747,0.000075800235,0.00049216766,0.00008825941,0.00031711775,0.0000024479432,0.022797486,0.0000072545427,0.00016569151,0.036906537],"study_design_scores_gemma":[0.012329498,0.00036964234,0.8289518,0.00016355276,0.00012419,0.000024926876,0.00009773947,0.00018256977,0.15739088,0.000012340674,0.00026842844,0.00008447621],"about_ca_topic_score_codex":0.00007224844,"about_ca_topic_score_gemma":0.0011894517,"teacher_disagreement_score":0.1345934,"about_ca_system_score_codex":0.000044135202,"about_ca_system_score_gemma":0.00018053039,"threshold_uncertainty_score":0.4254299},"labels":[],"label_agreement":null},{"id":"W2466341936","doi":"10.1182/blood.v126.23.2903.2903","title":"Systematic Review of the Efficacy and Safety of Alternative Azacitidine Regimens in Myelodysplastic Syndrome","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Tolerability; Medicine; Azacitidine; Regimen; Dosing; Internal medicine; Randomized controlled trial; Observational study; Clinical trial; Myelodysplastic syndromes; Chronic myelomonocytic leukemia; Oncology; Adverse effect; Bone marrow","score_opus":0.02108732249662249,"score_gpt":0.28551377442810627,"score_spread":0.2644264519314838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2466341936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.976295,0.019505313,0.000012390575,0.00075170735,0.000037402588,0.0020718516,0.000016144717,0.0000092739665,0.0013009073],"genre_scores_gemma":[0.996797,0.0026175433,0.0001399059,0.000104915955,0.0000150740725,0.000030120958,0.000003631804,0.000014179301,0.00027760048],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9984799,0.00021634801,0.0005456356,0.00015257172,0.00044935592,0.00015618802],"domain_scores_gemma":[0.99866545,0.00039407003,0.00021915707,0.0004314104,0.00018784803,0.0001020762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090985093,0.00010645407,0.0007454462,0.00009068648,0.000011689516,0.0000021333594,0.0001641314,0.000042326905,0.000011331032],"category_scores_gemma":[0.0031588627,0.00006309032,0.0000538746,0.0003686312,0.00013916538,0.000031254633,0.00012572552,0.0001852167,0.0000070095557],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039702054,0.0010881643,0.008640539,0.98262006,0.0009287049,0.00043552794,0.0015559486,0.000007527874,0.0026930391,0.0011409973,0.00045689766,0.0000355509],"study_design_scores_gemma":[0.022671834,0.0014087394,0.045957614,0.9160629,0.0023429613,0.003059058,0.00045731742,0.00018299604,0.0074485103,0.00013758414,0.00003393174,0.00023654914],"about_ca_topic_score_codex":0.00004035857,"about_ca_topic_score_gemma":0.0000027992496,"teacher_disagreement_score":0.06655718,"about_ca_system_score_codex":0.00007989762,"about_ca_system_score_gemma":0.00022949855,"threshold_uncertainty_score":0.37816817},"labels":[],"label_agreement":null},{"id":"W2466370808","doi":"10.1182/blood.v126.23.5244.5244","title":"Descriptive Analysis of Azacitidine Use in Four Adult University Teaching Hospitals in Quebec, Canada","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université Laval; Hôpital Notre-Dame; Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; International Prognostic Scoring System; Azacitidine; Internal medicine; Chronic myelomonocytic leukemia; Myelodysplastic syndromes; Population; Pharmacy; Pediatrics; Family medicine; Bone marrow","score_opus":0.02461848111633017,"score_gpt":0.24610899256940058,"score_spread":0.22149051145307042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2466370808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981555,0.000036343114,0.000025170266,0.00047003778,0.000017220473,0.00019313201,0.000035791294,0.000009860088,0.0010569784],"genre_scores_gemma":[0.9973808,0.000014067539,0.00064291304,0.00006271479,0.00001584927,0.0000013683201,0.000028511156,0.000009388608,0.0018444227],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987899,0.00016145069,0.00020533771,0.00021619385,0.00036715687,0.00025992704],"domain_scores_gemma":[0.99915975,0.000117298274,0.00006317411,0.0002557002,0.00021744138,0.00018662665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003314935,0.00010155477,0.00041630832,0.0006557907,0.000016351654,0.0000072330554,0.00013065974,0.00006813226,0.000014398092],"category_scores_gemma":[0.00097289146,0.00010111473,0.000059874717,0.0011017091,0.000043422115,0.00016596401,0.00007746253,0.00035131682,0.000001232381],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016423342,0.00020113193,0.993601,0.000019323907,0.00051188946,0.0014823461,0.0013595424,0.000107971486,0.00076314626,0.00011633999,0.0014845707,0.00018847556],"study_design_scores_gemma":[0.0068540736,0.00011179507,0.98188704,0.00010023879,0.00073802983,0.0000066444713,0.0067148865,0.0014736418,0.0015385951,0.0000065962677,0.00041923646,0.00014924606],"about_ca_topic_score_codex":0.9879203,"about_ca_topic_score_gemma":0.99558496,"teacher_disagreement_score":0.011714013,"about_ca_system_score_codex":0.0014044222,"about_ca_system_score_gemma":0.0017300148,"threshold_uncertainty_score":0.4123339},"labels":[],"label_agreement":null},{"id":"W2466592351","doi":"10.1182/blood.v122.21.3656.3656","title":"Transfusion-Related Iron Overload: A Covert Risk Of Supportive Cancer Care","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hamilton Health Sciences; McMaster Children's Hospital; McMaster University","funders":"","keywords":"Medicine; Blood transfusion; Hemoglobinopathy; Thalassemia; Pediatrics; Intensive care medicine; Emergency medicine; Surgery; Internal medicine; Hemolytic anemia","score_opus":0.003676841854361563,"score_gpt":0.2200996637017612,"score_spread":0.21642282184739964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2466592351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983789,0.00524529,0.000005032667,0.00034115833,0.00013531737,0.00061075785,0.00006565418,0.000048034562,0.009759754],"genre_scores_gemma":[0.9937568,0.0051777987,0.00005670296,0.00012089652,0.000025600748,0.000038844322,0.000031578456,0.00002282454,0.000768978],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99904305,0.000030906645,0.00029087372,0.00020175302,0.00020876243,0.00022468632],"domain_scores_gemma":[0.99938345,0.00002507903,0.00010545083,0.00020619047,0.0001512808,0.00012854877],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00004158745,0.00013724771,0.00028618117,0.00006014391,0.000053418942,0.0000049512746,0.000054438235,0.00020858555,0.0022133158],"category_scores_gemma":[0.00003768146,0.00010229524,0.00014963534,0.00018432534,0.0000762485,0.000052589497,0.000015148958,0.00025689587,0.000079007696],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033277672,0.0028841246,0.8002128,0.0011766078,0.0018748903,0.00012907587,0.027684364,0.00016116316,0.104091436,0.00012472307,0.007327259,0.05400078],"study_design_scores_gemma":[0.04940621,0.0034485366,0.7825822,0.0017153252,0.00761591,0.00017079341,0.02611425,0.00041845796,0.11765953,0.00044052862,0.00928557,0.0011426719],"about_ca_topic_score_codex":0.0056670066,"about_ca_topic_score_gemma":0.00008235102,"teacher_disagreement_score":0.052858107,"about_ca_system_score_codex":0.000026382984,"about_ca_system_score_gemma":0.00014156167,"threshold_uncertainty_score":0.9986988},"labels":[],"label_agreement":null},{"id":"W2466601478","doi":"10.1182/blood.v124.21.209.209","title":"Do Hematopoietic Cell Transplant Patients Treated on a Clinical Trial Do Better? Comparison of Characteristics and Outcomes of Patients Enrolled Versus Not Enrolled on Blood and Marrow Transplant Clinical Trials Network (BMT-CTN) 0201 Trial","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Toronto; University of Manitoba; Ottawa Hospital; Princess Margaret Cancer Centre; University of Ottawa","funders":"","keywords":"Medicine; Internal medicine; Clinical trial; Transplantation; Randomized controlled trial; Hematopoietic stem cell transplantation; Graft-versus-host disease; Myeloid leukemia; Bone marrow; Oncology","score_opus":0.04748386393352807,"score_gpt":0.3393377482853996,"score_spread":0.29185388435187154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2466601478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956782,0.00015275944,0.000021933784,0.000027352979,0.0014246503,0.0016973601,0.00088507344,0.000009150096,0.000103542],"genre_scores_gemma":[0.99744964,0.00091913604,0.00010953585,0.00013475033,0.0007709826,0.000050717834,0.00051008014,0.00004437281,0.000010807317],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9945425,0.0011985328,0.0027990222,0.0007321774,0.00035881245,0.000368999],"domain_scores_gemma":[0.9951031,0.002707889,0.0012702933,0.0005390625,0.00012174066,0.00025792312],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002226817,0.0004370101,0.0021813414,0.00007037745,0.00007927655,0.00003851846,0.00023143333,0.0005641732,0.000012193687],"category_scores_gemma":[0.0012302584,0.0003553691,0.0005706304,0.00006759221,0.00018470986,0.0000042260867,0.000059740203,0.00027619724,0.0000020583716],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4458093,0.0098704975,0.53837156,0.00008427553,0.0009628664,0.000003498527,0.00010934202,0.0000058342157,0.0008598018,0.000021240507,0.00016587846,0.0037358706],"study_design_scores_gemma":[0.81047904,0.053557787,0.12191384,0.00011871883,0.0028691804,6.6407165e-7,0.000008517813,0.000029084944,0.01013967,0.000017133805,0.00035262154,0.000513741],"about_ca_topic_score_codex":0.000008053174,"about_ca_topic_score_gemma":0.000009491858,"teacher_disagreement_score":0.41645774,"about_ca_system_score_codex":0.0000058256956,"about_ca_system_score_gemma":0.000071087015,"threshold_uncertainty_score":0.99988985},"labels":[],"label_agreement":null},{"id":"W2466689542","doi":"10.1182/blood.v116.21.3831.3831","title":"G-CSF as Secondary Prophylaxis of Febrile Neutropenia In the Management of Advanced-Stage Hodgkin Lymphoma Treated with ABVD Chemotherapy: A Decision Analysis.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"ABVD; Medicine; Febrile neutropenia; Internal medicine; Neutropenia; Life expectancy; Oncology; Vinblastine; Chemotherapy regimen; Dacarbazine; Surgery; Chemotherapy; Population","score_opus":0.005062588138338474,"score_gpt":0.25312239490354943,"score_spread":0.24805980676521094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2466689542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903024,0.00010714392,0.00003626915,0.00008400368,0.000030347977,0.00073228864,0.000017905108,0.000019079549,0.008670583],"genre_scores_gemma":[0.9975514,0.00009764385,0.0014217285,0.00013217192,0.000024651157,0.00009024729,0.000014662195,0.000020858952,0.0006466346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988839,0.00003534307,0.0003206387,0.00027813364,0.0003063407,0.00017562961],"domain_scores_gemma":[0.9990218,0.000037053404,0.00016486796,0.00062928995,0.000097031574,0.000049932256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017922909,0.00015728918,0.0004214369,0.00024957035,0.00004168874,0.000016741622,0.00017980169,0.00006242323,0.00030455668],"category_scores_gemma":[0.000005348315,0.000096475014,0.00014008881,0.0013131824,0.00007936243,0.00010071516,0.000029506478,0.00015968255,0.0000060307543],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056815096,0.00867406,0.5020449,0.00076193013,0.005664402,0.00070411316,0.0015056557,0.00020224653,0.24386391,0.0015006384,0.00013578718,0.22926085],"study_design_scores_gemma":[0.012538616,0.0017041551,0.8768076,0.00012693234,0.0013869815,0.00006717099,0.00044290858,0.000007321532,0.1044469,0.00004194734,0.002287705,0.00014181572],"about_ca_topic_score_codex":0.00032918644,"about_ca_topic_score_gemma":0.0006046896,"teacher_disagreement_score":0.37476265,"about_ca_system_score_codex":0.000018631828,"about_ca_system_score_gemma":0.00008659614,"threshold_uncertainty_score":0.3934137},"labels":[],"label_agreement":null},{"id":"W2466910529","doi":"10.1182/blood-2015-11-679282","title":"Concurrent influenza vaccination reduces anti-FVIII antibody responses in murine hemophilia A","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Janeway Children's Health and Rehabilitation Centre; Memorial University of Newfoundland; Queen's University","funders":"Canadian Institutes of Health Research; Baxalta","keywords":"Vaccination; Immunogenicity; Immunology; Adjuvant; Medicine; Influenza vaccine; Antibody; Virology; Antibody response","score_opus":0.0385359318245592,"score_gpt":0.36904182948426906,"score_spread":0.33050589765970984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2466910529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99454516,0.0010509714,0.000004184715,0.0025463435,0.00009753299,0.0004919623,0.000014148824,0.00006604217,0.001183638],"genre_scores_gemma":[0.9963272,0.0005083952,0.00005141903,0.00007470983,0.00017358025,0.00003053441,0.000015782838,0.000019963212,0.0027984232],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985949,0.00009637225,0.00029656859,0.00031648946,0.00034599,0.00034967277],"domain_scores_gemma":[0.9992596,0.00016899258,0.000053920394,0.00026264868,0.000111210415,0.00014365799],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031318126,0.00015819268,0.00029053158,0.0003425996,0.000051225143,0.000015500775,0.0000958649,0.000097250704,0.00029932478],"category_scores_gemma":[0.0004317027,0.000094098476,0.00007267746,0.00031312543,0.000054159795,0.00012252077,0.000058935246,0.00012434326,0.00016244616],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018796646,0.0015554242,0.6153575,0.0000724723,0.00007933741,0.00035156094,0.00014238464,8.7943675e-8,0.3609712,0.00009615722,0.00020216555,0.020983724],"study_design_scores_gemma":[0.010471575,0.00041930217,0.7226834,0.00033776904,0.000059424743,0.000071964205,0.000027509202,0.0000052911473,0.26343173,0.000047106205,0.002319236,0.00012565209],"about_ca_topic_score_codex":0.000016118298,"about_ca_topic_score_gemma":0.0000050341973,"teacher_disagreement_score":0.10732593,"about_ca_system_score_codex":0.000060853316,"about_ca_system_score_gemma":0.00015865911,"threshold_uncertainty_score":0.38372245},"labels":[],"label_agreement":null},{"id":"W2466990390","doi":"10.1182/blood.v122.21.2567.2567","title":"High Levels Of IL-27 Occur In Newly Diagnosed Acute Myeloid Leukemia (AML) and May Influence Outcome By Suppressing T Cell Function","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cytokine; Medicine; Immunology; Leukemia; Myeloid leukemia; Haematopoiesis; Myeloid; Immune system; Internal medicine; Stem cell; Biology","score_opus":0.01526804908344721,"score_gpt":0.2679916751975374,"score_spread":0.2527236261140902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2466990390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973151,0.00040749236,0.00008445938,0.00057263474,0.00009294888,0.00076854037,0.00010082912,0.000057936944,0.0006000423],"genre_scores_gemma":[0.9957923,0.00015214707,0.0015704221,0.0005158535,0.00007896121,0.000062697756,0.000042224186,0.00004664618,0.001738705],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99776465,0.00010337683,0.0006119706,0.00047467297,0.00049067225,0.00055465574],"domain_scores_gemma":[0.99859476,0.0002929741,0.00017757881,0.00049238844,0.0001823254,0.00025998568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031416427,0.00027558062,0.0005756169,0.00025913952,0.00006099898,0.000055692002,0.000210385,0.0002536936,0.00025316168],"category_scores_gemma":[0.00023990839,0.00024132444,0.00007027217,0.00038763956,0.00018848992,0.00042807104,0.00018281743,0.00058315444,0.00011009428],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013399041,0.0002801563,0.29009953,0.00027559564,0.00010764244,0.00011698862,0.00031187115,0.00002217696,0.7012312,0.00001829645,0.0043860334,0.0030165387],"study_design_scores_gemma":[0.014606154,0.00051168137,0.7215078,0.00017287319,0.0002797412,0.00005877469,0.00019262459,0.00015443127,0.26108256,0.00009436757,0.001027816,0.000311163],"about_ca_topic_score_codex":0.0019999947,"about_ca_topic_score_gemma":0.000025361855,"teacher_disagreement_score":0.4401486,"about_ca_system_score_codex":0.00023651593,"about_ca_system_score_gemma":0.00032198225,"threshold_uncertainty_score":0.98409253},"labels":[],"label_agreement":null},{"id":"W2467412215","doi":"10.1182/blood.v126.23.2596.2596","title":"Whole Exome Sequencing Reveals the Landscape of Clonal Evolution from MDS to AML Progression","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Exome sequencing; Somatic evolution in cancer; Exome; Biology; DNA sequencing; Computational biology; Indel; Genetics; Myeloid leukemia; Whole genome sequencing; Deep sequencing; Genome; Gene; Mutation; Cancer research; Genotype; Single-nucleotide polymorphism","score_opus":0.03904503971649254,"score_gpt":0.3181829077107077,"score_spread":0.27913786799421514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2467412215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933924,0.00068334455,0.0001390386,0.0031179034,0.0000651563,0.0004741634,0.000031360723,0.00004110931,0.0020555363],"genre_scores_gemma":[0.9954236,0.0000061421306,0.003097611,0.00022325173,0.00043624057,0.000037236103,0.000048976068,0.00001869893,0.000708227],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985914,0.00009565745,0.00022740978,0.00021169177,0.00062111014,0.00025267986],"domain_scores_gemma":[0.9990081,0.00008531796,0.0000721126,0.0004037914,0.00023613281,0.00019450589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006405087,0.00009945596,0.00021734703,0.00008933203,0.00004829564,0.000013069964,0.00017633851,0.00008982651,0.00004760489],"category_scores_gemma":[0.0004752173,0.00006148195,0.00005136747,0.0003085426,0.000053589974,0.00006070235,0.00013460052,0.00023189737,0.00013689842],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062509504,0.00041813983,0.22841431,0.000092471775,0.00019316596,0.00014133728,0.0028584003,0.000029356088,0.71387714,0.00023494093,0.050006744,0.0031088814],"study_design_scores_gemma":[0.027554525,0.005462107,0.6495591,0.0023340008,0.0009450494,0.00052416505,0.006532998,0.0026232852,0.27284154,0.0034964166,0.02735223,0.0007745592],"about_ca_topic_score_codex":0.00017662064,"about_ca_topic_score_gemma":0.000012787952,"teacher_disagreement_score":0.4410356,"about_ca_system_score_codex":0.00020081292,"about_ca_system_score_gemma":0.00054354017,"threshold_uncertainty_score":0.25071612},"labels":[],"label_agreement":null},{"id":"W2467512445","doi":"10.1182/blood.v110.11.1863.1863","title":"Consistent Venous Thromboembolism Risk Reduction by Extended- Versus Standard-Duration Enoxaparin Prophylaxis in Subgroups of Acutely Ill Medical Patients in the EXCLAIM Study.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Calgary","funders":"","keywords":"Medicine; Placebo; Internal medicine; Incidence (geometry); Population; Asymptomatic; Clinical endpoint; Relative risk; Surgery; Randomized controlled trial; Pediatrics; Confidence interval","score_opus":0.012548831540498932,"score_gpt":0.27691253226012874,"score_spread":0.26436370071962983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2467512445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954516,0.00033398875,0.000028019875,0.00025947747,0.00043955902,0.0022706385,0.000025160416,0.000029455661,0.0011620783],"genre_scores_gemma":[0.9990086,0.0004865597,0.00008953003,0.000115204726,0.00011065842,0.00009504036,0.00006029567,0.000025708307,0.000008420181],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967144,0.0002648523,0.0008762858,0.0004279334,0.0013043104,0.0004121821],"domain_scores_gemma":[0.9987923,0.00015162288,0.00029446927,0.0004615577,0.0001841201,0.00011593341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021381413,0.00022824046,0.00069905753,0.00025212448,0.00009228658,0.000020879539,0.00021830425,0.0001839167,0.000056397887],"category_scores_gemma":[0.00048081588,0.00017125993,0.00009376924,0.0005025528,0.00013381556,0.000101260266,0.00008052041,0.00047350427,0.0000069961948],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009505695,0.26642606,0.4193799,0.0007415186,0.0024757402,0.0010695524,0.07097194,0.00002737058,0.0018063447,0.0022840702,0.006394923,0.21891691],"study_design_scores_gemma":[0.018063819,0.010962505,0.9595306,0.00012685345,0.0005361723,0.00001417892,0.008048991,0.0000072767234,0.0017727439,0.00010375117,0.00062830275,0.00020478941],"about_ca_topic_score_codex":0.0015269071,"about_ca_topic_score_gemma":0.0018678255,"teacher_disagreement_score":0.5401507,"about_ca_system_score_codex":0.00016499535,"about_ca_system_score_gemma":0.00011881504,"threshold_uncertainty_score":0.6983778},"labels":[],"label_agreement":null},{"id":"W2467630230","doi":"10.1182/blood.v124.21.2883.2883","title":"Product Attributes and Donor Factors in Reported Cases of Transfusion-Associated Graft Versus Host Disease: A Systematic Review","year":2014,"lang":"en","type":"review","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children; University of Toronto; University Health Network; Canadian Blood Services; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Human leukocyte antigen; Medicine; Blood product; Graft-versus-host disease; Disease; Immunology; Blood transfusion; Transplantation; Antigen; Internal medicine; Surgery","score_opus":0.055867117000137974,"score_gpt":0.32315635064142534,"score_spread":0.26728923364128737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2467630230","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004157705,0.9887378,0.0000021445373,0.000034743123,0.00012740768,0.00659028,0.00026622272,0.00005296689,0.000030718496],"genre_scores_gemma":[0.0024393292,0.99594605,0.000017383609,0.000009770451,0.000026415337,0.00033700187,0.001101132,0.000057710284,0.00006518947],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9962758,0.00047882998,0.0019897786,0.00054277113,0.00045314137,0.0002596768],"domain_scores_gemma":[0.99687445,0.0011308509,0.0009933908,0.00065096654,0.00014439735,0.00020596107],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008419092,0.0004582474,0.0047692885,0.00023014833,0.00003156365,0.000010452491,0.00010935928,0.00018589973,0.000028692832],"category_scores_gemma":[0.0034650275,0.00033235864,0.00045562626,0.00058241346,0.000057557045,0.000036579895,0.000014430215,0.0002483487,0.0000070657625],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021524922,0.0003827456,0.0010281238,0.9970696,0.00075825653,0.00038779408,0.00005208243,4.9540043e-9,0.0000039805336,0.0000034011514,0.000021222597,0.00027124613],"study_design_scores_gemma":[0.0020926136,0.00016774186,0.00073749706,0.9455654,0.049273975,0.00040320092,0.000013735787,3.0596956e-7,0.000024055327,5.498593e-7,0.0014299788,0.00029096063],"about_ca_topic_score_codex":0.00006885079,"about_ca_topic_score_gemma":0.000040683582,"teacher_disagreement_score":0.051504232,"about_ca_system_score_codex":0.000062794956,"about_ca_system_score_gemma":0.0003586285,"threshold_uncertainty_score":0.99991286},"labels":[],"label_agreement":null},{"id":"W2467728751","doi":"10.1182/blood-2016-02-698951","title":"Cooperation of germ line JAK2 mutations E846D and R1063H in hereditary erythrocytosis with megakaryocytic atypia","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Faculty of Medicine and Dentistry, University of Alberta; Austrian Science Fund; Grantová Agentura České Republiky","keywords":"Context (archaeology); Germline; Cancer research; Erythropoietin; Mutation; STAT5; Erythropoiesis; Erythropoietin receptor; Cell biology; Biology; Signal transduction; Genetics; Medicine; Internal medicine; Gene","score_opus":0.011865529753330386,"score_gpt":0.24252917689663708,"score_spread":0.2306636471433067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2467728751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99677414,0.0005409734,0.00009293964,0.0016023307,0.00002393349,0.0004276565,0.00003226663,0.000019208868,0.00048653665],"genre_scores_gemma":[0.99782115,0.00032390383,0.0013453185,0.00011272318,0.000069713504,0.00010318212,0.000032053,0.000015394748,0.00017657605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992391,0.000029112516,0.0002346569,0.00021711804,0.00014497276,0.00013502839],"domain_scores_gemma":[0.9994349,0.00015199669,0.00006456713,0.00015262263,0.00011533755,0.00008057371],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000067486704,0.00013024488,0.00027875495,0.00009895769,0.000038734335,0.000006732595,0.00002394661,0.000055430497,0.00008670695],"category_scores_gemma":[0.000066173656,0.000074819305,0.000026003561,0.00015114913,0.00007952647,0.00009519434,0.000015059633,0.00005312452,0.000010609336],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005817084,0.0035288858,0.96461004,0.0001841117,0.00056453905,0.00034866022,0.00096067076,0.00001962191,0.020244904,0.0013927518,0.0002532614,0.0073108473],"study_design_scores_gemma":[0.023573343,0.0034945107,0.72378224,0.0010002677,0.00075359613,0.0003855664,0.00014896144,0.000101970254,0.24611872,0.0001485192,0.00024055237,0.00025171964],"about_ca_topic_score_codex":0.00006769778,"about_ca_topic_score_gemma":0.00041567048,"teacher_disagreement_score":0.24082777,"about_ca_system_score_codex":0.000036933154,"about_ca_system_score_gemma":0.00012050463,"threshold_uncertainty_score":0.30510426},"labels":[],"label_agreement":null},{"id":"W2467879725","doi":"10.1182/blood.v126.23.3546.3546","title":"Incidence of Catheter-Related Venous Thromboembolism Events in Acute Leukemia patients; A Comparative, Retrospective Study of the Safety of Peripherally-Inserted Vs Centrally-Inserted Central Venous Catheters","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Central Venous Catheters and Hemodialysis","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Alberta","funders":"","keywords":"Medicine; Peripherally inserted central catheter; Thrombosis; Incidence (geometry); Venous thrombosis; Surgery; Concomitant; Catheter; Deep vein; Central venous catheter; Central line; Acute leukemia; Internal medicine; Leukemia","score_opus":0.025123840354078733,"score_gpt":0.30428373963753225,"score_spread":0.2791598992834535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2467879725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99567467,0.0000899837,0.0000046140376,0.000047908703,0.0005165687,0.0031186952,0.00020400637,0.000039380913,0.00030418497],"genre_scores_gemma":[0.99957687,0.00006093257,0.00005881674,0.0000653905,0.0000269771,0.000064305044,0.00004649926,0.000048603757,0.000051610732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945092,0.0012199079,0.0018586388,0.00055429834,0.00090519735,0.0009527509],"domain_scores_gemma":[0.9965088,0.00014894715,0.0015059547,0.00090220204,0.0006854519,0.0002486482],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00056635356,0.00042301594,0.0017664664,0.00019773576,0.0002853502,0.0000043268155,0.0008086815,0.00030219066,0.000049745617],"category_scores_gemma":[0.00015756974,0.0003291818,0.00034849002,0.0009893541,0.00021317147,0.00016543154,0.0002980474,0.00079041015,0.0000067368132],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010459988,0.017904248,0.782109,0.00009500995,0.00094249455,0.000007990591,0.19550285,0.00027164604,0.00197963,0.00004172574,0.000049384566,0.00005000921],"study_design_scores_gemma":[0.011946579,0.0036103465,0.974669,0.00045414956,0.0007474056,0.0000027164326,0.006983747,0.00021092687,0.00092009,0.00015158579,0.000011452882,0.00029200042],"about_ca_topic_score_codex":0.006409518,"about_ca_topic_score_gemma":0.0027776335,"teacher_disagreement_score":0.19255999,"about_ca_system_score_codex":0.00097050535,"about_ca_system_score_gemma":0.001022859,"threshold_uncertainty_score":0.999916},"labels":[],"label_agreement":null},{"id":"W2468182232","doi":"10.1182/blood.v124.21.237.237","title":"Administration of Dexamethasone during Initial Exposure to Factor VIII Prevents the Development of Anti-Factor VIII Antibodies and Increases the Proportion of Thymic but Not Splenic Regulatory T Cells in the Exon 16 Knockout C57Bl6 Hemophilia Α Mouse Model","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Janeway Children's Health and Rehabilitation Centre; Memorial University of Newfoundland; Queen's University","funders":"","keywords":"Medicine; Immunology; FOXP3; Antibody; Dexamethasone; Spleen; Immune system; Immune tolerance; Internal medicine","score_opus":0.034064195015035735,"score_gpt":0.29537103011471405,"score_spread":0.26130683509967834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2468182232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983004,0.0001200784,0.000034898127,0.00016094674,0.000019246623,0.0012586677,0.000059917053,0.000010872223,0.000035028395],"genre_scores_gemma":[0.99922264,0.00007029039,0.00040340846,0.000017926517,0.000051204097,0.00004386257,0.000018521592,0.000018214983,0.00015393975],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99805224,0.0002150243,0.0005996451,0.00024162959,0.0006642601,0.00022722427],"domain_scores_gemma":[0.9989098,0.00021908365,0.00024809883,0.00042969277,0.00012648854,0.000066844004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005823302,0.0001905473,0.00038288705,0.00012751468,0.00011889627,0.000012352156,0.00019256824,0.000100765574,0.0000121269095],"category_scores_gemma":[0.00021041548,0.000095768104,0.000078161735,0.00015056842,0.00018224098,0.00007715907,0.00009288154,0.00016457646,0.0000012106282],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005247262,0.0014183493,0.052703027,0.000540828,0.00014445257,0.0000035809317,0.0041284137,0.000026058822,0.9390438,0.000019762814,0.0000028611728,0.0014441422],"study_design_scores_gemma":[0.0014993082,0.00044757914,0.2882513,0.00017047618,0.000080747595,0.000007757887,0.00035693112,0.000069625785,0.7090291,0.000014887087,0.000002373229,0.0000699083],"about_ca_topic_score_codex":0.00004703315,"about_ca_topic_score_gemma":0.00007890991,"teacher_disagreement_score":0.23554827,"about_ca_system_score_codex":0.000033187836,"about_ca_system_score_gemma":0.00027280318,"threshold_uncertainty_score":0.39053097},"labels":[],"label_agreement":null},{"id":"W2468369718","doi":"10.1182/blood.v108.11.15.15","title":"Outcome of Down Syndrome (DS) Children with Acute Myeloid Leukemia (AML) or Myelodysplasia (MDS) Treated with a Uniform Prospective Clinical Trial - Initial Report of the COG Trial A2971.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre","funders":"","keywords":"Medicine; Internal medicine; Regimen; Etoposide; Surgery; Gastroenterology; Chemotherapy","score_opus":0.0276040823361425,"score_gpt":0.3310719598564472,"score_spread":0.30346787752030474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2468369718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876816,0.000020249076,0.000024904073,0.0002150679,0.00016720389,0.0077157067,0.00020283074,0.00012386955,0.0038485182],"genre_scores_gemma":[0.9943475,0.000019436446,0.0010857813,0.000056905938,0.00082285947,0.00027860576,0.00018055066,0.000119912234,0.0030884081],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9938468,0.0003099477,0.0023977016,0.00094634487,0.0017289651,0.0007702684],"domain_scores_gemma":[0.995809,0.00041279668,0.0013125935,0.0015505054,0.0006273352,0.00028774314],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013660863,0.00060053397,0.0020482247,0.00030144321,0.00016875601,0.00003737916,0.00061073137,0.00051818544,0.00013098857],"category_scores_gemma":[0.00068576436,0.0003082428,0.000485755,0.0013998036,0.0012430971,0.00019387928,0.00023589518,0.0012965181,0.000011588028],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.59317845,0.0033283485,0.3926665,0.000083674066,0.004213499,0.0051958715,0.00008790274,0.000006259262,0.00062385516,0.000093848605,0.00036488005,0.00015695326],"study_design_scores_gemma":[0.5632618,0.024117857,0.37957054,0.00026148272,0.0043900036,0.018576996,0.00005732495,0.000013472125,0.009252669,0.00002643191,0.00009091872,0.00038051268],"about_ca_topic_score_codex":0.0018799779,"about_ca_topic_score_gemma":0.00046711825,"teacher_disagreement_score":0.029916625,"about_ca_system_score_codex":0.00043215608,"about_ca_system_score_gemma":0.004426474,"threshold_uncertainty_score":0.99993694},"labels":[],"label_agreement":null},{"id":"W2468527255","doi":"10.1182/blood.v122.21.4745.4745","title":"A Systematic Review On The Use Of Pharmacological Agents In Patients With Hereditary Hemorrhagic Telangiectasia (HHT)","year":2013,"lang":"en","type":"review","venue":"Blood","topic":"Vascular Anomalies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Mount Sinai Hospital; University of Manitoba; University of Toronto","funders":"","keywords":"Medicine; Telangiectasia; Tranexamic acid; Randomized controlled trial; Bevacizumab; Internal medicine; Clinical trial; MEDLINE; Pediatrics; Surgery; Chemotherapy","score_opus":0.08158753284021245,"score_gpt":0.3114268820491851,"score_spread":0.22983934920897267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2468527255","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038334099,0.986948,1.2959079e-7,0.00002306766,0.00004690025,0.008969328,0.000050193965,0.000017468179,0.00011146802],"genre_scores_gemma":[0.00026982298,0.9978559,0.00006997174,0.00036412533,0.00002978292,0.0009388909,0.00026738932,0.000046859976,0.00015726419],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9978473,0.0003702893,0.00077098474,0.0003148445,0.00045700144,0.00023953733],"domain_scores_gemma":[0.99856454,0.00022752276,0.00045158062,0.00059449754,0.000071314804,0.00009054837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015121739,0.0004190847,0.0027548457,0.000093543145,0.000026688745,0.000011982554,0.00018635672,0.00013985643,0.0002118611],"category_scores_gemma":[0.00016254613,0.00016951338,0.00055680086,0.00029604905,0.000038522066,0.000038076414,0.00005771925,0.0002944295,0.000207807],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015894137,0.0034160467,0.00077422295,0.98199195,0.0049412097,0.00045479188,0.000010275209,8.670944e-8,8.998291e-9,0.0000052530004,0.0011377807,0.007252502],"study_design_scores_gemma":[0.0029777475,0.00091889215,0.0005377116,0.9370732,0.046537038,0.00017352412,0.0000036062052,0.0000010393344,5.416187e-7,5.863785e-7,0.01154286,0.00023329238],"about_ca_topic_score_codex":0.00001962074,"about_ca_topic_score_gemma":0.0000010334721,"teacher_disagreement_score":0.044918768,"about_ca_system_score_codex":0.000067102716,"about_ca_system_score_gemma":0.00008058798,"threshold_uncertainty_score":0.6912555},"labels":[],"label_agreement":null},{"id":"W2468570663","doi":"10.1182/blood.v108.11.3331.3331","title":"Physician Perceptions and Preferences in the Treatment of Acquired Immunodeficiency Syndrome (AIDS)-Related Lymphoma (ARL).","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Paul's Hospital; Maple Leaf Medical Clinic; University of British Columbia; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Family medicine; Regimen; Internal medicine","score_opus":0.008829319288183328,"score_gpt":0.23362930623788036,"score_spread":0.22479998694969702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2468570663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986508,0.003989336,7.09658e-7,0.00014962892,0.000023670224,0.0002678285,0.000013281135,0.000019522982,0.0090280315],"genre_scores_gemma":[0.99906945,0.00058942713,0.000023422017,0.000046603003,0.000011028011,0.0000339113,0.000028725482,0.0000074489626,0.00018999667],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99931675,0.000038228616,0.00019591585,0.00014519042,0.00014249301,0.00016139324],"domain_scores_gemma":[0.99971485,0.000024728417,0.00006605392,0.00015707075,0.000020627305,0.000016682745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000055183547,0.00010495099,0.00021822727,0.000065349275,0.000064921864,0.000011223701,0.000054807686,0.00006198362,0.00003129065],"category_scores_gemma":[0.0000045188376,0.000067467816,0.000068483336,0.00026218154,0.00009154081,0.00004341407,0.0000054992656,0.000017483371,0.000005543254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029354033,0.04121292,0.77485526,0.00016458555,0.0007773761,0.00018562326,0.026362902,0.00007174644,0.056580406,0.0026521045,0.00033696851,0.09650658],"study_design_scores_gemma":[0.008695471,0.0019945009,0.98327297,0.000062599574,0.00033669863,0.000034316305,0.0039324844,0.000024142171,0.00038375435,0.0010531326,0.00011061632,0.00009931136],"about_ca_topic_score_codex":0.0012416112,"about_ca_topic_score_gemma":0.00010466472,"teacher_disagreement_score":0.20841773,"about_ca_system_score_codex":0.000042390908,"about_ca_system_score_gemma":0.000050547824,"threshold_uncertainty_score":0.27512577},"labels":[],"label_agreement":null},{"id":"W2468674839","doi":"10.1182/blood.v122.21.4815.4815","title":"Thromboprophylaxis In Pregnancy: Are Current Guidelines Working?","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan; University of Ottawa; Royal University Hospital","funders":"","keywords":"Medicine; Pregnancy; Miscarriage; Thrombophilia; Obstetrics; Population; Observational study; Gestation; Thrombosis; Postpartum period; Retrospective cohort study; Pediatrics; Intensive care medicine; Surgery; Internal medicine","score_opus":0.07114366987885058,"score_gpt":0.31542982915556655,"score_spread":0.244286159276716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2468674839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868406,0.0064113215,0.00013373772,0.0019424702,0.00051236764,0.00092358165,0.0000018966189,0.00016462688,0.003069402],"genre_scores_gemma":[0.9965229,0.00023347286,0.0022899527,0.00036529257,0.00020110025,0.00010777357,0.00000877905,0.000026091759,0.0002446379],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881667,0.000026273334,0.00036978503,0.0002791024,0.00025595605,0.00025221464],"domain_scores_gemma":[0.9992631,0.000016045762,0.00009929927,0.00033870141,0.00016738696,0.000115480754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000077823526,0.0001554558,0.00031172798,0.00012889058,0.000036244346,0.000027246842,0.00009047306,0.00008614245,0.00053036516],"category_scores_gemma":[0.00009661059,0.00012870884,0.000080153295,0.0002989476,0.000023828201,0.00007358331,0.000048184877,0.00017650462,0.00035095974],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021676966,0.005904132,0.72044444,0.00046607654,0.00023012699,0.00007253724,0.00060999545,0.000006909165,0.033044618,0.004533593,0.004210345,0.23045555],"study_design_scores_gemma":[0.008459183,0.0003942929,0.9413458,0.004679695,0.00021690832,0.000045687557,0.00021863678,0.00039048665,0.030641088,0.0072746472,0.0058351965,0.0004983497],"about_ca_topic_score_codex":0.000045746343,"about_ca_topic_score_gemma":0.000027331196,"teacher_disagreement_score":0.22995721,"about_ca_system_score_codex":0.000016612657,"about_ca_system_score_gemma":0.000044789605,"threshold_uncertainty_score":0.5807126},"labels":[],"label_agreement":null},{"id":"W2468676672","doi":"10.1182/blood.v122.21.532.532","title":"Interim Analysis Of The Mmrf Commpass Trial, a Longitudinal Study In Multiple Myeloma Relating Clinical Outcomes To Genomic and Immunophenotypic Profiles","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Clinical trial; Multiple myeloma; Interim analysis; Exome; Oncology; Internal medicine; Bioinformatics; Exome sequencing; Genetics; Biology; Gene","score_opus":0.10274117346414163,"score_gpt":0.3879965017064567,"score_spread":0.2852553282423151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2468676672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99648434,0.00010406574,0.000004844587,0.00025234921,0.0000506204,0.0030148188,0.000009667251,0.000014014938,0.0000653084],"genre_scores_gemma":[0.9989181,0.0000074741274,0.0006189371,0.000037647478,0.000025880123,0.00025886734,0.000007955733,0.000014444924,0.00011068238],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99813706,0.00031018292,0.0007055089,0.00031789244,0.00026851773,0.00026085362],"domain_scores_gemma":[0.9984547,0.0006299079,0.00014914942,0.00054289965,0.00008154656,0.00014179702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052834133,0.00015602406,0.0007400349,0.0002749518,0.00007902331,0.00002887074,0.0001692782,0.000062782536,0.00007267811],"category_scores_gemma":[0.0012221193,0.00009396017,0.00021660824,0.0005382017,0.00008686355,0.0000518567,0.00028358385,0.00024482544,0.000019707943],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019750667,0.003401269,0.98827565,0.00001639693,0.0029735041,0.000018384484,0.00054619374,0.0000029133255,0.0007047633,0.0000031319373,0.0000091544725,0.0020735688],"study_design_scores_gemma":[0.046882916,0.0013561237,0.9495063,0.000038746315,0.0011037542,0.000002397,0.0005933487,0.00033102464,0.000100673955,0.0000068898016,0.0000027377341,0.00007509721],"about_ca_topic_score_codex":0.0025076526,"about_ca_topic_score_gemma":0.0013956407,"teacher_disagreement_score":0.04490785,"about_ca_system_score_codex":0.000038040518,"about_ca_system_score_gemma":0.00005994407,"threshold_uncertainty_score":0.38315845},"labels":[],"label_agreement":null},{"id":"W2469018277","doi":"10.1182/blood-2016-03-704379","title":"Anaplastic variant of plasma cell myeloma with Dutcher bodies","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Multiple myeloma; Plasma cell; Plasma Cell Myeloma; Plasma cell leukemia; Plasmacytoma; Medicine; Cancer research; Pathology; Internal medicine","score_opus":0.015116557880913123,"score_gpt":0.2464288482005438,"score_spread":0.2313122903196307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2469018277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901435,0.000095429066,0.000083221144,0.00020569807,0.000017018989,0.00022607321,0.000027278153,0.000028808316,0.009172996],"genre_scores_gemma":[0.9946685,0.0000431336,0.0021410068,0.000010677926,0.000045215085,0.000021381196,0.0000037378163,0.000017808423,0.0030485652],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99914587,0.00002132115,0.0001313677,0.00017718923,0.00027211328,0.00025215928],"domain_scores_gemma":[0.9993074,0.00016188768,0.000047776888,0.00024041136,0.00008059699,0.00016195727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000050174713,0.00011277648,0.00021300103,0.000073817995,0.000027711463,0.000004614191,0.00005534165,0.000042819767,0.0002721971],"category_scores_gemma":[0.00009800063,0.000054928616,0.000042782074,0.000065229884,0.00008710102,0.000039597795,0.000027708924,0.00004838001,0.00012311233],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005051389,0.0060027665,0.67554843,0.000582423,0.0018082546,0.004513128,0.0005565416,9.655894e-7,0.282875,0.00024806836,0.0006737099,0.022139305],"study_design_scores_gemma":[0.031011006,0.0038634504,0.32914403,0.0003724385,0.00041171312,0.0003066774,0.000074502794,0.000026406207,0.6335633,0.00006280204,0.0009980771,0.00016561344],"about_ca_topic_score_codex":0.000043593707,"about_ca_topic_score_gemma":0.000060466118,"teacher_disagreement_score":0.35068828,"about_ca_system_score_codex":0.000018529003,"about_ca_system_score_gemma":0.00011107879,"threshold_uncertainty_score":0.29803672},"labels":[],"label_agreement":null},{"id":"W2469213834","doi":"10.1182/blood.v108.11.1609.1609","title":"The Natural History of the Neutrophil Elastase and Coagulation Factor Response to E.coli in a Baboon Model of E.coli/Sepsis Suggests That Elevated Neutrophil Elastase Activity Is Sustained Regardless of Outcome in Clinical Sepsis.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Fibrinogen; Elastase; Escherichia coli; Sepsis; Neutrophil elastase; Baboon; Antigen; Protease; Internal medicine; Immunology; Medicine; Pharmacology; Microbiology; Biology; Chemistry; Biochemistry; Enzyme; Inflammation","score_opus":0.04351103143592146,"score_gpt":0.3047625697028014,"score_spread":0.26125153826687997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2469213834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961592,0.0002636526,0.000030464307,0.0020907135,0.00018126209,0.0011213631,0.00009430735,0.000021020798,0.00003801548],"genre_scores_gemma":[0.9991222,0.000030268167,0.00014640174,0.00025100753,0.000025019941,0.000028587508,0.000008723556,0.00003506512,0.00035274107],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9968291,0.0007035077,0.0011440492,0.00041569074,0.0005652101,0.0003424333],"domain_scores_gemma":[0.99768037,0.0006014932,0.0006488071,0.0007019568,0.00025997538,0.000107429594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011380033,0.0002775746,0.00085129635,0.0003348863,0.000053903495,0.000009073207,0.00021491968,0.00025757667,0.000010690567],"category_scores_gemma":[0.0004922273,0.00019733125,0.00023626546,0.0005063351,0.00024851252,0.00011781714,0.00014794242,0.00046531868,6.3886984e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012939907,0.0036840083,0.26650244,0.00033099172,0.0001798597,0.000020183243,0.0013738183,0.001134111,0.71170896,0.0012050597,0.00021502475,0.00070559763],"study_design_scores_gemma":[0.008446619,0.00040817837,0.92566705,0.0001621784,0.00020193904,0.0000037417917,0.0001646028,0.0057312716,0.05871074,0.00025037504,0.00007108526,0.00018219414],"about_ca_topic_score_codex":0.00043235905,"about_ca_topic_score_gemma":0.00052708137,"teacher_disagreement_score":0.6591646,"about_ca_system_score_codex":0.0002289711,"about_ca_system_score_gemma":0.00039921876,"threshold_uncertainty_score":0.8046935},"labels":[],"label_agreement":null},{"id":"W2469246024","doi":"10.1182/blood.v106.11.1950.1950","title":"Thrombin Aptamer HD1 Inhibits Prothrombin Activation by Binding Proexosite 1 on Prothrombin.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"","keywords":"Prothrombinase; Thrombin; Chemistry; Hirudin; Biochemistry; Thromboplastin; Coagulation; Biology; Immunology; Platelet; Internal medicine; Medicine","score_opus":0.021604197797437497,"score_gpt":0.26826355049610745,"score_spread":0.24665935269866995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2469246024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846314,0.00005368205,0.00022125215,0.003721238,0.00012040239,0.0032632046,0.000013986827,0.0004251472,0.007549653],"genre_scores_gemma":[0.9930645,0.000015904952,0.0019934457,0.0015275459,0.00024017549,0.00042803405,0.0001400079,0.000102312144,0.0024880238],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997503,0.00008739905,0.00050414895,0.0006657549,0.0007131341,0.00052658125],"domain_scores_gemma":[0.9988211,0.000040699393,0.00023746562,0.00052479893,0.00012887118,0.00024708957],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002992869,0.00038793494,0.0005159817,0.00025013776,0.00022554482,0.00007588752,0.00013987176,0.00027255726,0.0005656357],"category_scores_gemma":[0.00008644646,0.00035392278,0.00014933494,0.00050101196,0.00008147423,0.00035884976,0.000056206256,0.00043205183,0.00075805775],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006558108,0.0044054585,0.0012831923,0.00009223144,0.00020145232,0.000003642777,0.0003593579,0.0000027423623,0.9840042,0.0033662163,0.0034284347,0.0027874769],"study_design_scores_gemma":[0.007451573,0.0012301117,0.0035918877,0.0004568887,0.00021624795,0.0000406049,0.00007289721,0.000102055244,0.9826245,0.00028475132,0.0035441152,0.0003844236],"about_ca_topic_score_codex":0.000014772248,"about_ca_topic_score_gemma":0.0000040206905,"teacher_disagreement_score":0.008433117,"about_ca_system_score_codex":0.00011629489,"about_ca_system_score_gemma":0.00011057605,"threshold_uncertainty_score":0.9998913},"labels":[],"label_agreement":null},{"id":"W2470085669","doi":"10.1182/blood.v110.11.420.420","title":"Integrin Linked Kinase Is Important in Platelet Signalling and Function.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Integrin-linked kinase; Integrin; Platelet; Thrombin; Chemistry; Clot retraction; Kinase; Cell biology; Collagen receptor; Platelet activation; Phosphorylation; Platelet Glycoprotein GPIIb-IIIa Complex; Integrin alpha M; Endocrinology; Internal medicine; Protein kinase A; Biology; Biochemistry; Medicine; Receptor; Cyclin-dependent kinase 2","score_opus":0.021494958768625498,"score_gpt":0.2858503020253185,"score_spread":0.264355343256693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2470085669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99643034,0.0011276399,0.0002451127,0.0002583835,0.000028253742,0.00023511061,0.0000015732028,0.000028566032,0.0016450032],"genre_scores_gemma":[0.99791163,0.00018259602,0.0006843805,0.000414504,0.000088439796,0.000005211432,0.000008591409,0.000017999158,0.00068664167],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989322,0.000015746333,0.00028415598,0.00023251961,0.00026140478,0.00027398864],"domain_scores_gemma":[0.99949235,0.000089543755,0.000034730932,0.00015346003,0.000053700514,0.00017621036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005370603,0.00009637976,0.00016710114,0.00022048564,0.000028016482,0.000013674556,0.000043753902,0.0000995515,0.0003423278],"category_scores_gemma":[0.0001206125,0.000082367624,0.000036871334,0.00024500734,0.000037032532,0.000027124608,0.00004694072,0.0003605987,0.00003812355],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000690479,0.00088188465,0.17096896,0.00014046114,0.000079906786,0.0037641732,0.00047900295,0.0000010211608,0.8005007,0.00011503063,0.0004255893,0.021952795],"study_design_scores_gemma":[0.011808734,0.0012100063,0.27467477,0.0002868452,0.00011050008,0.00035321477,0.00063164433,0.00050383253,0.6950223,0.0003923442,0.014688022,0.00031780094],"about_ca_topic_score_codex":0.00007914356,"about_ca_topic_score_gemma":0.000059216753,"teacher_disagreement_score":0.1054784,"about_ca_system_score_codex":0.00002476886,"about_ca_system_score_gemma":0.000057655318,"threshold_uncertainty_score":0.37482494},"labels":[],"label_agreement":null},{"id":"W2470146711","doi":"10.1182/blood-2015-12-688267","title":"A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorders","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":185,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Toronto; SickKids Foundation; Hospital for Sick Children; Queen's University; Health Sciences Centre","funders":"National Heart, Lung, and Blood Institute; NIHR BioResource; European Commission; Medical Research Council; British Society for Haematology; National Institute for Health and Care Research; Universitatea Sapientia; British Heart Foundation; Wellcome Trust; NHS Blood and Transplant; Bristol-Myers Squibb","keywords":"Platelet disorder; Platelet; Medicine; Etiology; Blood Platelet Disorders; Genetic testing; DNA sequencing; Gene; Internal medicine; Bioinformatics; Genetics; Biology; Platelet aggregation","score_opus":0.017283824526576546,"score_gpt":0.2542568578318436,"score_spread":0.23697303330526706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2470146711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960823,0.00064576743,0.00036761194,0.001690877,0.00008846001,0.000613546,0.00005451687,0.000106205036,0.0003507283],"genre_scores_gemma":[0.9948566,0.00071692275,0.0038349857,0.00021968313,0.00009091293,0.00007326788,0.000020237305,0.000042301934,0.00014510399],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897945,0.000008450993,0.00019842856,0.00033737862,0.00012370048,0.00035259372],"domain_scores_gemma":[0.9992252,0.00037748026,0.0000690472,0.00016697684,0.000039907456,0.00012138341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007366314,0.0001956477,0.0003592608,0.00006707256,0.00012684765,0.000026302307,0.00004496496,0.00010051192,0.000031864085],"category_scores_gemma":[0.0002695833,0.00013064237,0.0000628812,0.000101486774,0.00008614788,0.00013934661,0.00003241817,0.000059732087,0.000012489129],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029735366,0.0046389564,0.70321846,0.0006348288,0.0018821673,0.0009349148,0.0014511659,0.0000028628758,0.20705354,0.0018809991,0.0026883197,0.075316414],"study_design_scores_gemma":[0.22883238,0.013039151,0.3861389,0.0059039146,0.0057685594,0.00288721,0.0016295776,0.00043835898,0.29869196,0.03827267,0.015099659,0.0032976514],"about_ca_topic_score_codex":0.00011833348,"about_ca_topic_score_gemma":0.00007050199,"teacher_disagreement_score":0.31707957,"about_ca_system_score_codex":0.00004584689,"about_ca_system_score_gemma":0.000050023602,"threshold_uncertainty_score":0.5327441},"labels":[],"label_agreement":null},{"id":"W2470855502","doi":"10.1182/blood.v124.21.4260.4260","title":"Outcomes of Central Venous Catheter Associated Upper Extremity Deep Vein Thrombosis in Cancer Patents","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Central Venous Catheters and Hemodialysis","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Discontinuation; Surgery; Low molecular weight heparin; Thrombosis; Cancer; Catheter; Deep vein; Retrospective cohort study; Venous thrombosis; Heparin; Central venous catheter; Cohort; Internal medicine","score_opus":0.04322640070193308,"score_gpt":0.3396045301482215,"score_spread":0.29637812944628844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2470855502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99770576,0.00013265829,0.0000242589,0.00027514837,0.0003836317,0.00037246168,0.00006811223,0.000041981893,0.0009960002],"genre_scores_gemma":[0.9989202,0.0001485511,0.00007009109,0.00042597117,0.00008347425,0.00006685298,0.000030251693,0.00003089731,0.0002237046],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977065,0.0003745152,0.00057102327,0.00028156684,0.00025718246,0.0008092517],"domain_scores_gemma":[0.9989799,0.00020523189,0.00028130884,0.0003123454,0.000085539636,0.0001356747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039254522,0.00018541119,0.0006396436,0.00010143726,0.00019255457,0.0000056038853,0.0002015817,0.00024365392,0.00055536197],"category_scores_gemma":[0.00016077119,0.00015351044,0.00021670018,0.00019722307,0.000039790975,0.00006359381,0.00007833926,0.00035661133,0.000042961467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000115815465,0.0036456443,0.9882169,0.00005335018,0.0001651031,0.0000013117234,0.0064786673,0.000010381319,0.00047489977,0.00003724077,0.00007783759,0.0008271259],"study_design_scores_gemma":[0.0024146414,0.00011319741,0.99591726,0.000113160706,0.00020780468,1.20311e-7,0.00025257576,0.00014598093,0.00027557934,0.00015668261,0.00023284637,0.00017015876],"about_ca_topic_score_codex":0.00491461,"about_ca_topic_score_gemma":0.005042408,"teacher_disagreement_score":0.0077003953,"about_ca_system_score_codex":0.0001897262,"about_ca_system_score_gemma":0.00009925979,"threshold_uncertainty_score":0.7429453},"labels":[],"label_agreement":null},{"id":"W2470956552","doi":"10.1182/blood.v122.21.1172.1172","title":"Inducing Definitive Erythropoiesis From Human Embryonic Stem Cells Through a Novel Intracellular MPL Dimerization Strategy","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stemcell Technologies","funders":"","keywords":"Embryonic stem cell; Biology; Cell biology; Erythropoiesis; Cord blood; Stem cell; Progenitor cell; Induced pluripotent stem cell; Cellular differentiation; Stromal cell; Molecular biology; Immunology; Cancer research; Biochemistry; Internal medicine; Anemia; Medicine","score_opus":0.036920547706089,"score_gpt":0.2515219072590218,"score_spread":0.2146013595529328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2470956552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925803,0.00039167088,0.0024611608,0.00021019485,0.00031583259,0.0004950295,0.000035152254,0.00014407485,0.0033665672],"genre_scores_gemma":[0.99597406,0.000099088255,0.0016387522,0.0006750184,0.00042728076,0.000058609392,0.00023301464,0.00004855761,0.00084560155],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985839,0.00007617816,0.00035393803,0.00046191443,0.00019567009,0.00032839205],"domain_scores_gemma":[0.99906904,0.00010226861,0.00017700724,0.0003752751,0.0001569909,0.0001194328],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00006114378,0.00024527614,0.00041094417,0.00007323529,0.00018354514,0.000041334246,0.000085827516,0.0002483785,0.0015497518],"category_scores_gemma":[0.000017849588,0.00022299518,0.000110880115,0.00022488668,0.00011710723,0.00021690842,0.000050008108,0.00032566808,0.0006911149],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023825613,0.00068828254,0.00094602606,0.00004373347,0.00020183805,0.000017266571,0.00075312756,0.000015838126,0.99561113,0.0007467964,0.00037841895,0.00057371904],"study_design_scores_gemma":[0.008918229,0.0016767101,0.038542192,0.00028779783,0.00086334033,0.000068435016,0.004349518,0.0002252053,0.94161016,0.0013317675,0.0014610623,0.0006655927],"about_ca_topic_score_codex":0.0009260631,"about_ca_topic_score_gemma":0.000028509572,"teacher_disagreement_score":0.054000977,"about_ca_system_score_codex":0.000029681914,"about_ca_system_score_gemma":0.00009592139,"threshold_uncertainty_score":0.99936295},"labels":[],"label_agreement":null},{"id":"W2471021613","doi":"10.1182/blood.v126.23.3681.3681","title":"Identification of Existing Bioactive Compounds That Target Acute Myeloid Leukemia Stem Cells","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network; McGill University Health Centre","funders":"","keywords":"Stem cell; Daunorubicin; Haematopoiesis; Myeloid leukemia; Leukemia; Myeloid; Cancer research; Biology; Medicine; Oncology; Internal medicine; Immunology; Pharmacology; Genetics","score_opus":0.06591101255448366,"score_gpt":0.31787829763707476,"score_spread":0.2519672850825911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2471021613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98807853,0.00027502314,0.00076228456,0.0002228756,0.00016738244,0.00077492266,0.00007372055,0.00010678931,0.009538479],"genre_scores_gemma":[0.9929498,0.000044638058,0.0025487288,0.000068770285,0.00018742781,0.00004701259,0.000058160495,0.00004538922,0.004050093],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99798316,0.00010122001,0.00044350862,0.00037101412,0.0007343046,0.0003667769],"domain_scores_gemma":[0.9982688,0.00011572288,0.00029025675,0.00058499945,0.00045205202,0.00028819768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007349783,0.00019024716,0.00042356047,0.00020604399,0.00006750732,0.000036123947,0.00026711985,0.0001512336,0.000019887817],"category_scores_gemma":[0.000072293245,0.0001718807,0.0001040358,0.00037804627,0.0001745905,0.00017025025,0.00013697098,0.00034563808,0.0001436738],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044848342,0.0004566375,0.013962605,0.00018418302,0.000632622,0.00015657644,0.001791721,0.000016503502,0.97611314,0.00022484439,0.0048240623,0.001188648],"study_design_scores_gemma":[0.0046773087,0.0003489693,0.002776917,0.000084667474,0.0003078284,0.00013245383,0.0013779554,0.0007681787,0.98698604,0.00011232861,0.0022560642,0.00017128108],"about_ca_topic_score_codex":0.000095207404,"about_ca_topic_score_gemma":0.000002433379,"teacher_disagreement_score":0.011185688,"about_ca_system_score_codex":0.0005429013,"about_ca_system_score_gemma":0.0008588871,"threshold_uncertainty_score":0.70090914},"labels":[],"label_agreement":null},{"id":"W2471073614","doi":"10.1182/blood.v126.23.731.731","title":"Efficacy and Safety of Carfilzomib, Lenalidomide, and Dexamethasone Vs Lenalidomide and Dexamethasone in Patients with Relapsed Multiple Myeloma Based on Cytogenetic Risk Status: Subgroup Analysis from the Phase 3 Study Aspire (NCT01080391)","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Lenalidomide; Carfilzomib; Dexamethasone; Multiple myeloma; Medicine; Oncology; Pomalidomide; Internal medicine; Subgroup analysis; Thalidomide; Confidence interval","score_opus":0.02159025863719672,"score_gpt":0.2805427240642102,"score_spread":0.2589524654270135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2471073614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951429,0.0012458665,0.00009081961,0.00007065056,0.000015722417,0.002878446,0.00049423054,0.000028282255,0.00003310428],"genre_scores_gemma":[0.99691784,0.00015923996,0.0023917076,0.00006074119,0.00003259824,0.000102794365,0.00026884247,0.000052024236,0.000014204363],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959929,0.000945265,0.00064893527,0.00086223107,0.00094185234,0.000608821],"domain_scores_gemma":[0.9956107,0.0023134204,0.00032423917,0.0008226623,0.00026537682,0.00066357973],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010657308,0.00046080965,0.0011453702,0.00044998972,0.00016681723,0.00006153749,0.00013916485,0.00013057776,0.000024770563],"category_scores_gemma":[0.001976355,0.00029225452,0.000094486204,0.0009497299,0.0003367205,0.00011161824,0.00013879673,0.00040948,0.0000021514431],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04806212,0.0075819697,0.93190736,0.0000381584,0.0027165718,0.0001415255,0.0014727064,0.00008935316,0.00021813455,9.682736e-7,0.0000064274964,0.007764707],"study_design_scores_gemma":[0.22427954,0.0070189694,0.76171726,0.00011255283,0.003395265,0.0000022553302,0.00086832297,0.0014912239,0.000878014,0.000005815317,0.000015336414,0.00021543422],"about_ca_topic_score_codex":0.0061396826,"about_ca_topic_score_gemma":0.001990399,"teacher_disagreement_score":0.1762174,"about_ca_system_score_codex":0.000088969944,"about_ca_system_score_gemma":0.00017382132,"threshold_uncertainty_score":0.999953},"labels":[],"label_agreement":null},{"id":"W2471268158","doi":"10.1182/blood.v126.23.3322.3322","title":"High Risk Apml Treated Successfully with Four Cycles of ATO and ATRA Combination in Resource Constrained Settings","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Surgery; Cohort; Retrospective cohort study; Internal medicine; Gastroenterology","score_opus":0.005866185771474407,"score_gpt":0.20112342086186424,"score_spread":0.19525723509038984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2471268158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983847,0.00047458307,0.00009993913,0.000062006104,0.0000078463345,0.000114498136,0.00001435203,0.000009504165,0.00083253515],"genre_scores_gemma":[0.9989545,0.000069699076,0.0007438682,0.00002696296,0.000027535258,0.000008390361,0.00007264277,0.000012831646,0.00008360856],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999334,0.00006375738,0.0001598869,0.00021269856,0.00010513756,0.00012456876],"domain_scores_gemma":[0.99957633,0.000014967112,0.00012413773,0.0001394042,0.00008968799,0.000055475848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019518386,0.00010595251,0.0001372312,0.000036579073,0.00002485068,0.000013581527,0.00008614101,0.00010823463,0.0000016036709],"category_scores_gemma":[0.000093568684,0.000089527864,0.00001815322,0.000093644485,0.00013050399,0.000004125107,0.00003420899,0.00006644549,4.2851659e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040652277,0.00041859792,0.7642171,0.00015937623,0.0001398886,0.000040346386,0.0003164329,0.000092458584,0.2314066,0.00024318419,0.0002512396,0.0023082742],"study_design_scores_gemma":[0.00715944,0.00092695,0.020585924,0.00006215857,0.00010000912,0.00007560417,0.00040205946,0.00004015527,0.96936417,0.00029135888,0.0007760603,0.00021614354],"about_ca_topic_score_codex":0.00010629216,"about_ca_topic_score_gemma":0.000034939985,"teacher_disagreement_score":0.7436312,"about_ca_system_score_codex":0.000005231078,"about_ca_system_score_gemma":0.00007257864,"threshold_uncertainty_score":0.36508402},"labels":[],"label_agreement":null},{"id":"W2471444531","doi":"10.1182/blood.v116.21.1071.1071","title":"Severe Toxicities During Pediatric Acute Myeloid Leukemia Chemotherapy: A Report From the Children's Oncology Group.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Hospital for Sick Children","funders":"","keywords":"Medicine; Cytarabine; Internal medicine; Neutropenia; Gemtuzumab ozogamicin; Mitoxantrone; Etoposide; Common Terminology Criteria for Adverse Events; Chemotherapy; Regimen; Chemotherapy regimen; Febrile neutropenia; Adverse effect; Oncology; Gastroenterology; Surgery","score_opus":0.007731818240814547,"score_gpt":0.25890430097996237,"score_spread":0.25117248273914783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2471444531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99096084,0.00033641828,0.000010550293,0.0031403922,0.00029898618,0.00076721987,0.00006291742,0.00022390908,0.0041987756],"genre_scores_gemma":[0.9877841,0.00075017713,0.0022754795,0.001286543,0.004697036,0.00009804573,0.00019223613,0.00010054372,0.0028158748],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99755406,0.00008330634,0.00047969216,0.000619582,0.00059622584,0.0006671206],"domain_scores_gemma":[0.9979257,0.00031002422,0.00021267627,0.0011594697,0.0001253185,0.00026679342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004584422,0.0003214776,0.0005167797,0.00013237944,0.00028548605,0.000057461315,0.00050284114,0.00041852886,0.0006685048],"category_scores_gemma":[0.0002930712,0.00022513553,0.00021143035,0.0003874757,0.00021751226,0.0001283318,0.0002499335,0.0017267955,0.000145665],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000838963,0.0008963441,0.7459629,0.00007088951,0.0020146514,0.0057312152,0.0019985586,0.0000018378763,0.22065572,0.00010322938,0.01709845,0.0046271915],"study_design_scores_gemma":[0.01202623,0.0003523284,0.93852806,0.000023032375,0.0009924694,0.013336365,0.00021503527,0.000019113382,0.026560785,0.00018294023,0.007342585,0.00042107736],"about_ca_topic_score_codex":0.00073566445,"about_ca_topic_score_gemma":0.00016172274,"teacher_disagreement_score":0.19409494,"about_ca_system_score_codex":0.00031112146,"about_ca_system_score_gemma":0.0011190976,"threshold_uncertainty_score":0.91807604},"labels":[],"label_agreement":null},{"id":"W2471484989","doi":"10.1182/blood.v124.21.sci-23.sci-23","title":"miRNAs, Immune Signaling, and Myelodysplastic Syndromes Pathogenesis","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; Myeloid; Cancer research; Immunology; Innate immune system; Bone marrow; Haematopoiesis; Myeloid leukemia; Myelodysplastic syndromes; Progenitor cell; RUNX1; Stem cell; Immune system; Cell biology","score_opus":0.006568584418650612,"score_gpt":0.2259556582112611,"score_spread":0.2193870737926105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2471484989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838435,0.003685651,0.0115542635,0.000059044203,0.00009412869,0.00016101867,0.000012082728,0.000022152666,0.00056814356],"genre_scores_gemma":[0.9978838,0.00033354177,0.0009943494,0.00007468212,0.000138202,0.000029276596,0.000043721742,0.000037389833,0.00046504443],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989438,0.00008488485,0.00015599273,0.0003629765,0.00016749026,0.000284877],"domain_scores_gemma":[0.9994283,0.000018526158,0.000046205252,0.00033206958,0.00006010304,0.000114829905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021429137,0.00014800236,0.0001463083,0.000055593006,0.00008746937,0.000034064917,0.00015720399,0.00015930936,0.000036506113],"category_scores_gemma":[0.00015562444,0.0001482732,0.00006704348,0.00008258463,0.00006010942,0.000002012554,0.00015268555,0.00009236021,0.000020861855],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002235757,0.00006838274,0.00009332594,0.000027088328,0.000086057815,0.000010767411,0.00001060754,0.000019074481,0.9972208,0.000110821864,0.000058743164,0.0022719516],"study_design_scores_gemma":[0.0013229296,0.0004649385,0.0012761068,0.000026183425,0.000075511154,0.00015080572,0.000013850148,0.0000936973,0.9874754,0.00010503012,0.008773967,0.00022160752],"about_ca_topic_score_codex":0.000013896962,"about_ca_topic_score_gemma":0.0000066946845,"teacher_disagreement_score":0.014040277,"about_ca_system_score_codex":0.0000051624547,"about_ca_system_score_gemma":0.000046772366,"threshold_uncertainty_score":0.60464054},"labels":[],"label_agreement":null},{"id":"W2471503382","doi":"10.1182/blood.v126.23.469.469","title":"Ibrutinib Vs Temsirolimus: Results from a Phase 3, International, Randomized, Open-Label, Multicenter Study in Patients with Previously Treated Mantle Cell Lymphoma (MCL)","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Ibrutinib; Temsirolimus; Mantle cell lymphoma; Medicine; Internal medicine; Clinical endpoint; Phases of clinical research; International Prognostic Index; Oncology; Lymphoma; Febrile neutropenia; Neutropenia; Randomized controlled trial; Gastroenterology; Surgery; Rituximab; Clinical trial; Chemotherapy; Leukemia; Chronic lymphocytic leukemia","score_opus":0.03903562922247449,"score_gpt":0.3292918694018239,"score_spread":0.2902562401793494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2471503382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893251,0.00017055504,0.0000033057452,0.00011036461,0.00013320846,0.006343853,0.00018886814,0.00006503962,0.0036596963],"genre_scores_gemma":[0.99702084,0.000029723811,0.0004369992,0.00015016003,0.00009811506,0.00031097225,0.00070709,0.000067248846,0.0011788751],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.996393,0.00039808394,0.0008611373,0.00077417237,0.0010526124,0.00052094663],"domain_scores_gemma":[0.99772835,0.00042455262,0.00026595432,0.0008396898,0.0004027727,0.00033870162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010555473,0.00033604656,0.00095281366,0.00023901672,0.00004536873,0.00013950895,0.00061930926,0.0001179844,0.000069751004],"category_scores_gemma":[0.00090125174,0.00023818457,0.000056363497,0.00032751873,0.00012455316,0.00025588894,0.00042393504,0.00017972065,0.0001633653],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8098717,0.12518649,0.05283891,0.000043037337,0.0010143135,0.0010892968,0.007142588,0.0000048830625,0.00004985737,0.000001258288,0.0013746475,0.0013830347],"study_design_scores_gemma":[0.987699,0.0028147462,0.0035121765,0.0002878275,0.0005094786,0.000010071103,0.000610302,0.0026530027,0.0009807743,0.0000051009492,0.0006616292,0.00025589913],"about_ca_topic_score_codex":0.009570891,"about_ca_topic_score_gemma":0.00031752972,"teacher_disagreement_score":0.17782731,"about_ca_system_score_codex":0.0026814262,"about_ca_system_score_gemma":0.0021091644,"threshold_uncertainty_score":0.9970245},"labels":[],"label_agreement":null},{"id":"W2471675214","doi":"10.1182/blood.v124.21.422.422","title":"Pre-Transplant C-Reactive Protein (CRP), Ferritin and Albumin As Biomarkers to Predict Transplant Related Mortality (TRM) after Allogeneic Hematopoietic Cell Transplant (HCT)","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Ferritin; Medicine; Biomarker; Hematopoietic stem cell transplantation; Internal medicine; Transplantation; Albumin; Gastroenterology; C-reactive protein; Population; Cohort; Immunology; Oncology; Biology","score_opus":0.004987768515157853,"score_gpt":0.21471710495802424,"score_spread":0.20972933644286637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2471675214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991169,0.0012813453,0.0002627849,0.0010098128,0.000110627516,0.0024774824,0.00024856368,0.00022244247,0.0032179584],"genre_scores_gemma":[0.9978697,0.00035422554,0.00022792791,0.00047983724,0.000053720596,0.00031456014,0.0001786438,0.00009112009,0.0004302947],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996731,0.00021372703,0.0007701876,0.000917849,0.000559912,0.0008073693],"domain_scores_gemma":[0.9984785,0.00007857279,0.00012091351,0.0005073923,0.00006556031,0.00074910885],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00049799227,0.0005788947,0.00075262546,0.00021085085,0.00015001898,0.000039392147,0.00017368147,0.0005705374,0.00015334175],"category_scores_gemma":[0.000027968546,0.00047229766,0.0002546511,0.00031990558,0.00020948552,0.000099468816,0.000025621019,0.0005361087,0.000076223376],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006606235,0.006631314,0.38563865,0.0047578234,0.003519754,0.004069915,0.021019027,0.000030170284,0.5657455,0.00020787884,0.00025776817,0.0015159704],"study_design_scores_gemma":[0.036340762,0.006000574,0.4546231,0.0080871,0.009791564,0.0047764312,0.001166975,0.0005171202,0.47223154,0.0005807138,0.0030308103,0.0028533277],"about_ca_topic_score_codex":0.0007032954,"about_ca_topic_score_gemma":0.00017871446,"teacher_disagreement_score":0.09351397,"about_ca_system_score_codex":0.00003966248,"about_ca_system_score_gemma":0.00014872829,"threshold_uncertainty_score":0.99977285},"labels":[],"label_agreement":null},{"id":"W2471799713","doi":"10.1182/blood-2015-12-682591","title":"Pediatric-type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathway mutations","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":157,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"National Cancer Institute; Broad Institute","keywords":"Follicular lymphoma; Lymphoma; MAPK/ERK pathway; Cancer research; BCL10; Biology; Medicine; Immunology; Genetics; Signal transduction","score_opus":0.012658559891151494,"score_gpt":0.2261881892800804,"score_spread":0.2135296293889289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2471799713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99551225,0.0008965158,0.000110689485,0.00074667693,0.000114509436,0.00052012224,0.00007935026,0.00017520283,0.0018446727],"genre_scores_gemma":[0.9970057,0.00017066725,0.0016309097,0.00022712421,0.00031564196,0.0001814523,0.00008426766,0.000034336364,0.0003498971],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837625,0.000050041624,0.0003110876,0.000503076,0.00033616243,0.00042337403],"domain_scores_gemma":[0.99877787,0.00017669401,0.00012632222,0.0004515711,0.00017774574,0.00028981676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000091486676,0.00030129438,0.00038725935,0.000092789836,0.00013613595,0.00002881721,0.00011534141,0.00013267672,0.0001748792],"category_scores_gemma":[0.00013223478,0.00014716784,0.00016072718,0.00029122925,0.000092954375,0.000069133326,0.00005107884,0.000023391209,0.00036294197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023984436,0.007734852,0.96681285,0.000042648255,0.00050288514,0.0026520712,0.00008145884,3.5264668e-7,0.003131829,0.0012664068,0.00030317053,0.017231641],"study_design_scores_gemma":[0.028142955,0.0026062494,0.946234,0.00010908971,0.0011379702,0.0007944744,0.000029845485,0.000002056109,0.015677735,0.00023500019,0.0046802647,0.00035037345],"about_ca_topic_score_codex":0.0000663297,"about_ca_topic_score_gemma":0.00002415041,"teacher_disagreement_score":0.027903112,"about_ca_system_score_codex":0.0001790779,"about_ca_system_score_gemma":0.0003920533,"threshold_uncertainty_score":0.600133},"labels":[],"label_agreement":null},{"id":"W2471974048","doi":"10.1182/blood.v122.21.4811.4811","title":"Effect Of Antiplatelet Therapy On The Progression Of Osteonecrosis Of The Femoral Head: A Retrospective Analysis","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Bone and Joint Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Avascular necrosis; Retrospective cohort study; Context (archaeology); Surgery; Femoral head; Internal medicine","score_opus":0.010020353649208488,"score_gpt":0.2810822035481405,"score_spread":0.271061849898932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2471974048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99801505,0.00025656144,8.2495427e-7,0.0004503244,0.000017769287,0.00073942903,0.000018581655,0.00000887283,0.00049259345],"genre_scores_gemma":[0.99977136,0.00004338095,0.000025353329,0.000066585686,0.000011652103,0.000030667903,0.000003910847,0.000008393945,0.000038679125],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990902,0.00015580899,0.00022041635,0.00012406397,0.0003049862,0.00010455437],"domain_scores_gemma":[0.9990459,0.00015693286,0.00021431815,0.00043468885,0.00011557472,0.000032588992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022206076,0.00010007671,0.00044898022,0.000072167786,0.000034878856,0.000004095575,0.00008987561,0.00004736213,0.00015072156],"category_scores_gemma":[0.00011666862,0.000040661223,0.00036375737,0.00055115693,0.00014171915,0.000023801324,0.000027906057,0.000089869834,0.0000030904403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004470385,0.00084944174,0.9195427,0.000085629654,0.0010101367,0.0000019721776,0.00022935048,0.0000010230979,0.07437088,0.000040679464,0.00019067721,0.0032304958],"study_design_scores_gemma":[0.0015640926,0.0017055586,0.55614793,0.00014230111,0.0007297836,0.0000014232269,0.00002296418,0.000014301735,0.4396214,0.000019938961,0.000004601115,0.000025675998],"about_ca_topic_score_codex":0.000267366,"about_ca_topic_score_gemma":0.000008748939,"teacher_disagreement_score":0.36525053,"about_ca_system_score_codex":0.000004555652,"about_ca_system_score_gemma":0.000024262356,"threshold_uncertainty_score":0.16581166},"labels":[],"label_agreement":null},{"id":"W2471984836","doi":"10.1182/blood.v122.21.880.880","title":"SNS01-T Exhibits Significant Anti-Tumoral Activity In Models Of Multiple Myeloma and Non-Hodgkins B Cell Lymphoma and Induces Cell Death In Malignant But Not Normal B Cells","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Polyamine Metabolism and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Lymphoma; Cancer research; Mantle cell lymphoma; Transfection; Multiple myeloma; Apoptosis; Diffuse large B-cell lymphoma; B cell; Cell culture; Medicine; Biology; Molecular biology; Immunology; Antibody","score_opus":0.010790090089402198,"score_gpt":0.20772905732266492,"score_spread":0.1969389672332627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2471984836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99872357,0.00028698708,0.00012346791,0.00002076921,0.000019771769,0.0003824674,0.000110444234,0.000004574245,0.00032796315],"genre_scores_gemma":[0.99863565,0.0003493398,0.00076242595,0.000037409198,0.000033879314,0.000067685396,0.000023824261,0.000015283902,0.0000745319],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989453,0.000045651635,0.00024763588,0.00038541845,0.00008887567,0.00028710192],"domain_scores_gemma":[0.9994859,0.000022024904,0.000112256166,0.0002499522,0.000033160122,0.00009669119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000111699046,0.0001831352,0.0002545528,0.000082000995,0.000035101166,0.000022077033,0.0001329667,0.00013351819,0.000002279432],"category_scores_gemma":[0.0000068442855,0.0001723185,0.000034623128,0.00009492003,0.00007208259,0.000020265084,0.00016003962,0.00006568069,0.0000025180138],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017885613,0.0007392469,0.022213561,0.000039407332,0.0000054943393,0.000003952807,0.00008228985,0.000036629168,0.976162,0.000009332066,0.000008783189,0.0006813941],"study_design_scores_gemma":[0.002137948,0.00006249738,0.21131389,0.000009719597,0.000014556393,0.0000031788538,0.000047129837,0.00077427237,0.7854336,0.000021992653,0.00001910011,0.00016210398],"about_ca_topic_score_codex":0.0010619089,"about_ca_topic_score_gemma":0.000102436104,"teacher_disagreement_score":0.19072841,"about_ca_system_score_codex":0.0000037346522,"about_ca_system_score_gemma":0.000057858007,"threshold_uncertainty_score":0.7026944},"labels":[],"label_agreement":null},{"id":"W2472197357","doi":"10.1182/blood-2016-06-716902","title":"A pharmacogenetic analysis of the Canadian Cancer Trials Group MY.10 clinical trial of maintenance therapy for multiple myeloma","year":2016,"lang":"en","type":"letter","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Juravinski Hospital; Queen's University; London Health Sciences Centre; Princess Margaret Cancer Centre; Queen Elizabeth II Health Sciences Centre; University of New Brunswick; Dalhousie University; Saint John Regional Hospital; Vancouver General Hospital; University of Calgary","funders":"","keywords":"Medicine; Maintenance therapy; Melphalan; Multiple myeloma; Oncology; Internal medicine; Clinical trial; Randomized controlled trial; Chemotherapy; Cancer; Lenalidomide; Intensive care medicine","score_opus":0.14671447241158198,"score_gpt":0.42923783083892075,"score_spread":0.2825233584273388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2472197357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6175518,0.0054546525,0.00005694439,0.3295023,0.0023735003,0.02280285,0.021594383,0.000045839894,0.00061770505],"genre_scores_gemma":[0.8324011,0.0065735565,0.0010066385,0.123756394,0.016953832,0.0050705653,0.001788035,0.00028042487,0.012169465],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99550104,0.0008599497,0.0015517661,0.0005957641,0.0007568619,0.0007346214],"domain_scores_gemma":[0.99476755,0.002473704,0.001043184,0.00094590697,0.00047547178,0.00029417453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00189068,0.00036960994,0.0024194838,0.0005230741,0.0001009952,0.000015017311,0.00048722388,0.0006587326,0.00080028083],"category_scores_gemma":[0.0022737337,0.00018952056,0.0024971021,0.0005289355,0.00030956924,0.00002089813,0.000045503315,0.0005304886,0.0000059081517],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10121269,0.0023324036,0.08825414,0.00052969716,0.09960628,0.00026555074,0.00010290936,0.0000015377226,0.003424322,0.000003919423,0.5688068,0.13545975],"study_design_scores_gemma":[0.37142152,0.0022180018,0.026712073,0.00038220693,0.018255627,0.000004207306,0.0000043630757,0.00010622217,0.0056225406,0.00002195722,0.5749523,0.00029897573],"about_ca_topic_score_codex":0.025893893,"about_ca_topic_score_gemma":0.0672063,"teacher_disagreement_score":0.27020884,"about_ca_system_score_codex":0.00014771028,"about_ca_system_score_gemma":0.0019990737,"threshold_uncertainty_score":0.9805928},"labels":[],"label_agreement":null},{"id":"W2472478074","doi":"10.1182/blood.v110.11.2730.2730","title":"Pegylated Liposomal Doxorubicin (PLD) in Combination with Bortezomib (B) May Provide Therapeutic Advantage for High-Risk Multiple Myeloma Patients Relapsing within 12 Months of Stem Cell Transplant.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Multiple myeloma; Internal medicine; Bortezomib; Transplantation; Lenalidomide; Surgery; Melphalan; Gastroenterology","score_opus":0.01174926590662012,"score_gpt":0.24795790738812115,"score_spread":0.23620864148150103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2472478074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99510896,0.00026011313,0.0007821296,0.000035087585,0.00006940756,0.0032996447,0.00015810887,0.000061978004,0.00022454628],"genre_scores_gemma":[0.99645096,0.000046796802,0.002722697,0.000022632481,0.000024877925,0.00009554333,0.00036118226,0.00006715702,0.00020813731],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977102,0.0001013801,0.00063668314,0.00042916444,0.0005529608,0.00056957296],"domain_scores_gemma":[0.99860525,0.00035518163,0.0003187869,0.00032282865,0.00019720197,0.00020076278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042183223,0.00029424543,0.0004938909,0.0003227535,0.00010107013,0.000015652959,0.000115510295,0.00016294161,0.000007895079],"category_scores_gemma":[0.000032831213,0.00022427262,0.00008811465,0.00027896176,0.0000757714,0.00016779001,0.000017030196,0.00028258143,0.0000037127336],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009432041,0.005403934,0.94339937,0.00039279403,0.00031066572,0.00018737424,0.001771952,0.00001876092,0.022319356,0.000032676187,0.0000030071924,0.016728071],"study_design_scores_gemma":[0.06773437,0.0048827906,0.62483793,0.00043833963,0.00045125635,0.000016319793,0.00048804612,0.0010297173,0.29985383,0.000030616382,0.000016542717,0.00022026271],"about_ca_topic_score_codex":0.0006436332,"about_ca_topic_score_gemma":0.0013636996,"teacher_disagreement_score":0.31856143,"about_ca_system_score_codex":0.000099351935,"about_ca_system_score_gemma":0.00012260061,"threshold_uncertainty_score":0.9145572},"labels":[],"label_agreement":null},{"id":"W2472584734","doi":"10.1182/blood.v124.21.2843.2843","title":"The Rate of Pregnancy Loss in Von Willebrand Disease: A Cross-Sectional Study","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Von Willebrand disease; Pregnancy; Obstetrics; Von Willebrand factor; Population; Cross-sectional study; Hemostasis; Pediatrics; Gynecology; Internal medicine; Platelet; Pathology","score_opus":0.010594433208692989,"score_gpt":0.27579689018773557,"score_spread":0.2652024569790426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2472584734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979333,0.0009220776,0.0000023335674,0.00006547059,0.000048483995,0.0003841487,0.000007542644,0.000009640439,0.0006270035],"genre_scores_gemma":[0.99934983,0.00005652185,0.000005516498,0.000017466045,0.000020666199,0.000039134888,0.000007972228,0.0000072190774,0.00049568276],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994432,0.000040211762,0.0001585236,0.0001294309,0.00011362457,0.000115017974],"domain_scores_gemma":[0.9996425,0.00006624312,0.00004195706,0.00017016131,0.000030095287,0.000049046565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012520624,0.00006798803,0.00013472777,0.000026496571,0.00005940705,0.000011912369,0.000044832923,0.000021095759,0.000014663519],"category_scores_gemma":[0.00007767915,0.000041679566,0.00004048538,0.00007857254,0.000046137986,0.00002873961,0.000016176957,0.000052487918,0.000008641726],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002112771,0.0023466821,0.9966004,0.000022477141,0.000095492054,0.00012569301,0.00007119059,0.0000028236489,0.000039203696,0.000065300934,0.000007147216,0.00041234714],"study_design_scores_gemma":[0.010062035,0.00028731587,0.98870194,0.00006064526,0.00006910562,0.000009213561,0.000013786751,0.000020084222,0.000132744,0.0004988344,0.00010662873,0.00003768611],"about_ca_topic_score_codex":0.000034654968,"about_ca_topic_score_gemma":0.00006231942,"teacher_disagreement_score":0.009850757,"about_ca_system_score_codex":0.000006181996,"about_ca_system_score_gemma":0.000029665158,"threshold_uncertainty_score":0.16996434},"labels":[],"label_agreement":null},{"id":"W2472642740","doi":"10.1182/blood.v126.23.68.68","title":"Ischemic Stroke in Children and Young Adults with Sickle Cell Disease (SCD) in the Post-STOP Era","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Transcranial Doppler; Stroke (engine); Pediatrics; Anemia; Sickle cell anemia; Incidence (geometry); Cohort; Observational study; Disease; Internal medicine","score_opus":0.003260330195348271,"score_gpt":0.18878046069187518,"score_spread":0.1855201304965269,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2472642740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99078035,0.0031409517,5.261221e-7,0.0009413652,0.000022690703,0.00044472207,0.00001767907,0.000017252074,0.004634457],"genre_scores_gemma":[0.99905014,0.00015331432,0.000057006073,0.0003853164,0.000044355602,0.00001372903,0.000042323663,0.000013415753,0.00024040884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99929327,0.000029104009,0.00012357433,0.00018200968,0.00017488777,0.00019717612],"domain_scores_gemma":[0.99958575,0.000011957105,0.000028666007,0.00019208509,0.00002989988,0.0001516541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011321755,0.000110553505,0.00013521584,0.000060548446,0.000021319056,0.000012369468,0.00006814885,0.00006340374,0.0000068401237],"category_scores_gemma":[0.000035508543,0.000064869404,0.000021557104,0.00013540023,0.0000530565,0.0000469952,0.000023109234,0.00027260467,0.000009444296],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050579186,0.0009406164,0.992498,0.00003997556,0.00002412079,0.0001750049,0.0041928105,0.000005612512,0.00041215812,0.000008019736,0.00061950204,0.0005783927],"study_design_scores_gemma":[0.024418747,0.00062368583,0.967264,0.00022587151,0.00023857546,0.00022811917,0.0057627135,0.00006574914,0.00061443826,0.000009549081,0.00033717635,0.00021139043],"about_ca_topic_score_codex":0.00053467124,"about_ca_topic_score_gemma":0.000110735346,"teacher_disagreement_score":0.02523401,"about_ca_system_score_codex":0.000010400565,"about_ca_system_score_gemma":0.00011388527,"threshold_uncertainty_score":0.26452976},"labels":[],"label_agreement":null},{"id":"W2472813907","doi":"10.1182/blood.v124.21.495.495","title":"The Impact of Concurrent MYC BCL2 Protein Expression on the Risk of Secondary Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma (DLBCL)","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"","keywords":"BCL6; Diffuse large B-cell lymphoma; Tissue microarray; Immunohistochemistry; Lymphoma; Medicine; Oncology; Internal medicine; Gene expression profiling; Pathology; Biology; Cancer research; B cell; Antibody; Gene expression; Immunology; Gene; Germinal center","score_opus":0.00603476281861366,"score_gpt":0.22362022161915657,"score_spread":0.21758545880054292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2472813907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99582696,0.0012469803,0.0000034987584,0.00007413347,0.000089090034,0.0011013377,0.00011010115,0.000021998756,0.0015258814],"genre_scores_gemma":[0.99954873,0.00012375569,0.000013894574,0.00001563631,0.00006474367,0.00013600578,0.0000144231635,0.000021761505,0.000061036066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983184,0.0003452242,0.000442245,0.00022620225,0.0003077132,0.00036023566],"domain_scores_gemma":[0.9984702,0.0003877692,0.00035591316,0.000613586,0.00005265524,0.00011990806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004287653,0.0002123449,0.00040660377,0.000050889557,0.000104458915,0.000014126759,0.00015984732,0.000090944486,0.000014917775],"category_scores_gemma":[0.00014147586,0.00009278009,0.00027883268,0.00011240819,0.00006572143,0.000029024084,0.00006304795,0.00012087154,0.000011923763],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019345774,0.16470377,0.7385894,0.0014229331,0.0013093693,0.00023119953,0.0041842065,0.00002930013,0.036756832,0.0056446334,0.003158018,0.042035732],"study_design_scores_gemma":[0.07232466,0.0022065903,0.65288824,0.0016384968,0.00034950057,0.000029009576,0.0005587277,0.00043933888,0.2689148,0.000036725414,0.00044943162,0.00016451602],"about_ca_topic_score_codex":0.00046038447,"about_ca_topic_score_gemma":0.000024496558,"teacher_disagreement_score":0.23215795,"about_ca_system_score_codex":0.00015500018,"about_ca_system_score_gemma":0.00015568353,"threshold_uncertainty_score":0.3783462},"labels":[],"label_agreement":null},{"id":"W2473377956","doi":"10.1182/blood.v124.21.6000.6000","title":"Pediatric Oncology Clinic Care Model: How to Care for Patients to Achieve Better Continuity of Care in a Medium Sized Program","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Medicine; Internal medicine; Outpatient clinic; Ambulatory care; Oncology; Family medicine; Emergency medicine; Health care","score_opus":0.01712852751669468,"score_gpt":0.33577579031109706,"score_spread":0.31864726279440236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2473377956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98934156,0.00041991714,0.00010620314,0.0039186655,0.00036791342,0.005061472,0.00027113964,0.00009403262,0.00041909495],"genre_scores_gemma":[0.9831489,0.000010178889,0.012687527,0.002284062,0.00073477544,0.00081240083,0.00023500665,0.000059312802,0.000027874268],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99755746,0.00019851472,0.00065574766,0.00059143425,0.00049693114,0.0004999099],"domain_scores_gemma":[0.9976323,0.00033876498,0.00023736639,0.0005676733,0.00085684995,0.0003670356],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035609974,0.0002711528,0.001053801,0.00023913718,0.000052009185,0.000014177838,0.0002660892,0.00027732807,0.00000729132],"category_scores_gemma":[0.0011765591,0.0002621316,0.00023950497,0.00033039704,0.00003948763,0.000047570225,0.00015807024,0.00026564675,0.000009780817],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031818068,0.0029805785,0.76188034,0.0050093397,0.00015451471,0.000007386935,0.15153998,0.00002444189,0.00008327475,0.000008976563,0.002329979,0.07279941],"study_design_scores_gemma":[0.10711804,0.08605358,0.7137103,0.0010726674,0.003368944,0.0000052083487,0.04109789,0.00008577688,0.003379253,0.00011945837,0.042217232,0.001771634],"about_ca_topic_score_codex":0.00016441123,"about_ca_topic_score_gemma":0.0072202664,"teacher_disagreement_score":0.110442095,"about_ca_system_score_codex":0.00017948473,"about_ca_system_score_gemma":0.0005695466,"threshold_uncertainty_score":0.9999831},"labels":[],"label_agreement":null},{"id":"W2473454213","doi":"10.1182/blood.v122.21.1854.1854","title":"High Risk Multiple Myeloma Cases Are Identified In An MMRC Led Study By The SKY92 Gene Signature (MMprofiler)","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Hazard ratio; Medicine; Multiple myeloma; Internal medicine; Cohort; Oncology; Gene signature; Gastroenterology; Confidence interval; Gene expression; Gene; Biology; Genetics","score_opus":0.020987598677551653,"score_gpt":0.2844865496153304,"score_spread":0.2634989509377787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2473454213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99511874,0.0009034086,0.000002813121,0.00024445838,0.00009213444,0.003320203,0.00017521143,0.000086110274,0.00005693746],"genre_scores_gemma":[0.99751884,0.00005372681,0.00023940284,0.00009287009,0.00017276286,0.0007777208,0.00021365659,0.000047287063,0.0008837412],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99759555,0.0003662927,0.00034489165,0.0005423536,0.0005925647,0.00055831915],"domain_scores_gemma":[0.99823225,0.00031906,0.00013962005,0.00081592286,0.00018154272,0.00031161855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025835496,0.00029146398,0.00042131668,0.00013588522,0.00022519723,0.000110695226,0.00027535428,0.00014233994,0.00044074157],"category_scores_gemma":[0.000514608,0.0001813165,0.000092594644,0.00032075564,0.0000767519,0.00019862667,0.00010929419,0.00051305315,0.0002568227],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027544828,0.0070725596,0.9514906,0.000029293878,0.00043264494,0.0013181345,0.0005271143,0.000003403079,0.032298632,0.0000014287896,0.0015522254,0.004998543],"study_design_scores_gemma":[0.017904405,0.0010966524,0.94648415,0.00003877751,0.00022585195,0.00006440251,0.0015750409,0.00020374233,0.032152586,0.000024066387,0.00005059398,0.0001797373],"about_ca_topic_score_codex":0.0093947,"about_ca_topic_score_gemma":0.003825637,"teacher_disagreement_score":0.017628957,"about_ca_system_score_codex":0.000054491236,"about_ca_system_score_gemma":0.00005944477,"threshold_uncertainty_score":0.9972018},"labels":[],"label_agreement":null},{"id":"W2473516675","doi":"10.1182/blood-2016-01-692178","title":"Antibody-mediated immune suppression is improved when blends of anti-RBC monoclonal antibodies are used in mice","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Canadian Blood Services; St. Michael's Hospital","funders":"Canadian Institutes of Health Research; Health Canada; Government of Canada; Canadian Blood Services; Australian Government","keywords":"Monoclonal antibody; Polyclonal antibodies; Epitope; Antibody; Immunization; Immunology; Monoclonal; Isoantibodies; Immune system; Virology; Biology","score_opus":0.020571629051946233,"score_gpt":0.29763199986633254,"score_spread":0.2770603708143863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2473516675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99204797,0.0019204295,0.000023260367,0.0039606825,0.00014635411,0.0004452653,0.00036793845,0.00005637444,0.0010317303],"genre_scores_gemma":[0.99456483,0.0015591796,0.00062847167,0.00015304374,0.00017316714,0.000017135173,0.00016550104,0.000047273435,0.0026913977],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972282,0.00011328077,0.00076616346,0.0005393701,0.0006490944,0.0007038586],"domain_scores_gemma":[0.9983971,0.00036289415,0.00027167788,0.0004677575,0.00026497038,0.00023561313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003562619,0.00034761833,0.0009029675,0.00040144654,0.00008069132,0.000017129418,0.00032230833,0.00023973954,0.0008554235],"category_scores_gemma":[0.00024928414,0.00021941573,0.0002593868,0.0003315393,0.0003043842,0.00018716065,0.0002529175,0.0003208898,0.0000936585],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043404827,0.0006618214,0.35259396,0.00023816057,0.00014500206,0.000117576354,0.00034208206,8.0263604e-8,0.64445597,0.00001948173,0.00026199725,0.00072982436],"study_design_scores_gemma":[0.0060274955,0.00034354333,0.38718787,0.0009610279,0.0000819941,0.00006017942,0.00013439455,0.0000739176,0.60332096,0.00009542174,0.0014735982,0.00023960539],"about_ca_topic_score_codex":0.00057532947,"about_ca_topic_score_gemma":0.000040853007,"teacher_disagreement_score":0.041135,"about_ca_system_score_codex":0.00003101632,"about_ca_system_score_gemma":0.00021624226,"threshold_uncertainty_score":0.93662876},"labels":[],"label_agreement":null},{"id":"W2473614468","doi":"10.1182/blood.v126.23.1982.1982","title":"Myeloma Canada Research Network (MCRN)-001 Trial Utilizing Bortezomib (btz)-Based Induction, Enhanced Conditioning with IV Busulfan + Melphalan (BuMel) and Lenalidomide (len) Maintenance in Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplant (ASCT): A National Canadian Study Evaluating Achievement of Minimal Residual Disease (MRD) Negativity and Involved Serum HevyliteTMÂ chain (HLC) Normalization","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Hôpital Maisonneuve-Rosemont; University of British Columbia; McGill University; Saint John Regional Hospital; Saskatchewan Cancer Agency; University of Alberta; Queen Elizabeth II Health Sciences Centre; Ottawa Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Melphalan; Lenalidomide; Busulfan; Multiple myeloma; Maintenance therapy; Internal medicine; Urology; Thalidomide; Surgery; Oncology; Transplantation; Hematopoietic stem cell transplantation; Chemotherapy","score_opus":0.06906379413577311,"score_gpt":0.3158552214971248,"score_spread":0.24679142736135168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2473614468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933749,0.00016581196,0.0000614475,0.0002583566,0.00007140847,0.0053171497,0.0006893607,0.000021692207,0.000039868082],"genre_scores_gemma":[0.99724716,0.000009338276,0.0007260832,0.00005406679,0.0001131834,0.00077190576,0.0009961327,0.000041450523,0.000040672192],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954768,0.000744484,0.00071055174,0.0006791991,0.0014332904,0.0009556991],"domain_scores_gemma":[0.9968376,0.0005913296,0.0002660724,0.00024506034,0.0012233062,0.000836592],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024814762,0.00031893645,0.0005549655,0.000424315,0.00048774996,0.00006144463,0.000116958974,0.00010151083,0.0000051627526],"category_scores_gemma":[0.000646862,0.0002835426,0.000037189715,0.0005520689,0.00014480963,0.00021162159,0.000047775884,0.00029908167,2.8599962e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05126662,0.0026458346,0.9393993,0.00042602114,0.00032718875,0.00017946496,0.0017843203,0.0011489968,0.00056863524,0.00003281385,0.00010885285,0.002111965],"study_design_scores_gemma":[0.19449542,0.0054274695,0.7777106,0.0005484863,0.00022270312,0.0000057083353,0.0026968913,0.01464155,0.0038763566,0.00003994195,0.00001990425,0.00031497303],"about_ca_topic_score_codex":0.32044342,"about_ca_topic_score_gemma":0.88685304,"teacher_disagreement_score":0.5664096,"about_ca_system_score_codex":0.0006663291,"about_ca_system_score_gemma":0.004898741,"threshold_uncertainty_score":0.9999617},"labels":[],"label_agreement":null},{"id":"W2473625996","doi":"10.1182/blood.v124.21.4517.4517","title":"Chaetocin Anti-Leukemia Activity Against Chronic Myelogenous Leukemia Stem Cells Is Potentiated By Bone Marrow Stromal Factors and Overcomes Innate Imatinib Resistance","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Chronic myelogenous leukemia; Cancer research; Imatinib mesylate; Imatinib; Stem cell; Bone marrow; Immunology; Biology; Stromal cell; Leukemia; Cell biology; Myeloid leukemia","score_opus":0.009206879605860375,"score_gpt":0.21920697518989332,"score_spread":0.21000009558403296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2473625996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946466,0.002351764,0.000037642327,0.00016251925,0.00017543175,0.0009561273,0.0003992684,0.0002615048,0.0010091064],"genre_scores_gemma":[0.9954232,0.00074310583,0.0003161805,0.00022333508,0.00015792262,0.000040553925,0.000171699,0.0001257942,0.0027982257],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99657243,0.00017966422,0.0005886003,0.0010108924,0.0006636922,0.000984703],"domain_scores_gemma":[0.9978993,0.00017199319,0.00043359952,0.0009552214,0.00010053718,0.00043936292],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030256578,0.0007173338,0.0011432737,0.00017565266,0.000287373,0.00007865456,0.00023131559,0.0004043933,0.000110792986],"category_scores_gemma":[0.00004073672,0.0006321272,0.00021610444,0.00031385914,0.00022190264,0.00024557393,0.00018017099,0.0005822623,0.000051743562],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027650408,0.00067361374,0.04682165,0.0009954445,0.0010983299,0.00027021588,0.0007520405,0.000013796379,0.9380484,0.000020760486,0.004244868,0.0067843497],"study_design_scores_gemma":[0.024940016,0.00088106154,0.14002794,0.0005944255,0.000987894,0.00010271063,0.00013352133,0.00088537554,0.82637775,0.00002065289,0.0040929816,0.0009556588],"about_ca_topic_score_codex":0.0003764594,"about_ca_topic_score_gemma":0.00013059887,"teacher_disagreement_score":0.11167066,"about_ca_system_score_codex":0.003135957,"about_ca_system_score_gemma":0.0010735365,"threshold_uncertainty_score":0.999613},"labels":[],"label_agreement":null},{"id":"W2473701296","doi":"10.1182/blood.v104.11.2715.2715","title":"Factors Affecting Physicians’ Decisions to Transfuse Red Blood Cells to Patients Having Coronary Artery Bypass Graft Surgery: A National Survey.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Univariate analysis; Coronary artery disease; Cardiac surgery; Coronary artery bypass surgery; Cross-sectional study; Artery; Surgery; Emergency medicine; Internal medicine; Cardiology; Multivariate analysis","score_opus":0.0434750359650223,"score_gpt":0.26823944606195665,"score_spread":0.22476441009693435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2473701296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956277,0.000021358805,0.00084885344,0.00082142925,0.0005126786,0.0014632203,0.00014476044,0.00017233481,0.00038768043],"genre_scores_gemma":[0.9964465,0.00002600093,0.0010470921,0.0019353281,0.00010510449,0.00005679668,0.00020162949,0.00006811263,0.000113434995],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972851,0.00011442383,0.0005073707,0.0006381275,0.0009252197,0.00052974286],"domain_scores_gemma":[0.998324,0.00052031886,0.000076474666,0.0003720436,0.00027842788,0.00042874698],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005143469,0.0003472645,0.00054374966,0.00045174855,0.00022682782,0.000050608058,0.00016529422,0.000108584056,0.000063128704],"category_scores_gemma":[0.00036566492,0.00032613648,0.0002748332,0.00081824296,0.000024751802,0.0001322537,0.00006232344,0.00023006812,0.000068979294],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060850097,0.026129557,0.88820374,0.00016481058,0.0020571793,0.00035809365,0.0056142407,0.0004414837,0.060707014,0.00006740612,0.0056143175,0.010033676],"study_design_scores_gemma":[0.006291249,0.0004694963,0.9572418,0.00040156787,0.0005248486,0.000010065934,0.00019010808,0.0000013028794,0.03403597,0.000030353382,0.00042998634,0.0003732746],"about_ca_topic_score_codex":0.0002872265,"about_ca_topic_score_gemma":0.0010668038,"teacher_disagreement_score":0.069038056,"about_ca_system_score_codex":0.0000710992,"about_ca_system_score_gemma":0.00013194281,"threshold_uncertainty_score":0.99991906},"labels":[],"label_agreement":null},{"id":"W2473839398","doi":"10.1182/blood.v126.23.3171.3171","title":"Safety and Efficacy of Autologous Hematopoietic Cell Transplantation for Elderly Patients with Lymphoma: Chemosensitive Disease Rather Than Age or Co-Morbidity Index Predicts Outcome","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Transplantation; Internal medicine; Hematopoietic stem cell transplantation; Lymphoma; Mantle cell lymphoma; Surgery; Oncology","score_opus":0.018959670573517908,"score_gpt":0.2632550391210027,"score_spread":0.24429536854748476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2473839398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979098,0.00009661362,0.00010633456,0.00007066617,0.000033218646,0.0012607753,0.00029553854,0.00003613068,0.00019091957],"genre_scores_gemma":[0.9991466,0.000024098652,0.00028494667,0.000059648202,0.000025619229,0.000051243358,0.00030811655,0.000022528155,0.000077189165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905574,0.00003013819,0.00024633235,0.00024965598,0.00024313867,0.0001750039],"domain_scores_gemma":[0.9991734,0.00014515853,0.000121774225,0.00018296175,0.000114297334,0.00026238515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007296478,0.00017113371,0.00037059095,0.0000414081,0.00004157736,0.000009118964,0.000032887714,0.0000655946,0.0000039999913],"category_scores_gemma":[0.000048885096,0.00011192808,0.00006057407,0.00006298683,0.000079947094,0.000047702157,0.000008353409,0.000025106834,0.0000023647453],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006365614,0.005922251,0.98409605,0.0003917302,0.00018653582,0.00036416476,0.0011831243,0.0000026393368,0.000020215813,0.000012254156,0.000032981956,0.0014224333],"study_design_scores_gemma":[0.06614951,0.0019789012,0.9260592,0.0001212637,0.0012432999,0.000032331012,0.000094817675,0.000014795395,0.0041406085,0.000011588632,0.000035101766,0.00011862352],"about_ca_topic_score_codex":0.00004575924,"about_ca_topic_score_gemma":0.000026172305,"teacher_disagreement_score":0.0597839,"about_ca_system_score_codex":0.000047338333,"about_ca_system_score_gemma":0.00016790933,"threshold_uncertainty_score":0.45642945},"labels":[],"label_agreement":null},{"id":"W2474545869","doi":"10.1182/blood.v106.11.446.446","title":"A Phase I Trial of the Small Molecule Pan-Bcl-2 Family Inhibitor GX15-070 Administered Intravenously (IV) Every 3 Weeks to Patients with Previously Treated Chronic Lymphocytic Leukemia (CLL).","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pharmacokinetics; Apoptosis; Pharmacology; Adverse effect; Chronic lymphocytic leukemia; Pharmacodynamics; Medicine; In vivo; Cmax; Bcl-2 family; Internal medicine; Immunology; Leukemia; Programmed cell death; Chemistry; Biology; Biochemistry","score_opus":0.016700143308142294,"score_gpt":0.2672895160565252,"score_spread":0.2505893727483829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2474545869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99233913,0.000594338,0.000024133806,0.00012121194,0.00016796126,0.00544392,0.00007553495,0.00012970218,0.0011040408],"genre_scores_gemma":[0.996506,0.0000661018,0.00029309295,0.00044164836,0.0007682686,0.00034447623,0.000081136845,0.00014016357,0.0013591199],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9953781,0.00023559612,0.0010395544,0.0008499666,0.0013919456,0.0011048346],"domain_scores_gemma":[0.99689835,0.00019439273,0.0003575696,0.0015790851,0.0004155404,0.0005550308],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000407426,0.00056505896,0.0009750765,0.00025921417,0.0001528045,0.00006527159,0.00068287627,0.00030678583,0.000064082815],"category_scores_gemma":[0.0003868122,0.00038201245,0.00031035003,0.0008884801,0.00027998822,0.00011607538,0.000299553,0.00040167884,0.0001228319],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.56765276,0.07340236,0.0033500616,0.005528906,0.007488975,0.0020562462,0.011785666,0.0008401213,0.1582234,0.00009592612,0.009715263,0.1598603],"study_design_scores_gemma":[0.8687474,0.021777404,0.0011899713,0.0012423908,0.0012493221,0.00017405231,0.0000828242,0.0015990364,0.10122492,0.000003696017,0.002117398,0.00059156015],"about_ca_topic_score_codex":0.0014041832,"about_ca_topic_score_gemma":0.0005529079,"teacher_disagreement_score":0.30109465,"about_ca_system_score_codex":0.033965293,"about_ca_system_score_gemma":0.039628375,"threshold_uncertainty_score":0.9998632},"labels":[],"label_agreement":null},{"id":"W2474916704","doi":"10.1182/blood-2016-02-699561","title":"Polyphosphate is a novel cofactor for regulation of complement by a serpin, C1 inhibitor","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research","keywords":"Cofactor; Serpin; Colocalization; C1-inhibitor; Regulator; Biochemistry; Chemistry; Complement (music); Platelet; Heparin cofactor II; Function (biology); Antithrombin; Biology; Heparin; Cell biology; Immunology; Enzyme; Phenotype","score_opus":0.022405960314780697,"score_gpt":0.26610586480485515,"score_spread":0.24369990449007445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2474916704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98230547,0.0015984494,0.007901361,0.005401157,0.00022547986,0.001329776,0.0009424633,0.00010316017,0.00019266765],"genre_scores_gemma":[0.9939465,0.000036925234,0.002130308,0.0004412285,0.00024252913,0.000052999854,0.00010740304,0.00003629094,0.00300582],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986645,0.000009595025,0.0004694419,0.00028850508,0.00028754782,0.00028043284],"domain_scores_gemma":[0.99903923,0.000108497596,0.0002280898,0.0002889843,0.00019947343,0.00013569993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013987481,0.00017731663,0.0003463183,0.00007204251,0.00006589689,0.000010194617,0.00007382531,0.00008878272,0.0004990461],"category_scores_gemma":[0.00006555772,0.00012946941,0.00016807427,0.00012093434,0.00006514853,0.000102198166,0.000030130357,0.00002965301,0.000016359072],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046996606,0.0014623645,0.06117259,0.00023147123,0.00032820037,8.3137934e-7,0.00063604565,3.893276e-7,0.8943469,0.0027927377,0.029177403,0.009381091],"study_design_scores_gemma":[0.016182764,0.0007080252,0.090810865,0.00046403057,0.00034053304,0.000011836666,0.0000550639,0.00014361388,0.84182966,0.00041651822,0.048789453,0.0002476224],"about_ca_topic_score_codex":0.00007969297,"about_ca_topic_score_gemma":0.0000091288775,"teacher_disagreement_score":0.05251724,"about_ca_system_score_codex":0.000034871686,"about_ca_system_score_gemma":0.00008721879,"threshold_uncertainty_score":0.5464205},"labels":[],"label_agreement":null},{"id":"W2475008382","doi":"10.1182/blood-2016-05-718114","title":"The role of leukocytes in thrombosis","year":2016,"lang":"en","type":"review","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":300,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute; Queen's University","funders":"Canadian Institutes of Health Research","keywords":"Thrombogenicity; Coagulation; Thrombus; Platelet; Platelet activation; Fibrinolysis; Tissue factor; Proinflammatory cytokine; Immunology; Cell biology; Inflammation; Immune system; Cell adhesion molecule; Medicine; Biology; Internal medicine","score_opus":0.02616543426737979,"score_gpt":0.3150383997714071,"score_spread":0.2888729655040273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2475008382","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005545412,0.99172133,4.7308895e-8,0.000014395279,0.000024716117,0.00036209697,0.000018945551,0.000007968115,0.0072959797],"genre_scores_gemma":[0.00048293904,0.9991398,0.000014166443,0.000004435771,0.00002711599,0.00005167373,0.000014859599,0.000018861188,0.00024614317],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993344,0.000028972228,0.00025916687,0.00013083416,0.00010170304,0.00014495144],"domain_scores_gemma":[0.9994349,0.00014942927,0.00012076961,0.0002519902,0.000014199356,0.000028732902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000065235174,0.00014547318,0.00092586083,0.000053622694,0.000021076561,0.000004087561,0.00008880053,0.00011166063,0.000025985793],"category_scores_gemma":[0.00002988293,0.00006286456,0.0002158321,0.000097899414,0.000037519625,0.000011751908,0.000026336393,0.0000865302,0.00007049372],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000021269086,0.00031964405,0.00034540863,0.0010665267,0.00041150866,0.000029776571,0.000009354298,4.3681825e-10,0.0000017639644,0.00010435336,0.000029296138,0.99768025],"study_design_scores_gemma":[0.0010170661,0.00007424938,0.0001135787,0.010339996,0.0010913785,0.000043930813,0.000009232431,3.7052395e-8,0.000048404316,0.0002541582,0.986941,0.000067011155],"about_ca_topic_score_codex":0.000024055438,"about_ca_topic_score_gemma":0.000015160865,"teacher_disagreement_score":0.99761325,"about_ca_system_score_codex":0.000019285626,"about_ca_system_score_gemma":0.00012854599,"threshold_uncertainty_score":0.25635424},"labels":[],"label_agreement":null},{"id":"W2475561659","doi":"10.1182/blood.v124.21.2019.2019","title":"Patient, Disease and Treatment Characteristics of Long-Term Survivors of Multiple Myeloma","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Multiple myeloma; Univariate analysis; Internal medicine; Autologous stem-cell transplantation; Retrospective cohort study; Surgery; Stage (stratigraphy); Survival analysis; Transplantation; Disease; Multivariate analysis","score_opus":0.01840966357043382,"score_gpt":0.26834290251098697,"score_spread":0.24993323894055314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2475561659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99896103,0.00020013234,0.000018124621,0.000030544234,0.00002670958,0.00042882774,0.00014893421,0.000014232167,0.00017145113],"genre_scores_gemma":[0.99928755,0.00017569895,0.00021090484,0.000009208122,0.00003882804,0.000027065817,0.0001362011,0.000015515678,0.000099005265],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913645,0.000048511716,0.0002396911,0.00017995722,0.0002107467,0.00018463751],"domain_scores_gemma":[0.99908644,0.00012397884,0.000107193286,0.00029764452,0.00008347656,0.0003012717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000046596197,0.00013053694,0.0003288894,0.000077093915,0.000027585755,0.0000047110366,0.000033611726,0.00003464677,0.000033312244],"category_scores_gemma":[0.00020002737,0.000095834854,0.00007588807,0.00006101276,0.00009272334,0.000026999782,0.00003466523,0.000034657995,0.00000541896],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048481923,0.0023025954,0.92193854,0.00020484444,0.00026935263,0.00008715618,0.00011903877,5.3291824e-8,0.0034338383,0.000011842644,0.0000017684124,0.071146145],"study_design_scores_gemma":[0.0063641733,0.0014761002,0.96981674,0.000107229476,0.0002941087,0.000009656922,0.0000091333395,0.00008139078,0.02173812,0.0000047342382,0.000033022407,0.00006560512],"about_ca_topic_score_codex":0.00013900027,"about_ca_topic_score_gemma":0.00005512213,"teacher_disagreement_score":0.07108054,"about_ca_system_score_codex":0.000015053135,"about_ca_system_score_gemma":0.000045106928,"threshold_uncertainty_score":0.3908032},"labels":[],"label_agreement":null},{"id":"W2476336358","doi":"10.1182/blood.v126.23.894.894","title":"Xalia, a Non-Interventional Study Comparing Rivaroxaban with Standard Anticoagulation for Initial and Long-Term Therapy in Deep Vein Thrombosis","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Medicine; Rivaroxaban; Fondaparinux; Pulmonary embolism; Deep vein; Vitamin K antagonist; Thrombosis; Hazard ratio; Population; Concomitant; Surgery; Internal medicine; Warfarin; Confidence interval; Venous thromboembolism; Atrial fibrillation","score_opus":0.06894200490713757,"score_gpt":0.3513007790280303,"score_spread":0.2823587741208927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2476336358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996114,0.00017031813,0.0015078299,0.00011584873,0.00006956249,0.0017310032,0.0000050547255,0.000026757487,0.0002595915],"genre_scores_gemma":[0.9989736,0.00002531106,0.00060738524,0.000055968198,0.00010937884,0.00015758803,0.000036560945,0.000022603424,0.000011605849],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999008,0.00003227495,0.00024488688,0.00025270216,0.00027303176,0.00018911506],"domain_scores_gemma":[0.99954367,0.000025780088,0.000075602075,0.00016014853,0.000101678874,0.000093152936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031024945,0.00013780015,0.0004342803,0.00012451138,0.000051385265,0.000049560334,0.00005503942,0.000035050198,0.00001592531],"category_scores_gemma":[0.000015376216,0.000113048016,0.00004673228,0.00010186914,0.000035910205,0.00010337629,0.00004213043,0.00006936116,0.0000016534904],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041992197,0.0071466686,0.98782855,0.00008872267,0.0004003466,0.000029401066,0.002351337,0.00001531887,0.000104643266,0.000111334244,0.00005716181,0.0014466051],"study_design_scores_gemma":[0.023349145,0.007152569,0.96706945,0.00022108547,0.00030615632,0.0000086522605,0.000865955,0.00024254227,0.0005528565,0.00008225499,0.000016723867,0.00013262517],"about_ca_topic_score_codex":0.00014282737,"about_ca_topic_score_gemma":0.0008821995,"teacher_disagreement_score":0.022929223,"about_ca_system_score_codex":0.000062771884,"about_ca_system_score_gemma":0.000041308154,"threshold_uncertainty_score":0.46099642},"labels":[],"label_agreement":null},{"id":"W2476563847","doi":"10.1182/blood.v126.23.333.333","title":"A Clinicogenetic Risk Model (m7-FLIPI) Prospectively Identifies One-Half of Patients with Early Disease Progression of Follicular Lymphoma after First-Line Immunochemotherapy","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Follicular lymphoma; International Prognostic Index; Oncology; Clinical endpoint; Progression-free survival; Surgery; Clinical trial; Rituximab; Lymphoma; Overall survival","score_opus":0.010782754262841242,"score_gpt":0.24585561518972968,"score_spread":0.23507286092688842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2476563847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99498814,0.0028787404,0.0014335179,0.000018513003,0.00002551924,0.00047400736,0.00014874568,0.0000070104297,0.000025813695],"genre_scores_gemma":[0.9979235,0.0002839752,0.0013904546,0.000015242845,0.000041155727,0.00017587225,0.00005902778,0.000029208652,0.00008154081],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989584,0.00003597169,0.00029188843,0.00031054337,0.00025415263,0.00014902215],"domain_scores_gemma":[0.99869525,0.000003887494,0.00028504865,0.0005049449,0.00040671535,0.00010416302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000104244515,0.00014778557,0.00018307584,0.000036057332,0.00003730555,0.000013655428,0.00015772403,0.00008219768,0.000004064531],"category_scores_gemma":[0.00003682817,0.00011835134,0.000099644974,0.00009244188,0.00011646225,0.000008200659,0.000055475582,0.000032610467,0.0000012984277],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031241474,0.004014011,0.9687437,0.00008373646,0.00032944797,0.0000014274513,0.00031757707,0.0005473201,0.019801296,0.000014111134,0.000020731475,0.0030024918],"study_design_scores_gemma":[0.008827661,0.0015970337,0.80847377,0.00011862386,0.00031527944,5.2846826e-7,0.000021325937,0.00034873947,0.1794996,0.00031687054,0.00020291824,0.00027763378],"about_ca_topic_score_codex":0.000037906102,"about_ca_topic_score_gemma":0.000020927415,"teacher_disagreement_score":0.1602699,"about_ca_system_score_codex":0.000010105723,"about_ca_system_score_gemma":0.00015080157,"threshold_uncertainty_score":0.48262274},"labels":[],"label_agreement":null},{"id":"W2476655743","doi":"10.1182/blood.v122.21.2163.2163","title":"The Outcome Of Allogeneic Hematopoietic Cell Transplantation In Children With FLT3/ITD-Positive Acute Myelogenous Leukemia","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Cumulative incidence; Medicine; Hazard ratio; Hematopoietic stem cell transplantation; Internal medicine; Transplantation; Oncology; Proportional hazards model; Minimal residual disease; Leukemia; Confidence interval","score_opus":0.007420899564877665,"score_gpt":0.24201570897308392,"score_spread":0.23459480940820626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2476655743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99634355,0.0003455645,0.000084506435,0.0003946949,0.0000149398775,0.0013912321,0.000028028073,0.000029951203,0.0013675276],"genre_scores_gemma":[0.9979295,0.00037871412,0.00080123794,0.00014000668,0.000041939853,0.0001229475,0.000074227246,0.000039608083,0.00047177976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837977,0.00009222573,0.0003957364,0.00028039012,0.000412312,0.00043957253],"domain_scores_gemma":[0.9990869,0.00013588976,0.000111776906,0.0004032512,0.00013786208,0.00012430288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022883584,0.00019811287,0.00036809992,0.00012155715,0.0000911554,0.000022745136,0.00024118813,0.00012238746,0.000053428437],"category_scores_gemma":[0.000016691703,0.00012186724,0.000079129495,0.0002890276,0.00017927136,0.000080228594,0.000034764184,0.00035393966,0.000115353345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025424853,0.00035868256,0.9416286,0.00012214248,0.00055560103,0.00015823165,0.0014161419,0.000022304375,0.054535702,0.00007604098,0.000076918404,0.0007953941],"study_design_scores_gemma":[0.0063473205,0.00056722877,0.84984463,0.000065753324,0.00052855426,0.0010010363,0.00019566542,0.00002554488,0.14121,0.000049112386,0.0000070008027,0.00015814649],"about_ca_topic_score_codex":0.00080752047,"about_ca_topic_score_gemma":0.0000754681,"teacher_disagreement_score":0.091783956,"about_ca_system_score_codex":0.00016310097,"about_ca_system_score_gemma":0.0003131834,"threshold_uncertainty_score":0.4969602},"labels":[],"label_agreement":null},{"id":"W2478034115","doi":"10.1182/blood.v124.21.2174.2174","title":"Management of Cancer-Associated Venous Thromboembolism in Patients with Concomitant Thrombocytopenia: A Survey of Canadian Practitioners","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; William Osler Health System; Western University; University of Toronto","funders":"","keywords":"Medicine; Context (archaeology); Concomitant; Family medicine; Thrombosis; Venous thrombosis; Internal medicine","score_opus":0.013672527841537921,"score_gpt":0.24776919403717476,"score_spread":0.23409666619563685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2478034115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899415,0.00010850019,0.000002732632,0.0001744969,0.00009229667,0.0009775792,0.00011319016,0.000015519312,0.008574196],"genre_scores_gemma":[0.99904865,0.00029309423,0.00021724762,0.00015687296,0.000010959637,0.000058321664,0.00015374689,0.00003132164,0.000029767072],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984166,0.00011234339,0.00043718793,0.00027633682,0.0003922355,0.00036531422],"domain_scores_gemma":[0.99884605,0.000058947608,0.0003060028,0.00035114327,0.00027921106,0.00015865955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047854296,0.00018139175,0.0009674633,0.00042954026,0.00004508801,0.000008537737,0.00013980844,0.00008509963,0.00008551383],"category_scores_gemma":[0.00005742598,0.0001575755,0.000050250146,0.000829762,0.000081603306,0.00007095836,0.000044533517,0.00012371778,0.0000047313447],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010456195,0.007200521,0.9874194,0.00032800974,0.0015270914,0.00003139723,0.0004436234,0.000050451,0.000044018252,0.0012472378,0.00044430132,0.0011593756],"study_design_scores_gemma":[0.007978412,0.0010854899,0.98850703,0.000639889,0.0007422423,4.8944094e-7,0.0001094264,0.000008643008,0.0005098513,0.00002432432,0.00023513683,0.00015905761],"about_ca_topic_score_codex":0.38059208,"about_ca_topic_score_gemma":0.37232748,"teacher_disagreement_score":0.00910718,"about_ca_system_score_codex":0.00014955514,"about_ca_system_score_gemma":0.00019967448,"threshold_uncertainty_score":0.64257425},"labels":[],"label_agreement":null},{"id":"W2478766160","doi":"10.1182/blood.v116.21.1416.1416","title":"Use of a Population Pharmacokinetic Model of ADVATE In Pediatric and Adult Patients with Hemophilia A Permits Limited Blood Sampling for Individual Dose Tailoring.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Pharmacokinetics; Covariate; Population; Blood sampling; Sampling (signal processing); NONMEM; Internal medicine; Statistics; Mathematics","score_opus":0.051127659776155424,"score_gpt":0.29971042793482255,"score_spread":0.24858276815866714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2478766160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998758,0.00005198082,0.0000071067625,0.00004964061,0.000018515952,0.0009984543,0.00009291175,0.000013736011,0.000009624681],"genre_scores_gemma":[0.99304616,0.00007660924,0.0065198285,0.000012775817,0.000054456676,0.000050381183,0.00017964245,0.000024533925,0.000035620535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989319,0.000014506104,0.00029759895,0.00022624458,0.00031225453,0.00021748627],"domain_scores_gemma":[0.9992624,0.000099893055,0.00011418588,0.00015906834,0.00025998708,0.00010446138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000103872066,0.00013536974,0.00027442872,0.00033010347,0.000029302135,0.000008195325,0.000052300882,0.00008766097,0.0000036333583],"category_scores_gemma":[0.00020440671,0.000102052305,0.00004202622,0.00027272612,0.00003778939,0.00010997176,0.000037260208,0.0001721881,2.2131056e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056061835,0.0020969242,0.98396426,0.00045688017,0.00008960808,0.0000034864513,0.00028577645,0.000104461986,0.010738056,0.000017045557,0.0000017418383,0.0016811652],"study_design_scores_gemma":[0.021423412,0.0009595238,0.96341646,0.00009597185,0.0010225878,0.000004994517,0.000010092983,0.0047840998,0.008115285,0.000039224677,0.0000020177094,0.00012631732],"about_ca_topic_score_codex":0.000039600178,"about_ca_topic_score_gemma":0.000027239019,"teacher_disagreement_score":0.020862794,"about_ca_system_score_codex":0.000005481421,"about_ca_system_score_gemma":0.00004944508,"threshold_uncertainty_score":0.41615722},"labels":[],"label_agreement":null},{"id":"W2478928449","doi":"10.1182/blood.v120.21.3309.3309","title":"TLR3 Activation Is Involved in Venous Thrombosis Development","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"TLR3; Proinflammatory cytokine; Inflammation; Medicine; Chemokine; Immunology; Thrombus; Wound healing; HMGB1; Monocyte; Fibrosis; Pathology; Immune system; Toll-like receptor; Innate immune system; Internal medicine","score_opus":0.03662903718325376,"score_gpt":0.2799227990003961,"score_spread":0.24329376181714235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2478928449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99289227,0.00023588355,0.000035927493,0.0006531937,0.00010692491,0.0003961427,7.0071087e-7,0.000048260597,0.0056307022],"genre_scores_gemma":[0.9962525,0.00011018255,0.0016120848,0.0016526935,0.00014657028,0.00008333259,0.000018368899,0.000020079899,0.00010423396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99906236,0.000016969918,0.0002149555,0.00015833645,0.00021549253,0.0003318596],"domain_scores_gemma":[0.9995988,0.000019176998,0.000054122018,0.00019445484,0.000027913811,0.0001055227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001990468,0.00011875856,0.00027890387,0.00012693061,0.000052500563,0.0000108441145,0.000056201327,0.00006587776,0.0002393076],"category_scores_gemma":[0.000026405429,0.000109378605,0.000040058785,0.00018591297,0.000014290953,0.00012274555,0.00005156224,0.000093789335,0.00016495584],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025258742,0.024453498,0.9242527,0.00034024514,0.0005708998,0.000011304304,0.01633315,0.0000019067026,0.0129606,0.0010444405,0.008119259,0.011886748],"study_design_scores_gemma":[0.0015063895,0.00008944611,0.9004581,0.00013143376,0.000118906646,0.0000016187552,0.00033480377,0.00000210001,0.07858545,0.000029034032,0.018616244,0.00012648529],"about_ca_topic_score_codex":0.00008790789,"about_ca_topic_score_gemma":0.00002165231,"teacher_disagreement_score":0.065624855,"about_ca_system_score_codex":0.00008486274,"about_ca_system_score_gemma":0.00005545148,"threshold_uncertainty_score":0.446033},"labels":[],"label_agreement":null},{"id":"W2478932238","doi":"10.1182/blood-2016-03-707596","title":"Carfilzomib significantly improves the progression-free survival of high-risk patients in multiple myeloma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Onyx Pharmaceuticals; Agence Nationale de la Recherche; National Cancer Institute; Celgene; Amgen","keywords":"Carfilzomib; Multiple myeloma; Internal medicine; Oncology; Medicine; Overall survival; Progression-free survival; Cytogenetics; Lenalidomide; Biology; Genetics; Chromosome","score_opus":0.016309791118099017,"score_gpt":0.26684108587892624,"score_spread":0.25053129476082725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2478932238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978659,0.00012286971,0.0000073528754,0.00032789382,0.00009418652,0.0010303993,0.00022847862,0.000029833578,0.00029309568],"genre_scores_gemma":[0.9989201,0.00011154162,0.0005128117,0.000012277743,0.00007393374,0.000121781275,0.00002598445,0.00002553224,0.00019603466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99817497,0.00016084718,0.0003347894,0.00030184863,0.0006214814,0.00040603924],"domain_scores_gemma":[0.9983003,0.0005282951,0.00014763408,0.00069819984,0.00016145526,0.00016407829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028573873,0.00017194697,0.00032530245,0.000106022984,0.0000731191,0.000009217794,0.00026197368,0.00008131791,0.000044625955],"category_scores_gemma":[0.0016460132,0.00007760259,0.00009360148,0.0001984209,0.0001721142,0.00006835987,0.00015729906,0.00014021168,0.000029238252],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006149632,0.0018722033,0.9124592,0.0000383928,0.0001646692,0.000040450876,0.0001062518,9.527691e-8,0.012203081,0.000032227403,0.00008460771,0.07238385],"study_design_scores_gemma":[0.026439877,0.0008350542,0.92088133,0.00015216664,0.000081611164,0.000002232769,0.000053801894,0.000009754657,0.051242724,0.00013036364,0.00008229672,0.00008877437],"about_ca_topic_score_codex":0.0010506632,"about_ca_topic_score_gemma":0.00062714075,"teacher_disagreement_score":0.07229508,"about_ca_system_score_codex":0.00002875359,"about_ca_system_score_gemma":0.000106611915,"threshold_uncertainty_score":0.31645417},"labels":[],"label_agreement":null},{"id":"W2479223216","doi":"10.1182/blood.v126.23.5322.5322","title":"Low-Risk Multiple Myeloma By SKY92+ISS Validated in the Multiple Myeloma Genomics Initiative Study","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Multiple myeloma; Medicine; Internal medicine; Oncology","score_opus":0.05029673230955647,"score_gpt":0.3072337228935889,"score_spread":0.25693699058403247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2479223216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99407375,0.00045824895,0.000043907217,0.00024925784,0.000093647206,0.0032090906,0.00031976547,0.000107614534,0.0014447024],"genre_scores_gemma":[0.9978178,0.000065502405,0.00057757687,0.0002345297,0.00016388309,0.00042237848,0.000412128,0.000069866444,0.000236335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962871,0.0007612533,0.00056659733,0.00064585975,0.00093018514,0.0008089886],"domain_scores_gemma":[0.9974454,0.00070499495,0.00018571457,0.0008885868,0.00027122346,0.0005040517],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001022989,0.0004207975,0.0005852561,0.00022882839,0.0001981177,0.00009242698,0.00044419017,0.000158751,0.00006075282],"category_scores_gemma":[0.0019095561,0.00029168907,0.00013470571,0.0006281913,0.00013495322,0.00018082687,0.00018459592,0.0006225225,0.00030700656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011808657,0.013460917,0.9628655,0.000032505992,0.0007364607,0.0013223976,0.010900113,0.000012068177,0.0027577765,0.0000029606174,0.0017045756,0.005023868],"study_design_scores_gemma":[0.07794567,0.003847956,0.86743265,0.00008318447,0.00052362785,0.00013513076,0.018212548,0.0017743066,0.026667222,0.00006438915,0.0027773546,0.00053592457],"about_ca_topic_score_codex":0.001197549,"about_ca_topic_score_gemma":0.0010103284,"teacher_disagreement_score":0.09543281,"about_ca_system_score_codex":0.00019396313,"about_ca_system_score_gemma":0.00031339272,"threshold_uncertainty_score":0.9999535},"labels":[],"label_agreement":null},{"id":"W2479809460","doi":"10.1182/blood.v122.21.3147.3147","title":"Multiclonality In Multiple Myeloma: A Retrospective Analysis Of Clonal Progression and Selection","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Victoria Hospital; London Health Sciences Centre; Western University","funders":"","keywords":"Plasma cell dyscrasia; Multiple myeloma; Monoclonal gammopathy of undetermined significance; Medicine; Internal medicine; Serum protein electrophoresis; Plasma cell neoplasm; Dyscrasia; Monoclonal; Plasmacytoma; Oncology; Plasma cell; Immunology; Monoclonal antibody; Antibody; Immunoglobulin light chain","score_opus":0.018942612498810563,"score_gpt":0.3087086977262808,"score_spread":0.2897660852274702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2479809460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988631,0.00014281762,0.00001790279,0.00009613402,0.0000057466596,0.00061407406,0.000014886475,0.000019910734,0.00022543332],"genre_scores_gemma":[0.99700326,0.000022094633,0.002743343,0.000009765007,0.000018245759,0.000099854566,0.000036084566,0.000007420658,0.000059951217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989616,0.00006140799,0.00021506452,0.0002534043,0.000299923,0.00020856396],"domain_scores_gemma":[0.999447,0.00007943391,0.00006617434,0.00010714516,0.00016859263,0.0001316373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014356918,0.00009947989,0.0003324183,0.00032335502,0.00003926384,0.000010674382,0.000029475124,0.000066420755,0.00012885919],"category_scores_gemma":[0.0002736611,0.000076065495,0.000079241254,0.0007667053,0.00007312427,0.00008007745,0.00003398704,0.00012400925,0.0000066917196],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013439285,0.00148563,0.96508837,0.000037213376,0.00084529654,0.00001771335,0.00012547334,0.00000173851,0.026826175,0.000017608481,0.000005830505,0.0054145562],"study_design_scores_gemma":[0.0055750813,0.00031492815,0.96916264,0.00003594819,0.00047022637,0.000010767506,0.000033730157,0.009991044,0.014304659,0.000039120798,0.000004079193,0.000057791818],"about_ca_topic_score_codex":0.0010118111,"about_ca_topic_score_gemma":0.00049002137,"teacher_disagreement_score":0.012521516,"about_ca_system_score_codex":0.000054749602,"about_ca_system_score_gemma":0.000039125902,"threshold_uncertainty_score":0.3101861},"labels":[],"label_agreement":null},{"id":"W2480309755","doi":"10.1182/blood.v112.11.970.970","title":"Allogeneic Myeloablative Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia in the Imatinib Era.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Chronic myelogenous leukemia; Transplantation; Imatinib; Internal medicine; Imatinib mesylate; Hematopoietic stem cell transplantation; Stem cell; Busulfan; Leukemia; Surgery; Oncology; Immunology; Myeloid leukemia","score_opus":0.020669656392199538,"score_gpt":0.25117399639886223,"score_spread":0.2305043400066627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2480309755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928142,0.0022865355,0.00031301187,0.00017235008,0.00006374771,0.0020085473,0.000048026017,0.00006402819,0.0022295858],"genre_scores_gemma":[0.99639785,0.00077302096,0.0011587578,0.0002532197,0.00017440133,0.00048046838,0.0001730117,0.000046845715,0.0005424396],"study_design_codex":"qualitative","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99826974,0.000094818424,0.00043295766,0.00039302785,0.00033208658,0.00047735922],"domain_scores_gemma":[0.9989889,0.00030315464,0.00013131647,0.00043469283,0.000057738493,0.00008416407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022647982,0.0002760954,0.00040121345,0.00010968415,0.0001821092,0.000011428236,0.00019081104,0.00014897529,0.00004971835],"category_scores_gemma":[0.000010979551,0.0002013574,0.00016524202,0.0002601075,0.00009262798,0.0000728808,0.000013271941,0.0002492358,0.00006876651],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048280577,0.014487774,0.13405916,0.016973091,0.003936922,0.01762716,0.39148447,0.004157439,0.35266772,0.002240237,0.005098048,0.052439917],"study_design_scores_gemma":[0.1392477,0.007103059,0.27299643,0.0011161083,0.0043648514,0.017645786,0.004112729,0.002002292,0.54574,0.0006764047,0.003204753,0.0017898852],"about_ca_topic_score_codex":0.00009995111,"about_ca_topic_score_gemma":0.00010115428,"teacher_disagreement_score":0.38737175,"about_ca_system_score_codex":0.0011462488,"about_ca_system_score_gemma":0.0015132152,"threshold_uncertainty_score":0.8211116},"labels":[],"label_agreement":null},{"id":"W2480383381","doi":"10.1182/blood.v124.21.2628.2628","title":"Broncho-Alveolar Lavage and Lung Biopsy in Patients with Hematological Malignancy and Hematopoietic Stem Cell Transplantation Recipients: A Systematic Review and Meta-Analysis","year":2014,"lang":"en","type":"review","venue":"Blood","topic":"Pneumocystis jirovecii pneumonia detection and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hospital for Sick Children","funders":"","keywords":"Medicine; Hematopoietic stem cell transplantation; Lung cancer; Malignancy; Transplantation; Biopsy; Internal medicine; Lung biopsy; Bronchoalveolar lavage; Lung","score_opus":0.01970278226259344,"score_gpt":0.26683342663918097,"score_spread":0.24713064437658752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2480383381","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005213968,0.99033475,0.000032430562,0.000026770702,0.000010449206,0.0042136284,0.000093066774,0.000036362733,0.000038593265],"genre_scores_gemma":[0.02084788,0.9779405,0.00012818695,0.00008064064,0.0000039960546,0.0007063544,0.00012382955,0.00004287637,0.00012576017],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99698037,0.0004902121,0.0011402995,0.00077572255,0.00035261852,0.00026076895],"domain_scores_gemma":[0.99841064,0.00020170251,0.00063596864,0.0004710469,0.00005991258,0.000220742],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003598696,0.00062797515,0.0073798723,0.00036305754,0.000064624444,0.00004722505,0.00007263898,0.00023783342,0.000020873533],"category_scores_gemma":[0.000020323225,0.00035502858,0.0005512872,0.0005668398,0.0000605327,0.00006517044,0.00003279803,0.00025405982,0.0000066727234],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012172742,0.00051749294,0.0019925493,0.96599495,0.030895706,0.00019815663,0.00006313848,2.497921e-8,2.3444878e-7,0.000010809917,0.0000012532493,0.00031349584],"study_design_scores_gemma":[0.00217667,0.00031755253,0.0011018977,0.06825808,0.9263437,0.0013210727,0.000007240699,0.0000013289895,0.0000022900433,0.0000015522385,0.0001193468,0.00034927388],"about_ca_topic_score_codex":0.000007474826,"about_ca_topic_score_gemma":0.0000071058466,"teacher_disagreement_score":0.8977369,"about_ca_system_score_codex":0.00004232287,"about_ca_system_score_gemma":0.000028423085,"threshold_uncertainty_score":0.99989015},"labels":[],"label_agreement":null},{"id":"W2481364372","doi":"10.1182/blood.v122.21.1415.1415","title":"Second Bacteremia During Antibiotic Treatment In Children With Acute Myeloid Leukemia: A Report From The Canadian Infections In AML Research Group","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Janeway Children's Health and Rehabilitation Centre; Centre hospitalier universitaire de Québec; Kingston General Hospital; Centre Hospitalier Universitaire Sainte-Justine; London Health Sciences Centre; McMaster Children's Hospital; Hospital for Sick Children; Institute for Clinical Evaluative Sciences; Children's Hospital of Eastern Ontario; University of Toronto; Montreal Children's Hospital; Stollery Children's Hospital; Alberta Children's Hospital; Izaak Walton Killam Health Centre; University of Manitoba; SickKids Foundation; BC Children's Hospital; CancerCare Manitoba","funders":"","keywords":"Bacteremia; Medicine; Neutropenia; Internal medicine; Febrile neutropenia; Odds ratio; Sepsis; Retrospective cohort study; Antibiotics; Surgery; Chemotherapy","score_opus":0.015579825302447926,"score_gpt":0.2699566649746253,"score_spread":0.25437683967217734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2481364372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931622,0.000070999005,2.0378054e-7,0.0006082087,0.000041306634,0.001184577,0.000022770257,0.000024765548,0.004884966],"genre_scores_gemma":[0.99858844,0.00007058152,0.000027079574,0.00007207427,0.00016329091,0.000196688,0.00007063235,0.00002375866,0.00078747387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879926,0.00007562813,0.00021546206,0.0003233377,0.00016723479,0.0004190512],"domain_scores_gemma":[0.99921954,0.000048238493,0.000039180653,0.00044742116,0.000059158672,0.00018645752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013431323,0.00013630325,0.00021009376,0.0002724508,0.00024748914,0.00007173596,0.00007755697,0.000096129814,0.00037004304],"category_scores_gemma":[0.000018381768,0.00008974239,0.000039305585,0.00057122676,0.00008401907,0.00011997799,0.000025725254,0.0005124459,0.00007321277],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001312937,0.00025351788,0.99307114,0.000004183,0.00023543688,0.00046837394,0.00025142005,0.000002446973,0.0053671086,0.000011162588,0.00012783549,0.00019422325],"study_design_scores_gemma":[0.0035149867,0.0002819712,0.98873234,0.00007725081,0.000119231045,0.0022077055,0.00007361888,6.770784e-7,0.0044886647,0.000024999412,0.0003817161,0.00009681794],"about_ca_topic_score_codex":0.76573634,"about_ca_topic_score_gemma":0.95353764,"teacher_disagreement_score":0.18780129,"about_ca_system_score_codex":0.0011539212,"about_ca_system_score_gemma":0.001064993,"threshold_uncertainty_score":0.4051712},"labels":[],"label_agreement":null},{"id":"W2481626842","doi":"10.1182/blood.v116.21.1399.1399","title":"Prevalence of Suspected Collagen Disorders In the Adult Bleeding Disorder Clinic.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Connective tissue disorders research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Von Willebrand disease; Hemostasis; Joint hypermobility; Internal medicine; Von Willebrand factor; Cohort; Bleeding diathesis; Platelet; Haemophilia; Gastroenterology; Surgery; Physical therapy","score_opus":0.008819452448237505,"score_gpt":0.2908786364340997,"score_spread":0.2820591839858622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2481626842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934451,0.0005015402,0.000025135663,0.00031629662,0.00005477619,0.00040472808,0.000015559504,0.000006038566,0.0052308235],"genre_scores_gemma":[0.99884254,0.00046413235,0.00009901804,0.00003277182,0.00005797915,0.000056395937,0.000014132436,0.000015119336,0.00041794055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990046,0.00009844299,0.00019560511,0.000280086,0.00018571653,0.00023552726],"domain_scores_gemma":[0.9993094,0.00007707024,0.000060293485,0.00039980057,0.00012260348,0.000030815347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003476003,0.00010602701,0.00010385888,0.00005175653,0.00005073175,0.0000125687575,0.00044838004,0.000116521755,0.00015557968],"category_scores_gemma":[0.0008360391,0.00008572174,0.000063195715,0.00023348398,0.00015035119,0.0000034085679,0.00011014141,0.00015751302,0.0000094035595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005384854,0.00061646034,0.57179105,0.00007523163,0.000038694798,0.0000013107277,0.00031728443,0.0000018690502,0.42543933,0.00018159083,0.00018553555,0.0012977676],"study_design_scores_gemma":[0.0047228313,0.00082924496,0.855725,0.000035122826,0.0000714216,0.00001306285,0.0020207898,0.00005411329,0.13075407,0.00064758904,0.0047194054,0.0004073744],"about_ca_topic_score_codex":0.00012087396,"about_ca_topic_score_gemma":0.0035636781,"teacher_disagreement_score":0.29468524,"about_ca_system_score_codex":0.0000018617279,"about_ca_system_score_gemma":0.0000612637,"threshold_uncertainty_score":0.34956312},"labels":[],"label_agreement":null},{"id":"W2482802485","doi":"10.1182/blood.v106.11.415.415","title":"Gene Expression Distinguishes Burkitt Lymphoma from Other Aggressive Lymphomas and Identifies Patients Who Are Highly Curable with Intensive Chemotherapeutic Regimens.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Burkitt's lymphoma; Lymphoma; Diffuse large B-cell lymphoma; Immunophenotyping; Cancer research; Oncology; Gene expression profiling; Medicine; Germinal center; Biology; Internal medicine; Immunology; B cell; Gene; Antibody; Gene expression; Genetics; Antigen","score_opus":0.009498632206852663,"score_gpt":0.22039505022958755,"score_spread":0.2108964180227349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2482802485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923486,0.0055663,0.0000039155475,0.00065397617,0.000081063874,0.0004810347,0.00007763224,0.000088271256,0.0006991666],"genre_scores_gemma":[0.99569696,0.0004901708,0.0010668394,0.0013666652,0.00028135433,0.00009512888,0.000079621816,0.00006691661,0.0008563502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836636,0.000038212944,0.00028795388,0.0005902113,0.0003733433,0.000343901],"domain_scores_gemma":[0.9984723,0.000105756495,0.0004033648,0.00046183373,0.0003604108,0.00019636338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000033112225,0.0003599691,0.0005449818,0.00007707261,0.00016593744,0.00008387653,0.00009272964,0.00012145646,0.00006753848],"category_scores_gemma":[0.00010613369,0.00022374788,0.00008055177,0.00011089257,0.00014333354,0.00014918765,0.000072623836,0.00004836175,0.00003663418],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058406714,0.0031705962,0.96535367,0.00007193614,0.00091497146,0.00032595734,0.0020747103,0.0000015698903,0.0042757983,0.000013962718,0.0024653948,0.020747371],"study_design_scores_gemma":[0.022454536,0.0004195049,0.48597595,0.0019879963,0.00078668876,0.00009343274,0.00047579463,0.000017863165,0.48395443,0.00007276828,0.0034210114,0.00034002066],"about_ca_topic_score_codex":0.0003475173,"about_ca_topic_score_gemma":0.00004622878,"teacher_disagreement_score":0.47967863,"about_ca_system_score_codex":0.00012974115,"about_ca_system_score_gemma":0.00006247395,"threshold_uncertainty_score":0.91241735},"labels":[],"label_agreement":null},{"id":"W2482911513","doi":"10.1182/blood.v110.11.1212.1212","title":"C1q Complement Cascade Protein as a Novel Modulator of the SDF-1-CXCR4 Axis and Hematopoietic Stem/Progenitor Cell Trafficking.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Alberta","funders":"","keywords":"Homing (biology); Progenitor cell; CD34; Haematopoiesis; Stem cell; Cell biology; Bone marrow; Biology; Stromal cell; Cord blood; Complement system; Immunology; Chemistry; Molecular biology; Immune system; Cancer research","score_opus":0.015074577709333774,"score_gpt":0.23613162361745732,"score_spread":0.22105704590812356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2482911513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99479616,0.0027969938,0.00007038276,0.00008527249,0.0002241355,0.0014715825,0.0001700202,0.00005232362,0.00033310597],"genre_scores_gemma":[0.9991864,0.000002294087,0.00011329761,0.00004283202,0.00003665749,0.00006875332,0.000016305456,0.000023157714,0.0005103276],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985171,0.00010158016,0.00054069766,0.0003287517,0.000105355255,0.00040652067],"domain_scores_gemma":[0.9990423,0.000101516,0.00025617666,0.00048878894,0.000066192515,0.000045065848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034617365,0.00021751793,0.00031833036,0.00007237131,0.0001863718,0.00001283007,0.00033778057,0.00011612213,0.0002993089],"category_scores_gemma":[0.000022825865,0.00016473423,0.00013551857,0.00013702021,0.00016941075,0.00003330314,0.00022478597,0.0001415358,0.000043756023],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007618017,0.0014943256,0.013371347,0.00033157933,0.00027554267,0.0000058095447,0.0010436511,0.0000021501103,0.98175466,0.0009916043,0.00030954293,0.0003436201],"study_design_scores_gemma":[0.0043788175,0.00023342045,0.017364966,0.0001643678,0.0002092884,0.00015259205,0.0013480298,0.0000027875042,0.9716566,0.00004672968,0.0042093205,0.00023305765],"about_ca_topic_score_codex":0.00011277514,"about_ca_topic_score_gemma":0.00007284963,"teacher_disagreement_score":0.010098023,"about_ca_system_score_codex":0.000025149033,"about_ca_system_score_gemma":0.00006588571,"threshold_uncertainty_score":0.6717667},"labels":[],"label_agreement":null},{"id":"W2483350877","doi":"10.1182/blood.v126.23.1742.1742","title":"A Phase 2 Study of Ofatumumab in Combination with a Pan-AKT Inhibitor (Afuresertib) in Previously Treated Patients with Chronic Lymphocytic Leukemia (CLL)","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada); CancerCare Manitoba; Princess Margaret Cancer Centre","funders":"","keywords":"Ofatumumab; Medicine; Fludarabine; Internal medicine; Chronic lymphocytic leukemia; Refractory (planetary science); Regimen; Gastroenterology; Neutropenia; Phases of clinical research; Pharmacodynamics; Oncology; Pharmacology; Pharmacokinetics; Leukemia; Clinical trial; Cyclophosphamide; Chemotherapy","score_opus":0.018305244616029948,"score_gpt":0.28747154493414,"score_spread":0.26916630031811006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2483350877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953349,0.00032492905,0.0000026509963,0.000013060453,0.000023981429,0.003951951,0.0000064340825,0.000058274883,0.00028376645],"genre_scores_gemma":[0.9992603,0.0000106544585,0.000056279503,0.000015458927,0.000038329665,0.00032136022,0.0000814115,0.000067869834,0.00014831929],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9965986,0.00020729796,0.0006622943,0.00057037995,0.0013339062,0.00062751124],"domain_scores_gemma":[0.99829245,0.00009783165,0.00021516245,0.0006927547,0.00043018095,0.0002716285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045558187,0.00032896092,0.0007480561,0.0005800414,0.000028827944,0.000025153098,0.00023445358,0.00014198235,0.000014429369],"category_scores_gemma":[0.00024856572,0.00023892873,0.000039680956,0.0014248053,0.00013977767,0.0002072705,0.00010415531,0.00030524467,0.000012635973],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.04180794,0.1114536,0.8101943,0.0016861539,0.0009977677,0.0038936592,0.01946571,0.0011235023,0.001214696,0.000023355768,0.0002812574,0.007858033],"study_design_scores_gemma":[0.8898689,0.047862567,0.046532728,0.0013366337,0.00036506733,0.000098073695,0.00097023183,0.006216067,0.0063649453,0.000011520564,0.000021310958,0.00035194342],"about_ca_topic_score_codex":0.011083653,"about_ca_topic_score_gemma":0.007075651,"teacher_disagreement_score":0.84806097,"about_ca_system_score_codex":0.05038923,"about_ca_system_score_gemma":0.026199093,"threshold_uncertainty_score":0.99550164},"labels":[],"label_agreement":null},{"id":"W2483558044","doi":"10.1182/blood.v104.11.3969.3969","title":"In-Vitro Stability of B-Domain Deleted Recombinant Factor VIII in Syringe-Based Continuous Infusion Devices.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Winnipeg Regional Health Authority","funders":"","keywords":"Vial; Syringe; Chromatography; Chemistry; Saline; Medicine; Surgery; Anesthesia","score_opus":0.02307203590030949,"score_gpt":0.28116630372737095,"score_spread":0.25809426782706146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2483558044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99778026,0.00022548925,0.0000052163587,0.00089124765,0.000045808207,0.0006986204,0.000010434925,0.000021635922,0.0003213042],"genre_scores_gemma":[0.9991221,0.000021438087,0.0006846437,0.00006448075,0.000018122355,0.000026850617,0.000023217879,0.000014766397,0.00002438807],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986787,0.000076448654,0.00037881685,0.00024929937,0.00029156383,0.0003252011],"domain_scores_gemma":[0.9993696,0.000096266114,0.00006255037,0.00028400496,0.0000759806,0.00011160555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030899287,0.00013508416,0.00041219336,0.0002338761,0.000023272825,0.000005484838,0.00008221757,0.0001200096,0.00009801807],"category_scores_gemma":[0.00015250927,0.000103355924,0.000078933066,0.00037845428,0.00007146185,0.00004955176,0.000036563088,0.00022427776,0.000012561965],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067366735,0.005103609,0.6091233,0.00028802405,0.000032991495,0.00043794734,0.0004906586,0.000001937713,0.3823682,0.000013010175,0.0000029406506,0.0014637035],"study_design_scores_gemma":[0.022513766,0.0008066247,0.27939832,0.00030734247,0.000029740986,0.000008965934,0.00014353506,0.000013071488,0.69642127,0.00015321618,0.00009151021,0.00011265108],"about_ca_topic_score_codex":0.0005166797,"about_ca_topic_score_gemma":0.0003121285,"teacher_disagreement_score":0.329725,"about_ca_system_score_codex":0.00015995956,"about_ca_system_score_gemma":0.00029292994,"threshold_uncertainty_score":0.4214732},"labels":[],"label_agreement":null},{"id":"W2483627127","doi":"10.1182/blood.v116.21.2631.2631","title":"Identification and Function of Hematopoietic Stem and Progenitor Cell Specific Micrornas.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Haematopoiesis; Progenitor cell; Biology; Stem cell; Bone marrow; Myeloid; Hematopoietic stem cell; Cell biology; Immunology; Molecular biology","score_opus":0.005201337173247021,"score_gpt":0.19662953974442593,"score_spread":0.1914282025711789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2483627127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99736524,0.002098845,0.00020727812,0.0000134647735,0.00008992427,0.00015759985,0.000009022373,0.000005786135,0.000052843345],"genre_scores_gemma":[0.9994338,0.00006910211,0.00022958945,0.0000046311106,0.00009881561,0.000008859711,0.00002641963,0.000010284808,0.00011848638],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995475,0.000014360686,0.0001325904,0.00018712596,0.000051564166,0.00006687037],"domain_scores_gemma":[0.9996337,0.0000033282165,0.000084384395,0.000187857,0.000050317645,0.00004037497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000074932905,0.00006579697,0.000059297297,0.00002375476,0.000030407202,0.00001699351,0.000038578113,0.00008322445,0.000006168676],"category_scores_gemma":[0.000004351242,0.00006712151,0.000021373005,0.000030771556,0.00005810484,0.00000338024,0.000031420335,0.000035676516,0.000002609218],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016755746,0.000089231384,0.0046985433,0.0000639035,0.000013371625,2.3586244e-7,0.000021709719,1.2468395e-7,0.99422467,0.00004366421,0.00013475487,0.0006930177],"study_design_scores_gemma":[0.00048091533,0.000043960645,0.0330598,0.000004460366,0.000042173,0.00001614932,0.000027916123,0.0000027609997,0.9643377,0.000047131194,0.0018696408,0.00006737219],"about_ca_topic_score_codex":7.862372e-7,"about_ca_topic_score_gemma":0.0000017048723,"teacher_disagreement_score":0.029886967,"about_ca_system_score_codex":0.0000010836412,"about_ca_system_score_gemma":0.000013610815,"threshold_uncertainty_score":0.27371356},"labels":[],"label_agreement":null},{"id":"W2483857636","doi":"10.1182/blood.v106.11.512.512","title":"Sensing Iron: Reciprocal Regulation of Hepcidin mRNA by Soluble and Cell-Associated Hemojuvelin.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Xenon Pharmaceuticals (Canada)","funders":"","keywords":"Hepcidin; Ferroportin; Endocrinology; Biology; Internal medicine; Cell biology; Immunology; Inflammation; Medicine","score_opus":0.007379643652739789,"score_gpt":0.21999882883277225,"score_spread":0.21261918518003245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2483857636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926823,0.0024829388,0.000116944866,0.0006774555,0.000054583597,0.00014527322,0.000004484114,0.000036952402,0.0037990643],"genre_scores_gemma":[0.995028,0.00015138052,0.0025620584,0.00022688857,0.00010358397,7.812317e-7,0.0000425365,0.000016266365,0.001868473],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99925154,0.000027395085,0.00021395557,0.00016080687,0.00017701538,0.00016925744],"domain_scores_gemma":[0.9996264,0.000024304756,0.00009045533,0.0001301967,0.00005360835,0.00007504036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016261463,0.00009456275,0.00021357427,0.000042886782,0.000048062506,0.000007891879,0.000023331622,0.000103786195,0.000046963574],"category_scores_gemma":[0.00006496254,0.000089978166,0.00003690253,0.00009621892,0.000044049048,0.00006886377,0.000018428935,0.00008327184,0.000008320067],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021345973,0.0019081783,0.020543942,0.0002734235,0.00004480677,0.000007008662,0.0012900757,0.000024958961,0.91577846,0.0000956591,0.02779716,0.03202287],"study_design_scores_gemma":[0.023094898,0.000389178,0.058135808,0.00014892209,0.0009166164,0.000053301937,0.00063850614,0.0017449583,0.9002372,0.00021063465,0.013984807,0.00044515633],"about_ca_topic_score_codex":0.00005122511,"about_ca_topic_score_gemma":0.000015680645,"teacher_disagreement_score":0.037591863,"about_ca_system_score_codex":0.000010999547,"about_ca_system_score_gemma":0.000033786226,"threshold_uncertainty_score":0.3669203},"labels":[],"label_agreement":null},{"id":"W2484455285","doi":"10.1182/blood.v126.23.1137.1137","title":"Non-Specific Hemostatic Agents (PCC, aPCC, rVIIa) for Reversal of Direct Oral Anticoagulant Effect in Patients with Major Bleeding Complications: A Retrospective Review","year":2015,"lang":"en","type":"review","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Joseph’s Healthcare Hamilton; St. Joseph's Hospital; McMaster University","funders":"","keywords":"Medicine; Rivaroxaban; Dabigatran; Interquartile range; Warfarin; Apixaban; Surgery; Retrospective cohort study; Prothrombin complex concentrate; Anticoagulant; Thrombosis; Recombinant factor VIIa; Atrial fibrillation; Internal medicine","score_opus":0.0967117723487567,"score_gpt":0.37651947832624766,"score_spread":0.27980770597749094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2484455285","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007466573,0.98549944,0.000043715525,0.00010878662,0.00016382383,0.012550548,0.00013643505,0.000045830686,0.00070478726],"genre_scores_gemma":[0.00061322824,0.9961188,0.0015161195,0.000083226936,0.00016294088,0.00017071121,0.0010599379,0.000093930816,0.00018113662],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974415,0.00013260846,0.0010135076,0.00054614426,0.0005535724,0.0003127201],"domain_scores_gemma":[0.99790025,0.0002771126,0.00085901486,0.00054518733,0.0003166384,0.000101802514],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008411241,0.00045195813,0.0035933608,0.00033467548,0.000050205716,0.000018922019,0.00018671558,0.00013999318,0.000019348035],"category_scores_gemma":[0.0002829241,0.00032839397,0.00047404075,0.0008061718,0.000054924392,0.00008769028,0.00008045269,0.00019234809,0.000025897742],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060354394,0.0006867907,0.27962324,0.35441762,0.0035739767,0.00003260468,0.00012896993,7.161395e-7,0.0000013537341,0.0001443564,0.017709628,0.34307718],"study_design_scores_gemma":[0.020247154,0.002498766,0.06215187,0.20398952,0.017807646,0.000009524757,0.0000109089415,0.00001059589,0.000005861009,0.000029826882,0.6923838,0.00085451215],"about_ca_topic_score_codex":0.000010637375,"about_ca_topic_score_gemma":0.000002331002,"teacher_disagreement_score":0.6746742,"about_ca_system_score_codex":0.00020070044,"about_ca_system_score_gemma":0.00010625155,"threshold_uncertainty_score":0.9999168},"labels":[],"label_agreement":null},{"id":"W2484511921","doi":"10.1182/blood.v122.21.4613.4613","title":"Risk Model Incorporating Donor IL6 and ifng Genotype and Gut Gvhd Can Discriminate High Risk Patients For Steroid Refractory Acute Gvhd","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Internal medicine; Medicine; Single-nucleotide polymorphism; Gastroenterology; Univariate analysis; Transplantation; Immunology; SNP; Graft-versus-host disease; Genotype; Multivariate analysis; Biology; Gene","score_opus":0.008415516367032925,"score_gpt":0.2159909180011468,"score_spread":0.2075754016341139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2484511921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975234,0.00019242553,0.0004908123,0.000052942705,0.00006115845,0.00079693855,0.0006751048,0.00003602706,0.0001711413],"genre_scores_gemma":[0.9953455,0.00047607507,0.0034634748,0.00011287502,0.00006185989,0.00008142076,0.00034351088,0.000028313825,0.000087013585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991492,0.000034664932,0.0002075121,0.00028273492,0.00013582673,0.0001900682],"domain_scores_gemma":[0.9993219,0.00005684119,0.00016298909,0.0001612611,0.000115618044,0.00018140685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000071081755,0.00015855399,0.00020251163,0.00006179603,0.0001622598,0.000038697504,0.00004023979,0.000072586874,0.00001105266],"category_scores_gemma":[0.000014274925,0.00012963596,0.000035763464,0.00003947309,0.000045678175,0.00021629788,0.00002622319,0.00012245214,0.000004476099],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003356406,0.00055734045,0.9660822,0.0004676645,0.0009548725,0.00001388291,0.0030635153,0.000017964709,0.0021702664,0.0000961599,0.00010083852,0.02613967],"study_design_scores_gemma":[0.008389577,0.00055274204,0.9804524,0.000039591374,0.0045865295,0.0000039979464,0.00012187948,0.0022317935,0.001367951,0.0020506468,0.00000579759,0.00019708424],"about_ca_topic_score_codex":0.0010248122,"about_ca_topic_score_gemma":0.00009663922,"teacher_disagreement_score":0.025942584,"about_ca_system_score_codex":0.000015580363,"about_ca_system_score_gemma":0.000042322437,"threshold_uncertainty_score":0.52864003},"labels":[],"label_agreement":null},{"id":"W2484545802","doi":"10.1182/blood.v108.11.4596.4596","title":"Utility of Bone Marrow Biopsy, Bone Marrow Aspirate, Flow Cytometry, and Molecular Testing in the Clinical Staging of Lymphoma: An Institutional Experience.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Hematological disorders and diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Capital District Health Authority; Dalhousie University","funders":"","keywords":"Lymphoma; Medicine; Bone marrow; Biopsy; Pathology; Malignancy; Gold standard (test); Clinical significance; Internal medicine; Oncology","score_opus":0.047826127784043576,"score_gpt":0.3196444518084084,"score_spread":0.2718183240243648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2484545802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99584746,0.0010803724,0.00054654886,0.00013996968,0.000027418733,0.00023562975,0.000020871346,0.00001717002,0.0020845637],"genre_scores_gemma":[0.9926811,0.000016545713,0.007040424,0.0001894737,0.000030786545,0.00001141877,0.000020842834,0.0000067685396,0.0000026767696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844104,0.00011201709,0.0006756974,0.0002624164,0.00030270856,0.00020612623],"domain_scores_gemma":[0.99902016,0.00039016618,0.0001399321,0.0002603441,0.000108399734,0.00008101743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063909125,0.00012638075,0.0004316669,0.000094446994,0.000048056365,0.00001122119,0.000085011976,0.00012414572,0.000023961371],"category_scores_gemma":[0.0021285426,0.00008953339,0.0000664551,0.00047934498,0.00046451163,0.00005947802,0.000055544344,0.00011733904,8.022214e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057893372,0.0034785713,0.9859278,0.00012645614,0.000011212499,0.00041934528,0.00009514218,0.000006869565,0.006530782,0.0008292252,0.000024202494,0.002492506],"study_design_scores_gemma":[0.0038636113,0.0004079663,0.9879446,0.00014239305,0.00007033676,0.00020332233,0.000370786,0.0016227611,0.0043489267,0.0008689482,0.000042655596,0.00011366334],"about_ca_topic_score_codex":0.00023837299,"about_ca_topic_score_gemma":0.000017406821,"teacher_disagreement_score":0.006493875,"about_ca_system_score_codex":0.000004702411,"about_ca_system_score_gemma":0.000120465724,"threshold_uncertainty_score":0.36510655},"labels":[],"label_agreement":null},{"id":"W2484616545","doi":"10.1182/blood-2016-02-699520","title":"Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Quebec - Clinical Research Organization in Cancer; Ozmosis Research (Canada); McGill University; Health Sciences Centre; University of British Columbia; Hôpital du Sacré-Cœur de Montréal; BC Cancer Agency; Princess Margaret Cancer Centre; Simon Fraser University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Panobinostat; Rituximab; Diffuse large B-cell lymphoma; Oncology; Lymphoma; Internal medicine; Medicine; Refractory (planetary science); Cancer research; Biology; Genetics","score_opus":0.013963312564516661,"score_gpt":0.27180898345464327,"score_spread":0.2578456708901266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2484616545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979971,0.0001775263,0.0000039896536,0.00010705785,0.00002905204,0.0010455372,0.00003964433,0.000041880518,0.00055821793],"genre_scores_gemma":[0.9987968,0.00005736615,0.00015603662,0.000073520314,0.00002780596,0.00015518384,0.000006977221,0.000032414355,0.00069388817],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99867594,0.0000562133,0.0003224617,0.00033877755,0.00030096812,0.00030565792],"domain_scores_gemma":[0.9991012,0.00010989579,0.00011968262,0.00047514107,0.000060277136,0.00013380454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000094719355,0.00020888282,0.0005472838,0.0001234182,0.000032471453,0.000007236859,0.00007727852,0.000058614165,0.0000585525],"category_scores_gemma":[0.00003430373,0.00009879098,0.00005139203,0.00020208507,0.000038974624,0.000050742125,0.000038384795,0.000029929035,0.000038997463],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002275688,0.46753955,0.52344084,0.00004061652,0.00017655783,0.0010723582,0.00095880235,1.1386625e-8,0.001614925,0.000011434625,0.000056626362,0.002812617],"study_design_scores_gemma":[0.8469838,0.017301086,0.08639071,0.00032509185,0.0007129666,0.000088738496,0.00096257357,0.0000040886734,0.04667946,0.000004042612,0.00037056496,0.00017686341],"about_ca_topic_score_codex":0.00015776597,"about_ca_topic_score_gemma":0.0003482741,"teacher_disagreement_score":0.84470814,"about_ca_system_score_codex":0.00007642312,"about_ca_system_score_gemma":0.00015638547,"threshold_uncertainty_score":0.40285793},"labels":[],"label_agreement":null},{"id":"W2485574993","doi":"10.1182/blood.v122.21.577.577","title":"The First In Vitro and In Vivo Assessment Of Anfibatide, a Novel Glycoprotein Ib Antagonist, In Mice and In a Phase I Human Clinical Trial","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Von Willebrand factor; Platelet; In vivo; Hemostasis; Thrombus; Ex vivo; Fibrinogen; Pharmacology; Antithrombotic; Tirofiban; Medicine; Platelet adhesiveness; Chemistry; Platelet aggregation inhibitor; Platelet membrane glycoprotein; In vitro; Immunology; Internal medicine; Biology; Biochemistry","score_opus":0.03136198330342582,"score_gpt":0.35854225347538865,"score_spread":0.32718027017196283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2485574993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974199,0.00030469676,0.000001200857,0.00047875827,0.000020424935,0.001484663,0.000013184227,0.000003850497,0.000273325],"genre_scores_gemma":[0.9992365,0.00014966002,0.00032519558,0.000067284505,0.000020070458,0.00015825899,0.00000764147,0.00000910756,0.000026265518],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9987856,0.000054037006,0.0006032631,0.00023713516,0.000117313655,0.0002026603],"domain_scores_gemma":[0.99950755,0.00018215807,0.00010469029,0.00013787752,0.0000138589,0.000053859854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044610063,0.000119768316,0.0004589874,0.00012381608,0.00002919892,0.00001941616,0.00005146377,0.000091523456,0.000009287366],"category_scores_gemma":[0.00008871622,0.000086470296,0.000030579085,0.00016683139,0.000090064255,0.00006165681,0.000041580308,0.00020601218,4.912417e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025252169,0.04254002,0.8046131,0.0002187121,0.00018081715,0.0010345059,0.0007848806,0.0000016489029,0.11617562,0.00006944151,0.00006860542,0.009060462],"study_design_scores_gemma":[0.5092785,0.0021098952,0.48102883,0.00028460805,0.00006142339,0.000037832127,0.00024928397,0.00074269366,0.0056537692,0.00022863677,0.00016619475,0.0001583494],"about_ca_topic_score_codex":0.0026324342,"about_ca_topic_score_gemma":0.007482351,"teacher_disagreement_score":0.48402634,"about_ca_system_score_codex":0.000026821439,"about_ca_system_score_gemma":0.00006685263,"threshold_uncertainty_score":0.41753274},"labels":[],"label_agreement":null},{"id":"W2485578826","doi":"10.1182/blood.v106.11.1006.1006","title":"Use of a Tissue Microarray To Assess the Accuracy of Lymphoma Classification by Needle Biopsy.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Queen's University","funders":"","keywords":"Follicular lymphoma; Lymphoma; Medicine; Mantle cell lymphoma; Pathology; Marginal zone B-cell lymphoma; Biopsy; Anaplastic large-cell lymphoma; Chronic lymphocytic leukemia; Medical diagnosis; Lymphoid hyperplasia; Diffuse large B-cell lymphoma; Not Otherwise Specified; B cell; Internal medicine; Leukemia; Marginal zone; Antibody","score_opus":0.0583783329191686,"score_gpt":0.3074438142440557,"score_spread":0.2490654813248871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2485578826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99544257,0.00049611734,0.000036633428,0.0029437689,0.000030544754,0.00043809926,0.000053908923,0.00001579732,0.0005425699],"genre_scores_gemma":[0.9966686,0.00007752577,0.0023934157,0.00032523015,0.00005968612,0.000057756566,0.000032089087,0.0000124958415,0.00037321183],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99925756,0.000028096196,0.0002590474,0.0001547941,0.00017419996,0.00012626912],"domain_scores_gemma":[0.9990966,0.00019252229,0.00013480968,0.0004050916,0.000096826014,0.00007415854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000074396936,0.00010060112,0.00020824652,0.000049607126,0.000029521927,0.000013520792,0.0000881345,0.000052752293,0.000047147838],"category_scores_gemma":[0.00012821227,0.000063998516,0.00006017127,0.00018291787,0.000040500086,0.000068231915,0.000024177776,0.000019230893,0.000038280174],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000071372066,0.005465363,0.07331866,0.000047383546,0.00023322046,0.0000064654073,0.0006126439,0.0000021030596,0.8488342,0.00029232935,0.010022982,0.061093263],"study_design_scores_gemma":[0.0020990379,0.00018913647,0.23763022,0.00005455289,0.00024331124,0.00003896793,0.00009584062,0.000010537431,0.7149016,0.0000025865852,0.04467823,0.000055942397],"about_ca_topic_score_codex":0.00024342997,"about_ca_topic_score_gemma":0.000010071433,"teacher_disagreement_score":0.16431156,"about_ca_system_score_codex":0.0000428595,"about_ca_system_score_gemma":0.00007403227,"threshold_uncertainty_score":0.26097837},"labels":[],"label_agreement":null},{"id":"W2485954867","doi":"10.1182/blood.v126.23.3832.3832","title":"5-Hydroxymethylcytosine Is Correlated with TET2 or IDH1/2 Mutations However, May Not be a Prognostic Value to Predict the Survivals in Normal Karyotype AML","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"IDH1; IDH2; Mutation; Internal medicine; Biology; NPM1; Isocitrate dehydrogenase; Induction chemotherapy; Oncology; Medicine; Chemotherapy; Cancer research; Gastroenterology; Karyotype; Genetics; Gene; Chromosome","score_opus":0.04116434620026583,"score_gpt":0.30618611590368305,"score_spread":0.26502176970341723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2485954867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97664464,0.0001291221,0.00014903267,0.018042566,0.00011794174,0.0023185394,0.00010520085,0.0001356802,0.002357277],"genre_scores_gemma":[0.99143076,0.000018436782,0.0018357979,0.0020479958,0.00017480555,0.00025911038,0.00011250929,0.00007713967,0.004043472],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99712193,0.00026450396,0.00042401516,0.00047418007,0.0010473859,0.0006679998],"domain_scores_gemma":[0.9976548,0.00066741515,0.00009382988,0.00067365664,0.00040719795,0.0005030988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010749461,0.00029114672,0.00045346128,0.00032157765,0.00011012702,0.000053119424,0.0003578653,0.00017527335,0.00017895782],"category_scores_gemma":[0.0022429863,0.00017076249,0.00005959011,0.0017692354,0.00019716563,0.0001514433,0.000181047,0.00071990234,0.00022279168],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01558943,0.0068333023,0.865132,0.0004863371,0.002396255,0.0064291274,0.022939488,0.0024245607,0.018091476,0.00065203203,0.05606055,0.0029654447],"study_design_scores_gemma":[0.103777744,0.023570782,0.6828928,0.0019686297,0.0041393638,0.004976745,0.0050456487,0.021985885,0.10721469,0.00015037526,0.042051636,0.0022257126],"about_ca_topic_score_codex":0.0012237141,"about_ca_topic_score_gemma":0.00035097188,"teacher_disagreement_score":0.18223922,"about_ca_system_score_codex":0.00020757622,"about_ca_system_score_gemma":0.0017426142,"threshold_uncertainty_score":0.6963492},"labels":[],"label_agreement":null},{"id":"W2486042188","doi":"10.1182/blood.v126.23.4701.4701","title":"An Unusual Case of Acquired Hemophilia a and Factor XIII Consumption","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; St. Michael's Hospital; Hôpital Maisonneuve-Rosemont; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Thromboelastometry; Partial thromboplastin time; Recombinant factor VIIa; Tranexamic acid; Gastroenterology; Surgery; Desmopressin; Internal medicine; Coagulopathy; Bleeding diathesis; Hemostasis; Coagulation; Platelet","score_opus":0.07639342385341538,"score_gpt":0.3572868810314155,"score_spread":0.28089345717800007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2486042188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987598,0.0004180203,0.0000035838923,0.0001699474,0.000027399587,0.00023532625,0.000022460657,0.000028557888,0.00033488765],"genre_scores_gemma":[0.9992059,0.00003750344,0.00026659045,0.000018833764,0.000076237346,0.0000058875376,0.000019350759,0.000009893728,0.00035982026],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99939233,0.00003648676,0.00012110481,0.0001476938,0.00016168192,0.00014071872],"domain_scores_gemma":[0.99937725,0.000027234195,0.000026291511,0.00018404084,0.000090380636,0.00029482826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010848997,0.00007885588,0.00017273932,0.00007718094,0.000028104669,0.000008027021,0.00002656812,0.00007029539,0.000046328438],"category_scores_gemma":[0.000056944325,0.00005792644,0.000025676793,0.00006562277,0.000104998886,0.00006175677,0.000020236637,0.000034425422,0.000018673729],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005284187,0.0030466928,0.8524988,0.00029565088,0.00026810024,0.0066990964,0.00258057,2.7311194e-7,0.12342434,0.00014977308,0.00020665188,0.010301577],"study_design_scores_gemma":[0.058419872,0.01042434,0.26791057,0.0002717449,0.0011684777,0.023161938,0.0020871782,0.0007289126,0.6339575,0.000468685,0.0008115393,0.00058924063],"about_ca_topic_score_codex":0.000056596153,"about_ca_topic_score_gemma":0.000014050806,"teacher_disagreement_score":0.5845883,"about_ca_system_score_codex":0.000013435068,"about_ca_system_score_gemma":0.00008125165,"threshold_uncertainty_score":0.23621717},"labels":[],"label_agreement":null},{"id":"W2486308028","doi":"10.1182/blood.v126.23.3653.3653","title":"A Tumor Suppressor microRNA Defines the Leukemic Hierarchy in Acute Myeloid Leukemia","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"miR-155; microRNA; Cancer research; Leukemia; Bone marrow; Myeloid leukemia; Biology; Myeloid; Transplantation; In vivo; Medicine; Immunology; Internal medicine; Gene","score_opus":0.011398012072509827,"score_gpt":0.2341764651243891,"score_spread":0.2227784530518793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2486308028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967505,0.0021344256,0.000038805767,0.00019464603,0.00008859536,0.00023960281,0.000033758213,0.000016394437,0.00050328305],"genre_scores_gemma":[0.9985038,0.000044164364,0.00047096188,0.00025881355,0.00020464192,0.00005145549,0.00012482991,0.000027197628,0.00031411182],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990186,0.000082654704,0.00020475603,0.00029821473,0.00012985396,0.0002659344],"domain_scores_gemma":[0.99929804,0.000011429464,0.00007560916,0.00044841773,0.000067172805,0.00009932416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018320608,0.00015612302,0.00012942964,0.000045286713,0.000043151,0.000030935593,0.00030834103,0.00009262781,0.000008584857],"category_scores_gemma":[0.00009403551,0.00012165858,0.00007517179,0.00012364134,0.00008817952,0.0000052649,0.00015547732,0.000100216355,0.000032556123],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008921023,0.00007533474,0.0043121222,0.000010034474,0.00006697096,0.00002105453,0.000078223704,0.00005916503,0.9918614,0.000033788874,0.0032287536,0.0001639648],"study_design_scores_gemma":[0.0029719304,0.00010808593,0.031448644,0.000021176895,0.000099114615,0.00017889886,0.000055358625,0.00006223889,0.9486392,0.00030159103,0.01586268,0.00025103783],"about_ca_topic_score_codex":0.00005591738,"about_ca_topic_score_gemma":0.00005419096,"teacher_disagreement_score":0.043222133,"about_ca_system_score_codex":0.00005266502,"about_ca_system_score_gemma":0.00034823405,"threshold_uncertainty_score":0.49610928},"labels":[],"label_agreement":null},{"id":"W2486618869","doi":"10.1182/blood.v122.21.5465.5465","title":"MCP-1 and VCAM-1 As Pathological Markers In a Patient With Infection Induced Hemophagocytic Syndrome After Stem Cell Transplantation","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Transplantation; Stem cell; Immunology; Medicine; VCAM-1; Lymphocyte; Peripheral blood mononuclear cell; Cell adhesion molecule; Biology; Pathology; Internal medicine; ICAM-1","score_opus":0.008276704016882715,"score_gpt":0.2209770765024561,"score_spread":0.21270037248557339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2486618869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99754876,0.00019187959,0.000006538487,0.000084434236,0.000012900348,0.0007325875,0.0000011706129,0.00002938996,0.0013923284],"genre_scores_gemma":[0.9993491,0.00010785916,0.00004507172,0.00011048247,0.0000047109925,0.00023125444,0.000008182557,0.000013294073,0.00013004686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991384,0.00006687129,0.00019919754,0.0001990389,0.00019544395,0.00020103106],"domain_scores_gemma":[0.99970365,0.000023416165,0.000038605718,0.00011973444,0.000038591243,0.00007602723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008982483,0.00011264578,0.00019146012,0.00012557853,0.000030606545,0.000021098307,0.000022291108,0.0001017579,0.0001671986],"category_scores_gemma":[0.0000060315874,0.00008203231,0.00002524415,0.00014663163,0.00003970486,0.00014233284,0.0000138420855,0.00020488273,0.00008099445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018280676,0.002234745,0.90885967,0.0013232491,0.000106167,0.009499841,0.0043904185,0.000006766696,0.042042337,0.00001225432,0.000038327456,0.029658142],"study_design_scores_gemma":[0.004236912,0.002191178,0.9868979,0.00013282952,0.000055027616,0.0015199253,0.00034121776,0.000036688376,0.004430826,0.000017528118,0.000024406352,0.00011557337],"about_ca_topic_score_codex":0.00016348754,"about_ca_topic_score_gemma":0.000013907212,"teacher_disagreement_score":0.07803821,"about_ca_system_score_codex":0.000024175697,"about_ca_system_score_gemma":0.000059824786,"threshold_uncertainty_score":0.33451805},"labels":[],"label_agreement":null},{"id":"W2486896794","doi":"10.1182/blood.v124.21.3075.3075","title":"Safe and Effective Treatment of Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma (PTCL) and Low Baseline Platelet Counts with Belinostat","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Tolerability; Peripheral T-cell lymphoma; Clinical endpoint; Vincristine; Clinical trial; Prednisone; Gastroenterology; Cyclophosphamide; CHOP; Lymphoma; Refractory (planetary science); Oncology; Adverse effect; Surgery; Chemotherapy; Immunology; T cell; Immune system","score_opus":0.002810827406808201,"score_gpt":0.20409130660820227,"score_spread":0.20128047920139405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2486896794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988406,0.00031013938,0.00003558134,0.000006257019,0.000014510405,0.0002746195,0.000057456993,0.0000041440867,0.00045672382],"genre_scores_gemma":[0.99870837,0.00010837839,0.00038063948,0.00001673597,0.00004528871,0.00002019575,0.000116427094,0.00002006165,0.00058390177],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99936765,0.0000644146,0.00008811543,0.00023114789,0.00012012595,0.00012853734],"domain_scores_gemma":[0.99960667,0.00003096944,0.00004778002,0.00016276854,0.00008122296,0.00007061678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005919918,0.00012065878,0.00013999388,0.000023969946,0.000040118586,0.0000069132207,0.000030758514,0.00007155686,0.000011802333],"category_scores_gemma":[0.000024239996,0.000077400604,0.000013911348,0.0000351499,0.00010870098,0.0000030123992,0.000017922837,0.000025802112,0.0000023741275],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022771524,0.015755385,0.16941194,0.00077007926,0.0011132557,0.00016245313,0.0013410848,0.000029247829,0.61758804,0.000009969404,0.0023089591,0.16873804],"study_design_scores_gemma":[0.032273266,0.019957008,0.018924598,0.000071486575,0.000096289434,0.0000280593,0.00003350062,0.00006719464,0.8945827,0.0000011877207,0.033623345,0.0003413938],"about_ca_topic_score_codex":0.000020909118,"about_ca_topic_score_gemma":0.000038286304,"teacher_disagreement_score":0.27699462,"about_ca_system_score_codex":0.00001774768,"about_ca_system_score_gemma":0.000058159003,"threshold_uncertainty_score":0.3156305},"labels":[],"label_agreement":null},{"id":"W2487559809","doi":"10.1182/blood.v122.21.5417.5417","title":"Severe Adverse Skin Reaction Used For Sclerodermatous Chronic Graft Versus Host Disease Of The Skin","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor; Windsor Regional Hospital; Windsor Clinical Research","funders":"","keywords":"Medicine; Graft-versus-host disease; Dermatology; Tacrolimus; Skin biopsy; Photopheresis; Chronic myelogenous leukemia; Erythroderma; Hematopoietic stem cell transplantation; Adverse effect; Imatinib; Imatinib mesylate; Rash; Transplantation; Surgery; Biopsy; Disease; Leukemia; Immunology; Internal medicine","score_opus":0.015302082453512264,"score_gpt":0.23750644860095713,"score_spread":0.22220436614744488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2487559809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99546367,0.001683365,0.000004463709,0.00054749637,0.00048351628,0.0013647389,0.00005031804,0.000050592116,0.00035182427],"genre_scores_gemma":[0.9989029,0.00014823404,0.000026198348,0.00009262145,0.00024668564,0.00015891362,0.00003067851,0.000028308405,0.00036546722],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989812,0.000041919346,0.00028138974,0.0002167588,0.0002621834,0.00021654676],"domain_scores_gemma":[0.9989569,0.00009523067,0.00016493903,0.0004735815,0.00011977934,0.00018955406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006586515,0.00014220821,0.00022269608,0.00004901475,0.00008949794,0.000009367062,0.00011263702,0.00010086896,0.00009700589],"category_scores_gemma":[0.00012740011,0.000091735856,0.00028943137,0.00015048154,0.00006771536,0.00008739037,0.00003345118,0.000093037255,0.00006054547],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036862178,0.010447147,0.12969951,0.004562571,0.004384027,0.000041956482,0.002081846,0.00015788572,0.7650014,0.0005765616,0.06878343,0.010577396],"study_design_scores_gemma":[0.032314893,0.00036777742,0.92025155,0.0020930646,0.0025107793,0.000038388815,0.00071235065,0.0003349818,0.038982563,0.000039537965,0.0020360665,0.00031806147],"about_ca_topic_score_codex":0.00013781984,"about_ca_topic_score_gemma":0.000013262894,"teacher_disagreement_score":0.790552,"about_ca_system_score_codex":0.000063553125,"about_ca_system_score_gemma":0.0002134464,"threshold_uncertainty_score":0.37408796},"labels":[],"label_agreement":null},{"id":"W2487654999","doi":"10.1182/blood.v104.11.4013.4013","title":"The Care of Immigrant Children with Haemophilia.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Haemophilia; Medicine; Haemophilia A; Immigration; Population; Haemophilia B; Pediatrics; Health care; Demography; Family medicine; Geography; Environmental health","score_opus":0.01028004377955124,"score_gpt":0.2587420736543931,"score_spread":0.24846202987484187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2487654999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937171,0.0025201,0.0000015618682,0.0014186117,0.000011366181,0.0003612974,0.00000667306,0.000019291141,0.0019440359],"genre_scores_gemma":[0.9991568,0.00018804774,0.000191739,0.000020098887,0.000071363254,0.000012299738,0.000016438109,0.000011446927,0.00033181685],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993519,0.000009560086,0.00009300055,0.000111064044,0.0002594846,0.00017498694],"domain_scores_gemma":[0.9995451,0.000017676957,0.000022329583,0.00026451374,0.00008090027,0.00006949855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004946575,0.0000747541,0.00012772372,0.000030655247,0.00009541563,0.0000066187163,0.00007417316,0.00003450656,0.000008622905],"category_scores_gemma":[0.000016006325,0.000033823017,0.00005474133,0.0001239478,0.00012680763,0.000014847266,0.000018175866,0.00009393722,0.000018486395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004595389,0.0017308433,0.96747893,0.000118765216,0.0013188507,0.00026501904,0.0031525155,0.000010530344,0.008555061,0.0010174649,0.000088936715,0.015803572],"study_design_scores_gemma":[0.016366538,0.002268145,0.6726278,0.00023098139,0.000523946,0.00038559758,0.00093099073,4.182852e-7,0.30582812,0.00017879627,0.0005261943,0.00013245048],"about_ca_topic_score_codex":0.00015797121,"about_ca_topic_score_gemma":0.00007104431,"teacher_disagreement_score":0.29727307,"about_ca_system_score_codex":0.000015992591,"about_ca_system_score_gemma":0.00013271745,"threshold_uncertainty_score":0.13792625},"labels":[],"label_agreement":null},{"id":"W2487764397","doi":"10.1182/blood.v118.21.381.381","title":"Diagnostic Fidelity of Historically Diagnosed Patients with VWD Enrolled from 27 Centers in the ZPMCB-VWD","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Von Willebrand disease; Medicine; Von Willebrand factor; Pediatrics; Internal medicine; Gastroenterology; Platelet","score_opus":0.011266746624604217,"score_gpt":0.20125219815434747,"score_spread":0.18998545152974325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2487764397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99701375,0.00034507073,0.000007519793,0.000069887996,0.00007487805,0.0005950623,0.00004931507,0.000014771515,0.0018297618],"genre_scores_gemma":[0.9991475,0.00007090388,0.0003265971,0.00026077722,0.000015270341,0.000046870697,0.000096367556,0.000013633679,0.000022124297],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990239,0.00005655177,0.00025375537,0.00020778897,0.0002680513,0.00018992352],"domain_scores_gemma":[0.9991252,0.00033004326,0.000103601895,0.00031564196,0.00005743365,0.00006810434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006657795,0.0001380236,0.0003346329,0.000051026662,0.000025179334,0.0000037200653,0.00012096201,0.00005691481,0.000095843825],"category_scores_gemma":[0.0002555837,0.00008376627,0.000066059416,0.00013686961,0.000046564197,0.000042508982,0.000020251799,0.00010670854,0.000017683671],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003768457,0.00746069,0.9889964,0.000014804996,0.00017433878,0.0005486095,0.001428465,2.1666473e-7,0.000017518156,0.0000068522886,0.00028464638,0.0006906088],"study_design_scores_gemma":[0.017359504,0.0007279945,0.9808515,0.00008904206,0.0003306289,0.0000028986208,0.00007631375,0.0000012761774,0.00016145554,0.00012781346,0.00018737782,0.00008421125],"about_ca_topic_score_codex":0.0019315822,"about_ca_topic_score_gemma":0.00031086145,"teacher_disagreement_score":0.01698266,"about_ca_system_score_codex":0.000035187073,"about_ca_system_score_gemma":0.00004785524,"threshold_uncertainty_score":0.34158894},"labels":[],"label_agreement":null},{"id":"W2488017628","doi":"10.1182/blood.v122.21.1942.1942","title":"Anti Tumor Activity Of Selinexor (KPT-330), A First-In-Class Oral Selective Inhibitor Of Nuclear Export (SINE) XPO1/CRM1 Antagonist In Patients (pts) With Relapsed / Refractory Multiple Myeloma (MM) Or Waldenstrom’s Macroglobulinemia (WM)","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ozmosis Research (Canada); University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Neutropenia; Gastroenterology; Febrile neutropenia; Internal medicine; Medicine; Dysgeusia; Pharmacodynamics; Nausea; Adverse effect; Refractory (planetary science); Vomiting; Phases of clinical research; Leukopenia; Pharmacokinetics; Pharmacology; Toxicity; Biology","score_opus":0.00481352103557048,"score_gpt":0.19424172806053028,"score_spread":0.1894282070249598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2488017628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990387,0.000028089786,0.000008572103,0.00003990849,0.00010918008,0.000551504,0.00006176162,0.000015787356,0.0001464914],"genre_scores_gemma":[0.99862206,0.000019356714,0.00097483705,0.000057678477,0.00010746096,0.000019489313,0.000075854914,0.000054781078,0.00006847893],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984448,0.000072528856,0.00043446076,0.00049247587,0.0002284078,0.0003273061],"domain_scores_gemma":[0.9989224,0.000020946156,0.00034029328,0.00038246185,0.0002492741,0.00008463892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009818387,0.0002733467,0.00044101913,0.000107305226,0.000053258365,0.000015708078,0.00016513026,0.00022710052,0.00004788739],"category_scores_gemma":[0.00012472588,0.00022194069,0.000084910396,0.00027075695,0.00013448452,0.000027904523,0.000093723684,0.00023678227,0.0000067158935],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026042408,0.0016778607,0.28333786,0.00011176139,0.000113168164,0.000022749573,0.00015480576,0.000023148832,0.70994633,0.0000017963373,0.0009837465,0.0010225537],"study_design_scores_gemma":[0.008835596,0.0030325684,0.62290746,0.00009753295,0.00006147143,0.000025519937,0.00013538584,0.00014942887,0.36279163,0.0000037663756,0.0016224073,0.00033722297],"about_ca_topic_score_codex":0.00040070436,"about_ca_topic_score_gemma":0.0006741892,"teacher_disagreement_score":0.34715468,"about_ca_system_score_codex":0.000042517655,"about_ca_system_score_gemma":0.00012420489,"threshold_uncertainty_score":0.90504783},"labels":[],"label_agreement":null},{"id":"W2488182585","doi":"10.1182/blood.v116.21.39.39","title":"A Randomized Phase III Trial of Thalidomide and Prednisone as Maintenance Therapy Following Autologous Stem Cell Transplantation (ASCT) In Patients with Multiple Myeloma (MM): The NCIC CTG MY.10 Trial","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; London Health Sciences Centre; McGill University Health Centre; Hôpital Maisonneuve-Rosemont; Université de Montréal; Queen Elizabeth II Health Sciences Centre; University of Alberta; Saint John Regional Hospital; Saskatchewan Cancer Agency; Victoria Hospital; University of Calgary; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Thalidomide; Lenalidomide; Internal medicine; Prednisone; Multiple myeloma; Clinical endpoint; Maintenance therapy; Transplantation; Autologous stem-cell transplantation; Randomized controlled trial; Surgery; Clinical trial; Oncology; Chemotherapy","score_opus":0.013811884603905358,"score_gpt":0.27841976064123836,"score_spread":0.264607876037333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2488182585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910313,0.00015729225,0.000029942119,0.000075460914,0.00016594387,0.008188722,0.000042325235,0.000031346408,0.0002776826],"genre_scores_gemma":[0.9985272,0.000118189324,0.00031403813,0.00002371653,0.0000803923,0.0005837451,0.00008654546,0.000030213829,0.00023594391],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99778473,0.00036893488,0.0005650288,0.00035505625,0.00054471736,0.00038153934],"domain_scores_gemma":[0.9983074,0.00086750387,0.00023893158,0.0003502279,0.00008868044,0.00014726135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008483947,0.00025256342,0.0008858777,0.00013358593,0.00010065372,0.000027354505,0.00012701102,0.00013352439,0.00003765582],"category_scores_gemma":[0.00021557599,0.00013789869,0.00021411476,0.00017458409,0.00017796682,0.00010387813,0.00001682988,0.00029096156,0.0000042171937],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9754101,0.004852103,0.006817531,0.000046591726,0.0004901489,0.00013967724,0.0013198366,6.8585274e-7,0.0028703513,0.0000065371523,0.0000050373574,0.008041414],"study_design_scores_gemma":[0.9663871,0.0053258175,0.00980222,0.00009119507,0.0004286558,0.000015508662,0.00009757774,0.00015065553,0.017534446,0.000016793394,0.00001917457,0.0001308569],"about_ca_topic_score_codex":0.00031402035,"about_ca_topic_score_gemma":0.00013697492,"teacher_disagreement_score":0.014664094,"about_ca_system_score_codex":0.000018828467,"about_ca_system_score_gemma":0.0001784243,"threshold_uncertainty_score":0.5623346},"labels":[],"label_agreement":null},{"id":"W2488510469","doi":"10.1182/blood.v110.11.412.412","title":"Prolonged Overall Survival with Lenalidomide Plus Dexamethasone Compared with Dexamethasone Alone in Patients with Relapsed or Refractory Multiple Myeloma.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Dexamethasone; Medicine; Lenalidomide; Thalidomide; Placebo; Refractory (planetary science); Multiple myeloma; Internal medicine; Corticosteroid; Phases of clinical research; Gastroenterology; Urology; Surgery; Chemotherapy","score_opus":0.02657669359127127,"score_gpt":0.27442810623955693,"score_spread":0.24785141264828567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2488510469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954514,0.00017362364,0.0003902044,0.00008730571,0.000040290903,0.0030061472,0.000046865658,0.00015504276,0.0006491052],"genre_scores_gemma":[0.97730523,0.000018141218,0.021296209,0.00009620652,0.00008857445,0.00015467395,0.00034728853,0.00013770847,0.0005559922],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99543554,0.00023787738,0.0005887161,0.00090996514,0.0015649857,0.0012628963],"domain_scores_gemma":[0.9968843,0.00081935374,0.00028947587,0.0008669185,0.0004333477,0.00070661836],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00076790806,0.00060606044,0.0011599768,0.00044415705,0.00015069768,0.000047199068,0.00022627984,0.00020559442,0.00010497531],"category_scores_gemma":[0.00045112133,0.0003558339,0.000074695294,0.00082326634,0.00030077435,0.00027479406,0.00007606121,0.00073896284,0.00003246831],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13191168,0.0060590045,0.8551809,0.00013290638,0.0010397703,0.002660305,0.00044348463,0.000030195313,0.0007331201,0.0000032587827,0.000023515102,0.001781819],"study_design_scores_gemma":[0.18020497,0.0077830222,0.805907,0.00049249025,0.0003396877,0.00009063783,0.00017270302,0.000092190334,0.0043533905,0.0000019868512,0.00013345802,0.0004284354],"about_ca_topic_score_codex":0.0011783601,"about_ca_topic_score_gemma":0.009973891,"teacher_disagreement_score":0.049273916,"about_ca_system_score_codex":0.00037044514,"about_ca_system_score_gemma":0.0005881947,"threshold_uncertainty_score":0.9998894},"labels":[],"label_agreement":null},{"id":"W2489240616","doi":"10.1182/blood.v126.23.2745.2745","title":"Ibrutinib Therapy in Rituximab-Refractory Patients with Waldenström's Macroglobulinemia: Initial Results from an International, Multicenter, Open-Label Phase 3 Substudy (iNNOVATETM)","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; Royal Victoria Regional Health Centre; Royal Victoria Hospital; Dalhousie University","funders":"","keywords":"Ibrutinib; Rituximab; Medicine; Waldenstrom macroglobulinemia; Macroglobulinemia; Open label; Internal medicine; Refractory (planetary science); Lymphoplasmacytic Lymphoma; Phases of clinical research; Oncology; Clinical trial; Lymphoma; Leukemia; Multiple myeloma; Chronic lymphocytic leukemia","score_opus":0.09222182345165915,"score_gpt":0.4035739745569185,"score_spread":0.3113521511052594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2489240616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952856,0.00013231792,0.000004535033,0.00028955124,0.0003581663,0.0016421098,0.0004957825,0.00007548005,0.0017164941],"genre_scores_gemma":[0.99508363,0.00007992165,0.001576553,0.00053188764,0.00036782084,0.00007758806,0.0020746908,0.000069817885,0.00013806994],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99659353,0.00015733879,0.0007511357,0.0008097935,0.0011386618,0.00054951105],"domain_scores_gemma":[0.99753153,0.0001575615,0.000228327,0.0008955912,0.0007576807,0.00042931677],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005513529,0.00033571865,0.0005348528,0.00022765102,0.00005847638,0.00016264785,0.0008248917,0.00019220676,0.00010899638],"category_scores_gemma":[0.00054134696,0.00026621838,0.0000311204,0.00041618425,0.00016331425,0.0006253579,0.0003359691,0.00053291075,0.00010943651],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21708192,0.4550577,0.21159476,0.00007560308,0.002174344,0.0092978375,0.01134303,0.0000124003045,0.003971631,0.000039143037,0.0040142867,0.08533732],"study_design_scores_gemma":[0.9667381,0.0049890424,0.016158734,0.00023389049,0.000084325846,0.000042167194,0.00037661073,0.0013560413,0.005971636,0.000019754027,0.0036541969,0.00037551156],"about_ca_topic_score_codex":0.0051543075,"about_ca_topic_score_gemma":0.00047508004,"teacher_disagreement_score":0.74965614,"about_ca_system_score_codex":0.002371013,"about_ca_system_score_gemma":0.0031993503,"threshold_uncertainty_score":0.999979},"labels":[],"label_agreement":null},{"id":"W2489660615","doi":"10.1182/blood.v126.23.3252.3252","title":"Proxe: A Public Repository of Xenografts to Facilitate Studies of Biology and Expedite Preclinical Drug Development in Leukemia and Lymphoma","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lymphoma; Context (archaeology); Cancer research; Biology; Immunophenotyping; Transplantation; Leukemia; Computational biology; Medicine; Immunology; Flow cytometry; Internal medicine","score_opus":0.14710807587399818,"score_gpt":0.3776092034881212,"score_spread":0.23050112761412303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2489660615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99347204,0.005205724,0.0000017545034,0.00028168378,0.000058730897,0.00046508652,0.0000026014213,0.000010977679,0.0005014012],"genre_scores_gemma":[0.9972112,0.00021181177,0.0012054878,0.000028510573,0.000051484833,0.000067745335,0.0000028119637,0.0000084100375,0.0012125202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99883616,0.00011634157,0.0004243887,0.00024233492,0.00019123123,0.00018951728],"domain_scores_gemma":[0.999149,0.0002023694,0.00006386351,0.00018268071,0.00022328527,0.0001787704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085992017,0.000093848634,0.0004043339,0.0001801097,0.000017147517,0.000004633116,0.000059659305,0.00006281285,0.0000038864255],"category_scores_gemma":[0.0006119595,0.00007467203,0.00002095368,0.00016338013,0.00025969392,0.00003306832,0.00017515245,0.00006965682,9.280506e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010499422,0.0009001716,0.7950009,0.0005745866,0.0005107577,0.000055364348,0.040452123,2.9519816e-7,0.10549796,0.000028429566,0.00066134305,0.055268146],"study_design_scores_gemma":[0.03985304,0.004982834,0.5167046,0.0008132893,0.00015570411,0.000284184,0.009224445,0.000025110812,0.37973532,0.00034406467,0.047379717,0.0004976609],"about_ca_topic_score_codex":0.00007946495,"about_ca_topic_score_gemma":0.00007498313,"teacher_disagreement_score":0.27829626,"about_ca_system_score_codex":0.00007188382,"about_ca_system_score_gemma":0.00048707853,"threshold_uncertainty_score":0.30450374},"labels":[],"label_agreement":null},{"id":"W2489746138","doi":"10.1182/blood.v126.23.2944.2944","title":"Comparing Single-Agent Ibrutinib, Bendamustine Plus Rituximab (BR) and Ibrutinib Plus BR in Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): An Indirect Comparison of the RESONATE and HELIOS Trials","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Ibrutinib; Chemoimmunotherapy; Bendamustine; Internal medicine; Rituximab; Clinical endpoint; Ofatumumab; Oncology; Placebo; Progression-free survival; Chronic lymphocytic leukemia; Surgery; Clinical trial; Leukemia; Lymphoma; Chemotherapy; Pathology","score_opus":0.09230312178758879,"score_gpt":0.30836650103277735,"score_spread":0.21606337924518856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2489746138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98726535,0.008196625,0.0000075857492,0.00003308935,0.0001498136,0.0035179027,0.00005193663,0.00015429147,0.00062339235],"genre_scores_gemma":[0.99856967,0.00014469851,0.00034738696,0.000065273845,0.00021928256,0.00011919615,0.00014243013,0.00014651199,0.0002455614],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9929012,0.0010255239,0.001980449,0.0012516718,0.0015004323,0.0013407392],"domain_scores_gemma":[0.99567354,0.0007157231,0.00094572036,0.001335536,0.00044991935,0.00087956747],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022244672,0.0008310877,0.0030589052,0.0005580291,0.0002242882,0.00015539087,0.0005840384,0.0004092865,0.000029592622],"category_scores_gemma":[0.0014227191,0.0005923708,0.00018589583,0.0011709509,0.00076409266,0.00025243143,0.0006361777,0.00037336798,0.00001772777],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.09540025,0.017619457,0.75024176,0.011056732,0.0054517672,0.0013707157,0.031278554,0.011941167,0.004642844,0.00014222776,0.0010201226,0.06983438],"study_design_scores_gemma":[0.7244861,0.007973906,0.09956817,0.0039659827,0.002511458,0.0008323869,0.0008560179,0.13368794,0.024336169,0.000018965191,0.0005596303,0.0012032314],"about_ca_topic_score_codex":0.006180781,"about_ca_topic_score_gemma":0.0018501249,"teacher_disagreement_score":0.65067357,"about_ca_system_score_codex":0.06917291,"about_ca_system_score_gemma":0.035744965,"threshold_uncertainty_score":0.99965274},"labels":[],"label_agreement":null},{"id":"W2490416508","doi":"10.1182/blood.v116.21.353.353","title":"Novel Photodepletion Strategy to Preserve and Expand Tregs While Eliminating CD4+ Effector T Cells From Patients with Chronic Graft-Versus-Host Disease","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Ottawa Hospital; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Graft-versus-host disease; IL-2 receptor; FOXP3; Immunology; Transplantation; Biology; Medicine; T cell; Immune system; Internal medicine","score_opus":0.011036038127030346,"score_gpt":0.2321329884253559,"score_spread":0.22109695029832555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2490416508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99765676,0.000060780618,0.00028313848,0.000039827177,0.00016840693,0.0011537817,0.00029065792,0.00005786401,0.0002887988],"genre_scores_gemma":[0.9979549,0.000008121558,0.0013377541,0.000027051483,0.00015492733,0.000093702125,0.000340054,0.000040172952,0.00004330901],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99878806,0.000025391835,0.00020277766,0.00039386796,0.00034086368,0.00024902806],"domain_scores_gemma":[0.9989826,0.00019038965,0.00007451517,0.0003017388,0.00009157764,0.00035917247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000080511076,0.00019942402,0.0002271434,0.000066505636,0.00007026886,0.000041974137,0.00006970192,0.00008349609,0.00014501814],"category_scores_gemma":[0.00004353069,0.00016482784,0.000036509417,0.00011120436,0.00004057953,0.000111038906,0.000021099067,0.00017415578,0.000028689203],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015151518,0.0011963971,0.08555268,0.00057867,0.00013141529,0.00003492013,0.0008528069,0.000010201049,0.90928656,0.000011518066,0.00003616735,0.00079352246],"study_design_scores_gemma":[0.024084562,0.0019161003,0.687561,0.00054082903,0.0008368514,0.000004732264,0.00008457486,0.00023791993,0.28435034,0.0000029136252,0.00007859779,0.00030160393],"about_ca_topic_score_codex":0.00024012265,"about_ca_topic_score_gemma":0.00047935144,"teacher_disagreement_score":0.6249362,"about_ca_system_score_codex":0.000023464016,"about_ca_system_score_gemma":0.00008738279,"threshold_uncertainty_score":0.67214847},"labels":[],"label_agreement":null},{"id":"W2490755617","doi":"10.1182/blood.v126.23.4227.4227","title":"Phase 1/1b Pharmacokinetic (PK) and Safety Study of the Investigational Oral Proteasome Inhibitor (PI) Ixazomib in Relapsed/Refractory Multiple Myeloma (RRMM) Patients (Pts) with Severe Renal Impairment or End-Stage Renal Disease (ESRD) Requiring Hemodialysis","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Ixazomib; Medicine; Urology; Hemodialysis; Pharmacokinetics; Dosing; Cmax; Multiple myeloma; Dialysis; Renal function; Pharmacology; Internal medicine; Pharmacodynamics; End stage renal disease; Surgery; Proteasome inhibitor; Carfilzomib","score_opus":0.03441198321908557,"score_gpt":0.2973784338222597,"score_spread":0.26296645060317414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2490755617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99532306,0.00009958699,0.0000041499798,0.00014820797,0.00004762102,0.0039737,0.00030819842,0.000035877994,0.000059615944],"genre_scores_gemma":[0.9983514,0.000009759007,0.00052538473,0.000060368144,0.000111133704,0.0004113176,0.00017715147,0.000045662742,0.00030783194],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964927,0.00040245193,0.0006401399,0.0005966293,0.0013716468,0.000496447],"domain_scores_gemma":[0.99789345,0.00014585568,0.00028407216,0.00051308004,0.00026979353,0.00089372875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044776153,0.0003683028,0.0005245597,0.0002470819,0.00015303779,0.00003142815,0.00018598464,0.000073006515,0.00008754616],"category_scores_gemma":[0.00061917864,0.00022309535,0.00009051017,0.0005112789,0.00023905361,0.00021367866,0.00023494448,0.00037644865,0.0000048530355],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025366263,0.04034251,0.9228432,0.00019172321,0.0006406491,0.00057544356,0.0016506532,0.00012555449,0.0028906465,0.0000017887481,0.0000848845,0.0052866666],"study_design_scores_gemma":[0.28386804,0.008899544,0.6974599,0.000505136,0.00071112154,0.000034492834,0.00047635022,0.0014607417,0.006031395,0.000013453832,0.00020108726,0.0003387591],"about_ca_topic_score_codex":0.00024060695,"about_ca_topic_score_gemma":0.00034391895,"teacher_disagreement_score":0.25850177,"about_ca_system_score_codex":0.0002646209,"about_ca_system_score_gemma":0.00078333955,"threshold_uncertainty_score":0.9097565},"labels":[],"label_agreement":null},{"id":"W2491588201","doi":"10.1182/blood.v122.21.3529.3529","title":"Specific Gtpase Dynamin Isoforms Regulate Megakaryocyte Membrane Remodeling and The Formation Of Multivesicular Bodies and Microparticles","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Dynamin; Pleckstrin homology domain; Cell biology; Biology; GTPase; Endocytosis; Vesicle; Membrane; Signal transduction; Biochemistry; Cell","score_opus":0.008565210029648577,"score_gpt":0.20644259665678452,"score_spread":0.19787738662713594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2491588201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99454224,0.0041417833,0.00007851471,0.00054003217,0.000009227455,0.0004418996,0.000003721587,0.000014143187,0.00022845749],"genre_scores_gemma":[0.99700916,0.0015026114,0.0013265358,0.000043071836,0.000009200497,0.000015225633,0.000010742369,0.0000080437585,0.0000754275],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994747,0.000019148107,0.00018529397,0.00011089538,0.000088644105,0.000121285215],"domain_scores_gemma":[0.99967515,0.00003825412,0.000066095025,0.00012968821,0.000045952427,0.000044874145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009849362,0.000092908995,0.00021888157,0.000035977162,0.00007402916,0.000019899186,0.00002306636,0.000031763466,0.000006483673],"category_scores_gemma":[0.000018001367,0.000051896073,0.000034099347,0.000029393343,0.00013760474,0.00016241764,0.000025988047,0.000043731776,0.0000049776118],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001596246,0.0016874999,0.0130707845,0.00091782055,0.00085753866,0.0001802005,0.014300555,0.00006342134,0.88195753,0.0007994106,0.00014526074,0.08442374],"study_design_scores_gemma":[0.05373817,0.0004253992,0.06172596,0.00042461077,0.000959336,0.0009792006,0.0023937863,0.071572416,0.8025214,0.004716028,0.00020248843,0.0003412147],"about_ca_topic_score_codex":0.00008413546,"about_ca_topic_score_gemma":0.00000913021,"teacher_disagreement_score":0.08408253,"about_ca_system_score_codex":0.000004985575,"about_ca_system_score_gemma":0.00000477801,"threshold_uncertainty_score":0.21162605},"labels":[],"label_agreement":null},{"id":"W2492107421","doi":"10.1182/blood.v126.23.5231.5231","title":"Profiles of Telomere Length Adult and Childhood Myelodysplastic Syndromes: A Comparison with Hematologic Diseases","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Telomere; Telomerase; Dyskeratosis congenita; Biology; Aplastic anemia; Bone marrow failure; Fanconi anemia; Myelodysplastic syndromes; Leukemia; Stem cell; Bone marrow; Internal medicine; Immunology; Pathology; Cancer research; Medicine; Genetics; Haematopoiesis; DNA repair; Gene","score_opus":0.01944308792780474,"score_gpt":0.25063030315679485,"score_spread":0.2311872152289901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2492107421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99520385,0.003419909,0.00002281334,0.00018997787,0.000045221404,0.00048476987,0.00004392825,0.00012351276,0.00046601734],"genre_scores_gemma":[0.9980743,0.00010406878,0.0015283651,0.00007961403,0.000055847864,0.00003421297,0.000033648037,0.000028800285,0.000061177096],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998519,0.000044805838,0.00035392673,0.00036736534,0.00040655845,0.00030831335],"domain_scores_gemma":[0.9987746,0.00011120923,0.00016881876,0.00033207022,0.00021661361,0.0003967035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006452051,0.0002556327,0.00071809377,0.00013868003,0.000055545697,0.000016774693,0.000108709835,0.00008925311,0.000020390433],"category_scores_gemma":[0.00034187423,0.00017465353,0.000052236825,0.00027871577,0.00025855782,0.000092126706,0.000050278337,0.00016612756,0.000015971244],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003102319,0.00271457,0.99230886,0.0007194102,0.00026367718,0.00025261208,0.0013486417,0.0000026905277,0.00042565275,0.00042334248,0.00034294277,0.0008873441],"study_design_scores_gemma":[0.011889075,0.0034819143,0.96366286,0.0013105014,0.0013704003,0.0027537267,0.0045302315,0.00011347292,0.010089467,0.00017129713,0.00013525918,0.0004918219],"about_ca_topic_score_codex":0.000041410432,"about_ca_topic_score_gemma":0.00001682572,"teacher_disagreement_score":0.028646052,"about_ca_system_score_codex":0.000013256379,"about_ca_system_score_gemma":0.00022001789,"threshold_uncertainty_score":0.7122164},"labels":[],"label_agreement":null},{"id":"W2493623723","doi":"10.1182/blood.v112.11.2168.2168","title":"Similar 5-Year Survival after Peripheral Blood Autotransplants (AutoPB) Versus HLA Matched Sibling Myeloablative Transplants (AlloBMT) for Acute Myeloid Leukemia (AML) in First Complete Remission (CR1).","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Univariate analysis; Internal medicine; Gastroenterology; Myeloid leukemia; Bone marrow; Leukemia; Median follow-up; Surgery; Multivariate analysis; Oncology; Chemotherapy","score_opus":0.03901868597526447,"score_gpt":0.2943298293326669,"score_spread":0.2553111433574024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2493623723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927561,0.0004377687,0.00044939423,0.00080232037,0.00037582897,0.0020063622,0.00090376585,0.00028676557,0.0019816868],"genre_scores_gemma":[0.98637927,0.002406784,0.007851035,0.00025538728,0.0005503785,0.0003406976,0.00061332603,0.00021761414,0.0013855245],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9947497,0.00020114958,0.0010094389,0.0012369113,0.001165157,0.0016376403],"domain_scores_gemma":[0.9974262,0.00064643746,0.00018406221,0.000813924,0.00027309393,0.0006562846],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00062653125,0.00079362694,0.0013854085,0.0005339397,0.00043475142,0.000057812154,0.00055940956,0.00063781283,0.0004318513],"category_scores_gemma":[0.00016388275,0.00074902363,0.0004487442,0.0008070378,0.0003269048,0.00036983733,0.00010928796,0.0011997886,0.000073114585],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14824972,0.0066738026,0.33276868,0.004668859,0.012017486,0.03840935,0.035096515,0.0011435726,0.41708827,0.0003079536,0.002211146,0.0013646212],"study_design_scores_gemma":[0.41234034,0.0073932866,0.3903878,0.0044386643,0.008027745,0.004028873,0.0018402787,0.011642006,0.13940662,0.00021156107,0.0153660355,0.004916771],"about_ca_topic_score_codex":0.00028000516,"about_ca_topic_score_gemma":0.00034201503,"teacher_disagreement_score":0.27768168,"about_ca_system_score_codex":0.0006972733,"about_ca_system_score_gemma":0.0011679231,"threshold_uncertainty_score":0.9994961},"labels":[],"label_agreement":null},{"id":"W2494299950","doi":"10.1182/blood.v108.11.5073.5073","title":"Detection of FGFR3 by Immunohistochemistry in Multiple Myeloma Is Highly Predictive of t(4;14) by FISH and Is Associated with CD56 (NCAM1) Expression.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Immunohistochemistry; Molecular biology; Biology; Cyclin D1; Flow cytometry; Cancer; Cell cycle; Immunology; Genetics","score_opus":0.0034694018808860377,"score_gpt":0.2037125414006544,"score_spread":0.20024313951976835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2494299950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99824214,0.0005945985,0.00010700713,0.000022185577,0.000009419059,0.00018439529,0.0006218931,0.000008084106,0.00021029494],"genre_scores_gemma":[0.9991956,0.000029050789,0.00006993322,0.000019000958,0.000016139971,0.000028099765,0.000226253,0.000022321223,0.00039361458],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99896526,0.000046900514,0.00024477683,0.0003142312,0.00022142913,0.00020740725],"domain_scores_gemma":[0.99940294,0.00003227918,0.00016262496,0.00022951163,0.0001291672,0.000043465414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008755992,0.00014561365,0.00019289502,0.000039258535,0.000036771384,0.0000075316634,0.0001221219,0.00021268276,0.000008956865],"category_scores_gemma":[0.00009176778,0.00013848384,0.000042261465,0.00012266758,0.00015670607,0.000007158743,0.000082658284,0.000124758,2.7416087e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024106422,0.0003464656,0.024893785,0.000046723693,0.00006511221,0.0000011923089,0.000053464693,0.0000013011426,0.96941465,8.3866844e-8,0.0048704823,0.000065655506],"study_design_scores_gemma":[0.0025687083,0.0005034763,0.023490539,0.00008376894,0.000019861542,0.000003452756,0.000033683613,0.000026473725,0.9728631,0.0000054466323,0.0002712845,0.00013022027],"about_ca_topic_score_codex":0.00025455854,"about_ca_topic_score_gemma":0.00003206438,"teacher_disagreement_score":0.004599198,"about_ca_system_score_codex":0.000020211715,"about_ca_system_score_gemma":0.000041491756,"threshold_uncertainty_score":0.5647207},"labels":[],"label_agreement":null},{"id":"W2494722392","doi":"10.1182/blood.v126.23.248.248","title":"Higher Incidence of Treatment-Related Toxicities in Non-Hispanic Patients Undergoing Therapy for Newly Diagnosed Pediatric Acute Lymphoblastic Leukemia on Dana-Farber Cancer Institute ALL Consortium Protocol 05-001","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Hamilton Health Sciences; Centre hospitalier universitaire de Québec; Université de Montréal; McMaster Children's Hospital","funders":"","keywords":"Medicine; Incidence (geometry); Prednisone; Exact test; Internal medicine; Pediatric cancer; Pediatrics; Cumulative incidence; Retrospective cohort study; Asparaginase; Cohort; Cancer; Surgery; Leukemia; Lymphoblastic Leukemia","score_opus":0.02789804448033311,"score_gpt":0.318207220209107,"score_spread":0.2903091757287739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2494722392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96028215,0.00008529645,0.000033150787,0.000121854166,0.00035971426,0.038409766,0.00009174995,0.000071245486,0.0005450525],"genre_scores_gemma":[0.9457554,0.0002430182,0.00026865173,0.0004191708,0.00027565382,0.051509563,0.00011018293,0.000098676486,0.0013196407],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9969306,0.00009583892,0.0008412578,0.0006391362,0.00071718625,0.0007759858],"domain_scores_gemma":[0.99763787,0.00067008875,0.00037747604,0.00052967307,0.0004086858,0.0003762291],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022507698,0.00047861726,0.00078017823,0.00045214363,0.00006890336,0.000031165593,0.0002920716,0.0003110606,0.00007410159],"category_scores_gemma":[0.00037457602,0.00037374016,0.00014869896,0.0006199229,0.00019128487,0.00026673384,0.00008813069,0.00021477425,0.00003525211],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0246712,0.02455119,0.89303327,0.0020210163,0.0053413776,0.0015219795,0.0057736454,0.0042007063,0.009602296,0.0004904899,0.019887364,0.008905443],"study_design_scores_gemma":[0.7166893,0.04113061,0.20505147,0.0016201233,0.0024550497,0.000080424354,0.00020422997,0.004136195,0.021179797,0.0004628839,0.005341074,0.0016488776],"about_ca_topic_score_codex":0.001953932,"about_ca_topic_score_gemma":0.00048075154,"teacher_disagreement_score":0.6920181,"about_ca_system_score_codex":0.0042324723,"about_ca_system_score_gemma":0.006377529,"threshold_uncertainty_score":0.99987143},"labels":[],"label_agreement":null},{"id":"W2494811759","doi":"10.1182/blood.v110.11.950.950","title":"Effect of the Percent Decrease in Monoclonal Protein with Induction Therapy on the Outcome after Autologous Stem Cell Transplantation in Patients with IgG and IgA Multiple Myeloma.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Autologous stem-cell transplantation; Multiple myeloma; Internal medicine; Gastroenterology; Thalidomide; Transplantation; Dexamethasone; Creatinine; Beta-2 microglobulin; Bortezomib; Surgery; Urology; Oncology","score_opus":0.01083629602466205,"score_gpt":0.24550617452989026,"score_spread":0.23466987850522822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2494811759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972453,0.000051224106,0.000003396398,0.00006964974,0.00000851765,0.0025654885,0.0000138943105,0.000007883366,0.000034619305],"genre_scores_gemma":[0.99966276,0.000006848031,0.000070651455,0.000031984622,0.000007943931,0.00017562101,0.000014659937,0.000013803445,0.00001575323],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989307,0.00016945906,0.00017585044,0.00018548571,0.00033338374,0.00020514849],"domain_scores_gemma":[0.9995095,0.00014703542,0.00005826536,0.000177838,0.000031137442,0.0000762172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030452255,0.00014054119,0.00017826578,0.00009515456,0.000036163823,0.0000066961516,0.00004700666,0.000053596483,0.0000068217278],"category_scores_gemma":[0.000018750825,0.00005815009,0.000026287964,0.00016066321,0.0000674206,0.00003910648,0.000007528746,0.00018805217,9.208594e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01716938,0.0011080356,0.96945506,0.00009423827,0.00003745567,0.00007980539,0.0005791473,0.000003062877,0.0011458594,0.0000012646949,1.2191154e-7,0.010326536],"study_design_scores_gemma":[0.020167274,0.002964233,0.90313417,0.00016410384,0.000036925827,0.000009850295,0.00003169308,0.000016970771,0.07341742,8.731292e-7,9.601546e-7,0.00005551899],"about_ca_topic_score_codex":0.00025602913,"about_ca_topic_score_gemma":0.00045754557,"teacher_disagreement_score":0.07227156,"about_ca_system_score_codex":0.000043321645,"about_ca_system_score_gemma":0.00003757287,"threshold_uncertainty_score":0.23712918},"labels":[],"label_agreement":null},{"id":"W2494813373","doi":"10.1182/blood.v104.11.3030.3030","title":"Quantitative Assessment of Drug Treatment Side Effects in Children with Idiopathic Thrombocytopenic Purpura (ITP).","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Medicine; Nausea; Vomiting; Chills; Thrombocytopenic purpura; Abdominal pain; Pediatrics; Internal medicine; Surgery; Platelet","score_opus":0.010303708760240362,"score_gpt":0.2848857866561673,"score_spread":0.274582077895927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2494813373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99569863,0.0015904318,0.000036929505,0.00014903284,0.000017035638,0.0012102227,0.000009124172,0.00002780547,0.0012607576],"genre_scores_gemma":[0.99709815,0.00017737663,0.002482077,0.000041265663,0.000010636609,0.000103235914,0.000033469885,0.000023851213,0.000029943352],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989707,0.000043057713,0.00023044982,0.00028461526,0.00022921646,0.00024197897],"domain_scores_gemma":[0.99950343,0.000028151375,0.000105591054,0.0002491854,0.00003341154,0.00008022068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000078201316,0.00021702747,0.00061974477,0.000114107504,0.00003545939,0.000008726994,0.00005715776,0.000050915885,0.0000043272344],"category_scores_gemma":[0.000013515019,0.00014497415,0.00008020475,0.00021929451,0.00005898938,0.00007355149,0.000017268065,0.00010451673,0.00001270615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022281085,0.011685817,0.97545886,0.00012451535,0.0018232715,0.0014973675,0.000997322,0.0001524086,0.00488079,0.0017439271,0.0000014245688,0.0014114592],"study_design_scores_gemma":[0.034123234,0.0057251574,0.9318298,0.00059985905,0.00075649825,0.00030198964,0.00012549489,0.000009524131,0.025906084,0.00046796835,0.0000016534109,0.0001527306],"about_ca_topic_score_codex":0.0008854847,"about_ca_topic_score_gemma":0.0004184527,"teacher_disagreement_score":0.043629084,"about_ca_system_score_codex":0.00014768504,"about_ca_system_score_gemma":0.00028734424,"threshold_uncertainty_score":0.5911875},"labels":[],"label_agreement":null},{"id":"W2494846209","doi":"10.1182/blood.v120.21.265.265","title":"Desialylation: A Novel Platelet Clearance Mechanism and a Potential New Therapeutic Target in Anti-GPIb Antibody Mediated Thrombocytopenia","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Platelet; Immunology; Antibody; Platelet membrane glycoprotein; Autoantibody; Flow cytometry; Monoclonal antibody; Neuraminidase; Antigen; Platelet Glycoprotein GPIb-IX Complex; Chemistry; Platelet activation; Isoantibodies; Medicine","score_opus":0.018243705643812107,"score_gpt":0.2706936316896606,"score_spread":0.2524499260458485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2494846209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949065,0.0025540588,0.0011601736,0.00041829195,0.00010802798,0.00047137146,0.000012735726,0.000050734205,0.00031813505],"genre_scores_gemma":[0.99658513,0.00036430362,0.0023991659,0.0003079012,0.00011471461,0.000007860582,0.00009302322,0.000029427278,0.00009847159],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989226,0.000024192157,0.00022220396,0.00023757995,0.00020319365,0.00039024916],"domain_scores_gemma":[0.9995332,0.000025277039,0.00006849934,0.00016460141,0.000021996577,0.00018641997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012390464,0.00019275144,0.00043715772,0.0001034257,0.000060454662,0.000022523438,0.000055469314,0.00013812134,0.00014362612],"category_scores_gemma":[0.000018513392,0.0001631713,0.00004895982,0.00020893604,0.000031840285,0.00020442734,0.000029293336,0.00014555227,0.000048705722],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083788834,0.008423763,0.29181162,0.00016245098,0.001284346,0.0013137743,0.002117575,0.000013055083,0.68786454,0.0028622195,0.00012662727,0.0031821385],"study_design_scores_gemma":[0.03754048,0.00050241174,0.92405534,0.00017669315,0.0005029257,0.001510303,0.000112468304,0.0006405058,0.03217705,0.0015424549,0.000774488,0.00046485252],"about_ca_topic_score_codex":0.000106725834,"about_ca_topic_score_gemma":0.00001283555,"teacher_disagreement_score":0.6556875,"about_ca_system_score_codex":0.000015702864,"about_ca_system_score_gemma":0.00007211003,"threshold_uncertainty_score":0.66539323},"labels":[],"label_agreement":null},{"id":"W2494936849","doi":"10.1182/blood.v126.23.750.750","title":"Dyspnea, Quality of Life and Walking Capacity during 1 Year Follow-up after a First Episode of Pulmonary Embolism: Results of the E.L.O.P.E. Study","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Western University; Jewish General Hospital; University of Ottawa; University of Toronto; Dalhousie University; McGill University","funders":"","keywords":"Medicine; Pulmonary embolism; Contraindication; Quality of life (healthcare); Physical therapy; Pulmonary rehabilitation; Prospective cohort study; Cohort; VO2 max; Rehabilitation; Internal medicine; Blood pressure","score_opus":0.036340943976042574,"score_gpt":0.26436533096876574,"score_spread":0.22802438699272318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2494936849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969484,0.00033215477,0.0000015283116,0.00023319341,0.00013050326,0.0007398677,0.000041689735,0.000013498318,0.0015591724],"genre_scores_gemma":[0.9995957,0.00004421698,0.00009031845,0.00004017521,0.00006564358,0.000036903533,0.0000018483221,0.000016218079,0.00010900027],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983526,0.00012907623,0.00063104334,0.00024279446,0.00046633647,0.00017814638],"domain_scores_gemma":[0.99875635,0.00007565105,0.00032790666,0.0005696506,0.00015329468,0.000117131356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078432565,0.0001369619,0.00066909916,0.0000731218,0.00004015126,0.0000052023825,0.00013587155,0.000059742368,0.000009711642],"category_scores_gemma":[0.0005398568,0.00009939476,0.00011113303,0.00017510608,0.00011560695,0.000053106138,0.00025153853,0.000107628526,0.0000012776833],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090736826,0.005347595,0.9801021,0.0009416073,0.0004475439,0.000013016307,0.010014394,0.000005090305,0.0016835958,0.00008157754,0.00021699957,0.00023909386],"study_design_scores_gemma":[0.006835344,0.00027709216,0.98447096,0.00022329616,0.00040882186,0.000003153876,0.0023893546,0.000006017651,0.0051646526,0.00005849455,0.00006943791,0.000093391594],"about_ca_topic_score_codex":0.0018128067,"about_ca_topic_score_gemma":0.0009421393,"teacher_disagreement_score":0.0076250397,"about_ca_system_score_codex":0.000016327982,"about_ca_system_score_gemma":0.00003867408,"threshold_uncertainty_score":0.40532008},"labels":[],"label_agreement":null},{"id":"W2495110942","doi":"10.1182/blood.v110.11.454.454","title":"Effect of Anemia and Red Blood Cell Transfusion in Acute Myocardial Infarction.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; Lawson Health Research Institute; Western University","funders":"","keywords":"Medicine; Myocardial infarction; Hemoglobin; Anemia; Blood transfusion; Cardiology; Internal medicine; Ligation; Artery; Red blood cell; Surgery; Anesthesia","score_opus":0.003680804299704918,"score_gpt":0.24053370028343202,"score_spread":0.2368528959837271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2495110942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99386704,0.00053298974,0.000004881047,0.00020295082,0.000060334107,0.00036662567,0.000004383318,0.000026314245,0.0049345084],"genre_scores_gemma":[0.99838424,0.0008176477,0.00047935796,0.000041114992,0.000077073855,0.0000068796526,0.000014549002,0.000013244755,0.0001659025],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999243,0.00003778542,0.00020883133,0.0001820957,0.00015240499,0.00017585006],"domain_scores_gemma":[0.99961936,0.000091956106,0.00003773948,0.00014322683,0.000018895345,0.000088814755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031112976,0.00012247101,0.00027929683,0.00010182612,0.000026267951,0.00000312841,0.000024497416,0.000112092865,0.00003056121],"category_scores_gemma":[0.000015387044,0.00009528724,0.00007405142,0.00014361806,0.000051035004,0.000023033559,0.000012652791,0.0001323941,0.0000031376474],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081742246,0.0012374741,0.44794798,0.0003400789,0.00017202752,0.00045976488,0.00048238528,4.0891604e-7,0.5434245,0.00000690304,0.0000896332,0.005021424],"study_design_scores_gemma":[0.021754032,0.003296393,0.14972168,0.000118610486,0.0012363098,0.0002671639,0.000047155954,0.0000011298017,0.8232638,0.0000059625713,0.00019456394,0.00009317861],"about_ca_topic_score_codex":0.00008287089,"about_ca_topic_score_gemma":0.000014242056,"teacher_disagreement_score":0.2982263,"about_ca_system_score_codex":0.000012744693,"about_ca_system_score_gemma":0.000020986612,"threshold_uncertainty_score":0.3885701},"labels":[],"label_agreement":null},{"id":"W2495125619","doi":"10.1182/blood.v104.11.2313.2313","title":"Adult Matched Sibling Blood Cell Transplants (BCT) after Myeloablative Conditioning Incorporating Daily Intravenous (IV) Busulfan (BU) and Low-Dose Antithymocyte Globulin (ATG): Outcomes with Particular Respect to Transplant-Related Mortality (TRM) in 140 Patients.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre","funders":"","keywords":"Thymoglobulin; Medicine; Busulfan; Folinic acid; Fludarabine; Internal medicine; Gastroenterology; Cumulative incidence; Incidence (geometry); Regimen; Graft-versus-host disease; Surgery; Methotrexate; Transplantation; Chemotherapy; Hematopoietic stem cell transplantation; Cyclophosphamide; Kidney transplantation; Fluorouracil","score_opus":0.008245623298982268,"score_gpt":0.2311505871735632,"score_spread":0.22290496387458095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2495125619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961782,0.00010152697,0.0008799704,0.00023732189,0.00006915733,0.0018023602,0.00025153268,0.00014947171,0.00033043453],"genre_scores_gemma":[0.9939642,0.0000778811,0.0049948134,0.00031475053,0.000032539916,0.00013620466,0.00037728957,0.00008670568,0.000015591128],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964369,0.00015566932,0.0011443652,0.000855925,0.0007186766,0.0006884517],"domain_scores_gemma":[0.9985551,0.00014677632,0.0002669323,0.00040429717,0.00021772864,0.00040912136],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039538823,0.00056441064,0.00094562996,0.00037716684,0.00015782597,0.00007967097,0.00013407458,0.0002744187,0.000039419316],"category_scores_gemma":[0.000048925947,0.0004962588,0.000111625755,0.00076405116,0.00014828792,0.00029122984,0.00001784709,0.00049303204,0.000028521323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013449969,0.0025170117,0.9474926,0.0012090312,0.0005316467,0.0038068176,0.017992504,0.0009311567,0.024041926,0.00007262828,5.604725e-7,0.000059133698],"study_design_scores_gemma":[0.032978635,0.001074197,0.84070784,0.0033607676,0.0016354768,0.0002929846,0.00074859295,0.000106838255,0.11827518,0.00018838653,4.5435476e-7,0.0006306638],"about_ca_topic_score_codex":0.0005228654,"about_ca_topic_score_gemma":0.00076844177,"teacher_disagreement_score":0.10678477,"about_ca_system_score_codex":0.00008338335,"about_ca_system_score_gemma":0.00022574674,"threshold_uncertainty_score":0.9997489},"labels":[],"label_agreement":null},{"id":"W2495862253","doi":"10.1182/blood.v126.23.4777.4777","title":"First in Human Single-Ascending Dose Study: Safety, Biomarker, Pharmacokinetics and Exposure-Response Relationships of ALXN1210, a Humanized Monoclonal Antibody to C5, with Marked Half-Life Extension and Potential for Significantly Longer Dosing Intervals","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"","keywords":"Medicine; Pharmacokinetics; Cmax; Eculizumab; Pharmacodynamics; Pharmacology; Tolerability; Immunogenicity; Internal medicine; Paroxysmal nocturnal hemoglobinuria; Gastroenterology; Placebo; Adverse effect; Atypical hemolytic uremic syndrome; Immunology; Complement system; Antibody; Pathology","score_opus":0.0725644227953989,"score_gpt":0.32150630600059277,"score_spread":0.24894188320519386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2495862253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99584496,0.0011907431,0.00072031555,0.00016052749,0.00012669885,0.001827062,0.000079235804,0.000038828945,0.000011617768],"genre_scores_gemma":[0.9990321,0.0000062147337,0.00069476786,0.000021978172,0.000021690577,0.00006153832,0.00008127347,0.000032942953,0.000047490492],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976074,0.00084436766,0.00066799024,0.00047726365,0.000095985604,0.00030699614],"domain_scores_gemma":[0.99868387,0.000552175,0.00024748975,0.00025597637,0.00016298374,0.00009749406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014895219,0.00024728815,0.00047031182,0.0003584084,0.00026120804,0.000041882722,0.00014505557,0.00009328332,0.000040213712],"category_scores_gemma":[0.00037849124,0.00022727042,0.00004889922,0.00018092457,0.00013621266,0.00010344114,0.00019519578,0.00012326619,0.0000022165402],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014951194,0.0019115553,0.14416647,0.00010189848,0.0004044464,0.00003407738,0.0023803795,0.00003144225,0.83561254,0.000022375601,0.00019093604,0.0001926695],"study_design_scores_gemma":[0.043613587,0.0036386107,0.93037385,0.0006430299,0.0008158808,0.00011290147,0.00473305,0.00011433366,0.015103759,0.000048224705,0.00029127146,0.00051148806],"about_ca_topic_score_codex":0.000076698605,"about_ca_topic_score_gemma":0.00013850046,"teacher_disagreement_score":0.8205088,"about_ca_system_score_codex":0.00003582933,"about_ca_system_score_gemma":0.000054694505,"threshold_uncertainty_score":0.9267819},"labels":[],"label_agreement":null},{"id":"W2495886576","doi":"10.1182/blood.v122.21.1142.1142","title":"The Transfer Of Dabigatran and Rivaroxaban Across a Dually Perfused Isolated Human Placental Cotyledon – Implications For Therapy In Pregnancy","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital; Hospital for Sick Children","funders":"","keywords":"Rivaroxaban; Medicine; Dabigatran; Pregnancy; Transplacental; Obstetrics; Placenta; Fetus; Internal medicine; Atrial fibrillation; Warfarin","score_opus":0.029250260618540747,"score_gpt":0.3017974287041451,"score_spread":0.27254716808560436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2495886576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960556,0.00043015036,0.00020999026,0.0014091447,0.000023812052,0.0016731053,0.000027401222,0.0000332965,0.00013751491],"genre_scores_gemma":[0.9991864,0.00015808815,0.00015333873,0.00008735769,0.000018910752,0.00026452457,0.00002795812,0.000021916578,0.00008149792],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9992141,0.000030296884,0.00028113334,0.00018227063,0.000083282255,0.00020890897],"domain_scores_gemma":[0.9994934,0.000069585745,0.000039307422,0.00023361985,0.00009570421,0.00006835557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010563708,0.00011343856,0.00020833459,0.000032770557,0.00017205306,0.00002707504,0.00008095502,0.000084436186,0.000026038466],"category_scores_gemma":[0.000011991179,0.00008023987,0.0000676743,0.00011338101,0.00007939614,0.00006351048,0.000010305757,0.000087595996,0.0000014775699],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000071860115,0.0010305952,0.027116654,0.000047437043,0.000116174575,3.9478783e-7,0.002198529,2.9148097e-7,0.95667166,0.006716004,0.000016559592,0.006013848],"study_design_scores_gemma":[0.021975242,0.0015922996,0.7911261,0.00022656599,0.00011261325,0.000025115345,0.0004400449,0.00014355719,0.1817211,0.0023460893,0.00010825328,0.00018304367],"about_ca_topic_score_codex":0.00005492709,"about_ca_topic_score_gemma":0.00012896818,"teacher_disagreement_score":0.77495056,"about_ca_system_score_codex":0.0000072403277,"about_ca_system_score_gemma":0.000028858405,"threshold_uncertainty_score":0.3272087},"labels":[],"label_agreement":null},{"id":"W2496161080","doi":"10.1182/blood.v120.21.359.359","title":"No Survival Advantage After Double Umbilical Cord Blood (UCB) Compared to Single UCB Transplant in Children with Hematological Malignancy: Results of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0501) Randomized Trial","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; BC Children's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Umbilical cord; Single Center; Cord blood; Transplantation; Internal medicine; Randomized controlled trial; Clinical trial; Surgery; Oncology; Immunology","score_opus":0.05201349965096787,"score_gpt":0.32409922312941564,"score_spread":0.2720857234784478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2496161080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890847,0.0006907907,0.00019465017,0.0002935585,0.00056323013,0.007855362,0.00036808022,0.00008103492,0.0008686011],"genre_scores_gemma":[0.9959559,0.00028280192,0.0021456946,0.00017512676,0.00068082626,0.00041120214,0.00017881133,0.00006678861,0.00010288589],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99108046,0.0027675636,0.0034442707,0.0008492135,0.0008944513,0.0009640086],"domain_scores_gemma":[0.99428314,0.0036421968,0.0006255028,0.0007429745,0.00011423555,0.00059193035],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008824905,0.0006023841,0.0038271458,0.00013148037,0.00008821756,0.000036457517,0.0003064729,0.0005129753,0.00008617403],"category_scores_gemma":[0.00051852386,0.00036234324,0.0006654509,0.00045406775,0.0004397798,0.00011576003,0.00004332333,0.00062122603,0.000014044449],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6830844,0.005790354,0.30686948,0.00022951677,0.0010251099,0.00013370956,0.0006475624,0.000004896497,0.0020215774,0.0001335911,0.000022940616,0.000036842892],"study_design_scores_gemma":[0.9081699,0.0023367102,0.064554326,0.0017741057,0.008108473,0.0016013917,0.000034805777,0.000012909368,0.012852589,0.000022873724,0.000036831134,0.0004950714],"about_ca_topic_score_codex":0.000104142746,"about_ca_topic_score_gemma":0.00016101284,"teacher_disagreement_score":0.24231516,"about_ca_system_score_codex":0.000016155469,"about_ca_system_score_gemma":0.00016053939,"threshold_uncertainty_score":0.9998829},"labels":[],"label_agreement":null},{"id":"W2496245877","doi":"10.1182/blood.v124.21.117.117","title":"A Phase 1 Study of the BET-Bromodomain Inhibitor OTX015 in Patients with Advanced Acute Leukemia","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Bromodomain; Medicine; Leukemia; Minimal residual disease; Internal medicine; Bone marrow; Oncology; Pharmacology; Epigenetics; Biology; Gene; Genetics","score_opus":0.0032118276027519412,"score_gpt":0.21564995409884782,"score_spread":0.2124381264960959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2496245877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99921787,0.000019799798,0.000039148057,0.000015090791,0.00005360341,0.00047256914,0.000010660047,0.0000048624797,0.00016642216],"genre_scores_gemma":[0.99960536,0.0000015686248,0.00016245854,0.000054100557,0.00004572576,0.000033421624,0.000027388216,0.00001226211,0.000057693418],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992728,0.00008464797,0.0001725366,0.00019827185,0.00015287571,0.0001188503],"domain_scores_gemma":[0.99947953,0.000004647987,0.00010098459,0.000332196,0.00004988479,0.00003274693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000095393654,0.00009956649,0.00012142903,0.00002654713,0.000033673743,0.0000061876262,0.00014981873,0.000053370903,0.0000026483535],"category_scores_gemma":[0.000049145197,0.00006612959,0.000030888146,0.00011272282,0.00003578806,0.0000043069954,0.000074342744,0.00006280334,0.0000010232742],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010821191,0.014671067,0.29016823,0.00002882214,0.00027171496,0.0000025204781,0.0004473603,0.00005679939,0.68487495,0.00004451765,0.000509467,0.007842411],"study_design_scores_gemma":[0.0376765,0.0065540727,0.050546456,0.00003762305,0.00006761946,0.0000010228216,0.00010817379,0.00001101802,0.903592,0.00001704807,0.0011913293,0.00019711886],"about_ca_topic_score_codex":0.000009390169,"about_ca_topic_score_gemma":0.000036275393,"teacher_disagreement_score":0.23962177,"about_ca_system_score_codex":0.0000096592985,"about_ca_system_score_gemma":0.000040143932,"threshold_uncertainty_score":0.26966864},"labels":[],"label_agreement":null},{"id":"W2498636115","doi":"10.1182/blood-2016-03-704585","title":"Postthrombotic syndrome and other outcomes of lower extremity deep vein thrombosis in children","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children","funders":"University of Toronto; Sanofi","keywords":"Medicine; Thrombosis; Deep vein; Post-thrombotic syndrome; Surgery; Pediatrics","score_opus":0.01186311921844092,"score_gpt":0.2504665957645906,"score_spread":0.23860347654614972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2498636115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971014,0.00031495388,0.000019278668,0.00075739535,0.000056248733,0.00047206035,0.000012987026,0.000033080498,0.0012325706],"genre_scores_gemma":[0.9988791,0.0001903793,0.00028415772,0.00047300555,0.00001950571,0.000019574163,0.0000016093804,0.00002765112,0.00010504724],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989428,0.000030820134,0.00028908148,0.00028123875,0.00020168492,0.00025437633],"domain_scores_gemma":[0.99938935,0.00006234251,0.000081552425,0.00035219104,0.000024457833,0.00009013204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016548941,0.00016382632,0.000623872,0.00013611552,0.000022591705,0.0000072670523,0.000090771486,0.000078734294,0.00037203697],"category_scores_gemma":[0.00006414092,0.00010506059,0.000083609215,0.00011914556,0.0001008109,0.00006720425,0.00008903068,0.00006145787,0.000030472329],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007688323,0.0024346388,0.99383515,0.000040737166,0.00037452465,0.000020310224,0.00010617661,1.9941967e-7,0.0018411354,0.00044099096,0.00006982082,0.0008286466],"study_design_scores_gemma":[0.003676769,0.0003048299,0.99425185,0.00020706115,0.00037100143,0.000057062603,0.000027305792,0.0000010296939,0.0007242716,0.00018685964,0.000058914455,0.00013304368],"about_ca_topic_score_codex":0.00022592068,"about_ca_topic_score_gemma":0.000059708927,"teacher_disagreement_score":0.0036690808,"about_ca_system_score_codex":0.00002187154,"about_ca_system_score_gemma":0.000017770317,"threshold_uncertainty_score":0.42842466},"labels":[],"label_agreement":null},{"id":"W2499000030","doi":"10.1182/blood.v122.21.2312.2312","title":"Results From a Phase IV Open-Label Study Evaluating Changes In Bone Marrow Morphology In Adult Immune Thrombocytopenia (ITP) Patients Receiving Romiplostim: Analysis Of The 1- and 2-Year Romiplostim Cohorts","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Hematological disorders and diagnostics","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Romiplostim; Medicine; Bone marrow; Thrombopoietin; Biopsy; Cohort; Platelet; Pathology; Internal medicine; Surgery; Haematopoiesis; Stem cell","score_opus":0.04578250882668025,"score_gpt":0.33430357114888565,"score_spread":0.2885210623222054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2499000030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959178,0.00024179931,9.955912e-7,0.000680365,0.00004393299,0.002687541,0.00013764604,0.000013887967,0.00027600548],"genre_scores_gemma":[0.998437,0.000105901774,0.0008418388,0.00023249842,0.000011435032,0.00017405297,0.00015502248,0.000020880858,0.000021357198],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99750507,0.0003681585,0.00087879744,0.00055498054,0.0003585628,0.0003344319],"domain_scores_gemma":[0.99785936,0.00086960645,0.00035149095,0.00058609206,0.00023047812,0.00010299974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006287093,0.00023067123,0.0012916648,0.00024075902,0.00006456695,0.000041798372,0.0002707162,0.0001565275,0.00015684159],"category_scores_gemma":[0.006838976,0.0001623372,0.000050603525,0.0009973746,0.00010144951,0.00010494445,0.0004959395,0.0002808418,0.000008750646],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006418581,0.018065946,0.9676047,0.000026297752,0.00049518,0.00006503171,0.0021809004,0.000009594069,0.009045075,0.0000065760564,0.00007307412,0.0017857737],"study_design_scores_gemma":[0.05687648,0.0021232404,0.9346969,0.00032627565,0.0015407638,0.0000023096193,0.0011824289,0.0020815262,0.0008902069,0.00010808903,6.170687e-7,0.00017117502],"about_ca_topic_score_codex":0.005463052,"about_ca_topic_score_gemma":0.004348698,"teacher_disagreement_score":0.05623462,"about_ca_system_score_codex":0.00003021826,"about_ca_system_score_gemma":0.000050925653,"threshold_uncertainty_score":0.8258537},"labels":[],"label_agreement":null},{"id":"W2500482667","doi":"10.1182/blood-2016-02-699850","title":"Five-year survival and durability results of brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":395,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; Takeda Oncology","keywords":"Brentuximab vedotin; Medicine; Internal medicine; Refractory (planetary science); Oncology; Lymphoma; Complete remission; Gastroenterology; Hodgkin lymphoma; Chemotherapy; Biology","score_opus":0.009244482184418111,"score_gpt":0.22310387392984643,"score_spread":0.2138593917454283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2500482667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99837357,0.0000667093,3.9581928e-7,0.00025548312,0.000046785724,0.00039461377,0.000112941896,0.000020004123,0.0007295131],"genre_scores_gemma":[0.9994281,0.000061938,0.00022772941,0.000017698474,0.000022192418,0.000019985151,0.000022134209,0.000015322397,0.00018489888],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878436,0.000076845594,0.00033285865,0.00033718243,0.00027526714,0.00019349284],"domain_scores_gemma":[0.99902755,0.0002731256,0.00013161406,0.00037081304,0.00009403578,0.00010288477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017898795,0.00014936904,0.00036103005,0.00006948241,0.000021078418,0.0000050381814,0.000048446072,0.000076396995,0.000028972981],"category_scores_gemma":[0.0003113856,0.00007576846,0.00003808229,0.00012152915,0.000100311176,0.00006683552,0.000037706875,0.000029680077,0.000008688475],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006285593,0.0074980147,0.97305274,0.000048067453,0.00010155756,0.00004882372,0.00013864554,3.253616e-8,0.00015904536,0.000022938662,0.000086105785,0.012558446],"study_design_scores_gemma":[0.10533869,0.002524815,0.8885709,0.00030873623,0.00011361645,0.000004626056,0.000039712257,3.178932e-7,0.0027835013,0.000011645555,0.00020997235,0.00009344917],"about_ca_topic_score_codex":0.00023073354,"about_ca_topic_score_gemma":0.00014408208,"teacher_disagreement_score":0.0990531,"about_ca_system_score_codex":0.00009426856,"about_ca_system_score_gemma":0.00012924836,"threshold_uncertainty_score":0.30897483},"labels":[],"label_agreement":null},{"id":"W2501116232","doi":"10.1182/blood.v122.21.1056.1056","title":"Influenza Virus-Containing Immune Complexes Activate Platelets Through FcγRIIa Resulting In Bioactive Lipid Synthesis and Microparticle Release","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Diabetes and associated disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Platelet; Platelet activation; Immune system; Immunology; Innate immune system; Virus; Influenza A virus; Antibody; Biology; Receptor; Immunity; Biochemistry","score_opus":0.010037073408190902,"score_gpt":0.23182531569380255,"score_spread":0.22178824228561164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2501116232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99817705,0.0009446222,0.000004210449,0.0001153331,0.000022331416,0.00018479093,0.000019124776,0.000017156059,0.0005153512],"genre_scores_gemma":[0.999027,0.00014665996,0.00035331352,0.00031792145,0.000043877273,0.000047952046,0.000014206682,0.000023731516,0.000025311423],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989558,0.00007167935,0.00024347263,0.00031017495,0.00006644614,0.00035244427],"domain_scores_gemma":[0.9995452,0.000059153313,0.00011666083,0.00018169374,0.000041809362,0.000055453336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012106938,0.0001588156,0.00019254729,0.00003073164,0.00009764386,0.000059811802,0.00010433942,0.00011558273,0.000016484253],"category_scores_gemma":[0.00027366047,0.0001556315,0.000050234492,0.00009774568,0.00007377248,0.000022405266,0.00011780143,0.00010525523,0.000014714513],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006280493,0.00020065912,0.025080897,0.000011825121,0.0001035419,0.0000027279857,0.00029076234,0.0000120298855,0.9713287,0.000012196651,0.000031825104,0.00286206],"study_design_scores_gemma":[0.001704769,0.00012560483,0.04071245,0.000048656297,0.000029272349,0.000002373846,0.0007235042,0.000038866627,0.95535403,0.00007775852,0.0009614968,0.00022118553],"about_ca_topic_score_codex":0.0012664677,"about_ca_topic_score_gemma":0.00006504308,"teacher_disagreement_score":0.01597461,"about_ca_system_score_codex":0.000009063169,"about_ca_system_score_gemma":0.00001966495,"threshold_uncertainty_score":0.63464683},"labels":[],"label_agreement":null},{"id":"W2501188869","doi":"10.1182/blood.v126.23.5282.5282","title":"Ten Percent of Newly Diagnosed CLL Patients Are Treated within the First Year of Diagnosis: Results of a Canadian Retrospective Population-Based Study","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Population; Chronic lymphocytic leukemia; Incidence (geometry); Referral; Watchful waiting; Internal medicine; Pediatrics; Cancer; Leukemia; Family medicine; Prostate cancer","score_opus":0.025330566044579124,"score_gpt":0.2688225816794429,"score_spread":0.24349201563486378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2501188869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99732006,0.000055649707,7.278453e-8,0.0002695267,0.0000414052,0.0015346,0.0002467204,0.000012270142,0.0005197259],"genre_scores_gemma":[0.99964625,0.000006350225,0.000039713872,0.00003940147,0.000034301494,0.00008285525,0.000076618504,0.000023991395,0.000050527276],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99806285,0.00010562391,0.00054241373,0.00025680877,0.0008043172,0.00022797362],"domain_scores_gemma":[0.99785405,0.00021483094,0.00033265114,0.0006147392,0.00073402683,0.0002496791],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041584944,0.0001393772,0.00042690517,0.00033027373,0.000042456184,0.0000059103213,0.00019481005,0.00008621059,0.000012002685],"category_scores_gemma":[0.0025700745,0.00009573903,0.000079030266,0.0007516547,0.000082547616,0.00003137576,0.00003871802,0.00013103607,0.000010465186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066875253,0.0028747795,0.99174047,0.00006224939,0.00018026515,0.00004958552,0.003551425,0.0000872291,0.000004335664,0.000007988551,0.000746054,0.000026876112],"study_design_scores_gemma":[0.06991179,0.001968219,0.92291033,0.00029511907,0.00026755076,0.0000014771672,0.0028767812,0.00017418191,0.0014822736,0.000011249247,0.000022282231,0.0000787174],"about_ca_topic_score_codex":0.71734494,"about_ca_topic_score_gemma":0.37217692,"teacher_disagreement_score":0.34516805,"about_ca_system_score_codex":0.0027516696,"about_ca_system_score_gemma":0.0037411898,"threshold_uncertainty_score":0.71955204},"labels":[],"label_agreement":null},{"id":"W2501256008","doi":"10.1182/blood.v126.23.3114.3114","title":"Limited Efficacy of Prompt Therapy of Posttransplant Lymphoproliferative Disorder (PTLD) with Rituximab","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Foothills Medical Centre; University of Alberta; University of Calgary","funders":"","keywords":"Rituximab; Medicine; Post-transplant lymphoproliferative disorder; Internal medicine; Lymphoproliferative disorders; Salvage therapy; Gastroenterology; Neutropenia; Hematopoietic stem cell transplantation; Transplantation; Immunology; Lymphoma; Chemotherapy","score_opus":0.019588762995822195,"score_gpt":0.2552006805520778,"score_spread":0.2356119175562556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2501256008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99347043,0.002714315,0.00004355976,0.00040736797,0.00002673759,0.0005757788,0.00003823014,0.000036132024,0.002687471],"genre_scores_gemma":[0.9989514,0.00038334858,0.00030081073,0.00016518304,0.000028613324,0.000022463339,0.000047013084,0.000025264844,0.00007592816],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9989882,0.00003709755,0.00025021963,0.00018728874,0.00034038935,0.00019681867],"domain_scores_gemma":[0.9992287,0.000031233798,0.00015033293,0.00021630623,0.00026126727,0.000112118956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000106225656,0.00015440414,0.00043965332,0.000076805365,0.000023155546,0.0000045623215,0.00007485622,0.00008699171,0.000028754397],"category_scores_gemma":[0.00004007597,0.00010510815,0.00008006734,0.00027188932,0.000106623476,0.00004759859,0.000008030856,0.00008789383,0.00000364749],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027878778,0.04095629,0.8456117,0.00048031766,0.004060946,0.00013540685,0.022058185,0.00014595408,0.045917787,0.0006360539,0.0010732808,0.011045294],"study_design_scores_gemma":[0.47431576,0.024132386,0.21588294,0.0011212431,0.0015417585,0.00015876212,0.003534625,0.00021041022,0.2757037,0.000361527,0.0021414144,0.00089547836],"about_ca_topic_score_codex":0.0003009315,"about_ca_topic_score_gemma":0.00003627262,"teacher_disagreement_score":0.6297288,"about_ca_system_score_codex":0.00002077563,"about_ca_system_score_gemma":0.00036514932,"threshold_uncertainty_score":0.4286186},"labels":[],"label_agreement":null},{"id":"W2501425081","doi":"10.1182/blood.v124.21.302.302","title":"Final Results for the 1703 Phase 1b/2 Study of Elotuzumab in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Lenalidomide; Medicine; Dexamethasone; Regimen; Neutropenia; Multiple myeloma; Clinical endpoint; Internal medicine; Progressive disease; Phases of clinical research; Adverse effect; Gastroenterology; Dosing; Urology; Oncology; Toxicity; Chemotherapy; Clinical trial","score_opus":0.02640005774996663,"score_gpt":0.2912116139478415,"score_spread":0.2648115561978749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2501425081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969818,0.000063424835,0.00006148547,0.000078349185,0.000010679411,0.0026813461,0.000032297903,0.000011064362,0.00007953242],"genre_scores_gemma":[0.9988263,0.000008892582,0.000782854,0.000014820991,0.0000127946205,0.00021717604,0.00007247263,0.000021036953,0.000043603704],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985812,0.00014129012,0.0003177497,0.00030224904,0.00040139304,0.0002561697],"domain_scores_gemma":[0.9984126,0.0008862484,0.00014394982,0.0003150551,0.00015459918,0.00008755114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047990892,0.00015760543,0.00033011808,0.00018844167,0.00006238699,0.000012082519,0.00007666616,0.0000491885,0.0000016292149],"category_scores_gemma":[0.0007093937,0.0000903467,0.000020779002,0.00023105377,0.00008123896,0.0000907923,0.00002819676,0.00017258365,7.243736e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037157323,0.031024775,0.9138171,0.00006920178,0.0002032301,0.000027413671,0.00097647397,0.000009992813,0.00013050101,0.00000940273,0.000010867827,0.016563699],"study_design_scores_gemma":[0.3161948,0.016683977,0.66524404,0.00012188531,0.000105561856,0.000002981287,0.00028021476,0.0005919829,0.00066072453,0.000007658764,0.000035999063,0.000070166716],"about_ca_topic_score_codex":0.0004765338,"about_ca_topic_score_gemma":0.001638416,"teacher_disagreement_score":0.2790375,"about_ca_system_score_codex":0.000048430677,"about_ca_system_score_gemma":0.00006694757,"threshold_uncertainty_score":0.36842316},"labels":[],"label_agreement":null},{"id":"W2502145464","doi":"10.1182/blood.v110.11.1673.1673","title":"Second Cancers after Autologous Hematopoietic Stem Cell Transplantation (ASCT) for Relapsed/Refractory Aggressive Non-Hodgkin’s Lymphoma (NHL).","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Etoposide; Melphalan; Population; Oncology; Autologous stem-cell transplantation; Transplantation; Cumulative incidence; Cytarabine; Surgery; Chemotherapy regimen; Chemotherapy","score_opus":0.007702134531715824,"score_gpt":0.24148028239116637,"score_spread":0.23377814785945053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2502145464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917329,0.0031877372,0.000246437,0.00008550456,0.0003379051,0.001008048,0.00012515602,0.00007918245,0.0031971233],"genre_scores_gemma":[0.9967492,0.00031127318,0.00073458283,0.00048218953,0.0001741873,0.00043423404,0.0000860816,0.000050487564,0.0009777476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843836,0.000020621646,0.00039559745,0.00042993994,0.0002443891,0.00047111558],"domain_scores_gemma":[0.9989012,0.00022222966,0.00023991946,0.00031727133,0.00009310483,0.00022629586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014954992,0.0002805422,0.00041466343,0.00012393837,0.00009555982,0.000021102202,0.00007843158,0.00020885386,0.00016560314],"category_scores_gemma":[0.000006103555,0.00023514501,0.00021712022,0.0001067381,0.000057459292,0.00008670272,0.000011409798,0.0000664714,0.00006290559],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020840272,0.031526837,0.4753788,0.013439361,0.0055204704,0.048687883,0.051547613,0.000043015807,0.033301465,0.0004271714,0.01527953,0.30400756],"study_design_scores_gemma":[0.050524794,0.0027717329,0.49316385,0.00078266044,0.0026507522,0.0014536504,0.0007935291,0.000030190038,0.44012007,0.00006451681,0.0070243254,0.00061991945],"about_ca_topic_score_codex":0.00006759428,"about_ca_topic_score_gemma":0.00020428977,"teacher_disagreement_score":0.4068186,"about_ca_system_score_codex":0.00036492836,"about_ca_system_score_gemma":0.00030417458,"threshold_uncertainty_score":0.9588935},"labels":[],"label_agreement":null},{"id":"W2502416043","doi":"10.1182/blood.v126.23.1141.1141","title":"Safety of Lumbar Punctures in Adult Oncology Patients with Thrombocytopenia","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Hematological disorders and diagnostics","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Platelet; Platelet transfusion; Coagulopathy; Population; Retrospective cohort study; Lumbar puncture; Hematology; Surgery; Gastroenterology; Cerebrospinal fluid","score_opus":0.016772550357506306,"score_gpt":0.26955242215090885,"score_spread":0.25277987179340256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2502416043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836977,0.00010565664,0.000019269422,0.00032093388,0.00002805405,0.0002884853,0.000007974249,0.000012305606,0.015519632],"genre_scores_gemma":[0.9982179,0.00003185333,0.0011256221,0.00055285316,0.000012398675,0.000008037718,0.000024210678,0.0000068078266,0.000020356529],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993595,0.000027749235,0.00019466715,0.00011842365,0.00016402907,0.00013563779],"domain_scores_gemma":[0.99947697,0.000059806833,0.000052586303,0.00013061822,0.00017019873,0.00010980463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006303099,0.00007855116,0.0003572311,0.000032650525,0.000008300017,0.0000017852637,0.000048836027,0.00009632295,0.000048716873],"category_scores_gemma":[0.00073739723,0.000046925088,0.000022899516,0.00010727183,0.00006412276,0.000020430609,0.000026426978,0.0000945743,0.000014647259],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035644879,0.0030853304,0.9935651,0.000039944076,0.00003144332,0.00006618199,0.00027301194,0.0000042362885,0.000027405242,0.0009397529,0.0008845309,0.00072665885],"study_design_scores_gemma":[0.017253807,0.0026961416,0.9774541,0.00008732687,0.00010160763,0.00000998902,0.0001841603,0.000004828539,0.00055108726,0.00037359484,0.001201024,0.0000823307],"about_ca_topic_score_codex":0.000055371307,"about_ca_topic_score_gemma":0.000160444,"teacher_disagreement_score":0.016897358,"about_ca_system_score_codex":0.00001623376,"about_ca_system_score_gemma":0.00012434236,"threshold_uncertainty_score":0.19135495},"labels":[],"label_agreement":null},{"id":"W2502702190","doi":"10.1182/blood.v114.22.476.476","title":"CD47-Sirpα Interaction Modulates Homing and Engraftment of Human Acute Myeloid Leukemia Stem Cells in Mice.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children; University Health Network","funders":"","keywords":"CD47; Severe combined immunodeficiency; Nod; Stem cell; Haematopoiesis; Immunology; Leukemia; Biology; Homing (biology); Transplantation; Cancer research; Xenotransplantation; Myeloid; Myeloid leukemia; Immune system; Medicine; Cell biology; Internal medicine; Genetics","score_opus":0.010673963340690323,"score_gpt":0.23472561664626157,"score_spread":0.22405165330557125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2502702190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99761605,0.0018898302,0.0000064590336,0.000033624372,0.00011120519,0.00014315183,0.0000056382105,0.000018079458,0.00017595064],"genre_scores_gemma":[0.9994232,0.00017495597,0.000034665696,0.000021284723,0.000011918003,0.000004322816,0.000027664651,0.000006048515,0.00029590543],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99931026,0.00006477678,0.00027815244,0.00017148093,0.00002001345,0.00015530697],"domain_scores_gemma":[0.9996958,0.000025739464,0.00013082876,0.0001180118,0.000020413238,0.000009232874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000105321626,0.00011052637,0.00021973446,0.000111163085,0.00006259813,0.0000095368605,0.000067583496,0.00012276768,0.000021356604],"category_scores_gemma":[0.000001926248,0.00010334629,0.00004411083,0.000061935476,0.0000357658,0.00012162669,0.000027275924,0.00012457225,0.00000963886],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003545523,0.0001818077,0.0005962746,0.000008621351,0.00009016032,0.0000015350574,0.0005766859,0.00001176082,0.99022925,0.000092970455,0.000033249085,0.008142207],"study_design_scores_gemma":[0.0019248433,0.00027132436,0.04229351,0.000065445085,0.00007116713,0.000021844175,0.00016773131,0.00001827791,0.9547916,0.00008485932,0.00019380884,0.00009556402],"about_ca_topic_score_codex":0.00005922304,"about_ca_topic_score_gemma":0.000011097635,"teacher_disagreement_score":0.041697238,"about_ca_system_score_codex":0.00004527014,"about_ca_system_score_gemma":0.000014417861,"threshold_uncertainty_score":0.42143396},"labels":[],"label_agreement":null},{"id":"W2502727669","doi":"10.1182/blood.v122.21.416.416","title":"Multiple Myeloma (MM) In Older (&gt;70 year) Patients - Similar Benefit From Autologous Hematopoietic Cell Transplantation (AHCT) Compared With Younger Patients","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cohort; Multiple myeloma; Transplantation; Melphalan; Internal medicine; Hematopoietic stem cell transplantation; Surgery","score_opus":0.009803410104956507,"score_gpt":0.22317020891648995,"score_spread":0.21336679881153345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2502727669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968889,0.00009077395,0.000017884462,0.000072006565,0.00005919004,0.001877514,0.00022213339,0.00007356922,0.0006980547],"genre_scores_gemma":[0.99580055,0.000033556727,0.0015930142,0.000101995756,0.00003270379,0.00023953083,0.0019920024,0.00005355181,0.00015308667],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978706,0.00006138794,0.00038801058,0.0004958233,0.00063295447,0.0005512292],"domain_scores_gemma":[0.9988636,0.00012450876,0.000107805914,0.00038466987,0.00021662432,0.00030280382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000042538122,0.00030676142,0.00044973777,0.00017541133,0.0000801286,0.000041744934,0.00013476361,0.00014430034,0.0004956928],"category_scores_gemma":[0.00003317902,0.00023844144,0.00007820517,0.00021149003,0.000062709,0.00022541621,0.000031407453,0.00021209789,0.00043966967],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005073307,0.0049393014,0.9910539,0.0001322547,0.00014383462,0.00013103889,0.000985525,0.000008735184,0.00093061564,0.0000016632359,0.0001453999,0.0010203954],"study_design_scores_gemma":[0.038484927,0.0005885685,0.95038456,0.00019397307,0.00018575534,0.0000055547484,0.000098463366,0.0002159162,0.0095539875,0.000028352968,0.000028586284,0.00023138103],"about_ca_topic_score_codex":0.001303822,"about_ca_topic_score_gemma":0.00033636153,"teacher_disagreement_score":0.04066937,"about_ca_system_score_codex":0.00008500908,"about_ca_system_score_gemma":0.000060510047,"threshold_uncertainty_score":0.97233593},"labels":[],"label_agreement":null},{"id":"W2503681422","doi":"10.1182/blood.v122.21.740.740","title":"Familial AML With Germline CEBPA Mutations: Extended Clinical Outcomes and Analysis Of Secondary Mutations Using Whole Exome Sequencing","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; Vancouver General Hospital; University of British Columbia","funders":"","keywords":"CEBPA; Medicine; Oncology; Mutation; Hematopoietic stem cell transplantation; Internal medicine; Exome sequencing; Germline mutation; Penetrance; Transplantation; Genetics; Biology; Phenotype; Gene","score_opus":0.04624187712409622,"score_gpt":0.3553145546802938,"score_spread":0.3090726775561976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2503681422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99767435,0.00012365851,0.0008569017,0.00037238796,0.000024569446,0.00049239397,0.00007600766,0.000040911706,0.00033883756],"genre_scores_gemma":[0.9761447,0.000021888934,0.022924839,0.00022224576,0.000065244145,0.00003314483,0.00019201562,0.000026339603,0.0003696393],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982595,0.0001164235,0.00063842494,0.00035111976,0.0003579962,0.0002765229],"domain_scores_gemma":[0.99837965,0.00046441876,0.0001843116,0.00037872425,0.00038325146,0.0002096228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003873454,0.00016227302,0.0006815905,0.0005494363,0.000102713915,0.000029860137,0.00009143876,0.00011611985,0.00023742519],"category_scores_gemma":[0.00041278574,0.00012403762,0.0001738998,0.000887222,0.00035476682,0.0002071479,0.000064576045,0.00036271688,0.000015819312],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009349461,0.00068377977,0.9490082,0.00014203587,0.006530032,0.0001867501,0.0010593017,0.00025820214,0.036822796,0.000063334475,0.00005997506,0.005092078],"study_design_scores_gemma":[0.005722612,0.00031765513,0.9702881,0.000047798298,0.0049914187,0.000100234414,0.0014432287,0.015599984,0.0011954191,0.00011225779,0.000020583819,0.00016073584],"about_ca_topic_score_codex":0.00067604124,"about_ca_topic_score_gemma":0.00009996231,"teacher_disagreement_score":0.035627376,"about_ca_system_score_codex":0.000084195104,"about_ca_system_score_gemma":0.00068013946,"threshold_uncertainty_score":0.50581074},"labels":[],"label_agreement":null},{"id":"W2503893926","doi":"10.1182/blood.v126.23.56.56","title":"PRM-151 in Myelofibrosis: Durable Efficacy and Safety at 72 Weeks","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Myelofibrosis; Medicine; Bone marrow; Fibrosis; Internal medicine; Essential thrombocythemia; Gastroenterology; Ruxolitinib; Surgery; Polycythemia vera","score_opus":0.022584504499443842,"score_gpt":0.2630835879488786,"score_spread":0.24049908344943474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2503893926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98363286,0.002273785,0.00000236167,0.0018167057,0.000060032322,0.00059682166,0.000012384465,0.000044435645,0.0115606],"genre_scores_gemma":[0.996714,0.0004739633,0.0007179618,0.000277048,0.000097321514,0.00009460479,0.000033376775,0.000021883896,0.0015698598],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988587,0.00004746572,0.00025274133,0.00032108347,0.00022265359,0.00029734726],"domain_scores_gemma":[0.99927104,0.000101360885,0.00005039069,0.00023902758,0.000058820442,0.00027936237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019456173,0.00017775646,0.0003546877,0.000076883414,0.00006792355,0.000017756756,0.000041022795,0.00009017877,0.00009564138],"category_scores_gemma":[0.00012901501,0.00013633558,0.00003934053,0.00014304885,0.000046863795,0.000059670994,0.00007557296,0.00010845601,0.00013001972],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083451223,0.0030455363,0.98557806,0.00009639486,0.00021434862,0.00029561858,0.0012843695,0.0000063953516,0.0014992561,0.0005217823,0.0035616534,0.0030620676],"study_design_scores_gemma":[0.031067275,0.0014232958,0.9301308,0.00039273672,0.00027304413,0.00022602518,0.00014731896,0.000024542302,0.021786148,0.00010125413,0.014201252,0.00022630765],"about_ca_topic_score_codex":0.000085348256,"about_ca_topic_score_gemma":0.00014439676,"teacher_disagreement_score":0.055447266,"about_ca_system_score_codex":0.00009515726,"about_ca_system_score_gemma":0.00009182758,"threshold_uncertainty_score":0.55596036},"labels":[],"label_agreement":null},{"id":"W2504016118","doi":"10.1182/blood.v108.11.3570.3570","title":"A Systematic Review and Meta-Analysis of Thalidomide in Patients with Previously Untreated Multiple Myeloma.","year":2006,"lang":"en","type":"review","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sudbury Regional Hospital; McMaster University Medical Centre; Princess Margaret Cancer Centre; Cancer Care Ontario; McMaster University; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Thalidomide; Medicine; Multiple myeloma; Internal medicine; Number needed to treat; Adverse effect; Number needed to harm; Regimen; Relative risk; Cochrane Library; Meta-analysis; Oncology; Randomized controlled trial; Confidence interval","score_opus":0.04622355380127601,"score_gpt":0.32367140770596814,"score_spread":0.2774478539046921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2504016118","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00040054394,0.98885983,8.696905e-7,0.0000077074765,0.0000023929072,0.010140476,0.00045291035,0.000021668393,0.000113598166],"genre_scores_gemma":[0.0008381867,0.99537855,0.0002116235,0.000024659976,0.0000044157496,0.0013874653,0.0016881375,0.0000597429,0.00040724102],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9962099,0.0005943072,0.001546341,0.0006029425,0.0006436171,0.0004028562],"domain_scores_gemma":[0.99725777,0.0004511337,0.00089941116,0.0009641477,0.00022391621,0.00020362808],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004422874,0.0006207838,0.013900205,0.0008385841,0.000027307371,0.000018000479,0.00016597097,0.00017739488,0.00008186078],"category_scores_gemma":[0.00045401763,0.00031734403,0.0016665324,0.0017336743,0.00006752233,0.000047792324,0.000067441244,0.00023477692,0.00001198864],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021432432,0.0010994861,0.005200348,0.67843693,0.3146024,0.000090064445,0.000007844785,9.902744e-8,7.272151e-9,8.781211e-7,0.000008512786,0.0005319803],"study_design_scores_gemma":[0.0037441403,0.0002677862,0.0018408835,0.09048571,0.9031038,0.000018416225,0.0000012533638,0.0000017814932,4.620908e-7,2.7029105e-7,0.00032571523,0.00020974493],"about_ca_topic_score_codex":0.00033584927,"about_ca_topic_score_gemma":0.00024708596,"teacher_disagreement_score":0.58850145,"about_ca_system_score_codex":0.00007596429,"about_ca_system_score_gemma":0.0001630915,"threshold_uncertainty_score":0.9999279},"labels":[],"label_agreement":null},{"id":"W2504204972","doi":"10.1182/blood.v124.21.292.292","title":"Brentuximab Vedotin Combined with ABVD or AVD for Patients with Newly Diagnosed Advanced Stage Hodgkin Lymphoma: Long Term Outcomes","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"ABVD; Brentuximab vedotin; Dacarbazine; Medicine; Vinblastine; Regimen; Internal medicine; Bleomycin; Surgery; Oncology; Gastroenterology; Lymphoma; Vincristine; Chemotherapy; CD30","score_opus":0.009953442662376038,"score_gpt":0.2470614320194354,"score_spread":0.23710798935705935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2504204972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965869,0.00006482348,0.00031477422,0.00023500824,0.000110008645,0.0022562782,0.00008924557,0.00013386046,0.00020905258],"genre_scores_gemma":[0.9932302,0.000016487413,0.0040443907,0.00047221428,0.00004831855,0.0007231084,0.0003156434,0.000084767424,0.0010648638],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981354,0.000038905822,0.0003356891,0.0005463794,0.0004335688,0.00051006593],"domain_scores_gemma":[0.99833816,0.0004342732,0.00022245341,0.00057885546,0.00017946387,0.00024679716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008008552,0.00042359112,0.00073787075,0.00009752554,0.0001363726,0.00006470985,0.00013527354,0.00008741838,0.00003671985],"category_scores_gemma":[0.00015464744,0.00023685495,0.00012387676,0.00016161242,0.00006320905,0.000174894,0.00004100086,0.00004847814,0.000019092475],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039084707,0.014253928,0.9606669,0.00017784003,0.0006094396,0.00016509324,0.00013218157,0.000003971504,0.000016439993,0.0001480112,0.000121606245,0.019796116],"study_design_scores_gemma":[0.18610619,0.009819818,0.8007672,0.00027841862,0.00077289884,0.000011843149,0.000031805415,0.00001199005,0.0016222288,0.000011375661,0.0002721519,0.00029407698],"about_ca_topic_score_codex":0.00004908145,"about_ca_topic_score_gemma":0.00019822422,"teacher_disagreement_score":0.18219772,"about_ca_system_score_codex":0.000112403955,"about_ca_system_score_gemma":0.00016164673,"threshold_uncertainty_score":0.96586645},"labels":[],"label_agreement":null},{"id":"W2504424595","doi":"10.1182/blood.v122.21.3449.3449","title":"Heme Oxygenase 1 Plays a Role In The Pathophysiology Of β-Thalassemia","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Thalassemia; Heme; Globin; Hemoglobin; Medicine; Chemistry; Biochemistry; Internal medicine; Enzyme","score_opus":0.005264447637856118,"score_gpt":0.2122096684525513,"score_spread":0.20694522081469519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2504424595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916306,0.000984307,0.0000013415888,0.00084954116,0.00002462705,0.00030571714,0.0000024299634,0.000012169741,0.0061892755],"genre_scores_gemma":[0.9989435,0.00014761674,0.00009777991,0.00063980604,0.000033602144,0.000036594287,0.00000854009,0.000008129314,0.00008443439],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9993941,0.000042686643,0.00017778737,0.000114196024,0.0000983172,0.00017287671],"domain_scores_gemma":[0.99961716,0.00004485564,0.000041999152,0.00022531555,0.00003074887,0.00003991491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008442405,0.00007623118,0.00017466518,0.000045868797,0.000019317484,0.0000033487331,0.00008499752,0.00010904618,0.00013915243],"category_scores_gemma":[0.000051722214,0.00004424664,0.00005895165,0.00015497944,0.000048985577,0.00002322824,0.000020828802,0.00017443922,0.00008696214],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007213256,0.0033706806,0.04717134,0.00017599727,0.00013354521,0.00017744579,0.004215799,0.00001601556,0.93456316,0.0006052836,0.0043189684,0.005179657],"study_design_scores_gemma":[0.02520653,0.0032623946,0.84983057,0.00051678636,0.0006175479,0.00052018336,0.020437503,0.0011182707,0.081141084,0.011402675,0.0052751214,0.000671358],"about_ca_topic_score_codex":0.00021852403,"about_ca_topic_score_gemma":0.000007124556,"teacher_disagreement_score":0.85342205,"about_ca_system_score_codex":0.0000043701602,"about_ca_system_score_gemma":0.000035226207,"threshold_uncertainty_score":0.18043256},"labels":[],"label_agreement":null},{"id":"W2504451653","doi":"10.1182/blood.v120.21.675.675","title":"Results of the Phase 1 Trial of RG7112, a Small-Molecule MDM2 Antagonist, in Acute Leukemia","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Jewish General Hospital; University of Toronto","funders":"","keywords":"Medicine; Leukemia; Internal medicine; Bone marrow; Clinical trial; Immunology; Mdm2; Oncology; Phases of clinical research; Pharmacology; Biology; Apoptosis; Genetics","score_opus":0.020660867718479557,"score_gpt":0.28339315361538137,"score_spread":0.2627322858969018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2504451653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921036,0.0005871573,0.000025574844,0.00016624099,0.0002722083,0.0007582812,0.00009141487,0.000017291593,0.005978263],"genre_scores_gemma":[0.9992034,0.00005279546,0.0002071228,0.000082480154,0.0001554897,0.000022364773,0.000024381827,0.000024040184,0.0002279255],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99868363,0.00007976186,0.0005081942,0.00017388424,0.00027638522,0.0002781688],"domain_scores_gemma":[0.9989727,0.00004102907,0.00024021203,0.00059113465,0.000059472226,0.00009546566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035005985,0.00013199329,0.00036664173,0.000093018534,0.000020295573,0.0000030050942,0.00015048927,0.00013920022,0.00001377642],"category_scores_gemma":[0.00024134996,0.00009908453,0.00018043465,0.00035809106,0.0000982315,0.000030062258,0.00007370348,0.00024748896,0.0000056014032],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03497945,0.004331306,0.0004368662,0.00008675201,0.00037499782,0.000071040835,0.0010092811,0.0000049246114,0.95668894,0.0001427819,0.0007805106,0.0010931365],"study_design_scores_gemma":[0.22371976,0.0009802416,0.0009136966,0.00015641672,0.0005617196,0.00006553392,0.00003641817,0.000023194016,0.7721331,0.000007508139,0.0013123573,0.000090054345],"about_ca_topic_score_codex":0.00015441269,"about_ca_topic_score_gemma":0.000032869746,"teacher_disagreement_score":0.18874031,"about_ca_system_score_codex":0.00007794606,"about_ca_system_score_gemma":0.00039666484,"threshold_uncertainty_score":0.404055},"labels":[],"label_agreement":null},{"id":"W2505350742","doi":"10.1182/blood.v114.22.4920.4920","title":"Trolox Improves the Sensitivity of Multiple Myeloma to Arsenic Trioxide in Vitro and In Vivo.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Trolox; Arsenic trioxide; Viability assay; Cell culture; Acute promyelocytic leukemia; In vivo; Cell growth; Apoptosis; Cancer research; Toxicity; Chemistry; Pharmacology; Medicine; Biology; Biochemistry; Internal medicine; Retinoic acid; Antioxidant","score_opus":0.00440132103799997,"score_gpt":0.2115375558152915,"score_spread":0.2071362347772915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2505350742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986772,0.00067049905,0.000091045375,0.00016150044,0.0000151759805,0.0001538948,0.0000059782406,0.0000033513218,0.00022135962],"genre_scores_gemma":[0.9992107,0.000084271545,0.0003674796,0.00021394713,0.000043184216,0.0000075405283,0.0000038318803,0.000005902295,0.00006314338],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993296,0.000088763685,0.00015767799,0.00020577878,0.000060725724,0.00015745507],"domain_scores_gemma":[0.99967813,0.00004281109,0.00004088732,0.00018670996,0.000020454143,0.000031024938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032456702,0.00009140029,0.00013331714,0.000035785022,0.000017492152,0.0000075624284,0.00007673244,0.00008655759,6.5724123e-7],"category_scores_gemma":[0.00024520457,0.0000707498,0.000033948054,0.00010006596,0.000040860024,0.0000024050887,0.00004207624,0.00007302651,4.261175e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016599028,0.00011175377,0.0031772705,0.00001072194,0.000007035048,0.000009501397,0.00007542683,0.000012163891,0.99247956,0.0000036217848,0.000013090322,0.0039338702],"study_design_scores_gemma":[0.0010614912,0.00013510173,0.023888774,0.000009161021,0.000008775177,0.000018366794,0.00006718377,0.00007321683,0.97427964,0.000044005305,0.00033066643,0.000083626255],"about_ca_topic_score_codex":0.000034609315,"about_ca_topic_score_gemma":0.0001304896,"teacher_disagreement_score":0.020711504,"about_ca_system_score_codex":0.00000441737,"about_ca_system_score_gemma":0.000037970425,"threshold_uncertainty_score":0.2885093},"labels":[],"label_agreement":null},{"id":"W2505545269","doi":"10.1182/blood.v116.21.1763.1763","title":"Mocetinostat (MGCD0103), An Isotype-Selective Histone Deacetylase (HDAC) Inhibitor, Produces Clinical Responses In Relapsed/Refractory Hodgkin Lymphoma (HL): Update From a Phase II Clinical Study","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Cohort; Internal medicine; Adverse effect; Population; Gastroenterology; Refractory (planetary science); Phases of clinical research; Tolerability; Progressive disease; Surgery; Clinical trial; Chemotherapy","score_opus":0.028225977949934845,"score_gpt":0.3921089692585946,"score_spread":0.36388299130865975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2505545269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956541,0.00090185856,0.000006471588,0.00022258266,0.0012495705,0.0014179712,0.00023125671,0.00009283041,0.00022332603],"genre_scores_gemma":[0.9948142,0.00021501943,0.0010122382,0.00027965085,0.0022339204,0.00018016473,0.0004376633,0.00014103588,0.000686078],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9919583,0.0024097394,0.0017977263,0.0022289027,0.0006968551,0.0009084478],"domain_scores_gemma":[0.99610984,0.00043779984,0.00045449496,0.0019027886,0.0004413465,0.00065374485],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003951499,0.0005948438,0.0008749977,0.00029904745,0.000362511,0.000078142926,0.0008634155,0.0009394648,0.0000963505],"category_scores_gemma":[0.005703349,0.00059835654,0.0003072133,0.0005031448,0.00075911515,0.000039140326,0.0006374515,0.0015226176,0.00012101597],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011647086,0.08181899,0.098233365,0.000020378113,0.00042435422,0.0007007371,0.0009849102,0.0000015098192,0.77183884,0.0000061766764,0.0116708195,0.022652848],"study_design_scores_gemma":[0.058270216,0.030419018,0.08471133,0.00006428582,0.00028608975,0.00006715435,0.0006732504,0.00004637247,0.7822939,0.00006881575,0.04157678,0.0015227476],"about_ca_topic_score_codex":0.000546339,"about_ca_topic_score_gemma":0.0047445395,"teacher_disagreement_score":0.05139997,"about_ca_system_score_codex":0.00007470631,"about_ca_system_score_gemma":0.00141792,"threshold_uncertainty_score":0.9996468},"labels":[],"label_agreement":null},{"id":"W2505714974","doi":"10.1182/blood.v114.22.2405.2405","title":"Association Between Maternal Anti-HPA1a Antibodies and Birth Weight of the Newborn.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; St. Michael's Hospital","funders":"","keywords":"Neonatal alloimmune thrombocytopenia; Medicine; Pregnancy; Population; Birth weight; Small for gestational age; Gestational age; Antibody; Obstetrics; Fetus; Preeclampsia; Antigen; Immunology; Low birth weight; Prospective cohort study; Internal medicine; Biology","score_opus":0.007266883738067516,"score_gpt":0.23291967910363706,"score_spread":0.22565279536556954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2505714974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960448,0.00039527687,0.0000016480508,0.0010732604,0.000028429717,0.00010336321,0.00002311164,0.000013645636,0.0023164316],"genre_scores_gemma":[0.99876916,0.00023591724,0.00016406605,0.00008677136,0.000054816705,5.222975e-7,0.000006015555,0.000004156449,0.0006785889],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995635,0.000012208044,0.000103789724,0.0000815877,0.0001361874,0.0001026894],"domain_scores_gemma":[0.99976176,0.000016134176,0.00007913607,0.00009054558,0.000024874993,0.000027548484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004489551,0.00006355065,0.00018273329,0.000024813144,0.000039548522,0.000007155042,0.000031413725,0.00004515112,0.000011394258],"category_scores_gemma":[0.000017694683,0.000038587692,0.000037839392,0.000059009457,0.000013474124,0.000030611558,0.000011464927,0.00004688567,0.000003908474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005442745,0.00015718745,0.9946573,0.000012656455,0.00019884917,0.000015630212,0.000049237555,4.1316266e-8,0.001987441,0.000022378874,0.00013313832,0.0027607107],"study_design_scores_gemma":[0.0020481138,0.000101257094,0.97448826,0.000043571104,0.00032440104,0.000016377537,0.000006398486,0.0000012331283,0.02186776,0.00038653883,0.0006825467,0.00003352243],"about_ca_topic_score_codex":0.00003367295,"about_ca_topic_score_gemma":0.000003704156,"teacher_disagreement_score":0.020169007,"about_ca_system_score_codex":0.000008145003,"about_ca_system_score_gemma":0.000012899943,"threshold_uncertainty_score":0.15735604},"labels":[],"label_agreement":null},{"id":"W2506032492","doi":"10.1182/blood.v124.21.6009.6009","title":"The Worth of Surveillance for Vancomycin-Resistant Enterococci in the Hematology-Oncology Unit","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Neutropenia; Internal medicine; Hematology; Infection control; Outbreak; Febrile neutropenia; Incidence (geometry); Intensive care medicine; Virology; Chemotherapy","score_opus":0.01933550308418513,"score_gpt":0.30308174835019086,"score_spread":0.2837462452660057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2506032492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98623055,0.0004814553,0.00021017589,0.0032717607,0.00020429934,0.00062391354,0.000007640703,0.00001647029,0.0089537315],"genre_scores_gemma":[0.99909335,0.000061946885,0.000064616346,0.00039450696,0.000085027656,0.00015763978,0.0000037137718,0.0000074952563,0.00013171771],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.999332,0.0001179041,0.00020733717,0.00010621142,0.00007386282,0.0001626743],"domain_scores_gemma":[0.9988978,0.0006528811,0.00008340126,0.00028273647,0.000059552134,0.000023610917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044440292,0.00006591318,0.0002134955,0.000029397836,0.00008661575,0.0000051205716,0.00012651185,0.000042033935,0.000010503041],"category_scores_gemma":[0.0001041412,0.000034946162,0.00006384473,0.00012979419,0.00008170818,0.000011454038,0.000016587022,0.000108974375,0.0000035868954],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000721546,0.0011221378,0.9451486,0.00017108477,0.00016092834,0.000014216086,0.00052958034,0.000004414924,0.007678784,0.035934117,0.0032393858,0.0052752118],"study_design_scores_gemma":[0.0074098194,0.0014846815,0.48241463,0.000062115265,0.00013089643,0.0001544271,0.00039369552,0.000009973258,0.005954176,0.0016002085,0.5002883,0.00009706925],"about_ca_topic_score_codex":0.000036777434,"about_ca_topic_score_gemma":0.0026102795,"teacher_disagreement_score":0.4970489,"about_ca_system_score_codex":0.000009852845,"about_ca_system_score_gemma":0.00005998924,"threshold_uncertainty_score":0.14565973},"labels":[],"label_agreement":null},{"id":"W2506330890","doi":"10.1182/blood.v126.23.2636.2636","title":"Outcomes in Adolescents and Young Adults (AYA) with Hodgkin Lymphoma (HL) Treated on US Cooperative Group Protocols: An Adult Intergroup (E2496) and Children's Oncology Group (COG AHOD0031) Comparative Analysis","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Cog; ABVD; Young adult; Internal medicine; Hodgkin lymphoma; Chemotherapy regimen; Clinical trial; Randomized controlled trial; Pediatrics; Oncology; Chemotherapy; Lymphoma; Cyclophosphamide; Vincristine","score_opus":0.021829035189813176,"score_gpt":0.30520732927716804,"score_spread":0.2833782940873549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2506330890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989776,0.00016886095,0.000008359921,0.00010259971,0.000025494473,0.009374083,0.00006755978,0.00007406582,0.00040293776],"genre_scores_gemma":[0.99396986,0.000041625124,0.0004619578,0.00034214297,0.000047593414,0.0048185443,0.00026150476,0.000031603067,0.000025169524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99741036,0.00036216454,0.000500491,0.0009104514,0.00037892442,0.00043760517],"domain_scores_gemma":[0.9985522,0.00006573567,0.00022741783,0.00041913943,0.00023772457,0.00049778656],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001839938,0.0005480372,0.001373387,0.00043269247,0.00010078466,0.00007863449,0.00011455395,0.00019862581,0.000006833245],"category_scores_gemma":[0.000053299227,0.00036728088,0.000096529926,0.0006378348,0.00022457604,0.00022877859,0.00007710127,0.00015191846,0.0000077854775],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004732652,0.015553451,0.9703251,0.0000368995,0.0023289905,0.0004285275,0.0031365138,0.0000048149022,0.000035710298,0.0001092949,0.000018944116,0.0032890893],"study_design_scores_gemma":[0.0649116,0.016757304,0.912852,0.0007450712,0.0018952453,0.00018818487,0.0011187241,0.00028125037,0.0008706328,0.0000053486283,0.000014033756,0.00036061343],"about_ca_topic_score_codex":0.0036115297,"about_ca_topic_score_gemma":0.016249683,"teacher_disagreement_score":0.060178943,"about_ca_system_score_codex":0.00030192517,"about_ca_system_score_gemma":0.000095149735,"threshold_uncertainty_score":0.9998779},"labels":[],"label_agreement":null},{"id":"W2506867624","doi":"10.1182/blood.v114.22.3649.3649","title":"Molecular Mechanisms of the Pre-TCR Alpha Chain (pTa) Enhancer Transcriptional Regulation by Notch1.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Enhancer; T-cell receptor; Biology; Thymocyte; Transcription factor; Molecular biology; Transcriptional regulation; Regulation of gene expression; Gene; Gene expression; Cell biology; T cell; Genetics","score_opus":0.0030472562611386024,"score_gpt":0.20398359033750438,"score_spread":0.20093633407636577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2506867624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9597312,0.0013671299,0.037341166,0.00067128445,0.00014562359,0.00030550803,0.000035435685,0.000014015348,0.00038858675],"genre_scores_gemma":[0.99845815,0.000041649055,0.00048912194,0.00016945317,0.000104941726,0.000014667592,0.00014100605,0.000015429443,0.00056556315],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990839,0.000052910684,0.0002125072,0.00026267834,0.00023326493,0.00015479025],"domain_scores_gemma":[0.9994428,0.0000029885819,0.000117279174,0.00032745936,0.00007350074,0.00003596795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001050007,0.00012844539,0.000105881816,0.000023842113,0.000060165294,0.000008663907,0.00015561993,0.00018608481,0.00003053265],"category_scores_gemma":[0.000015031137,0.000112908354,0.00013319186,0.00011853046,0.00003915646,0.000004789195,0.00001836462,0.00006230421,0.000001619567],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003981605,0.00016426503,0.000023156614,0.000006417588,0.000048811293,1.5849122e-7,0.000032675925,0.0007348199,0.99599457,0.0011113287,0.00036984772,0.0014741498],"study_design_scores_gemma":[0.0009118563,0.00019178589,0.008447135,0.0000190258,0.00006910561,0.0000074417608,0.0000050176895,0.0002121683,0.9862921,0.0020222343,0.0016934855,0.00012862905],"about_ca_topic_score_codex":0.0000066426974,"about_ca_topic_score_gemma":0.0000075055696,"teacher_disagreement_score":0.03872692,"about_ca_system_score_codex":0.000014168461,"about_ca_system_score_gemma":0.0000553179,"threshold_uncertainty_score":0.4604269},"labels":[],"label_agreement":null},{"id":"W2506959456","doi":"10.1182/blood-2016-01-695460","title":"CML with complex chromosome rearrangements and dysplastic megakaryocytes","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; Ottawa Hospital","funders":"","keywords":"Basophilia; Thrombocytosis; Leukocytosis; Chronic myelogenous leukemia; Philadelphia chromosome; Hemoglobin; Medicine; Platelet; Pathology; Microcytosis; Leukemia; Anemia; Immunology; Biology; Internal medicine; Chromosomal translocation; Genetics; Gene","score_opus":0.017491442550165118,"score_gpt":0.24104105997089864,"score_spread":0.22354961742073354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2506959456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994922,0.00033863654,0.00003665856,0.0004972703,0.000028818833,0.00031975392,0.000020149697,0.00008343636,0.0037533226],"genre_scores_gemma":[0.9963833,0.00011813985,0.0013837839,0.00012725704,0.00010565771,0.000030380874,0.000015579164,0.000028731702,0.0018071509],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990935,0.000015848684,0.00013214951,0.000280319,0.00022629627,0.0002519421],"domain_scores_gemma":[0.9993951,0.00008270133,0.000046991387,0.00027986304,0.00003663821,0.00015874124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000042111304,0.00015971741,0.00023752547,0.000055456876,0.00005137777,0.000010676444,0.000049843802,0.000044596407,0.00047954186],"category_scores_gemma":[0.000038924994,0.00008714876,0.000023791814,0.00007973611,0.000108399254,0.00006814073,0.000041431023,0.00004991635,0.00013716746],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008482366,0.001986445,0.6594745,0.00038493588,0.002145285,0.0015116365,0.0003507831,3.1322705e-7,0.31442648,0.0003582577,0.0027842298,0.015728936],"study_design_scores_gemma":[0.07654466,0.0032144333,0.857772,0.0012172614,0.0017110577,0.0019813268,0.000050814968,0.00002263657,0.045561153,0.00011237056,0.011343024,0.00046925698],"about_ca_topic_score_codex":0.00002686054,"about_ca_topic_score_gemma":0.000017176144,"teacher_disagreement_score":0.26886532,"about_ca_system_score_codex":0.00011453808,"about_ca_system_score_gemma":0.00009746589,"threshold_uncertainty_score":0.5250647},"labels":[],"label_agreement":null},{"id":"W2507477543","doi":"10.1182/blood.v116.21.2434.2434","title":"Impact of Immunoglobulin Heavy Chain (IGH) Translocations In Chronic Lymphocytic Leukemia (CLL): Negative Effect on Patients with Isolated Deletion 13q Abnormality","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Chronic lymphocytic leukemia; Internal medicine; Chromosome abnormality; Medicine; Trisomy; IGHV@; Chromosomal translocation; Oncology; Biology; Leukemia; Karyotype; Chromosome; Genetics","score_opus":0.006105677215318659,"score_gpt":0.274013505344532,"score_spread":0.2679078281292133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2507477543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973723,0.00010588192,0.0000593731,0.000021263733,0.0000619407,0.0017962191,0.000049707873,0.000070846516,0.00046244272],"genre_scores_gemma":[0.99937826,0.000023307228,0.000112934365,0.000022282824,0.000081257334,0.00011257031,0.00016768696,0.000055173357,0.000046546833],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99742776,0.00021352066,0.0005706504,0.0004832952,0.0006673956,0.00063735753],"domain_scores_gemma":[0.99808556,0.00041117545,0.00018427096,0.00079656066,0.000292358,0.0002300682],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00054648233,0.00035740496,0.0006300882,0.00033674788,0.00009386484,0.000020383695,0.00022899217,0.00028199548,0.0001520866],"category_scores_gemma":[0.00028015958,0.00026240892,0.00020083545,0.00091255415,0.00028562747,0.00014682094,0.00003821217,0.0006826754,0.000054639913],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.106999524,0.02028635,0.5022345,0.0066346466,0.007942561,0.0012959333,0.01102884,0.029531801,0.26230878,0.0006644748,0.00038696214,0.050685603],"study_design_scores_gemma":[0.21097168,0.017477194,0.67543554,0.000936899,0.00041053197,0.00019018886,0.000022821145,0.031253338,0.062737964,0.00004126152,0.0000132252135,0.0005093735],"about_ca_topic_score_codex":0.011677542,"about_ca_topic_score_gemma":0.001132568,"teacher_disagreement_score":0.19957082,"about_ca_system_score_codex":0.040406134,"about_ca_system_score_gemma":0.026130615,"threshold_uncertainty_score":0.99998283},"labels":[],"label_agreement":null},{"id":"W2507507842","doi":"10.1182/blood.v122.21.4441.4441","title":"A Novel Small Molecule STAT Inhibitor, BP-4-018, Demonstrates Significant Anti-Tumour Activity and Synergism With Bortezomib In Pre-Clinical In Vivo Models Of Multiple Myeloma","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Bortezomib; Cancer research; STAT3; Angiogenesis; In vivo; Apoptosis; Biology; Chemistry; Multiple myeloma; Molecular biology; Immunology; Biochemistry","score_opus":0.033686052717683164,"score_gpt":0.28622486167558153,"score_spread":0.2525388089578984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2507507842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976058,0.00015795465,0.00027388518,0.00015609046,0.00001511993,0.0014782618,0.000057100715,0.000027282324,0.0002285002],"genre_scores_gemma":[0.99551576,0.00013418905,0.0040418175,0.000023972743,0.000027856675,0.00015296732,0.000011860097,0.000035249708,0.000056314977],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979544,0.00012145409,0.00052487553,0.00053374114,0.00034448222,0.0005210473],"domain_scores_gemma":[0.99872476,0.00033777952,0.0001452754,0.00032502558,0.00012248983,0.00034469887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029684248,0.00026784293,0.00067040493,0.00022789901,0.000029186993,0.000028571276,0.00010490124,0.0001618831,0.000022432594],"category_scores_gemma":[0.00019421181,0.00020209374,0.000070284,0.0002734793,0.00022274118,0.00020311323,0.0000897634,0.0003684958,0.000003992009],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006586278,0.005263752,0.5907671,0.00012915807,0.00016421605,0.00029689603,0.00020825221,0.000056655572,0.40105724,0.00001033026,0.000009856246,0.0013779212],"study_design_scores_gemma":[0.019413587,0.0010759948,0.7836559,0.00026883392,0.000062531384,0.00004762334,0.00011786701,0.020072548,0.17506717,0.000036332447,0.0000012073444,0.00018042087],"about_ca_topic_score_codex":0.0061597447,"about_ca_topic_score_gemma":0.002017062,"teacher_disagreement_score":0.22599006,"about_ca_system_score_codex":0.000034763354,"about_ca_system_score_gemma":0.00026951075,"threshold_uncertainty_score":0.93117326},"labels":[],"label_agreement":null},{"id":"W2507694805","doi":"10.1182/blood.v118.21.2470.2470","title":"Effects of LMO2 on Human T-Cell Development Are Modulated by Notch Signaling","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; University of Toronto","funders":"","keywords":"Biology; Cancer research; Myeloid; Haematopoiesis; Leukemia; Myeloid leukemia; Progenitor cell; Severe combined immunodeficiency; Stem cell; Immunology; Hematopoietic stem cell; Genetic enhancement; Cell biology; Gene; Genetics","score_opus":0.03933927042758498,"score_gpt":0.2833253290993687,"score_spread":0.24398605867178372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2507694805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99074835,0.00023991866,0.000015769356,0.000011861492,0.000030394722,0.00045833277,0.0000015713873,0.000043828753,0.008449982],"genre_scores_gemma":[0.9950774,0.000008740317,0.00040909022,0.000066563276,0.00003929974,0.000023707864,0.000014231379,0.000035009358,0.004325997],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998895,0.000045122746,0.00021349991,0.0002226667,0.00037008696,0.0002536637],"domain_scores_gemma":[0.999423,0.000061951796,0.00007529209,0.0002351215,0.00008412054,0.00012047144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017183778,0.00013194198,0.00025850814,0.000103851446,0.000050243438,0.0000048014153,0.000109368775,0.00009003747,0.0008850147],"category_scores_gemma":[0.000025897609,0.000115685514,0.00005960374,0.0001407886,0.00003418228,0.000015880805,0.000035409234,0.00017991062,0.000057655612],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001329201,0.0020264545,0.0037170614,0.00032317493,0.00012853689,0.00007798626,0.0008316594,6.415263e-7,0.9915064,0.000004359075,0.00020362633,0.0010471557],"study_design_scores_gemma":[0.0043501677,0.00057149003,0.011669277,0.00022709639,0.00006658005,0.0000041504536,0.00002853881,0.0000052283,0.98252106,0.000017198428,0.0004295263,0.000109682434],"about_ca_topic_score_codex":0.000050179857,"about_ca_topic_score_gemma":0.0000026796126,"teacher_disagreement_score":0.008985359,"about_ca_system_score_codex":0.000033060944,"about_ca_system_score_gemma":0.00005111742,"threshold_uncertainty_score":0.96902907},"labels":[],"label_agreement":null},{"id":"W2507731619","doi":"10.1182/blood.v118.21.87.87","title":"Gene Risk Scores Based on Expression of 6 Genes Quanitated by Nuclease Protection Assay in Formalin Fixed Paraffin-Embedded Tissue (FFPET) Specimens From CHOP and RCHOP Treated Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Predict Outcome: An ECOG and SWOG Study","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; CHOP; Rituximab; Oncology; Internal medicine; Proportional hazards model; International Prognostic Index; Medicine; Pathology; Biology; Immunohistochemistry; Lymphoma; Immunology","score_opus":0.020916844062654837,"score_gpt":0.255847837616466,"score_spread":0.23493099355381117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2507731619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959505,0.00016552622,0.000035468354,0.0000054263305,0.000024261048,0.0032506362,0.00043296066,0.000078160396,0.000057048444],"genre_scores_gemma":[0.99876964,0.000057696976,0.0005557462,0.000021069725,0.00003257956,0.00012998791,0.00027090474,0.00007952419,0.00008284661],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99733394,0.0005482404,0.00051937834,0.0006245419,0.0005728285,0.0004010694],"domain_scores_gemma":[0.998597,0.00011546188,0.00026366854,0.00057715795,0.0001432858,0.00030342236],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045030733,0.0003515208,0.0005652104,0.00031424998,0.00011126623,0.000031180396,0.00011920876,0.00016431903,0.00020544008],"category_scores_gemma":[0.0000977929,0.0002663206,0.00004005495,0.00028031296,0.00008509339,0.00016858187,0.00006420531,0.00022695916,0.000004194873],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009062744,0.044588536,0.7751779,0.00006340616,0.0001014015,0.0000649505,0.002056731,0.0000017928012,0.16561726,1.2062962e-7,0.000013130702,0.0032520574],"study_design_scores_gemma":[0.09085759,0.0066532237,0.55029804,0.00009832845,0.00021637113,0.0000018181283,0.00029643596,0.00120331,0.35015544,0.0000032492435,0.000013750743,0.00020245003],"about_ca_topic_score_codex":0.0019846247,"about_ca_topic_score_gemma":0.0005099132,"teacher_disagreement_score":0.22487983,"about_ca_system_score_codex":0.000058777347,"about_ca_system_score_gemma":0.000050491424,"threshold_uncertainty_score":0.9999789},"labels":[],"label_agreement":null},{"id":"W2508318535","doi":"10.1182/blood.v122.21.3742.3742","title":"RUNX1 Is Required For Maintenance Of Established T-ALL Blasts","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Gene knockdown; Biology; Gene silencing; Cancer research; RUNX1; Leukemia; Cell culture; Molecular biology; Genetics; Stem cell; Haematopoiesis; Gene","score_opus":0.020436533554668408,"score_gpt":0.282636154499018,"score_spread":0.2621996209443496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2508318535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97916234,0.00015356437,0.0014318875,0.00392045,0.00012736155,0.0021768927,0.00026310515,0.00009990501,0.01266449],"genre_scores_gemma":[0.9728067,0.000031362713,0.013652923,0.0012343803,0.00022714262,0.00033609295,0.00007892374,0.000055612196,0.01157688],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99855405,0.000016936854,0.00031249804,0.00027839126,0.00036449803,0.0004736167],"domain_scores_gemma":[0.99847364,0.00029476266,0.000098203,0.0004746813,0.00045662443,0.0002020818],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015683356,0.0001364362,0.00033339084,0.00010287991,0.000027441001,0.00001904917,0.00018948695,0.00011628279,0.0015916316],"category_scores_gemma":[0.00091512804,0.00010687772,0.00011735388,0.0001953848,0.00012224945,0.00013108722,0.00007984919,0.00010275484,0.00020220924],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039816918,0.0011659423,0.0025316668,0.0007352927,0.00051344594,0.00005177187,0.0007854062,8.545172e-7,0.14879683,0.00043541903,0.84004736,0.0045378245],"study_design_scores_gemma":[0.10205867,0.005734506,0.040986925,0.001745113,0.0014383214,0.00074459345,0.0012123012,0.010284426,0.63647395,0.0051517533,0.19298112,0.0011883114],"about_ca_topic_score_codex":0.00015730246,"about_ca_topic_score_gemma":0.000004458683,"teacher_disagreement_score":0.64706624,"about_ca_system_score_codex":0.00009677982,"about_ca_system_score_gemma":0.00036707977,"threshold_uncertainty_score":0.99932104},"labels":[],"label_agreement":null},{"id":"W2508349721","doi":"10.1182/blood.v116.21.612.612","title":"Predisposition to Myelodysplastic Syndrome with Deletion 5q Is Associated with TP53 Codon 72 Genotype","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; Genetics; Allele; Genotype; Myelodysplastic syndromes; Cancer research; Gene; Molecular biology; Bone marrow; Immunology","score_opus":0.010867038906772444,"score_gpt":0.25385446827998465,"score_spread":0.24298742937321222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2508349721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965429,0.000029356566,0.00023420237,0.00060158386,0.00005174079,0.0006480821,0.00005249496,0.00010197166,0.0017376796],"genre_scores_gemma":[0.9973872,0.0000076284905,0.000640561,0.00037586226,0.00011193328,0.000056727396,0.000095584655,0.000047927424,0.0012766011],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99846065,0.000026341771,0.00016647737,0.00033346337,0.0005860944,0.0004269798],"domain_scores_gemma":[0.9989995,0.00006200661,0.000058231057,0.00030130398,0.0002744989,0.00030445794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002114866,0.00017253523,0.00027646238,0.0001748224,0.00013988938,0.00005097085,0.000091239825,0.00015257929,0.0005444075],"category_scores_gemma":[0.000093094466,0.00012517525,0.00003773672,0.00046328412,0.00006438781,0.00008643545,0.000034886743,0.00044173023,0.0002910548],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008238991,0.0069245137,0.28119615,0.00047935045,0.0024050581,0.0048173913,0.0024448475,0.00003980885,0.6809954,0.0005257868,0.0050264434,0.006906246],"study_design_scores_gemma":[0.009817608,0.0075237113,0.94336337,0.00055091,0.0008929933,0.0017832618,0.00005137141,0.00024332466,0.030250058,0.00002989336,0.005016905,0.000476622],"about_ca_topic_score_codex":0.0001511127,"about_ca_topic_score_gemma":0.00081591815,"teacher_disagreement_score":0.6621672,"about_ca_system_score_codex":0.000050990297,"about_ca_system_score_gemma":0.00018239209,"threshold_uncertainty_score":0.5960881},"labels":[],"label_agreement":null},{"id":"W2508625171","doi":"10.1182/blood.v106.11.279.279","title":"Fondaparinux Combined with Intermittent Pneumatic Compression (IPC) Versus IPC Alone in the Prevention of Venous Thromboembolism after Major Abdominal Surgery: The Randomized APOLLO Study.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Medicine; Fondaparinux; Intermittent pneumatic compression; Pulmonary embolism; Surgery; Deep vein; Randomized controlled trial; Abdominal surgery; Venography; Anesthesia; Placebo; Thrombosis; Venous thromboembolism","score_opus":0.01844853713608561,"score_gpt":0.270211837506121,"score_spread":0.25176330037003536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2508625171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921656,0.0005955788,0.00004288964,0.0016381636,0.00020566097,0.004527987,0.000002849671,0.00003346457,0.00078779116],"genre_scores_gemma":[0.99806243,0.00011962243,0.00019260825,0.0003039672,0.00012831106,0.0010686625,0.00001683092,0.000034783407,0.00007279965],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99717534,0.00064578437,0.00079547206,0.00033444457,0.00068360235,0.00036538532],"domain_scores_gemma":[0.9980016,0.0007631474,0.00036610157,0.00072442385,0.00007805293,0.00006671385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017328538,0.00030018575,0.00163199,0.00017993282,0.000117782445,0.000045639703,0.00028946673,0.0000671749,0.0001198176],"category_scores_gemma":[0.00010803146,0.0001512432,0.0003086045,0.00028850045,0.00019926396,0.000101028316,0.00012770866,0.00027096638,0.00001856095],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5719956,0.2331909,0.029223358,0.0022004156,0.014735755,0.0010461211,0.08247483,0.00023029835,0.0018284009,0.001476729,0.0062422003,0.05535538],"study_design_scores_gemma":[0.43147114,0.0048230654,0.5455577,0.0015905118,0.007873878,0.000078968544,0.006125605,0.00028755658,0.001237172,0.00020393735,0.00033415583,0.00041636475],"about_ca_topic_score_codex":0.00027853728,"about_ca_topic_score_gemma":0.0005061958,"teacher_disagreement_score":0.5163343,"about_ca_system_score_codex":0.00004511683,"about_ca_system_score_gemma":0.00007674448,"threshold_uncertainty_score":0.6167519},"labels":[],"label_agreement":null},{"id":"W2508655015","doi":"10.1182/blood.v118.21.427.427","title":"CSF1R Expression of Hodgkin Reed Sternberg Cells Is Associated with the Number of Macrophages in the Tumor Microenvironment and Is Correlated with Treatment Outcome","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"ABVD; Medicine; Reed–Sternberg cell; Gene expression profiling; Lymph node; Lymphoma; CD68; Tissue microarray; Internal medicine; Oncology; Pathology; Phenotype; Immunohistochemistry; Cancer research; Gene expression; Biology; Hodgkin lymphoma; Chemotherapy; Gene; Vincristine","score_opus":0.017159621181930217,"score_gpt":0.22884347825105902,"score_spread":0.21168385706912882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2508655015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983164,0.00032679783,8.1131157e-7,0.00022836721,0.0000094022325,0.0006183466,0.00004908303,0.0000063685934,0.00044441805],"genre_scores_gemma":[0.998978,0.00012227678,0.0001905355,0.00024556328,0.0000051162096,0.00006627189,0.000007839129,0.000016818933,0.00036754247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990836,0.000077519144,0.00024296246,0.00020344363,0.00023427315,0.00015820994],"domain_scores_gemma":[0.9992847,0.000095427866,0.00022207087,0.0003362772,0.000020316487,0.00004121567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000094631396,0.00018347909,0.00035291412,0.000026168147,0.00003551652,0.0000056088334,0.00007318905,0.00004571184,0.00013130739],"category_scores_gemma":[0.0000034561538,0.000072509974,0.00005302949,0.000088818604,0.00012162612,0.000023017043,0.000026211655,0.00005414985,0.000005741212],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003680149,0.0046998123,0.9776138,0.000022847435,0.0003951545,0.00024307106,0.0073403637,3.4975227e-7,0.009045028,0.000002742137,0.000115936426,0.00015290186],"study_design_scores_gemma":[0.009168257,0.0011307078,0.6054778,0.00019194065,0.0006894014,0.000057247475,0.00059732917,0.000001898301,0.38258743,0.0000023049283,0.000035114164,0.000060579627],"about_ca_topic_score_codex":0.0005250414,"about_ca_topic_score_gemma":0.000042751748,"teacher_disagreement_score":0.3735424,"about_ca_system_score_codex":0.0000486283,"about_ca_system_score_gemma":0.000021525415,"threshold_uncertainty_score":0.29568708},"labels":[],"label_agreement":null},{"id":"W2508678492","doi":"10.1182/blood.v108.11.1646.1646","title":"Fondiparinux Worsens Leukocyte Endothelial Interactions Improved by Antithrombin and Increases Leukocyte Extravasation.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Antithrombin; Extravasation; Intravital microscopy; Proinflammatory cytokine; Heparan sulfate; Cremaster muscle; Immunology; Sepsis; Heparin; Anticoagulant; Chemistry; Endothelium; Inflammation; Medicine; Pharmacology; Microcirculation; Internal medicine; Biochemistry","score_opus":0.007394807114455431,"score_gpt":0.23370535925723473,"score_spread":0.22631055214277931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2508678492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98679686,0.0010627797,0.00018976942,0.00037608933,0.00014942355,0.0005285788,0.000037138212,0.000148413,0.010710925],"genre_scores_gemma":[0.9950559,0.0004612391,0.0007674332,0.0003487205,0.00033178506,0.000056431247,0.00013119358,0.00003818227,0.00280909],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988138,0.000032330172,0.00031177793,0.0003565489,0.00017812267,0.00030740607],"domain_scores_gemma":[0.99936706,0.00006061267,0.00010971051,0.00028272407,0.000055434117,0.0001244572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010121828,0.0002065402,0.0003883652,0.00012894094,0.00017094372,0.000075338445,0.00006722973,0.00006300486,0.00022333175],"category_scores_gemma":[0.000039650313,0.00019396827,0.00008902558,0.00012337892,0.00008945171,0.00014960596,0.000073911375,0.00014532791,0.00004595574],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020935638,0.0139838625,0.043388635,0.00031848782,0.0012067655,0.00020432805,0.00041036584,0.000011242627,0.8121045,0.005332023,0.11436891,0.008461494],"study_design_scores_gemma":[0.01914793,0.001202122,0.4188504,0.00033507572,0.003188993,0.00055053295,0.00052431464,0.0004588261,0.36021614,0.0007894082,0.19376923,0.0009670195],"about_ca_topic_score_codex":0.0039157206,"about_ca_topic_score_gemma":0.00044848156,"teacher_disagreement_score":0.45188838,"about_ca_system_score_codex":0.00004745851,"about_ca_system_score_gemma":0.000048936174,"threshold_uncertainty_score":0.7909797},"labels":[],"label_agreement":null},{"id":"W2508701852","doi":"10.1182/blood.v124.21.3084.3084","title":"A Phase 1 -2 Study of Brentuximab Vedotin (Bv) and Bendamustine (B) in Patients with Relapsed or Refractory Hodgkin Lymphoma (HL) and Anaplastic Large T-Cell Lymphoma (ALCL)","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency; University of Toronto","funders":"","keywords":"Brentuximab vedotin; Bendamustine; Medicine; Internal medicine; Oncology; Regimen; Refractory (planetary science); Salvage therapy; Progressive disease; Chemotherapy; Lymphoma; Surgery; Gastroenterology; Rituximab; Hodgkin lymphoma","score_opus":0.007415717431819893,"score_gpt":0.23379663349968477,"score_spread":0.22638091606786487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2508701852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99830616,0.00030953085,0.000003624561,0.000024659204,0.000045913923,0.0010035244,0.00005652327,0.00003319033,0.00021689708],"genre_scores_gemma":[0.9993873,0.000045673954,0.00022798651,0.000073033756,0.000035794215,0.00007399043,0.00006288871,0.00004185099,0.00005146956],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981641,0.00011015258,0.0004542551,0.00052790745,0.00038490546,0.0003586446],"domain_scores_gemma":[0.99883336,0.0002338811,0.00022264202,0.00038903244,0.00010095817,0.00022012829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018588219,0.0003199783,0.00068564,0.00022637624,0.00007569323,0.000021542557,0.000067720975,0.0000965899,0.00002398999],"category_scores_gemma":[0.0001340926,0.0002193374,0.000036170368,0.00026132664,0.000068321024,0.000089802365,0.00008263594,0.000053325904,0.0000039450097],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044595073,0.16310595,0.80910504,0.00017679922,0.00020800764,0.00019283488,0.0008826223,3.701965e-7,0.00008910993,0.000012846044,0.00005128584,0.021715606],"study_design_scores_gemma":[0.3154828,0.027382193,0.6549607,0.00021600274,0.0006417824,0.000027317357,0.00028048144,0.000069715425,0.00057984865,0.000002761745,0.00018007423,0.00017633321],"about_ca_topic_score_codex":0.00018631518,"about_ca_topic_score_gemma":0.00030145983,"teacher_disagreement_score":0.31102327,"about_ca_system_score_codex":0.00007079819,"about_ca_system_score_gemma":0.000100856596,"threshold_uncertainty_score":0.89443195},"labels":[],"label_agreement":null},{"id":"W2508758106","doi":"10.1182/blood.v118.21.508.508","title":"Success in Meeting the Primary Endpoint in Phase III Trials: A Comparison of Industry and Cooperative Group Trials","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Randomized controlled trial; Clinical trial; Medicine; Research design; Publication bias; Clinical endpoint; Family medicine; Actuarial science; Psychology; Meta-analysis; Internal medicine; Statistics; Economics","score_opus":0.6811599713391726,"score_gpt":0.5989578628793156,"score_spread":0.08220210845985698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2508758106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910017,0.001373299,0.000018587758,0.00065720594,0.00005525499,0.0011695389,0.000012323948,0.000009036699,0.005703046],"genre_scores_gemma":[0.998721,0.00034345302,0.0005067992,0.00017198842,0.00011432087,0.000069904294,0.0000066800358,0.000012560721,0.00005328132],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9940945,0.00266249,0.002125183,0.0003038016,0.0005590903,0.00025495648],"domain_scores_gemma":[0.9601419,0.038562104,0.00056373834,0.00039598346,0.00020267777,0.00013362188],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.048706084,0.00012292639,0.0014893884,0.00015260756,0.000039015053,0.000015199558,0.00019547374,0.0005189084,0.00013839122],"category_scores_gemma":[0.08701476,0.00007485052,0.00008719654,0.0003379319,0.0003499659,0.000057708512,0.00017615649,0.0022208742,0.000001304749],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021229146,0.024177881,0.83364964,0.0011654606,0.0007180238,0.00029567885,0.03616396,0.0000043471014,0.0536589,0.010734014,0.00019551151,0.018007413],"study_design_scores_gemma":[0.28044415,0.0077849682,0.30149645,0.006666672,0.0012402469,0.000031333297,0.020765437,0.00046832574,0.36691505,0.013273781,0.00024612283,0.0006675093],"about_ca_topic_score_codex":0.0006672298,"about_ca_topic_score_gemma":0.0009108957,"teacher_disagreement_score":0.53215325,"about_ca_system_score_codex":0.000029556062,"about_ca_system_score_gemma":0.0003384742,"threshold_uncertainty_score":0.9795573},"labels":[],"label_agreement":null},{"id":"W2509053325","doi":"10.1182/blood.v122.21.2680.2680","title":"Chemosensitization and Mobilization Of AML/ALL/MDS With Plerixafor (AMD 3100), a CXCR4 Antagonist: A Phase I Study Of Plerixafor + Cytarabine and Etoposide In Pediatric Patients With Acute Leukemia and MDS","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"","keywords":"Plerixafor; Medicine; Cytarabine; Etoposide; CXCR4 antagonist; Leukemia; Bone marrow; CXCR4; Acute leukemia; Chemotherapy; Internal medicine; Pharmacology; Oncology; Inflammation; Chemokine","score_opus":0.007548646088943208,"score_gpt":0.2571508213574301,"score_spread":0.2496021752684869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2509053325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99686587,0.00011954381,0.000073545954,0.00007418087,0.000008366121,0.0027585332,0.00003240045,0.000023367944,0.000044171782],"genre_scores_gemma":[0.99820495,0.00028714153,0.0011005772,0.00004730639,0.000033189055,0.0001086364,0.00012789351,0.000046640555,0.000043684155],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982899,0.00006386137,0.00046161274,0.0004410159,0.0004483803,0.00029522614],"domain_scores_gemma":[0.99881446,0.00008011881,0.00024099833,0.00028905302,0.00039491625,0.00018047233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018262836,0.00025679526,0.000574811,0.00034181782,0.00005338618,0.00002894812,0.000063854066,0.000110682406,0.000011620961],"category_scores_gemma":[0.00007161333,0.000190226,0.000016361737,0.0005874195,0.00017762848,0.00026534242,0.00009590165,0.00019404708,5.654717e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022124825,0.0030070194,0.97261786,0.0005829199,0.00029944192,0.00006684815,0.0032214047,0.000016478563,0.01673575,0.000008300797,0.000042450032,0.001189056],"study_design_scores_gemma":[0.07235232,0.012734426,0.89522266,0.00014534948,0.0010975227,0.00011717036,0.0012525002,0.0023811855,0.014386927,0.000011787817,0.0000067408682,0.0002914101],"about_ca_topic_score_codex":0.0005657075,"about_ca_topic_score_gemma":0.00013957644,"teacher_disagreement_score":0.07739519,"about_ca_system_score_codex":0.00008979162,"about_ca_system_score_gemma":0.0002603025,"threshold_uncertainty_score":0.7757191},"labels":[],"label_agreement":null},{"id":"W2509080586","doi":"10.1182/blood.v116.21.2129.2129","title":"A Drug Screen in Zebrafish Identifies a New Therapeutic Agent Active in Acute Lymphoblastic Leukemia","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Genetics, Bioinformatics, and Biomedical Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Zebrafish; In vivo; Biology; Cancer research; Leukemia; Lymphoblast; Pharmacology; Acute lymphocytic leukemia; Cell culture; Immunology; Lymphoblastic Leukemia; Genetics; Gene","score_opus":0.01073670418975331,"score_gpt":0.2626396007834832,"score_spread":0.2519028965937299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2509080586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99800974,0.00020564307,0.00010261188,0.00028905744,0.0001684547,0.00026904294,0.000022220453,0.000009751147,0.0009234652],"genre_scores_gemma":[0.9969882,0.00027384332,0.000391832,0.0003270163,0.00020182674,0.000021150518,0.00007467385,0.000018572367,0.0017028833],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99858385,0.00004447932,0.00032246418,0.00030233478,0.00029243404,0.00045446254],"domain_scores_gemma":[0.9993091,0.000028888928,0.00006320811,0.00034807023,0.0000508472,0.00019987946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025833203,0.00017535259,0.00019309676,0.00015316348,0.000037452748,0.000053388394,0.00039729313,0.00021704886,0.000049320297],"category_scores_gemma":[0.00014392816,0.00015529858,0.00008030329,0.00019642836,0.00015254553,0.0000085077145,0.00021793388,0.00027933987,0.00004886651],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016393754,0.0003537109,0.0046546147,0.00004560136,0.00015439499,0.00004001498,0.0008087758,0.000004689468,0.9736432,0.000028794744,0.001180588,0.018921679],"study_design_scores_gemma":[0.0074103507,0.00042649644,0.11053502,0.00007798014,0.00008579082,0.000049382354,0.00062289916,0.00040145527,0.8679521,0.0011631332,0.010700661,0.00057473005],"about_ca_topic_score_codex":0.00070218195,"about_ca_topic_score_gemma":0.006154508,"teacher_disagreement_score":0.10588041,"about_ca_system_score_codex":0.000029109013,"about_ca_system_score_gemma":0.00048898393,"threshold_uncertainty_score":0.6332893},"labels":[],"label_agreement":null},{"id":"W2509134839","doi":"10.1182/blood-2016-07-730325","title":"An upper bound for the half-removal time of neutrophils from circulation","year":2016,"lang":"en","type":"letter","venue":"Blood","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institutes of Health","keywords":"Immunology; Phenotype; Biology; Genetics","score_opus":0.014732539207834192,"score_gpt":0.2295980642974498,"score_spread":0.21486552508961562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2509134839","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5939182,0.010146386,0.0053411415,0.37416384,0.0046307985,0.004138457,0.006563321,0.00032402878,0.0007738054],"genre_scores_gemma":[0.39662987,0.00048898126,0.0017246328,0.52516055,0.02410042,0.00088401325,0.021398464,0.0007780331,0.028835047],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99818367,0.00028353033,0.00041885185,0.0005687319,0.00007391713,0.00047129975],"domain_scores_gemma":[0.9980423,0.00057391287,0.00034010777,0.0008706812,0.00015662934,0.000016381375],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001865875,0.00038300984,0.0005683803,0.000113484806,0.00023574999,0.000029513709,0.00060854235,0.0010516875,0.0010535644],"category_scores_gemma":[0.00002730126,0.00023607204,0.0003014509,0.00006417761,0.00024481656,0.00011267044,0.000065993496,0.0005972109,0.0005334332],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007041299,0.000098963355,0.000023470413,0.000023184408,0.00093465653,0.000028068716,0.000084977015,4.3308074e-7,0.9223341,0.00036708536,0.074906655,0.0011280425],"study_design_scores_gemma":[0.0026051803,0.00029443816,0.00027929078,0.000087818196,0.00085404096,0.00006312137,0.0000132495,0.0000018656891,0.39714506,0.0025158732,0.59578,0.00036004692],"about_ca_topic_score_codex":0.000092074275,"about_ca_topic_score_gemma":0.0000033603276,"teacher_disagreement_score":0.525189,"about_ca_system_score_codex":0.000021974784,"about_ca_system_score_gemma":0.000087664754,"threshold_uncertainty_score":0.99985963},"labels":[],"label_agreement":null},{"id":"W2509144358","doi":"10.1182/blood-2016-04-713289","title":"Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia A","year":2016,"lang":"en","type":"review","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":221,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; Uniformed Services University of the Health Sciences; Canada Research Chairs; Agence Nationale de la Recherche","keywords":"Medicine; Shadow (psychology); Association (psychology); Von Willebrand disease; Von Willebrand factor; Immunology; Psychology; Platelet; Psychoanalysis; Psychotherapist","score_opus":0.1501415149575406,"score_gpt":0.45752233505929785,"score_spread":0.30738082010175727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2509144358","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00061423285,0.97777873,0.0000014326357,0.016964909,0.000045670513,0.0037781463,0.00016168115,0.0000074541463,0.0006477209],"genre_scores_gemma":[0.005087983,0.9920936,0.000020444648,0.00013504477,0.00043144068,0.0010616749,0.00005560936,0.000022210079,0.0010919857],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99814504,0.00034254423,0.00073236314,0.00028091672,0.00023389774,0.00026525132],"domain_scores_gemma":[0.99571705,0.0032466622,0.0003550147,0.00043456702,0.00013443179,0.00011229031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021606905,0.00017985456,0.0010642422,0.00008149655,0.00009243504,0.000015537205,0.00022601784,0.00031469224,0.000008311577],"category_scores_gemma":[0.0031629184,0.00006914616,0.00042903447,0.00022243687,0.00006791042,0.000021735015,0.000058034617,0.00029910356,0.000020043488],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000098128476,0.0034803052,0.021053828,0.013618214,0.0021856395,0.000014958543,0.00027651104,4.861737e-9,0.0000124572725,0.014550798,0.009272152,0.935437],"study_design_scores_gemma":[0.004066327,0.0004323327,0.0042992677,0.005185485,0.0030747454,0.000046491834,0.00001681171,0.0000016303626,0.0000052025352,0.0006144482,0.982121,0.00013625802],"about_ca_topic_score_codex":0.000005734792,"about_ca_topic_score_gemma":0.000015868967,"teacher_disagreement_score":0.97284883,"about_ca_system_score_codex":0.000039131442,"about_ca_system_score_gemma":0.00074901263,"threshold_uncertainty_score":0.37865373},"labels":[],"label_agreement":null},{"id":"W2509149168","doi":"10.1182/blood.v126.23.1963.1963","title":"Evaluation of Varicella Zoster Prophylaxis after Allogeneic Hematopoietic Cell Transplantation Using Valacyclovir Followed By Vaccination","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Varicella zoster virus; Cumulative incidence; Rash; Discontinuation; Transplantation; Disease; Vaccination; Internal medicine; Pediatrics; Surgery; Immunology; Virus","score_opus":0.03427295859741435,"score_gpt":0.29635912308405377,"score_spread":0.2620861644866394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2509149168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946217,0.00068838947,0.00088353263,0.000015864525,0.000089912304,0.00065369974,0.00001954928,0.000023084414,0.0030042825],"genre_scores_gemma":[0.99875265,0.000021909655,0.00089956936,0.000021582628,0.00003130605,0.000065913555,0.000069134636,0.000020147667,0.00011775321],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987295,0.00013754706,0.0002493634,0.00018819119,0.00056848483,0.00012685727],"domain_scores_gemma":[0.9992243,0.000018321989,0.00009837396,0.00018056102,0.00039177274,0.000086658154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005300423,0.00012085029,0.0001720583,0.00010879298,0.00003002463,0.000010610997,0.000026819207,0.00009939582,0.0001314055],"category_scores_gemma":[0.000026965181,0.00010451149,0.000071040835,0.00019408861,0.000010297986,0.00008829886,0.000006790568,0.0000584125,0.000023328423],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012058668,0.021691648,0.61140054,0.0015559843,0.0017479154,0.0001846488,0.007563147,0.00073565333,0.2906095,0.000017819546,0.0005587056,0.062728524],"study_design_scores_gemma":[0.04311261,0.0022034273,0.098986045,0.00024416824,0.015605729,0.00031613593,0.00022362161,0.0020800403,0.83539814,0.0004839866,0.000787986,0.0005581235],"about_ca_topic_score_codex":0.00010150729,"about_ca_topic_score_gemma":0.000013643775,"teacher_disagreement_score":0.5447886,"about_ca_system_score_codex":0.00010226841,"about_ca_system_score_gemma":0.00017134858,"threshold_uncertainty_score":0.4261855},"labels":[],"label_agreement":null},{"id":"W2509231151","doi":"10.1182/blood.v122.21.3573.3573","title":"Quebec Platelet Disorder Is Associated With Greater Than Expected Increases In Urokinase Plasminogen Activator In Granulocytes and Monocytes","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Hospital for Sick Children; McMaster University","funders":"","keywords":"Plasminogen activator; Myeloid; Molecular biology; Urokinase; Platelet; Erythropoietin; Immunology; Chemistry; Biology; Internal medicine; Endocrinology; Medicine","score_opus":0.008859934199157617,"score_gpt":0.21257859610271415,"score_spread":0.20371866190355653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2509231151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982294,0.0006228441,4.0716867e-7,0.0001737387,0.0000069219373,0.00070281775,0.000033241708,0.000056134882,0.00017453828],"genre_scores_gemma":[0.9991116,0.000083142724,0.000060380557,0.00014974934,0.00001017414,0.00018277166,0.000102829,0.000035967958,0.00026338574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880093,0.00004905016,0.00022959897,0.00036818354,0.0001739856,0.0003782237],"domain_scores_gemma":[0.99945635,0.00010516296,0.00007327998,0.00018906969,0.000039717623,0.00013643976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003969645,0.00027567227,0.0004930857,0.00022655861,0.00004500844,0.00004089947,0.000057284087,0.00013566046,0.00013224417],"category_scores_gemma":[0.00007313995,0.00020016574,0.0000381865,0.00032336128,0.00007072526,0.00021441905,0.0000352771,0.00015226303,0.000017969238],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026518028,0.0020950497,0.99351054,0.000022400984,0.00026835556,0.0011753241,0.0007386938,5.107507e-7,0.00083503954,0.000003007926,0.00006804515,0.0010178637],"study_design_scores_gemma":[0.017535053,0.000370722,0.96206766,0.00022060299,0.00011414884,0.00010885978,0.0004776339,0.00005500042,0.018743183,0.000047413665,0.000023384975,0.00023632908],"about_ca_topic_score_codex":0.046562508,"about_ca_topic_score_gemma":0.018353445,"teacher_disagreement_score":0.031442862,"about_ca_system_score_codex":0.00005774112,"about_ca_system_score_gemma":0.00006398872,"threshold_uncertainty_score":0.99955904},"labels":[],"label_agreement":null},{"id":"W2509499585","doi":"10.1182/blood.v108.11.1047.1047","title":"Platelet-Activating Anti-Platelet Factor 4/Polyanion Antibodies without Preceding Heparin Therapy: A Transient Autoimmune Disorder Resembling Heparin-Induced Thrombocytopenia (“Spontaneous HIT”).","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Heparin-induced thrombocytopenia; Heparin; Platelet factor 4; Medicine; Platelet; Immunology; Thrombosis; Antibody; Platelet activation; Immune system; Internal medicine; Gastroenterology","score_opus":0.03505531450433809,"score_gpt":0.28898386853674274,"score_spread":0.25392855403240466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2509499585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98674303,0.0008864133,0.000115909206,0.00045240816,0.0005724372,0.0021657788,0.000037311373,0.00081907434,0.008207615],"genre_scores_gemma":[0.9963179,0.0006218844,0.0014325199,0.00013908742,0.00053371873,0.00010862597,0.00018085215,0.00028740958,0.00037800468],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.994121,0.00025063037,0.0014894531,0.0014693985,0.0010049369,0.0016645938],"domain_scores_gemma":[0.99743193,0.00026796627,0.00052546366,0.0011428344,0.00026989533,0.00036190124],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.00051023206,0.0011204572,0.0023152325,0.0004628803,0.0013306682,0.00051851507,0.0005207611,0.00063560583,0.00029615854],"category_scores_gemma":[0.00015777051,0.0009993056,0.0004972495,0.0009026374,0.00017641946,0.00063396053,0.0002230619,0.0011992062,0.000109935274],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045680825,0.0020597721,0.06517714,0.000180556,0.00078779587,0.0007315026,0.0014738122,0.000036631624,0.9188232,0.00010196955,0.00004165149,0.010129194],"study_design_scores_gemma":[0.012371331,0.0010332211,0.37500134,0.00067178067,0.00021224661,0.0020532904,0.00051756285,0.0004749542,0.6024042,0.0000658749,0.0038901172,0.0013040771],"about_ca_topic_score_codex":0.005257512,"about_ca_topic_score_gemma":0.000774905,"teacher_disagreement_score":0.31641898,"about_ca_system_score_codex":0.0002519612,"about_ca_system_score_gemma":0.0003805118,"threshold_uncertainty_score":0.9999695},"labels":[],"label_agreement":null},{"id":"W2509631380","doi":"10.1182/blood.v126.23.900.900","title":"Mir-125a Confers Multi-Lineage Long-Term Repopulating Stem Cell Activity to Human Hematopoietic Committed Progenitors","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Biology; Stem cell; Progenitor cell; Haematopoiesis; CD34; CD38; Cell biology; Transplantation; Immunology; Hematopoietic stem cell; Bone marrow; Internal medicine; Medicine","score_opus":0.038448612501742835,"score_gpt":0.2948056179683634,"score_spread":0.25635700546662055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2509631380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99822617,0.00020541988,0.0006696493,0.00002508842,0.00010308003,0.0005629885,0.000016559006,0.000048485337,0.00014256802],"genre_scores_gemma":[0.99833155,8.833865e-7,0.0008955833,0.00004001637,0.00017915963,0.000043743024,0.00014152894,0.000043618787,0.00032393957],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99875385,0.00010743947,0.00026385774,0.00042455253,0.00017682853,0.00027344626],"domain_scores_gemma":[0.9988666,0.0000059450076,0.00016320121,0.00054840907,0.0001378479,0.0002779853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001763794,0.00020608756,0.00018616722,0.000045793775,0.000098383374,0.000045810568,0.00018824777,0.00016329755,0.000005593827],"category_scores_gemma":[0.000032301727,0.00021766484,0.00009794222,0.00009436264,0.000040295614,0.0000064082246,0.0001615812,0.00008516349,0.00002018031],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002981464,0.00053244137,0.077005126,0.000071659626,0.000052220497,0.000017767721,0.00012242944,0.000021384265,0.9217907,0.0000020002958,0.00018573758,0.00016871709],"study_design_scores_gemma":[0.0018755236,0.00015605026,0.049571723,0.000030945706,0.000078440695,0.000023510142,0.000066066576,0.000036280613,0.9477473,0.0000015491472,0.00014219647,0.00027041015],"about_ca_topic_score_codex":0.000025127463,"about_ca_topic_score_gemma":0.000046404315,"teacher_disagreement_score":0.0274334,"about_ca_system_score_codex":0.000027623279,"about_ca_system_score_gemma":0.00007416369,"threshold_uncertainty_score":0.88761145},"labels":[],"label_agreement":null},{"id":"W2510316350","doi":"10.1182/blood.v122.21.172.172","title":"High Content Screening Identifies Synthetic Lethality Of Retinoid Receptor Agonists In IKZF1-Mutated BCR-ABL1 positive Acute Lymphoblastic Leukemia","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Cancer research; Chronic myelogenous leukemia; Leukemia; Lymphoid leukemia; Biology; CDKN2A; Imatinib; Immunology; Myeloid leukemia; ABL; Philadelphia chromosome; Tyrosine kinase; Chromosomal translocation; Receptor; Genetics; Cancer; Gene","score_opus":0.016279198228062598,"score_gpt":0.2427733639240559,"score_spread":0.22649416569599332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2510316350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99708194,0.00038523876,0.0000618054,0.00043172928,0.0001966037,0.0011781215,0.000105582396,0.0001028541,0.00045615586],"genre_scores_gemma":[0.9965102,0.00010058312,0.0018448939,0.000119431956,0.00007643912,0.0001449845,0.00022081728,0.000059770555,0.0009228568],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997237,0.00019047013,0.0008410576,0.0006152918,0.0005280918,0.0005880397],"domain_scores_gemma":[0.99817526,0.00030763503,0.00035145617,0.0006204604,0.00031552542,0.00022963615],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028255433,0.0003873965,0.00089341524,0.00021755484,0.00007889027,0.000041829746,0.00020319484,0.00022340303,0.00048499205],"category_scores_gemma":[0.00040010145,0.00034581692,0.00019073919,0.00036172583,0.00027182334,0.00018765642,0.00013686842,0.00029803385,0.0002563563],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007918841,0.0019670718,0.04672946,0.0005083532,0.0026730574,0.0007805186,0.0019323145,0.000056196102,0.9392624,0.00015574484,0.000764409,0.0043785986],"study_design_scores_gemma":[0.017303975,0.000670861,0.32223913,0.0017043025,0.0011994486,0.00032173825,0.0004925048,0.00024225871,0.6553089,0.00009160105,0.000028011595,0.00039729176],"about_ca_topic_score_codex":0.0070748944,"about_ca_topic_score_gemma":0.00007725234,"teacher_disagreement_score":0.28395352,"about_ca_system_score_codex":0.0012169941,"about_ca_system_score_gemma":0.0005217228,"threshold_uncertainty_score":0.9998994},"labels":[],"label_agreement":null},{"id":"W2510323411","doi":"10.1182/blood.v114.22.1513.1513","title":"Definition of the Responder to Hydroxyurea Therapy: Revisited.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Fetal hemoglobin; Acute chest syndrome; Placebo; Clinical endpoint; Randomization; Sickle cell anemia; Internal medicine; Anemia; Hydroxycarbamide; Clinical trial; Quartile; Randomized controlled trial; Pediatrics; Pregnancy; Chemotherapy; Disease; Fetus; Confidence interval; Pathology","score_opus":0.014738993968933519,"score_gpt":0.24545190067102116,"score_spread":0.23071290670208763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2510323411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9552617,0.0014179588,0.000009474586,0.007120639,0.000033734483,0.0002745227,0.0000034410973,0.000026502277,0.035851996],"genre_scores_gemma":[0.99384856,0.00033993355,0.00041619298,0.0051329937,0.000031506715,0.0000022649485,0.0000044606372,0.000006878664,0.00021720259],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9994704,0.000027394759,0.00014003085,0.00009915081,0.00015089885,0.00011211745],"domain_scores_gemma":[0.999594,0.0000142050385,0.00003615943,0.00025973938,0.000043002692,0.000052915217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007991965,0.00006619945,0.00012318822,0.000046393034,0.000038598177,0.000003889529,0.000060671835,0.000075798904,0.000055500837],"category_scores_gemma":[0.00006863287,0.00003815314,0.00008233531,0.0002868464,0.000019010095,0.000014929872,0.000009548013,0.00010521619,0.0000231636],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00179653,0.006143001,0.039241314,0.0001496575,0.00052115653,0.000106704414,0.004773797,0.000016475704,0.8305289,0.028221352,0.033948038,0.054553084],"study_design_scores_gemma":[0.019558102,0.004510252,0.69948703,0.0015117745,0.00072201435,0.00032239995,0.0006698479,0.000014762624,0.16410996,0.019763265,0.08874545,0.0005851501],"about_ca_topic_score_codex":0.0000062946933,"about_ca_topic_score_gemma":4.3766215e-7,"teacher_disagreement_score":0.6664189,"about_ca_system_score_codex":0.000005682804,"about_ca_system_score_gemma":0.000033514385,"threshold_uncertainty_score":0.155584},"labels":[],"label_agreement":null},{"id":"W2510352639","doi":"10.1182/blood.v124.21.1544.1544","title":"Influence of Thrombophilia on the Efficacy of Dabigatran Versus Warfarin for the Extended Treatment of Acute Venous Thromboembolism in RE-MEDY™","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Warfarin; Thrombophilia; Pulmonary embolism; Dabigatran; Vitamin K antagonist; Internal medicine; Randomized controlled trial; Deep vein; Randomization; Surgery; Thrombosis; Atrial fibrillation","score_opus":0.02884655342819285,"score_gpt":0.29921451719283687,"score_spread":0.270367963764644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2510352639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952189,0.00026945604,0.000011423024,0.0013032446,0.00013182551,0.0018873741,0.000032846652,0.00001667271,0.0011282893],"genre_scores_gemma":[0.9986049,0.0008058392,0.00014940734,0.00013167453,0.00008492114,0.00016626717,0.000010074513,0.00002791568,0.000019020388],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984663,0.00007462747,0.0005405876,0.00028316546,0.0003436103,0.00029172594],"domain_scores_gemma":[0.9975021,0.0011299758,0.00028811852,0.0009249119,0.00010166463,0.00005323709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038424187,0.00022323827,0.0009629224,0.000096928474,0.00006942205,0.0000055512673,0.00030282675,0.00008427593,0.000021291913],"category_scores_gemma":[0.00018838861,0.00012307819,0.00025036823,0.00022946688,0.00025057365,0.00003236526,0.000050060928,0.000094561045,0.0000034709346],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012867754,0.21066728,0.0154710505,0.0035866112,0.033908382,0.00010147893,0.060139656,0.011853018,0.31690875,0.22628498,0.002313382,0.10589767],"study_design_scores_gemma":[0.017588483,0.0118002035,0.8289142,0.00037816472,0.0038512966,0.000003556811,0.00042343812,0.00012375106,0.13512437,0.0008159599,0.0008024207,0.00017414725],"about_ca_topic_score_codex":0.00037408207,"about_ca_topic_score_gemma":0.00007665433,"teacher_disagreement_score":0.8134431,"about_ca_system_score_codex":0.000038033573,"about_ca_system_score_gemma":0.00006747453,"threshold_uncertainty_score":0.5018983},"labels":[],"label_agreement":null},{"id":"W2510491091","doi":"10.1182/blood.v108.11.4116.4116","title":"Inhibitors of Platelet Aggregation from Diverse Haematophagous and Predaceous Hirudinea from around the World.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Leech Biology and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Leech; Hirudin; Platelet aggregation; Biology; Platelet; Thrombin; Platelet-rich plasma; Immunology","score_opus":0.009472345714841611,"score_gpt":0.23189051466214408,"score_spread":0.22241816894730246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2510491091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968988,0.0011320607,0.000025458286,0.00077573746,0.000045867928,0.00024994792,0.000103276994,0.000032650885,0.00073624117],"genre_scores_gemma":[0.998479,0.000028359387,0.0005167935,0.00010510309,0.00033966993,0.000019239727,0.00014782864,0.000006489219,0.00035750936],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99950606,0.000020166623,0.0001600928,0.00015220874,0.00007703243,0.00008444641],"domain_scores_gemma":[0.99951035,0.00014643105,0.00008969417,0.0001979472,0.000027617665,0.000027974373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000044528348,0.00007645358,0.0001451025,0.000029972698,0.00007540905,0.0000068664867,0.000050346203,0.000070102564,0.000045674948],"category_scores_gemma":[0.000019612895,0.000051318424,0.0000321372,0.00009754652,0.00012738408,0.00003002256,0.000031639916,0.00009483171,0.000016222148],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019694286,0.0017613552,0.83471155,0.000044388464,0.00058798597,0.00011314532,0.00084314874,0.0000141683595,0.13466768,0.0021856958,0.010517466,0.014356481],"study_design_scores_gemma":[0.0053654164,0.00011889543,0.4254818,0.00011899807,0.0006913857,0.000060075676,0.0002833286,0.000091312606,0.5508817,0.009283828,0.0074407607,0.00018249784],"about_ca_topic_score_codex":0.001442342,"about_ca_topic_score_gemma":0.0003687017,"teacher_disagreement_score":0.41621405,"about_ca_system_score_codex":0.00000694166,"about_ca_system_score_gemma":0.000017040034,"threshold_uncertainty_score":0.21803991},"labels":[],"label_agreement":null},{"id":"W2510643843","doi":"10.1182/blood.v122.21.2066.2066","title":"Steroid Failure At Day 28 After Acute Graft-Versus-Host Disease Treatment and Long-Term Outcomes Following Allogeneic Transplantation: Adverse Impact On Survival and Non-Relapse Mortality But No Increasing Risk Of Relapse","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Transplantation; Internal medicine; Hematopoietic stem cell transplantation; Adverse effect; Population; Retrospective cohort study; Graft-versus-host disease; Incidence (geometry); Disease; Gastroenterology; Surgery","score_opus":0.01380927912295085,"score_gpt":0.2752494907256698,"score_spread":0.26144021160271896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2510643843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99770147,0.00026338978,0.00003408012,0.00006751921,0.00018675865,0.0011721179,0.00045337965,0.000043610427,0.000077673394],"genre_scores_gemma":[0.9984753,0.00072273717,0.00024136271,0.000026140715,0.00004341441,0.00009704437,0.00024338123,0.000046901194,0.00010371731],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980881,0.00021416566,0.0004885527,0.00049496,0.00038234986,0.00033186475],"domain_scores_gemma":[0.9984806,0.00037481668,0.00017476537,0.00043309777,0.00006279809,0.00047393213],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025990448,0.0004241636,0.0006540704,0.00012022854,0.000110871595,0.000027983575,0.000060587627,0.0001397354,0.000097048185],"category_scores_gemma":[0.000039053895,0.00030959034,0.00030937107,0.00008948374,0.000095340605,0.00022569198,0.000021736443,0.0001251947,0.00003377044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023482542,0.0004873725,0.97363037,0.00041329354,0.002166299,0.0006794923,0.0009794869,0.0000021319843,0.019235548,0.0000011104692,0.0000015527812,0.000055068107],"study_design_scores_gemma":[0.017899496,0.0006697909,0.9673564,0.00042659245,0.007515603,0.000060298888,0.00008312513,0.00001312175,0.005708417,0.0000022533616,5.689839e-7,0.00026434733],"about_ca_topic_score_codex":0.00055561773,"about_ca_topic_score_gemma":0.0003028939,"teacher_disagreement_score":0.015551243,"about_ca_system_score_codex":0.00008933936,"about_ca_system_score_gemma":0.00006802035,"threshold_uncertainty_score":0.9999356},"labels":[],"label_agreement":null},{"id":"W2510710599","doi":"10.1182/blood-2015-12-687814","title":"High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cells","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"Venetoclax; Cancer research; Medicine; Chronic lymphocytic leukemia; Leukemia; Internal medicine","score_opus":0.03884744232875944,"score_gpt":0.26862778532933745,"score_spread":0.229780343000578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2510710599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99715513,0.0008509415,0.00003996692,0.00048428008,0.00021516287,0.00052655075,0.000017421913,0.00009001868,0.00062054285],"genre_scores_gemma":[0.99195033,0.00015646106,0.0005408424,0.00008910076,0.00022380966,0.000050201892,0.000008896911,0.000048466878,0.006931916],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99776083,0.00009182481,0.00036867472,0.00048433934,0.0006849244,0.00060939946],"domain_scores_gemma":[0.99868065,0.0002901928,0.00010793631,0.00061429956,0.00009525879,0.00021166935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038320606,0.00021881283,0.0003920624,0.00024453914,0.000059890634,0.000037978712,0.00020208948,0.00015947422,0.00012949682],"category_scores_gemma":[0.00026048542,0.00015517951,0.00010723688,0.00033245547,0.00014990254,0.00021488704,0.0001548533,0.00022616205,0.00011077205],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008125686,0.0003462724,0.0038489248,0.0002078112,0.0001263888,0.0012572438,0.0002569019,0.0000036295096,0.9903746,0.00012674657,0.0014582801,0.0011806177],"study_design_scores_gemma":[0.03842214,0.00008440885,0.013689481,0.0015017063,0.00005751255,0.000028434117,0.00010970786,0.000010416511,0.94415444,0.00014540914,0.001590916,0.00020542392],"about_ca_topic_score_codex":0.0014022578,"about_ca_topic_score_gemma":0.00050793187,"teacher_disagreement_score":0.046220172,"about_ca_system_score_codex":0.004891433,"about_ca_system_score_gemma":0.0015225,"threshold_uncertainty_score":0.9989286},"labels":[],"label_agreement":null},{"id":"W2510788806","doi":"10.1182/blood.v110.11.1482.1482","title":"Predictors for Skeletal-Related Events in Patients with Advanced Multiple Myeloma.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Medicine; Multiple myeloma; Internal medicine; Zoledronic acid; Oncology; Bone pain; Population; Univariate analysis; Bone remodeling; Spinal cord compression; Cancer; Bone disease; Surgery; Osteoporosis; Multivariate analysis","score_opus":0.008242888841877996,"score_gpt":0.2609110036232772,"score_spread":0.25266811478139917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2510788806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99700654,0.00008325694,0.00009150465,0.000029509147,0.000056542274,0.002133809,0.000039653954,0.000062742954,0.0004964277],"genre_scores_gemma":[0.9967856,0.0000065996114,0.002324656,0.000024798126,0.000027572874,0.00010565815,0.00034655642,0.000039597788,0.0003389795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984166,0.000019007293,0.00029091738,0.00031619275,0.00039927947,0.0005579871],"domain_scores_gemma":[0.9991419,0.00013830059,0.0000699628,0.0002562564,0.00013001537,0.00026361083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018250436,0.00018005798,0.00026540464,0.00019516029,0.000057139096,0.000003699297,0.000076505705,0.000095042,0.000029070088],"category_scores_gemma":[0.0002617898,0.00013376081,0.00007239653,0.00027259585,0.000037898993,0.00009187305,0.000025891792,0.0001432771,0.000022915672],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019735585,0.003007421,0.98245126,0.00005501279,0.00027487506,0.000044335397,0.000077723045,0.0000029759915,0.00026288952,0.000006715188,0.000010506053,0.011832729],"study_design_scores_gemma":[0.06291535,0.0018711723,0.93184173,0.00011858263,0.00008751266,0.0000040903633,0.000023385535,0.000038499926,0.0027284834,0.000015558944,0.00023511639,0.00012050425],"about_ca_topic_score_codex":0.00002376757,"about_ca_topic_score_gemma":0.00010016227,"teacher_disagreement_score":0.06094179,"about_ca_system_score_codex":0.000076291326,"about_ca_system_score_gemma":0.00006118728,"threshold_uncertainty_score":0.54546076},"labels":[],"label_agreement":null},{"id":"W2510854332","doi":"10.1182/blood.v124.21.2774.2774","title":"Final Results from a Phase 4 Open-Label 3-Year Study Evaluating Changes in Bone Marrow (Bm) Morphology in Adult Immune Thrombocytopenia (ITP) Patients (Pts) Receiving the Thrombopoietin Mimetic Romiplostim","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Romiplostim; Medicine; Thrombopoietin; Cohort; Bone marrow; Platelet; Prospective cohort study; Internal medicine; Surgery; Gastroenterology; Pathology; Haematopoiesis; Stem cell","score_opus":0.05788527528940619,"score_gpt":0.34080138576190133,"score_spread":0.28291611047249515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2510854332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99453425,0.00024670103,0.0000012420134,0.0010294081,0.00013271214,0.0032066372,0.000115115006,0.000032139906,0.000701817],"genre_scores_gemma":[0.99758476,0.00006930009,0.0011220501,0.00031441895,0.000055548877,0.00034560013,0.00035208205,0.000053434473,0.000102786726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99677086,0.0006320623,0.0007886945,0.0007800335,0.00046443488,0.0005638975],"domain_scores_gemma":[0.99814624,0.00051652297,0.00032618456,0.0007784732,0.00013408477,0.00009850441],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012735464,0.00036312363,0.0010742487,0.00018047357,0.00015401845,0.000069414455,0.00043708488,0.00015255126,0.000140169],"category_scores_gemma":[0.001741507,0.00027045843,0.00004749776,0.00044913337,0.000081664824,0.00012871927,0.00037550286,0.00045370832,0.00009872153],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014475575,0.16638339,0.65210587,0.0001158301,0.0014204448,0.0024901866,0.023506032,0.000024539078,0.07829672,0.000030181898,0.0007050064,0.060446214],"study_design_scores_gemma":[0.339134,0.012535288,0.63874763,0.000808512,0.0008257891,0.000041405365,0.0022323583,0.0011095486,0.003738407,0.00031183966,0.000027985818,0.00048723625],"about_ca_topic_score_codex":0.0043852297,"about_ca_topic_score_gemma":0.004269705,"teacher_disagreement_score":0.32465842,"about_ca_system_score_codex":0.00008553573,"about_ca_system_score_gemma":0.00008028316,"threshold_uncertainty_score":0.9999748},"labels":[],"label_agreement":null},{"id":"W2510879407","doi":"10.1182/blood.v112.11.4920.4920","title":"CD19+,CD27+, IgM+ B Cells of Patients with Persistent Polyclonal B Cell (PPBL) Proliferate in a Low Intensity CD40-CD154 Interaction and Show Evidence of Immunoglobulin Isotype Switching","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Héma-Québec; Université Laval","funders":"","keywords":"CD154; CD19; Biology; CD40; Immunology; Immunoglobulin class switching; B cell; Isotype; Immunoglobulin M; Molecular biology; Antibody; Immunoglobulin G; Genetics; Cytotoxic T cell; Monoclonal antibody; In vitro","score_opus":0.01129481702017754,"score_gpt":0.19755446142854155,"score_spread":0.186259644408364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2510879407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953235,0.003772991,0.000019667556,0.00004996185,0.00033981184,0.0003397552,0.000016815295,0.000020599657,0.00011688878],"genre_scores_gemma":[0.9991478,0.0003739601,0.00013175978,0.00005168331,0.000011448167,0.000009578148,0.000028085564,0.000017578232,0.0002281187],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984918,0.00018062665,0.0005224555,0.00038421372,0.00007294513,0.00034793717],"domain_scores_gemma":[0.9989312,0.00015267881,0.00037302508,0.00029816924,0.0002197166,0.000025208794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001729596,0.00025234252,0.00053616776,0.00018633541,0.00011254081,0.0000064342757,0.0002072143,0.00023815788,0.000072129165],"category_scores_gemma":[0.000043787266,0.00020888814,0.00010841218,0.00016959918,0.00030518966,0.00018716847,0.00015913385,0.0004653911,0.00003318658],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023880377,0.0017354132,0.18413949,0.00012107171,0.00018715212,0.000013541462,0.0012538923,0.000013953798,0.80995345,0.000003207447,0.000029527075,0.00016126134],"study_design_scores_gemma":[0.0054308395,0.0020002078,0.087749906,0.0005016373,0.00014699006,0.00010946416,0.0005531904,0.000012071016,0.9031471,0.000006690855,0.00007408415,0.0002678431],"about_ca_topic_score_codex":0.00044806494,"about_ca_topic_score_gemma":0.00007320615,"teacher_disagreement_score":0.096389584,"about_ca_system_score_codex":0.000032343276,"about_ca_system_score_gemma":0.00009592694,"threshold_uncertainty_score":0.8518211},"labels":[],"label_agreement":null},{"id":"W2510919763","doi":"10.1182/blood.v122.21.1919.1919","title":"Tumor Suppressor Microrna-29a/b and Microrna-34a Mediate Small Molecule PRIMA-1Met-Induced Aoptosis In Multiple Myeloma Cells By Targeting c-Myc","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"microRNA; Apoptosis; Biology; Cancer research; Gene silencing; Cell culture; Molecular biology; In vivo; Gene; Genetics","score_opus":0.0065768060316957555,"score_gpt":0.19642955910501358,"score_spread":0.18985275307331784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2510919763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965079,0.0022695248,0.00005720258,0.00014807936,0.000100968355,0.0007118731,0.00010032888,0.000030135683,0.000073987576],"genre_scores_gemma":[0.9956212,0.00007511246,0.003271756,0.00023719775,0.00013352158,0.00012708842,0.0003686333,0.00007262442,0.00009285839],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980002,0.00013727903,0.00045458024,0.00070185505,0.0001443101,0.0005617448],"domain_scores_gemma":[0.99902356,0.000038265647,0.00021732309,0.00041688854,0.00011073357,0.00019323452],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018973855,0.0003370736,0.0002899289,0.00009158615,0.00009375803,0.0000855657,0.0002864395,0.00023262764,0.00005121098],"category_scores_gemma":[0.00015366988,0.000357927,0.000104142084,0.00013166669,0.000082951185,0.000015657726,0.0002505385,0.00015650457,0.000038370188],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032986907,0.00031606542,0.0048156427,0.00006763819,0.00007105622,0.000008776535,0.000071619776,0.0000038465528,0.99174875,6.7224386e-7,0.00258063,0.00028231603],"study_design_scores_gemma":[0.0025312833,0.00009605234,0.012716761,0.00003660524,0.000057449008,0.000013058302,0.00006601286,0.00009786705,0.98267907,0.000008897953,0.001277873,0.00041909018],"about_ca_topic_score_codex":0.00016743974,"about_ca_topic_score_gemma":0.00004314899,"teacher_disagreement_score":0.0090697,"about_ca_system_score_codex":0.000023611972,"about_ca_system_score_gemma":0.000060072205,"threshold_uncertainty_score":0.9998873},"labels":[],"label_agreement":null},{"id":"W2511093457","doi":"10.1182/blood.v112.11.1916.1916","title":"CXCR7 Is Expressed in B Acute Lymphoblastic Leukemia (ALL) Cells and Mediates Their Transendothelial Migration.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Alberta","funders":"","keywords":"Chemotaxis; Transfection; Jurkat cells; Cell culture; Chemotaxis assay; CXCR4; Chemokine receptor; Flow cytometry; Molecular biology; Chemokine; B cell; Stromal cell; Cancer research; Receptor; Leukemia; Downregulation and upregulation; Cell biology; Biology; Chemistry; Immunology; T cell; Antibody; Biochemistry; Gene","score_opus":0.012334273409435272,"score_gpt":0.2168894781885637,"score_spread":0.20455520477912842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2511093457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984889,0.0006163634,0.000053031214,0.0003271307,0.000059168815,0.00016663029,0.000046947272,0.000035858502,0.0002059565],"genre_scores_gemma":[0.99700266,0.0017705138,0.00042276626,0.00031653693,0.0001932678,0.000013669804,0.000016822585,0.000022031707,0.0002417255],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99918574,0.000017825007,0.00022043705,0.0002223906,0.00015309565,0.00020048484],"domain_scores_gemma":[0.9995944,0.00010414598,0.00003769805,0.00012910868,0.000026560754,0.000108072105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000060818595,0.00014918475,0.00027195894,0.00007974183,0.000041584943,0.000009611613,0.000049138955,0.00009105032,0.00011086829],"category_scores_gemma":[0.000016407632,0.00011650812,0.00006707313,0.00010236942,0.000056837856,0.000049388436,0.000011616915,0.00010399106,0.000010994603],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008834812,0.00019482826,0.011009317,0.000046279278,0.000099993194,0.00011265333,0.0039831125,0.0000050291983,0.9835319,0.000002963855,0.00065478083,0.0002708119],"study_design_scores_gemma":[0.006065226,0.0001117309,0.002931234,0.000077385375,0.0001501993,0.00016211167,0.00010180356,0.00046325038,0.9881058,0.000029880002,0.0016647769,0.00013660867],"about_ca_topic_score_codex":0.00008792406,"about_ca_topic_score_gemma":0.000026557567,"teacher_disagreement_score":0.008078083,"about_ca_system_score_codex":0.00003172001,"about_ca_system_score_gemma":0.00011593243,"threshold_uncertainty_score":0.4751063},"labels":[],"label_agreement":null},{"id":"W2511121889","doi":"10.1182/blood.v110.11.189.189","title":"Phase II Testing of Lenalidomide Plus Melphalan for Previously Untreated Older Patients with Multiple Myeloma: Toxicity Data from the NCIC CTG MY.11 Trial.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Moncton Hospital; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; London Health Sciences Centre; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Lenalidomide; Medicine; Neutropenia; Tolerability; Multiple myeloma; Adverse effect; Melphalan; Febrile neutropenia; Internal medicine; Phases of clinical research; Toxicity; Surgery; Oncology; Gastroenterology","score_opus":0.07021945872571524,"score_gpt":0.33511903297076184,"score_spread":0.2648995742450466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2511121889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929553,0.0002980851,0.00036636757,0.00008403617,0.00005360563,0.0046226755,0.0014286041,0.00006802809,0.00012328575],"genre_scores_gemma":[0.9910642,0.000007155101,0.0055686524,0.000063581625,0.00024096158,0.00010536135,0.0027790845,0.000049440117,0.0001215975],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9975549,0.00009004276,0.00055378536,0.00056563586,0.0006159223,0.00061969104],"domain_scores_gemma":[0.99610645,0.0017857059,0.00028505953,0.001172188,0.00036124792,0.00028935994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067214493,0.00028737384,0.00056933303,0.00008296029,0.0002628073,0.000023973898,0.00041234976,0.00010145686,0.000050820407],"category_scores_gemma":[0.0029385358,0.00016681908,0.00009049787,0.00032122602,0.00012241649,0.00013886248,0.00022499758,0.00016245445,0.000006457026],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11592283,0.028506657,0.815989,0.0002119356,0.0022526311,0.00022911296,0.0009491554,0.0000030587444,0.0057900995,0.000004734785,0.0009178952,0.029222867],"study_design_scores_gemma":[0.7291009,0.009168444,0.2142861,0.00047883188,0.0015632088,0.0000147830415,0.00015202996,0.0011481015,0.043426298,0.000011512582,0.00038227686,0.00026755297],"about_ca_topic_score_codex":0.0015908027,"about_ca_topic_score_gemma":0.0013523636,"teacher_disagreement_score":0.613178,"about_ca_system_score_codex":0.00006866264,"about_ca_system_score_gemma":0.00026145988,"threshold_uncertainty_score":0.68026847},"labels":[],"label_agreement":null},{"id":"W2511162758","doi":"10.1182/blood-2015-12-685958","title":"Apoptotic neutrophils in ascitic fluid","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Pancytopenia; Hepatosplenomegaly; Ascites; Medicine; Gastroenterology; Neutropenia; Cirrhosis; Internal medicine; Macrocytic anemia; Aplastic anemia; Ascitic fluid; Anemia; Immunology; Bone marrow; Chemotherapy","score_opus":0.005168606363122861,"score_gpt":0.20898972412722722,"score_spread":0.20382111776410436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2511162758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99716806,0.0008283247,0.000054627853,0.00021629555,0.00004786215,0.00009148498,0.000007951971,0.000008085538,0.0015773015],"genre_scores_gemma":[0.99914235,0.0001767784,0.00009295368,0.00012457937,0.00006635861,0.000020654923,0.000011293188,0.000013087996,0.0003519155],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994109,0.000020373142,0.000100002886,0.00021931442,0.000054574193,0.00019481023],"domain_scores_gemma":[0.9996936,0.000005612878,0.000019255525,0.00022023403,0.000014065731,0.000047242975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000033709217,0.00009272698,0.000082777944,0.000028328897,0.000020290056,0.000007001118,0.00008783272,0.00006911054,0.000023704506],"category_scores_gemma":[0.000023190123,0.000063731524,0.000045712764,0.000047815796,0.000030623156,0.0000020784091,0.000039007784,0.000018768396,0.000055521024],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003556066,0.0011212432,0.0759103,0.000010125403,0.00010887518,0.000034138564,0.000014561647,0.0000020507246,0.91486055,0.00028674275,0.00034023763,0.0072755967],"study_design_scores_gemma":[0.010002371,0.000623412,0.04333073,0.0000437979,0.0000785644,0.000035757363,0.000017230002,0.0000013305151,0.94037,0.0010809588,0.0041010906,0.00031471648],"about_ca_topic_score_codex":0.000014115021,"about_ca_topic_score_gemma":0.0000387277,"teacher_disagreement_score":0.032579567,"about_ca_system_score_codex":0.0000035765356,"about_ca_system_score_gemma":0.00002376594,"threshold_uncertainty_score":0.2598896},"labels":[],"label_agreement":null},{"id":"W2511310313","doi":"10.1182/blood.v112.11.3179.3179","title":"Richter Transformation of Chronic Lymphocytic Leukemia: Incidence, Risk Factors and Outcome","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; St. Paul's Hospital; University of British Columbia Hospital","funders":"","keywords":"Medicine; Chronic lymphocytic leukemia; Cytopenia; Internal medicine; Univariate analysis; Gastroenterology; Incidence (geometry); Lymph node; Stage (stratigraphy); Leukemia; Surgery; Multivariate analysis; Bone marrow","score_opus":0.024770050498074774,"score_gpt":0.28002272916793164,"score_spread":0.25525267866985685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2511310313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967937,0.0010311104,0.0001340126,0.000016391956,0.000051618328,0.0004116199,0.000014896458,0.000060157585,0.0014865332],"genre_scores_gemma":[0.99830484,0.0011303794,0.00015672202,0.000028799393,0.00008624209,0.000014072686,0.000015788273,0.000024532816,0.00023864664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833286,0.00004881702,0.00048796533,0.00024208387,0.00054192176,0.00034632965],"domain_scores_gemma":[0.9990816,0.00017422947,0.00012681122,0.00034916983,0.000083728926,0.00018442883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022817081,0.00018701126,0.0004333279,0.00019475492,0.00010552257,0.000007733197,0.00011125676,0.00015965066,0.00007480536],"category_scores_gemma":[0.00018983205,0.0001415667,0.000113389535,0.00028590282,0.00021188123,0.00017723003,0.00004713481,0.00022478004,0.000033298824],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0006308066,0.00092963036,0.96188325,0.0030355977,0.0011938489,0.0009301074,0.013412374,0.00044683315,0.011537594,0.00043153187,0.00057962764,0.0049888194],"study_design_scores_gemma":[0.18260524,0.0024781898,0.5693155,0.0004974275,0.0017795209,0.006398299,0.0005931754,0.048290018,0.18556195,0.00017347716,0.0014445967,0.0008625813],"about_ca_topic_score_codex":0.0021850422,"about_ca_topic_score_gemma":0.000049480605,"teacher_disagreement_score":0.39256772,"about_ca_system_score_codex":0.014125581,"about_ca_system_score_gemma":0.009855349,"threshold_uncertainty_score":0.9957579},"labels":[],"label_agreement":null},{"id":"W2511718478","doi":"10.1182/blood.v118.21.345.345","title":"Glycine Transporter 1 Plays a Crucial Role in Hemoglobinization","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital; McGill University; Jewish General Hospital","funders":"","keywords":"Reticulocyte; Glycine; Biochemistry; Heme; Transporter; Biology; Chemistry; Amino acid; Gene; Messenger RNA; Enzyme","score_opus":0.01971827399303116,"score_gpt":0.2232622364730786,"score_spread":0.20354396248004744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2511718478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97912246,0.000074813244,0.00013108518,0.00006473573,0.00011916405,0.0001407418,0.0000033424187,0.00004560265,0.020298047],"genre_scores_gemma":[0.9982233,0.000023324921,0.0005921012,0.00059123326,0.00018017548,0.000010755745,0.000039732506,0.000010851382,0.00032852162],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995033,0.00001469351,0.00015466551,0.00014401771,0.000060929415,0.00012239847],"domain_scores_gemma":[0.99977064,0.0000059256895,0.000026460755,0.00011746633,0.000026361784,0.000053154243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000041016716,0.000071372204,0.00015511154,0.00007336377,0.000015833304,0.0000012690809,0.000027454707,0.00008505305,0.00087207684],"category_scores_gemma":[0.000012012006,0.00006248066,0.00003837602,0.00013260984,0.00002042015,0.00003333588,0.000004775059,0.00009138608,0.00009148475],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022650745,0.0039892127,0.76751196,0.00011788566,0.00010196797,0.0004660568,0.006580227,0.0000036603249,0.21341239,0.000984774,0.0005123026,0.0040544597],"study_design_scores_gemma":[0.009069793,0.0008352211,0.9575469,0.00004990402,0.000102908336,0.00013424673,0.00017864097,0.000051524024,0.029724287,0.00036705917,0.0018012674,0.0001382582],"about_ca_topic_score_codex":0.000050541126,"about_ca_topic_score_gemma":0.000060190025,"teacher_disagreement_score":0.1900349,"about_ca_system_score_codex":0.0000070878614,"about_ca_system_score_gemma":0.00003241075,"threshold_uncertainty_score":0.95486295},"labels":[],"label_agreement":null},{"id":"W2511851904","doi":"10.1182/blood.v124.21.2520.2520","title":"Population Based Analysis of Outcomes of Primary Central Nervous System Lymphoma (PCNSL) Suggests a Treatment Strategy Including Intensive Chemotherapy with Autologous Stem Cell Transplantation Provides a Survival Advantage for Patients &lt;65 Years of Age","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of Calgary","funders":"","keywords":"Medicine; ThioTEPA; Primary central nervous system lymphoma; Busulfan; Cyclophosphamide; Autologous stem-cell transplantation; Population; Internal medicine; Surgery; Cytarabine; Transplantation; Oncology; Chemotherapy","score_opus":0.014066486172795696,"score_gpt":0.2472232859838945,"score_spread":0.23315679981109882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2511851904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980421,0.000054349803,0.00026670637,0.0000124395565,0.000031577045,0.0012260793,0.00029539427,0.00002843192,0.00004289619],"genre_scores_gemma":[0.99807847,0.000026219,0.00084159814,0.000016258347,0.000009056389,0.0000871389,0.00090568804,0.000028148675,0.0000074442687],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985851,0.000078236284,0.00054392626,0.00027307065,0.00029896022,0.00022072163],"domain_scores_gemma":[0.9986496,0.00027842986,0.00052307436,0.00024648485,0.00023116641,0.00007123736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009742556,0.00021686555,0.001086535,0.0002771605,0.00002895632,0.000006471354,0.000052791765,0.000078863515,0.0000015066971],"category_scores_gemma":[0.000010091681,0.00016224424,0.00029611177,0.0002251972,0.000030236668,0.00004709867,0.0000059838685,0.000015932676,1.2445253e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013057021,0.0035281242,0.9395708,0.0010734898,0.0021757814,0.000030201712,0.00097561796,0.00045652347,0.0015580836,0.00003727638,4.0984645e-7,0.04928803],"study_design_scores_gemma":[0.01730964,0.0035083324,0.9526547,0.00022665052,0.0066542234,0.000004074033,0.00037140097,0.00079929584,0.018349832,0.0000014429389,0.0000012493317,0.0001191692],"about_ca_topic_score_codex":0.000942756,"about_ca_topic_score_gemma":0.00044377006,"teacher_disagreement_score":0.049168862,"about_ca_system_score_codex":0.00024524188,"about_ca_system_score_gemma":0.000107951135,"threshold_uncertainty_score":0.66161275},"labels":[],"label_agreement":null},{"id":"W2511888356","doi":"10.1182/blood.v110.11.934.934","title":"Normal Response to Aspirin in Healthy Individuals: Cross-Comparison of Light Transmission Aggregometry, VerifyNow™ System, Platelet Count Drop, Thrombelastography (TEG®) and Urinary 11-dehydrothromboxane B2.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Aspirin; Medicine; Platelet; Urinary system; Prospective cohort study; Population; Internal medicine; Cohort; Anesthesia; Surgery","score_opus":0.011885200222793836,"score_gpt":0.301701241609422,"score_spread":0.2898160413866282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2511888356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98020273,0.017581876,0.0005517381,0.0001612126,0.000114873896,0.0009718875,0.000037837137,0.000102831254,0.0002749979],"genre_scores_gemma":[0.9987049,0.00034439118,0.0005650051,0.00015176467,0.00010122393,0.00002547482,0.000028186187,0.000054448195,0.00002461407],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968912,0.00022116309,0.0009098291,0.00056440424,0.0007954397,0.0006179417],"domain_scores_gemma":[0.99850726,0.00016871888,0.0001989295,0.00052228104,0.00010039758,0.0005023879],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020369103,0.00035661756,0.0010900251,0.0008407016,0.0001429181,0.00003328358,0.00018147327,0.00031201798,0.00005589549],"category_scores_gemma":[0.000045387176,0.00032514168,0.0003383839,0.0010315123,0.00016169391,0.00014668159,0.000058367285,0.0003344991,0.000011665575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02755967,0.006011774,0.88979715,0.0025790955,0.0013660557,0.001475885,0.004367745,0.00004174867,0.05311952,0.000054579836,0.00008828022,0.013538489],"study_design_scores_gemma":[0.0194357,0.0072087063,0.86448723,0.002001957,0.00048464834,0.0011276976,0.0012146056,0.000023225712,0.07904745,0.000008555974,0.02442856,0.0005316616],"about_ca_topic_score_codex":0.00010461264,"about_ca_topic_score_gemma":0.000018626277,"teacher_disagreement_score":0.02592793,"about_ca_system_score_codex":0.000060399776,"about_ca_system_score_gemma":0.0001470973,"threshold_uncertainty_score":0.99992007},"labels":[],"label_agreement":null},{"id":"W2511905967","doi":"10.1182/blood.v124.21.2109.2109","title":"Phase 1b/2 Study of Carfilzomib, Pomalidomide, and Dexamethasone (KPd) in Patients (Pts) with Lenalidomide-Exposed and/or -Refractory but Proteasome Inhibitor (PI)-Naive or -Sensitive Multiple Myeloma: A Multiple Myeloma Research Consortium Multi-Center Study","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Pomalidomide; Lenalidomide; Carfilzomib; Medicine; Internal medicine; Regimen; Discontinuation; Refractory (planetary science); Bortezomib; Population; Multiple myeloma; Dexamethasone; Daratumumab; Phases of clinical research; Gastroenterology; Oncology; Pharmacology; Toxicity; Biology","score_opus":0.060879720459982356,"score_gpt":0.3409894979192949,"score_spread":0.28010977745931254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2511905967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98386896,0.000093926166,0.000017987159,0.000043400625,0.000055769386,0.015573361,0.00022582762,0.00007999613,0.000040753315],"genre_scores_gemma":[0.99638385,0.000025696347,0.0014739963,0.00003611918,0.0001326581,0.001361936,0.000087504224,0.00014191122,0.0003563228],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99182624,0.0021714098,0.001217532,0.0015856654,0.0017923147,0.0014068664],"domain_scores_gemma":[0.99415755,0.0021660551,0.0004221956,0.0010005119,0.0013564855,0.00089719536],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001901327,0.000781245,0.001725496,0.001092808,0.00037005387,0.00010310569,0.00025768226,0.00025273443,0.000026892249],"category_scores_gemma":[0.0054752976,0.00052177144,0.000102877886,0.000907617,0.0006756075,0.00039653783,0.0005426899,0.0009909292,0.000016090622],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.061119854,0.166875,0.7495644,0.00030389518,0.0011379741,0.0017605871,0.0070942235,5.5420355e-7,0.007948302,8.217255e-7,0.000016895912,0.0041774646],"study_design_scores_gemma":[0.38994807,0.046634383,0.5339448,0.00036247267,0.0002925046,0.000066025146,0.014277862,0.00040534924,0.013662714,9.712477e-7,0.000017381026,0.00038749023],"about_ca_topic_score_codex":0.0027790267,"about_ca_topic_score_gemma":0.0053325235,"teacher_disagreement_score":0.32882822,"about_ca_system_score_codex":0.00022326787,"about_ca_system_score_gemma":0.00038243056,"threshold_uncertainty_score":0.9997234},"labels":[],"label_agreement":null},{"id":"W2512064859","doi":"10.1182/blood.v108.11.3322.3322","title":"Trends in Outcomes and Quality of Care in Acute Myeloid Leukemia over Four Decades in Ontario, Canada.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Healthcare Systems and Practices","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Referral; Cancer registry; Population; Logistic regression; Comorbidity; Cancer; Myeloid leukemia; Internal medicine; Emergency medicine; Demography; Pediatrics; Family medicine; Environmental health","score_opus":0.07589705044919919,"score_gpt":0.4240416135355268,"score_spread":0.3481445630863276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2512064859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99053544,0.0005372818,1.7119375e-7,0.0007208982,0.0001519965,0.00025134787,0.00005331407,0.000007319671,0.007742246],"genre_scores_gemma":[0.99785507,0.000019396908,0.00009165788,0.00022633954,0.000031656546,0.000041509044,0.000019870351,0.00001059848,0.0017039031],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975035,0.00076406426,0.00091502536,0.0002188931,0.00021738517,0.00038110532],"domain_scores_gemma":[0.9987512,0.0006708157,0.0002753543,0.0001902535,0.000042844764,0.00006951201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009573626,0.00012589914,0.0004907654,0.00022242323,0.00006921847,0.00000433497,0.00008322059,0.00021023609,0.00012370072],"category_scores_gemma":[0.00010735748,0.00011024871,0.000024976243,0.00025987657,0.000014368874,0.00012078279,0.000045581226,0.00065449777,9.433431e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004357179,0.000035486253,0.99367326,0.0002544055,0.00000999866,0.000032489566,0.0045649693,0.0000026988512,0.000037907615,0.00038088672,0.0002378967,0.0007264068],"study_design_scores_gemma":[0.002541475,0.000027634342,0.9847657,0.00019134885,0.000009060755,9.369596e-7,0.0025054987,0.0000011345702,0.000016803147,0.000037948437,0.009796132,0.00010629851],"about_ca_topic_score_codex":0.99946874,"about_ca_topic_score_gemma":0.99999034,"teacher_disagreement_score":0.009558235,"about_ca_system_score_codex":0.00088925124,"about_ca_system_score_gemma":0.0028105548,"threshold_uncertainty_score":0.49858037},"labels":[],"label_agreement":null},{"id":"W2512319798","doi":"10.1182/blood.v122.21.2222.2222","title":"Effectiveness Of An Analgesia Protocol For The Treatment Of Painful Vaso-Occlusive Crisis Of Sickle Cell Disease Patients In Emergency Room: A Retrospective Cohort Study","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Vaso-occlusive crisis; Retrospective cohort study; Logistic regression; Opiate; Emergency medicine; Guideline; Mann–Whitney U test; Emergency department; Cohort; Disease; Internal medicine; Sickle cell anemia","score_opus":0.006441128083315213,"score_gpt":0.27040472742417915,"score_spread":0.26396359934086394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2512319798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8326284,0.00004324455,0.000010257133,0.000014495044,0.000022418517,0.16715044,0.000040210696,0.0000068917566,0.000083616214],"genre_scores_gemma":[0.894856,0.000020641473,0.000025929961,0.0000026654054,0.000009530024,0.10503531,0.0000140470875,0.000017671104,0.0000182282],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866706,0.00017933725,0.0004509803,0.00025921757,0.0002693604,0.00017404338],"domain_scores_gemma":[0.99877053,0.00009283506,0.00024773667,0.00039169905,0.0004028804,0.000094331044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024333278,0.00016715762,0.0004954723,0.00009048427,0.000039887986,0.000002216171,0.000087265435,0.000062684,0.0000749553],"category_scores_gemma":[0.00007099008,0.000100421814,0.00016486052,0.00027998356,0.000035845598,0.000048640268,0.000020223728,0.000055850956,9.702666e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010548269,0.034319974,0.96128666,0.0007051049,0.00038583245,0.0000041016683,0.001532957,0.00003062387,0.00041908698,0.00000542566,0.00002530243,0.00023008596],"study_design_scores_gemma":[0.017069664,0.010707724,0.96299106,0.00009894633,0.00075722707,1.700143e-7,0.001651061,0.00013142293,0.0063515995,0.00014535664,0.000006760153,0.00008902012],"about_ca_topic_score_codex":0.00159297,"about_ca_topic_score_gemma":0.000047305097,"teacher_disagreement_score":0.062227547,"about_ca_system_score_codex":0.000059565264,"about_ca_system_score_gemma":0.00007813092,"threshold_uncertainty_score":0.4095083},"labels":[],"label_agreement":null},{"id":"W2512584198","doi":"10.1182/blood.v112.11.2673.2673","title":"Transplantation-Specific Cytogenetics Grouping Scheme for Patients with Myelodysplastic Syndromes: A Multicenter Validation Study","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cytogenetics; Myelodysplastic syndromes; Transplantation; Medicine; Internal medicine; Oncology; Single Center; International Prognostic Scoring System; Bone marrow; Biology","score_opus":0.03311754689248778,"score_gpt":0.275256076363018,"score_spread":0.24213852947053024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2512584198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99357957,0.000043539203,0.0036321885,0.000034868925,0.00005078005,0.0024828103,0.00004012089,0.00006157624,0.00007454084],"genre_scores_gemma":[0.9874618,0.00009680089,0.011669751,0.000034643195,0.00009086136,0.00021838125,0.00027945184,0.00005319071,0.000095104086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984763,0.000041045467,0.00028525628,0.00035830852,0.0005098325,0.00032921438],"domain_scores_gemma":[0.99904346,0.00016817563,0.000071470975,0.000274951,0.00030650164,0.00013541468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010687,0.00018321558,0.00025415618,0.00016530215,0.0001816254,0.000019475576,0.000104902654,0.00006439147,0.000032857322],"category_scores_gemma":[0.00005472279,0.00014888175,0.00005359697,0.00023536543,0.00006127548,0.000100054735,0.00001754746,0.00015608138,0.000036297053],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013290285,0.004300978,0.98908675,0.00023529393,0.00036539324,0.0002259217,0.002052138,0.000016044536,0.0020716994,0.0000079247,0.00009426985,0.0002145399],"study_design_scores_gemma":[0.05295965,0.004290449,0.93416077,0.0001880108,0.0005388672,0.00022587639,0.000379441,0.0002603431,0.0064430158,0.0000027983888,0.00025106856,0.00029971285],"about_ca_topic_score_codex":0.0000071079303,"about_ca_topic_score_gemma":0.000003561032,"teacher_disagreement_score":0.054926,"about_ca_system_score_codex":0.00008425274,"about_ca_system_score_gemma":0.00011064846,"threshold_uncertainty_score":0.6071222},"labels":[],"label_agreement":null},{"id":"W2512652587","doi":"10.1182/blood.v122.21.736.736","title":"Ubap2l-Bmi-1-Rnf2 Define a Novel Polycomb Complex Essential For Self-Renewal Of Hematopoietic Stem Cells","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"BMI1; Haematopoiesis; Stem cell; Polycomb-group proteins; Biology; Immunoprecipitation; Hematopoietic stem cell; Bone marrow; Cell biology; Cell cycle; Cell; Cancer research; Genetics; Transcription factor; Immunology; Cell culture; Repressor; Gene","score_opus":0.013637103292195528,"score_gpt":0.23450814714133722,"score_spread":0.2208710438491417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2512652587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989336,0.00092953444,0.008508996,0.00006442406,0.000120865494,0.00045793955,0.00005968399,0.000015929361,0.0005066352],"genre_scores_gemma":[0.98918605,0.00009454513,0.010068796,0.00003281615,0.0001800097,0.00005659122,0.00010382046,0.000030004376,0.00024737327],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99900347,0.000023745491,0.00032059447,0.0002860309,0.00012653839,0.00023960484],"domain_scores_gemma":[0.99924785,0.00002645471,0.00015328413,0.00033381986,0.00015556795,0.00008304151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000106361935,0.00015757995,0.00020589639,0.000037962793,0.000053814503,0.000023347933,0.00017260427,0.00014765115,0.000038455368],"category_scores_gemma":[0.000011326889,0.0001534559,0.00014076599,0.00006410433,0.00004218162,0.0000030545848,0.000085439366,0.00003888993,0.0000103605835],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000145240465,0.00053004373,0.0007163475,0.0000769984,0.00009767544,2.0336965e-7,0.000042424832,0.000020812637,0.99786997,0.00018219791,0.00019813138,0.00025064824],"study_design_scores_gemma":[0.0019916296,0.0003496049,0.0007744558,0.000009947858,0.00009781439,0.0000033096812,0.000027649547,0.00013016656,0.993772,0.00027090244,0.002390859,0.00018167176],"about_ca_topic_score_codex":0.00004923315,"about_ca_topic_score_gemma":0.000014390612,"teacher_disagreement_score":0.004098004,"about_ca_system_score_codex":0.0000039142183,"about_ca_system_score_gemma":0.000051602434,"threshold_uncertainty_score":0.625775},"labels":[],"label_agreement":null},{"id":"W2513033601","doi":"10.1182/blood.v122.21.2717.2717","title":"Dramatic Down-Regulation Of MNDA Expression In CP-CML Cells From The LSC Compartment","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Biology; K562 cells; Molecular biology; Myeloid; Myeloid leukemia; Immunology; Leukemia","score_opus":0.01243895763756645,"score_gpt":0.23603142204701646,"score_spread":0.22359246440945002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2513033601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974035,0.0004747402,0.0000185134,0.00032058524,0.00006758136,0.00083522865,0.0000105007375,0.00002083603,0.00084853877],"genre_scores_gemma":[0.9979273,0.00001973031,0.0014660598,0.000088644134,0.00006846638,0.00007197732,0.00007504657,0.000012421656,0.00027037438],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990613,0.000059659018,0.000302313,0.00016674782,0.00025646173,0.00015352658],"domain_scores_gemma":[0.9992139,0.00015973218,0.00011551547,0.000422148,0.000033072847,0.00005564027],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000073685194,0.000116518255,0.00024380228,0.000035099143,0.000027175618,0.000010519654,0.00008910111,0.00005955686,0.0010481079],"category_scores_gemma":[0.00002257178,0.000071538125,0.00005224489,0.00009424407,0.000038581522,0.00005867245,0.00004344639,0.00009196092,0.00023170127],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006029492,0.002333234,0.09850125,0.00012084916,0.00018779525,0.000012258172,0.0029957118,0.00010934708,0.8845669,0.000029889117,0.0054426193,0.005639843],"study_design_scores_gemma":[0.008771263,0.0001190385,0.5257349,0.00048395986,0.00017403465,0.0000039170804,0.00021965665,0.00083996955,0.4628763,0.0003109716,0.00038177375,0.00008423133],"about_ca_topic_score_codex":0.0010203744,"about_ca_topic_score_gemma":0.00005019142,"teacher_disagreement_score":0.42723364,"about_ca_system_score_codex":0.00013345413,"about_ca_system_score_gemma":0.000076529934,"threshold_uncertainty_score":0.99986506},"labels":[],"label_agreement":null},{"id":"W2513223133","doi":"10.1182/blood.v108.11.3550.3550","title":"Lenalidomide (Revlimid®) +/− Corticosteroids in Elderly Patients with Relapsed/Refractory Multiple Myeloma.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Lenalidomide; Medicine; Thalidomide; Internal medicine; Prednisone; Multiple myeloma; Regimen; Gastroenterology; Dexamethasone; Neutropenia; Refractory (planetary science); Creatinine; Surgery; Chemotherapy","score_opus":0.011800895330646,"score_gpt":0.24100791513177228,"score_spread":0.2292070198011263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2513223133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995779,0.0003777819,0.000016961456,0.00009321415,0.00004519733,0.00093277096,0.000032810916,0.00007608014,0.002646181],"genre_scores_gemma":[0.9975055,0.000024016113,0.0010192171,0.00007564343,0.00009253022,0.0000956623,0.00027133696,0.000050259103,0.0008658425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979625,0.00007007589,0.00038218847,0.00041801325,0.0005778622,0.0005894059],"domain_scores_gemma":[0.9989577,0.00013653883,0.00009910565,0.00043870913,0.0001389248,0.0002290156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009839495,0.0002553792,0.0003807976,0.00022641094,0.00007074714,0.000027461301,0.00010472319,0.000112579066,0.00009053359],"category_scores_gemma":[0.00013566593,0.0001901561,0.00008029533,0.00026991632,0.000084336236,0.00015328448,0.000042723237,0.00028772067,0.00012122772],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013722773,0.0052514547,0.9841161,0.000056298555,0.0001193936,0.0005477335,0.000043023778,0.0000038568905,0.0017566216,0.000009896778,0.00020459799,0.0065187807],"study_design_scores_gemma":[0.049391445,0.0017828996,0.9435183,0.00016670417,0.00011287739,0.000024376706,0.000020797122,0.000033422795,0.0038749077,0.000021879096,0.00086455187,0.0001878486],"about_ca_topic_score_codex":0.00065034215,"about_ca_topic_score_gemma":0.0007755027,"teacher_disagreement_score":0.048019167,"about_ca_system_score_codex":0.000106156884,"about_ca_system_score_gemma":0.00011468074,"threshold_uncertainty_score":0.7754341},"labels":[],"label_agreement":null},{"id":"W2513318543","doi":"10.1182/blood.v122.21.2206.2206","title":"An Analysis Of The Pediatric Sub-Group From The Phase 2 Study Of GMI 1070 – A Novel Agent For The Vaso-Occlusive Crisis Of Sickle Cell Anemia","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Sickle cell anemia; Vaso-occlusive crisis; Acute chest syndrome; Interim analysis; Placebo; Anemia; Visual analogue scale; Clinical trial; Internal medicine; Surgery; Pathology","score_opus":0.009834581452777408,"score_gpt":0.2533586287975161,"score_spread":0.24352404734473868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2513318543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959138,0.0014757207,0.00018319722,0.00040041006,0.0000749826,0.0016799683,0.00020331827,0.000009264282,0.000059318383],"genre_scores_gemma":[0.99928963,0.00023371402,0.000077070225,0.00019738116,0.00007460719,0.00006055761,0.00002532546,0.000017958777,0.000023761475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986549,0.00008146602,0.00048039583,0.00022945144,0.00036715606,0.00018662217],"domain_scores_gemma":[0.998052,0.00040139403,0.0003893967,0.0008662559,0.00023404356,0.00005690263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026301164,0.00015443643,0.00045136365,0.000093362265,0.00011920659,0.000009077339,0.00037114508,0.0000969689,0.0001111947],"category_scores_gemma":[0.00007669111,0.000068616755,0.00035266124,0.0008928012,0.00008286007,0.000036501526,0.00008220875,0.00015870792,0.0000016250917],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066715304,0.072280146,0.66626424,0.00046600497,0.010296392,0.0000082941715,0.050235383,0.0027405666,0.18934987,0.000050247494,0.0056832917,0.0019584238],"study_design_scores_gemma":[0.049005233,0.006512693,0.58621675,0.00005993349,0.113375746,0.000005062453,0.1903453,0.010390419,0.043257397,0.000075411415,0.00029686568,0.00045919925],"about_ca_topic_score_codex":0.004124432,"about_ca_topic_score_gemma":0.00022580802,"teacher_disagreement_score":0.14609247,"about_ca_system_score_codex":0.000010651165,"about_ca_system_score_gemma":0.00006583207,"threshold_uncertainty_score":0.62349343},"labels":[],"label_agreement":null},{"id":"W2513322051","doi":"10.1182/blood.v126.23.4543.4543","title":"Evan's Syndrome Associated with Pembrolizumab Therapy in Metastatic Non-Small Cell Lung Cancer","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Pembrolizumab; Carboplatin; Lung cancer; Internal medicine; Chemotherapy regimen; Cancer; Oncology; Surgery; Gastroenterology; Pathology; Chemotherapy; Immunotherapy","score_opus":0.023281058475851286,"score_gpt":0.27125456213981036,"score_spread":0.24797350366395907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2513322051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98930365,0.007841618,0.000013743845,0.000300079,0.00009520016,0.0006496724,0.000016055901,0.000047133217,0.0017328201],"genre_scores_gemma":[0.9972683,0.0005378912,0.00014089348,0.00057873933,0.000031784057,0.00012388185,0.000022341197,0.000041869018,0.0012542618],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988464,0.00006276095,0.00022947213,0.0002489768,0.00028894423,0.00032346052],"domain_scores_gemma":[0.9993863,0.00004159277,0.00010736729,0.00023776991,0.00009905454,0.00012791918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029452072,0.00019165511,0.00037511584,0.0001244579,0.00002708338,0.000019620204,0.000100997415,0.00006922877,0.00011377073],"category_scores_gemma":[0.000015944865,0.00013903946,0.0000721184,0.0003567517,0.00004643291,0.000060820243,0.000012918046,0.00017511417,0.000006738911],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017236914,0.01114441,0.89221156,0.0005639708,0.006235962,0.004598294,0.010095459,0.0001309803,0.044824913,0.000012167768,0.0045491317,0.0083962465],"study_design_scores_gemma":[0.21693376,0.0072136894,0.7366178,0.0017388262,0.001607217,0.0006832045,0.0007810383,0.00072389096,0.030407814,0.000041804105,0.0021652943,0.0010856492],"about_ca_topic_score_codex":0.00095227826,"about_ca_topic_score_gemma":0.0005477057,"teacher_disagreement_score":0.19969684,"about_ca_system_score_codex":0.00018202902,"about_ca_system_score_gemma":0.0005712526,"threshold_uncertainty_score":0.56698644},"labels":[],"label_agreement":null},{"id":"W2513407916","doi":"10.1182/blood.v116.21.1187.1187","title":"Analysis of Cell Aggregation In Thawed Hematopoietic Stem Cell Products Using Micro-Flow Imaging.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; Ottawa Hospital","funders":"","keywords":"Cryopreservation; Peripheral blood mononuclear cell; Andrology; Flow cytometry; Stem cell; Haematopoiesis; Chemistry; Cord blood; Progenitor cell; Cell; Umbilical cord; Live cell imaging; Molecular biology; Immunology; Cell biology; Medicine; Biology; Biochemistry; Embryo","score_opus":0.012182327590266667,"score_gpt":0.2413816394041331,"score_spread":0.22919931181386644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2513407916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99744743,0.00027719542,0.0003952259,0.00008259879,0.000118143995,0.0004472005,0.00001536728,0.000034790046,0.0011820369],"genre_scores_gemma":[0.9861498,0.00002137651,0.013537697,0.00003152836,0.000041868356,0.000008578439,0.000057352354,0.000028104485,0.00012369509],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985339,0.000050664177,0.0005104392,0.00035690484,0.00030365147,0.00024445826],"domain_scores_gemma":[0.99901396,0.00007523965,0.00020268667,0.00046953635,0.00015657362,0.00008202785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033497514,0.00016968616,0.00047165132,0.0005540113,0.00002773111,0.000014018324,0.000094354466,0.00009743341,0.00007375453],"category_scores_gemma":[0.000016079977,0.00016494657,0.00011991129,0.0012025784,0.00005628323,0.00007822789,0.000014706292,0.0002159296,0.000013831146],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002545027,0.0006606117,0.16082114,0.00077827496,0.00009279488,0.000051369003,0.0018455037,0.00005014313,0.8354419,0.000006350332,0.0000037559478,0.00022269815],"study_design_scores_gemma":[0.0024997445,0.000028593966,0.020025805,0.00014752438,0.0029254358,0.000075361466,0.00030237582,0.0047006123,0.9691248,0.000008318785,0.000013299544,0.00014812087],"about_ca_topic_score_codex":0.00005945068,"about_ca_topic_score_gemma":0.00002817208,"teacher_disagreement_score":0.14079534,"about_ca_system_score_codex":0.000019864245,"about_ca_system_score_gemma":0.00013081469,"threshold_uncertainty_score":0.6726326},"labels":[],"label_agreement":null},{"id":"W2513606159","doi":"10.1182/blood.v114.22.4918.4918","title":"miRNA Expression in Multiple Myeloma as Predictive Model of Response to Bortezomib.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Bortezomib; microRNA; Gene expression profiling; Multiple myeloma; Gene expression; Cancer research; Biology; Microarray; DNA microarray; Medicine; Immunology; Gene; Genetics","score_opus":0.00880756149329057,"score_gpt":0.24230233223110012,"score_spread":0.23349477073780955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2513606159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976459,0.00018179957,0.0016477962,0.000077968936,0.0000122087185,0.00023209031,0.000033903772,0.000007742086,0.00016056438],"genre_scores_gemma":[0.9965552,0.000008679197,0.003154171,0.00009993742,0.000031117033,0.000014065425,0.000030901014,0.000009125974,0.000096800475],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99933594,0.00005825694,0.0001638018,0.00021948954,0.00009676779,0.00012576819],"domain_scores_gemma":[0.9995498,0.000009910686,0.00005213038,0.00026829765,0.00004984965,0.00006999492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010879976,0.00008557763,0.00009176201,0.000060380637,0.000017415563,0.000003999948,0.000103068465,0.00009929252,0.000004085412],"category_scores_gemma":[0.00020981893,0.00008702289,0.000043700304,0.00006958513,0.000016161097,0.0000031914376,0.000043579774,0.00003285953,0.0000034295897],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002089189,0.0002857183,0.0012027787,0.000004411654,0.00000832567,0.000002475057,0.00008986474,0.0047162254,0.9910131,0.0000027809574,0.0002385406,0.0003466052],"study_design_scores_gemma":[0.0013840722,0.00038584197,0.0606631,0.000035987767,0.000010831802,0.0000024463775,0.000015071452,0.001782054,0.9353467,0.0000846133,0.00020010812,0.00008916807],"about_ca_topic_score_codex":0.0000032733883,"about_ca_topic_score_gemma":0.000004500004,"teacher_disagreement_score":0.059460323,"about_ca_system_score_codex":0.000009324687,"about_ca_system_score_gemma":0.00007026203,"threshold_uncertainty_score":0.35486904},"labels":[],"label_agreement":null},{"id":"W2513825725","doi":"10.1182/blood.v124.21.2692.2692","title":"Compound Heterozygosity for Hb S and a Novel Deletion of Dnase I Hypersensitivity Sites HS3 and HS4 of β-Globin Locus Control Region Results in Hb S/β+-Thalassemia Phenotype","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; University of Toronto","funders":"","keywords":"Biology; Compound heterozygosity; Genetics; Locus control region; Locus (genetics); Globin; Fetal hemoglobin; Thalassemia; Molecular biology; Missense mutation; Point mutation; Loss of heterozygosity; Allele; Hemoglobinopathy; Phenotype; Gene; Hemolytic anemia; Mutation; Immunology; Gene expression; Promoter","score_opus":0.01163888989864774,"score_gpt":0.22634509320946455,"score_spread":0.2147062033108168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2513825725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966372,0.0005127559,0.0014088763,0.0005240779,0.000029075347,0.0005217617,0.0000495372,0.000015019771,0.00030165017],"genre_scores_gemma":[0.999299,0.00010270057,0.00041284825,0.00009560288,0.000030006906,0.000005186937,0.000028526902,0.000012541363,0.000013601303],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990668,0.000057558987,0.00033379797,0.0002465398,0.00011808053,0.00017721763],"domain_scores_gemma":[0.9992062,0.00025562532,0.00016912904,0.00016847553,0.00011730392,0.00008330744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035532142,0.0001330311,0.00043685173,0.00009088817,0.000038587426,0.000006037827,0.00002706527,0.0001707616,4.0814066e-7],"category_scores_gemma":[0.0003623665,0.00011476592,0.000054442065,0.00010460256,0.00015532087,0.000045160607,0.000023091703,0.00012044703,3.1366372e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049658567,0.002475828,0.05806704,0.00110442,0.0002329552,0.000040342555,0.0007880329,0.000047498906,0.9249166,0.0005414315,0.00021187546,0.006608105],"study_design_scores_gemma":[0.25306752,0.00931372,0.49969935,0.0029004293,0.0028953278,0.0011943405,0.0015665244,0.035079446,0.19059105,0.001007427,0.0014679694,0.001216888],"about_ca_topic_score_codex":0.00027287216,"about_ca_topic_score_gemma":0.000115655756,"teacher_disagreement_score":0.7343256,"about_ca_system_score_codex":0.000013492677,"about_ca_system_score_gemma":0.00002728497,"threshold_uncertainty_score":0.4680018},"labels":[],"label_agreement":null},{"id":"W2513909258","doi":"10.1182/blood.v106.11.5011.5011","title":"The Role of Proteasome Inhibitors and the Trail Apoptotic Pathway in the Treatment of Chronic Lymphocytic Leukemia.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Chronic lymphocytic leukemia; Apoptosis; Proteasome; Proteasome inhibitor; Cancer research; Cytotoxic T cell; Monoclonal antibody; Programmed cell death; Leukemia; Cancer cell; Chlorambucil; Multiple myeloma; Biology; Antibody; Immunology; Cancer; Cell biology; Biochemistry; In vitro; Chemotherapy","score_opus":0.003600923299990195,"score_gpt":0.19695153380285177,"score_spread":0.19335061050286156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2513909258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9614086,0.037253425,0.000004249431,0.00007570825,0.000018677923,0.00040348346,0.0000034603795,0.0000025900404,0.00082979526],"genre_scores_gemma":[0.99620306,0.003297178,0.000024270515,0.000021162276,0.00019559635,0.00011258355,0.000005404143,0.000009452509,0.00013128486],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99921465,0.000112153866,0.00023294684,0.0001559899,0.00012336264,0.00016090463],"domain_scores_gemma":[0.9994632,0.00006295471,0.000109087305,0.00031975468,0.000027085924,0.000017909235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026241937,0.00011726058,0.00014378148,0.000013465942,0.00007623042,0.000014612716,0.00021979948,0.000078547244,0.0000017005324],"category_scores_gemma":[0.000038949842,0.000052458585,0.00008086742,0.000076912744,0.00033512706,0.0000026268501,0.000026321732,0.000046270965,8.5254624e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035048687,0.00062231603,0.0013175174,0.00013626598,0.00025078212,0.0000035905193,0.0034679878,0.000492749,0.8967145,0.0016978545,0.000035407924,0.094910555],"study_design_scores_gemma":[0.0036127456,0.0005415302,0.00012944957,0.000018746186,0.000045754598,0.000022956496,0.0005001302,0.0001820659,0.97798485,0.00024125002,0.01664967,0.00007087645],"about_ca_topic_score_codex":0.000053595646,"about_ca_topic_score_gemma":0.000062467596,"teacher_disagreement_score":0.09483968,"about_ca_system_score_codex":0.000096955424,"about_ca_system_score_gemma":0.0005101877,"threshold_uncertainty_score":0.21391991},"labels":[],"label_agreement":null},{"id":"W2514080251","doi":"10.1182/blood.v104.11.3130.3130","title":"A Survey of Researchers[rquo] Practice in Returning Research Results To Research Participants. Oral Abstracts Presented at ASH Annual Meeting 2003.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Interim; Family medicine; Research ethics; Medicine; Medical education; Obligation; Descriptive statistics; Research design; Psychology; Alternative medicine; Pathology","score_opus":0.7613433177824405,"score_gpt":0.6525150518376847,"score_spread":0.10882826594475581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2514080251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95211816,0.0008007614,0.0000021721191,0.017055096,0.00008849188,0.002317811,0.00019356937,0.00005447447,0.02736946],"genre_scores_gemma":[0.9884708,0.0006937619,0.0044254186,0.00016115009,0.00019965158,0.00016163447,0.00009657723,0.000104085324,0.005686936],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9651047,0.011718033,0.003092474,0.0021230723,0.013401271,0.004560424],"domain_scores_gemma":[0.7651102,0.17326228,0.0006917481,0.0046742754,0.05244192,0.0038195618],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.24169597,0.0002985709,0.00086749764,0.0016676474,0.00047330864,0.00012574998,0.0011952941,0.0009402387,0.00007615287],"category_scores_gemma":[0.8430354,0.00028284502,0.000093741015,0.010123343,0.0014630485,0.00038434388,0.0024922895,0.011522113,0.00049261574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12617563,0.048726674,0.5043708,0.004505025,0.0020634178,0.018757097,0.083936416,0.0031723275,0.14930132,0.003807954,0.049862895,0.0053204442],"study_design_scores_gemma":[0.027323758,0.00834224,0.8284845,0.0063108527,0.00009088014,0.0000955504,0.011748339,0.00010237886,0.10586917,0.0020879712,0.008919205,0.0006251914],"about_ca_topic_score_codex":0.04949983,"about_ca_topic_score_gemma":0.06204715,"teacher_disagreement_score":0.6013394,"about_ca_system_score_codex":0.000843867,"about_ca_system_score_gemma":0.0062184553,"threshold_uncertainty_score":0.9999624},"labels":[],"label_agreement":null},{"id":"W2514476269","doi":"10.1182/blood.v118.21.4677.4677","title":"HIV-Associated Thrombotic Thrombocytopenic Purpura","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Paul's Hospital; University of British Columbia; St. Michael's Hospital; University of Toronto","funders":"","keywords":"Medicine; Thrombotic thrombocytopenic purpura; Microangiopathic hemolytic anemia; Pediatrics; ADAMTS13; Internal medicine; Retrospective cohort study; Creatinine; Surgery; Gastroenterology; Platelet","score_opus":0.04138097892163807,"score_gpt":0.23553754502344398,"score_spread":0.19415656610180593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2514476269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9774344,0.0013884467,0.000014527349,0.000039060993,0.0005042362,0.0003405842,0.00006748701,0.00024094965,0.019970302],"genre_scores_gemma":[0.9978507,0.000012035246,0.000045943372,0.00008020305,0.000019263774,0.000040609546,0.00012631647,0.00002093019,0.0018039786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998832,0.00017816034,0.00028774753,0.0002755003,0.000038371705,0.00038821273],"domain_scores_gemma":[0.99933285,0.00006274348,0.00012415214,0.00040311355,0.000050363848,0.000026758697],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00013964859,0.00016782836,0.00029779633,0.000060162747,0.00014737654,0.000011060671,0.00035614602,0.00012449712,0.009882917],"category_scores_gemma":[0.000081675425,0.00015218218,0.00011404456,0.000119369084,0.00010382803,0.00008151985,0.00013487843,0.00012455879,0.0051357592],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009524769,0.0070009213,0.6662962,0.00007630538,0.0032706345,0.00007928136,0.002608221,4.5744088e-7,0.26684064,0.008347032,0.044971827,0.00041324913],"study_design_scores_gemma":[0.007153964,0.00038407894,0.86665547,0.000114984796,0.00075530965,0.000100683115,0.0005367123,6.7428795e-7,0.11828386,0.0013046458,0.004161111,0.00054848177],"about_ca_topic_score_codex":0.000087790715,"about_ca_topic_score_gemma":0.000032974556,"teacher_disagreement_score":0.2003593,"about_ca_system_score_codex":0.000023992034,"about_ca_system_score_gemma":0.000048181955,"threshold_uncertainty_score":0.99563885},"labels":[],"label_agreement":null},{"id":"W2514541241","doi":"10.1182/blood.v116.21.473.473","title":"Mutations In MLL2 and MEF2B Genes In Follicular Lymphoma and Diffuse Large B-Cell Lymphoma","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Biology; PAX5; Somatic hypermutation; Cancer research; Follicular lymphoma; Lymphoma; Genetics; Gene; B cell; Transcription factor; Immunology","score_opus":0.0032276325954807713,"score_gpt":0.20787698320308912,"score_spread":0.20464935060760833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2514541241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962808,0.003221969,0.00003147227,0.00006827593,0.00006610484,0.0001617196,0.0000149184925,0.000007707191,0.00014703108],"genre_scores_gemma":[0.99887615,0.00040944788,0.00037353352,0.000036875397,0.0000772169,0.000028040347,0.00007127466,0.000017521646,0.00010995641],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992942,0.000027858576,0.00015358829,0.0002807053,0.00006402485,0.0001796216],"domain_scores_gemma":[0.9996815,0.000009455195,0.00004206896,0.00018908437,0.00002168854,0.000056253455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009861454,0.00011209914,0.0001053335,0.00007688273,0.000039976978,0.00002061004,0.00005492434,0.00019407323,0.0000035733885],"category_scores_gemma":[0.000025113048,0.000119389195,0.000025825024,0.00010628587,0.000045612796,0.000005520343,0.00006324935,0.000037716793,0.0000017244747],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022241264,0.001076325,0.05537071,0.000019213936,0.0000204955,0.000011463944,0.00012965561,0.000009895591,0.93600863,0.000064235435,0.000020387435,0.0072467644],"study_design_scores_gemma":[0.024070386,0.00011004318,0.367419,0.000017602413,0.000057015033,0.00009376468,0.00009062075,0.0005725286,0.59933716,0.00019940009,0.0077087437,0.00032375674],"about_ca_topic_score_codex":0.00007461675,"about_ca_topic_score_gemma":0.0023108055,"teacher_disagreement_score":0.33667147,"about_ca_system_score_codex":0.000007814638,"about_ca_system_score_gemma":0.00005188044,"threshold_uncertainty_score":0.486855},"labels":[],"label_agreement":null},{"id":"W2514643390","doi":"10.1182/blood.v124.21.5539.5539","title":"Second Report of Arab Leukemia Net (ALN) Registry for Chronic Myeloid Leukemia (CML) in the Middle East &amp;North Africa Region (AFME). Epidemiology of CML and Additional Chromosomal Abnormalities (ACAs) in Egypt, Multicenter Results","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Isochromosome; Imatinib; Medicine; Imatinib mesylate; Myeloid leukemia; Philadelphia chromosome; Leukemia; Disease; Internal medicine; Oncology; Cancer research; Immunology; Biology; Chromosome; Genetics; Gene; Karyotype; Chromosomal translocation","score_opus":0.056383297708517334,"score_gpt":0.2643666379781462,"score_spread":0.20798334026962886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2514643390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99233645,0.0012594697,0.00003828455,0.0003096055,0.00010067906,0.001123283,0.0012379696,0.000027991371,0.003566245],"genre_scores_gemma":[0.9934652,0.00016235087,0.001507067,0.00014969152,0.00041219144,0.00030504304,0.002811491,0.000043221862,0.0011437673],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99608797,0.0003868263,0.0017616715,0.00074286235,0.00033854178,0.0006821338],"domain_scores_gemma":[0.9956737,0.0019147597,0.0010628846,0.0010492911,0.00015725767,0.00014209758],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013254936,0.00039668454,0.0010844745,0.0002410491,0.0000721965,0.000007229496,0.0002814988,0.00034281253,0.00015716834],"category_scores_gemma":[0.002424917,0.0003151772,0.00021702709,0.0002731058,0.000495605,0.00016020982,0.00010285822,0.0004958053,0.0000057841344],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015693964,0.0065682116,0.817328,0.014800976,0.0027986814,0.0034415056,0.032456655,0.0014074086,0.003968955,0.0056111715,0.08892392,0.007000592],"study_design_scores_gemma":[0.06997781,0.0027381375,0.83218753,0.0032172147,0.00073139515,0.0072668283,0.0015023169,0.002018665,0.0015183551,0.0008578631,0.077135965,0.0008478902],"about_ca_topic_score_codex":0.0005743574,"about_ca_topic_score_gemma":0.004221656,"teacher_disagreement_score":0.05428385,"about_ca_system_score_codex":0.0011502695,"about_ca_system_score_gemma":0.0013643629,"threshold_uncertainty_score":0.99993},"labels":[],"label_agreement":null},{"id":"W2514731023","doi":"10.1182/blood.v118.21.4438.4438","title":"Dasatinib As a Late Second Line Therapy in Chronic Myeloid Leukemia Patients: A Retrospective Study From a Tertiary Care Centre in India","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Dasatinib; Medicine; Imatinib mesylate; Imatinib; Transplantation; Internal medicine; Myeloid leukemia; Retrospective cohort study; Surgery","score_opus":0.011086752805389276,"score_gpt":0.24195531160317577,"score_spread":0.23086855879778648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2514731023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927984,0.0014666265,1.606151e-7,0.000012912222,0.00010302327,0.002578748,0.000112785485,0.000077809644,0.0028495246],"genre_scores_gemma":[0.99864155,0.00013852674,0.000121986704,0.00020767216,0.0001415045,0.00018000281,0.00026681068,0.00007470248,0.00022723805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99752086,0.00015579347,0.000595605,0.00078826386,0.0003856496,0.0005538513],"domain_scores_gemma":[0.998806,0.000046606172,0.00018411432,0.0006922896,0.00010387392,0.000167089],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000114165196,0.0004139309,0.00064239267,0.0002819066,0.0000438213,0.000014705967,0.00020605995,0.0002187562,0.0016372618],"category_scores_gemma":[0.000075333985,0.00036387728,0.00010526399,0.00041363374,0.00006457003,0.00014830098,0.00011235419,0.00060287426,0.00013431003],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041970238,0.0035227062,0.93674845,0.00003506202,0.00036588428,0.00082754676,0.05512567,9.2699344e-7,0.0004724789,0.0000020749176,0.00001724739,0.002462234],"study_design_scores_gemma":[0.06328049,0.0026574265,0.92504585,0.00029471368,0.00013788702,0.0000054923466,0.002990604,0.000014354749,0.0051740212,0.000072760704,0.000043176206,0.00028320213],"about_ca_topic_score_codex":0.005421506,"about_ca_topic_score_gemma":0.006566473,"teacher_disagreement_score":0.06286079,"about_ca_system_score_codex":0.005070492,"about_ca_system_score_gemma":0.0012642586,"threshold_uncertainty_score":0.9998813},"labels":[],"label_agreement":null},{"id":"W2514819484","doi":"10.1182/blood.v120.21.3770.3770","title":"Pharmacologic Monitoring of Dasatinib As First Line Therapy in Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CP-CML) Identifies Patients At Higher Risk of Pleural Effusion: A Sub-Analysis of the OPTIM-Dasatinib Trial","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Dasatinib; Medicine; Cmin; Chronic myelogenous leukemia; Internal medicine; Cumulative incidence; Imatinib mesylate; Imatinib; Randomization; Gastroenterology; Clinical trial; Oncology; Surgery; Leukemia; Cohort; Cmax; Pharmacokinetics; Myeloid leukemia","score_opus":0.030395112303557268,"score_gpt":0.3138880972698649,"score_spread":0.2834929849663076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2514819484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98934233,0.0070354817,0.0000017030723,0.000034810524,0.00088455895,0.0024000478,0.00017080735,0.00003705305,0.00009320268],"genre_scores_gemma":[0.99448115,0.0040726983,0.00008546856,0.000018573603,0.00072551164,0.00023991312,0.000138886,0.00005839319,0.00017942196],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959466,0.0003958147,0.0015190165,0.0005072152,0.0009302101,0.00070114096],"domain_scores_gemma":[0.9963478,0.0007598579,0.0014977625,0.0009808854,0.00022038535,0.00019335229],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006217993,0.00049269723,0.0014946255,0.00041385935,0.00015897992,0.000010073202,0.0004503565,0.00027840366,0.0008162018],"category_scores_gemma":[0.0003366302,0.0003465648,0.000792299,0.0013885938,0.00027815986,0.00015381078,0.00026771298,0.00042060774,0.000013358632],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010530519,0.009774282,0.864251,0.00031080967,0.0073954947,0.00003280504,0.00250372,0.0010852949,0.09769271,0.000002753622,0.00005278329,0.006367802],"study_design_scores_gemma":[0.22659574,0.003940403,0.4629098,0.00022889313,0.0070239333,0.000004475246,0.000052677333,0.00019695131,0.29872176,0.0000042819506,0.00008445077,0.00023663898],"about_ca_topic_score_codex":0.0014940551,"about_ca_topic_score_gemma":0.00029198846,"teacher_disagreement_score":0.40134123,"about_ca_system_score_codex":0.0024980477,"about_ca_system_score_gemma":0.0008746098,"threshold_uncertainty_score":0.9998986},"labels":[],"label_agreement":null},{"id":"W2514978986","doi":"10.1182/blood.v126.23.571.571","title":"Disruptive ARID1A Mutations in Follicular Lymphoma Impair DNA Repair Efficiency and Are Associated with Favorable Outcome in Patients Receiving First-Line Immunochemotherapy","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"ARID1A; Follicular lymphoma; Lymphoma; Cancer research; Internal medicine; Oncology; Medicine; Aggressive lymphoma; Mutation; Biology; Immunology; Rituximab; Genetics; Gene","score_opus":0.011283563923711444,"score_gpt":0.24180241455072762,"score_spread":0.2305188506270162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2514978986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987857,0.0006552157,0.000115163675,0.00004018465,0.000030725347,0.00021994625,0.000017149283,0.000025102732,0.0001108605],"genre_scores_gemma":[0.999401,0.000046066925,0.00024515216,0.00006486264,0.000018946126,0.000028626773,0.00010215851,0.000021989845,0.0000712321],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990359,0.00005330719,0.00025053925,0.0003036468,0.00013708498,0.00021951988],"domain_scores_gemma":[0.9994976,0.000016846483,0.00011934567,0.00020486738,0.00010188724,0.000059483456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023604157,0.00014791857,0.00019263773,0.00005396614,0.000050469753,0.00001792053,0.00007923554,0.00011359795,0.0000012881932],"category_scores_gemma":[0.0002201919,0.00013016103,0.00004518394,0.000198976,0.000041009574,0.0000071312247,0.000038089875,0.00005879004,8.007356e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009225667,0.0010648441,0.9943337,0.00001717097,0.00007143118,0.000008721615,0.00064509903,0.0018839135,0.0014534234,0.0000012085642,0.000021610287,0.00040663223],"study_design_scores_gemma":[0.019816864,0.0011028738,0.9636435,0.00028360702,0.000058327594,0.000008297593,0.00064507924,0.0038195043,0.009967164,0.0000740648,0.00009867944,0.0004820383],"about_ca_topic_score_codex":0.00015378742,"about_ca_topic_score_gemma":0.0007104946,"teacher_disagreement_score":0.03069019,"about_ca_system_score_codex":0.00006709269,"about_ca_system_score_gemma":0.00008177035,"threshold_uncertainty_score":0.53078127},"labels":[],"label_agreement":null},{"id":"W2515092742","doi":"10.1182/blood.v106.11.4109.4109","title":"Thromboembolism in Children with Sarcoma.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Central Venous Catheters and Hemodialysis","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster Children's Hospital","funders":"","keywords":"Medicine; Sarcoma; Epidemiology; Pediatrics; Cancer; Thrombosis; Venous thrombosis; Deep vein; Surgery; Internal medicine; Pathology","score_opus":0.018018748806238636,"score_gpt":0.3080963914085359,"score_spread":0.29007764260229724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2515092742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98981345,0.0002055666,0.000013105314,0.00058888114,0.000027931894,0.00037300636,0.000009089391,0.00005275141,0.008916248],"genre_scores_gemma":[0.9975718,0.000062460516,0.0007725754,0.00079361297,0.00036114536,0.000034332388,0.0000150700025,0.00001827628,0.0003707266],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900776,0.000074322226,0.00020464254,0.00017676326,0.00011882672,0.00041771156],"domain_scores_gemma":[0.99959487,0.00003221354,0.000058078364,0.00021547654,0.000020174257,0.00007918054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013896929,0.000095259034,0.0002175898,0.000069002024,0.00018269641,0.000004578048,0.00010999153,0.00008755917,0.00044032064],"category_scores_gemma":[0.0000074918285,0.000071569375,0.000038886566,0.00014991673,0.000022534974,0.00006421646,0.000035274737,0.00029333853,0.0003442632],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009703224,0.00060595066,0.99303204,0.000007690477,0.00005871977,0.0000019941501,0.0022874055,0.0000065579084,0.000152792,0.0005279565,0.00046765816,0.0028415236],"study_design_scores_gemma":[0.0029966552,0.000050725557,0.9931224,0.00004223942,0.00007389332,0.0000055119212,0.00014865723,0.000011900949,0.00015382949,0.0001116312,0.0031565719,0.0001259555],"about_ca_topic_score_codex":0.00033597066,"about_ca_topic_score_gemma":0.0011864237,"teacher_disagreement_score":0.008545522,"about_ca_system_score_codex":0.000038196744,"about_ca_system_score_gemma":0.00008098696,"threshold_uncertainty_score":0.48212022},"labels":[],"label_agreement":null},{"id":"W2515129332","doi":"10.1182/blood.v112.11.1880.1880","title":"Hemoglobin H-Constant Spring in North America: A Common Alpha Thalassemia with Frequent Complications.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"Thalassemia; Medicine; Alpha-thalassemia; Splenectomy; Gastroenterology; Internal medicine; Genotyping; Hemoglobin; Genotype; Spleen; Biology; Genetics; Gene","score_opus":0.011377228411293102,"score_gpt":0.22403835484348747,"score_spread":0.21266112643219437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2515129332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857664,0.0010244,0.000069292655,0.0009520195,0.00002404835,0.00043872793,0.00000853184,0.000094363924,0.011622196],"genre_scores_gemma":[0.99724454,0.0005887926,0.0014017567,0.00058954454,0.000020309511,0.00004035933,0.000030134695,0.000024804282,0.000059755523],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99887997,0.000026574484,0.0002878277,0.00027458157,0.00021690669,0.0003141232],"domain_scores_gemma":[0.9993089,0.000032761847,0.00008360105,0.0003764308,0.000048842692,0.0001494865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000043042877,0.00017065134,0.00032452188,0.00011344498,0.00010858008,0.0000075879957,0.00009765543,0.00007867217,0.000023247496],"category_scores_gemma":[0.000016597283,0.00013171636,0.000057626563,0.0005322444,0.00018796392,0.000048424747,0.00003278909,0.00032333456,0.000060151775],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052881052,0.001123293,0.99503154,0.00003922325,0.0000857109,0.0007287159,0.0004968404,0.000061091036,0.0010535514,0.00010601657,0.00015579835,0.0010653551],"study_design_scores_gemma":[0.008085246,0.0004597131,0.98099625,0.00028446797,0.00017102854,0.0015017829,0.00066994294,0.00023309828,0.0014683038,0.00001971491,0.005774413,0.00033605704],"about_ca_topic_score_codex":0.000544431,"about_ca_topic_score_gemma":0.0005146998,"teacher_disagreement_score":0.014035291,"about_ca_system_score_codex":0.00005904895,"about_ca_system_score_gemma":0.0001452866,"threshold_uncertainty_score":0.5371237},"labels":[],"label_agreement":null},{"id":"W2515531150","doi":"10.1182/blood.v104.11.529.529","title":"Prevalence of Antiphospholipid Anitbodies in Idiopathic Venous Thromboembolism.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Lupus anticoagulant; Pulmonary embolism; Venous thrombosis; Antiphospholipid syndrome; Venous thromboembolism; Internal medicine; Thrombosis; Retrospective cohort study","score_opus":0.012380078821173646,"score_gpt":0.24946246677924835,"score_spread":0.2370823879580747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2515531150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98990285,0.004866447,0.000018911338,0.00028387015,0.00014457127,0.00049820764,0.000007875919,0.000054114178,0.004223174],"genre_scores_gemma":[0.9960895,0.0029109605,0.0005329164,0.00025833852,0.00009930029,0.00003392722,0.0000025787158,0.000024622585,0.00004781069],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998696,0.000022595836,0.0003863768,0.00028745012,0.00029105452,0.00031647796],"domain_scores_gemma":[0.9993322,0.000014940849,0.000112329486,0.0003948357,0.00006682482,0.00007888643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025356375,0.00016408491,0.00066277536,0.000152402,0.000038093738,0.000008859545,0.00014345764,0.00008223294,0.000056973935],"category_scores_gemma":[0.00007944222,0.00015159372,0.00009855053,0.00024392511,0.000104428145,0.00008004899,0.000080886726,0.00015463242,0.00004264951],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031405065,0.0940737,0.6976906,0.020234503,0.0014795861,0.0019884415,0.020912876,0.000766223,0.09828459,0.05455033,0.0006454869,0.009059587],"study_design_scores_gemma":[0.0042938767,0.0010037093,0.93134,0.0013151724,0.00046861212,0.000050972372,0.00020737703,0.000002191283,0.059730925,0.0012576168,0.0001528147,0.00017676507],"about_ca_topic_score_codex":0.00030921295,"about_ca_topic_score_gemma":0.000032223557,"teacher_disagreement_score":0.23364934,"about_ca_system_score_codex":0.000039696766,"about_ca_system_score_gemma":0.00012024695,"threshold_uncertainty_score":0.6181812},"labels":[],"label_agreement":null},{"id":"W2515589610","doi":"10.1182/blood.v108.11.790.790","title":"Ferritin Heavy Chain Stimulates HbS-to-HbF Switching in Erythroid Precursor Cells from Sickle Cell Patients.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Biology; Globin; Fetal hemoglobin; Molecular biology; K562 cells; Ferritin; Cell culture; Gene; Genetics; Biochemistry","score_opus":0.0039768082987173495,"score_gpt":0.19967704449766244,"score_spread":0.19570023619894508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2515589610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99143845,0.0011737663,0.0000537355,0.00052357645,0.00020202062,0.00073960365,0.00004829669,0.000104215214,0.00571634],"genre_scores_gemma":[0.9973795,0.000052160354,0.0010725606,0.0005223232,0.0001625118,0.000020059042,0.00013233408,0.000054645065,0.0006039121],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99827325,0.000051545492,0.000454264,0.00043318613,0.0002816327,0.0005061373],"domain_scores_gemma":[0.99929446,0.00008278458,0.0000820709,0.00030348529,0.000053162355,0.00018405195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000121325174,0.00025666086,0.0003940629,0.00016268188,0.00007804988,0.000030012196,0.00011549999,0.00022077972,0.00012755685],"category_scores_gemma":[0.000039815335,0.00022957729,0.00010627407,0.0003008231,0.000027089362,0.00006289595,0.00006269058,0.0003690397,0.00023405693],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011055015,0.028678427,0.6200188,0.00062700995,0.0002668415,0.0008230007,0.0069572506,0.006295954,0.30734655,0.000106509935,0.014486208,0.013287969],"study_design_scores_gemma":[0.071718775,0.0034359053,0.32283348,0.0022868733,0.0010492773,0.000027977716,0.0021634581,0.0039125434,0.5677145,0.0021698326,0.020204596,0.0024827854],"about_ca_topic_score_codex":0.002577834,"about_ca_topic_score_gemma":0.00024232529,"teacher_disagreement_score":0.2971853,"about_ca_system_score_codex":0.00005027278,"about_ca_system_score_gemma":0.00006343309,"threshold_uncertainty_score":0.936189},"labels":[],"label_agreement":null},{"id":"W2515655827","doi":"10.1182/blood.v112.11.2399.2399","title":"Diagnostic Patterns of Care and Outcomes for Patients with Chronic Lymphocytic Leukemia in the Surveillance, Epidemiology, and End-Results (SEER)-Medicare Database","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Epidemiology; Population; Surveillance, Epidemiology, and End Results; Medical diagnosis; Diagnosis code; Logistic regression; Cancer registry; Chronic lymphocytic leukemia; Proportional hazards model; Internal medicine; Pediatrics; Emergency medicine; Leukemia; Pathology","score_opus":0.01888014995081654,"score_gpt":0.29038376065084665,"score_spread":0.2715036107000301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2515655827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942663,0.0032217277,0.000019735533,0.0001238075,0.00003865637,0.0014295392,0.0008177656,0.000018920804,0.00006355682],"genre_scores_gemma":[0.99696034,0.0016585955,0.00024154478,0.00018697277,0.00007845478,0.000162123,0.000661431,0.000027133918,0.000023372844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99796396,0.0001822425,0.0005029347,0.0004632949,0.00038298377,0.0005046064],"domain_scores_gemma":[0.991918,0.0070286677,0.00014951151,0.00058864383,0.00015252146,0.00016263711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063807255,0.00022843105,0.00066607003,0.000120076744,0.000090815396,0.000005181876,0.00018047375,0.00011754592,0.000006184434],"category_scores_gemma":[0.004868529,0.00013564689,0.00005713535,0.00015417275,0.00042347773,0.000059158807,0.000118922704,0.00018365985,0.0000013392333],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00038411823,0.00011002704,0.9954066,0.0011418579,0.00010312395,0.00014567745,0.0011257216,0.000015009588,0.000003566176,0.000019396164,0.00018865723,0.0013562413],"study_design_scores_gemma":[0.09045995,0.0014253608,0.90606946,0.00043278773,0.00012318096,0.00022037662,0.0003194212,0.00046823575,0.000059137623,0.0000062690933,0.00026475143,0.00015105077],"about_ca_topic_score_codex":0.0030831576,"about_ca_topic_score_gemma":0.0020555495,"teacher_disagreement_score":0.09007583,"about_ca_system_score_codex":0.0047120187,"about_ca_system_score_gemma":0.0067175454,"threshold_uncertainty_score":0.99910873},"labels":[],"label_agreement":null},{"id":"W2515800681","doi":"10.1182/blood.v122.21.1978.1978","title":"Outcomes and Correlative Studies Of a Phase I Trial With The Oral PARP1-2 Inhibitor Veliparib In Combination With Bortezomib In Patients With Relapsed Or Refractory Multiple Myeloma","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Veliparib; Bortezomib; PARP inhibitor; Medicine; Proteasome inhibitor; Carfilzomib; Synthetic lethality; Internal medicine; Oncology; Olaparib; Multiple myeloma; PARP1; Ixazomib; Pharmacology; Cancer research; Poly ADP ribose polymerase; DNA repair; Biology","score_opus":0.030036852261257182,"score_gpt":0.30982168037475627,"score_spread":0.2797848281134991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2515800681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99666214,0.00014684965,0.00001557497,0.00043009198,0.000055641332,0.00260693,0.00001568978,0.00002062431,0.000046449913],"genre_scores_gemma":[0.9986921,0.000020957697,0.00051760674,0.00014653345,0.000024361721,0.00046185416,0.000024232695,0.000025580333,0.00008680686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868786,0.00012725792,0.00036675885,0.00025458797,0.00037377878,0.00018977019],"domain_scores_gemma":[0.998777,0.00038224994,0.00029425562,0.00021937965,0.00027217052,0.0000549423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020094894,0.00020243887,0.00053193094,0.00014731722,0.00004973724,0.000011151471,0.000051175248,0.000068599235,0.000018260844],"category_scores_gemma":[0.00014944263,0.00009675728,0.00002065794,0.00033069885,0.0003056655,0.00021760236,0.00001932779,0.000246557,0.000001590482],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.095477276,0.0052454094,0.8921108,0.000052835527,0.00037023166,0.000019233024,0.0046838894,0.000004128476,0.00016257771,0.000012898071,0.00017482255,0.00168588],"study_design_scores_gemma":[0.4302533,0.013388828,0.5532284,0.00041146218,0.0001291586,0.0000035498895,0.0015437066,0.00003555668,0.0008070493,0.000014193167,0.00004973955,0.00013507262],"about_ca_topic_score_codex":0.00012553863,"about_ca_topic_score_gemma":0.00054824643,"teacher_disagreement_score":0.33888245,"about_ca_system_score_codex":0.000077264885,"about_ca_system_score_gemma":0.00013054966,"threshold_uncertainty_score":0.39456472},"labels":[],"label_agreement":null},{"id":"W2515837411","doi":"10.1182/blood.v126.23.4783.4783","title":"Fertility Recovery Following Allogeneic Bone Marrow Transplantation in Aplastic Anemia; A Study of 157 Patients","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Fertility; Aplastic anemia; Transplantation; Incidence (geometry); Hematopoietic stem cell transplantation; Cyclophosphamide; Infertility; Regimen; Internal medicine; Pregnancy; Surgery; Pediatrics; Bone marrow; Chemotherapy; Population","score_opus":0.02295788548898812,"score_gpt":0.2591940619739582,"score_spread":0.2362361764849701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2515837411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99819726,0.0000739207,0.00011807591,0.000011948969,0.00016777877,0.00088231626,0.0000135066575,0.000030295805,0.00050487195],"genre_scores_gemma":[0.99942875,0.000008363526,0.00035858215,0.000019161213,0.0000116473475,0.000037185346,0.000091430054,0.000018814153,0.00002606681],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99846625,0.00011506468,0.0005165495,0.00026301734,0.00045027857,0.00018884316],"domain_scores_gemma":[0.9993956,0.00010937823,0.0000902151,0.0002107741,0.00007702208,0.00011697789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003614814,0.0001375289,0.0003562305,0.00016300169,0.000016609689,0.0000055505675,0.000054815926,0.0000883686,0.000012415295],"category_scores_gemma":[0.0001050571,0.00013169588,0.00006606458,0.00024854502,0.000013483373,0.00008644955,0.0000065979843,0.00010559279,0.000010749758],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007358416,0.004245512,0.9815736,0.00046193713,0.000067377485,0.00023279186,0.0049314466,0.00003872736,0.007459919,8.5665226e-7,0.000003834217,0.00024818198],"study_design_scores_gemma":[0.023425406,0.0016820383,0.9605873,0.00030718022,0.0007388226,0.000026498266,0.0009523502,0.000025428324,0.012085336,0.0000320718,0.0000016813616,0.00013584984],"about_ca_topic_score_codex":0.00016471908,"about_ca_topic_score_gemma":0.00033391907,"teacher_disagreement_score":0.022689564,"about_ca_system_score_codex":0.000045277433,"about_ca_system_score_gemma":0.00009065697,"threshold_uncertainty_score":0.53704023},"labels":[],"label_agreement":null},{"id":"W2515870172","doi":"10.1182/blood.v104.11.3139.3139","title":"Zoledronic Acid (ZA)- Associated Nephrotoxicity: An Analysis of Adverse Drug Reaction (ADR) Reports by the Research on Adverse Drug Events and Reports (RADAR) Project.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Zoledronic acid; Adverse effect; Nephrotoxicity; Internal medicine; Multiple myeloma; Clinical trial; Malignancy; Surgery; Kidney","score_opus":0.02997519262693052,"score_gpt":0.3469414170315457,"score_spread":0.3169662244046152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2515870172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963556,0.00029836898,8.7229716e-7,0.0006064608,0.00009257839,0.0018615107,0.000029496292,0.00007591341,0.00067923195],"genre_scores_gemma":[0.99814934,0.00010098559,0.000057007645,0.00016550768,0.000034273184,0.0001508663,0.00037123013,0.00003424213,0.0009365465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965193,0.0003381906,0.0008026363,0.00066970504,0.0011191674,0.00055100047],"domain_scores_gemma":[0.9977471,0.00009017615,0.0006363909,0.0009618897,0.00026995834,0.00029444485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021083192,0.0002413935,0.0005865288,0.00050729286,0.0003318037,0.000007778381,0.000069714435,0.00015623374,0.000019596298],"category_scores_gemma":[0.0003715091,0.00017719122,0.00019117961,0.0014104303,0.00012217156,0.00018179952,0.000052377913,0.00052499847,0.00000486574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010277741,0.016728964,0.948586,0.00022888472,0.0063990545,0.0053757303,0.0043613096,0.00003589206,0.014193051,0.000038903505,0.0018702021,0.0011542675],"study_design_scores_gemma":[0.00862833,0.001360261,0.9470022,0.0003519098,0.0060929493,0.00076659955,0.0017201883,0.000031823412,0.03243752,0.00035345257,0.0009364225,0.00031839052],"about_ca_topic_score_codex":0.0100031495,"about_ca_topic_score_gemma":0.0033067092,"teacher_disagreement_score":0.018244466,"about_ca_system_score_codex":0.0004052557,"about_ca_system_score_gemma":0.0006391937,"threshold_uncertainty_score":0.9965893},"labels":[],"label_agreement":null},{"id":"W2515880454","doi":"10.1182/blood.v122.21.4010.4010","title":"Comparative Efficacy Among Chronic Phase-Chronic Myeloid Leukemia (CP-CML) Patients After Failure Of 2nd Generation Tyrosine Kinase Inhibitors (2G TKIs)","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bosutinib; Nilotinib; Ponatinib; Dasatinib; Internal medicine; Oncology; Imatinib; Clinical trial; Cochrane Library; Myeloid leukemia; Meta-analysis","score_opus":0.01315385967319664,"score_gpt":0.25550061569469507,"score_spread":0.24234675602149844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2515880454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941181,0.0023947002,0.000033024022,0.00009332752,0.00026337797,0.002494519,0.000073806994,0.000116888754,0.00041226987],"genre_scores_gemma":[0.9962074,0.000084341,0.0005353357,0.0000654404,0.0010486189,0.00041870496,0.0010504705,0.00008431332,0.0005053843],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968744,0.00011749426,0.00089056266,0.00075057807,0.0006841597,0.0006828092],"domain_scores_gemma":[0.99788105,0.00008506812,0.00042984175,0.00083200773,0.00041014765,0.00036187214],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00010984361,0.00057992723,0.00090359716,0.00024897166,0.00012863637,0.000055620636,0.00018874854,0.0003095209,0.0014324214],"category_scores_gemma":[0.00007130063,0.00050460186,0.0002646068,0.0004321635,0.0002949949,0.00044888534,0.0001237223,0.00042942102,0.00032974523],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000873992,0.019459916,0.22262536,0.0014711997,0.0033952813,0.00027299815,0.004616003,0.00068115717,0.6894773,0.000067276545,0.030996919,0.026062554],"study_design_scores_gemma":[0.08574687,0.005244915,0.27097636,0.00095756794,0.0015083294,0.000027228023,0.00010391904,0.002700956,0.6295754,0.000011803998,0.0023178698,0.0008288042],"about_ca_topic_score_codex":0.00056523934,"about_ca_topic_score_gemma":0.0004380761,"teacher_disagreement_score":0.08487288,"about_ca_system_score_codex":0.0030489794,"about_ca_system_score_gemma":0.0011700103,"threshold_uncertainty_score":0.99974054},"labels":[],"label_agreement":null},{"id":"W2516233390","doi":"10.1182/blood.v118.21.4848.4848","title":"The Relationship Between Pre-Pregnancy Sickle Cell Disease-Specific Complications and Maternal and Fetal Outcomes in Sickle Cell Disease Pregnancies","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Mount Sinai Hospital; University of Toronto; Health Sciences Centre; University Health Network","funders":"","keywords":"Medicine; Pregnancy; Acute chest syndrome; Population; Anemia; Obstetrics; Fetal hemoglobin; Fetus; Pediatrics; Disease; Sickle cell anemia; Internal medicine","score_opus":0.03329628624196067,"score_gpt":0.24100493321842995,"score_spread":0.2077086469764693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2516233390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97551936,0.019633211,0.000032390075,0.00067439355,0.000044928744,0.0006836128,0.00006473754,0.000056718905,0.0032906665],"genre_scores_gemma":[0.99700326,0.0011565092,0.00018422287,0.000040597362,0.00002154529,0.000070930684,0.000026115413,0.000026266638,0.001470563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888796,0.000055783254,0.00030387708,0.00029800434,0.00016997826,0.00028440062],"domain_scores_gemma":[0.9989225,0.00022323398,0.00008954252,0.00039311618,0.000033060907,0.00033851128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007979041,0.0001837127,0.00020743906,0.0000678254,0.00029443204,0.000042165368,0.0001119668,0.000074645344,0.0000137657435],"category_scores_gemma":[0.000057541543,0.00012610215,0.00006520563,0.00011547276,0.00024090405,0.00009990669,0.0000831495,0.00022831891,0.00002288624],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044516713,0.0004087754,0.99738544,0.00014865259,0.00002019889,0.000029727555,0.0006475618,7.2326554e-7,0.00003751187,0.0005883567,0.000045225755,0.0006432878],"study_design_scores_gemma":[0.002313232,0.00006518599,0.99460864,0.00031217007,0.00023620813,0.000004322029,0.00019738796,0.000017989762,0.00014351466,0.0016238083,0.0003280327,0.00014951984],"about_ca_topic_score_codex":0.00004401307,"about_ca_topic_score_gemma":0.000012579929,"teacher_disagreement_score":0.021483907,"about_ca_system_score_codex":0.000014320284,"about_ca_system_score_gemma":0.00006187075,"threshold_uncertainty_score":0.51422966},"labels":[],"label_agreement":null},{"id":"W2516502471","doi":"10.1182/blood.v120.21.3573.3573","title":"Cooperative Lethality of Polo-Like Kinases (PLK) and Aurora Kinases (AK) in Refractory Pediatric Leukemia","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; Alberta Children's Hospital","funders":"","keywords":"Polo-like kinase; Kinase; Leukemia; Mitosis; Biology; PLK1; Cancer research; Mitotic catastrophe; Cell cycle; Cancer; Cell biology; Immunology; Genetics","score_opus":0.009217671241615839,"score_gpt":0.2396325144276491,"score_spread":0.23041484318603325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2516502471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921686,0.0071420763,0.000020278463,0.000013344028,0.00008433765,0.00013320209,0.000052426643,0.0000062607965,0.0003794975],"genre_scores_gemma":[0.99781036,0.0014352212,0.00018719565,0.00011462247,0.00022831072,0.000012436987,0.000071343435,0.00001541058,0.00012512312],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99914783,0.00008635226,0.00021474432,0.00022575007,0.0000735811,0.00025173384],"domain_scores_gemma":[0.9995112,0.000025916428,0.000090866575,0.00023761114,0.000053823478,0.00008061087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016387561,0.00014523484,0.00018802185,0.000054978984,0.000034233468,0.000007918133,0.000099360615,0.00016330766,0.000012275223],"category_scores_gemma":[0.00009194555,0.00013783881,0.00004624172,0.00009573117,0.000081170736,0.000009349665,0.00011214454,0.00009881527,0.0000025004128],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041780517,0.0006162084,0.33361387,0.000078623816,0.000040967287,0.0000046791624,0.00015336626,0.000004718224,0.66449845,0.00008665044,0.00047942385,0.00038129315],"study_design_scores_gemma":[0.0023599123,0.00057545013,0.2608469,0.000024998339,0.00016716991,0.000039947357,0.000239844,0.0000055240985,0.7259773,0.00001689058,0.0092953,0.00045077308],"about_ca_topic_score_codex":0.0001785832,"about_ca_topic_score_gemma":0.00013535318,"teacher_disagreement_score":0.07276696,"about_ca_system_score_codex":0.00001417775,"about_ca_system_score_gemma":0.000100943886,"threshold_uncertainty_score":0.56209034},"labels":[],"label_agreement":null},{"id":"W2516703175","doi":"10.1182/blood.v110.11.3215.3215","title":"Comparison of Antigen and Activation Assays with a Probability Scoring Model for the Diagnosis of Heparin Induced Thrombocytopenia.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Heparin-induced thrombocytopenia; Heparin; Platelet factor 4; Medicine; Platelet activation; Platelet; Antigen; Internal medicine; Thrombosis; Immunoassay; Optical density; Pre- and post-test probability; Gastroenterology; Immunology; Surgery; Pharmacology; Antibody","score_opus":0.12834650620432567,"score_gpt":0.3644192636681461,"score_spread":0.23607275746382042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2516703175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990649,0.00007063775,0.006813213,0.00019293945,0.00002487312,0.0016874559,0.0000087052,0.000027311367,0.00052585866],"genre_scores_gemma":[0.99239016,0.000040019444,0.0073551135,0.00003000664,0.000038155296,0.00010118137,0.000007699227,0.000026714495,0.000010970637],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985617,0.000029514928,0.00052813586,0.0003170054,0.00028311103,0.0002805569],"domain_scores_gemma":[0.99841964,0.00049824844,0.00029642592,0.00044225782,0.00024484255,0.00009859805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077802455,0.00018820137,0.00075251726,0.00008899179,0.00011950266,0.000013154535,0.0001328192,0.00013197018,0.0000062160343],"category_scores_gemma":[0.00022712389,0.00012569917,0.000085262065,0.0002758513,0.00014345978,0.00013701177,0.000074556,0.00018697866,4.2966144e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003288698,0.0013356105,0.795398,0.0003032516,0.0003495884,5.488045e-7,0.0015200998,0.000049555212,0.19627987,0.00086203904,0.00000752546,0.0035650304],"study_design_scores_gemma":[0.0022916512,0.00057225366,0.4445275,0.0002021584,0.00037782337,0.000004260746,0.00022506491,0.001997319,0.54950076,0.00018727797,0.000012577691,0.000101366204],"about_ca_topic_score_codex":0.00029674923,"about_ca_topic_score_gemma":0.00023193208,"teacher_disagreement_score":0.35322088,"about_ca_system_score_codex":0.000035794066,"about_ca_system_score_gemma":0.00018273515,"threshold_uncertainty_score":0.51258636},"labels":[],"label_agreement":null},{"id":"W2516903124","doi":"10.1182/blood.v112.11.3340.3340","title":"Epigenetic Regulation of the WNT Canonical Pathway in Mantle Cell Lymphoma.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Wnt signaling pathway; Demethylating agent; LRP5; DNA methylation; Cancer research; Epigenetics; Biology; Mantle cell lymphoma; LRP6; GSK-3; Signal transduction; Cell biology; Gene expression; Lymphoma; Immunology; Genetics; Gene","score_opus":0.006128763857988941,"score_gpt":0.19177094544518322,"score_spread":0.18564218158719428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2516903124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99752533,0.0010837716,0.0000542196,0.00004845619,0.0000882458,0.00014325579,0.0000052527325,0.0000037123314,0.0010477514],"genre_scores_gemma":[0.99896336,0.000099512996,0.00010752911,0.000018092192,0.00008604777,0.00000889622,0.000021238491,0.00001202916,0.00068328134],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99935967,0.000048612048,0.00018542759,0.00017392737,0.000112110014,0.000120266246],"domain_scores_gemma":[0.99957055,0.0000055385112,0.00008009742,0.00028747835,0.00003267378,0.00002369284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000063137915,0.000074608266,0.00008179004,0.000023645198,0.000036337224,0.0000019878107,0.000109111905,0.00012715528,0.000010423371],"category_scores_gemma":[0.0000161128,0.00006298884,0.00006341033,0.00011498612,0.000063169515,0.0000013802385,0.000053136606,0.000030647658,0.0000032398439],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020277846,0.00021987941,0.00868841,0.00000963966,0.000010749945,0.0000010314031,0.000049558123,0.00090966414,0.98918,0.00001942884,0.000104687286,0.00078664965],"study_design_scores_gemma":[0.0011162825,0.000049940372,0.21811365,0.000008871081,0.000008327482,0.000017697965,0.000004781233,0.00004765244,0.77910525,0.000033159227,0.0014320688,0.00006233653],"about_ca_topic_score_codex":0.000056610068,"about_ca_topic_score_gemma":0.00016683753,"teacher_disagreement_score":0.21007478,"about_ca_system_score_codex":0.000017510374,"about_ca_system_score_gemma":0.00018529223,"threshold_uncertainty_score":0.25686103},"labels":[],"label_agreement":null},{"id":"W2517409896","doi":"10.1182/blood.v114.22.3206.3206","title":"Stable Long-Term Risk of Leukemia in Patients with Severe Congenital Neutropenia Maintained On G-CSF Therapy.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Neutropenia; Hazard ratio; Internal medicine; Sepsis; Pediatrics; Febrile neutropenia; Confidence interval; Surgery; Chemotherapy","score_opus":0.003490674274730315,"score_gpt":0.19403882613724277,"score_spread":0.19054815186251245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2517409896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982021,0.00033897907,0.000008415976,0.00000820991,0.000014817838,0.00029783993,0.000052893432,0.00000569084,0.0010710474],"genre_scores_gemma":[0.9993728,0.00012491274,0.0000894202,0.000097331,0.000017603363,0.000008585035,0.00017152015,0.000014790813,0.00010305426],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99928236,0.000030727075,0.00013611092,0.0002462847,0.00010785635,0.00019666363],"domain_scores_gemma":[0.9995528,0.000004418884,0.0000833766,0.00026358457,0.000050361574,0.00004549167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000033761757,0.00015312819,0.00015329546,0.00003252847,0.000032131255,0.00001110063,0.00010493568,0.000084378145,0.000015576463],"category_scores_gemma":[0.0000070215947,0.00011636839,0.00004651913,0.000069525326,0.000026579763,0.0000048285283,0.000019190393,0.00006358866,0.0000037500845],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009648298,0.001771283,0.9904927,0.0000037986295,0.00023192608,0.00001084007,0.000022071823,0.00004749928,0.0023210254,0.00001713183,0.00003249797,0.0040843957],"study_design_scores_gemma":[0.015684549,0.0037714343,0.93184304,0.000014002176,0.00006374574,0.0000020854409,0.000007839993,0.0000010256614,0.048385613,0.00003704002,0.00002976121,0.00015986507],"about_ca_topic_score_codex":0.00005154709,"about_ca_topic_score_gemma":0.00009633693,"teacher_disagreement_score":0.05864966,"about_ca_system_score_codex":0.000013660236,"about_ca_system_score_gemma":0.000064035834,"threshold_uncertainty_score":0.47453654},"labels":[],"label_agreement":null},{"id":"W2517535174","doi":"10.1182/blood.v122.21.3672.3672","title":"Haplotype Signatures At HBS1L-MYB In Global Populations","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University and Génome Québec Innovation Centre","funders":"","keywords":"Biology; Genetics; Haplotype; Allele; Population; Locus (genetics); Genetic variation; Evolutionary biology; Gene","score_opus":0.010555519318526342,"score_gpt":0.24971320356855856,"score_spread":0.23915768425003223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2517535174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96762925,0.0019588275,0.0000032136452,0.00210715,0.00013573453,0.0002836489,0.00000504393,0.00005537965,0.027821733],"genre_scores_gemma":[0.9976261,0.00006501003,0.0003388786,0.0003570313,0.000051464078,0.000014088192,0.000024617504,0.000010034129,0.0015127216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993759,0.000013468017,0.00014156933,0.0001461267,0.00012154699,0.00020143496],"domain_scores_gemma":[0.99960405,0.000007423287,0.000035283756,0.00022241703,0.000033415232,0.0000974325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000034753557,0.000088850895,0.00014107543,0.00003574329,0.000085485175,0.000016406693,0.000062805455,0.00015761837,0.0003784225],"category_scores_gemma":[0.00007970137,0.00007024037,0.00005361576,0.00011376076,0.000039872953,0.00005472308,0.000040799878,0.00013599198,0.00033383517],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003950979,0.0009926629,0.97280294,0.00005171629,0.00008731378,0.00013465148,0.0001790996,0.00006650972,0.003414707,0.001844665,0.013715961,0.006670261],"study_design_scores_gemma":[0.0033345553,0.000115845585,0.990399,0.00008642598,0.00010514212,0.00005781375,0.00013991089,0.00016588965,0.0002770557,0.0014744323,0.00370521,0.0001386936],"about_ca_topic_score_codex":0.00073124527,"about_ca_topic_score_gemma":0.00028851363,"teacher_disagreement_score":0.029996885,"about_ca_system_score_codex":0.0000386594,"about_ca_system_score_gemma":0.00003586192,"threshold_uncertainty_score":0.4290887},"labels":[],"label_agreement":null},{"id":"W2517743626","doi":"10.1182/blood.v112.11.996.996","title":"Platelet Activation Rather Than Apoptosis Contributes Most to the Platelet Storage Lesion during Conventional and Extended Storage of Platelet Concentrates","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Platelet; Platelet activation; Phosphatidylserine; Chemistry; Thrombin; Apoptosis; Andrology; Immunology; Medicine; Biochemistry; Membrane","score_opus":0.016130776449623425,"score_gpt":0.23530867449937706,"score_spread":0.21917789804975363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2517743626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953114,0.0003809093,0.00065475615,0.002003249,0.0001156299,0.0011223856,0.000044452983,0.00006565178,0.0003015878],"genre_scores_gemma":[0.99819845,0.00046110695,0.00014055005,0.00042233546,0.00008128816,0.00005168207,0.00006185258,0.000027157059,0.00055556855],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99863255,0.000064329055,0.0003537143,0.00032066833,0.0003505724,0.00027813922],"domain_scores_gemma":[0.9992831,0.0000867521,0.00012365557,0.0002602078,0.00011791282,0.00012838622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020674402,0.00021100932,0.00036909292,0.00013088573,0.00024961797,0.000020878237,0.00010599037,0.00010644712,0.00014704242],"category_scores_gemma":[0.000052318574,0.00015669467,0.000081849874,0.00026744293,0.00011985005,0.00010359382,0.00006215916,0.0001872396,0.000012265863],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035448666,0.004830108,0.018261498,0.0007439723,0.0022844346,0.00035235047,0.0035693347,0.00024009832,0.9491979,0.0038021011,0.0062969346,0.0068764016],"study_design_scores_gemma":[0.013767723,0.00044274586,0.14164421,0.0002523646,0.00015053741,0.00011850706,0.00044196518,0.000065580236,0.83620197,0.000051149935,0.006648852,0.00021443359],"about_ca_topic_score_codex":0.000064628184,"about_ca_topic_score_gemma":0.000014935352,"teacher_disagreement_score":0.12338271,"about_ca_system_score_codex":0.000028264174,"about_ca_system_score_gemma":0.000054975535,"threshold_uncertainty_score":0.6389823},"labels":[],"label_agreement":null},{"id":"W2518102938","doi":"10.1182/blood.v122.21.1950.1950","title":"Phase 1b/2a Open-Label, Multiple-Dose, Dose-Escalation Study To Evaluate The Safety and Tolerability Of Intravenous Infusion Of SNS01-T In Patients With Relapsed Or Refractory Multiple Myeloma, Mantle Cell Lymphoma, Or Diffuse Large B Cell Lymphoma","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Polyamine Metabolism and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Tolerability; Apoptosis; Cancer research; Medicine; Mantle cell lymphoma; Multiple myeloma; Lymphoma; Biology; Pharmacology; Immunology; Adverse effect","score_opus":0.012858868230483383,"score_gpt":0.2636663626480961,"score_spread":0.25080749441761274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2518102938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99642086,0.00011384676,0.000093477545,0.000019585148,0.0000326749,0.0029514297,0.00029349822,0.000007375301,0.00006726545],"genre_scores_gemma":[0.9987242,0.000058843714,0.0005839046,0.00005512176,0.000022421034,0.00018452122,0.00020561084,0.0000250817,0.00014029739],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982395,0.00021733892,0.00057562016,0.00047036217,0.00022975987,0.00026741173],"domain_scores_gemma":[0.99859434,0.00009497158,0.00024918257,0.0007493497,0.00020170926,0.000110468536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000375415,0.000233513,0.00036740085,0.000060543432,0.00012296964,0.000026273083,0.00036806572,0.00010067035,0.000016743063],"category_scores_gemma":[0.00015999198,0.00014391661,0.000027068994,0.00024576162,0.000077552475,0.000024079325,0.00038774143,0.00005594635,0.0000051949387],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008573665,0.254044,0.15724495,0.00011465026,0.00009486905,0.00000220684,0.0020068157,0.000009784141,0.54627824,0.000002912589,0.00009057766,0.031537317],"study_design_scores_gemma":[0.16496389,0.004678586,0.70198894,0.000025152296,0.0001220555,0.0000011748147,0.0004487146,0.00029286288,0.12661394,0.000004068245,0.0005992551,0.00026137923],"about_ca_topic_score_codex":0.0004536541,"about_ca_topic_score_gemma":0.00060162076,"teacher_disagreement_score":0.54474396,"about_ca_system_score_codex":0.000016824535,"about_ca_system_score_gemma":0.00012489225,"threshold_uncertainty_score":0.58687484},"labels":[],"label_agreement":null},{"id":"W2518318398","doi":"10.1182/blood.v124.21.4023.4023","title":"Further Elucidation of the Mechanism of Iron Transport Form Plasma Transferrin to Mitochondrial Ferrochelatase: Further Evidence for the “Kiss and Run” Hypothesis","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; McGill University; Jewish General Hospital","funders":"","keywords":"Ferrochelatase; Endosome; Transferrin receptor; Mitochondrion; Protoporphyrin IX; Transferrin; Cell biology; Chemistry; Biochemistry; Endocytosis; Red blood cell; Heme; Biology; Receptor; Enzyme","score_opus":0.03250799581579801,"score_gpt":0.25683194143451415,"score_spread":0.22432394561871616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2518318398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98651797,0.00011009106,0.009554589,0.0022958438,0.00025654532,0.0010897757,0.00004866507,0.000014224148,0.000112302936],"genre_scores_gemma":[0.99794316,0.000056511028,0.00116513,0.00033154126,0.00018519413,0.00008066725,0.0000062858535,0.000019029123,0.00021250253],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992053,0.00004620296,0.00025704113,0.00019175628,0.00016577066,0.00013395435],"domain_scores_gemma":[0.999078,0.0003969172,0.00007777298,0.000329559,0.000066719,0.00005108366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020293772,0.00011864096,0.00024908353,0.000038453625,0.00005532505,0.0000024732512,0.00011313083,0.00010401938,0.0000816449],"category_scores_gemma":[0.0001487579,0.000067066445,0.0001295976,0.00009506322,0.00006741982,0.00004044106,0.000010255955,0.000081582424,0.0000034112402],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019762507,0.00026244632,0.000740512,0.00034742022,0.00012075332,4.4291164e-7,0.00327599,0.00001950296,0.98627025,0.0010719369,0.0001313764,0.005783097],"study_design_scores_gemma":[0.008292355,0.0025901769,0.053292315,0.00044701024,0.0015445929,0.000042367086,0.0006987242,0.0004105817,0.9281038,0.0013138998,0.0030358036,0.00022834781],"about_ca_topic_score_codex":0.0000319455,"about_ca_topic_score_gemma":0.00011090338,"teacher_disagreement_score":0.058166444,"about_ca_system_score_codex":0.0000063899474,"about_ca_system_score_gemma":0.0000352887,"threshold_uncertainty_score":0.27348903},"labels":[],"label_agreement":null},{"id":"W2518324907","doi":"10.1182/blood.v114.22.430.430","title":"Carfilzomib (CFZ), a Novel Proteasome Inhibitor for Relapsed or Refractory Multiple Myeloma, Is Associated with Minimal Peripheral Neuropathic Effects.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Princess Margaret Cancer Centre","funders":"","keywords":"Carfilzomib; Proteasome inhibitor; Medicine; Bortezomib; Discontinuation; Adverse effect; Internal medicine; Multiple myeloma; Peripheral neuropathy; Refractory (planetary science); Oncology; Pharmacology; Endocrinology","score_opus":0.02275757229499013,"score_gpt":0.275534983373577,"score_spread":0.25277741107858687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2518324907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99444115,0.00024969582,0.00011610504,0.00045815957,0.00007896248,0.00401257,0.00018207886,0.00020811927,0.0002531384],"genre_scores_gemma":[0.9917837,0.000010578272,0.0040847682,0.0008186311,0.00031015323,0.00057890586,0.00013866846,0.00008396583,0.0021906728],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9973969,0.00012233101,0.00036386083,0.00065629353,0.00064602535,0.00081458513],"domain_scores_gemma":[0.99814695,0.0004618313,0.0001700284,0.0004616695,0.00029022846,0.00046928783],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028471331,0.0004116517,0.0006454912,0.0001500319,0.00021867611,0.00005591895,0.00014836254,0.0002301014,0.00004461688],"category_scores_gemma":[0.0024616339,0.00027797755,0.0002016272,0.00033518142,0.000091565984,0.00015561003,0.00003374952,0.00041898745,0.000020256413],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04444795,0.03161778,0.16253133,0.0010255502,0.0027705233,0.0055361553,0.0022353323,0.0000027518263,0.7162824,0.00002574559,0.0023061663,0.031218275],"study_design_scores_gemma":[0.16274647,0.04056012,0.674269,0.0013184451,0.0010812962,0.00046002274,0.00009820782,0.0020511034,0.11340818,0.000016176791,0.0031290874,0.0008618728],"about_ca_topic_score_codex":0.0000363518,"about_ca_topic_score_gemma":0.00004815382,"teacher_disagreement_score":0.6028743,"about_ca_system_score_codex":0.00016410895,"about_ca_system_score_gemma":0.00041912537,"threshold_uncertainty_score":0.9999672},"labels":[],"label_agreement":null},{"id":"W2518387705","doi":"10.1182/blood.v126.23.496.496","title":"Results of the Safety Run-in Phase of CLL14 (BO25323): A Prospective, Open-Label, Multicenter Randomized Phase III Trial to Compare the Efficacy and Safety of Obinutuzumab and Venetoclax (GDC-0199/ABT-199) with Obinutuzumab and Chlorambucil in Patients with Previously Untreated CLL and Coexisting Medical Conditions","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Venetoclax; Obinutuzumab; Medicine; Open label; Off-label use; Internal medicine; Phases of clinical research; Phase (matter); Oncology; Randomized controlled trial; Clinical trial; Leukemia; Chronic lymphocytic leukemia; Chemistry","score_opus":0.032577453587854424,"score_gpt":0.34248132132296,"score_spread":0.3099038677351056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2518387705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879343,0.00037575548,0.000009079761,0.00014302031,0.000024878922,0.011001633,0.00025340205,0.0000109817265,0.00024697458],"genre_scores_gemma":[0.9992912,0.000084649495,0.00023785477,0.000039499795,0.00002641244,0.00017121354,0.000088730456,0.000029026862,0.00003142726],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99649024,0.0005523478,0.0011800844,0.00054306525,0.00085735356,0.0003769237],"domain_scores_gemma":[0.99680096,0.0014576941,0.00048961386,0.0005146475,0.00038912374,0.00034799136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020112721,0.00030093864,0.0014708914,0.00014892772,0.0001053493,0.00003331398,0.00024459613,0.00010613887,0.000008081411],"category_scores_gemma":[0.0024931685,0.00016190516,0.000032114815,0.0005518031,0.0013671771,0.000118619224,0.00038229898,0.00034608663,1.8806325e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98405486,0.0032501272,0.0052095326,0.00027886662,0.00042155737,0.000047801823,0.0059198253,0.00003402807,0.00008419801,0.000063529296,0.00003894674,0.00059671106],"study_design_scores_gemma":[0.9788384,0.0051032817,0.006658165,0.0023301155,0.00054730446,0.00006877567,0.0005343199,0.0051875785,0.000518022,0.000012374615,0.000031025214,0.00017063199],"about_ca_topic_score_codex":0.003368119,"about_ca_topic_score_gemma":0.0014362128,"teacher_disagreement_score":0.011356911,"about_ca_system_score_codex":0.0018503449,"about_ca_system_score_gemma":0.0056378995,"threshold_uncertainty_score":0.9999992},"labels":[],"label_agreement":null},{"id":"W2518393375","doi":"10.1182/blood.v114.22.2938.2938","title":"Two Distinct Syndromes of Lymphoma-Associated Amyloidosis: Findings From a Case Series.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Toronto General Hospital; University Health Network; University of British Columbia","funders":"","keywords":"Amyloidosis; Lymphoma; Medicine; MALT lymphoma; AL amyloidosis; Immunoglobulin light chain; Lymphoplasmacytic Lymphoma; Pathology; Mucosa-associated lymphoid tissue; Gastroenterology; Internal medicine; Antibody; Waldenstrom macroglobulinemia; Immunology","score_opus":0.009698052784809865,"score_gpt":0.24761389658658267,"score_spread":0.2379158438017728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2518393375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99704975,0.0015135481,0.000009666081,0.00022748251,0.00007892195,0.00021592306,0.0003584086,0.000049576553,0.00049673335],"genre_scores_gemma":[0.9982082,0.00020348767,0.0005453588,0.00023578876,0.00007242778,0.000042790594,0.00034580546,0.00003348501,0.0003126168],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998518,0.00007415837,0.00037426964,0.0004905677,0.00017933296,0.00036366098],"domain_scores_gemma":[0.999045,0.000043510576,0.00019434451,0.000508811,0.00007857716,0.00012976899],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009812254,0.000309803,0.00040661616,0.000059026268,0.00010632548,0.000030112802,0.0002294701,0.00019864175,0.000058255206],"category_scores_gemma":[0.0002196036,0.00029447261,0.00023259946,0.0001697587,0.00008600378,0.000010447078,0.00009378159,0.000054016997,0.000017705246],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020913534,0.006060916,0.71295995,0.00002982279,0.00241643,0.002750008,0.00041910526,0.000007646092,0.2683851,0.00013953792,0.0023171667,0.004305149],"study_design_scores_gemma":[0.009775616,0.0013165894,0.28469184,0.00008926575,0.00095742574,0.0013898357,0.00027469863,0.0000041744574,0.6998395,0.00024236031,0.00075940037,0.0006593016],"about_ca_topic_score_codex":0.00039197013,"about_ca_topic_score_gemma":0.00029917026,"teacher_disagreement_score":0.43145436,"about_ca_system_score_codex":0.000034545537,"about_ca_system_score_gemma":0.000072308176,"threshold_uncertainty_score":0.99995077},"labels":[],"label_agreement":null},{"id":"W2518479252","doi":"10.1182/blood.v124.21.1949.1949","title":"Soluble CD23 (sCD23): A Forgotten Indicator of Prognosis and Identifier of Outcome in Patients with Chronic Lymphocytic Leukemia Utilizing a Novel Cba Approach","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"CD23; Immunoglobulin E; CD38; Chronic lymphocytic leukemia; Immunology; Antibody; Molecular biology; Immunoassay; Medicine; Leukemia; Biology; Gastroenterology; Internal medicine","score_opus":0.01896315766870237,"score_gpt":0.26026357011270096,"score_spread":0.24130041244399858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2518479252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975952,0.0002861085,0.00012752408,0.000011017782,0.000031624768,0.0011612055,0.000010369232,0.000029088274,0.00074784213],"genre_scores_gemma":[0.997673,0.000016064943,0.0019220713,0.000030135932,0.000043133696,0.000105434134,0.000029220388,0.000054111762,0.00012685485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99738294,0.000049705326,0.00070743484,0.0005033812,0.0008097799,0.00054675475],"domain_scores_gemma":[0.998665,0.0001356846,0.00029487038,0.00056202203,0.00014938819,0.00019308862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005896025,0.00024476284,0.00075539376,0.00038870616,0.000041421157,0.00001771275,0.00023259928,0.0001787315,0.000018436227],"category_scores_gemma":[0.00025188044,0.00019230002,0.000086523825,0.0004985561,0.00031961157,0.00013094173,0.00021327441,0.00021725518,0.0000052215914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0005722915,0.0014678079,0.98976415,0.0036622782,0.00034378865,0.000008129136,0.0006395014,0.000039545677,0.0019845509,0.00016668682,0.000037267528,0.0013139958],"study_design_scores_gemma":[0.2364304,0.0022713912,0.70533836,0.0012768451,0.0007285422,0.00009204438,0.00022245412,0.026268864,0.026700512,0.000033763936,0.00012610643,0.00051072123],"about_ca_topic_score_codex":0.0011441696,"about_ca_topic_score_gemma":0.000058891354,"teacher_disagreement_score":0.2844258,"about_ca_system_score_codex":0.007544125,"about_ca_system_score_gemma":0.0062950836,"threshold_uncertainty_score":0.9993383},"labels":[],"label_agreement":null},{"id":"W2518549838","doi":"10.1182/blood.v126.23.5630.5630","title":"National Trend in Splenectomy for Splenic Marginal Zone Lymphoma (SMZL): An Analysis of Surveillance, Epidemiology and End Results (SEER) Database","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Splenectomy; Splenic marginal zone lymphoma; Surveillance, Epidemiology, and End Results; Population; Poisson regression; Epidemiology; Rituximab; Database; Internal medicine; Surgery; Cancer registry; Lymphoma","score_opus":0.06159040810683565,"score_gpt":0.34013597863150186,"score_spread":0.2785455705246662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2518549838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956422,0.0010266338,0.00003422841,0.00047924207,0.000034287932,0.00027828175,0.002040944,0.000015269557,0.00044893872],"genre_scores_gemma":[0.9919092,0.00014330373,0.004164776,0.000115430135,0.00008841325,0.00007812371,0.003432819,0.000011161984,0.000056741308],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984136,0.00014689368,0.0005349002,0.0004239904,0.0002184622,0.00026215546],"domain_scores_gemma":[0.99830556,0.0008554351,0.00018506909,0.00030009059,0.00013495646,0.00021888429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013541918,0.00015827543,0.0007375249,0.0004664735,0.00002436886,0.000005045422,0.00006449693,0.000084333704,0.000020265477],"category_scores_gemma":[0.0008331757,0.0001297639,0.00011445372,0.00046369244,0.000082480175,0.00007550581,0.000036029585,0.000029369805,0.0000017085156],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012668361,0.0030801776,0.98911977,0.000044391196,0.0012366003,0.000057690675,0.0001726839,0.000051432417,0.00011604714,0.0010476179,0.0007194642,0.0030873173],"study_design_scores_gemma":[0.030012578,0.0007802176,0.96320194,0.000029590243,0.0011207962,0.00006116412,0.00008701598,0.0023541022,0.0004922843,0.00009506118,0.0016417396,0.00012349189],"about_ca_topic_score_codex":0.00067438185,"about_ca_topic_score_gemma":0.0066402503,"teacher_disagreement_score":0.02874574,"about_ca_system_score_codex":0.00009769277,"about_ca_system_score_gemma":0.00022312865,"threshold_uncertainty_score":0.5291618},"labels":[],"label_agreement":null},{"id":"W2518678966","doi":"10.1182/blood.v110.11.304.304","title":"Dalteparin Thromboprophylaxis in Critically Ill Patients with Severe Renal Insufficiency: The Direct Study.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Thrombosis; Renal function; Creatinine; Pulmonary embolism; Pharmacodynamics; Low molecular weight heparin; Internal medicine; Surgery; Anesthesia; Pharmacokinetics","score_opus":0.008224255221645993,"score_gpt":0.2459770464480217,"score_spread":0.23775279122637571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2518678966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9680237,0.0000851984,0.000024173696,0.00037247108,0.00007453233,0.0013589561,0.0000038670064,0.00004936622,0.030007724],"genre_scores_gemma":[0.9977908,0.000014803541,0.0003041331,0.0016467269,0.00007372775,0.000044167464,0.000007336401,0.00002511114,0.00009315738],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982986,0.000047817473,0.00031339974,0.00035463346,0.0005533383,0.00043222617],"domain_scores_gemma":[0.99895436,0.00009103105,0.000052479383,0.00045632463,0.00033855945,0.00010727787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005463803,0.00017874192,0.0003755633,0.000118571,0.00012586609,0.00002750756,0.00017123573,0.000046763063,0.00006869737],"category_scores_gemma":[0.00026449887,0.00010454523,0.000047730322,0.00042999428,0.00008916518,0.000058767902,0.00010442751,0.0002099877,0.000024583502],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015397862,0.042396232,0.9497382,0.000054056647,0.00023432582,0.0001946729,0.0018449792,0.000009734616,0.00006619523,0.0003791119,0.00055627665,0.0043722363],"study_design_scores_gemma":[0.0047295927,0.0038960136,0.9887569,0.00007428475,0.00023870765,0.0000060508105,0.00085397303,0.0000030675253,0.00018439212,0.000027060009,0.0010762815,0.00015366015],"about_ca_topic_score_codex":0.00027360854,"about_ca_topic_score_gemma":0.00068112765,"teacher_disagreement_score":0.039018717,"about_ca_system_score_codex":0.000045467095,"about_ca_system_score_gemma":0.00005392727,"threshold_uncertainty_score":0.4263231},"labels":[],"label_agreement":null},{"id":"W2518878080","doi":"10.1182/blood.v126.23.3031.3031","title":"Analysis of Pomalidomide Plus Low-Dose Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma with Vs without Moderate Renal Impairment","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Pomalidomide; Medicine; Lenalidomide; Neutropenia; Internal medicine; Dexamethasone; Multiple myeloma; Surgery; Refractory (planetary science); Population; Urology; Gastroenterology; Toxicity","score_opus":0.019148678171921084,"score_gpt":0.2665810931258431,"score_spread":0.24743241495392201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2518878080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981712,0.0001188851,0.00012954156,0.000039857885,0.000015402476,0.0011507929,0.00007333084,0.000042894444,0.00025810537],"genre_scores_gemma":[0.9939948,0.000010154301,0.00524498,0.000042215404,0.000024788878,0.00010729176,0.0003059338,0.000049525912,0.00022034602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971745,0.00017009978,0.0004631696,0.0005291397,0.0010986157,0.00056447415],"domain_scores_gemma":[0.99797326,0.00011811474,0.00023611842,0.0006531617,0.00043169645,0.0005876215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034167824,0.0003337482,0.0009746451,0.0007003108,0.00004793987,0.000022672419,0.00013576371,0.00010986715,0.000045649158],"category_scores_gemma":[0.00017873608,0.00021942753,0.00012445822,0.0009568549,0.0001415891,0.00017218664,0.00006873318,0.00027057383,0.00001528593],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035846572,0.005948676,0.95101887,0.000059366575,0.0037948336,0.00035760258,0.00067331735,0.0014287882,0.00023735517,0.0000015601576,0.000015720407,0.0006173651],"study_design_scores_gemma":[0.09819751,0.005665163,0.8841084,0.00021398305,0.0019275241,0.000010396167,0.00011597659,0.0064638653,0.003057405,0.000003099686,0.000010762455,0.00022590076],"about_ca_topic_score_codex":0.00084884575,"about_ca_topic_score_gemma":0.0009918496,"teacher_disagreement_score":0.06691043,"about_ca_system_score_codex":0.0002729634,"about_ca_system_score_gemma":0.00051781425,"threshold_uncertainty_score":0.89479953},"labels":[],"label_agreement":null},{"id":"W2519093455","doi":"10.1182/blood.v110.11.1861.1861","title":"Pharmacokinetics and Dose-Finding of Fragmin in Pediatric Patients at Risk for Thromboembolic Events.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; Stollery Children's Hospital","funders":"","keywords":"Medicine; Dosing; Cmax; Pharmacokinetics; Dose; Adverse effect; Blood sampling; Population; Pediatrics; Internal medicine","score_opus":0.04156039134614154,"score_gpt":0.3646683441284225,"score_spread":0.32310795278228094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2519093455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99588704,0.0024787092,0.000015334106,0.000079214326,0.000092633,0.00041156763,0.000021992004,0.000008201524,0.0010053263],"genre_scores_gemma":[0.99612284,0.0031595589,0.0003979643,0.00013209054,0.00013964748,0.0000076101837,0.000006134564,0.000010600988,0.000023548233],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99921703,0.00001944344,0.00024639422,0.00014251118,0.00014763938,0.00022696189],"domain_scores_gemma":[0.9992657,0.00040321203,0.0001317843,0.00006441526,0.000042155,0.00009273332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036680957,0.000087958266,0.00021540256,0.00007378145,0.000053575797,0.0000020478903,0.00003603694,0.000046284204,0.000026944019],"category_scores_gemma":[0.00029591293,0.00007397131,0.000039138744,0.00015435794,0.000021894291,0.000043257747,0.000063542684,0.00012225058,0.0000024914718],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022193845,0.00076139945,0.99245167,0.0001837615,0.000053155323,0.0000036293839,0.00021353964,4.0436922e-7,0.0008270884,0.00001087609,0.00008246618,0.0051900586],"study_design_scores_gemma":[0.009117411,0.00025580105,0.97946924,0.000016293538,0.0007315865,0.0000021230235,0.000029299614,0.000023257067,0.00559906,0.000051952396,0.004627915,0.00007603357],"about_ca_topic_score_codex":0.000020676678,"about_ca_topic_score_gemma":0.000018303881,"teacher_disagreement_score":0.012982416,"about_ca_system_score_codex":0.000016671598,"about_ca_system_score_gemma":0.000008587739,"threshold_uncertainty_score":0.30164623},"labels":[],"label_agreement":null},{"id":"W2519147980","doi":"10.1182/blood.v124.21.1784.1784","title":"Inhibitory Effects of Icaritin on TKI-Resistant CML Cells through Disruption of the BCR-ABL-GRB2-RAS-MAPK Signaling Pathway","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Nilotinib; Dasatinib; Cancer research; Imatinib mesylate; Tyrosine kinase; Imatinib; Myeloid leukemia; Stem cell; Population; Medicine; Progenitor cell; Tyrosine-kinase inhibitor; Biology; Cancer; Internal medicine; Cell biology; Receptor","score_opus":0.0077195876594145976,"score_gpt":0.22396764023192917,"score_spread":0.21624805257251456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2519147980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954856,0.00051550637,0.000057843048,0.00008071424,0.00029407383,0.00067438907,0.000023808212,0.000038969032,0.0028290697],"genre_scores_gemma":[0.99887645,0.000030731073,0.00042810335,0.00013376487,0.00024606442,0.000030505918,0.000016903885,0.00003767597,0.00019977354],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99828106,0.00018033161,0.0004277409,0.0003143911,0.00052534713,0.0002711089],"domain_scores_gemma":[0.9983767,0.000506108,0.00028385012,0.000682037,0.000077807264,0.00007347089],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002354144,0.0002228466,0.00045966855,0.000051325642,0.00006770611,0.000006587727,0.00014706001,0.00014303817,0.00003269868],"category_scores_gemma":[0.00026838534,0.00015235014,0.00021088538,0.00017707872,0.00012534806,0.0000474508,0.00006893041,0.00022196624,0.000021012836],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014805737,0.0014421175,0.0020223795,0.0009683169,0.00019842687,0.000024033196,0.0005663354,0.000024681674,0.99222153,0.0008531806,0.00015637797,0.0013745663],"study_design_scores_gemma":[0.0074695405,0.000957441,0.0056064087,0.0020765488,0.0004912777,0.0000079435,0.000059973085,0.000026616368,0.9823279,0.00023427798,0.00061610603,0.00012596018],"about_ca_topic_score_codex":0.00013917203,"about_ca_topic_score_gemma":0.000013981263,"teacher_disagreement_score":0.00989362,"about_ca_system_score_codex":0.00017531568,"about_ca_system_score_gemma":0.00018372573,"threshold_uncertainty_score":0.6212659},"labels":[],"label_agreement":null},{"id":"W2519484468","doi":"10.1182/blood.v126.23.2938.2938","title":"Improvement of Quality of Response with Ibrutinib Plus Bendamustine/Rituximab Vs Placebo Plus Bendamustine/Rituximab for Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Bendamustine; Chronic lymphocytic leukemia; Ibrutinib; Rituximab; Medicine; Ofatumumab; Internal medicine; Lymphoma; Placebo; Oncology; Leukemia; Immunology; Pathology","score_opus":0.05272534709758657,"score_gpt":0.31698921871421276,"score_spread":0.2642638716166262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2519484468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98733723,0.0030085654,0.00060842244,0.00017972008,0.00022996974,0.0070153424,0.00050178665,0.00038345033,0.00073548424],"genre_scores_gemma":[0.9906872,0.00020355417,0.004005948,0.00020107823,0.00046311956,0.0009948387,0.00040731026,0.00034553467,0.0026914398],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9894129,0.000621045,0.0031093773,0.00191182,0.002528363,0.0024165097],"domain_scores_gemma":[0.9896516,0.0022397237,0.0016282409,0.0028672619,0.0022073623,0.0014057669],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.004573889,0.0013461905,0.0037117172,0.0008395897,0.00023220293,0.00008588368,0.0011711853,0.00074908073,0.00011771501],"category_scores_gemma":[0.003781248,0.001152057,0.00075581926,0.0014946955,0.0011323986,0.00028033202,0.0006058954,0.00037881377,0.00007059878],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.80820274,0.0113076065,0.0010441764,0.032283954,0.007557689,0.00215426,0.0078080553,0.010338955,0.09831596,0.00084875955,0.003099277,0.017038537],"study_design_scores_gemma":[0.72843444,0.01627235,0.00091931043,0.0022508653,0.0029577888,0.0016704818,0.0011389091,0.05527047,0.18830898,0.000064368636,0.001303737,0.0014082771],"about_ca_topic_score_codex":0.009825507,"about_ca_topic_score_gemma":0.00086739653,"teacher_disagreement_score":0.08999302,"about_ca_system_score_codex":0.1646947,"about_ca_system_score_gemma":0.21908736,"threshold_uncertainty_score":0.9999289},"labels":[],"label_agreement":null},{"id":"W2519736008","doi":"10.1182/blood.v122.21.2116.2116","title":"Fludarabine Metabolite Level On Day Zero Does Not Affect Outcomes Of Hematopoietic Cell Transplantation In Patients With Normal Renal Function","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Queen's University; Alberta Health Services","funders":"","keywords":"Fludarabine; Medicine; Transplantation; Melphalan; Internal medicine; Hematopoietic stem cell transplantation; Gastroenterology; Creatinine; Renal function; Immunology; Chemotherapy; Cyclophosphamide","score_opus":0.00979936454489033,"score_gpt":0.2291599910058644,"score_spread":0.21936062646097407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2519736008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99754375,0.00001344408,0.0009084395,0.00011588635,0.000061735074,0.0007777036,0.00006235039,0.000024258805,0.000492456],"genre_scores_gemma":[0.9985657,0.000009294649,0.0005720745,0.00013255344,0.000028285402,0.00006024075,0.00012499947,0.000026697497,0.00048018177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984086,0.00007784544,0.0003158364,0.00025022982,0.00066069514,0.00028678382],"domain_scores_gemma":[0.9992138,0.00018433148,0.00009800198,0.00025478005,0.00014451073,0.00010454501],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018462502,0.00018116413,0.0003814914,0.00022578088,0.00002832677,0.000011685582,0.000080645885,0.000087929366,0.00010611379],"category_scores_gemma":[0.000049448965,0.00010516608,0.000062993204,0.00020777038,0.00005841921,0.0001532846,0.00001539975,0.00017625655,0.00005679347],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020861605,0.0025896647,0.95068645,0.0006056073,0.00023900307,0.000032040738,0.0006376283,0.00004449975,0.041756224,0.000068867404,0.00008141735,0.00117241],"study_design_scores_gemma":[0.017673472,0.0010554068,0.8206385,0.00010317434,0.00028663356,0.0000048872066,0.000018882925,0.000035727007,0.16005562,0.000018466488,0.0000059628173,0.00010329406],"about_ca_topic_score_codex":0.00018148347,"about_ca_topic_score_gemma":0.000016514932,"teacher_disagreement_score":0.130048,"about_ca_system_score_codex":0.000065005086,"about_ca_system_score_gemma":0.000114966344,"threshold_uncertainty_score":0.42885482},"labels":[],"label_agreement":null},{"id":"W2519777424","doi":"10.1182/blood.v126.23.368.368","title":"Evaluation of Circulating Tumour DNA for the Mutational Characterisation of Multiple Myeloma","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Collège Boréal","funders":"","keywords":"Neuroblastoma RAS viral oncogene homolog; Digital polymerase chain reaction; KRAS; Exome; Exome sequencing; DNA; Cell-free fetal DNA; Molecular biology; Liquid biopsy; Multiple myeloma; Cancer research; Biology; Mutation; Polymerase chain reaction; Cancer; Medicine; Genetics; Gene; Immunology","score_opus":0.1273705593362092,"score_gpt":0.36233882179121224,"score_spread":0.23496826245500305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2519777424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980416,0.00015494447,0.00037617437,0.00015425216,0.00003661822,0.0009651802,0.000038300765,0.000007693152,0.00022520254],"genre_scores_gemma":[0.9984534,0.0000017085622,0.0011435971,0.000008426532,0.00008789976,0.00012950554,0.00014765926,0.000008403947,0.000019426265],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99876416,0.00006778578,0.00020794675,0.00009427386,0.0007668715,0.000098974895],"domain_scores_gemma":[0.9983844,0.00025805846,0.00013777277,0.00012472096,0.0010378455,0.00005717434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001106697,0.00005581347,0.00012393652,0.000051883948,0.000034415625,0.000004187268,0.00003983626,0.000027871063,0.000022762622],"category_scores_gemma":[0.002262461,0.00003819319,0.000058042642,0.0000809464,0.000031615993,0.000050262188,0.000011650774,0.000032559143,0.0000033790711],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007381253,0.0021002754,0.42786035,0.00026011467,0.0012155322,0.000007882853,0.0025385055,0.00030755423,0.4336463,0.0001693881,0.00007302993,0.13108295],"study_design_scores_gemma":[0.011623749,0.00025903518,0.8262964,0.000042587024,0.00050930347,0.000019521049,0.00027263843,0.05273549,0.10796977,0.00022260858,0.000014344425,0.000034547444],"about_ca_topic_score_codex":0.000048173923,"about_ca_topic_score_gemma":0.0000108948125,"teacher_disagreement_score":0.39843607,"about_ca_system_score_codex":0.000037363337,"about_ca_system_score_gemma":0.0002951457,"threshold_uncertainty_score":0.27085406},"labels":[],"label_agreement":null},{"id":"W2519945198","doi":"10.1182/blood.v118.21.2326.2326","title":"Effectiveness, Time Utilization and Clinical Outcome of Partial Manual Red Cell Exchange in Patients with Sickle Cell Disease","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Phlebotomy; Anemia; Anemia of chronic disease; Pulmonary hypertension; Internal medicine; Surgery; Iron deficiency","score_opus":0.01926130503246613,"score_gpt":0.26221401056044286,"score_spread":0.24295270552797674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2519945198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99789405,0.00026414005,0.000010590517,0.000011350443,0.00004067009,0.0004963582,0.000011238703,0.000016726433,0.0012548501],"genre_scores_gemma":[0.9996812,0.000066773486,0.00006599259,0.000024537501,0.0000132737305,0.0000072556827,0.000037081154,0.000015110572,0.00008877475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991947,0.00008992136,0.00026008204,0.0001906074,0.00012812644,0.0001365978],"domain_scores_gemma":[0.99956113,0.000032371318,0.00008274885,0.00014899437,0.000043580214,0.00013116596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016759682,0.00009785935,0.00024239399,0.00004893685,0.000017230086,0.000002062606,0.00003104763,0.00009363662,0.00007240894],"category_scores_gemma":[0.000036147707,0.00007200121,0.000040962677,0.00009407664,0.00007614101,0.000038779217,0.000028296876,0.00010324315,0.000012175122],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012401191,0.003590513,0.994074,0.00034747663,0.000022411681,0.00002234318,0.00014509955,4.0762447e-7,0.000039647108,0.0000026013793,0.000014495333,0.00050092366],"study_design_scores_gemma":[0.013119378,0.0010531078,0.9838985,0.00009467818,0.00032033748,3.8485732e-7,0.000021612797,0.00005279155,0.001297193,0.000010850779,0.000044670283,0.00008646614],"about_ca_topic_score_codex":0.000025868761,"about_ca_topic_score_gemma":0.0000016519227,"teacher_disagreement_score":0.01187926,"about_ca_system_score_codex":0.000006054063,"about_ca_system_score_gemma":0.000027520013,"threshold_uncertainty_score":0.29361242},"labels":[],"label_agreement":null},{"id":"W2520309624","doi":"10.1182/blood.v124.21.4851.4851","title":"Transition of Care Under One Roof at the Mcmaster Hemoglobinopathy Clinic","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Hematologist; Medicine; Family medicine; Health care; Transitional care; Young adult; Pediatrics; Nursing; Disease; Gerontology","score_opus":0.05410292361896764,"score_gpt":0.3668610032991957,"score_spread":0.31275807968022806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2520309624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97986054,0.0011829577,0.00032222757,0.005846286,0.00038033864,0.00074108026,0.0000583426,0.00005338765,0.011554819],"genre_scores_gemma":[0.99412596,0.000089452566,0.000068967725,0.0030752951,0.0008699405,0.000024102506,0.00004532054,0.000020262589,0.0016807182],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998248,0.00056054414,0.00046382335,0.00018379158,0.00021920423,0.00032467418],"domain_scores_gemma":[0.9989475,0.00033413686,0.00018228957,0.00029610272,0.00014435452,0.000095631134],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004666029,0.00010500307,0.00022892602,0.000033014043,0.00040509537,0.0000019430977,0.00012360075,0.00021445274,0.0012201963],"category_scores_gemma":[0.00004311195,0.00007437763,0.000086533204,0.00012143746,0.00004329785,0.00003496435,0.000051565334,0.00038771247,0.0005187534],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010704452,0.001855459,0.7552032,0.013000826,0.00021652348,0.0000065974154,0.16638863,0.000033545002,0.0023553013,0.0020040425,0.025027324,0.03283814],"study_design_scores_gemma":[0.023719838,0.0019581248,0.7909847,0.0018730902,0.0012975673,0.000009158303,0.048181538,0.00008345238,0.0028437767,0.0016188349,0.12637793,0.0010520007],"about_ca_topic_score_codex":0.00008683297,"about_ca_topic_score_gemma":0.00031929568,"teacher_disagreement_score":0.11820709,"about_ca_system_score_codex":0.000042900043,"about_ca_system_score_gemma":0.00012475428,"threshold_uncertainty_score":0.9996928},"labels":[],"label_agreement":null},{"id":"W2520322016","doi":"10.1182/blood.v114.22.1761.1761","title":"Validation of a Scoring System to Establish the Pretest Probability of Myelodysplastic Syndrome in Patients with Unexplained Cytopenias or Macrocytosis.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Macrocytosis; Bone marrow; Bone marrow examination; Internal medicine; Gold standard (test); Myelodysplastic syndromes; Mean corpuscular volume; International Prognostic Scoring System; Medical diagnosis; Pediatrics; Pathology; Anemia; Hematocrit","score_opus":0.013129096304509147,"score_gpt":0.24401081157072574,"score_spread":0.2308817152662166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2520322016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972161,0.000009855547,0.00005392581,0.00017556017,0.000017718885,0.002188923,0.000020677548,0.000028964363,0.00028828662],"genre_scores_gemma":[0.99839747,0.0000010181482,0.0014221576,0.000025418674,0.0000144164715,0.00006632618,0.00001757342,0.00001626992,0.000039366263],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982535,0.000106342755,0.00047452157,0.00029001915,0.0005916179,0.00028395312],"domain_scores_gemma":[0.9986909,0.00021541883,0.00015454295,0.0005112224,0.0003202131,0.000107685606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052331126,0.00014739773,0.0004400054,0.000185973,0.000036419937,0.000015790558,0.0002218254,0.000064580316,0.000011040706],"category_scores_gemma":[0.0007239329,0.000086214844,0.000035842975,0.0009362305,0.000058194713,0.000119702,0.000065317276,0.00018467855,0.0000046379405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007142089,0.002814471,0.97058713,0.002525621,0.00019878853,0.00014632655,0.0018724367,0.00062308507,0.012709939,0.00027258586,0.000041356176,0.001066167],"study_design_scores_gemma":[0.009023961,0.0045233388,0.94627374,0.0017108681,0.0001854198,0.00007223504,0.00020864805,0.00011057851,0.037746027,0.0000102840695,0.000005424481,0.00012948793],"about_ca_topic_score_codex":0.00008005824,"about_ca_topic_score_gemma":0.00002399677,"teacher_disagreement_score":0.025036087,"about_ca_system_score_codex":0.00022363315,"about_ca_system_score_gemma":0.00031864975,"threshold_uncertainty_score":0.35157394},"labels":[],"label_agreement":null},{"id":"W2520401199","doi":"10.1182/blood.v104.11.3964.3964","title":"Clinical Associations and Significance of Biphasic aPTT Transmittance Waveforms.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Sepsis; Coagulation testing; Coagulation; Disseminated intravascular coagulation; Thrombophilia; Hemostasis; Clinical significance; Internal medicine; Thrombosis; Gastroenterology; Surgery","score_opus":0.037545617898025976,"score_gpt":0.31564184692316555,"score_spread":0.2780962290251396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2520401199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99451244,0.00034056272,0.0020474882,0.0009448851,0.00008590113,0.00027574942,0.000015345586,0.00005199753,0.0017256086],"genre_scores_gemma":[0.994337,0.00016219962,0.0049717287,0.00032963516,0.00007348732,0.000008872553,0.000008398728,0.000011313506,0.00009735304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991782,0.000019282737,0.00034306414,0.00016784703,0.00017092002,0.000120697914],"domain_scores_gemma":[0.99951655,0.000046709392,0.00010927406,0.00016028024,0.00007031691,0.000096849886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022379393,0.00007871113,0.0002896602,0.000041016752,0.000040276173,0.000005084032,0.000040451283,0.000096129676,0.00002353251],"category_scores_gemma":[0.00006558062,0.00006767954,0.00008759473,0.00015107574,0.000065226996,0.000048624952,0.000007701384,0.00011553371,0.000008712452],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001720518,0.009880329,0.5206324,0.0004827808,0.001672066,0.00005977432,0.002194075,0.000025463121,0.1971246,0.20438026,0.00010489442,0.063271336],"study_design_scores_gemma":[0.016066775,0.0009017881,0.8537203,0.0001705174,0.0007550505,0.00003334906,0.00010729635,0.000033143762,0.114867784,0.012524233,0.00060942845,0.00021030994],"about_ca_topic_score_codex":0.000014244237,"about_ca_topic_score_gemma":0.00001031017,"teacher_disagreement_score":0.33308795,"about_ca_system_score_codex":0.000010101299,"about_ca_system_score_gemma":0.00008752465,"threshold_uncertainty_score":0.27598915},"labels":[],"label_agreement":null},{"id":"W2520535381","doi":"10.1182/blood.v120.21.1704.1704","title":"Epigenetic Silencing of BCL2, ETS1, IL27RA and DICER1 in Low-Risk MDS Patients","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Epigenetics; Biology; DNA methylation; Gene expression profiling; Genetics; Gene; Bioinformatics; Bioconductor; Pyrosequencing; Gene expression; Computational biology; Methylation; Epigenomics","score_opus":0.004408864768362434,"score_gpt":0.21152080673815338,"score_spread":0.20711194196979094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2520535381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99574745,0.0035922437,0.000085229934,0.000006295147,0.000047515467,0.00008539712,0.000016934171,0.000002090933,0.00041687474],"genre_scores_gemma":[0.9987526,0.0008656794,0.00019883843,0.000023093537,0.00006421844,0.000015378031,0.000019939855,0.000008736212,0.00005149732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999498,0.000028295928,0.00013854346,0.0001266748,0.000059538794,0.00014896355],"domain_scores_gemma":[0.9996699,0.000006018922,0.00006605956,0.00017703198,0.000031602547,0.000049350358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009621403,0.00006585668,0.00007639577,0.000026522817,0.00002449113,0.0000040852537,0.000059735765,0.00006646698,0.000009917659],"category_scores_gemma":[0.00003785138,0.00006235316,0.00002350449,0.00005203593,0.00003378229,0.0000031632571,0.000040830786,0.00003949476,0.0000020885689],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009581337,0.000392009,0.81552833,0.0000246368,0.000021307293,1.1989088e-7,0.00022092466,0.000012751107,0.17813425,0.000016294372,0.00003035108,0.0056094187],"study_design_scores_gemma":[0.0009445328,0.000100362435,0.7153253,0.000019145042,0.00002883609,8.258645e-7,0.00007954023,0.000009221984,0.282799,0.000016952143,0.0005780131,0.00009827787],"about_ca_topic_score_codex":0.000062418265,"about_ca_topic_score_gemma":0.00002515041,"teacher_disagreement_score":0.10466476,"about_ca_system_score_codex":0.0000038699327,"about_ca_system_score_gemma":0.000017884859,"threshold_uncertainty_score":0.2542688},"labels":[],"label_agreement":null},{"id":"W2520717935","doi":"10.1182/blood.v122.21.4232.4232","title":"Characterizing The CpG Methylation Of Epstein-Barr Virus DNA In The Plasma Of Patients With Hodgkin Lymphoma and HIV-Associated Burkitt Lymphoma","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lytic cycle; CpG site; DNA methylation; Biology; Virus; Epstein–Barr virus; Virology; Lymphoma; Molecular biology; Cancer research; Immunology; Gene; Gene expression; Genetics","score_opus":0.007350961114972382,"score_gpt":0.20790945504720468,"score_spread":0.2005584939322323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2520717935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979069,0.00018275039,0.000002369506,0.0004334539,0.000031268388,0.00061402103,0.000038041766,0.000013813773,0.00077735056],"genre_scores_gemma":[0.99945295,0.000050919713,0.000023099703,0.0002877157,0.000017710456,0.00006312226,0.000053273467,0.000018926854,0.000032301275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878645,0.00013188027,0.00032908955,0.00016814636,0.00036814844,0.00021628062],"domain_scores_gemma":[0.9991149,0.00014103847,0.00035200495,0.00021875236,0.00013360853,0.00003972405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000283573,0.00014698622,0.0003208945,0.000084368694,0.000064341395,0.000018551898,0.000113947426,0.000104570114,0.000031006664],"category_scores_gemma":[0.00014055542,0.00008277355,0.000054861703,0.00034559943,0.00009703789,0.00010350887,0.000025241328,0.00006431021,0.0000035915427],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044389503,0.0023134477,0.94503075,0.00009451159,0.0004425118,0.000005270051,0.0065754093,0.0000036616261,0.024998035,0.00010270071,0.00020717538,0.019782642],"study_design_scores_gemma":[0.013997517,0.00049461157,0.9713308,0.00011997649,0.00022301557,0.0000017219708,0.0012467761,0.00008561352,0.012232078,0.00008073263,0.00008512605,0.000102039055],"about_ca_topic_score_codex":0.00074512925,"about_ca_topic_score_gemma":0.00014867028,"teacher_disagreement_score":0.026300054,"about_ca_system_score_codex":0.00005014494,"about_ca_system_score_gemma":0.00008156261,"threshold_uncertainty_score":0.33754075},"labels":[],"label_agreement":null},{"id":"W2520825437","doi":"10.1182/blood.v120.21.2895.2895","title":"An Open-Label Phase 2 Study of Lenalidomide in Combination with Oral Dexamethasone in the Previously Untreated, Symptomatic Patients with Chronic Lymphocytic Leukemia (CLL).","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Princess Margaret Cancer Centre","funders":"","keywords":"Lenalidomide; Medicine; Dexamethasone; Internal medicine; Multiple myeloma; Thalidomide; Dosing; Gastroenterology; Tumor lysis syndrome; Oncology; Pharmacology; Surgery; Chemotherapy","score_opus":0.03143025138109407,"score_gpt":0.3372177764847709,"score_spread":0.30578752510367685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2520825437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99404716,0.0003280951,0.000011746176,0.000014690116,0.000019665978,0.005365211,0.0000050781973,0.000031580832,0.00017674103],"genre_scores_gemma":[0.99901533,0.000017965902,0.00029046417,0.000058248745,0.00003295676,0.00042042314,0.000073433286,0.000059592003,0.000031559313],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9965632,0.0005998342,0.00060020975,0.00041492315,0.0010875541,0.0007342771],"domain_scores_gemma":[0.9981191,0.00029723177,0.00024172143,0.00096460956,0.00018071375,0.00019661791],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014583126,0.00031142306,0.00069941976,0.00031730576,0.00006611873,0.000066228575,0.00064885203,0.00010201575,0.00003266467],"category_scores_gemma":[0.00014415348,0.00018597623,0.000018608205,0.0011762644,0.00015584403,0.0005603706,0.00012608996,0.00028329372,0.00001231208],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.011863643,0.14709799,0.8043319,0.001285679,0.0008936596,0.00057494367,0.023207702,0.0005492682,0.00076037005,0.00012873749,0.000053005624,0.009253097],"study_design_scores_gemma":[0.8278512,0.03065464,0.1262545,0.001008787,0.00079218106,0.00021850318,0.0017942874,0.009629789,0.001427733,0.000013970049,0.000007621746,0.00034680843],"about_ca_topic_score_codex":0.009116783,"about_ca_topic_score_gemma":0.0031981273,"teacher_disagreement_score":0.8159875,"about_ca_system_score_codex":0.020805582,"about_ca_system_score_gemma":0.009105155,"threshold_uncertainty_score":0.9974816},"labels":[],"label_agreement":null},{"id":"W2521117656","doi":"10.1182/blood.v114.22.3992.3992","title":"Distribution and Clinical Signs of Venous, Arterial and Intracardiac Clots After Pediatric Cardiac Surgery.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Central Venous Catheters and Hemodialysis","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hospital for Sick Children","funders":"","keywords":"Medicine; Asymptomatic; Brachiocephalic vein; Surgery; Intracardiac injection; Vein; Population; Superior vena cava; Cardiac surgery; Cardiology; Radiology","score_opus":0.023723516703242166,"score_gpt":0.32759929603758997,"score_spread":0.3038757793343478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521117656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972534,0.0012333978,0.000033008935,0.00018548475,0.00050853845,0.00033395956,0.0003246141,0.000031294214,0.00009630931],"genre_scores_gemma":[0.9949427,0.0034009982,0.000049554466,0.00010284497,0.0013730862,0.000014852588,0.00008834717,0.000009807302,0.000017791072],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832344,0.00034750203,0.0005869502,0.00025443934,0.00013746819,0.00035017883],"domain_scores_gemma":[0.9989281,0.00045621482,0.0001887734,0.00018666094,0.00006595433,0.00017425652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007703175,0.00012510204,0.00059614616,0.000048795864,0.00017069737,0.000009462439,0.0000388304,0.00022675302,0.000033137625],"category_scores_gemma":[0.00012410381,0.00011181544,0.00020209223,0.00011542231,0.000053507054,0.000060305396,0.000037907314,0.0002489871,0.000010600378],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019168406,0.0008040734,0.98558444,0.00009586689,0.00009249557,0.000009105063,0.00058092474,5.2818184e-8,0.00027329763,0.00007292532,0.0017665364,0.010528604],"study_design_scores_gemma":[0.00071429246,0.000357633,0.9959303,0.000029104029,0.00068073923,0.0000013989293,0.0000716899,0.0000019360073,0.000041762156,0.00016433092,0.0018641851,0.00014263624],"about_ca_topic_score_codex":0.00003691582,"about_ca_topic_score_gemma":0.0000066158896,"teacher_disagreement_score":0.010385967,"about_ca_system_score_codex":0.000017999124,"about_ca_system_score_gemma":0.00010712533,"threshold_uncertainty_score":0.45597014},"labels":[],"label_agreement":null},{"id":"W2521203869","doi":"10.1182/blood.v108.11.1530.1530","title":"Platelet Tetraspanin Complexes and Their Relation to Lipid Rafts.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Tetraspanin; Cell biology; Platelet activation; Platelet; Lipid raft; Biology; CD63; Molecular biology; Signal transduction; Biochemistry; Microvesicles; Cell; Immunology","score_opus":0.009985613360356685,"score_gpt":0.22470824381417873,"score_spread":0.21472263045382203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521203869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99243784,0.00033654383,0.000052910622,0.0005200015,0.000027709184,0.00023368809,0.000015082175,0.000054085303,0.0063221203],"genre_scores_gemma":[0.9984929,0.000020919568,0.00059455365,0.0001923415,0.00007608432,0.000009029811,0.00007325276,0.000012640128,0.00052829675],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995258,0.0000083032,0.00010841618,0.00015309089,0.000067065455,0.00013733232],"domain_scores_gemma":[0.99976695,0.000027421589,0.000021935037,0.00010403606,0.0000165317,0.00006315733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000032479,0.00009825916,0.00017463895,0.00005553465,0.000052111685,0.0000128695,0.000020589452,0.000047589478,0.000033838813],"category_scores_gemma":[0.0000114722125,0.00007269666,0.000026702606,0.000086400614,0.000016990509,0.000044215358,0.000013683427,0.000052265335,0.000047315392],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049585855,0.0065064663,0.76343733,0.00016622414,0.00083106133,0.0012094926,0.0016018624,0.000039348855,0.17201017,0.0038842359,0.015655145,0.0341628],"study_design_scores_gemma":[0.01066221,0.00068760576,0.92223716,0.00009068336,0.00016139321,0.0005784925,0.000109266955,0.00008603717,0.043966543,0.0014510261,0.019722652,0.00024696017],"about_ca_topic_score_codex":0.00012359943,"about_ca_topic_score_gemma":0.00004917331,"teacher_disagreement_score":0.1587998,"about_ca_system_score_codex":0.00000815228,"about_ca_system_score_gemma":0.000010673641,"threshold_uncertainty_score":0.29644838},"labels":[],"label_agreement":null},{"id":"W2521213061","doi":"10.1182/blood.v118.21.2474.2474","title":"Identification of Lats 1 As a Putative Tumor Suppressor in HoxA9/Meis Induced Leukemia","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Hippo pathway signaling and YAP/TAZ","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Hippo signaling pathway; Biology; Leukemia; Haematopoiesis; Stem cell; Hox gene; Phenotype; Homeobox; Bone marrow; Cancer research; Transcription factor; Cell biology; Molecular biology; Genetics; Kinase; Gene; Immunology","score_opus":0.020370539223191906,"score_gpt":0.24780725889772107,"score_spread":0.22743671967452916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521213061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985698,0.00013288207,0.00004495293,0.0000053370622,0.000047397814,0.00012857134,0.000025684903,0.000011751101,0.0010336619],"genre_scores_gemma":[0.999484,0.0000071019026,0.00021251154,0.000033966917,0.0000399733,0.000027505772,0.000037862093,0.000014270325,0.00014278303],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992211,0.00006198397,0.00024563575,0.00023721125,0.00008800035,0.0001461026],"domain_scores_gemma":[0.9995354,0.000008331271,0.00011473084,0.00022982761,0.00006866472,0.000043068998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017801549,0.000096258365,0.0001263215,0.0000556094,0.000021783933,0.0000054790344,0.00013236997,0.00009859322,0.000019411895],"category_scores_gemma":[0.00011975284,0.000096220545,0.000063517604,0.00009426968,0.000037888793,0.0000036999534,0.00004023688,0.00007275346,0.000022736342],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042455726,0.00018993815,0.0020385357,0.000016524726,0.00003849396,0.000008464484,0.0007797224,0.0000037202155,0.9967301,0.00005969325,0.0000081202215,0.00008424237],"study_design_scores_gemma":[0.00079577265,0.00022209882,0.010480492,0.000015413008,0.00002784824,0.000008440386,0.00015052548,0.000016433949,0.987884,0.00023065064,0.00005972918,0.00010862438],"about_ca_topic_score_codex":0.00015362684,"about_ca_topic_score_gemma":0.00002445638,"teacher_disagreement_score":0.008846118,"about_ca_system_score_codex":0.00000766994,"about_ca_system_score_gemma":0.00011209596,"threshold_uncertainty_score":0.392376},"labels":[],"label_agreement":null},{"id":"W252126222","doi":"10.1182/blood.v96.1.259","title":"Overexpression of murine fizzy-related (fzr) increases natural killer cell–mediated cell death and suppresses tumor growth","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; University of Toronto","keywords":"Biology; Carcinogenesis; Suppression subtractive hybridization; Lymphoma; Cancer research; Natural killer cell; Cell culture; Cell growth; Cell; Cytotoxicity; Molecular biology; Gene; Immunology; Gene expression; Genetics; In vitro","score_opus":0.004247003367025644,"score_gpt":0.19399411470632769,"score_spread":0.18974711133930205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W252126222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909869,0.0034818768,6.809513e-7,0.000015805157,0.000040299998,0.00019687234,0.000077932425,0.000022494427,0.0051771463],"genre_scores_gemma":[0.9971757,0.0005838448,0.0002975662,0.0000842732,0.00007406131,0.000015409443,0.00029072442,0.000025051517,0.001453385],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99903774,0.000074263146,0.00022404132,0.00031129178,0.00012387944,0.00022875878],"domain_scores_gemma":[0.99949247,0.000034836892,0.00008845981,0.00022901915,0.00004988375,0.00010534021],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006916996,0.00018758162,0.00018341497,0.000035020043,0.000060381823,0.0000140569655,0.00014202292,0.00013118608,0.0004788362],"category_scores_gemma":[0.00005525055,0.00015946245,0.000066670436,0.00006762641,0.00006474568,0.000006620828,0.00009712589,0.00011290778,0.000012875977],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000120384735,0.0004938655,0.008592305,0.0001128095,0.000031407228,0.000011484257,0.00003644,0.0000016505967,0.9898355,0.000008611633,0.00065944775,0.0000960833],"study_design_scores_gemma":[0.002426191,0.00029363032,0.0067625227,0.000060509687,0.000046396824,0.000034336874,0.000011614065,0.000017171886,0.9878531,0.000052992506,0.0022331409,0.00020840486],"about_ca_topic_score_codex":0.00010915096,"about_ca_topic_score_gemma":0.0000031490413,"teacher_disagreement_score":0.0061887926,"about_ca_system_score_codex":0.0000022936215,"about_ca_system_score_gemma":0.00003877802,"threshold_uncertainty_score":0.650269},"labels":[],"label_agreement":null},{"id":"W2521417224","doi":"10.1182/blood.v126.23.1061.1061","title":"Value of Platelet Esoteric Testing in Laboratory Diagnosis of Platelet Disorders: A Single Center Experience","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Platelet; Platelet disorder; Internal medicine; Retrospective cohort study; Blood Platelet Disorders; Gastroenterology; Surgery","score_opus":0.0286595503250018,"score_gpt":0.2645101748588025,"score_spread":0.2358506245338007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521417224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99737006,0.00087568816,0.0000053740587,0.00006678892,0.000057693756,0.00028818063,0.00006236881,0.000026328355,0.0012474877],"genre_scores_gemma":[0.9982331,0.00006326832,0.0015131157,0.0000649742,0.000017201539,0.00005179459,0.000023838558,0.000022136806,0.000010616942],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988556,0.000036814414,0.00037154093,0.00023396731,0.00024744077,0.0002546563],"domain_scores_gemma":[0.99930125,0.0000963378,0.00015290405,0.00023677184,0.000095942305,0.00011681338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001005074,0.00016167593,0.0004437734,0.00013695734,0.000015947622,0.0000060787543,0.000093600116,0.000085225605,0.000018633616],"category_scores_gemma":[0.0003200548,0.00014313788,0.000049748935,0.0004933646,0.000086720815,0.00010992247,0.000049196275,0.00009263545,0.0000064575106],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011298795,0.006250083,0.9822469,0.000111013374,0.0000928211,0.00053407124,0.0025206448,0.00001890254,0.004213198,0.000011077861,0.000077715034,0.003810619],"study_design_scores_gemma":[0.09117748,0.009249221,0.3199388,0.0033204851,0.0004947269,0.00084101816,0.006972962,0.00062549877,0.56086606,0.001146883,0.0040300232,0.0013368308],"about_ca_topic_score_codex":0.0002567337,"about_ca_topic_score_gemma":0.000045352146,"teacher_disagreement_score":0.6623081,"about_ca_system_score_codex":0.00003086189,"about_ca_system_score_gemma":0.000090103924,"threshold_uncertainty_score":0.58369935},"labels":[],"label_agreement":null},{"id":"W2521453944","doi":"10.1182/blood.v120.21.3689.3689","title":"Long-Term Survival Analyses of an Ongoing Phase 2 Study of Brentuximab Vedotin in Patients with Relapsed or Refractory Hodgkin Lymphoma","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Brentuximab vedotin; Medicine; Internal medicine; Oncology; CD30; Population; Refractory (planetary science); Phases of clinical research; Lymphoma; Surgery; Chemotherapy","score_opus":0.040776685882515824,"score_gpt":0.33981409046630995,"score_spread":0.29903740458379413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521453944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989159,0.00021430696,8.3360334e-7,0.0000036165868,0.00006435998,0.0006629813,0.00002050626,0.00001753897,0.00009992681],"genre_scores_gemma":[0.9996444,0.000011407595,0.00014001159,0.000010138031,0.000044688535,0.000033620643,0.0000751403,0.000026243366,0.000014349445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845517,0.00013357386,0.00045566537,0.00024180482,0.00044937886,0.00026439477],"domain_scores_gemma":[0.9989191,0.00010322662,0.00027112316,0.00045268342,0.00010166437,0.00015215247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017393219,0.00019541151,0.000594492,0.00020041532,0.000026225365,0.0000060920033,0.00008336918,0.00005790126,0.000052328767],"category_scores_gemma":[0.000057346046,0.00012706126,0.000059685666,0.00029510853,0.00004013717,0.00016546206,0.00003558231,0.000044345685,0.0000026979571],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019988217,0.16921872,0.8176461,0.00006399896,0.00049910444,0.000083270555,0.0009710824,7.539295e-7,0.0003762365,0.0000010746545,0.0000017619989,0.009139071],"study_design_scores_gemma":[0.10590732,0.012085193,0.8697584,0.00018249545,0.0010323445,0.000006079696,0.00034866817,0.0000017450094,0.010563587,1.9949022e-7,0.0000020504172,0.00011187686],"about_ca_topic_score_codex":0.00047089375,"about_ca_topic_score_gemma":0.00026340384,"teacher_disagreement_score":0.15713352,"about_ca_system_score_codex":0.000079209334,"about_ca_system_score_gemma":0.00010506047,"threshold_uncertainty_score":0.5181408},"labels":[],"label_agreement":null},{"id":"W2521495368","doi":"10.1182/blood.v124.21.2801.2801","title":"Alternatively Spliced Tissue Factor As a New Therapeutic Target in Pancreatic Cancer","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal Children's Hospital","funders":"","keywords":"Pancreatic cancer; Cancer research; In vivo; Biology; Monoclonal antibody; Cancer; Pathology; Molecular biology; Antibody; Immunology; Medicine","score_opus":0.030311414718957156,"score_gpt":0.34376200763045006,"score_spread":0.3134505929114929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521495368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990103,0.0010857106,0.00029264367,0.0015442255,0.00004371034,0.00047902472,0.0000038182525,0.00004027927,0.006407581],"genre_scores_gemma":[0.9857632,0.0001900841,0.0007916487,0.0009896272,0.0002089357,0.000045695,0.000006197396,0.000036115423,0.01196848],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987553,0.00008277857,0.00018349683,0.00027685633,0.00038309966,0.0003184803],"domain_scores_gemma":[0.99923104,0.00010811311,0.000043701097,0.00027676768,0.000048573827,0.00029182053],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00010198264,0.00013866738,0.0002809786,0.000138279,0.000022579621,0.000018511613,0.00014007236,0.00006736948,0.00230893],"category_scores_gemma":[0.00022562293,0.00011299096,0.000044488257,0.00021684008,0.000029914348,0.000033179196,0.000046497877,0.00022242624,0.000430341],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017620453,0.00057699514,0.11465578,0.000115443356,0.00015276519,0.00013647966,0.0007339103,0.000004781876,0.8531263,0.00024096669,0.000451566,0.02962882],"study_design_scores_gemma":[0.009740707,0.00093944144,0.27916604,0.00024894514,0.00012357316,0.00004730639,0.000052263895,0.00042951078,0.6565826,0.0010071286,0.051372275,0.00029021595],"about_ca_topic_score_codex":0.0021447353,"about_ca_topic_score_gemma":0.00011789276,"teacher_disagreement_score":0.1965437,"about_ca_system_score_codex":0.000053441752,"about_ca_system_score_gemma":0.00028190276,"threshold_uncertainty_score":0.9986031},"labels":[],"label_agreement":null},{"id":"W2521534522","doi":"10.1182/blood.v126.23.4391.4391","title":"Donor Lymphocytes Depleted of Alloreactive T-Cells (ATIR101) Reduce Transplant Related Mortality and Improve Overall Survival in Haploidentical HSCT for Patients with AML and ALL, Using an Immunosuppressant-Free Transplant Regimen","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Hospital; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Hematopoietic stem cell transplantation; Graft-versus-host disease; Transplantation; Stem cell; Internal medicine; Regimen; Immunology; Biology","score_opus":0.03614941222380575,"score_gpt":0.2759380653512358,"score_spread":0.23978865312743003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521534522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974246,0.0001502378,0.0002711149,0.000031258867,0.00008127146,0.0014559992,0.00046219828,0.000033361164,0.0000899405],"genre_scores_gemma":[0.9969911,0.00009607067,0.0024636008,0.000017258908,0.000018931836,0.000034996334,0.00032225624,0.000048255,0.0000075599037],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980369,0.00012375209,0.0005922803,0.0004902375,0.00041333088,0.0003435073],"domain_scores_gemma":[0.99879843,0.00021731993,0.00017908914,0.00038281715,0.00016442916,0.00025789364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041070403,0.0002845415,0.0006186643,0.000118376745,0.000035543144,0.000023032753,0.00011837031,0.0001924062,0.0000032894293],"category_scores_gemma":[0.00004447263,0.00023776192,0.000052841424,0.0000990728,0.00016824032,0.00026376313,0.00001545398,0.00014722339,2.2580801e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008545022,0.0033858551,0.4812494,0.0012823762,0.0013455899,0.00015926913,0.012518771,0.000017176837,0.49119687,0.00018842996,0.0000045653765,0.000106688494],"study_design_scores_gemma":[0.09637695,0.0035761257,0.48441586,0.0014006316,0.0045006047,0.00026489267,0.00068423257,0.0027780507,0.40488672,0.00044805923,0.000005606472,0.0006622671],"about_ca_topic_score_codex":0.0009783062,"about_ca_topic_score_gemma":0.00014455881,"teacher_disagreement_score":0.08783192,"about_ca_system_score_codex":0.000059943883,"about_ca_system_score_gemma":0.00017730969,"threshold_uncertainty_score":0.96956503},"labels":[],"label_agreement":null},{"id":"W2521639558","doi":"10.1182/blood.v126.23.2807.2807","title":"Demographics, Baseline Characteristics, and Disease Symptom Burden in RESPONSE-2: A Randomized, Phase 3 Study of Ruxolitinib in Polycythemia Vera Patients (pts) Who Are Resistant to or Intolerant of Hydroxyurea (HU)","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Ruxolitinib; Internal medicine; Polycythemia vera; Phlebotomy; Myeloproliferative neoplasm; Thrombocytosis; Quality of life (healthcare); Anemia; Gastroenterology; Myelofibrosis; Bone marrow; Platelet","score_opus":0.01898396108697531,"score_gpt":0.2917810544879017,"score_spread":0.2727970934009264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521639558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955179,0.00038923402,0.0000039876786,0.0006783318,0.000041066734,0.0029539396,0.0003844959,0.000012807073,0.000018210627],"genre_scores_gemma":[0.99909174,0.00011552237,0.00012541962,0.00013369264,0.00005083254,0.00034333477,0.00006998181,0.000028813565,0.000040645544],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9971128,0.00062602916,0.0010602265,0.00043504976,0.00049102266,0.00027488574],"domain_scores_gemma":[0.99762404,0.0007561971,0.00032512334,0.0004073478,0.00032577344,0.00056151743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012304748,0.00029165865,0.0014753793,0.00053486606,0.000025558682,0.000014330919,0.00009203064,0.00007350535,0.00001917349],"category_scores_gemma":[0.004747206,0.00021005179,0.00009062262,0.00041130555,0.00010225004,0.000054626023,0.00007795531,0.00014897429,0.0000015239798],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37122294,0.014619262,0.6084457,0.00013491856,0.0002135184,0.00040058405,0.0043008174,0.0000021820274,0.0001525545,0.000014352988,0.00004684242,0.00044633736],"study_design_scores_gemma":[0.49897742,0.0044455864,0.4920691,0.0016078755,0.0006364862,0.0000035339604,0.001153111,0.00017504409,0.000629215,0.000025758676,0.00007061372,0.00020626013],"about_ca_topic_score_codex":0.00043862744,"about_ca_topic_score_gemma":0.00027642451,"teacher_disagreement_score":0.12775448,"about_ca_system_score_codex":0.000064376276,"about_ca_system_score_gemma":0.00027906866,"threshold_uncertainty_score":0.85656637},"labels":[],"label_agreement":null},{"id":"W2521713921","doi":"10.1182/blood.v124.21.3925.3925","title":"The NIH Chronic Gvhd Global Score and the CIBMTR Risk Score Correlate Well with Failure Free Survival Following Frontline Systemic Corticosteroid Therapy for Chronic Gvhd","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Systemic therapy; Internal medicine; Clinical endpoint; Oncology; Cancer; Clinical trial; Breast cancer","score_opus":0.008749267901323533,"score_gpt":0.2331503457347054,"score_spread":0.22440107783338187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521713921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9266885,0.067135915,0.00037922905,0.0013154978,0.0007727859,0.0025654477,0.00007412743,0.00008477424,0.0009837381],"genre_scores_gemma":[0.99519193,0.0032492212,0.000065024906,0.00011420396,0.00059877185,0.000391168,0.000021595211,0.000046689103,0.00032140914],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980882,0.0001427588,0.0003682227,0.00047708512,0.00039204364,0.00053168857],"domain_scores_gemma":[0.998353,0.00047133566,0.000246805,0.00070242083,0.00011275326,0.000113672526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005215568,0.00038426512,0.00068953075,0.000022385224,0.0007770206,0.000099360805,0.000254095,0.00010483206,0.00002030915],"category_scores_gemma":[0.00012768003,0.00017491757,0.0002452143,0.00015699434,0.0003178168,0.00006306519,0.00011700641,0.00024870742,0.0000070682995],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010413528,0.0007672247,0.85412216,0.00058033015,0.011077327,0.00010741395,0.0015931667,0.00009303169,0.0003277714,0.0014710636,0.0024637948,0.11698321],"study_design_scores_gemma":[0.2814322,0.021216718,0.6546973,0.0013739367,0.010298013,0.0005152256,0.0019450365,0.0023769485,0.0006530384,0.0013433797,0.022868592,0.001279579],"about_ca_topic_score_codex":0.00032363515,"about_ca_topic_score_gemma":0.005138968,"teacher_disagreement_score":0.27101868,"about_ca_system_score_codex":0.00027899368,"about_ca_system_score_gemma":0.00023377765,"threshold_uncertainty_score":0.7132932},"labels":[],"label_agreement":null},{"id":"W2521817506","doi":"10.1182/blood.v104.11.697.697","title":"High Cyclin D1 Expression Is Associated with Increased Proliferation Rate and Decreased Survival in Mantle Cell Lymphoma (MCL) and Is Caused by Genomic Deletions and Mutations that Enhance Stability of Cyclin D1 mRNA.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Alberta","funders":"","keywords":"Cyclin D1; Biology; Molecular biology; Mantle cell lymphoma; Cell growth; Gene; Untranslated region; Gene expression; Cyclin; Cancer research; Cyclin D; Messenger RNA; Genetics; Cell cycle; Lymphoma; Immunology","score_opus":0.010036719467475015,"score_gpt":0.22856251152927282,"score_spread":0.2185257920617978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521817506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976995,0.0007263511,0.00003117075,0.00034498918,0.000019673265,0.0008061116,0.00031725073,0.000025657253,0.00002932205],"genre_scores_gemma":[0.9985717,0.00041582625,0.00042954812,0.00013557727,0.000010164079,0.000114776194,0.00028348455,0.00002122524,0.000017702896],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873066,0.00013681776,0.00032844816,0.0004129681,0.00019027466,0.00020085984],"domain_scores_gemma":[0.999137,0.0002334501,0.0001891218,0.0002072478,0.00008256354,0.00015062184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023346774,0.00020861362,0.00040289832,0.000081192906,0.0001165985,0.000032003085,0.000031616368,0.00011913134,0.00002271417],"category_scores_gemma":[0.00007924035,0.00016963194,0.000030567564,0.00013901027,0.000114208204,0.00011003006,0.000027416902,0.00005566972,0.0000012385904],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025603297,0.0047659893,0.7984774,0.00009033933,0.00014552764,0.000029701803,0.0011697469,0.000003597961,0.19482416,0.000007797393,0.000024115705,0.0002056032],"study_design_scores_gemma":[0.016849894,0.00023517966,0.5296884,0.00014830376,0.00025865546,0.0000055907176,0.00011581077,0.00003502032,0.4524873,0.0000682378,0.000004121967,0.000103488936],"about_ca_topic_score_codex":0.0018068333,"about_ca_topic_score_gemma":0.0007093069,"teacher_disagreement_score":0.268789,"about_ca_system_score_codex":0.00012701984,"about_ca_system_score_gemma":0.00019092303,"threshold_uncertainty_score":0.69173896},"labels":[],"label_agreement":null},{"id":"W2521870844","doi":"10.1182/blood.v116.21.3648.3648","title":"Modeling Human T Cell Acute Lymphoblastic Leukemia In Vitro and In Vivo with LMO2.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and Retrovirus Studies","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; University of Toronto","funders":"","keywords":"Biology; Severe combined immunodeficiency; Progenitor cell; Haematopoiesis; Cancer research; Stem cell; T cell; CD8; In vivo; Cell culture; Leukemia; Genetic enhancement; Immunology; Molecular biology; Cell biology; Gene; Genetics; Antigen; Immune system","score_opus":0.005501561584467737,"score_gpt":0.1969258262815446,"score_spread":0.19142426469707685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521870844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974134,0.0007753233,0.0000118040225,0.000013918707,0.00011026961,0.000093385985,0.000010184347,0.000024180523,0.0015475628],"genre_scores_gemma":[0.99894375,0.00005737775,0.00009964901,0.00003144484,0.000017775998,0.000013038249,0.0000061106284,0.000011825022,0.0008190041],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99930847,0.00002587524,0.00015182742,0.00022373341,0.000017467217,0.00027262428],"domain_scores_gemma":[0.99979216,0.00002853853,0.00002847491,0.00012355954,0.000013872446,0.000013416123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006834816,0.00013273793,0.00021226365,0.00010056245,0.000104138606,0.0000079526235,0.00008607875,0.00016198099,0.000027849774],"category_scores_gemma":[0.0000058918,0.00009863652,0.000019376495,0.00007473763,0.00012223875,0.00003729116,0.00007069632,0.000310089,0.000021624675],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000107555374,0.00012214582,0.0051251845,0.0000133063995,0.00004816283,0.000027766127,0.0004296565,0.000058947553,0.9939728,0.00002637065,0.000013998281,0.000054118183],"study_design_scores_gemma":[0.008940446,0.00018466968,0.0018983593,0.000035886056,0.000117704316,0.00010964446,0.0002651378,0.00023503753,0.98752505,0.00010180889,0.00029513598,0.0002911391],"about_ca_topic_score_codex":0.00054254534,"about_ca_topic_score_gemma":0.0015979208,"teacher_disagreement_score":0.008832891,"about_ca_system_score_codex":0.000019955849,"about_ca_system_score_gemma":0.000047500987,"threshold_uncertainty_score":0.40222806},"labels":[],"label_agreement":null},{"id":"W2521924495","doi":"10.1182/blood.v118.21.707.707","title":"International Consortium for the Study of Clinical and Molecular Aspects of Bernard-Soulier Syndrome","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Bernard–Soulier syndrome; Von Willebrand disease; Von Willebrand factor; Genetics; Mutation; Blood Platelet Disorders; Platelet disorder; Medicine; Genotype; Ristocetin; Hemostasis; Disease; Molecular genetics; Biology; Internal medicine; Platelet; Gene","score_opus":0.04606035086492447,"score_gpt":0.32698847842364515,"score_spread":0.28092812755872065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521924495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955687,0.0001735982,0.000023438648,0.00007420517,0.00006824427,0.0004503286,0.000011088458,0.000004146241,0.0036262702],"genre_scores_gemma":[0.99957955,0.000038225517,0.0002609041,0.000035571597,0.000008771597,0.00001657744,0.0000024533047,0.0000060660964,0.000051894454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99950457,0.000013484016,0.00022411036,0.00009894012,0.00010430077,0.00005458525],"domain_scores_gemma":[0.9996389,0.00006840583,0.000085794556,0.00012588502,0.000052061536,0.000028962575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011288237,0.000049040853,0.00021617519,0.000021310261,0.000012250113,0.0000013364822,0.000051617742,0.000028125001,0.000035834088],"category_scores_gemma":[0.00007381179,0.000030724983,0.000055318298,0.000023961076,0.0000652238,0.000012117273,0.000023973545,0.000038654995,0.0000010075],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046839862,0.012139072,0.9786394,0.00003783743,0.003571826,0.0006906835,0.0007295617,2.1326078e-7,0.00041484475,0.0010827824,0.00004437887,0.0021809537],"study_design_scores_gemma":[0.016768508,0.0029242516,0.97388,0.000027844151,0.0012209922,0.00023418447,0.0005040383,0.00002152304,0.0034904324,0.00067477854,0.00020198089,0.000051450872],"about_ca_topic_score_codex":0.0000452911,"about_ca_topic_score_gemma":0.0000062941244,"teacher_disagreement_score":0.01630011,"about_ca_system_score_codex":0.0000010189577,"about_ca_system_score_gemma":0.000017151318,"threshold_uncertainty_score":0.12529284},"labels":[],"label_agreement":null},{"id":"W2521958344","doi":"10.1182/blood.v120.21.1025.1025","title":"Innate Immune Cell Expression of Pattern Recognition Receptors From β-Thalassemia Patients During Intensive Combination Chelation Therapy","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"","keywords":"Innate immune system; CD14; Thalassemia; Immunology; Deferasirox; Medicine; Pattern recognition receptor; Immune system; Deferoxamine; Internal medicine","score_opus":0.009435918729792938,"score_gpt":0.2136112797562899,"score_spread":0.20417536102649697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521958344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99773955,0.0008752957,0.000028091195,0.00006347348,0.00038626825,0.00036918375,0.000013485692,0.000038448903,0.00048618513],"genre_scores_gemma":[0.9984613,0.0006373436,0.00009156579,0.00005669521,0.000059929967,0.00001309484,0.00061346526,0.000024306011,0.000042313317],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99909335,0.000060024766,0.00031797134,0.00014241406,0.00020685286,0.00017935365],"domain_scores_gemma":[0.999197,0.000030953877,0.0002373998,0.00014951595,0.00031338842,0.0000717465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000085413085,0.00012611327,0.00019741232,0.00009614169,0.000055048975,0.0000050245617,0.000038391143,0.0001869302,0.0001553098],"category_scores_gemma":[0.0000689253,0.00010501487,0.000071880146,0.00012549713,0.000024731251,0.00017588717,0.000025336367,0.00018473348,0.00004061438],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015494149,0.0018967113,0.5221461,0.00006435956,0.0000526446,0.0000011253971,0.0026227718,6.2814587e-7,0.4586932,2.5166844e-7,0.000060691364,0.014306552],"study_design_scores_gemma":[0.0063607907,0.0001572931,0.3925845,0.00025164243,0.00006296899,0.0000011337584,0.00048338276,0.000008514982,0.5999545,0.000020725118,0.000029601546,0.0000849968],"about_ca_topic_score_codex":0.00008177856,"about_ca_topic_score_gemma":3.6278493e-7,"teacher_disagreement_score":0.14126125,"about_ca_system_score_codex":0.000028570368,"about_ca_system_score_gemma":0.0000119074375,"threshold_uncertainty_score":0.4282382},"labels":[],"label_agreement":null},{"id":"W2521962771","doi":"10.1182/blood.v108.11.193.193","title":"Factor V Binding to Multimerin 1: Modulation by Factor V Activation and Binding Sites in the Factor V C1 and C2 Domains.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Factor V; Binding site; Plasma protein binding; C2 domain; Biophysics; Factor IXa; Chemistry; Factor X; Tissue factor; Binding domain; Prothrombinase; Factor H; Thrombin; Biology; Platelet; Biochemistry; Complement system; Coagulation; Immunology; Internal medicine","score_opus":0.026642697460130847,"score_gpt":0.2689068344234853,"score_spread":0.24226413696335444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521962771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978771,0.00004397576,0.00071943225,0.0005031867,0.000040181298,0.00062327547,0.0000552793,0.000057041656,0.00008047827],"genre_scores_gemma":[0.99845195,0.000010757998,0.0010654249,0.00016731482,0.00007921783,0.000021993654,0.0000905728,0.000023166764,0.00008957834],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99893105,0.000054826232,0.00024595152,0.00029276215,0.00025992267,0.00021548863],"domain_scores_gemma":[0.99953663,0.00011917387,0.000086654574,0.00015841116,0.000029013832,0.000070085036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009867168,0.00017747069,0.00022147849,0.00020752737,0.00012301223,0.00007781735,0.00005051172,0.000111794885,0.000054553468],"category_scores_gemma":[0.00006596684,0.00013651908,0.000030991636,0.00026282383,0.000021367414,0.00018456698,0.00002948411,0.00013124982,0.000009851107],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001701665,0.00020595746,0.12036112,0.000024544695,0.00002327157,0.0000017030798,0.0007898934,0.0000023925663,0.87619853,0.00016638903,0.000033436892,0.0021757525],"study_design_scores_gemma":[0.0025809389,0.00015100402,0.7438008,0.00006361535,0.00003950105,0.000009002146,0.00022545869,0.00044148113,0.25219962,0.00007905629,0.00022734409,0.00018215671],"about_ca_topic_score_codex":0.00010023896,"about_ca_topic_score_gemma":0.000028491653,"teacher_disagreement_score":0.6239989,"about_ca_system_score_codex":0.000030481984,"about_ca_system_score_gemma":0.000012615109,"threshold_uncertainty_score":0.5567087},"labels":[],"label_agreement":null},{"id":"W2521999181","doi":"10.1182/blood.v112.11.1723.1723","title":"Phase I-II Trial of Oral Cyclophosphamide, Prednisone and Lenalidomide (Revlimid®) (CPR) for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Lenalidomide; Medicine; Thalidomide; Regimen; Multiple myeloma; Internal medicine; Cyclophosphamide; Prednisone; Gastroenterology; Surgery; Bortezomib; Transplantation; Chemotherapy","score_opus":0.030984845810534366,"score_gpt":0.2908620072020939,"score_spread":0.25987716139155953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521999181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943962,0.0020502368,0.000014384688,0.00006474552,0.000036369904,0.0031719725,0.00020724171,0.000015826143,0.00004301578],"genre_scores_gemma":[0.9954827,0.0022683963,0.0015560945,0.000010382555,0.00004500902,0.00023702663,0.00010114953,0.000026483372,0.0002727485],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9987644,0.000044054446,0.0003402386,0.0002731521,0.00032129415,0.0002568446],"domain_scores_gemma":[0.9987454,0.00041432912,0.0001819154,0.0003252942,0.00016290195,0.00017018752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009622073,0.00020239597,0.0005076481,0.00007372665,0.00017974188,0.0000042464244,0.00005157829,0.00007056254,0.000010938053],"category_scores_gemma":[0.00018340799,0.00011118258,0.00009291266,0.00009928082,0.0002854234,0.00006404576,0.000021801461,0.00005737709,4.322128e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.39594933,0.06742818,0.47004098,0.0002523112,0.0027053591,0.00008263853,0.0017566477,0.0000017588465,0.0024313894,0.0000087014305,0.00013706076,0.05920565],"study_design_scores_gemma":[0.68352294,0.064772144,0.22953044,0.000067153815,0.0007336785,0.000015823363,0.000050019804,0.00009050344,0.019672586,0.0000069607977,0.0014244741,0.00011328709],"about_ca_topic_score_codex":0.0002004919,"about_ca_topic_score_gemma":0.00003738411,"teacher_disagreement_score":0.2875736,"about_ca_system_score_codex":0.000029219385,"about_ca_system_score_gemma":0.00010397213,"threshold_uncertainty_score":0.4533894},"labels":[],"label_agreement":null},{"id":"W2522008311","doi":"10.1182/blood.v124.21.2885.2885","title":"Systematic Review of Cases of Transfusion Associated Graft-Versus-Host-Disease (TA-GVHD): Analysis of Patient Characteristics and Outcomes","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Blood donation and transfusion practices","field":"Business, Management and Accounting","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children; University of Toronto; University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Pancytopenia; Rash; Graft-versus-host disease; Complication; Disease; Blood transfusion; Internal medicine; Immunology; Surgery; Pediatrics; Bone marrow","score_opus":0.012862799983921352,"score_gpt":0.23891351811598074,"score_spread":0.2260507181320594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2522008311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960292,0.0022727973,0.00003469408,0.0002575295,0.00010851789,0.0005174299,0.00006674613,0.000027338781,0.00068572455],"genre_scores_gemma":[0.99781287,0.0016604265,0.000025669058,0.00037564244,0.000011392208,0.0000151279155,0.000078862584,0.000010608731,0.000009408885],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.9983815,0.00007717211,0.00086811336,0.00017001023,0.00040262213,0.0001005717],"domain_scores_gemma":[0.9976708,0.0004780021,0.0011742904,0.00024654507,0.0004083711,0.000021982685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005773965,0.00014447948,0.00091674615,0.0003381598,0.000048696995,0.000022993936,0.00010975511,0.000043002226,0.000215521],"category_scores_gemma":[0.002200254,0.00011442264,0.00025232558,0.0007564449,0.000042746644,0.00029926296,0.000034656146,0.000052542717,0.0000023779435],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002653838,0.005073567,0.31045526,0.66436666,0.009200454,0.000022865115,0.00027970746,0.000005919801,0.0006005867,0.008302876,0.000047390382,0.001379317],"study_design_scores_gemma":[0.0075566634,0.00023193542,0.79739815,0.040402036,0.15058249,0.0000017601419,0.00047016414,0.0016312486,0.00061395764,0.0001012002,0.00028504024,0.00072537846],"about_ca_topic_score_codex":0.00017640388,"about_ca_topic_score_gemma":0.00006933067,"teacher_disagreement_score":0.6239646,"about_ca_system_score_codex":0.00000346375,"about_ca_system_score_gemma":0.000012677502,"threshold_uncertainty_score":0.466602},"labels":[],"label_agreement":null},{"id":"W2522067962","doi":"10.1182/blood.v110.11.643.643","title":"90Y-Ibritumomab Tiuxetan (Zevalin®) Consolidation of First Remission in Advanced Stage Follicular Non-Hodgkin’s Lymphoma: First Results of the International Randomized Phase 3 First-Line Indolent Trial (FIT) in 414 Patients.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Ibritumomab tiuxetan; Internal medicine; Follicular lymphoma; Tolerability; Clinical endpoint; Gastroenterology; Radioimmunotherapy; Surrogate endpoint; Rituximab; Neutropenia; Surgery; Lymphoma; Randomized controlled trial; Chemotherapy; Adverse effect; Immunology","score_opus":0.015682039471903168,"score_gpt":0.2934166943824472,"score_spread":0.27773465491054405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2522067962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99480677,0.00024266858,0.00002024382,0.00057807943,0.00039582574,0.0030715114,0.00015702976,0.0000149836,0.00071288965],"genre_scores_gemma":[0.9986982,0.0003535892,0.0002819879,0.00005232693,0.00009123031,0.00014969474,0.0002762817,0.000022890028,0.000073815245],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9968379,0.00010505602,0.0016336708,0.00041158244,0.00073286827,0.00027891496],"domain_scores_gemma":[0.99768174,0.0007090544,0.0007989905,0.0004825097,0.00022174674,0.00010597017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011442221,0.000263997,0.0009229485,0.00028848078,0.000059618276,0.00001161439,0.00021095233,0.00015570769,0.000036089317],"category_scores_gemma":[0.0014572737,0.0001835062,0.0003258129,0.0003884025,0.00010797705,0.00010338586,0.000105193154,0.00009588954,0.0000024461115],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8337946,0.044193886,0.1121756,0.00026046915,0.00046342908,0.00018605635,0.0016834725,0.00028822426,0.0008586957,0.000059419403,0.00017112325,0.00586505],"study_design_scores_gemma":[0.8643401,0.00095400086,0.0419708,0.0011262381,0.00025504126,0.0000059444224,0.00008059467,0.00060868805,0.089234926,0.000017395567,0.0012615033,0.00014472904],"about_ca_topic_score_codex":0.0006083686,"about_ca_topic_score_gemma":0.0011774164,"teacher_disagreement_score":0.08837623,"about_ca_system_score_codex":0.00034621183,"about_ca_system_score_gemma":0.00015945014,"threshold_uncertainty_score":0.7483166},"labels":[],"label_agreement":null},{"id":"W2522080444","doi":"10.1182/blood.v106.11.2268.2268","title":"Genetic Interaction between SCL and c-Kit in Hematopoietic Cell Survival.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Biology; Progenitor cell; Stem cell factor; Haematopoiesis; Proto-Oncogene Proteins c-kit; Stem cell; Multipotent Stem Cell; Cell biology; Bone marrow; Cancer research; Molecular biology; Immunology","score_opus":0.02745427906386119,"score_gpt":0.3062629249647209,"score_spread":0.27880864590085974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2522080444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98823035,0.0011122352,0.0000086330065,0.0013676118,0.000029529265,0.00015065353,0.0000041223675,0.00001599092,0.009080854],"genre_scores_gemma":[0.9961712,0.00030731436,0.0007505282,0.00010253217,0.00035837683,0.0000069146786,0.000008197909,0.000012028453,0.0022829403],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991899,0.000034396002,0.00018586522,0.00017893752,0.00019880876,0.0002120513],"domain_scores_gemma":[0.99962044,0.00008897269,0.000025217783,0.000115728275,0.0000260573,0.00012359285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011446749,0.00009241953,0.00019432692,0.000103646016,0.000031893687,0.000014596189,0.000048923674,0.00005474993,0.00018606347],"category_scores_gemma":[0.000018660443,0.00007738632,0.00003683099,0.00010543527,0.000041508953,0.00004303351,0.000051924824,0.00020391936,0.00014069158],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006354875,0.00042546095,0.9783528,0.00020601768,0.000034092096,0.00007281773,0.00027870556,0.00000230849,0.0077368114,0.00003938842,0.00019757888,0.012590458],"study_design_scores_gemma":[0.002561258,0.00023922777,0.9555196,0.000112794085,0.00007468935,0.00012221716,0.00011105202,0.00008505407,0.023893692,0.000100419325,0.017036473,0.00014350914],"about_ca_topic_score_codex":0.0001401309,"about_ca_topic_score_gemma":0.000065957785,"teacher_disagreement_score":0.022833198,"about_ca_system_score_codex":0.000014824357,"about_ca_system_score_gemma":0.000027259528,"threshold_uncertainty_score":0.31557226},"labels":[],"label_agreement":null},{"id":"W2522083057","doi":"10.1182/blood.v118.21.4192.4192","title":"Long-Term Oral Anticoagulant Management Associated with Routine Medical Care (RMC) In Patients with Non-Valvular Atrial Fibrillation (NVAF) In Canada,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; University Health Network; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Atrial fibrillation; Warfarin; Prospective cohort study; Cohort; Anticoagulant; Quality of life (healthcare); valvular heart disease; Emergency medicine; Internal medicine; Pediatrics; Intensive care medicine","score_opus":0.022158590529653042,"score_gpt":0.2481316370751703,"score_spread":0.22597304654551725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2522083057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99759287,0.000058731755,0.000028389231,0.00011125957,0.00011388951,0.0010760375,0.0000070223514,0.000028426293,0.0009834035],"genre_scores_gemma":[0.99915045,0.000015433287,0.00019574245,0.000057727888,0.00015733133,0.0000020635634,0.000288004,0.000028475513,0.00010479187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979682,0.00006094032,0.0004176229,0.000311946,0.0008933861,0.0003478873],"domain_scores_gemma":[0.9993656,0.00003285021,0.00015319852,0.00022608643,0.00008656042,0.0001356775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018927798,0.00021106495,0.00045751655,0.00020207651,0.000037866466,0.000011782144,0.0000923367,0.000089086556,0.00014267223],"category_scores_gemma":[0.00005936245,0.00015750127,0.0000617199,0.00042237973,0.000028044362,0.00009103958,0.00006474595,0.00012985742,0.000004856716],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008103239,0.00004089849,0.9968739,0.000079988,0.00028909487,0.00042646338,0.00026483455,0.00005068215,4.2356206e-7,0.000020612479,0.000015490366,0.0011272983],"study_design_scores_gemma":[0.026188908,0.00037646331,0.97211903,0.00040837665,0.00042246355,0.000002097702,0.00013298768,0.00009784115,0.000023955088,0.0000021732385,0.000021347218,0.00020435601],"about_ca_topic_score_codex":0.0743768,"about_ca_topic_score_gemma":0.5687938,"teacher_disagreement_score":0.49441698,"about_ca_system_score_codex":0.00029256663,"about_ca_system_score_gemma":0.0003292738,"threshold_uncertainty_score":0.931787},"labels":[],"label_agreement":null},{"id":"W2522134251","doi":"10.1182/blood.v120.21.411.411","title":"Phase I/II Study of Volasertib (BI 6727), an Intravenous Polo-Like Kinase (Plk) Inhibitor, in Patients with Acute Myeloid Leukemia (AML): Results From the Randomized Phase II Part for Volasertib in Combination with Low-Dose Cytarabine (LDAC) Versus LDAC Monotherapy in Patients with Previously Untreated AML Ineligible for Intensive Treatment","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Myeloid leukemia; Cytarabine; Oncology; Clinical endpoint; Clinical trial","score_opus":0.015948448106605517,"score_gpt":0.28531192229843805,"score_spread":0.26936347419183254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2522134251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9742468,0.000121999255,0.000040212482,0.00020837138,0.00013270752,0.024256337,0.0009224733,0.00006243944,0.000008658626],"genre_scores_gemma":[0.9909013,0.00007299588,0.0005102321,0.00016193553,0.00010559297,0.0029112713,0.0051005445,0.00016409328,0.00007202022],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9947787,0.00057976367,0.0015310901,0.0010391122,0.0008853038,0.0011860558],"domain_scores_gemma":[0.9954871,0.0009634596,0.000777043,0.0010853147,0.0013195347,0.00036758292],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009678211,0.00085633993,0.0019808954,0.00068094546,0.0002397467,0.00004113885,0.00034455644,0.00025444388,0.00001029601],"category_scores_gemma":[0.00061627233,0.00051140203,0.00014059528,0.0010246516,0.00028798342,0.0005762509,0.000098964054,0.00048631328,0.0000017126029],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.80970365,0.10309355,0.06064978,0.00005458894,0.0017255892,0.00006793611,0.019668022,0.00009013137,0.00055269455,0.0000037599527,0.000109406676,0.004280864],"study_design_scores_gemma":[0.7947438,0.17356023,0.01861368,0.0005559372,0.0014177664,0.0000023331784,0.0015832495,0.0008898115,0.00811333,0.000009183511,0.00004047101,0.00047020637],"about_ca_topic_score_codex":0.0066130124,"about_ca_topic_score_gemma":0.0057110065,"teacher_disagreement_score":0.07046668,"about_ca_system_score_codex":0.0016456544,"about_ca_system_score_gemma":0.0009891877,"threshold_uncertainty_score":0.99973375},"labels":[],"label_agreement":null},{"id":"W2522249336","doi":"10.1182/blood.v112.11.944.944","title":"The off-Patent Anti-Fungal Ciclopirox Olamine Displays Preclinical Activity in Leukemia and Myeloma.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Synthesis and Biological Evaluation","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Propidium iodide; Pharmacology; Leukemia; Viability assay; Cytarabine; Cancer research; Medicine; Myeloid leukemia; Programmed cell death; Cell; Chemistry; Immunology; Apoptosis; Biochemistry","score_opus":0.06793708385049886,"score_gpt":0.28076620226974996,"score_spread":0.21282911841925112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2522249336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969869,0.0005454571,0.0000018021651,0.00024017284,0.000029199464,0.000065537424,0.000007739353,0.000025321862,0.0020978325],"genre_scores_gemma":[0.99843836,0.0010837206,0.000034703604,0.000027286123,0.00013129157,0.000019046696,0.0000050600697,0.000006386716,0.0002541715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911255,0.000063803156,0.00021368744,0.000250881,0.00016471824,0.0001943808],"domain_scores_gemma":[0.99911326,0.0005458361,0.000075008495,0.00019474908,0.000020692927,0.000050430408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003343086,0.00010997993,0.00017179103,0.000010152176,0.0001435953,0.000018190636,0.00011848935,0.0001479903,0.00008274015],"category_scores_gemma":[0.00045963455,0.00006420864,0.000052668063,0.000054948865,0.00013071093,0.000040730007,0.000075551616,0.00018383224,0.000009952357],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008739306,0.0004830707,0.7237877,0.00002048602,0.000034152425,0.000031975793,0.000056433615,0.000002663645,0.23552556,0.000039352748,0.00006310024,0.03986806],"study_design_scores_gemma":[0.00094476115,0.000041385014,0.8694986,0.000023040304,0.000023345956,0.000033035543,0.000015111386,0.00043919688,0.12809297,0.000059910402,0.00072300324,0.00010562683],"about_ca_topic_score_codex":0.000023923034,"about_ca_topic_score_gemma":0.0000315819,"teacher_disagreement_score":0.14571086,"about_ca_system_score_codex":0.000028734752,"about_ca_system_score_gemma":0.00004571018,"threshold_uncertainty_score":0.26183522},"labels":[],"label_agreement":null},{"id":"W2522288054","doi":"10.1182/blood.v126.23.3986.3986","title":"Phase 1b Study of PD-1 Blockade with Pembrolizumab in Patients with Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL)","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Oncology; Refractory (planetary science); Population; Phases of clinical research; Cohort; Clinical trial; Immunotherapy; Cancer","score_opus":0.011035163639854916,"score_gpt":0.23569552636451696,"score_spread":0.22466036272466205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2522288054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99599886,0.0003860367,0.000002082735,0.000027862132,0.00005111166,0.0012029292,0.000040956027,0.00004197798,0.0022482125],"genre_scores_gemma":[0.9991949,0.000010367683,0.00026520237,0.00008228777,0.00006190196,0.00012769211,0.00011159844,0.000047280577,0.00009876286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978329,0.000079304555,0.00040569194,0.00043150428,0.0008574372,0.0003931909],"domain_scores_gemma":[0.99865603,0.00006726033,0.00023014132,0.0005015685,0.00021837349,0.0003266463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015249102,0.00030761873,0.0006077222,0.000191454,0.0000395848,0.000010992553,0.000116701405,0.000085408625,0.000017431475],"category_scores_gemma":[0.000033596003,0.00020204451,0.00004836021,0.00030050406,0.00005756431,0.00011037198,0.000062026,0.00010338749,0.000017328799],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051048915,0.33697706,0.65419984,0.00006537551,0.00023008758,0.00063389196,0.0015879269,0.000001256754,0.00002391271,0.000002420596,0.00012259078,0.0010507249],"study_design_scores_gemma":[0.43426722,0.03033378,0.5324611,0.00014665484,0.00069704326,0.000033231383,0.0006118597,0.0000039475694,0.0010662489,0.0000013839882,0.0002113769,0.00016613274],"about_ca_topic_score_codex":0.00016476611,"about_ca_topic_score_gemma":0.00011570283,"teacher_disagreement_score":0.42916232,"about_ca_system_score_codex":0.00022708632,"about_ca_system_score_gemma":0.0005331863,"threshold_uncertainty_score":0.8239136},"labels":[],"label_agreement":null},{"id":"W2522316890","doi":"10.1182/blood.v126.23.2009.2009","title":"Outcomes of Allogeneic Transplantation in Patients Aged ≤ 60 Years with Acute Myeloid Leukemia in Second Complete Remission: A CIBMTR ® Cohort Analysis","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Cumulative incidence; Transplantation; Internal medicine; Myeloid leukemia; Hematopoietic stem cell transplantation; Incidence (geometry); Leukemia; Cohort; Surgery","score_opus":0.01937515415945602,"score_gpt":0.273288429438075,"score_spread":0.253913275278619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2522316890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983397,0.000040142946,0.000031843287,0.000061398874,0.000017140988,0.0006172115,0.00007838528,0.000020365247,0.00079381355],"genre_scores_gemma":[0.99766123,0.000045465473,0.0012958163,0.00011110857,0.0000139148615,0.000034323042,0.00045056647,0.000025940451,0.00036160732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979978,0.00013430882,0.00049263117,0.00036679162,0.0006819366,0.00032651823],"domain_scores_gemma":[0.99904835,0.00007406025,0.00013009348,0.00039413394,0.00013884237,0.00021449536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049712625,0.00018260234,0.0007260122,0.00069091615,0.000016347332,0.00000904279,0.00016907814,0.00013324148,0.00011359243],"category_scores_gemma":[0.000061465915,0.00014800426,0.000100486504,0.0011784848,0.000076788,0.00009223898,0.00003457742,0.00033078028,0.000013057765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092488277,0.0002706614,0.9926154,0.000059932867,0.0012600721,0.0009353764,0.0010462007,0.00016437547,0.002485506,0.0000018438318,0.00008189399,0.0001538271],"study_design_scores_gemma":[0.017494384,0.0004088741,0.978501,0.000064630774,0.0011828848,0.000023216338,0.00009016315,0.00020369343,0.0018318137,0.000007991373,0.00004312157,0.00014821647],"about_ca_topic_score_codex":0.000511469,"about_ca_topic_score_gemma":0.0010318705,"teacher_disagreement_score":0.0165695,"about_ca_system_score_codex":0.00048024624,"about_ca_system_score_gemma":0.0006284615,"threshold_uncertainty_score":0.6035438},"labels":[],"label_agreement":null},{"id":"W2522335594","doi":"10.1182/blood.v118.21.2701.2701","title":"First Evidence for High Incidence of Complete and Sustained Molecular Remissions and Maintenance of Immune Responses in Patients Receiving Consolidation with Y90 Ibritumomab Tiuxetan (90Y-RIT) Post R-CHOP for Newly Diagnosed Advanced Stage High and Intermediate Risk Follicular Lymphoma","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Rituximab; Ibritumomab tiuxetan; Internal medicine; Follicular lymphoma; Maintenance therapy; Regimen; Chemotherapy regimen; Gastroenterology; Clinical endpoint; Oncology; Chemotherapy; Lymphoma; Surgery; Radioimmunotherapy; Immunology; Clinical trial; Antibody","score_opus":0.013893546371635406,"score_gpt":0.24635784212886425,"score_spread":0.23246429575722885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2522335594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956722,0.001555267,0.00032243185,0.00012988849,0.000022900422,0.0019972639,0.0002808118,0.000014488889,0.000004694513],"genre_scores_gemma":[0.99070716,0.0011112316,0.0077925017,0.000036467492,0.0000053618905,0.00026187755,0.000046646634,0.000027454393,0.0000112893185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853086,0.00007894869,0.00053131016,0.00041661455,0.00017889784,0.00026334642],"domain_scores_gemma":[0.9974498,0.0012637208,0.0004590626,0.00030692006,0.0003950749,0.00012543499],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026811557,0.00022642178,0.0005738282,0.00014935042,0.00009093805,0.0000142281715,0.000077210876,0.00007286934,0.000003097908],"category_scores_gemma":[0.0026170688,0.00018034888,0.000052871135,0.00014358114,0.00021625872,0.0001969656,0.00007976427,0.000042105046,6.992844e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013205421,0.0017652079,0.9625258,0.0012767629,0.00031512915,0.00016582645,0.0016551586,0.0000057506327,0.012380737,0.0009915666,0.0000070664155,0.005705593],"study_design_scores_gemma":[0.035770718,0.004035151,0.9204278,0.0030670483,0.0004453155,0.00001832373,0.00037434732,0.00009146069,0.03524603,0.00034103554,0.0000068873246,0.000175875],"about_ca_topic_score_codex":0.0010167243,"about_ca_topic_score_gemma":0.00026502647,"teacher_disagreement_score":0.04209797,"about_ca_system_score_codex":0.00006424183,"about_ca_system_score_gemma":0.00013010879,"threshold_uncertainty_score":0.73544145},"labels":[],"label_agreement":null},{"id":"W2522431852","doi":"10.1182/blood.v126.23.2261.2261","title":"Absence of Viral Complications When Using Rituximab to Treat TTP with Plasma Exchange","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Hepatitis Viruses Studies and Epidemiology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Vancouver General Hospital; London Health Sciences Centre; University Health Network; Canadian Apheresis Group","funders":"","keywords":"Medicine; Rituximab; Internal medicine; Immunology; Gastroenterology; Immunosuppression; Hepatitis B; Viral load; Viral hepatitis; Refractory (planetary science); Lymphoma; Virus","score_opus":0.11643382483937219,"score_gpt":0.33067130769723135,"score_spread":0.21423748285785915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2522431852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903132,0.00023942527,0.0010484264,0.001031879,0.000032509273,0.00023445465,0.000026140817,0.000026792626,0.0070471847],"genre_scores_gemma":[0.9754761,0.00007981842,0.023258803,0.0008348291,0.00011392636,0.000028853001,0.000009288019,0.00001490591,0.00018350739],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993484,0.000027414113,0.00017726554,0.0001609692,0.00010254691,0.0001834065],"domain_scores_gemma":[0.9993907,0.000049466533,0.000056660258,0.00023261257,0.00011935433,0.0001511557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000099583805,0.00008736326,0.00031871305,0.000048419784,0.00004223814,0.0000024243163,0.000056119694,0.000039245024,0.000021099531],"category_scores_gemma":[0.00012236205,0.00006575233,0.000028530356,0.00008626283,0.0000708224,0.00002744788,0.000049618007,0.00005447041,0.00004272302],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003087863,0.0016535625,0.97235405,0.00016505289,0.00024509293,0.00006187195,0.003585959,0.00006019549,0.0069595072,0.0008902516,0.01145994,0.002255696],"study_design_scores_gemma":[0.09710761,0.020222377,0.7072575,0.0022972063,0.0043606516,0.0024169334,0.0039678505,0.007820669,0.029338187,0.0021321687,0.12087937,0.0021994724],"about_ca_topic_score_codex":0.0024462144,"about_ca_topic_score_gemma":0.0006766427,"teacher_disagreement_score":0.26509658,"about_ca_system_score_codex":0.00003052637,"about_ca_system_score_gemma":0.000053265012,"threshold_uncertainty_score":0.36979607},"labels":[],"label_agreement":null},{"id":"W2522592085","doi":"10.1182/blood.v126.23.4322.4322","title":"Generic Intravenous Busulfan in Hematopoietic Stem Cell Transplantation: Relevance of Therapeutic Drug Monitoring","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Busulfan; Medicine; Dosing; Hematopoietic stem cell transplantation; Transplantation; Pharmacokinetics; Therapeutic drug monitoring; Cohort; Regimen; Internal medicine; Bioequivalence; Clinical trial; Surgery; Pharmacology","score_opus":0.040410476004269856,"score_gpt":0.28631602559276365,"score_spread":0.24590554958849378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2522592085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99446446,0.0040502045,0.000054964115,0.000070063375,0.000057464273,0.00029111787,0.0000051689512,0.00002172276,0.0009848386],"genre_scores_gemma":[0.99819535,0.00056617736,0.0008314643,0.000009185944,0.00005949391,0.000029473687,0.000007644955,0.000016603715,0.0002846352],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990668,0.000047718073,0.00020818044,0.00015857558,0.00030117662,0.00021752721],"domain_scores_gemma":[0.9994941,0.000054127828,0.00004636383,0.00019458497,0.00006248198,0.00014835768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012202045,0.00009971533,0.00021610092,0.00008643041,0.000016802614,0.0000059907907,0.0000688303,0.000037130012,0.000006900054],"category_scores_gemma":[0.0000065421546,0.00008360424,0.00003730347,0.00019505613,0.000028192555,0.00004063338,0.000008625963,0.00010617609,0.000020365263],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089876784,0.004398409,0.8662871,0.0015867633,0.0002466814,0.0020655005,0.01468473,0.000082646424,0.06541732,0.000045551627,0.000019478444,0.044267017],"study_design_scores_gemma":[0.015959604,0.00064591505,0.3001395,0.00034648756,0.00021349467,0.00024471333,0.0013312395,0.00010074474,0.68066627,0.000118516604,0.00006512975,0.00016843787],"about_ca_topic_score_codex":0.000089876274,"about_ca_topic_score_gemma":0.0000113620945,"teacher_disagreement_score":0.6152489,"about_ca_system_score_codex":0.000038593855,"about_ca_system_score_gemma":0.000111343856,"threshold_uncertainty_score":0.3409282},"labels":[],"label_agreement":null},{"id":"W2522596820","doi":"10.1182/blood-2016-06-723098","title":"Acute myeloid leukemia with myelodysplasia-related changes demonstrating mixed-lineage phenotype","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pancytopenia; Medicine; Dysplasia; Hypoplasia; Bone marrow; Bone marrow examination; Myeloid leukemia; Pathology; Myeloid; Karyotype; Internal medicine; Biology; Genetics; Chromosome","score_opus":0.012089764852225203,"score_gpt":0.25105475674349015,"score_spread":0.23896499189126494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2522596820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831086,0.0002932968,0.0003873999,0.0038778926,0.00011566446,0.00069676054,0.000041947,0.00038611976,0.01109231],"genre_scores_gemma":[0.98539966,0.00031013586,0.0055261436,0.00033442164,0.00044656105,0.000081441074,0.00004522366,0.00012530306,0.0077310787],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99727774,0.00009351744,0.0003937109,0.0006651704,0.00067679846,0.00089304516],"domain_scores_gemma":[0.9981957,0.00022652918,0.00017125961,0.0007238666,0.00024770416,0.00043495029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038430592,0.00040062214,0.0005525516,0.00024421918,0.00018592822,0.00004057806,0.00030081702,0.00030378983,0.00030405892],"category_scores_gemma":[0.00022105177,0.0002362995,0.00010036675,0.00058658916,0.00026871858,0.00017256408,0.0001441439,0.00054501084,0.00052497006],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010330463,0.0004554113,0.020151392,0.00017874515,0.00226631,0.0027280247,0.00045681934,0.0000025166,0.915039,0.00073252094,0.0030576594,0.053898565],"study_design_scores_gemma":[0.034277312,0.0033676648,0.028046373,0.0013327809,0.0020528962,0.0035818531,0.00046694255,0.00024110494,0.91943264,0.00010655615,0.006045542,0.0010483367],"about_ca_topic_score_codex":0.00003987245,"about_ca_topic_score_gemma":0.0001007812,"teacher_disagreement_score":0.052850228,"about_ca_system_score_codex":0.00035236753,"about_ca_system_score_gemma":0.0009383729,"threshold_uncertainty_score":0.9636014},"labels":[],"label_agreement":null},{"id":"W2522651574","doi":"10.1182/blood.v126.23.407.407","title":"Interaction of Transferrin-Endosomes with Mitochondria: Implications for Iron Transport to Ferrochelatase in Erythroid Cells","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spartan Bioscience (Canada); Impact; McGill University; Jewish General Hospital","funders":"","keywords":"Endosome; Ferrochelatase; Endocytosis; Transferrin receptor; Cell biology; Transferrin; Mitochondrion; Intracellular; Cytosol; Biology; Chemistry; Heme; Biochemistry; Cell; Enzyme","score_opus":0.03269209076429773,"score_gpt":0.2874953790455348,"score_spread":0.25480328828123705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2522651574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99343336,0.000062071835,0.003598292,0.001135681,0.00015496834,0.0008366981,0.00010548461,0.00003112272,0.00064233894],"genre_scores_gemma":[0.9954104,0.000018262543,0.00362352,0.00027230018,0.000094358234,0.0001709574,0.00016998667,0.000018452914,0.00022175016],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993038,0.00001600785,0.00024046766,0.0002170725,0.00007450374,0.0001481399],"domain_scores_gemma":[0.99945045,0.000042501662,0.000040062765,0.00021584913,0.0001049096,0.00014622616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000059129965,0.000107855885,0.0002630259,0.00013946935,0.000017069933,0.0000018404952,0.000045585555,0.00007315574,0.000021223028],"category_scores_gemma":[0.00001685836,0.0000895654,0.000061847,0.0001920003,0.000028479553,0.00005674185,0.0000035802177,0.0001014145,0.000011457501],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033467233,0.0019807864,0.018048601,0.00023266714,0.00008062009,0.00001195804,0.0019609286,0.00026236387,0.97204155,0.0002475098,0.0011282664,0.00065802195],"study_design_scores_gemma":[0.040201396,0.010783751,0.19395709,0.00039985962,0.001006747,0.00034880592,0.0022971309,0.00004459746,0.7248289,0.00036445388,0.025208749,0.0005585245],"about_ca_topic_score_codex":0.00004541116,"about_ca_topic_score_gemma":0.00023381032,"teacher_disagreement_score":0.24721266,"about_ca_system_score_codex":0.00002606628,"about_ca_system_score_gemma":0.000102982696,"threshold_uncertainty_score":0.36523712},"labels":[],"label_agreement":null},{"id":"W2522728205","doi":"10.1182/blood.v118.21.4773.4773","title":"Rate and Time Course of Thromboembolism Events in Cancer Patients","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Trillium Health Centre; Sanofi (Canada); University of Calgary","funders":"","keywords":"Medicine; Cancer; Population; Medical record; Incidence (geometry); Emergency medicine; Emergency department; Venous thromboembolism; Cancer registry; Pediatrics; Intensive care medicine; Internal medicine; Thrombosis","score_opus":0.017735478083708053,"score_gpt":0.2598066162576464,"score_spread":0.24207113817393833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2522728205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945002,0.0003841209,5.7018804e-7,0.000058262627,0.00007450682,0.00039923427,0.000011820839,0.000013697407,0.004557592],"genre_scores_gemma":[0.99902886,0.00048266508,0.000077265824,0.00020919227,0.000025727995,0.000035877925,0.00000777612,0.000015002133,0.00011765714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99933606,0.00002562716,0.00019862654,0.00016583577,0.00010473522,0.000169108],"domain_scores_gemma":[0.99964327,0.000011821097,0.00007559394,0.0001515766,0.00004921059,0.0000685478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011774634,0.000101573954,0.00037876994,0.00006686662,0.000015788111,0.0000013965918,0.000052317526,0.000045258916,0.00029260106],"category_scores_gemma":[0.000013740072,0.00008482256,0.000033528704,0.0000916831,0.000036179732,0.000048258928,0.000055233308,0.000057652498,0.000017647557],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003629245,0.009798887,0.98298097,0.00016219278,0.00028894673,0.000010717634,0.0020596725,3.6142674e-7,0.0014098743,0.00032338678,0.00077063194,0.0021580474],"study_design_scores_gemma":[0.003314424,0.00029602984,0.9898448,0.00017155557,0.00028704875,7.5912067e-7,0.000041495394,0.0000066198872,0.005577941,0.00025886166,0.00011925122,0.00008122988],"about_ca_topic_score_codex":0.00044762852,"about_ca_topic_score_gemma":0.000038214122,"teacher_disagreement_score":0.009502857,"about_ca_system_score_codex":0.0000101080905,"about_ca_system_score_gemma":0.00003001721,"threshold_uncertainty_score":0.34589636},"labels":[],"label_agreement":null},{"id":"W2522744902","doi":"10.1182/blood.v120.21.475.475","title":"Age-Related Emergency Department Reliance and Healthcare Resource Utilization in Patients with Sickle Cell Disease","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Emergency department; Medicaid; Acute chest syndrome; Emergency medicine; Ambulatory; Pediatrics; Disease; Health care; Ambulatory care; Sickle cell anemia; Internal medicine","score_opus":0.009405382682870635,"score_gpt":0.23116713621642307,"score_spread":0.22176175353355243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2522744902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901775,0.0077895448,0.0000031605514,0.0004518273,0.0000585375,0.00050666643,0.000009416245,0.000035465615,0.00096785737],"genre_scores_gemma":[0.9986773,0.00058813475,0.00005645826,0.00013123552,0.000017213188,0.000014926404,0.00015366425,0.000020054915,0.00034102326],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991761,0.000036791655,0.00019711471,0.00016551226,0.00016378741,0.0002607122],"domain_scores_gemma":[0.9994621,0.000005303356,0.000056838056,0.00016281703,0.00003238222,0.000280509],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006440003,0.0001083476,0.00013036639,0.00005418347,0.00005394234,0.0000031675395,0.000024297118,0.00007391935,0.000033867676],"category_scores_gemma":[0.000019797559,0.00008251999,0.000020277477,0.00022504544,0.000029421997,0.000057456637,0.000018142244,0.00012477316,0.000011998033],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016177112,0.0014481386,0.996533,0.00015805282,0.000016743108,0.000016952532,0.00045781062,0.0000062996014,0.000011965068,0.00003189946,0.00028671528,0.0008706948],"study_design_scores_gemma":[0.005028867,0.00027764344,0.9908767,0.00014221593,0.0001297588,0.0000015824623,0.000120534016,0.000019553854,0.000065385335,0.000018362489,0.0032031622,0.000116249284],"about_ca_topic_score_codex":0.000024581312,"about_ca_topic_score_gemma":0.000008624607,"teacher_disagreement_score":0.008499766,"about_ca_system_score_codex":0.000019492987,"about_ca_system_score_gemma":0.00002872771,"threshold_uncertainty_score":0.33650675},"labels":[],"label_agreement":null},{"id":"W2522966186","doi":"10.1182/blood.v126.23.2699.2699","title":"Outcome of Observation As Initial Strategy in Patients with Mantle Cell Lymphoma","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Mantle cell lymphoma; Internal medicine; Lymphoma; B symptoms; Surgery","score_opus":0.038644228152236317,"score_gpt":0.27623849583019255,"score_spread":0.23759426767795624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2522966186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925986,0.000051745275,6.495979e-7,0.000039419247,0.000027160795,0.0002408153,0.000008737438,0.000010663188,0.007022225],"genre_scores_gemma":[0.9994895,0.0000023192788,0.00018671095,0.00010040035,0.000020915611,0.0000166514,0.00006039795,0.0000093586605,0.00011376369],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993676,0.00001378914,0.00018613657,0.000112611284,0.00021622621,0.00010363133],"domain_scores_gemma":[0.9996226,0.000014489897,0.00006299941,0.00013769622,0.00008776758,0.00007444118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000043533502,0.00008077806,0.00017670463,0.000047348323,0.00000743513,0.0000049687537,0.000029689914,0.000041519466,0.000017072975],"category_scores_gemma":[0.000016627768,0.000057280362,0.00002316021,0.00009716711,0.000015288724,0.000054211316,0.00001194922,0.000017276125,0.000031003045],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018422381,0.005937431,0.9924764,0.000026263902,0.000028939041,0.00005337373,0.000096132855,0.0000040083937,0.000009766156,0.00006801427,0.000048882222,0.0010665876],"study_design_scores_gemma":[0.034156244,0.001603555,0.95562893,0.000036787696,0.000107020845,0.0000035871751,0.000070327245,0.000004548859,0.008228447,0.000035102796,0.00006820802,0.000057209614],"about_ca_topic_score_codex":0.00044563098,"about_ca_topic_score_gemma":0.000024805964,"teacher_disagreement_score":0.036847416,"about_ca_system_score_codex":0.00005164219,"about_ca_system_score_gemma":0.00011248767,"threshold_uncertainty_score":0.23358254},"labels":[],"label_agreement":null},{"id":"W2523052506","doi":"10.1182/blood.v112.11.4841.4841","title":"Posaconazole as Prophylaxis in Immunocompromised Patients: A Single Center Experience","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Posaconazole; Internal medicine; Neutropenia; Mucositis; Hematopoietic stem cell transplantation; Discontinuation; Transplantation; Gastroenterology; Surgery; Chemotherapy; Aspergillosis; Immunology; Itraconazole; Antifungal; Dermatology","score_opus":0.016057621902210387,"score_gpt":0.24649214150510074,"score_spread":0.23043451960289035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2523052506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936658,0.0001929828,0.0000037457426,0.000039562226,0.000048587004,0.0004174672,0.000004427385,0.00003479304,0.005592636],"genre_scores_gemma":[0.9988667,0.000022672753,0.00019891611,0.00020597504,0.000028892598,0.000031196487,0.0000157663,0.000011744029,0.00061813614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900854,0.00002591904,0.00023735687,0.00026066677,0.00022983643,0.00023769603],"domain_scores_gemma":[0.99948883,0.000016814087,0.00004013689,0.0002901858,0.00008350718,0.00008053012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000045274646,0.00011055199,0.00020564857,0.000051505023,0.000058929338,0.000006381859,0.00007986624,0.00006418882,0.00017491856],"category_scores_gemma":[0.00011511157,0.00009339046,0.000069962574,0.00015898062,0.00011049184,0.00009078913,0.000031431595,0.00013731333,0.00008920545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030743907,0.004660041,0.94192815,0.00003134009,0.0000121145895,0.000121971214,0.0018396471,5.565343e-8,0.05031191,0.0000073815377,0.00003083112,0.00074912724],"study_design_scores_gemma":[0.007987864,0.0010389261,0.9435414,0.0000914652,0.000010456703,0.00004567827,0.00030460933,0.0000023114796,0.04593736,0.000019313211,0.0008799339,0.0001406492],"about_ca_topic_score_codex":0.00007117747,"about_ca_topic_score_gemma":0.00001724842,"teacher_disagreement_score":0.007680425,"about_ca_system_score_codex":0.00004481688,"about_ca_system_score_gemma":0.000069233836,"threshold_uncertainty_score":0.38083524},"labels":[],"label_agreement":null},{"id":"W2523207833","doi":"10.1182/blood.v110.11.1529.1529","title":"Inducible Expression of Leukemia-Associated Shp2 (Ptpn11) Affects Multiple Stages of Hematopoiesis and Causes a Fatal Myeloproliferative Disorder (MPD) in Mice","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"PTPN11; Juvenile myelomonocytic leukemia; Biology; Leukemia; Cancer research; Bone marrow; Progenitor cell; Haematopoiesis; Myeloid leukemia; Myeloid; Transplantation; Immunology; Stem cell; Mutation; Internal medicine; Medicine; Genetics; Gene","score_opus":0.007445077322978879,"score_gpt":0.23742792163970586,"score_spread":0.22998284431672697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2523207833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99253315,0.0068429704,0.00010465663,0.000011044828,0.000017729344,0.00030315339,0.00014898859,0.0000078074045,0.000030473051],"genre_scores_gemma":[0.9986913,0.0001221717,0.0009774081,0.00001652381,0.000018358334,0.00002163848,0.00011274166,0.000017067541,0.000022798406],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99907315,0.000055357672,0.0002510838,0.00027789472,0.00012850948,0.00021401267],"domain_scores_gemma":[0.9994292,0.00007161153,0.00018361158,0.0001979806,0.0000687933,0.000048777703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024918155,0.00015018981,0.000246403,0.00006974644,0.00003203621,0.000006622587,0.00010975318,0.00016096591,0.000003794346],"category_scores_gemma":[0.000588404,0.00014020992,0.00003999243,0.00014108853,0.00010084351,0.0000100226525,0.00015830588,0.00007574626,2.7841332e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010631807,0.00030420648,0.16126718,0.00008517795,0.000040534043,0.000005639218,0.00019317931,0.0000076213437,0.8378161,0.00002462877,0.000042582134,0.00010680447],"study_design_scores_gemma":[0.0022621045,0.00025698228,0.05802747,0.000120049684,0.00002376909,0.000003746275,0.00024159683,0.000002425727,0.9388765,0.000022069828,0.00002692914,0.0001363533],"about_ca_topic_score_codex":0.00024220094,"about_ca_topic_score_gemma":0.0008044117,"teacher_disagreement_score":0.10323971,"about_ca_system_score_codex":0.000011950445,"about_ca_system_score_gemma":0.00007565553,"threshold_uncertainty_score":0.5717594},"labels":[],"label_agreement":null},{"id":"W2523222265","doi":"10.1182/blood.v112.11.4779.4779","title":"A Novel B220+ NK Cell Progenitor Found in the Murine Lung with Potent in Vitro NK Potential Gives Rise to Mature NK Cells with Distinct NK Cell-Surface Receptor Expression","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute","funders":"","keywords":"Biology; Interleukin 21; Progenitor cell; Immunology; Interleukin 12; Janus kinase 3; Adoptive cell transfer; Cell biology; Innate lymphoid cell; Lymphokine-activated killer cell; Acquired immune system; T cell; Stem cell; Immune system; Cytotoxic T cell; In vitro","score_opus":0.0058025081560638255,"score_gpt":0.1933636012278878,"score_spread":0.18756109307182398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2523222265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944957,0.0016402544,0.00069436186,0.0001871207,0.0010841191,0.0010504205,0.000025924546,0.00006260712,0.0007594868],"genre_scores_gemma":[0.98989004,0.00010351095,0.0015654137,0.00015265979,0.00010486627,0.00009330765,0.00014807802,0.00004670062,0.007895447],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981288,0.00027776443,0.0003930365,0.0005443498,0.00012934855,0.0005267528],"domain_scores_gemma":[0.9991174,0.00007989413,0.00020924762,0.00043864406,0.000108238,0.000046573114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019484607,0.0003751333,0.00034829832,0.00014483012,0.00029733108,0.0000410189,0.00031157065,0.00027868542,0.00029715148],"category_scores_gemma":[0.000017193259,0.00024010075,0.00008666007,0.0003531273,0.00013109583,0.00018397022,0.000095821226,0.00078293844,0.00024160367],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040190415,0.002424021,0.0008331163,0.00009831699,0.000060808277,0.00006135559,0.0019064795,0.00026219068,0.9856663,8.5572265e-7,0.00462839,0.000039170965],"study_design_scores_gemma":[0.0067916666,0.0007267784,0.0027501811,0.00020213512,0.000091830836,0.00035603417,0.0012220951,0.000019904523,0.97895116,5.997456e-7,0.008517654,0.00036999228],"about_ca_topic_score_codex":0.00024781824,"about_ca_topic_score_gemma":0.00004178339,"teacher_disagreement_score":0.0071359607,"about_ca_system_score_codex":0.00006925325,"about_ca_system_score_gemma":0.000092588896,"threshold_uncertainty_score":0.97910243},"labels":[],"label_agreement":null},{"id":"W2523222835","doi":"10.1182/blood.v122.21.520.520","title":"Backtracking Subclonal Mutations Of TP53 In Myelodysplasia (MDS) With Del(5q) With Next-Generation Sequencing (NGS)","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement","funders":"","keywords":"Sanger sequencing; Somatic evolution in cancer; Biology; Amplicon; DNA sequencing; Genetics; Myelodysplastic syndromes; Primer (cosmetics); Exon; Molecular biology; Computational biology; Polymerase chain reaction; DNA; Gene; Chemistry; Immunology","score_opus":0.04601201259537919,"score_gpt":0.26651704851319596,"score_spread":0.22050503591781678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2523222835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995829,0.000095544136,0.00076585583,0.0005059277,0.000015186912,0.0006958079,0.0000051627467,0.000038237282,0.0020492834],"genre_scores_gemma":[0.98374575,0.000017689363,0.015475736,0.000120440774,0.00014051898,0.000106220636,0.00009426228,0.000041456802,0.00025794207],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99844414,0.000059305246,0.00032191243,0.00030510384,0.0005081719,0.00036135403],"domain_scores_gemma":[0.9990097,0.00009459708,0.000110493325,0.0002855343,0.00035729833,0.0001423659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021814782,0.00017173644,0.00028943704,0.00026692107,0.00006982032,0.00004381887,0.00010919331,0.00009776001,0.00022172912],"category_scores_gemma":[0.0000871221,0.00012849,0.000033336444,0.0005798529,0.0001305391,0.0003761561,0.000028470944,0.0003535775,0.00005207956],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019314727,0.00050955307,0.17866193,0.00023450922,0.00026428793,0.0003816412,0.0019508406,0.0012143775,0.81279,0.00051779,0.0002575521,0.0030243727],"study_design_scores_gemma":[0.026160313,0.0032172734,0.36838314,0.0013356967,0.0007399013,0.0025215426,0.0044801473,0.042700864,0.5492079,0.00018879725,0.00017996151,0.0008844525],"about_ca_topic_score_codex":0.0011472551,"about_ca_topic_score_gemma":0.00068909803,"teacher_disagreement_score":0.26358208,"about_ca_system_score_codex":0.00022677281,"about_ca_system_score_gemma":0.00088887924,"threshold_uncertainty_score":0.523967},"labels":[],"label_agreement":null},{"id":"W2523230898","doi":"10.1182/blood.v104.11.3895.3895","title":"Leptin-Mediated Activation of Human Platelets: Involvement of a Leptin Receptor and Phosphodiesterase 3A Cellular Signaling Complex.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Leptin; Internal medicine; Phosphorylation; Platelet activation; Phosphodiesterase; Endocrinology; Leptin receptor; Wortmannin; Protein kinase B; Chemistry; Platelet; Cell biology; Biology; Biochemistry; Medicine; Enzyme","score_opus":0.030703165909601954,"score_gpt":0.25815176080265434,"score_spread":0.22744859489305239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2523230898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984332,0.00057732995,0.00016739225,0.00018243174,0.00004171071,0.00039488816,0.000020453575,0.0000457843,0.00013684272],"genre_scores_gemma":[0.99787015,0.000041428768,0.001462668,0.00012294871,0.00009915341,0.000011104374,0.00029356786,0.00002556181,0.00007341958],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987024,0.000026404688,0.00054967176,0.0002403779,0.00028332102,0.00019784542],"domain_scores_gemma":[0.9991616,0.00007712568,0.0003119321,0.0002026592,0.00014114866,0.00010552346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019680116,0.00017675027,0.0004168806,0.00012563329,0.00008281729,0.000010244348,0.00006123411,0.000093532195,0.00019552861],"category_scores_gemma":[0.00006738339,0.000169137,0.00008638784,0.00018701551,0.000120330966,0.00009069628,0.000037435053,0.00009226899,0.000004767561],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000107619344,0.0010324202,0.02522191,0.00029351938,0.00014205824,0.0000070852543,0.0022843066,0.000029384253,0.9699441,0.0003220583,0.000058120822,0.0005574168],"study_design_scores_gemma":[0.0076104016,0.0006864798,0.01596807,0.00055656635,0.00016325331,0.0000049260707,0.0005662226,0.000042541207,0.9737734,0.00020223057,0.00026574938,0.00016016734],"about_ca_topic_score_codex":0.00039139017,"about_ca_topic_score_gemma":0.000018653558,"teacher_disagreement_score":0.009253841,"about_ca_system_score_codex":0.00003336324,"about_ca_system_score_gemma":0.000069938265,"threshold_uncertainty_score":0.68972063},"labels":[],"label_agreement":null},{"id":"W2523233730","doi":"10.1182/blood.v110.11.3857.3857","title":"Quantitative Flow Cytometric Assessment of CD36 (Platelet Glycoprotein IV) Expression on Monocytes and Platelets: Assay Development, Role in Plasmodium falciparum Risk Assessment, and Relationship to Sickle Hemoglobin.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"CD36; Plasmodium falciparum; Immunology; Platelet; Flow cytometry; Biology; Malaria; CD14; Medicine; Andrology; Receptor; Biochemistry","score_opus":0.018923095742744898,"score_gpt":0.3094102880557777,"score_spread":0.29048719231303277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2523233730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99152625,0.00083272974,0.0027703422,0.00016403322,0.00006585195,0.0011146031,0.0000345203,0.00005634704,0.003435318],"genre_scores_gemma":[0.9376112,0.00022106139,0.0618378,0.00007680971,0.000017601433,0.00004951361,0.000049261405,0.00003668421,0.00010006113],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99754494,0.00014726681,0.0007401013,0.0005625888,0.00049690035,0.0005082129],"domain_scores_gemma":[0.99826515,0.0007611046,0.00028034454,0.0002782932,0.00010830008,0.0003068268],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015131704,0.00033162622,0.0005814312,0.0010499672,0.00019526875,0.00003760711,0.00010188718,0.0003224433,0.000025691057],"category_scores_gemma":[0.00049390417,0.00028419183,0.000055764347,0.0011159169,0.000085412765,0.00016098656,0.000120558514,0.00065315445,0.000008290314],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001034695,0.0021823698,0.92829514,0.00024776114,0.00025403415,0.00019229607,0.0020028052,0.0005441521,0.04254729,0.0005472221,0.00011974292,0.022032497],"study_design_scores_gemma":[0.0110452175,0.0019709456,0.8767448,0.00078671484,0.00014037626,0.000061004812,0.0025609054,0.002721751,0.10265163,0.00028793962,0.00053960807,0.000489102],"about_ca_topic_score_codex":0.00009429817,"about_ca_topic_score_gemma":0.00004677331,"teacher_disagreement_score":0.060104344,"about_ca_system_score_codex":0.00015084872,"about_ca_system_score_gemma":0.0002199627,"threshold_uncertainty_score":0.999961},"labels":[],"label_agreement":null},{"id":"W2523237690","doi":"10.1182/blood.v124.21.116.116","title":"Phase 1/1b Study of RG7388, a Potent MDM2 Antagonist, in Acute Myelogenous Leukemia (AML) Patients (Pts)","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Gastroenterology; Refractory (planetary science); Pharmacodynamics; Pharmacokinetics; Adverse effect; Cytarabine; Pharmacology; Leukemia","score_opus":0.015206516914233234,"score_gpt":0.2954112388877334,"score_spread":0.28020472197350016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2523237690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99567986,0.00007315203,0.000051416093,0.000104922015,0.00008408023,0.0015866007,0.000037148344,0.00006015813,0.002322697],"genre_scores_gemma":[0.99869025,0.000051098803,0.00032662277,0.00020702927,0.00013523687,0.00008571481,0.00007979126,0.00006118788,0.0003630465],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99704385,0.00025337416,0.0006768649,0.00054956594,0.00083301775,0.00064333185],"domain_scores_gemma":[0.9983195,0.00011729567,0.0001793132,0.0008575924,0.0002413798,0.00028490057],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006464173,0.00029283285,0.0007239597,0.0003890056,0.00008819163,0.000019796686,0.00035932427,0.00016296616,0.000044645585],"category_scores_gemma":[0.00027146068,0.00025242835,0.000115800016,0.00055032776,0.00010858819,0.00008489182,0.0002292871,0.00052225334,0.000086362896],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056673544,0.20183805,0.58113426,0.00056661793,0.0024976505,0.002574926,0.011412463,0.000044655604,0.098905824,0.000102532926,0.0029859887,0.09226967],"study_design_scores_gemma":[0.47919005,0.052555125,0.38944143,0.00036220046,0.0022901313,0.00032088222,0.0024019727,0.0022771885,0.06618773,0.00010447848,0.0037406026,0.0011281912],"about_ca_topic_score_codex":0.0007596869,"about_ca_topic_score_gemma":0.00010263406,"teacher_disagreement_score":0.4735227,"about_ca_system_score_codex":0.0004732746,"about_ca_system_score_gemma":0.00045485757,"threshold_uncertainty_score":0.9999928},"labels":[],"label_agreement":null},{"id":"W2523247821","doi":"10.1182/blood.v122.21.774.774","title":"Practice Gaps and Barriers To Optimal Care Among Hematologists and Medical Oncologists Treating Patients With Chronic Myeloid Leukemia (CML), Acute Lymphoblastic Leukemia (ALL), and B-Cell Lymphomas In The United States: Results Of a Two-Phase Qualitative/Quantitative Study","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Axdev Group (Canada)","funders":"","keywords":"Medicine; Blinatumomab; Family medicine; Thematic analysis; Psychological intervention; Institutional review board; Qualitative research; Leukemia; Internal medicine; Nursing; Lymphoblastic Leukemia; Psychiatry","score_opus":0.017034367311028434,"score_gpt":0.2972834549298803,"score_spread":0.28024908761885187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2523247821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960442,0.0013908703,0.00009212164,0.00015877592,0.000031679716,0.0011369126,0.0003066521,0.000014748374,0.0008240303],"genre_scores_gemma":[0.99791986,0.00048340284,0.0010578568,0.00028554854,0.000016903807,0.00014157845,0.000054596363,0.000025791534,0.000014464535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978308,0.00018618943,0.0008710297,0.0005944639,0.00011421436,0.00040329594],"domain_scores_gemma":[0.9973602,0.0012122716,0.00070739776,0.00025803223,0.00014731396,0.00031473124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096388656,0.00029268954,0.00067322946,0.0002747822,0.00014035146,0.00011839889,0.00021537967,0.00013148405,0.000017259626],"category_scores_gemma":[0.0019709095,0.00023734043,0.000030130328,0.0003307144,0.00045601116,0.00054782344,0.00012484427,0.00019996626,0.0000057705324],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027121438,0.0018103187,0.54529715,0.00038288004,0.0008216658,0.00018503118,0.44229415,0.001418443,0.000015959646,0.0034392108,0.00027312434,0.0013499662],"study_design_scores_gemma":[0.16236097,0.026332125,0.46829626,0.00062526815,0.00055286713,0.00007687142,0.32654366,0.011225738,0.00021799139,0.000992496,0.00091994315,0.0018558188],"about_ca_topic_score_codex":0.011573982,"about_ca_topic_score_gemma":0.0017895851,"teacher_disagreement_score":0.15964882,"about_ca_system_score_codex":0.0005005731,"about_ca_system_score_gemma":0.00038971956,"threshold_uncertainty_score":0.99500805},"labels":[],"label_agreement":null},{"id":"W2523288082","doi":"10.1182/blood.v112.11.867.867","title":"Preliminary Results of CNTO 328, An Anti-Interleukin-6 Monoclonal Antibody, in Combination with Bortezomib in the Treatment of Relapsed or Refractory Multiple Myeloma","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Bortezomib; Medicine; Multiple myeloma; Regimen; Lenalidomide; Dexamethasone; Internal medicine; Transplantation; Oncology; Gastroenterology; Surgery","score_opus":0.03800804186316246,"score_gpt":0.31367291580299683,"score_spread":0.27566487393983435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2523288082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99791056,0.0002515227,0.00000448254,0.00012784833,0.000017687966,0.0012086259,0.000064898726,0.000016777314,0.00039760856],"genre_scores_gemma":[0.9978534,0.000487647,0.0010048873,0.0000125638735,0.000024866818,0.00007589209,0.0003501977,0.000021864738,0.00016870558],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981715,0.00020050326,0.0005248515,0.00032913638,0.0004825734,0.00029141718],"domain_scores_gemma":[0.9987331,0.00033935858,0.00018921561,0.00052354566,0.00011560953,0.00009917926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021724301,0.00020269467,0.00047486238,0.0003024442,0.00004626979,0.000004802835,0.00014043825,0.00009491803,0.000012192219],"category_scores_gemma":[0.00014771668,0.00011478394,0.00007263632,0.00036782373,0.00016248584,0.00013323758,0.00001727605,0.00013554693,0.0000025679308],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031968206,0.037513915,0.9013895,0.000095304604,0.00022425923,0.0034313886,0.0065476466,0.000011142598,0.014214835,0.000008896439,0.000025431045,0.004569495],"study_design_scores_gemma":[0.05529873,0.030419221,0.8776723,0.00021906754,0.00007660519,0.00023424103,0.00046932665,0.0005281251,0.034904342,0.0000049245527,0.000077263365,0.00009583788],"about_ca_topic_score_codex":0.0017055287,"about_ca_topic_score_gemma":0.0010711865,"teacher_disagreement_score":0.023717165,"about_ca_system_score_codex":0.00010342281,"about_ca_system_score_gemma":0.0002340136,"threshold_uncertainty_score":0.46807534},"labels":[],"label_agreement":null},{"id":"W2523292474","doi":"10.1182/blood.v112.11.3548.3548","title":"Risk for Septic Death in Severe Congenital Neutropenia","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Neutropenia; Sepsis; Internal medicine; Pneumonia; Granulocyte colony-stimulating factor; Otitis; Absolute neutrophil count; Cellulitis; Hematopoietic stem cell transplantation; Pediatrics; Surgery; Gastroenterology; Transplantation; Chemotherapy","score_opus":0.010089395829935625,"score_gpt":0.2261838940527245,"score_spread":0.21609449822278887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2523292474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967493,0.001158817,0.000051571136,0.000014843452,0.000033642722,0.0002492254,0.00005928754,0.0000070633314,0.0016762837],"genre_scores_gemma":[0.99815196,0.0002279403,0.0006870882,0.000069553156,0.0000575014,0.000061005954,0.000096560354,0.00001719712,0.0006312163],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99944377,0.000017347369,0.00009907971,0.0002173717,0.000042636253,0.00017980121],"domain_scores_gemma":[0.99973065,0.000006691026,0.000032365115,0.00016336385,0.00002338375,0.00004357136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000027651276,0.00010284236,0.000099173296,0.000019355159,0.000066521934,0.000006081473,0.000077099576,0.00008099276,0.000008730141],"category_scores_gemma":[0.000020292333,0.000094919,0.00007106575,0.00003522818,0.00002252007,0.0000021651651,0.000031914406,0.000037129394,0.000012952547],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001465634,0.001537148,0.98308635,0.000012207821,0.00037221974,0.000057421756,0.000081253515,0.000028509514,0.012654921,0.00005439866,0.0008665365,0.0011024512],"study_design_scores_gemma":[0.06017911,0.0038703978,0.6335732,0.000022795535,0.00081538677,0.0006767559,0.0001459183,0.000089141955,0.27507186,0.0008967786,0.023333332,0.0013253259],"about_ca_topic_score_codex":0.000055591812,"about_ca_topic_score_gemma":0.0001593966,"teacher_disagreement_score":0.34951317,"about_ca_system_score_codex":0.0000028906156,"about_ca_system_score_gemma":0.000037919282,"threshold_uncertainty_score":0.38706845},"labels":[],"label_agreement":null},{"id":"W2523324122","doi":"10.1182/blood.v112.11.4659.4659","title":"Economic Burden of High Risk Acute Lymphoblastic Leukemia (ALL) in Adults and Children","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Pediatrics; Disease; Chemotherapy regimen; Activity-based costing; Acute leukemia; Intensive care medicine; Leukemia; Chemotherapy; Internal medicine","score_opus":0.007891859028001201,"score_gpt":0.2375410638147448,"score_spread":0.22964920478674358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2523324122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984543,0.00028338493,0.000018052522,0.00008846051,0.000043451088,0.00043653592,0.000098916666,0.000039436472,0.00053747266],"genre_scores_gemma":[0.99682957,0.0018102397,0.00080383196,0.000043853073,0.00020689494,0.000021752508,0.00004536775,0.00003988271,0.00019863417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841607,0.000052852352,0.0004277419,0.00042236512,0.00026882885,0.0004121218],"domain_scores_gemma":[0.9990024,0.0001906365,0.00013591946,0.0004044179,0.00004584253,0.00022079266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014753563,0.00020893861,0.00050930097,0.00025550925,0.000048602455,0.0000067337055,0.00017106702,0.00016800751,0.00007781597],"category_scores_gemma":[0.0001395988,0.00018788739,0.00007001718,0.00014900073,0.0002554826,0.0000873574,0.00014954011,0.00023074917,0.00008962024],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024471893,0.00081609096,0.97945833,0.0002778766,0.002063769,0.0015443607,0.0031475495,0.0005036731,0.0033920987,0.00024714705,0.0016398719,0.0044620326],"study_design_scores_gemma":[0.04340472,0.00088301994,0.9410303,0.00029252208,0.0005259865,0.0030111496,0.000058061258,0.0029231084,0.0074322494,0.00011655866,0.000045083743,0.0002771921],"about_ca_topic_score_codex":0.008851191,"about_ca_topic_score_gemma":0.00010260185,"teacher_disagreement_score":0.040957533,"about_ca_system_score_codex":0.00057060923,"about_ca_system_score_gemma":0.0009654608,"threshold_uncertainty_score":0.997749},"labels":[],"label_agreement":null},{"id":"W2523384776","doi":"10.1182/blood.v112.11.510.510","title":"High Levels of MicroRNA-126 Bioactivity Specify the LSC Compartment in AML","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Discovery Centre; University Health Network","funders":"","keywords":"microRNA; Biology; Stem cell; Leukemia; Myeloid leukemia; Population; Gene expression profiling; Cancer research; Gene expression; Computational biology; Gene; Cell biology; Genetics; Medicine","score_opus":0.021754406822965706,"score_gpt":0.2404339455257944,"score_spread":0.2186795387028287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2523384776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985073,0.00077643275,0.00010194809,0.000118507895,0.00005117051,0.00017439383,0.000059459187,0.000004464269,0.00020629271],"genre_scores_gemma":[0.9992388,0.000058329442,0.00043227695,0.000043052274,0.00010067816,0.000008621272,0.00003591219,0.000009582577,0.00007274623],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99936306,0.000060500963,0.00017143787,0.0001791124,0.000092036076,0.00013383893],"domain_scores_gemma":[0.99951947,0.000010437106,0.000087098764,0.00031877327,0.000033272954,0.000030967585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009088187,0.00009296531,0.000117801595,0.000025190257,0.000039520564,0.0000037554798,0.00013458528,0.0000668379,0.000032380613],"category_scores_gemma":[0.000016994598,0.00007393634,0.00006374903,0.000074235155,0.000110706176,0.0000020709717,0.00006608781,0.000048476293,0.000007450394],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028561566,0.00043261462,0.013827393,0.0000107053775,0.000047540452,0.000005014911,0.000037006866,0.00003036882,0.98494315,0.000049205733,0.0003823407,0.0002061182],"study_design_scores_gemma":[0.00073891826,0.000039406128,0.33101973,0.000005751595,0.000016635258,0.000014818481,0.000007849323,0.0000032216926,0.6665098,0.000025576226,0.0015562167,0.00006208893],"about_ca_topic_score_codex":0.000040512834,"about_ca_topic_score_gemma":0.000042771724,"teacher_disagreement_score":0.31843334,"about_ca_system_score_codex":0.000010256204,"about_ca_system_score_gemma":0.00005026433,"threshold_uncertainty_score":0.30150363},"labels":[],"label_agreement":null},{"id":"W2523433174","doi":"10.1182/blood.v116.21.1094.1094","title":"Prothrombin Complex Concentrate Reverses the Anticoagulant Effect of Rivaroxaban In Healthy Volunteers.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rivaroxaban; Medicine; Antithrombotic; Saline; Anesthesia; Prothrombin complex concentrate; Bolus (digestion); Pharmacodynamics; Anticoagulant; Placebo; Pharmacokinetics; Prothrombin time; Warfarin; Surgery; Pharmacology; Internal medicine; Atrial fibrillation","score_opus":0.013377449769328396,"score_gpt":0.28434505904853535,"score_spread":0.27096760927920693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2523433174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937865,0.0001143715,0.0000032729697,0.0022257632,0.00018945374,0.0018064139,0.00000579087,0.000029859084,0.0018385724],"genre_scores_gemma":[0.9989429,0.000106855834,0.00014435257,0.00058679894,0.00008666375,0.000073574745,0.000011199353,0.000016757907,0.000030905947],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989283,0.00007469392,0.00028980256,0.00020508104,0.0002169146,0.00028520793],"domain_scores_gemma":[0.99932915,0.00007535036,0.00009244157,0.00039385594,0.00003472541,0.00007447888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054848386,0.0001379953,0.0005189247,0.00006195978,0.000052336505,0.00001145482,0.00014057002,0.000057931324,0.00016158857],"category_scores_gemma":[0.00007335249,0.00008646646,0.00008284711,0.00016610388,0.00014762007,0.000031858926,0.000054906177,0.00024637562,0.0000241532],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041178887,0.0059723,0.7596823,0.0017307767,0.0005083148,0.00016854456,0.0015326552,0.000007037326,0.20966639,0.008338699,0.01004556,0.0019356295],"study_design_scores_gemma":[0.007939016,0.0021608686,0.94216526,0.00019543678,0.00036685553,0.000035686182,0.00010219943,0.00010772407,0.04369284,0.000053250245,0.0030500118,0.00013087389],"about_ca_topic_score_codex":0.0008664487,"about_ca_topic_score_gemma":0.00030661878,"teacher_disagreement_score":0.18248293,"about_ca_system_score_codex":0.000012710002,"about_ca_system_score_gemma":0.000051876163,"threshold_uncertainty_score":0.3526},"labels":[],"label_agreement":null},{"id":"W2523522219","doi":"10.1182/blood.v110.11.1277.1277","title":"Differences in the Transcriptomes of Highly Purified Fetal Liver and Adult Bone Marrow Hematopoietic Stem Cells Revealed by Long Serial Analysis of Gene Expression (LongSAGE)","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"","keywords":"Biology; Haematopoiesis; Stem cell; Transcriptome; Molecular biology; Bone marrow; Gene; Embryonic stem cell; Gene expression; Cell biology; Genetics; Immunology","score_opus":0.012290868996831584,"score_gpt":0.22683250676756098,"score_spread":0.2145416377707294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2523522219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967559,0.0012399441,0.001210677,0.000055601446,0.00003959478,0.0004957076,0.00005042729,0.000014721707,0.00013740551],"genre_scores_gemma":[0.99876463,0.00028165532,0.000733535,0.000029938103,0.000023973675,0.00001191164,0.00004218204,0.000013640832,0.00009850322],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99818814,0.00013630989,0.0006890555,0.0002727429,0.0004892819,0.00022449232],"domain_scores_gemma":[0.9991023,0.00024974326,0.0002092298,0.00027687743,0.00008017195,0.0000816612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005584337,0.00017875846,0.0006944955,0.0002742789,0.000029908371,0.000010138542,0.00011723854,0.00014334742,0.00004244535],"category_scores_gemma":[0.000009260175,0.00012370214,0.00014434189,0.0005607444,0.000109020504,0.000057986934,0.000007951609,0.000121860074,9.467441e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035035415,0.0006418393,0.1312415,0.00087421207,0.00031107722,0.00012322806,0.007450559,6.9547644e-7,0.8587788,0.000017407529,0.000013943795,0.0001963787],"study_design_scores_gemma":[0.003658571,0.00017210616,0.16358842,0.00029413172,0.002302208,0.000052084015,0.0014721485,0.000031973417,0.8283163,0.0000036506058,0.0000010003905,0.00010742534],"about_ca_topic_score_codex":0.00009456187,"about_ca_topic_score_gemma":0.000082358616,"teacher_disagreement_score":0.03234691,"about_ca_system_score_codex":0.000008180498,"about_ca_system_score_gemma":0.000021378086,"threshold_uncertainty_score":0.50444263},"labels":[],"label_agreement":null},{"id":"W2523564648","doi":"10.1182/blood.v118.21.5209.5209","title":"Clinical, Phenotypic, and Genetic Characteristics of Non-CLL Type Monoclonal B Lymphocytosis (MBL)","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital; University of Ottawa","funders":"","keywords":"Lymphocytosis; CD5; clone (Java method); Chronic lymphocytic leukemia; Immunophenotyping; Lymphoplasmacytic Lymphoma; IGHV@; Biology; Splenic marginal zone lymphoma; Immunology; Lymphoma; Leukemia; Waldenstrom macroglobulinemia; B cell; Flow cytometry; Genetics; Antibody","score_opus":0.05198640457573206,"score_gpt":0.3189161861868372,"score_spread":0.26692978161110514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2523564648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964184,0.0006915817,0.000039267088,0.000018241175,0.0001407482,0.00027583318,0.000012026919,0.000025361613,0.002378527],"genre_scores_gemma":[0.98951304,0.0018775114,0.007868569,0.0001294804,0.00024659137,0.000009442436,0.000010182696,0.00003399196,0.00031118793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851865,0.00004440642,0.0005335414,0.00031537507,0.00028659162,0.00030142898],"domain_scores_gemma":[0.9987957,0.00013017125,0.00013379837,0.00048807135,0.00019598725,0.00025630184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022127145,0.00015003394,0.00046918148,0.00007973683,0.00003503917,0.000008030292,0.00014496208,0.00016339203,0.0002549417],"category_scores_gemma":[0.0002526769,0.00013034756,0.00008704016,0.00016478775,0.00026466334,0.000031743886,0.00014245466,0.00015058291,0.00010484595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034816014,0.0072623296,0.7863584,0.0014288462,0.0016962202,0.0013948948,0.0019488747,2.7519602e-7,0.02145988,0.0001691233,0.0013830648,0.17341648],"study_design_scores_gemma":[0.033531707,0.0014449883,0.94301665,0.0001785083,0.000685007,0.0005426942,0.00004717672,0.0011502188,0.01811141,0.00009608009,0.00095454766,0.00024103154],"about_ca_topic_score_codex":0.00027962567,"about_ca_topic_score_gemma":0.0000056172253,"teacher_disagreement_score":0.17317545,"about_ca_system_score_codex":0.0003347107,"about_ca_system_score_gemma":0.002603603,"threshold_uncertainty_score":0.53154194},"labels":[],"label_agreement":null},{"id":"W2523611938","doi":"10.1182/blood.v122.21.500.500","title":"Genetic Alterations In Immune Cell Crosstalk Genes In Diffuse Large B-Cell Lymphoma Predict Survival","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Biology; Lymphoma; Proportional hazards model; Cancer research; Oncology; Medicine; Immunology; Internal medicine","score_opus":0.007682276603494731,"score_gpt":0.22125829962040677,"score_spread":0.21357602301691203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2523611938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99148685,0.0045579807,0.0000065462677,0.00015982188,0.000119626944,0.000762668,0.00003517115,0.000038746377,0.002832566],"genre_scores_gemma":[0.9975788,0.0005461353,0.00043487785,0.0001026945,0.00009429244,0.0003849201,0.000064404245,0.000029907627,0.00076397916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985968,0.000058674494,0.0004094278,0.00031589073,0.00020533605,0.0004139084],"domain_scores_gemma":[0.99929523,0.00007135537,0.00006277667,0.00039321478,0.000045315213,0.00013210904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008264307,0.00020357333,0.000331874,0.00014434983,0.000058954032,0.000057621637,0.00009168304,0.000099874975,0.00016195033],"category_scores_gemma":[0.000016255455,0.00017139084,0.00009497913,0.00020578584,0.00003149787,0.00008795159,0.000063574094,0.000054911845,0.00023930392],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026886664,0.053301815,0.9334559,0.000074747484,0.000042873417,0.00037401647,0.0004887499,0.000006432991,0.010628574,0.000025364065,0.00012791029,0.0014467645],"study_design_scores_gemma":[0.058775306,0.00023987258,0.9035804,0.000057187015,0.000093554285,0.000025055071,0.00012810937,0.000261814,0.036137212,0.000026068366,0.000522786,0.00015258693],"about_ca_topic_score_codex":0.0017283162,"about_ca_topic_score_gemma":0.00046940625,"teacher_disagreement_score":0.058748417,"about_ca_system_score_codex":0.00009566179,"about_ca_system_score_gemma":0.0001232142,"threshold_uncertainty_score":0.69891155},"labels":[],"label_agreement":null},{"id":"W2523753771","doi":"10.1182/blood.v122.21.2386.2386","title":"Oral Anticoagulation Treatment and Persistence After Venous Thromboembolism In a Real World Population: The Q-VTE Study Cohort","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Cohort; Venous thromboembolism; Medical prescription; Population; Pediatrics; Internal medicine; Pulmonary embolism; Cohort study; Vitamin K antagonist; Diagnosis code; Intensive care medicine; Emergency medicine; Thrombosis; Warfarin; Atrial fibrillation","score_opus":0.02576221863970862,"score_gpt":0.27711119142205826,"score_spread":0.25134897278234963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2523753771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947944,0.00024447934,0.0000011802313,0.0007146226,0.00007585392,0.0025730275,0.0000015757446,0.00003839527,0.0015564439],"genre_scores_gemma":[0.9985421,0.00019225324,0.00010484221,0.00021888793,0.00010105333,0.00053261925,0.000012186165,0.000018212653,0.00027785762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893254,0.00006942106,0.0002531574,0.00030603036,0.0002014602,0.0002373984],"domain_scores_gemma":[0.99946094,0.000032083553,0.00005861837,0.00033653952,0.000038729926,0.000073102696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001587175,0.00016707934,0.00045768483,0.000118473894,0.00009878057,0.000062192434,0.00005508187,0.000034253815,0.0001336188],"category_scores_gemma":[0.000009779052,0.00010971153,0.000053178795,0.00021081809,0.00004313914,0.00014117635,0.000050121842,0.00007458158,0.000029430299],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016810522,0.0046379976,0.9891946,0.000019688418,0.00024734932,0.00004042873,0.0023764134,0.000006912194,0.000036132755,0.000114950366,0.000049659484,0.0032590919],"study_design_scores_gemma":[0.0022893697,0.00080808834,0.99478406,0.000047509704,0.0008308236,0.000010521615,0.0007966325,0.0000901999,0.000018641265,0.00011111474,0.00009926911,0.0001137786],"about_ca_topic_score_codex":0.00883684,"about_ca_topic_score_gemma":0.0036104699,"teacher_disagreement_score":0.005589486,"about_ca_system_score_codex":0.00007216587,"about_ca_system_score_gemma":0.00001881865,"threshold_uncertainty_score":0.9977634},"labels":[],"label_agreement":null},{"id":"W2523786227","doi":"10.1182/blood.v116.21.1954.1954","title":"Pooled Safety Analysis From Phase (Ph) 1 and 2 Studies of Carfilzomib (CFZ) In Patients with Relapsed and/or Refractory Multiple Myeloma (MM)","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Carfilzomib; Tolerability; Proteasome inhibitor; Neutropenia; Bortezomib; Medicine; Adverse effect; Internal medicine; Pharmacology; Multiple myeloma; Toxicity","score_opus":0.01912431446018829,"score_gpt":0.3009066052993577,"score_spread":0.2817822908391694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2523786227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983965,0.0005783252,0.0000036582687,0.000050117378,0.000019900848,0.00055661815,0.00030421882,0.00001828301,0.00007236006],"genre_scores_gemma":[0.9977997,0.00017322287,0.0015399246,0.000021141526,0.000026790669,0.000030433222,0.00026427253,0.000017835295,0.00012670983],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866325,0.00006461793,0.000315493,0.00036148445,0.00032798268,0.0002671553],"domain_scores_gemma":[0.99882185,0.0003328948,0.000116263414,0.00033677282,0.00018199174,0.00021022519],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014383774,0.00018909184,0.00064245163,0.00029318393,0.00006826196,0.000010028643,0.000055863686,0.000089976325,0.000081320555],"category_scores_gemma":[0.0005913865,0.00011908046,0.000056193327,0.00038558553,0.00018136743,0.00009346639,0.00007715002,0.00023591965,0.0000019838856],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006456325,0.0031215989,0.97316295,0.00006057892,0.0039765066,0.00015085658,0.0006812317,2.164976e-7,0.0053969384,0.00000351591,0.000009752014,0.006979523],"study_design_scores_gemma":[0.06451027,0.0015027897,0.92783743,0.000065853856,0.0017974665,0.000002054287,0.00032482672,0.00008832656,0.0036546618,0.000006993835,0.000094811054,0.000114535294],"about_ca_topic_score_codex":0.0007941386,"about_ca_topic_score_gemma":0.002700911,"teacher_disagreement_score":0.058053948,"about_ca_system_score_codex":0.000022739845,"about_ca_system_score_gemma":0.00005900627,"threshold_uncertainty_score":0.48559603},"labels":[],"label_agreement":null},{"id":"W2523935751","doi":"10.1182/blood.v114.22.1903.1903","title":"Diagnosis and Treatment of Essential Thrombocythemia: Assessment of Current Clinical Practice.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Paul's Hospital; Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Medicine; Essential thrombocythemia; Anagrelide; Cohort; Biopsy; Hematologist; Thrombosis; Medical history; Pediatrics; Internal medicine; Surgery; Polycythemia vera; Disease","score_opus":0.05866891199116746,"score_gpt":0.4357470174500861,"score_spread":0.3770781054589186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2523935751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916704,0.004355537,0.000029865636,0.0011650815,0.000108902794,0.00068621157,0.000026860198,0.000015783638,0.0019413073],"genre_scores_gemma":[0.9765789,0.017861204,0.00518397,0.000068979694,0.00017567023,0.000083337975,0.000022704058,0.000009545299,0.000015685615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985615,0.00008827796,0.0005949242,0.00030067016,0.0002950547,0.00015955712],"domain_scores_gemma":[0.9987089,0.0004082297,0.00029317636,0.00027918586,0.00016796788,0.00014255747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017015233,0.00018437259,0.0007040154,0.000059713424,0.000033687993,0.000007961093,0.00003489188,0.0000825027,0.00006854728],"category_scores_gemma":[0.0001416477,0.00012977238,0.00018277718,0.00009209096,0.00008979913,0.00006139147,0.00001723328,0.0000914113,0.0000022354818],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013580224,0.04527411,0.8381328,0.00007060813,0.0008583554,0.00007210056,0.00022190994,6.999944e-7,0.0006714078,0.0022220972,0.00019708335,0.11214301],"study_design_scores_gemma":[0.011973753,0.010118831,0.9144117,0.0002349821,0.0027813567,0.00006388647,0.00007055402,0.000016515378,0.055444572,0.00009269597,0.0046657478,0.00012541054],"about_ca_topic_score_codex":0.000013832861,"about_ca_topic_score_gemma":0.0000043042096,"teacher_disagreement_score":0.112017594,"about_ca_system_score_codex":0.000037976137,"about_ca_system_score_gemma":0.00016848679,"threshold_uncertainty_score":0.52919644},"labels":[],"label_agreement":null},{"id":"W2523982099","doi":"10.1182/blood.v118.21.366.366","title":"The Functional Role of TLR9 in Human Platelets","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"TLR9; Cell biology; Endosome; Biology; Platelet; Intracellular; Innate immune system; Receptor; Tetraspanin; Chemistry; Immune system; Immunology; Cell; Gene expression; Biochemistry","score_opus":0.02022912066585301,"score_gpt":0.22921101896405782,"score_spread":0.20898189829820482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2523982099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96909803,0.0005900738,6.6204797e-7,0.000024950255,0.000021894002,0.00008761949,0.0000018302705,0.0000081100225,0.030166812],"genre_scores_gemma":[0.99955314,0.000027160759,0.000035665864,0.00002060932,0.000013846405,0.00000824941,0.000007913498,0.000005106041,0.0003282785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996515,0.0000066944613,0.000100578836,0.0000681464,0.00007914969,0.000093954564],"domain_scores_gemma":[0.9998194,0.000013186581,0.000026794223,0.00010174777,0.000015015919,0.000023836332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000041792326,0.000045730303,0.000095572825,0.000027361533,0.00003664565,0.0000016039135,0.000028952925,0.000028767023,0.00010576913],"category_scores_gemma":[0.0000076896295,0.000028900637,0.00003012308,0.00004935495,0.000027565571,0.000016181688,0.000010306246,0.000049298396,0.000017690789],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035243205,0.008315333,0.94607586,0.000027770995,0.0005278722,0.00067370554,0.0012964313,6.716171e-7,0.022337789,0.006452699,0.00038615393,0.013553299],"study_design_scores_gemma":[0.006337096,0.00039277345,0.9383237,0.000030619638,0.00010142769,0.000120346616,0.00021973452,0.000007620496,0.047760822,0.0050768573,0.0015659386,0.00006307546],"about_ca_topic_score_codex":0.000117842545,"about_ca_topic_score_gemma":0.000078244826,"teacher_disagreement_score":0.030455124,"about_ca_system_score_codex":0.000004343382,"about_ca_system_score_gemma":0.0000158523,"threshold_uncertainty_score":0.11785338},"labels":[],"label_agreement":null},{"id":"W2524129486","doi":"10.1182/blood.v126.23.2936.2936","title":"Insights into the Management of Adverse Events in Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Experience from the Phase 3 HELIOS Study of Ibrutinib Combined with Bendamustine/Rituximab","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Ibrutinib; Bendamustine; Medicine; Internal medicine; Adverse effect; Chronic lymphocytic leukemia; Placebo; Rituximab; Ofatumumab; Oncology; Clinical endpoint; Neutropenia; Phases of clinical research; Randomized controlled trial; Lymphoma; Leukemia; Clinical trial; Chemotherapy; Pathology","score_opus":0.019031699791781185,"score_gpt":0.2684478979602277,"score_spread":0.24941619816844654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2524129486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934428,0.0007925731,0.00001040821,0.000013162551,0.000062101746,0.005401469,0.000011793956,0.000060443195,0.00020524902],"genre_scores_gemma":[0.9988425,0.00006857643,0.0001927616,0.000048192313,0.000049662034,0.00052241655,0.00008895827,0.00008323338,0.000103735074],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99531746,0.00034162693,0.0010272984,0.0008275328,0.0017881165,0.00069794705],"domain_scores_gemma":[0.9965525,0.00027567096,0.00051525224,0.001850065,0.0004965208,0.00030995876],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037358413,0.00056558003,0.0010099598,0.00022347526,0.00013930618,0.0000113946,0.00093460636,0.00012700392,0.00001986346],"category_scores_gemma":[0.00008980253,0.00029810585,0.000103882136,0.0014764348,0.0004831694,0.00016880628,0.00043116638,0.00018517862,0.000018999917],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.13960774,0.11106907,0.45013905,0.0040623443,0.0141388625,0.004603344,0.2534277,0.0090907505,0.0006527612,0.00017306222,0.00011945257,0.012915868],"study_design_scores_gemma":[0.86915946,0.017341029,0.07838605,0.0024415303,0.0022345914,0.00004485808,0.017417535,0.007457796,0.0049201497,0.0000222839,0.0000462891,0.0005284411],"about_ca_topic_score_codex":0.014236525,"about_ca_topic_score_gemma":0.0018923517,"teacher_disagreement_score":0.72955173,"about_ca_system_score_codex":0.03249916,"about_ca_system_score_gemma":0.016499816,"threshold_uncertainty_score":0.99994713},"labels":[],"label_agreement":null},{"id":"W2524172386","doi":"10.1182/blood.v106.11.1619.1619","title":"Computerized Tomographic Pulmonary Angiography Compared with Ventilation-Perfusion Lung Scanning as Inital Diagnostic Modality for Patients with Suspected Pulmonary Embolism: A Randomized Controlled Trial.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Ultrasound in Clinical Applications","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McGill University; Ottawa Hospital; Capital District Health Authority","funders":"","keywords":"Medicine; Pulmonary embolism; Pulmonary angiography; Radiology; Angiography; Deep vein; Lung; Thrombosis; Pre- and post-test probability; Venous thrombosis; Surgery; Internal medicine","score_opus":0.008936536654688224,"score_gpt":0.26784137151029636,"score_spread":0.2589048348556081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2524172386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9765556,0.0004185348,0.0029464723,0.0006054332,0.00013069146,0.018473804,0.00007435052,0.0002691311,0.0005259784],"genre_scores_gemma":[0.98304105,0.000044116015,0.009948895,0.00022022329,0.00049981964,0.0048876065,0.0012473599,0.00006858788,0.000042361953],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99675864,0.00026415562,0.0012132842,0.0006760549,0.0006394088,0.00044847952],"domain_scores_gemma":[0.9916177,0.006243194,0.0006166175,0.0005591133,0.0006622296,0.00030117488],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000674227,0.0004247277,0.0020372982,0.00038145075,0.00030697967,0.00006992149,0.00019952038,0.00016886514,0.000082606835],"category_scores_gemma":[0.0010753942,0.00029181386,0.0009248614,0.00092175236,0.00035041774,0.00019508292,0.000045310193,0.00027106656,0.000006252098],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8861935,0.0109636085,0.10034168,0.00006645978,0.0015156199,0.00001520069,0.00011263862,0.000057171972,0.0002376884,0.00018680525,0.000041476836,0.00026815187],"study_design_scores_gemma":[0.8692901,0.0010635538,0.120576374,0.00029873874,0.004010621,0.000032057553,0.000026944013,0.0039336532,0.000046006906,0.00030296476,0.000066610315,0.00035237364],"about_ca_topic_score_codex":0.000035641686,"about_ca_topic_score_gemma":0.0000080891705,"teacher_disagreement_score":0.020234697,"about_ca_system_score_codex":0.000033980737,"about_ca_system_score_gemma":0.00014539945,"threshold_uncertainty_score":0.9999534},"labels":[],"label_agreement":null},{"id":"W2524327689","doi":"10.1182/blood.v122.21.2517.2517","title":"The Role Of BIN1 Tumor Suppressor Isoforms In Regulation Of Proliferation, Apoptosis and Tumor Formation Of Human Cutanous T-Cell Lymphoma Cells In Vitro and In Vivo","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Mycosis fungoides; Cancer research; Biology; Lymphoma; Oncogene; Downregulation and upregulation; Leukemia; Cell culture; Cancer; Immunology; Cell cycle; Gene","score_opus":0.006069605604611075,"score_gpt":0.228142986085162,"score_spread":0.22207338048055092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2524327689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99780935,0.00026523788,0.0000030863125,0.00009366718,0.00000597957,0.0014242219,0.000017125043,0.000004376528,0.00037694044],"genre_scores_gemma":[0.9996087,0.00004323843,0.0001322314,0.000012991682,0.000007742076,0.00010507306,0.000012758179,0.000014345352,0.000062934734],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99846625,0.000101868565,0.0007265896,0.00017576592,0.00031554638,0.00021395889],"domain_scores_gemma":[0.9991817,0.00011706562,0.00024072366,0.00021121866,0.00020464073,0.000044680914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000358449,0.0001235493,0.00036974804,0.00033901221,0.00003887021,0.000018593371,0.00007680785,0.00005544666,0.00001952906],"category_scores_gemma":[0.000116379284,0.00009237847,0.000030718256,0.0003067789,0.00011081513,0.00019559206,0.000048667807,0.00006954878,9.3217704e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035183062,0.00086728006,0.07454361,0.00030446233,0.000008459946,0.000001632552,0.0019841965,0.0000114929835,0.92133397,0.00002024194,0.000011324756,0.0005615217],"study_design_scores_gemma":[0.0051869764,0.000344669,0.031107679,0.000101335725,0.000015271342,0.00004274243,0.001264544,0.0054968214,0.955809,0.0005520603,0.0000051285615,0.00007374812],"about_ca_topic_score_codex":0.00065371924,"about_ca_topic_score_gemma":0.00040119924,"teacher_disagreement_score":0.04343593,"about_ca_system_score_codex":0.00006564535,"about_ca_system_score_gemma":0.000082681225,"threshold_uncertainty_score":0.37670845},"labels":[],"label_agreement":null},{"id":"W2524477322","doi":"10.1182/blood.v120.21.745.745","title":"Gemcitabine, Dexamethasone, Cisplatin (GDP) Compared to Dexamethasone, Cytarabine, Cisplatin (DHAP) Chemotherapy Prior to Autologous Stem Cell Transplantation for Relapsed and Refractory Aggressive Lymphomas: Final Results of the Randomized Phase III NCIC CTG Study LY12","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research; Université de Montréal; Queen's University; London Health Sciences Centre; McMaster University; Sunnybrook Health Science Centre; University of Manitoba; Juravinski Cancer Centre; Credit Valley Hospital; Saskatchewan Cancer Agency; CancerCare Manitoba; Health Sciences Centre; Dalhousie University; Princess Margaret Cancer Centre","funders":"","keywords":"DHAP; Medicine; Internal medicine; Autologous stem-cell transplantation; Transplantation; Oncology; Gemcitabine; Urology; Gastroenterology; Chemotherapy; Surgery","score_opus":0.02409864014999413,"score_gpt":0.29737026374673914,"score_spread":0.273271623596745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2524477322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861214,0.0014210118,0.000659261,0.00043688662,0.00026106965,0.010342198,0.0003958804,0.00007590364,0.00028637538],"genre_scores_gemma":[0.9878696,0.00015307586,0.009507985,0.00037119005,0.00014105656,0.0014225696,0.000093672745,0.000075182754,0.00036563727],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99615735,0.000509871,0.0013166827,0.0007248572,0.0006292503,0.00066198746],"domain_scores_gemma":[0.9951762,0.0023884356,0.00092912954,0.0007679759,0.0002709866,0.0004672754],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014295976,0.00057277904,0.0017307042,0.00027022028,0.00023130285,0.000036934685,0.000243664,0.00021002314,0.000027837388],"category_scores_gemma":[0.00044809017,0.00038942148,0.00035662524,0.00050135166,0.0001282718,0.00015086171,0.000055735673,0.00015899414,0.000009408004],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.70376694,0.04617572,0.07503376,0.000852003,0.0030451466,0.00020046771,0.053643752,0.00010318831,0.03423964,0.00008957374,0.0016832139,0.081166565],"study_design_scores_gemma":[0.745836,0.0035276716,0.16815263,0.0004894437,0.0035550166,0.00014114307,0.0011015745,0.00019423914,0.07623131,0.000011094878,0.00030372376,0.0004561229],"about_ca_topic_score_codex":0.00028591347,"about_ca_topic_score_gemma":0.00007672194,"teacher_disagreement_score":0.09311886,"about_ca_system_score_codex":0.0001689085,"about_ca_system_score_gemma":0.00023334981,"threshold_uncertainty_score":0.99985576},"labels":[],"label_agreement":null},{"id":"W2524493588","doi":"10.1182/blood.v124.21.961.961","title":"The FLAG Chemotherapy Regimen Is an Alternative to Anthracycline Based Therapy for the Treatment of Acute Myeloid Leukemia for Patients with Multiple Co-Morbidities or Preexisting Cardiac Disease","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Flag (linear algebra); Anthracycline; Cytarabine; Internal medicine; Regimen; Myeloid leukemia; Surgery; Filgrastim; Chemotherapy regimen; Cardiotoxicity; Fludarabine; Chemotherapy; Neutropenia; Cancer; Cyclophosphamide; Breast cancer","score_opus":0.02900352675951404,"score_gpt":0.3261072911198131,"score_spread":0.29710376436029906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2524493588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987627,0.00023630405,0.0020993226,0.0018678646,0.00007992903,0.00681363,0.0011852428,0.000046217385,0.000044484703],"genre_scores_gemma":[0.98754394,0.0008804605,0.0055226884,0.00081990054,0.00071511127,0.0027086833,0.00037541948,0.00012346999,0.0013103499],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982364,0.00010021342,0.00030743756,0.00042924646,0.00046498948,0.00046168047],"domain_scores_gemma":[0.99611664,0.0021378666,0.00019382102,0.0008522671,0.000448632,0.00025074818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003639285,0.0002995351,0.00046052356,0.00006562724,0.0004106851,0.00004746478,0.00030866428,0.000056408604,0.000014381327],"category_scores_gemma":[0.00022798649,0.0001346583,0.00020833196,0.00013811047,0.00021373399,0.00007481559,0.000016595435,0.000082987804,0.0000018513505],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2435777,0.012957965,0.29077062,0.00054868247,0.015784945,0.000024305373,0.02017948,0.00027386224,0.013898217,0.00024959247,0.012366152,0.38936847],"study_design_scores_gemma":[0.16356361,0.06612342,0.18598989,0.00035010133,0.002685963,0.0000033135543,0.0014364275,0.041026272,0.36133525,0.00016130348,0.17635325,0.0009712261],"about_ca_topic_score_codex":0.00017270421,"about_ca_topic_score_gemma":0.000022525408,"teacher_disagreement_score":0.38839725,"about_ca_system_score_codex":0.00025247288,"about_ca_system_score_gemma":0.0005023724,"threshold_uncertainty_score":0.5491206},"labels":[],"label_agreement":null},{"id":"W2524531748","doi":"10.1182/blood.v122.21.2377.2377","title":"Comparison Of Ultrasound Versus Magnetic Resonance Venography For Diagnosis Of Catheter-Related Thrombosis In Children: A Multicenter Multinational Study","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Central Venous Catheters and Hemodialysis","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Asymptomatic; Radiology; Central venous catheter; Magnetic resonance imaging; Catheter; Venous thrombosis; Venography; Population; Thrombosis; Surgery","score_opus":0.037992274733098914,"score_gpt":0.3647343678222854,"score_spread":0.3267420930891865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2524531748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995564,0.00089365884,0.0000041847134,0.000052629886,0.00014255047,0.0031035938,0.00013937178,0.000017522607,0.00008249038],"genre_scores_gemma":[0.99821556,0.000078589626,0.0005958191,0.000019671757,0.00003005475,0.0009800048,0.00004216612,0.00002228962,0.00001583593],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980637,0.00020979278,0.00085847935,0.00027133955,0.00022852798,0.0003681665],"domain_scores_gemma":[0.9978577,0.0012529871,0.00035096105,0.00027442636,0.00020106763,0.00006288709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025629235,0.0001553667,0.0005177428,0.00020338004,0.00015149027,0.0000051075267,0.00019606831,0.00012776945,0.0003518072],"category_scores_gemma":[0.00020746917,0.00014334553,0.00019576217,0.00033252517,0.00007507846,0.000072978095,0.00004760122,0.0002128743,0.000015243455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000080179445,0.0118248565,0.9743263,0.000060142687,0.00014188506,9.116023e-8,0.012219198,0.000007868758,0.00034966005,0.000021592883,0.00016362895,0.00080457656],"study_design_scores_gemma":[0.010602289,0.001347466,0.98419017,0.00013177563,0.0002799883,9.143812e-8,0.0025971837,0.00013784005,0.00050513656,0.00003150364,0.0000466881,0.00012985327],"about_ca_topic_score_codex":0.0013413734,"about_ca_topic_score_gemma":0.00037314757,"teacher_disagreement_score":0.010522109,"about_ca_system_score_codex":0.00003267695,"about_ca_system_score_gemma":0.000040222163,"threshold_uncertainty_score":0.5845461},"labels":[],"label_agreement":null},{"id":"W2524550612","doi":"10.1182/blood.v126.23.2086.2086","title":"Assessment of Multiple Myeloma Patient Preferences on Treatment Choices: An International Discrete Choice Study","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Lenalidomide; Multiple myeloma; Adverse effect; Neutropenia; Internal medicine; Bortezomib; Thalidomide; Oncology; Surgery; Chemotherapy","score_opus":0.08459238000182355,"score_gpt":0.3872454119856169,"score_spread":0.30265303198379334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2524550612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903104,0.000035657155,0.0000063590196,0.000047476566,0.0001227951,0.0012482705,0.0000892222,0.00004118763,0.0080986805],"genre_scores_gemma":[0.99808806,0.000018986058,0.0010268233,0.00001970793,0.00012403136,0.0002458455,0.00019870356,0.00001732702,0.00026050903],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99814254,0.00011847954,0.0002910841,0.0003692924,0.00084262324,0.00023600682],"domain_scores_gemma":[0.9987322,0.00012500909,0.00011853929,0.00044908008,0.00019398105,0.00038118658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011562127,0.00020290115,0.00032052523,0.00013954671,0.000045165438,0.00002862567,0.00015004013,0.000042426793,0.00007002412],"category_scores_gemma":[0.00017243868,0.00012866972,0.00007543579,0.0001003775,0.000039736755,0.00014086581,0.00005574058,0.00008954709,0.000017591763],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003146177,0.019229993,0.9617184,0.000011230596,0.00082731684,0.00008263575,0.0007564938,0.000018526684,0.00037141627,0.0000163942,0.0000081695025,0.016644843],"study_design_scores_gemma":[0.01915384,0.02201952,0.95227176,0.00005263712,0.00018547813,0.000007486634,0.0009295223,0.0005959281,0.0038722774,0.000009729497,0.00079581945,0.00010598914],"about_ca_topic_score_codex":0.0013314228,"about_ca_topic_score_gemma":0.00064890477,"teacher_disagreement_score":0.018839223,"about_ca_system_score_codex":0.00017519832,"about_ca_system_score_gemma":0.00020070212,"threshold_uncertainty_score":0.5246999},"labels":[],"label_agreement":null},{"id":"W2524564151","doi":"10.1182/blood.v104.11.707.707","title":"Fixed-Dose, Weight-Adjusted, Unfractionated Heparin (UFH) Given Subcutaneously (sc) without Laboratory Monitoring for Acute Treatment of Venous Thromboembolism (VTE): Randomized Comparison with Low-Molecular-Weight-Heparin (LMWH).","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McMaster University","funders":"","keywords":"Medicine; Low molecular weight heparin; Partial thromboplastin time; Heparin; Venous thromboembolism; Warfarin; Anticoagulant; Anesthesia; Surgery; Internal medicine; Thrombosis; Platelet; Atrial fibrillation","score_opus":0.011414728709883538,"score_gpt":0.27985457947211434,"score_spread":0.2684398507622308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2524564151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98916835,0.0023714446,0.00085022603,0.00059473614,0.000587464,0.005001461,0.00010106532,0.00028601228,0.0010392154],"genre_scores_gemma":[0.9899163,0.001430853,0.006477206,0.00012770087,0.00040576866,0.0010338327,0.00021886753,0.00017386043,0.00021561467],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99632925,0.00016242161,0.001066074,0.0008693904,0.0007589092,0.00081394386],"domain_scores_gemma":[0.99733186,0.00022420629,0.0006850207,0.0008694054,0.00053127104,0.00035826772],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031479157,0.0007444567,0.003317573,0.00035391568,0.00025913992,0.00006458756,0.0002646345,0.00028896696,0.00004297879],"category_scores_gemma":[0.00006269262,0.00058472366,0.0004968056,0.0005363248,0.0002566827,0.00017450088,0.00007299921,0.00026085644,0.00003059048],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22288981,0.208503,0.08779687,0.0042268834,0.107091665,0.007940485,0.020540394,0.008554863,0.30410153,0.013166313,0.0024622367,0.012725972],"study_design_scores_gemma":[0.49048868,0.009801249,0.030033445,0.0013525365,0.026387973,0.0003604878,0.0005770292,0.00024478766,0.43441588,0.00040316881,0.0045676203,0.001367162],"about_ca_topic_score_codex":0.00080220477,"about_ca_topic_score_gemma":0.000119900986,"teacher_disagreement_score":0.26759887,"about_ca_system_score_codex":0.0004273984,"about_ca_system_score_gemma":0.00049776485,"threshold_uncertainty_score":0.99966043},"labels":[],"label_agreement":null},{"id":"W2524573478","doi":"10.1182/blood.v120.21.322.322","title":"Mir-137 and Mir-197 within Chromosome 1p Minimal Deletion Region Regulate Apoptotic Activity in Multiple Myeloma by Targeting MCL 1","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Biology; Molecular biology; microRNA; Transfection; Apoptosis; Gene; Cell culture; Cell growth; Population; Annexin; MiRBase; Cancer research; Cell biology; Genetics; Flow cytometry; Medicine","score_opus":0.010429941125081992,"score_gpt":0.22113375424495588,"score_spread":0.21070381311987388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2524573478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976025,0.001710243,0.0001781254,0.0000776217,0.00008632206,0.0002773,0.000018143552,0.000021694525,0.000028046969],"genre_scores_gemma":[0.99849206,0.00003079245,0.0008808208,0.000036636095,0.00022546042,0.000027721768,0.00021870779,0.000033380693,0.000054403332],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99878204,0.00012606278,0.000237148,0.00037132262,0.0001240137,0.00035939645],"domain_scores_gemma":[0.99939543,0.000017818122,0.00016061163,0.0002512924,0.000037839738,0.00013700183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024197866,0.0001954841,0.00016860728,0.00005113214,0.00008334305,0.000022543762,0.0000882194,0.00022779283,0.000005880776],"category_scores_gemma":[0.00012951482,0.0002084017,0.000054853157,0.00009634826,0.00007834906,0.000024797844,0.00008899943,0.00009813117,0.0000054066295],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000101980164,0.00032659777,0.029025346,0.00005511691,0.000032543365,0.000002314572,0.00012031763,0.0000101495,0.96959215,0.0000061331275,0.00048204034,0.00024533397],"study_design_scores_gemma":[0.001539566,0.00008956739,0.09169741,0.000037076665,0.000044251454,0.000037927384,0.00003682472,0.00024783265,0.90508604,0.0000130048,0.00090953714,0.00026096663],"about_ca_topic_score_codex":0.000045521752,"about_ca_topic_score_gemma":0.00002174438,"teacher_disagreement_score":0.06450609,"about_ca_system_score_codex":0.000028702205,"about_ca_system_score_gemma":0.000027892778,"threshold_uncertainty_score":0.8498375},"labels":[],"label_agreement":null},{"id":"W2524578933","doi":"10.1182/blood.v122.21.368.368","title":"High Response Rates To Crizotinib In Advanced, Chemoresistant ALK+ Lymphoma Patients","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont; Trillium Health Centre","funders":"","keywords":"Crizotinib; Anaplastic lymphoma kinase; Medicine; Lymphoma; Anaplastic large-cell lymphoma; Internal medicine; ALK inhibitor; Cancer research; Lung cancer; Oncology","score_opus":0.006270069326756354,"score_gpt":0.23959348460421814,"score_spread":0.23332341527746178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2524578933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99661845,0.00019212502,4.4796488e-7,0.0015844571,0.00008886166,0.0008658875,0.00001658268,0.000044964407,0.0005882523],"genre_scores_gemma":[0.9963202,0.000026191166,0.0016752308,0.0009784817,0.00003965676,0.0004284797,0.00003079097,0.000025088317,0.00047591192],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881357,0.000046981855,0.0002771209,0.0003169608,0.00022744053,0.00031790297],"domain_scores_gemma":[0.9991566,0.00013199732,0.000050147337,0.00033795196,0.000104742045,0.00021859675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000089172216,0.0001794706,0.00030030106,0.00012371517,0.0000371485,0.00002492394,0.00007581982,0.000059831,0.00019672558],"category_scores_gemma":[0.00025632247,0.00013922887,0.0000621907,0.0002199058,0.000020212998,0.000078229634,0.00005077362,0.000029472674,0.00063371606],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022500043,0.010312277,0.94490564,0.000045227884,0.000093946,0.00028520083,0.00037891767,0.00000263589,0.009758538,0.00010049756,0.003019803,0.028847335],"study_design_scores_gemma":[0.01774191,0.00082514196,0.88289964,0.000121737634,0.00005790338,0.000008434107,0.00006054815,0.000001315505,0.09595833,0.000044377444,0.0021477542,0.0001329099],"about_ca_topic_score_codex":0.00035583202,"about_ca_topic_score_gemma":0.000026411823,"teacher_disagreement_score":0.08619979,"about_ca_system_score_codex":0.00014483342,"about_ca_system_score_gemma":0.00008223559,"threshold_uncertainty_score":0.8145349},"labels":[],"label_agreement":null},{"id":"W2524612734","doi":"10.1182/blood.v104.11.3189.3189","title":"Iron Acquisition in Reticulocytes: Evidence for a Kiss and Run Mechanism.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Endosome; Endocytosis; Ferrochelatase; Transferrin receptor; Cell biology; Internalization; Chemistry; Mitochondrion; Biochemistry; Transferrin; Biophysics; Ferritin; Cytoplasm; Heme; Receptor; Biology; Enzyme","score_opus":0.020859125200388108,"score_gpt":0.28666256488378467,"score_spread":0.26580343968339654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2524612734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934606,0.0036981977,0.0011077861,0.0010071379,0.00004512118,0.00044856244,0.0000030365666,0.0000257539,0.00020381669],"genre_scores_gemma":[0.9944609,0.0003996275,0.004382667,0.0005649274,0.00007109641,0.000044504704,0.0000070913707,0.000010230123,0.000058997408],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994589,0.000009715255,0.00011618118,0.00016895968,0.00009783406,0.00014839334],"domain_scores_gemma":[0.99973994,0.000033079188,0.000024749887,0.0001200228,0.000023766172,0.000058440924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001346674,0.00007438633,0.00013414293,0.000059806636,0.00002871302,0.00000938631,0.000029077282,0.000058344398,0.0000182974],"category_scores_gemma":[0.00012607574,0.00006593183,0.000028400662,0.00007834452,0.000024760342,0.000076234544,0.000013727456,0.00004753464,0.0000070236415],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00396035,0.007044469,0.038872927,0.0066459826,0.00008486485,0.0004008204,0.012559469,0.00009109676,0.6838471,0.22949919,0.0005283428,0.01646537],"study_design_scores_gemma":[0.110587,0.004648103,0.34063902,0.0037650177,0.0019429543,0.00041633076,0.003941431,0.00012795739,0.4206253,0.11110656,0.0010236482,0.0011766623],"about_ca_topic_score_codex":0.00004788491,"about_ca_topic_score_gemma":0.000015665002,"teacher_disagreement_score":0.3017661,"about_ca_system_score_codex":0.0000120399645,"about_ca_system_score_gemma":0.00004362712,"threshold_uncertainty_score":0.26886222},"labels":[],"label_agreement":null},{"id":"W2524612988","doi":"10.1182/blood.v126.23.1247.1247","title":"Integrative Analysis of the Mutational Landscape of Mouse and Human AML Identifies Functionally Relevant Leukemia Disease Alleles","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Biology; Myeloid leukemia; Leukemia; Genetics; Allele; Immunophenotyping; Cancer research; Myeloid; Exome sequencing; Exome; Mutation; Gene; Flow cytometry","score_opus":0.020706417938867315,"score_gpt":0.2877555855156352,"score_spread":0.2670491675767679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2524612988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99825126,0.00032547186,0.000042182797,0.00036578096,0.000016688608,0.00017704532,0.000112377944,0.000011430802,0.0006977403],"genre_scores_gemma":[0.9961672,0.000021790036,0.00015955229,0.000045964865,0.00003957454,0.000014686247,0.00016089316,0.0000097763805,0.0033805578],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881244,0.00008126374,0.00026411464,0.0001785895,0.0005531864,0.00011042099],"domain_scores_gemma":[0.9988499,0.00013147575,0.0001289019,0.000266245,0.0004781056,0.00014531735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026536017,0.00009794426,0.00028841832,0.00024544293,0.000050240204,0.0000108573595,0.00011172257,0.000042782565,0.00007686257],"category_scores_gemma":[0.0005359587,0.00005961409,0.00013719764,0.0004743048,0.0002422625,0.000060599905,0.00009397048,0.0001459715,0.0000025268102],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000985585,0.00089287094,0.9137489,0.00023551402,0.007642304,0.0000612926,0.0035834596,0.0006522618,0.057532217,0.0054144426,0.009087925,0.00016322877],"study_design_scores_gemma":[0.003839192,0.00019517129,0.97529656,0.000065079104,0.003823165,0.0000119856995,0.0025292584,0.00132902,0.012052645,0.00061584375,0.0001384151,0.00010365385],"about_ca_topic_score_codex":0.00017119442,"about_ca_topic_score_gemma":0.00022342046,"teacher_disagreement_score":0.06154767,"about_ca_system_score_codex":0.00006863933,"about_ca_system_score_gemma":0.0006351491,"threshold_uncertainty_score":0.2430992},"labels":[],"label_agreement":null},{"id":"W2524807089","doi":"10.1182/blood.v126.23.12.12","title":"Platelet GPIba Is Important for Thrombopoietin Production and Thrombopoietin-Induced Platelet Generation","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Thrombopoietin; Thrombopoiesis; Platelet; Internal medicine; Megakaryocyte; Endocrinology; Romiplostim; Haematopoiesis; Chemistry; Biology; Immunology; Medicine; Cell biology; Stem cell","score_opus":0.051877027557990084,"score_gpt":0.29086476938261746,"score_spread":0.23898774182462737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2524807089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947886,0.00078913046,0.000026497857,0.0022421977,0.00033209793,0.0011990836,0.000037091915,0.000093266615,0.0004920551],"genre_scores_gemma":[0.9960965,0.000215979,0.0020919766,0.0003842226,0.00044138273,0.00010176186,0.0002565266,0.00004517098,0.0003664726],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998549,0.000021378388,0.00034660002,0.00050066,0.00026256446,0.00031980796],"domain_scores_gemma":[0.9991817,0.000017451723,0.00013947724,0.00029109788,0.00015986274,0.00021040741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026930674,0.00024271867,0.00043083244,0.00007823939,0.00012686825,0.0000387303,0.000047758014,0.00016772201,0.000031803505],"category_scores_gemma":[0.00015839165,0.00020209256,0.00007592742,0.00012729237,0.0000403499,0.00014251556,0.000026585583,0.00011781587,0.000023820638],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019186105,0.011354564,0.0754358,0.00068803306,0.004121207,0.0013706433,0.010899464,0.000010738261,0.7135073,0.00081652205,0.15195745,0.027919693],"study_design_scores_gemma":[0.025612302,0.0034004266,0.0074424464,0.00013805431,0.0009742099,0.002072956,0.0006888691,0.0005949225,0.94705397,0.0018839871,0.00944343,0.000694419],"about_ca_topic_score_codex":0.000057751375,"about_ca_topic_score_gemma":0.00004510657,"teacher_disagreement_score":0.2335467,"about_ca_system_score_codex":0.00003589321,"about_ca_system_score_gemma":0.00012477134,"threshold_uncertainty_score":0.82410955},"labels":[],"label_agreement":null},{"id":"W2524880168","doi":"10.1182/blood.v116.21.1751.1751","title":"Outcome of Patients with Chemotherapy Refractory and Early Progressive Diffuse Large B Cell Lymphoma After R-CHOP Treatment","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Refractory (planetary science); CHOP; Internal medicine; Rituximab; Gastroenterology; Diffuse large B-cell lymphoma; Lymphoma; B symptoms; Stage (stratigraphy); Chemotherapy; Progressive disease; Surgery","score_opus":0.0046010594749470515,"score_gpt":0.22424474328594318,"score_spread":0.21964368381099614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2524880168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983851,0.0004675191,2.8703639e-7,0.00005915592,0.000042868378,0.0006560759,0.000057414738,0.000025006026,0.0003065923],"genre_scores_gemma":[0.99891454,0.000050772913,0.00045613843,0.000110808876,0.000045737335,0.00017822406,0.000015698568,0.000029788656,0.00019831925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991324,0.000011592506,0.00019656504,0.00025134394,0.00019863031,0.0002094996],"domain_scores_gemma":[0.9992986,0.000031230993,0.00011644971,0.0003304784,0.00007542704,0.00014783497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000024863304,0.00020299811,0.00033306394,0.000053863758,0.000032491742,0.000013885748,0.000034210745,0.000085885935,0.000059738722],"category_scores_gemma":[0.000006188883,0.0001190152,0.00007131347,0.000052680058,0.00006156732,0.000054357566,0.000016974058,0.00003882715,0.000008249895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005074654,0.043967158,0.94947356,0.00003852787,0.00021800332,0.00010352153,0.0004977278,1.2555487e-9,0.0002250809,0.000007682828,0.000007013913,0.0049542626],"study_design_scores_gemma":[0.07968625,0.0026044731,0.90258336,0.0000333375,0.00038190302,0.0000078362245,0.000013992132,2.4460584e-7,0.013041125,0.0000026676742,0.0015351403,0.000109686334],"about_ca_topic_score_codex":0.000042887845,"about_ca_topic_score_gemma":0.000019019391,"teacher_disagreement_score":0.07917878,"about_ca_system_score_codex":0.000035754634,"about_ca_system_score_gemma":0.00004114788,"threshold_uncertainty_score":0.48532993},"labels":[],"label_agreement":null},{"id":"W2524912268","doi":"10.1182/blood.v116.21.284.284","title":"Clinical Activity of Lucatumumab (HCD122) In Patients (pts) with Relapsed/Refractory Hodgkin or Non-Hodgkin Lymphoma Treated In a Phase Ia/II Clinical Trial (NCT00670592)","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Princess Margaret Cancer Centre; Jewish General Hospital; University of Toronto","funders":"","keywords":"Medicine; Follicular lymphoma; Mantle cell lymphoma; Lymphoma; Internal medicine; Gastroenterology; Diffuse large B-cell lymphoma; Chronic lymphocytic leukemia; Oncology; Leukemia","score_opus":0.035364657079066546,"score_gpt":0.3763803681274077,"score_spread":0.34101571104834116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2524912268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959387,0.00003879105,0.000001512412,0.00012716667,0.0006604528,0.0023972227,0.00005458042,0.00005270366,0.0007288739],"genre_scores_gemma":[0.9981967,0.00010787377,0.00061750493,0.00013369485,0.00036469597,0.0002546288,0.00008626541,0.00006681033,0.00017177987],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99557626,0.00042755538,0.001845468,0.000962629,0.00060043065,0.00058767403],"domain_scores_gemma":[0.9966472,0.001030744,0.0006922718,0.0010332345,0.00016708519,0.00042945758],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012494181,0.00048818157,0.0017757294,0.00034281137,0.0000681077,0.000019523954,0.00024130942,0.00070251944,0.00017915166],"category_scores_gemma":[0.0011420607,0.00032942428,0.00040877706,0.00061819353,0.0003154528,0.00018315713,0.00012760957,0.00066429557,0.000034086494],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11038796,0.15561959,0.64439917,0.000033740063,0.00029386114,0.00045277772,0.00012416289,1.3150728e-7,0.00014860297,0.0000050723343,0.00017425638,0.08836066],"study_design_scores_gemma":[0.41634837,0.025497027,0.5549408,0.00018770722,0.00042061022,0.000016476857,0.000014909576,0.000021646933,0.0018728307,0.0000041635503,0.0004654241,0.00021004022],"about_ca_topic_score_codex":0.00084418815,"about_ca_topic_score_gemma":0.0017723172,"teacher_disagreement_score":0.30596042,"about_ca_system_score_codex":0.000169098,"about_ca_system_score_gemma":0.0009942921,"threshold_uncertainty_score":0.9999158},"labels":[],"label_agreement":null},{"id":"W2525064106","doi":"10.1182/blood.v114.22.1942.1942","title":"Diffuse Large B-Cell Lymphoma in the Very Elderly, a Study of Outcome in Patients Aged 80 and Older.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Rituximab; Internal medicine; International Prognostic Index; Regimen; Confidence interval; Lymphoma; Chemotherapy regimen; Oncology; Surgery; Chemotherapy","score_opus":0.011730174661212168,"score_gpt":0.2530456933996745,"score_spread":0.2413155187384623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2525064106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984169,0.00031204423,6.105701e-8,0.000098686185,0.000019145986,0.00080579636,0.0000064892424,0.000008147932,0.00033270437],"genre_scores_gemma":[0.9995699,0.000029353805,0.000011527476,0.00030650815,0.000010917834,0.00003539506,0.000007963529,0.000006441307,0.000021977023],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999078,0.000072291616,0.00027952244,0.0001785999,0.00021436984,0.00017724524],"domain_scores_gemma":[0.9995608,0.00006840683,0.00005911568,0.00025678883,0.000014567191,0.000040339066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013948676,0.00011851358,0.0002853927,0.00009071221,0.000024651585,0.000010014858,0.000064329746,0.000043622385,0.000004279789],"category_scores_gemma":[0.000028072618,0.000074316944,0.0000380349,0.00015208586,0.000010364709,0.000033726352,0.000022707054,0.00004418902,0.0000027927722],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058684473,0.14565367,0.8488974,0.000017197102,0.000022414335,0.0001548585,0.0031498598,3.689569e-8,0.000015708449,0.000005974854,0.00003534654,0.0019888617],"study_design_scores_gemma":[0.12097539,0.0025787957,0.8752242,0.000041818897,0.00012726065,0.0000036202011,0.0007583767,0.0000012656332,0.00020800637,0.000009272754,0.000014411795,0.000057612386],"about_ca_topic_score_codex":0.00018173813,"about_ca_topic_score_gemma":0.0001820997,"teacher_disagreement_score":0.14307487,"about_ca_system_score_codex":0.000029323606,"about_ca_system_score_gemma":0.000014768165,"threshold_uncertainty_score":0.3030557},"labels":[],"label_agreement":null},{"id":"W2525072188","doi":"10.1182/blood.v124.21.2732.2732","title":"Engage - a Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Investigate the Efficacy and Safety of Eliglustat in Adults with Gaucher Disease Type 1: Results after 18 Months","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; Mount Sinai Hospital","funders":"","keywords":"Medicine; Clinical endpoint; Placebo; Adverse effect; Randomized controlled trial; Double blind; Surgery; Internal medicine","score_opus":0.02728809472378711,"score_gpt":0.3171527097417952,"score_spread":0.2898646150180081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2525072188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98568684,0.00060268637,0.000032993325,0.00081327773,0.000031839776,0.012272432,0.000031527827,0.000028556075,0.00049984246],"genre_scores_gemma":[0.9982475,0.00006270607,0.00019151841,0.00024273578,0.00006206111,0.0007695139,0.000023603812,0.000046053934,0.0003543115],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9969376,0.00088901474,0.000653138,0.0005351629,0.0005697016,0.00041540622],"domain_scores_gemma":[0.9977155,0.0007962507,0.00013267953,0.00064497394,0.00023519677,0.000475448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002087138,0.0002973014,0.00093978853,0.00021660463,0.000080131496,0.000036039404,0.00018524147,0.000059052705,0.000038033864],"category_scores_gemma":[0.0027481825,0.00016510392,0.0000982389,0.00041128087,0.00026080126,0.00007745721,0.00014363108,0.0004033813,0.000018917262],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9593723,0.012065501,0.019978028,0.00012079897,0.00040166377,0.00020465242,0.0074078585,0.000028812876,0.000052101994,0.0000045952174,0.00006148701,0.0003022176],"study_design_scores_gemma":[0.9837713,0.0017919303,0.011489928,0.0004222586,0.0005536931,0.000006436667,0.00081721455,0.00078687194,0.00009290386,0.0000037698353,0.00007650171,0.00018717806],"about_ca_topic_score_codex":0.00039616908,"about_ca_topic_score_gemma":0.0006691676,"teacher_disagreement_score":0.024399031,"about_ca_system_score_codex":0.000029323892,"about_ca_system_score_gemma":0.00013837937,"threshold_uncertainty_score":0.6732743},"labels":[],"label_agreement":null},{"id":"W2525158945","doi":"10.1182/blood.v104.11.3917.3917","title":"The Proadhesive Properties of Multimerin in Supporting Cellular Adhesion: Evidence for RGD and Non-RGD Dependent Adhesive Mechanisms.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Integrin; Platelet; Cell adhesion; Cell biology; Extracellular matrix; Cell adhesion molecule; RGD motif; Immunology; Chemistry; Biology; Molecular biology; Cell; Biochemistry","score_opus":0.03427483468360892,"score_gpt":0.2788769533589225,"score_spread":0.24460211867531356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2525158945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939648,0.0037023383,0.00013542174,0.00044645704,0.000032761087,0.0016644902,0.000004791779,0.000013601449,0.00003532803],"genre_scores_gemma":[0.99725735,0.0003070509,0.0020148843,0.000044351633,0.000017299577,0.00023822977,0.000004155621,0.0000187285,0.00009795759],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989229,0.000018946874,0.0003285694,0.00025829824,0.00019526204,0.0002760349],"domain_scores_gemma":[0.99941593,0.0000849312,0.00015391916,0.00018925815,0.00008781923,0.000068136585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022816216,0.00015305736,0.00031004407,0.00005174186,0.00010480446,0.000015793019,0.000079765494,0.00006895806,0.0000034056113],"category_scores_gemma":[0.0002811608,0.000096341,0.00006851096,0.00007947158,0.000059751088,0.000087001674,0.000045474142,0.000084416824,0.0000039308075],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00097149354,0.001632239,0.011206729,0.0007268365,0.00032696378,0.00073822663,0.0030271101,0.000014964768,0.97687197,0.00023330019,0.000007785675,0.004242394],"study_design_scores_gemma":[0.007036273,0.0009486293,0.0036231745,0.00082103146,0.00023821094,0.0000725146,0.0012964506,0.00006849133,0.98501265,0.0007591646,0.000008570975,0.000114837814],"about_ca_topic_score_codex":0.00022124525,"about_ca_topic_score_gemma":0.00009453175,"teacher_disagreement_score":0.008140695,"about_ca_system_score_codex":0.000029299503,"about_ca_system_score_gemma":0.00014530444,"threshold_uncertainty_score":0.39286718},"labels":[],"label_agreement":null},{"id":"W2525391589","doi":"10.1182/blood-2015-10-673285","title":"Polyphosphate colocalizes with factor XII on platelet-bound fibrin and augments its plasminogen activator activity","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"British Heart Foundation; University of Aberdeen; McMaster University","keywords":"Fibrin; Platelet; Polyphosphate; Activator (genetics); Factor XII; Fibrinolysis; Plasminogen activator; Chemistry; Internal medicine; Endocrinology; Cell biology; Immunology; Biochemistry; Medicine; Biology; Coagulation; Receptor","score_opus":0.019479847613937767,"score_gpt":0.2493233263346618,"score_spread":0.22984347872072405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2525391589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99739635,0.0004999775,0.00004588072,0.0006611792,0.00011184382,0.0005270842,0.000091855894,0.00012975888,0.0005360781],"genre_scores_gemma":[0.9958249,0.00011260064,0.000104956416,0.00020296476,0.00016641192,0.00002808166,0.0000082037,0.000050365747,0.0035015265],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99846363,0.000041019393,0.0002064127,0.0004816822,0.00038122147,0.00042602126],"domain_scores_gemma":[0.99894154,0.00024448035,0.00013941318,0.00029865754,0.000060961593,0.0003149506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000085107684,0.000311778,0.0004124978,0.00009356167,0.00016014845,0.000041597035,0.000083483865,0.0001462737,0.00029873062],"category_scores_gemma":[0.000080533566,0.0001957515,0.00007149557,0.0001314486,0.00012043378,0.00024470294,0.000051088806,0.00010291272,0.00007737461],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006600907,0.0026729186,0.51683944,0.0003021032,0.0016469252,0.00039398068,0.00086490484,0.0000016552892,0.35212466,0.0008094243,0.00089936116,0.116843715],"study_design_scores_gemma":[0.0075361202,0.0010133451,0.3220438,0.00030206525,0.00012123097,0.00008377894,0.000016353175,0.000015523923,0.6653005,0.00002880323,0.0032835088,0.00025497924],"about_ca_topic_score_codex":0.0000725645,"about_ca_topic_score_gemma":0.000023756347,"teacher_disagreement_score":0.31317583,"about_ca_system_score_codex":0.000057674395,"about_ca_system_score_gemma":0.00012859264,"threshold_uncertainty_score":0.79825145},"labels":[],"label_agreement":null},{"id":"W2525487380","doi":"10.1182/blood.v120.21.2844.2844","title":"An Individual Patient Supply Program for Ruxolitinib for the Treatment of Patients with Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF).","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Myelofibrosis; Medicine; Ruxolitinib; Essential thrombocythemia; International Prognostic Scoring System; Polycythemia vera; Constitutional symptoms; Internal medicine; Adverse effect; Bone marrow; Anemia; Gastroenterology; Surgery; Myelodysplastic syndromes","score_opus":0.013883091863626726,"score_gpt":0.2724081887448032,"score_spread":0.2585250968811765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2525487380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97558075,0.0010114405,0.00007208833,0.0005873361,0.0003460464,0.013671109,0.008425015,0.00021180346,0.00009439799],"genre_scores_gemma":[0.95458305,0.00030492168,0.024949607,0.0005115055,0.0006989303,0.011241547,0.007350238,0.00025249485,0.00010770243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99483746,0.00013939061,0.0011931551,0.0010770101,0.0011542973,0.0015986566],"domain_scores_gemma":[0.9950438,0.0011146627,0.0007292689,0.0012557154,0.0011211315,0.00073543563],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002582636,0.0011376954,0.001575728,0.00026014514,0.000670252,0.00016201557,0.00038827065,0.00030402996,0.00025374605],"category_scores_gemma":[0.000112312875,0.00065161806,0.0007548255,0.00042784307,0.00038506545,0.0005253203,0.00009814561,0.00018667674,0.000014726052],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029712426,0.10198554,0.70264995,0.0013380239,0.008751733,0.000021779706,0.011411157,0.0000092504015,0.011202488,0.0003602535,0.0011614528,0.13139595],"study_design_scores_gemma":[0.033436857,0.08466596,0.6486055,0.00037618083,0.007840661,0.000072965784,0.0011113732,0.000024956456,0.21358676,0.000014256249,0.009327052,0.0009374621],"about_ca_topic_score_codex":0.00017868122,"about_ca_topic_score_gemma":0.00006711166,"teacher_disagreement_score":0.20238428,"about_ca_system_score_codex":0.00036104434,"about_ca_system_score_gemma":0.0006116431,"threshold_uncertainty_score":0.9995935},"labels":[],"label_agreement":null},{"id":"W2525525075","doi":"10.1182/blood.v120.21.lba-6.lba-6","title":"Pomalidomide in Combination with Low-Dose Dexamethasone: Demonstrates a Significant Progression Free Survival and Overall Survival Advantage, in Relapsed/Refractory MM: A Phase 3, Multicenter, Randomized, Open-Label Study","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Pomalidomide; Medicine; Lenalidomide; Thalidomide; Internal medicine; Population; Dexamethasone; Refractory (planetary science); Progression-free survival; Interim analysis; Phases of clinical research; Bortezomib; Surgery; Multiple myeloma; Intention-to-treat analysis; Neutropenia; Gastroenterology; Randomized controlled trial; Clinical trial; Chemotherapy","score_opus":0.03688351435222334,"score_gpt":0.3623769974216015,"score_spread":0.3254934830693782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2525525075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908754,0.000980816,0.00002504939,0.000109741515,0.000089188215,0.0074769114,0.000028897191,0.00003888423,0.00037510772],"genre_scores_gemma":[0.99615735,0.00017341982,0.0026825638,0.000019145671,0.000039573548,0.00072462065,0.00007852336,0.000050040075,0.00007474774],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9962089,0.001235923,0.0006085662,0.0005268959,0.0007148254,0.00070488645],"domain_scores_gemma":[0.99770164,0.0010770861,0.00021032564,0.00046773197,0.00010834546,0.0004348739],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024776452,0.00036711522,0.0010556497,0.00033522496,0.000087011744,0.000089549445,0.00022942871,0.00011500489,0.000025844603],"category_scores_gemma":[0.0011371553,0.0002569554,0.00004559597,0.00031092254,0.0001887265,0.0004723927,0.00023784996,0.00044970724,0.000006909765],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16952878,0.10657355,0.7137665,0.00010910324,0.0003328507,0.0010001014,0.00074327557,4.103155e-7,0.004059408,0.000051806037,0.0000042067477,0.0038299991],"study_design_scores_gemma":[0.81032634,0.0031111455,0.1822441,0.00041003074,0.00023592149,0.000028098333,0.0012452767,0.00055946613,0.0015687061,0.000029662848,0.000004361644,0.00023688797],"about_ca_topic_score_codex":0.0010724086,"about_ca_topic_score_gemma":0.0007183296,"teacher_disagreement_score":0.64079756,"about_ca_system_score_codex":0.00010617906,"about_ca_system_score_gemma":0.00016650402,"threshold_uncertainty_score":0.99998826},"labels":[],"label_agreement":null},{"id":"W2525632857","doi":"10.1182/blood.v114.22.3187.3187","title":"The Role of Lysine Residues 42, 43, and 44 in the Activation Peptide Region of TAFI in Its Activation by the Thrombin-Thrombomodulin Complex.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Thrombomodulin; Thrombin; Plasmin; Chemistry; Carboxypeptidase; Lysine; Biochemistry; Peptide; Enzyme activator; Enzyme; Protein C; Trypsin; Molecular biology; Amino acid; Biology; Platelet","score_opus":0.028302040869030095,"score_gpt":0.27077447647646635,"score_spread":0.24247243560743625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2525632857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990248,0.00029995284,0.000053552038,0.007388063,0.000013866422,0.000597818,0.00000241807,0.00001347064,0.0013828577],"genre_scores_gemma":[0.9992081,0.00016794319,0.000086155174,0.00040840748,0.000037637892,0.000013376476,0.000026467646,0.000009913552,0.00004198256],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987342,0.00020441959,0.00039344106,0.00017802717,0.00033376188,0.00015614521],"domain_scores_gemma":[0.9990441,0.000250136,0.00025620274,0.00034079226,0.00008547948,0.000023287585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054033304,0.0001265763,0.00026934696,0.000083046834,0.000099315235,0.000017921093,0.00014891646,0.00008555862,0.000009862628],"category_scores_gemma":[0.00015589669,0.00007047909,0.000044042226,0.00041909842,0.0000816598,0.00012437979,0.000021926471,0.000185387,8.47668e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013809894,0.0010406383,0.0033856889,0.000025835481,0.000046191686,0.0000011003433,0.00216612,0.000009449829,0.97573644,0.012637043,0.00035566167,0.004457709],"study_design_scores_gemma":[0.0023684455,0.0003708092,0.4278726,0.00016250435,0.00006574218,0.00001734364,0.0015122783,0.0002440705,0.55986714,0.0072248727,0.00022213697,0.00007203206],"about_ca_topic_score_codex":0.00014346669,"about_ca_topic_score_gemma":0.00009121338,"teacher_disagreement_score":0.4244869,"about_ca_system_score_codex":0.00001759756,"about_ca_system_score_gemma":0.00003419881,"threshold_uncertainty_score":0.28740537},"labels":[],"label_agreement":null},{"id":"W2525709004","doi":"10.1182/blood.v124.21.1326.1326","title":"Healthcare Resource Utilization Trends over Time with Continuous Lenalidomide Treatment (Tx) in Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM)","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Medicine; Lenalidomide; Multiple myeloma; Internal medicine; Transplantation; Surgery","score_opus":0.018483521177799583,"score_gpt":0.26934786888148005,"score_spread":0.2508643477036805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2525709004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961875,0.00013339873,0.000026883672,0.0003507461,0.000013933919,0.0010615363,0.000061858416,0.000099179066,0.002064942],"genre_scores_gemma":[0.9962717,0.000024193845,0.00063874933,0.00018101028,0.00008761336,0.00020390969,0.0008576467,0.00007010805,0.0016650232],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976383,0.00019749708,0.00033627867,0.0005743613,0.0006188669,0.00063469145],"domain_scores_gemma":[0.9985531,0.00020618546,0.0001421639,0.0005395107,0.00014228838,0.0004167496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012614907,0.00036680096,0.0005839868,0.0003170836,0.00011168876,0.000037574846,0.000095254254,0.00011963798,0.0001307402],"category_scores_gemma":[0.00012810816,0.00023842699,0.00007784633,0.0004353882,0.00008167542,0.000103816084,0.000030191026,0.00015347716,0.000051095565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053962353,0.004038524,0.9083372,0.000045096414,0.00026915476,0.00026036898,0.00038362105,0.000016277383,0.00007083022,0.000009587924,0.0001490898,0.08102402],"study_design_scores_gemma":[0.102563255,0.009501886,0.8812059,0.00029399266,0.00019391828,0.00002257529,0.000051809653,0.0006882735,0.00203572,0.0000031344146,0.0031970954,0.00024241665],"about_ca_topic_score_codex":0.0013636743,"about_ca_topic_score_gemma":0.0017507925,"teacher_disagreement_score":0.097167015,"about_ca_system_score_codex":0.00024055874,"about_ca_system_score_gemma":0.00012018604,"threshold_uncertainty_score":0.97227705},"labels":[],"label_agreement":null},{"id":"W2525758480","doi":"10.1182/blood-2016-03-703454","title":"Hedgehog pathway activation in T-cell acute lymphoblastic leukemia predicts response to SMO and GLI1 inhibitors","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"European Hematology Association","keywords":"GLI1; Hedgehog; Hedgehog signaling pathway; Transcription factor; Biology; Cancer research; Smoothened; In vivo; Gene; Signal transduction; Cell biology; Genetics","score_opus":0.006781317514613858,"score_gpt":0.2119062086239426,"score_spread":0.20512489110932874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2525758480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985938,0.00016896507,0.00043980413,0.00022116382,0.000088892426,0.00022679096,0.000028934188,0.000030811843,0.00020080218],"genre_scores_gemma":[0.99886423,0.00005199938,0.0002087266,0.00016728776,0.00016089091,0.000049036895,0.000008689324,0.000027739701,0.00046142165],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988379,0.00010658174,0.00021722823,0.00042587926,0.00012792372,0.0002845141],"domain_scores_gemma":[0.999424,0.00008411696,0.000057744735,0.0002600889,0.00005683553,0.00011724336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028090936,0.00018056872,0.00015633088,0.0001011776,0.000058665326,0.000015954081,0.00011119892,0.00015204963,0.000002255105],"category_scores_gemma":[0.00046109696,0.00014111529,0.000037240607,0.00012780876,0.00006227305,0.000006316376,0.00016828577,0.00004674559,0.000016992724],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046563975,0.0000851605,0.0041916342,0.000013189058,0.000038175927,0.00001214048,0.00019542879,0.0000065088448,0.9935447,0.000003035179,0.0004086172,0.001035749],"study_design_scores_gemma":[0.0028556045,0.0005710226,0.012884432,0.00010408393,0.000021902606,0.000007771709,0.000046248573,0.0000027179863,0.9803175,0.00001554291,0.002968743,0.00020443373],"about_ca_topic_score_codex":0.000010223598,"about_ca_topic_score_gemma":0.000016026726,"teacher_disagreement_score":0.013227224,"about_ca_system_score_codex":0.00005604926,"about_ca_system_score_gemma":0.00018423627,"threshold_uncertainty_score":0.57545143},"labels":[],"label_agreement":null},{"id":"W2525803372","doi":"10.1182/blood.v104.11.1359.1359","title":"Mutator Genes UDG and AID Appear To Be Normal in Class-Switch Deficient and Clonally Homogeneous Waldenstrom’s Macroglobulinemias Having Either Germline or Hypermutated Clonotypic IgH VDJ.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Somatic hypermutation; Biology; Germline; Immunoglobulin class switching; Molecular biology; Activation-induced (cytidine) deaminase; Cytidine deaminase; Genetics; clone (Java method); Mutation; Gene rearrangement; Germline mutation; Transversion; Point mutation; IGHV@; Immunoglobulin heavy chain; Gene; B cell; Antibody; Chronic lymphocytic leukemia; Leukemia","score_opus":0.018089453760460485,"score_gpt":0.2744380265701668,"score_spread":0.2563485728097063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2525803372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99395525,0.0030152502,0.00005331727,0.0016296799,0.00007214098,0.00095121586,0.00004000165,0.000091479254,0.00019163209],"genre_scores_gemma":[0.9930039,0.00030027432,0.0046304082,0.00094303524,0.0001975216,0.000060815382,0.000037982158,0.00008562582,0.00074041897],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99715143,0.000052008225,0.00056292454,0.00074862054,0.0006151363,0.0008698566],"domain_scores_gemma":[0.9986648,0.00010728211,0.000080210695,0.00044776982,0.00015380271,0.0005461314],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032257035,0.00037079165,0.00057360047,0.00029083234,0.00012853475,0.000080731144,0.00018113593,0.00023257884,0.000100956924],"category_scores_gemma":[0.00020243888,0.00030263665,0.000073437266,0.0005077885,0.00019525328,0.00007839971,0.0002911518,0.00035947197,0.00004780526],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01946487,0.014484357,0.11441954,0.0042651216,0.0020977964,0.09034298,0.016982932,0.0066007124,0.6154514,0.00083608815,0.000649336,0.11440485],"study_design_scores_gemma":[0.44063392,0.009385718,0.105279244,0.0027746814,0.0021376247,0.103778176,0.0034879777,0.013347582,0.2928861,0.00021880047,0.022092478,0.003977666],"about_ca_topic_score_codex":0.0011227945,"about_ca_topic_score_gemma":0.0012234774,"teacher_disagreement_score":0.42116907,"about_ca_system_score_codex":0.0017683839,"about_ca_system_score_gemma":0.0030395298,"threshold_uncertainty_score":0.9999426},"labels":[],"label_agreement":null},{"id":"W2525872647","doi":"10.1182/blood.v118.21.5057.5057","title":"Azacitidine Has Limited Activity in Patients with MDS and AML","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Azacitidine; Cytarabine; Internal medicine; Chemotherapy regimen; Chemotherapy; Oncology","score_opus":0.03317195565536706,"score_gpt":0.2428581854032528,"score_spread":0.20968622974788573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2525872647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956146,0.00002738357,0.000013455444,0.00014455401,0.000010119594,0.00033543044,0.0000065773793,0.00003128979,0.0038165746],"genre_scores_gemma":[0.9988731,0.000012286313,0.00080113247,0.000086258806,0.000026443022,0.0000152932,0.0000114271015,0.000019085499,0.00015497775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99923104,0.000031843512,0.000087178196,0.00020442063,0.0002083237,0.0002372226],"domain_scores_gemma":[0.9995235,0.000029196613,0.00002759331,0.00022115967,0.000068543566,0.00012997267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010150416,0.00009998677,0.00018273792,0.00013045073,0.00003243921,0.0000093826475,0.000051877676,0.00006739911,0.000075137454],"category_scores_gemma":[0.00007017434,0.00007401168,0.000014802946,0.00021517226,0.000109621134,0.00008575572,0.00005638617,0.00023655956,0.00001656958],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008401064,0.0012740635,0.99247795,0.00004080121,0.00006143558,0.00009223948,0.00039261603,2.7920253e-8,0.0013906974,0.00001699796,0.000116116935,0.0032969527],"study_design_scores_gemma":[0.011344079,0.001022268,0.972593,0.000052280986,0.000054760978,0.000013077127,0.00001923295,0.000019365334,0.014610009,0.00001523607,0.00017071592,0.000085963125],"about_ca_topic_score_codex":0.00023515226,"about_ca_topic_score_gemma":0.00005205689,"teacher_disagreement_score":0.019884933,"about_ca_system_score_codex":0.00004245889,"about_ca_system_score_gemma":0.00009657951,"threshold_uncertainty_score":0.30181086},"labels":[],"label_agreement":null},{"id":"W2525921399","doi":"10.1182/blood.v124.21.3879.3879","title":"Clinical Characteristics, Risk Factors and Outcomes of CMV Disease after Allogeneic Stem Cell Transplantation","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Viremia; Transplantation; Hematopoietic stem cell transplantation; Cytomegalovirus; Internal medicine; Immunology; Gastroenterology; Betaherpesvirinae; Disease; Viral disease; Herpesviridae; Virus","score_opus":0.023468333525014463,"score_gpt":0.3079191794173159,"score_spread":0.2844508458923014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2525921399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990642,0.00019081186,0.00006294995,0.000058005695,0.0000541688,0.00020160971,0.00021964287,0.000016506701,0.00013212503],"genre_scores_gemma":[0.99843997,0.0010266744,0.00008019195,0.00007281317,0.00008147357,0.000008719215,0.000033157346,0.000016491305,0.00024049992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898916,0.00009974256,0.0003354797,0.00020561392,0.00021055406,0.00015944696],"domain_scores_gemma":[0.99917215,0.0002068275,0.00008718651,0.00021152753,0.000050246796,0.0002720484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028529842,0.00011236707,0.00034878944,0.00006488306,0.000030454832,0.000010639191,0.00004734864,0.00007315227,0.00007866242],"category_scores_gemma":[0.00005007828,0.00007935105,0.0001191773,0.00004146686,0.00010250292,0.000032433905,0.000018425451,0.00015698475,0.000018229763],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034864765,0.00049029774,0.9929582,0.00023888213,0.00007609779,0.00002268082,0.00017632652,5.1917723e-8,0.0004361035,0.000007743054,0.000008494328,0.005236492],"study_design_scores_gemma":[0.0022345365,0.00020851415,0.9943507,0.000028579077,0.00051945396,0.0000014000084,0.000019493074,0.000023043292,0.0016334596,0.0000104853225,0.0008890659,0.00008127159],"about_ca_topic_score_codex":0.000060813105,"about_ca_topic_score_gemma":0.000018200242,"teacher_disagreement_score":0.0051552206,"about_ca_system_score_codex":0.000004591016,"about_ca_system_score_gemma":0.000040113784,"threshold_uncertainty_score":0.32358417},"labels":[],"label_agreement":null},{"id":"W2526225966","doi":"10.1182/blood.v126.23.505.505","title":"Pembrolizumab in Combination with Lenalidomide and Low-Dose Dexamethasone for Relapsed/Refractory Multiple Myeloma (RRMM): Keynote-023","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Lenalidomide; Medicine; Tolerability; Pembrolizumab; Dexamethasone; Internal medicine; Multiple myeloma; Oncology; Clinical endpoint; Phases of clinical research; Neutropenia; Gastroenterology; Surgery; Adverse effect; Clinical trial; Toxicity; Immunotherapy; Cancer","score_opus":0.035525364555547764,"score_gpt":0.29419090445438484,"score_spread":0.25866553989883706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2526225966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99662644,0.00073190645,0.00021482006,0.00033120706,0.000043857603,0.0015039913,0.000028524752,0.00006029381,0.00045897812],"genre_scores_gemma":[0.9939395,0.000062657695,0.004868637,0.000073554045,0.00007044859,0.00025973882,0.00013537052,0.000048056372,0.000542004],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983939,0.00008884639,0.00026100702,0.00039394907,0.000419368,0.00044296432],"domain_scores_gemma":[0.9985924,0.00037416836,0.00008813123,0.0003098543,0.00021728751,0.00041815246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003655882,0.0002185814,0.00038894184,0.00024031974,0.00006541288,0.000031241132,0.00007778368,0.0001248212,0.000011149214],"category_scores_gemma":[0.00092631474,0.00017027135,0.000052668212,0.00021009617,0.00010307435,0.0001756444,0.000045698613,0.00021341651,0.000021112055],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038053457,0.010926066,0.8862179,0.0006632591,0.0007388525,0.001262637,0.0016793677,0.000022641801,0.013868974,0.00022873985,0.0006251428,0.045712978],"study_design_scores_gemma":[0.34428295,0.007463283,0.61841846,0.00046551603,0.00031145688,0.00031931134,0.00045921528,0.0033038545,0.022837238,0.0004494585,0.0012600129,0.0004292398],"about_ca_topic_score_codex":0.000281322,"about_ca_topic_score_gemma":0.00034324083,"teacher_disagreement_score":0.3062295,"about_ca_system_score_codex":0.00012757958,"about_ca_system_score_gemma":0.0002810167,"threshold_uncertainty_score":0.6943464},"labels":[],"label_agreement":null},{"id":"W2526338989","doi":"10.1182/blood.v110.11.1790.1790","title":"Regulation of TLR Expression and Activation in Human Mesenchymal Stromal Cells by IFN-a, IFN-g and TNF-a.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Hematological disorders and diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"TLR2; Mesenchymal stem cell; TLR3; Innate immune system; TLR4; Biology; Tumor necrosis factor alpha; Downregulation and upregulation; Immune system; Toll-like receptor; Interferon; Immunology; Cell biology; Molecular biology; Biochemistry","score_opus":0.010952773917692534,"score_gpt":0.2633563529407129,"score_spread":0.25240357902302035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2526338989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978976,0.00015825711,0.0003560761,0.00008803346,0.000009072383,0.00016714903,0.0000026966243,0.000010422621,0.0013106789],"genre_scores_gemma":[0.9991613,0.000018222816,0.0006669905,0.000037017355,0.000017722485,0.0000020228595,0.00002119425,0.0000052439163,0.00007028872],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999437,0.000015362804,0.00019000305,0.00012950126,0.000116570416,0.00011158585],"domain_scores_gemma":[0.9996613,0.00012015852,0.000058809463,0.00007315704,0.0000237227,0.00006280427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012779566,0.00006637972,0.00015432661,0.00005549074,0.000026794176,0.0000047424282,0.000015993939,0.00010099732,0.000025702448],"category_scores_gemma":[0.00010958625,0.000054502296,0.0000127347175,0.0000674551,0.000045039986,0.000049832415,0.000020026659,0.000070064576,4.073967e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005367955,0.0004741519,0.072072245,0.00006730985,0.0000046150176,0.000004882416,0.00014615644,5.531939e-7,0.92551327,0.00028680792,0.00036805388,0.0010082799],"study_design_scores_gemma":[0.002042988,0.00026170915,0.43384174,0.0001095604,0.000019466675,0.0000036738525,0.0001436334,0.000018683615,0.5630823,0.0003699608,0.000056376623,0.000049973245],"about_ca_topic_score_codex":0.000029434303,"about_ca_topic_score_gemma":0.0000102837685,"teacher_disagreement_score":0.36243102,"about_ca_system_score_codex":0.000004542178,"about_ca_system_score_gemma":0.000007080778,"threshold_uncertainty_score":0.2222539},"labels":[],"label_agreement":null},{"id":"W2526339802","doi":"10.1182/blood.v114.22.3259.3259","title":"FTY720 but Not Its Immunosuppressive Phosphorylated Form FTY720-P Exerts Anti-Leukemic Activity towards Ph(+) and Ph(−) Myeloproliferative Disorders through Reactivation of the PP2A Tumor Suppressor.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Protein phosphatase 2; Dasatinib; Progenitor cell; Cancer research; Haematopoiesis; Stem cell; Tyrosine kinase; CD38; Myeloid leukemia; Biology; Chemistry; CD34; Cell biology; Phosphorylation; Phosphatase; Signal transduction; Imatinib","score_opus":0.013232047141679592,"score_gpt":0.25437814394041364,"score_spread":0.24114609679873406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2526339802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99087983,0.0008827874,0.000024657234,0.003215124,0.00015855898,0.0020992768,0.0001552119,0.00008342962,0.0025010984],"genre_scores_gemma":[0.9973503,0.0010554596,0.00024713643,0.00070407335,0.00009920184,0.00019056855,0.000057058274,0.000045622528,0.00025062845],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997532,0.00014276823,0.00053937436,0.0006973079,0.00056968984,0.00051885133],"domain_scores_gemma":[0.9982288,0.00020477273,0.00048479796,0.0006107052,0.0003280598,0.00014289613],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016684586,0.0005497169,0.0008981686,0.000091991664,0.00033339602,0.000054350836,0.00020397095,0.00021122172,0.000074460375],"category_scores_gemma":[0.00033584074,0.00037253814,0.00024129437,0.00037591712,0.00019381782,0.00059432467,0.00011696843,0.00044606163,0.0000071812183],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042207763,0.008134292,0.02964091,0.0003132043,0.0017495495,0.00009677145,0.0082702665,0.000033613607,0.93237907,0.0014429057,0.0006975196,0.013021109],"study_design_scores_gemma":[0.0066731763,0.001026148,0.30543977,0.00028519853,0.00044890985,0.000074630516,0.00016689119,0.000095618074,0.6849952,0.0003425217,0.00019814113,0.00025382166],"about_ca_topic_score_codex":0.00027284882,"about_ca_topic_score_gemma":0.000024920044,"teacher_disagreement_score":0.2757989,"about_ca_system_score_codex":0.00013971936,"about_ca_system_score_gemma":0.00031288445,"threshold_uncertainty_score":0.9998727},"labels":[],"label_agreement":null},{"id":"W2526347762","doi":"10.1182/blood.v122.21.808.808","title":"MMSET/WHSC1 Enhances DNA Damage Repair Leading To An Increase In Resistance To Chemotherapeutic Agents","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Biology; DNA damage; Histone; DNA repair; Gene knockdown; DNA repair protein XRCC4; Cancer research; Chromatin; Histone methyltransferase; Methyltransferase; Molecular biology; Cell biology; DNA; Cell culture; Nucleotide excision repair; Methylation; Genetics","score_opus":0.013132208961221206,"score_gpt":0.27468364272834894,"score_spread":0.26155143376712775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2526347762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99650717,0.0004020195,0.00023402066,0.00015463357,0.000047647267,0.00034845428,0.0000061314713,0.000021033024,0.0022789207],"genre_scores_gemma":[0.99390143,0.0000518629,0.0036933108,0.00061888766,0.00012865302,0.000071409064,0.00003482597,0.00002462687,0.0014750172],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989574,0.00007082286,0.00020402399,0.00039821854,0.00011488588,0.000254635],"domain_scores_gemma":[0.9992927,0.000009749577,0.000042608932,0.0004228834,0.00005797125,0.00017410751],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020572274,0.00013383912,0.00012702831,0.00007051538,0.00004737048,0.000037229693,0.00017769536,0.00009157536,0.000037489583],"category_scores_gemma":[0.00009451829,0.00013929288,0.00004383184,0.00016206584,0.00001637697,0.000008106292,0.00006503898,0.00005018191,0.00008322175],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023012684,0.0001561024,0.0089653665,0.000013426002,0.000015847992,0.000002115568,0.00015155804,0.000024543348,0.98960775,0.000010626371,0.0002175261,0.000812096],"study_design_scores_gemma":[0.0004420663,0.00022083144,0.055020783,0.000026091906,0.0000115334615,3.755077e-7,0.00004403136,0.000018406334,0.9334935,0.00010724615,0.010413498,0.00020164634],"about_ca_topic_score_codex":0.00008324465,"about_ca_topic_score_gemma":0.00071346073,"teacher_disagreement_score":0.056114286,"about_ca_system_score_codex":0.000011670855,"about_ca_system_score_gemma":0.000028178421,"threshold_uncertainty_score":0.5680199},"labels":[],"label_agreement":null},{"id":"W2526495709","doi":"10.1182/blood.v112.11.399.399","title":"Antibody- and Cell-Mediated Immune Thrombocytopenia Are Differentially Sensitive to Intravenous Gammaglobulin Therapy","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Immunology; Antibody; Immune system; Autoantibody; Platelet; CD8","score_opus":0.012532590098247427,"score_gpt":0.2412008757632353,"score_spread":0.22866828566498787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2526495709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967459,0.0010283067,0.000043420085,0.00034020076,0.00005567925,0.0005682634,0.000038895512,0.00006468739,0.0011146752],"genre_scores_gemma":[0.9963041,0.0024150591,0.00030598472,0.00040770162,0.00005329568,0.000009846932,0.00019162707,0.000029415996,0.00028298688],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990023,0.000029633287,0.00018701544,0.00029428417,0.00017603433,0.00031074727],"domain_scores_gemma":[0.9994254,0.00003574452,0.00006452958,0.00020994921,0.000069752925,0.00019458572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000037135396,0.00020905775,0.0005356464,0.00007149267,0.000122062156,0.0000141901955,0.000048280668,0.00009012665,0.00005430933],"category_scores_gemma":[0.00002055768,0.00016441797,0.000062531064,0.00013535321,0.00006053353,0.000036779802,0.000036591387,0.0001189659,0.00010817569],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083278265,0.006267042,0.109547496,0.000053906264,0.0008487437,0.014400349,0.0033495708,8.8372764e-7,0.8619371,0.000006211491,0.00017436124,0.0025815468],"study_design_scores_gemma":[0.012295655,0.0010709978,0.8684043,0.0000662642,0.00015747186,0.0011139908,0.00017146074,0.000008258039,0.116239235,0.000011490371,0.0002412814,0.0002195714],"about_ca_topic_score_codex":0.000115460796,"about_ca_topic_score_gemma":0.000016555654,"teacher_disagreement_score":0.75885683,"about_ca_system_score_codex":0.00001441022,"about_ca_system_score_gemma":0.000058055157,"threshold_uncertainty_score":0.67047703},"labels":[],"label_agreement":null},{"id":"W2526651726","doi":"10.1182/blood.v112.11.5373.5373","title":"The Tolerability, Safety and Efficacy of a New Oral Solution of Deferiprone in Children with Transfusional Iron Overload","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Apotex (Canada)","funders":"","keywords":"Deferiprone; Medicine; Tolerability; Deferasirox; Neutropenia; Internal medicine; Pediatrics; Adverse effect; Thalassemia; Chemotherapy","score_opus":0.008020029354927297,"score_gpt":0.21598970691653438,"score_spread":0.20796967756160709,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2526651726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99728906,0.0015388136,0.000030336514,0.0004722925,0.000009237423,0.00034890897,0.0000041616004,0.0000072469725,0.0002999615],"genre_scores_gemma":[0.9984631,0.0012066067,0.00023994735,0.000017220145,0.00001099424,0.0000013059266,0.0000068084405,0.0000057794264,0.000048221937],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99938595,0.000022833985,0.0002115962,0.00011343786,0.00015224985,0.00011395726],"domain_scores_gemma":[0.9997261,0.000027229678,0.00005466769,0.00012030275,0.000021439737,0.00005022987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000097412994,0.00006999951,0.00018911845,0.000026157322,0.000052638537,0.00000111845,0.00003252528,0.00006584213,0.0000140191305],"category_scores_gemma":[0.000029401048,0.00004114322,0.000034941408,0.00013724226,0.0001831492,0.000020127856,0.000012857126,0.00011420516,3.8007101e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019062514,0.0014938023,0.97559834,0.00004543914,0.00011566508,0.000004881267,0.0013261534,0.000050782477,0.0050402354,0.000105584,0.000031256925,0.014281641],"study_design_scores_gemma":[0.011210429,0.000620196,0.9865008,0.00007390315,0.00010299299,0.00017366087,0.00005751884,0.000027151727,0.0010960079,0.000018326033,0.00006948346,0.000049519498],"about_ca_topic_score_codex":0.0006891179,"about_ca_topic_score_gemma":0.00013191966,"teacher_disagreement_score":0.0142321205,"about_ca_system_score_codex":0.0000080162645,"about_ca_system_score_gemma":0.0001201409,"threshold_uncertainty_score":0.16777718},"labels":[],"label_agreement":null},{"id":"W2526841972","doi":"10.1182/blood.v110.11.1927.1927","title":"Periostin Is a Previously Uncharacterised Vitamin K Dependent γ-Carboxyglutamic Acid (Gla) Containing Protein Expressed by Marrow-Derived Mesenchymal Stromal Cells.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Vitamin K Research Studies","field":"Nursing","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Centre Hospitalier Universitaire Sainte-Justine; McGill University","funders":"","keywords":"Periostin; Mesenchymal stem cell; Matrix gla protein; Osteocalcin; Chemistry; Proteomics; Molecular biology; Biochemistry; Immunoprecipitation; Biology; Cell biology; Enzyme; Gene; Alkaline phosphatase","score_opus":0.010667197810023073,"score_gpt":0.2501199149817196,"score_spread":0.23945271717169653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2526841972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99413955,0.0009062319,0.00037494005,0.00066072226,0.00032813463,0.0022332172,0.00019277565,0.00034052704,0.00082391343],"genre_scores_gemma":[0.99618274,0.000027170277,0.0021143449,0.00026510278,0.00025574828,0.00028771404,0.000059123664,0.00014418241,0.0006638744],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9944212,0.00035029353,0.0008615494,0.0011078494,0.0013027645,0.0019563308],"domain_scores_gemma":[0.9978574,0.00025631292,0.00037630115,0.0007896619,0.0002598191,0.00046054058],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012600574,0.0006932461,0.0007965145,0.0002659076,0.00052963145,0.00026371275,0.0007169213,0.0002962962,0.0002051795],"category_scores_gemma":[0.0005149584,0.0006906646,0.00024558266,0.000369882,0.00027896676,0.00036774692,0.0004208796,0.000778732,0.0001065535],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008073079,0.00070896925,0.0045472593,0.0001845094,0.00022665037,0.00027302696,0.0046395944,8.117108e-7,0.9859257,0.000003076011,0.00070894865,0.001974171],"study_design_scores_gemma":[0.006430453,0.0013400508,0.015287432,0.0002884638,0.00017109988,0.000032563847,0.0016259416,0.000070985814,0.9729487,0.000016017559,0.0010687254,0.0007195975],"about_ca_topic_score_codex":0.00014858034,"about_ca_topic_score_gemma":0.00008593639,"teacher_disagreement_score":0.012977006,"about_ca_system_score_codex":0.00025819382,"about_ca_system_score_gemma":0.00010385284,"threshold_uncertainty_score":0.99955446},"labels":[],"label_agreement":null},{"id":"W2527059769","doi":"10.1182/blood.v112.11.193.193","title":"Differentially Expressed and Novel Transcripts in Highly Purified Chronic Phase CML Stem Cells","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"","keywords":"CD38; Stem cell; Biology; Haematopoiesis; CD34; Molecular biology; Cancer research; Immunology; Cell biology","score_opus":0.02778141772518316,"score_gpt":0.24876513662024582,"score_spread":0.22098371889506266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2527059769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964842,0.0017222653,0.0001474239,0.00014413163,0.00012624863,0.0006639332,0.000045040957,0.00008254254,0.0005841906],"genre_scores_gemma":[0.9974672,0.00048777577,0.00027196985,0.000075621625,0.00014702156,0.000058787067,0.00003095641,0.000041794203,0.0014188396],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985218,0.000029209617,0.0003408274,0.00043786637,0.00027470806,0.0003956072],"domain_scores_gemma":[0.99928075,0.000043951317,0.00006446573,0.00038511056,0.000027543241,0.00019815007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005557792,0.00025673618,0.0004461605,0.00012893227,0.00006311355,0.000012885423,0.000097877455,0.00013944569,0.00008075623],"category_scores_gemma":[0.0000057384964,0.00022787534,0.00008251257,0.00014164395,0.000088723864,0.00007947518,0.000026811027,0.00021419064,0.000023576495],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024281458,0.004129634,0.0019391584,0.00015224455,0.00017318616,0.0006798767,0.0007890596,0.0000021279716,0.98949873,0.000037149308,0.00013545174,0.0022205885],"study_design_scores_gemma":[0.12623589,0.0010952313,0.019002646,0.0002724785,0.00041788165,0.00033231522,0.000041613202,0.00016780893,0.8502566,0.000008097316,0.0018588165,0.0003106012],"about_ca_topic_score_codex":0.0001087258,"about_ca_topic_score_gemma":0.000057495596,"teacher_disagreement_score":0.1392421,"about_ca_system_score_codex":0.00025136388,"about_ca_system_score_gemma":0.00040736364,"threshold_uncertainty_score":0.9292487},"labels":[],"label_agreement":null},{"id":"W2527106842","doi":"10.1182/blood.v112.11.3078.3078","title":"Regulation of Human Thrombin-Activable Fibrinolysis Inhibitor Gene Expression in Megakaryocyte-Like (Dami) and Monocyte/Macrphage- Like (THP-1) Cell Lines","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor; Queen's University","funders":"","keywords":"Fibrinolysis; Thrombomodulin; Thrombin; Platelet; Megakaryocyte; Molecular biology; Chemistry; Biology; Internal medicine; Endocrinology; Cell biology; Immunology; Medicine; Progenitor cell","score_opus":0.02731113491341629,"score_gpt":0.2562338931428871,"score_spread":0.22892275822947078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2527106842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99759257,0.00086343236,0.00018431783,0.00006745535,0.00012006911,0.00042723533,0.000005619001,0.000083400184,0.0006558927],"genre_scores_gemma":[0.99343324,0.0003455526,0.004915901,0.00010602529,0.00014846124,0.000023881901,0.00005752218,0.000043662243,0.0009257499],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983511,0.00006429989,0.000521636,0.00043631752,0.0003636387,0.00026302703],"domain_scores_gemma":[0.9990519,0.00004195331,0.00022408924,0.0004367304,0.00010736413,0.00013794281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013763316,0.00024269747,0.0005587226,0.00024405053,0.00015058336,0.0000130565795,0.00008166712,0.00018455289,0.000114150535],"category_scores_gemma":[0.000014372988,0.00022947743,0.00012563878,0.00035126903,0.00008310694,0.00021536082,0.000099646735,0.00016020365,0.000008490055],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000685731,0.0010496207,0.010235744,0.00012567444,0.000051149946,0.000018618091,0.000673235,0.00002019151,0.98741627,0.00003761998,0.00016132469,0.00014195521],"study_design_scores_gemma":[0.005511323,0.00038636092,0.10265286,0.00017047046,0.00016480667,0.00005944306,0.00010256069,0.00029928022,0.8902653,0.000110182824,0.00008889365,0.0001885085],"about_ca_topic_score_codex":0.00010660383,"about_ca_topic_score_gemma":0.000013928749,"teacher_disagreement_score":0.09715099,"about_ca_system_score_codex":0.000027472446,"about_ca_system_score_gemma":0.000056583995,"threshold_uncertainty_score":0.9357818},"labels":[],"label_agreement":null},{"id":"W2527114204","doi":"10.1182/blood.v114.22.5127.5127","title":"Regulation of Complement Activation by Thrombomodulin.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Thrombomodulin; Complement system; Anaphylatoxin; Alternative complement pathway; Factor H; Cell biology; Thrombin; Complement control protein; Complement membrane attack complex; Fibrinolysis; Lectin pathway; Classical complement pathway; Complement component 5; CD46; Protein C; Chemistry; Biology; Immunology; Biochemistry; Platelet; Medicine; Immune system; Internal medicine","score_opus":0.026288613341522764,"score_gpt":0.28294009305810763,"score_spread":0.25665147971658486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2527114204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98373675,0.00005729905,0.005712385,0.0020751525,0.000045464563,0.00037464596,0.0000065721783,0.00007538878,0.007916351],"genre_scores_gemma":[0.99637586,0.000008863432,0.0028058148,0.00045898635,0.00004882944,0.0000029140547,0.00011136368,0.00000671572,0.0001806568],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99931425,0.00001754483,0.0002167646,0.00012750567,0.00022876471,0.00009517986],"domain_scores_gemma":[0.99957573,0.000010982221,0.00010332279,0.0001827702,0.00007906651,0.000048137135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008753075,0.00007423195,0.00017721162,0.00005109891,0.00003204235,0.0000047633707,0.000033336557,0.000050525152,0.00021573079],"category_scores_gemma":[0.00001548573,0.00006919173,0.000046954854,0.00012655894,0.000012159061,0.0000581969,0.0000064022906,0.00004716828,0.000008355802],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019106206,0.00096973317,0.000571704,0.0000137308725,0.000040999952,1.9748452e-7,0.00007068724,0.000002594402,0.9841203,0.009457885,0.0013703641,0.003362693],"study_design_scores_gemma":[0.002532848,0.0004828261,0.15777682,0.000050365274,0.00010763268,0.0000039312836,0.000024742743,0.00012663052,0.8349416,0.003062815,0.00082671636,0.000063059306],"about_ca_topic_score_codex":0.0000061271135,"about_ca_topic_score_gemma":4.7140702e-7,"teacher_disagreement_score":0.15720512,"about_ca_system_score_codex":0.00001142886,"about_ca_system_score_gemma":0.000018682245,"threshold_uncertainty_score":0.2821557},"labels":[],"label_agreement":null},{"id":"W2527307458","doi":"10.1182/blood.v122.21.5186.5186","title":"Impact Of Dedicated CML Clinic On The Outcome Of Patients With Newly Diagnosed CML: Experience Of a Single Canadian Center","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; McGill University Health Centre","funders":"","keywords":"Medicine; Imatinib mesylate; Imatinib; Internal medicine; Anagrelide; Single Center; Pediatrics; Oncology; Surgery; Myeloid leukemia","score_opus":0.022624023929361477,"score_gpt":0.27698677658597687,"score_spread":0.2543627526566154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2527307458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980899,0.000027177088,7.372236e-7,0.00009410779,0.000031195254,0.00073954585,0.0000776146,0.000008994769,0.00093073846],"genre_scores_gemma":[0.99957633,0.0000050658414,0.00010794341,0.000118418786,0.000013491774,0.00003825056,0.000039179646,0.000020795527,0.00008054611],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987962,0.000038526076,0.00041866436,0.00017456475,0.000309051,0.0002629655],"domain_scores_gemma":[0.9986721,0.00015777937,0.00027107284,0.00051546574,0.0001721772,0.00021138579],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000057421435,0.0001503229,0.00036303492,0.0000993166,0.000022428527,0.0000035565834,0.00015117525,0.00006765581,0.0010746277],"category_scores_gemma":[0.00024282947,0.000082002894,0.00011563733,0.00019487929,0.00015051,0.000045601762,0.000021380449,0.00009812957,0.00002949739],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008964321,0.0021017385,0.99543566,0.000027636816,0.00025149452,0.000008476638,0.0009397401,0.0000011493869,0.0005889953,0.0000019704707,0.00022053963,0.00033294436],"study_design_scores_gemma":[0.010991748,0.0023488249,0.9816324,0.00018845349,0.00013241851,0.0000024671388,0.00013620334,0.000006633027,0.004465321,0.0000022747045,0.000024329634,0.0000689337],"about_ca_topic_score_codex":0.095249124,"about_ca_topic_score_gemma":0.0058052223,"teacher_disagreement_score":0.08944391,"about_ca_system_score_codex":0.00024427447,"about_ca_system_score_gemma":0.0004361816,"threshold_uncertainty_score":0.99983853},"labels":[],"label_agreement":null},{"id":"W2527632616","doi":"10.1182/blood.v126.23.2318.2318","title":"Retrospective Cohort of Unprovoked Venous Thromboembolism Patients: What Proportion Have Potent Thrombophilias Necessitating Indefinite Anticoagulants?","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Thrombophilia; Medicine; Protein C deficiency; Antiphospholipid syndrome; Protein S deficiency; Protein S; Pulmonary embolism; Factor V Leiden; Internal medicine; Protein C; Thrombosis; Prothrombin G20210A; Factor V; Venous thrombosis; Gastroenterology","score_opus":0.023871400456440848,"score_gpt":0.2677730438185403,"score_spread":0.24390164336209944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2527632616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916816,0.0006654474,0.000053043826,0.00028912374,0.0005344079,0.0018000569,0.00001948274,0.00011482658,0.0048420373],"genre_scores_gemma":[0.9976461,0.0005823642,0.0008372438,0.00037476307,0.00019309323,0.00008371828,0.00016646986,0.00006399681,0.000052259722],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969455,0.00008774264,0.0007556443,0.00058549026,0.0011305602,0.00049507694],"domain_scores_gemma":[0.99767786,0.000026967526,0.0005609208,0.00059986074,0.0008579957,0.0002764058],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00060042494,0.00033610236,0.0013604173,0.00021607715,0.00011766748,0.000084192754,0.00017416428,0.00017062934,0.000038428883],"category_scores_gemma":[0.0003522321,0.00029307252,0.0001745294,0.00031715693,0.00016227512,0.0005123162,0.00016777846,0.0002644326,0.000040429124],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000084751504,0.01390356,0.972274,0.00034297,0.0013151839,0.000082649545,0.004950862,0.000025395506,0.0009230323,0.0011132223,0.0007193902,0.004265005],"study_design_scores_gemma":[0.005258041,0.0022829478,0.98092514,0.0006465729,0.0015873908,0.000017397548,0.0027698588,0.000053183052,0.0047895666,0.0012732609,0.00008736702,0.00030924208],"about_ca_topic_score_codex":0.0003015222,"about_ca_topic_score_gemma":0.00001976694,"teacher_disagreement_score":0.011620613,"about_ca_system_score_codex":0.00017662959,"about_ca_system_score_gemma":0.00017394919,"threshold_uncertainty_score":0.99995214},"labels":[],"label_agreement":null},{"id":"W2527703292","doi":"10.1182/blood.v126.23.1227.1227","title":"Reversion to an Embryonic Alternative Splicing Program Enhances Leukemia Stem Cell Self-Renewal","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"","keywords":"Biology; Embryonic stem cell; Stem cell; Reprogramming; Progenitor cell; Gene knockdown; Small hairpin RNA; Cancer research; Cell biology; Molecular biology; Cell; Cell culture; Genetics","score_opus":0.0168836633418151,"score_gpt":0.28647996430171596,"score_spread":0.26959630095990084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2527703292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972448,0.0002961341,0.00014202151,0.00004137185,0.00007624245,0.00034009374,0.000004259774,0.0000429475,0.0018121668],"genre_scores_gemma":[0.99379194,0.000063793734,0.0029758557,0.00009168678,0.00032102488,0.00004275731,0.000030704083,0.000020478037,0.0026617632],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988526,0.00007421844,0.000120602024,0.0003739006,0.00022761109,0.00035107762],"domain_scores_gemma":[0.99916476,0.000006052581,0.00004798424,0.000307366,0.00011685346,0.00035701052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024968552,0.0001332053,0.000118186006,0.0000447526,0.000072282215,0.00005033004,0.00027441542,0.00008714475,0.0000027373624],"category_scores_gemma":[0.000017570523,0.00012019408,0.00004731334,0.000103664475,0.000018981913,0.000008532366,0.00015615427,0.00009104898,0.000036106],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000065967266,0.00024997108,0.0006911069,0.000018841989,0.000038294,0.000014043053,0.00027207378,0.00008185283,0.9939214,0.0000071377744,0.0006079835,0.0040313336],"study_design_scores_gemma":[0.0011247719,0.0020402612,0.00009715908,0.000019375528,0.000020070143,0.000010357181,0.00048771364,0.00020423833,0.99074835,0.00001302783,0.005057427,0.00017723216],"about_ca_topic_score_codex":0.00015777712,"about_ca_topic_score_gemma":0.00005819515,"teacher_disagreement_score":0.0044494434,"about_ca_system_score_codex":0.000044803954,"about_ca_system_score_gemma":0.00021849698,"threshold_uncertainty_score":0.49013725},"labels":[],"label_agreement":null},{"id":"W2527826685","doi":"10.1182/blood-2016-08-729517","title":"B cells, PF4/heparin complexes, and complement","year":2016,"lang":"en","type":"letter","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Complement system; Heparin; Platelet factor 4; Alternative complement pathway; Factor H; Complement (music); Complement receptor; Platelet; Chemistry; Receptor; Platelet activation; Cell biology; Immunology; Biology; Biochemistry; Antibody; Phenotype","score_opus":0.0404370857114142,"score_gpt":0.27689238164438595,"score_spread":0.23645529593297177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2527826685","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.106641844,0.00076004013,0.00003797753,0.8503122,0.0009357469,0.0020842806,0.0006169362,0.00035934924,0.03825165],"genre_scores_gemma":[0.13410993,0.0009548379,0.0021208713,0.83619153,0.0121447025,0.0001772284,0.0013797292,0.00036436407,0.012556805],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972315,0.00010047329,0.0005481199,0.0008171114,0.0004946959,0.0008081223],"domain_scores_gemma":[0.99843115,0.00014324662,0.00019698749,0.0008876297,0.00009688645,0.00024408035],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017554294,0.00057212997,0.0012575776,0.00019759114,0.00014834326,0.00006466614,0.00025298054,0.00068706344,0.0013185983],"category_scores_gemma":[0.00001839111,0.00043834414,0.00020182534,0.000108017135,0.0001871256,0.000058211663,0.00029166028,0.0011596106,0.00063266],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015127579,0.00023536356,0.0026845513,0.0005261594,0.000827522,0.00072819815,0.00006752041,5.115402e-9,0.032956943,0.00013414198,0.9606645,0.0011599483],"study_design_scores_gemma":[0.004450693,0.00032735337,0.005205764,0.0004744691,0.0012293725,0.0002708227,0.000010373574,9.618475e-7,0.015975427,0.00018164235,0.97133756,0.0005355554],"about_ca_topic_score_codex":0.000223603,"about_ca_topic_score_gemma":0.000030185949,"teacher_disagreement_score":0.027468089,"about_ca_system_score_codex":0.00008178194,"about_ca_system_score_gemma":0.00016948681,"threshold_uncertainty_score":0.9998068},"labels":[],"label_agreement":null},{"id":"W2527858691","doi":"10.1182/blood.v108.11.3188.3188","title":"Fibrinogen Enhances Homing-Related Responses of CD34+ by Incorporating Membrane Type1-Matrix Metalloproteinase into Membrane Lipid Rafts.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Canadian Blood Services","funders":"","keywords":"Cell biology; Lipid raft; Chemistry; CD34; Molecular biology; Stem cell; Biology; Signal transduction","score_opus":0.004141172442878542,"score_gpt":0.21910386711609037,"score_spread":0.21496269467321183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2527858691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99379194,0.004372519,0.00015756737,0.00006452267,0.00010150649,0.000364479,0.000048150996,0.00003671432,0.0010625869],"genre_scores_gemma":[0.9951685,0.00008423741,0.0024626877,0.000034555538,0.00024977265,0.000048505182,0.00026045804,0.000038529513,0.0016527753],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99847084,0.00013946317,0.0004810844,0.00042785928,0.00021762848,0.00026309286],"domain_scores_gemma":[0.9990897,0.000022886563,0.0003003303,0.00040687015,0.00010373076,0.00007645941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035382874,0.00024387879,0.00030848602,0.00007084535,0.00010109852,0.000023405662,0.0002356679,0.0002469984,0.000046942634],"category_scores_gemma":[0.00013531157,0.00023207598,0.00015030622,0.00017564393,0.000095403746,0.000013697998,0.00013111261,0.00010643906,0.000018389479],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016873566,0.00025200905,0.000100683974,0.000079592275,0.0001189966,0.000011259596,0.000019211855,0.0000102407985,0.9986156,0.00016836297,0.0003229811,0.00013230804],"study_design_scores_gemma":[0.0013781153,0.00046466396,0.000010624938,0.000049176655,0.00010530869,0.000022070883,0.000023666458,0.00001856123,0.9951282,0.00037911287,0.0021465027,0.00027400974],"about_ca_topic_score_codex":0.00020449907,"about_ca_topic_score_gemma":0.00003338019,"teacher_disagreement_score":0.0042882813,"about_ca_system_score_codex":0.0000075555135,"about_ca_system_score_gemma":0.00010849332,"threshold_uncertainty_score":0.9463784},"labels":[],"label_agreement":null},{"id":"W2527882627","doi":"10.1182/blood.v116.21.4226.4226","title":"Genomic Evidence for Elements of a Programmed Cell Death Pathway In Plasmodium: Exploiting Programmed Parasite Death for Malaria Control?","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Machine Learning in Bioinformatics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of New Brunswick","funders":"","keywords":"Biology; Plasmodium falciparum; Plasmodium (life cycle); Genome; Malaria; Phylogenetics; Genetics; Evolutionary biology; Plasmodium yoelii; Parasite hosting; Gene; Immunology","score_opus":0.023354748994066553,"score_gpt":0.2906320862714622,"score_spread":0.26727733727739567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2527882627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98954797,0.00012526834,0.007613877,0.000051203908,0.00008866711,0.002397272,0.000067946305,0.000020832902,0.000086935266],"genre_scores_gemma":[0.8955918,0.00001095436,0.10301294,0.000065823384,0.00011154346,0.0009535247,0.00016797487,0.0000347911,0.000050634037],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99848336,0.000038888087,0.0005568877,0.0003106645,0.0001269553,0.00048324317],"domain_scores_gemma":[0.99895173,0.00011532706,0.00036432318,0.000346131,0.0001350993,0.000087357126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007283801,0.00020921172,0.0002627939,0.000060531973,0.000064225,0.000038823262,0.0003063308,0.00020352993,0.0000032653259],"category_scores_gemma":[0.0006377817,0.0001998483,0.00014293667,0.00005805356,0.000035969802,0.000009877576,0.000072291485,0.00016428145,0.0000014244958],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034105242,0.00041920794,0.28437403,0.00036029448,0.000068753056,0.0000010689619,0.00011608088,0.000035012476,0.71111125,0.00024242676,0.0000139048425,0.0029169125],"study_design_scores_gemma":[0.018995361,0.0027054232,0.034430787,0.00014392113,0.00019995698,0.000021759897,0.0001087899,0.0100767715,0.9245725,0.00019635004,0.007896732,0.000651608],"about_ca_topic_score_codex":0.00002404431,"about_ca_topic_score_gemma":0.00008049767,"teacher_disagreement_score":0.24994324,"about_ca_system_score_codex":0.000009125949,"about_ca_system_score_gemma":0.0001300413,"threshold_uncertainty_score":0.81495774},"labels":[],"label_agreement":null},{"id":"W2528167353","doi":"10.1182/blood.v108.11.2966.2966","title":"Systematic Review of Controlled Clinical Trials on the Use of Ursodeoxycholic Acid for the Prevention of Hepatic Sinusoidal Obstruction Syndrome in Hematopoietic Stem Cell Transplantation.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Internal medicine; Ursodeoxycholic acid; Context (archaeology); Transplantation; Hematopoietic stem cell transplantation; Randomized controlled trial; Clinical trial; Relative risk; Surgery; Gastroenterology; Confidence interval","score_opus":0.08243069464663894,"score_gpt":0.34069425944203857,"score_spread":0.25826356479539964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2528167353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9767075,0.0069377986,0.0038179788,0.00028333365,0.000121139514,0.011981999,0.00007601292,0.000015048165,0.000059150512],"genre_scores_gemma":[0.99609727,0.0026723752,0.00039864297,0.00006422005,0.000024421786,0.00059138134,0.00003753914,0.00002278812,0.00009133932],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9936818,0.001599639,0.0038370087,0.00021638347,0.0005091988,0.00015596165],"domain_scores_gemma":[0.98863095,0.00880132,0.0018523594,0.00049345335,0.00018859241,0.000033341184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005670693,0.00019006922,0.0021573862,0.00012210413,0.000031481424,0.000007827781,0.00013826622,0.00013308764,0.00002047114],"category_scores_gemma":[0.00077882514,0.00010339062,0.0007140887,0.00028380638,0.00009220901,0.00005939808,0.0000040118616,0.00014283884,0.000002563514],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019901735,0.002950221,0.0017988164,0.97570604,0.0008284408,0.000018549668,0.00077657733,0.00009266665,0.01413779,0.0015716532,0.000034342105,0.00009472818],"study_design_scores_gemma":[0.06765142,0.0031334576,0.014088313,0.6794359,0.03541896,0.0008603329,0.00069650664,0.001304005,0.19640854,0.00059043657,0.0000035826183,0.00040852302],"about_ca_topic_score_codex":0.00002714518,"about_ca_topic_score_gemma":0.00001122654,"teacher_disagreement_score":0.2962701,"about_ca_system_score_codex":0.000017315995,"about_ca_system_score_gemma":0.00009239057,"threshold_uncertainty_score":0.4216147},"labels":[],"label_agreement":null},{"id":"W2528175579","doi":"10.1182/blood.v104.11.157.157","title":"First Analysis of the Completed Mabthera International (Mint) Trial in Young Patients with Low-Risk Diffuse Large B-Cell Lymphoma (DLBCL): Addition of Rituximab to a CHOP-Like Regimen Significantly Improves Outcome of All Patients with the Identification of a Very Favorable Subgroup with IPI=O and No Bulky Disease.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Rituximab; Interim analysis; Diffuse large B-cell lymphoma; Internal medicine; Chemotherapy regimen; Regimen; Clinical endpoint; CHOP; Surgery; Median follow-up; International Prognostic Index; Neutropenia; Gastroenterology; Chemotherapy; Oncology; Lymphoma; Clinical trial","score_opus":0.0039887029909557985,"score_gpt":0.19879649946753983,"score_spread":0.19480779647658403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2528175579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968422,0.000027873046,0.000036273825,0.00007801835,0.000039182432,0.0016755885,0.0012783799,0.000006477319,0.000016009913],"genre_scores_gemma":[0.9992112,0.000016362594,0.00011100777,0.000034074703,0.000011226644,0.00014749476,0.00043702457,0.000019407438,0.000012229958],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981969,0.000045376724,0.0006325149,0.00031002256,0.00064853433,0.00016666262],"domain_scores_gemma":[0.9980787,0.00010608605,0.00087987195,0.00047340826,0.00038584776,0.00007608915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015942985,0.00019772502,0.00053488463,0.00022196407,0.000050671144,0.000015542291,0.0001663633,0.000042533982,0.0000074990808],"category_scores_gemma":[0.000055273485,0.00010408482,0.00012002469,0.0005209836,0.00012505679,0.000100963676,0.000048876675,0.00004674869,7.0264775e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015517875,0.044966083,0.93651485,0.00011665741,0.0016724329,0.0000022113986,0.00082225003,0.000054618926,0.00023771888,0.000020270949,0.000010995697,0.0000640177],"study_design_scores_gemma":[0.1947418,0.0013988245,0.7994341,0.00020645127,0.0027112854,3.0430022e-7,0.00011317573,0.0001223634,0.0011737379,0.000004643779,0.0000061217715,0.00008719869],"about_ca_topic_score_codex":0.0012397654,"about_ca_topic_score_gemma":0.0010988273,"teacher_disagreement_score":0.17922392,"about_ca_system_score_codex":0.000118475655,"about_ca_system_score_gemma":0.00009236739,"threshold_uncertainty_score":0.4244456},"labels":[],"label_agreement":null},{"id":"W2528355029","doi":"10.1182/blood.v118.21.1236.1236","title":"Comparison of the Villalta Post Thrombotic Syndrome (PTS) Score in the Ipsilateral Versus Contralateral Leg After a First Unprovoked Deep Vein Thrombosis (DVT): Results From the REVERSE Study","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; St. Joseph’s Healthcare Hamilton; Ottawa Hospital; St. Joseph's Hospital; University of Ottawa; McGill University Health Centre; Hôpital du Sacré-Cœur de Montréal; Dalhousie University; Jewish General Hospital; St. Paul's Hospital; McMaster University; London Health Sciences Centre","funders":"","keywords":"Post-thrombotic syndrome; Medicine; Thrombosis; Deep vein; Venous thrombosis; Population; Cohort; Surgery; Internal medicine","score_opus":0.05438314810530081,"score_gpt":0.2879918588680096,"score_spread":0.23360871076270878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2528355029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99319655,0.0002225108,7.7956287e-7,0.002046878,0.0005815117,0.0029982554,0.0001131862,0.00003760959,0.00080269465],"genre_scores_gemma":[0.9986191,0.00004176242,0.000053811917,0.0009208055,0.00009637372,0.00015794476,0.000046088095,0.00004062882,0.000023519067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970472,0.0003699279,0.0008679968,0.0005447363,0.0006461625,0.0005239916],"domain_scores_gemma":[0.9976281,0.00038233143,0.00031900033,0.0014964194,0.00008961215,0.00008451459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063770474,0.00037555047,0.00093426165,0.000072811854,0.00023573851,0.000059243408,0.0008034921,0.00012480763,0.00023576227],"category_scores_gemma":[0.00015066272,0.00018804744,0.00022513866,0.0003809203,0.00025228586,0.0001332953,0.00030374233,0.00046231152,0.00004657507],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016699773,0.013773144,0.9008697,0.0000735598,0.0012949931,0.0002500401,0.08007281,0.000024922096,0.0002572114,0.000112034024,0.0015286639,0.00007288477],"study_design_scores_gemma":[0.012971038,0.0020494892,0.97357863,0.00032252094,0.0018788147,0.000013035544,0.008445579,0.00004161245,0.0002453347,0.000032973443,0.0002027878,0.00021818293],"about_ca_topic_score_codex":0.009200755,"about_ca_topic_score_gemma":0.0141273625,"teacher_disagreement_score":0.072708875,"about_ca_system_score_codex":0.00005738558,"about_ca_system_score_gemma":0.00005746057,"threshold_uncertainty_score":0.99739707},"labels":[],"label_agreement":null},{"id":"W2528429690","doi":"10.1182/blood.v106.11.4554.4554","title":"Epidemiology of Adult Acute Lymphoblastic Leukemia in Manitoba, Canada: Does This Approximate Clinical Trial Data?.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Medicine; Population; Epidemiology; Confidence interval; Internal medicine; Transplantation; Pediatrics; Clinical trial; Regimen; Surgery","score_opus":0.0675959580324252,"score_gpt":0.35071361754861474,"score_spread":0.28311765951618956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2528429690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99497896,0.00023547874,0.00015046606,0.0013752094,0.00050082547,0.0010813229,0.00027573574,0.000048990973,0.0013530197],"genre_scores_gemma":[0.98764837,0.00047879244,0.007074667,0.0017466608,0.0017969673,0.000073654424,0.0003009877,0.0000626088,0.000817267],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9952654,0.00048542104,0.001904052,0.00086711487,0.0006138709,0.00086411624],"domain_scores_gemma":[0.99449277,0.0029371178,0.00038996956,0.0015649113,0.00021825059,0.0003969587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018900449,0.00030509607,0.0013656194,0.0001860918,0.00004848603,0.0000040796363,0.0008416974,0.000385737,0.00017335432],"category_scores_gemma":[0.0075656455,0.00021472084,0.00013712636,0.00033274657,0.00034954373,0.00013362888,0.0005357924,0.00059584936,0.000054886517],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09983941,0.0065270774,0.7580351,0.0012081548,0.004398542,0.0038474272,0.0003434508,0.0001456016,0.0011748819,0.0021503058,0.09843447,0.023895578],"study_design_scores_gemma":[0.7532143,0.0042259293,0.12148889,0.0009867159,0.0034283292,0.0013880376,0.00047176552,0.09813621,0.0051707434,0.00042568415,0.009721415,0.0013419581],"about_ca_topic_score_codex":0.2638702,"about_ca_topic_score_gemma":0.46272746,"teacher_disagreement_score":0.6533749,"about_ca_system_score_codex":0.0019336686,"about_ca_system_score_gemma":0.010872563,"threshold_uncertainty_score":0.9947349},"labels":[],"label_agreement":null},{"id":"W2528543273","doi":"10.1182/blood.v126.23.3552.3552","title":"Effect of Asparaginase and Dexamethasone on FVIIa-at Complex and F1.2 in Children with Acute Lymphoblastic Leukemia: Evidence of Hypercoagulable State","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; McMaster University; Hamilton Health Sciences; McMaster Children's Hospital","funders":"","keywords":"Medicine; Concomitant; Dexamethasone; Internal medicine; Gastroenterology; Pharmacology; Immunology","score_opus":0.02406610903175839,"score_gpt":0.2942694935240921,"score_spread":0.2702033844923337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2528543273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99776363,0.0010809589,0.000041795607,0.00006465328,0.000009949277,0.00079261285,0.00002560772,0.000020780208,0.00019999407],"genre_scores_gemma":[0.99850255,0.0002320912,0.0009919513,0.000045139677,0.000019568326,0.000027775764,0.000010924981,0.00003488073,0.00013514353],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99806553,0.00020447937,0.00032044802,0.00041771893,0.00062138436,0.00037041132],"domain_scores_gemma":[0.99805576,0.00094881316,0.00013261673,0.0004067895,0.00013363906,0.00032240522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075757894,0.000250543,0.0007474979,0.0002395026,0.000029277287,0.000011181943,0.00011879814,0.00009517592,0.000013070954],"category_scores_gemma":[0.0006040031,0.00017724412,0.00003033096,0.00036581556,0.00044853892,0.000110053246,0.00018503185,0.00018238113,0.000007965777],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013934263,0.00063399074,0.8951998,0.0010906577,0.0009742109,0.0006407362,0.0007482694,0.00025242998,0.0832024,0.000019730796,0.00032475358,0.0029787624],"study_design_scores_gemma":[0.076046914,0.029578693,0.52325267,0.0026270666,0.00178113,0.004838455,0.00006202602,0.003979804,0.35733032,0.000042216525,0.000012953707,0.00044776418],"about_ca_topic_score_codex":0.0008112989,"about_ca_topic_score_gemma":0.00003775813,"teacher_disagreement_score":0.37194714,"about_ca_system_score_codex":0.0004148997,"about_ca_system_score_gemma":0.00065894256,"threshold_uncertainty_score":0.7227805},"labels":[],"label_agreement":null},{"id":"W2529016552","doi":"10.1182/blood.v120.21.4244.4244","title":"Hemophilia Experiences, Results and Opportunities (HERO) Study: US Respondent Demographics and Impact of Diagnosis On Career and Lifestyle Decisions and Quality of Life","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Psychosocial; Medicine; Respondent; Quality of life (healthcare); Gerontology; Physical therapy; Pediatrics; Family medicine; Psychiatry; Nursing","score_opus":0.1788202832426508,"score_gpt":0.3895649630941051,"score_spread":0.2107446798514543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2529016552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912866,0.007689147,2.1535438e-7,0.00027388602,0.000021300879,0.0005010822,0.00008121489,0.000009965954,0.00013661517],"genre_scores_gemma":[0.9930356,0.0066642845,0.00007636692,0.000029719795,0.000046109624,0.000047455036,0.000007803142,0.000012000484,0.00008066518],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984626,0.00020472099,0.0003998986,0.00024540588,0.0004419152,0.00024544608],"domain_scores_gemma":[0.9979248,0.0010449884,0.00011048341,0.00028386738,0.00011280963,0.00052306097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010038181,0.00016525124,0.00046036422,0.0002432515,0.00009936997,0.000015637912,0.000043759155,0.000098696524,0.00001195522],"category_scores_gemma":[0.0011470758,0.0001103138,0.000054441884,0.00015038275,0.00040817418,0.00009510895,0.000115750205,0.000123193,1.9640459e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084300624,0.0016320674,0.98567426,0.00006504269,0.0002460472,0.000016208422,0.009168149,4.853999e-8,0.00031843293,0.00003962708,0.00005973566,0.0019373676],"study_design_scores_gemma":[0.005542759,0.0028741618,0.9806324,0.00013641812,0.0001766855,0.000018438644,0.009528658,0.0000019993809,0.00092197343,0.000010858379,0.00005433228,0.000101267826],"about_ca_topic_score_codex":0.0003944117,"about_ca_topic_score_gemma":0.000056294837,"teacher_disagreement_score":0.00504182,"about_ca_system_score_codex":0.000009580031,"about_ca_system_score_gemma":0.00009383481,"threshold_uncertainty_score":0.44984663},"labels":[],"label_agreement":null},{"id":"W2529155841","doi":"10.1182/blood.v114.22.4770.4770","title":"Rituximab Based Regimen May Decrease the Incidence of CNS Relapse in Patients with Diffuse Large B-Cell Lymphoma.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Rituximab; Internal medicine; Regimen; Diffuse large B-cell lymphoma; Gastroenterology; Lymphoma; Bone marrow; Chemotherapy regimen; Surgery; Chemotherapy","score_opus":0.005137391646318246,"score_gpt":0.21370799535844928,"score_spread":0.20857060371213104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2529155841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974733,0.0003925636,0.000005706186,0.0005739657,0.000015577743,0.00059786224,0.000026581256,0.000024667594,0.00088976446],"genre_scores_gemma":[0.9984646,0.00003118632,0.0004425365,0.00086162053,0.000016781414,0.000040396317,0.000045958743,0.000017154545,0.00007979837],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879515,0.000053719097,0.00026250415,0.0002603951,0.00035778966,0.00027045893],"domain_scores_gemma":[0.9989737,0.00010820489,0.00012572922,0.00055660924,0.00007765034,0.00015810743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013494279,0.00017861335,0.00032706544,0.00009247613,0.000051373183,0.0000108485665,0.000116484,0.000062502215,0.000033230794],"category_scores_gemma":[0.00009191462,0.0001061527,0.000078847144,0.00026071034,0.00004636349,0.000053876378,0.000024519235,0.000058159574,0.000018233108],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067543983,0.11346638,0.8821998,0.000030097333,0.000049746468,0.00021610911,0.0002104879,9.670495e-7,0.00005942296,0.00014540815,0.00026122903,0.0026848617],"study_design_scores_gemma":[0.11447998,0.0012082435,0.8771527,0.00022756636,0.00032125995,0.000008232885,0.000038795413,0.000029157336,0.006138262,0.00002229417,0.00026276152,0.00011073881],"about_ca_topic_score_codex":0.00017966749,"about_ca_topic_score_gemma":0.00006620701,"teacher_disagreement_score":0.11380454,"about_ca_system_score_codex":0.00007779411,"about_ca_system_score_gemma":0.00019355281,"threshold_uncertainty_score":0.43287814},"labels":[],"label_agreement":null},{"id":"W2529257304","doi":"10.1182/blood.v116.21.2634.2634","title":"Evidence That High-Mobility Group A2 (Hmga2) Expression Contributes to the Ontogeny-Dependent Properties of Fetal Hematopoietic Stem Cells.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Haematopoiesis; Biology; Stem cell; Fetus; Bone marrow; Phenotype; Progenitor cell; Transplantation; Immunology; Andrology; Cell biology; Gene; Internal medicine; Genetics; Medicine","score_opus":0.056120797995238475,"score_gpt":0.277491403344321,"score_spread":0.2213706053490825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2529257304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99223346,0.0035590893,0.00019303046,0.0013216181,0.00033494504,0.0020331396,0.000010828828,0.000053279757,0.00026062864],"genre_scores_gemma":[0.9978979,0.00009197991,0.00020756862,0.00010042671,0.00012739643,0.00018963323,0.0000018279712,0.000026898062,0.0013563416],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972148,0.00021699088,0.000433531,0.00048679614,0.0011707278,0.0004771702],"domain_scores_gemma":[0.9977823,0.0003683506,0.00015508468,0.0011316607,0.00028702634,0.00027561185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016198263,0.00022357376,0.00047866284,0.00008103253,0.00014972789,0.00005339271,0.00051608,0.0001797463,0.00025544196],"category_scores_gemma":[0.0004903014,0.00012386529,0.00013412062,0.00020779761,0.00021420051,0.000112340385,0.0004096903,0.0005929128,0.0001245383],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033084452,0.0008010279,0.018288938,0.00050898775,0.000056413264,0.0000273851,0.00052252755,0.0000011745395,0.97793776,0.00009726217,0.00022247108,0.0012052346],"study_design_scores_gemma":[0.0014374327,0.00036994382,0.010972884,0.0009880984,0.000119556345,0.00004153148,0.00045154957,0.00001614749,0.9849932,0.000029417753,0.00045276716,0.00012743499],"about_ca_topic_score_codex":0.00045514895,"about_ca_topic_score_gemma":0.00032586293,"teacher_disagreement_score":0.0073160543,"about_ca_system_score_codex":0.000043055694,"about_ca_system_score_gemma":0.0001551371,"threshold_uncertainty_score":0.505108},"labels":[],"label_agreement":null},{"id":"W2529344316","doi":"10.1182/blood.v112.11.911.911","title":"Philadelphia Chromosome Negative (Ph-) Very High Risk (VHR) Acute Lymphoblastic Leukemia (ALL) in Children and Adolescents: The Impact of Intensified Chemotherapy on Early Event Free Survival (EFS) in Children’s Oncology Group (COG) Study AALL0031.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Cancer Centre; Dalhousie University; BC Children's Hospital","funders":"","keywords":"Etoposide; Medicine; Vincristine; Cytarabine; Internal medicine; Cyclophosphamide; Induction chemotherapy; Chemotherapy; Regimen; Gastroenterology; Surgery; Chemotherapy regimen","score_opus":0.014657993856081545,"score_gpt":0.2845088315103038,"score_spread":0.2698508376542223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2529344316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955168,0.00017185815,0.0000134787315,0.00026521794,0.00009165246,0.0036142587,0.00023017045,0.000059727012,0.00003686133],"genre_scores_gemma":[0.9982496,0.00084028847,0.000058293255,0.00022636539,0.0002894737,0.00014256717,0.000062999316,0.00011554248,0.000014879049],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99516237,0.0007609447,0.001045213,0.0009869944,0.0010597383,0.0009847224],"domain_scores_gemma":[0.99722254,0.00064584916,0.00045061889,0.0011502969,0.00019955677,0.00033110654],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008325323,0.00067831366,0.0014175718,0.00063585804,0.00013489954,0.000026646672,0.00074549747,0.00039175758,0.000042962492],"category_scores_gemma":[0.0007108737,0.00047247042,0.00026158235,0.0009131005,0.0006484796,0.00018125973,0.00040454607,0.0012476023,0.00002271829],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004675416,0.0073406207,0.9780349,0.000019963216,0.0033221324,0.00040586918,0.003441118,0.00012247487,0.0019227936,0.0000118369335,0.00021964405,0.0004831895],"study_design_scores_gemma":[0.07010162,0.009623496,0.9169855,0.0002935029,0.00059175567,0.00064641185,0.00024515248,0.00029427774,0.00076824205,0.00008750123,6.7923503e-7,0.00036184624],"about_ca_topic_score_codex":0.023424987,"about_ca_topic_score_gemma":0.0006478399,"teacher_disagreement_score":0.0654262,"about_ca_system_score_codex":0.0024316905,"about_ca_system_score_gemma":0.0014831739,"threshold_uncertainty_score":0.9997727},"labels":[],"label_agreement":null},{"id":"W2529435313","doi":"10.1182/blood.v124.21.473.473","title":"Clearance and Genetic Variability of Von Willebrand Factor Are Major Determinants of the Pharmacokinetic Behavior of Factor VIII Concentrates in the Treatment of Pediatric Hemophilia A","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto; Queen's University","funders":"","keywords":"Von Willebrand factor; Coagulation; Medicine; Internal medicine; ABO blood group system; Pharmacokinetics; Volume of distribution; Immunology; Von Willebrand disease; Endocrinology; Platelet","score_opus":0.021644170332238283,"score_gpt":0.2957797370901489,"score_spread":0.2741355667579106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2529435313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976358,0.0010119582,4.9907555e-7,0.000056152898,0.0000334102,0.0011257629,0.000110998146,0.0000030447616,0.000022393266],"genre_scores_gemma":[0.9990803,0.0007535851,0.00004497214,0.0000050487592,0.000044458717,0.00003404845,0.000001526879,0.00001035067,0.000025725307],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986729,0.00020365213,0.0004317148,0.00019501656,0.00031205977,0.00018465446],"domain_scores_gemma":[0.99899566,0.00026966934,0.00022902613,0.00035893903,0.0000916104,0.00005510447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001174957,0.00014861894,0.00049037015,0.00006207155,0.000024826993,0.0000027321694,0.0001353959,0.00007122591,0.000040476494],"category_scores_gemma":[0.000080448895,0.00007449253,0.00011455812,0.00021774722,0.00024210304,0.000019484662,0.000023232955,0.000071516726,3.9667069e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017147283,0.002753828,0.9511177,0.0004535268,0.00004592049,0.0000075845846,0.00095141324,5.00029e-7,0.04144602,0.0000011733528,9.913575e-7,0.0030498595],"study_design_scores_gemma":[0.0050111846,0.0009537651,0.770136,0.00005804625,0.00044167304,0.000008118363,0.000043199165,0.000039441882,0.22324812,0.0000102502445,0.0000057391753,0.00004447975],"about_ca_topic_score_codex":0.00006753022,"about_ca_topic_score_gemma":0.000017075668,"teacher_disagreement_score":0.18180211,"about_ca_system_score_codex":0.000016068878,"about_ca_system_score_gemma":0.000066256216,"threshold_uncertainty_score":0.30377173},"labels":[],"label_agreement":null},{"id":"W2529484558","doi":"10.1182/blood.v126.23.4267.4267","title":"G Protein-Coupled Receptor 56 As a Potential Regulator of Normal and Leukemic Stem Cells","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Receptor Mechanisms and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Princess Margaret Cancer Centre; Hospital for Sick Children; University Health Network; McGill University","funders":"","keywords":"Biology; Stem cell; Haematopoiesis; Progenitor cell; Myeloid leukemia; Myeloid; Leukemia; CD34; Cancer research; Regulator; Cell biology; Immunology; Molecular biology; Gene; Genetics","score_opus":0.007706821041294473,"score_gpt":0.19928281490347502,"score_spread":0.19157599386218055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2529484558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980526,0.0008928493,0.0004796044,0.000014833931,0.00012592268,0.0002252293,0.00001029577,0.000009469389,0.00018922208],"genre_scores_gemma":[0.9966599,0.000029931949,0.0016802843,0.00002386696,0.00024234639,0.000015236723,0.0000160256,0.000020133359,0.0013123245],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99921125,0.000035143737,0.00018914574,0.00024295849,0.00014748525,0.0001740042],"domain_scores_gemma":[0.9994779,0.0000021420492,0.000098389064,0.00019810583,0.00009567468,0.00012774674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018863333,0.00012089214,0.00014994323,0.000025143076,0.00003211593,0.000016367274,0.00010903725,0.00014493974,0.000047829035],"category_scores_gemma":[0.0000120678005,0.0001117085,0.000073758754,0.00004130158,0.000039261733,0.000004075051,0.000087468085,0.000053821044,0.000009874891],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009668476,0.00007117215,0.0000418657,0.000021351758,0.000057276695,0.000002381477,0.000052030176,0.000016687432,0.99901533,0.000064064014,0.00014981817,0.00041134443],"study_design_scores_gemma":[0.0016535799,0.0005713537,0.000009623668,0.00001833562,0.000038019774,0.000018488723,0.00015290143,0.00006818448,0.9960455,0.000053962904,0.0012318894,0.00013819378],"about_ca_topic_score_codex":0.000030472465,"about_ca_topic_score_gemma":0.0000017359836,"teacher_disagreement_score":0.0029698566,"about_ca_system_score_codex":0.0000056180393,"about_ca_system_score_gemma":0.0001195969,"threshold_uncertainty_score":0.45553404},"labels":[],"label_agreement":null},{"id":"W2529749106","doi":"10.1182/blood.v118.21.2955.2955","title":"Identification and Characterization of Human Leukemia Stem Cell Functional Regulators","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University Health Network","funders":"","keywords":"Stem cell; Biology; Haematopoiesis; Cancer stem cell; Leukemia; Hematopoietic stem cell; Cord blood; Cancer research; Gene signature; Myeloid leukemia; Immunology; Cell biology; Gene; Gene expression; Genetics","score_opus":0.028941415344314922,"score_gpt":0.24656077677349647,"score_spread":0.21761936142918153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2529749106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978493,0.000030092086,0.0001314727,0.000023756762,0.00003701766,0.00020719931,0.0000068314603,0.000028922623,0.0016854133],"genre_scores_gemma":[0.9962239,0.000018562252,0.00006914819,0.000019867039,0.00007338118,0.000012403008,0.00007595301,0.00001516709,0.0034915693],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992796,0.000025428479,0.00021761104,0.00017019284,0.00020076802,0.000106375795],"domain_scores_gemma":[0.9994814,0.000009390743,0.00010516423,0.00021456284,0.000118587675,0.00007091142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001649938,0.00006929534,0.00012624728,0.000115049974,0.000050433304,0.0000066657058,0.000044873457,0.00007350996,0.00011900028],"category_scores_gemma":[0.0000059284944,0.00006473568,0.000028024117,0.00012606283,0.000068189656,0.00009008097,0.000031243962,0.00009349547,0.000019996776],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004176499,0.00013873167,0.03481412,0.00010520961,0.00002949119,0.0000039719653,0.00035353276,2.657327e-8,0.9634091,0.0004232569,0.00005977067,0.00062097405],"study_design_scores_gemma":[0.0009872161,0.000084429645,0.4836326,0.000015051345,0.00006058372,0.00001518512,0.000046261073,0.000020472473,0.51503533,0.000028226546,0.00003892479,0.000035712106],"about_ca_topic_score_codex":0.000018790275,"about_ca_topic_score_gemma":8.792587e-7,"teacher_disagreement_score":0.44881848,"about_ca_system_score_codex":0.00005896409,"about_ca_system_score_gemma":0.00010652155,"threshold_uncertainty_score":0.2639844},"labels":[],"label_agreement":null},{"id":"W2529895151","doi":"10.1182/blood.v118.21.269.269","title":"Randomized Phase II Trial Comparing GA101 (Obinutuzumab) with Rituximab in Patients with Relapsed CD20 Indolent B-Cell Non-Hodgkin Lymphoma: Preliminary Analysis of the GAUSS Study","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Rituximab; Medicine; Obinutuzumab; Internal medicine; Follicular lymphoma; Clinical endpoint; Regimen; Population; CD20; Neutropenia; Phases of clinical research; Clinical trial; Oncology; Lymphoma; Surgery; Gastroenterology; Chemotherapy","score_opus":0.02219480741726867,"score_gpt":0.27055187853694834,"score_spread":0.24835707111967967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2529895151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99172646,0.00007850359,0.00002589601,0.000008304746,0.00006570636,0.006683353,0.000011716668,0.000029822388,0.0013702664],"genre_scores_gemma":[0.99908096,0.0000060320135,0.00022752097,0.000022550488,0.000038270424,0.00037862745,0.000041753392,0.00005044132,0.00015384973],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99605745,0.0005295386,0.0009573181,0.00061234215,0.0013058885,0.00053745887],"domain_scores_gemma":[0.9975836,0.0002951133,0.00047910426,0.0012074889,0.00025393767,0.00018071823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011743986,0.00036841066,0.0020194508,0.00058729685,0.00012831115,0.000016195265,0.0004403154,0.00012057814,0.000064907814],"category_scores_gemma":[0.00017326826,0.00020634482,0.00032503108,0.0017734005,0.00033971446,0.000097259064,0.00031467617,0.00029543432,0.000005129028],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8707798,0.08776242,0.030006276,0.000098269156,0.0035574005,0.00014713443,0.0073517095,0.00005646429,0.000020168227,0.0000023688,0.000017421806,0.00020053393],"study_design_scores_gemma":[0.941757,0.01592141,0.02476476,0.00023607489,0.009657018,0.000008753749,0.00068169495,0.0050645107,0.0016741538,0.0000020360624,0.0000021589447,0.00023042622],"about_ca_topic_score_codex":0.0025659453,"about_ca_topic_score_gemma":0.00036756648,"teacher_disagreement_score":0.07184102,"about_ca_system_score_codex":0.00203719,"about_ca_system_score_gemma":0.0033903306,"threshold_uncertainty_score":0.84144974},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W2529928868","doi":"10.1182/blood.v120.21.3341.3341","title":"The International Prospective Glanzmann's Thrombasthenia Registry (GTR) Special Issues in Children","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Thrombasthenia; Surgery; Glanzmann's thrombasthenia; Platelet disorder; Prospective cohort study; Platelet; Pediatrics; Internal medicine; Platelet aggregation","score_opus":0.006526986056719256,"score_gpt":0.2550452950163076,"score_spread":0.24851830895958837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2529928868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97137547,0.00091168366,5.360005e-7,0.00096215727,0.00019602361,0.0002693544,0.000010019185,0.000020556425,0.026254207],"genre_scores_gemma":[0.9961089,0.00019252983,0.00010698824,0.00007827562,0.0014969993,0.000021963935,0.000033165325,0.00001075383,0.0019504128],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99937606,0.000010753805,0.00010941961,0.00011867956,0.00017988191,0.00020518643],"domain_scores_gemma":[0.99971646,0.00001658967,0.000040099003,0.00015557237,0.000021783026,0.00004949571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000083477054,0.00009010934,0.00013018119,0.000028340404,0.000058651778,0.000021369184,0.00009569727,0.000043800323,0.00009789955],"category_scores_gemma":[0.000040781408,0.00005798838,0.000042277257,0.000059940132,0.000044725366,0.00007441591,0.00003425364,0.00011089968,0.00009588235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006199775,0.0010987335,0.9943321,0.0000015322229,0.00022536359,0.000035092904,0.00028200875,5.6209235e-8,0.000052690077,0.0013175312,0.0015583695,0.0010345269],"study_design_scores_gemma":[0.0037700594,0.000065457796,0.9864743,0.000019494893,0.00006007465,0.0002576432,0.000088803296,9.897088e-7,0.001308905,0.00079909316,0.007091134,0.00006409324],"about_ca_topic_score_codex":0.00006832422,"about_ca_topic_score_gemma":0.00004012936,"teacher_disagreement_score":0.024733448,"about_ca_system_score_codex":0.000033617092,"about_ca_system_score_gemma":0.000022683824,"threshold_uncertainty_score":0.23646976},"labels":[],"label_agreement":null},{"id":"W2529935094","doi":"10.1182/blood.v112.11.3487.3487","title":"The Potent Deacetylase Inhibitor Trichostatin a (TSA) Increases CXCR4 Expression in Hematopoietic Stem/Progenitor Cells by Chromatin Remodelling","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Canadian Blood Services","funders":"","keywords":"Trichostatin A; Histone deacetylase; Cancer research; Biology; Progenitor cell; Haematopoiesis; Cell biology; Stem cell; Histone; Biochemistry","score_opus":0.010852995994497504,"score_gpt":0.2329938772508488,"score_spread":0.22214088125635129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2529935094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925774,0.00615447,0.00025589755,0.000084116684,0.00010033202,0.00060158886,0.000055699125,0.00003223854,0.0001382902],"genre_scores_gemma":[0.99638534,0.0009517062,0.0009023759,0.00005043627,0.00027260665,0.00016890997,0.00007742788,0.00006658315,0.0011245889],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973394,0.00034159588,0.0005649989,0.00059637486,0.00053553947,0.00062208564],"domain_scores_gemma":[0.9987127,0.00012114378,0.00016126965,0.00065467856,0.00011499625,0.0002351645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045756638,0.00030072356,0.00026563104,0.000091493865,0.0004366287,0.000050594303,0.00040323386,0.00023574743,0.000008853971],"category_scores_gemma":[0.00015676486,0.00024213197,0.00014812681,0.00026924952,0.00018735096,0.000011052191,0.00022427793,0.00029524823,0.000052286603],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001263776,0.00073220214,0.00024222738,0.0000404533,0.000023654546,0.000107946165,0.00021981065,0.000048307254,0.9870363,0.0000011359277,0.011084041,0.00033758345],"study_design_scores_gemma":[0.002321335,0.00024906904,0.000036053403,0.00008925705,0.000014744026,0.00013138316,0.00022004028,0.00016124397,0.99137956,0.00000511782,0.005101484,0.00029073877],"about_ca_topic_score_codex":0.00010665353,"about_ca_topic_score_gemma":0.00003824282,"teacher_disagreement_score":0.0059825573,"about_ca_system_score_codex":0.00005855017,"about_ca_system_score_gemma":0.00022677256,"threshold_uncertainty_score":0.98738545},"labels":[],"label_agreement":null},{"id":"W2529979203","doi":"10.1182/blood.v122.21.2445.2445","title":"The Splicing Factor Heterogeneous Nuclear Ribonucleoprotein L (hnRNPL) Restricts p53 Dependent and p53 Independent Cell Death Pathways In Hematopoietic Stem Cells","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Université de Montréal; Montreal Clinical Research Institute","funders":"","keywords":"Biology; RNA splicing; Haematopoiesis; Stem cell; Alternative splicing; Embryonic stem cell; Exon; Cell biology; Progenitor cell; RNA-binding protein; Ribonucleoprotein; Hematopoietic stem cell; Splicing factor; Transgene; Molecular biology; Genetics; Gene; Messenger RNA; RNA","score_opus":0.011742882678029377,"score_gpt":0.20925323474073754,"score_spread":0.19751035206270817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2529979203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973378,0.0014618059,0.000027402442,0.00005245216,0.00004768173,0.0006967267,0.000011298634,0.000019093513,0.00034574018],"genre_scores_gemma":[0.9982763,0.0007488943,0.00013876632,0.00007885411,0.000070669914,0.000060578102,0.0000043007103,0.000048597678,0.00057306484],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980741,0.00012548982,0.00032947675,0.00050440995,0.00032718893,0.0006393147],"domain_scores_gemma":[0.99902654,0.000039951916,0.000101312195,0.00052870985,0.00006156406,0.0002419473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002212546,0.00024350247,0.00020109757,0.000063041465,0.0002336596,0.0002081279,0.00036114085,0.00019924549,0.000017983273],"category_scores_gemma":[0.00002250504,0.00018694808,0.00007824091,0.00008400215,0.00005597041,0.00001058249,0.0003649711,0.00026581815,0.000058392663],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026338745,0.00015556824,0.0035542962,0.000042050917,0.000029930174,0.000057875925,0.00012181507,0.000029945397,0.99425584,0.00002948375,0.000031448217,0.0016654073],"study_design_scores_gemma":[0.0016015633,0.00042054738,0.0051100715,0.000037942827,0.0000150157875,0.000072272385,0.00038518652,0.0003068629,0.99131584,0.00007066641,0.00036258338,0.00030142404],"about_ca_topic_score_codex":0.00044408545,"about_ca_topic_score_gemma":0.0001688606,"teacher_disagreement_score":0.0029399765,"about_ca_system_score_codex":0.000026179587,"about_ca_system_score_gemma":0.000057746074,"threshold_uncertainty_score":0.7623521},"labels":[],"label_agreement":null},{"id":"W2530064551","doi":"10.1182/blood.v108.11.4169.4169","title":"A Novel Role of Complement Components C1q and C5a in Hematopoietic Stem/Progenitor Cell Migration.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Alberta","funders":"","keywords":"Haematopoiesis; CD34; Cell biology; Biology; Progenitor cell; Stem cell; Myeloid; Cord blood; Complement system; Immunology; Chemotaxis; Classical complement pathway; Immune system; Receptor","score_opus":0.012375033340667812,"score_gpt":0.2126946729276106,"score_spread":0.2003196395869428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530064551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939282,0.0050554397,0.000022077274,0.000037244416,0.000073823016,0.0004177151,0.00015529155,0.000021852691,0.00028837705],"genre_scores_gemma":[0.9995095,0.0000051971283,0.0001300088,0.0000103209095,0.000014937614,0.00004874636,0.00014172975,0.000009291589,0.00013026426],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990818,0.000068166046,0.00041120235,0.00019563548,0.000044759647,0.00019846676],"domain_scores_gemma":[0.9995683,0.00006167017,0.0001352413,0.00018793572,0.00003299375,0.000013878476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008944199,0.00012131802,0.00023639758,0.00008932401,0.00004986285,0.0000075543308,0.000119441866,0.000052571806,0.00013667575],"category_scores_gemma":[0.000002611299,0.00011912017,0.00004467111,0.00007270132,0.00005607676,0.000030372938,0.00008536154,0.000052520805,0.00003604713],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020618105,0.00153786,0.23849826,0.0000810917,0.000039013503,0.0000012724546,0.00017198261,0.0000028237678,0.7588881,0.00043462336,0.00029559538,0.000028737317],"study_design_scores_gemma":[0.009620683,0.0001739158,0.2744342,0.00013324895,0.00014713434,0.000056147528,0.0012666044,0.000017397457,0.7088501,0.00024696466,0.004780747,0.00027284634],"about_ca_topic_score_codex":0.0009247234,"about_ca_topic_score_gemma":0.00040204494,"teacher_disagreement_score":0.050038017,"about_ca_system_score_codex":0.000012772054,"about_ca_system_score_gemma":0.000018657911,"threshold_uncertainty_score":0.48575798},"labels":[],"label_agreement":null},{"id":"W2530076245","doi":"10.1182/blood.v110.11.1023.1023","title":"Growth Factor Independent 1b (Gfi1b) Is Highly Expressed in Human CML and Accelerates p210BCR-ABL Induced Leukemia in Mice.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"","keywords":"Myeloid leukemia; Tyrosine kinase; Cancer research; Haematopoiesis; Leukemia; Biology; Stem cell; Myeloid; Imatinib mesylate; Tyrosine-kinase inhibitor; ABL; Immunology; Imatinib; Cancer; Signal transduction; Cell biology; Genetics","score_opus":0.031074058810876805,"score_gpt":0.3042216675846502,"score_spread":0.27314760877377336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530076245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99587524,0.00028337122,0.0000062792537,0.00043751957,0.000051659412,0.00075753743,0.0000232982,0.00006912121,0.0024959848],"genre_scores_gemma":[0.99830097,0.00011758859,0.00028521838,0.0005516645,0.00019547495,0.00004181465,0.00003563465,0.000063623935,0.00040802616],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971291,0.00008972304,0.00062643876,0.0006631672,0.0006297227,0.0008618599],"domain_scores_gemma":[0.9988225,0.00020464674,0.0001076567,0.00039722802,0.00012810381,0.00033982546],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000692293,0.00033364477,0.0005612971,0.0007880365,0.0000808876,0.000067848814,0.0002988428,0.00042364444,0.0001770727],"category_scores_gemma":[0.00021452428,0.00030967005,0.00006336929,0.000652991,0.00009072768,0.00023862289,0.0002433963,0.0011389396,0.000037283316],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020843408,0.00050669996,0.20953393,0.00014002238,0.000069658665,0.0008042045,0.0018282019,3.1649284e-7,0.78563195,0.00009910152,0.00036251222,0.0008149789],"study_design_scores_gemma":[0.012164423,0.00027179558,0.4095628,0.00013879962,0.000031322295,0.000043105756,0.00035825552,0.000021226546,0.5768267,0.00014007835,0.0001937769,0.00024769508],"about_ca_topic_score_codex":0.003177921,"about_ca_topic_score_gemma":0.00084209326,"teacher_disagreement_score":0.20880523,"about_ca_system_score_codex":0.0008332336,"about_ca_system_score_gemma":0.00052937004,"threshold_uncertainty_score":0.99993557},"labels":[],"label_agreement":null},{"id":"W2530085416","doi":"10.1182/blood.v108.11.4745.4745","title":"IRL-1620 Increases the Efficacy of Radiation Treatment in Mice Bearing Lymphoma Cell Induced Tumors.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Radiation therapy; Lymphoma; Nuclear medicine; Internal medicine","score_opus":0.006638724342302929,"score_gpt":0.21513721262279198,"score_spread":0.20849848828048906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530085416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937139,0.0050155944,0.0000043171754,0.00001783894,0.00009628559,0.00018752091,0.0000121424655,0.000005515189,0.0009468651],"genre_scores_gemma":[0.9986206,0.00032774624,0.000048798993,0.000032359163,0.0007018614,0.000024633875,0.000065362365,0.000012030173,0.00016659715],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99939,0.00004566136,0.00017289065,0.00017718562,0.000070725204,0.00014351371],"domain_scores_gemma":[0.99965745,0.000020262216,0.00008365366,0.00019488043,0.000018297753,0.00002545145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007058692,0.00010287207,0.00012757898,0.000034288296,0.000033238164,0.000009316369,0.00009386205,0.00006715895,0.0000030496956],"category_scores_gemma":[0.00002438023,0.00008031221,0.00006975373,0.0000827196,0.000023219338,0.0000022903503,0.000029348084,0.000022037317,0.0000020267855],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004731133,0.00089111686,0.0062744063,0.000008386324,0.000021157235,0.0000012038964,0.000061000683,0.00003522884,0.98086345,0.000015805359,0.000097860786,0.011683095],"study_design_scores_gemma":[0.0033721856,0.00010517028,0.18209852,0.0000063595476,0.00004999158,0.0000054338825,0.000027145661,0.0000032701098,0.8078295,0.000008714842,0.0064162253,0.000077454424],"about_ca_topic_score_codex":0.0033172462,"about_ca_topic_score_gemma":0.0003653113,"teacher_disagreement_score":0.17582412,"about_ca_system_score_codex":0.000013937611,"about_ca_system_score_gemma":0.00009758069,"threshold_uncertainty_score":0.5014706},"labels":[],"label_agreement":null},{"id":"W2530132571","doi":"10.1182/blood.v118.21.4708.4708","title":"Effect of An Omega-3 Polyunsaturated Fatty Acid Enriched Diet, Acetylsalicylic Acid, and Aspirin-Triggered Lipoxin on Survival in a Murine Model of Acute Graft-Versus-Host Disease","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Fatty Acid Research and Health","field":"Nursing","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Docosahexaenoic acid; Eicosapentaenoic acid; Polyunsaturated fatty acid; Eicosanoid; Arachidonic acid; Lipoxin; Inflammation; Thromboxanes; Immunology; Lipid signaling; Fish oil; Aspirin; Biology; Pharmacology; Fatty acid; Biochemistry","score_opus":0.03307220536641935,"score_gpt":0.3052536403164401,"score_spread":0.27218143495002073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530132571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99777347,0.000432814,0.000024537541,0.00017247567,0.00017591937,0.00085495226,0.0002568614,0.000073844574,0.00023514012],"genre_scores_gemma":[0.9988874,0.00012460197,0.0006939693,0.000046170146,0.000055313296,0.000041808013,0.00008167751,0.000057788733,0.0000112616035],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969598,0.000649139,0.00053500116,0.0005621114,0.0005505775,0.00074337213],"domain_scores_gemma":[0.9981807,0.00020050038,0.0002156426,0.0006741798,0.00010885583,0.0006201273],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00080413994,0.00037210662,0.0007342936,0.00042951986,0.000098462166,0.000023482837,0.000356276,0.0001907939,0.000017287617],"category_scores_gemma":[0.00027308732,0.00031435685,0.00014183806,0.00060455466,0.00023900057,0.00027240714,0.00012672647,0.00047503374,0.000007626798],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09123219,0.003157986,0.015253773,0.0010430724,0.00031011304,0.000097875214,0.0013482781,0.000014932621,0.8848131,0.00015770145,0.000014026192,0.0025569606],"study_design_scores_gemma":[0.0194076,0.010964274,0.08393946,0.00018833384,0.00030596586,0.0000034157372,0.000049081522,0.0030742562,0.8816232,0.000106252366,0.0000024032015,0.00033574802],"about_ca_topic_score_codex":0.0005955697,"about_ca_topic_score_gemma":0.00037350247,"teacher_disagreement_score":0.07182459,"about_ca_system_score_codex":0.000059415066,"about_ca_system_score_gemma":0.00012590305,"threshold_uncertainty_score":0.99993086},"labels":[],"label_agreement":null},{"id":"W2530144024","doi":"10.1182/blood.v104.11.5152.5152","title":"Salvage of Primary Refractory Acute Leukemia (AL) with High-Dose Etoposide (VP) and Cyclophosphamide (CY) Followed by Early Stem Cell Transplantation (SCT): An Effective Treatment Strategy for AML but Not for All.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency","funders":"","keywords":"Medicine; Etoposide; Internal medicine; Vincristine; Mitoxantrone; Transplantation; Gastroenterology; Prednisone; Surgery; Cytarabine; Total body irradiation; Busulfan; Chemotherapy; Cyclophosphamide; Hematopoietic stem cell transplantation","score_opus":0.010192392701735033,"score_gpt":0.25730079853552607,"score_spread":0.24710840583379104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530144024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902513,0.0003503373,0.003344534,0.00012469916,0.00004408023,0.0046035717,0.0010480708,0.0000765169,0.00015686176],"genre_scores_gemma":[0.9917598,0.00041134248,0.0053627426,0.0002199411,0.00007131289,0.00087934034,0.0007511342,0.000106550746,0.00043786247],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978591,0.00006647271,0.0004163074,0.00064597174,0.00043930067,0.0005728196],"domain_scores_gemma":[0.99846417,0.00045876217,0.00020768517,0.00037660875,0.00017904975,0.0003137148],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021442964,0.0004002071,0.0007102188,0.00012620277,0.00011008463,0.00003335098,0.00012915397,0.00021967526,0.0000024848323],"category_scores_gemma":[0.000009949522,0.0003060863,0.00013162181,0.00013154659,0.00014218457,0.00026251422,0.00002116065,0.00016217325,0.000002031638],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023197537,0.0018400195,0.0008210251,0.0011136378,0.0015364874,0.0004726731,0.0018289681,0.000086151485,0.96068406,0.000083547886,0.00015069086,0.008185204],"study_design_scores_gemma":[0.08585087,0.026267722,0.024370503,0.00019664505,0.0028798217,0.00013899614,0.00017835197,0.000046409168,0.859577,0.00006935309,0.00008782214,0.00033648935],"about_ca_topic_score_codex":0.0012035044,"about_ca_topic_score_gemma":0.00010497484,"teacher_disagreement_score":0.101107046,"about_ca_system_score_codex":0.0013688947,"about_ca_system_score_gemma":0.0010920991,"threshold_uncertainty_score":0.99993914},"labels":[],"label_agreement":null},{"id":"W2530152170","doi":"10.1182/blood.v120.21.1638.1638","title":"CSF1R Inhibition by PLX3397 in Patients with Relapsed or Refractory Hodgkin Lymphoma: Results From a Phase 2 Single Agent Clinical Trial","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Gastroenterology; Lymphoma; Leukopenia; Refractory (planetary science); Anemia; Progression-free survival; Clinical endpoint; Adverse effect; Transplantation; Clinical trial; Surgery; Oncology; Toxicity; Chemotherapy","score_opus":0.04885471872648443,"score_gpt":0.3190104074154474,"score_spread":0.27015568868896295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530152170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99711204,0.00030004833,0.0000025645613,0.00014686547,0.00037394476,0.0011206425,0.00042937178,0.00005496718,0.00045957725],"genre_scores_gemma":[0.99658346,0.00005041204,0.00046955427,0.0003121331,0.0005106216,0.00010685617,0.0018141683,0.00003388012,0.00011891044],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99781823,0.00017634362,0.0007864013,0.00042860204,0.0004197989,0.00037061874],"domain_scores_gemma":[0.99856436,0.0003631857,0.00028114853,0.00042129226,0.000057051424,0.00031295008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033912592,0.00023444205,0.00049196096,0.00007928879,0.00004802602,0.000020277204,0.000048396294,0.0002080644,0.000081682876],"category_scores_gemma":[0.00045002848,0.00015433934,0.000111746594,0.00016694747,0.000057999983,0.00016617056,0.000034371456,0.00010490935,0.00007027148],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.31446666,0.31885326,0.3113078,0.000019911315,0.0004973631,0.0003310705,0.00072957674,1.0702217e-7,0.00034277164,0.0000046942405,0.012179084,0.041267704],"study_design_scores_gemma":[0.7228714,0.014189722,0.24954769,0.00023471635,0.0005065182,0.0000046135897,0.000040631017,0.0000014226159,0.004116404,0.0000035854546,0.008286708,0.00019655439],"about_ca_topic_score_codex":0.0002278341,"about_ca_topic_score_gemma":0.000040146417,"teacher_disagreement_score":0.4084048,"about_ca_system_score_codex":0.00024427293,"about_ca_system_score_gemma":0.0001429402,"threshold_uncertainty_score":0.6293776},"labels":[],"label_agreement":null},{"id":"W2530180470","doi":"10.1182/blood.v108.11.1351.1351","title":"A NUP98-HOX Fusion Gene Containing the Homeodomain of HOXA10 Promotes Significant Expansion of Primitive Human Hematopoietic Cells in Extended Cultures.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Viral Infectious Diseases and Gene Expression in Insects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer; BC Cancer Agency","funders":"","keywords":"Haematopoiesis; Biology; CD34; Stem cell; Stem cell factor; Molecular biology; In vitro; Fusion gene; Cell culture; Cell biology; Cancer research; Immunology; Gene; Genetics","score_opus":0.0063947688578369355,"score_gpt":0.23995360566094495,"score_spread":0.23355883680310802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530180470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979132,0.0008815959,0.000096312215,0.000016470854,0.000045061144,0.00039023248,0.000033546417,0.000008614203,0.0006149665],"genre_scores_gemma":[0.99941486,0.00006732192,0.00021153853,0.000030168303,0.000087710076,0.000044044893,0.000060902497,0.000017705182,0.00006575065],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988574,0.00012239664,0.00036936937,0.00028393778,0.00016916721,0.0001977366],"domain_scores_gemma":[0.999304,0.000021082598,0.00022995102,0.00031403103,0.000092144524,0.000038817365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001720189,0.00015767093,0.0002221878,0.000046656132,0.00008617499,0.000011206502,0.00016426589,0.00012787266,0.000017197064],"category_scores_gemma":[0.000029774994,0.00011093157,0.00013058659,0.00011051389,0.000128716,0.0000038935796,0.00010960661,0.00008170559,8.406065e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008005303,0.00067059137,0.0017045427,0.000051907933,0.000026167072,0.000006768619,0.00018325793,0.000060511695,0.9967304,0.00019166672,0.00022759811,0.000066570996],"study_design_scores_gemma":[0.001456225,0.00075800414,0.010187284,0.00009280331,0.000040796218,0.0000068793015,0.00034577952,0.0000070472497,0.9863343,0.00056654867,0.000064449705,0.00013986028],"about_ca_topic_score_codex":0.00019454154,"about_ca_topic_score_gemma":0.00004040851,"teacher_disagreement_score":0.010396042,"about_ca_system_score_codex":0.0000065914423,"about_ca_system_score_gemma":0.00005410248,"threshold_uncertainty_score":0.45236582},"labels":[],"label_agreement":null},{"id":"W2530181155","doi":"10.1182/blood.v122.21.2370.2370","title":"ABO Group As a Thrombotic Risk Factor In Children With Acute Lymphoblastic Leukemia: A Retrospective Study Of 523 Pediatric Patients","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"","keywords":"Medicine; ABO blood group system; Internal medicine; Thrombosis; Univariate analysis; Thrombophilia; Risk factor; Retrospective cohort study; Surgery; Multivariate analysis","score_opus":0.0037440695746467057,"score_gpt":0.2019228735258426,"score_spread":0.1981788039511959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530181155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974021,0.00007268532,0.000011357939,0.000006311596,0.00004233262,0.0022700368,0.000039776,0.000043131604,0.000112293],"genre_scores_gemma":[0.9995318,0.00009708534,0.00011655463,0.000020753036,0.00008120155,0.00008274781,0.000015920645,0.00004040672,0.000013495511],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839,0.000058093763,0.0003524535,0.00042292156,0.0004771144,0.00029938517],"domain_scores_gemma":[0.99918854,0.000031695905,0.00017034964,0.00033972782,0.00013562768,0.0001340632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000058592752,0.00024251976,0.0005229883,0.0002078413,0.000057863195,0.000014703029,0.00010779351,0.000112906455,0.00010196685],"category_scores_gemma":[0.000040343948,0.00017237238,0.00006613589,0.0005629881,0.00003697603,0.00013181103,0.00004081087,0.00030272728,0.000043657103],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011162886,0.007695197,0.9900643,0.000025590803,0.0005732974,0.000020569465,0.001143789,0.0000020631028,0.00013678169,0.0000057915977,0.0000054561156,0.00021549502],"study_design_scores_gemma":[0.027200615,0.009000145,0.9610096,0.00004585803,0.0021396216,0.000021549353,0.00020944206,0.0000101146925,0.00014083032,0.00005179542,9.906988e-8,0.00017031324],"about_ca_topic_score_codex":0.003026031,"about_ca_topic_score_gemma":0.00035422103,"teacher_disagreement_score":0.029054724,"about_ca_system_score_codex":0.00009156413,"about_ca_system_score_gemma":0.000097480224,"threshold_uncertainty_score":0.7029142},"labels":[],"label_agreement":null},{"id":"W2530252650","doi":"10.1182/blood.v124.21.3344.3344","title":"Comparison of Outcomes in Chronic Lymphocytic Leukemia (CLL) with the Addition of Rituximab to Initial Treatment: A Comparative Effectiveness Analysis in the Province of British Columbia (BC), Canada","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Paul's Hospital; Vancouver General Hospital; BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Chemoimmunotherapy; Internal medicine; Chronic lymphocytic leukemia; Rituximab; Hazard ratio; Population; Alemtuzumab; Proportional hazards model; Cohort; Oncology; Progression-free survival; Fludarabine; Chemotherapy; Cyclophosphamide; Leukemia; Lymphoma; Confidence interval; Transplantation","score_opus":0.01773383806693,"score_gpt":0.31428806678711785,"score_spread":0.29655422872018783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530252650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997791,0.00016270584,0.000038952603,0.000026286458,0.00001174914,0.0014464846,0.00016010244,0.0000056351923,0.00035710103],"genre_scores_gemma":[0.9995865,0.000005995755,0.000040489165,0.00002452326,0.000020887954,0.0001983848,0.000056383116,0.000012410545,0.00005443012],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976709,0.00052910135,0.00052120065,0.00029081432,0.0006865781,0.00030141967],"domain_scores_gemma":[0.9976558,0.0013814245,0.00024014145,0.00049628405,0.0001637911,0.00006254812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005008738,0.00014928299,0.0012482754,0.00014379802,0.0000396444,0.0000180027,0.00025746346,0.00006422005,0.000027595655],"category_scores_gemma":[0.00011233997,0.00011625874,0.000111009314,0.0011811217,0.0002624043,0.000044434848,0.00004551479,0.00013870299,8.8972e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0053551947,0.011157026,0.8790828,0.004529086,0.00932242,0.0010957861,0.01080017,0.06414063,0.0026718278,0.00012745708,0.0016681455,0.0100494595],"study_design_scores_gemma":[0.09965865,0.0041780765,0.8466304,0.00097627135,0.001997307,0.000084113824,0.0017046758,0.030441154,0.013958522,0.00001226238,0.00011209653,0.00024644294],"about_ca_topic_score_codex":0.9644217,"about_ca_topic_score_gemma":0.9954148,"teacher_disagreement_score":0.09430346,"about_ca_system_score_codex":0.024460007,"about_ca_system_score_gemma":0.027796142,"threshold_uncertainty_score":0.97928494},"labels":[],"label_agreement":null},{"id":"W2530254873","doi":"10.1182/blood.v114.22.4048.4048","title":"Genome-Wide Association Study Identifies Genetic Loci Associated with Iron Deficiency.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Soluble transferrin receptor; Hereditary hemochromatosis; Single-nucleotide polymorphism; Transferrin saturation; Iron deficiency; Genome-wide association study; Linkage disequilibrium; Genetics; Biology; Allele frequency; Ferritin; Serum iron; Genotype; Transferrin; Population; Minor allele frequency; Transferrin receptor; Genotyping; Hemochromatosis; Internal medicine; Medicine; Endocrinology; Anemia; Gene","score_opus":0.007456109597126735,"score_gpt":0.22660902501632463,"score_spread":0.2191529154191979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530254873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994066,0.0010932217,0.000034474713,0.0003139959,0.00005110923,0.00053578697,0.000003800969,0.000102853235,0.003798735],"genre_scores_gemma":[0.9967919,0.000043530472,0.000086259635,0.000538241,0.00006321258,0.000010965187,0.00003573184,0.000016594553,0.0024135623],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985801,0.00007158699,0.00023148915,0.0002644232,0.0005279238,0.00032448728],"domain_scores_gemma":[0.9993476,0.0000617966,0.00014926051,0.00023843424,0.00011994826,0.00008294691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002741265,0.0001523282,0.00026566567,0.00009577933,0.000116571246,0.000041936462,0.00008699942,0.00008407195,0.00006485199],"category_scores_gemma":[0.00046956938,0.0001257999,0.000052706695,0.00029542553,0.000019846011,0.00006764739,0.000013435733,0.00013412011,0.000058146525],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033623743,0.003409363,0.9933432,0.000014908422,0.000037685626,0.00005441269,0.0011907456,0.000022033806,0.0014006888,0.000005507144,0.0002671921,0.00022064969],"study_design_scores_gemma":[0.005277468,0.00081284385,0.99160415,0.000010268661,0.00089199137,0.0000027586493,0.00087803963,0.0000016432064,0.00023810698,0.0000692344,0.00006379054,0.00014971552],"about_ca_topic_score_codex":0.000032203658,"about_ca_topic_score_gemma":0.00007782105,"teacher_disagreement_score":0.0052438444,"about_ca_system_score_codex":0.000060111117,"about_ca_system_score_gemma":0.00007151508,"threshold_uncertainty_score":0.51299703},"labels":[],"label_agreement":null},{"id":"W2530306381","doi":"10.1182/blood.v124.21.777.777","title":"Dose Dependent Role of Gfi1 in Human MDS and AML and Its Suitability As a Novel Target","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Myeloid leukemia; Cancer research; Haematopoiesis; Bone marrow; Stem cell; Myeloid; Transcription factor; Leukemia; Medicine; Biology; Immunology; Gene; Genetics","score_opus":0.004985169714467528,"score_gpt":0.22784084059242088,"score_spread":0.22285567087795335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530306381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960513,0.002593431,0.00000803021,0.000018119581,0.000008200158,0.000121365585,0.000015534679,0.000002815051,0.001181181],"genre_scores_gemma":[0.9996819,0.000054817738,0.0001305979,0.000029955618,0.000016001884,0.000011825911,0.000025370071,0.0000075743196,0.000041967083],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99946314,0.00001861584,0.00011577981,0.00022711529,0.00005471658,0.00012063274],"domain_scores_gemma":[0.99974597,0.0000050356493,0.000036511756,0.00014308337,0.00002067134,0.000048737027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009421416,0.00008920244,0.00011986038,0.00001959029,0.0000279879,0.000007322226,0.000049739814,0.00008126381,0.0000060121074],"category_scores_gemma":[0.000029193994,0.000082049184,0.000021692815,0.000024870315,0.000031808857,0.0000025184572,0.000082248545,0.000032798718,6.7134044e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031492455,0.0014120198,0.32219404,0.00003349413,0.00006797582,0.0000012599276,0.0000845919,0.0000016774521,0.6743766,0.00049489434,0.0000032087194,0.0012987191],"study_design_scores_gemma":[0.006531259,0.0007355185,0.15219697,0.000011295755,0.00006087355,0.000015002394,0.00008244249,0.00002631221,0.8381042,0.0015879777,0.00048297466,0.00016519713],"about_ca_topic_score_codex":0.0001380525,"about_ca_topic_score_gemma":0.00023137651,"teacher_disagreement_score":0.16999707,"about_ca_system_score_codex":0.0000014908062,"about_ca_system_score_gemma":0.00001308868,"threshold_uncertainty_score":0.3345869},"labels":[],"label_agreement":null},{"id":"W2530308177","doi":"10.1182/blood.v120.21.1621.1621","title":"Young Adults Aged 18 to 30 Years with Hodgkin Lymphoma Can Tolerate a Modified Version of the Combined Modality German Paediatric HD95 Protocol with Minimal Neurotoxicity and Excellent Outcome. Results of the UK NCRN 18–30 Study (CRUK/08/012)","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Procarbazine; Vincristine; Radiation therapy; Prednisolone; Regimen; ABVD; Internal medicine; Etoposide; Pediatrics; Gastroenterology; Surgery; Cyclophosphamide; Chemotherapy","score_opus":0.022533222810805796,"score_gpt":0.28787555365752315,"score_spread":0.2653423308467174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530308177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94747317,0.0000055122105,0.0000056138424,0.00019013544,0.000050417642,0.05184924,0.00010075835,0.00002827193,0.00029686303],"genre_scores_gemma":[0.99353504,0.0000010694355,0.00011463438,0.000098821176,0.00008575728,0.0059406837,0.000005043402,0.000046941943,0.00017202897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99637496,0.0005172426,0.0006726562,0.0004981172,0.0013518339,0.000585156],"domain_scores_gemma":[0.997686,0.00020344532,0.00042104293,0.0011077893,0.00025008715,0.00033161524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081355363,0.00033570876,0.0006099484,0.0001303031,0.00016439988,0.000023596254,0.0004462308,0.000115292445,0.000031769305],"category_scores_gemma":[0.0002810555,0.00018017368,0.00009816776,0.00069552305,0.0002585955,0.00006712887,0.0005115261,0.00028560153,0.0000044791313],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022333492,0.005447731,0.95700574,0.0004671938,0.0002970849,0.00007939852,0.007483069,0.000047767615,0.0061102076,0.000005224184,0.0004775378,0.00024557952],"study_design_scores_gemma":[0.06389505,0.0037595707,0.9191133,0.00020787663,0.00037745477,0.000054250322,0.0007040755,0.00031870377,0.01134777,0.0000019716615,0.000014093728,0.00020589062],"about_ca_topic_score_codex":0.0018215379,"about_ca_topic_score_gemma":0.0003125412,"teacher_disagreement_score":0.046061832,"about_ca_system_score_codex":0.00021837182,"about_ca_system_score_gemma":0.0005648482,"threshold_uncertainty_score":0.73472697},"labels":[],"label_agreement":null},{"id":"W2530310322","doi":"10.1182/blood.v112.11.3426.3426","title":"Maternal Immune Response to Fetal Platelet GPIbα Causes More Frequent Miscarriage in An Animal Model: A Potential Explanation for Low Reported Incidence of Fetal and Neonatal Immune Thrombocytopenia Mediated by Anti-GPIbα Antibodies.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Antibody; Immunology; Neonatal alloimmune thrombocytopenia; Platelet; Immune system; Fetus; Miscarriage; Antigen; Pregnancy; Platelet membrane glycoprotein; Andrology; Biology","score_opus":0.01554809486882956,"score_gpt":0.27350878872884826,"score_spread":0.2579606938600187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530310322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967771,0.0009932428,0.0001431881,0.00020161217,0.00005920453,0.0011453128,0.00061690167,0.000056215536,0.000007197111],"genre_scores_gemma":[0.9972616,0.0002395229,0.0013987173,0.000047686957,0.00002205542,0.000057542762,0.00087987137,0.00004942652,0.00004356354],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99772817,0.00006952585,0.0008052809,0.00052674644,0.00044649708,0.0004237585],"domain_scores_gemma":[0.9989503,0.000059410842,0.00028931702,0.00034038047,0.00016667957,0.00019392106],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030202226,0.00032600158,0.0008870654,0.0002608418,0.0001299641,0.000028451772,0.0001437091,0.00018192004,0.00001843314],"category_scores_gemma":[0.00017649145,0.00030375965,0.000110622335,0.00020745334,0.00014689295,0.00037253968,0.000083857296,0.00015793741,0.0000025540976],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007397984,0.0012464144,0.052672748,0.000089869,0.0003455065,0.007040465,0.0014744486,0.00011211429,0.9293782,0.0000021583396,0.00003319994,0.00020687892],"study_design_scores_gemma":[0.019055147,0.0018050777,0.56967074,0.00024145079,0.00027188068,0.0040468965,0.00032074802,0.0074404217,0.3967375,0.000019301562,0.000007274506,0.00038359858],"about_ca_topic_score_codex":0.0010970378,"about_ca_topic_score_gemma":0.00012378003,"teacher_disagreement_score":0.53264076,"about_ca_system_score_codex":0.000054001797,"about_ca_system_score_gemma":0.00018258774,"threshold_uncertainty_score":0.99994147},"labels":[],"label_agreement":null},{"id":"W2530316220","doi":"10.1182/blood.v120.21.5157.5157","title":"Hereditary Hemolytic Anemia in Korea From 1997 to 2011: A Study by the Korean Hereditary Hemolytic Anemia Working Party of the Korean Society of Hematology","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hereditary spherocytosis; Thalassemia; Medicine; Pallor; Hemolytic anemia; Jaundice; Hemoglobinopathy; Anemia; Internal medicine; Hemoglobin electrophoresis; Hematology; Gastroenterology; Erythrocyte fragility; Spherocytosis; Pediatrics; Beta thalassemia; Hemolysis; Splenectomy","score_opus":0.02100654898115748,"score_gpt":0.2507207826279219,"score_spread":0.22971423364676444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530316220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99404293,0.002118188,0.000011718874,0.0012711292,0.00072280416,0.0010355397,0.00009626306,0.00004465715,0.0006567557],"genre_scores_gemma":[0.9969378,0.00003789675,0.00033363604,0.0016472479,0.0006456323,0.00005790981,0.000119543096,0.00004678432,0.00017353006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974767,0.0003168194,0.00075389293,0.0004455626,0.0004121339,0.0005948718],"domain_scores_gemma":[0.99793506,0.00051001116,0.0002924745,0.0009883957,0.00006504756,0.00020900776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048601118,0.00034545865,0.00085187634,0.00006686306,0.00011025604,0.000005273698,0.00039241876,0.00028049227,0.00025642966],"category_scores_gemma":[0.00009284893,0.00021415991,0.0002905978,0.00043227788,0.0002993899,0.000071073104,0.00025723243,0.0006219765,0.00003273115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060699706,0.0057068155,0.8376282,0.00028041273,0.00046473442,0.000077199446,0.010174459,0.000010336531,0.03380655,0.000032845637,0.110298626,0.0009128616],"study_design_scores_gemma":[0.020194449,0.0029980743,0.8347325,0.0009563353,0.0022935818,0.0014389051,0.024818517,0.00017003542,0.10850107,0.00047610336,0.0024282727,0.000992189],"about_ca_topic_score_codex":0.0010768356,"about_ca_topic_score_gemma":0.00029222626,"teacher_disagreement_score":0.107870355,"about_ca_system_score_codex":0.000052028154,"about_ca_system_score_gemma":0.00013909597,"threshold_uncertainty_score":0.8733188},"labels":[],"label_agreement":null},{"id":"W2530343061","doi":"10.1182/blood.v106.11.3598.3598","title":"Control of Oxidant-Stress and Inflammation by Iron Chelators Deferasirox (ICL670) or Deferoxamine in β-Thalassemia: An Ancillary Study of the Novartis CICL670A0107 Trial.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Deferasirox; Deferoxamine; Medicine; Lipid peroxidation; Deferiprone; Malondialdehyde; Internal medicine; Gastroenterology; Thalassemia; Oxidative stress; Ferritin; Pharmacology","score_opus":0.00834937162590162,"score_gpt":0.23490016479676537,"score_spread":0.22655079317086374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530343061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969985,0.00097349606,0.000006044099,0.00026030358,0.000051897343,0.001550914,0.000024855126,0.000020198975,0.000113784845],"genre_scores_gemma":[0.9995788,0.00015416984,0.000041579853,0.00004390168,0.000061483006,0.000031002717,0.000010009515,0.00002178327,0.00005727737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984108,0.00013960901,0.00066148094,0.00024323375,0.00032647979,0.00021835159],"domain_scores_gemma":[0.99914205,0.00008467707,0.00024614678,0.00035738805,0.000078389174,0.00009134683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033050947,0.00017813449,0.00046714215,0.00010496258,0.000046233497,0.0000078903895,0.00010513339,0.0002137699,0.00002238605],"category_scores_gemma":[0.00018322533,0.0001126727,0.000055617966,0.0003197165,0.00008703629,0.0001040727,0.000037064205,0.00025369634,9.983985e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008868722,0.011792654,0.8015898,0.00036728787,0.00030977099,0.00004021194,0.0043392023,0.00018375058,0.16531886,0.0000305614,0.000057843274,0.0071013616],"study_design_scores_gemma":[0.39777768,0.009293343,0.42139167,0.0006079657,0.001646449,0.000121904864,0.0076531675,0.0008217262,0.15990233,0.0000122545425,0.00028941574,0.00048210568],"about_ca_topic_score_codex":0.00015603252,"about_ca_topic_score_gemma":0.0004675984,"teacher_disagreement_score":0.38890895,"about_ca_system_score_codex":0.000025423442,"about_ca_system_score_gemma":0.00007401206,"threshold_uncertainty_score":0.45946592},"labels":[],"label_agreement":null},{"id":"W2530376066","doi":"10.1182/blood.v110.11.5105.5105","title":"Total Body Irradiation (TBI) Based Versus Chemotherapy-Based Preparative Regimens Before Autologous Stem Cell Transplant for Non-Hodgkin’s Lymphoma.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Total body irradiation; Etoposide; Internal medicine; Melphalan; Regimen; Surgery; Carmustine; Autologous stem-cell transplantation; Cytarabine; Cyclophosphamide; Gastroenterology; Chemotherapy; Oncology","score_opus":0.012747515764374115,"score_gpt":0.2662653159010444,"score_spread":0.2535178001366703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530376066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95653194,0.000065884626,0.037344612,0.00027951534,0.0003504302,0.0021436762,0.00014444589,0.0002066674,0.002932845],"genre_scores_gemma":[0.991763,0.0000051086386,0.006772112,0.00026772544,0.00016885974,0.00014738529,0.00045584267,0.00007239679,0.00034756013],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979985,0.000045130473,0.0005195743,0.00050339964,0.00040526543,0.0005281802],"domain_scores_gemma":[0.9986162,0.0004391968,0.00020095453,0.00038744466,0.00013349816,0.0002226595],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045567736,0.0003273641,0.00045815288,0.00018466172,0.00012012873,0.000019856041,0.000102291284,0.00028647794,0.000048446364],"category_scores_gemma":[0.000008860038,0.0003086809,0.00022670643,0.00021390348,0.00006192508,0.00006959518,0.0000027676617,0.00010226505,0.00002809349],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.113376565,0.024880858,0.054014016,0.013558871,0.0035552662,0.0026220889,0.062531665,0.001288026,0.68601644,0.0011636699,0.002297095,0.034695446],"study_design_scores_gemma":[0.07824093,0.0045690797,0.059908777,0.0003632786,0.0014126612,0.00013090589,0.00044243573,0.012294696,0.8415303,0.000014870529,0.000574571,0.0005174506],"about_ca_topic_score_codex":0.00002216571,"about_ca_topic_score_gemma":0.00003536046,"teacher_disagreement_score":0.15551391,"about_ca_system_score_codex":0.00015557023,"about_ca_system_score_gemma":0.00040304178,"threshold_uncertainty_score":0.9999365},"labels":[],"label_agreement":null},{"id":"W2530443495","doi":"10.1182/blood.v126.23.575.575","title":"Whole Exome Sequencing of Type 1 and Type 2 Enteropathy-Associated T Cell Lymphoma Reveals Genetic Basis of Eatl Oncogenesis","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; Exome sequencing; Exome; CDKN2A; Carcinogenesis; Cancer research; Cancer; Mutation; Oncology; Gene; Genetics; Medicine","score_opus":0.0344719235053381,"score_gpt":0.2545146792881229,"score_spread":0.2200427557827848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530443495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99494654,0.0034684704,0.0000026696073,0.000027905664,0.0002075967,0.00021333732,0.000023080986,0.000020816802,0.0010895575],"genre_scores_gemma":[0.99774736,0.0001395865,0.0015193651,0.00007240802,0.000039779057,0.0000050170734,0.000010152648,0.000030326133,0.00043601147],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988896,0.0000683877,0.0003343371,0.00021779779,0.00029772017,0.00019211238],"domain_scores_gemma":[0.9988376,0.00005360914,0.00018707385,0.00027530003,0.0004914051,0.0001550111],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002071759,0.00013854876,0.0004068313,0.00009231978,0.0000156356,0.0000046033656,0.000088101784,0.00012171822,0.000036731184],"category_scores_gemma":[0.0003660662,0.00012842816,0.000045884957,0.00036305384,0.000069390895,0.000019830688,0.00006760434,0.000045753455,0.000011375142],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015685738,0.00041347573,0.3651614,0.00019065564,0.0001125901,0.000026436537,0.00071922713,0.000013595929,0.63185006,7.0897295e-7,0.00039922705,0.0009557837],"study_design_scores_gemma":[0.0069239815,0.003450501,0.26636702,0.00027914334,0.00077831984,0.00007297006,0.00038955003,0.00008315951,0.7210828,0.00006742213,0.0002848267,0.00022034073],"about_ca_topic_score_codex":0.00015594279,"about_ca_topic_score_gemma":0.00001741762,"teacher_disagreement_score":0.09879438,"about_ca_system_score_codex":0.000116293566,"about_ca_system_score_gemma":0.00037697647,"threshold_uncertainty_score":0.52371484},"labels":[],"label_agreement":null},{"id":"W2530516992","doi":"10.1182/blood.v122.21.sci-50.sci-50","title":"Fetal and Neonatal Alloimmune Thrombocytopenia: Lessons Learned from Animal Models","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Neonatal alloimmune thrombocytopenia; Immunology; Fetus; Medicine; Antibody; Pregnancy; Antigen; Miscarriage; Obstetrics; Biology; Genetics","score_opus":0.04123224764989726,"score_gpt":0.27358999900190034,"score_spread":0.2323577513520031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530516992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920344,0.0021782103,0.000044130145,0.0023567232,0.000024321289,0.00028014538,0.000033143497,0.000052514763,0.0029964603],"genre_scores_gemma":[0.99761623,0.00034232577,0.001170899,0.00015331391,0.000033947574,0.000024514018,0.00010232048,0.000021088608,0.00053537963],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9992611,0.000012325142,0.00012610403,0.00025833587,0.0001319673,0.00021020797],"domain_scores_gemma":[0.9996139,0.00002471264,0.000031778265,0.00019071672,0.000027793698,0.000111096735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000023270903,0.0001417904,0.00032615362,0.000029330811,0.00006811922,0.00003644033,0.000053919226,0.000084131694,0.00029676553],"category_scores_gemma":[0.000009309738,0.0001139458,0.000053584994,0.00004707001,0.000051004576,0.00019528504,0.000066132925,0.00011927682,0.00016926604],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013771859,0.012370395,0.09874526,0.00019731223,0.008539542,0.0075613065,0.005465749,0.00002204584,0.3637677,0.005460302,0.0036897098,0.49280348],"study_design_scores_gemma":[0.08550363,0.0032008968,0.80405337,0.00032957766,0.0034337302,0.0018674021,0.001802303,0.0086524775,0.0509509,0.034639258,0.004100198,0.0014662393],"about_ca_topic_score_codex":0.0012471558,"about_ca_topic_score_gemma":0.00003797349,"teacher_disagreement_score":0.70530814,"about_ca_system_score_codex":0.000008247825,"about_ca_system_score_gemma":0.000029582012,"threshold_uncertainty_score":0.4646575},"labels":[],"label_agreement":null},{"id":"W2530541558","doi":"10.1182/blood.v118.21.1603.1603","title":"Patterns of Failure in Patients with Stage I/II Bulky Mediastinal Hodgkin Lymphoma (HL) Treated with ABVD + Radiotherapy or the Stanford V Regimen in the Randomized Phase III North American Intergroup Trial: E2496","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; University of Alberta; BC Cancer Agency","funders":"","keywords":"ABVD; Medicine; Radiation therapy; Surgery; Chemotherapy regimen; Mediastinum; Randomized controlled trial; Regimen; Chemotherapy; Vincristine; Cyclophosphamide","score_opus":0.013625426442576315,"score_gpt":0.2457542506291422,"score_spread":0.23212882418656589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530541558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953999,0.000059085214,0.000032941607,0.00024218549,0.000022873615,0.004062403,0.00007880255,0.000026724574,0.000075067095],"genre_scores_gemma":[0.99825907,0.00012397957,0.00029374138,0.00024330478,0.000044100132,0.0008016561,0.000101036545,0.000042702657,0.00009040287],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99780905,0.0002813225,0.0006394995,0.000366885,0.00053034996,0.0003728686],"domain_scores_gemma":[0.99831015,0.0003862293,0.0005181149,0.000600415,0.00008935571,0.00009576583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042285922,0.00037135897,0.0011470435,0.00018568963,0.00006352241,0.000023543822,0.00026590843,0.000048090933,0.000064754546],"category_scores_gemma":[0.000054251814,0.00013321679,0.00012725125,0.00057673285,0.00025247555,0.000107590175,0.000030341947,0.000113589915,8.534451e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4918323,0.011362842,0.48405272,0.00001905726,0.0006927294,0.00024660188,0.006589527,5.5071024e-7,0.0000039491656,0.0000124370235,0.000021907352,0.005165382],"study_design_scores_gemma":[0.6658345,0.012438368,0.3193156,0.00018358734,0.00048687326,0.00001810518,0.0010050472,0.000007652764,0.0004805727,6.785854e-7,0.00008987333,0.00013915815],"about_ca_topic_score_codex":0.0048414324,"about_ca_topic_score_gemma":0.010153996,"teacher_disagreement_score":0.17400219,"about_ca_system_score_codex":0.0001160567,"about_ca_system_score_gemma":0.00017552852,"threshold_uncertainty_score":0.731883},"labels":[],"label_agreement":null},{"id":"W2530569835","doi":"10.1182/blood.v108.11.481.481","title":"MabThera (Rituximab) Plus Cyclophosphamide, Vincristine and Prednisone (CVP) Chemotherapy Improves Survival in Previously Untreated Patients with Advanced Follicular Non-Hodgkin’s Lymphoma (NHL).","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Rituximab; Follicular lymphoma; Confidence interval; Prednisone; Vincristine; Internal medicine; International Prognostic Index; Surgery; Gastroenterology; Cyclophosphamide; Lymphoma; Chemotherapy","score_opus":0.002525771565474547,"score_gpt":0.19702309622568995,"score_spread":0.1944973246602154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530569835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939446,0.0030016203,0.000012663095,0.0001933966,0.00006273391,0.0018872748,0.000040133644,0.00011046182,0.00074711593],"genre_scores_gemma":[0.99643004,0.00055464264,0.001862253,0.00019043707,0.000081280654,0.0002865764,0.0002364565,0.00008872648,0.0002696095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978311,0.000043084627,0.00047718853,0.00068265665,0.0004014817,0.00056447694],"domain_scores_gemma":[0.9989648,0.00006926936,0.00018357656,0.0004690237,0.0001360096,0.00017730838],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010175686,0.0004830244,0.00085914903,0.0001207609,0.00009095874,0.000048641406,0.00009858841,0.00014891513,0.000031685497],"category_scores_gemma":[0.000019891875,0.0003576956,0.00009596666,0.0003231019,0.00009533609,0.0001290853,0.00004339186,0.00007313944,0.000012196731],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022239743,0.011154242,0.9580265,0.00014487715,0.00038688717,0.00037514852,0.0002167048,0.000009505451,0.0013202684,0.000032507276,0.00007991399,0.026029443],"study_design_scores_gemma":[0.12790552,0.001944288,0.8599444,0.00028792798,0.00035386163,0.000037887818,0.000029548599,0.00007039344,0.0085089095,0.000033463424,0.0005340221,0.00034980773],"about_ca_topic_score_codex":0.0021463712,"about_ca_topic_score_gemma":0.00034854852,"teacher_disagreement_score":0.12568153,"about_ca_system_score_codex":0.00027912276,"about_ca_system_score_gemma":0.00016191503,"threshold_uncertainty_score":0.9998875},"labels":[],"label_agreement":null},{"id":"W2530584373","doi":"10.1182/blood.v108.11.2214.2214","title":"Noggin Overexpression Enhances Leukemic Progenitors Self-Renewal in AML by Abrogating the BMP Pathway Activation.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Bone and Joint Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Noggin; Bone morphogenetic protein; Progenitor cell; Haematopoiesis; CD34; Bone morphogenetic protein 7; Biology; Bone morphogenetic protein 2; Stem cell; Bone marrow; Cell biology; Internal medicine; Cancer research; Molecular biology; Endocrinology; Immunology; Medicine; Genetics; Gene; In vitro","score_opus":0.005547645318219449,"score_gpt":0.22399777247303065,"score_spread":0.2184501271548112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530584373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99650997,0.0005162565,0.000007361739,0.0002492908,0.000035648314,0.00032118743,0.000009478799,0.00009557903,0.00225524],"genre_scores_gemma":[0.99878305,0.000017269966,0.00025331503,0.000156383,0.00032783524,0.00006266412,0.000048996215,0.000016501426,0.0003340099],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990908,0.000045308057,0.000227641,0.00019556747,0.0002339099,0.00020675545],"domain_scores_gemma":[0.9995686,0.00008239914,0.000092904054,0.00017666376,0.000030451833,0.00004898324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008958971,0.00012231326,0.0001486544,0.00004373025,0.00008865691,0.000021574897,0.00006396835,0.000067505,0.00004212485],"category_scores_gemma":[0.000053303196,0.00008140087,0.000059861675,0.00015981727,0.000028641241,0.00009964735,0.000026287753,0.00013939811,0.000014220388],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005863603,0.0011995508,0.073923424,0.00009649736,0.000030906725,0.000014543688,0.00027138615,0.000006055932,0.9187521,0.000046416215,0.0046335896,0.0009669027],"study_design_scores_gemma":[0.0030589965,0.0000910428,0.020991724,0.00039519617,0.00006556075,0.000011960193,0.00024978264,0.00003804356,0.97330976,0.00023175638,0.0014250035,0.00013119218],"about_ca_topic_score_codex":0.00037293616,"about_ca_topic_score_gemma":0.000020026187,"teacher_disagreement_score":0.054557648,"about_ca_system_score_codex":0.00003999956,"about_ca_system_score_gemma":0.0001276534,"threshold_uncertainty_score":0.33194312},"labels":[],"label_agreement":null},{"id":"W2530594373","doi":"10.1182/blood.v112.11.202.202","title":"An Upstream Insulator Element Regulates DLK1 Imprinting in AML","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Genetic Syndromes and Imprinting","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Biology; Genomic imprinting; MEG3; CpG site; DNA methylation; Methylation; Imprinting (psychology); Molecular biology; Promoter; Genetics; Cancer research; Gene; Uniparental disomy; Gene expression; Downregulation and upregulation; Long non-coding RNA; Chromosome","score_opus":0.008113948638552441,"score_gpt":0.22598488199235234,"score_spread":0.2178709333537999,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530594373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99892056,0.00027032057,0.00005703557,0.000025417032,0.000053965337,0.000117663556,0.0000023570622,0.000014722788,0.00053796277],"genre_scores_gemma":[0.9971552,0.000100948,0.002365069,0.000058011872,0.00014105404,0.000012983087,0.000026044243,0.000021671045,0.00011904006],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990217,0.000031285006,0.00023294211,0.0003278999,0.00009430665,0.00029183627],"domain_scores_gemma":[0.9994547,0.0000036116212,0.000062842264,0.00037173,0.000031258885,0.00007586459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001295313,0.00013050932,0.00012242743,0.000043687716,0.00006888067,0.000013972263,0.00017029875,0.00009421903,0.000022810133],"category_scores_gemma":[0.000031742442,0.00013045034,0.000053378215,0.00007871985,0.000034773107,0.0000032066846,0.000101092184,0.00006302336,0.000008842793],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000023689813,0.00024132601,0.35466307,0.000006805813,0.000020935606,0.000006148831,0.0000792509,0.000045787267,0.64285564,0.000013194555,0.000017405828,0.0020480254],"study_design_scores_gemma":[0.001001463,0.00022777538,0.42570633,0.000010566371,0.000009100022,0.00011518682,0.00008244731,0.00006794536,0.5714699,0.000025871623,0.0011169006,0.00016653264],"about_ca_topic_score_codex":0.000058201276,"about_ca_topic_score_gemma":0.00002013201,"teacher_disagreement_score":0.07138577,"about_ca_system_score_codex":0.0000053330587,"about_ca_system_score_gemma":0.000040094914,"threshold_uncertainty_score":0.5319611},"labels":[],"label_agreement":null},{"id":"W2530611281","doi":"10.1182/blood.v120.21.1667.1667","title":"Chaetocin Exhibits Anti-Leukemia Activity Against Chronic Myeloid Leukemia Stem Cells","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital; University of Saskatchewan","funders":"","keywords":"Myeloid leukemia; Cancer research; Imatinib; Stem cell; Imatinib mesylate; Tyrosine kinase; CD117; Leukemia; Biology; Cytotoxic T cell; CD34; Immunology; Cell biology; Signal transduction; Biochemistry; In vitro","score_opus":0.008639566506533029,"score_gpt":0.22018411629601575,"score_spread":0.21154454978948273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530611281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941271,0.003507501,0.00024174147,0.000029790946,0.00046274596,0.00030502677,0.000023696502,0.000044230906,0.0012581464],"genre_scores_gemma":[0.99632454,0.00057858106,0.00009049328,0.000057792022,0.0015942338,0.000029156841,0.00006943445,0.00005126959,0.0012045251],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99862695,0.00007066477,0.000200887,0.00039192764,0.00018590069,0.00052369665],"domain_scores_gemma":[0.9991129,0.000009635262,0.00014719785,0.0005130549,0.000052770698,0.00016446704],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018949971,0.00024302716,0.00020314693,0.00004872939,0.0001035351,0.000021709902,0.0001707872,0.00036314875,0.000022166972],"category_scores_gemma":[0.000007634891,0.00025600527,0.0001315522,0.00013885438,0.000060969287,0.0000147443625,0.00013155454,0.00016732095,0.00008262708],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020885782,0.00008260012,0.0012002506,0.000035678284,0.00009422904,0.0000012808614,0.000042460422,0.0005454903,0.98349047,0.000007310024,0.0009594027,0.013519927],"study_design_scores_gemma":[0.0013835339,0.00011377214,0.010907092,0.000026960259,0.00006612308,0.000016333233,0.00001200994,0.00014553686,0.97019446,0.0000016971422,0.016825495,0.00030701287],"about_ca_topic_score_codex":0.000020462056,"about_ca_topic_score_gemma":0.000027375223,"teacher_disagreement_score":0.015866091,"about_ca_system_score_codex":0.00035018066,"about_ca_system_score_gemma":0.00044661303,"threshold_uncertainty_score":0.9999892},"labels":[],"label_agreement":null},{"id":"W2530621468","doi":"10.1182/blood.v108.11.1277.1277","title":"A 17q25.3 Duplication Defines a New Dosage-Sensitive Congenital Neutropenia Locus and Implicates SOCS3 as a Candidate Gene for Cases Unexplained by ELA2 Mutation.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"","keywords":"Neutropenia; Biology; Gene duplication; Congenital Neutropenia; Cancer research; Immunology; Genetics; Gene; Chemotherapy","score_opus":0.004264292072605288,"score_gpt":0.22109804274991524,"score_spread":0.21683375067730995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530621468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935542,0.004489789,0.0005237676,0.00030353526,0.000016674543,0.0005182431,0.00040478847,0.000019051799,0.00016995036],"genre_scores_gemma":[0.99608856,0.00013291443,0.00066777406,0.00015530366,0.00010274226,0.00014701516,0.0021230667,0.000027352835,0.00055523776],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991896,0.000016197147,0.00015860668,0.00037073708,0.000056074463,0.000208749],"domain_scores_gemma":[0.999569,0.000024859692,0.00008319519,0.00016705805,0.00007737908,0.00007851981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000026475893,0.00017844012,0.00014380954,0.000024467752,0.0001271693,0.00004902842,0.000055269214,0.000098946555,0.0000029764244],"category_scores_gemma":[0.000026578995,0.00016519311,0.000059227634,0.000057265996,0.000049096947,0.000007192627,0.00003654609,0.000025778454,0.000006805596],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027737019,0.00061650143,0.0035724398,0.000016844744,0.00040965638,0.000045564622,0.000046951413,0.000006803573,0.9846626,0.00024262084,0.006834723,0.0032679215],"study_design_scores_gemma":[0.0064800857,0.00066682516,0.001759412,0.0000045045263,0.0003533548,0.000403635,0.000053764925,0.000012083431,0.9859401,0.00060344994,0.0034610312,0.00026173057],"about_ca_topic_score_codex":0.00183004,"about_ca_topic_score_gemma":0.0006915763,"teacher_disagreement_score":0.0062027154,"about_ca_system_score_codex":0.000005213421,"about_ca_system_score_gemma":0.00006673077,"threshold_uncertainty_score":0.673638},"labels":[],"label_agreement":null},{"id":"W2530661236","doi":"10.1182/blood.v120.21.576.576","title":"BP-2-047, a Novel Small-Molecule Inhibitor of Stat3 Is Active in Myeloma Pre-Clinical Models: Rationale for Treatment of Stat3-Dependent Multiple Myeloma","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Multiple myeloma; Cancer research; STAT3; Angiogenesis; Biology; In vivo; Cell culture; Phosphorylation; Immunology; Cell biology; Genetics","score_opus":0.10551439926021645,"score_gpt":0.36199295120694613,"score_spread":0.2564785519467297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530661236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930564,0.00072033855,0.0012688695,0.00014243093,0.00008184585,0.0031145697,0.0012225088,0.000023358814,0.00036963742],"genre_scores_gemma":[0.9874843,0.00018149699,0.010407151,0.000048087404,0.0001852336,0.00064658216,0.00029080122,0.000049697413,0.00070667267],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974314,0.00009697526,0.000863701,0.00044205404,0.0005459217,0.00061996304],"domain_scores_gemma":[0.99790007,0.00064936985,0.00028486238,0.00046165375,0.00030789874,0.0003961285],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030420863,0.00030052362,0.00078717567,0.0002254323,0.000049548267,0.000009063564,0.00011678659,0.00017817527,0.00007425346],"category_scores_gemma":[0.00030676957,0.0002455621,0.00030861868,0.0001825388,0.00012160453,0.00018597636,0.000067913395,0.00010919176,0.000010434699],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023025908,0.1194107,0.64443916,0.0010281804,0.005368635,0.000112824586,0.015092482,0.00009276008,0.14197885,0.00046494344,0.00032966692,0.048655882],"study_design_scores_gemma":[0.07201931,0.0062492224,0.27168408,0.00020246174,0.0005426846,0.000030115414,0.0008246383,0.0048504886,0.64283085,0.00010034214,0.00035401728,0.0003117931],"about_ca_topic_score_codex":0.00044361132,"about_ca_topic_score_gemma":0.0003438436,"teacher_disagreement_score":0.500852,"about_ca_system_score_codex":0.00017023264,"about_ca_system_score_gemma":0.0004144199,"threshold_uncertainty_score":0.99999964},"labels":[],"label_agreement":null},{"id":"W2530690564","doi":"10.1182/blood.v110.11.5091.5091","title":"Higher CD 34 Cell Doses Reduce Non Relapse Mortality (NRM) and Do Not Increase the Incidence of Graft Versus Host Disease (GVHD) Following Unrelated Donor Blood Stem Cell Transplantation (SCT).","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Transplantation; Gastroenterology; Graft-versus-host disease; Univariate analysis; Incidence (geometry); Methotrexate; Surgery; Multivariate analysis","score_opus":0.018493332839772614,"score_gpt":0.2676775254468279,"score_spread":0.24918419260705527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530690564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99373376,0.0011973433,0.00014727315,0.0000974476,0.00039168991,0.0010214319,0.000088263594,0.00008540962,0.003237354],"genre_scores_gemma":[0.99848145,0.0005313465,0.00036270302,0.00007674929,0.00009063758,0.000030825464,0.000101473364,0.000053159176,0.00027165326],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99736065,0.00015937496,0.0007838336,0.00055014424,0.0007201896,0.0004258115],"domain_scores_gemma":[0.9978037,0.0007863906,0.0002909982,0.00058785867,0.00011611512,0.0004149198],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009325842,0.00035170332,0.00045694973,0.00014811616,0.00016624076,0.000036712463,0.00018301088,0.00021092025,0.000057860754],"category_scores_gemma":[0.000037099282,0.00028112959,0.00019888023,0.00041105805,0.00014330912,0.00020301988,0.000026403159,0.0003374337,0.000015794429],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007396151,0.0031817793,0.36523765,0.0049784337,0.0008182919,0.0043173484,0.006741504,0.000021679609,0.6066631,0.00017969466,0.000036978323,0.00042740468],"study_design_scores_gemma":[0.015436604,0.00034616093,0.53260547,0.00047220837,0.006915708,0.0000580708,0.0005458131,0.000013671244,0.44327945,0.000013634979,0.000015879446,0.00029735317],"about_ca_topic_score_codex":0.0005320456,"about_ca_topic_score_gemma":0.00006540774,"teacher_disagreement_score":0.1673678,"about_ca_system_score_codex":0.000037591235,"about_ca_system_score_gemma":0.00017629152,"threshold_uncertainty_score":0.99996406},"labels":[],"label_agreement":null},{"id":"W2530737867","doi":"10.1182/blood.v112.11.4393.4393","title":"Pediatric Treatment Guidelines for Philadelphia Positive (Ph+) Acute Lymphoblastic Leukemia (ALL): What Are They in today’s Imatinib Era?","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Stollery Children's Hospital","funders":"","keywords":"Medicine; Imatinib; Acute lymphocytic leukemia; Transplantation; Imatinib mesylate; Philadelphia chromosome; Internal medicine; Hematopoietic cell; Pediatrics; Hematopoietic stem cell transplantation; Lymphoblastic Leukemia; Oncology; Leukemia; Haematopoiesis; Stem cell; Myeloid leukemia","score_opus":0.04565763939235168,"score_gpt":0.3121178310377678,"score_spread":0.2664601916454161,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530737867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897388,0.004628845,0.00003529632,0.002634953,0.0002715749,0.0020326243,0.00019805919,0.00014446833,0.00031535633],"genre_scores_gemma":[0.97903323,0.01102185,0.0055057267,0.0011092613,0.0011323967,0.00070740865,0.00045015762,0.00011775489,0.00092220225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973451,0.000053517757,0.0007843254,0.0007087019,0.00040508373,0.00070327934],"domain_scores_gemma":[0.99821854,0.00031370245,0.00028119463,0.00058293337,0.0003323655,0.00027126397],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012322264,0.00054546184,0.00083803205,0.00028418162,0.00014334824,0.000039789975,0.00016933997,0.00023216345,0.000068092246],"category_scores_gemma":[0.00023519881,0.00043012542,0.00031792233,0.00025226333,0.000055715253,0.00025480703,0.00006173698,0.00015373922,0.0001119291],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013467236,0.043990295,0.6911168,0.0027907814,0.02418066,0.04081119,0.03803717,0.0023984953,0.022931535,0.00064395077,0.07539064,0.04424126],"study_design_scores_gemma":[0.3578862,0.014592049,0.52404195,0.003073118,0.022474915,0.013284438,0.0028236299,0.0057318793,0.04548791,0.0009291224,0.005976327,0.003698435],"about_ca_topic_score_codex":0.00039977906,"about_ca_topic_score_gemma":0.00022368276,"teacher_disagreement_score":0.34441897,"about_ca_system_score_codex":0.002856724,"about_ca_system_score_gemma":0.0014741393,"threshold_uncertainty_score":0.99981505},"labels":[],"label_agreement":null},{"id":"W2530740161","doi":"10.1182/blood.v114.22.1588.1588","title":"FLT3 ITD Signaling Profiles in AML Samples Harboring Mutations.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Signal transduction; Context (archaeology); Cancer research; Mutation; Biology; Medicine; Oncology; Gene; Internal medicine; Genetics","score_opus":0.03043076232155739,"score_gpt":0.3056566482622949,"score_spread":0.2752258859407375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530740161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99450475,0.00039211081,0.000116402174,0.0014688992,0.00002246701,0.00037772875,0.000005468494,0.000089121626,0.003023076],"genre_scores_gemma":[0.99015415,0.000034084667,0.008975272,0.00023911509,0.00023075183,0.000028886448,0.00003433941,0.000017326867,0.00028609578],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988845,0.00003863976,0.00023073143,0.0002335794,0.00027777202,0.0003347731],"domain_scores_gemma":[0.9994645,0.000106493506,0.000035545276,0.00021473228,0.00007066275,0.00010808154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025596493,0.00011050759,0.00020428257,0.00023137443,0.000056267756,0.000026102198,0.00010233387,0.00007277147,0.000104740415],"category_scores_gemma":[0.0003386376,0.00010113779,0.000047734644,0.0003627527,0.000035150886,0.00008878381,0.00002440168,0.0003002612,0.00006529345],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017552942,0.0014205709,0.15265489,0.00019491058,0.00012444818,0.00106563,0.0018770347,0.00011959779,0.8164758,0.002134597,0.0006431777,0.023113834],"study_design_scores_gemma":[0.009444157,0.00056401436,0.3524667,0.0004952865,0.00016041585,0.00016393905,0.0007741278,0.0007103438,0.63168913,0.0013214553,0.0018501906,0.00036024873],"about_ca_topic_score_codex":0.000075195516,"about_ca_topic_score_gemma":0.000008344096,"teacher_disagreement_score":0.19981182,"about_ca_system_score_codex":0.00009655849,"about_ca_system_score_gemma":0.00022456792,"threshold_uncertainty_score":0.41242793},"labels":[],"label_agreement":null},{"id":"W2530761803","doi":"10.1182/blood.v120.21.4274.4274","title":"Patient Preferences for Stopping Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Victoria Hospital; London Health Sciences Centre; Western University","funders":"","keywords":"Nilotinib; Medicine; Dasatinib; Imatinib; Imatinib mesylate; Internal medicine; Oncology; Myeloid leukemia; Clinical trial; Family medicine","score_opus":0.02184095435986586,"score_gpt":0.2647925601303088,"score_spread":0.24295160577044292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530761803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895669,0.0075019524,0.00001747516,0.00008047506,0.00029008312,0.0011253274,0.000018821545,0.00007487671,0.0013240579],"genre_scores_gemma":[0.99742067,0.00012893912,0.0010652483,0.00010380178,0.00064940844,0.0003054454,0.00008378934,0.00003843306,0.00020425572],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99840176,0.000031640076,0.00037677388,0.0003015237,0.00024975283,0.00063854235],"domain_scores_gemma":[0.99920523,0.00009018317,0.00011309526,0.0003281792,0.000048393318,0.00021493067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016364377,0.00023554312,0.0003601109,0.00014948205,0.00006222657,0.000013397891,0.0000724748,0.00013593513,0.000089483285],"category_scores_gemma":[0.00011787033,0.0002010375,0.00010451378,0.00021034924,0.00004736657,0.00016354755,0.00006023306,0.00018776178,0.00004850956],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063515524,0.005384718,0.5916508,0.0018355051,0.00071878167,0.00013143382,0.005848852,0.000120260825,0.19658038,0.0005394144,0.0035989531,0.19295575],"study_design_scores_gemma":[0.052059736,0.004079167,0.3158329,0.0023347766,0.0010810676,0.00021012615,0.0007541258,0.0003951534,0.58450717,0.00016505734,0.037510715,0.0010699721],"about_ca_topic_score_codex":0.00019611567,"about_ca_topic_score_gemma":0.00008163993,"teacher_disagreement_score":0.3879268,"about_ca_system_score_codex":0.0025847724,"about_ca_system_score_gemma":0.000860584,"threshold_uncertainty_score":0.8198072},"labels":[],"label_agreement":null},{"id":"W2530814035","doi":"10.1182/blood-2016-04-708560","title":"Spectrum of somatic mutation dynamics in chronic myeloid leukemia following tyrosine kinase inhibitor therapy","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":139,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Mutation; Myeloid leukemia; Tyrosine-kinase inhibitor; Tyrosine kinase; Cancer research; Medicine; Persistence (discontinuity); Somatic cell; Biology; Immunology; Oncology; Internal medicine; Genetics; Receptor; Cancer; Gene","score_opus":0.009926625770245863,"score_gpt":0.24813385797908094,"score_spread":0.23820723220883508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530814035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967111,0.0014418066,0.0001059039,0.00036832364,0.00014138335,0.0006008726,0.000013367119,0.00006575928,0.00055152987],"genre_scores_gemma":[0.99842846,0.0002661952,0.0004725421,0.000035462526,0.00017688853,0.000044692675,0.00003997511,0.000047400183,0.0004883825],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99851763,0.00004405691,0.00046380082,0.0003060441,0.00031831086,0.00035014967],"domain_scores_gemma":[0.999193,0.00011010345,0.00015435247,0.00042376868,0.00002751359,0.00009127167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001613141,0.00021926567,0.00042549107,0.00020146207,0.000030318944,0.000007395561,0.00009466012,0.00012268263,0.000095265066],"category_scores_gemma":[0.000089240835,0.00015494927,0.00015672685,0.00029211215,0.000054085656,0.00012843806,0.00003157371,0.00011348335,0.00004721379],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042014816,0.0018559423,0.23939982,0.00050481653,0.00077049504,0.0012681959,0.0005691718,0.00002865585,0.70850223,0.00068370864,0.00005866645,0.04593815],"study_design_scores_gemma":[0.075758696,0.0018948319,0.13818231,0.0024714912,0.0003699837,0.00017211484,0.00012473279,0.0016855876,0.7780584,0.00078108424,0.000091637936,0.00040912078],"about_ca_topic_score_codex":0.00021170432,"about_ca_topic_score_gemma":0.0004197869,"teacher_disagreement_score":0.1012175,"about_ca_system_score_codex":0.005501592,"about_ca_system_score_gemma":0.0010697094,"threshold_uncertainty_score":0.9983161},"labels":[],"label_agreement":null},{"id":"W2530861981","doi":"10.1182/blood.v110.11.308.308","title":"Rivaroxaban - An Oral, Direct Factor Xa Inhibitor - for Thromboprophylaxis after Total Knee Arthoplasty: The RECORD3 Trial.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Rivaroxaban; Medicine; Pulmonary embolism; Surgery; Deep vein; Thrombosis; Population; Adverse effect; Randomized controlled trial; Enoxaparin sodium; Venous thrombosis; Internal medicine; Low molecular weight heparin; Warfarin; Atrial fibrillation","score_opus":0.021075676031802423,"score_gpt":0.28218544355614594,"score_spread":0.2611097675243435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530861981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913617,0.00025883314,0.00012943233,0.00066014985,0.0017659806,0.0031702172,0.00006687158,0.0001529608,0.0024338698],"genre_scores_gemma":[0.9940639,0.000045970475,0.0010136024,0.0009600496,0.00240288,0.00045648302,0.000038732705,0.000074168995,0.00094420864],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979761,0.000069574315,0.00047851313,0.00050710136,0.00037593703,0.000592765],"domain_scores_gemma":[0.9985859,0.00022716726,0.00013077297,0.0006867225,0.00012960713,0.00023984603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007363863,0.00030363546,0.00062687806,0.00012917441,0.00022410034,0.00008383169,0.00011926551,0.00014144342,0.00027986756],"category_scores_gemma":[0.00026564405,0.00020235052,0.00029168377,0.00021661959,0.00008819859,0.00015822216,0.000083638006,0.00022392586,0.000065695305],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10320459,0.110814445,0.03876361,0.002370316,0.010456361,0.0009167047,0.016510595,0.000015332476,0.057835642,0.0022687223,0.1821381,0.47470558],"study_design_scores_gemma":[0.1438035,0.034279283,0.4203621,0.00036367262,0.003126379,0.00007463994,0.0014723603,0.000031214364,0.06341169,0.00044363842,0.3310486,0.0015829214],"about_ca_topic_score_codex":0.000094194664,"about_ca_topic_score_gemma":0.0002181321,"teacher_disagreement_score":0.47312266,"about_ca_system_score_codex":0.000042471114,"about_ca_system_score_gemma":0.000063769294,"threshold_uncertainty_score":0.82516146},"labels":[],"label_agreement":null},{"id":"W2530865543","doi":"10.1182/blood.v108.11.2007.2007","title":"Management of Hyperleukocytosis in Acute Myelogenous Leukemia Using Hydroxyurea Rather Than Leukopheresis.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Western University; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University Health Network; University of Toronto; Health Sciences Centre","funders":"","keywords":"Leukostasis; Leukapheresis; Medicine; Cohort; Internal medicine; Surgery; Retrospective cohort study; Leukemia; Gastroenterology; Pediatrics","score_opus":0.017115321737536777,"score_gpt":0.2687622228218589,"score_spread":0.25164690108432214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530865543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9777032,0.0007987427,0.00008037007,0.00010068529,0.000038965354,0.0006526278,0.000012281712,0.00005909233,0.02055401],"genre_scores_gemma":[0.98832345,0.00020252517,0.008441167,0.00006960135,0.00012797632,0.00003441278,0.000027894344,0.0000719126,0.0027010357],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978449,0.000071555296,0.00051657966,0.00042693963,0.00053740566,0.0006026612],"domain_scores_gemma":[0.9990236,0.00004298151,0.00012267254,0.00062028493,0.00007804511,0.00011239782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030464752,0.00026178185,0.0005441857,0.0003104325,0.00005958875,0.000017030834,0.00026267167,0.0001813642,0.000114294606],"category_scores_gemma":[0.0000101271935,0.00023781564,0.00016277365,0.00067580066,0.00012333969,0.00008238726,0.00016617418,0.0003048609,0.000050808474],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001181919,0.003312089,0.2885587,0.0011944843,0.0026944112,0.01109729,0.00057034096,0.0008213939,0.6807565,0.0015666763,0.0012389923,0.0070071644],"study_design_scores_gemma":[0.03548714,0.0008986509,0.466802,0.0011279704,0.0031864075,0.0010651371,0.0008417401,0.0027450859,0.48342654,0.00080347754,0.0025269175,0.001088936],"about_ca_topic_score_codex":0.002157925,"about_ca_topic_score_gemma":0.00010391722,"teacher_disagreement_score":0.19733,"about_ca_system_score_codex":0.0007081817,"about_ca_system_score_gemma":0.00036216318,"threshold_uncertainty_score":0.969784},"labels":[],"label_agreement":null},{"id":"W2530875774","doi":"10.1182/blood.v114.22.1390.1390","title":"Empiric Antifungal Therapy with Amphotericin B in the Era of Fluconazole Prophylaxis: a Cohort Study in Adults with Acute Myeloid Leukemia Treated within An Institutional Antifungal Policy.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; Juravinski Cancer Centre","funders":"","keywords":"Fluconazole; Neutropenia; Amphotericin B; Caspofungin; Medicine; Febrile neutropenia; Internal medicine; Empiric therapy; Myeloid leukemia; Chemotherapy; Intensive care medicine; Surgery; Antifungal; Pathology; Dermatology","score_opus":0.01176790856906738,"score_gpt":0.2727000233351937,"score_spread":0.2609321147661263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530875774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99640095,0.00015635669,0.000010486433,0.00013700665,0.000014849487,0.0026885178,0.00003006551,0.00004901957,0.0005127261],"genre_scores_gemma":[0.99897015,0.00008504476,0.00027559025,0.0003800992,0.00007849187,0.00007711289,0.000069850146,0.00002405151,0.000039597213],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99720114,0.0002584336,0.00061486155,0.00066624716,0.0008178966,0.0004414085],"domain_scores_gemma":[0.9987275,0.00004424821,0.00019489588,0.0007221317,0.00019473468,0.000116467374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006890123,0.00037820864,0.00072171516,0.00028566155,0.00011351303,0.000036069323,0.0002817097,0.00013729626,0.000016610227],"category_scores_gemma":[0.00004488343,0.00021164188,0.000068449444,0.0016088114,0.0002931142,0.00027372813,0.00001636505,0.00065564096,0.0000027854076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010107504,0.0070319055,0.96303767,0.000041425687,0.00018890249,0.0011275626,0.0053769536,0.000035104837,0.012091368,0.000040352938,0.0000050072454,0.000916224],"study_design_scores_gemma":[0.015977006,0.013311282,0.9618065,0.00038454737,0.00012643459,0.00023143114,0.0016708378,0.0000672857,0.006155279,0.000014994261,0.0000023410025,0.0002521075],"about_ca_topic_score_codex":0.002397636,"about_ca_topic_score_gemma":0.003934122,"teacher_disagreement_score":0.006279377,"about_ca_system_score_codex":0.00017095152,"about_ca_system_score_gemma":0.0014565232,"threshold_uncertainty_score":0.8630505},"labels":[],"label_agreement":null},{"id":"W2530880721","doi":"10.1182/blood.v116.21.4207.4207","title":"Systematic Review of Pharmacologic and Compression Therapies for Treatment of Post-Thrombotic Syndrome","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Medicine; Randomized controlled trial; Compression stockings; Chronic venous insufficiency; Intermittent pneumatic compression; Post-thrombotic syndrome; Venous thrombosis; Deep vein; Quality of life (healthcare); Thrombosis; Surgery; Physical therapy; Internal medicine","score_opus":0.015162720169752654,"score_gpt":0.2988170666030083,"score_spread":0.2836543464332556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530880721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94580954,0.050469037,0.0000069137573,0.0003994322,0.00008305058,0.0030767783,0.000016281736,0.000015832322,0.00012312438],"genre_scores_gemma":[0.9750963,0.0236054,0.00069148774,0.0002676996,0.000015429856,0.00025552078,0.000011852447,0.0000106709895,0.000045632445],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99930763,0.000028290737,0.00033489644,0.000121174206,0.00010878805,0.00009918883],"domain_scores_gemma":[0.9993517,0.00011240007,0.0001923523,0.00020628309,0.00009196256,0.00004531689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015095895,0.00010446103,0.0009655255,0.000044916287,0.000024968846,0.0000027397232,0.00004692298,0.000033425673,0.000075863754],"category_scores_gemma":[0.00005093691,0.00006370053,0.00010807114,0.0000446633,0.00004840603,0.000020099822,0.000017227192,0.000021382097,0.0000015753512],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027294593,0.0067626163,0.00067623705,0.86630285,0.0016422276,0.000018191458,0.0004697853,1.4655201e-7,0.12300473,0.00057225686,0.00016800629,0.0003556725],"study_design_scores_gemma":[0.030787462,0.030798353,0.17225742,0.52367085,0.06429138,0.0007674521,0.0009717166,0.0000901954,0.17431934,0.0004394731,0.00083845924,0.0007679025],"about_ca_topic_score_codex":0.00001580825,"about_ca_topic_score_gemma":0.000002181662,"teacher_disagreement_score":0.342632,"about_ca_system_score_codex":0.0000061333244,"about_ca_system_score_gemma":0.000018693063,"threshold_uncertainty_score":0.2597632},"labels":[],"label_agreement":null},{"id":"W2530888279","doi":"10.1182/blood.v126.23.638.638","title":"Crispr-Cas9 Saturating Mutagenesis Reveals an Achilles Heel in the BCL11A Erythroid Enhancer for Fetal Hemoglobin Induction (by Genome Editing)","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Enhancer; CRISPR; Biology; Cas9; Genetics; Genome editing; Enhancer RNAs; Context (archaeology); Gene; Guide RNA; Gene expression","score_opus":0.023622979270725788,"score_gpt":0.28054709267012656,"score_spread":0.2569241133994008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530888279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99132127,0.0034131017,0.0002099806,0.0022660587,0.0004417047,0.00097618124,0.000042363816,0.00007314099,0.0012562111],"genre_scores_gemma":[0.9957143,0.00013891833,0.0016685384,0.00078410335,0.0009893973,0.000119780794,0.00018460215,0.000043497257,0.00035684337],"study_design_codex":"bench_or_experimental","study_design_gemma":"qualitative","domain_scores_codex":[0.99832433,0.00012544867,0.00041744998,0.00038208364,0.0003238361,0.00042684405],"domain_scores_gemma":[0.9991615,0.000060767747,0.00014828256,0.00033510744,0.000127159,0.00016720497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007777013,0.00022760419,0.00032955158,0.000093238596,0.00017758337,0.000051622563,0.0001552763,0.00026450012,0.000020997939],"category_scores_gemma":[0.00031533482,0.00015922585,0.00010916483,0.00029959815,0.0000772446,0.00018514688,0.00003359679,0.00034845367,0.000014981652],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076997705,0.0050288774,0.0123351775,0.0006769687,0.0006080515,0.00020749378,0.026220692,0.00019875259,0.87719965,0.0002713962,0.038762964,0.037720013],"study_design_scores_gemma":[0.11917595,0.017117308,0.070246644,0.0022871576,0.006116701,0.007012407,0.3324381,0.0024863037,0.25645366,0.0048179063,0.1758826,0.00596526],"about_ca_topic_score_codex":0.0001433814,"about_ca_topic_score_gemma":0.00004689143,"teacher_disagreement_score":0.62074596,"about_ca_system_score_codex":0.000060935512,"about_ca_system_score_gemma":0.00010803353,"threshold_uncertainty_score":0.64930415},"labels":[],"label_agreement":null},{"id":"W2530902519","doi":"10.1182/blood.v126.23.2799.2799","title":"Safety and Efficacy of Ruxolitinib in an 1869-Patient Cohort of JUMP: An Open-Label, Multicenter, Single-Arm, Expanded-Access Study in Patients with Myelofibrosis","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; St. Paul's Hospital; University Health Network; University of British Columbia","funders":"","keywords":"Medicine; Ruxolitinib; Myelofibrosis; Internal medicine; Tolerability; Clinical endpoint; Phases of clinical research; Median follow-up; Surgery; International Prognostic Scoring System; Clinical trial; Adverse effect; Chemotherapy; Bone marrow; Myelodysplastic syndromes","score_opus":0.05333994591219693,"score_gpt":0.32926492484195863,"score_spread":0.2759249789297617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530902519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960045,0.00006223686,0.0000012382567,0.000018849672,0.000034704713,0.0035297866,0.000055350854,0.000009780453,0.00028350708],"genre_scores_gemma":[0.9988071,0.000016180187,0.0008410394,0.00004207772,0.0000118203625,0.00014426392,0.00010305112,0.000028650393,0.0000058321166],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99792886,0.0002134997,0.00067488785,0.00048734684,0.0004422327,0.00025317335],"domain_scores_gemma":[0.99866545,0.00009168462,0.00025222034,0.0004301618,0.00029368285,0.00026677657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026071625,0.00024713072,0.0007654891,0.0001905281,0.00002940312,0.000037426074,0.00017721168,0.00006275074,0.000021078173],"category_scores_gemma":[0.000095612566,0.00018614609,0.000015418036,0.00027254713,0.00007898614,0.00035911065,0.0001855087,0.00010350169,9.666171e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004572495,0.13298209,0.8563442,0.000044810018,0.00014137839,0.000024497613,0.003071943,0.000008569172,0.00013296548,0.000008550983,0.000002569479,0.0026659127],"study_design_scores_gemma":[0.08199299,0.03383445,0.8771887,0.0003392032,0.00023377192,0.000001874503,0.0006479302,0.000020409701,0.0055781947,0.0000026327666,0.0000060388047,0.00015381133],"about_ca_topic_score_codex":0.0010147137,"about_ca_topic_score_gemma":0.0015029286,"teacher_disagreement_score":0.09914763,"about_ca_system_score_codex":0.00007483435,"about_ca_system_score_gemma":0.000100334924,"threshold_uncertainty_score":0.7590817},"labels":[],"label_agreement":null},{"id":"W2530906333","doi":"10.1182/blood.v106.11.5017.5017","title":"The Role of Histone Acetylation and Death Receptor 5 (DR5) Expression in the Treatment of Chronic Lymphocytic Leukemia (CLL).","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Chronic lymphocytic leukemia; Histone deacetylase; Cancer research; Acetylation; Chlorambucil; Histone deacetylase inhibitor; Histone; Histone deacetylase 2; HDAC11; Histone deacetylase 5; Chromatin immunoprecipitation; Biology; Leukemia; Immunology; Gene expression; Gene; Biochemistry; Promoter","score_opus":0.008553213278551363,"score_gpt":0.25027191115394154,"score_spread":0.2417186978753902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530906333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800591,0.019067252,0.000009223678,0.00002719411,0.000013312059,0.00019004276,0.000007893639,0.0000023322477,0.0006236804],"genre_scores_gemma":[0.9964031,0.003114556,0.00019709175,0.0000105542285,0.00011006923,0.000035039935,0.000019143663,0.000006004166,0.000104421844],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995251,0.000058050322,0.00013542823,0.000112055146,0.000072395385,0.00009692072],"domain_scores_gemma":[0.9996708,0.000021854308,0.00007397707,0.00020059384,0.00001673411,0.00001602725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011474561,0.00007098237,0.000078413104,0.000012522592,0.000046255198,0.0000051499924,0.000090488276,0.00006358105,0.000006520645],"category_scores_gemma":[0.000012756619,0.000041181123,0.000034262084,0.000030092215,0.00003920227,0.0000021168862,0.000019148216,0.00002063647,0.0000012658003],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041906,0.00009847931,0.0006325369,0.000008096346,0.000013091148,1.4788371e-7,0.0004132392,0.00003663359,0.97875404,0.000054639477,0.000020392847,0.019926785],"study_design_scores_gemma":[0.0012796381,0.00054566,0.0007479456,0.000015586613,0.00001680348,0.000004249618,0.000101118036,0.00012668171,0.96870714,0.000040532796,0.02836945,0.000045219935],"about_ca_topic_score_codex":0.00003827946,"about_ca_topic_score_gemma":0.000055242384,"teacher_disagreement_score":0.028349055,"about_ca_system_score_codex":0.000117552394,"about_ca_system_score_gemma":0.00015335213,"threshold_uncertainty_score":0.16793175},"labels":[],"label_agreement":null},{"id":"W2530914402","doi":"10.1182/blood.v106.11.4674.4674","title":"BCL-2 Expression May Adversely Affect Outcome in HIV-Associated Systemic Diffuse Large B Cell Lymphoma.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Diffuse large B-cell lymphoma; Medicine; Rituximab; Lymphoma; Internal medicine; CHOP; Gastroenterology; Oncology","score_opus":0.012768652552861307,"score_gpt":0.2563079367040805,"score_spread":0.24353928415121917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530914402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941755,0.0016424173,0.000002903719,0.00028544632,0.00010458885,0.00062764937,0.0000551969,0.00014194711,0.0029643842],"genre_scores_gemma":[0.9969395,0.00014505479,0.00016179738,0.00031114378,0.00011546828,0.00012969566,0.00009241662,0.000039738108,0.0020652069],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827707,0.000107408465,0.00043046946,0.00037818708,0.00032740016,0.000479488],"domain_scores_gemma":[0.9991192,0.00012115922,0.00014785324,0.00039103432,0.000033747383,0.00018695567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002186977,0.0002658286,0.0005281894,0.00014690367,0.00006671883,0.000019563126,0.000101414815,0.00018788624,0.00007290963],"category_scores_gemma":[0.000067826055,0.00020200213,0.00018407538,0.0001897172,0.000014963928,0.00009129061,0.00006343138,0.000078348436,0.00053938536],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000068305264,0.031932775,0.9593348,0.00013554461,0.00008534434,0.0005044636,0.0003491423,0.0000021140859,0.0055368086,0.000026313131,0.0015039411,0.00052045874],"study_design_scores_gemma":[0.15810087,0.00032862354,0.7691922,0.0010918395,0.00060645485,0.00013547332,0.00025208402,0.00009159569,0.0658403,0.0000025683248,0.0039680917,0.00038986237],"about_ca_topic_score_codex":0.00006441002,"about_ca_topic_score_gemma":0.000055989633,"teacher_disagreement_score":0.19014254,"about_ca_system_score_codex":0.0004464748,"about_ca_system_score_gemma":0.000075623146,"threshold_uncertainty_score":0.82374084},"labels":[],"label_agreement":null},{"id":"W2530940620","doi":"10.1182/blood.v116.21.501.501","title":"Mir-223 Is Dispensable for the Onset of Acute Myeloid Leukemia","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Myeloid leukemia; Haematopoiesis; Myeloid; Cancer research; microRNA; CD34; Biology; Progenitor cell; Leukemia; Phenotype; Stem cell; Immunology; Cell biology; Gene; Genetics","score_opus":0.007005107420772866,"score_gpt":0.24182501846882792,"score_spread":0.23481991104805505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530940620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984829,0.00023545063,0.000369546,0.00015762064,0.00009707439,0.00023298047,0.00021211141,0.000004890557,0.00020745241],"genre_scores_gemma":[0.99787116,0.000031376567,0.0009988575,0.00012286179,0.0001460296,0.00003102952,0.00012728288,0.00001405479,0.0006573615],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99955505,0.00000803216,0.00010758879,0.0001498417,0.00005934604,0.00012012236],"domain_scores_gemma":[0.9994596,0.00001535666,0.00006314117,0.00036946055,0.00005915446,0.00003325337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007989577,0.00007315496,0.000070938135,0.000009658443,0.00005300215,0.000009681348,0.00016372935,0.000092987866,0.00004683821],"category_scores_gemma":[0.000031129475,0.000054584183,0.00009136686,0.0000319801,0.00006246271,0.0000016215673,0.000048962997,0.00004345811,0.000006149627],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003351642,0.00006455618,0.0009536255,0.000012571358,0.00015212265,3.1089937e-7,0.00001416952,0.000001568715,0.99126434,0.000058915175,0.0071936273,0.00025067222],"study_design_scores_gemma":[0.00084108236,0.00005284513,0.008493251,0.000003333349,0.00017864336,0.000011838655,0.00000621736,0.00004833004,0.9595799,0.0001559201,0.030553242,0.000075386764],"about_ca_topic_score_codex":0.000014028726,"about_ca_topic_score_gemma":0.000029853352,"teacher_disagreement_score":0.031684436,"about_ca_system_score_codex":0.0000030060055,"about_ca_system_score_gemma":0.00007465421,"threshold_uncertainty_score":0.22258784},"labels":[],"label_agreement":null},{"id":"W2530979311","doi":"10.1182/blood.v110.11.2497.2497","title":"Genetic Variations in Genomic HAS1 Direct Aberrant Pre-mRNA Splicing That Generates the Prognostically Significant HAS1Vb Intronic Splice Variant.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Minigene; Exon; Intron; Biology; RNA splicing; Exonic splicing enhancer; Genetics; Splice site mutation; Molecular biology; Point mutation; Polypyrimidine tract; Exon trapping; Alternative splicing; Mutation; RNA; Gene","score_opus":0.012220484024628202,"score_gpt":0.25344021504311015,"score_spread":0.24121973101848196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530979311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859422,0.0013130752,0.009292136,0.0004380813,0.00008744149,0.00097323203,0.000017538907,0.000024488665,0.0019117948],"genre_scores_gemma":[0.99550277,0.00026688204,0.0030560615,0.00017604146,0.00034613704,0.00011297048,0.00004967585,0.00003752257,0.00045192637],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99808174,0.00014677823,0.000379404,0.00050775247,0.00027315342,0.0006111712],"domain_scores_gemma":[0.9990166,0.00010528502,0.00009674355,0.0005497466,0.00009846089,0.00013318913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008685688,0.00021564848,0.00018202809,0.00010693291,0.00020555539,0.00008150371,0.00039055553,0.00017434527,0.00006931143],"category_scores_gemma":[0.00024470553,0.00016733183,0.000085845095,0.00026157356,0.00010398692,0.00000644223,0.00016165577,0.0002478945,0.000035375975],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000120284836,0.00048546962,0.017994132,0.000023677123,0.00012325749,0.000055115765,0.0002189678,0.0006884038,0.9762245,0.00038448695,0.00016552776,0.0035161704],"study_design_scores_gemma":[0.0034690946,0.0005795369,0.47623202,0.00004709386,0.00013684736,0.00014124817,0.00013031099,0.004498519,0.50367254,0.00024231101,0.010217412,0.0006330783],"about_ca_topic_score_codex":0.0003102345,"about_ca_topic_score_gemma":0.0011143829,"teacher_disagreement_score":0.47255197,"about_ca_system_score_codex":0.000032971966,"about_ca_system_score_gemma":0.00022270606,"threshold_uncertainty_score":0.6823594},"labels":[],"label_agreement":null},{"id":"W2530984012","doi":"10.1182/blood.v114.22.1988.1988","title":"Abnormal Distribution of Erythroid Progenitors Populations in Mice Lacking p45 NF-E2.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Erythropoiesis; Bone marrow; Haematopoiesis; Progenitor cell; Biology; Erythroblast; Spleen; Erythropoietin; GATA1; Ineffective erythropoiesis; Immunology; Molecular biology; CD34; Stem cell; Cancer research; Cell biology; Internal medicine; Endocrinology; Anemia; Medicine","score_opus":0.02851016214394378,"score_gpt":0.28685654331959415,"score_spread":0.25834638117565034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530984012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99821645,0.00016838826,0.00012346504,0.00031949242,0.00014549159,0.00018967676,0.000015152277,0.000039727052,0.0007821604],"genre_scores_gemma":[0.99886674,0.000018321845,0.00044473488,0.0001420619,0.00019061341,0.000005206576,0.00025445642,0.0000055681044,0.00007227473],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99932814,0.000032920274,0.00024699877,0.0001357272,0.00010139221,0.00015482499],"domain_scores_gemma":[0.99968153,0.000016161248,0.000074439304,0.00012150124,0.000056248715,0.00005011473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000077826735,0.00008085801,0.00018500445,0.00006826187,0.000036284757,0.0000030756094,0.000032465632,0.00008821902,0.00003939117],"category_scores_gemma":[0.00006004253,0.000075788215,0.00006202076,0.00021067396,0.000028696639,0.000056285473,0.000008978252,0.00012632855,0.000017185275],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054186175,0.0042062737,0.6075698,0.00017632493,0.00007661753,0.00009909722,0.0007713516,0.00014135186,0.37415013,0.0041713086,0.0010700389,0.007025833],"study_design_scores_gemma":[0.002800811,0.0006006525,0.9671663,0.00007186835,0.000090079426,0.000113533286,0.00010149604,0.000093941046,0.027832842,0.00031941247,0.0007023378,0.000106700805],"about_ca_topic_score_codex":0.000030810817,"about_ca_topic_score_gemma":0.000020306667,"teacher_disagreement_score":0.3595965,"about_ca_system_score_codex":0.000022951202,"about_ca_system_score_gemma":0.000043365108,"threshold_uncertainty_score":0.30905536},"labels":[],"label_agreement":null},{"id":"W2530986446","doi":"10.1182/blood.v120.21.3367.3367","title":"Rates of Malposition and Expulsion of the Levonorgestrel-Releasing Intrauterine System Among Women with Inherited Bleeding Disorders","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; University of Manitoba","funders":"","keywords":"Medicine; Levonorgestrel; Intrauterine device; Obstetrics; Family planning; Menstrual bleeding; Metrorrhagia; Gynecology; Vaginal bleeding; Menstruation; Population; Pediatrics; Pregnancy; Internal medicine; Research methodology","score_opus":0.007472073943247688,"score_gpt":0.2180230944080692,"score_spread":0.2105510204648215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530986446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992337,0.00018614935,0.000016045478,0.000056015695,0.00003520591,0.00021692389,0.0000037460063,0.000015269614,0.00023689355],"genre_scores_gemma":[0.99951077,0.00005889187,0.00034245444,0.000004099738,0.000031693045,0.000015428966,0.000003987649,0.000012926941,0.000019724257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995131,0.000020522542,0.00014591552,0.00008138141,0.000098935314,0.00014016306],"domain_scores_gemma":[0.9996781,0.00001273803,0.0001085334,0.00011877577,0.000024975907,0.000056880453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000044848588,0.00008700302,0.00018011843,0.000039066676,0.00003544394,0.000004774849,0.000025769374,0.00003025112,0.0000057841953],"category_scores_gemma":[0.000005079651,0.00005136251,0.00001871193,0.0001101763,0.0000580801,0.00009545214,0.000035703266,0.00004210669,2.3502402e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000121533085,0.00037507308,0.96218985,0.0004235861,0.00016368572,0.0000025389877,0.0007809669,8.071769e-7,0.034359187,0.000049634586,0.0000011679562,0.0015319514],"study_design_scores_gemma":[0.002430718,0.0004026278,0.9616827,0.00070273073,0.0001982473,0.0000691572,0.0008522262,0.000031674022,0.033564135,0.0000035394723,0.000010560444,0.000051708168],"about_ca_topic_score_codex":0.00009760092,"about_ca_topic_score_gemma":0.0000036034992,"teacher_disagreement_score":0.0023091848,"about_ca_system_score_codex":0.000019493704,"about_ca_system_score_gemma":0.000007303821,"threshold_uncertainty_score":0.20945023},"labels":[],"label_agreement":null},{"id":"W2531019340","doi":"10.1182/blood.v114.22.4350.4350","title":"Preference of Patients and Physicians Concerning Treatment Options for Relapsed Follicular Lymphoma: A Discrete Choice Experiment.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of Calgary","funders":"","keywords":"Medicine; Follicular lymphoma; Radioimmunotherapy; Chemotherapy; Autologous stem-cell transplantation; Transplantation; Lymphoma; Oncology; Tolerability; Internal medicine; Adverse effect; Immunology","score_opus":0.026201862895615963,"score_gpt":0.27704980069445784,"score_spread":0.25084793779884185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531019340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996844,0.0014827108,0.0000327358,0.00016665083,0.000026467087,0.0008671374,0.00006935576,0.000027439377,0.00048352923],"genre_scores_gemma":[0.9977667,0.0002011603,0.0014046823,0.00008851959,0.000043718162,0.00024241346,0.00011003336,0.0000106483385,0.00013214248],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99928355,0.000014363984,0.00018042498,0.0002343514,0.00012112611,0.00016620362],"domain_scores_gemma":[0.999529,0.00005976145,0.00009594507,0.00018144998,0.00005954817,0.000074312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000018083823,0.00014875384,0.00028951812,0.000032787768,0.000073905365,0.000010747395,0.000031118965,0.000043589214,0.000005272596],"category_scores_gemma":[0.000022383938,0.00011217048,0.00011027778,0.00005743883,0.00003127031,0.00005139088,0.000009901647,0.000011307496,0.0000014825326],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007027398,0.04845028,0.7718938,0.00018034242,0.0024797285,0.000045210734,0.0062258276,0.000014835131,0.03289724,0.0041369344,0.00037021155,0.13260284],"study_design_scores_gemma":[0.048995975,0.00651105,0.7767401,0.00021845697,0.0014190222,0.0000053304393,0.00016194627,0.000066973946,0.16348156,0.00009392071,0.0021143025,0.00019138666],"about_ca_topic_score_codex":0.000054508408,"about_ca_topic_score_gemma":0.0000033323975,"teacher_disagreement_score":0.13241145,"about_ca_system_score_codex":0.00007806298,"about_ca_system_score_gemma":0.00003863276,"threshold_uncertainty_score":0.45741794},"labels":[],"label_agreement":null},{"id":"W2531065045","doi":"10.1182/blood.v126.23.2721.2721","title":"Gender and Obesity Do Not Impact Survival in Diffuse Large B-Cell Lymphoma: Justification for Full Weight-Based Chemotherapy Dosing in All Patients","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Febrile neutropenia; Diffuse large B-cell lymphoma; Neutropenia; Internal medicine; Rituximab; Chemotherapy; Vincristine; Population; Cyclophosphamide; Chemotherapy regimen; Dosing; Lymphoma; Oncology; Surgery","score_opus":0.037283778952045266,"score_gpt":0.2910235548419686,"score_spread":0.25373977588992336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531065045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984712,0.000365669,0.00003940324,0.00011345466,0.00007032574,0.00073212077,0.00005632331,0.000019822626,0.00013165192],"genre_scores_gemma":[0.99888337,0.00004567954,0.00051859836,0.00023112181,0.000047915775,0.000077952114,0.00016288224,0.000023274726,0.000009218544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989617,0.000043222804,0.00022931445,0.000293146,0.00019318308,0.0002794382],"domain_scores_gemma":[0.9993969,0.00008170026,0.00007666917,0.00021382199,0.00006995576,0.00016092879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024088597,0.00017017566,0.0002792062,0.00011381083,0.000026496622,0.000024563775,0.000043603904,0.00009808169,0.0000048685697],"category_scores_gemma":[0.000040745595,0.00013361068,0.000064987566,0.00010668365,0.000015481673,0.000061183564,0.00001418328,0.00003332431,0.0000050765807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006435424,0.04348847,0.9528579,0.000070132555,0.00004608935,0.000016017768,0.00062271114,0.0000010062085,0.0005363868,0.000024856752,0.00009933045,0.0015935324],"study_design_scores_gemma":[0.16487427,0.00041974787,0.8235414,0.00003834934,0.00012149807,0.0000022600836,0.00005500579,0.00032373855,0.010188229,0.000028386243,0.00027963976,0.00012747577],"about_ca_topic_score_codex":0.00017682218,"about_ca_topic_score_gemma":0.000067289555,"teacher_disagreement_score":0.16423073,"about_ca_system_score_codex":0.00026031496,"about_ca_system_score_gemma":0.00013843225,"threshold_uncertainty_score":0.54484856},"labels":[],"label_agreement":null},{"id":"W2531077141","doi":"10.1182/blood.v106.11.2234.2234","title":"IVIG Down-Regulates LPS-Induced TNFα Production Via Inhibition of IκBα Activation: A Possible Mechanism of Action in the Treatment of Bacterial Infections.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto; McMaster University; Canadian Blood Services","funders":"","keywords":"Monocyte; Tumor necrosis factor alpha; Cytokine; TLR4; Immunology; Lipopolysaccharide; Immune system; Biology; Innate immune system; Medicine","score_opus":0.013616956721296874,"score_gpt":0.23224969063094547,"score_spread":0.2186327339096486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531077141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982516,0.0006497831,0.000045452143,0.00015272334,0.00032585705,0.00040706294,0.0000069502194,0.000017874689,0.00014267759],"genre_scores_gemma":[0.99962205,0.00013390285,0.000015593923,0.00000558573,0.000017512833,0.00004562432,0.00009657843,0.000006789091,0.00005639031],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99909717,0.00016029149,0.00039792366,0.00016032126,0.000045156605,0.00013913517],"domain_scores_gemma":[0.99935335,0.000043510732,0.0002946621,0.0002286976,0.000077729776,0.0000020407813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018592845,0.00012159263,0.00022499671,0.00017426089,0.00009406859,0.0000036551728,0.00006628006,0.00015558438,0.00010383441],"category_scores_gemma":[0.000027483457,0.00009287821,0.00009285316,0.00029140845,0.00008470388,0.00017734054,0.000009761838,0.00008140861,0.000007653208],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014361745,0.0040457854,0.000108510285,0.000023745786,0.00008495746,9.040186e-8,0.002994595,0.000045042325,0.9757785,0.0004600819,0.0000028731947,0.016312156],"study_design_scores_gemma":[0.002395391,0.00094792433,0.007045653,0.000048331527,0.0000774509,0.000018765315,0.00072773616,0.0000050013573,0.9880304,0.00032280784,0.0003012566,0.00007931195],"about_ca_topic_score_codex":0.00036265596,"about_ca_topic_score_gemma":0.000048436345,"teacher_disagreement_score":0.016232844,"about_ca_system_score_codex":0.000030924104,"about_ca_system_score_gemma":0.000046299796,"threshold_uncertainty_score":0.37874636},"labels":[],"label_agreement":null},{"id":"W2531086345","doi":"10.1182/blood.v126.23.5515.5515","title":"Allogeneic Transplantation for P40 CGD Is Curative of Inflammatory Disease","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"","keywords":"Chronic granulomatous disease; Immunology; Medicine; Immunodeficiency; NADPH oxidase; Transplantation; Disease; Primary immunodeficiency; Immune system; Internal medicine","score_opus":0.025442359218744666,"score_gpt":0.25057814047627575,"score_spread":0.2251357812575311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531086345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958601,0.001275744,0.0014919917,0.00019066746,0.00020173087,0.00038493102,0.0003418928,0.00003130695,0.00022162533],"genre_scores_gemma":[0.9986411,0.000069236194,0.00027150707,0.0002067423,0.00003061695,0.00007330191,0.00022409497,0.000014037216,0.00046939423],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99932027,0.00008308956,0.00020226999,0.00019141524,0.000031276995,0.0001716543],"domain_scores_gemma":[0.9995189,0.00005344448,0.000095096984,0.00015434933,0.0001344711,0.000043772197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011394617,0.00012259405,0.00017811611,0.000061663326,0.000053667703,0.000003737742,0.000113973234,0.000089160036,0.000074041614],"category_scores_gemma":[0.000029018394,0.000105581625,0.00008080068,0.000055096014,0.00008140918,0.00008585423,0.00001526834,0.000064440064,0.00008374702],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054150977,0.0002746601,0.0016249774,0.00006795514,0.00022369865,0.0000144340875,0.0013449275,0.0000029128753,0.9895479,0.005109646,0.0007866328,0.00046073293],"study_design_scores_gemma":[0.0038930005,0.0002909115,0.002352575,0.000028717623,0.00022204698,0.000010064136,0.00018602621,9.193391e-7,0.98668474,0.0019736257,0.004223269,0.00013410507],"about_ca_topic_score_codex":0.0000051910747,"about_ca_topic_score_gemma":0.0000044783665,"teacher_disagreement_score":0.0034366364,"about_ca_system_score_codex":0.000007763799,"about_ca_system_score_gemma":0.00010088448,"threshold_uncertainty_score":0.43054938},"labels":[],"label_agreement":null},{"id":"W2531107772","doi":"10.1182/blood.v110.11.35.35","title":"Comparative Transcriptome Analysis of Different Subsets of CD34+ Normal and Chronic Myeloid Leukemia Cells Identifies Novel Perturbations in the CML Stem Cell Population.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"","keywords":"CD38; Biology; Myeloid leukemia; Stem cell; CD34; Haematopoiesis; Myelopoiesis; clone (Java method); Myeloid; Cancer research; Immunology; Population; Bone marrow; Leukemia; Molecular biology; Medicine; Cell biology; Genetics; Gene","score_opus":0.020682749448830775,"score_gpt":0.265246752713857,"score_spread":0.24456400326502623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531107772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99735564,0.0012930062,0.00016936737,0.00003073243,0.000044921195,0.0004986184,0.000084854335,0.000011894185,0.0005109719],"genre_scores_gemma":[0.999297,0.00009406091,0.00010869652,0.000020635376,0.000031394775,0.000015641663,0.00015926223,0.000011259032,0.00026203634],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984167,0.00005463733,0.0006257553,0.00025292535,0.00040229733,0.00024764144],"domain_scores_gemma":[0.999016,0.000256419,0.00022958625,0.00035111373,0.00007916874,0.0000677387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002528028,0.00019896391,0.0006625193,0.0004391889,0.000055315162,0.000011476779,0.00012689496,0.00009132936,0.000051037798],"category_scores_gemma":[0.0000053694475,0.0001409115,0.0001849635,0.0007594569,0.00010797828,0.000084656436,0.00002213146,0.0001676234,0.0000018207863],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018304246,0.0026076338,0.26889923,0.00047723568,0.0022826025,0.000022885926,0.018951213,0.0005988745,0.70540684,0.00019670321,0.00003693939,0.00033675673],"study_design_scores_gemma":[0.0051893336,0.00018866244,0.80290556,0.000064963395,0.0031070998,0.000008391907,0.001380974,0.0010122951,0.18602198,0.0000056449703,0.0000112212065,0.00010386953],"about_ca_topic_score_codex":0.000584419,"about_ca_topic_score_gemma":0.002161287,"teacher_disagreement_score":0.5340063,"about_ca_system_score_codex":0.00040438943,"about_ca_system_score_gemma":0.00014032448,"threshold_uncertainty_score":0.5746204},"labels":[],"label_agreement":null},{"id":"W2531128131","doi":"10.1182/blood.v124.21.3972.3972","title":"Autologous Stem Cell Transplantation Improves Survival for Patients with Follicular Lymphoma in First or Second Relapse: Results of a Comparative Effectiveness Instrumental Variable Analysis","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Foothills Medical Centre; Alberta Health Services; University of Alberta; University of Calgary","funders":"","keywords":"Medicine; Chemoimmunotherapy; Rituximab; Follicular lymphoma; Transplantation; Internal medicine; Population; Autologous stem-cell transplantation; Diffuse large B-cell lymphoma; Oncology; Chemotherapy regimen; Radiation therapy; Cancer; Lymphoma; Surgery","score_opus":0.008131069744632735,"score_gpt":0.22661918433901307,"score_spread":0.21848811459438033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531128131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978209,0.000034209632,0.00021123566,0.000007587477,0.000040687584,0.0011296957,0.0003400756,0.000015514928,0.0004000835],"genre_scores_gemma":[0.99829215,0.000008318762,0.00091726205,0.000008123143,0.000009900392,0.00022910134,0.00048734582,0.000011589009,0.000036224585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988902,0.00010363669,0.00032350954,0.00032081173,0.00018177523,0.00018001856],"domain_scores_gemma":[0.9989675,0.00051194994,0.00017652474,0.00019138066,0.00009051683,0.000062085484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019297986,0.00017348604,0.00063248427,0.00014808183,0.000051344796,0.000010179774,0.00005029615,0.00007801294,0.0000067921596],"category_scores_gemma":[0.000008783311,0.000116070725,0.000101629135,0.00039173223,0.000033737306,0.00006859742,0.000008892038,0.000025625577,0.0000010720123],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013617899,0.012917914,0.96552014,0.0010590132,0.00274316,0.000034227556,0.0015253403,0.00019080871,0.00066024746,0.000103382554,0.000008209045,0.0016196363],"study_design_scores_gemma":[0.06978239,0.003937425,0.8697759,0.00016367146,0.0027671282,0.000005305352,0.00010037207,0.00033597017,0.05294328,0.000007204979,0.00005379201,0.00012753431],"about_ca_topic_score_codex":0.00025252232,"about_ca_topic_score_gemma":0.0007453918,"teacher_disagreement_score":0.095744245,"about_ca_system_score_codex":0.00009162119,"about_ca_system_score_gemma":0.00007759278,"threshold_uncertainty_score":0.4733227},"labels":[],"label_agreement":null},{"id":"W2531184519","doi":"10.1182/blood.v108.11.861.861","title":"Multifunctional Role of Caspase-3 in Regulating Hematopoietic Stem Cells.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Stem cell; Biology; Haematopoiesis; Cell biology; Apoptosis; Molecular biology; Immunology; Biochemistry","score_opus":0.007125562225533912,"score_gpt":0.2022318570955248,"score_spread":0.1951062948699909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531184519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941997,0.0011575363,0.000066151435,0.000043221193,0.0000674427,0.00020390139,0.00000768921,0.000036031957,0.0042183558],"genre_scores_gemma":[0.9985889,0.0000032158168,0.00088435516,0.000020681186,0.000082412815,0.000012987137,0.000012380629,0.000021403555,0.00037366588],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99914896,0.000019128742,0.0002840815,0.00017489685,0.00021371766,0.00015922861],"domain_scores_gemma":[0.9995951,0.000028502593,0.000080976635,0.00020690504,0.000048274553,0.00004022135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000084726315,0.00009122826,0.00019485668,0.00010313734,0.000018649527,0.0000033922436,0.00003525257,0.00008522266,0.000053878623],"category_scores_gemma":[0.000008675793,0.000092944014,0.00007203861,0.00020004372,0.000030705145,0.000019719526,0.000020912179,0.00013098365,0.00001687566],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048875383,0.0007809674,0.011742811,0.0001111311,0.000036161884,0.00008371345,0.00020500988,0.0007040026,0.98472995,0.0005024271,0.00014226433,0.0009127001],"study_design_scores_gemma":[0.004812501,0.00011202243,0.013715871,0.00024608767,0.00012030636,0.00017392512,0.00019236494,0.00094591,0.9789142,0.000189593,0.00046224173,0.00011496293],"about_ca_topic_score_codex":0.0002727386,"about_ca_topic_score_gemma":0.00007763804,"teacher_disagreement_score":0.0058157216,"about_ca_system_score_codex":0.000040843268,"about_ca_system_score_gemma":0.00007515264,"threshold_uncertainty_score":0.3790147},"labels":[],"label_agreement":null},{"id":"W2531288952","doi":"10.1182/blood.v108.11.3327.3327","title":"Inadvertent Intrathecal Administration of Vincristine.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Vincristine; Intrathecal; Pharmacy; Adverse effect; Anesthesia; Surgery; Chemotherapy; Pharmacology; Cyclophosphamide; Family medicine","score_opus":0.03143041327589582,"score_gpt":0.329538649774567,"score_spread":0.2981082364986712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531288952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95913327,0.00065771374,0.00006177958,0.0016553547,0.000040378054,0.00009367317,0.0000042702713,0.000017802638,0.038335763],"genre_scores_gemma":[0.9991724,0.000045688037,0.00030843512,0.00013297105,0.00016768038,0.0000036287772,0.000007297298,0.0000035040528,0.0001583769],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99959016,0.000011880575,0.00013761448,0.000070577684,0.000108314394,0.00008148261],"domain_scores_gemma":[0.99975514,0.00006440068,0.0000447179,0.00006275537,0.00003761681,0.000035390538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006856151,0.00004544372,0.00010520105,0.000011374136,0.000024474335,0.0000034325844,0.000021203641,0.00002410692,0.000096099335],"category_scores_gemma":[0.00007280678,0.000034870565,0.00003165018,0.00005296604,0.000031131764,0.000026702459,0.000012362753,0.000063564614,0.000009882945],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041482346,0.028143913,0.3172292,0.0014430741,0.0012102756,0.0013386717,0.00031702078,0.000007401303,0.51688546,0.036429763,0.022056311,0.07079067],"study_design_scores_gemma":[0.0065951655,0.0017214371,0.53272474,0.00008179413,0.0012696038,0.0004062783,0.00012133846,0.00025208743,0.32584366,0.0009737212,0.12980236,0.00020781734],"about_ca_topic_score_codex":0.00009819021,"about_ca_topic_score_gemma":0.000018238014,"teacher_disagreement_score":0.21549553,"about_ca_system_score_codex":0.0000050245294,"about_ca_system_score_gemma":0.000020590827,"threshold_uncertainty_score":0.14219804},"labels":[],"label_agreement":null},{"id":"W2531315909","doi":"10.1182/blood.v126.23.800.800","title":"Prevalence and Prognostic Significance of KIT Mutations in Pediatric Core Binding Factor AML Patients Treated with Gemtuzumab Ozogamicin: Results from the Randomized Phase III Children's Oncology Group Trial AAML0531","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Population Health Research Institute; Hospital for Sick Children","funders":"","keywords":"Gemtuzumab ozogamicin; Medicine; Core binding factor; Internal medicine; Exon; Oncology; Missense mutation; CD33; Mutation; Gastroenterology; Biology; Genetics","score_opus":0.031900483545970845,"score_gpt":0.30485540291485325,"score_spread":0.2729549193688824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531315909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923361,0.00022666465,0.000019847817,0.00012461335,0.00005036275,0.0064809117,0.0006079354,0.000036461177,0.00011713701],"genre_scores_gemma":[0.99825674,0.00020022324,0.0003790376,0.000022059374,0.00019265902,0.0002646095,0.00059812877,0.000027812757,0.000058751524],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99749583,0.00048272975,0.0007046175,0.0004660465,0.00051797816,0.0003327926],"domain_scores_gemma":[0.99607724,0.0027137927,0.0004265458,0.00033909405,0.00024745666,0.0001958517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000715885,0.00022468109,0.0007860744,0.00022101494,0.000067582136,0.000017968978,0.00019292157,0.00014561591,0.000012485792],"category_scores_gemma":[0.0036819351,0.00013652723,0.00006548541,0.00058478856,0.00033050362,0.00010093667,0.000066795204,0.00039939236,0.000004811988],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.56442034,0.0026939048,0.42903692,0.00004763815,0.00024960493,0.00005908099,0.002371147,0.0000041127696,0.0003597021,0.0000049035384,0.000088362525,0.0006642883],"study_design_scores_gemma":[0.8350117,0.004155903,0.15875182,0.000100485464,0.0011122208,0.000010808675,0.00011714495,0.00015537192,0.00044216533,0.000010938055,0.0000037209554,0.00012773737],"about_ca_topic_score_codex":0.0009200865,"about_ca_topic_score_gemma":0.000068235015,"teacher_disagreement_score":0.27059135,"about_ca_system_score_codex":0.00019682535,"about_ca_system_score_gemma":0.0006950763,"threshold_uncertainty_score":0.5567419},"labels":[],"label_agreement":null},{"id":"W2531356683","doi":"10.1182/blood.v108.11.3533.3533","title":"Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Two Doses of Bortezomib (Btz) in Patients with Relapsed Multiple Myeloma (MM).","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Royal Victoria Hospital","funders":"","keywords":"Pharmacokinetics; Cmax; Medicine; Pharmacodynamics; Bortezomib; Volume of distribution; Pharmacology; Multiple myeloma; Distribution (mathematics); Internal medicine","score_opus":0.009579060015435492,"score_gpt":0.2762750528402685,"score_spread":0.266695992824833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531356683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977056,0.0001982996,0.0000038527132,0.000013008252,0.000023404255,0.0015856494,0.00006570506,0.000021673115,0.00038280868],"genre_scores_gemma":[0.9992259,0.00002240957,0.00048759943,0.000009662705,0.000026445052,0.000052944033,0.000077450386,0.00003075916,0.00006682536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837327,0.00008253844,0.00043061987,0.00030463227,0.0005050353,0.00030389815],"domain_scores_gemma":[0.99919784,0.00011111883,0.00015712889,0.00024996337,0.00015937176,0.00012458646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000107137894,0.0002022946,0.00045220836,0.00024658715,0.000032613247,0.0000068547665,0.00008537545,0.00003809299,0.000029243585],"category_scores_gemma":[0.00004171748,0.00015566905,0.00003931916,0.00032076173,0.00009440985,0.00007043565,0.0000587328,0.00015367761,0.0000018069567],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021425849,0.016415838,0.96874774,0.00013872689,0.00033111128,0.00014505979,0.00020196752,0.00003745696,0.009427087,0.0000034448576,0.00001242525,0.0023965791],"study_design_scores_gemma":[0.11441386,0.0024092188,0.86834013,0.0000875965,0.0003733085,0.000006966984,0.00009070076,0.0007385533,0.013411608,0.000006933657,0.000007901215,0.00011319522],"about_ca_topic_score_codex":0.0012572703,"about_ca_topic_score_gemma":0.0004676664,"teacher_disagreement_score":0.11227127,"about_ca_system_score_codex":0.000027763,"about_ca_system_score_gemma":0.000055487762,"threshold_uncertainty_score":0.63479996},"labels":[],"label_agreement":null},{"id":"W2531370406","doi":"10.1182/blood.v118.21.45.45","title":"Inhibition of Let-7 Processing in Adult Murine Hematopoietic Stem Cells Induces a Fetal-Like High Self-Renewal Pattern in Their Progeny","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Haematopoiesis; Biology; Stem cell; Myeloid; Cell biology; Fetus; Immunology; Progenitor cell; Molecular biology; Genetics","score_opus":0.030287367401418054,"score_gpt":0.2490856097616186,"score_spread":0.21879824236020054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531370406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971331,0.00030187538,0.000011078035,0.000056050176,0.000040505056,0.00093104946,0.0000052109963,0.00005076352,0.0014704058],"genre_scores_gemma":[0.9992555,0.00004224733,0.00035271473,0.000045078497,0.000054245735,0.00010645493,0.000008473388,0.00003706076,0.00009822204],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99799913,0.00011837048,0.00058071146,0.00038185596,0.00048358898,0.00043634538],"domain_scores_gemma":[0.9992109,0.000034572775,0.00016240556,0.00029206093,0.00016468277,0.00013541024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042201293,0.00021083563,0.00045340447,0.0003306224,0.000025789272,0.000013587349,0.0001324104,0.0001610956,0.00008959204],"category_scores_gemma":[0.000017990373,0.00016976615,0.000060662464,0.0005327696,0.0000634141,0.00010876381,0.000107975815,0.00032508626,0.000024418438],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003451868,0.010752645,0.3116211,0.007466527,0.00011124278,0.0012423515,0.02750469,0.0000016220536,0.61784,0.000053410833,0.00001560536,0.023045626],"study_design_scores_gemma":[0.0050039743,0.0004936089,0.020169053,0.0014757935,0.00004834725,0.00007821373,0.0011407828,0.00007334778,0.9712367,0.0000881457,0.0000069163602,0.00018511662],"about_ca_topic_score_codex":0.00076514774,"about_ca_topic_score_gemma":0.0003300336,"teacher_disagreement_score":0.35339668,"about_ca_system_score_codex":0.000059021917,"about_ca_system_score_gemma":0.0001935404,"threshold_uncertainty_score":0.69228625},"labels":[],"label_agreement":null},{"id":"W2531380553","doi":"10.1182/blood.v106.11.3569.3569","title":"The Role of Ca2+I in Procoagulant Surface Expression and Apoptosis in Human Platelets.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; Hospital for Sick Children","funders":"","keywords":"Phosphatidylserine; Platelet; Phospholipid scramblase; Annexin; Prothrombinase; Platelet activation; Annexin A5; Flow cytometry; Chemistry; Thrombin; Cell biology; Apoptosis; Molecular biology; Biophysics; Biology; Biochemistry; Phospholipid; Immunology; Membrane","score_opus":0.013860973914158956,"score_gpt":0.25930641184923164,"score_spread":0.24544543793507267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531380553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99738425,0.0008762174,0.0000025324964,0.00023140678,0.000012298319,0.000292714,0.0000011044468,0.000015328116,0.001184138],"genre_scores_gemma":[0.99933386,0.0000778879,0.0004330662,0.000037256963,0.000023145572,0.000011894763,0.0000031665886,0.000009998125,0.00006970301],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99930525,0.000033488748,0.00023694726,0.00013782184,0.00014230666,0.00014420474],"domain_scores_gemma":[0.9996871,0.00003388108,0.00005835367,0.00015687053,0.000019728623,0.00004409528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019803057,0.00007940978,0.00018869533,0.000054149896,0.000043743847,0.000007694484,0.000051399362,0.00006738806,0.000016305277],"category_scores_gemma":[0.000017618704,0.00005573635,0.000021542755,0.00011195476,0.000028731138,0.000041679516,0.000034297733,0.00010924843,0.0000021662988],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028589115,0.00072048954,0.04562404,0.000024677836,0.000013152687,0.0000018251158,0.00066793,0.000017900116,0.94834554,0.0013806403,0.000008951375,0.0031662602],"study_design_scores_gemma":[0.002948735,0.000106699496,0.03495051,0.00015888618,0.000023966477,0.000008164361,0.0003418999,0.0002780834,0.9601077,0.00048728625,0.0005225798,0.00006549583],"about_ca_topic_score_codex":0.00006723588,"about_ca_topic_score_gemma":0.00016175183,"teacher_disagreement_score":0.011762149,"about_ca_system_score_codex":0.000010073149,"about_ca_system_score_gemma":0.000017996545,"threshold_uncertainty_score":0.22728623},"labels":[],"label_agreement":null},{"id":"W2531381640","doi":"10.1182/blood.v106.11.2659.2659","title":"Mechanisms of Static and Shear-Induced Platelet Adhesion: Differences in the Adhesion Supported by MMRN1 Comparisons with Other β3 Integrin Ligands.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Platelet; Integrin; GPVI; Platelet adhesiveness; Chemistry; Platelet activation; Von Willebrand factor; Adhesion; Platelet membrane glycoprotein; Platelet Glycoprotein GPIIb-IIIa Complex; Collagen receptor; Thrombin; Fibrinogen; Glycoprotein Ib; Cell biology; Immunology; Biochemistry; Receptor; Biology","score_opus":0.021824068203792693,"score_gpt":0.25362497078105134,"score_spread":0.23180090257725866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531381640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99809444,0.00021883148,0.000049533264,0.00083380943,0.000009230804,0.00040266852,0.000022391076,0.000017665237,0.0003514065],"genre_scores_gemma":[0.99885195,0.00006650878,0.0006555467,0.0002671821,0.0000080268455,0.000023771001,0.000027873142,0.000014491766,0.00008464895],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991143,0.0000349102,0.00022764661,0.0001964144,0.00023485228,0.00019191288],"domain_scores_gemma":[0.9995722,0.00008342295,0.00008497568,0.00017224271,0.000021944395,0.00006517259],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011356187,0.00016064572,0.00038839524,0.00006647537,0.00004403391,0.000013722851,0.000073948824,0.00007304339,0.000068039066],"category_scores_gemma":[0.000012538338,0.000085925756,0.000028693194,0.00013845127,0.000041499963,0.000049872808,0.000014729723,0.00015147342,0.0000068565582],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027014236,0.026004076,0.5493821,0.000508162,0.0017277384,0.0014195351,0.014504118,0.0000021272576,0.37487185,0.001375144,0.0051218173,0.022381905],"study_design_scores_gemma":[0.031585414,0.006867203,0.23991822,0.00085226126,0.00079683133,0.00059145346,0.0061200745,0.000512806,0.7110752,0.00056638813,0.00061724853,0.00049691147],"about_ca_topic_score_codex":0.0002580236,"about_ca_topic_score_gemma":0.00035715912,"teacher_disagreement_score":0.33620334,"about_ca_system_score_codex":0.000008467278,"about_ca_system_score_gemma":0.000038036447,"threshold_uncertainty_score":0.35039505},"labels":[],"label_agreement":null},{"id":"W2531384229","doi":"10.1182/blood.v126.23.4556.4556","title":"Association of Helicobacter Pylori Infection with Iron Deficiency in Asians and Pacific Islanders but not in Caucasians, African Americans, or Hispanics","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Potassium and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"CagA; Helicobacter pylori; Iron deficiency; Medicine; Internal medicine; Antibody; Pacific islanders; Gastroenterology; Immunology; Ferritin; Gastritis; Serum iron; Population; Anemia; Biology; Gene; Virulence; Genetics","score_opus":0.013533337214388076,"score_gpt":0.23260479332012476,"score_spread":0.2190714561057367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531384229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99337494,0.00014798217,0.000035579622,0.0013166049,0.00005345826,0.0002370603,0.000007145226,0.000022916316,0.0048042815],"genre_scores_gemma":[0.99890375,0.0003405079,0.000090623136,0.000053042826,0.000016506629,0.000012273943,0.0000127657395,0.000014768213,0.00055573543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990752,0.00006264737,0.00022455779,0.00018694506,0.00022577129,0.00022489335],"domain_scores_gemma":[0.9995818,0.000032051896,0.0001362708,0.00011477482,0.000047748294,0.00008731087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022832032,0.00011564905,0.0002474396,0.00020852547,0.000016758046,0.0000079188,0.000026616033,0.00014138027,0.000005995438],"category_scores_gemma":[0.00010678033,0.00008413767,0.000021595453,0.0004799628,0.000050413415,0.000069315436,0.000009961667,0.00021047196,0.0000029090838],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038236976,0.0008887222,0.99136406,0.00008383615,0.00003669322,0.00003754585,0.00420563,0.000023123039,0.0018009292,0.000013494185,0.00017909687,0.0009845203],"study_design_scores_gemma":[0.018358698,0.0024160834,0.96091104,0.00023938662,0.00049085746,0.000117545314,0.0140741365,0.00018126567,0.0014563649,0.00003579611,0.0013706777,0.0003481721],"about_ca_topic_score_codex":0.0015798204,"about_ca_topic_score_gemma":0.004556875,"teacher_disagreement_score":0.030453023,"about_ca_system_score_codex":0.0001446522,"about_ca_system_score_gemma":0.00017909356,"threshold_uncertainty_score":0.34310344},"labels":[],"label_agreement":null},{"id":"W2531414011","doi":"10.1182/blood.v110.11.579.579","title":"Targeted ‘Off-the-Shelf’ Tumor Immunotherapy Using Allogeneic T-Cell Precursors.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Adoptive cell transfer; Cytotoxic T cell; Immunology; Cancer research; T cell; Major histocompatibility complex; Biology; Antigen; Immunotherapy; Chimeric antigen receptor; Transplantation; Stem cell; Immune system; Medicine; Cell biology; In vitro; Internal medicine","score_opus":0.024396877895186513,"score_gpt":0.3006860082770211,"score_spread":0.27628913038183456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531414011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98067653,0.00865449,0.00022452266,0.00021575038,0.00019133305,0.00088741217,0.0000063707894,0.000106977845,0.009036639],"genre_scores_gemma":[0.986996,0.00040193496,0.0025226988,0.0009707625,0.00067487685,0.00002239903,0.000021186406,0.00012474894,0.008265426],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99789536,0.000089824185,0.00036554053,0.00035341625,0.00058186776,0.00071398023],"domain_scores_gemma":[0.9986852,0.00016800743,0.00009669961,0.0007154146,0.00014186365,0.00019282018],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010593694,0.00023343597,0.0003227739,0.00017488867,0.00016770157,0.000038208327,0.00028474463,0.00011142011,0.002194257],"category_scores_gemma":[0.000056048302,0.00017531712,0.00021045278,0.00046331369,0.0001473234,0.00005207391,0.00005854121,0.0004102325,0.00009174683],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005108351,0.00079918996,0.008283166,0.000034862795,0.0002071324,0.00018378557,0.00037110253,0.0000042126308,0.97944754,0.000013725001,0.00019233633,0.009952119],"study_design_scores_gemma":[0.0073570106,0.0005477917,0.009264285,0.00004188386,0.00015131084,0.00041232994,0.00014901241,0.00010832725,0.93220246,0.00007296521,0.04943282,0.0002597863],"about_ca_topic_score_codex":0.000114823255,"about_ca_topic_score_gemma":0.000020790694,"teacher_disagreement_score":0.049240485,"about_ca_system_score_codex":0.000090574256,"about_ca_system_score_gemma":0.00020439528,"threshold_uncertainty_score":0.99871784},"labels":[],"label_agreement":null},{"id":"W2531421379","doi":"10.1182/blood.v124.21.4476.4476","title":"A Phase I Study of Ibrutinib and Lenalidomide in Patients with Relapsed and Refractory B-Cell Non-Hodgkin's Lymphoma","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Lenalidomide; Medicine; Ibrutinib; Neutropenia; Mantle cell lymphoma; Internal medicine; Febrile neutropenia; Gastroenterology; Mucositis; Rituximab; Oncology; Lymphoma; Toxicity; Multiple myeloma; Leukemia; Chronic lymphocytic leukemia","score_opus":0.007940417553765325,"score_gpt":0.26130985553531333,"score_spread":0.253369437981548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531421379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981122,0.00011242071,0.000003596313,0.000013756625,0.000015908972,0.000834455,0.000003509829,0.000013322309,0.00089085376],"genre_scores_gemma":[0.99958545,0.000017573597,0.0001673277,0.000036942318,0.00003060939,0.000022359889,0.000007173407,0.000027263102,0.00010529143],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9986136,0.00009197675,0.00029077832,0.0003344773,0.00041351022,0.00025565695],"domain_scores_gemma":[0.9990836,0.00018855608,0.000103713646,0.0003787123,0.00008657189,0.00015885162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003520915,0.00015069876,0.00039742072,0.00016138743,0.000031398802,0.0000116389165,0.000070463626,0.00007424909,0.00000924498],"category_scores_gemma":[0.00014429033,0.00011386701,0.000017793189,0.00017705424,0.00011558919,0.000065304346,0.000086207845,0.000111282905,0.000002777392],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017019827,0.11883145,0.8145925,0.0013080369,0.00044445,0.00041241158,0.008641128,0.0000025993522,0.005122888,0.000014571507,0.00022787448,0.03338229],"study_design_scores_gemma":[0.7721112,0.016750602,0.20523825,0.00022812915,0.00022995488,0.000030113057,0.0005061438,0.0004195828,0.0041275825,0.000007667956,0.00017587023,0.00017493914],"about_ca_topic_score_codex":0.00047072177,"about_ca_topic_score_gemma":0.000048627822,"teacher_disagreement_score":0.7550913,"about_ca_system_score_codex":0.00035522366,"about_ca_system_score_gemma":0.0006597101,"threshold_uncertainty_score":0.46433622},"labels":[],"label_agreement":null},{"id":"W2531422715","doi":"10.1182/blood.v126.23.2375.2375","title":"Distinct Regulatory Networks Govern Human Hematopoietic Stem Cell Across Development","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Stem cell; Biology; Haematopoiesis; CD90; Embryonic stem cell; Hematopoietic stem cell; Cell biology; CD34; Immunology; Stem cell factor; Bone marrow; Genetics","score_opus":0.02011523908273272,"score_gpt":0.2321107735417344,"score_spread":0.21199553445900168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531422715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953365,0.0010988178,0.0016234834,0.000009857326,0.00019897941,0.00010901008,0.0000071152385,0.000028282264,0.0015879923],"genre_scores_gemma":[0.9975648,0.00000806087,0.00025339538,0.00007991465,0.00026334118,0.000012859818,0.00008568882,0.000034134893,0.0016977937],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989344,0.000032481345,0.00023228809,0.0003161076,0.0001634859,0.00032122427],"domain_scores_gemma":[0.99936163,0.0000041598933,0.00007322757,0.00033309293,0.00005868672,0.00016919685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019049956,0.00017618739,0.0001506367,0.0000085027,0.00013079942,0.00003786583,0.00021277623,0.00016855724,0.0000049619557],"category_scores_gemma":[0.000003881785,0.00017095428,0.000067719746,0.00004645357,0.00006607709,0.0000026841758,0.000101521386,0.00009114399,0.000016079666],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020782788,0.0030286964,0.19583422,0.0002467403,0.00034887833,0.000080061116,0.0032184876,0.0005106083,0.7842036,0.00012778715,0.006967337,0.00522578],"study_design_scores_gemma":[0.004246721,0.00030439344,0.016906556,0.000038688337,0.00006357204,0.000038152393,0.00038367533,0.000054448818,0.93181485,0.00003110083,0.045427497,0.0006903234],"about_ca_topic_score_codex":0.000012532267,"about_ca_topic_score_gemma":0.00008241255,"teacher_disagreement_score":0.17892766,"about_ca_system_score_codex":0.00001903979,"about_ca_system_score_gemma":0.000080813435,"threshold_uncertainty_score":0.69713134},"labels":[],"label_agreement":null},{"id":"W2531488893","doi":"10.1182/blood.v126.23.2400.2400","title":"Natural Scaffold, from Bovine Bone Marrow, Reproduces Native Microenvironment and Supports CD34+ and Stromal Cells","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; St. Michael's Hospital","funders":"","keywords":"Extracellular matrix; Stromal cell; Cell biology; Decellularization; Bone marrow; Biology; Regeneration (biology); Immunology; Cancer research","score_opus":0.017987960134563108,"score_gpt":0.25533974709193913,"score_spread":0.23735178695737602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531488893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98754513,0.009199668,0.0000014922824,0.0009161967,0.000097732576,0.000490321,0.0000338208,0.000027792132,0.0016878597],"genre_scores_gemma":[0.99246025,0.00024739947,0.0015349337,0.00009397018,0.00025028974,0.000013075145,0.000050796956,0.000025549592,0.005323749],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99816304,0.00007889765,0.00024242076,0.00061661715,0.00054782344,0.0003512239],"domain_scores_gemma":[0.9989626,0.000082165745,0.000075186486,0.00037703337,0.00005738437,0.00044562307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044139873,0.00018942653,0.00033860418,0.000079328354,0.00005577432,0.00003860013,0.00006718744,0.00008035834,0.00018140589],"category_scores_gemma":[0.00014002611,0.00015439963,0.000034498375,0.00008079691,0.00018995372,0.00008818106,0.00022816948,0.00021951958,0.00003908964],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056375464,0.00069438876,0.11477216,0.000117398165,0.00022255251,0.0012776746,0.0011354315,1.8932549e-7,0.8734288,0.00001109212,0.0051340624,0.002642464],"study_design_scores_gemma":[0.009290149,0.0017550426,0.2240018,0.00015217482,0.000342344,0.0004294534,0.0010121134,0.00005682645,0.75341016,0.0001425569,0.009022413,0.00038499472],"about_ca_topic_score_codex":0.00024456048,"about_ca_topic_score_gemma":0.000025892023,"teacher_disagreement_score":0.12001868,"about_ca_system_score_codex":0.00004272164,"about_ca_system_score_gemma":0.00007293938,"threshold_uncertainty_score":0.6296234},"labels":[],"label_agreement":null},{"id":"W2531504577","doi":"10.1182/blood.v104.11.1715.1715","title":"Cofactor Directed Catalysis.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Prothrombinase; Chemistry; Thrombin; Cofactor; Biochemistry; Cleavage (geology); Factor V; Factor X; Thromboplastin; Tissue factor; Serine protease; Proteolysis; Stereochemistry; Enzyme; Coagulation; Platelet; Protease; Biology; Internal medicine; Immunology","score_opus":0.020127094966509235,"score_gpt":0.25898076695220856,"score_spread":0.23885367198569932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531504577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913263,0.00013195,0.00029938307,0.0008986588,0.000105435785,0.00017038372,0.0000036594104,0.00036138322,0.0067028715],"genre_scores_gemma":[0.996539,0.0000111947675,0.0023809313,0.000527186,0.00009017028,0.000008950927,0.00004450791,0.0000159951,0.00038205512],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99938804,0.000008815085,0.0001306902,0.0001604827,0.00017226081,0.00013968765],"domain_scores_gemma":[0.9995483,0.000008562937,0.000034352382,0.00023544757,0.00005279314,0.0001205459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004580028,0.000087472465,0.00018595204,0.000062293126,0.000043695054,0.000010191138,0.000042716067,0.00006251067,0.00026179303],"category_scores_gemma":[0.000039150444,0.00007509806,0.00007617621,0.0001945918,0.000017933422,0.000035843852,0.000015829093,0.000076931836,0.00025884766],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000087216315,0.00911715,0.022894008,0.00013150909,0.0014353392,0.0002436586,0.0010945636,0.000016576418,0.931593,0.029163286,0.0005602589,0.0036634435],"study_design_scores_gemma":[0.011411545,0.00033051957,0.112778254,0.000073148985,0.0009326948,0.00012499986,0.000055768644,0.000011835423,0.8692812,0.0017571193,0.0030193396,0.00022358503],"about_ca_topic_score_codex":0.000040225576,"about_ca_topic_score_gemma":0.000012513128,"teacher_disagreement_score":0.089884244,"about_ca_system_score_codex":0.000015777841,"about_ca_system_score_gemma":0.00005986952,"threshold_uncertainty_score":0.33270493},"labels":[],"label_agreement":null},{"id":"W2531520225","doi":"10.1182/blood-2016-08-733790","title":"Alternative genetic mechanisms of BRAF activation in Langerhans cell histiocytosis","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":169,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Human Genome Research Institute; Plexxikon; National Cancer Institute; National Institutes of Health; Lester and Sue Smith Foundation; Dan L. Duncan Cancer Center, Baylor College of Medicine; Howard Hughes Medical Institute; St. Baldrick's Foundation; Alex's Lemonade Stand Foundation for Childhood Cancer","keywords":"MAPK/ERK pathway; Langerhans cell histiocytosis; Cancer research; Fusion gene; Mutation; V600E; Biology; Gene; Medicine; Genetics; Signal transduction; Pathology; Disease","score_opus":0.010798775510966876,"score_gpt":0.22898519627626623,"score_spread":0.21818642076529937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531520225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884711,0.000038116566,0.0063359984,0.000116672716,0.000034853783,0.00017729637,0.0000098661585,0.000012555609,0.004803558],"genre_scores_gemma":[0.99736416,0.000026953552,0.0015240582,0.000043489053,0.00001619185,0.0000191503,0.000005196637,0.000010194325,0.0009906138],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999523,0.000013021843,0.00012588078,0.0001235186,0.000119106466,0.00009547722],"domain_scores_gemma":[0.99972767,0.000030729207,0.000056978017,0.00011899131,0.000030460735,0.000035146302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000026837715,0.00006717386,0.00013581217,0.00007956492,0.000009959195,0.0000014482025,0.00003301809,0.000035945217,0.0001181233],"category_scores_gemma":[0.00002544461,0.000045591645,0.00003246661,0.00007375187,0.000018107006,0.000025722145,0.000009808938,0.00002267594,0.000032964075],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022289263,0.0066872016,0.058566995,0.00018388778,0.00028353886,0.0001687041,0.0011539847,0.0000055569926,0.89192486,0.0026407065,0.00018581195,0.037975855],"study_design_scores_gemma":[0.011668959,0.0005301077,0.051139913,0.00022631181,0.00016694514,0.000008371533,0.000059095408,0.000019818857,0.93217295,0.00379475,0.00011376409,0.000098992656],"about_ca_topic_score_codex":0.00018799881,"about_ca_topic_score_gemma":0.000024053203,"teacher_disagreement_score":0.040248107,"about_ca_system_score_codex":0.00004793373,"about_ca_system_score_gemma":0.000032190266,"threshold_uncertainty_score":0.18591733},"labels":[],"label_agreement":null},{"id":"W2531553188","doi":"10.1182/blood.v120.21.4758.4758","title":"Safety and Long-Term Effects of Splenectomy At the Age of Two for Acute Splenic Sequestration in Sickle Cell Disease: A Retrospective Review","year":2012,"lang":"en","type":"review","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Splenectomy; Sepsis; Surgery; Thrombosis; Pneumonia; Retrospective cohort study; Venous thrombosis; Pediatrics; Internal medicine; Spleen","score_opus":0.013735616009589823,"score_gpt":0.30985553699827884,"score_spread":0.296119920988689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531553188","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032168087,0.99124944,0.000010638276,0.000040566403,0.0000747989,0.005054558,0.00014540306,0.000011805678,0.00019597856],"genre_scores_gemma":[0.0016662808,0.9971977,0.000035599955,0.000040024184,0.00006381469,0.00018035229,0.0005153392,0.000042616197,0.00025825878],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9984234,0.00016059088,0.0006753301,0.00029675424,0.00019723155,0.0002467207],"domain_scores_gemma":[0.99868387,0.00022466837,0.00048788873,0.0004390149,0.0000616562,0.000102928396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034951352,0.00029886287,0.001792663,0.00007515573,0.000038462193,0.0000038289772,0.000101744066,0.00018324955,0.00002381918],"category_scores_gemma":[0.000092936345,0.00018469515,0.00044649738,0.00025792303,0.00012057591,0.00003790776,0.0000703906,0.00027235813,0.0000035421192],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016920477,0.001243523,0.0049887323,0.8215385,0.0013803542,0.00018895765,0.00014971494,9.752815e-8,0.0001303847,0.00013607928,0.00010281373,0.16997164],"study_design_scores_gemma":[0.021274926,0.0019442458,0.030359022,0.597155,0.17128296,0.00035551956,0.00000973526,0.0000027319966,0.0005068538,0.00009412539,0.17578754,0.001227365],"about_ca_topic_score_codex":0.000012028032,"about_ca_topic_score_gemma":0.000021235543,"teacher_disagreement_score":0.2243835,"about_ca_system_score_codex":0.00008172794,"about_ca_system_score_gemma":0.0002072615,"threshold_uncertainty_score":0.75316495},"labels":[],"label_agreement":null},{"id":"W2531563325","doi":"10.1182/blood.v112.11.4122.4122","title":"Possible Selection for the Jak2 V617F Mutation in Bone Marrow Failure","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"","keywords":"Essential thrombocythemia; Myeloproliferative Disorders; Bone marrow; Medicine; Megakaryocyte; Bone marrow failure; Mutation; Anemia; Hematology; Myeloid; Polycythemia vera; Haematopoiesis; Pathology; Internal medicine; Immunology; Biology; Stem cell; Genetics; Gene","score_opus":0.018285054606670414,"score_gpt":0.25954804449136704,"score_spread":0.24126298988469663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531563325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940354,0.0006397269,0.00021902578,0.0036454976,0.000046801546,0.0008983047,0.0000065139325,0.000030455341,0.00047825315],"genre_scores_gemma":[0.99581224,0.00010474065,0.002399817,0.00025665222,0.00014365018,0.0004635091,0.0000336384,0.00001334035,0.00077242043],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993958,0.000019749681,0.00014719261,0.00016110062,0.00012625815,0.0001499201],"domain_scores_gemma":[0.99961764,0.00012958168,0.000042277377,0.00009717074,0.00007391772,0.000039394352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008545397,0.00009396173,0.00014976079,0.00006273341,0.00013813177,0.00000974716,0.000023149412,0.000054774915,0.0000622794],"category_scores_gemma":[0.0000694012,0.000060771265,0.000058293594,0.0001748587,0.000022308148,0.00004817856,0.000005796507,0.000079884005,0.000020341997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028314698,0.002839896,0.9762183,0.0000875958,0.00031077705,0.00012475578,0.001804507,0.00010551909,0.0062518474,0.0009791169,0.0061631473,0.004831381],"study_design_scores_gemma":[0.01709565,0.0016985052,0.83885795,0.000116749055,0.0004845595,0.0013427675,0.0003108925,0.0013615384,0.12858854,0.0003414523,0.009586157,0.00021524311],"about_ca_topic_score_codex":0.00008698598,"about_ca_topic_score_gemma":0.0004980538,"teacher_disagreement_score":0.13736036,"about_ca_system_score_codex":0.000036980437,"about_ca_system_score_gemma":0.00007297906,"threshold_uncertainty_score":0.24781802},"labels":[],"label_agreement":null},{"id":"W2531623326","doi":"10.1182/blood.v108.11.1613.1613","title":"Inhibition of Factor Xa in Prothrombinase Is Enhanced by Covalent Linkage of Antithrombin to Heparin.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Prothrombinase; Chemistry; Antithrombin; Covalent bond; Thrombin; Stereochemistry; Conjugate; Substrate (aquarium); Heparin; Biophysics; Biochemistry; Platelet; Organic chemistry; Immunology; Biology","score_opus":0.01393797338133419,"score_gpt":0.2620204303698061,"score_spread":0.24808245698847192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531623326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99677193,0.00008536476,0.0005558391,0.0002173799,0.000050052164,0.00093557016,0.000057413967,0.00003138315,0.0012950769],"genre_scores_gemma":[0.9984534,0.000016403588,0.0010050405,0.00018637704,0.000023792258,0.000037263046,0.000046590994,0.000020157444,0.00021099197],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987549,0.0000321908,0.00048873195,0.00024390114,0.00030047292,0.00017975799],"domain_scores_gemma":[0.9993924,0.000016462056,0.00015425269,0.0002585377,0.00010663775,0.00007171455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010455447,0.000136729,0.0004290295,0.00016404463,0.000016257676,0.00000492221,0.000049770508,0.0001127861,0.00024403328],"category_scores_gemma":[0.000025714415,0.00013485107,0.000080281934,0.00034001324,0.000034660727,0.000055505985,0.00003187541,0.00009328507,0.000020152993],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003583438,0.0031296392,0.0069555035,0.00020459297,0.000033127533,0.000003312468,0.0003214516,0.0000014735776,0.9882265,0.0005687811,0.00032855346,0.00019124775],"study_design_scores_gemma":[0.00474577,0.00068996503,0.051915087,0.0003213145,0.00007362893,0.0000023341318,0.000047368245,0.000010158173,0.94162613,0.00039552242,0.000060295806,0.0001123958],"about_ca_topic_score_codex":0.00032059668,"about_ca_topic_score_gemma":0.00004507101,"teacher_disagreement_score":0.046600323,"about_ca_system_score_codex":0.000021278483,"about_ca_system_score_gemma":0.00005924976,"threshold_uncertainty_score":0.54990673},"labels":[],"label_agreement":null},{"id":"W2531664488","doi":"10.1182/blood.v120.21.718.718","title":"Long-Term Follow-up of a Phase 2 Study of Single Agent Lenalidomide in Previously Untreated, Symptomatic Chronic Lymphocytic Leukemia (CLL)","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lenalidomide; Neutropenia; Internal medicine; Gastroenterology; Rash; Anemia; Febrile neutropenia; Tumor lysis syndrome; Adverse effect; Rituximab; Surgery; Multiple myeloma; Toxicity; Lymphoma; Chemotherapy","score_opus":0.03407372071081178,"score_gpt":0.32033588549665765,"score_spread":0.2862621647858459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531664488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99206287,0.0047592814,0.000012292159,0.000006860121,0.00014692037,0.0025100058,0.000008481005,0.000065025386,0.0004282767],"genre_scores_gemma":[0.99888605,0.00014429107,0.000054134358,0.000019480949,0.00017585901,0.00015328074,0.00002849513,0.00007719515,0.00046120334],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9960789,0.0002408425,0.0011928297,0.00044245285,0.0010459065,0.0009990712],"domain_scores_gemma":[0.99769104,0.00029387703,0.00037361286,0.0010964548,0.00016270844,0.00038234037],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008220349,0.00037421743,0.0011427649,0.00046824012,0.00004176421,0.000016978747,0.00037034412,0.00017601914,0.00021948678],"category_scores_gemma":[0.0003692477,0.00032291393,0.00022214989,0.0007845083,0.00017551144,0.00018113923,0.0002273009,0.00020853875,0.000059758182],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.010797703,0.11331666,0.45254403,0.025231957,0.008237656,0.004603829,0.049048137,0.0006686235,0.30842456,0.00009245379,0.00049845834,0.026535923],"study_design_scores_gemma":[0.75093347,0.011198192,0.0240681,0.0037642254,0.003302536,0.0013678726,0.0011634142,0.003258553,0.20026894,0.000012209485,0.000024552159,0.00063795317],"about_ca_topic_score_codex":0.0024676954,"about_ca_topic_score_gemma":0.0005336824,"teacher_disagreement_score":0.7401357,"about_ca_system_score_codex":0.041320886,"about_ca_system_score_gemma":0.012756574,"threshold_uncertainty_score":0.9999223},"labels":[],"label_agreement":null},{"id":"W2531677764","doi":"10.1182/blood.v104.11.1134.1134","title":"Redundant Leukemogenicity of NUP98-HOX Fusion Genes in Primary Murine Bone Marrow Cells Correlates with Gene Expression Changes Consistent with Common Key Target Genes.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Hox gene; Fusion gene; Biology; Gene; Myeloid leukemia; Homeobox; Myeloid; Molecular biology; Cancer research; Gene expression; Genetics","score_opus":0.011479420623789495,"score_gpt":0.22540458215255899,"score_spread":0.2139251615287695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531677764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99051154,0.0065140715,0.00012719102,0.0007805705,0.000059094025,0.0013308584,0.000052490355,0.000084268715,0.00053993386],"genre_scores_gemma":[0.9708565,0.0021059825,0.025870143,0.00023274339,0.00013109714,0.00009304474,0.00019870572,0.000100047386,0.00041172508],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99712485,0.00012337415,0.00054754986,0.00064812024,0.000903861,0.00065226026],"domain_scores_gemma":[0.9982793,0.00008903636,0.00030065305,0.00078615727,0.00024007485,0.0003048242],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004104007,0.00042280168,0.00094462396,0.00035994445,0.00011331154,0.000018855735,0.00023893274,0.00023726754,0.000081143444],"category_scores_gemma":[0.00002205306,0.00029547713,0.00009392351,0.00051574624,0.00037167658,0.00010072392,0.0002763271,0.00051956635,0.000015024259],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025912991,0.001704596,0.05620457,0.000521611,0.00015540856,0.001563847,0.00048450488,0.0005961424,0.93526226,0.000008379423,0.000123179,0.00078418147],"study_design_scores_gemma":[0.017906416,0.0020775476,0.022276701,0.0010659504,0.00024272868,0.00096156244,0.00020288806,0.000082369595,0.95443124,0.000021493812,0.00038140835,0.00034970324],"about_ca_topic_score_codex":0.0005613664,"about_ca_topic_score_gemma":0.00033919094,"teacher_disagreement_score":0.03392787,"about_ca_system_score_codex":0.00048340653,"about_ca_system_score_gemma":0.00096210797,"threshold_uncertainty_score":0.99994975},"labels":[],"label_agreement":null},{"id":"W2531679557","doi":"10.1182/blood.v118.21.4211.4211","title":"Comparative Net Cost Impact of the Utilization of Romiplostim and Intravenous Immunoglobulin for the Treatment of Patients with Immune Thrombocytopenia in Quebec,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Amgen (Canada)","funders":"","keywords":"Romiplostim; Medicine; Splenectomy; Thrombocytopenic purpura; Eltrombopag; Thrombopoietin; Rituximab; Pediatrics; Platelet; Immunology; Internal medicine; Immune thrombocytopenia; Antibody","score_opus":0.037034041579779374,"score_gpt":0.2831221632918815,"score_spread":0.24608812171210212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531679557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969479,0.0011097527,0.000013194693,0.000009505615,0.000011320326,0.0016766029,0.00011723658,0.000002060373,0.00011246586],"genre_scores_gemma":[0.9995825,0.00019025122,0.000112773094,0.000002522074,0.0000020747286,0.000034475146,0.00004870447,0.0000071681943,0.000019508243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999494,0.000023469485,0.00021931705,0.00008754789,0.000082303384,0.000093370094],"domain_scores_gemma":[0.999465,0.00006024202,0.00018351407,0.00019042849,0.00008412247,0.000016706272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000029033206,0.00010578528,0.00043359053,0.000027507858,0.000026362371,0.0000020121222,0.000050855742,0.00003157835,0.00001677483],"category_scores_gemma":[0.0000077634095,0.000046458405,0.0000639488,0.00010387553,0.00011389721,0.00003084402,0.000010603656,0.000023448569,2.0426704e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003359571,0.013327969,0.96309036,0.000053365107,0.0016950871,0.0000036635267,0.012478089,0.000022532588,0.0012454619,0.000043281303,0.0000066076814,0.004674038],"study_design_scores_gemma":[0.013019548,0.004064709,0.9549044,0.00007729388,0.00047782643,0.0000024154383,0.0002506711,0.000048637063,0.027084129,0.00002572863,0.0000060414577,0.000038612987],"about_ca_topic_score_codex":0.008649223,"about_ca_topic_score_gemma":0.0022114443,"teacher_disagreement_score":0.025838668,"about_ca_system_score_codex":0.000031851127,"about_ca_system_score_gemma":0.00007401513,"threshold_uncertainty_score":0.9979523},"labels":[],"label_agreement":null},{"id":"W2531688258","doi":"10.1182/blood.v126.23.3855.3855","title":"Transcriptome Analysis Reveals That G Protein-Coupled Receptors Are Potential Diagnostic Markers or Therapeutic Targets in Acute Myeloid Leukemia","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"G protein-coupled receptor; Biology; Receptor; Myeloid leukemia; Angiogenesis; Cancer research; Myeloid; Leukemia; Chemokine receptor; Chemokine; Cell biology; Pharmacology; Immunology; Biochemistry","score_opus":0.02144719159331413,"score_gpt":0.2567053018689591,"score_spread":0.235258110275645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531688258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950896,0.0022563338,0.0005524621,0.000588981,0.00021431147,0.0010272308,0.000018002347,0.00010125141,0.00015186067],"genre_scores_gemma":[0.99657065,0.00027175253,0.00071624434,0.00025354355,0.00022702264,0.00013806435,0.000113104164,0.00005916076,0.001650442],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99766207,0.00012383283,0.0005122291,0.00052777055,0.0006225364,0.00055154244],"domain_scores_gemma":[0.99877894,0.00011883592,0.0001965478,0.00039644758,0.0001340214,0.00037523784],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00058923225,0.00035107258,0.0009488341,0.00045213228,0.00006186836,0.00004627387,0.00018885738,0.00023015712,0.000806826],"category_scores_gemma":[0.0002727691,0.00026712663,0.0003822677,0.0012102079,0.00006604556,0.00012669711,0.000033328623,0.00036807868,0.000027225597],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004562421,0.002338778,0.45019698,0.0004670065,0.01269247,0.0025421595,0.0033520535,0.0004042028,0.5177246,0.000017206088,0.0022437691,0.0034584147],"study_design_scores_gemma":[0.08859323,0.0041941484,0.27319527,0.0029044587,0.055751473,0.0007405979,0.008306936,0.0066939658,0.5469667,0.00072524365,0.007709426,0.004218585],"about_ca_topic_score_codex":0.00014532638,"about_ca_topic_score_gemma":0.00009344467,"teacher_disagreement_score":0.17700168,"about_ca_system_score_codex":0.00025192086,"about_ca_system_score_gemma":0.00029000398,"threshold_uncertainty_score":0.99997807},"labels":[],"label_agreement":null},{"id":"W2531697186","doi":"10.1182/blood.v124.21.377.377","title":"Gemtuzumab Ozogamicin (GO) in Infants with Acute Myeloid Leukemia (AML) – Combined Results from the Children’s Oncology Group (COG) Trials, AAML03P1 and AAML0531","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Gemtuzumab ozogamicin; Medicine; Internal medicine; Leukemia; Induction chemotherapy; Myeloid leukemia; Juvenile myelomonocytic leukemia; Acute promyelocytic leukemia; Pediatrics; Clinical trial; Chemotherapy; Oncology; Surgery; Stem cell; CD33; CD34","score_opus":0.019084675674363297,"score_gpt":0.28482379123994617,"score_spread":0.2657391155655829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531697186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989014,0.00045368157,0.00006873677,0.0041521974,0.00013970544,0.0022102208,0.0002516889,0.00014767844,0.003562042],"genre_scores_gemma":[0.99333817,0.0007774165,0.0020037345,0.0017532511,0.0007636076,0.00013522126,0.00059711025,0.00009710895,0.00053435616],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99505675,0.0011555589,0.0011349337,0.0010280468,0.00074126385,0.0008834415],"domain_scores_gemma":[0.99464184,0.0031844052,0.0004256179,0.0012510959,0.0001372065,0.00035983545],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0033951064,0.0005066006,0.0015170483,0.00027884648,0.0001967733,0.00007995659,0.0005643652,0.0004785838,0.000057083933],"category_scores_gemma":[0.0024135953,0.00031516855,0.00013717935,0.000572668,0.00045948869,0.00016810052,0.0003682128,0.0013926121,0.00008624974],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20346552,0.006568815,0.37040377,0.00024074095,0.013737906,0.00414272,0.01179849,0.00006356759,0.114547685,0.0028619838,0.055291116,0.21687768],"study_design_scores_gemma":[0.17420653,0.0083368765,0.7933859,0.00043726835,0.00227161,0.0008860309,0.00032606383,0.0007890696,0.007731711,0.00049134466,0.01039536,0.00074220006],"about_ca_topic_score_codex":0.004745739,"about_ca_topic_score_gemma":0.001897114,"teacher_disagreement_score":0.4229822,"about_ca_system_score_codex":0.0005878623,"about_ca_system_score_gemma":0.0010365478,"threshold_uncertainty_score":0.99993},"labels":[],"label_agreement":null},{"id":"W2531700925","doi":"10.1182/blood.v106.11.2622.2622","title":"Defining Candidate Oncogenes Leading to Increased Susceptibility to Leukemia in eed Mutant Mice.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Animal Genetics and Reproduction","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Institute for Research in Immunology and Cancer","funders":"","keywords":"Biology; Mutant; Gene; Locus (genetics); Wild type; Genetics; Carcinogenesis; Insertional mutagenesis; Haploinsufficiency; Positional cloning; Leukemia; Molecular biology; Cancer research; Phenotype","score_opus":0.007167124929746537,"score_gpt":0.24809958673942512,"score_spread":0.2409324618096786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531700925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983236,0.00043957419,0.00017095979,0.0002264164,0.000065603046,0.00021709788,0.000013467795,0.000012812359,0.00053046603],"genre_scores_gemma":[0.9955618,0.000042429514,0.003366253,0.00036067364,0.00034481173,0.000019891932,0.000034909943,0.000020304271,0.00024895347],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988485,0.000038012917,0.00021963284,0.0005210349,0.00009438992,0.00027841752],"domain_scores_gemma":[0.999459,0.000004805069,0.00003794166,0.00030618368,0.0000513149,0.00014071226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026420318,0.00013727332,0.00014278268,0.0000683243,0.000058233072,0.000020047311,0.00013063337,0.00010022563,0.0000129878645],"category_scores_gemma":[0.000118046824,0.00013535267,0.000047878922,0.0001583917,0.000024249817,0.0000025285115,0.00011426481,0.00006503039,0.00006385749],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000088087254,0.00007672423,0.01421126,0.000007491408,0.000017500905,0.000003242045,0.00011309961,0.00095990935,0.98160714,0.000016084796,0.0001302782,0.002769198],"study_design_scores_gemma":[0.00063362985,0.0003298048,0.016014462,0.000017474431,0.000020201294,0.000017112634,0.00007565337,0.000025123945,0.96490943,0.000007461425,0.017737908,0.00021174618],"about_ca_topic_score_codex":0.00041937726,"about_ca_topic_score_gemma":0.0029447943,"teacher_disagreement_score":0.01760763,"about_ca_system_score_codex":0.00006507716,"about_ca_system_score_gemma":0.00013725083,"threshold_uncertainty_score":0.5519522},"labels":[],"label_agreement":null},{"id":"W2531711809","doi":"10.1182/blood.v120.21.3625.3625","title":"SL-401, A Targeted Therapy Directed to the Interleukin-3 Receptor Present On Leukemia Blasts and Cancer Stem Cells, Is Active As a Single Agent in Patients with Advanced AML","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Oncology; Leukemia; Stem cell; Cancer; Immunology; Biology","score_opus":0.018398359243683517,"score_gpt":0.27549451968944527,"score_spread":0.2570961604457618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531711809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955248,0.00085949356,0.0000016440423,0.0006254826,0.00016236688,0.0021816264,0.00004561664,0.000051961597,0.0005469818],"genre_scores_gemma":[0.995853,0.00032266,0.000078385216,0.00068091846,0.00017032638,0.00034808574,0.000013747591,0.00006179192,0.0024710577],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99815637,0.00014843681,0.00020276339,0.00038031864,0.0005808611,0.0005312393],"domain_scores_gemma":[0.9989908,0.000103276674,0.000080752325,0.00041110555,0.00013605555,0.0002780126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013901335,0.0002480762,0.00031282502,0.00014452926,0.00006215453,0.000027276787,0.00013767924,0.0000794185,0.00084418274],"category_scores_gemma":[0.000018843271,0.00015315802,0.00004953001,0.00038365333,0.00008192022,0.00009307894,0.00007343994,0.00032199264,0.000042283744],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023251692,0.00572256,0.08266065,0.00007346374,0.00088972726,0.000015735057,0.026584998,0.00003278135,0.49601784,0.000003440759,0.0035568029,0.3611903],"study_design_scores_gemma":[0.012881663,0.004173236,0.13924631,0.00032044243,0.000050111143,0.0000025121237,0.0004893889,0.000016993547,0.7969677,0.0000015724087,0.045597818,0.00025226132],"about_ca_topic_score_codex":0.00031643859,"about_ca_topic_score_gemma":0.00008790648,"teacher_disagreement_score":0.36093804,"about_ca_system_score_codex":0.00051814324,"about_ca_system_score_gemma":0.00013491523,"threshold_uncertainty_score":0.9243209},"labels":[],"label_agreement":null},{"id":"W2531712038","doi":"10.1182/blood.v112.11.993.993","title":"From Venus and Mars: Gender Specific Analysis of Blood Platelets","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of British Columbia","funders":"","keywords":"Platelet; Western blot; Proteome; Biology; Platelet activation; Signal transduction; Proteomics; Clot retraction; Cell biology; Molecular biology; Immunology; Biochemistry; Thrombin","score_opus":0.0257966915488859,"score_gpt":0.24028912541903488,"score_spread":0.214492433870149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531712038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99138296,0.0068954336,0.000005501473,0.000028382246,0.000024488994,0.00009866269,0.000088615416,0.000018900237,0.0014570481],"genre_scores_gemma":[0.99770766,0.0013512991,0.0006061197,0.000037651145,0.00004359306,0.0000038227363,0.0001430033,0.000011790555,0.00009504113],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992939,0.000011995308,0.00017339284,0.00021868973,0.00016119752,0.00014080918],"domain_scores_gemma":[0.99956375,0.000035686513,0.000060705668,0.00022872194,0.000026529013,0.00008461951],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000024887788,0.000110572386,0.00042623942,0.00015589983,0.00003806305,0.000003949108,0.0000366719,0.000067755085,0.00018335461],"category_scores_gemma":[0.000009039675,0.00009506777,0.000109384826,0.0002872091,0.000055208315,0.000028533308,0.000019226532,0.00006251991,0.000014210255],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020497882,0.0055119963,0.92882454,0.000044297507,0.026679577,0.012928559,0.002409805,0.0000053466765,0.019275479,0.00003450281,0.0005691598,0.0035117746],"study_design_scores_gemma":[0.010054948,0.00024001741,0.9566437,0.000026366935,0.013349704,0.0004809845,0.00010178,0.00002842309,0.017563824,0.0001729245,0.0011698216,0.00016750066],"about_ca_topic_score_codex":0.000120505916,"about_ca_topic_score_gemma":0.000007334919,"teacher_disagreement_score":0.02781918,"about_ca_system_score_codex":0.0000038432913,"about_ca_system_score_gemma":0.000018524941,"threshold_uncertainty_score":0.38767514},"labels":[],"label_agreement":null},{"id":"W2531715689","doi":"10.1182/blood.v118.21.3588.3588","title":"Association Between Obesity/Overweight and Leukemia: A Meta-Analysis of Prospective Cohort Studies,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Overweight; Leukemia; Internal medicine; Body mass index; Chronic lymphocytic leukemia; Obesity; Myeloid leukemia; Oncology","score_opus":0.07447484889507151,"score_gpt":0.30341973381964316,"score_spread":0.22894488492457166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531715689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99418765,0.0032695844,0.000011510475,0.000040034934,0.000017179258,0.00027618854,0.00006556916,0.000016694123,0.0021155842],"genre_scores_gemma":[0.9986218,0.00034755815,0.00016836719,0.00003192775,0.000042139807,0.000023580844,0.000013032272,0.0000068656177,0.00074472645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992235,0.00002505875,0.00021850933,0.0001929893,0.00023076398,0.00010921815],"domain_scores_gemma":[0.9993621,0.00007059888,0.00019052181,0.00016066206,0.00016261161,0.000053512682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025082144,0.00009536477,0.0009789959,0.000116721814,0.000030452506,0.0000033834845,0.000029456425,0.000072478826,0.00013890966],"category_scores_gemma":[0.0000824334,0.00006877585,0.00032456373,0.00034831095,0.000032053507,0.000040859144,0.000028786699,0.00009339107,0.0000020417876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000793643,0.00008967938,0.6813746,0.000013142184,0.3175973,0.0000023646053,0.00074013567,6.223875e-8,0.000023113436,0.0000379794,0.00010054996,0.000013123052],"study_design_scores_gemma":[0.00042578636,0.00008355995,0.5850948,0.0000015770989,0.4118388,3.8282383e-7,0.000059972015,8.6350315e-7,0.0023235308,0.00007837564,0.000053414136,0.00003894298],"about_ca_topic_score_codex":0.00090626266,"about_ca_topic_score_gemma":0.0002628173,"teacher_disagreement_score":0.09627981,"about_ca_system_score_codex":0.00015321709,"about_ca_system_score_gemma":0.00004645925,"threshold_uncertainty_score":0.28045976},"labels":[],"label_agreement":null},{"id":"W2531730587","doi":"10.1182/blood.v118.21.3606.3606","title":"A Phase I Combination Study of Ribavirin and Low Dose Cytarabine Arabinoside (ara-C) in M4/M5 Acute Myeloid Leukemia (AML) and AML with High eIF4E,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; Institute for Research in Immunology and Cancer; McGill University; Jewish General Hospital","funders":"","keywords":"Cytarabine; Medicine; EIF4E; Ribavirin; Myeloid leukemia; Oncology; Cancer; Cancer research; Leukemia; Myeloid; Internal medicine; Temozolomide; Chemotherapy; Immunology; Translation (biology); Biology; Gene; Messenger RNA","score_opus":0.012918365873787937,"score_gpt":0.2423963824091339,"score_spread":0.22947801653534594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531730587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99806887,0.00017010246,0.0000057981965,0.0001259437,0.00002170268,0.001081681,0.000009284172,0.00003350132,0.0004830944],"genre_scores_gemma":[0.99791545,0.00013972164,0.00087509304,0.00003178545,0.000013738313,0.00009234649,0.0000410949,0.000023124336,0.00086763885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987964,0.000049514183,0.00033899033,0.00035385948,0.00024208047,0.00021914615],"domain_scores_gemma":[0.9994145,0.000034146815,0.000119505225,0.00023438761,0.000068151996,0.00012933215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015688407,0.00023346973,0.00046426518,0.00023078495,0.00004788246,0.000011285103,0.00005451621,0.00006639522,0.000023284587],"category_scores_gemma":[0.000015078368,0.00017585733,0.000021121743,0.0002485697,0.00008555887,0.00012723805,0.000046220808,0.00013466305,0.0000057128404],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022226241,0.035384245,0.9277629,0.00020242993,0.0013028097,0.0014495562,0.015691532,8.058075e-7,0.009790127,0.00021108628,0.000100390134,0.0058814534],"study_design_scores_gemma":[0.12066719,0.006857686,0.820099,0.00029847492,0.0012197752,0.00015401021,0.00092453614,0.000036830465,0.049294487,0.00012990033,0.000028944394,0.00028919865],"about_ca_topic_score_codex":0.00032762453,"about_ca_topic_score_gemma":0.00029173083,"teacher_disagreement_score":0.11844456,"about_ca_system_score_codex":0.000060195795,"about_ca_system_score_gemma":0.000107235785,"threshold_uncertainty_score":0.7171254},"labels":[],"label_agreement":null},{"id":"W2531760402","doi":"10.1182/blood.v106.11.229.229","title":"Bendamustine HCl (TREANDATM) Treatment Results in High Rates of Objective Response in Patients with Rituximab-Refractory and Alkylator-Refractory Indolent B-Cell Non-Hodgkin’s Lymphoma (NHL): Results from a Phase II Multicenter Single-Agent Study (SDX-105-01).","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Public Health; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Bendamustine; Medicine; Rituximab; Internal medicine; Population; Refractory (planetary science); Gastroenterology; Salvage therapy; Progressive disease; Neutropenia; Oncology; Chemotherapy; Surgery; Lymphoma; Biology","score_opus":0.017716380277482582,"score_gpt":0.2854540597887837,"score_spread":0.2677376795113011,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531760402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930337,0.00043623443,0.000001242913,0.00012955595,0.00007416351,0.0036688766,0.0025050952,0.000041434785,0.0001096866],"genre_scores_gemma":[0.9974157,0.0001045981,0.0008370772,0.000038837694,0.00010265699,0.00019679416,0.0010561788,0.00007837944,0.00016973879],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952408,0.00057123625,0.0012855306,0.0012283938,0.000895029,0.0007790097],"domain_scores_gemma":[0.9969645,0.0008258835,0.0005079329,0.0009063651,0.0003112414,0.00048407447],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005534904,0.00068760687,0.0011511229,0.00072223984,0.00013435294,0.000036226003,0.00017225213,0.00019725887,0.00003491653],"category_scores_gemma":[0.0006061509,0.0005125243,0.000108412096,0.00041492216,0.00016987926,0.00028078523,0.00018818039,0.00029190147,0.000018384226],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.30088964,0.2865058,0.3679406,0.000041289495,0.0008131845,0.0011242386,0.01075562,0.00001530657,0.0043206895,7.508443e-8,0.000039061495,0.027554506],"study_design_scores_gemma":[0.3642315,0.034406483,0.57848364,0.00032653887,0.00027945387,0.000002576423,0.0007315733,0.000094681796,0.020998966,5.793363e-7,0.0001833022,0.00026071703],"about_ca_topic_score_codex":0.0050242497,"about_ca_topic_score_gemma":0.002632255,"teacher_disagreement_score":0.2520993,"about_ca_system_score_codex":0.00097430224,"about_ca_system_score_gemma":0.0003770718,"threshold_uncertainty_score":0.9997326},"labels":[],"label_agreement":null},{"id":"W2531879292","doi":"10.1182/blood.v118.21.1931.1931","title":"Plerixafor Is Highly Effective for the Mobilization of Autologous PBSC for Transplant in Children Failing to Mobilize by Conventional Means: International Experience with 40 Children From 19 Centers","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Plerixafor; Medicine; Surgery; Blood cancer; Chemotherapy; Mobilization; Transplantation; Internal medicine; Cancer; CXCR4","score_opus":0.012864356483083999,"score_gpt":0.26557867973374466,"score_spread":0.2527143232506607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531879292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874025,0.00008648046,0.0073256455,0.00016019362,0.00004130684,0.0036057269,0.0013420623,0.000019031224,0.000017043734],"genre_scores_gemma":[0.9963862,0.00002206718,0.0016088028,0.00013289032,0.000027344335,0.0013318285,0.00044101907,0.000018433093,0.000031455507],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990532,0.000024180885,0.00019950753,0.00030254322,0.00022329933,0.00019729922],"domain_scores_gemma":[0.9994654,0.00015103968,0.00006552236,0.0001474126,0.000083862724,0.00008676608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000730124,0.00012732699,0.00018637982,0.00007938618,0.000051323303,0.000008431319,0.00014691924,0.000038715476,0.000047903086],"category_scores_gemma":[0.000050433,0.00008490982,0.000081753504,0.000089481415,0.00007222949,0.000069197944,0.000016896864,0.000057949186,0.0000013198375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007233434,0.0026555033,0.96805114,0.000039490566,0.0013871122,0.0000070001465,0.0041787135,0.000019856621,0.014833796,0.00006642349,0.00021861447,0.0013089079],"study_design_scores_gemma":[0.018120427,0.0026569034,0.71579695,0.00018573453,0.0002525083,0.000047757756,0.00021602446,0.00042961258,0.26205185,0.00006118633,0.00004829559,0.00013272854],"about_ca_topic_score_codex":0.0005457701,"about_ca_topic_score_gemma":0.00006639796,"teacher_disagreement_score":0.25225416,"about_ca_system_score_codex":0.000033330263,"about_ca_system_score_gemma":0.00004311004,"threshold_uncertainty_score":0.3462522},"labels":[],"label_agreement":null},{"id":"W2531882130","doi":"10.1182/blood.v116.21.955.955","title":"The Function of Thymic Innate TCRαß+ CD8+ T Cells Is Regulated by Constitutive Expression of B7-H1","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Biology; CD8; Cytotoxic T cell; Natural killer T cell; Immunology; Interleukin 21; Innate immune system; T cell; Molecular biology; CD28; Cell biology; Antigen; Immune system; In vitro; Biochemistry","score_opus":0.004504559003238726,"score_gpt":0.19734446005325726,"score_spread":0.19283990105001853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531882130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885733,0.0009444675,0.000109852816,0.00007747994,0.004527185,0.00017956248,0.000019436331,0.000033595774,0.005535087],"genre_scores_gemma":[0.9896221,0.0001201635,0.000013500385,0.000067924586,0.000016895472,0.0000072748417,0.00005864187,0.000008241125,0.010085231],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99923944,0.00009670602,0.00031673972,0.00015840132,0.000036074955,0.00015263901],"domain_scores_gemma":[0.99916005,0.00010934754,0.0002853957,0.00028447976,0.00015060868,0.0000101247],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016569761,0.00011131819,0.0001634766,0.00005359921,0.00017223848,0.000006812848,0.00012679896,0.00023933114,0.0010956565],"category_scores_gemma":[0.00004454977,0.00007759001,0.0000827906,0.00008827283,0.00033174676,0.000088367044,0.000041922904,0.00034313096,0.00016869184],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002998805,0.00022302956,0.00016175353,0.000007885282,0.00012307441,1.4203741e-7,0.00016791109,4.78757e-7,0.9651851,0.00028553797,0.0327548,0.00079038885],"study_design_scores_gemma":[0.0012282663,0.00017696981,0.0004811153,0.00002644864,0.00007409284,0.000009929064,0.00015905467,0.0000019219192,0.88528043,0.000053947733,0.11243833,0.00006950616],"about_ca_topic_score_codex":0.00006189471,"about_ca_topic_score_gemma":0.000006095713,"teacher_disagreement_score":0.07990469,"about_ca_system_score_codex":0.0000053679737,"about_ca_system_score_gemma":0.000031256357,"threshold_uncertainty_score":0.9998175},"labels":[],"label_agreement":null},{"id":"W2531891923","doi":"10.1182/blood.v116.21.632.632","title":"Recurrent DNA Mutations In Non-Hodgkin Lymphomas Reveal Candidate Therapeutic Targets","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; Lymphoma; Germinal center; KRAS; Cancer research; Diffuse large B-cell lymphoma; Transcriptome; Computational biology; B cell; Gene; Genetics; Mutation; Immunology; Antibody; Gene expression","score_opus":0.005668140396024339,"score_gpt":0.2418828528533036,"score_spread":0.23621471245727926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531891923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969581,0.00084016594,0.00007680016,0.00013068796,0.00041420152,0.00015916972,0.000063535575,0.000005922688,0.0013514257],"genre_scores_gemma":[0.9983898,0.00022323814,0.00050812174,0.00023578895,0.00027090087,0.00004209257,0.00019692768,0.00001849226,0.00011464171],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993162,0.000015331963,0.00015857628,0.00023927406,0.000063156054,0.00020746492],"domain_scores_gemma":[0.99956286,0.00001591175,0.000048604656,0.00026649507,0.000036869656,0.00006925539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009615406,0.00011036655,0.00009699943,0.000039883507,0.0000467226,0.000022425624,0.00013204732,0.00010561844,0.00002981606],"category_scores_gemma":[0.00005194761,0.000112514135,0.000049067992,0.00007037376,0.000041074127,0.0000018776049,0.000054832464,0.00009726361,0.000014010928],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038573882,0.0004188144,0.014719079,0.000012042901,0.0000483645,0.000014304376,0.00016438017,0.000019378145,0.97535115,0.00024189265,0.0010021073,0.007969926],"study_design_scores_gemma":[0.005297791,0.0005102124,0.09884436,0.000023951809,0.00010708853,0.000056824352,0.00007790268,0.000110751665,0.810151,0.0014362992,0.08277628,0.000607547],"about_ca_topic_score_codex":0.00009423569,"about_ca_topic_score_gemma":0.0018472295,"teacher_disagreement_score":0.16520014,"about_ca_system_score_codex":0.000008879269,"about_ca_system_score_gemma":0.00012845724,"threshold_uncertainty_score":0.45881933},"labels":[],"label_agreement":null},{"id":"W2531903080","doi":"10.1182/blood.v110.11.4984.4984","title":"Chronic Graft-Versus-Host Disease after Tacrolimus Versus Cyclosporine for Graft-Versus-Host Disease Prophylaxis in Pediatric Patients Undergoing Matched Unrelated Donor Hematopoietic Stem Cell Transplantation. A Pediatric Blood and Marrow Transplant Consortium Study..","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Tacrolimus; Medicine; Graft-versus-host disease; Calcineurin; Methotrexate; Transplantation; Hematopoietic stem cell transplantation; Internal medicine; Gastroenterology; Surgery; Ciclosporin; Incidence (geometry); Immunology","score_opus":0.010778740354125384,"score_gpt":0.2389205482905157,"score_spread":0.22814180793639033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531903080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878923,0.003464843,0.00027555818,0.000100912206,0.0010040285,0.006222865,0.0006995783,0.0002461319,0.00009372621],"genre_scores_gemma":[0.99540174,0.0022561501,0.00023409624,0.000028497301,0.00049159426,0.00070173445,0.0005974212,0.00020434977,0.00008438879],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942316,0.0001915599,0.0016524956,0.0014642588,0.0011038721,0.0013562498],"domain_scores_gemma":[0.995786,0.0014985601,0.0004342687,0.000720749,0.00025080127,0.0013095981],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006234514,0.00096150214,0.0010207458,0.0008646002,0.00024508874,0.00008885889,0.00027778823,0.00034111642,0.00006507145],"category_scores_gemma":[0.000067445864,0.00095643976,0.00035427138,0.0012093172,0.0001269838,0.00034718902,0.000041300915,0.00056594843,0.00003631081],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06003997,0.0065013175,0.91291356,0.012309848,0.00043807976,0.0035976414,0.0037172334,0.000028052244,0.0003498581,0.000026105763,0.0000054187044,0.00007294007],"study_design_scores_gemma":[0.1760686,0.005549554,0.7978396,0.00040306116,0.016826138,0.000032857686,0.0008124097,0.000039459206,0.0012482831,0.000012159072,0.000008810502,0.001159061],"about_ca_topic_score_codex":0.000046769615,"about_ca_topic_score_gemma":0.00058208464,"teacher_disagreement_score":0.11602864,"about_ca_system_score_codex":0.00023517305,"about_ca_system_score_gemma":0.00073592,"threshold_uncertainty_score":0.9992886},"labels":[],"label_agreement":null},{"id":"W2532116000","doi":"10.1182/blood.v104.11.4345.4345","title":"A New Polycythemia Syndrome: Congenital Polycythemia with High Erythropoietin and Propensity for Malignant Hypertension Due to Paraganglioma.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of British Columbia","funders":"","keywords":"SDHB; SDHD; Erythropoietin; Germline mutation; Internal medicine; Medicine; Endocrinology; Pheochromocytoma; Polycythemia vera; Cancer research; Biology; Mutation; Gene; Genetics","score_opus":0.014472883178507022,"score_gpt":0.226411136550702,"score_spread":0.21193825337219496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2532116000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907582,0.00038399204,0.000342255,0.006186108,0.000062793595,0.0020403005,0.000042966796,0.00007642184,0.000106981264],"genre_scores_gemma":[0.97814685,0.000016959308,0.02036969,0.0007070546,0.00012257136,0.00019667104,0.000039842085,0.000053402142,0.00034696513],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985279,0.000018818273,0.00023645065,0.00055067637,0.00026652717,0.00039966192],"domain_scores_gemma":[0.9989417,0.00006864255,0.0000704472,0.0003192021,0.00012506577,0.00047489555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000088884735,0.0003216983,0.00062147074,0.00009963554,0.0001754479,0.00004299229,0.000058141344,0.00010718746,0.000040215404],"category_scores_gemma":[0.000059696016,0.00021062823,0.0000744025,0.00019354367,0.00006906833,0.00006338541,0.000055563953,0.00011840357,0.000037820642],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03248902,0.031225627,0.31726897,0.0018025433,0.013426032,0.18912911,0.007952429,0.000066432855,0.3460601,0.016525615,0.017071562,0.026982557],"study_design_scores_gemma":[0.03858425,0.010390821,0.19180176,0.0007771225,0.001839261,0.061031744,0.000185071,0.0000030068516,0.6937067,0.00046355516,0.0005676381,0.000649077],"about_ca_topic_score_codex":0.00047178648,"about_ca_topic_score_gemma":0.00016631147,"teacher_disagreement_score":0.3476466,"about_ca_system_score_codex":0.0000609182,"about_ca_system_score_gemma":0.00026767323,"threshold_uncertainty_score":0.858917},"labels":[],"label_agreement":null},{"id":"W2532164784","doi":"10.1182/blood.v106.11.3989.3989","title":"Treatment of Thrombotic Thrombocytopenic Purpura Using Solvent Detergent Treated Plasma.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Hôpital de l'Enfant-Jésus; London Health Sciences Centre; Vancouver General Hospital; St. Joseph's Hospital; Victoria Hospital; Princess Margaret Cancer Centre; Ottawa Hospital","funders":"","keywords":"Thrombotic thrombocytopenic purpura; Medicine; Internal medicine; Gastroenterology; Clinical endpoint; Statistical significance; Randomized controlled trial; Platelet; Surgery","score_opus":0.042450202514799626,"score_gpt":0.28304208566989253,"score_spread":0.2405918831550929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2532164784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954996,0.0032342998,0.000017564276,0.000043872184,0.00021777886,0.00053445157,0.00007065486,0.00006806427,0.00031369078],"genre_scores_gemma":[0.9992277,0.00008067411,0.00022460264,0.0000092634045,0.00004755373,0.000037442558,0.00007658277,0.000020632346,0.0002755346],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987477,0.000120299344,0.00045655086,0.00028511186,0.000047962723,0.00034234382],"domain_scores_gemma":[0.9992775,0.00006113315,0.00018009871,0.00040761082,0.000042256677,0.000031410684],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00004312029,0.00022342513,0.0004532907,0.00008955498,0.000109764725,0.000008798308,0.00016969763,0.000092988565,0.0017562979],"category_scores_gemma":[0.000010030624,0.0001839389,0.00019577135,0.00009672294,0.00008553495,0.00006325572,0.00005546328,0.000038919236,0.000323398],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008834989,0.004492039,0.053120088,0.00003789191,0.0013995431,0.000012883656,0.0005138385,0.00012409718,0.9379153,0.00014015083,0.0001261578,0.0020296206],"study_design_scores_gemma":[0.009439203,0.0010943505,0.023045795,0.00007968943,0.001165738,0.00019272584,0.00017940161,0.00008677622,0.9580466,0.000017493696,0.0063402625,0.00031194757],"about_ca_topic_score_codex":0.00015158743,"about_ca_topic_score_gemma":0.00008285626,"teacher_disagreement_score":0.030074293,"about_ca_system_score_codex":0.00011971555,"about_ca_system_score_gemma":0.00006428083,"threshold_uncertainty_score":0.99915624},"labels":[],"label_agreement":null},{"id":"W2532235959","doi":"10.1182/blood.v124.21.1328.1328","title":"Preliminary International Validation of the Quality of Life in Myelodysplasia Scale (QUALMS)","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario; Princess Margaret Cancer Centre","funders":"","keywords":"Quality of life (healthcare); International Prognostic Scoring System; Medicine; Psychosocial; Scale (ratio); Transplantation; Gerontology; Myelodysplastic syndromes; Internal medicine; Psychiatry; Bone marrow","score_opus":0.02493340395833677,"score_gpt":0.317302365270445,"score_spread":0.2923689613121082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2532235959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917174,0.00002735834,0.0000816033,0.0013461779,0.00006980353,0.00022287971,0.000008717884,0.000008417746,0.006517657],"genre_scores_gemma":[0.99897647,0.000010798318,0.0005081345,0.0000909335,0.00008533113,0.000010665203,0.000015199273,0.000008691841,0.00029380253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987118,0.00018515968,0.00039924748,0.00012978184,0.0004663356,0.00010765671],"domain_scores_gemma":[0.999129,0.0002032026,0.00015709117,0.00032032377,0.00014313559,0.000047247177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008819234,0.00006139504,0.00020700977,0.00009411577,0.0000136715325,0.0000030499348,0.00021407026,0.00006817215,0.00007531037],"category_scores_gemma":[0.0013104638,0.00004440283,0.00006538943,0.00018738788,0.00009612757,0.000046217123,0.00011713675,0.00016392607,0.000008731025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004643557,0.0008846537,0.90940845,0.00024017441,0.00007693219,0.0000011083206,0.0006817607,0.0000315719,0.08567705,0.0007278954,0.00042606393,0.0013799617],"study_design_scores_gemma":[0.003507106,0.00016194342,0.82718176,0.000100344754,0.000029365923,0.000006307629,0.000113520655,0.0003453059,0.16817586,0.00014405682,0.0001916069,0.00004280378],"about_ca_topic_score_codex":0.00018986838,"about_ca_topic_score_gemma":0.00001872112,"teacher_disagreement_score":0.082498804,"about_ca_system_score_codex":0.00004007007,"about_ca_system_score_gemma":0.00017597318,"threshold_uncertainty_score":0.18106948},"labels":[],"label_agreement":null},{"id":"W2532453942","doi":"10.1182/blood.v126.23.3570.3570","title":"Anti-RhD Mediates Loss of RhD Antigen Following Anti-RhD Infusion","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Antigen; Antibody; Immunology; Autoantibody; Complement system; Isoantibodies; Autoimmune hemolytic anemia; Red blood cell; Hemolysis; Medicine","score_opus":0.01979829601684165,"score_gpt":0.25867050455029045,"score_spread":0.2388722085334488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2532453942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99359155,0.002328229,0.0000661145,0.00057133014,0.0005119843,0.00039684447,0.000015665546,0.00011394531,0.0024043524],"genre_scores_gemma":[0.9977817,0.00056942436,0.00092976855,0.0001660075,0.00032809668,0.000006487934,0.00006232227,0.00004760492,0.00010861793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980435,0.000051176557,0.00048276165,0.0003721151,0.0006502649,0.00040020357],"domain_scores_gemma":[0.9988617,0.00005986918,0.00012560151,0.00046204115,0.00016946328,0.00032134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004696291,0.00025254468,0.00068987196,0.00018264081,0.00008284039,0.00001854075,0.0001703781,0.00022043109,0.000059807833],"category_scores_gemma":[0.00013856408,0.00020621262,0.00025458273,0.00040494037,0.00008359239,0.00016076231,0.00008944268,0.0002362088,0.000057370402],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006901017,0.0016539219,0.8552651,0.000182643,0.00032387103,0.00045378678,0.0013331646,0.0000037088976,0.13870032,0.000098809796,0.00043104595,0.0014846395],"study_design_scores_gemma":[0.02305605,0.001372191,0.5843232,0.0009600742,0.0015833367,0.0002606686,0.00064489583,0.000086502485,0.38180295,0.00034706751,0.0049768677,0.0005861817],"about_ca_topic_score_codex":0.000295555,"about_ca_topic_score_gemma":0.000025780872,"teacher_disagreement_score":0.27094185,"about_ca_system_score_codex":0.0000137047,"about_ca_system_score_gemma":0.0001638279,"threshold_uncertainty_score":0.8409106},"labels":[],"label_agreement":null},{"id":"W2532528872","doi":"10.1182/blood.v118.21.2791.2791","title":"Initial Transfusion Rate Predicts Survival in MDS","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Hematological disorders and diagnostics","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Blood transfusion; Myelodysplastic syndromes; Disease; International Prognostic Scoring System; Bone marrow","score_opus":0.05105698657781725,"score_gpt":0.2760764086170799,"score_spread":0.22501942203926262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2532528872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94291466,0.000112546244,0.0001308125,0.00014057902,0.00009595837,0.00018520748,0.0000050881235,0.000042950935,0.05637219],"genre_scores_gemma":[0.99915427,0.00017708508,0.0002623644,0.00028545258,0.000046384117,0.000011552094,0.000010390245,0.000008256561,0.000044271907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99940544,0.000038315513,0.00016083967,0.00013227895,0.00009528835,0.00016783219],"domain_scores_gemma":[0.9996837,0.00007734681,0.000014860242,0.000105195235,0.000023039225,0.0000959073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012305568,0.000075106866,0.00018407713,0.000042571828,0.000017129965,0.0000030509373,0.000040424173,0.00009710678,0.00043472962],"category_scores_gemma":[0.0002981812,0.0000576753,0.000039656257,0.000107708685,0.00003548841,0.000025547339,0.000013361155,0.00011760668,0.000050483624],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007237406,0.007978578,0.9761588,0.00018359597,0.00005601246,0.0023629933,0.0019794125,5.8136425e-7,0.002263797,0.004881645,0.0004432895,0.0029675455],"study_design_scores_gemma":[0.011740763,0.0012789381,0.96658164,0.00016291156,0.00014788704,0.000052540363,0.000236127,0.00003968084,0.01651061,0.002524544,0.00054424535,0.00018011173],"about_ca_topic_score_codex":0.00009690472,"about_ca_topic_score_gemma":0.000078767494,"teacher_disagreement_score":0.056327917,"about_ca_system_score_codex":0.0000029850553,"about_ca_system_score_gemma":0.000035441786,"threshold_uncertainty_score":0.47599843},"labels":[],"label_agreement":null},{"id":"W2532960187","doi":"10.1182/blood.v120.21.153.153","title":"Mature Results From ECOG Study E1405 – A Phase II Study of VcR-CVAD with Maintenance Rituximab for Previously Untreated Mantle Cell Lymphoma","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Regimen; Rituximab; Bortezomib; Mantle cell lymphoma; Vincristine; Internal medicine; Surgery; Cyclophosphamide; Maintenance therapy; Chemotherapy regimen; Phases of clinical research; Gastroenterology; Urology; Chemotherapy; Multiple myeloma; Lymphoma","score_opus":0.015373236774151637,"score_gpt":0.2680676121240122,"score_spread":0.25269437534986056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2532960187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99273616,0.0011433627,0.0000040725863,0.000101345846,0.0000890442,0.0045511643,0.00057879504,0.00007614585,0.00071993493],"genre_scores_gemma":[0.99729776,0.000037236798,0.00074125885,0.00006875313,0.00017006598,0.00056323,0.0002262999,0.000055213688,0.0008401542],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980081,0.000069672256,0.000512391,0.00052755844,0.0003614199,0.000520875],"domain_scores_gemma":[0.9983425,0.00015650855,0.00029489968,0.00078940875,0.0001793366,0.00023732646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020274396,0.00035700685,0.00077265425,0.00008759363,0.00013642116,0.00001867064,0.00013978897,0.00009854616,0.000029755827],"category_scores_gemma":[0.00005739443,0.00023186124,0.000112476635,0.00021367961,0.000035992256,0.00010364027,0.00007473346,0.000061556726,0.000022427083],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013001511,0.697926,0.25904214,0.00013880152,0.0026366978,0.0005625321,0.01723332,0.0000013785627,0.00059720327,0.000011017711,0.0029749402,0.00587449],"study_design_scores_gemma":[0.6600658,0.050772596,0.2470604,0.00037331795,0.007211083,0.00008122406,0.007527873,0.00002077522,0.024786092,0.00001030642,0.0016603057,0.00043019638],"about_ca_topic_score_codex":0.0010685707,"about_ca_topic_score_gemma":0.00034364677,"teacher_disagreement_score":0.6471534,"about_ca_system_score_codex":0.00009256762,"about_ca_system_score_gemma":0.00010246153,"threshold_uncertainty_score":0.9455027},"labels":[],"label_agreement":null},{"id":"W2532994364","doi":"10.1182/blood.v110.11.737.737","title":"Clinical Relevance of a Pharmacogenetic Approach Using Multiple Candidate Gene Polymorphisms To Predict Response and Resistance to Imatinib Mesylate Therapy in Chronic Myeloid Leukemia.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Imatinib mesylate; Single-nucleotide polymorphism; Myeloid leukemia; Pharmacogenetics; Oncology; Medicine; Population; Internal medicine; Imatinib; Biology; Genotype; Immunology; Genetics; Gene","score_opus":0.03150146730821448,"score_gpt":0.32829309079163177,"score_spread":0.2967916234834173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2532994364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902364,0.0065667517,0.001045483,0.00011772185,0.00008301896,0.0017219537,0.00005541566,0.000049747843,0.00012351386],"genre_scores_gemma":[0.9546515,0.00094331533,0.043478932,0.00035894747,0.00018948765,0.000058037716,0.000015066487,0.00006798347,0.00023677251],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99691397,0.0002537995,0.0010148021,0.00074251654,0.00042644233,0.0006484659],"domain_scores_gemma":[0.9979948,0.0005715652,0.00021869977,0.0006596853,0.000088082576,0.000467164],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020753774,0.00032587245,0.0007366756,0.00031093505,0.00006307078,0.000011435848,0.00018915022,0.00016225863,0.000017728415],"category_scores_gemma":[0.00055832573,0.00030143984,0.00010417689,0.00063612295,0.00012514036,0.0000590021,0.00010976973,0.00028914993,0.0000068415407],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018500825,0.00079431094,0.13463895,0.00014255686,0.00032030453,0.00035804414,0.0010518975,0.00032776437,0.8285247,0.0000024560516,0.0000772566,0.01526092],"study_design_scores_gemma":[0.049410652,0.0021506562,0.44808555,0.00076434104,0.0003181535,0.00024004368,0.000060811162,0.0029423132,0.49376917,0.000012958918,0.0017189527,0.0005264182],"about_ca_topic_score_codex":0.00025872132,"about_ca_topic_score_gemma":0.00021199755,"teacher_disagreement_score":0.33475554,"about_ca_system_score_codex":0.0013442488,"about_ca_system_score_gemma":0.001418804,"threshold_uncertainty_score":0.9999438},"labels":[],"label_agreement":null},{"id":"W2533046947","doi":"10.1182/blood.v114.22.1827.1827","title":"Influence of Cytogenetics in Patients with Relapsed and Refractory Multiple Myeloma (MM) Treated with Carfilzomib (CFZ).","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Carfilzomib; Cytogenetics; Multiple myeloma; Lenalidomide; Bortezomib; Refractory (planetary science); Internal medicine; Proteasome inhibitor; Medicine; Oncology; Fluorescence in situ hybridization; Biology; Chromosome; Genetics","score_opus":0.009380696814739794,"score_gpt":0.2380721969716121,"score_spread":0.2286915001568723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2533046947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988436,0.00015414473,0.0000011443559,0.000027246413,0.0000020371856,0.00066388154,0.00002855782,0.000023745122,0.0002556153],"genre_scores_gemma":[0.99864674,0.000045736153,0.0011102617,0.000037491223,0.000008661936,0.000015602796,0.000055444416,0.000018401954,0.00006168434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988189,0.000038864706,0.00021456176,0.00027632725,0.00036252724,0.00028883188],"domain_scores_gemma":[0.99918884,0.000054858647,0.00008493322,0.00030652402,0.00017227452,0.00019259569],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000049831397,0.00017876037,0.00032114872,0.00015578754,0.00003355882,0.000007538859,0.0000588301,0.00007666974,0.000005785234],"category_scores_gemma":[0.00008938289,0.00011847769,0.00002044984,0.0002649318,0.000098994715,0.00007262109,0.000017249122,0.00014269286,0.0000028988431],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027820785,0.002014152,0.9880943,0.000038641534,0.00011949337,0.00016318665,0.00013062052,0.000027406053,0.0037643446,0.0000018479891,0.000003173988,0.0028607713],"study_design_scores_gemma":[0.034115862,0.005604411,0.9394202,0.00021360982,0.00011050258,0.000013173639,0.000018800272,0.000019942785,0.020345887,0.0000029922344,0.000019659545,0.00011491737],"about_ca_topic_score_codex":0.00017167063,"about_ca_topic_score_gemma":0.00010429215,"teacher_disagreement_score":0.048674043,"about_ca_system_score_codex":0.000035088535,"about_ca_system_score_gemma":0.00008276364,"threshold_uncertainty_score":0.48313802},"labels":[],"label_agreement":null},{"id":"W2533157543","doi":"10.1182/blood.v114.22.132.132","title":"Lenalidomide, Bortezomib, Pegylated Liposomal Doxorubicin, and Dexamethasone in Newly Diagnosed Multiple Myeloma: Updated Results of Phase I/II MMRC Trial.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Lenalidomide; Medicine; Multiple myeloma; Dexamethasone; Regimen; Bortezomib; Internal medicine; Thalidomide; Melphalan; Transplantation; Phases of clinical research; Gastroenterology; Oncology; Urology; Chemotherapy","score_opus":0.02599818394216666,"score_gpt":0.3137119133069846,"score_spread":0.287713729364818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2533157543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950527,0.001038009,0.000008931704,0.0007491009,0.00005700414,0.0021140727,0.00017789048,0.000092436305,0.0007098626],"genre_scores_gemma":[0.99645376,0.0003125843,0.002087466,0.00011702306,0.00013083358,0.000053653966,0.0004967139,0.000033296186,0.00031464716],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99699664,0.00019573556,0.0009556442,0.00063547795,0.0005485104,0.000668019],"domain_scores_gemma":[0.99808896,0.00041243,0.00025076367,0.00057998154,0.00020124775,0.00046660047],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005427669,0.00035848902,0.0009209673,0.00045715942,0.00010613471,0.000025986752,0.0001494143,0.00023357067,0.00005585225],"category_scores_gemma":[0.0019116454,0.00029896174,0.00014469726,0.0007020565,0.00012914531,0.00016338498,0.00007568779,0.00035972934,0.000012567352],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4801135,0.06322706,0.032965872,0.00013748978,0.0011911689,0.0059087244,0.0014940684,0.000008760192,0.29304537,0.000034632034,0.0016006915,0.120272644],"study_design_scores_gemma":[0.7500491,0.011820707,0.09688521,0.00020753275,0.00032269457,0.00008954415,0.00009224394,0.0005616477,0.13920984,0.00003949786,0.000464891,0.00025708246],"about_ca_topic_score_codex":0.00082924304,"about_ca_topic_score_gemma":0.00024255016,"teacher_disagreement_score":0.26993558,"about_ca_system_score_codex":0.000054460943,"about_ca_system_score_gemma":0.00020658594,"threshold_uncertainty_score":0.99994624},"labels":[],"label_agreement":null},{"id":"W2533216488","doi":"10.1182/blood.v126.23.2719.2719","title":"A Randomized, Phase II Study with Biomarker Analysis of Panobinostat with or without Rituximab in Relapsed Diffuse Large B Cell Lymphoma","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; Queen Elizabeth II Health Sciences Centre; Hôpital du Sacré-Cœur de Montréal; Simon Fraser University; Princess Margaret Cancer Centre; McGill University","funders":"","keywords":"Panobinostat; Rituximab; Medicine; Internal medicine; Oncology; Diffuse large B-cell lymphoma; Confidence interval; Lymphoma; Chemoimmunotherapy; Biology; Histone deacetylase; Histone","score_opus":0.017234985909646665,"score_gpt":0.2973524630710236,"score_spread":0.2801174771613769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2533216488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99779594,0.0003472983,0.00016470325,0.000016268556,0.0000161518,0.0011467352,0.00007849197,0.00001419414,0.00042023096],"genre_scores_gemma":[0.998265,0.000017457407,0.0003687415,0.00002149977,0.000022009608,0.0001768141,0.00014413963,0.000043646396,0.00094064476],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.997615,0.00046542205,0.000440707,0.0005624211,0.00050596485,0.00041048817],"domain_scores_gemma":[0.9985987,0.00004759934,0.00019268884,0.0007064308,0.00025232366,0.00020227776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009232302,0.00027236776,0.0009199592,0.00041758447,0.00006643143,0.000019415,0.00024019968,0.00012475996,0.0000140397615],"category_scores_gemma":[0.00017350535,0.00017486881,0.0001397094,0.0010969709,0.00021087345,0.000006470018,0.00015444841,0.000089841305,0.000004074585],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6116577,0.22039565,0.035262637,0.000069804686,0.0058182306,0.0006226515,0.0039932607,0.000029814986,0.121500805,0.000003200563,0.000365829,0.00028041805],"study_design_scores_gemma":[0.86125547,0.0064120875,0.00017763188,0.000022163176,0.0016274013,0.000018396351,0.0011433845,0.00043210795,0.12833181,5.2265506e-7,0.0002956663,0.00028334852],"about_ca_topic_score_codex":0.00031689645,"about_ca_topic_score_gemma":0.0026582903,"teacher_disagreement_score":0.24959779,"about_ca_system_score_codex":0.000030839656,"about_ca_system_score_gemma":0.00040203932,"threshold_uncertainty_score":0.7130943},"labels":[],"label_agreement":null},{"id":"W2533230146","doi":"10.1182/blood.v112.11.2462.2462","title":"An RNA Interference Screen Reveals Fate Determinants Implicated in Asymmetric Cell Division as Potential Regulators of Hematopoietic Stem Cell Self-Renewal","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Genetics, Aging, and Longevity in Model Organisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Biology; Stem cell; Asymmetric cell division; Haematopoiesis; Cell biology; Cell fate determination; Cell division; Hematopoietic stem cell; Genetics; RNA interference; Cell; RNA; Transcription factor; Gene","score_opus":0.00848379325484711,"score_gpt":0.22481945955670332,"score_spread":0.21633566630185622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2533230146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99760497,0.0006553986,0.0010790469,0.000006834625,0.000076489654,0.0002583361,0.000020732257,0.000025177875,0.00027299995],"genre_scores_gemma":[0.9983629,0.00033694226,0.00093917904,0.000035891124,0.00005554791,0.000007968617,0.000040113402,0.00004302478,0.00017841993],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981834,0.00012958546,0.0005037707,0.00056516717,0.00022996443,0.00038808284],"domain_scores_gemma":[0.9987763,0.000010123984,0.00024285466,0.0006967999,0.00011017395,0.00016375491],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019614186,0.0002644726,0.00033567476,0.00017372819,0.0000798363,0.000019150362,0.00050431094,0.00026243346,0.0000084561],"category_scores_gemma":[0.000010309205,0.00026651676,0.00010864339,0.0002524507,0.00008064168,0.0000089730975,0.0002042279,0.00012449853,0.0000138869955],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003046246,0.0009088819,0.04109004,0.00007385656,0.000020956773,0.000031399006,0.0005356436,0.000078692414,0.95655316,0.000002015568,0.000030195073,0.0006446832],"study_design_scores_gemma":[0.0014345074,0.00087219715,0.02650053,0.000026817317,0.00005946585,0.0000672064,0.00008005996,0.0001293445,0.97044986,0.000065940614,0.000014405306,0.00029967906],"about_ca_topic_score_codex":0.00014919437,"about_ca_topic_score_gemma":0.00002384314,"teacher_disagreement_score":0.01458951,"about_ca_system_score_codex":0.000012961548,"about_ca_system_score_gemma":0.000085078704,"threshold_uncertainty_score":0.9999787},"labels":[],"label_agreement":null},{"id":"W2533290801","doi":"10.1182/blood.v110.11.971.971","title":"Fibrinolytic Agents for Restoration of Central Venous Catheter Patency: A Systematic Review.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Central Venous Catheters and Hemodialysis","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Medicine; Reteplase; Urokinase; Catheter; Hemodialysis; Surgery; Fibrinolytic agent; Thrombolysis; Adverse effect; Randomized controlled trial; Hemodialysis Catheter; Thrombolytic drug; Internal medicine; Tissue plasminogen activator","score_opus":0.047925742435573404,"score_gpt":0.3560451585615528,"score_spread":0.3081194161259794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2533290801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808073,0.008138433,0.0021720387,0.00022400016,0.00052815705,0.006926207,0.00009343812,0.00007853896,0.001031906],"genre_scores_gemma":[0.9973827,0.00074173097,0.00038390042,0.0005367758,0.00017173804,0.0001689546,0.00005644632,0.000027696537,0.0005300487],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99808323,0.00012769604,0.0008610895,0.00018115954,0.00020141814,0.000545381],"domain_scores_gemma":[0.9987153,0.00021982915,0.0004513098,0.0003520883,0.00014932155,0.00011214056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008516232,0.000119084885,0.0005792893,0.00006890795,0.00021226903,0.0000033486524,0.00013362753,0.00010770517,0.000043689637],"category_scores_gemma":[0.00023243211,0.00010011472,0.00022705173,0.00013129183,0.000017848024,0.000048567763,0.000026567914,0.00012025344,0.000043712385],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001586181,0.004171691,0.021702703,0.94723594,0.0006701811,0.000026233818,0.018238256,0.0000038956923,0.0032339916,0.0013263683,0.002785263,0.0004468549],"study_design_scores_gemma":[0.029771298,0.008708044,0.17691778,0.7105266,0.036215544,0.00009380013,0.0062622805,0.0007561401,0.016716218,0.0035883603,0.006758467,0.0036855093],"about_ca_topic_score_codex":0.0000856606,"about_ca_topic_score_gemma":0.00007698764,"teacher_disagreement_score":0.23670937,"about_ca_system_score_codex":0.00009236432,"about_ca_system_score_gemma":0.00010990552,"threshold_uncertainty_score":0.40825596},"labels":[],"label_agreement":null},{"id":"W2533355107","doi":"10.1182/blood.v122.21.3231.3231","title":"Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Induction Therapy For Newly Diagnosed Light Chain Amyloidosis","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bortezomib; Maintenance therapy; Regimen; AL amyloidosis; Autologous stem-cell transplantation; Multiple myeloma; Population; Melphalan; Cyclophosphamide; Internal medicine; Surgery; Transplantation; Dexamethasone; Oncology; Gastroenterology; Chemotherapy; Immunology","score_opus":0.009422756389824026,"score_gpt":0.2389838296463305,"score_spread":0.22956107325650646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2533355107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98892266,0.007397306,0.00026979155,0.0016366333,0.00018807378,0.0013308286,0.00003333299,0.000051497434,0.00016988369],"genre_scores_gemma":[0.98479795,0.008040875,0.0035274401,0.00096301356,0.0003392333,0.001690828,0.000129523,0.00007335927,0.00043774737],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984647,0.0000637577,0.00029472876,0.00062366994,0.00013389703,0.00041925083],"domain_scores_gemma":[0.99900377,0.000088076624,0.00015907147,0.0004623487,0.00011549238,0.00017121487],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014263892,0.0003360314,0.0003109404,0.000072169045,0.00015313725,0.00007615487,0.00017836518,0.00028853337,0.000055035678],"category_scores_gemma":[0.00016848046,0.0002956803,0.00015697963,0.00012984051,0.00007662242,0.00001859291,0.00007696836,0.0000852298,0.000020584728],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013981198,0.0016251168,0.27488318,0.0000377158,0.0009044746,0.0000063855964,0.0002182758,0.000005241902,0.63636696,0.00009560349,0.0084950235,0.0772222],"study_design_scores_gemma":[0.008425454,0.001021608,0.21450105,0.000020504041,0.00015333078,0.000015579573,0.0001553237,0.000008936464,0.75441414,0.00020341072,0.020590756,0.0004899176],"about_ca_topic_score_codex":0.00023925077,"about_ca_topic_score_gemma":0.000044876026,"teacher_disagreement_score":0.118047155,"about_ca_system_score_codex":0.000017301314,"about_ca_system_score_gemma":0.00004829891,"threshold_uncertainty_score":0.9999495},"labels":[],"label_agreement":null},{"id":"W2533487833","doi":"10.1182/blood.v116.21.566.566","title":"Economic Burden and Cost Determinants of Deep Venous Thrombosis During the Two Years Following Diagnosis: a Prospective Evaluation","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Centre Hospitalier de l’Université de Montréal; McGill University Health Centre; Hôpital Maisonneuve-Rosemont; Université Laval; Université de Montréal; Jewish General Hospital","funders":"","keywords":"Medicine; Venous thrombosis; Population; Emergency medicine; Health care; Deep vein; Pulmonary embolism; Cohort; Thrombosis; Physical therapy; Intensive care medicine; Surgery; Environmental health; Internal medicine","score_opus":0.012030246121372714,"score_gpt":0.29284871659227685,"score_spread":0.28081847047090414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2533487833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99726194,0.00032233712,0.0000011222951,0.00012152947,0.00023185743,0.0014417982,0.0000046934974,0.000021765076,0.00059293717],"genre_scores_gemma":[0.9988934,0.0001610376,0.00013294422,0.000033077544,0.00023777352,0.00050756504,0.0000022366648,0.000022067088,0.000009899139],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991272,0.000030385783,0.00021617375,0.00023878131,0.00019757722,0.00018987125],"domain_scores_gemma":[0.99943197,0.0000630423,0.00011286279,0.00029661978,0.000037447186,0.000058033977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039642007,0.00011379052,0.0003368225,0.000063944826,0.00010592947,0.000027486652,0.000091567585,0.000046300127,0.00008115615],"category_scores_gemma":[0.000084465515,0.00009130665,0.000087994435,0.000058528436,0.000059969625,0.00007683686,0.00008136041,0.00012458675,0.000014122657],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018266204,0.00086541945,0.9580894,0.00009504225,0.00059480953,0.000027464039,0.003947691,0.000032646767,0.007762635,0.00012056679,0.000023818395,0.02842225],"study_design_scores_gemma":[0.0034727561,0.00019746416,0.9839909,0.000095929645,0.0013248512,0.000017899752,0.00036759308,0.00030010132,0.0098987715,0.00014061538,0.000090815796,0.00010227417],"about_ca_topic_score_codex":0.00039554373,"about_ca_topic_score_gemma":0.0009758331,"teacher_disagreement_score":0.028319975,"about_ca_system_score_codex":0.000041864023,"about_ca_system_score_gemma":0.00004445277,"threshold_uncertainty_score":0.3723377},"labels":[],"label_agreement":null},{"id":"W2533610250","doi":"10.1182/blood.v118.21.780.780","title":"Diffuse Large B-Cell Lymphoma with Testicular Involvement: Outcome and Risk of CNS Relapse in the Rituximab Era","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Rituximab; Diffuse large B-cell lymphoma; Lymphoma; Internal medicine; Follicular lymphoma; Bone marrow; Oncology; CHOP; Chemotherapy regimen; Chemotherapy; Pathology","score_opus":0.017378654355922524,"score_gpt":0.22111848289391617,"score_spread":0.20373982853799363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2533610250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996828,0.0013346819,0.000007349517,0.00007947762,0.000014858615,0.00045520364,0.000034457968,0.000017040184,0.0012289293],"genre_scores_gemma":[0.99823004,0.00043405994,0.0009572211,0.00022158344,0.000016306556,0.00007466284,0.000012067547,0.000018287723,0.000035757632],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999056,0.000055257067,0.00025049612,0.00021699403,0.00021057393,0.00021071783],"domain_scores_gemma":[0.99929076,0.00009983029,0.00010842258,0.00039139818,0.000034569024,0.00007498765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020487214,0.00015896276,0.00030905145,0.00007484236,0.00004973345,0.00000903513,0.00007687046,0.000053210075,0.00002110941],"category_scores_gemma":[0.000047271355,0.00008761193,0.0000613427,0.00015048774,0.0000646317,0.000037923386,0.00004015088,0.000070460585,0.000011567084],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000081550046,0.04590091,0.95077217,0.000068423135,0.00015536802,0.0004163535,0.001733477,3.4923684e-8,0.00004620114,0.00028224345,0.00003115608,0.0005120979],"study_design_scores_gemma":[0.06654201,0.0009072318,0.9273801,0.00009081342,0.0012048472,0.00010875604,0.0004337305,0.000009893738,0.0029720138,0.00005704699,0.00019357516,0.000099971665],"about_ca_topic_score_codex":0.00050574576,"about_ca_topic_score_gemma":0.00026591713,"teacher_disagreement_score":0.06646045,"about_ca_system_score_codex":0.000021833555,"about_ca_system_score_gemma":0.00003861204,"threshold_uncertainty_score":0.35727108},"labels":[],"label_agreement":null},{"id":"W2533615934","doi":"10.1182/blood.v118.21.435.435","title":"Recurrent Oncogenic Mutations in CCND3 in Aggressive Lymphomas","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; Cancer research; Cyclin-dependent kinase 6; Diffuse large B-cell lymphoma; Cyclin-dependent kinase; Molecular biology; Cell cycle; Lymphoma; Gene; Genetics","score_opus":0.03349978620515748,"score_gpt":0.27113155496616315,"score_spread":0.23763176876100567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2533615934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98439336,0.0021810466,4.9464916e-7,0.00011593111,0.000080119105,0.0003094203,0.0000075176235,0.00002123544,0.012890867],"genre_scores_gemma":[0.9988808,0.00025361415,0.00046721,0.00009010824,0.000032033375,0.00017064078,0.00002576666,0.000010735288,0.00006910644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992551,0.000028040597,0.00021654803,0.00019656196,0.00011369213,0.00019001275],"domain_scores_gemma":[0.99960226,0.00003774534,0.000073947056,0.00017975885,0.000025286796,0.00008098723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000055667606,0.0001043407,0.00019312996,0.00015241075,0.00001768276,0.000004458151,0.000045021978,0.000055564684,0.00016888419],"category_scores_gemma":[0.00006517935,0.000086250875,0.00006206447,0.00021284608,0.000026464608,0.000038246446,0.0000215539,0.00005014317,0.000117939184],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008544956,0.010058954,0.95988667,0.000025150566,0.00009725514,0.0025857869,0.0027957403,4.902927e-7,0.00014274064,0.0006934738,0.00009908733,0.023529194],"study_design_scores_gemma":[0.013643239,0.00039623337,0.9702068,0.00029972746,0.00016299346,0.00016132758,0.00020169369,0.00000975268,0.014060324,0.00049504417,0.00025740117,0.00010543935],"about_ca_topic_score_codex":0.00042222784,"about_ca_topic_score_gemma":0.0004188168,"teacher_disagreement_score":0.023423756,"about_ca_system_score_codex":0.00013272479,"about_ca_system_score_gemma":0.00014007115,"threshold_uncertainty_score":0.35172087},"labels":[],"label_agreement":null},{"id":"W2533640475","doi":"10.1182/blood.v116.21.3146.3146","title":"The Eukaryotic Translation Initiation Factor eIF4E, a Recently Identified Therapeutic Target In AML, Is a Direct Transcriptional Target of NFkB","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"EIF4E; Cancer research; Chromatin immunoprecipitation; Biology; Eukaryotic translation; Myeloid leukemia; Translation (biology); Promoter; Gene expression; Messenger RNA; Gene; Genetics","score_opus":0.018950334448774434,"score_gpt":0.2605914280360613,"score_spread":0.24164109358728686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2533640475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949832,0.0024260993,0.00076820934,0.0002942977,0.00046367926,0.00028537848,0.00011231019,0.000013345439,0.0006534643],"genre_scores_gemma":[0.99854964,0.00020560354,0.0006461306,0.00014919347,0.0001637471,0.00004362867,0.00012673331,0.000023298511,0.00009202917],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99889725,0.00009307284,0.00031656068,0.00027115693,0.00021495714,0.00020700914],"domain_scores_gemma":[0.9994418,0.000047216632,0.00011619993,0.0002634407,0.00009237933,0.000038935654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026558273,0.0001411108,0.00013924294,0.00005177647,0.00007232564,0.00002789393,0.00020200347,0.00017477405,0.00011532307],"category_scores_gemma":[0.000047182137,0.00011943963,0.00010928341,0.0001387441,0.00008242498,0.000011604377,0.000010855631,0.00017113243,0.000004166539],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009846399,0.00017574958,0.018846678,0.000017493217,0.00008446784,7.3616457e-7,0.00029648156,0.00002459385,0.9793096,0.000049352966,0.000058675665,0.0010376907],"study_design_scores_gemma":[0.0015860301,0.00014179916,0.06868753,0.0000188435,0.00004534252,0.0000042004203,0.00002544738,0.00014468374,0.9214089,0.0007350362,0.007021702,0.00018049218],"about_ca_topic_score_codex":0.000020853862,"about_ca_topic_score_gemma":0.0002192667,"teacher_disagreement_score":0.05790072,"about_ca_system_score_codex":0.000008560045,"about_ca_system_score_gemma":0.00012271907,"threshold_uncertainty_score":0.48706067},"labels":[],"label_agreement":null},{"id":"W2533737381","doi":"10.1182/blood.v126.23.3863.3863","title":"Outcomes of Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) Vs. Classical Hodgkin Lymphoma (cHL) at Princess Margaret Cancer Centre","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Kingston General Hospital; Queen's University","funders":"","keywords":"Medicine; Internal medicine; Logistic regression; Proportional hazards model; Stage (stratigraphy); Oncology; Lymphoma; Cancer; Cancer registry; Classical Hodgkin lymphoma; Cohort; Hodgkin lymphoma; Biology","score_opus":0.020529453056335686,"score_gpt":0.2706861000937934,"score_spread":0.2501566470374577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2533737381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893781,0.003950545,0.00000876127,0.0026189259,0.0005658019,0.0010544946,0.00022516669,0.00015799521,0.0020402195],"genre_scores_gemma":[0.99380904,0.00076329184,0.0009901152,0.00067428185,0.00028732503,0.00024286879,0.00012222207,0.00010890684,0.003001967],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957926,0.00018166179,0.0009602983,0.0009446816,0.0012093884,0.0009113501],"domain_scores_gemma":[0.9969771,0.00021384869,0.00047874957,0.0011318366,0.00035125425,0.0008472055],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003366333,0.00068565144,0.0016155164,0.0001992818,0.00013185568,0.000045983394,0.00038444716,0.00035996852,0.00031275448],"category_scores_gemma":[0.00022093866,0.00050904095,0.00051131746,0.00037263494,0.00027828795,0.00014476312,0.000400509,0.00006511241,0.00021026272],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014181739,0.007943805,0.9554013,0.00021481265,0.0014658229,0.0011072635,0.0007083819,0.000010093741,0.0006296168,0.00040440727,0.0057486296,0.024947716],"study_design_scores_gemma":[0.0632474,0.0008486953,0.7804885,0.00045057767,0.0018934362,0.00037730523,0.00018780142,0.00017262003,0.10811487,0.000059886283,0.04355916,0.00059979485],"about_ca_topic_score_codex":0.0015408525,"about_ca_topic_score_gemma":0.00049251923,"teacher_disagreement_score":0.17491281,"about_ca_system_score_codex":0.0017674174,"about_ca_system_score_gemma":0.0013022717,"threshold_uncertainty_score":0.99973613},"labels":[],"label_agreement":null},{"id":"W2533984748","doi":"10.1182/blood.v120.21.1385.1385","title":"WT1 snp rs16754 Genotype Predicts Treatment Related Mortality (TRM) in African-American and Asian Pediatric AML Patients: A Report From the Children's Oncology Group","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Idarubicin; Internal medicine; Minor allele frequency; Regimen; Cytarabine; Medicine; Chemotherapy regimen; Oncology; SNP; Genotype; Context (archaeology); Gastroenterology; Allele frequency; Chemotherapy; Biology; Single-nucleotide polymorphism; Genetics","score_opus":0.017855258345023453,"score_gpt":0.29178696226287604,"score_spread":0.2739317039178526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2533984748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99313444,0.0009250914,0.0000029546773,0.0011442375,0.00011574612,0.001220191,0.000082650135,0.00007258679,0.003302082],"genre_scores_gemma":[0.99741745,0.00051793066,0.00044993256,0.00017533592,0.0007051046,0.00012990591,0.00046800612,0.000043223365,0.000093107476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975439,0.00029999338,0.0005466515,0.0004932143,0.00045321084,0.0006630288],"domain_scores_gemma":[0.998306,0.00023349994,0.00028168564,0.0007192493,0.00007060712,0.00038899953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050071906,0.0002662882,0.00054478267,0.00014744308,0.000107538435,0.000015598434,0.00015836452,0.0001828364,0.00007731602],"category_scores_gemma":[0.0003824395,0.00017712201,0.000087390676,0.0006427231,0.0002538933,0.000107976935,0.00014776732,0.0004782168,0.000034252353],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011749411,0.0029918745,0.986688,0.000007373587,0.0003746118,0.00029551412,0.0019568438,1.7992555e-7,0.000057906498,0.000010685721,0.00048581744,0.007013674],"study_design_scores_gemma":[0.0071078567,0.0014410029,0.9883065,0.000011058793,0.0008487577,0.0001939374,0.0002963093,0.000007449707,0.0000421596,0.000030369421,0.0015572342,0.00015733867],"about_ca_topic_score_codex":0.0067271627,"about_ca_topic_score_gemma":0.00033519458,"teacher_disagreement_score":0.0069903624,"about_ca_system_score_codex":0.00057158264,"about_ca_system_score_gemma":0.00037590865,"threshold_uncertainty_score":0.9998871},"labels":[],"label_agreement":null},{"id":"W2534077863","doi":"10.1182/blood.v126.23.4446.4446","title":"A Qualitative Research Study to Understand Post-Transfusion Well-Being in Patients with Myelodysplastic Syndromes","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Joseph’s Healthcare Hamilton; St. Joseph's Hospital; McMaster University","funders":"","keywords":"Medicine; Qualitative research; Coding (social sciences); Content analysis; Anemia; Family medicine; Summative assessment; Population; Pediatrics; Internal medicine; Psychology; Formative assessment","score_opus":0.06780434265700358,"score_gpt":0.39831451743745355,"score_spread":0.33051017478045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2534077863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925313,0.000020720754,0.0000604317,0.0007805188,0.000032148128,0.002618283,0.000006721589,0.000039704708,0.003910148],"genre_scores_gemma":[0.9987501,0.0000036681156,0.0005057657,0.000083055966,0.000036102363,0.00004904368,0.000020028114,0.00004743006,0.00050481386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996013,0.00075086975,0.00029399403,0.0005043757,0.0017938293,0.00064392015],"domain_scores_gemma":[0.9975765,0.00056502066,0.000027903603,0.00040283,0.0009226872,0.0005050714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023724132,0.00018532987,0.00037092765,0.0008023332,0.00010481743,0.000040726423,0.00019158419,0.000068630005,0.00004301786],"category_scores_gemma":[0.001056833,0.00013967151,0.000026514355,0.0013711371,0.00011812186,0.00012508527,0.00015197076,0.0006644734,0.00020003786],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073713223,0.009684218,0.62204784,0.00014747564,0.0003195612,0.001066533,0.35808328,0.000018932196,0.0003311326,0.00018449507,0.0005327074,0.00021251527],"study_design_scores_gemma":[0.051423125,0.035906147,0.52563274,0.0005949437,0.00016556351,0.000040063518,0.38490364,0.000026600366,0.0004909116,0.00036683597,0.00006567367,0.00038375353],"about_ca_topic_score_codex":0.0007418986,"about_ca_topic_score_gemma":0.00080429617,"teacher_disagreement_score":0.09641508,"about_ca_system_score_codex":0.0005843433,"about_ca_system_score_gemma":0.00070212595,"threshold_uncertainty_score":0.56956387},"labels":[],"label_agreement":null},{"id":"W2534304742","doi":"10.1182/blood.v120.21.2179.2179","title":"In Vitro and Ex Vivo Investigation of Aberrant and Alternative Splicing of Von Willebrand Factor.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; Queen's University","funders":"","keywords":"Von Willebrand disease; Von Willebrand factor; Intron; RNA splicing; Exon; Alternative splicing; Exon skipping; Molecular biology; Splicing factor; Biology; Genetics; splice; Platelet; Gene; RNA; Immunology","score_opus":0.015820664788502255,"score_gpt":0.25071239198594175,"score_spread":0.2348917271974395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2534304742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99858636,0.0008913364,0.0000031499694,0.00006191086,0.00001742151,0.00013585266,0.000011328115,0.000002443493,0.00029020017],"genre_scores_gemma":[0.99956477,0.00015499278,0.00020121605,0.000030007666,0.000013046362,0.0000019737597,0.0000040352647,0.000004763084,0.000025168963],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996578,0.000011006793,0.00011420175,0.000068202666,0.0000678187,0.00008096218],"domain_scores_gemma":[0.9998044,0.000027028185,0.000057460496,0.000048448295,0.000013105764,0.000049561073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004268122,0.000057110115,0.00018721596,0.00005648235,0.000007597446,0.0000013747235,0.0000095900505,0.000028488974,0.0000067037186],"category_scores_gemma":[0.000013320586,0.000045022436,0.000011439608,0.000043853815,0.000042370615,0.00008313214,0.000010339803,0.000032536682,2.8099427e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006675858,0.00018695244,0.5250085,0.00008063687,0.00006812099,0.0000093394,0.002747912,1.13490444e-7,0.47133034,0.000017118133,0.000004090209,0.0004800847],"study_design_scores_gemma":[0.0043968935,0.00010419694,0.2726974,0.00008266335,0.000079570695,0.000030210422,0.00009634305,0.00002667806,0.72227806,0.00015965341,0.000010294307,0.00003802523],"about_ca_topic_score_codex":0.0002308941,"about_ca_topic_score_gemma":0.000009840957,"teacher_disagreement_score":0.25231114,"about_ca_system_score_codex":0.0000042710617,"about_ca_system_score_gemma":0.0000072406183,"threshold_uncertainty_score":0.18359616},"labels":[],"label_agreement":null},{"id":"W2534318471","doi":"10.1182/blood.v126.23.4276.4276","title":"Conditioned Medium Represents a Useful Solution to Increase the Expansion of Multipotent Progenitors with Strong Platelet Engraftment Activity","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Canadian Blood Services","funders":"","keywords":"CD34; Progenitor cell; Haematopoiesis; Cord blood; Transplantation; Bone marrow; Mesenchymal stem cell; Andrology; Stem cell; Platelet; Immunology; Chemistry; Cell biology; Medicine; Biology; Internal medicine","score_opus":0.03465922827913289,"score_gpt":0.2767993071958298,"score_spread":0.2421400789166969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2534318471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957842,0.00002325523,0.0017455833,0.0004652211,0.000070317634,0.0016165023,0.000024400028,0.00004542016,0.00022505606],"genre_scores_gemma":[0.99823105,0.0000046745554,0.001373535,0.00003476953,0.00007343704,0.00016817047,0.000056265173,0.000017469352,0.000040636776],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99864167,0.00010858936,0.00021900072,0.00023068338,0.00061157416,0.00018847524],"domain_scores_gemma":[0.9990559,0.000076622644,0.000109263565,0.0003372143,0.00018194332,0.00023903548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024056772,0.00013136958,0.000219409,0.000072511415,0.00005286916,0.000008204446,0.000067366695,0.00006316407,0.000012694559],"category_scores_gemma":[0.00009029635,0.00008327041,0.00004361526,0.0001561388,0.00005404249,0.00007108631,0.000024085708,0.00010139406,0.000016088954],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006973694,0.005974644,0.20435277,0.00074907986,0.001179375,0.00042239673,0.012021612,0.0003467616,0.7647568,0.00008182969,0.0008169624,0.0023240761],"study_design_scores_gemma":[0.008686757,0.0009238237,0.073837526,0.0002736616,0.0004243493,0.0002391138,0.0011429654,0.00018025858,0.91406745,0.00000773313,0.00009844976,0.0001179185],"about_ca_topic_score_codex":0.00039152682,"about_ca_topic_score_gemma":0.000045850895,"teacher_disagreement_score":0.14931065,"about_ca_system_score_codex":0.00005407385,"about_ca_system_score_gemma":0.00018897612,"threshold_uncertainty_score":0.33956686},"labels":[],"label_agreement":null},{"id":"W2534323972","doi":"10.1182/blood.v118.21.3332.3332","title":"Frequency and Predictors of Post-Thrombotic Syndrome in Patients with a First, Unprovoked Deep Vein Thrombosis and No Prior Primary Venous Insufficiency: Results From the REVERSE Cohort Study,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; St. Joseph’s Healthcare Hamilton; St. Joseph's Hospital; McGill University Health Centre; Hôpital du Sacré-Cœur de Montréal; Dalhousie University; Jewish General Hospital; University of Ottawa; St. Paul's Hospital; McMaster University; London Health Sciences Centre","funders":"","keywords":"Post-thrombotic syndrome; Medicine; Pulmonary embolism; Deep vein; Venous thrombosis; Thrombosis; Univariate analysis; Compression stockings; Logistic regression; Internal medicine; Cohort; Concomitant; Surgery; Prospective cohort study; Complication; Multivariate analysis","score_opus":0.010116746617066259,"score_gpt":0.19806971369857843,"score_spread":0.18795296708151216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2534323972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99527305,0.00022482986,0.0000013244127,0.00010667409,0.0000912626,0.0031096486,0.00008570053,0.00003630617,0.0010712129],"genre_scores_gemma":[0.9987236,0.00026879922,0.00061713974,0.0001851981,0.000021065536,0.00008557589,0.00005660632,0.0000331203,0.00000887087],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998088,0.000083534615,0.0005236247,0.00054993684,0.00045277202,0.00030213132],"domain_scores_gemma":[0.99874693,0.00014934393,0.0002327305,0.0006028851,0.00015007684,0.00011800376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037050064,0.00025518538,0.00074149406,0.00011415319,0.000115670424,0.000017190943,0.00017372593,0.000083224804,0.000025020026],"category_scores_gemma":[0.00019647102,0.00016991305,0.000038584443,0.00025788718,0.00022211876,0.00012918726,0.00016886054,0.00018076402,0.000005243979],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017924207,0.023016198,0.96627635,0.00013692449,0.0006148713,0.000043853328,0.009534439,6.112328e-7,0.00003124563,0.0000128189195,0.000072995,0.00008046357],"study_design_scores_gemma":[0.009425323,0.010278286,0.97767574,0.000394586,0.0013695721,0.000004859158,0.00061930926,0.0000026343453,0.000019759524,0.000017389846,0.000012872669,0.00017968037],"about_ca_topic_score_codex":0.004773583,"about_ca_topic_score_gemma":0.0010589653,"teacher_disagreement_score":0.012737912,"about_ca_system_score_codex":0.000047543916,"about_ca_system_score_gemma":0.00009653117,"threshold_uncertainty_score":0.7216261},"labels":[],"label_agreement":null},{"id":"W2534379449","doi":"10.1182/blood.v114.22.408.408","title":"R-CHOP with Etoposide Substituted for Doxorubicin (R-CEOP): Excellent Outcome in Diffuse Large B Cell Lymphoma for Patients with a Contraindication to Anthracyclines.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Etoposide; Internal medicine; Anthracycline; Vincristine; Rituximab; Doxorubicin; Contraindication; Population; Surgery; Gastroenterology; Chemotherapy; Oncology; Lymphoma; Cyclophosphamide; Cancer; Breast cancer; Pathology","score_opus":0.009399722993428778,"score_gpt":0.26131768316793624,"score_spread":0.25191796017450746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2534379449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926599,0.00013616287,0.0007941005,0.0013861057,0.000046781926,0.0046358826,0.00013589057,0.00005539298,0.00014972695],"genre_scores_gemma":[0.9929425,0.000020747748,0.004240757,0.001353864,0.000070995244,0.00090108364,0.0003370658,0.000034213037,0.00009873913],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99838877,0.000015999516,0.00040915905,0.00045297845,0.00026325,0.00046984138],"domain_scores_gemma":[0.9989613,0.00014242898,0.00015378624,0.00034989518,0.00016831736,0.0002242413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011597331,0.00028582106,0.0005092344,0.00017219622,0.00009192594,0.000025338964,0.00008557237,0.000095966345,0.000004461705],"category_scores_gemma":[0.00007006412,0.00018782726,0.00009538369,0.00021392787,0.000022629525,0.00007700908,0.000010533997,0.000037855152,0.000007725446],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033195473,0.078789525,0.91214615,0.00012080911,0.00014067584,0.00006125604,0.0005906804,0.000003691364,0.00050730037,0.0003178091,0.00019695685,0.0038056034],"study_design_scores_gemma":[0.20562246,0.0037936051,0.7750041,0.00018159661,0.000516075,0.0000075803678,0.000062121995,0.000036461868,0.012910604,0.000023995248,0.0015941694,0.00024724926],"about_ca_topic_score_codex":0.0000608737,"about_ca_topic_score_gemma":0.00017213584,"teacher_disagreement_score":0.20230292,"about_ca_system_score_codex":0.00015430046,"about_ca_system_score_gemma":0.00011465776,"threshold_uncertainty_score":0.7659373},"labels":[],"label_agreement":null},{"id":"W2534433913","doi":"10.1182/blood.v108.11.3829.3829","title":"Vertebral Abnormalities by Spine Morphometry in Thalassemia.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Bone mineral; Beta thalassemia; Thalassemia; Odds ratio; Bone remodeling; Internal medicine; Osteoporosis","score_opus":0.0035798251243795713,"score_gpt":0.2049236473640137,"score_spread":0.20134382223963412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2534433913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9620065,0.004762379,0.000011091826,0.00062760897,0.00008073695,0.00013069191,0.0000090777785,0.000062094965,0.0323098],"genre_scores_gemma":[0.99470305,0.00019366089,0.00016281568,0.00031149626,0.00008057173,0.000008146653,0.000077922086,0.000017725803,0.004444588],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991675,0.000014940792,0.00021611676,0.00015644319,0.0001647537,0.0002802698],"domain_scores_gemma":[0.99972594,0.000010512511,0.00003007735,0.00015241296,0.000019903355,0.000061148356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008034837,0.00011561695,0.0002034405,0.00011265815,0.000029743247,0.00001111809,0.000052275765,0.00014186115,0.0001577639],"category_scores_gemma":[0.000024079809,0.00009617006,0.000059402464,0.0002820453,0.000047464422,0.000052824587,0.00002069898,0.00020473338,0.00005204958],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057275694,0.0037005327,0.87787014,0.0002668491,0.00012289998,0.0007114852,0.00021784643,0.00001900582,0.041175734,0.0013049095,0.073050246,0.0015030772],"study_design_scores_gemma":[0.043252867,0.0011490455,0.74458736,0.00071201124,0.0005890228,0.0011395883,0.0021651648,0.0003705811,0.1211173,0.0010016002,0.08276555,0.0011499013],"about_ca_topic_score_codex":0.00061338756,"about_ca_topic_score_gemma":0.000028406801,"teacher_disagreement_score":0.13328277,"about_ca_system_score_codex":0.000020712327,"about_ca_system_score_gemma":0.00003959185,"threshold_uncertainty_score":0.39217013},"labels":[],"label_agreement":null},{"id":"W2534551952","doi":"10.1182/blood.v116.21.3649.3649","title":"High-Level IGF1R Expression Is Required for Leukemia Stem Cell Activity In T-ALL and Is Supported by Notch Signaling.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; BC Cancer Agency","funders":"","keywords":"Protein kinase B; Insulin-like growth factor 1 receptor; PI3K/AKT/mTOR pathway; Stem cell; Biology; Cancer research; Cell biology; Signal transduction; PTEN; Cell growth; Leukemia; Immunology; Growth factor; Receptor; Genetics","score_opus":0.032312498174196236,"score_gpt":0.2905680117524677,"score_spread":0.2582555135782715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2534551952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99687034,0.00006978331,0.0005451294,0.00087245886,0.00011572494,0.0009173382,0.00033177526,0.000059779886,0.00021766209],"genre_scores_gemma":[0.9922767,0.000030113182,0.0035197402,0.0005953664,0.00016887192,0.000103637125,0.00007034817,0.00006532991,0.0031698744],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978595,0.00004801426,0.00034769505,0.00062386395,0.00051386404,0.0006070785],"domain_scores_gemma":[0.99846274,0.0004013749,0.0001330732,0.0005207987,0.00014195505,0.00034006356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042704647,0.00027003797,0.00047182813,0.00015577592,0.00008021418,0.000039804807,0.00019467296,0.00041925436,0.00016576755],"category_scores_gemma":[0.000095425734,0.00023273559,0.00008133563,0.0001917146,0.00010905843,0.00016438821,0.00014522724,0.0005137371,0.00002084907],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005393129,0.0005039442,0.0016287646,0.00024855288,0.000047541515,0.00005462437,0.00068020844,1.882297e-7,0.96859676,0.0000029499308,0.025329731,0.0023674506],"study_design_scores_gemma":[0.01735853,0.0003797437,0.0017484985,0.00009978495,0.00013418791,0.00003781265,0.000089364745,0.00077531487,0.9757395,0.000050789964,0.0033480758,0.00023839761],"about_ca_topic_score_codex":0.0004023062,"about_ca_topic_score_gemma":0.000027013784,"teacher_disagreement_score":0.021981655,"about_ca_system_score_codex":0.00023212629,"about_ca_system_score_gemma":0.0007397515,"threshold_uncertainty_score":0.9490682},"labels":[],"label_agreement":null},{"id":"W2534669535","doi":"10.1182/blood.v120.21.2242.2242","title":"Correlation of ELISA Optic Density with Clinical Diagnosis of Heparin-Induced Thrombocytopenia: A Retrospective Study of 104 Patients with Positive Anti-PF4/Heparin Antibodies.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Heparin-induced thrombocytopenia; Medicine; Retrospective cohort study; Heparin; Internal medicine; Thrombosis; Complication; Antibody; Surgery; Gastroenterology; Immunology","score_opus":0.028214147503296365,"score_gpt":0.3026167475094673,"score_spread":0.27440260000617095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2534669535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99600375,0.000035518347,0.00003017975,0.000024500274,0.00016739729,0.0025176327,0.00004763313,0.00004085158,0.0011325446],"genre_scores_gemma":[0.998873,0.000032582433,0.0008116803,0.000023410577,0.000081115446,0.000048251895,0.000052426833,0.00006659546,0.000010918533],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99632406,0.00031078438,0.001266124,0.0006305383,0.0009313171,0.0005371557],"domain_scores_gemma":[0.9962945,0.00029642094,0.0011079153,0.00087846373,0.0011227997,0.00029989617],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006489116,0.00045888094,0.002406451,0.00023704467,0.00011541976,0.000012009406,0.00022384501,0.0002788384,0.000050381794],"category_scores_gemma":[0.00032340735,0.0003465789,0.00020524963,0.00073738873,0.0003424066,0.00040191514,0.00020959829,0.00051748176,0.0000100408],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009355411,0.026550395,0.9635367,0.00012415834,0.0025018456,0.000019011617,0.0026755356,0.0000030035058,0.003313226,0.0001714709,0.000007441942,0.00016168185],"study_design_scores_gemma":[0.015439893,0.010060519,0.9193004,0.00045068993,0.0038370215,0.00002285635,0.00073176535,0.000013069611,0.049805418,0.000007709351,6.697487e-7,0.00033003348],"about_ca_topic_score_codex":0.0011667219,"about_ca_topic_score_gemma":0.00025585823,"teacher_disagreement_score":0.04649219,"about_ca_system_score_codex":0.00010675622,"about_ca_system_score_gemma":0.00020521133,"threshold_uncertainty_score":0.9998986},"labels":[],"label_agreement":null},{"id":"W2534693947","doi":"10.1182/blood.v112.11.1044.1044","title":"Very Short Telomeres Are Characteristic of Dyskeratosis Congenita and Not Other Inherited Bone Marrow Failure Syndromes","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute","funders":"","keywords":"Dyskeratosis congenita; Telomere; Bone marrow failure; Diamond–Blackfan anemia; Telomerase; Peripheral blood mononuclear cell; Anemia; Immunology; Biology; Medicine; Molecular biology; Pathology; Genetics; Internal medicine; Gene; Stem cell; Haematopoiesis; RNA","score_opus":0.027981419161458656,"score_gpt":0.23622375968715625,"score_spread":0.2082423405256976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2534693947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99689674,0.0019626734,0.0000046392715,0.0003457473,0.000078354526,0.00032348945,0.00012088078,0.00009390402,0.00017356282],"genre_scores_gemma":[0.99775016,0.00057802175,0.00044361936,0.0004110652,0.00011944315,0.000023490487,0.00003118694,0.000051563045,0.0005914178],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845797,0.000048417216,0.00043070462,0.00038771253,0.00034523284,0.00032996965],"domain_scores_gemma":[0.9990111,0.00008441572,0.00012453692,0.0004194839,0.00014543922,0.00021500954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009598936,0.00027566185,0.000710198,0.00020227654,0.000106284926,0.0000163946,0.000100792444,0.00016965557,0.00021984392],"category_scores_gemma":[0.00014298156,0.0002450615,0.000101304635,0.000290827,0.00030760813,0.00011027704,0.000052383984,0.0002009349,0.000022408934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019712828,0.00057963474,0.7170351,0.00041802204,0.00031614563,0.00087705324,0.0006352511,6.569018e-8,0.27829126,0.000015208226,0.0006417355,0.000993363],"study_design_scores_gemma":[0.002185557,0.00029367587,0.9097907,0.00032487724,0.0003490617,0.002130814,0.00033017382,0.000008885678,0.082158424,0.00000400884,0.0021038775,0.0003199239],"about_ca_topic_score_codex":0.00006344956,"about_ca_topic_score_gemma":0.00004151303,"teacher_disagreement_score":0.19613282,"about_ca_system_score_codex":0.000013960879,"about_ca_system_score_gemma":0.000077127865,"threshold_uncertainty_score":0.9993318},"labels":[],"label_agreement":null},{"id":"W2534814303","doi":"10.1182/blood.v114.22.603.603","title":"Comparative Whole Transcriptome Shotgun Sequencing (WTSS) of Myeloma at Diagnosis and at Drug-Resistant Relapse.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Alberta; Genome British Columbia; Saint John Regional Hospital; Dalhousie University","funders":"","keywords":"Multiple myeloma; Transcriptome; Population; Drug resistance; Bone marrow; Biology; Panobinostat; Carfilzomib; Cancer research; Medicine; Oncology; Internal medicine; Immunology; Gene; Gene expression; Genetics; Bortezomib","score_opus":0.0408339993105416,"score_gpt":0.3039775867542676,"score_spread":0.263143587443726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2534814303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906106,0.0037499138,0.000002302618,0.0007420165,0.0000218025,0.0005764998,0.00010253162,0.000041766096,0.004152562],"genre_scores_gemma":[0.99692893,0.0003181594,0.00048851967,0.000108499,0.000038088776,0.00004742587,0.00006648117,0.000014688837,0.0019892366],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99849516,0.00007039361,0.00029921162,0.00034146055,0.00041921213,0.00037453487],"domain_scores_gemma":[0.9990998,0.0001289184,0.00007660157,0.00029296035,0.00008664517,0.00031509847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012780708,0.00020414083,0.00051682116,0.00012413478,0.00014701443,0.000012289544,0.00007732703,0.00006924342,0.00014961514],"category_scores_gemma":[0.00004390262,0.00016377901,0.00011393849,0.00018264413,0.00012936097,0.00007894106,0.000040208863,0.00012992231,0.000045572833],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016906175,0.0017656832,0.20066349,0.00024801798,0.0007102674,0.00088122726,0.005162263,0.000003195957,0.78442127,0.00010187748,0.0020333063,0.0023187795],"study_design_scores_gemma":[0.011227473,0.0014134325,0.51967525,0.0003412335,0.00042240947,0.000121050434,0.00037711125,0.00007465771,0.46386343,0.00007536574,0.0022001062,0.00020848462],"about_ca_topic_score_codex":0.00008282319,"about_ca_topic_score_gemma":0.00019046589,"teacher_disagreement_score":0.32055786,"about_ca_system_score_codex":0.00018040193,"about_ca_system_score_gemma":0.00006536705,"threshold_uncertainty_score":0.6678714},"labels":[],"label_agreement":null},{"id":"W2534949195","doi":"10.1182/blood.v126.23.5587.5587","title":"The Thrombotic Microangiopathy Registry of North America","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Institutional review board; Thrombotic microangiopathy; Clinical trial; Family medicine; Observational study; Electronic data capture; Pathology; Disease; Surgery","score_opus":0.019546519067088965,"score_gpt":0.23609093441424825,"score_spread":0.2165444153471593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2534949195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901177,0.0076693837,0.000017770639,0.00012007189,0.00033794035,0.00015092548,0.000055250614,0.000036113914,0.0014948221],"genre_scores_gemma":[0.9991118,0.000024690638,0.00003418759,0.00003272023,0.000025499765,0.000013710353,0.00004484894,0.000007300526,0.00070529495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999353,0.00011215867,0.00020237998,0.00012051772,0.000031798816,0.00018015082],"domain_scores_gemma":[0.99923605,0.000098461125,0.00013877371,0.00044096398,0.00006592329,0.000019856563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008828505,0.00007985523,0.00014758513,0.000018569639,0.0000827138,0.0000067873707,0.0003115147,0.000028211001,0.00004634632],"category_scores_gemma":[0.00011576836,0.000054779073,0.00006580426,0.00008312026,0.00020906627,0.000018855546,0.00009176395,0.000058689504,0.00031217383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019322173,0.0018216462,0.7501457,0.000091967915,0.0012939355,0.000023513372,0.001448232,0.000015363941,0.06559405,0.0006657319,0.17269143,0.0060152537],"study_design_scores_gemma":[0.0073348875,0.0008450576,0.47491664,0.00010896422,0.00070371287,0.00021006883,0.002865686,0.0000018307693,0.06266119,0.00044409293,0.4493865,0.00052136],"about_ca_topic_score_codex":0.00007029748,"about_ca_topic_score_gemma":0.000051278268,"teacher_disagreement_score":0.27669507,"about_ca_system_score_codex":0.000008100556,"about_ca_system_score_gemma":0.0000693425,"threshold_uncertainty_score":0.4012467},"labels":[],"label_agreement":null},{"id":"W2534967356","doi":"10.1182/blood.v110.11.4052.4052","title":"The Impact of Telomere Shortening in Dyskeratosis Congenita Cells on DNA Damage Response Pathways.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; University of British Columbia","funders":"","keywords":"Dyskeratosis congenita; Telomere; Biology; Telomerase; DNA damage; Cytotoxic T cell; Bone marrow failure; Cancer research; Bone marrow; Immunology; Molecular biology; Cell biology; Haematopoiesis; Stem cell; Genetics; DNA; In vitro","score_opus":0.017698968820302356,"score_gpt":0.28243759688923514,"score_spread":0.2647386280689328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2534967356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969911,0.0004506014,0.000008106811,0.000087461136,0.00009135373,0.0003878905,0.000028546674,0.00004749385,0.0019074663],"genre_scores_gemma":[0.99927205,0.000097528784,0.00017393622,0.000098442244,0.00008826829,0.0000075472053,0.0000065008603,0.000035028017,0.00022067115],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998109,0.00014774008,0.0005239993,0.00030486874,0.0003770614,0.0005373363],"domain_scores_gemma":[0.99803257,0.0009087815,0.00012930499,0.0006116772,0.00010870121,0.00020897342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014129019,0.00023803044,0.00040060526,0.0002734361,0.00011593023,0.00002445233,0.00020636592,0.00013664438,0.000053372263],"category_scores_gemma":[0.00034715835,0.00015701485,0.00019188844,0.0005649297,0.00015601209,0.000061324106,0.00004336607,0.00034925135,0.000029563467],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037819776,0.0009322945,0.092790104,0.000029796318,0.00014660925,0.00060601265,0.0012618557,0.0000066376265,0.89314073,0.00006866094,0.00026346967,0.006971843],"study_design_scores_gemma":[0.002490653,0.0010014798,0.49415326,0.00013895947,0.00006547369,0.0000436101,0.00073560263,0.000034877597,0.50096357,0.000018000394,0.00019108473,0.00016341267],"about_ca_topic_score_codex":0.00016084102,"about_ca_topic_score_gemma":0.00010411209,"teacher_disagreement_score":0.40136316,"about_ca_system_score_codex":0.00007376674,"about_ca_system_score_gemma":0.0002248007,"threshold_uncertainty_score":0.64028794},"labels":[],"label_agreement":null},{"id":"W2535092373","doi":"10.1182/blood.v116.21.1285.1285","title":"High Herpesvirus-Specific T Cell Counts Are Associated with near-Zero Likelihood of Malignancy Relapse and a Low Likelihood of Infections Due to Any pathogen.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Calgary","funders":"","keywords":"Immunity; Immunology; Cellular immunity; CD8; Immune system; Biology; Virology; Medicine","score_opus":0.009040897161799828,"score_gpt":0.2343463990672651,"score_spread":0.22530550190546528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2535092373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99577224,0.0005251832,0.000030770185,0.00011951538,0.00011627211,0.00051948003,0.00031130578,0.00004645474,0.0025587755],"genre_scores_gemma":[0.9983512,0.00018208635,0.000808306,0.00007593565,0.00007451637,0.0000345353,0.000026308633,0.000052191554,0.00039492262],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99842095,0.00004576595,0.00035835843,0.00033373956,0.00044807204,0.0003931114],"domain_scores_gemma":[0.9985685,0.000092477,0.00018277953,0.00045276803,0.0003985412,0.00030494572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030643522,0.00020130973,0.0005193877,0.0001847223,0.00010020326,0.000031397998,0.00011078774,0.00022160016,0.0004410027],"category_scores_gemma":[0.00012089075,0.00016994933,0.00008678246,0.00058665866,0.00013943062,0.00006456062,0.00007288725,0.00046569252,0.000079857695],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074095634,0.011313207,0.31596094,0.00079987146,0.00068112754,0.0006544971,0.0013914501,0.0000047272806,0.6511215,0.00042086496,0.0069448827,0.009965987],"study_design_scores_gemma":[0.01953794,0.0047229487,0.7720383,0.0017966758,0.00080706074,0.00028367637,0.00023411954,0.000052221796,0.1595537,0.0006306366,0.039383367,0.0009593635],"about_ca_topic_score_codex":0.00019879873,"about_ca_topic_score_gemma":0.0005118024,"teacher_disagreement_score":0.4915678,"about_ca_system_score_codex":0.000024132318,"about_ca_system_score_gemma":0.00025581842,"threshold_uncertainty_score":0.6930332},"labels":[],"label_agreement":null},{"id":"W2535108132","doi":"10.1182/blood.v116.21.1115.1115","title":"Prothrombin Complex Concentrate (Octaplex®) In Patients Requiring Immediate Reversal of Vitamin K Antagonist Anticoagulation.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; St. Joseph's Hospital","funders":"","keywords":"Prothrombin complex concentrate; Medicine; Vitamin K antagonist; Warfarin; Fresh frozen plasma; PROTHROMBIN COMPLEX; Vitamin k; Surgery; Anesthesia; Retrospective cohort study; Internal medicine; Coagulation; Atrial fibrillation","score_opus":0.014487330301945735,"score_gpt":0.260448383251095,"score_spread":0.24596105294914924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2535108132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99651706,0.000014556168,0.000010432785,0.0002836922,0.00023749947,0.0011170141,0.000016275973,0.00003245956,0.0017710327],"genre_scores_gemma":[0.99852693,0.000038855887,0.001015862,0.00015849227,0.000083338084,0.000033085184,0.00008793592,0.000024123812,0.000031368443],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998672,0.00002908891,0.00044268725,0.0002626222,0.00028701738,0.00030656497],"domain_scores_gemma":[0.9992998,0.000027150883,0.00016994348,0.00031013822,0.000095876494,0.000097095464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020747806,0.00014862532,0.00047089453,0.000117411946,0.000048157504,0.000017329352,0.00010547449,0.000078248886,0.00015824435],"category_scores_gemma":[0.00007595719,0.00014230052,0.00006631546,0.00019099,0.00012124066,0.00010060039,0.00007050755,0.00018376664,0.000020039804],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006961585,0.005064323,0.844784,0.00026844468,0.00012021364,0.000027629532,0.00052703085,0.000003952152,0.14585455,0.0018840329,0.00056357216,0.000832597],"study_design_scores_gemma":[0.008260146,0.0003518972,0.9613327,0.00012493538,0.00012224638,0.0000024918463,0.00006479351,0.00008063006,0.029051553,0.00006549854,0.0004023978,0.00014072635],"about_ca_topic_score_codex":0.00016411797,"about_ca_topic_score_gemma":0.0000668624,"teacher_disagreement_score":0.116803,"about_ca_system_score_codex":0.00002090995,"about_ca_system_score_gemma":0.000051667597,"threshold_uncertainty_score":0.58028466},"labels":[],"label_agreement":null},{"id":"W2535110757","doi":"10.1182/blood.v110.11.1499.1499","title":"Increased Levels of Urinary N-Telopeptide of Type I Collagen Correlate with Reduced Survival in Patients with Advanced Multiple Myeloma.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Medicine; N-terminal telopeptide; Internal medicine; Multiple myeloma; Univariate analysis; Oncology; Creatinine; Gastroenterology; Proportional hazards model; Performance status; Cancer; Urology; Multivariate analysis; Alkaline phosphatase","score_opus":0.018165537692736898,"score_gpt":0.2698278280753894,"score_spread":0.25166229038265253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2535110757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974079,0.00008201136,0.0000111611835,0.000007689321,0.000027020265,0.0009988826,0.000060193684,0.000020549187,0.001384557],"genre_scores_gemma":[0.9957868,0.000009377953,0.0038986912,0.000007750045,0.000012836686,0.000011342267,0.000088215165,0.00003465118,0.0001503231],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983766,0.000057913796,0.00036787547,0.00026809418,0.000554233,0.00037527096],"domain_scores_gemma":[0.9987025,0.00019034336,0.00016963502,0.00034995325,0.000380587,0.00020697247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002457988,0.00018721638,0.00047082605,0.00021872454,0.000029263028,0.0000028925529,0.00009586656,0.0000745906,0.000047744892],"category_scores_gemma":[0.00024003578,0.00013301421,0.00003755458,0.0005876309,0.00011271764,0.000073425996,0.000043685657,0.00010911172,0.0000071680656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016696298,0.0039908774,0.9624279,0.00012186663,0.00033081466,0.00038592893,0.00016307425,0.000013956988,0.01305889,0.0000038313447,0.0000028357988,0.0028036956],"study_design_scores_gemma":[0.03683877,0.005003807,0.91280407,0.00033111044,0.00010490599,0.000015708372,0.00009623392,0.000017976618,0.044652015,0.0000016625261,0.000011909465,0.000121859644],"about_ca_topic_score_codex":0.00021635406,"about_ca_topic_score_gemma":0.0001682999,"teacher_disagreement_score":0.049623888,"about_ca_system_score_codex":0.00005147122,"about_ca_system_score_gemma":0.00024847712,"threshold_uncertainty_score":0.54241616},"labels":[],"label_agreement":null},{"id":"W2535148614","doi":"10.1182/blood.v110.11.2662.2662","title":"Modulation of IRP Binding Activity by Oxygen in Primary Erythroid Cells.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Ferritin; Transferrin receptor; Internal ribosome entry site; Erythropoietin; Transferrin; Hypoxia (environmental); Biology; Cell biology; Chemistry; Biochemistry; Messenger RNA; Molecular biology; Endocrinology; Oxygen; Translation (biology); Gene","score_opus":0.006959463455418981,"score_gpt":0.2281032768881548,"score_spread":0.22114381343273581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2535148614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99616003,0.0003318952,0.0017474146,0.000017912658,0.000033845357,0.00007818636,0.000016746755,0.0000033002743,0.0016106907],"genre_scores_gemma":[0.9991258,0.00011563103,0.00035866792,0.000019442214,0.000042818498,0.000004733054,0.00005728772,0.000007556741,0.0002680651],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99956393,0.0000123025575,0.00010988855,0.00014402627,0.00006298355,0.000106893494],"domain_scores_gemma":[0.9997285,0.0000042987203,0.000060445418,0.00016296486,0.00002158213,0.000022196296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015006999,0.000053963227,0.00006553535,0.000032224325,0.000019512547,0.000003889365,0.000062455074,0.00007563952,0.000005313588],"category_scores_gemma":[0.0000058497435,0.000056565503,0.000028310527,0.00007652048,0.000020977459,0.0000030696872,0.000022470904,0.000035877667,0.0000017115331],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019554935,0.00018923821,0.0057965,0.0000115407265,0.000010231348,3.5755843e-7,0.000016385336,0.000022295493,0.990583,0.0000051908482,0.00016032901,0.0031853945],"study_design_scores_gemma":[0.00047283032,0.000035536897,0.091059305,0.0000052623823,0.000006191412,9.345012e-7,0.000010855155,0.0000135499995,0.90687776,0.0000067304477,0.0014478558,0.00006321628],"about_ca_topic_score_codex":0.000029881528,"about_ca_topic_score_gemma":0.000018982908,"teacher_disagreement_score":0.085262805,"about_ca_system_score_codex":0.0000118264325,"about_ca_system_score_gemma":0.000025605636,"threshold_uncertainty_score":0.23066743},"labels":[],"label_agreement":null},{"id":"W2535197426","doi":"10.1182/blood.v106.11.1951.1951","title":"Exposure of Anion Binding Exosite I of Thrombin Is Required and Sufficient for Timely Cleavage and Activation of Factor V and Factor VIII.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Prothrombinase; Thrombin; Chemistry; Factor X; Factor IXa; Binding site; Cleavage (geology); Biochemistry; Active site; Stereochemistry; Enzyme; Factor V; Platelet; Biology","score_opus":0.03603556168223308,"score_gpt":0.2777853166949802,"score_spread":0.2417497550127471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2535197426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99873304,0.00021468848,0.00033106667,0.00013754754,0.000021123938,0.0004144476,0.000076791854,0.000012962134,0.00005835725],"genre_scores_gemma":[0.99811566,0.00006731352,0.0016831807,0.000036472837,0.000023492947,0.0000040614295,0.000012853917,0.000013897608,0.00004308341],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992599,0.000018181185,0.00028907973,0.00017546357,0.00015747675,0.00009992332],"domain_scores_gemma":[0.9994598,0.00006194289,0.00021512384,0.0001225349,0.00008112794,0.000059445192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009500311,0.00010234046,0.00031815667,0.000112687354,0.00003258122,0.000006060946,0.000024205488,0.00009490218,0.000025115105],"category_scores_gemma":[0.000038955586,0.00009088268,0.0000364433,0.00008796227,0.000054962093,0.00010369297,0.000025901127,0.00004198616,2.5221445e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000784013,0.00038078215,0.010249608,0.000266587,0.00007950286,1.1452812e-7,0.0019080775,2.0798655e-7,0.9842384,0.00043711867,0.0000157608,0.0023454477],"study_design_scores_gemma":[0.0034244142,0.0009251231,0.1362532,0.00015902896,0.000117579424,0.000004990324,0.00025102813,0.00012235931,0.85861045,0.00003738591,0.000027575285,0.00006685546],"about_ca_topic_score_codex":0.00000798918,"about_ca_topic_score_gemma":0.0000019289073,"teacher_disagreement_score":0.12600358,"about_ca_system_score_codex":0.000006753039,"about_ca_system_score_gemma":0.000018179227,"threshold_uncertainty_score":0.3706088},"labels":[],"label_agreement":null},{"id":"W2535239418","doi":"10.1182/blood.v112.11.1868.1868","title":"Increased Nucleosomal DNA Fragmentation in Leukocytes of Thalassemia Patients.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"DNA fragmentation; Apoptosis; Deferasirox; Fragmentation (computing); Thalassemia; Medicine; Immunology; Molecular biology; Internal medicine; Biology; Biochemistry; Programmed cell death","score_opus":0.007428790568909725,"score_gpt":0.21526195031956777,"score_spread":0.20783315975065805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2535239418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99477065,0.0002131575,0.0000014116888,0.000058698635,0.00003571445,0.00019600803,0.0000041534945,0.00002238283,0.004697829],"genre_scores_gemma":[0.999416,0.00016302217,0.00019657223,0.000104135695,0.000016718537,0.0000055438004,0.000042650106,0.000011159575,0.00004419347],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993494,0.000021221382,0.00021865091,0.00011406326,0.00016780122,0.00012883946],"domain_scores_gemma":[0.9997065,0.000023627297,0.000060104587,0.00010999065,0.000044379933,0.00005541382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003967232,0.00007564788,0.00016666265,0.00008860614,0.000027507585,0.0000014534451,0.00003473656,0.00009260653,0.00006529348],"category_scores_gemma":[0.00006408218,0.000064475935,0.000048015732,0.00017084749,0.00005107375,0.000043877535,0.000013536405,0.00009990455,0.00001533801],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007529613,0.0014812421,0.984331,0.00004947239,0.000035641086,0.00004784176,0.0005510711,0.0000035868206,0.01278165,0.00002676936,0.00016283555,0.00045356026],"study_design_scores_gemma":[0.009215525,0.0003156199,0.94148874,0.00010104844,0.0000690564,0.00002456686,0.00022249333,0.000033942673,0.048299223,0.000018585162,0.00013406428,0.00007713024],"about_ca_topic_score_codex":0.00018124752,"about_ca_topic_score_gemma":0.000007781063,"teacher_disagreement_score":0.04284229,"about_ca_system_score_codex":0.000017624887,"about_ca_system_score_gemma":0.00006341171,"threshold_uncertainty_score":0.26292524},"labels":[],"label_agreement":null},{"id":"W2535514752","doi":"10.1182/blood.v104.11.3637.3637","title":"Platelet Transfusions in a Medical- Surgical Intensive Care Unit.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Intensive care unit; Platelet transfusion; Prospective cohort study; Surgery; Platelet; Internal medicine","score_opus":0.017532327095283906,"score_gpt":0.2802721126326324,"score_spread":0.2627397855373485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2535514752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96942586,0.0005965895,0.00006432544,0.010335337,0.00011044202,0.0005123319,0.00000609465,0.00009686844,0.018852135],"genre_scores_gemma":[0.99571604,0.00083034515,0.0001641173,0.003012812,0.00007040601,0.000032333974,0.000027719267,0.000018610644,0.00012762447],"study_design_codex":"case_report","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99880195,0.00002534544,0.00024956337,0.00025030514,0.00041333472,0.00025950713],"domain_scores_gemma":[0.99934113,0.000029610144,0.000015642201,0.00021587685,0.00012567452,0.00027207445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010399954,0.00013391784,0.00028065837,0.00016305922,0.00004409078,0.0000065202403,0.000093705494,0.00014861098,0.00052701123],"category_scores_gemma":[0.00006814348,0.0001094954,0.00010256492,0.0003341753,0.000066064305,0.000027046086,0.00003095802,0.000357013,0.000060409446],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042919787,0.033455584,0.14839377,0.0038161783,0.0030130344,0.32754,0.124410756,0.00017746199,0.00887518,0.08625121,0.0034324555,0.2563424],"study_design_scores_gemma":[0.37470526,0.003874802,0.14917049,0.0049778083,0.0019748632,0.008845995,0.070801884,0.00003311364,0.056131758,0.0013751832,0.3263914,0.0017174328],"about_ca_topic_score_codex":0.00031365262,"about_ca_topic_score_gemma":0.0009481266,"teacher_disagreement_score":0.37041327,"about_ca_system_score_codex":0.000020945956,"about_ca_system_score_gemma":0.00016888679,"threshold_uncertainty_score":0.5770404},"labels":[],"label_agreement":null},{"id":"W2535536391","doi":"10.1182/blood.v114.22.2136.2136","title":"Investigation Into Mechanisms of Prothrombinase Complex Inhibition by a Covalent Antithrombin-Heparin Complex.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"","keywords":"Prothrombinase; Antithrombin; Chemistry; Thrombin; Heparin; Covalent bond; Coagulation; Stereochemistry; Biophysics; Biochemistry; Internal medicine; Organic chemistry; Platelet","score_opus":0.04420111792898917,"score_gpt":0.28045184679073565,"score_spread":0.23625072886174647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2535536391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98984665,0.000057325353,0.005339699,0.0020932877,0.00006773297,0.0012866167,0.000023430355,0.00019620122,0.0010890453],"genre_scores_gemma":[0.98441297,0.000017208793,0.01318259,0.0017100873,0.0000382964,0.0000318916,0.00049898494,0.00002711101,0.00008087148],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99817455,0.00008932426,0.00056804816,0.00038619034,0.00051981123,0.0002620667],"domain_scores_gemma":[0.99890226,0.000018732608,0.0002723638,0.00038742044,0.00020175615,0.00021748853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026483304,0.00024396119,0.00053588045,0.00016913867,0.00011874493,0.000022335349,0.000088024666,0.00015239646,0.00031645707],"category_scores_gemma":[0.000045867633,0.00024375095,0.00012584223,0.0003861129,0.00010928755,0.00014135282,0.000035977388,0.00015419135,0.00004378096],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004112237,0.00153121,0.00047561145,0.00012222276,0.00007382677,0.000008160098,0.0002752224,8.759399e-7,0.95357597,0.04214121,0.0013036614,0.00045093094],"study_design_scores_gemma":[0.006547882,0.0020279824,0.02854631,0.00020624432,0.0003053035,0.000056053424,0.00010590718,0.0003210309,0.90470034,0.056818705,0.00013044578,0.00023382297],"about_ca_topic_score_codex":0.00009126295,"about_ca_topic_score_gemma":0.000011659724,"teacher_disagreement_score":0.048875634,"about_ca_system_score_codex":0.00004186618,"about_ca_system_score_gemma":0.00008637079,"threshold_uncertainty_score":0.99398756},"labels":[],"label_agreement":null},{"id":"W2535537998","doi":"10.1182/blood.v116.21.2569.2569","title":"Impact of Treatment Strategies on Clinical Outcomes In Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients In Canada","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bristol-Myers Squibb (Canada)","funders":"","keywords":"Medicine; Imatinib; Myeloid leukemia; Internal medicine; Imatinib mesylate; Cancer","score_opus":0.022420404387260093,"score_gpt":0.34404296924215816,"score_spread":0.32162256485489804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2535537998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99746025,0.00016585302,2.2532943e-7,0.000033588414,0.00027928562,0.0010450023,0.00012971835,0.000025520785,0.0008605454],"genre_scores_gemma":[0.99911,0.0002537645,0.000047739657,0.000028349854,0.00016285638,0.00008028806,0.00015677851,0.000048150923,0.000112073394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972163,0.00008806485,0.0010497739,0.0005610683,0.00040675025,0.0006780785],"domain_scores_gemma":[0.99828243,0.00028310958,0.00027566077,0.0008120767,0.000062895255,0.00028380728],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016265734,0.0004598806,0.0010869373,0.00023014592,0.00003000592,0.000013434002,0.00019126937,0.00021760548,0.00032364996],"category_scores_gemma":[0.00013827135,0.00033725085,0.00031306833,0.0002717542,0.0001014353,0.00011183553,0.000044558205,0.0006183161,0.000025992105],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00032678584,0.004559024,0.9788492,0.00005328863,0.0005083081,0.00024866298,0.00008947623,0.0002134345,0.0018652527,0.000018985162,0.00005029837,0.013217287],"study_design_scores_gemma":[0.07661645,0.011743212,0.9084329,0.00014696519,0.0001982969,0.000013189634,0.00004351742,0.00019309239,0.0022354533,0.000013501354,0.00012554042,0.00023787346],"about_ca_topic_score_codex":0.8332166,"about_ca_topic_score_gemma":0.9589243,"teacher_disagreement_score":0.12570767,"about_ca_system_score_codex":0.03055676,"about_ca_system_score_gemma":0.047862813,"threshold_uncertainty_score":0.999908},"labels":[],"label_agreement":null},{"id":"W2535579634","doi":"10.1182/blood.v108.11.2739.2739","title":"Outcome in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with CHOP-R Can Be Predicted by Stage and Serum Lactate Dehydrogenase (LDH) Level.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; International Prognostic Index; Diffuse large B-cell lymphoma; Internal medicine; Rituximab; CHOP; Population; Stage (stratigraphy); Lymphoma; Gastroenterology; Performance status; Oncology; Cancer","score_opus":0.007077245684217713,"score_gpt":0.1979980715226487,"score_spread":0.19092082583843098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2535579634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947825,0.00015884648,0.0000014417335,0.0001586059,0.000011962092,0.00091680145,0.003460169,0.00009633705,0.00041334977],"genre_scores_gemma":[0.9969618,0.000022675551,0.00011239595,0.00029643424,0.000019423087,0.00010371343,0.0011087144,0.00006526583,0.0013096182],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982088,0.000044104276,0.00034374272,0.00048589683,0.00038275492,0.0005346648],"domain_scores_gemma":[0.9991469,0.000037213984,0.00013033941,0.00035424076,0.00007289214,0.00025840977],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00005515735,0.0003805888,0.0004906962,0.00012933365,0.00008599947,0.000036553167,0.00006477728,0.00010742496,0.000024198916],"category_scores_gemma":[0.000008735766,0.00024969014,0.00004595618,0.000271064,0.000060827282,0.0000876954,0.00003623532,0.00007111417,0.0000023985094],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048174377,0.039370228,0.958773,0.00006777433,0.00018790785,0.0005341312,0.00011912864,8.7494016e-7,0.0000821213,0.000006197172,0.00021270833,0.00016417737],"study_design_scores_gemma":[0.18254136,0.0012844101,0.80360156,0.00007857685,0.00045660674,0.000016766402,0.000040536688,0.000024234416,0.01120032,7.1741425e-7,0.0005108101,0.00024409062],"about_ca_topic_score_codex":0.0023030613,"about_ca_topic_score_gemma":0.001865596,"teacher_disagreement_score":0.1820596,"about_ca_system_score_codex":0.0001604255,"about_ca_system_score_gemma":0.000093848554,"threshold_uncertainty_score":0.9999955},"labels":[],"label_agreement":null},{"id":"W2535606979","doi":"10.1182/blood.v106.11.4558.4558","title":"Establishment and Characterization of a New Human Ph+ Erythroleukemic Cell Line, VES.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bone marrow; Cell culture; Stromal cell; Haematopoiesis; Biology; Glutamine; Molecular biology; Peripheral blood mononuclear cell; Transplantation; In vitro; Immunology; Stem cell; Andrology; Cancer research; Medicine; Cell biology; Internal medicine; Biochemistry; Genetics","score_opus":0.01302531600835706,"score_gpt":0.2449009218990427,"score_spread":0.23187560589068562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2535606979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965619,0.00013314324,0.0004594924,0.00024222484,0.000023940287,0.00023491749,0.000007266594,0.00003083314,0.0023062865],"genre_scores_gemma":[0.9972892,0.00015352937,0.0011120777,0.000121069854,0.00017438829,0.0000049542846,0.00010286605,0.00001464417,0.0010272921],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99936354,0.000010359305,0.00023461206,0.00013955744,0.00014590357,0.00010599627],"domain_scores_gemma":[0.99965155,0.00001263652,0.00007823568,0.00013527815,0.00003124945,0.0000910436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000064000065,0.00008354844,0.00016851057,0.000065700406,0.000020592315,0.000008278786,0.00002949623,0.000058069534,0.000088077555],"category_scores_gemma":[0.0000041201183,0.00007976112,0.000025367675,0.000076864315,0.000019535064,0.000068373796,0.000007422874,0.0000577377,0.000012597682],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002105386,0.00030615766,0.008833042,0.00028431497,0.000020891957,0.0000061186365,0.0012009956,0.0000010791533,0.98776466,0.00004204636,0.000043001543,0.00147665],"study_design_scores_gemma":[0.005418209,0.00021647065,0.049380325,0.00019992221,0.00028340972,0.0000661468,0.000041913627,0.00005502228,0.94319314,0.0000138523255,0.0010442695,0.00008733158],"about_ca_topic_score_codex":0.000020954933,"about_ca_topic_score_gemma":0.000004523522,"teacher_disagreement_score":0.04457152,"about_ca_system_score_codex":0.00001395476,"about_ca_system_score_gemma":0.00006010513,"threshold_uncertainty_score":0.3252564},"labels":[],"label_agreement":null},{"id":"W2535821575","doi":"10.1182/blood.v118.21.3100.3100","title":"Outcomes for Patients Aged 60 and Over Are Similar to Younger Patients Following Reduced-Intensity Allogeneic Stem Cell Transplant for CLL","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Vancouver Hospital and Health Sciences Centre; Leukemia & Lymphoma Society of Canada; University of British Columbia","funders":"","keywords":"Medicine; Fludarabine; Internal medicine; Chronic lymphocytic leukemia; Gastroenterology; Hematopoietic stem cell transplantation; Pediatrics; Leukemia; Transplantation; Surgery; Chemotherapy; Cyclophosphamide","score_opus":0.03430782214299646,"score_gpt":0.27027694589054735,"score_spread":0.23596912374755089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2535821575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962999,0.00007433389,0.00006600271,0.000052574982,0.0003118535,0.002800105,0.00022573264,0.00004909695,0.00012038541],"genre_scores_gemma":[0.99721247,0.000010951474,0.0011369692,0.000695396,0.00005773725,0.00021081415,0.000093693016,0.000064360866,0.0005175885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980961,0.000028287332,0.00035317644,0.0005138464,0.00043170128,0.00057689793],"domain_scores_gemma":[0.99883866,0.00015285735,0.00008782504,0.00038584997,0.00020650696,0.00032831708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023148913,0.00025741177,0.000536651,0.00011196043,0.00012382277,0.000018559458,0.00015510395,0.00015183869,0.000011822964],"category_scores_gemma":[0.00010333489,0.00020882061,0.0002608638,0.00008777561,0.000030382109,0.00009034229,0.00007070496,0.000107566,0.0000073334686],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030186218,0.0040049185,0.97883284,0.0010298255,0.0007677815,0.00012701814,0.0048087235,7.7554716e-7,0.003850062,0.000005139364,0.0027248024,0.00082948257],"study_design_scores_gemma":[0.1153503,0.002054173,0.8332746,0.00029605697,0.0012411118,0.000008936057,0.00022454896,0.000116555326,0.046217587,0.000032830954,0.00069984223,0.00048347647],"about_ca_topic_score_codex":0.0000994671,"about_ca_topic_score_gemma":0.000033259294,"teacher_disagreement_score":0.14555827,"about_ca_system_score_codex":0.00073174527,"about_ca_system_score_gemma":0.00035707746,"threshold_uncertainty_score":0.8515457},"labels":[],"label_agreement":null},{"id":"W2536084185","doi":"10.1182/blood.v126.23.4865.4865","title":"Outcomes of Mixed Phenotype Leukemia, Not Otherwise Specified (NOS), in Adults: A Single Centre Retrospective Review from 2000 to 2014","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Leukemia; Monosomy; Myeloid leukemia; Myeloid; Cytogenetics; Internal medicine; Not Otherwise Specified; Cancer; Oncology; Pathology; Karyotype; Pediatrics; Biology; Chromosome; Genetics","score_opus":0.028185245746012607,"score_gpt":0.28116089106202535,"score_spread":0.25297564531601274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2536084185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9783087,0.0078038685,0.000016326932,0.0041187266,0.0001406911,0.0014793299,0.0001753688,0.00006706162,0.007889977],"genre_scores_gemma":[0.9885343,0.0012128499,0.004561895,0.0023322687,0.00034989882,0.000048331865,0.000101221536,0.00009826758,0.0027609908],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99744046,0.00015601482,0.0006165154,0.00054602383,0.00075629423,0.00048467566],"domain_scores_gemma":[0.9979989,0.00015819314,0.00016241774,0.00084852515,0.00039952004,0.00043246514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048272844,0.00027420808,0.0010346984,0.00019987741,0.000018873237,0.0000112263415,0.0003059477,0.00015231395,0.00060996966],"category_scores_gemma":[0.0016022051,0.0002291303,0.00014243906,0.0006106969,0.000076488985,0.00008245757,0.00014851536,0.0003961611,0.0007324814],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058783656,0.0046388158,0.7255525,0.0018455975,0.0009774178,0.00081962533,0.008237712,0.000008172101,0.019002892,0.00026693274,0.22357804,0.009193947],"study_design_scores_gemma":[0.044468243,0.0019130534,0.86890346,0.009071333,0.0007363966,0.000023767709,0.0015188187,0.00004933431,0.049847044,0.00033598603,0.022202278,0.0009302681],"about_ca_topic_score_codex":0.0027770628,"about_ca_topic_score_gemma":0.0012270123,"teacher_disagreement_score":0.20137577,"about_ca_system_score_codex":0.0015009964,"about_ca_system_score_gemma":0.0010274258,"threshold_uncertainty_score":0.9414811},"labels":[],"label_agreement":null},{"id":"W2536092267","doi":"10.1182/blood.v126.23.3905.3905","title":"The Absolute Number of Extranodal Sites Detected By PET-CT Is a Powerful Predictor of Secondary Central Nervous System Involvement in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Univariate analysis; Proportional hazards model; Internal medicine; Regimen; Chemotherapy regimen; Primary central nervous system lymphoma; Lymphoma; Rituximab; Surgery; Chemotherapy; Multivariate analysis","score_opus":0.005104377987777108,"score_gpt":0.19253848104987442,"score_spread":0.18743410306209732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2536092267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997208,0.0006425155,0.0000015647984,0.000026700558,0.000031382762,0.0010210741,0.00057285157,0.00004360086,0.00045231963],"genre_scores_gemma":[0.99940395,0.000025242703,0.00008142914,0.000031911815,0.000015925481,0.00006497704,0.00019197277,0.00004695572,0.00013764414],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99808735,0.00006982382,0.00048265964,0.0003269096,0.0005764516,0.0004567988],"domain_scores_gemma":[0.9987316,0.00006820759,0.00027155204,0.00045934692,0.00022180032,0.0002474724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000101855316,0.00029782526,0.00051527633,0.00006584585,0.000045097015,0.000017740971,0.00011928704,0.000037406127,0.000027096834],"category_scores_gemma":[0.000012217189,0.00016995959,0.000089195615,0.00026342127,0.00008947094,0.00006556706,0.000039993418,0.000067701476,0.000006799311],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017296571,0.02197956,0.9735282,0.00021754982,0.0005676314,0.0002575046,0.000635733,4.1822068e-7,0.0002092891,0.00000477152,0.00051443645,0.00035526],"study_design_scores_gemma":[0.110160515,0.0023208656,0.8675141,0.00039881858,0.0006819122,0.000086906155,0.0006334822,0.00005147618,0.01780313,8.145663e-7,0.00017300269,0.00017501549],"about_ca_topic_score_codex":0.0006880014,"about_ca_topic_score_gemma":0.00028603198,"teacher_disagreement_score":0.10843086,"about_ca_system_score_codex":0.00021413706,"about_ca_system_score_gemma":0.00025735033,"threshold_uncertainty_score":0.69307506},"labels":[],"label_agreement":null},{"id":"W2536093755","doi":"10.1182/blood.v120.21.2370.2370","title":"Deep Phenotypic Characterization of Primitive Stem and Progenitor Compartments Reveals the Cellular Architecture of Aplastic Anemia.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Aplastic anemia; Progenitor cell; Stem cell; Biology; Myeloid; Haematopoiesis; CD38; CD34; Immunology; Myelodysplastic syndromes; Progenitor; Cancer research; Bone marrow; Cell biology","score_opus":0.010197938931544309,"score_gpt":0.19878739193223877,"score_spread":0.18858945300069446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2536093755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964964,0.00075274886,0.002375904,0.00000803333,0.000074752934,0.00022162398,0.000025757716,0.0000029783948,0.000041795673],"genre_scores_gemma":[0.99947214,0.00003537256,0.00021442541,0.000021238888,0.00012934963,0.000008770586,0.00008139727,0.000009966268,0.000027328166],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99951226,0.000050986106,0.00014920603,0.00009974815,0.000070401125,0.000117432064],"domain_scores_gemma":[0.9996832,0.000011879214,0.00010162885,0.00012618856,0.00004045159,0.00003664665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000068463494,0.00008302843,0.00011455143,0.000013603412,0.000030808264,0.0000040190234,0.00007037071,0.00006399273,0.0000022761938],"category_scores_gemma":[0.0000090419935,0.000060477916,0.000033007283,0.00003473469,0.00006703119,0.0000024614103,0.000024673178,0.000040881212,4.4645563e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046623478,0.00021686588,0.05266692,0.00007504441,0.000051317747,1.430127e-7,0.00026665357,0.0000024473275,0.9461156,0.000023664203,0.0000012091348,0.00053350854],"study_design_scores_gemma":[0.0005541573,0.00012677816,0.036375765,0.000016527378,0.00009330722,0.000004031525,0.000028533243,0.000010257463,0.9625659,0.0000065722766,0.00015361438,0.000064582906],"about_ca_topic_score_codex":0.0000014306355,"about_ca_topic_score_gemma":0.0000011692556,"teacher_disagreement_score":0.016450271,"about_ca_system_score_codex":0.0000017109119,"about_ca_system_score_gemma":0.000011669525,"threshold_uncertainty_score":0.24662179},"labels":[],"label_agreement":null},{"id":"W2536114505","doi":"10.1182/blood.v124.21.278.278","title":"Improvement in Treatment Outcome and Identification of a New Prognostic Parameter in Down Syndrome Acute Myeloid Leukemia (DS-AML): Results of the Children’s Oncology Group (COG) Phase III AAML0431 Trial","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Medicine; Daunorubicin; Cytarabine; Internal medicine; Minimal residual disease; Oncology; Myeloid leukemia; Absolute neutrophil count; Gastroenterology; Leukemia; Toxicity; Neutropenia","score_opus":0.02415389287430947,"score_gpt":0.3225078377355551,"score_spread":0.2983539448612456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2536114505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942883,0.00011590794,0.000027750699,0.0007372359,0.000105857594,0.004548341,0.0000637795,0.000016511682,0.000096262746],"genre_scores_gemma":[0.9985305,0.00011762711,0.0004203933,0.00007507253,0.00008099287,0.00031805472,0.00008074586,0.000025418447,0.00035120855],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9969867,0.00024405846,0.0014266162,0.000525933,0.00041832504,0.00039839212],"domain_scores_gemma":[0.99798733,0.00042835754,0.00050331216,0.0008675397,0.0000614755,0.00015200429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010677255,0.00024951238,0.00085028296,0.00032823216,0.00003402705,0.000015167986,0.000292668,0.00021747872,0.00000977694],"category_scores_gemma":[0.00079090684,0.00016822985,0.00014135624,0.00042056592,0.00021168213,0.00008104952,0.00018406144,0.0003302748,0.0000044746575],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12934776,0.024413021,0.24561864,0.00052945974,0.0028203519,0.0003917322,0.005492032,0.000019085046,0.34981915,0.00030892924,0.00035873955,0.2408811],"study_design_scores_gemma":[0.5816257,0.018778289,0.36391014,0.00019554881,0.0012592764,0.00024318925,0.000085006905,0.00071343797,0.032626186,0.00014224112,0.00018199859,0.00023900808],"about_ca_topic_score_codex":0.0021046782,"about_ca_topic_score_gemma":0.00047528505,"teacher_disagreement_score":0.45227793,"about_ca_system_score_codex":0.0006996353,"about_ca_system_score_gemma":0.0006243038,"threshold_uncertainty_score":0.6860214},"labels":[],"label_agreement":null},{"id":"W2536240519","doi":"10.1182/blood.v124.21.5105.5105","title":"Mixed Fields on RHD Typing As an Indicator of Malignancy-Associated Loss of Heterozygosity on Chromosome 1p in Myeloid Neoplasm","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Bone marrow; Leukemia; Myeloid leukemia; Malignancy; Myeloid; Pathology; Myeloproliferative neoplasm; Induction chemotherapy; Immunology; Gastroenterology; Internal medicine; Chemotherapy; Myelofibrosis","score_opus":0.01848761709350681,"score_gpt":0.2731125052129551,"score_spread":0.2546248881194483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2536240519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959219,0.000030643256,0.0000069222087,0.00033682794,0.00007343941,0.0003622073,0.000020906115,0.00003823317,0.0032089283],"genre_scores_gemma":[0.9991299,0.00003267078,0.00012963015,0.00035935658,0.000086057495,0.000016693437,0.000040349376,0.00003266028,0.00017266223],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981218,0.00022235213,0.00043758753,0.00036148287,0.00046883343,0.00038792615],"domain_scores_gemma":[0.9987017,0.00025408572,0.0002168348,0.0005604063,0.00009002319,0.0001769396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005976848,0.00018691662,0.00056769146,0.00032703017,0.00003850285,0.0000070512824,0.00025786317,0.00032061533,0.000090591406],"category_scores_gemma":[0.0006683442,0.00017029533,0.00009833865,0.0003498022,0.00010527433,0.000057619254,0.00008206297,0.00051534496,0.00006951858],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002982522,0.015770521,0.7104686,0.0013822434,0.0009624809,0.0005753386,0.0036336503,0.0000655435,0.24866904,0.0036191333,0.0010937274,0.010777192],"study_design_scores_gemma":[0.011992702,0.0050449716,0.48356727,0.0010356577,0.00010706411,0.000038274364,0.00008996352,0.00023234836,0.49722204,0.0002505814,0.000162192,0.00025694052],"about_ca_topic_score_codex":0.0003144247,"about_ca_topic_score_gemma":0.00012546749,"teacher_disagreement_score":0.248553,"about_ca_system_score_codex":0.0001389931,"about_ca_system_score_gemma":0.0002174789,"threshold_uncertainty_score":0.6944442},"labels":[],"label_agreement":null},{"id":"W2536295306","doi":"10.1182/blood.v126.23.5606.5606","title":"Combined Modality Therapy in the Upfront Treatment of Patients with Primary Central Nervous System Lymphoma: A Systematic Review","year":2015,"lang":"en","type":"review","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; Ottawa Hospital","funders":"","keywords":"Medicine; Primary central nervous system lymphoma; Randomized controlled trial; Radiation therapy; Clinical trial; Internal medicine; Oncology; Systematic review; MEDLINE; Chemotherapy; Pediatrics","score_opus":0.030430059450525737,"score_gpt":0.2771701190807356,"score_spread":0.24674005963020984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2536295306","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004236448,0.9782699,2.7178612e-7,0.000031902753,0.0000651,0.016920047,0.00019061152,0.000037267848,0.0002484845],"genre_scores_gemma":[0.0038998455,0.99112767,0.00002914292,0.000074057396,0.000040888503,0.0038309987,0.0009103776,0.000064929,0.000022074963],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9961287,0.0007702361,0.0014355882,0.00047269728,0.0008008757,0.00039192196],"domain_scores_gemma":[0.9971515,0.00019340738,0.00096863136,0.0013479105,0.00017623635,0.00016233497],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040828896,0.0006910814,0.0061134077,0.00011215617,0.000037759204,0.000020409083,0.00025468075,0.00017182424,0.0000043022515],"category_scores_gemma":[0.000024305045,0.00030072546,0.0007470435,0.0003815235,0.000050340896,0.00003242929,0.000025154324,0.00006350845,0.000013623747],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000072218914,0.016592704,0.001595744,0.78557664,0.0020854103,0.0002342448,0.00016245448,4.4168086e-8,3.2613974e-9,0.000028541946,0.000045054465,0.19360691],"study_design_scores_gemma":[0.021427851,0.0052556037,0.029675921,0.8949296,0.0359522,0.0002554857,0.000053312244,6.1098467e-7,4.63106e-7,0.0000015594059,0.0120407045,0.00040672685],"about_ca_topic_score_codex":0.00020649034,"about_ca_topic_score_gemma":0.000010079018,"teacher_disagreement_score":0.19320019,"about_ca_system_score_codex":0.0015128109,"about_ca_system_score_gemma":0.0008746545,"threshold_uncertainty_score":0.9999445},"labels":[],"label_agreement":null},{"id":"W2536296768","doi":"10.1182/blood.v124.21.244.244","title":"An Unexpected Role for Ribonuclease Inhibitor (RNH1) in Erythropoiesis","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"GATA1; Biology; Erythropoiesis; GATA2; Haematopoiesis; Cell biology; Transcription factor; Molecular biology; Gene expression; Diamond–Blackfan anemia; Gene; Stem cell; Genetics; RNA; Internal medicine","score_opus":0.003383844506995744,"score_gpt":0.25771241482414026,"score_spread":0.2543285703171445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2536296768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937283,0.00032711995,0.0053934916,0.00003765636,0.00006990274,0.00013185719,0.000011742235,0.000019336738,0.00028063467],"genre_scores_gemma":[0.9967786,0.000014366208,0.0026080066,0.00006290206,0.00035457188,0.00003382973,0.00007029748,0.000023758,0.000053669417],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994109,0.00001796461,0.00011786237,0.00022534747,0.000046174086,0.00018169446],"domain_scores_gemma":[0.9996285,0.0000075379467,0.00001899629,0.00024911764,0.000028244882,0.00006764016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008181476,0.00009599465,0.000092214235,0.000034656696,0.000029271743,0.000013747373,0.00009528498,0.00008887089,0.0000071510876],"category_scores_gemma":[0.00006512879,0.00010098901,0.00004591649,0.00005226308,0.000017839418,0.0000019596343,0.00002462132,0.000034248744,0.0000030591123],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025284739,0.00019451267,0.0026363155,0.0000140500315,0.000014028332,6.5357335e-7,0.00005003293,0.0002221418,0.9948374,0.000045224733,0.00016774931,0.0017926237],"study_design_scores_gemma":[0.0020288196,0.00044855435,0.008254984,0.000009615394,0.000025235784,0.0000060622183,0.000110796056,0.0011402315,0.9718822,0.00008992876,0.015790496,0.00021303026],"about_ca_topic_score_codex":0.000018349076,"about_ca_topic_score_gemma":0.00007576449,"teacher_disagreement_score":0.022955138,"about_ca_system_score_codex":0.0000030484582,"about_ca_system_score_gemma":0.000013483867,"threshold_uncertainty_score":0.41182125},"labels":[],"label_agreement":null},{"id":"W2536303125","doi":"10.1182/blood.v116.21.3688.3688","title":"Duration of Corticosteroid Tapering as First Line Treatment In Idiopathic Thrombocytopenic Purpura.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Hospital; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Thrombocytopenic purpura; Corticosteroid; Regimen; Retrospective cohort study; Surgery; Prednisone; Hydroxychloroquine; Internal medicine; Pediatrics; Disease","score_opus":0.014340044864345047,"score_gpt":0.264600308646667,"score_spread":0.25026026378232197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2536303125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99758106,0.00038237427,0.000002985281,0.00028728187,0.00007994925,0.00043726017,0.000004276641,0.000021405205,0.0012033731],"genre_scores_gemma":[0.9993256,0.0002652459,0.00012210781,0.000034534172,0.000036606627,0.000045939654,0.000025724996,0.000014378832,0.00012991352],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9992676,0.000009319367,0.0002819191,0.00017090082,0.00011766565,0.0001526126],"domain_scores_gemma":[0.9995898,0.000017239661,0.00008067367,0.000222229,0.000028018689,0.00006201097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000504783,0.0001217873,0.00033124603,0.000069563546,0.000031914908,0.000008641576,0.00003848145,0.0000798081,0.00008087019],"category_scores_gemma":[0.000051324427,0.00009480353,0.00005945272,0.00010570733,0.000026799538,0.000063551095,0.000015499487,0.00010040807,0.000045505793],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003443056,0.01015689,0.40766528,0.00017192424,0.0003732974,0.0020515996,0.0013908371,0.000008485665,0.5594586,0.00015367185,0.0000048669604,0.018220225],"study_design_scores_gemma":[0.029253876,0.0046515516,0.49705285,0.00032339315,0.00064105645,0.0011816784,0.00012463778,0.00019204775,0.4653072,0.0002928488,0.00070451334,0.00027433946],"about_ca_topic_score_codex":0.00028210334,"about_ca_topic_score_gemma":0.0016183362,"teacher_disagreement_score":0.0941514,"about_ca_system_score_codex":0.000025916175,"about_ca_system_score_gemma":0.000069228496,"threshold_uncertainty_score":0.38659757},"labels":[],"label_agreement":null},{"id":"W2536521233","doi":"10.1182/blood.v110.11.2895.2895","title":"ADAMTS-13 Levels Do Not Predict Outcome in Thrombotic Thrombocytopenic Purpura: Protein S Levels Are Maintained during Plasma Exchange with Solvent Detergent Treated Plasma.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital de l'Enfant-Jésus; Princess Margaret Cancer Centre; Vancouver General Hospital; Juravinski Hospital; London Health Sciences Centre; Queen Elizabeth II Health Sciences Centre; Canadian Apheresis Group","funders":"","keywords":"Thrombotic thrombocytopenic purpura; Medicine; Gastroenterology; ADAMTS; Internal medicine; Liter; Platelet; Metalloproteinase","score_opus":0.04008406345312412,"score_gpt":0.2648640064000651,"score_spread":0.22477994294694095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2536521233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99537927,0.00045481877,0.00006309731,0.00011744265,0.000279213,0.0028573307,0.00038056757,0.0002477948,0.00022046466],"genre_scores_gemma":[0.9982757,0.000005196719,0.00012281585,0.000036296966,0.00006795944,0.00040173283,0.00008426363,0.000080437465,0.00092561037],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99628645,0.0002950318,0.0011049489,0.0008564454,0.00021292196,0.0012441971],"domain_scores_gemma":[0.9983967,0.0001608559,0.0004642824,0.0007622887,0.00009782424,0.000118050106],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005892657,0.00060201413,0.0009497951,0.00037717432,0.0002757506,0.0000485724,0.0005610215,0.00029576162,0.0016587897],"category_scores_gemma":[0.000106071115,0.0005049632,0.00018740742,0.00036300987,0.00017517537,0.00019238364,0.0003167431,0.00040004044,0.000296676],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011951805,0.0019580817,0.65431577,0.00053132896,0.0010601119,0.00071273994,0.00082668127,0.000044804732,0.33898774,0.000091895134,0.000061123064,0.00021456386],"study_design_scores_gemma":[0.013785331,0.00051447545,0.73841226,0.0006060725,0.00023931805,0.00022363884,0.0006205416,0.0000053259573,0.24489821,0.000014670725,0.00014913344,0.00053099246],"about_ca_topic_score_codex":0.00020968166,"about_ca_topic_score_gemma":0.002849088,"teacher_disagreement_score":0.094089516,"about_ca_system_score_codex":0.00030710813,"about_ca_system_score_gemma":0.00010323202,"threshold_uncertainty_score":0.9997402},"labels":[],"label_agreement":null},{"id":"W2536610015","doi":"10.1182/blood.v114.22.3647.3647","title":"Identification of the ETS Family Member ELF1 as a Transcriptional Regulator of MEIS1 Expression.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; Hox gene; Genetics; Transcriptional regulation; Histone; Regulatory sequence; Gene; Regulation of gene expression; Molecular biology; Promoter; Transcription factor; Gene expression","score_opus":0.009821477187399154,"score_gpt":0.24555381420465325,"score_spread":0.2357323370172541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2536610015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971984,0.0010968791,0.0002987804,0.00017870392,0.000052382286,0.00010281491,0.00002457434,0.0000028771863,0.0010445956],"genre_scores_gemma":[0.9987773,0.00008301966,0.00013662686,0.00008464577,0.000050248276,0.000011661757,0.000016120286,0.000004701447,0.000835717],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994428,0.000027195509,0.0001996896,0.00013520259,0.00013201915,0.00006307767],"domain_scores_gemma":[0.99942976,0.0000023267128,0.000113828944,0.0003425968,0.00009174375,0.00001972398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008039973,0.0000553203,0.000065928485,0.000014501326,0.00003533982,0.000004522822,0.00015361694,0.00006633171,0.000018654626],"category_scores_gemma":[0.000017738956,0.000040877836,0.0000845674,0.00006409318,0.00004501914,0.0000030036745,0.000010875703,0.000028218665,0.0000016365876],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015768384,0.00018148891,0.0002016018,0.0000056665167,0.000016107066,4.9158075e-8,0.000036560858,0.000021463738,0.99772424,0.0008916208,0.00049080706,0.0004146367],"study_design_scores_gemma":[0.00037673142,0.000043793454,0.07011829,0.000012468597,0.000027612932,0.000002535987,0.000028444034,0.0000048512675,0.9257941,0.00036674205,0.003179508,0.000044881734],"about_ca_topic_score_codex":0.000004279396,"about_ca_topic_score_gemma":0.0000011227801,"teacher_disagreement_score":0.071930096,"about_ca_system_score_codex":0.00000237564,"about_ca_system_score_gemma":0.000052845196,"threshold_uncertainty_score":0.16669498},"labels":[],"label_agreement":null},{"id":"W2536726826","doi":"10.1182/blood.v126.23.3583.3583","title":"PLAG1 and USF2 Regulate Primitive Hematopoietic Expression of Musashi-2","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Biology; Ectopic expression; Stem cell; Transcription factor; Haematopoiesis; Regulation of gene expression; Context (archaeology); Gene expression; Cell biology; Genetics; Gene","score_opus":0.030816457340551183,"score_gpt":0.2904943886512641,"score_spread":0.25967793131071293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2536726826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98919886,0.0005587388,0.000033492048,0.0003963268,0.000023473158,0.00028474635,0.000005598478,0.00003255156,0.009466222],"genre_scores_gemma":[0.9962802,0.00004460061,0.0024204347,0.00008342161,0.00007179124,0.000011457937,0.000009139377,0.000019851133,0.0010590958],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990342,0.000046750356,0.00017704835,0.00019912006,0.0003461636,0.00019670605],"domain_scores_gemma":[0.99918634,0.00006763231,0.00005924386,0.0002895168,0.00015095972,0.00024629862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002555338,0.00009833795,0.00025318193,0.000086501896,0.00002255594,0.0000069028188,0.00007088867,0.00009746357,0.0000317082],"category_scores_gemma":[0.0002564394,0.000075630116,0.000033519,0.00011992505,0.00012260096,0.000058905563,0.00012571408,0.00016591129,0.000020553936],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009600633,0.001258662,0.035346918,0.0007475759,0.00019165326,0.00053377287,0.0072088013,0.0000022330048,0.9373809,0.0008893354,0.013504237,0.0019758104],"study_design_scores_gemma":[0.010986938,0.00066644145,0.02277253,0.00045146604,0.00016568876,0.00048461524,0.0010415413,0.0000609425,0.9611119,0.0005285205,0.0015841373,0.0001452476],"about_ca_topic_score_codex":0.00001940908,"about_ca_topic_score_gemma":0.0000012265829,"teacher_disagreement_score":0.023730991,"about_ca_system_score_codex":0.000035045952,"about_ca_system_score_gemma":0.00020246698,"threshold_uncertainty_score":0.30841067},"labels":[],"label_agreement":null},{"id":"W2536831387","doi":"10.1182/blood.v120.21.4433.4433","title":"Associations Between Baseline Mutation Status and Response to Treatment with Omacetaxine Mepesuccinate in Heavily Pretreated Patients with Chronic Myeloid Leukemia","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Myeloid leukemia; Tolerability; Imatinib; Phases of clinical research; Gastroenterology; Oncology; Immunology; Adverse effect; Clinical trial","score_opus":0.010706767314877245,"score_gpt":0.25315316635441687,"score_spread":0.24244639903953963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2536831387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967413,0.00053202634,0.0000308426,0.0002452289,0.000021461585,0.0018187652,0.00038125666,0.00009073218,0.00013838883],"genre_scores_gemma":[0.9965548,0.000051986775,0.001457082,0.00005807252,0.0001033357,0.00017379985,0.0011395647,0.00006360285,0.00039777483],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99780726,0.00021856016,0.00038071044,0.00043430878,0.00042486345,0.0007342989],"domain_scores_gemma":[0.9985405,0.0002784083,0.00016525296,0.00036979842,0.0001486204,0.0004973866],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033994936,0.00036550016,0.0005771396,0.00031070408,0.00010001782,0.00002220049,0.000045413246,0.00012054127,0.000041294403],"category_scores_gemma":[0.0001437053,0.00025906472,0.000037307665,0.00059481984,0.000040282997,0.0002136901,0.00002746037,0.00016039153,0.000030862826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021220117,0.0012372216,0.98696214,0.000025843903,0.000520811,0.000051602703,0.0013390402,0.000034355744,0.00042921884,0.0000019960776,0.000012103117,0.0072636465],"study_design_scores_gemma":[0.043153264,0.006792128,0.94257355,0.00018897184,0.0009697762,0.000018578794,0.000042738782,0.000029207962,0.0056030364,0.0000013849277,0.00037314612,0.0002542019],"about_ca_topic_score_codex":0.0013713028,"about_ca_topic_score_gemma":0.001024853,"teacher_disagreement_score":0.044388585,"about_ca_system_score_codex":0.0065211006,"about_ca_system_score_gemma":0.0010430814,"threshold_uncertainty_score":0.9999862},"labels":[],"label_agreement":null},{"id":"W2536848274","doi":"10.1182/blood.v106.11.2085.2085","title":"Outcomes of Salvage Chemotherapy and Autologous Stem Cell Transplantation for Relapsed or Refractory Primary Mediastinal Large B Cell Lymphoma (PMLCL) Are Inferior to Diffuse Large B Cell Lymphoma (DLBCL).","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Salvage therapy; Chemotherapy; Chemotherapy regimen; Internal medicine; Melphalan; Transplantation; Oncology; Autologous stem-cell transplantation; Surgery; Diffuse large B-cell lymphoma; Regimen; Hematopoietic stem cell transplantation","score_opus":0.010484356149444552,"score_gpt":0.24408833761440074,"score_spread":0.2336039814649562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2536848274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99460423,0.0015755416,0.0001804972,0.00053671974,0.00013047257,0.0015767723,0.0007163808,0.00012800313,0.000551373],"genre_scores_gemma":[0.9913747,0.0010189719,0.0037975588,0.0019266454,0.00014831695,0.00027998697,0.0001948586,0.00009589139,0.001163097],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975606,0.000069549234,0.0006981122,0.00061185186,0.00042240764,0.00063746254],"domain_scores_gemma":[0.9982141,0.0004470582,0.00037508705,0.00047555298,0.00012140145,0.00036679438],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023314814,0.000483709,0.0009786831,0.00020998206,0.00014314488,0.000029739973,0.00015448917,0.00027470526,0.000043909633],"category_scores_gemma":[0.000021658103,0.00036781954,0.0002436222,0.00017337178,0.000047658803,0.00014358113,0.000041310093,0.00006577141,0.000027839807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007695116,0.19263622,0.6721247,0.0049466267,0.0007550997,0.0010883517,0.009727576,0.0000017780446,0.034208693,0.00004931075,0.002289104,0.074477434],"study_design_scores_gemma":[0.15864556,0.0017865904,0.69620883,0.00016219963,0.0009070309,0.00009054484,0.00033190777,0.0000270922,0.13461009,0.0000026690025,0.006867685,0.00035979575],"about_ca_topic_score_codex":0.000028331839,"about_ca_topic_score_gemma":0.000091305876,"teacher_disagreement_score":0.19084963,"about_ca_system_score_codex":0.0002195855,"about_ca_system_score_gemma":0.00028757803,"threshold_uncertainty_score":0.9998774},"labels":[],"label_agreement":null},{"id":"W2536860185","doi":"10.1182/blood.v114.22.620.620","title":"Accurate Classification of Diffuse Large B Cell Lymphoma Into Germinal Center and Activated B Cell Subtypes Using a Nuclease Protection Assay On Formalin Fixed Paraffin Embedded Tissue: A Study From the Lymphoma and Leukemia Molecular Profiling Project.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"BCL6; Diffuse large B-cell lymphoma; Germinal center; Tissue microarray; Gene expression profiling; Cancer research; Biology; Lymphoma; Molecular biology; B cell; Immunohistochemistry; Computational biology; Gene expression; Gene; Antibody; Genetics; Immunology","score_opus":0.03007597998786294,"score_gpt":0.30898896765822115,"score_spread":0.2789129876703582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2536860185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961659,0.00015153762,0.00020135754,0.00008763145,0.000022383156,0.0031905577,0.000020936968,0.00005220118,0.00010751769],"genre_scores_gemma":[0.99899864,0.000027970245,0.00060822064,0.00007474751,0.000064378866,0.00007703861,0.00003939889,0.000039582224,0.000070016904],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980324,0.0003755065,0.00036365562,0.0004672191,0.00043527334,0.00032594442],"domain_scores_gemma":[0.9990024,0.000094067196,0.00023121653,0.0004318632,0.00013488438,0.00010555409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047849855,0.00025382405,0.00033656202,0.00015354066,0.00017132291,0.000076995355,0.00011584494,0.00014690206,0.0000147219125],"category_scores_gemma":[0.00009057367,0.00019009337,0.00005437872,0.0003265513,0.00005946744,0.00013626553,0.00006083082,0.00017781496,0.000002277265],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002507764,0.0072980477,0.0033892614,0.00010028834,0.00008052103,0.00006812192,0.0029669954,0.0000021358455,0.97249895,0.0000055356004,0.0000051983984,0.011077167],"study_design_scores_gemma":[0.029112728,0.0017334237,0.04511937,0.00012688272,0.0002484361,0.000038341062,0.0017102743,0.008219956,0.9134117,0.000026454874,0.0000511095,0.00020134395],"about_ca_topic_score_codex":0.00040156208,"about_ca_topic_score_gemma":0.000030008216,"teacher_disagreement_score":0.059087284,"about_ca_system_score_codex":0.00015743927,"about_ca_system_score_gemma":0.0002363968,"threshold_uncertainty_score":0.77517825},"labels":[],"label_agreement":null},{"id":"W2536902940","doi":"10.1182/blood.v126.23.5252.5252","title":"Assessing Disease Stability of Patients with Myelodysplastic Syndrome for an Age of Blood Randomized Controlled Trial: A Chart Review","year":2015,"lang":"en","type":"review","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Joseph’s Healthcare Hamilton; St. Joseph's Hospital; McMaster University","funders":"","keywords":"Medicine; Blood transfusion; Randomized controlled trial; Hematology; Pediatrics; Emergency medicine; Internal medicine; Intensive care medicine","score_opus":0.07038150723377104,"score_gpt":0.3750382234111799,"score_spread":0.30465671617740886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2536902940","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009283175,0.9302646,0.000045738983,0.000016391554,0.00010391416,0.05964725,0.00048890576,0.000044644774,0.0001054168],"genre_scores_gemma":[0.0016414087,0.98767453,0.00078148587,0.000026622758,0.00012277029,0.0072173486,0.0023094271,0.00016567655,0.00006070153],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99185365,0.0022811287,0.0030916096,0.0008078283,0.0014267787,0.0005389985],"domain_scores_gemma":[0.9905495,0.0032667932,0.0024463388,0.0014725397,0.0015270091,0.0007378409],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0064656297,0.0007371461,0.018152267,0.00035138795,0.000049487953,0.00003323391,0.0004399315,0.00028982662,0.000070957],"category_scores_gemma":[0.01249329,0.00043513862,0.002086528,0.00053879834,0.0004344637,0.00019074362,0.00011312261,0.0005282031,0.0000036565393],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6270572,0.0070189727,0.000027295177,0.3462198,0.0057560843,0.00011757909,0.000022875938,3.1450995e-8,0.0000011816002,0.0000121229195,0.000040564115,0.0137263],"study_design_scores_gemma":[0.8033372,0.0023855893,0.000014054125,0.08789075,0.099453755,0.000025454012,0.000004553483,0.000004245205,9.141472e-7,0.000010415106,0.0065649967,0.00030803782],"about_ca_topic_score_codex":0.000009790744,"about_ca_topic_score_gemma":0.0000013109609,"teacher_disagreement_score":0.25832906,"about_ca_system_score_codex":0.00013586367,"about_ca_system_score_gemma":0.005377151,"threshold_uncertainty_score":0.99981004},"labels":[],"label_agreement":null},{"id":"W2536912845","doi":"10.1182/blood.v124.21.5103.5103","title":"Utilization of Universal Group O Blood By Non Group O Recipients","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hamilton Regional Laboratory Medicine Program; University of Waterloo; McMaster University","funders":"","keywords":"ABO blood group system; Medicine; Rh blood group system; Red blood cell; Red Cell; Blood transfusion; Group B; Blood type (non-human); Economic shortage; Internal medicine; Immunology; Antibody","score_opus":0.010305828957832486,"score_gpt":0.22439313877532496,"score_spread":0.21408730981749247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2536912845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901048,0.00020467375,0.002970625,0.00008923214,0.00015245516,0.00027554276,0.000015360656,0.000056679222,0.0061306385],"genre_scores_gemma":[0.998432,0.00016119528,0.00074438413,0.000110472356,0.000112315545,0.0000047267085,0.000169807,0.000027823522,0.00023731375],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99895334,0.000040657855,0.00024573095,0.0002694806,0.0002865881,0.00020420663],"domain_scores_gemma":[0.9993997,0.000032903863,0.000086719556,0.00028955974,0.000066617,0.00012449439],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017839551,0.00014333038,0.00027556618,0.00009027423,0.000055619348,0.0000069037337,0.00009044874,0.0001376992,0.00008829273],"category_scores_gemma":[0.000026296239,0.00012936543,0.000092298455,0.00023657821,0.000053092983,0.000086523025,0.00002673251,0.00012541033,0.000013770079],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046653135,0.013355211,0.2994641,0.00047304065,0.0005877251,0.000037836016,0.00064826227,0.0000013816804,0.6514166,0.0050869356,0.0015704711,0.026891908],"study_design_scores_gemma":[0.071904115,0.009787343,0.39883825,0.0010915006,0.0059028286,0.00017599943,0.0002662143,0.00085168733,0.48288924,0.00049967814,0.02690546,0.0008876906],"about_ca_topic_score_codex":0.00013112003,"about_ca_topic_score_gemma":0.000023683468,"teacher_disagreement_score":0.16852736,"about_ca_system_score_codex":0.0000076198207,"about_ca_system_score_gemma":0.00001270047,"threshold_uncertainty_score":0.5275369},"labels":[],"label_agreement":null},{"id":"W2536948859","doi":"10.1182/blood.v106.11.33.33","title":"Differential Effects of HOXB4 Overexpression on Short and Long-Term Repopulating Cells in Nonhuman Primates.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Biology; Ex vivo; Haematopoiesis; Transplantation; Stem cell; CD34; Immunology; Cancer research; Chimera (genetics); Genetic enhancement; Transduction (biophysics); In vivo; Molecular biology; Cell biology; Internal medicine; Medicine; Genetics; Gene","score_opus":0.017957364346055476,"score_gpt":0.30558302989807307,"score_spread":0.2876256655520176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2536948859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99779606,0.00015516578,0.0000051107404,0.000017961072,0.000028040742,0.0005437578,0.0000035810706,0.000018680283,0.0014316493],"genre_scores_gemma":[0.9992334,0.000027592623,0.000190041,0.000018824689,0.00013038405,0.000016280368,0.000020062056,0.00002027494,0.0003431159],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99873346,0.000052685325,0.0002857864,0.00026896634,0.00040428847,0.0002548169],"domain_scores_gemma":[0.9993472,0.00017926938,0.000058127473,0.00026853054,0.000025605688,0.00012127106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000092530616,0.00012672076,0.00029589655,0.00012829149,0.000032244843,0.000012601549,0.00006248104,0.00009384334,0.0003772727],"category_scores_gemma":[0.00012277692,0.00010087297,0.000043706517,0.000081927385,0.000037421723,0.00004037018,0.0000971597,0.0002148246,0.000008235422],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008072373,0.0007397482,0.27649656,0.0009029802,0.000017388875,0.000112692935,0.000092819755,0.0000011140993,0.717626,0.000007220573,0.000043315133,0.0038794857],"study_design_scores_gemma":[0.0015674123,0.00028239164,0.4364902,0.0011666571,0.000026040954,0.000013085269,0.000002111899,0.000079942714,0.56030345,0.0000021835847,0.0000070251313,0.000059466598],"about_ca_topic_score_codex":0.000020402094,"about_ca_topic_score_gemma":0.000011883575,"teacher_disagreement_score":0.15999366,"about_ca_system_score_codex":0.000030716597,"about_ca_system_score_gemma":0.00001976094,"threshold_uncertainty_score":0.41308713},"labels":[],"label_agreement":null},{"id":"W2537111300","doi":"10.1182/blood.v116.21.3733.3733","title":"Differences In the Short Term Granulocyte and Platelet Producing Activity of Cord Blood and Mobilized Peripheral Blood Transplants Revealed by Quantitative Repopulation Assays In NOD/SCID-IL-2Rγc−/− Mice.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Leukapheresis; Haematopoiesis; Immunology; Transplantation; Cord blood; Platelet; Granulocyte; Progenitor cell; Medicine; Biology; CD34; Stem cell; Internal medicine; Cell biology","score_opus":0.02407695978302797,"score_gpt":0.2804833450476663,"score_spread":0.2564063852646383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2537111300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980144,0.00022335094,0.00004068196,0.00013979172,0.000059613674,0.0012772843,0.00007452246,0.000024540754,0.00014579677],"genre_scores_gemma":[0.99848074,0.00026299572,0.0010441547,0.000019152452,0.000024675364,0.00007402689,0.000057884146,0.000021021388,0.000015366788],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99807435,0.00023277149,0.00055476726,0.0005157342,0.00035020694,0.00027215364],"domain_scores_gemma":[0.99905413,0.00038445706,0.00015654399,0.00027808783,0.00005060747,0.00007617818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086627813,0.00024805943,0.0005980104,0.00014876097,0.00006590435,0.000027400096,0.00010140501,0.00018287779,0.000010956293],"category_scores_gemma":[0.000116840296,0.00018701721,0.00004694544,0.0002492114,0.00015525795,0.00015746741,0.000011293988,0.00044194184,2.6621444e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043408296,0.00072476047,0.5070301,0.0004384758,0.000059120397,0.00007953662,0.0053036767,1.6547659e-7,0.4856087,0.000016374315,8.952117e-7,0.0003040877],"study_design_scores_gemma":[0.007295682,0.0005481911,0.78491205,0.00047119072,0.00048278447,0.00061565405,0.0004241571,0.00012208984,0.20490547,0.000039837134,8.3088844e-7,0.00018205192],"about_ca_topic_score_codex":0.00036124937,"about_ca_topic_score_gemma":0.0013726491,"teacher_disagreement_score":0.28070325,"about_ca_system_score_codex":0.0000073503684,"about_ca_system_score_gemma":0.000049709222,"threshold_uncertainty_score":0.76263404},"labels":[],"label_agreement":null},{"id":"W2537140903","doi":"10.1182/blood.v112.11.1986.1986","title":"A Pooled Analysis of Four Pivotal Studies of Rivaroxaban for the Prevention of Venous Thromboembolism after Orthopaedic Surgery: Effects of Specified Co-Medications.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Rivaroxaban; Medicine; Placebo; Surgery; Hemostasis; Knee replacement; Anesthesia; Randomized controlled trial; Enoxaparin sodium; Arthroplasty; Internal medicine; Thrombosis; Warfarin; Low molecular weight heparin","score_opus":0.03648602830627829,"score_gpt":0.304460875318514,"score_spread":0.26797484701223573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2537140903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921293,0.0057579274,0.00037547105,0.0001646204,0.00012443478,0.0012764452,0.000047523612,0.000013302266,0.00011096651],"genre_scores_gemma":[0.99549806,0.0037031195,0.00033169388,0.00004177669,0.00007913151,0.00023971668,0.000037703852,0.000018943596,0.000049836883],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822074,0.00008692603,0.0008012265,0.00021828095,0.00048024356,0.00019259304],"domain_scores_gemma":[0.99733424,0.0010451658,0.00069496303,0.00052142184,0.0003525883,0.000051621453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005412851,0.00016081498,0.0016532283,0.00044064046,0.000059200214,0.0000015146794,0.0001245651,0.00006818666,0.000039514583],"category_scores_gemma":[0.00041747006,0.00011536414,0.00081809243,0.0007242543,0.00034526747,0.00003917828,0.000052800493,0.00006548477,7.7605455e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019860521,0.075799435,0.43484375,0.026620712,0.33782887,0.00017364354,0.031669274,0.00019913646,0.05750695,0.0034431447,0.011377446,0.018551573],"study_design_scores_gemma":[0.002289483,0.00088792143,0.92405325,0.0005001661,0.037296243,0.000006248251,0.00041396316,0.00003448526,0.034223914,0.0001130555,0.00008248825,0.00009877216],"about_ca_topic_score_codex":0.00007812919,"about_ca_topic_score_gemma":0.000033397184,"teacher_disagreement_score":0.4892095,"about_ca_system_score_codex":0.000015490818,"about_ca_system_score_gemma":0.00011598056,"threshold_uncertainty_score":0.4704413},"labels":[],"label_agreement":null},{"id":"W2537147572","doi":"10.1182/blood.v104.11.3226.3226","title":"EAR-2: Identification of a Gene Involved in Maintenance of Clonogenicity in Haematopoiesis.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Ontario Institute for Cancer Research","funders":"","keywords":"Biology; Haematopoiesis; Stem cell; Clonogenic assay; Cancer research; Population; Progenitor cell; Cell culture; Immunology; Cell biology; Genetics; Medicine","score_opus":0.006989408798384399,"score_gpt":0.22354315535227148,"score_spread":0.2165537465538871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2537147572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975968,0.0014045371,0.0007079698,0.000020159092,0.000021509873,0.00010272407,0.0000063114258,0.0000022299623,0.0001377781],"genre_scores_gemma":[0.9987907,0.00028746392,0.00081349845,0.000016193482,0.000016236481,0.000014256629,0.000021993663,0.000007400273,0.000032261858],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992577,0.0000250613,0.0003477781,0.00017940205,0.0000767408,0.000113307244],"domain_scores_gemma":[0.99955755,0.000004443636,0.00013802653,0.00022550453,0.000058088783,0.000016399406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020449345,0.00006897964,0.00014164488,0.000047896927,0.0000070971246,0.0000027766755,0.00014980172,0.000098202836,0.0000018231019],"category_scores_gemma":[0.00011048651,0.000069614325,0.000045484485,0.00014654807,0.000069421745,0.0000029989676,0.000033005188,0.00004717506,9.788546e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027044596,0.00026337607,0.034120176,0.000092572,0.00001175883,0.0000040935624,0.00010748869,0.00015860479,0.96501976,0.00014625082,0.000003899546,0.0000449794],"study_design_scores_gemma":[0.001336026,0.000054582903,0.019017592,0.000039900417,0.000008839689,0.0000053162253,0.00008585595,0.000004280455,0.97863716,0.0007236705,0.000019399544,0.00006735338],"about_ca_topic_score_codex":0.00011386718,"about_ca_topic_score_gemma":0.0001484061,"teacher_disagreement_score":0.015102582,"about_ca_system_score_codex":0.000010785388,"about_ca_system_score_gemma":0.00010165047,"threshold_uncertainty_score":0.28387898},"labels":[],"label_agreement":null},{"id":"W2537189179","doi":"10.1182/blood.v126.23.3935.3935","title":"Results of the Mantle Cell Lymphoma Subset from a Phase 2a Study of Copanlisib, a Novel PI3K Inhibitor, in Patients with Indolent and Aggressive Lymphoma","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Jewish General Hospital","funders":"","keywords":"Mantle cell lymphoma; Medicine; Internal medicine; Idelalisib; Lymphoma; Phases of clinical research; Chronic lymphocytic leukemia; Oncology; Progressive disease; Aggressive lymphoma; Clinical endpoint; Gastroenterology; Clinical trial; Ibrutinib; Rituximab; Leukemia; Disease","score_opus":0.019449860810403036,"score_gpt":0.2655987216363375,"score_spread":0.24614886082593448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2537189179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975242,0.00037873705,0.0000010073471,0.000021411557,0.00006165715,0.0014025707,0.0003551519,0.000010343395,0.0002449251],"genre_scores_gemma":[0.9996542,0.000010070138,0.00010078147,0.000030031786,0.00004655267,0.000032207547,0.00005191129,0.00002973105,0.000044563887],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9975698,0.000110651425,0.00055647123,0.00040434833,0.0010604066,0.00029831595],"domain_scores_gemma":[0.99815685,0.00015984412,0.00044735442,0.00071954937,0.00032288983,0.00019351605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002852447,0.0002066393,0.00050201826,0.00014475931,0.000028094399,0.000011599774,0.00022559383,0.000099183584,0.000004319225],"category_scores_gemma":[0.00035218088,0.0001311013,0.00004124695,0.00042346632,0.00019687225,0.000067613175,0.00028024212,0.00009262636,0.0000029495668],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.059333067,0.296381,0.5670418,0.0006626963,0.0010246357,0.0011770895,0.05452148,0.000031720425,0.005940093,0.000006473383,0.0018281305,0.01205178],"study_design_scores_gemma":[0.7432682,0.0063276524,0.20325603,0.00072650774,0.00026745076,0.000034361663,0.0027075645,0.00023381093,0.04295518,0.000007032948,0.000052121413,0.00016409617],"about_ca_topic_score_codex":0.0054968377,"about_ca_topic_score_gemma":0.0005372885,"teacher_disagreement_score":0.6839351,"about_ca_system_score_codex":0.0010676596,"about_ca_system_score_gemma":0.0033673015,"threshold_uncertainty_score":0.83096105},"labels":[],"label_agreement":null},{"id":"W2537241602","doi":"10.1182/blood.v110.11.2514.2514","title":"Pre-Clinical Validation of Polo-Like Kinase 1 as a Therapeutic Target in Multiple Myeloma with the Selective Inhibitor BI2536.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"PLK1; Cancer research; Bortezomib; Centrosome; Biology; Polo-like kinase; Mitosis; Multiple myeloma; Kinase; Cell cycle; Apoptosis; Immunology; Cell biology","score_opus":0.009748020548177914,"score_gpt":0.2652101127762276,"score_spread":0.25546209222804966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2537241602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99766254,0.0003830707,0.0012855144,0.00006109055,0.000050575018,0.0003225612,0.000008674449,0.0000064961732,0.0002194998],"genre_scores_gemma":[0.9987534,0.000041043066,0.0006156836,0.00025051663,0.00013308476,0.000016208778,0.00005373366,0.000017446164,0.00011884147],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991295,0.00008812742,0.00024407839,0.00024521738,0.00009694019,0.00019617938],"domain_scores_gemma":[0.99946564,0.000055926062,0.000114192226,0.00024563045,0.0000790911,0.00003954528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039927193,0.00011653736,0.00013392784,0.000037562942,0.000038632024,0.000009636885,0.00013377638,0.00015419461,0.000005456764],"category_scores_gemma":[0.00005671894,0.00008105088,0.0000638496,0.0001385393,0.00009965301,0.00000409278,0.000045485504,0.00012429274,0.000002956872],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046608216,0.0006782267,0.14025424,0.00001118089,0.00012571996,0.0000051885854,0.00020107755,0.00002393434,0.8572191,0.000020663841,0.00010874255,0.00088584743],"study_design_scores_gemma":[0.0019375071,0.00081732584,0.06430489,0.0000131098695,0.000046215806,0.000014710934,0.00013440245,0.000022171533,0.9306959,0.000028040315,0.0018634415,0.00012227526],"about_ca_topic_score_codex":0.00007027193,"about_ca_topic_score_gemma":0.00043368863,"teacher_disagreement_score":0.07594935,"about_ca_system_score_codex":0.0000065930553,"about_ca_system_score_gemma":0.00008882223,"threshold_uncertainty_score":0.3305159},"labels":[],"label_agreement":null},{"id":"W2537426197","doi":"10.1182/blood.v124.21.271.271","title":"Chemical Genomics Reveals JAK STAT Activation As a Mechanism of Resistance to HDAC Inhibitors in B Cell Lymphomas","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Panobinostat; Biology; Cancer research; Vorinostat; Cell culture; Gene expression profiling; Lymphoma; In vivo; Romidepsin; Gene expression; Molecular biology; Histone deacetylase; Gene; Immunology; Histone; Genetics","score_opus":0.004547658982032134,"score_gpt":0.20620454231746677,"score_spread":0.20165688333543463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2537426197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957236,0.000061023013,0.0007941874,0.00014291317,0.000050964,0.00023071178,0.000008129317,0.00000802432,0.0029804495],"genre_scores_gemma":[0.99667245,0.000021186494,0.0023204836,0.00028452644,0.00013020585,0.00002656044,0.0000396015,0.0000176804,0.00048730048],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99914336,0.00004877359,0.0002598628,0.00026530802,0.00012228059,0.00016044248],"domain_scores_gemma":[0.9994906,0.00001140968,0.000107033295,0.00026230267,0.00005584691,0.00007281772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017237259,0.00011072118,0.00013328197,0.00005832613,0.000020040976,0.000009478308,0.00013059605,0.00013680107,0.000008407966],"category_scores_gemma":[0.00018539555,0.000117601994,0.00004624777,0.00011690923,0.000020389547,0.000004702807,0.00007192571,0.000048930735,0.0000097449665],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005831023,0.000138789,0.00016989076,0.000023555815,0.0000061297246,3.7529122e-7,0.000059690894,0.00000282695,0.9977755,0.0008418774,0.0006506409,0.00027244756],"study_design_scores_gemma":[0.0010053304,0.00010856112,0.00012646955,0.00003211901,0.0000062503755,0.0000010435881,0.00003748267,0.0000032504754,0.98961407,0.00079406955,0.008138496,0.00013283704],"about_ca_topic_score_codex":0.000016290236,"about_ca_topic_score_gemma":0.000012857296,"teacher_disagreement_score":0.008161376,"about_ca_system_score_codex":0.00002335722,"about_ca_system_score_gemma":0.000059909005,"threshold_uncertainty_score":0.479567},"labels":[],"label_agreement":null},{"id":"W2537557937","doi":"10.1182/blood.v116.21.324.324","title":"A miRNA Risk Score for the Prediction of Response to Rituximab-CHOP Therapy and Survival of Patients with Diffuse Large B-Cell Lymphoma","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"microRNA; Gene expression profiling; Diffuse large B-cell lymphoma; Biology; CHOP; Gene expression; Oncology; Cancer research; Lymphoma; Gene; Immunology; Medicine; Genetics","score_opus":0.010552525419542495,"score_gpt":0.22448283048362502,"score_spread":0.21393030506408253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2537557937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977982,0.00023184286,0.000019545761,0.00011695368,0.000082533836,0.001085378,0.0006239434,0.000012159117,0.000029463868],"genre_scores_gemma":[0.99917483,0.00013990606,0.0004061601,0.00004865475,0.00003701619,0.00012305725,0.00001843889,0.000017011365,0.00003492908],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99928766,0.000038524355,0.00016977948,0.00016564743,0.00020310543,0.00013529664],"domain_scores_gemma":[0.9990103,0.00034652173,0.00011295225,0.00030615652,0.00014467206,0.00007935389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020785922,0.00011101854,0.0002266064,0.00005049122,0.00006468502,0.000006827645,0.000052103518,0.000053072283,0.000007389537],"category_scores_gemma":[0.00010200762,0.000059486865,0.000059171278,0.00008558753,0.00004952345,0.000026950205,0.000019752739,0.000034448472,9.791477e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007754378,0.026793176,0.9569326,0.00003297488,0.00022068387,0.0000022403503,0.0005405012,7.190461e-8,0.0032735358,0.000021491805,0.000070906375,0.0043574516],"study_design_scores_gemma":[0.110975295,0.0025611557,0.8635515,0.000036443365,0.0003298162,0.000002313247,0.000052854783,0.000012040958,0.02118677,0.000007312814,0.0012394978,0.000045029017],"about_ca_topic_score_codex":0.00007980511,"about_ca_topic_score_gemma":0.00005653974,"teacher_disagreement_score":0.10322092,"about_ca_system_score_codex":0.000009778185,"about_ca_system_score_gemma":0.00005841908,"threshold_uncertainty_score":0.2425804},"labels":[],"label_agreement":null},{"id":"W2537595153","doi":"10.1182/blood.v106.11.546.546","title":"Very Poor Survival of Patients with AML Who Relapse after Achieving a First Complete Remission: The Eastern Cooperative Oncology Group Experience.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nature Conservancy of Canada","funders":"","keywords":"Medicine; Internal medicine; Complete remission; Retrospective cohort study; Transplantation; Pediatrics; Surgery; Chemotherapy","score_opus":0.019225923631018913,"score_gpt":0.27532749540933704,"score_spread":0.2561015717783181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2537595153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99467176,0.00021012365,0.000067192705,0.0020530121,0.000056445042,0.0006436246,0.000021999442,0.000025325677,0.002250537],"genre_scores_gemma":[0.9972825,0.00004296066,0.00081760174,0.00058715034,0.00024090004,0.000102649734,0.000028218714,0.00003288374,0.0008651329],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822783,0.00017952519,0.0003338727,0.00033231167,0.0005574398,0.0003689972],"domain_scores_gemma":[0.9987295,0.00027018852,0.00011971243,0.0004529271,0.0002499884,0.00017764475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025195465,0.00019582233,0.00043294232,0.00007131846,0.00015046367,0.000018118284,0.00024008335,0.00011171316,0.00027631066],"category_scores_gemma":[0.0001862234,0.000112046444,0.00006734735,0.00025679468,0.00034750177,0.00013757408,0.00020482544,0.0004299692,0.000042370593],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070710937,0.0027222345,0.96389645,0.0001273813,0.00041915438,0.00025408994,0.016512118,0.000013668901,0.002056669,0.00006205934,0.0017412294,0.005123826],"study_design_scores_gemma":[0.03845772,0.00945705,0.7742515,0.0011736781,0.00049160863,0.000153521,0.0050363457,0.0011042067,0.0030276068,0.0000046391483,0.16620368,0.00063841103],"about_ca_topic_score_codex":0.000053597032,"about_ca_topic_score_gemma":0.00017541788,"teacher_disagreement_score":0.18964495,"about_ca_system_score_codex":0.00016301205,"about_ca_system_score_gemma":0.0002408697,"threshold_uncertainty_score":0.45691216},"labels":[],"label_agreement":null},{"id":"W2537657085","doi":"10.1182/blood.v120.21.4111.4111","title":"The Early Induction of PDL1 On Monocytes by Ivig Suppresses T Cell Activation in Allogeneic Mixed Lymphocyte Reactions","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"CD80; Immunology; Mixed lymphocyte reaction; CD86; T cell; CD28; Peripheral blood mononuclear cell; Medicine; Transplantation; Lymphocyte; CD40; Biology; Immune system; In vitro; Cytotoxic T cell; Internal medicine","score_opus":0.028962825321849985,"score_gpt":0.28811123406523376,"score_spread":0.2591484087433838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2537657085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99549735,0.0008138088,0.000008629627,0.00026457873,0.00009437056,0.00029432526,0.000008959186,0.00001973554,0.0029982391],"genre_scores_gemma":[0.9980062,0.00060895877,0.000036248937,0.000029751436,0.0001524415,0.000048797963,0.000018322251,0.000018369577,0.0010808978],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989761,0.000071830465,0.00023397936,0.00014015287,0.00028732704,0.00029059668],"domain_scores_gemma":[0.99926776,0.00021792129,0.00008832643,0.00026780393,0.00006732006,0.00009088171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003055877,0.000101381804,0.00015579899,0.00013653033,0.00010316881,0.000018917182,0.00008000392,0.00010500521,0.00005236441],"category_scores_gemma":[0.00011804501,0.00007317546,0.000053804903,0.0002717586,0.000059011236,0.00015612062,0.00002735826,0.00020527649,0.000035125522],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039462963,0.0016413088,0.03541539,0.000050098955,0.0000631416,9.671796e-7,0.00035066679,0.000005192706,0.9527378,0.00010059679,0.001302727,0.007937455],"study_design_scores_gemma":[0.0018609544,0.00019795625,0.11164302,0.000042299103,0.000034936347,0.000003993363,0.00016537713,0.00000783145,0.86371297,0.000023633129,0.022239927,0.00006712692],"about_ca_topic_score_codex":0.0010419027,"about_ca_topic_score_gemma":0.00004958069,"teacher_disagreement_score":0.08902488,"about_ca_system_score_codex":0.00008870075,"about_ca_system_score_gemma":0.00008589509,"threshold_uncertainty_score":0.29840088},"labels":[],"label_agreement":null},{"id":"W2537678552","doi":"10.1182/blood.v104.11.4205.4205","title":"CXCR4 Is a PAX Family Transcription Factor Regulated Gene.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Biology; CXCR4; Stem cell; Progenitor cell; Cell biology; Transcription factor; Molecular biology; Gene; Chemokine; Genetics; Receptor","score_opus":0.028774787804593385,"score_gpt":0.25296738856701695,"score_spread":0.22419260076242356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2537678552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994737,0.0026823685,0.000028582292,0.0014181836,0.00007387845,0.0002981176,0.000031120497,0.00009203299,0.00063867343],"genre_scores_gemma":[0.99751943,0.0002685138,0.00085650437,0.0010234566,0.000087248096,0.000035523564,0.000037768845,0.00001986241,0.00015171776],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9992803,0.000009379076,0.00014922005,0.00020782198,0.00017852773,0.0001747724],"domain_scores_gemma":[0.99959266,0.000008426615,0.000027711789,0.00022777342,0.00003794045,0.00010547693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000022046539,0.00012339231,0.00018294723,0.00005275036,0.00004152102,0.000012232659,0.000034780147,0.0000789719,0.00012957373],"category_scores_gemma":[0.0000060948255,0.0000972,0.000124364,0.000109687964,0.000018628214,0.000036330035,0.0000052977184,0.00006160524,0.00014504939],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001981847,0.013259385,0.16014518,0.00010174874,0.0013728681,0.001195553,0.0031184114,0.000008942607,0.79427403,0.00045318643,0.0012039645,0.024668556],"study_design_scores_gemma":[0.0103345495,0.00034252775,0.6346943,0.00008292453,0.00046101655,0.00009737125,0.000050616447,0.0000025817428,0.3513314,0.000215383,0.002268479,0.00011882502],"about_ca_topic_score_codex":0.00013430635,"about_ca_topic_score_gemma":0.000007788808,"teacher_disagreement_score":0.4745491,"about_ca_system_score_codex":0.000046297606,"about_ca_system_score_gemma":0.000049326805,"threshold_uncertainty_score":0.39637008},"labels":[],"label_agreement":null},{"id":"W2537755821","doi":"10.1182/blood.v118.21.5303.5303","title":"Are Red Cell Indices a Reliable Screening Tool in Pre-Natal Screening for the Avoidance of E-Beta Thalassemia and Beta Thalassemia Major Births? Results of a Population Survey From Eastern India","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Thalassemia; Beta thalassemia; Population; Pediatrics; Disease; Environmental health; Demography; Internal medicine","score_opus":0.029328321656273082,"score_gpt":0.2462016408919738,"score_spread":0.21687331923570072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2537755821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956547,0.002408944,0.00019703577,0.00007063222,0.000056018536,0.00090785,0.00041052242,0.000025004134,0.0002693099],"genre_scores_gemma":[0.9964525,0.00015926306,0.0028745132,0.000028589562,0.000036047924,0.000028711267,0.00026986314,0.000036722755,0.00011376225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981561,0.00011505717,0.00072256016,0.0003976806,0.00030165914,0.00030699346],"domain_scores_gemma":[0.99812865,0.00043494932,0.0008253339,0.00042833705,0.00011680054,0.00006591895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008254409,0.00022181627,0.0005231283,0.00016580363,0.00008505909,0.000016854958,0.00018932584,0.00028298344,0.00001098149],"category_scores_gemma":[0.0003303946,0.00016344807,0.00009538969,0.00034538493,0.00008603637,0.0001608488,0.0001030136,0.00032818384,7.3345655e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001706029,0.00027058437,0.9930738,0.00024374192,0.00016970583,0.000012799099,0.0018079935,0.000027252736,0.0017060714,0.0000047499134,0.000064658096,0.0009125811],"study_design_scores_gemma":[0.009236945,0.0002588574,0.9733806,0.0011673736,0.00030006882,0.0000061432106,0.0012030102,0.0008498907,0.013379927,0.000028647622,0.000025559808,0.0001629757],"about_ca_topic_score_codex":0.011041827,"about_ca_topic_score_gemma":0.0012616942,"teacher_disagreement_score":0.019693233,"about_ca_system_score_codex":0.000010077662,"about_ca_system_score_gemma":0.000041448588,"threshold_uncertainty_score":0.9955437},"labels":[],"label_agreement":null},{"id":"W2537814831","doi":"10.1182/blood.v108.11.1093.1093","title":"Lipopolysaccharide Binds Platelet Toll-Like Receptor 4 and Mediates the Activation of Phagocytes in the Reticuloendothelial System (RES): A Novel Mechanism of Host Immunity.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"TLR4; Innate immune system; Biology; Lipopolysaccharide; Phagocytosis; Cell biology; Toll-like receptor; Platelet; Platelet activation; Receptor; Immune system; Tumor necrosis factor alpha; Phagocyte; Immunology; Biochemistry","score_opus":0.006343975100569715,"score_gpt":0.1947064103643068,"score_spread":0.18836243526373708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2537814831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998046,0.0010074244,0.000057357312,0.00019256462,0.00015953774,0.00033004946,0.000025973699,0.00001654336,0.00016453966],"genre_scores_gemma":[0.99966854,0.00007746029,0.000031884792,0.000019485995,0.000032572574,0.00003441379,0.000053749845,0.000009119735,0.00007275435],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99890363,0.00031572502,0.0004418718,0.00011476509,0.00006211736,0.00016189474],"domain_scores_gemma":[0.998896,0.0005001724,0.0002905187,0.0002514424,0.000057856887,0.0000040159975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006531622,0.0001212475,0.00023503067,0.000116319155,0.00011345805,0.000010026732,0.00022777074,0.00015886727,0.000022331074],"category_scores_gemma":[0.00009584532,0.000072638744,0.00005219098,0.00012914179,0.00014364022,0.00008594752,0.000049015554,0.000191587,0.00000807954],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002550055,0.00020229732,0.00017741302,0.000039094928,0.000072825285,5.323842e-7,0.0016266395,0.0000015931435,0.9864547,0.010891971,0.000035888028,0.00024201021],"study_design_scores_gemma":[0.0022740324,0.00016846886,0.0018580034,0.00009468576,0.00005024753,0.000044497177,0.003033502,0.000012060475,0.9920343,0.000062192885,0.00029211747,0.000075897115],"about_ca_topic_score_codex":0.0007062408,"about_ca_topic_score_gemma":0.000033687837,"teacher_disagreement_score":0.010829778,"about_ca_system_score_codex":0.00001198902,"about_ca_system_score_gemma":0.000039890354,"threshold_uncertainty_score":0.2962122},"labels":[],"label_agreement":null},{"id":"W2537847509","doi":"10.1182/blood.v118.21.4335.4335","title":"Study of Octaplex Dosing Accuracy: An In Vitro Analysis","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Hospital; Western University; London Health Sciences Centre; McMaster University","funders":"","keywords":"Dosing; Warfarin; Medicine; Internal medicine; Gastroenterology; Factor IX; Prothrombin complex concentrate; Prothrombin time; Factor VII; Surgery; Coagulation; Atrial fibrillation","score_opus":0.20142735202482526,"score_gpt":0.4445880529881058,"score_spread":0.24316070096328052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2537847509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99542594,0.000524759,0.00001341264,0.000009963285,0.00025067784,0.0003428232,0.00003597936,0.000033109318,0.0033633125],"genre_scores_gemma":[0.9991222,0.00008648703,0.00040112203,0.00021225761,0.00008855408,0.0000330607,0.000013349023,0.000017322418,0.00002563676],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981255,0.0005853459,0.0004721865,0.00032507963,0.00014724939,0.00034466066],"domain_scores_gemma":[0.999133,0.00012144122,0.00018545816,0.00030553224,0.00006811233,0.00018646833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070749596,0.00018123849,0.00042718937,0.0004414226,0.000077766395,0.000008020866,0.00036502865,0.00014025935,0.00058047933],"category_scores_gemma":[0.000041727013,0.00017734755,0.00011451355,0.0008970786,0.000062061044,0.00010918946,0.000098007506,0.0003725836,0.000013794919],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006386777,0.021031525,0.26083523,0.000018244515,0.0024188433,0.00016840543,0.02390453,0.00030646106,0.6787764,0.000080897786,0.000016316051,0.011804522],"study_design_scores_gemma":[0.00804562,0.00025911437,0.12424472,0.0000021509939,0.0053970786,0.00000600067,0.0018058468,0.0012576686,0.8577346,0.00023634099,0.0007025293,0.0003083228],"about_ca_topic_score_codex":0.0002707947,"about_ca_topic_score_gemma":0.00011441538,"teacher_disagreement_score":0.17895825,"about_ca_system_score_codex":0.000008194368,"about_ca_system_score_gemma":0.000046583275,"threshold_uncertainty_score":0.72320235},"labels":[],"label_agreement":null},{"id":"W2537917759","doi":"10.1182/blood.v106.11.880.880","title":"Thrombotic and Hemorrhagic Events for Patients on Pediatric Oncology Group (POG) Protocols 9201, 9605, 9406.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Children's Hospital","funders":"","keywords":"Medicine; Prednisone; Internal medicine; Gastroenterology; Vincristine; Incidence (geometry); Coagulopathy; Surgery; Chemotherapy; Cyclophosphamide","score_opus":0.021582498097194536,"score_gpt":0.3287316080736357,"score_spread":0.3071491099764412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2537917759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9725565,0.000053668315,0.000106895925,0.0007572858,0.00008016293,0.024683332,0.000030877844,0.00007376078,0.0016575636],"genre_scores_gemma":[0.9803891,0.000025504054,0.005845249,0.0008675168,0.0010825547,0.010983033,0.00005704125,0.000066813154,0.0006831734],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998088,0.0000664747,0.00035336797,0.00045718814,0.00048199276,0.00055298035],"domain_scores_gemma":[0.99871534,0.00037723978,0.000120344666,0.00034506866,0.00014850852,0.00029352523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002621004,0.00022445033,0.00042558243,0.00017877176,0.00010678543,0.000014702574,0.00015646024,0.0002089896,0.00009742625],"category_scores_gemma":[0.00043796495,0.00018137867,0.00008558513,0.00019363442,0.000059977367,0.00006527399,0.00010232621,0.00023377636,0.0001626517],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068923077,0.060829666,0.72575915,0.004360075,0.0008872831,0.00030665493,0.001321382,0.0000221786,0.0021144447,0.0011574345,0.03983673,0.15651268],"study_design_scores_gemma":[0.22326738,0.05013455,0.6688035,0.00038810857,0.0020595302,0.00045894063,0.00010050677,0.0027235686,0.0036053772,0.0009545203,0.04623898,0.0012650255],"about_ca_topic_score_codex":0.000008506332,"about_ca_topic_score_gemma":0.000006763227,"teacher_disagreement_score":0.21637507,"about_ca_system_score_codex":0.00039446214,"about_ca_system_score_gemma":0.00036633434,"threshold_uncertainty_score":0.7396408},"labels":[],"label_agreement":null},{"id":"W2537944738","doi":"10.1182/blood.v124.21.2549.2549","title":"Prognostic Factors and Outcomes in Allogeneic Hematopoietic Stem Cell Transplant Vs. Non-Transplant Chronic Lymphocytic Leukemia (CLL) Patients: A Comparative Analysis with the Leukemia/BMT Program of British Columbia (BC) and the BC Provincial CLL Database","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Leukemia & Lymphoma Society of Canada; Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Fludarabine; Chronic lymphocytic leukemia; Hematopoietic stem cell transplantation; Internal medicine; Busulfan; Transplantation; Cohort; Population; Alemtuzumab; Cyclophosphamide; Oncology; Leukemia; Chemotherapy","score_opus":0.008856801126883319,"score_gpt":0.23552950443492304,"score_spread":0.22667270330803974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2537944738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99440205,0.00060337025,0.00006199301,0.00003418553,0.000026163367,0.004376883,0.00032578915,0.000055116514,0.00011443554],"genre_scores_gemma":[0.99861336,0.0002712833,0.00008923508,0.000054257987,0.000037220416,0.00049628,0.00023187477,0.00004501086,0.00016145676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99632514,0.00038473544,0.0007749776,0.0007942006,0.00094986253,0.00077111396],"domain_scores_gemma":[0.99741554,0.0011067407,0.00030008287,0.00073246367,0.00017362286,0.000271543],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007078052,0.00042318448,0.0015026598,0.00016574551,0.00020223418,0.00017839948,0.00039581544,0.00017620897,0.000017058452],"category_scores_gemma":[0.000037275327,0.00028939557,0.00021017747,0.0007930657,0.0012601638,0.00013452572,0.000119309676,0.0004412113,0.0000028442646],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0013476919,0.0012302408,0.9834718,0.0028259256,0.0021518685,0.00025641295,0.0073757996,0.00022101548,0.0001514636,0.000014754968,0.000088825866,0.00086420466],"study_design_scores_gemma":[0.17967789,0.0039949305,0.7552583,0.0016063827,0.012652951,0.0004624711,0.0015493063,0.041697845,0.0020885442,0.000011723559,0.00010773863,0.00089187385],"about_ca_topic_score_codex":0.088884555,"about_ca_topic_score_gemma":0.17527673,"teacher_disagreement_score":0.22821346,"about_ca_system_score_codex":0.0052665006,"about_ca_system_score_gemma":0.0077828835,"threshold_uncertainty_score":0.99995583},"labels":[],"label_agreement":null},{"id":"W2537965676","doi":"10.1182/blood.v116.21.1938.1938","title":"Carfilzomib: High Single Agent Response Rate with Minimal Neuropathy Even In High-Risk Patients","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary; Princess Margaret Cancer Centre","funders":"","keywords":"Carfilzomib; Medicine; Internal medicine; Bortezomib; Regimen; Multiple myeloma; Proteasome inhibitor; Adverse effect; Clinical endpoint; Refractory (planetary science); Gastroenterology; Oncology; Clinical trial; Biology","score_opus":0.011277986536664912,"score_gpt":0.24021254727957647,"score_spread":0.22893456074291155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2537965676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987069,0.000022260736,0.0000015738055,0.00021039715,0.00012896719,0.0006384172,0.00009158844,0.000047934675,0.00015197396],"genre_scores_gemma":[0.99821955,0.000011204267,0.0009988907,0.00007863331,0.00008616704,0.00006411244,0.000077497556,0.000043426997,0.00042054628],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821305,0.0003539173,0.00022643835,0.00037840984,0.00038040167,0.00044777044],"domain_scores_gemma":[0.9988206,0.00023362742,0.000083943174,0.00043921097,0.00011727555,0.000305339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037567646,0.00019745431,0.0002774038,0.0001814511,0.00007023928,0.000025250227,0.000107113316,0.00008057887,0.00008956557],"category_scores_gemma":[0.0008145486,0.00014247293,0.000048570735,0.00023214369,0.000072809875,0.00006882043,0.00006386754,0.00038806026,0.0001252978],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012547561,0.004454141,0.9355194,0.000021995576,0.00010956438,0.0017225347,0.00022546116,0.0000015145289,0.042449065,0.0000042555084,0.000075823424,0.0028687096],"study_design_scores_gemma":[0.025250718,0.0036162562,0.94288653,0.00004052019,0.00009443821,0.000026905618,0.00001983987,0.000016411177,0.02751645,0.000009960539,0.000391637,0.00013030584],"about_ca_topic_score_codex":0.00075786794,"about_ca_topic_score_gemma":0.00044302567,"teacher_disagreement_score":0.014932615,"about_ca_system_score_codex":0.000042052965,"about_ca_system_score_gemma":0.00013567974,"threshold_uncertainty_score":0.58098775},"labels":[],"label_agreement":null},{"id":"W2538114067","doi":"10.1182/blood.v124.21.4756.4756","title":"Outcome of 17p Deleted Multiple Myeloma (MM) in the Era of Novel Agents and Tandem Transplantation: A Single Centre Experience","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Transplantation; Multiple myeloma; Internal medicine; Surgery; Regimen; Single Center; Retrospective cohort study; Oncology","score_opus":0.049612190374744784,"score_gpt":0.3069341689529689,"score_spread":0.2573219785782241,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2538114067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988475,0.00007732292,0.00015638012,0.00017429693,0.000013785483,0.00035384702,0.000025637495,0.00000746117,0.0003437615],"genre_scores_gemma":[0.99858636,0.000032618525,0.0012263989,0.00007133678,0.000016325552,0.000015662792,0.000022917431,0.0000073839105,0.000021010232],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990812,0.000052116906,0.0002569118,0.00014877401,0.00028723764,0.00017379163],"domain_scores_gemma":[0.99945027,0.00018662174,0.00006269486,0.00018108459,0.000050011797,0.00006935015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001265302,0.00009151102,0.00021774518,0.000050273367,0.000029101837,0.0000059022364,0.00008063345,0.000042409843,0.000021892109],"category_scores_gemma":[0.00016735849,0.000060659455,0.000041910207,0.00014452191,0.000079375095,0.000041376938,0.000013063058,0.00008975757,0.0000012917957],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014474848,0.0016014616,0.9699508,0.0001279321,0.000046701913,0.000040140705,0.0041290093,0.0000013791239,0.02139435,0.000029424062,0.0000037594616,0.0025303198],"study_design_scores_gemma":[0.014183383,0.00029295738,0.9535636,0.00012906462,0.00006598067,0.000043628446,0.0005524666,0.00079635065,0.030262507,0.0000058847068,0.000047367343,0.00005680901],"about_ca_topic_score_codex":0.00015338819,"about_ca_topic_score_gemma":0.0001866592,"teacher_disagreement_score":0.016387174,"about_ca_system_score_codex":0.000008688321,"about_ca_system_score_gemma":0.00001604064,"threshold_uncertainty_score":0.24736208},"labels":[],"label_agreement":null},{"id":"W2538201644","doi":"10.1182/blood.v104.11.759.759","title":"Small-Molecule XIAP Inhibitors Derepress Downstream Effector Caspases and Induce Apoptosis of Leukemia Cell Lines and Patient Samples.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"XIAP; Leukemia; Inhibitor of apoptosis; Apoptosis; Caspase; Cancer research; Chemistry; Myeloid leukemia; Pharmacology; Medicine; Immunology; Programmed cell death; Biochemistry","score_opus":0.008026441275304167,"score_gpt":0.19506361648793516,"score_spread":0.187037175212631,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2538201644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99730307,0.0021584602,0.00015679398,0.000016018907,0.00005766364,0.0001884187,0.00002193781,0.000007746879,0.00008986697],"genre_scores_gemma":[0.9984231,0.0003711787,0.0009991871,0.000029465791,0.00007031667,0.000013046334,0.00005736011,0.000014900063,0.000021448772],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99934804,0.00002094993,0.00015964799,0.00027118356,0.00007086558,0.00012928977],"domain_scores_gemma":[0.999619,0.000010793611,0.00008531348,0.00016978991,0.000044967674,0.000070155205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003627869,0.00013362766,0.00013255692,0.00003342933,0.000049818784,0.000015149046,0.00004236225,0.00014080963,0.0000024579247],"category_scores_gemma":[0.000023071712,0.00011617162,0.00004224119,0.000044022225,0.000055850618,0.0000027824099,0.000091792564,0.00004117848,4.0987294e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018683095,0.00013772119,0.00086110295,0.00006932481,0.000028102659,0.0000012718918,0.0000781601,0.000056264937,0.99571586,0.000017379194,0.000017058768,0.0029990925],"study_design_scores_gemma":[0.0013055351,0.00042891398,0.0013340726,0.000036507055,0.000066240085,0.000014571904,0.000060218565,0.0000038199146,0.99639875,0.000027644028,0.00018536126,0.00013839043],"about_ca_topic_score_codex":0.00023894232,"about_ca_topic_score_gemma":0.00003128808,"teacher_disagreement_score":0.0028607019,"about_ca_system_score_codex":0.000006521896,"about_ca_system_score_gemma":0.00004249039,"threshold_uncertainty_score":0.4737341},"labels":[],"label_agreement":null},{"id":"W2538238951","doi":"10.1182/blood.v126.23.400.400","title":"Impact of CTLA4 Genotype and Other Immune Response Gene Polymorphisms on Outcomes after Umbilical Cord Blood Transplantation - a Eurocord, CBC-Ctiwb-EBMT, Netcord and FMRP-USP Study","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Umbilical Cord Blood Transplantation; Immunology; Transplantation; Medicine; Hematopoietic stem cell transplantation; Immune system; Biology; Internal medicine","score_opus":0.027261027527441525,"score_gpt":0.30325376861511716,"score_spread":0.27599274108767563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2538238951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977773,0.00046075712,0.0000664297,0.000109152,0.00007049328,0.0011953878,0.00009729926,0.00006020381,0.00016298977],"genre_scores_gemma":[0.9988889,0.000053305033,0.0005936359,0.00013779518,0.000048311624,0.000057651996,0.00002348072,0.000063611245,0.0001333219],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979215,0.00029398332,0.0005712432,0.00045335665,0.00045905847,0.0003008143],"domain_scores_gemma":[0.99874073,0.00028758522,0.0001452343,0.00042555472,0.00009881876,0.00030209104],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005069984,0.00032464237,0.00062427856,0.00021931382,0.000042308817,0.000024204284,0.000080695376,0.00014252933,0.000074947806],"category_scores_gemma":[0.00007333214,0.00025599462,0.00011767115,0.0001988418,0.000109771565,0.00007604565,0.000019071545,0.00018907353,0.000016336167],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024257476,0.002706564,0.89541566,0.000102938284,0.00054547715,0.0005107191,0.004893622,0.0000017044587,0.07116924,0.000007672393,0.000006951011,0.0003819409],"study_design_scores_gemma":[0.019954572,0.008401407,0.9546159,0.000108050575,0.0016693029,0.0011010855,0.0003000109,0.000011411483,0.01356639,0.000020679094,0.000011838277,0.00023936358],"about_ca_topic_score_codex":0.00051991566,"about_ca_topic_score_gemma":0.00004853555,"teacher_disagreement_score":0.059200197,"about_ca_system_score_codex":0.000024280645,"about_ca_system_score_gemma":0.00013921915,"threshold_uncertainty_score":0.9999892},"labels":[],"label_agreement":null},{"id":"W2538272154","doi":"10.1182/blood.v124.21.4296.4296","title":"Prothrombin Complex Concentrates Compared with Frozen Plasma for Urgent Reversal of Vitamin K Antagonists: A Single Centre Retrospective Review","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Medicine; Prothrombin complex concentrate; Dosing; Fresh frozen plasma; Retrospective cohort study; Warfarin; Vitamin K antagonist; Vitamin k; Demographics; Surgery; Pediatrics; Internal medicine; Atrial fibrillation","score_opus":0.048213923195927495,"score_gpt":0.2939828396217992,"score_spread":0.24576891642587173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2538272154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95164865,0.0019378972,0.0018679146,0.017188085,0.00035899758,0.015266376,0.00023059288,0.0003264952,0.011174991],"genre_scores_gemma":[0.99261934,0.00012530552,0.00587649,0.0003116798,0.00022000472,0.000012796419,0.00019982066,0.00002527099,0.00060926785],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.998924,0.000047707505,0.00034952306,0.00024076205,0.00023536052,0.00020260696],"domain_scores_gemma":[0.99915206,0.000093123104,0.00025177695,0.00022312222,0.000179763,0.00010016289],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017768666,0.00014916321,0.00063588377,0.000036963072,0.000053857235,0.000012218906,0.00006676901,0.000036411155,0.00019693469],"category_scores_gemma":[0.00022221412,0.00011811828,0.00012509203,0.00014889918,0.00008211028,0.0000488278,0.000024626936,0.000047633184,0.000008321683],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022097167,0.000955972,0.8746575,0.0101664215,0.0018549556,0.000017066031,0.0006892418,0.00000988187,0.05377507,0.012213043,0.042132128,0.0013189716],"study_design_scores_gemma":[0.09409843,0.007856411,0.34496728,0.013190639,0.008402058,0.00005911273,0.0010555584,0.0021892444,0.1409356,0.0004868187,0.3852363,0.0015225804],"about_ca_topic_score_codex":0.000009926479,"about_ca_topic_score_gemma":0.000011870571,"teacher_disagreement_score":0.52969027,"about_ca_system_score_codex":0.000043390348,"about_ca_system_score_gemma":0.000041471165,"threshold_uncertainty_score":0.48167238},"labels":[],"label_agreement":null},{"id":"W2538377591","doi":"10.1182/blood.v116.21.256.256","title":"Phenomenon of Pain In Thalassemia: A Prospective Analysis by the Thalassemia Clinical Research Network (TCRN)","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; Toronto General Hospital; University Health Network","funders":"","keywords":"Medicine; Thalassemia; Chronic pain; Observational study; Alpha-thalassemia; Prospective cohort study; Beta thalassemia; Hemoglobinopathy; Brief Pain Inventory; Physical therapy; Pediatrics; Internal medicine; Hemolytic anemia","score_opus":0.01986297115584786,"score_gpt":0.34295823710509704,"score_spread":0.3230952659492492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2538377591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98416543,0.0011320434,0.000023422743,0.0014465736,0.000097357966,0.00063868257,0.0000060827783,0.0000246987,0.012465686],"genre_scores_gemma":[0.9985655,0.0003531974,0.00020805791,0.00012036899,0.00021194684,0.00004992084,0.000017643366,0.000021050726,0.00045234084],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974424,0.00054919906,0.00057648215,0.00038435688,0.0004890287,0.00055852666],"domain_scores_gemma":[0.99798924,0.0009504792,0.00012497327,0.00060505007,0.00018943717,0.00014083652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0071982252,0.00014301532,0.0005253991,0.00016933863,0.000120629935,0.000017027107,0.00023026687,0.00039607394,0.00011540184],"category_scores_gemma":[0.0010405991,0.000089026515,0.00023887306,0.0022802849,0.00037128656,0.00003335622,0.00010285057,0.0020648288,0.000014235727],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117946816,0.0016347342,0.98507553,0.000030204757,0.00091327063,0.000032313517,0.00046841352,0.000018798906,0.0020798722,0.00032201214,0.0053840885,0.003922814],"study_design_scores_gemma":[0.01049862,0.0023959908,0.96545655,0.00024035256,0.002712501,0.000037891128,0.0037567413,0.0014939583,0.0015998387,0.003552368,0.007852927,0.00040225053],"about_ca_topic_score_codex":0.00021134953,"about_ca_topic_score_gemma":0.00038935148,"teacher_disagreement_score":0.01961897,"about_ca_system_score_codex":0.000024675415,"about_ca_system_score_gemma":0.00017851895,"threshold_uncertainty_score":0.8970768},"labels":[],"label_agreement":null},{"id":"W2538424099","doi":"10.1182/blood.v106.11.2238.2238","title":"Impact of Anemia on the Medical Cost of Injurious Falls in the Elderly.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Cerebral Palsy and Movement Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Anemia; Hip fracture; Pediatrics; Retrospective cohort study; Physical therapy; Osteoporosis; Emergency medicine; Surgery; Internal medicine","score_opus":0.014437696206975692,"score_gpt":0.30265860415818074,"score_spread":0.28822090795120503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2538424099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98581785,0.00016669514,0.0000016556485,0.004087935,0.000011359114,0.0003626554,0.0000066913594,0.000005001773,0.009540156],"genre_scores_gemma":[0.99840397,0.00009155051,0.000008314162,0.0013668393,0.000051936644,0.000009327091,0.0000054398884,0.000005265461,0.000057333054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991784,0.000050038423,0.00020894174,0.000079052654,0.00035539686,0.00012817049],"domain_scores_gemma":[0.9994763,0.00016571238,0.000059189955,0.00024038239,0.00001865851,0.000039734135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035732094,0.00007191726,0.00015897668,0.000041243977,0.000014809401,0.0000023664127,0.00014227345,0.00006015097,0.0005758014],"category_scores_gemma":[0.00021041198,0.000033105924,0.00009546146,0.00013339274,0.00007827669,0.000014302671,0.0000154153,0.00017802931,0.00000914698],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012687959,0.022243798,0.679392,0.00033180608,0.00080361,0.0001270095,0.012616261,0.000071996365,0.017645111,0.0073771677,0.0262584,0.23186404],"study_design_scores_gemma":[0.016364546,0.006623716,0.9564431,0.0005141482,0.00029167513,0.000058419024,0.0017084745,0.00006349001,0.012746435,0.00039424954,0.004581711,0.00021006216],"about_ca_topic_score_codex":0.00025130404,"about_ca_topic_score_gemma":0.00030493253,"teacher_disagreement_score":0.27705106,"about_ca_system_score_codex":0.000009898206,"about_ca_system_score_gemma":0.00009028538,"threshold_uncertainty_score":0.63046217},"labels":[],"label_agreement":null},{"id":"W2538425459","doi":"10.1182/blood.v104.11.1407.1407","title":"Rapid Infusion Rituximab in Combination with Steroid Containing Chemotherapy Can Be Given Safely and Substantially Reduces Resource Utilization.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Rituximab; Cytokine release syndrome; Rash; Chemotherapy; Prednisone; Dosing; Surgery; Anesthesia; Internal medicine; Lymphoma; Cancer; Immunotherapy","score_opus":0.022005853642565656,"score_gpt":0.2489310004317907,"score_spread":0.22692514678922504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2538425459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935587,0.0010493486,0.000015890933,0.0041689393,0.000013972026,0.00043545724,0.000005599373,0.00003476269,0.00071731646],"genre_scores_gemma":[0.99806285,0.0005123526,0.00065118686,0.0006086744,0.000027378386,0.000026737565,0.00006931066,0.000017811863,0.000023709084],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99925196,0.00002600423,0.00017131603,0.00021658257,0.00018609349,0.00014804426],"domain_scores_gemma":[0.9996565,0.000029807361,0.00007266775,0.00012213328,0.00005069285,0.000068172565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009122683,0.00012545261,0.00022225526,0.0000997956,0.00006706761,0.000027125738,0.000032627504,0.00005648047,0.000013799608],"category_scores_gemma":[0.000015456892,0.00009864818,0.000019690493,0.00016147758,0.00004847884,0.00006021024,0.000012555875,0.000051360825,8.5442383e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004573468,0.029991651,0.759748,0.00023652286,0.0007416598,0.0010986533,0.0275068,0.00004766842,0.030194784,0.0022712767,0.00016366667,0.14342585],"study_design_scores_gemma":[0.14441685,0.003939693,0.6991113,0.000712724,0.00020404448,0.00017620674,0.0012445255,0.000023429386,0.1476784,0.000115549854,0.002132342,0.00024492774],"about_ca_topic_score_codex":0.00024017847,"about_ca_topic_score_gemma":0.0002976789,"teacher_disagreement_score":0.14318092,"about_ca_system_score_codex":0.000085937696,"about_ca_system_score_gemma":0.000112115944,"threshold_uncertainty_score":0.4022756},"labels":[],"label_agreement":null},{"id":"W2538510330","doi":"10.1182/blood.v114.22.4286.4286","title":"Comparison of Healthcare Utilization and Costs Between Nilotinib and Dasatinib as Second Line Therapies in Chronic Myeloid Leukemia.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Nilotinib; Medicine; Dasatinib; Internal medicine; Myeloid leukemia; Medical prescription; Pharmacy; Imatinib; Pharmacology; Family medicine","score_opus":0.04967079517563694,"score_gpt":0.3562436461687651,"score_spread":0.30657285099312814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2538510330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791261,0.018810257,0.000005237509,0.000711063,0.000019850268,0.00062247284,0.000027031745,0.00003918793,0.000638779],"genre_scores_gemma":[0.9980273,0.0010819603,0.00031411636,0.00016444849,0.00012259217,0.000010074742,0.0001435395,0.000020005133,0.00011594669],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866503,0.0000674532,0.00047855053,0.0003250184,0.00020721948,0.00025673944],"domain_scores_gemma":[0.99926126,0.000118206204,0.00017392612,0.0002492377,0.000059358623,0.00013800855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016396804,0.00020100988,0.00060757686,0.0001406115,0.000048756734,0.000012366231,0.00005548595,0.00015657858,0.000059135815],"category_scores_gemma":[0.000059044494,0.00018363215,0.00003076268,0.00019771219,0.000085147534,0.00007663708,0.000029708703,0.00022714915,0.000003819018],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015338155,0.00040792642,0.8346806,0.00042898205,0.00015229445,0.000021261456,0.002793639,0.000002688356,0.0074265986,0.00027921124,0.00005123006,0.15360218],"study_design_scores_gemma":[0.016459433,0.0035149462,0.93088144,0.00063300924,0.00019203896,0.0000520921,0.00043085712,0.00023201945,0.046342224,0.00018330182,0.0008855732,0.00019307126],"about_ca_topic_score_codex":0.0003300131,"about_ca_topic_score_gemma":0.0005466013,"teacher_disagreement_score":0.15340911,"about_ca_system_score_codex":0.0005883859,"about_ca_system_score_gemma":0.00057518337,"threshold_uncertainty_score":0.7488302},"labels":[],"label_agreement":null},{"id":"W2538680438","doi":"10.1182/blood.v106.11.2706.2706","title":"High Prevalence of Fractures and Bone Pain in Thalassemia: The Thalassemia Clinical Research Network Experience.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University Health Network","funders":"","keywords":"Medicine; Thalassemia; Pediatrics; Bone pain; Internal medicine; Beta thalassemia; Alpha-thalassemia; Population; Observational study; Surgery; Gastroenterology; Genotype","score_opus":0.026891611811979396,"score_gpt":0.3601100151417883,"score_spread":0.3332184033298089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2538680438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825247,0.01301935,0.000008690353,0.0031598734,0.00006273813,0.00037446807,0.0000016890808,0.000018151946,0.0008303696],"genre_scores_gemma":[0.9918497,0.0066757808,0.0004922466,0.00035759003,0.000337156,0.000027719701,0.0000018144253,0.000013864917,0.00024413463],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794924,0.00045327222,0.0004816259,0.00028900613,0.0003930992,0.00043374466],"domain_scores_gemma":[0.9984082,0.0009476825,0.000082617145,0.00037668433,0.00007237213,0.00011242484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036558674,0.00011498122,0.00029831732,0.000059546204,0.00010380641,0.000012713767,0.00014475272,0.00028288751,0.00009406731],"category_scores_gemma":[0.00090088864,0.00006910166,0.00006486269,0.0003432988,0.0004307521,0.000050048555,0.00010841191,0.0009116389,0.0000061720443],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018016185,0.0010830226,0.9624164,0.00020112048,0.00006525164,0.00009033554,0.0018921231,0.00009243341,0.00092463125,0.00033728284,0.006093096,0.026624111],"study_design_scores_gemma":[0.0049793697,0.0011018877,0.97746277,0.0010572951,0.00013973897,0.000112531336,0.0023775408,0.00041253408,0.002254226,0.000658494,0.009241002,0.00020259005],"about_ca_topic_score_codex":0.000084582796,"about_ca_topic_score_gemma":0.000039677125,"teacher_disagreement_score":0.02642152,"about_ca_system_score_codex":0.000013580477,"about_ca_system_score_gemma":0.000112364294,"threshold_uncertainty_score":0.39606678},"labels":[],"label_agreement":null},{"id":"W2538698530","doi":"10.1182/blood.v116.21.2049.2049","title":"Transcriptional Regulation of Transferrin Receptor by Heme in Erythroid Cells","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Heme; Ferrochelatase; Transferrin receptor; Messenger RNA; Erythropoiesis; Transferrin; Chemistry; Receptor; Biochemistry; Biology; Cell biology; Molecular biology; Internal medicine; Enzyme; Gene","score_opus":0.005178026312095469,"score_gpt":0.20814380687773523,"score_spread":0.20296578056563977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2538698530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99812204,0.00023593033,0.00065826357,0.0001255535,0.00008678729,0.00008785963,0.00006858641,0.0000031329369,0.00061184267],"genre_scores_gemma":[0.9983165,0.00009420888,0.0008318635,0.000025599249,0.00006781682,0.000018908673,0.00014913804,0.000007752162,0.00048816702],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995699,0.000012847761,0.00013536164,0.00014009306,0.00006386107,0.00007794395],"domain_scores_gemma":[0.99977297,0.0000021527871,0.000023082834,0.00014811325,0.000030041583,0.000023644247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000068364,0.000054495344,0.00005922341,0.000020085927,0.000015193849,0.0000038213225,0.000071298404,0.00009171872,0.00014346403],"category_scores_gemma":[0.0000036212962,0.00005612324,0.0000397056,0.000049572373,0.00003863318,0.0000024711626,0.000003509123,0.000056843695,0.0000032771247],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016669033,0.00020518775,0.0007014368,0.0000067729297,0.000008567371,4.0246263e-8,0.00002858547,0.0000075514354,0.9975334,0.00024426435,0.00071230304,0.0005352529],"study_design_scores_gemma":[0.0007238803,0.00005184853,0.0070730285,0.0000029723483,0.00000690492,0.0000011362195,0.000010821241,0.0000073931324,0.9623062,0.000042709955,0.029708378,0.00006470629],"about_ca_topic_score_codex":0.000019667143,"about_ca_topic_score_gemma":0.000074183044,"teacher_disagreement_score":0.03522715,"about_ca_system_score_codex":0.0000019235972,"about_ca_system_score_gemma":0.000029421131,"threshold_uncertainty_score":0.22886392},"labels":[],"label_agreement":null},{"id":"W2538743598","doi":"10.1182/blood.v106.11.3158.3158","title":"Induction of Transient Cytopenia To Analyze Hematopoiesis in Mutant Mice.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Erythropoietin receptor; Erythropoiesis; Haematopoiesis; Biology; Erythropoietin; Immunology; Reticulocyte; Progenitor cell; Cell biology; Cancer research; Anemia; Stem cell; Genetics; Internal medicine; Medicine; Gene","score_opus":0.005971074110805029,"score_gpt":0.2290590364954715,"score_spread":0.22308796238466647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2538743598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983197,0.00051653344,0.00006521532,0.00023819925,0.00001987504,0.00013666338,0.000011698823,0.000003317873,0.0006887986],"genre_scores_gemma":[0.9989452,0.000052066047,0.000764917,0.000090009176,0.000036625508,0.00001651417,0.000019982475,0.000008280787,0.00006642215],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99946517,0.000015023575,0.0001534774,0.00018064484,0.00006476211,0.0001209008],"domain_scores_gemma":[0.9997524,0.0000018042738,0.00003074777,0.00015120971,0.000021846898,0.000041980187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004471862,0.0000803279,0.00011462807,0.00005063303,0.000014827277,0.000004269182,0.00006819613,0.000064758075,0.000017070344],"category_scores_gemma":[0.000008539313,0.00007503438,0.00004946366,0.00011394019,0.000013243564,0.0000023588618,0.000020544783,0.000025576224,0.000008080175],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059759335,0.0014951294,0.0091390675,0.000013694432,0.00011603282,0.0000048173843,0.00022002899,0.00011247274,0.9834306,0.000028890652,0.00013131279,0.005248149],"study_design_scores_gemma":[0.0017712114,0.00020307598,0.009054928,0.000011532702,0.000051598534,0.00001100161,0.000086370084,0.000003291272,0.9861763,0.000014752199,0.002522831,0.00009307102],"about_ca_topic_score_codex":0.000055076707,"about_ca_topic_score_gemma":0.00048761198,"teacher_disagreement_score":0.0051550777,"about_ca_system_score_codex":0.000004483778,"about_ca_system_score_gemma":0.000020690986,"threshold_uncertainty_score":0.30598134},"labels":[],"label_agreement":null},{"id":"W2538780749","doi":"10.1182/blood.v114.22.454.454","title":"Targeted Gene Sequencing to Identify Polymorphisms in the Protein C and EPCR Genes in Patients with Unprovoked Venous Thromboembolism.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Endothelial protein C receptor; Protein C; Exon; Biology; Gene; Medicine; Molecular biology; Immunology; Thrombin; Internal medicine; Genetics","score_opus":0.016159543129627422,"score_gpt":0.25320452564579626,"score_spread":0.23704498251616885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2538780749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971418,0.00025173326,0.000047189256,0.000806409,0.000031113545,0.0015294879,0.0000043759696,0.00003891242,0.00014899776],"genre_scores_gemma":[0.9964254,0.0000053957465,0.002025465,0.0013838625,0.000048905833,0.00005218012,0.000022196202,0.000019236804,0.000017362312],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986864,0.000079998405,0.0002706379,0.00031283815,0.00035120058,0.00029893377],"domain_scores_gemma":[0.9994668,0.000013194752,0.000066875305,0.00029923496,0.000056143264,0.00009779821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002456663,0.00017731122,0.00035447453,0.00019965919,0.00006349197,0.000035881534,0.00011190808,0.000085547836,0.000016040063],"category_scores_gemma":[0.000031851396,0.00012372449,0.000026883154,0.0004917897,0.000024460664,0.00009057081,0.000023495062,0.00016449028,0.000008666476],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032945166,0.0049132234,0.14157696,0.000059485883,0.00012541095,0.00020172576,0.006569029,0.000030163483,0.83555925,0.0014957861,0.000017345816,0.0091221705],"study_design_scores_gemma":[0.005106233,0.0012102058,0.905381,0.00014773221,0.000083636914,0.00001787308,0.00015111215,0.000015727659,0.087179236,0.0005331892,0.000012611794,0.00016144065],"about_ca_topic_score_codex":0.00011562488,"about_ca_topic_score_gemma":0.00006652967,"teacher_disagreement_score":0.763804,"about_ca_system_score_codex":0.000038096856,"about_ca_system_score_gemma":0.000072762494,"threshold_uncertainty_score":0.5045338},"labels":[],"label_agreement":null},{"id":"W2538805931","doi":"10.1182/blood.v116.21.3263.3263","title":"Targeting Survivin In Recalcitrant Acute Lymphoblastic Leukemia","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Survivin; Cancer research; In vivo; Leukemia; Medicine; MTT assay; Apoptosis; Immunology; Biology; Cancer; Internal medicine","score_opus":0.004251082676403362,"score_gpt":0.21116706760339046,"score_spread":0.2069159849269871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2538805931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978735,0.0001273815,0.0010708895,0.000020169931,0.00026272758,0.00008961364,0.000004795475,0.000010286797,0.0005406227],"genre_scores_gemma":[0.99763143,0.00009748997,0.0015454045,0.00003720083,0.00021312347,0.000008941862,0.000079163874,0.00001562574,0.00037163543],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993707,0.000020244112,0.00014109722,0.00021840984,0.00007130547,0.00017823243],"domain_scores_gemma":[0.99972177,0.0000069489456,0.00003594453,0.00016735087,0.00002325204,0.0000447425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016335817,0.00009180429,0.00008740982,0.000031642096,0.000036704765,0.000013551935,0.000089165755,0.00015853289,0.000030903346],"category_scores_gemma":[0.00003589136,0.000083299376,0.00004217005,0.000061641134,0.00002076775,0.0000019714605,0.000040795712,0.00008704825,0.0000092090095],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013204302,0.000055946202,0.0015038677,0.0000049893174,0.00001754447,0.0000066101315,0.00001672488,0.0000579584,0.99714136,0.00012101861,0.000047161073,0.0010136302],"study_design_scores_gemma":[0.0017356622,0.000120992605,0.010350835,0.000011418792,0.000041791707,0.000044973098,0.00001770631,0.00091893226,0.9812869,0.00020770606,0.0050265314,0.00023658546],"about_ca_topic_score_codex":0.000032554228,"about_ca_topic_score_gemma":0.00014544622,"teacher_disagreement_score":0.01585448,"about_ca_system_score_codex":0.000005786703,"about_ca_system_score_gemma":0.000060747945,"threshold_uncertainty_score":0.339685},"labels":[],"label_agreement":null},{"id":"W2538888658","doi":"10.1182/blood.v126.23.4074.4074","title":"Final Results of Anagrelide Controlled-Release (GALE-401) Safety, Efficacy and Pharmacokinetics in Subjects with Myeloproliferative Neoplasms (MPN)-Related Thrombocytosis","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"","keywords":"Anagrelide; Medicine; Thrombocytosis; Pharmacokinetics; Cmax; Pharmacology; Myelofibrosis; Platelet; Polycythemia vera; Essential thrombocythemia; Bioequivalence; Internal medicine; Gastroenterology; Bone marrow","score_opus":0.02599791101880424,"score_gpt":0.27693187463176766,"score_spread":0.25093396361296344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2538888658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897341,0.0018340844,0.000010610185,0.0015329261,0.000069444715,0.0020925158,0.00010164657,0.00005559302,0.004569092],"genre_scores_gemma":[0.9968645,0.0011840961,0.0011316855,0.00020347779,0.00007450189,0.00012783993,0.000101307036,0.000045382727,0.00026720925],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99722785,0.00020928713,0.00091754383,0.00061544636,0.0005772692,0.00045261593],"domain_scores_gemma":[0.9978689,0.0005821221,0.0003427693,0.00035542177,0.00039222912,0.0004585886],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043976746,0.00045894735,0.0013045043,0.00026964556,0.00007347126,0.000029417533,0.00009804789,0.00016776953,0.000034255485],"category_scores_gemma":[0.00055639754,0.00032281358,0.00009936447,0.00054171734,0.00022311641,0.00010844701,0.00006627833,0.00034972883,0.00001733037],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15507376,0.027812755,0.7688189,0.0005212745,0.0071769687,0.004171093,0.013510534,0.002009649,0.008233544,0.002038663,0.0032325452,0.007400281],"study_design_scores_gemma":[0.5343063,0.012091182,0.3442804,0.0012243427,0.0029895206,0.0006031613,0.00057469145,0.0013034485,0.101201974,0.00013193501,0.00058016035,0.000712932],"about_ca_topic_score_codex":0.00018494116,"about_ca_topic_score_gemma":0.00025147156,"teacher_disagreement_score":0.42453852,"about_ca_system_score_codex":0.00009070236,"about_ca_system_score_gemma":0.0004464001,"threshold_uncertainty_score":0.9999224},"labels":[],"label_agreement":null},{"id":"W2538912785","doi":"10.1182/blood.v126.23.1917.1917","title":"Incidence and Risk Factors for Nontuberculous Mycobacteria Infection after Allogeneic Hematopoietic Cell Transplantation","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Mycobacterium research and diagnosis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Nontuberculous mycobacteria; Cumulative incidence; Incidence (geometry); Internal medicine; Transplantation; Population; Epidemiology; Proportional hazards model; Hematopoietic stem cell transplantation; Immunology; Tuberculosis; Pathology; Mycobacterium","score_opus":0.017151985665869954,"score_gpt":0.26587210146622664,"score_spread":0.2487201158003567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2538912785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99833745,0.0003554764,0.0003313909,0.000046898782,0.0001000863,0.0005579938,0.00007697197,0.000045808687,0.00014789798],"genre_scores_gemma":[0.9975578,0.0014420571,0.0005190543,0.000044325894,0.00011401594,0.00017066245,0.00008426532,0.000019120504,0.000048660073],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991385,0.00004816478,0.00016321502,0.00022761278,0.00018682994,0.00023569874],"domain_scores_gemma":[0.99923486,0.00013486379,0.000050191735,0.00014858511,0.00011605762,0.00031546337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001951127,0.00013099176,0.00018862808,0.00008329425,0.000046794685,0.00003688736,0.00003068347,0.00009647046,0.000041387982],"category_scores_gemma":[0.00018215687,0.00010733885,0.00006175225,0.00008269474,0.000032042164,0.00012528518,0.000014506333,0.000093669325,0.000018498184],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003487263,0.00025526158,0.9891214,0.0003257525,0.00004388684,0.000029446466,0.0008480038,7.7679937e-7,0.008733441,0.000002389425,0.00009933634,0.00019159289],"study_design_scores_gemma":[0.0033590803,0.0008352994,0.9318514,0.00006048013,0.0005030545,0.00010261788,0.000052359297,0.000010965145,0.06272324,0.00008202754,0.0002889841,0.00013047995],"about_ca_topic_score_codex":0.0004909109,"about_ca_topic_score_gemma":0.00016787711,"teacher_disagreement_score":0.05726997,"about_ca_system_score_codex":0.000024422123,"about_ca_system_score_gemma":0.000077130586,"threshold_uncertainty_score":0.4377151},"labels":[],"label_agreement":null},{"id":"W2538970672","doi":"10.1182/blood.v126.23.3289.3289","title":"Predictors of the Trajectory of Neurocognitive Functioning in the First Six Months after Allogeneic Hematopoietic Stem Cell Transplantation","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Princess Margaret Cancer Centre; Women's College Hospital; University of Toronto","funders":"","keywords":"Neurocognitive; Medicine; Transplantation; Cambridge Neuropsychological Test Automated Battery; Hematopoietic stem cell transplantation; Pediatrics; Internal medicine; Cognition; Psychiatry; Working memory","score_opus":0.013847586877316137,"score_gpt":0.21927338408532757,"score_spread":0.20542579720801143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2538970672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99591726,0.00085868355,0.000019912297,0.0002443879,0.00016311006,0.0007779678,0.000028914315,0.000013394788,0.0019763578],"genre_scores_gemma":[0.9994712,0.00007298143,0.0000058311007,0.00018529475,0.00005398012,0.00012631247,0.0000039442,0.000013633152,0.000066848486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990147,0.00009465912,0.00027872014,0.0001487012,0.00032677178,0.00013645335],"domain_scores_gemma":[0.99942064,0.0001486926,0.00012417976,0.00014668547,0.00012902218,0.000030776235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018730952,0.00011778307,0.00020286081,0.000069792135,0.000035950186,0.0000032543064,0.00007370872,0.00005215602,0.000009920448],"category_scores_gemma":[0.000026605967,0.000072224146,0.00009385154,0.00025643804,0.00011866073,0.00004232902,0.000016425955,0.00015586929,0.00000252326],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083366246,0.0010217642,0.96184695,0.00051538396,0.00022652415,0.000040066883,0.03361935,0.00008206959,0.0014701106,0.0000032371127,0.00016800418,0.0001728629],"study_design_scores_gemma":[0.0052204537,0.00062934135,0.95599043,0.0004310614,0.0011215929,0.00004955416,0.0060194866,0.000007944312,0.03036426,0.00000922256,0.000076462056,0.0000801872],"about_ca_topic_score_codex":0.000037192636,"about_ca_topic_score_gemma":0.00015466007,"teacher_disagreement_score":0.028894149,"about_ca_system_score_codex":0.000024301053,"about_ca_system_score_gemma":0.000077883866,"threshold_uncertainty_score":0.2945215},"labels":[],"label_agreement":null},{"id":"W2539077236","doi":"10.1182/blood.v104.11.1772.1772","title":"Increased Incidence of Major Bleeding in Children Receiving Unfractionated Heparin for Clinical Management: A Prospective Cohort Study.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stollery Children's Hospital; Hospital for Sick Children","funders":"","keywords":"Medicine; Partial thromboplastin time; Heparin; Population; Prospective cohort study; Thrombosis; Dosing; Bleeding diathesis; Incidence (geometry); Cumulative incidence; Surgery; Anesthesia; Cohort; Internal medicine; Platelet","score_opus":0.026554309021450312,"score_gpt":0.33854266033158353,"score_spread":0.31198835131013325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2539077236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929671,0.000035916084,0.000061169245,0.000077551376,0.00007680009,0.0045218556,0.000007800814,0.00007006686,0.0021817356],"genre_scores_gemma":[0.9968153,0.00008368203,0.0024967168,0.000053996784,0.00009669378,0.00035341448,0.000024177758,0.000034100587,0.00004189019],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980037,0.00007070881,0.0007556104,0.0005563093,0.00030589092,0.00030775467],"domain_scores_gemma":[0.9990076,0.0001418975,0.00021732294,0.00035653074,0.000147951,0.00012873886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011467568,0.00019604199,0.00072123087,0.00024596512,0.00008245472,0.000017136757,0.00016148663,0.00013084905,0.000029844488],"category_scores_gemma":[0.00043036442,0.00019034947,0.00013257904,0.0005640379,0.00006706035,0.00015847536,0.00011573989,0.00029876747,0.000013351766],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021658251,0.0048091738,0.99118084,0.00005904998,0.0012168727,0.000027221877,0.00018695177,0.0000037205893,0.0016043319,0.00035656212,0.0000059459785,0.000332726],"study_design_scores_gemma":[0.018767718,0.0007736199,0.9726481,0.0003017543,0.0010919557,0.000041801,0.00023587294,0.000010016792,0.0054468303,0.00050386327,0.0000044179474,0.00017404507],"about_ca_topic_score_codex":0.0015340357,"about_ca_topic_score_gemma":0.00026521552,"teacher_disagreement_score":0.018551135,"about_ca_system_score_codex":0.00015739126,"about_ca_system_score_gemma":0.00014286414,"threshold_uncertainty_score":0.7762226},"labels":[],"label_agreement":null},{"id":"W2539088980","doi":"10.1182/blood.v108.11.4624.4624","title":"Molecular Characterization of Clonotypic VDJ Sequences in Waldenstrom’s Macroglobulinemia Suggests Independent Transformation Events in the Development of Biclonal B Cells.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"clone (Java method); Biology; Waldenstrom macroglobulinemia; Germline; B cell; Macroglobulinemia; Molecular biology; Immunology; Antibody; Genetics; Gene; Multiple myeloma; Lymphoma","score_opus":0.009768541110468978,"score_gpt":0.2553325074792774,"score_spread":0.2455639663688084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2539088980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998841,0.00005700082,0.00015393802,0.00010885025,0.000030612868,0.0005594045,0.0000088723555,0.000006279055,0.0002340737],"genre_scores_gemma":[0.9992364,0.000017274806,0.0005218267,0.000018486524,0.00001862743,0.000034236196,0.00012692488,0.0000087893195,0.000017433884],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982908,0.00008059294,0.0006288193,0.00015038865,0.00063577463,0.0002136195],"domain_scores_gemma":[0.9995854,0.00003260502,0.00012447262,0.00016002417,0.000070093156,0.000027391254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049887283,0.00010647877,0.00022190045,0.00019449704,0.000016050575,0.000003999861,0.00015205715,0.00009461179,0.00001618692],"category_scores_gemma":[0.000015382926,0.00008205259,0.00004321453,0.00037302217,0.000043941553,0.00006669799,0.000020588686,0.00014116651,0.000004224627],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017520481,0.0013765441,0.045714468,0.00048611872,0.000034871526,0.00007773698,0.0030135978,0.00011657685,0.9473464,0.00016603767,0.0000016177322,0.0014908448],"study_design_scores_gemma":[0.010269281,0.00006288202,0.32348636,0.00019794371,0.000024453377,0.000047011115,0.00011038939,0.0005252969,0.6651441,0.000045306617,0.000018295079,0.00006869587],"about_ca_topic_score_codex":0.0004157299,"about_ca_topic_score_gemma":0.0003280262,"teacher_disagreement_score":0.2822023,"about_ca_system_score_codex":0.0008277376,"about_ca_system_score_gemma":0.0019164231,"threshold_uncertainty_score":0.33996522},"labels":[],"label_agreement":null},{"id":"W2539127255","doi":"10.1182/blood.v120.21.2224.2224","title":"Recombinant B-Domain Deleted Porcine Factor VIII (OBI-1) Safety and Efficacy in the Treatment of Acquired Hemophilia A: Interim Results.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Interim analysis; Antibody; Adverse effect; Autoantibody; Clinical trial; Internal medicine; Recombinant DNA; Bleed; Gastroenterology; Surgery; Immunology","score_opus":0.041309265978590706,"score_gpt":0.3156874200950628,"score_spread":0.2743781541164721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2539127255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929974,0.0018557559,0.0000013396783,0.0026886677,0.00008638734,0.0009696644,0.000038740087,0.00002179253,0.0013402663],"genre_scores_gemma":[0.9974116,0.0013506135,0.00019012437,0.00004660928,0.00013020581,0.000027416982,0.000086961634,0.000019583125,0.0007368919],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844235,0.00015248371,0.00045575981,0.00024300217,0.00026876546,0.00043766192],"domain_scores_gemma":[0.99900407,0.00025580096,0.00008449845,0.00044261085,0.000042865322,0.00017013973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036950374,0.0002112899,0.00046926507,0.00014204963,0.00006562466,0.000009083588,0.00009651157,0.00010611947,0.000051602],"category_scores_gemma":[0.00010120301,0.000112225025,0.000107949025,0.0002646674,0.00012650818,0.000061382125,0.000032843487,0.00006980995,0.00001591895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016907765,0.08972019,0.60425544,0.00043507176,0.0017248354,0.0009279374,0.04430647,5.683803e-7,0.1482002,0.00066941424,0.0007172491,0.09213487],"study_design_scores_gemma":[0.048966255,0.007141896,0.8833455,0.00021415373,0.0002959692,0.00021610832,0.00078076456,0.000010279424,0.04529703,0.00003651457,0.013475684,0.00021986946],"about_ca_topic_score_codex":0.000071767536,"about_ca_topic_score_gemma":0.000015041709,"teacher_disagreement_score":0.27909005,"about_ca_system_score_codex":0.00008055965,"about_ca_system_score_gemma":0.000048931262,"threshold_uncertainty_score":0.45764038},"labels":[],"label_agreement":null},{"id":"W2539244465","doi":"10.1182/blood.v126.23.2960.2960","title":"A Pharmacogenetic Study of the NCIC CTG Clinical Trial My.10: Single Nucleotide Polymorphisms, Prognosis, and Predicting Benefit from IMiD® Compound Maintenance Therapy Following Autologous Stem Cell Transplant for Multiple Myeloma","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; London Health Sciences Centre; Princess Margaret Cancer Centre; Queen Elizabeth II Health Sciences Centre; University of New Brunswick; Dalhousie University; Saint John Regional Hospital; Vancouver General Hospital; University of Calgary","funders":"","keywords":"Medicine; Oncology; Internal medicine; Thalidomide; Single-nucleotide polymorphism; Progression-free survival; Lenalidomide; Multiple myeloma; Cereblon; Pomalidomide; Genotype; Biology; Genetics; Overall survival","score_opus":0.0958585646357947,"score_gpt":0.3364908829677887,"score_spread":0.24063231833199397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2539244465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99137515,0.0023785175,0.0000136764775,0.00012119851,0.00040527628,0.0054094917,0.00019679715,0.000062344036,0.000037543003],"genre_scores_gemma":[0.9984751,0.000078031226,0.00059168314,0.000054575106,0.0003016465,0.0003245797,0.000035874746,0.00005255653,0.00008597211],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99738735,0.0002583785,0.0007646603,0.00055016356,0.00054691616,0.00049255206],"domain_scores_gemma":[0.99812645,0.0007431745,0.00026446042,0.00039028376,0.00012323303,0.00035239937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005804618,0.00028221525,0.0006950404,0.000064458414,0.00017523329,0.00003659479,0.00024103471,0.00011374324,0.000008071266],"category_scores_gemma":[0.000101210855,0.00018539547,0.00029270156,0.00013794543,0.00010875182,0.000059210022,0.00007424012,0.000219078,0.0000025170993],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035810966,0.014413809,0.91270244,0.00005053543,0.0015637863,0.00020931354,0.0023278398,0.000004446246,0.017577391,3.2452576e-7,0.00006647296,0.015272683],"study_design_scores_gemma":[0.48898128,0.013433479,0.45244122,0.00029354874,0.0017206797,0.000040789622,0.0013347259,0.0020543241,0.03916011,0.000018931045,0.0002365518,0.00028437813],"about_ca_topic_score_codex":0.00031961306,"about_ca_topic_score_gemma":0.00013963651,"teacher_disagreement_score":0.46026123,"about_ca_system_score_codex":0.000043537017,"about_ca_system_score_gemma":0.00017559418,"threshold_uncertainty_score":0.7560208},"labels":[],"label_agreement":null},{"id":"W2539692935","doi":"10.1182/blood.v124.21.3517.3517","title":"The Ottawa Hospital Regional Warfarin Anticoagulation Management Service. Efficacy and a Patient Satisfaction Survey","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Healthcare Systems and Technology","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Warfarin; Apixaban; Atrial fibrillation; Dosing; Population; Rivaroxaban; Pharmacy; Vitamin K antagonist; Intensive care medicine; Thrombosis; Emergency medicine; Surgery; Internal medicine; Family medicine","score_opus":0.015344147651842754,"score_gpt":0.22306581412355977,"score_spread":0.20772166647171703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2539692935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941473,0.000077920224,0.00009831446,0.003652647,0.00029335264,0.0003904265,8.125226e-7,0.00011238154,0.0012268573],"genre_scores_gemma":[0.9991592,0.000016357568,0.000057829584,0.00050381187,0.00019384114,0.000024209656,0.000012900284,0.000013855778,0.000017956612],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913436,0.00003471189,0.00023464332,0.00021829171,0.00017542447,0.00020258092],"domain_scores_gemma":[0.9994243,0.00006643445,0.00016436382,0.0002258384,0.000108227854,0.000010827601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044085082,0.000108192806,0.00011246921,0.000082817125,0.00031478133,0.00014275522,0.00008034081,0.00007084673,0.0000047642566],"category_scores_gemma":[0.00005970675,0.00008103888,0.000018689116,0.00023198086,0.0000273148,0.00018007292,0.000104414954,0.00008209516,0.00005346613],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018213272,0.00016974403,0.57456374,0.00020529171,0.00007788351,0.0000036326262,0.00005737443,0.000007766551,0.00003411888,0.07202143,0.0016762286,0.35116458],"study_design_scores_gemma":[0.00072436844,0.000027403348,0.9311333,0.000027210033,0.000022867029,0.0000022078525,0.000067187095,0.00040999617,0.0000044003045,0.001059049,0.066418454,0.00010358963],"about_ca_topic_score_codex":0.007324396,"about_ca_topic_score_gemma":0.005029711,"teacher_disagreement_score":0.35656953,"about_ca_system_score_codex":0.00000940729,"about_ca_system_score_gemma":0.0000044715557,"threshold_uncertainty_score":0.99928594},"labels":[],"label_agreement":null},{"id":"W2540205079","doi":"10.1182/blood.v112.11.1576.1576","title":"Tolerability and Efficacy of Bortezomib Added to CVP-R for Previously Untreated Advanced Stage Follicular Lymphoma: Interim Analysis of a Phase II Study by the NCIC Clinical Trials Group.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Queen's University; Moncton Hospital; Sunnybrook Hospital; CancerCare Manitoba; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Tolerability; Bortezomib; Interim analysis; Internal medicine; Rituximab; Follicular lymphoma; Surgery; Prednisone; Vincristine; Proteasome inhibitor; Gastroenterology; Adverse effect; Oncology; Clinical trial; Cyclophosphamide; Lymphoma; Chemotherapy; Multiple myeloma","score_opus":0.06460014398101292,"score_gpt":0.3873754246503171,"score_spread":0.32277528066930417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2540205079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952331,0.0012034791,0.0005691925,0.000024750278,0.000028298537,0.0024057033,0.0005084519,0.000009495948,0.000017506201],"genre_scores_gemma":[0.99881285,0.00011155951,0.00047758681,0.000060021106,0.00004279709,0.00020879357,0.0002067159,0.000015283418,0.00006439122],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99747777,0.0006682185,0.0010362264,0.00048118352,0.00013664509,0.00019995424],"domain_scores_gemma":[0.9984394,0.00027832427,0.00041200774,0.00061350845,0.0001415826,0.00011519258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022279595,0.00018624592,0.0009336089,0.000055527566,0.00010151816,0.00000706626,0.00022163159,0.00011898981,0.000014432611],"category_scores_gemma":[0.0017640416,0.00013172913,0.00044971192,0.00028114152,0.0001251418,0.0000035834971,0.00014282866,0.00004477835,1.9202179e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005841186,0.020389948,0.016187875,0.00006557942,0.005393931,0.0000053658105,0.0011337172,0.0000149158095,0.9297114,0.000008643846,0.00020491311,0.021042544],"study_design_scores_gemma":[0.055175442,0.028672976,0.015371127,0.000029111485,0.0049144085,0.0000065203303,0.0004789823,0.00013405156,0.89220655,0.000007872858,0.0026306077,0.00037236593],"about_ca_topic_score_codex":0.000047585007,"about_ca_topic_score_gemma":0.00005008311,"teacher_disagreement_score":0.049334258,"about_ca_system_score_codex":0.0000059349936,"about_ca_system_score_gemma":0.000064982116,"threshold_uncertainty_score":0.53717583},"labels":[],"label_agreement":null},{"id":"W2540255710","doi":"10.1182/blood.v120.21.3352.3352","title":"Enhanced Fibrinolysis by Proteolysed Coagulation Factor Xa Is Inhibited by Rivaroxaban","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Blood Services; University of British Columbia","funders":"","keywords":"Plasmin; Fibrinolysis; Chemistry; Fibrin; Tissue plasminogen activator; Proteases; Fibrinogen; Plasminogen activator; Factor XIII; Protease; Biochemistry; Molecular biology; Pharmacology; Medicine; Immunology; Enzyme; Biology; Internal medicine","score_opus":0.02039220944210005,"score_gpt":0.2662096132380428,"score_spread":0.24581740379594277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2540255710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931477,0.00052329525,0.003169182,0.0005361558,0.000119289485,0.0008004245,0.000083457024,0.00023034836,0.0013901762],"genre_scores_gemma":[0.99635494,0.000016953938,0.00068643654,0.0008275259,0.00013828345,0.00006807783,0.00029728262,0.000046531663,0.0015639428],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99839723,0.00005590445,0.00035844964,0.00031239857,0.00044362474,0.0004324162],"domain_scores_gemma":[0.9990683,0.000029293808,0.00016568138,0.00038729023,0.000097987366,0.0002514481],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001059289,0.0002442025,0.0003846931,0.00010625008,0.000107109794,0.000028631594,0.000077321725,0.00020997324,0.001233645],"category_scores_gemma":[0.00004779532,0.00022644647,0.00013743834,0.0003434824,0.00003386309,0.00023036604,0.00003855943,0.00016258983,0.00023274511],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028463279,0.0010652423,0.0067983065,0.000038284008,0.00019639269,4.9279527e-7,0.0005946734,9.0322516e-8,0.98684734,0.00008817745,0.0025060528,0.0018365016],"study_design_scores_gemma":[0.0038155336,0.00017666751,0.015114549,0.000049847058,0.0003437688,0.000008720553,0.00004976751,0.000046743793,0.9772529,0.00003459134,0.0028584173,0.00024850536],"about_ca_topic_score_codex":0.000032057167,"about_ca_topic_score_gemma":7.5029055e-7,"teacher_disagreement_score":0.009594434,"about_ca_system_score_codex":0.000031661406,"about_ca_system_score_gemma":0.000028643844,"threshold_uncertainty_score":0.9996794},"labels":[],"label_agreement":null},{"id":"W2540265923","doi":"10.1182/blood.v116.21.567.567","title":"Cost Analysis Comparing Computed Tomographic Pulmonary Angiography (CTPA) and Ventilation-Perfusion (V/Q) Scanning for the Diagnosis of Pulmonary Embolism","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Capital District Health Authority; London Health Sciences Centre; University of Ottawa; Jewish General Hospital; Victoria Hospital; Ottawa Hospital; Dalhousie University","funders":"","keywords":"Medicine; Pulmonary embolism; Pulmonary angiography; Radiology; Cost-effectiveness analysis; Angiography; Cost effectiveness; Emergency medicine; Surgery","score_opus":0.023392523718499408,"score_gpt":0.27344935732284387,"score_spread":0.25005683360434444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2540265923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939136,0.0028291934,0.00088968483,0.00050975586,0.00019820144,0.0012112355,0.000022907197,0.000059459722,0.00036596894],"genre_scores_gemma":[0.9974835,0.00067319954,0.001061772,0.00014018128,0.0001661178,0.0003185167,0.00011971081,0.000026104308,0.000010907071],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868065,0.000026738846,0.00037558918,0.0003563154,0.00027867817,0.00028200005],"domain_scores_gemma":[0.9987605,0.00032229707,0.00019541504,0.00044956038,0.00014847102,0.00012376108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036068237,0.00019664141,0.0006147765,0.0006521711,0.00029735657,0.00004106584,0.00016770982,0.000093489674,0.000040425097],"category_scores_gemma":[0.00004093135,0.00015402348,0.0005707363,0.0012651598,0.00015286492,0.00008027899,0.00012964536,0.0001763746,8.0183617e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055037814,0.0018128688,0.9762465,0.00014340709,0.0022746888,0.000015378904,0.00023554509,0.00015662996,0.0033488644,0.00048637865,0.00021400755,0.015010728],"study_design_scores_gemma":[0.00092300656,0.000086648004,0.9736963,0.000128029,0.008649756,0.000016407768,0.00017172027,0.013339338,0.0016716953,0.00007504581,0.0010832639,0.00015882337],"about_ca_topic_score_codex":0.00022618262,"about_ca_topic_score_gemma":0.000097269345,"teacher_disagreement_score":0.0148519045,"about_ca_system_score_codex":0.0000047205394,"about_ca_system_score_gemma":0.000016013872,"threshold_uncertainty_score":0.6280895},"labels":[],"label_agreement":null},{"id":"W2540318517","doi":"10.1182/blood.v124.21.4888.4888","title":"Utility of Transient Elastography (Fibroscan) in Estimating Hepatic Iron Concentration in Comparison to MRI in Patients with Transfusion Dependent Hemoglobinopathies","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Providence Health Care","funders":"","keywords":"Medicine; Transient elastography; Cirrhosis; Internal medicine; Gastroenterology; Liver disease; Prospective cohort study; Hemochromatosis; Liver transplantation; Surgery; Transplantation; Liver fibrosis","score_opus":0.005648173600027416,"score_gpt":0.22343558194096366,"score_spread":0.21778740834093624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2540318517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99823713,0.00006793585,0.00031211379,0.00006254331,0.000032675795,0.0011599048,0.000014668761,0.0000111191675,0.00010190582],"genre_scores_gemma":[0.99835473,0.000010287371,0.0014759233,0.000031323383,0.00000642341,0.000064938744,0.000046742567,0.000009280767,3.41193e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987211,0.00009236307,0.00041857635,0.00026636085,0.00030406786,0.00019753487],"domain_scores_gemma":[0.9995891,0.000048594073,0.00006732586,0.00016057132,0.00003838843,0.00009601752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013747721,0.000140867,0.00036663757,0.0001551441,0.000016984368,0.000006570778,0.000040364233,0.000045365738,0.000009230001],"category_scores_gemma":[0.000017758763,0.00011618712,0.00004298012,0.0002980735,0.000027758562,0.00006145719,0.000007798075,0.00008717978,0.0000011101342],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048409554,0.007338863,0.9866977,0.00022407189,0.000016263946,0.00000474547,0.0021516182,0.00093758723,0.0002481569,0.000007750441,0.0000018700282,0.0018873241],"study_design_scores_gemma":[0.012349449,0.0012677953,0.9762048,0.0008159864,0.00012281314,3.526299e-7,0.00014046705,0.0034963351,0.0054981248,0.0000064581077,0.0000011502182,0.000096262724],"about_ca_topic_score_codex":0.00072902936,"about_ca_topic_score_gemma":0.002237123,"teacher_disagreement_score":0.011865354,"about_ca_system_score_codex":0.00004062811,"about_ca_system_score_gemma":0.00003568958,"threshold_uncertainty_score":0.47379732},"labels":[],"label_agreement":null},{"id":"W2540531495","doi":"10.1182/blood-2016-06-722694","title":"Dyserythropoiesis due to reactive hemophagocytic lymphohistiocytosis","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Hemophagocytic lymphohistiocytosis; Nausea; Vomiting; Cervical lymphadenopathy; Histiocyte; Biopsy; Pathology; Surgery; Disease","score_opus":0.01565854119897238,"score_gpt":0.27721559919764854,"score_spread":0.2615570579986762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2540531495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97936845,0.00035800514,0.00032574456,0.003799099,0.00006133457,0.00037903004,0.000009720327,0.00011155631,0.015587058],"genre_scores_gemma":[0.9910786,0.000070684895,0.00037422022,0.0005663071,0.000102738864,0.00007054632,0.0000031714046,0.000033444092,0.0077002733],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987593,0.000034071105,0.00023425044,0.00028799352,0.0003290684,0.00035526988],"domain_scores_gemma":[0.99906576,0.000085377826,0.00004258674,0.00046064393,0.00013933738,0.00020632244],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015271002,0.0001411316,0.00032623037,0.00015751961,0.000093040086,0.0000129695045,0.00012066462,0.000082180115,0.00077139324],"category_scores_gemma":[0.0003932424,0.000093125185,0.00009917925,0.00025166135,0.000098170785,0.00010507694,0.00008484842,0.000069854366,0.0018954854],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010760184,0.0023838764,0.041067116,0.00024935105,0.0008740447,0.0015010985,0.001099346,5.880704e-7,0.7982459,0.001133871,0.017907804,0.134461],"study_design_scores_gemma":[0.013757436,0.0012660722,0.1842488,0.00047510263,0.000330914,0.00060999853,0.00053412607,0.0000067896167,0.73636454,0.00026127888,0.061644003,0.00050093804],"about_ca_topic_score_codex":0.000055210672,"about_ca_topic_score_gemma":0.000004723443,"teacher_disagreement_score":0.1431817,"about_ca_system_score_codex":0.00015158976,"about_ca_system_score_gemma":0.00029882306,"threshold_uncertainty_score":0.99888164},"labels":[],"label_agreement":null},{"id":"W2540811655","doi":"10.1182/blood.v124.21.4301.4301","title":"Efficacy and safety of Prothrombin Complex Concentrates Weight-Based Dosing for Reversal of Warfarin Anticoagulation","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Victoria Hospital; London Health Sciences Centre","funders":"","keywords":"Dosing; Medicine; Warfarin; Regimen; Prothrombin complex concentrate; Nomogram; Internal medicine; Pediatrics","score_opus":0.059466688446574274,"score_gpt":0.3213812478249606,"score_spread":0.2619145593783863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2540811655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99204516,0.00004417029,0.00588381,0.0006049033,0.000035338875,0.001028506,0.0000047236304,0.000019791505,0.00033359745],"genre_scores_gemma":[0.992689,0.000005128023,0.0071017537,0.000028051254,0.00009273264,0.0000011143292,0.00004064023,0.00000742974,0.000034163877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99945813,0.000024122523,0.0002442681,0.00009814088,0.0000978222,0.000077520934],"domain_scores_gemma":[0.99949753,0.00018770427,0.0001351615,0.00009507646,0.00005850757,0.000026001455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016670242,0.00006155358,0.0002480664,0.000042177446,0.000029245386,0.0000040824293,0.000021105292,0.000032257518,0.000019487776],"category_scores_gemma":[0.00012236356,0.000052288317,0.00004792304,0.0000643852,0.00005366706,0.000029437184,0.000010549217,0.000018031738,4.3931072e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013008007,0.00010776251,0.7523538,0.00082733855,0.00015966022,2.8575667e-7,0.00012605342,0.000061264014,0.23083718,0.0108802235,0.000076958204,0.0032686621],"study_design_scores_gemma":[0.022306038,0.0004496145,0.839299,0.00016551868,0.00045908563,7.3094213e-7,0.000017416847,0.0061813807,0.12903301,0.00018144763,0.0018219076,0.00008481128],"about_ca_topic_score_codex":0.000008081394,"about_ca_topic_score_gemma":7.2250936e-7,"teacher_disagreement_score":0.10180417,"about_ca_system_score_codex":0.0000043027826,"about_ca_system_score_gemma":0.000015432435,"threshold_uncertainty_score":0.21322556},"labels":[],"label_agreement":null},{"id":"W2540857736","doi":"10.1182/blood.v116.21.213.213","title":"Chronic Graft-Versus-Host Disease and Its Association with Treatment-Related Mortality, Relapse, Leukemia-Free and Overall Survival After Umbilical Cord Blood Transplantation (UCBT) In Children and Adolescents with Acute Leukemia","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Cumulative incidence; Internal medicine; Hazard ratio; Transplantation; Graft-versus-host disease; Leukemia; Proportional hazards model; Immunology; Acute leukemia; Acute lymphocytic leukemia; Gastroenterology; Confidence interval","score_opus":0.00637281753572598,"score_gpt":0.23231204479217105,"score_spread":0.22593922725644505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2540857736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99789095,0.00038215317,0.0000060275293,0.000118861986,0.00006092177,0.0011938846,0.00020822565,0.000067639514,0.00007135756],"genre_scores_gemma":[0.9978842,0.0014154144,0.00010272622,0.000026062688,0.00007235399,0.000077260716,0.00029345733,0.000048492417,0.000079997386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982178,0.00007867959,0.00033487924,0.00057635823,0.0004415079,0.00035074633],"domain_scores_gemma":[0.99911386,0.000077085686,0.00013603778,0.0002785525,0.00006130531,0.00033316118],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016498246,0.0003348878,0.00042704213,0.00011665556,0.00007225114,0.000050194743,0.000060108498,0.0002473212,0.000014635263],"category_scores_gemma":[0.000023874822,0.0002686415,0.00003839642,0.00016224977,0.000093684575,0.0002322541,0.000017649294,0.00035992544,0.0000027344697],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037596372,0.00033886425,0.988616,0.00032607102,0.0008601077,0.0004993956,0.0004200014,0.0000017381005,0.005053907,0.000047579902,0.0000011190278,0.00007560259],"study_design_scores_gemma":[0.05723964,0.0013134939,0.93100685,0.0005602962,0.0061217225,0.00055945024,0.000012338457,0.00007352301,0.0028055932,0.000019807985,0.000001125693,0.00028615887],"about_ca_topic_score_codex":0.00031626958,"about_ca_topic_score_gemma":0.0024533898,"teacher_disagreement_score":0.057609126,"about_ca_system_score_codex":0.00022463377,"about_ca_system_score_gemma":0.00036068357,"threshold_uncertainty_score":0.9999766},"labels":[],"label_agreement":null},{"id":"W2541211874","doi":"10.1182/blood.v126.23.3370.3370","title":"Prospective Evaluation of Fetal Haemoglobin Induction in Maternal Erythrocytes: A Preliminary Analysis of a Cohort of 345 Parturients","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Centre Hospitalier de l’Université de Montréal; Hôpital Saint-Luc; Montreal Heart Institute; Université de Montréal; Hôpital Maisonneuve-Rosemont; Hôpital Notre-Dame","funders":"","keywords":"Fetal hemoglobin; Medicine; Prospective cohort study; Pregnancy; Fetus; Blood sampling; Andrology; Immunology; Internal medicine; Biology; Genetics","score_opus":0.024930586149247296,"score_gpt":0.2895665127036343,"score_spread":0.264635926554387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2541211874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99743235,0.0006566605,0.000013709207,0.000026925962,0.000062519684,0.0006887962,0.000016848311,0.0000086293,0.0010935492],"genre_scores_gemma":[0.9996795,0.000045279994,0.00015322086,0.000004262293,0.000013122607,0.00003236552,0.000038682185,0.000008089324,0.000025464346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984514,0.00008897971,0.0004862483,0.00018450941,0.00066955865,0.00011930039],"domain_scores_gemma":[0.9989035,0.000014095536,0.0002837113,0.00019845812,0.00053797645,0.000062274274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071627914,0.0000972162,0.00046454297,0.00040205396,0.00000924409,0.0000018184147,0.000048366684,0.00012955419,0.000033530534],"category_scores_gemma":[0.00020036752,0.000081632315,0.00011744316,0.000930835,0.000096668104,0.00006746694,0.000028259814,0.00010519604,0.0000012913915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006582983,0.0019358549,0.98686445,0.000102608166,0.0021675795,0.0000071642203,0.0024776706,0.0012103622,0.0035710381,0.000024030112,0.000019742814,0.0009612258],"study_design_scores_gemma":[0.00691328,0.0010130515,0.9224245,0.0002158533,0.00915147,0.000022511873,0.0014752423,0.004678616,0.053914875,0.00011412457,0.0000025716324,0.00007392563],"about_ca_topic_score_codex":0.00047503447,"about_ca_topic_score_gemma":0.000032766722,"teacher_disagreement_score":0.064439945,"about_ca_system_score_codex":0.00007170277,"about_ca_system_score_gemma":0.00022210812,"threshold_uncertainty_score":0.3328869},"labels":[],"label_agreement":null},{"id":"W2541294359","doi":"10.1182/blood.v120.21.3430.3430","title":"A Comparison of Chronic Manual and Automated Red Blood Cell Exchange Transfusion in Sickle Cell Disease Patients From Two Comprehensive Care Centres in the United Kingdom","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Apheresis; Hemoglobin; Phlebotomy; Internal medicine","score_opus":0.015701246318416375,"score_gpt":0.2781546466486209,"score_spread":0.26245340033020453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2541294359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98627603,0.012418241,7.287829e-7,0.00008805632,0.000076055134,0.00083319814,0.000086562795,0.000049639926,0.0001714701],"genre_scores_gemma":[0.9987924,0.0004912603,0.000029688254,0.00007710059,0.00004342316,0.000013551207,0.0005278411,0.000020543072,0.0000041699686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986797,0.00018077399,0.00034061074,0.00020945855,0.00025008392,0.00033934665],"domain_scores_gemma":[0.99937785,0.00008339085,0.000101237216,0.00022604858,0.00006312474,0.00014834419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000053802454,0.0001862414,0.00034341434,0.00017676376,0.000051554638,0.000008015345,0.00008926912,0.000114621056,0.00003582285],"category_scores_gemma":[0.0000124011085,0.00013606573,0.000057015917,0.000353535,0.000071465656,0.000050237715,0.00004078384,0.0002593397,0.00000327413],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026083973,0.0055616735,0.96787393,0.00057694124,0.00003559169,0.000038058108,0.020737844,0.00007466168,0.004423337,0.0000034731186,0.0000809207,0.00033273993],"study_design_scores_gemma":[0.03714201,0.00061090535,0.9391429,0.0005558751,0.0008725804,0.0000019679742,0.009560221,0.002356949,0.008481313,0.000004121167,0.0010224633,0.00024870652],"about_ca_topic_score_codex":0.0028803984,"about_ca_topic_score_gemma":0.00026736417,"teacher_disagreement_score":0.03688117,"about_ca_system_score_codex":0.000036828453,"about_ca_system_score_gemma":0.000042797292,"threshold_uncertainty_score":0.55485994},"labels":[],"label_agreement":null},{"id":"W2541300034","doi":"10.1182/blood.v112.11.1239.1239","title":"The Association Between SHP-2 Mutations and Platelet Function in Noonan Syndrome.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"PTPN11; Noonan syndrome; Missense mutation; Platelet; Protein tyrosine phosphatase; Mutation; Internal medicine; Platelet disorder; Biology; Endocrinology; Medicine; Cancer research; Genetics; Gene; Signal transduction; KRAS","score_opus":0.007793276957351646,"score_gpt":0.20832426257144848,"score_spread":0.20053098561409682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2541300034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962358,0.0032365606,0.00006937652,0.00014135282,0.000032678694,0.00012354081,0.000033011005,0.0000076368815,0.000120036515],"genre_scores_gemma":[0.9991608,0.0002476744,0.0000873159,0.00003546264,0.000059739185,0.000027760463,0.0001849231,0.000007069321,0.00018921125],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99954736,0.000030800995,0.0001023359,0.00012736599,0.00007384031,0.00011830386],"domain_scores_gemma":[0.99976164,0.000032316395,0.000051819912,0.00010702499,0.00002362408,0.000023581415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000117255586,0.000057127494,0.000056806755,0.00001608238,0.00013445588,0.000012780728,0.000051831,0.00007147717,0.0000016501282],"category_scores_gemma":[0.00013138539,0.00004856083,0.000017418892,0.00006294522,0.000029371091,0.0000037540838,0.000033785094,0.0000512189,0.000005709572],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046574412,0.00015448726,0.9676841,0.000012387897,0.00021978145,0.000029760064,0.00007227091,0.000014159492,0.025349403,0.0005049487,0.0014747613,0.0044373684],"study_design_scores_gemma":[0.0009695268,0.00017556608,0.8180127,0.0000054195725,0.000030007,0.00004713884,0.0000125056,0.0000022763145,0.17257367,0.0003014941,0.0077759796,0.000093678624],"about_ca_topic_score_codex":0.00003665243,"about_ca_topic_score_gemma":0.000060479706,"teacher_disagreement_score":0.14967136,"about_ca_system_score_codex":0.000010535007,"about_ca_system_score_gemma":0.00002823771,"threshold_uncertainty_score":0.19802532},"labels":[],"label_agreement":null},{"id":"W2541326991","doi":"10.1182/blood.v118.21.3074.3074","title":"Allogeneic Hematopoietic Cell Transplantation (HCT) for Neuroblastoma (NB): The CIBMTR Experience","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Alberta Children's Hospital; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Transplantation; Internal medicine; Hematopoietic stem cell transplantation; Surgery; Retrospective cohort study; Hematopoietic cell; Progressive disease; Gastroenterology; Disease; Stem cell; Haematopoiesis","score_opus":0.036071558404529754,"score_gpt":0.27322778461156466,"score_spread":0.23715622620703491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2541326991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99599415,0.00010781228,0.0002722475,0.00013474944,0.000058765047,0.0007997112,0.000013833055,0.00005661252,0.0025621473],"genre_scores_gemma":[0.9981103,0.00008548257,0.00065893336,0.00025479973,0.00004678576,0.00028106998,0.000011052159,0.000026645714,0.00052491383],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99902236,0.000036683665,0.00015585173,0.00025546816,0.00021609508,0.00031351566],"domain_scores_gemma":[0.9993869,0.00007991323,0.00004097212,0.0002982883,0.00005061038,0.0001433212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000059499,0.00013299621,0.00013743405,0.00005019627,0.00012065044,0.000013228173,0.00013378315,0.000039409977,0.000115080744],"category_scores_gemma":[0.000021315083,0.00008639545,0.000102657585,0.00011347657,0.00007853865,0.000055742246,0.000016525475,0.000090467336,0.000060833143],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003927718,0.010537696,0.060448047,0.001393093,0.0004716239,0.0032220117,0.023120012,0.0000027432795,0.89103425,0.0008116531,0.0012365127,0.003794634],"study_design_scores_gemma":[0.005106217,0.0016517874,0.040019013,0.000036885234,0.00025764885,0.0006131727,0.00018540618,0.000011986133,0.95147824,0.000151428,0.00037725145,0.00011095772],"about_ca_topic_score_codex":0.000018997405,"about_ca_topic_score_gemma":0.000012566575,"teacher_disagreement_score":0.06044399,"about_ca_system_score_codex":0.00000758306,"about_ca_system_score_gemma":0.00004963044,"threshold_uncertainty_score":0.3523104},"labels":[],"label_agreement":null},{"id":"W2541341949","doi":"10.1182/blood.v126.23.4640.4640","title":"The Global aHUS Registry: Characteristics of 826 Patients with Atypical Hemolytic Uremic Syndrome","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Eculizumab; Medicine; Atypical hemolytic uremic syndrome; Thrombotic microangiopathy; Pediatrics; Internal medicine; Kidney disease; Disease; Intensive care medicine; Complement system; Immunology","score_opus":0.010169675268683677,"score_gpt":0.2160361721111838,"score_spread":0.20586649684250014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2541341949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99808675,0.0005919168,0.000009944514,0.00006166263,0.0003159465,0.0002634143,0.00027904205,0.000033483142,0.00035783456],"genre_scores_gemma":[0.999595,0.0000025658576,0.000018397923,0.000024176321,0.000014658985,0.000014387672,0.00016469232,0.0000079353595,0.00015821536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991696,0.0001006787,0.0002606813,0.00016263156,0.000073023606,0.00023341332],"domain_scores_gemma":[0.9991621,0.00006857375,0.00018643569,0.0004147178,0.00012926324,0.00003895163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010122833,0.00011965512,0.00021373884,0.00001270883,0.000078141275,0.000011208603,0.00028998996,0.00007426293,0.000039685765],"category_scores_gemma":[0.00016290414,0.000076998534,0.00004168522,0.00008288975,0.00019325803,0.000025369032,0.00009243777,0.000078199446,0.00011163259],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005284744,0.00066341733,0.9944673,0.000028263697,0.00027815677,0.000013537034,0.000034242985,1.9288655e-7,0.00014289425,0.00064922986,0.0029556036,0.00023866826],"study_design_scores_gemma":[0.004234127,0.0005088859,0.98855245,0.0000842344,0.00020505974,0.0001657476,0.00007349701,3.9521717e-7,0.00032097506,0.0001536996,0.005567867,0.00013307815],"about_ca_topic_score_codex":0.000022718616,"about_ca_topic_score_gemma":0.000012131052,"teacher_disagreement_score":0.005914885,"about_ca_system_score_codex":0.000038262067,"about_ca_system_score_gemma":0.000103914244,"threshold_uncertainty_score":0.31399092},"labels":[],"label_agreement":null},{"id":"W2541451693","doi":"10.1182/blood.v122.21.2417.2417","title":"The Zinc Finger Transcription Factor Growth Factor Independence 1b (Gfi1b) Regulates The Wnt/Beta-Catenin Signaling Pathway In Hematopoietic Stem Cells Through Interaction With Inhibitory Proteins","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"","keywords":"Wnt signaling pathway; Stem cell; Biology; Cell biology; Haematopoiesis; Transcription factor; Beta-catenin; Bone marrow; Cancer research; Signal transduction; Immunology; Genetics","score_opus":0.01156672792642047,"score_gpt":0.2033533198066086,"score_spread":0.19178659188018812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2541451693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971166,0.0013561897,0.00012316278,0.000278777,0.00010132224,0.00088310835,0.000015232578,0.000019238576,0.000106366795],"genre_scores_gemma":[0.99913406,0.00008611499,0.00008415971,0.00006995321,0.00006917386,0.00027682487,0.000018999433,0.00003244198,0.00022827157],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986755,0.00012462444,0.00027480282,0.0003826729,0.00022907661,0.00031328536],"domain_scores_gemma":[0.99939173,0.00003367003,0.00014882887,0.0002847552,0.000095267766,0.00004574107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008691139,0.0002523233,0.00016452778,0.00002411967,0.00021755858,0.00012287432,0.00021773035,0.00017354693,0.000021139693],"category_scores_gemma":[0.0000062146987,0.0001393397,0.00009290287,0.00010416333,0.00009657907,0.000039257386,0.000043761833,0.00021462352,0.000021134816],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005982104,0.0005606522,0.0024788338,0.000035853955,0.00018417239,0.000005600021,0.0011113759,0.000019486066,0.9942808,0.000052242565,0.00003488078,0.0011762702],"study_design_scores_gemma":[0.0014440175,0.0003326904,0.0012219788,0.00006044906,0.000044255357,0.000015652455,0.00078904524,0.000007774584,0.9954582,0.00020929595,0.00021941168,0.00019723785],"about_ca_topic_score_codex":0.0003016965,"about_ca_topic_score_gemma":0.00028225515,"teacher_disagreement_score":0.0020174584,"about_ca_system_score_codex":0.000015186538,"about_ca_system_score_gemma":0.000062163046,"threshold_uncertainty_score":0.56821084},"labels":[],"label_agreement":null},{"id":"W2542022508","doi":"10.1182/blood.v110.11.31.31","title":"MicroRNAs Act as Decoy Molecules To Restore Granulocytic Maturation of Differentiation-Arrested BCR/ABL+ Myeloid Precursors.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Biology; microRNA; CEBPA; Chronic myelogenous leukemia; Cancer research; K562 cells; Myeloid leukemia; Imatinib mesylate; Molecular biology; ABL; Leukemia; Imatinib; Cell biology; Immunology; Genetics; Gene; Transcription factor; Signal transduction; Tyrosine kinase","score_opus":0.009725888427012245,"score_gpt":0.2688193717649545,"score_spread":0.2590934833379423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2542022508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961009,0.00068928633,0.00028541553,0.0002083137,0.00020780627,0.0008511412,0.000014962563,0.00009148663,0.0015507026],"genre_scores_gemma":[0.9958061,0.00004681174,0.0026134285,0.00012142106,0.00012533696,0.00002813587,0.00016832082,0.000045779347,0.001044692],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998356,0.00004066074,0.0004805932,0.00036554685,0.00038517232,0.0003720527],"domain_scores_gemma":[0.9988198,0.0001147217,0.00019048114,0.00050520804,0.00016102409,0.00020873956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016606005,0.0002486473,0.0003720846,0.00024516214,0.000065525564,0.000018507846,0.00013662693,0.0001604651,0.00013727466],"category_scores_gemma":[0.0002910334,0.0002224937,0.00012519916,0.0003492367,0.000042090865,0.000080641315,0.000045681565,0.00016317323,0.00016156434],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014927398,0.0021550488,0.13116649,0.0004210296,0.00078592275,0.00021586714,0.001946158,0.000014815913,0.8529828,0.00026464858,0.0009270678,0.007627391],"study_design_scores_gemma":[0.005761781,0.0004060882,0.4545752,0.0002992283,0.00044995348,0.00010403715,0.000082156526,0.000012426311,0.5377687,0.00005257624,0.0003328254,0.00015496704],"about_ca_topic_score_codex":0.0001799046,"about_ca_topic_score_gemma":0.00012272483,"teacher_disagreement_score":0.32340872,"about_ca_system_score_codex":0.00040150533,"about_ca_system_score_gemma":0.00031843528,"threshold_uncertainty_score":0.907303},"labels":[],"label_agreement":null},{"id":"W2542165792","doi":"10.1182/blood.v120.21.1946.1946","title":"Independent Validation of Chronic Graft-Versus-Host Disease (GVHD) Grading System Proposed by the NIH Consensus Criteria in Terms of Prognostic Stratification of the Patients Developed Chronic Gvhd","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Graft-versus-host disease; Hematopoietic stem cell transplantation; Overlap syndrome; Internal medicine; Grading (engineering); Transplantation; Disease; Gastroenterology; Surgery","score_opus":0.02241704327987402,"score_gpt":0.26726540938288434,"score_spread":0.24484836610301033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2542165792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99667937,0.0002482791,0.00008154572,0.00006621452,0.00030262815,0.0022040172,0.000077465236,0.000016418622,0.000324092],"genre_scores_gemma":[0.9996471,0.000010484615,0.00006887666,0.0000030002843,0.000034679888,0.00006403208,0.00013889749,0.000020381158,0.000012549994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99811023,0.00023493105,0.00073652586,0.00018068284,0.00051443075,0.00022317405],"domain_scores_gemma":[0.99870145,0.00020272683,0.0004937368,0.0003764706,0.00014851677,0.000077120414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004374991,0.00015251472,0.0002786677,0.00007829824,0.00004762305,0.0000078361745,0.00015023012,0.00007845597,0.000029873658],"category_scores_gemma":[0.00017751878,0.000098755576,0.000066955465,0.00029001903,0.00012514219,0.000069615744,0.000021716687,0.00011100775,0.0000026530024],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028509067,0.0016262662,0.8328022,0.0057090526,0.0001523319,0.0000025566999,0.0020261956,0.000008294738,0.1562769,0.0005370911,0.00001783748,0.00055624236],"study_design_scores_gemma":[0.0047332216,0.00019333241,0.62880534,0.0006633829,0.00050006167,0.0000063559846,0.00024346645,0.000109162276,0.3646516,0.000007238525,0.0000026927507,0.0000841414],"about_ca_topic_score_codex":0.000037744605,"about_ca_topic_score_gemma":0.000016598957,"teacher_disagreement_score":0.20837471,"about_ca_system_score_codex":0.0001893727,"about_ca_system_score_gemma":0.0003137552,"threshold_uncertainty_score":0.40271354},"labels":[],"label_agreement":null},{"id":"W2542433746","doi":"10.1182/blood.v104.11.703.703","title":"Enoxaparin Is Effective and Safe as Bridging Anticoagulation in Patients with a Mechanical Prosthetic Heart Valve who Require Temporary Interruption of Warfarin because of Surgery or an Invasive Procedure.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Cardiovascular Issues in Pregnancy","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Warfarin; Surgery; Thrombosis; Low molecular weight heparin; Anticoagulant; Cohort; Anesthesia; Cardiology; Internal medicine; Atrial fibrillation","score_opus":0.023102999650190553,"score_gpt":0.28014681446456974,"score_spread":0.2570438148143792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2542433746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977256,0.00032283412,0.00009242176,0.00005462806,0.00002685554,0.001718668,0.0000071165646,0.000023366396,0.000028492077],"genre_scores_gemma":[0.9993003,0.00003635226,0.0004622279,0.00004831144,0.000023170405,0.00005313134,0.000034492834,0.000033850276,0.000008156102],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985222,0.000111018715,0.00042605036,0.00037119046,0.0003966454,0.00017288685],"domain_scores_gemma":[0.9991172,0.00009639896,0.00017644074,0.00035916961,0.0001709322,0.00007987018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003422383,0.00017405568,0.0006631568,0.00023522845,0.000022285807,0.000008530533,0.000045558518,0.00011660799,0.0000071849295],"category_scores_gemma":[0.00046959767,0.00014137491,0.0001359227,0.00030309882,0.000095379706,0.0002921994,0.000066759385,0.00014475666,0.0000012507758],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018898314,0.0022512788,0.98284173,0.0017899951,0.00045975094,0.00011105794,0.0035298476,0.000021529962,0.004405511,0.000055502962,0.0000030466438,0.002640929],"study_design_scores_gemma":[0.008196239,0.002068602,0.85643744,0.0074523403,0.00043069018,0.00023828351,0.00014100553,0.00002000573,0.124640055,0.00020284171,0.0000013508859,0.00017116412],"about_ca_topic_score_codex":0.0001824383,"about_ca_topic_score_gemma":0.00007942117,"teacher_disagreement_score":0.1264043,"about_ca_system_score_codex":0.000057335696,"about_ca_system_score_gemma":0.0002444605,"threshold_uncertainty_score":0.5765102},"labels":[],"label_agreement":null},{"id":"W2542504629","doi":"10.1182/blood.v120.21.1158.1158","title":"Impact of Thrombophilia Screening On Venous Thromboembolism Management Practices","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Thrombophilia; Lupus anticoagulant; Retrospective cohort study; Thrombosis; Internal medicine; Incidence (geometry); Deep vein; Antiphospholipid syndrome; Cohort; Proportional hazards model","score_opus":0.04088410703266829,"score_gpt":0.34759563129762866,"score_spread":0.3067115242649604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2542504629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9386634,0.00083541346,0.000046126148,0.0001676852,0.00021330654,0.0007847247,0.000010612668,0.00009080599,0.05918793],"genre_scores_gemma":[0.9960374,0.0005703097,0.0023777832,0.00028826273,0.00042869293,0.000048328773,0.000022724822,0.000051010687,0.00017544845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99814993,0.0000550478,0.00036542828,0.00030193286,0.00052338967,0.00060424843],"domain_scores_gemma":[0.9984881,0.00007521122,0.00046796436,0.0006520325,0.000068098976,0.00024853688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041465383,0.00027406283,0.0007724414,0.00022476677,0.00010006634,0.00002203783,0.00017042983,0.000091791204,0.00040368922],"category_scores_gemma":[0.00007671058,0.00021785754,0.00030805374,0.00027037784,0.00006428861,0.00022926077,0.00013179537,0.00019117825,0.00013963458],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067717035,0.15132518,0.67448306,0.0025320936,0.025696812,0.00040671072,0.0063422835,0.00023638993,0.013358827,0.04190218,0.025711408,0.05732786],"study_design_scores_gemma":[0.00249994,0.0019137029,0.98875856,0.00028202665,0.002078882,0.000040016756,0.00025919592,0.000007520285,0.0019268858,0.00009653175,0.0019157709,0.0002209589],"about_ca_topic_score_codex":0.00019185065,"about_ca_topic_score_gemma":0.0000019977128,"teacher_disagreement_score":0.31427547,"about_ca_system_score_codex":0.0000513604,"about_ca_system_score_gemma":0.000030473904,"threshold_uncertainty_score":0.8883972},"labels":[],"label_agreement":null},{"id":"W2542967618","doi":"10.1182/blood.v112.11.4008.4008","title":"Pharmacokinetic Results from a Phase 1 Study of a Multi-Targeted Tyrosine Kinase Inhibitor, ABT-869, in Patients with Refractory or Relapsed Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pharmacokinetics; Internal medicine; Cohort; Pharmacodynamics; Dosing; Pharmacology; Oncology; Cmax; Tyrosine-kinase inhibitor; Gastroenterology; Cancer","score_opus":0.021109433626469908,"score_gpt":0.2692309816465821,"score_spread":0.2481215480201122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2542967618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944753,0.00038315196,0.0000070718474,0.000016938578,0.0002266956,0.003620247,0.0010659497,0.00017339179,0.000031272706],"genre_scores_gemma":[0.9960463,0.0001448787,0.0014907329,0.000076279044,0.00009923268,0.00022526263,0.0010615453,0.00016064865,0.0006951299],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9951742,0.00022854733,0.0014866629,0.0012086662,0.0010877055,0.0008141825],"domain_scores_gemma":[0.9970011,0.00042381976,0.0006486359,0.0011721901,0.000293437,0.00046080776],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017078253,0.0007723555,0.0014414754,0.00054196717,0.00015611132,0.000014239269,0.0003175024,0.00027599555,0.00024921802],"category_scores_gemma":[0.0004868595,0.0005403145,0.00011738532,0.0011613442,0.00020564548,0.00020941114,0.00014658578,0.0006999591,0.000058203503],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27010363,0.24658722,0.24929897,0.00053314114,0.009180615,0.12414868,0.02245844,0.00031709045,0.07143871,2.6803144e-7,0.0007783164,0.0051549133],"study_design_scores_gemma":[0.5373941,0.036092717,0.40699553,0.0009155618,0.0034758348,0.00065429765,0.00033400464,0.00033547418,0.012970385,4.9373824e-7,0.00012166095,0.00070991047],"about_ca_topic_score_codex":0.001878916,"about_ca_topic_score_gemma":0.0004960936,"teacher_disagreement_score":0.26729047,"about_ca_system_score_codex":0.0013958587,"about_ca_system_score_gemma":0.0017887962,"threshold_uncertainty_score":0.99970484},"labels":[],"label_agreement":null},{"id":"W2543679265","doi":"10.1182/blood-2016-06-723742","title":"Sensing of the microbiota by NOD1 in mesenchymal stromal cells regulates murine hematopoiesis","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health; Uehara Memorial Foundation; McGill University","keywords":"Haematopoiesis; NOD1; Mesenchymal stem cell; Cell biology; Biology; Stromal cell; Immunology; Bone marrow; Cancer research; Stem cell; Innate immune system; Immune system; NOD2","score_opus":0.0061249062206083366,"score_gpt":0.20641377560127727,"score_spread":0.20028886938066892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2543679265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977759,0.00010268578,0.00006556806,0.0008664821,0.000076283,0.0002642565,0.000034453165,0.000020652817,0.00079369836],"genre_scores_gemma":[0.9978166,0.000020866619,0.0013153013,0.00004252107,0.000029422701,0.0000015332521,0.0000043613895,0.000019161895,0.0007502386],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990218,0.00005243814,0.0003336598,0.00019302848,0.0001882709,0.00021075078],"domain_scores_gemma":[0.9993484,0.00013644139,0.00009381879,0.00032904037,0.000042508855,0.00004976426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015010434,0.00012263081,0.0002617549,0.00005817948,0.000023502991,0.0000044709955,0.00008293228,0.00008647191,0.00008671936],"category_scores_gemma":[0.000029785231,0.00007028018,0.00008055019,0.00016204451,0.00009295632,0.000033739274,0.000026382813,0.00006806235,0.00001657124],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029245448,0.00018303786,0.014658778,0.00019032709,0.000036204303,0.000020795324,0.0002521233,2.2656766e-7,0.9841919,0.000023541947,0.0002693874,0.00014441744],"study_design_scores_gemma":[0.0030538137,0.000048054797,0.02054327,0.0008126979,0.00011782508,0.00021948524,0.00007363144,0.0000049401415,0.97491944,0.00002484775,0.000099314384,0.00008270075],"about_ca_topic_score_codex":0.000047216283,"about_ca_topic_score_gemma":0.00001582657,"teacher_disagreement_score":0.009272496,"about_ca_system_score_codex":0.000019804338,"about_ca_system_score_gemma":0.00004547351,"threshold_uncertainty_score":0.28659424},"labels":[],"label_agreement":null},{"id":"W2543681710","doi":"10.1182/blood.v118.21.3849.3849","title":"An Expanded Multicenter Phase I/II Study of CYT387, a JAK- 1/2 Inhibitor for the Treatment of Myelofibrosis,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Myelofibrosis; Constitutional symptoms; Dosing; Internal medicine; Polycythemia vera; Multicenter study; Phases of clinical research; Gastroenterology; Adverse effect; Anemia; Surgery; Clinical trial; Bone marrow; Disease; Randomized controlled trial","score_opus":0.05319811628048467,"score_gpt":0.33065920913840763,"score_spread":0.277461092857923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2543681710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960893,0.00046994642,0.000023179362,0.00003275017,0.00009080255,0.0030473054,0.000092720584,0.000014665739,0.00013937186],"genre_scores_gemma":[0.99711794,0.00015698514,0.0013716301,0.000029641364,0.00013330161,0.0010525506,0.0000250514,0.000023027673,0.00008989932],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989478,0.00004729823,0.00038160858,0.00023270388,0.00018754396,0.00020303117],"domain_scores_gemma":[0.99900997,0.00012863133,0.00015830637,0.0004480867,0.00013813366,0.00011689183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000087954024,0.0001991122,0.00045013666,0.00006250585,0.000099429206,0.0000045169713,0.0000679437,0.000048300393,0.00011754792],"category_scores_gemma":[0.000022892333,0.00010917208,0.00014899836,0.00008207973,0.00004996464,0.00005522279,0.0000152979,0.00002921212,0.0000025525007],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045483746,0.4033497,0.51552725,0.000082446975,0.0023930287,0.000015871674,0.0396365,5.824942e-7,0.020991262,0.000068414054,0.00011523197,0.0132713225],"study_design_scores_gemma":[0.06700929,0.13183218,0.111455746,0.000068052985,0.002460081,0.0000069930497,0.0034569548,0.00003527868,0.6829673,0.0000047230624,0.00058603095,0.000117346564],"about_ca_topic_score_codex":0.00019710173,"about_ca_topic_score_gemma":0.00011535032,"teacher_disagreement_score":0.66197604,"about_ca_system_score_codex":0.000026189246,"about_ca_system_score_gemma":0.000039741433,"threshold_uncertainty_score":0.44519082},"labels":[],"label_agreement":null},{"id":"W2543738146","doi":"10.1182/blood.v120.21.4320.4320","title":"Clinical Characteristics, Outcomes and Prognostic Factors for Patients with Acute Myeloid Leukemia Admitted to Intensive Care Settings","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Juravinski Hospital; McMaster University","funders":"","keywords":"Medicine; Intensive care unit; Myeloid leukemia; Intensive care; Internal medicine; Medical record; Palliative care; Retrospective cohort study; Intensive care medicine; Emergency medicine; Pediatrics","score_opus":0.01756378600733526,"score_gpt":0.3030144295136738,"score_spread":0.28545064350633853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2543738146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979927,0.0000292423,0.000026986083,0.00021789384,0.0003203852,0.0011591492,0.00015515617,0.000051218154,0.0000472526],"genre_scores_gemma":[0.9972726,0.000008156504,0.0004582337,0.0016675624,0.00018421275,0.00010459385,0.0001686242,0.000028681734,0.00010729866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991841,0.000014674447,0.00022503358,0.00020292941,0.000112045454,0.00026123584],"domain_scores_gemma":[0.9987226,0.00015589558,0.00008297348,0.00015399094,0.00058884907,0.00029569556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000041737207,0.00014794065,0.00034016895,0.000047338912,0.00007854996,0.000015555073,0.000036964877,0.00006719828,0.00001083704],"category_scores_gemma":[0.00056010444,0.00010018762,0.00006603949,0.000068652385,0.000042028198,0.000069685986,0.000037199963,0.00013402282,0.000009308947],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015312327,0.00016435732,0.99682105,0.000058994785,0.00027028046,0.0000029144167,0.0010352675,7.5306845e-9,0.00005463488,0.0000061013266,0.0002686413,0.001164645],"study_design_scores_gemma":[0.0036610095,0.0013490636,0.9895515,0.00008659749,0.0012171669,0.0000101192,0.0006139847,1.5011084e-7,0.00040380796,8.5123634e-7,0.0029732217,0.00013253404],"about_ca_topic_score_codex":0.000010691967,"about_ca_topic_score_gemma":0.000005287717,"teacher_disagreement_score":0.007269539,"about_ca_system_score_codex":0.000041483534,"about_ca_system_score_gemma":0.00009048185,"threshold_uncertainty_score":0.40855327},"labels":[],"label_agreement":null},{"id":"W2544036771","doi":"10.1182/blood.v122.21.1988.1988","title":"FV-162 Is a Novel Orally Bioavailable Proteasome Inhibitor With Improved Pharmacokinetics That Displays Preclinical Efficacy In Vitro and In Vivo","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Bortezomib; Carfilzomib; Proteasome; Proteasome inhibitor; Pharmacology; In vivo; Pharmacokinetics; IC50; Bioavailability; Multiple myeloma; Cytotoxicity; Cell culture; Chemistry; Biology; In vitro; Biochemistry; Immunology","score_opus":0.03172782629800786,"score_gpt":0.30545610336298623,"score_spread":0.2737282770649784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2544036771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99565715,0.00026988503,0.0000064350193,0.0008426944,0.000021620783,0.0028513435,0.00004894023,0.00003100589,0.0002709181],"genre_scores_gemma":[0.99458635,0.00008868409,0.0038270243,0.00019378946,0.0000797548,0.00042170257,0.000018706152,0.000035643974,0.0007483647],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983838,0.000040265826,0.00029440693,0.00045534328,0.00030739536,0.00051873975],"domain_scores_gemma":[0.99912304,0.00013031258,0.00006843535,0.00028021526,0.00006097523,0.00033704742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015341211,0.00022817701,0.00039275413,0.00016526387,0.000032217104,0.000052331932,0.00009344484,0.00011267251,0.00025832222],"category_scores_gemma":[0.000113193986,0.0001588376,0.00004296142,0.0002045482,0.00011533083,0.00014748129,0.00009537044,0.00033677893,0.00006176346],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023176065,0.006892851,0.31496754,0.00018256229,0.0001641209,0.0001473896,0.00018696871,4.3293792e-7,0.67239726,9.0506364e-7,0.00018533008,0.0025570302],"study_design_scores_gemma":[0.06729207,0.0012901457,0.32551575,0.00028152906,0.00012700968,0.000073900635,0.000048986087,0.0023335759,0.6023246,0.0000057524703,0.00044346653,0.0002631951],"about_ca_topic_score_codex":0.0005444472,"about_ca_topic_score_gemma":0.000074952324,"teacher_disagreement_score":0.07007263,"about_ca_system_score_codex":0.000039914037,"about_ca_system_score_gemma":0.00013017734,"threshold_uncertainty_score":0.64772093},"labels":[],"label_agreement":null},{"id":"W2544048332","doi":"10.1182/blood.v114.22.3516.3516","title":"Pitfalls of Clinical Diagnosis Strategies for Heparin-Induced Thrombocytopenia (HIT) After Cardiac Surgery (CS).","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Heparin-induced thrombocytopenia; Medicine; Thrombosis; Cardiac surgery; Population; Gold standard (test); Complication; Exact test; Retrospective cohort study; Heparin; Internal medicine; Surgery","score_opus":0.08320763324300935,"score_gpt":0.36777577960874247,"score_spread":0.28456814636573313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2544048332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99129313,0.00049451325,0.00003068577,0.0008569639,0.00070263963,0.0014954678,0.00010815282,0.00014980766,0.004868616],"genre_scores_gemma":[0.9958473,0.0006391147,0.0014217839,0.00070388295,0.00080850226,0.00033559348,0.00007265501,0.0000728745,0.00009833332],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99595135,0.0002231494,0.0016985518,0.0008409992,0.00049353915,0.00079239433],"domain_scores_gemma":[0.99654526,0.0011577149,0.00041220814,0.0010603745,0.00035514755,0.00046931085],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001299482,0.00050205796,0.0029399076,0.00022569962,0.00011124129,0.00007979111,0.00027400328,0.0005296402,0.00023045082],"category_scores_gemma":[0.00058756396,0.00044555057,0.0014177858,0.0004013815,0.00014994224,0.00036300858,0.00008797809,0.00043791003,0.0000771786],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011557085,0.0074055325,0.89883834,0.00052067265,0.002342327,0.00014982186,0.00056421955,6.604815e-7,0.059543077,0.0024505563,0.0049195364,0.02210957],"study_design_scores_gemma":[0.003283672,0.0016701902,0.8996525,0.00032812677,0.0018396232,0.000022937578,0.00022049953,0.0000057710477,0.08779609,0.0010519051,0.0035697964,0.00055887696],"about_ca_topic_score_codex":0.00014746803,"about_ca_topic_score_gemma":0.00004258232,"teacher_disagreement_score":0.028253015,"about_ca_system_score_codex":0.00004244116,"about_ca_system_score_gemma":0.0009311812,"threshold_uncertainty_score":0.9997996},"labels":[],"label_agreement":null},{"id":"W2544327648","doi":"10.1182/blood.v124.21.2800.2800","title":"The Effect of Age on the Glycosylation of Human Alpha-2-Macroglobulin","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; McMaster University","funders":"","keywords":"Sialic acid; Glycosylation; Glycoprotein; Proteases; Serine; Thrombin; Biochemistry; Gel electrophoresis; Biology; Platelet; Chemistry; Molecular biology; Immunology; Enzyme","score_opus":0.007747959543225305,"score_gpt":0.26833871008409405,"score_spread":0.2605907505408687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2544327648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936874,0.00013192298,0.00005710594,0.00015387258,0.000027931712,0.00027065218,0.0000045451443,0.0000037014327,0.0056628874],"genre_scores_gemma":[0.9993571,0.000017036007,0.000016548816,0.000024244728,0.00007356095,0.000022986022,0.0000219189,0.000008563148,0.00045802267],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999167,0.00023508458,0.0001574626,0.00012374578,0.00019258528,0.00012408494],"domain_scores_gemma":[0.99933535,0.000106792875,0.00008687846,0.0003925224,0.00005328616,0.00002518861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006778907,0.00007621485,0.00009156952,0.000018348654,0.00012360947,0.000012182688,0.00021893252,0.00006336891,0.000019227122],"category_scores_gemma":[0.00035166126,0.000040243416,0.000078243174,0.00006757308,0.00011210655,0.0000010187409,0.000056164645,0.00007119514,0.000009051692],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000114114235,0.000061930754,0.002400558,0.00002128931,0.000053005333,5.036232e-7,0.000016300983,0.000012355484,0.99061763,0.0020005724,0.00039595226,0.004305797],"study_design_scores_gemma":[0.0008487198,0.0015675992,0.0051429253,0.0000110308365,0.000015230413,0.0000011876594,0.0000041564545,0.00004084308,0.9819803,0.00011631637,0.010226592,0.000045079225],"about_ca_topic_score_codex":0.000023403589,"about_ca_topic_score_gemma":0.000034566805,"teacher_disagreement_score":0.009830641,"about_ca_system_score_codex":0.0000020710108,"about_ca_system_score_gemma":0.000010509432,"threshold_uncertainty_score":0.16410789},"labels":[],"label_agreement":null},{"id":"W2544390755","doi":"10.1182/blood.v124.21.3928.3928","title":"The Risk Factors for IgG Hypogammaglobulinemia after Allogeneic Hematopoietic Stem Cell Transplantation and Its Impact on Transplant Outcomes","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Hypogammaglobulinemia; Medicine; Hematopoietic stem cell transplantation; Transplantation; Immunology; Univariate analysis; Internal medicine; Graft-versus-host disease; Population; Multivariate analysis; Oncology; Antibody","score_opus":0.012489935231819755,"score_gpt":0.27586789096823616,"score_spread":0.2633779557364164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2544390755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99766326,0.00069178996,0.00014530683,0.00018196242,0.00006907276,0.00088079803,0.00016648667,0.000045029814,0.00015628609],"genre_scores_gemma":[0.9983826,0.0008252993,0.000048467387,0.000087151166,0.000077998506,0.000102773214,0.000035648594,0.00004000416,0.00040002615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985003,0.00009039112,0.00028071812,0.00032013716,0.0003643832,0.00044407023],"domain_scores_gemma":[0.9980119,0.001328469,0.000073519645,0.00031522074,0.00005510573,0.00021580853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037245417,0.0002513687,0.00033418217,0.000064387255,0.00015125335,0.000038867103,0.00012173492,0.00012646071,0.000015989412],"category_scores_gemma":[0.000042276308,0.00013285894,0.00020508505,0.00007372745,0.000053885487,0.000040602015,0.000010301861,0.00017718355,0.000021555028],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02389306,0.005489677,0.8760688,0.010984386,0.0044734483,0.00085920026,0.027419709,0.0007287563,0.028545992,0.00086145,0.0010068171,0.019668737],"study_design_scores_gemma":[0.14431193,0.004424174,0.4947496,0.00053259725,0.004576154,0.00081226235,0.0005338364,0.009534915,0.33787513,0.00028654654,0.0012934171,0.0010694423],"about_ca_topic_score_codex":0.000060016897,"about_ca_topic_score_gemma":0.000031467192,"teacher_disagreement_score":0.38131917,"about_ca_system_score_codex":0.00040244582,"about_ca_system_score_gemma":0.00043917663,"threshold_uncertainty_score":0.54178303},"labels":[],"label_agreement":null},{"id":"W2544442903","doi":"10.1182/blood.v120.21.2381.2381","title":"Fetal Vs. Adult Hematopoietic Progenitors Respond Differently to NOTCH1: Implications for Pediatric Vs. Adult T-ALL.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Bone marrow; Progenitor cell; Haematopoiesis; Immunology; Immunophenotyping; Leukemia; Fetus; Cancer research; Medicine; Biology; Stem cell; Antigen; Genetics; Pregnancy","score_opus":0.01996570263040036,"score_gpt":0.3051384905767103,"score_spread":0.2851727879463099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2544442903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988541,0.0002655858,0.0011508707,0.006459196,0.00027116356,0.0025656733,0.00015070556,0.00017411093,0.00042167093],"genre_scores_gemma":[0.9877479,0.00005985792,0.005660262,0.0012808475,0.0023393333,0.001323368,0.0001175964,0.00010657222,0.0013642659],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973347,0.000055877077,0.00048964674,0.00048803788,0.0005458544,0.0010858715],"domain_scores_gemma":[0.9971149,0.00040181007,0.000109363114,0.0007604151,0.00064823386,0.0009652898],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022631278,0.00031678504,0.0004563924,0.00033605422,0.00016350644,0.00004419996,0.00033658626,0.00022237463,0.00006158271],"category_scores_gemma":[0.0014043833,0.0002661762,0.0002194859,0.00059250894,0.00006020202,0.00013408971,0.00017773635,0.0002487712,0.0004383777],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032734913,0.008303052,0.8745267,0.0017492725,0.00085580925,0.000041690393,0.0046519837,0.0000012829021,0.029510362,0.005219533,0.0681904,0.0036764217],"study_design_scores_gemma":[0.043045666,0.0044185263,0.85659873,0.00024863976,0.0039200904,0.0014515031,0.00059866474,0.00017076558,0.07311804,0.0006008062,0.0141341,0.0016944756],"about_ca_topic_score_codex":0.000031757147,"about_ca_topic_score_gemma":0.000007839045,"teacher_disagreement_score":0.0540563,"about_ca_system_score_codex":0.00029986014,"about_ca_system_score_gemma":0.00049333315,"threshold_uncertainty_score":0.999979},"labels":[],"label_agreement":null},{"id":"W2544600340","doi":"10.1182/blood.v120.21.1517.1517","title":"Interim Report of a Randomized, Open-Label, Multicenter Study to Evaluate the Safety and Efficacy of Decitabine As an Epigenetic Priming Agent When Combined with Induction Chemotherapy in Pediatric Patients (pts) with Newly Diagnosed Acute Myelogenous Leukemia (AML)","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"","keywords":"Decitabine; Medicine; Cytarabine; Internal medicine; Oncology; Etoposide; Azacitidine; Induction chemotherapy; Leukemia; Idarubicin; Daunorubicin; Chemotherapy regimen; Chemotherapy; Surgery; DNA methylation; Biology","score_opus":0.027338459029147905,"score_gpt":0.32228407957705196,"score_spread":0.2949456205479041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2544600340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988947,0.00014204628,0.00013974676,0.0002134951,0.000053965523,0.010415703,0.000004577169,0.000016563477,0.00006694875],"genre_scores_gemma":[0.99591756,0.0001757438,0.0032111157,0.00013342632,0.000075918724,0.00031707803,0.000036357065,0.00006710217,0.00006568542],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9966818,0.00061050395,0.00097246707,0.00048403148,0.0007908769,0.00046028703],"domain_scores_gemma":[0.997714,0.0003547721,0.00042714048,0.0007798285,0.00044502204,0.00027924794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025742606,0.00031572705,0.0011419427,0.00029182943,0.000081797385,0.000030585827,0.00035020235,0.00007710129,0.0000254898],"category_scores_gemma":[0.0006287562,0.00018284665,0.000044923778,0.00049539335,0.00015989656,0.00020248382,0.00027216747,0.0003103182,0.0000027914978],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.33457974,0.020757986,0.59770966,0.00012377002,0.0015555513,0.00020668116,0.03578326,0.000032165826,0.0031031314,0.000002971745,0.000019841867,0.0061252685],"study_design_scores_gemma":[0.50452566,0.009912349,0.47903705,0.00011871941,0.0016811034,0.00008307675,0.0009830426,0.000065300395,0.0034002138,0.00000286566,0.000008230587,0.00018237854],"about_ca_topic_score_codex":0.0009802459,"about_ca_topic_score_gemma":0.0001658823,"teacher_disagreement_score":0.16994591,"about_ca_system_score_codex":0.00029131395,"about_ca_system_score_gemma":0.00048603717,"threshold_uncertainty_score":0.74562705},"labels":[],"label_agreement":null},{"id":"W2545111307","doi":"10.1182/blood.v110.11.3851.3851","title":"The Role of Nramp1 in Erythrophagocytosis.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Internalization; Erythropoiesis; Phagocytosis; Macrophage; Hemoglobin; Heme; Cell biology; Biology; CD163; Red blood cell; Nitric oxide; Ferritin; Inflammation; Bone marrow; Pinocytosis; Immunology; Biochemistry; Anemia; Endocytosis; Cell; In vitro; Internal medicine; Endocrinology; Medicine","score_opus":0.005462021499486451,"score_gpt":0.24299704847471998,"score_spread":0.23753502697523352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2545111307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.961757,0.009055248,0.000013107912,0.00012357406,0.000049465518,0.000105181716,8.185373e-7,0.000010173886,0.028885424],"genre_scores_gemma":[0.9991934,0.00021262013,0.00022408125,0.00010904672,0.000055109784,0.000002113214,0.0000013216861,0.0000064125675,0.00019592397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99948925,0.000009852577,0.00015386325,0.00006915147,0.0001221897,0.00015566907],"domain_scores_gemma":[0.99969596,0.00005166232,0.0000303079,0.00016498694,0.000020873935,0.000036223864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027240088,0.000046415775,0.00010803991,0.000042570806,0.000023959274,0.0000026452362,0.00005043148,0.000035454257,0.000024275663],"category_scores_gemma":[0.000075203585,0.000030118501,0.000035965633,0.00012954861,0.000058075882,0.000015608135,0.000014206453,0.00006777037,0.0000141068895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048361372,0.00251182,0.7518612,0.00010215044,0.000050048428,0.000058988546,0.0016832632,0.000002133682,0.08886259,0.019103352,0.00037696524,0.13490388],"study_design_scores_gemma":[0.0061610937,0.0001501797,0.7348123,0.000027624588,0.00012805157,0.00002113945,0.0026635288,0.0000036944841,0.21936026,0.0016557734,0.034917932,0.00009842773],"about_ca_topic_score_codex":0.00007849978,"about_ca_topic_score_gemma":0.00007972326,"teacher_disagreement_score":0.13480546,"about_ca_system_score_codex":0.0000030206775,"about_ca_system_score_gemma":0.00002878217,"threshold_uncertainty_score":0.122819684},"labels":[],"label_agreement":null},{"id":"W2545173372","doi":"10.1182/blood.v104.11.2036.2036","title":"cDNA Microarray Analysis of Genes Up-Regulated by Treatment with 5-AZA-2′-Deoxycytidine in Combination with Trichostatin A Identifies Aberrant Metallothionein 1H Promoter Methylation at a High Frequency Iin Human AML.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Trace Elements in Health","field":"Nursing","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Trichostatin A; DNA methylation; Biology; Molecular biology; Methylation; Histone deacetylase; Cancer research; Histone; Gene; Gene expression; Genetics","score_opus":0.013976634540859392,"score_gpt":0.27099512634936396,"score_spread":0.25701849180850456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2545173372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965933,0.00074419926,0.0002772243,0.0005876969,0.0000873149,0.0014488251,0.00010063465,0.00014369338,0.000017114093],"genre_scores_gemma":[0.9939984,0.000028533083,0.0047368393,0.000024012787,0.000014575775,0.00017114214,0.00080251537,0.00005980426,0.00016415559],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972338,0.00028680448,0.00085861166,0.00063284463,0.00056420336,0.00042370983],"domain_scores_gemma":[0.9985264,0.00007625452,0.00063800195,0.00047929483,0.00019062139,0.00008942024],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040629503,0.0003774151,0.0007531085,0.0009198089,0.00019843187,0.000046347493,0.00015667966,0.00012895362,0.00006092975],"category_scores_gemma":[0.00002005875,0.0002950633,0.00010978184,0.0019072538,0.000109023655,0.0002849831,0.000019520798,0.00013292157,0.0000034412244],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068993756,0.0045518875,0.05296773,0.00012834837,0.0025293706,0.000020610029,0.007437154,0.001369102,0.92898005,0.00009861541,0.000015208968,0.0012119589],"study_design_scores_gemma":[0.018166408,0.0031936087,0.1458299,0.00016431561,0.0040303865,0.000008670323,0.00024449071,0.00014866433,0.827603,0.00020893845,0.000014433579,0.00038721546],"about_ca_topic_score_codex":0.008833415,"about_ca_topic_score_gemma":0.020803008,"teacher_disagreement_score":0.10137711,"about_ca_system_score_codex":0.0007525995,"about_ca_system_score_gemma":0.000066881694,"threshold_uncertainty_score":0.9999502},"labels":[],"label_agreement":null},{"id":"W2545387711","doi":"10.1182/blood.v126.23.4029.4029","title":"Treatment-Free Remission (TFR) Eligibility in Patients (pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) and Residual Disease on Long-Term Imatinib (IM) Who Switched to Second-Line Nilotinib (NIL)","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; McMaster University","funders":"","keywords":"Nilotinib; Medicine; Imatinib; Internal medicine; Imatinib mesylate; Myeloid leukemia; Dasatinib; Tyrosine-kinase inhibitor; Gastroenterology; Surgery; Cancer","score_opus":0.02562510594425862,"score_gpt":0.31139104084803493,"score_spread":0.28576593490377633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2545387711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940245,0.0012870778,0.0000052703385,0.00038064647,0.0000843028,0.0034707817,0.00021827819,0.00012731687,0.00040178653],"genre_scores_gemma":[0.99689317,0.00014010492,0.0002778783,0.00016895168,0.00030954333,0.00032689792,0.00075930235,0.000120392215,0.0010037535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99554443,0.00019268112,0.00096413714,0.0014684297,0.0008361167,0.0009941948],"domain_scores_gemma":[0.99617165,0.00015404986,0.00027326113,0.0018822893,0.00015147564,0.0013672916],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037485917,0.0008048118,0.0011163009,0.00043409632,0.00009443133,0.000052953223,0.00031779616,0.00021871168,0.00014578206],"category_scores_gemma":[0.0005150335,0.0006278796,0.00010770681,0.00057706225,0.00014956157,0.00025022382,0.00024305627,0.00046915794,0.000079594305],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0172277,0.010016881,0.94350946,0.00083426206,0.0003422974,0.001914979,0.0013833288,0.00020192255,0.0029111726,0.00001140116,0.0004937811,0.021152796],"study_design_scores_gemma":[0.25083905,0.022624489,0.7082576,0.0020085503,0.000535637,0.000060223072,0.000051025963,0.0003539012,0.014222299,0.00004966675,0.00026679257,0.0007307263],"about_ca_topic_score_codex":0.0005384514,"about_ca_topic_score_gemma":0.0048327995,"teacher_disagreement_score":0.23525184,"about_ca_system_score_codex":0.01666371,"about_ca_system_score_gemma":0.0057455623,"threshold_uncertainty_score":0.9998909},"labels":[],"label_agreement":null},{"id":"W2545396337","doi":"10.1182/blood.v104.11.3440.3440","title":"Ship Is Essential for Both Endotoxin- and CpG-Induced Tolerance and for Their Cross-Tolerance.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; BC Cancer Agency","funders":"","keywords":"Lipopolysaccharide; Autocrine signalling; TLR4; Biology; Cell biology; TLR9; Cytokine; Downregulation and upregulation; Receptor; Immune tolerance; Immunology; Haematopoiesis; Signal transduction; Immune system; Gene expression; Stem cell","score_opus":0.03327556308504895,"score_gpt":0.31453112578095105,"score_spread":0.28125556269590213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2545396337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99536866,0.00048191912,0.0018839469,0.00072757096,0.00020916415,0.000767925,0.00015271874,0.000045021046,0.0003631018],"genre_scores_gemma":[0.99653554,0.000035469813,0.0016744707,0.0006714426,0.0006407561,0.0002192853,0.000017636092,0.000028023065,0.0001773868],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99920374,0.000004943613,0.00019777064,0.00029035442,0.00007721476,0.00022597396],"domain_scores_gemma":[0.9995022,0.00008376726,0.00006205673,0.00016107828,0.000088770576,0.00010212258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008705744,0.00014508414,0.00024790087,0.00004546631,0.00017739255,0.000063602696,0.000041416377,0.000074757816,0.000026380527],"category_scores_gemma":[0.000057439553,0.00012195788,0.00010096644,0.00005007909,0.000052012358,0.00009340859,0.000015661677,0.000098992976,0.0000015835849],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000410928,0.00046219002,0.0024622222,0.00025811486,0.00011882513,0.000006352068,0.0009698628,0.0000071736936,0.9919802,0.0013193288,0.0002657776,0.0017390243],"study_design_scores_gemma":[0.012811134,0.0007410498,0.005512386,0.00020222463,0.00014695323,0.00014248831,0.00007430528,0.0001627296,0.97166944,0.0015479464,0.0068216347,0.00016771154],"about_ca_topic_score_codex":0.000033241417,"about_ca_topic_score_gemma":0.000015734915,"teacher_disagreement_score":0.020310763,"about_ca_system_score_codex":0.000011587592,"about_ca_system_score_gemma":0.00006471054,"threshold_uncertainty_score":0.4973298},"labels":[],"label_agreement":null},{"id":"W2545704931","doi":"10.1182/blood.v122.21.4040.4040","title":"Validation of Digital-PCR Analysis through Programmed imatinib Interruption in Q-RT-PCR Negative Chronic Myeloid Leukemia Patients","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Imatinib; Medicine; Imatinib mesylate; Discontinuation; Myeloid leukemia; Minimal residual disease; Digital polymerase chain reaction; Internal medicine; Oncology; Population; Leukemia; Immunology; Gastroenterology; Polymerase chain reaction; Biology; Genetics","score_opus":0.021275528157952882,"score_gpt":0.27987430172668853,"score_spread":0.2585987735687357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2545704931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955087,0.00011002076,0.00015687576,0.00009105858,0.000057399855,0.0016869986,0.0000350387,0.000076053024,0.0022778814],"genre_scores_gemma":[0.99680686,0.00004494825,0.0014401849,0.00003082794,0.00006863573,0.00031378097,0.0010064719,0.000036407982,0.00025189423],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977655,0.000067753084,0.00078391586,0.00047431528,0.000489819,0.00041869268],"domain_scores_gemma":[0.99855083,0.0001069928,0.00041780135,0.0005252457,0.00028594313,0.00011320385],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010620937,0.00029836496,0.0006600493,0.00034095527,0.00003784627,0.000056613273,0.00014676049,0.0001633172,0.0004016006],"category_scores_gemma":[0.00026890106,0.00025910052,0.00025659337,0.0012106526,0.00011166506,0.0006724035,0.0000874365,0.00021860028,0.00016529245],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016124884,0.003908695,0.94495934,0.00042226742,0.003201803,0.000017171766,0.003994072,0.00020522714,0.0038190978,0.000045683744,0.00016608974,0.039099332],"study_design_scores_gemma":[0.037868794,0.0023543916,0.8370824,0.00061922555,0.0039812224,0.000014332,0.0007360483,0.0026927781,0.113091715,0.00081515894,0.00014563209,0.0005983095],"about_ca_topic_score_codex":0.001101046,"about_ca_topic_score_gemma":0.00009118044,"teacher_disagreement_score":0.109272614,"about_ca_system_score_codex":0.0018974543,"about_ca_system_score_gemma":0.0004087171,"threshold_uncertainty_score":0.9999861},"labels":[],"label_agreement":null},{"id":"W2546061993","doi":"10.1182/blood.v124.21.703.703","title":"Clinical Significance of Genetic Aberrations in Diffuse Large B Cell Lymphoma","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Spinal Cord Injury BC; Simon Fraser University; BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Oncology; SNP array; Biology; CDKN2A; Population; PTEN; Cancer; Lymphoma; Cancer research; Internal medicine; Medicine; Genetics; Gene; Genotype; Single-nucleotide polymorphism","score_opus":0.0157311541427822,"score_gpt":0.280834132528888,"score_spread":0.2651029783861058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2546061993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944194,0.00035294725,0.00005344933,0.00013466876,0.00006161218,0.00023438214,0.000009428655,0.000015191315,0.0047189333],"genre_scores_gemma":[0.99791706,0.00014406662,0.0013592645,0.0002090901,0.00008737565,0.000049465205,0.000008680406,0.000010257662,0.00021475874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991252,0.00005883695,0.00035819603,0.0001857502,0.00011907889,0.0001529324],"domain_scores_gemma":[0.99936324,0.00014892756,0.000077609104,0.0002907745,0.000031465865,0.00008798373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013436914,0.00008294651,0.00026039718,0.000043851676,0.000018814944,0.0000042326196,0.00004997583,0.00006668227,0.000027751355],"category_scores_gemma":[0.00007306718,0.00006728966,0.00008870413,0.00009696617,0.000033737644,0.000015139128,0.00001875299,0.000030098665,0.000048104368],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019560033,0.041679762,0.9528773,0.00003945673,0.000036916168,0.000032387074,0.00009477662,6.965357e-7,0.00048562745,0.00026086075,0.00031499774,0.0041576573],"study_design_scores_gemma":[0.0369864,0.00041483642,0.9531122,0.000041551124,0.00016868429,0.0000066717566,0.000019451876,0.00011717895,0.006457865,0.0000595126,0.0025516965,0.00006398804],"about_ca_topic_score_codex":0.00005509832,"about_ca_topic_score_gemma":0.00006698377,"teacher_disagreement_score":0.041264925,"about_ca_system_score_codex":0.000017859244,"about_ca_system_score_gemma":0.000075425654,"threshold_uncertainty_score":0.27439925},"labels":[],"label_agreement":null},{"id":"W2546179059","doi":"10.1182/blood.v114.22.2130.2130","title":"Factor Xa and Factor VIIa Utilize Herpes Simplex Virus-Associated Tissue Factor to Increase Infection through Cellular Protease Activated Receptor 2.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of British Columbia","funders":"","keywords":"Tissue factor; Thrombin; Herpes simplex virus; Coagulation; Protease; Thromboplastin; Virus; Factor X; Thrombomodulin; Biology; Virology; Immunology; Enzyme; Medicine; Platelet; Biochemistry; Internal medicine","score_opus":0.0334309437971677,"score_gpt":0.29437393055894967,"score_spread":0.26094298676178196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2546179059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99552834,0.00009244921,0.0005359818,0.0006255184,0.00017505954,0.0019374647,0.00025512188,0.00051283924,0.00033721304],"genre_scores_gemma":[0.9971597,0.00005076522,0.00069681375,0.0011509568,0.00019427584,0.000055876695,0.00017411944,0.00006466536,0.00045281078],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997675,0.00019190881,0.0004835745,0.0006331541,0.00048707012,0.0005293164],"domain_scores_gemma":[0.9984869,0.000073241295,0.00022120525,0.0004430763,0.00021450531,0.0005611044],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00010281624,0.0004662373,0.00066435704,0.00017725115,0.00023581414,0.00009239372,0.00010543393,0.00038987803,0.0016110606],"category_scores_gemma":[0.00045595324,0.00042636387,0.00012542316,0.0005278004,0.00003977391,0.00033409518,0.00006284565,0.00029671108,0.00014810155],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021815575,0.0022772222,0.002133587,0.000052773998,0.00023406357,0.000018261633,0.0010152125,3.6607983e-7,0.9713175,0.000093433766,0.00021149105,0.022427922],"study_design_scores_gemma":[0.0047744964,0.001441419,0.10722977,0.00014033957,0.00021934797,0.000008656205,0.000040690673,0.000013728643,0.8696425,0.00025563067,0.015792983,0.0004404316],"about_ca_topic_score_codex":0.0006978244,"about_ca_topic_score_gemma":0.000071161325,"teacher_disagreement_score":0.10509618,"about_ca_system_score_codex":0.00010335315,"about_ca_system_score_gemma":0.000113359805,"threshold_uncertainty_score":0.9998188},"labels":[],"label_agreement":null},{"id":"W2546192931","doi":"10.1182/blood-2016-09-692996","title":"Emerging anticoagulant strategies","year":2016,"lang":"en","type":"review","venue":"Blood","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Medicine; Antithrombotic; Thrombosis; Intensive care medicine; Thrombus; Anticoagulant; Aspirin; Surgery; Internal medicine","score_opus":0.04112864323248677,"score_gpt":0.34529601477520755,"score_spread":0.3041673715427208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2546192931","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006773201,0.9926422,0.00004369455,0.00008502525,0.00034867038,0.0005449033,0.000033382777,0.00018220783,0.0060521513],"genre_scores_gemma":[0.00022152705,0.99519885,0.00015730967,0.000039039798,0.0012129843,0.000037566522,0.00012200676,0.000091798975,0.0029189046],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99812734,0.00005397258,0.0006397551,0.00045553586,0.00030308147,0.00042029828],"domain_scores_gemma":[0.99880695,0.00012232453,0.00029022834,0.00054255367,0.00006597383,0.00017197867],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016095236,0.0004537474,0.0017163205,0.00021611722,0.00009316969,0.00006100716,0.00016702391,0.00028874402,0.00043362263],"category_scores_gemma":[0.00005377562,0.0002926085,0.00066033367,0.00021918827,0.000071650844,0.00010703144,0.00006296552,0.00019858129,0.0004262022],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000038558032,0.00021602698,0.000115838564,0.011194574,0.0005662696,0.00016266793,0.000059365062,2.502431e-8,0.000005881759,0.0017434324,0.0008453791,0.9850867],"study_design_scores_gemma":[0.0009076463,0.00008049405,0.00010314799,0.027853008,0.0028127169,0.0004441346,0.000028254317,8.319676e-7,0.000017434293,0.00016218943,0.9672329,0.00035724646],"about_ca_topic_score_codex":0.000021654427,"about_ca_topic_score_gemma":0.0000038582916,"teacher_disagreement_score":0.9847294,"about_ca_system_score_codex":0.00002857137,"about_ca_system_score_gemma":0.0005824821,"threshold_uncertainty_score":0.9999526},"labels":[],"label_agreement":null},{"id":"W2546335501","doi":"10.1182/blood.v110.11.2693.2693","title":"Inhibition of the Thrombin-Thrombomodulin by a Covalent Antithrombin-Heparin.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Antithrombin; Thrombin; Thrombomodulin; Chemistry; Heparin; In vivo; Chondroitin sulfate; Reaction rate constant; Covalent bond; Substrate (aquarium); Anticoagulant; Protein C; Glycosaminoglycan; Chromatography; Stereochemistry; Kinetics; Biochemistry; Platelet; Internal medicine; Immunology; Organic chemistry; Biology","score_opus":0.016179476285490827,"score_gpt":0.2607198592431879,"score_spread":0.2445403829576971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2546335501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99008936,0.00022503528,0.00096134946,0.0005004179,0.0002910737,0.00050822605,0.000016255437,0.00007690033,0.007331398],"genre_scores_gemma":[0.99820143,0.000045395518,0.0007020924,0.0005955308,0.00007373058,0.00000577283,0.000026534713,0.000028392305,0.00032112107],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99847066,0.000042215634,0.00044314904,0.00026671664,0.0004943447,0.00028288717],"domain_scores_gemma":[0.9990313,0.000038842252,0.0001940532,0.00048956275,0.00012860142,0.000117658004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004404336,0.00016786884,0.00035533274,0.000073342584,0.00009927761,0.000010893804,0.00010414493,0.0001448223,0.00030378773],"category_scores_gemma":[0.000053676355,0.00012454792,0.0001785455,0.00037734254,0.00013134038,0.000065967186,0.00007535303,0.00019073392,0.000043213462],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028085533,0.00216467,0.009397506,0.000073135736,0.00014672763,0.0000065883064,0.00019911265,5.445864e-7,0.9818488,0.004396482,0.0013639458,0.0003744],"study_design_scores_gemma":[0.0038519695,0.0003110111,0.10813017,0.000148417,0.00032718884,0.0000742355,0.000101810794,0.000010701129,0.88555825,0.0008904385,0.00047150432,0.00012432455],"about_ca_topic_score_codex":0.000053224147,"about_ca_topic_score_gemma":0.000021795866,"teacher_disagreement_score":0.09873267,"about_ca_system_score_codex":0.000026727617,"about_ca_system_score_gemma":0.00007896672,"threshold_uncertainty_score":0.50789165},"labels":[],"label_agreement":null},{"id":"W2546416649","doi":"10.1182/blood.v112.11.1731.1731","title":"The Impact of Cytogenetics on the Outcomes of Treatment with Lenalidomide Plus Dexamethasone in Relapsed or Refractory Multiple Myeloma.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; BC Cancer Agency; Calgary Laboratory Services; Leukemia & Lymphoma Society of Canada; University of Calgary","funders":"","keywords":"Lenalidomide; Thalidomide; Multiple myeloma; Medicine; Dexamethasone; Internal medicine; Refractory (planetary science); Bortezomib; Gastroenterology; Surgery; Oncology; Biology","score_opus":0.06803620130697113,"score_gpt":0.33292646163777834,"score_spread":0.2648902603308072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2546416649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979524,0.00045044196,0.000002746694,0.00016411484,0.000010996185,0.0009631337,0.000041975738,0.000011747927,0.0004024474],"genre_scores_gemma":[0.99790776,0.00081123406,0.00043938687,0.000015048526,0.000019255878,0.0000888452,0.000009707837,0.000026436488,0.0006823221],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985788,0.00016002305,0.00033763042,0.00019808997,0.00039407535,0.00033137915],"domain_scores_gemma":[0.9972088,0.0017680269,0.00016229712,0.00064510235,0.00009489665,0.000120905104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019098971,0.00021681242,0.000490367,0.000100461366,0.000104233724,0.0000047462427,0.00013723876,0.00006400969,0.000037930025],"category_scores_gemma":[0.00052856136,0.00007581113,0.0001807887,0.00024137844,0.00026223986,0.000017136304,0.000027401322,0.00014627125,0.000007589914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077453707,0.0026671775,0.9785621,0.000014553678,0.001673856,0.00033035318,0.0006791651,0.000084041116,0.0052940664,0.000007885775,0.0000307546,0.00291064],"study_design_scores_gemma":[0.029008003,0.010676849,0.9040361,0.000079654186,0.00015271231,0.000083826075,0.00019937361,0.00017731189,0.055442203,0.0000059338813,0.000053308653,0.000084717125],"about_ca_topic_score_codex":0.001660028,"about_ca_topic_score_gemma":0.0006520348,"teacher_disagreement_score":0.07452603,"about_ca_system_score_codex":0.00024320873,"about_ca_system_score_gemma":0.0006209175,"threshold_uncertainty_score":0.30914882},"labels":[],"label_agreement":null},{"id":"W2546424014","doi":"10.1182/blood.v126.23.3346.3346","title":"Erythropoietin in Elderly Patients with Anemia of Unknown Etiology","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Etiology; Anemia; Cohort; Internal medicine; Myelodysplastic syndromes; Erythropoietin; Retrospective cohort study; Vitamin B12; Pediatrics; Bone marrow","score_opus":0.012842377974557189,"score_gpt":0.2439554740033385,"score_spread":0.2311130960287813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2546424014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99131954,0.00019281155,0.000003938428,0.0006163742,0.000048705242,0.00025485602,0.000004553286,0.000024751575,0.007534479],"genre_scores_gemma":[0.9970049,0.00002203835,0.0024228238,0.000078724,0.000038425474,0.000012099011,0.000050698753,0.000015419284,0.00035484837],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991842,0.000036020225,0.00021218897,0.00018758315,0.0001894577,0.00019057565],"domain_scores_gemma":[0.9994384,0.000027142349,0.0000725261,0.00021514547,0.0001278846,0.000118871154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008989755,0.00011925888,0.00028377143,0.00007346054,0.000011706602,0.0000023316752,0.000047069538,0.00009141501,0.0000698849],"category_scores_gemma":[0.000051376624,0.00008283292,0.00003242996,0.000151499,0.00012372834,0.000023747125,0.000020800177,0.00011503875,0.000026355325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002620683,0.0032638365,0.9933556,0.00006657554,0.000044277265,0.00007902566,0.00045587873,0.0000019818206,0.00024575167,0.0001398534,0.00088954053,0.0011956627],"study_design_scores_gemma":[0.07268298,0.016759144,0.88597053,0.00055075844,0.0004538148,0.00013391205,0.0009280138,0.0000034294164,0.01593267,0.00021600976,0.0059875874,0.00038117496],"about_ca_topic_score_codex":0.0001078002,"about_ca_topic_score_gemma":0.000059914008,"teacher_disagreement_score":0.10738504,"about_ca_system_score_codex":0.000033121833,"about_ca_system_score_gemma":0.00012479299,"threshold_uncertainty_score":0.33778286},"labels":[],"label_agreement":null},{"id":"W2546446541","doi":"10.1182/blood.v106.11.4605.4605","title":"Acute Leukemia in Patients Sixty Years of Age and Older: A Retrospective Review.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Leukemia; Myeloid leukemia; Acute leukemia; Retrospective cohort study; Univariate analysis; Internal medicine; Surgery; Population; Chemotherapy regimen; Chemotherapy; Pediatrics; Multivariate analysis","score_opus":0.00802559563790155,"score_gpt":0.2761007397175632,"score_spread":0.26807514407966165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2546446541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951498,0.0019267467,0.0000012280907,0.00026033822,0.00001193201,0.0005958098,0.000016829254,0.000017073296,0.00202026],"genre_scores_gemma":[0.9939278,0.004157126,0.0009119304,0.0004861478,0.000058506193,0.000017362969,0.000021743002,0.000019670195,0.00039971145],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892676,0.000037366175,0.00025783843,0.0002335545,0.0003188363,0.00022567499],"domain_scores_gemma":[0.99944055,0.000030887953,0.00006696173,0.00027844042,0.000083663035,0.000099516845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021077659,0.00009415251,0.00037591712,0.00011377143,0.00001258517,0.0000042169704,0.00008376446,0.0000766051,0.000049479797],"category_scores_gemma":[0.00021850217,0.00009193442,0.000049881703,0.00027801652,0.0000779857,0.00006482086,0.0000875227,0.0002854976,0.00002488045],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003299576,0.0012204758,0.92607474,0.0011894704,0.0004362456,0.000756436,0.001221923,6.126529e-7,0.005991821,0.00012475571,0.011842068,0.05081148],"study_design_scores_gemma":[0.008093707,0.00034049537,0.98732156,0.00078494905,0.00016713602,0.000020456257,0.00001056115,0.000013206197,0.0019698595,0.000018906389,0.0011706066,0.00008855392],"about_ca_topic_score_codex":0.000057931255,"about_ca_topic_score_gemma":0.000019815561,"teacher_disagreement_score":0.06124681,"about_ca_system_score_codex":0.00039915205,"about_ca_system_score_gemma":0.00017998314,"threshold_uncertainty_score":0.3748977},"labels":[],"label_agreement":null},{"id":"W2546496727","doi":"10.1182/blood.v116.21.475.475","title":"Development of A Clinical Prediction Rule for Risk Stratification of Recurrent Venous Thromboembolism In Patients with Cancer-Associated Venous Thromboembolism","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; Victoria Hospital; University of Ottawa; CancerCare Manitoba; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Venous thromboembolism; Malignancy; Univariate analysis; Cancer; Low molecular weight heparin; Internal medicine; Retrospective cohort study; Thrombosis; Multivariate analysis; Logistic regression; Venous thrombosis; Cohort; Stage (stratigraphy); Surgery","score_opus":0.021437739912472047,"score_gpt":0.30560997847388177,"score_spread":0.2841722385614097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2546496727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99628234,0.000101867416,0.0000609753,0.0000428686,0.00067960244,0.002232238,0.00026574655,0.000046108937,0.0002882523],"genre_scores_gemma":[0.99356735,0.00018864982,0.005360148,0.000026646976,0.00013556112,0.00033408715,0.00033564097,0.00004375288,0.000008148234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997231,0.00007191982,0.0013475626,0.00046541193,0.00052284263,0.00036123663],"domain_scores_gemma":[0.99783987,0.00010818676,0.001002978,0.00043692737,0.00048051216,0.0001315225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088974176,0.0002446965,0.0013552114,0.00018221527,0.00010444438,0.000011129029,0.00016787906,0.0002438068,0.000040801915],"category_scores_gemma":[0.0002841587,0.00021034549,0.00014101503,0.00029127474,0.000117007025,0.00009369218,0.0000464835,0.0003819299,0.00000249246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066492154,0.095646404,0.7861103,0.00079531944,0.0022426264,0.0000026709647,0.005562868,0.000034272314,0.003362886,0.00066339783,0.0003450076,0.10456935],"study_design_scores_gemma":[0.009458519,0.0023668718,0.9808119,0.0003993234,0.0011325806,4.729723e-7,0.0001364795,0.0000617084,0.0049513774,0.00016463622,0.0003319386,0.00018417038],"about_ca_topic_score_codex":0.00026079462,"about_ca_topic_score_gemma":0.0010164285,"teacher_disagreement_score":0.19470166,"about_ca_system_score_codex":0.00006116367,"about_ca_system_score_gemma":0.000519172,"threshold_uncertainty_score":0.857764},"labels":[],"label_agreement":null},{"id":"W2546527096","doi":"10.1182/blood.v104.11.3211.3211","title":"Geographic and Racial/Ethnic Differences in HFE Mutation Frequencies and Iron Phenotypes in the Hemochromatosis and Iron Overload Screening (HEIRS) Study.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Transferrin saturation; Hereditary hemochromatosis; Hemochromatosis; Demography; Genotype; Ethnic group; Pacific islanders; Medicine; Serum ferritin; Internal medicine; Ferritin; Gerontology; Population; Genetics; Biology; Environmental health","score_opus":0.017083936169881558,"score_gpt":0.25386597350860507,"score_spread":0.23678203733872352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2546527096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982045,0.017004188,0.000013462871,0.00029736353,0.00001990554,0.00047804436,0.0000028735924,0.00001821214,0.00012096236],"genre_scores_gemma":[0.9982137,0.001296702,0.00025506722,0.00015882016,0.000028820714,0.000027828191,0.000005360678,0.00000905561,0.0000046418754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99907786,0.000084157626,0.00019713229,0.0002526112,0.00020100098,0.00018721538],"domain_scores_gemma":[0.9996819,0.00008168634,0.000052868116,0.000124525,0.000012437937,0.000046587367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028301636,0.00014670691,0.0002538724,0.00018694093,0.000085092775,0.00003942141,0.000050678627,0.00006634975,0.000005120031],"category_scores_gemma":[0.000077077966,0.00010383272,0.000018528077,0.00024349122,0.00015701127,0.00012984154,0.000030257821,0.00014654917,5.358345e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060122842,0.00055677316,0.97263175,0.00013547356,0.000012429622,0.000043558546,0.01768459,0.0000040949544,0.0012219017,0.00023053137,8.582331e-7,0.00741791],"study_design_scores_gemma":[0.006407873,0.00027975993,0.9783116,0.00008271866,0.00015993245,0.000028672604,0.013776366,0.000008770971,0.00011246546,0.0007158729,0.0000021356248,0.000113820206],"about_ca_topic_score_codex":0.001664031,"about_ca_topic_score_gemma":0.002381467,"teacher_disagreement_score":0.016168715,"about_ca_system_score_codex":0.000004383922,"about_ca_system_score_gemma":0.00002023206,"threshold_uncertainty_score":0.42341754},"labels":[],"label_agreement":null},{"id":"W2546637334","doi":"10.1182/blood.v108.11.4507.4507","title":"Relationship between Fatigue and Cytokine Levels in Patients Age 50+ with Acute Myeloid Leukemia (AML).","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Cancer survivorship and care","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Depression (economics); Internal medicine; Hospital Anxiety and Depression Scale; Quality of life (healthcare); Cancer-related fatigue; Cancer; Myeloid leukemia; Anxiety; Oncology; Physical therapy; Psychiatry","score_opus":0.026503305099964108,"score_gpt":0.25826000330448345,"score_spread":0.23175669820451936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2546637334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995746,0.00012312645,0.0000861602,0.00011016234,0.000037281916,0.00026040227,0.000076138575,0.00003954713,0.003521165],"genre_scores_gemma":[0.99864906,0.0000033201686,0.0002583474,0.00007526456,0.00015991737,0.000018316317,0.00021239455,0.000022543949,0.0006008348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991323,0.000027916207,0.00019979535,0.00022200999,0.00022459908,0.0001933946],"domain_scores_gemma":[0.99956477,0.000069843314,0.000055165106,0.00019223457,0.00004252453,0.00007549333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008027008,0.0001323416,0.0002311212,0.00010587717,0.00004566992,0.000017202934,0.000045532077,0.00009332231,0.000013390744],"category_scores_gemma":[0.000020018111,0.000110857465,0.000026970954,0.00022653048,0.000047381684,0.00007598103,0.000023502722,0.00019602542,0.0000051047004],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057653673,0.00007840884,0.99881184,0.000039290422,0.000030287563,0.00005672505,0.0002525157,0.0000016246619,0.00010003475,0.000096978205,0.00008772702,0.0003869255],"study_design_scores_gemma":[0.0055379467,0.00026640255,0.99178535,0.0000955594,0.00023596358,0.000008483621,0.00003629493,6.329379e-7,0.0011836805,0.00017771122,0.00053737574,0.00013462127],"about_ca_topic_score_codex":0.0013448106,"about_ca_topic_score_gemma":0.0022960922,"teacher_disagreement_score":0.007026501,"about_ca_system_score_codex":0.0000743719,"about_ca_system_score_gemma":0.00007982243,"threshold_uncertainty_score":0.45206362},"labels":[],"label_agreement":null},{"id":"W2546644490","doi":"10.1182/blood.v108.11.1546.1546","title":"Calcein and the Labile Iron Pool.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Calcein; Chemistry; Ferritin; Cytosol; Biophysics; Biochemistry; Transferrin receptor; Fluorescence; Transferrin; Oxidative stress; Deferoxamine; Compartment (ship); Redox; Enzyme; Biology; Inorganic chemistry; Membrane","score_opus":0.003875174346743024,"score_gpt":0.21048153354606702,"score_spread":0.206606359199324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2546644490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9576338,0.004307781,0.000017468423,0.0014553033,0.000042168867,0.00015898056,0.0000024879891,0.000025454716,0.03635655],"genre_scores_gemma":[0.99589974,0.00006756969,0.00016109075,0.00047334787,0.00018444748,0.0000091197435,0.0000065399595,0.0000071578434,0.0031909996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99964046,0.00001910932,0.000072968454,0.00008322536,0.00008358724,0.00010064439],"domain_scores_gemma":[0.99979323,0.000026024525,0.000015075849,0.00012813733,0.000011335945,0.00002620748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009010471,0.000051279305,0.00010077386,0.000015556443,0.000041541898,0.0000085160655,0.000025706584,0.000028471557,0.00007438858],"category_scores_gemma":[0.000029023098,0.000029229248,0.000026776757,0.00004586617,0.000096026844,0.000016089336,0.000014149679,0.00005258305,0.000029234649],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020141348,0.0065924786,0.36699507,0.00110436,0.00015277896,0.00027315397,0.0025269769,0.00003193077,0.041033126,0.3668183,0.15589565,0.05656204],"study_design_scores_gemma":[0.079108946,0.00029639484,0.7123376,0.00004288531,0.0016033695,0.00020234125,0.0007595748,0.000054921522,0.013806866,0.0056454306,0.18574405,0.00039761845],"about_ca_topic_score_codex":0.0002996334,"about_ca_topic_score_gemma":0.00002397808,"teacher_disagreement_score":0.36117288,"about_ca_system_score_codex":0.000001219346,"about_ca_system_score_gemma":0.00001286612,"threshold_uncertainty_score":0.11919341},"labels":[],"label_agreement":null},{"id":"W2546689982","doi":"10.1182/blood.v126.23.4416.4416","title":"A Point-of-Care Platform for Hematopoietic Stem Cell Gene Therapy","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Progenitor cell; Genetic enhancement; CD34; Haematopoiesis; Bone marrow; Stem cell; Plerixafor; Medicine; Cell therapy; Immunology; Hematopoietic stem cell; Ex vivo; Cancer research; Biology; CXCR4; Cell biology; In vivo; Gene; Biotechnology; Chemokine; Genetics; Immune system","score_opus":0.0337217936459812,"score_gpt":0.29082260159197715,"score_spread":0.25710080794599594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2546689982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881944,0.010246669,0.00025937287,0.000039346007,0.000056868754,0.00048311235,0.000046679586,0.000012489819,0.00066105474],"genre_scores_gemma":[0.998101,0.00025135354,0.0007129176,0.000102455255,0.0001585054,0.00008957342,0.00009005664,0.000041452076,0.0004526678],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99909604,0.000028375165,0.00017611517,0.00025732353,0.00017704404,0.00026508028],"domain_scores_gemma":[0.999148,0.000012976582,0.00006498445,0.00043914473,0.0002114542,0.00012344215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020867467,0.00013669093,0.00016299443,0.000039671293,0.000036655598,0.000012723763,0.0002589035,0.00012425745,0.000010066023],"category_scores_gemma":[0.000008550899,0.000121745274,0.00012345244,0.00006928057,0.00004652671,0.000002840252,0.000058654026,0.00005175107,0.000010458529],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018088259,0.00029555883,0.00028557118,0.00006713005,0.000086444095,0.0000023930343,0.00056441675,0.000015081249,0.99273926,0.000017280723,0.00061627483,0.0035017764],"study_design_scores_gemma":[0.0046198256,0.0059734606,0.000010378774,0.0000065602912,0.000014979106,0.000008870986,0.00054154237,0.0000063131824,0.9841977,0.000099560115,0.0043766354,0.00014417221],"about_ca_topic_score_codex":0.0000037459658,"about_ca_topic_score_gemma":0.000013464738,"teacher_disagreement_score":0.009995315,"about_ca_system_score_codex":0.000009000322,"about_ca_system_score_gemma":0.00019345785,"threshold_uncertainty_score":0.4964628},"labels":[],"label_agreement":null},{"id":"W2546713708","doi":"10.1182/blood.v126.23.1732.1732","title":"Impact of High Risk Prognostic Parameters and Addition of Ibrutinib to Bendamustine/Rituximab (BR) on Outcomes for Patients with Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) from the Phase 3 Double-Blind HELIOS Trial","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Ibrutinib; Medicine; Internal medicine; Chemoimmunotherapy; Bendamustine; Chronic lymphocytic leukemia; Population; Oncology; Clinical endpoint; Rituximab; Placebo; Randomized controlled trial; Lymphoma; Leukemia; Pathology","score_opus":0.048080154085712694,"score_gpt":0.32360163818068133,"score_spread":0.2755214840949686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2546713708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892589,0.00022214233,0.00008084793,0.000050478095,0.00023047085,0.008277587,0.0017636379,0.000077318036,0.00003863913],"genre_scores_gemma":[0.9965847,0.000046135854,0.0012770649,0.000073401585,0.00027942986,0.00069387525,0.0008741712,0.0001237888,0.000047426183],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99559295,0.00021441771,0.0011292737,0.00090508384,0.0012795138,0.00087876304],"domain_scores_gemma":[0.9939211,0.0026832472,0.00075500214,0.0012183124,0.0007416364,0.00068068894],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006754556,0.00064082263,0.0014196403,0.00036801724,0.00014594772,0.000065845445,0.00044119847,0.0002990826,0.000039694947],"category_scores_gemma":[0.002743566,0.00040248054,0.0003834598,0.0006746834,0.00039299644,0.00014615216,0.0001689424,0.00020205518,0.000024542007],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.950063,0.01021375,0.015840184,0.0007025079,0.004545158,0.00009792163,0.0016043324,0.0024913508,0.000261555,0.00006451262,0.0010979058,0.01301786],"study_design_scores_gemma":[0.94061345,0.03446761,0.01244787,0.00080143556,0.0025420515,0.0000433688,0.00010743736,0.004318571,0.004100666,0.0000873225,0.000036589598,0.00043364533],"about_ca_topic_score_codex":0.011481505,"about_ca_topic_score_gemma":0.00022221525,"teacher_disagreement_score":0.02425386,"about_ca_system_score_codex":0.03142699,"about_ca_system_score_gemma":0.036123894,"threshold_uncertainty_score":0.9998427},"labels":[],"label_agreement":null},{"id":"W2546735259","doi":"10.1182/blood.v112.11.3472.3472","title":"The Role of C5a in the Mobilization of Hematopoietic Stem/Progenitor Cells","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Alberta","funders":"","keywords":"Haematopoiesis; Progenitor cell; CD34; Bone marrow; Cell biology; Myeloid; Stem cell; Stromal cell; Complement system; Biology; Flow cytometry; Immunology; Chemistry; Immune system; Cancer research","score_opus":0.011437062771549315,"score_gpt":0.2142876302983281,"score_spread":0.20285056752677877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2546735259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916088,0.007536671,0.0000030636434,0.000019972784,0.00008882172,0.00032830337,0.000018310173,0.000007633405,0.00038844987],"genre_scores_gemma":[0.9997796,0.00005047041,0.000004105641,0.0000067125234,0.0000087535345,0.000039362956,0.0000075407997,0.0000044145086,0.00009907107],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992951,0.00020737915,0.00026804034,0.00008140809,0.000038419577,0.0001096567],"domain_scores_gemma":[0.9993344,0.00021868263,0.00012064769,0.0002843027,0.00003798478,0.0000040148434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016398111,0.000057986705,0.00011890458,0.000026365999,0.00007792899,0.0000018785925,0.00025069664,0.000039473947,0.000052018324],"category_scores_gemma":[0.000015424555,0.000034015513,0.00005127104,0.00009817099,0.00011721936,0.000015114716,0.000036624126,0.000042510124,0.000026556823],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004947756,0.0012085334,0.15405066,0.00007644366,0.00013905283,0.0000025397467,0.003898583,0.000010031956,0.8374999,0.0020028315,0.000722733,0.00033917537],"study_design_scores_gemma":[0.0010233207,0.000094584066,0.012447932,0.000032653992,0.000055349672,0.000040311286,0.003893157,0.0000019006769,0.97911143,0.00022411568,0.00301895,0.000056292873],"about_ca_topic_score_codex":0.000034794764,"about_ca_topic_score_gemma":0.000017895125,"teacher_disagreement_score":0.1416115,"about_ca_system_score_codex":0.0000035210667,"about_ca_system_score_gemma":0.000029572633,"threshold_uncertainty_score":0.13871123},"labels":[],"label_agreement":null},{"id":"W2546744085","doi":"10.1182/blood.v114.22.3993.3993","title":"Impact of Thrombophilia On Arterial Ischemic Stroke or Cerebral Venous Sinus Thromboses in Children: A Systematic Review &amp; Meta-Analysis of Observational Studies.","year":2009,"lang":"en","type":"review","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hospital for Sick Children","funders":"","keywords":"Medicine; Thrombophilia; Stroke (engine); Odds ratio; Observational study; Meta-analysis; Cochrane Library; Pediatrics; Thrombosis; Internal medicine; Venous thrombosis","score_opus":0.2664236388100933,"score_gpt":0.42572235910081824,"score_spread":0.15929872029072495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2546744085","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005765242,0.9889669,0.0000023505,0.000029979261,0.000057569978,0.0042723124,0.00078733533,0.000034278564,0.00008404103],"genre_scores_gemma":[0.0062839356,0.99156606,0.00035554846,0.00016756187,0.00008849268,0.00025976927,0.0011000555,0.000064294894,0.00011427865],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99422896,0.0005432128,0.0031925861,0.0006936344,0.0009819081,0.00035971604],"domain_scores_gemma":[0.9951537,0.00043014594,0.0025627348,0.0013762469,0.00035025136,0.00012689685],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00083810766,0.00085647346,0.020425703,0.0008770586,0.00003860386,0.000013977809,0.00036959743,0.00036727326,0.00068624277],"category_scores_gemma":[0.0007402536,0.00050405745,0.006805216,0.0020939466,0.00008484209,0.000076166885,0.000070205875,0.0003965133,0.000022225624],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032052423,0.004512709,0.0000606785,0.42907453,0.56549925,0.000011663047,0.00008040309,0.0000039583,0.000032035343,0.000102439495,0.00015607596,0.000434242],"study_design_scores_gemma":[0.001319194,0.0009611021,0.0013532563,0.13209869,0.86361474,0.000119412725,0.0000060560983,0.0000010229165,0.00001291414,0.000016033146,0.00012880276,0.00036874885],"about_ca_topic_score_codex":0.000027151671,"about_ca_topic_score_gemma":0.000028315235,"teacher_disagreement_score":0.29811552,"about_ca_system_score_codex":0.0001503163,"about_ca_system_score_gemma":0.0006586191,"threshold_uncertainty_score":0.9997411},"labels":[],"label_agreement":null},{"id":"W2546806328","doi":"10.1182/blood.v104.11.3223.3223","title":"A Search for Genes Specifying HSCs through the Development of a New Retroviral-Based System That Creates Nested Deletions in ES cells.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Institute for Research in Immunology and Cancer","funders":"","keywords":"Biology; Retrovirus; Gene; Genetics; Cre recombinase; Inverse polymerase chain reaction; Virology; Molecular biology; Viral vector; genomic DNA; Transgene; Polymerase chain reaction; Nested polymerase chain reaction; Recombinant DNA","score_opus":0.05212601727927363,"score_gpt":0.3059724024190595,"score_spread":0.25384638513978586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2546806328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98945767,0.0018734435,0.007657157,0.00019727994,0.000031094878,0.0006510092,0.000017601576,0.000014618017,0.000100152756],"genre_scores_gemma":[0.98852986,0.00007428927,0.010960722,0.00005034386,0.00010134318,0.00010623412,0.000056531047,0.000031410604,0.00008927362],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99879867,0.0000784678,0.00026533272,0.0002940585,0.00022554047,0.0003379156],"domain_scores_gemma":[0.99937516,0.000039722203,0.00006394458,0.00037242082,0.00009301911,0.000055757355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033390446,0.00015123673,0.00017183051,0.00006396513,0.00013601557,0.000028407048,0.00031422896,0.000111348774,0.0000054594643],"category_scores_gemma":[0.00001747647,0.00011749282,0.00009424163,0.00020314752,0.00007142403,0.000004273314,0.000065124936,0.00008602053,0.0000041308726],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059500185,0.00025259907,0.0027408956,0.00015221514,0.00009780107,0.0000033022095,0.0007242671,0.0019905143,0.99182546,0.00009024358,0.000026404196,0.001501324],"study_design_scores_gemma":[0.002879719,0.00069054833,0.00048029906,0.00007937673,0.00001992259,0.0000034782588,0.00069206936,0.000032538446,0.99390465,0.000022908102,0.0010603775,0.00013408919],"about_ca_topic_score_codex":0.000114798335,"about_ca_topic_score_gemma":0.00057197333,"teacher_disagreement_score":0.0033035656,"about_ca_system_score_codex":0.000044851946,"about_ca_system_score_gemma":0.00075096806,"threshold_uncertainty_score":0.4791218},"labels":[],"label_agreement":null},{"id":"W2546846989","doi":"10.1182/blood.v106.11.3414.3414","title":"Multiple Myeloma (MM) in Young Patients (pts): Clinical Features and Outcome in 259 Patients Younger Than 40 Years in Comparison to 8,296 pts Aged ≥ 40 Years.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Internal medicine; Cohort; Creatinine; Multiple myeloma; Gastroenterology; Surgery","score_opus":0.03904975464525355,"score_gpt":0.3506064399552149,"score_spread":0.31155668530996133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2546846989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976136,0.00023742454,5.054097e-7,0.00015063047,0.00015277028,0.001505065,0.000058809146,0.000033524564,0.0002476639],"genre_scores_gemma":[0.99814737,0.000052174546,0.0009257817,0.00020457273,0.00010307881,0.00009059603,0.00018589625,0.000046417976,0.00024410678],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968281,0.00024566066,0.0009065325,0.00063861633,0.00065252354,0.00072860846],"domain_scores_gemma":[0.998724,0.00024982102,0.000116828305,0.00041206565,0.00006417413,0.00043313022],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045216497,0.00029048082,0.000751435,0.00052929437,0.00003690148,0.000042627096,0.00018614325,0.00024551828,0.000032421478],"category_scores_gemma":[0.0010363054,0.00027111685,0.00010555765,0.0004360544,0.00007289024,0.00017659506,0.00019570628,0.00066319125,0.000121210585],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013081884,0.0064010737,0.9682219,0.00003229296,0.00006874919,0.00020532939,0.0013772144,0.0000047112126,0.00004800816,9.352679e-7,0.00032799735,0.022003597],"study_design_scores_gemma":[0.036523063,0.0007398017,0.9617397,0.00016903222,0.000038542177,0.0000045115185,0.00010908986,0.00008803531,0.00011842328,0.0000034100904,0.00024784703,0.00021852784],"about_ca_topic_score_codex":0.0017961416,"about_ca_topic_score_gemma":0.016261123,"teacher_disagreement_score":0.035214875,"about_ca_system_score_codex":0.00019336167,"about_ca_system_score_gemma":0.00005692412,"threshold_uncertainty_score":0.99997413},"labels":[],"label_agreement":null},{"id":"W2546853358","doi":"10.1182/blood.v114.22.790.790","title":"Preliminary Results of Southwest Oncology Group Study S0106: An International Intergroup Phase 3 Randomized Trial Comparing the Addition of Gemtuzumab Ozogamicin to Standard Induction Therapy Versus Standard Induction Therapy Followed by a Second Randomization to Post-Consolidation Gemtuzumab Ozogamicin Versus No Additional Therapy for Previously Untreated Acute Myeloid Leukemia.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":183,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Gemtuzumab ozogamicin; Medicine; Interim analysis; Cytarabine; Internal medicine; Randomization; Induction chemotherapy; Randomized controlled trial; Surgery; Oncology; Chemotherapy","score_opus":0.03119918099127266,"score_gpt":0.3468058883991452,"score_spread":0.31560670740787256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2546853358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9709262,0.00009750399,0.0015969252,0.00081108965,0.001293113,0.01890598,0.0059809354,0.00013432573,0.00025392472],"genre_scores_gemma":[0.97758514,0.0004887721,0.0013936292,0.00023214036,0.00092837296,0.0017804236,0.017404992,0.00009056992,0.00009594939],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9936453,0.0014271842,0.00201348,0.0010310295,0.0012962722,0.0005867266],"domain_scores_gemma":[0.9936835,0.0018808943,0.0012321115,0.000788091,0.002137857,0.0002775165],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0030038839,0.00063610676,0.0019017665,0.0008982347,0.0003098068,0.00010745927,0.0005624821,0.000408547,0.00054149906],"category_scores_gemma":[0.001653916,0.0004951697,0.00047418702,0.00077947596,0.00023351805,0.00070406386,0.000073704105,0.0006022519,0.000007824808],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8701676,0.0045178747,0.000008985937,0.000014398306,0.002687865,0.0000097302445,0.00482267,0.00012512614,0.07590333,0.000029437166,0.0047661215,0.03694685],"study_design_scores_gemma":[0.80740577,0.1500873,0.00029507617,0.0001237464,0.0006078547,0.000022534576,0.0016690053,0.00043183158,0.036539685,0.000025640931,0.0024400323,0.00035153137],"about_ca_topic_score_codex":0.00029023734,"about_ca_topic_score_gemma":0.00021517277,"teacher_disagreement_score":0.14556943,"about_ca_system_score_codex":0.0020124195,"about_ca_system_score_gemma":0.0012530818,"threshold_uncertainty_score":0.99975},"labels":[],"label_agreement":null},{"id":"W2546886377","doi":"10.1182/blood.v114.22.3944.3944","title":"Number of Lymphoma-Associated-Macrophages (LAM) Is An Independent Predictor of Survival in Patients with Mantle Cell Lymphoma (MCL).","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Mantle cell lymphoma; Medicine; Lymphoma; Immunohistochemistry; Tissue microarray; Follicular lymphoma; Internal medicine; Oncology; Rituximab; CD20; Pathology; Cancer research; Cancer; CD163; Biology; Phenotype","score_opus":0.00686089275118308,"score_gpt":0.22739382071917222,"score_spread":0.22053292796798915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2546886377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963657,0.00020497099,7.11115e-7,0.000038394966,0.000058763584,0.00044430295,0.0001469664,0.000027897728,0.0027122826],"genre_scores_gemma":[0.9993966,0.00004386368,0.00015576775,0.00008461533,0.000023474035,0.000016032043,0.000095253214,0.000025924013,0.00015843169],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981918,0.000061721796,0.00045826673,0.00034283623,0.0006322694,0.00031315236],"domain_scores_gemma":[0.9989814,0.000041203253,0.00026678725,0.00040444967,0.00017743386,0.00012871879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012286752,0.00024084897,0.00059670454,0.00010023676,0.000028375604,0.000009852896,0.0001246005,0.0001437454,0.00012007907],"category_scores_gemma":[0.000019479587,0.00018399964,0.00010556456,0.00023520197,0.00005169419,0.00009268758,0.00003136164,0.000035591915,0.000014210981],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035702772,0.03768438,0.9575815,0.000054078562,0.00021705938,0.00007841662,0.0006523644,8.903028e-7,0.00020009762,0.000028427663,0.00005416012,0.0030915763],"study_design_scores_gemma":[0.047226015,0.0019593516,0.8988622,0.00016226256,0.00038602663,0.000006315825,0.00012725726,0.000005221772,0.051069066,0.000030191584,0.000020640984,0.00014544281],"about_ca_topic_score_codex":0.00043438113,"about_ca_topic_score_gemma":0.000044975513,"teacher_disagreement_score":0.05871931,"about_ca_system_score_codex":0.00014024304,"about_ca_system_score_gemma":0.00016592053,"threshold_uncertainty_score":0.7503287},"labels":[],"label_agreement":null},{"id":"W2546955272","doi":"10.1182/blood.v118.21.3930.3930","title":"Functional and Familial Risk of B Lineage Malignancies in Patients Carrying Single Nucleotide Polymorphisms (SNPs) in the Hyaluronan Synthase 1 Gene (HAS1),","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba; University of Alberta","funders":"","keywords":"Single-nucleotide polymorphism; Biology; Genetics; Exon; Allele; Intron; Haplotype; Genotype; Monoclonal gammopathy of undetermined significance; Minor allele frequency; Molecular biology; Gene; Monoclonal","score_opus":0.012997490378218974,"score_gpt":0.18807063409893013,"score_spread":0.17507314372071114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2546955272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99854046,0.00080596266,0.000030158879,0.0000068320005,0.0001056878,0.00013225168,0.000129504,0.0000019437714,0.0002471978],"genre_scores_gemma":[0.9991802,0.0001947729,0.0003585487,0.00008950848,0.000097021286,0.000011176392,0.000047920017,0.000011297062,0.0000095320365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993429,0.000041970226,0.00019530371,0.00019059742,0.000084189145,0.00014503102],"domain_scores_gemma":[0.99964684,0.000030726285,0.00007967142,0.00018279758,0.000031125033,0.000028835235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001386079,0.00009620725,0.000104446255,0.00004056167,0.000032580043,0.000007919716,0.000095853204,0.000066202345,0.000006586445],"category_scores_gemma":[0.0001154815,0.00008264778,0.000038859867,0.00005734687,0.00006769301,0.0000029066694,0.00006988352,0.000060209575,9.262402e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001968312,0.0012130865,0.7805457,0.000014468452,0.0000409984,0.000011091753,0.00059859327,0.000033147233,0.21518204,0.00004622546,0.000092497845,0.002025289],"study_design_scores_gemma":[0.0021584337,0.00062078907,0.7219405,0.000016437996,0.00004734263,0.0000035713308,0.00012648641,0.000010949114,0.27462232,0.000048168753,0.0002720276,0.00013298626],"about_ca_topic_score_codex":0.00060627906,"about_ca_topic_score_gemma":0.00044869268,"teacher_disagreement_score":0.05944028,"about_ca_system_score_codex":0.0000066488537,"about_ca_system_score_gemma":0.000035290956,"threshold_uncertainty_score":0.33702788},"labels":[],"label_agreement":null},{"id":"W2547020086","doi":"10.1182/blood.v108.11.3720.3720","title":"Large-Scale Production of Autologous CD14+-Monocyte Derived Dendritic Cells Co-Electroporated with Amplified Total Tumour mRNA and Human CD40L mRNA in Patients with B-Cell Chronic Lymphocytic Leukemia.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"","keywords":"Leukapheresis; CD14; Peripheral blood mononuclear cell; Medicine; CD20; Chronic lymphocytic leukemia; Dendritic cell; Immunology; ELISPOT; CD19; CD5; Immune system; Fludarabine; Antigen; Andrology; T cell; Leukemia; Biology; Internal medicine; Cyclophosphamide; CD34; In vitro; Chemotherapy; Stem cell","score_opus":0.003671635277657409,"score_gpt":0.1912685007987948,"score_spread":0.18759686552113738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547020086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99554384,0.0034892184,0.000021655753,0.0000069267153,0.00010419773,0.0006141711,0.000020751331,0.000073553914,0.00012566648],"genre_scores_gemma":[0.99842757,0.00004970975,0.00006912287,0.000013087672,0.000019863788,0.00003482693,0.00022528153,0.000044154327,0.0011164119],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982006,0.0002568444,0.0004386172,0.00045115317,0.000070871676,0.00058192434],"domain_scores_gemma":[0.9992275,0.00004513518,0.0002786722,0.00031661466,0.000113472,0.000018556653],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014920658,0.00031631225,0.00050531165,0.0002129474,0.00020696953,0.000020151669,0.0001428365,0.0002178632,0.00004573555],"category_scores_gemma":[0.0000076172546,0.0002608835,0.000046624766,0.0002632007,0.00035337053,0.00013195585,0.000031618605,0.00027775826,0.000020849022],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002190936,0.0008853825,0.013958078,0.000075378724,0.0001556962,0.000014188957,0.00027660822,0.00016353316,0.98213625,0.0000148481895,0.000051768224,0.00007732821],"study_design_scores_gemma":[0.018350746,0.002411395,0.12910876,0.0000968684,0.00012416733,0.00011202589,0.00011487887,0.000005039216,0.8492491,0.000011134162,0.00011211138,0.0003037376],"about_ca_topic_score_codex":0.0005928541,"about_ca_topic_score_gemma":0.00024037325,"teacher_disagreement_score":0.13288711,"about_ca_system_score_codex":0.0004439059,"about_ca_system_score_gemma":0.00059987354,"threshold_uncertainty_score":0.9999843},"labels":[],"label_agreement":null},{"id":"W2547033671","doi":"10.1182/blood.v120.21.3879.3879","title":"Inhibition of Fatty Acid Oxidation Leads to Apoptosis of Resting and Proliferating Chronic Lymphocytic Leukemia Cells in Vitro","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Chronic lymphocytic leukemia; Apoptosis; Fludarabine; Cancer research; Beta oxidation; Leukemia; Cancer cell; Biology; Context (archaeology); In vitro; Fatty acid; Chemistry; Pharmacology; Cancer; Immunology; Biochemistry; Chemotherapy","score_opus":0.008598997284045399,"score_gpt":0.23039290267456203,"score_spread":0.22179390539051663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547033671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99784374,0.0013257924,0.00025096885,0.000004798435,0.00029267947,0.00016462768,0.000011144686,0.0000039191164,0.000102354556],"genre_scores_gemma":[0.99655247,0.00012139994,0.0017194308,0.000026849197,0.001503785,0.000021107668,0.000026968748,0.000010013238,0.000017956156],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999375,0.00003280122,0.00021450296,0.00013994054,0.000072640025,0.00016510372],"domain_scores_gemma":[0.9996856,0.0000071324102,0.00009572157,0.0001231822,0.00004027844,0.000048104986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018373449,0.000079247104,0.00013786706,0.000050479757,0.000020366804,0.0000047246544,0.00003434091,0.00007791565,0.0000016265104],"category_scores_gemma":[0.00006793131,0.000082925144,0.000027597562,0.00008534178,0.000026716421,0.000007911937,0.000047472935,0.000034098222,6.245016e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004084335,0.000028015964,0.0020250794,0.00010798956,0.000007923105,8.221191e-9,0.000164331,0.00006361311,0.9961269,0.000006727798,0.000036989262,0.0013915659],"study_design_scores_gemma":[0.001132028,0.00008460436,0.0019194309,0.000047972226,0.000026148295,0.0000025935017,0.000042346117,0.000029957017,0.9963023,0.0000024481903,0.00032752808,0.00008265871],"about_ca_topic_score_codex":0.000071457915,"about_ca_topic_score_gemma":0.000022155235,"teacher_disagreement_score":0.0014684619,"about_ca_system_score_codex":0.0000769182,"about_ca_system_score_gemma":0.00020572088,"threshold_uncertainty_score":0.3381589},"labels":[],"label_agreement":null},{"id":"W2547050165","doi":"10.1182/blood.v104.11.3699.3699","title":"Complexities in the Rat Iron Loading Model for Pre-Clinical Testing of Iron Chelators.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Micropharma (Canada); University of Toronto","funders":"","keywords":"Deferiprone; Chelation therapy; Deferoxamine; Chelation; Toxicity; Chemistry; Medicine; Pharmacology; Pathology; Thalassemia; Physiology; Internal medicine","score_opus":0.055664329074379335,"score_gpt":0.32176653014321865,"score_spread":0.2661022010688393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547050165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99524033,0.00060099876,0.0004097702,0.00059692975,0.000054892418,0.000486359,0.000004045026,0.000025156281,0.0025815265],"genre_scores_gemma":[0.9948693,0.00003328816,0.004645586,0.0002682108,0.000067998,0.0000113822325,0.00000776998,0.000014537448,0.00008191897],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99912745,0.000023102224,0.000377075,0.00014659904,0.00013120478,0.00019456264],"domain_scores_gemma":[0.9994764,0.00019144216,0.000083794555,0.00017111404,0.000035659054,0.00004163786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003854221,0.00009440592,0.00023845295,0.000040505358,0.00005382957,0.000008167088,0.000086669155,0.00012398322,0.000003979676],"category_scores_gemma":[0.0003315224,0.000062808176,0.0000891492,0.00011833697,0.000092694405,0.00003783914,0.000020449746,0.00021916506,0.0000023261296],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003050836,0.03443827,0.5364201,0.010283775,0.0008770871,0.00030597005,0.09308167,0.15832517,0.069371946,0.064666666,0.00306812,0.026110401],"study_design_scores_gemma":[0.19916968,0.012935833,0.15274763,0.008864478,0.004985192,0.0008684572,0.032703757,0.47004277,0.03246504,0.08118407,0.0015004545,0.002532633],"about_ca_topic_score_codex":0.000060021,"about_ca_topic_score_gemma":0.000013116501,"teacher_disagreement_score":0.38367245,"about_ca_system_score_codex":0.000014620678,"about_ca_system_score_gemma":0.00010051211,"threshold_uncertainty_score":0.25612432},"labels":[],"label_agreement":null},{"id":"W2547075247","doi":"10.1182/blood.v126.23.4539.4539","title":"A Novel Case of Direct Antiglobulin Test-Negative Intravascular Hemolysis in a Patient with Smoldering Myeloma","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Plasmapheresis; Hemolysis; Gastroenterology; Hemoglobinuria; Hemolytic anemia; Paroxysmal nocturnal hemoglobinuria; Schistocyte; Anemia; Internal medicine; Coombs test; Immunology; Thrombotic thrombocytopenic purpura; Antibody","score_opus":0.015302062699211827,"score_gpt":0.22571160119064387,"score_spread":0.21040953849143204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547075247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977764,0.0010310436,0.000045478795,0.000017577495,0.000051532657,0.00036985084,0.00009790994,0.00003422999,0.0005760064],"genre_scores_gemma":[0.9991464,0.0000029253847,0.00073098694,0.000014292963,0.000007541823,0.000053090145,0.000013009569,0.000013224418,0.000018497207],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990576,0.00010262183,0.0003125685,0.00025163245,0.000047507903,0.00022805965],"domain_scores_gemma":[0.99920446,0.00022952465,0.0001415798,0.0002921712,0.00009878888,0.00003348771],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015004029,0.00014953579,0.00033229473,0.00012538074,0.00003370721,0.0000062197128,0.000105757215,0.0000610822,0.00006300972],"category_scores_gemma":[0.0003611312,0.00012429313,0.00005834308,0.00024963624,0.00009326221,0.000046907895,0.00008804809,0.00008133681,0.000018073355],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006880848,0.0131654935,0.45999518,0.00034656542,0.003018022,0.008066962,0.014556282,0.000388684,0.4919623,0.00010897434,0.0004947194,0.007208719],"study_design_scores_gemma":[0.02163,0.002316575,0.036876615,0.0006929691,0.0007209928,0.011974801,0.008255843,0.000038560298,0.9162753,0.00008201616,0.0004363561,0.0006999444],"about_ca_topic_score_codex":0.0013537204,"about_ca_topic_score_gemma":0.00062484504,"teacher_disagreement_score":0.424313,"about_ca_system_score_codex":0.000028257939,"about_ca_system_score_gemma":0.000079418096,"threshold_uncertainty_score":0.5068527},"labels":[],"label_agreement":null},{"id":"W2547075547","doi":"10.1182/blood.v106.11.1320.1320","title":"PedsQL™ and EuroQol Most Responsive Measures To Change in Health-Related Quality of Life in Children with Hodgkin’s Disease.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal Children's Hospital; Queen's University; Hospital for Sick Children; Izaak Walton Killam Health Centre; Stollery Children's Hospital; Alberta Children's Hospital; Children's Hospital of Eastern Ontario; Children's Hospital of Western Ontario; BC Children's Hospital; Toronto General Hospital; CancerCare Manitoba; Health Sciences Centre","funders":"","keywords":"Medicine; Quality of life (healthcare); Disease; Pediatrics; Family medicine; Gerontology; Internal medicine; Nursing","score_opus":0.2858779316949639,"score_gpt":0.4005672782491087,"score_spread":0.11468934655414481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547075547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9484408,0.0083928,0.000031136482,0.041184034,0.00004342654,0.0013930481,0.00035909258,0.000022065386,0.00013362982],"genre_scores_gemma":[0.9894433,0.00024592152,0.00079712755,0.009149866,0.0001073633,0.00016074427,0.000022581387,0.000028778411,0.00004432604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99463755,0.000739948,0.0035694626,0.00054566923,0.000116345254,0.0003910449],"domain_scores_gemma":[0.99733096,0.00039209556,0.0014252885,0.0004152466,0.000048738573,0.00038764832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011631789,0.00018066056,0.0010526343,0.0005944688,0.000061067425,0.000024633771,0.0001746287,0.00008804288,0.000053350148],"category_scores_gemma":[0.0035890965,0.00021902987,0.00003988744,0.00044409098,0.000056357443,0.00027343043,0.000053108706,0.00017396356,0.00010382218],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011322108,0.0003090233,0.9914442,0.00014566575,0.00004314414,6.183531e-7,0.0034808442,0.00013449154,0.0000012922553,0.0037654045,0.0002853718,0.00027677638],"study_design_scores_gemma":[0.0027189725,0.00012265664,0.99528354,0.0001465573,0.000004075052,0.0000028564898,0.0001949016,0.0001396666,0.0000020515977,0.00038222293,0.0007772206,0.00022529169],"about_ca_topic_score_codex":0.010062495,"about_ca_topic_score_gemma":0.0072171637,"teacher_disagreement_score":0.041002527,"about_ca_system_score_codex":0.0001872277,"about_ca_system_score_gemma":0.0002785652,"threshold_uncertainty_score":0.9965296},"labels":[],"label_agreement":null},{"id":"W2547136103","doi":"10.1182/blood.v118.21.1082.1082","title":"A Randomized Phase II Study Evaluating the Efficacy and Safety of Deferasirox Versus Deferoxamine in Patients with Sickle Cell Disease (SCD): 2-Year Results Including Pharmacokinetics (PK) and Safety of Deferasirox with Concomitant Hydroxyurea Therapy","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Deferasirox; Medicine; Deferoxamine; Concomitant; Adverse effect; Internal medicine; Gastroenterology; Surgery; Thalassemia","score_opus":0.0332366238534347,"score_gpt":0.29521365852623416,"score_spread":0.2619770346727995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547136103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99382615,0.0011620587,0.000010247395,0.000053747674,0.00003592708,0.004079892,0.00006408902,0.00002302001,0.00074485445],"genre_scores_gemma":[0.9986223,0.0007968749,0.00039569256,0.000033279965,0.00001627871,0.00004067042,0.000036991867,0.000043792174,0.0000141486635],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99747276,0.00041470848,0.0008558959,0.0004221319,0.0005227648,0.00031171856],"domain_scores_gemma":[0.99803036,0.00071450096,0.00044091258,0.00040489712,0.0002049015,0.00020440634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009797935,0.00034321772,0.0009124124,0.0001297419,0.00018103508,0.000009015859,0.000121996105,0.00008345541,0.000014115666],"category_scores_gemma":[0.00033348653,0.00018889371,0.00007211537,0.00033024533,0.00041125817,0.000063384636,0.00011172774,0.0003141602,3.0591352e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8858512,0.011564233,0.08678144,0.000115112576,0.000874307,0.000029099863,0.011824928,0.000060081464,0.0010118672,0.000015279216,0.0000024880476,0.0018699864],"study_design_scores_gemma":[0.8953687,0.018679295,0.07947733,0.00034542097,0.0022362473,0.0000029872385,0.0017303171,0.00032839394,0.0015761066,0.000007992565,0.0000062925405,0.00024094146],"about_ca_topic_score_codex":0.00010031674,"about_ca_topic_score_gemma":0.000015585514,"teacher_disagreement_score":0.010094611,"about_ca_system_score_codex":0.000022105098,"about_ca_system_score_gemma":0.00012550161,"threshold_uncertainty_score":0.7702862},"labels":[],"label_agreement":null},{"id":"W2547251167","doi":"10.1182/blood.v122.21.1474.1474","title":"Effectively Targeting Treatment-Naïve CML Stem/Progenitor Cells From Imatinib-Nonresponders With Combination Treatments Of JAK2 and ABL Inhibitors In Vitro and In Vivo","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Stem cell; Imatinib mesylate; Progenitor cell; Dasatinib; Nilotinib; Cancer research; Imatinib; Tyrosine kinase; CD34; Haematopoiesis; K562 cells; Tyrosine-kinase inhibitor; Myeloid leukemia; Medicine; Biology; Immunology; Leukemia; Internal medicine; Cell biology; Receptor; Cancer","score_opus":0.00753092431805815,"score_gpt":0.22145988514125378,"score_spread":0.21392896082319562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547251167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997001,0.00080381834,0.0000017552677,0.000042663538,0.000034698685,0.0018826288,0.000043730473,0.000024488118,0.00016521392],"genre_scores_gemma":[0.99777555,0.00009777506,0.0016456002,0.000012521224,0.000027683436,0.00025155614,0.000045139306,0.000036291207,0.000107849046],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99857837,0.00013503213,0.00036476887,0.00042560045,0.0002120021,0.0002842038],"domain_scores_gemma":[0.99916005,0.00031829518,0.00017267192,0.00018552161,0.000038648042,0.00012483401],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009638041,0.00029157285,0.0005479983,0.00023154041,0.00003591066,0.000021206059,0.000037289727,0.00012039895,0.000030612326],"category_scores_gemma":[0.000023440532,0.00022559981,0.000040737254,0.00018611211,0.00008200665,0.00017546838,0.000029840547,0.000098810764,0.0000075530625],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009601791,0.002422224,0.36109364,0.00009634725,0.00047167263,0.00012848242,0.0020786482,0.0000018927792,0.6241073,0.0000010814896,0.000012964977,0.008625552],"study_design_scores_gemma":[0.04285964,0.0016915954,0.13997784,0.00025418628,0.00035913143,0.00002063978,0.0008123644,0.00022213616,0.8136046,0.000027703078,0.000005883572,0.0001643126],"about_ca_topic_score_codex":0.003685149,"about_ca_topic_score_gemma":0.0001156013,"teacher_disagreement_score":0.2211158,"about_ca_system_score_codex":0.00049892813,"about_ca_system_score_gemma":0.00010970949,"threshold_uncertainty_score":0.9199693},"labels":[],"label_agreement":null},{"id":"W2547280020","doi":"10.1182/blood.v106.11.701.701","title":"Quality of Life in Survivors of Childhood and Adolescent Acute Myelogenous Leukemia (AML) Does Not Differ by Treatment (Bone Marrow Transplant (BMT) vs. Chemotherapy). A Report from the Children’s Oncology Group (COG).","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Quality of life (healthcare); Pediatrics; Chemotherapy; Leukemia; Randomized controlled trial; Internal medicine","score_opus":0.01451874975214566,"score_gpt":0.27079992306112144,"score_spread":0.25628117330897576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547280020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985483,0.0032435304,0.000030193529,0.008139266,0.00011688972,0.0015666636,0.001282988,0.000059382648,0.000078087854],"genre_scores_gemma":[0.99197775,0.0032559203,0.0005248323,0.0032373131,0.00038845275,0.00008149247,0.0004064325,0.00006622807,0.00006159038],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956026,0.0005249189,0.0018895474,0.00079182786,0.000691181,0.0004999077],"domain_scores_gemma":[0.9973703,0.0004286851,0.0008477368,0.0009907024,0.000071050286,0.0002915308],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001060656,0.0005120131,0.0018725136,0.00010846536,0.00007744266,0.000012860289,0.00025991665,0.00033056716,0.00007635906],"category_scores_gemma":[0.00011358145,0.00033411387,0.00033524947,0.00019174506,0.00033796512,0.00007237747,0.00005936638,0.0004008251,0.0000023846528],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032758545,0.010491745,0.9112585,0.00017996054,0.002584843,0.000094431314,0.014283621,0.0000024171022,0.04907779,0.000015316678,0.00036263888,0.008372859],"study_design_scores_gemma":[0.019800842,0.0010941008,0.9382892,0.00026582397,0.0008132917,0.00021728173,0.00030586924,0.0000041056073,0.03832041,0.000029888633,0.0005187584,0.00034041234],"about_ca_topic_score_codex":0.022316888,"about_ca_topic_score_gemma":0.021593684,"teacher_disagreement_score":0.027030693,"about_ca_system_score_codex":0.0002965013,"about_ca_system_score_gemma":0.00049861165,"threshold_uncertainty_score":0.99991107},"labels":[],"label_agreement":null},{"id":"W2547284263","doi":"10.1182/blood.v120.21.813.813","title":"Safety of PK-Guided IV Bu Cy VP-16 Preparative Regimen Prior to Autologous Hematopoietic Stem Cell Transplantation for Lymphoma: Findings From a Multi-Center Phase II Study in North America","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; University of Ottawa","funders":"","keywords":"Medicine; Busulfan; Regimen; Transplantation; Cyclophosphamide; Pharmacokinetics; Single Center; Hematopoietic stem cell transplantation; Internal medicine; Area under the curve; Gastroenterology; Surgery; Urology; Chemotherapy","score_opus":0.026115943945636308,"score_gpt":0.32136408221155255,"score_spread":0.2952481382659162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547284263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899087,0.000103915496,0.0050968225,0.00010624328,0.00006711393,0.0041567557,0.00037428818,0.00005195318,0.00013422596],"genre_scores_gemma":[0.9935023,0.000020062469,0.005215264,0.00010725165,0.00006552252,0.0004490359,0.0001874015,0.000046205794,0.00040691],"study_design_codex":"qualitative","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99765605,0.00013866398,0.0007029288,0.00047158648,0.00044750574,0.0005832739],"domain_scores_gemma":[0.9985712,0.00039078057,0.00018556122,0.00041720015,0.00015184538,0.00028341112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026329566,0.00027433108,0.0006861896,0.00022494489,0.000096684715,0.000010164389,0.00020477506,0.00011022623,0.000030594412],"category_scores_gemma":[0.000080577825,0.00023556415,0.000109862085,0.00040693625,0.00007119822,0.00014082104,0.000083961415,0.00010737496,0.000030023271],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03109372,0.15663992,0.2912913,0.0016580928,0.0017603473,0.00053214305,0.4644662,0.000057330162,0.035526127,0.000011781124,0.0023889095,0.014574104],"study_design_scores_gemma":[0.5932901,0.02129048,0.20239513,0.0008237217,0.002925676,0.00033529405,0.019072529,0.0030012082,0.15412027,0.00000789761,0.0015237222,0.0012140111],"about_ca_topic_score_codex":0.00036334636,"about_ca_topic_score_gemma":0.00016690833,"teacher_disagreement_score":0.5621963,"about_ca_system_score_codex":0.00050918735,"about_ca_system_score_gemma":0.00039166625,"threshold_uncertainty_score":0.9606027},"labels":[],"label_agreement":null},{"id":"W2547305506","doi":"10.1182/blood.v114.22.3995.3995","title":"Inter-Rater Reliability of the 4Ts Scoring System for Diagnosing Heparin-Induced Thrombocytopenia in Critically Ill Patients.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; St. Joseph’s Healthcare Hamilton; McMaster University; St. Joseph's Hospital","funders":"","keywords":"Medicine; Heparin-induced thrombocytopenia; Heparin; Pre- and post-test probability; Partial thromboplastin time; Intensive care medicine; Internal medicine; Platelet","score_opus":0.024846461595805003,"score_gpt":0.28410990618928317,"score_spread":0.25926344459347817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547305506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99352986,0.000025023272,0.00004373806,0.0012149604,0.00044252077,0.0018084251,0.000016750066,0.00007181095,0.0028468922],"genre_scores_gemma":[0.9980059,0.0000058026153,0.0009046086,0.0008254177,0.000108755616,0.00008172439,0.000010234811,0.000036988826,0.000020521004],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99750066,0.000139086,0.0008765326,0.0005640451,0.00036087868,0.0005587724],"domain_scores_gemma":[0.99753195,0.00023546239,0.00016613606,0.0008996201,0.0010006798,0.00016614878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000539263,0.00030281444,0.0009442561,0.00012227384,0.00012533317,0.00003952185,0.0003367042,0.00023299867,0.000016099924],"category_scores_gemma":[0.0018691871,0.0002196529,0.00027671384,0.0003664407,0.000086561435,0.00020133663,0.00013956924,0.00037106202,0.000011391981],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001885683,0.0033238817,0.86281747,0.00069406023,0.00009555558,0.000014778885,0.0007239639,0.0000024689039,0.12798601,0.001179215,0.000048066613,0.0029259608],"study_design_scores_gemma":[0.0048439605,0.00073982973,0.7447358,0.0011573605,0.0002775513,0.000012895954,0.00017446688,0.000042093616,0.24751224,0.00019479448,0.000094104296,0.00021490503],"about_ca_topic_score_codex":0.00019291697,"about_ca_topic_score_gemma":0.00007537586,"teacher_disagreement_score":0.11952622,"about_ca_system_score_codex":0.00022023085,"about_ca_system_score_gemma":0.00017027212,"threshold_uncertainty_score":0.8957185},"labels":[],"label_agreement":null},{"id":"W2547366458","doi":"10.1182/blood.v124.21.5857.5857","title":"Reduced Intensity Versus Myeloablative Conditioning for Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"","keywords":"Medicine; Internal medicine; Transplantation; Hematopoietic stem cell transplantation; Incidence (geometry); Leukemia; Cumulative incidence; Graft-versus-host disease; Regimen; Surgery; Myeloid leukemia; Gastroenterology; Oncology","score_opus":0.024385111947191507,"score_gpt":0.2858085364435489,"score_spread":0.2614234244963574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547366458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932568,0.000057197547,0.0019038828,0.00032841464,0.00017390662,0.00092958583,0.00005422995,0.0000819151,0.003214045],"genre_scores_gemma":[0.9953696,0.00010803322,0.002857509,0.00021692952,0.00019029573,0.00014002313,0.00038535523,0.000044220524,0.00068801804],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998377,0.00009509828,0.0003434432,0.00043805203,0.00028207124,0.00046431745],"domain_scores_gemma":[0.99883026,0.0003891906,0.000104092665,0.00028345935,0.00022775402,0.0001652414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045955373,0.0002091202,0.0004294279,0.0002344942,0.00011384707,0.00002369808,0.0001395778,0.00019105934,0.000027850961],"category_scores_gemma":[0.00007651675,0.00020387331,0.00011573601,0.00027945745,0.00008739758,0.00013038801,0.000029844476,0.00037332566,0.00004766674],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0108988,0.00046757,0.007929019,0.0006666995,0.00072339387,0.0003032113,0.0041569173,0.00016556735,0.9654286,0.00066180166,0.0011367287,0.007461683],"study_design_scores_gemma":[0.043408077,0.0017486335,0.054095022,0.00020433812,0.0009770752,0.00016638714,0.0007239481,0.0022895422,0.8951126,0.00017857483,0.0006844113,0.00041144027],"about_ca_topic_score_codex":0.00006973015,"about_ca_topic_score_gemma":0.000042571723,"teacher_disagreement_score":0.07031606,"about_ca_system_score_codex":0.00046777187,"about_ca_system_score_gemma":0.0003998922,"threshold_uncertainty_score":0.8313712},"labels":[],"label_agreement":null},{"id":"W2547384253","doi":"10.1182/blood.v126.23.7.7","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Safety and Efficacy of Romiplostim in Children with Immune Thrombocytopenia (ITP)","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Romiplostim; Medicine; Placebo; Platelet; Internal medicine; Clinical endpoint; Randomized controlled trial; Adverse effect; Eltrombopag; Thrombopoietin; Surgery; Immune thrombocytopenia; Gastroenterology","score_opus":0.023352573471969187,"score_gpt":0.29780024818990813,"score_spread":0.27444767471793896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547384253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879405,0.0007014557,0.000011070087,0.00023539775,0.000015787156,0.010532715,0.000008851757,0.000018907054,0.00053531013],"genre_scores_gemma":[0.9993615,0.00003229852,0.00016032807,0.000048424496,0.000022693415,0.00023260337,0.000021721591,0.00002285958,0.0000975265],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9986159,0.00013907316,0.0004891638,0.00027216293,0.00026458135,0.00021909509],"domain_scores_gemma":[0.9990424,0.0002357319,0.00014390015,0.00036504678,0.00006534817,0.0001475545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074247713,0.00022691008,0.0015979958,0.00011867567,0.000047244488,0.000019473497,0.00011168383,0.000040556373,0.000012703455],"category_scores_gemma":[0.00016384505,0.00011561386,0.00008617805,0.0002206203,0.00008506867,0.00005319711,0.00006752859,0.00012674785,0.000007956803],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95534164,0.015388066,0.024245216,0.000005581492,0.00209968,0.00014576153,0.001944608,0.000014016163,0.00012684688,0.000006096185,0.0000045713064,0.00067794655],"study_design_scores_gemma":[0.97806424,0.004058513,0.014057993,0.00006371957,0.0024072481,0.00020752873,0.00031126454,0.000052281142,0.0006442164,0.000008365028,0.0000032218193,0.000121387886],"about_ca_topic_score_codex":0.0003924104,"about_ca_topic_score_gemma":0.0001836142,"teacher_disagreement_score":0.02272265,"about_ca_system_score_codex":0.00001797228,"about_ca_system_score_gemma":0.00009548945,"threshold_uncertainty_score":0.47145963},"labels":[],"label_agreement":null},{"id":"W2547395346","doi":"10.1182/blood.v126.23.4891.4891","title":"Favorable Risk Group Acute Myeloid Leukemia in Children and Young Adult Treated in Uniform Protocol in Casablanca, Morocco. a Preliminary Analysis","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Cytarabine; Medicine; Etoposide; Daunorubicin; Pediatrics; Myeloid leukemia; Internal medicine; Leukemia; Surgery; Chemotherapy","score_opus":0.010370943646529516,"score_gpt":0.2736849881499889,"score_spread":0.26331404450345935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547395346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96676123,0.000094897325,0.000009731662,0.00007466873,0.0000075315756,0.03148927,0.000058288606,0.000060672053,0.0014437078],"genre_scores_gemma":[0.97608274,0.0001247729,0.000902028,0.000064582295,0.000060700495,0.021907475,0.0002393325,0.000053375916,0.0005649632],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99706453,0.00024658607,0.0006779257,0.0007123119,0.0005222777,0.0007763693],"domain_scores_gemma":[0.99867904,0.000063565116,0.00015402731,0.00059852016,0.00014646706,0.00035836754],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009589768,0.00035526606,0.0008709715,0.0015394023,0.000045383855,0.000044071225,0.00024344354,0.0003152254,0.000027355774],"category_scores_gemma":[0.00030699998,0.00030920317,0.00009891573,0.003202904,0.000113992246,0.00028444375,0.0002084984,0.0009742729,0.000024566738],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020251586,0.00064939883,0.99294347,0.000059454436,0.0006459109,0.0009473394,0.0009980338,0.00011097206,0.00033035607,0.000008069371,0.00023425235,0.0010475749],"study_design_scores_gemma":[0.034248915,0.0011236646,0.9511471,0.00015595176,0.00079648854,0.00035498856,0.0004009446,0.01020262,0.0011841443,0.00005369134,0.000023398656,0.0003080937],"about_ca_topic_score_codex":0.06278252,"about_ca_topic_score_gemma":0.016093183,"teacher_disagreement_score":0.046689335,"about_ca_system_score_codex":0.0015334362,"about_ca_system_score_gemma":0.0006813651,"threshold_uncertainty_score":0.999936},"labels":[],"label_agreement":null},{"id":"W2547445136","doi":"10.1182/blood.v112.11.933.933","title":"Natural Killer (NK) or NK/T Cell Lineage Large Granular Lymphocytosis Associated with Dasatinib Therapy for Philadelphia Chromosome Positive Leukemia.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Lymphocytosis; Dasatinib; Natural killer cell; Cytotoxicity; CD16; Immunology; K562 cells; Lymphokine-activated killer cell; Lymphocyte; CD3; Cancer research; Biology; Medicine; Leukemia; Myeloid leukemia; T cell; Interleukin 21; Imatinib; Immune system; CD8; In vitro","score_opus":0.024829255352907958,"score_gpt":0.2789961110279713,"score_spread":0.2541668556750633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547445136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925632,0.003042298,0.00008331646,0.00030068844,0.00021849178,0.0024774955,0.00021040051,0.00026208244,0.0008420398],"genre_scores_gemma":[0.9889115,0.0014101033,0.00081748527,0.0012887822,0.00059992267,0.00031803153,0.0007817527,0.00018791136,0.005684529],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99607396,0.00013506174,0.0005663716,0.00085080316,0.001101991,0.001271786],"domain_scores_gemma":[0.99729794,0.00073011685,0.0002457935,0.0007489146,0.0005773768,0.00039984618],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043417586,0.0005630656,0.0009513074,0.00022421508,0.00046490697,0.00004385983,0.0003702488,0.00040059083,0.00031739168],"category_scores_gemma":[0.00039573121,0.00038742367,0.00032841615,0.000755916,0.0002942771,0.0001940523,0.00010685887,0.00050384563,0.000058584475],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.11683172,0.08145025,0.028272064,0.0060955584,0.026059764,0.053186424,0.041375488,0.00029218607,0.4792198,0.000572196,0.16367783,0.002966716],"study_design_scores_gemma":[0.5087755,0.0060800086,0.009118185,0.001008421,0.0009597162,0.0027974003,0.00037471025,0.0073787537,0.45436233,0.00001748357,0.0076985657,0.0014289607],"about_ca_topic_score_codex":0.00020666387,"about_ca_topic_score_gemma":0.000060179314,"teacher_disagreement_score":0.39194372,"about_ca_system_score_codex":0.007468627,"about_ca_system_score_gemma":0.011361598,"threshold_uncertainty_score":0.9998578},"labels":[],"label_agreement":null},{"id":"W2547489497","doi":"10.1182/blood.v112.11.3357.3357","title":"Strategies to Re-Express Epigenetically-Silenced Tumor Suppressor Genes Converge on the Requirement for Inhibition of the Histone Methyltransferase SUV39H1.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Hospital; University of Saskatchewan","funders":"","keywords":"Biology; DNA methylation; Histone H3; Histone methyltransferase; Cancer research; Molecular biology; EZH2; Cancer epigenetics; Histone methylation; Epigenetics; Gene silencing; Epigenetics of physical exercise; Gene expression; Genetics; Gene","score_opus":0.01951637289891565,"score_gpt":0.264850823801942,"score_spread":0.24533445090302639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547489497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99454314,0.00059684855,0.0024763818,0.0009962136,0.00016517506,0.0009154157,0.00009525134,0.000009971155,0.00020159919],"genre_scores_gemma":[0.998666,0.00011195817,0.00041903352,0.0002253689,0.0001516736,0.0002100665,0.000045010118,0.000022372555,0.00014854476],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99891955,0.00009203213,0.00027885297,0.00029979757,0.00020893913,0.00020080544],"domain_scores_gemma":[0.9991926,0.000041148567,0.0000874369,0.0004879192,0.00014119767,0.000049718874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016491232,0.00014958574,0.000140779,0.00002718839,0.00015445087,0.000010419202,0.00019120357,0.00009012144,0.000029846491],"category_scores_gemma":[0.00006436729,0.000102090366,0.00013651296,0.00009478277,0.00015233029,0.0000045389675,0.00004803947,0.000056556382,0.0000021210003],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023109237,0.00015755284,0.00007654647,0.000025789954,0.000060930797,7.443952e-7,0.00015264734,0.0008795802,0.996907,0.0004324542,0.000993103,0.00008256361],"study_design_scores_gemma":[0.000951107,0.0005539053,0.0017075983,0.00003608251,0.00006888361,0.000005425334,0.000111060275,0.00002800576,0.99308705,0.0001236074,0.0031934099,0.00013385167],"about_ca_topic_score_codex":0.000025095955,"about_ca_topic_score_gemma":0.00004054197,"teacher_disagreement_score":0.004122828,"about_ca_system_score_codex":0.000017922943,"about_ca_system_score_gemma":0.00012263036,"threshold_uncertainty_score":0.41631243},"labels":[],"label_agreement":null},{"id":"W2547516456","doi":"10.1182/blood.v110.11.85.85","title":"A Noncatalytic, Ras-Independent Function of SHP-2 Is Essential in Hematopoietic Progenitors.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Biology; PTPN11; Cancer research; Myeloid; Haematopoiesis; Protein tyrosine phosphatase; Progenitor cell; Neuroblastoma RAS viral oncogene homolog; Myeloid leukemia; Cell biology; KRAS; Molecular biology; Signal transduction; Mutation; Genetics; Stem cell; Gene","score_opus":0.004871952892133717,"score_gpt":0.23222632050536113,"score_spread":0.22735436761322741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547516456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934968,0.0044893688,0.0013235626,0.000025850655,0.00012336657,0.00028666947,0.000024454288,0.000009344332,0.00022058413],"genre_scores_gemma":[0.99919885,0.000028396493,0.00034722092,0.000053442647,0.00018650356,0.000018899058,0.000084244195,0.00001710417,0.000065314845],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990543,0.000014912337,0.0002718524,0.00026600412,0.00016959426,0.00022333112],"domain_scores_gemma":[0.9994848,0.00000686496,0.00009672357,0.00030365362,0.000053549513,0.000054424792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022633403,0.0001181829,0.00013296408,0.000057246656,0.000020909727,0.00000849517,0.0001384131,0.00012606653,0.000029790448],"category_scores_gemma":[0.000047103455,0.00012164871,0.00007207738,0.000118480806,0.000050015176,0.0000041031662,0.00009820609,0.00006654139,0.000011238293],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020545462,0.0006854226,0.020458518,0.0000760092,0.00007723254,0.000021486368,0.000053730917,0.0000016323701,0.9768229,0.00023763665,0.00030649942,0.0010534781],"study_design_scores_gemma":[0.0014464911,0.00020969957,0.006892669,0.000020596577,0.000049986083,0.00002468201,0.000035591504,0.0000018885667,0.9903346,0.000091843154,0.0007673343,0.00012466489],"about_ca_topic_score_codex":0.000046405265,"about_ca_topic_score_gemma":0.000059060694,"teacher_disagreement_score":0.013565849,"about_ca_system_score_codex":0.0000075407065,"about_ca_system_score_gemma":0.00006025854,"threshold_uncertainty_score":0.496069},"labels":[],"label_agreement":null},{"id":"W2547569429","doi":"10.1182/blood.v118.21.5191.5191","title":"Prognostic Value of Epstein-Barr Virus Infected Tumor Cell Size in Patients with Extranodal Natural Killer T-Cell Lymphoma, Nasal Type","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lymphoma; Pathology; CD30; T-cell lymphoma; Epstein–Barr virus; Immunohistochemistry; Biology; Virus; Medicine; Virology","score_opus":0.006411175315301156,"score_gpt":0.1940415146247388,"score_spread":0.18763033930943762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547569429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954466,0.0004815624,3.222792e-7,0.000008218628,0.00021095473,0.00083720515,0.00001182852,0.000043788994,0.002959481],"genre_scores_gemma":[0.9987713,0.000011656375,0.0008067224,0.00009457207,0.000030735206,0.000047063055,0.00003791241,0.000040430783,0.00015959391],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986362,0.000051282062,0.0003323793,0.0003177679,0.00033088573,0.00033152528],"domain_scores_gemma":[0.99914956,0.00012112393,0.00014151057,0.00030111938,0.00014797796,0.00013872565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005404853,0.0002596496,0.00041022955,0.00009727702,0.00002971836,0.000007559935,0.00009105773,0.00008086519,0.00013756298],"category_scores_gemma":[0.00007551941,0.0001816764,0.00008030751,0.00029182923,0.000067047724,0.00006179044,0.000035017445,0.00007894374,0.00005777349],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008909615,0.019772794,0.97671777,0.00012013998,0.00012191689,0.00025125634,0.0004292697,7.2221604e-7,0.0013547174,0.00002289378,0.00004989136,0.00026766042],"study_design_scores_gemma":[0.03545633,0.0025948859,0.89325386,0.00016048712,0.00043017569,0.000014505304,0.000019869647,0.000007549089,0.06783544,0.0000086722775,0.000034093126,0.00018415399],"about_ca_topic_score_codex":0.00046642785,"about_ca_topic_score_gemma":0.000042052376,"teacher_disagreement_score":0.083463944,"about_ca_system_score_codex":0.00006953099,"about_ca_system_score_gemma":0.00022669762,"threshold_uncertainty_score":0.74085486},"labels":[],"label_agreement":null},{"id":"W2547612211","doi":"10.1182/blood.v104.11.783.783","title":"Sequencing the Multiple Myeloma Kinome: Absence of Mutation in Known Malignancy-Associated Kinases.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University Health Network; Ontario Institute for Cancer Research","funders":"","keywords":"Kinome; Biology; Receptor tyrosine kinase; Genetics; Cancer research; Tyrosine kinase; Kinase; Mutation; CDKN2A; Exon; Bruton's tyrosine kinase; Gene; Signal transduction","score_opus":0.025871643028557753,"score_gpt":0.2799492332638534,"score_spread":0.25407759023529564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547612211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978957,0.0004848736,0.000025740805,0.00024982108,0.000029159632,0.00055858673,0.000019342588,0.000031477724,0.000705285],"genre_scores_gemma":[0.99920744,0.000047613947,0.00046234837,0.000045372482,0.000026761718,0.000053241532,0.000047527115,0.000014980391,0.00009473211],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988411,0.000054060783,0.00026791752,0.00019823697,0.0003357239,0.00030297856],"domain_scores_gemma":[0.99931955,0.00014490196,0.000098941884,0.0002457747,0.00010613876,0.000084674095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020505388,0.000117051066,0.00021557034,0.00011706174,0.00005937665,0.000010105223,0.00009788652,0.000067178014,0.000029179937],"category_scores_gemma":[0.0006668784,0.00008167355,0.00007167336,0.00040002266,0.00007829265,0.00006827432,0.00003290443,0.00014515224,0.000027559134],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002566278,0.002964119,0.84557974,0.00016912675,0.00036781142,0.0023837774,0.002297092,0.00026884608,0.13527806,0.0003464479,0.000016309814,0.010072064],"study_design_scores_gemma":[0.01198835,0.00031876122,0.8279375,0.00039848732,0.00005358769,0.00006630523,0.00026802672,0.00020862154,0.1583975,0.00026859835,0.000009757931,0.00008451163],"about_ca_topic_score_codex":0.0017990129,"about_ca_topic_score_gemma":0.0008805332,"teacher_disagreement_score":0.02311944,"about_ca_system_score_codex":0.00019497954,"about_ca_system_score_gemma":0.00027560763,"threshold_uncertainty_score":0.33305508},"labels":[],"label_agreement":null},{"id":"W2547716381","doi":"10.1182/blood.v118.21.4218.4218","title":"Venous Thromboembolism Validation Study of the IMPROVE Risk Assessment Models in the Medical Patient (VTE-VALOURR),","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Emergency medicine; Randomized controlled trial; Guideline; Retrospective cohort study; Risk assessment; Atrial fibrillation; Intensive care medicine; Internal medicine","score_opus":0.02630018175938792,"score_gpt":0.27191035258612023,"score_spread":0.2456101708267323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547716381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98885,0.000093511684,0.000060165796,0.00030270964,0.00029781542,0.0022112979,0.0000077869645,0.000023139804,0.008153585],"genre_scores_gemma":[0.99891233,0.00014438054,0.00015421119,0.00044660785,0.000078051184,0.00023098118,0.0000044067187,0.000021397424,0.000007638192],"study_design_codex":"nonrandomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99744725,0.00035793555,0.0005188139,0.00029945213,0.0011044028,0.00027212763],"domain_scores_gemma":[0.9986855,0.00007643695,0.00026743693,0.00080520875,0.00008975246,0.00007567738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096525776,0.00017695298,0.0004973133,0.0000790857,0.00011986548,0.000016049884,0.0004000509,0.00009023435,0.00010357075],"category_scores_gemma":[0.000103577935,0.00009614734,0.00011835541,0.00025309803,0.00006644453,0.00008190991,0.00020889779,0.00037204332,0.00000565126],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017729372,0.4017997,0.25058216,0.0005078001,0.003513066,0.0005063376,0.26712337,0.0004977492,0.0008126426,0.01657587,0.0022334664,0.055670522],"study_design_scores_gemma":[0.005172127,0.0037587793,0.97258997,0.00013902223,0.0016975816,0.000018301584,0.011078961,0.0005153409,0.0016645683,0.0031070593,0.00008289861,0.00017540928],"about_ca_topic_score_codex":0.0019758542,"about_ca_topic_score_gemma":0.00021836364,"teacher_disagreement_score":0.7220078,"about_ca_system_score_codex":0.000037682155,"about_ca_system_score_gemma":0.00013148336,"threshold_uncertainty_score":0.39207748},"labels":[],"label_agreement":null},{"id":"W2547742335","doi":"10.1182/blood.v112.11.35.35","title":"Once-Daily Oral Rivaroxaban Compared with Subcutaneous Enoxaparin Every 12 Hours for Thromboprophylaxis after Total Knee Replacement: RECORD4","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McMaster University","funders":"","keywords":"Medicine; Rivaroxaban; Venography; Pulmonary embolism; Clinical endpoint; Surgery; Deep vein; Knee replacement; Population; Thrombosis; Anesthesia; Intention-to-treat analysis; Randomized controlled trial; Internal medicine; Arthroplasty; Warfarin; Atrial fibrillation","score_opus":0.019111722200031205,"score_gpt":0.23715514724973805,"score_spread":0.21804342504970683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547742335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99268085,0.0003994955,0.0001317752,0.00024423873,0.0003716326,0.0020359124,0.000047720292,0.00019220456,0.0038961929],"genre_scores_gemma":[0.99119085,0.000130185,0.0044095186,0.00060925627,0.00039890705,0.0005434224,0.000094642775,0.000096158416,0.002527064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976375,0.000053025095,0.0004422915,0.0006831809,0.00050103193,0.0006829441],"domain_scores_gemma":[0.99863744,0.000066497574,0.00016363162,0.0007400763,0.00013220227,0.00026014098],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018463183,0.00039576367,0.0009182768,0.00014866584,0.00024848708,0.00003873286,0.00013200716,0.00011748251,0.00026170476],"category_scores_gemma":[0.000043339718,0.00032815445,0.0002109768,0.00019281216,0.00016300881,0.00012587309,0.00009847876,0.00023383058,0.00007662854],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032391682,0.0477151,0.7416595,0.0023650918,0.008778708,0.012525191,0.0139351925,0.000259634,0.0059230593,0.00054186274,0.12065567,0.013249268],"study_design_scores_gemma":[0.03071929,0.028768746,0.90346307,0.00067625404,0.0030582442,0.0037742343,0.0009189149,0.000097890035,0.0052725994,0.00013259135,0.021535525,0.001582635],"about_ca_topic_score_codex":0.00032894086,"about_ca_topic_score_gemma":0.00021061652,"teacher_disagreement_score":0.16180354,"about_ca_system_score_codex":0.00009927658,"about_ca_system_score_gemma":0.00014118066,"threshold_uncertainty_score":0.99991703},"labels":[],"label_agreement":null},{"id":"W2547835656","doi":"10.1182/blood.v104.11.3685.3685","title":"A Retrospective Case Review of Adverse Drug Reactions Using Intravenous Iron in Non-Hemodialysis Patients.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Iron sucrose; Hemodialysis; Intravenous iron; Adverse effect; Incidence (geometry); Intravenous therapy; Adverse drug reaction; Retrospective cohort study; Surgery; Pediatrics; Internal medicine; Iron deficiency; Anemia; Drug; Pharmacology","score_opus":0.007608305471689803,"score_gpt":0.25050551135625687,"score_spread":0.24289720588456706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547835656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950059,0.0025976452,0.000030110199,0.00008074063,0.00006377914,0.00047221547,0.000016956114,0.000013215643,0.0017194162],"genre_scores_gemma":[0.99580145,0.0024308804,0.0014386267,0.00021184876,0.000041100186,0.000010085869,0.000022192968,0.000014610937,0.000029212688],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991074,0.000028929227,0.00033536274,0.00018981066,0.0001780165,0.00016047183],"domain_scores_gemma":[0.99941784,0.000009275885,0.00013461367,0.00026208695,0.00010702872,0.000069182344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015876244,0.00010941657,0.000377265,0.0001470854,0.000038148526,0.0000012637347,0.00003491974,0.00004500833,0.000053945187],"category_scores_gemma":[0.00020682925,0.00010196134,0.000109575674,0.00042866805,0.00004544432,0.00006900451,0.000018311413,0.0001375505,0.000008794095],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082004274,0.061341543,0.79916024,0.057216864,0.0006665202,0.009867818,0.028864175,0.0009312281,0.023118634,0.0017168553,0.0005539391,0.01574214],"study_design_scores_gemma":[0.084792666,0.0011919686,0.85021603,0.023399483,0.011656259,0.002592893,0.0053136903,0.000058060134,0.017673569,0.00084647466,0.0008155981,0.001443286],"about_ca_topic_score_codex":0.0019292134,"about_ca_topic_score_gemma":0.00013164463,"teacher_disagreement_score":0.08397262,"about_ca_system_score_codex":0.00008111976,"about_ca_system_score_gemma":0.00009986405,"threshold_uncertainty_score":0.41578627},"labels":[],"label_agreement":null},{"id":"W2547836063","doi":"10.1182/blood.v114.22.389.389","title":"Leukemic and Normal Stem Cell Transcriptional Signatures Determined by Functional Assays Are Predictive of the Overall Survival of AML Patients.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McMaster University; Institute for Clinical Evaluative Sciences; University Health Network; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Stem cell; Haematopoiesis; CD34; Progenitor cell; Biology; Leukemia; Cancer research; Hematopoietic stem cell; Cancer stem cell; Immunology; Stem cell marker; Cell biology","score_opus":0.009999280107587417,"score_gpt":0.2127123861217811,"score_spread":0.20271310601419368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547836063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997161,0.0005048333,0.00006599114,0.00016910088,0.000077658944,0.00036922772,0.0003687393,0.000014677304,0.0012688191],"genre_scores_gemma":[0.9990227,0.000035175337,0.000054529883,0.0001460129,0.000076477176,0.0000072924017,0.00007283617,0.0000124152075,0.000572565],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985331,0.0000868383,0.00027851405,0.0002130159,0.0006829185,0.0002055589],"domain_scores_gemma":[0.9992305,0.00010225129,0.00014763899,0.00019127835,0.00023692456,0.000091396796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015139923,0.00014173186,0.00027090774,0.00006734899,0.000053690386,0.0000055139067,0.00012164519,0.00013511839,0.000046365625],"category_scores_gemma":[0.000031104366,0.00010063631,0.000110529065,0.00011924884,0.00013605705,0.00008251402,0.000033442455,0.00032820538,9.2988523e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002394183,0.0024289472,0.2985303,0.00027241206,0.00028940744,0.000010870666,0.0005186672,0.00006421396,0.6870408,0.00018478262,0.006758357,0.0015070246],"study_design_scores_gemma":[0.008932555,0.0008841556,0.91797686,0.00006641085,0.00017641296,0.000009291218,0.00007503986,0.00021600701,0.0713758,0.000042767333,0.00015598442,0.000088737455],"about_ca_topic_score_codex":0.000017848435,"about_ca_topic_score_gemma":0.0000032424093,"teacher_disagreement_score":0.6194465,"about_ca_system_score_codex":0.000075061114,"about_ca_system_score_gemma":0.00021678119,"threshold_uncertainty_score":0.41038296},"labels":[],"label_agreement":null},{"id":"W2547863170","doi":"10.1182/blood.v104.11.2480.2480","title":"SDX-105 Demonstrates a High Response Rate as a Single-Agent with Acceptable Safety in Rituximab-Refractory, Relpased Indolent or Transformed Non-Hodgkin’s Lymphoma (NHL).","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Public Health; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Rituximab; Medicine; Internal medicine; Refractory (planetary science); Bendamustine; Gastroenterology; Lymphoma; Follicular lymphoma; Bone marrow; Oncology; Surgery; Biology","score_opus":0.012767488074740816,"score_gpt":0.2465276413827582,"score_spread":0.2337601533080174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547863170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941772,0.00044542638,0.00005498494,0.0022383495,0.000099124874,0.0017008089,0.00006177058,0.00013536701,0.0010869603],"genre_scores_gemma":[0.9959333,0.0003423735,0.0019438489,0.00080019806,0.00008021779,0.00043380487,0.000082504805,0.00008317849,0.00030058436],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99700654,0.00021549992,0.0007123957,0.000739101,0.0005218248,0.0008046415],"domain_scores_gemma":[0.9982773,0.00040281337,0.00018000037,0.00060312735,0.000109136374,0.00042758873],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005781151,0.0005528988,0.00088822865,0.0003156419,0.00016701131,0.000083199964,0.0001776408,0.00024478484,0.00029125757],"category_scores_gemma":[0.00016750643,0.00037476723,0.00018194888,0.0006148551,0.00014327589,0.00024003521,0.00003553993,0.00016994617,0.00016691134],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37867042,0.23178566,0.13257037,0.0009146078,0.004226749,0.050792336,0.010600921,0.0003875938,0.11694965,0.0004509899,0.00045406888,0.07219663],"study_design_scores_gemma":[0.17767665,0.010519775,0.5314068,0.0013216889,0.0009027195,0.0009935183,0.00063287927,0.000009878402,0.27331403,0.00007389288,0.0025453123,0.0006028266],"about_ca_topic_score_codex":0.001748424,"about_ca_topic_score_gemma":0.0012864331,"teacher_disagreement_score":0.39883646,"about_ca_system_score_codex":0.0010490854,"about_ca_system_score_gemma":0.0019606778,"threshold_uncertainty_score":0.9998704},"labels":[],"label_agreement":null},{"id":"W2547879229","doi":"10.1182/blood.v126.23.2090.2090","title":"Nilotinib Vs Dasatinib As Second-Line Therapy in Patients with Philadelphia-Positive Chronic Myeloid Leukemia in Chronic Phase (Ph+ CML-CP) Who Are Resistant or Intolerant to Imatinib: A Cost-Effectiveness Analysis (CEA) Based on Real-World Data","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nilotinib; Dasatinib; Medicine; Discontinuation; Internal medicine; Imatinib; Imatinib mesylate; Oncology; Myeloid leukemia","score_opus":0.055607528918262344,"score_gpt":0.347892726618645,"score_spread":0.29228519770038264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547879229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901832,0.00026729412,0.00008151614,0.000490847,0.000077374534,0.006584329,0.0015338138,0.00014072297,0.0006409198],"genre_scores_gemma":[0.99300337,0.00007998175,0.00048843276,0.0006854173,0.00023709457,0.00086773484,0.0042846003,0.00018376429,0.00016962594],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9934891,0.0007474072,0.001254731,0.0020010923,0.0013517523,0.0011559374],"domain_scores_gemma":[0.9946458,0.0007251155,0.0006881263,0.0027946166,0.00042077422,0.00072559656],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001326561,0.0009861161,0.0023129035,0.0017387482,0.000120897996,0.000086121414,0.00074562494,0.00022283632,0.0003559876],"category_scores_gemma":[0.00040855503,0.0007520342,0.00019144644,0.0044428543,0.00019823981,0.00035087607,0.00025336127,0.00084148004,0.00006914697],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.3024138,0.0297099,0.5900794,0.0016246736,0.009731305,0.0052055623,0.0038390576,0.024321828,0.0035990358,0.000056535795,0.0009846904,0.028434215],"study_design_scores_gemma":[0.22819744,0.033890363,0.6986345,0.0044692256,0.0018455888,0.000013629384,0.00018543411,0.019887969,0.010940445,0.000009678677,0.0007764169,0.0011492823],"about_ca_topic_score_codex":0.0043842,"about_ca_topic_score_gemma":0.053610757,"teacher_disagreement_score":0.10855512,"about_ca_system_score_codex":0.016403696,"about_ca_system_score_gemma":0.00778442,"threshold_uncertainty_score":0.99949306},"labels":[],"label_agreement":null},{"id":"W2547989191","doi":"10.1182/blood.v124.21.795.795","title":"Nelarabine in Combination with Etoposide and Cyclophosphamide Is Active in First Relapse of Childhood T-Acute Lymphocytic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LL)","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia; Hospital for Sick Children","funders":"","keywords":"Medicine; Etoposide; Internal medicine; Oncology; Lymphoblastic lymphoma; Cyclophosphamide; Immunology; Chemotherapy; T cell; Immune system","score_opus":0.0051210395297632645,"score_gpt":0.22278866586495844,"score_spread":0.21766762633519518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547989191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99707067,0.00040336794,0.000099284036,0.00041416415,0.000035862355,0.00085041515,0.000019055118,0.000048029327,0.0010591602],"genre_scores_gemma":[0.99768907,0.00065587304,0.00092341437,0.00038811896,0.000034801276,0.00007994741,0.000029962526,0.00007219278,0.00012660363],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99740064,0.000104268125,0.00061274023,0.0006982396,0.00059298193,0.00059114915],"domain_scores_gemma":[0.9982981,0.00058168214,0.00021378715,0.00047055047,0.00014529937,0.00029060026],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037016804,0.0003914714,0.00081200793,0.0005354837,0.00006839336,0.00003310295,0.00016494236,0.00026823956,0.000017969316],"category_scores_gemma":[0.00044081008,0.00033911015,0.00005167018,0.0007271236,0.000390182,0.0002576971,0.0001778715,0.00023076197,0.000008916728],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019518126,0.010242902,0.8417818,0.0041972348,0.003473968,0.0047072754,0.030619549,0.0007457417,0.024872093,0.0047435835,0.0005727507,0.054524988],"study_design_scores_gemma":[0.10150551,0.0028060314,0.85213464,0.0013906488,0.0005625351,0.0017595618,0.00031735518,0.011652401,0.026500406,0.00072513625,0.00014908129,0.0004967052],"about_ca_topic_score_codex":0.001468683,"about_ca_topic_score_gemma":0.00038129828,"teacher_disagreement_score":0.08198738,"about_ca_system_score_codex":0.002245337,"about_ca_system_score_gemma":0.0014395725,"threshold_uncertainty_score":0.99990606},"labels":[],"label_agreement":null},{"id":"W2547997579","doi":"10.1182/blood.v106.11.4181.4181","title":"Survey of Red Blood Cell Transfusion Practices in Medically Ill Patients.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Subspecialty; Transfusion medicine; Blood transfusion; Delirium; Gastrointestinal bleeding; Coronary artery disease; Emergency medicine; Internal medicine; Intensive care medicine; Family medicine","score_opus":0.02161448964480093,"score_gpt":0.2670538015254102,"score_spread":0.24543931188060927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547997579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97885096,0.00037065384,0.000021470129,0.0022621956,0.000078934754,0.0006676022,0.00001472857,0.000041253028,0.017692177],"genre_scores_gemma":[0.9961833,0.0012336818,0.0010510946,0.0009793598,0.000045560064,0.000016808932,0.00007005901,0.000022223847,0.0003979344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982698,0.0001423029,0.00052267604,0.00030738852,0.0005179187,0.00023990884],"domain_scores_gemma":[0.9989463,0.00011511502,0.00021318124,0.00031460918,0.00026074488,0.0001500158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007025842,0.00015107724,0.00034801284,0.00017705573,0.000027270038,0.0000063806992,0.0001317695,0.00012343632,0.00045273374],"category_scores_gemma":[0.00045143146,0.00012926015,0.00007406242,0.00035628103,0.00004581953,0.00009645323,0.00003076838,0.00023150975,0.000019383217],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007628014,0.044992033,0.89228415,0.00067941373,0.00031410193,0.000100301506,0.0012701954,0.0000056802164,0.02737516,0.000048262456,0.0019725189,0.030195348],"study_design_scores_gemma":[0.024213176,0.0008708629,0.93368924,0.0001413759,0.00063871837,0.0000056544336,0.0000819903,0.000030626637,0.032371245,0.0000043796595,0.0077844984,0.00016825741],"about_ca_topic_score_codex":0.000986989,"about_ca_topic_score_gemma":0.002790902,"teacher_disagreement_score":0.04412117,"about_ca_system_score_codex":0.0000094682455,"about_ca_system_score_gemma":0.0000775686,"threshold_uncertainty_score":0.5271076},"labels":[],"label_agreement":null},{"id":"W2548004659","doi":"10.1182/blood.v108.11.154.154","title":"Integrin Linked Kinase Is Expressed in Acute Myeloid Leukemia Blasts and Its Inhibition Is Cytotoxic to Leukemic Progenitors.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Terry Fox Research Institute","funders":"","keywords":"Integrin-linked kinase; Protein kinase B; Cancer research; Kinase; Myeloid leukemia; Leukemia; Fms-Like Tyrosine Kinase 3; PI3K/AKT/mTOR pathway; Myeloid; Chemistry; Biology; Molecular biology; Phosphorylation; Signal transduction; Protein kinase A; Cell biology; Immunology; Biochemistry; Cyclin-dependent kinase 2; Mutation","score_opus":0.013899536578015386,"score_gpt":0.2704722177240899,"score_spread":0.2565726811460745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548004659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968625,0.0003519892,0.000026854606,0.0008034766,0.000032033786,0.0012244398,0.000040487852,0.00007693935,0.0005813173],"genre_scores_gemma":[0.99598503,0.00012155552,0.0005335536,0.0006488616,0.00020179884,0.00017487885,0.00004886437,0.000053897693,0.0022315409],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99792016,0.00006599736,0.00040954095,0.0005856371,0.0005255107,0.0004931326],"domain_scores_gemma":[0.9991025,0.000051507457,0.00006115116,0.00035090657,0.00014641175,0.0002875331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018575312,0.00025476908,0.00034740067,0.00045606325,0.00005681189,0.000047651047,0.00011174785,0.00022122504,0.00015036113],"category_scores_gemma":[0.0001012432,0.00024054591,0.000081305545,0.00057557924,0.000058991456,0.00009621784,0.00018207655,0.00046790627,0.00026717762],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023683411,0.00036640753,0.003416122,0.00012688429,0.00003452519,0.0005775835,0.00037460934,0.000001914836,0.99131227,0.000012164201,0.0026157203,0.0009249836],"study_design_scores_gemma":[0.00554796,0.00041905267,0.023803843,0.0003050407,0.00007944089,0.000117586875,0.000057248893,0.00020225889,0.9679504,0.000057886726,0.0012336329,0.00022562721],"about_ca_topic_score_codex":0.00017560426,"about_ca_topic_score_gemma":0.000047733105,"teacher_disagreement_score":0.02336183,"about_ca_system_score_codex":0.0003094977,"about_ca_system_score_gemma":0.00030946254,"threshold_uncertainty_score":0.98091775},"labels":[],"label_agreement":null},{"id":"W2548040475","doi":"10.1182/blood.v106.11.4049.4049","title":"Delayed Treatment of Bleeding in Patients with Mild Hemophilia Can Very Significantly Affect Overall Need for Therapy.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Surgery; Range of motion; Aspirin; Medical history; Arthropathy; Hemarthrosis; Atrial fibrillation; Family history; Internal medicine; Osteoarthritis","score_opus":0.025565873772467513,"score_gpt":0.2798392327546283,"score_spread":0.2542733589821608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548040475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996841,0.00035260123,0.0000017267852,0.00058894546,0.000022056594,0.0017834117,0.000041232062,0.000023318325,0.00034568764],"genre_scores_gemma":[0.9980884,0.00015745133,0.00070777786,0.0000502126,0.00012151748,0.00011817327,0.000099549885,0.000031917065,0.00062496733],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888426,0.000024848394,0.00021652275,0.00024812695,0.0002800253,0.00034620575],"domain_scores_gemma":[0.99942297,0.00009791844,0.000055834633,0.00021451832,0.00008724366,0.00012151832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000081674494,0.0001911229,0.00038195125,0.00017585818,0.00004239001,0.000007800102,0.00005579454,0.000079647776,0.00002854132],"category_scores_gemma":[0.000012784761,0.00012050356,0.00010755456,0.00016531585,0.00004244363,0.000045618333,0.000007912853,0.000059292848,0.0000030906124],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053451615,0.010224916,0.96006995,0.00007991352,0.000854431,0.000027822032,0.0009050645,0.000015383403,0.012104255,0.000019151375,0.00012579924,0.010228152],"study_design_scores_gemma":[0.121139884,0.027283644,0.63603836,0.0002437258,0.00047981186,0.0000059036392,0.00013419066,0.00014455142,0.21351507,0.000024297537,0.0006458946,0.00034462954],"about_ca_topic_score_codex":0.00019125426,"about_ca_topic_score_gemma":0.00008832284,"teacher_disagreement_score":0.32403156,"about_ca_system_score_codex":0.00013026776,"about_ca_system_score_gemma":0.00011858225,"threshold_uncertainty_score":0.49139926},"labels":[],"label_agreement":null},{"id":"W2548051034","doi":"10.1182/blood.v104.11.4832.4832","title":"Successful Treatment of Cutaneous Chronic Lymphocytic Leukemia with a Topical Toll Receptor 7/8 Antagonist (Imiquimod).","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Imiquimod; Population; Chronic lymphocytic leukemia; Skin biopsy; Lymphoma; Pathology; Dermatology; Leukemia; Biopsy; Immunology","score_opus":0.013112132884904171,"score_gpt":0.26768396342049444,"score_spread":0.2545718305355903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548051034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944409,0.001331304,0.000063,0.00020198448,0.000081533035,0.00085676386,0.000022459295,0.00012420402,0.002877828],"genre_scores_gemma":[0.9960545,0.0006847376,0.0014071502,0.00006034238,0.00043256182,0.00008127456,0.000046823996,0.0000618702,0.0011707452],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99763376,0.000037746195,0.0004450055,0.0005423948,0.00066699804,0.0006740796],"domain_scores_gemma":[0.9985022,0.000103338134,0.000117836986,0.00080663135,0.00011635701,0.00035362775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006578202,0.00033671453,0.00070019177,0.000134864,0.000093250914,0.000029350307,0.00020913946,0.00019422403,0.000319898],"category_scores_gemma":[0.000038882783,0.00024151403,0.0001772423,0.00027939826,0.0003725261,0.00006765881,0.0000579844,0.0001366337,0.00015881477],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.060689226,0.049270794,0.043716084,0.018187614,0.021680936,0.1234766,0.01904693,0.027186824,0.48458362,0.0148318475,0.002190512,0.13513903],"study_design_scores_gemma":[0.28323486,0.021979379,0.00060264656,0.00089719414,0.0012761676,0.019425929,0.00028013616,0.0017312691,0.66146666,0.00015265131,0.008220444,0.0007326385],"about_ca_topic_score_codex":0.0042006467,"about_ca_topic_score_gemma":0.0003697081,"teacher_disagreement_score":0.22254565,"about_ca_system_score_codex":0.09106447,"about_ca_system_score_gemma":0.050620653,"threshold_uncertainty_score":0.9848656},"labels":[],"label_agreement":null},{"id":"W2548090821","doi":"10.1182/blood.v126.23.2702.2702","title":"Initial Therapy for Mantle Cell Lymphoma with Abbreviated R-CHOP Followed By Y90-Ibritumomab Tiuxetan: Ten Year Follow-up of the Phase 2 ECOG-ACRIN Study E1499","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Ibritumomab tiuxetan; Medicine; Mantle cell lymphoma; Radioimmunotherapy; Internal medicine; Clinical endpoint; CHOP; Rituximab; Salvage therapy; Surgery; Gastroenterology; Oncology; Lymphoma; Clinical trial; Chemotherapy; Immunology","score_opus":0.025508167334232855,"score_gpt":0.28938422311778567,"score_spread":0.26387605578355283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548090821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99354833,0.0010402867,0.000005767473,0.00023373563,0.00020548848,0.0026173294,0.0001969089,0.00005535508,0.0020967925],"genre_scores_gemma":[0.9980417,0.000048097958,0.00018556888,0.00018564977,0.00011270606,0.00037562937,0.0000813057,0.000060217466,0.00090910925],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99840236,0.000083643376,0.00036297104,0.00037987743,0.00044621332,0.00032496496],"domain_scores_gemma":[0.9987654,0.00007950268,0.0001886078,0.0005899609,0.00018504901,0.00019149063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018157627,0.0002934267,0.00057023094,0.00005660471,0.00008384917,0.00002915119,0.00019611619,0.00008093325,0.000044414068],"category_scores_gemma":[0.000039686412,0.00017020787,0.00021739396,0.00023301154,0.00006246439,0.000069546986,0.000048712627,0.000048633,0.000023256676],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020220244,0.2045392,0.6436384,0.00027755203,0.005843295,0.0008203371,0.006000995,0.0000022498846,0.014108288,0.00007764491,0.083146945,0.02132486],"study_design_scores_gemma":[0.6546982,0.022453975,0.042326014,0.00019780826,0.0028468056,0.00012479827,0.0021069162,0.000025127492,0.259128,0.000038920763,0.015522654,0.0005307608],"about_ca_topic_score_codex":0.0001935495,"about_ca_topic_score_gemma":0.000045455967,"teacher_disagreement_score":0.634478,"about_ca_system_score_codex":0.00007526631,"about_ca_system_score_gemma":0.0003137189,"threshold_uncertainty_score":0.69408756},"labels":[],"label_agreement":null},{"id":"W2548134605","doi":"10.1182/blood.v112.11.433.433","title":"Venous Thromboembolism Risk in Stroke Patients Receiving Extended-Duration Enoxaparin Prophylaxis: Sub-Analysis of the EXCLAIM Study","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary; McMaster University","funders":"","keywords":"Medicine; Pulmonary embolism; Stroke (engine); Placebo; Asymptomatic; Internal medicine; Deep vein; Population; Clinical endpoint; Surgery; Regimen; Thrombosis; Randomized controlled trial; Pathology","score_opus":0.013164580530253182,"score_gpt":0.23972898554006727,"score_spread":0.2265644050098141,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548134605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966626,0.00017525663,0.000010298526,0.000044553082,0.00015630122,0.0017204225,0.00002060891,0.000035642053,0.0011742867],"genre_scores_gemma":[0.99924153,0.00032604014,0.000072493676,0.00007541797,0.000056602017,0.00011314807,0.000018743614,0.000027222826,0.00006881562],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976084,0.00025260958,0.00069344626,0.00042988834,0.0006982363,0.00031737608],"domain_scores_gemma":[0.99853116,0.00006940399,0.00040384696,0.00076696207,0.00015533062,0.000073272575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043869924,0.0002181414,0.0009825217,0.00043919336,0.00019476014,0.0000147687715,0.00023147557,0.00009828557,0.000039200273],"category_scores_gemma":[0.00026585703,0.00015950728,0.00027067296,0.0011985922,0.000077932855,0.00009552971,0.00015350812,0.0003077104,0.00000907229],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029725426,0.02569909,0.9608109,0.000042926666,0.0027146665,0.000027818496,0.006021008,0.00014403716,0.0005889763,0.000036184574,0.000066458466,0.0038182235],"study_design_scores_gemma":[0.0031067908,0.0013408709,0.9869496,0.000046623696,0.0056001157,0.0000023188213,0.0006742713,0.00006570232,0.002011013,0.000027325834,0.000028199685,0.00014717404],"about_ca_topic_score_codex":0.0009619181,"about_ca_topic_score_gemma":0.0013660551,"teacher_disagreement_score":0.02613871,"about_ca_system_score_codex":0.00007807257,"about_ca_system_score_gemma":0.00008133594,"threshold_uncertainty_score":0.6504518},"labels":[],"label_agreement":null},{"id":"W2548147209","doi":"10.1182/blood.v122.21.2360.2360","title":"Long-Term Outcomes Of a Small Cohort At a Single Canadian Centre Of Severe Subunit A FXIII Deficient Patients (F13A1: c.691-1G&gt;A) Treated Prophylactically With Fibrogammin P","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Memorial University of Newfoundland; St. John’s Health Sciences Centre","funders":"","keywords":"Medicine; Cohort; Factor XIII deficiency; Pediatrics; Hemarthrosis; Surgery; Factor XIII; Compound heterozygosity; Internal medicine; Allele","score_opus":0.01818853324978805,"score_gpt":0.23005811441795485,"score_spread":0.2118695811681668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548147209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940878,0.00007383873,3.5751805e-7,0.00037087096,0.000015888587,0.0018685574,0.00007111679,0.00002563083,0.0034859076],"genre_scores_gemma":[0.9944979,0.000009589582,0.00027628368,0.000032781376,0.000011767379,0.000044312546,0.0001962863,0.000037659593,0.004893422],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981216,0.000057007408,0.0003634694,0.00033209653,0.00055475946,0.00057106063],"domain_scores_gemma":[0.99823284,0.00007720629,0.00012531079,0.0004464789,0.0005651684,0.0005529648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006258121,0.00025191467,0.0005472277,0.00025272093,0.000074869444,0.000016660797,0.00012887588,0.00014005246,0.0005512792],"category_scores_gemma":[0.000082496255,0.00016212829,0.00012023027,0.00032934366,0.00016212299,0.000054703116,0.00004525429,0.00012924983,0.00007954257],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022581246,0.003513612,0.99178684,0.00027320252,0.0005522392,0.00015823146,0.00037808067,8.23085e-7,0.0024024711,0.0000048927286,0.000055651828,0.0006481674],"study_design_scores_gemma":[0.0069552925,0.0021279743,0.97293955,0.00021210349,0.00053310324,0.000037131686,0.00006081877,0.000007506438,0.016914869,0.0000017081306,0.00004368207,0.00016626893],"about_ca_topic_score_codex":0.014173402,"about_ca_topic_score_gemma":0.032556348,"teacher_disagreement_score":0.018847274,"about_ca_system_score_codex":0.00022019655,"about_ca_system_score_gemma":0.00037356888,"threshold_uncertainty_score":0.9923913},"labels":[],"label_agreement":null},{"id":"W2548166613","doi":"10.1182/blood.v124.21.4228.4228","title":"Age-Related Increases in Plasma Factor VIII and Von Willebrand Factor in a C57BL/6 Mouse Model Are Associated with Increased Factor VIII and Von Willebrand Factor Gene Expression and Reduced Expression of the Clearance Receptor, Stabilin-2","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Von Willebrand factor; Internal medicine; Endocrinology; LDL receptor; Receptor; Factor IX; Scavenger receptor; Gene expression; ADAMTS13; Spleen; Biology; Platelet; Chemistry; Molecular biology; Immunology; Lipoprotein; Gene; Medicine; Cholesterol","score_opus":0.016834526813690853,"score_gpt":0.24380063921710718,"score_spread":0.22696611240341633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548166613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969655,0.00063081074,0.0000038856674,0.00012783351,0.000029007822,0.0016322947,0.00050234457,0.000068581714,0.00003968407],"genre_scores_gemma":[0.99864006,0.00059905363,0.0002200123,0.000027257416,0.000031747917,0.000060356524,0.00007573829,0.00008504422,0.00026071703],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99658,0.00057221664,0.0006832138,0.00084252574,0.0007229881,0.00059904804],"domain_scores_gemma":[0.99797094,0.0005796093,0.0003575274,0.00052584015,0.00013954648,0.00042655607],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026808053,0.00055900594,0.0010804043,0.00034056942,0.00020341025,0.000060775645,0.00017650503,0.00051938195,0.00006467748],"category_scores_gemma":[0.00095630705,0.00034269175,0.000091842085,0.00040664338,0.00041946754,0.00030686083,0.0001978365,0.00064333936,0.0000012723232],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014994987,0.0008948254,0.41282427,0.00016643431,0.000074598705,0.000015551142,0.0014542341,0.000008924098,0.58269346,8.025909e-7,0.000009901568,0.0003574636],"study_design_scores_gemma":[0.020169465,0.00057637057,0.47079667,0.0017114001,0.0000727733,0.0000102105,0.00019700718,0.0011857968,0.5049274,0.000017473074,0.000008674003,0.00032673683],"about_ca_topic_score_codex":0.00024738396,"about_ca_topic_score_gemma":0.00024696256,"teacher_disagreement_score":0.07776606,"about_ca_system_score_codex":0.000105939034,"about_ca_system_score_gemma":0.00015423546,"threshold_uncertainty_score":0.9999025},"labels":[],"label_agreement":null},{"id":"W2548177080","doi":"10.1182/blood.v110.11.181.181","title":"Determining the Mechanism of Transformation of Follicular Lymphoma into Diffuse Large B Cell Lymphoma.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Diffuse large B-cell lymphoma; clone (Java method); Somatic hypermutation; Lymphoma; Biology; Follicular lymphoma; Immunoglobulin heavy chain; Somatic evolution in cancer; Transplantation; Cancer research; Immunology; Antibody; B cell; Medicine; Internal medicine; Genetics; Cancer; Gene","score_opus":0.00833832788639711,"score_gpt":0.23590848741574102,"score_spread":0.22757015952934392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548177080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961106,0.00035102037,0.0007033008,0.00006648462,0.0000557993,0.00039055833,0.000012038492,0.000022120803,0.0022880605],"genre_scores_gemma":[0.99895644,0.000088516725,0.0007087077,0.00012569888,0.000035269597,0.000019753294,0.000024515803,0.00001658372,0.000024487414],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989088,0.000023181588,0.00040675135,0.0001365477,0.00030591214,0.00021879762],"domain_scores_gemma":[0.99928474,0.00009478031,0.00015998384,0.0002947431,0.000089022375,0.00007671308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029780786,0.00013977401,0.00028593096,0.00008512967,0.00006557458,0.000005900421,0.00009172325,0.00008658944,0.000012200419],"category_scores_gemma":[0.000021980919,0.00009009023,0.00017968318,0.00015045956,0.000032094347,0.000060757095,0.000022500535,0.000018334234,0.000007699405],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000930609,0.19060184,0.353099,0.0024214175,0.0022935723,0.0005312917,0.042374473,0.0000021002797,0.117326245,0.03634471,0.00017117044,0.2539036],"study_design_scores_gemma":[0.045733195,0.0005208211,0.15652579,0.000105306215,0.0007105642,0.000031317984,0.0005532348,0.00005893202,0.7949264,0.00021583251,0.00051747146,0.00010112405],"about_ca_topic_score_codex":0.000066936314,"about_ca_topic_score_gemma":0.000024991781,"teacher_disagreement_score":0.6776002,"about_ca_system_score_codex":0.000051528874,"about_ca_system_score_gemma":0.00006395435,"threshold_uncertainty_score":0.36737728},"labels":[],"label_agreement":null},{"id":"W2548184432","doi":"10.1182/blood.v110.11.2649.2649","title":"Identification of SCL and LMO Oncogenes as Transcriptional Repressors of HEB/E2A in the Thymus through Functional Genomic/Genetic Approaches.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and Retrovirus Studies","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Biology; Transcription factor; Chromatin immunoprecipitation; Ectopic expression; Gene; Genetics; Repressor; Transcription (linguistics); Thymocyte; Cellular differentiation; Promoter; Molecular biology; Cell biology; Gene expression; CD8","score_opus":0.03481052727564942,"score_gpt":0.22824110578113116,"score_spread":0.19343057850548173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548184432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9719805,0.025838485,0.00018486487,0.0000882775,0.00016204959,0.00015697384,0.000023012422,0.000006526073,0.0015592988],"genre_scores_gemma":[0.99899113,0.0005248584,0.00006899161,0.0000307725,0.000029780826,0.000011003624,0.000021664906,0.000005355221,0.0003164649],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9992157,0.00007565335,0.0003443734,0.00018249996,0.000047355712,0.00013441796],"domain_scores_gemma":[0.9995892,0.00009764769,0.00012542188,0.00014874681,0.000033931825,0.0000050736476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034873732,0.00008713872,0.00016075856,0.00005355123,0.00008593163,0.0000032182536,0.0001048756,0.00011049304,0.000034801244],"category_scores_gemma":[0.000022642254,0.000061398176,0.00005850672,0.00009196079,0.00033084815,0.000030503603,0.000024759605,0.000099140474,0.000010960351],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012322386,0.00046701726,0.019189658,0.000035054836,0.00018252622,0.0000013746952,0.0027216394,0.000017434735,0.9722247,0.0034548482,0.00003372539,0.001548813],"study_design_scores_gemma":[0.001588815,0.0001147796,0.5927299,0.0000126375535,0.00013324691,0.000079814876,0.0016349095,6.611056e-7,0.40071425,0.0014551413,0.001445627,0.00009017143],"about_ca_topic_score_codex":0.0001675794,"about_ca_topic_score_gemma":0.000085370375,"teacher_disagreement_score":0.5735403,"about_ca_system_score_codex":0.000005673207,"about_ca_system_score_gemma":0.000023190241,"threshold_uncertainty_score":0.25037447},"labels":[],"label_agreement":null},{"id":"W2548198175","doi":"10.1182/blood.v112.11.403.403","title":"Trousseau’s Syndrome Revisited: Should We Screen Extensively for Malignancy in Patients with Venous Thromboembolism? a Systematic Review and Meta-Analysis","year":2008,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Malignancy; Meta-analysis; MEDLINE; Internal medicine; Surgery","score_opus":0.06991148466101335,"score_gpt":0.3180662613323949,"score_spread":0.24815477667138156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548198175","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000029698373,0.9765016,0.000022882314,0.0001798749,0.00001862991,0.022529673,0.0005370341,0.000069566246,0.00011108411],"genre_scores_gemma":[0.00011223564,0.99236387,0.00067021686,0.0012339732,0.000029145172,0.004432564,0.0007201363,0.00018926659,0.00024856805],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99461,0.00039068874,0.002139523,0.0013216304,0.00081868505,0.0007194456],"domain_scores_gemma":[0.9961268,0.00026707287,0.0013647359,0.0015727482,0.00038325225,0.00028543084],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00056558615,0.0011901363,0.028378094,0.0009844507,0.00013539741,0.000059833623,0.00038540325,0.00035469086,0.00008569929],"category_scores_gemma":[0.00017972793,0.00072613265,0.0031932537,0.00168187,0.00008472287,0.000120469675,0.00015888203,0.00041214656,0.000027826898],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000052401692,0.002400312,0.000020102672,0.7648966,0.23107138,0.0002737087,0.000043602784,1.8936406e-7,2.8162488e-9,0.00006761766,0.0005657492,0.00065549905],"study_design_scores_gemma":[0.00135562,0.0009857852,0.0006202563,0.15575029,0.8285701,0.0002674214,0.000008896973,2.9506376e-7,2.5368287e-8,0.0000065500885,0.011822504,0.0006122194],"about_ca_topic_score_codex":0.00006107906,"about_ca_topic_score_gemma":0.000021253061,"teacher_disagreement_score":0.6091463,"about_ca_system_score_codex":0.000105517676,"about_ca_system_score_gemma":0.00017484631,"threshold_uncertainty_score":0.999519},"labels":[],"label_agreement":null},{"id":"W2548224955","doi":"10.1182/blood.v122.21.3303.3303","title":"Mycophenolate Compared to Methotrexate As Part of Cyclosporine Based-GVHD Prophylaxis Does Not Affect Transplant Outcomes, Reduces Organ Specific Acute And Chronic GVHD, but Increases The Risk of CMV Viremia In Matched Related Donor Peripheral Blood Stem Cell Transplantation","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Mucositis; Internal medicine; Methotrexate; Gastroenterology; Hematopoietic stem cell transplantation; Transplantation; Graft-versus-host disease; Viremia; Surgery; Toxicity; Immunology","score_opus":0.009509223230460882,"score_gpt":0.2318016315076868,"score_spread":0.2222924082772259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548224955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995747,0.0005174368,0.00006719188,0.00019952522,0.0001282367,0.0026000694,0.00046361107,0.00007712707,0.00019976911],"genre_scores_gemma":[0.99646145,0.0015575817,0.001371078,0.00002827933,0.000036397836,0.00016130261,0.00016400899,0.00006983891,0.00015004126],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99672455,0.0004939832,0.0012010091,0.0005988466,0.0005381016,0.00044354302],"domain_scores_gemma":[0.9980513,0.0005966394,0.0004547196,0.0005304952,0.00013632076,0.00023052978],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006181975,0.0004732972,0.00110637,0.00025579953,0.000088193396,0.000030379428,0.00023254141,0.00021816319,0.0005233255],"category_scores_gemma":[0.00001708313,0.00030302815,0.00018659068,0.0005047555,0.00018586096,0.00014882098,0.000015852671,0.00037636785,0.000019625175],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090462767,0.0010875314,0.2925654,0.0018492518,0.00066926854,0.00021085584,0.00543893,0.000090679765,0.6964398,0.000012196382,0.000004000969,0.0007274506],"study_design_scores_gemma":[0.0077726794,0.0006863275,0.4146088,0.00035727574,0.0016670144,0.00011309975,0.0003749888,0.000049593527,0.5741337,0.000012400245,0.0000024340245,0.0002217099],"about_ca_topic_score_codex":0.0018144166,"about_ca_topic_score_gemma":0.00018458911,"teacher_disagreement_score":0.12230612,"about_ca_system_score_codex":0.000059926497,"about_ca_system_score_gemma":0.00018528565,"threshold_uncertainty_score":0.9999422},"labels":[],"label_agreement":null},{"id":"W2548272203","doi":"10.1182/blood.v104.11.4643.4643","title":"Preferential Induction of B Cell Apoptosis Using Photodynamic Therapy.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Apoptosis; Programmed cell death; CD19; Cancer cell; Molecular biology; Biology; Flow cytometry; Cytotoxic T cell; Cancer research; Photodynamic therapy; Rhodamine 123; Chemistry; Cancer; In vitro; Biochemistry","score_opus":0.029638862655324862,"score_gpt":0.2989860170276575,"score_spread":0.26934715437233264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548272203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980848,0.00044359243,0.00008018424,0.000048053807,0.00009401359,0.00045351702,0.000011229464,0.000045341836,0.0007392708],"genre_scores_gemma":[0.9982876,0.00059204205,0.00086480565,0.00002552951,0.000088534325,0.00001687659,0.000010485146,0.000024292722,0.00008983286],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990293,0.000028389204,0.00020473823,0.00019776417,0.00030715708,0.00023265833],"domain_scores_gemma":[0.99949205,0.000015139378,0.00008350571,0.0002454235,0.000097177915,0.000066712106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010448832,0.00012969258,0.00026048458,0.00014205308,0.0000622967,0.0000064657374,0.00008221115,0.00007478558,0.000066410845],"category_scores_gemma":[0.000019424686,0.00010751023,0.00010407741,0.00022051847,0.000097590375,0.00006036745,0.000038684117,0.00016942155,0.000005012181],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019177042,0.0012003746,0.00034765052,0.0000642341,0.00021378347,0.0000019107151,0.00035916854,0.000024491308,0.99713165,0.0000124030985,0.000002816032,0.00044972257],"study_design_scores_gemma":[0.007182306,0.00051482284,0.004590608,0.000075062024,0.00010246924,0.000019046305,0.00013043478,0.000021516846,0.98708034,0.00016510661,0.00002687695,0.000091423164],"about_ca_topic_score_codex":0.00030185745,"about_ca_topic_score_gemma":0.000010320818,"teacher_disagreement_score":0.010051347,"about_ca_system_score_codex":0.00006891476,"about_ca_system_score_gemma":0.00014118828,"threshold_uncertainty_score":0.43841398},"labels":[],"label_agreement":null},{"id":"W2548276836","doi":"10.1182/blood-2018-07-865428","title":"Genomic alterations important for the prognosis in patients with follicular lymphoma treated in SWOG study S0016","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute","keywords":"CDKN2A; Internal medicine; Follicular lymphoma; Hazard ratio; Medicine; Oncology; Progression-free survival; Chromosome abnormality; Lymphoma; Biology; Chromosome; Overall survival; Cancer; Genetics; Confidence interval","score_opus":0.010818751055209616,"score_gpt":0.24258895208941822,"score_spread":0.2317702010342086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548276836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958087,0.00018552282,0.0000018482536,0.00018816473,0.000026961492,0.0036856423,0.000021801738,0.000019068584,0.000062258005],"genre_scores_gemma":[0.9984586,0.000012614773,0.00014983761,0.00008922237,0.000057565878,0.0011385677,0.000046422538,0.00002054179,0.000026612683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99906135,0.000026748174,0.000283813,0.00026144742,0.00014933638,0.00021729991],"domain_scores_gemma":[0.9994851,0.000062603314,0.000068203415,0.00025217378,0.00008009146,0.00005184333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010484146,0.00014490086,0.000227516,0.00008811483,0.00008465901,0.000023500166,0.000061146595,0.000034961213,0.00001591872],"category_scores_gemma":[0.000022944658,0.00007800221,0.000049191,0.00022009495,0.000032690532,0.000037861024,0.000018651834,0.000020796255,0.000008687612],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002442278,0.0153052015,0.98173857,0.000006224399,0.00029890216,0.00004991146,0.00065490213,7.368972e-7,0.000024989213,0.000015697891,0.000035464866,0.0016251456],"study_design_scores_gemma":[0.036605716,0.0040269876,0.9566707,0.00005087136,0.00050940586,0.0000049720547,0.00015746623,0.00005516529,0.0017085505,0.0000057902535,0.00011515149,0.00008920099],"about_ca_topic_score_codex":0.0004485842,"about_ca_topic_score_gemma":0.0015426464,"teacher_disagreement_score":0.03636149,"about_ca_system_score_codex":0.00011314322,"about_ca_system_score_gemma":0.000077479715,"threshold_uncertainty_score":0.3180838},"labels":[],"label_agreement":null},{"id":"W2548302270","doi":"10.1182/blood.v118.21.3587.3587","title":"A High-Throughput Screen to Identify Compounds Preserving Primary Human AML Stem Cells Ex-Vivo,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal","funders":"","keywords":"Ex vivo; Stem cell; Leukemia; Biology; CD34; Myeloid leukemia; Myeloid; Population; Cancer research; Cancer stem cell; Flow cytometry; Immunology; In vivo; Cell biology; Medicine; Genetics","score_opus":0.05385136489301224,"score_gpt":0.3112405400632569,"score_spread":0.2573891751702447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548302270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9562928,0.00017458736,0.00021635157,0.00043217302,0.00021133698,0.0011796041,0.00004073828,0.00024816516,0.041204236],"genre_scores_gemma":[0.9757354,0.00002972417,0.010344836,0.00096038636,0.0006709956,0.00007379033,0.000046659083,0.00011827524,0.012019901],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971619,0.00012911885,0.0004827123,0.00065907685,0.00080047105,0.0007666732],"domain_scores_gemma":[0.99784267,0.00008525832,0.00010992783,0.0012261714,0.00022686573,0.0005091293],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00053297076,0.00030107758,0.0005666408,0.00026486194,0.00018943136,0.00007041996,0.0007043212,0.00019123737,0.0008244328],"category_scores_gemma":[0.000030118857,0.0002803713,0.00014340716,0.00043453556,0.00011302604,0.00022728239,0.0008588893,0.0005294259,0.00084114744],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029583403,0.0023327342,0.020386463,0.0006044963,0.0006861831,0.0010877155,0.003309046,0.0000015174296,0.84949666,0.0006424066,0.12027358,0.0008833642],"study_design_scores_gemma":[0.01347358,0.002346809,0.17738968,0.000634539,0.0007460283,0.00015609924,0.00069131673,0.000021760547,0.77998745,0.0003813659,0.023260469,0.0009108813],"about_ca_topic_score_codex":0.002031173,"about_ca_topic_score_gemma":0.00008002115,"teacher_disagreement_score":0.15700322,"about_ca_system_score_codex":0.00025231251,"about_ca_system_score_gemma":0.00023589203,"threshold_uncertainty_score":0.99996483},"labels":[],"label_agreement":null},{"id":"W2548326868","doi":"10.1182/blood.v110.11.52.52","title":"LMO2 Protein Expression Predicts Survival in Patients with Diffuse Large B-Cell Lymphoma in the Pre- and Post-Rituximab Treatment Eras.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Rituximab; Medicine; Internal medicine; CHOP; Lymphoma; Oncology; Germinal center; Anthracycline; Tissue microarray; BCL6; Chemotherapy regimen; International Prognostic Index; Regimen; Chemotherapy; Immunohistochemistry; Immunology; Cancer; B cell; Antibody","score_opus":0.005175678119563806,"score_gpt":0.2138879122406205,"score_spread":0.20871223412105672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548326868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99648476,0.0004796899,0.0000017970507,0.000112933114,0.000024440315,0.0020922276,0.000041952997,0.000025190795,0.0007369854],"genre_scores_gemma":[0.9991669,0.00003752599,0.00017888531,0.000113668626,0.00003885045,0.00024670636,0.00009239195,0.000022657443,0.00010242497],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985533,0.000076436314,0.00026227042,0.0003427445,0.00037451857,0.0003907794],"domain_scores_gemma":[0.99934214,0.00009126031,0.000072373005,0.00033525738,0.00004159094,0.00011738656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021181653,0.0002393674,0.00031599926,0.00011376866,0.00006159245,0.000024744062,0.00006908194,0.00009227606,0.000007118466],"category_scores_gemma":[0.000022976234,0.00012640581,0.000041564672,0.000157516,0.000033210552,0.00007742512,0.00003667946,0.000055299184,0.0000056859276],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011160828,0.10702271,0.88636,0.000043651333,0.000041146428,0.00034686003,0.0016844311,1.04371736e-7,0.0004541431,0.000020143481,0.0000070007577,0.0029037315],"study_design_scores_gemma":[0.15767129,0.0027485415,0.82682735,0.00022033701,0.000107766995,0.000010554463,0.0002040439,0.0000027271124,0.011927153,0.0000043382424,0.00016488876,0.00011104068],"about_ca_topic_score_codex":0.00036075755,"about_ca_topic_score_gemma":0.00041681467,"teacher_disagreement_score":0.15655519,"about_ca_system_score_codex":0.00013961048,"about_ca_system_score_gemma":0.000072860574,"threshold_uncertainty_score":0.51546794},"labels":[],"label_agreement":null},{"id":"W2548341899","doi":"10.1182/blood-2016-06-722249","title":"Impact of CTLA4 genotype and other immune response gene polymorphisms on outcomes after single umbilical cord blood transplantation","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"Fundação de Amparo à Pesquisa do Estado de São Paulo; National Institute for Health and Care Research","keywords":"Genotype; Immune system; Umbilical cord; Umbilical Cord Blood Transplantation; Immunology; Transplantation; Biology; Cord blood; Gene; Medicine; Genetics; Human leukocyte antigen; Internal medicine; Antigen","score_opus":0.017895988632001255,"score_gpt":0.27561703742504606,"score_spread":0.2577210487930448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548341899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984459,0.00021655357,0.00023021286,0.0002826394,0.000045082936,0.00036163107,0.00014745771,0.000045520355,0.00022496552],"genre_scores_gemma":[0.998735,0.000059484057,0.00072400866,0.00010809627,0.0000347941,0.00002169034,0.000010024322,0.000041406845,0.00026546448],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99873024,0.00011252449,0.00038806148,0.00027082735,0.00026951806,0.00022882609],"domain_scores_gemma":[0.9990198,0.00038955334,0.00009476998,0.0003165738,0.000050233375,0.00012908221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023675806,0.00019574614,0.0003721186,0.00014059265,0.000024671783,0.000007552045,0.00005416897,0.00013239517,0.00029923161],"category_scores_gemma":[0.00005372571,0.0001226078,0.00015149185,0.0000981322,0.000096723634,0.000048322923,0.000006252301,0.000068530964,0.00003580695],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008927556,0.00089162675,0.2742989,0.00006374934,0.00022369377,0.000117336545,0.00043301872,1.3428627e-7,0.7144377,0.000015434016,0.0000018364277,0.000588959],"study_design_scores_gemma":[0.0068986025,0.0017515663,0.63577974,0.00021374521,0.000512648,0.00041641566,0.000005054256,5.899925e-7,0.35429156,0.00001789861,0.0000070632327,0.000105128915],"about_ca_topic_score_codex":0.00006172308,"about_ca_topic_score_gemma":0.0000059033237,"teacher_disagreement_score":0.36148083,"about_ca_system_score_codex":0.00002414125,"about_ca_system_score_gemma":0.00006619087,"threshold_uncertainty_score":0.4999801},"labels":[],"label_agreement":null},{"id":"W2548371395","doi":"10.1182/blood.v124.21.3039.3039","title":"Transfusion History and Risk of Non-Hodgkin Lymphoma (NHL): an Interlymph Pooled Analysis","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Odds ratio; Internal medicine; Confidence interval; Relative risk; Blood transfusion; Follicular lymphoma; Risk factor; Chronic lymphocytic leukemia; Confounding; Cohort; Lymphoma; Leukemia","score_opus":0.009105009205201192,"score_gpt":0.25619581730963703,"score_spread":0.24709080810443584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548371395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953186,0.0008413688,0.0011331022,0.00002874043,0.000054499706,0.00022660755,0.000007927977,0.00004190768,0.0023472682],"genre_scores_gemma":[0.99788445,0.0005127677,0.0009148355,0.000056792232,0.000109080014,0.0000131291945,0.000024095561,0.000028184173,0.00045668162],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99837214,0.00016834908,0.00034847428,0.00040230493,0.00042863213,0.0002801271],"domain_scores_gemma":[0.99869406,0.00015008418,0.00011154381,0.00065987906,0.00011634078,0.00026809884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063939753,0.00016754752,0.00055436156,0.00039981076,0.00004205024,0.000008405237,0.00015062743,0.00014108648,0.00019616945],"category_scores_gemma":[0.00015508468,0.000142574,0.00019417096,0.00035478504,0.00019039617,0.00007667694,0.0000495606,0.00009678198,0.000012162992],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035406854,0.010419883,0.20458709,0.0016757833,0.01766474,0.00037587393,0.014702021,0.000079212405,0.17248866,0.00026689994,0.0011028151,0.57309633],"study_design_scores_gemma":[0.2245321,0.0052959565,0.43652079,0.00038881274,0.040290557,0.0005451726,0.00070764095,0.20115313,0.08405358,0.00016425975,0.0054331594,0.0009148519],"about_ca_topic_score_codex":0.004826135,"about_ca_topic_score_gemma":0.00052104064,"teacher_disagreement_score":0.57218146,"about_ca_system_score_codex":0.0019860698,"about_ca_system_score_gemma":0.0012867684,"threshold_uncertainty_score":0.72957045},"labels":[],"label_agreement":null},{"id":"W2548373121","doi":"10.1182/blood.v104.11.1770.1770","title":"Retrospective Analysis of the Minimum Dosage Requirements for Enoxaparin in Neonates with Thromboembolic Disease.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"","keywords":"Medicine; Low molecular weight heparin; Gestational age; Retrospective cohort study; Surgery; Sepsis; Thrombosis; Inferior vena cava; Enoxaparin sodium; Pregnancy","score_opus":0.022099131080618676,"score_gpt":0.2778130714462587,"score_spread":0.25571394036564005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548373121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978016,0.00009200334,0.00038991516,0.00048395662,0.000038436545,0.00065775827,0.000031629836,0.000021769521,0.0004829145],"genre_scores_gemma":[0.9988536,0.000009854267,0.0007488873,0.00021164071,0.000023859706,0.000054762888,0.00002496359,0.000015847538,0.00005658674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99903065,0.000021049507,0.00023751945,0.00024371926,0.0002888382,0.00017821504],"domain_scores_gemma":[0.99932325,0.000018224764,0.00012314484,0.00037005224,0.00008823018,0.000077081364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000120565834,0.000120777426,0.0004139684,0.00018574118,0.000047938905,0.000008019254,0.00010365198,0.000046650614,0.000037339494],"category_scores_gemma":[0.000054716482,0.00007872428,0.00017056406,0.0009653192,0.00005992232,0.000048771202,0.00003096455,0.00007238356,0.000001330489],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022084426,0.0029429425,0.9384822,0.00009231074,0.0033317236,0.000009238665,0.00096202653,0.0003134534,0.029622862,0.023862101,0.000007998665,0.00015225828],"study_design_scores_gemma":[0.00621606,0.00025963518,0.9523238,0.00012375877,0.0043515735,0.0000011134886,0.00009870527,0.00013341602,0.032792386,0.0035965731,0.000012170584,0.000090819725],"about_ca_topic_score_codex":0.000058952417,"about_ca_topic_score_gemma":0.0002086004,"teacher_disagreement_score":0.020265527,"about_ca_system_score_codex":0.000048024438,"about_ca_system_score_gemma":0.00010367121,"threshold_uncertainty_score":0.3210283},"labels":[],"label_agreement":null},{"id":"W2548468823","doi":"10.1182/blood.v112.11.1292.1292","title":"Indirect Comparisons of Rivaroxaban Versus Alternative Prophylaxes for the Prevention of VTE in Patients Undergoing Total Knee Replacement.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Rivaroxaban; Medicine; Fondaparinux; Dabigatran; Knee replacement; Warfarin; Anesthesia; Pulmonary embolism; Thrombosis; Surgery; Internal medicine; Arthroplasty; Venous thromboembolism; Atrial fibrillation","score_opus":0.03335476945763836,"score_gpt":0.2823349681530233,"score_spread":0.24898019869538493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548468823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99721456,0.0001388367,0.00014251586,0.000049818518,0.00017136663,0.0013634647,0.0000116799465,0.0000088955,0.0008988602],"genre_scores_gemma":[0.99896276,0.00008218323,0.0006805535,0.00001110184,0.000034942328,0.00009058946,0.00001941294,0.000010900734,0.00010754823],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991687,0.000037850965,0.00029263372,0.00014572937,0.00022107674,0.00013400569],"domain_scores_gemma":[0.99931186,0.00019048768,0.00021231089,0.00019173988,0.000070366346,0.000023251143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016249093,0.00008626541,0.00030722705,0.0000921095,0.000058720318,0.000002553988,0.00005814004,0.00002734121,0.0000131932975],"category_scores_gemma":[0.00013915429,0.00006465562,0.0000911333,0.0001246485,0.00005371818,0.000040038176,0.000050924173,0.000064907385,0.0000012211813],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004054243,0.028638082,0.94367814,0.0012341777,0.0037883967,0.000010226225,0.007853472,0.0005828296,0.0011276318,0.0022116546,0.0029614486,0.0038597062],"study_design_scores_gemma":[0.021333963,0.006827575,0.95161235,0.00028767495,0.0005175275,0.0000012702487,0.0004862001,0.00016429902,0.018482123,0.000056693123,0.00013306248,0.00009725169],"about_ca_topic_score_codex":0.000099832905,"about_ca_topic_score_gemma":0.00007347062,"teacher_disagreement_score":0.021810507,"about_ca_system_score_codex":0.000029157374,"about_ca_system_score_gemma":0.000051325365,"threshold_uncertainty_score":0.263658},"labels":[],"label_agreement":null},{"id":"W2548536694","doi":"10.1182/blood.v122.21.3864.3864","title":"The Development Of Venous Thromboembolism May Increase The Risk Of Osteonecrosis In Children With Acute Lymphoblastic Leukemia","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Bone and Joint Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster Children's Hospital; McMaster University","funders":"","keywords":"Medicine; Asymptomatic; Pediatrics; Odds ratio; Medical record; Thrombophilia; Internal medicine; Surgery; Radiology; Thrombosis","score_opus":0.005108726352319696,"score_gpt":0.20793477415580205,"score_spread":0.20282604780348235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548536694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984852,0.0004123115,0.000006654052,0.000089538975,0.0000122764695,0.0005572706,0.000018715413,0.000012520085,0.00040552087],"genre_scores_gemma":[0.99913734,0.00013746675,0.0005021938,0.00006125574,0.000017326063,0.000067767316,0.000010212275,0.000015525091,0.00005093479],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990737,0.00005380537,0.00031169128,0.00013182493,0.00023491401,0.00019409777],"domain_scores_gemma":[0.99922055,0.00012727396,0.00016402744,0.00033767876,0.000075921525,0.00007453226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016114788,0.000121387166,0.00031639336,0.000043269905,0.00009826979,0.000010591198,0.00012492943,0.00004164876,0.00003116364],"category_scores_gemma":[0.000074628006,0.000056853434,0.000056407825,0.0001710175,0.0001609578,0.00003830514,0.000056294313,0.00009791597,0.000019178573],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023178014,0.001441156,0.9803403,0.00006050413,0.0019536628,0.0000097239445,0.0019587688,0.000009408377,0.0042974777,0.000056162124,0.00031101512,0.009330057],"study_design_scores_gemma":[0.0028557458,0.00021690871,0.9817836,0.00012991246,0.000951739,0.000048121117,0.0002490945,0.00001005868,0.01358308,0.000066278735,0.00003100475,0.00007440105],"about_ca_topic_score_codex":0.0020906215,"about_ca_topic_score_gemma":0.00022235728,"teacher_disagreement_score":0.009285602,"about_ca_system_score_codex":0.00003216366,"about_ca_system_score_gemma":0.0005586506,"threshold_uncertainty_score":0.31604084},"labels":[],"label_agreement":null},{"id":"W2548695469","doi":"10.1182/blood.v118.21.2672.2672","title":"MLN9708, a Novel, Investigational Proteasome Inhibitor, in Patients with Relapsed/Refractory Lymphoma: Results of a Phase 1 Dose-Escalation Study","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Bortezomib; Proteasome inhibitor; Pharmacokinetics; Pharmacology; Pharmacodynamics; Internal medicine; Adverse effect; Cmax; Phases of clinical research; Nausea; Gastroenterology; Surgery; Toxicity; Multiple myeloma","score_opus":0.02059746084414802,"score_gpt":0.2312924847047498,"score_spread":0.2106950238606018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548695469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99787724,0.000041273455,0.000024004214,0.000006273635,0.000038305043,0.0010517314,0.000107620064,0.000012026053,0.00084151415],"genre_scores_gemma":[0.9983007,0.0000016331381,0.0012023576,0.000025170157,0.00006838701,0.00012092439,0.00021387,0.000021746544,0.00004521799],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876577,0.00008000193,0.00037108015,0.0003577916,0.00024623206,0.00017912303],"domain_scores_gemma":[0.9992306,0.00000968443,0.00022271328,0.0003081866,0.00014802876,0.00008075748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002453902,0.00016267711,0.00016148729,0.00008465203,0.000037843787,0.000007430463,0.00013065564,0.00012366431,0.000009108567],"category_scores_gemma":[0.00014678409,0.00014240699,0.000035917517,0.00016419485,0.000081614286,0.000013307781,0.00006449602,0.00007407225,0.0000033437802],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006888274,0.05565743,0.59999955,0.00007479857,0.00022856564,0.000011378064,0.0029745742,0.0000054533066,0.3316604,0.000077795616,0.000099150515,0.002322651],"study_design_scores_gemma":[0.06305215,0.008786525,0.544079,0.00007448969,0.000052347867,0.0000028675165,0.0001127431,0.000006423649,0.38322654,0.00005214409,0.00026942554,0.000285326],"about_ca_topic_score_codex":0.00006922643,"about_ca_topic_score_gemma":0.00004836798,"teacher_disagreement_score":0.05616387,"about_ca_system_score_codex":0.000012246375,"about_ca_system_score_gemma":0.00017394923,"threshold_uncertainty_score":0.5807188},"labels":[],"label_agreement":null},{"id":"W2548713733","doi":"10.1182/blood.v108.11.4112.4112","title":"Frequency of “Special Population” Characteristics among Venous Thromboembolism Patients in Clinical Practice: Implications for Anticoagulant Therapy.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Victoria Hospital; McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Dosing; Low molecular weight heparin; Population; Venous thromboembolism; Cancer; Medical record; Internal medicine; Renal function; Thrombosis; Adverse effect; Heparin; Surgery; Intensive care medicine","score_opus":0.022844767606152824,"score_gpt":0.3257986658006798,"score_spread":0.30295389819452695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548713733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957185,0.000108882894,0.000055328837,0.00044185034,0.0003328035,0.0015162043,0.000086949156,0.000028681889,0.0017108094],"genre_scores_gemma":[0.9954316,0.00037911662,0.002162729,0.000245362,0.0011782455,0.00011660122,0.00043920122,0.000030769337,0.000016366821],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827087,0.000053156346,0.0009366193,0.00028962147,0.0001936586,0.00025608065],"domain_scores_gemma":[0.99871224,0.00017528729,0.00043030357,0.00035622492,0.00026394473,0.00006201337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003331773,0.00014876855,0.0007006493,0.00012045106,0.00007030596,0.000017066091,0.000106117426,0.00012627608,0.000022998473],"category_scores_gemma":[0.00032794086,0.00013770568,0.00014954437,0.00016489219,0.00006391985,0.000117897674,0.000030017767,0.000121478166,0.0000045455345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025780098,0.017253632,0.967474,0.00005705135,0.00012742908,0.000003608671,0.00010160429,0.0000014680339,0.00012416767,0.007994171,0.00084204855,0.00599505],"study_design_scores_gemma":[0.004087763,0.0005321245,0.99225557,0.00006729445,0.00036893712,0.0000026437099,0.000020477106,0.00000471441,0.000082930404,0.0017425313,0.0007039721,0.00013104161],"about_ca_topic_score_codex":0.0010752643,"about_ca_topic_score_gemma":0.00012053643,"teacher_disagreement_score":0.024781581,"about_ca_system_score_codex":0.000031181964,"about_ca_system_score_gemma":0.000056427747,"threshold_uncertainty_score":0.56154746},"labels":[],"label_agreement":null},{"id":"W2548849692","doi":"10.1182/blood.v114.22.3143.3143","title":"Age of Red Blood Cell Units Transfused in Canada.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Medical Association; Ottawa Hospital","funders":"","keywords":"Medicine; ABO blood group system; Blood transfusion; Observational study; Adverse effect; Red blood cell; Pediatrics; Internal medicine","score_opus":0.010477817740456273,"score_gpt":0.19726627342369843,"score_spread":0.18678845568324215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548849692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891653,0.00042267476,0.000007456565,0.0006093525,0.000040807096,0.00026964437,0.000013947502,0.000019067458,0.009451716],"genre_scores_gemma":[0.99915075,0.000137262,0.00019684133,0.00028410944,0.000037109912,0.0000028818893,0.000031386393,0.000012837576,0.00014683927],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990368,0.000025232714,0.00028729296,0.00018463764,0.0002389238,0.00022713859],"domain_scores_gemma":[0.9995424,0.000023099936,0.000034429242,0.0002340268,0.00005111273,0.00011489765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000077886616,0.00012225362,0.00031708073,0.000086817054,0.000019312974,0.0000027184462,0.00007530984,0.000071748706,0.000054466775],"category_scores_gemma":[0.000012169014,0.000111141424,0.00004203094,0.0004473481,0.000014424434,0.000026786787,0.0000034607267,0.00018462483,9.543431e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002616168,0.0046191844,0.0932665,0.000271503,0.000108997236,0.002367616,0.0007710881,0.000008129192,0.8948834,0.00017457147,0.000198161,0.0030692255],"study_design_scores_gemma":[0.022040047,0.000839547,0.43783808,0.00021087326,0.00065840024,0.000068126996,0.00017212293,0.00000949567,0.5370266,0.00007621964,0.00086550217,0.00019500259],"about_ca_topic_score_codex":0.26471445,"about_ca_topic_score_gemma":0.5738394,"teacher_disagreement_score":0.35785684,"about_ca_system_score_codex":0.000018161947,"about_ca_system_score_gemma":0.00056218996,"threshold_uncertainty_score":0.74018186},"labels":[],"label_agreement":null},{"id":"W2548905028","doi":"10.1182/blood.v116.21.1129.1129","title":"Identification of a Novel Coagulation Factor X Compound Heterozygous Mutation Associated with Differential Initiating Clotting Pathway Function.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; Providence Health Care; Canadian Blood Services; University of British Columbia","funders":"","keywords":"Bleeding diathesis; Partial thromboplastin time; Haemophilia A; Coagulation; Compound heterozygosity; Clotting factor; Exon; Factor V; Haemophilia; Medicine; Mutation; Internal medicine; Immunology; Gastroenterology; Biology; Endocrinology; Genetics; Gene; Surgery; Platelet; Thrombosis","score_opus":0.03638563637076592,"score_gpt":0.287236138019206,"score_spread":0.2508505016484401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548905028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975564,0.000009355161,0.00164784,0.00004533606,0.00011457164,0.00038927828,0.000030051986,0.000060236816,0.00014695525],"genre_scores_gemma":[0.99926496,7.363402e-7,0.00017763501,0.000007883296,0.00008136794,0.000020072877,0.00031561079,0.00001916053,0.000112565445],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989626,0.000030982927,0.00030218452,0.00017656309,0.00037452494,0.00015318295],"domain_scores_gemma":[0.9991757,0.00012171454,0.00022783357,0.00014601232,0.00027751052,0.000051177325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013424606,0.000102615624,0.0001772852,0.00011515428,0.00012027214,0.000030180856,0.000035742032,0.00010216439,0.00004642352],"category_scores_gemma":[0.0002356121,0.00007870041,0.000049281338,0.00017498375,0.000053257743,0.0001053043,0.00001297797,0.00019624054,0.0000045598954],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008368321,0.0013489831,0.09132928,0.000047646437,0.00019713063,0.000010230343,0.00032857995,0.000004989721,0.9049115,0.000040383908,0.000001037129,0.0016965406],"study_design_scores_gemma":[0.006617834,0.0004514773,0.78238535,0.00009444815,0.00023334868,0.00004054302,0.00009289907,0.0033444462,0.20661755,0.000019986966,0.0000035662297,0.000098574434],"about_ca_topic_score_codex":0.000019683304,"about_ca_topic_score_gemma":0.000035776015,"teacher_disagreement_score":0.698294,"about_ca_system_score_codex":0.000022570954,"about_ca_system_score_gemma":0.00006923457,"threshold_uncertainty_score":0.32093096},"labels":[],"label_agreement":null},{"id":"W2548934232","doi":"10.1182/blood.v104.11.905.905","title":"GDP (Gemcitabine, Dexamethasone, Cisplatin) Salvage Therapy Results in Superior Progression Free Survival Compared to Mini-Beam Prior to Autologous Stem Cell Transplantation for Relapsed or Refractory Hodgkin’s Lymphoma.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Etoposide; Salvage therapy; Gemcitabine; Autologous stem-cell transplantation; Internal medicine; Melphalan; Cytarabine; Filgrastim; Chemotherapy; Surgery; Transplantation; Oncology; Urology; Gastroenterology; Neutropenia","score_opus":0.028379540135469047,"score_gpt":0.29464323430954714,"score_spread":0.2662636941740781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548934232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920667,0.00049269927,0.00014414679,0.001504568,0.00030250716,0.0045444607,0.0004866802,0.00016348762,0.00029475894],"genre_scores_gemma":[0.972335,0.00019754573,0.024991682,0.0005315437,0.00012810092,0.0012072544,0.00026711664,0.00008108825,0.00026071272],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9970732,0.00010915448,0.00082429725,0.0008298315,0.00054257206,0.00062096096],"domain_scores_gemma":[0.9979941,0.0005750544,0.00017654426,0.00072655943,0.00014120886,0.0003865376],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004512974,0.00044617374,0.00080825505,0.00031070894,0.00013654889,0.00005291876,0.0002508455,0.00025308126,0.000016009437],"category_scores_gemma":[0.00013833474,0.00033181522,0.0001725888,0.0004942833,0.000038555358,0.00012613072,0.000037995014,0.000098527315,0.000036576308],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12815277,0.049591944,0.11386975,0.0013814206,0.00094494224,0.0047858665,0.037721984,0.00038097007,0.14290321,0.00011252683,0.002766916,0.5173877],"study_design_scores_gemma":[0.12913704,0.0077056233,0.66538674,0.00085448596,0.00033929592,0.00011046716,0.0004541099,0.00001305164,0.19255327,0.000015234527,0.0029157957,0.0005148785],"about_ca_topic_score_codex":0.00039028504,"about_ca_topic_score_gemma":0.0009321499,"teacher_disagreement_score":0.551517,"about_ca_system_score_codex":0.00038182648,"about_ca_system_score_gemma":0.00047970054,"threshold_uncertainty_score":0.9999134},"labels":[],"label_agreement":null},{"id":"W2548935397","doi":"10.1182/blood.v116.21.1861.1861","title":"Prognostic Impact of Monosomy 7 as a Single Anomaly In Primary MDS – Reclassification From Poor to Intermediate Prognosis","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"International Prognostic Scoring System; Myelodysplastic syndromes; Univariate analysis; Monosomy; Internal medicine; Medicine; Multivariate analysis; Chromosome abnormality; Oncology; Chemotherapy regimen; Bone marrow; Pediatrics; Chemotherapy; Karyotype; Biology; Genetics","score_opus":0.01917499101201396,"score_gpt":0.2964932101345466,"score_spread":0.2773182191225326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548935397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953175,0.00005623028,0.000015338166,0.000891216,0.0000642923,0.001351829,0.000040773786,0.000055578203,0.0022072222],"genre_scores_gemma":[0.9953421,0.00001043771,0.0037977244,0.00013070775,0.00017896567,0.00022259285,0.00012643907,0.000041013893,0.00015005813],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984338,0.000060665145,0.0004054956,0.00038834047,0.00034555155,0.00036610436],"domain_scores_gemma":[0.9987711,0.00021631537,0.00011710899,0.0004401101,0.00017763056,0.00027774053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024965385,0.00017714305,0.00037945228,0.00036022742,0.000021747574,0.000025071351,0.00023122714,0.00017332286,0.0001869356],"category_scores_gemma":[0.0011973795,0.00014747343,0.00011755748,0.0005470569,0.00008983814,0.00011372775,0.00011341482,0.00048045,0.00012741733],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025595026,0.0012565427,0.46821916,0.000039479695,0.00007792394,0.000044209894,0.00028911338,3.033103e-7,0.52260125,0.0000038717585,0.00018763806,0.0070245494],"study_design_scores_gemma":[0.0028766647,0.0014033173,0.8773473,0.00016696277,0.000113594964,0.000029719462,0.00004147654,0.00009977659,0.11762169,0.000041956115,0.00013253841,0.0001250341],"about_ca_topic_score_codex":0.0011519068,"about_ca_topic_score_gemma":0.0001324237,"teacher_disagreement_score":0.40912813,"about_ca_system_score_codex":0.00023176796,"about_ca_system_score_gemma":0.0007336199,"threshold_uncertainty_score":0.60137916},"labels":[],"label_agreement":null},{"id":"W2548957629","doi":"10.1182/blood.v106.11.2870.2870","title":"Role of Jak3 in Chronic Myeloid Leukemia: Evidence To Identify Jak3 as a Potential Therapeutic Target.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Myeloid leukemia; Imatinib mesylate; Cancer research; K562 cells; Imatinib; Tyrosine kinase; ABL; Biology; Nilotinib; Philadelphia chromosome; Leukemia; Immunology; Chromosomal translocation; Signal transduction; Cell biology; Genetics; Gene","score_opus":0.015271822040073057,"score_gpt":0.30017312717276945,"score_spread":0.2849013051326964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548957629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97580504,0.020732397,0.00004489899,0.00070715783,0.000084445004,0.00093424745,0.000007784806,0.00006781893,0.0016161754],"genre_scores_gemma":[0.99599385,0.0005458821,0.0013263753,0.00045336725,0.00048235542,0.00010649829,0.000014701419,0.00005611217,0.0010208343],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99751234,0.000078458885,0.0006043939,0.0005678294,0.0006256599,0.00061132765],"domain_scores_gemma":[0.9986921,0.00008957975,0.00014422489,0.00072490604,0.00010018304,0.00024900286],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029932283,0.00031364104,0.00056516065,0.0002902794,0.000050769846,0.000022533543,0.0003037638,0.00020917598,0.0008663424],"category_scores_gemma":[0.00014753957,0.00029403594,0.00019042501,0.00049859885,0.00007458199,0.00022439938,0.00013946103,0.00036535307,0.00075073383],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005042197,0.0013270302,0.02392048,0.00028441456,0.00053226104,0.0002504949,0.0013569822,0.0011730149,0.92536724,0.00013115146,0.0002436143,0.044909097],"study_design_scores_gemma":[0.021045694,0.0021988843,0.3294579,0.0017544974,0.0010415085,0.0006841687,0.0003438989,0.0014101929,0.6339808,0.0004901754,0.006943963,0.0006482934],"about_ca_topic_score_codex":0.0008372106,"about_ca_topic_score_gemma":0.00027437747,"teacher_disagreement_score":0.30553743,"about_ca_system_score_codex":0.0027919337,"about_ca_system_score_gemma":0.0021422252,"threshold_uncertainty_score":0.9999512},"labels":[],"label_agreement":null},{"id":"W2548959564","doi":"10.1182/blood.v126.23.1395.1395","title":"Estrogen Receptor Beta Is a Novel Target in Acute Myeloid Leukemia","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Waterloo","funders":"","keywords":"Myeloid leukemia; Leukemia; Cancer research; Apoptosis; Clonogenic assay; Stem cell; Biology; Programmed cell death; Pharmacology; Immunology; Cell biology; Biochemistry","score_opus":0.031985633874293366,"score_gpt":0.28712739920304575,"score_spread":0.2551417653287524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548959564","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6557365,0.0003188299,0.33993715,0.0014255088,0.0004386886,0.00019756371,0.000034022873,0.00013079339,0.0017809536],"genre_scores_gemma":[0.13885926,0.000007431374,0.85985893,0.0007716833,0.00014706269,0.000030050218,0.000016075724,0.000019361329,0.00029014473],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9985015,0.00009363376,0.00025440386,0.0004389377,0.00041285364,0.00029870655],"domain_scores_gemma":[0.9990904,0.00011473195,0.000078179066,0.00045602678,0.000091151414,0.0001695134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055822666,0.0001528282,0.00020218501,0.00013765675,0.000033168588,0.00011418199,0.0008889941,0.000064236076,0.000014236779],"category_scores_gemma":[0.00007203552,0.00015461398,0.000068112364,0.00059044064,0.00002959259,0.00051105075,0.00042317403,0.00015502483,0.00016294174],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023130317,0.0064021572,0.09148115,0.00012747505,0.0015502971,0.00046732152,0.03337999,0.08291161,0.06847036,0.596297,0.04718971,0.071491584],"study_design_scores_gemma":[0.021274166,0.0008637296,0.04485088,0.00017332469,0.00017383418,0.00043163728,0.00025115945,0.5027998,0.22050108,0.094183534,0.11174172,0.0027551465],"about_ca_topic_score_codex":0.0000618841,"about_ca_topic_score_gemma":0.0000031861725,"teacher_disagreement_score":0.5199218,"about_ca_system_score_codex":0.0001293257,"about_ca_system_score_gemma":0.0006469635,"threshold_uncertainty_score":0.6304976},"labels":[],"label_agreement":null},{"id":"W2548996487","doi":"10.1182/blood.v112.11.1885.1885","title":"Taxanes Induce a Rapid Mobilization of Different Populations of Circulating Endothelial Progenitors by SDF-1 Modulation in Cancer Patients.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Pharmacology; Gemcitabine; Cancer; Cyclophosphamide; Progenitor cell; Drug; Chemotherapy; Cancer research; Internal medicine; Stem cell; Biology","score_opus":0.02266006081426152,"score_gpt":0.2592610918289192,"score_spread":0.23660103101465768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548996487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987297,0.0007165801,0.00014165597,0.000004852719,0.00007077814,0.00021916187,0.00008176803,0.000003390744,0.00003208599],"genre_scores_gemma":[0.9993299,0.00017585467,0.00010185805,0.000007428581,0.000073152965,0.000053782707,0.00022729335,0.000013382581,0.000017297087],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993063,0.000034314486,0.00027770907,0.00016366676,0.00011939511,0.000098578064],"domain_scores_gemma":[0.999576,0.000004537413,0.00018414766,0.000116856456,0.00009682474,0.000021641663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000032450425,0.00008825792,0.00012831338,0.00004331533,0.000033346787,0.0000016587744,0.000056503308,0.00008828367,0.000012333102],"category_scores_gemma":[0.000029510113,0.00008324989,0.00006350619,0.00009903338,0.000035999154,0.0000044435055,0.0000226288,0.000023753273,1.2188985e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000101711385,0.0003326412,0.5316929,0.000015631284,0.000017385079,8.6101885e-8,0.00006906815,0.00028027734,0.46676448,0.000006748266,0.000018161916,0.00079241104],"study_design_scores_gemma":[0.00090926257,0.00012469132,0.31302834,0.00002135512,0.000022129232,9.4897456e-7,0.000017629658,0.00016615204,0.685565,0.000010132943,0.00004417214,0.00009021045],"about_ca_topic_score_codex":0.00017315632,"about_ca_topic_score_gemma":0.000054329063,"teacher_disagreement_score":0.2188005,"about_ca_system_score_codex":0.000011103076,"about_ca_system_score_gemma":0.000034945457,"threshold_uncertainty_score":0.3394832},"labels":[],"label_agreement":null},{"id":"W2549035250","doi":"10.1182/blood.v106.11.466.466","title":"MicroRNA Expression Profiling in Sorted AML Subpopulations: A Possible Role for miR-155/BIC in Stem Cell Maintenance and Leukemogenesis.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Biology; microRNA; Stem cell; Embryonic stem cell; Haematopoiesis; Gene expression profiling; Cancer research; Gene; Regulation of gene expression; Hematopoietic stem cell; Gene expression; Genetics; Cell biology","score_opus":0.008849604532199093,"score_gpt":0.22922894083401996,"score_spread":0.22037933630182086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549035250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946121,0.004436948,0.00023931502,0.00004311199,0.000017920318,0.0005565251,0.00002468613,0.000010497201,0.000058886282],"genre_scores_gemma":[0.9947018,0.0000782084,0.0045965207,0.000038109123,0.00007327079,0.00011282415,0.00013117281,0.000023941406,0.00024412865],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99909735,0.000039964536,0.00026185223,0.00030577133,0.000059633723,0.00023545627],"domain_scores_gemma":[0.9996069,0.000009731507,0.00008920985,0.00020345754,0.000040170587,0.00005053893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013202094,0.00012913771,0.00012646936,0.00008143114,0.00004219557,0.00001893479,0.00008805541,0.00013379687,0.0000027572778],"category_scores_gemma":[0.00001515919,0.00013270314,0.000043891392,0.00009604359,0.000021779331,0.000010170139,0.00005031593,0.000045119512,0.0000018800836],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007900602,0.00019292942,0.045425918,0.00005520312,0.000005940902,0.0000012272608,0.00005234322,0.00027922323,0.95316964,0.000007847146,0.00004505427,0.00068569055],"study_design_scores_gemma":[0.0027199874,0.00004307518,0.042843096,0.00006371315,0.000015881824,0.000007224083,0.00009083272,0.0007325622,0.95261806,0.000048240094,0.00065437425,0.00016293363],"about_ca_topic_score_codex":0.000013844424,"about_ca_topic_score_gemma":0.00016215391,"teacher_disagreement_score":0.0043587396,"about_ca_system_score_codex":0.000028081415,"about_ca_system_score_gemma":0.00006242659,"threshold_uncertainty_score":0.5411477},"labels":[],"label_agreement":null},{"id":"W2549039174","doi":"10.1182/blood.v126.23.2326.2326","title":"Association Between Hospitalization for Acute Medical Illness and VTE Risk: A Lower Efficacy of Thromboprophylaxis in Elderly Patients? Results from the Edith Case-Control Study","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Fondaparinux; Medical prescription; Asymptomatic; Low molecular weight heparin; Internal medicine; Heparin; Venous thromboembolism; Surgery; Emergency medicine; Thrombosis","score_opus":0.010783913053146828,"score_gpt":0.26896810305328256,"score_spread":0.2581841900001357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549039174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99569875,0.00009358377,0.0001844942,0.0005705051,0.00026815757,0.0025254786,0.0005892609,0.000020053305,0.00004971737],"genre_scores_gemma":[0.99919444,0.000042762735,0.00007328402,0.000077327844,0.0003683381,0.0000949671,0.000120820456,0.000018629205,0.00000941083],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998295,0.00015790011,0.00046908078,0.00029081534,0.0005967345,0.00019047155],"domain_scores_gemma":[0.9983226,0.0007229399,0.00032930262,0.00026256999,0.0002491514,0.000113435104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011832968,0.00013420108,0.00049665273,0.00005460571,0.00007872746,0.000022676488,0.00009137524,0.00012190889,0.000008805104],"category_scores_gemma":[0.0026411004,0.00009176693,0.000055961922,0.00015885351,0.00003061765,0.00007053868,0.00005152219,0.00012852334,0.0000019135157],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002970435,0.0053717457,0.97217584,0.000013751276,0.002612482,0.00005830054,0.0067423233,0.000004047869,0.0000019223871,0.000007005052,0.0022285965,0.010486968],"study_design_scores_gemma":[0.038522795,0.0034794612,0.9526355,0.00006817864,0.0040562726,0.0000011994525,0.00083377067,0.00006440653,0.000033887034,0.000062102474,0.00013459724,0.00010779894],"about_ca_topic_score_codex":0.0017810506,"about_ca_topic_score_gemma":0.00076813524,"teacher_disagreement_score":0.03822575,"about_ca_system_score_codex":0.000049350074,"about_ca_system_score_gemma":0.000060057948,"threshold_uncertainty_score":0.3742147},"labels":[],"label_agreement":null},{"id":"W2549056958","doi":"10.1182/blood.v106.11.5273.5273","title":"Upregulation of MT1-MMP by Molecules Present in Leukaphereis Products Primes CD34+ Cell Homing.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Alberta","funders":"","keywords":"Cell biology; Stromal cell; Priming (agriculture); Homing (biology); Chemistry; CD34; Bone marrow; Stem cell; Biology; Molecular biology; Immunology; Cancer research","score_opus":0.004648651873265081,"score_gpt":0.1999440287208815,"score_spread":0.19529537684761641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549056958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936103,0.0041881134,0.00021049129,0.00015168905,0.00003294119,0.00029126246,0.0000127155645,0.000009128408,0.0014933156],"genre_scores_gemma":[0.99691284,0.00007100783,0.0019096002,0.000037698617,0.00022678197,0.00002713992,0.00007371551,0.000016914732,0.00072433124],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99920076,0.00004230102,0.0001957744,0.00027612166,0.00011396177,0.00017106172],"domain_scores_gemma":[0.99955416,0.0000033400709,0.00008575751,0.00027202978,0.000048396323,0.000036296027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000095005984,0.000114003495,0.00011329334,0.000030076715,0.000019697767,0.000008119793,0.00011544419,0.00010958233,0.0000121813],"category_scores_gemma":[0.000027824404,0.00011300602,0.000043437587,0.000071889255,0.000024687835,0.0000060862276,0.00006431454,0.000049274728,0.000004996789],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024555888,0.00042439313,0.0004010107,0.000031823805,0.00001505495,8.532158e-7,0.00003488772,0.00004667282,0.9961376,0.000026122047,0.0018449973,0.0010120026],"study_design_scores_gemma":[0.000961968,0.00017587109,0.00028763342,0.00001722457,0.000017487322,0.000002613537,0.000013555684,0.00005138889,0.9928674,0.00006544235,0.0054119625,0.00012744365],"about_ca_topic_score_codex":0.000026462892,"about_ca_topic_score_gemma":0.000010106614,"teacher_disagreement_score":0.004117105,"about_ca_system_score_codex":0.0000065162894,"about_ca_system_score_gemma":0.000055720815,"threshold_uncertainty_score":0.46082518},"labels":[],"label_agreement":null},{"id":"W2549094580","doi":"10.1182/blood.v116.21.1023.1023","title":"Evolution of Human BCR-ABL1 lymphoblastic Leukaemia-Initiating Cells.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"CDKN2B; CDKN2A; Biology; clone (Java method); Somatic evolution in cancer; Cancer research; Genetics; Immunology; Transplantation; DNA; Gene; Medicine; Internal medicine","score_opus":0.012224264115574304,"score_gpt":0.2703071792172616,"score_spread":0.2580829151016873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549094580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98398376,0.000066699475,0.00037446013,0.000053019943,0.00021813989,0.00029026007,0.000014751628,0.00009900904,0.014899896],"genre_scores_gemma":[0.99659765,0.0000053325807,0.0021888902,0.00005391851,0.00049486384,0.000020588202,0.000019147612,0.000046706788,0.00057290634],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99813664,0.0000420536,0.0004337456,0.00032760622,0.0006013596,0.00045861935],"domain_scores_gemma":[0.9985568,0.00024960682,0.00015912156,0.0005365382,0.00026451092,0.00023343552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033512738,0.00018616098,0.00035522995,0.00022036549,0.00012688852,0.000016651371,0.00020950085,0.00022085736,0.00035616462],"category_scores_gemma":[0.0005494861,0.00016897204,0.00012154423,0.00033455197,0.00022237678,0.000087813074,0.00012262106,0.00042241978,0.00015398914],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046013145,0.0005790992,0.01801142,0.0002218977,0.000079610436,0.0000841166,0.00016949422,0.0000044833323,0.97866404,0.0012768942,0.0005656179,0.00029731457],"study_design_scores_gemma":[0.014247241,0.000966296,0.032731906,0.0002813087,0.00052493514,0.00048201106,0.00025629866,0.0021927499,0.9470379,0.0005790921,0.0003720921,0.0003281754],"about_ca_topic_score_codex":0.00027587212,"about_ca_topic_score_gemma":0.00003594622,"teacher_disagreement_score":0.031626146,"about_ca_system_score_codex":0.000260948,"about_ca_system_score_gemma":0.00091090164,"threshold_uncertainty_score":0.689048},"labels":[],"label_agreement":null},{"id":"W2549128571","doi":"10.1182/blood.v126.23.4654.4654","title":"Thrombotic Thrombocytopenic Purpura (TTP) Management at Foothills Medical Centre: A Retrospective Analysis Between 2005-2010 (Tertiary Centre, Calgary)","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Thrombotic thrombocytopenic purpura; Microangiopathic hemolytic anemia; Thrombotic microangiopathy; Pediatrics; Rituximab; Internal medicine; ADAMTS13; Retrospective cohort study; Incidence (geometry); Disease","score_opus":0.018035956201646275,"score_gpt":0.24969985602590788,"score_spread":0.2316638998242616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549128571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98578185,0.003895697,0.0002141715,0.0016232189,0.000947008,0.0012887637,0.00026570368,0.00032530955,0.005658282],"genre_scores_gemma":[0.991377,0.00007029909,0.00013168024,0.0002252899,0.00012275077,0.000039879862,0.0009243732,0.000043665892,0.007065075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963216,0.0005698438,0.0007865031,0.00090524624,0.00040923583,0.001007563],"domain_scores_gemma":[0.998059,0.00016744349,0.00028642552,0.0010402156,0.00013344012,0.00031351976],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0006193182,0.0004425544,0.0010014647,0.00033495418,0.00024420366,0.000041631247,0.00081440515,0.00033877353,0.011245787],"category_scores_gemma":[0.00015694942,0.00039420504,0.00043395453,0.0005929479,0.00026553255,0.00012637832,0.0009224887,0.00033784425,0.0028371776],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046055855,0.0010077268,0.92763966,0.00004927004,0.011818329,0.00015831998,0.0003470206,0.0000021575229,0.00050080655,0.0005310912,0.057627298,0.00027227929],"study_design_scores_gemma":[0.008437144,0.000128357,0.96442467,0.000118783435,0.00867884,0.000043703552,0.0003667959,0.00001198205,0.004361922,0.00031602645,0.012439802,0.00067195523],"about_ca_topic_score_codex":0.0002331308,"about_ca_topic_score_gemma":0.0008115399,"teacher_disagreement_score":0.045187496,"about_ca_system_score_codex":0.00037564914,"about_ca_system_score_gemma":0.00012107854,"threshold_uncertainty_score":0.999851},"labels":[],"label_agreement":null},{"id":"W2549161995","doi":"10.1182/blood.v126.23.1364.1364","title":"The Highly Potent Bromodomain (BRD) Inhibitor FV-281 Displays Preclinical Efficacy in Acute Myeloid Leukemia (AML)","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"","keywords":"Annexin A5; Bromodomain; Haematopoiesis; Viability assay; Myeloid; Biology; Leukemia; Daunorubicin; Cancer research; Molecular biology; Apoptosis; Immunology; Flow cytometry; Annexin; Stem cell; Cell biology; Biochemistry","score_opus":0.016077248805141716,"score_gpt":0.265930858458116,"score_spread":0.24985360965297426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549161995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955532,0.0010385527,0.00010736347,0.00084585027,0.00042429127,0.00038477028,0.000019990948,0.000026991185,0.0015989695],"genre_scores_gemma":[0.9966825,0.00024784377,0.00048009647,0.00027610137,0.0006280172,0.000058549078,0.000118663316,0.00002971827,0.0014784735],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99837416,0.0001694523,0.00042083443,0.00041893378,0.0002594924,0.00035710484],"domain_scores_gemma":[0.99902946,0.000047215555,0.000113886665,0.00053044857,0.000073936324,0.00020504711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005348494,0.00020075106,0.00018032674,0.000036138652,0.000107392945,0.00006339675,0.0003606091,0.0002453421,0.0000037668208],"category_scores_gemma":[0.0004503377,0.00014753737,0.0001244741,0.00013165777,0.00013260104,0.000008461308,0.0002272771,0.00022198615,0.00005510998],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010991469,0.002036036,0.00752392,0.000024191619,0.000400179,0.000109198714,0.00025226583,0.00009266728,0.92297363,0.0011673517,0.05081939,0.013502026],"study_design_scores_gemma":[0.008104209,0.0008720823,0.0072230883,0.000044597233,0.00007821972,0.00006730151,0.00008494994,0.000056331886,0.8488547,0.00027181508,0.13389334,0.00044935234],"about_ca_topic_score_codex":0.000026967637,"about_ca_topic_score_gemma":0.00006990356,"teacher_disagreement_score":0.08307395,"about_ca_system_score_codex":0.00004606953,"about_ca_system_score_gemma":0.00026614458,"threshold_uncertainty_score":0.6016399},"labels":[],"label_agreement":null},{"id":"W2549164273","doi":"10.1182/blood.v126.23.3458.3458","title":"Novel RUNX1 Mutation in a Family with an Uncharacterized Secretion Defect","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; McMaster University","funders":"","keywords":"Exome sequencing; Sanger sequencing; Blood Platelet Disorders; Platelet disorder; Platelet; Medicine; Internal medicine; Biology; Genetics; Gastroenterology; Immunology; Mutation; Gene","score_opus":0.026010538637948326,"score_gpt":0.2590670581617794,"score_spread":0.23305651952383105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549164273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982284,0.0000708413,0.00020338719,0.00006324028,0.000020848865,0.00026366062,0.0000066745242,0.00003690235,0.0011060494],"genre_scores_gemma":[0.99806565,0.000005304422,0.0014207739,0.00014361626,0.000020963553,0.000026154155,0.00025823637,0.000012229024,0.000047058184],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99951535,0.000014278971,0.00008918429,0.00013770133,0.00012993204,0.00011355404],"domain_scores_gemma":[0.9997243,0.000006837037,0.000034041517,0.00010353159,0.000040874147,0.00009040989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007482597,0.00008012621,0.00015224089,0.00006524702,0.000012684238,0.0000098529845,0.000018751452,0.000043511773,0.0000041593216],"category_scores_gemma":[0.000018084222,0.000059855192,0.000020837462,0.00011955009,0.000011734,0.00010053726,0.0000044345365,0.00005285811,0.000017190167],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006500412,0.01932735,0.63682973,0.00013151867,0.0007695225,0.006418056,0.0057794973,0.0000350236,0.3089185,0.0002059396,0.000049712402,0.015034725],"study_design_scores_gemma":[0.05994382,0.0036265752,0.93039656,0.00012558051,0.00040629928,0.0009371709,0.0006258134,0.00048980763,0.002850754,0.00019732569,0.00019402998,0.00020627811],"about_ca_topic_score_codex":0.00021582063,"about_ca_topic_score_gemma":0.00011195681,"teacher_disagreement_score":0.30606776,"about_ca_system_score_codex":0.000024062001,"about_ca_system_score_gemma":0.00007516533,"threshold_uncertainty_score":0.24408239},"labels":[],"label_agreement":null},{"id":"W2549167573","doi":"10.1182/blood.v110.11.3623.3623","title":"Increased Factor VIII Levels Have a Thrombogenic Effect In Vitro and In Vivo.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Thrombogenicity; Thromboelastography; In vivo; Coagulation; Tissue factor; Chemistry; In vitro; Fibrin; Internal medicine; Endocrinology; Antithrombin; Calcium; Hemostasis; Platelet; Factor IX; Thrombin; Immunology; Medicine; Biochemistry; Biology; Heparin","score_opus":0.02813182987280006,"score_gpt":0.3180592187681786,"score_spread":0.28992738889537856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549167573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971742,0.00045428937,0.0000018175316,0.00013821077,0.000015854954,0.0005639912,0.000012961215,0.000019657613,0.0016189853],"genre_scores_gemma":[0.9994313,0.00002683341,0.00011133994,0.00006235905,0.00005914164,0.000014720997,0.0000063244097,0.000014974841,0.0002730119],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99899596,0.000060696697,0.00017248941,0.00021344174,0.00020633964,0.0003510525],"domain_scores_gemma":[0.9993938,0.0002641088,0.00001745041,0.0001542458,0.000015860134,0.00015451938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004216275,0.00012448372,0.00029651748,0.0002504391,0.000023387085,0.000008919961,0.000041585994,0.0001103251,0.00010567819],"category_scores_gemma":[0.00014239732,0.00009011114,0.00004581923,0.00018189324,0.00005059508,0.000036514695,0.0000329039,0.00019374148,0.000016783406],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039324886,0.00045164436,0.4836106,0.00005571642,0.000042090207,0.000625639,0.00019063918,1.4399054e-8,0.5129226,0.0000010297196,0.0000074077343,0.0016993674],"study_design_scores_gemma":[0.007399449,0.00025648635,0.47708046,0.00005291234,0.000028525905,0.000025283656,0.000025211642,0.000009078784,0.5150197,0.00001286551,0.000032789063,0.000057234785],"about_ca_topic_score_codex":0.00025984104,"about_ca_topic_score_gemma":0.0002462885,"teacher_disagreement_score":0.0070062,"about_ca_system_score_codex":0.00005397494,"about_ca_system_score_gemma":0.0000584405,"threshold_uncertainty_score":0.36746258},"labels":[],"label_agreement":null},{"id":"W2549173225","doi":"10.1182/blood.v114.22.1582.1582","title":"Single Cell Network Profiles in Non-M3 AML Associated with Patient Response to Standard Induction Therapy.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Induction chemotherapy; Flow cytometry; Cell cycle; Context (archaeology); Biology; Medicine; Bioinformatics; Oncology; Immunology; Chemotherapy; Internal medicine; Cancer","score_opus":0.014066238969745836,"score_gpt":0.2573540539009737,"score_spread":0.24328781493122786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549173225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99556005,0.0001374673,0.000027152058,0.0017991931,0.000037732665,0.0010911585,0.000009922895,0.00006318968,0.0012741389],"genre_scores_gemma":[0.99728477,0.000019016226,0.0013140568,0.0006737841,0.00013711232,0.00004363767,0.000025071024,0.000028430817,0.00047412456],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983685,0.00019139407,0.00022117089,0.00028444038,0.0004868512,0.0004476282],"domain_scores_gemma":[0.9992221,0.00010221328,0.00007119013,0.00027464403,0.00017063247,0.0001592245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058307627,0.00015260899,0.0002680253,0.00017278644,0.00006325383,0.000024401208,0.00008134545,0.00012529273,0.000034928842],"category_scores_gemma":[0.00022284058,0.00011723862,0.000033915,0.0007905342,0.000029581352,0.000059663293,0.000023749404,0.00034549454,0.000017741975],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06290047,0.0080713555,0.07068122,0.00003748931,0.0002717295,0.0013071935,0.007763533,0.0005920051,0.74354655,0.000009050888,0.023367107,0.08145232],"study_design_scores_gemma":[0.023065126,0.034335814,0.55797225,0.00066805095,0.000080218066,0.000049857015,0.0006560845,0.00006147852,0.37576854,0.00006718022,0.0068056425,0.0004697637],"about_ca_topic_score_codex":0.000029034907,"about_ca_topic_score_gemma":0.000024659248,"teacher_disagreement_score":0.487291,"about_ca_system_score_codex":0.00042607007,"about_ca_system_score_gemma":0.00033312268,"threshold_uncertainty_score":0.47808522},"labels":[],"label_agreement":null},{"id":"W2549180194","doi":"10.1182/blood.v108.11.356.356","title":"Aberrant Immunoglobulin Class Switch Recombination and Switch Translocations in Activated B Cell-Like Diffuse Large B-Cell Lymphoma.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Germinal center; Immunoglobulin class switching; Biology; Lymphoma; Chromosomal translocation; B cell; Large-cell lymphoma; Immunoglobulin heavy chain; Molecular biology; Cancer research; Antibody; Genetics; Gene; Immunology","score_opus":0.00614617362832149,"score_gpt":0.21496292099129657,"score_spread":0.2088167473629751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549180194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99234873,0.0019031098,0.000022322189,0.00094090635,0.00008954034,0.00060339196,0.00002576975,0.00007536721,0.0039908676],"genre_scores_gemma":[0.9978602,0.0004595043,0.00024050071,0.00014955379,0.00004218084,0.00020635156,0.000217991,0.00003186201,0.0007918337],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998649,0.00004791451,0.0003741,0.00037173738,0.00021526,0.00034198136],"domain_scores_gemma":[0.9993641,0.00007989544,0.000091941176,0.00030319855,0.000066323475,0.000094566574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012628472,0.0002286504,0.0003218161,0.00015887311,0.00010660043,0.000035814308,0.000065924374,0.00015556393,0.000035563928],"category_scores_gemma":[0.000008878967,0.00020067775,0.00008175949,0.00032999247,0.000025842952,0.00010061005,0.000020580901,0.000081904764,0.00003696934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000501968,0.2722761,0.46593705,0.00045701678,0.0003141727,0.0005453015,0.0018243782,0.000008813501,0.24391834,0.001005985,0.002630197,0.010580663],"study_design_scores_gemma":[0.11478664,0.00035871626,0.6386538,0.00013959443,0.00045958412,0.000071914474,0.00020332662,0.00018135757,0.24067733,0.00021168088,0.003944826,0.00031123508],"about_ca_topic_score_codex":0.0010208167,"about_ca_topic_score_gemma":0.00030584613,"teacher_disagreement_score":0.27191737,"about_ca_system_score_codex":0.00015512305,"about_ca_system_score_gemma":0.00011597373,"threshold_uncertainty_score":0.8183401},"labels":[],"label_agreement":null},{"id":"W2549188419","doi":"10.1182/blood.v110.11.4041.4041","title":"Optimization of a Cytokine Cocktail for the Expansion of Cord Blood CD34+ Cells into Megakaryocytes Progenitors.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Héma-Québec","funders":"","keywords":"Cord blood; Haematopoiesis; Stem cell factor; Cytokine; Progenitor cell; Megakaryocyte; Platelet; Transplantation; CD34; Stem cell; Immunology; Thrombopoietin; Andrology; Ex vivo; Biology; Chemistry; Medicine; Internal medicine; In vivo; Cell biology; Biotechnology","score_opus":0.011998720805384167,"score_gpt":0.2602018343367645,"score_spread":0.24820311353138036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549188419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934665,0.0013565368,0.0037925052,0.00007531933,0.000077347075,0.00096267235,0.000023920755,0.000022259796,0.0002229682],"genre_scores_gemma":[0.98631436,0.0002184222,0.013173472,0.000033999422,0.000056549925,0.00003226864,0.00005148835,0.000020769756,0.00009866859],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99915594,0.0000101189,0.000318647,0.0001507928,0.00019848888,0.00016599087],"domain_scores_gemma":[0.99921453,0.00016222375,0.00016807728,0.00022380888,0.00017858346,0.00005280575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017325184,0.00012078291,0.0002943706,0.00007256555,0.000056092435,0.000003875918,0.00007326312,0.00007794103,0.000019875211],"category_scores_gemma":[0.00005979921,0.00007920036,0.00010995551,0.00017621671,0.000060895512,0.000037109403,0.00002268728,0.000049011822,0.0000012723159],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053231553,0.015882948,0.049751863,0.0014404728,0.0037937623,0.0002696363,0.0021507705,0.0010032378,0.8906492,0.0002669439,0.00061219436,0.0288558],"study_design_scores_gemma":[0.0089802835,0.0016276328,0.0013747581,0.00009416072,0.0014295712,0.00004351424,0.00022111481,0.00047477448,0.98537207,0.000056754463,0.00024260905,0.00008273468],"about_ca_topic_score_codex":0.00008006088,"about_ca_topic_score_gemma":0.000016519069,"teacher_disagreement_score":0.094722874,"about_ca_system_score_codex":0.0000082976085,"about_ca_system_score_gemma":0.00006006273,"threshold_uncertainty_score":0.3229697},"labels":[],"label_agreement":null},{"id":"W2549224192","doi":"10.1182/blood.v120.21.1875.1875","title":"Parallel Transcriptional Analysis of Multiple Stem and Progenitor Populations Identifies Novel Commonly Dysregulated and Functionally Relevant Targets in AML","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; Haematopoiesis; Stem cell; Progenitor cell; CD34; CD38; Myeloid leukemia; Cancer research; Myeloid; CD90; Immunology; Cell biology","score_opus":0.04465295989519462,"score_gpt":0.28784342391448725,"score_spread":0.24319046401929262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549224192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965915,0.0019160069,0.00055719534,0.0003457916,0.000042972817,0.0003742046,0.000110557405,0.000021179496,0.000040562943],"genre_scores_gemma":[0.9955118,0.00004452796,0.0037877304,0.000027525079,0.00005563094,0.000034682616,0.00023319472,0.000014150423,0.0002908052],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884784,0.000046033947,0.0003490956,0.00019331546,0.00032497654,0.00023874214],"domain_scores_gemma":[0.99939173,0.00009963639,0.00007065511,0.00016150466,0.00012897581,0.00014749618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029745937,0.00011676405,0.00033947086,0.00045451362,0.00006386593,0.000013120971,0.000045596098,0.00009475137,0.000035613033],"category_scores_gemma":[0.000067574736,0.00010386133,0.000076270866,0.0005354443,0.00011160274,0.00016002706,0.000033957105,0.00015828096,0.000001916252],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000203324,0.0008145534,0.883425,0.0000760929,0.00097384414,0.00000469599,0.0004984999,0.000055350276,0.11322461,0.0004988866,0.000039726834,0.00018540106],"study_design_scores_gemma":[0.004156255,0.00006183965,0.988646,0.000028720153,0.0011576581,0.0000413668,0.00019893551,0.004160736,0.0012922118,0.000023234024,0.0001408572,0.0000921931],"about_ca_topic_score_codex":0.00022369908,"about_ca_topic_score_gemma":0.0005019595,"teacher_disagreement_score":0.1119324,"about_ca_system_score_codex":0.00004437046,"about_ca_system_score_gemma":0.000068958165,"threshold_uncertainty_score":0.42353424},"labels":[],"label_agreement":null},{"id":"W2549241463","doi":"10.1182/blood.v126.23.3112.3112","title":"GSTA1 *B1a Haplotype Associated with Lower Busulfan Clearance in Conditioning before HSCT in Pediatric Patients","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Busulfan; Medicine; Pharmacokinetics; Haplotype; Internal medicine; Dosing; Hematopoietic stem cell transplantation; Therapeutic drug monitoring; Gastroenterology; Transplantation; Genotype; Biology","score_opus":0.013204724636094742,"score_gpt":0.234107257818813,"score_spread":0.22090253318271827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549241463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99645483,0.000055258774,0.000017250943,0.000058244208,0.00008889517,0.0003761433,0.000010743368,0.00004840033,0.002890245],"genre_scores_gemma":[0.9994082,0.0000085845495,0.00014925351,0.00007185022,0.000051434585,0.000021096472,0.00014935255,0.000028006762,0.00011223176],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988961,0.000047932564,0.0002707888,0.00020735779,0.0003375918,0.00024023217],"domain_scores_gemma":[0.9995148,0.000038602673,0.000086631015,0.0001303587,0.0001220135,0.000107552245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002173221,0.00011943733,0.0002320467,0.00016675689,0.000018306626,0.000010152465,0.00004931384,0.00010096598,0.00002285704],"category_scores_gemma":[0.00015136026,0.00010614601,0.000021453836,0.00049073657,0.000023607005,0.00009362569,0.0000068789523,0.00018330324,0.00004720819],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018631757,0.00086779776,0.99732465,0.00006460436,0.000016760305,0.00015069143,0.001238023,0.000027036247,0.0000116006895,0.00001937369,0.000039451596,0.000053678592],"study_design_scores_gemma":[0.012395736,0.00064189086,0.9859767,0.00033382548,0.000107545944,0.000009987316,0.0000902259,0.000067729336,0.00020434192,0.000046046604,0.000012827382,0.00011316421],"about_ca_topic_score_codex":0.000043638385,"about_ca_topic_score_gemma":0.0003986328,"teacher_disagreement_score":0.012209418,"about_ca_system_score_codex":0.000076331366,"about_ca_system_score_gemma":0.00012128117,"threshold_uncertainty_score":0.43285087},"labels":[],"label_agreement":null},{"id":"W2549252984","doi":"10.1182/blood.v126.23.2324.2324","title":"Role of Extended Thromboprophylaxis after Abdominal and Pelvic Surgery in Cancer Patients: A Systematic Review and Meta-Analysis","year":2015,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency; University of Alberta","funders":"","keywords":"Medicine; Pulmonary embolism; Randomized controlled trial; Surgery; Low molecular weight heparin; Abdominal surgery; Deep vein; Thrombosis; Observational study; Meta-analysis; Relative risk; Internal medicine; Confidence interval","score_opus":0.04633241044066338,"score_gpt":0.32757785321673083,"score_spread":0.28124544277606744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549252984","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00044556154,0.9953562,2.1042186e-7,0.00002994821,0.000016681579,0.003937348,0.00012075138,0.000009411401,0.00008388799],"genre_scores_gemma":[0.0021859095,0.99475116,0.000041505045,0.0001655818,0.000016843225,0.0026832093,0.000051754923,0.000040751038,0.00006330729],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9969536,0.00033571722,0.0014767738,0.0005385651,0.0004428616,0.00025247515],"domain_scores_gemma":[0.9980741,0.00015686199,0.0008229109,0.0006023422,0.00019066427,0.00015310553],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0009610112,0.00047401505,0.015548338,0.00058443524,0.000016351154,0.000019419134,0.00009615804,0.00014529855,0.00019589509],"category_scores_gemma":[0.00016134129,0.0002934805,0.0014782316,0.0007858111,0.00006281298,0.000057090478,0.0001306915,0.00017031938,0.0000056002855],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000028613706,0.0011683288,0.00013149693,0.88034743,0.11328078,0.000019216495,0.00006704812,1.1906238e-8,2.626777e-8,0.000004620239,0.000077412384,0.0049007866],"study_design_scores_gemma":[0.00030062834,0.00011372655,0.0010682914,0.06981476,0.9255229,0.000009668859,0.0000189538,2.8474028e-7,2.1249309e-7,0.000010708788,0.0029010596,0.00023880877],"about_ca_topic_score_codex":0.00024488932,"about_ca_topic_score_gemma":0.00011753918,"teacher_disagreement_score":0.8122421,"about_ca_system_score_codex":0.000054510612,"about_ca_system_score_gemma":0.00014221111,"threshold_uncertainty_score":0.9999517},"labels":[],"label_agreement":null},{"id":"W2549255458","doi":"10.1182/blood.v110.11.835.835","title":"TINF2, a Component of the Shelterin Telomere Protection Complex, Is Mutated in Dyskeratosis Congenita.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Dyskeratosis congenita; Telomere; Genetics; Biology; Shelterin; Bone marrow failure; Proband; Mutation; Gene","score_opus":0.029542248661139494,"score_gpt":0.2626653948322853,"score_spread":0.2331231461711458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549255458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99673796,0.00016609057,0.000065025815,0.0005901737,0.00010860343,0.00089334795,0.00001891044,0.00005393464,0.0013659331],"genre_scores_gemma":[0.9989425,0.000020568468,0.00036308644,0.00039492254,0.000062955005,0.000022132654,0.000009602554,0.000021577642,0.00016264514],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985461,0.000057559624,0.00048957404,0.00025576525,0.00033675306,0.0003142284],"domain_scores_gemma":[0.9992259,0.000044672634,0.0001395851,0.00037488667,0.00011545045,0.000099476616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029903115,0.00017252308,0.0003429439,0.0001738192,0.00007163104,0.000010258767,0.00013782218,0.00010296763,0.00019809183],"category_scores_gemma":[0.000064152846,0.00012797756,0.00010496088,0.0006350417,0.00013875104,0.000044748012,0.000055163433,0.00025389346,0.000023523597],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003436912,0.0014261557,0.1606432,0.00024412366,0.00012213181,0.00008168379,0.0017134032,0.0000019024894,0.82923865,0.000055035947,0.00019198815,0.0059380084],"study_design_scores_gemma":[0.0032344738,0.00018202575,0.5790009,0.00016497397,0.00007152253,0.00013783031,0.00031320978,0.000095227966,0.41536185,0.000022575925,0.0012836021,0.00013181598],"about_ca_topic_score_codex":0.0004742313,"about_ca_topic_score_gemma":0.00020719024,"teacher_disagreement_score":0.41835767,"about_ca_system_score_codex":0.0000446288,"about_ca_system_score_gemma":0.00006595346,"threshold_uncertainty_score":0.5218773},"labels":[],"label_agreement":null},{"id":"W2549257561","doi":"10.1182/blood.v114.22.2736.2736","title":"Antileukemic Effects of the Novel Agent Elesclomol.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Click Chemistry and Applications","field":"Chemistry","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Propidium iodide; Oxidative stress; Cancer research; Chemistry; Apoptosis; Biology; Pharmacology; Programmed cell death; Biochemistry","score_opus":0.006186001277716961,"score_gpt":0.21521728632069043,"score_spread":0.20903128504297347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549257561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98445785,0.000117768635,0.000020643869,0.00012680779,0.000015084189,0.000046681045,0.000011416444,0.000031282634,0.015172487],"genre_scores_gemma":[0.99863213,0.0000111913,0.00007869451,0.00007957779,0.00009356358,0.000010376831,0.0000053406875,0.0000051717047,0.0010839757],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995519,0.00000194876,0.000118958305,0.0001237931,0.000095898096,0.00010748223],"domain_scores_gemma":[0.99944496,0.00004441487,0.00006811718,0.00039402719,0.000017204253,0.000031301308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000018338056,0.0000738102,0.00008400648,0.0000042715483,0.000049666014,0.0000056475606,0.00022961902,0.000057312147,0.00005359966],"category_scores_gemma":[0.000041388237,0.000056416913,0.000079418125,0.000080756145,0.000029219289,0.000011615453,0.000027051758,0.00009784218,0.000007004558],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000013471497,0.00049308053,0.00042404802,0.000070928894,0.000013129618,8.3823727e-7,0.000027564934,0.000001606332,0.9979235,0.00026377453,0.00027658933,0.0005036001],"study_design_scores_gemma":[0.00068305654,0.000004814722,0.0032504357,0.00006312975,0.000055889217,0.00001213283,0.000007235246,0.00000771988,0.99376124,0.00018742633,0.0019031621,0.00006373552],"about_ca_topic_score_codex":0.000004233869,"about_ca_topic_score_gemma":3.8140996e-7,"teacher_disagreement_score":0.01417428,"about_ca_system_score_codex":0.000009446645,"about_ca_system_score_gemma":0.000022295508,"threshold_uncertainty_score":0.23006149},"labels":[],"label_agreement":null},{"id":"W2549268160","doi":"10.1182/blood.v104.11.2201.2201","title":"Prevalence and Incidence of Arterial and Venous Thrombosis in Critically Ill Patients.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Incidence (geometry); Thrombosis; Pulmonary embolism; Intensive care unit; Population; Medical record; Prospective cohort study; Venous thrombosis; Retrospective cohort study; Deep vein; Cohort; Cohort study; Internal medicine; Surgery; Pediatrics","score_opus":0.009620762531014782,"score_gpt":0.25014543019622676,"score_spread":0.24052466766521197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549268160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983853,0.00032294885,0.000010312461,0.0004345085,0.000044535467,0.00033078334,0.0000062166864,0.000010834117,0.00045456423],"genre_scores_gemma":[0.9976214,0.0008327272,0.00080935785,0.0006798304,0.000026977741,0.00001661676,0.0000018707001,0.000007746472,0.0000034653124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993329,0.000012603962,0.00018718079,0.00018209952,0.00014189308,0.00014331896],"domain_scores_gemma":[0.9996173,0.000024210669,0.000034006236,0.00012800185,0.00013095343,0.000065562774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008344278,0.00007962353,0.0002608358,0.00005507507,0.00002143407,0.00000874882,0.000038425387,0.00003958592,0.000017637843],"category_scores_gemma":[0.00023117605,0.00007297384,0.00001716159,0.00006154919,0.00009987041,0.00006134051,0.00006345524,0.00005188375,0.0000020006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007381012,0.014127344,0.9636831,0.0021174548,0.00013568331,0.00006999074,0.003481505,0.000003519808,0.008756,0.004166149,0.00007339225,0.0033120413],"study_design_scores_gemma":[0.0034147222,0.0009725923,0.9920802,0.00039229234,0.00018809395,0.0000063339003,0.00006295295,0.000001324699,0.0022074638,0.0005759743,0.000025721867,0.000072305134],"about_ca_topic_score_codex":0.00013264894,"about_ca_topic_score_gemma":0.000027532606,"teacher_disagreement_score":0.028397111,"about_ca_system_score_codex":0.000012614322,"about_ca_system_score_gemma":0.000025379148,"threshold_uncertainty_score":0.29757866},"labels":[],"label_agreement":null},{"id":"W2549281714","doi":"10.1182/blood.v108.11.3690.3690","title":"Dramatically Enhanced Immunopotency and Anti-Tumor Activity of Liposome-Encapsulated CpG Oligonucleotides (ODN) in Mice Is Paralleled by Vigorous and Broad-Based Immune Responses in Cynomolgus Monkeys after Both Intravenous (IV) and Subcutaneous (SC) Administration.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Inimex Pharmaceuticals (Canada)","funders":"","keywords":"CpG Oligodeoxynucleotide; Immune system; Immunology; Immunotherapy; CpG site; Biology; Antibody; Monoclonal antibody; Antigen; Cancer research; Medicine; Pharmacology; DNA methylation","score_opus":0.0029851931196986765,"score_gpt":0.20336695404498079,"score_spread":0.20038176092528212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549281714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957363,0.0036663564,0.00009717695,0.00007547458,0.000017069937,0.00029532093,0.00006083281,0.000009046948,0.000042405252],"genre_scores_gemma":[0.9987984,0.00056571513,0.00039007762,0.000071439325,0.000016012651,0.000035914225,0.000035658024,0.000020713536,0.00006612537],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99860585,0.00011891671,0.00045178205,0.00043545212,0.00010471352,0.00028328566],"domain_scores_gemma":[0.9994664,0.000049274346,0.00014709382,0.00023250324,0.000048139256,0.000056596164],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012256096,0.00024463155,0.00036242008,0.00009920746,0.000042331478,0.0000470165,0.000108536966,0.00017635664,0.000009636667],"category_scores_gemma":[0.00005159478,0.0002466939,0.000042748237,0.000110210014,0.00018592644,0.000017496095,0.00006130787,0.00012931586,8.710871e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001626445,0.00066715054,0.0059593264,0.000062125466,0.000041371088,0.00012454075,0.00012487089,0.0000063548437,0.99061453,0.0000023768152,0.0000061684177,0.0007647626],"study_design_scores_gemma":[0.0019860743,0.0012957304,0.11910421,0.00008338588,0.000041030242,0.00012913022,0.000041635692,0.00012883305,0.8768583,0.00005833516,0.000009840294,0.00026351705],"about_ca_topic_score_codex":0.0006872332,"about_ca_topic_score_gemma":0.00032673823,"teacher_disagreement_score":0.11375623,"about_ca_system_score_codex":0.000009125891,"about_ca_system_score_gemma":0.000096001924,"threshold_uncertainty_score":0.9999985},"labels":[],"label_agreement":null},{"id":"W2549309336","doi":"10.1182/blood.v114.22.5061.5061","title":"In Vivo Monitoring of Venous Thrombosis in Mice.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Thrombosis; Inferior vena cava; Medicine; Ligation; Venous thrombosis; Dissection (medical); Ultrasound; Radiology; In vivo; Surgery; Biology","score_opus":0.01818477409063716,"score_gpt":0.283480940178874,"score_spread":0.2652961660882368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549309336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99243885,0.0004625719,0.000001478949,0.00058624457,0.00009622366,0.00024675834,0.0000011482429,0.000015288393,0.006151409],"genre_scores_gemma":[0.9986234,0.00048866327,0.0005257111,0.00019188502,0.00010024367,0.0000115404,6.156323e-7,0.000008387372,0.000049561386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992628,0.0000136811295,0.00023668818,0.00014912787,0.00014202425,0.00019568128],"domain_scores_gemma":[0.99972105,0.000017086662,0.000045563007,0.00015983086,0.000017224877,0.000039222097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012143305,0.00008413932,0.00036749087,0.00017125485,0.000010527746,0.0000042074475,0.00006631945,0.000048438433,0.000052622156],"category_scores_gemma":[0.000022810946,0.00008214398,0.000045381927,0.0002281421,0.000012328763,0.000050155984,0.00001833541,0.00008680251,0.000007658682],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006096494,0.038576838,0.6223668,0.00043940954,0.00021855778,0.0004992962,0.005864493,0.00007862814,0.3220678,0.001834068,0.0017088861,0.0062842825],"study_design_scores_gemma":[0.0022081307,0.00055922853,0.8719383,0.00033190713,0.000098114724,0.0000041517724,0.00025261124,0.0000037103478,0.12395275,0.00023563919,0.000334515,0.00008096182],"about_ca_topic_score_codex":0.00025464807,"about_ca_topic_score_gemma":0.000025752792,"teacher_disagreement_score":0.2495715,"about_ca_system_score_codex":0.00003059678,"about_ca_system_score_gemma":0.000020775673,"threshold_uncertainty_score":0.33497342},"labels":[],"label_agreement":null},{"id":"W2549339569","doi":"10.1182/blood.v110.11.3377.3377","title":"Leukemia-Initiating Cells in Acute Megakaryoblastic Leukemia and Transient Leukemia of Down Syndrome.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Hospital for Sick Children","funders":"","keywords":"Acute megakaryoblastic leukemia; Leukemia; GATA1; Haematopoiesis; Down syndrome; Transplantation; Immunology; Acute leukemia; Medicine; Population; Cord blood; Biology; Stem cell; Cancer research; Internal medicine; Genetics","score_opus":0.011996066961740902,"score_gpt":0.26332576664020985,"score_spread":0.25132969967846897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549339569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907258,0.00049736793,0.00039684586,0.00009982241,0.00010965425,0.0007950678,0.000041834195,0.00008667432,0.0072468934],"genre_scores_gemma":[0.99524766,0.0003239616,0.0034479722,0.00022727321,0.00010499732,0.000025333848,0.000033741064,0.000080664184,0.00050836545],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99638563,0.000089207504,0.0010143549,0.00066919683,0.00080376584,0.001037852],"domain_scores_gemma":[0.9979917,0.0006102261,0.00020138429,0.00056915707,0.00016188642,0.00046567843],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012321805,0.0004047374,0.0008990441,0.0006966035,0.00009281485,0.00002753465,0.00027358046,0.00036468206,0.00010375655],"category_scores_gemma":[0.00021212769,0.00037756254,0.00016244441,0.0008994731,0.00030822633,0.00018693964,0.00015414123,0.0010120476,0.000041774736],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018701667,0.00078802963,0.029016387,0.0019423391,0.0011952673,0.015921876,0.0042352155,0.00028100517,0.9346911,0.00034876517,0.0014613012,0.008248554],"study_design_scores_gemma":[0.03534363,0.0027411964,0.38421857,0.0017312991,0.0014827742,0.006336863,0.0014502492,0.0030079954,0.5613435,0.00013441681,0.0011288231,0.001080681],"about_ca_topic_score_codex":0.0005180696,"about_ca_topic_score_gemma":0.00012363744,"teacher_disagreement_score":0.3733476,"about_ca_system_score_codex":0.0018253885,"about_ca_system_score_gemma":0.0018517178,"threshold_uncertainty_score":0.9998676},"labels":[],"label_agreement":null},{"id":"W2549351957","doi":"10.1182/blood.v108.11.4915.4915","title":"A Novel and Quantitative Assay To Detect JAK2 V617F Allele by Real-Time AS-PCR and Its Applicability to PV Initiating Mutation.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Allele; Biology; Allele frequency; Genetics; Polycythemia vera; Primer (cosmetics); Locked nucleic acid; Molecular biology; Point mutation; Mutation; DNA; Oligonucleotide; Immunology; Gene; Chemistry","score_opus":0.015234593508005594,"score_gpt":0.2833667801944113,"score_spread":0.2681321866864057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549351957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922544,0.0003032936,0.0006851826,0.0013089937,0.000009442971,0.001350533,0.00012958482,0.00005456722,0.0039040155],"genre_scores_gemma":[0.9742033,0.00002966002,0.024396684,0.0005236582,0.00005638338,0.00046293664,0.00007586105,0.000025530631,0.00022601105],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987132,0.000058344587,0.0002810668,0.0004849317,0.00021592648,0.0002465266],"domain_scores_gemma":[0.9989189,0.00047243104,0.000069592184,0.00015218758,0.00015001539,0.00023690054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026964623,0.00020876467,0.00035804324,0.00007213776,0.00012788724,0.000041697323,0.000035519188,0.00007202547,0.00005407362],"category_scores_gemma":[0.0004192907,0.00017873387,0.000035490546,0.00018716892,0.000028183133,0.000063086205,0.00005165707,0.00008445015,0.00008204973],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008737302,0.0067431014,0.098524876,0.00046352937,0.0010011723,0.00024847995,0.005630866,0.000067568435,0.8587961,0.006438994,0.0066881874,0.014523374],"study_design_scores_gemma":[0.017938938,0.00757287,0.4393326,0.00034778498,0.0009257324,0.00041516015,0.0007214112,0.00092338526,0.52647775,0.0010945958,0.0032354125,0.0010143183],"about_ca_topic_score_codex":0.0004493346,"about_ca_topic_score_gemma":0.00012421225,"teacher_disagreement_score":0.34080774,"about_ca_system_score_codex":0.000039521452,"about_ca_system_score_gemma":0.000047261226,"threshold_uncertainty_score":0.72885555},"labels":[],"label_agreement":null},{"id":"W2549378605","doi":"10.1182/blood.v126.23.3692.3692","title":"Novel FAO Inhibitor Avocatin B Induces Apoptosis of Acute Monocytic Leukemia Cells in Adipocyte Co-Culture System Via ER Stress and ATF4 Activation","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Apoptosis; Cell culture; Adipocyte; Cancer research; Biology; Cell growth; Chemistry; Molecular biology; Cell biology; Endocrinology; Biochemistry; Adipose tissue","score_opus":0.011901133089114037,"score_gpt":0.23837552355269978,"score_spread":0.22647439046358575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549378605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976221,0.00070048275,0.000295157,0.000015420814,0.00065201754,0.00021689176,0.00009843054,0.000009610714,0.0003899352],"genre_scores_gemma":[0.9976191,0.00019151358,0.0005032988,0.00005053537,0.0013302204,0.000031949057,0.00009660432,0.000017648135,0.00015911095],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99917394,0.00004199785,0.00022568848,0.0002697944,0.00012861875,0.00015996327],"domain_scores_gemma":[0.9994711,0.000006849365,0.00013860493,0.00020197284,0.00009323513,0.00008819858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013022037,0.00015016935,0.00021718498,0.000050916842,0.000023586908,0.000019175919,0.00010046275,0.0001990822,7.9507504e-7],"category_scores_gemma":[0.000018419036,0.00013629346,0.000042660264,0.00008731334,0.000045712495,0.0000123379605,0.00005564694,0.0000968708,0.0000015510102],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000697242,0.00010155348,0.00038485668,0.00009457854,0.000097774995,6.436132e-8,0.00048695,0.000027715234,0.9975118,0.000024319208,0.00089883705,0.0003018115],"study_design_scores_gemma":[0.0026438257,0.00011953996,0.0010422572,0.00009344541,0.00010651119,0.0000064083733,0.0004527781,0.000021738799,0.9909243,0.000003188228,0.0044282824,0.00015770966],"about_ca_topic_score_codex":0.00025343138,"about_ca_topic_score_gemma":0.000042434716,"teacher_disagreement_score":0.0065874998,"about_ca_system_score_codex":0.000042697815,"about_ca_system_score_gemma":0.00017777534,"threshold_uncertainty_score":0.5557886},"labels":[],"label_agreement":null},{"id":"W2549385334","doi":"10.1182/blood.v118.21.4981.4981","title":"Rituximab Resistant Follicular Lymphoma: Predictors of Rituximab Resistance, Incidence of Transformation and Prognosis","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Rituximab; Medicine; Follicular lymphoma; Internal medicine; Maintenance therapy; Oncology; Lymphoma; Surgery; Gastroenterology; Chemotherapy","score_opus":0.012702032061216721,"score_gpt":0.21635136003140196,"score_spread":0.20364932797018523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549385334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907876,0.0034044692,0.000019425517,0.0000752174,0.00003355565,0.0006034604,0.00005400546,0.000034235978,0.0049880343],"genre_scores_gemma":[0.9968175,0.00057197677,0.0024083848,0.000020487494,0.000019119147,0.00009451124,0.000016912898,0.000015105365,0.00003595914],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986846,0.0000367598,0.00051282585,0.00022946777,0.00035052566,0.00018581789],"domain_scores_gemma":[0.9992158,0.000044442306,0.000200396,0.00027413128,0.00015688284,0.00010838047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017604111,0.0001652145,0.0005120081,0.00012595218,0.00004625138,0.000005484551,0.00007372162,0.00009660737,0.000023439052],"category_scores_gemma":[0.00004893329,0.00013171995,0.00012414959,0.00022003427,0.00014375332,0.00013824746,0.000021915685,0.000030891177,0.0000031190334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024949715,0.037461292,0.92449003,0.0027990893,0.0015552826,0.000259828,0.008284081,1.2565907e-7,0.009898508,0.0074018966,0.00028552365,0.005069389],"study_design_scores_gemma":[0.025684794,0.0009310817,0.65694064,0.0006815695,0.0013815265,0.000041045176,0.0002337238,0.000005098887,0.31324697,0.0002465752,0.00046972543,0.00013723734],"about_ca_topic_score_codex":0.00019082394,"about_ca_topic_score_gemma":0.00006837667,"teacher_disagreement_score":0.30334848,"about_ca_system_score_codex":0.000037161248,"about_ca_system_score_gemma":0.000108860535,"threshold_uncertainty_score":0.5371384},"labels":[],"label_agreement":null},{"id":"W2549389531","doi":"10.1182/blood.v116.21.438.438","title":"Genetic Screen to Isolate “Lariat” Peptides for Characterizing ABL Kinase Activity and Conformation","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital; Health Sciences Centre; Sunnybrook Health Science Centre; University of Saskatchewan","funders":"","keywords":"ABL; Mutant; Biochemistry; Mutagenesis; Saturated mutagenesis; Chemistry; Peptide; Kinase; Protein kinase domain; In vitro; Biology; Stereochemistry; Gene; Tyrosine kinase; Signal transduction","score_opus":0.012502817356456015,"score_gpt":0.2577570151845734,"score_spread":0.2452541978281174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549389531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977963,0.000033384003,0.00033515194,0.00046464097,0.000084618776,0.00084502203,0.000036675785,0.00004867782,0.00035555137],"genre_scores_gemma":[0.98912907,0.000017649647,0.010083606,0.00027945568,0.00020236599,0.00006881818,0.000024842166,0.000018774019,0.00017544652],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99937385,0.000008331715,0.00013620495,0.00018105074,0.000095748605,0.00020483932],"domain_scores_gemma":[0.99945694,0.000045536675,0.000063009524,0.00022741617,0.00004874349,0.00015832265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000100708465,0.000120229146,0.00018263812,0.0000626247,0.000077463555,0.000023429351,0.00004091437,0.000081413134,0.00003079808],"category_scores_gemma":[0.0000949826,0.00010822936,0.000038919057,0.00005040353,0.00001971285,0.00011903663,0.000035244226,0.000119378186,0.000029705141],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001684806,0.00020745635,0.012452075,0.00011338855,0.00010324449,0.000011566023,0.00036577048,2.2155665e-7,0.96206653,0.000033254844,0.00007173415,0.024406264],"study_design_scores_gemma":[0.009053246,0.0005826384,0.8026044,0.00008118162,0.00036552464,0.00014732742,0.000023912315,0.00066486746,0.18189591,0.000030305808,0.00436688,0.0001838072],"about_ca_topic_score_codex":0.00014081072,"about_ca_topic_score_gemma":0.00007700891,"teacher_disagreement_score":0.7901523,"about_ca_system_score_codex":0.00003909783,"about_ca_system_score_gemma":0.00009010217,"threshold_uncertainty_score":0.44134653},"labels":[],"label_agreement":null},{"id":"W2549401922","doi":"10.1182/blood.v116.21.3169.3169","title":"Impact of Persistent Antiphospholipid Antibodies on Symptomatic Thromboembolism In Children: A Systematic Review &amp; Meta-Analysis [Observational Studies]","year":2010,"lang":"en","type":"review","venue":"Blood","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stollery Children's Hospital; McMaster University","funders":"","keywords":"Medicine; Odds ratio; Meta-analysis; Observational study; Antiphospholipid syndrome; Venous thrombosis; Thrombosis; Cochrane Library; Internal medicine; Lupus anticoagulant; Confidence interval; Stroke (engine); Thrombophilia; Pediatrics","score_opus":0.22302600308350162,"score_gpt":0.45062802396269597,"score_spread":0.22760202087919434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549401922","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0076898783,0.98230106,5.100132e-7,0.000040744006,0.0000662791,0.0094353845,0.00027932719,0.000046784222,0.00014005014],"genre_scores_gemma":[0.0005442534,0.9969735,0.00016336437,0.00006401544,0.00008835527,0.0011709185,0.0004956544,0.00011044174,0.00038950864],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9915261,0.0011495084,0.0038027654,0.0009478272,0.0019393276,0.00063442223],"domain_scores_gemma":[0.9928482,0.0013612026,0.0022497866,0.002610678,0.00070359255,0.00022649605],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.0032049634,0.0010941518,0.027350433,0.0015675575,0.000071450326,0.00003261723,0.0007030492,0.00047525534,0.00029971806],"category_scores_gemma":[0.003140913,0.0006059294,0.01893202,0.002951096,0.00019281937,0.000075457465,0.0002071293,0.0010034117,0.00018478191],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000023667312,0.0006840991,0.0026562302,0.59628487,0.40004483,0.000010150548,0.00012636629,9.2919373e-7,3.348326e-7,0.000014746817,0.00011132962,0.00006376623],"study_design_scores_gemma":[0.00053086807,0.00013883096,0.0002772612,0.37064752,0.62549955,0.0024038025,0.000021296928,0.0000017240171,2.5138647e-7,0.0000024750507,0.00016937102,0.00030707556],"about_ca_topic_score_codex":0.00006554201,"about_ca_topic_score_gemma":0.000017198907,"teacher_disagreement_score":0.22563733,"about_ca_system_score_codex":0.0003344564,"about_ca_system_score_gemma":0.00083085324,"threshold_uncertainty_score":0.9996392},"labels":[],"label_agreement":null},{"id":"W2549403704","doi":"10.1182/blood.v126.23.267.267","title":"Ibrutinib Plus Bendamustine/Rituximab (BR) Is Associated with Greater Reductions in Fatigue Than Placebo Plus BR Among Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia and Fatigue","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Chemoimmunotherapy; Internal medicine; Bendamustine; Ibrutinib; Chronic lymphocytic leukemia; Placebo; Randomized controlled trial; Rituximab; Gastroenterology; Leukemia; Lymphoma","score_opus":0.03389796985584335,"score_gpt":0.27046127765652356,"score_spread":0.23656330780068022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549403704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99517703,0.00059651514,0.00003571755,0.00009055051,0.00013171951,0.0018252716,0.00007831932,0.00019981574,0.0018650814],"genre_scores_gemma":[0.9967451,0.000049632195,0.000264653,0.00008836003,0.00019793538,0.00021241808,0.00031180118,0.00015333881,0.0019767336],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9955587,0.00020062886,0.0006660937,0.0010359281,0.0013805132,0.0011581788],"domain_scores_gemma":[0.99733657,0.00022214241,0.00032425014,0.0008642642,0.0004971371,0.0007556574],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004893876,0.000619683,0.0009942224,0.0004771405,0.0001931882,0.00010150812,0.00028317265,0.00043545733,0.0001029882],"category_scores_gemma":[0.00053665315,0.00047662354,0.00008644772,0.0009343953,0.0006934269,0.0004318905,0.00019751157,0.000774812,0.00003607126],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.03021211,0.007335663,0.8730486,0.0027413939,0.007119853,0.006585378,0.041127253,0.011046709,0.00045483574,0.0002091493,0.017167324,0.002951731],"study_design_scores_gemma":[0.7665681,0.005395601,0.18707508,0.0038860508,0.0015471955,0.00083264697,0.001516565,0.028315946,0.002897601,0.00003046162,0.00040717004,0.0015275567],"about_ca_topic_score_codex":0.005011066,"about_ca_topic_score_gemma":0.0018206188,"teacher_disagreement_score":0.736356,"about_ca_system_score_codex":0.072494954,"about_ca_system_score_gemma":0.039022326,"threshold_uncertainty_score":0.99976856},"labels":[],"label_agreement":null},{"id":"W2549404756","doi":"10.1182/blood.v108.11.3669.3669","title":"Important Role for Absolute Lymphocyte Count in Predicting Risk of Relapse in Pediatric Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Stem Cell Transplantation.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Total body irradiation; Hematopoietic stem cell transplantation; Cyclophosphamide; Internal medicine; Transplantation; Leukemia; Gastroenterology; Oncology; Immunology; Chemotherapy","score_opus":0.005414175711664238,"score_gpt":0.22332506025705393,"score_spread":0.21791088454538968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549404756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945363,0.0025354105,0.0004938488,0.00003903305,0.00009118177,0.0013850486,0.0004377752,0.00006652476,0.00041492493],"genre_scores_gemma":[0.99555224,0.0020973708,0.0013539657,0.00003986033,0.00020029274,0.00021836156,0.00017953507,0.00009524334,0.00026312287],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961979,0.00010451224,0.0014771596,0.00064053596,0.00073430425,0.0008456365],"domain_scores_gemma":[0.99789995,0.00073801144,0.0004889413,0.0004636049,0.00022389834,0.00018562222],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007974061,0.00037587728,0.000753236,0.00065958296,0.00007671247,0.00002210458,0.0002750594,0.00031379313,0.000015502512],"category_scores_gemma":[0.00008526213,0.0003527604,0.00021088254,0.0008110604,0.000085968066,0.00013304211,0.000055911674,0.00027950935,0.000015307774],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002961286,0.0019163023,0.9411728,0.0030523716,0.00025391483,0.0018309299,0.0018960827,0.0029910228,0.043430272,0.00009020015,0.00016924927,0.00023559145],"study_design_scores_gemma":[0.1020949,0.0020872592,0.76532644,0.0008328513,0.005021011,0.0018979681,0.0009145134,0.031262606,0.089034826,0.0004517946,0.00006017124,0.0010156521],"about_ca_topic_score_codex":0.0018679873,"about_ca_topic_score_gemma":0.00066561246,"teacher_disagreement_score":0.17584632,"about_ca_system_score_codex":0.0014479193,"about_ca_system_score_gemma":0.0027888215,"threshold_uncertainty_score":0.9998924},"labels":[],"label_agreement":null},{"id":"W2549408553","doi":"10.1182/blood.v106.11.979.979","title":"Establishment of a Waldenstrom’s Macroglobulinemia Cell Line (BCWM.1) with Productive In Vivo Engraftment in SCID-hu Mice.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Waldenstrom macroglobulinemia; Biology; Bone marrow; Macroglobulinemia; CD19; CD38; Immunophenotyping; Lymphoplasmacytic Lymphoma; CD5; Pathology; B cell; CD20; Molecular biology; Immunology; Flow cytometry; Stem cell; Multiple myeloma; CD34; Medicine; Antibody; Lymphoma; Cell biology","score_opus":0.009216784020834328,"score_gpt":0.2585757654293875,"score_spread":0.24935898140855314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549408553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934935,0.00079130667,0.0000093188055,0.0009050429,0.000027279648,0.0013299164,0.000018101513,0.000029043318,0.0033964778],"genre_scores_gemma":[0.9917901,0.00011382353,0.005839203,0.000094104435,0.0002215404,0.00011636226,0.000014264027,0.00003726361,0.0017733225],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975814,0.00006206373,0.0005315229,0.0005566161,0.0006678946,0.0006004849],"domain_scores_gemma":[0.9989297,0.00007512566,0.00011990127,0.00053620077,0.00016423089,0.00017488927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045314062,0.00023996766,0.00050025486,0.00034996407,0.00001984481,0.00001452398,0.00019133794,0.00010993812,0.00016657947],"category_scores_gemma":[0.000101413774,0.00019151771,0.00005976655,0.00067694444,0.00014936629,0.00010261655,0.0001206278,0.0003527901,0.000023934068],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014171099,0.08974788,0.13255234,0.00644709,0.0012087609,0.009751766,0.023549763,0.005882904,0.68515015,0.00036068543,0.007009436,0.024168132],"study_design_scores_gemma":[0.087683104,0.0013499532,0.0026009055,0.0006780862,0.00014523364,0.00033559694,0.00050734915,0.0014550841,0.9026879,0.000017983626,0.0022721442,0.0002666418],"about_ca_topic_score_codex":0.0015342499,"about_ca_topic_score_gemma":0.0015633156,"teacher_disagreement_score":0.21753778,"about_ca_system_score_codex":0.0049969964,"about_ca_system_score_gemma":0.0038936017,"threshold_uncertainty_score":0.9988226},"labels":[],"label_agreement":null},{"id":"W2549419806","doi":"10.1182/blood.v124.21.4554.4554","title":"Retrospective Analysis of Allogeneic Transplant Outcomes in Chronic Myeloid Leukemia Patients with Tyrosine Kinase Inhibitors Failure","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Toronto General Hospital; Juravinski Hospital; McMaster University; Princess Margaret Cancer Centre; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Internal medicine; Transplantation; Nilotinib; Retrospective cohort study; Myeloid leukemia; Dasatinib; Blast Crisis; Gastroenterology; Imatinib","score_opus":0.0048966949608432835,"score_gpt":0.2149515720510933,"score_spread":0.21005487709025003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549419806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987513,0.00016471316,0.000034828776,0.00007879252,0.0000358911,0.00054463715,0.00010180312,0.0000459276,0.00024212245],"genre_scores_gemma":[0.9988479,0.0000331275,0.0004731528,0.000050761806,0.000053077532,0.00004201775,0.00035544933,0.000040273222,0.000104216204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979907,0.00006345333,0.0004982615,0.0005122877,0.0005357265,0.0003995218],"domain_scores_gemma":[0.99887085,0.000057853227,0.00021200514,0.00058570714,0.00012469274,0.00014886819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014351336,0.00033018563,0.0010441465,0.0005375195,0.00003814015,0.00000837168,0.00012600931,0.00015740207,0.00012560259],"category_scores_gemma":[0.000057535333,0.00024111832,0.00024009412,0.0010229344,0.00010393649,0.000076091266,0.000028323084,0.00023641823,0.000013062748],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014192067,0.0008952545,0.9914141,0.000084076964,0.0026180001,0.000033903307,0.00026727034,0.00021202659,0.0039602504,0.000039191127,0.000012049632,0.0003219375],"study_design_scores_gemma":[0.019897347,0.0012454181,0.959966,0.00019797354,0.0052232128,0.0000043786727,0.000017887965,0.00013777203,0.013013246,0.0000064882797,0.00006859342,0.00022166366],"about_ca_topic_score_codex":0.00043132663,"about_ca_topic_score_gemma":0.0021501041,"teacher_disagreement_score":0.0314481,"about_ca_system_score_codex":0.0020662176,"about_ca_system_score_gemma":0.0004630204,"threshold_uncertainty_score":0.983252},"labels":[],"label_agreement":null},{"id":"W2549431830","doi":"10.1182/blood.v116.21.2474.2474","title":"Re-Expression of the AML1/ETO Target Gene LAT2/NTAL/LAB Results In Direct Interference with Myeloid Differentiation In AML1/ETO-Positive Cells","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; Myeloid; Molecular biology; Myeloid leukemia; Cell culture; Cell sorting; Transfection; Cell growth; Flow cytometry; Cancer research; Genetics","score_opus":0.00849449465902358,"score_gpt":0.24462484205948654,"score_spread":0.23613034740046296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549431830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99227244,0.00006827846,0.00006151341,0.00062786107,0.00012968233,0.00085921475,0.000096128235,0.000033750883,0.005851147],"genre_scores_gemma":[0.9971135,0.000059765065,0.00180862,0.000117207914,0.00011071322,0.000051437608,0.00008034302,0.000041439987,0.0006169664],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99768,0.00023832051,0.0005426195,0.00053541106,0.00056387624,0.00043978717],"domain_scores_gemma":[0.99842983,0.00023532231,0.00023459048,0.0007946063,0.00017709876,0.0001285766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000535257,0.000257789,0.00046659567,0.00028367923,0.000058626498,0.000021967047,0.00039081924,0.00022950226,0.00006501123],"category_scores_gemma":[0.00035934712,0.00016432922,0.000076935365,0.0006450635,0.00018645199,0.00013678418,0.0002788741,0.0010638407,0.000013047375],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015250779,0.0007949343,0.07146014,0.000072533396,0.00003401469,0.00006232804,0.0018197111,0.000018987981,0.9235422,0.000008062203,0.00026218433,0.00039983515],"study_design_scores_gemma":[0.0060778474,0.00031457847,0.27721372,0.0004610255,0.000041336276,0.000010910999,0.00014158162,0.00028373557,0.71524054,0.000020079486,0.000060279715,0.00013437172],"about_ca_topic_score_codex":0.0004709303,"about_ca_topic_score_gemma":0.0013911976,"teacher_disagreement_score":0.20830165,"about_ca_system_score_codex":0.00013660942,"about_ca_system_score_gemma":0.00028016654,"threshold_uncertainty_score":0.6701151},"labels":[],"label_agreement":null},{"id":"W2549442465","doi":"10.1182/blood.v104.11.2726.2726","title":"Analysis of Dosing Variability of IVIG in Community and Teaching Hospitals.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Dosing; Pediatrics; Internal medicine","score_opus":0.00881941889185411,"score_gpt":0.26424063383558205,"score_spread":0.25542121494372794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549442465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982523,0.0001221321,0.000032601525,0.000040754985,0.000004101398,0.00008481048,0.000009289303,0.000005215603,0.0014488506],"genre_scores_gemma":[0.99917877,0.0000146854445,0.0007717217,0.000012399266,0.0000014447822,0.0000013002034,0.000014645494,0.0000028782233,0.000002134811],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995676,0.00006697951,0.00016375133,0.00006718519,0.00006761214,0.00006684033],"domain_scores_gemma":[0.9996475,0.000071942864,0.00005441022,0.0001844431,0.00001637689,0.000025342455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035574383,0.000050756826,0.00032731483,0.00011541757,0.000026872189,0.0000018801288,0.00002754333,0.000033566215,0.0000043069767],"category_scores_gemma":[0.0001203899,0.000043035245,0.000050932274,0.00015741936,0.000041741125,0.000027835682,0.0000235533,0.00012747043,1.10785244e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015876933,0.0024364176,0.99289954,0.00006027718,0.0006188919,0.00001478903,0.0012866721,0.000022634173,0.0015705666,0.00014398666,1.18331236e-7,0.00093020796],"study_design_scores_gemma":[0.0032489155,0.00016970573,0.99168074,0.000071580485,0.0014431892,0.000004784255,0.00022072675,0.000029409275,0.0023471536,0.00074976374,7.173256e-7,0.00003329069],"about_ca_topic_score_codex":0.00281427,"about_ca_topic_score_gemma":0.00023364024,"teacher_disagreement_score":0.0032330388,"about_ca_system_score_codex":0.000013144238,"about_ca_system_score_gemma":0.000018051362,"threshold_uncertainty_score":0.42543533},"labels":[],"label_agreement":null},{"id":"W2549443206","doi":"10.1182/blood.v104.11.2883.2883","title":"A Phase II Study of Peripheral Blood Stem Cell (PBSC) Mobilization Using Stem Cell Factor (SCF), Filgrastin (G-CSF), and Cyclophosphamide (CY) in Patients at High Risk for Mobilization Failure.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Leukapheresis; Internal medicine; Cyclophosphamide; Chemotherapy regimen; Surgery; Chemotherapy; Gastroenterology; Plerixafor; Transplantation; Regimen; Stem cell; CD34; CXCR4","score_opus":0.013541263364116402,"score_gpt":0.2507613453857388,"score_spread":0.2372200820216224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549443206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99580365,0.0001944814,0.00044681242,0.000007860746,0.00014496126,0.0031511593,0.00017194502,0.000053537377,0.0000255658],"genre_scores_gemma":[0.9990156,0.000054634198,0.00041797623,0.000018937344,0.000057012123,0.00018650488,0.00007085276,0.000058481295,0.00011994899],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99821764,0.00007653329,0.0006066867,0.0005027109,0.00029561218,0.00030083297],"domain_scores_gemma":[0.9989245,0.000045102843,0.00035865774,0.0003074528,0.00022870144,0.0001355625],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009746977,0.00028143957,0.00046721788,0.00017415821,0.00025037513,0.000024654757,0.00007547113,0.00012742059,0.00003203086],"category_scores_gemma":[0.000010757982,0.00026779904,0.00008157843,0.00041777734,0.000042473792,0.00017785752,0.00007497677,0.00014981856,0.0000010531407],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090889086,0.04018304,0.8829226,0.0005097626,0.00015220576,0.000010302679,0.005143659,0.0048489454,0.0641917,0.000009130144,0.0000100925645,0.001109671],"study_design_scores_gemma":[0.24046114,0.041799735,0.20535958,0.00040238432,0.0031302674,0.000020928457,0.0038812743,0.0005558976,0.50332147,0.000042962205,0.00016269206,0.00086167187],"about_ca_topic_score_codex":0.00051805977,"about_ca_topic_score_gemma":0.0006619338,"teacher_disagreement_score":0.677563,"about_ca_system_score_codex":0.00017330288,"about_ca_system_score_gemma":0.00011262774,"threshold_uncertainty_score":0.9999774},"labels":[],"label_agreement":null},{"id":"W2549460638","doi":"10.1182/blood.v120.21.1184.1184","title":"The Influence of the Duration of Storage of Red Blood Cells On Cancer Survival","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Cancer; Proportional hazards model; Confounding; Internal medicine; Population; Survival analysis; Malignancy; Cohort; Blood transfusion; Analysis of variance; Surgery","score_opus":0.014065654845097721,"score_gpt":0.2485359906954401,"score_spread":0.23447033585034238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549460638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981263,0.0005228644,0.0000021699398,0.00030148795,0.00017866386,0.00025681185,0.000017866878,0.0000054161583,0.00058838323],"genre_scores_gemma":[0.9995173,0.00022670826,0.000027440861,0.000033357992,0.00008304077,0.000007394265,0.0000011706933,0.0000088151855,0.00009475161],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99918574,0.000056391218,0.00026640386,0.00007582885,0.00029195478,0.0001236871],"domain_scores_gemma":[0.9992692,0.00008871805,0.00017804831,0.0003225909,0.00010592527,0.00003551503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026960854,0.00007272372,0.0001751211,0.000020442347,0.000047401158,0.0000016605229,0.000098082186,0.000054416614,0.00001672723],"category_scores_gemma":[0.000042500385,0.000038181268,0.00007695887,0.0001477765,0.000088978246,0.000038918595,0.0000190213,0.00010398537,7.8993435e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000113167356,0.0010415141,0.10649317,0.00012509941,0.00012914684,5.3023757e-7,0.00048637277,0.000045169585,0.8907191,0.00052168325,0.00002499744,0.00030003858],"study_design_scores_gemma":[0.0013533107,0.00014918738,0.4174328,0.00011948906,0.00032810288,0.0000017788028,0.00004105332,0.000002561966,0.5804043,0.00001184337,0.0001284283,0.000027148211],"about_ca_topic_score_codex":0.00029761263,"about_ca_topic_score_gemma":0.00007344589,"teacher_disagreement_score":0.31093964,"about_ca_system_score_codex":0.0000040561226,"about_ca_system_score_gemma":0.000046275458,"threshold_uncertainty_score":0.1556987},"labels":[],"label_agreement":null},{"id":"W2549461025","doi":"10.1182/blood.v126.23.1048.1048","title":"Effects of Anti-Glycoprotein Antibodies on Response of Immune Thrombocytopenia Patients to Thrombopoietin Receptor Agonists and on Megakaryocytes Viability","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Eltrombopag; Romiplostim; Thrombopoietin; Thrombopoietin receptor; Medicine; Antibody; Platelet; Immunology; Megakaryocyte; Platelet Glycoprotein GPIb-IX Complex; Platelet membrane glycoprotein; Internal medicine; Immune thrombocytopenia; Biology; Haematopoiesis","score_opus":0.011115316225236661,"score_gpt":0.25873516886120035,"score_spread":0.2476198526359637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549461025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977066,0.00033463337,7.740633e-7,0.00019693038,0.000083906685,0.0013195871,0.00004537057,0.000025291034,0.00028691394],"genre_scores_gemma":[0.9991573,0.000046609337,0.000586488,0.0000697066,0.000011434927,0.00002450886,0.000024286614,0.000022195909,0.000057462123],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986099,0.00016080425,0.0003458299,0.00031961146,0.00035411652,0.0002097355],"domain_scores_gemma":[0.99890476,0.00027053428,0.00014898155,0.0003625077,0.00015573368,0.00015746099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003300554,0.00021531244,0.00081113185,0.00011309391,0.000041543393,0.000007588472,0.000081907885,0.00009343761,0.0000119501765],"category_scores_gemma":[0.0009781941,0.0001642383,0.000081037804,0.00015951185,0.00011982489,0.000046125653,0.00007025812,0.000092870454,0.000029071569],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01838024,0.017137855,0.31877416,0.000876458,0.0006904522,0.00012551785,0.0021571876,0.0000025447907,0.63949513,0.000061283165,0.00043885727,0.001860324],"study_design_scores_gemma":[0.0074080904,0.005522084,0.456715,0.0002981046,0.00010390584,0.0000027671115,0.00003255072,5.4086644e-7,0.5297461,0.000040555962,0.000047465783,0.0000828679],"about_ca_topic_score_codex":0.00011382321,"about_ca_topic_score_gemma":0.0000031465886,"teacher_disagreement_score":0.13794082,"about_ca_system_score_codex":0.00003384278,"about_ca_system_score_gemma":0.00007060956,"threshold_uncertainty_score":0.6697444},"labels":[],"label_agreement":null},{"id":"W2549500579","doi":"10.1182/blood.v122.21.2044.2044","title":"Outcomes of Allogeneic Hematopoietic Cell Transplantation In Aplastic Anemia Using Intermediate Dose Alemtuzumab Based-Conditioning","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Alemtuzumab; Medicine; Aplastic anemia; Hematopoietic stem cell transplantation; Transplantation; Internal medicine; Graft-versus-host disease; Gastroenterology; Bone marrow; Paroxysmal nocturnal hemoglobinuria; Surgery; Immunology","score_opus":0.014142255614822848,"score_gpt":0.25338039361335407,"score_spread":0.23923813799853122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549500579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958286,0.00007081173,0.0027327465,0.00005443086,0.000095412775,0.0006307601,0.000025772624,0.000044384044,0.00051706284],"genre_scores_gemma":[0.99539316,0.00002907448,0.004217212,0.000089938476,0.000023100823,0.00007857237,0.00010678774,0.00003552153,0.000026615253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840564,0.00007076586,0.0006461513,0.00027543167,0.00031015798,0.00029186887],"domain_scores_gemma":[0.9990518,0.00035303363,0.0001750885,0.00022499589,0.00007995716,0.000115102266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015343669,0.00021013185,0.00044983678,0.0003022078,0.000034033787,0.0000155192,0.00008868109,0.00013430296,0.00057673285],"category_scores_gemma":[0.00004038022,0.0001967551,0.00010414498,0.00021023968,0.000068164445,0.0001416959,0.000007194292,0.0001613498,0.0000874394],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008412687,0.000889691,0.7773203,0.0037291523,0.0000568299,0.00024442247,0.0015233448,0.00070097524,0.21526086,0.00003418005,0.0000061571536,0.0001499241],"study_design_scores_gemma":[0.0073246784,0.00014769299,0.6884819,0.0008736108,0.00065884454,0.0002552559,0.00025823739,0.0013523514,0.3003446,0.00007585993,9.532604e-7,0.00022600827],"about_ca_topic_score_codex":0.00013066948,"about_ca_topic_score_gemma":0.00002211688,"teacher_disagreement_score":0.08883842,"about_ca_system_score_codex":0.00004618545,"about_ca_system_score_gemma":0.00013633793,"threshold_uncertainty_score":0.8023441},"labels":[],"label_agreement":null},{"id":"W2549513283","doi":"10.1182/blood.v124.21.1945.1945","title":"Autoimmune Cytopenia in Chronic Lymphocytic Leukemia: Effect on Outcome and Survival, a Population Based Analysis in British Columbia, Canada","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC; St. Paul's Hospital; Vancouver General Hospital; Leukemia & Lymphoma Society of Canada; University of British Columbia","funders":"","keywords":"Medicine; Cytopenia; Internal medicine; Autoimmune hemolytic anemia; Gastroenterology; Population; Bone marrow; Immunology; Anemia","score_opus":0.008768652625857309,"score_gpt":0.2558261640616351,"score_spread":0.2470575114357778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549513283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985968,0.0003045525,0.0000069895696,0.000041131672,0.000066135,0.0006614555,0.000011647453,0.00003871035,0.00027257527],"genre_scores_gemma":[0.9990368,0.000016977681,0.000036803274,0.0001685769,0.000058648267,0.00007231998,0.00012241206,0.000036689264,0.0004507751],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972597,0.0003347083,0.0005795563,0.0005631768,0.0006859071,0.00057696446],"domain_scores_gemma":[0.9984749,0.00064432685,0.00009555157,0.0005645177,0.000042286174,0.00017840102],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001077547,0.00018238465,0.0009320895,0.0003057154,0.000071849594,0.00011491403,0.00015530337,0.00017615789,0.0001138668],"category_scores_gemma":[0.00070171535,0.00025015324,0.00010302316,0.0012391253,0.000049467653,0.000059927082,0.00006916375,0.00032298526,0.000007045013],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00007398553,0.00007671036,0.99299514,0.00036808514,0.0001580946,0.00062642863,0.000011285222,0.0025627923,0.00019406348,0.0000024422152,0.000035996854,0.0028949652],"study_design_scores_gemma":[0.049627576,0.00035993982,0.8374616,0.000256971,0.00035808183,0.000050513387,0.0000069906846,0.11151803,0.000086571206,0.0000038548587,0.00007303973,0.00019686468],"about_ca_topic_score_codex":0.994052,"about_ca_topic_score_gemma":0.99833775,"teacher_disagreement_score":0.15553358,"about_ca_system_score_codex":0.099691235,"about_ca_system_score_gemma":0.021465076,"threshold_uncertainty_score":0.99999505},"labels":[],"label_agreement":null},{"id":"W2549524390","doi":"10.1182/blood.v116.21.857.857","title":"A Phase 3 Trial Comparing Bortezomib Plus Rituximab with Rituximab Alone In Patients with Relapsed, Rituximab-Naive or -Sensitive, Follicular Lymphoma","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Rituximab; Internal medicine; Bortezomib; Follicular lymphoma; Refractory (planetary science); Gastroenterology; Lymphoma; Phases of clinical research; Randomization; Oncology; Surgery; Clinical trial; Multiple myeloma","score_opus":0.011473744818631277,"score_gpt":0.2484935082809262,"score_spread":0.23701976346229492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549524390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99504256,0.00011919683,0.000026400683,0.00017429709,0.00023560185,0.0031039594,0.000077464436,0.00014702788,0.0010734799],"genre_scores_gemma":[0.99538285,0.000020925365,0.003144383,0.00025544452,0.00024971337,0.00039013074,0.0003487006,0.00010248742,0.000105396],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9966119,0.00009022587,0.0006704813,0.0009506415,0.00087528065,0.0008015028],"domain_scores_gemma":[0.9979362,0.00015758537,0.00030178702,0.00086408283,0.00029861327,0.0004417378],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021428936,0.00064650667,0.0016385893,0.00030768744,0.0001978517,0.000092122355,0.00017592267,0.00025724195,0.00007721492],"category_scores_gemma":[0.000111466674,0.00042204364,0.00018726804,0.00056889566,0.00022935135,0.00025917013,0.00009003535,0.0003452611,0.0001119403],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34787053,0.30533603,0.32657892,0.00016040659,0.002151096,0.009532783,0.00092327676,0.0000046427003,0.000238424,0.00020015323,0.00036538806,0.006638363],"study_design_scores_gemma":[0.8707375,0.010821608,0.1100895,0.00042760072,0.0015930347,0.000365698,0.00011329846,0.00013965263,0.004420593,0.000008088706,0.00073404965,0.00054938375],"about_ca_topic_score_codex":0.0007439298,"about_ca_topic_score_gemma":0.0012698489,"teacher_disagreement_score":0.52286696,"about_ca_system_score_codex":0.00027144482,"about_ca_system_score_gemma":0.0006432644,"threshold_uncertainty_score":0.99982315},"labels":[],"label_agreement":null},{"id":"W2549537687","doi":"10.1182/blood.v114.22.1953.1953","title":"CD80 (B7.1) Is Expressed On Both Malignant B Cells and Tumor Infiltrating T Cells in Non-Hodgkin's Lymphomas.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"CD80; Follicular lymphoma; Lymphoma; Cancer research; Mantle cell lymphoma; Biology; Rituximab; Immunology; Immune system; Medicine; Cytotoxic T cell; CD40; In vitro","score_opus":0.008733650523847126,"score_gpt":0.2353902096997596,"score_spread":0.2266565591759125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549537687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935183,0.0005211672,0.000008556986,0.00051629264,0.00010690455,0.00038994316,0.000022428701,0.00003834792,0.0048780763],"genre_scores_gemma":[0.9939739,0.00026068778,0.00064967276,0.004594088,0.00012830671,0.000012715558,0.0000047713215,0.000021191603,0.00035467694],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99878204,0.000029511073,0.00031293984,0.00034163523,0.00021549872,0.00031836814],"domain_scores_gemma":[0.9994381,0.000048498867,0.00009704543,0.0002989291,0.000019479905,0.00009792082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001900883,0.00020494577,0.00031032783,0.00012300935,0.000054047247,0.000036894817,0.00008364732,0.00008371106,0.00010793199],"category_scores_gemma":[0.000009103503,0.00017220568,0.00007778557,0.00019058099,0.000046282603,0.000061746876,0.000014363974,0.00012343889,0.000013122188],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060713926,0.0006436437,0.0021956041,0.00005795217,0.00004242423,0.00020059056,0.0006896666,0.0000013210081,0.98593825,0.000008873677,0.0013958314,0.008218676],"study_design_scores_gemma":[0.0094297575,0.0010606406,0.034901537,0.00048800927,0.00005808658,0.000049398655,0.00015921661,0.000065254455,0.95102763,0.000028278788,0.0025068603,0.0002253371],"about_ca_topic_score_codex":0.00017541587,"about_ca_topic_score_gemma":0.000013462023,"teacher_disagreement_score":0.034910653,"about_ca_system_score_codex":0.000038021597,"about_ca_system_score_gemma":0.00006756238,"threshold_uncertainty_score":0.7022344},"labels":[],"label_agreement":null},{"id":"W2549565078","doi":"10.1182/blood.v104.11.4957.4957","title":"Anti-Thymocyte Globulin Increases Dramatically Natural Killer Cell Interferon Gamma Production While Respecting Other Functionnal Aspects of These Cells.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Molecular biology; Biology; Thymocyte; Natural killer cell; CD16; Peripheral blood mononuclear cell; CD3; Anti-thymocyte globulin; Flow cytometry; Aldesleukin; Immunology; Interleukin 21; T cell; Cytotoxicity; Cytokine; Interleukin 2; CD8; Antigen; Immune system; In vitro; Biochemistry; Globulin","score_opus":0.009574886905469357,"score_gpt":0.21081548182396234,"score_spread":0.201240594918493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549565078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833062,0.0017128794,0.00014196962,0.00018047412,0.0061104516,0.0002864231,0.0000023735847,0.00014071216,0.008118516],"genre_scores_gemma":[0.9927332,0.00005770871,0.00016086953,0.00011304218,0.00018753596,0.000013059647,0.000037079237,0.000030599713,0.0066669537],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985988,0.00016997707,0.000474095,0.0003768323,0.00007506529,0.00030521242],"domain_scores_gemma":[0.9991451,0.00006821781,0.00026674845,0.00033506856,0.0001611968,0.000023676599],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023943173,0.00023005286,0.00030266572,0.00017215018,0.00015257366,0.000027575725,0.00014923645,0.00019225042,0.0012350695],"category_scores_gemma":[0.00014784247,0.00019813357,0.00015248207,0.00020161051,0.00013479896,0.00022951857,0.000063144245,0.000448692,0.0007625161],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055943854,0.0013942625,0.00022639282,0.00004915034,0.00020431982,0.0000037847424,0.0005770318,0.00006973506,0.99528915,0.00041367346,0.00093565276,0.00027744056],"study_design_scores_gemma":[0.0025900314,0.0005625122,0.0021962172,0.0001465008,0.00014219152,0.00013085832,0.0005541347,0.0000029054643,0.98196846,0.000116589625,0.011372473,0.00021713789],"about_ca_topic_score_codex":0.00030932605,"about_ca_topic_score_gemma":0.00004490025,"teacher_disagreement_score":0.0133206695,"about_ca_system_score_codex":0.00006997637,"about_ca_system_score_gemma":0.000079230456,"threshold_uncertainty_score":0.99967796},"labels":[],"label_agreement":null},{"id":"W2549567777","doi":"10.1182/blood.v118.21.3477.3477","title":"Genomic and Molecular Properties of Relapsed CNS Lymphoma Using Novel Primary Meningeal Lymphoma Cell Lines and Intracranial Xenografts,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Lymphoma; Comparative genomic hybridization; Pathology; Cancer research; Cerebrospinal fluid; Biology; Medicine; Oncology; Chromosome; Gene; Genetics","score_opus":0.02525646246812333,"score_gpt":0.21018324454602993,"score_spread":0.1849267820779066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549567777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906373,0.008177215,0.000024281433,0.000040215615,0.00006416597,0.00041081395,0.000015959618,0.000035860747,0.0005941977],"genre_scores_gemma":[0.98674893,0.00039194344,0.012569269,0.000113029804,0.00008230987,0.000022151395,0.000008371726,0.000042582717,0.000021426555],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99889684,0.000022031698,0.00033895983,0.00032849604,0.00017096018,0.00024269037],"domain_scores_gemma":[0.9993964,0.000018069342,0.0001304572,0.00024109383,0.00006802868,0.00014596648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008972762,0.00023375828,0.0004328974,0.000113605354,0.00007335561,0.000017954524,0.00005788823,0.000111911504,0.000011787166],"category_scores_gemma":[0.000016077136,0.00018776118,0.00007700869,0.000090786074,0.00016408063,0.000062605424,0.00010411382,0.000030293884,0.0000016712188],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041539263,0.004002026,0.0677488,0.00034551052,0.00032541342,0.00022432818,0.0013802017,4.5313112e-7,0.91520506,0.0000423276,0.0000064237,0.010304081],"study_design_scores_gemma":[0.018023966,0.00069296086,0.40138614,0.00024672988,0.0012516727,0.00085693336,0.0001535348,0.000110310386,0.57694834,0.000015793461,0.00008613125,0.0002274904],"about_ca_topic_score_codex":0.00043061897,"about_ca_topic_score_gemma":0.0000072875596,"teacher_disagreement_score":0.3382567,"about_ca_system_score_codex":0.000054985554,"about_ca_system_score_gemma":0.00016099577,"threshold_uncertainty_score":0.76566786},"labels":[],"label_agreement":null},{"id":"W2549572931","doi":"10.1182/blood.v104.11.2587.2587","title":"A Meta-Analysis to Determine the Risk of Heparin Induced Thrombocytopenia (HIT) and Isolated Thrombocytopenia in Prophylaxis Studies Comparing Unfractioneted Heparin (UFH) and Low Molecular Weight Heparin (LMWH).","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Heparin-induced thrombocytopenia; Heparin; Odds ratio; Meta-analysis; Low molecular weight heparin; Internal medicine; Randomized controlled trial; Surgery","score_opus":0.0807545061861274,"score_gpt":0.3141963509389421,"score_spread":0.2334418447528147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549572931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993092,0.002658742,0.00012968332,0.00100552,0.000089291396,0.0024771504,0.000031524774,0.00011483515,0.00040123257],"genre_scores_gemma":[0.9963612,0.000742369,0.0020154456,0.0003349882,0.00005141372,0.00028986318,0.000027587022,0.00009933846,0.00007777701],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9944726,0.0005917367,0.001717546,0.0015049669,0.00078844884,0.00092466734],"domain_scores_gemma":[0.9964566,0.00041642654,0.00067384396,0.0015395015,0.0004081958,0.0005054248],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013763035,0.00094947993,0.005077577,0.0010060193,0.00039505734,0.00014284864,0.00049212354,0.00040628936,0.00007688549],"category_scores_gemma":[0.0005105183,0.0006771599,0.0008006804,0.0031337738,0.0004248144,0.00038411157,0.0008090661,0.0010988371,0.00002880602],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009789314,0.0034594946,0.31817612,0.0005566245,0.2577899,0.0004945055,0.008358343,0.000782969,0.40755326,0.00065098883,0.000018535837,0.001180324],"study_design_scores_gemma":[0.010545677,0.0021094286,0.63401264,0.00017234783,0.17423332,0.0002562088,0.0007826448,0.00091504067,0.17513683,0.0006883003,0.00005302034,0.0010945636],"about_ca_topic_score_codex":0.0061209556,"about_ca_topic_score_gemma":0.008129185,"teacher_disagreement_score":0.31583652,"about_ca_system_score_codex":0.00024310072,"about_ca_system_score_gemma":0.00027578554,"threshold_uncertainty_score":0.999568},"labels":[],"label_agreement":null},{"id":"W2549580878","doi":"10.1182/blood.v126.23.28.28","title":"Eloquent-2 Update: A Phase 3, Randomized, Open-Label Study of Elotuzumab in Combination with Lenalidomide/Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma - 3-Year Safety and Efficacy Follow-up","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre; Dalhousie University","funders":"","keywords":"Lenalidomide; Dexamethasone; Medicine; Multiple myeloma; Refractory (planetary science); Oncology; Internal medicine; Phases of clinical research; Daratumumab; Clinical trial; Biology","score_opus":0.031839832501048354,"score_gpt":0.31030300562441016,"score_spread":0.2784631731233618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549580878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99226606,0.00019807332,0.000022552696,0.000050752315,0.000031509833,0.007005534,0.000031100713,0.000024453388,0.00036998838],"genre_scores_gemma":[0.9980771,0.00003854838,0.001229539,0.000019535324,0.000008669693,0.00026402023,0.00020210056,0.000049703667,0.000110812165],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9969588,0.0006073689,0.00066114066,0.0005427439,0.0008172769,0.00041266473],"domain_scores_gemma":[0.9981458,0.00045660467,0.00027256433,0.0004827143,0.0003074167,0.00033485572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011456237,0.0003125402,0.0011811692,0.00040942556,0.000055351862,0.00004142123,0.000189876,0.00009695848,0.000016300643],"category_scores_gemma":[0.0008724448,0.00021342156,0.000031899985,0.00056230277,0.00016156866,0.00031142886,0.0001489291,0.00031470804,0.0000075832722],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4661323,0.06745853,0.45947042,0.000040220933,0.00058125023,0.00019522832,0.0017056509,0.0000026882742,0.000033082535,0.000025070349,0.000010997416,0.0043445486],"study_design_scores_gemma":[0.7393625,0.011585261,0.24721141,0.00024776807,0.0002805815,0.000006941484,0.0008569473,0.00009287457,0.00016124934,0.000011569774,0.000015184141,0.0001677415],"about_ca_topic_score_codex":0.0016330159,"about_ca_topic_score_gemma":0.0009105732,"teacher_disagreement_score":0.27323014,"about_ca_system_score_codex":0.0001731394,"about_ca_system_score_gemma":0.00027806518,"threshold_uncertainty_score":0.87030786},"labels":[],"label_agreement":null},{"id":"W2549633988","doi":"10.1182/blood.v124.21.5111.5111","title":"The Prospective Use of Prothrombin Complex Concentrates in an Administrative Region of the Province of Quebec.","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Health, Medicine and Society","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Prothrombin complex concentrate; Medical prescription; Bleed; Warfarin; Emergency medicine; Intensive care unit; Emergency department; Pediatrics; Surgery; Intensive care medicine; Internal medicine","score_opus":0.10554125774870117,"score_gpt":0.4045295683681454,"score_spread":0.29898831061944425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549633988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954072,0.000034568933,0.000020380863,0.0010017903,0.000058533453,0.002527231,0.000012595181,0.000008835644,0.00092884805],"genre_scores_gemma":[0.99918073,0.000023395225,0.00012560093,0.00024484217,0.00004554531,0.00008681184,0.0000025727848,0.000008376912,0.0002821292],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974471,0.0013904823,0.00058023393,0.00014436667,0.0002028765,0.00023494082],"domain_scores_gemma":[0.99768054,0.0010907729,0.0005375823,0.0003703277,0.00026852312,0.000052222575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083649106,0.00008516498,0.00029394118,0.000012315386,0.00021305023,0.0000023954835,0.00018782649,0.0001516996,0.000007562013],"category_scores_gemma":[0.00075447035,0.000045415924,0.000044126587,0.00017015116,0.0004535248,0.000083487095,0.0000380154,0.00046903364,6.5471926e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014205032,0.0010096827,0.88900465,0.00090640935,0.000040364423,0.0000014712954,0.054339364,0.000001603171,0.0042119673,0.048725616,0.001109501,0.0005073138],"study_design_scores_gemma":[0.0025228004,0.00084102125,0.96550083,0.00071532786,0.00003180058,8.419563e-7,0.02007479,0.00011124723,0.007851236,0.0010621614,0.001213009,0.00007494624],"about_ca_topic_score_codex":0.003568637,"about_ca_topic_score_gemma":0.024449095,"teacher_disagreement_score":0.07649616,"about_ca_system_score_codex":0.000039293074,"about_ca_system_score_gemma":0.0014633448,"threshold_uncertainty_score":0.9933522},"labels":[],"label_agreement":null},{"id":"W2549638472","doi":"10.1182/blood.v114.22.624.624","title":"MicroRNA Are Useful Biomarkers for Prediction of Response to Therapy and Survival of Patients with Diffuse Large B-Cell Lymphoma.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; microRNA; Lymphoma; Anthracycline; Cancer research; BCL6; Gene expression profiling; Biology; Carcinogenesis; Oncology; Gene expression; Gene; Medicine; Internal medicine; Cancer; Immunology; B cell; Antibody; Breast cancer; Genetics; Germinal center","score_opus":0.011860579349876759,"score_gpt":0.22483939562237118,"score_spread":0.21297881627249443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549638472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979855,0.00033666467,0.000011413779,0.0001951921,0.000028311864,0.00077607477,0.0006194883,0.0000141130395,0.00003327873],"genre_scores_gemma":[0.99919504,0.000065335735,0.0004982504,0.00010930579,0.00001222381,0.000027235232,0.00005302306,0.000011935128,0.00002768035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993193,0.000032300253,0.00017827295,0.00017600387,0.00015700421,0.0001370834],"domain_scores_gemma":[0.99940723,0.00008448781,0.000110770365,0.000189188,0.00011856903,0.000089757326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001132314,0.000112422924,0.00024981223,0.00008337143,0.000027443846,0.0000044141816,0.00003151093,0.000047194255,0.000002771424],"category_scores_gemma":[0.000031241776,0.00007784029,0.000053078566,0.000102110534,0.000020461499,0.000027308939,0.00000813752,0.000009702705,4.959934e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012564811,0.025464866,0.9493705,0.000042204963,0.00022848838,0.0000059526856,0.0002654674,5.940661e-8,0.009971888,0.0000044015874,0.00017483426,0.0019065001],"study_design_scores_gemma":[0.08613915,0.004355398,0.8510111,0.00008588489,0.00017445107,0.0000018364955,0.00005797936,0.0000015388534,0.05748533,0.000003150081,0.00063092913,0.000053228396],"about_ca_topic_score_codex":0.000007657458,"about_ca_topic_score_gemma":0.0000038122555,"teacher_disagreement_score":0.0983594,"about_ca_system_score_codex":0.000024040137,"about_ca_system_score_gemma":0.000041767624,"threshold_uncertainty_score":0.3174235},"labels":[],"label_agreement":null},{"id":"W2549657859","doi":"10.1182/blood.v106.11.4642.4642","title":"Common Variable Immunodeficiency Presenting with Hodgkin’s Disease.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Regional Hospital","funders":"","keywords":"Common variable immunodeficiency; Hypogammaglobulinemia; Medicine; Autoimmune hemolytic anemia; Lymphoma; Disease; Immunology; Immunodeficiency; Pediatrics; Internal medicine; Antibody; Immune system","score_opus":0.005857252173986124,"score_gpt":0.20525150166291042,"score_spread":0.1993942494889243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549657859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9259376,0.047787417,0.00024987877,0.00025041826,0.00023783746,0.00027860457,0.000022386997,0.000238611,0.024997242],"genre_scores_gemma":[0.99506503,0.0000667198,0.00019441554,0.000177352,0.000009370851,0.000040835574,0.00010399042,0.000029273031,0.0043130154],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99849945,0.0001113654,0.00031799433,0.00036624487,0.00006930233,0.00063565746],"domain_scores_gemma":[0.9991692,0.000072678704,0.00012879154,0.0005622341,0.000054890796,0.000012237226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022717137,0.00024251785,0.00026749953,0.00009098437,0.0005380752,0.000043865475,0.00044016467,0.00012073831,0.00070595206],"category_scores_gemma":[0.000038306323,0.00019947953,0.00008547735,0.0002671564,0.00023283903,0.00023307321,0.00011949104,0.00032807034,0.00066148106],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012130553,0.018544292,0.12619139,0.00028577464,0.0018833501,0.000087819535,0.005392472,0.0031851812,0.7550306,0.043814927,0.0015063816,0.04286477],"study_design_scores_gemma":[0.01910797,0.0006588358,0.20638385,0.00031388967,0.0012136732,0.00043799795,0.0014914714,0.0002190733,0.1145351,0.0012599465,0.6519576,0.002420636],"about_ca_topic_score_codex":0.00010291129,"about_ca_topic_score_gemma":0.0000031583297,"teacher_disagreement_score":0.6504512,"about_ca_system_score_codex":0.000015798743,"about_ca_system_score_gemma":0.00010260036,"threshold_uncertainty_score":0.8502221},"labels":[],"label_agreement":null},{"id":"W2549668171","doi":"10.1182/blood.v106.11.1378.1378","title":"Dominant and Pharmacologically Sensitized ENU Mutagenesis Screens Uncover Novel Regulators of Hematopoiesis and Model Hematopoietic Disease.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Ontario Institute for Cancer Research; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Biology; Haematopoiesis; Genetic screen; Genetics; Mutation; Mutagenesis; Frameshift mutation; Mutant; Gene; Stem cell","score_opus":0.017569629850471,"score_gpt":0.2775685893243949,"score_spread":0.2599989594739239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549668171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949816,0.0011351787,0.00078547007,0.0019826205,0.000010530812,0.00055785157,0.00006315623,0.000046900837,0.0004366939],"genre_scores_gemma":[0.98530614,0.00049740734,0.012963969,0.00050464546,0.00009136319,0.000025066478,0.000009643254,0.000037860063,0.0005639239],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983329,0.00004443924,0.00037435256,0.00043393075,0.00043544985,0.00037893385],"domain_scores_gemma":[0.9987707,0.00015399815,0.00010304179,0.00034413714,0.00014671293,0.00048138943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033038433,0.00023880694,0.00056999794,0.0002221308,0.00008527232,0.000017210763,0.0000889969,0.00012269171,0.00006312574],"category_scores_gemma":[0.0001796467,0.0001887867,0.00010518276,0.00026824712,0.00031981035,0.00008987353,0.00020078207,0.00017198976,0.0000066401176],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016076852,0.0015923533,0.008765368,0.0008814493,0.0005295133,0.00032983394,0.00048184593,0.00020947601,0.98185825,0.0010156232,0.0017469246,0.000981675],"study_design_scores_gemma":[0.05748162,0.0006225332,0.065830484,0.00065830257,0.0045415475,0.0019004329,0.00057564443,0.100566894,0.76490164,0.00076082343,0.0010249234,0.0011351649],"about_ca_topic_score_codex":0.0000135966675,"about_ca_topic_score_gemma":0.0000027399453,"teacher_disagreement_score":0.21695662,"about_ca_system_score_codex":0.000044436794,"about_ca_system_score_gemma":0.00020436852,"threshold_uncertainty_score":0.7698498},"labels":[],"label_agreement":null},{"id":"W2549702628","doi":"10.1182/blood.v108.11.1333.1333","title":"The Hematopoietic Activity of the Homeobox Gene HOXB4 Depends on a N-Terminal Proline-Rich Region In Vitro and In Vivo.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Homeobox; Biology; Haematopoiesis; Mutant; Molecular biology; In vitro; In vivo; Stem cell; Gene; Cancer research; Cell biology; Transcription factor; Genetics","score_opus":0.006381836200548598,"score_gpt":0.2342165173036614,"score_spread":0.22783468110311278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549702628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99829227,0.00068158505,0.00011871157,0.00021854491,0.000030048193,0.00031007262,0.0000058964547,0.0000028749662,0.00034002107],"genre_scores_gemma":[0.99948126,0.00013982867,0.000042770956,0.000027519438,0.000050022918,0.000051651434,0.000003123556,0.000015662095,0.00018813495],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990431,0.00011947178,0.00015374333,0.00025756343,0.0001868596,0.00023925441],"domain_scores_gemma":[0.99948215,0.000020525973,0.00006831716,0.0003722251,0.00003139191,0.000025389718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002004576,0.00011151523,0.00012269618,0.00005358591,0.00005536138,0.000015731799,0.000192619,0.00013260276,0.000001095432],"category_scores_gemma":[0.000049267324,0.000076313605,0.00004958319,0.00018859885,0.00008179252,0.0000022320269,0.00014030654,0.00018165946,4.0431536e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030568958,0.00023758906,0.0004616395,0.000016532795,0.000011358295,0.000030138284,0.000015113841,0.00003300199,0.997988,0.000023592325,0.00002756155,0.0008498099],"study_design_scores_gemma":[0.0013204841,0.00013182397,0.003843126,0.000022979704,0.00001014933,0.00011528331,0.000010252242,0.00007428354,0.9940329,0.0001272374,0.00022780205,0.000083687686],"about_ca_topic_score_codex":0.00009815413,"about_ca_topic_score_gemma":0.0004283345,"teacher_disagreement_score":0.003955082,"about_ca_system_score_codex":0.000018119872,"about_ca_system_score_gemma":0.00008203575,"threshold_uncertainty_score":0.31119785},"labels":[],"label_agreement":null},{"id":"W2549713075","doi":"10.1182/blood.v112.11.1311.1311","title":"Comprehensiveness of Quality of Life Instruments in Capturing Concerns Related to Chemotherapy-Induced Neutropenia","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Neutropenia; Medicine; Quality of life (healthcare); Anxiety; Visual analogue scale; Physical therapy; Cancer; Febrile neutropenia; Internal medicine; Intensive care medicine; Chemotherapy; Psychiatry; Nursing","score_opus":0.060438527657304585,"score_gpt":0.3264892365291766,"score_spread":0.26605070887187204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549713075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971288,0.00005806797,0.0000022183783,0.00025028072,0.00007957794,0.00040046137,0.0000074552413,0.000021670778,0.002051493],"genre_scores_gemma":[0.9994217,0.000040450806,0.00008170405,0.00031137335,0.000024781331,0.000016746633,0.0000037890595,0.000016526172,0.00008292859],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895287,0.00005578102,0.00048269675,0.00017797967,0.00018293306,0.00014775424],"domain_scores_gemma":[0.99934983,0.000025887466,0.00014212386,0.00025842403,0.00011607917,0.000107634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008163245,0.00010403763,0.00047116925,0.00010447696,0.00002844245,0.0000017127053,0.00007893722,0.00006586597,0.000074265736],"category_scores_gemma":[0.00003239037,0.00009942677,0.000075681295,0.00031858988,0.000051072893,0.000043107404,0.00003291791,0.0001322298,0.000007321229],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026233672,0.00056151487,0.576968,0.000088473535,0.00010835006,0.000008902183,0.0009579952,0.000029109873,0.4206027,0.00010049948,0.000011959137,0.00030016253],"study_design_scores_gemma":[0.0072404253,0.00022166666,0.7367725,0.00010592407,0.000032011067,0.000020605154,0.00011257058,0.0000015013359,0.2552932,0.000009715628,0.00011113748,0.00007879464],"about_ca_topic_score_codex":0.0011982999,"about_ca_topic_score_gemma":0.000060849765,"teacher_disagreement_score":0.16530953,"about_ca_system_score_codex":0.000031304808,"about_ca_system_score_gemma":0.00016935721,"threshold_uncertainty_score":0.40545058},"labels":[],"label_agreement":null},{"id":"W2549796089","doi":"10.1182/blood.v126.23.5481.5481","title":"Antithymocyte Globulin at Clinically Relevant Concentration Kills Leukemic Blasts","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Alberta; University of Calgary","funders":"","keywords":"Leukemia; Immunology; Medicine; Bone marrow; Methotrexate; Transplantation; Myeloid leukemia; Haematopoiesis; Chemotherapy; Internal medicine; Stem cell; Biology","score_opus":0.02930032877816228,"score_gpt":0.29196803633427587,"score_spread":0.26266770755611357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549796089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98392344,0.00019998255,0.00047860693,0.00036461154,0.00025659928,0.00043509682,0.00004597994,0.0001282064,0.014167457],"genre_scores_gemma":[0.99290514,0.00015728135,0.004356613,0.00042865393,0.00023363436,0.000014574189,0.00027928635,0.000026745009,0.0015980627],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99847627,0.000062399835,0.00051349035,0.00028880307,0.00040900437,0.00025004128],"domain_scores_gemma":[0.99896336,0.00016982152,0.00012361877,0.0002902507,0.0001504603,0.00030247757],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033301723,0.00014112661,0.00028331118,0.000029480761,0.000036834677,0.00001466722,0.000071885996,0.00014563574,0.00035882246],"category_scores_gemma":[0.00030785272,0.00012463912,0.00007619051,0.00012264904,0.00006379127,0.00006421305,0.00001962745,0.00013242781,0.0011603938],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034650643,0.003426504,0.56527287,0.001067882,0.000740341,0.0024687042,0.0058623683,0.00005583814,0.36588302,0.0009981396,0.04673455,0.0040247585],"study_design_scores_gemma":[0.092637725,0.005416512,0.18643184,0.0031450053,0.0031851705,0.0069870725,0.0006920681,0.0020308432,0.6558264,0.0007705692,0.04128784,0.0015889442],"about_ca_topic_score_codex":0.000013449763,"about_ca_topic_score_gemma":0.000008679756,"teacher_disagreement_score":0.378841,"about_ca_system_score_codex":0.00010660228,"about_ca_system_score_gemma":0.0003233305,"threshold_uncertainty_score":0.99961734},"labels":[],"label_agreement":null},{"id":"W2549803051","doi":"10.1182/blood.v110.11.866.866","title":"Accurate Detection of the microRNA Transcriptome in a Leukemia Progression Model.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Terry Fox Research Institute","funders":"","keywords":"microRNA; Deep sequencing; Biology; Myeloid leukemia; Transcriptome; Gene expression profiling; Computational biology; Small RNA; DNA microarray; Cancer research; Genetics; Gene; Gene expression; Genome","score_opus":0.008611776945099785,"score_gpt":0.25195028109597484,"score_spread":0.24333850415087505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549803051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99523723,0.000497009,0.0038620026,0.000014032305,0.00004336332,0.00019368516,0.0000049143214,0.000005170738,0.00014256855],"genre_scores_gemma":[0.9995722,0.00001346784,0.0002956247,0.000021128164,0.000037776266,0.000007114594,0.000008135011,0.000009931381,0.000034598128],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99945736,0.000023897754,0.00016934327,0.00014311697,0.000080511236,0.00012576266],"domain_scores_gemma":[0.99966687,0.0000026361408,0.000074515236,0.00019722282,0.000033615896,0.000025141637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016073097,0.00006996095,0.000059671784,0.000031529977,0.000024941033,0.00000410357,0.00010665717,0.00010249423,0.0000013690379],"category_scores_gemma":[0.000019888397,0.00005407124,0.00006148161,0.00010909285,0.000035530495,0.0000027377266,0.000028147719,0.000052143852,6.153784e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006625576,0.000079721554,0.0014313025,0.000018922168,0.000010301673,6.256319e-7,0.00003885852,0.000379195,0.9967612,0.0000045191405,0.0000078720905,0.0012012356],"study_design_scores_gemma":[0.00077506795,0.000034437326,0.03091093,0.000026345891,0.000018034312,0.000006226426,0.0000100766365,0.0005638617,0.9673914,0.000040623356,0.00016123432,0.00006177662],"about_ca_topic_score_codex":0.0000066915013,"about_ca_topic_score_gemma":0.00007247159,"teacher_disagreement_score":0.029479628,"about_ca_system_score_codex":0.000018059382,"about_ca_system_score_gemma":0.00005873032,"threshold_uncertainty_score":0.2204961},"labels":[],"label_agreement":null},{"id":"W2549813000","doi":"10.1182/blood.v108.11.3421.3421","title":"Chemical Library Screening Identifies Novel Inhibitors of Cyclin D2 (CCND2) Transactivation That Selectively Induce Apoptosis in Multiple Myeloma Cells.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Bioactive Compounds and Antitumor Agents","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Cyclin D2; Cancer research; Cell cycle; Biology; Chemistry; Cyclin; Molecular biology; Apoptosis; Biochemistry","score_opus":0.07967812500013023,"score_gpt":0.3235447068192255,"score_spread":0.24386658181909526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549813000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974776,0.00018451326,0.00051573256,0.00014824138,0.00030625745,0.00028871335,0.00009212344,0.000071016504,0.0009158273],"genre_scores_gemma":[0.99826324,0.00003597538,0.0011238687,0.00011901265,0.00019243304,0.000027214586,0.000058067206,0.000032875498,0.00014730298],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99857396,0.00013835836,0.00040974352,0.0003570348,0.00017604463,0.00034486523],"domain_scores_gemma":[0.9993025,0.00026950226,0.0002024993,0.00010883758,0.000042244144,0.000074422685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019660544,0.00022729051,0.00030060633,0.00020207472,0.000113724964,0.000027756298,0.00021153584,0.00033468063,0.000120081386],"category_scores_gemma":[0.000018591425,0.00023706428,0.00012634236,0.00042253506,0.00016743831,0.00039660654,0.000056080742,0.00055607496,0.000006068671],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018300458,0.0017475527,0.17702481,0.000047912807,0.00008685821,0.0000049818927,0.00020799457,0.00006469624,0.8190997,0.00003110445,0.00028560794,0.0012157204],"study_design_scores_gemma":[0.003474555,0.000033427128,0.08843738,0.000048706945,0.000084437204,0.0000042161137,0.000117673655,0.0003938702,0.90650547,0.00006220866,0.0006152542,0.00022283017],"about_ca_topic_score_codex":0.0001227873,"about_ca_topic_score_gemma":0.000020032034,"teacher_disagreement_score":0.08858744,"about_ca_system_score_codex":0.00001983878,"about_ca_system_score_gemma":0.000044071137,"threshold_uncertainty_score":0.9667201},"labels":[],"label_agreement":null},{"id":"W2549848218","doi":"10.1182/blood.v106.11.1919.1919","title":"C-myc Abnormalities in Non-Hodgkins Lymphoma - A Retrospective Review of Cytogenetic Patterns and Clinical Impact of c-myc Abnormalities by FISH Testing.","year":2005,"lang":"en","type":"review","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Lymphoma; Follicular lymphoma; Medicine; International Prognostic Index; Gastroenterology; Chromosomal translocation; Chromosome abnormality; Internal medicine; Diffuse large B-cell lymphoma; Histology; Pathology; Stage (stratigraphy); Non-Hodgkin's lymphoma; Large-cell lymphoma; Oncology; Biology; Karyotype; Chromosome","score_opus":0.0442738370873098,"score_gpt":0.37447319765478176,"score_spread":0.33019936056747196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549848218","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08045778,0.9146095,2.8879487e-7,0.00002594545,0.00005978303,0.0017363462,0.0020613184,0.000024410016,0.0010246271],"genre_scores_gemma":[0.020518465,0.978102,0.00016333292,0.00015377237,0.00022684822,0.0002418719,0.00038708237,0.00008182547,0.00012478676],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9953271,0.00034692034,0.0026050676,0.00069091056,0.0005097476,0.0005202466],"domain_scores_gemma":[0.9963629,0.0009417078,0.0013741349,0.000795144,0.00026240127,0.0002636845],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00079474883,0.00077807315,0.005284458,0.00026464273,0.000037093214,0.00002108456,0.00023720069,0.00039571,0.000115141374],"category_scores_gemma":[0.0006200985,0.0005610818,0.0013378838,0.000452577,0.00024839517,0.000087264154,0.00016597593,0.00024710517,0.0000070636065],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002316227,0.0037681584,0.43669084,0.09593703,0.0018661421,0.00017252396,0.00009396916,3.287534e-8,2.21622e-7,0.000008982276,0.0009500534,0.4604889],"study_design_scores_gemma":[0.0074571436,0.0037059118,0.5972618,0.3424118,0.011026632,0.0011767711,0.00003356661,0.0000015399794,0.000021478241,0.0000069526313,0.036228184,0.0006682316],"about_ca_topic_score_codex":0.0020949407,"about_ca_topic_score_gemma":0.00011327412,"teacher_disagreement_score":0.45982066,"about_ca_system_score_codex":0.0004240809,"about_ca_system_score_gemma":0.0009702651,"threshold_uncertainty_score":0.9996841},"labels":[],"label_agreement":null},{"id":"W2549870434","doi":"10.1182/blood.v108.11.4008.4008","title":"Unexpected Harmful Side Effects Triggered by Immune Modulation.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; St. Joseph's Hospital","funders":"","keywords":"Medicine; Gastroenterology; Internal medicine; Rheumatoid factor; Surgery; Cyclophosphamide; Factor IX; Rheumatoid arthritis; Chemotherapy","score_opus":0.009553426972603599,"score_gpt":0.2603334367042782,"score_spread":0.25078000973167464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549870434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861787,0.0022466315,0.000024374558,0.0009007022,0.000050226416,0.0005137691,0.000008363522,0.00012603331,0.009951199],"genre_scores_gemma":[0.98677206,0.000030988216,0.00029186695,0.000030137586,0.00019365127,0.000040008963,0.0002712328,0.000022936263,0.012347112],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99901235,0.000045523473,0.00019069288,0.0002008402,0.00028168975,0.00026890132],"domain_scores_gemma":[0.99946845,0.00009453796,0.00003347873,0.0002444805,0.00006842624,0.00009060318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000075131895,0.00012424983,0.00024237235,0.00009064475,0.00007731572,0.000017318593,0.000052544478,0.00008942496,0.00008703785],"category_scores_gemma":[0.00007240422,0.000093415976,0.00009405257,0.0002468751,0.00003822291,0.000041682186,0.000019250185,0.00011804457,0.00013392273],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012298925,0.0026659046,0.023753844,0.00011673713,0.00027450293,0.0003205848,0.000056171193,0.00000308156,0.96326554,0.00008516012,0.0050181886,0.004317297],"study_design_scores_gemma":[0.015662504,0.00044008592,0.23768465,0.000085771695,0.0003275125,0.0000515598,0.000016102553,0.00022196156,0.74240816,0.00026866005,0.0026549287,0.00017812902],"about_ca_topic_score_codex":0.00016994396,"about_ca_topic_score_gemma":0.000003162735,"teacher_disagreement_score":0.22085741,"about_ca_system_score_codex":0.000027807893,"about_ca_system_score_gemma":0.000050183924,"threshold_uncertainty_score":0.3809393},"labels":[],"label_agreement":null},{"id":"W2549870470","doi":"10.1182/blood.v120.21.2316.2316","title":"Studies in C4b-Deficient Mice Provide Further Evidence That Complement Cascade Orchestrates the Mobilization of Hematopoietic Stem/Progenitor Cells.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Canadian Blood Services; University of Alberta","funders":"","keywords":"Haematopoiesis; Progenitor cell; Cell biology; Complement system; Complement membrane attack complex; Bone marrow; Stem cell; Mobilization; Anaphylatoxin; Chemistry; Biology; Immunology; Immune system","score_opus":0.08773059149016808,"score_gpt":0.31175762963009046,"score_spread":0.22402703813992236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549870470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8305993,0.16825362,0.000023314087,0.00016992037,0.00034711527,0.0005585227,0.0000067825986,0.000019882602,0.0000215273],"genre_scores_gemma":[0.99749523,0.0018294416,0.000031174986,0.000058938575,0.000015647187,0.00011553461,0.0000049270147,0.000016445538,0.0004326591],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984241,0.0005559861,0.00039218416,0.00017832033,0.000065899214,0.00038351194],"domain_scores_gemma":[0.9987255,0.00062515953,0.00024985464,0.00031961923,0.00006950793,0.000010385883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074993534,0.00018209995,0.00028960098,0.00007576169,0.00012489979,0.000009893755,0.00026384727,0.000101925325,0.00008193514],"category_scores_gemma":[0.00005640014,0.00011845731,0.00008109353,0.00017528996,0.0003205595,0.00013784188,0.00009091887,0.00016587411,0.00007344582],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021670312,0.0008152215,0.010398139,0.00015641673,0.00029972597,0.0000011648737,0.021717964,0.000010371029,0.9654417,0.00012670868,0.00016181974,0.00065403956],"study_design_scores_gemma":[0.0010229901,0.00017686999,0.00477404,0.00025511853,0.00010291248,0.000057383455,0.017565193,0.0000010440663,0.97363454,0.000013453335,0.0022567713,0.000139683],"about_ca_topic_score_codex":0.00007174878,"about_ca_topic_score_gemma":0.000018310931,"teacher_disagreement_score":0.16689591,"about_ca_system_score_codex":0.00003306209,"about_ca_system_score_gemma":0.000055003155,"threshold_uncertainty_score":0.48305488},"labels":[],"label_agreement":null},{"id":"W2549876270","doi":"10.1182/blood.v124.21.5399.5399","title":"Lymphoplasmacytic Lymphoma and Marginal Zone Lymphoma in the Bone Marrow: Paratrabecular Involvement As an Important Distinguishing Feature","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Lymphoplasmacytic Lymphoma; Bone marrow; Waldenstrom macroglobulinemia; Pathology; Medicine; Marginal zone B-cell lymphoma; Lymphoma; Splenic marginal zone lymphoma; Macroglobulinemia; Marginal zone; Immunology; B cell; Multiple myeloma; Antibody","score_opus":0.01238119350136022,"score_gpt":0.26700206865361187,"score_spread":0.2546208751522516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549876270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99359626,0.0022052645,0.000023692895,0.001051265,0.00009231569,0.0007896903,0.000007906328,0.00007784477,0.002155751],"genre_scores_gemma":[0.99647284,0.0002246411,0.00084507745,0.001328446,0.00044259577,0.000108905115,0.00008527574,0.000065634544,0.0004265669],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9963789,0.00030118224,0.0005480929,0.00076958595,0.001120392,0.00088183436],"domain_scores_gemma":[0.997981,0.00030376573,0.00016394626,0.0010376992,0.00010427195,0.00040928822],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001876756,0.00040290027,0.000579226,0.00019660787,0.00021651303,0.00019676541,0.00038211382,0.00023069553,0.0000366232],"category_scores_gemma":[0.000620937,0.00029111977,0.00011648483,0.00046716136,0.0002476441,0.00016175045,0.00017689588,0.0002114475,0.000033904493],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009591828,0.03935669,0.48289075,0.0077653774,0.0027874038,0.08571064,0.036892716,0.00006679382,0.04744733,0.041543882,0.01075219,0.2351944],"study_design_scores_gemma":[0.47215807,0.005810858,0.30521116,0.0025386193,0.0023625554,0.06036606,0.008027369,0.05035153,0.021336878,0.004379015,0.06451647,0.0029414068],"about_ca_topic_score_codex":0.0022385418,"about_ca_topic_score_gemma":0.00080183765,"teacher_disagreement_score":0.46256626,"about_ca_system_score_codex":0.0023393207,"about_ca_system_score_gemma":0.0027697016,"threshold_uncertainty_score":0.9999541},"labels":[],"label_agreement":null},{"id":"W2549878120","doi":"10.1182/blood.v124.21.1059.1059","title":"Identification of Cytogenetically Normal Human CD34+CD38+ Hematopoietic Stem/Progenitor Cells from Inv(16)+ Leukemic Bone Marrow","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"CD34; Bone marrow; CD38; CD33; Haematopoiesis; Biology; Population; Leukemia; Progenitor cell; Stem cell; Immunology; Molecular biology; Cancer research; Medicine; Cell biology","score_opus":0.015047907244236054,"score_gpt":0.2623423048366062,"score_spread":0.24729439759237015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549878120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966403,0.0003918577,0.00063386065,0.0002464925,0.00012461742,0.00064419274,0.000051248742,0.000091833295,0.0011755537],"genre_scores_gemma":[0.9965275,0.000035937974,0.000807974,0.00013795483,0.00050795166,0.00006291558,0.00010744144,0.00007446385,0.0017378777],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99708927,0.00017107945,0.00089292065,0.00054037484,0.00080708525,0.0004992866],"domain_scores_gemma":[0.9978908,0.00015841598,0.00027278005,0.0010664986,0.0002914245,0.00032012543],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00060755934,0.00026470402,0.0005756685,0.00021308937,0.0001112334,0.000041261388,0.000384893,0.00025720004,0.00030226432],"category_scores_gemma":[0.00010747753,0.00025349463,0.00018985504,0.00029873234,0.00022509474,0.000086967404,0.0001856053,0.0003921902,0.00044214542],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009255573,0.0005071433,0.009172812,0.00025513922,0.00016521914,0.00003837973,0.00022865624,0.0000022219403,0.98730797,0.0002268611,0.0010939754,0.00090908504],"study_design_scores_gemma":[0.0049059256,0.00035981523,0.0104135275,0.00011380065,0.0004521352,0.00007360432,0.00011546174,0.00019258469,0.9822385,0.00033938303,0.00055970286,0.00023558208],"about_ca_topic_score_codex":0.00018761377,"about_ca_topic_score_gemma":0.000026204634,"teacher_disagreement_score":0.0050694738,"about_ca_system_score_codex":0.00019250876,"about_ca_system_score_gemma":0.00030550032,"threshold_uncertainty_score":0.9999917},"labels":[],"label_agreement":null},{"id":"W2549897972","doi":"10.1182/blood.v118.21.3176.3176","title":"Heterogeneity In Regional Myocardial T2* Improvement After Deferiprone Therapy,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Advanced MRI Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Deferiprone; Cardiac magnetic resonance; Thalassemia; Internal medicine; Nuclear medicine; Cardiology; Siderosis; Magnetic resonance imaging; Radiology","score_opus":0.044860644969480876,"score_gpt":0.28797101019273547,"score_spread":0.24311036522325458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549897972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99523455,0.00048777566,0.0020427413,0.000167143,0.000014341483,0.0004926117,0.000005343783,0.00006956844,0.0014859533],"genre_scores_gemma":[0.97920007,0.00033590713,0.019016746,0.0007672837,0.0000806208,0.0005197405,0.000008650557,0.000014399815,0.000056567853],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994486,0.0000063013813,0.00013364927,0.00017760204,0.00008881634,0.00014503709],"domain_scores_gemma":[0.9996372,0.000003906012,0.000028060138,0.00024905324,0.000024030638,0.000057772628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000051498784,0.000082903905,0.000120389515,0.00003457601,0.000017513465,0.000002291292,0.000046079946,0.00005060779,0.00006823075],"category_scores_gemma":[0.0000023577738,0.000069511836,0.00006214866,0.00007903063,0.00003298111,0.000028556904,0.000025331154,0.000084308755,0.000012581055],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021717981,0.014011216,0.44237316,0.000077908626,0.00026048653,0.00026565196,0.0016891011,0.0000023001005,0.35459954,0.0046782033,0.0010493259,0.17882133],"study_design_scores_gemma":[0.0057839667,0.0011362059,0.5676945,0.00005467085,0.000080957834,0.00007064731,0.000052312604,0.000007820275,0.39668572,0.0035356726,0.02459659,0.0003009364],"about_ca_topic_score_codex":0.000042329226,"about_ca_topic_score_gemma":0.000014719091,"teacher_disagreement_score":0.17852038,"about_ca_system_score_codex":0.000016465474,"about_ca_system_score_gemma":0.00002073285,"threshold_uncertainty_score":0.28346106},"labels":[],"label_agreement":null},{"id":"W2549898496","doi":"10.1182/blood.v114.22.2500.2500","title":"Transfusion Dependence and Low Hemoglobin Have the Greatest Impact On Quality of Life (QOL) in MDS Patients - a Tertiary Care Cross Sectional and Longitudinal Study.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Confounding; Quality of life (healthcare); Internal medicine; Prospective cohort study; Cross-sectional study; Anemia; Logistic regression; Ferritin; Physical therapy","score_opus":0.020363964447115013,"score_gpt":0.3239829172829956,"score_spread":0.3036189528358806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549898496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99883085,0.00037377904,8.2371145e-7,0.0001329419,0.000017850123,0.0005062202,0.000028317478,0.00001010807,0.00009907477],"genre_scores_gemma":[0.9997737,0.000060367318,0.000022430015,0.0000725993,0.000028299164,0.0000082397555,0.000014994937,0.000005530824,0.000013840388],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999063,0.00006644813,0.00023740892,0.00024149127,0.00025820552,0.00013345608],"domain_scores_gemma":[0.9995814,0.000067991285,0.000053528704,0.00014933605,0.00005979466,0.00008796216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014063636,0.00013669289,0.00021276111,0.000038735237,0.00007994904,0.000016585645,0.000035764187,0.00005753474,0.000014455761],"category_scores_gemma":[0.00004199485,0.00008029631,0.000050741353,0.000059364906,0.000074228505,0.000039365626,0.000014675465,0.00013246205,5.900704e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041038645,0.0027010713,0.99382174,0.000053611897,0.000040654348,0.00002900373,0.0017825165,0.0000029769114,0.00027849528,0.0000018671496,0.000002772429,0.0008749177],"study_design_scores_gemma":[0.009202117,0.002378726,0.9864977,0.00010007554,0.000053239113,0.000025701025,0.00059494906,0.0000048751713,0.0010580964,0.000011822932,2.6748452e-7,0.00007240057],"about_ca_topic_score_codex":0.0010182994,"about_ca_topic_score_gemma":0.00033244144,"teacher_disagreement_score":0.008791731,"about_ca_system_score_codex":0.000039611266,"about_ca_system_score_gemma":0.000045825665,"threshold_uncertainty_score":0.32743886},"labels":[],"label_agreement":null},{"id":"W2549899772","doi":"10.1182/blood.v110.11.600.600","title":"The MN1 Oncogene Blocks Differentiation of Multiple Hematopoietic Lineages.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Myeloid; Haematopoiesis; Biology; Bone marrow; Cancer research; Transplantation; Immunology; Leukemia; Molecular biology; Myeloid leukemia; Cellular differentiation; Andrology; Stem cell; Internal medicine; Medicine; Cell biology","score_opus":0.0073402874800659965,"score_gpt":0.22788080476278466,"score_spread":0.22054051728271867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549899772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99519145,0.0010144269,0.0027565763,0.000070818205,0.00011425269,0.00013140723,0.0000046673244,0.000008431543,0.000707985],"genre_scores_gemma":[0.9986793,0.00011207196,0.00031875225,0.00004221206,0.00018034846,0.0000062211006,0.00004409348,0.0000086856035,0.0006083603],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994248,0.000018760118,0.00019895316,0.00012298762,0.00010555926,0.00012889876],"domain_scores_gemma":[0.99954957,0.000023383012,0.00009342102,0.00023259704,0.000063560976,0.00003745118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002084838,0.00007067016,0.00006507172,0.000017596738,0.00007405139,0.000009492969,0.00011410004,0.00007813646,0.000008353851],"category_scores_gemma":[0.00013942024,0.000051388335,0.00006152413,0.000054179403,0.000046153724,0.0000013437871,0.000046371628,0.00004219458,0.0000032043645],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024102977,0.00015654127,0.005899232,0.0000072617327,0.000036026424,5.8489223e-7,0.00002186376,0.0000015515658,0.99094564,0.00006737359,0.0004013027,0.0024385196],"study_design_scores_gemma":[0.0007068724,0.00008372129,0.0033951967,0.0000061958144,0.000016972144,0.000004561635,0.000033696168,0.000015494034,0.9839058,0.000026693791,0.011740736,0.0000640468],"about_ca_topic_score_codex":0.0000063854122,"about_ca_topic_score_gemma":0.000042576637,"teacher_disagreement_score":0.0113394335,"about_ca_system_score_codex":0.000002657778,"about_ca_system_score_gemma":0.000018804489,"threshold_uncertainty_score":0.20955555},"labels":[],"label_agreement":null},{"id":"W2549915480","doi":"10.1182/blood.v110.11.3445.3445","title":"CHOP-R (Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, Rituximab) Compared to CPOP-R (Cyclophosphamide, Pixantrone, Vincristine, Prednisone, Rituxamib) in First-Line Therapy of Diffuse Large B Cell Lymphoma (DLBCL): An Interim Analysis.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Rituximab; Internal medicine; Vincristine; Diffuse large B-cell lymphoma; Prednisone; Regimen; CHOP; Interim analysis; Cyclophosphamide; Febrile neutropenia; Gastroenterology; Oncology; Surgery; Lymphoma; Neutropenia; Chemotherapy; Clinical trial","score_opus":0.0152712207846442,"score_gpt":0.28058744970144656,"score_spread":0.26531622891680234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549915480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984679,0.007111666,0.0012589225,0.0003873945,0.00037923333,0.0029347797,0.000690454,0.00035291395,0.0022056692],"genre_scores_gemma":[0.9882601,0.0024293538,0.0060989796,0.0010371243,0.00035375147,0.00035435054,0.0008340477,0.00021646719,0.00041584802],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99121255,0.00022784766,0.00300301,0.00204384,0.0014170689,0.0020956954],"domain_scores_gemma":[0.9940359,0.0005667016,0.00093378103,0.0024245954,0.0006720169,0.0013670024],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0013436835,0.0014277685,0.0034031116,0.0016393058,0.00030680868,0.00012253723,0.0009055978,0.0005415294,0.00031119213],"category_scores_gemma":[0.00030898236,0.0012807418,0.00091738545,0.0036532949,0.0002478854,0.00037665665,0.0003806877,0.00037989742,0.00011602765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006489687,0.19019811,0.7872777,0.00034772608,0.0023082367,0.0013237582,0.0014654316,0.000100434925,0.0043551857,0.0002138794,0.0010162856,0.0049035586],"study_design_scores_gemma":[0.13630088,0.0028435066,0.78989995,0.00035873614,0.0019732614,0.00008479342,0.00033455982,0.00064420636,0.059119876,0.00006263525,0.007302307,0.0010753301],"about_ca_topic_score_codex":0.0068179145,"about_ca_topic_score_gemma":0.0074606086,"teacher_disagreement_score":0.18735461,"about_ca_system_score_codex":0.00069484697,"about_ca_system_score_gemma":0.00039534317,"threshold_uncertainty_score":0.99984723},"labels":[],"label_agreement":null},{"id":"W2550064469","doi":"10.1182/blood.v120.21.3203.3203","title":"Association Between Increased Liver Iron Concentration and Vitamin D Deficiency in Patients with Transfusion Dependent Hemoglobinopathies in British Columbia","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Paul's Hospital; University of British Columbia; BC Children's Hospital; Providence Health Care","funders":"","keywords":"Medicine; Vitamin D and neurology; Internal medicine; Calcium metabolism; vitamin D deficiency; Parathyroid hormone; Gastroenterology; Thalassemia; Ferritin; Endocrinology; Liver disease; Calcium","score_opus":0.003585576759375906,"score_gpt":0.17989555403802673,"score_spread":0.17630997727865083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550064469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981609,0.00072603364,0.0000050347157,0.00003901504,0.00003789639,0.0006726442,0.000021203427,0.000024307274,0.00031295954],"genre_scores_gemma":[0.9993009,0.00037324955,0.00007453922,0.0000516713,0.000027916114,0.00001529226,0.00009034602,0.0000144297455,0.000051670755],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878675,0.00008573324,0.0002648807,0.00019987897,0.00031925968,0.0003435288],"domain_scores_gemma":[0.99962693,0.00004387491,0.00008151651,0.0000814186,0.00005037735,0.00011588102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030006905,0.000095099334,0.00023193788,0.000038937425,0.000067128145,0.000047165697,0.000030306115,0.00020413686,0.00002545753],"category_scores_gemma":[0.00006698207,0.000118479715,0.00002147208,0.00022377221,0.000032358977,0.0002016975,0.000013628585,0.000216549,0.0000033849926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034062297,0.0012180243,0.9943129,0.00007409042,0.000015559142,0.000014645657,0.00058385474,8.3470957e-7,0.00022385939,8.839504e-7,0.000025352327,0.0034959351],"study_design_scores_gemma":[0.011403401,0.00032984212,0.98721516,0.00022894412,0.00019272912,0.00000970825,0.0002487433,0.000009032996,0.00020329826,0.000003274299,0.00001515532,0.00014068719],"about_ca_topic_score_codex":0.01146874,"about_ca_topic_score_gemma":0.01900156,"teacher_disagreement_score":0.011369339,"about_ca_system_score_codex":0.00014239871,"about_ca_system_score_gemma":0.00004442343,"threshold_uncertainty_score":0.9988991},"labels":[],"label_agreement":null},{"id":"W2550066585","doi":"10.1182/blood.v106.11.3852.3852","title":"Left Ventricular Function Declines with Increasing Myocardial Ferritin Iron in Thalassemia Major.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Hemosiderin; Ferritin; Chemistry; Thalassemia; Nuclear magnetic resonance; Internal medicine; Cardiology; Medicine; Pathology; Biochemistry; Physics","score_opus":0.004896349089379909,"score_gpt":0.21389647126896955,"score_spread":0.20900012217958963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550066585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99276775,0.002122886,0.000042292544,0.0010608808,0.00006906621,0.00024719708,0.0000015741684,0.000069529255,0.0036188515],"genre_scores_gemma":[0.9984087,0.00014712922,0.0005905041,0.00033515372,0.00032450657,0.000006554462,0.000029635965,0.000024151488,0.0001336912],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990547,0.000049648188,0.00020662579,0.00021696594,0.00021000774,0.0002620962],"domain_scores_gemma":[0.9996293,0.000030227617,0.00004565226,0.00016051927,0.000036848356,0.00009744182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001832462,0.00013764553,0.00022021716,0.00011492023,0.00005597063,0.000015603147,0.000037380913,0.0001614481,0.000056441848],"category_scores_gemma":[0.00006339023,0.0001047758,0.0000661629,0.000190364,0.000033323315,0.00007297493,0.000017477862,0.0002478692,0.000041711715],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006272457,0.0011184193,0.9863354,0.00008814478,0.00015296959,0.00062209024,0.00016288673,0.00025551787,0.004942906,0.000046538076,0.00035614468,0.0052917595],"study_design_scores_gemma":[0.024938423,0.0009813141,0.9409532,0.0008009757,0.0014053734,0.0028006819,0.0008260528,0.00045174282,0.0060229674,0.00005146885,0.02024923,0.0005185535],"about_ca_topic_score_codex":0.000153071,"about_ca_topic_score_gemma":0.000100529,"teacher_disagreement_score":0.04538216,"about_ca_system_score_codex":0.00004252524,"about_ca_system_score_gemma":0.00007021694,"threshold_uncertainty_score":0.4272633},"labels":[],"label_agreement":null},{"id":"W2550074183","doi":"10.1182/blood.v118.21.2024.2024","title":"Allogeneic Stem Cell Transplantation Is Associated with Long Term Disease Control in Chemo Sensitive Follicular Lymphoma Patients","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Alemtuzumab; Follicular lymphoma; Transplantation; Surgery; Internal medicine; Chemotherapy; Rituximab; Autologous stem-cell transplantation; Gastroenterology; Chlorambucil; Lymphoma; Oncology; Cyclophosphamide","score_opus":0.009095405010583906,"score_gpt":0.1934741659445676,"score_spread":0.1843787609339837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550074183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99850523,0.00016570152,0.000012830134,0.000031248663,0.00002078824,0.00069217995,0.0001221901,0.000030580744,0.0004192677],"genre_scores_gemma":[0.99909294,0.000056068275,0.00002332243,0.00044494087,0.000013097323,0.00008319173,0.00021055723,0.000021640715,0.000054217282],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990786,0.00004700571,0.00017730141,0.0002606799,0.00021904628,0.00021738934],"domain_scores_gemma":[0.99948186,0.000033168377,0.00008710472,0.00015340441,0.00007914644,0.0001652941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000043824024,0.00017094296,0.00026166192,0.0000596638,0.000033359607,0.000007906298,0.000031462998,0.00006410883,0.000016934664],"category_scores_gemma":[0.000003879875,0.00012789384,0.00008031068,0.00010084455,0.000022723676,0.000052263582,0.000004807865,0.000025890124,0.000016282234],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060229335,0.0069636567,0.9865953,0.000048471433,0.0003692309,0.002691394,0.001147387,3.577511e-7,0.00020366632,0.00000216303,0.0000069876246,0.0013691367],"study_design_scores_gemma":[0.04082705,0.0004080523,0.9089387,0.00021246391,0.0015752942,0.000012680189,0.000026959666,0.000010201007,0.047854003,0.0000017800289,0.0000013252068,0.0001314762],"about_ca_topic_score_codex":0.00007945155,"about_ca_topic_score_gemma":0.00004905334,"teacher_disagreement_score":0.07765654,"about_ca_system_score_codex":0.00011663011,"about_ca_system_score_gemma":0.000078868,"threshold_uncertainty_score":0.521536},"labels":[],"label_agreement":null},{"id":"W2550077017","doi":"10.1182/blood.v116.21.3432.3432","title":"Pharmacokinetics of Dasatinib as a First Line Therapy In Newly Diagnosed CML Patients (OPTIM dasatinib trial): Correlation with Safety and Response.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Dasatinib; Cmin; Medicine; Cmax; Internal medicine; Pharmacokinetics; Adverse effect; Dosing; Tyrosine-kinase inhibitor; Gastroenterology; Pharmacology; Oncology; Tyrosine kinase; Cancer; Receptor","score_opus":0.012216324951888725,"score_gpt":0.27324229331482786,"score_spread":0.2610259683629391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550077017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967888,0.00013210415,0.000017454217,0.00030471518,0.00014516588,0.0019337297,0.00003610404,0.000034912293,0.00060699106],"genre_scores_gemma":[0.9971965,0.0005581384,0.0015672679,0.00013586832,0.00010359505,0.000069204776,0.00012353211,0.00004077824,0.00020512239],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984722,0.00010156595,0.0005166276,0.00032614567,0.000354049,0.0002294172],"domain_scores_gemma":[0.9984281,0.0006671473,0.00026656286,0.0003803604,0.000121352765,0.00013644138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003405499,0.00022911288,0.00042314813,0.00015017846,0.000050984876,0.000010611145,0.00008118647,0.00015215627,0.00019832987],"category_scores_gemma":[0.000570015,0.00017842182,0.00004698638,0.00026941596,0.00010721401,0.000072653755,0.00003194707,0.00034220572,0.000008928589],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27143046,0.007532709,0.6779488,0.0000898348,0.0003825215,0.00014534594,0.003488164,0.00008992628,0.007836778,0.000027626196,0.00009523295,0.030932622],"study_design_scores_gemma":[0.4527923,0.007599647,0.53037864,0.00017850156,0.00022851567,0.000026256257,0.00004134054,0.00039644388,0.0064760456,0.000013225893,0.0016869714,0.00018213266],"about_ca_topic_score_codex":0.00017413324,"about_ca_topic_score_gemma":0.00017306491,"teacher_disagreement_score":0.18136182,"about_ca_system_score_codex":0.00008243206,"about_ca_system_score_gemma":0.00035702254,"threshold_uncertainty_score":0.72758305},"labels":[],"label_agreement":null},{"id":"W2550078151","doi":"10.1182/blood.v108.11.545.545","title":"Endogenous Arteriolar Fibrinolysis Requires Urokinase Plasminogen Activator and Leukocyte Urokinase Plasminogen Activator Receptor-1.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Fibrin; Plasmin; Thrombus; Fibrinolysis; Urokinase; Plasminogen activator; Chemistry; Intravital microscopy; Tissue plasminogen activator; Platelet; Molecular biology; Immunology; Pathology; Endocrinology; Internal medicine; Biology; Microcirculation; Biochemistry; Medicine; Enzyme","score_opus":0.018020021578711916,"score_gpt":0.2286157357394485,"score_spread":0.21059571416073658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550078151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98965204,0.0014966504,0.000023881645,0.0005259609,0.0001791011,0.0010481635,0.00007430278,0.00027089467,0.006729002],"genre_scores_gemma":[0.9961643,0.00065635587,0.0008073019,0.0005997978,0.0007607472,0.00014257885,0.00013680858,0.000100825455,0.00063124346],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99695504,0.00009720119,0.00060418196,0.0009156068,0.0005706945,0.000857289],"domain_scores_gemma":[0.9982849,0.00012504825,0.00027242734,0.0008178341,0.000095281335,0.00040453518],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020650747,0.0005719977,0.0010015824,0.0002986904,0.0003477099,0.00013301939,0.00023304482,0.00023540412,0.0003026429],"category_scores_gemma":[0.00008960153,0.00053773075,0.00026689193,0.00031475016,0.0001469498,0.00030179124,0.0002016425,0.0002775605,0.00013831671],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049580756,0.005304147,0.015499871,0.00038824455,0.0012957207,0.0012317238,0.00056669675,0.000011755316,0.94986176,0.0008767938,0.011675726,0.012791773],"study_design_scores_gemma":[0.006181675,0.0013727581,0.079185866,0.0002071512,0.0016381245,0.00037759982,0.00019365216,0.000013782301,0.84306186,0.00014972535,0.06689327,0.0007245366],"about_ca_topic_score_codex":0.00048934907,"about_ca_topic_score_gemma":0.000028516251,"teacher_disagreement_score":0.106799886,"about_ca_system_score_codex":0.00013233566,"about_ca_system_score_gemma":0.00014145127,"threshold_uncertainty_score":0.9997074},"labels":[],"label_agreement":null},{"id":"W2550117305","doi":"10.1182/blood.v110.11.4894.4894","title":"Immunostimulatory Properties of the Human Ortholog of the GMCSF/IL2 Fusion Protein for Cell Based Therapy.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Cancer research; Immunology; Immunotherapy; Cancer immunotherapy; Cell therapy; Cytokine; Interleukin 21; Immune system; Biology; T cell; Cell biology; Stem cell","score_opus":0.016167495323720294,"score_gpt":0.21724694121419996,"score_spread":0.20107944589047966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550117305","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99545383,0.0017815065,0.000052644675,0.00007049334,0.00084519794,0.0008867458,0.0000030182655,0.000018162726,0.00088838075],"genre_scores_gemma":[0.9930368,0.0000056247222,0.000015214858,0.000115264804,0.000015424155,0.000026971566,0.000007094897,0.000012112375,0.0067654992],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99924564,0.00012928144,0.00031227327,0.00012058701,0.00003739484,0.00015482772],"domain_scores_gemma":[0.9992003,0.000043997024,0.00025830942,0.00036685812,0.00012634603,0.000004231604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033592278,0.00010464299,0.0001442904,0.000042881034,0.00024166319,0.0000030097717,0.00023165,0.00014950224,0.00016686808],"category_scores_gemma":[0.000048405556,0.000054065804,0.00018952563,0.000083857616,0.000197176,0.00003303535,0.00005049042,0.00017924627,0.000009018369],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028766782,0.00058254483,0.0021681904,0.000037452137,0.00005194674,5.4157507e-8,0.00020284775,0.0000041580074,0.99611396,0.00005211905,0.00024008333,0.00025900608],"study_design_scores_gemma":[0.0025569864,0.00029623258,0.015138911,0.00007866196,0.000040503608,0.0000030023966,0.00013762461,0.0000013880239,0.9731988,0.00001059945,0.00847129,0.00006601919],"about_ca_topic_score_codex":0.00005740161,"about_ca_topic_score_gemma":0.0000086843775,"teacher_disagreement_score":0.02291515,"about_ca_system_score_codex":0.000009558048,"about_ca_system_score_gemma":0.000046545894,"threshold_uncertainty_score":0.22047396},"labels":[],"label_agreement":null},{"id":"W2550126886","doi":"10.1182/blood.v108.11.274.274","title":"Antibodies to the Platelet Factor 4-Heparin Complex and Mortality in Chronic Hemodialysis Patients.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Western University; University of Ottawa","funders":"","keywords":"Medicine; Hemodialysis; Platelet factor 4; Asymptomatic; Heparin; Dialysis; Internal medicine; Gastroenterology; Immunology; Antibody","score_opus":0.0353841755441203,"score_gpt":0.2920787715676028,"score_spread":0.2566945960234825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550126886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957925,0.00010336142,0.0000060274438,0.00040705208,0.000050339764,0.00055756385,0.00004692076,0.00004078147,0.002995451],"genre_scores_gemma":[0.99929076,0.000040844065,0.00013203862,0.0002072654,0.00014945053,0.000025018955,0.00007939723,0.000018759774,0.000056432316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99874353,0.00005390531,0.0003180492,0.0003301375,0.00022063678,0.00033373496],"domain_scores_gemma":[0.9993644,0.00004965267,0.000055884084,0.00037768003,0.00004861278,0.0001038007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012068824,0.00018643624,0.00047419436,0.00010482457,0.000101638594,0.00003708634,0.00011168796,0.00008175877,0.00012925596],"category_scores_gemma":[0.000041464682,0.00013255466,0.00007316512,0.0002783154,0.000069947084,0.00006476386,0.00011267697,0.00015901455,0.000056378158],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000151085105,0.00050287636,0.98061883,0.00004364868,0.00012671221,0.0000146831035,0.00023314981,0.0000067539668,0.016428182,0.00011605365,0.0002053438,0.0016886622],"study_design_scores_gemma":[0.002632094,0.00015439723,0.9810669,0.000031426174,0.00012511162,0.0000054435404,0.000024099068,0.000049293925,0.013386206,0.000057525267,0.0023136742,0.00015386002],"about_ca_topic_score_codex":0.002559803,"about_ca_topic_score_gemma":0.0039955946,"teacher_disagreement_score":0.003498291,"about_ca_system_score_codex":0.00008884964,"about_ca_system_score_gemma":0.000070210146,"threshold_uncertainty_score":0.54054224},"labels":[],"label_agreement":null},{"id":"W2550132245","doi":"10.1182/blood.v114.22.1363.1363","title":"Shwachman-Diamond Syndrome: Development of a North American Registry to Assess Long-Term Outcomes, Risk of Leukemia and Other Complications.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Medicine; Neutropenia; Absolute neutrophil count; Sepsis; Pediatrics; Internal medicine; Leukemia; Surgery; Chemotherapy","score_opus":0.016159568955006386,"score_gpt":0.27156633759065374,"score_spread":0.2554067686356474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550132245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988671,0.00028300667,0.00032542125,0.000025311745,0.0000073227893,0.00017824429,0.00006418861,0.000005514382,0.00024390797],"genre_scores_gemma":[0.99522567,0.000042986823,0.0044558547,0.00013316207,0.000004942478,0.000016717015,0.000060887473,0.000010220024,0.000049573646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99931353,0.000019242103,0.00021649149,0.00023428595,0.00008788331,0.00012858886],"domain_scores_gemma":[0.99937356,0.0000068420636,0.00017653195,0.00032986887,0.0000396941,0.00007352537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003908714,0.00012464939,0.0002084791,0.00003485407,0.000041642536,0.000006463501,0.00012552859,0.00003556824,0.000001671184],"category_scores_gemma":[0.000013440826,0.00011120988,0.000044402525,0.00009750778,0.000060238453,0.0000018704624,0.00004625127,0.000035238056,0.0000015686111],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000132438245,0.0005591797,0.9852359,0.000015254832,0.0002399551,0.000002664878,0.0000413392,0.0000035934802,0.0034325796,0.000006646689,0.00002494774,0.010424689],"study_design_scores_gemma":[0.0009038309,0.00024972274,0.9652504,0.00001134887,0.00009077164,0.000013362744,0.000010108094,4.8658546e-7,0.033203725,0.0000050430726,0.0001491453,0.00011205371],"about_ca_topic_score_codex":0.000048024234,"about_ca_topic_score_gemma":0.00033614467,"teacher_disagreement_score":0.029771144,"about_ca_system_score_codex":0.0000068888758,"about_ca_system_score_gemma":0.000074022704,"threshold_uncertainty_score":0.45350075},"labels":[],"label_agreement":null},{"id":"W2550148757","doi":"10.1182/blood.v118.21.1834.1834","title":"Bortezomib Impairs Myeloma Cells (MM) Homologous Recombination Through Inhibition of the E2-Ubiquitin-Conjugating Enzyme UBC13","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"RAD51; Bortezomib; Homologous recombination; DNA repair; Biology; Molecular biology; Transfection; Proteasome; Genome instability; DNA damage; Proteasome inhibitor; Ubiquitin-conjugating enzyme; DNA; Ubiquitin; Cell biology; Gene; Ubiquitin ligase; Genetics; Multiple myeloma; Immunology","score_opus":0.013118164005257813,"score_gpt":0.21408495678852438,"score_spread":0.20096679278326657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550148757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918641,0.0001536535,0.00041413328,0.000033435404,0.000265619,0.0003001332,0.000020506255,0.000031359737,0.006917064],"genre_scores_gemma":[0.9961132,0.00003110269,0.0032136533,0.00014928849,0.00009078606,0.000032182128,0.000035908528,0.000028324186,0.00030557814],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988933,0.00010727541,0.00030517706,0.0003129641,0.0001438286,0.00023744907],"domain_scores_gemma":[0.99912274,0.000012103601,0.00025687815,0.00046185954,0.000109666566,0.000036739188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002433011,0.00015865263,0.00015004433,0.000024502697,0.000089231515,0.000009728458,0.00020508109,0.00020025055,0.000057261735],"category_scores_gemma":[0.000073313255,0.00013369528,0.00015060368,0.00010635194,0.000083676794,0.000009480444,0.00017022985,0.000101925594,0.00000921224],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018459472,0.00028576437,0.00030005947,0.000022624896,0.000048606627,0.0000046118294,0.0003870006,0.0000020271978,0.99753183,0.0006240186,0.00024406512,0.00053091964],"study_design_scores_gemma":[0.00089385407,0.00043366905,0.0008843712,0.000032630174,0.00006317567,0.000037539063,0.00020361038,0.000010817409,0.9949009,0.0021965902,0.00018482281,0.00015805331],"about_ca_topic_score_codex":0.00005121356,"about_ca_topic_score_gemma":0.00002372687,"teacher_disagreement_score":0.006611486,"about_ca_system_score_codex":0.000011091581,"about_ca_system_score_gemma":0.000058012734,"threshold_uncertainty_score":0.54519355},"labels":[],"label_agreement":null},{"id":"W2550150059","doi":"10.1182/blood.v116.21.1530.1530","title":"Institution-Wide Quantification of Iatrogenic Blood Loss Using a Novel Informatics-Driven Methodology","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Blood donation and transfusion practices","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Capital District Health Authority; Dalhousie University","funders":"","keywords":"Phlebotomy; Medicine; Population; Emergency medicine; Blood transfusion; Blood loss; Anemia; Intensive care medicine; Surgery; Internal medicine; Environmental health","score_opus":0.06847436516107637,"score_gpt":0.2952669254744784,"score_spread":0.22679256031340206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550150059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9712499,0.000033076405,0.023172105,0.00036414815,0.00054080324,0.00022212691,0.000006499374,0.0000871004,0.0043242746],"genre_scores_gemma":[0.9562969,0.000011304649,0.04288187,0.00049283856,0.0002528363,0.000009559219,0.000025585668,0.000014847604,0.000014207701],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988418,0.000017188746,0.0005478989,0.00016404707,0.00024456572,0.000184463],"domain_scores_gemma":[0.99859273,0.00018911467,0.0005978846,0.0002936713,0.0003098821,0.000016685002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006945334,0.00014402802,0.0002192445,0.00033508192,0.00018075918,0.00011338117,0.0002566291,0.0001364301,0.00025221996],"category_scores_gemma":[0.0006410361,0.00013864461,0.00013387878,0.00049298134,0.00011754013,0.001577588,0.000075354495,0.00024388541,0.000073709474],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059351463,0.0025477386,0.10719841,0.00047552714,0.00055133377,0.000006812856,0.000337384,0.00048134738,0.4457844,0.44159386,0.00004906118,0.0009147965],"study_design_scores_gemma":[0.062370043,0.0002475368,0.18391581,0.00053351454,0.024782607,0.0020424374,0.004395357,0.05550689,0.45966703,0.02318786,0.17834882,0.0050021],"about_ca_topic_score_codex":0.00033613286,"about_ca_topic_score_gemma":0.00026884818,"teacher_disagreement_score":0.418406,"about_ca_system_score_codex":0.000002714498,"about_ca_system_score_gemma":0.00007008482,"threshold_uncertainty_score":0.56537634},"labels":[],"label_agreement":null},{"id":"W2550150282","doi":"10.1182/blood.v104.11.2031.2031","title":"Identification of RIZ1 Targets Involvedin Erythroid Differentiation of K562 Human Erythroleukemia Cells Using Surface-Enhanced Laser Desorption Ionization Time-Of-Flight Mass Spectrometry (SELDI).","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"K562 cells; Molecular biology; Biology; Chemistry; Downregulation and upregulation; Gene; Cancer research; Cell biology; Biochemistry","score_opus":0.007953185535049694,"score_gpt":0.2291742478377499,"score_spread":0.2212210623027002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550150282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9805258,0.00046791913,0.018203614,0.000032989523,0.00014531017,0.00044203352,0.000021646865,0.00004113068,0.00011959049],"genre_scores_gemma":[0.99675536,0.00032164296,0.002508663,0.00000914626,0.00005267237,0.0000026660111,0.0001980204,0.0000331515,0.000118698605],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99821,0.000055364,0.00084183994,0.00027822674,0.00040673252,0.00020783868],"domain_scores_gemma":[0.9985523,0.000022583485,0.0007226054,0.00031195604,0.00032218883,0.000068371046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023137298,0.0001848359,0.00043024076,0.0002590097,0.00008061713,0.000009928601,0.000089565874,0.00026696848,0.00009593525],"category_scores_gemma":[0.00005120837,0.00017768881,0.00013983685,0.00066531537,0.00010909392,0.00015200266,0.000024627418,0.00016014348,0.000012735021],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052441042,0.000953524,0.0029278488,0.00035783034,0.00014823758,0.0000015981565,0.0006236269,0.004430132,0.9903672,0.00009019418,0.000011474859,0.000035906523],"study_design_scores_gemma":[0.004156231,0.0002603133,0.0067918063,0.00036835918,0.00051398115,0.000004177189,0.00022386452,0.0011605142,0.985868,0.0005044682,0.0000017632672,0.00014656688],"about_ca_topic_score_codex":0.000060679584,"about_ca_topic_score_gemma":0.000005448743,"teacher_disagreement_score":0.016229574,"about_ca_system_score_codex":0.00012840756,"about_ca_system_score_gemma":0.0001175885,"threshold_uncertainty_score":0.72459394},"labels":[],"label_agreement":null},{"id":"W2550170063","doi":"10.1182/blood.v106.11.800.800","title":"Deterministic Trigger of Self-Renewal in Expanded HSCs Expressing Hoxb4 + Antisense Pbx1.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; BC Cancer Agency; Institute for Research in Immunology and Cancer","funders":"","keywords":"Stem cell; Biology; Cell biology; Transplantation; Molecular biology; Induced pluripotent stem cell; Genetics; Embryonic stem cell; Gene; Medicine","score_opus":0.011774443349611726,"score_gpt":0.2667239357552777,"score_spread":0.25494949240566595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550170063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970419,0.00080626947,0.000051677715,0.000039466242,0.000033418753,0.00015309826,0.000010579312,0.0000122612655,0.001851352],"genre_scores_gemma":[0.99760175,0.0002156232,0.0014744961,0.000029155945,0.00015129356,0.000012545767,0.000022847471,0.000020934143,0.00047136768],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99883175,0.00008591343,0.00027766835,0.00030076937,0.00019275716,0.0003111298],"domain_scores_gemma":[0.99944013,0.00002247824,0.000073947565,0.0003369067,0.000048587357,0.00007794166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018171407,0.00013123875,0.00018322057,0.00008742807,0.000032592932,0.000016560169,0.00019074412,0.00013941106,0.000018713721],"category_scores_gemma":[0.00006845028,0.00012902686,0.0000732759,0.000098340424,0.000054038846,0.0000043016394,0.000120939374,0.00008492329,0.0000119422],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005153196,0.0005107437,0.004759889,0.000040341787,0.000034098695,0.000035059315,0.00006983024,0.000024908284,0.9929446,0.000002973872,0.00010122834,0.0014248207],"study_design_scores_gemma":[0.0025164667,0.00015619025,0.0020537917,0.000036905552,0.000025918136,0.000049173515,0.00002246602,0.00012742808,0.9925165,0.0000110272995,0.0023254242,0.00015867379],"about_ca_topic_score_codex":0.000012518197,"about_ca_topic_score_gemma":0.000032928634,"teacher_disagreement_score":0.0027060974,"about_ca_system_score_codex":0.000009739798,"about_ca_system_score_gemma":0.00009643783,"threshold_uncertainty_score":0.52615625},"labels":[],"label_agreement":null},{"id":"W2550207442","doi":"10.1182/blood.v108.11.2247.2247","title":"Systems Analysis Reveals Regulators of Apoptosis, Cell Cycle, Signal Transduction and Transcription as Novel Direct Targets of the Acute Promyelocytic Leukemia Fusion Protein NuMA-RAR α","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Biology; Signal transduction; Acute promyelocytic leukemia; Retinoid; Fusion protein; Cell biology; Transcription factor; Fusion gene; Retinoic acid; Transgene; Gene; Cancer research; Molecular biology; Genetics","score_opus":0.0029573622935497143,"score_gpt":0.18475969806069656,"score_spread":0.18180233576714686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550207442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950638,0.002387329,0.0013437817,0.000014497572,0.00005147564,0.0005204182,0.000039836905,0.000010202794,0.00056869385],"genre_scores_gemma":[0.9987191,0.00013220507,0.00036769995,0.0000040978002,0.00007798547,0.000046408775,0.000080750375,0.000019255831,0.00055250863],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987161,0.00009232795,0.00042376804,0.00035002592,0.00024587402,0.00017188943],"domain_scores_gemma":[0.99925023,0.000006015131,0.00028451142,0.00030342521,0.00011863924,0.00003718025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022443183,0.0001812926,0.00030729806,0.00007419815,0.00008268188,0.000015684906,0.00016517252,0.0002116247,0.0000068206073],"category_scores_gemma":[0.000010083141,0.00013913256,0.00020777633,0.00034551363,0.00012264297,0.000009277544,0.000024684707,0.000080176316,2.7360824e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000063160616,0.00017921795,0.0014756764,0.0003350272,0.00028226644,3.581853e-7,0.000060313676,0.0009814725,0.99652153,0.00004253714,0.000015192233,0.00004324317],"study_design_scores_gemma":[0.000987251,0.00019653275,0.0017907716,0.00006983534,0.0011548754,0.0000101376345,0.000052910334,0.00017532396,0.9952463,0.000059058635,0.00010088366,0.00015613035],"about_ca_topic_score_codex":0.0002027582,"about_ca_topic_score_gemma":0.000006815367,"teacher_disagreement_score":0.0036553238,"about_ca_system_score_codex":0.000022312077,"about_ca_system_score_gemma":0.00011520376,"threshold_uncertainty_score":0.5673661},"labels":[],"label_agreement":null},{"id":"W2550228008","doi":"10.1182/blood.v124.21.436.436","title":"Preclinical Determination of the Efficacy of Epigenetic Therapy in High Risk Myeloid Disease Using the Zebrafish Model","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; BC Cancer Agency; Université de Moncton; University of British Columbia; Atlantic Cancer Research Institute; McMaster University; Dalhousie University","funders":"","keywords":"Decitabine; Biology; Epigenetics; Cancer research; DNA methylation; Myeloid leukemia; Myeloid; DNA methyltransferase; Genetics; Gene expression; Gene","score_opus":0.01958261617507553,"score_gpt":0.28358058869706376,"score_spread":0.26399797252198826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550228008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98933315,0.000701958,0.009609105,0.00003977793,0.00004929485,0.00021933387,0.000012407643,0.0000017131736,0.000033281394],"genre_scores_gemma":[0.998268,0.0004075243,0.001191074,0.00002453314,0.000070869704,0.000006531021,0.000007991663,0.000011714894,0.000011738355],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990963,0.00023374667,0.0002783013,0.0001685816,0.00012442737,0.000098690936],"domain_scores_gemma":[0.999195,0.00007994957,0.00020933335,0.00042399828,0.000062489125,0.00002924966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039315975,0.000080996615,0.00010550424,0.000019674384,0.000042435175,0.0000056146187,0.00020248457,0.00007878383,0.0000016218653],"category_scores_gemma":[0.00039105507,0.00005143657,0.00009520145,0.00007390031,0.000090513015,0.0000017326886,0.00006343295,0.00006430694,1.438187e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010982673,0.00054508104,0.17953232,0.000017584389,0.000026691676,9.8936034e-8,0.000103803875,0.01957463,0.78295,0.00006108771,0.0000011135502,0.017077804],"study_design_scores_gemma":[0.0013635415,0.00013748225,0.35061544,0.000016088772,0.00005368595,1.246681e-7,0.0000038905955,0.021972697,0.6242168,0.0015180768,0.00003125479,0.00007089661],"about_ca_topic_score_codex":0.000034657107,"about_ca_topic_score_gemma":0.000028548311,"teacher_disagreement_score":0.17108312,"about_ca_system_score_codex":0.0000026730113,"about_ca_system_score_gemma":0.000055602322,"threshold_uncertainty_score":0.20975225},"labels":[],"label_agreement":null},{"id":"W2550240482","doi":"10.1182/blood.v118.21.837.837","title":"A Randomized Trial of Sirolimus-Based Graft Versus Host Disease (GVHD) Prophylaxis After Hematopoietic Stem Cell Transplantation (HSCT) in Selected Patients with CR1 and CR2 ALL: Results From Children's Oncology Group Study ASCT0431","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of Manitoba","funders":"","keywords":"Medicine; Internal medicine; Sirolimus; Graft-versus-host disease; ThioTEPA; Hematopoietic stem cell transplantation; Transplantation; Regimen; Tacrolimus; Busulfan; Surgery; Gastroenterology; Randomization; Methotrexate; Cyclophosphamide; Oncology; Randomized controlled trial; Chemotherapy","score_opus":0.012381790614827803,"score_gpt":0.24195941470421306,"score_spread":0.22957762408938526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550240482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99239546,0.00006827934,0.000042722877,0.000026426465,0.000073422656,0.0069712987,0.00027793815,0.000043735356,0.00010069164],"genre_scores_gemma":[0.99849117,0.00002106256,0.00038441684,0.000028628245,0.000049467457,0.0005804013,0.00038663918,0.00004878374,0.0000094104325],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9967435,0.0007478947,0.00077760965,0.00061803864,0.00072746695,0.0003854915],"domain_scores_gemma":[0.9977725,0.001017434,0.0002748566,0.0004189781,0.00021605825,0.00030013916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046543952,0.000311507,0.0009725622,0.00028501955,0.000035010817,0.0000140464,0.00013852674,0.0001679102,0.000032143744],"category_scores_gemma":[0.00023182883,0.00022550802,0.00009762603,0.00039612464,0.00022462985,0.00008389441,0.00003434873,0.0002840288,0.000004446002],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9083977,0.013671548,0.07200505,0.00015540479,0.00044593346,0.00044896596,0.0046393974,0.0000010679988,0.00007387178,7.004555e-7,0.0000032102032,0.0001571884],"study_design_scores_gemma":[0.6321006,0.011068233,0.35446653,0.000068250956,0.0014126386,0.0000018717144,0.00009051439,0.000037507754,0.00060574675,0.0000033175204,4.430998e-7,0.00014435219],"about_ca_topic_score_codex":0.00089802494,"about_ca_topic_score_gemma":0.00022163354,"teacher_disagreement_score":0.28246146,"about_ca_system_score_codex":0.00015248178,"about_ca_system_score_gemma":0.0006333226,"threshold_uncertainty_score":0.919595},"labels":[],"label_agreement":null},{"id":"W2550255191","doi":"10.1182/blood.v112.11.5126.5126","title":"Monoclonal Proteins in Elderly Patients with Osteoporosis","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Leukemia & Lymphoma Society of Canada; University of British Columbia","funders":"","keywords":"Serum protein electrophoresis; Medicine; Osteoporosis; Multiple myeloma; Monoclonal gammopathy of undetermined significance; Bone disease; Internal medicine; Myeloma protein; Monoclonal; Immunology; Antibody; Monoclonal antibody","score_opus":0.013602717463057402,"score_gpt":0.23409352664287442,"score_spread":0.220490809179817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550255191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99770933,0.00007821937,9.204025e-7,0.00024406136,0.0000154381,0.00067691226,0.0000072770426,0.000026341655,0.0012414961],"genre_scores_gemma":[0.99731565,0.000011314923,0.001983894,0.0001740492,0.000015583915,0.00008746801,0.000036498233,0.000012606226,0.00036296173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99933666,0.000010460539,0.0001272994,0.0001461578,0.0001800445,0.0001993765],"domain_scores_gemma":[0.9996555,0.000007797318,0.000032924883,0.00013466888,0.000037782516,0.00013134576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000019726891,0.00008459071,0.00014975545,0.00005473955,0.00004588787,0.0000018382685,0.000021274993,0.0000444729,0.000034102395],"category_scores_gemma":[0.000010742543,0.00006058726,0.00002028429,0.00011998449,0.00002413759,0.00003766603,0.000006683046,0.0000883647,0.00004366159],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017355688,0.0024181101,0.99530554,0.000023889115,0.00002559271,0.00015987945,0.0002627106,1.0856159e-7,0.000012393482,0.0000028646202,0.000033650198,0.001581711],"study_design_scores_gemma":[0.014861041,0.0018699053,0.98212063,0.000054605796,0.000041656676,0.000046525336,0.000011258804,8.3866917e-7,0.0007258024,0.000009324946,0.00019975261,0.000058664176],"about_ca_topic_score_codex":0.00036642715,"about_ca_topic_score_gemma":0.00013673556,"teacher_disagreement_score":0.014687483,"about_ca_system_score_codex":0.000021888423,"about_ca_system_score_gemma":0.00012211052,"threshold_uncertainty_score":0.24706767},"labels":[],"label_agreement":null},{"id":"W2550260109","doi":"10.1182/blood.v108.11.241.241","title":"A Novel Transgenic Mouse Model of Multiple Myeloma Reliably Predicts Drug Response.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Multiple myeloma; Somatic hypermutation; Paraproteinemia; Plasma cell; Immunology; Germinal center; Carfilzomib; Monoclonal; Biology; Genetically modified mouse; Cancer research; Monoclonal antibody; Antibody; Transgene; B cell; Bortezomib; Genetics","score_opus":0.023922140323694125,"score_gpt":0.2625121457514105,"score_spread":0.23859000542771638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550260109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962979,0.00023122372,0.0009180514,0.0002776025,0.00001981892,0.0007027685,0.00036365527,0.00010779804,0.001081207],"genre_scores_gemma":[0.9810594,0.000029187691,0.010475942,0.000037901846,0.0000664736,0.000071462266,0.00008545732,0.000046627338,0.008127562],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982074,0.00005302808,0.00038260684,0.00033871052,0.0005697624,0.00044848386],"domain_scores_gemma":[0.9988688,0.00017334313,0.00007780853,0.00050638494,0.00014772001,0.00022592765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000264479,0.0002044712,0.00036240145,0.00019094603,0.00006773287,0.000010579205,0.00013732299,0.00010118031,0.000031407082],"category_scores_gemma":[0.00022249471,0.00017201343,0.00018471172,0.00020026151,0.00009817538,0.00007707063,0.000035071036,0.00017274398,0.000030518848],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048340885,0.0046714083,0.032242645,0.00014475634,0.00025630568,0.000038389404,0.00024544442,0.00042763277,0.9562044,0.00004486725,0.00053679664,0.00035322274],"study_design_scores_gemma":[0.03460236,0.00058618345,0.09777464,0.000120104385,0.00031070775,0.000036273,0.00004423262,0.018919978,0.84713644,0.00006491442,0.00020067417,0.000203497],"about_ca_topic_score_codex":0.0005682302,"about_ca_topic_score_gemma":0.0001498207,"teacher_disagreement_score":0.10906801,"about_ca_system_score_codex":0.000042841853,"about_ca_system_score_gemma":0.00027485026,"threshold_uncertainty_score":0.7014504},"labels":[],"label_agreement":null},{"id":"W2550294901","doi":"10.1182/blood.v122.21.4840.4840","title":"Optimization Of Stepwise Hematopoietic Differentiation Of Human iPSCs","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"KLF4; Induced pluripotent stem cell; SOX2; Haematopoiesis; Biology; Stem cell; Small hairpin RNA; Cell biology; Cellular differentiation; Regenerative medicine; Molecular biology; Cell culture; Embryonic stem cell; Genetics; Gene knockdown","score_opus":0.010105575593905793,"score_gpt":0.2431139095580884,"score_spread":0.2330083339641826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550294901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966784,0.00016487563,0.002197973,0.000017095525,0.000015253385,0.0001911595,0.00000516293,0.0000037794032,0.0007262779],"genre_scores_gemma":[0.99879825,0.0000475094,0.0006705099,0.000004769103,0.00002295218,0.000014627616,0.00012375569,0.000009971175,0.000307675],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99941796,0.00003675,0.00018296266,0.00012436837,0.00013674785,0.00010119841],"domain_scores_gemma":[0.9995158,0.000004848022,0.00009505404,0.00022182673,0.00013005684,0.000032471915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005596929,0.000060416518,0.00009778432,0.000038949547,0.000019982586,0.000005954501,0.00011266092,0.00007016954,0.000084601714],"category_scores_gemma":[0.00002233569,0.000056750738,0.000046106194,0.000055497694,0.000039335595,0.0000030608378,0.00006691026,0.00002748976,0.000006530768],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000003859975,0.00026542498,0.0053398246,0.00008259931,0.000035509875,1.6574124e-7,0.000022818878,0.00033706165,0.99372125,0.00003459309,0.00010126542,0.00005563053],"study_design_scores_gemma":[0.00070719793,0.00018710826,0.006907312,0.000016478836,0.000022533086,0.0000018234018,0.000025025896,0.00038475706,0.99162734,0.00004554365,0.000013829352,0.000061042905],"about_ca_topic_score_codex":0.0000174377,"about_ca_topic_score_gemma":0.0000022866031,"teacher_disagreement_score":0.002119807,"about_ca_system_score_codex":0.0000020980694,"about_ca_system_score_gemma":0.000015191936,"threshold_uncertainty_score":0.2314228},"labels":[],"label_agreement":null},{"id":"W2550310472","doi":"10.1182/blood.v118.21.206.206","title":"Venous Thromboembolism (VTE) Prevention with Semuloparin in Cancer Patients Initiating Chemotherapy: Benefit-Risk Assessment by VTE Risk in SAVE-ONCO","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McGill University Health Centre","funders":"","keywords":"Medicine; Internal medicine; Chemotherapy; Cancer; Pulmonary embolism; Deep vein; Chemotherapy regimen; Surgery; Gastroenterology; Thrombosis; Oncology","score_opus":0.019118421167395414,"score_gpt":0.3078781504209401,"score_spread":0.28875972925354465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550310472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951552,0.00060998317,0.000010053711,0.000046433557,0.00011987477,0.0008312101,0.0000632671,0.000033946573,0.0031300115],"genre_scores_gemma":[0.99702024,0.0015195754,0.00069560425,0.00018375044,0.00008887382,0.00026815894,0.00008403982,0.00003794265,0.00010179927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876213,0.00008642404,0.00031337517,0.0003259729,0.00019047924,0.00032159916],"domain_scores_gemma":[0.99942654,0.00003485652,0.00024727374,0.00015799903,0.00005324789,0.00008010037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015993348,0.00020337534,0.0004256313,0.00011686876,0.00005427344,0.000008733236,0.00006836337,0.00010122299,0.00035148865],"category_scores_gemma":[0.000007838209,0.00017507724,0.000049388367,0.00022893432,0.00003201758,0.00010539068,0.000026045564,0.00032242158,0.0000052150785],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029433653,0.008384346,0.9693446,0.000040628085,0.00028870656,0.000019272085,0.0034805415,0.000008591415,0.0005131282,0.000006113925,0.000078797355,0.017540945],"study_design_scores_gemma":[0.021472238,0.002188729,0.96889985,0.00020316293,0.0005310702,0.00000383625,0.00010747374,0.000055960994,0.0059923823,0.00018479479,0.0001751706,0.00018536524],"about_ca_topic_score_codex":0.006947364,"about_ca_topic_score_gemma":0.0050102025,"teacher_disagreement_score":0.021177901,"about_ca_system_score_codex":0.00022884297,"about_ca_system_score_gemma":0.00015201476,"threshold_uncertainty_score":0.99966544},"labels":[],"label_agreement":null},{"id":"W2550328916","doi":"10.1182/blood.v108.11.560.560","title":"Twenty Years of Follow-Up among Survivors of Childhood and Young Adult Acute Myeloid Leukemia (AML): A Report from the Childhood Cancer Survivor Study (CCSS).","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Cumulative incidence; Internal medicine; Incidence (geometry); Cancer; Pediatrics; Chemotherapy; Myeloid leukemia; Breast cancer; Surgery; Cohort","score_opus":0.007519316263921244,"score_gpt":0.2506116853578316,"score_spread":0.24309236909391038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550328916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951401,0.0009625149,0.000010479751,0.00017493128,0.00032447334,0.0019386073,0.00035690796,0.000075316144,0.0010167095],"genre_scores_gemma":[0.9974267,0.00039486264,0.00019371806,0.0000633612,0.00043460052,0.00013376352,0.00015829886,0.00009771749,0.001096992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99605304,0.00024611494,0.0010742756,0.00078567705,0.0012404359,0.0006004408],"domain_scores_gemma":[0.9971908,0.00029655715,0.00058850506,0.0012754934,0.00044570595,0.0002029856],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00083668804,0.00039582865,0.0010113147,0.00018354628,0.00013104091,0.000037107984,0.0004690643,0.00022635059,0.00008319248],"category_scores_gemma":[0.0004018649,0.0003066535,0.00026344974,0.00069888245,0.00038079446,0.00015478741,0.00034782366,0.00066928734,0.0000062854992],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020116582,0.0015608689,0.98643875,0.000039230817,0.0018302293,0.00050334044,0.0034287781,0.0000049387504,0.0036058049,0.000011011455,0.0010849275,0.0012909656],"study_design_scores_gemma":[0.012324695,0.00041822434,0.97478086,0.00019682726,0.0014594101,0.00017499557,0.0016094309,0.000019331312,0.00862144,0.000049472463,0.000072910625,0.00027238112],"about_ca_topic_score_codex":0.19554678,"about_ca_topic_score_gemma":0.040846784,"teacher_disagreement_score":0.1547,"about_ca_system_score_codex":0.00017478333,"about_ca_system_score_gemma":0.0009000946,"threshold_uncertainty_score":0.99993855},"labels":[],"label_agreement":null},{"id":"W2550339374","doi":"10.1182/blood.v112.11.2685.2685","title":"Iron Overload and Haematopoiesis in MDS: Does Blood Transfusion Promote Progression to AML?","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Sunnybrook Hospital","funders":"","keywords":"Haematopoiesis; Myelodysplastic syndromes; Stem cell; Progenitor cell; Immunology; Biology; Medicine; Cancer research; Bone marrow; Cell biology","score_opus":0.013346613029223358,"score_gpt":0.2825761477354372,"score_spread":0.26922953470621386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550339374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99471736,0.0005782843,0.00001355301,0.0022832553,0.000035575307,0.001362894,0.00000834002,0.00009255429,0.00090818177],"genre_scores_gemma":[0.9935941,0.001033875,0.0041672788,0.00020053957,0.00012515095,0.00011847322,0.000011245429,0.000041467734,0.00070784555],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99819773,0.00006728689,0.00029601247,0.00047774383,0.0005075084,0.000453689],"domain_scores_gemma":[0.99918157,0.00005014964,0.000037625243,0.00036436564,0.000063093496,0.00030321552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026008955,0.00020609597,0.00038668077,0.0002735468,0.00012290169,0.000017149507,0.000117727875,0.00016856991,0.00008118987],"category_scores_gemma":[0.00014854371,0.00013909572,0.00005724359,0.00041225724,0.00010877899,0.00010819942,0.00010470761,0.0003422751,0.000034211505],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010169294,0.00420991,0.34185395,0.0010373652,0.00013640395,0.005478451,0.008993919,0.0000011645635,0.61510354,0.000053737393,0.00084195955,0.021272656],"study_design_scores_gemma":[0.02293725,0.0025515317,0.27865663,0.0015495012,0.00033820793,0.003105351,0.00043475447,0.00008475362,0.68667656,0.00009047225,0.0030109193,0.0005640682],"about_ca_topic_score_codex":0.000216005,"about_ca_topic_score_gemma":0.00010964646,"teacher_disagreement_score":0.071573004,"about_ca_system_score_codex":0.0000583306,"about_ca_system_score_gemma":0.00016996419,"threshold_uncertainty_score":0.5672159},"labels":[],"label_agreement":null},{"id":"W2550344624","doi":"10.1182/blood.v110.11.899.899","title":"A Phase I Study of Tipifarnib Combined with Conventional Induction and Consolidation Therapy for Previously Untreated Patients with Acute Myeloid Leukemia Age 60 and Over.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Hamilton Health Sciences; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cytarabine; Regimen; Daunorubicin; Myeloid leukemia; Internal medicine; Gastroenterology; Toxicity; Leukemia; Surgery","score_opus":0.01623682542114622,"score_gpt":0.29938824926713586,"score_spread":0.2831514238459896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550344624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99610543,0.00006557545,0.00018596866,0.000026839381,0.000014221433,0.0034731063,0.000033159642,0.000031832427,0.00006388388],"genre_scores_gemma":[0.99869657,0.00006295187,0.00058425416,0.000042597898,0.000034824956,0.00008839188,0.0003497147,0.000029764456,0.000110961104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988024,0.000043969943,0.0002624147,0.0003027534,0.00035715016,0.00023131233],"domain_scores_gemma":[0.9991342,0.000096974734,0.00016799952,0.00017943817,0.00029105693,0.00013035507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028125834,0.00017074357,0.00032382362,0.00016685322,0.00009273848,0.00002019411,0.000043406115,0.000079771475,0.000015932608],"category_scores_gemma":[0.000029600924,0.000119335324,0.000020457575,0.00022469103,0.00015789366,0.00011848221,0.0000215137,0.0001502762,3.770335e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0992937,0.024992684,0.80957466,0.00036409724,0.005041257,0.0004677374,0.004400232,0.0000025379245,0.034083437,0.000121606805,0.00027387743,0.021384146],"study_design_scores_gemma":[0.27576232,0.051164962,0.66060865,0.00011738084,0.0008231636,0.000077809585,0.0005404293,0.00006723395,0.010513731,0.000020283156,0.000111413,0.00019262529],"about_ca_topic_score_codex":0.00008142544,"about_ca_topic_score_gemma":0.00004897642,"teacher_disagreement_score":0.17646861,"about_ca_system_score_codex":0.00009273028,"about_ca_system_score_gemma":0.00020875351,"threshold_uncertainty_score":0.48663533},"labels":[],"label_agreement":null},{"id":"W2550348382","doi":"10.1182/blood.v106.11.2605.2605","title":"Stable Suppression of a Novel Oncogene, AHI-1, in Human Cutaneous T-Cell Leukemia Cells Normalizes Its Transforming Activity In Vitro and In Vivo and Aberrant Expression of AHI-1 Is Also Present in Leukemic Sezary Cells from Patients with Sezary Syndrome.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":188,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"","keywords":"Biology; Autocrine signalling; Cell culture; Leukemia; Provirus; Gene knockdown; Molecular biology; RNA interference; Small hairpin RNA; Cancer research; Immunology; Gene; RNA; Genetics","score_opus":0.005937374710615574,"score_gpt":0.20537445879371632,"score_spread":0.19943708408310076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550348382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983332,0.0007122575,0.000018365943,0.0000085619695,0.000019382604,0.00056809455,0.00022339253,0.00000350735,0.00011323033],"genre_scores_gemma":[0.9989137,0.0003445103,0.0005485747,0.000018538927,0.000013577868,0.000024106434,0.000055997825,0.000021369273,0.00005959843],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99860644,0.00007383959,0.00044537062,0.00041362923,0.00020190979,0.00025881262],"domain_scores_gemma":[0.999506,0.000025925068,0.00017131712,0.0002047631,0.00002544269,0.00006653932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012148641,0.00021533937,0.00035131257,0.00017627873,0.000024699664,0.000008967221,0.00011744555,0.00021985994,0.000013138791],"category_scores_gemma":[0.000005837943,0.00019658769,0.000032365475,0.00013330966,0.00005649667,0.00004509119,0.00009972955,0.00016690043,1.1752885e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065466284,0.0011326282,0.008235828,0.00014031249,0.000008629983,0.0000138046125,0.00038115913,0.0003173285,0.9886828,8.954001e-8,0.000022022281,0.0004107444],"study_design_scores_gemma":[0.0072480952,0.00024753326,0.0030389153,0.00036537932,0.000013101735,0.000006686483,0.00006225728,0.00054013537,0.9881557,0.000001678917,0.0001063421,0.00021413581],"about_ca_topic_score_codex":0.0009879487,"about_ca_topic_score_gemma":0.0006795016,"teacher_disagreement_score":0.0065934323,"about_ca_system_score_codex":0.00005429574,"about_ca_system_score_gemma":0.0000922564,"threshold_uncertainty_score":0.8016613},"labels":[],"label_agreement":null},{"id":"W2550403115","doi":"10.1182/blood.v110.11.467.467","title":"Interaction of a Novel Signaling Protein (AHI-1) with BCR-ABL Modulates BCR-ABL Transforming Activity and Imatinib Response of Chronic Myeloid Leukemia Progenitor Cells.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; Myeloid leukemia; K562 cells; Cancer research; Progenitor cell; ABL; Gene knockdown; Imatinib mesylate; breakpoint cluster region; Leukemia; Ectopic expression; Stem cell; Fusion protein; Molecular biology; Cell culture; Signal transduction; Tyrosine kinase; Immunology; Cell biology; Imatinib; Receptor; Gene; Genetics","score_opus":0.013463994117201455,"score_gpt":0.25779876929931145,"score_spread":0.24433477518211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550403115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956133,0.0003908694,0.0018142303,0.000037869864,0.000047538637,0.0018608429,0.000028831006,0.000065317814,0.00014122885],"genre_scores_gemma":[0.9896794,0.000022239008,0.009854356,0.00000763987,0.000117568066,0.00007488821,0.0000120650075,0.00006273307,0.00016913604],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979883,0.000069300324,0.00058638013,0.00044963157,0.00045614375,0.00045026795],"domain_scores_gemma":[0.99860644,0.0002695779,0.00041834108,0.00038117752,0.00015479191,0.00016967568],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000764563,0.0003395413,0.0006250912,0.00025529542,0.00008037009,0.000014144448,0.000097857745,0.00018591157,0.000036246976],"category_scores_gemma":[0.00009639811,0.00028250137,0.00012103592,0.00033410714,0.00016903621,0.0002639738,0.000036407328,0.0003379492,0.0000021231665],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070620496,0.0014065166,0.0010614442,0.0010199385,0.0004371085,0.00005471714,0.0011009129,0.00006771907,0.9786198,0.000006219371,0.0000013111109,0.009162231],"study_design_scores_gemma":[0.016058378,0.002537637,0.0034974485,0.0014924097,0.0005276602,0.00027253278,0.00026868613,0.0017142349,0.9733436,0.000004264424,0.00005092261,0.00023223367],"about_ca_topic_score_codex":0.00042068455,"about_ca_topic_score_gemma":0.000075031516,"teacher_disagreement_score":0.008996328,"about_ca_system_score_codex":0.0009673332,"about_ca_system_score_gemma":0.001105346,"threshold_uncertainty_score":0.9999627},"labels":[],"label_agreement":null},{"id":"W2550415955","doi":"10.1182/blood.v120.21.2593.2593","title":"Whole Exome Sequencing Analysis in AML with Normal Karyotype Not Harboring FLT3/ITD Mutation Reveals Novel Genetic Alterations.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Sanger sequencing; Biology; Genetics; Mutation; Exome sequencing; Missense mutation; dbSNP; Germline mutation; Gene; Cancer research; Genotype","score_opus":0.027635033462801783,"score_gpt":0.2834611603062218,"score_spread":0.25582612684342004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550415955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953115,0.00021353218,0.0030180872,0.00031485522,0.00003301551,0.00036736237,0.000014484982,0.00004597492,0.000681179],"genre_scores_gemma":[0.9800417,0.000013227839,0.01874696,0.00022625842,0.00030771364,0.00006381111,0.000093211485,0.000032463613,0.0004746453],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983217,0.00006187465,0.00035489502,0.00027980295,0.00046122275,0.00052051473],"domain_scores_gemma":[0.99909085,0.00007965399,0.00009304234,0.0003810752,0.00014445849,0.00021089996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000483819,0.00016474767,0.00033706625,0.0005955943,0.00008527452,0.000040117786,0.00010490289,0.000089005254,0.00009565723],"category_scores_gemma":[0.00013268336,0.00014395101,0.00007044089,0.0013519289,0.00004420339,0.00032032997,0.000047888385,0.0003059162,0.00007459121],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013833503,0.00045216383,0.63899785,0.00012040632,0.00072685577,0.00021647604,0.0021741246,0.0022318885,0.3542275,0.00007007452,0.00003105417,0.00061323773],"study_design_scores_gemma":[0.0040765703,0.00020543816,0.94776744,0.00009297085,0.0012208468,0.00020931527,0.00025529985,0.005119022,0.04073359,0.000003979794,0.000084862186,0.00023063808],"about_ca_topic_score_codex":0.00045196514,"about_ca_topic_score_gemma":0.0001725213,"teacher_disagreement_score":0.3134939,"about_ca_system_score_codex":0.00032534066,"about_ca_system_score_gemma":0.00025440223,"threshold_uncertainty_score":0.5870152},"labels":[],"label_agreement":null},{"id":"W2550437889","doi":"10.1182/blood.v120.21.2212.2212","title":"Inhibition of Platelet-Prothrombianse by a Covalent Antithrombin-Heparin Complex.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Prothrombinase; Antithrombin; Chemistry; Heparin; Thrombin; Platelet; Covalent bond; Biochemistry; Coagulation; Enzyme; Biophysics; Pharmacology; Stereochemistry; Internal medicine; Biology; Medicine","score_opus":0.03978694749780671,"score_gpt":0.280679342781851,"score_spread":0.24089239528404432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550437889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99426067,0.0003247609,0.0004416994,0.00023952086,0.00013672061,0.0005083067,0.000031601903,0.000091995345,0.003964702],"genre_scores_gemma":[0.99730986,0.000044170585,0.0018044933,0.00040577995,0.000093117706,0.00002148413,0.00013148655,0.000028802955,0.00016081848],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99880797,0.00004595027,0.00034272153,0.00017968175,0.0003229427,0.00030074918],"domain_scores_gemma":[0.9992897,0.000021711956,0.00013893239,0.00028235163,0.000078993085,0.00018831095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021416202,0.00015296029,0.00038476655,0.00008441224,0.000054744003,0.000008716385,0.00004744776,0.00011569528,0.0007869439],"category_scores_gemma":[0.000026004494,0.00014660585,0.00010374525,0.00019179036,0.000071980045,0.00012432424,0.00003744921,0.00011767461,0.000115354196],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043128515,0.00410526,0.019863019,0.00016127332,0.00018803585,0.0000051921375,0.00034747968,2.3755396e-7,0.96749383,0.0041560163,0.0030658506,0.00057069527],"study_design_scores_gemma":[0.006053123,0.00045565548,0.063821964,0.00012302572,0.00028073761,0.0001020852,0.000101329104,0.000025310663,0.92653835,0.00023257456,0.0020900702,0.00017574677],"about_ca_topic_score_codex":0.00004189166,"about_ca_topic_score_gemma":0.0000028790605,"teacher_disagreement_score":0.043958947,"about_ca_system_score_codex":0.000017398135,"about_ca_system_score_gemma":0.000031671454,"threshold_uncertainty_score":0.8616484},"labels":[],"label_agreement":null},{"id":"W2550448448","doi":"10.1182/blood.v104.11.4083.4083","title":"Are There Potential Predictors for Response to Enoxaparin in the Neonatal Population?.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"","keywords":"Medicine; Heparin; Antithrombin; Fibrinogen; Population; Sepsis; Dosing; Therapeutic index; Low molecular weight heparin; Dose; Internal medicine; Anesthesia; Surgery; Pharmacology; Drug","score_opus":0.020901736954450464,"score_gpt":0.2755076799659837,"score_spread":0.2546059430115332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550448448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927646,0.00006022522,0.0013281243,0.0046945796,0.00012126232,0.00087470526,0.000020499429,0.000049896233,0.00008611001],"genre_scores_gemma":[0.99690795,0.0000012771982,0.001454427,0.0012335125,0.00015689127,0.000089524336,0.00002889168,0.000018622997,0.000108922686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914736,0.00005823006,0.00018955895,0.00018896525,0.00023709526,0.00017882041],"domain_scores_gemma":[0.9995227,0.00004775377,0.000062570376,0.00025174802,0.00004081112,0.000074408716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003432978,0.000102170605,0.00016097608,0.00010142033,0.00007491186,0.000021176244,0.00010562577,0.00007869247,0.00003463527],"category_scores_gemma":[0.00016792881,0.00007396022,0.00007650572,0.00019516592,0.0000113618225,0.00004289936,0.000020995276,0.00009456753,0.00001996791],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02597197,0.019262291,0.5668699,0.00069504936,0.0015766411,0.0019419689,0.025277365,0.006607235,0.2601851,0.07304667,0.0019569327,0.01660887],"study_design_scores_gemma":[0.007729312,0.00048150105,0.98010856,0.00008847257,0.00014571192,0.00006955901,0.0006777843,0.000021955657,0.007211024,0.00236023,0.0009933318,0.00011253702],"about_ca_topic_score_codex":0.00005179358,"about_ca_topic_score_gemma":0.00012366824,"teacher_disagreement_score":0.41323864,"about_ca_system_score_codex":0.000025585763,"about_ca_system_score_gemma":0.00004297367,"threshold_uncertainty_score":0.30160102},"labels":[],"label_agreement":null},{"id":"W2550470734","doi":"10.1182/blood.v114.22.1071.1071","title":"Population Pharmacokinetics of Enoxaparin in Children at Risk for Symptomatic Thromboembolism.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stollery Children's Hospital","funders":"","keywords":"Medicine; NONMEM; Pharmacokinetics; Dosing; Population; Low molecular weight heparin; Regimen; Body surface area; Maintenance dose; Venous thrombosis; Thrombosis; Anesthesia; Surgery; Internal medicine","score_opus":0.009030150218471497,"score_gpt":0.2693023439529286,"score_spread":0.26027219373445715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550470734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970514,0.00036613087,0.00004982644,0.00017974796,0.000051970263,0.0013317608,0.00002147696,0.0000417286,0.00090592273],"genre_scores_gemma":[0.9975849,0.00041577045,0.0014212758,0.00026736033,0.00011261888,0.00003984671,0.00009388214,0.000017608309,0.000046766683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896646,0.000026518217,0.00037719944,0.00021207218,0.00018690797,0.00023087037],"domain_scores_gemma":[0.99945414,0.00003600048,0.00016678227,0.00024296062,0.0000359672,0.00006414457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018393555,0.00013624919,0.0005239271,0.00014505931,0.000041705385,0.000006448444,0.00008117632,0.00006218325,0.000051808154],"category_scores_gemma":[0.000052488,0.0001262832,0.000102984406,0.00015371402,0.000016576849,0.00004166158,0.000030643372,0.00007121886,0.0000074344835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006298054,0.005285767,0.9718991,0.00020138855,0.0003740697,0.000003265614,0.00043466987,0.00019713279,0.005087747,0.0015616143,0.0013663081,0.013525964],"study_design_scores_gemma":[0.0054349503,0.00046776395,0.9827816,0.00010148347,0.00095477764,0.000008512984,0.000011895922,0.00026490333,0.008857609,0.0009089253,0.000090149275,0.0001174673],"about_ca_topic_score_codex":0.00015281433,"about_ca_topic_score_gemma":0.000020666397,"teacher_disagreement_score":0.013408496,"about_ca_system_score_codex":0.00003855387,"about_ca_system_score_gemma":0.00001206748,"threshold_uncertainty_score":0.5149679},"labels":[],"label_agreement":null},{"id":"W2550485756","doi":"10.1182/blood.v104.11.4148.4148","title":"Induction of Transient Cytopenia to Detect Hematopoietic Defects in the Mouse.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Biology; Phenotype; Genetics; Penetrance; Cytopenia; Haematopoiesis; Genetic screen; Mutant; Immunology; Gene; Bone marrow; Stem cell","score_opus":0.019890808841104113,"score_gpt":0.27924340426676314,"score_spread":0.259352595425659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550485756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99636716,0.000120777404,0.00019463271,0.0016173649,0.00001646921,0.000694826,0.000001913792,0.0000181524,0.00096868776],"genre_scores_gemma":[0.99851406,0.00001788419,0.00097462576,0.0003264114,0.000047497095,0.00004948151,0.0000028666784,0.000014250651,0.000052931053],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990675,0.000049550927,0.00017971033,0.0001595713,0.00033136414,0.00021229079],"domain_scores_gemma":[0.9995213,0.00003574282,0.00002327372,0.00030386372,0.000043906846,0.00007190933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003265868,0.00008256269,0.00017978571,0.0001455375,0.000025060592,0.000006596541,0.00013808612,0.00006411195,0.000019476785],"category_scores_gemma":[0.00010835036,0.000055992732,0.00005509624,0.0004719678,0.00003622174,0.00003064796,0.000021705227,0.00024024368,0.00004891936],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024689754,0.00085722964,0.002206083,0.00023820293,0.000060821825,0.00023923893,0.007557192,0.00016208587,0.9857898,0.00039742346,0.00034959722,0.0018954652],"study_design_scores_gemma":[0.0070061404,0.0009333827,0.038366165,0.00011718009,0.000091376496,0.00041450068,0.0005961297,0.0000022146533,0.95153254,0.00027297827,0.0005677406,0.00009965276],"about_ca_topic_score_codex":0.00014720089,"about_ca_topic_score_gemma":0.000098618744,"teacher_disagreement_score":0.03616008,"about_ca_system_score_codex":0.0000914289,"about_ca_system_score_gemma":0.0001680229,"threshold_uncertainty_score":0.22833173},"labels":[],"label_agreement":null},{"id":"W2550517509","doi":"10.1182/blood.v112.11.4399.4399","title":"Pediatric Treatment Guidelines for Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML): What Are They in Today’s Imatinib Era?","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Stollery Children's Hospital","funders":"","keywords":"Medicine; Chronic myelogenous leukemia; Imatinib; Imatinib mesylate; Philadelphia chromosome; Internal medicine; Transplantation; Oncology; Leukemia; Pediatrics; Myeloid leukemia; Chromosomal translocation","score_opus":0.05288349843955804,"score_gpt":0.3092616858624974,"score_spread":0.2563781874229394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550517509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97137636,0.02224184,0.000026726795,0.0026162602,0.0002834656,0.0027846727,0.00015482242,0.00016481733,0.00035104452],"genre_scores_gemma":[0.9732212,0.018501395,0.0035238387,0.00062388956,0.0020700055,0.00079776614,0.0004177738,0.00012997354,0.0007141812],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969708,0.00006816681,0.0008741877,0.00080394634,0.00042142882,0.0008615062],"domain_scores_gemma":[0.9980541,0.00024826088,0.00032147294,0.00073333585,0.0003736066,0.000269224],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001708181,0.00060066517,0.0009386137,0.0003170835,0.0002288061,0.000039097606,0.00020087417,0.0002860679,0.000093661394],"category_scores_gemma":[0.00021658007,0.00048612276,0.00036190756,0.0003260365,0.00007273307,0.00028294144,0.00006762275,0.00024197595,0.0001188578],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068983086,0.039303597,0.6693461,0.004281321,0.010911143,0.026488619,0.03999469,0.0036617345,0.028576553,0.0005507581,0.034805726,0.13518147],"study_design_scores_gemma":[0.30083165,0.022230417,0.5611895,0.0031965133,0.0099038305,0.0117349,0.003388245,0.0033883143,0.06923633,0.00087062956,0.0099943485,0.004035385],"about_ca_topic_score_codex":0.00072332245,"about_ca_topic_score_gemma":0.00079391047,"teacher_disagreement_score":0.29393333,"about_ca_system_score_codex":0.0050421576,"about_ca_system_score_gemma":0.002868977,"threshold_uncertainty_score":0.999759},"labels":[],"label_agreement":null},{"id":"W2550524043","doi":"10.1182/blood.v118.21.2859.2859","title":"Interim Results for the Safety and Efficacy of Different Lenalidomide Starting Dose Regimens in Subjects with Relapsed or Refractory Chronic Lymphocytic Leukemia (CC-5013-CLL-009 Study)","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"","keywords":"Lenalidomide; Medicine; Tolerability; Bendamustine; Regimen; Internal medicine; Chronic lymphocytic leukemia; Interim analysis; Refractory (planetary science); Tumor lysis syndrome; Neutropenia; Oncology; Clinical trial; Pharmacology; Adverse effect; Leukemia; Chemotherapy; Multiple myeloma","score_opus":0.046875741056579774,"score_gpt":0.3025787118389563,"score_spread":0.2557029707823765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550524043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951984,0.0008036809,0.000032473345,0.000062286286,0.00006892632,0.0031302508,0.000012598904,0.000057134333,0.0006341912],"genre_scores_gemma":[0.99839944,0.0003078739,0.00022458461,0.00005235764,0.00013213084,0.00014435999,0.000012727953,0.000070967195,0.0006555877],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99691755,0.00020668335,0.00095731625,0.000663153,0.0005669866,0.0006883066],"domain_scores_gemma":[0.9963036,0.0018972346,0.00037201855,0.0010616059,0.00016317607,0.00020234095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011494107,0.0003601143,0.00077167223,0.00021419719,0.0001302176,0.000024446272,0.00031313513,0.0001429019,0.00001710089],"category_scores_gemma":[0.0013444127,0.00020063424,0.00009996665,0.00037538313,0.00027040028,0.00010349808,0.00021134737,0.00037487605,0.000004415206],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.75979567,0.037071347,0.014223918,0.0065796417,0.0072836853,0.0046947147,0.10476466,0.00033299255,0.036425557,0.0005864363,0.0010795364,0.02716181],"study_design_scores_gemma":[0.86815894,0.016581027,0.06310086,0.002205731,0.001282619,0.00031180773,0.0037450786,0.006250798,0.03753533,0.00003311194,0.0002568681,0.000537836],"about_ca_topic_score_codex":0.0023614422,"about_ca_topic_score_gemma":0.0025060412,"teacher_disagreement_score":0.10836324,"about_ca_system_score_codex":0.016436609,"about_ca_system_score_gemma":0.012072114,"threshold_uncertainty_score":0.99352854},"labels":[],"label_agreement":null},{"id":"W2550531387","doi":"10.1182/blood.v124.21.647.647","title":"Identification of an Epithelial-to-Mesenchymal Transition (EMT)-like Programme in t(4;14)-Positive Multiple Myeloma Reveals Novel Targets for Therapeutic Intervention","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Epithelial–mesenchymal transition; Multiple myeloma; Mesenchymal stem cell; Microarray analysis techniques; Cancer research; Biology; Microarray; Gene signature; Downregulation and upregulation; Gene expression; Oncology; Gene; Medicine; Immunology; Pathology; Genetics","score_opus":0.02590204199985138,"score_gpt":0.3117922808917032,"score_spread":0.28589023889185183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550531387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9656523,0.00006949958,0.030687777,0.0004055911,0.00007693778,0.0028583643,0.00017488126,0.00003981316,0.000034873],"genre_scores_gemma":[0.9936211,0.0000063915845,0.004965871,0.000088278815,0.000087988876,0.00056438893,0.0005139898,0.000031331474,0.00012067754],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982621,0.00013741205,0.00051100686,0.00038102348,0.00032989783,0.00037855378],"domain_scores_gemma":[0.998958,0.0001361968,0.00014255928,0.00030113914,0.00026949678,0.00019263431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084348343,0.00016685323,0.0003291114,0.00025797597,0.000059499398,0.000027060882,0.00010993593,0.00010138757,0.000010914303],"category_scores_gemma":[0.00025887863,0.00014964888,0.00016336206,0.00022401703,0.00004660542,0.00015931964,0.00002214253,0.0001001596,0.000013652448],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023742612,0.008052585,0.01477015,0.00039832745,0.00026847757,0.000009557516,0.0013483102,0.000016856246,0.85440993,0.0002025713,0.000005432135,0.11814356],"study_design_scores_gemma":[0.02394909,0.003841556,0.608847,0.0003063232,0.00023743772,0.00002660714,0.00020776274,0.008715164,0.35307336,0.0005104015,0.00009058437,0.00019471833],"about_ca_topic_score_codex":0.0001944348,"about_ca_topic_score_gemma":0.00026713312,"teacher_disagreement_score":0.5940769,"about_ca_system_score_codex":0.000056589062,"about_ca_system_score_gemma":0.000035542747,"threshold_uncertainty_score":0.6102504},"labels":[],"label_agreement":null},{"id":"W2550562044","doi":"10.1182/blood.v118.21.1270.1270","title":"In Vitro Expansion of Human Hematopoietic Cells with Delayed but Sustained Multi-Lineage Repopulating Activity","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Haematopoiesis; CD34; Bone marrow; CD38; Stromal cell; Stem cell; Biology; CD90; Immunology; Cell biology; Stem cell factor; Andrology; In vitro; Molecular biology; In vivo; Transplantation; Cord blood; Cancer research; Internal medicine; Medicine; Biochemistry; Genetics","score_opus":0.0336425550521244,"score_gpt":0.27667445078160097,"score_spread":0.24303189572947656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550562044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99645287,0.000020897534,0.0020470642,0.000013056589,0.000031538875,0.0005916792,0.0000066539274,0.000052775755,0.00078347255],"genre_scores_gemma":[0.98248965,0.0000036072254,0.017207645,0.000021882683,0.000022620567,0.000023292889,0.000017064982,0.000037100912,0.0001771563],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986231,0.00007149617,0.00046475156,0.0003023787,0.00027138984,0.00026690916],"domain_scores_gemma":[0.999149,0.000059201306,0.00021889043,0.00037859325,0.000095134594,0.000099176454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025699227,0.00018261271,0.00044086413,0.00015344328,0.000043189797,0.000004359129,0.000069855705,0.00011798017,0.000053196592],"category_scores_gemma":[0.000027357844,0.00015388471,0.00006588698,0.0002177117,0.000056690584,0.000097398704,0.00001802092,0.0001806083,0.0000051840852],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057258765,0.0011582244,0.011983538,0.0006896431,0.00005102842,0.0005904141,0.0035970886,0.0000020865398,0.9812805,0.000027338972,0.0000013630122,0.00004615375],"study_design_scores_gemma":[0.0069464296,0.00041347207,0.011960168,0.00031068083,0.0002404384,0.00019065235,0.0010644317,0.0002626593,0.97844726,0.000012180855,3.3413977e-7,0.00015126713],"about_ca_topic_score_codex":0.0006904333,"about_ca_topic_score_gemma":0.000057984933,"teacher_disagreement_score":0.01516058,"about_ca_system_score_codex":0.000030068684,"about_ca_system_score_gemma":0.000070555514,"threshold_uncertainty_score":0.62752366},"labels":[],"label_agreement":null},{"id":"W2550562105","doi":"10.1182/blood.v124.21.4186.4186","title":"Genotype Phenotype Correlation in Patients with aHUS and Abnormal Genetic Studies: A Single Centre Experience","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Atypical hemolytic uremic syndrome; Eculizumab; Thrombotic microangiopathy; Medicine; Factor H; Internal medicine; Gastroenterology; Complement system; Creatinine; Immunology; Antibody; Disease","score_opus":0.009791142084565845,"score_gpt":0.2131994854730464,"score_spread":0.20340834338848054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550562105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975203,0.0018380892,0.00004197919,0.0000104796645,0.00015617131,0.00024557547,0.0000064242604,0.00002530751,0.00015563225],"genre_scores_gemma":[0.99972856,0.0000048978122,0.00010717153,0.000030083305,0.000013422013,0.000013513426,0.000027147327,0.000007895897,0.00006731494],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99931973,0.000096945165,0.00016528911,0.0001984076,0.000033250748,0.00018638266],"domain_scores_gemma":[0.9996401,0.00006928061,0.0000707561,0.00015092547,0.000053857355,0.00001507693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000042805295,0.00010094458,0.00014505768,0.000044806882,0.000070590555,0.0000072361017,0.00006781805,0.000042159863,0.0000838598],"category_scores_gemma":[0.0000617574,0.00008343541,0.000011065733,0.00006850244,0.0000790857,0.00004907716,0.00005445258,0.000047949943,0.000048612997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009483722,0.00040407223,0.9949494,0.000021570588,0.00005897908,0.000001029072,0.0021806904,0.000014185615,0.0010137605,0.00004520173,0.00005722652,0.001159075],"study_design_scores_gemma":[0.0041493843,0.0003561867,0.99355096,0.00006313441,0.00005389441,0.000002254909,0.0005239031,0.0000068008817,0.0005870192,0.00002495933,0.000551324,0.00013018689],"about_ca_topic_score_codex":0.000020864576,"about_ca_topic_score_gemma":0.00008654248,"teacher_disagreement_score":0.0040545473,"about_ca_system_score_codex":0.000016071179,"about_ca_system_score_gemma":0.0000096622125,"threshold_uncertainty_score":0.34023973},"labels":[],"label_agreement":null},{"id":"W2550582210","doi":"10.1182/blood.v120.21.4029.4029","title":"A Phase I Study of the Safety and Pharmacokinetics of Escalating Doses of MFGR1877S, a Fibroblast Growth Factor Receptor 3 (FGFR3) Antibody, in Patients with Relapsed or Refractory t(4;14)-Positive Multiple Myeloma","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pharmacokinetics; Tolerability; Adverse effect; Internal medicine; Antibody; Toxicity; Multiple myeloma; Gastroenterology; Oncology; Immunology","score_opus":0.016703943797388352,"score_gpt":0.3009600301493398,"score_spread":0.28425608635195143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550582210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975548,0.00009827991,0.000006354474,0.000012072788,0.000029545728,0.0018562572,0.00036302183,0.0000097800075,0.000069920294],"genre_scores_gemma":[0.99919355,0.000033044274,0.0006116124,0.000005765394,0.000026044487,0.000017551025,0.00005343028,0.000029101104,0.000029872523],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981338,0.0002123719,0.00053476164,0.00022884058,0.0005644758,0.00032576622],"domain_scores_gemma":[0.99855894,0.00034210566,0.0003675908,0.00028399986,0.00027862293,0.00016871747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015200306,0.00021428124,0.0005334205,0.00015041626,0.000054378605,0.000004163286,0.000107948465,0.00006731462,0.000049837916],"category_scores_gemma":[0.0005037657,0.00012249837,0.00005729945,0.00038127849,0.00015933135,0.00013651053,0.00012297464,0.00020497774,7.136046e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009462858,0.02569709,0.90349954,0.0002852214,0.0004947536,0.000007682559,0.0034269362,5.7962905e-7,0.054660834,0.0000012180112,0.0000037835223,0.002459471],"study_design_scores_gemma":[0.070287995,0.007633719,0.82978773,0.00054909295,0.00020473923,0.0000032076891,0.0005589922,0.000030638563,0.09084212,2.8671244e-7,0.0000046359764,0.000096852265],"about_ca_topic_score_codex":0.00022303853,"about_ca_topic_score_gemma":0.00004309073,"teacher_disagreement_score":0.07371185,"about_ca_system_score_codex":0.000035660698,"about_ca_system_score_gemma":0.000081616425,"threshold_uncertainty_score":0.49953386},"labels":[],"label_agreement":null},{"id":"W2550586375","doi":"10.1182/blood.v104.11.3193.3193","title":"A Phase II Study with ICL670 (Exjade®), a Once-Daily Oral Iron Chelator, in Patients with Various Transfusion-Dependent Anemias and Iron Overload.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Deferasirox; Medicine; Thalassemia; Myelodysplastic syndromes; Deferiprone; Anemia; Deferoxamine; Population; Pediatrics; Internal medicine; Bone marrow","score_opus":0.004600684429497587,"score_gpt":0.21933105641562392,"score_spread":0.21473037198612632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550586375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99701196,0.00041404273,0.000013731638,0.00028668204,0.000039489547,0.0017081596,0.000013174655,0.00006780644,0.00044493837],"genre_scores_gemma":[0.9993103,0.000098909375,0.00017724332,0.0001369293,0.00002014538,0.000040155883,0.000023412187,0.000046388213,0.00014651386],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982287,0.000038424358,0.00030652725,0.00049891474,0.000526255,0.00040116903],"domain_scores_gemma":[0.99932265,0.000012223869,0.00007784408,0.00030057042,0.000053389223,0.00023329545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012150866,0.000305547,0.00042889192,0.00013522901,0.00014919744,0.000021606022,0.00007528255,0.00017671523,0.00004719722],"category_scores_gemma":[0.000015301359,0.00020547614,0.00003642274,0.0003107227,0.000097633565,0.00011297205,0.000037820908,0.00045744254,0.000005629244],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010726636,0.1096588,0.84234285,0.0002546747,0.00032915783,0.0015437993,0.02558141,0.00027285487,0.0012725444,0.000030806743,0.000025216546,0.007961239],"study_design_scores_gemma":[0.5495203,0.119830064,0.31870106,0.000845999,0.001983111,0.00026437716,0.006741799,0.000027196702,0.0007850421,0.000032734813,0.00030951394,0.000958781],"about_ca_topic_score_codex":0.0010266141,"about_ca_topic_score_gemma":0.00077987625,"teacher_disagreement_score":0.5387937,"about_ca_system_score_codex":0.0000839315,"about_ca_system_score_gemma":0.00018495177,"threshold_uncertainty_score":0.8379074},"labels":[],"label_agreement":null},{"id":"W2550619472","doi":"10.1182/blood.v110.11.3224.3224","title":"Peripartum Management of Women with Suspected Hereditary Thrombocytopenia.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Pediatrics; Pregnancy; Medical record; Platelet disorder; Retrospective cohort study; Obstetrics; Platelet; Surgery; Internal medicine","score_opus":0.008695774402702383,"score_gpt":0.23916775305528304,"score_spread":0.23047197865258065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550619472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97092956,0.00022800881,0.000020061407,0.00006680682,0.00002777617,0.00027136458,0.0000037086772,0.000036545713,0.028416181],"genre_scores_gemma":[0.99770474,0.00004202895,0.0014516016,0.00005343834,0.000024422176,0.000012366239,0.000017702847,0.000014534314,0.0006791465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992478,0.000004625939,0.00013185554,0.0001461145,0.0001824916,0.00028710937],"domain_scores_gemma":[0.99962056,0.000009091175,0.000039416394,0.00019125265,0.000032046875,0.00010761275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000087557484,0.00009879529,0.00026141197,0.000045602857,0.000025812244,0.0000033576368,0.000043989054,0.000031053256,0.00019296266],"category_scores_gemma":[0.0000018793165,0.00007080681,0.00002377439,0.00014987389,0.00003889303,0.000031951684,0.000020744534,0.000049819093,0.000019153207],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011083291,0.045345064,0.6929214,0.0027127296,0.022998393,0.15876256,0.008375351,0.000005843173,0.0147473365,0.004745495,0.0026534859,0.035649043],"study_design_scores_gemma":[0.019744162,0.002246757,0.9555879,0.00020120612,0.0006602799,0.0006940088,0.0028589007,0.0000019697252,0.016047636,0.00015576187,0.0016122699,0.00018909486],"about_ca_topic_score_codex":0.000023933926,"about_ca_topic_score_gemma":0.00001719728,"teacher_disagreement_score":0.26266655,"about_ca_system_score_codex":0.000043897144,"about_ca_system_score_gemma":0.000021678992,"threshold_uncertainty_score":0.2887418},"labels":[],"label_agreement":null},{"id":"W2550627817","doi":"10.1182/blood.v116.21.2278.2278","title":"Presence of Prior-to-Treatment BCR-ABL Mutations In CD34+CD38- Stem Cells of Newly Diagnosed Chronic Phase CML Patients and Their Correlation with Imatinib Resistance: Implications of Cancer Pharmacogenomics and Pre-Therapeutic Genetic Testing In Personalized Treatment of BCR-ABL+ Leukemia","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"","keywords":"Imatinib; CD38; Medicine; Imatinib mesylate; Internal medicine; Oncology; Cancer research; CD34; Population; Immunology; Gastroenterology; Myeloid leukemia; Stem cell; Biology; Genetics","score_opus":0.022299262848101662,"score_gpt":0.31692635000594077,"score_spread":0.2946270871578391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550627817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99420696,0.0029079579,0.000057055917,0.00002986672,0.00001866866,0.0025164033,0.00022360803,0.00000784696,0.00003161881],"genre_scores_gemma":[0.9964516,0.000802411,0.0022239415,0.0000050927697,0.00001607065,0.00038190762,0.00002383408,0.00002802909,0.00006712346],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984551,0.000076777345,0.0006443039,0.00034212414,0.0002276074,0.00025407906],"domain_scores_gemma":[0.998198,0.0006963937,0.00039649388,0.00032848938,0.0002636569,0.00011697842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011994371,0.00021126855,0.0005420951,0.00021925819,0.000038778107,0.000006464975,0.000090548136,0.00007937046,0.0000139652875],"category_scores_gemma":[0.00004843533,0.00016332479,0.000042769843,0.00046652817,0.0002684761,0.000058328573,0.00002973971,0.000090534886,2.2852642e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014135339,0.004716795,0.3047769,0.0009792364,0.00038057152,0.000010456165,0.014143569,0.0021023045,0.6021249,0.000021227075,0.0000018721393,0.069328606],"study_design_scores_gemma":[0.16229846,0.00426588,0.32108018,0.0010038872,0.00077169255,0.000019200363,0.0006301009,0.025680257,0.4839066,0.000043036052,0.00004171444,0.0002589933],"about_ca_topic_score_codex":0.0027721524,"about_ca_topic_score_gemma":0.0027292445,"teacher_disagreement_score":0.16088492,"about_ca_system_score_codex":0.0022491224,"about_ca_system_score_gemma":0.004022934,"threshold_uncertainty_score":0.71365124},"labels":[],"label_agreement":null},{"id":"W2550640392","doi":"10.1182/blood.v116.21.4921.4921","title":"Comparison of Single Agent GA101 In Japanese and European Patients with Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (B-NHL) – Results From Two Phase I Studies","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rituximab; Medicine; Tolerability; Internal medicine; Lymphoma; Refractory (planetary science); Neutropenia; Clinical trial; Oncology; Phases of clinical research; Diffuse large B-cell lymphoma; Gastroenterology; Adverse effect; Chemotherapy","score_opus":0.025383273169698236,"score_gpt":0.29962790603400213,"score_spread":0.2742446328643039,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550640392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959366,0.0009788645,2.3679044e-7,0.000049999533,0.0001301177,0.00042988255,0.00010445913,0.000023940298,0.0023459056],"genre_scores_gemma":[0.9989725,0.00007286898,0.000554731,0.00005011194,0.000077469565,0.00001348469,0.00015965723,0.000031758173,0.000067424764],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985624,0.000070998,0.00048018928,0.0003946409,0.00027703715,0.00021472474],"domain_scores_gemma":[0.998858,0.00021336084,0.00025569936,0.000414878,0.00011402739,0.00014403011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014417784,0.00023013868,0.00053205114,0.00009801504,0.00004809497,0.000014152651,0.00007317254,0.000050410057,0.000009563951],"category_scores_gemma":[0.000105386745,0.00016302416,0.00004944087,0.000117243646,0.00012242884,0.00006431451,0.000073153176,0.00009414228,0.00001650672],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017958103,0.050101392,0.90099466,0.000068526235,0.0003628624,0.00031453648,0.009523833,0.0000018367625,0.020462247,0.0000015103845,0.0003811251,0.015991673],"study_design_scores_gemma":[0.16288425,0.0044612335,0.7749606,0.00033897132,0.0005739837,0.000006009984,0.0010260621,0.000017375312,0.054635614,0.0000033246301,0.0008748822,0.00021770372],"about_ca_topic_score_codex":0.00046339093,"about_ca_topic_score_gemma":0.0003510455,"teacher_disagreement_score":0.16108844,"about_ca_system_score_codex":0.000048633243,"about_ca_system_score_gemma":0.000039006958,"threshold_uncertainty_score":0.6647932},"labels":[],"label_agreement":null},{"id":"W2550662061","doi":"10.1182/blood.v112.11.4472.4472","title":"Methylation Status of SMURF2 and Correlation with Clinical Parameters in Patients with Multiple Myeloma","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"DNA methylation; Biology; Methylation; Molecular biology; Cancer research; Epigenetics; SMAD; Transforming growth factor; CpG site; Gene; Cell biology; Gene expression; Genetics","score_opus":0.022715898433586647,"score_gpt":0.2677895507423681,"score_spread":0.24507365230878145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550662061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990672,0.00007857017,0.00008892906,0.000028353754,0.000016263937,0.0005580182,0.00000996969,0.0000100833495,0.00014259893],"genre_scores_gemma":[0.99387074,0.000106759246,0.005862084,0.000034998822,0.000008438428,0.000027708307,0.00006677624,0.000010744531,0.000011780474],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991687,0.000053390213,0.00025583172,0.00019171409,0.0001928206,0.00013753735],"domain_scores_gemma":[0.99934876,0.00022690957,0.00011811409,0.000115527306,0.00009514773,0.00009555523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000068615875,0.00010053199,0.00027087078,0.00006775828,0.000028992385,0.0000027591843,0.0000120031045,0.000053913594,0.000005763726],"category_scores_gemma":[0.00011272006,0.000064882115,0.000021226952,0.00011615082,0.00008407863,0.00006004202,0.0000075324947,0.0000872164,0.0000017687939],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008854586,0.0018394395,0.99411416,0.000015245988,0.00012548616,0.000018148536,0.00033761968,0.00004656325,0.0000070381343,0.000012327366,0.000005988005,0.0025925518],"study_design_scores_gemma":[0.018813346,0.0030335193,0.97644824,0.00008646095,0.00015024634,0.000008639406,0.000027569133,0.00020140322,0.0011370443,0.000003981384,0.000020533209,0.00006904813],"about_ca_topic_score_codex":0.00008995064,"about_ca_topic_score_gemma":0.00010385796,"teacher_disagreement_score":0.017927887,"about_ca_system_score_codex":0.00001849435,"about_ca_system_score_gemma":0.000061555,"threshold_uncertainty_score":0.2645816},"labels":[],"label_agreement":null},{"id":"W2550673660","doi":"10.1182/blood.v118.21.2072.2072","title":"Comparing Patterns for Transitioning the Care of Young Adults with Sickle Cell Disease Versus Hemophilia: The Toronto Experience","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Pediatrics; Disease; Sickle cell anemia; Health care; Population; Young adult; Internal medicine","score_opus":0.06963936710046693,"score_gpt":0.3404707193601006,"score_spread":0.2708313522596337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550673660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949052,0.0011654212,0.00032523746,0.00012878301,0.0003226632,0.0011985077,0.00007635829,0.00003237385,0.0018454946],"genre_scores_gemma":[0.99904066,0.0000620004,0.000102966704,0.000107586,0.0003469701,0.0002565002,0.00002462899,0.000017731445,0.00004093975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897355,0.00012501661,0.00024632525,0.00017229399,0.00016303748,0.00031977717],"domain_scores_gemma":[0.99913156,0.00018742774,0.00013496926,0.00030934945,0.00012353018,0.00011319126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011567045,0.00011006107,0.00014059621,0.000008584057,0.0007456422,0.0000036542021,0.00021630354,0.00005323471,0.00006619966],"category_scores_gemma":[0.000015557882,0.00006128036,0.000054902128,0.000049024056,0.00004520104,0.000082009916,0.000033226614,0.00018706272,0.0000028399163],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011607833,0.00011696387,0.7022158,0.0009968501,0.000012975963,0.0000023368475,0.2950576,0.0000023945586,0.000004904743,0.00014750224,0.000060775074,0.00022109298],"study_design_scores_gemma":[0.008785489,0.0004013641,0.5187709,0.00063781376,0.0003049593,6.673488e-7,0.47013938,0.000091347356,0.00027117445,0.000014875108,0.00033790202,0.00024413748],"about_ca_topic_score_codex":0.003082277,"about_ca_topic_score_gemma":0.008750574,"teacher_disagreement_score":0.18344493,"about_ca_system_score_codex":0.00003792033,"about_ca_system_score_gemma":0.00015580708,"threshold_uncertainty_score":0.5734952},"labels":[],"label_agreement":null},{"id":"W2550682521","doi":"10.1182/blood.v126.23.4122.4122","title":"Diffron C, a Novel Oligonucleotide Based Gene-Silencing Agent, Induces Terminal Differentiation in Primary Murine Cells","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Haematopoiesis; Stem cell; Bone marrow; Biology; Cancer research; Progenitor cell; Leukemia; Myeloid; Myelodysplastic syndromes; Cancer stem cell; Immunology; Cellular differentiation; Cell biology; Genetics; Gene","score_opus":0.03549281945001561,"score_gpt":0.27132520160638424,"score_spread":0.23583238215636862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550682521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997049,0.000120483324,0.00035781434,0.0002615352,0.00012375003,0.00047237016,0.000016407745,0.00006886823,0.0015297836],"genre_scores_gemma":[0.9945671,0.000018269087,0.0040931352,0.0003995332,0.00029887957,0.00004223474,0.00010464652,0.00004420286,0.00043198696],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981849,0.000064314,0.00035621086,0.00038198958,0.00056430016,0.0004482846],"domain_scores_gemma":[0.99904597,0.0000691462,0.00010202607,0.00038286284,0.00009954201,0.00030044914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003616038,0.00020802599,0.0003472609,0.0003476783,0.000039683488,0.000031759882,0.00017980188,0.00013010546,0.000048802394],"category_scores_gemma":[0.00012335427,0.0001860167,0.00007374665,0.000299956,0.000050916387,0.000121982725,0.00012566232,0.00039493677,0.00006611335],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019655864,0.0014895089,0.03002188,0.00016547808,0.000044447916,0.00032798073,0.00046886306,0.00002751473,0.9656772,0.0000036214321,0.00035588845,0.0012210669],"study_design_scores_gemma":[0.014567786,0.00034396,0.39114627,0.00018278392,0.00014219449,0.000092800256,0.00012881379,0.0024187595,0.5905783,0.0000098832015,0.00016181378,0.00022662156],"about_ca_topic_score_codex":0.00026615316,"about_ca_topic_score_gemma":0.000029426585,"teacher_disagreement_score":0.37509888,"about_ca_system_score_codex":0.00047242016,"about_ca_system_score_gemma":0.00058814144,"threshold_uncertainty_score":0.7585541},"labels":[],"label_agreement":null},{"id":"W2550682660","doi":"10.1182/blood.v126.23.3567.3567","title":"International Validation of a Dithiothreitol (DTT)-Based Method to Resolve the Daratumumab Interference with Blood Compatibility Testing","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; Centre Hospitalier de l’Université de Montréal; University of British Columbia","funders":"","keywords":"Daratumumab; Dithiothreitol; Medicine; CD38; Antibody; Immunology; Chemistry; Monoclonal antibody; Biology; Biochemistry","score_opus":0.09017427219985029,"score_gpt":0.3673204824453358,"score_spread":0.2771462102454855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550682660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9491137,0.000044713484,0.038110953,0.0010569047,0.000093068345,0.0009264746,0.000022216862,0.000070584945,0.0105613815],"genre_scores_gemma":[0.9049257,6.621158e-7,0.09463077,0.00015754042,0.00013441133,0.00005022822,0.000022843435,0.000019846571,0.000057996844],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979553,0.00019083804,0.0003728632,0.0003681358,0.00086694636,0.00024591543],"domain_scores_gemma":[0.9973785,0.0006767752,0.0001501575,0.0006778938,0.0009114733,0.00020517266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013186858,0.00015440986,0.00028967386,0.000120882876,0.000052209318,0.000037168113,0.0003742848,0.00006252689,0.00002934966],"category_scores_gemma":[0.0021299582,0.000096747135,0.000048087077,0.000498988,0.0001337651,0.00007179779,0.00015123177,0.00025350414,0.000015236055],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025765074,0.034946352,0.4652376,0.0031957682,0.00629811,0.001667889,0.0262884,0.01798986,0.33338174,0.0020486184,0.0064081983,0.07677241],"study_design_scores_gemma":[0.08229341,0.0043682777,0.0101767415,0.0013068927,0.00086777,0.0007399439,0.00064230204,0.06588343,0.8318692,0.00028698094,0.0011506698,0.0004143618],"about_ca_topic_score_codex":0.0006447344,"about_ca_topic_score_gemma":0.00004564055,"teacher_disagreement_score":0.49848747,"about_ca_system_score_codex":0.0008200673,"about_ca_system_score_gemma":0.0037081179,"threshold_uncertainty_score":0.6578042},"labels":[],"label_agreement":null},{"id":"W2550736281","doi":"10.1182/blood.v114.22.3490.3490","title":"Novel Compound Heterozygous Factor V Deficiency with Severe Clinical Phenotype.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of British Columbia","funders":"","keywords":"Compound heterozygosity; Asymptomatic; Exon; Medicine; Population; Molecular biology; Immunology; Factor V; Gastroenterology; Internal medicine; Mutation; Biology; Gene; Genetics; Thrombosis","score_opus":0.06275120019623807,"score_gpt":0.34739499639762783,"score_spread":0.28464379620138974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550736281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845587,0.0002477542,0.00007204506,0.0010116382,0.00004425517,0.00031826852,0.000009728311,0.00007249371,0.013665145],"genre_scores_gemma":[0.9959631,0.000037289305,0.0019576496,0.00034906995,0.00020078455,0.0000032297794,0.000016517286,0.000013252164,0.0014591342],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988663,0.000021425889,0.0002047427,0.00026568244,0.0003371476,0.0003046796],"domain_scores_gemma":[0.9993233,0.00006835285,0.00003470522,0.00028828322,0.00007398159,0.00021134077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009493737,0.00013261646,0.0002659697,0.000051578172,0.00007752569,0.000020373383,0.00008735508,0.00009523315,0.00011680973],"category_scores_gemma":[0.000041837302,0.00008093746,0.00008438749,0.00014113054,0.00007971899,0.000041646817,0.000017042375,0.00023401478,0.00013793627],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015031645,0.031454165,0.8760363,0.0001483701,0.0005806801,0.00221552,0.0005599444,0.0000036176534,0.028563652,0.0004341045,0.0013436091,0.057156857],"study_design_scores_gemma":[0.020772845,0.007924088,0.96355706,0.00013489868,0.00034379112,0.0014110496,0.000060955546,0.00003782538,0.003036892,0.000087668035,0.002308476,0.00032443958],"about_ca_topic_score_codex":0.000009232131,"about_ca_topic_score_gemma":0.000005466317,"teacher_disagreement_score":0.087520756,"about_ca_system_score_codex":0.000018615572,"about_ca_system_score_gemma":0.00012781908,"threshold_uncertainty_score":0.3300534},"labels":[],"label_agreement":null},{"id":"W2550739463","doi":"10.1182/blood.v126.23.5268.5268","title":"The Association of Dyslipidemia with the Development of Chronic Lymphocytic Leukemia: A Population-Based Study","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Dyslipidemia; Chronic lymphocytic leukemia; Internal medicine; Comorbidity; Cancer registry; Population; Metabolic syndrome; Diabetes mellitus; Cohort; Cancer; Incidence (geometry); Leukemia; Obesity; Environmental health; Endocrinology","score_opus":0.022195788371205404,"score_gpt":0.28887815894833746,"score_spread":0.26668237057713207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550739463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997929,0.00031361252,0.000061024257,0.00016828776,0.000048996662,0.00097194995,0.0000018179132,0.000025278983,0.00048005662],"genre_scores_gemma":[0.9988836,0.0000016869953,0.00030933972,0.000027434198,0.000098400866,0.00009070956,0.000011200551,0.00002198449,0.0005556683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997565,0.0001708532,0.0004937283,0.00019292721,0.001271116,0.00030642856],"domain_scores_gemma":[0.99779165,0.0007663695,0.00036341036,0.00053048565,0.00044678032,0.000101284415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020550939,0.00013613807,0.00031881273,0.00006398729,0.00013306981,0.000014564084,0.00023680604,0.000083978644,0.0000071255367],"category_scores_gemma":[0.0007199693,0.00006851797,0.000053713535,0.0004083771,0.000060532766,0.000034260276,0.00006326145,0.00016203936,0.000010946522],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0033403833,0.0038138956,0.93949306,0.0011512319,0.004866335,0.0000736794,0.01615909,0.01283291,0.0018494974,0.00031875158,0.003365036,0.012736109],"study_design_scores_gemma":[0.3474553,0.005238434,0.5477564,0.00080602494,0.0026050578,0.000047417656,0.008418386,0.04589142,0.037471294,0.00008517572,0.0035541113,0.0006710129],"about_ca_topic_score_codex":0.00064074906,"about_ca_topic_score_gemma":0.0019708213,"teacher_disagreement_score":0.39173672,"about_ca_system_score_codex":0.059455674,"about_ca_system_score_gemma":0.06889451,"threshold_uncertainty_score":0.9441549},"labels":[],"label_agreement":null},{"id":"W2550760380","doi":"10.1182/blood.v106.11.904.904","title":"Should High-Risk Patients with Chronic Atrial Fibrillation and Those with Coronary Artery Disease Receive Combined Aspirin-Oral Anticoagulant Therapy or Oral Anticoagulant Therapy Alone? A Systematic Review and Meta-Analysis.","year":2005,"lang":"en","type":"review","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Aspirin; Atrial fibrillation; Internal medicine; Coronary artery disease; Randomized controlled trial; Stroke (engine); Meta-analysis; Cardiology; Surgery","score_opus":0.13072325224162532,"score_gpt":0.3589093336600691,"score_spread":0.2281860814184438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550760380","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010930597,0.9747006,0.00003295568,0.00028171527,0.00005354987,0.013658043,0.00023048936,0.000108268534,0.0000037523653],"genre_scores_gemma":[0.0067818547,0.99022317,0.0003826039,0.00023857689,0.00037067116,0.000071285314,0.0014479553,0.00013036228,0.00035351675],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99492,0.0010115838,0.0016081458,0.0010475819,0.00094248913,0.00047018705],"domain_scores_gemma":[0.9961819,0.00045226607,0.0017379436,0.0010531873,0.00021480117,0.0003599095],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007532977,0.0011548501,0.010128134,0.0004715119,0.00020222037,0.00015093859,0.0001767284,0.00023222662,0.00016054968],"category_scores_gemma":[0.000087910914,0.0005526818,0.0016712177,0.0009178573,0.00015547952,0.00025378662,0.00008487518,0.00031202534,0.00001142859],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00390405,0.0002759714,0.060655765,0.35792732,0.52968645,0.00026789904,0.000098587865,0.000027661035,1.2638928e-7,0.000037124406,0.00006840324,0.047050606],"study_design_scores_gemma":[0.014208257,0.002633576,0.013983974,0.021570524,0.9363309,0.000062159546,0.0000048559073,0.000038607956,1.932737e-7,0.0000049126506,0.010286662,0.00087535573],"about_ca_topic_score_codex":0.00004619649,"about_ca_topic_score_gemma":0.00005722465,"teacher_disagreement_score":0.40664443,"about_ca_system_score_codex":0.000076451855,"about_ca_system_score_gemma":0.0003130774,"threshold_uncertainty_score":0.99969244},"labels":[],"label_agreement":null},{"id":"W2550781685","doi":"10.1182/blood.v108.11.282.282","title":"Cord Blood Mesenchymal Stem Cells for Acute Renal Failure Repair.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Mesenchymal stem cell; Transplantation; Medicine; Stem cell; Renal stem cell; Cord blood; Andrology; Immunology; Biology; Pathology; Progenitor cell; Internal medicine; Cell biology","score_opus":0.02109122166342621,"score_gpt":0.29194196151431834,"score_spread":0.27085073985089214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550781685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97797,0.00075124396,0.0002978841,0.0007726099,0.00016284882,0.0020019154,0.000103994564,0.00038879167,0.017550709],"genre_scores_gemma":[0.9050466,0.000059374222,0.015053931,0.0001979463,0.0015953645,0.00027699495,0.000115848976,0.00013024278,0.07752374],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996943,0.000080839556,0.0005473868,0.00068274606,0.0008598899,0.000886167],"domain_scores_gemma":[0.9982307,0.0002327115,0.00012951615,0.00074705837,0.00031290602,0.0003470871],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005377375,0.00031666897,0.00057261856,0.00018449688,0.00017591752,0.000052779436,0.0002503849,0.00026174384,0.0003913418],"category_scores_gemma":[0.000043649932,0.0002684056,0.00042248002,0.00038296188,0.00010966508,0.00009295385,0.000119361626,0.00037376586,0.00019435727],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009386878,0.002887048,0.011079392,0.0005827579,0.0015475943,0.0018448592,0.0000738926,0.0000052656155,0.89378893,0.0016129751,0.08428297,0.0013556286],"study_design_scores_gemma":[0.0144088,0.0034112425,0.0029923273,0.00020192131,0.00278465,0.00090429,0.000102847174,0.00022354357,0.87205774,0.00019378649,0.102193974,0.00052489806],"about_ca_topic_score_codex":0.000099587356,"about_ca_topic_score_gemma":0.000057872923,"teacher_disagreement_score":0.072923444,"about_ca_system_score_codex":0.000041670643,"about_ca_system_score_gemma":0.00024973636,"threshold_uncertainty_score":0.9999768},"labels":[],"label_agreement":null},{"id":"W2550781927","doi":"10.1182/blood.v104.11.4889.4889","title":"PTEN Gene Deletions in Patients with Multiple Myeloma.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"PTEN; Fluorescence in situ hybridization; Tumor suppressor gene; Biology; Molecular biology; Cancer research; Plasma cell leukemia; Chromosomal translocation; Multiple myeloma; PI3K/AKT/mTOR pathway; Cancer; Gene; Apoptosis; Chromosome; Carcinogenesis; Immunology; Genetics","score_opus":0.00464030670299001,"score_gpt":0.20135277658140172,"score_spread":0.1967124698784117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550781927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987506,0.00022456214,0.0005130222,0.00003742413,0.000048628524,0.00013686142,0.000028479133,0.00001167521,0.00024872436],"genre_scores_gemma":[0.9968323,0.000011637183,0.0027047964,0.00013550796,0.00009349683,0.000030506682,0.00012976423,0.00001979572,0.000042169653],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99936813,0.000012789943,0.00010717436,0.0002299641,0.00010060236,0.00018132453],"domain_scores_gemma":[0.9996258,0.000003633369,0.00003560116,0.00023342212,0.00005480882,0.0000467131],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000038177328,0.0000970462,0.00007783269,0.000029238008,0.000034567314,0.000008639214,0.00011343988,0.00008113766,0.000008763084],"category_scores_gemma":[0.000028650527,0.000088255045,0.00002835256,0.000081129525,0.000034869958,0.0000022678794,0.000037844537,0.000057613186,0.0000112385915],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012757855,0.0009837941,0.6933043,0.000010311858,0.00009687852,0.000009925607,0.000060239025,0.0015368017,0.30305746,0.000020896554,0.00011134569,0.0006804346],"study_design_scores_gemma":[0.009340974,0.00054251216,0.37452292,0.000030517154,0.000035595724,0.0000053115336,0.00000983897,0.00000456875,0.6124262,0.00004710988,0.0027560764,0.00027835032],"about_ca_topic_score_codex":0.000039639217,"about_ca_topic_score_gemma":0.00015505214,"teacher_disagreement_score":0.3187814,"about_ca_system_score_codex":0.000016876817,"about_ca_system_score_gemma":0.00006807503,"threshold_uncertainty_score":0.35989365},"labels":[],"label_agreement":null},{"id":"W2550791139","doi":"10.1182/blood.v112.11.3841.3841","title":"Hyperferritinemia: An Unexpected Effect of Treatment with Danazol","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Danazol; Medicine; Ferritin; Haptoglobin; Gastroenterology; Internal medicine; Autoimmune hemolytic anemia; Anemia; Discontinuation; Hemolytic anemia; Malignancy; Immunology; Endocrinology; Endometriosis","score_opus":0.007798664680822141,"score_gpt":0.2255625961452091,"score_spread":0.21776393146438697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550791139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928185,0.0006474537,0.0000027071826,0.000065883476,0.000016702057,0.0003107917,0.0000041677204,0.000065395994,0.00606844],"genre_scores_gemma":[0.9991159,0.00025869417,0.00015825992,0.00002620666,0.00003900738,0.00001791759,0.000030363066,0.00001853392,0.0003351236],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994212,0.000030664152,0.00012697399,0.00015591439,0.000111766734,0.00015351131],"domain_scores_gemma":[0.99956226,0.000024571053,0.000035584108,0.00023014705,0.000035244066,0.00011220362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000027693372,0.00012750764,0.00029318716,0.0000502138,0.000052230786,0.0000015434525,0.00003168851,0.000091228394,0.00004233876],"category_scores_gemma":[0.000012063742,0.00007291024,0.00005693369,0.00015096957,0.00007937269,0.000023726692,0.000005520307,0.000080030375,0.000008194781],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021806047,0.0067145815,0.74628186,0.00031957706,0.0013830379,0.002386106,0.0023239728,0.000035199824,0.22792268,0.000052446336,0.00024396004,0.010155947],"study_design_scores_gemma":[0.085986905,0.1051638,0.070589826,0.00042711865,0.0033932116,0.0063661714,0.0007829031,0.00020215406,0.7237917,0.0000055299347,0.0027234163,0.0005672214],"about_ca_topic_score_codex":0.00019418732,"about_ca_topic_score_gemma":0.000012449851,"teacher_disagreement_score":0.6756921,"about_ca_system_score_codex":0.000021560232,"about_ca_system_score_gemma":0.00008734816,"threshold_uncertainty_score":0.29731932},"labels":[],"label_agreement":null},{"id":"W2550804007","doi":"10.1182/blood.v124.21.4529.4529","title":"MiR-300 Acts As a Tumor Supressor in Ph+ Progenitors By Modulating the JAK2-SET/PP2A/β-Catenin Interplay","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Chronic myelogenous leukemia; Biology; Cancer research; Progenitor cell; Haematopoiesis; Stem cell; CD38; Leukemia; breakpoint cluster region; Tyrosine kinase; Protein phosphatase 2; Imatinib mesylate; Immunology; Cell biology; Imatinib; Signal transduction; CD34; Myeloid leukemia; Genetics; Phosphatase; Receptor; Phosphorylation","score_opus":0.010312455442733785,"score_gpt":0.2688393094466123,"score_spread":0.2585268540038785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550804007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938359,0.0004973225,0.00000804695,0.0007671376,0.00013210601,0.00088616356,0.000014109535,0.000098494456,0.0037607125],"genre_scores_gemma":[0.9977117,0.000006592901,0.00034603893,0.0004001466,0.0002588786,0.0001895299,0.000058586105,0.00006167024,0.0009668233],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980948,0.00013672162,0.00040550667,0.00044947758,0.00037475736,0.00053874886],"domain_scores_gemma":[0.9988705,0.00021485814,0.00014668326,0.00054341817,0.000047435227,0.00017711447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031538712,0.00029217647,0.00039521127,0.00008753592,0.000087385975,0.00003935319,0.00025045345,0.0001048424,0.00016472414],"category_scores_gemma":[0.0004264483,0.00020004652,0.000113768765,0.00022281223,0.000080757156,0.000088510955,0.000118068376,0.00036663728,0.00025328906],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011549051,0.006755035,0.4112367,0.0007466885,0.002424148,0.0011841039,0.0136479465,0.000065201544,0.5308106,0.00042585787,0.01317121,0.018377593],"study_design_scores_gemma":[0.042441923,0.0016749998,0.03877395,0.0012635482,0.0015195498,0.001443393,0.0008252886,0.006224026,0.8834098,0.00033841532,0.021140413,0.0009447191],"about_ca_topic_score_codex":0.00071522064,"about_ca_topic_score_gemma":0.00009997254,"teacher_disagreement_score":0.37246278,"about_ca_system_score_codex":0.00023687824,"about_ca_system_score_gemma":0.0001908945,"threshold_uncertainty_score":0.81576604},"labels":[],"label_agreement":null},{"id":"W2550828294","doi":"10.1182/blood.v110.11.389.389","title":"Phase II Study of R-CHOP Followed by 90Y-Ibritumomab Tiuxetan in Untreated Mantle Cell Lymphoma: Eastern Cooperative Oncology Group Study E1499.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Rituximab; Neutropenia; Febrile neutropenia; Mantle cell lymphoma; Ibritumomab tiuxetan; Gastroenterology; Vincristine; Alemtuzumab; CHOP; Cyclophosphamide; Radioimmunotherapy; Surgery; Urology; Transplantation; Lymphoma; Chemotherapy; Immunology","score_opus":0.014200861247355942,"score_gpt":0.3031764204823627,"score_spread":0.2889755592350068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550828294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99199575,0.0007944065,0.0000034529508,0.000050456936,0.000107636464,0.0028434214,0.000033266162,0.0000562307,0.0041154004],"genre_scores_gemma":[0.9987937,0.00002922175,0.000053290965,0.00008157346,0.000053768366,0.00017026514,0.00006965646,0.000041985233,0.0007065327],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99757016,0.00018937293,0.00076514133,0.00059504143,0.00040609456,0.00047421217],"domain_scores_gemma":[0.9988027,0.00017141737,0.00021222707,0.00047425868,0.000120053475,0.00021935048],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034329205,0.00036406593,0.0009525748,0.00023760805,0.00011248474,0.000014971086,0.00014550441,0.00013518079,0.0000685296],"category_scores_gemma":[0.000033388704,0.00029539215,0.00010216927,0.0005112184,0.000058797053,0.00007947863,0.00011914825,0.000097896,0.000036724796],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017845288,0.54031277,0.43256322,0.000022453798,0.00073197647,0.005005172,0.006798547,6.7652775e-7,0.005642686,0.0000051651014,0.000509924,0.006622863],"study_design_scores_gemma":[0.5807895,0.17352737,0.17108884,0.00010896517,0.0025248628,0.00013402906,0.025258617,0.000032198903,0.044916138,0.000003609566,0.0011434092,0.00047243762],"about_ca_topic_score_codex":0.0017132695,"about_ca_topic_score_gemma":0.002654151,"teacher_disagreement_score":0.579005,"about_ca_system_score_codex":0.0002798604,"about_ca_system_score_gemma":0.00015965887,"threshold_uncertainty_score":0.9999498},"labels":[],"label_agreement":null},{"id":"W2550863734","doi":"10.1182/blood.v114.22.1698.1698","title":"Hypoxia Inducible Factor 1a (HIF-1a) Regulates CD20 Expression in Lymphoma Cells: Possible Implications for Rituximab Based Therapy in Diffuse Large B Cell Lymphoma (DLBCL).","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"CHOP; Lymphoma; Cancer research; Diffuse large B-cell lymphoma; Follicular lymphoma; Rituximab; CD20; Internal medicine; Angiogenesis; Medicine; BCL10; Biology; Oncology","score_opus":0.012943009405058785,"score_gpt":0.24958210768156316,"score_spread":0.23663909827650437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550863734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99091333,0.007001483,0.0003453889,0.00019019427,0.0002489311,0.00072974333,0.0002720001,0.00003384628,0.0002651057],"genre_scores_gemma":[0.99505067,0.0013454164,0.0017399547,0.0005838283,0.00045351035,0.00020501795,0.0002564358,0.000049295686,0.00031589993],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980746,0.00007625268,0.0004050831,0.00070234545,0.00013263812,0.0006091025],"domain_scores_gemma":[0.9988392,0.000034995548,0.00014918638,0.00074826006,0.0000829326,0.00014541924],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017809133,0.0003188134,0.0003593551,0.000185472,0.0001288419,0.000055477936,0.00035640146,0.00036609362,0.0000124889],"category_scores_gemma":[0.000033676013,0.0003080643,0.00018446482,0.00029696128,0.000037384103,0.000018754075,0.000053245574,0.000068976704,0.000005127642],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002679158,0.011870918,0.0011645529,0.000021481608,0.000012672342,0.0000011853572,0.00010780004,0.0000053218428,0.9739939,0.000022932483,0.0009400017,0.011591312],"study_design_scores_gemma":[0.045223042,0.00037533534,0.06871626,0.000032052118,0.000019026951,0.0000036936722,0.000039416147,0.00003579449,0.8546593,0.0002542948,0.030283269,0.00035846903],"about_ca_topic_score_codex":0.000043548847,"about_ca_topic_score_gemma":0.00008549301,"teacher_disagreement_score":0.11933456,"about_ca_system_score_codex":0.000035258305,"about_ca_system_score_gemma":0.00026578503,"threshold_uncertainty_score":0.9999371},"labels":[],"label_agreement":null},{"id":"W2550933491","doi":"10.1182/blood.v120.21.1721.1721","title":"Validation of the Nordic Scoring System for Erythropoietic Stimulating Agents in MDS Using IWG 2006 Erythroid Response Criteria","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; International Prognostic Scoring System; Erythropoietin; Internal medicine; Population; Medical record; Myelodysplastic syndromes","score_opus":0.038577179436751534,"score_gpt":0.31629244311987503,"score_spread":0.2777152636831235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550933491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99760455,0.00064086716,0.00028523552,0.00011528246,0.0004730606,0.00067498937,0.000010188231,0.000026121827,0.00016970049],"genre_scores_gemma":[0.9987641,0.0000070117662,0.001005945,0.000029351633,0.000108659064,0.000012861014,0.000005273363,0.000027205935,0.00003958082],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99885625,0.00013847173,0.00038116222,0.0001371971,0.00018652804,0.00030037647],"domain_scores_gemma":[0.9993833,0.0001030167,0.00014034647,0.00024522847,0.000065737804,0.00006242696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070645416,0.00011572022,0.00023638747,0.0001024863,0.000108445536,0.000010395817,0.00006442609,0.000113564456,0.000012491806],"category_scores_gemma":[0.00029959274,0.000086120286,0.00009719167,0.00027884427,0.000047343856,0.00009148742,0.000044826345,0.00011728789,0.0000027711324],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007941305,0.00095733244,0.45332903,0.0018758185,0.0001431508,0.000010342988,0.0032566022,0.0016745602,0.53725433,0.000059387567,0.0000710223,0.00057427],"study_design_scores_gemma":[0.033906482,0.0010519605,0.44064164,0.012063523,0.0027103277,0.00061880826,0.011136061,0.028135102,0.46830285,0.00006904997,0.00045988752,0.00090431416],"about_ca_topic_score_codex":0.00008169509,"about_ca_topic_score_gemma":0.0000014613292,"teacher_disagreement_score":0.068951525,"about_ca_system_score_codex":0.00008164806,"about_ca_system_score_gemma":0.00008008034,"threshold_uncertainty_score":0.35118833},"labels":[],"label_agreement":null},{"id":"W2550933501","doi":"10.1182/blood.v126.23.4740.4740","title":"Significant Increase in Reporting of Transfusion Reactions with the Implementation of an Electronic Reporting System","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Blood donation and transfusion practices","field":"Business, Management and Accounting","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; University of Toronto; Western University","funders":"","keywords":"Medicine; Medical emergency; Transfusion medicine; Emergency medicine; Documentation; Blood transfusion; Surgery; Computer science","score_opus":0.02665822711237494,"score_gpt":0.28112738093214484,"score_spread":0.2544691538197699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550933501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945717,0.000025681256,0.0001639829,0.0004054608,0.000035999255,0.0003511271,0.0000011450054,0.00004887472,0.004396036],"genre_scores_gemma":[0.99964446,0.0000044483086,0.00015993597,0.000041904,0.00007887949,0.000028237626,0.000019416622,0.000013928356,0.000008766747],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976109,0.00004522822,0.0016453314,0.00019114859,0.0003445447,0.00016283542],"domain_scores_gemma":[0.99430287,0.00004923035,0.0051157326,0.00021386481,0.0003040331,0.00001426333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036545966,0.000096227195,0.00022344511,0.00018808502,0.0000825433,0.000045686218,0.00009975665,0.000033651297,0.000020522899],"category_scores_gemma":[0.00033704774,0.00006678886,0.00004304851,0.0005786747,0.000026946422,0.0008817765,0.000016144579,0.00013210585,0.0000013596631],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006559623,0.0027578587,0.80296403,0.001572103,0.0003203686,0.00020027516,0.0029950808,0.0006905225,0.10935841,0.06315265,0.000063957305,0.015268799],"study_design_scores_gemma":[0.023038762,0.0008286238,0.5863207,0.0010014573,0.0029994964,0.0005135058,0.22214742,0.0043066973,0.14776582,0.0012174109,0.0086308075,0.0012292936],"about_ca_topic_score_codex":0.01594019,"about_ca_topic_score_gemma":0.0062934663,"teacher_disagreement_score":0.21915235,"about_ca_system_score_codex":0.000017705135,"about_ca_system_score_gemma":0.00014033899,"threshold_uncertainty_score":0.99061275},"labels":[],"label_agreement":null},{"id":"W2550950130","doi":"10.1182/blood.v114.22.2876.2876","title":"Infectious Complications in Advanced Relapsed/Refractory Multiple Myeloma Patients Treated with Lenalidomide (Revlimid +/- Corticosteroids).","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre","funders":"","keywords":"Lenalidomide; Medicine; Neutropenia; Thalidomide; Multiple myeloma; Internal medicine; Surgery; Chemotherapy","score_opus":0.014501217070552748,"score_gpt":0.2675675724735097,"score_spread":0.25306635540295697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550950130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99509436,0.00017896853,0.00002140317,0.0001734265,0.000017594437,0.0013010317,0.0000294199,0.00013624365,0.0030475447],"genre_scores_gemma":[0.99833745,0.00007879921,0.00064200675,0.00025361992,0.00002472689,0.00014292914,0.0003093041,0.000030118541,0.0001810726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836224,0.000068354166,0.00035033654,0.00040893623,0.00034580694,0.0004643502],"domain_scores_gemma":[0.9987921,0.00012210473,0.00011453206,0.00048609867,0.00019155616,0.00029362558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000056239303,0.00024291714,0.0003660261,0.00024476927,0.00010348186,0.00002020236,0.00009164284,0.00008797384,0.00003014955],"category_scores_gemma":[0.0002183636,0.00018928738,0.0000695481,0.00039040417,0.00005990411,0.00015660505,0.000021685773,0.0002583946,0.00008867199],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011042919,0.0066539585,0.9600151,0.00002090717,0.00011725819,0.00017051876,0.00007795897,0.000009845205,0.0066107605,0.00000809588,0.000036813617,0.02517445],"study_design_scores_gemma":[0.043732744,0.003113494,0.946853,0.00015844333,0.00010431511,0.000052359475,0.000017519453,0.00007544202,0.0054239673,0.00001590828,0.0002800521,0.0001727735],"about_ca_topic_score_codex":0.00011285132,"about_ca_topic_score_gemma":0.00020746022,"teacher_disagreement_score":0.042628452,"about_ca_system_score_codex":0.00014906176,"about_ca_system_score_gemma":0.00008087004,"threshold_uncertainty_score":0.77189153},"labels":[],"label_agreement":null},{"id":"W2550956595","doi":"10.1182/blood.v126.23.258.258","title":"Safety, Efficacy, and Determination of the Recommended Phase 2 Dose for the Oral Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330)","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Calgary; Princess Margaret Cancer Centre","funders":"","keywords":"Tolerability; Nuclear export signal; Medicine; Population; Cancer; Pharmacology; Cancer research; Internal medicine; Oncology; Adverse effect; Cell nucleus","score_opus":0.016167123869874546,"score_gpt":0.2671373893955417,"score_spread":0.25097026552566715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550956595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99848354,0.00014312833,0.00034179815,0.0002876904,0.00017570751,0.0003613628,0.00003254821,0.0000049267023,0.0001693006],"genre_scores_gemma":[0.99868375,0.000024135546,0.0009459741,0.00009687362,0.00016358355,0.00000542355,0.000020188303,0.000013273673,0.000046813064],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99954116,0.000034816163,0.00015158743,0.00012634823,0.00007025978,0.00007581812],"domain_scores_gemma":[0.9995157,0.00002038461,0.00011806271,0.00017658343,0.00014213077,0.000027112703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001638526,0.00007297435,0.00009281278,0.000012899502,0.000053481293,0.0000058381693,0.00008480495,0.00007608616,0.0000029877267],"category_scores_gemma":[0.00013034145,0.000044625154,0.000047933532,0.00005609985,0.00005388703,0.0000035991918,0.000055926354,0.000044396584,2.3459847e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015698735,0.00048097642,0.00041738516,0.00003082052,0.00013211388,3.147969e-7,0.00048760866,0.000004118496,0.9518495,0.00008025373,0.0046276664,0.040319357],"study_design_scores_gemma":[0.014201515,0.0027736821,0.006650684,0.000022154667,0.00035961127,0.000040434767,0.00039386362,0.0004018162,0.9132508,0.00025656162,0.061463613,0.00018527068],"about_ca_topic_score_codex":0.0000074589743,"about_ca_topic_score_gemma":0.000012153793,"teacher_disagreement_score":0.05683595,"about_ca_system_score_codex":0.000004235984,"about_ca_system_score_gemma":0.000038312657,"threshold_uncertainty_score":0.1819761},"labels":[],"label_agreement":null},{"id":"W2550997923","doi":"10.1182/blood.v108.11.3345.3345","title":"A Population-Based Analysis of the Frequency of Anemia and Its Management before and during Chemotherapy in Patients with Malignant Lymphoma.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; ABVD; Internal medicine; Anemia; Vincristine; CHOP; Rituximab; Vinblastine; Population; Chemotherapy; Surgery; Gastroenterology; Oncology; Lymphoma; Cyclophosphamide","score_opus":0.0027592056934062923,"score_gpt":0.19077218641681656,"score_spread":0.18801298072341027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550997923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993564,0.00017891964,2.8776472e-7,0.000050523417,0.0000032534756,0.0003138384,0.000015921138,0.0000036384583,0.0000772184],"genre_scores_gemma":[0.99973375,0.000009443774,0.00017134135,0.000020852332,0.0000032196858,0.000015039492,0.000027640794,0.0000058395444,0.00001290176],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994702,0.000009944825,0.00016851374,0.00012714624,0.00014802687,0.000076166005],"domain_scores_gemma":[0.99971884,0.000008481595,0.00009159594,0.00013558991,0.00002677378,0.000018714441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000026552669,0.00007657519,0.00021039687,0.00012799252,0.000019294677,0.0000029261203,0.000022352217,0.000022927323,0.0000058008295],"category_scores_gemma":[0.0000018685544,0.000044409033,0.00003558581,0.00030486332,0.000015845646,0.000016657608,0.000009581305,0.000008512123,4.561141e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046368932,0.0012468206,0.9975301,0.00012076409,0.00034392776,0.0000070817364,0.00004876188,0.00002050757,0.0000881208,0.00012364119,2.820809e-7,0.00042360136],"study_design_scores_gemma":[0.011816386,0.00011230374,0.9816997,0.00013808007,0.001199476,7.3868125e-7,0.000009063975,0.00004060572,0.004926558,0.000017699085,2.918308e-7,0.000039101444],"about_ca_topic_score_codex":0.0005832227,"about_ca_topic_score_gemma":0.0003434117,"teacher_disagreement_score":0.015830427,"about_ca_system_score_codex":0.000031929576,"about_ca_system_score_gemma":0.000010771319,"threshold_uncertainty_score":0.18109478},"labels":[],"label_agreement":null},{"id":"W2551013397","doi":"10.1182/blood.v126.23.4422.4422","title":"In Vivo Genome Editing in Neonatal Mouse Liver Preferentially Utilizes Homology Directed Repair","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Zinc finger nuclease; Homology (biology); Genome editing; Homology directed repair; Biology; Gene; Zinc finger; In vivo; Molecular biology; DNA; Nuclease; Cell biology; Genome; DNA repair; Genetics; Nucleotide excision repair; Transcription factor","score_opus":0.010808936989615272,"score_gpt":0.2542070559458054,"score_spread":0.24339811895619012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551013397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99660623,0.0021983634,0.00026344848,0.000015316771,0.00013245932,0.00011213199,0.000014404196,0.000039464623,0.0006181863],"genre_scores_gemma":[0.9978081,0.00010861477,0.001223652,0.000034943165,0.0002630608,0.000019727779,0.0000383862,0.000019182933,0.00048434493],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991993,0.000039345745,0.00017947973,0.00026846115,0.00007240915,0.00024105796],"domain_scores_gemma":[0.99966294,0.000006570128,0.000026242395,0.00020143302,0.000034665194,0.000068135065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013052233,0.00011595195,0.00012704167,0.00007103951,0.000011539801,0.0000074447685,0.00011368714,0.00013438762,0.000024792824],"category_scores_gemma":[0.00009512239,0.00012584931,0.000044284778,0.00008345434,0.000024821986,0.0000035692901,0.000112097274,0.00009117687,0.00000480399],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007533589,0.00027472238,0.014193627,0.00004344788,0.00006583068,0.00012981832,0.00073602854,0.0008800301,0.9825155,0.000025247817,0.0007105046,0.00034990665],"study_design_scores_gemma":[0.003691835,0.00032067334,0.011331787,0.000018062587,0.00003028895,0.000080551516,0.00024231085,0.0005349706,0.96032083,0.000030240435,0.023021761,0.00037666413],"about_ca_topic_score_codex":0.00010508572,"about_ca_topic_score_gemma":0.00081684464,"teacher_disagreement_score":0.022311255,"about_ca_system_score_codex":0.000009605152,"about_ca_system_score_gemma":0.000043986212,"threshold_uncertainty_score":0.5131986},"labels":[],"label_agreement":null},{"id":"W2551016480","doi":"10.1182/blood.v110.11.3420.3420","title":"Preliminary Pharmacokinetic (PK) Analysis of Eastern Cooperative Oncology Group Protocol E4402: Rituximab Extended Schedule or Re-Treatment Trial (RESORT).","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Rituximab; Medicine; Follicular lymphoma; Dosing; Internal medicine; Clinical endpoint; Randomized controlled trial; Neutropenia; Gastroenterology; Lymphoma; Randomization; Urology; Surgery; Chemotherapy","score_opus":0.02369911680455644,"score_gpt":0.34585339719267477,"score_spread":0.32215428038811833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551016480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97622263,0.00035690583,0.0009887597,0.000041949515,0.00013906872,0.020506822,0.00011472473,0.000014307972,0.0016148489],"genre_scores_gemma":[0.9838598,0.00014333393,0.0019415711,0.00015799861,0.00049857394,0.012720944,0.00020483865,0.000032778586,0.00044016103],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984319,0.00008616128,0.0005223731,0.00047727133,0.00015178844,0.0003305027],"domain_scores_gemma":[0.9989566,0.000092298804,0.00024604567,0.00041672797,0.00014959744,0.00013873822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002504353,0.0002460114,0.00048918556,0.00015123238,0.000063463754,0.000016521988,0.00019527253,0.00019698615,0.00014875183],"category_scores_gemma":[0.00009614346,0.0002002774,0.00023754447,0.000320543,0.00010791609,0.0000036989259,0.00012692515,0.00007994695,0.0000065646577],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.30534416,0.052792184,0.005165157,0.00015845649,0.013852624,0.0005757538,0.00082779373,0.0011991888,0.5456609,0.0001685007,0.0011475985,0.07310764],"study_design_scores_gemma":[0.20826668,0.05323093,0.0024208345,0.000028982275,0.0051313182,0.00002989619,0.00031945205,0.00065323873,0.66054976,0.000015698402,0.06873454,0.00061866327],"about_ca_topic_score_codex":0.00005977241,"about_ca_topic_score_gemma":0.00069694535,"teacher_disagreement_score":0.114888825,"about_ca_system_score_codex":0.000051873136,"about_ca_system_score_gemma":0.00030965553,"threshold_uncertainty_score":0.81670755},"labels":[],"label_agreement":null},{"id":"W2551029062","doi":"10.1182/blood.v120.21.2281.2281","title":"A Comparison of Automated Red Blood Cell Depletion/Exchange to Automated Red Cell Blood Exchange in Sickle Cell Patients.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Apheresis; Hematocrit; Hemoglobin; Red Cell; Red blood cell; PCSK9; Internal medicine","score_opus":0.013470331670976712,"score_gpt":0.26370111598934537,"score_spread":0.25023078431836865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551029062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797649,0.0038960618,0.0000045061843,0.00027373157,0.0004059472,0.0017335427,0.00008032087,0.0011765661,0.01266445],"genre_scores_gemma":[0.9967905,0.00026002363,0.0013233249,0.00022761435,0.00013114401,0.000112046066,0.00034205764,0.00012431681,0.00068895676],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962295,0.0002176467,0.0011366686,0.0005910654,0.0006757426,0.0011493214],"domain_scores_gemma":[0.9978783,0.00008544225,0.00044565398,0.0007452531,0.00021034962,0.0006349702],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041236833,0.0005287446,0.0010601252,0.00057305186,0.00011697079,0.000022004122,0.00028211955,0.0005954864,0.00042805084],"category_scores_gemma":[0.00008664835,0.0004976458,0.000221445,0.0010653059,0.000079921236,0.00014770306,0.00019517489,0.00047939504,0.00023010821],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048770194,0.059832178,0.71116346,0.0031641054,0.00035493358,0.0001226713,0.013274862,0.00011955042,0.16997692,0.000006798327,0.04115602,0.00034077404],"study_design_scores_gemma":[0.07093824,0.0054721655,0.18483298,0.00096114364,0.004409125,0.000051320007,0.0021868818,0.004530725,0.7113312,0.000006541765,0.01354666,0.0017330047],"about_ca_topic_score_codex":0.00047168438,"about_ca_topic_score_gemma":0.00006372904,"teacher_disagreement_score":0.5413543,"about_ca_system_score_codex":0.00007153657,"about_ca_system_score_gemma":0.00012569115,"threshold_uncertainty_score":0.9997475},"labels":[],"label_agreement":null},{"id":"W2551042557","doi":"10.1182/blood.v118.21.227.227","title":"Mutated EZH2 Collaborates with Myc in Inducing Lymphoma in a Mouse Model","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; BC Cancer Agency","funders":"","keywords":"EZH2; Lymphoma; Germinal center; Cancer research; Biology; Transgene; Follicular lymphoma; Genetically modified mouse; Spleen; Molecular biology; Immunology; B cell; Genetics; Antibody; Histone; Gene","score_opus":0.010993740298633902,"score_gpt":0.20765960292043073,"score_spread":0.19666586262179683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551042557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987713,0.00026884556,0.000109467495,0.000013241453,0.000015018184,0.00016460959,0.000010078047,0.000011678436,0.0006357464],"genre_scores_gemma":[0.998423,0.000041596202,0.0011713471,0.000028414923,0.000022533679,0.00003103528,0.000042853753,0.000022168504,0.00021704832],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999338,0.000025578964,0.000149181,0.0002478686,0.000064632004,0.00017478832],"domain_scores_gemma":[0.99966645,0.0000022615393,0.000051487314,0.00019387141,0.00005124339,0.00003466541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007264673,0.000105298874,0.00010068116,0.00008079536,0.000016022832,0.000007851055,0.00007523421,0.00014612636,0.000004631954],"category_scores_gemma":[0.0000150480855,0.000102656995,0.0000147448645,0.0002575529,0.000027399039,0.000004786304,0.000030507079,0.000042538413,0.000002438429],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025307146,0.00040836495,0.023247534,0.000012073283,0.000044728036,0.000012198393,0.0007023848,0.0082217585,0.96615094,0.000021452268,0.000025642132,0.0008998355],"study_design_scores_gemma":[0.0034295737,0.00017057,0.013911872,0.000027453341,0.000014992327,0.000010869137,0.000083290746,0.0031851258,0.97892547,0.000043432497,0.000023654013,0.00017372491],"about_ca_topic_score_codex":0.0002098942,"about_ca_topic_score_gemma":0.0017044087,"teacher_disagreement_score":0.012774485,"about_ca_system_score_codex":0.00002518965,"about_ca_system_score_gemma":0.00018011131,"threshold_uncertainty_score":0.4186231},"labels":[],"label_agreement":null},{"id":"W2551131842","doi":"10.1182/blood.v108.11.3535.3535","title":"Analysis of Varicella Zoster Virus Reactivation among Bortezomib-Treated Patients in the APEX Study.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bortezomib; Varicella zoster virus; Incidence (geometry); Internal medicine; Dexamethasone; Adverse effect; Proteasome inhibitor; Multiple myeloma; Gastroenterology; Surgery; Immunology; Virus","score_opus":0.008276541528620887,"score_gpt":0.24449162997323515,"score_spread":0.23621508844461425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551131842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99204445,0.0000103469665,0.0000053131234,0.000008518955,0.000015152057,0.0005103484,0.000010899996,0.000015007804,0.0073799663],"genre_scores_gemma":[0.9996699,0.0000035933722,0.000012934791,0.000027198257,0.000018285966,0.000041290845,0.000115856514,0.000008094812,0.0001028238],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99917823,0.00007807775,0.00027197713,0.00015839344,0.00020381396,0.00010949116],"domain_scores_gemma":[0.99950194,0.000058454334,0.00007815545,0.00026992633,0.000072393814,0.000019140294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012854465,0.00009529649,0.0002335158,0.00031490458,0.00003963235,0.000010184242,0.000039629773,0.000048927046,0.00004723611],"category_scores_gemma":[0.000017871955,0.00006160259,0.000087516935,0.0011647835,0.000019122363,0.00004793738,0.000010430891,0.00007372554,0.0000074245118],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028285798,0.01176613,0.98567235,0.0000034437971,0.0009321175,0.00002158754,0.00025304535,0.0000117496,0.00019246023,0.000003914128,0.000016767644,0.001098167],"study_design_scores_gemma":[0.0033468453,0.00024191327,0.99074835,0.000009293007,0.003652555,6.5647555e-7,0.000085366126,0.000043153905,0.0017011262,0.000005229618,0.00011580569,0.000049687234],"about_ca_topic_score_codex":0.012746686,"about_ca_topic_score_gemma":0.0023804,"teacher_disagreement_score":0.011524217,"about_ca_system_score_codex":0.000029488789,"about_ca_system_score_gemma":0.000011669567,"threshold_uncertainty_score":0.9938275},"labels":[],"label_agreement":null},{"id":"W2551167602","doi":"10.1182/blood.v116.21.lba-3.lba-3","title":"GATA2 is a New Predisposition Gene for Familial Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"CEBPA; Genetics; Biology; Missense mutation; GATA2; Mutation; Myeloid leukemia; Cancer research; Gene; Transcription factor","score_opus":0.01069589578026284,"score_gpt":0.26379597518658676,"score_spread":0.2531000794063239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551167602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99448115,0.00021256247,0.0015320382,0.0012171975,0.00031445845,0.0013515273,0.0002755191,0.00014693635,0.00046863334],"genre_scores_gemma":[0.9729656,0.00027439196,0.018191908,0.0008268582,0.0012675665,0.00018206672,0.00033207823,0.00011379142,0.0058457535],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978431,0.000024416588,0.00035945946,0.0006451084,0.00046768753,0.0006602586],"domain_scores_gemma":[0.9983654,0.00019039969,0.000089627865,0.0005682692,0.0001617819,0.0006245319],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002395493,0.0003165263,0.00047672846,0.0002195823,0.00018252974,0.00006924519,0.00022221892,0.0003553879,0.00017706689],"category_scores_gemma":[0.00022808943,0.0002870815,0.0001387446,0.00025542994,0.00016654778,0.00019724843,0.00015221188,0.00067341764,0.00011228373],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009781554,0.00025548728,0.0021160454,0.00027928437,0.00070398126,0.0005602329,0.0004731459,0.0000010317268,0.9779716,0.00021778699,0.01016058,0.0062826285],"study_design_scores_gemma":[0.076350704,0.0072545838,0.1710353,0.0005006623,0.006798918,0.0285585,0.00019230648,0.0054988894,0.6713348,0.0020705317,0.028581906,0.001822876],"about_ca_topic_score_codex":0.00017387707,"about_ca_topic_score_gemma":0.000033386,"teacher_disagreement_score":0.3066368,"about_ca_system_score_codex":0.00015513528,"about_ca_system_score_gemma":0.001089438,"threshold_uncertainty_score":0.99995816},"labels":[],"label_agreement":null},{"id":"W2551180450","doi":"10.1182/blood.v106.11.3189.3189","title":"Hospitalization Rate and Regional Differences in Comprehensive Care in Transfused Patients with Sickle Cell Disease Compared to Thalassemia: A Report from the Multi-Center Study of Iron Overload.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Thalassemia; Acute chest syndrome; Sickle cell anemia; Internal medicine; Pediatrics; Disease; Anemia; Gastroenterology","score_opus":0.009631630723176769,"score_gpt":0.22172470621259302,"score_spread":0.21209307548941625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551180450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99801254,0.00045309344,0.0000052821147,0.0002516255,0.000018889703,0.001201944,0.000028977729,0.000008835812,0.000018782035],"genre_scores_gemma":[0.9996234,0.000043816526,0.000046941608,0.000115366776,0.00000965722,0.000026089308,0.0001169752,0.0000101526,0.0000076085084],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99915856,0.00006485372,0.00024650103,0.00023253528,0.00018381931,0.00011370585],"domain_scores_gemma":[0.999575,0.000037790072,0.00007138794,0.00016523193,0.00007506916,0.000075512035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000024809915,0.00011679949,0.00022917007,0.00004806794,0.000027424123,0.0000071826935,0.00004480915,0.000041563213,0.0000036481172],"category_scores_gemma":[0.000011865709,0.000072403294,0.000020150803,0.00013606933,0.00003576047,0.000038091493,0.000016119848,0.00010467179,5.0141614e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005127016,0.006239083,0.9785156,0.000036301823,0.000027314185,0.00005954724,0.014313796,0.00010552244,0.00008908151,1.868422e-7,0.000020715652,0.00008010061],"study_design_scores_gemma":[0.02553298,0.0004188638,0.96311146,0.00019725303,0.0001144871,9.3399063e-7,0.010342498,0.00012213549,0.00004467381,6.0549036e-7,0.000030503425,0.000083600156],"about_ca_topic_score_codex":0.0005553229,"about_ca_topic_score_gemma":0.0016203002,"teacher_disagreement_score":0.025020279,"about_ca_system_score_codex":0.000019076278,"about_ca_system_score_gemma":0.00003548377,"threshold_uncertainty_score":0.29525205},"labels":[],"label_agreement":null},{"id":"W2551183227","doi":"10.1182/blood.v106.11.4983.4983","title":"Clinical Progression and Outcome of Patients with Monoclonal Lymphocytosis of Undetermined Significance.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Lymphocytosis; Organomegaly; Medicine; Chronic lymphocytic leukemia; Internal medicine; Gastroenterology; Immunophenotyping; Lymphocyte; Monoclonal; Leukocytosis; Immunology; Leukemia; Antigen; Monoclonal antibody; Polyneuropathy; Antibody","score_opus":0.029788433931925835,"score_gpt":0.35390370927618353,"score_spread":0.3241152753442577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551183227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988735,0.00017908184,0.000012729089,0.00006045831,0.000017850782,0.00045951793,0.00001503904,0.000015117949,0.00036672613],"genre_scores_gemma":[0.9943092,0.000038856753,0.0053903027,0.000036352485,0.00007160315,0.000015201101,0.000011854315,0.000017890174,0.0001087802],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984606,0.000043213142,0.0005503486,0.00024053434,0.0005065892,0.00019871173],"domain_scores_gemma":[0.99900776,0.00018039242,0.00018977368,0.00029930734,0.00016923985,0.00015349982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025153108,0.000113269794,0.00043393328,0.000071508846,0.000018947136,0.000003811357,0.00008609935,0.0000959415,0.000041293326],"category_scores_gemma":[0.00014579862,0.000076236,0.000067426794,0.00013044672,0.0002870956,0.000049647766,0.00007104831,0.000093909104,0.0000036536353],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011619516,0.002192229,0.96738124,0.0002863066,0.00012723594,0.0000136274375,0.000060013197,0.0000012684653,0.00037087663,0.000014293694,0.000029639332,0.028361307],"study_design_scores_gemma":[0.11497077,0.0025376803,0.84894323,0.00036458633,0.00037816988,0.000032234326,0.000025389634,0.00091285125,0.031304814,0.000009333322,0.00035851126,0.00016240818],"about_ca_topic_score_codex":0.000035123834,"about_ca_topic_score_gemma":0.000009000736,"teacher_disagreement_score":0.118438,"about_ca_system_score_codex":0.000442502,"about_ca_system_score_gemma":0.0013324535,"threshold_uncertainty_score":0.31088138},"labels":[],"label_agreement":null},{"id":"W2551196508","doi":"10.1182/blood.v110.11.4587.4587","title":"Short-Term Cost Per Responder among New Tyrosine Kinase Inhibitors for Imatinib-Resistant CML in Chronic Phase (CML-CP) — Canada and Germany Perspectives.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Dasatinib; Nilotinib; Medicine; Imatinib; Internal medicine; Oncology; Cost effectiveness; Drug holiday; Adverse effect; Tyrosine-kinase inhibitor; Surrogate endpoint; Imatinib mesylate; Pharmacology; Immunology; Cancer","score_opus":0.014634641788989407,"score_gpt":0.29216159735608727,"score_spread":0.27752695556709783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551196508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99193335,0.005403664,0.00005335116,0.00026181433,0.00011385124,0.0016902565,0.00008413316,0.000046064557,0.00041351045],"genre_scores_gemma":[0.99717575,0.000101048725,0.00047032972,0.00010034007,0.0005010154,0.00007278738,0.00008842405,0.00006958505,0.0014207128],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99780166,0.000029484021,0.00051589275,0.0005812755,0.0003811837,0.0006904837],"domain_scores_gemma":[0.99872994,0.00017101661,0.000105634426,0.0004308345,0.000093742856,0.00046879993],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029950065,0.0003466306,0.00047913558,0.0002105149,0.00010406037,0.000030039088,0.000095749754,0.00014191635,0.00013888627],"category_scores_gemma":[0.00012961129,0.00031884725,0.000090391266,0.0002316836,0.00012337224,0.00012107935,0.00005544422,0.00027099045,0.0000034217908],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011523049,0.0087064,0.26058078,0.0018065529,0.0019595614,0.011247281,0.0127852,0.000024019986,0.6163027,0.0005711008,0.020608258,0.053885054],"study_design_scores_gemma":[0.10819894,0.0021512562,0.76297975,0.001020694,0.0012000066,0.00033048805,0.0021180687,0.000215669,0.11200826,0.000033535212,0.008691386,0.0010519347],"about_ca_topic_score_codex":0.108264506,"about_ca_topic_score_gemma":0.5363123,"teacher_disagreement_score":0.5042945,"about_ca_system_score_codex":0.0040135747,"about_ca_system_score_gemma":0.0029438476,"threshold_uncertainty_score":0.9999264},"labels":[],"label_agreement":null},{"id":"W2551225699","doi":"10.1182/blood.v114.22.1554.1554","title":"The International Prognostic Factor Project Score (IPS) in Advanced Stage Hodgkin Lymphoma Has Limited Utility in Patients Treated in the Modern Era.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; ABVD; Internal medicine; Nodular sclerosis; Dacarbazine; Population; Chemotherapy regimen; Stage (stratigraphy); Vinblastine; Surgery; Cancer; Oncology; Gastroenterology; Lymphoma; Chemotherapy; Hodgkin lymphoma; Vincristine; Cyclophosphamide","score_opus":0.0353803538980371,"score_gpt":0.27440296826576205,"score_spread":0.23902261436772496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551225699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99633104,0.00024393952,5.992763e-7,0.0008198274,0.000048184123,0.0019183715,0.000052619347,0.00002975073,0.00055566727],"genre_scores_gemma":[0.99916875,0.000058419155,0.000048269398,0.00024576683,0.000020521675,0.0002623054,0.00013206081,0.0000118005255,0.000052093994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842,0.00012686606,0.00038879394,0.00034097486,0.00040466795,0.0003187036],"domain_scores_gemma":[0.9992435,0.00021499298,0.00009290226,0.00034133033,0.000066372086,0.000040898143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018226777,0.0002072599,0.0002496071,0.00016291841,0.000060888622,0.00006732585,0.0002176814,0.00007802144,0.00000891347],"category_scores_gemma":[0.00026833537,0.00011510511,0.000068494606,0.00039659263,0.000039450002,0.00009790068,0.000030828345,0.00011781937,0.000005399886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004809246,0.008423401,0.9245663,0.0000085671245,0.00003950841,0.00014292465,0.0015547938,0.0000038328317,0.000044578333,0.000019031826,0.000033919318,0.06468221],"study_design_scores_gemma":[0.019056136,0.0006773921,0.97815216,0.00016218208,0.0000356025,0.0000053649583,0.00016035771,0.00057725754,0.00080562115,0.000083438754,0.00017905662,0.00010544629],"about_ca_topic_score_codex":0.0003999517,"about_ca_topic_score_gemma":0.0011629424,"teacher_disagreement_score":0.06457676,"about_ca_system_score_codex":0.00023633418,"about_ca_system_score_gemma":0.00016266978,"threshold_uncertainty_score":0.46938503},"labels":[],"label_agreement":null},{"id":"W2551246384","doi":"10.1182/blood.v110.11.4228.4228","title":"Myeloid-Associated Antigen Expression Is an Adverse Factor for Complete Remission Following Induction Chemotherapy of Adult Precursor T-Lymphoblastic Leukemia/Lymphoma (T-ALL).","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and Retrovirus Studies","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Univariate analysis; Internal medicine; Chemotherapy; Gastroenterology; Induction chemotherapy; Chemotherapy regimen; Myeloid; Myeloid leukemia; Surgery; Multivariate analysis","score_opus":0.02010366225837958,"score_gpt":0.2520012165944848,"score_spread":0.23189755433610523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551246384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974907,0.0006337673,0.00025082243,0.000034670236,0.00074239087,0.00044186626,0.00014577001,0.000109025685,0.00015100765],"genre_scores_gemma":[0.9983479,0.00014687277,0.0003189207,0.0001291325,0.00006692937,0.000014459564,0.00013290039,0.000036429676,0.00080646446],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99853826,0.00006106977,0.00044713487,0.00039668346,0.000081078004,0.0004758056],"domain_scores_gemma":[0.99910784,0.00012859814,0.0003210448,0.0002453686,0.00014984647,0.00004729343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019169194,0.00026016246,0.00043372792,0.000122165,0.00030812412,0.000006145487,0.00019094854,0.0004530013,0.00007112268],"category_scores_gemma":[0.00013561391,0.0002109616,0.00023975037,0.0001353511,0.000107445114,0.00012492832,0.000052668405,0.00011514199,0.0000210056],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004850317,0.00060291437,0.0055325665,0.000035424135,0.00046332285,0.000002241375,0.0026405884,7.785128e-7,0.98229533,0.0000066906837,0.0004856341,0.007449479],"study_design_scores_gemma":[0.009254089,0.00061270955,0.033197716,0.00016611826,0.00012986478,0.000008316577,0.00082909584,0.000005440789,0.95127225,0.000038554375,0.004220452,0.0002654114],"about_ca_topic_score_codex":0.000117725234,"about_ca_topic_score_gemma":0.0000321908,"teacher_disagreement_score":0.031023094,"about_ca_system_score_codex":0.00011453883,"about_ca_system_score_gemma":0.00007930776,"threshold_uncertainty_score":0.8602764},"labels":[],"label_agreement":null},{"id":"W2551275755","doi":"10.1182/blood.v110.11.968.968","title":"Operationalizing the Concept of “Immobility” for Better Targeting of Thromboprophylaxis in Medical Patients: How the Literature Falls Short.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Ambulatory; Randomized controlled trial; Operationalization; Clinical trial; Intensive care medicine; MEDLINE; Physical therapy; Audit; Stroke (engine); Emergency medicine; Internal medicine","score_opus":0.010796487060739875,"score_gpt":0.2672661768310045,"score_spread":0.25646968977026463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551275755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938334,0.0010840077,0.00024181805,0.0032916558,0.0001093619,0.0011499331,0.00002619228,0.0000071392997,0.00025645245],"genre_scores_gemma":[0.9977111,0.00004790295,0.00057293713,0.0013241284,0.00018480768,0.000053549233,0.00007575467,0.000012637646,0.000017174838],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869037,0.000049942722,0.00039612467,0.00017951395,0.00047977737,0.00020426117],"domain_scores_gemma":[0.99905646,0.0003220289,0.000089418776,0.00025653475,0.00023312744,0.000042421398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010862411,0.00010838977,0.0003278661,0.000049875587,0.000062345876,0.000016267275,0.00017861917,0.00008963245,0.000050163464],"category_scores_gemma":[0.0005054613,0.00005671214,0.0001115535,0.00020606251,0.00014958568,0.00005563495,0.00006942984,0.00016763026,4.196337e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038021294,0.023541147,0.76302004,0.0026824963,0.002211943,0.000072106595,0.06386136,0.000059445036,0.027345376,0.022530666,0.02204917,0.07224605],"study_design_scores_gemma":[0.006794471,0.0016645495,0.8920915,0.0012831225,0.00045921793,0.000005890679,0.004271668,0.00008883645,0.08263318,0.00038107313,0.010042916,0.0002835628],"about_ca_topic_score_codex":0.000028249862,"about_ca_topic_score_gemma":0.000039739512,"teacher_disagreement_score":0.12907149,"about_ca_system_score_codex":0.000015575215,"about_ca_system_score_gemma":0.000041668976,"threshold_uncertainty_score":0.2312654},"labels":[],"label_agreement":null},{"id":"W2551278569","doi":"10.1182/blood.v106.11.3715.3715","title":"A Prospective, Observational Study of the Effectiveness and Safety of a Weekly Fixed Dose of Darbepoetin alfa with Current Practice Iron Management for the Treatment of Chemotherapy-Induced Anemia (CIA): A Subanalysis in Patients (pts) with Lymphoproliferative Malignancies (LPM).","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Berger (Canada)","funders":"","keywords":"Darbepoetin alfa; Medicine; Transferrin saturation; Anemia; Internal medicine; Clinical endpoint; Ferritin; Dosing; Gastroenterology; Hemoglobin; Surgery; Clinical trial; Iron deficiency","score_opus":0.018137942600710305,"score_gpt":0.2822221122686721,"score_spread":0.2640841696679618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551278569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938924,0.00033897616,0.000015968997,0.00028614549,0.000009706717,0.00532834,0.00003219951,0.00000433578,0.00009196525],"genre_scores_gemma":[0.9981192,0.00019197789,0.001053919,0.000013413791,0.0000133168305,0.00055637065,0.00001033783,0.000016699043,0.000024785566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985496,0.00016309498,0.00042702336,0.00028774177,0.0004343422,0.00013824394],"domain_scores_gemma":[0.99836713,0.0003960229,0.000490957,0.0003402162,0.00037744726,0.000028225248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024803245,0.00021254351,0.00054799253,0.000074052085,0.000059549173,0.0000041996054,0.00007648476,0.000033590513,0.0000039045162],"category_scores_gemma":[0.00004225573,0.00010295906,0.00008235472,0.00037021816,0.00013135056,0.000055390654,0.000022966,0.000047282854,4.9799898e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014353662,0.034544494,0.9342721,0.0005065976,0.0018200553,0.000002162982,0.006406393,0.00010866241,0.0011449315,0.000096825,0.000002976319,0.006741133],"study_design_scores_gemma":[0.049265686,0.011179291,0.90014666,0.0004630452,0.0022252074,0.0000038817807,0.003567912,0.000028287956,0.033001233,0.000005616791,0.000024404166,0.00008878643],"about_ca_topic_score_codex":0.00022105084,"about_ca_topic_score_gemma":0.00024179842,"teacher_disagreement_score":0.034912024,"about_ca_system_score_codex":0.00014366824,"about_ca_system_score_gemma":0.00011001916,"threshold_uncertainty_score":0.41985485},"labels":[],"label_agreement":null},{"id":"W2551279281","doi":"10.1182/blood.v116.21.3661.3661","title":"An Unintended Benefit of Anabolic Steroid Use: Therapy of Hemophilia B Leiden.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Anabolic steroid; Medicine; Stanozolol; Factor IX; Surgery; Internal medicine; Pediatrics; Anabolism","score_opus":0.031126062641536223,"score_gpt":0.31445930642094105,"score_spread":0.28333324377940483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551279281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981378,0.00023809148,0.0000010434816,0.00039510132,0.000060601003,0.00030398995,0.000019458263,0.000026650867,0.0008173004],"genre_scores_gemma":[0.997849,0.0003006853,0.0005826718,0.000041631385,0.000113891336,0.0000073643414,0.000028413731,0.000022933393,0.0010534087],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990113,0.000023267261,0.00024380234,0.00018921254,0.00031571384,0.0002167532],"domain_scores_gemma":[0.99891126,0.000042205265,0.00006952186,0.00057599385,0.00023940076,0.00016164477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014938498,0.00012167778,0.0003232007,0.00015784324,0.000027939272,0.000008609085,0.00014766173,0.000116634386,0.00028477272],"category_scores_gemma":[0.00005148482,0.000086109154,0.00009771639,0.0002070411,0.00020447267,0.00009204567,0.000024126846,0.00020576039,0.000010035079],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016600513,0.0017987204,0.26988456,0.000036053512,0.00015703215,0.000028466322,0.00018683299,2.2778455e-7,0.72075117,0.0005929672,0.000030571304,0.006367411],"study_design_scores_gemma":[0.004497282,0.0011188572,0.35135797,0.000034672288,0.000054889282,0.00003559865,0.00004901695,0.00001616567,0.64195687,0.00023420765,0.0005726623,0.00007185202],"about_ca_topic_score_codex":0.00015707366,"about_ca_topic_score_gemma":0.000059476686,"teacher_disagreement_score":0.08147341,"about_ca_system_score_codex":0.000004883403,"about_ca_system_score_gemma":0.000084749634,"threshold_uncertainty_score":0.3511429},"labels":[],"label_agreement":null},{"id":"W2551356538","doi":"10.1182/blood.v118.21.1750.1750","title":"Results of Phase II Clinical Trial MPD-RC 101: Allogeneic Hematopoietic Stem Cell Transplantation Conditioned with Fludarabine/Melphalan in Patients with Myelofibrosis","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Fludarabine; Myelofibrosis; Melphalan; Internal medicine; Essential thrombocythemia; Gastroenterology; Transplantation; Hematopoietic stem cell transplantation; Polycythemia vera; Surgery; Regimen; Bone marrow; Chemotherapy; Cyclophosphamide","score_opus":0.037058609019289014,"score_gpt":0.28498216602791193,"score_spread":0.24792355700862292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551356538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967402,0.000041311825,0.000023722845,0.000048539638,0.000056615634,0.0018444526,0.00023434969,0.000023709448,0.0009870798],"genre_scores_gemma":[0.9979332,0.00007563068,0.0010943807,0.000054092303,0.000046204277,0.00019152844,0.00050589786,0.000028819853,0.000070228154],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9979439,0.00013589613,0.00084478874,0.00044042314,0.00039323856,0.00024178748],"domain_scores_gemma":[0.99888057,0.00013146154,0.00033461791,0.00031532222,0.00017164885,0.00016640563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022431277,0.00025510267,0.00064983097,0.00013171688,0.00007064841,0.0000067847554,0.000070169546,0.00012735752,0.00009505823],"category_scores_gemma":[0.000012771495,0.00016955183,0.00009960534,0.00020616074,0.00010338194,0.000083208404,0.0000112065045,0.00013725834,0.000013280835],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19857298,0.054982655,0.7404111,0.00025627963,0.0004923078,0.00019925556,0.0033278207,0.0000019617341,0.00039437786,0.000057612786,0.000060185568,0.0012434855],"study_design_scores_gemma":[0.45852703,0.043760326,0.42554957,0.00034355954,0.0010328182,0.000014299969,0.000084281404,0.0000018716083,0.0704876,0.0000074277896,0.000012764576,0.0001784566],"about_ca_topic_score_codex":0.000046964225,"about_ca_topic_score_gemma":0.00010306326,"teacher_disagreement_score":0.3148615,"about_ca_system_score_codex":0.000022748512,"about_ca_system_score_gemma":0.00012793053,"threshold_uncertainty_score":0.69141227},"labels":[],"label_agreement":null},{"id":"W2551364694","doi":"10.1182/blood.v112.11.574.574","title":"Gamma Delta T Cells (GDTCs) to Eliminate Minimal Residual Disease (MRD) in Chronic Myeloid Leukemia (CML) : A Pre-Clinical Model","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Minimal residual disease; Peripheral blood mononuclear cell; Medicine; Flow cytometry; clone (Java method); Molecular biology; Immunology; Concanavalin A; Immunophenotyping; Leukemia; Chemistry; Biology; In vitro","score_opus":0.049167904948384175,"score_gpt":0.3399301732050876,"score_spread":0.2907622682567034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551364694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99441564,0.0008893395,0.000059892747,0.0008082784,0.00008249455,0.0012418575,0.000056089328,0.000097251745,0.0023491567],"genre_scores_gemma":[0.97561914,0.0009185176,0.0012774186,0.00055852643,0.0008084494,0.00015340585,0.000045942492,0.00009952899,0.020519055],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9963397,0.0001924601,0.0007840084,0.00085247046,0.00088139717,0.0009499844],"domain_scores_gemma":[0.9974589,0.0002479151,0.00008081604,0.0009898506,0.00013981058,0.0010827392],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00072003924,0.00033179496,0.00062521355,0.00030698424,0.00009573772,0.000024643541,0.0003925,0.00023209608,0.0008976621],"category_scores_gemma":[0.00033603612,0.00031898,0.00024895289,0.0004578443,0.00023362803,0.00009671114,0.00027788064,0.00078168634,0.00030717836],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028302338,0.008381257,0.07830309,0.0010525443,0.00075148226,0.014165503,0.004576206,0.0077069034,0.7833649,0.00010274124,0.03782023,0.03547281],"study_design_scores_gemma":[0.075484045,0.010320764,0.583478,0.0012773053,0.001146191,0.00059433293,0.00018608253,0.08818628,0.21722494,0.00042044668,0.019201258,0.0024803968],"about_ca_topic_score_codex":0.00018915025,"about_ca_topic_score_gemma":0.00022737046,"teacher_disagreement_score":0.56613994,"about_ca_system_score_codex":0.0005380967,"about_ca_system_score_gemma":0.0032931042,"threshold_uncertainty_score":0.9999262},"labels":[],"label_agreement":null},{"id":"W2551370002","doi":"10.1182/blood.v104.11.4078.4078","title":"Safety and Efficacy of Venous Thromboembolism Prophylaxis with Low Molecular Weight Heparin in Hospitalised Patients with Acute Medical Illness and Renal Failure.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph's Hospital","funders":"","keywords":"Medicine; Pulmonary embolism; Warfarin; Incidence (geometry); Prospective cohort study; Surgery; Asymptomatic; Low molecular weight heparin; Heparin; Internal medicine; Atrial fibrillation","score_opus":0.0018591020607152938,"score_gpt":0.1959560774053299,"score_spread":0.1940969753446146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551370002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99759877,0.00034211343,0.00014489706,0.000419826,0.000024280369,0.0011639092,0.0000129930495,0.000029325969,0.00026390303],"genre_scores_gemma":[0.99822736,0.00025314663,0.0012046149,0.00016527735,0.000029920297,0.000039468654,0.000038447197,0.000038474172,0.0000032765286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982367,0.000033629167,0.00032672047,0.0004300075,0.0006501897,0.00032271],"domain_scores_gemma":[0.9992214,0.000026199727,0.00011932204,0.0003085041,0.00008913732,0.00023546375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013742755,0.00025301529,0.0007994105,0.00013908817,0.000065066095,0.000017454575,0.00010409673,0.00012958971,0.000022870869],"category_scores_gemma":[0.00003759253,0.00017331859,0.000036140864,0.00026880286,0.00026777555,0.00008338909,0.00010000195,0.0002080407,0.0000013715506],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009966046,0.1493526,0.69257647,0.0044811587,0.019294769,0.012595014,0.022397421,0.00038469472,0.007827481,0.0175552,0.00019660048,0.06337257],"study_design_scores_gemma":[0.03359346,0.0051510097,0.95328575,0.0010409942,0.0010031927,0.00006612074,0.000074375,0.000004058082,0.0052663144,0.000093087634,0.00010653755,0.00031512138],"about_ca_topic_score_codex":0.00020805288,"about_ca_topic_score_gemma":0.0001526676,"teacher_disagreement_score":0.2607093,"about_ca_system_score_codex":0.000029707962,"about_ca_system_score_gemma":0.00015246679,"threshold_uncertainty_score":0.7067727},"labels":[],"label_agreement":null},{"id":"W2551396183","doi":"10.1182/blood.v124.21.3877.3877","title":"A Risk Score to Predict CMV Viremia within the First 100 Days after Allogeneic Stem Cell Transplantation Based on Pre-Transplant Parameters","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Transplantation; Internal medicine; Viremia; Hematopoietic stem cell transplantation; Odds ratio; Framingham Risk Score; Cytomegalovirus; Gastroenterology; Human cytomegalovirus; Surgery; Immunology; Viral disease; Herpesviridae; Human immunodeficiency virus (HIV); Virus; Disease","score_opus":0.01502914641069124,"score_gpt":0.24771957338149553,"score_spread":0.23269042697080428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551396183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99552596,0.00009528729,0.0011395578,0.0005548777,0.00008832853,0.0012219774,0.00023646111,0.000082839666,0.00105472],"genre_scores_gemma":[0.99719185,0.00009100362,0.00039174815,0.0016095425,0.00013498802,0.0002730592,0.00004647255,0.0000512005,0.00021016425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99790996,0.00016668423,0.0003444251,0.00047462052,0.00068346626,0.00042086164],"domain_scores_gemma":[0.998658,0.00030036218,0.00008152424,0.0006205077,0.000054747194,0.00028488672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006872865,0.00026201486,0.00030369847,0.00017142454,0.00018947005,0.000057493344,0.00023519773,0.00014916057,0.000075108255],"category_scores_gemma":[0.000020887323,0.00016958019,0.00015690395,0.00025979828,0.00009172236,0.00004887824,0.000015910979,0.0004379582,0.00015319564],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019743383,0.003197282,0.91453016,0.002100679,0.00051990856,0.0006177113,0.012880436,0.009089837,0.027113646,0.000052653555,0.0011536756,0.009000628],"study_design_scores_gemma":[0.014052879,0.005130484,0.79181725,0.0014518284,0.0019614846,0.00009068025,0.000120727585,0.013521627,0.16363072,0.000031226777,0.007464013,0.0007270587],"about_ca_topic_score_codex":0.00036459774,"about_ca_topic_score_gemma":0.0008291388,"teacher_disagreement_score":0.13651708,"about_ca_system_score_codex":0.000045747718,"about_ca_system_score_gemma":0.00011698135,"threshold_uncertainty_score":0.69152796},"labels":[],"label_agreement":null},{"id":"W2551407937","doi":"10.1182/blood.v120.21.23.23","title":"Effects of Dabigatran and Rivaroxaban On Routine and Specialized Coagulation Assays: A Study Using Actual Patient Plasma Samples","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Dabigatran; Rivaroxaban; Medicine; Phlebotomy; Antithrombin; Apixaban; Coagulation; Internal medicine; Coagulation testing; Thrombin time; Venous blood; Anticoagulant; Pharmacology; Anesthesia; Gastroenterology; Heparin; Partial thromboplastin time; Atrial fibrillation; Warfarin","score_opus":0.0654000762621751,"score_gpt":0.31475331506164933,"score_spread":0.24935323879947424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551407937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986958,0.00010754159,0.00004205315,0.000049993214,0.00009984616,0.0008453751,0.000002478503,0.000021184784,0.00013573591],"genre_scores_gemma":[0.99888265,0.000009364399,0.0006704492,0.000018647977,0.00038051873,0.0000013670433,0.000007310703,0.000011095266,0.000018615214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992875,0.00006433335,0.0001997809,0.00012067327,0.00019360973,0.00013412644],"domain_scores_gemma":[0.9994981,0.0002152425,0.0001013993,0.00009029885,0.000022276585,0.00007263021],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001572519,0.00010430319,0.00026128374,0.00008946707,0.00005568592,0.00001097579,0.000014368293,0.000036227302,0.000010918448],"category_scores_gemma":[0.00016956026,0.00008357327,0.00003376304,0.00007677578,0.00002777176,0.00007643555,0.000036222966,0.00003867788,9.614052e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002953235,0.00023898933,0.98283577,0.000099166275,0.00016156225,0.000003366738,0.002328952,0.0000030338517,0.011064502,0.00035823614,0.0000057774996,0.002605327],"study_design_scores_gemma":[0.008932844,0.0007503433,0.97143954,0.00006116508,0.00077616755,0.0000064639985,0.0003857427,0.00008071885,0.017325152,0.000018457993,0.00013280443,0.00009060518],"about_ca_topic_score_codex":0.000037222904,"about_ca_topic_score_gemma":0.000004374365,"teacher_disagreement_score":0.011396227,"about_ca_system_score_codex":0.000010934071,"about_ca_system_score_gemma":0.0000071845734,"threshold_uncertainty_score":0.34080192},"labels":[],"label_agreement":null},{"id":"W2551413196","doi":"10.1182/blood.v106.11.4653.4653","title":"Are Ovaries a Sanctuary for Lymphoma? Report of a Cure of Recurrent Lymphoma in Both Ovaries after Bilateral Oophorectomy.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; St. Boniface Hospital","funders":"","keywords":"Medicine; Lymphoma; Follicular lymphoma; Abdomen; Abdominal pain; Surgery; Pathology","score_opus":0.014674465749908478,"score_gpt":0.26486467778562495,"score_spread":0.25019021203571645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551413196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99187225,0.0060790014,0.000008790646,0.0006113185,0.00012858058,0.00081318815,0.00012528252,0.000033270924,0.00032833515],"genre_scores_gemma":[0.99526155,0.00021459459,0.0034777964,0.00017472614,0.00016587434,0.0004877917,0.00006099087,0.00003183804,0.00012484039],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981916,0.000028740798,0.00077016436,0.0003889896,0.00029216945,0.00032831926],"domain_scores_gemma":[0.9987292,0.00010749231,0.0004412446,0.00047047564,0.00014858537,0.000102999715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016529532,0.0002692307,0.00076831004,0.00020754892,0.000030464042,0.00001329333,0.00008100865,0.00014318961,0.000066591136],"category_scores_gemma":[0.00012918995,0.00020750125,0.00027147605,0.00024059853,0.00012706898,0.00009513617,0.0000541193,0.00003179988,0.000003667155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005028988,0.013549304,0.94665915,0.00081589277,0.0007180661,0.0017858836,0.0017465424,0.0000032103464,0.0005301792,0.00016958162,0.0018434748,0.02714971],"study_design_scores_gemma":[0.017461158,0.0006871253,0.9315538,0.000801269,0.0005307103,0.00073397654,0.00011723922,0.000025251607,0.03828169,0.00016309324,0.009443999,0.00020068543],"about_ca_topic_score_codex":0.0001795604,"about_ca_topic_score_gemma":0.00021595994,"teacher_disagreement_score":0.03775151,"about_ca_system_score_codex":0.0001357698,"about_ca_system_score_gemma":0.00029275691,"threshold_uncertainty_score":0.8461655},"labels":[],"label_agreement":null},{"id":"W2551419281","doi":"10.1182/blood.v118.21.5295.5295","title":"POST Marketing Observational Study of Children (6 years or older) Treated with Deferasirox (Exjade ICL 670)-One Year analysis","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Deferasirox; Medicine; Observational study; Pediatrics; Thalassemia; Population; Internal medicine","score_opus":0.027672096266529524,"score_gpt":0.23838466208433684,"score_spread":0.2107125658178073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551419281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977579,0.00008861508,0.000004034982,0.00003627814,0.000008225865,0.0004832805,0.000021404401,0.000050486575,0.0015497584],"genre_scores_gemma":[0.9985492,0.000023786777,0.0006902847,0.000052250136,0.00002394186,0.000011427734,0.00007557618,0.00002607065,0.0005474604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886024,0.00007244942,0.00029955432,0.0002611883,0.00030811058,0.00019847447],"domain_scores_gemma":[0.9993131,0.0000410542,0.00012628849,0.000289845,0.00013334733,0.00009633293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018759361,0.0001404416,0.00037712159,0.00021088598,0.00004933177,0.000007021691,0.00008938406,0.000098585064,0.00077740377],"category_scores_gemma":[0.000075480384,0.00009994268,0.000094790106,0.0008686993,0.000047178437,0.000032262105,0.0000300361,0.00015038562,0.000011603474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007758116,0.0043392302,0.98861015,0.000021688966,0.003867116,0.000035096637,0.0015353895,0.0000065662643,0.00044501422,0.00000366904,0.000022207494,0.00033803788],"study_design_scores_gemma":[0.007000271,0.0011049439,0.9839984,0.00006845589,0.0052487315,0.000020955036,0.0019528692,0.000014103223,0.00045979765,0.0000010514722,0.0000033584777,0.00012706897],"about_ca_topic_score_codex":0.0009873348,"about_ca_topic_score_gemma":0.00020262967,"teacher_disagreement_score":0.0062244595,"about_ca_system_score_codex":0.000010656634,"about_ca_system_score_gemma":0.000068874695,"threshold_uncertainty_score":0.8512026},"labels":[],"label_agreement":null},{"id":"W2551428084","doi":"10.1182/blood.v106.11.3159.3159","title":"Ex Vivo Expansion of Human SCID-Repopulating Cells Using Recombinant TAT-HOXB4 Protein.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Haematopoiesis; Transplantation; Stem cell; Ex vivo; Biology; CD34; In vivo; Recombinant DNA; Cancer research; Immunology; Molecular biology; Cell biology; Medicine; Internal medicine; Gene; Genetics","score_opus":0.03168807472005872,"score_gpt":0.2935462573322529,"score_spread":0.2618581826121942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551428084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965756,0.00009018295,0.00045199727,0.000053070307,0.00008284776,0.00069317955,0.0000028946708,0.000060294158,0.001989936],"genre_scores_gemma":[0.9754828,0.0000055184146,0.023912149,0.000028130253,0.00011767865,0.000010367055,0.000010188177,0.000035490477,0.0003976634],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985402,0.00005379509,0.00055787363,0.00026101404,0.0003420085,0.0002450566],"domain_scores_gemma":[0.9992676,0.000029242397,0.00021140132,0.00030652882,0.00008627775,0.00009897115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002973737,0.00015154984,0.00032794892,0.00011799753,0.0000894465,0.000010076751,0.00006597742,0.00010171847,0.00016931443],"category_scores_gemma":[0.000024366505,0.00013917264,0.00008773468,0.00016443849,0.000040739957,0.00008558224,0.000017083154,0.000121066965,0.000020090954],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002091303,0.0003681776,0.0036599792,0.000490768,0.000028585066,0.000038518632,0.0007375357,0.000022475204,0.99404806,0.00007946353,0.000012230263,0.0004933115],"study_design_scores_gemma":[0.002886162,0.00022348156,0.0012731613,0.0012982889,0.00023115713,0.000136136,0.00018477667,0.0004602293,0.99305964,0.00005255247,0.00005375536,0.00014068867],"about_ca_topic_score_codex":0.00012754375,"about_ca_topic_score_gemma":0.000011836041,"teacher_disagreement_score":0.02346015,"about_ca_system_score_codex":0.000035384746,"about_ca_system_score_gemma":0.00006649792,"threshold_uncertainty_score":0.56752956},"labels":[],"label_agreement":null},{"id":"W2551431064","doi":"10.1182/blood.v112.11.4558.4558","title":"Immune Thrombocytopenic Purpura Due to Passenger Donor Lymphocytes in Liver Transplantation","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Liver transplantation; Thrombocytopenic purpura; Thrombotic thrombocytopenic purpura; Transplantation; Platelet; Gastroenterology; Immunology; Complication; Internal medicine","score_opus":0.015343683870223956,"score_gpt":0.23827928513463079,"score_spread":0.22293560126440684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551431064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99543345,0.0013447601,0.00001468236,0.00027304716,0.000039700353,0.000406579,0.000009817952,0.000035682016,0.0024422663],"genre_scores_gemma":[0.9969432,0.0018335807,0.0005138907,0.00022334298,0.000027127324,0.0000479147,0.00005777018,0.00001646014,0.00033674986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999276,0.000017253898,0.00017938798,0.000193349,0.0001298679,0.00020414322],"domain_scores_gemma":[0.9996931,0.000027861752,0.000025421974,0.00015445755,0.000022674156,0.00007649868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000037797938,0.0001217804,0.0002959377,0.00009904753,0.00004953932,0.0000065417885,0.000049671242,0.000063092724,0.000122681],"category_scores_gemma":[0.000010400693,0.00010278735,0.000058757763,0.00017957923,0.000019397856,0.00007873915,0.000009437948,0.000061443636,0.0002492559],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035288995,0.02141665,0.44091812,0.0010333522,0.0018441657,0.31895846,0.021243135,0.000055438504,0.15612842,0.00035450436,0.0015302347,0.03298862],"study_design_scores_gemma":[0.013995974,0.00037729694,0.91937405,0.00012354521,0.00022529348,0.005816423,0.00006290944,0.000016919541,0.059403654,0.000026370375,0.0003971915,0.00018035808],"about_ca_topic_score_codex":0.00039016086,"about_ca_topic_score_gemma":0.00014981373,"teacher_disagreement_score":0.47845596,"about_ca_system_score_codex":0.000041798678,"about_ca_system_score_gemma":0.00007005899,"threshold_uncertainty_score":0.41915467},"labels":[],"label_agreement":null},{"id":"W2551433805","doi":"10.1182/blood.v116.21.417.417","title":"Hodgkin Lymphoma Patients with Stage II B or Stage II Bulky Disease Have Advanced Disease and Should Not Be Included In Limited Stage Trials","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"ABVD; Nodular sclerosis; Medicine; Stage (stratigraphy); Internal medicine; B symptoms; Gastroenterology; Lymphoma; Cancer; Surgery; Chemotherapy; Hodgkin lymphoma; Cyclophosphamide; Vincristine","score_opus":0.03977289244726998,"score_gpt":0.3057230368685737,"score_spread":0.2659501444213037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551433805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925596,0.00024722048,0.0000018547679,0.0013466208,0.00015929091,0.002718212,0.002745276,0.000107830616,0.000114058836],"genre_scores_gemma":[0.99316883,0.00015885815,0.00041579432,0.0012085845,0.00011110042,0.00053099106,0.0006755911,0.00008187877,0.0036483812],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99696016,0.000109130306,0.00073808135,0.0008170577,0.0007976,0.00057798525],"domain_scores_gemma":[0.9971028,0.00039435382,0.00034527743,0.0008721153,0.00014507254,0.0011403664],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041121355,0.00053198927,0.0009966,0.00025412766,0.00029987437,0.00006445053,0.00015416506,0.0001472904,0.00036081512],"category_scores_gemma":[0.0013619846,0.00034727211,0.00015445091,0.00025731372,0.00015154805,0.00024487227,0.00030359838,0.00017553208,0.000005443731],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018776486,0.022442553,0.9476212,0.00028778086,0.00047784753,0.0021955606,0.0006530578,0.000009199292,0.0013768909,0.00019246571,0.0001723741,0.0057945764],"study_design_scores_gemma":[0.08769124,0.002198027,0.8915032,0.00024616742,0.0011287781,0.0000024054414,0.000122693,0.000055572997,0.0064132605,0.000009112997,0.010170923,0.00045858082],"about_ca_topic_score_codex":0.00019400204,"about_ca_topic_score_gemma":0.0006340135,"teacher_disagreement_score":0.068914756,"about_ca_system_score_codex":0.0001292692,"about_ca_system_score_gemma":0.0005286794,"threshold_uncertainty_score":0.99989796},"labels":[],"label_agreement":null},{"id":"W2551458747","doi":"10.1182/blood.v112.11.1979.1979","title":"Safe Treatment of Pulmonary Embolism on An Outpatient Basis.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Hospital","funders":"","keywords":"Medicine; Pulmonary embolism; Warfarin; Emergency department; Thrombosis; Low molecular weight heparin; Medical diagnosis; Emergency medicine; Heparin; Pediatrics; Internal medicine; Radiology; Atrial fibrillation","score_opus":0.02870049861889339,"score_gpt":0.26442219030163555,"score_spread":0.23572169168274215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551458747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96536386,0.00039045446,0.000004541684,0.00035345528,0.0001216737,0.00052928575,0.0000125123715,0.000044478944,0.033179738],"genre_scores_gemma":[0.9965205,0.001471869,0.00034590377,0.00041620716,0.00018053089,0.000067982925,0.000042975495,0.000023948789,0.00093004305],"study_design_codex":"nonrandomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9989872,0.000031063777,0.0002459342,0.00025795784,0.00026675727,0.00021110708],"domain_scores_gemma":[0.9992527,0.000021677513,0.00007566047,0.00045670808,0.00004486785,0.00014840915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004607888,0.00016089933,0.00045828903,0.00010984713,0.00007127354,0.0000029505945,0.00006133364,0.000059099275,0.00017844858],"category_scores_gemma":[0.000010679142,0.00012467617,0.00012722712,0.00009125305,0.000048526603,0.00003752563,0.000019099718,0.000041512383,0.00006708451],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011620912,0.44629785,0.24345659,0.0006245656,0.003165795,0.0047787777,0.017070074,0.00014594574,0.0134337535,0.010292692,0.010052676,0.24951917],"study_design_scores_gemma":[0.005340585,0.010719898,0.9101217,0.000107201675,0.0007912788,0.0001110978,0.00023992702,0.00003955002,0.03720159,0.000055047974,0.035030138,0.00024200778],"about_ca_topic_score_codex":0.00015241916,"about_ca_topic_score_gemma":0.0000063059433,"teacher_disagreement_score":0.6666651,"about_ca_system_score_codex":0.000042419164,"about_ca_system_score_gemma":0.000041022355,"threshold_uncertainty_score":0.5084146},"labels":[],"label_agreement":null},{"id":"W2551475395","doi":"10.1182/blood.v104.11.1963.1963","title":"Complications of Hyperleukocytosis and Leukapheresis in Pediatric Acute Leukemias.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Hematological disorders and diagnostics","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Leukostasis; Leukapheresis; Medicine; Leukocytosis; Acute leukemia; Leukoreduction; Leukemia; Surgery; Myeloid; Internal medicine; Blood transfusion","score_opus":0.018380251552760678,"score_gpt":0.26326857965077044,"score_spread":0.24488832809800976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551475395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915976,0.0010548077,0.0000708468,0.0006549765,0.000007678819,0.00015219572,0.000007895345,0.000018636956,0.006435377],"genre_scores_gemma":[0.9960749,0.001457573,0.0021776152,0.00023445977,0.000013357371,0.000015279455,0.000006837045,0.0000061024734,0.000013837731],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994979,0.0000071894965,0.00017925061,0.00012407271,0.00008017524,0.000111443056],"domain_scores_gemma":[0.99964374,0.00008997669,0.00003506238,0.00012870823,0.00003088714,0.00007159791],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000032718293,0.00006485611,0.00020018303,0.00006422133,0.00001900401,0.0000034017266,0.000038350296,0.00006522762,0.000011045476],"category_scores_gemma":[0.00015780385,0.000053719268,0.00003309686,0.00021583374,0.00004320116,0.00001953647,0.000023696477,0.00007083996,0.000010159331],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038932816,0.0023696136,0.9880373,0.00022266123,0.000059691032,0.00009446953,0.00021253883,0.00001402446,0.0014914282,0.006190168,0.00046538434,0.0008038022],"study_design_scores_gemma":[0.0053305076,0.00024428626,0.98923266,0.000046735302,0.00034692153,0.00006727358,0.00007535493,0.000006369483,0.0030646855,0.0013979459,0.00010133391,0.000085931235],"about_ca_topic_score_codex":0.00006543248,"about_ca_topic_score_gemma":0.000026415946,"teacher_disagreement_score":0.0064215395,"about_ca_system_score_codex":0.0000123448735,"about_ca_system_score_gemma":0.00007297918,"threshold_uncertainty_score":0.21906082},"labels":[],"label_agreement":null},{"id":"W2551484494","doi":"10.1182/blood.v108.11.1875.1875","title":"Treatment of Adult Acute Lymphoblastic Leukemia (ALL) with a Modified DFCI Pediatric Regimen - The Princess Margaret Experience.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Imatinib mesylate; Vincristine; Acute lymphocytic leukemia; Internal medicine; Surgery; Regimen; Chemotherapy; Gastroenterology; Imatinib; Leukemia; Cyclophosphamide; Lymphoblastic Leukemia","score_opus":0.0121145379472796,"score_gpt":0.2593700144690974,"score_spread":0.2472554765218178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551484494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99228364,0.00025399966,0.00041694872,0.00038008924,0.00004904018,0.0009856714,0.000028863336,0.00009101559,0.005510748],"genre_scores_gemma":[0.99535525,0.00030489938,0.0009496821,0.00008577658,0.00041084865,0.00033377836,0.00004485818,0.00005635347,0.002458548],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974645,0.000066336965,0.00044752963,0.0005007392,0.0009056656,0.0006152375],"domain_scores_gemma":[0.9982591,0.00025707632,0.00021000621,0.00082797924,0.00025894237,0.00018687693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006941535,0.00034237612,0.00051104336,0.0001607849,0.00011648798,0.000033509463,0.0003281405,0.00014098613,0.000048492373],"category_scores_gemma":[0.0000538462,0.00018658399,0.00012759506,0.00057556323,0.00029681931,0.000092456576,0.000079708196,0.0001180305,0.000028804037],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027449694,0.030447662,0.78155357,0.002415394,0.011215795,0.018106304,0.029104892,0.002673199,0.05729502,0.01835466,0.014374139,0.007009647],"study_design_scores_gemma":[0.27251446,0.030198488,0.32542357,0.00070922927,0.021583436,0.012489896,0.0040075583,0.021421956,0.30174327,0.00093264,0.005734661,0.0032408277],"about_ca_topic_score_codex":0.0013508437,"about_ca_topic_score_gemma":0.000048712634,"teacher_disagreement_score":0.45613003,"about_ca_system_score_codex":0.0009266358,"about_ca_system_score_gemma":0.0014615637,"threshold_uncertainty_score":0.7608674},"labels":[],"label_agreement":null},{"id":"W2551517087","doi":"10.1182/blood.v112.11.1980.1980","title":"Aspirin Resistance in Children after Interventional Cardiac Catheterisation.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Aspirin; Medicine; Platelet; Internal medicine; Platelet activation; Epinephrine; Cardiology; Anesthesia","score_opus":0.007987917336856288,"score_gpt":0.2186450616404423,"score_spread":0.21065714430358604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551517087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856829,0.013087336,0.000031912805,0.00004538833,0.000035220262,0.00018553114,0.000020201263,0.000029626332,0.0008818875],"genre_scores_gemma":[0.99851453,0.00029373568,0.00022818135,0.00009543106,0.00014595324,0.000050906663,0.000053433876,0.00001266819,0.0006051348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993399,0.000043511896,0.00014565817,0.00016509465,0.00018366652,0.00012217592],"domain_scores_gemma":[0.99969065,0.0000063057532,0.000022009026,0.00020264905,0.000024904095,0.000053468415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000084403124,0.0000816096,0.0001839722,0.00005689763,0.000030363404,0.0000044039302,0.000039399263,0.000042963988,0.00012613292],"category_scores_gemma":[0.000010481738,0.000075961434,0.00035017743,0.00009118811,0.000049645652,0.00004860737,0.000013950074,0.000074155796,0.000045512028],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015788712,0.0005271764,0.99797744,0.000020777861,0.000407041,0.00013559325,0.000121708625,5.8726965e-7,0.00010194653,0.000032915606,0.00013303863,0.00038386448],"study_design_scores_gemma":[0.0022804826,0.000050637464,0.9947629,0.00008383523,0.000120315526,0.00013076479,0.000008087514,2.2028935e-7,0.0006593867,0.00005415851,0.0017640638,0.00008513371],"about_ca_topic_score_codex":0.0000113706665,"about_ca_topic_score_gemma":0.0000051492266,"teacher_disagreement_score":0.012831659,"about_ca_system_score_codex":0.000014652969,"about_ca_system_score_gemma":0.000038345446,"threshold_uncertainty_score":0.30976176},"labels":[],"label_agreement":null},{"id":"W2551536162","doi":"10.1182/blood.v104.11.2960.2960","title":"Transplantation of Immunodeficient Mice with Chronic Myeloid Leukemia (CML) Cells from Chronic Phase Patients Reveals a Hierarchy of CD34+ Aldehyde Dehydrogenase-Positive Cells with Short- and Long-Term Repopulating Activity and Transient Responsiveness to Imatinib Mesylate in Vivo.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Nod; Biology; Haematopoiesis; CD34; Bone marrow; CD38; Immunology; Transplantation; Severe combined immunodeficiency; Myeloid; Stem cell; Leukemia; Immunophenotyping; Cancer research; Medicine; Antigen; Internal medicine; Cell biology; Endocrinology; In vivo","score_opus":0.008369133972260287,"score_gpt":0.2499668929042245,"score_spread":0.24159775893196422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551536162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956919,0.0010363733,0.000423624,0.000022790307,0.00002740861,0.0022550547,0.00049672334,0.000025866451,0.00002025146],"genre_scores_gemma":[0.99758434,0.00028915465,0.001788812,0.000021385365,0.000020188401,0.000084738866,0.00014023221,0.00006204086,0.000009084271],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99740064,0.00015451865,0.0007070027,0.0007507417,0.00052290515,0.00046416995],"domain_scores_gemma":[0.99867415,0.00017882683,0.00035515736,0.00044166922,0.00015016097,0.00020002443],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022163063,0.0004332503,0.0008604273,0.00027721608,0.000082413855,0.000016972219,0.000101262776,0.00013734178,0.000012380623],"category_scores_gemma":[0.000015301539,0.00036227927,0.00007472935,0.00041227357,0.00018871437,0.0001758944,0.000035427816,0.00024736105,7.671941e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058302134,0.0016792268,0.02208134,0.0010555955,0.00040401844,0.00036953096,0.0045212274,0.0026136064,0.959037,0.0000016633851,2.965163e-7,0.0024062935],"study_design_scores_gemma":[0.032291636,0.004795763,0.182155,0.003712948,0.0008521455,0.00010590275,0.000045655954,0.00012759339,0.7756337,0.0000032523046,6.800115e-7,0.00027571752],"about_ca_topic_score_codex":0.00149602,"about_ca_topic_score_gemma":0.0013785674,"teacher_disagreement_score":0.18340327,"about_ca_system_score_codex":0.0015829178,"about_ca_system_score_gemma":0.00096941116,"threshold_uncertainty_score":0.99988294},"labels":[],"label_agreement":null},{"id":"W2551573847","doi":"10.1182/blood.v116.21.2648.2648","title":"A Comparison of Two Pain Assessment Tools, the Adolescent Pediatric Pain Tool and PAINReportIt and Use of the Composite Pain Index in Sickle Cell Disease","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; McGill Pain Questionnaire; Pain assessment; Schmidt sting pain index; Physical therapy; Brief Pain Inventory; Chronic pain; Thalassemia; Internal medicine; Visual analogue scale; Pain management","score_opus":0.01330848731691567,"score_gpt":0.26873468162439884,"score_spread":0.25542619430748315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551573847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969586,0.0009757404,0.00029597103,0.000850447,0.000058213853,0.0007835512,0.000015895339,0.000012861458,0.000048684626],"genre_scores_gemma":[0.99897593,0.0001533626,0.00024304168,0.0005174197,0.00004142,0.000013966372,0.00001039753,0.000015575555,0.000028872166],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804056,0.0006991928,0.0005349723,0.00021601067,0.0002994227,0.00020981491],"domain_scores_gemma":[0.9985528,0.0005878755,0.00027830538,0.00040200632,0.000058485624,0.00012050161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002795665,0.00015812588,0.00033642407,0.00006619514,0.000068543275,0.000027016147,0.00009431469,0.000094449155,0.000010617674],"category_scores_gemma":[0.0006205692,0.0000916849,0.00008159495,0.00023138213,0.00015842191,0.00004824785,0.000099833866,0.0005071076,2.3020498e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057351353,0.0018831126,0.98739374,0.0004435788,0.000027022934,0.000018540612,0.0003474388,0.000047045927,0.004253545,0.00003522098,0.00034149364,0.0051519154],"study_design_scores_gemma":[0.0029419716,0.0001853095,0.9847055,0.00016059366,0.00033023875,0.000004375395,0.0005296101,0.0098955305,0.0004501306,0.00004672003,0.000617778,0.00013223014],"about_ca_topic_score_codex":0.00016719822,"about_ca_topic_score_gemma":0.00009631259,"teacher_disagreement_score":0.009848485,"about_ca_system_score_codex":0.000010519869,"about_ca_system_score_gemma":0.00015100159,"threshold_uncertainty_score":0.37388018},"labels":[],"label_agreement":null},{"id":"W2551604298","doi":"10.1182/blood.v112.11.3379.3379","title":"Novel VWF Sequence Variations Identified in a Second Cohort of Index Cases Enrolled in the TS Zimmerman Program for the Molecular and Clinical Biology of VWD (ZPMCB-VWD).","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"RNA regulation and disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Missense mutation; Cohort; Nonsense mutation; Genetics; Mutation; Medicine; Penetrance; Biology; Internal medicine; Gene; Phenotype","score_opus":0.032857133241602915,"score_gpt":0.3400177541574345,"score_spread":0.30716062091583163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551604298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978611,0.00047976276,0.000626025,0.000106044325,0.000025217727,0.0007391583,0.00005558706,0.0000024148062,0.00010469607],"genre_scores_gemma":[0.99920624,0.00008367751,0.0003131188,0.00014804561,0.000022450453,0.00013022264,0.00006831317,0.000005772838,0.000022130496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992049,0.0000955182,0.00034160865,0.00018864835,0.00006179706,0.00010755798],"domain_scores_gemma":[0.99941313,0.00012692917,0.00012220154,0.00024693325,0.00006267772,0.000028117052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028678152,0.000072650975,0.00014965066,0.000038181515,0.00003713725,0.000005719113,0.00014182097,0.000106857726,0.000004671764],"category_scores_gemma":[0.0002620532,0.00005176588,0.00007973995,0.0001029947,0.00021411531,0.000003087993,0.00004086048,0.00005247688,1.4692274e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022196554,0.0017070126,0.6885185,0.000036322424,0.00018752995,0.000014193002,0.00013894298,0.000043790587,0.30613792,0.0018370532,0.000041217438,0.0011155192],"study_design_scores_gemma":[0.004582975,0.00031053933,0.9761756,0.000008548719,0.00008100047,0.000058436723,0.000068886846,0.00045339522,0.01747728,0.00016625228,0.0005175902,0.00009947162],"about_ca_topic_score_codex":0.000072912,"about_ca_topic_score_gemma":0.00029232242,"teacher_disagreement_score":0.28866065,"about_ca_system_score_codex":0.0000017672255,"about_ca_system_score_gemma":0.00012956018,"threshold_uncertainty_score":0.21109514},"labels":[],"label_agreement":null},{"id":"W2551618679","doi":"10.1182/blood.v106.11.583.583","title":"A Prospective Cohort Study of the Epidemiology of Symptomatic Venous Thromboembolism (VTE) after Isolated Leg Fractures Distal to the Knee without Thromboprophylaxis.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; University of Toronto","funders":"","keywords":"Medicine; Pulmonary embolism; Prospective cohort study; Venography; Surgery; Asymptomatic; Incidence (geometry); Deep vein; Rivaroxaban; Thrombosis; Cohort; Anticoagulant; Warfarin; Internal medicine; Atrial fibrillation","score_opus":0.008641972836683736,"score_gpt":0.27603513000132973,"score_spread":0.267393157164646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551618679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910222,0.0007543778,0.000051247258,0.0011150092,0.00020002582,0.005727128,0.000017147077,0.000051799176,0.0010610212],"genre_scores_gemma":[0.99763095,0.000033011063,0.00020491339,0.0011229261,0.00023644048,0.0006256014,0.0000037528382,0.00004792852,0.000094491545],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975054,0.0002898162,0.00081017695,0.00048618947,0.00047203267,0.0004363525],"domain_scores_gemma":[0.99794537,0.00018841615,0.00040072654,0.0011746988,0.00018110286,0.00010968306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006830597,0.00032143982,0.0015193857,0.000105393476,0.00014118096,0.000009215977,0.00036356223,0.00012027118,0.0001287453],"category_scores_gemma":[0.00032115428,0.00017043167,0.00022938599,0.00039319368,0.00020633078,0.00006268369,0.00029573395,0.0003155158,0.000027590748],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015343724,0.014418192,0.96893436,0.00016065703,0.0023204265,0.000010064224,0.011842357,0.00016882415,0.0005158047,0.00033641164,0.00043928358,0.00070018467],"study_design_scores_gemma":[0.0021657487,0.0032739956,0.9898619,0.00018887546,0.0018579344,0.000022811691,0.0009113559,0.000049678638,0.00110069,0.00020685761,0.00018551339,0.00017465591],"about_ca_topic_score_codex":0.0005395002,"about_ca_topic_score_gemma":0.00056429073,"teacher_disagreement_score":0.020927526,"about_ca_system_score_codex":0.000061891486,"about_ca_system_score_gemma":0.00007786351,"threshold_uncertainty_score":0.6950002},"labels":[],"label_agreement":null},{"id":"W2551649272","doi":"10.1182/blood.v108.11.2710.2710","title":"Phase II Results of Bendamustine in Combination with Rituximab in Relapsed Indolent and Mantle-Cell Non-Hodgkin’s Lymphoma.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Hôpital Notre-Dame; Northeast Cancer Centre; Ottawa Hospital","funders":"","keywords":"Bendamustine; Rituximab; Mantle cell lymphoma; Medicine; Internal medicine; Follicular lymphoma; Population; Gastroenterology; Lymphoma; Oncology","score_opus":0.006791410188091333,"score_gpt":0.23272023249351448,"score_spread":0.22592882230542313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551649272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950953,0.00045976555,0.0000020311834,0.00033037143,0.000019347965,0.00050604716,0.000032363798,0.000013528727,0.0035412344],"genre_scores_gemma":[0.99900275,0.00006262037,0.0005470241,0.000034823366,0.000020032438,0.00004919714,0.00011694887,0.00001434925,0.00015223348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989492,0.000024088515,0.00038443707,0.00026219015,0.00019967662,0.00018034846],"domain_scores_gemma":[0.99953103,0.000053977503,0.00012892806,0.00019020242,0.0000458406,0.000050015664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014253525,0.00014583523,0.00034057628,0.00021158537,0.000026934335,0.000006141623,0.000035067176,0.000072684794,0.000006050639],"category_scores_gemma":[0.000017424542,0.00011467591,0.000027270511,0.00023572255,0.000044186494,0.00003874885,0.000029860328,0.00004736678,0.000002479806],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007759877,0.44620413,0.49657005,0.0004944497,0.00013392739,0.002250818,0.0019562114,0.000024106841,0.009112976,0.00042083775,0.0006670077,0.03440561],"study_design_scores_gemma":[0.43931252,0.005607723,0.48273426,0.00035228365,0.00015824536,0.000055625635,0.00007505659,0.00016197283,0.0712226,0.000045566852,0.0001524298,0.00012170767],"about_ca_topic_score_codex":0.0013312625,"about_ca_topic_score_gemma":0.00047321778,"teacher_disagreement_score":0.4405964,"about_ca_system_score_codex":0.00007795813,"about_ca_system_score_gemma":0.0000747782,"threshold_uncertainty_score":0.4676348},"labels":[],"label_agreement":null},{"id":"W2551684983","doi":"10.1182/blood.v112.11.520.520","title":"Genome-Wide Expression Profiling Predicts Treatment Outcome in Classical Hodgkin Lymphoma","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Oncology; Univariate analysis; Lymphoma; International Prognostic Index; Progression-free survival; Gene expression profiling; Immunohistochemistry; CD20; Rituximab; Diffuse large B-cell lymphoma; Logistic regression; Pathology; Multivariate analysis; Chemotherapy; Gene expression; Biology; Gene","score_opus":0.03628988350224209,"score_gpt":0.2729385662410259,"score_spread":0.2366486827387838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551684983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99488693,0.0008915019,0.0000070030974,0.00042276978,0.000078960154,0.0007395359,0.000013089874,0.00010234896,0.0028578837],"genre_scores_gemma":[0.99651396,0.0003390445,0.001666542,0.00017768516,0.0001676187,0.0003040724,0.00007168248,0.000030231235,0.0007291796],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844766,0.00004705219,0.00040498358,0.00041788843,0.00030072796,0.00038166367],"domain_scores_gemma":[0.99917257,0.00011149333,0.00007335623,0.0003814984,0.00002924423,0.00023182065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000064254746,0.00025506451,0.00047281102,0.00013453397,0.00009117512,0.000010484785,0.00006789866,0.00013215495,0.000055500364],"category_scores_gemma":[0.00006857414,0.00017738083,0.00015880603,0.00015504022,0.000056146044,0.000062593404,0.000044227385,0.000051898303,0.000119609474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011852179,0.0077300533,0.98342884,0.000025651982,0.00009359445,0.002611702,0.0003067956,0.000003980501,0.0041057793,0.000018009587,0.000055958357,0.0015011037],"study_design_scores_gemma":[0.020257099,0.0009063765,0.8822152,0.00008703173,0.00016681083,0.00030716354,0.000038453396,0.000020337407,0.09397094,0.000011503935,0.0018737743,0.0001452952],"about_ca_topic_score_codex":0.000048184866,"about_ca_topic_score_gemma":0.000009612413,"teacher_disagreement_score":0.101213634,"about_ca_system_score_codex":0.00038818517,"about_ca_system_score_gemma":0.00018825516,"threshold_uncertainty_score":0.72333807},"labels":[],"label_agreement":null},{"id":"W2551712301","doi":"10.1182/blood.v124.21.3693.3693","title":"Predictive Value of Molecular Remissions Post Consolidation Chemotherapy in Patients with Core Binding Factor (CBF) Acute Myeloid Leukemias – a Single Centre Analysis","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada","funders":"","keywords":"Cytarabine; Daunorubicin; Medicine; Chemotherapy; Chemotherapy regimen; Gastroenterology; Internal medicine; Myeloid leukemia; Leukemia; Induction chemotherapy; Surgery","score_opus":0.009692334264617368,"score_gpt":0.25239856009881784,"score_spread":0.24270622583420046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551712301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976444,0.000016867021,0.0006381653,0.00021806835,0.0000156185,0.00068360654,0.00015619276,0.00004308478,0.00058396516],"genre_scores_gemma":[0.9975555,0.0000112928465,0.0015353714,0.00014723353,0.000026065756,0.000010652261,0.0005334195,0.000043364093,0.00013712129],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99810123,0.0001052514,0.00036735288,0.00041658228,0.000633191,0.00037641035],"domain_scores_gemma":[0.99855596,0.00011920766,0.00021584943,0.0004747698,0.00041771124,0.00021650954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015981332,0.00022230136,0.0005487372,0.0006019427,0.00005418372,0.000015736698,0.00015810861,0.00016476482,0.00010654896],"category_scores_gemma":[0.00028832167,0.00017651134,0.00013497361,0.0012569656,0.00011019039,0.00009717738,0.00005686099,0.0003004662,0.000006498862],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011918956,0.0014550915,0.7742475,0.000071990864,0.0024881805,0.000035919635,0.0013405445,0.00009981547,0.21812849,0.000041991214,0.000041595493,0.0008569686],"study_design_scores_gemma":[0.021527007,0.0019971912,0.68720007,0.00033638914,0.0027898748,0.00000809612,0.000363065,0.0026503506,0.2827305,0.000013768574,0.00007402236,0.00030968268],"about_ca_topic_score_codex":0.00008489838,"about_ca_topic_score_gemma":0.000014541486,"teacher_disagreement_score":0.08704745,"about_ca_system_score_codex":0.0003520482,"about_ca_system_score_gemma":0.00030395025,"threshold_uncertainty_score":0.71979237},"labels":[],"label_agreement":null},{"id":"W2551720520","doi":"10.1182/blood.v108.11.992.992","title":"A Large Mennonite Family with a Novel K570N TERT Gene Mutation: Association with a Clinical Spectrum of Bone Marrow Failure, Acute Myeloid Leukemia, and Acute Liver Failure.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Dyskeratosis congenita; Bone marrow failure; Aplastic anemia; Proband; Medicine; Bone marrow; Telomerase RNA component; Leukemia; Myeloid leukemia; Telomerase; Immunology; Telomerase reverse transcriptase; Internal medicine; Biology; Mutation; Stem cell; Haematopoiesis; Genetics; Gene","score_opus":0.008636648863566587,"score_gpt":0.23403868536737765,"score_spread":0.22540203650381108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551720520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99573565,0.0005171064,0.0018617164,0.00064194365,0.000045135235,0.0005909712,0.00022321376,0.00009954141,0.00028470877],"genre_scores_gemma":[0.9780344,0.00025605183,0.019283356,0.00051167695,0.00031495705,0.000034541594,0.0001941838,0.000057154954,0.0013137074],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975355,0.000063507185,0.0006455079,0.0005621485,0.0006792905,0.00051399245],"domain_scores_gemma":[0.998582,0.00012144782,0.0004894392,0.0003777424,0.00024207457,0.00018728829],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004247138,0.0003332381,0.00076044403,0.00019139973,0.000111219044,0.00004646853,0.00009831786,0.00025121073,0.000025456702],"category_scores_gemma":[0.000018257437,0.0002568333,0.00011413977,0.0004779887,0.0001359476,0.00021346155,0.00004973693,0.0003764163,0.000012051745],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022448178,0.0033185885,0.81075376,0.00026769328,0.0035235016,0.0024164175,0.001142091,0.0000053536614,0.17389093,0.00036781825,0.0014831234,0.0005858998],"study_design_scores_gemma":[0.03070345,0.0027462507,0.9346129,0.00033040758,0.0041028447,0.0023228861,0.00040917267,0.000218174,0.019589461,0.000049163453,0.004254392,0.0006609155],"about_ca_topic_score_codex":0.00030209046,"about_ca_topic_score_gemma":0.0010268773,"teacher_disagreement_score":0.15430146,"about_ca_system_score_codex":0.00010225704,"about_ca_system_score_gemma":0.00036396738,"threshold_uncertainty_score":0.9999884},"labels":[],"label_agreement":null},{"id":"W2551820001","doi":"10.1182/blood.v114.22.2700.2700","title":"The Impact of Outcome and Hepatic Toxicity in HCV-Infected Patients with Diffuse Large B-Cell Lymphoma Treated with Rituximab Plus CHOP Therapy; A Retrospective Multicenter Japanese Analysis.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Rituximab; Internal medicine; Diffuse large B-cell lymphoma; Gastroenterology; International Prognostic Index; Vincristine; Hepatitis C virus; Lymphoma; Cyclophosphamide; Hepatitis C; Chemotherapy; Immunology; Virus","score_opus":0.009199285270774559,"score_gpt":0.2810349918901205,"score_spread":0.2718357066193459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551820001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980742,0.00013031042,0.0000053255008,0.00003490752,0.0000032987296,0.0012043754,0.00007664055,0.000035786208,0.0004351771],"genre_scores_gemma":[0.99962354,0.000106387866,0.000044131408,0.00004850058,0.000010604266,0.000031056883,0.000043134423,0.000027745384,0.00006489899],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794304,0.00019466446,0.00039530548,0.0003770875,0.0005735888,0.0005163188],"domain_scores_gemma":[0.9986458,0.00013060808,0.00017588768,0.0005305287,0.00032231852,0.00019484664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023773251,0.00028808476,0.00083062425,0.00033263344,0.00009688964,0.000040848023,0.0001230892,0.000094443036,0.000024805026],"category_scores_gemma":[0.00016478279,0.0001447881,0.00013980296,0.0012892842,0.00012608095,0.000109933935,0.0000306699,0.00020771814,0.0000034105572],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002825439,0.019047305,0.9751953,0.00001769066,0.00090965023,0.00006858948,0.0010315878,0.0000024919734,0.00033895034,6.9528267e-7,0.0000023987557,0.0005599096],"study_design_scores_gemma":[0.10991426,0.0035577314,0.8838122,0.000046779936,0.00041700364,0.000002060495,0.000046093675,0.0014526029,0.0006019999,0.0000011271449,0.0000017659949,0.00014640969],"about_ca_topic_score_codex":0.0026259245,"about_ca_topic_score_gemma":0.0024070553,"teacher_disagreement_score":0.10708882,"about_ca_system_score_codex":0.00027927183,"about_ca_system_score_gemma":0.00009970158,"threshold_uncertainty_score":0.5904287},"labels":[],"label_agreement":null},{"id":"W2551837462","doi":"10.1182/blood.v108.11.497.497","title":"T-Cells with Extremely Short Telomeres and High Telomerase Activity in T-Cell Prolymphocytic Leukemia (T-PLL): The Ideal Target for Telomerase Inhibition.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute","funders":"","keywords":"Telomere; Telomerase; Biology; Molecular biology; clone (Java method); Prolymphocytic leukemia; Leukemia; Cancer research; Immunology; Chronic lymphocytic leukemia; Genetics; DNA; Gene","score_opus":0.009126911273314907,"score_gpt":0.21371760222115344,"score_spread":0.20459069094783852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551837462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937586,0.0018279499,0.00024322818,0.00053839316,0.00011133181,0.0024046549,0.00012063555,0.00016430336,0.00083085767],"genre_scores_gemma":[0.9939127,0.00020803596,0.0035780873,0.000419559,0.0004191148,0.00044122757,0.00010681314,0.000111815825,0.00080264616],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99665403,0.00012047447,0.00065282895,0.0009751399,0.0006412633,0.0009562406],"domain_scores_gemma":[0.998224,0.00040218484,0.00019263444,0.0007004322,0.00018369693,0.000297027],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000499065,0.00062721374,0.0008242812,0.0003772659,0.00034386976,0.0001124475,0.00019962028,0.00025069588,0.00004521771],"category_scores_gemma":[0.00006866395,0.00043840188,0.00014874383,0.0007535115,0.00043883873,0.0003012145,0.00008430281,0.00048256386,0.000017026936],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005250005,0.0065541356,0.1512461,0.0017829566,0.0003223134,0.0018234268,0.0007391371,0.00037256785,0.80449116,0.0005606806,0.0051852535,0.021672236],"study_design_scores_gemma":[0.021381354,0.0015367158,0.10523257,0.0003795089,0.00058272405,0.00053234515,0.00031100243,0.0006660866,0.8642491,0.00048029202,0.0035795397,0.0010687802],"about_ca_topic_score_codex":0.0020429883,"about_ca_topic_score_gemma":0.00056282914,"teacher_disagreement_score":0.0597579,"about_ca_system_score_codex":0.00029488603,"about_ca_system_score_gemma":0.0008006646,"threshold_uncertainty_score":0.99980676},"labels":[],"label_agreement":null},{"id":"W2551846360","doi":"10.1182/blood.v120.21.964.964","title":"Autologous Hematopoietic Stem Cell Transplantation Versus Intravenous Pulse Therapy Cyclophosphamide for Severe or Rapidly Progressive Systemic Sclerosis, the Astis Trial","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Medicine; Transplantation; Internal medicine; Surgery; Gastroenterology; Hematopoietic stem cell transplantation; Cyclophosphamide; Clinical endpoint; Randomized controlled trial; Chemotherapy","score_opus":0.036437512292502756,"score_gpt":0.26576086209678695,"score_spread":0.2293233498042842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551846360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92866236,0.06448281,0.00006497795,0.00012991435,0.0016051666,0.0046278425,0.000082386985,0.00015278057,0.00019176434],"genre_scores_gemma":[0.9914765,0.0060921283,0.00009892876,0.00011581649,0.0008481896,0.001047545,0.00006612804,0.00006209962,0.00019268313],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9979884,0.00016706208,0.0005790363,0.00032886138,0.0003762204,0.00056040805],"domain_scores_gemma":[0.9983986,0.0005232693,0.00031596966,0.00039919486,0.00011755613,0.00024539357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036827996,0.00030727172,0.00052666425,0.000064640975,0.00025182613,0.00004529336,0.0001828577,0.0002768665,0.000079472506],"category_scores_gemma":[0.000038758124,0.00017114221,0.00027019682,0.00021478134,0.00008594872,0.00010202365,0.000012949125,0.00018625322,0.000036136855],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6476015,0.02098069,0.01013876,0.008401596,0.0064222384,0.00042273192,0.041907594,0.00008358758,0.076182194,0.0004520094,0.004065867,0.18334126],"study_design_scores_gemma":[0.7782886,0.013242287,0.028108904,0.009933413,0.010029058,0.0058860965,0.012178587,0.000060640607,0.14016013,0.000021798734,0.00060548563,0.0014850186],"about_ca_topic_score_codex":0.000018062383,"about_ca_topic_score_gemma":0.00000148743,"teacher_disagreement_score":0.18185624,"about_ca_system_score_codex":0.000060025282,"about_ca_system_score_gemma":0.0002287555,"threshold_uncertainty_score":0.6978977},"labels":[],"label_agreement":null},{"id":"W2551853876","doi":"10.1182/blood.v108.11.4756.4756","title":"In Vitro and In Vivo Anti Lymphoma Effect of GX15-070 in Mantle Cell Lymphoma.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Mantle cell lymphoma; Vincristine; In vivo; Viability assay; Cancer research; Biology; Cytotoxic T cell; Apoptosis; Cell culture; Lymphoma; In vitro; Pharmacology; Immunology; Biochemistry; Chemotherapy; Cyclophosphamide","score_opus":0.003176389736245062,"score_gpt":0.19862368254615564,"score_spread":0.19544729280991058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551853876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99453795,0.0019619903,0.0000022567683,0.000013185121,0.000028242748,0.00019957093,0.000023786919,0.00000353219,0.0032295068],"genre_scores_gemma":[0.9995023,0.00010355161,0.000110310684,0.000033076376,0.00005139659,0.000023260178,0.000019197947,0.000013846973,0.00014304138],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991865,0.00008957645,0.00020406618,0.00024189627,0.00006589592,0.000212079],"domain_scores_gemma":[0.9997329,0.000020598332,0.000049012793,0.00016287017,0.000008699723,0.00002591206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021106616,0.0001250131,0.00020107973,0.00009058237,0.000010373405,0.000007053848,0.0000896753,0.00014243435,0.000007731929],"category_scores_gemma":[0.000017435348,0.000121213976,0.000035793444,0.00011649029,0.000040285504,0.0000034217007,0.000065354936,0.000029555502,0.0000025129038],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013437023,0.00040753686,0.050582398,0.00008581073,0.0000036380964,0.00003968222,0.000019450556,0.0000039350925,0.9480487,0.000005329919,0.000044246888,0.00062489684],"study_design_scores_gemma":[0.006478595,0.00017103762,0.025261817,0.000025528416,0.0000070334104,0.000016331052,0.000007890571,0.000016962633,0.9670311,0.00003827651,0.0008196137,0.00012580458],"about_ca_topic_score_codex":0.00037076266,"about_ca_topic_score_gemma":0.00016611315,"teacher_disagreement_score":0.02532058,"about_ca_system_score_codex":0.000008461734,"about_ca_system_score_gemma":0.000031581658,"threshold_uncertainty_score":0.49429625},"labels":[],"label_agreement":null},{"id":"W2551914787","doi":"10.1182/blood.v106.11.113.113","title":"PKC δ Inhibition Restores PTEN Activity in Myeloma Cells and Prolongs Survival of GFP+ Myeloma SCID/NOD Mice In Vivo.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary","funders":"","keywords":"Rottlerin; PTEN; Protein kinase B; Phosphorylation; Cancer research; PI3K/AKT/mTOR pathway; Molecular biology; Protein kinase C; Chemistry; Biology; Kinase; Cell biology; Signal transduction","score_opus":0.008930084301501462,"score_gpt":0.23786020519427883,"score_spread":0.22893012089277737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551914787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983631,0.00065426074,0.000019503716,0.00013083314,0.00007196108,0.0002047998,0.000037867383,0.000009187534,0.00050851936],"genre_scores_gemma":[0.9990776,0.00008593575,0.0004467814,0.000050714083,0.00019531262,0.000026485312,0.000010431163,0.000020799767,0.00008590683],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988997,0.00009887427,0.00022944088,0.00037679958,0.00014970613,0.00024545944],"domain_scores_gemma":[0.9995362,0.00002516603,0.00011192414,0.00022786635,0.000047094596,0.000051742554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003130775,0.0001513505,0.00019840473,0.00009159003,0.00002461031,0.000012578643,0.00011034763,0.00020229384,0.000011985188],"category_scores_gemma":[0.000052417807,0.00016193763,0.000041249725,0.0001405721,0.00010693668,0.000011991959,0.000095315285,0.00012823462,0.0000019964825],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017179965,0.00029072413,0.021476835,0.000044172182,0.00001917052,0.0000093935605,0.00012180142,0.000037537124,0.97606236,0.000008565485,0.00010995873,0.0016476816],"study_design_scores_gemma":[0.0016915452,0.00019728113,0.045250166,0.00005730526,0.000015291089,0.00000832615,0.000024880625,0.000039374077,0.9515082,0.000025251282,0.0010135031,0.00016883732],"about_ca_topic_score_codex":0.00014354757,"about_ca_topic_score_gemma":0.0013678563,"teacher_disagreement_score":0.024554122,"about_ca_system_score_codex":0.000025332938,"about_ca_system_score_gemma":0.000081355414,"threshold_uncertainty_score":0.6603625},"labels":[],"label_agreement":null},{"id":"W2551927314","doi":"10.1182/blood.v114.22.4956.4956","title":"Osteonecrosis of the Jaw in Multiple Myeloma Patients: Incidence and Characteristics in Korean Patients.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Bone health and treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Osteonecrosis of the jaw; Multiple myeloma; Incidence (geometry); Bisphosphonate; Medical record; Internal medicine; Surgery; Retrospective cohort study; Complication; Osteoporosis","score_opus":0.009291934683526765,"score_gpt":0.23421731087732792,"score_spread":0.22492537619380115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551927314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991188,0.000033494838,1.3606564e-7,0.00017017162,0.00003783596,0.0004604627,0.000025253368,0.0000057487528,0.00014807747],"genre_scores_gemma":[0.99941856,0.00003841772,0.00009649911,0.00038798002,0.0000019294275,0.000009529958,0.000025837573,0.000005682695,0.000015577152],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992377,0.000028459432,0.0002906849,0.00013462326,0.00014323843,0.00016528291],"domain_scores_gemma":[0.99957293,0.000038621918,0.00009831303,0.00017124259,0.000050172563,0.00006873342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000056506393,0.00008528212,0.00020819288,0.00005983774,0.000025900477,0.0000032251817,0.000042102954,0.000054915745,0.000002891262],"category_scores_gemma":[0.00023472973,0.000059765134,0.000021656537,0.00016441927,0.000033838714,0.000042276424,0.000024244942,0.00009898362,0.0000021504825],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008345699,0.0017619864,0.98244137,0.000034178778,0.000004433948,0.000005456843,0.00036013118,2.150356e-8,0.00008619354,0.000005518905,0.000005058399,0.01521217],"study_design_scores_gemma":[0.007680886,0.00047590374,0.99025184,0.00020697844,0.000028812816,0.0000015129111,0.000014083492,0.000008017304,0.0012426524,0.000023107903,0.000019633853,0.00004654849],"about_ca_topic_score_codex":0.00094325223,"about_ca_topic_score_gemma":0.00091112737,"teacher_disagreement_score":0.015165621,"about_ca_system_score_codex":0.000028184822,"about_ca_system_score_gemma":0.00003648791,"threshold_uncertainty_score":0.24371515},"labels":[],"label_agreement":null},{"id":"W2551937125","doi":"10.1182/blood.v124.21.1250.1250","title":"Allogeneic Hematopoietic Stem Cell Transplantation Is an Effective Salvage Therapy for Patients with Chronic Myeloid Leukemia Failing Treatment with Tyrosine Kinase Inhibitors","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada; BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Dasatinib; Nilotinib; Internal medicine; Hematopoietic stem cell transplantation; Myeloid leukemia; Transplantation; Imatinib; Tyrosine-kinase inhibitor; Population; Oncology; Imatinib mesylate; Cancer","score_opus":0.007256990767380318,"score_gpt":0.22156768665226786,"score_spread":0.21431069588488755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551937125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99427485,0.00080337696,0.0005412219,0.000036487723,0.00005800691,0.003982123,0.00007477411,0.00013191771,0.00009721088],"genre_scores_gemma":[0.9966491,0.00025207744,0.0011096741,0.000110247485,0.00021289231,0.0008397591,0.00054279185,0.00012816598,0.00015530406],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980048,0.00008733114,0.00031190462,0.00071853754,0.00037988252,0.0004975762],"domain_scores_gemma":[0.9987535,0.00014155636,0.00019028981,0.0005399954,0.00013451207,0.00024015312],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010475085,0.00051494676,0.0005638552,0.00012156645,0.00016662473,0.000034437016,0.00009227692,0.00014822738,0.00002240342],"category_scores_gemma":[0.0000023229,0.000337612,0.00012573125,0.0001849928,0.00007555484,0.00015564049,0.000007561147,0.00011832139,0.00001473512],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016250428,0.017762274,0.5900546,0.0032793712,0.0034821657,0.00027812034,0.015938543,0.00046820904,0.09733856,0.000047955196,0.00006884053,0.25503093],"study_design_scores_gemma":[0.123807214,0.050609276,0.06987702,0.0006163822,0.002085292,0.00007170667,0.00012555055,0.00023942278,0.7514186,0.000009816668,0.0005219955,0.0006177394],"about_ca_topic_score_codex":0.00012994518,"about_ca_topic_score_gemma":0.00011594435,"teacher_disagreement_score":0.65408003,"about_ca_system_score_codex":0.0015613914,"about_ca_system_score_gemma":0.00044064684,"threshold_uncertainty_score":0.9999076},"labels":[],"label_agreement":null},{"id":"W2551953317","doi":"10.1182/blood.v110.11.3306.3306","title":"Cyclic Neutropenia Is Not Associated with Transformation to MDS and AML.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Cyclic neutropenia; Neutropenia; Congenital Neutropenia; Medicine; Internal medicine; Absolute neutrophil count; Pediatrics; Febrile neutropenia; Leukopenia; Surgery; Chemotherapy","score_opus":0.005806597318427435,"score_gpt":0.22144859566740394,"score_spread":0.2156419983489765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551953317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99685735,0.00015987355,0.00029076886,0.00019681036,0.0000129572445,0.00015966821,0.000018146691,0.000009207499,0.0022952142],"genre_scores_gemma":[0.9987559,0.00003491456,0.00015525681,0.00075610494,0.000021774002,0.000007883193,0.0000658242,0.000011213369,0.00019113916],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995236,0.000008257591,0.00008758146,0.00015525604,0.00006899936,0.00015629844],"domain_scores_gemma":[0.9997712,0.0000035912867,0.00002521558,0.00010142242,0.000027022332,0.000071583854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000061001338,0.00008917628,0.0000758948,0.000022457196,0.000052674706,0.000016286127,0.000042624626,0.000070722264,0.000005049544],"category_scores_gemma":[0.000006984402,0.00007282924,0.000021459671,0.000064018874,0.000015701216,0.0000033070107,0.000013676207,0.000027896227,0.0000059619415],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008575121,0.0028998777,0.14784813,0.000038293598,0.0014267748,0.000045730438,0.0017727213,0.000011702454,0.803769,0.00022050133,0.0012861288,0.03982366],"study_design_scores_gemma":[0.0050662165,0.0009821892,0.10847088,0.000014036713,0.00015098986,0.000014655522,0.00007558925,0.0000019690783,0.88051635,0.000017376075,0.00449236,0.00019737489],"about_ca_topic_score_codex":0.00002317852,"about_ca_topic_score_gemma":0.00022395127,"teacher_disagreement_score":0.07674739,"about_ca_system_score_codex":0.000002704415,"about_ca_system_score_gemma":0.000011068861,"threshold_uncertainty_score":0.29698902},"labels":[],"label_agreement":null},{"id":"W2551970609","doi":"10.1182/blood.v124.21.2840.2840","title":"Regions on Chromosomes 1 and 14 Are Associated with VWF:Ag Levels in African Americans Using Mapping By Admixture Linkage Disequilibrium","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Hospital for Sick Children","funders":"","keywords":"International HapMap Project; Linkage disequilibrium; Genetics; Biology; Genetic association; Population; Genome-wide association study; Allele; Ancestry-informative marker; Single-nucleotide polymorphism; SNP; Allele frequency; Haplotype; Genotype; Gene; Demography","score_opus":0.021612228189514342,"score_gpt":0.2437061453505499,"score_spread":0.22209391716103558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551970609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970588,0.00024377627,0.00095547433,0.00074607815,0.000027325554,0.00012217791,0.000079823825,0.000013446728,0.0007531052],"genre_scores_gemma":[0.9983679,0.00004497262,0.0006511666,0.00048707158,0.0000894102,0.000014314692,0.000107097156,0.000023011842,0.00021502153],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99887884,0.00018529134,0.00018877811,0.00035904962,0.000079819365,0.00030824178],"domain_scores_gemma":[0.99938023,0.00006439775,0.00019915984,0.00022549185,0.000044012395,0.00008670309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019668459,0.00016092432,0.00026567339,0.00004729337,0.000089617126,0.000014904914,0.000100911944,0.0001873596,0.0000033867623],"category_scores_gemma":[0.00042357596,0.00014388385,0.000040318995,0.00016071205,0.0000978293,0.0000027689402,0.000056653946,0.00012837256,8.555301e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002558025,0.0005673731,0.7854843,0.000024980242,0.00030400525,0.000010071429,0.00028162813,0.00028527918,0.21004917,0.00014192334,0.0024578527,0.00036783202],"study_design_scores_gemma":[0.0029739542,0.0008739588,0.9819962,0.00017614377,0.00012385298,0.000022357337,0.00045859005,0.00061830314,0.006050439,0.00036174565,0.005704091,0.0006403618],"about_ca_topic_score_codex":0.000041493684,"about_ca_topic_score_gemma":0.00016836161,"teacher_disagreement_score":0.20399873,"about_ca_system_score_codex":0.000016697004,"about_ca_system_score_gemma":0.00004834723,"threshold_uncertainty_score":0.5867413},"labels":[],"label_agreement":null},{"id":"W2551999103","doi":"10.1182/blood.v120.21.4281.4281","title":"Reporting Bleeding Outcomes in Adult and Pediatric Studies of Primary Immune Thrombocytopenia: A Systematic Review","year":2012,"lang":"en","type":"review","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; McMaster University","funders":"","keywords":"Medicine; MEDLINE; Clinical endpoint; Prospective cohort study; Clinical trial; Pediatrics; Adverse effect; Randomized controlled trial; Internal medicine","score_opus":0.09008991487042421,"score_gpt":0.36872182351032606,"score_spread":0.27863190863990184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551999103","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0048406995,0.99142915,6.388718e-8,0.000017873754,0.00006737275,0.0033645555,0.000008385765,0.000020411591,0.00025148533],"genre_scores_gemma":[0.0005543008,0.99874395,0.00014618228,0.000035457375,0.000034986326,0.00032096065,0.000035290854,0.000040653766,0.000088240275],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.995652,0.00010505055,0.003398971,0.00029951698,0.0002696438,0.00027481662],"domain_scores_gemma":[0.99536127,0.00029248727,0.003776407,0.0003976986,0.0001075325,0.00006463286],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010171015,0.0003988572,0.012077469,0.0002147598,0.000033320503,0.000006531039,0.000085702304,0.00014947192,0.0000034348327],"category_scores_gemma":[0.0017790928,0.0002488383,0.00045864153,0.00034134916,0.00003031861,0.000071196955,0.00013082313,0.0002450899,0.000007874163],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[9.830972e-7,0.00044841185,0.005935054,0.9853143,0.0017626113,0.00039208203,0.000071880604,5.961721e-10,2.0409682e-7,0.000004097581,0.0000036557656,0.006066718],"study_design_scores_gemma":[0.0013925108,0.00009354995,0.0009208214,0.91364145,0.08203561,0.001451815,0.000059005142,2.494274e-8,5.866395e-7,0.0000045686497,0.00016301432,0.00023702785],"about_ca_topic_score_codex":0.000017778806,"about_ca_topic_score_gemma":0.0000031526286,"teacher_disagreement_score":0.080272995,"about_ca_system_score_codex":0.00006892948,"about_ca_system_score_gemma":0.00013240018,"threshold_uncertainty_score":0.99999636},"labels":[],"label_agreement":null},{"id":"W2552009301","doi":"10.1182/blood.v108.11.3486.3486","title":"Oncolytic Virotherapy for Multiple Myeloma.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Lunenfeld-Tanenbaum Research Institute; Toronto General Hospital","funders":"","keywords":"Oncolytic virus; Biology; Cell culture; Virotherapy; Flow cytometry; Viability assay; Bone marrow; Xenotransplantation; Cancer research; Molecular biology; MTT assay; Virology; Virus; Transplantation; Immunology; Medicine","score_opus":0.013582699284729388,"score_gpt":0.28419764364706696,"score_spread":0.2706149443623376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552009301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99634427,0.0010563283,0.00090764,0.00011580475,0.00004436662,0.0004713622,0.000037468115,0.000021131036,0.0010016024],"genre_scores_gemma":[0.99506015,0.000057734236,0.0011721078,0.00023299726,0.0006604481,0.00017660864,0.0001257039,0.000044300155,0.0024699743],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991649,0.000032436405,0.00013158776,0.00027284847,0.000112049755,0.00028617724],"domain_scores_gemma":[0.9995198,0.000022172433,0.000032952208,0.0003190601,0.0000570473,0.000048940517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014617998,0.00011664738,0.00010068928,0.000033181983,0.000079302845,0.000020592024,0.00017842982,0.00010214184,0.000028946764],"category_scores_gemma":[0.000027134407,0.000112944406,0.00010104681,0.000060091068,0.000046307716,0.0000015534831,0.000026370799,0.00004472228,0.000021050158],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067638623,0.00032191467,0.0019596082,0.000008671061,0.00005068933,0.0000016815,0.0000051911557,0.00003236663,0.9922403,0.000025665178,0.0016686132,0.0030088997],"study_design_scores_gemma":[0.003820945,0.0020060353,0.0011112172,0.0000032681946,0.000012484546,0.0000050745707,0.0000057598827,0.00005912361,0.9439707,0.00017159061,0.04868167,0.00015214793],"about_ca_topic_score_codex":0.000020940124,"about_ca_topic_score_gemma":0.00033203914,"teacher_disagreement_score":0.04826963,"about_ca_system_score_codex":0.000007970112,"about_ca_system_score_gemma":0.000073485244,"threshold_uncertainty_score":0.4605739},"labels":[],"label_agreement":null},{"id":"W2552024236","doi":"10.1182/blood.v124.21.1305.1305","title":"Development of Quality Metrics to Evaluate Pediatric Hematologic Oncology Care in the Outpatient Setting","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Delphi Technique in Research","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Delphi method; Metric (unit); Likert scale; MEDLINE; Delphi; Family medicine; Interquartile range; Quality (philosophy); Pediatric oncology; Internal medicine; Computer science; Statistics; Cancer; Operations management","score_opus":0.17995734133700303,"score_gpt":0.4961285050390304,"score_spread":0.31617116370202736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552024236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832074,0.00011040294,0.00022042077,0.001130125,0.000060958526,0.00058461365,0.0000015702692,0.00003244133,0.014652077],"genre_scores_gemma":[0.9790802,0.0000114618215,0.020595742,0.00013920288,0.000047415844,0.000109760396,0.0000013918616,0.0000042557112,0.000010561143],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9966467,0.0015560954,0.00040499112,0.00018323566,0.00089395355,0.00031503776],"domain_scores_gemma":[0.9981623,0.0011909605,0.00013568923,0.00020428373,0.00024590612,0.000060814204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011374235,0.00006614098,0.00018041454,0.00023753005,0.00018135832,0.000018475293,0.0005829508,0.00011004584,0.000013501743],"category_scores_gemma":[0.0055507645,0.000049243376,0.000033361608,0.0011878865,0.000056894536,0.000027783282,0.00014872922,0.00017237141,0.00001997106],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031621763,0.0014799875,0.37913314,0.00028846628,0.000021292228,0.000013839162,0.464654,0.000027867161,0.00026598288,0.015352783,0.0007155762,0.13801545],"study_design_scores_gemma":[0.0047266237,0.002287239,0.3772384,0.00012075003,0.00019851839,0.000006985388,0.42008993,0.000067845154,0.018583978,0.009117181,0.16620323,0.0013593372],"about_ca_topic_score_codex":0.0003917711,"about_ca_topic_score_gemma":0.0025584267,"teacher_disagreement_score":0.16548766,"about_ca_system_score_codex":0.00016288632,"about_ca_system_score_gemma":0.000489976,"threshold_uncertainty_score":0.6645185},"labels":[],"label_agreement":null},{"id":"W2552031241","doi":"10.1182/blood-2016-02-636316","title":"Approach to the diagnosis and treatment of high-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements","year":2016,"lang":"en","type":"review","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":169,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"BCL6; Lymphoma; Germinal center; Fluorescence in situ hybridization; Oncology; Diffuse large B-cell lymphoma; Clinical trial; Medicine; Internal medicine; B cell; Cancer research; Biology; Immunology; Genetics; Gene; Chromosome","score_opus":0.04915020023697943,"score_gpt":0.2885356051003054,"score_spread":0.239385404863326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552031241","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016296554,0.9793142,0.0000013828586,0.00023195289,0.00003303255,0.0029526928,0.00019287725,0.00002469629,0.00095258537],"genre_scores_gemma":[0.0055675437,0.99029785,0.0007899498,0.000057808993,0.00013073308,0.0022339907,0.000056757894,0.000059406313,0.0008059541],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99836975,0.00008419847,0.00037193013,0.0006275589,0.00026140435,0.0002851547],"domain_scores_gemma":[0.9986764,0.0002718127,0.00021116761,0.0005463399,0.00003340794,0.00026088013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008682463,0.0005315416,0.0016314859,0.0001274363,0.00009081421,0.00003576323,0.000081739556,0.0001570845,0.000016721333],"category_scores_gemma":[0.000014806829,0.00020549401,0.0001340082,0.00016315197,0.00011788378,0.000031151634,0.00008103313,0.00003847667,0.000009712498],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008667133,0.0066767307,0.0060711405,0.0048071826,0.0019711817,0.00010104407,0.00029989483,1.175929e-8,5.4532995e-7,0.00008482733,0.0004526097,0.97944814],"study_design_scores_gemma":[0.017644752,0.0042896196,0.0051301,0.008980564,0.012994045,0.00056585984,0.000058196125,1.8965714e-7,0.00013137024,0.000005502981,0.9498421,0.00035769143],"about_ca_topic_score_codex":0.0002704357,"about_ca_topic_score_gemma":0.000027172217,"teacher_disagreement_score":0.97909045,"about_ca_system_score_codex":0.00010580743,"about_ca_system_score_gemma":0.00014505767,"threshold_uncertainty_score":0.8379802},"labels":[],"label_agreement":null},{"id":"W2552033398","doi":"10.1182/blood.v116.21.713.713","title":"Evaluation of the Severity and Pattern of Epistaxis In Children with a Mucocutaneous Bleeding Disorder and In Healthy Children Using a Standardized Questionnaire","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Vascular Anomalies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Hospital for Sick Children","funders":"","keywords":"Medicine; Desmopressin; Mucocutaneous zone; Von Willebrand disease; Cauterization; Pediatrics; Platelet disorder; Von Willebrand factor; Platelet; Disease; Internal medicine; Surgery","score_opus":0.007824871229737414,"score_gpt":0.2600970065519892,"score_spread":0.2522721353222518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552033398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99862313,0.0006174635,0.000014405121,0.000073210074,0.000008645428,0.00063360104,0.000017360844,0.0000031801246,0.000008981068],"genre_scores_gemma":[0.9997325,0.0000322681,0.00019741135,0.000010491498,0.000008570816,0.0000065790055,0.0000042468414,0.000007429665,5.2930767e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99931425,0.000065559085,0.00014782528,0.00013089745,0.000255916,0.00008554256],"domain_scores_gemma":[0.9996974,0.000007726211,0.00007510202,0.00012582638,0.000066416615,0.000027522703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035084115,0.0000724088,0.00018944779,0.000051404593,0.000029737752,0.0000043024806,0.00002112082,0.000041807423,0.0000040668524],"category_scores_gemma":[0.000047165027,0.000047647667,0.00002146307,0.000104106315,0.000065254615,0.000029273911,0.000023536095,0.00009620798,2.109737e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009137822,0.00028323336,0.9914225,0.000029978002,0.0001312143,0.0000014898493,0.00032772927,0.000008400363,0.00022720222,0.0000015562778,3.998709e-8,0.0074752765],"study_design_scores_gemma":[0.009394668,0.00018436664,0.9883332,0.00020839712,0.00042577353,0.00053639605,0.000035971912,0.0004565283,0.00035221805,0.000028952263,1.15603136e-7,0.000043389013],"about_ca_topic_score_codex":0.0035526725,"about_ca_topic_score_gemma":0.00438625,"teacher_disagreement_score":0.00930329,"about_ca_system_score_codex":0.000019166244,"about_ca_system_score_gemma":0.00009374693,"threshold_uncertainty_score":0.53706014},"labels":[],"label_agreement":null},{"id":"W2552034981","doi":"10.1182/blood.v114.22.133.133","title":"HLA-DR Protein Expression Correlates with Non-Neoplastic T-Cell Infiltration and Predicts Survival in Patients with Primary Mediastinal Large B Cell Lymphoma (PMBCL) Treated with CHOP Chemotherapy.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Tissue microarray; CHOP; Medicine; Lymphoma; International Prognostic Index; Diffuse large B-cell lymphoma; CD8; Human leukocyte antigen; Immunohistochemistry; Cancer research; Pathology; Oncology; Antigen; Immunology","score_opus":0.0028529832276552184,"score_gpt":0.17413168719475255,"score_spread":0.17127870396709732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552034981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965196,0.00015488017,0.000050872408,0.00006052772,0.00001562366,0.0016956244,0.000025098461,0.00006684805,0.0014109177],"genre_scores_gemma":[0.9984314,0.000033351662,0.000806488,0.0001076428,0.000045644236,0.0001398638,0.00025525878,0.00004200572,0.00013838006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982942,0.00004338948,0.00027117244,0.00048136825,0.0005170273,0.00039287697],"domain_scores_gemma":[0.9991769,0.000063225045,0.00018154195,0.00025743255,0.00010854618,0.00021231822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007717867,0.0003762498,0.00045167573,0.00013171534,0.00008499662,0.000036818645,0.0000584826,0.00012732318,0.000015440932],"category_scores_gemma":[0.000009829956,0.00022423053,0.000026622052,0.00026623666,0.00005670832,0.00017238338,0.000014909044,0.00010280356,0.000004888867],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045787957,0.016805485,0.97285956,0.00013499847,0.00006912013,0.00021063333,0.0004407525,0.000012718152,0.003580355,0.0000014349699,0.000031484058,0.0012746671],"study_design_scores_gemma":[0.10487664,0.009314134,0.8351022,0.00095927133,0.00027118652,0.000032546097,0.00004762762,0.000084134015,0.049051415,0.0000015803463,0.0000171597,0.0002421336],"about_ca_topic_score_codex":0.0000412425,"about_ca_topic_score_gemma":0.000034701854,"teacher_disagreement_score":0.13775739,"about_ca_system_score_codex":0.00009865042,"about_ca_system_score_gemma":0.00020229674,"threshold_uncertainty_score":0.91438556},"labels":[],"label_agreement":null},{"id":"W2552051894","doi":"10.1182/blood.v114.22.890.890","title":"First-Line Rituximab Efficacy and Safety in Patients with Acquired Idiopathic Thrombotic Thrombocytopenic Purpura Experiencing a Non Optimal Response to Therapeutical Plasma Exchange: Results of a Prospective Multicenter Phase 2 Study From the French Reference Center for the Management of Thrombotic Microangiopathies.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Rituximab; Medicine; Thrombotic thrombocytopenic purpura; Internal medicine; ADAMTS13; Gastroenterology; Thrombotic microangiopathy; Prospective cohort study; Refractory (planetary science); Surgery; Platelet; Disease; Lymphoma","score_opus":0.020402603143819406,"score_gpt":0.2828149266710213,"score_spread":0.2624123235272019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552051894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99091333,0.0009605,0.00017190368,0.00025615245,0.00009108438,0.007058463,0.00051765353,0.000020923928,0.000009990559],"genre_scores_gemma":[0.9992136,0.000027752192,0.0002769236,0.00005201587,0.000013920256,0.00032461467,0.000059970695,0.000020723995,0.000010526236],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99751645,0.00045183138,0.00082588795,0.0006182729,0.00016727897,0.00042026606],"domain_scores_gemma":[0.99804175,0.0007016812,0.00031401074,0.0007523353,0.00015623658,0.00003399452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007736377,0.00032717342,0.0006661077,0.00008902448,0.00023269268,0.000028250402,0.0005273644,0.00008527067,0.000027999498],"category_scores_gemma":[0.00009911422,0.00019366966,0.000076968885,0.0002544588,0.0002278019,0.00009811457,0.00025803782,0.00014521711,0.0000046110576],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4433341,0.12885362,0.16426523,0.00060479256,0.007845762,0.00006927378,0.18371004,0.00034009697,0.05965957,0.00009402475,0.00015742588,0.011066058],"study_design_scores_gemma":[0.10771216,0.009454768,0.8718852,0.0008666696,0.0006293659,0.0000029510852,0.0041194996,0.000041451858,0.005034211,0.000008195141,0.000026587708,0.0002189613],"about_ca_topic_score_codex":0.00013163518,"about_ca_topic_score_gemma":0.00017587199,"teacher_disagreement_score":0.70761997,"about_ca_system_score_codex":0.00006509615,"about_ca_system_score_gemma":0.000038044655,"threshold_uncertainty_score":0.78976196},"labels":[],"label_agreement":null},{"id":"W2552106802","doi":"10.1182/blood.v108.11.4143.4143","title":"Red Blood Cell Transfusion and Chemotherapy Administration: A Study of Resource Utilization at the London Regional Cancer Program (LRCP).","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; Chemotherapy; Internal medicine; Blood transfusion; Hematology; Incidence (geometry); Multiple myeloma; Cancer; Retrospective cohort study; Breast cancer","score_opus":0.021459637566489168,"score_gpt":0.2856372833222259,"score_spread":0.2641776457557367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552106802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940341,0.0017925415,0.0000027918852,0.0011445803,0.000015640286,0.0018121286,0.000007123769,0.000052255524,0.0011388296],"genre_scores_gemma":[0.996733,0.00043406646,0.00015712387,0.000080639926,0.00012982528,0.00019063661,0.00007937412,0.000024413674,0.0021708861],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989046,0.000056018005,0.00026873944,0.0002870826,0.00033398188,0.0001495921],"domain_scores_gemma":[0.99943686,0.00003895082,0.00012112803,0.0002960825,0.00005889367,0.000048097867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009412891,0.00014892533,0.00020438482,0.000037497877,0.00010836107,0.0000110741885,0.000054802436,0.00007663633,0.00010915149],"category_scores_gemma":[0.0000047578324,0.00010468168,0.00004805565,0.00018497556,0.00006997749,0.000027654109,0.000014809789,0.00008609682,9.272194e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004144312,0.06373357,0.8069821,0.0006367206,0.0010098704,0.00021696537,0.0058351303,0.000050651248,0.0726014,0.00004645973,0.006305189,0.038437616],"study_design_scores_gemma":[0.107803725,0.01101578,0.5593758,0.00030535212,0.0033805077,0.00044163293,0.0010713596,0.0002501711,0.28107342,0.00003502606,0.034841776,0.0004054386],"about_ca_topic_score_codex":0.0005066466,"about_ca_topic_score_gemma":0.0013245377,"teacher_disagreement_score":0.2476063,"about_ca_system_score_codex":0.000073622585,"about_ca_system_score_gemma":0.00016000695,"threshold_uncertainty_score":0.42687953},"labels":[],"label_agreement":null},{"id":"W2552110041","doi":"10.1182/blood.v124.21.2112.2112","title":"Impact of Renal Impairment (RI) on Outcomes after Treatment (Tx) with Lenalidomide and Low-Dose Dexamethasone (Rd) in Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts): First Trial Results","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal; Ottawa Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lenalidomide; Multiple myeloma; Renal function; Internal medicine; Thalidomide; Melphalan; Urology; Creatinine; Dialysis; Surgery; Gastroenterology","score_opus":0.01653517012503599,"score_gpt":0.2859744430745613,"score_spread":0.26943927294952535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552110041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99634695,0.00007649453,0.0000055238265,0.00017677394,0.000044411823,0.0029149821,0.00025799623,0.000033475153,0.00014337436],"genre_scores_gemma":[0.99824554,0.000085107786,0.0006869502,0.00003884225,0.00009573163,0.00049256074,0.0001794124,0.000049995826,0.00012583246],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971321,0.00022057716,0.00066521345,0.00064241927,0.0006776008,0.00066207984],"domain_scores_gemma":[0.9974508,0.0010496418,0.0002321784,0.000652287,0.000114581904,0.000500459],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031034416,0.0004902558,0.00092733675,0.0003394035,0.00007178923,0.00003069848,0.00009377785,0.00013433734,0.00004137182],"category_scores_gemma":[0.00084753643,0.00028948285,0.00026699746,0.0002216539,0.00012413925,0.0000986609,0.000060627703,0.00018012484,0.000019443047],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21930243,0.014575539,0.7547827,0.000053014453,0.0007899396,0.0003811734,0.000477791,0.00003298065,0.00007794544,6.2558405e-7,0.000040845098,0.00948506],"study_design_scores_gemma":[0.3705019,0.023525761,0.6038279,0.0002682523,0.000179532,0.000007658623,0.000015986961,0.00014674365,0.0013395313,0.0000031926456,0.000026016554,0.00015749874],"about_ca_topic_score_codex":0.0024459793,"about_ca_topic_score_gemma":0.0018729621,"teacher_disagreement_score":0.15119949,"about_ca_system_score_codex":0.0003326736,"about_ca_system_score_gemma":0.00016898473,"threshold_uncertainty_score":0.9999557},"labels":[],"label_agreement":null},{"id":"W2552111400","doi":"10.1182/blood.v124.21.2648.2648","title":"Clinical Outcomes for Chronic Lymphocytic Leukemia (CLL) Patients with 11q Deletion in British Columbia (BC), Canada: Results of a Population-Based Cohort","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; St. Paul's Hospital; Royal Columbian Hospital; Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Proportional hazards model; Population; Chronic lymphocytic leukemia; Oncology; Hazard ratio; Cohort; Trisomy; Survival analysis; Leukemia; Confidence interval; Biology; Genetics","score_opus":0.010096903613272654,"score_gpt":0.2655742751269964,"score_spread":0.25547737151372374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552111400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99777323,0.000035179557,0.000051402076,0.000036478195,0.00011307184,0.0016961647,0.00013244958,0.00003394483,0.0001280998],"genre_scores_gemma":[0.9976259,0.000008848985,0.00073706446,0.00017223069,0.00010847725,0.0001347166,0.000798493,0.00004739682,0.0003668805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970333,0.00012771806,0.0010083359,0.0005260839,0.0008105135,0.0004940624],"domain_scores_gemma":[0.9975922,0.0009961795,0.00027493096,0.0005551677,0.00036660317,0.00021493019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008307313,0.00015388033,0.0007280687,0.000074031064,0.00006812906,0.00003592715,0.00016688505,0.0001826153,0.00002667502],"category_scores_gemma":[0.0021618656,0.00018510717,0.00012333535,0.0002713236,0.00010172028,0.000052548505,0.000036178295,0.00017534656,0.0000022892082],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00040948446,0.00031634548,0.994033,0.00031688204,0.00012531961,0.000026482652,0.0000064035753,0.00048588894,0.00000195703,0.0000022351792,0.0012431985,0.0030328268],"study_design_scores_gemma":[0.13612944,0.0008075851,0.842242,0.00040783957,0.00019280867,0.000010873305,0.0000047344506,0.019508652,0.000027008487,0.000009819472,0.00049165176,0.0001675664],"about_ca_topic_score_codex":0.97042066,"about_ca_topic_score_gemma":0.9890991,"teacher_disagreement_score":0.15179096,"about_ca_system_score_codex":0.039701477,"about_ca_system_score_gemma":0.048634075,"threshold_uncertainty_score":0.96398497},"labels":[],"label_agreement":null},{"id":"W2552118461","doi":"10.1182/blood.v118.21.3334.3334","title":"Rofecoxib Does Not Appear to Increase the Risk of Venous Thromboembolism: A Systematic Review of the Literature,","year":2011,"lang":"en","type":"review","venue":"Blood","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; St. Joseph's Hospital; McMaster University","funders":"","keywords":"Rofecoxib; Medicine; Placebo; Blinding; Randomization; Confidence interval; Internal medicine; Relative risk; Clinical trial; Surgery; Alternative medicine","score_opus":0.013205948213314014,"score_gpt":0.2691224007621944,"score_spread":0.2559164525488804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552118461","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006604655,0.9903795,4.591849e-7,0.000021994194,0.00040968604,0.0078060916,0.00022983803,0.000022708384,0.00046923547],"genre_scores_gemma":[0.00023727196,0.9982201,0.0000342004,0.0003595339,0.00031669487,0.00049988256,0.000020447253,0.000070718605,0.00024117925],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9960442,0.0014544914,0.0013863633,0.00032242454,0.000502278,0.00029023664],"domain_scores_gemma":[0.99552613,0.0005240629,0.0015822945,0.0019704916,0.00023502823,0.00016200118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020392023,0.0004927616,0.0050521246,0.0001243199,0.00008012982,0.000011546535,0.0006694322,0.0002851947,0.000047978177],"category_scores_gemma":[0.0024854944,0.00017408525,0.0013287938,0.0006014939,0.000102325845,0.00002822478,0.00019346793,0.00066144875,0.00006947661],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009856267,0.000324463,0.000007318297,0.9937696,0.0010464913,0.000022267885,0.000480285,5.916592e-9,0.000002565835,0.00012077419,0.00021791819,0.0039984477],"study_design_scores_gemma":[0.00034820405,0.00021588507,0.000029345128,0.92670137,0.033934493,0.00018615498,0.000012945904,8.7896055e-8,0.000097781594,0.000010989632,0.03827712,0.00018562765],"about_ca_topic_score_codex":0.00005592215,"about_ca_topic_score_gemma":0.0000044323497,"teacher_disagreement_score":0.06706824,"about_ca_system_score_codex":0.000027223616,"about_ca_system_score_gemma":0.00037974582,"threshold_uncertainty_score":0.709899},"labels":[],"label_agreement":null},{"id":"W2552123441","doi":"10.1182/blood-2016-09-738815","title":"Is the lymphoma better? Not easy to determine","year":2016,"lang":"en","type":"letter","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Lymphoma; Intensive care medicine; Immunology","score_opus":0.02447466684640398,"score_gpt":0.25474237090522805,"score_spread":0.23026770405882407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552123441","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07042735,0.00036212575,0.0000027611136,0.92285144,0.0003599206,0.0008030755,0.00023537544,0.00007777849,0.004880179],"genre_scores_gemma":[0.019168586,0.00007870239,0.00021424826,0.9576423,0.009116982,0.00039755294,0.00008424368,0.00008953256,0.013207851],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979669,0.000045984,0.00031911352,0.0005781552,0.0005456123,0.00054424687],"domain_scores_gemma":[0.9982247,0.0002501076,0.00011690385,0.0011860499,0.00007688965,0.00014538999],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007830402,0.00043751777,0.00056732993,0.00011411581,0.00009727775,0.000051403204,0.000290857,0.00043622954,0.0004714022],"category_scores_gemma":[0.000041147672,0.00021661505,0.00036807283,0.00010325858,0.00005855808,0.00002724776,0.00012972046,0.00018014679,0.002300136],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024443414,0.00028187127,0.0048602796,0.000070885355,0.0005917331,0.0029931061,0.00007150028,2.3493494e-9,0.00014430314,0.0000034000057,0.9383752,0.052583274],"study_design_scores_gemma":[0.0055001234,0.00036429465,0.018645477,0.0004472404,0.001288573,0.00051558466,0.0000018481146,2.6845444e-7,0.014370398,0.000022620825,0.95857096,0.00027261712],"about_ca_topic_score_codex":0.00007051058,"about_ca_topic_score_gemma":0.0000040353443,"teacher_disagreement_score":0.052310657,"about_ca_system_score_codex":0.00013721996,"about_ca_system_score_gemma":0.00013943587,"threshold_uncertainty_score":0.9984767},"labels":[],"label_agreement":null},{"id":"W2552124982","doi":"10.1182/blood.v114.22.2631.2631","title":"Analysis of the Serum Free Light Chain Ratio and Its Prognostic Value in a Cohort of Patients with Chronic Lymphocytic Leukemia.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Royal Victoria Hospital","funders":"","keywords":"Medicine; Chronic lymphocytic leukemia; Internal medicine; Gastroenterology; Fludarabine; Proportional hazards model; Survival analysis; Population; Cohort; Log-rank test; Oncology; Leukemia; Chemotherapy; Cyclophosphamide","score_opus":0.005933703671480233,"score_gpt":0.22709867192789804,"score_spread":0.2211649682564178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552124982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99726176,0.0010111963,0.000005344684,0.000104097446,0.0000149032685,0.0012337322,0.000026646841,0.000014622174,0.00032769935],"genre_scores_gemma":[0.99962795,0.000062127976,0.000036628302,0.000053660664,0.00002595794,0.00002721265,0.000016715461,0.000015784752,0.00013393597],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980566,0.000092074966,0.0004417616,0.00032580437,0.0007481842,0.00033559068],"domain_scores_gemma":[0.99870235,0.00013255305,0.0001784286,0.00069096894,0.0001925957,0.000103102946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000311584,0.00017471355,0.0006156179,0.0003396071,0.00003533365,0.00000852285,0.000247245,0.00010451995,0.000024948307],"category_scores_gemma":[0.00043466096,0.000111179106,0.00010231783,0.0016530439,0.00010022474,0.00006132803,0.0001018255,0.00014519357,0.0000013618586],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00039500836,0.00088741095,0.98976594,0.00054098055,0.0020347275,0.000057932197,0.00076239975,0.0028472508,0.001778097,0.0003007452,0.000031138276,0.0005983729],"study_design_scores_gemma":[0.037495676,0.0007409666,0.8889915,0.00036996117,0.0026547266,0.000014277857,0.000018172223,0.055104863,0.014459588,0.000023629553,0.000008039474,0.00011862675],"about_ca_topic_score_codex":0.00042623,"about_ca_topic_score_gemma":0.00031445984,"teacher_disagreement_score":0.10077447,"about_ca_system_score_codex":0.008602413,"about_ca_system_score_gemma":0.011030486,"threshold_uncertainty_score":0.9952034},"labels":[],"label_agreement":null},{"id":"W2552129324","doi":"10.1182/blood.v106.11.3636.3636","title":"Antagonistic Roles of ERK1/2 and p38 MAP Kinases in Hemoglobin Synthesis.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"p38 mitogen-activated protein kinases; MAPK/ERK pathway; Heme; Kinase; Cell biology; Biology; Transferrin receptor; Hemoglobin; Protein kinase A; Globin; Signal transduction; Mitogen-activated protein kinase; Molecular biology; Biochemistry; Chemistry; Transferrin; Enzyme","score_opus":0.011091534175815274,"score_gpt":0.2405113637130342,"score_spread":0.22941982953721893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552129324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961322,0.0013164209,0.0000056740323,0.00062078866,0.000041232383,0.0000912661,0.000008889154,0.0000202437,0.0017633063],"genre_scores_gemma":[0.9984236,0.00018818221,0.00064647355,0.00032976543,0.00012771778,0.000008150678,0.000005732111,0.000007645155,0.00026277304],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995037,0.000027545788,0.00015859946,0.00013527971,0.00006244923,0.00011245128],"domain_scores_gemma":[0.9996681,0.00009997045,0.000038520335,0.00012562198,0.000019743067,0.000048042515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000062973464,0.00007386993,0.00022739299,0.00007180702,0.000015691938,0.0000023932773,0.000025875932,0.000059953465,0.00016401429],"category_scores_gemma":[0.00010336362,0.000062802035,0.000029069404,0.0000619324,0.000064200016,0.000021629497,0.000017192235,0.00006973522,0.000030640993],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010338855,0.004330107,0.20389956,0.0010594199,0.00019056952,0.0002754816,0.00073245243,0.000028379898,0.73874575,0.0016163812,0.0026485855,0.045439396],"study_design_scores_gemma":[0.00950405,0.0011873188,0.37713435,0.0006727144,0.0005430676,0.00051297736,0.0005080925,0.000274203,0.577612,0.00033829684,0.031325847,0.00038710184],"about_ca_topic_score_codex":0.000018675597,"about_ca_topic_score_gemma":0.000063473824,"teacher_disagreement_score":0.17323478,"about_ca_system_score_codex":0.000007808332,"about_ca_system_score_gemma":0.000029004337,"threshold_uncertainty_score":0.25609925},"labels":[],"label_agreement":null},{"id":"W2552135403","doi":"10.1182/blood.v124.21.2717.2717","title":"Screening for Neurocognitive Dysfunction in an Adult Population with Sickle Cell Disease","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Montreal Cognitive Assessment; Medicine; Population; Cognition; Cronbach's alpha; Pediatrics; Physical therapy; Clinical psychology; Psychiatry; Cognitive impairment; Psychometrics","score_opus":0.00785660405762517,"score_gpt":0.22433959707380022,"score_spread":0.21648299301617505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552135403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99473953,0.00003240515,0.0037387724,0.00020500914,0.000031233,0.00050292205,0.000005203741,0.0000469319,0.0006979714],"genre_scores_gemma":[0.9983092,0.000005643319,0.0008663564,0.00042028102,0.00007781977,0.00003898292,0.0001704969,0.000020258696,0.00009096996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994501,0.000025725387,0.000107258435,0.00018020974,0.00009537593,0.00014135275],"domain_scores_gemma":[0.99964887,0.00002356792,0.000039283652,0.00010031844,0.000070832415,0.00011715538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000056246074,0.00008157271,0.000105609906,0.00006339743,0.000051614195,0.000009587158,0.000019075127,0.000048923972,0.000006847288],"category_scores_gemma":[0.00006242903,0.00006365258,0.000028881057,0.000100537516,0.000013640011,0.00008332157,0.000005029938,0.00008830275,0.0000033051967],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025822094,0.0020111583,0.963841,0.0003216354,0.000035024157,0.00003599691,0.00041727372,0.00060933654,0.0021420952,0.00024269072,0.00005620542,0.027705336],"study_design_scores_gemma":[0.025452942,0.0026951234,0.9476764,0.00035160276,0.00065786263,0.000012438183,0.000733985,0.020031117,0.001563796,0.00025122208,0.0002904605,0.000283033],"about_ca_topic_score_codex":0.00006442786,"about_ca_topic_score_gemma":0.000051580675,"teacher_disagreement_score":0.027422303,"about_ca_system_score_codex":0.00000581714,"about_ca_system_score_gemma":0.000016214719,"threshold_uncertainty_score":0.25956768},"labels":[],"label_agreement":null},{"id":"W2552169191","doi":"10.1182/blood.v114.22.4198.4198","title":"Molecular Basis for A Thrombophilic Patient's Combined Deficiencies in Proteins C and S.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Exon; Protein S; Molecular biology; Biology; Gene; Genetics; Thrombophilia; Protein C; Biochemistry","score_opus":0.01690773346924985,"score_gpt":0.2503070362092595,"score_spread":0.23339930274000964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552169191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961097,0.00026577237,0.00034063286,0.0013053422,0.00002128212,0.001015834,0.000003927499,0.000049224833,0.0008882676],"genre_scores_gemma":[0.99542856,0.000011047349,0.003379554,0.0010776721,0.00001110909,0.0000625214,0.0000069903513,0.000010179054,0.000012364823],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992849,0.000016578602,0.00017340232,0.00020193483,0.00014114787,0.00018202192],"domain_scores_gemma":[0.99966145,0.000019646184,0.000040476625,0.00016047418,0.000045805245,0.000072162875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008561687,0.00010379971,0.00022310721,0.00010360814,0.000042829342,0.000014986584,0.000036023375,0.00006496987,0.000011244213],"category_scores_gemma":[0.000085564476,0.00009340408,0.000049277758,0.00017810044,0.000023464512,0.000042010124,0.000013270276,0.00006038552,0.0000021775372],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015023208,0.0043779393,0.0047758087,0.00012976244,0.00007908683,0.000043058328,0.0014291026,0.0000065391787,0.9324713,0.04640038,0.000035309648,0.010101484],"study_design_scores_gemma":[0.013842233,0.0068030343,0.18182264,0.0002732281,0.00034728754,0.00006261346,0.0004292226,0.0005518953,0.7786874,0.016603462,0.00021200949,0.00036493974],"about_ca_topic_score_codex":0.0000063833104,"about_ca_topic_score_gemma":0.0000045433003,"teacher_disagreement_score":0.17704684,"about_ca_system_score_codex":0.00001007685,"about_ca_system_score_gemma":0.00003425887,"threshold_uncertainty_score":0.3808908},"labels":[],"label_agreement":null},{"id":"W2552170145","doi":"10.1182/blood.v116.21.64.64","title":"Differential Gene and MicroRNA Expression In a HOXA9-MEIS1 Model of Leukemia","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Leukemia; Biology; Cancer research; Myeloid leukemia; Fusion gene; Phenotype; Hox gene; Immunology; Gene; Gene expression; Genetics","score_opus":0.014859684098693267,"score_gpt":0.2644805373627279,"score_spread":0.24962085326403466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552170145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99876183,0.000096746364,0.0002440013,0.00012154906,0.0000342932,0.0002405557,0.000014055854,0.000018367262,0.00046861338],"genre_scores_gemma":[0.9918725,0.00007703833,0.0075044394,0.000040540366,0.000099561235,0.000015155395,0.000013188303,0.000021830205,0.00035573068],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99907786,0.000019962681,0.00021159189,0.00023287574,0.0002199377,0.00023775628],"domain_scores_gemma":[0.99942046,0.000035800775,0.00004766546,0.00030876874,0.000051438776,0.00013588362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010179509,0.00011354306,0.0002717272,0.0001492034,0.000024053279,0.000008103015,0.00010656872,0.0001624336,0.00006541588],"category_scores_gemma":[0.00008257097,0.00009201468,0.000042149237,0.00009730245,0.000101969345,0.00004585518,0.00014214778,0.00048891513,0.0000051300017],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013817684,0.00022452089,0.013928131,0.000071828654,0.000017480039,0.00002229711,0.00023286216,0.0000040685404,0.9845211,0.000025349207,0.00015318673,0.0006610314],"study_design_scores_gemma":[0.0071595074,0.00009246047,0.03050537,0.00006696124,0.0000521205,0.000061422565,0.000023658102,0.007691407,0.9540962,0.000104876635,0.000050899394,0.000095112264],"about_ca_topic_score_codex":0.00006718399,"about_ca_topic_score_gemma":0.000027676804,"teacher_disagreement_score":0.030424863,"about_ca_system_score_codex":0.000037862625,"about_ca_system_score_gemma":0.00027006713,"threshold_uncertainty_score":0.37522495},"labels":[],"label_agreement":null},{"id":"W2552176673","doi":"10.1182/blood.v120.21.4055.4055","title":"A Phase 2, Multicenter, Nonrandomized, Open-Label Study of Dovitinib (TKI258) in Patients with Relapsed or Refractory Multiple Myeloma with or without t(4;14) Translocation","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Multiple myeloma; Refractory (planetary science); Internal medicine; Clinical endpoint; Chromosomal translocation; Phases of clinical research; Gastroenterology; Tyrosine-kinase inhibitor; Regimen; Oncology; Clinical trial; Cancer; Biology","score_opus":0.05020356072462877,"score_gpt":0.3489929799330997,"score_spread":0.2987894192084709,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552176673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909228,0.00009413438,0.000046468638,0.000022444921,0.000042971646,0.0086086085,0.00005843649,0.000040550924,0.00016359494],"genre_scores_gemma":[0.99478674,0.000018002009,0.0037612387,0.000040053845,0.000044086064,0.0008006404,0.00016341617,0.000074666386,0.00031116334],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99717844,0.00031069445,0.0006268389,0.00046598585,0.00080003217,0.0006179873],"domain_scores_gemma":[0.9980552,0.0003249041,0.00028286557,0.0006228005,0.00029930877,0.00041491992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004684207,0.00036251094,0.0009646305,0.00026070038,0.000095279276,0.00003245887,0.00023353192,0.00009977777,0.00010100459],"category_scores_gemma":[0.00035094286,0.00019717234,0.00003568859,0.0004711743,0.000092871735,0.00049198425,0.00006165343,0.0002854366,0.000015385653],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24260062,0.1837014,0.5647795,0.0001026324,0.0006184786,0.00009399978,0.0021628996,3.5439942e-7,0.000519357,2.7136693e-7,0.0000083949935,0.0054120813],"study_design_scores_gemma":[0.75531584,0.029560454,0.21003199,0.0004834172,0.00053562934,0.000016680742,0.0010636529,0.00019161435,0.0025185694,1.2110935e-7,0.000054725042,0.00022727878],"about_ca_topic_score_codex":0.00080836035,"about_ca_topic_score_gemma":0.0023310948,"teacher_disagreement_score":0.5127152,"about_ca_system_score_codex":0.00008121025,"about_ca_system_score_gemma":0.00024330935,"threshold_uncertainty_score":0.8040455},"labels":[],"label_agreement":null},{"id":"W2552184449","doi":"10.1182/blood.v110.11.5133.5133","title":"Effects of G-CSF vs. No G-CSF on Outcomes Post-Autologous Stem Cell Transplant - A Two-Centre Retrospective Study.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; University of Calgary; University of Alberta","funders":"","keywords":"Medicine; Neutropenia; Febrile neutropenia; Granulocyte colony-stimulating factor; Transplantation; Autologous stem-cell transplantation; Surgery; Absolute neutrophil count; Internal medicine; Stem cell; Chemotherapy","score_opus":0.005594860658371062,"score_gpt":0.24622344456660566,"score_spread":0.2406285839082346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552184449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883166,0.00011441624,0.000012468221,0.00017691765,0.0004250861,0.0012889182,0.000029805426,0.00011460753,0.009521181],"genre_scores_gemma":[0.9978506,0.000020934813,0.000032768392,0.00048246238,0.00012443414,0.000024613477,0.0000061854,0.000034353587,0.00142367],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852306,0.00006315689,0.00033412897,0.00036186562,0.00035828538,0.00035948606],"domain_scores_gemma":[0.9990096,0.00016991925,0.00012161088,0.0003444641,0.00019951527,0.00015489713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017342619,0.00023982399,0.0005860479,0.00015132112,0.0000834147,0.000010769575,0.00010282418,0.00008601505,0.00006769302],"category_scores_gemma":[0.000021521708,0.00018653898,0.0001957044,0.00021940695,0.000049371494,0.00004756518,0.000019733017,0.00030048474,0.00012459896],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012966525,0.009920624,0.93216676,0.0003500407,0.0005674488,0.0012648922,0.0029202197,0.0000018264022,0.050484143,0.00015379218,0.00019801891,0.000675562],"study_design_scores_gemma":[0.014073049,0.004775655,0.8130622,0.00013959513,0.0011557827,0.000050500235,0.0003390055,6.2854275e-7,0.16604647,0.000009689906,0.00016155538,0.0001858798],"about_ca_topic_score_codex":0.00018821964,"about_ca_topic_score_gemma":0.00017553073,"teacher_disagreement_score":0.119104594,"about_ca_system_score_codex":0.0000791507,"about_ca_system_score_gemma":0.00006949711,"threshold_uncertainty_score":0.7606839},"labels":[],"label_agreement":null},{"id":"W2552187469","doi":"10.1182/blood.v112.11.3782.3782","title":"Prognostic Significance of BCL6 Translocation in Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"BCL6; Chromosomal translocation; CHOP; Diffuse large B-cell lymphoma; Lymphoma; Internal medicine; Tissue microarray; Medicine; Fluorescence in situ hybridization; Rituximab; Pathology; Cancer research; Oncology; Gastroenterology; Biology; Immunohistochemistry; Immunology; Germinal center; B cell; Genetics; Chromosome; Antibody","score_opus":0.009164332024263876,"score_gpt":0.20633243642297772,"score_spread":0.19716810439871385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552187469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99806786,0.00035933265,0.0000074137292,0.000034131477,0.000010631527,0.0008072148,0.000026010486,0.000029227109,0.000658208],"genre_scores_gemma":[0.99922675,0.00018070769,0.00018325311,0.00004261773,0.0000127601,0.00017125864,0.000080348,0.000018746954,0.000083545456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909604,0.000027683693,0.0002364674,0.00022108175,0.00021945313,0.00019930744],"domain_scores_gemma":[0.9995014,0.000051792693,0.00008212865,0.00020073708,0.0000848808,0.00007908014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003151949,0.00014101445,0.0002690052,0.0000850305,0.00003237183,0.0000028746986,0.00004160963,0.00005523479,0.000009683903],"category_scores_gemma":[0.000019739991,0.000101857986,0.000046215016,0.0002560015,0.000041807085,0.000045581623,0.0000052356854,0.000026182313,0.000012131649],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019593361,0.07441799,0.9229632,0.00006574458,0.00005787507,0.00015023131,0.00045679006,5.739877e-7,0.0005713033,0.000007281294,0.000021188624,0.0010918763],"study_design_scores_gemma":[0.08560136,0.0010435019,0.8569071,0.0001513162,0.00019273344,0.000018307202,0.000024719968,0.000013868739,0.055899292,0.0000014811704,0.00005537669,0.00009091048],"about_ca_topic_score_codex":0.00018141003,"about_ca_topic_score_gemma":0.000049256687,"teacher_disagreement_score":0.085405424,"about_ca_system_score_codex":0.00005477649,"about_ca_system_score_gemma":0.000107765365,"threshold_uncertainty_score":0.4153648},"labels":[],"label_agreement":null},{"id":"W2552201383","doi":"10.1182/blood.v112.11.2365.2365","title":"Does Location Matter? a Population-Based Analysis of Survival after Blood and Marrow Transplantation in Rural Versus Urban Manitobans","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Medicine; Cancer registry; Rural area; Residence; Proportional hazards model; Demography; Population; Univariate analysis; Cancer; Pediatrics; Internal medicine; Multivariate analysis; Environmental health","score_opus":0.008956944190449326,"score_gpt":0.22764046704178445,"score_spread":0.21868352285133513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552201383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99933237,0.00016271196,0.00001231036,0.00013772942,0.000048892533,0.00018287185,0.0000410314,0.000011750145,0.000070315444],"genre_scores_gemma":[0.99927944,0.00006925781,0.0001769785,0.0000382365,0.000025639909,0.00005193311,0.00033336383,0.000007906392,0.000017231147],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99933904,0.00003283759,0.00021572823,0.00014713663,0.00016368904,0.00010155908],"domain_scores_gemma":[0.9996546,0.00007200044,0.000057124234,0.00013247064,0.000039388204,0.000044395714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000040538984,0.00009956557,0.00025369736,0.00024346619,0.000024729543,0.000005536455,0.00002017295,0.00004796664,0.000059190126],"category_scores_gemma":[0.000006594173,0.000069096706,0.00007083615,0.0003506265,0.000023069257,0.00004678761,0.0000028493387,0.000025665171,0.0000028074717],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044583748,0.001007733,0.9970322,0.00008002431,0.00058707834,0.000094571595,0.00038047327,0.000033868186,0.00023441741,0.0000084690255,0.000001774545,0.000093521754],"study_design_scores_gemma":[0.009896252,0.00014111778,0.98175144,0.00006474075,0.004828036,0.0000072625203,0.00006870956,0.00012592276,0.0030376927,0.0000025817114,0.0000011825206,0.000075052514],"about_ca_topic_score_codex":0.0021951352,"about_ca_topic_score_gemma":0.0029820162,"teacher_disagreement_score":0.015280782,"about_ca_system_score_codex":0.000028461372,"about_ca_system_score_gemma":0.000028333534,"threshold_uncertainty_score":0.33184025},"labels":[],"label_agreement":null},{"id":"W2552221915","doi":"10.1182/blood.v126.23.37.37","title":"Effect of Romiplostim on Health-Related Quality of Life in Children with Immune Thrombocytopenia and Associated Burden in Their Parents: Results from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Romiplostim; Medicine; Placebo; Randomized controlled trial; Immune thrombocytopenia; Quality of life (healthcare); Pediatrics; Thrombopoietin; Thrombopoietin receptor; Internal medicine; Platelet","score_opus":0.03251777106106803,"score_gpt":0.3256980423312073,"score_spread":0.2931802712701393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552221915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98861784,0.0014952621,2.9120474e-7,0.00015485485,0.000021327585,0.009338607,0.00021593194,0.000023465343,0.00013243688],"genre_scores_gemma":[0.9991485,0.000068777255,0.000010515734,0.000015506412,0.000008449019,0.00021355518,0.00049951463,0.000023989816,0.000011189044],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99581736,0.0016083077,0.0015329898,0.00039765608,0.00038185247,0.00026184542],"domain_scores_gemma":[0.99729806,0.0012001464,0.00090488413,0.00035465747,0.000076634235,0.00016561613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003739969,0.00030916376,0.0039982838,0.00020929324,0.000025544323,0.00001001119,0.00009844913,0.00013476585,0.0000049391306],"category_scores_gemma":[0.0014504509,0.00018708267,0.000118879885,0.00031726377,0.00008286609,0.00006090594,0.000040011728,0.00025548233,0.000001937617],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.80897146,0.011700036,0.17195773,0.00001945326,0.0038734216,0.00003704073,0.0031441639,0.000030470937,0.00006916958,9.94141e-7,0.0000029116518,0.0001931737],"study_design_scores_gemma":[0.92506576,0.0088056,0.063692756,0.00042326754,0.000752213,0.000004047649,0.0004705606,0.00009283167,0.0005382803,0.000024464834,4.9793723e-8,0.00013018279],"about_ca_topic_score_codex":0.030380871,"about_ca_topic_score_gemma":0.0018003819,"teacher_disagreement_score":0.11609431,"about_ca_system_score_codex":0.00006435276,"about_ca_system_score_gemma":0.00020074514,"threshold_uncertainty_score":0.9760759},"labels":[],"label_agreement":null},{"id":"W2552245275","doi":"10.1182/blood.v126.23.3848.3848","title":"Prospective Next-Generation Sequencing Molecular Profiling of Myeloid Malignancies: Assessment of Information Benefit and Impact on Patient Care","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"CEBPA; Myeloid leukemia; Medicine; DNA sequencing; Sanger sequencing; Myeloid; Oncology; Computational biology; Bioinformatics; Internal medicine; Gene; Biology; Genetics; Mutation","score_opus":0.031194010548905655,"score_gpt":0.286453979460118,"score_spread":0.2552599689112124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552245275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973341,0.00037187987,0.00012263861,0.000026491285,0.000029795146,0.00093899766,0.00004790597,0.000011945719,0.0011162339],"genre_scores_gemma":[0.99403894,0.000032082207,0.005618797,0.000044352775,0.000021892167,0.00010516647,0.00012898125,0.0000083267605,0.0000014720466],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990819,0.00002232007,0.0003097245,0.00013477157,0.0003378089,0.00011347767],"domain_scores_gemma":[0.9989884,0.000019837415,0.00020104524,0.00014618266,0.00055194495,0.00009260526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000089335954,0.0001383855,0.00027031483,0.000101860845,0.000029484485,0.000016728056,0.000020986565,0.000051791743,0.0000045300862],"category_scores_gemma":[0.000061768296,0.000099890065,0.000056356967,0.00010619772,0.000022414733,0.00016984418,0.000019846633,0.00006127194,8.758898e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017362666,0.00084546395,0.77671313,0.00044886154,0.00048539063,0.000021979307,0.0117595205,0.0038289381,0.1943024,0.004831649,0.000012472634,0.006576567],"study_design_scores_gemma":[0.00311268,0.0053275838,0.0746652,0.00024637958,0.0002032651,0.000017277289,0.0025135304,0.0012012135,0.9125624,0.0000499932,0.0000037027662,0.00009682108],"about_ca_topic_score_codex":0.00008583186,"about_ca_topic_score_gemma":0.000006416478,"teacher_disagreement_score":0.71825993,"about_ca_system_score_codex":0.00024195992,"about_ca_system_score_gemma":0.00030037423,"threshold_uncertainty_score":0.40733987},"labels":[],"label_agreement":null},{"id":"W2552255104","doi":"10.1182/blood.v108.11.3557.3557","title":"Lenalidomide Overcomes Poor Prognosis Conferred by Deletion of Chromosome 13 and t(4;14) in Multiple Myeloma: MM016 Trial.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Calgary","funders":"","keywords":"Lenalidomide; Multiple myeloma; Medicine; Dexamethasone; Internal medicine; Thalidomide; Gastroenterology; Fluorescence in situ hybridization; Refractory (planetary science); Progressive disease; Oncology; Surgery; Chemotherapy; Chromosome; Biology","score_opus":0.020678194487749005,"score_gpt":0.26935233987854346,"score_spread":0.24867414539079447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552255104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99595225,0.0013825686,0.000007957334,0.000399073,0.0000327868,0.0014619168,0.0000914386,0.00003510084,0.0006369268],"genre_scores_gemma":[0.9984874,0.00015585113,0.0003961059,0.0000335179,0.00008548436,0.00019216155,0.0002056061,0.000022835424,0.0004210032],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853,0.0000838114,0.00040097328,0.00030019315,0.00034886086,0.00033619508],"domain_scores_gemma":[0.99935734,0.00017506252,0.00010290393,0.00016650929,0.00008576178,0.00011243348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018406195,0.00017550049,0.00045839004,0.00017056573,0.00004252083,0.00001898822,0.000058767,0.00010947098,0.000058168636],"category_scores_gemma":[0.00024406238,0.00014278972,0.00008393027,0.00018472111,0.000103915474,0.00009175573,0.000038466656,0.00011844297,0.000011458687],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012160764,0.007182588,0.79583126,0.00028270084,0.0003142934,0.00021157511,0.00006917123,8.8683896e-7,0.17693493,0.000045158748,0.001979665,0.0049870284],"study_design_scores_gemma":[0.3106772,0.0015202035,0.42738995,0.0002285095,0.00021108428,0.000057928348,0.00004463297,0.00023901058,0.2582921,0.00008120925,0.0010466713,0.00021149732],"about_ca_topic_score_codex":0.0018140186,"about_ca_topic_score_gemma":0.00032753643,"teacher_disagreement_score":0.3684413,"about_ca_system_score_codex":0.000043063155,"about_ca_system_score_gemma":0.00008120322,"threshold_uncertainty_score":0.58227956},"labels":[],"label_agreement":null},{"id":"W2552262126","doi":"10.1182/blood.v118.21.4121.4121","title":"Absolute Lymphocyte Count As Predictor of Overall Survival for Patients with Multiple Myeloma Treated with Single Autologous Stem Cell Transplant: Experience of a Single Centre,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Multiple myeloma; Stem cell; Medicine; Oncology; Internal medicine; Cancer research; Biology","score_opus":0.0228822897816177,"score_gpt":0.2250548619356589,"score_spread":0.20217257215404122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552262126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99621487,0.00011898194,0.000089634486,0.0000034762736,0.00003066603,0.001799637,0.00060106453,0.00005736095,0.0010842961],"genre_scores_gemma":[0.9977493,0.000014000701,0.0015675251,0.000007716385,0.000015305577,0.00011142648,0.00018126027,0.000048933194,0.0003045309],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981282,0.000045803143,0.000373322,0.0003940763,0.0005623561,0.0004962528],"domain_scores_gemma":[0.9986401,0.00012916492,0.00023599627,0.00037722898,0.00035934136,0.00025817472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005263174,0.0002792039,0.00055596186,0.0001061663,0.000058730664,0.000007734038,0.00013950693,0.00009951085,0.000049500868],"category_scores_gemma":[0.000018953944,0.00018934465,0.000095027775,0.00015047994,0.00018755563,0.000102300655,0.00002040302,0.000058378122,0.000003880829],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018698376,0.01725342,0.9390735,0.0005149067,0.0006999055,0.00019018345,0.005801786,0.0000024691587,0.016624724,0.000009123177,0.0000063770476,0.0011252428],"study_design_scores_gemma":[0.056800734,0.013204301,0.4976304,0.0004297623,0.0005208772,0.000027428365,0.00031483336,0.00014308389,0.430625,0.0000024625874,0.00006809558,0.00023304508],"about_ca_topic_score_codex":0.0006329134,"about_ca_topic_score_gemma":0.00016238797,"teacher_disagreement_score":0.44144312,"about_ca_system_score_codex":0.000084582534,"about_ca_system_score_gemma":0.00017372194,"threshold_uncertainty_score":0.77212507},"labels":[],"label_agreement":null},{"id":"W2552283892","doi":"10.1182/blood.v110.11.102.102","title":"IVIg-Primed Splenocytes Ameliorate Murine ITP in an MHC Class II-Unrestricted Manner.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Canadian Blood Services; St. Michael's Hospital","funders":"","keywords":"Splenocyte; Immunology; MHC class II; Major histocompatibility complex; MHC class I; Biology; Immune system; Medicine","score_opus":0.016864934237737016,"score_gpt":0.28222582646138344,"score_spread":0.26536089222364645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552283892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937575,0.0006964458,0.0000071009513,0.00026291233,0.00007615446,0.00038870375,0.00001307114,0.00011831957,0.0046798093],"genre_scores_gemma":[0.9977286,0.00013701983,0.00065432145,0.00027196857,0.00010143235,0.000014555765,0.00016660003,0.000034218247,0.00089131395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986116,0.000025945223,0.00031499314,0.00033673976,0.00022734367,0.00048335738],"domain_scores_gemma":[0.99925387,0.00004360982,0.00007315768,0.00034598896,0.00005984825,0.00022354737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015823191,0.00021449137,0.0003785818,0.00026326047,0.00007644426,0.000016223827,0.000101330486,0.00013514882,0.000102074984],"category_scores_gemma":[0.000052408683,0.00018357362,0.00006132653,0.00051123864,0.000043130367,0.00011036174,0.000051367344,0.00019890172,0.000076730124],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016188613,0.021800624,0.8712293,0.00014247098,0.00062004215,0.025937788,0.0009859323,0.0000136950985,0.05273673,0.00043877846,0.0010172165,0.023458546],"study_design_scores_gemma":[0.029321266,0.0021970556,0.8885044,0.00015099466,0.00041953378,0.00036191972,0.00028603544,0.0001246071,0.0729667,0.00034344883,0.0048760097,0.00044801773],"about_ca_topic_score_codex":0.00023835164,"about_ca_topic_score_gemma":0.00052706595,"teacher_disagreement_score":0.027702404,"about_ca_system_score_codex":0.0000429783,"about_ca_system_score_gemma":0.000061067796,"threshold_uncertainty_score":0.7485915},"labels":[],"label_agreement":null},{"id":"W2552319985","doi":"10.1182/blood.v120.21.5195.5195","title":"Analysis of Changes in Endothelial Cell Protein Expression and Phosphorylation Induced by Cleaved High Molecular Weight Kininogen","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"High-molecular-weight kininogen; Kininogen; Kallikrein; Angiogenesis; Molecular biology; Signal transduction; Endothelial stem cell; Cell biology; Chemistry; Phosphorylation; Biology; Biochemistry; In vitro; Cancer research; Enzyme","score_opus":0.009912423817958076,"score_gpt":0.22824919935707338,"score_spread":0.21833677553911532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552319985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99655694,0.002606604,0.000039384995,0.00010349714,0.000037657574,0.00038627538,0.00002514035,0.00002390268,0.00022059972],"genre_scores_gemma":[0.9991015,0.000059126785,0.00040835937,0.000056676778,0.000082139995,0.00003540262,0.00010256004,0.000019925688,0.00013431434],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990232,0.000053850075,0.00025690152,0.00020580924,0.00023224085,0.00022798553],"domain_scores_gemma":[0.99945533,0.00003105149,0.00015357058,0.00020276048,0.0000413444,0.00011596589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017680063,0.00014161777,0.00035825442,0.00025663077,0.000029729481,0.0000070070755,0.000047086407,0.00012955512,0.000107618005],"category_scores_gemma":[0.000031211937,0.00012673976,0.00007214197,0.00041274473,0.000027780998,0.00008166364,0.00003172854,0.00007735112,0.000002428156],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007122401,0.00044398347,0.17416601,0.00003654333,0.00011824828,0.0000023885266,0.0006652394,0.0000010699569,0.82345724,0.000045749064,0.000010967713,0.0009813285],"study_design_scores_gemma":[0.0023125825,0.00011020492,0.1868776,0.000056557896,0.0006446197,0.0000010207735,0.00005084381,0.00006816742,0.80963886,0.000018574963,0.00011598454,0.00010499205],"about_ca_topic_score_codex":0.00024176476,"about_ca_topic_score_gemma":0.0000225167,"teacher_disagreement_score":0.013818398,"about_ca_system_score_codex":0.0000144382,"about_ca_system_score_gemma":0.000020774814,"threshold_uncertainty_score":0.5168297},"labels":[],"label_agreement":null},{"id":"W2552358023","doi":"10.1182/blood.v116.21.3796.3796","title":"Safety of Outpatient Treatment In Acute Pulmonary Embolism.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Pulmonary embolism; Low molecular weight heparin; Retrospective cohort study; Cohort; Outpatient clinic; Surgery; Heparin; Emergency medicine; Internal medicine","score_opus":0.009329696604517922,"score_gpt":0.25297882008899686,"score_spread":0.24364912348447892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552358023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819017,0.00012426036,0.0000040447035,0.0005713168,0.00020919724,0.00062875124,0.000016215712,0.000025665038,0.016518848],"genre_scores_gemma":[0.9981497,0.0004905368,0.0005624901,0.0001497504,0.00008169144,0.0000710204,0.000029198716,0.000016561382,0.00044905834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913037,0.000014985927,0.000286466,0.00020019562,0.00016426569,0.00020373496],"domain_scores_gemma":[0.99943805,0.000022293503,0.000068697926,0.00035153682,0.00003267124,0.00008674802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009241508,0.0001274779,0.00041809978,0.00011783312,0.00002312632,0.0000040195973,0.00006717701,0.00007473387,0.00017852677],"category_scores_gemma":[0.000015070244,0.00010032361,0.00009732425,0.00012145348,0.000037021502,0.000032433087,0.00004482616,0.00010877538,0.000027389953],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074268284,0.11135207,0.575809,0.000480331,0.0027330518,0.0018829989,0.006388531,0.000024827348,0.13905908,0.016893514,0.00120695,0.14342694],"study_design_scores_gemma":[0.0051923776,0.001241273,0.94627637,0.00008144182,0.0008679186,0.00004182232,0.00015238648,0.000031475003,0.0283571,0.00012344767,0.017478002,0.00015640228],"about_ca_topic_score_codex":0.0002824441,"about_ca_topic_score_gemma":0.00014667898,"teacher_disagreement_score":0.37046733,"about_ca_system_score_codex":0.000026149264,"about_ca_system_score_gemma":0.000049561386,"threshold_uncertainty_score":0.4091078},"labels":[],"label_agreement":null},{"id":"W2552363071","doi":"10.1182/blood.v104.11.3481.3481","title":"The Effect of a Toll Receptor-7 Agonist (S28690) on the Immunogenicity of Chronic Lymphocytic Leukemia Cells.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"CD80; Chronic lymphocytic leukemia; Biology; TLR7; Immunogenicity; Molecular biology; T cell; CD40; Immunology; Toll-like receptor; Leukemia; Immune system; Cytotoxic T cell; Innate immune system; In vitro","score_opus":0.008072363663069935,"score_gpt":0.24998551979396136,"score_spread":0.24191315613089143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552363071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918244,0.0032396931,0.000006441541,0.00023219897,0.00019889371,0.0011589478,0.0000174455,0.00004392888,0.003278072],"genre_scores_gemma":[0.99828345,0.00064522744,0.00003387616,0.000055890927,0.00020089923,0.00007939278,0.000008615169,0.00004768746,0.0006449799],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99734074,0.00023382028,0.0005696096,0.00034575316,0.00091827335,0.0005918028],"domain_scores_gemma":[0.99660516,0.0014822566,0.00024400011,0.0014175881,0.00012543004,0.00012558339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011898839,0.00028582886,0.0005632063,0.000075058546,0.0002466226,0.000026748208,0.00063145376,0.00016850868,0.00009363836],"category_scores_gemma":[0.0005476368,0.00014725338,0.00037187984,0.000441682,0.0007528193,0.000033076733,0.00018519725,0.00037607536,0.00016633896],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.008789039,0.0012561217,0.0002947985,0.0031478566,0.0032928518,0.00028918622,0.0014630213,0.0032846194,0.9579208,0.0041960413,0.0038847183,0.012180955],"study_design_scores_gemma":[0.046584368,0.0032183263,0.00013543548,0.0004872905,0.00032323503,0.00013514541,0.00005384397,0.0005622931,0.9464676,0.00007037955,0.00182617,0.00013594232],"about_ca_topic_score_codex":0.0023762814,"about_ca_topic_score_gemma":0.00006949601,"teacher_disagreement_score":0.037795328,"about_ca_system_score_codex":0.033041887,"about_ca_system_score_gemma":0.022059154,"threshold_uncertainty_score":0.98348486},"labels":[],"label_agreement":null},{"id":"W2552369836","doi":"10.1182/blood.v106.11.2690.2690","title":"Iron Chelation Efficiency of Deferasirox (Exjade®, ICL670) in Patients with Transfusional Hemosiderosis.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital","funders":"","keywords":"Deferasirox; Excretion; Hemosiderosis; Deferoxamine; Internal medicine; Deferiprone; Thalassemia; Chemistry; Chelation; Chelation therapy; Medicine; Endocrinology; Inorganic chemistry","score_opus":0.0036373773412397953,"score_gpt":0.19160707954834907,"score_spread":0.1879697022071093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552369836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965706,0.00028130086,0.00004020118,0.0004948828,0.000021745564,0.00033018633,0.000004859834,0.000021445137,0.002234768],"genre_scores_gemma":[0.99920183,0.000043655582,0.0004967664,0.000095371484,0.00002109956,0.000005698914,0.000029626319,0.000014211363,0.0000917133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990913,0.000016698337,0.00025666994,0.00017323082,0.0002844191,0.00017766158],"domain_scores_gemma":[0.99968314,0.000018065077,0.000053186024,0.0001289388,0.00005213775,0.00006450625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000071876035,0.00010708302,0.00019241322,0.000097925644,0.00003243832,0.000003162542,0.00004009074,0.00011498083,0.00013211375],"category_scores_gemma":[0.000019060164,0.00007936893,0.000047123838,0.0002365602,0.000050598606,0.00005698204,0.000007730525,0.00015760343,0.000010729587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000358685,0.0053627887,0.98327583,0.00009669257,0.00003574224,0.0000031794505,0.0010152924,0.00036206754,0.0047754184,0.000089468376,0.000041958443,0.0045828545],"study_design_scores_gemma":[0.018541252,0.0008756642,0.968069,0.00022363008,0.00016621027,0.000008561473,0.000116342286,0.00016010588,0.011391376,0.000012853458,0.00028044253,0.00015453254],"about_ca_topic_score_codex":0.000028032187,"about_ca_topic_score_gemma":0.000024151792,"teacher_disagreement_score":0.018182566,"about_ca_system_score_codex":0.000022086253,"about_ca_system_score_gemma":0.00005373024,"threshold_uncertainty_score":0.32365713},"labels":[],"label_agreement":null},{"id":"W2552377170","doi":"10.1182/blood.v118.21.868.868","title":"KIT Induced Myeloproliferative Disease Is Dependent on PI3Kinase and SHP2 Phosphatase: Identification of SHP2 As a Druggable Target for Treating MPD and AML","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Cancer research; Stromal cell; Biology; Molecular biology; Chemistry","score_opus":0.014627917368862783,"score_gpt":0.22837613451046399,"score_spread":0.2137482171416012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552377170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99508953,0.0031751627,0.000054192875,0.000079598016,0.00007994068,0.00046929484,0.00050071377,0.000017672664,0.0005338703],"genre_scores_gemma":[0.9975197,0.00008497799,0.00015966958,0.00009203872,0.000015504585,0.000089584326,0.00020837359,0.000013367422,0.001816836],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991688,0.000045126948,0.00025664736,0.00031669266,0.0000310283,0.00018169633],"domain_scores_gemma":[0.99948174,0.000056957128,0.00016513602,0.000194096,0.00005519912,0.000046866156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014847385,0.00014194752,0.00020660313,0.00006491526,0.00016741359,0.000014047087,0.00007162618,0.00009466884,0.00030605428],"category_scores_gemma":[0.00006564845,0.00012732341,0.000035896708,0.00004553292,0.00008835156,0.00007011814,0.00004159122,0.0000814467,0.0000220162],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029060207,0.003485924,0.017895522,0.00054579147,0.0006971284,0.000035209545,0.012158164,6.960996e-7,0.9315691,0.018274669,0.0012199965,0.011211785],"study_design_scores_gemma":[0.0035170445,0.0006151874,0.008971658,0.00004171665,0.00020917025,0.000010730251,0.0003075167,0.000010698616,0.9836123,0.0010883132,0.00144621,0.00016946545],"about_ca_topic_score_codex":0.00017249683,"about_ca_topic_score_gemma":0.000017993274,"teacher_disagreement_score":0.052043196,"about_ca_system_score_codex":0.0000074719246,"about_ca_system_score_gemma":0.000038936614,"threshold_uncertainty_score":0.5192098},"labels":[],"label_agreement":null},{"id":"W2552384732","doi":"10.1182/blood.v114.22.2729.2729","title":"Sunitinib in Relapsed or Refractory Diffuse Large B Cell Lymphoma: Results of a Phase II Multi-Center Study of the NCIC Clinical Trials Group.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; Health Sciences Centre; University of Toronto; University Health Network; Fraser Health; Sunnybrook Health Science Centre","funders":"","keywords":"Sunitinib; Medicine; Diffuse large B-cell lymphoma; Internal medicine; Clinical endpoint; Phases of clinical research; Oncology; Chemotherapy regimen; Gastroenterology; Lymphoma; Clinical trial; Chemotherapy; Cancer","score_opus":0.10995409880555077,"score_gpt":0.4067856245798212,"score_spread":0.2968315257742704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552384732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971953,0.00029222856,4.7090424e-7,0.00018342202,0.00015149685,0.0017195634,0.00017923531,0.000020395843,0.0002578889],"genre_scores_gemma":[0.9990711,0.00015618622,0.00010854931,0.00024127781,0.00009140138,0.00004536696,0.00003300252,0.000017202907,0.00023591972],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99616957,0.00097020494,0.0018615648,0.00036821284,0.0003642116,0.0002662524],"domain_scores_gemma":[0.9973749,0.00091645506,0.00072367664,0.0007741607,0.00008571957,0.0001251225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022195743,0.0002140648,0.0010972245,0.000111843954,0.000057711924,0.000005405528,0.00017214676,0.00015495822,0.000017802819],"category_scores_gemma":[0.0019647272,0.000115524985,0.00033011957,0.00027055028,0.00005023357,0.000034942,0.000080771686,0.00012536519,0.0000039977726],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008972714,0.89925086,0.080424175,0.00003657659,0.00025466253,0.00032632484,0.0020964579,6.9957075e-8,0.0012687441,0.0000065782856,0.00043937605,0.006923475],"study_design_scores_gemma":[0.6396367,0.016665382,0.33663154,0.00021500325,0.0007725862,0.000011279813,0.000665929,0.00001346361,0.004563549,0.0000026273642,0.0007238646,0.00009805226],"about_ca_topic_score_codex":0.00012677533,"about_ca_topic_score_gemma":0.00024218208,"teacher_disagreement_score":0.88258547,"about_ca_system_score_codex":0.000052408108,"about_ca_system_score_gemma":0.00015193064,"threshold_uncertainty_score":0.47109723},"labels":[],"label_agreement":null},{"id":"W2552407180","doi":"10.1182/blood.v114.22.3366.3366","title":"First Line Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma (MCL).","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Fludarabine; Transplantation; Surgery; Salvage therapy; Chemotherapy; Mantle cell lymphoma; Autologous stem-cell transplantation; Hematopoietic stem cell transplantation; Internal medicine; Chemotherapy regimen; Stem cell; Cyclophosphamide; Busulfan; Oncology; Lymphoma","score_opus":0.014747762836063388,"score_gpt":0.25475151521269884,"score_spread":0.24000375237663546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552407180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890549,0.0017312662,0.00007310351,0.00029886945,0.000049101593,0.0004429075,0.000011025653,0.00006266292,0.00827614],"genre_scores_gemma":[0.9960199,0.0011655793,0.00029140615,0.0002623618,0.00011371737,0.000017286988,0.000048771002,0.000025970265,0.0020550208],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984658,0.000038723425,0.00031995052,0.0003396354,0.0003939281,0.00044197572],"domain_scores_gemma":[0.9993351,0.000080203,0.000050123093,0.00035470375,0.00004383794,0.00013601355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019204666,0.00017251838,0.00026908683,0.00017157603,0.00004656504,0.000017721966,0.0001482969,0.00015108417,0.00008530011],"category_scores_gemma":[0.0000065991812,0.00015781746,0.00008152358,0.0002983394,0.000031162992,0.00006076822,0.000016005868,0.00012078972,0.00022550924],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009084644,0.08783281,0.027417904,0.015425585,0.00051233365,0.046966925,0.026321923,0.0032062312,0.5411193,0.00050423964,0.0040686233,0.23753951],"study_design_scores_gemma":[0.18925722,0.0013455022,0.03498889,0.00039593165,0.00035526484,0.001107886,0.00026049535,0.0036052077,0.76504946,0.00011240787,0.0030326308,0.00048908376],"about_ca_topic_score_codex":0.000250748,"about_ca_topic_score_gemma":0.00011644103,"teacher_disagreement_score":0.23705043,"about_ca_system_score_codex":0.0014284323,"about_ca_system_score_gemma":0.00129953,"threshold_uncertainty_score":0.64356095},"labels":[],"label_agreement":null},{"id":"W2552450041","doi":"10.1182/blood.v118.21.3170.3170","title":"Genetic Linkage of the Dehydrated Hereditary Stomatocytosis Locus to Chromosome 16 in Two Kindreds and Refinement of the Candidate Gene Region to 16q24.2 - 16qter,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Locus (genetics); Genetics; Biology; Genetic linkage; Allele; Gene mapping; Genetic marker; Genotyping; Genotype; Molecular biology; Gene; Chromosome","score_opus":0.020022643379286983,"score_gpt":0.23902706846008154,"score_spread":0.21900442508079454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552450041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99799037,0.00032282955,0.000024605224,0.00043624936,0.0002320747,0.0005895762,0.000012826961,0.000013414489,0.0003780554],"genre_scores_gemma":[0.99833,0.000056194625,0.00035322792,0.00097341475,0.00008648497,0.000035175624,0.0000036461547,0.00001622058,0.00014562966],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990204,0.000102446786,0.00032504293,0.00022151085,0.00015363227,0.00017695558],"domain_scores_gemma":[0.9991996,0.00001927818,0.000110181776,0.0005115753,0.000066059125,0.00009325902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008810997,0.000128369,0.0002829037,0.0000954502,0.00003646405,0.0000018686278,0.00014011892,0.00006458182,0.00006642738],"category_scores_gemma":[0.000036669615,0.00007802162,0.000060458446,0.00037895763,0.000070600916,0.000015046884,0.00014247186,0.00011694599,0.0000059493095],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006516719,0.0010439911,0.14206503,0.00023110792,0.00019248114,0.00008802919,0.0042109475,0.000036922414,0.84805095,0.000030457773,0.0013279922,0.002070427],"study_design_scores_gemma":[0.0036861973,0.0009108871,0.48437697,0.0002970612,0.00019543886,0.0001695458,0.00012505296,0.000014440719,0.50955486,0.000052414824,0.0004970979,0.000120034056],"about_ca_topic_score_codex":0.0011637945,"about_ca_topic_score_gemma":0.0009189772,"teacher_disagreement_score":0.34231192,"about_ca_system_score_codex":0.000031014886,"about_ca_system_score_gemma":0.00007548046,"threshold_uncertainty_score":0.31816292},"labels":[],"label_agreement":null},{"id":"W2552510069","doi":"10.1182/blood.v124.21.92.92","title":"Apolipoprotein Α-IV Is a Novel Ligand of Platelet αIIbβ3 Integrin and an Endogenous Thrombosis Inhibitor: Measurement of Single-Molecular Interactions By Biomembrane Force Probe","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada; Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Integrin; Platelet; Hemostasis; Platelet activation; Platelet Glycoprotein GPIIb-IIIa Complex; Chemistry; Integrin alpha M; Chinese hamster ovary cell; Cell biology; Biology; Biochemistry; Molecular biology; Receptor; Immunology; Internal medicine; Medicine","score_opus":0.034118776008001554,"score_gpt":0.2574819560384101,"score_spread":0.22336318003040856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552510069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99719185,0.00050669204,0.00060407113,0.00016325962,0.000036327583,0.0006225398,0.000079238474,0.00002570761,0.0007703212],"genre_scores_gemma":[0.99865365,0.000034409517,0.0010617261,0.000086165775,0.00002591681,0.000034203902,0.000046496287,0.000029355895,0.000028098928],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987748,0.000026105012,0.00035451973,0.00028850482,0.0003410755,0.00021496887],"domain_scores_gemma":[0.9992233,0.00002122854,0.00017660725,0.0002991101,0.00015074962,0.00012900504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015493156,0.00020169614,0.0004921905,0.00013343459,0.000042988035,0.00001293184,0.000068957095,0.00008822517,0.000016397966],"category_scores_gemma":[0.000060046354,0.00016966872,0.00008520448,0.0001509045,0.000085483254,0.0000854564,0.000036256963,0.000104443614,0.0000025915565],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008236645,0.0046868813,0.0006826269,0.00022339908,0.0005143035,0.000010188094,0.0005878865,3.728235e-7,0.9907576,0.000034765944,0.000038858518,0.0023807753],"study_design_scores_gemma":[0.006473109,0.0016977431,0.0002225049,0.00031109777,0.00041072702,0.00018490158,0.00012380084,0.000036625574,0.9898763,0.0000907833,0.00043514592,0.00013726956],"about_ca_topic_score_codex":0.0005074693,"about_ca_topic_score_gemma":0.00006779669,"teacher_disagreement_score":0.0063907425,"about_ca_system_score_codex":0.0000311312,"about_ca_system_score_gemma":0.000042230084,"threshold_uncertainty_score":0.691889},"labels":[],"label_agreement":null},{"id":"W2552512434","doi":"10.1182/blood.v108.11.2232.2232","title":"Aberrant Co-Expression of Micrornas and Host Genes in Leukemia: Evidence for a Common Transcript from Meta-Analysis and Microarray Data.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Biology; Gene; Gene expression; microRNA; Transcriptome; Genetics; Gene expression profiling; Regulation of gene expression; Gene silencing; Molecular biology","score_opus":0.055760871779118405,"score_gpt":0.303326341030241,"score_spread":0.24756546925112258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552512434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9377936,0.059853364,0.0011690202,0.00004716437,0.000007819654,0.00024201497,0.00087766175,0.0000030936758,0.0000062353474],"genre_scores_gemma":[0.9946935,0.00039583942,0.003818874,0.000025798408,0.000037852133,0.000021811886,0.0009712712,0.0000118153375,0.00002322397],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990214,0.000068265035,0.00028643425,0.00042979445,0.00007382778,0.000120246776],"domain_scores_gemma":[0.99928504,0.000048257953,0.00012293117,0.00047271446,0.00003527323,0.000035755893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018520869,0.00013283505,0.0003756325,0.000064666136,0.0000330914,0.00001858023,0.00015925415,0.00011838092,0.000008371702],"category_scores_gemma":[0.000021446207,0.00011571035,0.00014579837,0.0000824309,0.0000768839,0.0000104918145,0.000060945426,0.000034075194,1.4336382e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000084108106,0.00008805243,0.019171532,0.000047047844,0.0022723437,0.0000011409229,0.000022929775,0.000012514445,0.9780966,0.0000011939915,0.00015210747,0.000050409093],"study_design_scores_gemma":[0.00093408814,0.000036392874,0.048624508,0.0000133466565,0.017041894,0.0000023161738,0.000012803566,0.000051832416,0.9327092,0.000025109235,0.00042958139,0.000118936965],"about_ca_topic_score_codex":0.00087009586,"about_ca_topic_score_gemma":0.0011944874,"teacher_disagreement_score":0.059457526,"about_ca_system_score_codex":0.000005411751,"about_ca_system_score_gemma":0.000033820135,"threshold_uncertainty_score":0.47185308},"labels":[],"label_agreement":null},{"id":"W2552533929","doi":"10.1182/blood.v126.23.3792.3792","title":"Preliminary Report of the Phase 1 Study of the DOT1L Inhibitor, Pinometostat, EPZ-5676, in Children with Relapsed or Refractory MLL-r Acute Leukemia: Safety, Exposure and Target Inhibition","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Leukemia; Cancer research; Medicine; Acute leukemia; Histone H3; Pharmacology; Internal medicine; Biology; Methylation; Gene; Genetics","score_opus":0.017467892813978342,"score_gpt":0.28176794928908505,"score_spread":0.2643000564751067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552533929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958545,0.0003586769,0.000005134778,0.00047807634,0.000064190455,0.0027443618,0.00006497055,0.000022221971,0.0004078993],"genre_scores_gemma":[0.99874157,0.000054061748,0.00029263017,0.0000714517,0.00010661708,0.0000754434,0.000045599736,0.00004847632,0.00056413224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99707466,0.00034008588,0.00079926563,0.00046689322,0.0009945201,0.00032455384],"domain_scores_gemma":[0.99782467,0.000108677035,0.0005022057,0.0011060638,0.00028805668,0.0001703251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009914142,0.0002625412,0.0005716887,0.00019928387,0.000091405396,0.000011395239,0.000244344,0.00018398589,0.000015713746],"category_scores_gemma":[0.00053103967,0.00013381388,0.00007534924,0.0008732034,0.00033912872,0.00014413243,0.00040689152,0.0008121098,0.0000011500309],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011853031,0.009242436,0.9394914,0.00016277174,0.001076355,0.0017974798,0.007722566,0.000032247102,0.025550526,0.000009697954,0.0022959365,0.0007655706],"study_design_scores_gemma":[0.08140299,0.020061081,0.8327632,0.00060630083,0.0012075406,0.0054022,0.004165285,0.000031916923,0.05375291,0.00004200771,0.00026223843,0.00030234168],"about_ca_topic_score_codex":0.00039339482,"about_ca_topic_score_gemma":0.00008879106,"teacher_disagreement_score":0.106728196,"about_ca_system_score_codex":0.00030049175,"about_ca_system_score_gemma":0.001645189,"threshold_uncertainty_score":0.5456772},"labels":[],"label_agreement":null},{"id":"W2552542954","doi":"10.1182/blood.v116.21.1962.1962","title":"Efficacy Analysis From Phase I Study of Lorvotuzumab Mertansine (IMGN901), Used as Monotherapy, In Patients with Heavily Pre-Treated CD56-Positive Multiple Myeloma - A Preliminary Efficacy Analysis","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Multiple myeloma; Internal medicine; Pharmacokinetics; Adverse effect; Phases of clinical research; Refractory (planetary science); Cohort; Toxicity; Chemotherapy; Cancer; Tolerability; Nausea; Gastroenterology; Surgery; Oncology; Pharmacology","score_opus":0.010735552580372445,"score_gpt":0.29714161753965307,"score_spread":0.2864060649592806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552542954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955759,0.00007962341,0.000057048514,0.000039068545,0.000019041641,0.0036986773,0.00040084322,0.00008247855,0.00004732051],"genre_scores_gemma":[0.99642295,0.000007053554,0.0007217134,0.000022209002,0.000038428145,0.0001728643,0.002486425,0.00006888411,0.00005949098],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99600613,0.00030715836,0.0008315388,0.0010496894,0.0011843995,0.0006210667],"domain_scores_gemma":[0.99673903,0.000703081,0.00035999395,0.0012996453,0.00042272903,0.00047553974],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001872935,0.00055750756,0.0016431505,0.0016508338,0.00012815552,0.000044453715,0.00028598597,0.0001973854,0.0002953826],"category_scores_gemma":[0.0002814806,0.00041812667,0.00044504373,0.004271286,0.00014568692,0.00016201564,0.00008443221,0.0004853052,0.000016823025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037495576,0.09067986,0.82279086,0.000013241952,0.037881013,0.00044455638,0.0033858325,0.00019417913,0.0034340983,5.583027e-7,0.0000021574278,0.0036780795],"study_design_scores_gemma":[0.15262501,0.013438003,0.80279815,0.000049049228,0.019289244,0.0000017918876,0.0002459387,0.0025039478,0.008758061,0.0000015094355,0.0000019423499,0.00028732704],"about_ca_topic_score_codex":0.014463837,"about_ca_topic_score_gemma":0.0069663986,"teacher_disagreement_score":0.11512944,"about_ca_system_score_codex":0.000093271505,"about_ca_system_score_gemma":0.00014857951,"threshold_uncertainty_score":0.999827},"labels":[],"label_agreement":null},{"id":"W2552552813","doi":"10.1182/blood.v106.11.696.696","title":"Bioluminescent Imaging of Human Leukemic Stem Cell Engraftment.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Bone marrow; Stem cell; Haematopoiesis; Biology; Myeloid; Progenitor cell; Immunology; CD34; Transplantation; Cord blood; Cancer research; Medicine; Cell biology; Internal medicine","score_opus":0.016417530557696278,"score_gpt":0.2625888383529784,"score_spread":0.24617130779528212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552552813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99007434,0.0004991918,0.00002675313,0.00019201475,0.000059197286,0.00012682629,0.000008316499,0.000046892474,0.008966471],"genre_scores_gemma":[0.99815756,0.000016219146,0.00027591785,0.0001263271,0.0002576986,0.0000062795984,0.00001588674,0.000014830336,0.0011293081],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99939007,0.000009676991,0.00022507196,0.00013265431,0.000109923836,0.0001326299],"domain_scores_gemma":[0.99960285,0.0000128068705,0.00007562111,0.00018862601,0.000059195427,0.000060887287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000054236294,0.00008487344,0.00015303177,0.00008194378,0.000044609416,0.0000068629547,0.000047028785,0.000021504156,0.00021427784],"category_scores_gemma":[0.0000032405142,0.000074931486,0.00009596999,0.00007217043,0.000023526198,0.00004108902,0.000020231999,0.00009601756,0.000041477782],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007824021,0.00079149916,0.009461037,0.00004291655,0.000026884414,0.0000075376583,0.00017770048,0.0000017613478,0.98698634,0.000048253096,0.0009503984,0.001497835],"study_design_scores_gemma":[0.0020400535,0.00014963136,0.0029202085,0.00010878016,0.00014990642,0.000047512785,0.00014909642,0.000070729606,0.98530567,0.0000028418738,0.008983277,0.000072309376],"about_ca_topic_score_codex":0.000045337594,"about_ca_topic_score_gemma":0.000004580565,"teacher_disagreement_score":0.008083195,"about_ca_system_score_codex":0.000036597346,"about_ca_system_score_gemma":0.000035862904,"threshold_uncertainty_score":0.30556172},"labels":[],"label_agreement":null},{"id":"W2552594981","doi":"10.1182/blood.v110.11.2598.2598","title":"Mesenchymal Stromal Cells Genetically Engineered To Overexpress Insulin-Like Growth Factor-1 Provide Paracrine Support for Cell-Based Erythropoietin Therapy of Chronic Renal Failure-Induced Anemia.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Jewish General Hospital","funders":"","keywords":"Erythropoietin; Mesenchymal stem cell; Medicine; Paracrine signalling; Cell therapy; Bone marrow; Stromal cell; Growth factor; Progenitor cell; Cancer research; Population; Genetic enhancement; Immunology; Internal medicine; Endocrinology; Biology; Stem cell; Cell biology; Pathology; Receptor","score_opus":0.021398840139870864,"score_gpt":0.2890840768027099,"score_spread":0.26768523666283905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552594981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98822606,0.00029406228,0.006484459,0.0003534768,0.00013637145,0.0035466042,0.00019274978,0.00010314198,0.0006630947],"genre_scores_gemma":[0.9823557,0.000045791217,0.015912833,0.00016251439,0.00055045716,0.0001431007,0.000108539534,0.00012313713,0.0005979217],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99538016,0.00009964318,0.000997395,0.0008343419,0.0013345111,0.0013539236],"domain_scores_gemma":[0.9968516,0.0005756795,0.00021262665,0.0008228741,0.0006438629,0.0008933499],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008791135,0.00051362504,0.0008223814,0.00037702793,0.00009297773,0.00003125826,0.0004704897,0.00034646885,0.0006915989],"category_scores_gemma":[0.0002545351,0.0004502988,0.00031844026,0.00050283794,0.00011897718,0.00007458508,0.00011706615,0.0005055449,0.00004419921],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017970135,0.0022212132,0.0014730159,0.00075882435,0.000121457364,0.00017802621,0.00016099263,0.000045531848,0.991192,0.000027370244,0.0008533998,0.0011711511],"study_design_scores_gemma":[0.014139577,0.009460733,0.010788234,0.00011945567,0.00008721221,0.000032399897,0.00004991067,0.00022240398,0.9602029,0.000007693902,0.004471441,0.00041807152],"about_ca_topic_score_codex":0.00011588753,"about_ca_topic_score_gemma":0.00004295906,"teacher_disagreement_score":0.030989137,"about_ca_system_score_codex":0.00018195815,"about_ca_system_score_gemma":0.0011692083,"threshold_uncertainty_score":0.9997949},"labels":[],"label_agreement":null},{"id":"W2552596132","doi":"10.1182/blood.v120.21.2490.2490","title":"Different Characteristics Identified by Single Nucleotide Polymorphism Array Analsysis in Leukemia Suggest the Need for Different Application Strategics Depending On Disease Category.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"SNP array; SNP; Single-nucleotide polymorphism; Karyotype; Leukemia; Biology; Oncology; Cytogenetics; Genetics; Medicine; Internal medicine; Genotype; Chromosome; Gene","score_opus":0.023656376102816037,"score_gpt":0.27310434108822934,"score_spread":0.2494479649854133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552596132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949674,0.00033502388,0.0012185404,0.0011796334,0.00017573277,0.0016340511,0.00013049372,0.000071060465,0.00028804204],"genre_scores_gemma":[0.9971245,0.000112611204,0.000032368644,0.0003095593,0.0006132811,0.00046646319,0.0008312355,0.00008208836,0.00042790803],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976828,0.00011888799,0.0004968659,0.00042000666,0.0005167749,0.0007646659],"domain_scores_gemma":[0.99818796,0.00034394997,0.00020558247,0.00069966365,0.00007481423,0.00048800078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033803852,0.00034304228,0.00046979444,0.00019615683,0.00015794934,0.0000954062,0.00029911168,0.00013323018,0.00007536213],"category_scores_gemma":[0.00017468873,0.00023518111,0.00016453098,0.00024863554,0.00009108263,0.00011994089,0.000066722896,0.0004477552,0.00003865933],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001163035,0.004691559,0.28169483,0.0004352483,0.00029876796,0.000023265484,0.0005570471,0.0000032748512,0.7044931,0.0019005928,0.0016206806,0.003118584],"study_design_scores_gemma":[0.007007232,0.00033312375,0.8772769,0.00019032847,0.00087708136,0.000016821868,0.0004838895,0.0009908255,0.11056788,0.00027153504,0.0014487703,0.00053563423],"about_ca_topic_score_codex":0.00013182532,"about_ca_topic_score_gemma":0.0000309961,"teacher_disagreement_score":0.59558207,"about_ca_system_score_codex":0.00075636635,"about_ca_system_score_gemma":0.00013122607,"threshold_uncertainty_score":0.9590407},"labels":[],"label_agreement":null},{"id":"W2552600182","doi":"10.1182/blood.v116.21.3298.3298","title":"Phase I Trial Results for SL-401, a Novel Cancer Stem Cell (CSC) Targeting Agent, Demonstrate Clinical Efficacy at Tolerable Doses In Patients with Heavily Pre-Treated AML, Poor Risk Elderly AML, and High Risk MDS","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Regimen; Stem cell; Oncology; Myeloid leukemia; Myelodysplastic syndromes; Phases of clinical research; Gastroenterology; Clinical trial; Pharmacology; Bone marrow; Biology","score_opus":0.031739725853460424,"score_gpt":0.33958333020650794,"score_spread":0.30784360435304753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552600182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934494,0.0002245986,0.000020997635,0.00009022586,0.00032381873,0.0045164814,0.0011203268,0.00008280843,0.00017133441],"genre_scores_gemma":[0.9957295,0.00038466687,0.0012065024,0.000045307224,0.00052453723,0.00022502443,0.00021537022,0.000087600674,0.0015814761],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99643064,0.00022253869,0.0010782381,0.0009368483,0.0005545809,0.00077713083],"domain_scores_gemma":[0.9971897,0.0009737064,0.0005374247,0.0005438691,0.00029737508,0.0004579319],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014325514,0.0003946229,0.00084437215,0.00017061555,0.00025528652,0.00008343179,0.00018794251,0.0003419131,0.000120351724],"category_scores_gemma":[0.000421179,0.000302521,0.00017402972,0.00035412525,0.00024011053,0.00012355672,0.00008700849,0.0010273618,0.000006572961],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.40342182,0.02079027,0.48046887,0.0001513181,0.0005991542,0.000046893387,0.00042234908,0.00001960422,0.046726383,0.0000014354964,0.0008773009,0.04647462],"study_design_scores_gemma":[0.7689316,0.022156658,0.1472555,0.00021529279,0.00096807774,0.0000060255716,0.000049538383,0.00054409297,0.05721245,0.000005691508,0.002168206,0.0004868466],"about_ca_topic_score_codex":0.0027604108,"about_ca_topic_score_gemma":0.0016200487,"teacher_disagreement_score":0.3655098,"about_ca_system_score_codex":0.00007985654,"about_ca_system_score_gemma":0.00031036112,"threshold_uncertainty_score":0.9999427},"labels":[],"label_agreement":null},{"id":"W2552620919","doi":"10.1182/blood.v114.22.302.302","title":"Updated Results of Bortezomib-Naive Patients in PX-171-004, An Ongoing Open-Label, Phase II Study of Single-Agent Carfilzomib (CFZ) in Patients with Relapsed or Refractory Myeloma (MM).","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Royal Victoria Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Carfilzomib; Bortezomib; Medicine; Tolerability; Proteasome inhibitor; Multiple myeloma; Internal medicine; Phases of clinical research; Refractory (planetary science); Adverse effect; Clinical endpoint; Pharmacology; Oncology; Gastroenterology; Clinical trial; Biology","score_opus":0.04407682764474058,"score_gpt":0.3293003965449342,"score_spread":0.2852235689001936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552620919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995005,0.00003383536,4.2388513e-7,0.000027394797,0.00004134948,0.0040757973,0.00023967859,0.000029434867,0.00054708694],"genre_scores_gemma":[0.9981521,0.000013559956,0.0005647814,0.00004294863,0.00001828505,0.0000580605,0.0009774738,0.000045671575,0.0001271475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99611443,0.0003309761,0.0012005565,0.00074813084,0.0009979223,0.000607979],"domain_scores_gemma":[0.9976449,0.00008623747,0.0005403032,0.0008874548,0.00048760345,0.00035348276],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038245812,0.0003835708,0.0009610595,0.0005866257,0.00009427867,0.000024902882,0.00038347923,0.00014501889,0.000038088427],"category_scores_gemma":[0.0004653519,0.00028563142,0.000038114933,0.0009244296,0.000075339245,0.00040450052,0.00018796761,0.00034715858,0.0000036756276],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.057725526,0.29799896,0.61146003,0.0000517883,0.00037473015,0.0005542057,0.0035684034,0.0000071379122,0.0025966996,0.0000010791556,0.00008420663,0.025577256],"study_design_scores_gemma":[0.27674365,0.09958197,0.61888725,0.00037666658,0.00015584652,0.0000017571438,0.00045744318,0.00003348234,0.0035405399,0.0000024795509,0.000025324402,0.00019362655],"about_ca_topic_score_codex":0.0018951289,"about_ca_topic_score_gemma":0.0023374122,"teacher_disagreement_score":0.21901812,"about_ca_system_score_codex":0.00023892785,"about_ca_system_score_gemma":0.00028851323,"threshold_uncertainty_score":0.9999596},"labels":[],"label_agreement":null},{"id":"W2552673806","doi":"10.1182/blood.v104.11.3122.3122","title":"Prognostic Factors in Localized Hodgkin’s Lymphoma: How To Define Intermediate/Unfavourable Disease?.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Stage (stratigraphy); Internal medicine; Lymphoma; Nomogram; Mediastinum; Chemotherapy; Gastroenterology; Classical Hodgkin lymphoma; Hodgkin lymphoma; Oncology; Surgery","score_opus":0.013752239020366742,"score_gpt":0.2401178732550698,"score_spread":0.22636563423470307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552673806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99469405,0.0008182512,0.000029911525,0.0029171351,0.00013483537,0.0009619763,0.000035346387,0.00010387936,0.00030458323],"genre_scores_gemma":[0.9983452,0.00008431306,0.00045260158,0.00047805093,0.00008220871,0.00027886374,0.000095861265,0.000036208203,0.00014670767],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985308,0.000028172164,0.0002455502,0.000421184,0.00030995323,0.00046434847],"domain_scores_gemma":[0.99888253,0.00009470238,0.000055471504,0.0003576708,0.00005263239,0.0005569661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007299308,0.00027216834,0.00042939337,0.00021341917,0.000047251608,0.00004709429,0.000108145185,0.00007830728,0.000045927907],"category_scores_gemma":[0.00040733282,0.00020509525,0.00014007938,0.00036842198,0.00004147135,0.00007827905,0.000063159714,0.000055992154,0.00013140724],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019416824,0.0061946227,0.9896415,0.00007904109,0.00013104672,0.0013183187,0.00027927617,0.000019373598,0.00019456897,0.00021596784,0.0002730502,0.0014590921],"study_design_scores_gemma":[0.024349513,0.0006436769,0.96331775,0.00043798832,0.00043921798,0.000035342706,0.00010124633,0.000004637296,0.008848332,0.00021942558,0.0013743708,0.00022849649],"about_ca_topic_score_codex":0.0002754859,"about_ca_topic_score_gemma":0.00013160643,"teacher_disagreement_score":0.02632372,"about_ca_system_score_codex":0.00033403773,"about_ca_system_score_gemma":0.00032035395,"threshold_uncertainty_score":0.83635414},"labels":[],"label_agreement":null},{"id":"W2552675878","doi":"10.1182/blood.v110.11.2498.2498","title":"The Multiple Myeloma Research Consortium Genomics Initiative.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Genomics; Comparative genomic hybridization; Computational biology; Genome; Human genome; Biology; DNA sequencing; Genetics; Gene","score_opus":0.09746773302003374,"score_gpt":0.3785845686649132,"score_spread":0.28111683564487944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552675878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9685899,0.0010380123,0.00006118111,0.0009999376,0.00007342148,0.0008080492,0.000015763275,0.000057171797,0.028356543],"genre_scores_gemma":[0.9968818,0.00021352094,0.00082506397,0.00010637062,0.00026615988,0.00004425144,0.000024957548,0.000028141572,0.0016097333],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978307,0.00012909698,0.00026191634,0.00026506762,0.00066199736,0.0008512174],"domain_scores_gemma":[0.99733734,0.0014183391,0.000041661133,0.00048096108,0.0003599466,0.00036176553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017889092,0.0001247985,0.0001701271,0.00014597585,0.0005719139,0.000052174626,0.0001776158,0.00008548073,0.00005812505],"category_scores_gemma":[0.0015217308,0.00007986303,0.000079997386,0.0003265298,0.00036055784,0.0000471446,0.0001213543,0.00045154057,0.00041699279],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002546054,0.0030229902,0.8614515,0.00008357622,0.0011225312,0.0030702562,0.0012071712,4.442093e-7,0.05357364,0.0018320208,0.003763919,0.068325885],"study_design_scores_gemma":[0.01139105,0.00074821856,0.79352784,0.00004155988,0.00007067055,0.00020273191,0.0012864742,0.000082108694,0.14254561,0.00038188236,0.04957221,0.0001496169],"about_ca_topic_score_codex":0.000074405696,"about_ca_topic_score_gemma":0.00031929833,"teacher_disagreement_score":0.08897197,"about_ca_system_score_codex":0.00010955762,"about_ca_system_score_gemma":0.00028764305,"threshold_uncertainty_score":0.5359738},"labels":[],"label_agreement":null},{"id":"W2552676814","doi":"10.1182/blood.v106.11.5144.5144","title":"Salvage Thalidomide Improves Survival of Relapsed Multiple Myeloma Patients When Compared to Other Salvage Chemotherapies: A Retrospective Analysis.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Thalidomide; Medicine; Salvage therapy; Melphalan; Surgery; Multiple myeloma; Regimen; Lenalidomide; Internal medicine; Retrospective cohort study; Prednisone; Refractory (planetary science); Chemotherapy regimen; Chemotherapy; Dexamethasone; Oncology","score_opus":0.01682169155940251,"score_gpt":0.2758087390662176,"score_spread":0.2589870475068151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552676814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947467,0.00014258386,0.00017979225,0.00032538985,0.00004617913,0.0012272029,0.00024398816,0.00009360769,0.0029945544],"genre_scores_gemma":[0.9920472,0.00001101901,0.006289036,0.00027193173,0.00014807089,0.00008087528,0.000133614,0.00006366963,0.0009546192],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974227,0.00011890016,0.00053197617,0.0005741335,0.0007941854,0.0005581322],"domain_scores_gemma":[0.9981768,0.00017052543,0.00019721735,0.00075087644,0.00031191183,0.0003926357],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002649239,0.00032481828,0.00095145486,0.00043121204,0.000083845465,0.00002872661,0.00022382625,0.00012021167,0.00039284353],"category_scores_gemma":[0.0003262001,0.0002654878,0.00038165646,0.00068161293,0.00009693164,0.00011245072,0.00009221914,0.00019582751,0.000099681965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013058564,0.0036621853,0.95229197,0.0000493206,0.004979466,0.000021920076,0.0016377413,0.0000075595185,0.033740357,0.000023779943,0.0003518838,0.0019279915],"study_design_scores_gemma":[0.022748947,0.00068429194,0.92551,0.000052793683,0.00091369014,0.0000017766118,0.00021413532,0.0003943707,0.048359815,0.000021956348,0.0008698649,0.00022837671],"about_ca_topic_score_codex":0.00058396347,"about_ca_topic_score_gemma":0.00085385406,"teacher_disagreement_score":0.026781961,"about_ca_system_score_codex":0.00015856492,"about_ca_system_score_gemma":0.00007116204,"threshold_uncertainty_score":0.99997973},"labels":[],"label_agreement":null},{"id":"W2552678045","doi":"10.1182/blood.v104.11.1035.1035","title":"Coagulation Abnormalities in Patients with Noonan Syndrome - a Single Centre Case Series.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Von Willebrand disease; Gastroenterology; Internal medicine; Noonan syndrome; Von Willebrand factor; Coagulation; Short stature; Surgery; Pediatrics; Platelet","score_opus":0.004155598429591578,"score_gpt":0.17613564653416663,"score_spread":0.17198004810457507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552678045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99890393,0.0006098731,0.00003358186,0.00004085801,0.000022689937,0.00021921111,0.00009382364,0.000011921003,0.00006412216],"genre_scores_gemma":[0.9986329,0.0000030356857,0.0008104488,0.000043730637,0.00001973445,0.000012081191,0.0004107525,0.000015441165,0.00005189582],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994196,0.000015618793,0.000117264055,0.00018624964,0.000086868255,0.00017434235],"domain_scores_gemma":[0.9996762,0.0000019372983,0.000045426477,0.00019120265,0.000043027187,0.000042175383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000030977142,0.000106683714,0.000085459695,0.000025791802,0.000038362334,0.000017162396,0.000056193145,0.000058530146,0.00000832406],"category_scores_gemma":[0.000021646498,0.00009887692,0.000018593439,0.00007075942,0.000042893367,0.000011231496,0.00004369751,0.000034714943,0.000003827718],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009462587,0.0058820345,0.96082944,0.00021330692,0.00024857346,0.005329578,0.00062445167,0.0011909769,0.021106035,0.0023524237,0.00014152993,0.0011354063],"study_design_scores_gemma":[0.010502077,0.001955541,0.10869582,0.000106541396,0.000056334033,0.0022567606,0.0001303076,6.8732544e-7,0.8749236,0.00023699609,0.00065549306,0.00047987208],"about_ca_topic_score_codex":0.00013526678,"about_ca_topic_score_gemma":0.00047540004,"teacher_disagreement_score":0.8538175,"about_ca_system_score_codex":0.000017179229,"about_ca_system_score_gemma":0.00004129546,"threshold_uncertainty_score":0.40320835},"labels":[],"label_agreement":null},{"id":"W2552678756","doi":"10.1182/blood.v110.11.547.547","title":"A Unique Pre-Clinical Model Providing Access to a Drug Resistant Population within the Multiple Myeloma Stem Cell Niche in a Novel 3-D Culture System for Bone Marrow.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Bone marrow; Stromal cell; Haematopoiesis; Stem cell; Biology; clone (Java method); Progenitor cell; Tumor microenvironment; Population; Cancer research; Immunology; Cell biology; Pathology; Medicine; Immune system","score_opus":0.06046261450685329,"score_gpt":0.3585497915231922,"score_spread":0.2980871770163389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552678756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98887557,0.00019552142,0.004629986,0.00038250993,0.0000653342,0.0053626867,0.00007594259,0.00009401093,0.00031841226],"genre_scores_gemma":[0.98653215,0.0000040792524,0.010869517,0.00014427207,0.00012982462,0.00050495396,0.00006868478,0.000048524056,0.0016979686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975458,0.0001161975,0.00080799946,0.00052762905,0.0004765866,0.00052582676],"domain_scores_gemma":[0.9983861,0.00040214258,0.00021307592,0.00050162576,0.00016049884,0.00033657753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019459854,0.00024279009,0.00045436318,0.00016500786,0.00016301361,0.00008247258,0.00025822668,0.00017720336,0.0000010082188],"category_scores_gemma":[0.00035467048,0.00015505665,0.00015231666,0.000378845,0.000028908742,0.00014100643,0.00013514208,0.00035193315,0.0000042660786],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024334699,0.007845433,0.8339331,0.0037584892,0.00056382956,0.000563016,0.011039931,0.0015498874,0.110757805,0.000734944,0.00081203633,0.0041067917],"study_design_scores_gemma":[0.06434528,0.0018891724,0.5999595,0.0027639747,0.00071820157,0.00016179978,0.0036924977,0.18863864,0.13650633,0.00010445633,0.00036646595,0.0008537121],"about_ca_topic_score_codex":0.0006035259,"about_ca_topic_score_gemma":0.0033925776,"teacher_disagreement_score":0.23397367,"about_ca_system_score_codex":0.00027454816,"about_ca_system_score_gemma":0.000264561,"threshold_uncertainty_score":0.63230264},"labels":[],"label_agreement":null},{"id":"W2552704352","doi":"10.1182/blood.v108.11.2031.2031","title":"Bone Marow (BM) Involvement in Diffuse Large B Cell Lymphoma (DLBCL): Clinical Impact of Discordant Disease.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Medicine; Lymphoma; Bone marrow; Pathology; Malignancy; Not Otherwise Specified; Internal medicine; Stage (stratigraphy); Oncology; Biology","score_opus":0.015517804188697151,"score_gpt":0.2942985743858516,"score_spread":0.27878077019715447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552704352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99577796,0.0023655738,0.000004587334,0.00018189884,0.00007903731,0.00055251404,0.00016566351,0.00003012251,0.00084261876],"genre_scores_gemma":[0.99859905,0.00036711866,0.00016879255,0.00011882957,0.00017024476,0.00007436877,0.0001922097,0.000029109433,0.00028026063],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980741,0.000071689814,0.0007292806,0.00037669286,0.0003301576,0.0004180871],"domain_scores_gemma":[0.9988604,0.00010899824,0.00017760837,0.00052003283,0.00004005289,0.00029289594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002178961,0.0002455998,0.00059130543,0.000119314056,0.00003155901,0.000014396002,0.000085004685,0.000063925305,0.000062033985],"category_scores_gemma":[0.00003660414,0.00017156698,0.0004887108,0.00018153388,0.00006339262,0.000053811207,0.000085415995,0.00005936712,0.00003816098],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027686902,0.15459442,0.8417694,0.00008279519,0.00012295583,0.001045725,0.000025654648,9.490481e-7,0.00027801903,0.00012677885,0.0011078332,0.0005685729],"study_design_scores_gemma":[0.08318608,0.00079071167,0.9119173,0.00015945925,0.0004939566,0.000014028544,0.000026217891,0.000042089676,0.0027445513,0.00012294631,0.00034873254,0.00015391063],"about_ca_topic_score_codex":0.0011552739,"about_ca_topic_score_gemma":0.00020518174,"teacher_disagreement_score":0.15380372,"about_ca_system_score_codex":0.00017179539,"about_ca_system_score_gemma":0.00028529,"threshold_uncertainty_score":0.69962984},"labels":[],"label_agreement":null},{"id":"W2552737980","doi":"10.1182/blood.v126.23.1789.1789","title":"Resistance to Lenalidomide in Multiple Myeloma Is Associated with a Switch in Gene Expression Profile","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Cereblon; Lenalidomide; Biology; Transcriptome; Gene expression; Gene; Gene expression profiling; Pomalidomide; Genetics; Multiple myeloma; Computational biology; Cancer research; Molecular biology; Ubiquitin ligase; Immunology; Ubiquitin","score_opus":0.041941598536092514,"score_gpt":0.2928726285631699,"score_spread":0.2509310300270774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552737980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965176,0.00025844207,0.000014020755,0.00049852865,0.000014777964,0.0010391033,0.00003808064,0.000039487808,0.0015799862],"genre_scores_gemma":[0.9924546,0.000007692826,0.00492155,0.00015014752,0.000033636763,0.00028570156,0.000062714535,0.000028603206,0.0020553644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983244,0.00009140394,0.00024241523,0.00036581972,0.0005185987,0.00045735124],"domain_scores_gemma":[0.9990447,0.000090039815,0.000053766755,0.0003145477,0.00012376692,0.00037315922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030032243,0.00016185941,0.0003322363,0.00022032642,0.000030381763,0.000016415055,0.000096262265,0.000088146655,0.000037284983],"category_scores_gemma":[0.000817541,0.00012025567,0.000030924584,0.00049272523,0.000024069168,0.000077037934,0.000057308163,0.00017945966,0.0000720951],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033528127,0.002030534,0.93808794,0.000035157533,0.00007445763,0.0018234359,0.0011510421,0.0000044754834,0.051605135,0.0000017747469,0.0014656248,0.00036761502],"study_design_scores_gemma":[0.038913473,0.00051958294,0.5333388,0.00084880675,0.000028091774,0.000017985816,0.00019930289,0.00009749464,0.42551607,0.000026278185,0.00031712087,0.00017701475],"about_ca_topic_score_codex":0.00028246306,"about_ca_topic_score_gemma":0.0023359966,"teacher_disagreement_score":0.40474916,"about_ca_system_score_codex":0.00019792958,"about_ca_system_score_gemma":0.0002309331,"threshold_uncertainty_score":0.49038836},"labels":[],"label_agreement":null},{"id":"W2552743555","doi":"10.1182/blood.v104.11.3762.3762","title":"Prevalence of Alpha-Globin Gene Deletions amongst Patients with Unexplained Microcytosis in a North-American Population.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Microcytosis; Genotype; Thalassemia; Multiplex ligation-dependent probe amplification; Alpha-thalassemia; Genotyping; Biology; Microcytic anemia; Population; Genetics; Medicine; Gene; Internal medicine; Hemoglobin; Anemia; Iron deficiency","score_opus":0.0038821938970626407,"score_gpt":0.19992169011737623,"score_spread":0.19603949622031358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552743555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99895513,0.00013633227,0.00009717629,0.00018589757,0.000016003567,0.0004474289,0.0000401362,0.000029864023,0.000092001654],"genre_scores_gemma":[0.99584216,0.00012547152,0.0037617006,0.00010220169,0.000011080836,0.000022051592,0.00009110197,0.000018260871,0.000025969586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905276,0.000018649802,0.0002909083,0.00021856176,0.00020618293,0.00021292584],"domain_scores_gemma":[0.99945855,0.000012142609,0.00013065238,0.00021083085,0.00009600488,0.00009182977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003819719,0.00012866117,0.00024022751,0.00013189015,0.00004396677,0.000004042652,0.000066950226,0.00004901299,0.000012635109],"category_scores_gemma":[0.000029664143,0.0001025926,0.000050376188,0.00067731674,0.00008228485,0.00004931478,0.000019533396,0.0001259363,0.000006129086],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009674773,0.0015714921,0.9961475,0.00010456282,0.00005976443,0.000015147962,0.00024366989,0.00046418406,0.0007091636,0.000010757258,0.0000068069676,0.0005701853],"study_design_scores_gemma":[0.0073279226,0.00059834257,0.98932743,0.00014624969,0.00020872374,0.000013876663,0.000080745085,0.000011102679,0.0021460361,0.0000053835247,0.000015119766,0.00011907186],"about_ca_topic_score_codex":0.0014545218,"about_ca_topic_score_gemma":0.00089545536,"teacher_disagreement_score":0.007231175,"about_ca_system_score_codex":0.000052197254,"about_ca_system_score_gemma":0.00006817562,"threshold_uncertainty_score":0.4183605},"labels":[],"label_agreement":null},{"id":"W2552767721","doi":"10.1182/blood.v106.11.1760.1760","title":"Intravenous Busulfan: Pharmacokinetic Disposition and Clinical Outcomes in Children Undergoing Hematopoietic Stem Cell Transplant.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Busulfan; Medicine; Hepatic veno-occlusive disease; Pharmacokinetics; Hematopoietic stem cell transplantation; Cumulative incidence; Gastroenterology; Internal medicine; Transplantation; Surgery","score_opus":0.011905934510097799,"score_gpt":0.27355623887134983,"score_spread":0.26165030436125203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552767721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99668974,0.00051263924,0.0005745586,0.0004662593,0.00006147472,0.00069629145,0.000018732968,0.00008306294,0.00089721463],"genre_scores_gemma":[0.99733526,0.0011024033,0.0009320978,0.0002760686,0.00012458544,0.000018578463,0.00004784522,0.000037264337,0.00012593056],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827635,0.000096919,0.00066495454,0.0003851563,0.000258457,0.00031814087],"domain_scores_gemma":[0.9992316,0.00026582836,0.00008838424,0.00020305342,0.000021149637,0.00019002824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002729239,0.00022416847,0.00047927213,0.00013775461,0.00004784093,0.000021397116,0.000076606164,0.00015140505,0.000054282842],"category_scores_gemma":[0.0000050102662,0.00020392981,0.000107887834,0.00013748433,0.00006280036,0.000088522684,0.000011274631,0.0002857214,0.000052017615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009819534,0.0019493636,0.98734003,0.00039569897,0.00016096629,0.000117680516,0.0016050123,0.000012763724,0.0039004544,0.00004887787,0.0000070815618,0.0043638526],"study_design_scores_gemma":[0.01589673,0.0003862638,0.9561788,0.00047332697,0.0012168686,0.0015726995,0.00015633485,0.00020358541,0.023569431,0.000024005352,0.000016478318,0.00030550227],"about_ca_topic_score_codex":0.000020329673,"about_ca_topic_score_gemma":0.000041305357,"teacher_disagreement_score":0.03116128,"about_ca_system_score_codex":0.000027952572,"about_ca_system_score_gemma":0.00005943274,"threshold_uncertainty_score":0.8316016},"labels":[],"label_agreement":null},{"id":"W2552779478","doi":"10.1182/blood.v120.21.1364.1364","title":"Chronic Inhibition of Mitochondrial Translation Alters Metabolism and Stemness in AML","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Advanced biosensing and bioanalysis techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Mitochondrion; Oxidative phosphorylation; Biology; Cell biology; Respiratory chain; Stem cell; Mitochondrial respiratory chain; Glycolysis; Anaerobic glycolysis; Molecular biology; Biochemistry; Metabolism","score_opus":0.00959033299133005,"score_gpt":0.25218156367418143,"score_spread":0.24259123068285138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552779478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99599,0.0026315928,0.0011331311,0.000028403027,0.0000380725,0.00008562331,0.0000073459933,0.0000072859693,0.0000785701],"genre_scores_gemma":[0.99525356,0.00022416595,0.0041706576,0.000012858228,0.00027258653,0.0000044076437,0.000045908448,0.0000060627353,0.000009763891],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995533,0.00003348759,0.00013555343,0.00011407898,0.00005308293,0.000110499226],"domain_scores_gemma":[0.99980354,0.000004045112,0.00005355352,0.000094565214,0.00001862967,0.000025651503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000078201156,0.0000668438,0.00010206746,0.00004517795,0.000014351016,0.0000034269417,0.000021340791,0.00008161458,5.511537e-7],"category_scores_gemma":[0.00000903711,0.00006004036,0.000035926285,0.0000666065,0.00004189294,0.0000060219368,0.000012967024,0.000033030774,1.5060776e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001689076,0.00006660437,0.0011616434,0.000013671493,0.000017399956,2.2773067e-7,0.000031137675,0.0000010226605,0.9943711,0.000021809032,0.0000058667783,0.004292601],"study_design_scores_gemma":[0.0007462585,0.000055288834,0.0020937386,0.000015662938,0.000050028233,0.0000048318984,0.000018005856,0.000005558435,0.99620736,0.000029705532,0.000698564,0.00007500269],"about_ca_topic_score_codex":0.00000976356,"about_ca_topic_score_gemma":0.000033638993,"teacher_disagreement_score":0.004217598,"about_ca_system_score_codex":0.000003309538,"about_ca_system_score_gemma":0.000010331266,"threshold_uncertainty_score":0.24483748},"labels":[],"label_agreement":null},{"id":"W2552779764","doi":"10.1182/blood.v112.11.1535.1535","title":"The Src-Like Adaptor Proteins, SLAP and SLAP2, Regulate Flt3-Dependent Dendritic Cell Development.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Cell biology; Syk; Biology; Signal transducing adaptor protein; Haematopoiesis; Progenitor cell; CD11c; Dendritic cell; Receptor; Ubiquitin ligase; Signal transduction; Tyrosine kinase; Stem cell; Ubiquitin; Immunology; Phenotype; Immune system","score_opus":0.009383132195207172,"score_gpt":0.19102060880840238,"score_spread":0.1816374766131952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552779764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9480275,0.049997568,0.000035834408,0.00015440886,0.00050960307,0.0004313119,0.0000075401736,0.00008841479,0.0007478138],"genre_scores_gemma":[0.96456885,0.0020402682,0.00027735298,0.000113542636,0.000026732814,0.00008830729,0.000019310415,0.000032835556,0.0328328],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99848104,0.00028179726,0.00035522037,0.00030694224,0.00006535701,0.0005096636],"domain_scores_gemma":[0.999221,0.00018531544,0.000110335335,0.00040358078,0.000055169763,0.000024598834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030269963,0.00024200644,0.00024039987,0.00006580068,0.0012725618,0.000032376374,0.00030557998,0.00021520884,0.00011906786],"category_scores_gemma":[0.00004032067,0.00017491891,0.000068015856,0.0000859623,0.00036405592,0.000093488474,0.00011863055,0.00029979766,0.0003827856],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057910825,0.00047182603,0.0014669836,0.000026098629,0.00039534082,0.000048419457,0.0015156985,2.5557236e-7,0.9888285,0.00019829185,0.0011284469,0.005341029],"study_design_scores_gemma":[0.0035747236,0.00016647308,0.010700329,0.00003122844,0.000040892977,0.0007730603,0.00019073245,2.4178027e-7,0.7839086,0.000037846246,0.20031501,0.00026083726],"about_ca_topic_score_codex":0.0000332919,"about_ca_topic_score_gemma":0.000016911725,"teacher_disagreement_score":0.20491989,"about_ca_system_score_codex":0.000019434106,"about_ca_system_score_gemma":0.00018907596,"threshold_uncertainty_score":0.9787646},"labels":[],"label_agreement":null},{"id":"W2552802489","doi":"10.1182/blood.v120.21.1142.1142","title":"Postpartum Venous Thromboembolic Events Among Carriers of Factor V Leiden and/or Prothrombin Gene Variant: A Cohort Study and Updated Systematic Review. Is Prophylaxis Really Required?","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Sherbrooke; Children's Hospital of Eastern Ontario; Queen's University; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Factor V Leiden; Pregnancy; Obstetrics; Postpartum period; Cohort study; Prospective cohort study; Thrombophilia; Gynecology; Venous thrombosis; Internal medicine; Thrombosis","score_opus":0.020659725684642208,"score_gpt":0.27894790014182896,"score_spread":0.25828817445718677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552802489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855511,0.0043457844,0.000015700725,0.000075423915,0.00010382195,0.009687493,0.00004229701,0.00007571644,0.00010263769],"genre_scores_gemma":[0.9980413,0.00085964944,0.00025652972,0.00020652411,0.00005029905,0.00036639013,0.000028483184,0.000055435114,0.00013540439],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974439,0.00029801234,0.0008476646,0.0004244857,0.00059545325,0.00039049835],"domain_scores_gemma":[0.9982739,0.000033022872,0.00045762068,0.00067984767,0.00020062884,0.00035499627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008044974,0.00032215504,0.0015937999,0.00013727648,0.000110203706,0.000019313558,0.0001273076,0.00015379136,0.00013986172],"category_scores_gemma":[0.00023368665,0.00023774958,0.00009051251,0.00032881452,0.00008244336,0.00022109138,0.00010637664,0.00017013539,0.000011749771],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014047055,0.009756017,0.829483,0.11581457,0.004102695,0.00008842174,0.008052856,3.7308038e-8,0.032244373,0.0001329064,0.00010307054,0.00008161655],"study_design_scores_gemma":[0.004336229,0.004077229,0.95582914,0.015210367,0.006917983,0.00039696644,0.0005956049,0.000013643513,0.012192126,0.000045926052,0.0000029877258,0.00038180297],"about_ca_topic_score_codex":0.00015371428,"about_ca_topic_score_gemma":0.00001551712,"teacher_disagreement_score":0.12634617,"about_ca_system_score_codex":0.00002677568,"about_ca_system_score_gemma":0.00010755093,"threshold_uncertainty_score":0.96951467},"labels":[],"label_agreement":null},{"id":"W2552810623","doi":"10.1182/blood.v104.11.261.261","title":"Improved Leukemia-Free Survival after Post-Consolidation Treatment with Histamine Dihydrochloride and Interleukin-2 in AML: A Randomized Phase III Trial.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Gastroenterology; Randomized controlled trial; Leukemia; Surgery","score_opus":0.00701838896968833,"score_gpt":0.25574009629980693,"score_spread":0.2487217073301186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552810623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973406,0.00062417897,0.00023216735,0.00015393001,0.000073853065,0.0013399388,0.00004409351,0.000015496822,0.00017572902],"genre_scores_gemma":[0.9979855,0.00018050034,0.00028911032,0.00004890908,0.00016665299,0.0006079568,0.00019600161,0.000033980003,0.0004914036],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9985862,0.00012427896,0.00035766728,0.00046372958,0.0001666199,0.00030154604],"domain_scores_gemma":[0.99920005,0.000042861346,0.000094707,0.0004583949,0.00008433852,0.000119668104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033325813,0.00024004151,0.00044183372,0.00012165343,0.0000431938,0.000036686855,0.00012742289,0.00013468119,0.000010720902],"category_scores_gemma":[0.00020405103,0.00018702165,0.00010299922,0.000100061065,0.00019489028,0.000009727005,0.000087124055,0.00010449757,0.000002679553],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.45037827,0.0010150856,0.000019082332,0.0000138908335,0.00016211707,0.00008466202,0.00029984134,0.000004671596,0.547415,0.000008201225,0.00000739068,0.0005917805],"study_design_scores_gemma":[0.5658518,0.0024425196,0.0000066113766,0.000022332515,0.00006672696,0.000023860182,0.000039361144,0.000014706695,0.43106702,0.0000100337065,0.00030849487,0.00014654025],"about_ca_topic_score_codex":0.0009583566,"about_ca_topic_score_gemma":0.0024006143,"teacher_disagreement_score":0.11634801,"about_ca_system_score_codex":0.00017782692,"about_ca_system_score_gemma":0.00035160268,"threshold_uncertainty_score":0.76265216},"labels":[],"label_agreement":null},{"id":"W2552811530","doi":"10.1182/blood.v116.21.4214.4214","title":"In Vivo Monitoring of Venous Thrombosis In Mice Using Ultrasonography","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Medicine; Thrombosis; In vivo; Inferior vena cava; Venous thrombosis; Ligation; Thrombus; Ultrasound; Venous stasis; Animal model; Radiology; Pathology; Cardiology; Surgery; Internal medicine; Biology","score_opus":0.019995429455879083,"score_gpt":0.2872682183053391,"score_spread":0.26727278884946004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552811530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978125,0.00015801821,0.0000034412767,0.000080957514,0.00031210628,0.00027248677,0.0000025603947,0.000015245907,0.0013426724],"genre_scores_gemma":[0.99659103,0.0001800967,0.0029983672,0.000051313655,0.00013971119,0.00001529826,6.2862455e-7,0.000017291408,0.000006249922],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991705,0.000014887354,0.00025749853,0.00017892451,0.00014930473,0.00022889303],"domain_scores_gemma":[0.99961746,0.00003645912,0.00006722396,0.00019980491,0.00002753896,0.00005150237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017748609,0.00010330259,0.00037600065,0.0002978732,0.000019843095,0.0000073543215,0.000083128056,0.00007623936,0.000059488302],"category_scores_gemma":[0.000034765388,0.00010357675,0.00006918508,0.000384498,0.000037007983,0.00007282277,0.00002922334,0.00019781897,0.0000025556994],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005900324,0.0032959771,0.49468502,0.00011354639,0.000057047266,0.000027308182,0.0008068683,0.000011246466,0.50072163,0.00010631455,0.000025165136,0.00014398585],"study_design_scores_gemma":[0.0018403489,0.000163333,0.7006142,0.00027599517,0.00017253439,0.000010158665,0.00040792153,0.000014267295,0.29611683,0.000061646235,0.00021393345,0.00010880807],"about_ca_topic_score_codex":0.0011030479,"about_ca_topic_score_gemma":0.00016353358,"teacher_disagreement_score":0.20592922,"about_ca_system_score_codex":0.000014094987,"about_ca_system_score_gemma":0.000028850827,"threshold_uncertainty_score":0.4223737},"labels":[],"label_agreement":null},{"id":"W2552812069","doi":"10.1182/blood.v110.11.1471.1471","title":"Treatment of MDS Related Transfusion-Dependent Anemia with Epoetin alfa: A Meta-Analysis Perspective.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Epoetin alfa; Blood transfusion; Anemia; Internal medicine; Population; Erythropoietin; Meta-analysis","score_opus":0.01706307990148552,"score_gpt":0.2651024308252967,"score_spread":0.24803935092381119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552812069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96668303,0.011376734,0.00024967446,0.0014291222,0.000022660444,0.0005819599,0.000017557284,0.00006885714,0.019570397],"genre_scores_gemma":[0.9958302,0.0009101716,0.00074115227,0.00004002511,0.00001561072,0.000013656137,0.000020836898,0.000024813096,0.0024035298],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99851096,0.000042412794,0.0004179568,0.0003650621,0.00038083742,0.00028277055],"domain_scores_gemma":[0.99908423,0.000067281326,0.00012220131,0.0003849426,0.0001719563,0.00016937983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020495694,0.00022972567,0.0009673785,0.00029308413,0.00006508433,0.00000550503,0.000055144625,0.0001894855,0.0007321782],"category_scores_gemma":[0.000020282509,0.00013334553,0.00087918225,0.00089715543,0.000094980394,0.000025519075,0.0000070520305,0.00014419414,0.0000134017055],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024254846,0.021350345,0.07372683,0.00015784828,0.84522635,0.004665573,0.020226026,0.0004058132,0.027395256,0.0019029194,0.000047616686,0.0024699068],"study_design_scores_gemma":[0.015756644,0.0044352673,0.0134562105,0.000015099396,0.9153169,0.0006624202,0.008784752,0.000033809974,0.040648427,0.00010071387,0.00043354376,0.0003562286],"about_ca_topic_score_codex":0.0014530884,"about_ca_topic_score_gemma":0.00038926787,"teacher_disagreement_score":0.07009051,"about_ca_system_score_codex":0.00007452139,"about_ca_system_score_gemma":0.00008742,"threshold_uncertainty_score":0.80168384},"labels":[],"label_agreement":null},{"id":"W2552815603","doi":"10.1182/blood.v124.21.1589.1589","title":"Effects of Irradiation on the Functional Characteristics of Human Bone Marrow Mesenchymal Stromal/Stem Cells","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Mesenchymal stem cell; Stem cell; Haematopoiesis; Bone marrow; Stromal cell; Transplantation; Progenitor cell; Andrology; Cancer research; Molecular biology; Immunology; Chemistry; Biology; Medicine; Pathology; Cell biology; Internal medicine","score_opus":0.01913778672078162,"score_gpt":0.24565021704823498,"score_spread":0.22651243032745336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552815603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944478,0.000056819783,0.00002848798,0.00018212096,0.00011986407,0.0005036568,0.000008486946,0.000016198752,0.00463654],"genre_scores_gemma":[0.9978733,0.000009347127,0.000037671583,0.000052879204,0.00025488183,0.00002232903,0.000015209292,0.00001974796,0.0017146528],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99833727,0.00018898955,0.00034872463,0.00019210197,0.0007159397,0.00021696126],"domain_scores_gemma":[0.99849874,0.0006862819,0.00020900558,0.00034561197,0.00015600129,0.00010436658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006081456,0.00012635265,0.00033862054,0.000106826454,0.00006555057,0.000008118046,0.00010381121,0.000090666545,0.00020793304],"category_scores_gemma":[0.00018799509,0.00008716505,0.00010396493,0.00015230053,0.00009357746,0.000024176283,0.000040487575,0.00021094082,0.000048958304],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011890201,0.0007526949,0.014791131,0.0006982875,0.000090389585,0.000011961528,0.00008596759,9.343393e-7,0.9782461,0.003282554,0.00042407215,0.0014970413],"study_design_scores_gemma":[0.0017775667,0.0013568917,0.45580915,0.00016465592,0.00013417032,0.00000881495,0.00001997075,0.0001234235,0.5402274,0.000037440423,0.00027143484,0.000069101734],"about_ca_topic_score_codex":0.000018203857,"about_ca_topic_score_gemma":0.0000013953689,"teacher_disagreement_score":0.44101802,"about_ca_system_score_codex":0.00002243367,"about_ca_system_score_gemma":0.000054255335,"threshold_uncertainty_score":0.35544875},"labels":[],"label_agreement":null},{"id":"W2552817076","doi":"10.1182/blood.v120.21.1180.1180","title":"Are Children with Cancer Receiving Myelosuppressive Therapy At Risk for Transfusion-Related Iron Overload?","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Transfusion therapy; Blood transfusion; Population; Chelation therapy; Pediatrics; Ferritin; Anemia; Intensive care medicine; Emergency medicine; Thalassemia; Surgery; Internal medicine","score_opus":0.008398737165008404,"score_gpt":0.23659697069222319,"score_spread":0.22819823352721477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552817076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98287827,0.014330534,0.000015686333,0.0006520057,0.0001672833,0.0011093481,0.000095972704,0.000088728004,0.0006621723],"genre_scores_gemma":[0.9889022,0.009585479,0.00015068405,0.00025502895,0.00018982188,0.00012032899,0.000048238628,0.000057796173,0.0006904297],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890316,0.00003565902,0.0001918374,0.00024572643,0.00018894012,0.00043466812],"domain_scores_gemma":[0.99929637,0.000046355453,0.00018510727,0.00022756815,0.000057854268,0.00018676116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010484083,0.00020374317,0.00028235686,0.000051074025,0.00023085508,0.0000082914,0.00006263346,0.00022328767,0.00041113142],"category_scores_gemma":[0.00003252261,0.0001329667,0.00012118431,0.00014687235,0.00006225679,0.00008262733,0.000014078704,0.00025612887,0.000014561298],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005178383,0.00075276836,0.98214114,0.00004162118,0.00070288655,0.000004728633,0.0019034449,0.000034074892,0.004356714,0.000006155455,0.0010585316,0.0084801195],"study_design_scores_gemma":[0.019310167,0.00045707272,0.9597992,0.00036195456,0.0010750854,0.00012835926,0.00035265376,0.00002424431,0.013974322,0.00001506861,0.0041816626,0.00032025413],"about_ca_topic_score_codex":0.0002486762,"about_ca_topic_score_gemma":0.000068656365,"teacher_disagreement_score":0.022341961,"about_ca_system_score_codex":0.00004254852,"about_ca_system_score_gemma":0.00004191975,"threshold_uncertainty_score":0.54222244},"labels":[],"label_agreement":null},{"id":"W2552828698","doi":"10.1182/blood.v126.23.3630.3630","title":"Conditional Deletion of the Hoxa Cluster in MLL-AF9 Is Incompatible with Leukemia Maintenance","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Leukemia; Biology; Ectopic expression; Progenitor cell; Cancer research; Haematopoiesis; Stem cell; Hox gene; Fusion gene; Molecular biology; Genetics; Gene; Gene expression","score_opus":0.007997007789821393,"score_gpt":0.21206261703060109,"score_spread":0.20406560924077968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552828698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997782,0.00018960585,0.00039627557,0.00024612894,0.00004676473,0.000101994716,0.000054448323,0.0000014813234,0.0011813117],"genre_scores_gemma":[0.9987201,0.00003396189,0.00032500192,0.00064489985,0.00007482043,0.000011973862,0.00004564484,0.000007402678,0.00013616557],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995803,0.000015259893,0.00010421291,0.00012072004,0.00008487158,0.00009459189],"domain_scores_gemma":[0.9996392,0.000008051093,0.000059220372,0.00017338461,0.000089225236,0.0000309109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000069555776,0.000060040704,0.0000693227,0.000014445597,0.000014859279,0.000006057757,0.0000979979,0.00004958787,0.0000055015053],"category_scores_gemma":[0.000039272116,0.000043159886,0.000025287047,0.000057348476,0.000057619716,0.0000016719509,0.000059609694,0.000043250464,0.000002483794],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095874077,0.0011496182,0.6468234,0.000117325435,0.00026612644,0.000021969969,0.0009372871,0.013457925,0.22845203,0.0037481422,0.103255816,0.00081160816],"study_design_scores_gemma":[0.013833398,0.0010435857,0.19606344,0.00013416045,0.0000934764,0.00008592064,0.00024901616,0.0006372298,0.7295851,0.0030264726,0.054773677,0.00047448388],"about_ca_topic_score_codex":0.00011753116,"about_ca_topic_score_gemma":0.00044069043,"teacher_disagreement_score":0.5011331,"about_ca_system_score_codex":0.000025172112,"about_ca_system_score_gemma":0.0002516636,"threshold_uncertainty_score":0.17600091},"labels":[],"label_agreement":null},{"id":"W2552830870","doi":"10.1182/blood.v126.23.2074.2074","title":"Management Experience of Peripherally Inserted Central Catheters in Pediatric Oncology Patients: A 15 Year Population-Based Study from Maritimes, Canada","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Central Venous Catheters and Hemodialysis","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Izaak Walton Killam Health Centre","funders":"","keywords":"Medicine; Pediatric oncology; Pharmacy; Population; Cancer; Emergency medicine; Pediatrics; Family medicine; Database; Internal medicine","score_opus":0.02147810972876991,"score_gpt":0.29904957681280675,"score_spread":0.27757146708403685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552830870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979805,0.000043099062,0.0000047443514,0.00007885551,0.00034059398,0.0009415349,0.00006963274,0.000018210758,0.00052283175],"genre_scores_gemma":[0.99888253,0.000009182158,0.00039311804,0.00030820307,0.00006696143,0.000112809736,0.00015618674,0.000017053273,0.00005393789],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980639,0.00032125827,0.0005516907,0.00027418832,0.00034988468,0.0004390633],"domain_scores_gemma":[0.9991579,0.00008791548,0.00020669878,0.000266865,0.00009516866,0.00018544184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014368645,0.00013561195,0.00032569517,0.000103919796,0.00009563408,0.0000045338734,0.00019318335,0.00008402436,0.0001629135],"category_scores_gemma":[0.00004468517,0.00013034472,0.00004647578,0.0002619846,0.00001028963,0.00004769112,0.000066250046,0.00017772561,0.0000053758467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011089648,0.002425676,0.986456,0.000027751403,0.00003611279,0.000028075588,0.010243394,0.00005959303,0.0000017930463,0.0000064392743,0.0003323659,0.00027192748],"study_design_scores_gemma":[0.006575981,0.00025169153,0.9845073,0.00001943005,0.00012110092,3.075208e-8,0.008001399,0.00006361205,0.0000028607103,0.00001613185,0.00030862686,0.00013182276],"about_ca_topic_score_codex":0.6749437,"about_ca_topic_score_gemma":0.6739824,"teacher_disagreement_score":0.006465085,"about_ca_system_score_codex":0.000630547,"about_ca_system_score_gemma":0.00082132325,"threshold_uncertainty_score":0.5315303},"labels":[],"label_agreement":null},{"id":"W2552837482","doi":"10.1182/blood.v118.21.sci-16.sci-16","title":"Oncogenic Regulation of Tissue Factor Expression","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Hospital; Montreal Children's Hospital","funders":"","keywords":"Cancer research; Biology; Cancer; Epidermal growth factor receptor; Cancer cell; Downregulation and upregulation; Immunology; Genetics; Gene","score_opus":0.05436391406357001,"score_gpt":0.2802541998374577,"score_spread":0.2258902857738877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552837482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98941314,0.00011496953,0.00091421907,0.000023204871,0.00009467803,0.00021030952,0.0000036774813,0.00005858098,0.0091672465],"genre_scores_gemma":[0.9929611,0.000008845757,0.00627712,0.000041353964,0.000052425563,0.000005323531,0.000009806987,0.000012776023,0.0006312358],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994247,0.000019618092,0.00018218791,0.0001223395,0.00016307343,0.00008805654],"domain_scores_gemma":[0.9995455,0.000009068492,0.00008702986,0.00022798589,0.00006286101,0.00006751215],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000047401198,0.00007051097,0.00016309385,0.000060758823,0.000019597428,0.0000015630046,0.000041377138,0.00007964915,0.0019617788],"category_scores_gemma":[0.000020449654,0.000059359783,0.000048026293,0.0000862933,0.00001710164,0.000048412352,0.000018870065,0.00004754215,0.000076713506],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027691527,0.0005068415,0.0027870121,0.000029698616,0.000030574036,0.0000019252664,0.00035214899,6.1575705e-8,0.99298584,0.0010033547,0.000045371005,0.0022294836],"study_design_scores_gemma":[0.0013561205,0.00023820453,0.17241001,0.00005103455,0.00009567858,0.000011131894,0.000024461047,0.000005978395,0.8249803,0.00058674015,0.00019127515,0.000049021848],"about_ca_topic_score_codex":0.000010460456,"about_ca_topic_score_gemma":7.9537483e-7,"teacher_disagreement_score":0.169623,"about_ca_system_score_codex":0.000004774767,"about_ca_system_score_gemma":0.000024244684,"threshold_uncertainty_score":0.99895054},"labels":[],"label_agreement":null},{"id":"W2552855124","doi":"10.1182/blood.v126.23.730.730","title":"Impact of Cytogenetics on Outcomes of Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma Treated with Continuous Lenalidomide Plus Low-Dose Dexamethasone in the First (MM-020) Trial","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont; University of Calgary; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lenalidomide; Internal medicine; Multiple myeloma; Melphalan; Population; Clinical endpoint; Oncology; Surgery; Randomized controlled trial","score_opus":0.030789792210626134,"score_gpt":0.2931294713694757,"score_spread":0.2623396791588496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552855124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966494,0.00008301849,0.000011981814,0.000055550045,0.000016811415,0.002739423,0.00028194906,0.000022170276,0.00013968638],"genre_scores_gemma":[0.9989892,0.000032116368,0.00051816774,0.000028703402,0.000034153803,0.0001293278,0.00019645502,0.000042619096,0.000029225053],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99767226,0.0001575013,0.00049384724,0.00032109613,0.0008902414,0.0004650501],"domain_scores_gemma":[0.998013,0.00068766094,0.00023197936,0.0005423732,0.0002638137,0.00026112937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025031177,0.0003446462,0.0009171186,0.00024082349,0.000039101535,0.000016073745,0.00020619809,0.00010293498,0.000017283537],"category_scores_gemma":[0.0003508441,0.00016821102,0.00017437879,0.0004298799,0.00014488626,0.000053117776,0.000018128983,0.00019067859,0.0000068545905],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14911018,0.0071906834,0.840482,0.00005966638,0.00088882144,0.0004206073,0.00092273497,0.00024434162,0.00011975704,0.0000010006853,0.00002396286,0.00053623517],"study_design_scores_gemma":[0.35060984,0.012740147,0.63019204,0.00020461467,0.00035292437,0.000013007114,0.00009070176,0.000060689446,0.0056100492,0.0000013120562,0.0000042165825,0.00012044548],"about_ca_topic_score_codex":0.0031987382,"about_ca_topic_score_gemma":0.0013800677,"teacher_disagreement_score":0.21028996,"about_ca_system_score_codex":0.00009657991,"about_ca_system_score_gemma":0.00035679943,"threshold_uncertainty_score":0.6859446},"labels":[],"label_agreement":null},{"id":"W2552867110","doi":"10.1182/blood.v126.23.223.223","title":"On the Origins of AML Relapse","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Myeloid leukemia; Population; clone (Java method); Biology; Oncology; Leukemia; CD33; Stem cell; Myeloid; Immunology; Medicine; Internal medicine; CD34; Genetics; Gene","score_opus":0.04237384355777724,"score_gpt":0.3058867926023476,"score_spread":0.26351294904457034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552867110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9527291,0.00008874022,0.000009186254,0.0035579463,0.000043960543,0.00019110968,0.00000396333,0.000022887187,0.043353096],"genre_scores_gemma":[0.99664044,0.000014572068,0.00024588805,0.0004799051,0.00011640556,0.000009626138,0.0000034180036,0.000012499878,0.002477244],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99928814,0.000039116156,0.000100700396,0.0000971433,0.00033378816,0.00014111905],"domain_scores_gemma":[0.9992329,0.00013868087,0.000027927634,0.0003847774,0.00010291818,0.000112798094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000334169,0.00005599888,0.00011766685,0.00004559137,0.000018286944,0.000003835067,0.000115829374,0.000044400767,0.000103109145],"category_scores_gemma":[0.0006629294,0.00003101516,0.000038338883,0.00015983256,0.00007035433,0.000015939744,0.00003992162,0.0002146847,0.00031877146],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015209505,0.004266444,0.03732145,0.00019218554,0.0008480251,0.0008226875,0.0036682931,0.000013362199,0.05261274,0.4015576,0.49339157,0.00378471],"study_design_scores_gemma":[0.038243458,0.006484375,0.019781942,0.00043010167,0.00072148925,0.00056863885,0.001855263,0.00043118084,0.5144051,0.009267868,0.40734994,0.00046067103],"about_ca_topic_score_codex":0.00009420796,"about_ca_topic_score_gemma":0.000003322372,"teacher_disagreement_score":0.46179235,"about_ca_system_score_codex":0.00010279131,"about_ca_system_score_gemma":0.00030408823,"threshold_uncertainty_score":0.40972686},"labels":[],"label_agreement":null},{"id":"W2552881311","doi":"10.1182/blood.v116.21.666.666","title":"ABO In Morbidity and Mortality of Plasmodium Falciparum malaria","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"ABO blood group system; Malaria; Plasmodium falciparum; Biology; Cerebral Malaria; Immunology; Internal medicine; Medicine","score_opus":0.01698480311646499,"score_gpt":0.26766069102336704,"score_spread":0.25067588790690204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552881311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969772,0.00006995672,0.000006649104,0.00026812023,0.0001193605,0.00017410479,0.000014396249,0.000015916308,0.0023542675],"genre_scores_gemma":[0.9993833,0.000037052407,0.0004248173,0.00004152753,0.000059584545,0.0000055051046,0.0000071324616,0.000008059273,0.00003302234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994047,0.00001159471,0.00017215981,0.00015765116,0.00012428768,0.00012958319],"domain_scores_gemma":[0.99963945,0.000019234318,0.00003069971,0.00020842366,0.000025424908,0.000076743454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017700554,0.000076654745,0.00020927508,0.000049563856,0.00001673172,0.000003992058,0.000038289796,0.000109723725,0.00007174199],"category_scores_gemma":[0.000025811225,0.00006493993,0.00003504989,0.00008676137,0.00006322104,0.0000372841,0.00002130586,0.0002429834,0.000002766273],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003458651,0.00078519975,0.8566667,0.000088360015,0.000033183027,0.00003416249,0.00010573525,1.1687096e-7,0.14080508,0.0011901262,0.000012819905,0.00024395449],"study_design_scores_gemma":[0.0033201727,0.00010618181,0.9221367,0.000027325395,0.00014345282,0.00003879093,0.000015743417,0.000029518253,0.07373056,0.0002607063,0.00013391156,0.000056918707],"about_ca_topic_score_codex":0.00064938347,"about_ca_topic_score_gemma":0.0010573219,"teacher_disagreement_score":0.067074515,"about_ca_system_score_codex":0.0000014592323,"about_ca_system_score_gemma":0.000027920716,"threshold_uncertainty_score":0.26481736},"labels":[],"label_agreement":null},{"id":"W2552984492","doi":"10.1182/blood.v126.23.2861.2861","title":"Panobinostat Plus Azacitidine in Adult Patients with MDS, CMML, or AML: Results of a Phase 2b Study","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre","funders":"","keywords":"Panobinostat; Medicine; Azacitidine; Chronic myelomonocytic leukemia; Internal medicine; Phases of clinical research; International Prognostic Scoring System; Neutropenia; Myelodysplastic syndromes; Bone marrow; Clinical endpoint; Gastroenterology; Oncology; Toxicity; Clinical trial","score_opus":0.03451281276309057,"score_gpt":0.32088668575843354,"score_spread":0.286373872995343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552984492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996453,0.00003381467,0.0000052300497,0.00020090722,0.000036642014,0.0016742432,0.0001495018,0.000043064443,0.0014036156],"genre_scores_gemma":[0.99829537,0.000013514485,0.0005605508,0.000100632686,0.00007198359,0.00006902962,0.00015232567,0.00004083513,0.00069577736],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99766725,0.00012198048,0.0005068894,0.00039287005,0.00089816115,0.00041287436],"domain_scores_gemma":[0.99814624,0.00011444169,0.0001383675,0.0005758751,0.00070050533,0.00032459068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004015362,0.00020174097,0.00049842725,0.0002687976,0.000024001703,0.000011612281,0.00018164997,0.000080104604,0.000025613004],"category_scores_gemma":[0.0011987797,0.00013276152,0.00003410161,0.00067368255,0.00010002154,0.00010815786,0.00011403325,0.00031575587,0.000030960557],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12476373,0.078393474,0.74584,0.00042062462,0.0009916876,0.0046681557,0.02078202,0.00002211392,0.0019750667,0.000026054826,0.015135042,0.006982011],"study_design_scores_gemma":[0.8097191,0.050296072,0.11342708,0.00062596885,0.0005848665,0.000083525956,0.00907624,0.00030259686,0.013982069,0.000010728256,0.001379664,0.0005121327],"about_ca_topic_score_codex":0.0009972659,"about_ca_topic_score_gemma":0.00057749165,"teacher_disagreement_score":0.68495536,"about_ca_system_score_codex":0.00020767082,"about_ca_system_score_gemma":0.00094333553,"threshold_uncertainty_score":0.54138577},"labels":[],"label_agreement":null},{"id":"W2553030279","doi":"10.1182/blood.v120.21.3823.3823","title":"SF3B1 Mutations Are Associated with Favorable Cytogenetics in Patients with Myelodysplastic Syndromes with Ring Sideroblasts","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Myelodysplastic syndromes; International Prognostic Scoring System; Gene mutation; Medicine; Cytogenetics; Dysplasia; Internal medicine; Exon; Mutation; Oncology; Genetics; Pathology; Biology; Bone marrow; Chromosome; Gene","score_opus":0.01584725277878122,"score_gpt":0.2403556184477952,"score_spread":0.224508365669014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553030279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99817157,0.00007188412,0.00012323803,0.00007568636,0.000016963337,0.00067924184,0.000025817664,0.000079158635,0.0007564565],"genre_scores_gemma":[0.9974028,0.00000446725,0.0019370024,0.000054393993,0.000035679557,0.00006841466,0.00010240868,0.00008076795,0.00031409768],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997987,0.00007025076,0.00022884294,0.0002852617,0.00068972935,0.00073894334],"domain_scores_gemma":[0.9987782,0.00020139835,0.00014806264,0.0003106685,0.00027150376,0.00029011947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016467359,0.00024970406,0.00039059267,0.00025269928,0.00010901137,0.000032001502,0.000105493695,0.00010500576,0.000040081864],"category_scores_gemma":[0.00023216911,0.0001705466,0.000022830898,0.00074987824,0.00012574662,0.0001946518,0.00004900361,0.00039480918,0.000041292016],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026570048,0.001462658,0.9967286,0.00007900467,0.0003546897,0.00014038986,0.00042045373,0.00035326375,0.00010023121,0.000011190095,0.000026968457,0.000056841527],"study_design_scores_gemma":[0.013853421,0.001385551,0.98121643,0.0008833274,0.00037456022,0.0000947218,0.00034010832,0.00009082749,0.0014962585,0.0000036785189,0.000015755277,0.0002453851],"about_ca_topic_score_codex":0.00004339314,"about_ca_topic_score_gemma":0.00028424393,"teacher_disagreement_score":0.015512204,"about_ca_system_score_codex":0.00025805924,"about_ca_system_score_gemma":0.00028055493,"threshold_uncertainty_score":0.69546884},"labels":[],"label_agreement":null},{"id":"W2553044273","doi":"10.1182/blood.v126.23.1567.1567","title":"Identification and Characterization of New Microrna Biomarkers and Target Genes in Drug-Insensitive CD34+ CML Stem/Progenitor Cells Using Global Comparative RNA-Seq Analyses","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; BC Cancer Agency","funders":"","keywords":"microRNA; CD34; Stem cell; Progenitor cell; Biology; Cancer research; Haematopoiesis; MiRBase; Gene; Genetics","score_opus":0.07088415501151525,"score_gpt":0.33085009260272763,"score_spread":0.2599659375912124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553044273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976708,0.0014849892,0.000116878924,0.000049321974,0.0000792692,0.00047045838,0.00007345205,0.000014839496,0.000039952614],"genre_scores_gemma":[0.997973,0.00007922089,0.0016905178,0.000015645866,0.00006518682,0.000003970175,0.00009351948,0.000009969743,0.000068917485],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99900526,0.00008050756,0.00032597655,0.0002754851,0.0001714814,0.00014132066],"domain_scores_gemma":[0.9993238,0.000021408354,0.00022799855,0.0001467674,0.00013141315,0.00014860506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012010335,0.00015330591,0.00035055022,0.000104588056,0.000027378674,0.000021306698,0.000032682314,0.000062962354,0.00000280662],"category_scores_gemma":[0.0000114679415,0.00014404926,0.000031226722,0.0002742288,0.00007726968,0.00012056438,0.000035173514,0.00004183464,0.000003057492],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015634546,0.00019780626,0.06645895,0.000054283977,0.00031819282,0.000025075668,0.0015643158,0.0000042492543,0.9305492,0.0000020140476,0.000024206372,0.000645378],"study_design_scores_gemma":[0.0055797985,0.00007109492,0.10569222,0.00011033586,0.00047130277,0.00006808903,0.0010510994,0.00091895653,0.88588655,0.000013224719,0.000024205134,0.00011312891],"about_ca_topic_score_codex":0.00094877643,"about_ca_topic_score_gemma":0.000064305874,"teacher_disagreement_score":0.044662636,"about_ca_system_score_codex":0.00024250572,"about_ca_system_score_gemma":0.00033200587,"threshold_uncertainty_score":0.5874159},"labels":[],"label_agreement":null},{"id":"W2553077423","doi":"10.1182/blood.v116.21.138.138","title":"Studies of BP-1-102, a Novel Direct Small-Molecule Inhibitor of Stat3 Demonstrates Substantial Anti-Myeloma Pre-Clinical Activity","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"STAT3; Angiogenesis; Cell biology; Chemistry; Biology; SH2 domain; Cancer research; Phosphopeptide; Phosphorylation; Tyrosine phosphorylation","score_opus":0.06712066682499301,"score_gpt":0.37671051634063724,"score_spread":0.3095898495156442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553077423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977071,0.00042854907,0.000021191974,0.00008548193,0.00016804042,0.0005997558,0.00013788816,0.000039152088,0.0008127827],"genre_scores_gemma":[0.9970237,0.00015246778,0.002455891,0.000010169737,0.00016535712,0.000023754978,0.000015332223,0.000025988711,0.00012733358],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99822354,0.000087945235,0.0005205243,0.00036875802,0.0004294258,0.000369802],"domain_scores_gemma":[0.99823827,0.0005235264,0.00023282881,0.00043662122,0.00033496716,0.00023377615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043977922,0.00021396362,0.00079449377,0.000118899145,0.00005830895,0.000009615215,0.00012723632,0.00015457105,0.00004029957],"category_scores_gemma":[0.0011356713,0.00016357584,0.00022558834,0.00023080164,0.0005156332,0.00006755267,0.000108777924,0.00037257886,0.0000066066764],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069177337,0.005290995,0.31409788,0.00021621371,0.0012110067,0.00009034659,0.0001242244,1.2312302e-7,0.6757203,0.000017217799,0.00004299166,0.002496925],"study_design_scores_gemma":[0.0069275084,0.00091717334,0.38940296,0.0000981305,0.00027560536,0.000023925826,0.000049172086,0.000032173833,0.6021556,0.0000051599113,0.000026161973,0.00008642189],"about_ca_topic_score_codex":0.00017376842,"about_ca_topic_score_gemma":0.00035650088,"teacher_disagreement_score":0.07530507,"about_ca_system_score_codex":0.00001026774,"about_ca_system_score_gemma":0.00029483647,"threshold_uncertainty_score":0.6670429},"labels":[],"label_agreement":null},{"id":"W2553080860","doi":"10.1182/blood.v120.21.1016.1016","title":"Daily Pain Is Unrelated to Admission Rate in Adult Patients with Sickle Cell Disease","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Disease; McGill Pain Questionnaire; Prospective cohort study; Sickle cell anemia; Cohort; Pediatrics; Visual analogue scale; Physical therapy; Internal medicine","score_opus":0.003803109477291546,"score_gpt":0.20158488656425416,"score_spread":0.19778177708696262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553080860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962727,0.0003806384,0.000028041806,0.0010105168,0.00006484088,0.0005155841,0.000012116886,0.000049101945,0.0016664773],"genre_scores_gemma":[0.99584234,0.000040487772,0.00014073629,0.0028948376,0.00003244104,0.000016913335,0.000057460227,0.000030436766,0.0009443393],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989304,0.00009787582,0.00019126749,0.00020016104,0.00020053983,0.00037975382],"domain_scores_gemma":[0.99890107,0.00003466842,0.00004407242,0.00023542465,0.000079644924,0.0007051482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023401175,0.0001540931,0.00017484205,0.00009721304,0.000045387293,0.000007522799,0.00005256889,0.00010289169,0.00017906458],"category_scores_gemma":[0.00019618637,0.0001059609,0.0000409708,0.0003379761,0.000018147206,0.000074400145,0.000028883704,0.00019038026,0.00017693662],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054509775,0.003720701,0.9880023,0.000115352224,0.000035365836,0.000043375276,0.0012776833,0.000010758425,0.000632393,0.000007669334,0.0034350706,0.0021742391],"study_design_scores_gemma":[0.022514751,0.0010521924,0.96124166,0.00088360143,0.00046730728,0.000001977154,0.0006182406,0.00020652529,0.0037007027,0.000016467337,0.008822213,0.00047435716],"about_ca_topic_score_codex":0.000039996277,"about_ca_topic_score_gemma":0.0000030242827,"teacher_disagreement_score":0.02676063,"about_ca_system_score_codex":0.000023301503,"about_ca_system_score_gemma":0.00007455814,"threshold_uncertainty_score":0.432096},"labels":[],"label_agreement":null},{"id":"W2553084570","doi":"10.1182/blood.v126.23.sci-46.sci-46","title":"The Role of the Tumor Microenvironment in Lymphoid Malignancies","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Tumor microenvironment; Biology; Immune system; Cancer research; Population; Immunology; Medicine","score_opus":0.008041100225880034,"score_gpt":0.20170292537103712,"score_spread":0.1936618251451571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553084570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898235,0.0059892996,5.9068324e-8,0.0007083493,0.000043028012,0.00021525388,0.00000406076,0.0000046192595,0.003211801],"genre_scores_gemma":[0.9994027,0.00011166079,0.000045443954,0.00015839447,0.000025226114,0.000045739358,9.9832e-7,0.0000057928787,0.00020403131],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994792,0.000023861605,0.00012904326,0.000084665844,0.00016124973,0.000121991165],"domain_scores_gemma":[0.9996037,0.00003181013,0.00004601308,0.00026340087,0.000011711095,0.000043377604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009667255,0.00006382961,0.00010569258,0.000011127926,0.000030179408,0.0000053742306,0.00007829371,0.000015364345,0.000007196846],"category_scores_gemma":[0.000030569387,0.000029178285,0.000052313993,0.000054666365,0.000063089,0.000010933823,0.000052022875,0.000020804719,0.00002005264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027453909,0.0011762492,0.98854566,0.000005284153,0.000046393758,0.000022310975,0.00032799813,0.0000018549108,0.0074787973,0.00030622215,0.00027097904,0.0017908013],"study_design_scores_gemma":[0.0044191577,0.00013733954,0.6078375,0.00006234535,0.00010383256,0.00010799862,0.00062354095,0.0000045441207,0.36641166,0.00024961823,0.020001955,0.00004049882],"about_ca_topic_score_codex":0.00012751656,"about_ca_topic_score_gemma":0.000032730346,"teacher_disagreement_score":0.38070816,"about_ca_system_score_codex":0.000071030605,"about_ca_system_score_gemma":0.000081307866,"threshold_uncertainty_score":0.11898559},"labels":[],"label_agreement":null},{"id":"W2553090920","doi":"10.1182/blood.v118.21.494.494","title":"Older Adults with Chronic Myelogenous Leukemia (CML), During the Tyrosine Kinase Inhibitor (TKI) Era, Can Be Successfully Treated with Reduced Intensity Conditioning (RIC) Hematopoietic Cell Transplant (HCT) Using Sibling or Unrelated Donors: A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Cohort; Graft-versus-host disease; Transplantation; Tyrosine-kinase inhibitor; Hematopoietic cell; Chronic myelogenous leukemia; Hematopoietic stem cell transplantation; Leukemia; Gastroenterology; Oncology; Surgery; Cancer; Stem cell; Haematopoiesis","score_opus":0.023914268884525323,"score_gpt":0.25561950522369226,"score_spread":0.23170523633916693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553090920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963891,0.00047174952,0.0000959347,0.00013642652,0.0000675769,0.0021338335,0.0005011375,0.0001160685,0.00008819565],"genre_scores_gemma":[0.997029,0.0002435518,0.0009603872,0.000055017146,0.00021290196,0.00023866442,0.0009590875,0.00011161621,0.00018973865],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99652886,0.0001459595,0.00067235605,0.0010102506,0.00070969725,0.0009328833],"domain_scores_gemma":[0.99768686,0.00019211642,0.00027705808,0.0005843049,0.0009228201,0.0003368314],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037950373,0.00056808087,0.0008133567,0.00075625174,0.00064088334,0.00010462557,0.0002719984,0.00023805024,0.00017524099],"category_scores_gemma":[0.000045058237,0.00035724166,0.00018893284,0.001283935,0.0003792338,0.00019319543,0.000053792824,0.0007112849,0.0000016491606],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040514722,0.0063316617,0.70918435,0.003584988,0.021293562,0.008239218,0.043993536,0.0004494335,0.16617493,0.000019318437,0.000030110683,0.00018417712],"study_design_scores_gemma":[0.10202828,0.00411371,0.109694466,0.006637375,0.020753955,0.0051436233,0.0023765895,0.0029435463,0.745226,0.000004717251,0.000009166781,0.0010685195],"about_ca_topic_score_codex":0.0045889434,"about_ca_topic_score_gemma":0.0051186434,"teacher_disagreement_score":0.59948987,"about_ca_system_score_codex":0.0011510367,"about_ca_system_score_gemma":0.0010974888,"threshold_uncertainty_score":0.99988794},"labels":[],"label_agreement":null},{"id":"W2553095985","doi":"10.1182/blood.v124.21.3936.3936","title":"Validation of Favourable Impact of Large Granular Lymphocytosis after Allogeneic Hematopoietic Cell Transplantation","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Leukemia & Lymphoma Society of Canada; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Lymphocytosis; Medicine; Cumulative incidence; Transplantation; Incidence (geometry); Internal medicine; Hematopoietic stem cell transplantation; Hematopoietic cell; Immunology; Gastroenterology; Haematopoiesis; Biology; Stem cell","score_opus":0.008379520726586506,"score_gpt":0.25029380437091875,"score_spread":0.24191428364433223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553095985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922231,0.00019946494,0.005765739,0.000019344014,0.00003831564,0.00038288496,0.000077258395,0.000032283308,0.0012616286],"genre_scores_gemma":[0.998194,0.00015449259,0.0013200453,0.000024471348,0.000028044085,0.000029224184,0.00017228752,0.000031677446,0.00004578786],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99854153,0.00009911861,0.00052845693,0.0002245413,0.00036485132,0.00024149625],"domain_scores_gemma":[0.99914205,0.00010328935,0.0001981571,0.00031687817,0.00013647969,0.0001031186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003536375,0.00017915764,0.00045338142,0.00016884264,0.000025613619,0.0000059217996,0.00007522341,0.00013395541,0.00023741036],"category_scores_gemma":[0.000018314395,0.00015519245,0.00025609144,0.00022267654,0.0000366861,0.00007978134,0.0000054406755,0.000063390835,0.000025269668],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037756094,0.0010920919,0.34486726,0.0032576602,0.00013127929,0.000020901489,0.0018070069,0.0000801092,0.64821446,0.000064057065,0.000011695967,0.00007590938],"study_design_scores_gemma":[0.0060994504,0.00042229972,0.13960372,0.0003148374,0.0010059105,0.00012680181,0.00004468636,0.000055381504,0.8521176,0.000078839716,0.0000068591244,0.0001236091],"about_ca_topic_score_codex":0.000064520646,"about_ca_topic_score_gemma":0.0000037736459,"teacher_disagreement_score":0.20526356,"about_ca_system_score_codex":0.000029193738,"about_ca_system_score_gemma":0.000097165765,"threshold_uncertainty_score":0.6328564},"labels":[],"label_agreement":null},{"id":"W2553096308","doi":"10.1182/blood.v126.23.1484.1484","title":"Classification of Non-Hodgkin Lymphoma in Seven Geographic Regions Around the World: Review of 4539 Cases from the International Non-Hodgkin Lymphoma Classification Project","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Lymphoma; Medicine; Hodgkin lymphoma; Internal medicine; Demography","score_opus":0.06014153233966715,"score_gpt":0.3246387048681435,"score_spread":0.2644971725284764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553096308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.976486,0.009039804,0.000021838465,0.008610356,0.00022002985,0.0017204543,0.00012432845,0.00002683245,0.0037503203],"genre_scores_gemma":[0.9916002,0.006046766,0.00040834604,0.00064482103,0.00022506772,0.0005290439,0.00036121995,0.000026242984,0.00015828348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997723,0.00019456308,0.0008065329,0.00039859183,0.00066130096,0.00021604047],"domain_scores_gemma":[0.9973686,0.00064843113,0.0006135648,0.000928568,0.00035975463,0.00008109458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073522516,0.00024177966,0.0004902244,0.0002548069,0.00006947044,0.000029471757,0.00042009342,0.000095195755,0.000022004657],"category_scores_gemma":[0.00039807067,0.00014316663,0.00023068636,0.0009310184,0.00020742776,0.00011877996,0.00008371806,0.00007448029,0.000016354415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003965806,0.0083436165,0.92177016,0.00056032866,0.0010515227,0.000095859854,0.0015685573,0.000002654096,0.001807097,0.0021337532,0.02085984,0.04141002],"study_design_scores_gemma":[0.0071208295,0.00027348296,0.97080076,0.0040201517,0.00079777825,0.00011636566,0.0011935738,0.00037760104,0.0018983565,0.00019383297,0.0130485315,0.00015875229],"about_ca_topic_score_codex":0.0032966689,"about_ca_topic_score_gemma":0.0012553496,"teacher_disagreement_score":0.049030576,"about_ca_system_score_codex":0.00022597192,"about_ca_system_score_gemma":0.0006668398,"threshold_uncertainty_score":0.5838166},"labels":[],"label_agreement":null},{"id":"W2553096850","doi":"10.1182/blood.v116.21.576.576","title":"The Reduced Lymphopoietic Potential of a Novel Subclass of Hematopoietic Stem Cells Is Mediated by Specific Defects In the Production and Activity of Their Common Lymphoid Progenitor (CLP) Progeny","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Terry Fox Research Institute","funders":"","keywords":"Haematopoiesis; Biology; Stem cell; Bone marrow; Progenitor cell; Myeloid; Immunology; Population; Cell biology; Lymphopoiesis; Medicine","score_opus":0.01361600778926229,"score_gpt":0.23062021925727766,"score_spread":0.21700421146801538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553096850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969647,0.0004937456,0.000022609125,0.00030427412,0.00023102156,0.0018233061,0.000073588024,0.000018935849,0.000067844565],"genre_scores_gemma":[0.9994781,0.00019388748,0.00012261547,0.00001166785,0.00005719721,0.00007717156,0.000010695467,0.000031109183,0.000017563338],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980662,0.00016860827,0.00062375556,0.00033535704,0.0005423503,0.00026375402],"domain_scores_gemma":[0.99831605,0.00038045572,0.00044892836,0.00061810086,0.00016526658,0.00007122795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083849765,0.00022723145,0.00049954257,0.00009784046,0.000071733266,0.000014126182,0.00021762874,0.00017737175,0.000006262662],"category_scores_gemma":[0.000045524772,0.00014011144,0.00012010773,0.00039261053,0.00038788814,0.00006221808,0.00002845793,0.00021556031,0.0000013184637],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034084372,0.0019599143,0.009442907,0.00086413324,0.00009655043,0.0000047556073,0.003315976,5.4157255e-7,0.9833662,0.000031373784,0.00004078986,0.00053605164],"study_design_scores_gemma":[0.0031011112,0.0002676377,0.009922799,0.00026599283,0.00026556017,0.00048596048,0.00094751443,0.00007244847,0.9845098,0.000019053774,0.000026019008,0.00011605988],"about_ca_topic_score_codex":0.000049991708,"about_ca_topic_score_gemma":0.000033829165,"teacher_disagreement_score":0.0027602674,"about_ca_system_score_codex":0.000019776991,"about_ca_system_score_gemma":0.00016985871,"threshold_uncertainty_score":0.5713579},"labels":[],"label_agreement":null},{"id":"W2553101160","doi":"10.1182/blood.v114.22.1108.1108","title":"Late Development of Cytogenetic Abnormalities in Ph Negative Cells of Chronic Myeloid Leukemia Patients Treated with Imatinib.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Imatinib; Medicine; Internal medicine; Imatinib mesylate; Myeloid leukemia; Chronic myelogenous leukemia; Philadelphia chromosome; Confidence interval; Gastroenterology; Cytogenetics; Leukemia; Cohort; Surgery; Chromosomal translocation; Biology; Genetics","score_opus":0.009663185553796073,"score_gpt":0.2261462707512802,"score_spread":0.2164830851974841,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553101160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967409,0.00025814728,0.000006691483,0.000010006564,0.00001569103,0.0007103508,0.000023496317,0.000027908747,0.0022068142],"genre_scores_gemma":[0.99577373,0.000061423336,0.0036798231,0.00002549229,0.000020991522,0.000029172264,0.00006941328,0.000024729838,0.0003152456],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982528,0.000045740177,0.0006717514,0.00028472327,0.0003877419,0.00035724466],"domain_scores_gemma":[0.99907225,0.000056124183,0.0003078638,0.00031703626,0.00014954041,0.0000972056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000094572366,0.00027157002,0.0005895966,0.00019283868,0.00003048885,0.0000043600126,0.00010882894,0.00009765432,0.00007939355],"category_scores_gemma":[0.000018396735,0.00021477012,0.000061116974,0.00033908244,0.000094158655,0.00006705335,0.000028927574,0.000130856,0.00001305135],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019015907,0.009097897,0.7665105,0.0015153934,0.0015453541,0.00022928754,0.016466621,0.0005284499,0.15835994,0.00004106477,0.000060500606,0.0437434],"study_design_scores_gemma":[0.01707244,0.0015821784,0.36587015,0.0005851452,0.00017949681,0.000007643328,0.000082943494,0.000056707464,0.61438876,0.000012502718,0.00001653145,0.00014551365],"about_ca_topic_score_codex":0.00017818423,"about_ca_topic_score_gemma":0.000102348735,"teacher_disagreement_score":0.45602882,"about_ca_system_score_codex":0.0010306428,"about_ca_system_score_gemma":0.0013992647,"threshold_uncertainty_score":0.87580717},"labels":[],"label_agreement":null},{"id":"W2553114211","doi":"10.1182/blood.v126.23.2580.2580","title":"Clinical Response to Idasanutlin (RG7388) in Acute Myeloid Leukemia Patients Is Associated with Pre-Treatment MDM2 Protein Expression in Leukemic Blasts and Leukemic Stem Cells","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Jewish General Hospital","funders":"","keywords":"Medicine; Cytarabine; Myeloid leukemia; Mdm2; Leukemia; Minimal residual disease; Internal medicine; Stem cell; Cancer research; Oncology; Immunology; Biology; Apoptosis","score_opus":0.026269537097037745,"score_gpt":0.30767903773946204,"score_spread":0.2814095006424243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553114211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951484,0.00012279139,0.000008561933,0.00027880643,0.00006876334,0.00396352,0.00010995679,0.00011080555,0.00018837857],"genre_scores_gemma":[0.9925851,0.00009735901,0.0013197849,0.00036855644,0.000092465525,0.00047769892,0.00005061043,0.00011700178,0.0048914272],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99457127,0.001050365,0.0011213339,0.001220939,0.00102955,0.0010065449],"domain_scores_gemma":[0.9971233,0.0004602669,0.000277741,0.00083662366,0.00034786822,0.0009541897],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019730784,0.000566367,0.0010886823,0.00065090595,0.00006862086,0.000049284856,0.00032195757,0.00054911367,0.00002095465],"category_scores_gemma":[0.00054068776,0.00044164844,0.00010481498,0.0009885731,0.00020437993,0.0002137472,0.00035948976,0.0008241864,0.000120004064],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.056537233,0.0051411726,0.61970204,0.000109032066,0.00059397443,0.0021353012,0.0066619385,0.000053410306,0.2956494,0.0000010227104,0.003905216,0.009510241],"study_design_scores_gemma":[0.099565014,0.018658316,0.5154144,0.0028012705,0.00031268504,0.000073359646,0.00060663145,0.0006740489,0.3594296,0.000019277535,0.0015683625,0.00087702554],"about_ca_topic_score_codex":0.0002968374,"about_ca_topic_score_gemma":0.00023976406,"teacher_disagreement_score":0.10428763,"about_ca_system_score_codex":0.0055802236,"about_ca_system_score_gemma":0.002903268,"threshold_uncertainty_score":0.99980354},"labels":[],"label_agreement":null},{"id":"W2553125824","doi":"10.1182/blood.v116.21.2290.2290","title":"Subcutaneous Omacetaxine (OM) Treatment of Chronic Phase (CP) Chronic Myeloid Leukemia (CML) Patients Following Multiple Tyrosine Kinase Inhibitor (TKI) Failure","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Nilotinib; Dasatinib; Imatinib; Internal medicine; Myeloid leukemia; Adverse effect; Imatinib mesylate; Population; Tyrosine-kinase inhibitor; Oncology; Gastroenterology; Cancer","score_opus":0.009099521023974712,"score_gpt":0.2515323980287856,"score_spread":0.24243287700481086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553125824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992909,0.002820963,0.0000145314325,0.00014043508,0.000902567,0.0023127866,0.00024795666,0.00025882182,0.0003928947],"genre_scores_gemma":[0.99452996,0.00022300873,0.0015295396,0.00003691872,0.0012747818,0.00023274342,0.0009612072,0.00018807243,0.0010237666],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958969,0.00007389245,0.0010233965,0.0010466225,0.0008452787,0.0011139599],"domain_scores_gemma":[0.9970549,0.00019249925,0.00043826262,0.0014936767,0.00021679077,0.0006039158],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013683946,0.000871396,0.0012956472,0.00031373967,0.0002268125,0.000041401658,0.00028864635,0.00047198072,0.0005754073],"category_scores_gemma":[0.0002270074,0.0007401987,0.00071556814,0.00049537525,0.00020364804,0.00020665099,0.00012170547,0.0005233974,0.00019562936],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000856694,0.016998071,0.037175354,0.0004444467,0.0016706735,0.0018402461,0.00044544155,0.000023531886,0.90396374,0.000025291602,0.00034836942,0.036208123],"study_design_scores_gemma":[0.17121282,0.020456657,0.0044886745,0.0005079781,0.0029380633,0.0006094827,0.00005109069,0.0006988014,0.77660483,0.000013443477,0.021536224,0.0008819435],"about_ca_topic_score_codex":0.00057573844,"about_ca_topic_score_gemma":0.0016368311,"teacher_disagreement_score":0.17035612,"about_ca_system_score_codex":0.0045550233,"about_ca_system_score_gemma":0.0023068136,"threshold_uncertainty_score":0.9995049},"labels":[],"label_agreement":null},{"id":"W2553142552","doi":"10.1182/blood.v108.11.4699.4699","title":"Single Institution Experience with Y-90 Ibritumomab Tiuxetan in the Treatment of Non-Hodgkin Lymphoma.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Fludarabine; Radioimmunotherapy; Ibritumomab tiuxetan; Lymphoma; Chemotherapy; Internal medicine; Surgery; Non-Hodgkin's lymphoma; Chlorambucil; Gastroenterology; Cyclophosphamide; Immunology; Antibody","score_opus":0.012388196634163413,"score_gpt":0.2433066486071378,"score_spread":0.2309184519729744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553142552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905397,0.0007487174,0.000009884321,0.00015222625,0.000027645263,0.00047113092,0.0000055782157,0.000017620918,0.008027457],"genre_scores_gemma":[0.99907535,0.00007227229,0.00045522084,0.0000502971,0.00007195316,0.00017804466,0.000022531676,0.000008573257,0.00006575863],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99918413,0.00002133703,0.00020344915,0.00019812076,0.00021988036,0.00017308653],"domain_scores_gemma":[0.9995455,0.00003490817,0.00006490557,0.00029388184,0.000027984079,0.000032783584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000032237404,0.000141959,0.0002330998,0.00006017871,0.000045537097,0.000014248886,0.0000560337,0.000039840343,0.00001021179],"category_scores_gemma":[0.0000040488117,0.00007704157,0.00006107064,0.00021389486,0.00009447276,0.0000550592,0.00000555221,0.000012697059,0.000007826659],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027226622,0.05026006,0.91517746,0.000036228947,0.000119943456,0.00117591,0.003585716,0.000018115214,0.00696925,0.00081885373,0.00007671227,0.02148946],"study_design_scores_gemma":[0.016601812,0.0036148066,0.8130846,0.00012143461,0.00024057754,0.00030348796,0.00041885313,0.000016397762,0.16223952,0.000021197962,0.0032340148,0.00010327625],"about_ca_topic_score_codex":0.0015524391,"about_ca_topic_score_gemma":0.00041227633,"teacher_disagreement_score":0.15527028,"about_ca_system_score_codex":0.00014865621,"about_ca_system_score_gemma":0.00008573255,"threshold_uncertainty_score":0.3141664},"labels":[],"label_agreement":null},{"id":"W2553143951","doi":"10.1182/blood.v116.21.3031.3031","title":"Baseline Peripheral Neuropathy Does Not Impact the Efficacy and Tolerability of the Novel Proteasome Inhibitor Carfilzomib (CFZ): Results of a Subset Analysis of a Phase 2 Trial In Patients with Relapsed and Refractory Multiple Myeloma (R/R MM)","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Calgary; Princess Margaret Cancer Centre","funders":"","keywords":"Carfilzomib; Tolerability; Medicine; Bortezomib; Proteasome inhibitor; Peripheral neuropathy; Adverse effect; Internal medicine; Multiple myeloma; Clinical trial; Thalidomide; Lenalidomide; Pharmacology; Oncology; Endocrinology","score_opus":0.014051712405646682,"score_gpt":0.28277856389058453,"score_spread":0.26872685148493786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553143951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99569887,0.000025577965,0.0000015645007,0.0001148831,0.00003782104,0.0025642787,0.0015437135,0.000006802392,0.0000064985506],"genre_scores_gemma":[0.9995895,0.0000062700406,0.00018898654,0.000011869092,0.00004265559,0.000049994556,0.00008429625,0.000015925945,0.000010487742],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99793434,0.00026969213,0.0006585797,0.0003637867,0.0005391765,0.00023439772],"domain_scores_gemma":[0.9978717,0.00060168153,0.0003923,0.00071313814,0.00027160437,0.00014956617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007226253,0.00020665568,0.0006971053,0.00018220457,0.00005654476,0.000010699937,0.0001259136,0.00008895479,0.000012666185],"category_scores_gemma":[0.0029940319,0.000088682784,0.00015616952,0.0005859845,0.00040187463,0.00007197806,0.00008276436,0.00034956037,6.350553e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16741185,0.010814973,0.7046532,0.00007695484,0.0007591516,0.00000660702,0.0008433008,0.000004106099,0.11343424,5.317218e-7,0.0000021716135,0.001992898],"study_design_scores_gemma":[0.23809917,0.0034170747,0.73590225,0.000053356187,0.00067617244,0.0000017168563,0.00003334034,0.00065173814,0.021092676,5.1309434e-7,0.000006361382,0.00006565627],"about_ca_topic_score_codex":0.0010966205,"about_ca_topic_score_gemma":0.0008507536,"teacher_disagreement_score":0.092341565,"about_ca_system_score_codex":0.000021482514,"about_ca_system_score_gemma":0.00016521869,"threshold_uncertainty_score":0.3616379},"labels":[],"label_agreement":null},{"id":"W2553146240","doi":"10.1182/blood.v120.21.58.58","title":"The Addition of Bevacizumab to Standard Therapy with R-CHOP in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma Is Associated with an Increased Rate of Cardiac Adverse Events: Final Analysis of Safety and Efficacy Outcomes From the Placebo-Controlled Phase 3 MAIN Study","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Diffuse large B-cell lymphoma; Ejection fraction; CHOP; Adverse effect; Bevacizumab; Hazard ratio; Gastroenterology; Oncology; Surgery; Urology; Lymphoma; Chemotherapy; Heart failure; Confidence interval","score_opus":0.008138752680167215,"score_gpt":0.24735177314037263,"score_spread":0.2392130204602054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553146240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931483,0.00021899784,0.0000033456497,0.00003337061,0.000008146751,0.003670663,0.002891043,0.000011694337,0.000014399816],"genre_scores_gemma":[0.9990902,0.00007762114,0.000039232633,0.000057235873,0.000007025117,0.0001776015,0.00051657174,0.000024585293,0.000009947495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976916,0.0006671417,0.00053491595,0.0002807583,0.00052482536,0.000300782],"domain_scores_gemma":[0.99755126,0.0009727968,0.00053914427,0.00053692143,0.0002521926,0.00014765904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006788279,0.0002955718,0.0012960032,0.00014477695,0.00010185111,0.000007799439,0.00010107736,0.000055147975,0.000027721257],"category_scores_gemma":[0.00012451677,0.00012726295,0.00014643461,0.000644948,0.0000664937,0.00009502152,0.000024629964,0.00005087636,2.9318514e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13992573,0.05280673,0.7918491,0.0000054022184,0.011832405,0.000006644946,0.002831928,0.000006126438,0.000019753761,0.0000014177107,0.000004887662,0.0007098824],"study_design_scores_gemma":[0.36649805,0.006618864,0.61791337,0.00009397317,0.007616112,1.7804527e-7,0.0006583834,0.000013493168,0.00049385004,3.2700385e-7,0.000004484184,0.00008894295],"about_ca_topic_score_codex":0.0011013432,"about_ca_topic_score_gemma":0.00088441104,"teacher_disagreement_score":0.2265723,"about_ca_system_score_codex":0.00013611445,"about_ca_system_score_gemma":0.00014309118,"threshold_uncertainty_score":0.5189632},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W2553187720","doi":"10.1182/blood.v116.21.3985.3985","title":"Identification of AML and MDS Patients Who Could Potentially Benefit From Temozolomide Therapy: Proportion of Patients with Low Methyl Guanine Methyltransferase (MGMT) Expression Level","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada); McMaster University Medical Centre; London Health Sciences Centre; Collège de Maisonneuve; Princess Margaret Cancer Centre","funders":"","keywords":"Temozolomide; Methyltransferase; O-6-methylguanine-DNA methyltransferase; Myeloid leukemia; Methylation; Medicine; Cancer research; Oncology; Leukemia; Decitabine; DNA methylation; Cytarabine; DNA methyltransferase; Bone marrow; Chemotherapy; Internal medicine; Biology; Gene expression; DNA; Genetics","score_opus":0.010951990293684561,"score_gpt":0.25385913638132007,"score_spread":0.2429071460876355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553187720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99686134,0.00008881131,0.0011385051,0.00007948504,0.000071705545,0.0012872423,0.00042107774,0.000025134015,0.000026696927],"genre_scores_gemma":[0.995278,0.000105729836,0.0037545783,0.00003492781,0.00005316589,0.000042470405,0.00061171444,0.000047707428,0.00007170301],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99765104,0.000069928305,0.0006747444,0.00043234768,0.0009338502,0.00023810832],"domain_scores_gemma":[0.9978256,0.00008358033,0.0003786256,0.0005555905,0.001000745,0.00015585063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037118752,0.00022240392,0.00047855658,0.0001982568,0.00006843784,0.000017702821,0.00017085332,0.00021360151,0.00008711284],"category_scores_gemma":[0.00020216052,0.00016172211,0.00007229086,0.00023586814,0.00018876181,0.00021294411,0.00005265801,0.0003790177,0.0000026632567],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012344056,0.0015366988,0.2985368,0.000097866716,0.00015790669,0.0000031229856,0.00021714946,0.0000012883097,0.6892204,0.000012366614,0.000031487136,0.008950493],"study_design_scores_gemma":[0.008163786,0.00051416026,0.47717914,0.000086024804,0.00013550941,7.079993e-7,0.00001894277,0.000030004154,0.51371187,0.000054832133,0.000016847353,0.00008819339],"about_ca_topic_score_codex":0.00027445288,"about_ca_topic_score_gemma":0.00004650153,"teacher_disagreement_score":0.17864233,"about_ca_system_score_codex":0.000028606348,"about_ca_system_score_gemma":0.00015091886,"threshold_uncertainty_score":0.6594836},"labels":[],"label_agreement":null},{"id":"W2553187946","doi":"10.1182/blood.v118.21.278.278","title":"Consistent Benefit of Ruxolitinib Over Placebo in Spleen Volume Reduction and Symptom Improvement Across Subgroups and Overall Survival Advantage: Results From COMFORT-I","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ruxolitinib; Medicine; Myelofibrosis; Placebo; Internal medicine; Gastroenterology; Surgery; Bone marrow; Pathology","score_opus":0.022704609610613855,"score_gpt":0.2660786291448861,"score_spread":0.24337401953427226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553187946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968843,0.0004136379,0.0000017596757,0.00014111023,0.00011712598,0.000778079,0.00064856926,0.000020593592,0.0009948313],"genre_scores_gemma":[0.99828666,0.0005104033,0.00054872053,0.000056835357,0.00007615184,0.00006545383,0.00018882369,0.000020734242,0.00024618598],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984399,0.00003548232,0.0005295365,0.0004670739,0.00023742598,0.00029059034],"domain_scores_gemma":[0.99919343,0.00010402011,0.00019198682,0.0002813603,0.00007029441,0.00015889666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024134108,0.00022620313,0.00049665564,0.000059042493,0.000056079167,0.000018612847,0.00004072098,0.000107064654,0.00006986804],"category_scores_gemma":[0.00004911939,0.00019369287,0.00005769291,0.0000590117,0.00011804351,0.000099733625,0.00009030428,0.00013096933,0.0000023619498],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002084177,0.0017736675,0.98448825,0.00008291256,0.0003626742,0.00007037256,0.0035051145,6.746745e-7,0.0050916355,0.0006962752,0.000046021014,0.0017982027],"study_design_scores_gemma":[0.02625158,0.0011925267,0.9446156,0.00020257419,0.00026488918,0.00003659962,0.0007727577,0.00003861411,0.026097443,0.0002090296,0.00013977555,0.00017858153],"about_ca_topic_score_codex":0.0036720373,"about_ca_topic_score_gemma":0.0008150747,"teacher_disagreement_score":0.039872643,"about_ca_system_score_codex":0.000047868914,"about_ca_system_score_gemma":0.000037350666,"threshold_uncertainty_score":0.7898566},"labels":[],"label_agreement":null},{"id":"W2553203976","doi":"10.1182/blood.v104.11.39.39","title":"Prevention of Anti-FVIII Inhibitor Formation Post Protein Infusion in Hemophilic Mice by Prior Feeding of the FVIII-C2 Domain.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Antibody; Adjuvant; Antigen; Immunology; Pharmacology","score_opus":0.011514231029246856,"score_gpt":0.26265753993651647,"score_spread":0.2511433089072696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553203976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963994,0.00019237818,0.0000059060603,0.0015051783,0.0000291898,0.0015448506,0.000009582416,0.0000141316905,0.00029939174],"genre_scores_gemma":[0.9992317,0.000031052226,0.00040814755,0.000018621235,0.000050080856,0.000031620828,0.000028580958,0.000012540506,0.00018766087],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988326,0.00005004131,0.00038089455,0.00014113351,0.00040664495,0.00018870365],"domain_scores_gemma":[0.9994781,0.00001761484,0.00015586217,0.0001816904,0.000117407435,0.000049323953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002814829,0.00010660492,0.00022747745,0.00014778775,0.000060683997,0.000006459161,0.000092741975,0.00010840587,0.000012867313],"category_scores_gemma":[0.00009833544,0.000070137125,0.000098906356,0.00038411806,0.00006821549,0.00014758091,0.00006726668,0.00015296535,0.0000052448754],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009454356,0.001377248,0.007832293,0.00038760842,0.000024953673,0.000004686583,0.0010064084,0.0000014807852,0.9884923,0.00005516706,0.000017334502,0.000705984],"study_design_scores_gemma":[0.0074563427,0.0005491046,0.033432808,0.0012121344,0.00005036163,0.00002237757,0.00033861722,0.0000052312066,0.9565903,0.0002484225,0.000030657997,0.00006366817],"about_ca_topic_score_codex":0.00009037456,"about_ca_topic_score_gemma":0.00003225049,"teacher_disagreement_score":0.03190202,"about_ca_system_score_codex":0.000077913974,"about_ca_system_score_gemma":0.00014865774,"threshold_uncertainty_score":0.2860109},"labels":[],"label_agreement":null},{"id":"W2553228633","doi":"10.1182/blood.v126.23.3908.3908","title":"Mass Cytometry Based Classification of Inter- and Intra-Tumoral Heterogeneity in Diffuse Large B-Cell Lymphoma","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lymph node; Biology; Mass cytometry; Lymphoma; Population; Somatic evolution in cancer; Diffuse large B-cell lymphoma; Hematopathology; Mantle cell lymphoma; Cancer research; Pathology; Cancer; Immunology; Phenotype; Genetics; Medicine; Gene; Cytogenetics; Chromosome","score_opus":0.015544120862302594,"score_gpt":0.24570164000701442,"score_spread":0.23015751914471183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553228633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966102,0.00070383225,0.0021329774,0.00003725868,0.00005993107,0.00008468565,0.0000684293,0.0000034698198,0.0002991704],"genre_scores_gemma":[0.99900305,0.00007490259,0.0006499086,0.00010800533,0.000054980446,0.000009885216,0.000077005614,0.000011361953,0.000010890309],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994297,0.000028839504,0.00016028092,0.00019209961,0.00005745915,0.00013162984],"domain_scores_gemma":[0.9995823,0.00001210938,0.00006681404,0.00021257726,0.000046945366,0.00007925837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013854308,0.00008445389,0.0001100297,0.000053174233,0.000010629934,0.000012060373,0.00008655165,0.000083797386,0.0000011319357],"category_scores_gemma":[0.000073164476,0.00008811353,0.000030584397,0.00007205345,0.00003609454,0.000002073477,0.000056062803,0.000027948927,0.000001342244],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011662126,0.0032076351,0.2370388,0.000043213888,0.000017920125,0.0000070244428,0.000040840318,0.000004570649,0.758494,0.000060195733,0.00020454783,0.00076458434],"study_design_scores_gemma":[0.018178973,0.00041546056,0.04143106,0.0000146085895,0.000032342792,0.000005763216,0.00010327248,0.0006042635,0.93685496,0.00007464607,0.0020961838,0.00018844589],"about_ca_topic_score_codex":0.000022275475,"about_ca_topic_score_gemma":0.00011014537,"teacher_disagreement_score":0.19560775,"about_ca_system_score_codex":0.000013856714,"about_ca_system_score_gemma":0.0000830134,"threshold_uncertainty_score":0.35931656},"labels":[],"label_agreement":null},{"id":"W2553233139","doi":"10.1182/blood.v118.21.lba-6.lba-6","title":"Results of Eastern Cooperative Oncology Group Protocol E4402 (RESORT): A Randomized Phase III Study Comparing Two Different Rituximab Dosing Strategies for Low Tumor Burden Follicular Lymphoma","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Rituximab; Follicular lymphoma; Interim analysis; Hazard ratio; Internal medicine; Clinical endpoint; Randomized controlled trial; Oncology; Progression-free survival; Chemotherapy; Surgery; Lymphoma; Confidence interval","score_opus":0.043929145144591966,"score_gpt":0.33856769130066294,"score_spread":0.294638546156071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553233139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88346416,0.00009452567,0.0002519327,0.000023832728,0.000058853668,0.114573106,0.000029292387,0.00006284918,0.0014414238],"genre_scores_gemma":[0.8829209,0.000002808902,0.00081266573,0.000031659172,0.00012763194,0.11599534,0.000039771174,0.000035543413,0.000033637567],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972117,0.00034273206,0.0011212406,0.00057341816,0.00033670707,0.00041418523],"domain_scores_gemma":[0.99822354,0.0003559423,0.0005266183,0.0004639949,0.00024497014,0.00018494195],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004946891,0.00042620144,0.0021498594,0.00014176169,0.00012569758,0.000047394686,0.00016235492,0.000075948876,0.000024990606],"category_scores_gemma":[0.000105182895,0.00028496914,0.00037160245,0.00012431202,0.00016876466,0.00011948652,0.00009814675,0.00007364306,0.0000064323144],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.71074593,0.23568496,0.010112623,0.0005233127,0.006688223,0.0015170556,0.022054868,0.000017837701,0.0025820762,0.0008980828,0.000065684304,0.009109318],"study_design_scores_gemma":[0.9585574,0.011580756,0.0016611434,0.0004618854,0.0025445397,0.000077046796,0.0037910182,0.001600176,0.019286603,0.00008488329,0.00009111241,0.00026342206],"about_ca_topic_score_codex":0.001566608,"about_ca_topic_score_gemma":0.00040516947,"teacher_disagreement_score":0.24781147,"about_ca_system_score_codex":0.00013897404,"about_ca_system_score_gemma":0.0003033743,"threshold_uncertainty_score":0.99996024},"labels":[],"label_agreement":null},{"id":"W2553242004","doi":"10.1182/blood.v106.11.1809.1809","title":"Clinical Outcomes and the Impact of Anti-Thymocyte Globulin (ATG) and Chronic Graft Versus Host Disease (cGVHD) Following Pediatric Allogeneic Stem Cell Transplantation: A Comparison between Peripheral Blood and Bone Marrow as a Source of Stem Cells.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Children's Hospital; Stollery Children's Hospital; University of Calgary","funders":"","keywords":"Medicine; Transplantation; Graft-versus-host disease; Anti-thymocyte globulin; Internal medicine; Stem cell; Leukemia; Bone marrow; Regimen; Hematopoietic stem cell transplantation; Surgery; Gastroenterology","score_opus":0.020431459346370594,"score_gpt":0.3020979979796384,"score_spread":0.2816665386332678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553242004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98426014,0.014406242,0.00010172532,0.00012215461,0.00006453029,0.00087503914,0.00007967116,0.000034433888,0.00005605169],"genre_scores_gemma":[0.99550426,0.003875079,0.00028764812,0.00001755145,0.00017923354,0.000014917772,0.000026784968,0.00003937412,0.00005512392],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975378,0.00025779553,0.0010243682,0.00043960224,0.0004164407,0.00032401067],"domain_scores_gemma":[0.9980387,0.00089220196,0.00035262157,0.00030826713,0.000052650907,0.0003555605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005848237,0.0003343523,0.0011361754,0.000111373294,0.00009591925,0.000029896175,0.00010755852,0.00016504273,0.000012604594],"category_scores_gemma":[0.0000101985215,0.00024023173,0.00037086898,0.00018683006,0.00024178225,0.00009585888,0.000031703818,0.00023677186,0.0000022210202],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014041766,0.0005385409,0.9900527,0.0013034012,0.000717041,0.00007506895,0.0017791472,0.000038746057,0.0033248176,0.0000052830273,0.000005098314,0.00075597194],"study_design_scores_gemma":[0.057297997,0.0012894744,0.91888374,0.00020820343,0.010908576,0.00007284917,0.00036101625,0.00025419254,0.010420403,0.00000227412,0.000010079121,0.00029119232],"about_ca_topic_score_codex":0.00012236205,"about_ca_topic_score_gemma":0.000023857272,"teacher_disagreement_score":0.07116897,"about_ca_system_score_codex":0.000024251689,"about_ca_system_score_gemma":0.00022190418,"threshold_uncertainty_score":0.97963655},"labels":[],"label_agreement":null},{"id":"W2553261733","doi":"10.1182/blood.v108.11.2415.2415","title":"Transmission of a Follicular Lymphoma by Allogeneic Bone Marrow Tranplantation — Evidence to Support the Existence of a Lymphoma Progenitor Cell.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Alberta","funders":"","keywords":"Follicular lymphoma; Lymphoma; Biology; Progenitor cell; Germinal center; Bone marrow; Cancer research; Fusion gene; Gene rearrangement; Chromosomal translocation; Immunology; B cell; Stem cell; Genetics; Gene; Antibody","score_opus":0.014148059898175138,"score_gpt":0.24796812798983975,"score_spread":0.2338200680916646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553261733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99212724,0.0057737944,0.0001039181,0.0005151592,0.00003568917,0.0010078377,0.000050993473,0.000024536987,0.00036081846],"genre_scores_gemma":[0.99726415,0.00031374398,0.001707483,0.000115575545,0.000048735335,0.00019504807,0.000051380626,0.000020985754,0.00028290483],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984075,0.000058970803,0.0004917989,0.00030257957,0.0004999797,0.00023915901],"domain_scores_gemma":[0.9991375,0.00010781617,0.00017135807,0.0003476386,0.000114791976,0.000120862154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018415472,0.0001941764,0.0003823009,0.000068395966,0.000056317258,0.000010145334,0.00013248036,0.00008682399,0.00003723681],"category_scores_gemma":[0.000018765304,0.00012708727,0.0002120814,0.0002658054,0.00006221945,0.000060307488,0.000015555031,0.00001769611,0.000011059458],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006105163,0.007388153,0.06019367,0.00051021896,0.00017509713,0.0002410601,0.0005992951,0.000005678714,0.893009,0.000052096668,0.0018568389,0.035358366],"study_design_scores_gemma":[0.0067200735,0.0013616784,0.084907435,0.00036138468,0.00080919534,0.00024054006,0.000062642546,0.000011945704,0.9036358,0.000020189582,0.0017434303,0.00012570857],"about_ca_topic_score_codex":0.00046131035,"about_ca_topic_score_gemma":0.0000148840145,"teacher_disagreement_score":0.035232656,"about_ca_system_score_codex":0.00005588797,"about_ca_system_score_gemma":0.00021694954,"threshold_uncertainty_score":0.5182468},"labels":[],"label_agreement":null},{"id":"W2553279539","doi":"10.1182/blood.v118.21.2561.2561","title":"Elderly AML Patients Treated with Intensive Chemotherapy- Developing A Prognostic Scoring System. A Study On 381 Patients From British Columbia","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Leukemia & Lymphoma Society of Canada; Vancouver Hospital and Health Sciences Centre; University of British Columbia; Vancouver General Hospital","funders":"","keywords":"Medicine; Internal medicine; Proportional hazards model; Cytarabine; Chemotherapy; Performance status; Univariate analysis; Chemotherapy regimen; Population; Induction chemotherapy; Surgery; Oncology; Multivariate analysis","score_opus":0.022520384456630137,"score_gpt":0.2366253162829681,"score_spread":0.21410493182633797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553279539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954089,0.000021739172,0.000014758408,0.000013461122,0.00006429234,0.0034791306,0.000044207343,0.00019373903,0.00075979484],"genre_scores_gemma":[0.9981998,0.000005256284,0.00082621496,0.0002283891,0.000068300214,0.00028734677,0.0001081535,0.000097902965,0.00017863113],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99767387,0.00010612621,0.0003908234,0.0006449505,0.0006739527,0.00051029806],"domain_scores_gemma":[0.9979586,0.00008190377,0.00015983732,0.0004282352,0.0011563393,0.00021506166],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010292444,0.00023710313,0.0005272553,0.000104277395,0.00015846376,0.00012618054,0.00019740987,0.0001102624,0.00005148595],"category_scores_gemma":[0.0002886419,0.00026044511,0.000055345077,0.0003997256,0.000066551205,0.00010199428,0.000080207225,0.00033729244,0.000058776805],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046695277,0.0030810947,0.9892282,0.000090805624,0.0006854799,0.0005722484,0.002160165,2.6158615e-8,0.000053584215,5.0274116e-7,0.00030291162,0.0033580633],"study_design_scores_gemma":[0.02506491,0.008264806,0.96179324,0.0019007407,0.00036174833,0.000026752512,0.0018263662,0.000005948317,0.0004552021,0.0000022691904,0.000022139073,0.00027587067],"about_ca_topic_score_codex":0.025366979,"about_ca_topic_score_gemma":0.0030479014,"teacher_disagreement_score":0.027434919,"about_ca_system_score_codex":0.00038625137,"about_ca_system_score_gemma":0.0002440099,"threshold_uncertainty_score":0.9999848},"labels":[],"label_agreement":null},{"id":"W2553294201","doi":"10.1182/blood.v118.21.3515.3515","title":"Genome-Wide Single-Nucleotide Polymorphism-Array Can Improve Prognostic Stratification of Core Binding Factor Acute Myeloid Leukemia, Especially in the Subgroup with Inv(16)/t(16;16) or without D816 C-KIT Mutation,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"SNP array; Core binding factor; SNP; Single-nucleotide polymorphism; Cytogenetics; Biology; Cytarabine; Karyotype; Myeloid leukemia; Leukemia; Pathology; Cancer research; Internal medicine; Molecular biology; Oncology; Medicine; Genetics; Chromosome; Gene; Genotype","score_opus":0.04162617733784461,"score_gpt":0.26409597598572626,"score_spread":0.22246979864788166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553294201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99310017,0.00011331035,0.0003878589,0.00048618455,0.00009829744,0.0028407976,0.00015361715,0.00010141086,0.00271838],"genre_scores_gemma":[0.995711,0.00005710743,0.0015924054,0.00029839753,0.00030703426,0.00022624423,0.0004328928,0.00012496093,0.0012499013],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99631727,0.0001992419,0.0009104951,0.00075151864,0.0010142991,0.0008071771],"domain_scores_gemma":[0.9973585,0.0004035025,0.0005715154,0.0009340289,0.0004518046,0.00028066392],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000590579,0.00048586118,0.0007020869,0.0005197576,0.00018883887,0.00008637962,0.00064626517,0.00025069306,0.0002473865],"category_scores_gemma":[0.0005361492,0.00032023116,0.00011629739,0.0011518743,0.00043681287,0.0002857718,0.00007358525,0.00079597125,0.000035172514],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021565116,0.0013776325,0.27036786,0.00033547566,0.0007146429,0.00060790934,0.016130377,0.0000016372255,0.7060287,0.00019286746,0.00015443197,0.0019319778],"study_design_scores_gemma":[0.016296377,0.0068528387,0.49715894,0.0006255003,0.0016746266,0.0009014327,0.009113232,0.000041662224,0.4655238,0.00034281565,0.00038863978,0.0010801242],"about_ca_topic_score_codex":0.0021058077,"about_ca_topic_score_gemma":0.006331461,"teacher_disagreement_score":0.24050488,"about_ca_system_score_codex":0.0013764822,"about_ca_system_score_gemma":0.0020847113,"threshold_uncertainty_score":0.99992496},"labels":[],"label_agreement":null},{"id":"W2553306917","doi":"10.1182/blood.v116.21.4206.4206","title":"Incidence and Predictive Factors of Symptomatic Thrombosis Related to Peripherally Inserted Central Catheters In Chemotherapy Patients","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Central Venous Catheters and Hemodialysis","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Peripherally inserted central catheter; Thrombosis; Surgery; Deep vein; Univariate analysis; Incidence (geometry); Complication; Chemotherapy; Retrospective cohort study; Asymptomatic; Catheter; Cohort; Internal medicine; Multivariate analysis","score_opus":0.011334801332412782,"score_gpt":0.29479017945338387,"score_spread":0.2834553781209711,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553306917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99849653,0.000011695203,0.0000070315664,0.00015214553,0.00020755225,0.0008578531,0.000045644876,0.000034770546,0.00018678661],"genre_scores_gemma":[0.9993754,0.000039767394,0.00021079162,0.00024935268,0.000014463205,0.00003611841,0.000023738305,0.000024337749,0.000026050075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984805,0.00011600428,0.00049454544,0.00026141142,0.00019576793,0.000451771],"domain_scores_gemma":[0.99917233,0.00013452755,0.00017982778,0.00023895092,0.00008715468,0.00018723242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001566973,0.00016367159,0.00036860196,0.00012861373,0.00014588368,0.0000063897655,0.00015217908,0.00019660269,0.00016579252],"category_scores_gemma":[0.000114395996,0.00013765422,0.00006945255,0.00027469156,0.000060995182,0.000099676305,0.00005697952,0.00039224696,0.000006284245],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038968323,0.00061933324,0.9406313,0.00005422969,0.00006742691,5.063449e-7,0.04864602,0.0000036091199,0.009650694,0.000021181382,0.000024187453,0.00024257443],"study_design_scores_gemma":[0.0022078156,0.00026704106,0.9951687,0.00013369917,0.000057158955,2.270747e-7,0.000885269,0.0001240013,0.0009028005,0.00009755855,0.000020446332,0.00013527366],"about_ca_topic_score_codex":0.00051935157,"about_ca_topic_score_gemma":0.0005561144,"teacher_disagreement_score":0.05453744,"about_ca_system_score_codex":0.00005523431,"about_ca_system_score_gemma":0.00009316688,"threshold_uncertainty_score":0.5613376},"labels":[],"label_agreement":null},{"id":"W2553310906","doi":"10.1182/blood.v118.21.350.350","title":"Growth Factor Independence 1b (Gfi1b) Is Required for the Regulation of Fetal Globin Genes in Both Fetal and Adult Erythroid Cells","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Haematopoiesis; Erythropoiesis; Biology; Bone marrow; Megakaryocyte; Cre recombinase; Molecular biology; Erythroblast; Thrombopoietin; Hematopoietic growth factor; Stem cell; Platelet; Thrombopoiesis; GATA2; Cell biology; Transgene; Immunology; Gene; Genetically modified mouse; Internal medicine; Anemia; Genetics; Medicine","score_opus":0.01322304570284011,"score_gpt":0.22018624315831548,"score_spread":0.20696319745547537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553310906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99692416,0.0021684007,0.00020598285,0.000033586297,0.000040343,0.000312514,0.00009733114,0.000003825804,0.00021386602],"genre_scores_gemma":[0.99856,0.00042032404,0.0007793256,0.00005119438,0.000029549283,0.000027585065,0.000032782777,0.000011960952,0.00008725314],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993752,0.000018423818,0.00015354372,0.00022879458,0.00008240637,0.00014158574],"domain_scores_gemma":[0.99963886,0.0000095089445,0.000082090395,0.00018193535,0.00005849847,0.000029124503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000047880716,0.00011270818,0.0001121352,0.000020169466,0.000044239405,0.000008185001,0.00009773125,0.00011884695,0.000010065073],"category_scores_gemma":[0.000015157775,0.0000845485,0.000057279478,0.00004589369,0.00006798682,0.0000069158305,0.000050861425,0.0000293962,9.5160726e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031038863,0.001421912,0.12871821,0.000083267034,0.00041385528,0.0000028792358,0.0007531624,0.0000013259179,0.85897577,0.00023664912,0.0001577504,0.00892484],"study_design_scores_gemma":[0.0032137441,0.0003787376,0.06862169,0.000009586179,0.00009771356,0.00000675482,0.00011306099,0.000035281362,0.9268726,0.00045467992,0.0000783462,0.00011779552],"about_ca_topic_score_codex":0.0002519408,"about_ca_topic_score_gemma":0.00022192951,"teacher_disagreement_score":0.06789686,"about_ca_system_score_codex":0.0000022866243,"about_ca_system_score_gemma":0.000028567338,"threshold_uncertainty_score":0.34477875},"labels":[],"label_agreement":null},{"id":"W2553316197","doi":"10.1182/blood.v124.21.3236.3236","title":"HSC-Independent Yolk Sac Progenitors Bear Hallmarks of JMML in a PTPN11D61Y Mouse Model","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University Health Network","funders":"","keywords":"Juvenile myelomonocytic leukemia; Biology; Yolk sac; Myeloid; Progenitor cell; Transplantation; Haematopoiesis; PTPN11; Cancer research; Bone marrow; Embryonic stem cell; Stem cell; Immunology; Internal medicine; KRAS; Cell biology; Genetics; Medicine; Mutation; Embryo","score_opus":0.015600654543327739,"score_gpt":0.271610204845462,"score_spread":0.25600955030213424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553316197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919349,0.00014947448,0.000330584,0.00040557812,0.00003262114,0.0006475845,0.000013468394,0.000055737873,0.006430085],"genre_scores_gemma":[0.99346197,0.000045179688,0.0034700097,0.00013846936,0.00015212066,0.0000663446,0.000017925639,0.00005363294,0.0025943387],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997951,0.00009373845,0.00042134535,0.0003687718,0.00068253186,0.00048265318],"domain_scores_gemma":[0.9988471,0.00006976893,0.000091117494,0.00060921983,0.00014320412,0.00023956758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006377364,0.0001881063,0.000446938,0.00030022307,0.0000324794,0.000012691992,0.00026152597,0.00021544012,0.000060368417],"category_scores_gemma":[0.0003132616,0.00016723147,0.00015455701,0.0002583597,0.00009241399,0.00007496385,0.00015142334,0.000507539,0.000063269756],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016338206,0.008804991,0.24298564,0.0016325756,0.0011411585,0.0004924735,0.0038647081,0.0013380562,0.71891445,0.0026481766,0.0039253095,0.01261864],"study_design_scores_gemma":[0.037099753,0.0018752684,0.022216214,0.0004710564,0.000635317,0.00029046953,0.0005991822,0.083868854,0.84957796,0.000780426,0.0017325818,0.00085289165],"about_ca_topic_score_codex":0.00024198828,"about_ca_topic_score_gemma":0.00006624669,"teacher_disagreement_score":0.22076942,"about_ca_system_score_codex":0.0001357097,"about_ca_system_score_gemma":0.00042075437,"threshold_uncertainty_score":0.68195015},"labels":[],"label_agreement":null},{"id":"W2553350762","doi":"10.1182/blood.v116.21.182.182","title":"Remission Rates In Childhood Acute Myeloid Leukemia (AML) Utilizing a Dose-Intensive Induction Regimen with or without Gemtuzumab Ozogamicin (GO): Initial Results From the Children's Oncology Group Phase III Trial, AAML0531","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Hospital for Sick Children","funders":"","keywords":"Medicine; Gemtuzumab ozogamicin; Cytarabine; Regimen; Internal medicine; Etoposide; Induction chemotherapy; Transplantation; Myeloid leukemia; Surgery; Gastroenterology; Pediatrics; Chemotherapy; CD33; Stem cell","score_opus":0.028875405537464385,"score_gpt":0.3402817247852424,"score_spread":0.311406319247778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553350762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893553,0.00010506407,0.000022670058,0.0034975566,0.0004616763,0.004320939,0.00014997013,0.00021367015,0.0018731207],"genre_scores_gemma":[0.9921153,0.00030612288,0.002194314,0.0011770299,0.0023925123,0.00021469746,0.000980593,0.0001439078,0.0004755017],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9949778,0.0005368388,0.0011786197,0.0013552201,0.0009270533,0.001024512],"domain_scores_gemma":[0.9960331,0.0009345148,0.0006356244,0.0014495646,0.000503312,0.00044391572],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0014217388,0.0006620206,0.0012989262,0.00042582647,0.00040889313,0.00010891902,0.00064474996,0.0008150567,0.00013179047],"category_scores_gemma":[0.0020863777,0.00039755547,0.00017495923,0.001028477,0.0005573087,0.00038883873,0.00033315248,0.0037281162,0.000051495528],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.61496794,0.004650577,0.0030616005,0.000031468717,0.0022207128,0.0026750944,0.0124273235,0.0000040256073,0.31878358,0.00006874975,0.0068167597,0.03429218],"study_design_scores_gemma":[0.8459977,0.0148054585,0.019971369,0.0009084687,0.001993546,0.004214757,0.006326814,0.0003855107,0.10067493,0.00011377908,0.003652659,0.00095503975],"about_ca_topic_score_codex":0.0036416026,"about_ca_topic_score_gemma":0.0014153961,"teacher_disagreement_score":0.23102973,"about_ca_system_score_codex":0.0008310373,"about_ca_system_score_gemma":0.0035688435,"threshold_uncertainty_score":0.99984765},"labels":[],"label_agreement":null},{"id":"W2553355410","doi":"10.1182/blood.v124.21.2304.2304","title":"High-Throughput Drug Screening Identifies Pyrimethamine As a Potent and Selective Inhibitor of Acute Myeloid Leukemia","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; BC Cancer Agency","funders":"","keywords":"Cytarabine; Myeloid leukemia; Pharmacology; Tretinoin; Leukemia; Retinoic acid; Differentiation therapy; Myeloid; Acute promyelocytic leukemia; Cancer research; Medicine; Immunology; Biology; Cell culture","score_opus":0.003934715121365889,"score_gpt":0.21612102531630373,"score_spread":0.21218631019493783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553355410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994762,0.0013403448,0.0026293346,0.000045305424,0.00009969326,0.0001257908,0.0000124129065,0.000018211764,0.0009669328],"genre_scores_gemma":[0.99450576,0.00038201714,0.0034887376,0.00008970736,0.00032751984,0.000015585601,0.00007054855,0.000028065046,0.001092072],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988741,0.00007182079,0.00024806336,0.0004090254,0.0001722212,0.00022471302],"domain_scores_gemma":[0.99934286,0.000024395024,0.000147744,0.00027328022,0.00013979668,0.00007192288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002261123,0.00018904675,0.00024423155,0.000045087818,0.00008734398,0.000029964678,0.00016386063,0.00014452278,0.000005709797],"category_scores_gemma":[0.000119168486,0.00017558974,0.000077108,0.000104303144,0.00016093109,0.00000883991,0.00018199153,0.00011671996,0.0000041249214],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000065179614,0.00006454632,0.0010782531,0.00007030053,0.00028659264,0.00000502475,0.00013532439,0.000014806964,0.996097,0.00012790081,0.0004573275,0.0015977431],"study_design_scores_gemma":[0.0013921257,0.00033784244,0.0011657287,0.000038601444,0.00020645939,0.000058146237,0.000090291396,0.000017896074,0.9948062,0.00045166013,0.0012304076,0.00020468507],"about_ca_topic_score_codex":0.00012084392,"about_ca_topic_score_gemma":0.000008771833,"teacher_disagreement_score":0.0013930581,"about_ca_system_score_codex":0.000010208277,"about_ca_system_score_gemma":0.0000990127,"threshold_uncertainty_score":0.7160342},"labels":[],"label_agreement":null},{"id":"W2553377881","doi":"10.1182/blood.v118.21.1694.1694","title":"Clonal Evolution but Not Variant Chromosomal Translocations Is An Adverse Prognostic Marker for Cytogenetic Response and Survival in CML Patients Treated with Imatinib","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada","funders":"","keywords":"Internal medicine; Imatinib; Imatinib mesylate; Medicine; Chromosomal translocation; Gastroenterology; Cohort; Oncology; Biology; Genetics; Myeloid leukemia","score_opus":0.02470868249571424,"score_gpt":0.2440317924407672,"score_spread":0.21932310994505297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553377881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99764127,0.00004816414,0.00013035485,0.000047063568,0.00002712608,0.0016873247,0.00024944707,0.000043799533,0.00012546264],"genre_scores_gemma":[0.99470717,0.0000064761166,0.0045365854,0.000037387636,0.000029324388,0.00032870928,0.00019700866,0.00003850253,0.00011883173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865735,0.00012852812,0.0002900486,0.00039723868,0.00022329505,0.00030353598],"domain_scores_gemma":[0.9992189,0.00012486766,0.00007869697,0.0002828037,0.00012773603,0.00016699142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019076391,0.00020934561,0.00026193284,0.00013123173,0.00007366454,0.0000066503017,0.000058407415,0.000104438746,0.00008969326],"category_scores_gemma":[0.00010840064,0.00017393654,0.000043663716,0.00017825406,0.000087987275,0.00010082512,0.000012457954,0.0000892114,0.0000077787545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010529764,0.0037143948,0.9792469,0.00010097103,0.00022705275,0.00011713508,0.0016776462,0.0000015122151,0.003828946,0.000028436289,0.000004869373,0.00052238617],"study_design_scores_gemma":[0.028956965,0.0033370685,0.9606439,0.00014687156,0.0007150472,0.00011587858,0.00012050025,0.00060066575,0.0051649227,0.000013805142,0.000010192218,0.00017417289],"about_ca_topic_score_codex":0.0003549298,"about_ca_topic_score_gemma":0.0002238937,"teacher_disagreement_score":0.018602975,"about_ca_system_score_codex":0.00020805179,"about_ca_system_score_gemma":0.00045090212,"threshold_uncertainty_score":0.7092926},"labels":[],"label_agreement":null},{"id":"W2553381390","doi":"10.1182/blood.v116.21.3816.3816","title":"Publication Patterns of Cancer Cost-Effectiveness Studies Presented at the American Society of Hematology: Timeliness of Publication, Quality and Possible Bias.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Family medicine; Publication bias; Statistic; MEDLINE; Quality (philosophy); Actuarial science; Internal medicine; Meta-analysis; Statistics; Law; Mathematics; Business","score_opus":0.4367420996944581,"score_gpt":0.49902784367629005,"score_spread":0.062285743981831954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553381390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9711812,0.002053663,0.0003110021,0.02467542,0.00009953529,0.00081209076,0.0007759689,0.000013915503,0.00007717979],"genre_scores_gemma":[0.9976846,0.00050437753,0.00038344992,0.00082228973,0.00005647985,0.00035202788,0.000060300357,0.000014025008,0.00012246273],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99658394,0.00036653187,0.0024604043,0.00032833905,0.00009059117,0.00017020866],"domain_scores_gemma":[0.99208146,0.0017393056,0.0047760247,0.0005615454,0.0007857756,0.000055883644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010180552,0.00011722035,0.00094565994,0.00011670579,0.00009918326,0.0000164414,0.00023076788,0.00007463129,0.00007428951],"category_scores_gemma":[0.0038865113,0.00010872012,0.00010451355,0.00030968356,0.00040524677,0.00020542552,0.00011447938,0.00011088579,0.000008924366],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013783335,0.0002338735,0.98417455,0.0010516607,0.00030612238,9.394498e-9,0.0008173059,0.0000067891788,0.00039723303,0.01022164,0.0024818457,0.00029517477],"study_design_scores_gemma":[0.0009719974,0.00003925231,0.98949933,0.00004927017,0.000030247265,0.0000017107564,0.0008463977,0.00035106365,0.00504478,0.0008997848,0.002144516,0.00012166918],"about_ca_topic_score_codex":0.0042844545,"about_ca_topic_score_gemma":0.0010672773,"teacher_disagreement_score":0.026503362,"about_ca_system_score_codex":0.000057416153,"about_ca_system_score_gemma":0.0001093875,"threshold_uncertainty_score":0.6476842},"labels":[],"label_agreement":null},{"id":"W2553381768","doi":"10.1182/blood.v112.11.522.522","title":"Genetic Alterations Detected by High-Resolution Array Comparative Genomic Hybridization in Microdissected HRS Cells Correlate with Treatment Outcome in Classical Hodgkin Lymphoma","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Comparative genomic hybridization; Microdissection; CDKN2A; Biology; Laser capture microdissection; Lymphoma; Internal medicine; Oncology; Cancer research; Cancer; Molecular biology; Genetics; Medicine; Genome; Gene","score_opus":0.01088231314139863,"score_gpt":0.23513266474154548,"score_spread":0.22425035160014686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553381768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98596555,0.0002469346,0.012976567,0.00005816893,0.000015674212,0.00057385117,0.00006656242,0.000027337437,0.00006933024],"genre_scores_gemma":[0.9919854,0.00022782818,0.0064737345,0.00005209173,0.000027552316,0.0002665069,0.00072778447,0.000020266849,0.00021888109],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988329,0.00011425343,0.0003289824,0.00042992466,0.00005910556,0.00023487995],"domain_scores_gemma":[0.9995237,0.000009882563,0.000091547976,0.00027635726,0.000041607982,0.000056884066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000036173187,0.00020184339,0.00020793272,0.000066506,0.00009373241,0.000010730727,0.000108316635,0.00016592773,0.0000111338395],"category_scores_gemma":[0.000004652851,0.00018210438,0.00004422768,0.00018972642,0.00010645092,0.0000034548846,0.0000176701,0.00006636671,0.000010584541],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006265547,0.0007009091,0.018882817,0.0000020620673,0.00003465896,0.000013061989,0.00006063066,0.0005902562,0.97933394,0.00001072885,0.0001229143,0.00018535247],"study_design_scores_gemma":[0.0030461126,0.00062851084,0.1920337,0.000008574599,0.000037492722,0.000077904966,0.000011244855,0.00039233206,0.8023143,0.000009202496,0.0011836668,0.00025699133],"about_ca_topic_score_codex":0.00018472747,"about_ca_topic_score_gemma":0.00056948594,"teacher_disagreement_score":0.17701967,"about_ca_system_score_codex":0.000065542605,"about_ca_system_score_gemma":0.00007375709,"threshold_uncertainty_score":0.74260014},"labels":[],"label_agreement":null},{"id":"W2553384650","doi":"10.1182/blood.v108.11.874.874","title":"The Effect of Dalteparin on Coagulation Activation during Pregnancy in Women with Thrombophilia: A Randomised Trial.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; St Mary's Hospital Centre; Queen Elizabeth II Health Sciences Centre; Jewish General Hospital; Victoria Hospital; Ottawa Hospital","funders":"","keywords":"Medicine; Thrombophilia; Pregnancy; Randomized controlled trial; Obstetrics; Randomization; Coagulopathy; Anticoagulant; Thrombosis; Heparin; Internal medicine","score_opus":0.009121282358296387,"score_gpt":0.24163370912678248,"score_spread":0.2325124267684861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553384650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960903,0.00005172246,0.000030474843,0.0001401583,0.00004507692,0.0020613652,7.7189856e-7,0.000038750553,0.001541381],"genre_scores_gemma":[0.99940705,0.000011097968,0.00003639451,0.000009939698,0.00006878608,0.00030878754,0.000008019301,0.00001866775,0.0001312456],"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988701,0.00013743507,0.00032434214,0.00018726263,0.00029161543,0.00018929128],"domain_scores_gemma":[0.99928015,0.00020837833,0.00018229062,0.0002606573,0.000034770863,0.000033722627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028222037,0.00013480929,0.0003575854,0.00010089303,0.00009147898,0.000013640989,0.000052049905,0.000072830946,0.000013648373],"category_scores_gemma":[0.00008008554,0.000081214115,0.00004672937,0.000253824,0.000032609976,0.00006013713,0.000010959495,0.00011347811,0.0000026591956],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.53814673,0.0032773723,0.02136867,0.00058004225,0.0005025776,0.000025772566,0.0006389094,0.00054874684,0.4265274,0.0028746661,0.000019849016,0.0054892655],"study_design_scores_gemma":[0.41393706,0.0031878494,0.16630992,0.0007093546,0.00011438488,0.000004961564,0.000024544384,0.00005455855,0.41526166,0.0003012832,0.0000061691726,0.000088232766],"about_ca_topic_score_codex":0.00002713183,"about_ca_topic_score_gemma":0.000015178796,"teacher_disagreement_score":0.14494126,"about_ca_system_score_codex":0.000047317793,"about_ca_system_score_gemma":0.00003005528,"threshold_uncertainty_score":0.33118156},"labels":[],"label_agreement":null},{"id":"W2553388645","doi":"10.1182/blood.v120.21.3017.3017","title":"The Immune “Combination Therapy” of Leukemia Using Adoptive Transfer and TGF-β Blockade.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Tumor microenvironment; Adoptive cell transfer; Immunology; Immunotherapy; Cytokine; Immune system; Cancer research; T cell; Leukemia; Biology; Medicine","score_opus":0.01639241161390912,"score_gpt":0.27003920498708367,"score_spread":0.25364679337317453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553388645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829556,0.016578328,0.000046337023,0.00002077827,0.000023899105,0.00011707995,0.0000071301615,0.0000017431083,0.00024914357],"genre_scores_gemma":[0.997464,0.0023455792,0.000046005884,0.000006152297,0.000048080514,0.0000097999455,0.000010819919,0.000006621075,0.000062943196],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99962723,0.000027774317,0.0000676155,0.000071092916,0.00006838861,0.0001379235],"domain_scores_gemma":[0.99980325,0.000008373306,0.000014877042,0.00010720308,0.00003097176,0.00003531514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000085755506,0.00005382663,0.000051189494,0.0000105120625,0.00007036196,0.000007938012,0.000047155314,0.000037644328,0.0000033696203],"category_scores_gemma":[0.000008565339,0.000036568163,0.000032078664,0.000030379435,0.000059945658,0.000003136679,0.000019497507,0.000030846517,4.6964144e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011133904,0.00019954126,0.00922017,0.0000047933263,0.00018479854,3.9409247e-7,0.00011569303,8.3811653e-7,0.9838345,0.00014107715,0.0000059617437,0.0061809104],"study_design_scores_gemma":[0.0018675217,0.00021747552,0.017616073,0.0000048256647,0.00001811236,0.000007907157,0.000041616982,0.0000049707255,0.9781367,0.000027923666,0.002011038,0.00004584168],"about_ca_topic_score_codex":0.000097973956,"about_ca_topic_score_gemma":0.0000126501445,"teacher_disagreement_score":0.014508436,"about_ca_system_score_codex":0.000008583807,"about_ca_system_score_gemma":0.00003936217,"threshold_uncertainty_score":0.14912063},"labels":[],"label_agreement":null},{"id":"W2553397542","doi":"10.1182/blood.v116.21.87.87","title":"Survivin Modulates Gene Expression That Connects through An Extensive Functional Signaling Network and Regulates Proliferation of Hematopoietic Stem Cells through Evi-1","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Survivin; Biology; Stem cell; Cancer research; Haematopoiesis; Progenitor cell; Cell biology; Molecular biology; Apoptosis; Genetics","score_opus":0.014072802823298222,"score_gpt":0.22011691423384955,"score_spread":0.20604411141055132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553397542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99468714,0.001320353,0.003403612,0.000020946225,0.00021934467,0.00027914566,0.000017605633,0.000015256776,0.000036610552],"genre_scores_gemma":[0.9929953,0.00028236862,0.006010576,0.00009909851,0.00036268076,0.000019032908,0.00014898762,0.000028409167,0.000053499298],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99896485,0.00007151978,0.00022661028,0.0003970852,0.00012630822,0.00021360339],"domain_scores_gemma":[0.9992797,0.000029637604,0.00015697964,0.0003330732,0.00014912727,0.00005151626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014889335,0.00018403708,0.00020790151,0.000013349818,0.00012123698,0.00003111367,0.00009222155,0.00023555635,0.000015172647],"category_scores_gemma":[0.000011428787,0.00016587223,0.000059672344,0.000048005117,0.000083993495,0.000027291326,0.0000827254,0.00010714267,0.0000010937482],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047373374,0.00014864384,0.0038987438,0.000045213732,0.000048288002,0.0000011903902,0.00018868216,0.0008040322,0.99446696,0.00017821585,0.000114296716,0.000058378813],"study_design_scores_gemma":[0.00071966165,0.00018687584,0.0006101148,0.00004568439,0.00005975862,0.000042491836,0.000100026,0.00022852882,0.9970127,0.00060061546,0.00019811912,0.00019544094],"about_ca_topic_score_codex":0.000012520954,"about_ca_topic_score_gemma":0.000035531513,"teacher_disagreement_score":0.003288629,"about_ca_system_score_codex":0.0000022115257,"about_ca_system_score_gemma":0.000038446055,"threshold_uncertainty_score":0.67640734},"labels":[],"label_agreement":null},{"id":"W2553422306","doi":"10.1182/blood.v112.11.479.479","title":"Expression of Hypoxia-Inducible Factor (HIF) Is An Independent Favorable Prognostic Factor in Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Rituximab; CHOP; Lymphoma; Cancer research; Medicine; Internal medicine; Pathology; Oncology","score_opus":0.025031357013272595,"score_gpt":0.24144383998781074,"score_spread":0.21641248297453813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553422306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974179,0.000618634,0.0000068847676,0.00003561878,0.000032413067,0.0010156285,0.00018273588,0.000088010616,0.0006021536],"genre_scores_gemma":[0.99855494,0.00019139347,0.00036441008,0.000092705115,0.00004289524,0.00014572788,0.00008164142,0.00006051116,0.00046574612],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99772894,0.00007343609,0.0004434595,0.0006302084,0.0005822849,0.0005416493],"domain_scores_gemma":[0.9985806,0.00008768942,0.00019884639,0.0006758348,0.000117222524,0.0003398399],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000057556772,0.00038544458,0.000653236,0.00024829837,0.00011432876,0.000019920397,0.00014469899,0.00021344813,0.00016111034],"category_scores_gemma":[0.000038747217,0.00026559818,0.00011857403,0.0003837832,0.000054098127,0.00021137843,0.000059172653,0.00010784917,0.000040349063],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026062195,0.08797603,0.87741256,0.000096763004,0.00009945288,0.0008964313,0.001372812,4.476192e-7,0.031317763,0.0000035617625,0.000076000084,0.00048755525],"study_design_scores_gemma":[0.056351177,0.0013296428,0.5180519,0.0002142444,0.0001378795,0.00010242579,0.00013298025,0.000011529972,0.42336145,0.000002595205,0.00012378552,0.00018035827],"about_ca_topic_score_codex":0.00056231255,"about_ca_topic_score_gemma":0.00006965897,"teacher_disagreement_score":0.39204368,"about_ca_system_score_codex":0.0001475463,"about_ca_system_score_gemma":0.00029170275,"threshold_uncertainty_score":0.9999796},"labels":[],"label_agreement":null},{"id":"W2553435097","doi":"10.1182/blood.v118.21.5253.5253","title":"Venous Thromboembolism in Cancer Patients Following Major Surgery","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Pulmonary embolism; Deep vein; Cancer; Venous thromboembolism; Thrombosis; Surgery; Medical diagnosis; Venous thrombosis; Internal medicine; Radiology","score_opus":0.033356400715084805,"score_gpt":0.26291869018454544,"score_spread":0.22956228946946064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553435097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98712075,0.0006920354,0.0000020069615,0.00008918181,0.0006421325,0.00048766614,0.00000535813,0.000068406785,0.010892474],"genre_scores_gemma":[0.9983996,0.00027570053,0.0001746228,0.0007283672,0.00012183772,0.00014556403,0.000016634996,0.000039765186,0.00009790099],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986729,0.000029200644,0.00032185923,0.00029992755,0.0002602663,0.00041585809],"domain_scores_gemma":[0.9994552,0.000035516437,0.000076700955,0.00027447022,0.00003845477,0.00011964766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001820476,0.00017285136,0.00067450764,0.00019957163,0.0000546317,0.0000109714465,0.00009159576,0.00008155159,0.0003683489],"category_scores_gemma":[0.000052404026,0.00015839277,0.00018983791,0.00023502507,0.000022868164,0.00009450387,0.00006644986,0.00012533917,0.00007611766],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024227142,0.015363279,0.97328365,0.00015054624,0.0005036458,0.00031227164,0.0021821903,3.7463425e-7,0.00020057731,0.00021901763,0.0027149452,0.0050452473],"study_design_scores_gemma":[0.0021805705,0.0001916305,0.9932719,0.00026701737,0.0005385267,0.0000022726192,0.00008023727,0.0000012582992,0.0023249,0.00014831434,0.0008119609,0.00018144841],"about_ca_topic_score_codex":0.001914292,"about_ca_topic_score_gemma":0.00022121545,"teacher_disagreement_score":0.019988187,"about_ca_system_score_codex":0.00005045765,"about_ca_system_score_gemma":0.000077237484,"threshold_uncertainty_score":0.6459069},"labels":[],"label_agreement":null},{"id":"W2553443291","doi":"10.1182/blood.v126.23.5434.5434","title":"The Stem Cell Drive: A Canadian Perspective","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Stem Cell Network; University of Toronto","funders":"","keywords":"Stem cell; Donation; Medicine; Confidentiality; Family medicine; Biology; Computer science; Political science; Genetics","score_opus":0.021562173608133308,"score_gpt":0.2680152995421884,"score_spread":0.24645312593405508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553443291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5268801,0.0061793895,0.00006991814,0.1955096,0.0007265356,0.0006211387,0.000012354422,0.00007774395,0.26992324],"genre_scores_gemma":[0.99513817,0.000026218231,0.00006045062,0.00042483103,0.0001609833,0.0000033670387,0.0000025085496,0.0000056813374,0.0041777915],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99954355,0.000017918685,0.000057935875,0.00007940206,0.0001744412,0.00012673005],"domain_scores_gemma":[0.99933666,0.000021487349,0.000016185899,0.00011920195,0.00015236257,0.00035408448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019142861,0.000038697657,0.000054028045,0.00002682904,0.000083532446,0.000012121655,0.00004135711,0.000083466366,0.0000095596115],"category_scores_gemma":[0.000018176981,0.00002181276,0.000024090581,0.00008873906,0.00016515022,0.0000101818605,0.0000090613285,0.00014012697,0.000041724383],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000341096,0.0027888934,0.025600217,0.00020397028,0.0010974304,0.0011307057,0.081176914,0.000009743381,0.010270593,0.6678147,0.1255407,0.08402503],"study_design_scores_gemma":[0.01674356,0.0015903201,0.060917214,0.00016643509,0.00074877264,0.00032021533,0.05026907,0.0010303744,0.012073679,0.038976464,0.81662565,0.00053821696],"about_ca_topic_score_codex":0.020616317,"about_ca_topic_score_gemma":0.025298133,"teacher_disagreement_score":0.691085,"about_ca_system_score_codex":0.00007233357,"about_ca_system_score_gemma":0.00068720157,"threshold_uncertainty_score":0.9924876},"labels":[],"label_agreement":null},{"id":"W2553445886","doi":"10.1182/blood.v118.21.2091.2091","title":"Comparison of Comorbidity Scores and the Impact of Comorbidities on Length of Stay and Survival in Patients with Non−Hodgkin's Lymphoma Treated with Autologous Stem Cell Transplant","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; Juravinski Hospital","funders":"","keywords":"Medicine; Comorbidity; Internal medicine; International Prognostic Index; Autologous stem-cell transplantation; Oncology; Transplantation; Diffuse large B-cell lymphoma; Proportional hazards model; Melphalan; Performance status; Population; Surgery; Lymphoma; Cancer","score_opus":0.02261437515667966,"score_gpt":0.24938126208688952,"score_spread":0.22676688693020985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553445886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99850243,0.00022358644,9.341073e-7,0.0000043824284,0.000008056958,0.00053449837,0.00016267346,0.0000072191965,0.0005562429],"genre_scores_gemma":[0.99979824,0.00009455709,0.000047799895,0.0000026129899,0.0000030190586,0.000013800296,0.000023247278,0.000012700677,0.0000040235645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908495,0.00008997921,0.0002951016,0.00016556116,0.00022036214,0.000144072],"domain_scores_gemma":[0.9992384,0.00018339787,0.00023261069,0.00021499806,0.00007207233,0.00005852336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010060652,0.00018556863,0.00075445784,0.00008151865,0.000024397388,0.0000033385872,0.000051871866,0.00005150661,0.0000064289884],"category_scores_gemma":[0.000002492308,0.000086306914,0.000049259517,0.000091977476,0.00037740174,0.000030037325,0.00001296559,0.00004248719,1.4404985e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006840494,0.0071369703,0.9794963,0.00013572001,0.0004730366,0.000025575939,0.004954881,0.000004307725,0.000036282323,0.000036143305,0.000003827076,0.00085646077],"study_design_scores_gemma":[0.040819008,0.009321132,0.90506655,0.00029143773,0.0005434107,0.000008785211,0.00049716904,0.000036520843,0.04333382,0.0000029610064,1.7196767e-7,0.00007903453],"about_ca_topic_score_codex":0.0049141324,"about_ca_topic_score_gemma":0.00027482843,"teacher_disagreement_score":0.07442975,"about_ca_system_score_codex":0.000023304417,"about_ca_system_score_gemma":0.00006461466,"threshold_uncertainty_score":0.74287313},"labels":[],"label_agreement":null},{"id":"W2553456942","doi":"10.1182/blood.v106.11.548.548","title":"Prophylactic Low Molecular Weight Heparin (LMWH) during Pregnancy Is Not Associated with a Decrease in Bone Mineral Density (BMD). The TIPPS (Thrombophilia in Pregnancy Prophylaxis Study) BMD Substudy.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Université Laval; University of Toronto; Ottawa Public Health; Dalhousie University; Western University; Centre Hospitalier Universitaire Sainte-Justine; Queen's University; McGill University","funders":"","keywords":"Medicine; Thrombophilia; Randomized controlled trial; Bone mineral; Pregnancy; Low molecular weight heparin; Obstetrics; Bone density; Surgery; Gynecology; Thrombosis; Internal medicine; Osteoporosis","score_opus":0.013350274100913087,"score_gpt":0.23712251631498585,"score_spread":0.22377224221407277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553456942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939769,0.00091532705,0.000009164013,0.0005806563,0.00006301185,0.0041018655,0.000006538929,0.00012849554,0.00021802147],"genre_scores_gemma":[0.9984308,0.000023218568,0.00029885792,0.00022377429,0.00006300971,0.00043890867,0.000016086153,0.00009202091,0.00041333563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962796,0.0003675651,0.0007851201,0.00089183985,0.00094157876,0.00073428464],"domain_scores_gemma":[0.99820375,0.00006383448,0.0003062123,0.0009384415,0.00020406856,0.00028366572],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031918468,0.0005284736,0.0008795762,0.00034314813,0.00017251975,0.000061760285,0.00025872377,0.00023474744,0.000107987296],"category_scores_gemma":[0.00031477082,0.00038644078,0.00014757575,0.0011731574,0.000099618635,0.00022699269,0.00014485764,0.0007039426,0.00003502291],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008959718,0.038648218,0.8524991,0.00047023164,0.00077532924,0.0048126625,0.0068177665,0.000041500753,0.09285135,0.00021769537,0.0000057636366,0.0019643814],"study_design_scores_gemma":[0.021713551,0.0016314031,0.87737244,0.0018667543,0.0005986263,0.0001490201,0.00019328888,0.00025311718,0.09560469,0.00010315852,0.0000018436242,0.00051209226],"about_ca_topic_score_codex":0.00018669177,"about_ca_topic_score_gemma":0.001797423,"teacher_disagreement_score":0.037016813,"about_ca_system_score_codex":0.00019767045,"about_ca_system_score_gemma":0.0002550943,"threshold_uncertainty_score":0.99985874},"labels":[],"label_agreement":null},{"id":"W2553459805","doi":"10.1182/blood.v118.21.560.560","title":"Growth Factor Independent-1 (Gfi1) As a New Target for Human Leukemia Therapy","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Cancer research; Leukemia; Lymphoma; Transgene; Biology; B cell; Cre recombinase; Genetically modified mouse; Immunology; Gene; Genetics; Antibody","score_opus":0.036466757715918646,"score_gpt":0.25969426584669325,"score_spread":0.2232275081307746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553459805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894882,0.002569756,0.00014409664,0.000050035833,0.00044481686,0.00037053917,0.000043500586,0.00010750927,0.0067815315],"genre_scores_gemma":[0.97806054,0.00006722739,0.00017703747,0.0003478522,0.000054712662,0.000036933412,0.00006727861,0.000030139488,0.021158252],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990392,0.00009358929,0.00022360122,0.0002511442,0.000026057125,0.0003664459],"domain_scores_gemma":[0.99951696,0.00005570165,0.000082534076,0.0002464548,0.00005815222,0.000040199615],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000086706255,0.00019177215,0.00023480089,0.00009555665,0.00016496284,0.000013767692,0.0003114596,0.00026734325,0.0065220348],"category_scores_gemma":[0.00008915722,0.00015893325,0.00015674939,0.000046360925,0.00007390799,0.00007808913,0.00005040614,0.00020357691,0.0008239721],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010954073,0.00044458453,0.0020108707,0.000009281898,0.00054532057,0.0000073486167,0.0019675803,9.580714e-9,0.9788847,0.004531756,0.00862999,0.0018731772],"study_design_scores_gemma":[0.006061543,0.0016073646,0.0066394205,0.000012907563,0.000030711584,0.00007930342,0.00011851859,3.347794e-8,0.94461,0.0017015131,0.03892856,0.0002101012],"about_ca_topic_score_codex":0.0005312073,"about_ca_topic_score_gemma":0.000013580458,"teacher_disagreement_score":0.034274653,"about_ca_system_score_codex":0.00002412097,"about_ca_system_score_gemma":0.00022231073,"threshold_uncertainty_score":0.999954},"labels":[],"label_agreement":null},{"id":"W2553478512","doi":"10.1182/blood.v110.11.1902.1902","title":"Prolonged Clinical and Molecular Remissions Following High-Dose Therapy/Autologous Stem Cell Transplantation (HDT/ASCT) and Rituximab and Interferon-alpha Maintenance for Relapsed High-Risk Follicular Lymphoma.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Rituximab; Internal medicine; Follicular lymphoma; Autologous stem-cell transplantation; Transplantation; Salvage therapy; Maintenance therapy; Gastroenterology; Cyclophosphamide; Oncology; Surgery; Lymphoma; Chemotherapy","score_opus":0.012568968355577883,"score_gpt":0.26939498162371844,"score_spread":0.2568260132681406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553478512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880127,0.009023181,0.00082468515,0.00040752685,0.00014450376,0.0014104247,0.000038276416,0.0000746462,0.00006408792],"genre_scores_gemma":[0.99042124,0.005189831,0.0037833648,0.00027889822,0.000058765287,0.00012293427,0.000049081817,0.000043559954,0.00005233207],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981748,0.000104613835,0.00052810967,0.00062134553,0.00018895553,0.00038217305],"domain_scores_gemma":[0.9988014,0.00040994876,0.00016084714,0.0002816879,0.000058872716,0.00028720702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006335547,0.00029299286,0.0006082195,0.00007514812,0.00018540536,0.00003916827,0.0000595161,0.00024513697,0.0000018440584],"category_scores_gemma":[0.0000481805,0.000221489,0.00016754617,0.00009233997,0.0001137951,0.00007966305,0.000027093922,0.00011087888,0.0000013480413],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009745176,0.012839711,0.50943893,0.0006920701,0.0027867206,0.0055198106,0.0021873037,0.0000013038112,0.020648805,0.0011470697,0.0002135504,0.43477952],"study_design_scores_gemma":[0.18031372,0.0052036606,0.70698774,0.0005470171,0.0033330838,0.0005771102,0.0002678114,0.00008815177,0.10092364,0.000585567,0.0006881607,0.0004843592],"about_ca_topic_score_codex":0.00009647825,"about_ca_topic_score_gemma":0.000021830174,"teacher_disagreement_score":0.43429515,"about_ca_system_score_codex":0.000035353965,"about_ca_system_score_gemma":0.000068700225,"threshold_uncertainty_score":0.90320593},"labels":[],"label_agreement":null},{"id":"W2553498421","doi":"10.1182/blood.v126.23.2613.2613","title":"Ikaros Gene Deletion Significantly Predicts Relapse in Pediatric B-ALL Patients with Low End-Induction Minimal Residual Disease","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Hamilton Health Sciences; Centre hospitalier universitaire de Québec; Université de Montréal; McMaster Children's Hospital","funders":"","keywords":"Minimal residual disease; Medicine; Multiplex ligation-dependent probe amplification; Internal medicine; Oncology; Gastroenterology; Immunology; Leukemia; Gene; Biology; Genetics","score_opus":0.015411510915088172,"score_gpt":0.2415837693313653,"score_spread":0.22617225841627714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553498421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99813354,0.0001266514,0.000058902526,0.000267514,0.000120425575,0.00087903393,0.00005450984,0.00008331663,0.0002760833],"genre_scores_gemma":[0.9974929,0.000037672147,0.0009144251,0.0001004482,0.00071898516,0.000084944135,0.00036528497,0.000051765142,0.00023358321],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99737453,0.00011742489,0.00034592327,0.00048552762,0.0011841353,0.0004924492],"domain_scores_gemma":[0.9983946,0.00007461682,0.000109666325,0.000383471,0.0003133873,0.0007242392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003212164,0.00021223698,0.00025152348,0.00032744755,0.000039340815,0.000023521929,0.00012726222,0.00014229026,0.000025371979],"category_scores_gemma":[0.000628773,0.00017249543,0.00003922288,0.00047835763,0.000075996846,0.0001869339,0.00007024497,0.00029869808,0.00008730875],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004573801,0.0035603014,0.9846709,0.00018206859,0.000078799785,0.0009332849,0.00051111134,0.000058445403,0.000857132,0.000009252349,0.004138388,0.0004265219],"study_design_scores_gemma":[0.035370007,0.002212603,0.9581598,0.00009308087,0.0006379475,0.000051957813,0.00009222672,0.0003590462,0.0025989679,0.000030638083,0.000112946516,0.00028074675],"about_ca_topic_score_codex":0.00007151236,"about_ca_topic_score_gemma":0.000017025766,"teacher_disagreement_score":0.030796207,"about_ca_system_score_codex":0.00044664647,"about_ca_system_score_gemma":0.0015396711,"threshold_uncertainty_score":0.703416},"labels":[],"label_agreement":null},{"id":"W2553523735","doi":"10.1182/blood.v112.11.764.764","title":"Phase 1/2 Trial of the XIAP Antisense Oligonucleotide (AEG35156) in Combination with Idarubicin and Cytarabine in Patients with Relapsed/Refractory AML","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aegera Therapeutics (Canada); Hôpital Maisonneuve-Rosemont; Princess Margaret Cancer Centre","funders":"","keywords":"Cytarabine; Medicine; Internal medicine; Idarubicin; Gastroenterology; Regimen; Neutropenia; Refractory (planetary science); XIAP; Febrile neutropenia; Adverse effect; Nausea; Phases of clinical research; Chemotherapy regimen; Chemotherapy; Surgery; Pharmacology; Apoptosis; Biology","score_opus":0.00509312970122007,"score_gpt":0.1997481760663979,"score_spread":0.19465504636517783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553523735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993144,0.00007306265,0.000031135318,0.00001845066,0.000038246068,0.00043034533,0.000005782418,0.0000026863534,0.00008583885],"genre_scores_gemma":[0.9996094,0.0000851624,0.00015213757,0.000017402102,0.000020132547,0.0000065977497,0.00004319518,0.000011802775,0.000054169162],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99938893,0.000049953836,0.00016468523,0.00017384678,0.00012179559,0.00010079664],"domain_scores_gemma":[0.99965453,0.000006265041,0.00010148974,0.0001725784,0.000042257863,0.000022895856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008045215,0.00009198185,0.00012227334,0.000047792608,0.000034547083,0.0000033612096,0.000048676706,0.00007345855,0.000001857638],"category_scores_gemma":[0.000015788473,0.00005928002,0.000018890376,0.000108577246,0.00007092818,0.000005673332,0.000024971217,0.000062800944,1.7432194e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03072571,0.013292697,0.17728604,0.000054973298,0.000082361126,0.000022505685,0.0005061403,0.0001363501,0.7736694,0.00012439654,0.000038591643,0.004060801],"study_design_scores_gemma":[0.27597007,0.0073905895,0.37899753,0.000074614,0.00004323752,0.000013358151,0.000032559867,0.000052177395,0.33703965,0.000033372777,0.00016065803,0.00019217409],"about_ca_topic_score_codex":0.000038640283,"about_ca_topic_score_gemma":0.000063158644,"teacher_disagreement_score":0.43662977,"about_ca_system_score_codex":0.0000058545056,"about_ca_system_score_gemma":0.000035811718,"threshold_uncertainty_score":0.24173692},"labels":[],"label_agreement":null},{"id":"W2553530314","doi":"10.1182/blood.v104.11.4700.4700","title":"Defective Production of Myeloid Dendritic Cells Results from Skewing of Chronic Myelogenous Leukemia Progenitors.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Dendritic cell; Progenitor cell; Biology; CD86; Chronic myelogenous leukemia; Immunology; CD34; CD38; CD80; Haematopoiesis; CD14; Flow cytometry; Molecular biology; CD40; Stem cell; Cancer research; Cell biology; Immune system; T cell; Leukemia; Cytotoxic T cell; In vitro","score_opus":0.008282050793645466,"score_gpt":0.20899015477760263,"score_spread":0.20070810398395716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553530314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817996,0.016452616,0.00004273488,0.000024349742,0.0010177741,0.00039155403,0.00008447671,0.000048434646,0.00013843158],"genre_scores_gemma":[0.99880946,0.00046075237,0.00021072892,0.000007830266,0.000088948276,0.000020193042,0.00007890471,0.000024500981,0.00029867678],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985486,0.00021400141,0.00054058875,0.0003341724,0.000051957497,0.00031063665],"domain_scores_gemma":[0.99896693,0.00015213451,0.00030291948,0.00043459336,0.00013214046,0.000011289813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024001354,0.00019028933,0.00037882882,0.00012715654,0.00013193818,0.0000049365112,0.00021236076,0.00024904084,0.00003770006],"category_scores_gemma":[0.0001747897,0.00017996765,0.00015721185,0.00019172957,0.00030024681,0.00009247777,0.00004824599,0.00023530038,0.000072135495],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00097104,0.00068202417,0.00010201446,0.00003899401,0.0006304045,0.0000045804954,0.0023711345,0.00008995454,0.9922622,0.000038127546,0.000017820044,0.0027917253],"study_design_scores_gemma":[0.0058233864,0.0008333177,0.0043108286,0.00018758418,0.00019008141,0.00007000148,0.0002746786,1.2381807e-7,0.98729044,0.0001754991,0.00067347585,0.00017055712],"about_ca_topic_score_codex":0.00089931005,"about_ca_topic_score_gemma":0.0000338746,"teacher_disagreement_score":0.017009836,"about_ca_system_score_codex":0.00014799244,"about_ca_system_score_gemma":0.0005058079,"threshold_uncertainty_score":0.73388684},"labels":[],"label_agreement":null},{"id":"W2553547613","doi":"10.1182/blood.v124.21.1364.1364","title":"Uncovering the Role of Heme Oxygenase 1 in the Pathophysiology of β-Thalassemia","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Thalassemia; Heme; Globin; Beta thalassemia; Medicine; Hemoglobin; Chemistry; Internal medicine; Biochemistry; Enzyme","score_opus":0.003942614512181728,"score_gpt":0.20791354966143305,"score_spread":0.20397093514925133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553547613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99189514,0.0009850936,0.000004027902,0.00032954768,0.000027912116,0.00013608478,0.0000018849638,0.00000532068,0.0066149696],"genre_scores_gemma":[0.9995192,0.00013133664,0.00004011811,0.00024079646,0.000032435593,0.000006124011,0.0000021316882,0.0000061161186,0.000021721879],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994508,0.00007051877,0.00017832019,0.00008132984,0.00010335411,0.00011567955],"domain_scores_gemma":[0.99953216,0.00010138018,0.00006527362,0.00026055882,0.000023400398,0.000017206028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023058233,0.000060044735,0.00016356746,0.000026756343,0.000019392797,0.0000013640225,0.00010583259,0.000068295936,0.000018273062],"category_scores_gemma":[0.00010519743,0.000029123574,0.000060466664,0.00013852332,0.000067305016,0.000010294852,0.000025944859,0.00014146934,0.000005158542],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012732342,0.0014531784,0.052187026,0.00020783575,0.00013053737,0.000020441872,0.004176371,0.00023154088,0.925282,0.0022708331,0.00023907943,0.013673846],"study_design_scores_gemma":[0.018981656,0.0036441574,0.39602426,0.0008455666,0.0009974757,0.00021018549,0.021434546,0.0019082392,0.50175834,0.026058545,0.027605008,0.0005320357],"about_ca_topic_score_codex":0.00009435616,"about_ca_topic_score_gemma":0.000009528785,"teacher_disagreement_score":0.42352366,"about_ca_system_score_codex":0.0000029486755,"about_ca_system_score_gemma":0.000025481771,"threshold_uncertainty_score":0.118762486},"labels":[],"label_agreement":null},{"id":"W2553549203","doi":"10.1182/blood.v126.23.586.586","title":"The Combination of Brentuximab Vedotin (Bv) and Bendamustine (B) Demonstrates Marked Activity in Heavily Treated Patients with Relapsed or Refractory Hodgkin Lymphoma (HL) and Anaplastic Large T-Cell Lymphoma (ALCL): Results of an International Multi Center Phase I/II Experience","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; University of British Columbia; Princess Margaret Cancer Centre; University of Toronto; BC Cancer Agency","funders":"","keywords":"Brentuximab vedotin; Medicine; Bendamustine; Tolerability; Internal medicine; Anaplastic large-cell lymphoma; Refractory (planetary science); Gastroenterology; Oncology; Lymphoma; Surgery; Rituximab; Adverse effect; Hodgkin lymphoma","score_opus":0.01620286099635074,"score_gpt":0.27134298050607547,"score_spread":0.2551401195097247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553549203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998792,0.00010780812,0.0000036679974,0.000056680296,0.0000585495,0.00053736946,0.00029596276,0.000016811915,0.00013116217],"genre_scores_gemma":[0.9992543,0.00008820103,0.00030817208,0.000013616116,0.000010527773,0.000043315344,0.00023042316,0.000016972219,0.000034506575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855715,0.00011943756,0.00040747438,0.00034970112,0.00035105925,0.00021516635],"domain_scores_gemma":[0.99880993,0.00021193724,0.0003226403,0.00024626186,0.00024732752,0.00016191664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021622695,0.00020940637,0.00034109273,0.000130141,0.00008002139,0.000021173935,0.00008700294,0.00007997397,0.00000304443],"category_scores_gemma":[0.00023647239,0.00013096629,0.000028566143,0.00017888531,0.00016829598,0.00023862344,0.00006533305,0.00004092648,3.0207977e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029060222,0.11278174,0.82023424,0.000055909863,0.00016767457,0.00009563968,0.0017370242,7.62523e-7,0.0016489179,0.000014689202,0.00002302124,0.03418016],"study_design_scores_gemma":[0.25269267,0.007678521,0.7181863,0.00019554223,0.000118169984,0.000026025242,0.00034370623,0.0010832452,0.019509178,0.0000022720862,0.00005169701,0.00011267724],"about_ca_topic_score_codex":0.0003000837,"about_ca_topic_score_gemma":0.00033119615,"teacher_disagreement_score":0.22363244,"about_ca_system_score_codex":0.00010443289,"about_ca_system_score_gemma":0.00012925286,"threshold_uncertainty_score":0.534065},"labels":[],"label_agreement":null},{"id":"W2553559912","doi":"10.1182/blood.v108.11.5472.5472","title":"Ex Vivo Gene Therapy for Haemophilia A: FVIII-Overexpressing Mesenchymal Stromal Cells Fail To Produce Sustained Therapeutic Levels of Circulating FVIII In Vivo.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; McGill University; Jewish General Hospital","funders":"","keywords":"Ex vivo; Mesenchymal stem cell; Genetic enhancement; Stromal cell; Immunology; Medicine; Bone marrow; In vivo; Cancer research; Progenitor cell; Cell therapy; Stem cell; Biology; Pathology; Cell biology; Gene","score_opus":0.03810474012376936,"score_gpt":0.30603078455546284,"score_spread":0.2679260444316935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553559912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99474967,0.0007511883,0.0001780318,0.0008421569,0.000069760594,0.0023048292,0.00007487685,0.000050763614,0.0009787563],"genre_scores_gemma":[0.9936543,0.000014899905,0.0033364971,0.00007889429,0.00046346354,0.000099501915,0.000015542206,0.00006538905,0.0022714732],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99748594,0.000091691785,0.00056512764,0.0005708635,0.00055050617,0.0007358695],"domain_scores_gemma":[0.998818,0.00018187624,0.0001257121,0.00048340255,0.00024384639,0.00014717813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047397852,0.00030374262,0.00059603265,0.00029743614,0.00012196055,0.000038968636,0.00017893642,0.00015960244,0.00012807435],"category_scores_gemma":[0.000075623466,0.00024330209,0.000184768,0.00045597172,0.000084856874,0.000110254485,0.00005859849,0.00018228992,0.0000048470433],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000377537,0.0012112553,0.027242046,0.0001956963,0.00014838677,0.000098656434,0.0006639634,0.00007421623,0.9674462,0.00007851209,0.00012186533,0.0023416334],"study_design_scores_gemma":[0.009157709,0.0008900916,0.027965173,0.00017983039,0.0000931005,0.000028053975,0.00035769635,0.00024756856,0.960283,0.00029152652,0.00026717485,0.00023906575],"about_ca_topic_score_codex":0.00014629221,"about_ca_topic_score_gemma":0.000020610967,"teacher_disagreement_score":0.008780171,"about_ca_system_score_codex":0.00009642324,"about_ca_system_score_gemma":0.00029026085,"threshold_uncertainty_score":0.9921571},"labels":[],"label_agreement":null},{"id":"W2553573182","doi":"10.1182/blood.v124.21.480.480","title":"Gene Expression and Mutation Analysis (GEMA) –Guided Precision Medicine Targeting PARP1 to Induce Synthetic Lethality in DNA-PK –Deficient Quiescent and BRCA-Deficient Proliferating Leukemia Stem and Progenitor Cells","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital; Princess Margaret Cancer Centre; McGill University; University Health Network","funders":"","keywords":"PARP1; Synthetic lethality; Homologous recombination; Cancer research; Biology; RAD51; DNA repair; DNA damage; Stem cell; Progenitor cell; DNA replication; Molecular biology; DNA; Poly ADP ribose polymerase; Cell biology; Genetics; Polymerase","score_opus":0.011285970962995264,"score_gpt":0.2454446032413944,"score_spread":0.23415863227839911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553573182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957121,0.0007159232,0.0027498417,0.00006544402,0.00006627389,0.0006310071,0.0000069605626,0.000019204484,0.00003322943],"genre_scores_gemma":[0.99504554,0.000043157444,0.004615688,0.00006097484,0.00009112872,0.00006772001,0.000032502463,0.000020493284,0.000022820474],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979722,0.0002661788,0.00045613872,0.00073853706,0.00028840313,0.00027853847],"domain_scores_gemma":[0.99921536,0.00005041503,0.00017006115,0.0003050075,0.00009491397,0.00016422033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001206773,0.00022088086,0.00031940112,0.00014840926,0.00012461323,0.00005154096,0.0000913021,0.00015160929,0.0000023465282],"category_scores_gemma":[0.0002879724,0.00018718757,0.000038548285,0.00021385646,0.000059898648,0.000008677189,0.00023850276,0.00009175901,6.67458e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003539462,0.00009450087,0.0062999683,0.00007343134,0.000037679667,0.000003831287,0.00065498764,0.0003215319,0.99032325,0.000008478873,0.000012470821,0.002134489],"study_design_scores_gemma":[0.0010426329,0.00036485825,0.0031285156,0.000117090334,0.00017943388,0.000020404965,0.0003957589,0.002203313,0.9922568,0.000018759165,0.00006156647,0.00021083068],"about_ca_topic_score_codex":0.000037778445,"about_ca_topic_score_gemma":0.000019913028,"teacher_disagreement_score":0.0031714528,"about_ca_system_score_codex":0.000033459924,"about_ca_system_score_gemma":0.00003403467,"threshold_uncertainty_score":0.7633288},"labels":[],"label_agreement":null},{"id":"W2553573514","doi":"10.1182/blood.v118.21.318.318","title":"Pre-Operative Cytokine-Induced Mobilization of Bone Marrow-Derived Cells, Followed by Revascularization Surgery: Early and Long-Term Results of a Prospective Study in Patients with End-Stage Ischemic Cardiac Disease","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Cardiac and Coronary Surgery Techniques","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Myocardial infarction; Bone marrow; Stem cell; Heart failure; Cardiology; Inflammation; Cytokine; Internal medicine; Coronary artery disease; Surgery; Bone Marrow Stem Cell; Revascularization; Biology","score_opus":0.009292472600072118,"score_gpt":0.22472536564758697,"score_spread":0.21543289304751484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553573514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965899,0.00020799029,0.00003446323,0.0000030137828,0.000028345288,0.0027685896,0.00024094309,0.00004137622,0.000085402186],"genre_scores_gemma":[0.9993122,0.000051650895,0.000060552873,0.000004100001,0.00000930804,0.0001723334,0.0003090528,0.000031267795,0.00004952597],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984321,0.0001772322,0.00048411023,0.00039753204,0.00035212416,0.00015688891],"domain_scores_gemma":[0.9989414,0.000052605857,0.00026986064,0.0003648488,0.0002716925,0.00009956629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003072834,0.00020110699,0.0006522677,0.00016120607,0.000025630772,0.000006230022,0.000035354176,0.000071559065,0.000008260394],"category_scores_gemma":[0.000081587175,0.0001721399,0.00011887284,0.00031033295,0.00006177165,0.00017213915,0.0000414823,0.00009699935,1.7942016e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041994154,0.0032859251,0.91772306,0.000118455544,0.0002629351,0.000026181697,0.0023151925,2.3008226e-7,0.07186618,0.0000017505266,0.0000151997365,0.00018547825],"study_design_scores_gemma":[0.0043511875,0.0010185437,0.8075048,0.00019514326,0.0004037806,3.9602057e-7,0.0001002709,0.0000010611386,0.18628863,9.266568e-7,9.931161e-7,0.00013429347],"about_ca_topic_score_codex":0.00024635627,"about_ca_topic_score_gemma":0.000017995382,"teacher_disagreement_score":0.11442244,"about_ca_system_score_codex":0.0000328299,"about_ca_system_score_gemma":0.00010911854,"threshold_uncertainty_score":0.70196617},"labels":[],"label_agreement":null},{"id":"W2553582313","doi":"10.1182/blood.v116.21.2497.2497","title":"Combinations of Epigenetic Modifying Agents Accentuate Retinoid-Mediated Gene Expression Over Single Agent Therapies In Acute Myelogenous Leukemia Cells","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Princess Margaret Cancer Centre; Hamilton Health Sciences","funders":"","keywords":"Epigenetics; Cancer research; Epigenetic therapy; Histone deacetylase; Biology; Acute promyelocytic leukemia; DNA methylation; Decitabine; Retinoic acid; Tretinoin; Histone deacetylase inhibitor; Histone; Leukemia; Hypomethylating agent; Molecular biology; Gene expression; Cell culture; Immunology; Gene; Genetics","score_opus":0.010403296195546786,"score_gpt":0.23709454384923825,"score_spread":0.22669124765369147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553582313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99743485,0.0010721699,0.00039285264,0.000016294256,0.00027170024,0.0002663813,0.000037293437,0.000018001965,0.00049046974],"genre_scores_gemma":[0.9965063,0.0012814186,0.0015360538,0.000068145324,0.000080935504,0.000038911738,0.0002146118,0.00004044795,0.0002332131],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985479,0.00008010093,0.00039311493,0.000414625,0.00022711445,0.0003371264],"domain_scores_gemma":[0.9990944,0.00002491398,0.00020753269,0.0004805608,0.00010499346,0.00008757576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017786246,0.00022478194,0.00022554156,0.00009227775,0.000097936514,0.000028201062,0.00037126528,0.0002925304,0.00005267955],"category_scores_gemma":[0.000064930646,0.00021398788,0.00010143608,0.00016809562,0.00012371344,0.0000081292565,0.0001692862,0.00021143732,0.000008254834],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032250147,0.0007068518,0.004452441,0.00003895008,0.000072056544,0.000016748763,0.00034268925,0.000068635854,0.9937539,0.000006640796,0.00008389666,0.00042492853],"study_design_scores_gemma":[0.0024198939,0.000183125,0.003499676,0.00002845225,0.00005648792,0.000010880237,0.000057083755,0.00006505803,0.992238,0.000091800066,0.0011152108,0.0002343716],"about_ca_topic_score_codex":0.000026741503,"about_ca_topic_score_gemma":0.000018804338,"teacher_disagreement_score":0.0023876438,"about_ca_system_score_codex":0.000024960751,"about_ca_system_score_gemma":0.00014924804,"threshold_uncertainty_score":0.8726172},"labels":[],"label_agreement":null},{"id":"W2553612058","doi":"10.1182/blood.v104.11.1414.1414","title":"VDJ-Switch Region Analysis in Multiple Myeloma Patients Reveals Homogeneity and Long-Term Stability of Switch Junctions, and Ongoing Mutation Upstream of Switch Mu.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Immunoglobulin class switching; V(D)J recombination; Biology; Recombination; Molecular biology; Immunoglobulin heavy chain; Antibody; Genetics; Gene; B cell","score_opus":0.0246147609555835,"score_gpt":0.2775926377406795,"score_spread":0.252977876785096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553612058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983747,0.00037939587,0.00018555406,0.00006437737,0.000021454773,0.0008688825,0.000046852958,0.000019141078,0.000039658673],"genre_scores_gemma":[0.998803,0.00019718506,0.00073511485,0.000008306075,0.000016451293,0.000039484203,0.00016901232,0.000016363796,0.000015072089],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981737,0.000103657905,0.0005734402,0.00044870115,0.0004155972,0.0002849131],"domain_scores_gemma":[0.99873066,0.00013484262,0.0002414818,0.00042082462,0.0002788315,0.00019333039],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029647228,0.00019943331,0.00059235387,0.0004373448,0.000078751975,0.000012784053,0.00006159384,0.0001196202,0.000013440697],"category_scores_gemma":[0.0004683095,0.00017300238,0.00011867522,0.00076028076,0.00012439801,0.00014004332,0.00006769019,0.00014157269,0.000001172341],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041619944,0.0028353974,0.98241585,0.00039365064,0.0006323263,0.00005701425,0.0004933773,0.000007019481,0.004570388,0.000004293071,0.000001029132,0.008173444],"study_design_scores_gemma":[0.012455968,0.000572949,0.94617194,0.00017852057,0.0007907124,0.000020995109,0.00013026863,0.00006300113,0.03944103,0.000062308776,3.7636943e-7,0.00011194563],"about_ca_topic_score_codex":0.0016824102,"about_ca_topic_score_gemma":0.0027241341,"teacher_disagreement_score":0.036243938,"about_ca_system_score_codex":0.000096093936,"about_ca_system_score_gemma":0.00009361959,"threshold_uncertainty_score":0.70548326},"labels":[],"label_agreement":null},{"id":"W2553615480","doi":"10.1182/blood.v112.11.3394.3394","title":"Quebec Platelet Disorder Is Caused by a Cis-Acting Mutation near the Plasminogen Activator Gene (PLAU) That Increases PLAU Transcription by Megakaryocytes.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Hospital for Sick Children; University of Toronto; McMaster University","funders":"","keywords":"Biology; Molecular biology; Southern blot; Genetics; Gene; Allele","score_opus":0.017361376483937072,"score_gpt":0.2315310887408171,"score_spread":0.21416971225688003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553615480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949458,0.0026170046,0.00011684366,0.00084743474,0.00006370108,0.00073306455,0.00035061553,0.00012651754,0.0001989645],"genre_scores_gemma":[0.9962905,0.000431945,0.00012996973,0.00071189494,0.0000536797,0.00010269855,0.0010059614,0.000062453044,0.0012109128],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99834096,0.0000660621,0.00029450498,0.00042922288,0.00044603916,0.0004231956],"domain_scores_gemma":[0.9991825,0.00013834597,0.00015711354,0.00030734434,0.000045936784,0.00016871346],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008064176,0.00034296972,0.00042406184,0.00005779824,0.00062222115,0.00007124778,0.00011905305,0.00018313568,0.0001971079],"category_scores_gemma":[0.000042392276,0.00025159176,0.00015031372,0.00020533,0.00015028573,0.0002974116,0.000018176137,0.0002328016,0.000051039122],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004536026,0.02098646,0.1271724,0.00039570022,0.008362219,0.0067006866,0.031852745,0.000035088302,0.63274,0.00002103802,0.13156846,0.03562917],"study_design_scores_gemma":[0.027285455,0.000846852,0.021132955,0.000119223696,0.0012119323,0.0017953991,0.0012723841,0.00045952838,0.9041989,0.000027418453,0.040907275,0.0007427145],"about_ca_topic_score_codex":0.011990416,"about_ca_topic_score_gemma":0.0010919509,"teacher_disagreement_score":0.27145883,"about_ca_system_score_codex":0.000077473516,"about_ca_system_score_gemma":0.0001840089,"threshold_uncertainty_score":0.9999936},"labels":[],"label_agreement":null},{"id":"W2553627673","doi":"10.1182/blood.v104.11.1933.1933","title":"Human Platelets Contain Forms of Factor V in Disulfide-Linkage with Multimerin.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Platelet; Chemistry; Factor IXa; Factor V; Platelet factor 4; Molecular biology; Immunoprecipitation; Fibrinogen; Factor X; Thrombin; Biochemistry; Immunology; Biology; Internal medicine; Medicine; Gene","score_opus":0.020765101631302182,"score_gpt":0.27456844003069647,"score_spread":0.2538033383993943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553627673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977067,0.00007972863,0.00043407147,0.00010382314,0.000021062395,0.0003666179,0.00000784191,0.000046116227,0.0012340085],"genre_scores_gemma":[0.99844897,0.0000070102674,0.0013023268,0.000106442916,0.000022030688,0.00001348914,0.000018425193,0.000021793358,0.000059484417],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991735,0.000010558627,0.00026069203,0.00017426442,0.00019854409,0.00018241016],"domain_scores_gemma":[0.9995551,0.0000113346605,0.00008823468,0.00021674522,0.00003965065,0.00008892746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000647594,0.00012647797,0.0003224369,0.00010752805,0.000028036053,0.0000056160343,0.000058530622,0.00008282977,0.00009807563],"category_scores_gemma":[0.000014029888,0.000093411094,0.000050133032,0.00014974325,0.000036967805,0.000076690594,0.000017960094,0.00012754183,0.00001274442],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025284034,0.009923655,0.14798117,0.00043389876,0.00045707266,0.00046043858,0.0025454916,0.000090037945,0.80027515,0.033439193,0.00000460867,0.004136418],"study_design_scores_gemma":[0.027986445,0.0016208296,0.31714645,0.00038723464,0.00013447969,0.00007191848,0.00024190203,0.000013363615,0.6507404,0.0013496698,0.00008655175,0.00022074809],"about_ca_topic_score_codex":0.00007862972,"about_ca_topic_score_gemma":0.00017897465,"teacher_disagreement_score":0.16916528,"about_ca_system_score_codex":0.00002064724,"about_ca_system_score_gemma":0.000046472065,"threshold_uncertainty_score":0.3809194},"labels":[],"label_agreement":null},{"id":"W2553643169","doi":"10.1182/blood.v124.21.4706.4706","title":"Initial Results of an Ex Vivo Microfluidic Cis-Coculture Csra to Predict Response for Myeloma Patients","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Bortezomib; Multiple myeloma; Ex vivo; In vivo; Tumor microenvironment; Cancer research; In vitro; Cancer; Cell culture; Proteasome inhibitor; Immunology; Medicine; Chemistry; Biology; Internal medicine; Tumor cells; Biochemistry","score_opus":0.018259453241484765,"score_gpt":0.30537341731362627,"score_spread":0.2871139640721415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553643169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99616265,0.00007332518,0.00007628078,0.00028010525,0.00008551462,0.0014682052,0.00094014464,0.000052699514,0.0008610746],"genre_scores_gemma":[0.99639094,0.000010164681,0.0019466664,0.00020182475,0.00025010615,0.000104677,0.00039138342,0.000035679925,0.00066853996],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981455,0.00018178778,0.0003892233,0.00040466915,0.00045780608,0.00042097276],"domain_scores_gemma":[0.9982654,0.00025972383,0.00009152581,0.00053209544,0.0003719551,0.00047928773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047495318,0.00019540548,0.0003522862,0.0001758634,0.00008084726,0.000018007284,0.00016457088,0.00013650715,0.000028626762],"category_scores_gemma":[0.002170176,0.00015157252,0.000118087286,0.000185218,0.000056846307,0.00008304116,0.000060484428,0.000108444816,0.000031289514],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21511008,0.014323786,0.0557064,0.00054417114,0.001031737,0.0001960606,0.003000332,0.0000012768226,0.6187986,0.000040390176,0.029627059,0.061620094],"study_design_scores_gemma":[0.0557116,0.016305206,0.25953612,0.00020822824,0.00023444815,0.00002334964,0.00007196772,0.00004474782,0.64180475,0.00003890057,0.025811898,0.00020879191],"about_ca_topic_score_codex":0.00004998623,"about_ca_topic_score_gemma":0.000012903777,"teacher_disagreement_score":0.2038297,"about_ca_system_score_codex":0.0000343876,"about_ca_system_score_gemma":0.00011225226,"threshold_uncertainty_score":0.6180948},"labels":[],"label_agreement":null},{"id":"W2553645262","doi":"10.1182/blood.v114.22.810.810","title":"Financial Conflicts of Interest Are Common and Frequently Influence Conclusions of Economic Analyses Presented at the American Society of Hematology Annual Meeting.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Conflict of interest; Reimbursement; Pharmaceutical industry; Liberian dollar; Product (mathematics); Gross domestic product; Economic impact analysis; Health care; Business; Medicine; Family medicine; Finance; Economics; Economic growth","score_opus":0.37355152071295844,"score_gpt":0.5383786678802222,"score_spread":0.1648271471672637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553645262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939321,0.0014192932,0.0000010538832,0.0034990932,0.00006102222,0.00025092243,0.000576437,0.000014317348,0.00024571808],"genre_scores_gemma":[0.9970903,0.0004945758,0.000034139335,0.002277242,0.00004730786,0.000006815147,0.000012257804,0.0000062098975,0.00003118008],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99841595,0.00043914752,0.00058614294,0.00020958458,0.00007161726,0.00027756917],"domain_scores_gemma":[0.99807817,0.00073134317,0.0007154435,0.00019280614,0.00013830065,0.0001439255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038256551,0.00015754954,0.0005865452,0.000043620723,0.0001718358,0.0000025127251,0.00026248087,0.0002452328,0.00007958081],"category_scores_gemma":[0.00012546734,0.00012697864,0.0001275414,0.00014888796,0.0014064997,0.000053948588,0.00018839753,0.0006261229,0.0000022577294],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009363801,0.001374235,0.67812777,0.00033504865,0.00061539694,0.00002221884,0.002620044,0.00048472703,0.3048363,0.0039058034,0.004728103,0.002013974],"study_design_scores_gemma":[0.0029613548,0.0007490029,0.2128138,0.00014072776,0.00060827844,0.000062343934,0.0011055799,0.000483257,0.7743841,0.00061942317,0.0058494555,0.00022272191],"about_ca_topic_score_codex":0.0002644088,"about_ca_topic_score_gemma":0.0002774482,"teacher_disagreement_score":0.46954775,"about_ca_system_score_codex":0.000021327109,"about_ca_system_score_gemma":0.00009772803,"threshold_uncertainty_score":0.5182307},"labels":[],"label_agreement":null},{"id":"W2553666848","doi":"10.1182/blood.v124.21.3018.3018","title":"FAS Mutations Accelerate Lymphoma Growth and Induce Therapeutic Resistance","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Spinal Cord Injury BC; McGill University; BC Cancer Agency; Jewish General Hospital","funders":"","keywords":"Fas ligand; Fas receptor; Cancer research; Apoptosis; Lymphoma; Immunology; Chemotherapy; Medicine; Biology; Rituximab; Programmed cell death; Internal medicine; Genetics","score_opus":0.017282354308950917,"score_gpt":0.24937727136809731,"score_spread":0.2320949170591464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553666848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983554,0.0011639874,0.000019528441,0.0016461044,0.000036784302,0.00017570703,0.0000044019753,0.000049781833,0.01334969],"genre_scores_gemma":[0.9979825,0.00014092075,0.0004790201,0.0008901651,0.0000763911,0.000055328714,0.0000129270675,0.00001381687,0.0003489085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99940383,0.00002865261,0.00011633338,0.00019255924,0.00011472191,0.00014392652],"domain_scores_gemma":[0.9995733,0.00008522371,0.000038244558,0.00017111085,0.000039149127,0.000092994494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000050549083,0.000104312894,0.00015634908,0.000041283187,0.0000902654,0.00003116091,0.00003477686,0.00004654072,0.00001691276],"category_scores_gemma":[0.00003590065,0.000080277976,0.000034203666,0.00009879289,0.000041541818,0.000048347916,0.000014676544,0.00002437046,0.00002830761],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021163745,0.0073271645,0.83941245,0.00033389975,0.001254923,0.0002678759,0.0017953791,4.814174e-7,0.022607205,0.058837295,0.00095753797,0.06699415],"study_design_scores_gemma":[0.009320872,0.00022638879,0.92730826,0.00007427564,0.00047084884,0.000067829875,0.000049310485,0.00000960484,0.05700163,0.0017397727,0.0035978847,0.00013334255],"about_ca_topic_score_codex":0.00002711919,"about_ca_topic_score_gemma":0.00001665216,"teacher_disagreement_score":0.08789579,"about_ca_system_score_codex":0.000017918326,"about_ca_system_score_gemma":0.0000437948,"threshold_uncertainty_score":0.32736406},"labels":[],"label_agreement":null},{"id":"W2553667979","doi":"10.1182/blood.v104.11.394.394","title":"Microgranular Variant (M3V) of Acute Promyelocytic Leukemia (APL) Does Not Have a Worse Prognosis than Classical APL in the Atra Era: A Report of 153 Patients Treated on Intergroup 0129 and Pethema LPA96 and LPA99.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Idarubicin; Acute promyelocytic leukemia; Cytarabine; Internal medicine; Daunorubicin; Chemotherapy; Gastroenterology; Chemotherapy regimen; White blood cell; Induction chemotherapy; Anthracycline; Oncology; Surgery; Cancer; Biology; Retinoic acid","score_opus":0.005003913008085411,"score_gpt":0.21735824201644305,"score_spread":0.21235432900835763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553667979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99881804,0.00028328458,0.00003950738,0.00011513071,0.000027627217,0.0005144104,0.000033992947,0.0000075547036,0.00016045083],"genre_scores_gemma":[0.9988121,0.00024871767,0.00058253796,0.000050063176,0.000046254383,0.00008004438,0.00009003385,0.000022749331,0.00006752634],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985282,0.00008490934,0.00046174493,0.00047440088,0.0002083946,0.00024236414],"domain_scores_gemma":[0.99921906,0.0000261686,0.00024231429,0.00035605626,0.00009519196,0.00006120584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024205427,0.00024039953,0.0003208231,0.00006504089,0.000048044738,0.000028199622,0.00019861713,0.00021542635,0.0000015594302],"category_scores_gemma":[0.000086154716,0.00015037712,0.00010175615,0.00011992615,0.00028433217,0.000008444977,0.000100979785,0.00017946023,2.8130938e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009165803,0.0026919798,0.20018454,0.0005693097,0.00072290073,0.0008143351,0.0020639058,0.000003395765,0.7895281,0.00019628412,0.000031860694,0.0022768597],"study_design_scores_gemma":[0.0043212697,0.0015948474,0.020359814,0.00023124125,0.00036211315,0.0004099695,0.00019489523,0.000009307615,0.9718938,0.00025690455,0.00013334419,0.0002324918],"about_ca_topic_score_codex":0.000088621804,"about_ca_topic_score_gemma":0.00005902606,"teacher_disagreement_score":0.18236575,"about_ca_system_score_codex":0.000025682233,"about_ca_system_score_gemma":0.00014529949,"threshold_uncertainty_score":0.6132201},"labels":[],"label_agreement":null},{"id":"W2553701282","doi":"10.1182/blood.v108.11.3009.3009","title":"Hematopoietic Stem Cell Transplantation (SCT) for Hematologic Malignancy from Matched Related Donors (MRD) with a Myeloablative Once Daily IV Busulfan (Bu)/Fludarabine (Flu) Based Regimen (FLUBUP) with Thymoglobulin: Outcomes in 200 Patients with over One Year Follow-Up.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre","funders":"","keywords":"Thymoglobulin; Medicine; Busulfan; Fludarabine; Transplantation; Surgery; Internal medicine; Gastroenterology; Regimen; Cumulative incidence; Folinic acid; Hematopoietic stem cell transplantation; Chemotherapy; Antimetabolite; Cyclophosphamide; Tacrolimus; Fluorouracil","score_opus":0.008813277192227563,"score_gpt":0.2187481092584244,"score_spread":0.2099348320661968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553701282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99282247,0.00017912213,0.001564217,0.000506536,0.00003254457,0.0035455413,0.00030017341,0.0001738105,0.00087558123],"genre_scores_gemma":[0.9826486,0.000023112589,0.013946096,0.0001652432,0.00003269869,0.00040170562,0.0011245784,0.00015725743,0.0015006978],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961617,0.00016072564,0.00080660585,0.0010128357,0.0010048284,0.0008533068],"domain_scores_gemma":[0.99785554,0.0004113652,0.00042405693,0.0007369094,0.00034696583,0.00022518117],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002634946,0.00063346623,0.0012431996,0.00032726765,0.00013622906,0.000054978296,0.00028391398,0.00032404673,0.00010261572],"category_scores_gemma":[0.000021156931,0.0004358469,0.00012907443,0.00086986955,0.00019719468,0.000284051,0.000031374468,0.00052481197,0.000030677347],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013325529,0.0031332478,0.976127,0.0007952477,0.0006246955,0.00058417296,0.002003669,0.0003117537,0.002731584,0.00010917935,0.00019796086,0.000055941204],"study_design_scores_gemma":[0.16893195,0.005043684,0.7695288,0.0026465629,0.001951992,0.000058747817,0.0011733223,0.000565356,0.048581675,0.00027058518,0.000033948592,0.0012133798],"about_ca_topic_score_codex":0.0010126098,"about_ca_topic_score_gemma":0.00061572576,"teacher_disagreement_score":0.20659822,"about_ca_system_score_codex":0.00032824354,"about_ca_system_score_gemma":0.0005427331,"threshold_uncertainty_score":0.9998093},"labels":[],"label_agreement":null},{"id":"W2553702823","doi":"10.1182/blood.v124.21.5734.5734","title":"A Phase II Study of AT9283, an Aurora Kinase Inhibitor, in Patients with Relapased or Refractory Multiple Myloma; NCIC Clinical Trials Group IND.191","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Princess Margaret Cancer Centre; University of Alberta; Juravinski Cancer Centre; Saint John Regional Hospital; Dalhousie University; University of New Brunswick; Queen's University","funders":"","keywords":"Medicine; Multiple myeloma; Aurora inhibitor; Internal medicine; Clinical endpoint; Refractory (planetary science); Oncology; Phases of clinical research; Aurora kinase; Clinical trial; Aurora B kinase; Gastroenterology; Pharmacology; Cancer; Cell cycle; Cytokinesis; Chemistry; Cell; Biology","score_opus":0.03187653087238147,"score_gpt":0.3314587685954111,"score_spread":0.29958223772302967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553702823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986697,0.000056381556,0.00008966304,0.000004407549,0.00012761203,0.0009641511,0.000057598307,0.000013200366,0.000017303599],"genre_scores_gemma":[0.99874717,0.00002135566,0.00046485182,0.000095090225,0.00021920455,0.000053173626,0.00032798122,0.000040227475,0.00003093097],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99702203,0.0009545072,0.0009943681,0.0005704952,0.00019943003,0.0002591514],"domain_scores_gemma":[0.9984783,0.00011291741,0.00044226565,0.0007059597,0.00011085941,0.00014968595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015356017,0.00023806699,0.00059117726,0.000087815446,0.00006694287,0.000013386999,0.00023688047,0.00028091436,0.00000917882],"category_scores_gemma":[0.001019987,0.00017959364,0.000108829656,0.0001374036,0.000072116934,0.000011343082,0.00013513827,0.00020754042,0.0000017675708],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012492638,0.14881282,0.499368,0.00006189282,0.00037083158,0.000022989509,0.00056544214,0.000008468242,0.31629908,0.0000054692414,0.00022764188,0.021764716],"study_design_scores_gemma":[0.39009008,0.3122238,0.16367942,0.000265491,0.0009407649,0.000006430855,0.00089964265,0.00023374762,0.12100647,0.000014711835,0.009109258,0.0015302117],"about_ca_topic_score_codex":0.00008885874,"about_ca_topic_score_gemma":0.001118263,"teacher_disagreement_score":0.37759745,"about_ca_system_score_codex":0.0000094112165,"about_ca_system_score_gemma":0.0000900428,"threshold_uncertainty_score":0.7323616},"labels":[],"label_agreement":null},{"id":"W2553727767","doi":"10.1182/blood.v106.11.4619.4619","title":"A Multicenter Randomized Trial Comparing Response-Adapted (RA), Non-Cross-Resistant Induction and Consolidation with Idarubicin/Cytarabine (IDAC) Followed by Mitoxantrone/Etoposide (NOVE) Compared with Consolidation with High Dose Cytarabine (HDAC) in Adult Patients with AML. A Study by the Canadian Leukemia Studies Group (CLSG).","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Idarubicin; Cytarabine; Etoposide; Mitoxantrone; Medicine; Internal medicine; Nuclear medicine; Gastroenterology; Chemotherapy","score_opus":0.013516994683953678,"score_gpt":0.2718383185078674,"score_spread":0.2583213238239137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553727767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847425,0.00021789693,0.00007585868,0.0013503354,0.000055302902,0.013312972,0.000118265234,0.00008357533,0.0000432629],"genre_scores_gemma":[0.99631697,0.000037730148,0.0011351098,0.00029523412,0.0001142953,0.0011742585,0.0006525724,0.00011934535,0.00015449678],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9945342,0.0009124789,0.0011376052,0.0010780026,0.001349841,0.0009878876],"domain_scores_gemma":[0.9962243,0.0008248173,0.00064513995,0.00073143916,0.0011228845,0.000451438],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016374638,0.00078482245,0.0018981735,0.0005613805,0.000649463,0.00025883075,0.00027077863,0.00019217152,0.00001506257],"category_scores_gemma":[0.00047343,0.00044932056,0.000068542744,0.0008973191,0.0010955587,0.0005356534,0.00008182173,0.0009465417,0.000005291052],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8656414,0.0022234411,0.11996822,0.00006783642,0.0020266555,0.00011434631,0.003288516,0.00021343426,0.005918359,0.0000074643576,0.000450583,0.000079713674],"study_design_scores_gemma":[0.87236536,0.007396467,0.10896641,0.0006020421,0.0015609727,0.000064287546,0.00300586,0.0015862293,0.003774624,0.0000011530179,0.00008306742,0.0005935397],"about_ca_topic_score_codex":0.06447321,"about_ca_topic_score_gemma":0.3793032,"teacher_disagreement_score":0.31482998,"about_ca_system_score_codex":0.002218064,"about_ca_system_score_gemma":0.0014725251,"threshold_uncertainty_score":0.99979585},"labels":[],"label_agreement":null},{"id":"W2553739468","doi":"10.1182/blood.v106.11.3075.3075","title":"Genetically Modified DCs Engineered To Express PSA and/or PSMA Can Induce a Potent Immune Response Against Prostate Cancer Cells.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"CD80; Prostate cancer; Immune system; Cancer research; CD86; Antigen; CD40; CD11c; Dendritic cell; Immunology; Immunotherapy; Prostate; Medicine; Bone marrow; IL-2 receptor; Cancer; Biology; T cell; Cytotoxic T cell; Internal medicine","score_opus":0.011035676927498997,"score_gpt":0.23038648803241588,"score_spread":0.2193508111049169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553739468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97605854,0.020880245,0.000049754224,0.0016038503,0.00034800218,0.00070328894,0.00014110179,0.00012083759,0.0000943852],"genre_scores_gemma":[0.9853852,0.002173677,0.0006207271,0.0009699073,0.00005386107,0.00025499295,0.00002744461,0.000059964303,0.010454225],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99783736,0.00044192822,0.0004950811,0.0004626551,0.00006835853,0.000694624],"domain_scores_gemma":[0.99896955,0.00021578533,0.00010105825,0.0005442682,0.00009727074,0.000072051764],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039096904,0.00036357477,0.0004334485,0.00020806248,0.00024298867,0.000047028163,0.00034685576,0.0003081891,0.00015321748],"category_scores_gemma":[0.000121199846,0.00030312748,0.00010032736,0.00021408826,0.00015265803,0.000074695075,0.00015361277,0.00036487475,0.00010350837],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010622731,0.00048047933,0.00002212768,0.000017588387,0.00037328183,0.00002178552,0.0031036176,0.00023160888,0.9582214,0.000017064944,0.00028823284,0.02660011],"study_design_scores_gemma":[0.0056333644,0.00063905615,0.0060119615,0.00009941784,0.00009236052,0.00007570854,0.00018516155,0.000012251383,0.9315445,0.0000030954411,0.055265732,0.00043741733],"about_ca_topic_score_codex":0.0001624038,"about_ca_topic_score_gemma":0.00003157761,"teacher_disagreement_score":0.0549775,"about_ca_system_score_codex":0.000049286322,"about_ca_system_score_gemma":0.0002516717,"threshold_uncertainty_score":0.99994206},"labels":[],"label_agreement":null},{"id":"W2553759174","doi":"10.1182/blood.v110.11.1993.1993","title":"Assessment of Individual Characteristics on the Pharmacokinetics of Oral Busulfan in Adults Patients Undergoing Hematopoietic Stem-Cell Transplantation.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Busulfan; Pharmacokinetics; Medicine; Hematopoietic stem cell transplantation; Internal medicine; Transplantation; Pharmacology; Bilirubin; Gastroenterology; Therapeutic drug monitoring; Oncology","score_opus":0.016141054534961695,"score_gpt":0.29051272463544603,"score_spread":0.27437167010048436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553759174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974141,0.000017371509,0.0003199656,0.00007367608,0.000054929984,0.00052173116,0.0000867535,0.000009231005,0.0015022014],"genre_scores_gemma":[0.99906987,0.0000937622,0.0005644973,0.00011199378,0.00002581483,0.000008537056,0.000073886666,0.00002104264,0.00003059443],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812764,0.00006641571,0.00054687227,0.00016922306,0.0008263266,0.00026354892],"domain_scores_gemma":[0.9987343,0.00062540744,0.0001982638,0.00021051525,0.00015091685,0.000080577985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054247706,0.00013187835,0.0002782167,0.00017181685,0.0000249697,0.000006319576,0.00017585536,0.0000740142,0.000040852625],"category_scores_gemma":[0.000042025855,0.00009590347,0.000051266525,0.00028194473,0.00008359115,0.000027787999,0.00003612946,0.00022932296,0.0000034613977],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012863401,0.009381429,0.95903337,0.00395559,0.0003236203,0.00026666853,0.005679236,0.00002811818,0.012985997,0.00082322606,0.00015218911,0.0060842335],"study_design_scores_gemma":[0.016722972,0.0010834531,0.9037444,0.00076594565,0.0002742306,0.0000156746,0.00047831246,0.00019634781,0.07659047,0.0000119726665,0.000011167245,0.000105071806],"about_ca_topic_score_codex":0.000016728804,"about_ca_topic_score_gemma":0.000009888927,"teacher_disagreement_score":0.063604474,"about_ca_system_score_codex":0.00008913849,"about_ca_system_score_gemma":0.0003049184,"threshold_uncertainty_score":0.391083},"labels":[],"label_agreement":null},{"id":"W2553766880","doi":"10.1182/blood.v124.21.4464.4464","title":"Mature Results of a Phase 1-2 Open-Label, Dose-Escalation Study of Intravenous SNS01-T in Patients (pts) with Relapsed or Refractory B-Cell Malignancies","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Polyamine Metabolism and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Medicine; Tolerability; Internal medicine; Gastroenterology; Aldesleukin; Multiple myeloma; Oncology; Immunology; Adverse effect; Cytokine; Interleukin 2","score_opus":0.012497135094002906,"score_gpt":0.26313901597804595,"score_spread":0.25064188088404304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553766880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986137,0.0000781596,0.00004453273,0.000011368161,0.000019135778,0.0005975394,0.00012845443,0.000003939105,0.0005031319],"genre_scores_gemma":[0.99891216,0.000024070907,0.00052880915,0.000021565635,0.000026990021,0.00004389569,0.00024011113,0.000012086833,0.00019032901],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99909776,0.000074883596,0.00032458582,0.00025698348,0.000120930694,0.0001248291],"domain_scores_gemma":[0.99916714,0.000015034049,0.00025250582,0.00043045342,0.000098035925,0.000036833757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001632778,0.00011299017,0.00020540453,0.000046962417,0.000027548964,0.000008642579,0.00023454531,0.000086887565,0.0000020764194],"category_scores_gemma":[0.00006579034,0.00008506486,0.000012551972,0.00015931384,0.000037575253,0.0000066876596,0.000089021014,0.00006553393,0.0000011498523],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004068488,0.05385019,0.005646173,0.000070218244,0.00007860553,0.0000020667005,0.0009052967,0.000016295606,0.9287987,0.000034307028,0.0004080514,0.0061216108],"study_design_scores_gemma":[0.17115831,0.026142303,0.09113536,0.000096159245,0.00027919066,0.0000031457616,0.00052245555,0.000028975392,0.7037064,0.00002984805,0.006435286,0.00046259764],"about_ca_topic_score_codex":0.00006997212,"about_ca_topic_score_gemma":0.000116005845,"teacher_disagreement_score":0.22509235,"about_ca_system_score_codex":0.000002857085,"about_ca_system_score_gemma":0.00004608951,"threshold_uncertainty_score":0.34688443},"labels":[],"label_agreement":null},{"id":"W2553768844","doi":"10.1182/blood.v118.21.3316.3316","title":"Safety of Recombinant Activated Factor VII (rFVIIa) in Patients with Congenital Hemophilia with Inhibitors: Overall Dose Exposure and Intervals Following &gt;240 Mcg/Kg Doses Across Trial, Registry and Diary Studies,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Adverse effect; Data monitoring committee; Bleed; Hemostasis; Clinical trial; Randomized controlled trial; Observational study; Prospective cohort study; Pediatrics; Emergency medicine; Surgery; Internal medicine","score_opus":0.03658406872647954,"score_gpt":0.2923937353953448,"score_spread":0.2558096666688653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553768844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99726474,0.00092909375,2.5337667e-7,0.00006472239,0.00011717848,0.0014265638,0.00004584149,0.000029204793,0.00012239761],"genre_scores_gemma":[0.9991345,0.000282423,0.00015102672,0.000014795428,0.000042875858,0.000044123935,0.000041255495,0.000037145153,0.00025185838],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981898,0.00012215089,0.00044023534,0.00045062994,0.00039906026,0.00039813982],"domain_scores_gemma":[0.99902743,0.00016580266,0.0001637698,0.0003249295,0.00013193733,0.00018613623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002929659,0.00030097214,0.0007344414,0.00010790912,0.00010534338,0.00002015891,0.00007900198,0.0001524431,0.000013566938],"category_scores_gemma":[0.0001903809,0.00018447558,0.00007139813,0.00018566789,0.00027118268,0.0002290678,0.00011399513,0.00025837775,9.0787535e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037781548,0.0030751068,0.946202,0.00026300288,0.0014709682,0.00033094035,0.0049241707,1.8263107e-8,0.004311246,0.0000019338358,0.00003339326,0.0016056806],"study_design_scores_gemma":[0.17917979,0.010910322,0.7639461,0.0012606189,0.0003137104,0.000024342078,0.0011620319,4.81115e-7,0.0428371,0.00001771004,0.000036118312,0.00031164533],"about_ca_topic_score_codex":0.00009070906,"about_ca_topic_score_gemma":0.000053098047,"teacher_disagreement_score":0.18225586,"about_ca_system_score_codex":0.000055560035,"about_ca_system_score_gemma":0.00009542988,"threshold_uncertainty_score":0.75226957},"labels":[],"label_agreement":null},{"id":"W2553775977","doi":"10.1182/blood.v116.21.4445.4445","title":"Predictors of Unsuccessful Mobilization with Granulocyte-Colony Stimulating Factor (G-CSF) Alone In Patients with Hematological Malignancies Undergoing Autologous Hematopoietic Stem Cell (AHSCT) Transplant","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Plerixafor; Medicine; Mobilization; Granulocyte colony-stimulating factor; Internal medicine; Stem cell; Haematopoiesis; CD34; Regimen; Hematopoietic stem cell transplantation; Chemotherapy; Oncology; Surgery; Transplantation; Gastroenterology; CXCR4; Biology","score_opus":0.007445410619043965,"score_gpt":0.21209247680139728,"score_spread":0.20464706618235332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553775977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981499,0.000040862702,0.00029836196,0.000025599782,0.00008213351,0.000887345,0.000027969903,0.0000988105,0.00038902997],"genre_scores_gemma":[0.9994272,0.000009385214,0.00035786527,0.000024439732,0.000020136396,0.00006739817,0.00003271437,0.00003189113,0.000028999144],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985646,0.000043209886,0.0004037785,0.00033828922,0.0003530907,0.00029704007],"domain_scores_gemma":[0.9991594,0.00012870917,0.00019163854,0.00026525414,0.00014486272,0.00011016053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006739294,0.00022752212,0.00051221205,0.0001326765,0.00008356305,0.00001634482,0.00009159367,0.00014675039,0.00004888188],"category_scores_gemma":[0.000011503631,0.0001548613,0.000051839033,0.00034821942,0.00013824807,0.00012509456,0.000016940454,0.00030106725,0.0000025085496],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038522357,0.0013218374,0.9905599,0.00048427886,0.000063177904,0.000049713755,0.0007987872,0.0002615647,0.005968832,0.000070479444,0.0000018634897,0.000034365592],"study_design_scores_gemma":[0.011704687,0.002257636,0.9253439,0.00054468715,0.0003919489,0.00013110327,0.00018267917,0.000049012582,0.05913071,0.0000141009405,0.0000070220276,0.00024256119],"about_ca_topic_score_codex":0.000044810884,"about_ca_topic_score_gemma":0.000445254,"teacher_disagreement_score":0.06521603,"about_ca_system_score_codex":0.000028877468,"about_ca_system_score_gemma":0.00016718238,"threshold_uncertainty_score":0.6315061},"labels":[],"label_agreement":null},{"id":"W2553800278","doi":"10.1182/blood.v126.23.893.893","title":"A Prospective Cohort Study of Upper Extremity Deep Vein Thrombosis","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; McGill University; University of Ottawa; Jewish General Hospital; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Warfarin; Surgery; Pulmonary embolism; Thrombosis; Prospective cohort study; Low molecular weight heparin; Deep vein; Central venous catheter; Internal medicine; Catheter; Atrial fibrillation","score_opus":0.025379991561311408,"score_gpt":0.2852931577042919,"score_spread":0.2599131661429805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553800278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9729859,0.00024811746,0.000019464936,0.00008724172,0.000104055776,0.0018446815,0.0000020640962,0.00006071899,0.024647739],"genre_scores_gemma":[0.99904794,0.000043731594,0.00032296986,0.00010528389,0.00009674388,0.0001893357,0.0000047381986,0.000021771917,0.00016751734],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875844,0.000043595926,0.00025271342,0.00030392778,0.0004412926,0.0002000097],"domain_scores_gemma":[0.99911076,0.000020149439,0.00009029304,0.00044091322,0.00018893644,0.00014896334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031932385,0.00013894806,0.0005516554,0.00008204821,0.000036495934,0.000010742254,0.000096805285,0.0000493011,0.000111306304],"category_scores_gemma":[0.00009035193,0.00011462152,0.00007110458,0.00019932669,0.00004057627,0.00005722187,0.000102339756,0.00009893365,0.000041727995],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022614355,0.018120864,0.97574705,0.000035381476,0.0007546204,0.000018346464,0.0033922107,0.0000029810085,0.00019554104,0.00022320531,0.0012176596,0.00026951078],"study_design_scores_gemma":[0.005219306,0.0015031934,0.98662144,0.00003626822,0.0013991008,0.0000053907615,0.003440099,0.000012040041,0.0012877877,0.00013981598,0.00022361941,0.0001119162],"about_ca_topic_score_codex":0.00045252842,"about_ca_topic_score_gemma":0.000103152175,"teacher_disagreement_score":0.026061991,"about_ca_system_score_codex":0.000051099065,"about_ca_system_score_gemma":0.00005338035,"threshold_uncertainty_score":0.467413},"labels":[],"label_agreement":null},{"id":"W2553811141","doi":"10.1182/blood.v106.11.349.349","title":"Maintenance Rituximab after CVP Results in Superior Clinical Outcome in Advanced Follicular Lymphoma (FL): Results of the E1496 Phase III Trial from the Eastern Cooperative Oncology Group and the Cancer and Leukemia Group B.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Rituximab; Follicular lymphoma; Hazard ratio; Internal medicine; Vincristine; Gastroenterology; Randomization; Cyclophosphamide; Prednisone; Surgery; Lymphoma; Chemotherapy; Confidence interval; Oncology; Randomized controlled trial","score_opus":0.023039637695874533,"score_gpt":0.33214290679565267,"score_spread":0.30910326909977814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553811141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854187,0.0046421858,0.0000014375208,0.007228993,0.00020716208,0.0020854038,0.00025236976,0.000009430015,0.00015432297],"genre_scores_gemma":[0.99519014,0.0018266366,0.0001859342,0.001736254,0.000298399,0.00063190714,0.00002330397,0.000018034389,0.000089367255],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9971367,0.00051532144,0.0012228332,0.0005699907,0.00024340351,0.0003117444],"domain_scores_gemma":[0.99760985,0.0014029909,0.0002740236,0.0005697787,0.00005312561,0.000090241054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010586593,0.00026166014,0.00093167956,0.000035736484,0.000079521866,0.000025784031,0.00018979849,0.00017870041,0.000007294648],"category_scores_gemma":[0.0006215742,0.000115099196,0.00016408165,0.00018317084,0.00056724163,0.000092044844,0.00017022829,0.00021608698,0.0000023296734],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.52732795,0.012692505,0.32714304,0.000021960943,0.00062324083,0.0005032186,0.00739504,0.00001077607,0.0001743113,0.00024382673,0.00025935416,0.12360477],"study_design_scores_gemma":[0.7211743,0.0014237151,0.2715134,0.00028269645,0.0003613833,0.000026270094,0.0004671554,0.00028630445,0.00024884395,0.000029340017,0.0040644454,0.0001221411],"about_ca_topic_score_codex":0.0038261178,"about_ca_topic_score_gemma":0.015927989,"teacher_disagreement_score":0.19384636,"about_ca_system_score_codex":0.00027247664,"about_ca_system_score_gemma":0.00025682355,"threshold_uncertainty_score":0.8888192},"labels":[],"label_agreement":null},{"id":"W2553813954","doi":"10.1182/blood.v114.22.1291.1291","title":"The Prevalence of Non-Neutralizing Anti-FVIII Antibodies in the Canadian Hemophilia Population.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Queen's University","funders":"","keywords":"Antibody; Population; Medicine; Clotting factor; Immunology; Serial dilution; Antigen; Microtiter plate; Neutralizing antibody; Virology; Internal medicine; Biology; Molecular biology; Pathology","score_opus":0.024144965732375446,"score_gpt":0.31194770262666177,"score_spread":0.2878027368942863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553813954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986788,0.0008700495,1.2914136e-7,0.0072559407,0.000026351527,0.00039478397,0.000005645516,0.0000070581987,0.004652059],"genre_scores_gemma":[0.9984957,0.00046929118,0.000061422645,0.00015457865,0.00006801585,0.0000052869173,0.0000070004994,0.000004989155,0.00073369837],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909824,0.000047969326,0.00017703621,0.00012407597,0.0002696741,0.00028300585],"domain_scores_gemma":[0.9994795,0.00007593063,0.000031790707,0.00029002377,0.000049025082,0.0000737843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000368121,0.00008239317,0.00013662953,0.00009761141,0.0002297191,0.000024343211,0.0001662623,0.000052621413,0.000011301358],"category_scores_gemma":[0.00007608379,0.000041560466,0.000053792803,0.00024559634,0.000072412426,0.000042863332,0.000009008191,0.00014970438,0.000007734336],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011851767,0.00021836934,0.99476683,0.000100393925,0.000026241485,0.00009076729,0.00065090274,0.0000025317456,0.0017672434,0.0005004379,0.00018649688,0.0016779222],"study_design_scores_gemma":[0.0007440636,0.00012543045,0.9954362,0.000108984335,0.00005809381,0.00003063974,0.000085634936,0.0000289011,0.0029127197,0.0002218959,0.00020274603,0.00004470664],"about_ca_topic_score_codex":0.013225097,"about_ca_topic_score_gemma":0.018684532,"teacher_disagreement_score":0.011707734,"about_ca_system_score_codex":0.000028518996,"about_ca_system_score_gemma":0.00013116765,"threshold_uncertainty_score":0.9992219},"labels":[],"label_agreement":null},{"id":"W2553842621","doi":"10.1182/blood.v110.11.3597.3597","title":"Lenalidomide Overcomes Poor Prognosis Conferred by del13q and t(4;14) but Not del17p13 in Multiple Myeloma: Results of the Canadian MM016 Trial.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency; University of Calgary","funders":"","keywords":"Lenalidomide; Medicine; Thalidomide; Multiple myeloma; Internal medicine; Refractory (planetary science); Gastroenterology; Oncology; Urology; Biology","score_opus":0.036015507475953355,"score_gpt":0.28671566278572924,"score_spread":0.2507001553097759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553842621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99368566,0.0004304763,0.0000019000167,0.0017162861,0.00007416691,0.0019100601,0.0003989745,0.00001882625,0.0017636416],"genre_scores_gemma":[0.9983375,0.00006458265,0.00030369425,0.00025997218,0.00006319835,0.00006887394,0.00007180649,0.000024767867,0.0008055743],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979025,0.00010451379,0.00053579075,0.00035168458,0.00048136103,0.0006241262],"domain_scores_gemma":[0.99854594,0.00042914963,0.00012529276,0.00032722126,0.00014380865,0.00042860175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007307432,0.00020504963,0.0004211481,0.00023513754,0.00013775397,0.000028468356,0.0001519181,0.00016215525,0.000017574675],"category_scores_gemma":[0.001601673,0.00013903146,0.00010592547,0.0002847645,0.00018247832,0.000066524124,0.0000616835,0.00023978653,0.000007880127],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0653979,0.0038483946,0.8633664,0.00021560813,0.0009412421,0.00081690925,0.0007369893,0.0000011326458,0.042513654,0.000079359816,0.004783398,0.017298969],"study_design_scores_gemma":[0.24766313,0.0006533595,0.5190819,0.00018285218,0.00017158291,0.000053459473,0.00015200442,0.000091387345,0.22853722,0.000015519925,0.0032078722,0.0001897507],"about_ca_topic_score_codex":0.20262389,"about_ca_topic_score_gemma":0.44440112,"teacher_disagreement_score":0.34428456,"about_ca_system_score_codex":0.00014186557,"about_ca_system_score_gemma":0.00053087244,"threshold_uncertainty_score":0.8026859},"labels":[],"label_agreement":null},{"id":"W2553847352","doi":"10.1182/blood.v120.21.3308.3308","title":"Gas6-Induced Tissue Factor Expression in Endothelial Cells Is Mediated Through Caveolin-1-Enriched Domains","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"GAS6; Caveolae; Cell biology; Receptor tyrosine kinase; Biology; Lipid raft; Signal transduction; Protein kinase B; Caveolin; Caveolin 1; Tyrosine kinase","score_opus":0.021771902972625046,"score_gpt":0.26260614783704356,"score_spread":0.2408342448644185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553847352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948441,0.0028431166,0.000059421724,0.000068475994,0.0008529169,0.00029239221,0.00008783039,0.00006387355,0.0008878851],"genre_scores_gemma":[0.99866337,0.00015322048,0.00012728646,0.00014316125,0.0001224337,0.000027356544,0.00011579343,0.000025909945,0.00062146835],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985852,0.00021779939,0.00035374067,0.00024542498,0.00005693201,0.00054090127],"domain_scores_gemma":[0.9993674,0.000120088225,0.00014300278,0.00030795234,0.000028623144,0.0000329223],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00014127592,0.0002153828,0.00031983125,0.00008702304,0.00010654283,0.00001062879,0.00017574984,0.00038886894,0.0009970589],"category_scores_gemma":[0.000043311185,0.00018165566,0.00007252143,0.0001335052,0.000051593637,0.00027804577,0.00007884235,0.00025532336,0.0009172143],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042459993,0.0007901955,0.0027927828,0.000008651438,0.000051882977,0.0000017951893,0.0026984466,2.1852101e-7,0.992719,0.000046783185,0.00042701967,0.00042078138],"study_design_scores_gemma":[0.0035850757,0.000086685,0.020490231,0.000023741293,0.00003420264,0.000015557294,0.00011220191,5.9997296e-7,0.9585836,0.000041194315,0.01681984,0.00020706434],"about_ca_topic_score_codex":0.0001306794,"about_ca_topic_score_gemma":0.000009649801,"teacher_disagreement_score":0.034135375,"about_ca_system_score_codex":0.00003471257,"about_ca_system_score_gemma":0.000034193352,"threshold_uncertainty_score":0.99991614},"labels":[],"label_agreement":null},{"id":"W2553852706","doi":"10.1182/blood.v108.11.1607.1607","title":"Effects of Multimerin 1 on Platelet and Plasma FV as Determined by Calibrated Automated Thrombography.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Platelet; Phosphatidylserine; Chemistry; Thrombin; Platelet activation; Phosphatidylethanolamine; Phosphatidylcholine; Tissue factor; Factor V; Biochemistry; Phospholipid; Molecular biology; Immunology; Internal medicine; Coagulation; Biology; Medicine","score_opus":0.005814728467775373,"score_gpt":0.23323033550319516,"score_spread":0.2274156070354198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553852706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978153,0.00014590874,0.000017289147,0.00007859128,0.000063340776,0.0004709557,0.000013961501,0.00039828717,0.0009963799],"genre_scores_gemma":[0.9987534,0.000016827009,0.0007767541,0.00017104679,0.000027888114,0.000018932653,0.000062601765,0.000031577387,0.00014091578],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99902123,0.00004934849,0.0002620579,0.00025607148,0.00020989485,0.00020141307],"domain_scores_gemma":[0.9994564,0.00011553729,0.00010751748,0.00017664317,0.000038746697,0.00010516428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005555757,0.00018946793,0.00038788054,0.00013314905,0.00004549604,0.000013672112,0.000049410028,0.00014910924,0.00004827292],"category_scores_gemma":[0.000030179957,0.00016517939,0.000067917186,0.00024580918,0.00006296161,0.000046150577,0.00001993905,0.00009506566,0.000019580268],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000109669534,0.0016767106,0.002664284,0.00017155557,0.0001959427,0.00006214151,0.00004658674,0.0000029549071,0.99306273,0.0004144999,0.0009249603,0.0006679346],"study_design_scores_gemma":[0.009582871,0.0010357861,0.054157656,0.00014448482,0.00025578353,0.000049577528,0.00000778347,0.0026929653,0.9316653,0.00009328478,0.00016005058,0.00015445234],"about_ca_topic_score_codex":0.00017612925,"about_ca_topic_score_gemma":0.0000056985305,"teacher_disagreement_score":0.061397456,"about_ca_system_score_codex":0.0000047010617,"about_ca_system_score_gemma":0.000022317812,"threshold_uncertainty_score":0.673582},"labels":[],"label_agreement":null},{"id":"W2553864385","doi":"10.1182/blood-2016-09-740654","title":"Distinct signaling programs control human hematopoietic stem cell survival and proliferation","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of British Columbia; Institute for Research in Immunology and Cancer; Occupational Cancer Research Centre; University of Toronto; BC Cancer Agency","funders":"","keywords":"Stem cell; Haematopoiesis; Hematopoietic stem cell; Cell growth; Biology; Hematopoietic cell; Cancer research; Medicine; Immunology; Cell biology; Genetics","score_opus":0.01894997200634186,"score_gpt":0.24581950369614816,"score_spread":0.2268695316898063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553864385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99215114,0.0001186603,0.004608522,0.0002492685,0.000054076423,0.00086017355,0.000007697268,0.00012507991,0.001825403],"genre_scores_gemma":[0.99895614,0.000007966063,0.00025095596,0.000026196481,0.00012653106,0.000076156175,0.000017505234,0.000029744402,0.0005087832],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99882185,0.000070949674,0.0003157407,0.00027927352,0.00027606366,0.00023610813],"domain_scores_gemma":[0.99936825,0.00013790924,0.000085237145,0.00018827096,0.00007327236,0.00014707725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027214125,0.0001572864,0.00028243306,0.000046599544,0.00009071899,0.000032216183,0.000043590207,0.00008584399,0.000039481238],"category_scores_gemma":[0.0000098273085,0.000105062565,0.00005136672,0.000067069406,0.000059978207,0.00006615865,0.000007842606,0.0000677797,0.000032367352],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010687337,0.00085909007,0.37165263,0.001118378,0.00010390159,0.00010684611,0.00090529316,1.574858e-7,0.6207744,0.0011390977,0.000009722248,0.0032236285],"study_design_scores_gemma":[0.04511995,0.0018159554,0.06105574,0.0020929074,0.0019006043,0.0007445027,0.0006449024,0.00006195703,0.8849807,0.0005603781,0.0002864988,0.00073593634],"about_ca_topic_score_codex":0.0000042778715,"about_ca_topic_score_gemma":0.0000066923003,"teacher_disagreement_score":0.31059688,"about_ca_system_score_codex":0.000014924217,"about_ca_system_score_gemma":0.000040254163,"threshold_uncertainty_score":0.4284327},"labels":[],"label_agreement":null},{"id":"W2553893461","doi":"10.1182/blood.v116.21.5031.5031","title":"A Multicenter Randomized Phase II Trial of Mapatumumab, a TRAIL-R1 Agonist Monoclonal Antibody, In Combination with Bortezomib In Patients with Relapsed/Refractory Multiple Myeloma (MM)","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Alberta","funders":"","keywords":"Bortezomib; Medicine; Multiple myeloma; Internal medicine; Adverse effect; Refractory (planetary science); Surgery; Gastroenterology; Biology","score_opus":0.010980151753230805,"score_gpt":0.2828969533631146,"score_spread":0.2719168016098838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553893461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943746,0.000030628362,0.00002241264,0.00009068521,0.000099948695,0.0049863886,0.000081848935,0.000030247442,0.00028325059],"genre_scores_gemma":[0.9967945,0.000013471869,0.002003461,0.00002184132,0.00004568633,0.0003329211,0.00064766145,0.000046218945,0.000094239185],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99742144,0.00021291348,0.00068507897,0.00045780372,0.00074507185,0.00047769563],"domain_scores_gemma":[0.9985043,0.00032144025,0.00029341053,0.00041837752,0.000228126,0.0002343494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005026732,0.00031734625,0.0009917791,0.00045978514,0.00007867237,0.000021510543,0.00013340868,0.00016812669,0.00007249312],"category_scores_gemma":[0.00055656297,0.0002160401,0.0001390228,0.0003336223,0.00029623866,0.00020369886,0.000047942744,0.00059168646,0.0000058089686],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.64047194,0.045507062,0.30611846,0.00006576796,0.00029766725,0.00018988183,0.0005066034,6.859063e-7,0.0039240224,0.000012087326,0.0000049339496,0.0029008621],"study_design_scores_gemma":[0.73467845,0.007819486,0.2535131,0.00019398186,0.00017968005,0.000006476705,0.000038421862,0.00062159175,0.002751732,0.000007126321,0.00003111542,0.00015883666],"about_ca_topic_score_codex":0.0005411405,"about_ca_topic_score_gemma":0.00092493655,"teacher_disagreement_score":0.09420648,"about_ca_system_score_codex":0.000059687278,"about_ca_system_score_gemma":0.0002635322,"threshold_uncertainty_score":0.880986},"labels":[],"label_agreement":null},{"id":"W2553902451","doi":"10.1182/blood.v118.21.2956.2956","title":"Comparing Human Fetal Liver, Cord Blood and Adult Bone Marrow Stem/Progenitor Hematopoietic Cells As Cells of Origin of Human MLL Leukemias","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research; University of Toronto; Université Laval","funders":"","keywords":"Progenitor cell; Stem cell; Biology; Bone marrow; Haematopoiesis; Leukemia; Cord blood; Myeloid; Cancer research; Immunology; Genetics","score_opus":0.040370549770106255,"score_gpt":0.2755658365567631,"score_spread":0.23519528678665683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553902451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937311,0.00065681984,0.000012241567,0.000008000316,0.00008513265,0.0007716208,0.000025544521,0.00006743368,0.004642112],"genre_scores_gemma":[0.99700975,0.00009131679,0.0013120983,0.000031056905,0.00014255196,0.00002679576,0.00001812577,0.000077686454,0.0012906408],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99712425,0.00009907653,0.0008662639,0.00054310134,0.00078524876,0.0005820623],"domain_scores_gemma":[0.99798125,0.000116864976,0.00039015192,0.00072784215,0.00038703575,0.00039686644],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030497168,0.00036845377,0.001026427,0.00027030366,0.00012453202,0.000017774157,0.00033572465,0.00024107122,0.0002592789],"category_scores_gemma":[0.000034898134,0.0003418886,0.00018589351,0.00027251337,0.00048681645,0.0000985841,0.00030557872,0.0003761007,0.000062640494],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038888134,0.002609598,0.03387976,0.0022223573,0.0006086482,0.0009990989,0.0018277973,2.8082897e-7,0.95599264,0.00072466535,0.000606216,0.00014004204],"study_design_scores_gemma":[0.014801687,0.002630114,0.0035031938,0.0004994736,0.0012544412,0.0006299722,0.0005774254,0.00007192858,0.9756064,0.00007438801,0.000043498858,0.00030750432],"about_ca_topic_score_codex":0.0017483592,"about_ca_topic_score_gemma":0.00007211949,"teacher_disagreement_score":0.030376565,"about_ca_system_score_codex":0.00011732745,"about_ca_system_score_gemma":0.00037218808,"threshold_uncertainty_score":0.9999033},"labels":[],"label_agreement":null},{"id":"W2553947646","doi":"10.1182/blood.v110.11.93.93","title":"Differential Expression and Re-Localization of Potential Cell Fate Determinants in Hematopoietic and Leukemia Stem Cells.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Biology; Stem cell; Haematopoiesis; Progenitor cell; Molecular biology; Stem cell marker; Cell biology; Genetics","score_opus":0.006658621103958617,"score_gpt":0.2151692956203146,"score_spread":0.20851067451635596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553947646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970652,0.0015647801,0.0009792326,0.0000025402182,0.0001763743,0.0001091066,0.0000047830413,0.000011637017,0.00008637668],"genre_scores_gemma":[0.99926513,0.00016768041,0.00001790414,0.000009688054,0.0000065105105,0.000001884831,0.0000040127456,0.00000924353,0.0005179184],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992515,0.00009415448,0.00027442255,0.00016638589,0.000023936105,0.00018960363],"domain_scores_gemma":[0.9997189,0.000047311572,0.00009081374,0.00010930029,0.00001905175,0.0000146440725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011028151,0.000106857886,0.00019663716,0.00010795844,0.00005180312,0.000007433539,0.00006061178,0.00017767855,0.000059336184],"category_scores_gemma":[0.000005219767,0.00009152294,0.00002610112,0.0000413911,0.00010535439,0.000042357624,0.000082433355,0.00010526885,0.0000067155497],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036699383,0.0001406099,0.0041703987,0.00007266157,0.000009335253,0.000012487112,0.00062602886,7.871866e-7,0.99312955,0.0000058796218,0.000024497318,0.0014407797],"study_design_scores_gemma":[0.0027665482,0.0001740183,0.004729109,0.00010310979,0.000030376217,0.00004824063,0.0003886817,0.000020515288,0.9915205,0.000008959905,0.000115894196,0.00009404737],"about_ca_topic_score_codex":0.00003057209,"about_ca_topic_score_gemma":0.000014647848,"teacher_disagreement_score":0.0023995542,"about_ca_system_score_codex":0.000008977974,"about_ca_system_score_gemma":0.000015826858,"threshold_uncertainty_score":0.3732197},"labels":[],"label_agreement":null},{"id":"W2553962359","doi":"10.1182/blood.v104.11.3259.3259","title":"Lymphoma-Associated Macrophage (LAM) Content Is an Independent Predictor of Survival in Patients with Follicular Lymphoma (FL).","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Follicular lymphoma; Medicine; Lymphoma; Internal medicine; CD68; Tissue microarray; CD20; Biopsy; Stage (stratigraphy); Survival analysis; High-power field; Pathology; Oncology; Rituximab; Cancer; Immunohistochemistry; Biology","score_opus":0.01467646296049819,"score_gpt":0.21822741827620287,"score_spread":0.2035509553157047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553962359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980405,0.00031347093,0.0000034724228,0.00009624233,0.00010409207,0.00091010804,0.00015581596,0.0000549521,0.0003213351],"genre_scores_gemma":[0.9991813,0.000034950575,0.00014871253,0.00019350428,0.000034407487,0.0000819479,0.00020690203,0.000045371744,0.00007293963],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99771804,0.00006540543,0.000495758,0.00046676784,0.00083382014,0.00042018885],"domain_scores_gemma":[0.99877423,0.000028994718,0.00022352408,0.00047643934,0.00023212876,0.0002646708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001525085,0.00030907267,0.00066204177,0.00014416347,0.000051351868,0.000020272335,0.00013444296,0.00017966364,0.000048599097],"category_scores_gemma":[0.00004685716,0.00022992311,0.00014755913,0.00028797652,0.000069791735,0.000114726165,0.00005235474,0.000046463312,0.000015642408],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004905771,0.030849416,0.96497446,0.00003942505,0.0007535966,0.00045162236,0.0006443879,0.0000056371287,0.00021216656,0.00009810163,0.000009909138,0.0014707167],"study_design_scores_gemma":[0.10694595,0.0026335022,0.86963755,0.00025875072,0.0005205638,0.000013070154,0.00012740481,0.0000038694116,0.019611487,0.000027788908,0.000028985205,0.00019106345],"about_ca_topic_score_codex":0.00159218,"about_ca_topic_score_gemma":0.00032894293,"teacher_disagreement_score":0.10645537,"about_ca_system_score_codex":0.0005222981,"about_ca_system_score_gemma":0.00031097626,"threshold_uncertainty_score":0.93759924},"labels":[],"label_agreement":null},{"id":"W2554005559","doi":"10.1182/blood.v116.21.5034.5034","title":"Neutropenia and G-CSF Use In Patients with Relapsed/Refractory Multiple Myeloma Treated with Lenalidomide Plus Dexamethasone","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Neutropenia; Medicine; Lenalidomide; Dexamethasone; Febrile neutropenia; Internal medicine; Absolute neutrophil count; Refractory (planetary science); Gastroenterology; Surgery; Chemotherapy","score_opus":0.015002457150749576,"score_gpt":0.2386497411046597,"score_spread":0.22364728395391012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554005559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998352,0.00005707686,0.0000045674865,0.000049949685,0.000019453915,0.0011529018,0.000037528436,0.00006238305,0.00026417398],"genre_scores_gemma":[0.9953642,0.000019468864,0.0037942529,0.000057861183,0.000037899754,0.00008328333,0.00013429766,0.000061072766,0.00044766898],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827653,0.00007564771,0.00023029154,0.0004882921,0.00043437033,0.00049486867],"domain_scores_gemma":[0.9985854,0.00024455698,0.000088637804,0.0004908698,0.00017730742,0.0004132397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011183244,0.00029078187,0.00044636938,0.00022099928,0.000085619155,0.000061739185,0.00008633967,0.0001326315,0.000059971488],"category_scores_gemma":[0.0002796889,0.00018380434,0.00003504024,0.00027646607,0.00017698396,0.0003094324,0.00005378746,0.00052221573,0.000024712388],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007659991,0.0022381821,0.9822214,0.000036085003,0.00026627208,0.000603876,0.00009724392,0.0000012256819,0.0043731644,0.0000047500475,0.000019869341,0.0024778876],"study_design_scores_gemma":[0.082825325,0.0021753726,0.908995,0.00011748585,0.00018277546,0.000056559176,0.000021648344,0.000059809114,0.0051303166,0.0000013546443,0.00023688696,0.00019751755],"about_ca_topic_score_codex":0.0012043973,"about_ca_topic_score_gemma":0.0030256321,"teacher_disagreement_score":0.07516533,"about_ca_system_score_codex":0.000052235275,"about_ca_system_score_gemma":0.00013861357,"threshold_uncertainty_score":0.74953234},"labels":[],"label_agreement":null},{"id":"W2554041296","doi":"10.1182/blood.v112.11.261.261","title":"PROPEL: A Multi-Center Phase 2 Open-Label Study of Pralatrexate (PDX) with Vitamin B12 and Folic Acid Supplementation in Patients with Replapsed or Refractory Peripheral T-Cell Lymphoma","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Interim analysis; Clinical endpoint; Internal medicine; Phases of clinical research; Antifolate; Oncology; Refractory (planetary science); Clinical trial; Neutropenia; Peripheral T-cell lymphoma; Gastroenterology; Cancer; Surgery; Pharmacology; Chemotherapy; Immunology; Antimetabolite; T cell; Immune system","score_opus":0.03122741258708996,"score_gpt":0.29557249084233417,"score_spread":0.2643450782552442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554041296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964084,0.00005525112,0.0000019298036,0.000027930255,0.000019051076,0.0033391726,0.00005172559,0.000017873483,0.00007864696],"genre_scores_gemma":[0.9970642,0.00003818371,0.0020142007,0.000074187694,0.000011893179,0.00036038933,0.00015575797,0.0000375385,0.00024369647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859935,0.000072986906,0.0003496658,0.00042933755,0.00031239842,0.00023626929],"domain_scores_gemma":[0.99923396,0.00001905806,0.00020866607,0.00032174474,0.000101875434,0.00011466562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006774436,0.00023849451,0.00042237784,0.00010127633,0.00007236157,0.000021922178,0.00008069249,0.000041942225,0.00002877036],"category_scores_gemma":[0.000010584297,0.0001411394,0.000014779099,0.0001874335,0.00005647802,0.00023072577,0.0000619215,0.000045147437,0.0000019979755],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066286335,0.22975607,0.7574969,0.00005476518,0.00022569766,0.000400084,0.0031702025,1.8464793e-7,0.0003538366,2.2165895e-7,0.000060849772,0.0018525404],"study_design_scores_gemma":[0.44669038,0.025380373,0.52253836,0.0001214586,0.0002650124,0.00004656859,0.00050527084,0.000013283583,0.004253041,6.382175e-8,0.00005389558,0.00013225677],"about_ca_topic_score_codex":0.00046654156,"about_ca_topic_score_gemma":0.00058507326,"teacher_disagreement_score":0.44006175,"about_ca_system_score_codex":0.00010222563,"about_ca_system_score_gemma":0.00016141524,"threshold_uncertainty_score":0.5755498},"labels":[],"label_agreement":null},{"id":"W2554066639","doi":"10.1182/blood.v126.23.4953.4953","title":"Sarcopenia and Adipopenia Are Independent Prognostic Factors in Patients with Acute Myeloid Leukemia","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sarcopenia; Medicine; Adipose tissue; Myeloid leukemia; Internal medicine; Skeletal muscle; Hounsfield scale; Chemotherapy; Gastroenterology; Surgery; Computed tomography","score_opus":0.024693563985776126,"score_gpt":0.26917999406535814,"score_spread":0.244486430079582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554066639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982222,0.0001900688,0.0000027264755,0.00025837313,0.00005453004,0.0006921103,0.000012936924,0.000038261303,0.0005288459],"genre_scores_gemma":[0.99882007,0.000016996844,0.0005348631,0.00037640228,0.000036699286,0.000023346918,0.00004411925,0.000019607587,0.00012788344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99903786,0.000027888122,0.00019126656,0.00021493887,0.00029254294,0.00023549079],"domain_scores_gemma":[0.9993443,0.000020374817,0.00007364318,0.00013945057,0.00009830343,0.00032392045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010828869,0.0001233201,0.00025896035,0.00011664787,0.000037642414,0.000019105877,0.0000491544,0.00006764493,0.000022515967],"category_scores_gemma":[0.00005488673,0.000092375645,0.000013086227,0.00014222223,0.00003310056,0.00008784166,0.00003815448,0.00022324028,0.000018160248],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022665427,0.00033987843,0.9984176,0.00008127049,0.000035970294,0.00008608212,0.00038094446,2.1661677e-7,0.000029087514,0.00001043329,0.00018602614,0.0002058329],"study_design_scores_gemma":[0.01517668,0.00055057445,0.98238313,0.00033837432,0.0001260635,0.000027519616,0.00017991693,0.0000039098422,0.00043611336,0.000031243886,0.00063358026,0.00011288642],"about_ca_topic_score_codex":0.00007042948,"about_ca_topic_score_gemma":0.000104815466,"teacher_disagreement_score":0.016034465,"about_ca_system_score_codex":0.00010111251,"about_ca_system_score_gemma":0.00020655674,"threshold_uncertainty_score":0.37669694},"labels":[],"label_agreement":null},{"id":"W2554067679","doi":"10.1182/blood.v126.23.4659.4659","title":"Persistent Thrombopoietin Mimetic Induced Myelofibrosis in a Woman with Chronic Refractory Immune Thrombocytopenia","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Thrombopoietin; Eltrombopag; Romiplostim; Medicine; Myelofibrosis; Splenectomy; Pancytopenia; Bone marrow; Thrombocytopenic purpura; Internal medicine; Platelet; Gastroenterology; Megakaryocyte; Immunology; Haematopoiesis; Spleen; Stem cell; Immune thrombocytopenia","score_opus":0.027141317677531522,"score_gpt":0.2575508550426451,"score_spread":0.23040953736511355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554067679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908962,0.0032447155,8.97085e-7,0.00036798432,0.00004923267,0.00067057804,0.0000038547914,0.00005779643,0.004708701],"genre_scores_gemma":[0.99890137,0.000076852375,0.00039996539,0.00010317616,0.00003898805,0.000091613925,0.000040214025,0.00004018529,0.00030766486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986371,0.00004558189,0.00025347545,0.0003505612,0.0003215827,0.0003917458],"domain_scores_gemma":[0.99921286,0.000020340638,0.0000852602,0.0004128291,0.00006135274,0.00020735331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013250919,0.00023656973,0.00060307124,0.00013144786,0.00004606572,0.000022056247,0.00010701597,0.000118544995,0.000084902975],"category_scores_gemma":[0.00002771082,0.0001768139,0.00010517491,0.00029726812,0.00006153905,0.00010204342,0.00004975336,0.00022127308,0.0001327176],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00414093,0.038424283,0.5094953,0.0008577341,0.006540563,0.012147947,0.013667705,0.00003413352,0.4013168,0.00014735755,0.0015255802,0.011701649],"study_design_scores_gemma":[0.09006854,0.021036236,0.82635266,0.0013219481,0.0022919225,0.0017309434,0.0030235841,0.0000729407,0.0505373,0.00011161936,0.0024052626,0.0010470764],"about_ca_topic_score_codex":0.0005434731,"about_ca_topic_score_gemma":0.00025770065,"teacher_disagreement_score":0.35077947,"about_ca_system_score_codex":0.00024228336,"about_ca_system_score_gemma":0.00036701918,"threshold_uncertainty_score":0.7210262},"labels":[],"label_agreement":null},{"id":"W2554074230","doi":"10.1182/blood.v104.11.4035.4035","title":"D-Dimer Assay during Menstrual Period.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Blood properties and coagulation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Fibrin; D-dimer; Medicine; Menstrual cycle; Fibrinolysis; Internal medicine; Physiology; Immunology; Hormone","score_opus":0.011506485141718434,"score_gpt":0.22327504613779106,"score_spread":0.21176856099607264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554074230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99287385,0.00045147582,0.000018667037,0.0009559118,0.00007196937,0.00011492729,9.912105e-7,0.00007300874,0.0054392163],"genre_scores_gemma":[0.9978069,0.000009980087,0.0008016576,0.00016527636,0.00022954616,0.000007974425,0.0000053013073,0.000014882887,0.00095846195],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99944407,0.000009123635,0.00011277687,0.00013278202,0.00014993167,0.00015129149],"domain_scores_gemma":[0.99971664,0.000002707483,0.000022795673,0.00015726047,0.000032365802,0.00006822524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000055989225,0.00007585899,0.00011695893,0.000029677112,0.000070785456,0.000012918317,0.00003076225,0.0000554011,0.00015742338],"category_scores_gemma":[0.000017788565,0.000060349277,0.00004922337,0.00006672468,0.000022446893,0.000047682024,0.000020781568,0.00009277507,0.00009936644],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043190064,0.0029647907,0.13589427,0.00039694775,0.00083037926,0.0005515671,0.0038536645,0.0001605377,0.8428986,0.0022918922,0.00022849548,0.009496972],"study_design_scores_gemma":[0.018575009,0.0005939914,0.3860686,0.00023985535,0.0006992698,0.0013323447,0.00048202893,0.000022777433,0.5885218,0.0003085318,0.0027888722,0.0003669208],"about_ca_topic_score_codex":0.00003523234,"about_ca_topic_score_gemma":0.000004411139,"teacher_disagreement_score":0.2543768,"about_ca_system_score_codex":0.000015378111,"about_ca_system_score_gemma":0.000045480592,"threshold_uncertainty_score":0.2460972},"labels":[],"label_agreement":null},{"id":"W2554081271","doi":"10.1182/blood.v120.21.895.895","title":"SOX11 Directly Represses Wnt/β-Catenin Signaling and Identifies a Subgroup of Mantle Cell Lymphoma Patients with Improved Survival with Intensive Treatment","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Wnt signaling pathway; Chromatin immunoprecipitation; Cell growth; Biology; Cancer research; Cell culture; Cell cycle; Molecular biology; Beta-catenin; Transcription factor; Catenin; Signal transduction; Mantle cell lymphoma; Cell; Cell biology; Gene expression; Lymphoma; Gene; Immunology; Genetics; Promoter","score_opus":0.009932888377457547,"score_gpt":0.2128905059918844,"score_spread":0.20295761761442685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554081271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99716127,0.0016679377,0.000004640033,0.000031410367,0.00006120247,0.0005948964,0.000032291515,0.000035833644,0.00041049928],"genre_scores_gemma":[0.99890757,0.0001447823,0.00047413845,0.000028131746,0.000052552412,0.00010143927,0.000058576516,0.000034105866,0.00019868821],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988974,0.00003347793,0.00022739364,0.0003034111,0.00022941282,0.0003089085],"domain_scores_gemma":[0.9990333,0.00011274656,0.00017443691,0.00023525975,0.00027653706,0.00016776005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000054882465,0.00025550017,0.00046994662,0.000071401635,0.00006443109,0.000022711163,0.000040024916,0.000055113956,0.000015785998],"category_scores_gemma":[0.000023084905,0.00014938823,0.000061959705,0.000105344276,0.00009457968,0.00012489878,0.000036131176,0.000024278977,0.0000049339064],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075263565,0.0072315,0.97424227,0.0001206358,0.0008207701,0.000050828075,0.0014860287,3.8159558e-7,0.013594656,0.000012557571,0.000014119985,0.001673634],"study_design_scores_gemma":[0.017175145,0.0019433256,0.42994112,0.00015030491,0.0013475739,0.000028781345,0.00058618514,0.0000018451814,0.54865414,0.0000030077313,0.000028984881,0.00013962582],"about_ca_topic_score_codex":0.00076868903,"about_ca_topic_score_gemma":0.000059502177,"teacher_disagreement_score":0.54430115,"about_ca_system_score_codex":0.000060270006,"about_ca_system_score_gemma":0.00006208033,"threshold_uncertainty_score":0.6091875},"labels":[],"label_agreement":null},{"id":"W2554088166","doi":"10.1182/blood.v114.22.2822.2822","title":"High Oct-2 Protein Expression Is Associated with Decreased Overall Survival, While High Bob-1 Protein Expression Is Associated with Improved Overall Survival in Myeloma Patients.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saint John Regional Hospital; Dalhousie University; University of Calgary; University of Alberta","funders":"","keywords":"Multiple myeloma; Tissue microarray; Immunohistochemistry; Biology; Malignancy; Pathology; Medicine; Cancer research; Oncology; Internal medicine; Immunology","score_opus":0.014685023646101764,"score_gpt":0.24293257550759256,"score_spread":0.2282475518614908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554088166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923727,0.00009083859,0.000022014978,0.00057061604,0.000054013846,0.00558222,0.00048181342,0.00028897682,0.0005368176],"genre_scores_gemma":[0.9936524,0.00001457652,0.0011443938,0.0002734447,0.00009743548,0.0006134704,0.001926472,0.00014293042,0.0021348605],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99355906,0.00064688135,0.0008232464,0.0013022156,0.0021676202,0.0015009742],"domain_scores_gemma":[0.99668795,0.00021111415,0.0006337949,0.0009715004,0.00069654244,0.00079909863],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005455852,0.0008900508,0.0013566378,0.00035596872,0.00030221327,0.00014452686,0.0003626978,0.00055232673,0.0004087717],"category_scores_gemma":[0.0008673213,0.0006295089,0.00018850737,0.00068245345,0.00011072328,0.00047921282,0.00013725545,0.0008162979,0.000028981975],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017598191,0.03445993,0.43557733,0.00020329186,0.0015667658,0.0017178489,0.0009482332,0.0000056848357,0.50381404,0.00003304996,0.0017630378,0.0023126001],"study_design_scores_gemma":[0.05844429,0.0054697217,0.598106,0.0033221336,0.00018142218,0.000004125546,0.00003367569,0.000090147034,0.33352524,0.00010744354,0.00005108094,0.0006646499],"about_ca_topic_score_codex":0.0018265011,"about_ca_topic_score_gemma":0.00044155994,"teacher_disagreement_score":0.17028879,"about_ca_system_score_codex":0.0005214597,"about_ca_system_score_gemma":0.00047314577,"threshold_uncertainty_score":0.9996156},"labels":[],"label_agreement":null},{"id":"W2554103893","doi":"10.1182/blood.v126.23.4863.4863","title":"Adrenal Suppression in Pediatric Patients during Treatment for Acute Lymphoblastic Leukemia","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Adrenal Hormones and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"","keywords":"Adrenal crisis; Medicine; Adrenal insufficiency; Context (archaeology); Hypoglycemia; Intensive care medicine; Pediatrics; Internal medicine","score_opus":0.014851134348280273,"score_gpt":0.26452393239098665,"score_spread":0.24967279804270637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554103893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99868447,0.0003466758,0.000022795672,0.000024653116,0.000078009514,0.00042150775,0.000017459775,0.00002718245,0.00037723908],"genre_scores_gemma":[0.99892145,0.00007400055,0.000378983,0.000023365574,0.00015561833,0.0000666223,0.0000788365,0.00001817757,0.00028295387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99926436,0.000006479237,0.00017154873,0.00018085288,0.00015123487,0.00022553148],"domain_scores_gemma":[0.99959207,0.00002230022,0.000044700788,0.00012052558,0.000049509443,0.00017090343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000027872324,0.0001208167,0.0001946263,0.000098401964,0.000029560277,0.00000549917,0.000037680828,0.000061264385,0.000007487622],"category_scores_gemma":[0.0000486769,0.000089437366,0.00006524544,0.00010634569,0.000009480586,0.000046210294,0.000023006573,0.00003357956,0.0000156114],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00213575,0.0027384611,0.99111325,0.00009884598,0.00012289632,0.00011655418,0.00061910745,0.000073176794,0.00077797123,0.000014378929,0.0006850993,0.0015044962],"study_design_scores_gemma":[0.088979684,0.0037022557,0.89964753,0.00007180561,0.0013889383,0.00004293745,0.00013052108,0.0004349919,0.004888009,0.00015169807,0.00028040656,0.0002812217],"about_ca_topic_score_codex":0.000029575962,"about_ca_topic_score_gemma":0.000009965766,"teacher_disagreement_score":0.091465734,"about_ca_system_score_codex":0.0001732672,"about_ca_system_score_gemma":0.00016347444,"threshold_uncertainty_score":0.364715},"labels":[],"label_agreement":null},{"id":"W2554107398","doi":"10.1182/blood.v104.11.2878.2878","title":"Generation of Dendritic Cells in a Closed System Using GMP Guidelines.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Blood Services","funders":"","keywords":"CD14; Dendritic cell; Leukapheresis; CD80; CD86; Cell culture; Monocyte; Immunology; Viability assay; Immune system; Medicine; In vitro; Biology; Chemistry; CD40; T cell; Cell biology; Biochemistry; CD34; Stem cell","score_opus":0.050447933651573115,"score_gpt":0.27847186888973663,"score_spread":0.2280239352381635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554107398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883012,0.010175129,0.00067152246,0.000026618825,0.00056572503,0.00016524382,0.000012200248,0.000023166078,0.000059172264],"genre_scores_gemma":[0.9986016,0.000087131055,0.0010432204,0.000044401473,0.000029178462,0.000006736915,0.000019024768,0.000012956383,0.0001557216],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990592,0.00014276672,0.00044100036,0.00014097974,0.000025068472,0.00019099851],"domain_scores_gemma":[0.99958616,0.000030154357,0.000102426304,0.0001986927,0.00007708878,0.00000544486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022559697,0.00010652993,0.00022728495,0.00013264715,0.00005922032,0.000005969279,0.000109453315,0.0001605042,0.000030098232],"category_scores_gemma":[0.00003685667,0.000100380945,0.00006566629,0.0001339068,0.000059188824,0.00005683545,0.00001936257,0.000099621175,0.000046759815],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000072732626,0.00022158414,0.00012975634,0.0000310531,0.00006903306,0.0000088342595,0.00023158717,0.00026657924,0.9983297,0.0002952084,0.000019069957,0.00032486496],"study_design_scores_gemma":[0.0046722647,0.00010261141,0.0003275533,0.00016952955,0.000042577914,0.00012871916,0.00019654253,0.00001938707,0.9936258,0.000013096078,0.0005967984,0.000105076455],"about_ca_topic_score_codex":0.00037681518,"about_ca_topic_score_gemma":0.000024486842,"teacher_disagreement_score":0.010300407,"about_ca_system_score_codex":0.00004211365,"about_ca_system_score_gemma":0.00011936472,"threshold_uncertainty_score":0.40934163},"labels":[],"label_agreement":null},{"id":"W2554151492","doi":"10.1182/blood.v108.11.343.343","title":"Maintenance Therapy with Rituximab for Follicular Lymphoma Is Cost-Effective – A Canadian Perspective.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Roche (Canada)","funders":"","keywords":"Rituximab; Medicine; Follicular lymphoma; Maintenance therapy; Internal medicine; Oncology; Progression-free survival; Lymphoma; Surgery; Chemotherapy","score_opus":0.008133117094952168,"score_gpt":0.2399589474155724,"score_spread":0.2318258303206202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554151492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97744095,0.003517352,0.000090984235,0.0039131013,0.00005036487,0.005513613,0.00017258526,0.00006564611,0.009235404],"genre_scores_gemma":[0.9941535,0.000081229955,0.0008776517,0.0014665263,0.0001621701,0.0026568107,0.000037464288,0.00003776084,0.00052686525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892217,0.0000160818,0.00011311956,0.00037423422,0.00015585823,0.00041856442],"domain_scores_gemma":[0.9991913,0.000057703222,0.00004692104,0.0002714293,0.00023946914,0.00019318063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005632339,0.00021098104,0.0003181101,0.00009295645,0.0001348302,0.000029444745,0.000057247056,0.00007463226,0.000037245587],"category_scores_gemma":[0.000015245704,0.00014366696,0.00014943609,0.00015734027,0.000054925516,0.00004443527,0.000005492151,0.000029187144,0.000029029301],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041764453,0.045993615,0.73757684,0.00016903189,0.0070889164,0.005433399,0.0034925742,0.000009940266,0.0017139523,0.05176448,0.044613406,0.097967416],"study_design_scores_gemma":[0.1471679,0.0037171214,0.63469195,0.00023229186,0.0009143692,0.0007261015,0.00056077447,0.000049769522,0.06018774,0.0014380988,0.14979081,0.00052309386],"about_ca_topic_score_codex":0.13590604,"about_ca_topic_score_gemma":0.042683832,"teacher_disagreement_score":0.14299145,"about_ca_system_score_codex":0.0006046702,"about_ca_system_score_gemma":0.000405498,"threshold_uncertainty_score":0.9747847},"labels":[],"label_agreement":null},{"id":"W2554175692","doi":"10.1182/blood.v112.11.3102.3102","title":"Age-Adjusted Telomere Length Is Not Associated with Variation in Hematological Parameters in Ageing Women","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Telomere; Ageing; Dyskeratosis congenita; Biology; Telomerase; Bone marrow; Context (archaeology); Transplantation; Haematopoiesis; Bone marrow failure; Senescence; Stem cell; Internal medicine; Immunology; Andrology; Physiology; Genetics; Medicine; Gene","score_opus":0.0370525353637846,"score_gpt":0.24017847722988206,"score_spread":0.20312594186609745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554175692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984547,0.00008724112,0.000013906317,0.00043065433,0.000037715978,0.00039296853,0.000006246137,0.00010843877,0.00046815243],"genre_scores_gemma":[0.9979047,0.00009398926,0.0007345753,0.0009424718,0.000023068516,0.000057104146,0.000020282396,0.000026268473,0.00019753553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99807745,0.000121406694,0.00043385138,0.00042896063,0.00038986563,0.00054846326],"domain_scores_gemma":[0.99918884,0.00020598163,0.00013309623,0.00026759718,0.00005453574,0.00014997848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002826724,0.0002260422,0.00059060974,0.0002958461,0.00006659905,0.000014322784,0.000111173,0.00021825837,0.00005837409],"category_scores_gemma":[0.0005096165,0.00018544856,0.000050332026,0.00086941896,0.00010290576,0.00011484166,0.000029096784,0.000409285,0.000019687515],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062076095,0.0034451005,0.9515776,0.00012498973,0.0002270035,0.0149012655,0.01950235,0.000042648033,0.008160814,0.000078047015,0.000119044256,0.0012003828],"study_design_scores_gemma":[0.007515016,0.0003913906,0.9860404,0.00026750992,0.000050586197,0.00024430265,0.00047707796,0.0001625762,0.0045089317,0.000038525475,0.000044699125,0.00025894216],"about_ca_topic_score_codex":0.00029898525,"about_ca_topic_score_gemma":0.00023191709,"teacher_disagreement_score":0.034462847,"about_ca_system_score_codex":0.00016633846,"about_ca_system_score_gemma":0.00011667511,"threshold_uncertainty_score":0.75623727},"labels":[],"label_agreement":null},{"id":"W2554212826","doi":"10.1182/blood.v118.21.1951.1951","title":"Incidence, Risk Factors for Early Hepatotoxicity and Its Impact on Survival in Patients with Myelofibrosis Undergoing Allogeneic Hematopoietic Cell Transplantation","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Gastroenterology; Internal medicine; Myelofibrosis; Portal vein thrombosis; Polycythemia vera; Transplantation; Portal hypertension; Liver transplantation; Incidence (geometry); Liver function; Hepatic veno-occlusive disease; Cumulative incidence; Surgery; Hematopoietic stem cell transplantation; Thrombosis; Bone marrow; Cirrhosis","score_opus":0.0164703155606479,"score_gpt":0.24091360007786822,"score_spread":0.22444328451722032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554212826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984733,0.00004655011,0.000036437923,0.000006137003,0.000023688523,0.0011081471,0.00012588242,0.000020975733,0.00015891677],"genre_scores_gemma":[0.9993126,0.00013779548,0.00033920349,0.000016457017,0.000011526725,0.000092774935,0.000055898996,0.000025566527,0.000008214572],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899024,0.000056626057,0.00020339736,0.00030283985,0.0002097762,0.00023712132],"domain_scores_gemma":[0.999326,0.00025894574,0.000104915816,0.000118339834,0.000057981317,0.00013385197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008810311,0.00022588967,0.00032064313,0.00011223307,0.00007767356,0.000013883013,0.00003588129,0.00007818682,0.000021864704],"category_scores_gemma":[0.000028192444,0.00014689397,0.000067184716,0.00011155005,0.000019400135,0.00009218393,0.0000073078195,0.000089496585,0.0000037112034],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087407016,0.0018247068,0.9951287,0.00012988405,0.00012004254,0.000012234349,0.001695144,0.0000045908228,0.00012652448,0.00003669887,9.820083e-7,0.00004642613],"study_design_scores_gemma":[0.008020135,0.0046204003,0.9114217,0.00019023418,0.00033712035,0.0000024313476,0.00004707309,0.0000065207896,0.07518006,0.00003217704,2.0055049e-7,0.00014190328],"about_ca_topic_score_codex":0.00027728916,"about_ca_topic_score_gemma":0.00024731952,"teacher_disagreement_score":0.08370695,"about_ca_system_score_codex":0.00004324632,"about_ca_system_score_gemma":0.000054499207,"threshold_uncertainty_score":0.59901625},"labels":[],"label_agreement":null},{"id":"W2554220734","doi":"10.1182/blood.v120.21.3626.3626","title":"CPX-351 Is Effective in Newly Diagnosed Older Patients with AML and with Multiple Risk Factors","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Internal medicine; Medicine; Gastroenterology; Cytarabine; Adverse effect; Leukemia; Surgery","score_opus":0.006283914608022035,"score_gpt":0.2377982916331505,"score_spread":0.23151437702512848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554220734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979691,0.00015944023,0.000028433486,0.000045545366,0.000021709466,0.001411437,0.000039896826,0.00003452869,0.00028990477],"genre_scores_gemma":[0.9989099,0.00003100877,0.00062025886,0.00010678664,0.000066186636,0.000097155564,0.000032382446,0.00004402629,0.00009229419],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986652,0.000089762245,0.00012726693,0.00027864872,0.00036253288,0.00047655625],"domain_scores_gemma":[0.998892,0.0004047818,0.00006521365,0.0002683957,0.0000868824,0.00028270806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001448151,0.00020151224,0.00029883656,0.00014471776,0.00005928935,0.000014662283,0.000062309206,0.000097298405,0.00004749254],"category_scores_gemma":[0.0002456537,0.00012376448,0.00002540477,0.00026820067,0.00010256685,0.00017201455,0.00005511339,0.00038803634,0.000020906382],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000377939,0.0011479738,0.99258155,0.000047896498,0.00016958275,0.000028836197,0.003525399,8.014713e-7,0.00008494314,0.0000011056488,0.00021213535,0.0018218233],"study_design_scores_gemma":[0.028098218,0.0009691303,0.96514755,0.00011384178,0.00017637854,0.000007098063,0.0003134497,0.000024456374,0.004773858,0.0000012942187,0.00021403033,0.00016069012],"about_ca_topic_score_codex":0.0013664324,"about_ca_topic_score_gemma":0.00017577759,"teacher_disagreement_score":0.02772028,"about_ca_system_score_codex":0.00009902911,"about_ca_system_score_gemma":0.00006603397,"threshold_uncertainty_score":0.50469685},"labels":[],"label_agreement":null},{"id":"W2554253273","doi":"10.1182/blood.v106.11.5375.5375","title":"Eosinophilia, Positive ANA, and Hypergammaglobulinemia at Presentation of Extensive Chronic GVHD in Children: A Children’s Oncology Group Study.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Eosinophilia; Medicine; Hypergammaglobulinemia; Internal medicine; Eosinophil; Hydroxychloroquine; Immunology; Gastroenterology; Disease; Asthma","score_opus":0.00415862272038962,"score_gpt":0.2261588614266591,"score_spread":0.2220002387062695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554253273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95242995,0.046005514,0.0000047858584,0.0001289839,0.00010148933,0.00085656886,0.0000428479,0.000028948914,0.00040092488],"genre_scores_gemma":[0.99903,0.00037872719,0.00003179832,0.00008522577,0.0000137366505,0.00004114587,0.00022590233,0.000016928989,0.00017654174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840826,0.00027159348,0.00046623987,0.00042403265,0.00005004292,0.00037982204],"domain_scores_gemma":[0.9993698,0.00009107421,0.0002034367,0.00026488636,0.00006139166,0.000009414007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019562879,0.0002249767,0.0004254988,0.00017975588,0.0001627704,0.0000066530806,0.00019110696,0.00023304483,0.00018029063],"category_scores_gemma":[0.00004825484,0.00021946266,0.00007221423,0.00019816746,0.0003201741,0.00012473013,0.00016926495,0.0002878902,0.00005847762],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040563353,0.007387841,0.61283964,0.000016001453,0.00080149865,0.000013195642,0.0057402956,0.00010684922,0.28229794,0.00018582206,0.00006252061,0.090142764],"study_design_scores_gemma":[0.009762771,0.0015162134,0.96065354,0.000018297304,0.00017147047,0.00023161121,0.00061213906,0.0000035946448,0.026630323,0.000015506026,0.00016650501,0.00021800866],"about_ca_topic_score_codex":0.00075925456,"about_ca_topic_score_gemma":0.00024249971,"teacher_disagreement_score":0.34781393,"about_ca_system_score_codex":0.00010177875,"about_ca_system_score_gemma":0.00007210395,"threshold_uncertainty_score":0.89494276},"labels":[],"label_agreement":null},{"id":"W2554268710","doi":"10.1182/blood.v104.11.4066.4066","title":"Standard of Care Evaluation of Venous Thromboembolism Prophylaxis in Selected Solid Tumour Patients at a Tertiary Cancer Care Teaching Hospital.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Antithrombotic; Retrospective cohort study; Observational study; Low molecular weight heparin; Internal medicine; Venous thromboembolism; Cancer; Intensive care medicine; Lung cancer; Medical record; Emergency medicine; Heparin; Thrombosis","score_opus":0.00762243321563909,"score_gpt":0.2768437494048121,"score_spread":0.269221316189173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554268710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99289304,0.0041686767,0.000002747537,0.000077119956,0.00016815205,0.0020051661,0.00009394864,0.000031504107,0.00055963127],"genre_scores_gemma":[0.99918437,0.00018121827,0.00022114233,0.000035132838,0.00006582758,0.00016141935,0.00010836666,0.000039180206,0.000003350147],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997865,0.00009524334,0.00047966168,0.00033480301,0.0009247434,0.00030049786],"domain_scores_gemma":[0.99835277,0.000013369602,0.0002544668,0.00030115558,0.0010039407,0.00007430775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021806352,0.00020314928,0.00078312494,0.00020515165,0.00007453753,0.0000070998135,0.000115915005,0.000104757135,0.00003898962],"category_scores_gemma":[0.0001324047,0.00018567972,0.000100799996,0.00025791765,0.00004823644,0.00007642302,0.00009763516,0.00018996718,0.0000023351845],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037291614,0.01852406,0.73596174,0.006557729,0.0011826302,0.00005452874,0.1692574,0.002533884,0.02444258,0.00014738459,0.00028791564,0.04067722],"study_design_scores_gemma":[0.010577634,0.004455234,0.90805894,0.0014178469,0.0011835636,0.0000013317567,0.0025683881,0.0000075043517,0.07144499,0.00004437305,0.00003713979,0.00020305254],"about_ca_topic_score_codex":0.0015117057,"about_ca_topic_score_gemma":0.0013108919,"teacher_disagreement_score":0.1720972,"about_ca_system_score_codex":0.0006145998,"about_ca_system_score_gemma":0.00046693685,"threshold_uncertainty_score":0.7571799},"labels":[],"label_agreement":null},{"id":"W2554284156","doi":"10.1182/blood.v114.22.3384.3384","title":"FluBup-ATG-TBI for High-Risk or Advanced Adult ALL in Remission: A Retrospective Review of a Mature Cohort.","year":2009,"lang":"en","type":"review","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre","funders":"","keywords":"Medicine; Fludarabine; Busulfan; Internal medicine; Transplantation; Cohort; Imatinib mesylate; Hematopoietic stem cell transplantation; Total body irradiation; Population; Gastroenterology; Surgery; Median follow-up; Acute lymphocytic leukemia; Leukemia; Cyclophosphamide; Chemotherapy; Imatinib; Lymphoblastic Leukemia; Myeloid leukemia","score_opus":0.022507297620351155,"score_gpt":0.34004128672208894,"score_spread":0.3175339891017378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554284156","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011834536,0.98926574,0.000003316766,0.00014111084,0.00013851098,0.008985659,0.0004840337,0.00007801666,0.00078526145],"genre_scores_gemma":[0.000010765159,0.98865426,0.0060179844,0.0003704397,0.0002952691,0.0011424872,0.0011853372,0.00013135704,0.0021920844],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996054,0.00018787726,0.0015883845,0.0010437369,0.000579306,0.00054670067],"domain_scores_gemma":[0.9963665,0.00029711187,0.0013925729,0.0013363557,0.00037062322,0.0002368219],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046929467,0.00082260935,0.0054635475,0.00022916462,0.000037177062,0.000007662473,0.00031750574,0.0007447836,0.0002546198],"category_scores_gemma":[0.002428064,0.0005395348,0.00088242796,0.0007665585,0.000049032788,0.00005924471,0.00007146487,0.00097012735,0.000026168847],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025090663,0.0012952652,0.00025048244,0.3073679,0.001657265,0.000409168,0.000038326645,4.0606523e-8,0.0000022971049,0.00006822613,0.006545144,0.682115],"study_design_scores_gemma":[0.008828592,0.0011347956,0.00036981504,0.4399664,0.013402101,0.0003775749,0.0000039845736,4.696605e-7,0.000023289258,0.00006139827,0.53545684,0.00037475378],"about_ca_topic_score_codex":0.00006754156,"about_ca_topic_score_gemma":0.000036161546,"teacher_disagreement_score":0.6817402,"about_ca_system_score_codex":0.0015137243,"about_ca_system_score_gemma":0.0018104998,"threshold_uncertainty_score":0.9997056},"labels":[],"label_agreement":null},{"id":"W2554288161","doi":"10.1182/blood.v104.11.1685.1685","title":"Progression of Avascular Necrosis of the Hip in Sickle Cell Disease: 2 Year Follow-Up of Randomized Trial of Aggressive Physical Therapy and Hip Coring Decompression.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Bone and Joint Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Medicine; Avascular necrosis; Surgery; Randomized controlled trial; Clinical endpoint; Femoral head","score_opus":0.013868849745638673,"score_gpt":0.26861072048077517,"score_spread":0.2547418707351365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554288161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939472,0.004562117,0.0000049768823,0.00005948887,0.000057964455,0.0012883055,0.000016757369,0.000006521135,0.00005668528],"genre_scores_gemma":[0.99917877,0.00050725817,0.00017522123,0.000009618616,0.000048224083,0.000045962348,0.0000048259517,0.000013726938,0.000016389955],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99876595,0.00015282791,0.00043237768,0.00015596433,0.00037669842,0.00011620336],"domain_scores_gemma":[0.99872553,0.0001890226,0.00061398535,0.00030331468,0.00008774218,0.0000803767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021838334,0.00012015987,0.0008581972,0.00006441729,0.000018180483,0.0000023429309,0.000081432816,0.000049600076,0.000011805405],"category_scores_gemma":[0.00034975287,0.00006914759,0.00043944365,0.0001467223,0.0002352472,0.00003543259,0.000053750737,0.00008438437,2.3212789e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.71603364,0.010542137,0.024199257,0.0010523876,0.000440284,0.00002088937,0.001869171,0.00003249023,0.2413959,0.000104674626,0.000032501826,0.0042766905],"study_design_scores_gemma":[0.57863754,0.00031545784,0.00880898,0.001394973,0.00049898477,5.3864954e-7,0.00006154752,0.000017244756,0.40969536,0.00051574764,0.0000024866151,0.000051171417],"about_ca_topic_score_codex":0.00006154147,"about_ca_topic_score_gemma":8.9240626e-7,"teacher_disagreement_score":0.16829945,"about_ca_system_score_codex":0.000005727678,"about_ca_system_score_gemma":0.00013848509,"threshold_uncertainty_score":0.2819757},"labels":[],"label_agreement":null},{"id":"W2554311364","doi":"10.1182/blood.v120.21.687.687","title":"Response-Adapted Therapy for Diffuse Large B-Cell Non-Hodgkin's Lymphoma (DLBCL)Based On Early [18F] FDG-PET Scanning: An Eastern Cooperative Oncology Group Study (E3404)","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Lymphoma; Internal medicine; CHOP; Nuclear medicine; Stage (stratigraphy); Oncology; Radiology","score_opus":0.028403923910432182,"score_gpt":0.31087513810236694,"score_spread":0.28247121419193477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554311364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944274,0.00033741558,0.00009425336,0.00040331171,0.00027173097,0.0034233043,0.000093260365,0.00013194418,0.0008173908],"genre_scores_gemma":[0.9949349,0.000020449657,0.0008262325,0.0018421374,0.0003394993,0.0013386874,0.00013211393,0.00010899191,0.00045697534],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970469,0.00056129176,0.00044934027,0.0006435791,0.00044864888,0.0008502238],"domain_scores_gemma":[0.9976092,0.00066947046,0.00020329624,0.00078392547,0.00019625858,0.00053785695],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008412065,0.00050182076,0.000789991,0.00022845407,0.0002803651,0.000062081686,0.00020010525,0.00014912387,0.00005017986],"category_scores_gemma":[0.000091593145,0.00037786085,0.00021256303,0.00024405564,0.000064950065,0.00019067062,0.00004694317,0.00011444674,0.00009411597],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025669934,0.4612852,0.49315986,0.000025505555,0.00083165057,0.00079003634,0.0069915876,0.000002572751,0.0034940217,0.000088069064,0.00060515665,0.0070563965],"study_design_scores_gemma":[0.30397996,0.082125716,0.58261544,0.00009822207,0.000766978,0.00006682885,0.0021737276,0.0005791434,0.013704854,0.0000042760553,0.013350015,0.00053485675],"about_ca_topic_score_codex":0.00015042235,"about_ca_topic_score_gemma":0.000062176965,"teacher_disagreement_score":0.3791595,"about_ca_system_score_codex":0.00027676753,"about_ca_system_score_gemma":0.0003789228,"threshold_uncertainty_score":0.9998673},"labels":[],"label_agreement":null},{"id":"W2554315884","doi":"10.1182/blood.v104.11.4084.4084","title":"Differential Digestion of Different LMWHs by Heparinase-I and Heparinase-II: Drug Developmental Implications.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Proteoglycans and glycosaminoglycans research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chemistry; Sulfation; Biochemistry; Heparin; Depolymerization; Enzyme; Organic chemistry","score_opus":0.0069670311464595435,"score_gpt":0.23340969721199695,"score_spread":0.2264426660655374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554315884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979137,0.00048609954,0.00053462986,0.00022080333,0.00002771656,0.00029394287,0.00009785338,0.000012712081,0.00041249482],"genre_scores_gemma":[0.99833524,0.00042301018,0.00040151222,0.00002680916,0.000053856613,0.000081320344,0.00035416987,0.000018297324,0.00030576327],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989603,0.000028351857,0.00022386973,0.00035927485,0.00015950944,0.00026865624],"domain_scores_gemma":[0.99950826,0.000006833828,0.00006516308,0.00023360868,0.00005711724,0.00012898701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000050515417,0.00017378501,0.00016763463,0.000047767357,0.00016344382,0.000022586482,0.00017875168,0.00009994811,0.00001818161],"category_scores_gemma":[0.00002864698,0.000156218,0.000055523888,0.000071369504,0.00013064388,0.0000055878604,0.00027022554,0.00009290273,0.0000019565389],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067170884,0.0008326576,0.02501415,0.000034349185,0.00007625665,0.0000015961369,0.000055475088,0.0000010708452,0.970808,0.0003271694,0.000313652,0.0024684092],"study_design_scores_gemma":[0.0021613026,0.00032775753,0.056524362,0.000020392526,0.00003111026,0.00003827206,0.000026189306,0.0000023567022,0.93904674,0.00027417138,0.0013532757,0.00019406123],"about_ca_topic_score_codex":0.00018854384,"about_ca_topic_score_gemma":0.00012256253,"teacher_disagreement_score":0.031761296,"about_ca_system_score_codex":0.000022325636,"about_ca_system_score_gemma":0.00009005847,"threshold_uncertainty_score":0.6370385},"labels":[],"label_agreement":null},{"id":"W2554333293","doi":"10.1182/blood.v118.21.1556.1556","title":"Selective Small Molecule Inhibition of P110α and δ Isoforms of PI3 Kinase Is Cytotoxic to Human AML Progenitors","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"IC50; Kinase; Myeloid leukemia; Progenitor cell; Molecular biology; Protein kinase B; Gene isoform; Chemistry; Biology; Stem cell; Cancer research; Biochemistry; In vitro; Signal transduction; Gene; Cell biology","score_opus":0.02857760411720545,"score_gpt":0.27477208911779405,"score_spread":0.2461944850005886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554333293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967295,0.00005334762,0.000040270563,0.000055243057,0.000008760466,0.0007755883,0.000018940882,0.00002354068,0.0022948273],"genre_scores_gemma":[0.99811435,0.0000088307925,0.0014819192,0.0000859927,0.000044617867,0.000051285162,0.000008402033,0.000025493955,0.00017908592],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990295,0.000028288237,0.0002515651,0.00022913927,0.00022382138,0.00023766591],"domain_scores_gemma":[0.99925613,0.000015788633,0.000085491876,0.00023791306,0.00023872603,0.00016593309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001594469,0.00012043708,0.00026321833,0.00021732625,0.000039404305,0.0000034363236,0.000066616354,0.000096011296,0.00006315081],"category_scores_gemma":[0.00008482042,0.000102068545,0.000058173122,0.00030774254,0.00010410884,0.00004364406,0.00008882418,0.00016060236,0.000011033853],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001976381,0.00075627264,0.026450366,0.00024021091,0.00013009355,0.000031318777,0.003038519,4.677638e-8,0.96862584,0.00008716539,0.000223018,0.00021951084],"study_design_scores_gemma":[0.0025719574,0.0019849823,0.04809645,0.00010623574,0.00010863018,0.000026751259,0.00023164901,0.000006028354,0.94665223,0.00011421694,0.000011250847,0.00008961222],"about_ca_topic_score_codex":0.00027850037,"about_ca_topic_score_gemma":0.00002377457,"teacher_disagreement_score":0.021973604,"about_ca_system_score_codex":0.000052044765,"about_ca_system_score_gemma":0.00012854072,"threshold_uncertainty_score":0.41622344},"labels":[],"label_agreement":null},{"id":"W2554353371","doi":"10.1182/blood.v114.22.1678.1678","title":"Pralatrexate Induces Responses in Patients with Highly Refractory Peripheral T-Cell Lymphoma (PTCL).","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Refractory (planetary science); Peripheral T-cell lymphoma; Clinical trial; Phases of clinical research; CHOP; Antifolate; Oncology; Lymphoma; Gastroenterology; Methotrexate; Immunology; Antimetabolite; T cell","score_opus":0.007547297400685275,"score_gpt":0.22278721077641303,"score_spread":0.21523991337572776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554353371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953016,0.0005122796,1.5558156e-7,0.0004094808,0.00004327159,0.00038842333,0.000010300459,0.000057538105,0.0032769646],"genre_scores_gemma":[0.9983192,0.000052693507,0.0003901646,0.00051576423,0.000060063237,0.000027271675,0.0000380785,0.000018907218,0.0005778242],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988308,0.00005372874,0.00022129856,0.00030864164,0.00029529797,0.0002902287],"domain_scores_gemma":[0.9993759,0.000043764074,0.000088880864,0.00029937798,0.00005923505,0.00013287217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006316785,0.0002063493,0.00028958893,0.00012161781,0.00004780478,0.000024870562,0.00006606156,0.00009228509,0.00003477879],"category_scores_gemma":[0.000024842719,0.00014289032,0.000054666652,0.00017773113,0.000031086973,0.000118794254,0.00001436908,0.000060617673,0.00003062511],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013131219,0.016753161,0.9689361,0.00001539303,0.00006516149,0.00033651548,0.00028638076,6.7225994e-7,0.0007156404,0.00001941967,0.00019339928,0.01136504],"study_design_scores_gemma":[0.033981927,0.0037650592,0.95103824,0.000115559975,0.00014719913,0.000012891797,0.000029933606,8.1484313e-7,0.009410586,0.000011704957,0.0013235494,0.00016252833],"about_ca_topic_score_codex":0.000073035655,"about_ca_topic_score_gemma":0.000011689258,"teacher_disagreement_score":0.032668803,"about_ca_system_score_codex":0.00014503438,"about_ca_system_score_gemma":0.00016808379,"threshold_uncertainty_score":0.5826898},"labels":[],"label_agreement":null},{"id":"W2554358156","doi":"10.1182/blood-2016-04-706978","title":"Controlled stem cell amplification by HOXB4 depends on its unique proline-rich region near the N terminus","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Stem cell; Biology; Haematopoiesis; Cancer research; Hematopoietic stem cell; Proline; Cell biology; Genetics; Amino acid","score_opus":0.01478551771666104,"score_gpt":0.23551087525711706,"score_spread":0.22072535754045602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554358156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99311346,0.0014792002,0.002222392,0.00061304733,0.00006529589,0.0004901375,0.00001595155,0.00001535294,0.001985153],"genre_scores_gemma":[0.9952903,0.00045733518,0.00006014414,0.00011579228,0.00014782243,0.00009494856,0.000037876107,0.000022729451,0.003773044],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990645,0.00013242174,0.0002094089,0.00029369091,0.00012430108,0.00017565548],"domain_scores_gemma":[0.9992396,0.00004668377,0.00015049908,0.00041156792,0.000098312674,0.000053284886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002211799,0.000136972,0.00012999169,0.000018695931,0.00013116049,0.000044228327,0.0001754853,0.00015362809,0.0000047103763],"category_scores_gemma":[0.000041837244,0.00007749626,0.00006716785,0.000054754113,0.00004151739,0.000003013778,0.000033042248,0.000055291155,0.000021580141],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014608022,0.00018193759,0.00091554207,0.0000064443802,0.000026550182,0.0000018289718,0.00002805465,0.000005626347,0.9924273,0.000052533298,0.00040461487,0.0058034738],"study_design_scores_gemma":[0.0035303617,0.0003529103,0.00069412735,0.000010145068,0.000037316244,0.0000036826864,0.00000792362,0.000022370023,0.97061074,0.000049884256,0.02455002,0.00013049312],"about_ca_topic_score_codex":0.0000028349166,"about_ca_topic_score_gemma":0.000003995764,"teacher_disagreement_score":0.024145406,"about_ca_system_score_codex":0.000007793966,"about_ca_system_score_gemma":0.000055508466,"threshold_uncertainty_score":0.31602058},"labels":[],"label_agreement":null},{"id":"W2554373928","doi":"10.1182/blood.v114.22.1296.1296","title":"Quantitation of Changes in VWF and FVIII Following Elective Orthopedic Surgery in Normal Individuals.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Kingston General Hospital","funders":"","keywords":"Medicine; Partial thromboplastin time; Thromboelastography; Von Willebrand factor; Orthopedic surgery; Prothrombin time; Factor IX; Coagulation; Surgery; Internal medicine; Gastroenterology; Platelet","score_opus":0.016614150871145473,"score_gpt":0.27422340740085854,"score_spread":0.25760925652971306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554373928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99722826,0.0011149317,0.0000019262022,0.0006943593,0.000025348927,0.00028647977,0.0000039380247,0.000008756701,0.00063601637],"genre_scores_gemma":[0.99910444,0.00039859719,0.00022866938,0.00016692135,0.000026534646,0.00003544202,0.000022160171,0.00000603212,0.000011219914],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99927855,0.00004686906,0.00020481016,0.00016224949,0.00015191217,0.0001556173],"domain_scores_gemma":[0.99961376,0.00018928744,0.00006087957,0.00006722368,0.000026381023,0.000042480955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000245828,0.00009456973,0.0003207728,0.00029472183,0.000018960234,0.0000060006046,0.000014880997,0.00005547264,0.000009146376],"category_scores_gemma":[0.00014687485,0.00008323497,0.000041061077,0.000275012,0.000013321913,0.00006598655,0.000008069889,0.00008025931,0.0000013279356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037765007,0.00090423744,0.99184954,0.000031340176,0.000054070115,0.000099969024,0.0009942229,6.5573295e-7,0.0007009466,0.00029489014,0.000013500169,0.005018855],"study_design_scores_gemma":[0.002793979,0.0005087947,0.98240733,0.000264968,0.00008713176,0.000012814027,0.0001419297,0.0000063450357,0.013605696,0.000078192905,0.00002393379,0.00006890937],"about_ca_topic_score_codex":0.000094585324,"about_ca_topic_score_gemma":0.0011765144,"teacher_disagreement_score":0.012904749,"about_ca_system_score_codex":0.000017728747,"about_ca_system_score_gemma":0.00007441091,"threshold_uncertainty_score":0.33942235},"labels":[],"label_agreement":null},{"id":"W2554393998","doi":"10.1182/blood.v120.21.3537.3537","title":"Defined, Serum-Free Conditions for in Vitro culture of Primary Human T-ALL Blasts","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; In vitro; Disease; Malignancy; Chemotherapy; Cell culture; Chemotherapy regimen; Cancer research; Immunology; Oncology; Internal medicine; Biology; Genetics","score_opus":0.02510964093480153,"score_gpt":0.30448366413618566,"score_spread":0.27937402320138416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554393998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836747,0.00038163396,0.000074001146,0.00036927525,0.00006290405,0.0009412271,0.0013907853,0.000051781666,0.01305367],"genre_scores_gemma":[0.99140555,0.000010379627,0.005578884,0.0003845295,0.00027405427,0.0001467407,0.00079129287,0.00003219666,0.0013763562],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988202,0.000027211883,0.00026381618,0.00016183793,0.00028848212,0.00043845843],"domain_scores_gemma":[0.9990629,0.0001837199,0.00006855867,0.00039673765,0.00011130579,0.00017676217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018064653,0.00012645268,0.00031193395,0.00013550791,0.00004068417,0.0000053596796,0.00016828837,0.00014081778,0.00021299401],"category_scores_gemma":[0.00036066625,0.00010650748,0.00009647386,0.00017459459,0.000090990034,0.0000938013,0.00010150323,0.00017105952,0.000027070915],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031427547,0.003083183,0.014379282,0.0007825269,0.0002940189,0.000028094873,0.0012431622,9.119595e-7,0.8936631,0.0011119493,0.08480887,0.00029063062],"study_design_scores_gemma":[0.08281543,0.0015949582,0.18417668,0.0005701833,0.0012116935,0.00062253623,0.0006562673,0.00010987664,0.69687426,0.0021037066,0.02860966,0.00065471913],"about_ca_topic_score_codex":0.000030273475,"about_ca_topic_score_gemma":0.000013335708,"teacher_disagreement_score":0.19678882,"about_ca_system_score_codex":0.00017834353,"about_ca_system_score_gemma":0.00022126583,"threshold_uncertainty_score":0.4343249},"labels":[],"label_agreement":null},{"id":"W2554448427","doi":"10.1182/blood.v116.21.4161.4161","title":"Central Nervous System (CNS) Prophylaxis Does Not Decrease the Rates of CNS Relapse From Diffuse Large B-Cell Lymphoma In the Era of R-CHOP","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Chemotherapy; Internal medicine; CHOP; Diffuse large B-cell lymphoma; Chemotherapy regimen; Gastroenterology; Lymphoma; Methotrexate; Surgery; Oncology","score_opus":0.0069403166531025635,"score_gpt":0.22195687967015423,"score_spread":0.21501656301705166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554448427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99709785,0.0007021663,0.0000014455223,0.0005216869,0.00020584972,0.00085068477,0.00028769378,0.000024445795,0.0003081665],"genre_scores_gemma":[0.999218,0.000102447644,0.0001367847,0.00016388576,0.0001502807,0.00011973925,0.000038885184,0.000026819369,0.00004318207],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984148,0.0001385647,0.00046256676,0.00028019218,0.00037051132,0.00033334715],"domain_scores_gemma":[0.9982649,0.0004858484,0.00021337964,0.0008179241,0.00007715738,0.00014075838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025549662,0.00022072192,0.0004383247,0.000052126667,0.00007712355,0.000023982275,0.0002633875,0.00012854472,0.00004630283],"category_scores_gemma":[0.00018875657,0.00009756977,0.00020763041,0.00019510747,0.000109515975,0.00004212524,0.0000631558,0.00018670125,0.0000110358915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082698674,0.0719823,0.8360972,0.00053917797,0.00055641297,0.0008622906,0.006903998,0.0000012864441,0.069625095,0.0020470633,0.000247893,0.010310307],"study_design_scores_gemma":[0.024291815,0.0003969244,0.7657372,0.00024064063,0.00058976834,0.00005783105,0.0015524281,0.00006027471,0.20664129,0.00003210348,0.00027454464,0.00012518885],"about_ca_topic_score_codex":0.0038659975,"about_ca_topic_score_gemma":0.0011575021,"teacher_disagreement_score":0.13701619,"about_ca_system_score_codex":0.00003867903,"about_ca_system_score_gemma":0.00018107152,"threshold_uncertainty_score":0.58442575},"labels":[],"label_agreement":null},{"id":"W2554485111","doi":"10.1182/blood.v108.11.3201.3201","title":"Oral Administration of PBI-1402 Significantly Reduces Erythropenia and Accelerates Peripheral Blood Recovery in Myeloablated Mice Post Transplantation.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Cytopenia; Transplantation; Medicine; Bone marrow; Progenitor cell; White blood cell; Red blood cell; Andrology; Pharmacology; Internal medicine; Stem cell; Biology","score_opus":0.012588727399299934,"score_gpt":0.2629151406986487,"score_spread":0.25032641329934874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554485111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99627346,0.00055217557,0.00000779508,0.0007976387,0.00003310807,0.0005282895,0.00008636432,0.000039774244,0.0016814007],"genre_scores_gemma":[0.99643385,0.0004694941,0.0018909455,0.00008088725,0.00010130583,0.000025111005,0.0003457033,0.000030739804,0.000621971],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99843264,0.00009930803,0.0005037774,0.0003580892,0.00029228014,0.00031392518],"domain_scores_gemma":[0.99932957,0.00010228149,0.00011579681,0.00016527284,0.00019352058,0.00009357628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025131347,0.00019381935,0.00037246596,0.000206706,0.000060458835,0.000052423635,0.000106011634,0.00016099983,0.00015594668],"category_scores_gemma":[0.000060884173,0.00017856093,0.00005463979,0.00039983008,0.0001478107,0.00026264184,0.000018105844,0.00025968967,0.000006670171],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018021893,0.0011518467,0.020552723,0.0002357483,0.00015543116,0.0005640799,0.0004231483,0.00001559515,0.9739334,0.000051763218,0.0002170437,0.0008970313],"study_design_scores_gemma":[0.009986862,0.0016675988,0.24384537,0.00019694952,0.00045642507,0.0007458121,0.00047124445,0.000104369086,0.74214846,0.00006361363,0.000063718704,0.00024960027],"about_ca_topic_score_codex":0.0012791592,"about_ca_topic_score_gemma":0.00048412936,"teacher_disagreement_score":0.23178497,"about_ca_system_score_codex":0.000044053868,"about_ca_system_score_gemma":0.00047731525,"threshold_uncertainty_score":0.72815037},"labels":[],"label_agreement":null},{"id":"W2554488594","doi":"10.1182/blood.v110.11.2702.2702","title":"Factor Va Cofactor Activity Is Dependent on the Interaction of Prothrombin with the Membrane Surface.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Prothrombinase; Chemistry; Thrombin; Cleavage (geology); Cofactor; Stereochemistry; Membrane; Enzyme; Biochemistry; Biophysics; Platelet; Biology","score_opus":0.03770532616521552,"score_gpt":0.28524383745050524,"score_spread":0.24753851128528973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554488594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934978,0.000012298433,0.0004394501,0.0029575734,0.000103101236,0.0009141835,0.000010992651,0.000040692074,0.0020239437],"genre_scores_gemma":[0.9989526,0.000006315182,0.00007862419,0.00054772326,0.000049932867,0.00001060587,0.0000024520014,0.000020767648,0.00033098148],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989463,0.00006247736,0.00016352425,0.0001914675,0.00045856566,0.0001776502],"domain_scores_gemma":[0.99906266,0.00021388945,0.00016482054,0.00040145096,0.00009342964,0.00006376135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032089854,0.00014590916,0.00022160538,0.000037553196,0.00009476356,0.000018302813,0.00010188707,0.00007444543,0.00057883264],"category_scores_gemma":[0.000032081956,0.00006945286,0.000073418814,0.00015553096,0.000055988123,0.000068880065,0.00002311105,0.00026739,0.00003022046],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063219015,0.002178911,0.0055806777,0.00006516039,0.00063342974,0.000008645289,0.001388943,0.0000060839116,0.9870582,0.0012095842,0.00013601061,0.0011021479],"study_design_scores_gemma":[0.0018004391,0.0006884885,0.05039198,0.00006991478,0.00018315036,0.000022600281,0.0004088289,0.0000294083,0.9460118,0.000025628311,0.0002864629,0.00008132906],"about_ca_topic_score_codex":0.00007055115,"about_ca_topic_score_gemma":0.000070006914,"teacher_disagreement_score":0.0448113,"about_ca_system_score_codex":0.000024543311,"about_ca_system_score_gemma":0.00004669115,"threshold_uncertainty_score":0.63378114},"labels":[],"label_agreement":null},{"id":"W2554497099","doi":"10.1182/blood.v118.21.3931.3931","title":"Clinically Significant Aberrant HAS1Vb Splicing of the Hyaluronan Synthase 1 Gene (HAS1) Requires a Combination of Mutations and Deletions in Introns 3 and 4 of HAS1 Minigene,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Proteoglycans and glycosaminoglycans research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Minigene; Intron; Exon; RNA splicing; Biology; Polypyrimidine tract; Splice site mutation; Alternative splicing; Exon skipping; Molecular biology; Genetics; Exonic splicing enhancer; Gene; RNA","score_opus":0.02505051427665622,"score_gpt":0.2675932152711312,"score_spread":0.242542700994475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554497099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984279,0.0003326437,0.00046004824,0.00009541232,0.00001697937,0.0003438769,0.00010750773,0.0000017103836,0.000213905],"genre_scores_gemma":[0.9978572,0.0002014803,0.0018250176,0.000011275486,0.000010567674,0.000031945805,0.00001918596,0.00000928149,0.00003404242],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998983,0.00010209269,0.00043856242,0.00020790186,0.00012566191,0.00014277836],"domain_scores_gemma":[0.9993235,0.000049315444,0.00017583834,0.00028172022,0.00012054914,0.000049108647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032849284,0.00008930767,0.00018529552,0.00007502349,0.000047403253,0.000004311131,0.00014700477,0.0000929298,0.000007186654],"category_scores_gemma":[0.00022272185,0.00007160107,0.000052635005,0.00012688171,0.0004083823,0.0000048070915,0.00011487888,0.00007863865,1.0419879e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010392367,0.000699407,0.046176396,0.00006305981,0.000059340484,0.0000018420469,0.0003951893,0.000007937477,0.94990563,0.00029160024,0.000008478897,0.002287183],"study_design_scores_gemma":[0.0017506555,0.0010633152,0.14993918,0.00006318861,0.000063404834,0.000008370323,0.00021597913,0.00014058447,0.8463084,0.00032586756,0.00002972955,0.000091345806],"about_ca_topic_score_codex":0.0006263188,"about_ca_topic_score_gemma":0.00042152693,"teacher_disagreement_score":0.103762776,"about_ca_system_score_codex":0.0000034738107,"about_ca_system_score_gemma":0.00012500849,"threshold_uncertainty_score":0.29198068},"labels":[],"label_agreement":null},{"id":"W2554498751","doi":"10.1182/blood.v116.21.2512.2512","title":"Efficacy of Eltrombopag In Splenectomized Versus Nonsplenectomized Patients with Chronic ITP In the RAISE Study","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Eltrombopag; Medicine; Concomitant; Splenectomy; Placebo; Internal medicine; Gastroenterology; Thrombopoietin; Platelet; Surgery; Immune thrombocytopenia","score_opus":0.008693149591819369,"score_gpt":0.2576317065831066,"score_spread":0.2489385569912872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554498751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99712557,0.00009534459,2.897501e-7,0.000050183906,0.00008358502,0.0020431862,0.000010043082,0.000016651862,0.00057512295],"genre_scores_gemma":[0.9996531,0.0000133627045,0.00011252172,0.000018599463,0.000022639992,0.00010848132,0.00004185272,0.000019869249,0.0000095998475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987851,0.00009377792,0.00029808097,0.00025338485,0.00030945113,0.00026023292],"domain_scores_gemma":[0.99905694,0.00031946826,0.00009939134,0.00043308703,0.000042037645,0.000049106147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023203825,0.00017855992,0.0005440456,0.00015636125,0.000028063836,0.000008637842,0.00014668256,0.00006420058,0.00007394497],"category_scores_gemma":[0.00016879431,0.000104838975,0.0000659819,0.0003597704,0.00004961613,0.000046055826,0.000025593778,0.0002807517,0.000012178039],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015608134,0.02786662,0.9524807,0.000026941461,0.0003526232,0.0002949246,0.001044545,0.000003326671,0.001317581,0.000009881073,0.000009109626,0.0009856623],"study_design_scores_gemma":[0.311304,0.0019446127,0.6857874,0.00003961263,0.00029131232,0.0000048382617,0.00008976832,0.000006524035,0.0004219665,0.0000042852944,0.000025076904,0.00008063094],"about_ca_topic_score_codex":0.0003926286,"about_ca_topic_score_gemma":0.004080832,"teacher_disagreement_score":0.29569587,"about_ca_system_score_codex":0.000026804877,"about_ca_system_score_gemma":0.00013353708,"threshold_uncertainty_score":0.42752093},"labels":[],"label_agreement":null},{"id":"W2554503446","doi":"10.1182/blood.v110.11.4097.4097","title":"Anti-Glycophorin C Induces a Loss of Mitochondrial Membrane Potential but Fails To Activate Apoptotic Caspases.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Biology; Erythropoiesis; Cell biology; K562 cells; Propidium iodide; Apoptosis; Caspase; Molecular biology; Programmed cell death; Biochemistry; Internal medicine; Anemia; Medicine","score_opus":0.014497690338676206,"score_gpt":0.25984262618574905,"score_spread":0.24534493584707284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554503446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99642026,0.000049496248,0.0004901466,0.00022162774,0.0013131631,0.00039673306,0.000014500347,0.00006062632,0.0010334293],"genre_scores_gemma":[0.9961728,0.000026022159,0.0015344857,0.00036159647,0.0012989127,0.000008147805,0.000022983933,0.000024521578,0.0005505576],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99864405,0.000036695623,0.000365188,0.0003238589,0.000269652,0.00036053357],"domain_scores_gemma":[0.9991257,0.00007441515,0.00011366329,0.00031584554,0.00012649971,0.0002438783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012794713,0.00018110352,0.00047621306,0.00021616257,0.00005321266,0.00000964769,0.00009556893,0.00018386623,0.000338985],"category_scores_gemma":[0.00014472198,0.0001585899,0.00014137373,0.00031469806,0.00007832361,0.0000703504,0.000050766528,0.0002181015,0.000104413826],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010599378,0.0006881086,0.00042167638,0.00008388223,0.00012842169,0.0003313109,0.00018032601,0.000011778728,0.99625725,0.000025302515,0.00020978715,0.0006022373],"study_design_scores_gemma":[0.0051594344,0.0009951104,0.01561617,0.00007712581,0.00022634855,0.00035422973,0.00026583075,0.0000026258517,0.97639775,0.000014357788,0.0007290281,0.0001620002],"about_ca_topic_score_codex":0.00015495376,"about_ca_topic_score_gemma":0.000014707121,"teacher_disagreement_score":0.019859493,"about_ca_system_score_codex":0.000020660553,"about_ca_system_score_gemma":0.00009631635,"threshold_uncertainty_score":0.6467109},"labels":[],"label_agreement":null},{"id":"W2554514455","doi":"10.1182/blood.v124.21.3990.3990","title":"First Report of the Myeloma Canada Research Network (MCRN)-001 Trial Utilizing Bortezomib-Based Induction, Enhanced Conditioning with IV Busulfan + Melphalan (BuMel) and Lenalidomide Maintenance: Feasibility of a National Canadian Study Based on Achievement of Minimal Residual Disease (MRD) Negativity","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Hôpital Maisonneuve-Rosemont; Leukemia & Lymphoma Society of Canada; McGill University Health Centre; Saint John Regional Hospital; Saskatchewan Cancer Agency; Queen Elizabeth II Health Sciences Centre; Ottawa Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lenalidomide; Melphalan; Multiple myeloma; Maintenance therapy; Busulfan; Bortezomib; Minimal residual disease; Internal medicine; Regimen; Progressive disease; Plerixafor; Oncology; Autologous stem-cell transplantation; Surgery; Bone marrow; Urology; Transplantation; Chemotherapy; Hematopoietic stem cell transplantation; CXCR4","score_opus":0.0489398456507827,"score_gpt":0.3201919338570257,"score_spread":0.271252088206243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554514455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995749,0.00001608884,0.00001407321,0.0010156429,0.00005684275,0.0025431404,0.00024645013,0.0000071884124,0.0003515749],"genre_scores_gemma":[0.99923503,0.0000010026514,0.00021842348,0.00004725927,0.00012771484,0.00016396293,0.00014476442,0.000019440298,0.000042395586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99584866,0.0006779632,0.0006318155,0.00048646188,0.0018320085,0.000523099],"domain_scores_gemma":[0.9967555,0.0007540085,0.000374905,0.0005986667,0.0010485043,0.00046842362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026969172,0.00020038012,0.0004853275,0.00019444247,0.00039941425,0.00001540043,0.00015085745,0.000058702255,0.000036500707],"category_scores_gemma":[0.002982875,0.00013995478,0.00006616175,0.00051277986,0.00034241498,0.00005119992,0.000048594866,0.00031113054,1.474075e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03979884,0.0039123264,0.9533918,0.00027995193,0.0004147553,0.00020366156,0.00012838226,0.00074698543,0.0004837809,0.000088009045,0.00037662973,0.0001748711],"study_design_scores_gemma":[0.066255085,0.0025222395,0.924343,0.0004546027,0.00015844965,0.000007888793,0.00032455352,0.0008413308,0.0049068164,0.000046380377,0.000028485772,0.000111192036],"about_ca_topic_score_codex":0.5482177,"about_ca_topic_score_gemma":0.8999126,"teacher_disagreement_score":0.35169485,"about_ca_system_score_codex":0.00041527642,"about_ca_system_score_gemma":0.006469782,"threshold_uncertainty_score":0.9991626},"labels":[],"label_agreement":null},{"id":"W2554514813","doi":"10.1182/blood.v108.11.1651.1651","title":"Unexpected and Sustained Symmetry in the Repopulation Programs Displayed by Clonally Amplified Hematopoietic Stem Cells.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Biology; Haematopoiesis; Stem cell; Bone marrow; Myeloid; Lineage (genetic); Congenic; Immunology; Transplantation; Induced pluripotent stem cell; Molecular biology; Genetics; Internal medicine; Gene; Medicine; Embryonic stem cell","score_opus":0.006991604854616061,"score_gpt":0.19953697205880655,"score_spread":0.1925453672041905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554514813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99813396,0.0007693351,0.00036534414,0.00009363005,0.00003966718,0.0002859187,0.000007698865,0.00001534612,0.00028912147],"genre_scores_gemma":[0.9991483,0.000022228392,0.00014017665,0.000070371614,0.00007383241,0.00002535838,0.00026874378,0.000015984982,0.00023501251],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99914217,0.00006585822,0.00022453078,0.00026071674,0.00011402955,0.0001927191],"domain_scores_gemma":[0.9996589,0.000012235709,0.00006146228,0.00020787935,0.00003192106,0.000027593254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012564141,0.00012696312,0.00011239182,0.000023401195,0.0000624619,0.000054723936,0.00011127118,0.00012260665,9.038016e-7],"category_scores_gemma":[0.000005481032,0.000098616954,0.000043276923,0.00012518534,0.000044846554,0.0000029316468,0.0000200075,0.000075615324,5.7820023e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000066187255,0.00065805035,0.04493127,0.00004452293,0.000023012542,0.000012285328,0.00012215323,0.0000048147976,0.9528821,0.0004675759,0.0002870989,0.0005009137],"study_design_scores_gemma":[0.0066170315,0.00073493225,0.02741154,0.000052829357,0.00016389228,0.00010562854,0.0012102871,0.00019816715,0.95718235,0.0008433709,0.0047644656,0.000715493],"about_ca_topic_score_codex":0.00018059905,"about_ca_topic_score_gemma":0.00018025814,"teacher_disagreement_score":0.01751973,"about_ca_system_score_codex":0.0000054283655,"about_ca_system_score_gemma":0.000017883105,"threshold_uncertainty_score":0.40214828},"labels":[],"label_agreement":null},{"id":"W2554537840","doi":"10.1182/blood.v110.11.1101.1101","title":"Nasal Epithelial Cells of Donor Origin after Allogeneic HCT.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Tumors and Oncological Cases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Cytokeratin; Immunocytochemistry; Biology; Pathology; Stem cell; Antibody; Amplicon; Epithelium; Immunology; Andrology; Medicine; Polymerase chain reaction; Immunohistochemistry; Gene; Genetics","score_opus":0.016892802471475184,"score_gpt":0.2760405035166182,"score_spread":0.259147701045143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554537840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963965,0.00036889286,0.000062086125,0.00007823429,0.0001444438,0.00014469991,0.000020964026,0.00002785838,0.0027563593],"genre_scores_gemma":[0.99661607,0.000020556989,0.0016175794,0.00045195495,0.00048150172,0.000005659763,0.0000037511209,0.000010039151,0.0007929065],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99927807,0.000012277062,0.00020993866,0.00014211002,0.0001494995,0.00020812401],"domain_scores_gemma":[0.99956834,0.00007010125,0.00004738322,0.00014867599,0.00004388463,0.000121582554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017637499,0.00008798664,0.00022014123,0.000043563312,0.000014173723,0.000003135458,0.000048271137,0.00007833978,0.00050656643],"category_scores_gemma":[0.00003527235,0.000060536036,0.000094664254,0.00008684858,0.00006104611,0.000015407588,0.000025063138,0.00008624429,0.00006413207],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015973618,0.0028493484,0.4080082,0.00012935838,0.000057572914,0.0039704456,0.00014273581,8.997056e-7,0.5763935,0.00029418146,0.0008874362,0.005668983],"study_design_scores_gemma":[0.0031345962,0.0011426127,0.39042884,0.000025633706,0.0001868741,0.00013415741,0.000032974254,6.7391477e-7,0.57889986,0.00007208777,0.025838453,0.000103253085],"about_ca_topic_score_codex":0.00003263427,"about_ca_topic_score_gemma":0.000029161016,"teacher_disagreement_score":0.024951017,"about_ca_system_score_codex":0.000011366831,"about_ca_system_score_gemma":0.00004282583,"threshold_uncertainty_score":0.5546547},"labels":[],"label_agreement":null},{"id":"W2554537892","doi":"10.1182/blood.v114.22.sci-34.sci-34","title":"Point: AML Stem Cells are Immature, Rare, and Targets for Curative Therapy in AML.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Stem cell; Haematopoiesis; Leukemia; clone (Java method); Biology; Cancer stem cell; Progenitor cell; Cancer research; Homogeneous; Mitosis; Immunology; Cell biology; Genetics; DNA","score_opus":0.019253157655615517,"score_gpt":0.2861368933592812,"score_spread":0.2668837357036657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554537892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871732,0.005086233,0.000085680906,0.004104577,0.000054401593,0.0017062061,0.00004873601,0.000057096542,0.0016838912],"genre_scores_gemma":[0.99363375,0.001046149,0.0014933954,0.001684482,0.0001860428,0.00007026467,0.000023799108,0.000030501304,0.0018315986],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99883586,0.00005140903,0.00021181062,0.00031831287,0.00020912832,0.00037350415],"domain_scores_gemma":[0.9992972,0.00012514506,0.000070575006,0.0002467767,0.00011810267,0.000142219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002180651,0.0001742226,0.00035376544,0.00014592984,0.000053556687,0.000025341038,0.000102684855,0.0001422455,0.000029403967],"category_scores_gemma":[0.000040106926,0.00013466386,0.000064157015,0.0002045843,0.00004865084,0.00010496319,0.000024067389,0.00032248057,0.000014529863],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014331519,0.0076828836,0.032819856,0.0009241566,0.0011564009,0.0029249028,0.013750972,0.000011216093,0.6312534,0.002999701,0.13142808,0.1607169],"study_design_scores_gemma":[0.045957416,0.0040673222,0.122873865,0.00042412907,0.000099690405,0.00017309547,0.0018206296,0.00033173407,0.793877,0.002027529,0.027769132,0.00057842984],"about_ca_topic_score_codex":0.0000140153925,"about_ca_topic_score_gemma":0.000008363787,"teacher_disagreement_score":0.16262361,"about_ca_system_score_codex":0.000065539105,"about_ca_system_score_gemma":0.00011222103,"threshold_uncertainty_score":0.5491433},"labels":[],"label_agreement":null},{"id":"W2554544625","doi":"10.1182/blood.v112.11.1786.1786","title":"Loss of CIITA and MHC Class II Expression in Diffuse Large B-Cell Lymphoma Is Not Explained by Methylation of CIITA Promoters III and IV.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"CIITA; Biology; Diffuse large B-cell lymphoma; Cancer research; Major histocompatibility complex; MHC class II; MHC class I; Immunology; Lymphoma; Immune system","score_opus":0.011161958031149805,"score_gpt":0.22953216104503596,"score_spread":0.21837020301388615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554544625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970582,0.0018210183,0.000007222928,0.00031812297,0.000019800242,0.0004105035,0.00007128437,0.000012732445,0.00028112467],"genre_scores_gemma":[0.99830425,0.001011165,0.0003127538,0.000099942015,0.000016966,0.000033171727,0.000041173706,0.000016229087,0.00016435953],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99893594,0.000040616134,0.00033476134,0.00027763628,0.00022871155,0.00018235006],"domain_scores_gemma":[0.9993869,0.000077872806,0.00015262958,0.00023607894,0.00004440648,0.000102097976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000107670974,0.00016083661,0.00040057104,0.00010692746,0.00006282281,0.000003890127,0.00004235698,0.000111893976,0.000014120537],"category_scores_gemma":[0.000029729692,0.00012712822,0.000050526636,0.00010977851,0.000076560355,0.0000845393,0.000079292164,0.00003453856,7.4576127e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007287993,0.045297157,0.5264324,0.00044101165,0.00018636636,0.00020318141,0.009481656,1.5170747e-7,0.41322628,0.000047043217,0.0014760691,0.0024799022],"study_design_scores_gemma":[0.07775619,0.00077409187,0.14615224,0.00023110998,0.00016862551,0.000047609603,0.00019501663,0.00006935723,0.7741088,0.000014987225,0.00035919182,0.00012273376],"about_ca_topic_score_codex":0.00010273408,"about_ca_topic_score_gemma":0.000009113943,"teacher_disagreement_score":0.38028017,"about_ca_system_score_codex":0.000030055351,"about_ca_system_score_gemma":0.000040873834,"threshold_uncertainty_score":0.51841384},"labels":[],"label_agreement":null},{"id":"W2554551398","doi":"10.1182/blood.v108.11.5512.5512","title":"Febrile Neutropenia in Lymphoma Patients Is Associated with Substantial Resource Use and Healthcare Costs in Clinical Practice in Spain.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Berger (Canada)","funders":"","keywords":"Medicine; Febrile neutropenia; Lymphoma; Neutropenia; Internal medicine; Chemotherapy; Chemotherapy regimen; Pediatrics","score_opus":0.01943290639466259,"score_gpt":0.30067909515642494,"score_spread":0.28124618876176233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554551398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99682283,0.00022124848,3.8375813e-7,0.0011820717,0.000050228085,0.0005919267,0.000023852645,0.000025062585,0.0010824043],"genre_scores_gemma":[0.9981344,0.00009412698,0.00007143955,0.0014330314,0.00007357116,0.000029876863,0.000051186165,0.000026425743,0.00008597468],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824435,0.00032742598,0.0005224871,0.0003563065,0.00024028661,0.0003091732],"domain_scores_gemma":[0.9990412,0.00038228786,0.00015914119,0.00019935018,0.00011753662,0.00010049402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040084345,0.00014021069,0.00036999251,0.00016005506,0.000040673487,0.000037490394,0.000047494555,0.00014404036,0.000010521988],"category_scores_gemma":[0.00041756028,0.00012775516,0.000032158743,0.0005802068,0.000059089594,0.00021718902,0.00003221298,0.00030143984,0.000004656749],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007590062,0.0027279372,0.9940268,0.000014053075,0.000021172431,0.00040531572,0.00017028603,0.0000024738306,0.000027777141,0.000034589157,0.0003766794,0.0014339047],"study_design_scores_gemma":[0.02073774,0.00069913676,0.97389466,0.00030621781,0.00007125313,0.000046161327,0.0000995726,0.000007479221,0.00009875448,0.0000050684043,0.0039035517,0.00013041952],"about_ca_topic_score_codex":0.010536982,"about_ca_topic_score_gemma":0.03311159,"teacher_disagreement_score":0.02257461,"about_ca_system_score_codex":0.000193845,"about_ca_system_score_gemma":0.00018328411,"threshold_uncertainty_score":0.99605197},"labels":[],"label_agreement":null},{"id":"W2554574741","doi":"10.1182/blood.v108.11.1673.1673","title":"Optimization of a Cytokine Cocktail for the Expansion of Cord Blood (CB) CD34+ Cells into Megakaryocytes (MK) Progenitors towards the Ex Vivo Production of Platelets.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Héma-Québec","funders":"","keywords":"Ex vivo; Progenitor cell; Haematopoiesis; Thrombopoietin; Cord blood; Platelet; Cytokine; CD34; Immunology; Stem cell; Andrology; Stem cell factor; Biology; In vivo; Chemistry; Cell biology; Medicine; Biotechnology","score_opus":0.012639397844048104,"score_gpt":0.2382896041000368,"score_spread":0.2256502062559887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554574741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955093,0.0016485297,0.00039851922,0.00032456536,0.00017123693,0.0017013376,0.000042504744,0.000024253824,0.00017971807],"genre_scores_gemma":[0.995736,0.00034499425,0.0033742927,0.0000133220265,0.00011449762,0.00009155518,0.00006683969,0.000028211702,0.00023025717],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998756,0.00003395304,0.00048168772,0.00023081998,0.00032343154,0.00017410383],"domain_scores_gemma":[0.99883777,0.00009493374,0.00036591155,0.0003647924,0.00030764553,0.000028946137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019695247,0.0001781306,0.00040889587,0.00008340398,0.000087229324,0.000006155787,0.00012144283,0.000094138966,0.000020566362],"category_scores_gemma":[0.000080367885,0.00010119853,0.00015569391,0.0002867562,0.0001451765,0.00006577364,0.000032535943,0.00007283023,6.3919555e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031836343,0.011006845,0.010539922,0.0015338417,0.0023770495,0.00004446209,0.0017235744,0.00891648,0.9448309,0.00020380365,0.0015987074,0.014040775],"study_design_scores_gemma":[0.0048714755,0.0012282834,0.0011408778,0.00012202248,0.0015332183,0.000056291676,0.00026133592,0.00068085303,0.9896009,0.00012835246,0.00028430443,0.000092097296],"about_ca_topic_score_codex":0.00050652714,"about_ca_topic_score_gemma":0.000034937562,"teacher_disagreement_score":0.04476998,"about_ca_system_score_codex":0.000013547033,"about_ca_system_score_gemma":0.00010855585,"threshold_uncertainty_score":0.41267565},"labels":[],"label_agreement":null},{"id":"W2554579566","doi":"10.1182/blood.v104.11.249.249","title":"Development of a Novel NOD/SCID Transplant System That Provides Enhanced Detection of Rapid-SRC and Insight into Their Self-Renewal and Mobilization.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Nod; Homing (biology); Biology; CD38; Immunology; Stem cell; Severe combined immunodeficiency; Haematopoiesis; Transplantation; Population; CD34; Cancer research; Molecular biology; Cell biology; Medicine; Internal medicine; In vivo","score_opus":0.022671113765403376,"score_gpt":0.24224219975149883,"score_spread":0.21957108598609545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554579566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99104536,0.001045694,0.006637221,0.0000180122,0.000025466028,0.0007418742,0.0000034429136,0.000036264897,0.00044664583],"genre_scores_gemma":[0.9927826,0.00015883225,0.0069555766,0.0000049522214,0.000018081848,0.00004723719,0.000005494524,0.000014532014,0.000012695637],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99895334,0.000027704917,0.00031928677,0.00023405242,0.00031389706,0.0001517133],"domain_scores_gemma":[0.9994684,0.000054999204,0.00010160471,0.00014495215,0.00012246502,0.00010760198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002756129,0.00012885922,0.0002961062,0.00013776508,0.00006466564,0.00000887593,0.000050896084,0.00008684519,0.000003387328],"category_scores_gemma":[0.000027601916,0.00009524589,0.000027441767,0.00017954374,0.00006402815,0.00005756004,0.00003094608,0.000073810144,5.124691e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013093253,0.00047044663,0.0015534379,0.0026967095,0.00013262162,0.0000039579904,0.012291578,0.0000036319718,0.9787137,0.00004716002,6.4297915e-8,0.0039557703],"study_design_scores_gemma":[0.004595058,0.0003606606,0.00404691,0.0007343041,0.000083661114,0.000073477604,0.00091906945,0.00009956892,0.98895127,0.000006581845,0.00004364878,0.00008577761],"about_ca_topic_score_codex":0.00008144221,"about_ca_topic_score_gemma":0.00018954041,"teacher_disagreement_score":0.0113725085,"about_ca_system_score_codex":0.00005633634,"about_ca_system_score_gemma":0.00023110695,"threshold_uncertainty_score":0.38840145},"labels":[],"label_agreement":null},{"id":"W2554613555","doi":"10.1182/blood.v108.11.4666.4666","title":"Improved Survival of Patients with HIV-Related Systemic B-Cell Non-Hodgkin’s Lymphoma (NHL) Expressing the Epstein-Barr Virus (EBV) in Malignant Cells Provided Patients Received HAART with Lymphoma Therapy.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"AIDS Vancouver; BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Lymphoma; Internal medicine; Diffuse large B-cell lymphoma; Rituximab; CHOP; Oncology; International Prognostic Index; Gastroenterology; Immunology","score_opus":0.004921524810031597,"score_gpt":0.18790758256617718,"score_spread":0.18298605775614557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554613555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99492216,0.0006743646,0.000007600036,0.000043687844,0.0001643348,0.0032509237,0.00009916446,0.00007637489,0.0007613692],"genre_scores_gemma":[0.99856055,0.000072968054,0.00027800872,0.000071410665,0.000047119072,0.0003793746,0.00023285512,0.00011637769,0.00024132596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996565,0.00022801741,0.0009774793,0.0007515906,0.00080278,0.0006751765],"domain_scores_gemma":[0.9976656,0.000184999,0.00074366806,0.00087332126,0.00037545146,0.00015696787],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023367805,0.00061561936,0.00093730714,0.00019195463,0.0001617473,0.00006320952,0.00027244646,0.00021517789,0.000019870322],"category_scores_gemma":[0.00001529185,0.00034065926,0.00016749944,0.0004635553,0.00015139735,0.00016170724,0.00006629842,0.00009323462,0.000016926393],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025783682,0.020262228,0.9399507,0.00020327965,0.0004335342,0.00013026666,0.00089694076,0.00004202147,0.031595007,0.00000617429,0.000099361765,0.003802118],"study_design_scores_gemma":[0.09297855,0.002531228,0.6662808,0.001139789,0.00046105948,0.000016517986,0.00018805974,0.00010762362,0.23581202,0.0000044564267,0.000074799194,0.00040507814],"about_ca_topic_score_codex":0.0022165386,"about_ca_topic_score_gemma":0.0001996488,"teacher_disagreement_score":0.2736699,"about_ca_system_score_codex":0.00032661087,"about_ca_system_score_gemma":0.00041311973,"threshold_uncertainty_score":0.9999045},"labels":[],"label_agreement":null},{"id":"W2554622256","doi":"10.1182/blood.v116.21.1855.1855","title":"Arginase and YKL-40, Effectors of Immunosuppressive Myeloid Cells, Are Over-Expressed In the Bone Marrow of Most Chronic Myelomonocytic Leukemia Patients, and Are Potential Prognostic Biomarkers In Myelodysplastic Syndrome","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Terry Fox Research Institute; University of Toronto","funders":"","keywords":"Arginase; Bone marrow; Cancer research; Immunology; Myeloid; Myelodysplastic syndromes; Immune system; Cytokine; Medicine; Biology; Arginine","score_opus":0.0026919012634965983,"score_gpt":0.18411345315647343,"score_spread":0.18142155189297682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554622256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98926127,0.008903146,0.0000021909493,0.000023930306,0.0006333905,0.00095307134,0.0001814718,0.000014957054,0.000026559626],"genre_scores_gemma":[0.9993899,0.00032394103,0.000033082368,0.00001674139,0.000012919263,0.00009243064,0.00007621759,0.000033299682,0.00002147291],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980472,0.0003323407,0.00059244863,0.0004522594,0.00010069052,0.0004751015],"domain_scores_gemma":[0.99827904,0.0006166183,0.0005360037,0.00046830956,0.000073385534,0.000026628284],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031683454,0.00033662934,0.00062182755,0.00028685984,0.000087109314,0.000018187377,0.0003476468,0.00039042707,0.00006606991],"category_scores_gemma":[0.00026357465,0.0002768206,0.000069332964,0.00031060522,0.0007764341,0.00011708003,0.00021826959,0.0006701229,0.0000051438797],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045793017,0.0005717319,0.104163185,0.0006161797,0.00024997053,0.000110261826,0.00046942572,0.00003025161,0.892838,0.0000073091956,0.00008080822,0.0004049552],"study_design_scores_gemma":[0.009869073,0.00050201773,0.69404936,0.0005779432,0.00024037194,0.00010954773,0.00033503454,0.000031450323,0.2939196,0.000025027883,0.000053666303,0.00028692704],"about_ca_topic_score_codex":0.00034737986,"about_ca_topic_score_gemma":0.00019391677,"teacher_disagreement_score":0.5989184,"about_ca_system_score_codex":0.0000753699,"about_ca_system_score_gemma":0.0001698004,"threshold_uncertainty_score":0.9999684},"labels":[],"label_agreement":null},{"id":"W2554665350","doi":"10.1182/blood.v118.21.987.987","title":"A miRNA Risk Score for the Prediction of Response to Lenalidomide in Multiple Myeloma (MM) Patients","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary","funders":"","keywords":"Lenalidomide; microRNA; Multiple myeloma; Oncology; Internal medicine; Biology; Cancer research; Gene expression profiling; Cohort; Medicine; Gene expression; Bioinformatics; Gene; Genetics","score_opus":0.059242968423758834,"score_gpt":0.2827313778567519,"score_spread":0.22348840943299306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554665350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972241,0.000087140725,0.00011157757,0.00007682202,0.00005478485,0.0019871504,0.0003185919,0.000018863557,0.00012098224],"genre_scores_gemma":[0.9975676,0.000026939415,0.0017964928,0.000034111672,0.000036538044,0.00035640917,0.000027900433,0.000018557663,0.00013546676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989057,0.00010772652,0.00026173162,0.00020291851,0.0002591463,0.00026274446],"domain_scores_gemma":[0.99885464,0.00045793844,0.00007696851,0.00033091736,0.00013800689,0.00014155888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000384435,0.000108052634,0.00019334668,0.00016108398,0.00006860571,0.0000046977757,0.000103000726,0.000055068336,0.00003267291],"category_scores_gemma":[0.0019225831,0.00006949707,0.00009108621,0.00017456454,0.000045283876,0.000043303877,0.00004375936,0.00010058208,0.000017992767],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018624876,0.0017780364,0.96689284,0.000039562612,0.00018343236,0.000016122493,0.00101398,0.0000012058089,0.0037557955,0.0000032285186,0.000142405,0.0075485054],"study_design_scores_gemma":[0.020996237,0.0017536207,0.93672776,0.00010070092,0.00013019876,0.000003796775,0.00009411792,0.00019079664,0.039624162,0.000027455852,0.0003042599,0.000046892837],"about_ca_topic_score_codex":0.0006314673,"about_ca_topic_score_gemma":0.00021516318,"teacher_disagreement_score":0.03586837,"about_ca_system_score_codex":0.00003800392,"about_ca_system_score_gemma":0.00007052345,"threshold_uncertainty_score":0.28340083},"labels":[],"label_agreement":null},{"id":"W2554701938","doi":"10.1182/blood.v108.11.3333.3333","title":"Breast Cancer in Young Women after Treatment with Irradiation for Hodgkin’s Lymphoma.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Breast cancer; Radiation therapy; Population; Incidence (geometry); Cohort; Amenorrhea; Mammography; Gynecology; Cancer; Pediatrics; Obstetrics; Internal medicine; Pregnancy","score_opus":0.0031404209523494915,"score_gpt":0.20931863658080507,"score_spread":0.2061782156284556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554701938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997685,0.0011341901,0.000026500496,0.00016031678,0.000042387444,0.00026358705,0.00040125047,0.000009932656,0.0002768339],"genre_scores_gemma":[0.9967291,0.00013727955,0.0001940094,0.000034309054,0.00028381735,0.002212434,0.000092099086,0.00002174289,0.00029520842],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99932665,0.0000111202335,0.0000978008,0.0002628143,0.000056868408,0.00024472896],"domain_scores_gemma":[0.99975485,0.0000045115416,0.000038885366,0.00014066303,0.000033530912,0.000027585453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000022750843,0.00014771613,0.00012395006,0.00002968606,0.000036004138,0.000011923488,0.00003464387,0.0000536049,0.000012877768],"category_scores_gemma":[7.392317e-7,0.000114553986,0.000035417834,0.000054321346,0.000026578944,0.0000034348316,0.000013188336,0.000008681981,0.0000015070891],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00100411,0.0011159282,0.98143995,0.000017470109,0.000304069,0.0000088481565,0.00025737294,0.00005257149,0.005166996,0.000012971028,0.00008038949,0.0105393445],"study_design_scores_gemma":[0.007648139,0.00030071716,0.9822331,0.00001403883,0.000081303,0.00004412079,0.00006579436,0.000003992078,0.008145032,0.00002764379,0.0012682418,0.00016784693],"about_ca_topic_score_codex":0.0013457752,"about_ca_topic_score_gemma":0.0075513814,"teacher_disagreement_score":0.010371498,"about_ca_system_score_codex":0.00015715825,"about_ca_system_score_gemma":0.000070038885,"threshold_uncertainty_score":0.4671376},"labels":[],"label_agreement":null},{"id":"W2554703575","doi":"10.1182/blood.v110.11.3813.3813","title":"Zoledronic Acid Increases Bone Mineral Density in Patients with Thalassemia Intermedia-Induced Osteoporosis Regardless of the Incessant Bone Marrow Expansion.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Zoledronic acid; Osteoporosis; Thalassemia; Osteopenia; Bone mineral; Internal medicine; Bone density; Bone marrow; Bone remodeling; Femoral neck; Endocrinology; Gastroenterology","score_opus":0.004930152620348559,"score_gpt":0.20649195652923383,"score_spread":0.20156180390888526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554703575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99820375,0.00041335184,0.0000022759273,0.00018950201,0.00012510536,0.00054107246,0.000008369805,0.000029780402,0.00048677393],"genre_scores_gemma":[0.999519,0.000046640107,0.0001019102,0.00015732822,0.00003770748,0.0000091348975,0.000025803603,0.000028693703,0.000073820855],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982605,0.000066794,0.0004900086,0.0002900392,0.0004941083,0.0003985399],"domain_scores_gemma":[0.9989493,0.00005708688,0.00022899147,0.0004653624,0.00014981844,0.00014945645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032488798,0.0002225268,0.0004679795,0.0001485966,0.00006627543,0.000008028347,0.00013521124,0.00021373371,0.000021920274],"category_scores_gemma":[0.00016649376,0.00013271793,0.00010921223,0.00044216012,0.00016163665,0.00008288779,0.0001228939,0.000396906,0.0000034964105],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072769955,0.0021516874,0.9648377,0.00011241533,0.000080690974,0.00012601691,0.0006421567,0.0000011730765,0.02973224,0.00000614576,0.000121150566,0.0014609345],"study_design_scores_gemma":[0.011302767,0.00061529066,0.916987,0.00080048025,0.00027291614,0.000080040016,0.0010839932,0.000006517815,0.068633355,0.000009161374,0.000023313,0.0001851528],"about_ca_topic_score_codex":0.00035551278,"about_ca_topic_score_gemma":0.0006519766,"teacher_disagreement_score":0.04785068,"about_ca_system_score_codex":0.00007052331,"about_ca_system_score_gemma":0.0001766888,"threshold_uncertainty_score":0.541208},"labels":[],"label_agreement":null},{"id":"W2554727182","doi":"10.1182/blood.v106.11.3210.3210","title":"The Clinical Impact of Mild Hemophilia A, Report of a Cohort Study.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. John’s Health Sciences Centre; Memorial University of Newfoundland","funders":"","keywords":"Medicine; Interquartile range; Cohort; Internal medicine; Gastroenterology; Demography","score_opus":0.05668386712949789,"score_gpt":0.42317204885961485,"score_spread":0.36648818173011694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554727182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99282783,0.00039412937,3.417511e-7,0.00065716344,0.00003526372,0.00084470044,0.0000038226963,0.000013099192,0.0052236393],"genre_scores_gemma":[0.99542636,0.00017242829,0.0001516857,0.000007584536,0.00023388742,0.000016588237,0.0000061636097,0.000011598164,0.0039737234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984297,0.000079992635,0.0006414564,0.00018916183,0.0004608586,0.00019881771],"domain_scores_gemma":[0.9987,0.00022689588,0.00014489263,0.0006289171,0.00017318975,0.00012608255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013435741,0.000095374875,0.00040071513,0.000047059977,0.000047851892,0.0000040986865,0.00010820599,0.00006920711,0.000084093495],"category_scores_gemma":[0.0004327109,0.000047680456,0.00031044995,0.00015893717,0.00016993385,0.000020809526,0.00004928612,0.00017338023,0.00001843591],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017668249,0.004899834,0.98955107,0.000012960273,0.0012879014,0.00023769979,0.000072003786,5.481434e-7,0.00046599252,0.0000048526495,0.0011987678,0.0020916935],"study_design_scores_gemma":[0.003852883,0.002068806,0.9901052,0.000027079885,0.0004718073,0.0001742498,0.00006155038,0.000011348605,0.0027183867,0.000011557141,0.00045370654,0.00004343878],"about_ca_topic_score_codex":0.000116030926,"about_ca_topic_score_gemma":0.000020149051,"teacher_disagreement_score":0.0036762003,"about_ca_system_score_codex":0.00002156669,"about_ca_system_score_gemma":0.000274142,"threshold_uncertainty_score":0.19443525},"labels":[],"label_agreement":null},{"id":"W2554733259","doi":"10.1182/blood.v110.11.3721.3721","title":"A Chemical Genetic Screen Identified Small Molecules Modulating Zebrafish Vascular Development and Angiogenesis.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Zebrafish Biomedical Research Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Zebrafish; Angiogenesis; Biology; Genetic screen; Green fluorescent protein; Cell biology; Embryo; Molecular biology; Biochemistry; Genetics; Gene","score_opus":0.012915266619908326,"score_gpt":0.24813559157388607,"score_spread":0.23522032495397774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554733259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96315455,0.0018706126,0.03415961,0.000064363696,0.000012683865,0.00026446013,0.0000073132055,0.000026639462,0.00043977448],"genre_scores_gemma":[0.9448157,0.00007601159,0.054455902,0.00018045215,0.00017285784,0.000051508705,0.00014981632,0.00003362591,0.00006412966],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99847406,0.0000283582,0.00029275034,0.00048484094,0.00027657155,0.00044341883],"domain_scores_gemma":[0.9991636,0.000025718411,0.00005484985,0.00035348456,0.00008778143,0.0003145085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041725405,0.00016126486,0.00013521679,0.00007129157,0.000107002175,0.00004281155,0.00025448293,0.00017335825,0.000012120474],"category_scores_gemma":[0.0002206542,0.00016449101,0.000075133736,0.00016958272,0.00013321244,0.0000025543509,0.00029464916,0.00008309018,0.000012452104],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000127977,0.00017959454,0.0023141745,0.000021959295,0.00014734006,0.000013897976,0.000029321081,0.0000011991892,0.97478366,0.000047649028,0.0001399603,0.022308446],"study_design_scores_gemma":[0.00097623933,0.00003886442,0.06716093,0.000011822644,0.000040889026,0.000025986195,0.000028891855,0.00003770527,0.92356735,0.00006986295,0.0078067896,0.00023469562],"about_ca_topic_score_codex":0.000024323244,"about_ca_topic_score_gemma":0.000046587153,"teacher_disagreement_score":0.064846754,"about_ca_system_score_codex":0.00001108716,"about_ca_system_score_gemma":0.0000858017,"threshold_uncertainty_score":0.6707749},"labels":[],"label_agreement":null},{"id":"W2554766738","doi":"10.1182/blood.v112.11.2576.2576","title":"Human Mesenchymal Stromal Cells (MSCs) Suppress Cytotoxicity of Natural Killer (NK) Cell Lines and Can Be Targets for NK-Mediated Cytolysis","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Mesenchymal stem cell; K562 cells; Cytolysis; Interleukin 12; Natural killer cell; Perforin; Cytotoxicity; Biology; Flow cytometry; Lymphokine-activated killer cell; Granzyme; Cell culture; Immunophenotyping; Cell; NK-92; Immunology; Interleukin 21; Cell biology; Immune system; Cytotoxic T cell; In vitro; T cell; Leukemia; CD8","score_opus":0.026565303084922023,"score_gpt":0.28171832819409354,"score_spread":0.25515302510917154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554766738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957207,0.0011259288,0.000010053803,0.0002267737,0.00016041657,0.0012101101,0.00018816213,0.00006208187,0.0012957669],"genre_scores_gemma":[0.99130905,0.00015845183,0.0014300514,0.000088531706,0.00030151635,0.00006940903,0.00020065422,0.000059688602,0.006382646],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99702424,0.000114332855,0.0005939066,0.00059731293,0.00090887817,0.00076131994],"domain_scores_gemma":[0.9980726,0.00032334536,0.00019685808,0.00049188425,0.00045768658,0.00045763032],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036005478,0.00035275103,0.0008149719,0.00026240462,0.0002616758,0.000019760324,0.00025903306,0.0002751624,0.00032233453],"category_scores_gemma":[0.00026669865,0.0002968408,0.00023593967,0.00031291356,0.00035137663,0.000089352616,0.00018028889,0.00045645042,0.0000069400025],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020529932,0.001031966,0.01698051,0.00077703176,0.00020825287,0.00020809202,0.00061094324,0.0000040296427,0.9770102,0.00001226121,0.0029259142,0.000025498575],"study_design_scores_gemma":[0.007410058,0.0010227629,0.023071492,0.00007393339,0.0002669557,0.0000996876,0.00019166007,0.0004071782,0.9665203,0.0000072645566,0.00062002323,0.00030866291],"about_ca_topic_score_codex":0.00044741487,"about_ca_topic_score_gemma":0.00014202017,"teacher_disagreement_score":0.01048988,"about_ca_system_score_codex":0.00003996404,"about_ca_system_score_gemma":0.00020213865,"threshold_uncertainty_score":0.9999484},"labels":[],"label_agreement":null},{"id":"W2554782859","doi":"10.1182/blood.v124.21.4271.4271","title":"Pilot/Feasibility Metrics, Real-Time Remote Monitoring, and Inter-Observer Agreement on Veno-Occlusion in a National Multicenter Randomized Controlled Trial of Pediatric Venous Thromboembolism: Findings from the Pilot/Feasibility Phase of the Kids-DOTT Trial","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"","keywords":"Medicine; Randomization; Randomized controlled trial; Data monitoring committee; Population; Clinical trial; Multicenter trial; Cohort; Cohen's kappa; Pediatrics; Surgery; Multicenter study; Internal medicine; Statistics","score_opus":0.040728725553191465,"score_gpt":0.3187856884078504,"score_spread":0.2780569628546589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554782859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98332554,0.00022565774,0.00001926693,0.00039978276,0.0011788622,0.014187925,0.00006196242,0.000026474832,0.00057455286],"genre_scores_gemma":[0.99797106,0.0005131103,0.00025076538,0.000113902264,0.00092006964,0.0001326673,0.000022969614,0.000030978383,0.00004446624],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99442965,0.0015405294,0.001742466,0.00065837504,0.001268383,0.00036057862],"domain_scores_gemma":[0.9943422,0.0033546255,0.00094655034,0.0008988617,0.00033007053,0.00012765882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0065981285,0.00038631406,0.0027745087,0.00025646194,0.00014842329,0.000034569464,0.00040812886,0.00010993506,0.00008774238],"category_scores_gemma":[0.0076884013,0.00022429739,0.0005982281,0.0004404556,0.000250122,0.00008386742,0.0003356085,0.00034986596,0.0000065117356],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.955237,0.029769558,0.010152585,0.00012306622,0.000737188,0.0000036969973,0.0007355456,0.000006468803,0.0026658373,0.00012295075,0.00021348314,0.00023266528],"study_design_scores_gemma":[0.8866581,0.0076125134,0.100741036,0.00023716535,0.0024469136,6.9660547e-7,0.000048204143,0.0003767517,0.0011558827,0.0005391105,0.000011985078,0.00017164472],"about_ca_topic_score_codex":0.0017449,"about_ca_topic_score_gemma":0.00006802774,"teacher_disagreement_score":0.09058845,"about_ca_system_score_codex":0.00018921665,"about_ca_system_score_gemma":0.00018821064,"threshold_uncertainty_score":0.920429},"labels":[],"label_agreement":null},{"id":"W2554784016","doi":"10.1182/blood.v118.21.3021.3021","title":"Herpesvirus Viremia and Engraftment Status of Umbilical Cord Blood in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplant","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Viremia; Medicine; Umbilical cord; Hematopoietic stem cell transplantation; Cord blood; Stem cell; Immunology; Hematopoietic stem cell; Transplantation; Haematopoiesis; Gastroenterology; Internal medicine; Virus; Biology","score_opus":0.02646235324791849,"score_gpt":0.26193715189407013,"score_spread":0.23547479864615165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554784016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928464,0.0044839364,0.000006920196,0.00001831366,0.000023254363,0.00069968327,0.000035151203,0.00003675887,0.0018495423],"genre_scores_gemma":[0.99577534,0.0035518291,0.0003878984,0.00006074604,0.00003180934,0.000026446545,0.00001424434,0.000041320836,0.00011035625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99791145,0.00008600861,0.00050378125,0.0004412986,0.000397728,0.000659746],"domain_scores_gemma":[0.99901384,0.00009421991,0.000084086045,0.00037185408,0.00005139207,0.00038460002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002534968,0.00023826901,0.0005353784,0.00021071047,0.000051593797,0.000013949918,0.00012714574,0.00017319224,0.00018916767],"category_scores_gemma":[0.000011069634,0.00020991701,0.000099521014,0.0002800825,0.00014014792,0.000053782373,0.000070714625,0.00034862422,0.00001915769],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010008363,0.0044376655,0.9207534,0.00052537024,0.00037979282,0.0002875264,0.003270301,7.4720197e-7,0.06430263,0.00019849607,0.000012775682,0.0048304466],"study_design_scores_gemma":[0.016656786,0.0028628814,0.5107247,0.00040072447,0.0008022156,0.00065250194,0.00045605178,0.000014923837,0.46666348,0.00012261017,0.00022249893,0.00042061438],"about_ca_topic_score_codex":0.0010511595,"about_ca_topic_score_gemma":0.00038903116,"teacher_disagreement_score":0.4100287,"about_ca_system_score_codex":0.000041217,"about_ca_system_score_gemma":0.00027885108,"threshold_uncertainty_score":0.85601676},"labels":[],"label_agreement":null},{"id":"W2554791934","doi":"10.1182/blood.v106.11.3323.3323","title":"Functional and Molecular Analysis of Maturation of Thymocytes in Bcl10 or Malt1 Deficient Mice.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Biology; T-cell receptor; BCL10; Cell biology; CD8; T cell; Cytotoxic T cell; Negative selection; Transgene; Molecular biology; Immune system; Cancer research; Immunology; Lymphoma; In vitro; Genetics; Gene","score_opus":0.019880569465848454,"score_gpt":0.28697990934894885,"score_spread":0.2670993398831004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554791934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99778384,0.00088863744,0.000076007906,0.00025212244,0.000007258114,0.00013602598,0.000006543882,0.0000046105715,0.00084497867],"genre_scores_gemma":[0.99854475,0.000092782684,0.0007373025,0.000055759152,0.000020466048,0.0000057813177,0.000024705712,0.00000561068,0.0005128405],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99931663,0.000025683821,0.00019109716,0.00011756391,0.00025816265,0.0000908497],"domain_scores_gemma":[0.99966425,0.000051901814,0.00004452469,0.00012727652,0.00007855292,0.00003352367],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016868346,0.000051561034,0.00020147067,0.00034920388,0.000008011625,0.0000036594931,0.000026750316,0.000040303225,0.0011136403],"category_scores_gemma":[0.000042525022,0.000040524545,0.000060798084,0.0005716408,0.00003941752,0.000023911634,0.000016948103,0.00006489127,0.000002070227],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000665184,0.0005608515,0.022113867,0.000053618718,0.0004506915,0.000010617267,0.00016340938,0.00028315868,0.97258073,0.00012159909,0.00002254357,0.0029737153],"study_design_scores_gemma":[0.0033666005,0.00031422474,0.29195997,0.000036302536,0.0009041948,0.000023788463,0.00013474825,0.002827244,0.70009613,0.000017069926,0.00025469065,0.00006503311],"about_ca_topic_score_codex":0.000044343215,"about_ca_topic_score_gemma":0.00010940849,"teacher_disagreement_score":0.2724846,"about_ca_system_score_codex":0.000017930286,"about_ca_system_score_gemma":0.000047485722,"threshold_uncertainty_score":0.9997995},"labels":[],"label_agreement":null},{"id":"W2554797011","doi":"10.1182/blood.v110.11.449.449","title":"A Tissue Microarray Classification in Multiple Myeloma (MM) Predicts Survival Post Autologous Stem Cell Transplant (ASCT).","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Oncology; Internal medicine; Tissue microarray; Proportional hazards model; Multiple myeloma; Univariate analysis; Immunohistochemistry; Pathology; Multivariate analysis","score_opus":0.03051540818010379,"score_gpt":0.27904577169476963,"score_spread":0.24853036351466584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554797011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938636,0.000568998,0.00031456994,0.00029235063,0.00013169226,0.0010596521,0.00012673205,0.00012356527,0.0035188464],"genre_scores_gemma":[0.99753314,0.00008224971,0.00085773005,0.00006261471,0.00011696797,0.00004877731,0.00030979922,0.000040226485,0.0009484885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99781543,0.000098915894,0.0004451675,0.00047168258,0.00046431366,0.0007044976],"domain_scores_gemma":[0.99877286,0.0002441071,0.00008345725,0.00041493902,0.00010854552,0.00037610563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045813248,0.00024386936,0.00037900134,0.00028608632,0.00008937109,0.0000213761,0.00015201514,0.00021249575,0.000061190185],"category_scores_gemma":[0.00004720906,0.00020949832,0.00008390249,0.00029442474,0.000083224375,0.00007645871,0.000023886,0.00030448483,0.00019262717],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012504053,0.0034322832,0.4781362,0.00022911737,0.00013122079,0.0026146956,0.0012121203,9.489374e-7,0.4773678,0.000019952045,0.000057700356,0.035547536],"study_design_scores_gemma":[0.011272189,0.000584833,0.71746653,0.00008894714,0.000094363,0.00013072611,0.00031621163,0.000115863404,0.26916534,0.0000036227132,0.00061199605,0.00014940309],"about_ca_topic_score_codex":0.00041767178,"about_ca_topic_score_gemma":0.0011474914,"teacher_disagreement_score":0.23933028,"about_ca_system_score_codex":0.000104989864,"about_ca_system_score_gemma":0.00016076342,"threshold_uncertainty_score":0.8543094},"labels":[],"label_agreement":null},{"id":"W2554848301","doi":"10.1182/blood.v114.22.652.652","title":"Obesity Adversely Affects Survival of Pediatric Patients with Severe Aplastic Anemia After Hematopoietic Cell Transplantation.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; BC Children's Hospital","funders":"","keywords":"Medicine; Overweight; Underweight; Body mass index; Aplastic anemia; Transplantation; Obesity; Population; Percentile; Internal medicine; Anemia; Hematopoietic stem cell transplantation; Proportional hazards model; Pediatrics; Environmental health; Bone marrow","score_opus":0.005309452347425533,"score_gpt":0.1999807347691543,"score_spread":0.19467128242172876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554848301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960565,0.00010686567,0.0005830973,0.00002472272,0.00007795034,0.0006470148,0.000060129867,0.000066469845,0.0023772346],"genre_scores_gemma":[0.9983612,0.00006153229,0.0012138223,0.000054389788,0.00006994685,0.000013485665,0.00011382536,0.000026059486,0.00008578769],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845994,0.000056221757,0.00030765907,0.00031366275,0.0005747649,0.00028776095],"domain_scores_gemma":[0.99915886,0.00014959213,0.0001341927,0.0002545928,0.0001302804,0.00017247212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009711085,0.00023945974,0.00039247586,0.00014221703,0.00003910586,0.000008408698,0.00007900968,0.00012810883,0.00012268673],"category_scores_gemma":[0.0000117629015,0.00020051806,0.00008609362,0.00031762084,0.000032474178,0.000099030425,0.0000041342587,0.0001524313,0.000042721334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083879137,0.0022317718,0.9918791,0.0028997043,0.00003903386,0.00026209332,0.00096958404,0.000020083116,0.0007641906,0.000025633795,0.000028863036,0.000041141935],"study_design_scores_gemma":[0.010871031,0.0010244731,0.97400355,0.00022427292,0.0018257417,0.0000973166,0.0000463008,0.000003183438,0.011642896,0.000018373907,0.0000029799942,0.00023988512],"about_ca_topic_score_codex":0.000003940917,"about_ca_topic_score_gemma":0.000005455616,"teacher_disagreement_score":0.017875563,"about_ca_system_score_codex":0.000019217525,"about_ca_system_score_gemma":0.00010536926,"threshold_uncertainty_score":0.81768894},"labels":[],"label_agreement":null},{"id":"W2554875937","doi":"10.1182/blood.v112.11.980.980","title":"An Adaptive-Design Dose-Ranging Study of PD 0348292, a New Oral Factor Xa Inhibitor, for Thromboprophylaxis after Total Knee Replacement Surgery.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Guelph General Hospital","funders":"","keywords":"Medicine; Dose-ranging study; Discontinuation; Pulmonary embolism; Venography; Interim analysis; Deep vein; Surgery; Incidence (geometry); Thrombosis; Clinical endpoint; Adverse effect; Randomized controlled trial; Anesthesia; Internal medicine; Placebo; Double blind","score_opus":0.10928089854880405,"score_gpt":0.3191115857407069,"score_spread":0.20983068719190287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554875937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952293,0.00013276392,0.0017982892,0.00010169593,0.000319768,0.0022616137,0.000008691246,0.00008842868,0.00005945108],"genre_scores_gemma":[0.9943536,0.000006668298,0.0032562804,0.000039300226,0.0009263448,0.000026451442,0.000012663138,0.00003935222,0.0013393462],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983761,0.00009279806,0.0004956676,0.00035177535,0.00040815034,0.00027552043],"domain_scores_gemma":[0.99902797,0.00020185027,0.00016568949,0.00036932202,0.000094876035,0.00014026926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030159584,0.00021552725,0.0005742135,0.00020979786,0.000102645055,0.00001553425,0.000047068053,0.000067854715,0.00014036598],"category_scores_gemma":[0.00010802672,0.00018110617,0.00021890488,0.00023177553,0.000030362988,0.00017280613,0.00004000567,0.00007849114,0.000011353502],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010116989,0.0017942021,0.96623135,0.00017003009,0.001253356,0.00011600431,0.0061664176,0.00008994857,0.00758878,0.000029717874,0.0022674934,0.0041757175],"study_design_scores_gemma":[0.023910936,0.014351474,0.9489763,0.00009925781,0.0008261805,0.000025121713,0.0018177324,0.00024850818,0.008056789,0.00003840094,0.0011412946,0.00050802476],"about_ca_topic_score_codex":0.00008797796,"about_ca_topic_score_gemma":0.000010859755,"teacher_disagreement_score":0.017255064,"about_ca_system_score_codex":0.00003155379,"about_ca_system_score_gemma":0.00011125101,"threshold_uncertainty_score":0.7385295},"labels":[],"label_agreement":null},{"id":"W2554878864","doi":"10.1182/blood.v108.11.1634.1634","title":"Sbds Deficient Neutrophils Exhibit Normal Numbers, Chemotaxis and Phagocytic Functions, but Impaired NADPH Oxidase Activity.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Biology; NADPH oxidase; Molecular biology; Immunology; Reactive oxygen species; Cell biology","score_opus":0.00387153517709511,"score_gpt":0.1901339561250899,"score_spread":0.1862624209479948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554878864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99527425,0.0023105787,0.00010983951,0.000103411374,0.000073427174,0.0002066303,0.000066242595,0.000028746972,0.0018268743],"genre_scores_gemma":[0.9981439,0.000080815174,0.0001509469,0.00008489629,0.00015211033,0.00003398704,0.00015639665,0.000026085549,0.0011708479],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99894655,0.000030289213,0.00015155572,0.00041904455,0.00012233351,0.00033025007],"domain_scores_gemma":[0.99947685,0.00000707894,0.0000692176,0.00030553897,0.000039932795,0.00010136062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000052369316,0.00022044993,0.00016331814,0.000037227404,0.00016627456,0.000044112894,0.00007897785,0.00014049832,0.000022278347],"category_scores_gemma":[0.000011072714,0.00021054702,0.000102822785,0.0000894042,0.00007416461,0.000008451141,0.00008611211,0.00007070437,0.000020630432],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002705289,0.005183632,0.054946277,0.00006812672,0.00041804864,0.000088674,0.00003250398,0.000046265242,0.9287279,0.000068394635,0.0029445547,0.0072050863],"study_design_scores_gemma":[0.010003856,0.0009219906,0.048881657,0.000016601029,0.00043661933,0.0002800337,0.00008638377,0.00004071751,0.9332751,0.0000894333,0.005385501,0.0005821164],"about_ca_topic_score_codex":0.0005515818,"about_ca_topic_score_gemma":0.00017491974,"teacher_disagreement_score":0.009733328,"about_ca_system_score_codex":0.000011953023,"about_ca_system_score_gemma":0.000063364845,"threshold_uncertainty_score":0.85858583},"labels":[],"label_agreement":null},{"id":"W2554918032","doi":"10.1182/blood.v112.11.3096.3096","title":"TERT Mutations in Patients with Squamous Cell Carcinoma of the Tongue and Refractory Anemia","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; BC Cancer Agency; Terry Fox Research Institute","funders":"","keywords":"Dyskeratosis congenita; Telomere; Bone marrow failure; Telomerase RNA component; Pathology; Cancer; Medicine; Gastroenterology; Cancer research; Internal medicine; Telomerase; Biology; Telomerase reverse transcriptase; Genetics; Gene","score_opus":0.007610738989962625,"score_gpt":0.19628313257388627,"score_spread":0.18867239358392365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554918032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99867564,0.00019429531,6.812508e-7,0.000044002536,0.000025897396,0.00021595173,0.000008995365,0.000008701715,0.0008258397],"genre_scores_gemma":[0.99955386,0.000007399341,0.00011290811,0.00008415761,0.000017682549,0.000004589399,0.000009126458,0.0000097292095,0.00020055434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99943787,0.000021193771,0.00013786407,0.00012813356,0.00016181503,0.00011315195],"domain_scores_gemma":[0.9995999,0.00003629211,0.000054329463,0.00020707714,0.00005198514,0.000050465314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000025181998,0.000076291086,0.00013288019,0.000054388835,0.00004561842,0.0000018068924,0.000049906186,0.000040297742,0.000012268652],"category_scores_gemma":[0.000029777008,0.00004861438,0.000019107161,0.0001445246,0.00011135974,0.00003488546,0.000016918708,0.00010532046,0.0000014953564],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046640922,0.00068511954,0.9963792,0.00005295638,0.0000027998333,0.00003838648,0.0012386463,5.992689e-7,0.0013227654,0.0000018317322,0.00004272563,0.00018831994],"study_design_scores_gemma":[0.00395392,0.00030212593,0.9840201,0.00002587671,0.00004350378,0.000030040701,0.00010230216,0.0000019522408,0.011394047,0.0000019758786,0.000065316584,0.000058803063],"about_ca_topic_score_codex":0.00019384864,"about_ca_topic_score_gemma":0.000053634445,"teacher_disagreement_score":0.012359073,"about_ca_system_score_codex":0.000011328721,"about_ca_system_score_gemma":0.00007730732,"threshold_uncertainty_score":0.19824369},"labels":[],"label_agreement":null},{"id":"W2554921082","doi":"10.1182/blood.v104.11.3464.3464","title":"A Phase II Study of ZD6474, a Vascular Endothelial Growth Factor Receptor (VEGFR) and Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) in Patients with Relapsed Multiple Myeloma (MM).","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Regional Laboratory Medicine Program; Princess Margaret Cancer Centre; London Health Sciences Centre","funders":"","keywords":"Medicine; Internal medicine; Transplantation; Vascular endothelial growth factor; Angiogenesis; Pharmacology; Gastroenterology","score_opus":0.014658817334158268,"score_gpt":0.25519929410555714,"score_spread":0.24054047677139886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554921082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99419993,0.0002379633,0.00001314135,0.00013039359,0.00012795531,0.0041991468,0.00095061545,0.000105924264,0.000034905213],"genre_scores_gemma":[0.9973176,0.00007242833,0.0015894456,0.00004652029,0.00018042569,0.00028416672,0.00032517122,0.00012246383,0.00006178215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956097,0.00025727742,0.0009057783,0.0010136206,0.0012781535,0.0009354898],"domain_scores_gemma":[0.9976007,0.00022666091,0.0003093732,0.0006474669,0.00047490222,0.0007409516],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002029797,0.00067539216,0.0011547878,0.0005524247,0.00023988592,0.0000434679,0.00022598729,0.00023466256,0.00017818938],"category_scores_gemma":[0.0012163088,0.0005206663,0.00018632898,0.000649907,0.00021456351,0.00037086994,0.0002090018,0.00052244304,0.000029954375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008841959,0.075796396,0.8684636,0.0003337401,0.0010856182,0.0002816386,0.0034525902,0.000001025165,0.038766656,0.0000148692325,0.000038093738,0.0029238423],"study_design_scores_gemma":[0.30625823,0.035638887,0.53074855,0.00048627335,0.00032242393,0.00001187522,0.00039874073,0.000010547609,0.12547746,0.000012490985,0.00008410806,0.0005504222],"about_ca_topic_score_codex":0.0012493272,"about_ca_topic_score_gemma":0.0002559464,"teacher_disagreement_score":0.33771503,"about_ca_system_score_codex":0.00024177037,"about_ca_system_score_gemma":0.0002837201,"threshold_uncertainty_score":0.9997245},"labels":[],"label_agreement":null},{"id":"W2554928161","doi":"10.1182/blood.v124.21.4188.4188","title":"Incidence and Aetiology of Thrombocytopenia in Twin Pregnancies in a Tertiary Referral Centre","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Pregnancy; Incidence (geometry); Etiology; Cohort; Obstetrics; Population; Pediatrics; Gestational age; Cohort study; Twin Pregnancy; Gestation; Internal medicine","score_opus":0.010884390691416517,"score_gpt":0.2512569006533245,"score_spread":0.24037250996190798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554928161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980457,0.00068259524,0.0000012440029,0.00025909685,0.000011951599,0.0001556589,0.0000017631207,0.000006126035,0.0008358569],"genre_scores_gemma":[0.99950373,0.00010669469,0.00022258383,0.000087408094,0.000005716992,0.0000057849165,0.00000628732,0.000004470508,0.000057326422],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99951804,0.000033597094,0.00014207765,0.0001290325,0.000050231418,0.00012704215],"domain_scores_gemma":[0.99979925,0.00003310339,0.000030685547,0.00009940186,0.000010007149,0.000027547323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006462567,0.000064525535,0.00024995077,0.00006424775,0.000006768611,0.0000017753528,0.000029972858,0.00005438449,0.000014333635],"category_scores_gemma":[0.00004703969,0.00005132293,0.000014002665,0.00006376253,0.00004519693,0.00003596836,0.000028357475,0.00006260512,0.000003544966],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037132195,0.0004187453,0.9941595,0.00004632043,0.0000145864615,0.00013506885,0.0005372514,4.2752893e-7,0.0032358866,0.00008246016,0.000013539987,0.0013190757],"study_design_scores_gemma":[0.004704416,0.0001603347,0.99066573,0.00026023207,0.000028904009,0.00009692382,0.00007733714,0.000030623858,0.0032968898,0.00060082285,0.000031484095,0.000046303463],"about_ca_topic_score_codex":0.00025996295,"about_ca_topic_score_gemma":0.00097078865,"teacher_disagreement_score":0.004667284,"about_ca_system_score_codex":0.000007914337,"about_ca_system_score_gemma":0.000020713225,"threshold_uncertainty_score":0.20928885},"labels":[],"label_agreement":null},{"id":"W2554972944","doi":"10.1182/blood.v120.21.2095.2095","title":"Celiac Disease: Association with Iron Deficiency in Caucasians but Not in Non-Caucasians.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Celiac Disease Research and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Iron deficiency; Medicine; Hemochromatosis; Ferritin; Serum iron; Iron-deficiency anemia; Hereditary hemochromatosis; Anemia; Internal medicine; Population; Transferrin saturation; Disease; Gastroenterology; Immunology; Physiology; Environmental health","score_opus":0.009098683637148185,"score_gpt":0.2583511958411314,"score_spread":0.24925251220398323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554972944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864221,0.0008315068,0.000034928464,0.0014122429,0.00005676599,0.00074495305,0.000022821863,0.000030955136,0.010443705],"genre_scores_gemma":[0.99696934,0.0001610982,0.00008195818,0.00023730437,0.00012729221,0.0001288718,0.00004518102,0.000023251929,0.0022256745],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981903,0.00007690095,0.00020601865,0.00021414354,0.0006087238,0.0007039058],"domain_scores_gemma":[0.9991435,0.000042834556,0.00005618323,0.00027850355,0.000040013405,0.00043898725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005392568,0.00014443834,0.00020856803,0.00024508708,0.00004687316,0.00002156597,0.000078426434,0.000058372527,0.00006999046],"category_scores_gemma":[0.00016923588,0.00012313914,0.000054997985,0.00038721474,0.00002408511,0.00016000636,0.000049649774,0.000276845,0.000113118236],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027323441,0.0042978055,0.9904294,0.00044128887,0.000024971425,0.00031758545,0.00056382205,0.0000068817358,0.0010401038,0.000101964055,0.0007348946,0.0017680541],"study_design_scores_gemma":[0.0044402205,0.00016505508,0.99225974,0.0001474932,0.00016476795,0.000005186775,0.0005629564,0.000021838774,0.00075815566,0.0000109236635,0.0013127667,0.0001508811],"about_ca_topic_score_codex":0.0004479469,"about_ca_topic_score_gemma":0.00042017427,"teacher_disagreement_score":0.010547248,"about_ca_system_score_codex":0.0003049962,"about_ca_system_score_gemma":0.00015440617,"threshold_uncertainty_score":0.50214684},"labels":[],"label_agreement":null},{"id":"W2555000332","doi":"10.1182/blood.v114.22.3132.3132","title":"Prevention of Venous Thromboembolism (VTE) Associated with Pregnancy in Women with a Past History of VTE.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Victoria Hospital","funders":"","keywords":"Medicine; Pregnancy; Warfarin; Low molecular weight heparin; Thrombosis; Risk factor; Obstetrics; Venous thrombosis; Venous thromboembolism; Postpartum period; Pediatrics; Surgery; Internal medicine; Atrial fibrillation","score_opus":0.01165092739767433,"score_gpt":0.22439850951544998,"score_spread":0.21274758211777567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555000332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897498,0.0016491017,0.000020087864,0.00010337037,0.00003862927,0.00075860607,0.0000039570286,0.00003753317,0.007638946],"genre_scores_gemma":[0.99876016,0.00021358099,0.00024924564,0.00011929696,0.00002708265,0.00006442433,0.000012841393,0.00002303891,0.00053031556],"study_design_codex":"nonrandomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.998698,0.000049361523,0.000352223,0.00024498664,0.00035151566,0.000303913],"domain_scores_gemma":[0.99916947,0.000021603058,0.00031424282,0.00031257418,0.00010783738,0.00007424695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017805173,0.00016754915,0.0008197964,0.00017709055,0.000014777565,0.0000029636633,0.00009529501,0.00007928018,0.00006242062],"category_scores_gemma":[0.000026695006,0.00013267195,0.000049479855,0.00025271197,0.000074000476,0.000076132405,0.000018889416,0.00012021729,0.0000017619878],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046172445,0.41861296,0.175986,0.005745646,0.011262506,0.0017734185,0.14202964,0.00039897917,0.049985316,0.0065824804,0.009255736,0.17375007],"study_design_scores_gemma":[0.008457933,0.009355039,0.9743971,0.00469285,0.00065974315,0.000010228515,0.00034893394,0.0000045200545,0.00127833,0.00024720837,0.00036254377,0.00018556279],"about_ca_topic_score_codex":0.000069905946,"about_ca_topic_score_gemma":0.00006928313,"teacher_disagreement_score":0.79841113,"about_ca_system_score_codex":0.0002614365,"about_ca_system_score_gemma":0.00020835086,"threshold_uncertainty_score":0.5410205},"labels":[],"label_agreement":null},{"id":"W2555002983","doi":"10.1182/blood.v126.23.1604.1604","title":"The Impact of Anemia on Overall Survival in Patients with Myelofibrosis Treated with Ruxolitinib: An Exploratory Analysis of the Comfort Studies","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; St. Paul's Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Ruxolitinib; Medicine; Anemia; Myelofibrosis; International Prognostic Scoring System; Internal medicine; Proportional hazards model; Survival analysis; Surgery; Gastroenterology; Myelodysplastic syndromes; Bone marrow","score_opus":0.035604383041803925,"score_gpt":0.2994456234511574,"score_spread":0.2638412404093535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555002983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989251,0.00011830799,1.9883514e-7,0.00004291875,0.000011507718,0.0004950341,0.000079564736,0.000009649607,0.00031775393],"genre_scores_gemma":[0.9997499,0.000038901093,0.000029262634,0.000021612661,0.000012029108,0.00005933868,0.00005076596,0.000016041678,0.000022151626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870074,0.00015711137,0.00028322122,0.00020636414,0.0004646438,0.00018792576],"domain_scores_gemma":[0.99868876,0.0001712829,0.00021254021,0.00046971423,0.0003563632,0.00010137117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019935702,0.00019981788,0.0006126057,0.000121141755,0.000057151054,0.000008409846,0.00008809978,0.00003840553,0.000005313658],"category_scores_gemma":[0.000059455735,0.000075586184,0.000121493315,0.00059533137,0.00015302269,0.00005777491,0.000026632706,0.00008492145,4.8488243e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001679968,0.0028593875,0.9896115,0.000013054647,0.0038368595,0.0000053680096,0.0014672618,0.00030058337,0.000019256802,0.00005678937,0.00003390891,0.00011603087],"study_design_scores_gemma":[0.008617864,0.006723261,0.9781373,0.00013638899,0.0020354858,5.8794706e-7,0.0008403457,0.000019364354,0.0033965448,0.000007152377,0.0000029736746,0.00008270636],"about_ca_topic_score_codex":0.00034652336,"about_ca_topic_score_gemma":0.0007930994,"teacher_disagreement_score":0.011474206,"about_ca_system_score_codex":0.000097490454,"about_ca_system_score_gemma":0.0001474209,"threshold_uncertainty_score":0.3082315},"labels":[],"label_agreement":null},{"id":"W2555050655","doi":"10.1182/blood.v106.11.1556.1556","title":"The Classical Illegitimate Switch Translocation Model Is Unable To Account for at Least Half of the Translocation Breakpoints from t(4;14)(p16;q32) Multiple Myeloma.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Breakpoint; Chromosomal translocation; Biology; Genetics; Derivative chromosome; Locus (genetics); Chromosome; Immunoglobulin class switching; Gene; Molecular biology; Chromosome 22; B cell","score_opus":0.02577253144406177,"score_gpt":0.2849630355202376,"score_spread":0.25919050407617583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555050655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95919085,0.00067355216,0.0058505,0.030040987,0.00007877651,0.0030212933,0.000557844,0.000056362576,0.0005298176],"genre_scores_gemma":[0.9930986,0.00013510881,0.0038166589,0.00036369145,0.00017220258,0.00048224226,0.00014486066,0.000044269334,0.0017423665],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99800426,0.00005036901,0.00044099224,0.00041264712,0.00061516085,0.00047657802],"domain_scores_gemma":[0.9984599,0.00025011593,0.000102518934,0.0006788129,0.00029135562,0.00021733309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002525662,0.00022767443,0.00031842428,0.000061032504,0.00039722386,0.000038718874,0.0002776029,0.00012519295,0.000050135634],"category_scores_gemma":[0.00014374402,0.00013651718,0.00023157992,0.000215318,0.00010847896,0.00013125443,0.000043422828,0.00014988256,0.000059919606],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013186163,0.009109346,0.021721993,0.00048720703,0.0028478852,0.000014337865,0.011609044,0.005443971,0.5240564,0.0010988661,0.012616695,0.39780813],"study_design_scores_gemma":[0.024941405,0.00045353637,0.03175589,0.00032900408,0.00056065765,0.000027934624,0.00025146405,0.29527208,0.6267802,0.0004884914,0.018791966,0.00034738024],"about_ca_topic_score_codex":0.0004083447,"about_ca_topic_score_gemma":0.0022504136,"teacher_disagreement_score":0.39746076,"about_ca_system_score_codex":0.00015072124,"about_ca_system_score_gemma":0.00021481332,"threshold_uncertainty_score":0.5567009},"labels":[],"label_agreement":null},{"id":"W2555070547","doi":"10.1182/blood.v106.11.4578.4578","title":"Long-Term Follow-Up Results of Adults with T-Cell Acute Lymphoblastic Leukemia (T-ALL)-The Vancouver Experience.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Medicine; Vincristine; Cytarabine; Cyclophosphamide; Internal medicine; Gastroenterology; Chemotherapy; Induction chemotherapy; Acute lymphocytic leukemia; Surgery; Chemotherapy regimen; Prednisone; Regimen; Leukemia; Lymphoblastic Leukemia","score_opus":0.01045295890415442,"score_gpt":0.2557652477779778,"score_spread":0.2453122888738234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555070547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918093,0.00018602991,0.00037776903,0.00024181114,0.00021759287,0.00084094756,0.000049182523,0.00010102745,0.00617635],"genre_scores_gemma":[0.98975575,0.0001259555,0.001596224,0.0004114483,0.00039630386,0.00010484379,0.000043570308,0.000079425256,0.0074864603],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965528,0.00006741067,0.00067862624,0.000659083,0.0012454852,0.00079659635],"domain_scores_gemma":[0.9974905,0.0003636323,0.00027720747,0.0011530995,0.00034581745,0.0003697251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002465267,0.00038980195,0.00055216724,0.00016507928,0.00012090456,0.000030668365,0.0005567901,0.00020187859,0.0001575472],"category_scores_gemma":[0.00021924383,0.00024053812,0.0001748512,0.0005112681,0.00044646804,0.00018991191,0.000193844,0.0003291663,0.00014724511],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15389091,0.017509513,0.12952106,0.0038777571,0.00932188,0.012898951,0.0997775,0.00087881443,0.30150193,0.00017486242,0.22859403,0.04205281],"study_design_scores_gemma":[0.2963238,0.006896449,0.034417883,0.0021159574,0.0038942264,0.0022351102,0.0025762944,0.0034470707,0.63929677,0.000014817559,0.0073276884,0.001453955],"about_ca_topic_score_codex":0.00016543045,"about_ca_topic_score_gemma":0.0005065838,"teacher_disagreement_score":0.33779484,"about_ca_system_score_codex":0.00069085194,"about_ca_system_score_gemma":0.0014707877,"threshold_uncertainty_score":0.98088604},"labels":[],"label_agreement":null},{"id":"W2555093393","doi":"10.1182/blood-2016-08-732230","title":"Disseminated MAC infection with marrow noncaseating granuloma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Mycobacterium research and diagnosis","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Diarrhea; Weakness; Weight loss; Productive Cough; Granuloma; Surgery; Pediatrics; Internal medicine; Immunology; Lung; Obesity","score_opus":0.009697953807632744,"score_gpt":0.26092737173248487,"score_spread":0.25122941792485215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555093393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99388176,0.000048462698,0.000086680615,0.0009012463,0.000024973077,0.00020184854,0.000011104088,0.00008664384,0.0047572628],"genre_scores_gemma":[0.99853516,0.000085311534,0.00027278802,0.000085148895,0.00013288064,0.000052128104,0.000014624982,0.000016871996,0.00080508477],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992724,0.000029332465,0.00009420189,0.00016385547,0.00020119315,0.00023898711],"domain_scores_gemma":[0.9994106,0.000111468544,0.000030112382,0.00017887582,0.00008600892,0.00018293055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000109720284,0.00008651021,0.00012469856,0.000072880975,0.000051872295,0.000015224561,0.00002891921,0.000043869364,0.00045017427],"category_scores_gemma":[0.00024328791,0.00004659666,0.000035902252,0.00016196669,0.000037808004,0.000079496735,0.000018349467,0.00006801729,0.00011518255],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015552709,0.0002953416,0.82473135,0.000062413455,0.000050011105,0.00018778579,0.000021695918,1.0622879e-8,0.16588391,0.000023785411,0.0010383766,0.007549789],"study_design_scores_gemma":[0.0043589445,0.00094644795,0.75037646,0.00051723456,0.00011765097,0.00025315798,0.000009284836,0.000002784661,0.24118333,0.000022160486,0.0021046805,0.00010784776],"about_ca_topic_score_codex":0.00012483243,"about_ca_topic_score_gemma":0.000035927136,"teacher_disagreement_score":0.075299405,"about_ca_system_score_codex":0.000019620258,"about_ca_system_score_gemma":0.00004086241,"threshold_uncertainty_score":0.49290925},"labels":[],"label_agreement":null},{"id":"W2555133796","doi":"10.1182/blood.v112.11.4833.4833","title":"Dermatofibrosarcoma Protuberans in 3 Patients with ADA-SCID","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Dermatofibrosarcoma protuberans; PDGFB; Factor XIIIa; Medicine; CD34; Pathology; Sarcoma; Severe combined immunodeficiency; Birthmark; Immunohistochemistry; Dermatology; Biology; Internal medicine","score_opus":0.008403775148690059,"score_gpt":0.227512785521867,"score_spread":0.21910901037317693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555133796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988035,0.00021102304,0.000015367857,0.000041644158,0.000010887084,0.00039354057,0.000011525843,0.0000102529775,0.0005022771],"genre_scores_gemma":[0.9992015,0.00003038201,0.00028307605,0.00013037244,0.000043731117,0.000057814344,0.00007443298,0.000025341518,0.00015338004],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991091,0.00005426316,0.00011586414,0.00024788507,0.0001998031,0.00027307353],"domain_scores_gemma":[0.9995357,0.0000034810625,0.000024050632,0.0003082284,0.000060005317,0.00006855339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000057868758,0.00011416591,0.000098787175,0.000048150712,0.00006116193,0.00000729721,0.0001635764,0.000071428214,0.000021618524],"category_scores_gemma":[0.000010158545,0.00009679971,0.00003099889,0.0001222973,0.000074124924,0.0000032640373,0.000044651544,0.00008207009,0.000017888893],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018519589,0.0010407786,0.8467434,0.000015333151,0.00006038081,0.000030097739,0.000077799225,0.00001712715,0.14932822,0.000002151936,0.00028209525,0.0005506758],"study_design_scores_gemma":[0.0069474564,0.0033821857,0.23875646,0.00001272258,0.0000063125976,0.000022150325,0.0000065171166,0.0000031183145,0.7492866,0.000006657811,0.0013627806,0.00020702538],"about_ca_topic_score_codex":0.0000106879215,"about_ca_topic_score_gemma":0.00012160766,"teacher_disagreement_score":0.6079869,"about_ca_system_score_codex":0.0000061328105,"about_ca_system_score_gemma":0.0000998766,"threshold_uncertainty_score":0.39473778},"labels":[],"label_agreement":null},{"id":"W2555159995","doi":"10.1182/blood.v114.22.3879.3879","title":"Preliminary Results of a Phase I Study of the Pan-PI3 Kinase Inhibitor SF1126 in Patients with Relapsed and Refractory Myeloma.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Bortezomib; Cancer research; Medicine; PI3K/AKT/mTOR pathway; Multiple myeloma; Angiogenesis; In vivo; Dexamethasone; Population; Melphalan; PTEN; Paclitaxel; Cancer; Internal medicine; Pharmacology; Oncology; Chemistry; Biology; Apoptosis","score_opus":0.014277882728381123,"score_gpt":0.28028821199197446,"score_spread":0.26601032926359336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555159995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998061,0.00015455595,1.2433044e-7,0.000072436604,0.000014767792,0.0013764072,0.000045259334,0.000009693155,0.000265733],"genre_scores_gemma":[0.9997371,0.000010581349,0.00008967672,0.000016847005,0.000016706595,0.000018197885,0.000022276374,0.000010312391,0.000078338104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986793,0.00010376251,0.00033777778,0.00023915667,0.00045132267,0.00018871207],"domain_scores_gemma":[0.99913895,0.00007355803,0.00014820078,0.00043539572,0.00010696118,0.00009692177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013777806,0.00013063091,0.00028792507,0.0001220502,0.000034883506,0.000003827529,0.00007674528,0.000051203846,0.000003124013],"category_scores_gemma":[0.00023586414,0.000075733056,0.000032223288,0.000250689,0.00006602876,0.000059096412,0.0000442874,0.00016019565,7.0435095e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0391911,0.079030946,0.8471435,0.000094932846,0.00022656869,0.00023781178,0.002688529,5.4874437e-7,0.0041751745,0.0000024203641,0.00007974157,0.027128749],"study_design_scores_gemma":[0.105283014,0.03515467,0.85121197,0.00024074057,0.00014100382,0.0000032506075,0.0002987487,0.000005882454,0.0075850408,0.0000045870743,0.000013002666,0.000058103986],"about_ca_topic_score_codex":0.00010922278,"about_ca_topic_score_gemma":0.000033358963,"teacher_disagreement_score":0.06609191,"about_ca_system_score_codex":0.000020642243,"about_ca_system_score_gemma":0.00007060684,"threshold_uncertainty_score":0.30883044},"labels":[],"label_agreement":null},{"id":"W2555162116","doi":"10.1182/blood.v106.11.4371.4371","title":"Short Nucleotide Insertions in the MCL-1 Promoter Affect Its Gene Expression.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital","funders":"","keywords":"Luciferase; Transfection; Molecular biology; HeLa; Biology; Reporter gene; Plasmid; Phorbol; K562 cells; Cell culture; Gene; Gene expression; Signal transduction; Biochemistry; Protein kinase C; Genetics","score_opus":0.03127767896194254,"score_gpt":0.3132241160925438,"score_spread":0.28194643713060125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555162116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99200666,0.000576097,0.000011656086,0.0019302554,0.000030181045,0.0007989455,0.0000042294237,0.00005322045,0.0045887823],"genre_scores_gemma":[0.997142,0.000063486215,0.0008303319,0.00066530006,0.00038994948,0.00013012037,0.0000125351025,0.000026582427,0.00073964975],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985263,0.00010758182,0.00022155281,0.00026630316,0.00048579846,0.00039248774],"domain_scores_gemma":[0.99914455,0.0001261618,0.000018903746,0.0005472304,0.000048327416,0.00011479664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043539234,0.00013069565,0.0001822058,0.00010641208,0.00007605617,0.000026398433,0.00023608579,0.00008923,0.00018362426],"category_scores_gemma":[0.00020809735,0.00008174225,0.000078979916,0.0002703541,0.000051452702,0.000096319956,0.000084477455,0.00029344799,0.00032095],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043859213,0.012375841,0.01727893,0.0004930424,0.00028573826,0.0022437104,0.007573213,0.000107101354,0.9178309,0.00028514324,0.020928001,0.020159801],"study_design_scores_gemma":[0.029591333,0.00031974923,0.048087403,0.0003770907,0.0001785459,0.0014798904,0.00018179188,0.001991162,0.9038873,0.000041715426,0.0135665955,0.00029746353],"about_ca_topic_score_codex":0.00003348773,"about_ca_topic_score_gemma":0.000054440836,"teacher_disagreement_score":0.030808473,"about_ca_system_score_codex":0.0009560589,"about_ca_system_score_gemma":0.0009149554,"threshold_uncertainty_score":0.412527},"labels":[],"label_agreement":null},{"id":"W2555197100","doi":"10.1182/blood.v118.21.3266.3266","title":"Comprehensive In Vitro and In Vivo Characterization of Loss and Gain-of-Function Von Willebrand Factor Collagen Binding Variants Using a Mouse Model System,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Von Willebrand factor; Mutant; Molecular biology; Chemistry; In vivo; Platelet; Missense mutation; Phenotype; In vitro; Von Willebrand disease; Recombinant DNA; Cell biology; Biology; Biochemistry; Immunology; Genetics; Gene","score_opus":0.03112513891638903,"score_gpt":0.23452753889118774,"score_spread":0.2034023999747987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555197100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99923474,0.00007002777,0.00018513788,0.0000019563033,0.000017424065,0.0003562858,0.000084659434,0.0000066479784,0.000043115586],"genre_scores_gemma":[0.99959254,0.00005199665,0.0003010746,0.0000061672918,0.0000036948059,0.0000044129647,0.000017102313,0.00001035113,0.000012650042],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99947816,0.000022530763,0.00020023566,0.00013311634,0.00007074196,0.00009521149],"domain_scores_gemma":[0.99975246,0.00001189428,0.00010221581,0.000067831395,0.000032716198,0.000032860375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000033402503,0.0000871158,0.00029702453,0.00016627231,0.000017129836,0.0000035891653,0.0000133704425,0.0000641754,0.0000027226247],"category_scores_gemma":[0.000006351674,0.000078891775,0.000013647867,0.000105925326,0.000023654524,0.00008597939,0.000015071383,0.000027390166,1.5282247e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005717059,0.0003197177,0.089096,0.0003000398,0.00006403466,0.00004365093,0.0011041993,0.0000071011464,0.90842164,0.0000052875803,5.571484e-8,0.0000665951],"study_design_scores_gemma":[0.016764995,0.000290674,0.17541403,0.00063222874,0.00030300274,0.000102428945,0.00053902186,0.030336915,0.7754249,0.000021379872,6.9835363e-7,0.00016971395],"about_ca_topic_score_codex":0.00012231177,"about_ca_topic_score_gemma":0.000008938418,"teacher_disagreement_score":0.1329967,"about_ca_system_score_codex":0.000018072842,"about_ca_system_score_gemma":0.000022922748,"threshold_uncertainty_score":0.3217113},"labels":[],"label_agreement":null},{"id":"W2555209176","doi":"10.1182/blood.v110.11.2651.2651","title":"Microarray Identification of Differentially Expressed Genes in AHI-1- Mediated Leukemic Transformation of Human Cutaneous T-Cell Lymphoma Cells.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Biology; Cancer research; Insertional mutagenesis; Cell culture; Autocrine signalling; Molecular biology; Lymphoma; Gene; Immunology; Genetics","score_opus":0.012802835533294003,"score_gpt":0.26791331148808256,"score_spread":0.2551104759547886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555209176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99687994,0.00048813273,0.0005232502,0.000028912784,0.000041532065,0.0007706252,0.00004259441,0.000030172727,0.001194864],"genre_scores_gemma":[0.99904996,0.00025600812,0.00010243764,0.000014073371,0.000026148593,0.000015593065,0.00020133003,0.000031955413,0.00030247803],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978187,0.00007453746,0.0009893993,0.000264562,0.00053460797,0.0003181998],"domain_scores_gemma":[0.9989363,0.0001160336,0.00026210747,0.00033303854,0.00025903984,0.00009346169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003612635,0.00017837972,0.0004170233,0.00049037323,0.000043438253,0.000010933103,0.00018049835,0.00016598114,0.00009640383],"category_scores_gemma":[0.000054455446,0.00017630294,0.000114330454,0.00038891062,0.0001401652,0.000067766436,0.00002095347,0.00009660934,0.000010870753],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003993804,0.002613733,0.0070502134,0.0005758888,0.000055836543,0.000063881416,0.0024321608,0.000008112869,0.9846521,0.00001922087,0.000010562588,0.00211891],"study_design_scores_gemma":[0.007584253,0.00031650375,0.007926118,0.00008712422,0.00009369562,0.00013350244,0.0005501169,0.00016661095,0.98294765,0.00003624154,0.000025651001,0.00013252447],"about_ca_topic_score_codex":0.00023524223,"about_ca_topic_score_gemma":0.00023716029,"teacher_disagreement_score":0.0071848724,"about_ca_system_score_codex":0.00011439106,"about_ca_system_score_gemma":0.00018306595,"threshold_uncertainty_score":0.7189426},"labels":[],"label_agreement":null},{"id":"W2555214289","doi":"10.1182/blood.v106.11.32.32","title":"Adult Human Blood Leukocytes as a Source of Tissue-Committed Progenitors for Cellular Therapy of Cardiovascular Disease.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Progenitor cell; CD34; Population; Cell therapy; Stem cell; Biology; Cell biology; CD31; Bone marrow; Endothelial stem cell; Immunology; Molecular biology; Chemistry; Angiogenesis; In vitro; Cancer research; Medicine; Biochemistry","score_opus":0.02593161506748623,"score_gpt":0.29178191667745046,"score_spread":0.26585030160996426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555214289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9792823,0.017436134,0.00011763188,0.00013430553,0.000024402147,0.0020395357,0.00001343795,0.000054701046,0.0008975066],"genre_scores_gemma":[0.99649656,0.00032745744,0.0009944235,0.00002812955,0.00044188858,0.00018263285,0.00004459645,0.00006909855,0.0014152116],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975812,0.00011415338,0.0005042799,0.00039474602,0.0009817068,0.0004239431],"domain_scores_gemma":[0.99801344,0.000109705354,0.00013749975,0.00090634415,0.0005126502,0.00032037814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004536698,0.0002303618,0.0006824769,0.00016953594,0.000084525054,0.000011189974,0.00026831328,0.00012409071,0.00016373143],"category_scores_gemma":[0.00025009876,0.00019565823,0.0005959585,0.00027213234,0.00015490016,0.000048027756,0.00006007531,0.00016124065,0.000018398938],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080634264,0.0062567173,0.039637472,0.0016939059,0.0075237746,0.00010723294,0.0007814849,0.00007533985,0.9212217,0.00031562007,0.00027086906,0.021309571],"study_design_scores_gemma":[0.009600117,0.0012777217,0.0018798116,0.00015457472,0.0012417657,0.000017387652,0.00008584646,0.000056877463,0.9577371,0.000043355943,0.02772685,0.00017860137],"about_ca_topic_score_codex":0.00030911333,"about_ca_topic_score_gemma":0.0000037827192,"teacher_disagreement_score":0.03775766,"about_ca_system_score_codex":0.000020698837,"about_ca_system_score_gemma":0.00018157777,"threshold_uncertainty_score":0.7978711},"labels":[],"label_agreement":null},{"id":"W2555232473","doi":"10.1182/blood.v104.11.3875.3875","title":"Chemical Agonists and High Shear Stress Induce Apoptosis in Human Platelets.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Platelet; Apoptosis; Thrombopoiesis; Platelet activation; Cell biology; Chemistry; Programmed cell death; Immunology; Biology; Haematopoiesis; Biochemistry; Stem cell; Megakaryocyte","score_opus":0.011109493550128574,"score_gpt":0.25042186604217953,"score_spread":0.23931237249205095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555232473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99820787,0.0002638802,9.2502256e-7,0.00036979845,0.000020924204,0.0001716938,0.000010771114,0.00003119152,0.0009229269],"genre_scores_gemma":[0.9994097,0.0000556721,0.00027620216,0.00009968302,0.00003202471,0.000014106653,0.000059123737,0.0000149540365,0.000038586673],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99932534,0.0000058450923,0.00013528959,0.00021536084,0.0001147132,0.00020346465],"domain_scores_gemma":[0.99972636,0.000009135165,0.000023936205,0.00013109845,0.000011379216,0.00009809432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000026429681,0.000117816635,0.000244345,0.000059859787,0.000037018144,0.000013420261,0.000037293317,0.0001054223,0.000020672152],"category_scores_gemma":[0.000011658163,0.000103867475,0.00002674323,0.000093159826,0.00004342067,0.000039396262,0.000027291637,0.00013891987,0.000011298849],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004806595,0.040360067,0.34090915,0.0006816316,0.0014167912,0.010588749,0.0031012392,0.000021931754,0.5755407,0.004846424,0.00024176924,0.021810839],"study_design_scores_gemma":[0.028165689,0.0003907918,0.078819215,0.00028413767,0.00021556349,0.00032219893,0.000093563256,0.0000018176686,0.88973093,0.0016005046,0.00011069334,0.0002648832],"about_ca_topic_score_codex":0.00043886952,"about_ca_topic_score_gemma":0.00002564961,"teacher_disagreement_score":0.3141902,"about_ca_system_score_codex":0.000028561524,"about_ca_system_score_gemma":0.000026364129,"threshold_uncertainty_score":0.42355928},"labels":[],"label_agreement":null},{"id":"W2555241823","doi":"10.1182/blood.v112.11.3814.3814","title":"Independent Risk Factors of Catheter-Related Thrombosis (CRT) in Adult Cancer Patients: An Individual Patient-Level Data (IPD) Meta-Analysis of Randomized Clinical Trials and Prospective Cohort Studies","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Central Venous Catheters and Hemodialysis","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Odds ratio; Prospective cohort study; Surgery; Randomized controlled trial; Thrombosis; Confidence interval; Internal medicine","score_opus":0.3940813857064753,"score_gpt":0.4849329146153855,"score_spread":0.09085152890891024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555241823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864672,0.0018053227,0.000012750823,0.000029852245,0.00017707926,0.0033237033,0.00814278,0.000019151817,0.000022205524],"genre_scores_gemma":[0.99068725,0.008061758,0.00018716388,0.000050030612,0.000025952613,0.0003465125,0.0006002739,0.000026251337,0.000014777038],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98494947,0.008669454,0.0043890374,0.00081535743,0.00075586827,0.00042080798],"domain_scores_gemma":[0.9883477,0.006233498,0.0035570217,0.00090871134,0.00078095944,0.00017208452],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.009534562,0.00035137654,0.007412084,0.0005007667,0.00030092927,0.0000064684186,0.00040074156,0.00035230909,0.00025729366],"category_scores_gemma":[0.008717419,0.00022437274,0.0015159622,0.0007588389,0.00042949367,0.0002310392,0.0004307844,0.00061334524,0.0000012862431],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012382087,0.0034895977,0.72385174,0.000031385596,0.24440514,8.51314e-7,0.0268315,0.000015116185,0.0000039241127,0.000011485068,0.000034888733,0.00008619209],"study_design_scores_gemma":[0.040015515,0.00030844915,0.62591714,0.000026873997,0.33087474,9.1475926e-8,0.0024485807,0.00010224298,0.000068567446,0.000056851422,9.585757e-7,0.00017996615],"about_ca_topic_score_codex":0.011718797,"about_ca_topic_score_gemma":0.0074161603,"teacher_disagreement_score":0.09793457,"about_ca_system_score_codex":0.00006710273,"about_ca_system_score_gemma":0.00022504487,"threshold_uncertainty_score":0.9996326},"labels":[],"label_agreement":null},{"id":"W2555266496","doi":"10.1182/blood.v112.11.942.942","title":"Synergistic Cytarabine:Daunorubicin Ratios Delivered by CPX-351 to Human Leukemia Xenografts Is Associated with Liposome-Mediated Bone Marrow Drug Accumulation, Intracellular Delivery of Encapsulated Agents to Leukemia Cells, and Increased Efficacy.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celator Pharmaceuticals (Canada)","funders":"","keywords":"Daunorubicin; Cytarabine; Leukemia; Bone marrow; Pharmacology; Medicine; Immunology","score_opus":0.015378347710823664,"score_gpt":0.24695195662463765,"score_spread":0.23157360891381398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555266496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962974,0.00031164204,0.00018076148,0.00022150393,0.000060312075,0.0022294703,0.00038434635,0.00021525264,0.00009930743],"genre_scores_gemma":[0.9952323,0.000111851725,0.0008990977,0.00081072043,0.00012222634,0.00008233025,0.0014365831,0.0001548741,0.0011500381],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99488765,0.00030310426,0.0011865973,0.0010627186,0.001544908,0.0010150378],"domain_scores_gemma":[0.9958981,0.0006070013,0.00041619095,0.0008614666,0.0010085659,0.0012086668],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00051356235,0.0006935884,0.0012347884,0.00067345286,0.0003889248,0.00005246539,0.00039288995,0.00040449874,0.00024184708],"category_scores_gemma":[0.0010217881,0.0006430317,0.0001378465,0.00176159,0.000370887,0.00019574446,0.00024771877,0.000523158,0.00011009892],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013835178,0.0011879487,0.010787216,0.00015570187,0.0009590737,0.0011453303,0.0021914265,0.0006789238,0.9515451,0.0000036064798,0.0298709,0.00009122613],"study_design_scores_gemma":[0.050489902,0.0027543886,0.08960975,0.0011861139,0.0017078231,0.00022360758,0.00022825398,0.012026491,0.83991015,0.0000074634554,0.0004973536,0.0013587312],"about_ca_topic_score_codex":0.0037207748,"about_ca_topic_score_gemma":0.00015088313,"teacher_disagreement_score":0.11163501,"about_ca_system_score_codex":0.0018063065,"about_ca_system_score_gemma":0.0017027808,"threshold_uncertainty_score":0.9996021},"labels":[],"label_agreement":null},{"id":"W2555269684","doi":"10.1182/blood.v104.11.2334.2334","title":"Culture Conditions for Generating Human Bone Marrow Stromal Cells Influence Cell Immunophenotype and In Vivo Biodistribution in Immune Deficient Mice.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Bone marrow; Mesenchymal stem cell; Stromal cell; Immunophenotyping; Flow cytometry; Biology; Biodistribution; Immunology; Transplantation; In vivo; Stem cell; Pathology; Molecular biology; Cancer research; Cell biology; Medicine; Internal medicine","score_opus":0.013072327430577024,"score_gpt":0.27620578627297726,"score_spread":0.26313345884240025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555269684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965877,0.0018505667,0.000033125758,0.0000890304,0.000029150342,0.0009099157,0.00012153189,0.000018797517,0.00036016267],"genre_scores_gemma":[0.9980976,0.000045054774,0.0013334604,0.000030676536,0.000036646547,0.00009010489,0.00015421204,0.000013974279,0.0001982557],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986738,0.000039647603,0.00037956669,0.00029623936,0.00022044407,0.0003902912],"domain_scores_gemma":[0.99949497,0.000037768506,0.00007812381,0.00018942055,0.00010532589,0.00009441674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002886712,0.0001453243,0.00025087278,0.00013819164,0.00015130539,0.000037797578,0.00007683146,0.00012688388,0.000039228595],"category_scores_gemma":[0.000073385476,0.00013779338,0.00004646495,0.00028201926,0.0000811018,0.0000741237,0.000055345263,0.0002613379,0.000009286431],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004981471,0.0006305848,0.004497925,0.00016460323,0.000008273188,0.00006180354,0.00030622608,0.00030364972,0.9937555,0.00018232623,0.000022767348,0.000016532671],"study_design_scores_gemma":[0.008492926,0.00054472487,0.027293274,0.00024072707,0.000044876753,0.00004391178,0.0003449903,0.0001239569,0.96245694,0.0001204115,0.00011957202,0.00017368406],"about_ca_topic_score_codex":0.00041045036,"about_ca_topic_score_gemma":0.00016332974,"teacher_disagreement_score":0.03129855,"about_ca_system_score_codex":0.00013529252,"about_ca_system_score_gemma":0.00010808113,"threshold_uncertainty_score":0.56190515},"labels":[],"label_agreement":null},{"id":"W2555276064","doi":"10.1182/blood.v124.21.1804.1804","title":"The Use of Statin Enhances Chance of Achieving MR4.5 in Chronic Myeloid Leukemia Patients in Chronic Phase Following Imatinib Therapy","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Imatinib; Myeloid leukemia; Statin; Imatinib mesylate; Chronic myelogenous leukemia; Tyrosine-kinase inhibitor; Internal medicine; Oncology; Discontinuation; Population; Cancer; Leukemia","score_opus":0.013081381650168665,"score_gpt":0.26787590327494204,"score_spread":0.2547945216247734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555276064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917145,0.007179585,0.00014226911,0.000010595338,0.00062568387,0.00026424034,0.000017066513,0.0000035900978,0.000042473795],"genre_scores_gemma":[0.99333906,0.005417334,0.0002056182,0.000030728606,0.00086725806,0.000045042958,0.00003204334,0.000017949378,0.000044971188],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988344,0.00011549366,0.0003980823,0.00023993257,0.00014314575,0.00026897131],"domain_scores_gemma":[0.9993319,0.000058269754,0.00021856838,0.00032022168,0.00004142698,0.000029598305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029584143,0.00014056794,0.00025209785,0.000047480593,0.0000404222,0.000012167412,0.00020357485,0.00007929611,0.000003520146],"category_scores_gemma":[0.00012860546,0.00011246173,0.000097974116,0.000126327,0.00007089574,0.000011968853,0.00005390922,0.00009256106,5.621804e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009241095,0.00017395592,0.0043541123,0.000045107226,0.000040695242,4.7290577e-8,0.00021828664,0.00014394471,0.9491906,0.000021347214,0.000080809405,0.04563865],"study_design_scores_gemma":[0.011071049,0.0009454156,0.023082392,0.0001734383,0.000021641286,3.7735273e-7,0.000041272357,0.00027440517,0.9091136,0.000019714176,0.05504423,0.00021249008],"about_ca_topic_score_codex":0.00026423516,"about_ca_topic_score_gemma":0.001188612,"teacher_disagreement_score":0.05496342,"about_ca_system_score_codex":0.000058451416,"about_ca_system_score_gemma":0.00030980026,"threshold_uncertainty_score":0.45860562},"labels":[],"label_agreement":null},{"id":"W2555297165","doi":"10.1182/blood-2016-09-739003","title":"CCL2 is a KIT D816V–dependent modulator of the bone marrow microenvironment in systemic mastocytosis","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Austrian Science Fund","keywords":"Systemic mastocytosis; Bone marrow; In vivo; Cytokine; CCL2; Immunology; Medicine; Cancer research; Chemokine; Biology; Inflammation","score_opus":0.005478793058310664,"score_gpt":0.17054603633624696,"score_spread":0.1650672432779363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555297165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949844,0.0034134816,0.000013971509,0.00047857588,0.00022502072,0.00027329125,0.00009649786,0.0000105434,0.00050423987],"genre_scores_gemma":[0.988905,0.00015855304,0.000018179133,0.000082671984,0.000013951305,0.00002789794,0.0000028588115,0.000013482895,0.010777398],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990461,0.00009215826,0.000321829,0.00024439872,0.00004636449,0.00024915335],"domain_scores_gemma":[0.9993622,0.000032069493,0.00014226875,0.00043688275,0.000011479348,0.000015136785],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012921974,0.0001337902,0.0002540465,0.00005655803,0.000046881654,0.000002903029,0.00022107719,0.0001403122,0.0014143835],"category_scores_gemma":[0.000009928924,0.00007718108,0.00009655376,0.000056660476,0.0001314681,0.000023461367,0.00013836191,0.0000986366,0.00027324606],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003738414,0.00036019605,0.016598038,0.000044346467,0.00006853754,0.0000042058364,0.00020068989,7.047023e-7,0.98141956,0.000087650384,0.00045814234,0.0007205463],"study_design_scores_gemma":[0.0044337725,0.0000977641,0.02392297,0.00022282162,0.00008457452,0.00014431124,0.00007481157,4.027418e-7,0.96149606,0.000024796187,0.009348463,0.00014924647],"about_ca_topic_score_codex":0.00009108859,"about_ca_topic_score_gemma":0.000044629644,"teacher_disagreement_score":0.019923493,"about_ca_system_score_codex":0.00004365864,"about_ca_system_score_gemma":0.000021328467,"threshold_uncertainty_score":0.9994985},"labels":[],"label_agreement":null},{"id":"W2555313151","doi":"10.1182/blood.v118.21.3776.3776","title":"Cycling Toward Leukemia Stem Cell Elimination Wtih a Selective Sonic Hedgehog Antagonist,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"","keywords":"Biology; Progenitor cell; Stem cell; Sonic hedgehog; Transcriptome; Cell biology; Cell cycle; Induced pluripotent stem cell; Cancer research; Molecular biology; Cell; Gene expression; Signal transduction; Genetics; Gene","score_opus":0.027405242946224054,"score_gpt":0.23195130276012166,"score_spread":0.20454605981389762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555313151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816726,0.0020947508,0.0009678298,0.0000147768105,0.00016625284,0.00020547307,0.000013751998,0.000050020535,0.014814551],"genre_scores_gemma":[0.99746144,0.00019533072,0.001139098,0.0001211999,0.00024491362,0.000044983248,0.00003145244,0.000037800954,0.00072380475],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99882156,0.00006244601,0.00022779508,0.00043961633,0.00012606416,0.00032252437],"domain_scores_gemma":[0.99937516,0.000011096625,0.00011106674,0.0002714792,0.0001516234,0.00007955053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015928166,0.00020864439,0.00017975613,0.00005241506,0.00013249768,0.000018917213,0.00019836321,0.0001756758,0.0000070137635],"category_scores_gemma":[0.000026615295,0.00021002193,0.000109116605,0.00011038721,0.00006109242,0.000004695376,0.00012599927,0.00012530769,0.00003662865],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006782977,0.0004266147,0.00476914,0.0000812614,0.00016462369,0.000017558577,0.0022205242,0.00001170145,0.9882069,0.000067383204,0.00041474134,0.0035517237],"study_design_scores_gemma":[0.00085129315,0.00040090267,0.0036500227,0.00002281797,0.000100942736,0.000021168937,0.0006000093,0.000022576281,0.9927139,0.00004765116,0.0012943416,0.00027434865],"about_ca_topic_score_codex":0.000038514,"about_ca_topic_score_gemma":0.000019088768,"teacher_disagreement_score":0.015788823,"about_ca_system_score_codex":0.000041875435,"about_ca_system_score_gemma":0.0003079314,"threshold_uncertainty_score":0.8564446},"labels":[],"label_agreement":null},{"id":"W2555341938","doi":"10.1182/blood.v114.22.3226.3226","title":"Peripheral Blood Stem Cell Harvests Performed Beyond the Initial Two Days of Apheresis May Not Contribute to Accelerate Granulocyte and Platelet Engraftment After Autologous Stem Cell Transplantation.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Leukapheresis; Medicine; Apheresis; CD34; Stem cell; Etoposide; Transplantation; Haematopoiesis; Cyclophosphamide; Granulocyte colony-stimulating factor; Internal medicine; Chemotherapy; Immunology; Urology; Platelet; Biology","score_opus":0.016693710225210715,"score_gpt":0.27257413159382093,"score_spread":0.2558804213686102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555341938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931924,0.00087941426,0.000065209424,0.0021412706,0.00007888958,0.001717217,0.00039334144,0.000072920106,0.0014593584],"genre_scores_gemma":[0.9953614,0.00041479972,0.0006272301,0.0018915586,0.00017905934,0.00015690345,0.000074226664,0.000048479687,0.001246343],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99709916,0.00023369062,0.0006447367,0.00056809705,0.00068780954,0.00076652394],"domain_scores_gemma":[0.99847335,0.00023198969,0.00015430537,0.00051906257,0.00021786735,0.00040340255],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048343677,0.00042076397,0.00069281727,0.00017107229,0.00020462941,0.000102483486,0.00030114924,0.00019685978,0.00014001517],"category_scores_gemma":[0.000007942645,0.00030159208,0.00015874783,0.0003118276,0.00015594265,0.00017453672,0.000065459775,0.0005321552,0.000028446571],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036636773,0.008749571,0.021160182,0.0037583015,0.0026183827,0.013667316,0.04358264,0.00030262212,0.78553534,0.00040442773,0.0034883674,0.08009608],"study_design_scores_gemma":[0.026886638,0.0025492876,0.057555076,0.00011930428,0.0010809609,0.00056189223,0.0005590874,0.00013541433,0.90924984,0.000012809301,0.00088164315,0.00040802266],"about_ca_topic_score_codex":0.00007236037,"about_ca_topic_score_gemma":0.000067251196,"teacher_disagreement_score":0.12371453,"about_ca_system_score_codex":0.000094827046,"about_ca_system_score_gemma":0.00032840215,"threshold_uncertainty_score":0.9999436},"labels":[],"label_agreement":null},{"id":"W2555361697","doi":"10.1182/blood.v104.11.1932.1932","title":"Secretable Human Megakaryocyte Factor V Endocytosed from Plasma in Complex with Multimerin: The Origin of Human Megakaryocyte Factor V.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Megakaryocyte; Molecular biology; Fibrinogen; Platelet; Blood proteins; Biology; Chemistry; Immunology; Cell biology; Biochemistry; Haematopoiesis; Stem cell","score_opus":0.03869831486646037,"score_gpt":0.28290667211135107,"score_spread":0.2442083572448907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555361697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964949,0.0002713399,0.000011134908,0.00012584856,0.000034046938,0.0008813432,0.00029243907,0.00007946082,0.0018095232],"genre_scores_gemma":[0.9982792,0.000029655455,0.0007980045,0.00009636295,0.00005725195,0.000046156947,0.00040371972,0.000057287318,0.0002323457],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99810386,0.00005033865,0.0004660949,0.0004598162,0.00043515227,0.0004847675],"domain_scores_gemma":[0.99891704,0.00007590326,0.00020580072,0.0005806541,0.00005924703,0.00016136169],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000048779377,0.0003903142,0.0008118254,0.00014123516,0.00017781189,0.000029262947,0.00024197061,0.000120166034,0.0005150522],"category_scores_gemma":[0.000015549367,0.0002511262,0.00013595313,0.0002664299,0.00016581966,0.00013628072,0.000057738864,0.00030620908,0.000036041412],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011783643,0.0076323836,0.4129743,0.00017082039,0.0028272353,0.0031674395,0.004639066,0.000110243665,0.56579274,0.0005000963,0.00007233465,0.0009349846],"study_design_scores_gemma":[0.060827363,0.0018073671,0.59483045,0.00026805652,0.0005604099,0.00012620355,0.00035576988,0.000058182013,0.33925828,0.00030265516,0.0011074982,0.0004977509],"about_ca_topic_score_codex":0.0064795758,"about_ca_topic_score_gemma":0.0027948648,"teacher_disagreement_score":0.22653443,"about_ca_system_score_codex":0.000096039446,"about_ca_system_score_gemma":0.00012954285,"threshold_uncertainty_score":0.9999941},"labels":[],"label_agreement":null},{"id":"W2555374335","doi":"10.1182/blood.v112.11.1025.1025","title":"Quantitation of Non-Inhibitory Anti-Factor VIII Antibodies in human Plasma","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Antibody; Nijmegen breakage syndrome; Chemistry; Human plasma; Titer; Immunoassay; Recombinant DNA; Molecular biology; Multiplex; Isoantibodies; Internal medicine; Immunology; Pharmacology; Medicine; Chromatography; Biochemistry; Biology","score_opus":0.04439899766834895,"score_gpt":0.328854556273577,"score_spread":0.2844555586052281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555374335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964601,0.00016104992,0.0000018674958,0.00009385865,0.00003983228,0.00022245187,0.0000054570446,0.000018495986,0.0029969008],"genre_scores_gemma":[0.9988204,0.00016352392,0.00029928656,0.00000730299,0.00007874661,0.0000049568293,0.000021283993,0.000011575084,0.0005929153],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99924004,0.000018101668,0.00019804013,0.00013838478,0.00023770002,0.00016771154],"domain_scores_gemma":[0.99966425,0.00004062801,0.00003832473,0.00014258672,0.00006009973,0.00005413237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000652421,0.000083634775,0.00023531534,0.00020654104,0.000058756144,0.0000025700544,0.000040811105,0.00006911082,0.000049645903],"category_scores_gemma":[0.000040736548,0.00006598902,0.00005899259,0.00014911633,0.00010373123,0.00005310704,0.00001779812,0.000103459395,0.000031660118],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022293221,0.00087006215,0.626822,0.00008997656,0.000041194355,0.00019393933,0.00060282485,6.656858e-7,0.3711126,0.000026585069,0.000109188644,0.000108656364],"study_design_scores_gemma":[0.003215119,0.000310034,0.61646956,0.000102357604,0.000022450897,0.000025292487,0.00007310937,0.000024916782,0.37966272,0.000006519869,0.000037787588,0.00005013396],"about_ca_topic_score_codex":0.0000627071,"about_ca_topic_score_gemma":0.000018111265,"teacher_disagreement_score":0.010352452,"about_ca_system_score_codex":0.0000145637905,"about_ca_system_score_gemma":0.00007259825,"threshold_uncertainty_score":0.26909542},"labels":[],"label_agreement":null},{"id":"W2555378139","doi":"10.1182/blood.v104.11.2713.2713","title":"Transfusion of Red Blood Cells under Shock Conditions in the Rat Microvasculature.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Trauma, Hemostasis, Coagulopathy, Resuscitation","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Resuscitation; Microcirculation; Hematocrit; Shock (circulatory); Medicine; Andrology; Packed red blood cells; Blood volume; Saline; Red blood cell; Anesthesia; Blood transfusion; Surgery; Internal medicine","score_opus":0.01441321165058026,"score_gpt":0.25558433427301264,"score_spread":0.24117112262243237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555378139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99486196,0.00058387424,0.00012953306,0.0025865212,0.00012804529,0.00072687265,0.00002353185,0.000037828755,0.0009218397],"genre_scores_gemma":[0.99806577,0.00018271769,0.0010683419,0.00044718574,0.00006942375,0.000026842217,0.00008056681,0.000021706912,0.00003744462],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99881095,0.00007749569,0.00033005225,0.00023717279,0.00033544333,0.00020886224],"domain_scores_gemma":[0.9993159,0.00008088763,0.00006761352,0.00039740876,0.0000817991,0.000056364846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023552455,0.00014329467,0.00024710118,0.00014402656,0.00006244263,0.0000115942175,0.00012138894,0.00013486734,0.00004517652],"category_scores_gemma":[0.000035921472,0.00010841998,0.00015169637,0.00045012686,0.000079573234,0.000063852916,0.000010558597,0.00025387423,0.000013395813],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007470441,0.0025814935,0.0024976146,0.0001343167,0.00011791782,0.00007781677,0.0019103595,0.00020946788,0.9911965,0.00081689475,0.00014858399,0.0002342907],"study_design_scores_gemma":[0.016438568,0.00037060652,0.16712616,0.00028574542,0.000863568,0.00017933783,0.0012814098,0.0000027985604,0.8114729,0.0015609761,0.00025124027,0.00016672097],"about_ca_topic_score_codex":0.0000706124,"about_ca_topic_score_gemma":0.00031624804,"teacher_disagreement_score":0.17972368,"about_ca_system_score_codex":0.000026502974,"about_ca_system_score_gemma":0.00011794711,"threshold_uncertainty_score":0.44212386},"labels":[],"label_agreement":null},{"id":"W2555379581","doi":"10.1182/blood.v126.23.4106.4106","title":"Age-Associated Acquired Mutations in Hematopoietic Cells Predominantly Affect Epigenetic Regulators TET2 and DNMT3A and Are Associated with Distinct Biological and Hematological Profiles","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"CEBPA; NPM1; Biology; Myeloid; Myelodysplastic syndromes; Population; Neuroblastoma RAS viral oncogene homolog; Myeloid leukemia; Genetics; Cancer research; KRAS; Oncology; Immunology; Mutation; Internal medicine; Medicine; Gene; Bone marrow; Chromosome; Karyotype","score_opus":0.030212744178972618,"score_gpt":0.2745883247164481,"score_spread":0.2443755805374755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555379581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99718547,0.0010406133,0.000010419823,0.00040199625,0.000015015695,0.0010944763,0.000037391732,0.00007264341,0.00014199161],"genre_scores_gemma":[0.99900496,0.00006781301,0.0005264824,0.000029067964,0.000017576442,0.00009531755,0.00007637103,0.000028586512,0.00015383527],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979665,0.00035260207,0.00033504062,0.0005440651,0.0003168787,0.00048488047],"domain_scores_gemma":[0.99852365,0.0006012228,0.00016207364,0.0002026173,0.00012382877,0.00038662675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006396973,0.00027690074,0.0007271691,0.00014690126,0.00010525364,0.000052000963,0.000082405684,0.00032698372,0.000011758656],"category_scores_gemma":[0.0020612539,0.00018627803,0.00003436938,0.00040762892,0.0007170564,0.000057759262,0.00015049642,0.00024627833,0.0000037392476],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002883773,0.00095284666,0.9895975,0.000115881776,0.00018858268,0.0015395028,0.000892243,0.0000010689809,0.0060974425,0.00003874312,0.00012246726,0.00016534304],"study_design_scores_gemma":[0.011041821,0.001411215,0.9758591,0.00047190711,0.00024927,0.000458961,0.0009771824,0.0002564921,0.008530978,0.00045467197,0.000009404687,0.00027896813],"about_ca_topic_score_codex":0.000027260317,"about_ca_topic_score_gemma":0.000108980064,"teacher_disagreement_score":0.013738373,"about_ca_system_score_codex":0.0001125168,"about_ca_system_score_gemma":0.00015134522,"threshold_uncertainty_score":0.7596198},"labels":[],"label_agreement":null},{"id":"W2555386364","doi":"10.1182/blood.v110.11.324.324","title":"Properties of CD34+ CML Cells That Predict Clinical Response to Tyrosine Kinase Inhibitors.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"CD38; Tyrosine kinase; Cancer research; Myeloid leukemia; Imatinib; CD34; Stem cell; Progenitor cell; Haematopoiesis; Biology; Tyrosine-kinase inhibitor; Imatinib mesylate; ABL; Signal transduction; Cell biology; Genetics; Cancer","score_opus":0.03740029712751713,"score_gpt":0.2989407790691427,"score_spread":0.26154048194162555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555386364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966301,0.000919414,0.000020379108,0.0005132383,0.00033409795,0.0008148603,0.000018652892,0.000092874754,0.0006563945],"genre_scores_gemma":[0.9956974,0.00005801907,0.0014531604,0.00032436225,0.00041640693,0.000017875333,0.000007878504,0.000041870197,0.001983058],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99798965,0.00011148394,0.00065220526,0.00037978767,0.00047367293,0.0003932063],"domain_scores_gemma":[0.9985589,0.0001901982,0.00013801518,0.0006314765,0.00011512639,0.00036631635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013319134,0.00021159118,0.00048586444,0.00015922158,0.000040385687,0.000008943926,0.00012574553,0.00018057397,0.00007117134],"category_scores_gemma":[0.00058917253,0.0001601511,0.00017370864,0.00023553001,0.0001425933,0.00005298423,0.00010868918,0.0002221362,0.00013626942],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011430618,0.004519362,0.14649615,0.00023657171,0.0003541415,0.000702965,0.000701534,0.0000021220155,0.82562697,0.000005496357,0.004517858,0.005406187],"study_design_scores_gemma":[0.01061943,0.001984941,0.09541158,0.0005316859,0.00034987455,0.000061769104,0.00009514607,0.0000055697355,0.8852347,0.0000020571235,0.005562956,0.00014027664],"about_ca_topic_score_codex":0.00007874541,"about_ca_topic_score_gemma":0.00001596179,"teacher_disagreement_score":0.05960772,"about_ca_system_score_codex":0.00018378432,"about_ca_system_score_gemma":0.00045624783,"threshold_uncertainty_score":0.65307724},"labels":[],"label_agreement":null},{"id":"W2555404791","doi":"10.1182/blood.v118.21.3277.3277","title":"Toll-Like Receptor 3 Activation Is Involved in Venous Thrombosis Development,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"TLR3; RNA; Thrombus; Inflammation; Proinflammatory cytokine; Toll-like receptor; Immunology; Biology; Medicine; Immune system; Internal medicine; Innate immune system; Biochemistry","score_opus":0.05304739432852425,"score_gpt":0.2616411365094246,"score_spread":0.20859374218090038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555404791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98659027,0.00006787672,0.000033763477,0.00026948703,0.00014827662,0.0004938448,0.000001639867,0.0000736656,0.012321163],"genre_scores_gemma":[0.993243,0.00017915362,0.0044444473,0.0016676433,0.00006834832,0.0001101808,0.000026781428,0.000028727269,0.00023176071],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893665,0.000021370624,0.0002778216,0.00028218277,0.00020438578,0.00027760057],"domain_scores_gemma":[0.9995075,0.000014823081,0.00007922146,0.00026420437,0.00004577915,0.0000884693],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001532222,0.00015035535,0.00034694117,0.00016544707,0.00006141236,0.000011414171,0.00009795002,0.00008999148,0.00091753976],"category_scores_gemma":[0.000025205452,0.00014178181,0.000051740226,0.00022536374,0.000023713359,0.00010358289,0.00006211786,0.00011409745,0.00024402869],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022868736,0.05264635,0.7446867,0.0008975068,0.0020911584,0.00007966561,0.06996201,9.880879e-7,0.04539754,0.0017685572,0.05311468,0.029126158],"study_design_scores_gemma":[0.002678241,0.0003089392,0.79783756,0.00024928877,0.00015919644,0.0000015445434,0.00065789226,0.00000198831,0.1751283,0.00010039311,0.022651557,0.00022511139],"about_ca_topic_score_codex":0.00023672266,"about_ca_topic_score_gemma":0.00008460662,"teacher_disagreement_score":0.12973076,"about_ca_system_score_codex":0.00007078931,"about_ca_system_score_gemma":0.000091560956,"threshold_uncertainty_score":0.99999577},"labels":[],"label_agreement":null},{"id":"W2555410598","doi":"10.1182/blood.v118.21.26.26","title":"Indoleamine 2,3-Dioxygenase and Peripheral Tolerance to Exogenous Factor VIII: A Multi-Centre Pilot Study","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Immunology; Immune tolerance; Peripheral tolerance; Medicine; Indoleamine 2,3-dioxygenase; Immune system; Peripheral blood mononuclear cell; Antibody; Biology; In vitro","score_opus":0.08720855550008119,"score_gpt":0.3021944321714809,"score_spread":0.2149858766713997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555410598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99741393,0.0004238665,0.000010634844,0.00010809971,0.0000440685,0.0013954255,0.00001795673,0.000066801505,0.00051919004],"genre_scores_gemma":[0.99524206,0.000027153386,0.0011622414,0.00012120556,0.00012587244,0.000046982248,0.0000053272684,0.000029889823,0.0032392547],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987991,0.000049170696,0.0001764436,0.00035170495,0.0002516069,0.00037196145],"domain_scores_gemma":[0.99917424,0.000017745646,0.000022642376,0.00030732318,0.00008091338,0.00039716225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007697987,0.00018816169,0.00029507896,0.00008733924,0.00009593166,0.000017431355,0.000084417654,0.00003825392,0.0004734749],"category_scores_gemma":[0.000047251608,0.00013702078,0.000035536166,0.00013785894,0.000039682975,0.000044672077,0.000072458184,0.00014319179,0.00008907473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014788675,0.042624634,0.8607941,0.000113411974,0.00049960986,0.0022360384,0.021142093,2.911222e-7,0.06431172,0.000003711494,0.000095860276,0.0066996478],"study_design_scores_gemma":[0.024392642,0.013418476,0.90712106,0.00007837946,0.0001237367,0.00011705823,0.0017107553,0.00003055212,0.05237887,0.0000021415453,0.00033411742,0.00029219422],"about_ca_topic_score_codex":0.00020729967,"about_ca_topic_score_gemma":0.00016849996,"teacher_disagreement_score":0.046326958,"about_ca_system_score_codex":0.000027164659,"about_ca_system_score_gemma":0.00005710291,"threshold_uncertainty_score":0.5587545},"labels":[],"label_agreement":null},{"id":"W2555413593","doi":"10.1182/blood.v110.11.1265.1265","title":"Generation of Megakaryocytes from Human Embryonic Stem Cells.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Megakaryocyte; Population; Haematopoiesis; Biology; Embryonic stem cell; Progenitor cell; Stem cell; Thrombopoietin; Embryoid body; Megakaryocytopoiesis; Immunology; Cell biology; Bone marrow; CD34; Stem cell marker; Molecular biology; Adult stem cell; Medicine; Genetics","score_opus":0.03332134618493185,"score_gpt":0.26928917491896226,"score_spread":0.2359678287340304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555413593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960588,0.0011695792,0.00004202489,0.000028138784,0.000056546538,0.0001250844,0.000012322516,0.000022670647,0.002484838],"genre_scores_gemma":[0.9986222,0.000034744833,0.00043054062,0.000049858798,0.00009348071,0.0000021190465,0.00007295855,0.000010105127,0.0006839862],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99949414,0.0000066546563,0.00014734705,0.000120850564,0.000117683325,0.00011330768],"domain_scores_gemma":[0.9997058,0.000016733356,0.00005365162,0.00014705374,0.000027471893,0.000049280563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000057454643,0.00007190329,0.00017010876,0.00004216962,0.000033648153,0.0000041498474,0.000029478435,0.000052332736,0.00006131763],"category_scores_gemma":[0.00000191831,0.0000601055,0.000048349848,0.00005640453,0.000015732729,0.000026341895,0.0000094872985,0.00004249339,0.00002319532],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032398202,0.0013776756,0.033319533,0.000022537652,0.00030526583,0.0003187447,0.00019776156,0.0000011751505,0.9606063,0.00012340947,0.00041799594,0.0032772447],"study_design_scores_gemma":[0.003914511,0.00022483969,0.024818312,0.000023412618,0.00026941427,0.000012308401,0.000049498074,0.000016434382,0.97019726,0.000059261838,0.00035506775,0.00005970855],"about_ca_topic_score_codex":0.00012792386,"about_ca_topic_score_gemma":0.000097548276,"teacher_disagreement_score":0.009590972,"about_ca_system_score_codex":0.000010794475,"about_ca_system_score_gemma":0.000017822893,"threshold_uncertainty_score":0.2451031},"labels":[],"label_agreement":null},{"id":"W2555424733","doi":"10.1182/blood.v126.23.722.722","title":"Identification of Initiating Trunk Mutations and Distinct Molecular Subtypes: An Interim Analysis of the Mmrf Commpass Study","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neuroblastoma RAS viral oncogene homolog; KRAS; Multiple myeloma; Interim analysis; Oncology; Internal medicine; Cohort; Medicine; Exome sequencing; Clinical trial; Biology; Mutation; Cancer; Genetics; Gene","score_opus":0.05618595741210662,"score_gpt":0.36633362297908895,"score_spread":0.3101476655669823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555424733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992454,0.000055052187,0.0001277291,0.000042206524,0.000009654399,0.00031738548,0.000033463723,0.0000065713157,0.00016250748],"genre_scores_gemma":[0.9997952,9.075089e-7,0.00009843989,0.0000049692517,0.0000052759524,0.000018833094,0.000059194113,0.0000052005103,0.000011985308],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999231,0.00013076929,0.00022666743,0.00010882181,0.00023375872,0.000068980866],"domain_scores_gemma":[0.99929017,0.000050128154,0.00012073118,0.00028654266,0.00017644696,0.00007597686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024173273,0.000052009946,0.0001794566,0.000120831064,0.000032190837,0.000009545239,0.000064838445,0.000016297481,0.0000071601935],"category_scores_gemma":[0.0003946404,0.000035296955,0.000047123805,0.00040069182,0.000060462084,0.000040353087,0.00003762873,0.000045024914,6.3455764e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005021904,0.002464113,0.9771169,0.000023585033,0.0014841504,0.000012512525,0.0025725658,0.000010133357,0.015560471,0.000029630932,0.0000012517382,0.00067448494],"study_design_scores_gemma":[0.0026094473,0.00049122894,0.9683256,0.000014518909,0.0024133143,0.0000032843657,0.0028987217,0.0018240572,0.021353772,0.00003617842,8.21093e-7,0.000029038461],"about_ca_topic_score_codex":0.00025220553,"about_ca_topic_score_gemma":0.00021972257,"teacher_disagreement_score":0.008791263,"about_ca_system_score_codex":0.0000113140095,"about_ca_system_score_gemma":0.000044555887,"threshold_uncertainty_score":0.1439368},"labels":[],"label_agreement":null},{"id":"W2555439343","doi":"10.1182/blood.v104.11.4585.4585","title":"Predicting Risk of Febrile Neutropenia after CHOP Chemotherapy.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Internal medicine; Febrile neutropenia; Rituximab; Neutropenia; CHOP; Gastroenterology; Chemotherapy; Absolute neutrophil count; International Prognostic Index; Performance status; Bone marrow; Lymphoma; Surgery","score_opus":0.005921873562251743,"score_gpt":0.23464812529431667,"score_spread":0.22872625173206493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555439343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991823,0.000354551,0.000043791104,0.00025513998,0.00011387665,0.00025261263,0.000017175387,0.00006785654,0.007071962],"genre_scores_gemma":[0.9983391,0.00018743482,0.00048785633,0.00028330577,0.00030939927,0.0000478921,0.000002564284,0.000025189504,0.00031723047],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993269,0.000013683849,0.00018638262,0.00016989975,0.00013928108,0.00016384856],"domain_scores_gemma":[0.9995018,0.000012536965,0.00008191204,0.0002614567,0.000059228314,0.000083056046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000065861925,0.00009931147,0.00020187427,0.000052412805,0.000048807386,0.0000087795415,0.00005068868,0.00005172903,0.00032696975],"category_scores_gemma":[0.00001828334,0.00008413573,0.00010978282,0.00016374765,0.00004498641,0.000057823796,0.000019640527,0.00015849803,0.000042982945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024328464,0.00087472197,0.9623946,0.00007287269,0.00027583723,0.000034909368,0.00042067876,0.000036938065,0.03398536,0.00007081128,0.00010369372,0.0014862869],"study_design_scores_gemma":[0.010184553,0.0005458708,0.83775127,0.00015252586,0.00059620035,0.00015356397,0.000049020786,0.0000020052244,0.1466708,0.00014447935,0.0036244711,0.00012525672],"about_ca_topic_score_codex":0.00032069272,"about_ca_topic_score_gemma":0.00006124523,"teacher_disagreement_score":0.12464335,"about_ca_system_score_codex":0.000024489213,"about_ca_system_score_gemma":0.000086706,"threshold_uncertainty_score":0.35800892},"labels":[],"label_agreement":null},{"id":"W2555449661","doi":"10.1182/blood.v104.11.2983.2983","title":"A New Functional Coagulation Assay for Measurement of Total Factor V Activity in Human Plasma and Its Application to Samples from Patients with Disseminated Intravascular Coagulation.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Thrombin; Chemistry; Coagulation; Tissue factor; Protein C; Fibrinogen; Factor V; Clotting factor; Prothrombinase; Thromboplastin; Platelet; Biochemistry; Internal medicine; Medicine; Thrombosis","score_opus":0.028580488466196954,"score_gpt":0.25035865922135314,"score_spread":0.22177817075515618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555449661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9101495,0.000022147726,0.08821166,0.00010703654,0.000028160459,0.0013869011,0.000057111814,0.000028743974,0.000008702782],"genre_scores_gemma":[0.9964517,7.5026935e-7,0.0030861716,0.000016637048,0.000045848265,0.00008372469,0.00028864067,0.000019422296,0.000007158991],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988262,0.00002523318,0.00025280338,0.0002970923,0.0004686492,0.00012999194],"domain_scores_gemma":[0.9992807,0.000039125152,0.00012972308,0.00015147602,0.00027335843,0.00012560595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013734461,0.00014449339,0.00028009596,0.00012965583,0.00005948424,0.000011541737,0.000028977598,0.000092195136,0.000024937344],"category_scores_gemma":[0.00007352914,0.00013151618,0.000040659143,0.00018044964,0.00001103216,0.00010629769,0.000015871745,0.00006258239,0.0000013958481],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004997304,0.0016618,0.074505985,0.000079327874,0.0002547016,3.1871528e-7,0.0003858589,0.00087989465,0.9142647,0.0015441922,0.000005784421,0.0059177363],"study_design_scores_gemma":[0.0077110017,0.0003600956,0.6800989,0.00010868564,0.00014910683,6.662973e-7,0.000015883967,0.0002775578,0.31089815,0.00027541615,0.000005206054,0.00009932365],"about_ca_topic_score_codex":0.00020972393,"about_ca_topic_score_gemma":0.00026464002,"teacher_disagreement_score":0.6055929,"about_ca_system_score_codex":0.00007989843,"about_ca_system_score_gemma":0.00008142135,"threshold_uncertainty_score":0.53630745},"labels":[],"label_agreement":null},{"id":"W2555465584","doi":"10.1182/blood.v124.21.4179.4179","title":"Gas6 Is Required for Thrombin-Induced Expression of VCAM-1 through Foxo-1 in Endothelial Cells","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Royal Victoria Hospital; McGill University","funders":"","keywords":"Phosphorylation; Thrombin; Protein kinase B; PI3K/AKT/mTOR pathway; Cell adhesion molecule; Cell biology; Cell adhesion; Gene silencing; Biology; Small interfering RNA; Transfection; Thrombomodulin; Endothelial stem cell; Molecular biology; Signal transduction; Cancer research; Platelet; Immunology; Cell culture; Cell; Biochemistry; In vitro","score_opus":0.02280194278170644,"score_gpt":0.2563739107242832,"score_spread":0.23357196794257679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555465584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967821,0.0005116743,0.00061419635,0.00006626238,0.00042587024,0.00035169607,0.00004303532,0.000024875482,0.0011802947],"genre_scores_gemma":[0.99903846,0.000040314542,0.00043454854,0.00007487302,0.000041223357,0.000036252153,0.000043658616,0.000017258959,0.0002734031],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99902743,0.000100911944,0.00035028622,0.00023638328,0.000031988613,0.00025297588],"domain_scores_gemma":[0.9993444,0.00013155294,0.00017492304,0.00029586387,0.00004461461,0.0000086366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020357511,0.0001320747,0.0003195253,0.000055241104,0.00006752221,0.000005320032,0.00015923234,0.00023157576,0.00010537248],"category_scores_gemma":[0.0000526975,0.00011536236,0.000113021204,0.00007057971,0.00005626389,0.000117572956,0.000047842,0.00009006932,0.000044574776],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009637351,0.00048685752,0.00019106669,0.000027369062,0.000033164437,1.2629738e-7,0.0006769062,9.075307e-7,0.9961418,0.0008269694,0.0008142902,0.00070416747],"study_design_scores_gemma":[0.0054555773,0.0003425452,0.0011849169,0.0000778659,0.000040694857,0.0000046553837,0.000049776096,0.0000052144806,0.9860331,0.0015765678,0.0051057218,0.00012340937],"about_ca_topic_score_codex":0.000060476672,"about_ca_topic_score_gemma":0.000005154462,"teacher_disagreement_score":0.010108747,"about_ca_system_score_codex":0.000011015135,"about_ca_system_score_gemma":0.000026136751,"threshold_uncertainty_score":0.47043404},"labels":[],"label_agreement":null},{"id":"W2555473291","doi":"10.1182/blood.v124.21.2238.2238","title":"Aldehyde Dehydrogenases Play a Role in Acute Myeloid Leukemia and Have Prognostic and Therapeutic Significance","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Aldehyde dehydrogenase; CD34; Haematopoiesis; Stem cell; Cancer research; Myeloid leukemia; Biology; Leukemia; Flow cytometry; Acute leukemia; Molecular biology; Chemistry; Immunology; Cell biology; Biochemistry; Enzyme","score_opus":0.011979279263112815,"score_gpt":0.2615263201239825,"score_spread":0.2495470408608697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555473291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943663,0.0025923941,0.000034928526,0.0004500217,0.000014414113,0.00076966,0.000010115338,0.00006437229,0.0016978219],"genre_scores_gemma":[0.99757445,0.00046261304,0.0007024636,0.0005458977,0.000108217275,0.00013181569,0.000013425682,0.00004530668,0.00041579697],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983549,0.00011212506,0.00025559362,0.0004875773,0.00029145947,0.00049831264],"domain_scores_gemma":[0.99895215,0.00035540274,0.000058028058,0.00032554977,0.000050429615,0.000258448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003531493,0.00023114044,0.0003937142,0.00017836038,0.0000783177,0.000043132193,0.00011865443,0.00014452646,0.000020635729],"category_scores_gemma":[0.00020938457,0.00019376782,0.000038849288,0.00019282298,0.00022293873,0.000064579064,0.00010156223,0.0003895465,0.000020489259],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005055622,0.0005282619,0.6138126,0.0003008293,0.0005423421,0.0005423957,0.002002705,0.000009197645,0.35427698,0.00053267146,0.00014739374,0.026799046],"study_design_scores_gemma":[0.028816491,0.002902591,0.6488693,0.00063414057,0.0014733606,0.002286484,0.00089507835,0.015448695,0.28843474,0.002928968,0.006226378,0.001083792],"about_ca_topic_score_codex":0.00019363905,"about_ca_topic_score_gemma":0.000122043464,"teacher_disagreement_score":0.06584224,"about_ca_system_score_codex":0.00011170097,"about_ca_system_score_gemma":0.00027524834,"threshold_uncertainty_score":0.7901622},"labels":[],"label_agreement":null},{"id":"W2555484425","doi":"10.1182/blood.v118.21.1875.1875","title":"Unfavorable Cytogenetic Characteristics Do Not Adversely Impact Response Rates in Patients with Relapsed and/or Refractory Multiple Myeloma Treated with Single-Agent Carfilzomib on the 003 (A1) Study","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Calgary; Princess Margaret Cancer Centre","funders":"","keywords":"Carfilzomib; Multiple myeloma; Medicine; Internal medicine; Refractory (planetary science); Fluorescence in situ hybridization; Oncology; Transplantation; Lenalidomide; Gastroenterology; Biology","score_opus":0.04537408221526898,"score_gpt":0.2718674968393186,"score_spread":0.22649341462404962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555484425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970489,0.00003460753,6.3118773e-7,0.0000344476,0.000017572735,0.0025704815,0.00010717755,0.000047519232,0.00013863097],"genre_scores_gemma":[0.9991151,0.000016023027,0.00020125727,0.000055256776,0.000018979757,0.00015635705,0.00006612302,0.000070210735,0.0003006922],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975395,0.00048562023,0.00033344148,0.0005227961,0.0005675997,0.00055105024],"domain_scores_gemma":[0.9982229,0.00043864007,0.0001639575,0.0006739949,0.00017603893,0.00032447686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003642644,0.0003972474,0.00049217645,0.0002369867,0.00016139566,0.000043584296,0.00013413084,0.00009102292,0.00013004955],"category_scores_gemma":[0.0004890889,0.00019106081,0.00005188849,0.00037813303,0.0001330455,0.00008716952,0.000053535823,0.00030253583,0.000032070406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10664084,0.011081389,0.87578696,0.00001917484,0.00062196,0.0010193061,0.0014910992,8.1617634e-7,0.0023240244,4.2178732e-7,0.000011281774,0.0010027485],"study_design_scores_gemma":[0.037405796,0.03223515,0.9195157,0.00021640718,0.00030547738,0.000021018473,0.00058700563,0.000019383908,0.009451386,5.392068e-7,0.000023095814,0.00021904304],"about_ca_topic_score_codex":0.0005286345,"about_ca_topic_score_gemma":0.00023209772,"teacher_disagreement_score":0.06923504,"about_ca_system_score_codex":0.00018391613,"about_ca_system_score_gemma":0.00021697363,"threshold_uncertainty_score":0.77912337},"labels":[],"label_agreement":null},{"id":"W2555499891","doi":"10.1182/blood.v112.11.1688.1688","title":"HLA Specificities and Predisposition to the Development of Multiple Myeloma (MM).","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Human leukocyte antigen; Haplotype; Immunology; Allele; Population; Medicine; Allele frequency; Linkage disequilibrium; Typing; Biology; Genetics; Antigen; Gene","score_opus":0.036371028711575,"score_gpt":0.27140737298833717,"score_spread":0.23503634427676218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555499891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997299,0.00026617263,0.00011989926,0.00023844051,0.00002148645,0.00045897515,0.00001599514,0.00001945967,0.0015605612],"genre_scores_gemma":[0.9925714,0.000039727267,0.0065959115,0.000035217596,0.00006861108,0.000049135277,0.000025777857,0.000009153509,0.0006050483],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992548,0.000019721496,0.00016289117,0.00013683266,0.00025836175,0.00016736421],"domain_scores_gemma":[0.99956447,0.000061513834,0.000026136415,0.0001628458,0.000061356644,0.00012367232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007650106,0.00008198533,0.00013560808,0.00006191253,0.00014164903,0.000005677974,0.000048371632,0.000027689515,0.000033391527],"category_scores_gemma":[0.00006763981,0.00005235529,0.000026826381,0.000088763474,0.00006178525,0.000035140314,0.00004698202,0.000054563185,0.000032659947],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001060723,0.0023044029,0.88077843,0.00022649382,0.0006842258,0.0002842886,0.014997749,0.0000044879507,0.054875087,0.000096493255,0.0010783327,0.043609273],"study_design_scores_gemma":[0.0028171209,0.00023442169,0.869538,0.000056509154,0.000032579854,0.000116347604,0.0002946865,0.000038755996,0.12473393,0.0000057516377,0.0020762195,0.000055639994],"about_ca_topic_score_codex":0.000022060816,"about_ca_topic_score_gemma":0.0000567401,"teacher_disagreement_score":0.06985884,"about_ca_system_score_codex":0.000016955299,"about_ca_system_score_gemma":0.0000763123,"threshold_uncertainty_score":0.21349868},"labels":[],"label_agreement":null},{"id":"W2555521441","doi":"10.1182/blood.v120.21.3540.3540","title":"A Novel Model of Immune-Mediated Disease Equilibrium in Acute Lymphoblastic Leukemia","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; University of British Columbia","funders":"","keywords":"Leukemia; Adoptive cell transfer; Immune system; Cancer research; Biology; Cytotoxic T cell; Immunology; Bone marrow; Minimal residual disease; Antigen; Molecular biology; T cell; Medicine; In vitro","score_opus":0.016438984784405964,"score_gpt":0.26828265481821884,"score_spread":0.25184367003381286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555521441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972185,0.001926349,0.00034297523,0.000025975642,0.000035333287,0.00016856543,0.00012093424,0.000009254625,0.0001521385],"genre_scores_gemma":[0.9991105,0.00010651293,0.0002609409,0.00007017004,0.00007722953,0.00003613258,0.00013414957,0.000031870182,0.00017246057],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998911,0.000038232305,0.00024035151,0.00020872816,0.0001793191,0.00042237516],"domain_scores_gemma":[0.9992633,0.000015162655,0.000061617626,0.0004210725,0.000050067356,0.00018880327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021073595,0.00013912903,0.00016199474,0.000074217605,0.000016043128,0.000006087204,0.00024219713,0.00010176144,0.000016469377],"category_scores_gemma":[0.00009119533,0.00013638406,0.00009196717,0.00013580396,0.00007721626,0.0000065075424,0.00015591289,0.00007370341,0.0000144158275],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011633458,0.000560221,0.0037180493,0.000024610476,0.00009376127,0.0000021752928,0.00003740931,0.00114179,0.9931493,0.000009358345,0.0000271194,0.000072871386],"study_design_scores_gemma":[0.0038181997,0.0004667282,0.0047709956,0.000018910287,0.0000610071,0.0000049199616,0.000009658366,0.006510815,0.984083,0.000020395479,0.000036119465,0.0001992755],"about_ca_topic_score_codex":0.000017846607,"about_ca_topic_score_gemma":0.000013717271,"teacher_disagreement_score":0.0090663135,"about_ca_system_score_codex":0.000025975518,"about_ca_system_score_gemma":0.00037573735,"threshold_uncertainty_score":0.55615807},"labels":[],"label_agreement":null},{"id":"W2555526897","doi":"10.1182/blood.v118.21.1024.1024","title":"The Multiple Myeloma Research Consortium (MMRC): Accelerated Start up and Accrual Metrics Speeds Drug Development","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Biosimilar; Clinical trial; Receipt; Family medicine; Internal medicine; Computer science","score_opus":0.1733591990452234,"score_gpt":0.3415105808589491,"score_spread":0.1681513818137257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555526897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98872656,0.005294336,0.0000519865,0.00050843245,0.0005453987,0.00036101084,0.00001838079,0.000060893628,0.0044330326],"genre_scores_gemma":[0.9896824,0.0002741874,0.0034798253,0.00013250216,0.000029541556,0.000020352012,0.000010230321,0.000015408707,0.006355573],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99806815,0.00057452335,0.00033780246,0.00033140686,0.00009146789,0.00059665926],"domain_scores_gemma":[0.9985172,0.0008221873,0.000063626394,0.00028933169,0.00024408744,0.0000635797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021659283,0.00016272021,0.00022442792,0.00014529575,0.00068030425,0.000051776682,0.00033739518,0.0002367884,0.00035854813],"category_scores_gemma":[0.0006836309,0.00010111296,0.000043419597,0.0004874807,0.00065466913,0.000051847008,0.00030854528,0.0005348767,0.00012424459],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019624103,0.0034312117,0.27426392,0.0001151885,0.0038210445,0.00011306924,0.010353401,6.323875e-8,0.39614928,0.008567308,0.063750766,0.23747233],"study_design_scores_gemma":[0.0020301885,0.0001367105,0.071533754,0.000013538566,0.000072357485,0.000035601977,0.0010814801,0.0000035020792,0.77317053,0.00030034315,0.15140551,0.00021645451],"about_ca_topic_score_codex":0.00006226346,"about_ca_topic_score_gemma":0.00014040974,"teacher_disagreement_score":0.37702125,"about_ca_system_score_codex":0.000018365126,"about_ca_system_score_gemma":0.0001335014,"threshold_uncertainty_score":0.52324194},"labels":[],"label_agreement":null},{"id":"W2555574679","doi":"10.1182/blood.v114.22.2923.2923","title":"The Percentage of Cytotoxic T-Cells in Mantle Cell Lymphoma (MCL) Biopsies Predicts Response to Rituximab.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Mantle cell lymphoma; Follicular lymphoma; Medicine; Lymphoma; Rituximab; Biopsy; Pathology; Bone marrow; Cyclin D1; Survivin; CD8; Gene signature; Immunophenotyping; Cancer research; Biology; Internal medicine; Immunology; Flow cytometry; Cancer; Cell cycle; Gene expression; Immune system","score_opus":0.00752316400009752,"score_gpt":0.23580274760942868,"score_spread":0.22827958360933115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555574679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99487007,0.0011194807,4.9411994e-7,0.0014168009,0.00006348416,0.00056948065,0.00003388613,0.00003935291,0.0018869826],"genre_scores_gemma":[0.99830294,0.0002874729,0.00021098854,0.00048450692,0.00003284379,0.00003755758,0.0000055816763,0.000013005508,0.0006251322],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998858,0.0000759564,0.00028533704,0.00023081672,0.0002577712,0.000292147],"domain_scores_gemma":[0.99919295,0.0001862204,0.000057184352,0.00041992503,0.000030724517,0.00011302142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022671859,0.00015451937,0.0002776853,0.000113966904,0.000063959356,0.00001897499,0.00012326018,0.00006746036,0.000018041197],"category_scores_gemma":[0.000051236006,0.000101822865,0.00009488538,0.00017641463,0.00004574863,0.000031541607,0.000036141293,0.00003740593,0.00010122146],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055466653,0.039140195,0.062439453,0.000095588,0.000160013,0.0012727189,0.0024846748,0.0000072621297,0.8652819,0.00011674868,0.005270109,0.018184667],"study_design_scores_gemma":[0.015985455,0.001255999,0.44971514,0.00013121436,0.000107509695,0.000039152805,0.00026271818,0.0000087494755,0.52721465,0.0000133359235,0.005173441,0.000092641865],"about_ca_topic_score_codex":0.0000530404,"about_ca_topic_score_gemma":0.00001662363,"teacher_disagreement_score":0.3872757,"about_ca_system_score_codex":0.00009427878,"about_ca_system_score_gemma":0.0001075691,"threshold_uncertainty_score":0.4152216},"labels":[],"label_agreement":null},{"id":"W2555600028","doi":"10.1182/blood.v104.11.1052.1052","title":"The Use of a Clinical Prediction Model and D-Dimer (DD) Testing in the Diagnosis of Deep Vein Thrombosis (DVT): A Systematic Review.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Pre- and post-test probability; Clinical prediction rule; Deep vein; MEDLINE; Clinical trial; Thrombosis; Prospective cohort study; Internal medicine; Surgery","score_opus":0.11496958588408367,"score_gpt":0.3468443392933053,"score_spread":0.23187475340922165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555600028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98390657,0.01163386,0.00014001028,0.0014001529,0.000047200727,0.002651864,0.0000088500055,0.000019446801,0.00019204545],"genre_scores_gemma":[0.98063666,0.01652505,0.0015102105,0.0008691509,0.00003275087,0.0004048995,0.0000028873767,0.000014317063,0.0000040890413],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99806416,0.00019077508,0.0010551313,0.00019234986,0.00033461145,0.00016294626],"domain_scores_gemma":[0.9978469,0.0011318043,0.00037939384,0.0004897595,0.00010765407,0.000044514672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016481539,0.00011805116,0.0008395781,0.000048603397,0.000064645385,0.000016051148,0.0001320318,0.00006100158,0.0000018654031],"category_scores_gemma":[0.0030071582,0.00006492355,0.00012751488,0.00027142334,0.00011007609,0.00007294835,0.00006497704,0.0001520608,0.0000013910551],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008626014,0.028239358,0.5377014,0.40271097,0.0035370616,0.000056338893,0.007292541,0.0048066205,0.00050414866,0.0059650587,0.0029075206,0.0061926874],"study_design_scores_gemma":[0.00890799,0.0025922013,0.7400021,0.21016665,0.018251473,0.00006251771,0.0011296646,0.01672804,0.00049860636,0.0012068328,0.000088614055,0.0003653307],"about_ca_topic_score_codex":0.00017913149,"about_ca_topic_score_gemma":0.00008368628,"teacher_disagreement_score":0.20230064,"about_ca_system_score_codex":0.000012228583,"about_ca_system_score_gemma":0.000044913835,"threshold_uncertainty_score":0.36000663},"labels":[],"label_agreement":null},{"id":"W2555604935","doi":"10.1182/blood.v106.11.2170.2170","title":"Monoclonal IgG Specific for the CD44 Antigen Mimics the Action of IVIg in the Amelioration of ITP.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; St. Michael's Hospital","funders":"","keywords":"Antibody; Monoclonal antibody; Immunology; Medicine; Antigen; Blocking antibody; CD44; Immune system; Receptor; In vitro; Chemistry; Internal medicine","score_opus":0.04500788207435224,"score_gpt":0.29979442623318264,"score_spread":0.2547865441588304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555604935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951798,0.0010453972,0.00013965795,0.0026938012,0.000033743563,0.0005165015,0.000014583158,0.0000035176508,0.00037299815],"genre_scores_gemma":[0.99871,0.00072339433,0.0002563145,0.00012561164,0.000093874594,0.000025203324,0.000020844956,0.000005461089,0.00003932911],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99955964,0.000020605674,0.00014669915,0.000069658374,0.00012465958,0.000078758276],"domain_scores_gemma":[0.9995806,0.00012372897,0.00007827249,0.00017500515,0.00003437548,0.000007988359],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016554385,0.000055264158,0.00010764672,0.000025305946,0.00004600433,0.000005414432,0.000072520976,0.000031549083,0.000011854801],"category_scores_gemma":[0.00001752843,0.000024876721,0.000057167526,0.000109145614,0.000036944664,0.00003174725,0.0000061010355,0.00005717847,0.0000028988038],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031139357,0.021520179,0.23759367,0.0003695016,0.0023923283,0.00007793366,0.02435485,0.0011435174,0.19058007,0.0063595804,0.015604337,0.4968901],"study_design_scores_gemma":[0.018243985,0.0013600904,0.6649409,0.00014699207,0.0010243645,0.00019782675,0.0069530923,0.0031485346,0.2426188,0.002266401,0.05886084,0.00023819719],"about_ca_topic_score_codex":0.000055317236,"about_ca_topic_score_gemma":0.00017053931,"teacher_disagreement_score":0.4966519,"about_ca_system_score_codex":0.0000076162687,"about_ca_system_score_gemma":0.000022978322,"threshold_uncertainty_score":0.10144433},"labels":[],"label_agreement":null},{"id":"W2555608740","doi":"10.1182/blood.v104.11.3147.3147","title":"An Operational Definition of Cobalamin Replacement Based upon Administrative Health Data.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Manitoba Health; University of Manitoba","funders":"","keywords":"Medicine; Medical prescription; Anemia; Pediatrics; Vitamin B12; Cobalamin; Emergency medicine; Internal medicine","score_opus":0.1279759378210989,"score_gpt":0.4045022691768891,"score_spread":0.2765263313557902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555608740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99398035,0.00012599319,0.0006686383,0.0025819242,0.000021610576,0.0004023711,0.00025579552,0.000021260228,0.0019420362],"genre_scores_gemma":[0.9865876,0.000029115216,0.010270934,0.00046413843,0.000053933378,0.000011050142,0.0025434871,0.00000770518,0.00003207358],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990122,0.000052378615,0.0002226903,0.00022069177,0.00034672534,0.00014531444],"domain_scores_gemma":[0.9992659,0.000024567738,0.000052586052,0.00043401902,0.00010183373,0.00012107018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037937984,0.000068472335,0.00014846679,0.00006183392,0.000055204553,0.000011014998,0.00009271184,0.000037615864,0.00012786832],"category_scores_gemma":[0.00006374029,0.000058856524,0.000019728417,0.00011646419,0.000037828006,0.00009989487,0.00002120787,0.00009271581,0.00001725215],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011670618,0.13223761,0.12779298,0.0041374145,0.002091671,0.0010229262,0.0056990967,0.00048651863,0.5702753,0.11755117,0.012699103,0.014335557],"study_design_scores_gemma":[0.07528889,0.060981873,0.23742338,0.0012788525,0.00043932867,0.00036976073,0.0017865313,0.003177545,0.61283267,0.0013778475,0.004310217,0.0007331366],"about_ca_topic_score_codex":0.00013846938,"about_ca_topic_score_gemma":0.00015255986,"teacher_disagreement_score":0.11617333,"about_ca_system_score_codex":0.00004345243,"about_ca_system_score_gemma":0.0011991017,"threshold_uncertainty_score":0.24000993},"labels":[],"label_agreement":null},{"id":"W2555628542","doi":"10.1182/blood.v116.21.2767.2767","title":"Lack of IL-7 Receptor Alpha Chain (CD127) Expression In T Cells Is a Hallmark of T-Cell Immunodeficiency In Schimke Immuno-Osseous Dysplasia (SIOD)","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Interleukin-7 receptor; Common gamma chain; Biology; Immunodeficiency; Immunology; Severe combined immunodeficiency; Receptor; T cell; Molecular biology; IL-2 receptor; Immune system; Genetics; Gene; Interleukin 10","score_opus":0.00761097727388331,"score_gpt":0.22315001363237916,"score_spread":0.21553903635849586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555628542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9771276,0.018174235,0.000012159415,0.000055904187,0.0009325777,0.0004899535,0.00009362737,0.00003799021,0.0030759238],"genre_scores_gemma":[0.9979778,0.00067550945,0.00023843037,0.000049620237,0.0000037211996,0.000037795835,0.000064887914,0.00004097547,0.0009112509],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970183,0.0002732294,0.0012633456,0.00056675664,0.0001270312,0.0007513875],"domain_scores_gemma":[0.99817586,0.0002402342,0.0005389941,0.00093338743,0.00009896211,0.000012588803],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008444237,0.00040135297,0.0008037677,0.0005088755,0.00012636576,0.000012768009,0.0009089951,0.0006512681,0.000926952],"category_scores_gemma":[0.00013779745,0.0003826572,0.00023358373,0.000609393,0.0005416408,0.0001650528,0.00025281284,0.0010716454,0.00020836978],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028290614,0.004011497,0.0023538272,0.00012276837,0.000037018046,0.0000057775324,0.0034438323,0.000017029637,0.98788786,0.00013070356,0.000054980395,0.0016517891],"study_design_scores_gemma":[0.006512662,0.00032271352,0.007596377,0.00025992998,0.000033359447,0.000013756204,0.001416959,0.000011682711,0.9802711,0.000090111964,0.0030863036,0.00038504286],"about_ca_topic_score_codex":0.00067173317,"about_ca_topic_score_gemma":0.000035917492,"teacher_disagreement_score":0.02085018,"about_ca_system_score_codex":0.000019385874,"about_ca_system_score_gemma":0.00018852075,"threshold_uncertainty_score":0.99998635},"labels":[],"label_agreement":null},{"id":"W2555639438","doi":"10.1182/blood.v120.21.3943.3943","title":"Lenalidomide Suppresses 5′-Cap-Independent C-MYC Translation in Multiple Myeloma Cells","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Cereblon; Ubiquitin ligase; Biology; Molecular biology; Ubiquitin; Lenalidomide; Cancer research; Cell biology; Multiple myeloma; Biochemistry; Immunology","score_opus":0.016647545131635143,"score_gpt":0.22920755773049106,"score_spread":0.21256001259885593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555639438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962325,0.0016127091,0.00040490317,0.00006205409,0.00018519381,0.00020246435,0.000014521331,0.000013033602,0.0012726374],"genre_scores_gemma":[0.99830896,0.0000872689,0.00084228447,0.00008484521,0.0002950001,0.000028847462,0.00009626069,0.000014960629,0.00024158545],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992483,0.000058318798,0.00017707312,0.00017170572,0.0001133342,0.00023123917],"domain_scores_gemma":[0.9996602,0.000014897129,0.000045705732,0.00018410057,0.00002172167,0.00007337248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015744544,0.00010624387,0.00008839661,0.000043855012,0.00003473694,0.000014909786,0.00009582525,0.00012419249,0.000049543873],"category_scores_gemma":[0.00004722446,0.000103529324,0.000055540735,0.00006022464,0.000022261884,0.000011319544,0.000027727005,0.00006713969,0.000031391788],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003265201,0.0002805879,0.01672343,0.000011146212,0.000015814088,0.0000010915949,0.000089775,0.0000112055895,0.9810613,0.000016160222,0.00042507154,0.0013317905],"study_design_scores_gemma":[0.0016579435,0.0000430781,0.007810924,0.000008516858,0.000012208657,0.0000058806368,0.000045244524,0.0000151681115,0.9700295,0.000009615954,0.02022795,0.00013401767],"about_ca_topic_score_codex":0.000026307118,"about_ca_topic_score_gemma":0.000070318754,"teacher_disagreement_score":0.019802878,"about_ca_system_score_codex":0.0000052115493,"about_ca_system_score_gemma":0.000022153521,"threshold_uncertainty_score":0.42218032},"labels":[],"label_agreement":null},{"id":"W2555641563","doi":"10.1182/blood.v122.21.50.50","title":"Leukemic Engraftment In NOD.SCID Mice Is Correlated With Clinical Parameters and Predicts Outcome In Human AML","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"CD33; Bone marrow; Xenotransplantation; Nod; Leukemia; Myeloid; Myeloid leukemia; CD19; Transplantation; Immunophenotyping; Medicine; Flow cytometry; CD34; Severe combined immunodeficiency; Immunology; Cancer research; Biology; Stem cell; Internal medicine; In vivo","score_opus":0.019343205286841265,"score_gpt":0.27582303053355,"score_spread":0.25647982524670876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555641563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992429,0.0002071358,0.000009810454,0.00007490854,0.00004225648,0.00024291483,0.000005481433,0.0000061794603,0.00016841723],"genre_scores_gemma":[0.9987712,0.0001263508,0.00020567741,0.00052769354,0.000025178611,0.00003555079,0.000039804174,0.000011146106,0.00025742335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999038,0.000049693288,0.00031841936,0.00032753707,0.00006710173,0.00019929702],"domain_scores_gemma":[0.99963266,0.000013659761,0.000061385224,0.00019746431,0.00002860832,0.00006621843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000121091776,0.00012627312,0.00017100449,0.000048598344,0.000019568588,0.000019035531,0.000114494454,0.00016092234,0.000019442625],"category_scores_gemma":[0.000022859153,0.0001046956,0.000036605346,0.000057046,0.00007410856,0.000005263635,0.00006531562,0.00014974507,0.00002432795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050915718,0.00028991493,0.8166235,0.000010815435,0.00006354074,0.000016916812,0.00011074887,0.000011082771,0.18201444,0.0000017377087,0.00040888056,0.0003975222],"study_design_scores_gemma":[0.0075706835,0.002128242,0.85978806,0.000104219995,0.0000673168,0.000038538838,0.0002209818,0.0001666805,0.12912981,0.000051463157,0.00033432155,0.000399699],"about_ca_topic_score_codex":0.0003308098,"about_ca_topic_score_gemma":0.00018779974,"teacher_disagreement_score":0.052884627,"about_ca_system_score_codex":0.00000872155,"about_ca_system_score_gemma":0.000028495098,"threshold_uncertainty_score":0.4269363},"labels":[],"label_agreement":null},{"id":"W2555658602","doi":"10.1182/blood.v108.11.1041.1041","title":"Clinical Implications of Pharmacokinetic Variables in the Management of Patients with Severe Hemophilia A.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Pharmacokinetics; Analysis of variance; Internal medicine; Pediatrics; Clinical trial; Gastroenterology","score_opus":0.022932394048787455,"score_gpt":0.3262391989715722,"score_spread":0.3033068049227848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555658602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98594016,0.00008096013,0.0000057484453,0.0006819169,0.000008951968,0.00058205985,0.000016730479,0.000005244346,0.012678201],"genre_scores_gemma":[0.9984781,0.00005821536,0.0009809281,0.000030968557,0.000028254062,0.000029241666,0.000049384777,0.000006271527,0.00033859315],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992341,0.000040474868,0.00026604618,0.0001184168,0.00022429645,0.00011671297],"domain_scores_gemma":[0.9995389,0.00006680101,0.000055523637,0.00024494925,0.00006936293,0.000024478773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018265404,0.000061007606,0.0001545657,0.000049552335,0.000016638827,0.000002050093,0.00009727173,0.000029331113,0.000037640075],"category_scores_gemma":[0.0000043133296,0.00003306657,0.00004212905,0.00025113215,0.000069842914,0.000014664511,0.000023774799,0.000076053424,0.000003430575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008661734,0.0047201207,0.9919159,0.00016379473,0.00014841411,0.000011635434,0.000020259477,0.0000040862815,0.00008911298,0.0007875157,0.00021884144,0.0018337199],"study_design_scores_gemma":[0.00656611,0.00027649084,0.99156755,0.00008209724,0.00031146803,0.0000033578808,0.000018823672,0.0000039210713,0.00049202656,0.00033604202,0.000308316,0.00003381698],"about_ca_topic_score_codex":0.00002005322,"about_ca_topic_score_gemma":0.0000031573195,"teacher_disagreement_score":0.012537956,"about_ca_system_score_codex":0.0000062603817,"about_ca_system_score_gemma":0.000024418552,"threshold_uncertainty_score":0.13484158},"labels":[],"label_agreement":null},{"id":"W2555691904","doi":"10.1182/blood.v110.11.3868.3868","title":"Effects of c-Src Overexpression in CD40-Activated Human B Lymphocytes.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; Université Laval; Toronto General Hospital; Héma-Québec","funders":"","keywords":"Proto-oncogene tyrosine-protein kinase Src; Biology; Molecular biology; Tyrosine-protein kinase CSK; Tyrosine kinase; Kinase; Signal transduction; Cell biology; SH3 domain","score_opus":0.011129298492958805,"score_gpt":0.281853923204431,"score_spread":0.2707246247114722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555691904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99318916,0.000099458324,0.00004291518,0.000016761123,0.000050252416,0.00019648175,0.000001762791,0.000035870413,0.006367313],"genre_scores_gemma":[0.9995294,0.000004959159,0.00014974388,0.00008558518,0.00008593049,0.00000504724,0.000010493661,0.000014516943,0.000114317976],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99931705,0.000014668681,0.00023606162,0.00013467591,0.0001383713,0.00015915827],"domain_scores_gemma":[0.99955446,0.00011335907,0.000077200784,0.00014564906,0.00004514329,0.00006416721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000110412875,0.00008700298,0.00019336966,0.00015957825,0.00002798028,0.0000035675864,0.00004075287,0.00006918738,0.000075499396],"category_scores_gemma":[0.000097041135,0.0000741361,0.00006457421,0.00017754716,0.000021646047,0.00004515339,0.000021492513,0.000120163604,0.000006030358],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009871985,0.0010851979,0.006366104,0.00013407663,0.000025976393,0.00006749922,0.0001099717,0.0000011702763,0.9915703,0.00011538335,0.000112695205,0.00031291338],"study_design_scores_gemma":[0.004586518,0.0002890247,0.07061985,0.00091907865,0.00003970638,0.000019412159,0.000023449842,0.0000042929064,0.92288923,0.000028862374,0.0005166602,0.000063936495],"about_ca_topic_score_codex":0.00013645616,"about_ca_topic_score_gemma":0.000006667533,"teacher_disagreement_score":0.06868109,"about_ca_system_score_codex":0.000043219065,"about_ca_system_score_gemma":0.00003535682,"threshold_uncertainty_score":0.30231825},"labels":[],"label_agreement":null},{"id":"W2555695633","doi":"10.1182/blood.v104.11.4398.4398","title":"The Expression of Fas Antigen (CD 95) on Clonogenic Acute Myeloid Leukemia Cells Correlates with Their In Vitro Sensitivity to Farnesyltransferase Inhibitor (FTI; Zarnestra TM).","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Clonogenic assay; Farnesyltransferase inhibitor; Molecular biology; Bone marrow; Biology; Myeloid leukemia; Leukemia; In vitro; Apoptosis; Antigen; Cancer research; Immunology; Farnesyltransferase; Prenylation; Biochemistry","score_opus":0.00602203360676804,"score_gpt":0.20752706411041577,"score_spread":0.20150503050364774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555695633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969206,0.0004977209,0.0005890404,0.00031484582,0.00020569129,0.0010996857,0.000085930275,0.00007795115,0.00020853484],"genre_scores_gemma":[0.9983098,0.00040284693,0.0007660811,0.00022242394,0.000116060684,0.00003945774,0.00003572833,0.000071152754,0.000036436686],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980658,0.000111640875,0.0004142354,0.0005098947,0.0004108644,0.00048755683],"domain_scores_gemma":[0.99875575,0.00014514924,0.000114844,0.0006580254,0.0001025461,0.00022365946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028549487,0.00035230245,0.00049145956,0.00013649384,0.00012093529,0.000025244086,0.0001336691,0.00022727915,0.000005473857],"category_scores_gemma":[0.00004329839,0.00023387211,0.00016975013,0.00045550725,0.00013659352,0.00006524815,0.0000482887,0.00056930556,0.000027586777],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021567175,0.0005224312,0.00041514513,0.000032903554,0.00014583734,0.0007038006,0.0010160911,0.0012428972,0.992496,0.000013582499,0.00003471988,0.001219888],"study_design_scores_gemma":[0.0071120923,0.0010471492,0.003406296,0.0006416396,0.00018016234,0.00027327015,0.0002073001,0.000022258535,0.9865608,0.000023572891,0.0002640317,0.00026142292],"about_ca_topic_score_codex":0.00020589924,"about_ca_topic_score_gemma":0.0001654422,"teacher_disagreement_score":0.005935182,"about_ca_system_score_codex":0.00021129064,"about_ca_system_score_gemma":0.0005244618,"threshold_uncertainty_score":0.9537028},"labels":[],"label_agreement":null},{"id":"W2555770765","doi":"10.1182/blood.v124.21.2186.2186","title":"Characterizing Transcriptional and Epigenetic Signatures Induced By FLT3-ITD Activation","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Biology; Gene expression; Epigenetics; Gene; Mutant; Cancer research; Genetics; Molecular biology","score_opus":0.016361155378703054,"score_gpt":0.2604758264768682,"score_spread":0.24411467109816512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555770765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99603474,0.0001772345,0.00030245804,0.0021203402,0.00003303526,0.00022557641,0.000006552284,0.000043593758,0.0010564799],"genre_scores_gemma":[0.99821055,0.00003753653,0.00039686816,0.0007331182,0.00024168122,0.000021830285,0.000081907325,0.000021345762,0.00025514132],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991448,0.000053098473,0.0001301133,0.00021706308,0.0002510649,0.00020387028],"domain_scores_gemma":[0.99957615,0.000073281386,0.00003322739,0.00014058217,0.000053106334,0.00012367024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017926714,0.00010434229,0.0001546743,0.00008307185,0.00007037536,0.000023416198,0.00005699014,0.00012559086,0.00007451277],"category_scores_gemma":[0.00011827495,0.00009260364,0.000030735362,0.000098102275,0.000036718833,0.00007872725,0.000017481578,0.00028739634,0.000015645137],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005168686,0.00011744491,0.0015361861,0.000042580992,0.000042970994,0.0000019229694,0.0001555539,1.00487036e-7,0.9908223,0.00013529585,0.00018088568,0.006913031],"study_design_scores_gemma":[0.003818603,0.00034067038,0.24859606,0.000068111025,0.00007394755,0.000024064482,0.000034597135,0.00015534833,0.7377453,0.0000979494,0.008908447,0.00013694483],"about_ca_topic_score_codex":0.000024290282,"about_ca_topic_score_gemma":0.0000011741346,"teacher_disagreement_score":0.2530771,"about_ca_system_score_codex":0.00003160839,"about_ca_system_score_gemma":0.00006253164,"threshold_uncertainty_score":0.37762666},"labels":[],"label_agreement":null},{"id":"W2555778026","doi":"10.1182/blood.v108.11.3380.3380","title":"Kinetics of Autologous Stem Cell Mobilization Failure: Comparison of AMD3100/G-CSF, G-CSF, GM-/G-CSF, and Chemotherapy/G-CSF on Remobilization Success.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Apheresis; CD34; Multiple myeloma; Autologous stem-cell transplantation; Transplantation; Mobilization; Chemotherapy; Stem cell; Progenitor cell; Population; Internal medicine; Urology; Surgery; Gastroenterology; Oncology; Biology; Platelet","score_opus":0.011673108027647336,"score_gpt":0.25321759972313335,"score_spread":0.241544491695486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555778026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987888,0.0005632814,0.0056210975,0.00025489283,0.00010977386,0.0011296012,0.00003747797,0.000118868855,0.0042770207],"genre_scores_gemma":[0.99620587,0.00016381546,0.0028357985,0.00008555185,0.00008428277,0.00002484758,0.00023444968,0.00007163177,0.0002937329],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99731964,0.0001257146,0.0011198802,0.0005000625,0.00061737956,0.00031734747],"domain_scores_gemma":[0.99810654,0.0002331107,0.0005991231,0.0005199483,0.00042954524,0.0001117095],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000219237,0.0003419568,0.00082335086,0.0002771855,0.000053737214,0.000026624775,0.00014351346,0.00033438957,0.00006836189],"category_scores_gemma":[0.0000313946,0.00032736082,0.00011214375,0.00051658734,0.00018397237,0.0001234588,0.000021559548,0.00018493409,0.000009212011],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005464264,0.006494792,0.333726,0.004816252,0.0001670687,0.000027418995,0.002502159,0.0015938097,0.6440051,0.0013465949,0.0007272248,0.0040471763],"study_design_scores_gemma":[0.0064726262,0.0013504446,0.07537392,0.0005238562,0.00054367806,0.000062389474,0.0003902202,0.002204967,0.9123097,0.00012564458,0.00035237643,0.0002901625],"about_ca_topic_score_codex":0.00010080609,"about_ca_topic_score_gemma":0.000072844334,"teacher_disagreement_score":0.26830462,"about_ca_system_score_codex":0.000047130594,"about_ca_system_score_gemma":0.000059640668,"threshold_uncertainty_score":0.99991786},"labels":[],"label_agreement":null},{"id":"W2555788587","doi":"10.1182/blood.v120.21.5192.5192","title":"Gas6 Regulates Thrombin-Induced of VCAM-1 Expression by a FoxO1 Dependent Mechanism","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"FOXO1; Thrombin; GAS6; Biology; Cell biology; Protein kinase B; Phosphorylation; PI3K/AKT/mTOR pathway; Endothelial stem cell; VCAM-1; Signal transduction; Molecular biology; Cell adhesion molecule; Immunology; ICAM-1; Biochemistry; Platelet","score_opus":0.013580700448048292,"score_gpt":0.22874360199549904,"score_spread":0.21516290154745074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555788587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99246365,0.0061836345,0.00008470816,0.000028192306,0.00042229873,0.00017996498,0.000016071943,0.000046994846,0.0005745037],"genre_scores_gemma":[0.9991655,0.00006323729,0.000078341036,0.000021594247,0.00002879795,0.000017627252,0.00008465275,0.000017749555,0.00052251964],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99902236,0.00013135865,0.00028531664,0.00017303509,0.000051416282,0.00033653213],"domain_scores_gemma":[0.9994033,0.00004403401,0.00018154169,0.00030530506,0.00004006416,0.00002577009],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022610219,0.00014894658,0.0002611183,0.00005543433,0.00010284883,0.0000057969683,0.00015318753,0.00025182677,0.0003565761],"category_scores_gemma":[0.000027367658,0.00012476464,0.00008841483,0.00006485015,0.00003988112,0.00017528943,0.00009062293,0.00012220874,0.00010078686],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022574119,0.00092120736,0.00077308604,0.000010569964,0.00010441473,1.803935e-7,0.00028192185,1.0357761e-7,0.99554676,0.00092448306,0.0009050979,0.00050957943],"study_design_scores_gemma":[0.0017339792,0.00014604093,0.0060365223,0.000044539538,0.00008797094,0.00004239937,0.00009180629,5.529388e-7,0.9907004,0.00050868676,0.0004682533,0.0001388189],"about_ca_topic_score_codex":0.000043487624,"about_ca_topic_score_gemma":0.0000011576445,"teacher_disagreement_score":0.0067018494,"about_ca_system_score_codex":0.000013615337,"about_ca_system_score_gemma":0.000016692351,"threshold_uncertainty_score":0.5087755},"labels":[],"label_agreement":null},{"id":"W2555789082","doi":"10.1182/blood.v112.11.1605.1605","title":"A Novel Chromene-Based Pan-PI3 Kinase Inhibitor Displays Preclinical Activity in Leukemia and Myeloma.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Hospital for Sick Children; Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Kinase; Protein kinase B; Cell cycle; Cancer research; Cyclin; Leukemia; Cyclin-dependent kinase; PI3K/AKT/mTOR pathway; Biology; Chemistry; Phosphorylation; Biochemistry; Molecular biology; Cell biology; Cell; Signal transduction; Immunology","score_opus":0.02255427564725975,"score_gpt":0.26804051269704326,"score_spread":0.2454862370497835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555789082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981915,0.00047729423,0.00082117843,0.00007301021,0.00008749104,0.00016348252,0.000038067206,0.000010160966,0.00013784332],"genre_scores_gemma":[0.9984082,0.00023803409,0.00066609186,0.00026730864,0.00022658704,0.00004110516,0.000025611735,0.000020793246,0.000106279214],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991479,0.000025794188,0.00014911228,0.00035980096,0.000096753945,0.00022062549],"domain_scores_gemma":[0.9995713,0.000016946082,0.000052261727,0.00025270085,0.000021928756,0.00008484917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011090998,0.00014334638,0.00015954903,0.000033582397,0.000057827125,0.000010919085,0.00008796206,0.0001692653,0.0000064334968],"category_scores_gemma":[0.000023126982,0.00014124396,0.000060501043,0.0000682805,0.00007547463,0.0000032824796,0.000072724964,0.00011159776,0.0000018242296],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015879354,0.00044496852,0.0019881255,0.000016664815,0.000027055632,0.000016058368,0.000027837448,0.0000073434644,0.9950096,0.00002462013,0.00003248621,0.0022464662],"study_design_scores_gemma":[0.004529942,0.00050009706,0.023547392,0.000021428183,0.00002749046,0.000032595723,0.00000708839,0.000116430274,0.9676354,0.000025093685,0.003346267,0.00021077956],"about_ca_topic_score_codex":0.00005891629,"about_ca_topic_score_gemma":0.00017267061,"teacher_disagreement_score":0.027374184,"about_ca_system_score_codex":0.000024501558,"about_ca_system_score_gemma":0.00023235958,"threshold_uncertainty_score":0.5759762},"labels":[],"label_agreement":null},{"id":"W2555793660","doi":"10.1182/blood.v120.21.4184.4184","title":"Prognostic Power of Chronic Gvhd Risk Score Model by Ibmtr Can Be Improved with Addition of Absolute Lymphocyte Counts and Eosinophil Counts At the Onset of Chronic Gvhd","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Graft-versus-host disease; Hematopoietic stem cell transplantation; Transplantation; Cohort; Framingham Risk Score; Gastroenterology; Disease","score_opus":0.01031071285735634,"score_gpt":0.22179786760564432,"score_spread":0.21148715474828797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555793660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934535,0.0031375098,0.000089088215,0.000031436335,0.000055933357,0.0004680382,0.0010525078,0.000011452508,0.0017005116],"genre_scores_gemma":[0.998969,0.00043598632,0.00008921699,0.000021453296,0.000025968282,0.000019531339,0.00016306381,0.000020114567,0.00025564054],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992638,0.000021974443,0.00020877321,0.000114078866,0.00022892638,0.00016242017],"domain_scores_gemma":[0.99940693,0.0000657916,0.0001851958,0.00020709037,0.00007957272,0.000055445078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012689938,0.00010492995,0.00020295552,0.00003208374,0.000027426311,0.000002174785,0.000046109853,0.00006952258,0.0003741324],"category_scores_gemma":[0.000015772455,0.00007326597,0.000028714938,0.000072455805,0.00014796607,0.000032949796,0.000010966436,0.00006246824,0.00000731975],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004133575,0.012798489,0.28298786,0.027402775,0.006283034,0.00008752348,0.020049652,0.00038848296,0.5792215,0.0010150286,0.04140991,0.024222175],"study_design_scores_gemma":[0.03618416,0.0051910053,0.23737904,0.0028248536,0.008343631,0.0009787166,0.00032395526,0.012601403,0.69275004,0.00010384,0.002301925,0.0010174309],"about_ca_topic_score_codex":0.000064963664,"about_ca_topic_score_gemma":0.000040855863,"teacher_disagreement_score":0.11352855,"about_ca_system_score_codex":0.00009133858,"about_ca_system_score_gemma":0.00029451697,"threshold_uncertainty_score":0.40964872},"labels":[],"label_agreement":null},{"id":"W2555812629","doi":"10.1182/blood.v118.21.3643.3643","title":"Incidence and Predictors of Bleomycin Pulmonary Toxicity in Hodgkin Lymphoma (HL) Patients Treated with Adriamycin, Bleomycin, Vinblastine and Dacarbazine (ABVD),","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"ABVD; Medicine; Dacarbazine; Bleomycin; Vinblastine; Internal medicine; Surgery; Chemotherapy regimen; Pulmonary toxicity; Gastroenterology; Chemotherapy; Lung; Vincristine; Cyclophosphamide","score_opus":0.008961378640314979,"score_gpt":0.19879171144491,"score_spread":0.18983033280459502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555812629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99681294,0.0009382709,0.000001966867,0.000045714136,0.000027868413,0.0007295149,0.000048827453,0.00004543434,0.0013494625],"genre_scores_gemma":[0.9987315,0.00040650705,0.00050469924,0.000097699216,0.000038022612,0.00007825298,0.0000502874,0.0000310324,0.00006198047],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983347,0.000059184207,0.0004561759,0.0005132963,0.00030850127,0.00032811763],"domain_scores_gemma":[0.99893606,0.000093303555,0.00018894317,0.00033979135,0.00021209086,0.00022982807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012289091,0.00032781117,0.00060558674,0.00021401765,0.000046989167,0.000012556754,0.00008048531,0.00013440085,0.000030870415],"category_scores_gemma":[0.00011100706,0.00023614604,0.000043591746,0.00034425204,0.00018005967,0.00019841956,0.00010047607,0.0000710002,0.000002350671],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007923994,0.0053614187,0.9885958,0.00013303684,0.00021784217,0.00039802288,0.0004191029,2.5459664e-7,0.0016672831,0.000021809969,0.00003244148,0.0023605875],"study_design_scores_gemma":[0.015395154,0.0028651527,0.92669916,0.0005293826,0.00055196695,0.00020156146,0.00006457983,0.000026572932,0.05342952,0.000016015278,0.000023066343,0.00019784381],"about_ca_topic_score_codex":0.0011818164,"about_ca_topic_score_gemma":0.00026188637,"teacher_disagreement_score":0.06189662,"about_ca_system_score_codex":0.00006175403,"about_ca_system_score_gemma":0.00009351256,"threshold_uncertainty_score":0.9629756},"labels":[],"label_agreement":null},{"id":"W2555817780","doi":"10.1182/blood.v114.22.664.664","title":"Comparison of Outcomes of Mismatched Related Stem Cell and Unrelated Cord Blood Transplants in Children with Severe T-Cell Deficiencies.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Medicine; Umbilical cord; Hematopoietic stem cell transplantation; Transplantation; Cord blood; Severe combined immunodeficiency; Cumulative incidence; Incidence (geometry); Stem cell; Surgery; Pediatrics; Internal medicine; Immunology","score_opus":0.007430528386377969,"score_gpt":0.2141037090444762,"score_spread":0.20667318065809823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555817780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9760205,0.022230675,0.000005373135,0.00002428549,0.000043488115,0.00032908816,0.00003736397,0.000038146227,0.0012710748],"genre_scores_gemma":[0.9994562,0.00013609011,0.000027625501,0.00001757226,2.9362582e-7,0.0000027917295,0.000065693384,0.000012557142,0.00028114743],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985394,0.00011404598,0.00064882636,0.00028682826,0.000064228145,0.00034670826],"domain_scores_gemma":[0.9992928,0.00007277587,0.00031662747,0.00026747037,0.000041504387,0.000008845278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001716879,0.00024259696,0.0006761255,0.00015634901,0.00008015022,0.0000048353318,0.0002450676,0.00029899308,0.000028475015],"category_scores_gemma":[0.0000048288884,0.00019752639,0.00007554855,0.00032715904,0.000226835,0.00006544979,0.000020725553,0.0003431134,0.000008071759],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021931565,0.004702308,0.58946675,0.00004889595,0.00023709843,0.0000032672685,0.0038103845,0.00011694858,0.4003589,0.000055257056,0.0000037023124,0.0009771544],"study_design_scores_gemma":[0.012441648,0.0011324879,0.5936895,0.00008659611,0.00040802784,0.000092508446,0.0013756024,0.000006160329,0.39047262,0.00002259305,0.000007988711,0.0002642284],"about_ca_topic_score_codex":0.00012790343,"about_ca_topic_score_gemma":0.0000042608112,"teacher_disagreement_score":0.023435725,"about_ca_system_score_codex":0.000004742875,"about_ca_system_score_gemma":0.00005401111,"threshold_uncertainty_score":0.80548924},"labels":[],"label_agreement":null},{"id":"W2555822990","doi":"10.1182/blood.v124.21.4833.4833","title":"Making Decisions about Thromboprophylaxis in Pregnancy: Women's Values and Preferences","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Medicine; Pregnancy; Low molecular weight heparin; Obstetrics; Absolute risk reduction; Risk assessment; Venous thromboembolism; Thrombosis; Confidence interval; Surgery; Internal medicine","score_opus":0.028967573803469454,"score_gpt":0.28984071139844303,"score_spread":0.26087313759497355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555822990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842826,0.001266938,0.0000589586,0.00015277062,0.000082058315,0.000371898,0.0000016649622,0.000048416714,0.013734673],"genre_scores_gemma":[0.9970698,0.0010522159,0.0012591037,0.00026626574,0.00007053361,0.00011044024,0.0000022976733,0.000015989546,0.00015334995],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989519,0.000041238127,0.0002122125,0.0002964088,0.00020626202,0.0002919868],"domain_scores_gemma":[0.99945635,0.000105782645,0.000053093278,0.00027068425,0.00002860423,0.000085497006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002094753,0.00013024834,0.00037750992,0.00012993802,0.00006980221,0.000037991605,0.00008559137,0.000058635505,0.000100245285],"category_scores_gemma":[0.00019800868,0.000103159335,0.000032220298,0.00014875167,0.000056463115,0.0000666791,0.00010111558,0.00010342883,0.000020637144],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006728358,0.007906634,0.4629499,0.00092038116,0.00057868287,0.00013091647,0.016187973,0.000016659676,0.0023437086,0.014794805,0.0009561988,0.49314687],"study_design_scores_gemma":[0.0020318292,0.00074893056,0.98140675,0.0015404703,0.0001067956,0.00000813537,0.00046896446,0.000041940028,0.00041046555,0.011917829,0.0011596967,0.00015820416],"about_ca_topic_score_codex":0.000031173713,"about_ca_topic_score_gemma":0.00003599437,"teacher_disagreement_score":0.5184569,"about_ca_system_score_codex":0.00002050281,"about_ca_system_score_gemma":0.00002681026,"threshold_uncertainty_score":0.42067158},"labels":[],"label_agreement":null},{"id":"W2555838647","doi":"10.1182/blood.v116.21.4664.4664","title":"The Frequency and Clinical Significance of Thrombocytopenia Complicating Critical Illness: A Systematic Review","year":2010,"lang":"en","type":"review","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University","funders":"","keywords":"Medicine; Intensive care unit; Sepsis; Incidence (geometry); Confounding; Internal medicine; Multivariate analysis; Epidemiology; Intensive care; Intensive care medicine; Prospective cohort study; MEDLINE; Emergency medicine","score_opus":0.08545516677647065,"score_gpt":0.4188569780123299,"score_spread":0.33340181123585927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555838647","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011645942,0.9914631,0.000006873463,0.00029639783,0.00028255593,0.0060310746,0.000046554203,0.00006219348,0.001694762],"genre_scores_gemma":[0.0009366453,0.9969507,0.00077902805,0.00019383055,0.00022400897,0.00074514555,0.000028090197,0.000100898214,0.000041664138],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9937698,0.0009816432,0.0034067351,0.00082713214,0.0004894328,0.0005252114],"domain_scores_gemma":[0.9910416,0.004957654,0.0012286789,0.0020351699,0.00035089595,0.00038600864],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0026882526,0.0006272455,0.008680244,0.00007456037,0.00032109642,0.000070191476,0.0007323,0.0006632915,0.000039339342],"category_scores_gemma":[0.0075584142,0.00037247143,0.0010541937,0.00043471094,0.00092671864,0.00007650039,0.0002643514,0.0017347638,0.000101559766],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000017486896,0.00043976656,0.000058150315,0.9546979,0.00084893405,0.000026373484,0.00001865212,9.209084e-11,0.000025304484,0.0035560995,0.000033141805,0.040293906],"study_design_scores_gemma":[0.0006706296,0.00032006475,0.000136501,0.9056419,0.04297236,0.001078352,0.000027127257,6.76631e-7,0.0000122622605,0.00020529427,0.048369747,0.00056508963],"about_ca_topic_score_codex":0.000031062507,"about_ca_topic_score_gemma":0.000017247183,"teacher_disagreement_score":0.049056027,"about_ca_system_score_codex":0.00003840006,"about_ca_system_score_gemma":0.0007611594,"threshold_uncertainty_score":0.99987274},"labels":[],"label_agreement":null},{"id":"W2555862615","doi":"10.1182/blood.v118.21.3585.3585","title":"AML Cells Have Increased Mitochondrial Mass but Less Reserve in Their Respiratory Chain Complexes Leading to Heightened Sensitivity to Inhibition of Mitochondrial Protein Translation,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Mitochondrial biogenesis; Mitochondrion; Citrate synthase; Mitochondrial respiratory chain; Respiratory chain; Oxidative phosphorylation; Antimycin A; Mitochondrial DNA; CD34; Haematopoiesis; Respiratory system; Biology; Cell biology; Chemistry; Molecular biology; Internal medicine; Biochemistry; Medicine; Stem cell; Enzyme; Gene","score_opus":0.039700250177295685,"score_gpt":0.2426472526239415,"score_spread":0.20294700244664582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555862615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98540574,0.00004321648,0.011745063,0.00008996053,0.0004684107,0.0014510624,0.00020356546,0.000024071847,0.0005688846],"genre_scores_gemma":[0.98270595,0.0000032156818,0.015455876,0.00035594575,0.0009792495,0.00017072124,0.00012941372,0.000044393524,0.0001552056],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99754477,0.00067839253,0.000556105,0.0006488848,0.00019465512,0.00037720526],"domain_scores_gemma":[0.9989241,0.000043930853,0.00015357045,0.000491277,0.00018628378,0.0002008746],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034568913,0.00028188474,0.0004072876,0.00025014373,0.000080765974,0.00001752229,0.0001502282,0.00034452757,0.00003680489],"category_scores_gemma":[0.00018985537,0.00028412932,0.00014625255,0.00022298234,0.000081142345,0.000013002637,0.000075751705,0.0001677485,0.000018355158],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019000117,0.00031948913,0.00079469394,0.00003381132,0.00003528922,0.000028069611,0.00074839423,0.000041937845,0.9955692,0.00006216714,0.00028957406,0.00017734357],"study_design_scores_gemma":[0.003400042,0.0008836997,0.00049726944,0.00007401176,0.00002473891,0.000007444157,0.00024550804,0.000014326125,0.9930363,0.00009494044,0.0014076551,0.0003140597],"about_ca_topic_score_codex":0.00053963525,"about_ca_topic_score_gemma":0.0037912724,"teacher_disagreement_score":0.0037108136,"about_ca_system_score_codex":0.000018757499,"about_ca_system_score_gemma":0.000090715286,"threshold_uncertainty_score":0.9999611},"labels":[],"label_agreement":null},{"id":"W2555873966","doi":"10.1182/blood.v110.11.2700.2700","title":"Understanding the Factor Va Cofactor Effect within Prothrombinase.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Prothrombinase; Chemistry; Thrombin; Cleavage (geology); Enzyme; Cofactor; Stereochemistry; Divalent; Factor V; Enzyme activator; Biophysics; Biochemistry; Platelet; Immunology; Internal medicine; Biology","score_opus":0.08325578964481106,"score_gpt":0.30033236249826495,"score_spread":0.2170765728534539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555873966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826152,0.00006775384,0.010173139,0.0004415549,0.00038464108,0.0012043102,0.0000044909752,0.00019326856,0.004915687],"genre_scores_gemma":[0.99881,0.0000026090145,0.00029980234,0.00041822888,0.00014333182,0.000016110413,0.000007384369,0.0000314466,0.00027106554],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99884003,0.00005555136,0.00024017422,0.00021847885,0.00035942876,0.0002863046],"domain_scores_gemma":[0.9992238,0.00017565991,0.0000953687,0.00032367857,0.000034662593,0.00014678475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055179786,0.0001687353,0.00025263787,0.00007532879,0.00017790923,0.000033409764,0.00009347869,0.0001121053,0.00026231277],"category_scores_gemma":[0.00010138757,0.00010356453,0.00010531617,0.00021788217,0.00006341392,0.000056473214,0.000029704155,0.0002354065,0.00007614793],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005456086,0.002763549,0.13053331,0.00047455652,0.0014704098,0.00024894625,0.005079006,0.0000035683533,0.75313294,0.1038226,0.00059864175,0.0013268552],"study_design_scores_gemma":[0.009379395,0.0018321434,0.090240106,0.00019486531,0.0006446708,0.00016827945,0.000780328,0.00006545161,0.89327496,0.002701142,0.00039814797,0.00032048416],"about_ca_topic_score_codex":0.000009254186,"about_ca_topic_score_gemma":0.000015361942,"teacher_disagreement_score":0.14014202,"about_ca_system_score_codex":0.00006139098,"about_ca_system_score_gemma":0.000049592207,"threshold_uncertainty_score":0.4223239},"labels":[],"label_agreement":null},{"id":"W2555900028","doi":"10.1182/blood.v126.23.3154.3154","title":"Guidelines for the Standardization of Acute Graft-Versus-Host Disease Clinical Data Collection: An International Consensus Report","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Rash; Internal medicine; Vomiting; Graft-versus-host disease; Diarrhea; Nausea; Gastroenterology; Surgery; Disease; Pediatrics","score_opus":0.2855552961843687,"score_gpt":0.4727907495123016,"score_spread":0.1872354533279329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555900028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.617605,0.0007110747,0.32066387,0.037722196,0.009942492,0.0046551754,0.0044249394,0.00028773842,0.003987577],"genre_scores_gemma":[0.9059645,0.0006269184,0.08176641,0.0005630906,0.0022524225,0.00009502951,0.0071589653,0.00006473018,0.0015079307],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99854505,0.000047773792,0.00065276865,0.00025799114,0.00041159883,0.00008482656],"domain_scores_gemma":[0.9973037,0.00030811396,0.00020582629,0.00067683106,0.0013428385,0.0001626936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001229387,0.000080467624,0.00018280925,0.000038893435,0.00004736716,0.000015124093,0.00017218565,0.000052503514,0.000021113858],"category_scores_gemma":[0.0022864963,0.000058013677,0.000060785493,0.00010977499,0.0000825603,0.00007602724,0.000031914704,0.000054597604,0.0000021486062],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050888453,0.0060474435,0.6259645,0.00071623485,0.011151381,0.0021712487,0.0015114581,0.00031330052,0.0028410403,0.0029424762,0.29131386,0.0041385875],"study_design_scores_gemma":[0.18956862,0.006124711,0.21659768,0.001138324,0.04307978,0.005659583,0.0033122683,0.10396893,0.015863094,0.0009501859,0.4124192,0.0013176245],"about_ca_topic_score_codex":0.000017617538,"about_ca_topic_score_gemma":0.000017009825,"teacher_disagreement_score":0.40936685,"about_ca_system_score_codex":0.00001680316,"about_ca_system_score_gemma":0.00058883725,"threshold_uncertainty_score":0.2737315},"labels":[],"label_agreement":null},{"id":"W2555914769","doi":"10.1182/blood.v110.11.4757.4757","title":"Molecular Quantification of Pre-Treatment Bone Marrow Clonal Cells in Multiple Myeloma Is a Novel Predictive Indicator of Remission Length.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Multiple myeloma; Medicine; Bone marrow; Plasmacytosis; Internal medicine; Prednisone; Thalidomide; Plasma cell; Monoclonal gammopathy of undetermined significance; Melphalan; Oncology; Pathology; Immunology; Gastroenterology; Antibody; Monoclonal","score_opus":0.023328859945617786,"score_gpt":0.29575386112002783,"score_spread":0.27242500117441004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555914769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997004,0.00051388366,0.00084941974,0.00007886323,0.000025238942,0.0010574802,0.00019541167,0.000019179266,0.00025654456],"genre_scores_gemma":[0.99554104,0.00009610523,0.0040339734,0.000013556429,0.000025285279,0.000043633074,0.00011562242,0.000022699542,0.00010810746],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99823284,0.000038526843,0.00051945145,0.00034702575,0.00054735923,0.00031480266],"domain_scores_gemma":[0.9988878,0.00014739808,0.00022734335,0.00039759677,0.00012215534,0.0002177383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029511785,0.00017691779,0.00038567706,0.0003207709,0.000028643959,0.0000035066346,0.0000818069,0.00014309255,0.000042601474],"category_scores_gemma":[0.00014585762,0.00014396306,0.00012499758,0.0002797094,0.00009869408,0.000047222195,0.000037756592,0.00011584378,0.000008249564],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001736594,0.006292667,0.23026319,0.00012919602,0.00025657055,0.00009790246,0.0005537995,0.0000060835737,0.7567445,0.000015345646,0.00001327718,0.0038908669],"study_design_scores_gemma":[0.007995797,0.00081963366,0.38105395,0.00013188325,0.00009758956,0.000012806889,0.000071996794,0.0004320955,0.60925806,0.0000058203477,0.00006346389,0.000056877725],"about_ca_topic_score_codex":0.0003263239,"about_ca_topic_score_gemma":0.000032682045,"teacher_disagreement_score":0.15079078,"about_ca_system_score_codex":0.00011285254,"about_ca_system_score_gemma":0.0001784031,"threshold_uncertainty_score":0.5870643},"labels":[],"label_agreement":null},{"id":"W2555926193","doi":"10.1182/blood.v120.21.3083.3083","title":"Are Outcomes After Myeloablative Conditioning Regimen in Double Cord Blood Transplantation (UCBT) Better Than Single UCBT for Adults with Acute Leukemia in Remission?.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; ThioTEPA; Internal medicine; Transplantation; Regimen; Hematopoietic stem cell transplantation; Gastroenterology; Surgery; Chemotherapy; Cyclophosphamide","score_opus":0.020518483581718407,"score_gpt":0.28995703417033986,"score_spread":0.26943855058862143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555926193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99602944,0.0001428417,0.00013900938,0.0009170017,0.00005141484,0.0016000138,0.00008900417,0.00006352463,0.00096773886],"genre_scores_gemma":[0.99240106,0.000029998439,0.00475734,0.000549782,0.00016949174,0.0006365884,0.00030055773,0.000071655355,0.0010835234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978383,0.00007455202,0.00043696715,0.00045083728,0.00043220923,0.00076710456],"domain_scores_gemma":[0.9988452,0.0002294763,0.00020768045,0.00033704986,0.00013849225,0.00024209736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034056604,0.00031019785,0.00054360315,0.00037129642,0.000078530116,0.000031821288,0.00013329467,0.00022957502,0.00009464807],"category_scores_gemma":[0.00005434387,0.00024471447,0.00009365586,0.0003635418,0.00009238851,0.00046199915,0.000033299882,0.0004801959,0.000023122244],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010948176,0.0008389694,0.9733112,0.00041194077,0.00041773036,0.00079451693,0.0056438977,0.000008946361,0.007077051,0.000033290344,0.0002092126,0.0003050692],"study_design_scores_gemma":[0.059307545,0.0009050329,0.8634315,0.0018023658,0.0008704105,0.0003640633,0.0013236449,0.000071616116,0.071104795,0.000058563055,0.00027334492,0.00048709445],"about_ca_topic_score_codex":0.0001944468,"about_ca_topic_score_gemma":0.00039938136,"teacher_disagreement_score":0.10987968,"about_ca_system_score_codex":0.0004909678,"about_ca_system_score_gemma":0.0002668433,"threshold_uncertainty_score":0.9979166},"labels":[],"label_agreement":null},{"id":"W2555962573","doi":"10.1182/blood.v118.21.1810.1810","title":"Alternate Splicing Factor Fox2 Affects Growth and Survival of Multiple Myeloma Cells","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Exon; RNA splicing; Alternative splicing; Biology; Small hairpin RNA; Splicing factor; Cell growth; Molecular biology; Cell culture; Gene expression; Cancer research; Gene; Cell biology; Gene knockdown; RNA; Genetics","score_opus":0.03719988467604131,"score_gpt":0.27203678170868434,"score_spread":0.23483689703264304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555962573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953285,0.00018340386,0.00003371825,0.000015112796,0.00007126316,0.00039973174,0.000036191617,0.00003744907,0.0038946492],"genre_scores_gemma":[0.998104,0.00010714503,0.0015118434,0.0000144222595,0.000058259007,0.000012694834,0.000008793532,0.000024816016,0.00015807502],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989959,0.00004442078,0.0001495839,0.0002412334,0.0002606265,0.00030825182],"domain_scores_gemma":[0.9992827,0.00012449945,0.00006431607,0.00022593529,0.000051109484,0.00025139702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000073252544,0.00014952321,0.00029863443,0.000101530946,0.000040442348,0.000007664746,0.000074206626,0.00005848404,0.00007434778],"category_scores_gemma":[0.00010624218,0.00011647829,0.00006820252,0.00008469083,0.00006529956,0.00005933174,0.00007303005,0.00010418265,0.000020707572],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022924475,0.00066871935,0.71761525,0.00021471438,0.00026833874,0.00024841976,0.00043871035,2.1188052e-8,0.27821186,0.000053571308,0.000006205322,0.0020449301],"study_design_scores_gemma":[0.005284877,0.00040810212,0.44606644,0.000056531717,0.00006837886,0.00002443342,0.000029390618,0.000032579323,0.5479358,0.000021350039,0.0000066869893,0.00006544711],"about_ca_topic_score_codex":0.00066794344,"about_ca_topic_score_gemma":0.000052548206,"teacher_disagreement_score":0.2715488,"about_ca_system_score_codex":0.000009023994,"about_ca_system_score_gemma":0.000031729047,"threshold_uncertainty_score":0.47498468},"labels":[],"label_agreement":null},{"id":"W2555967025","doi":"10.1182/blood.v114.22.2071.2071","title":"Improved Selectivity against Acute Myeloid Leukemia (AML) Blasts Over Normal Hematopoietic Progenitors for Cytarabine: Daunorubicin Delivered as CPX-351 Liposome Injection.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Celator Pharmaceuticals (Canada); BC Cancer Agency","funders":"","keywords":"Daunorubicin; Cytarabine; Medicine; Myeloid leukemia; Leukemia; Pharmacology; Chemotherapy; Progenitor cell; Internal medicine; Immunology; Oncology; Cancer research; Stem cell; Biology","score_opus":0.004694487365373824,"score_gpt":0.22925352289543674,"score_spread":0.22455903553006293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555967025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99743545,0.00036319465,0.00056974246,0.00006413906,0.00026668087,0.0006973767,0.00006816023,0.000060238897,0.0004750254],"genre_scores_gemma":[0.99614567,0.00020402661,0.00050889206,0.0006582549,0.00070256897,0.00010480227,0.00029285782,0.00004123841,0.0013416951],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981544,0.000050349547,0.0003628557,0.00068118144,0.00017743233,0.00057375804],"domain_scores_gemma":[0.9989554,0.000016296583,0.0001605499,0.00046291167,0.00023924792,0.00016556059],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013986633,0.0003748608,0.00031076476,0.00009067022,0.00019987309,0.00006926293,0.00031561506,0.00034501604,0.000019573312],"category_scores_gemma":[0.00006952179,0.00037080568,0.00028091125,0.00018813921,0.00005925433,0.00002743712,0.000091150076,0.00019154663,0.00002719663],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047810242,0.0003610752,0.0006357371,0.00002545853,0.00034038883,0.000010652398,0.00008235476,0.00007177715,0.9935974,0.0000112154,0.0013733774,0.0030124541],"study_design_scores_gemma":[0.0030267385,0.0034816116,0.0016639477,0.00002794159,0.00021913239,0.00014463582,0.00003520224,0.00036813048,0.988972,0.00006717162,0.0014840856,0.0005093786],"about_ca_topic_score_codex":0.00005948545,"about_ca_topic_score_gemma":0.000051314448,"teacher_disagreement_score":0.004625383,"about_ca_system_score_codex":0.000063843254,"about_ca_system_score_gemma":0.0003174756,"threshold_uncertainty_score":0.9998744},"labels":[],"label_agreement":null},{"id":"W2555978778","doi":"10.1182/blood.v120.21.4053.4053","title":"Treatment Outcomes with Pomalidomide (POM) in Combination with Low-Dose Dexamethasone (LoDex) in Patients with Relapsed and Refractory Multiple Myeloma (RRMM) and Del(17p13) and/or t(4;14)(p16;q32) Cytogenetic Abnormalities Who Have Received Prior Therapy with Lenalidomide (LEN) and Bortezomib (BORT)","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Calgary","funders":"","keywords":"Pomalidomide; Medicine; Tolerability; Internal medicine; Multiple myeloma; Lenalidomide; Bortezomib; Oncology; Adverse effect; Population; Expanded access; Surgery","score_opus":0.01879581665067745,"score_gpt":0.26038265894574447,"score_spread":0.24158684229506702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555978778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943215,0.0022243233,0.000014265249,0.00015657819,0.000011100618,0.003116933,0.000053700893,0.0000448264,0.000056777095],"genre_scores_gemma":[0.9938176,0.0014744732,0.0035961266,0.00008438806,0.00002177588,0.00041398496,0.00011150027,0.00009445088,0.00038565326],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99716836,0.0002730597,0.00046347769,0.000708146,0.0005989519,0.00078800623],"domain_scores_gemma":[0.9981123,0.0005098209,0.000244383,0.00042858097,0.00018014139,0.00052478095],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029888208,0.00064390065,0.0010236909,0.00042287773,0.00017170532,0.00008385283,0.0000678055,0.00016314327,0.0000102367585],"category_scores_gemma":[0.00010402862,0.00035484173,0.000030812604,0.00025605955,0.0004308544,0.00053326384,0.000051546845,0.0002720676,8.2063536e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034413543,0.003863813,0.94499785,0.00014834155,0.0007929251,0.00031175133,0.003039118,0.0000027280462,0.00022349013,0.0000052196233,0.0000012752345,0.012199929],"study_design_scores_gemma":[0.15521562,0.011290819,0.8281508,0.00048819595,0.00029762735,0.00018047952,0.0007306497,0.00007257729,0.0031363564,0.000003740553,0.000037334397,0.00039576986],"about_ca_topic_score_codex":0.0014645634,"about_ca_topic_score_gemma":0.0040766164,"teacher_disagreement_score":0.12080208,"about_ca_system_score_codex":0.00017481088,"about_ca_system_score_gemma":0.00021103321,"threshold_uncertainty_score":0.9998903},"labels":[],"label_agreement":null},{"id":"W2555995186","doi":"10.1182/blood.v116.21.5166.5166","title":"Comparison of Overt and Cryptic Labile Plasma Iron In Thalassemia Patients In Israel and Gaza-Palestine","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chemistry; Transferrin; Chelation therapy; Chelation; Antioxidant; Thalassemia; Siderophore; Biochemistry; Internal medicine; Medicine; Inorganic chemistry","score_opus":0.006225028867921088,"score_gpt":0.2555502482850016,"score_spread":0.24932521941708052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555995186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99812615,0.0003719691,1.8821764e-7,0.00009065747,0.000053950713,0.00022014204,0.0000034853017,0.000009186691,0.0011242806],"genre_scores_gemma":[0.9995593,0.00012703576,0.00022360314,0.000028099765,0.000010136254,0.000004600284,0.000010500458,0.000009496247,0.000027259133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99934536,0.00001447728,0.00023950366,0.0001511237,0.000105084495,0.00014443604],"domain_scores_gemma":[0.9996955,0.000050630068,0.000054961463,0.000107454274,0.000024243547,0.000067215085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000077374345,0.00009054767,0.00025332195,0.00009226159,0.000013575701,0.000004385117,0.00002682267,0.00014815218,0.000013225724],"category_scores_gemma":[0.00014254123,0.00007528732,0.000013844911,0.0001163936,0.00007395218,0.000031671825,0.000030835512,0.00029029258,0.0000025580982],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049774924,0.0010765778,0.9849658,0.00013999091,0.000007014233,0.0000090809235,0.00039433074,0.0000020307702,0.011420927,0.00003790202,0.000040693674,0.0018558842],"study_design_scores_gemma":[0.007972936,0.00036745716,0.9866532,0.00017534217,0.000050189974,0.000012270173,0.00047707392,0.00074632664,0.0033213254,0.00002319335,0.000115897885,0.00008480054],"about_ca_topic_score_codex":0.00035952366,"about_ca_topic_score_gemma":0.00049871404,"teacher_disagreement_score":0.008099602,"about_ca_system_score_codex":0.0000062767976,"about_ca_system_score_gemma":0.00002458049,"threshold_uncertainty_score":0.30701277},"labels":[],"label_agreement":null},{"id":"W2555998803","doi":"10.1182/blood.v126.23.2020.2020","title":"Extramedullary Disease at Diagnosis of Acute Myeloid Leukemia Does Not Influence Outcome of Patients Undergoing Allogeneic Hematopoietic Cell Transplant in First Complete Remission","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Hematopoietic stem cell transplantation; Myeloid leukemia; Transplantation; Bone marrow; Surgery; Gastroenterology; Leukemia; Myeloid; Chemotherapy","score_opus":0.02473724611772345,"score_gpt":0.27051655221250254,"score_spread":0.24577930609477908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555998803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978216,0.0004803685,0.000010239216,0.0004065428,0.000054995013,0.00072373444,0.00034721787,0.000031716052,0.00012357363],"genre_scores_gemma":[0.99753475,0.0012898244,0.0006068614,0.00017130708,0.00002499793,0.000066755856,0.00015276311,0.000047969697,0.000104770625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971415,0.00010984584,0.00089183537,0.00045386088,0.00092060765,0.00048238708],"domain_scores_gemma":[0.997854,0.00041232503,0.00026390818,0.00063309446,0.00021717508,0.0006195019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033195384,0.00028711229,0.00069293485,0.00025525034,0.000055570323,0.000007952622,0.0003400705,0.00016146236,0.000046146088],"category_scores_gemma":[0.00030994214,0.00021634575,0.0001694291,0.00033442365,0.00019566207,0.00013186851,0.00020843727,0.0003110059,0.0000182511],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010746195,0.0008843283,0.97851557,0.0016976728,0.000102683305,0.00034682188,0.0008642072,0.00012045715,0.016256655,0.000009764158,0.00007899397,0.00004822204],"study_design_scores_gemma":[0.015490043,0.0005591425,0.81417334,0.0012480732,0.00070650724,0.000024349309,0.00009167608,0.00013490922,0.16694894,0.00005204351,0.00024144806,0.00032954154],"about_ca_topic_score_codex":0.0002475175,"about_ca_topic_score_gemma":0.00012945016,"teacher_disagreement_score":0.16434225,"about_ca_system_score_codex":0.00060380285,"about_ca_system_score_gemma":0.00062823435,"threshold_uncertainty_score":0.88223237},"labels":[],"label_agreement":null},{"id":"W2556003890","doi":"10.1182/blood.v116.21.2529.2529","title":"Expression of the Neonatal Fc Receptor FcRn Is Not Required for the Amelioration of Murine ITP by IVIg or a Monoclonal Antibody","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services","funders":"","keywords":"Neonatal Fc receptor; Antibody; Immunology; Monoclonal antibody; Immunoglobulin G; Receptor; Fc receptor; Immune system; Chemistry; Autoantibody; Medicine; Internal medicine","score_opus":0.02640949171771641,"score_gpt":0.3278809205356248,"score_spread":0.3014714288179084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556003890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921129,0.00035064114,0.00013674801,0.005413229,0.00023501235,0.0008161984,0.0007097592,0.000013223442,0.00021231163],"genre_scores_gemma":[0.9932295,0.00018944009,0.0015203728,0.00029978206,0.00038341992,0.000054107302,0.00014625472,0.000023705126,0.0041534314],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985127,0.000044500826,0.0003844936,0.0002340389,0.0005742574,0.0002500508],"domain_scores_gemma":[0.99866164,0.00038847313,0.00019803918,0.0004543359,0.00020924953,0.00008823889],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002856282,0.00015406896,0.00029138086,0.000050342976,0.00015574394,0.000012014916,0.0003180639,0.000120380784,0.000451201],"category_scores_gemma":[0.00026671356,0.000071941744,0.00020403136,0.00021505648,0.00027538784,0.00006858946,0.00014989362,0.00029674303,0.000009798538],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022651937,0.0004078814,0.005797383,0.0001813718,0.00008133585,0.0000018393584,0.00034403408,3.1005587e-7,0.97708815,0.00007554635,0.009598619,0.0041583106],"study_design_scores_gemma":[0.002292604,0.00060425425,0.0067516603,0.00012681392,0.00009993753,0.000029145009,0.00008879523,0.000232668,0.9364418,0.00003953976,0.053204354,0.000088424364],"about_ca_topic_score_codex":0.00017245502,"about_ca_topic_score_gemma":0.000044337863,"teacher_disagreement_score":0.043605734,"about_ca_system_score_codex":0.0000048262696,"about_ca_system_score_gemma":0.00015569404,"threshold_uncertainty_score":0.49403343},"labels":[],"label_agreement":null},{"id":"W2556008211","doi":"10.1182/blood.v118.21.4196.4196","title":"Volume of Cerebrospinal Fluid Removal Prior to Intrathecal Chemotherapy Administration: A Survey of Canadian Hematology/Oncology Practitioners,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Medicine; Hematology; Chemotherapy; Internal medicine; Oncology; Lumbar puncture; Cerebrospinal fluid","score_opus":0.04220120922005354,"score_gpt":0.29160931450952876,"score_spread":0.2494081052894752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556008211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99386907,0.0001656139,0.000010726555,0.0016723343,0.00006692055,0.0004060892,0.000063466214,0.000010897121,0.0037348578],"genre_scores_gemma":[0.9925306,0.000032834498,0.0070264624,0.0002110771,0.000031857715,0.0000317737,0.000049838236,0.00001305511,0.00007253256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991047,0.00006286507,0.0003277398,0.0001887528,0.00012306415,0.00019287363],"domain_scores_gemma":[0.99909556,0.00003978391,0.00013130697,0.0002440938,0.00022958187,0.00025965826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002120241,0.00010956408,0.00037583418,0.00024085012,0.00003098538,0.0000029049552,0.00006730685,0.00012753632,0.00051408994],"category_scores_gemma":[0.00013146718,0.00009807007,0.000060514874,0.000344012,0.00007183281,0.000031026368,0.000009434003,0.00006591684,0.000027620497],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017557071,0.010129718,0.95276505,0.00012301508,0.00084463356,0.0015053479,0.001937115,2.3138975e-7,0.016911231,0.0048452793,0.0055504977,0.0036321573],"study_design_scores_gemma":[0.003587003,0.0041629565,0.84751,0.00005152203,0.00017704097,0.00118235,0.000093748946,0.0000031207562,0.14006557,0.000023415934,0.0030518183,0.000091497255],"about_ca_topic_score_codex":0.0627007,"about_ca_topic_score_gemma":0.084610105,"teacher_disagreement_score":0.12315434,"about_ca_system_score_codex":0.00004655971,"about_ca_system_score_gemma":0.0008912711,"threshold_uncertainty_score":0.9435409},"labels":[],"label_agreement":null},{"id":"W2556025265","doi":"10.1182/blood.v114.22.2475.2475","title":"Cost-Effectiveness of Filgrastim and Pegfilgrastim as Primary Prophylaxis against Febrile Neutropenia in Lymphoma Patients Receiving R-CHOP Chemotherapy.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Pegfilgrastim; Medicine; Filgrastim; Febrile neutropenia; Internal medicine; CHOP; Rituximab; Chemotherapy regimen; Neutropenia; Vincristine; Chemotherapy; Regimen; Oncology; Diffuse large B-cell lymphoma; Surgery; Lymphoma; Cyclophosphamide","score_opus":0.012267286590867933,"score_gpt":0.26601104899298694,"score_spread":0.253743762402119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556025265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901115,0.00023067967,0.000014724906,0.00006439703,0.00009678251,0.0014092593,0.000013352951,0.000049694092,0.008009663],"genre_scores_gemma":[0.9989244,0.00019270215,0.00020900191,0.0003755156,0.00006305906,0.00009193573,0.000037743725,0.000029855808,0.0000757952],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866265,0.00010780317,0.00031539027,0.00038100022,0.0002480317,0.00028514906],"domain_scores_gemma":[0.9992368,0.00010636185,0.00011567873,0.00027258802,0.00013380923,0.00013474829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018968152,0.00022020057,0.0004897783,0.00019013435,0.000070536305,0.000022473765,0.00008638018,0.00011232702,0.000037769867],"category_scores_gemma":[0.0000770549,0.00020140561,0.000083250816,0.0004388248,0.00007609936,0.00012619399,0.000033912707,0.00015901428,0.000010309461],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013618078,0.0038138248,0.7094292,0.00041720134,0.000091126734,0.000056907942,0.00026956413,0.000020388932,0.09287788,0.000030046518,0.00008929367,0.19154274],"study_design_scores_gemma":[0.013118098,0.001988614,0.95505,0.0004942962,0.00007384454,0.00004395753,0.000018016488,0.0000060827233,0.028639516,0.00007045424,0.0003128039,0.00018431916],"about_ca_topic_score_codex":0.00008833945,"about_ca_topic_score_gemma":0.000015140438,"teacher_disagreement_score":0.24562079,"about_ca_system_score_codex":0.00011284565,"about_ca_system_score_gemma":0.0001566599,"threshold_uncertainty_score":0.82130826},"labels":[],"label_agreement":null},{"id":"W2556062232","doi":"10.1182/blood.v118.21.2735.2735","title":"BCL2 Splice Isoform Switching Promotes Leukemia Stem Cell Survival and Sensitivity to a Novel Pan BCL2 Inhibitor","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"","keywords":"Dasatinib; Biology; Progenitor cell; Cancer research; Myeloid leukemia; Transplantation; Leukemia; Stem cell; Immunology; Nilotinib; Molecular biology; Imatinib; Medicine; Internal medicine; Genetics","score_opus":0.027240904311153967,"score_gpt":0.23638403108706824,"score_spread":0.20914312677591426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556062232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924624,0.00015689609,0.00023258361,0.00008096763,0.00014370325,0.0009174953,0.000027917411,0.0001606822,0.005817356],"genre_scores_gemma":[0.9948267,0.000018946284,0.003922218,0.00014594551,0.00029183176,0.00003374419,0.000012118846,0.00006416304,0.0006843421],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99817115,0.000044088996,0.00032526325,0.0005884045,0.00034155152,0.00052953424],"domain_scores_gemma":[0.9987842,0.00012023719,0.00011359726,0.00051515346,0.00008367555,0.00038317515],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037991692,0.0003420046,0.000509193,0.00011203879,0.000120813915,0.000023059289,0.00006469823,0.00016389757,0.00003347496],"category_scores_gemma":[0.00004946664,0.00029739682,0.00009004129,0.00019474277,0.00003784845,0.00013955236,0.00019002498,0.00029940903,0.0001457959],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009360354,0.0059382725,0.096897915,0.0010541545,0.0007494125,0.0014772671,0.01727537,0.0000014075563,0.8483323,0.00018314285,0.00022645986,0.026928289],"study_design_scores_gemma":[0.030962257,0.0023857772,0.24868093,0.0006965948,0.0012623214,0.0015106791,0.0018977621,0.0003761544,0.71040136,0.0000342796,0.00085041585,0.0009414863],"about_ca_topic_score_codex":0.0015627263,"about_ca_topic_score_gemma":0.00039334383,"teacher_disagreement_score":0.15178302,"about_ca_system_score_codex":0.0004769327,"about_ca_system_score_gemma":0.00042973724,"threshold_uncertainty_score":0.9999478},"labels":[],"label_agreement":null},{"id":"W2556091347","doi":"10.1182/blood.v126.23.1675.1675","title":"Prognostic Impact of TS, MTHFR and XRCC1 Genetic Variants in 113 Patients with Myelodysplastic Syndromes","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Methylenetetrahydrofolate reductase; XRCC1; Myelodysplastic syndromes; Single-nucleotide polymorphism; Genotype; Internal medicine; International Prognostic Scoring System; XRCC3; Biology; Oncology; Hazard ratio; Genetics; Proportional hazards model; Gastroenterology; Medicine; Gene; Bone marrow; Confidence interval","score_opus":0.016695920142588926,"score_gpt":0.27090638050264637,"score_spread":0.25421046036005746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556091347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99847245,0.00038450136,0.000017210004,0.0000346658,0.000019882998,0.0006903242,0.00002101108,0.000019349221,0.00034059954],"genre_scores_gemma":[0.9985659,0.000030918625,0.0012166353,0.000013733484,0.000027006039,0.000024734849,0.000021565185,0.000031668787,0.00006779904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986453,0.00006012715,0.00024371731,0.00026076267,0.00043646255,0.00035360747],"domain_scores_gemma":[0.99903345,0.00012580046,0.000071791925,0.00026277496,0.00019446011,0.00031172065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012566132,0.00016598332,0.00036172778,0.00023685742,0.000016286525,0.000013083623,0.00009469354,0.00008296524,0.00002989749],"category_scores_gemma":[0.00054703717,0.00011428163,0.000030426938,0.00037144677,0.00011377405,0.0000712703,0.00007418045,0.00020069157,0.00001928495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031469556,0.0008010703,0.99700767,0.000120737706,0.00016518586,0.00026206565,0.00033371456,0.000017889954,0.00020131457,0.000004554881,0.00010764902,0.0006634437],"study_design_scores_gemma":[0.012799053,0.003250333,0.9826852,0.00025354023,0.00019235243,0.00023801261,0.000044644177,0.00027616034,0.000104871884,0.000032964166,0.000006002173,0.000116859315],"about_ca_topic_score_codex":0.00021087221,"about_ca_topic_score_gemma":0.000019561798,"teacher_disagreement_score":0.014322472,"about_ca_system_score_codex":0.000113623566,"about_ca_system_score_gemma":0.0006637966,"threshold_uncertainty_score":0.46602696},"labels":[],"label_agreement":null},{"id":"W2556106584","doi":"10.1182/blood.v104.11.5153.5153","title":"Outcome of Stem Cell Transplantation for Pediatric Acute Lymphoblastic Leukemia: Comparison of Matched Related Donor Verses Matched Unrelated Donor. Important Role of Graft Versus Host Disease in Preventing Relapse.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Transplantation; Total body irradiation; Methotrexate; Cyclophosphamide; Graft-versus-host disease; Gastroenterology; Surgery; Internal medicine; Leukemia; Stem cell; Acute lymphocytic leukemia; Acute leukemia; Lymphoblastic Leukemia; Chemotherapy; Biology","score_opus":0.015715702044626238,"score_gpt":0.2817447564728036,"score_spread":0.26602905442817737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556106584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99661463,0.0009360031,0.0002699553,0.000039527367,0.00015228183,0.0015497776,0.0002972891,0.00005956909,0.000080965605],"genre_scores_gemma":[0.99785215,0.00036502053,0.0013014731,0.0000048481966,0.00003319396,0.000073447714,0.00022320042,0.00007544483,0.00007123988],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9960494,0.00008746361,0.002151147,0.00048738625,0.00068268616,0.00054192933],"domain_scores_gemma":[0.99730164,0.0006742726,0.0010205177,0.00046808177,0.000268049,0.00026741726],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004432029,0.0003551891,0.001177821,0.0005298852,0.000050266393,0.000008617309,0.0002677029,0.00034151538,0.000018572877],"category_scores_gemma":[0.00014655532,0.00033672727,0.00033201976,0.00094579323,0.00013233571,0.00015141694,0.00006287884,0.000322641,0.000006699385],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014911309,0.003453763,0.8398935,0.0057674665,0.0008742297,0.00024121221,0.003992784,0.0034502242,0.12716636,0.00015489716,0.000011541973,0.00008270976],"study_design_scores_gemma":[0.18299176,0.0036080421,0.36579397,0.0014395514,0.01437914,0.00006297497,0.003084391,0.0070175924,0.42048925,0.00032133135,0.0000048708266,0.0008071228],"about_ca_topic_score_codex":0.00047560164,"about_ca_topic_score_gemma":0.000046424113,"teacher_disagreement_score":0.47409955,"about_ca_system_score_codex":0.0006828506,"about_ca_system_score_gemma":0.001501398,"threshold_uncertainty_score":0.99990845},"labels":[],"label_agreement":null},{"id":"W2556106714","doi":"10.1182/blood.v126.23.1121.1121","title":"Comparing the Efficacy of Aspirin or Low Molecular Weight Heparin or Vitamin K Antagonists in the Risk of Thromboembolic Events in Patients with Multiple Myeloma Treated with Lenalidomide-Based Therapy","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Lenalidomide; Multiple myeloma; Internal medicine; Surgery; Oncology; Intensive care medicine","score_opus":0.027133644205496344,"score_gpt":0.2784189445408723,"score_spread":0.25128530033537594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556106714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973646,0.000103075305,0.000018146178,0.000055313958,0.000009383567,0.0023183334,0.000032568234,0.0000163034,0.00008230227],"genre_scores_gemma":[0.9992569,0.000027038519,0.00038135095,0.00004259821,0.000013254291,0.00013022011,0.00009706372,0.000039506667,0.0000120363175],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99739426,0.00052531244,0.00046118908,0.00033239194,0.00086304365,0.00042380733],"domain_scores_gemma":[0.9983461,0.00038778235,0.00026047276,0.0006839766,0.0001829481,0.00013873933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004783223,0.00029919308,0.0006898558,0.00020634464,0.000051624407,0.000011334596,0.00031475825,0.00007371414,0.000012150763],"category_scores_gemma":[0.00022870334,0.00011837128,0.00007962878,0.00077528873,0.00019085535,0.00006303713,0.00004021257,0.00026351094,0.0000037932134],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02474226,0.009304743,0.96272975,0.00006995027,0.00045467285,0.00019092759,0.00062168186,0.00018266196,0.00056911475,0.0000027365627,0.000004991898,0.0011265347],"study_design_scores_gemma":[0.102942705,0.003337467,0.8569104,0.00040478632,0.00015560245,0.000009219802,0.0001102638,0.0005319986,0.035460375,0.0000025683025,0.000009027075,0.00012559493],"about_ca_topic_score_codex":0.0024327897,"about_ca_topic_score_gemma":0.0018072501,"teacher_disagreement_score":0.10581934,"about_ca_system_score_codex":0.000069068454,"about_ca_system_score_gemma":0.00034078144,"threshold_uncertainty_score":0.48270407},"labels":[],"label_agreement":null},{"id":"W2556182164","doi":"10.1182/blood.v124.21.2226.2226","title":"Ibrutinib Sensitizes AML Cells to ROS Inducers Via a BTK-Independent Mechanism","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Mount Sinai Hospital; University of Toronto; University Health Network","funders":"","keywords":"Ibrutinib; Bruton's tyrosine kinase; Cancer research; Tyrosine kinase; Cytotoxicity; Pharmacology; Leukemia; Cell culture; Immunology; Chronic lymphocytic leukemia; Medicine; Chemistry; Biology; Signal transduction; In vitro; Biochemistry","score_opus":0.012707387365654065,"score_gpt":0.2623440579190436,"score_spread":0.2496366705533895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556182164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98986715,0.000033276403,0.0015117972,0.0008000426,0.00027957303,0.00081802503,0.0000068021336,0.00016806475,0.0065152533],"genre_scores_gemma":[0.9929877,0.000010677175,0.0021930835,0.001833595,0.0005452231,0.000040438546,0.000011331288,0.00006332502,0.0023146323],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99746907,0.000100279656,0.00031177342,0.0005369761,0.00087978004,0.0007021432],"domain_scores_gemma":[0.9982784,0.00015953767,0.000060356204,0.000759931,0.00013995402,0.0006018318],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005815329,0.00023979844,0.0004129973,0.00018805289,0.00009020625,0.00004504816,0.00020834104,0.00020555113,0.00026606125],"category_scores_gemma":[0.00022072061,0.00021303628,0.00012945452,0.00027460232,0.000051453666,0.00004791747,0.00022673121,0.0003168998,0.0018176967],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027364693,0.0009435962,0.00006237824,0.00022851845,0.000298823,0.0008131202,0.001055752,0.000021033065,0.9855788,0.0011221684,0.0038105869,0.0057915775],"study_design_scores_gemma":[0.028776897,0.00065651076,0.0002477307,0.000121724275,0.00020437066,0.000654951,0.00011689003,0.002180716,0.96198386,0.00047134003,0.004285198,0.00029979786],"about_ca_topic_score_codex":0.0005773689,"about_ca_topic_score_gemma":0.000040798826,"teacher_disagreement_score":0.02850325,"about_ca_system_score_codex":0.0018161007,"about_ca_system_score_gemma":0.0017332188,"threshold_uncertainty_score":0.9989595},"labels":[],"label_agreement":null},{"id":"W2556211593","doi":"10.1182/blood.v126.23.1119.1119","title":"Management of Cancer-Associated Upper Extremity Deep Vein Thrombosis with and without Venous Catheters at a Tertiary Care Center","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Cancer; Internal medicine; Population; Univariate analysis; Surgery; Thrombosis; Retrospective cohort study; Venous thrombosis; Deep vein; Breast cancer; Lung cancer; Multivariate analysis","score_opus":0.014564551553213975,"score_gpt":0.26314191555551286,"score_spread":0.24857736400229888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556211593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99317074,0.0023601556,0.000007706997,0.00031422375,0.000075039585,0.0006929604,0.000024929222,0.00005377484,0.003300492],"genre_scores_gemma":[0.99812084,0.00068967784,0.00048789673,0.00032176083,0.000030007994,0.00010844734,0.000040602004,0.000038104787,0.00016263036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987784,0.000033443925,0.00020956027,0.00032928222,0.0003444376,0.00030485447],"domain_scores_gemma":[0.99925417,0.0000074482664,0.00012295828,0.00031845857,0.00010924565,0.00018774296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000097613236,0.00020096399,0.00047280928,0.00007092177,0.00006432136,0.000013715511,0.00008855338,0.00006352225,0.00003361946],"category_scores_gemma":[0.0000054828106,0.00015586054,0.00006638851,0.00010807277,0.00008254447,0.000051587944,0.00015917556,0.0000779626,0.0000057037],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007102653,0.0031334574,0.98704755,0.00045660115,0.0016519534,0.000057019122,0.0046847574,0.000007541294,0.00017172785,0.000022232834,0.000452675,0.002243476],"study_design_scores_gemma":[0.0085694725,0.00072328903,0.9812425,0.00079448865,0.0026172707,0.000014036724,0.0026452548,0.00001692369,0.002133872,0.000009392463,0.0010013256,0.00023222451],"about_ca_topic_score_codex":0.0005678904,"about_ca_topic_score_gemma":0.0005526409,"teacher_disagreement_score":0.008498446,"about_ca_system_score_codex":0.00017768318,"about_ca_system_score_gemma":0.000034078483,"threshold_uncertainty_score":0.63558084},"labels":[],"label_agreement":null},{"id":"W2556217933","doi":"10.1182/blood.v112.11.lba-1.lba-1","title":"Rituximab, Fludarabine, and Cyclophosphamide (R-FC) Prolongs Progression Free Survival in Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) Compared with FC Alone: Final Results from the International Randomized Phase III REACH Trial","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre","funders":"","keywords":"Fludarabine; Medicine; Rituximab; Internal medicine; Tolerability; Clinical endpoint; Regimen; Progression-free survival; Gastroenterology; Refractory (planetary science); Cyclophosphamide; Surgery; Randomized controlled trial; Oncology; Chemotherapy; Adverse effect; Lymphoma","score_opus":0.034452724998572305,"score_gpt":0.3069382083251383,"score_spread":0.27248548332656597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556217933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99073416,0.0024683618,0.00001913351,0.0006353688,0.00038178184,0.0046010767,0.00019103201,0.00015270944,0.00081639586],"genre_scores_gemma":[0.9943024,0.0010670506,0.0009779024,0.00012965909,0.0010169597,0.00059837924,0.0007877674,0.000083845625,0.0010360209],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99423295,0.0006553192,0.0013740078,0.0010736238,0.0018911513,0.0007729639],"domain_scores_gemma":[0.9948222,0.0028259873,0.0005056559,0.0012611606,0.0002653242,0.0003196475],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025088044,0.000529477,0.0016527971,0.00021016836,0.00027092238,0.00007820255,0.0007485409,0.00032146997,0.000114253504],"category_scores_gemma":[0.0035582886,0.0003093191,0.00019071977,0.00051289663,0.0010751223,0.00019582012,0.000354122,0.0008730479,0.000032554137],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.98797774,0.0020658378,0.000144343,0.00006683502,0.0005858833,0.0034371985,0.001337626,0.00005405323,0.0006535739,0.000008788841,0.0021435544,0.0015245773],"study_design_scores_gemma":[0.9681836,0.002762928,0.00058537896,0.00084577844,0.00043003948,0.0010192145,0.00011699899,0.022994312,0.0016072319,0.000036734786,0.0010520709,0.00036575372],"about_ca_topic_score_codex":0.007944983,"about_ca_topic_score_gemma":0.002193616,"teacher_disagreement_score":0.022940258,"about_ca_system_score_codex":0.017019823,"about_ca_system_score_gemma":0.030963704,"threshold_uncertainty_score":0.99993587},"labels":[],"label_agreement":null},{"id":"W2556241839","doi":"10.1182/blood.v114.22.940.940","title":"The Novel Proteasome Inhibitor 5-Amino-8-Hydroxyquinole (5AHQ) Overcomes Bortezomib Resistance in Malignant Hematological Cell Line Models Harboring Mutations in the PSMB5 Gene.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Bortezomib; Proteasome; Proteasome inhibitor; Cell culture; Cancer research; Pharmacology; Multiple myeloma; Biology; Chemistry; Medicine; Molecular biology; Immunology; Biochemistry; Genetics","score_opus":0.020020458789916606,"score_gpt":0.23922414609791434,"score_spread":0.21920368730799775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556241839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919002,0.0036532828,0.00056463794,0.00083921297,0.00004812222,0.0008267111,0.00003303821,0.000019346111,0.0021154368],"genre_scores_gemma":[0.99733925,0.00022785588,0.0014108522,0.00033639115,0.00016921587,0.00022757203,0.00004087686,0.00001617655,0.00023182853],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99839735,0.00012311956,0.00039654222,0.0004194991,0.00021939965,0.0004440734],"domain_scores_gemma":[0.99923694,0.000051749004,0.000113795315,0.0004963118,0.000044841014,0.00005636948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005018483,0.0002163279,0.00019657362,0.000048924343,0.00017337265,0.0000710571,0.00044074998,0.00018289086,0.0000023990178],"category_scores_gemma":[0.00008388124,0.00014089326,0.00009226479,0.00021137802,0.000079893915,0.0000124106555,0.00007584368,0.0002411693,0.0000043005257],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000104076935,0.0011921375,0.0011209284,0.000032765303,0.000017244416,0.00005986074,0.00040918877,0.00033814606,0.99040264,0.006067234,0.0000775339,0.00017826914],"study_design_scores_gemma":[0.0023661128,0.00028160965,0.004812371,0.000074684045,0.000022472634,0.000039072762,0.00019809592,0.00036010897,0.98513174,0.004714675,0.001675537,0.00032350858],"about_ca_topic_score_codex":0.000013962623,"about_ca_topic_score_gemma":0.0001456855,"teacher_disagreement_score":0.0054390193,"about_ca_system_score_codex":0.000015384243,"about_ca_system_score_gemma":0.000086697946,"threshold_uncertainty_score":0.57454604},"labels":[],"label_agreement":null},{"id":"W2556243957","doi":"10.1182/blood.v112.11.2430.2430","title":"Functional analysis of the Human Pbx Interacting Protein (HPIP) in Human Hematopoiesis","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; Transactivation; Progenitor cell; Stem cell; Haematopoiesis; Molecular biology; Cell biology; CD34; Population; Transcription factor; Genetics; Gene","score_opus":0.031171550260716913,"score_gpt":0.2959181461756912,"score_spread":0.2647465959149743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556243957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99583405,0.000028121554,0.000040548843,0.00023378462,0.000025927195,0.00031101238,0.0000043326713,0.000020570516,0.003501637],"genre_scores_gemma":[0.99720675,0.0000010465843,0.00017062877,0.000052185496,0.00007447586,0.00004198424,0.000017803337,0.000015324022,0.0024197898],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855846,0.00007459588,0.00037738643,0.00022192349,0.00054257055,0.00022504377],"domain_scores_gemma":[0.9991933,0.0000906055,0.00012802555,0.00041318557,0.00011360395,0.000061247905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023554156,0.00010997459,0.00035333933,0.00041076838,0.00015721258,0.00000638092,0.00015753965,0.000071888506,0.0005117],"category_scores_gemma":[0.0003181496,0.00007762424,0.00020467427,0.001204298,0.00014577425,0.000054494343,0.00012811572,0.0002644022,0.000010221381],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007301275,0.0016543365,0.5207519,0.0001479713,0.002039024,0.00020239798,0.0013697703,0.000051904753,0.47182244,0.000725054,0.0010999772,0.000062227584],"study_design_scores_gemma":[0.005630679,0.00014981536,0.78811806,0.00026954306,0.0011801415,0.00017110426,0.00038493815,0.0004956573,0.20324412,0.00008499853,0.000120541255,0.0001503786],"about_ca_topic_score_codex":0.00044539597,"about_ca_topic_score_gemma":0.0001479871,"teacher_disagreement_score":0.26857832,"about_ca_system_score_codex":0.00017208203,"about_ca_system_score_gemma":0.0001989511,"threshold_uncertainty_score":0.5602756},"labels":[],"label_agreement":null},{"id":"W2556265301","doi":"10.1182/blood.v110.11.2976.2976","title":"Phase I Clinical Trial of Haplotype Mismatched Myeloablative Stem Cell Transplantation: Higher Doses of Donor Lymphocyte Infusions Depleted of Alloreactive Cells Using ATIR May Improve Outcome without Causing GVHD.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Transplantation; Stem cell; Immunology; CD8; Graft-versus-host disease; Donor lymphocyte infusion; Hematopoietic stem cell transplantation; Immune system; Internal medicine; Gastroenterology; Biology","score_opus":0.0892912263225017,"score_gpt":0.41191997491784665,"score_spread":0.32262874859534496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556265301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99667454,0.00018781734,0.00041279112,0.000025279442,0.00030941484,0.0015657722,0.00022426744,0.000032059546,0.00056803675],"genre_scores_gemma":[0.9967727,0.00019585375,0.0026518537,0.000031211228,0.00012718694,0.000011905647,0.000023055582,0.00004464236,0.00014158804],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969077,0.00021669563,0.0015592691,0.00036024282,0.0005812082,0.0003748706],"domain_scores_gemma":[0.9968869,0.0011631914,0.0009117926,0.0003816697,0.000482107,0.00017432368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010876976,0.0002777183,0.0012114978,0.00023634573,0.00006759278,0.0000052417,0.00012735138,0.00019901853,0.000044742766],"category_scores_gemma":[0.00009235297,0.00022624599,0.00031332832,0.0003795772,0.00043612914,0.000097420976,0.00005621621,0.00027000267,0.0000011071033],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.057377424,0.0041710823,0.0057277605,0.00044316973,0.00093242346,0.00007452336,0.002784072,0.000005852193,0.92677015,0.0000064064684,0.0000015035504,0.0017056281],"study_design_scores_gemma":[0.15829536,0.0035199118,0.014023586,0.00016215438,0.0011485195,0.000009978505,0.00075690454,0.00011918149,0.8217655,0.000011375687,0.000015178379,0.00017234158],"about_ca_topic_score_codex":0.00037210007,"about_ca_topic_score_gemma":0.0000502743,"teacher_disagreement_score":0.105004646,"about_ca_system_score_codex":0.00010397431,"about_ca_system_score_gemma":0.00040182323,"threshold_uncertainty_score":0.9226044},"labels":[],"label_agreement":null},{"id":"W2556280457","doi":"10.1182/blood.v126.23.3119.3119","title":"Influence of Fludarabine Pharmacokinetics on Outcome of Allogeneic Stem Cell Transplantation with Fludarabine-Busulfan Conditioning","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Fludarabine; Busulfan; Medicine; Transplantation; Total body irradiation; Pharmacokinetics; Internal medicine; Surgery; Gastroenterology; Hematopoietic stem cell transplantation; Urology; Cyclophosphamide; Chemotherapy","score_opus":0.03258313300281569,"score_gpt":0.30516925668600553,"score_spread":0.27258612368318985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556280457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997506,0.00020255471,0.00010875118,0.000062476975,0.000026675018,0.00046274567,0.00005028947,0.000033629312,0.0015468398],"genre_scores_gemma":[0.9987593,0.0000716293,0.0006445743,0.000087025976,0.00004874975,0.000020015228,0.00006144432,0.00003139953,0.00027580332],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981543,0.00005971037,0.00049348455,0.00025028345,0.0007793917,0.00026284636],"domain_scores_gemma":[0.998735,0.00011817113,0.00019661244,0.0003398975,0.00040435104,0.00020592767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029203307,0.00017486152,0.00040251188,0.00016403582,0.000027272137,0.0000059560884,0.00014746284,0.00008181955,0.000028093871],"category_scores_gemma":[0.000031716347,0.00013887869,0.000058906026,0.00028650663,0.00016730453,0.00007149941,0.000020162615,0.0001743462,0.000026237863],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065097557,0.0049602757,0.18446384,0.0063126865,0.00079872913,0.0012975065,0.0045155226,0.05275245,0.73642814,0.00040287548,0.00026600654,0.0012921948],"study_design_scores_gemma":[0.0606834,0.001913284,0.025678221,0.0003733957,0.0006020834,0.00028016273,0.00015621817,0.0004686427,0.9095853,0.000013366127,0.0000732383,0.00017267402],"about_ca_topic_score_codex":0.00010745614,"about_ca_topic_score_gemma":0.0000060945567,"teacher_disagreement_score":0.17315716,"about_ca_system_score_codex":0.00049412425,"about_ca_system_score_gemma":0.0015078677,"threshold_uncertainty_score":0.56633085},"labels":[],"label_agreement":null},{"id":"W2556287997","doi":"10.1182/blood.v104.11.491.491","title":"A Canadian Multicenter Case-Control Study of the Risk of Venous Thrombosis in Car and Airplane Travelers.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Notre-Dame; Jewish General Hospital","funders":"","keywords":"Medicine; Confounding; Odds ratio; Body mass index; Risk factor; Epidemiology; Venous thrombosis; Logistic regression; Internal medicine; Thrombosis; Surgery","score_opus":0.008551688669514605,"score_gpt":0.22775080395407063,"score_spread":0.21919911528455602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556287997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980483,0.0002009715,0.0000010427556,0.00024223443,0.000047373152,0.0011779942,0.00006519405,0.000004768995,0.00021210684],"genre_scores_gemma":[0.99969286,0.00007638556,0.0000388061,0.00013148587,0.000018748106,0.000024731014,8.389576e-7,0.000011542079,0.0000046270147],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992366,0.000053479314,0.00023511892,0.0001538749,0.00013374738,0.00018722311],"domain_scores_gemma":[0.9994891,0.000030963525,0.0000907331,0.00026733548,0.000031757878,0.000090076006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016675779,0.00009844758,0.00040071856,0.000109365224,0.000048184447,0.0000041065314,0.00006633408,0.000042834887,0.000017051541],"category_scores_gemma":[0.00004232387,0.00006982387,0.000048252437,0.00012232039,0.00003738038,0.000018408344,0.000020915719,0.0001093879,9.605177e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027214717,0.008890294,0.9719489,0.0001287797,0.0008757979,0.00065505685,0.016175408,0.00020797785,0.00043033503,0.000038368347,0.000025168256,0.00059666653],"study_design_scores_gemma":[0.011524071,0.00097065064,0.98142916,0.00010138448,0.0014407798,0.0000655591,0.0038270906,0.000012707336,0.00054152164,0.00001253681,0.000012339556,0.00006217383],"about_ca_topic_score_codex":0.4734797,"about_ca_topic_score_gemma":0.5916551,"teacher_disagreement_score":0.11817538,"about_ca_system_score_codex":0.00005125961,"about_ca_system_score_gemma":0.00008829293,"threshold_uncertainty_score":0.5300265},"labels":[],"label_agreement":null},{"id":"W2556313701","doi":"10.1182/blood.v126.23.3548.3548","title":"Risk Factors for Venous Ulcer Following ACUTE Venous Thromboembolism: Results from the Riete Registry","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Diagnosis and Treatment of Venous Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Pulmonary embolism; Chronic venous insufficiency; Venous leg ulcer; Venous thromboembolism; Internal medicine; Venous thrombosis; Diabetes mellitus; Surgery; Thrombosis","score_opus":0.03497428240939892,"score_gpt":0.2882821273725619,"score_spread":0.253307844963163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556313701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99175984,0.0023269586,0.00001495517,0.0007226831,0.0004972463,0.0007856676,0.002145685,0.00013539998,0.0016115778],"genre_scores_gemma":[0.9973127,0.00019581798,0.0005451164,0.0002980194,0.00056573946,0.00008295252,0.0007337228,0.000053916865,0.00021198181],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849164,0.00004866982,0.00028881952,0.00041538512,0.00037961412,0.00037589215],"domain_scores_gemma":[0.99816203,0.00056382164,0.00018321263,0.00070852943,0.000088305205,0.0002941175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017916589,0.00025170232,0.00054058124,0.000028579956,0.0002458442,0.0000716793,0.00019647065,0.00011536953,0.000008914274],"category_scores_gemma":[0.0007837023,0.00015948787,0.0003905087,0.000102086706,0.00005660515,0.0000839498,0.00004869078,0.00014334376,0.00004120062],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004952459,0.17625634,0.5721867,0.0001306148,0.045268495,0.0032133956,0.031072548,0.00007296497,0.0006732483,0.00032065317,0.15683666,0.0090159215],"study_design_scores_gemma":[0.06917846,0.02080779,0.7971869,0.00073114043,0.05193845,0.00008044294,0.0050880746,0.0000670044,0.008764872,0.003858103,0.041127987,0.0011707676],"about_ca_topic_score_codex":0.0011468023,"about_ca_topic_score_gemma":0.000047676993,"teacher_disagreement_score":0.22500019,"about_ca_system_score_codex":0.00005200727,"about_ca_system_score_gemma":0.00023062446,"threshold_uncertainty_score":0.6503727},"labels":[],"label_agreement":null},{"id":"W2556313900","doi":"10.1182/blood.v108.11.4034.4034","title":"An Essential Role of the Factor VIII Light Chain in Facilitating Heavy Chain Secretion.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Intein; Immunoglobulin light chain; Secretion; Chemistry; Transfection; Molecular biology; Biology; Biochemistry; RNA splicing; Gene; Genetics; Antibody; RNA","score_opus":0.006167168195931991,"score_gpt":0.25302697207845265,"score_spread":0.24685980388252066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556313900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99839336,0.00080896897,0.00006504179,0.00011181302,0.00003017301,0.00020867815,0.00005225713,0.000007448712,0.00032226287],"genre_scores_gemma":[0.9994469,0.0000139029025,0.0000994191,0.00003338291,0.00017094519,0.000020637,0.000050584767,0.000016529766,0.00014767422],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989324,0.0001909927,0.00020060403,0.00024960816,0.00018649432,0.00023985567],"domain_scores_gemma":[0.999455,0.000010678155,0.000058111837,0.00038851608,0.000049353446,0.000038355665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022034964,0.000109503766,0.00011059808,0.00004448333,0.0000607848,0.000013284665,0.00025980425,0.000108175715,0.00003301653],"category_scores_gemma":[0.0000330785,0.000089105415,0.000073983334,0.00013305874,0.00006138103,0.000003292457,0.00006345021,0.00009969143,0.0000030385293],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001634345,0.00028377614,0.00620021,0.00001027998,0.000015982658,7.654711e-7,0.00015143769,0.00014073195,0.9923275,0.000029089682,0.000013281524,0.00066347804],"study_design_scores_gemma":[0.0008955859,0.0005694882,0.0048891567,0.000009493916,0.000004579489,0.0000020269692,0.00015697793,0.00014626158,0.9926049,0.000118659955,0.0004998829,0.000102990336],"about_ca_topic_score_codex":0.000166531,"about_ca_topic_score_gemma":0.0011419093,"teacher_disagreement_score":0.0013110538,"about_ca_system_score_codex":0.000008177538,"about_ca_system_score_gemma":0.00007614729,"threshold_uncertainty_score":0.36336133},"labels":[],"label_agreement":null},{"id":"W2556320347","doi":"10.1182/blood.v122.21.606.606","title":"Unraveling The Molecular and Metabolic Basis For Glutamine Addiction In Leukemias","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Glutaminolysis; Oxidative phosphorylation; Glutamine; Biology; Citric acid cycle; Stromal cell; Metabolic pathway; Cancer cell; Cell biology; Leukemia; Cancer research; Biochemistry; Chemistry; Metabolism; Immunology; Cancer; Genetics","score_opus":0.006683819320145071,"score_gpt":0.21746414554304372,"score_spread":0.21078032622289866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556320347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9722191,0.025913216,0.0008457626,0.00017843206,0.00021640507,0.0003654289,0.000016906108,0.0000070601814,0.00023769583],"genre_scores_gemma":[0.995494,0.0021400247,0.00077357993,0.0004117429,0.0006796212,0.00022040476,0.00003187738,0.000019371562,0.00022934162],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993815,0.000027351854,0.00013183804,0.00021630862,0.00006065152,0.00018236213],"domain_scores_gemma":[0.9996591,0.000013824708,0.0000389679,0.0001964241,0.000048312493,0.000043339885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012806673,0.00010222277,0.000117348776,0.000033547156,0.00005050838,0.000025594434,0.00008556413,0.000087381886,0.000010481137],"category_scores_gemma":[0.000087453525,0.00007935925,0.00005819953,0.000069989495,0.000036634563,0.000004074371,0.000044132365,0.000054651675,0.0000025771794],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015114463,0.000052904456,0.0003096837,0.000009590021,0.00007474339,2.917822e-7,0.00006457265,0.000017681881,0.97820413,0.0002638659,0.00094002334,0.020047389],"study_design_scores_gemma":[0.0023835562,0.00008747203,0.015633529,0.000013343627,0.00017205485,0.000022513314,0.000112756665,0.00014766425,0.73649913,0.00016324068,0.24456301,0.00020170896],"about_ca_topic_score_codex":0.00013665523,"about_ca_topic_score_gemma":0.000055696026,"teacher_disagreement_score":0.24362299,"about_ca_system_score_codex":0.000003446191,"about_ca_system_score_gemma":0.000040546915,"threshold_uncertainty_score":0.32361764},"labels":[],"label_agreement":null},{"id":"W2556339349","doi":"10.1182/blood.v114.22.3203.3203","title":"Mechanisms of Erythropoietic Failure in Shwachman Diamond Syndrome Caused by Loss of Ribosome-Related Protein SBDS.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"K562 cells; Downregulation and upregulation; Biology; Diamond–Blackfan anemia; Small hairpin RNA; Cancer research; Ineffective erythropoiesis; Cell biology; Erythropoiesis; Gene knockdown; Molecular biology; Apoptosis; Leukemia; Immunology; Anemia; Ribosome; Medicine; Internal medicine; Gene; Genetics; RNA","score_opus":0.002932894822587437,"score_gpt":0.19805247888372798,"score_spread":0.19511958406114055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556339349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99775195,0.0013542392,0.000060993934,0.00015025555,0.000016022155,0.00038730496,0.00006375167,0.000008123593,0.00020734749],"genre_scores_gemma":[0.9992484,0.00005072402,0.0003155753,0.00002590629,0.0000036493398,0.000019620022,0.00015600161,0.000017050841,0.00016308081],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99900246,0.000041449966,0.00031401168,0.00028529373,0.00013400233,0.00022276404],"domain_scores_gemma":[0.99945444,0.000003251315,0.00013807547,0.00031175953,0.000037111873,0.00005534299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000064790336,0.00017293703,0.00027316238,0.00005640083,0.000021700584,0.0000050989765,0.0001497808,0.00021605867,0.000023265962],"category_scores_gemma":[0.000015608299,0.000163045,0.00009166011,0.00015915275,0.00006895729,0.0000043690457,0.00003618182,0.00007397329,0.0000031478712],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002585912,0.0026608636,0.0040107323,0.000042083757,0.00019510272,0.000045832297,0.000050791674,0.000007567527,0.99235976,0.00025136155,0.000110075955,0.00023999685],"study_design_scores_gemma":[0.0048033935,0.0016007723,0.0053046932,0.00005830914,0.00009168217,0.000023110124,0.00004556522,0.0000024380447,0.9847149,0.003118071,0.000050385628,0.00018665427],"about_ca_topic_score_codex":0.00004194423,"about_ca_topic_score_gemma":0.000072802315,"teacher_disagreement_score":0.0076448075,"about_ca_system_score_codex":0.000004625292,"about_ca_system_score_gemma":0.00003645268,"threshold_uncertainty_score":0.6648782},"labels":[],"label_agreement":null},{"id":"W2556350020","doi":"10.1182/blood.v106.11.4160.4160","title":"Existing Warfarin Therapy in Long-Term Care Facilities Maybe Inadequate.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph's Hospital; McMaster University","funders":"","keywords":"Warfarin; Medicine; Atrial fibrillation; Contraindication; Emergency medicine; Cohort; Stroke (engine); Thrombosis; Intensive care medicine; Internal medicine","score_opus":0.31774822746270176,"score_gpt":0.40800696163059513,"score_spread":0.09025873416789337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556350020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9705211,0.011522861,0.00017444363,0.004789469,0.0002094138,0.00053382874,0.00016616948,0.00007520468,0.012007532],"genre_scores_gemma":[0.9942459,0.00041274368,0.0011301786,0.001927878,0.00043861772,0.00011981453,0.000052849315,0.00003380394,0.0016382312],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99620974,0.00016357802,0.0025444343,0.0005155426,0.0000780348,0.00048866915],"domain_scores_gemma":[0.9983341,0.00031335087,0.00073607423,0.00045684294,0.000041685773,0.0001179213],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0037128082,0.00020706178,0.0006915447,0.00031659452,0.00014143926,0.00008801425,0.0002884404,0.00015539453,0.0005913327],"category_scores_gemma":[0.00064610294,0.00027120084,0.00009862833,0.00015580571,0.000052507265,0.00041142778,0.00004964455,0.0002078593,0.0017165882],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021149792,0.00050191523,0.90731776,0.0007638494,0.00009605657,0.000009885621,0.04294827,0.00021495447,0.000009515378,0.035884596,0.0010229803,0.011209063],"study_design_scores_gemma":[0.009943387,0.0003268809,0.8831543,0.00034166398,0.000011601851,0.000026811194,0.013945074,0.00074697065,0.00035130832,0.0064189797,0.08323525,0.0014978138],"about_ca_topic_score_codex":0.0015087742,"about_ca_topic_score_gemma":0.0010386412,"teacher_disagreement_score":0.08221227,"about_ca_system_score_codex":0.00037449462,"about_ca_system_score_gemma":0.000100114295,"threshold_uncertainty_score":0.999974},"labels":[],"label_agreement":null},{"id":"W2556397983","doi":"10.1182/blood.v118.21.4669.4669","title":"4Ts HIT Scoring in the Medical-Surgical ICU","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; St. Joseph's Hospital","funders":"","keywords":"Heparin-induced thrombocytopenia; Medicine; Thrombosis; Venous thrombosis; Emergency medicine; Internal medicine","score_opus":0.03826223437459709,"score_gpt":0.2714082646505175,"score_spread":0.2331460302759204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556397983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8616323,0.00036161125,0.0000057729562,0.0013775917,0.00010614776,0.0002559006,3.92031e-7,0.000033692915,0.1362266],"genre_scores_gemma":[0.99783486,0.00030824,0.00014309539,0.0012874919,0.00022321453,0.00005062147,0.0000021714823,0.000010105385,0.0001401901],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901253,0.000039937873,0.00017544845,0.00015990122,0.00039140176,0.00022080562],"domain_scores_gemma":[0.9995573,0.000044016815,0.000026863689,0.00026347846,0.000013707995,0.0000946182],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00046927563,0.00008234995,0.00021250507,0.000053263026,0.000035502264,0.0000083589575,0.0001692188,0.00006029558,0.0010046376],"category_scores_gemma":[0.00007048136,0.00005063123,0.0000576515,0.0001393717,0.000039042156,0.000027381266,0.000063889114,0.00016489925,0.00012817458],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025506536,0.06393955,0.5696653,0.00095226965,0.0013898575,0.049151,0.032921486,0.0000020349128,0.00038756942,0.14955096,0.0312574,0.10052748],"study_design_scores_gemma":[0.0070007322,0.00053815934,0.9391174,0.00043329815,0.00043104525,0.00047202632,0.0008466124,0.000017076294,0.0016325037,0.00085243897,0.04844173,0.00021697803],"about_ca_topic_score_codex":0.00020109824,"about_ca_topic_score_gemma":0.000055756016,"teacher_disagreement_score":0.36945206,"about_ca_system_score_codex":0.000008678548,"about_ca_system_score_gemma":0.000032217442,"threshold_uncertainty_score":0.99990857},"labels":[],"label_agreement":null},{"id":"W2556398862","doi":"10.1182/blood.v112.11.4702.4702","title":"Adequacy of Bone Marrow Trephine Biopsy in a Tertiary Care Center","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Hematological disorders and diagnostics","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Bone marrow; Trephine; Biopsy; Bone marrow examination; Tertiary care; Surgery; Pathology","score_opus":0.01392808649392974,"score_gpt":0.24936392755646805,"score_spread":0.23543584106253831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556398862","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993959,0.0022386957,0.0000085682095,0.0005168601,0.000021881016,0.0001638943,0.000016189533,0.000022772501,0.0030521303],"genre_scores_gemma":[0.9986725,0.00019608096,0.00062377355,0.00036793918,0.000024389827,0.000009522112,0.000034638957,0.000008933093,0.000062261235],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99933445,0.000013838923,0.00024126723,0.00013561102,0.00011825247,0.00015655921],"domain_scores_gemma":[0.9996338,0.000049223538,0.000037415582,0.00016616707,0.000037575523,0.000075817115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00002513373,0.00008424209,0.00025786777,0.00007188481,0.000014453411,0.0000012406296,0.000035172612,0.00007591321,0.00013089749],"category_scores_gemma":[0.00023446184,0.000063470805,0.0000708118,0.000119589415,0.000057987785,0.000019494453,0.000026115145,0.00008873868,0.000019056335],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041144092,0.0017290482,0.99354327,0.00015489556,0.000014290613,0.0013212899,0.0004761037,2.7715888e-7,0.0019127198,0.000053491505,0.00044886547,0.0003046221],"study_design_scores_gemma":[0.0075931167,0.00027007368,0.9838806,0.0002281708,0.000056617202,0.0006609598,0.0002813177,0.000009119635,0.006285906,0.00007533239,0.00054733077,0.000111450594],"about_ca_topic_score_codex":0.000048963593,"about_ca_topic_score_gemma":0.000012933599,"teacher_disagreement_score":0.009662647,"about_ca_system_score_codex":0.0000059919957,"about_ca_system_score_gemma":0.000031576565,"threshold_uncertainty_score":0.25882643},"labels":[],"label_agreement":null},{"id":"W2556420569","doi":"10.1182/blood.v116.21.4728.4728","title":"An Interesting Case of Hemophagocytic Lymphohistiocytosis Presenting with Pulmonary Hypertension","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Medicine; Hemophagocytosis; Hemophagocytic lymphohistiocytosis; Hepatosplenomegaly; Cytopenia; Internal medicine; Immunology; Gastroenterology; Pancytopenia; Bone marrow","score_opus":0.019959184125658027,"score_gpt":0.2798901778821334,"score_spread":0.2599309937564754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556420569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968554,0.00014828744,0.000019862155,0.00004439866,0.000032083193,0.00021277733,0.000001827034,0.00005539313,0.0026299788],"genre_scores_gemma":[0.99840736,0.000006676513,0.0012954844,0.000032482967,0.00006738588,0.000010849067,0.000012556343,0.000027598218,0.00013961052],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990853,0.000029683732,0.00025401652,0.00021225252,0.0001946639,0.00022405564],"domain_scores_gemma":[0.99912906,0.00005336549,0.00009051914,0.0004331453,0.00018127728,0.00011263956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019381223,0.00011111904,0.0002534427,0.0001146874,0.00010536819,0.000013596583,0.000089843634,0.000075666634,0.00007570847],"category_scores_gemma":[0.00018128003,0.00008488792,0.000047148846,0.00016528931,0.00012523348,0.0001318653,0.000052802774,0.0002467238,0.000007642574],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001917829,0.0014267775,0.1612773,0.00033926492,0.00009224477,0.013581713,0.00029199015,0.000005304358,0.8120775,0.000046494475,0.000018680235,0.010650947],"study_design_scores_gemma":[0.0125959,0.001956035,0.16284956,0.00057788,0.0008536791,0.1493138,0.002979614,0.030357221,0.6373051,0.000066520064,0.00050695275,0.0006377519],"about_ca_topic_score_codex":0.0001996343,"about_ca_topic_score_gemma":0.000026601643,"teacher_disagreement_score":0.17477241,"about_ca_system_score_codex":0.0000081956705,"about_ca_system_score_gemma":0.0001600091,"threshold_uncertainty_score":0.3461629},"labels":[],"label_agreement":null},{"id":"W2556435626","doi":"10.1182/blood.v114.22.1369.1369","title":"Diagnostic Delays and Survival for Medicare Patients with Chronic Myeloid Leukemia in the Pre-Imatinib Era.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Cancer Care Ontario","funders":"","keywords":"Medicine; Imatinib; Medical diagnosis; Imatinib mesylate; Epidemiology; Internal medicine; Proportional hazards model; Surveillance, Epidemiology, and End Results; Pediatrics; Cancer registry; Myeloid leukemia; Pathology","score_opus":0.007608612429487388,"score_gpt":0.2430349537698107,"score_spread":0.23542634134032334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556435626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955017,0.0010584,0.000056558198,0.00053335977,0.000052827963,0.0018991863,0.000040951752,0.000042060732,0.00081495836],"genre_scores_gemma":[0.99814755,0.00013066598,0.0006228901,0.0004018362,0.00019168497,0.0002089263,0.00021126925,0.000025764779,0.000059443122],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985013,0.000056649136,0.0002755711,0.0003475158,0.0004221172,0.00039686094],"domain_scores_gemma":[0.9986048,0.00072181097,0.000089617555,0.0003943242,0.00007010512,0.000119373915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002155495,0.00023258901,0.00033798788,0.000066612265,0.00008772262,0.000022344964,0.00014158864,0.00010430204,0.000028468832],"category_scores_gemma":[0.00045564005,0.00014223116,0.0000497463,0.000175055,0.00007321047,0.00007431886,0.000022918066,0.00023964277,0.0000061098594],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087516924,0.0033390496,0.9205584,0.00066102267,0.00053886266,0.00033011072,0.0051771603,0.00007578285,0.00016245032,0.00040014,0.0014595006,0.06642235],"study_design_scores_gemma":[0.03515116,0.0031874776,0.9591263,0.00041212054,0.0005212545,0.00005921529,0.00010848766,0.00017273249,0.00024516715,0.00012083908,0.00070235424,0.00019286832],"about_ca_topic_score_codex":0.00010816509,"about_ca_topic_score_gemma":0.0002942038,"teacher_disagreement_score":0.06622948,"about_ca_system_score_codex":0.00061282364,"about_ca_system_score_gemma":0.0007228749,"threshold_uncertainty_score":0.58000183},"labels":[],"label_agreement":null},{"id":"W2556440321","doi":"10.1182/blood.v126.23.799.799","title":"Treatment of 11q23/MLL + AML with Gemtuzumab Ozogamicin: Results from the Randomized Phase III Children's Oncology Group Trial AAML0531","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Population Health Research Institute; Hospital for Sick Children","funders":"","keywords":"Gemtuzumab ozogamicin; CD33; Internal medicine; Medicine; Myeloid leukemia; Leukemia; Oncology; Gastroenterology; Biology; CD34; Stem cell; Genetics","score_opus":0.034103467105335544,"score_gpt":0.3246124944877472,"score_spread":0.2905090273824117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556440321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98581153,0.00068134256,0.00008365799,0.0030812079,0.00015878948,0.0047604013,0.0002575785,0.00007528612,0.0050902036],"genre_scores_gemma":[0.99474406,0.00033147386,0.0014776847,0.00020957203,0.0013424124,0.00024642126,0.0007708007,0.000051436586,0.0008261099],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9968652,0.00065557426,0.00079024944,0.00053439185,0.0006893825,0.0004651689],"domain_scores_gemma":[0.9964061,0.0016790705,0.00037960176,0.0009770831,0.00022948059,0.00032871208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010112281,0.00033172485,0.0015768324,0.00011887343,0.00008264552,0.000019349605,0.000285787,0.00022074445,0.000059857477],"category_scores_gemma":[0.0008655739,0.00016821166,0.00027997445,0.00029000084,0.00051435805,0.00006392173,0.00007995898,0.0003191147,0.000043809985],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9790001,0.0064962455,0.00015310575,0.0000046844098,0.002170833,0.00038865383,0.0025682477,0.0000026108678,0.00084533804,0.000071990224,0.0026137223,0.0056844503],"study_design_scores_gemma":[0.9675504,0.018718898,0.00019036143,0.000042999523,0.0024058586,0.00019661016,0.00037481383,0.00012821316,0.005902866,0.000059381266,0.0042656413,0.00016393578],"about_ca_topic_score_codex":0.005159606,"about_ca_topic_score_gemma":0.00018456034,"teacher_disagreement_score":0.012222653,"about_ca_system_score_codex":0.00049745245,"about_ca_system_score_gemma":0.0013250716,"threshold_uncertainty_score":0.77998155},"labels":[],"label_agreement":null},{"id":"W2556460980","doi":"10.1182/blood.v116.21.4409.4409","title":"Hemolytic Reaction Following Intravenous Immunoglobulin (IVIg) for Platelet Alloimmunization During Pregnancy","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Pregnancy; Regimen; Hemolysis; Platelet; Gastroenterology; Gestation; Creatinine; Fetal hemoglobin; Internal medicine; Surgery; Obstetrics; Fetus","score_opus":0.006918955357258391,"score_gpt":0.22787191324455214,"score_spread":0.22095295788729374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556460980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99675465,0.00043474374,0.00040178708,0.00020030026,0.0005183694,0.000830185,0.000005156341,0.00014606536,0.00070876756],"genre_scores_gemma":[0.9968017,0.00010139508,0.0023438968,0.00003014908,0.00022043906,0.000059325215,0.00010180691,0.00004845471,0.00029283998],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99903166,0.000010583547,0.00026497903,0.00025428567,0.00016790302,0.00027059802],"domain_scores_gemma":[0.9994231,0.000035147674,0.00006740804,0.00033070962,0.000066155684,0.000077519304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000097148026,0.00015549448,0.00024231756,0.000081969694,0.00020133487,0.000025687188,0.000077420256,0.00017982442,0.000023886176],"category_scores_gemma":[0.0000685691,0.00014765828,0.0001596614,0.00014787338,0.000017913953,0.00013178267,0.000018493341,0.00030479959,0.000014699739],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012528306,0.00087324635,0.0034256182,0.00020857368,0.00018816437,0.000082394756,0.0003269477,8.5275286e-7,0.9856745,0.00014736607,0.0000037456239,0.008943279],"study_design_scores_gemma":[0.023516653,0.00081157073,0.12942493,0.0010833421,0.0012492957,0.0012701779,0.000121279314,0.00013246354,0.8405167,0.00034726548,0.0010833751,0.0004429587],"about_ca_topic_score_codex":0.000049952472,"about_ca_topic_score_gemma":0.000028340726,"teacher_disagreement_score":0.14515784,"about_ca_system_score_codex":0.000015653197,"about_ca_system_score_gemma":0.000044394146,"threshold_uncertainty_score":0.60213304},"labels":[],"label_agreement":null},{"id":"W2556470338","doi":"10.1182/blood.v108.11.368.368","title":"A Chemical Biology Screen Identifies Glucocorticoids as Inhibitors of C-Maf and C-Maf-Dependent Transactivation of Cyclin D2.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Transactivation; Cyclin D2; Cyclin D1; Cyclin; Biology; Cancer research; Cyclin D3; Molecular biology; Cell cycle; Cell; Biochemistry; Transcription factor; Gene","score_opus":0.01181211805639537,"score_gpt":0.2817117927313165,"score_spread":0.26989967467492115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556470338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981983,0.0004481393,0.00008889035,0.00011327738,0.000018966313,0.00034007986,0.000036030735,0.000017061473,0.0007393016],"genre_scores_gemma":[0.99914825,0.00004727173,0.0004761553,0.000007920609,0.00006343525,0.000018080324,0.00008605792,0.000011287122,0.00014153848],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990243,0.0000346247,0.00033830505,0.00019602854,0.00022662293,0.00018015338],"domain_scores_gemma":[0.9994931,0.0000832436,0.00009534823,0.000157751,0.00008884595,0.00008167517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010186576,0.00010477527,0.00028833293,0.00012260208,0.000020405027,0.0000051677557,0.00004517699,0.00010203129,0.00005388839],"category_scores_gemma":[0.00010353442,0.000085005,0.00006948887,0.000110321555,0.00015618067,0.00004763177,0.000021591575,0.00009025506,0.000004760489],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030194264,0.0010890479,0.1571454,0.0001038734,0.00017043712,0.000025233308,0.00006637346,3.500396e-7,0.83587956,0.0001477158,0.000010314853,0.0050597796],"study_design_scores_gemma":[0.006142217,0.00033168212,0.102443404,0.00007109115,0.00014858403,0.00003272469,0.000045558667,0.000015308635,0.89000034,0.00069732603,0.000013822992,0.00005791218],"about_ca_topic_score_codex":0.0016290286,"about_ca_topic_score_gemma":0.000044187316,"teacher_disagreement_score":0.054701988,"about_ca_system_score_codex":0.000013810263,"about_ca_system_score_gemma":0.000053647735,"threshold_uncertainty_score":0.34664032},"labels":[],"label_agreement":null},{"id":"W2556475996","doi":"10.1182/blood.v110.11.411.411","title":"Phase 1 Single Agent Antitumor Activity of Twice Weekly Consecutive Day Dosing of the Proteasome Inhibitor Carfilzomib (PR-171) in Hematologic Malignancies.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Carfilzomib; Proteasome inhibitor; Bortezomib; Medicine; Dosing; Pharmacology; Multiple myeloma; Mantle cell lymphoma; Tolerability; Proteasome; Internal medicine; Lymphoma; Adverse effect; Chemistry; Biochemistry","score_opus":0.019622068817900563,"score_gpt":0.259396809851684,"score_spread":0.23977474103378343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556475996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973429,0.0006085944,0.00018966218,0.00004943544,0.00010996423,0.00070712145,0.000085846696,0.00001099407,0.00089549966],"genre_scores_gemma":[0.99938285,0.000013614151,0.00038227247,0.00005401919,0.00006722486,0.00002420991,0.000010064642,0.000015536103,0.000050193037],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987186,0.00014657665,0.0003481073,0.00030136463,0.00017917634,0.0003061281],"domain_scores_gemma":[0.9991264,0.000040078263,0.000309447,0.00036471893,0.00010120347,0.0000581896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005739373,0.0001743515,0.00028443977,0.00005605643,0.000053468102,0.00000827666,0.00022337015,0.00015854031,0.000007848284],"category_scores_gemma":[0.00024601803,0.00013702731,0.00012912272,0.00021178497,0.0002333932,0.000006338073,0.00016857385,0.00013327497,0.0000013469498],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019746296,0.0019197132,0.00463321,0.00011280875,0.000038089744,0.000019492747,0.00024735986,0.0000010495856,0.9923594,0.00005946601,0.000040185823,0.00037173624],"study_design_scores_gemma":[0.0028883424,0.00073784124,0.0030593963,0.00014462335,0.00003306502,0.00004221567,0.00015991746,0.0000037387385,0.99242294,0.000032582015,0.00031835976,0.00015699571],"about_ca_topic_score_codex":0.00006010803,"about_ca_topic_score_gemma":0.000055719327,"teacher_disagreement_score":0.0026908794,"about_ca_system_score_codex":0.0000176726,"about_ca_system_score_gemma":0.00013256363,"threshold_uncertainty_score":0.55878115},"labels":[],"label_agreement":null},{"id":"W2556477008","doi":"10.1182/blood.v110.11.3779.3779","title":"Baseline Characteristics of 65 Subjects in the Correction of Anemia with Darbepoetin alfa (DA) in the Community-Dwelling Frail Elderly (CAFE) Study.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Darbepoetin alfa; Anemia; Placebo; Quality of life (healthcare); Randomization; Internal medicine; Randomized controlled trial; Ambulatory; Physical therapy","score_opus":0.021615324910806106,"score_gpt":0.2775698895769438,"score_spread":0.2559545646661377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556477008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969042,0.00012104985,0.000058182442,0.0003207095,0.000057443835,0.000643532,0.0000047903873,0.000011035824,0.0018790344],"genre_scores_gemma":[0.9993231,0.00004879457,0.00027615236,0.00017631735,0.00006876783,0.0000127175435,0.000038250222,0.00001414767,0.000041706982],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984453,0.00043509275,0.00044811898,0.00012237187,0.0003593506,0.00018978419],"domain_scores_gemma":[0.9984023,0.0008268269,0.00019218845,0.00046331692,0.000087387285,0.00002796288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002531195,0.0001439232,0.0003164826,0.00011299696,0.00007776497,0.000009187006,0.00016736185,0.000069737485,0.000014902413],"category_scores_gemma":[0.00017168197,0.00007937098,0.000041232895,0.0004162522,0.00010748039,0.000023575396,0.000018791827,0.0005783063,0.0000016071713],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007054529,0.014611141,0.93517965,0.00023064346,0.00007589503,0.00030782868,0.035895567,0.000009508605,0.0036130599,0.000019348336,0.00012551504,0.0092263995],"study_design_scores_gemma":[0.008533102,0.0056491434,0.90585065,0.0006469595,0.00039426485,0.00017908694,0.065682985,0.000037791007,0.012623659,0.000011664246,0.00024929535,0.00014140883],"about_ca_topic_score_codex":0.0015440529,"about_ca_topic_score_gemma":0.0021176918,"teacher_disagreement_score":0.029787414,"about_ca_system_score_codex":0.000022431337,"about_ca_system_score_gemma":0.000058301433,"threshold_uncertainty_score":0.32366544},"labels":[],"label_agreement":null},{"id":"W2556482722","doi":"10.1182/blood.v122.21.428.428","title":"The Erythropoietin Receptor Regulates The Number Of Cell Divisions and The Duration Of Erythroblast Terminal Differentiation By Regulating Erythroblast Iron","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Erythropoietin receptor; Erythroblast; Biology; Erythropoiesis; Cell biology; Erythropoietin; Progenitor cell; Transferrin receptor; Molecular biology; Receptor; Stem cell; Signal transduction; Genetics; Internal medicine; Haematopoiesis; Medicine","score_opus":0.005362818780536639,"score_gpt":0.21740992405360005,"score_spread":0.21204710527306342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556482722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944567,0.00030743823,0.000097217526,0.0035245987,0.00017059187,0.0006504629,0.000012752813,0.000022977458,0.0007572334],"genre_scores_gemma":[0.9974318,0.00038359055,0.00032125504,0.0001074157,0.00015224684,0.00005327204,0.0000488583,0.000021506054,0.0014800546],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99844825,0.00027302466,0.00057733373,0.00022485534,0.00026649353,0.00021006468],"domain_scores_gemma":[0.9980651,0.000744445,0.00049851893,0.0004442191,0.00019509577,0.000052610103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034215034,0.00017785988,0.0003160882,0.000025850573,0.000418581,0.000034161945,0.00012263808,0.00011430031,0.00035518702],"category_scores_gemma":[0.00018421156,0.000082003186,0.00012352913,0.00016107304,0.00086095644,0.00009168609,0.0000927459,0.00021436615,0.000028517132],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005240072,0.00070213183,0.015536643,0.00026106188,0.00016651512,4.301955e-7,0.002533939,0.000010734858,0.9623266,0.0011103733,0.012807653,0.0040199286],"study_design_scores_gemma":[0.02301045,0.0015736374,0.46980685,0.0008099566,0.0014171699,0.00030469827,0.009551701,0.0045279185,0.48236617,0.0031435187,0.002836409,0.00065151503],"about_ca_topic_score_codex":0.00012684328,"about_ca_topic_score_gemma":0.000016178841,"teacher_disagreement_score":0.4799604,"about_ca_system_score_codex":0.000011146477,"about_ca_system_score_gemma":0.00002984522,"threshold_uncertainty_score":0.38890487},"labels":[],"label_agreement":null},{"id":"W2556504054","doi":"10.1182/blood.v128.22.4144.4144","title":"Five-Year Survival Data from a Pivotal Phase 2 Study of Brentuximab Vedotin in Patients with Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Brentuximab vedotin; Medicine; Anaplastic large-cell lymphoma; Internal medicine; Oncology; Chemotherapy regimen; Peripheral T-cell lymphoma; Adverse effect; Progression-free survival; Lymphoma; Clinical endpoint; Phases of clinical research; Gastroenterology; Surgery; CD30; Chemotherapy; Clinical trial; Immunology; T cell","score_opus":0.01639331992627599,"score_gpt":0.25679773646639986,"score_spread":0.24040441654012387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556504054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99725497,0.000153065,0.0000040923674,0.00001046955,0.00012854622,0.00094968785,0.0013764718,0.000030438543,0.00009225502],"genre_scores_gemma":[0.9993094,0.000021483012,0.00005632075,0.000010294265,0.000053311138,0.000042798067,0.00037453836,0.000035064262,0.00009675477],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980994,0.00012797165,0.00044350917,0.0005546856,0.00048337664,0.0002910944],"domain_scores_gemma":[0.9982495,0.00031852955,0.00022040373,0.00099592,0.00008204797,0.00013364611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013156982,0.00023331704,0.00057169364,0.00011350658,0.000033646156,0.000010088889,0.00021670507,0.00007359455,0.00010477759],"category_scores_gemma":[0.000114257055,0.00012708691,0.00003600882,0.00017692336,0.000029776495,0.00012889077,0.00015023595,0.000046320096,0.00005404367],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053012366,0.13535908,0.85687375,0.00006442932,0.0003655468,0.00038240323,0.00039219524,9.719472e-8,0.00021503813,0.0000014908604,0.00014545092,0.0008992754],"study_design_scores_gemma":[0.32841045,0.010142802,0.658941,0.0006057528,0.0006800743,0.000005081071,0.00061794673,0.000009114285,0.00039703143,5.620579e-7,0.000045281842,0.00014494352],"about_ca_topic_score_codex":0.0004724725,"about_ca_topic_score_gemma":0.0005002515,"teacher_disagreement_score":0.3231092,"about_ca_system_score_codex":0.0001255781,"about_ca_system_score_gemma":0.00020886557,"threshold_uncertainty_score":0.51824534},"labels":[],"label_agreement":null},{"id":"W2556547291","doi":"10.1182/blood.v126.23.4030.4030","title":"Pulmonary Complications in Patients Treated with Tyrosine Kinase Inhibitors, a Systematic Review and Meta-Analysis","year":2015,"lang":"en","type":"review","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Bosutinib; Dasatinib; Nilotinib; Internal medicine; Ponatinib; Imatinib; Cumulative incidence; Pleural effusion; Subgroup analysis; Meta-analysis; Gastroenterology; Surgery; Myeloid leukemia; Cohort","score_opus":0.05895177354479435,"score_gpt":0.31572737349242075,"score_spread":0.2567755999476264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556547291","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000028905113,0.99150383,4.0800157e-7,0.000049150814,0.0000038765697,0.007705966,0.00030289943,0.0000460294,0.00035890922],"genre_scores_gemma":[0.00019784449,0.99340826,0.00013188629,0.00009987315,0.000011949429,0.0025112922,0.002992196,0.00006969045,0.00057699997],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9969613,0.0003637718,0.0012767958,0.00068093365,0.0004511645,0.0002660464],"domain_scores_gemma":[0.99737597,0.000105804414,0.00076776644,0.0012642962,0.00023210021,0.00025406713],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032498362,0.000652262,0.009988843,0.0004968083,0.00003702542,0.000019898756,0.00014706714,0.00018811366,0.000051089795],"category_scores_gemma":[0.000106825086,0.00036515007,0.0009864251,0.0018415928,0.00005609795,0.000053208394,0.0000725613,0.000273618,0.000049819082],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004175068,0.0016493598,0.00050798105,0.8437652,0.15306263,0.00014321422,0.000008382965,4.6949076e-8,1.0975028e-8,0.0000028143263,0.00008088373,0.00077529845],"study_design_scores_gemma":[0.0014732112,0.00016479215,0.000093721545,0.0918893,0.90152055,0.00021135565,0.0000015521066,8.146562e-7,1.3597577e-7,5.3402283e-7,0.004384216,0.0002597952],"about_ca_topic_score_codex":0.00010854293,"about_ca_topic_score_gemma":0.000020765941,"teacher_disagreement_score":0.7518759,"about_ca_system_score_codex":0.00053083996,"about_ca_system_score_gemma":0.00038996976,"threshold_uncertainty_score":0.9998801},"labels":[],"label_agreement":null},{"id":"W2556574152","doi":"10.1182/blood.v114.22.245.245","title":"The Population Based Incidence of Myelodysplastic Syndrome (MDS): Utility of Multiple Data Sources and Follow-up.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Shared Health; CancerCare Manitoba","funders":"","keywords":"Incidence (geometry); Chronic myelomonocytic leukemia; Medicine; Cancer registry; Myelodysplastic syndromes; Population; Internal medicine; Bone marrow; Epidemiology; Diagnosis code; Pediatrics","score_opus":0.030219923904350174,"score_gpt":0.2926817103978841,"score_spread":0.2624617864935339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556574152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99854934,0.00047445841,0.00014782949,0.00034787421,0.000025582216,0.00031991795,0.000051081268,0.000018372271,0.00006553036],"genre_scores_gemma":[0.998937,0.000036203623,0.00081590033,0.000037521215,0.00002016971,0.0000029346763,0.00008241987,0.00000782322,0.000059996622],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987882,0.000076093995,0.00030445357,0.00024040973,0.00040468207,0.00018620725],"domain_scores_gemma":[0.99825495,0.0006369408,0.00012404646,0.0007999961,0.000102111146,0.00008197205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006228262,0.00009463096,0.00025363057,0.00006646036,0.0000801729,0.0000102333415,0.0002839085,0.00006586301,0.000017098344],"category_scores_gemma":[0.0019422458,0.00006521319,0.000032548636,0.00020483554,0.00012140594,0.00009519864,0.00012151541,0.00015224773,0.0000020004375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048228158,0.00029825798,0.9826901,0.0001868874,0.00007647791,0.000034238197,0.000091194706,0.000005202431,0.010632387,0.000030174395,0.00013453409,0.00533827],"study_design_scores_gemma":[0.0032874895,0.00032590586,0.9781823,0.00011976704,0.00014215904,0.0000615043,0.000048146572,0.012590565,0.005044856,0.00008793599,0.00005279071,0.00005657937],"about_ca_topic_score_codex":0.00038287003,"about_ca_topic_score_gemma":0.000096907665,"teacher_disagreement_score":0.012585362,"about_ca_system_score_codex":0.000015722684,"about_ca_system_score_gemma":0.00015749829,"threshold_uncertainty_score":0.26593167},"labels":[],"label_agreement":null},{"id":"W2556577832","doi":"10.1182/blood.v118.21.4042.4042","title":"Combining Oncolytic Vaccinia Virotherapy with Adoptive T Cell Therapy,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Oncolytic virus; Biology; Cytotoxic T cell; T cell; Chimeric antigen receptor; Virotherapy; Antigen; CD8; Immunotherapy; Cancer immunotherapy; Cancer research; Immunology; Vaccinia; Adoptive cell transfer; Virology; Immune system; In vitro","score_opus":0.025218511851916373,"score_gpt":0.2585864539464211,"score_spread":0.23336794209450473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556577832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98815864,0.0011924746,0.00008656336,0.000024466774,0.000027285947,0.00035934878,0.000006824696,0.000027165845,0.010117223],"genre_scores_gemma":[0.99743074,0.00048518222,0.0007755081,0.00034289743,0.00011497936,0.00006575103,0.00002289264,0.00006571762,0.00069632387],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988471,0.000097671145,0.00014326777,0.00037869308,0.00018113825,0.00035209768],"domain_scores_gemma":[0.99923116,0.000009619536,0.000068209,0.0004958863,0.00008168596,0.000113466405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017798021,0.00020276943,0.00015810179,0.000051845684,0.000089510155,0.000018719755,0.0003114822,0.00011964048,0.0002625682],"category_scores_gemma":[0.0000039539054,0.00016408939,0.00006958054,0.00012390024,0.0000730034,0.000004139539,0.0000477034,0.00013794038,0.000043170858],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004881533,0.0010597071,0.005566749,0.000005762133,0.00021672725,0.000020808791,0.0004983276,0.000003279381,0.98535556,0.00001263242,0.0001480325,0.0022309043],"study_design_scores_gemma":[0.0055476422,0.01595865,0.0020191993,0.000007659791,0.000017579776,0.000014232472,0.0001048114,0.000004086112,0.9746048,0.00003045712,0.001443491,0.0002473992],"about_ca_topic_score_codex":0.000027452317,"about_ca_topic_score_gemma":0.00005364973,"teacher_disagreement_score":0.014898943,"about_ca_system_score_codex":0.0000080058735,"about_ca_system_score_gemma":0.00014263747,"threshold_uncertainty_score":0.6691371},"labels":[],"label_agreement":null},{"id":"W2556627884","doi":"10.1182/blood.v124.21.486.486","title":"Gemtuzumab Ozogamicin Reduces Relapse Risk in FLT3-ITD+ Acute Myeloid Leukemia: A Report from the Children's Oncology Group","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Gemtuzumab ozogamicin; Medicine; Calicheamicin; CD33; Internal medicine; Oncology; Induction chemotherapy; Chemotherapy; Myeloid leukemia; Stem cell; CD34; Biology","score_opus":0.009803910134536695,"score_gpt":0.2724915109283486,"score_spread":0.2626876007938119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556627884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861754,0.0007834827,0.00009616368,0.0035728614,0.00027705295,0.0011049114,0.00006462827,0.00017789815,0.0077475784],"genre_scores_gemma":[0.9917294,0.0011227251,0.002879325,0.00091356976,0.0014275737,0.00013688694,0.0004093161,0.00010128455,0.0012799385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99575514,0.00069074554,0.0008982191,0.0010246206,0.00074256177,0.00088869693],"domain_scores_gemma":[0.9964828,0.0010266707,0.00042612283,0.001624639,0.00013173319,0.00030802574],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020258364,0.0004197425,0.0008902569,0.0002475643,0.00023735498,0.00005103577,0.00069363875,0.00056835316,0.00016011731],"category_scores_gemma":[0.0019371447,0.00029544518,0.00023833443,0.0006537858,0.00037986485,0.00015321556,0.00041555488,0.0022947807,0.00029831968],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004375214,0.0036049422,0.677606,0.00007057776,0.005238052,0.013988762,0.0044393656,0.00004113157,0.09547767,0.0007852829,0.07200936,0.12236362],"study_design_scores_gemma":[0.028742459,0.0027393745,0.9016591,0.00024431729,0.002575629,0.0066948337,0.0005155073,0.00046797318,0.020374175,0.0015069774,0.03371391,0.0007657636],"about_ca_topic_score_codex":0.006943203,"about_ca_topic_score_gemma":0.0007405554,"teacher_disagreement_score":0.22405306,"about_ca_system_score_codex":0.0011546467,"about_ca_system_score_gemma":0.0011591646,"threshold_uncertainty_score":0.99994975},"labels":[],"label_agreement":null},{"id":"W2556648691","doi":"10.1182/blood.v120.21.1247.1247","title":"A Novel Perspective On Hematopoietic Stem/Progenitor Cell Homing - an Expanding Family of Bone Marrow Homing Factors That Can Support SDF-1-Mediated Homing or Even Replace SDF-1","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Homing (biology); Progenitor cell; Bone marrow; CXCR4; Stromal cell; Haematopoiesis; Stem cell; Cell biology; Plerixafor; Male-pattern baldness; Biology; Cancer research; Immunology; Chemistry; Chemokine; Inflammation; Anatomy","score_opus":0.04444486115754844,"score_gpt":0.28710432697105615,"score_spread":0.2426594658135077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556648691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99573684,0.0004008275,0.00048849476,0.0000810782,0.00044284816,0.0012454494,0.0001510535,0.00018977105,0.0012636187],"genre_scores_gemma":[0.9965444,0.000039203096,0.0021373392,0.0000980108,0.00023800826,0.0000726014,0.00013424263,0.00016339448,0.00057275133],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99634385,0.00013759722,0.000865616,0.0007298849,0.0009525133,0.0009705205],"domain_scores_gemma":[0.9972516,0.0006265124,0.00055146863,0.00073737436,0.0001957966,0.00063725875],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008012732,0.0005812763,0.0010869993,0.00046583434,0.00019769074,0.000043977507,0.00021074044,0.00033450985,0.00014055232],"category_scores_gemma":[0.00015491626,0.00049864285,0.00025769815,0.00046292835,0.00010613624,0.00035530108,0.00005380739,0.0004405177,0.000029884372],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074171077,0.0022699889,0.1552919,0.0013475493,0.00030069737,0.00018510177,0.051303677,0.000002568213,0.7883844,0.000058720336,0.000039523256,0.00007416977],"study_design_scores_gemma":[0.0098529495,0.0010784573,0.026640484,0.0012482603,0.0012766279,0.000829113,0.0902053,0.000055097913,0.8680631,0.0000052897285,0.000036773337,0.00070856296],"about_ca_topic_score_codex":0.0003427225,"about_ca_topic_score_gemma":0.0000394912,"teacher_disagreement_score":0.12865143,"about_ca_system_score_codex":0.00034183712,"about_ca_system_score_gemma":0.00037350383,"threshold_uncertainty_score":0.9997465},"labels":[],"label_agreement":null},{"id":"W2556666587","doi":"10.1182/blood.v114.22.2138.2138","title":"The Effects of Activated Protein C, Heparin, and Antithrombin On Thresholding Behaviour in Prothrombin Activation by Prothrombinase.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Thrombin; Prothrombinase; Chemistry; Antithrombin; Biophysics; Phosphatidylserine; Tissue factor; Coagulation; Thromboplastin; Biochemistry; Heparin; Internal medicine; Immunology; Phospholipid; Biology; Platelet","score_opus":0.008755584599310378,"score_gpt":0.251681005886794,"score_spread":0.2429254212874836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556666587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99484766,0.0001467608,0.000015696574,0.0007989074,0.000037292335,0.003742603,0.0000014838711,0.000068177396,0.0003414121],"genre_scores_gemma":[0.99929243,0.000038786726,0.00016309542,0.00013392139,0.00001761718,0.000200284,0.000011977946,0.000024393621,0.00011746906],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986181,0.00009008941,0.0003400848,0.0003312388,0.00034176416,0.00027872514],"domain_scores_gemma":[0.99927104,0.00008096053,0.00018049784,0.0003196109,0.00006324331,0.00008465565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025416774,0.00020993396,0.00036868523,0.00012447813,0.00012892425,0.000034068144,0.00009123879,0.00014894924,0.0000073973697],"category_scores_gemma":[0.00018504176,0.00015778294,0.00005153158,0.00033961574,0.00007094597,0.00013044773,0.000024990655,0.00027721428,0.0000022992565],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013436296,0.0025815654,0.004801215,0.0001192914,0.000044387794,0.000006831774,0.00014245875,2.0844371e-7,0.98593944,0.003912418,0.000073236486,0.0022445887],"study_design_scores_gemma":[0.0055496157,0.00296538,0.1281638,0.000818803,0.00006474103,0.000007122154,0.000036483798,0.0000137305715,0.86080456,0.0014207541,0.000020533356,0.00013447592],"about_ca_topic_score_codex":0.000045685923,"about_ca_topic_score_gemma":0.000004913652,"teacher_disagreement_score":0.12513487,"about_ca_system_score_codex":0.00003274863,"about_ca_system_score_gemma":0.000051443534,"threshold_uncertainty_score":0.6434201},"labels":[],"label_agreement":null},{"id":"W2556671040","doi":"10.1182/blood.v124.21.3069.3069","title":"Outcome in Unselected Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Following R-CHOP When Stem Cell Transplantation Is Not Feasible","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Diffuse large B-cell lymphoma; Transplantation; Oncology; Population; CHOP; Salvage therapy; Surgery; Chemotherapy regimen; Rituximab; Lymphoma; Cancer; Chemotherapy","score_opus":0.0097347692266039,"score_gpt":0.217364886351237,"score_spread":0.20763011712463308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556671040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99718416,0.00016937948,0.000038067803,0.00007997332,0.000111219764,0.00066939567,0.000057149926,0.000089337256,0.0016013111],"genre_scores_gemma":[0.99787194,0.000043961267,0.00033094324,0.00071750954,0.000037747628,0.00008077704,0.00022451524,0.00005885701,0.00063372805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981156,0.00008767915,0.0004187148,0.00045807674,0.00047043146,0.00044947327],"domain_scores_gemma":[0.9990909,0.00013641901,0.00013781604,0.00038089024,0.00006531969,0.0001886674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013015374,0.00030573568,0.00046996653,0.00017825628,0.000091301954,0.000032435728,0.00009760652,0.00015261164,0.000025346622],"category_scores_gemma":[0.00000947406,0.00023553884,0.00014984715,0.00021379863,0.000014292799,0.00015339258,0.000014519701,0.000099937395,0.000083920924],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000404577,0.032639578,0.9629969,0.00018243781,0.00011047558,0.00015783172,0.0014809982,4.171714e-7,0.00044711973,0.0000110702495,0.000097167765,0.0014714547],"study_design_scores_gemma":[0.17898579,0.0010483331,0.7954237,0.00018409947,0.0008041381,0.0000074332697,0.000056904028,0.000023202598,0.022243006,0.000005910468,0.0009448028,0.00027269096],"about_ca_topic_score_codex":0.00015347253,"about_ca_topic_score_gemma":0.00008915337,"teacher_disagreement_score":0.17858121,"about_ca_system_score_codex":0.00016296988,"about_ca_system_score_gemma":0.000085519976,"threshold_uncertainty_score":0.9604995},"labels":[],"label_agreement":null},{"id":"W2556681956","doi":"10.1182/blood.v112.11.1264.1264","title":"The Clinical Course of Untreated Gaucher Disease in 22 Patients Over 10 Years: Hematological and Skeletal Manifestations.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Mount Sinai Hospital; Queen's University; University of Ottawa","funders":"","keywords":"Enzyme replacement therapy; Medicine; Hepatosplenomegaly; Gastroenterology; Internal medicine; Anemia; Bone marrow; Surgery; Disease","score_opus":0.030171807418009334,"score_gpt":0.33984372685352465,"score_spread":0.3096719194355153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556681956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984298,0.00075216667,5.408421e-7,0.00014255056,0.000015000889,0.00029156273,0.000012308858,0.000011311222,0.00034476895],"genre_scores_gemma":[0.9992579,0.0003291474,0.00003249062,0.00004021456,0.000017256887,0.00001320005,0.000024050789,0.000008872559,0.0002768525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990821,0.00009670072,0.00025410377,0.00015772495,0.00024616963,0.00016322754],"domain_scores_gemma":[0.9993675,0.00020340827,0.0000441351,0.0001692485,0.00007880262,0.00013691922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013156122,0.000069946705,0.00017162092,0.00003074513,0.000041457086,0.0000049396417,0.000060817503,0.000060916285,0.00017398514],"category_scores_gemma":[0.0005329637,0.000045295237,0.00005363858,0.0001263668,0.00030737245,0.000030114037,0.00004716339,0.00014329627,0.000019709645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021711172,0.0023039582,0.9952474,0.000019470506,0.00003931973,0.00045924363,0.00007497631,1.578869e-7,0.00000755934,0.000031431457,0.0006241436,0.0009752299],"study_design_scores_gemma":[0.0052706064,0.0002328572,0.99386185,0.00002147043,0.000043565626,0.000019855224,0.000038779963,0.000040962248,0.000016077514,0.000052167557,0.0003551572,0.00004665965],"about_ca_topic_score_codex":0.000036832935,"about_ca_topic_score_gemma":0.00001541967,"teacher_disagreement_score":0.0050534946,"about_ca_system_score_codex":0.000008569846,"about_ca_system_score_gemma":0.00009788048,"threshold_uncertainty_score":0.19050153},"labels":[],"label_agreement":null},{"id":"W2556703504","doi":"10.1182/blood.v118.21.4327.4327","title":"Bridging Anticoagulation in Patients Who Require Temporary Interruption of Warfarin for Elective Surger or Procedure - the BRIDGE Trial: Design, Rationale and Clinical Implications","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Perioperative; Warfarin; Surgery; Population; Randomized controlled trial; Contraindication; Stroke (engine); Low molecular weight heparin; Anesthesia; Regimen; Clinical trial; Atrial fibrillation; Anticoagulant; Placebo; Heparin; Internal medicine","score_opus":0.19305824596117913,"score_gpt":0.372057626558593,"score_spread":0.17899938059741385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556703504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919517,0.000041855197,0.0036290993,0.00057969586,0.000056932116,0.0036201805,0.000010195734,0.0000148475465,0.00009546902],"genre_scores_gemma":[0.9987701,0.00006649515,0.00052195514,0.00017744534,0.00007341471,0.00027934674,0.000045921286,0.000013588839,0.000051735842],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990767,0.00007378198,0.0004435871,0.00019984685,0.00009635184,0.000109701316],"domain_scores_gemma":[0.9993235,0.00016404364,0.0001899653,0.00015929776,0.00013118419,0.000032001437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056879845,0.00008007064,0.00027229835,0.000078118595,0.000058129648,0.000008941097,0.000047966685,0.000055612916,0.0000094384895],"category_scores_gemma":[0.00036141014,0.000054719276,0.0000575333,0.0001330912,0.000046768513,0.00013315515,0.00002995397,0.000064382475,6.270699e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066354373,0.006114521,0.9732053,0.00018107721,0.0002582149,9.676957e-7,0.0010588818,0.0000020450677,0.00012941951,0.0012701424,0.0022083314,0.008935629],"study_design_scores_gemma":[0.014375859,0.0013590208,0.9826752,0.00010885222,0.00021240255,0.0000014580468,0.000037076614,0.00020743185,0.00047411802,0.00042834543,0.00005906812,0.00006117261],"about_ca_topic_score_codex":0.000066367116,"about_ca_topic_score_gemma":0.000037478603,"teacher_disagreement_score":0.009469862,"about_ca_system_score_codex":0.000015963094,"about_ca_system_score_gemma":0.00008904549,"threshold_uncertainty_score":0.22313873},"labels":[],"label_agreement":null},{"id":"W2556705153","doi":"10.1182/blood.v114.22.407.407","title":"Bortezomib Added to CVP-R Is Safe and Effective for Previously Untreated Advanced Stage Follicular Lymphoma: A Phase II Study by the NCIC Clinical Trials Group.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Queen Elizabeth II Health Sciences Centre; Ontario Institute for Cancer Research; Sunnybrook Health Science Centre; BC Cancer Agency; Hôpital Notre-Dame; Health Sciences Centre; CancerCare Manitoba; University Health Network; Moncton Hospital; University of British Columbia; Hôpital de l'Enfant-Jésus","funders":"","keywords":"Medicine; Bortezomib; Rituximab; Vincristine; Internal medicine; Prednisone; Follicular lymphoma; Surgery; Gastroenterology; Cyclophosphamide; Oncology; Lymphoma; Chemotherapy; Multiple myeloma","score_opus":0.03917964931880858,"score_gpt":0.41068659031426863,"score_spread":0.37150694099546006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556705153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799408,0.0041281004,0.000070086775,0.0012512801,0.000079865924,0.01410152,0.00027462782,0.0000772461,0.00007650049],"genre_scores_gemma":[0.99481505,0.00027295007,0.0004899493,0.0018185701,0.0001674656,0.0019731785,0.000100296646,0.00003682292,0.00032573106],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.997138,0.0005044228,0.000907673,0.0007344067,0.00029614725,0.00041932808],"domain_scores_gemma":[0.997254,0.0013882592,0.00026576396,0.0006174095,0.00011239021,0.00036214417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019254226,0.00037652676,0.0013310873,0.00007280755,0.00026982446,0.000046506528,0.00011638489,0.00012608041,0.000035892295],"category_scores_gemma":[0.0012671647,0.00022765274,0.00041403805,0.0002549314,0.000045902132,0.000061102466,0.000054897533,0.000073618234,0.000009449468],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009257744,0.08131204,0.014065747,0.00004735881,0.003245855,0.0002779283,0.001960676,6.981515e-7,0.0036443418,0.00005114734,0.007496905,0.8786396],"study_design_scores_gemma":[0.54090226,0.15902963,0.22726652,0.00035809356,0.014082538,0.000112896116,0.0011389599,0.00008265002,0.027001815,0.00010901,0.02914832,0.00076731347],"about_ca_topic_score_codex":0.00007817576,"about_ca_topic_score_gemma":0.000031054176,"teacher_disagreement_score":0.8778722,"about_ca_system_score_codex":0.00009826155,"about_ca_system_score_gemma":0.0000828279,"threshold_uncertainty_score":0.928341},"labels":[],"label_agreement":null},{"id":"W2556710404","doi":"10.1182/blood.v118.21.813.813","title":"Final Results From the Bortezomib-naive Group of PX-171-004, a Phase 2 Study of Single-Agent Carfilzomib in Patients with Relapsed and/or Refractory MM","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary; Princess Margaret Cancer Centre","funders":"","keywords":"Carfilzomib; Bortezomib; Tolerability; Medicine; Multiple myeloma; Regimen; Refractory (planetary science); Proteasome inhibitor; Internal medicine; Clinical endpoint; Oncology; Cohort; Progression-free survival; Surgery; Adverse effect; Overall survival; Clinical trial","score_opus":0.06477484060319613,"score_gpt":0.29062869432444255,"score_spread":0.22585385372124642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556710404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978122,0.00013289518,0.0000016335691,0.000015291833,0.00002587151,0.0013901467,0.0002692041,0.000011472156,0.0003412631],"genre_scores_gemma":[0.99927616,0.000022154496,0.0004211704,0.000016395572,0.000023963441,0.000043176806,0.00012074027,0.000019642597,0.000056618326],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832654,0.00015659034,0.00045257478,0.00033332442,0.00048822933,0.00024273964],"domain_scores_gemma":[0.9987736,0.00021546312,0.00023377276,0.00050245377,0.0001357075,0.0001390513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001917425,0.00017500915,0.00040316654,0.0001030542,0.000042468964,0.000005203079,0.0001202491,0.00005963039,0.000043751417],"category_scores_gemma":[0.00030846885,0.000095402436,0.00004115249,0.0001899561,0.00011394452,0.00006618917,0.00007040076,0.00018338145,0.0000024717813],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044009168,0.055040088,0.883593,0.000039862884,0.0007403702,0.00037060416,0.010376072,1.6806482e-7,0.0010207134,0.0000017845676,0.00004389946,0.004764236],"study_design_scores_gemma":[0.1310741,0.021461898,0.8433659,0.0002260677,0.00033608067,0.000002735236,0.001380437,0.0000067729898,0.0020371056,0.00000596776,0.000019893734,0.00008301928],"about_ca_topic_score_codex":0.004657253,"about_ca_topic_score_gemma":0.0010083177,"teacher_disagreement_score":0.08706493,"about_ca_system_score_codex":0.00003712109,"about_ca_system_score_gemma":0.000082667946,"threshold_uncertainty_score":0.70404047},"labels":[],"label_agreement":null},{"id":"W2556728679","doi":"10.1182/blood.v116.21.2230.2230","title":"Longitudinal Changes In Telomere Length In Patients with Dyskeratosis Congenita","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute","funders":"","keywords":"Dyskeratosis congenita; Telomere; Fluorescence in situ hybridization; Biology; Bone marrow failure; Chromosome instability; Pathology; Genetics; Chromosome; Medicine; Gene; Stem cell","score_opus":0.008461050523238341,"score_gpt":0.21935109653456897,"score_spread":0.21089004601133063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556728679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979606,0.0001221972,6.750801e-7,0.00036260195,0.00013036678,0.0004473608,0.000014987376,0.000046582805,0.00091460923],"genre_scores_gemma":[0.9990299,0.000032759704,0.0004344426,0.00018044694,0.00010920182,0.000038549144,0.00002829163,0.000030081,0.00011632859],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865365,0.000026429767,0.00022677804,0.00037651137,0.0003144786,0.0004021569],"domain_scores_gemma":[0.9992794,0.000047299567,0.000060086408,0.0003626396,0.00009717594,0.00015341502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012820723,0.0002090356,0.00035862796,0.00029677787,0.000039976734,0.000019658357,0.0001203898,0.00013329697,0.00017955163],"category_scores_gemma":[0.00008971053,0.00016651342,0.000030310386,0.00047236533,0.00009717557,0.00009548955,0.000035649115,0.0004730059,0.00003513561],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019270998,0.001426074,0.9911103,0.000052238014,0.000036018027,0.00012221244,0.0003328065,1.4194961e-7,0.0029642533,0.000047278256,0.000035478057,0.0036804536],"study_design_scores_gemma":[0.0077978494,0.00047461165,0.9823876,0.00011150952,0.00006475916,0.000021496637,0.00009343372,0.0000044828653,0.008455107,0.000008220397,0.00036966064,0.00021127259],"about_ca_topic_score_codex":0.00019804703,"about_ca_topic_score_gemma":0.007502613,"teacher_disagreement_score":0.00872274,"about_ca_system_score_codex":0.000020850279,"about_ca_system_score_gemma":0.00008181807,"threshold_uncertainty_score":0.679022},"labels":[],"label_agreement":null},{"id":"W2556728766","doi":"10.1182/blood.v114.22.1371.1371","title":"The Impact of the Child with Thalassemia On the Family: Parental Assessment by Child Health Questionnaire.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Population; Thalassemia; Medicine; Quality of life (healthcare); Context (archaeology); Cohort; Demography; Pediatrics; Psychology; Clinical psychology; Internal medicine","score_opus":0.004338874842747039,"score_gpt":0.26134748000481356,"score_spread":0.25700860516206653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556728766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9290159,0.004088052,0.000007807076,0.04507832,0.000075455864,0.0007540954,0.000020099591,0.000038406255,0.020921875],"genre_scores_gemma":[0.9971085,0.0010026299,0.000007578272,0.0017242574,0.000052478546,0.000009817208,0.0000105963445,0.000013958222,0.00007015844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988691,0.00011450364,0.00021809571,0.00016266975,0.00035534948,0.00028027655],"domain_scores_gemma":[0.9992072,0.00004267725,0.00015759701,0.00046724893,0.000032612174,0.00009268216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025982974,0.00016604672,0.0001959254,0.000017671306,0.00052834064,0.000021722075,0.00017693212,0.00006815554,0.000010941715],"category_scores_gemma":[0.000029747847,0.0000547926,0.00015359353,0.00020834194,0.00012361543,0.00002278828,0.000019400592,0.0005055145,0.000003287239],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012407346,0.020927096,0.63894475,0.00017287003,0.003754567,0.000059229882,0.0044101616,0.00073954335,0.0038526384,0.01481409,0.23837814,0.07270617],"study_design_scores_gemma":[0.002425428,0.0025191822,0.9915039,0.0008395391,0.00011397463,0.00015696745,0.00076999574,0.000065188484,0.00051371905,0.000075566146,0.00091383164,0.00010270888],"about_ca_topic_score_codex":0.00027489968,"about_ca_topic_score_gemma":0.00001604149,"teacher_disagreement_score":0.35255912,"about_ca_system_score_codex":0.00007640624,"about_ca_system_score_gemma":0.00025777894,"threshold_uncertainty_score":0.40636227},"labels":[],"label_agreement":null},{"id":"W2556739215","doi":"10.1182/blood.v118.21.5284.5284","title":"Application of Self-Efficacy Theory in Adherence to Iron Chelation Therapy: A Single-Center Cross-Sectional Study","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Deferasirox; Deferiprone; Thalassemia; Population; Cross-sectional study; Deferoxamine; Family medicine; Internal medicine; Environmental health","score_opus":0.02999396994193632,"score_gpt":0.28266910920949145,"score_spread":0.25267513926755514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556739215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99565876,0.00009572409,0.00019236829,0.000011341943,0.000045909022,0.0010797714,0.000001958294,0.000042423027,0.0028717532],"genre_scores_gemma":[0.9995003,0.000012331834,0.0002698751,0.000056585734,0.0000261468,0.00006143448,0.000007512738,0.000011924661,0.00005389512],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999227,0.000045648907,0.00026533127,0.00019498117,0.0001510528,0.0001159957],"domain_scores_gemma":[0.999611,0.00002462295,0.000069697606,0.0001809803,0.00006470979,0.000048959384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002468092,0.000082866805,0.00012540547,0.00009111909,0.00002732684,0.000005480945,0.000059915918,0.00008959365,0.000078102625],"category_scores_gemma":[0.000031522453,0.00006814845,0.000039349787,0.00021675482,0.00002510675,0.00004093736,0.000017871585,0.000110138375,0.000032872424],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037485638,0.016438322,0.96750265,0.000017043722,0.000048349106,0.0000029611222,0.0041203694,0.000006113632,0.0070472267,0.0001207414,0.0000017804549,0.0043195626],"study_design_scores_gemma":[0.006798688,0.001559082,0.98813045,0.000020417405,0.000028213202,0.000009251988,0.00029315436,0.000021049345,0.0029230015,0.00009359835,0.000053482643,0.00006961157],"about_ca_topic_score_codex":0.00007369954,"about_ca_topic_score_gemma":0.000013414248,"teacher_disagreement_score":0.020627776,"about_ca_system_score_codex":0.00001861166,"about_ca_system_score_gemma":0.000028819031,"threshold_uncertainty_score":0.27790132},"labels":[],"label_agreement":null},{"id":"W2556763113","doi":"10.1182/blood.v110.11.257.257","title":"Identification of Vacuolar H+- ATPase as a Target for Myeloma Therapeutics.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"ATP Synthase and ATPases Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Bafilomycin; Viability assay; Cell culture; MTT assay; Gene knockdown; Small hairpin RNA; Apoptosis; Cell growth; Molecular biology; Multiple myeloma; Cytotoxic T cell; Biology; Cancer research; Chemistry; In vitro; Immunology; Biochemistry; Autophagy; Genetics","score_opus":0.015211789335615128,"score_gpt":0.3180286673935708,"score_spread":0.30281687805795565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556763113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98577714,0.0008837509,0.012542446,0.000059753795,0.000036084388,0.00023275547,0.000045032164,0.0000070926594,0.00041592808],"genre_scores_gemma":[0.9979683,0.000072086186,0.0009215968,0.00007868689,0.00016860616,0.000019731488,0.000102251695,0.000017423792,0.00065128494],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99927044,0.000018304752,0.0002045335,0.0001905303,0.000118937,0.00019724622],"domain_scores_gemma":[0.9994687,0.000023542361,0.000071968236,0.00026033216,0.00012496668,0.00005053495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037667653,0.00007604957,0.00008318449,0.000036591115,0.000050077422,0.000009981411,0.00014302431,0.000095961965,0.00001660877],"category_scores_gemma":[0.000075454904,0.00007179347,0.00008977589,0.00006573508,0.000045373778,0.0000024150008,0.00003683378,0.00003685996,0.0000109494895],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000110006535,0.0002495304,0.001187785,0.00002605493,0.00009041399,0.0000026614077,0.00002269369,0.0000010306492,0.9946177,0.00015120403,0.00010632808,0.003434604],"study_design_scores_gemma":[0.0007818245,0.0003309026,0.0012150243,0.0000041988887,0.00003533139,0.0000032242058,0.00005665134,0.000016211961,0.97941136,0.00022228197,0.017840022,0.00008298085],"about_ca_topic_score_codex":0.0000054912407,"about_ca_topic_score_gemma":0.000004592856,"teacher_disagreement_score":0.017733693,"about_ca_system_score_codex":0.000002973576,"about_ca_system_score_gemma":0.000051958785,"threshold_uncertainty_score":0.29276526},"labels":[],"label_agreement":null},{"id":"W2556796635","doi":"10.1182/blood.v116.21.2903.2903","title":"ARNT/HIF-1β: An AML Biomarker?","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Aryl hydrocarbon receptor nuclear translocator; Cancer research; Bone marrow; Haematopoiesis; Chromosomal translocation; Biology; Fusion gene; Myeloid; Transcription factor; Stem cell; Medicine; Immunology; Gene; Aryl hydrocarbon receptor; Genetics","score_opus":0.008690700705519687,"score_gpt":0.24660520491620666,"score_spread":0.23791450421068697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556796635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919899,0.0012917457,0.0000632424,0.0000684226,0.0015986005,0.00009955427,0.000028582379,0.000026133099,0.0048338138],"genre_scores_gemma":[0.9941181,0.00024393761,0.0009704903,0.00029874552,0.0029836798,0.000019029841,0.000108920765,0.00002758028,0.0012295388],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991995,0.000024029303,0.00012376277,0.00031789648,0.00009283838,0.00024196095],"domain_scores_gemma":[0.99925005,0.0000034006946,0.000045006833,0.000506624,0.000050331135,0.00014457658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000119195414,0.00013110043,0.000114071176,0.000030666266,0.000073024195,0.000028051894,0.00020612174,0.00018111848,0.00008478403],"category_scores_gemma":[0.000043939617,0.00012496325,0.000083786865,0.00006762999,0.000068275236,0.000003854565,0.0000639678,0.00011208172,0.000030558553],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020960251,0.00020344189,0.00090819114,0.0000059490985,0.000035809764,0.000001395153,0.000020460002,1.7784792e-7,0.98441,0.000121646866,0.00240766,0.0118643455],"study_design_scores_gemma":[0.0010488778,0.000088936795,0.013125998,0.0000016381463,0.000052071093,0.00004276273,0.000016834274,0.0000035726032,0.44452485,0.00008101128,0.54083145,0.00018202164],"about_ca_topic_score_codex":0.000034463585,"about_ca_topic_score_gemma":0.00022955029,"teacher_disagreement_score":0.5398851,"about_ca_system_score_codex":0.0000011758844,"about_ca_system_score_gemma":0.000067755784,"threshold_uncertainty_score":0.5095853},"labels":[],"label_agreement":null},{"id":"W2556797897","doi":"10.1182/blood.v116.21.3704.3704","title":"Evaluation of Romiplostim In a Randomized Placebo-Controlled Phase 3 Study of a Japanese Population with Chronic Immune Thrombocytopenia (ITP).","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Romiplostim; Medicine; Placebo; Thrombopoietin; Internal medicine; Clinical endpoint; Population; Splenectomy; Platelet; Dosing; Randomized controlled trial; Gastroenterology","score_opus":0.015699681065553934,"score_gpt":0.31250066072532584,"score_spread":0.2968009796597719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556797897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924907,0.00038478148,0.0000011075132,0.000021746268,0.000034428693,0.0066270805,0.00000384653,0.000012185452,0.00042412063],"genre_scores_gemma":[0.9993784,0.0000081263315,0.000084682586,0.0000024328779,0.000015498948,0.00042040096,0.000049322553,0.00001594908,0.00002520874],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99825644,0.0002675943,0.0005720858,0.00019061092,0.00058084034,0.0001324436],"domain_scores_gemma":[0.9989658,0.00015439079,0.0003328982,0.00029071578,0.00021934685,0.000036863155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016401773,0.00014977777,0.0015284951,0.00017289023,0.000022408218,0.0000049441055,0.00005292879,0.00006720584,0.00013012972],"category_scores_gemma":[0.00043620126,0.0000983897,0.00010169855,0.00018739032,0.000041960313,0.000073465744,0.000013090226,0.00012401154,0.0000025593752],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.78622544,0.0620052,0.026748454,0.00015188417,0.005075333,0.00014871823,0.008182804,0.00026641716,0.10717592,0.00001727325,0.0000015784932,0.0040009865],"study_design_scores_gemma":[0.95446545,0.0024456782,0.029420156,0.00010329817,0.0055240523,0.00002905278,0.00035279512,0.004819951,0.002710889,0.00004726952,8.8942436e-8,0.0000812934],"about_ca_topic_score_codex":0.0018715907,"about_ca_topic_score_gemma":0.0023968688,"teacher_disagreement_score":0.16824004,"about_ca_system_score_codex":0.000036455538,"about_ca_system_score_gemma":0.00017132769,"threshold_uncertainty_score":0.40122154},"labels":[],"label_agreement":null},{"id":"W2556811127","doi":"10.1182/blood.v110.11.3995.3995","title":"Venous Thromboembolism and Non-Small Cell Lung Cancer: A Pooled Analysis of National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) Trials.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre; Queen's University; Health Sciences Centre; Sunnybrook Health Science Centre; University Health Network; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Internal medicine; Lung cancer; Vinorelbine; Oncology; Erlotinib; Randomized controlled trial; Cancer; Bevacizumab; Clinical trial; Chemotherapy; Surgery; Cisplatin","score_opus":0.07261791559963969,"score_gpt":0.4240663307849462,"score_spread":0.3514484151853065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556811127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98707753,0.009445608,0.000038275186,0.00031556323,0.0009867304,0.0007155186,0.00043239605,0.000008859339,0.0009795295],"genre_scores_gemma":[0.9958675,0.0023476428,0.00017512712,0.0004778869,0.00078735116,0.00005700159,0.00007940689,0.000013375969,0.00019468725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99738175,0.00023114245,0.0014779131,0.0002909407,0.00036457006,0.00025367984],"domain_scores_gemma":[0.99746615,0.0010876395,0.00081941346,0.00014474544,0.00024745558,0.00023458664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003925226,0.00017423634,0.0023045859,0.00026863228,0.000047642392,0.0000043540294,0.00008405587,0.00014485845,0.00036431671],"category_scores_gemma":[0.0005036001,0.00014176352,0.0003744853,0.00054948364,0.000100873105,0.00003431186,0.000028684655,0.00015952608,1.7495128e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053802026,0.008309499,0.8237123,0.0009524447,0.069994815,0.00021369201,0.001440576,0.00035911243,0.06271841,0.0001563101,0.013453532,0.013309125],"study_design_scores_gemma":[0.043469045,0.0009033372,0.8083257,0.00018620346,0.106850125,0.000008761952,0.000085426254,0.00048387598,0.034627307,0.000032738204,0.004691552,0.00033594537],"about_ca_topic_score_codex":0.28436103,"about_ca_topic_score_gemma":0.5459589,"teacher_disagreement_score":0.26159784,"about_ca_system_score_codex":0.0001796017,"about_ca_system_score_gemma":0.0034796712,"threshold_uncertainty_score":0.72040445},"labels":[],"label_agreement":null},{"id":"W2556818689","doi":"10.1182/blood.v120.21.2291.2291","title":"Efficient Erythropoiesis From Human Embryonic Stem Cells Through Dimerization of Intracellular MPL.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stemcell Technologies","funders":"","keywords":"Embryonic stem cell; Cell biology; Biology; Erythropoiesis; Stem cell; Cord blood; Progenitor cell; Induced pluripotent stem cell; Erythropoietin; Stromal cell; Molecular biology; Immunology; Cancer research; Biochemistry; Internal medicine; Genetics; Medicine","score_opus":0.021022013902810048,"score_gpt":0.2503453631641468,"score_spread":0.22932334926133674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556818689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951188,0.0015491565,0.0011862734,0.00008135112,0.00060823205,0.00022729277,0.000019536055,0.00006476746,0.0011446148],"genre_scores_gemma":[0.9978168,0.00006547268,0.0008762411,0.00016792891,0.00044940037,0.000009168476,0.00007451195,0.000025381356,0.00051511073],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990069,0.00007532502,0.00028497662,0.00019821912,0.00018442569,0.00025013447],"domain_scores_gemma":[0.9992869,0.000055707787,0.0001551227,0.00034101313,0.00006738143,0.000093901755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009310897,0.00014152659,0.00032950184,0.000049999773,0.00007658514,0.0000039267834,0.000057494886,0.00013602966,0.00065159873],"category_scores_gemma":[0.000010525991,0.0001233907,0.00010626778,0.0001632228,0.00010030976,0.00003873977,0.000037470974,0.00013019503,0.00016199387],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045012377,0.0013024596,0.0062353713,0.000075957345,0.00012664836,0.0000040206564,0.0009800938,0.000043751945,0.9902798,0.00042691478,0.00029874,0.00018122279],"study_design_scores_gemma":[0.0026052564,0.00041867825,0.017841592,0.00007700969,0.00053538254,0.000012736911,0.0005198511,0.00008854272,0.97362447,0.000038767528,0.00406672,0.00017097677],"about_ca_topic_score_codex":0.00006717889,"about_ca_topic_score_gemma":0.0000020404264,"teacher_disagreement_score":0.01665532,"about_ca_system_score_codex":0.00001545524,"about_ca_system_score_gemma":0.000029724137,"threshold_uncertainty_score":0.7134549},"labels":[],"label_agreement":null},{"id":"W2556823464","doi":"10.1182/blood.v120.21.1629.1629","title":"Pharmacokinetics (PK), Safety and Overall Response Rate (ORR) Achieved with Subcutaneous (SC) Administration of Rituximab in Combination with Chemotherapy Were Comparable to Those Achieved with Intravenous (IV) Administration in Patients (pts) with Follicular Lymphoma (FL) in the First-Line Setting: Stage 1 Results of the Phase III SABRINA Study (BO22334)","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Rituximab; Dosing; Pharmacokinetics; Clinical endpoint; Chemotherapy; Internal medicine; Phases of clinical research; Gastroenterology; Urology; Pharmacology; Surgery; Randomized controlled trial; Lymphoma","score_opus":0.011807747936582538,"score_gpt":0.26929800657728414,"score_spread":0.25749025864070163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556823464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941617,0.000059525595,0.000021066955,0.0010712681,0.000014097501,0.004498301,0.00010034047,0.000014340924,0.000059325866],"genre_scores_gemma":[0.99913925,0.000034207664,0.00031720978,0.00018224331,0.000014122061,0.00012379799,0.00012704467,0.000035336503,0.000026775568],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99740374,0.0005195771,0.0007242007,0.00040155556,0.00059812324,0.00035277684],"domain_scores_gemma":[0.99843127,0.00030675408,0.0004994775,0.0005014006,0.00015435286,0.00010676195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010758843,0.00036220573,0.0006295925,0.00015561568,0.00009376659,0.000032726126,0.00015121483,0.00007485965,0.0000026638766],"category_scores_gemma":[0.000052009607,0.00019668124,0.000031641084,0.0005843843,0.00010485983,0.00015181616,0.00002330879,0.00014876592,3.331086e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3916469,0.09765916,0.49693006,0.00010835024,0.0002848649,0.00037538604,0.010600475,0.00027718613,0.0004978373,0.000030169787,0.0000054408406,0.0015841927],"study_design_scores_gemma":[0.21648307,0.039966293,0.72738934,0.00046050843,0.0003230574,0.00013165115,0.0009905678,0.00015362543,0.013821235,0.0000015438044,0.00007691572,0.00020217663],"about_ca_topic_score_codex":0.00036436185,"about_ca_topic_score_gemma":0.0026662606,"teacher_disagreement_score":0.23045929,"about_ca_system_score_codex":0.00017690343,"about_ca_system_score_gemma":0.0003112643,"threshold_uncertainty_score":0.8020428},"labels":[],"label_agreement":null},{"id":"W2556829509","doi":"10.1182/blood.v116.21.2509.2509","title":"The North American Chronic Immune Thrombocytopenia Registry (NACIR): Demographics and Treatment Responses","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario; Hospital for Sick Children","funders":"","keywords":"Medicine; Splenectomy; Immune thrombocytopenia; Incidence (geometry); Pediatrics; Internal medicine; Population; Cohort; Evans syndrome; Univariate analysis; Platelet; Multivariate analysis; Spleen; Anemia","score_opus":0.009742350774386507,"score_gpt":0.2581970453510016,"score_spread":0.24845469457661506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556829509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99574727,0.0022028924,6.760461e-7,0.0009840775,0.00006191176,0.00032191398,0.000019435363,0.000045121997,0.000616694],"genre_scores_gemma":[0.99477005,0.0041224547,0.00018120176,0.00005522918,0.00006815978,0.000041181436,0.000024935838,0.000019227584,0.0007175648],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992115,0.000026603417,0.00015382392,0.00022259305,0.00012567354,0.00025982826],"domain_scores_gemma":[0.99916863,0.0001205841,0.00008718842,0.00048271116,0.000028472785,0.0001123951],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006306485,0.00016651896,0.00031467757,0.000039807484,0.00028285087,0.000037282512,0.00007708571,0.000042563457,0.000009226902],"category_scores_gemma":[0.00004508171,0.00009746513,0.00008037359,0.00017783028,0.00037347048,0.00003077867,0.00002867854,0.00017127329,0.000012458436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041191967,0.0012565365,0.9313733,0.00001434398,0.00086052204,0.00071376504,0.00013927881,8.8734986e-8,0.008177505,0.00013766225,0.00007698164,0.056838125],"study_design_scores_gemma":[0.00491756,0.0016191314,0.9743078,0.00001342115,0.00047994146,0.0006203008,0.000075909666,0.0000058689698,0.0026395896,0.00002779749,0.015167162,0.00012554099],"about_ca_topic_score_codex":0.00029489363,"about_ca_topic_score_gemma":0.006202486,"teacher_disagreement_score":0.056712583,"about_ca_system_score_codex":0.000022323024,"about_ca_system_score_gemma":0.00015015062,"threshold_uncertainty_score":0.39745125},"labels":[],"label_agreement":null},{"id":"W2556836548","doi":"10.1182/blood.v104.11.75.75","title":"Altered Kinetics and Localization of MMSET Variants Suggests That RE-IIBP Overexpression Is a Unifying Event in t(4;14)(p16;q32) Multiple Myeloma.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Breakpoint; Chromosomal translocation; Exon; Biology; Locus (genetics); Genetics; Gene; Alternative splicing; Gene duplication; RNA splicing; Molecular biology; RNA","score_opus":0.03245402061892937,"score_gpt":0.3058172494883735,"score_spread":0.27336322886944414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556836548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99746805,0.0005164593,0.0007872748,0.00017520481,0.000038077997,0.00066774763,0.00006449405,0.000026895506,0.00025582087],"genre_scores_gemma":[0.99750715,0.00030327644,0.0018078277,0.00008776096,0.000051330873,0.000024654968,0.00012390409,0.000028004371,0.00006609072],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984655,0.00006835357,0.00032666308,0.00034154335,0.00045765363,0.00034031607],"domain_scores_gemma":[0.9991616,0.00008021355,0.00011923199,0.00034285616,0.000086920285,0.00020915859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014296862,0.00018799318,0.00032944808,0.00020406018,0.000051930656,0.000017996897,0.000077549965,0.0001301845,0.00005892331],"category_scores_gemma":[0.00023707078,0.00015872343,0.00006509315,0.00023587797,0.000063600004,0.00010352984,0.00009537773,0.0001442884,0.000007884932],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009501207,0.003630087,0.9311539,0.00055388705,0.00024848196,0.0003117182,0.0017476421,0.0002940758,0.057261914,0.00002956843,0.00011973214,0.0036988612],"study_design_scores_gemma":[0.032859225,0.0009054649,0.71578234,0.0018621784,0.00014146406,0.00006662731,0.00020986986,0.0022608773,0.24527912,0.00029542606,0.00012841992,0.00020898847],"about_ca_topic_score_codex":0.0005254687,"about_ca_topic_score_gemma":0.00019768656,"teacher_disagreement_score":0.21537156,"about_ca_system_score_codex":0.000073321266,"about_ca_system_score_gemma":0.00008499186,"threshold_uncertainty_score":0.64725536},"labels":[],"label_agreement":null},{"id":"W2556851306","doi":"10.1182/blood.v114.22.2516.2516","title":"A Sensitized Screen Uncovers a Novel Platelet Phenotype in a Loss-of-Function Jak2 Allele.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Toronto; Toronto Centre for Phenogenomics; Ontario Institute for Cancer Research","funders":"","keywords":"Transversion; Biology; Mutation; Molecular biology; Mutant; Genetics; Phenotype; Exon; Allele; Mutagenesis; Gene","score_opus":0.016266446433028076,"score_gpt":0.2545703167140906,"score_spread":0.2383038702810625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556851306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942301,0.00019604083,0.00020122014,0.00087508047,0.00003688236,0.00051624747,0.000021645144,0.00003694962,0.0038858352],"genre_scores_gemma":[0.9966701,0.000073533556,0.0021676046,0.00078928797,0.00008942681,0.000017349146,0.000077138604,0.000013168817,0.00010234261],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989818,0.000024475772,0.0002772538,0.00026130542,0.00023701749,0.00021819343],"domain_scores_gemma":[0.9994589,0.00006847882,0.00008394435,0.0002089309,0.00008553829,0.00009417583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000114047754,0.00017,0.0004052311,0.00012962033,0.000028126318,0.000008745592,0.00003367076,0.00009654854,0.00009120496],"category_scores_gemma":[0.00007368209,0.00013963443,0.00009304069,0.00023662813,0.000027241578,0.000052650295,0.000012420534,0.0001265931,0.00003185321],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009280906,0.033318948,0.7914149,0.00024828146,0.0025048568,0.0025635893,0.0026156574,0.00032792304,0.10830355,0.0132641895,0.0028512576,0.03330592],"study_design_scores_gemma":[0.062517926,0.0049359696,0.85297346,0.00044669348,0.00076448434,0.00026666754,0.00015552921,0.00025216205,0.07352157,0.0007737999,0.0029694808,0.0004222364],"about_ca_topic_score_codex":0.00016747437,"about_ca_topic_score_gemma":0.00009188777,"teacher_disagreement_score":0.06155856,"about_ca_system_score_codex":0.000044631306,"about_ca_system_score_gemma":0.000096451426,"threshold_uncertainty_score":0.5694127},"labels":[],"label_agreement":null},{"id":"W2556853014","doi":"10.1182/blood.v108.11.1283.1283","title":"Mouse Model for Shwachman-Diamond Syndrome with the R126T Disease Mutation Leads to Severe Growth and Developmental Deficiencies with Impairment of Hematopoiesis.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Biology; Haematopoiesis; Allele; Diamond–Blackfan anemia; Exocrine pancreatic insufficiency; Mutation; Bone marrow; Null allele; Phenotype; Internal medicine; Genetics; Endocrinology; Immunology; Stem cell; Gene; Medicine; Cystic fibrosis; RNA","score_opus":0.004518694521432114,"score_gpt":0.18913392642843407,"score_spread":0.18461523190700196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556853014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99738693,0.0002850292,0.0015762026,0.00013409546,0.0000024152791,0.0004526475,0.00007830185,0.000006632726,0.0000777611],"genre_scores_gemma":[0.9961494,0.000005200028,0.0033176963,0.00007720185,0.0000053353947,0.00013814663,0.00008126427,0.000015683709,0.00021002765],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99943626,0.0000074882682,0.00009168715,0.0002108411,0.00010284904,0.00015088824],"domain_scores_gemma":[0.99974924,0.0000061007663,0.000043417953,0.00010688715,0.000039640843,0.000054735323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000031425687,0.00012613734,0.00010023989,0.000021537668,0.00009358269,0.000016626145,0.00006438911,0.000028128097,5.8436393e-7],"category_scores_gemma":[0.0000044976537,0.00007732509,0.000026152347,0.00005031313,0.00006163194,0.0000053930053,0.000032375057,0.00001526302,3.1348446e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035074549,0.011170367,0.7696905,0.0010805133,0.0015259456,0.00012447008,0.0030071116,0.01739027,0.1883252,0.0021452135,0.0015770704,0.000455881],"study_design_scores_gemma":[0.01881887,0.0055998177,0.086795606,0.00009851189,0.0012315412,0.0005389376,0.0021516045,0.000969569,0.88183534,0.0007119861,0.000058733996,0.0011894566],"about_ca_topic_score_codex":0.000026666235,"about_ca_topic_score_gemma":0.00018708373,"teacher_disagreement_score":0.6935102,"about_ca_system_score_codex":0.000004698606,"about_ca_system_score_gemma":0.00007216969,"threshold_uncertainty_score":0.31532255},"labels":[],"label_agreement":null},{"id":"W2556867900","doi":"10.1182/blood.v124.21.38.38","title":"Thymoglobulin Decreases the Need for Immunosuppression at 12 Months after Myeloablative and Nonmyeloablative Unrelated Donor Transplantation: CBMTG 0801, a Randomized, Controlled Trial","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; McGill University; Dalhousie University; University of Saskatchewan; Leukemia & Lymphoma Society of Canada; Université de Montréal; Juravinski Hospital; Hôpital Maisonneuve-Rosemont; BC Children's Hospital; Université Laval; University of British Columbia; Vancouver General Hospital; Princess Margaret Cancer Centre; University of Manitoba; BC Cancer Agency; University of Toronto; McMaster University","funders":"","keywords":"Thymoglobulin; Medicine; Transplantation; Randomized controlled trial; Immunosuppression; Internal medicine; Hazard ratio; Alemtuzumab; Graft-versus-host disease; Regimen; Surgery; Gastroenterology; Tacrolimus; Confidence interval","score_opus":0.0075298974495408896,"score_gpt":0.2370342881773783,"score_spread":0.2295043907278374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556867900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97131175,0.001357573,0.007279531,0.0009235175,0.0002759596,0.014869044,0.00007150557,0.00009888206,0.003812232],"genre_scores_gemma":[0.99265605,0.00056124514,0.0013770806,0.00026625223,0.0002574786,0.0036525438,0.00018168337,0.000048516908,0.0009991748],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99719733,0.00071431865,0.0009123348,0.00043943332,0.00038501166,0.00035156077],"domain_scores_gemma":[0.99277675,0.0062359925,0.0003275777,0.00031302823,0.00017228207,0.00017438462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013092797,0.00038309573,0.0015124112,0.000116839,0.00026464305,0.000047408288,0.000099667246,0.00024090704,0.00019211571],"category_scores_gemma":[0.0006632716,0.00022091827,0.00046866838,0.00012479842,0.00025825988,0.0001235913,0.000018888046,0.00018762701,0.000018156972],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98953724,0.00035351134,0.00058396405,0.00021186579,0.0011084413,0.000024123423,0.004801046,0.000010314057,0.0028526322,0.0002431956,0.000035815883,0.00023787662],"study_design_scores_gemma":[0.975161,0.0007229103,0.001822217,0.0005219325,0.0061221244,0.0001735476,0.0002589827,0.0019788956,0.012417886,0.00040643386,0.00015050052,0.0002635363],"about_ca_topic_score_codex":0.000049739447,"about_ca_topic_score_gemma":0.00002955682,"teacher_disagreement_score":0.021344269,"about_ca_system_score_codex":0.00003141581,"about_ca_system_score_gemma":0.00008625308,"threshold_uncertainty_score":0.9008786},"labels":[],"label_agreement":null},{"id":"W2556871045","doi":"10.1182/blood.v112.11.2895.2895","title":"Human Cord Blood Progenitors with High Aldehyde Dehydrogenase Activity Improve Vascular Density in a Model of Acute Myocardial Infarction","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Tissue Engineering and Regenerative Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials","funders":"","keywords":"Homing (biology); Stem cell; Transplantation; Biology; Paracrine signalling; Progenitor cell; Immunology; CD34; Angiogenesis; Cell biology; Pathology; Cancer research; Medicine; Internal medicine","score_opus":0.011443427956562842,"score_gpt":0.22930213010952988,"score_spread":0.21785870215296704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556871045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979293,0.00033304622,0.0008860691,0.00006966289,0.0001064851,0.0005581087,0.0000147335,0.000082329,0.00002028789],"genre_scores_gemma":[0.9973415,0.000058186517,0.0019486605,0.000013133835,0.0002907888,0.000050258535,0.00002235163,0.000038600436,0.00023647958],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99872845,0.00004233044,0.00023986983,0.0003295194,0.00038285516,0.00027695572],"domain_scores_gemma":[0.9992643,0.000010974486,0.00009450575,0.0003563094,0.00011242955,0.00016145562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013353428,0.00023700493,0.00054674136,0.00017864158,0.00008415805,0.0000030121282,0.00006215073,0.00013157725,0.0000040958253],"category_scores_gemma":[0.000022503351,0.0001827848,0.00011763087,0.00026800972,0.00015482234,0.00006682636,0.000029865987,0.00031664272,0.0000017241675],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021474177,0.0014438634,0.028718218,0.0000866872,0.0014731034,0.00045121447,0.0003277152,0.0010198017,0.96603405,0.000051245766,0.000016203821,0.00016312605],"study_design_scores_gemma":[0.012033144,0.0022149596,0.05378864,0.00011342308,0.002035961,0.0006648132,0.000016726555,0.0018198342,0.9270243,0.0000097296825,0.000020707681,0.00025777653],"about_ca_topic_score_codex":0.00025954942,"about_ca_topic_score_gemma":0.000033145978,"teacher_disagreement_score":0.039009795,"about_ca_system_score_codex":0.00003638432,"about_ca_system_score_gemma":0.00013542366,"threshold_uncertainty_score":0.7453748},"labels":[],"label_agreement":null},{"id":"W2556946221","doi":"10.1182/blood.v110.11.135.135","title":"Protein Phosphatase1 gamma (PP1cγ) Is Required for Thrombin-Induced Integrin αIIbβ3 Activation.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Protein phosphatase 1; Integrin; Platelet; Thrombin; Phosphatase; Phosphorylation; Biology; Molecular biology; Cell biology; Biochemistry; Receptor; Immunology","score_opus":0.02927016378246742,"score_gpt":0.2933758769140205,"score_spread":0.26410571313155307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556946221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942029,0.0001789887,0.0004113491,0.0008438707,0.00006646578,0.0016062891,0.000044202377,0.00008337104,0.0025625743],"genre_scores_gemma":[0.99528027,0.000009614613,0.0023614857,0.0005392169,0.000098386845,0.00013315475,0.00020003159,0.000034333483,0.0013434818],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99887604,0.000008105134,0.0002551525,0.00029956718,0.00020409464,0.000357061],"domain_scores_gemma":[0.99933475,0.000051511004,0.00009434954,0.0002946859,0.00009253031,0.00013214607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017051863,0.0001818141,0.0002969363,0.000082191094,0.000090765716,0.000017223974,0.00007486678,0.00013409046,0.000114198],"category_scores_gemma":[0.00011716881,0.00014965971,0.00011128956,0.00017428523,0.00002409676,0.00011323016,0.00002058255,0.00011465336,0.00007376238],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020911896,0.009817777,0.0062904027,0.00036147604,0.0016686158,0.0007886827,0.0012242082,1.5611852e-7,0.9083293,0.0028477197,0.009431136,0.05714933],"study_design_scores_gemma":[0.011898688,0.0008056797,0.005176447,0.0001464817,0.00019617275,0.000057535068,0.00015015945,0.000007716767,0.9755967,0.0009868667,0.0048102103,0.00016732873],"about_ca_topic_score_codex":0.00009504031,"about_ca_topic_score_gemma":0.000017431385,"teacher_disagreement_score":0.06726741,"about_ca_system_score_codex":0.000047021273,"about_ca_system_score_gemma":0.000081204525,"threshold_uncertainty_score":0.6102946},"labels":[],"label_agreement":null},{"id":"W2556952828","doi":"10.1182/blood.v110.11.3544.3544","title":"The JAK2 Kinase Inhibitor LS104 Induces Growth-Arrest and Apoptosis in JAK2V617F Positive Cells.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Erythropoietin receptor; Kinase; Janus kinase 2; Protein kinase B; Autophosphorylation; Biology; Molecular biology; Apoptosis; Cancer research; Cell biology; Signal transduction; Protein kinase A; Biochemistry","score_opus":0.008962523663792315,"score_gpt":0.2438089026847542,"score_spread":0.23484637902096187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556952828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925026,0.0013520317,0.0000028505617,0.002151512,0.00018304185,0.0005697586,0.000014899007,0.000025112797,0.0031981543],"genre_scores_gemma":[0.9980664,0.00075857225,0.00025399285,0.00042569812,0.0002692378,0.00007267704,0.0000133912135,0.000021235457,0.000118763055],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99873626,0.00005074953,0.00028812303,0.00032235938,0.00024180426,0.00036071608],"domain_scores_gemma":[0.99899787,0.00046858014,0.00007078346,0.00018476306,0.000092412556,0.00018561207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003294479,0.00021011353,0.00026684202,0.00010792096,0.00018658895,0.000049968745,0.000060976887,0.000108846485,0.000014605168],"category_scores_gemma":[0.00010801336,0.00013581368,0.000058879927,0.00022974107,0.000117304946,0.00006637077,0.00005440122,0.0002188634,0.00002554344],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008680574,0.007759403,0.8417813,0.00015789048,0.00073248905,0.0010887932,0.004217708,5.908408e-7,0.11639596,0.0047860225,0.0018612302,0.020350557],"study_design_scores_gemma":[0.003844516,0.00048165786,0.27941266,0.00015488183,0.00015091793,0.00002418729,0.00037042797,0.0000013860507,0.7147562,0.00010695427,0.0005603886,0.00013581521],"about_ca_topic_score_codex":0.00021502069,"about_ca_topic_score_gemma":0.0003111365,"teacher_disagreement_score":0.59836024,"about_ca_system_score_codex":0.000050670402,"about_ca_system_score_gemma":0.00005488308,"threshold_uncertainty_score":0.55383205},"labels":[],"label_agreement":null},{"id":"W2556974834","doi":"10.1182/blood.v118.21.303.303","title":"A Phase 2 Study of Elotuzumab in Combination with Lenalidomide and Low-Dose Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Lenalidomide; Dexamethasone; Medicine; Regimen; Multiple myeloma; Premedication; Internal medicine; Phases of clinical research; Pharmacology; Gastroenterology; Chemotherapy; Surgery","score_opus":0.023982915378325333,"score_gpt":0.2728240151189493,"score_spread":0.248841099740624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556974834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978558,0.00007012186,0.0000048077954,0.000005857335,0.000007446318,0.001857637,0.000010213981,0.000016410408,0.00017173083],"genre_scores_gemma":[0.99894655,0.000010113289,0.00083278446,0.000008004902,0.0000043305495,0.00011313842,0.000035585967,0.000027094267,0.000022399468],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858063,0.00012391285,0.00029594594,0.0003157412,0.000414101,0.00026964085],"domain_scores_gemma":[0.99921936,0.00010724646,0.000119786186,0.00028437492,0.00012476195,0.0001444727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018137296,0.00017777379,0.00038818782,0.00035031306,0.000028127803,0.0000062797653,0.00006187884,0.000056529854,0.000019539017],"category_scores_gemma":[0.00014551583,0.00012452569,0.00001709345,0.00033055813,0.00008016048,0.00014989832,0.00003596048,0.00019740716,0.0000026722976],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015388181,0.077902384,0.89736617,0.00007367274,0.00018919024,0.00034773702,0.0025517105,5.70376e-7,0.00032620537,0.000003057174,8.459461e-7,0.005850273],"study_design_scores_gemma":[0.25026467,0.018979266,0.72768736,0.00019248282,0.00008400233,0.0000058278074,0.000514217,0.000047665744,0.0021269086,0.000005003829,0.0000011231659,0.00009148497],"about_ca_topic_score_codex":0.0011392669,"about_ca_topic_score_gemma":0.0012875911,"teacher_disagreement_score":0.23487648,"about_ca_system_score_codex":0.00006244087,"about_ca_system_score_gemma":0.000088917375,"threshold_uncertainty_score":0.507801},"labels":[],"label_agreement":null},{"id":"W2556978135","doi":"10.1182/blood.v126.23.4261.4261","title":"In Multiple Myeloma Progression Free and Overall Survival in the Relapsed Setting Remains Poor with Early Exposure to Novel Agents: Experience from a Real-World Cohort","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Alberta","funders":"","keywords":"Medicine; Lenalidomide; Multiple myeloma; Cohort; Bortezomib; Regimen; Internal medicine; Oncology; Progression-free survival; Refractory (planetary science); Maintenance therapy; Overall survival; Chemotherapy","score_opus":0.041236579819620964,"score_gpt":0.3169666778374186,"score_spread":0.27573009801779763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556978135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963361,0.00008961813,0.000013466832,0.0010834446,0.000038955033,0.0015789958,0.000043353564,0.00003125473,0.000784834],"genre_scores_gemma":[0.993836,0.000012447692,0.0052377926,0.0002422004,0.00009340912,0.00032829275,0.00004512812,0.00002676317,0.00017797905],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979007,0.00014710549,0.00027743887,0.00046127284,0.0007763354,0.0004371339],"domain_scores_gemma":[0.99880016,0.00021559275,0.00006677839,0.0005205393,0.00007796321,0.00031897653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050414423,0.00020175302,0.00031791034,0.00016648593,0.00006704611,0.000053981195,0.00020441004,0.00006961557,0.0000127498715],"category_scores_gemma":[0.00065352564,0.00012427625,0.000027070826,0.0003816656,0.00006715227,0.00017259114,0.0001351835,0.00025846544,0.000008845172],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012674374,0.0012386973,0.98501647,0.000015464093,0.000059777303,0.0010114879,0.0075967903,0.0000018259957,0.003181393,0.000015351827,0.00013782311,0.00045751102],"study_design_scores_gemma":[0.026236147,0.0009194956,0.96938413,0.000367261,0.00003513124,0.000024066976,0.0011937784,0.00013757683,0.0014185326,0.000024041325,0.000121727426,0.00013811298],"about_ca_topic_score_codex":0.0068872757,"about_ca_topic_score_gemma":0.012752449,"teacher_disagreement_score":0.02496871,"about_ca_system_score_codex":0.00008413047,"about_ca_system_score_gemma":0.000116715564,"threshold_uncertainty_score":0.99972594},"labels":[],"label_agreement":null},{"id":"W2556986934","doi":"10.1182/blood.v112.11.3032.3032","title":"Case Fatality Rates of Recurrent Venous Thromboembolism during and Following Anticoagulation Therapy","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Case fatality rate; Pulmonary embolism; Thrombosis; Deep vein; Mortality rate; Etiology; Internal medicine; Surgery; Pediatrics; Epidemiology","score_opus":0.044062214883059364,"score_gpt":0.2986845766677558,"score_spread":0.25462236178469644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556986934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99657494,0.0023512314,0.000010979439,0.000074725984,0.00012536706,0.000454228,0.0000037989755,0.0000419516,0.00036278562],"genre_scores_gemma":[0.99770206,0.0018184831,0.00028038528,0.000052681342,0.000086999644,0.000015156014,0.000010418748,0.000018119656,0.000015713373],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991118,0.000032563967,0.0002590882,0.00022494452,0.00018566704,0.00018596707],"domain_scores_gemma":[0.9995241,0.000028230217,0.00009045924,0.00023798253,0.00004179548,0.00007740852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012763128,0.0001320217,0.0004997983,0.00007971505,0.00016372518,0.000008515897,0.00003632544,0.000050909824,0.000021512522],"category_scores_gemma":[0.000028553563,0.000115957184,0.00009948194,0.00011452642,0.000058147347,0.00008371694,0.000043210315,0.00007500209,0.0000025865504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024553438,0.023264715,0.8060482,0.0013240967,0.00345526,0.017718628,0.015575459,0.00002291456,0.1135141,0.0011142418,0.00032070643,0.017396135],"study_design_scores_gemma":[0.0038658031,0.0004448642,0.94599986,0.00012142357,0.00033538614,0.001913167,0.00017577077,0.000020825402,0.046852987,0.00006888884,0.00006164065,0.00013938767],"about_ca_topic_score_codex":0.00017948693,"about_ca_topic_score_gemma":0.000007672348,"teacher_disagreement_score":0.13995165,"about_ca_system_score_codex":0.000012287939,"about_ca_system_score_gemma":0.00002539773,"threshold_uncertainty_score":0.47285965},"labels":[],"label_agreement":null},{"id":"W2557010481","doi":"10.1182/blood.v124.21.800.800","title":"Ibrutinib Monotherapy in Relapsed/Refractory Follicular Lymphoma (FL): Preliminary Results of a Phase 2 Consortium (P2C) Trial","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Ibrutinib; Medicine; Internal medicine; Tolerability; Mantle cell lymphoma; Oncology; Bruton's tyrosine kinase; Follicular lymphoma; Clinical endpoint; Lymphoma; Clinical trial; Chronic lymphocytic leukemia; Adverse effect; Leukemia; Tyrosine kinase","score_opus":0.022535855873941347,"score_gpt":0.3137643005637181,"score_spread":0.29122844468977677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557010481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927516,0.00089979975,0.000027621136,0.00022976506,0.00017991113,0.0014456484,0.000027409373,0.000071598784,0.0043666693],"genre_scores_gemma":[0.9976925,0.00015065045,0.00044496363,0.00016526443,0.00040981063,0.00010853507,0.000051214534,0.000059796123,0.0009172308],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9968503,0.00029114913,0.0010010351,0.0005687836,0.000729347,0.0005593483],"domain_scores_gemma":[0.9975885,0.0006973673,0.00028400272,0.0010458293,0.0001312589,0.00025303932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00125313,0.00026625177,0.0007399732,0.0003116155,0.0000435259,0.00001425989,0.0002644802,0.00030183038,0.00007066752],"category_scores_gemma":[0.0014681367,0.00023425117,0.00022993692,0.00041397338,0.00022679467,0.000067863584,0.00008304222,0.00023406076,0.00004946814],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.85987175,0.03870433,0.00038174193,0.0006129202,0.0007333913,0.001577185,0.0029019034,0.000028216275,0.0373889,0.0002988257,0.0036532595,0.053847615],"study_design_scores_gemma":[0.9223303,0.011813777,0.00056217524,0.0003054275,0.00018418742,0.00018903486,0.00009126586,0.002918804,0.050494067,0.000079023346,0.010798764,0.00023317253],"about_ca_topic_score_codex":0.0005684195,"about_ca_topic_score_gemma":0.000018686022,"teacher_disagreement_score":0.062458586,"about_ca_system_score_codex":0.0012503952,"about_ca_system_score_gemma":0.003830301,"threshold_uncertainty_score":0.95524853},"labels":[],"label_agreement":null},{"id":"W2557024324","doi":"10.1182/blood.v104.11.2885.2885","title":"Ex-Vivo Expansion of Megakaryocyte Progenitors.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services","funders":"","keywords":"Megakaryocyte; Progenitor cell; Thrombopoietin; CD34; Bone marrow; Haematopoiesis; Stem cell; Megakaryocytopoiesis; Platelet; Immunology; Ex vivo; Andrology; Biology; Chemistry; Cell biology; Medicine; In vivo","score_opus":0.010937700534890139,"score_gpt":0.24522861109310237,"score_spread":0.23429091055821225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557024324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99518746,0.00073300424,0.000011595192,0.000112891874,0.00004746355,0.00021946733,0.000005523653,0.00003374232,0.003648822],"genre_scores_gemma":[0.99838156,0.00007051875,0.0012141974,0.00004954071,0.00003794554,0.000008676055,0.000011817792,0.000011680928,0.00021404325],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99948645,0.00000462547,0.00012433766,0.00011849392,0.00014353351,0.00012255456],"domain_scores_gemma":[0.99970454,0.000005669851,0.000037385038,0.00015664005,0.00003210498,0.00006368169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000024507384,0.00007943426,0.00018802844,0.00004210183,0.000020736581,0.0000025219692,0.00003108622,0.00004850938,0.00004163474],"category_scores_gemma":[0.000013015592,0.00006129534,0.00006502554,0.00008716572,0.000023811499,0.00003272263,0.000013076352,0.00004257746,0.00003665793],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092532596,0.022442464,0.1702819,0.0006752716,0.002265057,0.007560827,0.0023227797,0.000024742778,0.77598226,0.0015485339,0.0008096243,0.015161229],"study_design_scores_gemma":[0.0135610085,0.0007141882,0.012405216,0.00012959645,0.0003796629,0.00035419685,0.00006972459,0.0000014239037,0.9709822,0.0006167051,0.0006884982,0.00009756135],"about_ca_topic_score_codex":0.00006364348,"about_ca_topic_score_gemma":0.000005003267,"teacher_disagreement_score":0.19499998,"about_ca_system_score_codex":0.000011757445,"about_ca_system_score_gemma":0.000073092364,"threshold_uncertainty_score":0.24995512},"labels":[],"label_agreement":null},{"id":"W2557042778","doi":"10.1182/blood.v116.21.518.518","title":"Trough Level of First Dose of Busulfan (Cmin1) Is a Stronger Predictor of Graft Rejection Than Steady State Concentration (Css1) In Patients with Beta Thalassemia Major Undergoing Allogeneic Hematopoietic Stem Cell Transplantation","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Busulfan; Medicine; Dosing; Gastroenterology; Transplantation; Internal medicine; Cohort; Thalassemia; Hematopoietic stem cell transplantation; Median follow-up; Surgery; Oncology; Chemotherapy","score_opus":0.010305494083573277,"score_gpt":0.21103184412015435,"score_spread":0.20072635003658107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557042778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984623,0.00010431616,0.00012679053,0.000055985416,0.0000915849,0.00077504496,0.0002055403,0.000015424708,0.00016299711],"genre_scores_gemma":[0.9993821,0.00013360969,0.00024154136,0.000007384102,0.000011036709,0.000012448634,0.00011756262,0.000026907854,0.000067433386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985228,0.000043678607,0.00058943656,0.00024267742,0.00038387123,0.0002175302],"domain_scores_gemma":[0.99906677,0.000059008933,0.00039782954,0.00023714488,0.00016702015,0.000072237475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012550515,0.00017800613,0.0003795885,0.00011203022,0.00003327709,0.000005217414,0.00007156997,0.00017455016,0.000018471528],"category_scores_gemma":[0.0000070660285,0.00014369057,0.000073868134,0.00024903484,0.00009452878,0.00011418432,0.0000093938,0.00021841022,7.663398e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096986996,0.0021991571,0.9358185,0.001840715,0.00019981425,0.0000070212086,0.0076598395,0.00008821683,0.050916314,0.00001796565,0.000012943522,0.0002696594],"study_design_scores_gemma":[0.019964442,0.0014525963,0.7156382,0.00076166785,0.0006757557,0.000010340321,0.0012733819,0.00007961275,0.2599616,0.000015809255,0.000004924062,0.00016163799],"about_ca_topic_score_codex":0.00022846862,"about_ca_topic_score_gemma":0.00090512534,"teacher_disagreement_score":0.22018024,"about_ca_system_score_codex":0.000022048536,"about_ca_system_score_gemma":0.00014424945,"threshold_uncertainty_score":0.5859532},"labels":[],"label_agreement":null},{"id":"W2557057878","doi":"10.1182/blood.v124.21.1247.1247","title":"Nonmyeloablative Versus Myeloablative Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Deficiency","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Fludarabine; Medicine; Busulfan; Total body irradiation; Internal medicine; Hematopoietic stem cell transplantation; Cyclophosphamide; Gastroenterology; Transplantation; Oncology; Immunology; Chemotherapy","score_opus":0.02572765525116614,"score_gpt":0.27615175575716994,"score_spread":0.2504241005060038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557057878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95350415,0.00089712,0.011861931,0.0006713268,0.00023988487,0.0019378678,0.00012740391,0.0001814373,0.030578865],"genre_scores_gemma":[0.99444747,0.0000968921,0.0029533552,0.00016772826,0.0002303588,0.00019117542,0.00008263035,0.00007229013,0.0017581265],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99763775,0.00011159628,0.00039086927,0.00060731935,0.0004912052,0.00076127273],"domain_scores_gemma":[0.9979921,0.00080667046,0.000117251046,0.00054979057,0.00021276834,0.00032143475],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005352233,0.00031878363,0.0005268523,0.0001781952,0.00019407443,0.000027571476,0.00028753615,0.00019773425,0.00009500458],"category_scores_gemma":[0.00007818508,0.00026939003,0.0002221335,0.0003334354,0.00016571378,0.00009366836,0.000058121153,0.0003382244,0.0002092004],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027507583,0.014242395,0.027669892,0.00987542,0.0039074523,0.0011162112,0.06616224,0.0004040684,0.7406012,0.040038873,0.011306383,0.057168286],"study_design_scores_gemma":[0.085896604,0.009784085,0.006625174,0.0005577594,0.0028249011,0.00040116513,0.003292111,0.003378998,0.8704328,0.00096642657,0.01426187,0.001578119],"about_ca_topic_score_codex":0.000020681508,"about_ca_topic_score_gemma":0.000011076797,"teacher_disagreement_score":0.1298316,"about_ca_system_score_codex":0.00014212835,"about_ca_system_score_gemma":0.00033385277,"threshold_uncertainty_score":0.9999758},"labels":[],"label_agreement":null},{"id":"W2557070851","doi":"10.1182/blood.v124.21.2570.2570","title":"Outcomes after Double Umbilical Cord Blood Transplantation in Children: A Survey on Behalf of Eurocord and PDWP-EBMT","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cyclophosphamide; Fludarabine; Population; Internal medicine; Gastroenterology; Surgery; Chemotherapy","score_opus":0.015006809211074291,"score_gpt":0.26364251487951573,"score_spread":0.24863570566844145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557070851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99828494,0.000042842115,0.000114947594,0.000080880774,0.00003715676,0.0005796622,0.000055812783,0.00003140798,0.0007723633],"genre_scores_gemma":[0.99906844,0.00009170746,0.00042157285,0.00014159622,0.000025265394,0.000037993763,0.00013579841,0.000025881798,0.000051718063],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986703,0.00012457052,0.0004146824,0.00031121005,0.00027869822,0.00020056155],"domain_scores_gemma":[0.99927866,0.00026628454,0.000072766,0.00023520521,0.00004439181,0.00010269967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003987326,0.00017207264,0.00040803995,0.00014855879,0.000018267594,0.0000094539755,0.00005705305,0.000117699325,0.000040782397],"category_scores_gemma":[0.000038910995,0.00015068361,0.000057976733,0.00015731783,0.000057994996,0.000045140932,0.0000068765607,0.0001532891,0.000013501824],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013009469,0.0009972639,0.99492234,0.00024039335,0.00006944011,0.000029300647,0.00033022612,0.0000011446275,0.0016235402,0.00007554099,0.000002753844,0.00040711407],"study_design_scores_gemma":[0.014851711,0.0007022219,0.9641918,0.00020979076,0.0004074877,0.00020474893,0.000007637588,0.000009778294,0.019258264,0.000020775211,0.0000036674485,0.00013214393],"about_ca_topic_score_codex":0.00041902816,"about_ca_topic_score_gemma":0.00039607598,"teacher_disagreement_score":0.030730562,"about_ca_system_score_codex":0.0000054281845,"about_ca_system_score_gemma":0.000025424899,"threshold_uncertainty_score":0.61446995},"labels":[],"label_agreement":null},{"id":"W2557112905","doi":"10.1182/blood.v114.22.2485.2485","title":"Impact of Hydroxyurea On Employment Among Patients with Sickle Cell Anemia.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Sickle cell anemia; Placebo; Anemia; Observational study; Pediatrics; Attendance; Disease; Physical therapy; Clinical trial; Internal medicine; Alternative medicine; Pathology","score_opus":0.003684196053056328,"score_gpt":0.2154479027875266,"score_spread":0.21176370673447026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557112905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98289716,0.00008911818,0.0000021688672,0.000055004548,0.000017131355,0.0003034485,0.000007573874,0.00003255667,0.016595835],"genre_scores_gemma":[0.99941194,0.000022619954,0.00004977763,0.00011068012,0.00001779878,0.000001958369,0.000030031524,0.000013507859,0.00034166293],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992484,0.000010783391,0.00015654525,0.00014909728,0.00023537311,0.00019981933],"domain_scores_gemma":[0.9995117,0.000009769503,0.00007521523,0.00022709799,0.000050700743,0.00012546989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000031386557,0.00013091169,0.00020481888,0.00006187131,0.000027299977,0.0000041159487,0.000045339515,0.00008851848,0.00005607645],"category_scores_gemma":[0.000008887011,0.00007980778,0.000090902526,0.00013316188,0.00003600158,0.000027629934,0.0000065869663,0.0001392063,0.00001664097],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030172832,0.00657842,0.9884911,0.000029997958,0.00009732903,0.00003700774,0.00026751132,0.00014842914,0.0013599425,0.00000697773,0.0009765133,0.0017050477],"study_design_scores_gemma":[0.008704289,0.008210105,0.976433,0.0001329197,0.00021844049,0.000002905622,0.000027231557,0.000009940593,0.0060765683,0.0000114710365,0.000056310266,0.00011683337],"about_ca_topic_score_codex":0.00007738421,"about_ca_topic_score_gemma":0.0000014535328,"teacher_disagreement_score":0.0165148,"about_ca_system_score_codex":0.000023694578,"about_ca_system_score_gemma":0.000049857823,"threshold_uncertainty_score":0.3254467},"labels":[],"label_agreement":null},{"id":"W2557113503","doi":"10.1182/blood.v122.21.4400.4400","title":"Final Results Of a Phase I Study Of The Anti-CD79b Antibody-Drug Conjugate DCDS4501A In Relapsed Or Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (NHL)","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; BC Cancer Agency; Jewish General Hospital","funders":"","keywords":"Tolerability; Medicine; Neutropenia; Internal medicine; Gastroenterology; Adverse effect; Rituximab; Anemia; Hypokalemia; Fludarabine; Surgery; Toxicity; Lymphoma; Chemotherapy; Cyclophosphamide","score_opus":0.01929168676749963,"score_gpt":0.29220923973439844,"score_spread":0.2729175529668988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557113503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99576485,0.00028821407,2.76709e-7,0.00025889973,0.00012448667,0.0019059984,0.00006045118,0.000021456648,0.0015753746],"genre_scores_gemma":[0.998793,0.00012222433,0.00011295442,0.00011478479,0.00004907117,0.00010144788,0.00002281765,0.000030109595,0.0006535951],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977507,0.00016801232,0.0008805394,0.0004198186,0.00046223903,0.00031870438],"domain_scores_gemma":[0.99813676,0.00024679935,0.00045708843,0.0008779356,0.00016557224,0.00011581849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032140515,0.00027096926,0.0007230977,0.00015547498,0.000056218294,0.00001345509,0.00023147008,0.000099656325,0.000060947514],"category_scores_gemma":[0.00014952866,0.00015870684,0.00015721982,0.00041858663,0.00010861258,0.00007570603,0.00011100957,0.00010799966,0.00003485664],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004650216,0.28980622,0.54876715,0.00047456907,0.0008704134,0.0011118855,0.00941954,0.000011102178,0.13155209,0.00001497229,0.004202157,0.009119679],"study_design_scores_gemma":[0.19777955,0.005915736,0.6461632,0.0005009352,0.0006121428,0.000044984678,0.0013763288,0.000077574805,0.14698535,0.000009601145,0.0003426829,0.00019191767],"about_ca_topic_score_codex":0.0035086484,"about_ca_topic_score_gemma":0.00015949985,"teacher_disagreement_score":0.2838905,"about_ca_system_score_codex":0.00006538851,"about_ca_system_score_gemma":0.00031164213,"threshold_uncertainty_score":0.6471877},"labels":[],"label_agreement":null},{"id":"W2557135000","doi":"10.1182/blood.v112.11.570.570","title":"Distinct Gab2-Mediated Signaling Pathways Are Essential for Myeloid or Lymphoid Transformation and Leukemogenesis by BCR-ABL","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Chronic myelogenous leukemia; Cancer research; Biology; Leukemia; breakpoint cluster region; Myeloid; Tyrosine kinase; Dasatinib; Myeloid leukemia; Immunology; Signal transduction; Imatinib; Cell biology; Genetics","score_opus":0.021270133654297252,"score_gpt":0.2350585023237531,"score_spread":0.21378836866945586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557135000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957849,0.0012112149,0.000889764,0.00019207761,0.00009088329,0.00101571,0.00041463439,0.00016127164,0.0002395552],"genre_scores_gemma":[0.99645543,0.0005218877,0.0011234133,0.00014221006,0.00024129105,0.00017977464,0.00092940795,0.000059511516,0.00034708026],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984034,0.00003521265,0.00042998092,0.000392862,0.00032021292,0.00041836494],"domain_scores_gemma":[0.99900436,0.00019982475,0.00015680968,0.0003085785,0.00009995972,0.00023044093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012509512,0.000294903,0.00045502977,0.00009334737,0.00027236584,0.000020565356,0.000103955485,0.00016962801,0.00011519302],"category_scores_gemma":[0.00020345022,0.00023916751,0.00012557735,0.00018733568,0.00009104368,0.00014684939,0.000026560689,0.00008796106,0.000024092735],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004508921,0.0047303056,0.08408081,0.0026702862,0.0021242858,0.0010505341,0.0062250216,0.000020262363,0.87188154,0.000042530446,0.007939458,0.014726047],"study_design_scores_gemma":[0.09070742,0.0016853901,0.022683458,0.00053493393,0.0024545814,0.0033126187,0.0007491831,0.0020922006,0.86671793,0.00005658183,0.00800904,0.0009966313],"about_ca_topic_score_codex":0.00008621131,"about_ca_topic_score_gemma":0.000030335768,"teacher_disagreement_score":0.0861985,"about_ca_system_score_codex":0.00030906688,"about_ca_system_score_gemma":0.0004990658,"threshold_uncertainty_score":0.9752968},"labels":[],"label_agreement":null},{"id":"W2557153347","doi":"10.1182/blood.v124.21.4185.4185","title":"Clinical Features of Heparin-Induced Thrombocytopenia Diagnosed By Lumi-Aggregometry","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Heparin-induced thrombocytopenia; Platelet; Heparin; Platelet factor 4; Medicine; Antibody; Platelet activation; Gold standard (test); Internal medicine; Immunology","score_opus":0.028638281566826913,"score_gpt":0.32337936309377174,"score_spread":0.29474108152694484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557153347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9718973,0.00033242544,0.00004839938,0.00049967936,0.0004913814,0.00065588835,0.000023796149,0.00017020895,0.025880937],"genre_scores_gemma":[0.99615496,0.00028069594,0.0012434436,0.0008012128,0.0004830105,0.000035971636,0.00007076677,0.00009004909,0.0008398814],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965156,0.00030739367,0.0011054309,0.00081368256,0.0005999245,0.000658024],"domain_scores_gemma":[0.99692446,0.000651811,0.00039291708,0.001259235,0.00021091128,0.00056066836],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009896136,0.0004485513,0.0018395531,0.00020707586,0.00012820789,0.000040972147,0.00046260163,0.00055765634,0.0003484273],"category_scores_gemma":[0.0012443446,0.00038842266,0.00050043,0.00059082336,0.00024198908,0.00015568863,0.00022368261,0.0007608865,0.00022019482],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019341806,0.006168316,0.52678365,0.0002925616,0.0013104833,0.00007570843,0.00025942683,2.1243034e-7,0.42769614,0.0017818053,0.009720119,0.025718177],"study_design_scores_gemma":[0.009953414,0.0017498609,0.71864974,0.00023473795,0.00088849285,0.000104894585,0.00006431284,0.000009452558,0.26006454,0.00018404338,0.0076338514,0.0004626628],"about_ca_topic_score_codex":0.00031574126,"about_ca_topic_score_gemma":0.00005501443,"teacher_disagreement_score":0.1918661,"about_ca_system_score_codex":0.000038786722,"about_ca_system_score_gemma":0.00019854191,"threshold_uncertainty_score":0.99985677},"labels":[],"label_agreement":null},{"id":"W2557230233","doi":"10.1182/blood.v108.11.1621.1621","title":"Implications of Heparinoid-Induced Inactivation of Coagulation Cascade Factors and In Vivo Proenzyme Concentration.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Heparinoid; In vivo; Heparin; Thrombin; Antithrombin; Coagulation; Chemistry; Pharmacology; Factor IXa; Anticoagulant; Factor IX; Factor X; Biochemistry; Internal medicine; Medicine; Biology; Platelet","score_opus":0.025548065248821854,"score_gpt":0.2699009097732717,"score_spread":0.24435284452444983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557230233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976397,0.000037484482,0.00021827448,0.0001798424,0.000020816611,0.00044053965,0.00000941249,0.000020776803,0.0014331077],"genre_scores_gemma":[0.99948967,0.0000058906694,0.0003791598,0.00001985399,0.000023169501,0.000014799244,0.00003730991,0.000008828259,0.000021348984],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992491,0.000025745449,0.00035599121,0.00014006626,0.00013554298,0.00009357282],"domain_scores_gemma":[0.999488,0.00004012339,0.00018967724,0.00014155969,0.00010733943,0.00003328896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007153534,0.00008479756,0.00022500478,0.0001009443,0.000025020268,0.000004501208,0.000026487716,0.00008326027,0.000024570312],"category_scores_gemma":[0.000033708675,0.0000785953,0.000030510026,0.00024258146,0.000028121483,0.000094390874,0.000010479219,0.00005625961,2.9016607e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011907868,0.0003652278,0.3277522,0.000033093966,0.000013547007,1.6876088e-7,0.00010001341,0.000008702512,0.6648896,0.00677461,0.000007918565,0.00004301956],"study_design_scores_gemma":[0.0010431216,0.000060317143,0.48437834,0.000023984372,0.000045185305,0.000002936212,0.000038513863,0.00008982369,0.5137573,0.0005221684,0.000005272156,0.000033056887],"about_ca_topic_score_codex":0.00036661123,"about_ca_topic_score_gemma":0.00011321115,"teacher_disagreement_score":0.15662612,"about_ca_system_score_codex":0.000021369136,"about_ca_system_score_gemma":0.00005325177,"threshold_uncertainty_score":0.32050234},"labels":[],"label_agreement":null},{"id":"W2557267400","doi":"10.1182/blood.v116.21.1511.1511","title":"Descriptive Analysis and Review of Utilization of Rituximab In the Maintenance Treatment of Non-Hodgkin's Lymphoma In Five University Teaching Hospitals In Quebec, Canada.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Centre Hospitalier Universitaire de Sherbrooke; Hôpital Notre-Dame","funders":"","keywords":"Rituximab; Medicine; Follicular lymphoma; Pharmacy; Lymphoma; Internal medicine; Thrombocytopenic purpura; Bendamustine; Population; CD20; Oncology; Pediatrics; Family medicine","score_opus":0.010824389544470202,"score_gpt":0.2649733400692523,"score_spread":0.25414895052478215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557267400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969993,0.0019572587,0.000014578049,0.0001831469,0.000008505727,0.00046976845,0.000018495944,0.0000011766559,0.0003477718],"genre_scores_gemma":[0.9961578,0.0035236797,0.00016663058,0.000018816143,0.000004308039,0.000004238839,0.000012404377,0.0000040936748,0.000107999746],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99903154,0.00013585646,0.0002877832,0.00016199397,0.00023844354,0.00014439705],"domain_scores_gemma":[0.9993127,0.00016488657,0.00013557564,0.0002658588,0.0000888878,0.000032084485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004255099,0.00008501085,0.0005047911,0.00023684445,0.000011099489,0.0000016413835,0.00010286534,0.000047804187,0.000007854266],"category_scores_gemma":[0.0002781448,0.00006215151,0.000052591437,0.00074666744,0.00009948425,0.000046945766,0.000028497492,0.00008003446,7.246696e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010582603,0.015704185,0.86324036,0.009830371,0.0016814799,0.0018653277,0.03547643,0.000044701857,0.005199564,0.00088009104,0.0004003699,0.06461884],"study_design_scores_gemma":[0.055625908,0.00033038572,0.9240322,0.0037845206,0.0009136884,0.000021987824,0.0057310886,0.0027802119,0.0064100265,0.000015240255,0.00022127945,0.00013347113],"about_ca_topic_score_codex":0.92549115,"about_ca_topic_score_gemma":0.96040785,"teacher_disagreement_score":0.06448537,"about_ca_system_score_codex":0.002501578,"about_ca_system_score_gemma":0.0036888092,"threshold_uncertainty_score":0.6543789},"labels":[],"label_agreement":null},{"id":"W2557293680","doi":"10.1182/blood.v126.23.251.251","title":"Homozygosity for the 2R Tandem Repeat Polymorphism in the Thymidylate Synthase (TS) Promoter Is Associated with Increased Risk for Bony Morbidity Among Children Treated for Acute Lymphoblastic Leukemia on DFCI Protocol 05-001","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Internal medicine; Acute lymphocytic leukemia; Single-nucleotide polymorphism; Avascular necrosis; Leukemia; Gastroenterology; Oncology; Surgery; Biology; Genotype; Genetics; Femoral head; Gene","score_opus":0.022694450315607486,"score_gpt":0.2896708924949645,"score_spread":0.26697644217935707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557293680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85898006,0.000019621035,0.00078293734,0.0005407615,0.00003788887,0.13789965,0.0014611987,0.00015113849,0.00012675353],"genre_scores_gemma":[0.8437217,0.000006622048,0.0003888227,0.0006127083,0.00035570646,0.15366681,0.00048694032,0.00014968497,0.0006110011],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99582857,0.0003575584,0.0006838506,0.0009490191,0.0010215868,0.00115943],"domain_scores_gemma":[0.99459225,0.0027003165,0.0005213525,0.0012012741,0.000589381,0.00039545438],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020394095,0.00063445425,0.0008867067,0.00021601057,0.00055286364,0.00014654473,0.00068979344,0.00042943514,0.000019051753],"category_scores_gemma":[0.003092147,0.00033718525,0.00032239687,0.00060957036,0.0003702737,0.00017656651,0.0001107314,0.00051153987,0.000010461643],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.094752975,0.030724738,0.6930572,0.0009024974,0.02185434,0.0015128317,0.0062197265,0.00023398561,0.003238869,0.00015561719,0.14115715,0.00619006],"study_design_scores_gemma":[0.36980906,0.020472681,0.5037864,0.0014190818,0.011922109,0.0008674812,0.00029882716,0.055036243,0.03301757,0.00068020105,0.0011494879,0.0015408435],"about_ca_topic_score_codex":0.0026655933,"about_ca_topic_score_gemma":0.00045006291,"teacher_disagreement_score":0.2750561,"about_ca_system_score_codex":0.0016931564,"about_ca_system_score_gemma":0.0018205195,"threshold_uncertainty_score":0.99990803},"labels":[],"label_agreement":null},{"id":"W2557309119","doi":"10.1182/blood.v106.11.4982.4982","title":"Presenting Features Predictive of Long-Term Stability in Chronic Lymphocytic Leukemia.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Chronic lymphocytic leukemia; Medicine; Internal medicine; Gastroenterology; Group B; Group A; B cell; CD38; Stage (stratigraphy); Leukemia; Immunology; Antibody; Biology","score_opus":0.019691240370425557,"score_gpt":0.2983537377978847,"score_spread":0.27866249742745913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557309119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991481,0.003114814,0.000018363547,0.000051361894,0.000044822656,0.0008996008,0.000013330883,0.00008033971,0.004296373],"genre_scores_gemma":[0.9984232,0.00018735616,0.00022125088,0.00003146087,0.00044149597,0.00006224614,0.00002430726,0.000038700797,0.00056996144],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974428,0.00010414441,0.0005540508,0.000510186,0.0007262253,0.0006625919],"domain_scores_gemma":[0.9984959,0.0002630631,0.0001321022,0.0007568758,0.00015513522,0.00019692043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050540915,0.00022695844,0.00053534616,0.0002167768,0.000043897195,0.000017393582,0.0002629409,0.00020434782,0.0002328508],"category_scores_gemma":[0.00044154713,0.0002036209,0.00014976214,0.0004442545,0.0002740259,0.00016406979,0.00021803348,0.0003764841,0.000033860208],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.005616278,0.0057928306,0.7480342,0.013961113,0.002417399,0.0037981144,0.011710018,0.008325326,0.15406722,0.00030936644,0.0012916167,0.044676546],"study_design_scores_gemma":[0.096593715,0.0005916094,0.41467333,0.0008734529,0.0003526902,0.0007939978,0.00014239203,0.021315021,0.46420932,0.00003541126,0.00007815802,0.0003409061],"about_ca_topic_score_codex":0.0009577673,"about_ca_topic_score_gemma":0.0007148232,"teacher_disagreement_score":0.33336085,"about_ca_system_score_codex":0.07308312,"about_ca_system_score_gemma":0.032352243,"threshold_uncertainty_score":0.97313344},"labels":[],"label_agreement":null},{"id":"W2557311790","doi":"10.1182/blood.v126.23.1945.1945","title":"Risk Factor Analysis for the Development of Large Granular Lymphocytosis after Allogeneic Hematopoietic Cell Transplantation: Randomized Stratification and Propensity Score Analysis","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Lymphocytosis; Transplantation; Population; Immunology; Medicine; Internal medicine; Biology","score_opus":0.02321633510519383,"score_gpt":0.23282074768963,"score_spread":0.20960441258443616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557311790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9329383,0.002388706,0.06384433,0.000020881229,0.0001465242,0.0005643539,0.000047170084,0.000015610629,0.000034171186],"genre_scores_gemma":[0.99858385,0.00019394472,0.0003184167,0.000021666247,0.0000062392032,0.00016307089,0.00032498332,0.000006291286,0.0003815286],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99888396,0.00026718236,0.00044384768,0.00021895791,0.000050489976,0.00013553261],"domain_scores_gemma":[0.99911755,0.00020170964,0.00026691513,0.00021037621,0.00018433611,0.000019138852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000641259,0.00013028551,0.0004821304,0.00019241052,0.00016995086,0.000018373645,0.00008009139,0.00010651675,0.00020282477],"category_scores_gemma":[0.00004248655,0.00008510452,0.00029134474,0.00034926328,0.000073254276,0.00006532697,0.000013112714,0.00007058379,0.000012259353],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.072946705,0.0022293876,0.6398459,0.00032348244,0.062149324,0.00000225017,0.030935068,0.00038650152,0.18939064,0.0001155407,0.00012812267,0.0015470615],"study_design_scores_gemma":[0.07523444,0.0000880924,0.2475832,0.000011093208,0.03954266,0.000007484281,0.00070255,0.00015238122,0.6359637,0.000023119152,0.00044210308,0.0002492128],"about_ca_topic_score_codex":0.000045462562,"about_ca_topic_score_gemma":0.00021730454,"teacher_disagreement_score":0.44657302,"about_ca_system_score_codex":0.00001719595,"about_ca_system_score_gemma":0.0000637483,"threshold_uncertainty_score":0.34704614},"labels":[],"label_agreement":null},{"id":"W2557322602","doi":"10.1182/blood.v126.23.169.169","title":"Rearrangements in Nucleoporin Family of Genes in Childhood Acute Myeloid Leukemia: A Report from Children Oncology Group and NCI/COG Target AML Initiative","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Cog; Myeloid leukemia; ETV6; Oncology; NPM1; Cancer research; Internal medicine; Gene; Biology; Medicine; Genetics; Chromosomal translocation; Karyotype; Chromosome","score_opus":0.027037623847647577,"score_gpt":0.2955566117537695,"score_spread":0.26851898790612194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557322602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911564,0.0019697887,0.000019787885,0.00030396818,0.00008250781,0.0010461815,0.00011188043,0.000041839172,0.00526762],"genre_scores_gemma":[0.99049836,0.00078496145,0.0074130613,0.00039886605,0.00022361007,0.00009729682,0.00045041836,0.000056448906,0.000077002085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99719894,0.00022473703,0.00081573037,0.0006563854,0.0005792835,0.00052494294],"domain_scores_gemma":[0.9986257,0.00012199177,0.00027983735,0.00051593763,0.00014592976,0.00031058647],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00089387875,0.00028533462,0.00088209985,0.00047370774,0.000029648021,0.000013098435,0.00022952605,0.00034130257,0.000033217708],"category_scores_gemma":[0.00039507603,0.00026730724,0.00007163756,0.0005648984,0.00020048287,0.0001849777,0.00033416675,0.00070715515,0.000018116523],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071964326,0.0018566995,0.9600874,0.000033205633,0.0008664129,0.0054700733,0.0049228673,0.0000034020345,0.018590314,0.000025166315,0.0014183769,0.006006439],"study_design_scores_gemma":[0.022741104,0.0010794115,0.96722513,0.00012797822,0.0002564478,0.0005907361,0.0010191823,0.000048664784,0.0054807863,0.0005246201,0.00066235417,0.0002435778],"about_ca_topic_score_codex":0.0045054476,"about_ca_topic_score_gemma":0.00046890628,"teacher_disagreement_score":0.022021461,"about_ca_system_score_codex":0.0005981798,"about_ca_system_score_gemma":0.0013527082,"threshold_uncertainty_score":0.9999779},"labels":[],"label_agreement":null},{"id":"W2557324465","doi":"10.1182/blood.v116.21.3340.3340","title":"Transfusion-Related Epstein-Barr Virus (EBV) Infection Among Stem Cell Transplant Recipients: a Retrospective Cohort Study In Children","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Blood transfusion; Incidence (geometry); Cord blood; Immunology; Epstein–Barr virus infection; Transplantation; Internal medicine; Epstein–Barr virus; Virus","score_opus":0.004075265286911541,"score_gpt":0.2139067177625688,"score_spread":0.20983145247565727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557324465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933255,0.00010394065,0.0000047159406,0.000032181397,0.00036598725,0.002292197,0.000036826958,0.00015420867,0.003684493],"genre_scores_gemma":[0.9991156,0.00029682735,0.000005938289,0.000041135798,0.000060329297,0.0001368293,0.000050505336,0.000045308414,0.00024751923],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981484,0.00008937259,0.0004442591,0.0005257732,0.00042717316,0.00036503607],"domain_scores_gemma":[0.9993034,0.000018569626,0.00012579431,0.0003242891,0.00007660605,0.00015132682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041212997,0.0002549934,0.000488406,0.00022013926,0.00012423984,0.000023276538,0.00009018936,0.00030185303,0.00019862804],"category_scores_gemma":[0.000016315367,0.00023471622,0.00014988035,0.00058135885,0.000060754996,0.00012164366,0.000011570261,0.0008895376,0.000025571191],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015012549,0.0040923473,0.986033,0.0000091176735,0.0003019739,0.00003721782,0.0024463907,0.0000071146187,0.006492213,0.000004799433,0.000031657903,0.0003940302],"study_design_scores_gemma":[0.018078642,0.0010666952,0.97612816,0.0000675069,0.00072779297,0.000019153875,0.00019847149,0.000019557625,0.003417081,0.000025225523,0.000006886071,0.0002448004],"about_ca_topic_score_codex":0.008163431,"about_ca_topic_score_gemma":0.009984298,"teacher_disagreement_score":0.017928516,"about_ca_system_score_codex":0.00013921392,"about_ca_system_score_gemma":0.00008836472,"threshold_uncertainty_score":0.9984413},"labels":[],"label_agreement":null},{"id":"W2557333929","doi":"10.1182/blood.v118.21.714.714","title":"Diagnosis of Isolated Sub-Segmental Pulmonary Embolism on Computed Tomography Pulmonary Angiography; How Sure Are We of the Diagnosis?","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Pulmonary embolism; Pulmonary angiography; Radiology; Retrospective cohort study; Angiography; Computed tomography angiography; Anticoagulant therapy; Incidence (geometry); Thrombosis; Internal medicine","score_opus":0.023128023258949852,"score_gpt":0.22072551071318408,"score_spread":0.19759748745423422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557333929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870754,0.0067922454,0.0000076144415,0.002127037,0.00039432946,0.001514627,0.00016872524,0.000106932486,0.0018130717],"genre_scores_gemma":[0.9947427,0.0041953195,0.0001104097,0.00041381683,0.000119941426,0.0002761822,0.000036115795,0.00006587513,0.000039659986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976747,0.00014909942,0.0005334453,0.00053440634,0.0006281338,0.0004802036],"domain_scores_gemma":[0.9980233,0.00013865798,0.00053014146,0.0009342988,0.00018276907,0.00019086609],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019651683,0.00042050908,0.0009751401,0.0005526431,0.00012336561,0.000015344207,0.0004617932,0.00021226356,0.00013010058],"category_scores_gemma":[0.000027773429,0.00031122213,0.0011210949,0.0013533778,0.00029532565,0.000111222966,0.00024673183,0.00027087197,0.0000062409053],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016168713,0.021418618,0.9605657,0.000631513,0.0018651376,0.00023051041,0.00059070915,0.0000039790266,0.0018367872,0.00030887502,0.008725308,0.0036611652],"study_design_scores_gemma":[0.0015106904,0.00080642937,0.9174039,0.0014882446,0.0017530748,0.000035142624,0.00045396056,0.000021186615,0.075047374,0.00013701546,0.0010470464,0.00029593808],"about_ca_topic_score_codex":0.00019841015,"about_ca_topic_score_gemma":0.000029553346,"teacher_disagreement_score":0.07321059,"about_ca_system_score_codex":0.000017933111,"about_ca_system_score_gemma":0.00003225596,"threshold_uncertainty_score":0.99993396},"labels":[],"label_agreement":null},{"id":"W2557339756","doi":"10.1182/blood.v114.22.4521.4521","title":"Vascular Access Devices: A Retrospective Review Amongst Patients Treated at the Ottawa Hospital with Induction Chemotherapy for Acute Leukemia.","year":2009,"lang":"en","type":"review","venue":"Blood","topic":"Central Venous Catheters and Hemodialysis","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Seldinger technique; Surgery; Thrombosis; Deep vein; Catheter","score_opus":0.030467786404150748,"score_gpt":0.36120399585577595,"score_spread":0.3307362094516252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557339756","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030666601,0.9827115,0.000012044474,0.00023030325,0.00023752908,0.012719529,0.00039839355,0.00011116327,0.00051288365],"genre_scores_gemma":[0.000033725075,0.9929913,0.000058086138,0.0009664564,0.00048632803,0.0025758417,0.0016823144,0.00014460346,0.0010613222],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962819,0.0004693496,0.0010831535,0.00088342984,0.0004744448,0.00080770394],"domain_scores_gemma":[0.9966249,0.00014909133,0.0016308483,0.0009691154,0.00045871225,0.00016736657],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005373468,0.00073354616,0.0028099422,0.00011712791,0.0011482155,0.000047188343,0.0006785254,0.0006077332,0.00020760462],"category_scores_gemma":[0.000060600847,0.00039739936,0.0011693566,0.0007847685,0.000078651545,0.00019441797,0.00011037798,0.00087718456,0.00007524123],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009021406,0.0023315237,0.012696701,0.066111796,0.011757734,0.000014951733,0.0013038301,1.7130044e-7,2.4939203e-7,0.000034824152,0.04776189,0.8578961],"study_design_scores_gemma":[0.0026967179,0.00068667845,0.003535129,0.03804447,0.019445242,0.0000037229574,0.000016949249,3.3265863e-7,0.0000013151032,0.000011243911,0.93497705,0.00058117375],"about_ca_topic_score_codex":0.000196582,"about_ca_topic_score_gemma":0.0003530212,"teacher_disagreement_score":0.88721514,"about_ca_system_score_codex":0.0014259062,"about_ca_system_score_gemma":0.00059898687,"threshold_uncertainty_score":0.99984777},"labels":[],"label_agreement":null},{"id":"W2557356536","doi":"10.1182/blood.v122.21.3729.3729","title":"Ezh2 Is An Essential Regulator Of T-Cell Development and Oncogenic Transformation","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Biology; EZH2; Histone H3; T-cell receptor; Chromatin; Molecular biology; Genetics; Gene; Cancer research; T cell","score_opus":0.0071769080025800465,"score_gpt":0.21701334089049298,"score_spread":0.20983643288791293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557356536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99771017,0.0006113381,0.0009867975,0.00002056796,0.000021866725,0.00012311932,0.0000032368364,0.0000032889052,0.0005195973],"genre_scores_gemma":[0.9963345,0.000093349096,0.0033406855,0.00001909891,0.00004078837,0.00000948621,0.00005787786,0.0000074127165,0.00009678204],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995572,0.000015888183,0.00015463095,0.00012173625,0.00007043888,0.00008011121],"domain_scores_gemma":[0.9997326,0.0000018493025,0.000049080274,0.000115873416,0.00005361296,0.000046969733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006606391,0.00006258761,0.00006169803,0.000020203825,0.000030641037,0.000011344089,0.00004475693,0.000074958836,0.000021800837],"category_scores_gemma":[0.0000031877669,0.000060249848,0.000021496167,0.000025245294,0.000019210436,0.0000052567607,0.000014663923,0.000018760582,0.0000039456418],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000041954477,0.00010160186,0.0008561398,0.000020181582,0.000015209996,5.977017e-8,0.00033218574,0.00000195865,0.99370015,0.000011267751,0.000008596305,0.0049484354],"study_design_scores_gemma":[0.0005853457,0.00012707173,0.0062063136,0.0000030528745,0.000017729124,7.961036e-7,0.000046831163,0.00002910938,0.99121064,0.00006975436,0.0016256602,0.000077686826],"about_ca_topic_score_codex":0.000012307108,"about_ca_topic_score_gemma":0.000006731334,"teacher_disagreement_score":0.005350174,"about_ca_system_score_codex":0.0000015822153,"about_ca_system_score_gemma":0.000033668555,"threshold_uncertainty_score":0.24569176},"labels":[],"label_agreement":null},{"id":"W2557360792","doi":"10.1182/blood.v116.21.3700.3700","title":"Activation of Caspases-8 and -9 Occurs In Platelets From Children with Immune, but Not Chemotherapy-Related, Thrombocytopenia.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Platelet; Phosphatidylserine; Apoptosis; Platelet activation; Immunology; Medicine; Hematology; Caspase; Internal medicine; Andrology; Pathology; Biology; Programmed cell death; Biochemistry; Membrane","score_opus":0.006045293914153095,"score_gpt":0.22305863622951055,"score_spread":0.21701334231535746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557360792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998796,0.00013429056,0.0000016032803,0.00018027284,0.000020412237,0.0003907758,0.000033451357,0.000019368264,0.00042385075],"genre_scores_gemma":[0.99923515,0.000081138605,0.000418839,0.00007829304,0.000014133165,0.000008678542,0.00010647403,0.000019334662,0.000037984577],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99934757,0.000009165313,0.00017849501,0.00020288171,0.00012434897,0.00013754467],"domain_scores_gemma":[0.9996071,0.00003275465,0.00009085097,0.00019879382,0.000021833564,0.000048676746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000041023097,0.00013386837,0.00034819855,0.00006927884,0.000025641144,0.000007947571,0.000044329612,0.00011653204,0.00008107224],"category_scores_gemma":[0.000014319094,0.00010065133,0.000028445875,0.00010487102,0.000060584764,0.00008275756,0.000013424856,0.00019829981,0.000005251885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006515021,0.0017469085,0.6781934,0.000014836738,0.00073472323,0.00016723621,0.00049676886,0.0000012216683,0.31200606,0.000037267167,0.000010529969,0.005939545],"study_design_scores_gemma":[0.012136967,0.000257035,0.69028443,0.00005831851,0.000107682914,0.00014807789,0.000029313522,0.000007231211,0.29682714,0.000052885527,0.000009592824,0.00008130842],"about_ca_topic_score_codex":0.0020740377,"about_ca_topic_score_gemma":0.00019616522,"teacher_disagreement_score":0.0151789,"about_ca_system_score_codex":0.0000067064493,"about_ca_system_score_gemma":0.000042305473,"threshold_uncertainty_score":0.4104442},"labels":[],"label_agreement":null},{"id":"W2557375195","doi":"10.1182/blood.v126.23.344.344","title":"Dose-Optimized Nilotinib (NIL) in Patients (Pts) with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Final Results from ENESTxtnd Study","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Nilotinib; Medicine; Internal medicine; Adverse effect; Clinical endpoint; Imatinib mesylate; Imatinib; Phases of clinical research; Gastroenterology; Myeloid leukemia; Clinical trial; Surgery","score_opus":0.03109947596682438,"score_gpt":0.28580327226961083,"score_spread":0.25470379630278644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557375195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932918,0.0011619254,0.000007734905,0.00011474918,0.00021412234,0.00397869,0.0001775893,0.00016780787,0.00088556454],"genre_scores_gemma":[0.9959558,0.00012353703,0.0011872527,0.00009980043,0.00049040205,0.0004512417,0.0011094228,0.00014204014,0.0004405015],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9944927,0.00034992147,0.0013695944,0.0014701026,0.0011748436,0.0011428467],"domain_scores_gemma":[0.99691314,0.00038676528,0.00044958314,0.0014450649,0.00019654488,0.0006088887],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00063479,0.0008008708,0.001364327,0.0004790942,0.000078086516,0.00006092621,0.00043495084,0.00030945832,0.00014164667],"category_scores_gemma":[0.00055603194,0.0006799519,0.00013439835,0.00094405754,0.0001908216,0.0003161536,0.00019765334,0.0008363577,0.00020963214],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.06765252,0.06723721,0.7785246,0.00027917026,0.0022328154,0.01435288,0.014100605,0.011337699,0.0013312364,0.000009368727,0.0025396796,0.040402237],"study_design_scores_gemma":[0.7302939,0.018436434,0.244622,0.00083963,0.00077243854,0.000032276206,0.0006331584,0.0014150853,0.0014526247,0.00001528658,0.0007510695,0.0007360561],"about_ca_topic_score_codex":0.014835524,"about_ca_topic_score_gemma":0.013828321,"teacher_disagreement_score":0.6626414,"about_ca_system_score_codex":0.014550908,"about_ca_system_score_gemma":0.008787913,"threshold_uncertainty_score":0.9995652},"labels":[],"label_agreement":null},{"id":"W2557379370","doi":"10.1182/blood.v126.23.1117.1117","title":"Assessing Incidence of and Risk Predictors Ascertained at Diagnosis for Symptomatic Venous Thrombotic Events in Pediatric Cancer Patients: A 20-Year Population Based Study from the Maritimes, Canada","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Central Venous Catheters and Hemodialysis","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Medicine; Cancer registry; Incidence (geometry); Pediatric cancer; Cancer; Generalizability theory; Population; Medical record; Cohort; Pediatrics; Emergency medicine; Surgery; Internal medicine; Environmental health","score_opus":0.027290657532346642,"score_gpt":0.32138953327862085,"score_spread":0.2940988757462742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557379370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99729156,0.00031829916,0.0000071503214,0.00007895432,0.0001995966,0.0017629545,0.00032489703,0.000012000534,0.0000045809747],"genre_scores_gemma":[0.999102,0.00007165353,0.00009734403,0.00006309634,0.00010018743,0.0004172415,0.00012340727,0.000019602992,0.0000054530424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981657,0.00048746003,0.00048334672,0.0002310278,0.00034134428,0.00029107436],"domain_scores_gemma":[0.99798506,0.0011823789,0.00039054148,0.00020300459,0.00013064643,0.00010835493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046836183,0.00012814422,0.00033404917,0.000055305416,0.00031414194,0.0000076167385,0.00012343736,0.00007549919,0.000027608916],"category_scores_gemma":[0.0005961509,0.00009726958,0.000038378086,0.00020313438,0.000008691509,0.000095870135,0.000070577364,0.00015244039,6.303881e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030611078,0.0009987336,0.9957869,0.000093072646,0.00006047838,6.6946984e-7,0.0025707844,0.00015459732,6.444343e-7,3.625772e-7,0.00017088208,0.00013225841],"study_design_scores_gemma":[0.003958478,0.0002049537,0.9926294,0.00015468679,0.0007461668,2.484923e-8,0.0011625915,0.0009864345,0.0000021017017,0.00005320281,0.000004285218,0.00009769158],"about_ca_topic_score_codex":0.718857,"about_ca_topic_score_gemma":0.8373061,"teacher_disagreement_score":0.11844909,"about_ca_system_score_codex":0.0004814994,"about_ca_system_score_gemma":0.00070450554,"threshold_uncertainty_score":0.3966538},"labels":[],"label_agreement":null},{"id":"W2557385370","doi":"10.1182/blood.v104.11.1887.1887","title":"Stimulation of Precursor-B Acute Lymphoblastic Leukemia Cells with Toll-Like Receptor Ligands Alters Their Immunogenicity.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Immune system; TLR2; Immunology; Immunogenicity; Toll-like receptor; Antigen; TLR3; Biology; B cell; T cell; TLR9; Cancer research; TLR4; Innate immune system; Antibody; DNA methylation","score_opus":0.005009751337599002,"score_gpt":0.19402109599224848,"score_spread":0.18901134465464947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557385370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99765015,0.00088114134,0.00053514517,0.00003917302,0.00031644097,0.0002923691,0.000024615685,0.00006342592,0.00019751792],"genre_scores_gemma":[0.9987676,0.00015890591,0.00020567556,0.000035860794,0.000021825781,0.000019499452,0.00015550978,0.000022817892,0.00061230984],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990269,0.000070006754,0.00035430613,0.00022171068,0.00004962664,0.00027746437],"domain_scores_gemma":[0.99926335,0.0000889081,0.00022179732,0.00031734948,0.00009175169,0.000016823475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014358362,0.00020215819,0.0002868151,0.000120791476,0.00011815942,0.000012300588,0.0001860254,0.000212453,0.00010568653],"category_scores_gemma":[0.000016170246,0.00015721566,0.000097672215,0.00016465956,0.0001359444,0.00016491521,0.000041585903,0.0001360432,0.00029269443],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001177706,0.00018886376,0.00020826973,0.00001942391,0.0006435423,0.000002876183,0.0009637637,0.0010490026,0.99502474,0.0000965211,0.00007826672,0.0005470088],"study_design_scores_gemma":[0.0068758586,0.0008198687,0.0016185803,0.00011344853,0.00024123567,0.00007500762,0.00011033631,0.0000067550736,0.9891536,0.00004161012,0.00075298187,0.00019071877],"about_ca_topic_score_codex":0.00004556628,"about_ca_topic_score_gemma":0.0000059121003,"teacher_disagreement_score":0.0058711567,"about_ca_system_score_codex":0.00008988488,"about_ca_system_score_gemma":0.0002652259,"threshold_uncertainty_score":0.64110684},"labels":[],"label_agreement":null},{"id":"W2557391554","doi":"10.1182/blood.v106.11.5542.5542","title":"Initiation of a Pre-Clinical Gene Therapy Study in Non-Human Primates Using Lentivectors Targeting Hematopoietic Cells for Correction of Fabry Disease.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Globotriaosylceramide; Leukapheresis; Genetic enhancement; CD34; Apheresis; Haematopoiesis; Stem cell; Hematopoietic stem cell transplantation; Immunology; Medicine; Fabry disease; Biology; Transplantation; Internal medicine; Disease; Gene; Cell biology","score_opus":0.03358046671294535,"score_gpt":0.37291071725092173,"score_spread":0.3393302505379764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557391554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99787045,0.0006078866,0.0005364026,0.000005077161,0.00006892901,0.00088127126,0.000013684691,0.0000048119227,0.000011501541],"genre_scores_gemma":[0.9991754,0.00010937377,0.0004115748,0.000012208493,0.00015092747,0.000047377456,0.000051081613,0.000023982817,0.000018024533],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988288,0.00015311115,0.00044676155,0.00025956347,0.00014373465,0.00016802154],"domain_scores_gemma":[0.9993911,0.000040278184,0.00019354258,0.00020723158,0.00012287643,0.00004501957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005777099,0.00010962272,0.00020209319,0.00007560064,0.00004288216,0.000007100605,0.00012046522,0.00007581956,0.000011604426],"category_scores_gemma":[0.000058205234,0.000109143,0.00010560252,0.000097534175,0.000051515122,0.0000060553616,0.00004023126,0.00006251797,4.039629e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011453511,0.002220134,0.109973595,0.000041296957,0.00008435901,4.7352364e-7,0.00021398709,0.00056694367,0.88485825,2.1874953e-7,0.000014531889,0.00088084413],"study_design_scores_gemma":[0.0031228673,0.002714081,0.029720858,0.000022450507,0.000035907506,3.4276997e-7,0.000095513504,0.00094750646,0.9632193,0.000009036392,0.000008245666,0.00010390462],"about_ca_topic_score_codex":0.000019364856,"about_ca_topic_score_gemma":0.000048051235,"teacher_disagreement_score":0.08025274,"about_ca_system_score_codex":0.0000115478315,"about_ca_system_score_gemma":0.00008738618,"threshold_uncertainty_score":0.44507226},"labels":[],"label_agreement":null},{"id":"W2557392219","doi":"10.1182/blood.v126.23.4213.4213","title":"Prima-1Met Combined with Bortezomib Has Synergistic Anti-Myeloma Activity By Modulation of Apoptosis and Cell Cycle Regulating Genes","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Bortezomib; Multiple myeloma; In vivo; Cytotoxicity; Housekeeping gene; Biology; Apoptosis; Cancer research; Cell culture; Gene expression; Pharmacology; Chemistry; Gene; Immunology; In vitro; Biochemistry; Genetics","score_opus":0.02752699093899491,"score_gpt":0.2632618762589371,"score_spread":0.2357348853199422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557392219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983252,0.0002296608,0.00024470783,0.00012467772,0.000014556868,0.0004292491,0.00002815976,0.000037106944,0.0005666483],"genre_scores_gemma":[0.99704796,0.000017495959,0.002641484,0.0000071864238,0.000027802505,0.000020187688,0.00007047177,0.000023578554,0.00014381528],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998927,0.000057023557,0.0001624776,0.00025127476,0.00037232463,0.0002299071],"domain_scores_gemma":[0.99917465,0.00006689787,0.00011880649,0.00025921586,0.00013719435,0.00024325671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013680654,0.00014687543,0.0003242655,0.00007602312,0.00007328214,0.00002405674,0.000044371765,0.00006200997,0.0000072869775],"category_scores_gemma":[0.000084712774,0.000112611815,0.00003131004,0.00015197542,0.00010950658,0.00009925689,0.000041469015,0.00007638684,0.0000025791735],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010182529,0.0020991839,0.3496486,0.00025741744,0.0003040151,0.000024953471,0.00017143815,0.000050726954,0.6362037,0.000012078526,0.00011943814,0.010090216],"study_design_scores_gemma":[0.013600058,0.0011914088,0.3329226,0.000073617615,0.00025384984,0.000015430958,0.00005221112,0.005537649,0.6461778,0.00003105725,0.000017700895,0.00012659395],"about_ca_topic_score_codex":0.00031825222,"about_ca_topic_score_gemma":0.000010347378,"teacher_disagreement_score":0.016725987,"about_ca_system_score_codex":0.000029462797,"about_ca_system_score_gemma":0.000106712,"threshold_uncertainty_score":0.45921767},"labels":[],"label_agreement":null},{"id":"W2557413597","doi":"10.1182/blood.v106.11.3487.3487","title":"Molecular Quantitation of Minimal Residual Disease in Multiple Myeloma Patients Achieving Complete Remission after Treatment with Revlimid or Velcade.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Lenalidomide; Minimal residual disease; Multiple myeloma; Bortezomib; Thalidomide; Medicine; Proteasome inhibitor; Cancer research; Molecular biology; Oncology; Internal medicine; Biology; Bone marrow","score_opus":0.03274675511642622,"score_gpt":0.29304314996062786,"score_spread":0.26029639484420164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557413597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982107,0.0004456267,0.000025027743,0.00024412603,0.0000087612225,0.00087136537,0.00009688877,0.000021734433,0.00007573029],"genre_scores_gemma":[0.9949166,0.00006791444,0.00447849,0.000037742302,0.00003844021,0.000120066536,0.0002282583,0.000029318917,0.00008317843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985315,0.00008723583,0.0003163289,0.00032123362,0.0004320446,0.0003116532],"domain_scores_gemma":[0.9991371,0.000094396935,0.00009098285,0.0002898452,0.00009736216,0.00029028245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000067272704,0.00019594414,0.00029953034,0.0001781546,0.00004197518,0.00001069395,0.000052525556,0.000052170737,0.000046267425],"category_scores_gemma":[0.00019658224,0.00012659607,0.000065027394,0.0001794209,0.00005555288,0.00009906204,0.000032232725,0.00008440875,0.000012138095],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013127187,0.004304932,0.9659869,0.00012460671,0.00014981153,0.00070582295,0.0002404844,0.00004299715,0.0071168,0.0000034028988,0.0000069711996,0.008190062],"study_design_scores_gemma":[0.021870157,0.0029260283,0.96107876,0.0004696778,0.00021251944,0.0000071151658,0.000037696933,0.0011573575,0.011917071,9.60319e-7,0.00019382066,0.0001288458],"about_ca_topic_score_codex":0.00007870408,"about_ca_topic_score_gemma":0.00020037752,"teacher_disagreement_score":0.0087429695,"about_ca_system_score_codex":0.00010909762,"about_ca_system_score_gemma":0.00012905529,"threshold_uncertainty_score":0.5162438},"labels":[],"label_agreement":null},{"id":"W2557415821","doi":"10.1182/blood.v112.11.1265.1265","title":"Gaucher Disease: A Systematic Review and Meta-Analysis of Bone Complications and Their Response to Treatment.","year":2008,"lang":"en","type":"review","venue":"Blood","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Ottawa","funders":"","keywords":"Medicine; Enzyme replacement therapy; Hepatosplenomegaly; Systematic review; Meta-analysis; Disease; Magnetic resonance imaging; Surgery; Clinical trial; MEDLINE; Internal medicine; Radiology","score_opus":0.13786238290335365,"score_gpt":0.39512778597253667,"score_spread":0.257265403069183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557415821","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000031835465,0.99284446,0.000006082225,0.0006530975,0.0000014364474,0.0057287123,0.0006261196,0.00001834999,0.00008988633],"genre_scores_gemma":[0.00004863938,0.9959984,0.00007997421,0.00019080495,0.000004110779,0.0021240204,0.00015499756,0.000037684487,0.0013613753],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9974449,0.00077093614,0.0008422895,0.00047556157,0.0002752046,0.00019106826],"domain_scores_gemma":[0.9973892,0.0006468056,0.00030843,0.001117635,0.0001567375,0.00038119603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037609556,0.00039334028,0.008282477,0.00056419807,0.00006212481,0.000014071063,0.00011253432,0.00008729443,0.00010347467],"category_scores_gemma":[0.00076647487,0.00021112847,0.0017827923,0.001282399,0.00009199441,0.000020687294,0.00008015619,0.00010526908,0.000018160772],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022881877,0.0006656686,0.000006641999,0.7480983,0.24950506,0.00005365907,0.000089609064,1.9794642e-8,0.000001059509,0.000006742729,0.00009067699,0.0014596601],"study_design_scores_gemma":[0.00031149472,0.00014145997,0.00009019161,0.024258135,0.9213625,0.00016769004,0.000009968026,7.3309457e-7,2.3861892e-7,0.0000010333504,0.053503215,0.00015329766],"about_ca_topic_score_codex":0.000023897857,"about_ca_topic_score_gemma":0.000008183952,"teacher_disagreement_score":0.7238402,"about_ca_system_score_codex":0.000055852855,"about_ca_system_score_gemma":0.00023209689,"threshold_uncertainty_score":0.8609569},"labels":[],"label_agreement":null},{"id":"W2557419037","doi":"10.1182/blood.v118.21.3075.3075","title":"Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: Early Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Multiple sclerosis; Expanded Disability Status Scale; Transplantation; Internal medicine; Clinical endpoint; Hematopoietic stem cell transplantation; Adverse effect; Clinical trial; Prednisone; Surgery; Oncology; Immunology","score_opus":0.09360182902522937,"score_gpt":0.29179131266278896,"score_spread":0.1981894836375596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557419037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99339604,0.0038097207,0.0000109687435,0.00014013181,0.00020074542,0.0018720259,0.00007198476,0.000035345427,0.0004630499],"genre_scores_gemma":[0.98820716,0.008294772,0.0030704772,0.000014832577,0.00015611867,0.000105372725,0.000013403713,0.000033374796,0.000104507606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972862,0.0003615293,0.0010593056,0.00044618713,0.00044758423,0.0003992177],"domain_scores_gemma":[0.9973588,0.0009536607,0.0006312037,0.000678768,0.0002756409,0.000101948805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044779936,0.00029086415,0.00093323045,0.000047597965,0.00020367508,0.000012640316,0.00019547896,0.00016340512,0.00001469107],"category_scores_gemma":[0.00022552494,0.00016557593,0.00022060373,0.00027239017,0.0005642664,0.00007632566,0.000055298704,0.0002480526,0.0000013358448],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36800253,0.013946713,0.5134014,0.00072644,0.0029556584,0.00011525911,0.038951,0.00013490206,0.041188534,0.00003917266,0.00012060016,0.020417785],"study_design_scores_gemma":[0.182299,0.005975526,0.7541682,0.0008074063,0.00036098916,0.000038534563,0.00018726304,0.000038674898,0.055960286,0.0000071500044,0.000015399311,0.00014155432],"about_ca_topic_score_codex":0.0010635323,"about_ca_topic_score_gemma":0.00005615712,"teacher_disagreement_score":0.24076682,"about_ca_system_score_codex":0.000020739768,"about_ca_system_score_gemma":0.00013621632,"threshold_uncertainty_score":0.67519903},"labels":[],"label_agreement":null},{"id":"W2557422667","doi":"10.1182/blood.v110.11.2412.2412","title":"Langerhans Cell Histiocytosis with Hematological Dysfunction, Refractory to Standard Therapy Could Be Cured by an Association of 2-CdA and Ara-C: Concordant Results from the Observational Survey of Treated Patients and from a Nation Wide Registry.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Langerhans cell histiocytosis; Medicine; Regimen; Internal medicine; Gastroenterology; Surgery; Refractory (planetary science); Methotrexate; Pediatrics","score_opus":0.03446661351365968,"score_gpt":0.25778335517969075,"score_spread":0.22331674166603108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557422667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99524117,0.00024307694,0.00016161539,0.00030058427,0.000024302435,0.0003707972,0.0035250476,0.000013935992,0.00011947899],"genre_scores_gemma":[0.9951054,0.00011122827,0.00045279425,0.0001945226,0.000011480758,0.000008914252,0.0039995885,0.000010258035,0.00010580705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885696,0.000093037386,0.00032804758,0.00023631942,0.00038401582,0.000101617254],"domain_scores_gemma":[0.9981871,0.00079567934,0.00035141507,0.00015805903,0.00043183294,0.000075869335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033965177,0.00011888916,0.00028462266,0.00002761396,0.000062713916,0.000009804525,0.000037325986,0.00010135088,0.0000114940385],"category_scores_gemma":[0.00060909404,0.000077270495,0.000017572795,0.00013206353,0.000056763845,0.000052631178,0.000007769875,0.000069805355,2.6187718e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004000741,0.0010990808,0.98913133,0.000006103388,0.00019174378,0.0000031499249,0.00059767975,6.09008e-7,0.0023094243,0.000002700521,0.002085738,0.00057172764],"study_design_scores_gemma":[0.014606812,0.0014894215,0.9748978,0.000045436725,0.00017903048,5.2171083e-7,0.00012494586,0.000011765023,0.00781034,0.000017710545,0.00073850824,0.00007772815],"about_ca_topic_score_codex":0.00871137,"about_ca_topic_score_gemma":0.0028538366,"teacher_disagreement_score":0.014233522,"about_ca_system_score_codex":0.00008327429,"about_ca_system_score_gemma":0.00007000243,"threshold_uncertainty_score":0.9978897},"labels":[],"label_agreement":null},{"id":"W2557428466","doi":"10.1182/blood.v114.22.4756.4756","title":"Clinical Development of MGCD0103, An Isotype-Selective HDAC Inhibitor: Pericarditis/Pericardial Effusion in the Context of Overall Safety and Efficacy.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pyrogenesis (Canada)","funders":"","keywords":"Medicine; Internal medicine; Neutropenia; Gastroenterology; Context (archaeology); Tolerability; Adverse effect; Febrile neutropenia; Anemia; Oncology; Surgery; Chemotherapy","score_opus":0.012929244382439802,"score_gpt":0.3053250331894924,"score_spread":0.2923957888070526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557428466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979737,0.0005731647,0.00004325928,0.00005501348,0.00004603068,0.00029705724,0.000015036651,0.0000043772084,0.0009924085],"genre_scores_gemma":[0.9987426,0.00019576319,0.0006949121,0.00010949548,0.000175305,0.000006432122,0.000045701978,0.000010688251,0.00001910058],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983602,0.00033964452,0.0005055079,0.0003271195,0.00026382628,0.00020369547],"domain_scores_gemma":[0.9993325,0.00006829622,0.00011166782,0.00030274398,0.000112744754,0.000072068586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007355791,0.00013161734,0.00030629174,0.000051595496,0.000063783955,0.000007815508,0.00018233861,0.00016752322,0.0000036921765],"category_scores_gemma":[0.00021927642,0.00010526662,0.00010213512,0.00012325008,0.00017706641,0.00000506939,0.000077196295,0.0001900185,0.0000017088453],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011718464,0.0026103787,0.010697676,0.00003067354,0.00009879762,0.000014242553,0.0028354544,0.000005485605,0.92818624,0.000046911384,0.000669116,0.053633157],"study_design_scores_gemma":[0.006033125,0.0029672058,0.30720225,0.000051877243,0.000042265445,0.000022378366,0.00047611364,0.000009872179,0.6729603,0.000016658383,0.009946999,0.00027099467],"about_ca_topic_score_codex":0.000018037199,"about_ca_topic_score_gemma":0.00003560459,"teacher_disagreement_score":0.29650456,"about_ca_system_score_codex":0.0000145056965,"about_ca_system_score_gemma":0.00018701461,"threshold_uncertainty_score":0.42926484},"labels":[],"label_agreement":null},{"id":"W2557431629","doi":"10.1182/blood.v118.21.542.542","title":"The MAGELLAN Study: An Analysis of Outcomes Utilizing D-Dimer","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton General Hospital; University of Calgary","funders":"","keywords":"Medicine; D-dimer; Rivaroxaban; Placebo; Asymptomatic; Clinical endpoint; Intention-to-treat analysis; Population; Post-hoc analysis; Internal medicine; Deep vein; Thrombosis; Surgery; Venous thrombosis; Randomized controlled trial; Gastroenterology; Warfarin; Atrial fibrillation","score_opus":0.05076418236070809,"score_gpt":0.30605730704793777,"score_spread":0.25529312468722964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557431629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98045653,0.00010521107,0.000004961497,0.000074294534,0.000052464726,0.00033134996,0.000002002263,0.000029960609,0.0189432],"genre_scores_gemma":[0.9993466,0.000048239872,0.00018257464,0.00014565673,0.000018202569,0.000020008374,0.000003930494,0.000011045874,0.00022375613],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991979,0.000045636814,0.00022604519,0.00016592603,0.00020588166,0.00015859625],"domain_scores_gemma":[0.9992302,0.000038028233,0.0000764201,0.00054335827,0.00004809651,0.00006387486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031435405,0.000090180474,0.00040846135,0.00012907949,0.00008172469,0.000010142056,0.00013249724,0.000022680893,0.00020763182],"category_scores_gemma":[0.000028946408,0.0000538581,0.00014523255,0.00027961817,0.000037933765,0.00002723826,0.000057576646,0.000052503696,0.000011132704],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013008093,0.0053639417,0.9834199,0.000010901587,0.005690694,0.000021110003,0.003023313,0.0000010958786,0.00014466193,0.0009761393,0.0000908134,0.0012444019],"study_design_scores_gemma":[0.00082528836,0.00044062015,0.9809549,0.0000051215543,0.011040744,5.1056804e-7,0.0056630233,0.000024350196,0.00070337026,0.000027952317,0.00025630544,0.0000578418],"about_ca_topic_score_codex":0.0007213725,"about_ca_topic_score_gemma":0.0005569182,"teacher_disagreement_score":0.018890029,"about_ca_system_score_codex":0.00000509772,"about_ca_system_score_gemma":0.000011064103,"threshold_uncertainty_score":0.2273423},"labels":[],"label_agreement":null},{"id":"W2557434158","doi":"10.1182/blood.v124.21.1518.1518","title":"Regional Differences in Patient-Reported Outcomes in a Study of Adult Prophylaxis Versus on-Demand Treatment with Bayer’s Sucrose-Formulated Recombinant Factor VIII: 3-Year Data from Spinart","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Regimen; Quality of life (healthcare); Randomized controlled trial; Patient satisfaction; Pediatrics; Internal medicine; Physical therapy; Surgery","score_opus":0.08327734073023758,"score_gpt":0.32254040916342325,"score_spread":0.23926306843318568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557434158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980815,0.000033996163,2.4452842e-7,0.00015659825,0.00006546018,0.0014851788,0.000036044486,0.000021704343,0.000119247496],"genre_scores_gemma":[0.9994497,0.000046762903,0.000063958905,0.000007795804,0.00001880947,0.00007200882,0.00019019112,0.000019787858,0.00013100433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980254,0.00012377012,0.00046281898,0.0005391754,0.00055377645,0.00029507023],"domain_scores_gemma":[0.9986339,0.00020883039,0.00013674356,0.0008119588,0.00008980085,0.000118732416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000087092485,0.0002488609,0.0006882667,0.00023519882,0.000040397717,0.00001396084,0.00016091723,0.000083653664,0.000044105826],"category_scores_gemma":[0.00015267711,0.00013636904,0.000043739965,0.00025852732,0.000060599734,0.000071442926,0.000070977156,0.00016479584,0.000010222306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004286054,0.018904673,0.9729383,0.000021777367,0.00056239916,0.00042831982,0.0012153919,4.6476524e-7,0.00017668994,0.0000026319462,0.000007676169,0.0014556416],"study_design_scores_gemma":[0.0525139,0.0413525,0.90364844,0.00022027396,0.00014610433,0.000005122121,0.0008406056,0.0001225887,0.0009798475,0.000011563008,0.0000135065875,0.000145531],"about_ca_topic_score_codex":0.0028764145,"about_ca_topic_score_gemma":0.0028511689,"teacher_disagreement_score":0.069289826,"about_ca_system_score_codex":0.00008335809,"about_ca_system_score_gemma":0.00012678295,"threshold_uncertainty_score":0.5560968},"labels":[],"label_agreement":null},{"id":"W2557439120","doi":"10.1182/blood.v116.21.870.870","title":"Therapeutic Potential for Toll-Like Receptor 2 Agonists In Pediatric Acute Lymphoblastic Leukemia (pre-B ALL): Induction of Apoptosis and Anti-ALL Immunogenicity","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Immunology; Medicine; Leukemia; Minimal residual disease; Immunogenicity; Immune system; TLR9; Transplantation; Cancer research; Biology; Internal medicine","score_opus":0.006792298349318342,"score_gpt":0.22731221588079678,"score_spread":0.22051991753147843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557439120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969917,0.00127576,0.000121097946,0.000070588925,0.0010714034,0.00040031743,0.000022008293,0.000030383942,0.000016736361],"genre_scores_gemma":[0.99845654,0.00095071143,0.00015096551,0.00003816099,0.000070036156,0.000047315334,0.0001379188,0.000018052377,0.0001303091],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989112,0.00011657793,0.0003998804,0.00024591558,0.0000382401,0.0002882025],"domain_scores_gemma":[0.9993904,0.00010024727,0.00020017891,0.00022530237,0.00006849874,0.000015356809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028944324,0.00016802203,0.0002860476,0.00019532154,0.00009390636,0.000015902395,0.00015223354,0.00040154677,0.000054995504],"category_scores_gemma":[0.000047157253,0.00015850388,0.000098618184,0.000121245495,0.000098931494,0.0001450033,0.00005406815,0.00024284504,0.00002366674],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006074561,0.00019504495,0.0012278834,0.000038362705,0.00032874075,5.4251484e-7,0.00031418694,0.0000037665332,0.9949513,0.000068385125,0.00007578642,0.0021885345],"study_design_scores_gemma":[0.005489365,0.00029241855,0.043252613,0.0000110600595,0.000575378,0.000088413304,0.000043316948,0.000015423102,0.94878286,0.00007250313,0.0011722606,0.000204366],"about_ca_topic_score_codex":0.00008846521,"about_ca_topic_score_gemma":0.000013118253,"teacher_disagreement_score":0.046168428,"about_ca_system_score_codex":0.000028780152,"about_ca_system_score_gemma":0.00012564122,"threshold_uncertainty_score":0.6463601},"labels":[],"label_agreement":null},{"id":"W2557440595","doi":"10.1182/blood.v112.11.3962.3962","title":"Outcome of Patients Age 60 and Over with Acute Lymphoblastic Leukemia (ALL) Treated with a Modified Pediatric Protocol","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Vincristine; Imatinib mesylate; Asparaginase; Internal medicine; Gastroenterology; Induction chemotherapy; Acute lymphocytic leukemia; Chemotherapy; Mercaptopurine; Sepsis; Dexamethasone; Surgery; Leukemia; Imatinib; Cyclophosphamide; Lymphoblastic Leukemia; Myeloid leukemia","score_opus":0.018691260147351504,"score_gpt":0.272742173901601,"score_spread":0.2540509137542495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557440595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9746199,0.000006352082,0.000097177566,0.000010101903,0.000006808878,0.024051,0.00004029094,0.00007810377,0.0010902489],"genre_scores_gemma":[0.9884208,0.000010623536,0.0010338391,0.00008455013,0.000069279246,0.009496825,0.000039684124,0.000074175434,0.0007702666],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976411,0.000046580593,0.00044655448,0.00047141188,0.00089496037,0.0004994089],"domain_scores_gemma":[0.99867684,0.00012421279,0.0001951297,0.0004574657,0.00021447943,0.00033189042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000078838675,0.00033853084,0.0006194785,0.000272114,0.000081353675,0.000014326011,0.00014534053,0.00015234081,0.00003674728],"category_scores_gemma":[0.000074439224,0.00021180931,0.000058841488,0.00054155703,0.0002756355,0.00011766586,0.00009279294,0.00020588293,0.000010395418],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004973495,0.0013177579,0.98627317,0.00049872376,0.0005848853,0.005272851,0.00027732502,0.000018885574,0.0004830506,0.000011758286,0.00022612808,0.00006197881],"study_design_scores_gemma":[0.07963215,0.0048758765,0.9101801,0.00010079999,0.0014044832,0.000851618,0.000013629201,0.0005408224,0.0019834226,0.000004990741,0.00007437843,0.00033773982],"about_ca_topic_score_codex":0.00020907531,"about_ca_topic_score_gemma":0.000014257456,"teacher_disagreement_score":0.07609307,"about_ca_system_score_codex":0.00035975905,"about_ca_system_score_gemma":0.00088507467,"threshold_uncertainty_score":0.8637333},"labels":[],"label_agreement":null},{"id":"W2557448012","doi":"10.1182/blood.v116.21.sci-42.sci-42","title":"Stability of Self-Renewal in Hematopoietic Stem Cells","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Immunotoxicology and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research","funders":"","keywords":"Biology; Haematopoiesis; Transplantation; Stem cell; Immunology; Myeloid; Progenitor cell; Cell biology; Medicine; Internal medicine","score_opus":0.008005504777871106,"score_gpt":0.213255683205369,"score_spread":0.2052501784274979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557448012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968366,0.0012334439,0.0000019474214,0.000036613656,0.0006989039,0.00020893426,0.000011661095,0.00005260765,0.00091927586],"genre_scores_gemma":[0.9995197,0.000028468485,0.00007629265,0.000021964503,0.000007373651,0.00002021737,0.00000507904,0.000010117041,0.00031076538],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988198,0.00026950636,0.00037674495,0.00021157636,0.000023908675,0.00029846272],"domain_scores_gemma":[0.99912363,0.0002876976,0.00010862886,0.00042578793,0.00004275306,0.000011526647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045630505,0.00013597164,0.00031377992,0.00009508277,0.00005988275,0.000003528482,0.00025495363,0.00039298175,0.00066947244],"category_scores_gemma":[0.000039139304,0.00012382607,0.00008498573,0.00013136043,0.000256626,0.000047255435,0.00008537447,0.0004839496,0.00019091737],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013808327,0.0014810374,0.02089746,0.000033774817,0.00009392525,0.0000051803063,0.0008934361,9.3717425e-8,0.9757119,0.0005185123,0.000029134622,0.00019748964],"study_design_scores_gemma":[0.0023039673,0.00017178395,0.011235925,0.000011958285,0.000044333105,0.000072404466,0.0002084442,1.5149647e-7,0.9843606,0.00009380055,0.0013773313,0.000119352924],"about_ca_topic_score_codex":0.000044634806,"about_ca_topic_score_gemma":0.00006824391,"teacher_disagreement_score":0.009661534,"about_ca_system_score_codex":0.000007604053,"about_ca_system_score_gemma":0.000116282026,"threshold_uncertainty_score":0.7330254},"labels":[],"label_agreement":null},{"id":"W2557455968","doi":"10.1182/blood.v118.21.3235.3235","title":"Development of a Novel Method for in Vitro Analysis of CD8 Thymocyte Selection and Maturation,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal","funders":"","keywords":"CD8; Stromal cell; Biology; Thymocyte; Cell biology; T cell; T-cell receptor; Major histocompatibility complex; Immunology; Molecular biology; Cancer research; Immune system","score_opus":0.05900095867821804,"score_gpt":0.3447154979956255,"score_spread":0.2857145393174075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557455968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9675544,0.00006536883,0.03163923,0.000016381226,0.0000069242033,0.0003025786,0.0000052695677,0.0000054554475,0.0004044195],"genre_scores_gemma":[0.62911403,0.000008028402,0.37065196,0.000009230707,0.000008462483,0.000027269256,0.000013341081,0.000005776001,0.000161911],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99943745,0.000017590652,0.00022182216,0.00011145001,0.00012438485,0.000087294444],"domain_scores_gemma":[0.9996481,0.000051867286,0.000060242885,0.000081177765,0.0001305536,0.000028090411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042779598,0.000047893587,0.0002360541,0.00034532475,0.0000126886725,0.0000017960324,0.000026273268,0.000040141967,0.000086392705],"category_scores_gemma":[0.00004815894,0.0000416255,0.000046527257,0.0005407981,0.000012105075,0.000021431697,0.000011873955,0.00004407021,1.2199506e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008593373,0.00046909193,0.0029770134,0.0000707387,0.00074074016,3.0037927e-7,0.0021757332,0.0000012107744,0.9833578,0.000030666757,0.0000015562747,0.009315823],"study_design_scores_gemma":[0.0025658372,0.00009138939,0.05446777,0.000012386375,0.00048757426,0.0000051887946,0.000103389655,0.0020364858,0.9400807,0.000014683821,0.00009882198,0.000035782938],"about_ca_topic_score_codex":0.00009159543,"about_ca_topic_score_gemma":0.00019574915,"teacher_disagreement_score":0.3390127,"about_ca_system_score_codex":0.000017789727,"about_ca_system_score_gemma":0.00008349081,"threshold_uncertainty_score":0.16974387},"labels":[],"label_agreement":null},{"id":"W2557465898","doi":"10.1182/blood.v126.23.109.109","title":"Comprehensive MYC and BCL2 Genetic Profiling in De Novo Diffuse Large B-Cell Lymphoma Demonstrates Clinically Relevant Genetic Alterations According to Cell of Origin Subtype","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Simon Fraser University; BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Amplicon; Biology; Lymphoma; Gene expression profiling; Tissue microarray; SNP array; Population; Cancer research; Exon; Gene; Genetics; Single-nucleotide polymorphism; Cancer; Medicine; Gene expression; Genotype; Polymerase chain reaction; Immunology","score_opus":0.030808842962708624,"score_gpt":0.2953082477320594,"score_spread":0.26449940476935074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557465898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966602,0.0020687855,0.00009575026,0.00011785844,0.00005929543,0.000648016,0.000023452261,0.000024086637,0.00030261133],"genre_scores_gemma":[0.96911186,0.00036537318,0.030074779,0.00024357691,0.00006772815,0.00006424126,0.000015686217,0.000024802493,0.000031970358],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857384,0.00007088003,0.00051686366,0.0003317837,0.00017694046,0.0003296667],"domain_scores_gemma":[0.99894506,0.0002108404,0.00011389676,0.00027048972,0.00014867334,0.00031101963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012790138,0.00018347775,0.00039095912,0.000120642304,0.000042626947,0.000026928585,0.00007423664,0.00009329688,0.0000034192985],"category_scores_gemma":[0.00009383636,0.00015825356,0.000060069382,0.00018858699,0.00003704343,0.00003365682,0.00006909104,0.00006044005,0.000021133392],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011947357,0.008041916,0.9676226,0.00011685071,0.000047930207,0.00030981994,0.000477124,0.000035450983,0.022354832,0.000024971961,0.000022687318,0.0008263474],"study_design_scores_gemma":[0.059832834,0.0019966592,0.81142294,0.0002857785,0.00059960585,0.0002675624,0.0011971322,0.0011411788,0.12251984,0.000117880576,0.00028994435,0.0003286326],"about_ca_topic_score_codex":0.00010711144,"about_ca_topic_score_gemma":0.000042055133,"teacher_disagreement_score":0.15619965,"about_ca_system_score_codex":0.00007735249,"about_ca_system_score_gemma":0.00040882523,"threshold_uncertainty_score":0.6453393},"labels":[],"label_agreement":null},{"id":"W2557466934","doi":"10.1182/blood.v116.21.94.94","title":"Enriched MicroRNA-126 Bioactivity Marks the Primitive Compartment In AML and Regulates LSC Numbers","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Université de Montréal; Institute for Research in Immunology and Cancer; University Health Network","funders":"","keywords":"microRNA; Gene knockdown; Biology; Myeloid leukemia; Leukemia; Cancer research; Stem cell; Gene expression profiling; Population; Haematopoiesis; Cell culture; Molecular biology; Immunology; Gene expression; Cell biology; Gene; Medicine; Genetics","score_opus":0.004988656750912345,"score_gpt":0.2235710306018483,"score_spread":0.21858237385093596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557466934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982945,0.0005039998,0.000021855463,0.00024596258,0.00006857606,0.0002724981,0.000015711907,0.000008086168,0.0005688579],"genre_scores_gemma":[0.99921614,0.0000398755,0.0004043288,0.000079068945,0.000087657136,0.000023199622,0.000063787,0.000012744945,0.00007322701],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993014,0.000065044354,0.00012631246,0.00026544483,0.0000705096,0.00017131554],"domain_scores_gemma":[0.9995289,0.000022133565,0.00006916004,0.00029237327,0.00003179495,0.000055656656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016515171,0.00012227426,0.000100460325,0.000023782823,0.000059203197,0.000025784682,0.000106688196,0.00011687089,0.000017024588],"category_scores_gemma":[0.00004185633,0.000097244156,0.000042827323,0.000058799993,0.00014647277,0.0000039700712,0.00009522293,0.00011558204,0.0000035542043],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003632023,0.00021426055,0.023523621,0.000009745677,0.000051007915,0.0000021438684,0.000063352694,0.0000016169537,0.97529066,0.00006602901,0.00020264181,0.00053859805],"study_design_scores_gemma":[0.0009108911,0.000031272564,0.41963235,0.000005183486,0.00004158512,0.000020691197,0.000039860148,0.00002216894,0.57684976,0.00008117224,0.0022485228,0.000116517534],"about_ca_topic_score_codex":0.000040891442,"about_ca_topic_score_gemma":0.0002878519,"teacher_disagreement_score":0.39844087,"about_ca_system_score_codex":0.0000071993977,"about_ca_system_score_gemma":0.000037005055,"threshold_uncertainty_score":0.39655018},"labels":[],"label_agreement":null},{"id":"W2557468307","doi":"10.1182/blood.v120.21.1863.1863","title":"Meta-Analysis of the Efficacy and Safety of Bortezomib Retreatment in Patients with Multiple Myeloma (MM)","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Bortezomib; Medicine; Multiple myeloma; Internal medicine; Oncology; Adverse effect; Refractory (planetary science); Proteasome inhibitor; Dexamethasone; Hematology; Surgery","score_opus":0.03913274468234272,"score_gpt":0.2819730903136505,"score_spread":0.24284034563130774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557468307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99797064,0.00085171446,0.0000022538961,0.000053555596,0.000007237941,0.0007500857,0.00010289145,0.0000047784292,0.00025681424],"genre_scores_gemma":[0.99929094,0.00001946296,0.0004991361,0.0000132263585,0.0000063844245,0.00002693536,0.00004809065,0.000010241868,0.00008557361],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880695,0.000088981804,0.00028868127,0.00016275747,0.0004172731,0.00023535003],"domain_scores_gemma":[0.99903876,0.00017526439,0.00013290586,0.00043874225,0.000085058055,0.00012925516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016841409,0.00013362718,0.0007278777,0.00016770004,0.000029924598,0.0000026015675,0.000062600324,0.000042283038,0.00008334919],"category_scores_gemma":[0.00011187791,0.00006459418,0.00025346634,0.0005462742,0.00008551828,0.00004607262,0.00005468478,0.000072497656,0.0000013690441],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007539736,0.003771112,0.91651046,0.000024827543,0.07804969,0.0000030063268,0.00023866366,0.0000034258808,0.00009882992,0.000008886682,0.0000022969311,0.0005348305],"study_design_scores_gemma":[0.012914269,0.0003513712,0.8887261,0.000010598958,0.09370397,9.620725e-7,0.000020438241,0.000015892701,0.0041934536,7.1433254e-7,0.000015774145,0.000046410718],"about_ca_topic_score_codex":0.0002275092,"about_ca_topic_score_gemma":0.00012229051,"teacher_disagreement_score":0.027784318,"about_ca_system_score_codex":0.000026191728,"about_ca_system_score_gemma":0.00003072848,"threshold_uncertainty_score":0.2634074},"labels":[],"label_agreement":null},{"id":"W2557468465","doi":"10.1182/blood.v124.21.906.906","title":"Preclinical and Clinical Pharmacodynamics of Pan-Pim Inhibition By AZD1208 in Acute Myeloid Leukemia: Assessment of Pim Isoform Dependency for Bad and 4EBP1 Phosphorylation","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Phosphorylation; mTORC1; PIM1; Serine; Cancer research; Kinase; P70-S6 Kinase 1; Chemistry; Pharmacology; Biology; Biochemistry; Protein kinase B","score_opus":0.016098065558035578,"score_gpt":0.3571809041447373,"score_spread":0.34108283858670174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557468465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924399,0.000388881,0.006095263,0.00014461648,0.00011004431,0.0005902966,0.00006348394,0.000012292621,0.0001552212],"genre_scores_gemma":[0.9921009,0.0029030414,0.004626367,0.00013737493,0.00008082109,0.00003335541,0.00006666807,0.000017544777,0.000033946537],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99873513,0.000043400923,0.00065141736,0.0002566248,0.00017250585,0.00014092578],"domain_scores_gemma":[0.9992151,0.00024092583,0.0002482185,0.00013688092,0.000079991616,0.00007885108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082757627,0.00011626423,0.00044160738,0.00005653179,0.000023534985,0.0000059193326,0.000034095454,0.00017395563,0.000014546741],"category_scores_gemma":[0.00005850361,0.00010526859,0.000083655985,0.00007101171,0.00006506527,0.000077172204,0.000030758805,0.00019184883,1.6127548e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002944502,0.0042894674,0.27865222,0.00092128385,0.0009016089,0.000009490774,0.00045373358,0.000007622418,0.35006154,0.005748332,0.00024863787,0.35576156],"study_design_scores_gemma":[0.103182875,0.014398223,0.5750843,0.0008521317,0.0026559134,0.000076249555,0.0002513323,0.05140737,0.23901418,0.011310457,0.0011010788,0.0006658394],"about_ca_topic_score_codex":0.000057828118,"about_ca_topic_score_gemma":0.00007571745,"teacher_disagreement_score":0.3550957,"about_ca_system_score_codex":0.000041144074,"about_ca_system_score_gemma":0.00012844437,"threshold_uncertainty_score":0.42927286},"labels":[],"label_agreement":null},{"id":"W2557492947","doi":"10.1182/blood.v120.21.2892.2892","title":"The Valproic Acid-Fludarabine Combination Induces a Synergistic Response in Chronic Lymphocytic Leukemia Via a Mechanism Involving the Lysosomal Protease Cathepsin B.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Fludarabine; Chronic lymphocytic leukemia; XIAP; Cancer research; Cathepsin B; Vorinostat; Caspase; Histone deacetylase; Chemistry; Apoptosis; Leukemia; Programmed cell death; Biology; Immunology; Medicine; Biochemistry; Histone; Internal medicine; Chemotherapy","score_opus":0.020177939974214073,"score_gpt":0.2797355347718299,"score_spread":0.2595575947976158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557492947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990844,0.0055262605,0.00012799943,0.00065139565,0.00021973335,0.002320612,0.000004240393,0.00012161995,0.0001841435],"genre_scores_gemma":[0.9975533,0.00014324505,0.00009232534,0.00017671622,0.00043649884,0.000847784,0.000013940981,0.00008184147,0.0006543886],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9956625,0.000882528,0.00064417295,0.0004643655,0.0010799792,0.0012664221],"domain_scores_gemma":[0.9968828,0.0012495391,0.00021461303,0.0011479768,0.00017101022,0.0003340801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003933755,0.00037799796,0.0004269665,0.00026647406,0.00052857725,0.00011297755,0.00058054866,0.00024658782,0.000040915016],"category_scores_gemma":[0.0027526466,0.00022917503,0.00015359312,0.00092394074,0.00036560677,0.0002575115,0.00030812348,0.0006705673,0.00016849722],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0064474368,0.0015559763,0.0006400219,0.00083254173,0.0005610935,0.0007800464,0.0061379503,0.00014583684,0.9664965,0.011700674,0.00024722103,0.004454697],"study_design_scores_gemma":[0.13735162,0.003040195,0.019155944,0.0016324783,0.0011545204,0.0028563894,0.0016108492,0.12462155,0.7001471,0.0062551824,0.00089882547,0.0012753502],"about_ca_topic_score_codex":0.0017069012,"about_ca_topic_score_gemma":0.00013187226,"teacher_disagreement_score":0.2663494,"about_ca_system_score_codex":0.068355195,"about_ca_system_score_gemma":0.03636175,"threshold_uncertainty_score":0.9691012},"labels":[],"label_agreement":null},{"id":"W2557504094","doi":"10.1182/blood.v118.21.1856.1856","title":"Novel AKT Inhibitor GSK2110183 Shows Favorable Safety, Pharmacokinetics, and Clinical Activity in Multiple Myeloma. Preliminary Results From a Phase I First-Time-In-Human Study","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Chronic lymphocytic leukemia; Multiple myeloma; Internal medicine; Pharmacokinetics; Lenalidomide; Neutropenia; Lymphoma; Pharmacology; Oncology; Toxicity; Leukemia","score_opus":0.05237532207231623,"score_gpt":0.3222238660342339,"score_spread":0.2698485439619177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557504094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99623877,0.0001230229,0.000011738614,0.0003199665,0.000112074085,0.0018057605,0.0002117548,0.00007127683,0.0011056531],"genre_scores_gemma":[0.9952533,0.00006174394,0.002431714,0.00003876835,0.00017427764,0.00007435581,0.00013348654,0.000041215335,0.0017911067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99748003,0.00013540818,0.0008763582,0.00079867843,0.0002992123,0.00041029515],"domain_scores_gemma":[0.9986683,0.0004128854,0.00017160033,0.00043582177,0.000050561383,0.0002608335],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006646551,0.00034117012,0.000703378,0.00021350932,0.0001094711,0.00001809033,0.00013092572,0.00015844827,0.00013839967],"category_scores_gemma":[0.00024291515,0.00030459792,0.0000891653,0.00022416553,0.00010021103,0.0001422339,0.0002003787,0.00039776077,0.000047076643],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016627666,0.11177454,0.8397437,0.000052349507,0.00072608946,0.0015900853,0.009737737,0.0000013244211,0.011557944,0.0000013412439,0.00074775226,0.007439467],"study_design_scores_gemma":[0.20185678,0.0046879547,0.75499016,0.00035986758,0.00086828443,0.000022391925,0.00058550085,0.0007986265,0.034523856,0.000015398009,0.00079185504,0.00049936085],"about_ca_topic_score_codex":0.0009529138,"about_ca_topic_score_gemma":0.0019552796,"teacher_disagreement_score":0.18522911,"about_ca_system_score_codex":0.00007386961,"about_ca_system_score_gemma":0.00010254909,"threshold_uncertainty_score":0.99994063},"labels":[],"label_agreement":null},{"id":"W2557550388","doi":"10.1182/blood.v118.21.907.907","title":"Molecular and Functional Characterization of Early Lineage Commitment of Human Hematopoietic Stem Cells","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Biology; Progenitor cell; Haematopoiesis; Stem cell; Myeloid; Cell biology; Immunology; Cellular differentiation; Lineage markers; Genetics; Gene","score_opus":0.027687629757685753,"score_gpt":0.23101266969842635,"score_spread":0.20332503994074058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557550388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99734217,0.00004017195,0.0012870078,0.000008214022,0.000036871472,0.0002930549,0.00001566095,0.000015988784,0.00096085225],"genre_scores_gemma":[0.99947506,0.0000119347,0.00034240828,0.000019987518,0.000013428269,0.000010004992,0.000031759853,0.000013761296,0.00008165883],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992721,0.00002733141,0.00030916423,0.00012349314,0.00018679423,0.000081093945],"domain_scores_gemma":[0.9995638,0.000015522544,0.00013054267,0.0001604755,0.00007464212,0.000055020402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009230304,0.00008451261,0.0002193602,0.000067751615,0.000017005157,0.0000022482243,0.000027623662,0.000058691483,0.00008149656],"category_scores_gemma":[0.000001157783,0.000079347294,0.000043152846,0.00006965423,0.000050756968,0.000030040923,0.000010180557,0.00004750011,0.0000045540182],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042725875,0.00051538943,0.026963586,0.00062873785,0.00007783558,0.000016991598,0.0017656281,9.562104e-8,0.9691078,0.00083783246,9.3729625e-7,0.000042451833],"study_design_scores_gemma":[0.0016534935,0.00037988974,0.114631474,0.00017578651,0.00026820073,0.000031929645,0.000065681685,0.0000047922513,0.8827154,0.000017601556,0.000003089236,0.000052685366],"about_ca_topic_score_codex":0.000012492285,"about_ca_topic_score_gemma":4.211813e-7,"teacher_disagreement_score":0.08766789,"about_ca_system_score_codex":0.0000041053454,"about_ca_system_score_gemma":0.000019030236,"threshold_uncertainty_score":0.32356888},"labels":[],"label_agreement":null},{"id":"W2557558365","doi":"10.1182/blood.v124.21.1533.1533","title":"Gas6 Promotes Pro-Inflammatory (Ly6Chi) Monocyte Recruitment in Venous Thrombosis","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Monocyte; Thrombomodulin; CCR2; GAS6; Thrombin; Tissue factor; Thrombus; Thromboplastin; Endothelium; Inflammation; Immunology; Medicine; Biology; Pathology; Internal medicine; Chemokine; Receptor; Platelet; Coagulation","score_opus":0.039296183201061034,"score_gpt":0.26497646703239675,"score_spread":0.2256802838313357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557558365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99396396,0.0028199262,0.000029393283,0.00012802944,0.00024696728,0.00064365414,0.000003240428,0.00007982106,0.002084985],"genre_scores_gemma":[0.9991488,0.00010178921,0.0000943228,0.00004712924,0.000039272767,0.0001676123,0.00004624283,0.000019324245,0.00033554705],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988498,0.00021382666,0.0003075195,0.00027075876,0.00003395128,0.00032412325],"domain_scores_gemma":[0.99947274,0.00005322417,0.00011358893,0.00031666504,0.000027447843,0.000016332551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000334807,0.00016171894,0.00028054477,0.00010086072,0.00010280378,0.00001438035,0.00015885204,0.0001844699,0.0001026664],"category_scores_gemma":[0.00004312404,0.0001443139,0.00007165925,0.00009878677,0.00006929695,0.00009618619,0.0000620957,0.00017312686,0.0003292415],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035743782,0.0017096292,0.012154519,0.00003906596,0.00017058912,0.0000017798828,0.000740065,0.0000065012514,0.96456605,0.0011617258,0.00016230732,0.019252006],"study_design_scores_gemma":[0.0028517274,0.00047696067,0.19005205,0.000097937744,0.000074687036,0.000026630014,0.00004594899,0.000022943224,0.792246,0.00064515823,0.013218469,0.00024148327],"about_ca_topic_score_codex":0.00003857101,"about_ca_topic_score_gemma":0.000025138224,"teacher_disagreement_score":0.17789753,"about_ca_system_score_codex":0.0000361482,"about_ca_system_score_gemma":0.00003765653,"threshold_uncertainty_score":0.588495},"labels":[],"label_agreement":null},{"id":"W2557562932","doi":"10.1182/blood.v108.11.948.948","title":"Comparison of 7-Day Storage of Buffy-Coat Derived Platelet Concentrates in an Osmotically Balanced, Interface Stabilizing Platelet Storage Solution and in Plasma.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Blood donation and transfusion practices","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of British Columbia","funders":"","keywords":"Buffy coat; Platelet; Chemistry; Blood product; Viscosity; Platelet concentrate; Chromatography; Andrology; Materials science; Immunology; Biology; Medicine; Surgery; Composite material","score_opus":0.020571960371023025,"score_gpt":0.264295424719868,"score_spread":0.24372346434884498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557562932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99793947,0.00032488367,0.00038996982,0.00015423301,0.00009271846,0.0002728725,0.000008855399,0.000037229314,0.0007797963],"genre_scores_gemma":[0.9994748,0.000022705863,0.00035595638,0.000038880255,0.000047889193,0.0000064555393,0.000032242107,0.000016596672,0.0000044683256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985987,0.00006377136,0.0006019973,0.00027781623,0.00022371378,0.00023399037],"domain_scores_gemma":[0.99913824,0.00017796847,0.00042840236,0.00013599226,0.00010443042,0.00001496784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005141456,0.0001666288,0.00039203605,0.00024313625,0.000048233684,0.00008278746,0.00014132078,0.0001075891,0.00008380458],"category_scores_gemma":[0.00010094964,0.00016964118,0.00002957105,0.0003489025,0.000102123566,0.0011794644,0.00005734254,0.00020973494,0.0000039120146],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003248499,0.0029493268,0.72542924,0.000460687,0.000034015557,0.000030750056,0.00070071686,0.004474541,0.26135176,0.0025748205,0.00002549083,0.0016438141],"study_design_scores_gemma":[0.014673525,0.00015276928,0.6728198,0.0004464826,0.00013355528,0.0000069550542,0.002810753,0.08153312,0.22534588,0.00068363233,0.0007488922,0.00064465904],"about_ca_topic_score_codex":0.0008636175,"about_ca_topic_score_gemma":0.0037984033,"teacher_disagreement_score":0.07705858,"about_ca_system_score_codex":0.00001450117,"about_ca_system_score_gemma":0.000022421455,"threshold_uncertainty_score":0.69177663},"labels":[],"label_agreement":null},{"id":"W2557591055","doi":"10.1182/blood.v118.21.1981.1981","title":"Immune Reconstitution After Antithymocyte Globulin (ATG)-Conditioned Hematopoietic Cell Transplantation (HCT)","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Immune system; Immunology; CD8; Myeloid; Transplantation; Hematopoietic stem cell transplantation; Medicine; Biology; Internal medicine","score_opus":0.01585046659076065,"score_gpt":0.22418090276935884,"score_spread":0.2083304361785982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557591055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95610297,0.0005875598,0.006159567,0.00006595272,0.0002635012,0.00071298145,0.000058332775,0.00019281209,0.035856318],"genre_scores_gemma":[0.9924422,0.00042755532,0.0061504105,0.00013738363,0.00008385756,0.0001076392,0.0002566514,0.00003699603,0.00035732638],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99832237,0.000065878296,0.00057882926,0.0003889335,0.00031282325,0.00033114268],"domain_scores_gemma":[0.99919045,0.0000424324,0.00013076699,0.0003668231,0.000103460865,0.00016608837],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00021497288,0.00025299867,0.0003631336,0.00017559472,0.00009499243,0.000019587102,0.000090413836,0.00019897806,0.0015085015],"category_scores_gemma":[0.000011238642,0.00024547224,0.00016559442,0.00023795734,0.000117858835,0.0002198728,0.000007639343,0.00018111609,0.0008101884],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006236252,0.011153821,0.37136036,0.013122005,0.0010394354,0.009881013,0.032418177,0.000010030829,0.5467036,0.0059562596,0.00026396159,0.001855141],"study_design_scores_gemma":[0.0074005565,0.0003070345,0.21186948,0.00062388676,0.0012827659,0.002430594,0.00022848154,0.000011586592,0.775072,0.00033101658,0.00009276307,0.0003498282],"about_ca_topic_score_codex":0.00006881032,"about_ca_topic_score_gemma":0.000012931408,"teacher_disagreement_score":0.22836846,"about_ca_system_score_codex":0.000033482687,"about_ca_system_score_gemma":0.00012282211,"threshold_uncertainty_score":0.99999976},"labels":[],"label_agreement":null},{"id":"W2557600559","doi":"10.1182/blood.v116.21.792.792","title":"Small Molecule SHIP Agonist AQX-MN100 Inhibits Multiple Myeloma (MM) Cell Growth In NOD/SCID Mice and Reduces Immune Suppressive Myeloid Derived Suppressor Cells (MDSC) and Regulatory T Cells (Tregs) In Mouse Model","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Synthesis and Characterization of Heterocyclic Compounds","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"PI3K/AKT/mTOR pathway; Protein kinase B; Biology; Haematopoiesis; Cancer research; Cell biology; Signal transduction; Myeloid; Immune system; Phosphoinositide 3-kinase; Stem cell; Immunology","score_opus":0.009112518230682782,"score_gpt":0.18745860154597274,"score_spread":0.17834608331528995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557600559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979413,0.00031187024,0.000011094443,0.00010968207,0.000080735605,0.00024080573,0.00016202212,0.00007682674,0.0010656711],"genre_scores_gemma":[0.99775857,0.00015711212,0.0009859543,0.00005591328,0.000088694396,0.00007695146,0.000085424144,0.00009303232,0.0006983256],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975119,0.00007296499,0.00070389203,0.00086770183,0.00025866416,0.0005848344],"domain_scores_gemma":[0.9986143,0.00023998372,0.00031199778,0.00052660145,0.00007843091,0.0002286804],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017671895,0.00048896094,0.0005599966,0.00019337096,0.00015797751,0.00019954183,0.00041940005,0.0004017579,0.000104375504],"category_scores_gemma":[0.00006841157,0.0005256335,0.00009678262,0.00012096039,0.0002297951,0.00023345038,0.00032181654,0.00055906107,0.000009489938],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010934898,0.0007407549,0.0025188029,0.00022608716,0.00002575662,0.000028556944,0.0013160578,0.00002000675,0.99488664,0.000007859079,0.000014491681,0.00010566535],"study_design_scores_gemma":[0.0035679128,0.000023584895,0.0027561653,0.000111900205,0.00004444591,0.000017833698,0.0003475374,0.0023585053,0.99012417,0.000035639125,0.000033107408,0.0005792285],"about_ca_topic_score_codex":0.00012515957,"about_ca_topic_score_gemma":0.00017525195,"teacher_disagreement_score":0.004762472,"about_ca_system_score_codex":0.00002938847,"about_ca_system_score_gemma":0.00007230109,"threshold_uncertainty_score":0.9997195},"labels":[],"label_agreement":null},{"id":"W2557616120","doi":"10.1182/blood.v126.23.384.384","title":"Proteomic Analysis of Reprograming of Mesenchymal Stem/Stromal Cells (MSC) Following Interferon Gamma Identifies Pathways That Are Upregulated in Suppression","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Mesenchymal stem cell; Downregulation and upregulation; Stromal cell; Proteome; Biology; Cancer research; Interferon gamma; Stem cell; Immunology; Molecular biology; Chemistry; Cytokine; Cell biology; Biochemistry","score_opus":0.03123578931583127,"score_gpt":0.24560972470130943,"score_spread":0.21437393538547816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557616120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960869,0.0025728613,0.000031446525,0.000007930367,0.0007277833,0.00037531077,0.00002867435,0.00003779212,0.00013131513],"genre_scores_gemma":[0.9993263,0.00001441426,0.00013604682,0.0000028370919,0.0000083636105,0.00003394807,0.00006762369,0.000020102345,0.00039034864],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982213,0.00032046868,0.00062603527,0.00039139375,0.00009915637,0.00034168016],"domain_scores_gemma":[0.9987517,0.00006837543,0.0004914829,0.0005773623,0.000089812056,0.000021252894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006041744,0.00020085466,0.0007225327,0.00042598974,0.00003816905,0.000012605364,0.00034432215,0.00030197168,0.00006257323],"category_scores_gemma":[0.000046281348,0.00018424842,0.0003008955,0.00052050035,0.00015404444,0.00013644532,0.0002377369,0.00024867032,0.000010410101],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021598098,0.0003439283,0.08820988,0.00006229169,0.0013050556,0.000017517325,0.00223454,0.00012259127,0.90709287,0.0000034497627,0.000045396646,0.00034650555],"study_design_scores_gemma":[0.0024572762,0.000210878,0.021716073,0.00031905383,0.0009032205,0.0000061482206,0.0016042882,0.000028468998,0.9725587,0.000016591319,0.000019734476,0.00015956999],"about_ca_topic_score_codex":0.00024909226,"about_ca_topic_score_gemma":0.00004594555,"teacher_disagreement_score":0.06649381,"about_ca_system_score_codex":0.000046617482,"about_ca_system_score_gemma":0.00006386538,"threshold_uncertainty_score":0.75134325},"labels":[],"label_agreement":null},{"id":"W2557618506","doi":"10.1182/blood.v116.21.4411.4411","title":"Quality of Life Outcomes of the Age of Blood In Highly Transfusion Dependent Patients with Myelodysplasia: Prospective Randomized Controlled N-of-1 Studies","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Victoria Hospital; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Blood transfusion; Anemia; Quality of life (healthcare); Randomized controlled trial; Randomization; Myelodysplastic syndromes; Prospective cohort study; Intensive care medicine; Internal medicine","score_opus":0.007111577873026696,"score_gpt":0.24836475635967065,"score_spread":0.24125317848664396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557618506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99536717,0.0008742094,0.0000030804615,0.00015596209,0.0001509127,0.0029597904,0.000015318132,0.000007855626,0.00046570812],"genre_scores_gemma":[0.9994558,0.00028850994,0.00012800764,0.000018680159,0.000006063488,0.000045597102,0.0000029980813,0.00001212498,0.00004223214],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9977828,0.00024215972,0.0011469809,0.00017190198,0.0005161899,0.00013995414],"domain_scores_gemma":[0.99802536,0.0005489559,0.0006332449,0.00030136286,0.00045123452,0.00003983056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008570916,0.00017107851,0.002385833,0.00010091887,0.000025560696,0.0000012432708,0.000106436026,0.00014137766,0.0000075273497],"category_scores_gemma":[0.0019182897,0.00007902788,0.0003307889,0.00024187706,0.00044528497,0.000026524487,0.00003429364,0.0002706002,1.3883268e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08142825,0.0048089954,0.8770201,0.00048059365,0.0033173077,0.0000032683888,0.0031164463,0.000006208227,0.029514553,0.00026774086,0.0000012005751,0.00003533534],"study_design_scores_gemma":[0.55870813,0.00044444425,0.41605696,0.00022473912,0.0016588295,8.263264e-7,0.0007943976,0.0000013111445,0.02193484,0.00010986813,2.9471573e-7,0.00006536928],"about_ca_topic_score_codex":0.0002649508,"about_ca_topic_score_gemma":0.0004112752,"teacher_disagreement_score":0.47727987,"about_ca_system_score_codex":0.0000053900694,"about_ca_system_score_gemma":0.00013003225,"threshold_uncertainty_score":0.32226634},"labels":[],"label_agreement":null},{"id":"W2557622830","doi":"10.1182/blood.v124.21.4472.4472","title":"Results of a Phase 2 Study of MEDI-551 and Bendamustine Vs Rituximab and Bendamustine in Relapsed or Refractory Chronic Lymphocytic Leukemia","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Toronto; Jewish General Hospital","funders":"","keywords":"Bendamustine; Rituximab; Medicine; Chronic lymphocytic leukemia; Internal medicine; Neutropenia; Population; Fludarabine; Adverse effect; Gastroenterology; Tolerability; Leukemia; Immunology; Chemotherapy; Lymphoma; Cyclophosphamide","score_opus":0.02092777761060369,"score_gpt":0.3141411403582586,"score_spread":0.29321336274765486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557622830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99671465,0.0014273049,0.0000043019527,0.00007356643,0.00006258708,0.0011681614,0.000046588197,0.000047361867,0.00045546566],"genre_scores_gemma":[0.9985485,0.00037869302,0.00030415566,0.000034520675,0.00019551674,0.00004431464,0.000031708183,0.00005722302,0.00040534843],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9964483,0.00022379911,0.0012046867,0.00072849495,0.00082658743,0.00056817045],"domain_scores_gemma":[0.99724436,0.0009492501,0.00037924407,0.0008821281,0.00021667799,0.00032832535],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013645656,0.00034643558,0.0012443672,0.0004885146,0.000058140486,0.000013395375,0.00021682697,0.0002287756,0.00006184464],"category_scores_gemma":[0.0026353505,0.0002755286,0.00005978869,0.00062802667,0.0004119652,0.000090792055,0.00027698302,0.0004015054,0.0000048079296],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.22816087,0.123885974,0.014434095,0.04115004,0.005776677,0.011913178,0.05631528,0.0009428947,0.29102305,0.00042620004,0.0046768636,0.22129488],"study_design_scores_gemma":[0.9053098,0.025701774,0.0064318734,0.0014922309,0.0009574501,0.00085886725,0.001138747,0.04268196,0.013977976,0.000027987342,0.0009941546,0.00042718567],"about_ca_topic_score_codex":0.0036950856,"about_ca_topic_score_gemma":0.0012674708,"teacher_disagreement_score":0.67714894,"about_ca_system_score_codex":0.0070887255,"about_ca_system_score_gemma":0.011070998,"threshold_uncertainty_score":0.99996966},"labels":[],"label_agreement":null},{"id":"W2557622858","doi":"10.1182/blood.v120.21.920.920","title":"Targeted Repression of TP53 Promotes Erythropoiesis in Del(5q) MDS and Overcomes Clinical Resistance to Lenalidomide","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Lenalidomide; Molecular biology; Biology; Erythropoiesis; Cancer research; Immunology; Medicine; Internal medicine; Anemia; Multiple myeloma","score_opus":0.011849090905171143,"score_gpt":0.33018588557214357,"score_spread":0.3183367946669724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557622858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924123,0.006550901,0.00057287724,0.00007140664,0.00007295498,0.00011835981,0.000007465274,0.000005990263,0.00018772221],"genre_scores_gemma":[0.99450284,0.00035377903,0.0048139896,0.000038999187,0.00012194401,0.000009365364,0.000008229006,0.000012127947,0.00013873949],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99925935,0.000041591626,0.00025478753,0.0001952275,0.00006907399,0.00017999054],"domain_scores_gemma":[0.99958587,0.000025130017,0.000041889034,0.00023656055,0.000024137511,0.0000864137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029078688,0.000089549,0.00016054281,0.00003315761,0.000016771726,0.0000045174297,0.00007011696,0.00010105374,0.000006441417],"category_scores_gemma":[0.0002481547,0.00008247207,0.0000435078,0.00006323214,0.000035307443,0.000003258602,0.00009488756,0.000053670934,9.953072e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000089264344,0.000245579,0.27417278,0.00006199032,0.000039497198,0.0000015521549,0.00013279231,0.000021140382,0.7238373,0.000021518292,0.00051921123,0.0008573814],"study_design_scores_gemma":[0.00082588755,0.0000985968,0.23776536,0.000054156735,0.000024180408,0.0000038723383,0.00004173369,0.0000052305204,0.7578571,0.00001878804,0.0031845137,0.00012057763],"about_ca_topic_score_codex":0.000013357443,"about_ca_topic_score_gemma":0.000039105307,"teacher_disagreement_score":0.036407415,"about_ca_system_score_codex":0.0000023739472,"about_ca_system_score_gemma":0.000013345434,"threshold_uncertainty_score":0.33631134},"labels":[],"label_agreement":null},{"id":"W2557623691","doi":"10.1182/blood.v108.11.1545.1545","title":"Symptoms and Signs of Hemochromatosis in HFE C282Y Homozygotes Identified by Screening in Primary Care.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Transferrin saturation; Medicine; Hemochromatosis; Hereditary hemochromatosis; Internal medicine; Diabetes mellitus; Gastroenterology; Ferritin; Endocrinology; Serum ferritin","score_opus":0.004260767951165953,"score_gpt":0.20486907423725137,"score_spread":0.20060830628608542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557623691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98352027,0.012416371,0.000048392754,0.000049904356,0.000024183715,0.00021282597,0.000015616079,0.000019892392,0.0036925182],"genre_scores_gemma":[0.9988954,0.000103482496,0.00065544405,0.00008663456,0.000026617236,0.000010897505,0.000085469364,0.000015810198,0.00012025354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999132,0.000028714838,0.000281666,0.00019510815,0.00017130803,0.00019122065],"domain_scores_gemma":[0.99968845,0.000040360108,0.000055980712,0.00015255743,0.000022230015,0.000040425195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009928871,0.00011025114,0.00031170718,0.00017308527,0.000018288574,0.00001000572,0.000051085924,0.000078143596,0.000015274933],"category_scores_gemma":[0.000023656445,0.000107461114,0.00003710199,0.00022290107,0.00006539559,0.00006947968,0.00003378162,0.00009053036,0.0000017946844],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005403296,0.0006012316,0.85597694,0.0005515818,0.000012527985,0.00003560801,0.000518501,0.000005064057,0.13960938,0.00007921831,0.00034238133,0.0022135105],"study_design_scores_gemma":[0.00979338,0.00009874744,0.9261404,0.0002502345,0.00014052542,0.000017293325,0.0007062218,0.00000679725,0.06248354,0.00007886553,0.00011452107,0.00016942841],"about_ca_topic_score_codex":0.0010648277,"about_ca_topic_score_gemma":0.00013838687,"teacher_disagreement_score":0.07712584,"about_ca_system_score_codex":0.000007651997,"about_ca_system_score_gemma":0.000033873977,"threshold_uncertainty_score":0.4382137},"labels":[],"label_agreement":null},{"id":"W2557646217","doi":"10.1182/blood.v116.21.654.654","title":"The Lectin-Like Domain of Thrombomodulin Protects Against Diabetic Nephropathy by Inhibiting Complement Activation","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Thrombomodulin; Complement system; Diabetic nephropathy; Osteopontin; Inflammation; Nephropathy; Medicine; Chemistry; Immunology; Pharmacology; Internal medicine; Cancer research; Endocrinology; Kidney; Thrombin; Diabetes mellitus; Platelet; Immune system","score_opus":0.013925011104885855,"score_gpt":0.25035453791972584,"score_spread":0.23642952681483997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557646217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99535453,0.000042833468,0.0008155064,0.0011287326,0.0002647001,0.0009406676,0.0000037722539,0.00006948481,0.0013797964],"genre_scores_gemma":[0.99684685,0.000010100201,0.0023622594,0.00043316308,0.00012814673,0.000072202376,0.000035666024,0.000027758511,0.00008386942],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987206,0.00007194614,0.00036159952,0.00022234571,0.0003631165,0.00026040175],"domain_scores_gemma":[0.99915457,0.000101067824,0.00022832713,0.00030308327,0.00012409213,0.00008885141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047498738,0.00014887373,0.00024647577,0.00005203323,0.00026129853,0.000028780727,0.000100575955,0.00008974598,0.00004940966],"category_scores_gemma":[0.00011373975,0.00011049809,0.00007643164,0.00021588952,0.00008451287,0.000057536272,0.00005342933,0.00031780903,0.000011488033],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001694948,0.0005369986,0.00049122336,0.00004087223,0.00007146156,0.000001039432,0.00024369117,6.636487e-7,0.9926196,0.0016687724,0.00030773156,0.0040010447],"study_design_scores_gemma":[0.003330192,0.00030657626,0.004507943,0.000102835285,0.000067245855,0.0000076057026,0.00027088044,0.000099394274,0.98691726,0.0014025392,0.0028584735,0.00012907674],"about_ca_topic_score_codex":0.000019513262,"about_ca_topic_score_gemma":0.000026673393,"teacher_disagreement_score":0.005702314,"about_ca_system_score_codex":0.0000140052425,"about_ca_system_score_gemma":0.00006609887,"threshold_uncertainty_score":0.45059815},"labels":[],"label_agreement":null},{"id":"W2557669629","doi":"10.1182/blood.v104.11.1278.1278","title":"Leukemia Inhibitory Factor: A Newly Identified Chemoattractant and Regulator of Metastasis of Rhabdomyosarcomas and Neuroblastomas to Bone Marrow.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Leukemia inhibitory factor; Cancer research; Stromal cell; Bone marrow; Biology; Cytokine; Chemotaxis; CD34; Internal medicine; Chemistry; Cell biology; Receptor; Medicine; Immunology; Interleukin 6; Stem cell","score_opus":0.015568791343446136,"score_gpt":0.24803315845600285,"score_spread":0.23246436711255672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557669629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983769,0.0005719688,0.00009497303,0.00035360572,0.00007032824,0.0002547268,0.000038493316,0.0000267779,0.00021220367],"genre_scores_gemma":[0.9974048,0.000034823308,0.0022966582,0.00008786859,0.000059932758,0.0000046906,0.000004765395,0.000022289156,0.000084142004],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990039,0.000015321308,0.00036662605,0.00024853364,0.00021252767,0.00015309003],"domain_scores_gemma":[0.99928504,0.000044099124,0.00014685527,0.00024498414,0.00010166193,0.00017733409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009591559,0.00014283489,0.00040645743,0.00014906788,0.000041926654,0.000012377846,0.000041487365,0.00006018951,0.000050563605],"category_scores_gemma":[0.00010504528,0.00013253745,0.00009090221,0.00013849362,0.00009288343,0.000080591475,0.000060345745,0.00013445425,0.0000030769984],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012613209,0.00029173127,0.0011841033,0.00016763213,0.00010493054,0.000029881263,0.0006611723,0.0000069563034,0.9961776,0.000086147535,0.00012368915,0.0010400196],"study_design_scores_gemma":[0.003612189,0.0006306478,0.038656637,0.00031389666,0.00030215734,0.00035483637,0.00016180219,0.0000070169654,0.95500255,0.00007928315,0.0007646381,0.0001143535],"about_ca_topic_score_codex":0.00018517407,"about_ca_topic_score_gemma":0.000045518667,"teacher_disagreement_score":0.041175064,"about_ca_system_score_codex":0.000025496001,"about_ca_system_score_gemma":0.00012349652,"threshold_uncertainty_score":0.54047203},"labels":[],"label_agreement":null},{"id":"W2557680626","doi":"10.1182/blood.v116.21.3800.3800","title":"Systematic Review to Identify Validated Manual Warfarin Maintenance Dosing Tools.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Dosing; Warfarin; Medicine; Observational study; Nomogram; Intensive care medicine; MEDLINE; Medical physics; Internal medicine","score_opus":0.052894619101133876,"score_gpt":0.36810876413162164,"score_spread":0.3152141450304878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557680626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9608385,0.0040488974,0.00082106947,0.013724415,0.0014630071,0.0072075333,0.000012979072,0.000501628,0.011382001],"genre_scores_gemma":[0.9742572,0.00053054374,0.0037186267,0.0042123646,0.0008007897,0.000033627766,0.000065408574,0.00004823316,0.016333234],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99883497,0.00004029397,0.00045608656,0.00020233482,0.00026846508,0.00019787136],"domain_scores_gemma":[0.999182,0.00007388295,0.00012135731,0.00042410722,0.0000873341,0.000111310015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054511265,0.00012693087,0.00050663506,0.00007791045,0.000052778072,0.00005917964,0.00011410137,0.000049350972,0.00019554468],"category_scores_gemma":[0.0011228665,0.0000952638,0.00014082597,0.0002553289,0.000013608348,0.000105892395,0.00007400486,0.00012353488,0.0006371052],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014795359,0.00020672442,0.037964158,0.73140275,0.0016630612,0.0004245156,0.0005028632,0.0000032123467,0.19399422,0.010841563,0.020738363,0.0021106068],"study_design_scores_gemma":[0.022927795,0.0008420716,0.26283428,0.5400168,0.03064236,0.0010996412,0.0005483388,0.00013340416,0.04870911,0.0007816965,0.08852979,0.0029347644],"about_ca_topic_score_codex":0.000008001548,"about_ca_topic_score_gemma":0.0000049945584,"teacher_disagreement_score":0.22487012,"about_ca_system_score_codex":0.000011351084,"about_ca_system_score_gemma":0.000015300411,"threshold_uncertainty_score":0.81889105},"labels":[],"label_agreement":null},{"id":"W2557686778","doi":"10.1182/blood.v104.11.1721.1721","title":"Role of Thrombin Exosites in Protection from Inhibition by Antithrombin in the Presence of Heparin and Fibrin.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Blood properties and coagulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Antithrombin; Ternary complex; Chemistry; Heparin; Thrombin; Fibrin; Fibrinogen; Binding site; Biochemistry; Stereochemistry; Platelet; Enzyme; Immunology; Biology","score_opus":0.010466066405545855,"score_gpt":0.21067457666669992,"score_spread":0.20020851026115408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557686778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99796045,0.0011829003,0.000013437233,0.00024444168,0.000006349239,0.00042295046,0.0000051672837,0.0000059134727,0.00015840316],"genre_scores_gemma":[0.99969316,0.000079740705,0.00015635337,0.000018037132,0.000012096002,0.00001978509,0.000011712991,0.0000046527953,0.0000044622248],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994694,0.00003774921,0.00018657894,0.000111537105,0.00012499213,0.000069755624],"domain_scores_gemma":[0.99978024,0.000016550277,0.00006057897,0.0001112007,0.000019948984,0.000011474891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011601343,0.0000542555,0.00014274732,0.000044352866,0.000012039005,0.0000050474205,0.000026859265,0.000052784086,0.00000813092],"category_scores_gemma":[0.000028881876,0.00003969279,0.000016161679,0.00015136183,0.00004529654,0.00008039484,0.000017201364,0.00008055663,5.4399163e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000645338,0.0006458696,0.08732559,0.00005693007,0.000010431665,0.0000014395914,0.0013263855,0.000017461409,0.9096477,0.00015169923,0.0000048465504,0.0007470908],"study_design_scores_gemma":[0.0020653154,0.00028322107,0.38166893,0.0002672353,0.000022443555,0.000008537495,0.00031454273,0.00006957212,0.6128606,0.0024040327,0.0000039481765,0.000031588577],"about_ca_topic_score_codex":0.0069840043,"about_ca_topic_score_gemma":0.00050846144,"teacher_disagreement_score":0.29678708,"about_ca_system_score_codex":0.000007120734,"about_ca_system_score_gemma":0.000018505654,"threshold_uncertainty_score":0.9996286},"labels":[],"label_agreement":null},{"id":"W2557689159","doi":"10.1182/blood.v112.11.2585.2585","title":"A Prospective Multicenter Phase II Study by the Puget Sound Oncology Consortium (PSOC) of Gemcitabine (G), Carboplatin (C), Dexamethasone (D), and Rituximab (R) in Patients with Relapsed/Refractory Lymphoma","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cascades (Canada)","funders":"","keywords":"Medicine; Internal medicine; Salvage therapy; Regimen; Rituximab; Chemotherapy regimen; Carboplatin; Gastroenterology; Lenalidomide; Phases of clinical research; Surgery; Oncology; Lymphoma; Chemotherapy; Dexamethasone","score_opus":0.011225189908982757,"score_gpt":0.2589632845206553,"score_spread":0.24773809461167257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557689159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99599224,0.0010004679,0.0000013419518,0.000106704254,0.000042978507,0.002340014,0.000066373155,0.000022468674,0.00042742927],"genre_scores_gemma":[0.99917805,0.00005884857,0.00020390082,0.000106395164,0.00002402821,0.00027906988,0.000034664834,0.000027961349,0.000087064036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840266,0.00013701979,0.00042091898,0.00041633975,0.00034163042,0.0002814435],"domain_scores_gemma":[0.9989177,0.0002390913,0.00023086282,0.00034928802,0.00014777743,0.00011526757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015817702,0.0002536384,0.0006328817,0.00009098087,0.00014016568,0.0000068352456,0.00007436783,0.00009545777,0.000020669511],"category_scores_gemma":[0.00011009908,0.00015501684,0.000051055602,0.00018936823,0.000300308,0.00007938056,0.000079414116,0.00012010249,0.000002999104],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030718253,0.16165079,0.8279955,0.000017855535,0.00052940205,0.00020778869,0.003220972,1.8285982e-7,0.00006865398,0.000006083532,0.00009322009,0.003137719],"study_design_scores_gemma":[0.25020015,0.021810314,0.7259112,0.000041432322,0.00054147624,0.00005111998,0.000546953,0.0000074840355,0.0006504495,0.000007782975,0.00011078162,0.000120873214],"about_ca_topic_score_codex":0.00037735124,"about_ca_topic_score_gemma":0.00021377175,"teacher_disagreement_score":0.24712832,"about_ca_system_score_codex":0.0002048783,"about_ca_system_score_gemma":0.00015606677,"threshold_uncertainty_score":0.6321403},"labels":[],"label_agreement":null},{"id":"W2557709293","doi":"10.1182/blood.v108.11.626.626","title":"Clinical Outcomes in Patients Receiving Venous Thromboembolism (VTE) Prophylaxis after Orthopedic Surgery (OS). A Systematic Review and Meta-Analysis of Proportions.","year":2006,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Pulmonary embolism; Randomized controlled trial; Meta-analysis; Orthopedic surgery; Thrombosis; Pulmonary angiography; Venography; Surgery; Internal medicine; Venous thrombosis; Incidence (geometry)","score_opus":0.06056280275950007,"score_gpt":0.35370222608363533,"score_spread":0.29313942332413523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557709293","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010684606,0.9892945,0.0000011636433,0.000038449387,0.00008218956,0.008969757,0.0003705485,0.000040559706,0.00013437179],"genre_scores_gemma":[0.0014591068,0.99352676,0.00012452342,0.000340511,0.00003505906,0.0034727394,0.0006633173,0.00009334637,0.00028466206],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99146575,0.0010245711,0.0052395873,0.0009775537,0.00081971724,0.000472849],"domain_scores_gemma":[0.99461883,0.000965619,0.0025626826,0.0014028548,0.000266449,0.00018357174],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0026641276,0.0007912938,0.03236807,0.001269054,0.000047970327,0.00003307366,0.00021524046,0.00041171332,0.0005113512],"category_scores_gemma":[0.0015404727,0.0004919881,0.006285176,0.0017335347,0.0001283344,0.00008738404,0.00020885892,0.0005211065,0.000024533363],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000018274199,0.006876903,0.012997932,0.7728866,0.2016862,0.00007170128,0.000020798781,5.749636e-8,4.9337034e-10,0.0000036201266,0.0005118135,0.004942579],"study_design_scores_gemma":[0.00029703497,0.000231225,0.05999781,0.06930149,0.8646986,0.0000065679815,0.0000031138416,1.1057486e-7,8.597077e-9,0.000002358448,0.0050946167,0.0003670973],"about_ca_topic_score_codex":0.00012163459,"about_ca_topic_score_gemma":0.00012105537,"teacher_disagreement_score":0.7035851,"about_ca_system_score_codex":0.0000667239,"about_ca_system_score_gemma":0.00027839272,"threshold_uncertainty_score":0.9997532},"labels":[],"label_agreement":null},{"id":"W2557709742","doi":"10.1182/blood.v110.11.184.184","title":"Vascularization Predicts Overall Survival (OS) &amp; Risk of Transformation (RT) in Uniformly Treated Patients with Follicular Lymphoma (FL).","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Follicular lymphoma; CD34; Angiogenesis; Medicine; Pathology; Tumor microenvironment; Lymphoma; Stage (stratigraphy); Radiation therapy; Internal medicine; Cancer; Biology","score_opus":0.006151472392422119,"score_gpt":0.20839546170370432,"score_spread":0.2022439893112822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557709742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965329,0.00010655736,0.0005980723,0.0000206986,0.0000326025,0.0008401592,0.00004742304,0.00004198774,0.0017795807],"genre_scores_gemma":[0.9985404,0.0001269302,0.00039723236,0.000025492713,0.000022221508,0.000024270232,0.00081439625,0.000020691336,0.000028335553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986362,0.00004657647,0.00040706326,0.00020160788,0.00046631123,0.00024223751],"domain_scores_gemma":[0.99927485,0.000048110367,0.00015380088,0.00025224168,0.00016450498,0.00010647171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025034376,0.00018037525,0.0003237612,0.00017733542,0.00004131332,0.000010369123,0.000045133296,0.00011729576,0.000018421155],"category_scores_gemma":[0.000038984657,0.00013090186,0.000102049,0.00032136965,0.00002680591,0.00016636362,0.000008087834,0.000041826373,0.0000085573065],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046866664,0.004883256,0.9893061,0.00006665087,0.0004248308,0.00002537338,0.000603755,0.000046328256,0.000088717985,0.00018864711,0.000006069467,0.0038915926],"study_design_scores_gemma":[0.04147171,0.0006227135,0.94758797,0.00015308143,0.00078942085,0.0000074428185,0.000027524273,0.000047949427,0.008877808,0.000026520198,0.00026831147,0.00011955737],"about_ca_topic_score_codex":0.0008763236,"about_ca_topic_score_gemma":0.00061741937,"teacher_disagreement_score":0.04171815,"about_ca_system_score_codex":0.00012252753,"about_ca_system_score_gemma":0.00007481747,"threshold_uncertainty_score":0.5338023},"labels":[],"label_agreement":null},{"id":"W2557717970","doi":"10.1182/blood.v106.11.4095.4095","title":"Undetected Factor VIII Level in a Type III von Willebrand Disease (vWD) Patient Masquerading as Severe Hemophilia A.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"","keywords":"Medicine; Haemophilia; Haemophilia A; Von Willebrand factor; Von Willebrand disease; Hemarthrosis; Coagulopathy; Pediatrics; Bleeding time; Gastroenterology; Surgery; Internal medicine; Platelet","score_opus":0.016611828705448018,"score_gpt":0.24526075964834274,"score_spread":0.2286489309428947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557717970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99625117,0.0008801483,0.0000026110492,0.00048762155,0.000065455904,0.00045674824,0.00004502171,0.0000590819,0.0017521236],"genre_scores_gemma":[0.9982359,0.00009334322,0.00019304031,0.00038360571,0.000051260125,0.000017308776,0.00006935551,0.00002721316,0.0009289846],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899465,0.000020676354,0.00021413663,0.0002776366,0.00021062096,0.0002822622],"domain_scores_gemma":[0.9994431,0.00002482343,0.000049773513,0.00021594737,0.000037753423,0.00022859707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000022136908,0.00018701029,0.0002817304,0.00011058653,0.000055523094,0.000014857859,0.000048811835,0.000076608725,0.00031016342],"category_scores_gemma":[0.00006098863,0.00015767757,0.00006566524,0.0002103236,0.000019917208,0.00008759162,0.000028627941,0.00013434605,0.00012848373],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008416029,0.022795543,0.762179,0.0004936816,0.0020110796,0.014719666,0.0061293687,0.00013674908,0.018984625,0.0003479023,0.0018614436,0.16192488],"study_design_scores_gemma":[0.0902681,0.0029124406,0.86434835,0.0010422652,0.0012322904,0.0008384374,0.00041054824,0.00091244036,0.020516003,0.0013148985,0.014703376,0.0015008464],"about_ca_topic_score_codex":0.00006708585,"about_ca_topic_score_gemma":0.00009376552,"teacher_disagreement_score":0.16042404,"about_ca_system_score_codex":0.00007848142,"about_ca_system_score_gemma":0.0001051928,"threshold_uncertainty_score":0.64299047},"labels":[],"label_agreement":null},{"id":"W2557724490","doi":"10.1182/blood.v104.11.3613.3613","title":"Low Bone Mass in Thalassemia: The Thalassemia Clinical Research Network (TCRN) Experience.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Hospital for Sick Children","funders":"","keywords":"Medicine; Thalassemia; Internal medicine; Bone mineral; Gastroenterology; Bone pain; Osteoporosis; Anemia; Bone density; Pediatrics","score_opus":0.04021715302607884,"score_gpt":0.3637155376609516,"score_spread":0.3234983846348728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557724490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9783333,0.0028659713,0.000030372965,0.0054329974,0.00034655613,0.0005958186,0.0000012807496,0.00006441677,0.012329297],"genre_scores_gemma":[0.9956176,0.0021114096,0.0004255895,0.00057648384,0.0005929638,0.000072713585,0.000007390136,0.00003459331,0.00056123035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971199,0.00024614288,0.0006036944,0.00045282923,0.00063566025,0.00094174256],"domain_scores_gemma":[0.9985775,0.00035515102,0.000071844355,0.0006590771,0.000105581195,0.00023087753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021513978,0.00018282843,0.00039577545,0.00009428192,0.00024559582,0.000038967653,0.00026605,0.00046647448,0.00009083096],"category_scores_gemma":[0.00049828656,0.00011522156,0.00016813337,0.00095863314,0.00045020063,0.000067983245,0.00013171142,0.0018142987,0.00018035724],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063555385,0.0066490117,0.9520565,0.00018748482,0.00032626494,0.0045130933,0.0057045743,0.0010491449,0.0062762327,0.0037800556,0.0121654775,0.006656559],"study_design_scores_gemma":[0.08606239,0.00587903,0.7483592,0.0065317512,0.0007821837,0.0023555078,0.03990253,0.0006021183,0.023141747,0.02178028,0.06248355,0.0021197048],"about_ca_topic_score_codex":0.00012434363,"about_ca_topic_score_gemma":0.00006626681,"teacher_disagreement_score":0.20369734,"about_ca_system_score_codex":0.000070673064,"about_ca_system_score_gemma":0.00043847298,"threshold_uncertainty_score":0.7882326},"labels":[],"label_agreement":null},{"id":"W2557744148","doi":"10.1182/blood.v108.11.4680.4680","title":"Fludarabine, Mitoxantrone and Dexamethasone for the First Line Treatment of Patients with Indolent Non-Hodgkin Lymphoma (NHL): GATLA First Interim Report (Grupo Argentino de Tratamiento de la Leucemia Aguda).","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Mitoxantrone; Internal medicine; Fludarabine; Vincristine; Gastroenterology; Prednisone; Interim analysis; Lymphoma; Cyclophosphamide; Surgery; Chemotherapy; Clinical trial","score_opus":0.007957061818872176,"score_gpt":0.24656747609851568,"score_spread":0.2386104142796435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557744148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956349,0.0013592034,0.00055098074,0.00046588358,0.00006487519,0.0015594801,0.00011508877,0.000034023404,0.0002155278],"genre_scores_gemma":[0.99481654,0.00043528722,0.003340049,0.000073209136,0.0001943389,0.00069253665,0.00022801913,0.000049328333,0.00017066894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825704,0.000037140264,0.00052161526,0.00044455132,0.0002931378,0.00044650387],"domain_scores_gemma":[0.99851286,0.0004145042,0.00029654734,0.0004942252,0.00012501859,0.00015683791],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021124013,0.0003553098,0.00056165305,0.000089258836,0.00017718162,0.000042744123,0.00008279218,0.0001332424,0.000014758457],"category_scores_gemma":[0.000056586956,0.00021428359,0.000181381,0.00015103436,0.00017438416,0.00005226202,0.00003753307,0.000042987067,0.000001699382],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011373968,0.016300408,0.97366554,0.00016519967,0.0008300118,0.00040654384,0.0004808971,0.000024947854,0.0005117836,0.000038769078,0.00066629745,0.0057721916],"study_design_scores_gemma":[0.03863964,0.0040535266,0.88901055,0.00024714242,0.0018396525,0.00042645395,0.00006253047,0.00012873487,0.05818779,0.000020246567,0.0071796007,0.00020411814],"about_ca_topic_score_codex":0.0010014672,"about_ca_topic_score_gemma":0.0004791598,"teacher_disagreement_score":0.08465499,"about_ca_system_score_codex":0.00033537464,"about_ca_system_score_gemma":0.00024995557,"threshold_uncertainty_score":0.8738231},"labels":[],"label_agreement":null},{"id":"W2557782308","doi":"10.1182/blood.v118.21.1229.1229","title":"Whole-Exome Sequencing Identifies Novel Risk Variant for Thrombotic Storm","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Catastrophic antiphospholipid syndrome; Context (archaeology); Thrombotic microangiopathy; Venous thrombosis; Thrombophilia; Thrombosis; Pulmonary embolism; Antiphospholipid syndrome; Internal medicine; Disease","score_opus":0.05385898924816386,"score_gpt":0.2614058030971113,"score_spread":0.20754681384894746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557782308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98113936,0.00032491016,0.010107144,0.0001990826,0.0006028451,0.0012276795,0.000056662193,0.00016973347,0.006172589],"genre_scores_gemma":[0.9899459,0.0001273745,0.008446783,0.00037544107,0.0002680289,0.00014416825,0.000022688864,0.000045621957,0.0006240273],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99876547,0.000014841198,0.00029291396,0.0003427297,0.00021370393,0.00037032354],"domain_scores_gemma":[0.9991531,0.000048701884,0.00013882037,0.00043613394,0.00009627883,0.0001270136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003640096,0.00018140076,0.00044203596,0.00011112167,0.00015980829,0.000031333228,0.00013852166,0.000079286634,0.0001675911],"category_scores_gemma":[0.00012583582,0.00015695418,0.00016065012,0.00011563963,0.00005200882,0.00012008821,0.00007528808,0.00012269308,0.00010077554],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005399492,0.06544708,0.08343841,0.00722318,0.01914712,0.0017258921,0.07895049,0.00011749984,0.54204977,0.13597345,0.051488936,0.01389823],"study_design_scores_gemma":[0.013785371,0.0023522147,0.88647425,0.00061834406,0.008468522,0.00020483298,0.0034101752,0.00028922237,0.06929589,0.0047869445,0.009465157,0.0008490541],"about_ca_topic_score_codex":0.00052419555,"about_ca_topic_score_gemma":0.00014829048,"teacher_disagreement_score":0.80303586,"about_ca_system_score_codex":0.000056589965,"about_ca_system_score_gemma":0.000075696415,"threshold_uncertainty_score":0.6400406},"labels":[],"label_agreement":null},{"id":"W2557822497","doi":"10.1182/blood.v126.23.4492.4492","title":"Hematopoietic Stem Cell Transplant Activity in Latin America: Predominant Increase in Autologous and Modest Increase in Allogeneic HCT with High Use of Unrelated Cord Blood Grafts","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Transplantation; Cord blood; Hematology; Bone marrow; Hematopoietic cell; Internal medicine; Haematopoiesis; Stem cell; Immunology; Biology","score_opus":0.02243059483820208,"score_gpt":0.23240577513663052,"score_spread":0.20997518029842843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557822497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99809486,0.000256974,0.00011632895,0.00007073676,0.000020396334,0.0012027967,0.000080242055,0.00004771284,0.00010995864],"genre_scores_gemma":[0.99764836,0.00018254419,0.0018992842,0.000029343071,0.0000074056215,0.00008894386,0.000060836846,0.0000491017,0.000034192297],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974801,0.00040496408,0.00071476,0.00054938724,0.000396334,0.00045443297],"domain_scores_gemma":[0.9985678,0.00041423636,0.00023076459,0.00039678605,0.00006896624,0.00032145207],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004527194,0.00036236393,0.0009773833,0.00046263542,0.000018906798,0.000014139395,0.000103502585,0.0002474841,0.000008933167],"category_scores_gemma":[0.00004045859,0.00030922896,0.00004640005,0.00070094876,0.00017017146,0.00015357192,0.000027106074,0.00038999118,0.000004086444],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066620274,0.006693748,0.9041501,0.0014906273,0.00012716619,0.007008096,0.0059344745,0.0005785554,0.06685839,0.00005569176,0.0000029787993,0.00043808817],"study_design_scores_gemma":[0.054940876,0.0030251017,0.7230457,0.0031411904,0.0014552168,0.002223963,0.0007336858,0.0031361575,0.20748815,0.00007817837,0.000004145033,0.00072762975],"about_ca_topic_score_codex":0.009060971,"about_ca_topic_score_gemma":0.0025138324,"teacher_disagreement_score":0.18110444,"about_ca_system_score_codex":0.000065790024,"about_ca_system_score_gemma":0.0003903005,"threshold_uncertainty_score":0.999936},"labels":[],"label_agreement":null},{"id":"W2557857454","doi":"10.1182/blood.v112.11.4880.4880","title":"Somatic CNVs and LOH in Acute Myelomonocitic Leukemia","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Copy-number variation; SNP array; Loss of heterozygosity; Biology; Genetics; Comparative genomic hybridization; Copy number analysis; Single-nucleotide polymorphism; Cytogenetics; Gene dosage; SNP genotyping; SNP; Allele; Genome; Gene; Chromosome; Genotype; Gene expression","score_opus":0.01932669342744189,"score_gpt":0.27212961806239755,"score_spread":0.2528029246349557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557857454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931491,0.00056988257,0.00002256046,0.00061388727,0.000024861118,0.00036884568,0.0000039716892,0.00006462918,0.005182255],"genre_scores_gemma":[0.99429506,0.00067252555,0.0022500693,0.0003669518,0.00009936221,0.00003865191,0.000012322078,0.00003215547,0.0022329034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987279,0.000048338214,0.0002478169,0.00027960638,0.00028464987,0.00041164825],"domain_scores_gemma":[0.99928355,0.00010902498,0.000034160534,0.00032235376,0.000043216885,0.00020766548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017473628,0.00015080045,0.0003492568,0.00020837077,0.000071878385,0.000011467752,0.00010360523,0.00011997801,0.000081637125],"category_scores_gemma":[0.00015132077,0.00013258931,0.000047289544,0.00029759487,0.00016531722,0.00009006923,0.00008947948,0.0003755671,0.00015992917],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050542917,0.0014392094,0.75353336,0.0009786478,0.0011124967,0.027210262,0.0068573393,0.000006780676,0.18922153,0.0005344505,0.0069978163,0.011602658],"study_design_scores_gemma":[0.023681406,0.0007216766,0.9282585,0.00032823702,0.0004368398,0.010416383,0.00032971468,0.0015275045,0.03187792,0.00067656103,0.001266641,0.0004786429],"about_ca_topic_score_codex":0.000105861545,"about_ca_topic_score_gemma":0.000013927271,"teacher_disagreement_score":0.1747251,"about_ca_system_score_codex":0.00022907366,"about_ca_system_score_gemma":0.00052008696,"threshold_uncertainty_score":0.54068357},"labels":[],"label_agreement":null},{"id":"W2557859626","doi":"10.1182/blood.v108.11.2019.2019","title":"Empirical Versus Pre-Emptive Antifungal Therapy in High-Risk Febrile Neutropenic Patients: A Prospective Randomized Study.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Internal medicine; Neutropenia; Febrile neutropenia; Mucositis; Randomized controlled trial; Clinical endpoint; Surgery; Chemotherapy","score_opus":0.012515978995588446,"score_gpt":0.28766324454365916,"score_spread":0.27514726554807073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557859626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929917,0.00038326066,0.000017844603,0.0000529912,0.0001793248,0.0042519514,0.000027840453,0.000081603015,0.0020134833],"genre_scores_gemma":[0.99882245,0.00009889399,0.00013255874,0.000051687744,0.00019222598,0.00023569548,0.00003739035,0.0000335162,0.00039558142],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997326,0.0005226481,0.0005923164,0.00065180584,0.00049964065,0.00040758876],"domain_scores_gemma":[0.9985722,0.00045409147,0.00018195738,0.0004603741,0.00023805677,0.000093331306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065731327,0.00028837015,0.0010144352,0.00012179193,0.00010962095,0.000033691562,0.00012560097,0.00012384303,0.00012617717],"category_scores_gemma":[0.00050238107,0.00021077141,0.00025547144,0.00040573548,0.00019543018,0.00013510365,0.00005139947,0.00042252976,0.000039610637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1804285,0.009088592,0.8090255,0.00001019374,0.00023990632,0.000045932484,0.00063493405,0.0000025671602,0.00010888245,0.00003497854,0.00017176053,0.00020819512],"study_design_scores_gemma":[0.36603448,0.0020780154,0.6306424,0.000022899007,0.00022367908,6.954658e-7,0.00019403143,0.0000076262977,0.0005135917,0.00012998341,0.000015785927,0.0001368167],"about_ca_topic_score_codex":0.0018134357,"about_ca_topic_score_gemma":0.0011625997,"teacher_disagreement_score":0.18560597,"about_ca_system_score_codex":0.00012698687,"about_ca_system_score_gemma":0.00014547973,"threshold_uncertainty_score":0.8595009},"labels":[],"label_agreement":null},{"id":"W2557859648","doi":"10.1182/blood.v104.11.3625.3625","title":"Role of P-Selectin and GPIbα in the Fast and Delayed Clearance of Transfused Platelets.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Platelet; Platelet activation; In vivo; Flow cytometry; In vitro; P-selectin; Chemistry; Platelet transfusion; Immunology; Andrology; Receptor; Molecular biology; Medicine; Biology; Biochemistry","score_opus":0.00546118277221305,"score_gpt":0.21162676300542935,"score_spread":0.2061655802332163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557859648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960796,0.0011081531,0.000049587226,0.00065324636,0.000006730253,0.0003327013,0.0000027867834,0.000008387792,0.0017587943],"genre_scores_gemma":[0.99880743,0.00069735677,0.0002914508,0.00016843107,0.000007632436,0.0000068122076,0.0000011088622,0.000006430895,0.0000133250305],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99950135,0.000017453633,0.00016194826,0.00011135488,0.00011612019,0.000091793016],"domain_scores_gemma":[0.99980336,0.000021187378,0.000026638743,0.000106546075,0.00001554444,0.000026691925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013376382,0.00006377241,0.00017079044,0.000055247023,0.000016358006,0.000002909109,0.000038921207,0.00003680851,0.000007739372],"category_scores_gemma":[0.000007763462,0.00004565824,0.000023856035,0.00014451385,0.00005441168,0.00002070605,0.0000061431083,0.0000911338,4.1887137e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029929574,0.010002238,0.049184617,0.0015721595,0.00086921867,0.00018642175,0.052418966,0.000085535416,0.73613274,0.015583503,0.000054972945,0.13091666],"study_design_scores_gemma":[0.042378634,0.0022109763,0.6499291,0.00036005827,0.00068017095,0.00022829701,0.0046876427,0.000051677565,0.29690006,0.0011862426,0.0011787643,0.0002083571],"about_ca_topic_score_codex":0.00023514239,"about_ca_topic_score_gemma":0.00028965462,"teacher_disagreement_score":0.6007445,"about_ca_system_score_codex":0.0000019902313,"about_ca_system_score_gemma":0.000015259917,"threshold_uncertainty_score":0.18618889},"labels":[],"label_agreement":null},{"id":"W2557861511","doi":"10.1182/blood.v124.21.896.896","title":"A New AHI-1-DNM2-BCR-ABL Complex Regulates Endocytosis Processes in Chronic Myeloid Leukemia","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Stem cell; Progenitor cell; Cancer research; CD34; Biology; Myeloid leukemia; CD38; Cell biology","score_opus":0.018846216180627328,"score_gpt":0.2585228386021348,"score_spread":0.2396766224215075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557861511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98358357,0.0035020013,0.000078046534,0.00051196286,0.000089894056,0.00085017836,0.000011626489,0.00028104134,0.011091678],"genre_scores_gemma":[0.9913163,0.0004104621,0.0036542565,0.00030732548,0.0007463526,0.00009146373,0.000117530086,0.00008426734,0.0032720324],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975414,0.00006782805,0.0005406744,0.00066468917,0.00044665142,0.0007387513],"domain_scores_gemma":[0.9984514,0.00020469395,0.00016911022,0.00075096986,0.00008414107,0.00033967078],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000184802,0.00041046494,0.0007624325,0.00024223853,0.000087607536,0.000042294316,0.00024202598,0.00019425579,0.00079069246],"category_scores_gemma":[0.00032683203,0.00037005273,0.00012804482,0.0006390752,0.00008880868,0.00015100586,0.000112614674,0.00031479157,0.00032204366],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015760427,0.005126772,0.21937838,0.010434121,0.0029875136,0.0020296997,0.0058777425,0.00072213,0.43816745,0.0022085956,0.044678453,0.2668131],"study_design_scores_gemma":[0.110301144,0.003758279,0.20312375,0.0033052485,0.0020823092,0.0021996403,0.0002141833,0.0019793329,0.4815706,0.0015103593,0.18807536,0.0018797977],"about_ca_topic_score_codex":0.0010644894,"about_ca_topic_score_gemma":0.0008380969,"teacher_disagreement_score":0.2649333,"about_ca_system_score_codex":0.0023975414,"about_ca_system_score_gemma":0.0036623913,"threshold_uncertainty_score":0.9998751},"labels":[],"label_agreement":null},{"id":"W2557866449","doi":"10.1182/blood.v126.23.5221.5221","title":"Development and Validation of a LC-ESI-MS/MS-MRM Analytical Method to Quantify 5hmC Levels in Human Blood Cells","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Concordia University; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Selected reaction monitoring; Chemistry; Chromatography; Electrospray ionization; Mass spectrometry; Tandem mass spectrometry; Triple quadrupole mass spectrometer; Formic acid; DNA methylation; High-performance liquid chromatography; Biochemistry; Gene expression; Gene","score_opus":0.061617233402502684,"score_gpt":0.34109113275161956,"score_spread":0.27947389934911687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557866449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908534,0.00032127646,0.007870072,0.000037399983,0.000030952626,0.00017461462,0.000008934808,0.0000048805555,0.0006984247],"genre_scores_gemma":[0.9354515,0.000010664689,0.06427515,0.000026194748,0.00005493563,0.000011020732,0.000042453692,0.000014154382,0.0001138935],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989035,0.00009975458,0.00034191977,0.0003117689,0.00016695795,0.0001760582],"domain_scores_gemma":[0.99945277,0.0000174519,0.000083202765,0.00020605918,0.000106471896,0.00013406467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007308153,0.00012643274,0.00018514456,0.00009804485,0.000029771812,0.000019032437,0.00009848732,0.00014140086,0.0000062761724],"category_scores_gemma":[0.00008471527,0.00012742043,0.00003269865,0.0001347459,0.000022582662,0.0000033916592,0.00010062139,0.000056066194,0.0000028731079],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013844398,0.00028544886,0.011540792,0.000020836247,0.000048789745,0.0000026915495,0.00032467645,0.00011841415,0.98613626,0.00014070018,0.0000122015335,0.0013553195],"study_design_scores_gemma":[0.0012351854,0.00024739176,0.014144036,0.000014230673,0.00005660707,0.0000019341953,0.000049112583,0.00003709876,0.9811517,0.00013546474,0.0027678034,0.00015945626],"about_ca_topic_score_codex":0.000043669377,"about_ca_topic_score_gemma":0.000057487017,"teacher_disagreement_score":0.05640508,"about_ca_system_score_codex":0.0000076171077,"about_ca_system_score_gemma":0.000083475905,"threshold_uncertainty_score":0.51960546},"labels":[],"label_agreement":null},{"id":"W2557883555","doi":"10.1182/blood.v112.11.1824.1824","title":"Circulating Blasts Are Associated with High Levels of vWF and Thrombin Activation in Children with Newly Diagnosed ALL.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster Children's Hospital; Centre Hospitalier Universitaire Sainte-Justine; McMaster University","funders":"","keywords":"Medicine; Fibrinogen; Internal medicine; Von Willebrand factor; Thrombin; Coagulation; Platelet; Antithrombin; Platelet activation; Plasminogen activator; Immunology; Gastroenterology; Endocrinology; Heparin","score_opus":0.010399200580889032,"score_gpt":0.20575990441731334,"score_spread":0.19536070383642432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557883555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99954605,0.00010528297,0.00004334809,0.000019488916,0.0000031239724,0.00018514793,0.000018155293,0.000006091802,0.000073338706],"genre_scores_gemma":[0.99955815,0.000026628511,0.0002241107,0.000039277944,0.000010733285,0.00001266583,0.00010490817,0.000015208384,0.000008303557],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994628,0.000021195214,0.00009929673,0.00020200809,0.000088155946,0.00012658835],"domain_scores_gemma":[0.9996985,0.000009351297,0.00011684837,0.00011204854,0.000034831246,0.00002838153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000026065143,0.000107015105,0.00013988632,0.000025490508,0.000038870283,0.000005010314,0.000039066283,0.00007962032,0.0000019621828],"category_scores_gemma":[0.00002711091,0.000087053224,0.000015265914,0.00008236235,0.000049254122,0.000005471717,0.000020004696,0.000041211333,1.716771e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002555035,0.00074887153,0.9609062,0.000003941139,0.00040673083,0.000010578136,0.00007756905,0.000057031128,0.037560146,0.00001057092,0.0000066669713,0.00018614513],"study_design_scores_gemma":[0.0065468443,0.0003816788,0.8583722,0.00004254765,0.000056172074,0.000026216818,0.000026257978,0.000002285595,0.13442539,0.000018892844,7.3406216e-7,0.00010079484],"about_ca_topic_score_codex":0.00016167799,"about_ca_topic_score_gemma":0.00030449918,"teacher_disagreement_score":0.102534,"about_ca_system_score_codex":0.0000038317417,"about_ca_system_score_gemma":0.00003926282,"threshold_uncertainty_score":0.35499275},"labels":[],"label_agreement":null},{"id":"W2557893350","doi":"10.1182/blood.v110.11.4777.4777","title":"Spontaneous Tumoural Regression in a Patient with t(4;14) Translocation Multiple Myeloma. A Case Report.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Multiple myeloma; Medicine; Serum protein electrophoresis; Bone marrow; Bence Jones protein; Gastroenterology; Proteinuria; Internal medicine; Beta-2 microglobulin; Pathology; Chemotherapy; Urology; Immunology; Antibody; Monoclonal; Immunoglobulin light chain; Monoclonal antibody; Kidney","score_opus":0.016141757091846797,"score_gpt":0.2818803929631768,"score_spread":0.26573863587133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557893350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997542,0.00030275952,0.000119157856,0.00013925892,0.000030899428,0.00087448786,0.000007228111,0.000058262765,0.00092589407],"genre_scores_gemma":[0.9967699,0.000012576716,0.0027680567,0.00003344167,0.00004729457,0.000048559406,0.00008655785,0.000025792271,0.00020780214],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9984215,0.00004010496,0.00035522215,0.00033188867,0.00042700375,0.00042429563],"domain_scores_gemma":[0.9990802,0.00010422389,0.0000912388,0.00033243417,0.000109842345,0.00028206152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025040278,0.00017291165,0.00024545428,0.00020338323,0.000074225856,0.0000124418775,0.0000366821,0.00007714651,0.000032553602],"category_scores_gemma":[0.00020182457,0.000116344774,0.000053627766,0.00027340258,0.000043108063,0.000063444175,0.000014601119,0.00020257497,0.000014695432],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020906972,0.0015602907,0.06760467,0.00004110873,0.0000611531,0.8930092,0.0006949682,0.000002630546,0.0039982563,0.0000023303699,0.0000123684495,0.030922333],"study_design_scores_gemma":[0.012846862,0.0011885065,0.07420823,0.0003434053,0.00007347595,0.8721657,0.00048142156,0.00019548176,0.03822129,0.000004950414,0.00012352022,0.00014719629],"about_ca_topic_score_codex":0.00088224787,"about_ca_topic_score_gemma":0.005189837,"teacher_disagreement_score":0.034223035,"about_ca_system_score_codex":0.000097257085,"about_ca_system_score_gemma":0.000114194074,"threshold_uncertainty_score":0.47444022},"labels":[],"label_agreement":null},{"id":"W2557903862","doi":"10.1182/blood.v120.21.1602.1602","title":"Population Survey of Mantle Cell Lymphoma (MCL) in British Columbia (BC) – A Heterogeneous Disorder with Improved Outcomes in the Modern Era","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Mantle cell lymphoma; Rituximab; Internal medicine; Population; Context (archaeology); Oncology; Stage (stratigraphy); Surgery; Lymphoma","score_opus":0.010270966413909,"score_gpt":0.22516290101540204,"score_spread":0.21489193460149303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557903862","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982416,0.00095667975,0.0000016153527,0.000032757733,0.000027123056,0.00054715347,0.000040243616,0.0000101367705,0.00014270612],"genre_scores_gemma":[0.9994511,0.0000390408,0.00010092579,0.00008248403,0.0000099227145,0.00009736102,0.00009454768,0.00001807069,0.00010656859],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99910885,0.00009128555,0.00023530374,0.0001556299,0.00017359316,0.00023531933],"domain_scores_gemma":[0.9995339,0.000089066096,0.00007551511,0.00023248208,0.000029363788,0.000039679708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001936674,0.00009270547,0.0003009179,0.0000324373,0.000026033642,0.000032094962,0.000060685357,0.000058524784,0.000018648785],"category_scores_gemma":[0.00002419051,0.00008227335,0.00004558658,0.00014097469,0.000019625257,0.00005836031,0.000019266536,0.000035350757,0.000002668314],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030186031,0.007526468,0.985485,0.000032991436,0.000047573893,0.000040522806,0.00027394836,0.000005185075,0.00003585338,7.0326894e-7,0.000008897253,0.006512629],"study_design_scores_gemma":[0.011260222,0.0002419205,0.9877613,0.000047318783,0.00009169735,0.00008179733,0.000038277838,0.00009860439,0.00026493456,0.000012748506,0.000011300408,0.0000898853],"about_ca_topic_score_codex":0.35977262,"about_ca_topic_score_gemma":0.49405247,"teacher_disagreement_score":0.13427985,"about_ca_system_score_codex":0.00004821348,"about_ca_system_score_gemma":0.000035581903,"threshold_uncertainty_score":0.6444907},"labels":[],"label_agreement":null},{"id":"W2557914993","doi":"10.1182/blood.v126.23.458.458","title":"Comparison of Efficacy and Safety Results in 103 Treatment-Naïve Acute Myeloid Leukemia (TN-AML) Patients Not Candidates for Intensive Chemotherapy Using 5-Day and 10-Day Regimens of Guadecitabine (SGI-110), a Novel Hypomethylating Agent (HMA)","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Tolerability; Regimen; Internal medicine; Chemotherapy regimen; Clinical endpoint; Chemotherapy; Neutropenia; Gastroenterology; Surgery; Adverse effect; Clinical trial","score_opus":0.06681648524867487,"score_gpt":0.3531600435505407,"score_spread":0.28634355830186586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557914993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99634945,0.00051571795,0.00017621837,0.00038386337,0.000053744847,0.0019048895,0.00042037066,0.000022619139,0.0001731435],"genre_scores_gemma":[0.9887626,0.0002064889,0.010266345,0.00008491565,0.00008399393,0.000033288907,0.0002486072,0.00006643024,0.00024733672],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971566,0.00012655361,0.0010722267,0.0006115324,0.000496805,0.00053628127],"domain_scores_gemma":[0.9967834,0.0009684973,0.00057092565,0.00046249037,0.00089570624,0.00031902635],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009270554,0.0003828201,0.0012413145,0.00040634803,0.00007656684,0.000019964595,0.00013796461,0.00021661058,0.000006519652],"category_scores_gemma":[0.0022807915,0.00031612185,0.000097864795,0.00045360925,0.00026872926,0.00012328496,0.00014926396,0.00023944702,0.0000011675062],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03382653,0.005126713,0.1440913,0.0005946188,0.003185708,0.000068096015,0.04776664,0.00020900772,0.7189641,0.000034096865,0.0012055922,0.0449276],"study_design_scores_gemma":[0.23577368,0.0100152865,0.16167077,0.0010876112,0.0012191804,0.00006269192,0.0038446398,0.016929114,0.5675392,0.000024927002,0.0011846382,0.0006482383],"about_ca_topic_score_codex":0.0006185,"about_ca_topic_score_gemma":0.00007608866,"teacher_disagreement_score":0.20194715,"about_ca_system_score_codex":0.00077561906,"about_ca_system_score_gemma":0.0005829881,"threshold_uncertainty_score":0.9999291},"labels":[],"label_agreement":null},{"id":"W2557917230","doi":"10.1182/blood.v106.11.3023.3023","title":"Functional Engraftment of Retrovirally Transduced and Pre-Selected Hematopoietic Cells into Partially Ablated Recipient Fabry Mice.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Fludarabine; Haematopoiesis; Genetic enhancement; Cyclophosphamide; Busulfan; Bone marrow; Transplantation; Total body irradiation; Immunology; Cancer research; Biology; Hematopoietic stem cell transplantation; Medicine; Stem cell; Internal medicine; Chemotherapy; Cell biology","score_opus":0.008518024041827285,"score_gpt":0.24085554104974805,"score_spread":0.23233751700792077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557917230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975555,0.0014483127,0.00030993175,0.00020104088,0.000039415758,0.00030456905,0.000013151796,0.000017555638,0.000110551584],"genre_scores_gemma":[0.998175,0.00029913004,0.00071699644,0.0001003408,0.00013768548,0.00003745678,0.000088407825,0.000026833795,0.00041813904],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987219,0.00010413002,0.00029005873,0.00036649915,0.00024750715,0.0002699085],"domain_scores_gemma":[0.99936056,0.000014665434,0.00007215195,0.00028192057,0.00015637967,0.000114327995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002205333,0.00016473772,0.00017036973,0.000057911086,0.00006200793,0.000015620704,0.00013808471,0.00015122889,0.00010230925],"category_scores_gemma":[0.000024835335,0.00015991565,0.00007018459,0.00014754858,0.000086536966,0.000004578732,0.000046610086,0.000113071954,0.000009562443],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013853112,0.0005061723,0.00038420566,0.000036874633,0.00015879779,0.000002009472,0.00018402284,0.0001276231,0.99455565,0.000006157554,0.00030441757,0.002348751],"study_design_scores_gemma":[0.002323982,0.0027011489,0.0019847427,0.000013750434,0.00005300408,0.0000099678755,0.000013654183,0.000050529175,0.99180645,0.000022212469,0.0008568097,0.0001637357],"about_ca_topic_score_codex":0.000014485326,"about_ca_topic_score_gemma":0.00019133344,"teacher_disagreement_score":0.0027491942,"about_ca_system_score_codex":0.000014972642,"about_ca_system_score_gemma":0.00015604057,"threshold_uncertainty_score":0.6521171},"labels":[],"label_agreement":null},{"id":"W2557950298","doi":"10.1182/blood.v114.22.1982.1982","title":"Persistence and Compliance of Deferoxamine Versus Deferasirox in Medicaid Patients with Sickle-Cell Disease.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Deferasirox; Medicine; Deferoxamine; Discontinuation; Adverse effect; Internal medicine; Pediatrics; Surgery; Thalassemia","score_opus":0.015902866986473682,"score_gpt":0.22030100249406392,"score_spread":0.20439813550759023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557950298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947571,0.0017441643,0.0000056338135,0.00031363932,0.00002478324,0.00023480256,0.000008090593,0.000015786442,0.0028960085],"genre_scores_gemma":[0.9992706,0.00018742682,0.00030198146,0.00014101912,0.000009047109,0.0000025917157,0.000021437754,0.0000078818775,0.000057973295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99923784,0.000015176376,0.00016394482,0.00018875673,0.00021822639,0.00017603609],"domain_scores_gemma":[0.99953014,0.00003237924,0.000052753756,0.0001642322,0.000051558556,0.00016893259],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000042219755,0.00010961646,0.00020911684,0.000056087312,0.000025253179,0.0000034408902,0.000051482188,0.00005437851,0.000016343489],"category_scores_gemma":[0.00005016694,0.00008150827,0.000029052102,0.00016428268,0.00010228187,0.00003390751,0.000012940409,0.00012421071,0.000003253123],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019248413,0.0036594148,0.9893355,0.00025002577,0.00005389101,0.00008421785,0.0004634271,0.000008654963,0.0005922476,0.00005642823,0.000059840095,0.0035115234],"study_design_scores_gemma":[0.023494799,0.0016814143,0.97322917,0.00042412055,0.00026009936,0.0000037993998,0.00026262022,0.000043085525,0.00034139853,0.00002009335,0.00010609283,0.00013329551],"about_ca_topic_score_codex":0.000010139191,"about_ca_topic_score_gemma":0.000006403738,"teacher_disagreement_score":0.021569958,"about_ca_system_score_codex":0.000011177759,"about_ca_system_score_gemma":0.000046712114,"threshold_uncertainty_score":0.33238107},"labels":[],"label_agreement":null},{"id":"W2557956032","doi":"10.1182/blood.v108.11.1622.1622","title":"Interaction of Plasminogen and Angiostatin with Heat Shock Proteins.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Health Canada","funders":"","keywords":"Angiostatin; Heat shock protein; Umbilical vein; Molecular biology; Biology; Kringle domain; Chemistry; Cell biology; Biochemistry; Cancer research; Angiogenesis; In vitro; Recombinant DNA; Gene","score_opus":0.004315065127973887,"score_gpt":0.19720905273836428,"score_spread":0.1928939876103904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557956032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979487,0.00037713558,0.00036318347,0.000019341858,0.000013850667,0.00016251212,0.000010489698,0.000005111003,0.0010996916],"genre_scores_gemma":[0.9981016,0.000010420538,0.0016143381,0.000022494109,0.00008809115,0.00001987498,0.000037190857,0.000008079315,0.00009789526],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99965864,0.000011691197,0.000078459605,0.00012529285,0.000050284754,0.00007564514],"domain_scores_gemma":[0.999831,0.0000017985237,0.000027794136,0.00009426084,0.000025664414,0.000019435493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000028570155,0.00006169679,0.000058626665,0.000015900492,0.00001923903,0.000005837561,0.000028185188,0.000043489756,0.000004536201],"category_scores_gemma":[0.000004746329,0.000050542203,0.00001759001,0.000023794695,0.000019174737,0.0000027766512,0.000021767028,0.000024130517,9.37056e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055402757,0.00010030456,0.00097380136,0.0000138012865,0.000018072815,0.0000022424929,0.0000078417015,0.000003993425,0.99844295,0.0001017322,0.00013232662,0.00014751495],"study_design_scores_gemma":[0.00069951604,0.0005584033,0.00042178252,0.00001872473,0.000019839614,0.000031484342,0.000018934878,0.0000064749743,0.9968068,0.00007051617,0.0012803255,0.000067199515],"about_ca_topic_score_codex":0.00006465059,"about_ca_topic_score_gemma":0.00003400238,"teacher_disagreement_score":0.0016361674,"about_ca_system_score_codex":0.0000013940557,"about_ca_system_score_gemma":0.000015096096,"threshold_uncertainty_score":0.20610513},"labels":[],"label_agreement":null},{"id":"W2557965693","doi":"10.1182/blood.v126.23.1596.1596","title":"Treatment Patterns and Healthcare Costs in Newly Diagnosed Patients with Chronic Myeloid Leukemia Receiving Dasatinib or Nilotinib As First-Line Therapy in the United States: A Retrospective Claims Database Analysis","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nilotinib; Medicine; Dasatinib; Discontinuation; Internal medicine; Myeloid leukemia; Retrospective cohort study; Imatinib","score_opus":0.03002437962263441,"score_gpt":0.2961061800249184,"score_spread":0.26608180040228396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557965693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99534094,0.0005312189,0.00001243357,0.001009101,0.000033991862,0.002599489,0.00037153222,0.00005810581,0.000043183252],"genre_scores_gemma":[0.9905696,0.004199649,0.00016332505,0.0005652779,0.00008849226,0.00046151702,0.003836054,0.00006026931,0.00005582058],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970154,0.00034670142,0.00057922525,0.0007915148,0.0006540538,0.0006130657],"domain_scores_gemma":[0.9978508,0.00046955212,0.00026331522,0.0009029312,0.00019821251,0.00031522918],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036146858,0.0004938517,0.00081026054,0.0005896968,0.000107475986,0.000053480162,0.00018688782,0.00013602353,0.00006442138],"category_scores_gemma":[0.00020075667,0.00028477793,0.0000798359,0.0020326183,0.000089240675,0.00015838842,0.000059846672,0.00039587758,0.000008339619],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018239107,0.0022684117,0.98163384,0.000058646154,0.0009150233,0.0007753346,0.008222927,0.0001725379,0.0000027070632,0.000004864238,0.000027276308,0.004094534],"study_design_scores_gemma":[0.080983736,0.010697088,0.90400034,0.0004893543,0.00071927335,0.00003842954,0.0016026056,0.0008779405,0.00009310729,0.000011424024,0.00020402663,0.00028264665],"about_ca_topic_score_codex":0.06554815,"about_ca_topic_score_gemma":0.14224471,"teacher_disagreement_score":0.079159826,"about_ca_system_score_codex":0.006824821,"about_ca_system_score_gemma":0.001427956,"threshold_uncertainty_score":0.9999604},"labels":[],"label_agreement":null},{"id":"W2557971489","doi":"10.1182/blood.v108.11.3029.3029","title":"Fludarabine-Busulfan Conditioning and In Vivo T-Cell Depletion with Reduced Dose of ATG Followed by Allografting Induces Durable Responses in Patients with Advanced Multiple Myeloma with No Grade III-IV aGvHD.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Thymoglobulin; Busulfan; Fludarabine; Multiple myeloma; Surgery; Gastroenterology; Internal medicine; Regimen; Folinic acid; Melphalan; Transplantation; Plasma cell leukemia; Urology; Chemotherapy; Cyclophosphamide; Hematopoietic stem cell transplantation; Kidney transplantation","score_opus":0.007054677525832847,"score_gpt":0.23079158084238416,"score_spread":0.2237369033165513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557971489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979817,0.00019474095,0.0000073849556,0.000056437682,0.000009869558,0.0013256165,0.000053280895,0.00003953939,0.00033139615],"genre_scores_gemma":[0.9959652,0.000023268702,0.0032733595,0.000016889653,0.000015047959,0.00016229079,0.000287069,0.00004605669,0.0002108265],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980151,0.000118102675,0.00038808084,0.00047862265,0.00051065086,0.0004894276],"domain_scores_gemma":[0.99902624,0.00018892248,0.00021711412,0.00024943473,0.00017493204,0.00014335239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016448714,0.000286012,0.00047678757,0.0003253757,0.000104131665,0.000026896605,0.00007213927,0.00009195541,0.000013028526],"category_scores_gemma":[0.00011183599,0.00020474335,0.000029088076,0.0005112841,0.00014673204,0.00023915248,0.000027358805,0.00022295573,0.0000012198868],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010697889,0.0021770787,0.75970227,0.00008986524,0.000076424265,0.0001457849,0.00013347315,0.00003268508,0.22675882,9.35239e-7,0.000024074447,0.0001606894],"study_design_scores_gemma":[0.064084694,0.0026569583,0.7644139,0.00060097495,0.00007929511,0.000016809228,0.00015080228,0.000050299903,0.16772203,0.0000024213077,0.000018319915,0.00020352047],"about_ca_topic_score_codex":0.0012309287,"about_ca_topic_score_gemma":0.0013596897,"teacher_disagreement_score":0.05903679,"about_ca_system_score_codex":0.000068590394,"about_ca_system_score_gemma":0.00012554701,"threshold_uncertainty_score":0.83491915},"labels":[],"label_agreement":null},{"id":"W2557976939","doi":"10.1182/blood.v120.21.2648.2648","title":"Genetic Abnormalities in Follicular Lymphoma and Transformed Follicular Lymphoma.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Follicular lymphoma; Lymphoma; PTEN; Biology; Comparative genomic hybridization; Chromosomal translocation; SNP array; Diffuse large B-cell lymphoma; Copy number analysis; Cancer research; Univariate analysis; Chromosome; Chromosome abnormality; Gene expression profiling; Genetics; Oncology; Karyotype; Gene; Internal medicine; Medicine; Copy-number variation; Single-nucleotide polymorphism; Immunology; Gene expression; Multivariate analysis; Genome; PI3K/AKT/mTOR pathway","score_opus":0.010740610537022943,"score_gpt":0.23070006359121256,"score_spread":0.21995945305418962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557976939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97336507,0.023675084,0.000009170609,0.0002332848,0.000087649816,0.0005247415,0.000011560751,0.000055125427,0.0020382951],"genre_scores_gemma":[0.9969519,0.0013160682,0.00077570486,0.00037256206,0.00017119074,0.00020689683,0.000020767682,0.0000327094,0.00015223207],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985173,0.000046385005,0.00032416335,0.00026253585,0.00027725636,0.0005723965],"domain_scores_gemma":[0.9992682,0.000057636273,0.000045740504,0.0002910312,0.000027887707,0.00030952113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014783577,0.0002591222,0.00042012983,0.00013805709,0.00006952545,0.00002660265,0.00006000972,0.00013624635,0.00005291557],"category_scores_gemma":[0.00002167618,0.00020795088,0.00014521928,0.00017730852,0.00006662709,0.00014674157,0.00002685828,0.000027826683,0.00004164852],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006129961,0.0037597893,0.97184646,0.00013318918,0.00032337962,0.0004392157,0.0012738092,6.5032117e-7,0.0003753686,0.00059844437,0.000074516545,0.021113893],"study_design_scores_gemma":[0.020248549,0.00023294926,0.9545202,0.000116005154,0.000602142,0.00093774754,0.00025857243,0.000012363017,0.016717698,0.00006588295,0.006055824,0.00023201798],"about_ca_topic_score_codex":0.00038659244,"about_ca_topic_score_gemma":0.000056728797,"teacher_disagreement_score":0.02358678,"about_ca_system_score_codex":0.00011330349,"about_ca_system_score_gemma":0.000094277246,"threshold_uncertainty_score":0.8479991},"labels":[],"label_agreement":null},{"id":"W2558000714","doi":"10.1182/blood.v118.21.5290.5290","title":"A Retrospective Review of the Management of Patients with Porphyria Cutanea Tarda At a Tertiary Care Centre","year":2011,"lang":"en","type":"review","venue":"Blood","topic":"Porphyrin Metabolism and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; St. Joseph's Hospital; University of Toronto; McMaster University","funders":"","keywords":"Phlebotomy; Porphyria cutanea tarda; Medicine; Hydroxychloroquine; Internal medicine; Gastroenterology; Hemochromatosis; Hematology; Surgery; Dermatology; Pediatrics","score_opus":0.004906708966232235,"score_gpt":0.21484450375871497,"score_spread":0.20993779479248273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558000714","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012434704,0.994433,0.0000010577802,0.000002283122,0.0000795052,0.0012146226,0.00050592626,0.000003486691,0.0025166343],"genre_scores_gemma":[0.0005914981,0.99828416,0.00015671711,0.00004987687,0.000026305222,0.00004361054,0.0006082613,0.00003608866,0.00020350267],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99871093,0.00010204265,0.00041024844,0.00038462365,0.00020820549,0.00018397182],"domain_scores_gemma":[0.99836224,0.000002029305,0.00060255046,0.0008418089,0.0001475853,0.00004376288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000060643,0.0003071689,0.00079288677,0.0000248919,0.000032346124,0.000002208563,0.00043007257,0.00014119864,0.00005208859],"category_scores_gemma":[0.000010921234,0.00017982317,0.00045618808,0.00014349341,0.00008967628,0.0000017214879,0.0003700415,0.00008524647,0.0000038039516],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000103239865,0.0019415832,0.037572294,0.70903355,0.0064858543,0.000018759418,0.00021623302,9.351528e-8,0.000022229024,0.00027818736,0.0041108727,0.24021709],"study_design_scores_gemma":[0.00097185996,0.000092544564,0.0051697106,0.041630466,0.005133327,0.000005226007,0.00002314758,2.4265405e-9,0.00018719582,0.0000059720137,0.946464,0.00031654816],"about_ca_topic_score_codex":0.000008372953,"about_ca_topic_score_gemma":0.0000069907605,"teacher_disagreement_score":0.9423531,"about_ca_system_score_codex":0.000012940099,"about_ca_system_score_gemma":0.000076419914,"threshold_uncertainty_score":0.7332976},"labels":[],"label_agreement":null},{"id":"W2558013362","doi":"10.1182/blood.v104.11.4023.4023","title":"A Post-Marketing Surveillance Study of the Safety and Efficiacy of Refacto® (Moroctocog Alfa, B-Domain Deleted Recombinant Factor VIII) (St. Louis-Derived Active Substance in the Treatment and Prevension of Bleeding Episodes in Hemophilia a Patients.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Medicine; Adverse effect; Dosing; Concomitant; Regimen; Postmarketing surveillance; Internal medicine; Surgery; Clinical endpoint; Clinical trial","score_opus":0.015209073674041161,"score_gpt":0.2644722875788598,"score_spread":0.24926321390481865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558013362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963573,0.00042186765,3.674077e-7,0.0002787382,0.000019715548,0.0028292523,0.00004988437,0.000005047668,0.0000377791],"genre_scores_gemma":[0.9993885,0.00047252647,0.000051817093,0.0000080269965,0.000007019765,0.00003832617,0.000009405674,0.000014953751,0.00000939906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99813396,0.0004482442,0.0005302573,0.00030177413,0.00033384518,0.00025191982],"domain_scores_gemma":[0.9986725,0.0005908895,0.0002447906,0.00029164238,0.00015227379,0.000047938054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005643624,0.00020156427,0.0005792562,0.0001544272,0.000070527305,0.0000052869314,0.000103264676,0.00007550573,0.0000036904823],"category_scores_gemma":[0.00029031764,0.00010732711,0.000064512824,0.00045452733,0.00013687753,0.000039228704,0.000048173,0.00016313538,1.0219962e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027942448,0.008442496,0.9237999,0.0001734623,0.00016834334,0.000022973867,0.01890358,0.0000064600513,0.0408293,0.0000053694193,2.413684e-7,0.004853647],"study_design_scores_gemma":[0.019256817,0.0027939247,0.9470941,0.0006174699,0.000063432606,0.000006195864,0.004028205,0.000008867021,0.026006008,0.000033611843,0.0000026452076,0.00008872516],"about_ca_topic_score_codex":0.000572931,"about_ca_topic_score_gemma":0.0015128636,"teacher_disagreement_score":0.023294216,"about_ca_system_score_codex":0.000114840564,"about_ca_system_score_gemma":0.00007840873,"threshold_uncertainty_score":0.43766725},"labels":[],"label_agreement":null},{"id":"W2558014492","doi":"10.1182/blood.v124.21.3915.3915","title":"HCT-CI Has Prognostic Value in Acute, but Not Chronic Gvhd Specific Survival","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Graft-versus-host disease; Hazard ratio; Proportional hazards model; Incidence (geometry); Hematopoietic stem cell transplantation; Retrospective cohort study; Transplantation; Oncology; Cumulative incidence; Gastroenterology; Immunology; Confidence interval","score_opus":0.026980562987475604,"score_gpt":0.25053834416463827,"score_spread":0.22355778117716266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558014492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98683494,0.00024751245,0.0013260625,0.0005250371,0.00035791693,0.0006584747,0.000016370504,0.00010691506,0.00992674],"genre_scores_gemma":[0.99782974,0.000103441875,0.0010398232,0.00008973551,0.00035326421,0.000042604832,0.00007057109,0.000042116142,0.0004287152],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839765,0.00010477639,0.00037228662,0.0003579978,0.00039038545,0.00037690965],"domain_scores_gemma":[0.99910355,0.0002781663,0.000063256346,0.00036871622,0.00004745087,0.00013883784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037704138,0.00019025775,0.00037184937,0.00013206774,0.000049190374,0.000029561912,0.000114967035,0.00013420537,0.00028540433],"category_scores_gemma":[0.00007530809,0.00017557359,0.0000789039,0.00022793612,0.00007562925,0.000051192685,0.000017184624,0.00022766391,0.00058365817],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056790235,0.0045357086,0.60186964,0.0031311554,0.0007406114,0.0023163292,0.002779305,0.00011389989,0.36478257,0.008650325,0.0009077959,0.009604781],"study_design_scores_gemma":[0.019200485,0.0010931754,0.7115055,0.0007094415,0.00092416356,0.0006803124,0.000104622806,0.00071391306,0.2585831,0.00022690422,0.0056976057,0.0005608405],"about_ca_topic_score_codex":0.000051490897,"about_ca_topic_score_gemma":0.00003155815,"teacher_disagreement_score":0.10963584,"about_ca_system_score_codex":0.00006255852,"about_ca_system_score_gemma":0.00015814714,"threshold_uncertainty_score":0.75019395},"labels":[],"label_agreement":null},{"id":"W2558016334","doi":"10.1182/blood.v118.21.2169.2169","title":"Cellular and Biochemical Properties of Cell-Free DNA: A Prognostic Marker In Severe Sepsis Patients","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Lipoteichoic acid; Sepsis; Medicine; Lipopolysaccharide; Immunology; Peptidoglycan; Neutrophil extracellular traps; Cell-free fetal DNA; Microbiology; Biology; Inflammation; Bacteria; Staphylococcus aureus","score_opus":0.008959992776530987,"score_gpt":0.17378792347851976,"score_spread":0.16482793070198878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558016334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961291,0.002729125,0.000004828642,0.000009797474,0.000029631055,0.00019794768,0.000041027026,0.0000030608983,0.0008555003],"genre_scores_gemma":[0.9990516,0.00022005894,0.0005425298,0.000048005797,0.000026307856,0.000033252,0.000022603332,0.000015157446,0.000040533243],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993813,0.000017232667,0.0001680995,0.00021921206,0.00006581977,0.00014835242],"domain_scores_gemma":[0.9995862,0.000007142539,0.00005366089,0.0002507032,0.00005190892,0.00005036653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000049308634,0.00011262721,0.0001433986,0.00002832463,0.000014371632,0.0000056660056,0.00012672228,0.00010123678,0.000012720437],"category_scores_gemma":[0.00010919077,0.00009819041,0.000052223266,0.00004442721,0.00006638974,0.0000019042749,0.00019560101,0.000042424763,0.0000010729204],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000092610244,0.0009115354,0.1980017,0.00012283468,0.00012652224,0.0000040035197,0.00017105749,4.1933646e-7,0.80008703,0.000009439706,0.00040054639,0.0000722994],"study_design_scores_gemma":[0.0016897141,0.0002451651,0.023614472,0.000021586877,0.00019551424,0.0000019939228,0.0000305406,0.000002902803,0.97379726,0.00006010855,0.00019245109,0.0001483182],"about_ca_topic_score_codex":0.000054381748,"about_ca_topic_score_gemma":0.000023535435,"teacher_disagreement_score":0.17438723,"about_ca_system_score_codex":0.0000034309792,"about_ca_system_score_gemma":0.00003702778,"threshold_uncertainty_score":0.40040886},"labels":[],"label_agreement":null},{"id":"W2558057034","doi":"10.1182/blood.v108.11.3554.3554","title":"Lenalidomide (L) in Combination with Dexamethasone (D) Significantly Improves Time to Progression (TTP) in Non-Stem Cell Transplant Patients (pts) with Relapsed or Refractory (rel/ref) Multiple Myeloma (MM): Analysis from MM-009 and MM-010 Randomized Phase III Clinical Trials.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lenalidomide; Internal medicine; Neutropenia; Multiple myeloma; Refractory (planetary science); Progression-free survival; Autologous stem-cell transplantation; Gastroenterology; Phases of clinical research; Toxicity; Oncology; Surgery; Chemotherapy","score_opus":0.024475023768014963,"score_gpt":0.3249339793342329,"score_spread":0.30045895556621793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558057034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99264044,0.00028657573,0.000409745,0.00011360781,0.000028277913,0.006164776,0.0002008738,0.000073640695,0.00008205755],"genre_scores_gemma":[0.9935943,0.00010708708,0.0040336936,0.000040206512,0.00006593323,0.00061165873,0.0011653121,0.000074464144,0.00030737746],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9937601,0.0018496787,0.0018660044,0.0010151896,0.00089422,0.00061479444],"domain_scores_gemma":[0.99443126,0.0037302575,0.0006432835,0.000507874,0.00020441487,0.00048291674],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0032373173,0.0005117437,0.002792725,0.0008339472,0.000095866795,0.000064334956,0.00015789988,0.00030639465,0.000064398126],"category_scores_gemma":[0.00056104583,0.00029982705,0.0002861435,0.0010462863,0.0001715102,0.00020294293,0.000038296534,0.0005301858,0.000021880085],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6855879,0.0257306,0.2229427,0.00011790641,0.001912387,0.00104569,0.00064277527,0.000020374493,0.021242574,5.757085e-7,0.00003573115,0.040720783],"study_design_scores_gemma":[0.81577605,0.006279712,0.14667022,0.0006154801,0.0033013287,0.000005474685,0.000094853705,0.005960736,0.02087994,0.0000049038454,0.000024735149,0.00038656633],"about_ca_topic_score_codex":0.001797916,"about_ca_topic_score_gemma":0.002268832,"teacher_disagreement_score":0.13018815,"about_ca_system_score_codex":0.00012173927,"about_ca_system_score_gemma":0.00022973705,"threshold_uncertainty_score":0.9999454},"labels":[],"label_agreement":null},{"id":"W2558081637","doi":"10.1182/blood.v104.11.1372.1372","title":"Primary Central Nervous System Lymphoma of T Cell Origin: A Descriptive Analysis of 45 Cases from the International PCNSL Collaborative Group.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Primary central nervous system lymphoma; Univariate analysis; Hazard ratio; Confidence interval; Methotrexate; Cerebrospinal fluid; Internal medicine; Central nervous system; Gastroenterology; Retrospective cohort study; Lymphoma; Performance status; Multivariate analysis; Surgery; Cancer","score_opus":0.012712734260146883,"score_gpt":0.2257978811412929,"score_spread":0.21308514688114602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558081637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956166,0.0014713965,0.000031832416,0.00016458891,0.00013483147,0.00034983826,0.00093722955,0.000021249949,0.0012724048],"genre_scores_gemma":[0.9983343,0.00012735359,0.00096810615,0.0000818985,0.000088454915,0.000043910022,0.00032212454,0.000012665501,0.00002122487],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988304,0.000043653246,0.0003534749,0.00023558264,0.00037632586,0.0001605641],"domain_scores_gemma":[0.99895614,0.00019676784,0.00024836118,0.00029555525,0.0002219687,0.00008121398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000066370456,0.00015561316,0.0005022606,0.00012073871,0.00004104655,0.00001524962,0.00013751005,0.00005648842,0.000037208927],"category_scores_gemma":[0.000031909884,0.00010267352,0.00024879593,0.00062459696,0.000082590996,0.0000485774,0.00004737328,0.000031990858,0.0000039758006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00127164,0.018344548,0.8981215,0.0002151459,0.030965757,0.002103693,0.011066886,0.0004762294,0.027818786,0.0033633031,0.0004586801,0.0057938397],"study_design_scores_gemma":[0.0076875417,0.0003999112,0.9161101,0.00020753672,0.008611072,0.00004302828,0.0039147283,0.000035045858,0.06269117,0.000016305525,0.00018554104,0.00009805043],"about_ca_topic_score_codex":0.0049265595,"about_ca_topic_score_gemma":0.00045742354,"teacher_disagreement_score":0.03487238,"about_ca_system_score_codex":0.00041289182,"about_ca_system_score_gemma":0.00033308016,"threshold_uncertainty_score":0.7447517},"labels":[],"label_agreement":null},{"id":"W2558098955","doi":"10.1182/blood.v118.21.585.585","title":"High-Resolution Chromatin Immunoprecipitation (ChIP) Sequencing Identifies Novel Binding Targets and Prognostic Role for SOX11 in Mantle Cell Lymphoma","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Chromatin immunoprecipitation; Biology; Transcription factor; Chromatin; Mantle cell lymphoma; Molecular biology; Gene; Immunoprecipitation; Chromosome conformation capture; Promoter; DNA methylation; Genetics; Cancer research; Computational biology; Gene expression; Lymphoma; Enhancer","score_opus":0.021899379373241986,"score_gpt":0.2281966931849598,"score_spread":0.20629731381171781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558098955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970894,0.0013776992,0.00012565956,0.00002946058,0.000111756344,0.00082921004,0.000027511738,0.000045169007,0.00036416715],"genre_scores_gemma":[0.98924804,0.00006230895,0.010121965,0.000018494315,0.00004996818,0.0002981513,0.000096286625,0.000022768307,0.00008204497],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990732,0.000017605209,0.00027085157,0.00026241943,0.0001258935,0.00025003572],"domain_scores_gemma":[0.99955493,0.00008760867,0.000109452885,0.0001403663,0.000048003578,0.000059621667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015447523,0.0001496786,0.00022558603,0.00014561684,0.000096171374,0.000027772612,0.000042847554,0.000078216784,0.000015508394],"category_scores_gemma":[0.000072506395,0.00013348844,0.000050705537,0.00010002489,0.000029688363,0.00014188426,0.00003094447,0.000029372959,0.000017811035],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026812925,0.006654174,0.26973704,0.0006778123,0.00028692826,0.00009540364,0.009261852,0.0000083798,0.70693207,0.0009047956,0.000069314374,0.0051041185],"study_design_scores_gemma":[0.012026057,0.00042848248,0.598152,0.00028152196,0.00031489393,0.00004632828,0.00072292925,0.0003965875,0.38711306,0.0003569559,0.000014189889,0.00014697784],"about_ca_topic_score_codex":0.0007775625,"about_ca_topic_score_gemma":0.00009750317,"teacher_disagreement_score":0.32841498,"about_ca_system_score_codex":0.00013995844,"about_ca_system_score_gemma":0.00007301781,"threshold_uncertainty_score":0.5443501},"labels":[],"label_agreement":null},{"id":"W2558149620","doi":"10.1182/blood.v116.21.4758.4758","title":"Dose Adjustment and Treatment Interruptions Associated with Second-Line Nilotinib or Dasatinib In Real-World Treatment of Chronic Myeloid Leukemia","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Nilotinib; Dasatinib; Medicine; Internal medicine; Myeloid leukemia; Imatinib; Tyrosine-kinase inhibitor; Adverse effect; Imatinib mesylate; Oncology; Cancer","score_opus":0.033580665530182026,"score_gpt":0.30357519657101895,"score_spread":0.2699945310408369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558149620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99404246,0.00047916654,0.000001169851,0.00014904117,0.00013852293,0.0018053097,0.00016414131,0.000108864064,0.0031113322],"genre_scores_gemma":[0.9875507,0.0010883628,0.0007489721,0.00003652459,0.00024097557,0.00044894844,0.00038983137,0.00007479947,0.009420904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977478,0.00007270009,0.00069230853,0.00064388185,0.00029691998,0.0005464198],"domain_scores_gemma":[0.998325,0.0002600561,0.00031680844,0.000719947,0.000087071974,0.00029110114],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012036003,0.0005306466,0.0010050045,0.00035763351,0.00007262945,0.000016801949,0.00009515149,0.00018877622,0.0010580459],"category_scores_gemma":[0.000057216894,0.0003444046,0.00013250372,0.0004719192,0.00019964867,0.00009366797,0.000043054846,0.00023855445,0.000018131379],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008238311,0.07392102,0.5724604,0.000690281,0.0118271485,0.0045786356,0.0097970115,0.000102067796,0.11329882,0.0006554993,0.00026913476,0.20416167],"study_design_scores_gemma":[0.11960424,0.029959053,0.7837529,0.0007681428,0.002490468,0.0005050024,0.000258881,0.00046133174,0.05898619,0.000021694346,0.0026243546,0.0005677051],"about_ca_topic_score_codex":0.0025551866,"about_ca_topic_score_gemma":0.14458504,"teacher_disagreement_score":0.21129254,"about_ca_system_score_codex":0.00428719,"about_ca_system_score_gemma":0.00201721,"threshold_uncertainty_score":0.9999008},"labels":[],"label_agreement":null},{"id":"W2558158598","doi":"10.1182/blood.v116.21.2995.2995","title":"Inhibiting Translation as a Novel Strategy to Target Multiple Myeloma","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Biology; Apoptosis; Flow cytometry; Molecular biology; Viability assay; Cell culture; Cytotoxicity; Bortezomib; Annexin A5; Peripheral blood mononuclear cell; Cell biology; Annexin; Biochemistry; Multiple myeloma; Immunology; In vitro","score_opus":0.01909367073031665,"score_gpt":0.26287415636694345,"score_spread":0.2437804856366268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558158598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98293746,0.00003545349,0.0003176804,0.0014026088,0.00006584138,0.00042822416,0.000009186659,0.00008794595,0.014715582],"genre_scores_gemma":[0.95498186,0.0000013223593,0.041625265,0.0001400458,0.0001515554,0.00003900635,0.000068250054,0.000019788627,0.0029729092],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992218,0.0000058705,0.00017851143,0.00020752361,0.00017914732,0.00020717081],"domain_scores_gemma":[0.9995933,0.000038875016,0.00003001093,0.0001269578,0.000047377267,0.00016345171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009353895,0.00012484909,0.00015360961,0.000087700726,0.000066003646,0.000019088486,0.000036740796,0.00007309246,0.0001920453],"category_scores_gemma":[0.00006383339,0.00010717751,0.00005026487,0.00014864697,0.000012972611,0.0000567115,0.00001103754,0.00014187518,0.0002910269],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000101850346,0.0017506527,0.057619754,0.00004858781,0.00019056183,0.0002080879,0.0024708116,0.000006163597,0.90853715,0.000490234,0.00023830363,0.028337825],"study_design_scores_gemma":[0.019056652,0.00053646025,0.059186213,0.00016345436,0.00033811713,0.0005145862,0.0004743366,0.00044230593,0.88884395,0.00022017119,0.02972066,0.0005031152],"about_ca_topic_score_codex":0.000020267471,"about_ca_topic_score_gemma":0.00009993524,"teacher_disagreement_score":0.041307583,"about_ca_system_score_codex":0.000009365457,"about_ca_system_score_gemma":0.00009994143,"threshold_uncertainty_score":0.4370572},"labels":[],"label_agreement":null},{"id":"W2558161163","doi":"10.1182/blood.v104.11.3084.3084","title":"Characterization of the Pharmacokinetics of rFVIII in Young Pre-School Children with Hemophilia, Including an Analysis of the Influence of Age and Body Weight.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Pharmacokinetics; Medicine; Dosing; Cohort; Clotting factor; Pediatrics; Internal medicine","score_opus":0.010714630358920143,"score_gpt":0.277669165949315,"score_spread":0.2669545355903949,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558161163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992981,0.00004291099,0.000002744706,0.000101219346,0.0000060111847,0.00046476308,0.000029842857,0.0000030446809,0.0000513425],"genre_scores_gemma":[0.99972254,0.000119444216,0.000070685484,0.000010363093,0.000014946101,0.000005598159,0.000019708943,0.00000781795,0.000028891007],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990812,0.00005073203,0.0002947427,0.00013041687,0.00033755213,0.00010534925],"domain_scores_gemma":[0.9993302,0.000015858477,0.00019821855,0.0003039928,0.000107555934,0.00004414645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014756167,0.000086558626,0.0003043092,0.00017388923,0.000027589147,0.0000026676214,0.00013837536,0.000044807995,0.0000075266585],"category_scores_gemma":[0.0000471385,0.00004518442,0.00006085262,0.0008973186,0.00018088995,0.000061709114,0.00007611042,0.000106432846,5.27344e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004753606,0.00038936504,0.55823517,0.00005376666,0.00032437916,0.0000013878303,0.00050119415,0.000119562705,0.44028318,0.0000106008865,2.790519e-8,0.000033845718],"study_design_scores_gemma":[0.0018768487,0.00014199848,0.65861315,0.0001664704,0.0009195393,0.000004024997,0.000015340005,0.000073604795,0.33815283,0.000009378157,1.8463138e-7,0.00002664157],"about_ca_topic_score_codex":0.00029354225,"about_ca_topic_score_gemma":0.000090754664,"teacher_disagreement_score":0.10213034,"about_ca_system_score_codex":0.000016280204,"about_ca_system_score_gemma":0.00008387071,"threshold_uncertainty_score":0.18425672},"labels":[],"label_agreement":null},{"id":"W2558188208","doi":"10.1182/blood.v104.11.5303.5303","title":"Time and Cost Savings with Bio-Set® Device in Reconstituting FVIII Concentrate.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Blood donation and transfusion practices","field":"Business, Management and Accounting","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Vial; Medicine; Diluent; Chemistry; Chromatography","score_opus":0.016151167278240636,"score_gpt":0.22218431087295218,"score_spread":0.20603314359471153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558188208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9583053,0.00016642098,0.000023975801,0.0017833032,0.000051165607,0.00024011069,0.0000018411437,0.00008410592,0.039343778],"genre_scores_gemma":[0.9976477,0.00003094602,0.00032956206,0.0017856219,0.00010807921,0.000009118068,0.000012330302,0.000012021635,0.00006464684],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99927765,0.0000064950436,0.00017468758,0.00022412359,0.00012710877,0.00018992086],"domain_scores_gemma":[0.9996784,0.000041152733,0.000116276344,0.0000864094,0.00006263854,0.000015138396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022791045,0.000117828604,0.00012989115,0.00012305898,0.00013410562,0.00023169196,0.000082371975,0.000047147227,0.00017512335],"category_scores_gemma":[0.00005671733,0.00010212788,0.000014803619,0.000365536,0.00008716988,0.0012074962,0.00003250853,0.00012399987,0.000192017],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047296766,0.0034799618,0.7927681,0.00076649484,0.00041492018,0.0008525418,0.0016622726,0.00074725796,0.012095383,0.14400935,0.00041988536,0.04231082],"study_design_scores_gemma":[0.120903686,0.00026633547,0.26884216,0.00350127,0.002349665,0.0006915797,0.0067086834,0.002395623,0.017457204,0.006225963,0.5659713,0.004686524],"about_ca_topic_score_codex":0.0006058702,"about_ca_topic_score_gemma":0.0008508037,"teacher_disagreement_score":0.5655514,"about_ca_system_score_codex":0.000007976212,"about_ca_system_score_gemma":0.00003929792,"threshold_uncertainty_score":0.4164654},"labels":[],"label_agreement":null},{"id":"W2558223196","doi":"10.1182/blood.v106.11.3702.3702","title":"γ-Carboxylation Is Not Required for gas6-Axl Binding but Is Necessary for gas6-Dependent Endothelial Cell Survival.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"GAS6; AXL receptor tyrosine kinase; Receptor tyrosine kinase; Biology; Protein kinase B; Biochemistry; Endothelium; Endothelial stem cell; Cell biology; Receptor; Apoptosis; Chemistry; Endocrinology","score_opus":0.02789519677603188,"score_gpt":0.25752519331907164,"score_spread":0.22962999654303975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558223196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905098,0.0019205514,0.0023631048,0.0010677226,0.0010358668,0.0011320756,0.000863223,0.000113630944,0.0009940377],"genre_scores_gemma":[0.98823,0.00014233189,0.0006885765,0.00032967166,0.00037529902,0.0001724691,0.00044815525,0.00005256066,0.009560922],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99837995,0.000085178646,0.00049221667,0.0004578614,0.000072899296,0.00051190687],"domain_scores_gemma":[0.9990037,0.00022332428,0.00027501077,0.00034545283,0.00012295709,0.000029541468],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040064653,0.00025449845,0.00036929152,0.00014052262,0.00034202114,0.00003914328,0.0002303104,0.00034825245,0.00025914697],"category_scores_gemma":[0.000053473323,0.00024989547,0.0002559616,0.00008618711,0.000055884546,0.00026189035,0.00005837435,0.00013322954,0.00019584049],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035497607,0.00040962838,0.0007020201,0.0000508022,0.00018661866,2.911191e-7,0.0004275502,0.000008488375,0.99051404,0.00018515294,0.002571987,0.004588426],"study_design_scores_gemma":[0.008493311,0.00028197494,0.0008521283,0.000027832013,0.00024214594,0.000010621176,0.00012929365,0.000116774754,0.95016885,0.0001210204,0.039273728,0.0002823201],"about_ca_topic_score_codex":0.000040301362,"about_ca_topic_score_gemma":0.000011744111,"teacher_disagreement_score":0.04034521,"about_ca_system_score_codex":0.000055722154,"about_ca_system_score_gemma":0.00006836752,"threshold_uncertainty_score":0.99999535},"labels":[],"label_agreement":null},{"id":"W2558228672","doi":"10.1182/blood.v106.11.3137.3137","title":"Cbl-Deficient Mice Display Erythropoietin Hypersensitivity and Enhanced Phosphorylation of Protein Kinase B/Akt.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Erythropoiesis; Erythropoietin; Erythropoietin receptor; Biology; Haematopoiesis; Protein kinase B; Cancer research; Signal transduction; Protein tyrosine phosphatase; Myeloid; Endocrinology; Internal medicine; Cell biology; Immunology; Anemia; Medicine; Stem cell","score_opus":0.00855326071563405,"score_gpt":0.2401275501575437,"score_spread":0.23157428944190964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558228672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99557734,0.0007435413,0.000107362284,0.00097528484,0.000023255288,0.0007713438,0.000022733391,0.00002653231,0.0017525818],"genre_scores_gemma":[0.9959135,0.000081468046,0.0034992758,0.00009924687,0.00007424847,0.00007493044,0.00002315244,0.000014681114,0.00021948939],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99906856,0.000041426763,0.00022317354,0.0002797573,0.00021501583,0.00017209115],"domain_scores_gemma":[0.999458,0.00006060006,0.0001008955,0.00017526305,0.000106015046,0.00009922434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012250175,0.00015517372,0.0002871161,0.000048228914,0.000066610315,0.000009692588,0.000020342224,0.00006567222,0.000053380154],"category_scores_gemma":[0.00007967344,0.00012346085,0.00006037909,0.000100640136,0.00008036102,0.000050979306,0.000024744304,0.0000862023,0.000025493166],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003906868,0.0066649164,0.02323972,0.00021162709,0.00023471934,0.000060098737,0.0015681349,0.000019856661,0.9331577,0.0010185413,0.000074967174,0.033359073],"study_design_scores_gemma":[0.003982003,0.0005467167,0.060987912,0.00017320456,0.00021420905,0.000032613163,0.00011949246,0.00010387424,0.93308616,0.0000112621165,0.0006275564,0.00011501437],"about_ca_topic_score_codex":0.00005528833,"about_ca_topic_score_gemma":0.000056206627,"teacher_disagreement_score":0.03774819,"about_ca_system_score_codex":0.000033491135,"about_ca_system_score_gemma":0.0000435414,"threshold_uncertainty_score":0.50345874},"labels":[],"label_agreement":null},{"id":"W2558240189","doi":"10.1182/blood.v108.11.5102.5102","title":"Quantitative Detection Using SYBR Green of Residual Disease in Myeloma Patients Treated with Revlimid or Velcade.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Minimal residual disease; clone (Java method); Multiple myeloma; TaqMan; Lenalidomide; Melting curve analysis; Gene rearrangement; Biology; Medicine; Polymerase chain reaction; Cancer research; Immunology; Gene; Leukemia; Genetics","score_opus":0.03352409807380212,"score_gpt":0.30068276354716295,"score_spread":0.2671586654733608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558240189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990239,0.000119622164,0.000026639207,0.000022015194,0.0000075851112,0.0006028073,0.000052981784,0.00002356038,0.00012089801],"genre_scores_gemma":[0.99895394,0.000009202776,0.0007002834,0.0000068171325,0.00002990453,0.000025935607,0.00009715013,0.000021943522,0.00015481179],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99889153,0.000075671975,0.00023167784,0.00022643604,0.00032958822,0.00024509098],"domain_scores_gemma":[0.99940735,0.00006144925,0.000089181456,0.00017056604,0.00014105829,0.00013041242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005979619,0.00013531663,0.00023786977,0.00022048972,0.000044562512,0.0000067249466,0.000039980696,0.00004614448,0.000017108596],"category_scores_gemma":[0.0001150574,0.00009065329,0.000035332243,0.00037679393,0.00006833075,0.00008346903,0.000019036015,0.000092191265,0.000004063233],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073523507,0.00212112,0.98512197,0.00012797411,0.00011818421,0.00047960458,0.0000432489,0.000027661305,0.0037325048,0.0000065704066,0.000002346539,0.000866487],"study_design_scores_gemma":[0.012631107,0.0018949851,0.9579848,0.0002444272,0.0002308998,0.000008939481,0.000030256168,0.0010510708,0.025820393,0.000008911104,0.0000037808709,0.0000904078],"about_ca_topic_score_codex":0.0044672517,"about_ca_topic_score_gemma":0.00093348685,"teacher_disagreement_score":0.027137125,"about_ca_system_score_codex":0.00006710941,"about_ca_system_score_gemma":0.00010163737,"threshold_uncertainty_score":0.67531776},"labels":[],"label_agreement":null},{"id":"W2558243690","doi":"10.1182/blood.v124.21.560.560","title":"Long-Term Safety of Hydroxyurea in Sickle Cell Anemia and Other Benign Diseases: Systematic Review and Meta-Analysis","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Calgary","funders":"","keywords":"Medicine; Observational study; Adverse effect; Meta-analysis; Cochrane Library; MEDLINE; Anemia; Sample size determination; Internal medicine; Clinical trial; Randomized controlled trial; Pediatrics","score_opus":0.010016314246312748,"score_gpt":0.2399251983436882,"score_spread":0.22990888409737545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558243690","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4085166,0.58502096,0.00010015489,0.0008266106,0.000011024755,0.0021153155,0.000062344865,0.000034584133,0.0033124238],"genre_scores_gemma":[0.9944751,0.004245181,0.0000506568,0.0008403433,0.0000052815235,0.000025535855,0.000012159478,0.000014365228,0.0003313209],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99890435,0.00013262815,0.00047105376,0.00021222033,0.00014707893,0.00013267218],"domain_scores_gemma":[0.9992725,0.00007999207,0.00015782176,0.00034619047,0.00002777197,0.00011570048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003259082,0.00014489573,0.0015923545,0.000103651015,0.000021785543,0.000006623661,0.000050804374,0.000076934906,0.00013867274],"category_scores_gemma":[0.000081731865,0.0000906242,0.00027672347,0.00028476803,0.000057682042,0.000025012061,0.000026058815,0.000087977634,0.000004137639],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052650088,0.0016298052,0.17348169,0.76526415,0.058259897,0.000065302775,0.00066003506,0.000021518708,0.00028152726,0.00014628902,0.00009965137,0.000037480208],"study_design_scores_gemma":[0.0020736298,0.0001287598,0.008157267,0.0021078682,0.98707753,0.000023747793,0.00006424365,0.000060980434,0.00010507624,0.000021739379,0.000016501901,0.00016264331],"about_ca_topic_score_codex":0.00003664585,"about_ca_topic_score_gemma":0.000025221945,"teacher_disagreement_score":0.92881763,"about_ca_system_score_codex":0.000005145892,"about_ca_system_score_gemma":0.000014931379,"threshold_uncertainty_score":0.36955476},"labels":[],"label_agreement":null},{"id":"W2558249533","doi":"10.1182/blood.v112.11.5325.5325","title":"Oncogenic HOXA9 Inhibits Cellular Apoptosis Induced by Ionizing Radiation (IR) in Transgenic Zebrafish","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Zebrafish Biomedical Research Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Biology; Zebrafish; Cancer research; Danio; Transcription factor; Oncogene; Carcinogenesis; Cell biology; Myeloid leukemia; Transgene; Apoptosis; Genetics; Gene; Cell cycle","score_opus":0.01563965005680965,"score_gpt":0.250086057463425,"score_spread":0.23444640740661535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558249533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99720615,0.0009634278,0.0005045538,0.00049250474,0.00003294615,0.0003730772,0.000035143963,0.000025283945,0.0003669258],"genre_scores_gemma":[0.99795014,0.0006456664,0.00022341814,0.00020490038,0.0001617029,0.00015189103,0.0004680936,0.00003193402,0.00016223967],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99840873,0.00009040699,0.0003084513,0.000456201,0.00031630992,0.0004199009],"domain_scores_gemma":[0.9992731,0.000023970068,0.000063661595,0.00036179338,0.000055500295,0.00022195456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022741969,0.00016175934,0.00015966901,0.00010464514,0.00012205984,0.000018004335,0.00028352608,0.00026820088,0.000043332533],"category_scores_gemma":[0.00017881756,0.00017521426,0.0001018527,0.0004320868,0.00009549259,0.000008784315,0.00006817944,0.00021608877,0.00006203327],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014754665,0.00042676902,0.0012075312,0.000009522698,0.00004004655,0.000001241473,0.00004791413,8.344715e-7,0.9947703,0.000010390019,0.0023626352,0.0011080619],"study_design_scores_gemma":[0.001969738,0.00017229578,0.0027588464,0.0000093911385,0.000016924872,0.0000061596843,0.000018754534,0.000012191402,0.9866341,0.00002935238,0.0081783,0.00019394094],"about_ca_topic_score_codex":0.000060825423,"about_ca_topic_score_gemma":0.000022417835,"teacher_disagreement_score":0.008136193,"about_ca_system_score_codex":0.000030410942,"about_ca_system_score_gemma":0.00019511468,"threshold_uncertainty_score":0.71450305},"labels":[],"label_agreement":null},{"id":"W2558252914","doi":"10.1182/blood.v112.11.3851.3851","title":"Acute Kidney Injury in Patients Receiving Subcutaneous Deferoxamine Therapy.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Deferoxamine; Chelation therapy; Kidney disease; Surgery; Acute kidney injury; Nephrectomy; Kidney; Internal medicine; Gastroenterology; Thalassemia","score_opus":0.007767876417591353,"score_gpt":0.2185304294385376,"score_spread":0.21076255302094624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558252914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99382126,0.0002633722,0.0000012906227,0.00032969235,0.00013555126,0.0003155826,0.000013957127,0.00007169297,0.0050475732],"genre_scores_gemma":[0.9953344,0.0025699993,0.00014803237,0.0010950638,0.000042578955,0.000009016051,0.000060166196,0.000030079944,0.00071065954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900687,0.000028406874,0.00024484133,0.0002204685,0.00020593741,0.0002934941],"domain_scores_gemma":[0.99947596,0.000012517112,0.00004737122,0.00023140507,0.000051465435,0.00018131132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000054240438,0.00014774999,0.00024397422,0.000118598546,0.00006961363,0.0000048465427,0.00007170998,0.00015903321,0.000093486895],"category_scores_gemma":[0.00008691726,0.00011897789,0.00007024918,0.0002743469,0.000052384705,0.000041879954,0.00002651493,0.00025635835,0.000062461746],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007435743,0.003031167,0.97317684,0.000029682664,0.00024078586,0.001133388,0.0010099076,6.813883e-7,0.005295462,0.000006810926,0.0038931742,0.011438519],"study_design_scores_gemma":[0.038530547,0.0053753154,0.92024344,0.0004265984,0.0003224814,0.0015162794,0.00008642017,0.000030247755,0.015129456,0.00006212106,0.017544597,0.0007325179],"about_ca_topic_score_codex":0.000036908812,"about_ca_topic_score_gemma":0.0000012937521,"teacher_disagreement_score":0.05293343,"about_ca_system_score_codex":0.000025014091,"about_ca_system_score_gemma":0.00009414132,"threshold_uncertainty_score":0.48517776},"labels":[],"label_agreement":null},{"id":"W2558269041","doi":"10.1182/blood.v104.11.2076.2076","title":"Distinctive Efficacy of IVIG in Ameliorating Thrombocytopenia Induced by Anti-Platelet GPIIbIIIa and GPIbα Antibodies.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto; Canadian Blood Services","funders":"","keywords":"Platelet; Antibody; Autoantibody; Immunology; Monoclonal antibody; Medicine; Autoimmune disease","score_opus":0.01433989772617962,"score_gpt":0.27249096133891726,"score_spread":0.25815106361273765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558269041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973402,0.00063546316,0.000006272029,0.00013134802,0.000027619742,0.00040946717,0.000029037157,0.000026756155,0.0013938462],"genre_scores_gemma":[0.99932635,0.00011908717,0.00038901722,0.000052265237,0.000016044076,0.0000064571796,0.0000580833,0.000019893401,0.000012822176],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990187,0.000019367604,0.00027889988,0.00028516364,0.00015555708,0.00024229441],"domain_scores_gemma":[0.99955463,0.00004808139,0.00010897817,0.00016816329,0.000040288403,0.000079838544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007824224,0.00017889874,0.0005658125,0.000088673136,0.00005241192,0.000014781182,0.000051737105,0.00009742391,0.000015773057],"category_scores_gemma":[0.000093976145,0.00015114371,0.000043719705,0.00023291139,0.00007501972,0.00009441896,0.000045855428,0.00015800018,0.000008427372],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024803,0.009557805,0.49226123,0.00024189007,0.00073519367,0.0018806119,0.0029870158,0.00000701955,0.4702245,0.00022880589,0.00006567156,0.021562219],"study_design_scores_gemma":[0.03303421,0.00085069076,0.76501215,0.0004154111,0.00023714051,0.00016690501,0.0002931118,0.000010636882,0.19938882,0.0002884311,0.000043379332,0.00025914633],"about_ca_topic_score_codex":0.00049324415,"about_ca_topic_score_gemma":0.00007080184,"teacher_disagreement_score":0.27275088,"about_ca_system_score_codex":0.000025866133,"about_ca_system_score_gemma":0.000063717176,"threshold_uncertainty_score":0.6163462},"labels":[],"label_agreement":null},{"id":"W2558274044","doi":"10.1182/blood.v106.11.3582.3582","title":"Effects of Mitochondrial Ferritin Expression on Tumor Iron Metabolism and Tumor Growth in Nude Mice Xenografts.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Ferritin; Mitochondrion; Cytosol; Deferoxamine; Transferrin receptor; Biology; Heme; Transferrin; Frataxin; Cancer research; Intracellular; Aconitase; Chemistry; Cell biology; Biochemistry","score_opus":0.003738249029133165,"score_gpt":0.21501303884293146,"score_spread":0.2112747898137983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558274044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99636614,0.0029314517,0.000035918667,0.000067338166,0.00007810747,0.00019308597,0.000010952211,0.000005205047,0.00031182254],"genre_scores_gemma":[0.99765956,0.00019952173,0.0014347977,0.00014890535,0.00039282136,0.000060922834,0.000014570482,0.000013655429,0.00007522428],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99933743,0.000047051984,0.00015175795,0.00024278292,0.000083372826,0.00013760079],"domain_scores_gemma":[0.9997048,0.0000134941465,0.000063397296,0.00014606508,0.00002569837,0.000046537378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004587357,0.00010488059,0.00012880401,0.000045059416,0.00002832558,0.00000952611,0.000094975294,0.00005459026,0.00000477787],"category_scores_gemma":[0.000046747362,0.00009456903,0.000040252784,0.000053158758,0.00003768676,0.000004096629,0.000037583184,0.00006251654,0.000002288972],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008017213,0.0003464753,0.00035212364,0.000041200696,0.00000787895,0.0000027606732,0.000036274065,0.0000055405826,0.99833125,0.000072840405,0.0002889517,0.00043451952],"study_design_scores_gemma":[0.002303426,0.000115628965,0.011664804,0.000044925997,0.000027443692,0.0000065429476,0.000014176445,0.000005049105,0.98200446,0.000017225057,0.0036891843,0.00010712323],"about_ca_topic_score_codex":0.000028660916,"about_ca_topic_score_gemma":0.000016124373,"teacher_disagreement_score":0.016326793,"about_ca_system_score_codex":0.000004121347,"about_ca_system_score_gemma":0.000021975395,"threshold_uncertainty_score":0.3856413},"labels":[],"label_agreement":null},{"id":"W2558300628","doi":"10.1182/blood.v118.21.2236.2236","title":"Apolipoprotein(a)-Dependent Inhibition of Pericellular Plasminogen Activation Is Mediated by Specific Cellular Receptors","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor","funders":"","keywords":"Plasmin; Apolipoprotein B; Umbilical vein; Kringle domain; Population; Fibrinolysis; Biology; Chemistry; Molecular biology; Cancer research; Cell biology; Biochemistry; Medicine; Internal medicine; Cholesterol; In vitro","score_opus":0.019861483008038236,"score_gpt":0.20892028825807965,"score_spread":0.18905880525004143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558300628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99261934,0.0015808013,0.000967385,0.000097230004,0.00012996982,0.0009594349,0.00003294009,0.00007435284,0.0035385333],"genre_scores_gemma":[0.9975326,0.00042403108,0.00092044583,0.00013419603,0.000268836,0.00006232825,0.00022130384,0.00004863079,0.00038764506],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980495,0.00008408719,0.00045172535,0.00038170852,0.00072972145,0.00030323284],"domain_scores_gemma":[0.9988319,0.000012997713,0.00020717244,0.0005909316,0.00015771578,0.000199274],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041660338,0.0002093778,0.00042599475,0.00013963472,0.00006955477,0.000008179786,0.00008171564,0.00021334253,0.001159077],"category_scores_gemma":[0.00003696006,0.00019069405,0.00023583169,0.00028453546,0.000065298074,0.00010856292,0.000036799072,0.00021461277,0.0000992428],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017082284,0.0012692454,0.0019339253,0.00027040078,0.0003594503,0.00003596156,0.001412811,1.4285095e-7,0.9887471,0.000070265785,0.0016659182,0.0040639075],"study_design_scores_gemma":[0.003203436,0.0004098578,0.001166952,0.00011647279,0.0001968246,0.000024199611,0.00029132448,0.000004271141,0.9855178,0.000050182007,0.008837442,0.00018121718],"about_ca_topic_score_codex":0.0006898036,"about_ca_topic_score_gemma":0.0000021492915,"teacher_disagreement_score":0.0071715233,"about_ca_system_score_codex":0.00006220642,"about_ca_system_score_gemma":0.00008781643,"threshold_uncertainty_score":0.999754},"labels":[],"label_agreement":null},{"id":"W2558301987","doi":"10.1182/blood.v114.22.139.139","title":"Tyrosine 641 of the EZH2 Oncogene Is Frequently Mutated in Follicular and Diffuse Large B-Cell Lymphomas of Germinal Center Origin.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Canada's Michael Smith Genome Sciences Centre; Genome British Columbia; Terry Fox Research Institute; BC Cancer Agency","funders":"","keywords":"Biology; Germinal center; Follicular lymphoma; Diffuse large B-cell lymphoma; Cancer research; Genetics; EZH2; Gene; B cell; Lymphoma; Histone; Immunology","score_opus":0.008534875285076397,"score_gpt":0.24221617540749896,"score_spread":0.23368130012242255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558301987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956749,0.0025158338,9.224819e-7,0.00046906446,0.00003359476,0.00032838708,0.00007564095,0.000009383712,0.0008922452],"genre_scores_gemma":[0.9988401,0.0003269104,0.00015620446,0.00046478448,0.00002567239,0.000009180782,0.000017834847,0.00001082373,0.00014851699],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990393,0.000030825893,0.00030354632,0.00020055116,0.00021850008,0.00020729126],"domain_scores_gemma":[0.999421,0.000023401553,0.00012096297,0.000307086,0.000051304196,0.000076259115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000071451155,0.0001489869,0.00034463953,0.000067527726,0.000024744386,0.000005518973,0.0000712084,0.00007193201,0.000036034147],"category_scores_gemma":[0.000013161126,0.00009433201,0.00012003364,0.00019307157,0.00004350048,0.00003040959,0.000030096478,0.000042072337,0.0000033382846],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018089334,0.037014764,0.89642483,0.000117919015,0.00018180803,0.00034573436,0.00073770754,3.0717894e-7,0.06291109,0.00023041187,0.0002798972,0.0015746232],"study_design_scores_gemma":[0.041572478,0.00048936816,0.46286497,0.00020052379,0.00036684587,0.00009718435,0.000037054855,0.000016438347,0.49329016,0.000053799387,0.0009256857,0.00008549696],"about_ca_topic_score_codex":0.00014817058,"about_ca_topic_score_gemma":0.000020751862,"teacher_disagreement_score":0.43355986,"about_ca_system_score_codex":0.000046559373,"about_ca_system_score_gemma":0.00007506914,"threshold_uncertainty_score":0.38467476},"labels":[],"label_agreement":null},{"id":"W2558344898","doi":"10.1182/blood.v114.22.379.379","title":"Necdin Regulates Hematopoietic Stem Cell Quiescence and Sensitivity to Genotoxic Stress.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Genetic Syndromes and Imprinting","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Haematopoiesis; Biology; Stem cell; Null cell; Bone marrow; Stromal cell; Transplantation; Myeloid; Cancer research; Cell biology; Immunology; Cell culture; Genetics; Internal medicine; Medicine","score_opus":0.005984711559342947,"score_gpt":0.20369361230941213,"score_spread":0.1977089007500692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558344898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99803704,0.00086173374,0.00027434173,0.00015700473,0.00003282827,0.00015023525,0.0000058799083,0.000013910445,0.00046702757],"genre_scores_gemma":[0.9979557,0.000070039896,0.001245382,0.00022495264,0.00006941586,0.0000030898616,0.0000055495534,0.000011326077,0.00041455321],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991721,0.000033764038,0.00013275704,0.0003316214,0.00008397249,0.00024576476],"domain_scores_gemma":[0.9995233,0.0000073493848,0.00004038753,0.00028039576,0.000030697076,0.00011790093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010825085,0.00013324028,0.00012795765,0.000024105486,0.000063116655,0.000034659315,0.00006236164,0.00008216332,0.000003993299],"category_scores_gemma":[0.0000114985105,0.00013150506,0.00003844123,0.00005966108,0.00002393575,0.0000019625159,0.000095440046,0.00004462687,0.000009078322],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000027108083,0.0000969916,0.0040723933,0.000020645824,0.000009356354,0.000007950459,0.00010827001,0.000021721275,0.99145645,0.000010218294,0.00005490267,0.0041383663],"study_design_scores_gemma":[0.00039542443,0.00030253746,0.061777256,0.000024961235,0.00002071261,0.00014457083,0.00012693678,0.000021372864,0.9365962,0.00002522191,0.00038406654,0.00018073905],"about_ca_topic_score_codex":0.000006161241,"about_ca_topic_score_gemma":0.0000065356576,"teacher_disagreement_score":0.057704862,"about_ca_system_score_codex":0.0000025755353,"about_ca_system_score_gemma":0.000017824968,"threshold_uncertainty_score":0.53626204},"labels":[],"label_agreement":null},{"id":"W2558345374","doi":"10.1182/blood.v106.11.1241.1241","title":"Rituximab for the Treatment of Adults with ITP: A Systematic Review.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Rituximab; Internal medicine; Publication bias; Randomized controlled trial; Pediatrics; Thrombocytopenic purpura; Funnel plot; Meta-analysis; Clinical trial; MEDLINE; Platelet; Lymphoma","score_opus":0.009696086263274244,"score_gpt":0.2563784921984198,"score_spread":0.24668240593514554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558345374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7764553,0.21256825,0.00007629954,0.0020989578,0.000020973932,0.007948537,0.000047455025,0.000037187463,0.0007470301],"genre_scores_gemma":[0.9837032,0.013294071,0.0012100488,0.000312344,0.000039726357,0.00085407175,0.000025449479,0.000016639593,0.000544475],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9994894,0.000009419508,0.00018415766,0.00010279659,0.000106384265,0.00010780799],"domain_scores_gemma":[0.9994978,0.00007745344,0.00008469576,0.0002586137,0.00004852069,0.00003297413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000399203,0.000095301984,0.0005092257,0.000015868985,0.00003147498,0.000002687586,0.000035132132,0.00001913703,0.000011433487],"category_scores_gemma":[0.000020245388,0.00004229741,0.00010122295,0.000056256304,0.000017261824,0.000016372496,0.0000021634921,0.000014076174,0.000016973123],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028352698,0.09898821,0.0055878996,0.8406471,0.015963757,0.0005892163,0.005011199,0.000006753354,0.00020670852,0.00038032935,0.0018317881,0.027951766],"study_design_scores_gemma":[0.3598031,0.04135794,0.0038387128,0.4463436,0.107561,0.003451775,0.0015152397,0.0010807132,0.023246221,0.00009509118,0.010756031,0.00095058],"about_ca_topic_score_codex":0.00001559284,"about_ca_topic_score_gemma":0.000038074417,"teacher_disagreement_score":0.3943035,"about_ca_system_score_codex":0.000016800983,"about_ca_system_score_gemma":0.000024177778,"threshold_uncertainty_score":0.17248383},"labels":[],"label_agreement":null},{"id":"W2558346369","doi":"10.1182/blood.v112.11.3333.3333","title":"Effect of Obesity on Outcomes after Autologous Hematopoietic Stem Cell Transplantation (Auto HCT) for Multiple Myeloma (MM): An Analysis from the Center for International Blood and Marrow Transplant Research (CIBMTR).","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Melphalan; Univariate analysis; Body mass index; Proportional hazards model; Transplantation; Multiple myeloma; Overweight; Surgery; Hematopoietic stem cell transplantation; Cumulative incidence; Underweight; Total body irradiation; Gastroenterology; Chemotherapy; Multivariate analysis; Cyclophosphamide","score_opus":0.014539962080834986,"score_gpt":0.28945803007794674,"score_spread":0.27491806799711177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558346369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99605703,0.00022226344,0.0006116311,0.00007461101,0.00008160545,0.000901383,0.0020159532,0.00001065433,0.00002484962],"genre_scores_gemma":[0.99795735,0.00010763467,0.00029263878,0.000029312912,0.00012215627,0.00033144475,0.0010041253,0.000025684561,0.00012965342],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982508,0.00033344782,0.00028292122,0.00048404484,0.0003499236,0.0002988725],"domain_scores_gemma":[0.9986665,0.00056844315,0.00006736407,0.0003718132,0.00023794148,0.00008789654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006209757,0.00018134889,0.00029266602,0.000129951,0.0001799427,0.00002053973,0.00027488213,0.00016888583,0.0000086176415],"category_scores_gemma":[0.000083547646,0.00013251726,0.0002492821,0.0001080641,0.00016569192,0.000008670195,0.000030148243,0.00013110868,0.000001718014],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047872094,0.0016581329,0.56629837,0.00034868726,0.0013373106,0.000053114753,0.002163366,0.00004911572,0.42251837,0.0000066230255,0.00018605113,0.0005936373],"study_design_scores_gemma":[0.005555414,0.0014629863,0.06790465,0.00002756941,0.00050962775,0.00001719934,0.00004617031,0.0003125268,0.9237827,0.0000041739177,0.00022400818,0.00015294993],"about_ca_topic_score_codex":0.00009196462,"about_ca_topic_score_gemma":0.00034681088,"teacher_disagreement_score":0.5012644,"about_ca_system_score_codex":0.000013072064,"about_ca_system_score_gemma":0.000041944815,"threshold_uncertainty_score":0.5403897},"labels":[],"label_agreement":null},{"id":"W2558351072","doi":"10.1182/blood.v110.11.1875.1875","title":"Thromboprophylaxis for Catheter-Related Thrombosis in Patients with Cancer: A Systematic Review.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Warfarin; Thrombosis; Relative risk; Jadad scale; Population; Low molecular weight heparin; Randomized controlled trial; Surgery; Venous thrombosis; Clinical trial; Cancer; Internal medicine; Confidence interval; Cochrane Library","score_opus":0.009167874937091681,"score_gpt":0.2679277727820571,"score_spread":0.2587598978449654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558351072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848501,0.0063039977,0.000054186236,0.000334604,0.00011630667,0.0074689356,0.000019007042,0.000066099805,0.00078676123],"genre_scores_gemma":[0.99626356,0.0014389582,0.000398555,0.001028825,0.00002999031,0.0006723388,0.00004117666,0.000046334873,0.000080272905],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.99837047,0.000025149797,0.0005745856,0.00031858397,0.00032635537,0.00038484408],"domain_scores_gemma":[0.9990622,0.00006276301,0.00020204493,0.00042245336,0.00014856766,0.00010199718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048102264,0.00019820167,0.0010945273,0.00013685129,0.000051947154,0.0000110828505,0.00011073492,0.00007024936,0.00005268586],"category_scores_gemma":[0.00008790262,0.0001423622,0.00012637921,0.00035340016,0.000033038552,0.000057998943,0.000030254956,0.00010273222,0.000016707134],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015365287,0.031173931,0.3050864,0.6554278,0.0031409974,0.000042367854,0.0015315153,0.0000041678704,0.00015885438,0.00072414975,0.0018594913,0.0006966602],"study_design_scores_gemma":[0.012343676,0.004487831,0.8368104,0.1385923,0.0062640384,0.000004217141,0.00011382129,0.000005949135,0.000752797,0.0000668673,0.000113903974,0.00044418068],"about_ca_topic_score_codex":0.00016842518,"about_ca_topic_score_gemma":0.00014630584,"teacher_disagreement_score":0.53172404,"about_ca_system_score_codex":0.00009133241,"about_ca_system_score_gemma":0.00004032348,"threshold_uncertainty_score":0.5805362},"labels":[],"label_agreement":null},{"id":"W2558377764","doi":"10.1182/blood.v112.11.4502.4502","title":"Hemophilia a Carriers Experience Errors and Deficiencies in Care Leading to Emotional and Behavioral Responses That Could Further Compromise Their Care","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Feeling; Medicine; Disappointment; Haemophilia; Qualitative research; Haemophilia A; Health care; Family medicine; Psychology; Psychiatry; Pediatrics; Psychotherapist; Social psychology","score_opus":0.07986098851700338,"score_gpt":0.3424109939147495,"score_spread":0.2625500053977461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558377764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956522,0.0032259068,7.9283154e-7,0.00035502276,0.000028575983,0.00046700457,0.00003357331,0.000028808072,0.00020813703],"genre_scores_gemma":[0.99910235,0.00011133572,0.00030699733,0.000057793277,0.000025909718,0.000048570302,0.000013241694,0.000016349652,0.00031742206],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892455,0.000043692628,0.000121695106,0.0003236304,0.00028737113,0.00029906112],"domain_scores_gemma":[0.99947333,0.00004739665,0.000018143834,0.00016795979,0.00007111008,0.00022202736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005870284,0.00015907352,0.00023872452,0.00018224514,0.00019470918,0.000015372238,0.00005870949,0.00008337285,0.000020577912],"category_scores_gemma":[0.000039563274,0.00011986904,0.000037615337,0.00017522238,0.00031119882,0.000066702494,0.00006802094,0.00014627524,0.0000033258166],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013810828,0.00012468378,0.87151396,0.000051916137,0.000009483756,0.00032927428,0.11777448,0.0000013538589,0.009478406,0.000003534954,0.000009047882,0.000565766],"study_design_scores_gemma":[0.0039179204,0.00088715495,0.8108034,0.0002328386,0.00004944084,0.0005511282,0.14544335,0.000010895009,0.03759744,0.0000036393649,0.00026198287,0.00024080645],"about_ca_topic_score_codex":0.00010923153,"about_ca_topic_score_gemma":0.000103013066,"teacher_disagreement_score":0.06071054,"about_ca_system_score_codex":0.00006655923,"about_ca_system_score_gemma":0.00012104712,"threshold_uncertainty_score":0.48881173},"labels":[],"label_agreement":null},{"id":"W2558380786","doi":"10.1182/blood.v116.21.3404.3404","title":"Combined Targeting of BCR-ABL and JAK2 with ABL and JAK2 Inhibitors Is Effective Against CML Patients' Leukemic Stem/Progenitor Cells.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Progenitor cell; Stem cell; Imatinib mesylate; Cancer research; Haematopoiesis; Tyrosine kinase; ABL; Imatinib; K562 cells; Biology; Myeloid leukemia; Medicine; Immunology; Leukemia; Cell biology; Signal transduction","score_opus":0.002756804409487737,"score_gpt":0.19052913707364796,"score_spread":0.1877723326641602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558380786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997222,0.000498611,0.000001476714,0.000037718983,0.00022180434,0.0014283316,0.000052669566,0.0000585122,0.0004788926],"genre_scores_gemma":[0.998309,0.00007398504,0.0010350761,0.00009357717,0.00015825835,0.000072160765,0.00005141342,0.00006203942,0.00014449227],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983505,0.000053606287,0.00036882004,0.0005077964,0.0003489831,0.00037027453],"domain_scores_gemma":[0.99879223,0.00016984681,0.0002451967,0.00036125846,0.00017928434,0.00025220908],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016787807,0.00034054203,0.00055214274,0.00011883962,0.00011152491,0.000022430344,0.000079143705,0.00019413022,0.000024086079],"category_scores_gemma":[0.00006322237,0.00026564187,0.00006607702,0.00018549962,0.00020745334,0.00010436788,0.000103172686,0.0003876521,0.000010630895],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049787597,0.0013179599,0.75368893,0.00061315956,0.0006588563,0.000063842956,0.0016720159,6.3865724e-7,0.2334095,0.000007810085,0.00041711642,0.0076522883],"study_design_scores_gemma":[0.044389103,0.002818764,0.13145113,0.0005021843,0.0009925916,0.00003976661,0.00035157197,0.000091810856,0.8184626,0.000012302197,0.00045940475,0.00042878286],"about_ca_topic_score_codex":0.000245372,"about_ca_topic_score_gemma":0.000018348881,"teacher_disagreement_score":0.6222378,"about_ca_system_score_codex":0.00014437687,"about_ca_system_score_gemma":0.00021483364,"threshold_uncertainty_score":0.99997956},"labels":[],"label_agreement":null},{"id":"W2558382609","doi":"10.1182/blood.v126.23.4714.4714","title":"Evaluating the Effect of Ethnicity on the Risk of Venous Thromboembolism (VTE): A Systematic Review","year":2015,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Incidence (geometry); Ethnic group; Population; Context (archaeology); Observational study; Demography; Internal medicine; Environmental health","score_opus":0.08731230610018047,"score_gpt":0.4056023774483024,"score_spread":0.31829007134812193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558382609","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008952778,0.98162436,0.0000013627549,0.00009012959,0.00018004842,0.015586022,0.00005335954,0.000031887495,0.0015375247],"genre_scores_gemma":[0.00037663858,0.9975133,0.000025884541,0.00021271678,0.00015268245,0.0015571411,0.000024318782,0.00008095166,0.000056356705],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99207395,0.0041186046,0.0017422307,0.000432635,0.0012908109,0.00034178],"domain_scores_gemma":[0.9915994,0.0030988692,0.0027163283,0.0022561532,0.00023478217,0.000094494404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011769614,0.00058778876,0.009409698,0.00011129497,0.000120695455,0.000014267935,0.00075258286,0.00021433813,0.000049713173],"category_scores_gemma":[0.005051116,0.00023834758,0.0015070899,0.0005493342,0.0001598665,0.000020117872,0.00023958825,0.00075195933,0.00008627118],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005790442,0.0007904806,0.0000016266185,0.93704927,0.0039328723,0.0000071281565,0.00016038715,0.0000010521765,5.343372e-7,0.00016281109,0.00090892497,0.05697914],"study_design_scores_gemma":[0.0007049755,0.0042934236,0.00002862318,0.82275957,0.16373368,0.000048669444,0.000023433073,0.0000041905228,0.000015804542,0.000039467694,0.008144516,0.00020366962],"about_ca_topic_score_codex":0.000105300496,"about_ca_topic_score_gemma":0.000003159987,"teacher_disagreement_score":0.15980081,"about_ca_system_score_codex":0.000076170676,"about_ca_system_score_gemma":0.00028221824,"threshold_uncertainty_score":0.9719533},"labels":[],"label_agreement":null},{"id":"W2558396912","doi":"10.1182/blood.v120.21.3655.3655","title":"First-Line Treatment and Outcome of Elderly Patients with Primary Central Nervous System Lymphoma (PCNSL) – A Systematic Review and Individual Patient Data Meta-Analysis","year":2012,"lang":"en","type":"review","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Primary central nervous system lymphoma; Performance status; Observational study; Internal medicine; Randomized controlled trial; Oncology; Lymphoma; Pediatrics; Chemotherapy","score_opus":0.1192867515422079,"score_gpt":0.30465940021365456,"score_spread":0.18537264867144665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558396912","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015654125,0.9858575,0.000002103156,0.000025059242,0.000031570995,0.008257071,0.0041973093,0.00003828183,0.000025684854],"genre_scores_gemma":[0.008513105,0.9842596,0.00033795254,0.00006246819,0.00003037495,0.0014082203,0.0052727484,0.0000843625,0.000031155556],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9953234,0.00035831414,0.0021698778,0.00095247664,0.00070090947,0.00049502915],"domain_scores_gemma":[0.99503523,0.0003436663,0.0018172468,0.0022297504,0.00013420095,0.0004398778],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035253903,0.001033072,0.013241815,0.0003360231,0.00008985355,0.000049767685,0.0002756132,0.00021678141,0.000024582112],"category_scores_gemma":[0.000047211543,0.00051972526,0.0014192675,0.00054915994,0.00007533704,0.00011646517,0.00030960588,0.00007988166,0.0000062694685],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008716554,0.0034405552,0.0049624033,0.6264142,0.29904172,0.00005838976,0.00005350578,6.5908075e-8,7.336308e-10,0.0000047329313,0.0000065118506,0.06600922],"study_design_scores_gemma":[0.0027460288,0.0014422031,0.006330639,0.06659635,0.91789645,0.00031398318,0.000013261966,6.4690147e-7,1.3075956e-7,8.446657e-8,0.0042848256,0.00037541834],"about_ca_topic_score_codex":0.00021523135,"about_ca_topic_score_gemma":0.00007124269,"teacher_disagreement_score":0.6188547,"about_ca_system_score_codex":0.00027682615,"about_ca_system_score_gemma":0.00018183254,"threshold_uncertainty_score":0.99972546},"labels":[],"label_agreement":null},{"id":"W2558398014","doi":"10.1182/blood.v118.21.5136.5136","title":"CYBOR-D Induction Therapy In Clinical Practice","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Regimen; Internal medicine; Bortezomib; Surgery; Maintenance therapy; Clinical trial; Cyclophosphamide; Multiple myeloma; Chemotherapy","score_opus":0.16078938800462997,"score_gpt":0.42137277113476673,"score_spread":0.26058338313013674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558398014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9725773,0.00028648772,0.0000050609456,0.00027899575,0.0000713263,0.00029065917,9.695426e-7,0.000026198964,0.026463013],"genre_scores_gemma":[0.99442625,0.0006462753,0.0043005426,0.00022449403,0.00014190727,0.000025350762,0.000006882511,0.000009727287,0.00021854824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99921983,0.000099005854,0.00019390302,0.00015852792,0.00016743649,0.00016126572],"domain_scores_gemma":[0.99950254,0.00008502241,0.00004014545,0.00019451299,0.00006314811,0.000114616574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035519307,0.000060618728,0.0001271504,0.000064323875,0.00001835948,0.0000045351953,0.000038342292,0.00007286533,0.00018028263],"category_scores_gemma":[0.00058845425,0.00004489666,0.000037403028,0.00011802746,0.000032997697,0.00009791757,0.00001370074,0.00020744088,0.00016420898],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013227919,0.008650642,0.81211865,0.000007948136,0.0002511682,0.0008556125,0.00038288123,1.1177366e-8,0.00080460875,0.000118622855,0.000157644,0.17532942],"study_design_scores_gemma":[0.009411072,0.0014362971,0.98105735,0.000016717528,0.000035298915,0.0001140072,0.00009406359,0.000003049271,0.004250484,0.00006753964,0.0034698253,0.00004430074],"about_ca_topic_score_codex":0.0003057493,"about_ca_topic_score_gemma":0.00001776114,"teacher_disagreement_score":0.17528512,"about_ca_system_score_codex":0.000012518676,"about_ca_system_score_gemma":0.00007350745,"threshold_uncertainty_score":0.2110629},"labels":[],"label_agreement":null},{"id":"W2558403319","doi":"10.1182/blood.v110.11.2699.2699","title":"Single Amino Acid Substitution (Asp111Ala) in Coagulation Factor Va Causes Subunit Dissociation and Disrupted Calcium and Copper Binding.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of British Columbia","funders":"","keywords":"Prothrombinase; Chemistry; Divalent; Thrombin; Factor X; Biochemistry; Stereochemistry; Platelet; Biology","score_opus":0.04535067973177507,"score_gpt":0.2951464120684045,"score_spread":0.2497957323366294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558403319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99815637,0.00028143733,0.0005949768,0.00021371043,0.000113764036,0.00036151207,0.000024027035,0.00007746987,0.00017674718],"genre_scores_gemma":[0.9993362,0.000030375668,0.00020748551,0.00009127564,0.00006202438,0.0000058656337,0.00012481851,0.000018407245,0.00012356752],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989427,0.000036637044,0.00028821826,0.00025571944,0.00023756592,0.00023916023],"domain_scores_gemma":[0.9995142,0.00006501437,0.000109290195,0.00012316038,0.00007345642,0.00011486037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023282472,0.00015228924,0.00024603494,0.00023300335,0.00010247768,0.000030168207,0.000024956065,0.00017488353,0.000030577765],"category_scores_gemma":[0.00011348851,0.00014729836,0.000028887698,0.00027316835,0.00004976206,0.00018639481,0.000023377208,0.00012501549,0.000007217656],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054431104,0.00052146346,0.43708697,0.000045704957,0.000045069926,0.000015145143,0.000690376,5.172008e-7,0.55899954,0.0006828762,0.0000064888986,0.0018514165],"study_design_scores_gemma":[0.002896894,0.00016190142,0.7561315,0.000069036956,0.00013436508,0.000028412958,0.00019232758,0.00008323188,0.23999833,0.00006556018,0.00010483201,0.00013366273],"about_ca_topic_score_codex":0.00006666996,"about_ca_topic_score_gemma":0.00024656687,"teacher_disagreement_score":0.31904447,"about_ca_system_score_codex":0.00008346647,"about_ca_system_score_gemma":0.000025294476,"threshold_uncertainty_score":0.6006652},"labels":[],"label_agreement":null},{"id":"W2558410094","doi":"10.1182/blood.v110.11.3419.3419","title":"Durable Complete Responses Following Therapy with Epratuzumab Plus Rituximab: Final Efficacy Results of a Multicenter Study in Recurrent Indolent Non-Hodgkin’s Lymphoma (NHL).","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"","keywords":"Rituximab; Medicine; Follicular lymphoma; Internal medicine; Regimen; Lymphoma; Gastroenterology; Refractory (planetary science); Oncology; Chemotherapy regimen; Chemotherapy; Surgery","score_opus":0.041996748575949476,"score_gpt":0.31457864161054594,"score_spread":0.27258189303459646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558410094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99596715,0.00094294077,0.000008914492,0.00016622129,0.000135336,0.0021977765,0.00003572484,0.00004152369,0.0005044021],"genre_scores_gemma":[0.9985989,0.00010819661,0.0008679519,0.000104357714,0.00006243198,0.00011720856,0.000033984677,0.000038063677,0.00006892997],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973202,0.00014551883,0.00080075715,0.00057546335,0.00062965654,0.00052841037],"domain_scores_gemma":[0.99834245,0.00052104256,0.00024377221,0.00060864916,0.00011157132,0.00017251722],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007816817,0.00034968316,0.00079524535,0.0003172589,0.000090690686,0.000028257664,0.00015086305,0.00008774173,0.000010775827],"category_scores_gemma":[0.00013557707,0.0002486902,0.00018918319,0.0004034863,0.000060185044,0.00008147202,0.0000604605,0.00012520398,0.000018266248],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.087635174,0.10679326,0.7653524,0.00007867644,0.0014573954,0.00618889,0.009451715,0.000012181324,0.0024852161,0.000008400128,0.00012681786,0.020409856],"study_design_scores_gemma":[0.23354097,0.007109724,0.74595064,0.0006433768,0.00028469987,0.000049581726,0.0008163214,0.000029992498,0.011029302,0.0000010872697,0.0003510695,0.00019323596],"about_ca_topic_score_codex":0.0009781178,"about_ca_topic_score_gemma":0.0005378455,"teacher_disagreement_score":0.1459058,"about_ca_system_score_codex":0.00033968117,"about_ca_system_score_gemma":0.0003376365,"threshold_uncertainty_score":0.99999654},"labels":[],"label_agreement":null},{"id":"W2558423221","doi":"10.1182/blood.v126.23.1472.1472","title":"Integrative Analysis of Diffuse Large B Cell Lymphoma Mutational Landscape: A Lysa Study","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"BCL6; Diffuse large B-cell lymphoma; Lymphoma; Germinal center; Cancer research; Biology; Gene expression profiling; Gene; B cell; Gene expression; Genetics; Immunology; Antibody","score_opus":0.016554696944858074,"score_gpt":0.2774045934494269,"score_spread":0.26084989650456886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558423221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99528205,0.0003837314,0.000016116031,0.000059527385,0.000028939568,0.00029777465,0.000085151914,0.000024055007,0.0038226342],"genre_scores_gemma":[0.99911606,0.00000870245,0.0002100296,0.00006778917,0.000033317032,0.00006650211,0.00015858712,0.0000092126975,0.00032978723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990313,0.000051552535,0.00023042643,0.00020661743,0.0003418,0.00013829091],"domain_scores_gemma":[0.99924505,0.00008265247,0.00009804703,0.00023523216,0.00019303898,0.00014598717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013014088,0.00012960681,0.00042714528,0.00023646948,0.000024939283,0.000010113066,0.000053911655,0.000038942784,0.00006958619],"category_scores_gemma":[0.00006126155,0.00008624419,0.00016994127,0.00057911064,0.00001801563,0.00003528649,0.00003189659,0.000023722274,0.000026323643],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009939021,0.08013807,0.91011864,0.000008229479,0.003867236,0.00022297679,0.0047045746,0.0000030824986,0.00003837321,0.00009257084,0.0004356374,0.00027124182],"study_design_scores_gemma":[0.06564968,0.0012836498,0.90970355,0.000015528096,0.012130305,0.000013230956,0.007164939,0.00031277342,0.0034217394,0.000021724567,0.00017861564,0.00010427415],"about_ca_topic_score_codex":0.00013150462,"about_ca_topic_score_gemma":0.00015614022,"teacher_disagreement_score":0.07885443,"about_ca_system_score_codex":0.000047159985,"about_ca_system_score_gemma":0.00015225317,"threshold_uncertainty_score":0.3516936},"labels":[],"label_agreement":null},{"id":"W2558427779","doi":"10.1182/blood.v108.11.78.78","title":"Physician Adherence to Local Treatment Policies and American Society of Hematology (ASH) Quality Metrics in Chronic Lymphocytic Leukemia (CLL) Management.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Chronic lymphocytic leukemia; Internal medicine; Stage (stratigraphy); Hematology; Cancer; Leukemia","score_opus":0.03147614589071248,"score_gpt":0.3402858005656068,"score_spread":0.30880965467489435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558427779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99574506,0.0011373133,0.00028675894,0.00010263407,0.000017298516,0.00065680215,0.000013976806,0.000045641995,0.0019945276],"genre_scores_gemma":[0.99710643,0.0004736297,0.0013897497,0.00024305905,0.000080297774,0.000082848885,0.000016067674,0.000027435945,0.0005804743],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99794006,0.00007847891,0.0004985453,0.00045813277,0.00043084455,0.0005939089],"domain_scores_gemma":[0.9989531,0.00019223405,0.00013888904,0.0004964537,0.00006638961,0.00015293893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002213745,0.00024195193,0.00073446234,0.00025194776,0.000044697423,0.000014055511,0.00015239527,0.000085006846,0.000010141628],"category_scores_gemma":[0.000023466417,0.00021242564,0.0001404483,0.0013047386,0.00051309867,0.000043509004,0.00016422478,0.00009958632,0.000020660353],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.003362256,0.012339062,0.11044717,0.018542673,0.006362363,0.0025198418,0.010344413,0.008798066,0.07635806,0.045935072,0.01008554,0.69490546],"study_design_scores_gemma":[0.32244498,0.0153445555,0.23386073,0.0017395904,0.0020917102,0.0008876196,0.012849895,0.048745923,0.3501299,0.0016156475,0.007968068,0.0023213888],"about_ca_topic_score_codex":0.06288254,"about_ca_topic_score_gemma":0.002068974,"teacher_disagreement_score":0.6925841,"about_ca_system_score_codex":0.047457248,"about_ca_system_score_gemma":0.005888729,"threshold_uncertainty_score":0.999747},"labels":[],"label_agreement":null},{"id":"W2558434046","doi":"10.1182/blood.v104.11.2764.2764","title":"Long-Term Results of Allogeneic Hematopoietic Stem Cell Transplantation Using Unrelated or HLA Mismatched Family Donors for Acute and Chronic Lymphoid Malignancy.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Medicine; Transplantation; Internal medicine; Busulfan; Gastroenterology; Malignancy; Multiple myeloma; Hematopoietic stem cell transplantation; Immunology","score_opus":0.023153051376859465,"score_gpt":0.2900033554513082,"score_spread":0.2668503040744487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558434046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915606,0.002083281,0.004713973,0.000068048925,0.000066832254,0.0011735066,0.0002032564,0.000054927117,0.00007558425],"genre_scores_gemma":[0.9949261,0.0019799522,0.0024877181,0.000039513227,0.00007512598,0.00004145951,0.00017874289,0.00006233532,0.00020906297],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981144,0.00004000377,0.00059369684,0.0004432516,0.00035400531,0.00045465011],"domain_scores_gemma":[0.99896306,0.00016813487,0.00019693881,0.00033301674,0.00014904853,0.00018983177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021012661,0.00025279776,0.0004884781,0.00016226557,0.00008068067,0.000018497778,0.00013763516,0.00021711478,0.0000063156613],"category_scores_gemma":[0.000015723163,0.00020406717,0.00010914239,0.00026859823,0.00012408498,0.00008556932,0.00003189334,0.0001179152,0.0000062787162],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046497444,0.00081835967,0.002808417,0.004044531,0.0006778898,0.00095434685,0.002223392,0.00023901415,0.9826253,0.000024245213,0.00002529299,0.00090945314],"study_design_scores_gemma":[0.08546572,0.0015404508,0.0056602764,0.0018088631,0.0031781655,0.00305672,0.00015046298,0.0004251472,0.89831597,0.00004957613,0.00001091763,0.0003377156],"about_ca_topic_score_codex":0.0000930488,"about_ca_topic_score_gemma":0.000046134497,"teacher_disagreement_score":0.08430933,"about_ca_system_score_codex":0.00043248048,"about_ca_system_score_gemma":0.0015907021,"threshold_uncertainty_score":0.8321618},"labels":[],"label_agreement":null},{"id":"W2558442718","doi":"10.1182/blood.v104.11.4004.4004","title":"Ten-Year Follow-Up of Inhibitor Induction in Previously Untreated Patients (PUPs) on Recombinate.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Factor IX; Internal medicine; Titer; Pharmacology; Immunology; Virus","score_opus":0.019259513856162203,"score_gpt":0.26883586793783615,"score_spread":0.24957635408167395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558442718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966311,0.000052103507,1.4432004e-7,0.0003097241,0.00013532059,0.0006448541,0.0000042727997,0.000029441677,0.0021930735],"genre_scores_gemma":[0.998808,0.000072273346,0.00006689847,0.000019873329,0.00005438824,0.000023379263,0.00005940333,0.000018341123,0.000877419],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999007,0.00003643467,0.00022908371,0.0002057496,0.00029367275,0.00022809938],"domain_scores_gemma":[0.99954337,0.000018859684,0.00004918167,0.00019453609,0.000101642276,0.00009241943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011239319,0.0001132518,0.00023185839,0.0002281797,0.00002676443,0.000005110968,0.00004713922,0.00012234009,0.00004708493],"category_scores_gemma":[0.00012138396,0.00008395212,0.00006477763,0.0003403874,0.000035561665,0.000049081224,0.000019814333,0.00017466786,0.00008725797],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009342323,0.013489927,0.9726933,0.00013796543,0.00016474341,0.000098962286,0.0007811007,0.0000033505034,0.005124701,0.00013073927,0.00021730571,0.0062236264],"study_design_scores_gemma":[0.08349245,0.009418988,0.50460607,0.0010963419,0.00019113075,0.000011775545,0.00015683206,0.0000016333472,0.40025744,0.00043077327,0.00013773027,0.0001988021],"about_ca_topic_score_codex":0.00014530303,"about_ca_topic_score_gemma":0.00002420163,"teacher_disagreement_score":0.46808726,"about_ca_system_score_codex":0.00010550981,"about_ca_system_score_gemma":0.00009661944,"threshold_uncertainty_score":0.34234682},"labels":[],"label_agreement":null},{"id":"W2558443141","doi":"10.1182/blood.v112.11.2459.2459","title":"A Functional Screen to Identify Novel Effectors of Hematopoietic Stem Cell Activity","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Université de Montréal","funders":"","keywords":"Stem cell; Biology; Haematopoiesis; Cell biology; Hematopoietic stem cell; Gene expression profiling; Cellular differentiation; Context (archaeology); Genetics; Gene expression; Gene","score_opus":0.03810562865189869,"score_gpt":0.29635357189884814,"score_spread":0.25824794324694944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558443141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99518335,0.00007038279,0.0018882246,0.00024045137,0.000058224596,0.0005095652,0.000022475548,0.0000483353,0.0019789715],"genre_scores_gemma":[0.99646086,0.000007640488,0.00087813276,0.00009297926,0.00013429385,0.00002908867,0.000008656211,0.000027633829,0.0023607085],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99863136,0.000039172646,0.00018224257,0.0002704058,0.00059962436,0.00027720915],"domain_scores_gemma":[0.9990638,0.00015835823,0.000056991976,0.00034929972,0.00013364034,0.0002379476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021894438,0.0001331424,0.00031776226,0.0001783977,0.00006659344,0.000005418861,0.00011532835,0.00009420496,0.00012060231],"category_scores_gemma":[0.000052538027,0.000117155345,0.000121138786,0.0003775541,0.00007810118,0.000058648486,0.00011536604,0.00024806804,0.0002003163],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003181157,0.0014453618,0.021506492,0.00026487553,0.00013051042,0.00011229577,0.00027985423,0.0000069951743,0.97217727,0.00001974613,0.003355886,0.00038257983],"study_design_scores_gemma":[0.0046812836,0.00040477814,0.32650343,0.000062384715,0.00010416478,0.00034656777,0.00004074528,0.000030337704,0.6675315,0.0000020286,0.00018830271,0.000104484156],"about_ca_topic_score_codex":0.00013538875,"about_ca_topic_score_gemma":0.000004230327,"teacher_disagreement_score":0.30499694,"about_ca_system_score_codex":0.00008466276,"about_ca_system_score_gemma":0.00028564243,"threshold_uncertainty_score":0.47774562},"labels":[],"label_agreement":null},{"id":"W2558462170","doi":"10.1182/blood.v104.11.4062.4062","title":"Incorporation of a Comprehensive Pediatric Thrombosis Program into the Multidisciplinary Care Team for Children with Congenital Heart Disease: A Prospective Cohort Study.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Congenital Heart Disease Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Stollery Children's Hospital; University of Alberta","funders":"","keywords":"Medicine; Thrombosis; Heart disease; Cohort; Pediatrics; Prospective cohort study; Referral; Venous thrombosis; Surgery; Intensive care medicine; Internal medicine; Family medicine","score_opus":0.011637524237449189,"score_gpt":0.29166447062126627,"score_spread":0.2800269463838171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558462170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817344,0.0019700117,0.000008192142,0.00016873512,0.000032582004,0.015803752,0.000113919465,0.000109137036,0.0000592987],"genre_scores_gemma":[0.9948452,0.000013951688,0.0014097065,0.00002299346,0.00019887979,0.00335518,0.00010444836,0.000037995265,0.000011638964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986193,0.000037301525,0.0002728873,0.00042515883,0.0004206029,0.0002247204],"domain_scores_gemma":[0.9985682,0.00005812628,0.00009777527,0.0003792102,0.0007466768,0.00015004423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000059664853,0.00024229997,0.00042467378,0.00008795997,0.0003009709,0.000018392384,0.00008114068,0.000038257785,0.000002647776],"category_scores_gemma":[0.000045570392,0.00015721071,0.00013993145,0.00037895128,0.00023209682,0.0000887783,0.00011896342,0.0001247493,0.000004512649],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061934046,0.0053386707,0.98598474,0.0001745799,0.0010513588,0.000007710046,0.0065164925,0.000005590464,0.00005445188,0.000009589256,0.000022466444,0.00021499749],"study_design_scores_gemma":[0.00907687,0.0048120185,0.9729865,0.00003663674,0.004648215,0.000012649337,0.007993719,0.000005973583,0.00014825849,0.00009853717,0.000002777945,0.00017780797],"about_ca_topic_score_codex":0.00015891336,"about_ca_topic_score_gemma":0.00038029568,"teacher_disagreement_score":0.013110835,"about_ca_system_score_codex":0.00008083286,"about_ca_system_score_gemma":0.00038797216,"threshold_uncertainty_score":0.6410867},"labels":[],"label_agreement":null},{"id":"W2558464910","doi":"10.1182/blood.v108.11.5222.5222","title":"Impact of Disease and Mobilizing Agents on Initial and Remobilization Failure.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Multiple myeloma; Autologous stem-cell transplantation; Internal medicine; Transplantation; Regimen; Mobilization; Population; Gastroenterology; Chemotherapy; Granulocyte colony-stimulating factor; Surgery; Apheresis; Oncology","score_opus":0.014384277948269535,"score_gpt":0.2926998192286883,"score_spread":0.2783155412804188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558464910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988607,0.00037132835,0.0000015735263,0.000055098895,0.000008748933,0.00020636014,0.000015523601,0.000011420528,0.0004692399],"genre_scores_gemma":[0.9997178,0.00006044641,0.00008078274,0.00002492654,0.000047649697,0.000010469963,0.000035595567,0.0000066483635,0.00001568727],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999625,0.000009080346,0.000093616254,0.00011861118,0.00008310594,0.00007057535],"domain_scores_gemma":[0.9997559,0.000022401051,0.000031933967,0.000092715054,0.00002022002,0.000076803335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000022297221,0.00006884955,0.000109762805,0.000039429084,0.00002258267,0.0000077885725,0.0000085514,0.000022284472,0.000016610951],"category_scores_gemma":[0.000018394609,0.000049328577,0.00003552422,0.000040746265,0.000025730573,0.00002727174,0.000010332428,0.000014357746,0.0000013267857],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011605542,0.0018072091,0.9950556,0.00004672144,0.00007676759,0.0000418467,0.000036187404,0.000007077881,0.0014221123,0.0001223992,0.00016279212,0.0011052096],"study_design_scores_gemma":[0.00448684,0.0006066867,0.99132335,0.00008934785,0.000272268,0.000012631637,0.000008518344,0.00003108166,0.0030069712,0.000091899135,0.000028548888,0.000041860058],"about_ca_topic_score_codex":0.00012240725,"about_ca_topic_score_gemma":0.000008756703,"teacher_disagreement_score":0.004370785,"about_ca_system_score_codex":0.000018763985,"about_ca_system_score_gemma":0.000029043516,"threshold_uncertainty_score":0.2011561},"labels":[],"label_agreement":null},{"id":"W2558513717","doi":"10.1182/blood.v120.21.1662.1662","title":"Identification of a Unique Autophagy Gene Expression Signature in CD34+ CML Stem/Progenitor Cells That Correlates with Clinical Response to Imatinib Mesylate","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada; Genome British Columbia; BC Cancer Agency","funders":"","keywords":"Stem cell; Autophagy; ATG5; Imatinib mesylate; Cancer research; CD34; Progenitor cell; Nilotinib; Dasatinib; Myeloid leukemia; Biology; Tyrosine-kinase inhibitor; Haematopoiesis; Imatinib; Medicine; Tyrosine kinase; Internal medicine; Apoptosis; Cell biology; Cancer; Genetics; Receptor","score_opus":0.0215117853545327,"score_gpt":0.30171182606775976,"score_spread":0.28020004071322707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558513717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99751234,0.0007903751,0.00010187716,0.00010809403,0.00022153014,0.0011406102,0.000027130527,0.000058594724,0.000039465125],"genre_scores_gemma":[0.9954957,0.000050646235,0.0033482942,0.00006599117,0.00011147369,0.000103190476,0.000024735371,0.000044342032,0.0007556307],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99794275,0.00036227802,0.00064783177,0.00034805475,0.0003591699,0.00033991013],"domain_scores_gemma":[0.99839115,0.0003388271,0.00031096567,0.0006095197,0.00009457483,0.00025496178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010943637,0.00021618992,0.00046090086,0.00016709673,0.000033492153,0.000010446799,0.00013645767,0.00027809117,0.00004957333],"category_scores_gemma":[0.00013597378,0.00016126517,0.00009321807,0.00026612455,0.000051912342,0.00013130916,0.0000694166,0.00031829448,0.00006680092],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035786375,0.0016217387,0.13698235,0.00008469758,0.00011913649,0.000070357346,0.0011154704,0.000012595716,0.8557797,0.000004446731,0.00012918477,0.0005016956],"study_design_scores_gemma":[0.0069609247,0.0005161704,0.12531844,0.00035512712,0.00023680554,0.000062771986,0.000110803965,0.000041276366,0.8661672,0.0000046611653,0.00009090682,0.00013491297],"about_ca_topic_score_codex":0.000015567448,"about_ca_topic_score_gemma":0.0000036807146,"teacher_disagreement_score":0.011663922,"about_ca_system_score_codex":0.0001748045,"about_ca_system_score_gemma":0.0002914096,"threshold_uncertainty_score":0.65762025},"labels":[],"label_agreement":null},{"id":"W2558529571","doi":"10.1182/blood.v126.23.3728.3728","title":"CD20 Expression Is Associated with Higher Risk of Early Relapse at 1 Year Following Chemotherapy Treatment for Adolescent and Adult Acute Lymphoblastic Leukemia Patients","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; CD20; Chemotherapy; Hematopoietic stem cell transplantation; Chemotherapy regimen; Population; Cohort; Acute lymphocytic leukemia; Transplantation; Oncology; Leukemia; Lymphoma; Lymphoblastic Leukemia","score_opus":0.01476629870494163,"score_gpt":0.25760701392729185,"score_spread":0.24284071522235023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558529571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982619,0.00009783942,0.00007538039,0.00006489691,0.00007141988,0.0010121921,0.00014925418,0.000050652383,0.00021641926],"genre_scores_gemma":[0.995727,0.000096496806,0.0012913734,0.00014070752,0.000071378374,0.000085705695,0.00009281392,0.00007888426,0.0024156172],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816346,0.00006122248,0.00030269485,0.00041645337,0.0006542949,0.00040186784],"domain_scores_gemma":[0.99857605,0.00015538899,0.0002196575,0.00034603153,0.00034972015,0.00035316948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013184547,0.0002713859,0.0005065265,0.000093250834,0.00008311046,0.000016270547,0.00009250327,0.0001908754,0.000019623869],"category_scores_gemma":[0.00019928599,0.00018445187,0.00013406631,0.00016561105,0.00007800516,0.0000781366,0.00006543655,0.000095043164,0.00001210633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009194508,0.0025864919,0.9649445,0.00010539635,0.002915727,0.00010148965,0.002669195,0.0000041371804,0.0077984994,0.0000055841815,0.008680753,0.0009937172],"study_design_scores_gemma":[0.31617475,0.018658036,0.49015254,0.0019093744,0.0048719337,0.000029525312,0.00019451861,0.0006013804,0.16563451,0.000060490056,0.001022915,0.0006900241],"about_ca_topic_score_codex":0.00012133597,"about_ca_topic_score_gemma":0.000007961149,"teacher_disagreement_score":0.47479194,"about_ca_system_score_codex":0.001700285,"about_ca_system_score_gemma":0.0005103222,"threshold_uncertainty_score":0.7521729},"labels":[],"label_agreement":null},{"id":"W2558531515","doi":"10.1182/blood.v104.11.255.255","title":"Influence of the Variable Number of Tandem Repeat and Kozak Sequence Polymorphisms in Platelet GPIbα and the C807t α2 Integrin Polymorphism in Type 1 von Willebrand Disease.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Hospital for Sick Children","funders":"","keywords":"Von Willebrand factor; Von Willebrand disease; Platelet membrane glycoprotein; Locus (genetics); Genetics; Haplotype; Genotyping; Genotype; Population; Molecular biology; Platelet; Biology; Immunology; Gene; Medicine","score_opus":0.007937358316345795,"score_gpt":0.234116162284504,"score_spread":0.2261788039681582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558531515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99601734,0.0022972403,0.000001167704,0.0006783907,0.0000229179,0.00042488598,0.000018449338,0.000007230829,0.0005323878],"genre_scores_gemma":[0.9990718,0.0005035875,0.00010847897,0.00018549732,0.000008236204,0.000013772686,0.0000050313943,0.0000120671775,0.00009155149],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990462,0.00005155187,0.00030670268,0.00022237322,0.00018444435,0.00018870027],"domain_scores_gemma":[0.9994063,0.00008517487,0.00011311275,0.00028994406,0.000035915604,0.000069595575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019045408,0.0001494807,0.00038289215,0.00005657189,0.00004351776,0.000009545288,0.00009941374,0.000078793564,0.000014904718],"category_scores_gemma":[0.00015527115,0.00008477232,0.00003591297,0.00035243016,0.00040244515,0.000088111774,0.00007285037,0.00017691041,0.000001415119],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007196469,0.00052482117,0.990158,0.000065354674,0.000095305295,0.0002331302,0.0008372378,0.000120156205,0.004588362,0.0023378583,0.0000054275597,0.0003146737],"study_design_scores_gemma":[0.025907457,0.0001465326,0.951499,0.0010389958,0.00023607184,0.00044046275,0.00008943558,0.00003862901,0.007856563,0.012534369,0.00004885278,0.00016366472],"about_ca_topic_score_codex":0.0018340738,"about_ca_topic_score_gemma":0.00016399282,"teacher_disagreement_score":0.03865906,"about_ca_system_score_codex":0.000025710113,"about_ca_system_score_gemma":0.00016764,"threshold_uncertainty_score":0.3456915},"labels":[],"label_agreement":null},{"id":"W2558541011","doi":"10.1182/blood.v114.22.3094.3094","title":"Southwest Oncology Group Study S0530: A Phase 2 Trial of Clofarabine/ Cytarabine for Relapsed/ Refractory Acute Lymphocytic Leukemia.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Clofarabine; Medicine; Internal medicine; Cytarabine; Refractory (planetary science); Gastroenterology; Oncology; Leukemia; Myeloid leukemia; Acute leukemia; Surgery; Biology","score_opus":0.04012716055413526,"score_gpt":0.38761912166545354,"score_spread":0.3474919611113183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558541011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99157524,0.00029007308,0.0002095191,0.00036368048,0.00019857885,0.004292213,0.000055371398,0.00008450725,0.0029308044],"genre_scores_gemma":[0.9946694,0.00017738277,0.00225218,0.00036560334,0.0005950707,0.00036194583,0.000102334525,0.000034176097,0.0014419217],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9973283,0.00021913007,0.00089952257,0.0005030336,0.00047315913,0.0005768724],"domain_scores_gemma":[0.997895,0.0006054912,0.00029479456,0.0006579801,0.0002465279,0.00030018153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011615865,0.0002775078,0.0014691562,0.0002652542,0.0001250064,0.00000992503,0.00024106153,0.0003297331,0.00010187946],"category_scores_gemma":[0.00068483566,0.00022601096,0.0002595732,0.00029838693,0.00020117636,0.000075690834,0.000048024398,0.00035285373,0.000032318607],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7069423,0.12809606,0.022562485,0.00040871723,0.006222775,0.0029815636,0.006199504,0.000004875984,0.07957362,0.00067110074,0.005905496,0.040431485],"study_design_scores_gemma":[0.7845085,0.19395201,0.008997176,0.00007987112,0.005303183,0.0002406201,0.0007082169,0.00032682737,0.00095278997,0.00027647443,0.0043863445,0.0002679885],"about_ca_topic_score_codex":0.00015369803,"about_ca_topic_score_gemma":0.000034795896,"teacher_disagreement_score":0.07862082,"about_ca_system_score_codex":0.0009013718,"about_ca_system_score_gemma":0.002885367,"threshold_uncertainty_score":0.92164594},"labels":[],"label_agreement":null},{"id":"W2558552995","doi":"10.1182/blood.v106.11.958.958","title":"The Efficacy of Photochemical Treatment with Amotosalen and UVA (INTERCEPT) for Inactivation of T. cruzi In Buffy Coat Platelet Components.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Trypanosoma species research and implications","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Buffy coat; Infectivity; Trypanosoma cruzi; Platelet; Parasitemia; Inoculation; Biology; Chagas disease; In vivo; In vitro; Virology; Microbiology; Andrology; Immunology; Parasite hosting; Medicine; Plasmodium falciparum; Virus; Malaria","score_opus":0.026426730029464603,"score_gpt":0.3017733108079396,"score_spread":0.275346580778475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558552995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976956,0.00011408397,0.000035374796,0.00076380634,0.000002803761,0.0009803381,0.000027144048,0.0000063236866,0.00037449365],"genre_scores_gemma":[0.99888384,0.00013133568,0.00068293756,0.000012581726,0.000030933206,0.00011819546,0.000038137372,0.000007386739,0.00009467144],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99948376,0.00001145795,0.00016927073,0.00010325954,0.00011059754,0.00012162118],"domain_scores_gemma":[0.99944997,0.00022536713,0.000055084118,0.00016277442,0.000056426838,0.00005034935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000127319845,0.00006342435,0.00015768819,0.00004351172,0.000027738683,0.000004580175,0.00004627149,0.00003080486,0.000010562013],"category_scores_gemma":[0.000054297965,0.000037682505,0.000029614295,0.000075405456,0.000117754214,0.000028552631,0.000014091609,0.00004927856,8.628374e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001037408,0.0014860674,0.0054196687,0.000035917117,0.00008413316,7.2356744e-7,0.0002796201,6.750115e-7,0.9844168,0.00011935591,0.00010859076,0.007011085],"study_design_scores_gemma":[0.009792707,0.0012689629,0.29339895,0.0000622367,0.00003993566,0.000018915236,0.00012637037,0.00007997131,0.6907807,0.000011646167,0.004382207,0.000037424583],"about_ca_topic_score_codex":0.0000731196,"about_ca_topic_score_gemma":0.00005942091,"teacher_disagreement_score":0.29363605,"about_ca_system_score_codex":0.000039011444,"about_ca_system_score_gemma":0.000039697185,"threshold_uncertainty_score":0.15366478},"labels":[],"label_agreement":null},{"id":"W2558595032","doi":"10.1182/blood.v116.21.2679.2679","title":"Risk of Treatment-Related Stomach Cancer Among Hodgkin Lymphoma Survivors","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"","keywords":"Medicine; Stomach cancer; Stomach; Cancer; Internal medicine; Odds ratio; Radiation therapy; Gastroenterology; Population","score_opus":0.0077386141037159295,"score_gpt":0.2500418968355029,"score_spread":0.24230328273178695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558595032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921625,0.00024202946,0.0000035966755,0.00010381413,0.00040183208,0.0003075735,0.000023525048,0.00007235623,0.006682721],"genre_scores_gemma":[0.99432075,0.0003214556,0.00015068233,0.000025953852,0.00010952051,0.000032679847,0.000015001548,0.000021398837,0.005002534],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991992,0.000022497929,0.00022199407,0.0001959922,0.00015680587,0.00020349333],"domain_scores_gemma":[0.9993575,0.000044352386,0.0001461179,0.00031303737,0.00004641574,0.0000925531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001027948,0.00014311926,0.00029947952,0.00012182592,0.000040721254,0.000007739143,0.000077449826,0.00008516833,0.0005805837],"category_scores_gemma":[0.00003611615,0.00010931776,0.00013999046,0.0002526029,0.000078097764,0.000043496533,0.000026552027,0.00008726846,0.000016542757],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003724793,0.0004004993,0.9743051,0.000023554769,0.00060947414,0.0000201583,0.00023902651,0.0000030626654,0.0014200641,0.000048353984,0.00015371098,0.022739748],"study_design_scores_gemma":[0.008210014,0.0002978982,0.9810237,0.000020424493,0.0014183559,0.0000070374213,0.000058384176,0.00006636162,0.0059991465,0.000022661949,0.0027786763,0.00009733048],"about_ca_topic_score_codex":0.0122253755,"about_ca_topic_score_gemma":0.005560867,"teacher_disagreement_score":0.022642419,"about_ca_system_score_codex":0.000040035095,"about_ca_system_score_gemma":0.000081276914,"threshold_uncertainty_score":0.9943523},"labels":[],"label_agreement":null},{"id":"W2558604525","doi":"10.1182/blood.v112.11.4054.4054","title":"Practical Application of the 10 Mg Warfarin Initiation Nomogram","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Nomogram; Warfarin; Medicine; Retrospective cohort study; Clinical trial; Heparin; Surgery; Internal medicine","score_opus":0.09264466842017169,"score_gpt":0.35392205788086034,"score_spread":0.2612773894606887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558604525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9771825,0.000024862351,0.0023889618,0.0053545525,0.000067418034,0.0005018378,0.0000012020827,0.000046631878,0.0144320205],"genre_scores_gemma":[0.9970221,0.0000130922135,0.0014214212,0.00010298725,0.000238151,0.0000031334748,0.000011873266,0.000005208065,0.0011820173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995452,0.000019107816,0.0001431419,0.00007458989,0.00016076479,0.000057176287],"domain_scores_gemma":[0.9996172,0.00005160882,0.00008862995,0.00017191347,0.00005025515,0.000020345435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007639742,0.000041295025,0.00008744222,0.000027292848,0.000046768506,0.0000024340275,0.000029644883,0.000035500452,0.00006114085],"category_scores_gemma":[0.00016341578,0.000028153287,0.00006330184,0.00014854925,0.000032887896,0.00004576614,0.00002567277,0.000043185926,0.000047080473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058106816,0.0000931885,0.9884563,0.00003246032,0.000047707785,0.0000026843377,0.00009959184,0.0000044540548,0.003976337,0.0047112512,0.00095176965,0.0015661503],"study_design_scores_gemma":[0.001738226,0.00005631945,0.96071136,0.000007287779,0.0002039828,0.000027383363,0.00002364014,0.00022578801,0.009175412,0.00011882064,0.027664835,0.000046942045],"about_ca_topic_score_codex":0.000008492304,"about_ca_topic_score_gemma":0.0000014873142,"teacher_disagreement_score":0.027744936,"about_ca_system_score_codex":0.000006183476,"about_ca_system_score_gemma":0.000028439577,"threshold_uncertainty_score":0.11480577},"labels":[],"label_agreement":null},{"id":"W2558604928","doi":"10.1182/blood.v120.21.2526.2526","title":"Genome-Wide Genotype-Based Risk Model for Survival in Acute Myeloid Leukemia Patients with Normal Karyotype.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Single-nucleotide polymorphism; Proportional hazards model; Minor allele frequency; SNP; Oncology; Myeloid leukemia; Biology; Genome-wide association study; Genotype; Linkage disequilibrium; Internal medicine; Tag SNP; Genetics; Medicine; Gene","score_opus":0.014540412130725051,"score_gpt":0.2499428317118142,"score_spread":0.23540241958108915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558604928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904303,0.00017198827,0.0064197206,0.00010776193,0.00007953406,0.0014495808,0.00020264521,0.000077143384,0.001061348],"genre_scores_gemma":[0.98462653,0.000038328337,0.013313881,0.00032143158,0.00022756563,0.00018630321,0.00044527542,0.00010849441,0.0007321716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99748015,0.0000789518,0.00036530718,0.00039931844,0.00060190586,0.0010743884],"domain_scores_gemma":[0.99840266,0.00022540169,0.00012605969,0.00056781305,0.00025595867,0.0004221297],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005800976,0.00031086322,0.00047946422,0.00027257405,0.00011944778,0.00002045453,0.00024445305,0.00020521472,0.00005973979],"category_scores_gemma":[0.00023015954,0.0002503718,0.000118638505,0.0003608852,0.00010119686,0.00022800558,0.0000918106,0.00054728484,0.00010122052],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023269,0.00092816766,0.99347055,0.00009815197,0.00029318617,0.000015473188,0.00035509764,0.0009980054,0.00084308325,0.000021802927,0.0001793251,0.00047026697],"study_design_scores_gemma":[0.026234265,0.0007223586,0.9542054,0.000039050654,0.00061312213,0.0000058274986,0.000028553974,0.014707274,0.0023684923,0.000024023022,0.00067810254,0.00037352255],"about_ca_topic_score_codex":0.00014159051,"about_ca_topic_score_gemma":0.000098492725,"teacher_disagreement_score":0.039265133,"about_ca_system_score_codex":0.00057020533,"about_ca_system_score_gemma":0.0010121966,"threshold_uncertainty_score":0.9999949},"labels":[],"label_agreement":null},{"id":"W2558613112","doi":"10.1182/blood.v122.21.4628.4628","title":"Donor-Recipient Matching For Killer Immunoglobulin-Like Receptor Genotypes Confers Protection Against Graft Versus Host Disease Without Affecting Disease Relapse After Allogeneic Hematopoietic Cell Transplantation","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Foothills Medical Centre; Calgary Laboratory Services; Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Transplantation; Immunology; Hematopoietic stem cell transplantation; Human leukocyte antigen; Graft-versus-host disease; Disease; Genotype; Medicine; Biology; Internal medicine; Oncology; Gene; Antigen; Genetics","score_opus":0.009304234948543018,"score_gpt":0.2124337396459537,"score_spread":0.20312950469741067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558613112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859136,0.001721329,0.0026038766,0.0002476813,0.0070659663,0.0020625093,0.00003130465,0.0001846182,0.00016915712],"genre_scores_gemma":[0.9938317,0.0002177837,0.00018733933,0.00018540274,0.00009907609,0.0011875808,0.0006862564,0.00005935441,0.0035455362],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983622,0.00020544628,0.0004195326,0.00050289894,0.000071613176,0.0004383062],"domain_scores_gemma":[0.99910575,0.00009717364,0.00021779057,0.0003215777,0.00015719638,0.00010051783],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016074767,0.000332624,0.00025863745,0.0001400842,0.00041227377,0.00008227682,0.000131228,0.00019240541,0.00085327885],"category_scores_gemma":[0.000052519303,0.0003111752,0.00025114295,0.00009697139,0.000077889934,0.00033001543,0.00003199993,0.00031115208,0.00117773],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008837753,0.00091790844,0.0031406495,0.00041272884,0.00045345913,0.000006721238,0.0015997218,0.00009175971,0.9823003,0.000018139792,0.001025231,0.0011956573],"study_design_scores_gemma":[0.06273648,0.0027956564,0.12958795,0.0015131526,0.0051184194,0.0000933023,0.0048197545,0.00013694851,0.7142815,0.00019299198,0.07480347,0.0039203605],"about_ca_topic_score_codex":0.00010595774,"about_ca_topic_score_gemma":0.000018236624,"teacher_disagreement_score":0.26801875,"about_ca_system_score_codex":0.00008314083,"about_ca_system_score_gemma":0.00007363381,"threshold_uncertainty_score":0.999934},"labels":[],"label_agreement":null},{"id":"W2558624453","doi":"10.1182/blood.v110.11.4152.4152","title":"SOCS2 Expression in AML: A Context Dependent Effect?.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"SOCS2; SOCS3; Suppressor of cytokine signaling 1; Cytokine; Suppressor of cytokine signalling; Cancer research; Biology; Signal transduction; Context (archaeology); Suppressor; Gene; Immunology; STAT3; Cell biology; Genetics","score_opus":0.013892200442541119,"score_gpt":0.28635659252242807,"score_spread":0.27246439207988693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558624453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913541,0.00043899345,0.0005460906,0.00007491611,0.00015169049,0.0002214,0.0000022623967,0.000047361784,0.007163181],"genre_scores_gemma":[0.9991479,0.0000084129515,0.00016577955,0.00019506297,0.00017456742,0.000012106339,0.0000068530608,0.0000130824865,0.00027626802],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993086,0.000019241988,0.00018389727,0.00015397473,0.00015411334,0.00018016365],"domain_scores_gemma":[0.9996068,0.000107004256,0.000033071025,0.00014346778,0.000027695867,0.000081949045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028316,0.00008363024,0.00017094157,0.00010782769,0.000031461954,0.000008155686,0.00003400593,0.000060579878,0.00022550652],"category_scores_gemma":[0.00010192217,0.00006619969,0.00008326911,0.00008724278,0.000013376872,0.000038391143,0.0000209183,0.00019359597,0.00007705957],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020417657,0.000765176,0.038214866,0.00003874613,0.00003517716,0.00027445835,0.00026404203,0.0000013110193,0.9481992,0.00003490967,0.00036310963,0.01160479],"study_design_scores_gemma":[0.0043745185,0.00045418512,0.023356609,0.0002738545,0.00006276902,0.00012497818,0.00013761353,0.000012077906,0.9656873,0.000012371962,0.0054276357,0.00007610297],"about_ca_topic_score_codex":0.000091138805,"about_ca_topic_score_gemma":0.00010261462,"teacher_disagreement_score":0.017488046,"about_ca_system_score_codex":0.000025846608,"about_ca_system_score_gemma":0.000021299807,"threshold_uncertainty_score":0.26995447},"labels":[],"label_agreement":null},{"id":"W2558638322","doi":"10.1182/blood.v120.21.1867.1867","title":"Secondary Myelodysplastic Syndrome/Acute Myeloblastic Leukemia During Lenalidomide-Based Regimens in Relapsed and/or Refractory Multiple Myeloma Patients: Single Center Experience","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lenalidomide; Multiple myeloma; Internal medicine; Cyclophosphamide; Melphalan; Prednisone; Surgery; Oncology; Gastroenterology; Chemotherapy","score_opus":0.016737049798718855,"score_gpt":0.25496423057625867,"score_spread":0.23822718077753982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558638322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99793273,0.00033383563,0.000017635643,0.00003814472,0.00019551624,0.0008922135,0.00008159341,0.00010899113,0.00039934542],"genre_scores_gemma":[0.99786365,0.000036792568,0.00095125154,0.00011698425,0.00009515175,0.00020413433,0.00013401567,0.00007767388,0.00052036566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969628,0.00014302757,0.0005662966,0.00059374486,0.0005908785,0.0011432801],"domain_scores_gemma":[0.998008,0.00048351055,0.00016221152,0.0005194129,0.00010397043,0.0007228834],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015583295,0.00042643354,0.00058169116,0.00040609163,0.00018135966,0.000042789747,0.00014907055,0.00019218471,0.00026771342],"category_scores_gemma":[0.0008259723,0.00034479232,0.000110493485,0.00034471732,0.00019704679,0.0003597681,0.00013822428,0.0004718575,0.00009574204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034390707,0.004902273,0.96777976,0.0003538042,0.00029595298,0.0018487602,0.00094582245,0.0000039930005,0.019200563,0.0000029131236,0.000040009378,0.0011870929],"study_design_scores_gemma":[0.048985552,0.0015510531,0.928808,0.00070762436,0.000182841,0.0006835852,0.00016147886,0.00015151342,0.018105889,0.0000018041594,0.00028190066,0.00037877558],"about_ca_topic_score_codex":0.000069258684,"about_ca_topic_score_gemma":0.00005706296,"teacher_disagreement_score":0.04554648,"about_ca_system_score_codex":0.0005640401,"about_ca_system_score_gemma":0.00025686252,"threshold_uncertainty_score":0.9999004},"labels":[],"label_agreement":null},{"id":"W2558641380","doi":"10.1182/blood.v120.21.2793.2793","title":"Baseline Predictors of Response to Bosutinib in Patients with Chronic Phase Chronic Myeloid Leukemia Following Resistance or Intolerance to Imatinib Plus Dasatinib and/or Nilotinib.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Nilotinib; Dasatinib; Bosutinib; Medicine; Internal medicine; Imatinib; Gastroenterology; Myeloid leukemia; Tolerability; Imatinib mesylate; Tyrosine-kinase inhibitor; Oncology; Adverse effect; Cancer","score_opus":0.0127938758954647,"score_gpt":0.2793898243812088,"score_spread":0.2665959484857441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558641380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946289,0.0011923665,0.00011799837,0.00026033638,0.0002400143,0.0030795126,0.00016300341,0.00011648329,0.00020135676],"genre_scores_gemma":[0.9914609,0.00003645243,0.0059509045,0.0002817021,0.0003709143,0.00035268575,0.00009628177,0.00012589319,0.0013242721],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958278,0.00027081932,0.0011094349,0.00080005627,0.0008695428,0.0011223272],"domain_scores_gemma":[0.9971271,0.0006017371,0.000323159,0.0010168435,0.00014830954,0.00078283896],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011966623,0.00058882544,0.0011275626,0.00042890036,0.00011141192,0.000022856195,0.000273444,0.0001883412,0.00019307023],"category_scores_gemma":[0.0012917889,0.00043400095,0.0001164874,0.0011478593,0.00010666704,0.0003049139,0.00017883307,0.00036941966,0.00004008293],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19167262,0.008210438,0.7465538,0.0024358283,0.0014599797,0.00051630335,0.01193019,0.00027019455,0.02186818,0.00002769173,0.0017985638,0.013256259],"study_design_scores_gemma":[0.23460995,0.020170758,0.6889498,0.0073313615,0.0011506503,0.00006352225,0.00030934086,0.00021212923,0.035274792,0.00000198681,0.010689078,0.0012366126],"about_ca_topic_score_codex":0.00010764002,"about_ca_topic_score_gemma":0.00080805266,"teacher_disagreement_score":0.05760393,"about_ca_system_score_codex":0.0037189345,"about_ca_system_score_gemma":0.0035491972,"threshold_uncertainty_score":0.9998112},"labels":[],"label_agreement":null},{"id":"W2558654705","doi":"10.1182/blood.v116.21.4516.4516","title":"The Use of Intravenous Antibiotics at the Onset of Neutropenia In Patients Receiving Hematopoietic Stem Cell Transplants: A Pre-Emptive Strategy.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Neutropenia; Hematopoietic stem cell transplantation; Febrile neutropenia; Internal medicine; Retrospective cohort study; Surgery; Transplantation; Chemotherapy","score_opus":0.015898442997402763,"score_gpt":0.23653022502384374,"score_spread":0.220631782026441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558654705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99847883,0.0000661662,0.000003763377,0.00007252301,0.00013468678,0.00063836726,0.00007280485,0.0000101394,0.00052270177],"genre_scores_gemma":[0.9994225,0.00015339299,0.000031474792,0.000031170366,0.000020010586,0.000004702038,0.00000833745,0.000018354434,0.00031003772],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900365,0.000078271296,0.00036111186,0.00015803771,0.00019832225,0.00020063511],"domain_scores_gemma":[0.9990472,0.00021876206,0.00016918736,0.0004116713,0.00010190428,0.000051262814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013890828,0.000121721736,0.00024782465,0.00004151649,0.00010192404,0.000017461562,0.00013662736,0.00007452529,0.000030149791],"category_scores_gemma":[0.000013296361,0.0000707937,0.000073169416,0.00018671862,0.00017008948,0.000056488912,0.000033512155,0.00032762202,0.0000048305087],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094850996,0.0035107234,0.88417166,0.00042822614,0.00020287454,0.00003000419,0.0052274372,0.00009152461,0.10228105,0.00017106794,0.0002484834,0.0026884263],"study_design_scores_gemma":[0.0036437379,0.0008945069,0.7260481,0.00022414647,0.0003356351,0.00006149026,0.00025939426,0.000008393685,0.26806664,0.000013605884,0.00033618984,0.00010815442],"about_ca_topic_score_codex":0.00016322974,"about_ca_topic_score_gemma":0.0014122876,"teacher_disagreement_score":0.1657856,"about_ca_system_score_codex":0.000017286518,"about_ca_system_score_gemma":0.00010081859,"threshold_uncertainty_score":0.28868833},"labels":[],"label_agreement":null},{"id":"W2558668705","doi":"10.1182/blood.v112.11.1293.1293","title":"The Cost of HIT-Safe Anticoagulant Use at a Tertiary Care, Adult, Academic Hospital.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Heparin-induced thrombocytopenia; Pharmacy; Adverse effect; Emergency medicine; Heparin; Internal medicine; Surgery; Family medicine","score_opus":0.029129954075963842,"score_gpt":0.27305570821893843,"score_spread":0.2439257541429746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558668705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99602526,0.0008612754,0.0000036336287,0.00070489355,0.00020505187,0.00071150326,0.000027221136,0.000059294747,0.0014018583],"genre_scores_gemma":[0.9962004,0.0024914287,0.00016106463,0.0003310045,0.00013945454,0.00003856248,0.000028242199,0.00003899876,0.0005708729],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984352,0.000055908837,0.0004368354,0.0003096453,0.00034721862,0.00041517348],"domain_scores_gemma":[0.9986658,0.00017161085,0.00014500503,0.0006141859,0.00020061599,0.00020279025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009137165,0.00021351954,0.00045951476,0.00006263642,0.00027166994,0.000009786505,0.00022404257,0.00019970103,0.000034067045],"category_scores_gemma":[0.00026056226,0.00014408516,0.0001679805,0.0001734407,0.0002600977,0.00011076051,0.00016364966,0.0003644369,0.000113377515],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058626818,0.0004443099,0.92663056,0.00008552981,0.00030458285,0.00016526185,0.0015941081,4.5748547e-7,0.06836308,0.00019901902,0.00133865,0.0008158473],"study_design_scores_gemma":[0.0030796407,0.00024787066,0.8430784,0.00016175365,0.00043187378,0.0003076626,0.00019315479,0.000009747998,0.1491046,0.000011337617,0.0031949705,0.00017902452],"about_ca_topic_score_codex":0.00024197981,"about_ca_topic_score_gemma":0.00003849136,"teacher_disagreement_score":0.08355217,"about_ca_system_score_codex":0.000063011394,"about_ca_system_score_gemma":0.00015052542,"threshold_uncertainty_score":0.5875622},"labels":[],"label_agreement":null},{"id":"W2558690058","doi":"10.1182/blood.v120.21.268.268","title":"Ivig, but Not a Monoclonal Anti-RBC Antibody, Requires the Presence of Gr-1+ Cells to Ameliorate Immune Thrombocytopenia in a Murine Model","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services","funders":"","keywords":"Immunology; Medicine; Antibody; Monoclonal antibody; Immune system; Neutropenia; Platelet; Chemotherapy; Internal medicine","score_opus":0.02606720497871875,"score_gpt":0.29779154574912486,"score_spread":0.27172434077040614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558690058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970757,0.00077882456,0.000050939478,0.0005843464,0.000072344825,0.0006396772,0.000048326623,0.000021475249,0.0007283836],"genre_scores_gemma":[0.99772507,0.00027936633,0.0012224499,0.00018560562,0.000044823566,0.00003424065,0.000019138835,0.000023763096,0.00046556897],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986715,0.000040680607,0.00034740262,0.0002262842,0.00028115886,0.0004330272],"domain_scores_gemma":[0.99921227,0.00006015216,0.000104010636,0.00044306845,0.000055253146,0.0001252467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022111156,0.00019275538,0.00053920713,0.000100435165,0.00005056664,0.000012772741,0.00018948474,0.00007020861,0.000031853153],"category_scores_gemma":[0.00004683242,0.000116770636,0.00008935682,0.00022144362,0.00007818419,0.0001594427,0.00014704186,0.00014555488,0.000054724787],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030364367,0.0035543593,0.061410796,0.00009297494,0.00022117887,0.00021369451,0.0012851398,0.0002734859,0.9317868,0.00019637478,0.00014264956,0.00051891914],"study_design_scores_gemma":[0.006691247,0.0004137264,0.24229091,0.00028067201,0.0003136591,0.00012762925,0.00018771167,0.0019284181,0.7471819,0.00016737594,0.00015877873,0.00025795028],"about_ca_topic_score_codex":0.00069331727,"about_ca_topic_score_gemma":0.000036377773,"teacher_disagreement_score":0.18460487,"about_ca_system_score_codex":0.000015948568,"about_ca_system_score_gemma":0.00007364734,"threshold_uncertainty_score":0.47617683},"labels":[],"label_agreement":null},{"id":"W2558695084","doi":"10.1182/blood.v124.21.4037.4037","title":"Exogenous Apo-Transferrin Increases Monoferric Transferrin, Decreasing Cytosolic Iron Uptake and Heme and Globin Synthesis in β-Thalassemic Mice","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Ineffective erythropoiesis; Erythropoiesis; Chemistry; Transferrin saturation; Thalassemia; Anemia; Hemoglobin; Transferrin; Internal medicine; Biochemistry; Endocrinology; Iron deficiency; Biology; Medicine","score_opus":0.0075817167161826736,"score_gpt":0.21239113513072008,"score_spread":0.2048094184145374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558695084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917849,0.0050161337,0.000068333975,0.00042882503,0.000035175326,0.00051123294,0.000016203556,0.000103574166,0.0020356213],"genre_scores_gemma":[0.9954538,0.003571841,0.0005003,0.00026589673,0.00006301286,0.000040771396,0.00001288497,0.00005776299,0.000033745837],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99813867,0.00014127606,0.00044552208,0.0005267853,0.00021675747,0.0005309717],"domain_scores_gemma":[0.99906594,0.00022131336,0.000040425555,0.00028034946,0.0000320114,0.00035993592],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032713468,0.000343832,0.000586608,0.0002352622,0.00012915103,0.000037938516,0.00009929991,0.00030136458,0.000030489166],"category_scores_gemma":[0.0002107229,0.0003098433,0.00008838999,0.00028340388,0.00014309608,0.000095888005,0.00003136407,0.00031703786,0.000008970101],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013557946,0.006270596,0.4365883,0.0026402387,0.00063767383,0.0008070076,0.0047386666,0.000033912045,0.43603638,0.00082750065,0.00008815081,0.10997577],"study_design_scores_gemma":[0.03849118,0.0027738544,0.8447362,0.0043121725,0.0048531285,0.009153074,0.004514471,0.0026631588,0.08137761,0.000927636,0.0035239318,0.002673564],"about_ca_topic_score_codex":0.0018663587,"about_ca_topic_score_gemma":0.00043540268,"teacher_disagreement_score":0.40814793,"about_ca_system_score_codex":0.00003703784,"about_ca_system_score_gemma":0.00007654129,"threshold_uncertainty_score":0.9999354},"labels":[],"label_agreement":null},{"id":"W2558706989","doi":"10.1182/blood.v110.11.2606.2606","title":"Gene Expression Model of Survival and Transformation in Follicular Lymphoma (FL): A Study by the LLMPP.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Bioconductor; Follicular lymphoma; Proportional hazards model; Survival analysis; Medicine; Oncology; Internal medicine; Biopsy; Gene expression profiling; Lymphoma; Gene expression; Gene; Biology; Genetics","score_opus":0.016335822115357,"score_gpt":0.25679401171520677,"score_spread":0.24045818959984977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558706989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99770826,0.0008133553,0.00020625719,0.00009777574,0.000014377679,0.0005750817,0.000008376767,0.000009400007,0.0005671438],"genre_scores_gemma":[0.9995954,0.00009830472,0.0001934082,0.00002954824,0.000012384302,0.00003411242,0.000011297346,0.0000069242265,0.000018619361],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993266,0.000025561172,0.00021346932,0.00011437112,0.00020387393,0.00011611988],"domain_scores_gemma":[0.99970233,0.000042989876,0.0000397807,0.00014820955,0.000021892387,0.000044764587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002875866,0.00008337472,0.00017398498,0.000040370287,0.00003250495,0.0000053684053,0.00003341633,0.000039380582,0.0000025790332],"category_scores_gemma":[0.00000873106,0.000049674654,0.00003541299,0.000080878555,0.000017732817,0.00004253206,0.000012008284,0.000020715872,7.687033e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005887257,0.026416704,0.76256204,0.00010024724,0.00032342452,0.00011800844,0.013311975,0.00007132638,0.16247092,0.000153622,0.000119911296,0.033763085],"study_design_scores_gemma":[0.027475253,0.000594466,0.36384785,0.000069110385,0.00031783598,0.000028852342,0.0018823039,0.0007331991,0.6048662,0.000048608046,0.000041319156,0.000095014155],"about_ca_topic_score_codex":0.00015238031,"about_ca_topic_score_gemma":0.000058601032,"teacher_disagreement_score":0.44239527,"about_ca_system_score_codex":0.000024895695,"about_ca_system_score_gemma":0.000023257298,"threshold_uncertainty_score":0.20256735},"labels":[],"label_agreement":null},{"id":"W2558712894","doi":"10.1182/blood.v116.21.1286.1286","title":"Recovery of Functional EBV Specific T Cells Is Not Impaired In Patients with Chronic Gvhd.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Calgary","funders":"","keywords":"Immunology; Medicine; CD8; Peripheral blood mononuclear cell; Virus; Immune system; Biology; In vitro","score_opus":0.016248832845871537,"score_gpt":0.24025061160506755,"score_spread":0.22400177875919602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558712894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99707854,0.000074187104,0.000004057523,0.00011057227,0.00015215344,0.00033219822,0.00005292857,0.000013207793,0.0021821384],"genre_scores_gemma":[0.9985993,0.00004086714,0.00016385652,0.00009006554,0.00018797477,0.000011523569,0.000027208258,0.000021475773,0.00085775316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884117,0.000013904018,0.00021790576,0.00022654366,0.00044840534,0.00025204933],"domain_scores_gemma":[0.999365,0.000042491192,0.000056754103,0.00031061366,0.00011995081,0.00010520814],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014029483,0.000108445616,0.00023181531,0.00017834945,0.000029156132,0.000011451397,0.00007143872,0.00009724044,0.0042574117],"category_scores_gemma":[0.000014070216,0.00008402089,0.00006579346,0.00021558718,0.000077201585,0.00006495201,0.00003449625,0.00036138357,0.00015321],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00295973,0.004352017,0.7296929,0.00020522976,0.00019235436,0.0000430459,0.0001833476,0.0000062791773,0.23266594,0.000054068692,0.006262219,0.023382876],"study_design_scores_gemma":[0.0089425985,0.0009770659,0.87668484,0.000034750905,0.000028770526,0.0000033761498,0.0000065223967,0.000009070226,0.10049075,0.000012063368,0.012710352,0.00009986052],"about_ca_topic_score_codex":0.00010914078,"about_ca_topic_score_gemma":0.00019431734,"teacher_disagreement_score":0.14699192,"about_ca_system_score_codex":0.000047440764,"about_ca_system_score_gemma":0.00025306264,"threshold_uncertainty_score":0.99665284},"labels":[],"label_agreement":null},{"id":"W2558739263","doi":"10.1182/blood.v104.11.2552.2552","title":"FLT3 Expression Is Increased by MEIS1 and Collaborates with NUP98-HOX Fusion Genes in the Induction of Acute Myeloid Leukemia.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Hox gene; Biology; Cell culture; Fusion gene; Cancer research; Myeloid; Myeloid leukemia; Cell biology; Transcription factor; Genetics; Gene","score_opus":0.009865528840342657,"score_gpt":0.25539101980702505,"score_spread":0.24552549096668239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558739263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99621254,0.0011709628,0.000025601023,0.0014908557,0.000017460045,0.00066346594,0.000048174898,0.000028521132,0.00034241317],"genre_scores_gemma":[0.99630016,0.0014303869,0.0015687275,0.000334135,0.00008658607,0.000060061615,0.00007326756,0.000028944933,0.00011770567],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985271,0.00010383749,0.00025782394,0.00031997648,0.00052172283,0.00026953302],"domain_scores_gemma":[0.99916726,0.00007251861,0.00010914791,0.0003737642,0.00016797693,0.00010930224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000348633,0.00018422917,0.00031508712,0.00016437467,0.0000977698,0.00002569864,0.00015394473,0.00016715426,0.000032488293],"category_scores_gemma":[0.000049627834,0.00011031,0.000028647199,0.0007273458,0.00017159562,0.0001479197,0.00007547041,0.00032098262,0.0000060268953],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000653559,0.00038249363,0.016211648,0.00008912531,0.000098954195,0.00008912586,0.0016170834,0.0000041245485,0.9779756,0.000018048315,0.0016284207,0.0012318345],"study_design_scores_gemma":[0.011848489,0.000814024,0.025543792,0.00030292058,0.00023455328,0.00024814793,0.0011973948,0.000021682536,0.958585,0.00006645824,0.0009899642,0.00014752499],"about_ca_topic_score_codex":0.00078116154,"about_ca_topic_score_gemma":0.00003491516,"teacher_disagreement_score":0.019390535,"about_ca_system_score_codex":0.00016798967,"about_ca_system_score_gemma":0.0006843784,"threshold_uncertainty_score":0.44983113},"labels":[],"label_agreement":null},{"id":"W2558740236","doi":"10.1182/blood.v112.11.5370.5370","title":"Palmitoylation Augments the Association of Tetraspanin CD63 with the αIIbβ3-CD9 Complex and the Actin Cytoskeleton in Thrombin-Activated Platelets","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Tetraspanin; Palmitoylation; Cell biology; Immunoprecipitation; Biology; Platelet activation; Cytoskeleton; Actin cytoskeleton; Platelet; Biochemistry; Cysteine; Cell; Immunology","score_opus":0.014098952995945527,"score_gpt":0.22949762405085164,"score_spread":0.21539867105490612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558740236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99399585,0.00015933723,0.000005553136,0.003098043,0.000020948059,0.00073535426,0.0000071837744,0.00001735103,0.0019603989],"genre_scores_gemma":[0.99927545,0.00020742191,0.000037157704,0.0001694715,0.000020992125,0.000031064617,0.000033677956,0.000014323644,0.00021044578],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990116,0.00012754377,0.00019454867,0.00015510203,0.0003231359,0.00018810901],"domain_scores_gemma":[0.9991724,0.00033574755,0.00021622257,0.00019797073,0.000051029874,0.00002662854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024123116,0.00013622195,0.00028831002,0.00003903,0.00019544798,0.000012608526,0.00007762911,0.00007212066,0.000020458936],"category_scores_gemma":[0.0000682613,0.00005833913,0.000041480023,0.00025447726,0.00013942161,0.000076024866,0.000022679931,0.00019343142,0.0000036167098],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023518528,0.0030297886,0.8944552,0.000069327005,0.0022653607,0.00028953823,0.009368827,0.000055045486,0.082050286,0.00045251634,0.0014630868,0.0041491496],"study_design_scores_gemma":[0.020500064,0.00029439188,0.9583226,0.00005151621,0.00027562748,0.00021237246,0.00066838594,0.00009915759,0.019090367,0.00013215067,0.0002611473,0.000092218674],"about_ca_topic_score_codex":0.00036864282,"about_ca_topic_score_gemma":0.00020907207,"teacher_disagreement_score":0.063867375,"about_ca_system_score_codex":0.00004643677,"about_ca_system_score_gemma":0.000054626307,"threshold_uncertainty_score":0.23790006},"labels":[],"label_agreement":null},{"id":"W2558755097","doi":"10.1182/blood.v106.11.1637.1637","title":"Factor XIII Val34Leu Polymorphism and the Risk of Myocardial Infarction: A Meta-Analysis.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Blood properties and coagulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Myocardial infarction; Odds ratio; Medicine; Meta-analysis; Internal medicine; Genotype; Factor XIII; Genotyping; Confidence interval; Publication bias; Gastroenterology; Genetics; Biology; Fibrinogen","score_opus":0.031170099492841614,"score_gpt":0.2432307522667113,"score_spread":0.21206065277386968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558755097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.979324,0.013187095,0.00011124113,0.0054571126,0.000031094452,0.00028751045,0.000024505247,0.000026195805,0.0015512382],"genre_scores_gemma":[0.9981286,0.00021453123,0.00035218798,0.0004974924,0.00022282937,0.000027622484,0.000004759807,0.000007905762,0.00054408977],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9991838,0.000103328966,0.0002441567,0.00014527077,0.00022269269,0.00010077598],"domain_scores_gemma":[0.9994122,0.00006296057,0.00012441257,0.00028539027,0.000064422326,0.000050638886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024164902,0.00009908181,0.0005857894,0.000072596595,0.00006964489,0.000012569154,0.000044117885,0.000056089237,0.00044667823],"category_scores_gemma":[0.000047360692,0.00005060079,0.0006559128,0.0002112406,0.00009801856,0.000052010928,0.000029392355,0.00011013202,0.000007855806],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011704039,0.0009858343,0.12978354,0.000058561192,0.8462468,0.0000046897107,0.0035965052,0.0002836525,0.0023102756,0.0019243591,0.0005596026,0.013075787],"study_design_scores_gemma":[0.007049538,0.00016552309,0.23763576,0.0000023821267,0.74453753,0.000034038185,0.000081235026,0.00060347386,0.004005009,0.0001386075,0.0056227585,0.00012411033],"about_ca_topic_score_codex":0.00033409303,"about_ca_topic_score_gemma":0.000031001477,"teacher_disagreement_score":0.10785222,"about_ca_system_score_codex":0.0000039640527,"about_ca_system_score_gemma":0.000021724172,"threshold_uncertainty_score":0.48908132},"labels":[],"label_agreement":null},{"id":"W2558759353","doi":"10.1182/blood.v108.11.3256.3256","title":"Development of Improved Lentiviral ‘Suicide’ Gene Therapy for the Management of GvHD and GvL/GvT Responses in Allogeneic BMT.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Suicide gene; Cytotoxic T cell; Genetic enhancement; Cancer research; CD8; Prodrug; Immunology; Immune system; Transplantation; Gemcitabine; Biology; Cancer; Medicine; Pharmacology; Internal medicine; In vitro; Gene","score_opus":0.02256971369725846,"score_gpt":0.29526355587177816,"score_spread":0.2726938421745197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558759353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99242353,0.006532016,0.00027208767,0.000065679335,0.000018725159,0.000596056,0.000017341845,0.0000028206082,0.00007171941],"genre_scores_gemma":[0.9931328,0.0008672821,0.0054656873,0.000038810795,0.00002971551,0.00013276585,0.00002778088,0.000017481112,0.00028761968],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99915624,0.000051491268,0.00025841896,0.0002185056,0.00011448074,0.00020084644],"domain_scores_gemma":[0.99956185,0.00003096285,0.00007625453,0.00026421848,0.00004916555,0.000017542117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046808648,0.000109210414,0.00012750093,0.00005247557,0.00004479702,0.0000068825166,0.000185909,0.00006106305,0.000006088297],"category_scores_gemma":[0.00000672975,0.00008234173,0.000052931755,0.00007775996,0.000081328944,0.0000017037876,0.00008370924,0.000033610537,2.6155854e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020096076,0.00029621762,0.0030883676,0.0000378348,0.00022227548,0.0000012147383,0.000039544473,0.000011117258,0.97033834,0.000017022918,0.000017506281,0.023920966],"study_design_scores_gemma":[0.0029798825,0.00070594903,0.03919723,0.0000075464195,0.000017812621,0.0000011438195,0.000052496067,0.000009434646,0.9556521,0.000042725103,0.001244121,0.00008956669],"about_ca_topic_score_codex":0.000026468024,"about_ca_topic_score_gemma":0.00026455562,"teacher_disagreement_score":0.036108863,"about_ca_system_score_codex":0.0000058804108,"about_ca_system_score_gemma":0.000074780815,"threshold_uncertainty_score":0.33577985},"labels":[],"label_agreement":null},{"id":"W2558772309","doi":"10.1182/blood.v104.11.4030.4030","title":"Retrospective Audit of a Factor VIII Continuous Infusion Protocol to Examine Inhibitor Formation, Complications and Product Use.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Retrospective cohort study; Surgery; Factor IX; Adverse effect; Pediatrics; Internal medicine","score_opus":0.0315044479848923,"score_gpt":0.3113705032307544,"score_spread":0.27986605524586206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558772309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9548221,0.000009124335,0.000043539363,0.0018258919,0.000009826141,0.042669073,0.000029054043,0.0000370688,0.000554302],"genre_scores_gemma":[0.98587245,0.0000034645504,0.0013812016,0.00004626641,0.00007659762,0.012271959,0.000020128602,0.000011059767,0.00031686822],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99921197,0.000015404548,0.00021144479,0.00018684145,0.0002303955,0.00014394357],"domain_scores_gemma":[0.9992624,0.00001788377,0.00006140943,0.00023375584,0.00030386436,0.00012072365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006693592,0.00009323569,0.00019343039,0.00012042326,0.00007267694,0.000015401594,0.000037708283,0.000039031827,0.000019045454],"category_scores_gemma":[0.00024461315,0.00006760772,0.000027951697,0.00022245149,0.000054549568,0.00011721938,0.00004809108,0.00008369593,0.000018718687],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029504855,0.0039871447,0.4008669,0.00046199118,0.00014752937,0.000024185003,0.002842061,0.0000013640216,0.5858154,0.0005220658,0.0006918894,0.0043444196],"study_design_scores_gemma":[0.005463287,0.0012537995,0.7326446,0.00019952594,0.00003425838,0.00004070383,0.000041028663,0.0000017695519,0.25841358,0.000079034384,0.0017578194,0.00007058042],"about_ca_topic_score_codex":0.000041577347,"about_ca_topic_score_gemma":0.000017838298,"teacher_disagreement_score":0.33177775,"about_ca_system_score_codex":0.000059815393,"about_ca_system_score_gemma":0.00008284925,"threshold_uncertainty_score":0.27569628},"labels":[],"label_agreement":null},{"id":"W2558778524","doi":"10.1182/blood.v108.11.3432.3432","title":"Accumulation of Inherited and Acquired Mutations in Hyaluronan Synthase1 Gene May Contribute Oncogenesis in Multiple Myeloma and Waldenstrom’s Macroglobulinemia.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Intron; Biology; Macroglobulinemia; Exon; RNA splicing; Waldenstrom macroglobulinemia; Molecular biology; Bone marrow; Cancer research; Haematopoiesis; Gene; Germline; Mutation; Multiple myeloma; Stem cell; Genetics; Immunology; Lymphoma; RNA","score_opus":0.0381868998615135,"score_gpt":0.31499227700920823,"score_spread":0.2768053771476947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558778524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99779373,0.0010260404,0.000028942044,0.00021744783,0.00001102668,0.0006765173,0.00016599354,0.000020746638,0.00005957218],"genre_scores_gemma":[0.9966654,0.00006260001,0.0027172472,0.00001718523,0.000031221694,0.000057144774,0.0003705822,0.000017109694,0.000061467035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879724,0.00007354288,0.0003733543,0.00027017583,0.00020780205,0.0002778968],"domain_scores_gemma":[0.9993817,0.00019433243,0.000078933495,0.0001567188,0.00007850906,0.00010978243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014078272,0.00014570939,0.00032963904,0.0002561421,0.000041743384,0.0000142581575,0.00003677994,0.00010149811,0.000014939465],"category_scores_gemma":[0.00020997188,0.0001367604,0.000033121054,0.0002869775,0.0000989074,0.00007458622,0.00004096899,0.00006314494,0.0000021982114],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031107702,0.00081371324,0.87898684,0.00006943724,0.000054206503,0.00031733612,0.00007220406,0.00003100552,0.11081523,0.000010545364,0.000005390175,0.00851302],"study_design_scores_gemma":[0.017406093,0.00023274311,0.92907196,0.000098683304,0.000078892066,0.00007536967,0.000047289566,0.0029717044,0.049861737,0.000032828026,0.000028135953,0.000094577044],"about_ca_topic_score_codex":0.0020138305,"about_ca_topic_score_gemma":0.0015659188,"teacher_disagreement_score":0.06095349,"about_ca_system_score_codex":0.000050243703,"about_ca_system_score_gemma":0.00006471274,"threshold_uncertainty_score":0.5576927},"labels":[],"label_agreement":null},{"id":"W2558843921","doi":"10.1182/blood.v106.11.3738.3738","title":"Folate Assays Are No Longer Useful as Screening Tests for Malabsorption Syndrome. Now, Iron and B12 Deficiency Are More Common Than Folate Deficiency in Adults with Untreated Celiac Disease.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; St. Boniface Hospital","funders":"","keywords":"Medicine; Malabsorption; Gastroenterology; Iron deficiency; Coeliac disease; Internal medicine; Disease; Vitamin B12; Red Cell; Pernicious anaemia; Sprue; Immunology; Anemia; Biology","score_opus":0.016093302156835677,"score_gpt":0.2711078894248909,"score_spread":0.2550145872680552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558843921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948084,0.0024257784,0.00003352926,0.000639806,0.000028042487,0.0015190963,0.00011033255,0.00011430552,0.0003207284],"genre_scores_gemma":[0.9977749,0.00027343072,0.0006678433,0.00009712346,0.00007479751,0.00012670965,0.0001727884,0.000080269085,0.0007321596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972778,0.00006819121,0.0004238478,0.00076249,0.00062470854,0.00084299303],"domain_scores_gemma":[0.9985008,0.00012633171,0.00019532607,0.0005101195,0.0002722611,0.00039512652],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003145464,0.00040145553,0.00053245615,0.00040549668,0.00020986403,0.00008107702,0.00018333897,0.00020196679,0.000037829166],"category_scores_gemma":[0.00015046992,0.0003189028,0.00010544779,0.00061606214,0.00013062062,0.00034936957,0.000098844626,0.00038582884,0.00008427157],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018015237,0.0015293512,0.9911831,0.0007800771,0.000048721588,0.0008313561,0.0002795942,0.000050372273,0.0013606923,0.000011829243,0.00009133992,0.0020320215],"study_design_scores_gemma":[0.010211654,0.0025309229,0.97915226,0.0021706747,0.00035459906,0.00036567627,0.0003153086,0.0037294216,0.0006296026,0.000021664157,0.000087622626,0.0004305628],"about_ca_topic_score_codex":0.00017796346,"about_ca_topic_score_gemma":0.0009491675,"teacher_disagreement_score":0.01203083,"about_ca_system_score_codex":0.00008406431,"about_ca_system_score_gemma":0.00009893187,"threshold_uncertainty_score":0.9999263},"labels":[],"label_agreement":null},{"id":"W2558859525","doi":"10.1182/blood.v126.23.3865.3865","title":"Clinical Characteristics and Outcomes of Patients with Hodgkin Lymphoma with Central Nervous System Involvement: An International Multicenter Collaboration","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Lymphoma; Incidence (geometry); Disease; Stage (stratigraphy); Retrospective cohort study; Pediatrics; Oncology","score_opus":0.01780319739080778,"score_gpt":0.27781759636841546,"score_spread":0.2600143989776077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558859525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99901706,0.000021540107,0.000015933178,0.00007845598,0.00016253682,0.00046797292,0.0001239496,0.000024670882,0.00008790017],"genre_scores_gemma":[0.9980306,0.000012727157,0.0013834316,0.000092005896,0.00007234728,0.000026410875,0.00035156286,0.00001654833,0.0000143783145],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989805,0.000039398325,0.0003196236,0.00020774001,0.00032435782,0.00012838289],"domain_scores_gemma":[0.99902385,0.000029899838,0.00019214845,0.00019037473,0.00035663132,0.00020709106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000087950764,0.00012934976,0.000309694,0.000047886515,0.000021331814,0.000028567089,0.000046976333,0.000047832225,0.0000038525313],"category_scores_gemma":[0.000032912554,0.00008156684,0.000025212481,0.0000618863,0.00005463467,0.00012229914,0.000024088917,0.000024605672,0.0000019396903],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075422274,0.0051682126,0.98676556,0.000041863794,0.00045002406,0.00004487948,0.00034099413,6.057407e-7,0.0000033106865,0.00007305178,0.000013000487,0.0063442765],"study_design_scores_gemma":[0.024059119,0.0019909367,0.9724324,0.00012487352,0.0004746426,0.000008406134,0.0003961731,0.00011289872,0.0001411968,4.422126e-7,0.00017399984,0.000084931184],"about_ca_topic_score_codex":0.000057045036,"about_ca_topic_score_gemma":0.000058112015,"teacher_disagreement_score":0.023304896,"about_ca_system_score_codex":0.00008541109,"about_ca_system_score_gemma":0.000116092066,"threshold_uncertainty_score":0.3326199},"labels":[],"label_agreement":null},{"id":"W2558867271","doi":"10.1182/blood.v126.23.417.417","title":"Glucose Transporter 3 in Platelets Facilitates Alpha-Granule Mediated Glucose Uptake, Driving Intragranular Glycolysis That Is Required for Platelet Degranulation and Activation","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"GLUT3; Glucose transporter; Platelet; Glucose uptake; Glycolysis; Internal medicine; Platelet activation; Endocrinology; Glycogen; Biology; Degranulation; GLUT1; Carbohydrate metabolism; Chemistry; Biochemistry; Metabolism; Insulin; Medicine","score_opus":0.030433351608243814,"score_gpt":0.25804698192531866,"score_spread":0.22761363031707485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558867271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958672,0.0012357289,0.0004640291,0.00062013714,0.00006343835,0.0014178618,0.00011633194,0.0001024695,0.00011278194],"genre_scores_gemma":[0.99682283,0.0003513956,0.0011158743,0.00020669891,0.000035764708,0.00016309513,0.0012009102,0.000045810662,0.000057643338],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99808764,0.00003971561,0.00049458817,0.0005409961,0.00037388448,0.00046315152],"domain_scores_gemma":[0.9990537,0.00014875183,0.00014333804,0.00026420728,0.00011710754,0.000272899],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031005093,0.00034906517,0.00064964505,0.00030778974,0.00009239821,0.000041923417,0.000076817996,0.00026270316,0.000029017267],"category_scores_gemma":[0.00012342386,0.00030983175,0.00012909308,0.0003403175,0.00006483114,0.00043448797,0.00001429266,0.00015646682,0.00001284442],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008732571,0.009690741,0.51328015,0.0009709994,0.0033812968,0.0027519814,0.027345272,0.000081699975,0.2804529,0.0001070451,0.00093163864,0.15227367],"study_design_scores_gemma":[0.095812246,0.0018505392,0.27486974,0.000569778,0.001502852,0.00031368836,0.0016195145,0.0046962947,0.6095539,0.002380943,0.0057225167,0.0011080442],"about_ca_topic_score_codex":0.00019266558,"about_ca_topic_score_gemma":0.00018919849,"teacher_disagreement_score":0.32910094,"about_ca_system_score_codex":0.0000760716,"about_ca_system_score_gemma":0.000081740734,"threshold_uncertainty_score":0.9999354},"labels":[],"label_agreement":null},{"id":"W2558871324","doi":"10.1182/blood-2016-01-689422","title":"Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":289,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Alberta; University of Manitoba","funders":"National Cancer Institute; Cancer Research UK","keywords":"Medicine; Intensive care medicine; Pancytopenia; Minimal residual disease; Clinical trial; Disease; Transplantation; Disease management; Quality of life (healthcare); Leukemia; Immunology; Internal medicine; Nursing","score_opus":0.04892216517246414,"score_gpt":0.31038624141703014,"score_spread":0.261464076244566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558871324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99548584,0.0010390087,0.00012587188,0.0015176513,0.000038792296,0.0011788245,0.000036595033,0.000017518583,0.0005598943],"genre_scores_gemma":[0.9943479,0.0010527988,0.0026493433,0.0001648039,0.00006693358,0.00023446286,0.0000046958144,0.000024137382,0.0014549297],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99906063,0.000013723101,0.0002174396,0.00019619886,0.00030074298,0.00021129138],"domain_scores_gemma":[0.9987283,0.00047308413,0.00007139503,0.00033924612,0.00031538398,0.00007262965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016188127,0.000102015,0.00017734776,0.000035478206,0.00004584509,0.0000061724886,0.000088023546,0.000040834548,0.00002131597],"category_scores_gemma":[0.00011016491,0.00004457821,0.000040865594,0.000075982774,0.0001835132,0.000015441841,0.000076544005,0.000033281238,0.0000051745146],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006033273,0.004985533,0.4734881,0.009548593,0.0047389967,0.00035221936,0.00047263605,0.000031114378,0.0014495946,0.001482386,0.19341032,0.30400726],"study_design_scores_gemma":[0.5400711,0.0035696218,0.2770217,0.0036024381,0.0044247797,0.00007288218,0.0006550351,0.001416523,0.07624645,0.00023742992,0.09198466,0.0006973177],"about_ca_topic_score_codex":0.00005712988,"about_ca_topic_score_gemma":0.00001535717,"teacher_disagreement_score":0.5340379,"about_ca_system_score_codex":0.00059047056,"about_ca_system_score_gemma":0.00066766166,"threshold_uncertainty_score":0.18178467},"labels":[],"label_agreement":null},{"id":"W2558898059","doi":"10.1182/blood.v108.11.762.762","title":"Reduction in Factor VIII Inhibitors Mediated through Tolerogenic Antigen Presentation by immature Dendritic Cells.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Immunology; Medicine; Antigen; Bone marrow; Immune system; Dendritic cell; Immune tolerance; Immunotherapy; Antigen-presenting cell; Myeloid; Antibody; T cell","score_opus":0.013264885564150496,"score_gpt":0.2762519890032589,"score_spread":0.2629871034391084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558898059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956498,0.0018525774,0.000002987473,0.00074529275,0.00016032338,0.0005386752,0.00002685575,0.00006240255,0.0009610416],"genre_scores_gemma":[0.9973101,0.00030899898,0.00012602645,0.00001819218,0.0003099999,0.000028864844,0.00043499138,0.000023420414,0.0014394082],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99880725,0.00005393446,0.00024440265,0.00025431404,0.00034592443,0.000294175],"domain_scores_gemma":[0.9996464,0.000031991345,0.000041674888,0.00015769104,0.000053976742,0.000068266774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000055735996,0.000134994,0.00019179352,0.00010586382,0.00005349009,0.000020000798,0.0000496913,0.00017363769,0.00011029701],"category_scores_gemma":[0.000022551181,0.00011031024,0.000068382215,0.00034470978,0.000050988732,0.00012909429,0.000017020802,0.00020309338,0.00007946914],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000088666464,0.0013700488,0.049199324,0.00007054989,0.00006812822,0.00010881216,0.00038565017,0.0000025300528,0.94218165,0.000007544991,0.0062792315,0.00023788713],"study_design_scores_gemma":[0.0042694723,0.00015664609,0.04733783,0.00007600792,0.000066089815,0.000047071808,0.00016868186,0.000020901565,0.9464691,0.00007201939,0.0011909943,0.00012512635],"about_ca_topic_score_codex":0.00038087455,"about_ca_topic_score_gemma":0.000031476422,"teacher_disagreement_score":0.005088237,"about_ca_system_score_codex":0.000059734994,"about_ca_system_score_gemma":0.000067550616,"threshold_uncertainty_score":0.4498321},"labels":[],"label_agreement":null},{"id":"W2558903074","doi":"10.1182/blood.v126.23.4934.4934","title":"Clinical Pharmacokinetics of Apto-253 Support Its Use As a Novel Agent for the Treatment of Relapsed or Refractory Hematologic Malignancies","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Kruppel-like factors research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aptose Biosciences (Canada)","funders":"","keywords":"KLF4; Medicine; Cancer research; Leukemia; Internal medicine; Chemistry; Transcription factor; Biochemistry; Gene","score_opus":0.1746794313617384,"score_gpt":0.4086025269642068,"score_spread":0.23392309560246838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558903074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99758303,0.0008972854,0.00023268566,0.000096991476,0.0001757043,0.000712549,0.00021266726,0.000007737106,0.00008133756],"genre_scores_gemma":[0.9944306,0.0019371611,0.0010757609,0.000081093836,0.00012095212,0.00008426403,0.00008350493,0.00002605814,0.0021605983],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998626,0.00007742346,0.00048527823,0.00029559288,0.0002477951,0.00026789997],"domain_scores_gemma":[0.99854356,0.00023079925,0.00021502844,0.000484701,0.00040505693,0.0001208748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003535044,0.00016718042,0.00031592548,0.000034307683,0.00003084095,0.000011255014,0.0002753236,0.00018407904,0.000034162094],"category_scores_gemma":[0.00086260017,0.0000998136,0.00021614158,0.00007786865,0.00016843932,0.000004679048,0.000091261594,0.00006435141,0.000007884859],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018766866,0.0068506952,0.022702772,0.00011459764,0.00082149036,0.000024240984,0.00022466223,0.000018756886,0.96073276,0.00006333477,0.005432381,0.00113762],"study_design_scores_gemma":[0.0063908976,0.007853959,0.0019165407,0.000013391236,0.00022177168,0.000034198783,0.000119230004,0.000037019527,0.86160487,0.0000072380435,0.12166627,0.00013463666],"about_ca_topic_score_codex":0.00003211302,"about_ca_topic_score_gemma":0.000018657052,"teacher_disagreement_score":0.116233885,"about_ca_system_score_codex":0.000016241025,"about_ca_system_score_gemma":0.000409129,"threshold_uncertainty_score":0.40702808},"labels":[],"label_agreement":null},{"id":"W2558913508","doi":"10.1182/blood.v120.21.3400.3400","title":"Central Venous Catheters and Venous Thrombotic Events in Pediatric Oncology Patients: A Multicenter Case Control Study","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Central Venous Catheters and Hemodialysis","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital; University of Manitoba; CancerCare Manitoba; BC Children's Hospital; Children's Hospital of Eastern Ontario; Stollery Children's Hospital; University of Alberta","funders":"","keywords":"Medicine; Asymptomatic; Cancer; Surgery; Internal medicine","score_opus":0.024332918121884078,"score_gpt":0.3315693463411432,"score_spread":0.3072364282192591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558913508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99608135,0.00046164772,0.000011547612,0.000068056775,0.00077732734,0.0023631752,0.00006224216,0.000039760813,0.00013491152],"genre_scores_gemma":[0.9988312,0.000097601755,0.000052199997,0.0003823786,0.00041053945,0.00015731028,0.000010177513,0.000038178627,0.000020422533],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99674714,0.00083382614,0.00060275686,0.0003265738,0.00019830363,0.0012914261],"domain_scores_gemma":[0.99870414,0.00034952862,0.00023717241,0.00027407322,0.00006299473,0.00037210336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005603009,0.00023624153,0.00058296794,0.00017560685,0.0004076059,0.0000053783688,0.000117029165,0.00019117823,0.00009171996],"category_scores_gemma":[0.00010879217,0.00020882282,0.000095283154,0.00017995111,0.000029414037,0.00014797613,0.00009438267,0.00049659715,0.000065841894],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001053795,0.028235424,0.92925406,0.000079290934,0.000117849646,0.00020732137,0.04104784,0.0000037784669,0.000006890241,0.0000035165951,0.000021433887,0.00091724447],"study_design_scores_gemma":[0.016662925,0.0015975854,0.9762542,0.000021564823,0.0009645351,0.00003731116,0.0041054096,0.000030701118,0.0000013726923,0.0000076022407,0.00009575549,0.00022100568],"about_ca_topic_score_codex":0.0007045675,"about_ca_topic_score_gemma":0.0010051952,"teacher_disagreement_score":0.047000203,"about_ca_system_score_codex":0.00027540216,"about_ca_system_score_gemma":0.00011742046,"threshold_uncertainty_score":0.85155475},"labels":[],"label_agreement":null},{"id":"W2558920446","doi":"10.1182/blood.v116.21.123.123","title":"Induction of Micro RNA-143 and 145 In Pre-Treatment CD34+ Cells From Patients with Myelodysplastic Syndrome (MDS) After In Vitro exposure to Lenalidomide Correlates with Clinical Response In Patients Harboring the Del5q Abnormality","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Lenalidomide; CD34; Oncology; Medicine; Internal medicine; Cohort; microRNA; Myelodysplastic syndromes; Immunology; Cancer research; Bone marrow; Stem cell; Biology; Multiple myeloma; Gene; Genetics","score_opus":0.007451592987781739,"score_gpt":0.24800559568296301,"score_spread":0.24055400269518126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558920446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981808,0.000037084206,0.0000034163834,0.00010821464,0.00009614564,0.0014910082,0.000067331566,0.000010905686,0.000005078192],"genre_scores_gemma":[0.998818,0.000013791673,0.00085538643,0.00005215013,0.000028959004,0.00015217485,0.00002789871,0.000032781645,0.000018893526],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977163,0.00037446516,0.0006461414,0.00047789523,0.00040969523,0.00037548612],"domain_scores_gemma":[0.9984474,0.0006539637,0.00015091362,0.00046071346,0.0001190811,0.00016789825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007215894,0.00024576875,0.00051860913,0.0002772603,0.00003040035,0.000019971978,0.00012968315,0.00019755783,0.000013203158],"category_scores_gemma":[0.00026780876,0.00015037663,0.000036811594,0.00036804224,0.00016396384,0.00013735023,0.00010761548,0.000751678,0.0000058983],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047616195,0.0022292812,0.93189275,0.00002927665,0.000096952775,0.00020479137,0.0013257797,0.00002162712,0.015997794,1.7477215e-7,0.0000020220277,0.0005833503],"study_design_scores_gemma":[0.024056166,0.003972402,0.946504,0.00033095857,0.0001156514,0.000013574067,0.000083482286,0.000018530929,0.0247448,0.0000027981985,0.0000075326993,0.00015012786],"about_ca_topic_score_codex":0.001325886,"about_ca_topic_score_gemma":0.0010480726,"teacher_disagreement_score":0.02356003,"about_ca_system_score_codex":0.00019246979,"about_ca_system_score_gemma":0.00024628243,"threshold_uncertainty_score":0.61321807},"labels":[],"label_agreement":null},{"id":"W2558924416","doi":"10.1182/blood.v114.22.1853.1853","title":"Sequencing Novel Agents in Relapsed/Refractory Multiple Myeloma: Use of Bortezomib-Based Therapy After Lenalidomide + Dexamethasone.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Lenalidomide; Medicine; Bortezomib; Internal medicine; Multiple myeloma; Dexamethasone; Gastroenterology; Refractory (planetary science); Neutropenia; Autologous stem-cell transplantation; Salvage therapy; Transplantation; Thalidomide; Surgery; Oncology; Chemotherapy","score_opus":0.09113696582219274,"score_gpt":0.31763674621006927,"score_spread":0.22649978038787652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558924416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979025,0.00068785826,0.00011075433,0.00016066858,0.00003832968,0.000845279,0.00005308089,0.000049583723,0.00015196203],"genre_scores_gemma":[0.990861,0.000113586575,0.008092733,0.0005782084,0.000058107416,0.00006760023,0.000052047722,0.000036470043,0.00014025376],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997933,0.00010323789,0.00047987862,0.00041833273,0.00053129724,0.00053428323],"domain_scores_gemma":[0.99856985,0.00033645408,0.00013461805,0.00055776513,0.00013221461,0.00026913043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027119133,0.0002715301,0.00050487363,0.00035851318,0.00004008203,0.000022231001,0.00011685217,0.0001624471,0.000111220885],"category_scores_gemma":[0.0005442737,0.00022348911,0.00018764977,0.00034124375,0.0000759052,0.00014876436,0.000021880396,0.0003139629,0.000020868247],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042348993,0.0065247733,0.76886165,0.00006120285,0.0002522509,0.0011368465,0.00026911945,0.00006317531,0.20676306,0.0000047592716,0.00005255205,0.011775717],"study_design_scores_gemma":[0.040386125,0.00095683214,0.8456944,0.00027202236,0.00007165853,0.000026260159,0.000027113423,0.0010609956,0.11095788,0.000010737075,0.00035310263,0.00018287233],"about_ca_topic_score_codex":0.000585552,"about_ca_topic_score_gemma":0.00012648125,"teacher_disagreement_score":0.095805176,"about_ca_system_score_codex":0.00017835268,"about_ca_system_score_gemma":0.00032422613,"threshold_uncertainty_score":0.9113622},"labels":[],"label_agreement":null},{"id":"W2558955680","doi":"10.1182/blood.v110.11.1321.1321","title":"Initial and Long-Term Outcomes of Splenectomy in Adult Immune Thrombocytopenic Purpura (ITP) Patients: A Systematic Review and Meta-Analysis.","year":2007,"lang":"en","type":"review","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Splenectomy; Medicine; Meta-analysis; Thrombocytopenic purpura; Observational study; Surgery; Internal medicine; Platelet; Spleen","score_opus":0.07826006106429419,"score_gpt":0.3770314806406659,"score_spread":0.2987714195763717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558955680","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005764108,0.9889029,8.0812066e-7,0.000020634203,0.000013834021,0.00503489,0.00014483134,0.000012714228,0.00010524413],"genre_scores_gemma":[0.0034542033,0.9954064,0.0000502093,0.0001564444,0.0000044379844,0.00036912123,0.00043993347,0.00004018552,0.000079058256],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99671036,0.00022057795,0.0019354405,0.00049408566,0.00035655426,0.00028300475],"domain_scores_gemma":[0.9978929,0.00023338772,0.0009783262,0.0006452682,0.00013768183,0.00011241482],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00038652157,0.0006043104,0.016275903,0.00051291275,0.000027681004,0.000019999801,0.000144319,0.00022964452,0.00009925792],"category_scores_gemma":[0.00023583003,0.00034979594,0.0017272409,0.0007032271,0.00006741447,0.00007698827,0.00010388273,0.00024563228,0.000009463032],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000040691834,0.0010517251,0.0032401024,0.7778817,0.21556462,0.00033885418,0.000025136585,1.8005535e-9,1.8266892e-8,0.0000070375477,0.0000015084422,0.0018852543],"study_design_scores_gemma":[0.0025833384,0.00017191815,0.0043109306,0.052080806,0.9403663,0.00016500617,0.0000041743024,4.8418702e-8,5.490263e-7,0.000002299541,0.00006054087,0.00025404093],"about_ca_topic_score_codex":0.000062426305,"about_ca_topic_score_gemma":0.0000960429,"teacher_disagreement_score":0.7258009,"about_ca_system_score_codex":0.000033251712,"about_ca_system_score_gemma":0.00007169632,"threshold_uncertainty_score":0.9998954},"labels":[],"label_agreement":null},{"id":"W2558961081","doi":"10.1182/blood.v110.11.2107.2107","title":"Novel Mouse Anti-Mouse β3 Integrin Monoclonal Antibodies: Development and Characterization of New Reagents for Research in Thrombosis and Thrombocytopenia.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Canadian Blood Services; St. Michael's Hospital","funders":"","keywords":"Monoclonal antibody; Epitope; Integrin; Molecular biology; Platelet; Antibody; Antigenicity; Antigen; Biology; Platelet activation; Recombinant DNA; Western blot; Immunology; Chemistry; Biochemistry; Gene; Receptor","score_opus":0.12573370468342335,"score_gpt":0.37765633513695274,"score_spread":0.25192263045352936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558961081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986374,0.000102856284,0.0002613507,0.00014006974,0.000017645898,0.00068825675,0.000029369558,0.000012419661,0.00011064442],"genre_scores_gemma":[0.990865,0.0005365522,0.008073855,0.00003901039,0.000020719717,0.000012550144,0.00013086644,0.000020136791,0.00030133274],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989276,0.000011832351,0.00030710947,0.0002645835,0.00020561313,0.0002832505],"domain_scores_gemma":[0.9995499,0.00006588649,0.00006565949,0.00012242541,0.000082207254,0.00011388833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043549872,0.00012688014,0.0003704915,0.00022626936,0.000065353575,0.000017090211,0.00004794986,0.00009325235,0.0000057274233],"category_scores_gemma":[0.00004087295,0.0001085815,0.00002186295,0.00017130082,0.00006194477,0.00009734817,0.000060444017,0.000107079395,0.0000016331572],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017711738,0.0016363695,0.2518693,0.00018606227,0.00019182189,0.000023985056,0.0018091328,6.541668e-8,0.73876977,0.00006866534,0.000023659624,0.005244069],"study_design_scores_gemma":[0.0064597274,0.00021026772,0.60643816,0.00013617819,0.000043227286,0.000021300588,0.00021549812,0.0000108005415,0.3860599,0.000018759849,0.0002992532,0.00008690387],"about_ca_topic_score_codex":0.00019101301,"about_ca_topic_score_gemma":0.00016241072,"teacher_disagreement_score":0.3545689,"about_ca_system_score_codex":0.000030368079,"about_ca_system_score_gemma":0.000112514725,"threshold_uncertainty_score":0.44278252},"labels":[],"label_agreement":null},{"id":"W2558962826","doi":"10.1182/blood.v114.22.2036.2036","title":"A Small Molecule Inhibitor of D-Cyclin Transactivation Displays Preclinical Efficacy in Myeloma and Leukemia.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto; SickKids Foundation; Ontario Institute for Cancer Research; Hospital for Sick Children; Princess Margaret Cancer Centre","funders":"","keywords":"Transactivation; Cyclin; Cyclin D1; Cancer research; Cyclin D; Cell cycle; Biology; Molecular biology; Cyclin B; Cyclin D3; Leukemia; Gene expression; Cell; Biochemistry; Immunology; Gene","score_opus":0.020152241652432394,"score_gpt":0.2677229679402543,"score_spread":0.2475707262878219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558962826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99723035,0.00057688303,0.00047316012,0.000351451,0.0000369624,0.0004488584,0.000005602341,0.000032926186,0.00084378285],"genre_scores_gemma":[0.99869084,0.00007535624,0.000927342,0.00016233134,0.00006709707,0.00000904088,0.00001530448,0.00001689841,0.000035798013],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99894506,0.000042840038,0.0004004254,0.0002733557,0.00016146497,0.00017683308],"domain_scores_gemma":[0.9994754,0.000081449645,0.00008539925,0.00022015031,0.000036515677,0.000101077116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015492144,0.00012688019,0.00031946687,0.00011588164,0.0000152400535,0.000005540735,0.000048316462,0.00018378132,0.000010107103],"category_scores_gemma":[0.00019881393,0.00012376148,0.00008161431,0.00022270386,0.000048328413,0.000033526878,0.000009245915,0.00027818384,0.0000026826995],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008023233,0.0024517216,0.0029278055,0.00010569376,0.00007264267,0.00013539329,0.00067772315,0.000042626143,0.9668315,0.00010298571,0.000034382872,0.025815167],"study_design_scores_gemma":[0.016769916,0.0014833232,0.28833807,0.0005410397,0.00024245969,0.00007921863,0.00002553261,0.00034052102,0.69183445,0.000067156994,0.000100754696,0.00017758942],"about_ca_topic_score_codex":0.000020998965,"about_ca_topic_score_gemma":0.00002331112,"teacher_disagreement_score":0.28541026,"about_ca_system_score_codex":0.000048314716,"about_ca_system_score_gemma":0.00014827162,"threshold_uncertainty_score":0.5046846},"labels":[],"label_agreement":null},{"id":"W2558970713","doi":"10.1182/blood.v112.11.4071.4071","title":"A Trauma Transfusion Pathway Decreases Coagulopathy without Increasing Blood Product Utilization","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Trauma, Hemostasis, Coagulopathy, Resuscitation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Cryoprecipitate; Medicine; Blood product; Coagulopathy; Fresh frozen plasma; Recombinant factor VIIa; Prothrombin complex concentrate; Blood transfusion; Packed red blood cells; Transfusion therapy; Injury Severity Score; Retrospective cohort study; Resuscitation; Platelet; Surgery; Emergency medicine; Intensive care medicine; Internal medicine; Poison control; Injury prevention; Warfarin","score_opus":0.049998066490927445,"score_gpt":0.2775850181011442,"score_spread":0.22758695161021678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558970713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99201196,0.0021916572,0.00051974936,0.00025123803,0.00020070639,0.0014567001,0.00003289497,0.0005355104,0.002799607],"genre_scores_gemma":[0.9923458,0.00068201846,0.005704858,0.0002018097,0.00044859626,0.000091891256,0.00025122424,0.0001102096,0.00016355318],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99686146,0.00026800256,0.00066857133,0.0008179685,0.0008315325,0.00055249705],"domain_scores_gemma":[0.99824023,0.0001360738,0.00019944433,0.00067067647,0.0003723007,0.0003812632],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005112658,0.0004276749,0.0006025716,0.00034247868,0.00040678243,0.000037941067,0.00015668929,0.00018358688,0.00008290287],"category_scores_gemma":[0.00087237085,0.00040398614,0.00020073929,0.0007642093,0.00018799349,0.00032043448,0.00003208497,0.00031016453,0.00004644682],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016777156,0.00823286,0.61116844,0.00057671213,0.0003269945,0.0010304687,0.005269343,0.000012493115,0.29761598,0.00012189666,0.00010407508,0.07386299],"study_design_scores_gemma":[0.011333984,0.00085435796,0.48482946,0.0004666935,0.0009343641,0.0043867957,0.0003486363,0.00008196754,0.49546054,0.00006154822,0.0007560089,0.00048563015],"about_ca_topic_score_codex":0.00023999374,"about_ca_topic_score_gemma":0.00013061393,"teacher_disagreement_score":0.19784456,"about_ca_system_score_codex":0.000057837613,"about_ca_system_score_gemma":0.00040331934,"threshold_uncertainty_score":0.9998412},"labels":[],"label_agreement":null},{"id":"W2558976223","doi":"10.1182/blood.v118.21.4182.4182","title":"Time Course of Venous Thromboembolism Events and Influence of Risk Factors in High Risk Medical Patients,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Trillium Health Centre; Sanofi (Canada); University of Calgary","funders":"","keywords":"Medicine; Medical record; Venous thromboembolism; Population; Emergency medicine; Risk factor; Intensive care medicine; Emergency department; Pediatrics; Internal medicine; Thrombosis","score_opus":0.007490570708244631,"score_gpt":0.22472523051339624,"score_spread":0.2172346598051516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558976223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99897504,0.00020478759,0.000001521464,0.000011759988,0.000059011596,0.0003940797,0.00008795707,0.0000180309,0.00024781132],"genre_scores_gemma":[0.9984532,0.0013052664,0.00013228561,0.000036012145,0.000019842679,0.000009970236,0.000018940193,0.000019615394,0.0000048467655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985488,0.00008357017,0.0004625451,0.00023984947,0.00043202634,0.00023319546],"domain_scores_gemma":[0.99901813,0.000094425806,0.0003147331,0.000306639,0.00010494293,0.00016113943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030119516,0.00016520517,0.00076827436,0.00012405295,0.00003018204,0.0000017513104,0.00014166273,0.00013159249,0.00019764989],"category_scores_gemma":[0.00036105548,0.0001325116,0.00006580994,0.00015604647,0.0001715016,0.000070528346,0.000117344425,0.00019265145,0.000009487671],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028334545,0.0102959145,0.983817,0.000106441585,0.00030222573,0.000011060917,0.0035131902,0.0000052721607,0.00005058447,0.000094464114,0.000053500884,0.0017220074],"study_design_scores_gemma":[0.003581201,0.00084020745,0.99155897,0.00025709008,0.0006990762,0.0000015753649,0.0001544331,0.000008918869,0.0023793217,0.00039085565,0.00001807689,0.00011025086],"about_ca_topic_score_codex":0.004322517,"about_ca_topic_score_gemma":0.00008601224,"teacher_disagreement_score":0.009455707,"about_ca_system_score_codex":0.000011977279,"about_ca_system_score_gemma":0.00006601574,"threshold_uncertainty_score":0.65343815},"labels":[],"label_agreement":null},{"id":"W2559034347","doi":"10.1182/blood.v106.11.4392.4392","title":"BCL11AXL Protein: Its Distribution in Normal and Malignant Tissues and Use as a Marker for Plasmacytoid Dendritic Cells.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Biology; B cell; Molecular biology; Germinal center; Thymocyte; Antibody; Cancer research; Immunology; Antigen; CD8","score_opus":0.016072468799134317,"score_gpt":0.27709898768581187,"score_spread":0.26102651888667755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559034347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966866,0.0013052241,0.000021083393,0.00043896737,0.000019099767,0.0012970266,0.00006364885,0.000026132977,0.00014223644],"genre_scores_gemma":[0.99614805,0.0002474498,0.0009263454,0.000059086124,0.00010236479,0.00017584095,0.000052299387,0.000021882075,0.0022666906],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988307,0.000032743887,0.00021708451,0.00029664423,0.00022642921,0.0003964446],"domain_scores_gemma":[0.9994206,0.00014036914,0.00003158446,0.00016215854,0.00006855054,0.00017673221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002289707,0.00013614028,0.00021879263,0.00006657679,0.000055374483,0.000052681367,0.00004825673,0.00010499256,0.00004181875],"category_scores_gemma":[0.00029401307,0.00012019711,0.00002846753,0.0000978644,0.000077356715,0.00017228522,0.00007572737,0.000120862824,0.000028642484],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01417962,0.01198877,0.048504632,0.014025739,0.0011322055,0.0070901117,0.005426951,0.0000324858,0.80625886,0.008621087,0.0070616305,0.07567794],"study_design_scores_gemma":[0.09874857,0.0009778148,0.011470612,0.001049074,0.00025280856,0.0025294435,0.00014854906,0.012393217,0.84018344,0.00011459429,0.031661026,0.00047086625],"about_ca_topic_score_codex":0.00019147515,"about_ca_topic_score_gemma":0.0001338982,"teacher_disagreement_score":0.084568955,"about_ca_system_score_codex":0.00074626337,"about_ca_system_score_gemma":0.0006940696,"threshold_uncertainty_score":0.4901496},"labels":[],"label_agreement":null},{"id":"W2559039573","doi":"10.1182/blood.v106.11.2410.2410","title":"Cell Based Assays Completed with the Mantle Cell Lymphoma Cell Lines Z138 and NCEB-1 Indicate That Combinations of Bortezomid and Flavopiridol Interact To Achieve Synergistic Activity.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Bortezomib; Mantle cell lymphoma; Propidium iodide; Cancer research; Proteasome inhibitor; CHOP; Cyclin D1; Viability assay; Lymphoma; Combination therapy; Medicine; Cytotoxicity; Pharmacology; Cell cycle; Chemistry; Apoptosis; Immunology; Internal medicine; Programmed cell death; Multiple myeloma; In vitro; Cancer; Biochemistry","score_opus":0.007259351326440037,"score_gpt":0.20735239025234944,"score_spread":0.2000930389259094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559039573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99545276,0.0003158671,0.0018332308,0.0009984648,0.00002427743,0.00029738067,0.000056235946,0.000010021984,0.001011747],"genre_scores_gemma":[0.9983583,0.0000362401,0.0006628847,0.0004978309,0.00005248426,0.000026357371,0.000057321224,0.000017314584,0.00029126977],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992951,0.000070397466,0.00012422662,0.00024747322,0.0001172863,0.00014551147],"domain_scores_gemma":[0.9994456,0.000041854062,0.00013284181,0.00024397124,0.00005450243,0.00008122148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010228617,0.00014736236,0.00013747683,0.000056407098,0.00009719534,0.00003359591,0.00013102253,0.00007084637,0.000007714989],"category_scores_gemma":[0.000017171655,0.00010794958,0.000031810843,0.00008434642,0.00009918741,0.000008559414,0.000082200844,0.00006127821,0.0000034764055],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013280394,0.0010635854,0.0012997773,0.000054497767,0.000028884997,0.0000023124085,0.000089255875,0.0000403364,0.99406517,0.000009369602,0.0020961934,0.0011178195],"study_design_scores_gemma":[0.003106308,0.00047754947,0.00364508,0.000018084855,0.00005731551,0.000004331316,0.000057992766,0.0004665062,0.9859376,0.0000034520983,0.006073669,0.00015208627],"about_ca_topic_score_codex":0.000022425944,"about_ca_topic_score_gemma":0.00004042947,"teacher_disagreement_score":0.008127539,"about_ca_system_score_codex":0.0000058795813,"about_ca_system_score_gemma":0.00004277919,"threshold_uncertainty_score":0.4402056},"labels":[],"label_agreement":null},{"id":"W2559051711","doi":"10.1182/blood.v112.11.3485.3485","title":"Human SIRPA Polymorphism Modulates Macrophage-Mediated Suppression of Human Hematopoiesis","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University Health Network","funders":"","keywords":"CD47; Biology; Haematopoiesis; Immunoglobulin superfamily; Myeloid; Immune system; Antibody; Cell biology; Molecular biology; Immunology; Stem cell","score_opus":0.016226214419785057,"score_gpt":0.23713833848891447,"score_spread":0.2209121240691294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559051711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938938,0.0048317146,0.0000058160936,0.000036121222,0.00013881543,0.00014546559,0.000026423102,0.00007858215,0.00084325334],"genre_scores_gemma":[0.99767345,0.00004384403,0.00002870694,0.000019328603,0.000026248319,0.000011066807,0.0002665,0.00002214203,0.001908708],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99889857,0.000115385585,0.0004167819,0.00023828732,0.000054337266,0.00027665254],"domain_scores_gemma":[0.9992905,0.000039584756,0.00021830725,0.00036650145,0.00006277462,0.000022308965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000955857,0.00017750963,0.0003633051,0.0001328881,0.00040361637,0.000004726383,0.00020706991,0.00024859133,0.00070288737],"category_scores_gemma":[0.000027310738,0.00015587494,0.00013118151,0.00014027944,0.00025012525,0.000104533945,0.000092646136,0.00015100483,0.000121332196],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012589926,0.0006071693,0.005564748,0.000019881989,0.00013944673,0.000011683937,0.00032599457,0.0000016559642,0.99204725,0.00027841644,0.0009259442,0.00006521842],"study_design_scores_gemma":[0.0023421226,0.00016148706,0.10962064,0.000039236165,0.00006249572,0.00012830255,0.000028069382,0.0000017040462,0.8870159,0.00011743382,0.00033329462,0.00014936099],"about_ca_topic_score_codex":0.0001436955,"about_ca_topic_score_gemma":0.000002617551,"teacher_disagreement_score":0.1050314,"about_ca_system_score_codex":0.000011396505,"about_ca_system_score_gemma":0.00001953491,"threshold_uncertainty_score":0.7696124},"labels":[],"label_agreement":null},{"id":"W2559062045","doi":"10.1182/blood.v108.11.4489.4489","title":"Presence of Comorbidities Do Not Predict Early Mortality or Survival in Older Patients (≥60 Years) with Acute Myeloid Leukemia (AML) Undergoing Intensive Induction Therapy.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Comorbidity; Internal medicine; Cytarabine; Myeloid leukemia; Pediatrics; Surgery","score_opus":0.02570946057538467,"score_gpt":0.27852819928661005,"score_spread":0.2528187387112254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559062045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99787533,0.000076851,0.000032076077,0.00009715189,0.0001309469,0.00097120577,0.00006978257,0.00006156609,0.0006850717],"genre_scores_gemma":[0.99837345,0.00021875101,0.00027495154,0.000079886195,0.00018919657,0.000057512334,0.00009186048,0.00005302749,0.0006613468],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99748284,0.00015432903,0.00048332597,0.00045492148,0.00096414256,0.00046045115],"domain_scores_gemma":[0.99833935,0.00023340236,0.00020766494,0.0005132621,0.0005993709,0.00010695233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003160658,0.00025364736,0.0005136074,0.00026226844,0.000053766726,0.00003489758,0.00021946381,0.00018617792,0.00006616435],"category_scores_gemma":[0.00021317707,0.00019108485,0.00007489453,0.00054370775,0.00027794528,0.00028698816,0.00011398994,0.0005478444,0.000009196994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024976383,0.0008563595,0.9828759,0.00014993438,0.0005549759,0.0007781615,0.0016489365,0.00005008931,0.009052575,0.00006925357,0.0006353939,0.00083081634],"study_design_scores_gemma":[0.011964585,0.0012608367,0.964022,0.00032483292,0.00014329788,0.000049064245,0.0007798049,0.000040491825,0.021134807,0.00004552815,0.000038935974,0.00019585593],"about_ca_topic_score_codex":0.004671258,"about_ca_topic_score_gemma":0.0008615606,"teacher_disagreement_score":0.018853905,"about_ca_system_score_codex":0.0003110945,"about_ca_system_score_gemma":0.00096282735,"threshold_uncertainty_score":0.7792214},"labels":[],"label_agreement":null},{"id":"W2559073273","doi":"10.1182/blood.v114.22.1486.1486","title":"Heterogenous Nuclear Ribonucleoprotein L (hnRNPL) Is Required for the Functional Integrity of Hematopoietic Stem Cells.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Cre recombinase; Biology; Haematopoiesis; Transgene; Molecular biology; Heterogeneous nuclear ribonucleoprotein; RNA splicing; Regulator; Alternative splicing; Stem cell; Cell biology; Conditional gene knockout; Genetically modified mouse; Exon; Gene; Genetics; Phenotype; RNA","score_opus":0.022463614172891208,"score_gpt":0.24986141790055172,"score_spread":0.2273978037276605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559073273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974345,0.0007691992,0.00079167157,0.00040923647,0.000040614803,0.0003409951,0.000029064322,0.000009517029,0.00017518876],"genre_scores_gemma":[0.99840146,0.000073805175,0.00038941577,0.00032636433,0.00011958691,0.000015382138,0.00000885099,0.00001382774,0.00065128185],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992031,0.000027341228,0.00017169383,0.00021354672,0.00015546323,0.00022888847],"domain_scores_gemma":[0.9994175,0.000018585586,0.000061642415,0.00034190153,0.00009917408,0.00006120363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002006629,0.00010041691,0.00012011861,0.000019707802,0.00012227256,0.000020924199,0.00020354372,0.00010098087,0.00002150383],"category_scores_gemma":[0.00002032445,0.00007314497,0.0001470286,0.000054259275,0.000060637318,0.0000029395735,0.00004774825,0.0000964307,0.0000078214425],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013041201,0.0001993245,0.0000673287,0.000026465957,0.000070668684,0.0000013282785,0.00006232057,0.000005615681,0.9956121,0.00019393295,0.0011872398,0.0024432726],"study_design_scores_gemma":[0.0010367032,0.00081503956,0.00054010627,0.000015341835,0.000033896053,0.000020207066,0.00012458532,0.0001683951,0.9926249,0.00016284842,0.004355546,0.000102455946],"about_ca_topic_score_codex":0.000018724915,"about_ca_topic_score_gemma":0.000005018288,"teacher_disagreement_score":0.0031683065,"about_ca_system_score_codex":0.000005386846,"about_ca_system_score_gemma":0.000042872347,"threshold_uncertainty_score":0.2982765},"labels":[],"label_agreement":null},{"id":"W2559081861","doi":"10.1182/blood.v120.21.2069.2069","title":"Attitudes of Researchers to the Return of Incidental and Targeted Genomic Findings Obtained in a Research Setting to Participants","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario; Institute for Clinical Evaluative Sciences; McGill University; University of British Columbia; Hospital for Sick Children; McGill Genome Centre; Montreal Children's Hospital; Izaak Walton Killam Health Centre; SickKids Foundation; BC Children's Hospital; Dalhousie University","funders":"","keywords":"Medicine; Family medicine; Psychology; Medical education","score_opus":0.6188006782092684,"score_gpt":0.6029517916415897,"score_spread":0.01584888656767869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559081861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929274,0.0004927832,0.0000018655435,0.00528406,0.000023557706,0.0008340303,0.000009562107,0.0000068381173,0.0004199059],"genre_scores_gemma":[0.9979586,0.000073756746,0.0013909183,0.0001674437,0.000094447634,0.00005514191,0.000001918799,0.00002050257,0.00023727653],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963886,0.0005250555,0.0005336908,0.00026650782,0.0014209996,0.0008651518],"domain_scores_gemma":[0.99099,0.00748087,0.000047380257,0.0004935397,0.00047254242,0.0005156855],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.027239334,0.0000850351,0.0002967164,0.00036074308,0.00007996093,0.000015275557,0.00033597424,0.00016791065,0.000051835766],"category_scores_gemma":[0.056271985,0.00006199714,0.00004214357,0.0008730185,0.00036078182,0.000056200905,0.000798613,0.0014715808,0.000025045705],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034269138,0.00049511297,0.82015306,0.00025637803,0.00006277784,0.000010705476,0.0070628473,0.0000014319667,0.17095128,0.00030047484,0.0001394651,0.00022377852],"study_design_scores_gemma":[0.0012658683,0.0006400211,0.92345905,0.00048234948,0.000020869888,0.0000052209193,0.002032597,0.000017751967,0.07161672,0.00033920223,0.00006085237,0.000059520804],"about_ca_topic_score_codex":0.0005923167,"about_ca_topic_score_gemma":0.00085403846,"teacher_disagreement_score":0.103305966,"about_ca_system_score_codex":0.00009169166,"about_ca_system_score_gemma":0.0003657274,"threshold_uncertainty_score":0.95167744},"labels":[],"label_agreement":null},{"id":"W2559083394","doi":"10.1182/blood.v110.11.1171.1171","title":"Phase 1 Dose Escalation Study of the Monoclonal Antibody Against the Insulin Like Growth Factor I Receptor CP-751,871 in Patients with Multiple Myeloma.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Multiple myeloma; Tolerability; Internal medicine; Dexamethasone; Oncology; Pharmacology; Gastroenterology; Adverse effect","score_opus":0.011644300731076343,"score_gpt":0.2551122982631251,"score_spread":0.24346799753204876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559083394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997138,0.00008490792,0.00002434194,0.00008861678,0.0002172857,0.0021127213,0.00005534706,0.000044759734,0.00023399729],"genre_scores_gemma":[0.99931645,0.000017188433,0.00013183625,0.00020151687,0.00011773487,0.000023103838,0.000114353905,0.00004656252,0.0000312336],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974983,0.00014002601,0.0007314269,0.00040096501,0.000799738,0.00042957696],"domain_scores_gemma":[0.99844825,0.00020649463,0.00032585286,0.0005815451,0.00028656394,0.00015128692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039057346,0.0003186578,0.0004303235,0.00020714417,0.00015991332,0.000020014733,0.0002927168,0.00014974034,0.000021096725],"category_scores_gemma":[0.00027183426,0.00017278595,0.00011264502,0.0008857186,0.00012427551,0.0001849441,0.000100549376,0.00048457028,0.000012242434],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015729804,0.016885074,0.96531403,0.000030325193,0.00016411804,0.000009656608,0.0031156095,0.0000021614424,0.010095357,0.0000055150113,0.00005361051,0.0027515402],"study_design_scores_gemma":[0.036502138,0.0031056295,0.9466785,0.00008020388,0.0001456613,0.0000015375796,0.00076889904,0.00003482847,0.012356139,0.000003922198,0.00012400998,0.00019851814],"about_ca_topic_score_codex":0.00016649623,"about_ca_topic_score_gemma":0.00011198508,"teacher_disagreement_score":0.034929156,"about_ca_system_score_codex":0.00006268958,"about_ca_system_score_gemma":0.00010309256,"threshold_uncertainty_score":0.7046007},"labels":[],"label_agreement":null},{"id":"W2559100699","doi":"10.1182/blood.v118.21.4422.4422","title":"Effect of Switching to Nilotinib in Patients with Imatinib-Related Low-Grade Non-Hematologic Adverse Events","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Princess Margaret Cancer Centre","funders":"","keywords":"Nilotinib; Medicine; Imatinib; Adverse effect; Internal medicine; Imatinib mesylate; Gastroenterology; Myeloid leukemia","score_opus":0.006665188434979954,"score_gpt":0.2330796546725744,"score_spread":0.22641446623759445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559100699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969872,0.000019015572,0.000008403109,0.000010829231,0.00006328784,0.0015496826,0.0000061425153,0.00004902197,0.0013063728],"genre_scores_gemma":[0.99839956,0.0000016408285,0.0013743063,0.00003921636,0.000007791586,0.000064067324,0.000028322082,0.000037023176,0.00004809336],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984775,0.00007958039,0.00043979098,0.00033597785,0.00032036862,0.00034675174],"domain_scores_gemma":[0.9991027,0.00008668063,0.00018702561,0.00041887196,0.0000453229,0.0001593784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021407197,0.0002565676,0.0005878495,0.0001895081,0.00002548228,0.0000011246461,0.00012747591,0.000113334594,0.000105846164],"category_scores_gemma":[0.00013689755,0.00017850426,0.00008410498,0.0003429608,0.000022439708,0.000077232005,0.00006454129,0.00019981925,0.000120534256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009213907,0.002486093,0.9934261,0.00031826805,0.00023872011,0.000105318104,0.0011833656,0.000004932512,0.00077893696,0.0000054745187,0.000006976384,0.00052443694],"study_design_scores_gemma":[0.045988724,0.0050448836,0.8928807,0.00126404,0.00044232127,0.000029626322,0.000032633685,0.000030521926,0.054084033,0.0000134153115,0.0000015602365,0.00018756307],"about_ca_topic_score_codex":0.00016257506,"about_ca_topic_score_gemma":0.000015462912,"teacher_disagreement_score":0.100545414,"about_ca_system_score_codex":0.00014978305,"about_ca_system_score_gemma":0.00009546109,"threshold_uncertainty_score":0.7279193},"labels":[],"label_agreement":null},{"id":"W2559105259","doi":"10.1182/blood.v120.21.2067.2067","title":"Pneumococcal Bacteremia Among Patients with Hematological Malignancies: Clinical Impact, Serotype Distribution and Antibiotic Resistance Profile in Tertiary-Care Centers","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institut National de Santé Publique du Québec; Hôpital du Sacré-Cœur de Montréal; Hôpital Notre-Dame; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Internal medicine; Streptococcus pneumoniae; Bacteremia; Hematopoietic stem cell transplantation; Population; Pneumococcal polysaccharide vaccine; Pneumococcal conjugate vaccine; Transplantation; Immunology; Antibiotics; Pneumococcal disease","score_opus":0.010273272326669183,"score_gpt":0.2763782130055769,"score_spread":0.2661049406789077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559105259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986737,0.00017545934,0.00000997031,0.00004738075,0.00008704075,0.0005920676,0.000067501416,0.0000383857,0.0003085307],"genre_scores_gemma":[0.99953187,0.000022947534,0.000075782904,0.00004440083,0.00006838892,0.000019155294,0.00019064928,0.000013747628,0.000033067055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895585,0.000065343644,0.0002709215,0.00023715325,0.00013546574,0.00033525957],"domain_scores_gemma":[0.99941355,0.000035503945,0.000081544604,0.00018510937,0.0000730911,0.00021119564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009489045,0.0001460934,0.00027358584,0.00003139938,0.000057845267,0.000016697082,0.000042301017,0.00011364082,0.000038407125],"category_scores_gemma":[0.00004670621,0.00009873215,0.00006109604,0.00013754312,0.00012896948,0.0001632414,0.00003383427,0.00023234311,0.000010125025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022132492,0.0008485465,0.998197,0.00011557397,0.00003669097,0.000015541162,0.00007459136,7.354686e-8,0.00028404847,0.000017496699,0.00009734371,0.00009176781],"study_design_scores_gemma":[0.0035442314,0.00032137975,0.99418914,0.00035937878,0.00012426029,0.000025264539,0.000063025254,4.1504143e-7,0.0011294622,0.0000014156138,0.00012147309,0.00012052694],"about_ca_topic_score_codex":0.000019511874,"about_ca_topic_score_gemma":0.000060160364,"teacher_disagreement_score":0.004007834,"about_ca_system_score_codex":0.000067347064,"about_ca_system_score_gemma":0.00004679068,"threshold_uncertainty_score":0.402618},"labels":[],"label_agreement":null},{"id":"W2559129390","doi":"10.1182/blood.v112.11.372.372","title":"Interim Positron Emission Tomography (PET) in Diffuse Large B-Cell Lymphoma: Independent Expert Nuclear Medicine Evaluation of ECOG 3404","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Interim; Diffuse large B-cell lymphoma; Nuclear medicine; Positron emission tomography; Concordance; Rituximab; Cohen's kappa; Lymphoma; Radiology; Internal medicine; Statistics","score_opus":0.024495990509121424,"score_gpt":0.28302685563606267,"score_spread":0.25853086512694123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559129390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916931,0.0035204664,0.0000018778861,0.00036157804,0.00010931582,0.00055052177,0.000006182868,0.000038422626,0.0037185305],"genre_scores_gemma":[0.9984551,0.00082641054,0.00012721935,0.0002899143,0.000097765005,0.0000605347,0.000058611146,0.000030164641,0.00005426712],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980135,0.000113003334,0.00045738777,0.00034292453,0.000802866,0.00027029874],"domain_scores_gemma":[0.9991024,0.000047144178,0.00015172755,0.00038399905,0.00014794485,0.00016679996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036063476,0.0002147962,0.00044606705,0.0003059164,0.00006375712,0.00000504737,0.0001048957,0.0000955523,0.00023229836],"category_scores_gemma":[0.00006742034,0.00016081444,0.00013909211,0.00026760428,0.00006568682,0.00008072094,0.00006777818,0.00006647445,0.000017686083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009571559,0.18613726,0.6631074,0.00022759652,0.00054368016,0.0015015207,0.010834027,0.00000170103,0.120538294,0.000102364684,0.006123527,0.0099254865],"study_design_scores_gemma":[0.2152427,0.0022172963,0.6562934,0.0008889025,0.00090394303,0.00056148897,0.0009022647,0.00044903424,0.12065852,0.000055672754,0.0015252325,0.0003015547],"about_ca_topic_score_codex":0.00036332652,"about_ca_topic_score_gemma":0.000026295407,"teacher_disagreement_score":0.21428555,"about_ca_system_score_codex":0.00019499558,"about_ca_system_score_gemma":0.00012174506,"threshold_uncertainty_score":0.6557823},"labels":[],"label_agreement":null},{"id":"W2559130395","doi":"10.1182/blood.v120.21.3432.3432","title":"Topical Application of Tranexamic Acid to Reduce Post-Operative Bleeding in Coronary Artery Bypass Surgery","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Cardiac and Coronary Surgery Techniques","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital; University of Saskatchewan; University of Calgary","funders":"","keywords":"Tranexamic acid; Medicine; Anesthesia; Antifibrinolytic; Surgery; Placebo; Randomized controlled trial; Hemostasis; Cardiac surgery; Blood loss","score_opus":0.01720338266212557,"score_gpt":0.27771331866800575,"score_spread":0.2605099360058802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559130395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99663097,0.0004990727,0.00030301846,0.0006416567,0.000101779326,0.00034755637,0.000008939331,0.00006326613,0.0014037722],"genre_scores_gemma":[0.99867976,0.000034507364,0.00048474097,0.0003622609,0.00019964826,0.000118915996,0.000037834427,0.000015425156,0.00006690462],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990636,0.000053266056,0.00029992053,0.00017483564,0.00016583024,0.0002425472],"domain_scores_gemma":[0.9994356,0.0001214272,0.000043725224,0.00021058483,0.00006154657,0.0001271299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032272848,0.00011454796,0.0003631248,0.00015911125,0.00001879531,0.0000036045244,0.000043190812,0.000090562506,0.00003773013],"category_scores_gemma":[0.00004904787,0.00010836648,0.000119057666,0.0002008794,0.00002995268,0.00012510915,0.000023668686,0.00012635835,0.0000138534015],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022631577,0.0007238449,0.47894233,0.00004324133,0.00005760642,0.000026125454,0.00051612675,2.4640082e-7,0.46469977,0.00014133097,0.00022429989,0.054398756],"study_design_scores_gemma":[0.00039003592,0.00012850639,0.79864866,0.00007758817,0.00006965324,0.0002307747,0.00017888904,0.0000027239462,0.19942786,0.000008847026,0.0007262114,0.000110246394],"about_ca_topic_score_codex":0.00004785237,"about_ca_topic_score_gemma":0.0000059034073,"teacher_disagreement_score":0.31970632,"about_ca_system_score_codex":0.00003500891,"about_ca_system_score_gemma":0.00005733261,"threshold_uncertainty_score":0.44190568},"labels":[],"label_agreement":null},{"id":"W2559151048","doi":"10.1182/blood.v108.11.3374.3374","title":"A Novel Role for Thrombin in Hematopoietic Stem/Progenitor Cell Homing.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Alberta","funders":"","keywords":"Cell biology; Thrombin; Stem cell; Homing (biology); Biology; Progenitor cell; Chemistry; Molecular biology; Immunology; Platelet","score_opus":0.012882848236441207,"score_gpt":0.23979198517829575,"score_spread":0.22690913694185455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559151048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946805,0.0013146115,0.00008328223,0.0003433386,0.000059159167,0.0011294009,0.000032148713,0.00003765317,0.0023198905],"genre_scores_gemma":[0.9948079,0.000014854893,0.003456806,0.00011051988,0.00017857853,0.00060458004,0.00003484179,0.000030669067,0.0007612476],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99900657,0.00001121844,0.00026657892,0.0002866784,0.00015363992,0.000275328],"domain_scores_gemma":[0.9995189,0.000094119096,0.00006185403,0.00020067515,0.000053433578,0.000071066985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000082585575,0.00016928955,0.0003360949,0.00007528051,0.000048237885,0.000019341765,0.00005016121,0.000082650826,0.000033476248],"category_scores_gemma":[0.000009825645,0.00013915678,0.000111675,0.00011341553,0.000020078402,0.000032890417,0.000019257928,0.000072841736,0.00003704445],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025440528,0.029713433,0.62486804,0.00062915735,0.00024181392,0.00016319171,0.0009568425,0.000012912231,0.33659682,0.0033427225,0.0023156726,0.0009050017],"study_design_scores_gemma":[0.020952208,0.00077628216,0.05868455,0.00015098322,0.00035464452,0.00013743788,0.00023816482,0.0000917427,0.9164136,0.00038806387,0.0015850626,0.0002272295],"about_ca_topic_score_codex":0.00011086806,"about_ca_topic_score_gemma":0.00010675493,"teacher_disagreement_score":0.5798168,"about_ca_system_score_codex":0.00004213345,"about_ca_system_score_gemma":0.00007427525,"threshold_uncertainty_score":0.5674649},"labels":[],"label_agreement":null},{"id":"W2559157710","doi":"10.1182/blood.v104.11.3323.3323","title":"Family Cord Blood Banking: Experience and Views of Pediatric Hematopoietic Stem Cell Transplant Physicians.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Ethics and Legal Issues in Pediatric Healthcare","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Cord blood; Medicine; Umbilical cord; Fanconi anemia; Surgery; Anemia; Pediatrics; Internal medicine; Immunology","score_opus":0.03976871345419174,"score_gpt":0.3085965896744061,"score_spread":0.26882787622021437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559157710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791459,0.017678224,0.000086888365,0.0002601277,0.00014080341,0.0003644089,0.00002035469,0.00004594057,0.0022573723],"genre_scores_gemma":[0.99173874,0.006521762,0.00074430427,0.0004483453,0.00039849547,0.000023156103,0.000007028896,0.000028304763,0.00008988488],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983832,0.000041830375,0.00048634916,0.00035565812,0.00041100566,0.00032192486],"domain_scores_gemma":[0.9991295,0.00008049754,0.00015890287,0.00034775786,0.00010661743,0.00017672697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021387133,0.00020041464,0.00047531974,0.00009888326,0.000078846366,0.000012908827,0.00012973225,0.00017915398,0.000012763611],"category_scores_gemma":[0.000010709473,0.00017763984,0.00009781965,0.0003340277,0.0000990883,0.00006055009,0.000029160912,0.00040434045,0.0000072401567],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069305423,0.018938862,0.47300506,0.034946915,0.0005140571,0.003755625,0.3426668,0.000030856027,0.09533696,0.016638907,0.00033395155,0.013138965],"study_design_scores_gemma":[0.08494414,0.020299992,0.16890483,0.004872074,0.017042363,0.0022809478,0.026659515,0.000049694438,0.6501421,0.006322678,0.013710883,0.004770829],"about_ca_topic_score_codex":0.00013835261,"about_ca_topic_score_gemma":0.0000058912296,"teacher_disagreement_score":0.5548051,"about_ca_system_score_codex":0.000011673314,"about_ca_system_score_gemma":0.00018177646,"threshold_uncertainty_score":0.72439426},"labels":[],"label_agreement":null},{"id":"W2559190882","doi":"10.1182/blood.v112.11.1671.1671","title":"Validation of a Novel Tissue Array Based Classification of Multiple Myeloma (MM).","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"","keywords":"Cohort; Medicine; Multiple myeloma; Oncology; Internal medicine; Immunohistochemistry; Pathology; Tissue microarray; Immunoperoxidase; Immunology; Antibody; Monoclonal antibody","score_opus":0.06481948848454816,"score_gpt":0.3147652170580641,"score_spread":0.24994572857351594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559190882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950196,0.00006179994,0.002957533,0.000120657285,0.000020269536,0.0004521574,0.00004951533,0.000024080224,0.0012943844],"genre_scores_gemma":[0.9879322,0.000013022348,0.011584343,0.000011083017,0.000037564412,0.00003386854,0.00018121167,0.000013901385,0.00019277728],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990296,0.000028925544,0.00026375786,0.00016647387,0.0003625156,0.00014873191],"domain_scores_gemma":[0.9991517,0.00010615093,0.00013031243,0.00030636947,0.00020473675,0.00010070227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000094498464,0.00009011253,0.00022319802,0.00013186845,0.00003881433,0.000002030789,0.00006106749,0.00006366159,0.000076366276],"category_scores_gemma":[0.0003066838,0.00007733983,0.00006279401,0.0001979774,0.000083983214,0.00004701406,0.000008863106,0.00006212279,0.000016578058],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016971995,0.0026163678,0.2151196,0.00009958551,0.00007965093,0.000012095821,0.000097831784,0.0000044847166,0.7804542,0.000015981803,0.000031316642,0.0012991257],"study_design_scores_gemma":[0.006932636,0.00027850043,0.37128863,0.000042094536,0.000052892447,0.000018909774,0.000015810909,0.00045685112,0.6207713,0.0000018652454,0.000103991435,0.000036550744],"about_ca_topic_score_codex":0.00010167284,"about_ca_topic_score_gemma":0.0000062258036,"teacher_disagreement_score":0.15968297,"about_ca_system_score_codex":0.000019713827,"about_ca_system_score_gemma":0.00014414471,"threshold_uncertainty_score":0.31538266},"labels":[],"label_agreement":null},{"id":"W2559199601","doi":"10.1182/blood.v106.11.1112.1112","title":"Quantification by Magnetic Resonance Imaging (MRI) and Consequences of Post-Transfusionnal Iron Overload in Long Bone Marrow Transplant Survivors.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Gastroenterology; Internal medicine; Ferritin; Siderosis; Population; Liver function; Liver function tests; Liver disease; Transplantation","score_opus":0.004619478428837092,"score_gpt":0.21229696253761726,"score_spread":0.20767748410878017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559199601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93884397,0.057023726,0.000037294816,0.003379245,0.000032731856,0.0002365486,0.00004089994,0.000019170566,0.0003864417],"genre_scores_gemma":[0.98910606,0.0103642335,0.00021986297,0.00014290062,0.00001413889,0.0000059400595,0.000034844972,0.000010850798,0.00010117462],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99906504,0.00004256389,0.00031037518,0.00022411432,0.00017026326,0.00018762774],"domain_scores_gemma":[0.99968415,0.00003430815,0.000049531016,0.00012794233,0.000038441034,0.00006561561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018744427,0.00011125625,0.00020713569,0.000093571514,0.000037462974,0.000007966119,0.00004204376,0.000079426245,0.000064053624],"category_scores_gemma":[0.000017213786,0.00009677945,0.000035438843,0.00015304392,0.0001933504,0.00006749866,0.0000052527093,0.00014961103,0.0000034885086],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000265585,0.0007289999,0.35121715,0.00024893394,0.000008534873,0.0001005265,0.0014058024,0.0000062750114,0.6094494,0.00008398581,0.00007725912,0.03640754],"study_design_scores_gemma":[0.015394724,0.00075881294,0.7980835,0.001917778,0.00045040748,0.0011459026,0.0015658129,0.001164381,0.17515871,0.00005586983,0.0037157838,0.00058832054],"about_ca_topic_score_codex":0.0014642766,"about_ca_topic_score_gemma":0.0008166079,"teacher_disagreement_score":0.44686633,"about_ca_system_score_codex":0.000009435936,"about_ca_system_score_gemma":0.000046977424,"threshold_uncertainty_score":0.39465514},"labels":[],"label_agreement":null},{"id":"W2559200630","doi":"10.1182/blood.v116.21.4669.4669","title":"Assessment of Safety and Efficacy of a New Intravenous Immunoglobulin (IGIV3I 10% Grifols) In Subjects with Chronic Immune Thrombocytopenia","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Clinical endpoint; Adverse effect; Internal medicine; Bleeding diathesis; Immune thrombocytopenia; Clinical trial; Platelet","score_opus":0.007279425791655949,"score_gpt":0.2592700842792749,"score_spread":0.2519906584876189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559200630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954453,0.0013765818,0.000011196318,0.00007205542,0.000030342799,0.00054278946,0.000010069859,0.000012489528,0.0024991825],"genre_scores_gemma":[0.9979677,0.00036059102,0.0014393557,0.000008644117,0.000021864234,0.000005652759,0.000031666317,0.000018212826,0.00014630398],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990422,0.000017440521,0.00034336234,0.00020712096,0.00018066348,0.0002092229],"domain_scores_gemma":[0.9993614,0.000051549276,0.00014612329,0.00032142655,0.000041530908,0.00007796179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011491496,0.00015909359,0.0006578742,0.000081043036,0.000024133311,0.000006338161,0.00007997922,0.000092218805,0.0001406342],"category_scores_gemma":[0.000023974542,0.00011891313,0.00004813208,0.0001854931,0.00008787463,0.00004620728,0.000040440376,0.00021227432,0.0000038878397],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037376098,0.017222838,0.30535272,0.0007416607,0.0027845062,0.0013956731,0.0016896203,0.000026007478,0.6300916,0.0014110112,0.00003320337,0.03551354],"study_design_scores_gemma":[0.02920737,0.0021772527,0.93907845,0.00022224273,0.00032858714,0.00023629365,0.00003380773,0.000014323465,0.028417917,0.000032234504,0.00013985469,0.00011164261],"about_ca_topic_score_codex":0.001046068,"about_ca_topic_score_gemma":0.00078744837,"teacher_disagreement_score":0.63372576,"about_ca_system_score_codex":0.000028904611,"about_ca_system_score_gemma":0.00050750514,"threshold_uncertainty_score":0.48491365},"labels":[],"label_agreement":null},{"id":"W2559223604","doi":"10.1182/blood.v112.11.1355.1355","title":"Heterogeneity of Acute Myeloid Leukemia at the Stem Cell Level.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; BC Cancer Agency","funders":"","keywords":"Stem cell; Biology; Myeloid leukemia; Myeloid; Leukemia; Bone marrow; Transplantation; Cancer research; Immunology; Molecular biology; Cell biology; Medicine; Internal medicine","score_opus":0.04330468186836346,"score_gpt":0.2801666809180438,"score_spread":0.23686199904968036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559223604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99089515,0.00074008544,0.000031676704,0.00041813077,0.00005923829,0.00045748346,0.00008515444,0.000051737094,0.0072613657],"genre_scores_gemma":[0.9746317,0.0006121998,0.00044210174,0.00033459032,0.00014812856,0.000028662183,0.000027848455,0.00004200365,0.023732722],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99820065,0.00009249874,0.0003329952,0.00032294204,0.00061648735,0.00043443943],"domain_scores_gemma":[0.9985704,0.00012125801,0.000114397946,0.000852034,0.00015328299,0.00018864393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027273945,0.00019291107,0.00037391591,0.000079871344,0.00020071551,0.000006047338,0.0003232723,0.00014247658,0.00017032947],"category_scores_gemma":[0.000017884771,0.00012632509,0.00020339155,0.0002867978,0.00032310182,0.000051089526,0.00030595987,0.0003703241,0.0003211295],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006252653,0.0007519081,0.09702273,0.00026545735,0.0012295886,0.0013291371,0.001210106,0.000012048489,0.86315393,0.000038094844,0.032036945,0.002324792],"study_design_scores_gemma":[0.004624653,0.00032086423,0.049759135,0.000024168778,0.00035570667,0.001328182,0.000058776644,0.000039876202,0.93740547,0.00000384249,0.005941847,0.00013746055],"about_ca_topic_score_codex":0.00011585873,"about_ca_topic_score_gemma":0.000022691756,"teacher_disagreement_score":0.074251555,"about_ca_system_score_codex":0.0003463264,"about_ca_system_score_gemma":0.00066837226,"threshold_uncertainty_score":0.51513875},"labels":[],"label_agreement":null},{"id":"W2559260065","doi":"10.1182/blood.v104.11.4966.4966","title":"An Exaggerated B Cell CpG Response in Human Chronic Graft-versus-Host Disease: A Potential Mechanism and Biomarker for Diagnosis of Chronic GVHD.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Immunology; Graft-versus-host disease; Medicine; Immune system; Transplantation; TLR9; Flow cytometry; Peripheral blood mononuclear cell; Biology; Internal medicine; DNA methylation; In vitro","score_opus":0.015363561869654147,"score_gpt":0.2796392379094252,"score_spread":0.26427567603977103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559260065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99615824,0.0010356494,0.0012375383,0.00019668374,0.000103237064,0.0010832595,0.00010309669,0.00004738507,0.000034897243],"genre_scores_gemma":[0.9988621,0.0001667164,0.0003969106,0.000021492411,0.000065895554,0.00030038474,0.00011822839,0.000041977175,0.000026334159],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99862695,0.00009470678,0.00035885556,0.0003628993,0.00021929364,0.00033729305],"domain_scores_gemma":[0.99916357,0.00014135688,0.00009351058,0.00029907204,0.000065226566,0.0002372413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003689723,0.0001862695,0.0002986268,0.00021975745,0.00006733109,0.000016088896,0.00008008378,0.00012145361,0.00015283114],"category_scores_gemma":[0.000050530114,0.00018555709,0.00007884497,0.00021084672,0.000070974915,0.00008725455,0.000013154976,0.000085973625,0.000003789952],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006234538,0.003110223,0.004524275,0.0018426167,0.00013808635,0.00040619783,0.00053316425,0.000035935132,0.98232406,0.00065104186,0.000011060621,0.00018881499],"study_design_scores_gemma":[0.05299815,0.0049025393,0.1765505,0.0007579797,0.0011563699,0.000039356735,0.0001283678,0.00033016587,0.7623125,0.0004435611,0.000034488046,0.00034605895],"about_ca_topic_score_codex":0.00007517416,"about_ca_topic_score_gemma":0.000080913414,"teacher_disagreement_score":0.22001158,"about_ca_system_score_codex":0.00016320279,"about_ca_system_score_gemma":0.0004439062,"threshold_uncertainty_score":0.7566799},"labels":[],"label_agreement":null},{"id":"W2559269147","doi":"10.1182/blood.v110.11.2571.2571","title":"Treatment of Relapsed or Refractory Lymphoma with the Oral Isotype-Selective Histone Deacetylase Inhibitor MGCD0103: Interim Results from a Phase II Study.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Jewish General Hospital","funders":"","keywords":"Medicine; Tolerability; Follicular lymphoma; Internal medicine; Dosing; Refractory (planetary science); Lymphoma; Gastroenterology; Diffuse large B-cell lymphoma; Interim analysis; Oncology; Pharmacokinetics; Histone deacetylase inhibitor; Clinical trial; Pharmacology; Adverse effect; Histone deacetylase; Chemistry; Biology; Histone","score_opus":0.019870546665625533,"score_gpt":0.32204390535163124,"score_spread":0.3021733586860057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559269147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971976,0.0007383448,0.00007979241,0.000101507845,0.00010893992,0.00086540676,0.0002576471,0.00002714306,0.000623613],"genre_scores_gemma":[0.996128,0.00004802994,0.00042424144,0.000033624783,0.00034736152,0.00007082453,0.000229601,0.000057926707,0.0026603832],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977881,0.00020835883,0.0004907622,0.0006744963,0.00040151592,0.0004367705],"domain_scores_gemma":[0.9983424,0.0001224171,0.00025181848,0.00086868927,0.00024769118,0.00016697036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038107255,0.0003284061,0.0003690085,0.000109255474,0.00023066062,0.000016893408,0.0002805913,0.00019109213,0.000023438884],"category_scores_gemma":[0.0002280511,0.0002030283,0.00012487355,0.00029801784,0.00029102986,0.000009007449,0.00013468608,0.00012890251,0.00001274723],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029696627,0.021648835,0.00012722718,0.000007446817,0.0006670779,0.00035586735,0.003923759,0.0000020362993,0.9269305,0.0000013365303,0.0029089232,0.013730354],"study_design_scores_gemma":[0.034826677,0.044207934,0.0004336297,0.000021872589,0.00017865321,0.00004378501,0.0012511612,0.0000046976284,0.892774,0.0000010836213,0.025999185,0.00025731156],"about_ca_topic_score_codex":0.00088170054,"about_ca_topic_score_gemma":0.0033444988,"teacher_disagreement_score":0.0341565,"about_ca_system_score_codex":0.00018682507,"about_ca_system_score_gemma":0.00042205353,"threshold_uncertainty_score":0.82792544},"labels":[],"label_agreement":null},{"id":"W2559295313","doi":"10.1182/blood.v106.11.5171.5171","title":"A Supervised Group Exercise Program for Patients with Multiple Myeloma.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Physical therapy; Aerobic exercise; Depression (economics); Quality of life (healthcare); Anxiety","score_opus":0.011162306660536182,"score_gpt":0.27557070673184675,"score_spread":0.26440840007131056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559295313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99662375,0.00026534774,0.00001085748,0.00025055624,0.000047613565,0.002286047,0.000025778329,0.00011141634,0.00037861368],"genre_scores_gemma":[0.98315483,0.000025084208,0.014756651,0.00019274927,0.00021925631,0.0010539552,0.00023792942,0.000023623112,0.0003359294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994203,0.0000055075675,0.00009971625,0.00017277188,0.000094819145,0.00020689542],"domain_scores_gemma":[0.9996646,0.000033501372,0.000026184336,0.000116322146,0.000060539995,0.000098860444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000022236754,0.00010725882,0.00017533536,0.000036729638,0.000043135886,0.000007094519,0.00003636482,0.000042928732,0.00010952155],"category_scores_gemma":[0.000006986049,0.0000776312,0.000056788947,0.00007281538,0.00002484871,0.000045114346,0.000009736807,0.000044274395,0.000017354641],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030011851,0.019016897,0.7290415,0.00012377287,0.00028480554,0.0000114501945,0.00030605594,7.056673e-7,0.0006805188,0.0000155007,0.0017052244,0.24581236],"study_design_scores_gemma":[0.16385305,0.012286691,0.6775385,0.00016322262,0.0028794568,0.000013746211,0.000041032825,0.0003584245,0.010837781,0.000018016968,0.13162632,0.00038374064],"about_ca_topic_score_codex":0.000011575722,"about_ca_topic_score_gemma":0.000052714735,"teacher_disagreement_score":0.2454286,"about_ca_system_score_codex":0.000022018394,"about_ca_system_score_gemma":0.000027627459,"threshold_uncertainty_score":0.31657085},"labels":[],"label_agreement":null},{"id":"W2559326805","doi":"10.1182/blood.v124.21.1550.1550","title":"The Effects of Thrombocytopenia on Clotting Profile in Whole Blood As Determined By Thromboelastography When Anticoagulant Is Present at Therapeutic or Prophylactic Concentration","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; University of Manitoba; Shared Health; McMaster University","funders":"","keywords":"Thromboelastography; Medicine; Whole blood; Hemostasis; Anticoagulant; Platelet; Coagulation; Clotting time; Heparin; Fondaparinux; Pharmacology; Anesthesia; Surgery; Thrombosis; Internal medicine; Venous thromboembolism","score_opus":0.009506520893946626,"score_gpt":0.25594868862460635,"score_spread":0.24644216773065972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559326805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961702,0.0009042705,0.000006180944,0.00045232437,0.000073969,0.0016245377,0.000008272174,0.000029040619,0.0007311593],"genre_scores_gemma":[0.9989258,0.00009846189,0.00009856164,0.00024265857,0.00003177102,0.00010629436,0.000026013999,0.000028046474,0.00044239525],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985947,0.00012552572,0.00030495334,0.00031133654,0.00032808437,0.00033540596],"domain_scores_gemma":[0.9989773,0.00037424313,0.00018026325,0.00035163708,0.000042491654,0.00007404655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013259253,0.00021382519,0.0004511784,0.00004606027,0.00013724795,0.000029857509,0.00011166599,0.00008912425,0.000028813116],"category_scores_gemma":[0.00010139449,0.00012293173,0.00009100843,0.00015315149,0.00009560971,0.00006268599,0.0000356755,0.00012734141,0.000028253316],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001709719,0.008026738,0.14843714,0.0010689996,0.0013905455,0.00033226828,0.0025886872,0.0000011472948,0.8186001,0.000119398406,0.00070466567,0.017020581],"study_design_scores_gemma":[0.019727033,0.0075512812,0.05076375,0.00048774612,0.0010797625,0.00011650745,0.00007678421,0.0002586021,0.9183709,0.0004027626,0.00091747043,0.00024738882],"about_ca_topic_score_codex":0.00008418335,"about_ca_topic_score_gemma":0.000031959757,"teacher_disagreement_score":0.09977081,"about_ca_system_score_codex":0.000021279606,"about_ca_system_score_gemma":0.000055992114,"threshold_uncertainty_score":0.50130105},"labels":[],"label_agreement":null},{"id":"W2559352070","doi":"10.1182/blood.v110.11.3953.3953","title":"Evaluation of Inherited Prothrombotic Risk Factors in Children with Acute Lymphoblastic Leukemia.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Prothrombin G20210A; Protein S; Factor V Leiden; Methylenetetrahydrofolate reductase; Protein S deficiency; Factor V; Internal medicine; Gastroenterology; Population; Antithrombin; Protein C deficiency; Gene mutation; Thrombophilia; Protein C; Genotype; Pediatrics; Immunology; Mutation; Thrombosis; Heparin; Venous thrombosis; Genetics; Biology","score_opus":0.0244208365037167,"score_gpt":0.2806758590573038,"score_spread":0.2562550225535871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559352070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975255,0.00005354429,0.0006655215,0.000009101105,0.000029245666,0.0012071873,0.0000068906884,0.000047318787,0.00045566476],"genre_scores_gemma":[0.99878585,0.000009838344,0.0010528759,0.000027763788,0.00003089582,0.000020328956,0.00003531115,0.00002531638,0.0000118299295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99838436,0.00008742607,0.0003206261,0.00022525208,0.00077065534,0.00021169888],"domain_scores_gemma":[0.9992155,0.000035344063,0.00017732978,0.00024789153,0.00023369858,0.00009026115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009810317,0.00014848328,0.00031424317,0.0002246342,0.000031713163,0.0000063700213,0.00005913816,0.00010757704,0.00008811083],"category_scores_gemma":[0.00011572298,0.00011552736,0.00004695942,0.0004795676,0.000045369612,0.00006349755,0.000016189146,0.00012973149,0.0000072558787],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000086065374,0.0010997547,0.9586618,0.00001990264,0.0009220898,0.0000056544127,0.0004249227,0.00015604631,0.036922988,0.00013582305,0.0000028682616,0.0015621105],"study_design_scores_gemma":[0.009456305,0.00054086436,0.87398565,0.00010006874,0.0026640354,0.000049720158,0.00008010228,0.0007576993,0.11208025,0.00017423929,8.839483e-7,0.000110194],"about_ca_topic_score_codex":0.00018690941,"about_ca_topic_score_gemma":0.000099762416,"teacher_disagreement_score":0.08467615,"about_ca_system_score_codex":0.00012647403,"about_ca_system_score_gemma":0.00032853347,"threshold_uncertainty_score":0.4711069},"labels":[],"label_agreement":null},{"id":"W2559378733","doi":"10.1182/blood.v110.11.1351.1351","title":"Bendamustine Is Safe and Effective in Patients with Rituximab-Refractory, Indolent B-Cell Non-Hodgkin Lymphoma.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Bendamustine; Rituximab; Medicine; Internal medicine; Follicular lymphoma; Refractory (planetary science); Chronic lymphocytic leukemia; Neutropenia; Lymphoma; Oncology; Clinical endpoint; Non-Hodgkin's lymphoma; Salvage therapy; Gastroenterology; Surgery; Chemotherapy; Leukemia; Clinical trial","score_opus":0.003795729831162938,"score_gpt":0.23946237270392845,"score_spread":0.2356666428727655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559378733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99426174,0.00028919536,0.000039475475,0.000042733893,0.000047522466,0.0012649551,0.000013809101,0.000028214345,0.0040123733],"genre_scores_gemma":[0.9987071,0.000030166284,0.0005617311,0.00024304516,0.000106275584,0.000031913798,0.00002746502,0.000046582667,0.00024568033],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99791664,0.00003988378,0.00030986653,0.00047971727,0.00065032794,0.00060356886],"domain_scores_gemma":[0.99883944,0.00024594855,0.00008723043,0.00038987503,0.00014463239,0.0002928943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045207966,0.00024881595,0.0004280148,0.0002754166,0.000054001935,0.000019071997,0.00010544029,0.00015841659,0.00006650879],"category_scores_gemma":[0.000094700896,0.00019485505,0.00004475765,0.00036472935,0.00013978775,0.000086696185,0.00011779075,0.00023826802,0.000064217274],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008700088,0.030912295,0.83498484,0.0012459852,0.0004081208,0.001664473,0.0038214044,0.0000022188542,0.0019777021,0.000012689246,0.0007741817,0.11549598],"study_design_scores_gemma":[0.26542643,0.0020631994,0.70651495,0.00030209837,0.00013241386,0.000054063967,0.00008582754,0.00008527922,0.024143595,0.000005942469,0.0009557624,0.00023044278],"about_ca_topic_score_codex":0.0005832785,"about_ca_topic_score_gemma":0.00008890614,"teacher_disagreement_score":0.25672632,"about_ca_system_score_codex":0.002508691,"about_ca_system_score_gemma":0.0011129631,"threshold_uncertainty_score":0.79459584},"labels":[],"label_agreement":null},{"id":"W2559388362","doi":"10.1182/blood.v126.23.4319.4319","title":"Influence of Prophylactic Antibiotics Aiming at Gut Decontamination on Gastrointestinal Graft-Versus-Host Disease and Overall Survival Following Allogeneic Haematopoietic Stem Cell Transplantation","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; McGill University Health Centre; Centre hospitalier universitaire de Québec; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Transplantation; Stem cell; Hematopoietic stem cell transplantation; Antibiotics; Immunology; Haematopoiesis; Gastrointestinal tract; Internal medicine; Gut flora; Biology; Microbiology","score_opus":0.023729416439763246,"score_gpt":0.26454841161854,"score_spread":0.24081899517877672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559388362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99886996,0.00009487442,0.00011037554,0.00007284584,0.00012611212,0.0003502381,0.000011747374,0.000032460226,0.00033136774],"genre_scores_gemma":[0.99953014,0.000025311367,0.00023126721,0.000034400662,0.000041664203,0.0000040056216,0.000016980306,0.000019027404,0.00009722403],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990574,0.000050609684,0.0002197072,0.00022538763,0.00027894625,0.00016793446],"domain_scores_gemma":[0.99934244,0.00007988637,0.00010855082,0.00015911278,0.000100526624,0.00020948591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001211462,0.00013820402,0.0002048079,0.000081117134,0.00007333858,0.000015519823,0.00004333448,0.000030180754,0.0000030352924],"category_scores_gemma":[0.000034282803,0.00012970525,0.000066699824,0.000094532435,0.000041861866,0.00012280355,0.00001744824,0.00009442361,0.0000070862775],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018801811,0.0006966565,0.7887741,0.0009325679,0.00007516483,0.00043880657,0.0005201507,0.00078103587,0.20562251,0.00015751191,0.0000058019236,0.00011552401],"study_design_scores_gemma":[0.011473299,0.0020450207,0.90694,0.00061642536,0.0016680949,0.00022282946,0.00016433297,0.000065902765,0.076549344,0.000021666789,0.000013281189,0.00021983261],"about_ca_topic_score_codex":0.000031100724,"about_ca_topic_score_gemma":0.000038647275,"teacher_disagreement_score":0.12907316,"about_ca_system_score_codex":0.00006962844,"about_ca_system_score_gemma":0.00012670804,"threshold_uncertainty_score":0.5289227},"labels":[],"label_agreement":null},{"id":"W2559405438","doi":"10.1182/blood.v124.21.2336.2336","title":"Bone Marrow Aspirates Alone without a Trephine Biopsy May be Insufficient for the Detection of Residual Leukemia Following Intensive Chemotherapy for the Treatment of Acute Myeloid Leukemia","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hematological disorders and diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Bone marrow; Internal medicine; Myeloid leukemia; Leukemia; Chemotherapy regimen; Minimal residual disease; Hematology; Chemotherapy; Biopsy; Bone marrow examination; Induction chemotherapy; Oncology; Surgery","score_opus":0.020849573909656187,"score_gpt":0.2785631876675065,"score_spread":0.2577136137578503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559405438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881759,0.0018811072,0.005702037,0.0021900926,0.00011656313,0.0018067368,0.000058490506,0.000031482316,0.000037579193],"genre_scores_gemma":[0.9968262,0.0004474687,0.0012892145,0.0008300029,0.00011245919,0.00033366634,0.00002605494,0.000030430017,0.00010454563],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988664,0.000027454245,0.00041200581,0.0002471423,0.00019766892,0.00024937905],"domain_scores_gemma":[0.99779505,0.001299534,0.00021868842,0.00036754878,0.00026326746,0.000055907727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002586315,0.00020785682,0.00058839505,0.000055373115,0.00013408758,0.000011591001,0.0000992801,0.00012437762,0.000008011171],"category_scores_gemma":[0.00071584916,0.00010220389,0.0003369757,0.00016054556,0.00014451187,0.0000215671,0.00001629244,0.00006850692,7.9372387e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010539311,0.0066499077,0.028678028,0.00069943396,0.008428208,0.000042143176,0.007190672,0.00022053614,0.83815664,0.001235932,0.001256655,0.09690254],"study_design_scores_gemma":[0.029484952,0.014657411,0.0152980955,0.00018779236,0.004915885,0.00008757138,0.0017027821,0.0059641674,0.92074,0.00039638227,0.0062895115,0.00027541898],"about_ca_topic_score_codex":0.00015190395,"about_ca_topic_score_gemma":0.000048370166,"teacher_disagreement_score":0.09662712,"about_ca_system_score_codex":0.000076804725,"about_ca_system_score_gemma":0.00011039171,"threshold_uncertainty_score":0.41677538},"labels":[],"label_agreement":null},{"id":"W2559408837","doi":"10.1182/blood.v114.22.2841.2841","title":"Splicing Mutations in the Hyaluronan Synthase I Gene of Patients with Monoclonal Gammopathy of Undetermined Significance.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"RNA splicing; Intron; Biology; Exon; Mutation; Monoclonal gammopathy of undetermined significance; Genetics; Molecular biology; Gene; Monoclonal; Monoclonal antibody; RNA; Antibody","score_opus":0.01753480009453971,"score_gpt":0.2729657599082055,"score_spread":0.25543095981366576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559408837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99887866,0.000054904856,0.00003282208,0.00007681128,0.0000047141675,0.00051723595,0.000046583613,0.000005598759,0.00038267171],"genre_scores_gemma":[0.99836904,0.0000039152064,0.0014698352,0.000031796535,0.000012955743,0.000021103533,0.00006750524,0.000006141804,0.000017679467],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99915326,0.00004127527,0.00019740932,0.0001255623,0.0003240853,0.00015841181],"domain_scores_gemma":[0.9994843,0.00009087512,0.00007696027,0.00021201385,0.000079524514,0.000056326877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008736677,0.000082192426,0.00017958148,0.00009383204,0.000023916058,0.0000034755096,0.00007352927,0.000023072726,0.000015693231],"category_scores_gemma":[0.00006418546,0.000049475762,0.00003806391,0.00019549114,0.000053416738,0.000031437423,0.0000068337217,0.000068677735,0.0000016897171],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008766553,0.0065793586,0.95664793,0.000066213106,0.00011802924,0.00019222044,0.0007089461,0.000024470826,0.013936247,0.00005888359,0.0000051567613,0.0207859],"study_design_scores_gemma":[0.007281925,0.002193706,0.9545044,0.00006993487,0.000103837265,0.0000074197956,0.00007924802,0.00009223464,0.035574477,0.000045418044,0.0000030104768,0.00004443516],"about_ca_topic_score_codex":0.00009826582,"about_ca_topic_score_gemma":0.000028013063,"teacher_disagreement_score":0.021638231,"about_ca_system_score_codex":0.0000148295385,"about_ca_system_score_gemma":0.00008206447,"threshold_uncertainty_score":0.2017563},"labels":[],"label_agreement":null},{"id":"W2559414602","doi":"10.1182/blood.v104.11.1844.1844","title":"Negative Impact of Pre-Transplant Anemia on Long-Term Outcome after Allogeneic Hematopoietic Stem Cell Transplantation.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Hematological disorders and diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University; Robarts Clinical Trials; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Transplantation; Gastroenterology; Hematopoietic stem cell transplantation; Anemia; Hemoglobin; Surgery","score_opus":0.015608093117173311,"score_gpt":0.2830850165853892,"score_spread":0.2674769234682159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559414602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976932,0.0004220416,0.0004337988,0.000093584495,0.000029462237,0.00048391544,0.00012516796,0.000042693446,0.0006761501],"genre_scores_gemma":[0.99918765,0.00020597917,0.00022524837,0.00020865657,0.000020199748,0.000034682333,0.000042207124,0.000021007756,0.000054356296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988281,0.000026592143,0.00039337736,0.00024259005,0.0002429577,0.00026635604],"domain_scores_gemma":[0.99929696,0.00016183584,0.00008537581,0.00022979578,0.000048485774,0.00017753991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000052881493,0.00021550228,0.00043094408,0.000070712325,0.00002702534,0.000008434842,0.000081327285,0.00014697012,0.00015471068],"category_scores_gemma":[0.000015796852,0.00014702443,0.000239898,0.00011978135,0.00007067948,0.000034373417,0.000006881487,0.0001541212,0.000047683814],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008832414,0.0028947454,0.9883212,0.0013602396,0.00009671981,0.0015367689,0.0016568258,0.00016294334,0.002908699,0.00010836465,0.000006386538,0.000063885054],"study_design_scores_gemma":[0.0060708635,0.001624856,0.9105873,0.00038480049,0.00056635775,0.00024156751,0.000030706262,8.2115685e-7,0.08015464,0.00016490594,3.024375e-7,0.00017286933],"about_ca_topic_score_codex":0.000032656546,"about_ca_topic_score_gemma":0.000017424676,"teacher_disagreement_score":0.07773387,"about_ca_system_score_codex":0.000027026274,"about_ca_system_score_gemma":0.00008649995,"threshold_uncertainty_score":0.5995482},"labels":[],"label_agreement":null},{"id":"W2559422573","doi":"10.1182/blood.v116.21.804.804","title":"Identification of Genes Frequently Mutated In FL and DLBCL with Transcriptome, Genome and Exome Sequencing","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Germinal center; Biology; Follicular lymphoma; Exome; Exome sequencing; Cancer research; Lymphoma; Gene expression profiling; Genetics; Gene; Mutation; B cell; Immunology; Gene expression","score_opus":0.00906692428152137,"score_gpt":0.2243887047164775,"score_spread":0.21532178043495614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559422573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99821216,0.0012634167,0.000005413164,0.00010908188,0.00002032381,0.0002513757,0.000012390811,0.000013979469,0.00011188732],"genre_scores_gemma":[0.99925035,0.00021992222,0.00040574372,0.000025856347,0.000016523863,0.000028453034,0.000015593941,0.000009628784,0.00002789725],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999447,0.000009713649,0.00018230402,0.00016810936,0.00009384857,0.00009901073],"domain_scores_gemma":[0.99970454,0.000016263328,0.000052413106,0.00012871297,0.000036715966,0.000061365434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008607937,0.00008200784,0.0001694998,0.00009088434,0.000020906284,0.000012231006,0.000021116337,0.00004485693,0.000009181893],"category_scores_gemma":[0.00000845371,0.00006110858,0.000014555249,0.00010138915,0.00006260445,0.00005781878,0.000005504187,0.000047300986,0.0000012104259],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020690475,0.00033134734,0.31206027,0.00006436754,0.000055562163,0.00006372337,0.00052811956,3.6737148e-7,0.6859548,0.00006836729,3.2382877e-7,0.00085203635],"study_design_scores_gemma":[0.0059813457,0.00016946734,0.7558362,0.000042365908,0.00019670773,0.00021183954,0.00012877682,0.000019044106,0.23728816,0.00003924009,0.000025354575,0.00006147697],"about_ca_topic_score_codex":0.00020160663,"about_ca_topic_score_gemma":0.00018958878,"teacher_disagreement_score":0.44866666,"about_ca_system_score_codex":0.000015620406,"about_ca_system_score_gemma":0.00004502783,"threshold_uncertainty_score":0.24919355},"labels":[],"label_agreement":null},{"id":"W2559435609","doi":"10.1182/blood.v126.23.902.902","title":"PP2A Is Required for B Cell Survival and Represents a Therapeutic Target in Acute Lymphoblastic Leukemia","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Protein phosphatase 2; Biology; Cancer research; Protein kinase B; Leukemia; Protein subunit; Myeloid leukemia; Myeloid; Lymphoblast; PI3K/AKT/mTOR pathway; breakpoint cluster region; Stem cell; Phosphatase; Phosphorylation; Immunology; Signal transduction; Genetics; Cell culture; Gene","score_opus":0.03293970052511146,"score_gpt":0.2863745782250327,"score_spread":0.25343487769992123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559435609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99393,0.0016297244,0.000108624474,0.00027504613,0.00016731273,0.00086159224,0.000039822302,0.000056057903,0.0029318656],"genre_scores_gemma":[0.9941347,0.00010335248,0.0018665636,0.00026277604,0.00012388638,0.000111708185,0.00005309609,0.000048813577,0.0032951068],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99853593,0.000044383334,0.00028726144,0.0004493246,0.00028458072,0.00039850204],"domain_scores_gemma":[0.99903816,0.00012497026,0.00008113804,0.00043615454,0.000073469055,0.0002461327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022142915,0.0002158144,0.0004250655,0.000101077465,0.000033466622,0.00001944589,0.00009781674,0.00013544744,0.000030011237],"category_scores_gemma":[0.00009404661,0.00018673918,0.00007265777,0.00016591413,0.00005681683,0.00008139134,0.00006842075,0.00009736157,0.00003873676],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073938863,0.007435433,0.86981875,0.001317598,0.003998831,0.0023490079,0.010776382,0.000048268066,0.075946204,0.00037430384,0.013899634,0.006641702],"study_design_scores_gemma":[0.5155476,0.008107903,0.20667143,0.00090375385,0.0068275523,0.0013046545,0.0019810349,0.013901458,0.21084405,0.007600606,0.02417938,0.00213061],"about_ca_topic_score_codex":0.00018078033,"about_ca_topic_score_gemma":0.00001766829,"teacher_disagreement_score":0.66314733,"about_ca_system_score_codex":0.0006546703,"about_ca_system_score_gemma":0.00084579596,"threshold_uncertainty_score":0.7615003},"labels":[],"label_agreement":null},{"id":"W2559444424","doi":"10.1182/blood.v106.11.5192.5192","title":"The Effects of Zoledronic Acid Dose and Infusion Rate on Pharmacokinetics (PK), Pharmacodynamics (PD), and Renal Function in Patients with Multiple Myeloma.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Zoledronic acid; Pharmacokinetics; Multiple myeloma; Cmax; Renal function; Pharmacodynamics; Regimen; Urology; Surgery; Internal medicine","score_opus":0.005260010415583243,"score_gpt":0.24511728963827012,"score_spread":0.23985727922268688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559444424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980906,0.00077141763,0.0000076260517,0.00009200304,0.000037507394,0.00090244546,0.000011047058,0.000016670256,0.00007065599],"genre_scores_gemma":[0.9986518,0.0009614665,0.0001296012,0.000068178066,0.000046931524,0.000039284434,0.000035616184,0.000018984061,0.00004816325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989934,0.000083101964,0.00018203232,0.00021288078,0.000269297,0.00025926574],"domain_scores_gemma":[0.9993323,0.00023471592,0.00007401,0.00015289363,0.000064457614,0.00014161035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013329634,0.00015745361,0.000182497,0.00010325865,0.000091687856,0.00001528078,0.000042767322,0.00004594141,0.000004812143],"category_scores_gemma":[0.00009426407,0.00009552864,0.000022225293,0.00013509784,0.00008972289,0.00007020234,0.000049950464,0.00019284111,0.0000035940257],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009589215,0.002395565,0.7686944,0.0002566215,0.0003449406,0.000045857516,0.00016594335,0.000029838735,0.07519441,0.000008741751,0.00003237518,0.14324209],"study_design_scores_gemma":[0.050321043,0.002508185,0.8921443,0.00017589859,0.00020961171,0.0000049153123,0.0000073795795,0.0029119658,0.051393524,0.000004647358,0.00022958191,0.00008894947],"about_ca_topic_score_codex":0.000016154854,"about_ca_topic_score_gemma":0.00006685888,"teacher_disagreement_score":0.14315313,"about_ca_system_score_codex":0.000035601137,"about_ca_system_score_gemma":0.00003512854,"threshold_uncertainty_score":0.38955447},"labels":[],"label_agreement":null},{"id":"W2559455083","doi":"10.1182/blood.v112.11.4190.4190","title":"CD38 Expression above 20% Predicts Disease Progression in Chronic Lymphocytic Leukemia and Is a Useful Prognostic Marker Where Cytogenetic and Molecular Markers Are Not Available","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; St. Paul's Hospital; University of British Columbia Hospital","funders":"","keywords":"CD38; Chronic lymphocytic leukemia; Medicine; Internal medicine; Univariate analysis; Stage (stratigraphy); Oncology; Leukemia; Gastroenterology; Lymphocyte; Disease; Immunology; Multivariate analysis; Biology","score_opus":0.01639218791434852,"score_gpt":0.259159605116991,"score_spread":0.24276741720264247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559455083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9669079,0.030267844,0.000008392771,0.0001681891,0.000043087857,0.0020082537,0.000040949668,0.000104442224,0.00045090014],"genre_scores_gemma":[0.9922112,0.0048726955,0.00050241617,0.00024843446,0.00011723501,0.00032910574,0.000032933396,0.00010697423,0.0015790113],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99625015,0.00017524882,0.00051761203,0.0010922053,0.0010277607,0.00093700294],"domain_scores_gemma":[0.99780685,0.00019234484,0.00016441235,0.0008064359,0.00012755879,0.0009024047],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003147544,0.00046918966,0.00059087237,0.00028030082,0.0001790111,0.00006111485,0.00019621305,0.00028280687,0.0002709119],"category_scores_gemma":[0.0004040714,0.00040358442,0.00009760647,0.00041856602,0.0004633597,0.00018471415,0.00039110612,0.0003628452,0.00007262806],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.008637973,0.0015121499,0.79619074,0.01144641,0.00056218525,0.036809254,0.0013877293,0.00018969238,0.12351089,0.000006494334,0.016308809,0.0034376779],"study_design_scores_gemma":[0.22079039,0.002220128,0.516276,0.021154301,0.001445287,0.0059800395,0.00025075316,0.10394833,0.120832786,0.00007996876,0.0051071662,0.001914828],"about_ca_topic_score_codex":0.00018427172,"about_ca_topic_score_gemma":0.000034534594,"teacher_disagreement_score":0.2799147,"about_ca_system_score_codex":0.012473898,"about_ca_system_score_gemma":0.018341469,"threshold_uncertainty_score":0.99984163},"labels":[],"label_agreement":null},{"id":"W2559465717","doi":"10.1182/blood.v116.21.587.587","title":"A Novel Synthetic GMCSF and MCP3 Fusion Cytokine Induces IL10-Producing B Cells with Immune Modulatory Properties on Antigen Presentation and Th17 Development","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer; Jewish General Hospital","funders":"","keywords":"Immunology; Experimental autoimmune encephalomyelitis; Immune system; Biology; Cytokine; Interleukin 10; Chemokine; Antigen presentation; Regulatory B cells; Cancer research; T cell","score_opus":0.012344056314682286,"score_gpt":0.202602400536756,"score_spread":0.19025834422207372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559465717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99440783,0.0046845027,0.000022953867,0.000114166985,0.0002475776,0.00039001272,0.000005239125,0.000052283576,0.00007545465],"genre_scores_gemma":[0.9984417,0.00030325964,0.00049111474,0.000050322258,0.000021358639,0.000034279452,0.000013390157,0.000026032643,0.00061856204],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989856,0.000084870575,0.00024512436,0.00036692925,0.000054893284,0.0002625844],"domain_scores_gemma":[0.9994568,0.000066802626,0.000116750794,0.00028856678,0.00005386312,0.000017184242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027679687,0.00022172753,0.00023932481,0.00012850738,0.00040295263,0.00004472116,0.00011686972,0.00017043951,0.000040892282],"category_scores_gemma":[0.00003944078,0.00015536079,0.000022304192,0.00007319611,0.00026285186,0.00014102903,0.00008077917,0.0003338425,0.000021111762],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055548945,0.00040877247,0.0010339395,0.000034931036,0.00019608295,0.0000020889593,0.0031741748,0.0000024288174,0.9873793,0.0000265346,0.0000058452674,0.007180382],"study_design_scores_gemma":[0.002238963,0.00029479372,0.08633875,0.00014850755,0.00003853983,0.00015586583,0.0002837718,0.0000019938955,0.9087546,0.0000038324283,0.0015200538,0.00022036071],"about_ca_topic_score_codex":0.00011791629,"about_ca_topic_score_gemma":0.000020563406,"teacher_disagreement_score":0.08530481,"about_ca_system_score_codex":0.0000071578784,"about_ca_system_score_gemma":0.0000846283,"threshold_uncertainty_score":0.6335429},"labels":[],"label_agreement":null},{"id":"W2559478920","doi":"10.1182/blood.v104.11.2855.2855","title":"Recombinant TAT-HOXB4 Protein Promotes Ex Vivo Expansion of Primitive Human Hematopoietic Cells.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Haematopoiesis; Stem cell; CD34; Transplantation; Ex vivo; In vivo; Biology; Bone marrow; Cancer research; Peripheral blood mononuclear cell; Hematopoietic stem cell transplantation; Immunology; Hematopoietic stem cell; Molecular biology; In vitro; Medicine; Cell biology; Internal medicine; Genetics","score_opus":0.015327244648518128,"score_gpt":0.2524915727305592,"score_spread":0.2371643280820411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559478920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930962,0.000131631,0.00058612134,0.00020138516,0.00008375281,0.0017552924,0.0000097404045,0.00010636814,0.004029517],"genre_scores_gemma":[0.9929652,0.000021798598,0.0062633143,0.000034777113,0.000042059375,0.000084541665,0.00002734368,0.000050298182,0.0005106638],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99825495,0.000057023124,0.0005567065,0.0003764857,0.0004384108,0.00031640127],"domain_scores_gemma":[0.9990609,0.000038741364,0.00019650198,0.00040616124,0.00014746771,0.00015018099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002458165,0.00023490963,0.0004784411,0.00013590103,0.00007288321,0.000011251454,0.00010985568,0.00015389714,0.00014478667],"category_scores_gemma":[0.000033276992,0.00020498908,0.00013296668,0.00022058822,0.00010957669,0.00007386566,0.000023045503,0.00018214468,0.00006507676],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005251093,0.0015905646,0.00050551136,0.0015503855,0.000068483736,0.00017347604,0.0029389965,0.0000017128756,0.9912951,0.0017239723,0.000013755538,0.0000855024],"study_design_scores_gemma":[0.006784344,0.001022929,0.0018184236,0.0023616222,0.00029851377,0.00023293078,0.00037575126,0.0000020028438,0.9855053,0.0013601084,0.00003580215,0.00020229901],"about_ca_topic_score_codex":0.000069910086,"about_ca_topic_score_gemma":0.0000072937914,"teacher_disagreement_score":0.0067318333,"about_ca_system_score_codex":0.00004431643,"about_ca_system_score_gemma":0.00017440369,"threshold_uncertainty_score":0.83592117},"labels":[],"label_agreement":null},{"id":"W2559499796","doi":"10.1182/blood.v110.11.1507.1507","title":"A High Throughput Screen Identified Cyproheptadine That Decreases D-Type Cyclins, Arrests Cells in the G1 Phase, and Induces Apoptosis in Multiple Myeloma and Leukemia Cells.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cyproheptadine; Cancer research; Viability assay; Cyclin B; Cyclin; Cyclin D; Cyclin D1; Cyclin B1; Cyclin D3; Apoptosis; Cell cycle checkpoint; Cyclin A; Cell cycle; Cell growth; Biology; Cyclin E; Cyclin-dependent kinase 1; Molecular biology; Biochemistry","score_opus":0.026885064577257478,"score_gpt":0.29046616117431256,"score_spread":0.2635810965970551,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559499796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99331015,0.005368345,0.00008250782,0.00020812941,0.0001361311,0.0007157819,0.000028253415,0.000048035792,0.00010266735],"genre_scores_gemma":[0.9962132,0.00096686906,0.00199446,0.00046009003,0.00020521643,0.000028352933,0.000038463004,0.000038787806,0.00005453482],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982903,0.00007458583,0.00037951954,0.0004890308,0.00031963844,0.00044692194],"domain_scores_gemma":[0.9988661,0.000428638,0.00013601886,0.00037637367,0.000046464185,0.00014642124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004804901,0.00028387355,0.0004461187,0.00022974082,0.00008700489,0.000050667546,0.00016280283,0.00014748695,0.000020781732],"category_scores_gemma":[0.00010130851,0.00021411467,0.000043599626,0.0004639594,0.00022002436,0.00023074892,0.0000745067,0.00032017817,0.0000050526314],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029261592,0.002144348,0.20390272,0.0002478264,0.00025268507,0.00043749937,0.0045768623,0.000015408046,0.7217068,0.00008200815,0.00017232838,0.063535355],"study_design_scores_gemma":[0.017122928,0.00031901788,0.30498576,0.00031818904,0.00017098259,0.00007867797,0.0015998107,0.000019470392,0.67389256,0.00028727425,0.0009223882,0.00028295195],"about_ca_topic_score_codex":0.0018490433,"about_ca_topic_score_gemma":0.0018639001,"teacher_disagreement_score":0.101083055,"about_ca_system_score_codex":0.00007223155,"about_ca_system_score_gemma":0.0000860075,"threshold_uncertainty_score":0.8731343},"labels":[],"label_agreement":null},{"id":"W2559499811","doi":"10.1182/blood.v126.23.4026.4026","title":"Propensity Score Matching Analysis Demonstrates the Use of Statin Enhances Chance of Achieving MR4.5 in Chronic Myeloid Leukemia Patients in Chronic Phase Following Imatinib Therapy Regardless of Other Clinical Features Including Age of the Patients","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Statin; Imatinib; Internal medicine; Myeloid leukemia; Imatinib mesylate; Oncology; Propensity score matching; Clinical trial; Randomized controlled trial; Dosing","score_opus":0.06649470221399313,"score_gpt":0.32772167059318463,"score_spread":0.2612269683791915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559499811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99673426,0.002361029,0.000058133293,0.0000058868336,0.0003019684,0.00047071328,0.000048852427,0.0000020840034,0.000017084076],"genre_scores_gemma":[0.99893785,0.00053350645,0.0002221383,0.000021741273,0.00020763374,0.000016155875,0.000035547917,0.000015820075,0.000009603772],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99811256,0.00035310537,0.0007751741,0.0002774806,0.0002762489,0.00020541575],"domain_scores_gemma":[0.99858963,0.00007617665,0.00073967635,0.0004224023,0.00013870583,0.000033420038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007013431,0.00016684634,0.0005683428,0.000083667335,0.000037385533,0.000010062688,0.0003361662,0.000115535935,0.0000014105348],"category_scores_gemma":[0.00024025774,0.00010731976,0.00026101802,0.0003833928,0.00019093385,0.00002085229,0.00016451058,0.000168178,4.657391e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024156747,0.00051751017,0.5992475,0.00008714752,0.00035309812,1.03968006e-7,0.0010333185,0.0008939674,0.39290664,0.0000052119412,0.00001607684,0.00469784],"study_design_scores_gemma":[0.006616697,0.00048438675,0.56721056,0.00035471458,0.00019566891,1.7305139e-7,0.00013435518,0.00006257178,0.42461732,0.000017727905,0.00015843737,0.00014741528],"about_ca_topic_score_codex":0.0010887887,"about_ca_topic_score_gemma":0.0031338078,"teacher_disagreement_score":0.032036986,"about_ca_system_score_codex":0.00005636292,"about_ca_system_score_gemma":0.00045620857,"threshold_uncertainty_score":0.4376373},"labels":[],"label_agreement":null},{"id":"W2559499926","doi":"10.1182/blood.v106.11.4183.4183","title":"A Multicenter, Randomized, Controlled Clinical Pilot Trial of the Feasibility of an Intensive RBC Transfusion Policy for Patients with Acute Leukemia Treated with Induction Chemotherapy or Stem Cell Transplant.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Dalhousie University; Queen Elizabeth II Health Sciences Centre; University of Waterloo; McMaster University; Canadian Blood Services","funders":"","keywords":"Medicine; Randomized controlled trial; Chemotherapy; Internal medicine; Induction chemotherapy; Acute leukemia; Surgery; Blood transfusion; Clinical trial; Leukemia","score_opus":0.03304321397160581,"score_gpt":0.33178530807059814,"score_spread":0.29874209409899233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559499926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981801,0.000014984654,0.00022607036,0.00050611317,0.000047370828,0.017180208,0.00012893623,0.000030242463,0.00006512355],"genre_scores_gemma":[0.99753124,0.00018613129,0.001055157,0.000203508,0.00023488812,0.00034080664,0.00005543886,0.000049812526,0.00034301475],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99693805,0.000641836,0.001116185,0.00043278973,0.00055981794,0.00031133852],"domain_scores_gemma":[0.99707085,0.0006843844,0.00052868266,0.0005529509,0.0009970487,0.00016609317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010802145,0.00028966277,0.0019525893,0.00014819435,0.00006770106,0.000008758339,0.00020201271,0.00018455976,0.00001738195],"category_scores_gemma":[0.00022121954,0.00012745585,0.0004406602,0.0003158936,0.00044270023,0.00011196616,0.000011521153,0.0003581181,4.993712e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9769938,0.00742864,0.0052177235,0.00010397557,0.0014356825,0.0000053109297,0.00091375527,0.0000048665484,0.0054204413,0.0000022153288,0.000013502152,0.0024601028],"study_design_scores_gemma":[0.9320087,0.024962755,0.0030132553,0.0001885035,0.0027201665,0.000020994246,0.00019588578,0.00075726275,0.035993677,0.0000018367598,0.000007811232,0.0001291821],"about_ca_topic_score_codex":0.0003329291,"about_ca_topic_score_gemma":0.00016884106,"teacher_disagreement_score":0.044985116,"about_ca_system_score_codex":0.00021027341,"about_ca_system_score_gemma":0.0011989683,"threshold_uncertainty_score":0.5197498},"labels":[],"label_agreement":null},{"id":"W2559507418","doi":"10.1182/blood.v110.11.2740.2740","title":"Effect of Disease Stage and Time Since Diagnosis on Time to Progression for Pegylated Liposomal Doxorubicin + Bortezomib vs Bortezomib Alone in Relapsed or Refractory Multiple Myeloma.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Bortezomib; Multiple myeloma; Medicine; Internal medicine; Population; Oncology; Gastroenterology; Proteasome inhibitor; Refractory (planetary science); Biology","score_opus":0.011713872575113204,"score_gpt":0.31308591590509854,"score_spread":0.30137204332998535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559507418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942328,0.00038771375,0.0000082541565,0.0002880078,0.000026822787,0.004569464,0.0002616764,0.00008538785,0.00013991422],"genre_scores_gemma":[0.9964802,0.000036004723,0.000932247,0.00008050352,0.00008403173,0.00046483925,0.00025080433,0.00007055883,0.0016007927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974231,0.0001707391,0.0005236001,0.0006296955,0.000556633,0.0006962224],"domain_scores_gemma":[0.9964817,0.0019264406,0.00015435272,0.0004999167,0.00011198369,0.0008256144],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000826645,0.00036227968,0.000733922,0.00041229418,0.00009512157,0.000019760602,0.00012410326,0.00017036781,0.00014767375],"category_scores_gemma":[0.0022123007,0.00025481964,0.00012682652,0.000391291,0.00009174466,0.0000850071,0.00008713982,0.00022992064,0.00010795303],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18021348,0.009076558,0.580992,0.0012455066,0.00047208712,0.0026710215,0.00022331093,0.000006577258,0.155081,0.0000035467315,0.0005246005,0.06949029],"study_design_scores_gemma":[0.053075045,0.02444215,0.5597183,0.0015150107,0.00038172377,0.0000135367545,0.00000985549,0.0009798663,0.35864824,0.0000020758998,0.0008848378,0.00032934351],"about_ca_topic_score_codex":0.00007289696,"about_ca_topic_score_gemma":0.000039037874,"teacher_disagreement_score":0.20356725,"about_ca_system_score_codex":0.000116191,"about_ca_system_score_gemma":0.00014091065,"threshold_uncertainty_score":0.9999904},"labels":[],"label_agreement":null},{"id":"W2559507836","doi":"10.1182/blood.v116.21.4927.4927","title":"Case Report of a Primary Splenic Marginal Zone Lymphoma Patient Presenting with Factor VII Inhibitor","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Windsor Regional Hospital; University of Windsor; Western University","funders":"","keywords":"Splenic marginal zone lymphoma; Medicine; Lupus anticoagulant; Gastroenterology; Pathology; Internal medicine; Spleen; Splenectomy","score_opus":0.011212725838199244,"score_gpt":0.22631268797334642,"score_spread":0.21509996213514718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559507836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99709636,0.00014242917,0.0000031229508,0.000094558236,0.000113666494,0.00050556933,0.000032821357,0.000044350047,0.0019671365],"genre_scores_gemma":[0.9967181,0.0000064333876,0.0027397242,0.000046471392,0.00017023168,0.00007118562,0.000040770938,0.000026425767,0.0001806376],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987203,0.000015674637,0.00036125132,0.00030677987,0.0003548936,0.00024111185],"domain_scores_gemma":[0.99893177,0.000056493198,0.00023770047,0.0004757603,0.00012872618,0.00016953434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006205104,0.00017855663,0.0003517544,0.00007424509,0.000059252394,0.0000140172415,0.00003946946,0.00007931935,0.0001132674],"category_scores_gemma":[0.000047740552,0.00012334024,0.000104956736,0.00011691272,0.00006783424,0.000063627085,0.000059754126,0.00007543774,0.000009672971],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022153044,0.007722889,0.6965216,0.0002220623,0.0004852675,0.2686976,0.0004682744,2.2791987e-7,0.015062962,0.000026086198,0.00018335573,0.010388202],"study_design_scores_gemma":[0.012488176,0.0012147668,0.5130162,0.00013149074,0.00074189436,0.28399923,0.0000846053,0.0000068553904,0.18640327,0.0000033486874,0.0017069136,0.00020324915],"about_ca_topic_score_codex":0.0003483969,"about_ca_topic_score_gemma":0.00007242726,"teacher_disagreement_score":0.18350536,"about_ca_system_score_codex":0.000046185567,"about_ca_system_score_gemma":0.00026392742,"threshold_uncertainty_score":0.50296694},"labels":[],"label_agreement":null},{"id":"W2559525672","doi":"10.1182/blood.v114.22.2221.2221","title":"Single Nucleotide Polymorphism (SNP) Approach of Multiple Candidate Pathways Predicting the Risk of Acute / Chronic Graft-Versus-Host Disease or Transplant Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation: Potential Involvement of Nuclear Factor Kappa-B (NFKB), Platelet-Derived Growth Factor (PDGF) and Transforming Growth Factor-Beta (TGF-β) Pathway with Chronic Graft-Versus-Host Disease Graft-Versus-Host Disease.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Hematopoietic stem cell transplantation; Immunology; Graft-versus-host disease; Transplantation; Single-nucleotide polymorphism; Medicine; Biology; Internal medicine; Genotype; Genetics","score_opus":0.018668487892957945,"score_gpt":0.2191365289335273,"score_spread":0.20046804104056937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559525672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9785986,0.0017077426,0.0013662827,0.00017793138,0.0004512835,0.003908001,0.013491315,0.00026940918,0.000029424842],"genre_scores_gemma":[0.99538654,0.002022725,0.00040382604,0.000041748317,0.00016664257,0.00013100576,0.0015712964,0.00026419913,0.000012027328],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99262744,0.0004417216,0.002023161,0.0015425913,0.0019966762,0.001368386],"domain_scores_gemma":[0.9952032,0.0007129466,0.001154408,0.001140783,0.00026956567,0.001519116],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00032110143,0.0014419218,0.0018985259,0.0004655449,0.0006045611,0.000108865745,0.00076132815,0.00032667432,0.00010379941],"category_scores_gemma":[0.000037228965,0.0010634178,0.0009955668,0.0006338626,0.00049201126,0.00086391927,0.00005917464,0.0006623542,0.000004029727],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.072264105,0.0082791075,0.1942672,0.018323986,0.009573945,0.002827443,0.031974934,0.0002673737,0.6613337,0.00024110774,0.000004004082,0.0006431019],"study_design_scores_gemma":[0.11093028,0.009655546,0.49752003,0.004210471,0.027488034,0.00009111009,0.004032818,0.0018404962,0.34152055,0.00001806518,0.000017400778,0.0026752204],"about_ca_topic_score_codex":0.0003437939,"about_ca_topic_score_gemma":0.0002568032,"teacher_disagreement_score":0.31981316,"about_ca_system_score_codex":0.00032339484,"about_ca_system_score_gemma":0.0011354766,"threshold_uncertainty_score":0.99983305},"labels":[],"label_agreement":null},{"id":"W2559531480","doi":"10.1182/blood.v116.21.3307.3307","title":"A Phase I Study of ENMD-2076 In Patients with Relapsed or Refractory Leukemia","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Refractory (planetary science); Dosing; Pharmacodynamics; Bone marrow; Internal medicine; Phases of clinical research; Pharmacology; Gastroenterology; Pharmacokinetics; Chemotherapy; Oncology; Biology","score_opus":0.004874727344726023,"score_gpt":0.23193190335747482,"score_spread":0.2270571760127488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559531480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99942344,0.00001945057,0.000007684425,0.0000018236544,0.00005218353,0.00031506026,0.000015129813,0.000004609135,0.00016059705],"genre_scores_gemma":[0.9994667,0.0000071092386,0.00021095597,0.000027221555,0.00003933035,0.000018786777,0.00005904843,0.000017126195,0.00015368033],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993541,0.000024855453,0.00017508915,0.00022108741,0.0000910153,0.00013380889],"domain_scores_gemma":[0.9994601,0.000005929023,0.000082967235,0.00035276957,0.000057983256,0.000040241837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006608377,0.000104812156,0.00013525579,0.000040816016,0.000019331876,0.0000046444757,0.00013036799,0.000112029964,0.000015747843],"category_scores_gemma":[0.000037685255,0.00007895831,0.000022914162,0.000073405565,0.000029557435,0.0000027518179,0.000049096012,0.00013593974,0.0000015734939],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008976976,0.012847222,0.21076708,0.000015108798,0.00008684596,0.000008423339,0.00021359797,0.0000022476447,0.77398026,0.0000029976031,0.00008303217,0.0010955033],"study_design_scores_gemma":[0.12748767,0.034438126,0.21915808,0.000053850836,0.00025900302,0.000011303394,0.0005270469,0.000017397764,0.610264,0.000006855154,0.007034246,0.00074239465],"about_ca_topic_score_codex":0.000048834023,"about_ca_topic_score_gemma":0.00094411516,"teacher_disagreement_score":0.16371624,"about_ca_system_score_codex":0.0000053514323,"about_ca_system_score_gemma":0.00009887597,"threshold_uncertainty_score":0.32198262},"labels":[],"label_agreement":null},{"id":"W2559543703","doi":"10.1182/blood.v112.11.2049.2049","title":"Genetic Abnormalities Involved in the Development and Progression of Follicular Lymphoma.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Comparative genomic hybridization; Follicular lymphoma; Biology; Gene dosage; Gene expression profiling; Chromosomal translocation; SNP array; Copy-number variation; Copy number analysis; Lymphoma; Gene duplication; Cancer research; Genetics; Gene; Gene expression; Single-nucleotide polymorphism; Immunology; Genome; Genotype","score_opus":0.021395208109363177,"score_gpt":0.24738348448994765,"score_spread":0.22598827638058447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559543703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99475926,0.0043290076,9.2092716e-7,0.000100315236,0.000009897049,0.00027035893,7.677736e-7,0.000007947359,0.00052151014],"genre_scores_gemma":[0.9969377,0.00029396501,0.0025404228,0.000087115586,0.000016617043,0.00009099336,0.00000508463,0.000004847215,0.000023236287],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99941957,0.000025553552,0.00017254225,0.00009971085,0.0001766103,0.00010600015],"domain_scores_gemma":[0.9997532,0.000032406275,0.000037292422,0.00012508559,0.000019551153,0.00003248078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007505864,0.00007500788,0.00014140281,0.0000400959,0.000045458703,0.0000036396648,0.00003553168,0.00003156594,0.000004204251],"category_scores_gemma":[0.000010870707,0.000042253283,0.000025780202,0.00007372244,0.00005048385,0.000017010916,0.00002014337,0.000014419205,0.000002275894],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018963166,0.0015490849,0.98661715,0.00005642667,0.000057943183,0.00031870237,0.0038187744,1.8442242e-7,0.000117152136,0.00006121951,0.00003531571,0.0073490953],"study_design_scores_gemma":[0.004794695,0.00016431918,0.9619421,0.000113777496,0.000062260755,0.00021334006,0.00036250023,0.0000026080147,0.031395994,0.000015038029,0.00088692555,0.00004647876],"about_ca_topic_score_codex":0.000040611685,"about_ca_topic_score_gemma":0.000022162705,"teacher_disagreement_score":0.031278845,"about_ca_system_score_codex":0.000017409016,"about_ca_system_score_gemma":0.00009915684,"threshold_uncertainty_score":0.17230389},"labels":[],"label_agreement":null},{"id":"W2559560402","doi":"10.1182/blood.v124.21.339.339","title":"Dynamin 2-Dependent Endocytosis Regulates Megakaryopoiesis","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Thrombopoiesis; Dynamin; Thrombopoietin; Endocytic cycle; Biology; Endocytosis; Cell biology; Megakaryocyte; Bone marrow; Endosome; Molecular biology; Immunology; Haematopoiesis; Biochemistry; Receptor; Stem cell","score_opus":0.007158762943446614,"score_gpt":0.22445475714599822,"score_spread":0.2172959942025516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559560402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97549564,0.00035421905,0.000038152153,0.00046206702,0.0000609805,0.00017089775,0.000008015122,0.00009638201,0.023313679],"genre_scores_gemma":[0.99632174,0.00006965185,0.00072793965,0.00021111243,0.00005819983,0.000022982556,0.000037240065,0.000021344364,0.002529803],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991943,0.000021887,0.00014465961,0.00022101728,0.00019227697,0.0002258256],"domain_scores_gemma":[0.9994865,0.0000459689,0.000039939838,0.00028489964,0.000028780882,0.00011392199],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000070565955,0.00013363948,0.00027054863,0.00006602128,0.00006143941,0.000015091412,0.00005926718,0.000063474676,0.00013026968],"category_scores_gemma":[0.000052662683,0.00010643049,0.00008646322,0.00008379,0.000027574783,0.000042325053,0.000028819744,0.00006638754,0.00018272885],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008471157,0.022079732,0.68511844,0.0007026818,0.006463737,0.0052177054,0.001286283,0.00002265802,0.08354761,0.005607049,0.007366439,0.18174052],"study_design_scores_gemma":[0.05116401,0.0028538243,0.36591357,0.0003430569,0.0043078684,0.0027618594,0.00029583427,0.00094721984,0.5488283,0.005351115,0.016155504,0.0010778247],"about_ca_topic_score_codex":0.000066042616,"about_ca_topic_score_gemma":0.000026948852,"teacher_disagreement_score":0.4652807,"about_ca_system_score_codex":0.00001820597,"about_ca_system_score_gemma":0.000018297535,"threshold_uncertainty_score":0.43401092},"labels":[],"label_agreement":null},{"id":"W2559572513","doi":"10.1182/blood.v104.11.5119.5119","title":"Potential TH9402-Based ECP Treatment for cGvHD Patients.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Corneal Surgery and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Graft-versus-host disease; Immunology; Hematopoietic stem cell transplantation; Extracorporeal Photopheresis; Immune system; Transplantation; Photopheresis; T cell; Autoimmunity; Internal medicine; Lymphoma","score_opus":0.015981994489934818,"score_gpt":0.25092136443443164,"score_spread":0.23493936994449682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559572513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976589,0.00010279988,0.00020750478,0.0003250798,0.00015995254,0.00070829573,0.00006669968,0.000067202614,0.00070355635],"genre_scores_gemma":[0.99806315,0.00000896306,0.00077793736,0.00021230362,0.000116176765,0.00012727971,0.00031702794,0.000019504667,0.00035768485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99929297,0.0000075708585,0.00014877408,0.00020774924,0.00012519193,0.00021771884],"domain_scores_gemma":[0.99956656,0.000025845331,0.000041942298,0.00019073277,0.000053319818,0.000121609926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000252438,0.00013914243,0.00020842644,0.000049357008,0.00007873475,0.00000907759,0.000023617768,0.000054363172,0.00005768041],"category_scores_gemma":[0.000018544939,0.000103530416,0.00020626652,0.00006527488,0.000018295892,0.000028509801,0.0000064629744,0.000027848731,0.000058498958],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034697095,0.07689771,0.8485695,0.00020400237,0.002096418,0.00087552017,0.00030126446,0.0002760684,0.0025047173,0.0005165368,0.0006124196,0.06367615],"study_design_scores_gemma":[0.17317158,0.0136373015,0.6003558,0.00021885014,0.0041373814,0.000058048732,0.000028845147,0.00005080981,0.1913611,0.0011309618,0.01528299,0.0005663272],"about_ca_topic_score_codex":0.000069016765,"about_ca_topic_score_gemma":0.000011883043,"teacher_disagreement_score":0.2482137,"about_ca_system_score_codex":0.00008587201,"about_ca_system_score_gemma":0.00011534632,"threshold_uncertainty_score":0.42218477},"labels":[],"label_agreement":null},{"id":"W2559572693","doi":"10.1182/blood.v116.21.252.252","title":"Self-Complementary AAV Vectors Cause a Substantially Heightened TLR9-Dependent Innate Immune Response In the Liver","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Immune system; Capsid; Biology; Vector (molecular biology); Genetic enhancement; Transduction (biophysics); TLR9; Chemokine; Innate immune system; Immunology; Virology; Molecular biology; Recombinant DNA; Gene; Virus; Gene expression; Genetics","score_opus":0.01494602926121875,"score_gpt":0.27665795528620885,"score_spread":0.2617119260249901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559572693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978099,0.0010019888,0.0000044037006,0.00046097738,0.00010929359,0.00044260855,0.000035932775,0.000020631936,0.00011428305],"genre_scores_gemma":[0.99857426,0.00040251805,0.00024999547,0.0003559744,0.00016469025,0.000057207133,0.00007213091,0.000035018405,0.000088237466],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980961,0.0005149145,0.00026135298,0.000374087,0.0003283299,0.0004252248],"domain_scores_gemma":[0.9989485,0.000055752782,0.00006286077,0.0007885237,0.00007299986,0.00007137167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014029484,0.00019307192,0.00014473185,0.00009597088,0.000118533426,0.00004863794,0.00064550305,0.00013689212,0.00011165242],"category_scores_gemma":[0.000058623365,0.00014929393,0.00009213682,0.00018367951,0.000077394805,0.000005512828,0.0001586532,0.00034876834,0.00003598158],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046186955,0.0006179209,0.0014050561,0.0000095380365,0.00016146534,0.00015736278,0.00047139474,0.0000024871247,0.9922,0.000024450886,0.00007827962,0.00025332265],"study_design_scores_gemma":[0.0034737748,0.0020905116,0.01483857,0.000005307015,0.00004341939,0.00006744256,0.00011027256,0.000016963812,0.97342455,0.000029633093,0.0056642178,0.00023531985],"about_ca_topic_score_codex":0.000108316046,"about_ca_topic_score_gemma":0.0037628526,"teacher_disagreement_score":0.01877546,"about_ca_system_score_codex":0.000012129758,"about_ca_system_score_gemma":0.00019203054,"threshold_uncertainty_score":0.608803},"labels":[],"label_agreement":null},{"id":"W2559573030","doi":"10.1182/blood.v108.11.1297.1297","title":"Recurrent De Novo Mutations of EPOR Gene in Primary Congenital Polycythemia.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Erythropoietin receptor; Proband; Mutation; Genetics; Biology; Point mutation; Gene; Molecular biology","score_opus":0.00986511976744703,"score_gpt":0.24692547316659078,"score_spread":0.23706035339914375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559573030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99252516,0.0010181601,0.00002183331,0.00030743785,0.00003368506,0.00030977096,0.000045477518,0.000015349426,0.0057231123],"genre_scores_gemma":[0.99549234,0.00004533568,0.0038755503,0.00007149019,0.0000853343,0.00009019366,0.00013592243,0.00001138244,0.00019247501],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99929255,0.0000197092,0.0002527906,0.00014419937,0.00013412269,0.00015660646],"domain_scores_gemma":[0.99964935,0.000063515094,0.00006153288,0.00012425847,0.00004834089,0.00005299017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006129564,0.00009641706,0.0002138225,0.00008222195,0.000020526586,0.000004436292,0.000027741336,0.00004605333,0.00006299284],"category_scores_gemma":[0.000027746226,0.00008191846,0.00005981345,0.00011910051,0.000037262205,0.000023330014,0.000013149033,0.00006960523,0.000011415251],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000957208,0.005449344,0.9553935,0.00005578237,0.00013971534,0.0003776742,0.00021755052,0.0000070663436,0.036113128,0.0004132954,0.0001614349,0.0015758226],"study_design_scores_gemma":[0.0057088174,0.00033423738,0.7056167,0.00005512905,0.0002000614,0.0002465855,0.000027126574,0.000009918239,0.2873764,0.0001511584,0.00019170734,0.00008211091],"about_ca_topic_score_codex":0.0001055754,"about_ca_topic_score_gemma":0.00009722192,"teacher_disagreement_score":0.2512633,"about_ca_system_score_codex":0.00006758103,"about_ca_system_score_gemma":0.00016387922,"threshold_uncertainty_score":0.33405378},"labels":[],"label_agreement":null},{"id":"W2559576124","doi":"10.1182/blood.v114.22.512.512","title":"Haploidentical Stem Cell Transplantation: High Doses of Alloreactive-T Cell Depleted Donor Lymphocytes Administered Post-Transplant Decrease Infections and Improve Survival without Causing Severe Gvhd.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Stem cell; CD8; Transplantation; Immunology; Alemtuzumab; IL-2 receptor; Cytotoxic T cell; Immune system; T cell; Internal medicine; Biology; In vitro","score_opus":0.01171573637766494,"score_gpt":0.24135551172494382,"score_spread":0.2296397753472789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559576124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945497,0.00021995282,0.0011038911,0.0001278655,0.0001884751,0.000771826,0.00032714088,0.00011340021,0.0025977436],"genre_scores_gemma":[0.99772435,0.00031860452,0.0012991756,0.00012714404,0.000077737255,0.000021236754,0.00027651546,0.000042871954,0.00011238059],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99794453,0.0001239416,0.0006375071,0.000492239,0.00042836537,0.0003734299],"domain_scores_gemma":[0.99853075,0.0003450633,0.00019629973,0.00030318127,0.00021675426,0.000407973],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018080072,0.00035579188,0.00061096315,0.00018984816,0.0001287966,0.000045440906,0.000074671574,0.00021558887,0.00007745189],"category_scores_gemma":[0.00001326375,0.0003336056,0.00012966368,0.00020804832,0.0001076396,0.00019466893,0.000008076169,0.0001937418,0.000008341852],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025130867,0.0036835102,0.12165263,0.0030707107,0.00030860372,0.0010857129,0.0044504446,0.000008232071,0.86188275,0.00026221303,0.000004104339,0.0010780302],"study_design_scores_gemma":[0.016088268,0.001591413,0.23205249,0.00040020465,0.0030875243,0.0018580814,0.0006661485,0.00003793526,0.7437498,0.000034257348,0.000009982248,0.00042391618],"about_ca_topic_score_codex":0.00031768714,"about_ca_topic_score_gemma":0.00011326742,"teacher_disagreement_score":0.11813294,"about_ca_system_score_codex":0.00004882313,"about_ca_system_score_gemma":0.000347682,"threshold_uncertainty_score":0.9999116},"labels":[],"label_agreement":null},{"id":"W2559595459","doi":"10.1182/blood.v124.21.4138.4138","title":"RIAM Interacts with the Hematopoietic-Specific Adaptor Protein Gads and Forms a LAT-Independent Node of Signal Integration That Regulates Activation of PLC-γ1","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Protein Kinase Regulation and GTPase Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Pleckstrin homology domain; Signal transducing adaptor protein; Second messenger system; Cell biology; Phosphorylation; Phosphatidylinositol; Diacylglycerol kinase; Biology; Tyrosine phosphorylation; Gq alpha subunit; Inositol; Signal transduction; Biochemistry; G protein; Protein kinase C; Receptor","score_opus":0.009069318273871012,"score_gpt":0.20642827533202018,"score_spread":0.19735895705814918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559595459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98082805,0.00018117025,0.01831833,0.00016240239,0.000008134734,0.00034672927,0.0000048906386,0.000006466347,0.00014384955],"genre_scores_gemma":[0.9987597,0.000011866517,0.0010252546,0.0000249245,0.000054367832,0.00003178254,0.00002989948,0.000013269302,0.0000489442],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993038,0.000057143563,0.00017636576,0.00018492855,0.0001745988,0.000103117585],"domain_scores_gemma":[0.99935967,0.000017959954,0.00027166447,0.00021466159,0.00010307784,0.000032949334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022903316,0.00011734744,0.00014176914,0.00003692464,0.000048031532,0.000018487472,0.00008537983,0.000087529814,0.000009277339],"category_scores_gemma":[0.000025891188,0.000073374016,0.00004265792,0.000057711855,0.00008176748,0.000011791413,0.000041901763,0.0000650423,3.367253e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018488873,0.000104133345,0.00036021162,0.000043901775,0.00003981461,2.6066974e-7,0.00012553154,0.000034651406,0.99714273,0.0008496601,0.000017572609,0.0010966352],"study_design_scores_gemma":[0.0010147153,0.000266409,0.002513975,0.0002199356,0.000021804031,0.000009179036,0.0001924385,0.00023649208,0.9949228,0.0002518147,0.00025451058,0.00009592557],"about_ca_topic_score_codex":0.000008425395,"about_ca_topic_score_gemma":0.000014336159,"teacher_disagreement_score":0.017931666,"about_ca_system_score_codex":0.0000048917127,"about_ca_system_score_gemma":0.000021499143,"threshold_uncertainty_score":0.29921055},"labels":[],"label_agreement":null},{"id":"W2559607846","doi":"10.1182/blood.v108.11.2810.2810","title":"The Vascular Endothelial Growth Factor (VEGF) Autocrine Survival Signaling Pathway in Chronic Lymphocytic Leukemia (CLL) Is Regulated by Lysophosphatidic Acid (LPA).","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Autocrine signalling; Vascular endothelial growth factor; Cancer research; Angiogenesis; Lysophosphatidic acid; Vascular endothelial growth factor A; Biology; Chronic lymphocytic leukemia; Protein kinase B; Receptor; Internal medicine; Endocrinology; Signal transduction; Immunology; Leukemia; Cell biology; Medicine; VEGF receptors","score_opus":0.010853041335017402,"score_gpt":0.2417009393627176,"score_spread":0.2308478980277002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559607846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98473,0.011860292,0.00006376525,0.00019582939,0.00025383694,0.0012493898,0.00011065004,0.00026659353,0.0012696297],"genre_scores_gemma":[0.99581563,0.0005148133,0.000075335614,0.00013149471,0.0007080899,0.00014714024,0.00016185256,0.00015553665,0.0022900954],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9947402,0.0002604363,0.0010145077,0.00094451924,0.0014686703,0.0015716675],"domain_scores_gemma":[0.99761957,0.00055486563,0.00022049755,0.0010365722,0.00024476286,0.0003237366],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00078734296,0.00059254345,0.00082604354,0.00022000927,0.0003343264,0.00014371407,0.0005944308,0.00034258098,0.0004196878],"category_scores_gemma":[0.00037996133,0.00044988876,0.0003778239,0.000945801,0.00036295466,0.0001709914,0.00023148203,0.00058300624,0.0002082801],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0010330202,0.0009281442,0.0025447477,0.0010407986,0.001501458,0.001904214,0.00067090883,0.0004294984,0.97981155,0.001027088,0.0034807946,0.005627806],"study_design_scores_gemma":[0.08206243,0.00044215965,0.0014296055,0.0002932836,0.00023940903,0.00024818676,0.00006428171,0.01284948,0.89321864,0.00039569527,0.008139416,0.0006174379],"about_ca_topic_score_codex":0.010241095,"about_ca_topic_score_gemma":0.00039035722,"teacher_disagreement_score":0.086592905,"about_ca_system_score_codex":0.059009925,"about_ca_system_score_gemma":0.030113243,"threshold_uncertainty_score":0.99979526},"labels":[],"label_agreement":null},{"id":"W2559633807","doi":"10.1182/blood.v108.11.4795.4795","title":"Higher Prevalence of Prior Prostate Cancer in Patients Diagnosed with Chronic Myelogenous Leukemia.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Prostate cancer; Imatinib; Internal medicine; Chronic myelogenous leukemia; Cancer; Population; Incidence (geometry); Imatinib mesylate; Pediatrics; Leukemia; Oncology; Myeloid leukemia","score_opus":0.005851050836075837,"score_gpt":0.22422903359861238,"score_spread":0.21837798276253653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559633807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99448925,0.0032317978,4.8566534e-7,0.00003673984,0.000059912632,0.0012675395,0.00007013267,0.000043038417,0.0008011279],"genre_scores_gemma":[0.9964151,0.00035588638,0.0002047884,0.000031334537,0.00010436473,0.00022730362,0.00003668817,0.00004229011,0.0025822758],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998494,0.000028657769,0.0003479317,0.00036438767,0.00037027497,0.00039470612],"domain_scores_gemma":[0.999231,0.00003929706,0.00017197416,0.0003848953,0.00010188697,0.000070961345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005693064,0.00021767418,0.00037012814,0.000096322765,0.000029297033,0.000005494435,0.00010170605,0.000089535686,0.00025132147],"category_scores_gemma":[0.00001296136,0.00016711964,0.000048342252,0.00026132065,0.00009294303,0.00006828477,0.00003542968,0.0001520647,0.00001624577],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002677638,0.0015306649,0.991995,0.00079222256,0.00010754276,0.0001480961,0.00018305062,0.00011666851,0.0012805497,0.0000089076,0.00008059187,0.0034889549],"study_design_scores_gemma":[0.029847248,0.0011901853,0.9549885,0.00072887685,0.0003603937,0.000007890031,0.0000040545,0.000010654056,0.012428817,0.0000075752882,0.00026460315,0.00016119675],"about_ca_topic_score_codex":0.0030267555,"about_ca_topic_score_gemma":0.0009749245,"teacher_disagreement_score":0.037006482,"about_ca_system_score_codex":0.0016522874,"about_ca_system_score_gemma":0.0012778245,"threshold_uncertainty_score":0.6814941},"labels":[],"label_agreement":null},{"id":"W2559664427","doi":"10.1182/blood.v116.21.4698.4698","title":"Transfer of Recipient MHC Proteins to Donor Cells (trogocytosis) During Xenograft Bone Marrow Transplantation","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Immunology; Bone marrow; Transplantation; Biology; Haematopoiesis; Major histocompatibility complex; Stem cell; MHC class I; Hematopoietic stem cell transplantation; MHC class II; Immune system; Cancer research; Medicine; Cell biology; Internal medicine","score_opus":0.005940077053276265,"score_gpt":0.19900248880466256,"score_spread":0.1930624117513863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559664427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960532,0.00009335678,0.00031230724,0.00016326454,0.001993829,0.0004400564,0.000025510804,0.000059305297,0.0008591384],"genre_scores_gemma":[0.9961301,0.000053151813,0.00017937337,0.00007629341,0.000042045227,0.00006834299,0.00007168666,0.000016963406,0.0033620268],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991462,0.000059970924,0.00031696225,0.00021667623,0.000037992333,0.00022214826],"domain_scores_gemma":[0.9996261,0.000023816547,0.00004808755,0.00020864294,0.000067698595,0.000025658217],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000115418596,0.00013486779,0.00018747029,0.00015319388,0.00010831749,0.000009374957,0.000098033335,0.00018194366,0.001470122],"category_scores_gemma":[0.0000108462145,0.00012703738,0.00011248918,0.00011640264,0.000044260658,0.00012755388,0.000010167523,0.0003112993,0.0004065822],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053354405,0.00047268032,0.00018610107,0.000053974054,0.00009761698,0.000002712802,0.0007282128,0.0000047857834,0.9972935,0.000068364396,0.00018976262,0.0003687941],"study_design_scores_gemma":[0.0023776866,0.00029656058,0.0028934982,0.00003730593,0.00011668252,0.000077416385,0.00008358116,3.6325838e-7,0.97627807,0.000002796076,0.017700339,0.00013570917],"about_ca_topic_score_codex":0.000064000116,"about_ca_topic_score_gemma":0.00009898244,"teacher_disagreement_score":0.02101539,"about_ca_system_score_codex":0.000009187062,"about_ca_system_score_gemma":0.000018990586,"threshold_uncertainty_score":0.9994427},"labels":[],"label_agreement":null},{"id":"W2559682469","doi":"10.1182/blood.v106.11.2556.2556","title":"A Phase I–II Trial of Bortezomib (Velcade) (Vc) and Oral Cyclophosphamide (CY) Plus Prednisone (P) for Relapsed/Refractory Multiple Myeloma (MM).","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Thalidomide; Prednisone; Lenalidomide; Internal medicine; Gastroenterology; Regimen; Multiple myeloma; Melphalan; Cyclophosphamide; Refractory (planetary science); Surgery; Urology; Chemotherapy","score_opus":0.030952904249561767,"score_gpt":0.3238474744655238,"score_spread":0.29289457021596205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559682469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936693,0.0017885542,0.00011798733,0.00037993345,0.0001114965,0.0030092928,0.00027468774,0.000085346874,0.0005634219],"genre_scores_gemma":[0.9883374,0.00031734165,0.00823329,0.000082381994,0.00045300752,0.00035699195,0.00018321765,0.00005973165,0.0019766502],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99776787,0.00006055436,0.00058886345,0.00050340104,0.00047924975,0.00060006144],"domain_scores_gemma":[0.99839526,0.00031763897,0.00019818501,0.00046926347,0.0001560492,0.00046357454],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031319456,0.00030496684,0.0007133485,0.00017681687,0.00018205494,0.000020047122,0.00013370188,0.0002116099,0.000079257174],"category_scores_gemma":[0.0008040105,0.0002585002,0.00021358495,0.00017048308,0.00016148797,0.00017603938,0.00010340748,0.00023790052,0.000014714648],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.38428673,0.06974787,0.017549496,0.0008057249,0.003126948,0.00042989975,0.0019708322,0.000007792832,0.07683974,0.00014532465,0.0036554518,0.4414342],"study_design_scores_gemma":[0.8705214,0.023240983,0.010756362,0.00014882568,0.00074836344,0.000077139906,0.00009532504,0.0015652392,0.069432616,0.000044261244,0.023050006,0.00031945243],"about_ca_topic_score_codex":0.00013052663,"about_ca_topic_score_gemma":0.00009090391,"teacher_disagreement_score":0.4862347,"about_ca_system_score_codex":0.000094367635,"about_ca_system_score_gemma":0.00027370578,"threshold_uncertainty_score":0.9999867},"labels":[],"label_agreement":null},{"id":"W2559683755","doi":"10.1182/blood.v112.11.2943.2943","title":"MMP-14 Mediates Migration of Acute Myelogenous Leukemia Cells","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Canadian Blood Services","funders":"","keywords":"Matrigel; Cancer research; Myeloid leukemia; Cell culture; Stromal cell; Leukemia; K562 cells; Molecular biology; Biology; Chemistry; Immunology; Angiogenesis","score_opus":0.0064802475472917065,"score_gpt":0.19586262210820965,"score_spread":0.18938237456091794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559683755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983059,0.0006355733,0.00023674565,0.000018891487,0.000098321136,0.00011419757,0.000035851215,0.000010431016,0.0005441002],"genre_scores_gemma":[0.9974412,0.00075424404,0.0009457824,0.000112620415,0.00023761283,0.000013827923,0.00010980008,0.000012685589,0.00037225228],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994434,0.000021162778,0.00014355105,0.00016953044,0.00008449107,0.00013785732],"domain_scores_gemma":[0.9996158,0.0000032398912,0.00006761743,0.00020863638,0.000056748842,0.00004796015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000050931405,0.000092298804,0.00010212547,0.00002215044,0.000049662824,0.000002984368,0.00010377821,0.00012566744,0.00001377466],"category_scores_gemma":[0.000010786349,0.000085769774,0.00007069499,0.000043547072,0.000038868795,0.0000024625176,0.000040282455,0.000041688196,0.000016393495],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001683695,0.000087366265,0.00023579523,0.000006946169,0.00007389659,0.000009578434,0.000063636624,0.0000020783048,0.9979017,0.000014857536,0.0015131258,0.000074220494],"study_design_scores_gemma":[0.00059151824,0.0003232779,0.00015048166,0.00000497939,0.00005841373,0.000040167397,0.000007848482,0.0000057082084,0.99606305,0.00006273271,0.0025914032,0.000100395664],"about_ca_topic_score_codex":0.00003078385,"about_ca_topic_score_gemma":0.000010790328,"teacher_disagreement_score":0.0018385882,"about_ca_system_score_codex":0.000004843623,"about_ca_system_score_gemma":0.00009704996,"threshold_uncertainty_score":0.34975898},"labels":[],"label_agreement":null},{"id":"W2559683905","doi":"10.1182/blood.v106.11.4816.4816","title":"Generation of a Fully Human High Affinity Neutralizing Antibody Against MT-SP1/Matriptase and Its Potential Role for the Treatment of B Cell Lymphoma.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Helix Biopharma (Canada)","funders":"","keywords":"Molecular biology; Biology; Antibody; Plasminogen activator; Cell culture; Serine protease; Cancer research; Protease; Biochemistry; Enzyme; Immunology","score_opus":0.036610916354093005,"score_gpt":0.3130703993131619,"score_spread":0.27645948295906886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559683905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960762,0.0026555734,0.000083678126,0.00018849349,0.000025446452,0.00077612,0.000050459217,0.000013068154,0.00013092732],"genre_scores_gemma":[0.99753076,0.0009178794,0.0008502647,0.000034191326,0.0002479834,0.00002868513,0.00011598489,0.000019496947,0.0002547758],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990757,0.00004386262,0.000271187,0.00019114936,0.0002321848,0.00018591706],"domain_scores_gemma":[0.99940395,0.00004725469,0.000104301806,0.00023254135,0.00013036818,0.00008156628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012890472,0.000118364995,0.00023436638,0.000087264336,0.00011201477,0.000013156143,0.00006837578,0.00006428503,0.00002393573],"category_scores_gemma":[0.000017686121,0.000083625135,0.00010974883,0.00008986701,0.000042152813,0.000036137182,0.000025336796,0.000033293734,0.0000029357752],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011424065,0.002670835,0.00027385648,0.00009417107,0.00008078198,0.000012305022,0.0002344394,0.00005904089,0.9911547,0.00006954084,0.000044264874,0.0051918593],"study_design_scores_gemma":[0.009491255,0.0012997941,0.004446986,0.000016986627,0.0003277448,0.00001077545,0.00008201825,0.0045458716,0.97874993,0.000005916371,0.00095202815,0.00007067773],"about_ca_topic_score_codex":0.00006647419,"about_ca_topic_score_gemma":0.000025263773,"teacher_disagreement_score":0.012404718,"about_ca_system_score_codex":0.00002964279,"about_ca_system_score_gemma":0.0000722285,"threshold_uncertainty_score":0.3410134},"labels":[],"label_agreement":null},{"id":"W2559685064","doi":"10.1182/blood.v126.23.3034.3034","title":"Analysis of Final Data from the Multinational, Non-Interventional, Observational Emmos Study (NCT01241396) in Patients (Pts) with Multiple Myeloma (MM) in Real-World Clinical Practice","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Internal medicine; Clinical trial; Family medicine; Surgery","score_opus":0.26823362071252094,"score_gpt":0.44903554697545567,"score_spread":0.18080192626293473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559685064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99711305,0.00005344478,0.000025676052,0.0005457752,0.00004384939,0.0012801591,0.00062106765,0.000011793976,0.00030516382],"genre_scores_gemma":[0.99026006,0.000010471108,0.004290079,0.00010431605,0.000080072445,0.00010102979,0.004979878,0.000018187988,0.00015587873],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962516,0.0005030746,0.000981371,0.0006048886,0.001392635,0.00026642065],"domain_scores_gemma":[0.99535567,0.0024017117,0.0003751711,0.0009713923,0.0007139584,0.00018211213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017477621,0.00019308573,0.00057539105,0.00038075633,0.000049278093,0.00002847817,0.00045841173,0.00005566837,0.00010434847],"category_scores_gemma":[0.0048287204,0.00013047231,0.000117134936,0.0014594722,0.000100156074,0.00037849465,0.00031057443,0.00034168555,0.00002266104],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029337173,0.034662396,0.95748585,0.000010107154,0.002945578,0.00014877503,0.00028274665,0.00008137417,0.000002319042,0.0000077689165,0.00044303125,0.0009963289],"study_design_scores_gemma":[0.037497595,0.0012362648,0.9492679,0.000098332275,0.001460833,0.0000012908497,0.0006138275,0.009495642,0.000007811325,0.000007986945,0.00020337566,0.00010908776],"about_ca_topic_score_codex":0.009430491,"about_ca_topic_score_gemma":0.040908396,"teacher_disagreement_score":0.03456388,"about_ca_system_score_codex":0.00010909927,"about_ca_system_score_gemma":0.00042408652,"threshold_uncertainty_score":0.9971658},"labels":[],"label_agreement":null},{"id":"W2559698750","doi":"10.1182/blood.v108.11.1404.1404","title":"Identification of Meis1 Target Genes Involved in the Induction of AML in Collaboration with NUP98-HOXD13.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Hox gene; Biology; Homeobox; Cancer research; Downregulation and upregulation; Transcription factor; Leukemia; Molecular biology; Cell biology; Genetics; Gene","score_opus":0.013573322949529697,"score_gpt":0.27047657623779203,"score_spread":0.25690325328826236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559698750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980146,0.00026701717,0.00008889345,0.0007156174,0.000018640529,0.0005712443,0.000007927269,0.000007985313,0.0003080269],"genre_scores_gemma":[0.99900466,0.000040823594,0.0006408015,0.000019800576,0.00006712489,0.00005205547,0.000073236806,0.000010053019,0.00009142475],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99891,0.00011396576,0.00037029892,0.00014165654,0.00034886715,0.00011522939],"domain_scores_gemma":[0.99932307,0.0000432482,0.0001558546,0.00024880504,0.00021475228,0.000014264925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055782835,0.0000687489,0.0001709761,0.0002460269,0.00001610397,0.000008455563,0.00009224774,0.00007419329,0.000008801178],"category_scores_gemma":[0.000076560296,0.000047900696,0.000016937614,0.0010718284,0.00007667968,0.00011209274,0.000011817798,0.00013362853,0.0000025413467],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002215056,0.0009537036,0.28561136,0.00013838142,0.000024428582,0.000013071678,0.0010834835,0.00019863214,0.7105408,0.00057985896,0.0003273334,0.00030745598],"study_design_scores_gemma":[0.0035054921,0.00019711576,0.42374852,0.00006106186,0.00004267649,0.00000926173,0.0019265218,0.00032534832,0.5697222,0.00027776073,0.00013023421,0.000053797474],"about_ca_topic_score_codex":0.000701245,"about_ca_topic_score_gemma":0.0009836409,"teacher_disagreement_score":0.14081857,"about_ca_system_score_codex":0.0000718182,"about_ca_system_score_gemma":0.00024379422,"threshold_uncertainty_score":0.19533336},"labels":[],"label_agreement":null},{"id":"W2559702819","doi":"10.1182/blood.v124.21.4773.4773","title":"Selinexor Demonstrates Marked Synergy with Dexamethasone (Sel-Dex) in Preclinical Models and in Patients with Heavily Pretreated Refractory Multiple Myeloma (MM)","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ozmosis Research (Canada); University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Nuclear export signal; Cancer research; Dexamethasone; Apoptosis; Medicine; Chemistry; Pharmacology; Molecular biology; Biology; Cell nucleus; Internal medicine; Cytoplasm; Biochemistry","score_opus":0.006818085361498307,"score_gpt":0.20687992707058325,"score_spread":0.20006184170908495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559702819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99906147,0.00012302109,0.00026203578,0.000015400023,0.000021192602,0.00020576223,0.000008082165,0.000012932268,0.00029013358],"genre_scores_gemma":[0.99693376,0.000029643708,0.0027540193,0.000064260326,0.00004364226,0.000014660999,0.000089437046,0.000026925096,0.0000436797],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900925,0.00010596487,0.00020026746,0.00038905672,0.00010003859,0.00019544135],"domain_scores_gemma":[0.99953175,0.00004134905,0.00007181588,0.00022705573,0.000059751066,0.00006826701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012954841,0.00016243008,0.00018775713,0.000049928694,0.000027116304,0.000015598045,0.00006698206,0.00018842539,0.0000035710482],"category_scores_gemma":[0.00007916218,0.00012044504,0.000018606323,0.000102715334,0.00006970937,0.000011429583,0.000032207397,0.00013452883,6.928559e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023531045,0.0004891014,0.9776048,0.00002001951,0.00006547639,0.0000033995561,0.00003887072,0.0002473372,0.014538824,0.000005728936,0.000015595819,0.0046177176],"study_design_scores_gemma":[0.009485971,0.0021150645,0.975693,0.000072425515,0.000054069398,0.000009012294,0.00003007372,0.0015833625,0.010341207,0.00004028423,0.0002896453,0.00028587444],"about_ca_topic_score_codex":0.00007116908,"about_ca_topic_score_gemma":0.0007389425,"teacher_disagreement_score":0.007132867,"about_ca_system_score_codex":0.000007919226,"about_ca_system_score_gemma":0.0000423154,"threshold_uncertainty_score":0.49116063},"labels":[],"label_agreement":null},{"id":"W2559705994","doi":"10.1182/blood.v118.21.4748.4748","title":"Preoperative Hemoglobin Levels, Characteristics, and Resource Utilization in Total Hip Replacement Patients with An Anemia Diagnosis Versus without An Anemia Diagnosis: An Electronic Medical Record Analysis","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Anemia; Medical record; Hemoglobin; Retrospective cohort study; Population; Surgery; Pediatrics; Electronic medical record; Internal medicine; Emergency medicine","score_opus":0.027899391026416757,"score_gpt":0.26700406201671095,"score_spread":0.2391046709902942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559705994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979799,0.00008678833,0.000113721944,0.00015578722,0.00005652259,0.001168339,0.00003824383,0.000096027914,0.00030466515],"genre_scores_gemma":[0.9973722,0.00033399402,0.00070285896,0.00036779494,0.00007171739,0.0003675615,0.00069162337,0.000044879198,0.000047375925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972283,0.00028047874,0.0005098943,0.0008452137,0.00064548256,0.00049062376],"domain_scores_gemma":[0.99853945,0.00004571994,0.00015132957,0.00060579565,0.00013832397,0.0005193676],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046455028,0.00033678397,0.0005606808,0.00032902832,0.00011643337,0.000045581248,0.00016217506,0.00019323897,0.00079361605],"category_scores_gemma":[0.00011671276,0.0002856978,0.000053658296,0.00058432185,0.000102970305,0.00032090815,0.00006175401,0.0003401459,0.0000036061772],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027752405,0.0062508592,0.9751698,0.00007241516,0.00048133428,0.000056640005,0.002535869,0.0000011854981,0.000009909389,0.0000716084,0.00003383009,0.0125413295],"study_design_scores_gemma":[0.0154615445,0.009746158,0.968914,0.00014137286,0.0029959285,0.0000074337727,0.00085770554,0.00037590312,0.00088558637,0.00000623638,0.0002574853,0.0003506903],"about_ca_topic_score_codex":0.0006071321,"about_ca_topic_score_gemma":0.004361461,"teacher_disagreement_score":0.012686304,"about_ca_system_score_codex":0.000106568674,"about_ca_system_score_gemma":0.00014000534,"threshold_uncertainty_score":0.9999595},"labels":[],"label_agreement":null},{"id":"W2559734821","doi":"10.1182/blood.v108.11.1514.1514","title":"The Interaction of Prothrombin and Its Activation Products with Platelets.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Prothrombinase; Thrombin; Platelet; Chemistry; Phosphatidylserine; Calcium; Biochemistry; Platelet activation; Biophysics; Membrane; Phospholipid; Immunology; Biology","score_opus":0.01791779307539586,"score_gpt":0.2811895018065831,"score_spread":0.2632717087311872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559734821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99557114,0.000098466626,0.000009065639,0.0016906064,0.000004049817,0.00029793012,6.985299e-7,0.000012926053,0.002315103],"genre_scores_gemma":[0.9994593,0.000014271804,0.00009262793,0.000010790117,0.00006376634,0.00003955855,0.0000059625945,0.000003732883,0.0003099554],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997469,0.0000039197967,0.00006881687,0.00007391898,0.000058955793,0.000047443093],"domain_scores_gemma":[0.9998089,0.000024613486,0.00003565551,0.00006858644,0.000047075686,0.000015169498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000033206143,0.000034054992,0.00004711752,0.000005912697,0.000043098746,0.000004922813,0.0000151119375,0.000016329726,0.0000036485974],"category_scores_gemma":[0.00002068545,0.000020326786,0.0000055365244,0.00007134935,0.000029451627,0.000032371507,0.0000037383481,0.000060901773,0.0000010834667],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007817666,0.00027406335,0.00088883564,0.000089501096,0.000021092277,8.9210516e-7,0.00001599165,0.0000020171447,0.9970301,0.0008541493,0.000075241354,0.0006699804],"study_design_scores_gemma":[0.0007591008,0.000052734908,0.007417288,0.000032554042,0.000044581164,0.00005472317,0.000015783424,0.0000448534,0.988696,0.00006133077,0.0027975298,0.000023544511],"about_ca_topic_score_codex":0.0000029525627,"about_ca_topic_score_gemma":2.4737875e-7,"teacher_disagreement_score":0.0083340835,"about_ca_system_score_codex":0.0000041454255,"about_ca_system_score_gemma":0.000014949784,"threshold_uncertainty_score":0.08289023},"labels":[],"label_agreement":null},{"id":"W2559753801","doi":"10.1182/blood.v118.21.1644.1644","title":"Rituximab Cerebrospinal Fluid Levels in Patients with Primary Central Nervous System Lymphoma Treated with Intravenous High Dose Rituximab","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"","keywords":"Rituximab; Cerebrospinal fluid; Medicine; Multiple sclerosis; Lymphoma; Cytarabine; Methotrexate; Central nervous system; Primary central nervous system lymphoma; Gastroenterology; CSF albumin; Internal medicine; Chemotherapy; Immunology","score_opus":0.009874460096272353,"score_gpt":0.18257567985426912,"score_spread":0.17270121975799677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559753801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961856,0.00027000482,0.00001116656,0.000030175619,0.00007035966,0.001401141,0.00011795671,0.0001886761,0.001724928],"genre_scores_gemma":[0.9975137,0.00001475342,0.001737427,0.00010783206,0.00007988954,0.00017882587,0.00021930973,0.00009384302,0.000054402095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974115,0.00006668151,0.00048536318,0.00066977047,0.000552222,0.000814494],"domain_scores_gemma":[0.9986589,0.000026201935,0.00017386198,0.0006243914,0.00016457953,0.0003520855],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000071304275,0.0005118137,0.0009938856,0.00020461144,0.000111986235,0.000037885926,0.00015432054,0.00016321601,0.00007839086],"category_scores_gemma":[0.000007508307,0.00034966093,0.00009944687,0.00038943926,0.00011773802,0.00014733509,0.00005140184,0.00011093183,0.00007234379],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038420625,0.044837236,0.9222725,0.00031202115,0.00068071554,0.0026943667,0.0005356199,0.0000012924161,0.00005166029,0.00017758326,0.000024507173,0.024570424],"study_design_scores_gemma":[0.10392775,0.005699341,0.8844147,0.0007683451,0.0009782312,0.00044659068,0.000087453445,0.000005814639,0.0032733486,0.0000034868026,0.000022349857,0.00037263837],"about_ca_topic_score_codex":0.0023740456,"about_ca_topic_score_gemma":0.00012961456,"teacher_disagreement_score":0.10008568,"about_ca_system_score_codex":0.00067385886,"about_ca_system_score_gemma":0.00032796295,"threshold_uncertainty_score":0.9998955},"labels":[],"label_agreement":null},{"id":"W2559755697","doi":"10.1182/blood.v128.22.3010.3010","title":"Treatment Outcome of North American Patients with Adult T-Cell Leukemia/Lymphoma: Princess Margaret Cancer Centre Experience","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and Retrovirus Studies","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Lymphoma; Internal medicine; Population; Cancer; Oncology; Pediatrics","score_opus":0.006533429767613959,"score_gpt":0.20962798265186902,"score_spread":0.20309455288425507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559755697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99853,0.00042760515,0.000004662411,0.000058419828,0.00017218894,0.00020168156,0.00019046635,0.000035500805,0.00037952483],"genre_scores_gemma":[0.99728,0.0004105833,0.000037285594,0.000036449786,0.000015384163,0.000048758742,0.000016589656,0.000014771924,0.0021401618],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990358,0.000043921504,0.00023339494,0.0002980698,0.000051157494,0.00033767434],"domain_scores_gemma":[0.9993496,0.00004518291,0.00021977162,0.00024146958,0.00011613178,0.0000278628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000009831483,0.00021033314,0.00035486626,0.000037577698,0.00010633083,0.0000028428344,0.00015938781,0.00004490383,0.000049691713],"category_scores_gemma":[0.000010026226,0.00010284054,0.00006357636,0.00010997435,0.00044708012,0.000042952557,0.00006576055,0.00003478056,0.000049573773],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016219787,0.00093486416,0.97965705,0.000014041526,0.00022037863,0.0000039877655,0.0007531356,3.2873393e-7,0.0030418455,0.000008404163,0.000041268544,0.0151624745],"study_design_scores_gemma":[0.008356728,0.00062823767,0.8987684,0.0000257223,0.00012093239,0.0000019698537,0.00021311616,3.359653e-8,0.08869323,4.369264e-7,0.002999681,0.00019147356],"about_ca_topic_score_codex":0.0021351979,"about_ca_topic_score_gemma":0.003922084,"teacher_disagreement_score":0.08565139,"about_ca_system_score_codex":0.00010881763,"about_ca_system_score_gemma":0.00006369484,"threshold_uncertainty_score":0.41937155},"labels":[],"label_agreement":null},{"id":"W2559763402","doi":"10.1182/blood.v112.11.2587.2587","title":"Incidence, Predictors, and Significance of Severe Toxicity in Patients with HIV-Associated Hodgkin Lymphoma","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; BC Cancer Agency; Sunnybrook Hospital; AIDS Vancouver; St. Paul's Hospital","funders":"","keywords":"ABVD; Medicine; Internal medicine; Ritonavir; Gastroenterology; Population; Regimen; Lymphoma; Incidence (geometry); Toxicity; Vinblastine; Viral load; Immunology; Chemotherapy; Vincristine; Human immunodeficiency virus (HIV); Cyclophosphamide; Antiretroviral therapy","score_opus":0.0057086452654385895,"score_gpt":0.19618268035155398,"score_spread":0.19047403508611538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559763402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99815494,0.00021080559,0.0000024794006,0.00004976495,0.000020386778,0.000346095,0.000056141806,0.00003211614,0.0011272595],"genre_scores_gemma":[0.9994362,0.000114504655,0.00008025619,0.00013304481,0.000012394978,0.000014729078,0.00003935579,0.000015849406,0.00015367584],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896383,0.00003764836,0.0002288314,0.0002177826,0.0003289331,0.00022294202],"domain_scores_gemma":[0.99948525,0.000033440756,0.0001521127,0.00013909646,0.00010231184,0.00008780601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008643163,0.0001303227,0.00032828242,0.00007996696,0.00004678274,0.0000035172122,0.00005585805,0.00011195632,0.000020292338],"category_scores_gemma":[0.00010095535,0.000109786895,0.000032163087,0.00033872196,0.000112626745,0.00008138825,0.000017250291,0.000084585634,0.0000014589858],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029577428,0.0013255024,0.9969528,0.00002994876,0.00008603605,0.000022228533,0.00049931026,0.000006210026,0.0001249263,0.000004724336,0.00044910682,0.00020346814],"study_design_scores_gemma":[0.01874095,0.00082294235,0.979271,0.00014605629,0.00008769151,0.000004836332,0.00007422185,0.000010632352,0.00066258234,0.000020302961,0.000034817946,0.00012396621],"about_ca_topic_score_codex":0.00023628294,"about_ca_topic_score_gemma":0.00017265031,"teacher_disagreement_score":0.018445175,"about_ca_system_score_codex":0.00008470184,"about_ca_system_score_gemma":0.0001822792,"threshold_uncertainty_score":0.44769797},"labels":[],"label_agreement":null},{"id":"W2559764713","doi":"10.1182/blood.v108.11.4222.4222","title":"PBI-1402: A Low Molecular Weight Synthetic Hematopoietic Growth Stimulant.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Haematopoiesis; Bone marrow; Cancer research; Progenitor cell; Myeloid; Hematopoietic growth factor; Biology; Neutropenia; Stem cell; Pharmacology; Chemistry; Immunology; Internal medicine; Medicine; Cell biology; Chemotherapy","score_opus":0.0057404006294827295,"score_gpt":0.23691024993433443,"score_spread":0.2311698493048517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559764713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9725806,0.0011648707,0.000805559,0.0015103074,0.00005901302,0.0005607123,0.0000116025385,0.0002016877,0.023105625],"genre_scores_gemma":[0.99534875,0.000050665676,0.0019573544,0.0003714344,0.00026335593,0.000051864667,0.000038954015,0.000076942146,0.0018406505],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979087,0.00006780973,0.00032018076,0.0004499159,0.0006386609,0.0006147282],"domain_scores_gemma":[0.9988311,0.00010207474,0.000058164984,0.0006259073,0.00015490958,0.00022785093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020267085,0.00024931866,0.00040656148,0.00020264907,0.00007690884,0.000034162647,0.00023157016,0.00016216417,0.00038620408],"category_scores_gemma":[0.00015671464,0.0002112754,0.00016983361,0.000385635,0.00014062601,0.000054566593,0.00010668944,0.00037678616,0.0007286364],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007554704,0.008922814,0.032563217,0.002274493,0.0012577033,0.024678051,0.00039444145,0.0000425759,0.8621748,0.035981733,0.029400246,0.0015544717],"study_design_scores_gemma":[0.016775731,0.00088227977,0.010501955,0.0006876357,0.0012520576,0.003786052,0.00006096382,0.0010602114,0.9546572,0.0060930345,0.0034362029,0.0008066518],"about_ca_topic_score_codex":0.0001586966,"about_ca_topic_score_gemma":0.0000036348504,"teacher_disagreement_score":0.09248244,"about_ca_system_score_codex":0.00010496938,"about_ca_system_score_gemma":0.00024295751,"threshold_uncertainty_score":0.936539},"labels":[],"label_agreement":null},{"id":"W2559772841","doi":"10.1182/blood.v118.21.430.430","title":"A Gene Expression Signature in Diagnostic Formalin Fixed Paraffin Embedded Tissue Predicts Overall Survival in Locally Advanced and Advanced Stage Classical Hodgkin Lymphoma – a Correlative Study From the E2496 Intergroup Trial","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; BC Cancer Agency","funders":"","keywords":"Oncology; Medicine; ABVD; Internal medicine; Log-rank test; Stage (stratigraphy); Proportional hazards model; Clinical trial; Chemotherapy; Biology; Vincristine","score_opus":0.018238065820834804,"score_gpt":0.26275503174900616,"score_spread":0.24451696592817135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559772841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936958,0.0014798199,0.00009583902,0.00010790134,0.0003253548,0.0040094787,0.00009835438,0.000057340905,0.00013012675],"genre_scores_gemma":[0.996983,0.00021082068,0.0013391116,0.00014711714,0.00012570938,0.0009823474,0.00010253941,0.000041292722,0.00006806987],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972754,0.00043019012,0.00070877746,0.0006911844,0.0004410061,0.00045342557],"domain_scores_gemma":[0.99717176,0.0018628434,0.00022941055,0.00048482505,0.00005377434,0.0001973993],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030663153,0.00041866614,0.00077583425,0.000108059896,0.00007045249,0.000030126734,0.00019499149,0.00024270029,0.000060364313],"category_scores_gemma":[0.0009506526,0.00027663988,0.00008886537,0.00022503202,0.00008955968,0.00022144875,0.00020200743,0.0002880715,0.000008549921],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.123046994,0.058274217,0.7143974,0.0000678453,0.00071697356,0.0064889737,0.040884726,0.00011325312,0.011937045,0.000182766,0.00015118913,0.04373866],"study_design_scores_gemma":[0.32150656,0.006994405,0.6412158,0.000701617,0.00029809758,0.000013324227,0.002124165,0.00016873587,0.026431067,0.0001488059,0.00007003124,0.0003273504],"about_ca_topic_score_codex":0.00044333932,"about_ca_topic_score_gemma":0.0017334888,"teacher_disagreement_score":0.19845958,"about_ca_system_score_codex":0.0001518695,"about_ca_system_score_gemma":0.00015107385,"threshold_uncertainty_score":0.9999686},"labels":[],"label_agreement":null},{"id":"W2559781323","doi":"10.1182/blood.v108.11.4393.4393","title":"Bortezomib Activity Against Mantle Cell Lymphoma Overcomes Classic Mechanisms of Drug Resistance and Targets Cell Cycle Control.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Bortezomib; Mantle cell lymphoma; Proteasome inhibitor; Cyclin D1; Cancer research; Cell culture; Drug resistance; Cell cycle; Proteasome; Chemistry; Biology; Pharmacology; Cell; Lymphoma; Immunology; Biochemistry; Multiple myeloma; Genetics","score_opus":0.003315730825562614,"score_gpt":0.19019065101868396,"score_spread":0.18687492019312135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559781323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779686,0.0032095097,0.00009089341,0.00037279833,0.00006646945,0.0003992859,0.00007725673,0.00004610629,0.017769089],"genre_scores_gemma":[0.99645317,0.00017698045,0.0010273365,0.00019853261,0.000058365495,0.000040984363,0.00002076253,0.000026841408,0.0019970047],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99885106,0.000043180084,0.00023880176,0.00033111972,0.00025850662,0.00027733407],"domain_scores_gemma":[0.9992473,0.00010773383,0.00016856391,0.0003171377,0.000051494404,0.00010776357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000097393546,0.00021318681,0.00045935976,0.000062946936,0.00007636861,0.000017270817,0.00006117998,0.0000843339,0.000017609698],"category_scores_gemma":[0.000008089179,0.0001775951,0.00011398992,0.00008784541,0.000058725065,0.00007165974,0.000032054155,0.000043086267,0.000012547855],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016602725,0.054079894,0.18291,0.0016853259,0.00069412356,0.0017183879,0.00040204497,0.00002240732,0.7308666,0.0057851523,0.015025607,0.005150149],"study_design_scores_gemma":[0.029328605,0.00014950093,0.2239482,0.000080606194,0.00048301343,0.000009403982,0.000038587328,0.000052727977,0.74331224,0.0013028147,0.0010990773,0.00019523138],"about_ca_topic_score_codex":0.00018720333,"about_ca_topic_score_gemma":0.00009252809,"teacher_disagreement_score":0.05393039,"about_ca_system_score_codex":0.00007015104,"about_ca_system_score_gemma":0.00008234019,"threshold_uncertainty_score":0.7242118},"labels":[],"label_agreement":null},{"id":"W2559793479","doi":"10.1182/blood.v112.11.2549.2549","title":"Distinct Proteomic Signaling Networks Stratify Responses to Ara-C Based Induction Therapy in Patients with Acute Myeloid Leukemia (AML)","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Daunorubicin; Cytarabine; Myeloid leukemia; Cytokine; Cancer research; Medicine; Leukemia; Signal transduction; Immunology; Biology; Internal medicine; Cell biology","score_opus":0.020508332030833937,"score_gpt":0.26496548882235665,"score_spread":0.24445715679152272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559793479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99623394,0.000039615694,0.0008574999,0.00030185175,0.00004550754,0.002261272,0.000014978646,0.00009835235,0.00014696218],"genre_scores_gemma":[0.9945355,0.000024118362,0.004167125,0.00037006437,0.00022625095,0.0002560856,0.00010372751,0.00006864439,0.00024845978],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99771047,0.0001913088,0.00037914864,0.000521225,0.00062511204,0.0005727234],"domain_scores_gemma":[0.9988289,0.00011342422,0.000105099636,0.00048278307,0.00020805924,0.00026177158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003472301,0.00029112754,0.00040325115,0.00035450133,0.00016825492,0.000029506971,0.00018628784,0.00019475854,0.000063914056],"category_scores_gemma":[0.0001300809,0.00022494618,0.00006519067,0.00080023595,0.00009738533,0.00013894695,0.000038135622,0.0007183434,0.000024961317],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018802593,0.0012149254,0.93135554,0.000037088837,0.00029950266,0.00074282894,0.0005098673,0.00078858656,0.04042556,0.000004209935,0.000356219,0.005463099],"study_design_scores_gemma":[0.016879752,0.0033871261,0.93955344,0.00018942956,0.000067253335,0.0000726851,0.000029943902,0.0007079455,0.03869985,0.000004624963,0.000104488114,0.0003034386],"about_ca_topic_score_codex":0.00017088903,"about_ca_topic_score_gemma":0.000022980545,"teacher_disagreement_score":0.008197945,"about_ca_system_score_codex":0.0005334965,"about_ca_system_score_gemma":0.0012966769,"threshold_uncertainty_score":0.9173039},"labels":[],"label_agreement":null},{"id":"W2559808144","doi":"10.1182/blood.v120.21.4195.4195","title":"The Anti-CD25 Antibody Daclizumab Delays Treg Reconstitution, Promotes CD4 Memory, and Does Not Prevent Acute or Chronic Gvhd After Allogeneic Stem Cell Transplantation","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McMaster University","funders":"","keywords":"Daclizumab; Medicine; Transplantation; Internal medicine; Aplastic anemia; Graft-versus-host disease; Gastroenterology; IL-2 receptor; Randomization; Hematopoietic stem cell transplantation; Immunology; Bone marrow; Randomized controlled trial; T cell; Tacrolimus; Immune system","score_opus":0.012647582106530383,"score_gpt":0.26200066937096184,"score_spread":0.24935308726443145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559808144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937256,0.002441537,0.00084306893,0.00038312364,0.00036499172,0.0013065644,0.00010531837,0.00008515981,0.0007446446],"genre_scores_gemma":[0.9936476,0.0043009217,0.0005125534,0.000076669836,0.00022869256,0.00014018214,0.00012069875,0.000036353074,0.0009363491],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982095,0.0001325969,0.0004922168,0.00035249878,0.0003218076,0.00049140636],"domain_scores_gemma":[0.99905896,0.0001844576,0.00014344369,0.00034479416,0.00006953715,0.00019879398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004168893,0.00028052746,0.00034250444,0.00008332952,0.00023026823,0.000049675193,0.00010635756,0.00016464549,0.00012360458],"category_scores_gemma":[0.0000075347016,0.00015976782,0.00009509133,0.00013780827,0.00016387216,0.00022635178,0.000015161844,0.00016782129,0.000044253185],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023378409,0.003331455,0.16102915,0.0068480326,0.0017736149,0.0010652374,0.013431866,0.000006415233,0.7839933,0.0003466046,0.00008587716,0.025750585],"study_design_scores_gemma":[0.0058695525,0.00045390503,0.094402365,0.00039823967,0.0030803245,0.002333297,0.00027538984,0.000029657032,0.89233506,0.0000119780725,0.00046229942,0.0003479273],"about_ca_topic_score_codex":0.00001606207,"about_ca_topic_score_gemma":0.000073288495,"teacher_disagreement_score":0.10834174,"about_ca_system_score_codex":0.000054600387,"about_ca_system_score_gemma":0.00022119081,"threshold_uncertainty_score":0.65151423},"labels":[],"label_agreement":null},{"id":"W2559820985","doi":"10.1182/blood.v116.21.4410.4410","title":"A Transfusion Audit In An Ugandan Hospital","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Blood donation and transfusion practices","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Audit; Blood transfusion; Blood bank; Emergency medicine; Surgery","score_opus":0.008745050599608598,"score_gpt":0.22373561769137904,"score_spread":0.21499056709177045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559820985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97464967,0.000014771223,0.000023855835,0.0023370532,0.0005442752,0.000175982,0.000001275286,0.00012375871,0.022129387],"genre_scores_gemma":[0.9982434,0.000012219296,0.00023090157,0.0007757986,0.0006190241,0.000016574413,0.000016525366,0.000017883214,0.00006769841],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99921167,0.0000068523836,0.00017635465,0.0002397567,0.00019244345,0.00017294972],"domain_scores_gemma":[0.99964285,0.000021847836,0.000069155976,0.00018068934,0.00006915587,0.000016318807],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025502886,0.00011211419,0.000107523985,0.00020485086,0.00010750148,0.00023033802,0.00017951083,0.000085789834,0.0011322201],"category_scores_gemma":[0.00005337923,0.000104126695,0.000042541513,0.00033653187,0.000027363647,0.0019056462,0.000023546858,0.00027932922,0.0002108844],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011068071,0.009919461,0.772686,0.00014733752,0.00005090209,0.0001600775,0.0007730044,0.0000062015447,0.08598148,0.07434202,0.00065843906,0.055164415],"study_design_scores_gemma":[0.012480508,0.000118397424,0.7236318,0.000048836042,0.00026129378,0.000015753,0.00063985045,0.00080989813,0.0050725844,0.0058294376,0.25016445,0.00092719385],"about_ca_topic_score_codex":0.00040011213,"about_ca_topic_score_gemma":0.0049047847,"teacher_disagreement_score":0.24950601,"about_ca_system_score_codex":0.0000015838817,"about_ca_system_score_gemma":0.000015343769,"threshold_uncertainty_score":0.9997809},"labels":[],"label_agreement":null},{"id":"W2559835676","doi":"10.1182/blood.v106.11.3783.3783","title":"Hemoglobin Ville-Marie: A New β-Globin Variant (del480C) Causing Oxydative Hemolysis.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Hemolysis; Molecular biology; Haptoglobin; Exon; Hemoglobin; Biology; Sanger sequencing; Genetics; Gene; Biochemistry; Immunology; DNA sequencing","score_opus":0.009970092667529148,"score_gpt":0.23918914888115886,"score_spread":0.2292190562136297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559835676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9046988,0.00901495,0.0036184061,0.021554152,0.00055874593,0.0014272315,0.00003435016,0.0006158657,0.0584775],"genre_scores_gemma":[0.97697604,0.0006003558,0.009927726,0.0036312665,0.0008140485,0.000015119173,0.00008075993,0.00008683552,0.007867843],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976385,0.0000673657,0.00055526226,0.0005816591,0.00046779477,0.0006893806],"domain_scores_gemma":[0.9984922,0.00008722282,0.0001550129,0.0005822338,0.00011961712,0.0005637593],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002593868,0.00037908863,0.000606132,0.00018408897,0.00020096738,0.000055238408,0.00013925333,0.0003410951,0.00091911556],"category_scores_gemma":[0.0002946579,0.00031777247,0.00025649994,0.00066782726,0.00011115685,0.0001713965,0.000113350216,0.00052105583,0.00041998678],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030262123,0.026185425,0.024546029,0.0012096381,0.010572568,0.019260699,0.023697926,0.0028802764,0.23154159,0.013496706,0.18892902,0.4546539],"study_design_scores_gemma":[0.08284842,0.0024407487,0.0051442445,0.0019481597,0.00818981,0.013880159,0.004806707,0.00818812,0.10047796,0.001617607,0.76671743,0.003740624],"about_ca_topic_score_codex":0.00038560893,"about_ca_topic_score_gemma":0.00006536916,"teacher_disagreement_score":0.5777884,"about_ca_system_score_codex":0.00014012742,"about_ca_system_score_gemma":0.0005259523,"threshold_uncertainty_score":0.99999416},"labels":[],"label_agreement":null},{"id":"W2559850121","doi":"10.1182/blood.v116.21.4881.4881","title":"Pralatrexate Reverses the Trend to Progressive Resistance to Successive Systemic Treatment Regimens In Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL)","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Peripheral T-cell lymphoma; Internal medicine; Refractory (planetary science); Lymphoma; Progression-free survival; Oncology; Chemotherapy; Surgery; Immunology; T cell","score_opus":0.00498397604007538,"score_gpt":0.2199687550884725,"score_spread":0.2149847790483971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559850121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939186,0.000648392,4.9364667e-7,0.00093842833,0.00016973868,0.0024756768,0.00006529392,0.00005559522,0.0017278009],"genre_scores_gemma":[0.99502593,0.000025689336,0.000602348,0.0003092486,0.000115232324,0.0009836841,0.000049153925,0.000049297392,0.0028393937],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980888,0.00007808024,0.00034482454,0.0006022682,0.0004125873,0.00047343504],"domain_scores_gemma":[0.9985062,0.00011331299,0.00020518433,0.0007363029,0.00012229799,0.00031671068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000079349215,0.0003804131,0.00047500577,0.00013201077,0.00014481947,0.000055062344,0.00016310714,0.00011280632,0.000040191968],"category_scores_gemma":[0.000052866715,0.00020973296,0.00009862269,0.00036150956,0.000066700006,0.000100941616,0.000048274956,0.0001011964,0.0000535725],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002008908,0.012130648,0.97522795,0.00008787094,0.00035050153,0.0008489765,0.0036844541,0.000006457854,0.001063985,0.00006305886,0.0012519902,0.0032752003],"study_design_scores_gemma":[0.044602424,0.0053453823,0.92741966,0.00094175024,0.0007214625,0.000058383284,0.0005190293,0.0000011422426,0.011067677,0.000003992836,0.008885791,0.0004333286],"about_ca_topic_score_codex":0.00018507012,"about_ca_topic_score_gemma":0.0015274317,"teacher_disagreement_score":0.047808312,"about_ca_system_score_codex":0.00045678538,"about_ca_system_score_gemma":0.0002449918,"threshold_uncertainty_score":0.8552662},"labels":[],"label_agreement":null},{"id":"W2559873140","doi":"10.1182/blood.v116.21.930.930","title":"Notch Signaling Is Required for Mast Cell Development In the Zebrafish and May Represent a Novel Therapeutic Strategy In Systemic Mastocytosis","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Kruppel-like factors research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Izaak Walton Killam Health Centre","funders":"","keywords":"Zebrafish; Notch signaling pathway; Biology; GATA1; GATA2; Gene knockdown; Morpholino; Haematopoiesis; Cell biology; Myeloid; Mast cell; Progenitor cell; Signal transduction; Immunology; Genetics; Stem cell; Gene","score_opus":0.03316938868863666,"score_gpt":0.2874881905540104,"score_spread":0.25431880186537376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559873140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981718,0.0003222814,0.0002778506,0.00019222457,0.000035423473,0.0007509255,0.000020300604,0.0000049506457,0.00022421061],"genre_scores_gemma":[0.9987629,0.000018692757,0.0005651179,0.00012782087,0.00007067924,0.00022024526,0.000030441826,0.000023917342,0.00018019862],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986995,0.00006117608,0.0002829137,0.00041055866,0.00018736238,0.0003585258],"domain_scores_gemma":[0.9994158,0.000056219473,0.00006117072,0.0003548626,0.000059510072,0.000052424806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058908644,0.00015403867,0.00015363967,0.000075839955,0.000059102134,0.00006446412,0.00030132034,0.00017973657,0.0000102608465],"category_scores_gemma":[0.00004209545,0.000120390985,0.000043507043,0.0001215686,0.000048307622,0.0000052817436,0.00010285741,0.00020077503,0.000002576932],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005598691,0.00026399005,0.013765798,0.00008051153,0.000025771747,0.0000035399937,0.00045183644,0.000011055045,0.98487824,0.000014330912,0.000039968552,0.00040893976],"study_design_scores_gemma":[0.0021665627,0.00013822199,0.006056397,0.000030645795,0.000012963929,0.000031612195,0.00057824637,0.00005896731,0.98957074,0.000020537262,0.0011620655,0.00017301539],"about_ca_topic_score_codex":0.000073404684,"about_ca_topic_score_gemma":0.00027913676,"teacher_disagreement_score":0.0077094003,"about_ca_system_score_codex":0.00001326525,"about_ca_system_score_gemma":0.00016686812,"threshold_uncertainty_score":0.49094018},"labels":[],"label_agreement":null},{"id":"W2559898148","doi":"10.1182/blood.v106.11.2765.2765","title":"Studies on GM-CSF Induced Signaling and Cell Growth in JMML: An Experimental Model To Identify Mechanism Directed Targeted Therapeutics.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Juvenile myelomonocytic leukemia; Signal transduction; Granulocyte macrophage colony-stimulating factor; Cytokine; Cancer research; Antibody; Biology; Leukemia inhibitory factor receptor; Context (archaeology); Immunology; Cell biology; Stem cell; Haematopoiesis; Leukemia inhibitory factor","score_opus":0.07053464675567143,"score_gpt":0.36817974374404644,"score_spread":0.297645096988375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559898148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976136,0.0007226309,0.00003320447,0.00051541685,0.00003772939,0.00057644176,0.00000553367,0.00012284385,0.0003725944],"genre_scores_gemma":[0.99391675,0.00006303269,0.0043871207,0.0012106065,0.0001292438,0.00008245988,0.000011164039,0.000052670748,0.0001469224],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99841243,0.000094292365,0.00028113343,0.000437965,0.00039278186,0.0003814258],"domain_scores_gemma":[0.9993333,0.000063994106,0.00004596324,0.00023428448,0.00011756018,0.0002048463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031679322,0.00021466994,0.0003291032,0.00030248938,0.000084616084,0.00003279334,0.00012830521,0.000121033234,0.000019025709],"category_scores_gemma":[0.000059947,0.00019152148,0.00003794763,0.00027656517,0.000032187178,0.00013331258,0.000115440394,0.00034010885,0.000024386769],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019338429,0.00096635445,0.00022736366,0.000027672235,0.000098060234,0.000051503688,0.0062343236,0.000048342506,0.99179876,0.00014641593,0.00003414652,0.00017365726],"study_design_scores_gemma":[0.004751858,0.0007387485,0.0005568272,0.00006787523,0.00007013698,0.000010805765,0.0018855022,0.009405976,0.9821424,0.00017105413,0.0000053673953,0.00019346047],"about_ca_topic_score_codex":0.000043406402,"about_ca_topic_score_gemma":0.000023301553,"teacher_disagreement_score":0.009656387,"about_ca_system_score_codex":0.00019972595,"about_ca_system_score_gemma":0.0001033776,"threshold_uncertainty_score":0.7810019},"labels":[],"label_agreement":null},{"id":"W2559898561","doi":"10.1182/blood.v126.23.3927.3927","title":"Phase III Study of Response Adapted Therapy for the Treatment of Children with Newly Diagnosed Very High Risk Hodgkin Lymphoma (Stages IIIB/IVB) (AHOD0831): A Report from the Children's Oncology Group","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Etoposide; Ifosfamide; Internal medicine; Oncology; Vinorelbine; Radiation therapy; Vincristine; Chemotherapy; Cyclophosphamide; ABVD; Vinblastine; Chemotherapy regimen; Cisplatin","score_opus":0.023640852799731753,"score_gpt":0.29485200536085504,"score_spread":0.27121115256112327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559898561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987893,0.004378733,0.00002720326,0.00058324944,0.0001117921,0.006394288,0.0005383149,0.00005575094,0.000017688299],"genre_scores_gemma":[0.99556446,0.0016539454,0.0005925255,0.00011208956,0.00026336548,0.0013990778,0.0003147222,0.00005752582,0.000042261687],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973044,0.00052235066,0.00072028424,0.0005817773,0.00053472933,0.0003364771],"domain_scores_gemma":[0.99494374,0.002507864,0.0008095928,0.0013505891,0.00020913582,0.00017908313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065173296,0.00043045534,0.0010216532,0.00009076555,0.00018614122,0.000021002908,0.00025213545,0.00013408378,0.00001922967],"category_scores_gemma":[0.00021410566,0.0001977683,0.0002630243,0.00026337174,0.0002017948,0.000056952646,0.00004091269,0.000065778375,0.0000018623047],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04542202,0.12159902,0.74224716,0.0000021517887,0.010104471,0.00053618656,0.005925262,0.000018523555,0.00016964495,0.000010099324,0.00066121976,0.07330424],"study_design_scores_gemma":[0.25055894,0.06458119,0.67324954,0.000034157132,0.0038003207,0.00017529879,0.0013349109,0.000006030605,0.005415746,0.000014850014,0.00068458286,0.00014442392],"about_ca_topic_score_codex":0.022071984,"about_ca_topic_score_gemma":0.0010751723,"teacher_disagreement_score":0.20513691,"about_ca_system_score_codex":0.00022116916,"about_ca_system_score_gemma":0.00055639085,"threshold_uncertainty_score":0.98444015},"labels":[],"label_agreement":null},{"id":"W2559903511","doi":"10.1182/blood.v110.11.4470.4470","title":"High Dose Aracytine, Rituximab, and Dexamethasone Based Chemotherapy for Elderly Patients with Mantle Cell Lymphoma.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Mantle cell lymphoma; Rituximab; Internal medicine; Chemotherapy; Chemotherapy regimen; Regimen; Gastroenterology; Dexamethasone; Surgery; Lymphoma","score_opus":0.005805039722158378,"score_gpt":0.2205581837468564,"score_spread":0.21475314402469803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559903511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976075,0.00037813906,0.00032886676,0.00023689358,0.000041481962,0.0009077774,0.000033421304,0.000047877078,0.0004179896],"genre_scores_gemma":[0.9747311,0.000030158979,0.024065543,0.00073684595,0.00008123214,0.000069920316,0.00009532629,0.00003776091,0.00015209653],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998995,0.000008785336,0.00018730249,0.00030569683,0.00020289437,0.00030030706],"domain_scores_gemma":[0.9992318,0.00017134518,0.000085767235,0.000247169,0.000098289915,0.00016560567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001171061,0.00019664432,0.0003083977,0.00007182444,0.00006995522,0.000020492465,0.00004204761,0.0000781314,0.000033491193],"category_scores_gemma":[0.000015379599,0.00013885873,0.000060615494,0.00009490013,0.00004285507,0.000043751883,0.000008575838,0.00002714243,0.00000985612],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002980056,0.03433109,0.8445679,0.0002249411,0.00032118178,0.00012201,0.00012326898,6.1527084e-7,0.0006911901,0.000076904216,0.00043130206,0.11612957],"study_design_scores_gemma":[0.17360306,0.0028409802,0.73606443,0.000071686954,0.0004195125,0.000010898103,0.000018558982,0.000014981452,0.084420115,0.000023015979,0.0023343677,0.00017839568],"about_ca_topic_score_codex":0.00009388489,"about_ca_topic_score_gemma":0.000018080544,"teacher_disagreement_score":0.170623,"about_ca_system_score_codex":0.000048547012,"about_ca_system_score_gemma":0.00006693772,"threshold_uncertainty_score":0.56624943},"labels":[],"label_agreement":null},{"id":"W2559916272","doi":"10.1182/blood.v126.23.2635.2635","title":"An Adjustable Markov Model to Project Life Expectancy (LE) for Early Stage Favorable Risk Hodgkin Lymphoma Patients Treated with Contemporary Therapy","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Life expectancy; Cohort; Randomized controlled trial; Internal medicine; Pediatrics; Population","score_opus":0.047531144721292495,"score_gpt":0.2966457335350691,"score_spread":0.24911458881377663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559916272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871739,0.0002904991,0.0040399125,0.00008289327,0.000028925944,0.0040137144,0.00036605456,0.00021066326,0.0037934307],"genre_scores_gemma":[0.9832079,0.000030469972,0.0115493,0.00033014218,0.00012415038,0.00078140653,0.00020241256,0.00015162426,0.0036225982],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972327,0.00015991731,0.0003902995,0.0006925519,0.0008060787,0.00071848393],"domain_scores_gemma":[0.997283,0.00010394837,0.00016461445,0.0007995138,0.00078370934,0.0008652346],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042602583,0.00037045332,0.00058752234,0.00027772473,0.00014484464,0.00008046064,0.00029315913,0.00017286903,0.000010240109],"category_scores_gemma":[0.00030949482,0.00027340525,0.00008562024,0.0005266487,0.00007054347,0.00038040784,0.000056590903,0.00013532152,0.000018052286],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04891359,0.015915325,0.8760897,0.0002621931,0.0015586498,0.0002890999,0.009023945,0.00031265474,0.0025461179,0.000072001356,0.037345126,0.007671632],"study_design_scores_gemma":[0.59608746,0.08252465,0.10944398,0.0007455176,0.00091920356,0.0000709664,0.007264172,0.12745288,0.06484327,0.00014616795,0.0074633015,0.0030384308],"about_ca_topic_score_codex":0.004673049,"about_ca_topic_score_gemma":0.00004817673,"teacher_disagreement_score":0.76664567,"about_ca_system_score_codex":0.0003544827,"about_ca_system_score_gemma":0.005927918,"threshold_uncertainty_score":0.9999718},"labels":[],"label_agreement":null},{"id":"W2559917972","doi":"10.1182/blood.v104.11.3645.3645","title":"Complications of Pediatric Apheresis.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Apheresis; Thrombosis; Anemia; Immunoadsorption; Surgery; Adverse effect; Pediatrics; Internal medicine; Immunology","score_opus":0.019335638194532663,"score_gpt":0.2540877165005663,"score_spread":0.23475207830603362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559917972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99096894,0.0032871838,0.000105020335,0.00011101187,0.00011970025,0.00016276985,0.00006592851,0.00005212105,0.0051273345],"genre_scores_gemma":[0.9996381,0.00001639233,0.00013359464,0.000023761275,0.000022002103,0.000020276746,0.00004004089,0.0000047410767,0.000101125166],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99959004,0.000027599519,0.00016484401,0.00009875695,0.000015725182,0.000103031794],"domain_scores_gemma":[0.9996266,0.000039372895,0.00007084837,0.00022021848,0.00003392453,0.000009075307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000034524717,0.00005162791,0.00009550778,0.00004535198,0.00004931004,0.0000018189456,0.00013735359,0.000034007637,0.0002985049],"category_scores_gemma":[0.000022927046,0.000048840495,0.00004763672,0.00009180414,0.000037034777,0.000016794205,0.000035909634,0.000032755892,0.00044164815],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003848349,0.0065935734,0.4574391,0.00024002622,0.00072616787,0.0000049012115,0.00047536023,0.00006420945,0.45988047,0.060164493,0.0137987565,0.00057445816],"study_design_scores_gemma":[0.007773886,0.00017553833,0.8585478,0.000033140746,0.00052793603,0.00003871285,0.00018242678,6.7205114e-8,0.121163696,0.0035092675,0.0077985637,0.00024898085],"about_ca_topic_score_codex":0.000046801502,"about_ca_topic_score_gemma":0.000011137631,"teacher_disagreement_score":0.40110868,"about_ca_system_score_codex":0.0000053323774,"about_ca_system_score_gemma":0.000036622103,"threshold_uncertainty_score":0.5676641},"labels":[],"label_agreement":null},{"id":"W2559918862","doi":"10.1182/blood.v128.22.1267.1267","title":"Erythropoiesis-Stimulating Agents in Elderly Patients with Anemia of Unknown Etiology: Treatment Response and Cardiovascular Outcomes","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Etiology; Anemia; Cohort; Myelodysplastic syndromes; Erythropoietin; Erythropoiesis; Internal medicine; Retrospective cohort study; Hemoglobin; Pediatrics; Disease; Intensive care medicine; Bone marrow","score_opus":0.017171710547153513,"score_gpt":0.26139910764476726,"score_spread":0.24422739709761374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559918862","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983025,0.00043017167,0.0000054344046,0.0005474275,0.000027631055,0.0004756205,0.000018495653,0.000027802716,0.00016489108],"genre_scores_gemma":[0.9981269,0.00015757802,0.0012729657,0.000030279021,0.000015505824,0.000028984254,0.00001069387,0.000022511418,0.00033455677],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880654,0.00012609139,0.00027449636,0.00032539314,0.00022943405,0.00023804395],"domain_scores_gemma":[0.9991609,0.00022168453,0.00007175584,0.00038460077,0.00006504475,0.0000960063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016984792,0.00021103746,0.0005832599,0.0001103141,0.000041393425,0.000004060607,0.00003628582,0.00009544922,0.00004267097],"category_scores_gemma":[0.00011293002,0.00010914625,0.00013072339,0.00009771778,0.00015815409,0.000039827883,0.000026127169,0.000047393634,0.00000561694],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090683816,0.0013627001,0.98859406,0.000042948184,0.0006136048,0.00011539227,0.00024717307,0.0000029925238,0.0008064525,0.00000818877,0.000012673909,0.0072869603],"study_design_scores_gemma":[0.029300729,0.0051449663,0.9608063,0.0003098939,0.0006050884,0.000024205387,0.00008197545,0.000001089192,0.003299761,0.000007529989,0.00028423828,0.00013419759],"about_ca_topic_score_codex":0.00009948894,"about_ca_topic_score_gemma":0.000023630151,"teacher_disagreement_score":0.02839389,"about_ca_system_score_codex":0.00007739284,"about_ca_system_score_gemma":0.00006533621,"threshold_uncertainty_score":0.44508547},"labels":[],"label_agreement":null},{"id":"W2559920443","doi":"10.1182/blood.v114.22.447.447","title":"Growth Factor Independence 1 (Gfi1) Is Required for Initiation, Maintenance, Progression, and Transplantability of Lymphoma.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Lymphoma; Cancer research; Biology; Cre recombinase; Severe combined immunodeficiency; Leukemia; Molecular biology; Gene; Immunology; Transgene; Genetics; Genetically modified mouse","score_opus":0.029778444391304233,"score_gpt":0.3229154177450543,"score_spread":0.29313697335375005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559920443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99621904,0.00044194475,0.00019283072,0.00082384446,0.000018497036,0.0007894912,0.000268296,0.000031344814,0.001214741],"genre_scores_gemma":[0.99824184,0.000282576,0.000982257,0.0002857122,0.000055661367,0.000031239113,0.000024467647,0.000010184626,0.00008607541],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881995,0.000022819997,0.0002932299,0.00026803935,0.00034255083,0.00025342984],"domain_scores_gemma":[0.9991756,0.00007901628,0.000075615535,0.00020173055,0.000339971,0.0001280767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024294802,0.00011473899,0.0002812137,0.00008874044,0.00006774849,0.000014464651,0.00008030779,0.000121757104,0.00006931647],"category_scores_gemma":[0.00016687292,0.00008852132,0.0000710238,0.00016568956,0.00009276087,0.000112887334,0.000012663906,0.000080219936,0.0000027614838],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006505252,0.007567454,0.5843861,0.003162027,0.0003903697,0.00011266026,0.0056342725,8.003953e-8,0.2294036,0.005030192,0.0028770033,0.154931],"study_design_scores_gemma":[0.010944633,0.0013921409,0.718017,0.0003375119,0.00013517613,0.000079770216,0.000062430525,0.000038543214,0.26440614,0.0025159232,0.0018875645,0.00018314863],"about_ca_topic_score_codex":0.000029307186,"about_ca_topic_score_gemma":0.000011647818,"teacher_disagreement_score":0.15474784,"about_ca_system_score_codex":0.000020654848,"about_ca_system_score_gemma":0.0001776437,"threshold_uncertainty_score":0.36097947},"labels":[],"label_agreement":null},{"id":"W2559940386","doi":"10.1182/blood.v106.11.2321.2321","title":"Mature Sickle and Normal Red Cells Exhibit Regulatory Volume Decrease Activated by Urea and Mediated by KCl Cotransport.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Reticulocyte; Incubation; Urea; Cotransporter; Hemoglobin; Chemistry; Red blood cell; Molecular biology; Biochemistry; Biology; Internal medicine; Messenger RNA; Medicine; Sodium","score_opus":0.0024139382825489435,"score_gpt":0.17877537574597735,"score_spread":0.17636143746342842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559940386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874209,0.008378268,0.0000057339253,0.001938528,0.00004167377,0.00034672106,0.00012793812,0.00013750148,0.0016027084],"genre_scores_gemma":[0.9939625,0.0016285169,0.00017969144,0.0009768408,0.00006259593,0.0000081304515,0.00043233758,0.00004610687,0.002703261],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987428,0.000029552346,0.0002785539,0.00035089478,0.00023884233,0.0003593314],"domain_scores_gemma":[0.99903905,0.000028046628,0.00008395755,0.00023722091,0.00005113451,0.0005605678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011098042,0.00024538307,0.00033540535,0.000059909802,0.00010179375,0.000020013966,0.000055938162,0.00042135728,0.00037047494],"category_scores_gemma":[0.00003649606,0.00020955162,0.000051347823,0.00016445549,0.00015764392,0.00011957445,0.000021219601,0.00037457314,0.00001883543],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003826705,0.0009891187,0.010713242,0.00014803672,0.00024927192,0.00010585779,0.00044365277,0.000001999957,0.85660577,0.000005246777,0.1280475,0.0023076448],"study_design_scores_gemma":[0.025822978,0.0006475736,0.019077035,0.00033068354,0.0014273414,0.0004719255,0.00047050207,0.00030652518,0.6557974,0.000016679076,0.29473448,0.00089686655],"about_ca_topic_score_codex":0.00006839219,"about_ca_topic_score_gemma":0.000011552796,"teacher_disagreement_score":0.20080836,"about_ca_system_score_codex":0.00001635731,"about_ca_system_score_gemma":0.00007278533,"threshold_uncertainty_score":0.85452676},"labels":[],"label_agreement":null},{"id":"W2559948760","doi":"10.1182/blood.v118.21.4269.4269","title":"Targeting EVI1-Overexpressing AML with Darinaparsin","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Jewish General Hospital; McGill University","funders":"","keywords":"Arsenic trioxide; Medicine; Cancer research; Cytarabine; Mitoxantrone; Myeloid; Internal medicine; Oncology; Chemotherapy; Myeloid leukemia; Biology; Apoptosis","score_opus":0.03344768634119733,"score_gpt":0.2682430929113709,"score_spread":0.23479540657017356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559948760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92610985,0.0003088979,0.00037701154,0.00012336868,0.00002811901,0.00027524406,0.0000028257978,0.00011378462,0.0726609],"genre_scores_gemma":[0.9710123,0.000020514848,0.02738917,0.00018078859,0.00018552472,0.00001627923,0.000011647654,0.000041747542,0.0011420586],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988182,0.000037157948,0.00015870959,0.0002727046,0.00031532225,0.00039790288],"domain_scores_gemma":[0.9992911,0.00003466269,0.000052923497,0.0003448518,0.000097866316,0.00017855041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020774048,0.00013440751,0.00021324767,0.00008356697,0.00009570002,0.00002016571,0.0001277049,0.00007421794,0.00043991505],"category_scores_gemma":[0.00011045674,0.00009961184,0.00003826499,0.00018647453,0.000102281956,0.000112148875,0.00008601185,0.00032829292,0.00012402922],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024537854,0.0037645423,0.48950666,0.0007963045,0.0011312278,0.0047465255,0.008102842,0.000005312877,0.45816603,0.0015468987,0.016503977,0.0132759055],"study_design_scores_gemma":[0.032538783,0.0037128264,0.15596385,0.0017832591,0.0012456643,0.0026120683,0.0024911903,0.00073843094,0.7725619,0.0004245904,0.02465021,0.0012772148],"about_ca_topic_score_codex":0.00014832587,"about_ca_topic_score_gemma":0.000002969516,"teacher_disagreement_score":0.3335428,"about_ca_system_score_codex":0.000056956455,"about_ca_system_score_gemma":0.00022790009,"threshold_uncertainty_score":0.48167613},"labels":[],"label_agreement":null},{"id":"W2559959838","doi":"10.1182/blood.v106.11.901.901","title":"Self-Managed Long-Term Low-Molecular-Weight Heparin Compared with Usual-Care Anticoagulation for Patients with Proximal Venous Thrombosis: Harm Associated with Bleeding!.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of British Columbia","funders":"","keywords":"Medicine; Low molecular weight heparin; Deep vein; Thrombosis; Heparin; Randomized controlled trial; Context (archaeology); Confidence interval; Surgery; Anticoagulant; Internal medicine","score_opus":0.010570960682825455,"score_gpt":0.24604910740318955,"score_spread":0.2354781467203641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559959838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938289,0.00015548446,0.00046707888,0.0001991854,0.000049687016,0.0040262965,0.000032504144,0.00031620663,0.00092465716],"genre_scores_gemma":[0.9940254,0.00002615449,0.00418095,0.00030892694,0.00013740432,0.0004061189,0.0007544646,0.0001254078,0.000035185465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976009,0.00004346356,0.00036613655,0.000641509,0.0007147929,0.0006331804],"domain_scores_gemma":[0.9984893,0.000041010644,0.00031997453,0.0004365152,0.00051474466,0.00019842995],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012311543,0.00043841562,0.00084403454,0.00017120343,0.00025714946,0.00010202643,0.00016390938,0.00011931903,0.000024158495],"category_scores_gemma":[0.000021491269,0.0003205005,0.00009786536,0.00035542302,0.00007739768,0.00022882446,0.000057309535,0.00017960326,0.000009636454],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073876616,0.027574902,0.961773,0.0011541627,0.0046749087,0.00008890814,0.0025051865,0.00019498725,0.0002548,0.00017718445,0.00019732244,0.0006659062],"study_design_scores_gemma":[0.024392677,0.005527525,0.9590145,0.0012365076,0.005234302,0.000007220751,0.00015293383,0.00026682235,0.003527999,0.0000032533346,0.00010920493,0.0005270547],"about_ca_topic_score_codex":0.000014563981,"about_ca_topic_score_gemma":0.00013753475,"teacher_disagreement_score":0.023653911,"about_ca_system_score_codex":0.00019014928,"about_ca_system_score_gemma":0.000111613765,"threshold_uncertainty_score":0.9999247},"labels":[],"label_agreement":null},{"id":"W2559960264","doi":"10.1182/blood.v124.21.3717.3717","title":"Epitope Spreading Is Required for Long-Term Protection Against Acute Lymphoblastic Leukemia","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia; Child and Family Research Institute","funders":"","keywords":"Immune system; Antigen; Immunology; Biology; Chimeric antigen receptor; Leukemia; Epitope; Immunotherapy; Cancer research; T cell; Immune tolerance","score_opus":0.029530755368999295,"score_gpt":0.29937104822267463,"score_spread":0.26984029285367533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559960264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98868763,0.00009167871,0.005472274,0.00035949177,0.00019779251,0.0016007363,0.000009495419,0.00013253398,0.0034483422],"genre_scores_gemma":[0.9891553,0.000093386756,0.00051197544,0.00037584454,0.0009179491,0.00029568217,0.000035690406,0.00007053425,0.008543669],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985919,0.000046900488,0.00024201129,0.00037387223,0.0003183619,0.00042697284],"domain_scores_gemma":[0.9990663,0.00010267794,0.000073811134,0.00044894483,0.00013282317,0.00017545142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034562516,0.00017146683,0.00031216032,0.00014536051,0.00012330305,0.00004598467,0.00012866282,0.00014230775,0.00025195672],"category_scores_gemma":[0.00019932489,0.00015547113,0.00015559749,0.00018908888,0.00005898848,0.000085805485,0.00004710503,0.00015418245,0.000106398715],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050969917,0.00018021674,0.0036963134,0.00025736165,0.000309611,0.000028440285,0.00018736042,0.000002329786,0.90665734,0.000024541429,0.0003447385,0.08780203],"study_design_scores_gemma":[0.014732478,0.0017547782,0.010845682,0.0004370582,0.00053582736,0.00022127478,0.000014149003,0.0027956762,0.9630473,0.00018265675,0.0051047434,0.0003283712],"about_ca_topic_score_codex":0.000020134745,"about_ca_topic_score_gemma":0.000010643305,"teacher_disagreement_score":0.08747366,"about_ca_system_score_codex":0.00024076179,"about_ca_system_score_gemma":0.00016667954,"threshold_uncertainty_score":0.63399285},"labels":[],"label_agreement":null},{"id":"W2559960476","doi":"10.1182/blood.v126.23.3604.3604","title":"TLR3 or TLR4 Activation Enhances MSC-Mediated Treg Generation Via Notch Signaling","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"TLR3; Mesenchymal stem cell; TLR4; Immunology; Immune system; Innate immune system; Biology; Cell biology; Toll-like receptor; Cancer research","score_opus":0.11622554362651577,"score_gpt":0.3392927435080339,"score_spread":0.22306719988151813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559960476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915697,0.00017769296,0.0032544031,0.0005973874,0.00013398795,0.00046887784,0.0000023797832,0.00008571711,0.0037098366],"genre_scores_gemma":[0.99410343,0.000026122167,0.001060853,0.0001592861,0.0009863413,0.000042208078,0.00013330247,0.000025475169,0.0034629644],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983517,0.000097114826,0.00026514294,0.00028284677,0.00071354985,0.00028962846],"domain_scores_gemma":[0.9989704,0.0001416849,0.00008144254,0.00022780844,0.00030887852,0.0002697928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005191163,0.00013289157,0.00022017141,0.00012996263,0.00007080123,0.000039412353,0.00008834586,0.00012643855,0.00044567094],"category_scores_gemma":[0.0008507955,0.000099095385,0.000041688763,0.0003593258,0.000033099586,0.0001462413,0.000032260024,0.00018459644,0.00033901853],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017420492,0.00032653587,0.001441577,0.000049276652,0.000052604744,0.000040650844,0.0003532465,0.000009186822,0.99162143,0.0000066501357,0.0010693889,0.0048552686],"study_design_scores_gemma":[0.002797185,0.0005368726,0.000716293,0.00006692251,0.00006328138,0.000027105025,0.000120740995,0.0027228852,0.9899448,0.00002057294,0.002858377,0.00012497099],"about_ca_topic_score_codex":0.00018854087,"about_ca_topic_score_gemma":0.000074812044,"teacher_disagreement_score":0.0047302977,"about_ca_system_score_codex":0.00007650511,"about_ca_system_score_gemma":0.0003159648,"threshold_uncertainty_score":0.48797843},"labels":[],"label_agreement":null},{"id":"W2559970740","doi":"10.1182/blood.v116.21.2098.2098","title":"Gvhd Increases Apoptosis of CD8+, but Not CD4+, T Cells Expanded by Vaccines but Is Not Dependent on Fas Ligand","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Immunology; CD8; Graft-versus-host disease; Antigen; Cytotoxic T cell; T cell; Adoptive cell transfer; Medicine; Minor histocompatibility antigen; Transplantation; Immune system; Major histocompatibility complex; Biology; Internal medicine","score_opus":0.0131798061936019,"score_gpt":0.2471326997642577,"score_spread":0.2339528935706558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559970740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962056,0.000055405777,0.000049875136,0.00032984777,0.00027027176,0.00047791205,0.00026621588,0.00007557317,0.0022692888],"genre_scores_gemma":[0.9971118,0.00015504211,0.00060665153,0.00062493625,0.00016216596,0.000037731035,0.00006350001,0.0000460803,0.0011920909],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99817353,0.000038398684,0.00050498947,0.00040533254,0.00057300576,0.0003047445],"domain_scores_gemma":[0.9986303,0.0003096146,0.0001725002,0.0005252248,0.00013463039,0.00022774901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017901226,0.00026952947,0.00050412223,0.00013550976,0.000059861333,0.000020644115,0.0001603755,0.00023093953,0.000554564],"category_scores_gemma":[0.00008753231,0.00023134252,0.00013569034,0.00013396933,0.000044811666,0.00006032737,0.000024979641,0.00026589297,0.00013347562],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029015762,0.0012904159,0.010789711,0.00038459644,0.00014470247,0.000024094355,0.00043070383,3.6501345e-7,0.985412,0.000026935291,0.000559068,0.0006472325],"study_design_scores_gemma":[0.0061354837,0.00038006462,0.005903079,0.00014839676,0.0006375914,0.00008486985,0.0003030965,0.0000064181695,0.9860377,0.000010902285,0.00013501247,0.00021744106],"about_ca_topic_score_codex":0.00055523426,"about_ca_topic_score_gemma":0.00004655798,"teacher_disagreement_score":0.0058453265,"about_ca_system_score_codex":0.000012091878,"about_ca_system_score_gemma":0.00008157636,"threshold_uncertainty_score":0.9433874},"labels":[],"label_agreement":null},{"id":"W2559974337","doi":"10.1182/blood.v120.21.393.393","title":"A Multicenter Randomized Placebo Controlled Trial of Compression Stockings to Prevent the Post-Thrombotic Syndrome After Proximal Deep Venous Thrombosis: The S.O.X. Trial","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Hospital; Hôpital du Sacré-Cœur de Montréal; Hôpital Maisonneuve-Rosemont; McMaster University; Toronto General Hospital; Hamilton General Hospital; Centre Hospitalier de l’Université de Montréal; London Health Sciences Centre; St Mary's Hospital Centre; Western University; McMaster University Medical Centre; Victoria Heart Institute Foundation; Ottawa Hospital; Université de Montréal; Queen Elizabeth II Health Sciences Centre; Hôpital Notre-Dame; Hôpital de l'Enfant-Jésus; Montreal General Hospital; St. Boniface Hospital; Jewish General Hospital","funders":"","keywords":"Medicine; Post-thrombotic syndrome; Compression stockings; Placebo; Randomized controlled trial; Surgery; Venous thrombosis; Thrombosis; Blinding; Deep vein; Intention-to-treat analysis","score_opus":0.012406359267290596,"score_gpt":0.2721783086215165,"score_spread":0.2597719493542259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559974337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9573213,0.0009885825,0.00008568113,0.0023171385,0.001187859,0.037624817,0.000007546299,0.00005552167,0.00041154024],"genre_scores_gemma":[0.98887163,0.00007262122,0.000240988,0.0012787387,0.00063167396,0.008729499,0.0000090384765,0.00005433957,0.00011144959],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99626064,0.00088824204,0.0010296907,0.0003494216,0.00081127847,0.0006606953],"domain_scores_gemma":[0.9973895,0.0009810586,0.0004533047,0.000795623,0.00015782089,0.00022272328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024854424,0.0003774386,0.002206981,0.00012044221,0.00019889146,0.00005148463,0.00034844544,0.00012873144,0.00028075874],"category_scores_gemma":[0.0007632761,0.00018086671,0.0007741465,0.00017273196,0.00020411663,0.00011624257,0.00026110208,0.00029655275,0.000057818175],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9667687,0.02465451,0.00007292089,0.00011933352,0.0023011088,0.000011884281,0.0050705234,0.000012917082,0.00046402647,0.00011789892,0.00021425645,0.00019194685],"study_design_scores_gemma":[0.98131514,0.004499235,0.0052745105,0.0003612214,0.006985086,0.000025113872,0.0004140867,0.00008643312,0.0005468135,0.00002043125,0.00026139722,0.00021054345],"about_ca_topic_score_codex":0.00009506789,"about_ca_topic_score_gemma":0.0000139914055,"teacher_disagreement_score":0.031550337,"about_ca_system_score_codex":0.000049608578,"about_ca_system_score_gemma":0.00007771202,"threshold_uncertainty_score":0.73755306},"labels":[],"label_agreement":null},{"id":"W2559986076","doi":"10.1182/blood.v106.11.120.120","title":"The Transcriptional Profile of PV Displays Limited Similarity to EPO Stimulated Progenitor Cells: Evidence That JAK2 V617F Confers a Novel Program to Malignant Hematopoietic Stem Cells.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Erythropoietin; Haematopoiesis; Progenitor cell; Biology; Polycythemia vera; CD34; Stem cell; Mutation; Cancer research; Molecular biology; Immunology; Gene; Genetics","score_opus":0.05183238357207373,"score_gpt":0.29658073716076766,"score_spread":0.24474835358869393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559986076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986494,0.0007944412,0.00046780505,0.005151473,0.0001528251,0.0064846515,0.00021225114,0.000116931646,0.00012560641],"genre_scores_gemma":[0.99074304,0.00009848558,0.006216772,0.0004601352,0.000113890674,0.001776025,0.000027240176,0.00004510401,0.0005193121],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99744457,0.000084052124,0.0005833399,0.00059233437,0.00074809487,0.000547596],"domain_scores_gemma":[0.9981417,0.00032960565,0.00018050613,0.00050898344,0.0003778715,0.0004613244],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030422854,0.0003810919,0.0005554694,0.00010455207,0.00020473359,0.00007770005,0.00022470597,0.00013896372,0.000100563404],"category_scores_gemma":[0.000060992294,0.0002487231,0.00022285423,0.0003822687,0.0001037624,0.000098266166,0.000061565195,0.00019968562,0.00008746322],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030795166,0.03358373,0.06542969,0.001388125,0.0022192732,0.00021807296,0.007017138,0.0009286283,0.86718005,0.0014334136,0.0028860073,0.014636354],"study_design_scores_gemma":[0.004486585,0.0027465206,0.016234621,0.00095429044,0.0008101178,0.00006853445,0.0002901916,0.0013762146,0.96582353,0.000004706656,0.00686487,0.00033983364],"about_ca_topic_score_codex":0.000025871625,"about_ca_topic_score_gemma":0.000044861434,"teacher_disagreement_score":0.09864346,"about_ca_system_score_codex":0.0001014785,"about_ca_system_score_gemma":0.0002579675,"threshold_uncertainty_score":0.9999965},"labels":[],"label_agreement":null},{"id":"W2559998476","doi":"10.1182/blood.v126.23.2191.2191","title":"SIRPαFc, a CD47-Blocking Cancer Immunotherapeutic, Sensitizes Malignant B Cells to Macrophage-Mediated Destruction","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Western University; Trillium Therapeutics (Canada); London Health Sciences Centre; Lawson Health Research Institute","funders":"","keywords":"CD47; Macrophage; Phagocytosis; Cancer research; Cancer cell; Immunology; Biology; Cancer; In vitro","score_opus":0.022631070990346346,"score_gpt":0.2514786809339319,"score_spread":0.22884760994358555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559998476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889977,0.00868523,0.00023976485,0.00022241064,0.0011698941,0.00029031004,0.00005285198,0.0001136561,0.00022817923],"genre_scores_gemma":[0.9980172,0.00014715383,0.00022128895,0.00027053332,0.00008950788,0.00004047595,0.00008211804,0.000031139705,0.0011005831],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987713,0.00015163176,0.00030710184,0.00030565896,0.000062666084,0.00040161062],"domain_scores_gemma":[0.99933714,0.000045978715,0.00012787481,0.00028878075,0.0001462844,0.00005393264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002222597,0.00020692682,0.0002789682,0.000120085264,0.00014916724,0.000033250424,0.0001463217,0.00021495727,0.00019888814],"category_scores_gemma":[0.000030948017,0.00018720065,0.00008030126,0.00021600665,0.00006873292,0.0000848551,0.000070839866,0.00016011993,0.00055322755],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001270938,0.0001236136,0.0009817734,0.000006897727,0.0002250116,0.0000071860286,0.00063479267,0.00006907443,0.9936249,0.00004566565,0.0007219989,0.0034319547],"study_design_scores_gemma":[0.0028926206,0.0001664446,0.005469582,0.000055664354,0.00012613767,0.000101030615,0.00018837291,0.00001999363,0.9785252,0.000047518053,0.012158489,0.0002489247],"about_ca_topic_score_codex":0.0003854167,"about_ca_topic_score_gemma":0.000028431286,"teacher_disagreement_score":0.015099716,"about_ca_system_score_codex":0.000070049246,"about_ca_system_score_gemma":0.000100959376,"threshold_uncertainty_score":0.7633821},"labels":[],"label_agreement":null},{"id":"W2560000017","doi":"10.1182/blood.v126.23.2885.2885","title":"Association Between Mitochondrial DNA Haplogroup and Myelodysplastic Syndromes","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Metabolism and Genetic Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Haplogroup; Mitochondrial DNA; Odds ratio; Human mitochondrial DNA haplogroup; Medicine; Population; Genetics; Biology; Haplotype; Internal medicine; Genotype; Gene; Environmental health","score_opus":0.012284270665491004,"score_gpt":0.22722357021734216,"score_spread":0.21493929955185115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560000017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99667346,0.0013548166,0.00029342104,0.00010928052,0.0002710877,0.00009874127,0.000021957378,0.00001154602,0.0011656777],"genre_scores_gemma":[0.9969659,0.00012156877,0.00078659586,0.00006495129,0.00059766695,0.000011652876,0.00010290951,0.000014669099,0.0013340992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99927104,0.00004673114,0.00012310581,0.00022132954,0.0001415476,0.00019625647],"domain_scores_gemma":[0.9996,0.000015610964,0.000059755756,0.00014692609,0.000048368707,0.00012933665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013030409,0.00010022927,0.00013199415,0.0000248628,0.000034371016,0.000027888625,0.000084473,0.00013632733,0.0000074557906],"category_scores_gemma":[0.0002716617,0.00009706522,0.000032417305,0.00004602374,0.00002664051,0.000002684931,0.00006345714,0.000042198422,0.000019180732],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007488275,0.00034072174,0.8170081,0.000044417695,0.0009640543,0.000007644906,0.00028540744,0.0000103416905,0.15338388,0.00014828827,0.023495981,0.0042363186],"study_design_scores_gemma":[0.017031819,0.001321277,0.52145493,0.000030884883,0.0015957975,0.000053113945,0.00035122907,0.00001526661,0.14814383,0.0021444175,0.30670595,0.0011515273],"about_ca_topic_score_codex":0.000008406202,"about_ca_topic_score_gemma":0.000015767233,"teacher_disagreement_score":0.29555315,"about_ca_system_score_codex":0.000002085377,"about_ca_system_score_gemma":0.000047065245,"threshold_uncertainty_score":0.39582047},"labels":[],"label_agreement":null},{"id":"W2560016996","doi":"10.1182/blood.v120.21.382.382","title":"Psi Domain of b3 Integrin Has Endogenous Thiol Isomerase Function and Is a Potential New Target for Anti-Thrombotic Therapy","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; St. Michael's Hospital","funders":"","keywords":"Integrin; Molecular biology; Platelet activation; Platelet; Chemistry; Biochemistry; Biology; Cell biology; Immunology","score_opus":0.03503457272968608,"score_gpt":0.2500281939656574,"score_spread":0.21499362123597132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560016996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99095255,0.006711654,0.0010002917,0.00034931744,0.00015331166,0.00062305835,0.000033273118,0.000022988492,0.00015356923],"genre_scores_gemma":[0.9967736,0.00036885226,0.0022408408,0.00023889034,0.00016471864,0.000019730764,0.000058547794,0.00002084597,0.000113994196],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993164,0.000015904685,0.0001613968,0.00015118031,0.000111804125,0.00024331728],"domain_scores_gemma":[0.9996097,0.000018840921,0.00006697697,0.00014219934,0.000031376385,0.0001308778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000757625,0.00013624594,0.00031259423,0.000059914615,0.00006730865,0.000010568896,0.000029403815,0.00007969534,0.00011605472],"category_scores_gemma":[0.00001091704,0.000102208236,0.00009242738,0.000064731095,0.0000384455,0.00007982313,0.00001147906,0.00006361345,0.000008323857],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002410984,0.016892325,0.16435811,0.00035680758,0.004544137,0.00017131836,0.005507324,0.0000028003315,0.7357426,0.00035977896,0.0036058775,0.066047885],"study_design_scores_gemma":[0.16793473,0.015183246,0.32672474,0.00035404824,0.004191101,0.0024719525,0.0016410977,0.00012432832,0.4506778,0.012623664,0.016985998,0.0010872723],"about_ca_topic_score_codex":0.00014906823,"about_ca_topic_score_gemma":0.000002827417,"teacher_disagreement_score":0.28506485,"about_ca_system_score_codex":0.000008072623,"about_ca_system_score_gemma":0.00005700435,"threshold_uncertainty_score":0.41679308},"labels":[],"label_agreement":null},{"id":"W2560039482","doi":"10.1182/blood.v104.11.2167.2167","title":"Revising the Genomic Structure of the Human GM-CSF Receptor Alpha (GMRα) Subunit: Characterization of a Novel Membrane-Spanning GMRα Isoform Which Contains a Previously Undescribed Exon.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Exon; Alternative splicing; Biology; Molecular biology; Gene isoform; Alu element; RNA splicing; Gene; Cell biology; Genetics; Human genome; RNA; Genome","score_opus":0.01335511950904263,"score_gpt":0.2211947783076706,"score_spread":0.20783965879862795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560039482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99769616,0.0006517254,0.00018162557,0.00037464473,0.0002243683,0.00068108086,0.000045679506,0.00002964619,0.00011505862],"genre_scores_gemma":[0.9992304,0.00012867257,0.000048364946,0.00009796871,0.000046911584,0.000009949195,0.00022514226,0.00002474573,0.00018784817],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986499,0.00021459606,0.00058868626,0.00019785471,0.000067571666,0.00028138084],"domain_scores_gemma":[0.99861825,0.000066458495,0.00060305436,0.00048548792,0.00021513109,0.000011636839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003576668,0.00019559177,0.0003396636,0.0000894639,0.00036238245,0.000022392662,0.00039657622,0.00024008926,0.0001138035],"category_scores_gemma":[0.00015014992,0.0001273219,0.00012407322,0.00028942587,0.00016633382,0.0001804833,0.00010523961,0.0003100689,0.000008938889],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000116181436,0.00013945528,0.0004639607,0.00007550523,0.00021500626,2.070894e-7,0.0037113915,0.000023301885,0.9934989,0.0014399092,0.0000055035202,0.00031068226],"study_design_scores_gemma":[0.0032144615,0.00014452645,0.035182957,0.0003483212,0.00016753495,0.00004975962,0.0003406183,0.0000026850016,0.9592781,0.000046319245,0.0010809067,0.00014379775],"about_ca_topic_score_codex":0.00013269403,"about_ca_topic_score_gemma":0.000078532015,"teacher_disagreement_score":0.034718998,"about_ca_system_score_codex":0.000053263717,"about_ca_system_score_gemma":0.00018347049,"threshold_uncertainty_score":0.5192036},"labels":[],"label_agreement":null},{"id":"W2560046425","doi":"10.1182/blood.v114.22.3286.3286","title":"Efficacy and Safety of Nilotinib in Elderly Patients with Imatinib-Resistant or -;Intolerant Chronic Myeloid Leukemia (CML) in Chronic Phase (CP): A Sub-Analysis of the ENACT (Expanding Nilotinib Access in Clinical Trials) Study.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nilotinib; Medicine; Imatinib; Internal medicine; Imatinib mesylate; Myeloid leukemia; Tyrosine-kinase inhibitor; Cancer","score_opus":0.05427079988921533,"score_gpt":0.3957849007024577,"score_spread":0.34151410081324235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560046425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942434,0.0007481588,0.0000086842465,0.00007842331,0.00005969844,0.0046824357,0.00007752381,0.00002541001,0.0000762781],"genre_scores_gemma":[0.9992914,0.00029714938,0.000078960446,0.000039242495,0.000075650605,0.000083740466,0.00007159375,0.000043771473,0.000018470113],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99231875,0.0013273326,0.0038861437,0.0009299265,0.0008623472,0.0006755296],"domain_scores_gemma":[0.99533916,0.0017972215,0.0014792896,0.0010629268,0.00012757616,0.00019384846],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0037034387,0.0005423823,0.0032146736,0.0009510327,0.00006690881,0.000037295253,0.00049228163,0.00024204557,0.000096669006],"category_scores_gemma":[0.001764632,0.0003317137,0.00039492868,0.0028960654,0.00021008159,0.0002108849,0.00015487884,0.0007660214,0.0000012051896],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030413356,0.023415172,0.8797187,0.00036493826,0.003341271,0.00022224787,0.0023787615,0.0008031233,0.0050784755,0.00001121788,0.000007200008,0.05424549],"study_design_scores_gemma":[0.19065596,0.010066664,0.790042,0.0013383651,0.0037096983,0.000005249831,0.00017888001,0.00082096126,0.0029046682,0.000005358784,0.000008051151,0.0002641779],"about_ca_topic_score_codex":0.0011799573,"about_ca_topic_score_gemma":0.011180466,"teacher_disagreement_score":0.16024262,"about_ca_system_score_codex":0.00256536,"about_ca_system_score_gemma":0.003137653,"threshold_uncertainty_score":0.9999135},"labels":[],"label_agreement":null},{"id":"W2560051287","doi":"10.1182/blood.v126.23.172.172","title":"Predictors of Early Death in Childhood Acute Promyelocytic Leukemia: Results of an International Retrospective Study","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Population Health Research Institute; Hospital for Sick Children","funders":"","keywords":"Acute promyelocytic leukemia; Medicine; Univariate analysis; Incidence (geometry); Pediatrics; Hematology; Internal medicine; Retrospective cohort study; Multivariate analysis; Retinoic acid","score_opus":0.00937585680001602,"score_gpt":0.25049264402058935,"score_spread":0.24111678722057334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560051287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970324,0.0000923085,0.00001266857,0.0000047585063,0.00010515578,0.00027365683,0.00005173755,0.000007447331,0.0024198692],"genre_scores_gemma":[0.99932706,0.000029272882,0.00028447527,0.000004493742,0.00013385294,0.000019218092,0.00007845141,0.000014334146,0.000108850014],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989046,0.00006041202,0.00033745123,0.00031228075,0.00025574648,0.00012949394],"domain_scores_gemma":[0.9992289,0.000004188528,0.00017234919,0.00032273354,0.00020870923,0.00006314956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028613902,0.00011691475,0.00018277373,0.00006486045,0.0000116066,0.000008424707,0.00032132276,0.000116378,0.000001308819],"category_scores_gemma":[0.00020724277,0.00010739709,0.000041945867,0.00011559183,0.000052740204,0.00001145069,0.00010469632,0.000104051214,6.882486e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051008083,0.0018929958,0.93712825,0.000013488601,0.0004063345,0.000028351733,0.0019444213,0.00005173325,0.057864953,0.000026353995,0.000024777444,0.00010826589],"study_design_scores_gemma":[0.007695174,0.003829519,0.53761387,0.000023472472,0.00009913215,0.000018364468,0.0003843084,0.000011863412,0.4500526,0.0001008415,0.00003730363,0.00013358713],"about_ca_topic_score_codex":0.00009241501,"about_ca_topic_score_gemma":0.000025780833,"teacher_disagreement_score":0.3995144,"about_ca_system_score_codex":0.000043257074,"about_ca_system_score_gemma":0.00036513587,"threshold_uncertainty_score":0.43795264},"labels":[],"label_agreement":null},{"id":"W2560052986","doi":"10.1182/blood.v124.21.1520.1520","title":"New Data on the Safety and Efficacy of Recombinant FXIII in Patients with Congenital FXIII A-Subunit Deficiency","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Interim analysis; Dosing; Haemophilia; Clinical trial; Internal medicine; Recombinant DNA; Surgery; Pediatrics","score_opus":0.013528141403706881,"score_gpt":0.22625231376487118,"score_spread":0.2127241723611643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560052986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99588376,0.00010568238,0.00001321016,0.0002192813,0.000031916315,0.00035550105,0.000018472407,0.000008210269,0.0033639693],"genre_scores_gemma":[0.999504,0.000032507964,0.00014963081,0.00007045824,0.00000723938,0.0000016423277,0.0000988463,0.00001042272,0.00012522227],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993091,0.000028947838,0.0001558265,0.00020159408,0.00016126885,0.00014326928],"domain_scores_gemma":[0.9992816,0.000118988275,0.00005882399,0.00045695444,0.000022885537,0.000060767838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011027672,0.00010283299,0.00021187347,0.00004198962,0.0000404776,0.000006534515,0.00011582202,0.000033765402,0.000027318309],"category_scores_gemma":[0.00010285137,0.000056289715,0.000013910461,0.00011565485,0.00004128052,0.000042066542,0.000060494385,0.00008514463,0.000009421393],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017621242,0.006777855,0.93840563,0.000033940763,0.00025845255,0.000044935645,0.00038323482,0.0000015008796,0.000037007114,0.0010348363,0.00034515065,0.050915305],"study_design_scores_gemma":[0.024549471,0.0018697089,0.9722772,0.000093281444,0.00022878702,0.000010710986,0.000035032357,0.000027336526,0.00013204858,0.00007505944,0.0006136363,0.000087725115],"about_ca_topic_score_codex":0.00013374005,"about_ca_topic_score_gemma":0.00006686583,"teacher_disagreement_score":0.050827578,"about_ca_system_score_codex":0.0000063782613,"about_ca_system_score_gemma":0.000040583844,"threshold_uncertainty_score":0.22954279},"labels":[],"label_agreement":null},{"id":"W2560056817","doi":"10.1182/blood.v128.22.3107.3107","title":"Safety and Efficacy of Ruxolitinib for the Final Enrollment of JUMP: An Open-Label, Multicenter, Single-Arm, Expanded-Access Study in Patients with Myelofibrosis (N = 2233)","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Ruxolitinib; Medicine; Myelofibrosis; Internal medicine; Tolerability; Clinical endpoint; Discontinuation; Phases of clinical research; Clinical trial; Adverse effect; Expanded access; Placebo; Surgery; Bone marrow; Pathology","score_opus":0.0618019106275395,"score_gpt":0.3331993970182839,"score_spread":0.2713974863907444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560056817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99518156,0.00009718636,0.000034188593,0.00020441985,0.000031748274,0.004244688,0.00012619073,0.000007638931,0.00007240661],"genre_scores_gemma":[0.99878013,0.000055559434,0.0006955337,0.00005421546,0.00002219793,0.00031287735,0.000020003577,0.00002176325,0.000037733927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986306,0.000081272054,0.00045460238,0.00034447983,0.0002719457,0.00021712862],"domain_scores_gemma":[0.9986281,0.000511221,0.00021910257,0.00035655758,0.00018916497,0.00009585011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021177901,0.00019499823,0.00049716997,0.000069804235,0.00007041926,0.00002677352,0.00019196236,0.000038292514,0.000033243206],"category_scores_gemma":[0.00009705315,0.00009358264,0.000026552363,0.00010723801,0.00008793821,0.0001581071,0.00014241962,0.00004405463,5.3171146e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007752262,0.06645521,0.9089505,0.00006113606,0.0003664107,0.0000032673809,0.00071747915,8.5396147e-7,0.0006962745,0.000041568095,0.000008622165,0.014946393],"study_design_scores_gemma":[0.11861363,0.021339832,0.8433968,0.0004129221,0.00043106524,0.000001152424,0.00017231141,0.0000055282744,0.0154726105,0.0000053348444,0.000048862876,0.00009993945],"about_ca_topic_score_codex":0.000108460066,"about_ca_topic_score_gemma":0.00013055543,"teacher_disagreement_score":0.11086137,"about_ca_system_score_codex":0.00003521503,"about_ca_system_score_gemma":0.0000552943,"threshold_uncertainty_score":0.38161892},"labels":[],"label_agreement":null},{"id":"W2560062761","doi":"10.1182/blood.v106.11.2239.2239","title":"A Prospective Cost Analysis of Non-Myeloablative Hematopoietic Stem Cell Transplantation.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Memorial University of Newfoundland; Hôpital Maisonneuve-Rosemont; Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Transplantation; Hematopoietic stem cell transplantation; Emergency medicine; Hematopoietic cell; Activity-based costing; Psychological intervention; Indirect costs; Intensive care medicine; Health care; Surgery; Stem cell; Haematopoiesis; Nursing","score_opus":0.01206114277188204,"score_gpt":0.2825017095740649,"score_spread":0.27044056680218287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560062761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98475724,0.0002871325,0.00074223196,0.00009277985,0.000011485295,0.00075622066,0.000044457804,0.00003054379,0.013277896],"genre_scores_gemma":[0.99731827,0.00009488991,0.00082960067,0.000043939286,0.000056396926,0.000067668756,0.00003193476,0.000018460825,0.001538852],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99862826,0.00003280954,0.00032189942,0.0002825373,0.00047268625,0.00026180872],"domain_scores_gemma":[0.99909276,0.00015984302,0.000097283926,0.00032775267,0.00018865424,0.00013368987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001700862,0.00013323671,0.00046497906,0.00032345703,0.00003854132,0.0000090218855,0.000101035206,0.00007946294,0.00021800555],"category_scores_gemma":[0.000011325557,0.00011380437,0.00019316588,0.0011234268,0.00009816989,0.00006767056,0.000019665908,0.00013733526,0.00006716298],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008072101,0.04487757,0.31772667,0.012668882,0.06434664,0.0041615423,0.2732321,0.011774775,0.21731009,0.0028036071,0.0021355208,0.04089051],"study_design_scores_gemma":[0.07313372,0.0005513176,0.09369133,0.00024673986,0.015259175,0.0002556523,0.0017323238,0.026104873,0.78841126,0.000031445365,0.00020968069,0.00037248802],"about_ca_topic_score_codex":0.000116505864,"about_ca_topic_score_gemma":0.00007230823,"teacher_disagreement_score":0.5711012,"about_ca_system_score_codex":0.0013418345,"about_ca_system_score_gemma":0.0014480327,"threshold_uncertainty_score":0.46408075},"labels":[],"label_agreement":null},{"id":"W2560085348","doi":"10.1182/blood.v104.11.3934.3934","title":"ADP Signaling Defect in Children with Severe Acquired Aplastic Anemia: A Potential Common Pathway for Development of Aplastic Anemia.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Aplastic anemia; Medicine; Gastroenterology; Internal medicine; Platelet; Immunology; Anemia; Bone marrow","score_opus":0.010785364430516675,"score_gpt":0.22336459052517788,"score_spread":0.2125792260946612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560085348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99553835,0.0001402564,0.0034045724,0.000026242393,0.00008340126,0.00067221466,0.000021563214,0.00005001033,0.00006336495],"genre_scores_gemma":[0.9914955,0.0000051984734,0.007960154,0.00010797246,0.00012026386,0.00006253699,0.0001888765,0.000030440893,0.000029082985],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988012,0.000031149913,0.00037000072,0.00030877985,0.00018366936,0.0003052291],"domain_scores_gemma":[0.9994292,0.00008984233,0.00013407873,0.000170185,0.000073684554,0.00010298175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000109655186,0.00020365785,0.0004322695,0.00014498933,0.00007725517,0.000005852389,0.00007358695,0.00016191632,0.000039975846],"category_scores_gemma":[0.000056696783,0.00016587503,0.00008853237,0.0001996677,0.000060113987,0.000039519728,0.000029220158,0.00014277028,0.0000115961375],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008232158,0.0060192556,0.1742163,0.0018582233,0.0010273746,0.00031284383,0.0029122017,0.013439967,0.78722006,0.00022511491,0.00007075463,0.004465724],"study_design_scores_gemma":[0.09827173,0.009665792,0.4703222,0.0022270277,0.0018190888,0.0039997785,0.0005541024,0.00015159335,0.41128653,0.0003527724,0.00013283336,0.001216544],"about_ca_topic_score_codex":0.000019371124,"about_ca_topic_score_gemma":0.000078404286,"teacher_disagreement_score":0.37593353,"about_ca_system_score_codex":0.000056511155,"about_ca_system_score_gemma":0.00040146985,"threshold_uncertainty_score":0.6764187},"labels":[],"label_agreement":null},{"id":"W2560094861","doi":"10.1182/blood.v108.11.1008.1008","title":"Urokinase-Type Plasminogen Activator Production by Cultured Megakaryocytes and Blood Outgrowth Endothelial Cells in the Quebec Platelet Disorder.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; McMaster University","funders":"","keywords":"Plasminogen activator; Platelet; Molecular biology; Progenitor cell; Peripheral blood mononuclear cell; CD34; Thrombopoietin; Biology; Immunology; Andrology; Chemistry; Endocrinology; Stem cell; Cell biology; In vitro; Medicine; Haematopoiesis; Biochemistry","score_opus":0.005654392750909939,"score_gpt":0.20831620427047623,"score_spread":0.2026618115195663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560094861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99569833,0.0018085976,0.0000011069425,0.0006190225,0.000103990984,0.0007362809,0.00008414981,0.000051925606,0.0008966211],"genre_scores_gemma":[0.9974031,0.00026857515,0.00011557478,0.000115148614,0.00016120874,0.00004707004,0.00020341626,0.000028294275,0.0016576549],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987638,0.00005700907,0.00022901103,0.00038923245,0.0002510461,0.00030991423],"domain_scores_gemma":[0.99954385,0.00005002932,0.000080568294,0.00023653572,0.000032300704,0.000056743425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009190959,0.00024713526,0.00030950268,0.000068354384,0.00011660193,0.000044015906,0.00009050669,0.00012109053,0.000018646244],"category_scores_gemma":[0.00003472784,0.00016222043,0.00005456645,0.00022439983,0.0000746112,0.00012092954,0.000022053517,0.00018485049,0.000015157196],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001117468,0.017022839,0.16294783,0.00021466405,0.0008152163,0.0017262286,0.0021136606,0.000010675906,0.7940244,0.00019353979,0.016483922,0.003329527],"study_design_scores_gemma":[0.015748126,0.000685894,0.024421979,0.00006585489,0.0006956843,0.00066445116,0.0004593556,0.000009306622,0.93587846,0.0002000303,0.02080293,0.0003679191],"about_ca_topic_score_codex":0.0040189684,"about_ca_topic_score_gemma":0.0018870361,"teacher_disagreement_score":0.14185405,"about_ca_system_score_codex":0.000019401508,"about_ca_system_score_gemma":0.000052904565,"threshold_uncertainty_score":0.6615157},"labels":[],"label_agreement":null},{"id":"W2560121116","doi":"10.1182/blood.v106.11.5258.5258","title":"Control of Cell Death Levels Using Th9402-Based PDT Treatment on Fresh PBMC, and Potential Application to Patients with cGvHD.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Peripheral blood mononuclear cell; Apoptosis; Immune system; Medicine; Ex vivo; Programmed cell death; TUNEL assay; Immunology; Extracorporeal Photopheresis; Photodynamic therapy; In vivo; Graft-versus-host disease; Cancer research; Biology; Internal medicine; Transplantation; Chemistry; Immunohistochemistry; In vitro","score_opus":0.013897336602740491,"score_gpt":0.2751040319660351,"score_spread":0.2612066953632946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560121116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99584156,0.00007056486,0.0025084477,0.00015804876,0.000006820889,0.001174976,0.000103315324,0.000017683893,0.00011859821],"genre_scores_gemma":[0.9977831,0.000008791629,0.0018772263,0.0001609145,0.00004878154,0.000059285634,0.00001430813,0.000016627213,0.00003091938],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991772,0.000025492778,0.00013918387,0.00020573396,0.0002687433,0.00018361476],"domain_scores_gemma":[0.99949265,0.00004044751,0.000060707407,0.00020485667,0.00009850266,0.00010284652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000056727207,0.00012669354,0.00024398557,0.00008656722,0.000055130473,0.000006118111,0.000036083442,0.00003194076,0.000013031484],"category_scores_gemma":[0.000011246326,0.000087376364,0.00003349296,0.00007139765,0.000035806497,0.000022257465,0.00001097003,0.000047186608,0.0000034770762],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029761994,0.0066108317,0.13500962,0.000087451604,0.0005076374,0.000012116581,0.00033796203,0.0010216557,0.8479213,0.000017589458,0.000015935426,0.0054817186],"study_design_scores_gemma":[0.04341341,0.0056999098,0.4764863,0.000120150646,0.0005267285,0.0000034600046,0.000032049273,0.003538237,0.4697854,0.000009585661,0.00018966827,0.00019512039],"about_ca_topic_score_codex":0.00011363873,"about_ca_topic_score_gemma":0.000040903873,"teacher_disagreement_score":0.3781359,"about_ca_system_score_codex":0.00008338883,"about_ca_system_score_gemma":0.000062037674,"threshold_uncertainty_score":0.35631046},"labels":[],"label_agreement":null},{"id":"W2560125229","doi":"10.1182/blood.v116.21.2786.2786","title":"Interleukin-2 Enhances Angiogenesis and Preserves Cardiac Function Following Myocardial infarction","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Atherosclerosis and Cardiovascular Diseases","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; Jewish General Hospital","funders":"","keywords":"Angiogenesis; Cardiac function curve; Medicine; Adoptive cell transfer; Immune system; Myocardial infarction; In vivo; Interleukin 15; Internal medicine; Immunology; T cell; Cytokine; Interleukin; Biology; Heart failure","score_opus":0.005221999186212461,"score_gpt":0.1949846218845182,"score_spread":0.18976262269830574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560125229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862276,0.011045968,0.00004203596,0.00001962779,0.0019912485,0.0001349105,0.000016738877,0.00007863057,0.000443265],"genre_scores_gemma":[0.9992574,0.00023039464,0.00002573052,0.000031465886,0.0001837101,0.00004774975,0.000041695737,0.000015028652,0.00016683116],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9992593,0.00012115339,0.0001285331,0.00025921583,0.000042263742,0.00018953726],"domain_scores_gemma":[0.9996312,0.000036955073,0.000040733335,0.00023733544,0.000027771635,0.000026007181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020925747,0.00012936581,0.00021870037,0.000046457284,0.00017898803,0.000034910383,0.00008033866,0.00016875112,0.00007352564],"category_scores_gemma":[0.00004120773,0.00011514424,0.00043177133,0.00006601393,0.00008020854,0.00013766998,0.00006469514,0.0001277486,0.00005485563],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002356928,0.00007391923,0.08271793,0.0000061772785,0.0014382647,4.2743847e-7,0.00008127188,2.852559e-7,0.9087576,0.00005392734,0.0001889751,0.006657638],"study_design_scores_gemma":[0.0011687749,0.00010635527,0.7790449,0.000014674443,0.0011267514,0.000009016235,0.00015411362,1.9885296e-7,0.19615597,0.00006521757,0.021961104,0.00019291337],"about_ca_topic_score_codex":0.00007176973,"about_ca_topic_score_gemma":0.000018222758,"teacher_disagreement_score":0.71260166,"about_ca_system_score_codex":0.000003429615,"about_ca_system_score_gemma":0.000017606599,"threshold_uncertainty_score":0.4695446},"labels":[],"label_agreement":null},{"id":"W2560125532","doi":"10.1182/blood.v112.11.3237.3237","title":"A Population (Registry) Based Analysis of the Impact of Bcr-Abl Specific Tyrosine Kinase Inhibition on Survival after Diagnosis of Philadelphia Chromosome Positive Chronic Myelogenous Leukemia..","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; Chronic myelogenous leukemia; Philadelphia chromosome; Population; Internal medicine; Alpha interferon; Cytarabine; Leukemia; Oncology; Immunology; Interferon; Chromosomal translocation; Biology","score_opus":0.017478972537347242,"score_gpt":0.2561987802988473,"score_spread":0.23871980776150006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560125532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99713963,0.0011247025,0.000016479877,0.00009520138,0.0000503266,0.00068876473,0.0007350722,0.000022154389,0.00012768166],"genre_scores_gemma":[0.9987694,0.0002899249,0.00008398123,0.000020952499,0.00012207188,0.0000655331,0.0005890162,0.00003886202,0.00002022701],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977819,0.00014823255,0.00070875045,0.00040837287,0.0006442887,0.0003084647],"domain_scores_gemma":[0.99793077,0.00018182085,0.0006317051,0.00091273006,0.00023234959,0.0001106161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014379539,0.00032301713,0.0009916474,0.00045553618,0.00007044453,0.0000040940254,0.00012396678,0.00018171432,0.0004230969],"category_scores_gemma":[0.00008947837,0.00023432903,0.000862831,0.0015350154,0.00024328774,0.00006907862,0.00004555349,0.00019355935,0.0000043879036],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013164543,0.004730133,0.8960541,0.0002519408,0.00429445,0.0002335394,0.00042923773,0.0061347573,0.08610799,0.000019674286,0.00009168028,0.0003360559],"study_design_scores_gemma":[0.0063407486,0.0013471093,0.79041713,0.00042864023,0.0027704157,0.000026850059,0.000010807376,0.00040615586,0.19810444,0.000005488121,0.000002455984,0.00013976383],"about_ca_topic_score_codex":0.0031714665,"about_ca_topic_score_gemma":0.00017203853,"teacher_disagreement_score":0.11199646,"about_ca_system_score_codex":0.0021291727,"about_ca_system_score_gemma":0.00079752674,"threshold_uncertainty_score":0.95556605},"labels":[],"label_agreement":null},{"id":"W2560139878","doi":"10.1182/blood.v106.11.222.222","title":"Adenovirus Induced Thrombocytopenia: The Role of P-Selectin and von Willebrand Factor in Virus- Mediated Platelet Clearance.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Platelet; Von Willebrand factor; Platelet activation; Immunology; In vivo; Virus; P-selectin; Chemistry; Medicine; Biology","score_opus":0.011628012227955113,"score_gpt":0.24384903311636683,"score_spread":0.2322210208884117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560139878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952383,0.0027030474,2.027046e-7,0.00030813157,0.000017087103,0.0004007093,0.000024042012,0.000022301738,0.0012861791],"genre_scores_gemma":[0.9991843,0.0005005144,0.00004390277,0.00015751261,0.000036258316,0.000014366352,0.0000122410065,0.000018818195,0.000032065826],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991331,0.000034260036,0.00023652712,0.0001997049,0.00017493576,0.00022144384],"domain_scores_gemma":[0.99959415,0.00007433196,0.000075796306,0.00016723573,0.00002490163,0.00006355912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007688735,0.00014670487,0.000398465,0.00007739577,0.00004761824,0.000010621394,0.00006898875,0.000115624716,0.000101770325],"category_scores_gemma":[0.000051293246,0.00009752507,0.00003967474,0.0002126764,0.000047486406,0.00008343252,0.00002680967,0.00020617252,0.000026018357],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013086136,0.0036800676,0.3768846,0.00006335173,0.0007623832,0.00029765253,0.0041928543,0.0000037922866,0.5478845,0.00007629109,0.00010259136,0.064743266],"study_design_scores_gemma":[0.016054668,0.0005959344,0.53635293,0.000086175576,0.00014906426,0.0001782521,0.00023880851,0.00008228512,0.44330773,0.00013896276,0.0026280684,0.00018711876],"about_ca_topic_score_codex":0.00026733527,"about_ca_topic_score_gemma":0.0006795746,"teacher_disagreement_score":0.15946832,"about_ca_system_score_codex":0.000017072969,"about_ca_system_score_gemma":0.00004748694,"threshold_uncertainty_score":0.3976957},"labels":[],"label_agreement":null},{"id":"W2560144914","doi":"10.1182/blood.v104.11.152.152","title":"A Novel Triple Purge Strategy for Eliminating Chronic Myelogenous Leukemia (CML) Cells from Autografts.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute","funders":"","keywords":"Chronic myelogenous leukemia; Stem cell; Progenitor cell; CD34; Transplantation; Medicine; Immunology; Granulocyte colony-stimulating factor; Haematopoiesis; Cancer research; Imatinib mesylate; Allotransplantation; Leukemia; Autotransplantation; Imatinib; Internal medicine; Biology; Chemotherapy; Myeloid leukemia; Cell biology","score_opus":0.025405745969745114,"score_gpt":0.26564080718873034,"score_spread":0.24023506121898522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560144914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99074745,0.0027273367,0.0022719072,0.0001779781,0.00031269516,0.0018150772,0.00033601097,0.000286058,0.0013255071],"genre_scores_gemma":[0.98013526,0.000105764666,0.0172915,0.00019063057,0.0007937787,0.00027592728,0.00034407046,0.00010805645,0.00075498334],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976391,0.000016625405,0.00052190217,0.00067712076,0.00036008636,0.0007851346],"domain_scores_gemma":[0.99864537,0.00013811086,0.0002027006,0.0006315217,0.000105866224,0.0002764513],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015646455,0.00039740346,0.0005963451,0.00012514235,0.00018293395,0.000045134733,0.00020992452,0.00026872102,0.00017624798],"category_scores_gemma":[0.00009479845,0.0003721163,0.00029289926,0.00024790948,0.000075722324,0.00009951642,0.00006519297,0.00029193127,0.000120782046],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034916124,0.00413096,0.0006683802,0.0005273131,0.001736177,0.0004982451,0.0011957244,0.0018055256,0.9446494,0.0005334952,0.00052669056,0.043378904],"study_design_scores_gemma":[0.14398898,0.0047404342,0.009462138,0.00082437176,0.0033310875,0.0005117805,0.0004247453,0.0020416887,0.8259646,0.0009996097,0.0066023003,0.00110825],"about_ca_topic_score_codex":0.002214374,"about_ca_topic_score_gemma":0.00045372677,"teacher_disagreement_score":0.14363983,"about_ca_system_score_codex":0.0030002506,"about_ca_system_score_gemma":0.0033094685,"threshold_uncertainty_score":0.9998731},"labels":[],"label_agreement":null},{"id":"W2560156880","doi":"10.1182/blood.v116.21.3803.3803","title":"The Multiple Myeloma Research Consortium (MMRC) Model: Reduced Time to Trial Activation and Improved Accrual Metrics.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Genetics, Bioinformatics, and Biomedical Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Multiple myeloma; Accrual; Lenalidomide; Medicine; Oncology; Internal medicine; Accounting","score_opus":0.03179164255915278,"score_gpt":0.3222439515670128,"score_spread":0.29045230900786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560156880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99607706,0.000049020553,0.0003548498,0.0011653238,0.00013220066,0.000875852,0.000022231086,0.000012932706,0.0013105082],"genre_scores_gemma":[0.9942668,0.00008233989,0.0023209695,0.00010887151,0.00047930365,0.00008492789,0.000053751322,0.00001966526,0.0025833503],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982906,0.00009227449,0.00030157578,0.0003179873,0.00048484863,0.00051270373],"domain_scores_gemma":[0.99858904,0.00019378976,0.00005967444,0.00048183228,0.00037197836,0.00030367068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016626486,0.00013229744,0.000132207,0.00012743019,0.0003404108,0.00015310955,0.00040453134,0.00026635805,0.000017459854],"category_scores_gemma":[0.005415166,0.00009411823,0.0000543793,0.00025493125,0.00031118045,0.000006944204,0.00042143604,0.00037898473,0.00005197227],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016039222,0.00014191007,0.00002812694,0.000008989236,0.00003849607,3.5889533e-7,0.000058363825,0.0000014030174,0.9800901,0.000016207554,0.0027515874,0.015260569],"study_design_scores_gemma":[0.011210041,0.0012344536,0.00041490037,0.000005221833,0.000015497371,0.0000049804726,0.00011018315,0.0072668614,0.95489854,0.00012886488,0.024514176,0.00019629498],"about_ca_topic_score_codex":0.000020544978,"about_ca_topic_score_gemma":0.000052791227,"teacher_disagreement_score":0.025191542,"about_ca_system_score_codex":0.000008242327,"about_ca_system_score_gemma":0.00027805928,"threshold_uncertainty_score":0.64828503},"labels":[],"label_agreement":null},{"id":"W2560172367","doi":"10.1182/blood.v124.21.1667.1667","title":"Cell-of-Origin Subtype Classification of Diffuse Large B-Cell Lymphoma Using the Lymph2Cx Assay Retains Relevance in the Context of BCL2 and MYC Expression Status","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Agency","funders":"","keywords":"clone (Java method); Germinal center; Tissue microarray; Diffuse large B-cell lymphoma; Immunohistochemistry; Context (archaeology); Lymphoma; Pathology; Biology; Gene expression profiling; Cancer research; Molecular biology; B cell; Antibody; Medicine; Gene; Gene expression; Immunology; Genetics","score_opus":0.021916762165122006,"score_gpt":0.26596518144859016,"score_spread":0.24404841928346815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560172367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959441,0.002623441,0.000056042765,0.0001433094,0.000034235043,0.00037734545,0.000024057483,0.0000061564615,0.00079132384],"genre_scores_gemma":[0.9987763,0.000754226,0.000282028,0.000079930425,0.000030706215,0.00001940211,0.000014401408,0.000012983787,0.000029978371],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987973,0.00022414888,0.0003527476,0.00018482363,0.00025931303,0.00018164334],"domain_scores_gemma":[0.9984306,0.00064509717,0.00032904552,0.0004679972,0.000083499326,0.000043777552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004718757,0.00012377038,0.00029831252,0.00005253084,0.00004781034,0.000007054839,0.00009716907,0.000073798874,0.0000042137895],"category_scores_gemma":[0.00015153897,0.00006698342,0.00006339241,0.0001507644,0.00009274453,0.000043661246,0.000031999763,0.000039643648,0.0000011281177],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021194352,0.013838971,0.75405365,0.0003435619,0.000049961283,0.000008981217,0.0037953274,0.0000014452648,0.22024524,0.001266642,0.0001944168,0.0059898705],"study_design_scores_gemma":[0.03295864,0.0004591987,0.530281,0.00045090547,0.0004299025,0.000014533872,0.0021380275,0.0010360806,0.42874137,0.00007356932,0.0032908292,0.00012593885],"about_ca_topic_score_codex":0.00020668081,"about_ca_topic_score_gemma":0.000022678205,"teacher_disagreement_score":0.22377264,"about_ca_system_score_codex":0.00004374467,"about_ca_system_score_gemma":0.00009875157,"threshold_uncertainty_score":0.27315047},"labels":[],"label_agreement":null},{"id":"W2560173732","doi":"10.1182/blood.v104.11.1786.1786","title":"Identification of Medical Patients Who Should Receive Venous Thromboembolism Prophylaxis.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Hamilton General Hospital","funders":"","keywords":"Medicine; Venous thromboembolism; Low molecular weight heparin; Intensive care medicine; Medical illness; Heparin; Risk factor; Disease; Internal medicine; Thrombosis; Diabetes mellitus","score_opus":0.016543632433720812,"score_gpt":0.2794869415102028,"score_spread":0.262943309076482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560173732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949685,0.00027836455,0.00011903837,0.0013013803,0.00029282534,0.00083438115,0.0000124257085,0.00006440874,0.0021286798],"genre_scores_gemma":[0.99839735,0.0005663355,0.00014795887,0.0005103838,0.00017548428,0.00006152309,0.00004164075,0.00003250881,0.00006681858],"study_design_codex":"nonrandomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9976623,0.00003205281,0.0005432257,0.0003284863,0.0011637933,0.00027015025],"domain_scores_gemma":[0.9989276,0.000021164264,0.0002097848,0.00044547915,0.00020972054,0.00018624791],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035197943,0.00016587405,0.0006026603,0.00013822073,0.00007058337,0.000018979694,0.0002285816,0.00020414537,0.00014504221],"category_scores_gemma":[0.00026577283,0.00014370865,0.00012281502,0.000255483,0.00010910627,0.00008248113,0.00009723067,0.00021449632,0.00008002698],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050452776,0.34722403,0.2059116,0.008510975,0.008239566,0.0009756153,0.03215138,0.000219604,0.046873316,0.13163728,0.020490332,0.19726177],"study_design_scores_gemma":[0.008233338,0.0023486153,0.91993916,0.0005907254,0.00079068344,0.000018119172,0.00018979314,0.000006159119,0.064252734,0.0019828675,0.0013726205,0.00027520498],"about_ca_topic_score_codex":0.00017089375,"about_ca_topic_score_gemma":0.00001861069,"teacher_disagreement_score":0.7140275,"about_ca_system_score_codex":0.00005391663,"about_ca_system_score_gemma":0.00016509833,"threshold_uncertainty_score":0.58602685},"labels":[],"label_agreement":null},{"id":"W2560178749","doi":"10.1182/blood.v114.22.701.701","title":"Baf250a Is a Regulator of HSC Populations.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Hôpital Maisonneuve-Rosemont; Université de Montréal","funders":"","keywords":"Biology; Clonogenic assay; Transplantation; Molecular biology; Deep sequencing; Context (archaeology); Progenitor cell; Cancer research; Genetics; Stem cell; Cell culture; Gene; Medicine; Internal medicine","score_opus":0.017112962138882575,"score_gpt":0.2531845636388764,"score_spread":0.23607160149999384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560178749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913014,0.0007125035,0.00007743738,0.0002295482,0.00003646131,0.000094068826,0.000024301784,0.00000784252,0.007516417],"genre_scores_gemma":[0.99712265,0.000023329172,0.0016406002,0.00023817644,0.00013195416,0.0000035508313,0.00003132931,0.0000058543446,0.0008025825],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99956983,0.0000136148565,0.00011088824,0.00013881265,0.00006732582,0.00009949585],"domain_scores_gemma":[0.9995187,0.0000012230183,0.00006781332,0.0003361859,0.000038572376,0.00003748995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006086601,0.00006504411,0.00007998624,0.000016864213,0.00004740946,0.000008509621,0.000117432974,0.000079013975,0.00003734407],"category_scores_gemma":[0.0000372475,0.000063299376,0.000062788095,0.000025564672,0.000022759063,0.0000015535888,0.000022625665,0.000027579383,0.000007247294],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001813249,0.00017574108,0.0048207394,0.000010625193,0.000022570504,0.000001610866,0.00004172827,9.86914e-7,0.98814595,0.00096513407,0.0017563821,0.0040403795],"study_design_scores_gemma":[0.00053207355,0.0002150791,0.021731416,0.0000118399785,0.000019857514,0.0000100490915,0.0000055693254,0.0000037985901,0.96537656,0.0009253089,0.01108275,0.00008570947],"about_ca_topic_score_codex":0.00000560758,"about_ca_topic_score_gemma":0.0000024352205,"teacher_disagreement_score":0.022769421,"about_ca_system_score_codex":0.0000011182474,"about_ca_system_score_gemma":0.000025349382,"threshold_uncertainty_score":0.25812736},"labels":[],"label_agreement":null},{"id":"W2560189532","doi":"10.1182/blood.v112.11.469.469","title":"The Zinc Finger Protein Gfi1 Controls TLR4-Mediated Inflammatory Response by Directly Antagonizing NF-κB Transcription Factor","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Transcription factor; Cell biology; TLR4; Biology; Signal transduction; NF-κB; Innate immune system; NFKB1; Tumor necrosis factor alpha; Receptor; Immune system; Immunology; Gene; Biochemistry","score_opus":0.009527238851922358,"score_gpt":0.20076060450066266,"score_spread":0.1912333656487403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560189532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899024,0.0076895114,0.000046875164,0.00083961204,0.0003188511,0.00074746343,0.00004936122,0.00020225045,0.00020367588],"genre_scores_gemma":[0.9942265,0.0003952587,0.000014522429,0.00012084687,0.00004145308,0.00015664441,0.00013010587,0.000032401127,0.004882259],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99748343,0.0011161022,0.000523121,0.0002808897,0.00008705692,0.0005094248],"domain_scores_gemma":[0.9986905,0.0005981371,0.00020683474,0.0003687152,0.00010495905,0.000030850813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071209826,0.0002546987,0.00028759113,0.00010257411,0.0008779087,0.000036361307,0.000259703,0.00035319434,0.00013548917],"category_scores_gemma":[0.0005777627,0.00019139356,0.00014164064,0.00014209455,0.000277294,0.00024120489,0.000030441919,0.00040374757,0.0006107638],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031213223,0.00014251209,0.0005153685,0.000008395794,0.00020570504,0.000020810985,0.0010124847,3.1312223e-7,0.99251574,0.00003537881,0.0014752819,0.00094669266],"study_design_scores_gemma":[0.0037137386,0.00021363217,0.007399623,0.00003511992,0.000029997174,0.00008679778,0.00008812979,0.0000024568703,0.8204246,0.0000090809,0.16778293,0.00021385204],"about_ca_topic_score_codex":0.00003229663,"about_ca_topic_score_gemma":0.000009638905,"teacher_disagreement_score":0.1720911,"about_ca_system_score_codex":0.000043759483,"about_ca_system_score_gemma":0.00017170224,"threshold_uncertainty_score":0.7850337},"labels":[],"label_agreement":null},{"id":"W2560196217","doi":"10.1182/blood.v106.11.1780.1780","title":"The Prevalence of von Willebrand Disease in the Primary Care Setting.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Von Willebrand disease; Pediatrics; Referral; Context (archaeology); Epidemiology; Population; Prevalence; Disease; Haemophilia; Von Willebrand factor; Family medicine; Internal medicine","score_opus":0.005002861257361339,"score_gpt":0.22767780398054674,"score_spread":0.2226749427231854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560196217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98135483,0.0137944985,2.5014566e-7,0.0012641196,0.000011239914,0.0002904822,0.000021004505,0.000006850638,0.0032567373],"genre_scores_gemma":[0.9986827,0.0006521016,0.000044576995,0.0002714837,0.00003091779,0.000019123232,0.000013613749,0.0000049154673,0.00028059568],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995338,0.000026514797,0.00010020737,0.00008770138,0.0001454367,0.00010638893],"domain_scores_gemma":[0.999651,0.00006375665,0.000031001655,0.00020617383,0.000017505163,0.000030567255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007143162,0.000057521447,0.00008247322,0.000013934043,0.000049914135,0.0000055979745,0.00007895035,0.00001690601,0.000008323676],"category_scores_gemma":[0.000028767758,0.00002798921,0.000039613,0.00005543014,0.00003790557,0.000025774621,0.000013708572,0.00005733147,0.000005436071],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018753175,0.0010538143,0.97084445,0.0006849978,0.00006531614,0.0001927252,0.0022741822,0.000004672034,0.00014398474,0.00004178249,0.0003116723,0.024194889],"study_design_scores_gemma":[0.0036919797,0.00009789343,0.99172103,0.00015533465,0.0002988573,0.000018839433,0.0002078618,0.000011922923,0.00041205695,0.00005423203,0.003282675,0.00004730899],"about_ca_topic_score_codex":0.000008018562,"about_ca_topic_score_gemma":0.000016239082,"teacher_disagreement_score":0.02414758,"about_ca_system_score_codex":0.000010213078,"about_ca_system_score_gemma":0.000048570448,"threshold_uncertainty_score":0.11413668},"labels":[],"label_agreement":null},{"id":"W2560200396","doi":"10.1182/blood.v108.11.717.717","title":"The Effect of Low Molecular Weight Heparin (LMWH) on Cancer Survival. A Systematic Review and Meta-Analysis (MA) of Randomized Trials.","year":2006,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Internal medicine; Meta-analysis; Cochrane Library; Hazard ratio; Randomized controlled trial; Placebo; Cancer; Relative risk; Odds ratio; Surgery; Low molecular weight heparin; Confidence interval; Heparin; Pathology","score_opus":0.06142003807163265,"score_gpt":0.3748242033211495,"score_spread":0.31340416524951686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560200396","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000115794965,0.98171985,0.000016317686,0.00013600077,0.00006396813,0.017367369,0.00008862029,0.000014079433,0.00058222737],"genre_scores_gemma":[0.000118755335,0.9931079,0.000018218136,0.0000847777,0.00003548839,0.006107101,0.00006036869,0.000052151492,0.00041524475],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98747325,0.007515547,0.0035196552,0.00047770835,0.0007663501,0.00024750357],"domain_scores_gemma":[0.98871136,0.006300348,0.0035087923,0.0012560576,0.00014048662,0.00008296509],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.015060585,0.00064570777,0.053644795,0.00031343382,0.000048060432,0.00002329518,0.00028816814,0.00017035447,0.000104550345],"category_scores_gemma":[0.0029371122,0.0002649728,0.012115233,0.0007456681,0.00012278536,0.000013584052,0.00008778002,0.00020465485,0.0000044580784],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013844029,0.00021509567,3.7513132e-7,0.60970217,0.3888447,0.0000091211405,0.0000030268343,7.406381e-7,1.287534e-7,0.00017091712,0.00026614443,0.0006491309],"study_design_scores_gemma":[0.016062692,0.00016529307,5.7351724e-7,0.09323929,0.8852579,0.0000029134878,6.891019e-7,0.0000011630377,0.000029467194,0.0000048497686,0.005063886,0.00017129064],"about_ca_topic_score_codex":0.00028136862,"about_ca_topic_score_gemma":0.000034119923,"teacher_disagreement_score":0.51646286,"about_ca_system_score_codex":0.00003089879,"about_ca_system_score_gemma":0.00008104078,"threshold_uncertainty_score":0.9999803},"labels":[],"label_agreement":null},{"id":"W2560200978","doi":"10.1182/blood.v104.11.4005.4005","title":"U.S. Factor XI Patients: Is There a Safer Treatment? Yes - Hemoleven.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Fresh frozen plasma; Surgery; Complication; Hemostasis; Heparin; Internal medicine; Platelet","score_opus":0.017127695334281882,"score_gpt":0.2502613359281923,"score_spread":0.2331336405939104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560200978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99367523,0.0020598732,0.000016505943,0.0008697162,0.000117348936,0.0003260212,0.00007039622,0.00010214879,0.0027627863],"genre_scores_gemma":[0.99561185,0.00015693842,0.00028850147,0.0006391863,0.00021946116,0.000017490187,0.00007640595,0.00003341264,0.0029567599],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990772,0.000010774616,0.00020840304,0.00025166917,0.00020478618,0.00024715642],"domain_scores_gemma":[0.99942815,0.000022333876,0.00006291164,0.0002835149,0.000064596665,0.00013851943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000018823786,0.00019344794,0.0002572366,0.000055432312,0.000081800885,0.000020016103,0.000057050805,0.00009149808,0.0007847515],"category_scores_gemma":[0.000022837296,0.00014578622,0.0001637301,0.000113956725,0.000037700054,0.000083771985,0.000016751663,0.000051529772,0.00023547054],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012802373,0.0053180153,0.9625827,0.00006786911,0.0005695819,0.00007005218,0.004014938,0.0000022704949,0.0011010398,0.000470705,0.0007920192,0.024882758],"study_design_scores_gemma":[0.016362134,0.0011956113,0.90306693,0.0001575633,0.0003952899,0.000023723176,0.00011657414,0.0000031889713,0.05345709,0.0007607043,0.02417982,0.0002813923],"about_ca_topic_score_codex":0.00024998165,"about_ca_topic_score_gemma":0.00003436898,"teacher_disagreement_score":0.059515815,"about_ca_system_score_codex":0.00006608362,"about_ca_system_score_gemma":0.00010083779,"threshold_uncertainty_score":0.85924786},"labels":[],"label_agreement":null},{"id":"W2560209617","doi":"10.1182/blood.v126.23.3978.3978","title":"Analysis of Minimal Residual Disease in Follicular Lymphoma Patients in Gadolin, a Phase III Study of Obinutuzumab Plus Bendamustine Versus Bendamustine in Relapsed/Refractory Indolent Non-Hodgkin Lymphoma","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Bendamustine; Medicine; Obinutuzumab; Internal medicine; Minimal residual disease; Follicular lymphoma; Rituximab; Oncology; Surrogate endpoint; Gastroenterology; Lymphoma; Leukemia","score_opus":0.026164572999325782,"score_gpt":0.29756838606130903,"score_spread":0.27140381306198325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560209617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970288,0.00074802403,7.438453e-7,0.000030720763,0.00014400762,0.0017115494,0.0002091818,0.000020933754,0.000106017724],"genre_scores_gemma":[0.9989723,0.000060104947,0.000116500356,0.000026843001,0.000056501038,0.00026623593,0.00044076217,0.000045030232,0.000015753349],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956058,0.0002495509,0.0016895033,0.00080107356,0.0010868057,0.00056722295],"domain_scores_gemma":[0.9975862,0.00023890441,0.00056476914,0.0008383967,0.0002865382,0.00048520064],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005090782,0.00048755232,0.0017360031,0.001936831,0.000028388842,0.000011876945,0.00024368986,0.00018262134,0.000030923533],"category_scores_gemma":[0.0005364331,0.00044430932,0.0002813249,0.0024698924,0.0000939816,0.00011502666,0.0001995783,0.00011563601,0.000003994831],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024957104,0.09552331,0.8659159,0.000105625186,0.0015852922,0.0021558611,0.005038308,0.0013881862,0.000057788053,0.0000038726457,0.00005092339,0.0032178143],"study_design_scores_gemma":[0.31439164,0.0063006156,0.67151386,0.00027432907,0.003616168,0.000002031634,0.0017056413,0.0013980974,0.00054266764,0.0000015124997,0.000015726358,0.0002376947],"about_ca_topic_score_codex":0.0092250435,"about_ca_topic_score_gemma":0.0051746843,"teacher_disagreement_score":0.28943452,"about_ca_system_score_codex":0.0016647985,"about_ca_system_score_gemma":0.0013752882,"threshold_uncertainty_score":0.99980086},"labels":[],"label_agreement":null},{"id":"W2560215254","doi":"10.1182/blood.v108.11.860.860","title":"SCL and Its Partner E2A Are Required for Long-Term Stem Cell Activity.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Haematopoiesis; Biology; Stem cell; Transplantation; Progenitor cell; Myeloid; Bone marrow; Molecular biology; Immunology; Cell biology; Cancer research; Internal medicine; Medicine","score_opus":0.03585712411166919,"score_gpt":0.3007376615160513,"score_spread":0.2648805374043821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560215254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941327,0.0011163001,0.000063282285,0.00081946066,0.00004010993,0.00084139785,0.000029483985,0.000070691654,0.0028865528],"genre_scores_gemma":[0.98219824,0.00005459536,0.00013490538,0.000093333474,0.00043280996,0.00008831693,0.000024580206,0.000042876818,0.016930345],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99882495,0.00003400169,0.00015472082,0.00033168128,0.00025168853,0.00040293345],"domain_scores_gemma":[0.99925894,0.000112173184,0.000073754454,0.00028040292,0.0001252345,0.00014948202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017261984,0.00015187878,0.0002814167,0.00008742537,0.00008761488,0.0000315973,0.00008806341,0.00013126551,0.000025532243],"category_scores_gemma":[0.000028448687,0.00012948588,0.000068844936,0.00012186276,0.00004607033,0.00010394042,0.00007205133,0.00017119062,0.00004554726],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001298538,0.0033752082,0.31623194,0.0030802088,0.0003323633,0.0011810807,0.0002786114,0.0000021735523,0.6402094,0.00029432733,0.020432703,0.013283447],"study_design_scores_gemma":[0.015198996,0.0005366693,0.35749412,0.00018363904,0.00035874228,0.00016651716,0.00005246631,0.00020350095,0.6226049,0.000040048835,0.0028656563,0.0002947678],"about_ca_topic_score_codex":0.000016730119,"about_ca_topic_score_gemma":0.000023930432,"teacher_disagreement_score":0.04126216,"about_ca_system_score_codex":0.00006423407,"about_ca_system_score_gemma":0.00012249468,"threshold_uncertainty_score":0.52802813},"labels":[],"label_agreement":null},{"id":"W2560219832","doi":"10.1182/blood.v118.21.3983.3983","title":"Central Nervous System (CNS) Involvement with Multiple Myeloma (MM) – Longterm Survival Can Be Achieved with Radiation, Intrathecal (IT) Chemotherapy, and Immunomodulatory Agents (IMiDs),","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pomalidomide; Multiple myeloma; Internal medicine; Bortezomib; Disease; Oncology; Surgery; Gastroenterology","score_opus":0.02790396314340708,"score_gpt":0.23915716930922393,"score_spread":0.21125320616581683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560219832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99717516,0.0002926174,0.000100966,0.00022799429,0.000071685725,0.0013671188,0.00006515413,0.00012099047,0.00057830935],"genre_scores_gemma":[0.9978512,0.0000831706,0.0011791703,0.00020083932,0.00013339763,0.000121230405,0.00016780726,0.000078196375,0.00018497182],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99767905,0.00010941547,0.00033087243,0.0005373437,0.0006136178,0.00072972034],"domain_scores_gemma":[0.99857324,0.000041880896,0.0001379817,0.00054428814,0.00012923032,0.0005734042],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018089857,0.00038692728,0.00048576845,0.00012080005,0.00019070176,0.000050387953,0.00015820903,0.000112123766,0.00006674361],"category_scores_gemma":[0.00001913686,0.00026792742,0.00006726849,0.00017218225,0.00018809167,0.00011764877,0.00005444324,0.00022060718,0.000006577216],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030508866,0.0019827073,0.9809693,0.0002920156,0.0018919425,0.0009389695,0.0038534142,0.0000024845215,0.0014217913,0.000051382034,0.00009782469,0.0054472974],"study_design_scores_gemma":[0.02540991,0.0021253377,0.95812756,0.000216884,0.00032193706,0.00024983345,0.0011441092,0.00038044833,0.011555497,0.0000018839743,0.00016593999,0.00030068046],"about_ca_topic_score_codex":0.0017724696,"about_ca_topic_score_gemma":0.0010886954,"teacher_disagreement_score":0.022841746,"about_ca_system_score_codex":0.00018792253,"about_ca_system_score_gemma":0.0002706651,"threshold_uncertainty_score":0.9999773},"labels":[],"label_agreement":null},{"id":"W2560232397","doi":"10.1182/blood.v104.11.1896.1896","title":"In Vitro Growth Regulation and the Identification of Potential Signaling Pathways in T (4; 11), Pediatric Pre-B Acute Lymphoblastic Leukemia (ALL).","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"","keywords":"Antibody; Cell growth; CD19; Cell culture; In vitro; Biology; Molecular biology; Growth factor; Acute lymphocytic leukemia; Immunology; Leukemia; Cancer research; Receptor; Lymphoblastic Leukemia; Biochemistry; Genetics","score_opus":0.008021877796116971,"score_gpt":0.23792024444831394,"score_spread":0.22989836665219698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560232397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962801,0.0002318157,0.0022535818,0.00040332894,0.000062908766,0.00069259404,0.000012469267,0.00002235557,0.000040843097],"genre_scores_gemma":[0.99888647,0.00017646725,0.0005378135,0.00006602037,0.00018112856,0.000055358716,0.000033832635,0.000025702244,0.000037227546],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99800086,0.000110237095,0.0007081801,0.00033039777,0.00053912646,0.00031119943],"domain_scores_gemma":[0.9990887,0.00021516973,0.0002180702,0.00027507238,0.00012228092,0.000080677826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078017946,0.00015769062,0.00033564487,0.0003959501,0.00004475421,0.00002669973,0.00015158353,0.00014368775,0.000007981724],"category_scores_gemma":[0.0004009446,0.00012110793,0.000067341134,0.0006185606,0.00015910232,0.00018339168,0.00008544965,0.00018482837,0.0000071175896],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023060679,0.00050857733,0.0047379057,0.00033971542,0.00010176771,0.00022472408,0.001975091,0.0018694386,0.9863371,0.001398985,0.000018794184,0.00018178106],"study_design_scores_gemma":[0.08952154,0.00026674062,0.17233561,0.00018592726,0.001252706,0.00056096,0.00021893028,0.021523293,0.7042422,0.009557637,0.0000028602185,0.00033155121],"about_ca_topic_score_codex":0.0005351323,"about_ca_topic_score_gemma":0.000018629706,"teacher_disagreement_score":0.28209493,"about_ca_system_score_codex":0.0005873006,"about_ca_system_score_gemma":0.0007473567,"threshold_uncertainty_score":0.4938638},"labels":[],"label_agreement":null},{"id":"W2560238486","doi":"10.1182/blood.v104.11.2734.2734","title":"Thrombotic Events in Adults with Acute Lymphoblastic Leukemia.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Asparaginase; Internal medicine; Chemotherapy; Venous thrombosis; Pediatrics; Pulmonary embolism; Thrombosis; Acute lymphocytic leukemia; Deep vein; Young adult; Family history; Surgery; Lymphoblastic Leukemia; Leukemia","score_opus":0.008612975631468301,"score_gpt":0.25222577373803984,"score_spread":0.24361279810657155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560238486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99553484,0.00009956553,0.0005534998,0.00035158554,0.0000577899,0.0006931323,0.000008068747,0.000104344705,0.0025971483],"genre_scores_gemma":[0.99643326,0.00007780659,0.0025775288,0.0002872401,0.00012304162,0.000071484465,0.0000296485,0.000064555,0.000335461],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99773735,0.000031823816,0.0003222491,0.0004923342,0.0007317639,0.0006845027],"domain_scores_gemma":[0.99893814,0.000090225774,0.00006710867,0.0005012687,0.000103755396,0.00029950164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013359591,0.00026897457,0.00045737086,0.00024784336,0.00005570382,0.0000104258215,0.00021489734,0.00015585628,0.00007349299],"category_scores_gemma":[0.0001266157,0.00020304503,0.00007078675,0.00065487594,0.00012686691,0.00012705268,0.0000930526,0.00030002743,0.00036793406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031911213,0.032064937,0.7241175,0.0057158046,0.009533818,0.09869911,0.015979331,0.008163142,0.059947427,0.0060585006,0.0015827977,0.006226412],"study_design_scores_gemma":[0.3022187,0.0075094826,0.62622666,0.007950004,0.001891655,0.013791391,0.00070632214,0.0013523768,0.035039887,0.0018250886,0.00013633216,0.0013520776],"about_ca_topic_score_codex":0.00040998243,"about_ca_topic_score_gemma":0.0001488755,"teacher_disagreement_score":0.2703075,"about_ca_system_score_codex":0.0016619898,"about_ca_system_score_gemma":0.0027568229,"threshold_uncertainty_score":0.8279936},"labels":[],"label_agreement":null},{"id":"W2560251417","doi":"10.1182/blood.v108.11.5293.5293","title":"Multicenter Evaluation of Fungal Prophylaxis in Hematopoietic Stem Cell Transplantation.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Abbott (Canada)","funders":"","keywords":"Medicine; Fluconazole; Internal medicine; Hematopoietic stem cell transplantation; Guideline; Posaconazole; Transplantation; Empiric therapy; Aspergillosis; Retrospective cohort study; Voriconazole; Surgery; Pediatrics; Antifungal; Immunology; Pathology; Dermatology","score_opus":0.01677503406526083,"score_gpt":0.2633426632576947,"score_spread":0.24656762919243386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560251417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99515647,0.0005860057,0.00006026141,0.000026539841,0.00002487485,0.0004721741,0.000008644978,0.000011719376,0.003653332],"genre_scores_gemma":[0.99949414,0.0000133175245,0.00016944288,0.000011456372,0.000026901515,0.000017152452,0.000016061753,0.000007449292,0.00024408218],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895936,0.000069246125,0.00028427472,0.00015955,0.0004102324,0.00011735898],"domain_scores_gemma":[0.9995864,0.00003129411,0.000056400844,0.00015976165,0.00014054195,0.000025597068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039732302,0.000072371986,0.000164268,0.000059667236,0.000014571202,0.0000035429305,0.000032782104,0.000058048983,0.00007357864],"category_scores_gemma":[0.000009124445,0.00006172275,0.00005656301,0.00012459615,0.00003200051,0.000043361324,0.0000035046007,0.000079998244,0.00001351207],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002276943,0.0019639756,0.9196497,0.00086309796,0.0000115337,0.00003215531,0.00066868885,0.000030449928,0.07555765,0.000046710546,0.0000209208,0.00092737784],"study_design_scores_gemma":[0.0055039926,0.0001616685,0.8061378,0.00011834017,0.00023356269,0.0000074724926,0.00024890964,0.00017924652,0.18727139,0.000066591536,0.0000065410363,0.000064467946],"about_ca_topic_score_codex":0.000068804555,"about_ca_topic_score_gemma":0.0001739153,"teacher_disagreement_score":0.11351192,"about_ca_system_score_codex":0.000027258508,"about_ca_system_score_gemma":0.00008263862,"threshold_uncertainty_score":0.25169808},"labels":[],"label_agreement":null},{"id":"W2560257042","doi":"10.1182/blood.v112.11.3029.3029","title":"Venous Thromboembolism Recurrence after a First Episode of Provoked Venous Thrombosis Due to a Transient Risk Factor. A Systematic Review of the Literature","year":2008,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Risk factor; Venous thromboembolism; Venous thrombosis; Surgery; Randomized controlled trial; Thrombosis; Internal medicine","score_opus":0.019046171275997115,"score_gpt":0.28104859729035936,"score_spread":0.26200242601436224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560257042","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00090978877,0.98017544,0.000009538479,0.00014286289,0.00038923175,0.016984385,0.0011520027,0.000052916905,0.00018384306],"genre_scores_gemma":[0.002085667,0.99356043,0.00022401715,0.0003830521,0.0001396085,0.0033692236,0.000055481672,0.00014121464,0.00004130808],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.994093,0.0006510395,0.0025315424,0.0009204393,0.0011569201,0.0006470871],"domain_scores_gemma":[0.9945636,0.00028828,0.0019614187,0.0024877063,0.00042737226,0.0002716209],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048161802,0.0010230693,0.011354553,0.00033997267,0.00015736363,0.00003099229,0.000923635,0.0004524845,0.000075037184],"category_scores_gemma":[0.00076746993,0.00060963834,0.0024747918,0.0016328417,0.00016646385,0.00007293174,0.0002744834,0.0008288255,0.000043881988],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000077268505,0.0057705725,0.000010659798,0.97673965,0.002305887,0.00010471542,0.0034961428,2.9402568e-7,5.2802085e-7,0.000019336896,0.00075696164,0.010787543],"study_design_scores_gemma":[0.00056341157,0.0009881634,0.001433567,0.92248714,0.030019078,0.0004244802,0.000019709907,3.4017e-7,0.000011608423,0.000006982626,0.04354555,0.00049995247],"about_ca_topic_score_codex":0.000100897545,"about_ca_topic_score_gemma":0.00005506385,"teacher_disagreement_score":0.054252476,"about_ca_system_score_codex":0.00015050497,"about_ca_system_score_gemma":0.00040663185,"threshold_uncertainty_score":0.9996355},"labels":[],"label_agreement":null},{"id":"W2560258553","doi":"10.1182/blood.v118.21.4052.4052","title":"Cryopreserved Allogeneic Peripheral Blood Stem Cells Result in Outcome Equivalent to Those of Fresh Infusions Enabling Rational Scheduling of Donations,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cryopreservation; Medicine; Stem cell; Transplantation; Andrology; Hematopoietic stem cell transplantation; Hazard ratio; Immunology; Internal medicine; Biology; Confidence interval; Embryo","score_opus":0.08710887861378912,"score_gpt":0.30581229321883285,"score_spread":0.21870341460504372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560258553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99691415,0.0002597853,0.000795496,0.00009936755,0.00009946593,0.0006994385,0.00006257584,0.00002804175,0.0010416984],"genre_scores_gemma":[0.9712845,0.000065732675,0.028286412,0.00006742107,0.000042828917,0.000048084872,0.00003089046,0.000023993334,0.00015012106],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979112,0.00009594998,0.0009968806,0.00027842558,0.00047358157,0.00024395886],"domain_scores_gemma":[0.99889153,0.00016076729,0.00019837661,0.00035740502,0.00025260256,0.0001393197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054860953,0.00016037849,0.0004076088,0.00031893764,0.000039757568,0.0000064627775,0.00016934924,0.00012440502,0.00027052916],"category_scores_gemma":[0.00010944791,0.00015280236,0.000114316426,0.00037914392,0.00004249276,0.00008303359,0.000054760803,0.00015192029,0.000007746333],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002907827,0.0015293563,0.24059157,0.00052130886,0.00012558713,0.000040752468,0.004822197,0.00041273132,0.7509407,0.0006626341,0.0000058004443,0.00005662257],"study_design_scores_gemma":[0.006267338,0.00045123269,0.10804616,0.00069890084,0.00036537572,0.00002313732,0.0010674777,0.00014588515,0.8826787,0.0000622539,0.00001972674,0.00017381755],"about_ca_topic_score_codex":0.00017149413,"about_ca_topic_score_gemma":0.00014117004,"teacher_disagreement_score":0.13254541,"about_ca_system_score_codex":0.000024352054,"about_ca_system_score_gemma":0.00016606832,"threshold_uncertainty_score":0.62310994},"labels":[],"label_agreement":null},{"id":"W2560262608","doi":"10.1182/blood.v124.21.2651.2651","title":"The ASH Practice Improvement Module in Non-Hodgkin Lymphoma: Assessing the Feasibility, Reliability and Usefulness of a New Quality Improvement Tool","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; Princess Margaret Cancer Centre; University Health Network; Southlake Regional Health Center; University of Toronto","funders":"","keywords":"Medicine; Quality assurance; Quality management; Family medicine; Internal medicine; Pathology; Operations management","score_opus":0.03744967942290632,"score_gpt":0.29349324627626716,"score_spread":0.2560435668533608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560262608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98947674,0.0005474108,0.001974858,0.0020191392,0.00030043288,0.00064850494,0.00002921304,0.0000119005545,0.004991819],"genre_scores_gemma":[0.99837685,0.00016739342,0.0005751027,0.00047834768,0.00014152001,0.000054260916,0.0000016828257,0.00001815356,0.000186665],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99781704,0.00006893228,0.0011567589,0.0005103268,0.00007263214,0.00037433067],"domain_scores_gemma":[0.99749655,0.000611713,0.00087531196,0.0008639273,0.000073379924,0.000079150675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056009595,0.0001902992,0.00047137038,0.00004987154,0.00020446954,0.0002184898,0.0003624355,0.00010751444,0.000013803204],"category_scores_gemma":[0.0021242818,0.00014653441,0.00010278562,0.00015581049,0.00016629593,0.00058552995,0.00021839816,0.00016080361,0.000010293915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024869264,0.0024853938,0.5501985,0.0002553163,0.00021038932,0.0000015120944,0.0023327784,0.00020073097,0.00081139326,0.15713744,0.0005370047,0.28558087],"study_design_scores_gemma":[0.004561792,0.0004037674,0.9079575,0.000028629025,0.000032068914,0.00000210448,0.00047557958,0.00091430574,0.0019411537,0.07174656,0.0115956925,0.00034085027],"about_ca_topic_score_codex":0.004830021,"about_ca_topic_score_gemma":0.00044594958,"teacher_disagreement_score":0.357759,"about_ca_system_score_codex":0.0001760043,"about_ca_system_score_gemma":0.00012446665,"threshold_uncertainty_score":0.7301579},"labels":[],"label_agreement":null},{"id":"W2560285798","doi":"10.1182/blood.v108.11.3402.3402","title":"FISH and Chips: Novel, Point of Care Technology To Detect Chromosomal Abnormalities.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Fluorescence in situ hybridization; Chromosomal translocation; Microfluidics; Chromosome; Computational biology; Microfluidic chip; Biology; Computer science; Biomedical engineering; Materials science; Nanotechnology; Genetics; Medicine; Gene","score_opus":0.003335673373620827,"score_gpt":0.19804939037230673,"score_spread":0.1947137169986859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560285798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966035,0.0007403983,0.00023852836,0.00017080772,0.000043256696,0.00014296304,0.00016898966,0.000018601708,0.0018729777],"genre_scores_gemma":[0.99634826,0.000025905538,0.0030406052,0.0001097664,0.00015409423,0.00002821622,0.000073980176,0.000015506323,0.00020365255],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992737,0.000011255742,0.00021455748,0.00022863549,0.00006762847,0.00020420719],"domain_scores_gemma":[0.99955827,0.000004834804,0.000061582,0.00024739388,0.00008689866,0.000041013518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000044734592,0.00012678481,0.00014940626,0.00007511443,0.000065161876,0.000014303999,0.00012846719,0.00013942255,0.000015806425],"category_scores_gemma":[0.000019954034,0.00012824318,0.00004714561,0.000097101794,0.00007213261,0.0000035237003,0.00014536532,0.000048256778,0.0000021435253],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044853543,0.00017428509,0.015506267,0.00014075098,0.00009587594,0.000006374085,0.00036175782,0.00006854814,0.9807068,0.0018384508,0.00037964064,0.00067636656],"study_design_scores_gemma":[0.0010202321,0.0005562746,0.009686649,0.00001836089,0.000041216077,0.0001170498,0.000681614,8.9627537e-7,0.97811836,0.0001769065,0.009391961,0.00019046538],"about_ca_topic_score_codex":0.00012098509,"about_ca_topic_score_gemma":0.0002849335,"teacher_disagreement_score":0.00901232,"about_ca_system_score_codex":0.0000065776426,"about_ca_system_score_gemma":0.00004175096,"threshold_uncertainty_score":0.5229605},"labels":[],"label_agreement":null},{"id":"W2560293426","doi":"10.1182/blood.v110.11.1920.1920","title":"Mesenchymal Stromal Cells (MSCs) Acquire Cardiac-Specific Markers but Do Not Become Functional Cardiomyocytes and Retain the Stromal Phenotype.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Tissue Engineering and Regenerative Medicine","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Princess Margaret Cancer Centre; Heart and Stroke Foundation; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Mesenchymal stem cell; Biology; Green fluorescent protein; Cell biology; Vimentin; CD90; Molecular biology; CD34; Immunology; Stem cell; Immunohistochemistry; Gene","score_opus":0.013033290110569296,"score_gpt":0.21886661143565342,"score_spread":0.2058333213250841,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560293426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.974248,0.02084404,0.0010620651,0.00086720684,0.0010670727,0.00036563998,0.000042935128,0.00010223889,0.0014008036],"genre_scores_gemma":[0.9898402,0.00019361146,0.0010538073,0.000048398702,0.0029553345,0.000013839921,0.000038359354,0.00004383506,0.005812626],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99821264,0.00006811372,0.00030575186,0.00039802768,0.000544223,0.000471266],"domain_scores_gemma":[0.9989798,0.000217076,0.00006263598,0.00038667806,0.000093593655,0.00026020367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077167206,0.00028574056,0.00046340094,0.00012347978,0.00019828278,0.000034153436,0.000095303134,0.00013581559,0.00014234199],"category_scores_gemma":[0.00005137523,0.0001890065,0.00016142665,0.00020223303,0.00026595494,0.000055990884,0.00006043157,0.00037859537,0.000024928417],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014386248,0.00054244266,0.04364348,0.00028712652,0.0026007653,0.0011973038,0.0011762695,0.00022669033,0.9029177,0.004745888,0.019261722,0.021962006],"study_design_scores_gemma":[0.009372073,0.0016074718,0.706714,0.00022300008,0.0013726694,0.00086006173,0.0030471117,0.00019565156,0.12142018,0.000022591097,0.15440015,0.00076507387],"about_ca_topic_score_codex":0.000019538775,"about_ca_topic_score_gemma":0.00000289471,"teacher_disagreement_score":0.7814975,"about_ca_system_score_codex":0.000047839356,"about_ca_system_score_gemma":0.000058496156,"threshold_uncertainty_score":0.7707461},"labels":[],"label_agreement":null},{"id":"W2560297658","doi":"10.1182/blood.v114.22.1948.1948","title":"High Microvascular Density Correlates with Poor Outcome in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Rituximab Plus Chemotherapy (R-CT).","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Rituximab; Medicine; Diffuse large B-cell lymphoma; Lymphoma; Pathology; Internal medicine; Follicular lymphoma; Oncology; Chemotherapy; Chemotherapy regimen","score_opus":0.003814903704562985,"score_gpt":0.1905765277721619,"score_spread":0.18676162406759894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560297658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978441,0.00039613506,0.00001308232,0.00025569013,0.000019558525,0.0011801401,0.000024516023,0.00012466522,0.00014213864],"genre_scores_gemma":[0.99738973,0.000048864873,0.0010471991,0.0009410171,0.000028330798,0.000048087015,0.00020799445,0.0000652527,0.0002234967],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794847,0.00004214743,0.00033833756,0.00060962304,0.00048075625,0.0005806567],"domain_scores_gemma":[0.9988554,0.0000359255,0.00015995087,0.000583454,0.00013699419,0.00022829088],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00007405418,0.00050322595,0.0009224225,0.00015204749,0.0001014176,0.00003912818,0.00011137465,0.00010083506,0.00002649605],"category_scores_gemma":[0.0000070447736,0.00029539593,0.00011285487,0.0003737926,0.00006508955,0.00010548135,0.000018405319,0.000108720466,0.00004035355],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023865015,0.08675301,0.9075375,0.000034716126,0.0005068409,0.0013997442,0.00012614866,0.0000024862136,0.000049063885,0.00002199814,0.00004437088,0.0011376097],"study_design_scores_gemma":[0.3218719,0.0030856032,0.66200113,0.00016430729,0.0007806567,0.00011996897,0.000027705455,0.000010295337,0.011553327,0.000003206691,0.00009026543,0.00029166404],"about_ca_topic_score_codex":0.0005053224,"about_ca_topic_score_gemma":0.00013236399,"teacher_disagreement_score":0.3194854,"about_ca_system_score_codex":0.00028856183,"about_ca_system_score_gemma":0.00013016567,"threshold_uncertainty_score":0.9999498},"labels":[],"label_agreement":null},{"id":"W2560300269","doi":"10.1182/blood.v120.21.4450.4450","title":"Treatment Response and Predictors of Response Among Patients with Chronic Myeloid Leukemia: A Retrospective Medical Record Review","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Nilotinib; Dasatinib; Imatinib; Internal medicine; Imatinib mesylate; Myeloid leukemia; Logistic regression; Oncology; Medical record","score_opus":0.00787791313397045,"score_gpt":0.2425229670254747,"score_spread":0.23464505389150425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560300269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833975,0.014195696,0.0000022255933,0.00029810268,0.000111597736,0.0016134788,0.000053658256,0.00007755849,0.00025017466],"genre_scores_gemma":[0.9919598,0.0066518416,0.00022288077,0.00010516394,0.00018599122,0.00019224008,0.00005007305,0.00006193929,0.0005700317],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970756,0.00046031183,0.0005515702,0.0004648265,0.0008874721,0.00056021084],"domain_scores_gemma":[0.997765,0.0004301671,0.00029754292,0.00070284074,0.00015751911,0.0006469492],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00085124926,0.0003777186,0.000890202,0.00014965028,0.0000749557,0.0000061583187,0.00010740883,0.00023049065,0.00029882384],"category_scores_gemma":[0.0012731039,0.00026516157,0.00013097505,0.00033832755,0.0003301618,0.00016772878,0.00008027904,0.0002789722,0.000020840454],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0089683,0.0015718574,0.9839603,0.0004420392,0.00079526065,0.00010461343,0.0003630153,5.69899e-8,0.00018866538,0.0000039765437,0.00026504608,0.0033369185],"study_design_scores_gemma":[0.02439085,0.008727651,0.9577638,0.003220458,0.0016646868,0.00017455943,0.000017939668,0.0000035836892,0.001502264,0.0000013726416,0.0023220265,0.00021079431],"about_ca_topic_score_codex":0.00018013953,"about_ca_topic_score_gemma":0.00005465748,"teacher_disagreement_score":0.026196437,"about_ca_system_score_codex":0.0034945165,"about_ca_system_score_gemma":0.001980566,"threshold_uncertainty_score":0.99998003},"labels":[],"label_agreement":null},{"id":"W2560329719","doi":"10.1182/blood.v126.23.249.249","title":"Effectiveness of Antibacterial Prophylaxis during Induction Chemotherapy in Children with Acute Lymphoblastic Leukemia","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Hamilton Health Sciences; Centre hospitalier universitaire de Québec; Université de Montréal; McMaster Children's Hospital","funders":"","keywords":"Medicine; Cefepime; Induction chemotherapy; Internal medicine; Neutropenia; Febrile neutropenia; Antibiotic prophylaxis; Antibiotics; Vincristine; Acute lymphocytic leukemia; Chemotherapy; Surgery; Leukemia; Cyclophosphamide; Lymphoblastic Leukemia; Antibiotic resistance","score_opus":0.007117012640039276,"score_gpt":0.2347771444624034,"score_spread":0.2276601318223641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560329719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99916583,0.000021789272,0.000016082171,0.000008799254,0.000092269154,0.00049110234,0.0000039159777,0.000030574687,0.00016962075],"genre_scores_gemma":[0.9996878,0.000013036561,0.00006629232,0.000004788465,0.00013721704,0.000038192793,0.000008943574,0.0000192057,0.000024559671],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994164,0.000042335185,0.00011974497,0.00016808484,0.00013075647,0.00012266307],"domain_scores_gemma":[0.99966794,0.0000068093836,0.00005292969,0.00014797896,0.00006291551,0.00006143155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000089491594,0.0000971069,0.00022969849,0.000101768026,0.00001978041,0.0000069792327,0.000036215468,0.000058746708,0.000009066489],"category_scores_gemma":[0.000009773071,0.000075343174,0.000028824374,0.00026790556,0.000045153745,0.00007870062,0.000011479449,0.00009148224,0.000003872007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015963096,0.00033442423,0.5988939,0.00007345185,0.00021882406,0.000012753053,0.000082331084,0.000017551145,0.3985625,0.000006500208,0.0000014234772,0.00020001693],"study_design_scores_gemma":[0.010651859,0.0008836619,0.6126801,0.00011637999,0.00009600551,0.00042070105,0.000006631595,3.5290802e-7,0.37508166,0.000006799036,0.0000025297682,0.000053312167],"about_ca_topic_score_codex":0.0001853108,"about_ca_topic_score_gemma":0.000007804587,"teacher_disagreement_score":0.023480836,"about_ca_system_score_codex":0.00014386297,"about_ca_system_score_gemma":0.0002964768,"threshold_uncertainty_score":0.30724055},"labels":[],"label_agreement":null},{"id":"W2560333353","doi":"10.1182/blood.v106.11.4245.4245","title":"Evaluation of Progenitor Cells (CFU-GM, CFU-GEMM, BFU-E, CD34+ Cells) and White Blood Cells in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma Treated with Rituximab-CHOP-14 and Supported with Pegfilgrastim.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CD34; Pegfilgrastim; CHOP; Haematopoiesis; Progenitor cell; Lymphoma; Medicine; Andrology; Rituximab; Chemotherapy; Stem cell; Immunology; Biology; Internal medicine; Neutropenia; Filgrastim","score_opus":0.006512409454660638,"score_gpt":0.20846990341093047,"score_spread":0.20195749395626983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560333353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99529165,0.0006048316,0.00000514921,0.00006220099,0.00003190451,0.0032660398,0.0003239704,0.00007409341,0.00034014066],"genre_scores_gemma":[0.9966689,0.00018993363,0.002119896,0.000094863004,0.0000699056,0.00034651457,0.0002531801,0.00010936148,0.00014744251],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996215,0.0001920735,0.00062292936,0.0009306264,0.0013370389,0.0007023743],"domain_scores_gemma":[0.99776113,0.00012616093,0.00041125613,0.00059592945,0.0006670123,0.0004385067],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035859685,0.00068105076,0.00095055293,0.00033503547,0.000118929594,0.00007021942,0.000113385715,0.0002171737,0.00007224426],"category_scores_gemma":[0.00002122957,0.00045954227,0.0000755529,0.0005502811,0.00017796126,0.0002479035,0.000059737577,0.00013362494,0.000014989706],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017801601,0.08814497,0.8997192,0.00022632469,0.0008290469,0.00029293058,0.00078216253,0.000021583663,0.0044718254,0.0000015131212,0.00013475123,0.0035955412],"study_design_scores_gemma":[0.29716846,0.0050149863,0.49227327,0.00039676318,0.0061809407,0.00003940729,0.00015530216,0.0003039245,0.19789863,0.0000012512642,0.00010232344,0.0004647422],"about_ca_topic_score_codex":0.0002605881,"about_ca_topic_score_gemma":0.0007261921,"teacher_disagreement_score":0.4074459,"about_ca_system_score_codex":0.00014901544,"about_ca_system_score_gemma":0.00038734247,"threshold_uncertainty_score":0.9997856},"labels":[],"label_agreement":null},{"id":"W2560338088","doi":"10.1182/blood.v120.21.1100.1100","title":"Radioulnar Synostosis-Hematology (RUS-H) Syndrome: Description of the New Syndrome and Comparison to Similar Syndromes","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; PTPN11; Noonan syndrome; Macrocytic anemia; Neutropenia; Leukocytosis; Pediatrics; Hypoplasia; Internal medicine; Anemia; Dermatology; Gastroenterology; Cancer","score_opus":0.02179334662971057,"score_gpt":0.24569709173228416,"score_spread":0.22390374510257358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560338088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9781093,0.01944123,0.00010570551,0.00066948053,0.0009563924,0.00035879386,0.000016608272,0.000051949708,0.0002905691],"genre_scores_gemma":[0.99695873,0.000065095155,0.00015832316,0.00020635544,0.000010910484,0.000016271639,0.000009467793,0.000024440995,0.002550392],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984043,0.0003580927,0.00043669087,0.00023716342,0.000055491746,0.0005082655],"domain_scores_gemma":[0.99911636,0.00016690762,0.00016192444,0.0004455247,0.000038020367,0.0000712895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026236972,0.0002352797,0.00058396126,0.0001603816,0.00016344458,0.0000130782655,0.00033078523,0.00028154225,0.0003232865],"category_scores_gemma":[0.00017843422,0.00017522289,0.00012531488,0.00020036827,0.0002235446,0.00014389485,0.00021902521,0.0002780341,0.00029013943],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057087594,0.0020351012,0.20927273,0.00020633607,0.0015806198,0.000035238954,0.0048527895,0.000004585518,0.74848706,0.004518178,0.027439784,0.0009967228],"study_design_scores_gemma":[0.0030806118,0.0013075871,0.4137024,0.00033054102,0.0005530919,0.02713429,0.0008090794,0.0000012599911,0.5239364,0.00007721544,0.028600084,0.00046746997],"about_ca_topic_score_codex":0.000076208176,"about_ca_topic_score_gemma":0.0000099617955,"teacher_disagreement_score":0.22455066,"about_ca_system_score_codex":0.000020033167,"about_ca_system_score_gemma":0.00005426538,"threshold_uncertainty_score":0.7145382},"labels":[],"label_agreement":null},{"id":"W2560342184","doi":"10.1182/blood.v106.11.4050.4050","title":"Ferritin Levels in a Cohort of Affected Males of Mild Hemophilia A Carriers and Their Unaffected Siblings.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. John’s Health Sciences Centre; Memorial University of Newfoundland","funders":"","keywords":"Medicine; Cohort; Ferritin; Iron status; Internal medicine; Cohort study; Iron deficiency; Demography; Anemia","score_opus":0.012957285681219934,"score_gpt":0.24858957879547056,"score_spread":0.23563229311425063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560342184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99487853,0.003242469,0.000009106759,0.00015343011,0.000020681371,0.00043294323,0.00004765419,0.000024363457,0.0011908112],"genre_scores_gemma":[0.99885064,0.00013519498,0.0007466102,0.00009022102,0.000041585892,0.000011039821,0.000015711825,0.000016463857,0.00009255743],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991592,0.00005089247,0.00027503565,0.00018786326,0.00013903661,0.00018796319],"domain_scores_gemma":[0.999523,0.000055727312,0.00008277586,0.00019321371,0.000062114705,0.00008320413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018972732,0.00013855124,0.0004548548,0.00022126373,0.000015352964,0.0000031501122,0.000056733665,0.000100042045,0.000046558456],"category_scores_gemma":[0.00019824642,0.00011313512,0.00006224606,0.00034828435,0.00013341877,0.000043090306,0.00002627288,0.000111597736,0.0000010435583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021771176,0.0013160176,0.75300425,0.00082399306,0.00012431022,0.000014635494,0.0020489688,0.0000083799405,0.23833556,0.00032789318,0.00012469463,0.0036535987],"study_design_scores_gemma":[0.0070959846,0.00014573542,0.8738068,0.00016063816,0.00016441975,0.000018330295,0.00046464175,0.000041916574,0.117859766,0.000037982747,0.0000965746,0.00010724914],"about_ca_topic_score_codex":0.00017447217,"about_ca_topic_score_gemma":0.00015305438,"teacher_disagreement_score":0.12080254,"about_ca_system_score_codex":0.000006946918,"about_ca_system_score_gemma":0.000071395574,"threshold_uncertainty_score":0.4613516},"labels":[],"label_agreement":null},{"id":"W2560353228","doi":"10.1182/blood.v112.11.1819.1819","title":"The Association Between Antiphospholipid Antibodies and Adverse Pregnancy Outcomes: A Metaanalysis.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Pregnancy; Antiphospholipid syndrome; Placental abruption; Obstetrics; Odds ratio; Lupus anticoagulant; Adverse effect; Antibody; Internal medicine; Immunology; Gestation","score_opus":0.02819819141269608,"score_gpt":0.29369284337171325,"score_spread":0.26549465195901717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560353228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914191,0.004833987,0.00000994581,0.00058432115,0.00005857524,0.00040092994,0.000009348192,0.000058718793,0.0026250836],"genre_scores_gemma":[0.9887359,0.0021283878,0.00017830137,0.000033258002,0.00008201059,0.000017053011,0.00000883522,0.000019553316,0.008796685],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835366,0.00010294431,0.000331175,0.00023236175,0.0006441974,0.00033563585],"domain_scores_gemma":[0.99861234,0.00056241674,0.00015796279,0.0003862406,0.00016678001,0.00011423116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005145367,0.00013808152,0.00047446394,0.00008996442,0.00031144122,0.000017971697,0.0001107165,0.00009507671,0.000012637099],"category_scores_gemma":[0.00093398266,0.0000818824,0.00015444413,0.0002569377,0.00008970753,0.00007301025,0.00007390131,0.0001753397,0.00006412828],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005938857,0.000078495555,0.99683595,0.000083393374,0.0014905641,0.00004383863,0.00070529117,5.3835514e-8,0.00018583522,0.000028154062,0.00031809966,0.00022439372],"study_design_scores_gemma":[0.003414767,0.000070093636,0.9910674,0.00025189196,0.001171024,0.0005024508,0.00044814104,0.0000070851233,0.0017166745,0.000031215357,0.0012051513,0.00011412265],"about_ca_topic_score_codex":0.000053429736,"about_ca_topic_score_gemma":0.00001468224,"teacher_disagreement_score":0.0061716014,"about_ca_system_score_codex":0.000059833103,"about_ca_system_score_gemma":0.000088026485,"threshold_uncertainty_score":0.3339067},"labels":[],"label_agreement":null},{"id":"W2560357275","doi":"10.1182/blood.v122.21.3785.3785","title":"The Eukaryotic Translation Initiation Factor 4E (eIF4E) Has Oncogenic Functions and May Represent a New Therapeutic Target In Diffuse Large B Cell Lymphoma (DLBCL)","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"EIF4E; Biology; Cancer research; Eukaryotic translation; Eukaryotic initiation factor; Gene expression; Diffuse large B-cell lymphoma; Translation (biology); Gene; Oncogene; Messenger RNA; EIF4A1; Molecular biology; Lymphoma; Genetics; Cell cycle; Immunology","score_opus":0.04030467544395052,"score_gpt":0.2785872854694714,"score_spread":0.2382826100255209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560357275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893018,0.0048602377,0.00038236633,0.0026749813,0.00011321294,0.0013108659,0.000012120058,0.00006806639,0.0012763196],"genre_scores_gemma":[0.99626124,0.00044796846,0.00015183276,0.00018349214,0.00018854307,0.00011249066,0.00004604211,0.00004054849,0.0025678687],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99811316,0.00015478834,0.0003863857,0.00037265097,0.0004575219,0.0005155262],"domain_scores_gemma":[0.99865085,0.0004514512,0.00008291294,0.0004996915,0.00008096785,0.00023414548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025148544,0.00019579465,0.00024430623,0.00014640314,0.00022431776,0.00013333176,0.0001272504,0.00015089403,0.00018806076],"category_scores_gemma":[0.00010969215,0.0001402026,0.00009454452,0.00034164844,0.000097722994,0.00020231116,0.00005116906,0.00019786149,0.00018842859],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033443759,0.09138028,0.2841605,0.0021239202,0.0029437453,0.000890758,0.043568753,0.000083392486,0.11477687,0.0013364882,0.014895152,0.44049576],"study_design_scores_gemma":[0.47779733,0.0009793097,0.43977898,0.00024063453,0.00068628986,0.00047669036,0.0018750799,0.035874918,0.018717445,0.0022548945,0.020514805,0.0008036386],"about_ca_topic_score_codex":0.0013995237,"about_ca_topic_score_gemma":0.00033686886,"teacher_disagreement_score":0.47445294,"about_ca_system_score_codex":0.0011751531,"about_ca_system_score_gemma":0.0027950006,"threshold_uncertainty_score":0.5717296},"labels":[],"label_agreement":null},{"id":"W2560387080","doi":"10.1182/blood.v118.21.1986.1986","title":"A Phase 1 Open Label, Dose Escalation Study of Nilotinib in Steroid Dependent/Refractory Chronic Graft-Versus-Host Disease","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada","funders":"","keywords":"Nilotinib; Medicine; Prednisone; Adverse effect; Refractory (planetary science); Internal medicine; Tyrosine-kinase inhibitor; Pharmacology; Dosing; Imatinib; Corticosteroid; Gastroenterology; Urology; Cancer","score_opus":0.08625308435952153,"score_gpt":0.3471174880040857,"score_spread":0.2608644036445642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560387080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950523,0.00059649674,0.000002607823,0.000017732116,0.00014305738,0.0025487752,0.00003778844,0.000045034012,0.001556207],"genre_scores_gemma":[0.9990789,0.00004834082,0.00016331045,0.000024231238,0.000078289406,0.00018699998,0.000069937785,0.000045390185,0.00030456643],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99815685,0.00012594783,0.00051166845,0.00048349975,0.0003919872,0.00033007632],"domain_scores_gemma":[0.99862945,0.000066103756,0.00021733485,0.000749566,0.00006775203,0.00026976308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022360524,0.0002494674,0.00045153368,0.0001838906,0.00004596441,0.000017460648,0.0003078449,0.00007967897,0.00048353808],"category_scores_gemma":[0.00010201712,0.00022758234,0.00004698619,0.0002582049,0.000048419137,0.0002783966,0.00024293199,0.00021544695,0.00006972851],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025920492,0.36633283,0.5591146,0.00051068934,0.0018690749,0.0026497624,0.009351122,0.0000047292374,0.018399794,0.00006230339,0.00012095458,0.015663683],"study_design_scores_gemma":[0.51466584,0.02217477,0.4536332,0.0003436422,0.0019181627,0.000016696775,0.0009056243,0.00012034562,0.005683508,0.000025573132,0.00013205802,0.00038055333],"about_ca_topic_score_codex":0.0010278873,"about_ca_topic_score_gemma":0.0014059657,"teacher_disagreement_score":0.4887454,"about_ca_system_score_codex":0.00054357713,"about_ca_system_score_gemma":0.0006757429,"threshold_uncertainty_score":0.92805386},"labels":[],"label_agreement":null},{"id":"W2560401193","doi":"10.1182/blood.v126.23.4730.4730","title":"Dabigatran Etexilate or Warfarin in the Treatment of Acute Venous Thromboembolism in Western European Patients: A Pooled Analysis of RE-COVER® and RE-COVER II™","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Dabigatran; Warfarin; Population; Hazard ratio; Proportional hazards model; Randomized controlled trial; Venous thromboembolism; Internal medicine; Atrial fibrillation; Confidence interval; Thrombosis","score_opus":0.030207687330492446,"score_gpt":0.2832770100666746,"score_spread":0.25306932273618216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560401193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995246,0.000405662,0.000002263212,0.00026108784,0.000049532493,0.0008458163,0.000055937282,0.000014764382,0.003118932],"genre_scores_gemma":[0.998023,0.0012111617,0.00008172235,0.0003436598,0.00003410313,0.00003247355,0.0000796037,0.000027995964,0.00016631387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99815243,0.00020118007,0.00061606365,0.0003537597,0.00038711584,0.00028943422],"domain_scores_gemma":[0.9989632,0.00006177886,0.00022869684,0.0005766454,0.00007277728,0.00009692035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042472154,0.00023801028,0.0011851459,0.0003984482,0.00003184155,0.00001627366,0.00017416106,0.000066619585,0.000046439338],"category_scores_gemma":[0.00003317218,0.00015040545,0.00015920105,0.00076923915,0.00007752879,0.00008192917,0.000084354826,0.00009553814,0.0000093527515],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009604331,0.0603391,0.8030534,0.0002630129,0.01533548,0.00067757774,0.11048223,0.0004758418,0.0010542133,0.000087793276,0.00062631065,0.0066446466],"study_design_scores_gemma":[0.010560882,0.0056474796,0.9679077,0.00014013499,0.01272519,0.000004162833,0.000601305,0.00007620617,0.00073230144,0.000024678322,0.0014155003,0.00016446057],"about_ca_topic_score_codex":0.001101378,"about_ca_topic_score_gemma":0.00077108515,"teacher_disagreement_score":0.16485433,"about_ca_system_score_codex":0.000062911684,"about_ca_system_score_gemma":0.000052945983,"threshold_uncertainty_score":0.6133356},"labels":[],"label_agreement":null},{"id":"W2560443112","doi":"10.1182/blood.v124.21.4270.4270","title":"Post-Hoc Analysis of RE-MEDY™ Demonstrates Significant Real-World Net Clinical Benefit for Dabigatran Versus Warfarin in Prevention of Secondary Venous Thromboembolism","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Dabigatran; Medicine; Warfarin; Hazard ratio; Internal medicine; Confidence interval; Direct thrombin inhibitor; Myocardial infarction; Atrial fibrillation; Anesthesia","score_opus":0.27094916036971034,"score_gpt":0.44607610255752034,"score_spread":0.17512694218781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560443112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929339,0.00046061556,0.00044770868,0.0013626646,0.00038239988,0.0007566013,0.00086410186,0.000021785741,0.002770196],"genre_scores_gemma":[0.99516463,0.00022273307,0.003738747,0.000264245,0.00016882634,0.00007389681,0.00025130445,0.000028732931,0.00008689048],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9930749,0.00032005445,0.0055624344,0.00059047,0.000094884046,0.00035726145],"domain_scores_gemma":[0.99375015,0.0024682856,0.0028976453,0.00062211783,0.00012636092,0.00013546395],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.013539582,0.00019153005,0.002159154,0.0008302267,0.00006527926,0.000022220047,0.00031942187,0.00021184351,0.00018434672],"category_scores_gemma":[0.0014854162,0.00024608884,0.00047996576,0.0005657848,0.00012279654,0.00021057401,0.00003866348,0.00018772951,0.000027088401],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010946827,0.0065338523,0.73865527,0.0022417677,0.0064520994,0.0000020456505,0.003625025,0.0027383957,0.00029084086,0.22615531,0.0008685352,0.011342194],"study_design_scores_gemma":[0.008100404,0.0023363985,0.9611353,0.00012362767,0.00074103737,5.1321393e-7,0.00083848764,0.0076959133,0.00026861485,0.01714364,0.0011482867,0.0004677489],"about_ca_topic_score_codex":0.0022596081,"about_ca_topic_score_gemma":0.009709954,"teacher_disagreement_score":0.22248007,"about_ca_system_score_codex":0.00009708594,"about_ca_system_score_gemma":0.00020230506,"threshold_uncertainty_score":0.99999917},"labels":[],"label_agreement":null},{"id":"W2560443961","doi":"10.1182/blood.v112.11.2036.2036","title":"Reactive Oxygen Species Regulate Spontaneous and Fas-Mediated Apoptosis in SBDS-Deficient Cells.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Propidium iodide; Apoptosis; Viability assay; Annexin; Biology; Molecular biology; Programmed cell death; Annexin A5; Reactive oxygen species; MTT assay; Cancer research; Chemistry; Cell biology; Biochemistry","score_opus":0.0070093437347194905,"score_gpt":0.18520655488744747,"score_spread":0.178197211152728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560443961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955694,0.0016495559,0.0000055428222,0.0000581147,0.000044922803,0.00016652733,0.000034103916,0.000011602418,0.0024602506],"genre_scores_gemma":[0.9976156,0.001015277,0.00019683116,0.00007780878,0.000036674886,0.000015546555,0.00012529205,0.000017654707,0.00089932914],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991763,0.00002752291,0.00013982868,0.00033182144,0.00009638193,0.00022811601],"domain_scores_gemma":[0.99963844,0.000009946178,0.000047753503,0.00020915779,0.000027204931,0.000067508685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000036897844,0.0001539609,0.00015201006,0.000047956673,0.00007559823,0.000010241655,0.00007461934,0.00011673433,0.000010015841],"category_scores_gemma":[0.000017799763,0.00014213534,0.00004645556,0.000088446315,0.000082185965,0.0000027701576,0.00006780964,0.000056621855,0.000008488879],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015982785,0.001762641,0.024301093,0.000015729907,0.00022823714,0.00048666465,0.00047015375,0.000022545799,0.97150356,0.00002310646,0.00050937175,0.00051707367],"study_design_scores_gemma":[0.0048396387,0.0005811575,0.048895575,0.000016846814,0.00009286889,0.0005307255,0.00027010514,0.000015335885,0.9368245,0.00003818277,0.0075161234,0.00037894605],"about_ca_topic_score_codex":0.00007391855,"about_ca_topic_score_gemma":0.00008169615,"teacher_disagreement_score":0.034679063,"about_ca_system_score_codex":0.000008871455,"about_ca_system_score_gemma":0.000030903022,"threshold_uncertainty_score":0.57961106},"labels":[],"label_agreement":null},{"id":"W2560461349","doi":"10.1182/blood.v126.23.3306.3306","title":"Feasibility of Routine Frailty Screening Assessment for Patients in a Hematologic Oncology Clinic: Results from a Pilot Study","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Frailty in Older Adults","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Grip strength; Population; Weight loss; Geriatrics; Physical therapy; Test (biology); Geriatric oncology; Internal medicine; Cancer; Obesity","score_opus":0.21601456962146423,"score_gpt":0.42763248899330164,"score_spread":0.2116179193718374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560461349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944306,0.00003394256,0.00019612523,0.00048152704,0.00017032736,0.0032049746,0.00027141062,0.000052922103,0.00115815],"genre_scores_gemma":[0.9729416,0.0000023480509,0.026384385,0.00011297332,0.00006922583,0.00013336657,0.00024824546,0.000020455069,0.00008740884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99727774,0.00027499726,0.0011468912,0.0005696019,0.00042098842,0.00030976304],"domain_scores_gemma":[0.9974027,0.00094121293,0.00041269348,0.0006555131,0.0003951637,0.0001926934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014375367,0.0001959445,0.0008458831,0.00010373934,0.000025579,0.0000065469267,0.00018460261,0.00011539983,0.000018919412],"category_scores_gemma":[0.0046905624,0.00016588847,0.00007589419,0.00020719193,0.000071283255,0.00006297954,0.00014931706,0.0002836169,0.000007878855],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005014817,0.038025133,0.9537228,0.000039366118,0.00013238608,0.000036855592,0.0012493568,0.000002932855,0.00007513355,0.0000035587004,0.0005416374,0.0011560728],"study_design_scores_gemma":[0.1058385,0.03227854,0.8593281,0.00014318826,0.00024740226,0.0000044761555,0.0013212729,0.00012161233,0.00024221923,0.00025555154,0.00008428652,0.00013486644],"about_ca_topic_score_codex":0.0018345255,"about_ca_topic_score_gemma":0.0017733871,"teacher_disagreement_score":0.10082368,"about_ca_system_score_codex":0.000151777,"about_ca_system_score_gemma":0.00032318922,"threshold_uncertainty_score":0.67647356},"labels":[],"label_agreement":null},{"id":"W2560481436","doi":"10.1182/blood.v104.11.5320.5320","title":"Long-Term Follow-Up of 98 Cases of Recombinant Human Erythropoietin (epoetin) Induced Pure Red Cell Aplasia (PRCA): Outcomes and Treatment Data from the Research on Adverse Drug Reactions and Reports (RADAR) Program.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pure red cell aplasia; Erythropoietin; Transplantation; Immunosuppression; Epoetin alfa; Anemia; Internal medicine","score_opus":0.08714968557601484,"score_gpt":0.3549325577032629,"score_spread":0.26778287212724805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560481436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959847,0.00052266987,3.2150197e-7,0.0014901188,0.00014414049,0.0014741243,0.00006230601,0.00003459009,0.0002870768],"genre_scores_gemma":[0.9982743,0.0005918167,0.000377648,0.000013126652,0.000051177336,0.000048406986,0.00032860125,0.000029443976,0.00028544976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980865,0.000118275435,0.00053694815,0.00056201173,0.00043944985,0.00025681098],"domain_scores_gemma":[0.99806273,0.00027005305,0.00022290453,0.0012023513,0.000110154084,0.00013180883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004900077,0.00021331217,0.0004887458,0.00011085161,0.00025574304,0.000018920495,0.00012314873,0.00012082644,0.000030677773],"category_scores_gemma":[0.00011110721,0.00013323897,0.00008829251,0.00020316153,0.0002206178,0.000084256375,0.00011894595,0.00029686172,0.000001142177],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007491109,0.016906846,0.9148641,0.0003791268,0.00090128917,0.0026125698,0.002634616,2.71248e-7,0.052610826,0.000095710166,0.0004649774,0.0077805496],"study_design_scores_gemma":[0.01690503,0.00424768,0.9052508,0.0008160952,0.001330732,0.0004174034,0.0013998738,4.2072114e-7,0.0688232,0.00016722346,0.00046004253,0.00018148354],"about_ca_topic_score_codex":0.006513943,"about_ca_topic_score_gemma":0.003883326,"teacher_disagreement_score":0.016212374,"about_ca_system_score_codex":0.000031260603,"about_ca_system_score_gemma":0.000116205774,"threshold_uncertainty_score":0.9847176},"labels":[],"label_agreement":null},{"id":"W2560491873","doi":"10.1182/blood.v118.21.2112.2112","title":"Serum Metabolite Profiles Are Reflective of Iron Overload in Thalassemia Major Patients on Chelation Therapy","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Deferasirox; Deferiprone; Deferoxamine; Thalassemia; Chelation therapy; Medicine; Ferritin; Internal medicine; Pharmacology; Biochemistry; Gastroenterology; Chemistry","score_opus":0.015769066536813328,"score_gpt":0.24275390815593417,"score_spread":0.22698484161912086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560491873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861733,0.00077941536,7.3571863e-7,0.000060243954,0.00006750015,0.00050695153,0.000018714889,0.00002306513,0.012370083],"genre_scores_gemma":[0.9992083,0.00031581972,0.00012882777,0.000113454946,0.000019944853,0.000019711146,0.000020934334,0.000017417246,0.0001555933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992117,0.000044869943,0.00021777021,0.00018194426,0.00017931497,0.00016438561],"domain_scores_gemma":[0.9995571,0.000014593998,0.0001353792,0.00017287876,0.00007383207,0.00004625148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000080263344,0.00011983424,0.00023554316,0.00011816914,0.00002264183,0.0000021860583,0.000044186287,0.00015282368,0.000095238946],"category_scores_gemma":[0.00004294832,0.00008825235,0.00006230336,0.00020430324,0.000030322233,0.000050267096,0.0000117888485,0.00017837426,0.000018869077],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004680502,0.0023862245,0.98576677,0.000056907054,0.00008921884,0.000009035217,0.0020416554,0.000001039604,0.0055704713,0.00013483728,0.000032095464,0.0034436942],"study_design_scores_gemma":[0.0062797577,0.00059883605,0.90648514,0.00014994513,0.00007023091,0.0000014712092,0.00031621734,0.000004767178,0.08577878,0.00015764788,0.00007405159,0.00008315963],"about_ca_topic_score_codex":0.00009926169,"about_ca_topic_score_gemma":0.000009784624,"teacher_disagreement_score":0.08020831,"about_ca_system_score_codex":0.000020748528,"about_ca_system_score_gemma":0.0000318319,"threshold_uncertainty_score":0.35988262},"labels":[],"label_agreement":null},{"id":"W2560514258","doi":"10.1182/blood.v110.11.46.46","title":"A Comparison of Stem Cell Source in Recipients of T-Cell Depleted Myeloablative Transplants for Leukaemia: No Difference in Mortality Using BM or PBSC.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Stem cell; Graft-versus-host disease; Transplantation; Bone marrow; Internal medicine; Gastroenterology; Immunology; Biology","score_opus":0.08179203764433995,"score_gpt":0.3498523398984876,"score_spread":0.2680603022541476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560514258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98734623,0.000079646234,0.010752015,0.0000024470867,0.000057847763,0.001029742,0.00006651793,0.000014345125,0.0006512306],"genre_scores_gemma":[0.9968142,0.000013441183,0.0029897678,0.0000104200635,0.000015738782,0.000013493397,0.000036371544,0.00002424028,0.00008234029],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979899,0.000072876814,0.0009912668,0.00028864286,0.00033335673,0.0003239693],"domain_scores_gemma":[0.9987822,0.0004908942,0.0003058156,0.000221056,0.00011355133,0.000086485954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052048767,0.00018332731,0.0007173134,0.00022268516,0.000018493294,0.0000027495676,0.00010448762,0.00018943106,0.0000131376555],"category_scores_gemma":[0.000021288435,0.00016325522,0.00007708922,0.0003635107,0.000058087928,0.000039158618,0.000008927589,0.00018599065,0.0000015326938],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010471764,0.0015970182,0.6628096,0.0020445422,0.000028618928,0.000027017291,0.00553885,0.00004116782,0.32668132,0.0000024055348,7.650975e-7,0.0001815142],"study_design_scores_gemma":[0.009304035,0.00035099068,0.3101116,0.0011128669,0.00024872812,0.000010093717,0.00096678047,0.0019635009,0.6758019,0.000005345743,0.0000014668553,0.00012270917],"about_ca_topic_score_codex":0.00025335056,"about_ca_topic_score_gemma":0.00047290363,"teacher_disagreement_score":0.352698,"about_ca_system_score_codex":0.000059918155,"about_ca_system_score_gemma":0.00012184182,"threshold_uncertainty_score":0.6657355},"labels":[],"label_agreement":null},{"id":"W2560517927","doi":"10.1182/blood.v124.21.1607.1607","title":"Two Novel, Co-Inherited, Telomerase Reverse Transcriptase (TERT) Mutations Resulting in Inherited Aplastic Anemia and Telomere Shortening","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Aplastic anemia; Medicine; Bone marrow failure; Bone marrow; Pediatrics; Anemia; Megaloblastic anemia; Myeloid; Immunology; Gastroenterology; Internal medicine; Biology; Haematopoiesis; Genetics; Stem cell","score_opus":0.018832348896906215,"score_gpt":0.27330425013308807,"score_spread":0.25447190123618185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560517927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99670315,0.0004908749,0.0004947081,0.00033898387,0.00013735975,0.0005652549,0.00008203836,0.00021036618,0.0009772894],"genre_scores_gemma":[0.9894717,0.00008690726,0.008973575,0.0007572194,0.00022417444,0.00004762863,0.00019139498,0.000075489945,0.00017192679],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9972914,0.00012588422,0.000776458,0.00073734304,0.00040638802,0.00066254445],"domain_scores_gemma":[0.99849075,0.0003343502,0.00015337166,0.00046546286,0.00012771063,0.0004283808],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004771646,0.00041460257,0.000647544,0.00050347554,0.0002221973,0.000072290575,0.00014948938,0.00019158595,0.000083869345],"category_scores_gemma":[0.00066429784,0.00041137953,0.00009950833,0.0008327233,0.00023394449,0.00024857206,0.000036672573,0.00060791586,0.000028015938],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006234704,0.0017843468,0.25183338,0.000732364,0.00014586793,0.0010036059,0.0051741316,0.00005443916,0.72290754,0.00019501016,0.0003310599,0.015214774],"study_design_scores_gemma":[0.1055482,0.0024615212,0.7509103,0.0049518556,0.0024961198,0.006007544,0.01048997,0.017654356,0.07999505,0.00018814632,0.015395988,0.0039009824],"about_ca_topic_score_codex":0.0005067679,"about_ca_topic_score_gemma":0.00021722582,"teacher_disagreement_score":0.6429125,"about_ca_system_score_codex":0.00005274586,"about_ca_system_score_gemma":0.000118838856,"threshold_uncertainty_score":0.9998338},"labels":[],"label_agreement":null},{"id":"W2560521267","doi":"10.1182/blood.v118.21.1159.1159","title":"HIT Antibody Seropositivity and Thromboembolic Events After Cardiac Surgery","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Heparin-induced thrombocytopenia; Platelet factor 4; Thrombosis; Adverse effect; Heparin; Internal medicine; Prospective cohort study; Surgery; Clinical endpoint; Platelet activation; Platelet; Clinical trial","score_opus":0.03396015449441926,"score_gpt":0.2748105735203076,"score_spread":0.24085041902588833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560521267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909084,0.0004088536,0.000007399251,0.00008944873,0.00026265238,0.00034918985,0.000033983255,0.000101267484,0.007838803],"genre_scores_gemma":[0.9987907,0.00032592853,0.00028607005,0.00021114554,0.00016897803,0.000033610337,0.000032505824,0.000045246707,0.00010581728],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99856466,0.00011181075,0.00026744424,0.00041436794,0.00021758938,0.00042410442],"domain_scores_gemma":[0.99906874,0.000056539622,0.000066017594,0.00045081362,0.00006457067,0.000293347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029274562,0.0002458992,0.0008213061,0.000119969984,0.0000875507,0.000015575173,0.00006423865,0.00016695895,0.00031339988],"category_scores_gemma":[0.000047564285,0.0002180103,0.00020893449,0.00018671546,0.000091982605,0.00017547251,0.000110305235,0.00020284523,0.00016800413],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047652687,0.0008566285,0.95361143,0.00009284246,0.00038182354,0.00011328314,0.00049152557,1.2130233e-9,0.043384764,0.00007349131,0.00008281466,0.0008637456],"study_design_scores_gemma":[0.00065700535,0.00011635274,0.9459085,0.00011961207,0.0007393457,0.000082949315,0.00004103412,5.739701e-7,0.051644504,0.00015183276,0.0003075209,0.00023076335],"about_ca_topic_score_codex":0.00035310927,"about_ca_topic_score_gemma":0.000014705046,"teacher_disagreement_score":0.008259743,"about_ca_system_score_codex":0.000021142518,"about_ca_system_score_gemma":0.00010115243,"threshold_uncertainty_score":0.88902026},"labels":[],"label_agreement":null},{"id":"W2560524290","doi":"10.1182/blood.v128.22.5583.5583","title":"Temporal Profiles of Lymphocyte Subsets and the Correlation with Infectious Events in Idelalisib-Treated Patients","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Idelalisib; Ofatumumab; Bendamustine; Internal medicine; Placebo; Population; Rituximab; Immunology; Chronic lymphocytic leukemia; Lymphoma; Leukemia; Ibrutinib","score_opus":0.006812006081608902,"score_gpt":0.23602123687365067,"score_spread":0.22920923079204178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560524290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99840224,0.00014196505,0.000017146775,0.000081532395,0.000020874466,0.00081646844,0.000007470054,0.000019546365,0.00049278664],"genre_scores_gemma":[0.99957544,0.00006811793,0.000031020223,0.000019927711,0.000019179975,0.000048447815,0.00001701167,0.000016206142,0.0002046231],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895746,0.00009385842,0.00024323064,0.00017831777,0.00034160857,0.00018550566],"domain_scores_gemma":[0.9992899,0.0001900798,0.000106278625,0.00022525422,0.00012918025,0.00005933445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024453833,0.00010504276,0.00023082523,0.000101865044,0.000028218015,0.0000034958161,0.000054886055,0.00006913644,0.00001627623],"category_scores_gemma":[0.00021062137,0.00004771279,0.000027261543,0.00022286692,0.0001941167,0.00008058516,0.00004338166,0.00006014233,0.000010210992],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013651362,0.00040386326,0.99593735,0.00005950304,0.000076069904,0.000017487675,0.00021594061,0.0000017665292,0.00016783152,0.000065693894,0.000017384093,0.0016719748],"study_design_scores_gemma":[0.2849836,0.000529007,0.7049267,0.00062150374,0.00014330831,0.00013325308,0.00003258457,0.00050179247,0.007832631,0.00015345003,0.0000299306,0.00011222418],"about_ca_topic_score_codex":0.0015380371,"about_ca_topic_score_gemma":0.00020152856,"teacher_disagreement_score":0.29101062,"about_ca_system_score_codex":0.0009361325,"about_ca_system_score_gemma":0.0009379418,"threshold_uncertainty_score":0.2447954},"labels":[],"label_agreement":null},{"id":"W2560541587","doi":"10.1182/blood.v122.21.4601.4601","title":"Risk Factors For Chronic Eye and Mouth GVHD In Unrelated Hematopoietic Cell Transplantation: T Cell Depletion Is The Only Risk Factor Identified and Appears To Be Favorable","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Transplantation; Internal medicine; Graft-versus-host disease; Alemtuzumab; Hematopoietic stem cell transplantation; Gastroenterology; Myeloid leukemia; Leukemia; Chronic lymphocytic leukemia; Immunology; Surgery","score_opus":0.012801843245764851,"score_gpt":0.2373127035403457,"score_spread":0.22451086029458084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560541587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941554,0.00061297737,0.0016086823,0.00039680986,0.00008221832,0.002523853,0.00029457483,0.000060299935,0.00026515662],"genre_scores_gemma":[0.9976566,0.001047596,0.0005192841,0.000119120145,0.00002787436,0.00009861101,0.00009311981,0.00004940741,0.0003883799],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983315,0.00011003747,0.00045393634,0.00046392475,0.0002729426,0.00036769456],"domain_scores_gemma":[0.9988563,0.0004292288,0.00016039102,0.00028081448,0.00007246534,0.00020077723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024236387,0.00026976893,0.00035444985,0.00015571134,0.0001851154,0.00008574723,0.00009418056,0.00019046426,0.00020981823],"category_scores_gemma":[0.00004022933,0.00020642264,0.000078710786,0.00023744669,0.0000612891,0.00014053265,0.000013508667,0.00027030217,0.000042012747],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002669725,0.0008545729,0.86675483,0.004535412,0.0002620468,0.00003473939,0.07328009,0.00008351174,0.051268686,0.000044054428,0.00027895957,0.0023361105],"study_design_scores_gemma":[0.009673629,0.00043103038,0.84704846,0.00021148376,0.0011446702,0.00005003366,0.0031106942,0.00038110683,0.13731907,0.0001444772,0.0001140325,0.00037131924],"about_ca_topic_score_codex":0.0010102993,"about_ca_topic_score_gemma":0.00019751857,"teacher_disagreement_score":0.08605039,"about_ca_system_score_codex":0.000043321772,"about_ca_system_score_gemma":0.00007873694,"threshold_uncertainty_score":0.8417671},"labels":[],"label_agreement":null},{"id":"W2560544338","doi":"10.1182/blood.v114.22.3042.3042","title":"Augmented Revascularization and Recovery From Acute Limb Ischemia After Transplantation of Human Umbilical Cord Blood Progenitor Cells with High Aldehyde Dehydrogenase Activity.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Progenitor cell; Stem cell; Angiogenesis; Haematopoiesis; Biology; Transplantation; Bone marrow; Immunology; Therapeutic angiogenesis; Endothelial stem cell; Cancer research; Neovascularization; Pathology; Medicine; Cell biology; Internal medicine; In vitro; Biochemistry","score_opus":0.008722206034448256,"score_gpt":0.2529376982506203,"score_spread":0.24421549221617203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560544338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981575,0.00024530775,0.00018243231,0.00010760077,0.000019188441,0.0009867104,0.000074237134,0.0000456832,0.00018134584],"genre_scores_gemma":[0.9973213,0.0002520874,0.0017450068,0.000055137723,0.00010665258,0.00005255589,0.0002185132,0.000029217905,0.00021951947],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983022,0.000096402495,0.00029142926,0.00045376303,0.00057551946,0.0002806432],"domain_scores_gemma":[0.99912006,0.00006691256,0.00011427624,0.00035443145,0.00012242208,0.00022187598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015345194,0.00020900957,0.00038932223,0.00011094951,0.00005959596,0.00002662779,0.00007794292,0.00017488627,0.00011118329],"category_scores_gemma":[0.00001965978,0.00017505973,0.000088424276,0.00023061132,0.00007620207,0.0001393468,0.000018511848,0.0002270176,0.000006529677],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003294927,0.0015557756,0.008396266,0.00020832384,0.0005999974,0.00043114045,0.0001070272,9.2474625e-7,0.9843469,0.0000048578554,0.000012188462,0.0010416493],"study_design_scores_gemma":[0.006918034,0.003691724,0.043397825,0.00024029691,0.0020939722,0.00012014216,0.000008740687,0.00002852797,0.9432893,0.000031076626,0.00001124144,0.0001691109],"about_ca_topic_score_codex":0.00014387192,"about_ca_topic_score_gemma":0.00003718101,"teacher_disagreement_score":0.041057613,"about_ca_system_score_codex":0.000024159626,"about_ca_system_score_gemma":0.00008427801,"threshold_uncertainty_score":0.71387285},"labels":[],"label_agreement":null},{"id":"W2560546162","doi":"10.1182/blood.v106.11.1334.1334","title":"CLL/SLL Is More Common Than Registry Incidence Suggests: A Population-Based Study in Manitoba, Canada.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Cancer registry; Medicine; Incidence (geometry); Population; Immunophenotyping; Chronic lymphocytic leukemia; Cancer; Epidemiology; Internal medicine; Leukemia; Immunology; Flow cytometry; Environmental health","score_opus":0.021641843046053582,"score_gpt":0.29995669862698204,"score_spread":0.27831485558092844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560546162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961679,0.00026883907,0.0000010636028,0.0021780059,0.000041685787,0.00084346964,0.00001869762,0.000043224147,0.00043709503],"genre_scores_gemma":[0.9980623,0.000006206351,0.00015208901,0.0009758306,0.00021133466,0.00006363805,0.00004832592,0.000031936615,0.0004483534],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977569,0.00007647046,0.0003984522,0.00038952215,0.0009370219,0.00044164635],"domain_scores_gemma":[0.9986211,0.00017309918,0.000088102424,0.0008229241,0.00008735894,0.00020742434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002824988,0.00018583826,0.00034087634,0.00013117965,0.000069705806,0.000024503635,0.00026938663,0.000098458826,0.00009325883],"category_scores_gemma":[0.00022009137,0.00017536212,0.000044053468,0.00039122134,0.000036405763,0.000067145316,0.00007767969,0.00033123992,0.000021948375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00011394433,0.0013909744,0.99435216,0.00009110638,0.00004427384,0.0013034159,0.00037476828,0.0000956246,0.000043283533,0.000006480887,0.0016146199,0.00056936004],"study_design_scores_gemma":[0.02895861,0.00018456348,0.962924,0.0002316668,0.00009663146,0.00013103381,0.0012741874,0.004016372,0.001302239,0.000007604053,0.00065686106,0.00021624511],"about_ca_topic_score_codex":0.9258972,"about_ca_topic_score_gemma":0.984152,"teacher_disagreement_score":0.05825483,"about_ca_system_score_codex":0.0113316225,"about_ca_system_score_gemma":0.010689989,"threshold_uncertainty_score":0.99491847},"labels":[],"label_agreement":null},{"id":"W2560572912","doi":"10.1182/blood.v114.22.5089.5089","title":"Phenobarbital for Long-Term Management of Marked Hyperbilirubinemia.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Neonatal Health and Biochemistry","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba; St. Boniface Hospital","funders":"","keywords":"Unconjugated hyperbilirubinemia; Phenobarbital; Internal medicine; Medicine; Hemolytic anemia; Gastroenterology; Bilirubin; Endocrinology","score_opus":0.012134678515406895,"score_gpt":0.28791042947430984,"score_spread":0.27577575095890294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560572912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887711,0.000934934,0.000035860445,0.00039027847,0.000038646616,0.00044868325,0.00001457297,0.000027589982,0.009338351],"genre_scores_gemma":[0.99522793,0.00006215369,0.0025364007,0.00032577122,0.00012238098,0.000013583758,0.000056441804,0.000006780912,0.0016485817],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99937415,0.0000026326961,0.00017309473,0.00014884744,0.00012063851,0.00018064179],"domain_scores_gemma":[0.9996046,0.000012249259,0.000040598698,0.00019237447,0.000040231105,0.00010997261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006652762,0.00007909801,0.00015234365,0.000018757875,0.000019918698,0.0000021684582,0.000056648194,0.000051000985,0.000039647428],"category_scores_gemma":[0.000008593301,0.00006659776,0.00007034477,0.000059060912,0.000019728754,0.00001362805,0.000012654613,0.00004896815,0.0000047305753],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060775173,0.013051862,0.10481703,0.029762799,0.0008081021,0.0012201708,0.0001428591,2.682802e-7,0.37246567,0.00145274,0.0051103197,0.46509066],"study_design_scores_gemma":[0.017334092,0.0016597578,0.43323317,0.0007404743,0.00065964216,0.00022771939,0.000066182256,0.000008373989,0.5447021,0.0002811715,0.0008393856,0.00024789703],"about_ca_topic_score_codex":9.3598214e-7,"about_ca_topic_score_gemma":2.0667464e-7,"teacher_disagreement_score":0.46484277,"about_ca_system_score_codex":0.000010567042,"about_ca_system_score_gemma":0.000027651347,"threshold_uncertainty_score":0.27157778},"labels":[],"label_agreement":null},{"id":"W2560576598","doi":"10.1182/blood.v112.11.732.732","title":"A Functional Screen Identifies Polarity Genes Implicated in HSC Fate","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Invertebrate Immune Response Mechanisms","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Biology; Stem cell; Transplantation; Cell biology; Gene; Cell fate determination; Genetics; Medicine","score_opus":0.024375904722360786,"score_gpt":0.2242087745745062,"score_spread":0.1998328698521454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560576598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955003,0.0031675047,0.00018629423,0.00014404608,0.00031847894,0.00017025888,0.000033261753,0.00010667393,0.0003731489],"genre_scores_gemma":[0.9961209,0.000110181296,0.000073494906,0.00013251597,0.000022173446,0.00002785147,0.00015555914,0.000016981394,0.0033403288],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99884975,0.00021838544,0.00026267694,0.00027671433,0.000038917948,0.00035353826],"domain_scores_gemma":[0.999545,0.000057184396,0.00006414785,0.00026032538,0.00005755267,0.000015816328],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020514468,0.0001533605,0.00022037473,0.00017777702,0.00022366107,0.000009894194,0.00018797039,0.00024360267,0.0007171052],"category_scores_gemma":[0.00004745512,0.00014769661,0.00007735513,0.0002110456,0.00014894812,0.000100083125,0.00010780818,0.00025835095,0.0018882562],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013908473,0.0003136272,0.008588643,0.0000042065517,0.00011981551,0.00004373565,0.00012264187,0.0000011573258,0.9891949,0.00051496667,0.0007147007,0.00024247097],"study_design_scores_gemma":[0.002435326,0.00006725277,0.15441418,0.000009669967,0.000028497749,0.0007533843,0.000047653364,0.000002557823,0.8402551,0.00033034425,0.0014932002,0.00016283825],"about_ca_topic_score_codex":0.00067640113,"about_ca_topic_score_gemma":0.00011123319,"teacher_disagreement_score":0.14893985,"about_ca_system_score_codex":0.000020162704,"about_ca_system_score_gemma":0.000089748406,"threshold_uncertainty_score":0.9988889},"labels":[],"label_agreement":null},{"id":"W2560580245","doi":"10.1182/blood.v116.21.4471.4471","title":"Significant Discrepancy In Peripheral Blood Compared to Bone Marrow BCR-ABL Transcript Levels In Chronic Phase Chronic Myeloid Leukemia (CML)","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Imatinib mesylate; Imatinib; Myeloid leukemia; Medicine; Bone marrow; Philadelphia chromosome; Chronic myelogenous leukemia; Internal medicine; Leukemia; Cancer research; Chromosomal translocation; Immunology; Oncology; Biology; Genetics","score_opus":0.02024127394987327,"score_gpt":0.2851995279233199,"score_spread":0.2649582539734466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560580245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99174607,0.002186903,0.00003661956,0.0007085636,0.00041268687,0.0025242853,0.00016070882,0.00020991535,0.002014267],"genre_scores_gemma":[0.9943186,0.00012488135,0.002150779,0.00023031932,0.00073667,0.00053071155,0.00019009253,0.00016020199,0.0015577406],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9949579,0.000140011,0.0012596244,0.0013283895,0.00072127994,0.0015927671],"domain_scores_gemma":[0.9975391,0.00009715499,0.00018932289,0.0013737443,0.00008535464,0.00071530085],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00048366492,0.00079635857,0.0013934112,0.0005417804,0.00011875284,0.00006913979,0.00046548547,0.00041103177,0.0016237486],"category_scores_gemma":[0.00013264395,0.0007647672,0.0003072556,0.0009901844,0.00020779026,0.0002568131,0.00010848211,0.0014307748,0.00017294321],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052064995,0.0045909183,0.013262205,0.00040071754,0.00032080198,0.0024665112,0.0015866129,0.0001126054,0.9695784,0.00015918285,0.00021369451,0.0067877057],"study_design_scores_gemma":[0.30890882,0.007024725,0.18569438,0.0022578244,0.0019589975,0.00156963,0.0005002184,0.0034617388,0.4678581,0.00018320986,0.017835015,0.002747359],"about_ca_topic_score_codex":0.0025095022,"about_ca_topic_score_gemma":0.016059473,"teacher_disagreement_score":0.5017203,"about_ca_system_score_codex":0.00477822,"about_ca_system_score_gemma":0.0048669153,"threshold_uncertainty_score":0.9994803},"labels":[],"label_agreement":null},{"id":"W2560581580","doi":"10.1182/blood.v112.11.1176.1176","title":"Graft-Versus-Host Disease (Gvhd) Prophylaxis with Tacrolimus and Mycophenolate Mofetil (MMF) in 131 Matched Sibling Nonmyeloablative (NMA) Transplant Recipients: Long-Term Follow-up Confirms Extremely Low Incidence of Acute (a) Gvhd, High Incidence of Extensive Chronic (c) Gvhd and Favorable Disease Outcome.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Fleurimont; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Mucositis; Tacrolimus; Internal medicine; Fludarabine; Gastroenterology; Regimen; Transplantation; Methotrexate; Surgery; Toxicity; Graft-versus-host disease; Cyclophosphamide; Chemotherapy","score_opus":0.02607188366044243,"score_gpt":0.2812328357312887,"score_spread":0.25516095207084627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560581580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936934,0.0032120217,0.00012764965,0.00010874278,0.000108695356,0.0021198066,0.0005528682,0.00004346017,0.000033320965],"genre_scores_gemma":[0.99615467,0.002507218,0.00073329575,0.000034564237,0.00003563366,0.00016295936,0.00013658073,0.00006759361,0.00016751072],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99621624,0.00015937135,0.0008199141,0.0009575784,0.0010323176,0.0008145943],"domain_scores_gemma":[0.9970431,0.00033880392,0.0004194549,0.0006930913,0.00050392986,0.0010016371],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023883056,0.0005733782,0.0011323759,0.0004653203,0.00019573134,0.000033336084,0.00024678552,0.0001297077,0.00012747492],"category_scores_gemma":[0.00032581418,0.0004520247,0.00016711582,0.0007188219,0.00078304094,0.0004848207,0.00015674082,0.0004137015,0.000006842926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019193111,0.0012863053,0.95851004,0.0011456815,0.0010094322,0.011132136,0.0012877099,0.00002056212,0.0044488497,0.000010039908,0.0000014718385,0.0019546559],"study_design_scores_gemma":[0.037723683,0.0025105667,0.95133734,0.0009856562,0.0011182608,0.00011337818,0.00010430296,0.00024534308,0.0054193297,0.000041165375,4.5120947e-7,0.00040053076],"about_ca_topic_score_codex":0.0007723518,"about_ca_topic_score_gemma":0.00038755478,"teacher_disagreement_score":0.018530574,"about_ca_system_score_codex":0.0001874537,"about_ca_system_score_gemma":0.0008076504,"threshold_uncertainty_score":0.9997932},"labels":[],"label_agreement":null},{"id":"W2560603191","doi":"10.1182/blood.v108.11.809.809","title":"Gene Expression Differences between Low and High Stage Diffuse Large B Cell Lymphoma (DLBCL).","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Stage (stratigraphy); Gene expression profiling; CTGF; Biology; Diffuse large B-cell lymphoma; Cancer research; Gene expression; Gene; Lymphoma; Internal medicine; Oncology; Immunology; Medicine; Genetics; Growth factor","score_opus":0.005493859729586025,"score_gpt":0.20259203067240267,"score_spread":0.19709817094281665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560603191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997039,0.0020205465,0.0004031936,0.0000079954725,0.00004118646,0.00010028051,0.00021836258,0.000029848487,0.00013957695],"genre_scores_gemma":[0.99765533,0.00004448327,0.0006348013,0.00003332229,0.0004145388,0.0000151305485,0.00033476393,0.000025106816,0.00084252004],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99902576,0.00004656016,0.00017070577,0.0003596073,0.000133484,0.00026388685],"domain_scores_gemma":[0.9994831,0.000019055806,0.000078588695,0.00029516342,0.000026693875,0.000097414624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000051283103,0.00017150305,0.0001489941,0.000027889362,0.00010786855,0.000040620027,0.00016359283,0.00013741155,0.000016188706],"category_scores_gemma":[0.000016092608,0.00015086436,0.000049234422,0.000034452394,0.000051661602,0.0000036665658,0.00015342905,0.000033154283,0.0000069147845],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018428162,0.0022619618,0.18694359,0.000051077477,0.000021917727,0.000010683458,0.000014495006,0.000001094955,0.8102561,0.0000064323676,0.00022329303,0.00019088347],"study_design_scores_gemma":[0.004745713,0.000077695666,0.15366113,0.000018684563,0.0000434339,0.0000013044139,0.000011466987,0.0000021297008,0.84011453,0.000032933338,0.001108414,0.00018258524],"about_ca_topic_score_codex":0.000034818793,"about_ca_topic_score_gemma":0.000009557747,"teacher_disagreement_score":0.033282455,"about_ca_system_score_codex":0.0000034870088,"about_ca_system_score_gemma":0.000035010595,"threshold_uncertainty_score":0.615207},"labels":[],"label_agreement":null},{"id":"W2560612526","doi":"10.1182/blood.v120.21.731.731","title":"MLN9708, a Novel, Investigational Oral Proteasome Inhibitor, in Patients with Relapsed or Refractory Light-Chain Amyloidosis (AL): Results of a Phase 1 Study","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Tolerability; Internal medicine; Adverse effect; Proteasome inhibitor; Bortezomib; Pharmacodynamics; Refractory (planetary science); Phases of clinical research; Pharmacokinetics; Gastroenterology; Multiple myeloma; Clinical trial","score_opus":0.015701550948749286,"score_gpt":0.2670340245809415,"score_spread":0.2513324736321922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560612526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99776864,0.00015697641,0.000006648137,0.00018636529,0.000080644495,0.0015020084,0.00019526405,0.000020659689,0.00008279854],"genre_scores_gemma":[0.99736565,0.0000131480865,0.0014223685,0.0002058634,0.00009732139,0.00043928158,0.00026973966,0.000048830578,0.00013776676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979824,0.00014652286,0.0005627043,0.0004915743,0.00040995705,0.0004068807],"domain_scores_gemma":[0.9987266,0.000046856214,0.00036117868,0.0005259798,0.00014392337,0.00019546751],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032842477,0.00032253936,0.00036468045,0.00014819244,0.000060733888,0.000014942701,0.00019289012,0.00016460028,0.000014988447],"category_scores_gemma":[0.0004473066,0.00024198576,0.00007557623,0.00029471933,0.000095685646,0.000030429977,0.00012401376,0.00014370844,0.000006139625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027100008,0.034793127,0.90351063,0.000024479705,0.0003874508,0.000005908002,0.00065304176,0.0000032387138,0.056835257,0.000007167166,0.0007590577,0.00031065533],"study_design_scores_gemma":[0.093062036,0.012558405,0.6131279,0.00014074842,0.0003167161,0.000005134857,0.00036004288,0.0000022235452,0.27635142,0.000004370535,0.0034411247,0.0006298922],"about_ca_topic_score_codex":0.000088670306,"about_ca_topic_score_gemma":0.00013279567,"teacher_disagreement_score":0.29038274,"about_ca_system_score_codex":0.00004539854,"about_ca_system_score_gemma":0.00018208362,"threshold_uncertainty_score":0.98678935},"labels":[],"label_agreement":null},{"id":"W2560620586","doi":"10.1182/blood.v110.11.4987.4987","title":"Efficacy of Oral Ciprofloxacin Prophylaxis in BMT Recipients: A Case-Control Study.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Ciprofloxacin; Internal medicine; Neutropenia; Confounding; Antibiotic prophylaxis; Surgery; Antibiotics; Chemotherapy; Biology","score_opus":0.017930886292581386,"score_gpt":0.30628593932239917,"score_spread":0.2883550530298178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560620586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965485,0.00010408526,0.000044299257,0.000047680882,0.0001450913,0.0012865943,0.000007474964,0.00003405154,0.0017822416],"genre_scores_gemma":[0.9994804,0.0000025590814,0.00010925594,0.00006556185,0.00009287885,0.000046681133,0.0000011578529,0.000016280786,0.00018519958],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989735,0.00004885522,0.0003491049,0.00021454842,0.00018181873,0.00023219782],"domain_scores_gemma":[0.99940765,0.00006977036,0.000068650545,0.00028496745,0.000078713085,0.00009024632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004346987,0.00010797422,0.00029901954,0.00020165773,0.000036673122,0.0000054231164,0.000051009945,0.00005866324,0.00011661245],"category_scores_gemma":[0.00009767016,0.00009000469,0.00007266411,0.00048556644,0.000035991157,0.000043295757,0.000018825656,0.00020575116,0.000019371873],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093994115,0.0079653915,0.96022314,0.000037324447,0.00018116258,0.0033787333,0.00088426465,0.0000037663726,0.013394241,0.000031226384,0.000039056275,0.012921756],"study_design_scores_gemma":[0.029306734,0.003265273,0.95535207,0.00006361032,0.00034925202,0.00060037686,0.00046434585,0.0000013665823,0.01015102,0.000008784679,0.00032291966,0.00011427639],"about_ca_topic_score_codex":0.00046921498,"about_ca_topic_score_gemma":0.0008971302,"teacher_disagreement_score":0.028366793,"about_ca_system_score_codex":0.00004224708,"about_ca_system_score_gemma":0.00006492629,"threshold_uncertainty_score":0.36702845},"labels":[],"label_agreement":null},{"id":"W2560622290","doi":"10.1182/blood.v104.11.5156.5156","title":"Fludarabine and Busulfan (FluBuP Regimen) as Myeloablative Conditioning Regimen for Allogeneic PBSCT in 71 Leukemic Patients (A Unicenteric Study).","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Busulfan; Fludarabine; Mucositis; Gastroenterology; Regimen; Internal medicine; Surgery; Hemorrhagic cystitis; Transplantation; Cyclophosphamide; Toxicity; Chemotherapy; Hematopoietic stem cell transplantation","score_opus":0.014573127512305243,"score_gpt":0.29173611566313595,"score_spread":0.27716298815083074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560622290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947154,0.00035984913,0.000034606477,0.00060811656,0.000060785373,0.0028711471,0.000034109406,0.000069322494,0.0012466908],"genre_scores_gemma":[0.9968652,0.000095301286,0.001000774,0.00037335296,0.00011089748,0.00030604732,0.00021997966,0.00006655982,0.0009618741],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977486,0.00010687856,0.00046481684,0.00064591435,0.00043327577,0.00060048053],"domain_scores_gemma":[0.9987968,0.00012278672,0.00015202304,0.00044721543,0.0002387765,0.00024237833],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004231567,0.00029714647,0.0005168834,0.0003581039,0.0001637687,0.000038854418,0.00018873891,0.00014264841,0.000041699233],"category_scores_gemma":[0.0003881685,0.00027796463,0.00007404237,0.0004840994,0.00015122499,0.00020941783,0.00016208063,0.00038082132,0.000040652736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008441255,0.021646732,0.826411,0.0010822362,0.003743543,0.002617715,0.025347259,0.0003417326,0.092324086,0.0015661612,0.0027439317,0.013734337],"study_design_scores_gemma":[0.16065696,0.0118351765,0.79629874,0.0008342865,0.000811345,0.00030059143,0.004787118,0.00015470959,0.020566983,0.0014141165,0.0014440835,0.0008958731],"about_ca_topic_score_codex":0.00045846403,"about_ca_topic_score_gemma":0.00007547785,"teacher_disagreement_score":0.1522157,"about_ca_system_score_codex":0.00069718796,"about_ca_system_score_gemma":0.00054042565,"threshold_uncertainty_score":0.9999673},"labels":[],"label_agreement":null},{"id":"W2560624178","doi":"10.1182/blood.v108.11.3742.3742","title":"Effect of Cytosolic Hereditary Spherocytosis Mutations of Human Erythrocyte Anion Exchanger 1 on Its Interaction with Cytoskeletal Protein 4.2.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Band 3; Ankyrin; Cytoskeleton; Hereditary spherocytosis; Membrane protein; Red blood cell; Mutant protein; Mutant; Biology; Spherocytosis; Cytosol; Vesicle-associated membrane protein 8; Cell biology; Ankyrin repeat; Biochemistry; Molecular biology; Chemistry; Cell; Membrane; Enzyme; Genetics; Gene","score_opus":0.014427550175932185,"score_gpt":0.2720583728429189,"score_spread":0.2576308226669867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560624178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954783,0.00009601683,0.000049429887,0.00005681377,0.000097906166,0.0007613784,0.000020401389,0.00006644728,0.0033733326],"genre_scores_gemma":[0.9987312,0.0000056973117,0.00016266789,0.000037287613,0.00037431138,0.00009895519,0.0001808471,0.000033500364,0.0003755597],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988118,0.00013978948,0.00034171744,0.0002686065,0.0002513796,0.00018674495],"domain_scores_gemma":[0.9992095,0.000092695314,0.00024903895,0.00025004556,0.0001405586,0.000058130958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011340356,0.00020665354,0.00046084152,0.00016901807,0.000068901114,0.0000038959797,0.000051718795,0.00012788994,0.000246157],"category_scores_gemma":[0.00003271221,0.00015760078,0.00013225226,0.0002555328,0.00009182553,0.0000936001,0.000018244325,0.00019861812,0.000032760898],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001593142,0.0011405827,0.0016948878,0.00071472675,0.00013996482,0.000038287253,0.00010117487,0.000043028947,0.99359065,0.00011338564,0.000173294,0.00065689185],"study_design_scores_gemma":[0.005685176,0.015545806,0.0115442695,0.00048672964,0.00034446892,0.00013332463,0.00006051625,0.000025703714,0.9658981,0.000020561922,0.00011853353,0.00013679033],"about_ca_topic_score_codex":0.00015773835,"about_ca_topic_score_gemma":0.000065928936,"teacher_disagreement_score":0.027692514,"about_ca_system_score_codex":0.000030737945,"about_ca_system_score_gemma":0.000036828,"threshold_uncertainty_score":0.6426773},"labels":[],"label_agreement":null},{"id":"W2560627052","doi":"10.1182/blood.v116.21.1566.1566","title":"Stromal Cell Regulation of Murine Hematopoietic Stem Cells.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Terry Fox Research Institute","funders":"","keywords":"Haematopoiesis; Stem cell; Stromal cell; In vivo; Biology; Cell biology; Cell division; Myeloid; Immunology; In vitro; Bone marrow; Molecular biology; Cell; Cancer research; Genetics","score_opus":0.009391628578586055,"score_gpt":0.22349453908530006,"score_spread":0.214102910506714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560627052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98969656,0.000041239884,0.00030378337,0.000066755565,0.00018974047,0.0003204629,0.000010134169,0.00006124111,0.009310072],"genre_scores_gemma":[0.9948893,0.00000869633,0.003821132,0.00001923701,0.00009273678,0.000009419948,0.00001898189,0.000025877891,0.0011145714],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989585,0.000019915744,0.00034934568,0.00019910712,0.00030030173,0.00017281195],"domain_scores_gemma":[0.9992583,0.000061028015,0.00011948028,0.00036405982,0.00008699912,0.00011015409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014883961,0.00012418027,0.00025556944,0.00008653727,0.000026254427,0.0000064821447,0.00007114883,0.00012266479,0.00037464945],"category_scores_gemma":[0.000004331407,0.00011461909,0.00008224271,0.00013331846,0.000050883456,0.000043490763,0.000012020007,0.00017298266,0.00007549992],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034857276,0.00056033797,0.009634197,0.00077278423,0.000023674014,0.000021380232,0.0004626338,0.0000022707027,0.98785716,0.0004229908,0.00004972871,0.00015795293],"study_design_scores_gemma":[0.0030812055,0.00016725017,0.019875454,0.000091336864,0.00027210204,0.00018680796,0.00009440998,0.000058769427,0.975858,0.000056983834,0.000160821,0.000096871336],"about_ca_topic_score_codex":0.000009958687,"about_ca_topic_score_gemma":0.0000049525556,"teacher_disagreement_score":0.011999203,"about_ca_system_score_codex":0.0000054340544,"about_ca_system_score_gemma":0.00005807233,"threshold_uncertainty_score":0.46740308},"labels":[],"label_agreement":null},{"id":"W2560645318","doi":"10.1182/blood.v116.21.3567.3567","title":"Rituximab Purging and Maintenance Improves Progression Free Survival but Not Overall Survival In Patients with Relapsed or Resistant Follicular Lymphoma Prior Receiving An Autologous Transplant","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Follicular lymphoma; Maintenance therapy; Chemotherapy; Rituximab; Internal medicine; Surgery; Progression-free survival; Chemotherapy regimen; Lymphoma; Transplantation; Clinical endpoint; Gastroenterology; Autologous stem-cell transplantation; Oncology; Clinical trial","score_opus":0.007361580718688364,"score_gpt":0.22749481188854798,"score_spread":0.2201332311698596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560645318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980278,0.00012201642,0.00000410135,0.00029144756,0.00019016473,0.0010330573,0.00007510701,0.000100091784,0.00015623671],"genre_scores_gemma":[0.99631226,0.000059118745,0.003212694,0.00006741566,0.000056468736,0.000113794275,0.00006844008,0.00005136296,0.000058440437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99778134,0.00009218386,0.00040243365,0.0006535923,0.0005357545,0.0005346982],"domain_scores_gemma":[0.99874425,0.00014272823,0.00016050103,0.0006069826,0.00009656576,0.00024894363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034010885,0.00034371138,0.00064262166,0.00011494917,0.00015461615,0.00006528458,0.00015288034,0.00018665858,0.000012192596],"category_scores_gemma":[0.00015328749,0.00021296712,0.00006769269,0.00014092337,0.00010648591,0.00018950686,0.00005799346,0.00017838128,0.000001958133],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0072375727,0.009010053,0.94855934,0.00018675017,0.00020654598,0.0018296542,0.000524527,2.7348517e-7,0.0118480725,0.00021085527,0.0000071065147,0.020379227],"study_design_scores_gemma":[0.067570195,0.002262513,0.9212164,0.00066426507,0.0002969713,0.000092976356,0.00006412724,0.000047510533,0.0073750024,0.000022281018,0.00009597322,0.00029173782],"about_ca_topic_score_codex":0.0004937415,"about_ca_topic_score_gemma":0.0018486409,"teacher_disagreement_score":0.06033262,"about_ca_system_score_codex":0.00008220059,"about_ca_system_score_gemma":0.00020217731,"threshold_uncertainty_score":0.8684547},"labels":[],"label_agreement":null},{"id":"W2560656584","doi":"10.1182/blood.v110.11.309.309","title":"Once Daily YM150, an Oral Direct Factor Xa Inhibitor, for Prevention of Venous Thromboembolism in Patients Undergoing Elective Primary Hip Replacement.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton General Hospital","funders":"","keywords":"Medicine; Clinical endpoint; Surgery; Deep vein; Venography; Incidence (geometry); Thrombosis; Adverse effect; Venous thrombosis; Intention-to-treat analysis; Randomized controlled trial; Internal medicine","score_opus":0.018265091858778434,"score_gpt":0.2861262333802319,"score_spread":0.26786114152145346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560656584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99377346,0.00018247918,0.0003368314,0.000030728348,0.00028484716,0.0020742342,0.000020002828,0.000061224855,0.003236175],"genre_scores_gemma":[0.99716353,0.00007262923,0.0020317903,0.00019857385,0.0001458611,0.0000715859,0.00014793417,0.000048592607,0.0001194864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99800265,0.00006596048,0.0005904005,0.00046621388,0.00039592682,0.0004788654],"domain_scores_gemma":[0.9989671,0.00012469194,0.00027386236,0.00035693342,0.00015723312,0.00012017103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005384365,0.00022524511,0.00074370916,0.00024691055,0.00008194072,0.000017260509,0.00011404166,0.0001225615,0.000024273064],"category_scores_gemma":[0.00014535413,0.00022433729,0.00013110631,0.00026502443,0.0000404475,0.00022769884,0.00006813332,0.00014041334,0.0000033552276],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004453186,0.12780608,0.67098916,0.004048597,0.002710631,0.000044258944,0.012000133,0.000049271497,0.055409703,0.0017789871,0.002801725,0.11790825],"study_design_scores_gemma":[0.012056273,0.008129247,0.9205287,0.00048305027,0.00046282957,0.0000014158366,0.00030311072,0.000007805999,0.05699579,0.0003248192,0.00044649903,0.00026046197],"about_ca_topic_score_codex":0.00010892622,"about_ca_topic_score_gemma":0.00025196254,"teacher_disagreement_score":0.24953951,"about_ca_system_score_codex":0.00023638185,"about_ca_system_score_gemma":0.00012893793,"threshold_uncertainty_score":0.9148209},"labels":[],"label_agreement":null},{"id":"W2560676248","doi":"10.1182/blood.v110.11.2691.2691","title":"Zinc Enhances the Protection of Fibrin-Bound Thrombin from Antithro Inhibition.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Blood properties and coagulation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Chemistry; Ternary complex; Fibrin; Thrombin; Antithrombin; Binding site; Fibrinogen; Heparin; Molecular biology; Biophysics; Biochemistry; Stereochemistry; Enzyme; Platelet; Immunology; Biology","score_opus":0.02142447492606499,"score_gpt":0.24586592349128925,"score_spread":0.22444144856522424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560676248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99546534,0.000792443,0.00064677227,0.00051254,0.00009684391,0.000358097,0.0000035419541,0.000033566608,0.0020908758],"genre_scores_gemma":[0.9990646,0.00003518955,0.00029708794,0.00010376179,0.00027629075,0.000008814335,0.000010806668,0.000009223051,0.00019419185],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993613,0.000018754798,0.00019971564,0.00012350139,0.00018570453,0.000111039706],"domain_scores_gemma":[0.9996132,0.000026129948,0.000085219755,0.00017867914,0.00007008337,0.00002664194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018569635,0.00006925881,0.00013005632,0.00002847445,0.0000823653,0.000011930628,0.00003220139,0.00005977166,0.00012216042],"category_scores_gemma":[0.000027565653,0.000043921398,0.000050066184,0.00012904787,0.000075768505,0.000066146895,0.000018391178,0.0000913681,0.000018521929],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000112212205,0.00034564696,0.004018955,0.000044273158,0.00009367013,0.0000046216737,0.00040484327,0.000001277193,0.989771,0.00022163862,0.00008484233,0.0048970054],"study_design_scores_gemma":[0.0010761422,0.00028477487,0.10970814,0.00011146418,0.00013713994,0.000021630502,0.00019287918,0.000016430668,0.8870388,0.000710364,0.0006498836,0.00005230515],"about_ca_topic_score_codex":0.0006624298,"about_ca_topic_score_gemma":0.000113125374,"teacher_disagreement_score":0.10568918,"about_ca_system_score_codex":0.00000788478,"about_ca_system_score_gemma":0.000028739878,"threshold_uncertainty_score":0.17910627},"labels":[],"label_agreement":null},{"id":"W2560681657","doi":"10.1182/blood.v120.21.1221.1221","title":"The Hemoglobin-Haptoglobin Receptor (CD163) Is Expressed by a Subpopulation of Erythroid and Granulo-Macrophagic Progenitors and Can Be Stimulated in Vitro and in Vivo by Physiological and Pharmacological Ligands to Stimulate Hematopoiesis","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobin structure and function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Therapure Biopharma (Canada)","funders":"","keywords":"Biology; Haematopoiesis; CD34; Population; Progenitor cell; CD163; Molecular biology; Bone marrow; Stem cell; Immunology; Cell biology; Medicine; In vitro; Macrophage; Biochemistry","score_opus":0.007972345390810072,"score_gpt":0.24336677173339313,"score_spread":0.23539442634258306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560681657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957307,0.0033886884,0.000011267133,0.0002113558,0.000046876565,0.00044813528,0.00014718481,0.000008905122,0.000006909374],"genre_scores_gemma":[0.9987957,0.0006494225,0.00014835948,0.0002319047,0.000050479146,0.0000348822,0.000058125035,0.000013277851,0.000017851968],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99885476,0.000080420876,0.00027887977,0.0003713592,0.00010299022,0.0003115813],"domain_scores_gemma":[0.9995742,0.000041870342,0.000077972516,0.000117905634,0.00003248776,0.00015556224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001855147,0.00021132415,0.0002683475,0.000038361766,0.00009091196,0.000026581689,0.000062839325,0.00021913099,0.000006254425],"category_scores_gemma":[0.00005641754,0.00015486691,0.000025502994,0.0001353132,0.00015716277,0.000013132034,0.00011987992,0.00010687552,1.3664872e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004730218,0.00014445643,0.025958108,0.000024751218,0.00003687098,8.3499083e-7,0.0001678175,0.0000029028317,0.97186214,0.0000015493437,0.0007652528,0.0005622851],"study_design_scores_gemma":[0.002313792,0.0002944641,0.010783528,0.000012029196,0.00004593354,0.000014574439,0.00007560065,0.00007356295,0.98536754,0.000031912146,0.0007952147,0.00019188107],"about_ca_topic_score_codex":0.00006690865,"about_ca_topic_score_gemma":0.000012457824,"teacher_disagreement_score":0.01517458,"about_ca_system_score_codex":0.000009998754,"about_ca_system_score_gemma":0.000011329771,"threshold_uncertainty_score":0.6315289},"labels":[],"label_agreement":null},{"id":"W2560682240","doi":"10.1182/blood.v120.21.1958.1958","title":"Long Term Outcomes of Hematopoietic Stem Cell Transplantation in Patients with Severe Phenotype Hurler Syndrome: an International Multi-Center Study","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre","funders":"","keywords":"Hurler syndrome; Medicine; Hematopoietic stem cell transplantation; Transplantation; Mucopolysaccharidosis type I; Mucopolysaccharidosis I; Internal medicine; Mucopolysaccharidosis; Proportional hazards model; Pediatrics; Disease; Enzyme replacement therapy","score_opus":0.02337610262382519,"score_gpt":0.290183323992578,"score_spread":0.26680722136875284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560682240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988442,0.000030110381,0.000023268574,0.000011400783,0.00006270062,0.00080358185,0.00001953023,0.00001594386,0.00018928094],"genre_scores_gemma":[0.9995885,0.000003961655,0.00013312305,0.00001787802,0.000009565582,0.000024294513,0.00008374713,0.000023337354,0.000115585965],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988225,0.000055592187,0.00022851182,0.0001712918,0.00050496164,0.00021710702],"domain_scores_gemma":[0.99952966,0.000018328563,0.00006367842,0.00019656715,0.00009562738,0.00009615458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010768808,0.00012061901,0.00022968091,0.00013974222,0.000018811745,0.0000091089005,0.00012035115,0.000044762597,0.00009252716],"category_scores_gemma":[0.000004900169,0.00009091651,0.000031187457,0.0001182432,0.00002344257,0.00026504596,0.000023262606,0.00012150616,0.000015989754],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026859707,0.026273819,0.9685861,0.00016033319,0.0001250064,0.000055758515,0.00414427,0.0000012903892,0.000043686097,0.000001107594,6.3945276e-7,0.0003394024],"study_design_scores_gemma":[0.023894254,0.00066708087,0.97444326,0.000062834144,0.00010326545,0.000024154946,0.00048446225,0.0000032649825,0.00022143302,2.1813382e-7,5.4009814e-7,0.000095261326],"about_ca_topic_score_codex":0.000037230722,"about_ca_topic_score_gemma":0.00005961767,"teacher_disagreement_score":0.025606737,"about_ca_system_score_codex":0.000033461318,"about_ca_system_score_gemma":0.000022527494,"threshold_uncertainty_score":0.37074676},"labels":[],"label_agreement":null},{"id":"W2560700254","doi":"10.1182/blood.v104.11.1529.1529","title":"The Hox a Locus Is Strongly Targeted by MMLV in an E2a-PBX1 Induced B-Cell Leukemia Model.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Institute for Research in Immunology and Cancer","funders":"","keywords":"Molecular biology; Biology; Locus (genetics); Transgene; Genetically modified mouse; Gene; Cancer research; Genetics","score_opus":0.010582588758458805,"score_gpt":0.2272948701050966,"score_spread":0.2167122813466378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560700254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962807,0.0013527008,0.00024519613,0.000120114004,0.000039520623,0.00024536822,0.00006772032,0.000018409959,0.0016302575],"genre_scores_gemma":[0.9986001,0.000100800244,0.00043621965,0.0002827506,0.00009834958,0.000054134605,0.00010323039,0.00002976997,0.00029460847],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988892,0.000051219657,0.00019798022,0.00035843212,0.00013485659,0.00036829908],"domain_scores_gemma":[0.9993346,0.0000055627115,0.000065073735,0.0004404704,0.00004574732,0.000108585264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016152555,0.00017818961,0.000120042765,0.00002365083,0.00011317002,0.000046559137,0.00032091717,0.0002213131,0.000008872616],"category_scores_gemma":[0.000022131331,0.00014629135,0.00006424739,0.00008906348,0.00004637075,0.0000060959655,0.00008496253,0.00018681548,0.000015999178],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000429886,0.00025133003,0.00024978057,0.00000733775,0.000018222403,0.0000045739453,0.00015539002,0.0003767014,0.99793565,0.00005149563,0.0003546028,0.0005519463],"study_design_scores_gemma":[0.002725244,0.00041128704,0.000067903326,0.000008009206,0.000013999802,0.0000049814016,0.000084971005,0.00029848784,0.99404347,0.00030161123,0.0018235167,0.00021651262],"about_ca_topic_score_codex":0.000105938336,"about_ca_topic_score_gemma":0.00016910487,"teacher_disagreement_score":0.003892155,"about_ca_system_score_codex":0.000027765615,"about_ca_system_score_gemma":0.00026365128,"threshold_uncertainty_score":0.5965588},"labels":[],"label_agreement":null},{"id":"W2560705311","doi":"10.1182/blood.v126.23.428.428","title":"Outcomes of Low-Molecular-Weight Heparintreatment for Venous Thromboembolism in Patients with Primary and Metastatic Brain Tumors","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Joseph’s Healthcare Hamilton; St. Joseph's Hospital; McMaster University","funders":"","keywords":"Medicine; Retrospective cohort study; Cancer; Internal medicine; Thrombosis; Incidence (geometry); Cohort; Venous thrombosis; Brain metastasis; Confidence interval; Low molecular weight heparin; Deep vein; Surgery; Metastasis","score_opus":0.009987878774972014,"score_gpt":0.24058765871530413,"score_spread":0.23059977994033212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560705311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99673533,0.0002928862,0.00007348673,0.00044010984,0.00004213326,0.0016693032,0.000022105116,0.000020495962,0.0007041489],"genre_scores_gemma":[0.9963819,0.000015214926,0.00260005,0.0007011357,0.000012388997,0.00014976326,0.000071325136,0.000032298292,0.00003592228],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886113,0.000030981293,0.0002923765,0.00026625022,0.00029418967,0.00025505654],"domain_scores_gemma":[0.99931735,0.000061991894,0.000114917115,0.00026418408,0.00009580863,0.0001457637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016535661,0.00019004678,0.00086916203,0.00012658682,0.00002096652,0.000010101986,0.0000631045,0.000031015003,0.0000050040944],"category_scores_gemma":[0.00006351769,0.00013660216,0.000059740527,0.00011042519,0.000058905378,0.00005432316,0.000059234913,0.000052344898,0.0000021385624],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031449762,0.024811473,0.9647765,0.000927486,0.0017683812,0.00012954701,0.0015832067,0.000019794874,0.0001392837,0.0020796293,0.00061689777,0.0028332728],"study_design_scores_gemma":[0.01784817,0.0025989113,0.97663134,0.0001682001,0.00086690375,0.0000043590603,0.000094935414,0.000006769337,0.0011989125,0.0003179155,0.000113677364,0.00014989778],"about_ca_topic_score_codex":0.000097410906,"about_ca_topic_score_gemma":0.000024816836,"teacher_disagreement_score":0.022212561,"about_ca_system_score_codex":0.00005218904,"about_ca_system_score_gemma":0.00009590984,"threshold_uncertainty_score":0.5570474},"labels":[],"label_agreement":null},{"id":"W2560706611","doi":"10.1182/blood.v108.11.3547.3547","title":"Lenalidomide Plus High-Dose Dexamethasone Provides Improved Overall Survival Compared to High-Dose Dexamethasone Alone for Relapsed or Refractory Multiple Myeloma (MM): Results of 2 Phase III Studies (MM-009, MM-010) and Subgroup Analysis of Patients with Impaired Renal Function.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Lenalidomide; Dexamethasone; Medicine; Placebo; Refractory (planetary science); Multiple myeloma; Internal medicine; Randomization; Phases of clinical research; Gastroenterology; Corticosteroid; Urology; Toxicity; Randomized controlled trial; Pathology; Biology","score_opus":0.03302685785422914,"score_gpt":0.2975950705888775,"score_spread":0.26456821273464837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560706611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99067134,0.0008584455,0.0009408503,0.00013650184,0.00012252401,0.004516853,0.0026347956,0.000108630324,0.000010060893],"genre_scores_gemma":[0.9738928,0.000084108164,0.0218782,0.00004235466,0.00014947604,0.00050079415,0.002859236,0.00009824446,0.0004947628],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9945679,0.00037456106,0.001702727,0.0012227593,0.0011906365,0.00094145734],"domain_scores_gemma":[0.9935203,0.0023280447,0.0010314081,0.0010597243,0.0014978402,0.000562687],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009773895,0.0007384452,0.0027995745,0.0010276483,0.00025731573,0.00004517006,0.00024042244,0.0002281754,0.00003071394],"category_scores_gemma":[0.0022381374,0.00052598154,0.00037404904,0.001435242,0.00041428406,0.00031424357,0.0001880819,0.00029669647,0.0000020271334],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6358464,0.026892902,0.13767523,0.0012154353,0.034376115,0.00021776395,0.0012686658,0.00058496714,0.15188956,0.000028189146,0.000850074,0.009154744],"study_design_scores_gemma":[0.34400296,0.016627368,0.5963699,0.00034837594,0.009679467,0.000005889667,0.00038390924,0.0025095677,0.029351939,0.000030123436,0.00011261465,0.00057783275],"about_ca_topic_score_codex":0.00941641,"about_ca_topic_score_gemma":0.007966228,"teacher_disagreement_score":0.45869473,"about_ca_system_score_codex":0.00029700197,"about_ca_system_score_gemma":0.00038602395,"threshold_uncertainty_score":0.9997192},"labels":[],"label_agreement":null},{"id":"W2560711903","doi":"10.1182/blood.v104.11.4917.4917","title":"Weekly Cyclophosphamide and Alternate Day Prednisone: An Effective, Convenient and Well Tolerated Treatment for Relapsed Multiple Myeloma Following Autologous Stem Cell Transplant.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Discontinuation; Prednisone; Cyclophosphamide; Multiple myeloma; Regimen; Surgery; Internal medicine; Transplantation; Autologous stem-cell transplantation; Gastroenterology; Chemotherapy","score_opus":0.012781175069763851,"score_gpt":0.26063540561940984,"score_spread":0.247854230549646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560711903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938068,0.0018719,0.00021408031,0.00012163221,0.000115275856,0.003338465,0.00015325125,0.00014027463,0.000238371],"genre_scores_gemma":[0.9967796,0.00033943346,0.0014593006,0.000047055488,0.000048052203,0.00051566435,0.00023762418,0.000055127297,0.0005181051],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99814713,0.000090288544,0.00029774665,0.0006595395,0.00023629484,0.0005689803],"domain_scores_gemma":[0.9988191,0.00023906448,0.00007677602,0.00030055802,0.000053302327,0.00051120203],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015828815,0.0003669602,0.0005603762,0.00011025316,0.00022939492,0.000053856715,0.00007034657,0.00014672587,0.00000698486],"category_scores_gemma":[0.000015684074,0.00028815732,0.00012761442,0.0000962165,0.00007400551,0.00012841956,0.000023474468,0.0001200969,0.000010169288],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0095361415,0.011801947,0.699117,0.00088444806,0.0037635893,0.007253517,0.008664622,0.00011263255,0.17586444,0.000063202424,0.000030001007,0.082908474],"study_design_scores_gemma":[0.1642825,0.014115005,0.2986678,0.0003739454,0.001569569,0.0005142481,0.0003178927,0.0020125746,0.5169015,0.00007482592,0.0006223584,0.0005477895],"about_ca_topic_score_codex":0.0004394989,"about_ca_topic_score_gemma":0.00011742011,"teacher_disagreement_score":0.4004492,"about_ca_system_score_codex":0.00012761533,"about_ca_system_score_gemma":0.00009080691,"threshold_uncertainty_score":0.9999571},"labels":[],"label_agreement":null},{"id":"W2560713193","doi":"10.1182/blood.v106.11.3005.3005","title":"c-MYC Is a Major Downstream Target of NOTCH in T-Cell Acute Lymphoblastic Leukemia.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; BC Cancer Agency","funders":"","keywords":"Notch signaling pathway; Biology; Cell growth; Cancer research; Cell biology; Signal transduction; Cell culture; Notch proteins; Genetics","score_opus":0.003116888826433206,"score_gpt":0.20561113165247094,"score_spread":0.20249424282603773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560713193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967075,0.0011611945,0.00018831491,0.000107325584,0.00005657254,0.00014261503,0.000047797166,0.000008637301,0.0015800215],"genre_scores_gemma":[0.9967929,0.00016322028,0.0016484611,0.00009435763,0.000201068,0.000014946716,0.00009563626,0.000020590742,0.0009688111],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99914515,0.000019897274,0.00024388894,0.0002738574,0.000115022835,0.00020216944],"domain_scores_gemma":[0.99951094,0.00000669524,0.000095542964,0.00029274792,0.000045015182,0.000049070677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006109404,0.00013096213,0.00015108184,0.00006332719,0.000018483617,0.0000064305427,0.00012510974,0.0001925232,0.00006336559],"category_scores_gemma":[0.000012245892,0.00013706886,0.00007907396,0.00013792486,0.000038013568,0.0000037451332,0.000054474247,0.00005556706,0.00002547649],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006493655,0.0002277894,0.0024778415,0.000020293355,0.000076929915,0.0000024085796,0.00007039593,0.00094624376,0.9935293,0.0000038668213,0.0012703527,0.0013096427],"study_design_scores_gemma":[0.003035884,0.00015088436,0.0026312696,0.00001856635,0.00007959418,0.000019079322,0.000010959344,0.00041649787,0.987449,0.000019501778,0.0060156896,0.0001530738],"about_ca_topic_score_codex":0.000046323614,"about_ca_topic_score_gemma":0.00007197906,"teacher_disagreement_score":0.006080299,"about_ca_system_score_codex":0.000048916452,"about_ca_system_score_gemma":0.00018961889,"threshold_uncertainty_score":0.55895054},"labels":[],"label_agreement":null},{"id":"W2560717368","doi":"10.1182/blood.v110.11.705.705","title":"Low Cytosolic Non-Heme Iron Levels in Erythroid Cells Prevent IRP2-Mediated Ferritin Upregulation during Differentiation.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Ferritin; Transferrin receptor; Heme; Biochemistry; Chemistry; Cytosol; Ferric; Cell biology; Transferrin; Biology; Enzyme; Inorganic chemistry","score_opus":0.00695372562895087,"score_gpt":0.2283573607227164,"score_spread":0.22140363509376554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560717368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973334,0.00027207215,0.0016633024,0.000044344844,0.00008119287,0.00024265278,0.000025590707,0.000012860431,0.00032458533],"genre_scores_gemma":[0.998678,0.00012118827,0.00019622479,0.00003285947,0.00021366861,0.000034292985,0.00019067398,0.000021464735,0.0005115816],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99901396,0.000025556286,0.0002780135,0.0002998987,0.00012396435,0.00025861987],"domain_scores_gemma":[0.9994973,0.000007744523,0.00009544924,0.00029139328,0.0000449783,0.000063116866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013678326,0.0001320422,0.00011050355,0.00006716093,0.00006649104,0.000020657742,0.00011737938,0.00014225718,0.000040316863],"category_scores_gemma":[0.000014302993,0.0001398272,0.00005644055,0.000117466276,0.000025883557,0.0000069759453,0.0000456222,0.000073975345,0.000014531267],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018101815,0.0003936629,0.005649452,0.000030855022,0.000016844098,0.000002136556,0.000060752198,0.00015308268,0.99328727,0.000006860256,0.000048350063,0.00033265786],"study_design_scores_gemma":[0.0009982347,0.000034704488,0.34383062,0.000020383444,0.000011239461,0.00000281301,0.000022405453,0.000051333715,0.65475684,0.000011419181,0.00014091448,0.00011909776],"about_ca_topic_score_codex":0.000021422495,"about_ca_topic_score_gemma":0.00020691603,"teacher_disagreement_score":0.3385304,"about_ca_system_score_codex":0.000028016027,"about_ca_system_score_gemma":0.00003657093,"threshold_uncertainty_score":0.5701988},"labels":[],"label_agreement":null},{"id":"W2560731263","doi":"10.1182/blood.v112.11.4481.4481","title":"Deregulated Expression of Ubiquitin-Specific Peptidase Genes in Myeloid Leukemia","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Myeloid leukemia; Biology; Deubiquitinating enzyme; RUNX1; Transcription factor; Gene; RUNX1T1; Chromosomal translocation; Leukemia; Myeloid; Ubiquitin; Cancer research; Mdm2; Fusion gene; Molecular biology; Genetics","score_opus":0.01721438007755645,"score_gpt":0.2204346415641006,"score_spread":0.20322026148654415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560731263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99379295,0.0036517563,0.0000780383,0.000011720004,0.000035701472,0.0001581047,0.00001622453,0.000014027222,0.002241456],"genre_scores_gemma":[0.9971601,0.0010711688,0.0012136543,0.000032817123,0.00011770668,0.000022418844,0.000079474674,0.00002069483,0.00028197397],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990863,0.00006215024,0.00024283337,0.00027558158,0.00011763108,0.00021551158],"domain_scores_gemma":[0.9994777,0.000009027707,0.000082449245,0.00031515682,0.000052758176,0.000062924286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009989212,0.00013518649,0.00016352125,0.000056382796,0.000051657178,0.0000044619896,0.00015935165,0.00016354282,0.000058574788],"category_scores_gemma":[0.000020279796,0.00012960393,0.00007191628,0.00010110679,0.000084640444,0.0000032664793,0.00009181492,0.00008520942,0.000011251832],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054818098,0.00014764456,0.0050427807,0.000025396963,0.000008802162,0.000024905672,0.00010652662,0.000014442264,0.9932071,0.000022512872,0.00032081563,0.0010242871],"study_design_scores_gemma":[0.0014852308,0.00014440702,0.009623423,0.000045734887,0.000004862662,0.00006723862,0.000040711675,0.000003309904,0.9825732,0.000030327315,0.0058273748,0.00015419383],"about_ca_topic_score_codex":0.000014831941,"about_ca_topic_score_gemma":0.000008389064,"teacher_disagreement_score":0.010633881,"about_ca_system_score_codex":0.000008483968,"about_ca_system_score_gemma":0.00009827124,"threshold_uncertainty_score":0.5285095},"labels":[],"label_agreement":null},{"id":"W2560740663","doi":"10.1182/blood.v112.11.3655.3655","title":"NR2F6 Initiates Myelodysplasia and Acute Leukemia by Promoting Stem Cell Self-Renewal","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Stem cell; Leukemia; Medicine; Biology; Cancer research; Internal medicine; Gerontology; Oncology; Genetics","score_opus":0.006440546198141961,"score_gpt":0.21817216950171578,"score_spread":0.2117316233035738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560740663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955186,0.0014926952,0.000013366407,0.0000368986,0.00003981996,0.00018994646,0.000040236064,0.000041177536,0.0026272212],"genre_scores_gemma":[0.9969004,0.0005757792,0.0004161563,0.000052674324,0.00017061947,0.00002803523,0.00010014216,0.00003864414,0.0017175584],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987246,0.000093082286,0.00020457087,0.0004186823,0.00019813949,0.00036096398],"domain_scores_gemma":[0.9994161,0.000017921742,0.00006551998,0.00026127117,0.00006535433,0.00017381324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016269967,0.0001797831,0.00015304562,0.00004071128,0.00019570677,0.000024241339,0.00016001503,0.00019173691,0.000007820425],"category_scores_gemma":[0.000018214816,0.00018066893,0.00005329627,0.000088216424,0.000104068284,0.0000057397647,0.0001587866,0.00016095067,0.00002690494],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001682759,0.00017227813,0.0018205702,0.000036985788,0.00008762176,0.00008408902,0.0003201022,5.580809e-7,0.99273825,0.0000015516252,0.0044777174,0.00024344522],"study_design_scores_gemma":[0.0013224971,0.00031326132,0.00011797038,0.000011061848,0.000041931213,0.00032294847,0.000038020895,0.000024450752,0.9908172,0.000002453979,0.00677967,0.0002085309],"about_ca_topic_score_codex":0.000022906223,"about_ca_topic_score_gemma":0.0000076055408,"teacher_disagreement_score":0.0023019523,"about_ca_system_score_codex":0.000025516434,"about_ca_system_score_gemma":0.00020245576,"threshold_uncertainty_score":0.7367465},"labels":[],"label_agreement":null},{"id":"W2560745335","doi":"10.1182/blood.v110.11.1443.1443","title":"Polymorphisms in Multidrug Resistance-Associated Protein Genes Are Associated with Worse Outcome in Childhood Acute Lymphoblastic Leukemia.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Haplotype; Biology; Allele; Single-nucleotide polymorphism; Linkage disequilibrium; Gene; Drug resistance; Multidrug Resistance-Associated Proteins; Genetics; Genotype; Cancer research; ATP-binding cassette transporter; Transporter","score_opus":0.008889091299081334,"score_gpt":0.2235178495985078,"score_spread":0.21462875829942646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560745335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99671453,0.00057168264,0.00007860304,0.00023689281,0.00009519824,0.0012759158,0.0000531752,0.00019342134,0.00078059203],"genre_scores_gemma":[0.9943917,0.000027777089,0.0007716204,0.00018116509,0.000058627465,0.00008689947,0.00012166191,0.00009475447,0.0042658322],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968043,0.0000692092,0.0008786758,0.00060315995,0.0006743011,0.00097035785],"domain_scores_gemma":[0.9987902,0.00008703503,0.00037017078,0.00039796458,0.0001097615,0.00024488356],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00079629046,0.0004434263,0.0009391266,0.0004897898,0.00009519794,0.000021884818,0.00020597561,0.00036595244,0.00003375626],"category_scores_gemma":[0.00018728098,0.00036292124,0.00014552292,0.0012931352,0.00009387445,0.00011452311,0.000024897301,0.0004992969,0.00001564094],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010242576,0.004134747,0.96530104,0.0000796575,0.00048880914,0.00863547,0.0010079419,0.000022342208,0.018982101,0.000087343455,0.000014281741,0.0002220026],"study_design_scores_gemma":[0.02110782,0.00017309452,0.9552514,0.0021790399,0.00037153813,0.000021861137,0.0003417495,0.000015891897,0.019958273,0.000079369725,0.000033999222,0.00046596554],"about_ca_topic_score_codex":0.00015723557,"about_ca_topic_score_gemma":0.022548992,"teacher_disagreement_score":0.022391757,"about_ca_system_score_codex":0.0006957686,"about_ca_system_score_gemma":0.0003378508,"threshold_uncertainty_score":0.9998823},"labels":[],"label_agreement":null},{"id":"W2560761889","doi":"10.1182/blood.v126.23.5140.5140","title":"High Prevalence of Peripheral Artery Occlusive Disease (PAOD) Among Patients with Chronic Myeloid Leukemia (CML) Receiving Tyrosine Kinase Inhibitors (TKIs): A Cross-Sectional Study","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Nilotinib; Internal medicine; Dasatinib; Diabetes mellitus; Population; Imatinib; Coronary artery disease; Myeloid leukemia; Imatinib mesylate; Surgery; Gastroenterology","score_opus":0.011089586736931367,"score_gpt":0.24601862072024425,"score_spread":0.23492903398331288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560761889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99654365,0.00063278223,0.000011999545,0.000017708637,0.00037554096,0.0020447276,0.00015651104,0.00012115595,0.000095941476],"genre_scores_gemma":[0.99803406,0.000019579425,0.00022241607,0.000033195913,0.0005212838,0.00018728008,0.00017374531,0.00008380881,0.0007246348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965001,0.00012302605,0.00072480674,0.00083578133,0.0012600815,0.0005562137],"domain_scores_gemma":[0.9974389,0.00007150354,0.00040840424,0.0008199978,0.0005927575,0.00066844845],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027175923,0.00047456415,0.00056337175,0.00017448832,0.00015808185,0.000057971538,0.00022159284,0.00013396714,0.00019810547],"category_scores_gemma":[0.00026665052,0.00039037748,0.00014601664,0.00039247493,0.00034159992,0.0004068161,0.00019291537,0.00035638877,0.00002538607],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014873357,0.004124073,0.991649,0.00041696144,0.00045407392,0.00031324752,0.0006579261,0.0003604206,0.00022384399,0.0000036551378,0.00010277073,0.00020670377],"study_design_scores_gemma":[0.03859685,0.0039346092,0.95459414,0.0005067436,0.0007710833,0.00002923839,0.00007668877,0.00008832528,0.0010291858,0.00001181791,0.00001722264,0.00034409488],"about_ca_topic_score_codex":0.00065521133,"about_ca_topic_score_gemma":0.00017497079,"teacher_disagreement_score":0.037109513,"about_ca_system_score_codex":0.0032835293,"about_ca_system_score_gemma":0.0024776412,"threshold_uncertainty_score":0.9998548},"labels":[],"label_agreement":null},{"id":"W2560769489","doi":"10.1182/blood.v118.21.1965.1965","title":"Myeloablative Conditioning with Pharmacokinetic-Targeted Intravenous Busulfan and Cyclophosphamide in Unrelated Cord Blood Transplantation for Myeloid Malignancies in Children","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Busulfan; Medicine; Transplantation; Cyclophosphamide; Internal medicine; Myeloid leukemia; Total body irradiation; Myeloid; Hematopoietic stem cell transplantation; Oncology; Pharmacokinetics; Gastroenterology; Chemotherapy; Surgery; Pharmacology","score_opus":0.011332584988855166,"score_gpt":0.2294593523778355,"score_spread":0.21812676738898032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560769489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959015,0.0003788523,0.0011387337,0.000033799286,0.000030047086,0.0016724218,0.00009021152,0.00006570327,0.00068869465],"genre_scores_gemma":[0.9924919,0.0005041599,0.006265362,0.00007455263,0.000023652952,0.0001741407,0.00039586963,0.000041480234,0.000028856406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986281,0.00005406847,0.000438188,0.0003670707,0.000174434,0.00033817516],"domain_scores_gemma":[0.99947214,0.00011557008,0.000118061835,0.000112571244,0.00007948593,0.000102155915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019354648,0.0002319727,0.000365623,0.00025497563,0.000055546418,0.00001185443,0.00005636707,0.00012631016,0.000056456905],"category_scores_gemma":[0.000020822077,0.0002157163,0.000031868687,0.0003531051,0.00009573278,0.00012512914,0.0000046091127,0.00019456322,0.000003089225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027083207,0.001342294,0.89699274,0.00065133994,0.00044959813,0.0005074725,0.015728852,0.00004329275,0.08004925,0.00034110583,0.000002050276,0.0011836762],"study_design_scores_gemma":[0.017725725,0.0008240652,0.7364705,0.0006177755,0.00076152,0.0008833497,0.00027839708,0.00006208829,0.24204816,0.000118967255,0.000001421832,0.0002079745],"about_ca_topic_score_codex":0.00025785697,"about_ca_topic_score_gemma":0.00011328888,"teacher_disagreement_score":0.16199893,"about_ca_system_score_codex":0.00002097922,"about_ca_system_score_gemma":0.00007847417,"threshold_uncertainty_score":0.8796655},"labels":[],"label_agreement":null},{"id":"W2560781244","doi":"10.1182/blood.v118.21.5101.5101","title":"The Potent STAT3/5 Inhibitor, BP-1-102 Demonstrates Significant Anti-Tumor Activity Against Waldenstrom Macroglobulinemia","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"STAT3; Cancer research; Macroglobulinemia; Transcription factor; Biology; Angiogenesis; Lymphoma; Waldenstrom macroglobulinemia; Carcinogenesis; Signal transduction; Medicine; Immunology; Cancer; Gene; Cell biology; Multiple myeloma; Genetics","score_opus":0.026279873232991996,"score_gpt":0.25939152377977037,"score_spread":0.23311165054677838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560781244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98832107,0.00068116415,0.000046636804,0.0003146177,0.00027087165,0.00084282603,0.000036974303,0.00015901652,0.009326853],"genre_scores_gemma":[0.99754626,0.0002847853,0.00063883624,0.00017901683,0.0003595358,0.00007191919,0.0000137359075,0.000061819,0.00084410113],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969329,0.00014346719,0.000440731,0.0005784265,0.0008048846,0.0010995717],"domain_scores_gemma":[0.9979633,0.00024497134,0.0001612283,0.00093675056,0.000192477,0.00050124153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063277467,0.00033979124,0.0004357794,0.0000874484,0.00033619368,0.00008394234,0.00037924023,0.00014315957,0.00010278644],"category_scores_gemma":[0.00022856022,0.0002264859,0.00020539411,0.00032238767,0.0005148672,0.00009752626,0.00021851779,0.0005684706,0.00023289482],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004081257,0.018112166,0.045522083,0.0010641081,0.003537409,0.02794027,0.0034402192,0.000017266395,0.7422375,0.0016850784,0.016714316,0.13564831],"study_design_scores_gemma":[0.04627513,0.0011542302,0.041846503,0.0003332636,0.0005610605,0.0016783053,0.0015476865,0.0016792865,0.8998884,0.0001951506,0.0040575657,0.0007834283],"about_ca_topic_score_codex":0.0007416097,"about_ca_topic_score_gemma":0.00004919208,"teacher_disagreement_score":0.15765087,"about_ca_system_score_codex":0.0016820878,"about_ca_system_score_gemma":0.0049368,"threshold_uncertainty_score":0.92358273},"labels":[],"label_agreement":null},{"id":"W2560781645","doi":"10.1182/blood.v116.21.4252.4252","title":"Nitrogen Monoxide Inhibits Heme Synthesis In Reticulocytes","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Heme; Sodium nitroprusside; Nitric oxide; Chemistry; Reticulocyte; Globin; Transferrin; Biochemistry; Erythropoiesis; Hemoglobin; Nitric oxide synthase; Biology; Anemia; Enzyme; Messenger RNA; Internal medicine; Medicine","score_opus":0.011008513965122122,"score_gpt":0.23468428219853657,"score_spread":0.22367576823341445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560781645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99368656,0.00009941344,0.0000040982723,0.0005051097,0.00016043203,0.0001399151,0.0000031143584,0.00006613464,0.0053352444],"genre_scores_gemma":[0.9975516,0.00003481607,0.0013538548,0.0005384596,0.00024094335,0.00003629056,0.000007217183,0.00001614451,0.00022066683],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993184,0.00002765309,0.00017271686,0.00019953723,0.0000914113,0.0001902667],"domain_scores_gemma":[0.9994818,0.00010331054,0.0000354433,0.00024406624,0.00003977081,0.000095608004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010336252,0.000101078,0.00021528242,0.00009980915,0.000026695547,0.000004991393,0.000046944177,0.0001375048,0.00046825077],"category_scores_gemma":[0.00035364338,0.00008593791,0.000063955886,0.00014445868,0.000051902156,0.00003024062,0.000025346717,0.00027998752,0.00024715316],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009074132,0.00046756622,0.08975805,0.000035872785,0.000030759173,0.00007364197,0.000085701824,3.8658223e-7,0.9078358,0.00024304283,0.00030642914,0.0010720324],"study_design_scores_gemma":[0.002057566,0.00016131806,0.06298061,0.000056198354,0.00009989262,0.00022682782,0.00006835967,0.000029732728,0.93011236,0.00048513693,0.0035821397,0.00013985096],"about_ca_topic_score_codex":0.00003410353,"about_ca_topic_score_gemma":0.00006518095,"teacher_disagreement_score":0.026777446,"about_ca_system_score_codex":0.000007368243,"about_ca_system_score_gemma":0.0000486875,"threshold_uncertainty_score":0.51270175},"labels":[],"label_agreement":null},{"id":"W2560782884","doi":"10.1182/blood.v124.21.4551.4551","title":"Comparative Efficacy Among 3rd Line Post-Imatinib Chronic Phase-Chronic Myeloid Leukemia (CP-CML) Patients after Failure of Dasatinib or Nilotinib Tyrosine Kinase Inhibitors","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Nilotinib; Dasatinib; Medicine; Imatinib; Ponatinib; Internal medicine; Bosutinib; Imatinib mesylate; Tyrosine-kinase inhibitor; Tyrosine kinase; Oncology; Myeloid leukemia; Cancer","score_opus":0.014707307269292999,"score_gpt":0.2779437002241801,"score_spread":0.2632363929548871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560782884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994447,0.000960705,0.000053012,0.00017393882,0.00033076556,0.0026688443,0.00033544228,0.00025573515,0.00077458087],"genre_scores_gemma":[0.99451154,0.00005448541,0.0015590306,0.00017933123,0.0011568106,0.0002795667,0.0013598003,0.0001686249,0.00073079154],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9948835,0.0002611845,0.0016056448,0.0011264047,0.0010402532,0.0010830215],"domain_scores_gemma":[0.9959987,0.0004925239,0.00090281456,0.0013913227,0.00062816776,0.0005864818],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003419674,0.00096362294,0.0017698327,0.00037148182,0.00017791915,0.000053178166,0.00040078256,0.00044793417,0.0013292071],"category_scores_gemma":[0.0005735361,0.0007646528,0.00043298115,0.0007170243,0.00053678383,0.0003356609,0.0002678525,0.00079317,0.00029932597],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029121457,0.08432079,0.39838842,0.011843033,0.010945085,0.0013817071,0.019241856,0.0010839185,0.3182209,0.0003199684,0.017196756,0.10793608],"study_design_scores_gemma":[0.24270628,0.034054983,0.25691065,0.004609931,0.0036105367,0.00010415236,0.00029408163,0.0024850417,0.44624457,0.000020087959,0.0070890584,0.0018706132],"about_ca_topic_score_codex":0.00023317947,"about_ca_topic_score_gemma":0.0006058106,"teacher_disagreement_score":0.21358483,"about_ca_system_score_codex":0.002189509,"about_ca_system_score_gemma":0.002078014,"threshold_uncertainty_score":0.9995837},"labels":[],"label_agreement":null},{"id":"W2560799608","doi":"10.1182/blood.v106.11.3587.3587","title":"DMT1 Mutation in a Patient with Hypochromic Microcytic Anemia: Functional Consequences and Response to Erythropoietin.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"DMT1; Chinese hamster ovary cell; Erythropoietin; Exon; Mutation; Hemoglobin; Biology; Microcytic anemia; Molecular biology; Point mutation; Anemia; Internal medicine; Endocrinology; Biochemistry; Medicine; Cell culture; Transporter; Genetics; Gene","score_opus":0.00725800633598263,"score_gpt":0.22444713599593197,"score_spread":0.21718912965994933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560799608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954938,0.0009625992,0.000029251898,0.0028241929,0.000025416577,0.00028311065,0.0000049662667,0.000020731164,0.0003558909],"genre_scores_gemma":[0.99599874,0.000024792633,0.0026702178,0.0011027411,0.00004221127,0.000023653784,0.000009377141,0.000009357741,0.00011892646],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9993242,0.00004472255,0.00014517094,0.00019194574,0.00014668322,0.00014726241],"domain_scores_gemma":[0.9996993,0.00005126073,0.00003210202,0.000093916904,0.00003708129,0.00008635121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011701871,0.000091943526,0.00013503357,0.00013024376,0.000037842718,0.000011234371,0.000018559116,0.00004410877,0.000075906835],"category_scores_gemma":[0.0000842361,0.00007357877,0.000014055346,0.00014256546,0.00012654769,0.000053299478,0.000011319843,0.00008005634,0.000035833003],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032910924,0.003926387,0.05953775,0.00044071538,0.00009475053,0.0022850905,0.017108336,0.00089214096,0.84480923,0.00049894105,0.0041604596,0.03333525],"study_design_scores_gemma":[0.042618163,0.0044304566,0.82431847,0.00035578883,0.0005788626,0.0069423146,0.008680396,0.000046511752,0.10447247,0.00021014232,0.0066051255,0.0007413079],"about_ca_topic_score_codex":0.000058925638,"about_ca_topic_score_gemma":0.000102114,"teacher_disagreement_score":0.7647807,"about_ca_system_score_codex":0.00002845548,"about_ca_system_score_gemma":0.00018667507,"threshold_uncertainty_score":0.30004552},"labels":[],"label_agreement":null},{"id":"W2560804360","doi":"10.1182/blood.v104.11.2161.2161","title":"Stress Erythropoiesis Elicits a Program of Gene Regulation That Overlaps with Interferon-γ.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Erythropoiesis; Erythropoietin; Biology; Transferrin receptor; Cell culture; Molecular biology; Internal medicine; Endocrinology; Immunology; Anemia; Transferrin; Medicine; Genetics","score_opus":0.01707439361137792,"score_gpt":0.2538755641006442,"score_spread":0.2368011704892663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560804360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99698716,0.00016050228,0.0005102649,0.00024361139,0.00008422968,0.00039153613,0.000009497581,0.000100105106,0.0015130811],"genre_scores_gemma":[0.9934004,0.000042696316,0.0059703304,0.0001238243,0.0001237562,0.000031652144,0.000068363865,0.000019083936,0.00021992314],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993071,0.000019034322,0.0001566645,0.00019450708,0.00017074813,0.00015196891],"domain_scores_gemma":[0.99946487,0.000015010451,0.00010018399,0.00025264506,0.000100322184,0.00006696751],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000036683494,0.00011729746,0.0002448075,0.00007523906,0.000032516476,0.000005303781,0.00004142604,0.00008610178,0.0001026794],"category_scores_gemma":[0.00001415186,0.000087007655,0.00005918222,0.00015528026,0.000100578465,0.000052175328,0.000014916062,0.000091221926,0.000014945767],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006322131,0.01811757,0.13262054,0.0015526841,0.0016667843,0.00022857303,0.0038654774,0.0006756719,0.79861027,0.00191325,0.00061284745,0.033814225],"study_design_scores_gemma":[0.011322024,0.0085452935,0.23853104,0.0005251984,0.00045093248,0.0002913002,0.00042819767,0.00002137093,0.73880196,0.00017634322,0.00069155695,0.00021476638],"about_ca_topic_score_codex":0.000054590215,"about_ca_topic_score_gemma":0.00004395964,"teacher_disagreement_score":0.10591051,"about_ca_system_score_codex":0.000021906679,"about_ca_system_score_gemma":0.00007056772,"threshold_uncertainty_score":0.35480693},"labels":[],"label_agreement":null},{"id":"W2560807277","doi":"10.1182/blood.v124.21.4767.4767","title":"A Phase I Trial of Pomalidomide, Bortezomib (Velcade), and Dexamethasone (PVD) As Initial Treatment of AL Amyloidosis and Light Chain Deposition Disease","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pomalidomide; AL amyloidosis; Medicine; Bortezomib; Ixazomib; Multiple myeloma; Lenalidomide; Amyloidosis; Plasma cell dyscrasia; Plasma cell; Plasma cell neoplasm; Internal medicine; Pharmacology; Gastroenterology; Immunoglobulin light chain; Carfilzomib; Immunology; Plasmacytoma; Antibody","score_opus":0.010552543139302643,"score_gpt":0.29057934295815174,"score_spread":0.2800267998188491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560807277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996135,0.0023723093,0.00009294367,0.0004257142,0.00006315463,0.00063578016,0.00012407938,0.000012314458,0.00013871773],"genre_scores_gemma":[0.996957,0.0016992737,0.00063613657,0.00015189157,0.00017876565,0.00017476242,0.0001376575,0.000029247378,0.00003525042],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986495,0.00015792357,0.00038085793,0.00043424964,0.00015945137,0.00021806225],"domain_scores_gemma":[0.99907607,0.00008264333,0.00023908718,0.00033512828,0.000051136034,0.00021593747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012488286,0.0002660653,0.00043045802,0.000083626976,0.000060012484,0.00001760839,0.00007683957,0.00014171872,0.000009367221],"category_scores_gemma":[0.00017286323,0.00023211633,0.00015389117,0.000071062605,0.00013935135,0.000008947717,0.00006297747,0.000034131583,0.0000011842268],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03158865,0.01799289,0.042499702,0.00012584054,0.0014483919,0.000043618133,0.0003319029,0.0000020789512,0.87713206,0.0002616091,0.00016544852,0.028407792],"study_design_scores_gemma":[0.12581913,0.009628831,0.0048829406,0.00003420304,0.0009329854,0.000020343843,0.00003864839,0.000017983013,0.8577074,0.00005541366,0.00063267915,0.00022948181],"about_ca_topic_score_codex":0.0000852083,"about_ca_topic_score_gemma":0.000020197715,"teacher_disagreement_score":0.09423047,"about_ca_system_score_codex":0.000012602532,"about_ca_system_score_gemma":0.00006086227,"threshold_uncertainty_score":0.9465429},"labels":[],"label_agreement":null},{"id":"W2560809041","doi":"10.1182/blood.v106.11.1333.1333","title":"Anemia in the Elderly and the Risk of Injurious Falls.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Anemia; Poison control; Osteoporosis; Incidence (geometry); Pediatrics; Physical therapy; Surgery; Internal medicine; Emergency medicine","score_opus":0.004567086753079876,"score_gpt":0.22751185965980372,"score_spread":0.22294477290672385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560809041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984542,0.006019514,0.0000041112994,0.0016622592,0.000013785114,0.00020014054,0.0000031205975,0.000005919103,0.0075491657],"genre_scores_gemma":[0.9979846,0.0010120481,0.00017617646,0.0006411312,0.00007352492,0.0000066983134,0.0000013006792,0.0000043580117,0.00010016099],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99953383,0.000071164446,0.00011927344,0.00007120006,0.00011415232,0.00009035106],"domain_scores_gemma":[0.999656,0.000085902,0.00003978576,0.00018954603,0.000011380417,0.000017371702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033586723,0.00005270325,0.00012609901,0.000027955053,0.00002643517,0.0000055566525,0.0000688221,0.00003236598,0.000019341023],"category_scores_gemma":[0.00009875197,0.000024346202,0.000031507116,0.000083614956,0.00011361969,0.000019491219,0.000012498906,0.0001218201,0.0000061284495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014281581,0.0033960284,0.5460272,0.0003600369,0.00013557608,0.00004598735,0.054272633,0.000019542227,0.0022047537,0.018407362,0.0058577587,0.367845],"study_design_scores_gemma":[0.04557809,0.0005214138,0.9207312,0.000044186163,0.001240851,0.00010047713,0.0047513302,0.000028853758,0.0021297643,0.0019959516,0.02269819,0.0001797182],"about_ca_topic_score_codex":0.00019899593,"about_ca_topic_score_gemma":0.000120047625,"teacher_disagreement_score":0.374704,"about_ca_system_score_codex":0.0000010815402,"about_ca_system_score_gemma":0.000018454324,"threshold_uncertainty_score":0.09928093},"labels":[],"label_agreement":null},{"id":"W2560819401","doi":"10.1182/blood.v104.11.866.866","title":"A Multicentre, Double-Blind, Randomized, Phase 2 Trial Comparing Pegfilgrastim with Filgrastim as an Adjunct to Chemotherapy for Acute Myeloid Leukaemia (AML).","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Filgrastim; Pegfilgrastim; Medicine; Cytarabine; Chemotherapy; Febrile neutropenia; Neutropenia; Idarubicin; Induction chemotherapy; Internal medicine; Granulocyte colony-stimulating factor; Surgery; Gastroenterology","score_opus":0.03301226243484864,"score_gpt":0.35189878985335715,"score_spread":0.31888652741850854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560819401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802486,0.00006926139,0.008728706,0.000861393,0.00035711922,0.008104275,0.000027104628,0.00018185905,0.0014217308],"genre_scores_gemma":[0.98811555,0.00004389339,0.0070299106,0.0010428919,0.0010735439,0.0019810053,0.00016131617,0.00009058534,0.00046127796],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99806774,0.000039012546,0.0004649539,0.0005726513,0.0003435717,0.0005120919],"domain_scores_gemma":[0.9985767,0.00010283946,0.00015581468,0.00045761638,0.00020587459,0.0005011336],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024969026,0.00037032913,0.0010671945,0.00019499987,0.0002242157,0.00008772399,0.00016405493,0.00011746977,0.00016757577],"category_scores_gemma":[0.00004424212,0.0002794723,0.00030283874,0.00036433918,0.00009871077,0.00016607993,0.000024735733,0.00025749565,0.0000681032],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.986225,0.0037962452,0.0001378103,0.000038404396,0.0012801753,0.000057673893,0.000589027,0.00026133895,0.00620772,0.0003015919,0.00019444502,0.00091057137],"study_design_scores_gemma":[0.93982244,0.00580015,0.000036361198,0.0001423438,0.0031156433,0.00023564289,0.0001038884,0.000083550556,0.048817232,0.000089291316,0.0014175118,0.00033592831],"about_ca_topic_score_codex":0.0003630153,"about_ca_topic_score_gemma":0.0003151097,"teacher_disagreement_score":0.04640254,"about_ca_system_score_codex":0.00010579872,"about_ca_system_score_gemma":0.000430175,"threshold_uncertainty_score":0.9999657},"labels":[],"label_agreement":null},{"id":"W2560829508","doi":"10.1182/blood.v128.22.4413.4413","title":"Anti-Infectious Pathogen Specificity of Purified Monoclonal Immunoglobulins from Patients with MGUS and Multiple Myeloma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Agence Nationale de la Recherche","keywords":"Virology; Herpes simplex virus; Lymphoma; Helicobacter pylori; Immunology; Hepatitis C virus; Antibody; Antigen; Multiple myeloma; Medicine; Virus; Biology; Gastroenterology","score_opus":0.011497414487927684,"score_gpt":0.22921147056051355,"score_spread":0.21771405607258587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560829508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973177,0.0004794055,0.000044122757,0.00020989495,0.000054566284,0.00035143577,0.000616449,0.000033645872,0.0008928281],"genre_scores_gemma":[0.9983568,0.00023363945,0.0007739931,0.000040816867,0.00015126167,0.0000066150433,0.0000785968,0.000022490096,0.00033574953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986313,0.000045135275,0.0002715427,0.00032761632,0.00043056995,0.00029383125],"domain_scores_gemma":[0.99904215,0.00020646722,0.000099126,0.0002741902,0.00019759807,0.00018043973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000082328166,0.00018556442,0.00039584312,0.00007902345,0.000079775695,0.00001178134,0.00009526036,0.00008989863,0.00018189472],"category_scores_gemma":[0.00008263566,0.00010532799,0.00007823359,0.00011461578,0.00020863235,0.000067676105,0.000094214505,0.00012403316,0.00003362208],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000780706,0.00089617143,0.846197,0.000034606634,0.00023565305,0.00005265121,0.00007059231,1.3947356e-7,0.1453554,0.000031895852,0.000046499354,0.0062986505],"study_design_scores_gemma":[0.0076007023,0.00075355644,0.9170897,0.00013113911,0.000099671226,0.00002598861,0.000013447376,0.0000053283334,0.07295786,0.0000712483,0.001105784,0.0001455699],"about_ca_topic_score_codex":0.00043022193,"about_ca_topic_score_gemma":0.000040559604,"teacher_disagreement_score":0.072397545,"about_ca_system_score_codex":0.000016591719,"about_ca_system_score_gemma":0.00006423842,"threshold_uncertainty_score":0.4295151},"labels":[],"label_agreement":null},{"id":"W2560868850","doi":"10.1182/blood.v126.23.3201.3201","title":"Analysis of Impact of Comorbidities Constituting the HCT-CI Score on the Outcome of Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Myeloid leukemia; Hematopoietic stem cell transplantation; Bone marrow; Single Center; Transplantation; Hematopoietic cell; Gastroenterology; Surgery; Acute leukemia; Leukemia; Haematopoiesis; Stem cell","score_opus":0.05229257650455247,"score_gpt":0.32170096523119884,"score_spread":0.26940838872664635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560868850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99701554,0.00017676638,0.00015255818,0.00013564382,0.00003675582,0.0007963984,0.0005572201,0.000012642235,0.001116468],"genre_scores_gemma":[0.9994318,0.00006678184,0.00015192172,0.000074500706,0.000028515351,0.000026429603,0.000117837335,0.000023139297,0.000079066755],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980418,0.00011607664,0.0006731394,0.00021413792,0.0006236481,0.00033117313],"domain_scores_gemma":[0.99740094,0.0011124044,0.00040271776,0.00059905765,0.00037011472,0.00011476963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072982523,0.00020826844,0.0008130138,0.00026581378,0.00008154814,0.000009173627,0.00035617952,0.00009775878,0.00003174273],"category_scores_gemma":[0.00029062768,0.000108694556,0.0005797121,0.00058581564,0.0004193399,0.000036688336,0.0000625566,0.00022902664,0.0000026227094],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070759177,0.0005483159,0.9767421,0.00045500125,0.007118503,0.000014015476,0.003124242,0.0012820058,0.009072256,0.0005118522,0.00035054368,0.000073563584],"study_design_scores_gemma":[0.033738565,0.0072929766,0.35082304,0.0010849348,0.04594078,0.000068805384,0.0074225017,0.0047358037,0.5476611,0.00041771756,0.00006670963,0.00074705255],"about_ca_topic_score_codex":0.00027050343,"about_ca_topic_score_gemma":0.000056924287,"teacher_disagreement_score":0.62591904,"about_ca_system_score_codex":0.00021680704,"about_ca_system_score_gemma":0.0010528774,"threshold_uncertainty_score":0.44324353},"labels":[],"label_agreement":null},{"id":"W2560941332","doi":"10.1182/blood.v114.22.2634.2634","title":"Mutational Analysis of BCR-Abl From Subjects with Relapsed Ph+ALL Treated On the COG Protocol AALL0031: a Report From the Children's Oncology Group.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Imatinib; Cohort; Medicine; Internal medicine; Imatinib mesylate; Acute lymphocytic leukemia; Oncology; Clinical endpoint; Surgery; Leukemia; Lymphoblastic Leukemia; Clinical trial; Myeloid leukemia","score_opus":0.015325575877178317,"score_gpt":0.28136079700191335,"score_spread":0.26603522112473504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560941332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97175753,0.000041869396,0.000014125454,0.0016028371,0.000015184968,0.0232672,0.00014728468,0.000067051275,0.003086911],"genre_scores_gemma":[0.9874038,0.000004022475,0.0006713434,0.0011034772,0.00015199446,0.008641682,0.0017991081,0.000026051846,0.0001985407],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978394,0.0002202692,0.0005262787,0.0005309966,0.00061179255,0.00027126473],"domain_scores_gemma":[0.9975387,0.00077013794,0.00050430826,0.0009603088,0.00012590773,0.00010066153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025145416,0.00028382716,0.00066254626,0.000118489224,0.00010101566,0.00001723752,0.00020967363,0.00016374624,0.0004704745],"category_scores_gemma":[0.00022951797,0.00014094274,0.00023217565,0.00073557225,0.00013024855,0.000040542385,0.00002423554,0.0003134312,0.000020040892],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0082485415,0.0155044105,0.89018744,0.000018250936,0.05760282,0.0052385232,0.0032458024,0.00022609404,0.010537564,0.00037020206,0.0035590848,0.0052612773],"study_design_scores_gemma":[0.019798946,0.0023846098,0.95654833,0.00011432156,0.01279526,0.00016931619,0.00007883581,0.00015066763,0.0070081404,0.00016126022,0.00062793616,0.00016238834],"about_ca_topic_score_codex":0.0032491714,"about_ca_topic_score_gemma":0.00073475856,"teacher_disagreement_score":0.06636089,"about_ca_system_score_codex":0.00029043425,"about_ca_system_score_gemma":0.0005071158,"threshold_uncertainty_score":0.5747478},"labels":[],"label_agreement":null},{"id":"W2560998810","doi":"10.1182/blood.v126.23.2136.2136","title":"The Phenotypic Spectrum of Pyruvate Kinase Deficiency (PKD) from the PKD Natural History Study (NHS): Description of Four Severity Groups By Anemia Status","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; University of Toronto; University Health Network; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Splenectomy; Medicine; Cohort; Anemia; Pediatrics; Internal medicine; Spleen","score_opus":0.02969200080058222,"score_gpt":0.23056297354083324,"score_spread":0.200870972740251,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560998810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99096555,0.00666685,0.000038772956,0.00021775643,0.0010208065,0.0004171189,0.00003243562,0.000034626504,0.0006060893],"genre_scores_gemma":[0.998879,0.00011354322,0.00009857998,0.00022022348,0.00016872823,0.000011698163,0.000044074462,0.000014890695,0.0004492434],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986408,0.000226621,0.00032810293,0.0002339383,0.00032110495,0.00024945792],"domain_scores_gemma":[0.998916,0.00014955393,0.00022133168,0.00048118152,0.00013697238,0.000094978626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003548044,0.00014835158,0.0002865554,0.000032289856,0.000087807246,0.0000054923744,0.00015688935,0.00007395186,0.000048607417],"category_scores_gemma":[0.00021210813,0.00008726137,0.00008177153,0.00013715909,0.00021144946,0.000060847884,0.000060192633,0.00029956675,0.000010318548],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053396723,0.007942268,0.39676052,0.00016326386,0.00047087995,0.00007642582,0.019755205,0.0000151488175,0.5080267,0.00056911993,0.057252016,0.003628768],"study_design_scores_gemma":[0.013383007,0.0041127075,0.95135546,0.0000625566,0.0009290922,0.00002765763,0.010064164,0.00020431716,0.00840156,0.0012797888,0.009850352,0.00032932544],"about_ca_topic_score_codex":0.001333082,"about_ca_topic_score_gemma":0.0004263132,"teacher_disagreement_score":0.55459493,"about_ca_system_score_codex":0.00012480919,"about_ca_system_score_gemma":0.00019792526,"threshold_uncertainty_score":0.35584152},"labels":[],"label_agreement":null},{"id":"W2561051382","doi":"10.1182/blood.v114.22.4670.4670","title":"Despite Tolerance of Imatinib Prior to Transplant, Imatinib Induces Prolonged Exanthematous Pustulosis in a Patient with Sclerodermatous Graft-Versus-Host Disease: A Case Report.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Regional Hospital; University of Windsor; Western University","funders":"","keywords":"Medicine; Graft-versus-host disease; Tacrolimus; Dermatology; Imatinib; Posaconazole; Extracorporeal Photopheresis; Skin biopsy; Surgery; Transplantation; Immunology; Internal medicine; Myeloid leukemia; Biopsy; Voriconazole","score_opus":0.01654670527963685,"score_gpt":0.25299740193007175,"score_spread":0.2364506966504349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561051382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99412256,0.0027711934,0.00002013879,0.00045611855,0.000079661266,0.0020918353,0.00009695392,0.00010759647,0.00025392376],"genre_scores_gemma":[0.99840665,0.00010297087,0.00092934264,0.00021193014,0.000047364178,0.00022267876,0.000026804704,0.000038559934,0.00001372511],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99737084,0.000091172304,0.0009849131,0.00055561756,0.00056182145,0.00043561976],"domain_scores_gemma":[0.9982105,0.00010186263,0.00040069275,0.00063170266,0.0001685896,0.0004866334],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020029211,0.00034085815,0.00072854763,0.00025174237,0.00009078005,0.000027669117,0.00012149101,0.00012640456,0.000024536836],"category_scores_gemma":[0.00018300212,0.0002495297,0.00015196818,0.0006060447,0.00006741538,0.000115893345,0.000020015972,0.00019847877,0.0000069837747],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02457817,0.025536146,0.13642876,0.0038556543,0.0014611059,0.6591497,0.030284066,0.0002636775,0.10107254,0.00007733636,0.00049658853,0.016796224],"study_design_scores_gemma":[0.06435427,0.007677769,0.5571404,0.043203138,0.0052806064,0.18549314,0.0047197887,0.0003827996,0.12955289,0.00003688038,0.00004795378,0.0021103171],"about_ca_topic_score_codex":0.000088540495,"about_ca_topic_score_gemma":0.0000410059,"teacher_disagreement_score":0.4736566,"about_ca_system_score_codex":0.000037169062,"about_ca_system_score_gemma":0.0002145799,"threshold_uncertainty_score":0.9999957},"labels":[],"label_agreement":null},{"id":"W2561142812","doi":"10.1182/blood.v114.22.170.170","title":"Phase II Dose-Finding Study with TAK-442, An Oral Factor Xa Inhibitor, in Patients Undergoing Elective Knee Arthroplasty.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McGill University Health Centre","funders":"","keywords":"Medicine; Pulmonary embolism; Regimen; Surgery; Deep vein; Venography; Clinical endpoint; Thrombosis; Asymptomatic; Population; Adverse effect; Randomized controlled trial; Anesthesia; Internal medicine","score_opus":0.017829153166786443,"score_gpt":0.2863147005874999,"score_spread":0.26848554742071346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561142812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99705714,0.000044042357,0.000016723461,0.00007249989,0.000113816226,0.0017005138,0.000005932267,0.000092919465,0.000896398],"genre_scores_gemma":[0.9991359,0.000013326749,0.00027637449,0.00027572535,0.00012384227,0.00004591337,0.00002902399,0.00003446651,0.00006539717],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982586,0.000066890876,0.00031448965,0.00047832905,0.00042385975,0.0004578374],"domain_scores_gemma":[0.99930024,0.000027364333,0.00011609912,0.0003069885,0.00007669736,0.00017262118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012305306,0.00027047118,0.00052006025,0.00026052646,0.00018481916,0.0000447631,0.0000674242,0.00006582052,0.000055695833],"category_scores_gemma":[0.000044294822,0.00022427546,0.000047430847,0.00038039975,0.000026054433,0.00025108995,0.000051184663,0.00022042835,0.00001184458],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010747398,0.24177301,0.70117015,0.000060891074,0.00062118267,0.00038744847,0.008962418,0.000028555101,0.000817056,0.00018468288,0.00036541815,0.04455447],"study_design_scores_gemma":[0.05595234,0.08963839,0.8507037,0.0002076528,0.0003634382,0.000004481782,0.0014500552,0.000014043938,0.0011042462,0.00003040381,0.00022058397,0.0003106439],"about_ca_topic_score_codex":0.00008569208,"about_ca_topic_score_gemma":0.0007966946,"teacher_disagreement_score":0.15213463,"about_ca_system_score_codex":0.000107904976,"about_ca_system_score_gemma":0.00010917152,"threshold_uncertainty_score":0.9145688},"labels":[],"label_agreement":null},{"id":"W2561143716","doi":"10.1182/blood.v104.11.3213.3213","title":"Identification of a New Population of Human Cord Blood Cells with Lymphoid-Restricted Reconstituting Potential in Sublethally Irradiated Immunodeficient Mice.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; Haematopoiesis; Population; CD38; CD34; Lymphopoiesis; Stem cell; Myeloid; Cord blood; Immunology; Molecular biology; Cell biology; Medicine","score_opus":0.008938571813497801,"score_gpt":0.22639635472340494,"score_spread":0.21745778290990714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561143716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99685293,0.0020466535,0.00009276685,0.000017198543,0.00040451175,0.00036567086,0.000020348441,0.000036908958,0.00016298723],"genre_scores_gemma":[0.9993249,0.000055092154,0.00022603577,0.0000087582375,0.00001214679,0.000009231079,0.00015576414,0.000019631296,0.0001883936],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984188,0.0000971557,0.00082838174,0.00030183277,0.000072669565,0.00028114353],"domain_scores_gemma":[0.998828,0.000029417697,0.0006584243,0.00035214503,0.00011785104,0.000014158412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020110328,0.00017474468,0.00034185473,0.0002777537,0.00008858821,0.000010284214,0.00024893033,0.00023365348,0.00005944507],"category_scores_gemma":[0.000031860447,0.00017642775,0.000070173926,0.00044642636,0.00017210409,0.00009683086,0.00004612178,0.00018638838,0.000016349944],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023517599,0.00088385027,0.008895675,0.000048112986,0.00016965454,0.0000073006922,0.0003771726,0.0017753763,0.9870674,0.00024457384,0.000007163811,0.00028852],"study_design_scores_gemma":[0.009165138,0.00033699916,0.09567485,0.0001768567,0.00025246266,0.00008141936,0.00011205049,0.000002733784,0.8939064,0.00010702029,0.00000935816,0.0001746735],"about_ca_topic_score_codex":0.0065842574,"about_ca_topic_score_gemma":0.00023880306,"teacher_disagreement_score":0.09316099,"about_ca_system_score_codex":0.00007009201,"about_ca_system_score_gemma":0.00026485932,"threshold_uncertainty_score":0.99534714},"labels":[],"label_agreement":null},{"id":"W2561150745","doi":"10.1182/blood.v114.22.1376.1376","title":"The Association Between Red Blood Cell Transfusions and Development of Non-Hodgkin Lymphoma.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Funnel plot; Medicine; Observational study; Publication bias; Odds ratio; Confidence interval; Meta-analysis; Relative risk; Internal medicine","score_opus":0.008474066238531345,"score_gpt":0.2249967203365241,"score_spread":0.21652265409799276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561150745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949615,0.0004472703,0.00010893713,0.0009102676,0.000035303823,0.00033044245,0.000006760497,0.000029421913,0.0031701098],"genre_scores_gemma":[0.996633,0.00032952396,0.0026178856,0.00006802636,0.0000861378,0.0000073421265,0.000013556591,0.000011501452,0.0002330146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989312,0.000028594988,0.0003382839,0.00018495023,0.00029739118,0.00021954182],"domain_scores_gemma":[0.99945015,0.00010774509,0.00009464285,0.00017352274,0.00007309383,0.00010082516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034361513,0.00012319381,0.0002513533,0.00004947545,0.00023734476,0.0000134728725,0.00006753337,0.00012943905,0.000008494136],"category_scores_gemma":[0.000021201206,0.00008733149,0.00006138247,0.00014946987,0.000020313926,0.000025055575,0.000010670508,0.000098709,0.000003380696],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016889909,0.004622262,0.39975157,0.00016522044,0.0008897647,0.00002744273,0.005023133,5.059157e-7,0.35399747,0.00009269162,0.00018935968,0.2350717],"study_design_scores_gemma":[0.008020319,0.00038935253,0.7814442,0.00006805149,0.0008547355,0.00000841036,0.00008788785,0.0000029258977,0.2065085,0.00005279662,0.0024614795,0.00010133662],"about_ca_topic_score_codex":0.000014633804,"about_ca_topic_score_gemma":0.000025198773,"teacher_disagreement_score":0.38169265,"about_ca_system_score_codex":0.000016537677,"about_ca_system_score_gemma":0.00010940402,"threshold_uncertainty_score":0.3561275},"labels":[],"label_agreement":null},{"id":"W2561150920","doi":"10.1182/blood.v110.11.2088.2088","title":"Clinical and Outcomes Findings for Thrombotic Thrombocytopenic Purpura among 467 Persons with Severely Versus Not Severely Deficient ADAMTS-13 Levels.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Apheresis Group","funders":"","keywords":"ADAMTS13; Thrombotic thrombocytopenic purpura; Medicine; Thrombotic microangiopathy; Microangiopathic hemolytic anemia; Internal medicine; Gastroenterology; Pediatrics; Platelet; Disease","score_opus":0.06099010723279662,"score_gpt":0.3243219378792406,"score_spread":0.26333183064644394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561150920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957993,0.0006925702,0.00026407372,0.00017505947,0.00089111045,0.0011759794,0.00027429964,0.00012876224,0.00059886015],"genre_scores_gemma":[0.9982636,0.000010628191,0.00050279696,0.00018581733,0.000046504854,0.00006189589,0.00007140396,0.000044937253,0.000812394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997659,0.00012349838,0.00065944466,0.000689882,0.00011856586,0.00074958213],"domain_scores_gemma":[0.99775755,0.0013592065,0.00021473582,0.0004683349,0.000101961545,0.00009818536],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007519592,0.0003663231,0.00071541936,0.00011814461,0.00040604433,0.000050939812,0.0003532055,0.00026256466,0.00034835012],"category_scores_gemma":[0.00025973225,0.00029292254,0.00023506378,0.00013925185,0.0005255424,0.00014636584,0.00019227737,0.0002847941,0.000120783974],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017538625,0.0009946257,0.9900241,0.00009551578,0.0015736879,0.000024070812,0.00046953897,0.0000026702335,0.0012926493,0.00094332336,0.0024620937,0.00036389675],"study_design_scores_gemma":[0.016030738,0.0012611857,0.9772791,0.00007797514,0.00084007264,0.00006667834,0.00081584085,0.00000268341,0.0017706805,0.00002076147,0.0014100778,0.00042415253],"about_ca_topic_score_codex":0.00008247323,"about_ca_topic_score_gemma":0.0005974544,"teacher_disagreement_score":0.014276876,"about_ca_system_score_codex":0.000045953806,"about_ca_system_score_gemma":0.00012969229,"threshold_uncertainty_score":0.9999523},"labels":[],"label_agreement":null},{"id":"W2561214156","doi":"10.1182/blood.v118.21.4437.4437","title":"A Canadian Expanded Access Trial of Oral Nilotinb in Adult Patients with Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Novartis (Canada); St. John’s Health Sciences Centre; Jewish General Hospital; McMaster University Medical Centre; Capital District Health Authority; Health Sciences Centre; Windsor Regional Hospital; Ottawa Hospital; London Health Sciences Centre; Brampton Civic Hospital; St. Paul's Hospital; Hôpital Maisonneuve-Rosemont; University of British Columbia; McGill University; McGill University Health Centre; University of Ottawa; Victoria Hospital; Hôpital de l'Enfant-Jésus","funders":"","keywords":"Nilotinib; Medicine; Discontinuation; Internal medicine; Adverse effect; Imatinib; Rash; Imatinib mesylate; Myeloid leukemia; Phases of clinical research; Cytopenia; Surgery; Gastroenterology; Clinical trial; Bone marrow","score_opus":0.0408920691426776,"score_gpt":0.3157582836705189,"score_spread":0.27486621452784127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561214156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949194,0.00014595351,0.0000058121377,0.00005209788,0.00015201712,0.0038935181,0.00025434137,0.00006975567,0.000507081],"genre_scores_gemma":[0.9981163,0.00011211501,0.00040178158,0.00012343048,0.00012491175,0.0004927733,0.00037648715,0.000111688816,0.00014052211],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9956765,0.00016621359,0.0014223137,0.00086842786,0.0006603771,0.0012061574],"domain_scores_gemma":[0.99760705,0.000079573045,0.00049838074,0.0008535612,0.00033102033,0.00063041487],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026626044,0.0006591293,0.0013425018,0.0008548761,0.00008870755,0.000050605417,0.00050631334,0.00029215173,0.0018323753],"category_scores_gemma":[0.00022267911,0.00045648636,0.0001288876,0.0014613961,0.00012805795,0.00041209272,0.00009491666,0.000571361,0.00002405203],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.8440988,0.05494283,0.043758217,0.0022522535,0.0023471408,0.008966001,0.008028385,0.00006563526,0.0069419397,0.000034843077,0.0011318024,0.027432129],"study_design_scores_gemma":[0.9217945,0.026162017,0.01295455,0.0014901835,0.0007108913,0.000060485287,0.00033209246,0.00078689645,0.03488492,0.000006178693,0.00013734403,0.00067994697],"about_ca_topic_score_codex":0.26035544,"about_ca_topic_score_gemma":0.6953464,"teacher_disagreement_score":0.434991,"about_ca_system_score_codex":0.011970783,"about_ca_system_score_gemma":0.024750607,"threshold_uncertainty_score":0.9997887},"labels":[],"label_agreement":null},{"id":"W2561216302","doi":"10.1182/blood.v110.11.1402.1402","title":"Direct and Enhanced Cytotoxicity of the Bcl-2 Family Inhibitor GX15-070 on Rituximab-Sensitive and Rituximab-Resistant B-NHL Clones.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cytostasis; Apoptosis; CHOP; Rituximab; Cancer research; Bcl-2 family; XIAP; Raji cell; Cytotoxicity; Pharmacology; Vincristine; Biology; Caspase; Chemistry; Lymphoma; Immunology; Programmed cell death; Biochemistry; Chemotherapy; Cyclophosphamide","score_opus":0.004899064023516795,"score_gpt":0.2062292170854741,"score_spread":0.20133015306195728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561216302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99668205,0.0009505599,0.00037850026,0.00002803727,0.00010183208,0.0002512167,0.000032714568,0.000008592208,0.0015664839],"genre_scores_gemma":[0.9989379,0.00030877744,0.00027164453,0.00009863408,0.00014347074,0.0000042393776,0.000016191825,0.00001526777,0.0002038973],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99912655,0.00004473703,0.00019671129,0.0003075404,0.00014296988,0.00018150262],"domain_scores_gemma":[0.9995207,0.000026518384,0.000103742175,0.00021834044,0.00007026899,0.000060383045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024031063,0.00014862834,0.00018831599,0.00003130328,0.00010865315,0.000013421699,0.000059267826,0.00016005941,0.0000013235408],"category_scores_gemma":[0.0000391401,0.00010731438,0.000059439848,0.000067704015,0.00012818332,0.0000031566046,0.000091004695,0.00006832556,0.0000010322424],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018012353,0.00038579045,0.00006742188,0.00002434549,0.000037559665,0.0000034257419,0.000055247947,0.0000010217743,0.99762106,0.00017411807,0.000028659784,0.0014212008],"study_design_scores_gemma":[0.0027593295,0.00029810108,0.02575221,0.00004053446,0.000048104197,0.000008226534,0.00007413501,0.000005957446,0.97037506,0.00005659006,0.00044677212,0.00013496682],"about_ca_topic_score_codex":0.000032796834,"about_ca_topic_score_gemma":0.000076019554,"teacher_disagreement_score":0.027246011,"about_ca_system_score_codex":0.0000061164837,"about_ca_system_score_gemma":0.00002274838,"threshold_uncertainty_score":0.43761533},"labels":[],"label_agreement":null},{"id":"W2561245808","doi":"10.1182/blood.v112.11.3667.3667","title":"Pre-Clinical Evaluation of a Small Molecule Inhibitor of CDK1 as Potential Therapy for MYC Expressing Mutiple Myeloma Tumors","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cyclin-dependent kinase 6; Multiple myeloma; Cancer research; Cell cycle; Cyclin-dependent kinase 1; Cyclin-dependent kinase; Biology; Cyclin; Cell growth; Cell culture; Viability assay; Cancer; Immunology; Genetics","score_opus":0.08537788657400636,"score_gpt":0.3780388125341908,"score_spread":0.29266092596018445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561245808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99674064,0.0008849379,0.00020202094,0.000051148254,0.00005598912,0.0015698068,0.000028245477,0.000020406673,0.00044678108],"genre_scores_gemma":[0.9955891,0.000087985,0.0037132595,0.000026390022,0.00019041574,0.00013817583,0.00007346713,0.000025588419,0.00015563697],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981264,0.00016805486,0.00050275156,0.00027020994,0.00068309,0.00024953272],"domain_scores_gemma":[0.99870867,0.00013633061,0.00019769139,0.00031105572,0.0004922763,0.00015399452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059055054,0.00013256834,0.00038117103,0.00010063361,0.00006884578,0.0000051764123,0.00008871428,0.000098657496,0.00009288629],"category_scores_gemma":[0.0006976026,0.00010746274,0.00023226389,0.00010898801,0.00013927567,0.000045830373,0.000033818244,0.00009949853,0.000005658359],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009249434,0.015403836,0.18340634,0.0003620002,0.0017224634,0.00024383707,0.0014947864,0.000034490105,0.7024255,0.000020140547,0.00039647584,0.085240714],"study_design_scores_gemma":[0.036515176,0.0031184244,0.28366393,0.0001733909,0.0003175438,0.00010187728,0.00006265464,0.003141216,0.6726714,0.00009287198,0.000034981862,0.00010656459],"about_ca_topic_score_codex":0.000097893935,"about_ca_topic_score_gemma":0.0000048440734,"teacher_disagreement_score":0.10025758,"about_ca_system_score_codex":0.000020158124,"about_ca_system_score_gemma":0.0004935226,"threshold_uncertainty_score":0.43822035},"labels":[],"label_agreement":null},{"id":"W2561251250","doi":"10.1182/blood.v110.11.1327.1327","title":"The MHC I Immunopeptidome Is Moulded by the Transcriptome and Conceals a Tissue-Specific Signature.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"vaccines and immunoinformatics approaches","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Biology; Major histocompatibility complex; CD8; Transcriptome; MHC class I; Epitope; Cell biology; Immunosurveillance; Cytotoxic T cell; Computational biology; Immune system; Antigen; Gene; Immunology; Genetics; Gene expression; In vitro","score_opus":0.008507060383153152,"score_gpt":0.22630654334234,"score_spread":0.21779948295918683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561251250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9380156,0.05840766,0.0004552163,0.00074441294,0.00010260558,0.00032949852,0.000029735014,0.000011378348,0.0019039334],"genre_scores_gemma":[0.99474204,0.0027175867,0.00010161937,0.0005160029,0.00011096463,0.000015317237,0.000042005537,0.000018360992,0.0017360852],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991354,0.00002050871,0.0002625533,0.00016829402,0.00012026685,0.00029299644],"domain_scores_gemma":[0.99939173,0.00003247244,0.0000782242,0.0004061988,0.000044672535,0.00004672433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043254546,0.00015614637,0.00011556257,0.00001246132,0.00036762303,0.0001310738,0.00030965358,0.00013552651,0.000011693231],"category_scores_gemma":[0.000013876938,0.00008742855,0.00005963852,0.00007736286,0.00014314993,0.000005610512,0.000067522284,0.00014722366,0.0000066486914],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005049789,0.000051719853,0.00006962226,0.000008054055,0.00008407591,6.552169e-7,0.00046098194,2.524921e-7,0.98280483,0.00016952108,0.011063562,0.005236205],"study_design_scores_gemma":[0.0010079483,0.00016152626,0.0006995922,0.000004780347,0.00002717296,0.000038057067,0.0006089017,0.0000035345136,0.5305744,0.000051717394,0.46668866,0.00013373831],"about_ca_topic_score_codex":0.000009197356,"about_ca_topic_score_gemma":0.0000045511083,"teacher_disagreement_score":0.45562512,"about_ca_system_score_codex":0.0000031332943,"about_ca_system_score_gemma":0.00001716033,"threshold_uncertainty_score":0.35652328},"labels":[],"label_agreement":null},{"id":"W2561277297","doi":"10.1182/blood.v104.11.2669.2669","title":"RXRα Null Haematopoietic Cells Fail To Reconstitute Haematopoiesis in Lethally Irradiated Recipient Mice.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Biology; Haematopoiesis; Retinoid X receptor; Molecular biology; Cre recombinase; Stem cell; Cell biology; Cancer research; Nuclear receptor; Transgene; Transcription factor; Genetically modified mouse; Genetics","score_opus":0.006762036556376771,"score_gpt":0.21808870389508003,"score_spread":0.21132666733870326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561277297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929237,0.0011311217,0.0006567638,0.00036531052,0.0002834179,0.00034059925,0.000014337925,0.000033912453,0.0042508435],"genre_scores_gemma":[0.9944356,0.000309312,0.0038301758,0.00052755687,0.00013942296,0.00007465321,0.000048477395,0.00003830541,0.0005965088],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99832016,0.00005349538,0.00039887303,0.00059554196,0.00018197457,0.00044992313],"domain_scores_gemma":[0.9991563,0.00001290247,0.00009102089,0.00047992668,0.00008149966,0.00017833455],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022916612,0.00026345125,0.0002842619,0.00011014949,0.000075787764,0.000047955175,0.00038420493,0.0002605548,0.00003938216],"category_scores_gemma":[0.000114203605,0.00026738129,0.00011093254,0.00027893495,0.00009732305,0.000007876472,0.00013769825,0.00015688641,0.00017158958],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059193877,0.000392098,0.0013313042,0.00011680575,0.00006784583,0.0001718156,0.0004013016,0.0008448554,0.99525195,0.0002663083,0.00076636986,0.0003301389],"study_design_scores_gemma":[0.0019987382,0.00023331853,0.00044064163,0.00012112178,0.000043885106,0.0001517488,0.00015920597,0.0000019806798,0.98506826,0.000361235,0.011027277,0.00039255703],"about_ca_topic_score_codex":0.00009268772,"about_ca_topic_score_gemma":0.00019537959,"teacher_disagreement_score":0.010260908,"about_ca_system_score_codex":0.00004412946,"about_ca_system_score_gemma":0.00029383326,"threshold_uncertainty_score":0.9999778},"labels":[],"label_agreement":null},{"id":"W2561281452","doi":"10.1182/blood.v120.21.1023.1023","title":"Sildenafil Therapy in Patients with Thalassemia and an Elevated Tricuspid Regurgitant Jet Velocity (TRV) On Doppler Echocardiography At Risk for Pulmonary Hypertension: Report From the Thalassemia Clinical Research Network","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Sildenafil; Internal medicine; Cardiology; Pulmonary hypertension; DLCO; Thalassemia; Population; Surgery; Lung; Diffusing capacity","score_opus":0.06492757509239544,"score_gpt":0.34347666694178697,"score_spread":0.27854909184939153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561281452","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941553,0.0022994697,0.0000025872487,0.00049599126,0.00014655344,0.0024389948,0.00013606391,0.000058872196,0.00026616943],"genre_scores_gemma":[0.9950163,0.0021850078,0.0005677452,0.00034709048,0.0007274284,0.00026266577,0.0007305838,0.00007125352,0.00009193878],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949004,0.0011231058,0.0006360283,0.00088843866,0.0012525871,0.0011994356],"domain_scores_gemma":[0.99479187,0.0025308477,0.00020960982,0.0012525733,0.00052037265,0.0006947511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003752273,0.00037909255,0.0007771023,0.00018744584,0.0005571971,0.000040762963,0.00022082012,0.00032562422,0.00002928676],"category_scores_gemma":[0.00071995676,0.00019716786,0.00023172516,0.00085640966,0.00029353212,0.00021144756,0.00016204544,0.00093094946,0.000013982417],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007461419,0.006074149,0.971173,0.000007726603,0.0006851555,0.0019439796,0.000026446622,0.0000012784382,0.00009117423,0.000002808911,0.008682247,0.0038506433],"study_design_scores_gemma":[0.012547683,0.0033023003,0.9802393,0.00016072698,0.00023973147,0.00034421452,0.0000571777,0.000093854505,0.00022741605,0.000109380264,0.0024535167,0.00022473597],"about_ca_topic_score_codex":0.00026400803,"about_ca_topic_score_gemma":0.000026894671,"teacher_disagreement_score":0.009066291,"about_ca_system_score_codex":0.000079806756,"about_ca_system_score_gemma":0.00014768995,"threshold_uncertainty_score":0.8040272},"labels":[],"label_agreement":null},{"id":"W2561304254","doi":"10.1182/blood.v112.11.sci-26.sci-26","title":"The Path of Iron from Plasma Transferrin to Hemoglobin in Developing Red Blood Cells.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Endosome; Ferrochelatase; Transferrin receptor; Heme; Endocytosis; DMT1; Biochemistry; Transferrin; Chemistry; Cell biology; Hemoglobin; Mitochondrion; Red blood cell; Biology; Receptor; Transporter; Enzyme","score_opus":0.018384343658570612,"score_gpt":0.22632781236348345,"score_spread":0.20794346870491284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561304254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973416,0.0001570356,0.000050162347,0.00086862175,0.00018253509,0.0002650037,0.000012889037,0.000029360754,0.0010928261],"genre_scores_gemma":[0.9958191,0.0004166918,0.0027081908,0.0005714441,0.0001046387,0.000020152667,0.000017181217,0.000015403139,0.00032720898],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991019,0.000056687342,0.00028940733,0.00021174886,0.00013725956,0.00020300137],"domain_scores_gemma":[0.99950427,0.000109629334,0.000036221718,0.00023836667,0.000036898156,0.00007462124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000827558,0.00011422478,0.00026305768,0.000059588427,0.00006648742,0.0000023629175,0.000088215565,0.00009472251,0.000046931327],"category_scores_gemma":[0.00004087731,0.000084396495,0.000060911276,0.00020292749,0.000051199215,0.000017582592,0.000021490569,0.00014415156,0.00003267186],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000991571,0.0009232196,0.016664058,0.000086690336,0.00010648494,0.0003053453,0.0025483775,0.000025938585,0.9758582,0.0001670163,0.001189433,0.001133664],"study_design_scores_gemma":[0.009862085,0.00081970403,0.16761993,0.00020530274,0.00013050757,0.00012442244,0.00024434362,0.000031457083,0.81202286,0.00007408309,0.008652459,0.00021286265],"about_ca_topic_score_codex":0.00013147906,"about_ca_topic_score_gemma":0.0001455127,"teacher_disagreement_score":0.16383536,"about_ca_system_score_codex":0.00001511159,"about_ca_system_score_gemma":0.00011128214,"threshold_uncertainty_score":0.34415892},"labels":[],"label_agreement":null},{"id":"W2561311361","doi":"10.1182/blood.v118.21.5229.5229","title":"Characterization of the Role of the Tumor Suppressor BIN1 as a Potential Mediator of the AHI-1 Oncogene in Human Cutaneous T-Cell Lymphomas","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Cancer research; Mycosis fungoides; Biology; Oncogene; Lymphoma; Leukemia; Immunology; Cell cycle; Cell","score_opus":0.00883467071446946,"score_gpt":0.22744567201744187,"score_spread":0.2186110013029724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561311361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957012,0.0001545473,7.373719e-7,0.00017328167,0.00009260901,0.0010826506,0.000083832885,0.000008238019,0.0027029037],"genre_scores_gemma":[0.9991415,0.000019681203,0.000013351498,0.00006959787,0.000048725768,0.000031486627,0.000009549778,0.00003225386,0.00063384615],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998089,0.00024538473,0.0004890121,0.00021916334,0.0007053351,0.00025207395],"domain_scores_gemma":[0.9985931,0.00004187712,0.00035887916,0.00073747017,0.00021365816,0.00005504025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001662719,0.0001601372,0.00034911066,0.00009045242,0.0000811619,0.000005193844,0.00056402717,0.0000934966,0.0002995321],"category_scores_gemma":[0.00021393159,0.00008607474,0.00021481344,0.00041701365,0.00027749522,0.000031472053,0.00026875158,0.00015677331,0.0000038729154],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022034209,0.0016331247,0.09229786,0.0001007082,0.000064791195,0.000022838076,0.0018662129,0.000001458301,0.9035962,0.000077724864,0.00000617127,0.0001125405],"study_design_scores_gemma":[0.0024653033,0.00026918773,0.029901385,0.000112186746,0.00015542065,0.00048021023,0.0003611349,0.00006476179,0.96583605,0.0002113197,0.00006617866,0.00007686761],"about_ca_topic_score_codex":0.00065818476,"about_ca_topic_score_gemma":0.00020087787,"teacher_disagreement_score":0.06239647,"about_ca_system_score_codex":0.00006501154,"about_ca_system_score_gemma":0.00043823296,"threshold_uncertainty_score":0.3510026},"labels":[],"label_agreement":null},{"id":"W2561343461","doi":"10.1182/blood.v118.21.3141.3141","title":"Reasons for Failure to Remove Inferior Vena Cava Filters: Retrospective Study in a Tertiary Care and Trauma Centre","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Pulmonary embolism; Inferior vena cava filter; Retrospective cohort study; Inferior vena cava; Percutaneous; Univariate analysis; Surgery; Venous thrombosis; Multivariate analysis; Thrombosis; Internal medicine","score_opus":0.0149462038395049,"score_gpt":0.25450651905258426,"score_spread":0.23956031521307936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561343461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99485236,0.00022858489,0.000008026782,0.0004565776,0.000059319413,0.0026748197,0.000035942267,0.00004049148,0.0016438949],"genre_scores_gemma":[0.9972936,0.000017649541,0.0019290467,0.00036014387,0.000076784585,0.00019770763,0.000011536528,0.00002750168,0.00008604852],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99902695,0.000027051869,0.00018226706,0.00036500365,0.00012909733,0.0002696239],"domain_scores_gemma":[0.9994465,0.000016440577,0.00004056573,0.0002878467,0.000070529626,0.00013808998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009852722,0.0001549716,0.0003616957,0.00012458744,0.000050547995,0.000016585389,0.00007099314,0.000047854744,0.000044783053],"category_scores_gemma":[0.000081632694,0.00013869196,0.00005692865,0.00011762317,0.000018713788,0.00005424532,0.00007426498,0.000095299576,0.000007223102],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008726555,0.0033653947,0.9316887,0.00016609805,0.00023278347,0.00019923912,0.057694014,1.735463e-7,0.00018522622,0.00011916794,0.0017865236,0.0044754082],"study_design_scores_gemma":[0.004679528,0.0016455489,0.9703246,0.00022275193,0.00043773625,0.000009685827,0.020752834,0.0000012984071,0.00089344126,0.000046576068,0.00083541364,0.00015059464],"about_ca_topic_score_codex":0.00058732735,"about_ca_topic_score_gemma":0.0033410522,"teacher_disagreement_score":0.038635883,"about_ca_system_score_codex":0.000062781895,"about_ca_system_score_gemma":0.000024721185,"threshold_uncertainty_score":0.5655694},"labels":[],"label_agreement":null},{"id":"W2561344970","doi":"10.1182/blood.v110.11.2042.2042","title":"A Phase II Study of Lenalidomide in Previously Untreated, Symptomatic Chronic Lymphocytic Leukemia (CLL).","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Lenalidomide; Medicine; Neutropenia; Internal medicine; Tumor lysis syndrome; Gastroenterology; Chronic lymphocytic leukemia; Rituximab; Febrile neutropenia; Immunology; Surgery; Multiple myeloma; Leukemia; Lymphoma; Chemotherapy","score_opus":0.018716855911150805,"score_gpt":0.325668133740166,"score_spread":0.3069512778290152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561344970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99358314,0.0019073741,0.000020214131,0.000015949854,0.000062283034,0.0025235845,0.000004142036,0.000121442165,0.0017618561],"genre_scores_gemma":[0.99862814,0.00011119363,0.00011928108,0.000051227424,0.00018285296,0.00009298458,0.000016230037,0.000071274655,0.0007268084],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9960398,0.00012656131,0.0011630163,0.0005913807,0.0010479799,0.0010312396],"domain_scores_gemma":[0.99785537,0.0003648341,0.00023065144,0.00104066,0.00015809866,0.00035037042],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014735002,0.00035775124,0.00093462295,0.0006251209,0.000090806534,0.000019588402,0.0003770024,0.00019371639,0.00016827729],"category_scores_gemma":[0.0004102639,0.00031106285,0.00015090985,0.0011299074,0.00016198946,0.00011185816,0.00025147232,0.00032089328,0.000075483964],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.039092574,0.27787596,0.050641544,0.02551037,0.013047377,0.07726172,0.098158605,0.0044259476,0.23696585,0.000769448,0.0029909709,0.17325963],"study_design_scores_gemma":[0.87546307,0.028509514,0.0025416834,0.0019121561,0.0014288394,0.0022078138,0.0021236525,0.015520408,0.06943398,0.000058521826,0.0002018904,0.00059849664],"about_ca_topic_score_codex":0.005368334,"about_ca_topic_score_gemma":0.0018157179,"teacher_disagreement_score":0.83637047,"about_ca_system_score_codex":0.058578,"about_ca_system_score_gemma":0.024410345,"threshold_uncertainty_score":0.99993414},"labels":[],"label_agreement":null},{"id":"W2561477522","doi":"10.1182/blood.v126.23.1668.1668","title":"Suspicious, Non-MDS-Diagnostic Bone Marrows Have a High Incidence of Clonal Hematopoiesis (CHIP), with MDS-like Clone Size but Restricted Mutation Burden","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Cytopenia; Myelodysplastic syndromes; Medicine; Sanger sequencing; Internal medicine; Dysplasia; International Prognostic Scoring System; Oncology; Biology; Bone marrow; DNA sequencing; Genetics; Gene","score_opus":0.012901542360262419,"score_gpt":0.2587920971529594,"score_spread":0.245890554792697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561477522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994982,0.0005923733,0.00022539965,0.0018435057,0.000076588956,0.0012146737,0.00005879309,0.00011776321,0.0008888908],"genre_scores_gemma":[0.9877024,0.00009992973,0.009603869,0.00021886121,0.00037954035,0.00015481269,0.00012996713,0.00008282017,0.0016277545],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99645436,0.00015131415,0.0006733776,0.0005754044,0.0015075101,0.0006380242],"domain_scores_gemma":[0.9958377,0.0015019435,0.00032934517,0.0007871486,0.000983273,0.0005605875],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00050797337,0.00035468914,0.00078674173,0.00030816684,0.00008995826,0.00003560155,0.00030896123,0.00025951883,0.00010671638],"category_scores_gemma":[0.0048261033,0.00029687394,0.000098148805,0.0007729905,0.00031442815,0.0001868228,0.0001939343,0.0005741774,0.000097503864],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018252198,0.008912544,0.44539037,0.0042487886,0.004070493,0.04989391,0.014691417,0.00083267805,0.3964509,0.001000298,0.052323487,0.0039329063],"study_design_scores_gemma":[0.10428215,0.014983983,0.56181014,0.0034901672,0.0043273955,0.013064784,0.007420061,0.002830668,0.28258023,0.0017542664,0.001182281,0.0022739011],"about_ca_topic_score_codex":0.00594777,"about_ca_topic_score_gemma":0.00027611034,"teacher_disagreement_score":0.11641975,"about_ca_system_score_codex":0.00029691434,"about_ca_system_score_gemma":0.0016751321,"threshold_uncertainty_score":0.9999483},"labels":[],"label_agreement":null},{"id":"W2561481733","doi":"10.1182/blood.v106.11.4987.4987","title":"Long-Term Results of a Low-Dose Cytarabine-Based Regimen for the Treatment of Acute Megakaryoblastic Leukemia and Myelodysplastic Syndrome in Children with Down Syndrome.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Cytarabine; Medicine; Acute megakaryoblastic leukemia; Regimen; Chemotherapy; Internal medicine; Down syndrome; Leukemia; Chemotherapy regimen; Population; Gastroenterology; Pediatrics","score_opus":0.009387277260244554,"score_gpt":0.25414687957566945,"score_spread":0.2447596023154249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561481733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99561894,0.0006669357,0.00012039771,0.0006030262,0.00001476038,0.0026397246,0.00025046142,0.00002934838,0.000056422086],"genre_scores_gemma":[0.9975468,0.0003431977,0.0012652086,0.000036740523,0.00004908702,0.00026391185,0.00012893222,0.00004601977,0.00032012904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997941,0.000056021334,0.00058525946,0.0004881829,0.00044251085,0.00048701986],"domain_scores_gemma":[0.99810535,0.00067245524,0.00022720055,0.00069661305,0.00012136672,0.00017700253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025613263,0.00032904503,0.00074211275,0.00032283246,0.00006193763,0.000014723866,0.00021677715,0.0001359423,0.000013185212],"category_scores_gemma":[0.00008893605,0.00019894833,0.00011894987,0.00043055834,0.00033801433,0.00008158784,0.00003230604,0.00019172186,0.0000047141993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.081770696,0.021652695,0.79776883,0.0032574907,0.02350726,0.0056794034,0.0035244094,0.0045302254,0.034565534,0.00013677868,0.000524642,0.02308206],"study_design_scores_gemma":[0.06272264,0.011007789,0.9032057,0.0007010601,0.00208621,0.003161845,0.000017550234,0.0017256901,0.015137643,0.00000450856,0.000012905973,0.00021644172],"about_ca_topic_score_codex":0.0001652667,"about_ca_topic_score_gemma":0.00010455025,"teacher_disagreement_score":0.10543692,"about_ca_system_score_codex":0.00039231073,"about_ca_system_score_gemma":0.0007555831,"threshold_uncertainty_score":0.8112877},"labels":[],"label_agreement":null},{"id":"W2561489460","doi":"10.1182/blood.v114.22.644.644","title":"Safety and Efficacy of Subcutaneous-Administered Omacetaxine Mepesuccinate in Imatinib-Resistant Chronic Myeloid Leukemia (CML) Patients Who Harbor the Bcr- Abl T315I Mutation–Results of An Ongoing Multicenter Phase 2/3 Study.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Imatinib; Imatinib mesylate; Dasatinib; Adverse effect; Gastroenterology; Myeloid leukemia","score_opus":0.010307821270581765,"score_gpt":0.28015971471022333,"score_spread":0.26985189343964155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561489460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99601984,0.00051146984,0.0000040682125,0.00018771652,0.00005115497,0.002601196,0.0002004863,0.000040964267,0.00038312192],"genre_scores_gemma":[0.9988949,0.00009198495,0.00056994084,0.00006219747,0.00005916212,0.000024955354,0.00015159743,0.000042015014,0.00010326848],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9966094,0.0002488099,0.0014306267,0.0006256896,0.0006098574,0.00047560612],"domain_scores_gemma":[0.9974892,0.0003619658,0.00067452056,0.0010747123,0.00020496918,0.0001946055],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00051447784,0.00040805995,0.0008795108,0.00021685855,0.000110498804,0.000025795911,0.0003080328,0.00011638467,0.00003842968],"category_scores_gemma":[0.00057535357,0.00030228414,0.00011989336,0.0003687845,0.00013057109,0.000160257,0.00009373613,0.00029005873,0.000004292601],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22261156,0.16160479,0.06089028,0.0029205894,0.005145335,0.0072695115,0.05010684,0.0008978044,0.16790068,0.00013926582,0.0001533186,0.32036],"study_design_scores_gemma":[0.27430978,0.026460594,0.65789396,0.0009160322,0.0011503433,0.00009220728,0.0006332268,0.0029977567,0.035040144,0.0000104345,0.000104428,0.00039111153],"about_ca_topic_score_codex":0.00034759744,"about_ca_topic_score_gemma":0.00037492532,"teacher_disagreement_score":0.59700364,"about_ca_system_score_codex":0.00072713534,"about_ca_system_score_gemma":0.0005171249,"threshold_uncertainty_score":0.9999429},"labels":[],"label_agreement":null},{"id":"W2561500062","doi":"10.1182/blood.v108.11.4899.4899","title":"Baseline Demographics and Disease Characteristics of Patients with Hypereosinophilic Syndrome in a Placebo-Controlled Trial Evaluating the Steroid-Sparing Effects of the Anti-IL-5 Monoclonal Antibody, Mepolizumab.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Mepolizumab; Medicine; Hypereosinophilic syndrome; Prednisone; Internal medicine; Population; Eosinophilia; Clinical endpoint; Eosinophil; Placebo; Gastroenterology; Immunology; Clinical trial; Asthma; Pathology","score_opus":0.0074747420715447245,"score_gpt":0.24293313183058257,"score_spread":0.23545838975903785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561500062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958459,0.00060319126,0.000011245374,0.00020645451,0.00009738239,0.0031427182,0.000043385517,0.000012261889,0.00003742302],"genre_scores_gemma":[0.99959075,0.000036334375,0.00010521753,0.000052686573,0.0000455953,0.00007891331,0.00003809252,0.000027039847,0.000025337748],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99799114,0.00025152226,0.0006512996,0.0002699716,0.00057416403,0.0002618836],"domain_scores_gemma":[0.9984583,0.00051535846,0.00039833394,0.00041117633,0.00012504481,0.00009175893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050112064,0.00023362471,0.0007856335,0.00014711049,0.00009483255,0.000017205339,0.00014860243,0.00007117052,0.0000040798777],"category_scores_gemma":[0.00062968535,0.00012589601,0.00014773315,0.00033001872,0.00023477162,0.00005368207,0.00007863504,0.00019845349,2.047145e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03427411,0.0024255954,0.9609046,0.00048465727,0.00018755216,0.00003528024,0.00008030032,0.000009861099,0.0011660042,0.00009003352,0.0000022836757,0.00033973125],"study_design_scores_gemma":[0.20882657,0.0014232852,0.78748477,0.0004959193,0.0008958529,0.000020648282,0.0000122983365,0.0005504721,0.00007828883,0.00010185644,0.0000011247114,0.00010889244],"about_ca_topic_score_codex":0.00007840875,"about_ca_topic_score_gemma":0.00001697155,"teacher_disagreement_score":0.17455247,"about_ca_system_score_codex":0.000009635823,"about_ca_system_score_gemma":0.0001617165,"threshold_uncertainty_score":0.51338905},"labels":[],"label_agreement":null},{"id":"W2561546557","doi":"10.1182/blood.v110.11.382.382","title":"3D Nuclear Organization of Telomeres in Hodgkin and Reed-Sternberg Cells.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Telomere; Telomerase; Interphase; Shelterin; Molecular biology; Mitosis; Peripheral blood mononuclear cell; Biology; Chemistry; DNA; Cell biology; Genetics; Gene; In vitro","score_opus":0.006823281619134251,"score_gpt":0.219648129548433,"score_spread":0.21282484792929873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561546557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976719,0.00030081876,0.000038442668,0.00008970187,0.00006283678,0.00015468152,0.0000033547008,0.000042927717,0.0016353102],"genre_scores_gemma":[0.99749047,0.00023857632,0.0017817864,0.00016088889,0.00007472978,4.8040897e-7,0.000007367072,0.000028465034,0.0002172633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911225,0.000017760298,0.00028905988,0.00020058904,0.00018023804,0.0002001298],"domain_scores_gemma":[0.99949986,0.000048927355,0.00007655489,0.00020024164,0.00007923892,0.00009517684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000200768,0.00010802404,0.00023495316,0.00019119214,0.000027459153,0.000008262084,0.000063320025,0.00009544403,0.000111183326],"category_scores_gemma":[0.00010383251,0.000100464735,0.000019858018,0.00044044215,0.00007498021,0.00005860554,0.00003827108,0.00011266365,0.000017931105],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000083845276,0.000664107,0.6008417,0.00022096367,0.00003566481,0.00015555491,0.0018804995,8.153488e-7,0.38588917,0.00020101416,0.0001440523,0.009882629],"study_design_scores_gemma":[0.0031447401,0.00022050086,0.7167124,0.0001732008,0.00008458214,0.00009977657,0.0005147639,0.00001664019,0.2768872,0.00001786521,0.0019636902,0.0001646251],"about_ca_topic_score_codex":0.00014572241,"about_ca_topic_score_gemma":0.00007572645,"teacher_disagreement_score":0.11587071,"about_ca_system_score_codex":0.000013632813,"about_ca_system_score_gemma":0.000028544764,"threshold_uncertainty_score":0.40968332},"labels":[],"label_agreement":null},{"id":"W2561561373","doi":"10.1182/blood.v116.21.1753.1753","title":"Pralatrexate Is Effective In Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma (PTCL) with Prior Ifosfamide, Carboplatin, and Etoposide (ICE)-Based Regimens","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Ifosfamide; Carboplatin; Regimen; Internal medicine; Etoposide; Oncology; Surgery; Chemotherapy regimen; Rituximab; Chemotherapy; Lymphoma; Cisplatin","score_opus":0.003302812425045068,"score_gpt":0.19966496025942582,"score_spread":0.19636214783438075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561561373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965287,0.00015476663,0.000001015155,0.00021267752,0.00005779877,0.0017128923,0.000023401908,0.00006332897,0.0012454494],"genre_scores_gemma":[0.9967352,0.000013447907,0.0020522042,0.00047443007,0.00004690789,0.00023876416,0.000040658942,0.00006299101,0.00033538186],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983399,0.00006435746,0.0002602951,0.0005785122,0.00037719446,0.00037977853],"domain_scores_gemma":[0.9987754,0.00018783755,0.00018257285,0.00048516074,0.00013137351,0.00023764404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000099917306,0.00036840342,0.00049247267,0.00012776132,0.00009501838,0.000036986516,0.00006414046,0.00017721619,0.000050591432],"category_scores_gemma":[0.000043870165,0.00022105449,0.000052759442,0.00023041012,0.00012686012,0.00011889162,0.000028156555,0.00019781763,0.000009039696],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003702011,0.00670959,0.98262155,0.000110399975,0.00020907189,0.00049272075,0.0006928707,0.0000014121972,0.0011468726,0.000005949291,0.00007765392,0.004229887],"study_design_scores_gemma":[0.0850478,0.00607137,0.8880758,0.00029840771,0.000560142,0.000044534343,0.00005060805,0.000035296343,0.019142266,0.000002774061,0.00038576007,0.0002851973],"about_ca_topic_score_codex":0.00043197768,"about_ca_topic_score_gemma":0.0007140789,"teacher_disagreement_score":0.094545715,"about_ca_system_score_codex":0.00014250247,"about_ca_system_score_gemma":0.0003467703,"threshold_uncertainty_score":0.90143406},"labels":[],"label_agreement":null},{"id":"W2561597693","doi":"10.1182/blood.v124.21.2768.2768","title":"Histones Induce Endothelial Von Willebrand Factor Release and Subsequent Platelet Capture in In Vitro and In Vivo Models","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Von Willebrand factor; Platelet; Platelet activation; Histone; Chemistry; Immunology; Histone H4; Molecular biology; Whole blood; Andrology; Internal medicine; Endocrinology; Biology; Medicine; DNA; Biochemistry","score_opus":0.012227061891731006,"score_gpt":0.22421456133814074,"score_spread":0.21198749944640974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561597693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973249,0.0015816822,0.0000030644746,0.000220149,0.000028257535,0.00033447595,0.000041810763,0.000012877193,0.0004528075],"genre_scores_gemma":[0.99930966,0.0002827503,0.00009779754,0.00014389487,0.000017971075,0.00002203063,0.000014122959,0.000017176846,0.00009456794],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99914694,0.000038986043,0.0002001156,0.00027442686,0.000110763205,0.00022875922],"domain_scores_gemma":[0.9996934,0.00004336464,0.000037642636,0.00011886169,0.000009276423,0.000097440956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000072983166,0.00016185643,0.00037350898,0.00018113758,0.000017578946,0.000010477362,0.000030295476,0.00013258365,0.00001003096],"category_scores_gemma":[0.000035055862,0.00013634663,0.000020076128,0.000094216055,0.00003970038,0.000098268654,0.000019829662,0.00018354194,0.0000012437655],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050388677,0.0059585157,0.5319414,0.00052386493,0.00019969388,0.008024348,0.010289366,0.00009630465,0.41933277,0.00024963924,0.000087154214,0.018258046],"study_design_scores_gemma":[0.2237627,0.0014397864,0.32739276,0.0012844717,0.00036508343,0.0020114847,0.00096249435,0.009284981,0.422228,0.0070759333,0.0023438972,0.0018484024],"about_ca_topic_score_codex":0.0011714842,"about_ca_topic_score_gemma":0.001154941,"teacher_disagreement_score":0.21872383,"about_ca_system_score_codex":0.000040010054,"about_ca_system_score_gemma":0.000031617914,"threshold_uncertainty_score":0.5560054},"labels":[],"label_agreement":null},{"id":"W2561619633","doi":"10.1182/blood.v106.11.5251.5251","title":"Improved Suicide Gene Therapy: Lentiviral Gene Transfer of Equine Herpes Virus Type 4 Thymidine Kinase into Target Cells.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Suicide gene; Thymidine kinase; Genetic enhancement; Ganciclovir; Viral vector; Biology; Virology; CD19; Cancer research; Herpes simplex virus; Gene; Human cytomegalovirus; Virus; Cell; Genetics; Recombinant DNA","score_opus":0.015665457209402846,"score_gpt":0.2729608108389068,"score_spread":0.25729535362950395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561619633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833115,0.01542079,0.00044484297,0.00018057942,0.00008462905,0.0003533582,0.000063513035,0.000024485844,0.000116332434],"genre_scores_gemma":[0.99264807,0.0032916798,0.0024282127,0.00036232715,0.0005150812,0.00003054732,0.00020055863,0.000074197495,0.00044933017],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983716,0.000097862314,0.00034372625,0.00047510886,0.00024519142,0.0004665285],"domain_scores_gemma":[0.9990184,0.000014367063,0.000054713888,0.00061036466,0.00017168341,0.00013050225],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032187044,0.00028173134,0.00028699977,0.00008310251,0.00007428966,0.000022706956,0.00039970654,0.0002022557,0.00021818472],"category_scores_gemma":[0.00002088621,0.00025723866,0.0001788378,0.00019356135,0.00013192283,0.000010378737,0.000086646396,0.00012206299,0.00002407229],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030013195,0.0010018148,0.0000985627,0.000018769884,0.0002810619,0.0000066735315,0.000082183586,0.00008146718,0.9825598,0.0000030487104,0.00014524833,0.012720031],"study_design_scores_gemma":[0.0036684535,0.0067226905,0.000036719433,0.0000059650606,0.000034547582,0.0000045970773,0.000011622165,0.00008725817,0.98254055,0.00003050777,0.0065775984,0.00027951982],"about_ca_topic_score_codex":0.00011331922,"about_ca_topic_score_gemma":0.00037176054,"teacher_disagreement_score":0.012440511,"about_ca_system_score_codex":0.00001479005,"about_ca_system_score_gemma":0.00015729044,"threshold_uncertainty_score":0.99998796},"labels":[],"label_agreement":null},{"id":"W2561629989","doi":"10.1182/blood.v112.11.3239.3239","title":"Safety and Efficacy of Subcutaneous (SC) Omacetaxine Mepesuccinate in Imatinib(IM)-Resistant Chronic Myeloid Leukemia (CML) Patients (pts) with the T315I Mutation – Results of An Ongoing Multicenter Phase II Study.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Homoharringtonine; Imatinib; Internal medicine; Adverse effect; Dasatinib; Myeloid leukemia; Imatinib mesylate; Phases of clinical research; Gastroenterology; Clinical trial","score_opus":0.00963936395558686,"score_gpt":0.25648359686461075,"score_spread":0.24684423290902388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561629989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99686456,0.0003237437,0.0000042920265,0.0000887989,0.000030054678,0.0022841408,0.00011088762,0.00003769401,0.0002558556],"genre_scores_gemma":[0.9989293,0.00010109182,0.00053990004,0.000020412223,0.00004153781,0.000032036824,0.00017476126,0.000047987218,0.00011297121],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972949,0.00019874898,0.000943171,0.000544864,0.0006277678,0.00039055463],"domain_scores_gemma":[0.9979856,0.00024498024,0.0005706854,0.0008476871,0.00021130974,0.00013972931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037292318,0.00034437017,0.0006886732,0.00019350214,0.00019745644,0.000008154847,0.00020933295,0.00009150658,0.000020885085],"category_scores_gemma":[0.00027915838,0.0002293178,0.00007142385,0.00038692795,0.00021699654,0.00014074973,0.00012011818,0.00026621646,0.000002416637],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.31823075,0.15488973,0.105012484,0.0023270666,0.0056623956,0.013936796,0.12314855,0.0029489063,0.12712425,0.000032098993,0.00014453972,0.14654244],"study_design_scores_gemma":[0.4518016,0.062129743,0.43848786,0.0008782356,0.0013669325,0.000603765,0.0012562658,0.0025302623,0.040384043,0.0000026322155,0.00010008961,0.0004585753],"about_ca_topic_score_codex":0.0010091447,"about_ca_topic_score_gemma":0.0013873765,"teacher_disagreement_score":0.33347538,"about_ca_system_score_codex":0.0007577349,"about_ca_system_score_gemma":0.0005285939,"threshold_uncertainty_score":0.93513083},"labels":[],"label_agreement":null},{"id":"W2561643684","doi":"10.1182/blood.v108.11.2240.2240","title":"Molecular and Pharmacologic Suppression of MAPK Activity Rescues Differentiation of BCR/ABL+ Myeloid Progenitors by Releasing C/EBPa from the Inhibitory Effect of hnRNP E2.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"K562 cells; ABL; breakpoint cluster region; Progenitor cell; Chronic myelogenous leukemia; Myeloid; Biology; Molecular biology; Cancer research; Myeloid leukemia; Leukemia; Stem cell; Cell biology; Immunology; Receptor; Signal transduction; Tyrosine kinase; Genetics","score_opus":0.005215759300502526,"score_gpt":0.23902528953109806,"score_spread":0.23380953023059553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561643684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99580204,0.00318195,0.000013068112,0.00004738938,0.00007852967,0.00068935094,0.00007157709,0.000022414326,0.00009367331],"genre_scores_gemma":[0.9995463,0.00010610728,0.00010451458,0.0000063725565,0.00008286395,0.000024671837,0.000089496454,0.000019602576,0.00002008216],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99871385,0.00027526374,0.0002971821,0.00024078811,0.00031752212,0.00015540174],"domain_scores_gemma":[0.999028,0.00031313355,0.00030354442,0.0002601362,0.000053940705,0.00004123858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013005034,0.0001740973,0.00041466538,0.000048690494,0.00004131507,0.0000044633416,0.00007544698,0.00012216772,0.000019800416],"category_scores_gemma":[0.00008676089,0.0001126931,0.000101156504,0.00010595808,0.00012832951,0.00005782011,0.00006782495,0.00014534462,5.7318016e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004178663,0.00063442846,0.11405302,0.00023224358,0.00021019687,0.000008096442,0.00009272294,0.0000028384386,0.88215554,0.0000014444455,0.00024365167,0.0019479662],"study_design_scores_gemma":[0.0068793935,0.00049736793,0.12254794,0.00026175848,0.00094234414,0.000005078122,0.000017143304,0.00005710324,0.8686833,0.000019467032,0.000021962167,0.000067182475],"about_ca_topic_score_codex":0.0007301566,"about_ca_topic_score_gemma":0.000005332799,"teacher_disagreement_score":0.0134722665,"about_ca_system_score_codex":0.00007551993,"about_ca_system_score_gemma":0.000066307926,"threshold_uncertainty_score":0.45954913},"labels":[],"label_agreement":null},{"id":"W2561655537","doi":"10.1182/blood.v126.23.4973.4973","title":"Practical Acute Myeloid Leukemia (AML) Biomarker Testing Using Next-Generation Sequencing (NGS) Technology: A Comprehensive, Rapid, Inexpensive and Flexible Approach","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences North","funders":"","keywords":"CEBPA; Computational biology; Minimal residual disease; Personalized medicine; NPM1; Biomarker; DNA sequencing; Myeloid leukemia; Biomarker discovery; Medicine; Bioinformatics; Oncology; Biology; Leukemia; Gene; Internal medicine; Genetics; Mutation; Proteomics; Chromosome","score_opus":0.2668825862060752,"score_gpt":0.3620575923762642,"score_spread":0.09517500617018904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561655537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893451,0.00107294,0.0048057204,0.0010737394,0.00008666921,0.000986029,0.000008344777,0.00034991995,0.0022715556],"genre_scores_gemma":[0.71150535,0.00007795952,0.28713563,0.0005399806,0.00037419863,0.000057224883,0.00007481912,0.00008298431,0.0001518452],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9973017,0.00015568879,0.00047616096,0.0007634198,0.00059970253,0.00070331985],"domain_scores_gemma":[0.9974889,0.00021017382,0.00020070482,0.0005658456,0.0010799535,0.0004543836],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00051899714,0.00036865417,0.00059803185,0.00060468784,0.00025674104,0.00013768607,0.00015085381,0.00043803724,0.000010052224],"category_scores_gemma":[0.0018014214,0.00033433616,0.00006212502,0.0013112513,0.0004091535,0.00050590833,0.00038953745,0.0008439307,0.000027735698],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018588168,0.00015644488,0.003748008,0.00010176974,0.00043453995,0.0006862731,0.00032559742,0.000050362953,0.9889598,0.00015896281,0.0018090333,0.003383327],"study_design_scores_gemma":[0.0237513,0.0016721706,0.001521685,0.00043446492,0.0022148984,0.039097182,0.008790612,0.517803,0.40049288,0.00032637615,0.0025787402,0.0013166787],"about_ca_topic_score_codex":0.00022613247,"about_ca_topic_score_gemma":0.000002805064,"teacher_disagreement_score":0.58846694,"about_ca_system_score_codex":0.0009849132,"about_ca_system_score_gemma":0.0027298864,"threshold_uncertainty_score":0.9999109},"labels":[],"label_agreement":null},{"id":"W2561661150","doi":"10.1182/blood.v104.11.3104.3104","title":"Persistence of High Viral Load Abrogates Long-Term HIV-Specific Memory CD4 T-Cells Producing Interleukin-2.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University Health Centre","funders":"","keywords":"Biology; CD8; Immunology; Memory T cell; Virology; T cell; Viral load; Cytotoxic T cell; Immune system; Virus; In vitro","score_opus":0.014730192453371784,"score_gpt":0.22774894659679087,"score_spread":0.2130187541434191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561661150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99205804,0.0063977893,0.000024600602,0.00014395351,0.0002424663,0.0002909873,0.00008175394,0.00004899492,0.0007113994],"genre_scores_gemma":[0.99708015,0.00022854088,0.00022398987,0.00001557117,0.00003988217,0.000023721444,0.00012731807,0.000015119454,0.0022457258],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998787,0.00007472146,0.00024561537,0.00039274344,0.00007421437,0.00042571774],"domain_scores_gemma":[0.9993149,0.000046041805,0.00008387945,0.00041698755,0.00009802378,0.000040156985],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013420708,0.00017744774,0.0002713892,0.000085939944,0.000112556154,0.0000150281685,0.00026914635,0.00011708103,0.00047145376],"category_scores_gemma":[0.000024463283,0.00014709822,0.00011944349,0.00009591755,0.00029822867,0.00008067639,0.00009950349,0.0002147758,0.0022148865],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017944627,0.0018966161,0.0062799607,0.000077310586,0.000522611,0.00017079708,0.001929349,0.000011539528,0.98541355,0.0001090591,0.00042801438,0.00298172],"study_design_scores_gemma":[0.0053339484,0.00055644923,0.019822242,0.00012570663,0.000071389906,0.00011357404,0.00016726532,2.7285134e-8,0.9732887,0.000046100322,0.00032929252,0.00014530522],"about_ca_topic_score_codex":0.00015434276,"about_ca_topic_score_gemma":0.00005455636,"teacher_disagreement_score":0.0135422805,"about_ca_system_score_codex":0.00009040422,"about_ca_system_score_gemma":0.0001505264,"threshold_uncertainty_score":0.998562},"labels":[],"label_agreement":null},{"id":"W2561698783","doi":"10.1182/blood.v118.21.68.68","title":"Discovery of Novel Recurrent Mutations in Childhood Early T-Cell Precursor Acute Lymphoblastic Leukemia by Whole Genome Sequencing - a Report From the St Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Biology; Genetics; Exome sequencing; Fusion gene; Chromosomal translocation; Gene; Mutation","score_opus":0.024863549248756393,"score_gpt":0.26861110288859164,"score_spread":0.24374755363983525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561698783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99233234,0.00092598493,0.00021615643,0.00011843967,0.000113663344,0.0021915985,0.003483446,0.000057190122,0.0005611849],"genre_scores_gemma":[0.99640864,0.000568606,0.0008533309,0.0000193635,0.00032001815,0.000082650615,0.0008506217,0.0000822124,0.00081456115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99588263,0.00024437997,0.0006772479,0.0009664062,0.0012913063,0.0009380218],"domain_scores_gemma":[0.99767894,0.00044432204,0.00038220076,0.00090432033,0.0003756879,0.00021454788],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00082193845,0.00036757003,0.0005618778,0.00052923826,0.00026409212,0.00007023337,0.00081279286,0.0002450276,0.000034400888],"category_scores_gemma":[0.00039329164,0.00030114414,0.0001876336,0.0018478865,0.00037306803,0.0004912646,0.0005091191,0.0009893782,0.000020152258],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020959286,0.01604824,0.70874023,0.00053413014,0.003139965,0.0035339198,0.064733505,0.00014401227,0.19739363,0.00006335716,0.0032332109,0.00033990358],"study_design_scores_gemma":[0.017084677,0.0016026346,0.97035646,0.00031864454,0.0016118025,0.00021516708,0.002099027,0.0001829461,0.005779826,0.00003614599,0.00011090265,0.0006017613],"about_ca_topic_score_codex":0.021798788,"about_ca_topic_score_gemma":0.00031832754,"teacher_disagreement_score":0.26161626,"about_ca_system_score_codex":0.003038065,"about_ca_system_score_gemma":0.0078003844,"threshold_uncertainty_score":0.9999441},"labels":[],"label_agreement":null},{"id":"W2561700016","doi":"10.1182/blood.v104.11.2709.2709","title":"Variation in Transfusion Rates amongst Canadian Academic and Community Medical Centers.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Blood Services; University of Ottawa","funders":"","keywords":"Medicine; Trauma center; Retrospective cohort study; Odds ratio; Blood transfusion; Single Center; Cohort; Surgery; Emergency medicine; Pediatrics; Internal medicine","score_opus":0.014247233965339752,"score_gpt":0.2567470089568213,"score_spread":0.24249977499148154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561700016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859123,0.00014093246,0.00009169782,0.010794415,0.00006133409,0.00035094356,0.000003498583,0.00003030162,0.0026145629],"genre_scores_gemma":[0.9964731,0.0012215256,0.000097996824,0.0021128699,0.000031574753,0.000011713514,0.000019760379,0.000009259894,0.000022220887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992414,0.00008030938,0.00017575698,0.00011861029,0.00019495934,0.00018893239],"domain_scores_gemma":[0.9995009,0.000025292762,0.000014749434,0.00012878212,0.000011959892,0.0003183384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038323068,0.0000847699,0.0001420271,0.00016440559,0.000113164424,0.000007183739,0.000071187,0.0001547601,0.00009465261],"category_scores_gemma":[0.000058692847,0.00007744351,0.000023132376,0.00015420577,0.00004316874,0.000050411287,0.000016302036,0.0007234165,0.000006481247],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044828473,0.009199551,0.84158707,0.0011277316,0.00049205247,0.0014594216,0.041764,0.00001965684,0.062623695,0.009462964,0.00033013572,0.031485435],"study_design_scores_gemma":[0.012406056,0.0002056113,0.98308396,0.0003199739,0.00013242291,0.00006716169,0.00053120207,0.000023119414,0.0020448274,0.00028813822,0.0007891683,0.00010836912],"about_ca_topic_score_codex":0.22296092,"about_ca_topic_score_gemma":0.35514593,"teacher_disagreement_score":0.14149688,"about_ca_system_score_codex":0.000034143777,"about_ca_system_score_gemma":0.00015415534,"threshold_uncertainty_score":0.78221345},"labels":[],"label_agreement":null},{"id":"W2561740562","doi":"10.1182/blood.v108.11.3373.3373","title":"Factors Influencing Varicella-Zoster Virus (VZV) Infection after Allogeneic Peripheral Blood Stem Cell Transplantation: Low-Dose Acyclovir Prophylaxis and Pre-Transplant Diagnosis of Lymphoproliferative Disorders.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Transplantation; Cumulative incidence; Varicella zoster virus; Incidence (geometry); Internal medicine; Immunology; Hematopoietic stem cell transplantation; Gastroenterology; Virus","score_opus":0.006547304663574172,"score_gpt":0.21742653120830788,"score_spread":0.2108792265447337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561740562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99731326,0.0008194542,0.00009827046,0.000014493685,0.00009421618,0.0009149293,0.00016226059,0.000074355165,0.00050875143],"genre_scores_gemma":[0.9981394,0.0010464299,0.000111041256,0.000045523822,0.000080416336,0.0003242005,0.00006779037,0.0000436725,0.00014154715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984402,0.00009391971,0.00046344363,0.00043229113,0.00025965963,0.0003104842],"domain_scores_gemma":[0.99934614,0.00007573506,0.00013862846,0.00023078335,0.00008676437,0.000121968005],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000071276976,0.00036305754,0.00041564365,0.00017831686,0.00014449986,0.000039642047,0.0000435748,0.00020722635,0.00010307498],"category_scores_gemma":[0.0000029526666,0.00028656604,0.00016273618,0.00025960963,0.00009383458,0.00019729887,0.00001570323,0.00015554759,0.0000054973143],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026936422,0.003546249,0.98139906,0.00057683565,0.00037406653,0.00008118618,0.0024913545,0.000051265943,0.008918329,0.00000435254,0.0000020069133,0.0022859056],"study_design_scores_gemma":[0.0055449433,0.0010085739,0.790975,0.0001711042,0.001363248,0.00006639602,0.00004097643,0.00000830964,0.20044214,0.000017005588,0.00011521888,0.00024708657],"about_ca_topic_score_codex":0.0025411225,"about_ca_topic_score_gemma":0.001232899,"teacher_disagreement_score":0.1915238,"about_ca_system_score_codex":0.000059874903,"about_ca_system_score_gemma":0.00009056761,"threshold_uncertainty_score":0.99995863},"labels":[],"label_agreement":null},{"id":"W2561740607","doi":"10.1182/blood.v110.11.1450.1450","title":"Preliminary Results of a Phase II Study of Decitabine Administered Daily for 5 Days Every 4 Weeks to Adults with Myelodysplastic Syndrome (MDS).","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Decitabine; Medicine; International Prognostic Scoring System; Regimen; Internal medicine; Chronic myelomonocytic leukemia; Myelodysplastic syndromes; Phases of clinical research; Clinical endpoint; Bone marrow; Surgery; Gastroenterology; Clinical trial","score_opus":0.021236378653873487,"score_gpt":0.3115170207281743,"score_spread":0.29028064207430077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561740607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943612,0.00008864198,0.0005093018,0.00017449538,0.000057796817,0.003989777,0.0002821578,0.000048758277,0.00048785328],"genre_scores_gemma":[0.99376804,0.0000045452475,0.0048536644,0.000054484324,0.000089541085,0.000163436,0.00010029233,0.000069196896,0.00089682057],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99691683,0.000052076764,0.0009774388,0.0006115179,0.0008344574,0.00060769665],"domain_scores_gemma":[0.99700123,0.00077933347,0.0002885038,0.000920278,0.0005769336,0.00043372344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009084379,0.00029701996,0.0008091704,0.00051383977,0.0000926851,0.000007025594,0.00032551817,0.00013451299,0.00001959501],"category_scores_gemma":[0.0011903044,0.00023753694,0.000096068965,0.00072113035,0.000109136694,0.00008927057,0.00022886069,0.00025330536,0.0000074380296],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7747926,0.10101896,0.0060778027,0.002869532,0.003025285,0.0063766786,0.027530773,0.00004397879,0.06000029,0.000028425417,0.004576639,0.013659018],"study_design_scores_gemma":[0.28072137,0.5725937,0.09056824,0.0020407818,0.0018730436,0.0015554121,0.0082230335,0.00022392538,0.041204233,0.000007989999,0.00047502376,0.0005132537],"about_ca_topic_score_codex":0.00011061919,"about_ca_topic_score_gemma":0.00010305282,"teacher_disagreement_score":0.49407127,"about_ca_system_score_codex":0.000089781235,"about_ca_system_score_gemma":0.00046834754,"threshold_uncertainty_score":0.96864754},"labels":[],"label_agreement":null},{"id":"W2561764353","doi":"10.1182/blood.v114.22.4184.4184","title":"Live Term Birth and Two Ongoing Viable Pregnancies with Therapeutic Enoxaparin and Aspirin After Failure of Prophylactic Enoxaparin and Aspirin in Two Women with Thrombophilia and Recurrent Pregnancy Loss.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Thrombophilia; Aspirin; Low molecular weight heparin; Antiphospholipid syndrome; Pregnancy; Live birth; Heparin; Thrombosis; Obstetrics; Gynecology; Surgery; Internal medicine","score_opus":0.0044249988317293844,"score_gpt":0.21783911561039582,"score_spread":0.21341411677866642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561764353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97714025,0.022098612,0.000007964782,0.00004103396,0.000006658838,0.0005800317,0.000013093892,0.000009023217,0.000103337356],"genre_scores_gemma":[0.9982776,0.0009671889,0.0004911077,0.000057755795,0.000015083125,0.000106193904,0.000009500616,0.000024140263,0.000051411193],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987582,0.000045158795,0.00019426637,0.00054564717,0.000117318894,0.00033939315],"domain_scores_gemma":[0.9994875,0.000010984292,0.000112463524,0.00024325319,0.000038505717,0.00010729106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000061459934,0.0002991816,0.0003308992,0.00006586382,0.00006060613,0.00005105311,0.00006377919,0.00007471928,0.0000027710714],"category_scores_gemma":[0.000004570761,0.00021928849,0.000015175737,0.00009427278,0.00022024011,0.000026297592,0.00008462365,0.00011038807,2.1872202e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007115536,0.0011940382,0.94638264,0.00042754432,0.00028626595,0.000060345064,0.0017566712,0.000003993652,0.015806904,0.000052326715,5.3143805e-7,0.033317205],"study_design_scores_gemma":[0.018901141,0.011807399,0.9269503,0.0014724631,0.00034640147,0.00026699353,0.0005155769,0.000013928497,0.038030446,0.00086338155,0.00009500039,0.000736998],"about_ca_topic_score_codex":0.00008885896,"about_ca_topic_score_gemma":0.001080524,"teacher_disagreement_score":0.032580208,"about_ca_system_score_codex":0.000008611937,"about_ca_system_score_gemma":0.000060510996,"threshold_uncertainty_score":0.8942325},"labels":[],"label_agreement":null},{"id":"W2561767782","doi":"10.1182/blood.v120.21.2277.2277","title":"Transfusion Managament in Cardiac Surgery in British Columbia: Review of 8352 Patients.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Cardiac surgery; Cryoprecipitate; Blood management; Packed red blood cells; Surgery; Blood transfusion; Fresh frozen plasma; Transplantation; Cardiopulmonary bypass; Internal medicine; Platelet","score_opus":0.010505232079096,"score_gpt":0.22185591891172188,"score_spread":0.21135068683262587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561767782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9645377,0.030531771,0.0000024959593,0.00027109886,0.00022073976,0.0011959429,0.000013392529,0.00001801117,0.0032088403],"genre_scores_gemma":[0.86703855,0.13160934,0.00007226126,0.00088783127,0.00003364682,0.00008151984,0.000048717226,0.000015736401,0.00021240977],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871,0.00008695019,0.0004791266,0.00016683097,0.00029316035,0.0002639637],"domain_scores_gemma":[0.99957746,0.00003603715,0.00005102131,0.00020065383,0.000036714824,0.00009808874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006725266,0.000076371,0.0005638715,0.00008935327,0.000012902145,0.0000070798314,0.000043211177,0.000055947447,0.0003124754],"category_scores_gemma":[0.000039769522,0.00010860558,0.00016853174,0.00033984086,0.000020445377,0.00006506267,0.000022330638,0.00011695503,0.000008047549],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007826167,0.0034947933,0.93460673,0.0055232737,0.0000460399,0.000024819283,0.00007493269,2.3939206e-8,0.00004047789,0.000004481213,0.0042624623,0.051914144],"study_design_scores_gemma":[0.0022063933,0.00006458126,0.9635169,0.010054871,0.00027311707,0.000004371072,0.000054082313,1.8607308e-7,0.00019125846,0.0000028797745,0.023521759,0.00010962903],"about_ca_topic_score_codex":0.0061411364,"about_ca_topic_score_gemma":0.007196647,"teacher_disagreement_score":0.10107757,"about_ca_system_score_codex":0.000026797436,"about_ca_system_score_gemma":0.000025500514,"threshold_uncertainty_score":0.92836016},"labels":[],"label_agreement":null},{"id":"W2561803583","doi":"10.1182/blood.v126.23.1358.1358","title":"Broad Activity of Apto-253 in AML and Other Hematologic Malignancies Correlates with KLF4 Expression Level","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aptose Biosciences (Canada)","funders":"","keywords":"KLF4; Medicine; Cancer research; Myeloid leukemia; Leukemia; Myeloid; In vivo; Transcription factor; Biology; Internal medicine; Gene; Biochemistry; Genetics; SOX2","score_opus":0.044699027983813346,"score_gpt":0.26992499622529653,"score_spread":0.2252259682414832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561803583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975939,0.00076102593,0.000028619364,0.000053017066,0.00002030515,0.00027335243,0.000010295167,0.000026950715,0.0012325767],"genre_scores_gemma":[0.9982108,0.000019021452,0.0013243936,0.000033694956,0.000013405303,0.000020051808,0.000002877617,0.000015408976,0.00036033848],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999299,0.000032429092,0.00013284244,0.0001972833,0.00017533629,0.00016311674],"domain_scores_gemma":[0.9995186,0.00005695401,0.000089823174,0.0002128901,0.00003436315,0.00008739656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009197001,0.00012939602,0.0003144311,0.000059683833,0.000013757718,0.0000041504036,0.000041661493,0.00009147277,0.00002420113],"category_scores_gemma":[0.000069522044,0.000085089254,0.000020608637,0.00009467991,0.000088479486,0.000056904904,0.000041225463,0.00010075904,0.000007909745],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004813251,0.0011706912,0.9229612,0.00015442952,0.00008162767,0.00018509496,0.00091848866,0.0000041998755,0.07304339,0.00004985433,0.0001900608,0.00075967936],"study_design_scores_gemma":[0.030039437,0.001080029,0.2764168,0.0012602342,0.00024098696,0.000781851,0.0005291722,0.00008001646,0.6889605,0.00017961088,0.00020092403,0.00023043329],"about_ca_topic_score_codex":0.00030273272,"about_ca_topic_score_gemma":0.00007422716,"teacher_disagreement_score":0.64654434,"about_ca_system_score_codex":0.00007425913,"about_ca_system_score_gemma":0.00016181677,"threshold_uncertainty_score":0.3469839},"labels":[],"label_agreement":null},{"id":"W2561804054","doi":"10.1182/blood.v124.21.4813.4813","title":"APTO-253 Induces KLF4 to Promote Potent in Vitro Pro-Apoptotic Activity in Hematologic Cancer Cell Lines and Antitumor Efficacy As a Single Agent and in Combination with Azacitidine in Animal Models of Acute Myelogenous Leukemia (AML)","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Kruppel-like factors research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aptose Biosciences (Canada)","funders":"","keywords":"Medicine; Cancer research; Azacitidine; KLF4; Leukemia; Myelodysplastic syndromes; In vivo; Myeloid leukemia; Myeloid; Bone marrow; Internal medicine; Pharmacology; Transcription factor; Biology; SOX2","score_opus":0.017776779914747992,"score_gpt":0.2654805475534647,"score_spread":0.24770376763871668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561804054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99873346,0.00025940663,0.00003206231,0.000104672006,0.0000091059555,0.000798034,0.000014774946,0.000004671955,0.00004383099],"genre_scores_gemma":[0.999349,0.00014303831,0.00036121637,0.000017484526,0.000010518659,0.00007183939,0.000018653285,0.000017224598,0.000011016052],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99876225,0.0001146431,0.00023374055,0.00042307543,0.00015589884,0.0003104063],"domain_scores_gemma":[0.9996119,0.000018739083,0.000081233695,0.00016107694,0.000055068194,0.00007196133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002452597,0.0001732142,0.00031564236,0.0001714347,0.000018586288,0.000019429155,0.000112364934,0.00013696129,0.0000010485013],"category_scores_gemma":[0.000053441054,0.00015151134,0.000017523467,0.0002294048,0.000065907756,0.0000184202,0.00014560584,0.00015024608,2.7202546e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077706826,0.001265152,0.016387032,0.00012247033,0.000017383094,0.000032105283,0.00030241173,0.00027025916,0.9799128,0.0000032891435,5.265326e-7,0.0009094718],"study_design_scores_gemma":[0.0035628206,0.0013100154,0.06339263,0.00009631179,0.000013377235,0.000021315958,0.000043718515,0.0010038522,0.93036294,0.000026834115,0.0000020093478,0.000164186],"about_ca_topic_score_codex":0.0014562176,"about_ca_topic_score_gemma":0.002188942,"teacher_disagreement_score":0.049549904,"about_ca_system_score_codex":0.000085650325,"about_ca_system_score_gemma":0.00014446987,"threshold_uncertainty_score":0.6178453},"labels":[],"label_agreement":null},{"id":"W2561810797","doi":"10.1182/blood.v126.23.553.553","title":"LMO2 Regulates DNA Replication in Hematopoietic Cells","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Biology; DNA replication; DNA replication factor CDT1; Transcription factor; Cell biology; Origin recognition complex; Eukaryotic DNA replication; Control of chromosome duplication; Molecular biology; DNA; Genetics; Gene","score_opus":0.025809404738455853,"score_gpt":0.28935631868522493,"score_spread":0.2635469139467691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561810797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98917574,0.00019716733,0.000047025816,0.0011273351,0.0000421354,0.0003240744,0.000001673916,0.00006318039,0.009021686],"genre_scores_gemma":[0.995737,0.0000150272635,0.001241798,0.00016859978,0.00010964434,0.000032812128,0.000014976887,0.000021567756,0.0026585832],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99887997,0.000033820495,0.00021075802,0.00028879993,0.00034574908,0.0002409175],"domain_scores_gemma":[0.9989126,0.0000666122,0.000039788658,0.00068056426,0.00010255119,0.00019789387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038647093,0.00008775239,0.00018058371,0.000110560206,0.000014397944,0.000012084151,0.00010688944,0.000091992595,0.000041584877],"category_scores_gemma":[0.00036662378,0.00007510096,0.000031641088,0.00028327925,0.000052270043,0.000046371988,0.000059469545,0.00012077418,0.00034587967],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008789115,0.0059195026,0.062718414,0.0008428052,0.0002781365,0.0017985837,0.006574284,0.00006610775,0.8332046,0.0026357744,0.0792542,0.0058286674],"study_design_scores_gemma":[0.015887469,0.0004492643,0.0126656685,0.00022422601,0.00012053449,0.0006723419,0.00039074276,0.0015879825,0.96023786,0.0018636214,0.005671648,0.00022867034],"about_ca_topic_score_codex":0.00006119576,"about_ca_topic_score_gemma":0.000005793018,"teacher_disagreement_score":0.12703322,"about_ca_system_score_codex":0.00020127205,"about_ca_system_score_gemma":0.0003859563,"threshold_uncertainty_score":0.44456986},"labels":[],"label_agreement":null},{"id":"W2561813404","doi":"10.1182/blood.v126.23.1130.1130","title":"Efficacy and Safety of Weight-Adjusted Extended Duration Tinzaparin for Prevention of Post-Operative Venous Thromboembolism after Bariatric Surgery","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; St. Joseph's Hospital; McMaster University","funders":"","keywords":"Medicine; Pulmonary embolism; Surgery; Low molecular weight heparin; Deep vein; Thrombosis; Body mass index; Retrospective cohort study; Dosing; Venous thrombosis; Internal medicine","score_opus":0.02525261430602556,"score_gpt":0.2799885330053088,"score_spread":0.25473591869928325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561813404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99588716,0.0011149625,0.00038042708,0.00025768252,0.0001681731,0.001593297,0.000028528824,0.000027488399,0.0005423038],"genre_scores_gemma":[0.9977982,0.0003174856,0.001305391,0.00007357175,0.00014191138,0.0001233188,0.000099569814,0.000024518462,0.000116040064],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986564,0.00007609937,0.00057655585,0.0002575093,0.00024111992,0.00019233633],"domain_scores_gemma":[0.99885166,0.00014384577,0.00026146084,0.00024418937,0.00038755566,0.00011130668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004359603,0.00015812353,0.0007735917,0.00018332397,0.000039152863,0.000009768351,0.000047152513,0.000099292556,0.00003815012],"category_scores_gemma":[0.00026241073,0.00013588366,0.00012513789,0.00018354211,0.000054759515,0.00011210554,0.000050618677,0.000063930194,0.0000032603439],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044445455,0.210624,0.110523306,0.018588783,0.020206891,0.0002975901,0.06388138,0.0002256918,0.16653566,0.04238282,0.02062214,0.3016663],"study_design_scores_gemma":[0.010188296,0.0025059653,0.96151084,0.00033039192,0.0022415614,0.000019546007,0.00036669467,0.00005810657,0.021600336,0.0003868854,0.0005885686,0.00020279438],"about_ca_topic_score_codex":0.00008025188,"about_ca_topic_score_gemma":0.000029851486,"teacher_disagreement_score":0.85098755,"about_ca_system_score_codex":0.000024876828,"about_ca_system_score_gemma":0.00014258768,"threshold_uncertainty_score":0.55411744},"labels":[],"label_agreement":null},{"id":"W2561889323","doi":"10.1182/blood.v120.21.2099.2099","title":"Potential New Treatment Option for Iron Deficiency Anemia Patients with a History of Unsatisfactory Oral Iron Therapy- Results of a Phase III, Randomized, Open-Label, Active-Controlled Trial of Ferumoxytol.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ferumoxytol; Medicine; Iron sucrose; Transferrin saturation; Anemia; Iron deficiency; Internal medicine; Randomized controlled trial; Iron-deficiency anemia; Surgery; Gastroenterology; Iron therapy; Intravenous iron","score_opus":0.024290919654334622,"score_gpt":0.2860634191391015,"score_spread":0.2617724994847669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561889323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98653823,0.0029177803,0.00025216484,0.000022030195,0.00034161864,0.009067094,0.000094604,0.0000116165875,0.00075485493],"genre_scores_gemma":[0.99688995,0.00024656777,0.0015977953,0.000020289235,0.000104904684,0.00025552756,0.00015067772,0.000023969409,0.00071033894],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99811727,0.00018902695,0.0008032309,0.0002448862,0.00037180696,0.00027376707],"domain_scores_gemma":[0.99837106,0.00014549869,0.0008602734,0.00032484342,0.00016187578,0.00013645424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045512803,0.0002471433,0.0014741807,0.00015023067,0.000029401106,0.0000036204867,0.00011445882,0.00011494175,0.000047415957],"category_scores_gemma":[0.00016149873,0.0001604557,0.0002034582,0.0000800429,0.00016103947,0.00019333181,0.00001923536,0.000060754504,5.639316e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94694376,0.024448173,0.0002420108,0.000102783335,0.00012294498,5.859933e-7,0.0015402981,0.0000035668436,0.010938806,0.00006497942,0.00015836422,0.015433732],"study_design_scores_gemma":[0.98110783,0.010929314,0.0011259754,0.000035843455,0.0025374042,0.0000010152658,0.00008810837,0.000010473372,0.0038725666,0.0000109135835,0.0001386483,0.00014190342],"about_ca_topic_score_codex":0.0007012756,"about_ca_topic_score_gemma":0.000012278346,"teacher_disagreement_score":0.03416408,"about_ca_system_score_codex":0.00009456896,"about_ca_system_score_gemma":0.00052405143,"threshold_uncertainty_score":0.65431935},"labels":[],"label_agreement":null},{"id":"W2561925403","doi":"10.1182/blood.v118.21.3178.3178","title":"Further Evidence for the “Kiss and Run” Hypothesis of Iron Delivery to Mitochondria in Erythroid Cells,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Jewish General Hospital; McGill University","funders":"","keywords":"Endosome; Ferrochelatase; Mitochondrion; Transferrin receptor; Cell biology; DMT1; Endocytosis; Transferrin; Chemistry; Ferritin; Heme; Biochemistry; Biology; Cell; Transporter; Intracellular; Enzyme","score_opus":0.07341775025179592,"score_gpt":0.2668657674290771,"score_spread":0.19344801717728116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561925403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970955,0.0014367157,0.0001057588,0.0003796964,0.00016083592,0.0004951957,0.0000052702767,0.000011468535,0.00030954686],"genre_scores_gemma":[0.9913858,0.0005286274,0.00676213,0.00074734766,0.00011709211,0.00003705562,6.815224e-7,0.000014228738,0.00040699352],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9994535,0.000029146458,0.00015470182,0.00016900273,0.00006448697,0.00012916054],"domain_scores_gemma":[0.99927366,0.0003637636,0.00004350117,0.00022075768,0.000045427176,0.000052890857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010510396,0.00008135801,0.00017903533,0.000055540808,0.000024170311,0.000002173705,0.000061486055,0.00006199252,0.000119517405],"category_scores_gemma":[0.0001239315,0.000054630833,0.00004911955,0.00008719247,0.000054514938,0.000029858607,0.000026624164,0.000061610466,0.000019897421],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017253788,0.0006442042,0.013009749,0.00024816688,0.00007543779,0.000011795494,0.004620983,0.0000023445361,0.9707623,0.00006578823,0.0015226185,0.0073112166],"study_design_scores_gemma":[0.0068083154,0.003664001,0.5687096,0.0005889677,0.00068696175,0.000068236055,0.0019673954,0.000049659116,0.41222018,0.0005157286,0.004396213,0.00032476374],"about_ca_topic_score_codex":0.00010132059,"about_ca_topic_score_gemma":0.00006283047,"teacher_disagreement_score":0.55854213,"about_ca_system_score_codex":0.000006237534,"about_ca_system_score_gemma":0.000029023138,"threshold_uncertainty_score":0.22277807},"labels":[],"label_agreement":null},{"id":"W2561937338","doi":"10.1182/blood.v126.23.5246.5246","title":"Validation of Predictive Models for Response to Erythropoiesis-Stimulating Agents in Myelodysplastic Syndromes","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; International Prognostic Scoring System; Cohort; Internal medicine; Myelodysplastic syndromes; Anemia; Darbepoetin alfa; Epoetin alfa; Erythropoietin; Retrospective cohort study; Bone marrow; Oncology","score_opus":0.08688143157122795,"score_gpt":0.35472902064484113,"score_spread":0.26784758907361317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561937338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98786557,0.000037062182,0.00997545,0.0004622123,0.00004892293,0.0011544705,0.000049404523,0.00003333894,0.0003736001],"genre_scores_gemma":[0.99114424,0.0000026174507,0.00825165,0.000044017455,0.00005087386,0.00012024538,0.000029250728,0.000029778768,0.00032730377],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99860317,0.00011811205,0.00032860987,0.00025137048,0.00042065288,0.00027811297],"domain_scores_gemma":[0.99860454,0.0005454149,0.00006735992,0.00024801228,0.00032545722,0.00020924112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009442468,0.00011597014,0.0003051864,0.0003514537,0.000026799618,0.000008997372,0.00010330398,0.00008883137,0.000010484568],"category_scores_gemma":[0.0031722556,0.000108613836,0.000048728907,0.0003786735,0.000043359352,0.00012546047,0.0000817846,0.0001192628,0.00001339346],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08732511,0.005937428,0.20171143,0.0019942645,0.001521342,0.00070773,0.034033984,0.43247363,0.2235635,0.00047906302,0.007564809,0.0026877006],"study_design_scores_gemma":[0.07342168,0.016694356,0.12580107,0.0020713473,0.0009795101,0.00030628228,0.0050258962,0.57320803,0.19747883,0.0039004951,0.00031287572,0.0007996172],"about_ca_topic_score_codex":0.000039725022,"about_ca_topic_score_gemma":0.0000023664784,"teacher_disagreement_score":0.14073442,"about_ca_system_score_codex":0.00024722907,"about_ca_system_score_gemma":0.0004908258,"threshold_uncertainty_score":0.44291437},"labels":[],"label_agreement":null},{"id":"W2561947536","doi":"10.1182/blood.v122.21.4824.4824","title":"Use Of Prothrombin Complex Concentrates In Warfarin Anticoagulation Reversal In The Emergency Department: A Quality Improvement Study Of Administration Delays","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Emergency department; Warfarin; Prothrombin complex concentrate; Audit; Emergency medicine; Retrospective cohort study; Patient safety; Medical prescription; Quality management; Medical emergency; Surgery; Operations management; Health care; Internal medicine; Nursing","score_opus":0.17034073978229877,"score_gpt":0.380121302866817,"score_spread":0.20978056308451823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561947536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99597025,0.000013572561,0.0000199056,0.000351043,0.00002924007,0.003531628,0.0000033894655,0.0000072043526,0.00007379103],"genre_scores_gemma":[0.9996587,0.000011850472,0.00018254596,0.000018217668,0.00002528698,0.000031164705,0.000040602197,0.000004747668,0.000026862728],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868107,0.00013823927,0.00068342703,0.00013288215,0.00025820843,0.000106149404],"domain_scores_gemma":[0.99942523,0.000061974475,0.00023729862,0.00018936017,0.000068117646,0.00001803151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032662967,0.000083074694,0.00024507428,0.00006989916,0.000017344597,0.00000913944,0.00005077958,0.000030220577,0.000102193604],"category_scores_gemma":[0.00008519358,0.00006119542,0.000042132604,0.00023093547,0.000019903686,0.00014154146,0.000021624768,0.00004505478,0.0000020584741],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009769079,0.00087750086,0.97729665,0.0000884133,0.000053450607,0.0000016309722,0.0011650347,0.00002510376,0.01953692,0.00046515308,0.000026840076,0.00036561937],"study_design_scores_gemma":[0.0038155173,0.00093275466,0.9894109,0.000018533516,0.00008994467,3.9694572e-7,0.0016768723,0.0003603782,0.0035094076,0.0001110535,0.000018620809,0.000055664113],"about_ca_topic_score_codex":0.0011319139,"about_ca_topic_score_gemma":0.00056983787,"teacher_disagreement_score":0.016027514,"about_ca_system_score_codex":0.00001500755,"about_ca_system_score_gemma":0.00002302832,"threshold_uncertainty_score":0.24954766},"labels":[],"label_agreement":null},{"id":"W2561971436","doi":"10.1182/blood.v124.21.2787.2787","title":"Utility of Complement and ADAMTS13 Testing in Diagnosis of Thrombotic Microangiopathy: A Single Centre Retrospective Review","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Thrombotic microangiopathy; Medicine; Eculizumab; ADAMTS13; Factor H; Plasmapheresis; Internal medicine; Pediatrics; Complement system; Immunology; Antibody; Von Willebrand factor; Disease","score_opus":0.03010805914722934,"score_gpt":0.2483147097612636,"score_spread":0.21820665061403427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561971436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97209764,0.026664844,0.0000066684156,0.00007872309,0.00005007109,0.00050302583,0.00009873525,0.000015063439,0.00048523414],"genre_scores_gemma":[0.99956733,0.00015858965,0.00017753923,0.000032585605,0.0000062320087,0.00001721442,0.00002650307,0.000006838632,0.0000071868776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987982,0.00027744155,0.0004786219,0.00022343067,0.00003877945,0.00018351804],"domain_scores_gemma":[0.9990406,0.00033436852,0.00025954162,0.000253698,0.000097452736,0.0000143518655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033219752,0.000109157874,0.0004763342,0.000050889277,0.000030136716,0.0000021906574,0.00011427314,0.000035913978,0.0002899626],"category_scores_gemma":[0.0005884915,0.00010673567,0.000055276894,0.0001486885,0.00011270816,0.000025384423,0.00011814602,0.000058709364,0.0000058236087],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000074196773,0.00087795506,0.9620097,0.0010787614,0.00007195393,7.075886e-7,0.00013121215,1.01183e-7,0.034224283,0.00015562604,0.00038310603,0.0010591472],"study_design_scores_gemma":[0.0016205155,0.00021964402,0.9467941,0.0031683322,0.00021476448,0.00000642935,0.0001182266,0.000002981456,0.047241822,0.00015101676,0.0003543436,0.000107827414],"about_ca_topic_score_codex":0.00019762569,"about_ca_topic_score_gemma":0.00017704857,"teacher_disagreement_score":0.027469676,"about_ca_system_score_codex":0.000011603983,"about_ca_system_score_gemma":0.000019370289,"threshold_uncertainty_score":0.43525544},"labels":[],"label_agreement":null},{"id":"W2561981345","doi":"10.1182/blood.v120.21.4261.4261","title":"Utilization and Costs of Red Blood Cell Transfusions Pre- and Post-Azacitidine in Higher-Risk Myelodysplastic Syndromes","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Azacitidine; Myelodysplastic syndromes; Blood transfusion; Anemia; Internal medicine; Retrospective cohort study; Pediatrics; Surgery; Bone marrow","score_opus":0.025144437800082985,"score_gpt":0.2738148508525346,"score_spread":0.2486704130524516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561981345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946626,0.0031957624,0.000021780133,0.00029379234,0.00004554673,0.00056216604,0.00006276526,0.000030968364,0.0011246289],"genre_scores_gemma":[0.99626124,0.0026726753,0.00045889636,0.00003384009,0.00006017167,0.000023915885,0.000037832957,0.000029228077,0.00042217292],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998781,0.00010128379,0.0002866123,0.00023411207,0.00025315717,0.00034379956],"domain_scores_gemma":[0.9991497,0.00025202104,0.00006810184,0.00019334201,0.00009204758,0.0002448116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002858888,0.00015461716,0.0003249661,0.00024519447,0.00005343235,0.000008929605,0.000054447533,0.0001443535,0.00010461675],"category_scores_gemma":[0.00020303421,0.00013624033,0.000031758995,0.00031613692,0.00011861679,0.0001321159,0.00005627488,0.00026558363,0.0000033706112],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041722972,0.0022445603,0.6348555,0.00058313453,0.00017344549,0.000076182994,0.0013290917,0.0000013145338,0.3557626,0.00018815648,0.00007313474,0.0042956728],"study_design_scores_gemma":[0.009681648,0.0007819472,0.9365926,0.00023463124,0.0006512357,0.000281645,0.00017713482,0.000101124126,0.051215794,0.000012286613,0.00012544615,0.00014454973],"about_ca_topic_score_codex":0.00018041162,"about_ca_topic_score_gemma":0.0000332174,"teacher_disagreement_score":0.3045468,"about_ca_system_score_codex":0.000032464635,"about_ca_system_score_gemma":0.000087006454,"threshold_uncertainty_score":0.5555719},"labels":[],"label_agreement":null},{"id":"W2561981940","doi":"10.1182/blood.v126.23.4273.4273","title":"A Humanized Zebrafish Transplant Model Expressing CXCL12 Provides an Enhanced In Vivo Therapeutic Screening Platform for T-ALL","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Zebrafish Biomedical Research Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Zebrafish; Cancer research; Biology; Leukemia; Xenotransplantation; Context (archaeology); Transplantation; Population; Immunophenotyping; Humanized mouse; Immunology; Cancer; Medicine; Flow cytometry; Genetics; Gene; Internal medicine","score_opus":0.05880472037074872,"score_gpt":0.3258376580783883,"score_spread":0.2670329377076396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561981940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8315549,0.00024228897,0.16670798,0.00014748133,0.000013082476,0.00075336604,0.00007193062,0.000031864936,0.000477122],"genre_scores_gemma":[0.98364973,0.000024663672,0.015096721,0.0002707732,0.000114223585,0.00051276106,0.00019799799,0.00003547816,0.000097639735],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986723,0.00003170062,0.00023828902,0.00040398515,0.00023212125,0.00042161663],"domain_scores_gemma":[0.9992315,0.000027920767,0.000055408418,0.00033393205,0.00009405365,0.0002571955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038205727,0.00015060006,0.00016060198,0.00006640999,0.00006934644,0.0000556396,0.000331026,0.00016199515,0.0000057270317],"category_scores_gemma":[0.0001048251,0.0001399449,0.0000634164,0.00009012524,0.00008471822,0.00001905719,0.000052011073,0.00011021946,0.0000013340756],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002293032,0.00037918353,0.000060413622,0.000023620943,0.00004398645,0.0000013870894,0.00030969537,0.00007217806,0.99545854,0.00014553877,0.0001243689,0.0031517919],"study_design_scores_gemma":[0.005578539,0.00040939334,0.00006412227,0.00004460176,0.00003962515,0.0000060796924,0.00016944455,0.017753765,0.9713661,0.0021768834,0.0021292032,0.00026222278],"about_ca_topic_score_codex":0.00002525193,"about_ca_topic_score_gemma":0.0001720369,"teacher_disagreement_score":0.15209486,"about_ca_system_score_codex":0.000014129789,"about_ca_system_score_gemma":0.00019015171,"threshold_uncertainty_score":0.5706787},"labels":[],"label_agreement":null},{"id":"W2561985459","doi":"10.1182/blood.v112.11.241.241","title":"Anti-CD3 Therapy Expands the CD4+CD25+ Compartment in Hemophilia a Mice Inducing Tregs That Potently Prevent Factor VIII Inhibitor Formation","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"CD3; CD8; Medicine; Immunology; IL-2 receptor; Internal medicine; Antigen; Endocrinology; Pharmacology; T cell; Immune system","score_opus":0.0657640995945231,"score_gpt":0.2998720441736606,"score_spread":0.23410794457913747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561985459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942631,0.0013606752,0.00001127796,0.002217664,0.00009372131,0.0013973234,0.000011854355,0.000054691758,0.00058967026],"genre_scores_gemma":[0.99775,0.00095828844,0.00009716265,0.0001689087,0.0002303949,0.00011549636,0.000058199286,0.000025989177,0.00059557625],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99824166,0.00010138825,0.00033815583,0.00028478605,0.00059461646,0.00043940794],"domain_scores_gemma":[0.99926233,0.000081072925,0.000091768634,0.00035918862,0.000059774946,0.00014583564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021471705,0.0002355594,0.00037109232,0.00017848096,0.00023330608,0.000027864166,0.00014393033,0.00011681839,0.000088219276],"category_scores_gemma":[0.00002167658,0.00013813525,0.00014573915,0.00029133787,0.000086407585,0.00018904853,0.000052599768,0.0003038902,0.00006944319],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079642324,0.013756263,0.72220814,0.00026106442,0.000717131,0.00094101677,0.023036927,0.000014183332,0.21567564,0.000032877677,0.0017905316,0.020769795],"study_design_scores_gemma":[0.014671653,0.0007646196,0.45000917,0.00029505647,0.000079883896,0.00037337188,0.0007607907,0.0002109237,0.5309286,0.000037694805,0.001591718,0.0002765203],"about_ca_topic_score_codex":0.00007790517,"about_ca_topic_score_gemma":0.000034074194,"teacher_disagreement_score":0.31525296,"about_ca_system_score_codex":0.000118330376,"about_ca_system_score_gemma":0.00012779221,"threshold_uncertainty_score":0.56329924},"labels":[],"label_agreement":null},{"id":"W2562003278","doi":"10.1182/blood.v114.22.2477.2477","title":"Costs to Medicare of Treating Chronic Lymphocytic Leukemia Patients with Alemtuzumab.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Alemtuzumab; Medicine; Chronic lymphocytic leukemia; Leukemia; Internal medicine; Adverse effect; Cytopenia; Transplantation; Bone marrow","score_opus":0.006612052808214281,"score_gpt":0.2581684653623194,"score_spread":0.2515564125541051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562003278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99120736,0.00039771694,0.000030638428,0.000088049615,0.000034274446,0.00084140385,0.000016010257,0.00008763545,0.007296908],"genre_scores_gemma":[0.9980829,0.00002441464,0.0008638189,0.00026288786,0.00017653717,0.000026961872,0.000057735768,0.000037905393,0.00046687206],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9974691,0.0000402044,0.00040659693,0.00042497652,0.0010712184,0.00058789045],"domain_scores_gemma":[0.99834496,0.00012334336,0.0001142884,0.000665766,0.0003085257,0.00044313233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000169779,0.00024035628,0.0004995819,0.00020295708,0.000065634646,0.000014469379,0.00023013102,0.00012461098,0.00013445107],"category_scores_gemma":[0.00032860154,0.00018195898,0.00008710794,0.00056322705,0.000102069214,0.00007017451,0.00006578514,0.00016720414,0.00007139826],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0090982495,0.006425722,0.11447502,0.0039804345,0.0031810442,0.0034571758,0.0082046585,0.0019094833,0.024838159,0.0008887644,0.012779484,0.8107618],"study_design_scores_gemma":[0.53548574,0.02736735,0.2891303,0.0072883284,0.0020233204,0.00088361383,0.0004797224,0.007638221,0.12497129,0.00005628129,0.0031455534,0.0015302701],"about_ca_topic_score_codex":0.0006719665,"about_ca_topic_score_gemma":0.000070213246,"teacher_disagreement_score":0.8092315,"about_ca_system_score_codex":0.058447924,"about_ca_system_score_gemma":0.024586955,"threshold_uncertainty_score":0.9809427},"labels":[],"label_agreement":null},{"id":"W2562012807","doi":"10.1182/blood.v126.23.646.646","title":"Tet2 Is a Novel Regulator of Murine Macrophage Differentiation and Polarization","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Haematopoiesis; Biology; Molecular biology; Bone marrow; Epigenetics; Myeloid; Gene expression; Cancer research; Immunology; Stem cell; Gene; Genetics","score_opus":0.012304349779182192,"score_gpt":0.2318989602564117,"score_spread":0.21959461047722953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562012807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99283,0.0013728443,0.005459311,0.000034213237,0.00003855599,0.000072590396,0.000019795369,0.0000037196758,0.00016899258],"genre_scores_gemma":[0.9978922,0.000059337126,0.0016140745,0.000017126195,0.00007055921,0.000002327263,0.00008994224,0.000008982146,0.00024547236],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995937,0.000013735195,0.000115202776,0.00013190808,0.000080806545,0.00006464599],"domain_scores_gemma":[0.9996618,0.0000025772536,0.000068080735,0.00013306546,0.00008453822,0.000049909286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000079283214,0.00005915035,0.00006463718,0.00002454657,0.000016858308,0.0000083716195,0.000035520046,0.000075454554,0.0000036767478],"category_scores_gemma":[0.00004988027,0.0000571543,0.000019259129,0.00004305223,0.00002054107,0.0000022549102,0.00004076426,0.000019408375,6.6512393e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001148477,0.00010472993,0.0371325,0.00001152902,0.000022081522,9.572294e-8,0.00005075035,0.000004371656,0.9621585,0.00005457687,0.000008756788,0.0004406273],"study_design_scores_gemma":[0.0010961567,0.00014501585,0.07477102,0.0000044764593,0.000033565204,0.0000012401114,0.00000992251,0.00010579774,0.9229782,0.00016166156,0.00063039904,0.00006250887],"about_ca_topic_score_codex":0.000013934793,"about_ca_topic_score_gemma":0.0000043638306,"teacher_disagreement_score":0.039180256,"about_ca_system_score_codex":0.0000020050138,"about_ca_system_score_gemma":0.000019309706,"threshold_uncertainty_score":0.23306847},"labels":[],"label_agreement":null},{"id":"W2562016023","doi":"10.1182/blood.v104.11.1155.1155","title":"A Noninvasive Oral Neutrophil Assay To Monitor Engraftment, Neutrophil Function and Susceptibility to Infection Following Bone Marrow Transplantation (BMT) in Children and Adolescents.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Absolute neutrophil count; Medicine; Bone marrow; Hemocytometer; Immunology; Neutrophile; Granulocyte; Neutropenia; Transplantation; Bone marrow transplantation; Internal medicine; Pathology; Toxicity; Inflammation","score_opus":0.008053929932713639,"score_gpt":0.24606718101953068,"score_spread":0.23801325108681703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562016023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970552,0.00011112584,0.0005037022,0.00059905334,0.00021591873,0.0013670764,0.000017196073,0.00008395894,0.000046771438],"genre_scores_gemma":[0.9987074,0.00014787524,0.00030391332,0.00042642586,0.00020144723,0.000128326,0.00003801962,0.000029662639,0.000016939312],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986602,0.000070842776,0.00027746373,0.00050576264,0.0001957271,0.00028999095],"domain_scores_gemma":[0.99941725,0.0000140964385,0.000048654187,0.00019506014,0.000052709136,0.00027225836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018938094,0.0002215607,0.00030783785,0.00028219985,0.00014175818,0.00004949701,0.000029426363,0.000105066305,0.000006506931],"category_scores_gemma":[0.000025579417,0.00022164533,0.00008377601,0.00042578898,0.000027684402,0.00019424234,0.000026817823,0.00023346534,0.000014054541],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050138595,0.0007561753,0.9087612,0.00008807767,0.00009218319,0.00005751761,0.00032602967,0.00016968403,0.08673089,0.000029461928,0.000012437932,0.0024749406],"study_design_scores_gemma":[0.008970254,0.0012954863,0.97593576,0.0002789586,0.00051768025,0.00031604915,0.000028732982,8.2016845e-7,0.012340333,0.00008579404,0.00002789029,0.00020223814],"about_ca_topic_score_codex":0.0016861293,"about_ca_topic_score_gemma":0.002135754,"teacher_disagreement_score":0.07439056,"about_ca_system_score_codex":0.00015540022,"about_ca_system_score_gemma":0.000057203943,"threshold_uncertainty_score":0.90384346},"labels":[],"label_agreement":null},{"id":"W2562057618","doi":"10.1182/blood.v104.11.3496.3496","title":"Generation and Verification of a Three-Dimensional Model of the ALK Kinase Domain: ALK - a “Supermutant” of Abl.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Anaplastic lymphoma kinase; ABL; Protein kinase domain; Tyrosine kinase; Cancer research; Biology; Imatinib mesylate; Chemistry; Molecular biology; Imatinib; Biochemistry; Medicine; Receptor; Internal medicine","score_opus":0.0291674528069216,"score_gpt":0.24343910952395972,"score_spread":0.21427165671703813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562057618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984981,0.00054306217,0.0002011217,0.00021829102,0.000022893157,0.000298708,0.000039115133,0.0000063885404,0.000172355],"genre_scores_gemma":[0.99469364,0.000025851079,0.0051526735,0.000039598937,0.000029836314,0.000010611188,0.000023856484,0.000009945503,0.000013981958],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992604,0.000013982494,0.00025049562,0.00014270039,0.00025078666,0.000081607475],"domain_scores_gemma":[0.99942213,0.000017514758,0.00012547919,0.0003115764,0.00008875929,0.000034547535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000080874735,0.00008414224,0.0001935536,0.000037890408,0.000026437232,0.0000014003035,0.000046673442,0.00006086544,0.000011165036],"category_scores_gemma":[0.000037470243,0.00005910626,0.000055652003,0.00009895458,0.0000996442,0.00003621257,0.000027372767,0.00005101007,7.2585897e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000080484366,0.00081892684,0.002817368,0.00009151736,0.00011608212,0.0000036986387,0.00048112503,0.0023197297,0.991196,0.0015968784,0.000015983236,0.00046223943],"study_design_scores_gemma":[0.01367194,0.00025966775,0.01859613,0.00020564366,0.0004633271,0.00007053042,0.000031968335,0.011227019,0.9538273,0.0015521657,0.000012315447,0.0000819905],"about_ca_topic_score_codex":0.00014421795,"about_ca_topic_score_gemma":0.00006149919,"teacher_disagreement_score":0.037368663,"about_ca_system_score_codex":0.00007050835,"about_ca_system_score_gemma":0.0003611705,"threshold_uncertainty_score":0.24102834},"labels":[],"label_agreement":null},{"id":"W2562058298","doi":"10.1182/blood.v112.11.2815.2815","title":"Combined FOXP3+ and PD1+ T Cell Density and Architectural Patterns Predict Overall Survival and Risk of Transformation in Uniformly Treated Patients with Follicular Lymphoma","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Follicular lymphoma; Medicine; Internal medicine; FOXP3; Oncology; Lymphoma; Univariate analysis; Germinal center; Tissue microarray; Survival analysis; Antibody; Immunology; Multivariate analysis; Cancer; B cell; Immune system","score_opus":0.004769795071634621,"score_gpt":0.17548887306491065,"score_spread":0.17071907799327604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562058298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991058,0.00013268871,0.0000078023595,0.000023148048,0.000008186252,0.00053703494,0.00006933309,0.000015276994,0.00010072238],"genre_scores_gemma":[0.9992322,0.00053519825,0.00007994195,0.000012084435,0.000005664762,0.000013101975,0.00010573839,0.000009732777,0.0000063752286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992839,0.000042585758,0.0001909636,0.00017222791,0.00017036412,0.00013995683],"domain_scores_gemma":[0.99963075,0.000046127054,0.00007400821,0.000104108374,0.0000475758,0.00009740541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004833351,0.00014912002,0.00029730238,0.00007296405,0.000053490832,0.000006899305,0.000016895288,0.000053173797,0.0000017352969],"category_scores_gemma":[0.000007772344,0.000101816346,0.0000248352,0.0000696743,0.000061844636,0.000070526265,0.000013692896,0.000035614685,1.9007788e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005176495,0.0013411962,0.9952029,0.00009639199,0.00014668687,0.00005307961,0.00085343485,0.0000015224751,0.00005310493,0.0000059947424,0.0000010083111,0.0017270349],"study_design_scores_gemma":[0.04544071,0.0016158111,0.9452522,0.00008690914,0.00040234663,0.0000615877,0.00003497096,0.00010334536,0.006896192,0.000009667016,0.0000024334518,0.000093872375],"about_ca_topic_score_codex":0.0013163197,"about_ca_topic_score_gemma":0.00023593592,"teacher_disagreement_score":0.04995074,"about_ca_system_score_codex":0.000022168435,"about_ca_system_score_gemma":0.000024948791,"threshold_uncertainty_score":0.41519502},"labels":[],"label_agreement":null},{"id":"W2562070942","doi":"10.1182/blood.v120.21.3159.3159","title":"Improving Rates of Appropriate Venous Thromboembolism Prophylaxis in a Community Hospital.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Credit Valley Hospital; Trillium Health Centre","funders":"","keywords":"Medicine; Emergency department; Emergency medicine; Pharmacy; Audit; Pharmacist; Venous thromboembolism; Intensive care medicine; Community hospital; Thrombosis; Internal medicine; Family medicine; Nursing","score_opus":0.028310681506389938,"score_gpt":0.29039293430213586,"score_spread":0.26208225279574593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562070942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99612904,0.0008249237,0.000050707935,0.00008551573,0.00008964159,0.00033635861,0.0000017762649,0.000022620046,0.002459393],"genre_scores_gemma":[0.99881566,0.000025055006,0.00080221775,0.00008825486,0.000079874146,0.00004273979,0.0000067006117,0.000009329224,0.00013016736],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992971,0.00007113998,0.0002103199,0.00007622662,0.00014767866,0.00019754659],"domain_scores_gemma":[0.9993625,0.000036204336,0.00011056534,0.0003450371,0.00005763418,0.00008804242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034103787,0.0000780451,0.00025960192,0.000051243373,0.000038453774,0.0000036385434,0.000114483744,0.000060676422,0.00009158347],"category_scores_gemma":[0.00017581989,0.00006512496,0.000033197677,0.00018257486,0.000067297195,0.00007509779,0.00004365087,0.00029629917,0.0000993608],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006585958,0.025124019,0.80838734,0.0017417836,0.00015237585,0.000012737123,0.014906426,4.9158297e-7,0.10343401,0.00083897746,0.00021022776,0.04512577],"study_design_scores_gemma":[0.003060595,0.0013517822,0.93042976,0.0003316287,0.00008929334,0.000022495253,0.0017940796,0.000028968481,0.06212613,0.000394347,0.00020520283,0.00016574716],"about_ca_topic_score_codex":0.0003463665,"about_ca_topic_score_gemma":0.0000034347393,"teacher_disagreement_score":0.12204241,"about_ca_system_score_codex":0.000011619386,"about_ca_system_score_gemma":0.00007015594,"threshold_uncertainty_score":0.2655719},"labels":[],"label_agreement":null},{"id":"W2562103664","doi":"10.1182/blood.v120.21.1140.1140","title":"High Mortality After Venous Thromboembolism: A Population-Based Cohort Study","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Pulmonary embolism; Population; Cohort; Deep vein; Diagnosis code; Current Procedural Terminology; Venous thrombosis; Retrospective cohort study; Reimbursement; Emergency medicine; Health care; Pediatrics; Internal medicine; Thrombosis; Database; Surgery","score_opus":0.014931648685341362,"score_gpt":0.2772825645617427,"score_spread":0.26235091587640136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562103664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99577683,0.00027847305,0.000028699895,0.00014378906,0.00045618834,0.001975567,0.00001379663,0.00015924187,0.0011674067],"genre_scores_gemma":[0.99738026,0.000012651101,0.00033995303,0.000954219,0.00059102365,0.00053436466,0.00007914189,0.000046701272,0.000061683146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982007,0.000075250224,0.00035718267,0.00033542718,0.0005360503,0.00049538893],"domain_scores_gemma":[0.9988538,0.000033663517,0.00009771704,0.00070132466,0.00006524207,0.00024826976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045213738,0.00023579507,0.0007581896,0.000108381544,0.00010286302,0.000028879249,0.000096082294,0.00008172424,0.0007186791],"category_scores_gemma":[0.000043731143,0.00020597104,0.00013111533,0.00019437443,0.000026449132,0.00015514083,0.000060660717,0.00014157202,0.00016109899],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019729127,0.024118595,0.9739554,0.00007201993,0.0007309888,0.00005263722,0.00032580429,0.000008702992,0.00002779908,0.00025503724,0.00027964363,0.0001536669],"study_design_scores_gemma":[0.002436755,0.00047760646,0.9931908,0.00003734382,0.0030462453,0.0000056493395,0.00009964225,0.0000053549584,0.00019107733,0.000053577525,0.0002383859,0.0002175306],"about_ca_topic_score_codex":0.0024242972,"about_ca_topic_score_gemma":0.00012882563,"teacher_disagreement_score":0.023640988,"about_ca_system_score_codex":0.000061749924,"about_ca_system_score_gemma":0.000042214357,"threshold_uncertainty_score":0.8399255},"labels":[],"label_agreement":null},{"id":"W2562165295","doi":"10.1182/blood.v108.11.306.306","title":"Clinical Efficacy of Lenalidomide {Revlimid®} in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL): Updated Results of a Phase II Clinical Trial.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Lenalidomide; Neutropenia; Internal medicine; Fludarabine; Gastroenterology; Rituximab; Rash; Thalidomide; Tumor lysis syndrome; Bendamustine; Chronic lymphocytic leukemia; Pomalidomide; Refractory (planetary science); Progressive disease; Febrile neutropenia; Multiple myeloma; Leukemia; Toxicity; Lymphoma; Chemotherapy; Cyclophosphamide","score_opus":0.043796044907813976,"score_gpt":0.3750465100802808,"score_spread":0.3312504651724668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562165295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99552256,0.00034178345,0.000006694779,0.000039120187,0.00024154385,0.0027613835,0.00008237827,0.00007885186,0.00092566357],"genre_scores_gemma":[0.996904,0.00018911297,0.0006510432,0.000061134495,0.00058597146,0.000036901612,0.0004269307,0.00009252415,0.0010523595],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9914783,0.00076058507,0.0045776353,0.0010368003,0.0013277129,0.00081894547],"domain_scores_gemma":[0.9937982,0.0022819964,0.0013573156,0.0016756073,0.0005141731,0.00037268447],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0032467698,0.00044253885,0.002054958,0.0004118012,0.000068573565,0.000012754824,0.00048548842,0.0006390877,0.00012921872],"category_scores_gemma":[0.0043896474,0.0003130321,0.00046291383,0.0010748215,0.0008927611,0.00014360146,0.00024882753,0.00084930303,0.000029193017],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.9291276,0.04273463,0.008818707,0.00054847746,0.00092921645,0.00072037993,0.00012222634,0.00014879102,0.00046718842,0.000024707042,0.0047930405,0.011565046],"study_design_scores_gemma":[0.9268704,0.03844366,0.027179642,0.0010648018,0.00078207435,0.000030012357,0.000015902335,0.0013776098,0.0021578583,0.0000094263,0.0017489799,0.00031961338],"about_ca_topic_score_codex":0.0016936165,"about_ca_topic_score_gemma":0.0002897211,"teacher_disagreement_score":0.04121468,"about_ca_system_score_codex":0.01468138,"about_ca_system_score_gemma":0.05589606,"threshold_uncertainty_score":0.99993217},"labels":[],"label_agreement":null},{"id":"W2562167373","doi":"10.1182/blood.v104.11.753.753","title":"Combination Therapy with Rituximab and Fludarabine in Waldenstrom’s Macroglobulinemia.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Fludarabine; Rituximab; Medicine; Neutropenia; Macroglobulinemia; Waldenstrom macroglobulinemia; Internal medicine; Gastroenterology; Surgery; Chemotherapy; Lymphoma; Multiple myeloma; Cyclophosphamide","score_opus":0.010835678723124739,"score_gpt":0.25912982323051975,"score_spread":0.248294144507395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562167373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960583,0.0008948688,0.000026665357,0.0013447689,0.000016086262,0.00045584503,0.0000024167682,0.00004460979,0.0011564558],"genre_scores_gemma":[0.99774015,0.00035498306,0.0013715761,0.0001823952,0.000050784558,0.000028717144,0.00001766219,0.000021714268,0.00023203439],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9989824,0.000018014602,0.00016018147,0.00024713212,0.00032238776,0.00026985785],"domain_scores_gemma":[0.9995383,0.000030418725,0.000029300429,0.00022653613,0.00006892216,0.000106512336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014597537,0.000121661986,0.0002296058,0.000110397086,0.000033146443,0.000019625462,0.00006018629,0.00007592132,0.000030058736],"category_scores_gemma":[0.000037093232,0.00009131108,0.000021492748,0.00024379126,0.00011348833,0.00006148335,0.000028109685,0.00018253153,0.000022776027],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023936143,0.14194362,0.29813185,0.003700341,0.0027514051,0.04029354,0.015026037,0.0004700553,0.21611427,0.03420581,0.001337694,0.22208923],"study_design_scores_gemma":[0.847547,0.0030468926,0.06140897,0.0005500446,0.00009873567,0.004497396,0.0001765872,0.0005276077,0.07957289,0.0013051218,0.0009013817,0.0003673725],"about_ca_topic_score_codex":0.0004986571,"about_ca_topic_score_gemma":0.00010695145,"teacher_disagreement_score":0.82361084,"about_ca_system_score_codex":0.0012606375,"about_ca_system_score_gemma":0.0015511807,"threshold_uncertainty_score":0.37235576},"labels":[],"label_agreement":null},{"id":"W2562200677","doi":"10.1182/blood.v110.11.3040.3040","title":"Allogeneic Stem Cell Transplantation as Treatment for Relapsed and High-Risk Peripheral T-Cell Lymphoma.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and Retrovirus Studies","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Hospital and Health Sciences Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Peripheral T-cell lymphoma; Internal medicine; Transplantation; Lymphoma; Gastroenterology; International Prognostic Index; Anaplastic large-cell lymphoma; Surgery; Oncology; Diffuse large B-cell lymphoma; T cell; Immunology; Immune system","score_opus":0.008108949018590744,"score_gpt":0.2093946749237523,"score_spread":0.20128572590516156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562200677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859073,0.011462383,0.0002519049,0.000026288282,0.00035659914,0.000351894,0.00010327074,0.000055297864,0.001485039],"genre_scores_gemma":[0.986678,0.0032323152,0.00021786022,0.000040693165,0.000045963294,0.000034802015,0.00008921002,0.000018023564,0.009643121],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99913687,0.000051154195,0.00019841998,0.00027283464,0.000021332824,0.00031937327],"domain_scores_gemma":[0.9996222,0.00012485016,0.00008550336,0.00011690716,0.00002530279,0.00002521649],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001120486,0.00018482824,0.00022446916,0.000047731854,0.00030277824,0.00000853939,0.000058946047,0.0001972036,0.000024144472],"category_scores_gemma":[0.0000018171344,0.00013899473,0.000086536355,0.000039844228,0.00008719837,0.000027373206,0.000011482919,0.000049019687,0.000058539386],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010044777,0.0016442654,0.017025119,0.000086437954,0.00047105332,0.000030816394,0.0033041204,0.0000026154817,0.94608694,0.00014756407,0.00014737593,0.030049233],"study_design_scores_gemma":[0.021988325,0.0018823779,0.012181447,0.000008897844,0.00068728556,0.00006544553,0.00068011694,3.5299328e-7,0.9509,0.00006049705,0.011318456,0.00022676389],"about_ca_topic_score_codex":0.0003687229,"about_ca_topic_score_gemma":0.00021146775,"teacher_disagreement_score":0.029822469,"about_ca_system_score_codex":0.000029221197,"about_ca_system_score_gemma":0.000028364662,"threshold_uncertainty_score":0.56680405},"labels":[],"label_agreement":null},{"id":"W2562208778","doi":"10.1182/blood.v126.23.3754.3754","title":"The Safety and Tolerability of Azacitidine (AZA) Are Comparable in Patients with Acute Myeloid Leukemia (AML) or Higher-Risk Myelodysplastic Syndromes (MDS)","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Tolerability; Internal medicine; Myelodysplastic syndromes; Azacitidine; Adverse effect; Population; Neutropenia; Lenalidomide; Oncology; Multiple myeloma; Chemotherapy; Bone marrow","score_opus":0.0195225028924699,"score_gpt":0.2586856472973217,"score_spread":0.23916314440485179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562208778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971785,0.00035479208,0.000028650025,0.00041825688,0.00007703591,0.0009770008,0.00013006803,0.000049012673,0.00078670244],"genre_scores_gemma":[0.99801755,0.00030429635,0.00063635997,0.00005327966,0.000052251857,0.00004112782,0.000046813057,0.000042560205,0.0008057878],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972639,0.00021869899,0.000620095,0.0004895646,0.00082260027,0.00058513775],"domain_scores_gemma":[0.9975677,0.00061339507,0.00028213242,0.00072062446,0.00043414184,0.00038197436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007832662,0.00030647728,0.0008399584,0.00013936004,0.00015523816,0.000035254794,0.00027312027,0.00014898373,0.000044284865],"category_scores_gemma":[0.000520095,0.00017437233,0.0000540627,0.0005969077,0.00048499226,0.00015810816,0.00020235188,0.0006161437,0.000018376033],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0101122,0.0007179856,0.98591083,0.0001887804,0.0005003627,0.00019414334,0.00031797038,0.000076822704,0.00011122134,0.000059750677,0.00076686894,0.0010430363],"study_design_scores_gemma":[0.024059646,0.0021498653,0.9696555,0.0002824303,0.0004172843,0.00010253987,0.00026221067,0.00031594263,0.0010109803,0.000074126285,0.001431199,0.0002382599],"about_ca_topic_score_codex":0.000370583,"about_ca_topic_score_gemma":0.00025922316,"teacher_disagreement_score":0.016255341,"about_ca_system_score_codex":0.0005018949,"about_ca_system_score_gemma":0.00090622867,"threshold_uncertainty_score":0.7110697},"labels":[],"label_agreement":null},{"id":"W2562211759","doi":"10.1182/blood.v126.23.872.872","title":"Five-Year Direct Cost of Pediatric Patients with Acute Lymphoblastic Leukemia (ALL) Undergoing Allogeneic Stem Cell Transplantation (HSCT): An Analysis from US Payers' Perspective","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Hematopoietic stem cell transplantation; Pediatrics; Transplantation; Pharmacy; Health care; Disease; Intensive care medicine; Emergency medicine; Internal medicine; Family medicine","score_opus":0.011899888564293505,"score_gpt":0.2504639288958231,"score_spread":0.2385640403315296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562211759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954183,0.00016982813,0.0015702624,0.00001707254,0.000056798603,0.0007014271,0.0004877805,0.000079357495,0.0014991602],"genre_scores_gemma":[0.9971581,0.00018743245,0.0015076392,0.000053255353,0.00016530215,0.000036890102,0.0006635464,0.000066057255,0.00016177047],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99698347,0.0002047976,0.00044214004,0.0007018644,0.0011703057,0.00049740967],"domain_scores_gemma":[0.997476,0.000424437,0.0002676003,0.0005471844,0.00073495164,0.00054985116],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020947293,0.00034229018,0.00070140546,0.00055685453,0.00007040659,0.000036328394,0.0002566578,0.00019117075,0.00003954069],"category_scores_gemma":[0.00006170603,0.0002762903,0.00017597068,0.0011750624,0.00010237538,0.00023046776,0.000048451675,0.0001946637,0.000037158345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040404317,0.00185358,0.9761722,0.00016875834,0.005872803,0.0006083635,0.006033442,0.0038064595,0.0011999118,0.000024724037,0.00010383834,0.000115506846],"study_design_scores_gemma":[0.073264904,0.005054242,0.8384301,0.00012232743,0.056677926,0.00004551972,0.0056268536,0.005723434,0.014102002,0.00003960706,0.000014120934,0.0008989532],"about_ca_topic_score_codex":0.0019920382,"about_ca_topic_score_gemma":0.0005364275,"teacher_disagreement_score":0.13774207,"about_ca_system_score_codex":0.001754945,"about_ca_system_score_gemma":0.0023528617,"threshold_uncertainty_score":0.99996895},"labels":[],"label_agreement":null},{"id":"W2562222354","doi":"10.1182/blood.v110.11.594.594","title":"Mutations That Cooperate with Nf1 Inactivation in Leukemogenesis Influence Therapeutic Response to MEK Inhibition.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Haematopoiesis; Myeloid leukemia; Cancer research; Progenitor cell; Leukemia; MEK inhibitor; Biology; Myeloid; Immunology; MAPK/ERK pathway; Stem cell; Kinase; Genetics","score_opus":0.02148522940554561,"score_gpt":0.2969390722871466,"score_spread":0.275453842881601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562222354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99504006,0.00006627501,0.0012943539,0.002200166,0.000011647921,0.0007729197,0.0000058595215,0.00006515171,0.00054354995],"genre_scores_gemma":[0.99592465,0.00001335741,0.0019008233,0.0015345579,0.000037362974,0.00008419681,0.00002082891,0.00003420899,0.00045003238],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998563,0.00012253638,0.00023175686,0.0002956601,0.0004150382,0.00037200772],"domain_scores_gemma":[0.99885124,0.00035422266,0.00004798432,0.00029743573,0.00026788426,0.00018123531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094332435,0.00014747151,0.00019438208,0.00054172706,0.00009433695,0.000029445824,0.000076613826,0.0000887962,0.00003895232],"category_scores_gemma":[0.00032939468,0.00012120393,0.000025085346,0.0013046995,0.00007935502,0.00019651887,0.000033765653,0.0002453618,0.000088063236],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007006736,0.00054752245,0.08666149,0.000042290252,0.000093853414,0.00073187216,0.0019507939,0.00045623406,0.8995752,0.00013944891,0.0000576534,0.0027369477],"study_design_scores_gemma":[0.0047319103,0.0005564545,0.5818203,0.00012455894,0.000050873507,0.00016584505,0.0006458962,0.000031813914,0.41129652,0.000025820655,0.0004120977,0.00013793142],"about_ca_topic_score_codex":0.00018248257,"about_ca_topic_score_gemma":0.00021012328,"teacher_disagreement_score":0.4951588,"about_ca_system_score_codex":0.0004486384,"about_ca_system_score_gemma":0.0006297159,"threshold_uncertainty_score":0.49425527},"labels":[],"label_agreement":null},{"id":"W2562226353","doi":"10.1182/blood.v120.21.5106.5106","title":"Outcome of Young Children with Non-Hodgkin's Lymphoma","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Lymphoma; Anaplastic large-cell lymphoma; Internal medicine; Incidence (geometry); Pediatrics; Lymphoblastic lymphoma; Gastroenterology; Immunology; T cell","score_opus":0.011676017144236835,"score_gpt":0.2518759554987278,"score_spread":0.240199938354491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562226353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927424,0.00054104894,0.000006492316,0.00006879778,0.000057685596,0.00026627327,0.000010806851,0.000027835744,0.006278622],"genre_scores_gemma":[0.99841565,0.000022307213,0.0010418567,0.00010446841,0.0001567936,0.000031431373,0.000019235571,0.000018772655,0.00018947126],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992689,0.000008770368,0.00016987015,0.00012152769,0.00019840217,0.0002325577],"domain_scores_gemma":[0.9994643,0.000017482625,0.00006676827,0.000277043,0.00003363811,0.00014077076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000062805884,0.00012464079,0.00027004036,0.00004682624,0.000027022923,0.0000048141133,0.00004606597,0.000047303667,0.00005497926],"category_scores_gemma":[0.000010709753,0.00007941049,0.0000761372,0.00009318783,0.000035140627,0.000059351012,0.000023103898,0.000021639376,0.00005655671],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031859385,0.0033324035,0.9935405,0.000018179886,0.00042181075,0.000015634476,0.00015174053,9.555437e-8,0.0001606438,0.00011416943,0.00010691932,0.002106045],"study_design_scores_gemma":[0.009706169,0.000401981,0.96354306,0.000043208474,0.00077750435,0.00041357445,0.000023175546,5.6049214e-7,0.024864627,0.0000021891385,0.00013773177,0.00008619991],"about_ca_topic_score_codex":0.00021089436,"about_ca_topic_score_gemma":0.000007999795,"teacher_disagreement_score":0.02999742,"about_ca_system_score_codex":0.00003035459,"about_ca_system_score_gemma":0.000033465123,"threshold_uncertainty_score":0.32382658},"labels":[],"label_agreement":null},{"id":"W2562282041","doi":"10.1182/blood.v126.23.3139.3139","title":"Donor Type, Chronic Gvhd Subtype , and the Severity of Chronic Gvhd at the Time of Initiation of Chronic Gvhd Treatment Affect Failure-Free Survival in the Patients with Chronic Gvhd","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Proportional hazards model; Internal medicine; Hazard ratio; Graft-versus-host disease; Cumulative incidence; Hematopoietic stem cell transplantation; Multivariate analysis; Survival analysis; Transplantation; Oncology; Surgery; Confidence interval","score_opus":0.013788844219684937,"score_gpt":0.23521825730536772,"score_spread":0.22142941308568279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562282041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905093,0.004362314,0.000027662903,0.00041828223,0.00016004348,0.0024883843,0.000106007414,0.000024072639,0.001903941],"genre_scores_gemma":[0.99890745,0.0004171068,0.000038452272,0.000025485855,0.00014360737,0.00009895641,0.0002087115,0.000044258813,0.00011599001],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99715817,0.0005722005,0.0006648212,0.00038415156,0.000814597,0.0004060636],"domain_scores_gemma":[0.9973466,0.0007225073,0.00052141986,0.0010482109,0.00027011757,0.00009113846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010785015,0.0003591074,0.0007672572,0.00011360452,0.00008920469,0.00001587133,0.00035851807,0.00017506385,0.00041393188],"category_scores_gemma":[0.00013629762,0.0001838986,0.00013201071,0.0005236083,0.0005354887,0.0001149169,0.00008246841,0.00023732132,0.000026337606],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008416508,0.011544323,0.89160985,0.009649662,0.004796291,0.00013532506,0.029965797,0.0011039395,0.0100123,0.0019628608,0.0012198858,0.029583279],"study_design_scores_gemma":[0.07375393,0.0118557615,0.8543518,0.0004371384,0.002724124,0.000110797555,0.00040367458,0.00056799146,0.054796167,0.000109356464,0.0004442463,0.00044500685],"about_ca_topic_score_codex":0.0006651247,"about_ca_topic_score_gemma":0.004316853,"teacher_disagreement_score":0.06533742,"about_ca_system_score_codex":0.000834626,"about_ca_system_score_gemma":0.0013758015,"threshold_uncertainty_score":0.74991673},"labels":[],"label_agreement":null},{"id":"W2562290868","doi":"10.1182/blood.v118.21.5243.5243","title":"Venous Thromboembolism Following Major Surgery and Risk of Recurrence: A Population-Based Cohort Study","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Pulmonary embolism; Deep vein; Cohort; Surgery; Confidence interval; Retrospective cohort study; Population; Thrombosis; Venous thromboembolism; Cohort study; Internal medicine","score_opus":0.021014472696568427,"score_gpt":0.2553524479129632,"score_spread":0.23433797521639477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562290868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99692184,0.00048350502,0.000017890126,0.000015901525,0.0002434495,0.0012153796,0.00001007626,0.000053865926,0.0010380745],"genre_scores_gemma":[0.9990637,0.00016394383,0.0005019414,0.00005531613,0.000057365403,0.000096418014,0.00002108726,0.000026492224,0.00001379445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986143,0.00009391709,0.00040018364,0.0003284869,0.00032887812,0.0002342336],"domain_scores_gemma":[0.999102,0.00013354502,0.000198984,0.00039883135,0.000057114215,0.000109521774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006807601,0.00017079082,0.00087717857,0.00017788165,0.00010384368,0.000010951018,0.00006893642,0.00006207341,0.00008928079],"category_scores_gemma":[0.00018194273,0.00015134133,0.00016468433,0.00019859121,0.000030011452,0.000058711415,0.00004469418,0.00011338828,0.000006838332],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021266313,0.007401719,0.9890487,0.000099295445,0.0010870652,0.000059604758,0.00087912445,6.730422e-7,0.00001937289,0.00004292358,0.0001129463,0.0012272688],"study_design_scores_gemma":[0.0016994689,0.0005402901,0.99275255,0.00014689456,0.0039059005,0.0000036769109,0.00027763908,0.000010245667,0.00038253065,0.000117892814,0.000017998593,0.00014492638],"about_ca_topic_score_codex":0.0041000596,"about_ca_topic_score_gemma":0.00012858058,"teacher_disagreement_score":0.006861429,"about_ca_system_score_codex":0.000015559894,"about_ca_system_score_gemma":0.0000621381,"threshold_uncertainty_score":0.6198091},"labels":[],"label_agreement":null},{"id":"W2562336370","doi":"10.1182/blood.v118.21.443.443","title":"Brentuximab Vedotin (SGN-35) in Patients with Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma: A Phase 2 Study Update","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Brentuximab vedotin; Medicine; Anaplastic large-cell lymphoma; Internal medicine; Oncology; CD30; Refractory (planetary science); Phases of clinical research; Adverse effect; Lymphoma; Clinical trial; Surgery; Gastroenterology","score_opus":0.012372046938557585,"score_gpt":0.2338100124608789,"score_spread":0.2214379655223213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562336370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99720216,0.00035392947,0.0000031313803,0.000006728746,0.00013019597,0.0016042776,0.00006386075,0.000078316494,0.0005574073],"genre_scores_gemma":[0.99922615,0.000030212213,0.00014006598,0.00008334611,0.000037623515,0.00021453206,0.00008192092,0.00005208798,0.00013404991],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980564,0.00010431163,0.00046560564,0.0005132768,0.00039981926,0.0004606039],"domain_scores_gemma":[0.9988965,0.000058061127,0.00019730275,0.00054991676,0.00008661165,0.00021164476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014351301,0.00032031766,0.00056103175,0.00019743537,0.00006987475,0.000017134249,0.00012159323,0.00009169804,0.00015437935],"category_scores_gemma":[0.000036971796,0.00020756123,0.00006682947,0.00030410223,0.000027270293,0.000107918306,0.000057946392,0.0000880523,0.00016328426],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004247137,0.21244517,0.77870834,0.00011474852,0.00029209643,0.0016592373,0.0014139826,1.3399928e-7,0.00001547524,0.000005233268,0.00014049391,0.0009579706],"study_design_scores_gemma":[0.33619443,0.016770227,0.643529,0.00040593543,0.0011521761,0.000048537866,0.00066740165,0.0000100899315,0.00076940935,0.0000013429449,0.00018227701,0.00026916643],"about_ca_topic_score_codex":0.00014246754,"about_ca_topic_score_gemma":0.00014238857,"teacher_disagreement_score":0.3319473,"about_ca_system_score_codex":0.00020323248,"about_ca_system_score_gemma":0.00022255832,"threshold_uncertainty_score":0.8464101},"labels":[],"label_agreement":null},{"id":"W2562371662","doi":"10.1182/blood.v104.11.2538.2538","title":"Autologous Gamma-Delta T (GD-T) Cells in Acute Myeloid Leukemia (AML): Potential Immune Effector Cells for Minimal Disease?.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Immune system; Immunology; Myeloid; T cell; Medicine; Population; Cancer research; Flow cytometry","score_opus":0.00960392900285659,"score_gpt":0.2671208666193089,"score_spread":0.2575169376164523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562371662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945633,0.00096613646,0.00026916774,0.0005641793,0.000448893,0.0023675382,0.00025280373,0.00014547758,0.00042253218],"genre_scores_gemma":[0.99192125,0.00027173862,0.0018432525,0.0001867191,0.0005627555,0.00028815455,0.00021358825,0.0001235692,0.004588985],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99705476,0.00009689538,0.0005561888,0.0006890696,0.0006007626,0.0010023107],"domain_scores_gemma":[0.99837065,0.00016919628,0.00011135809,0.0007477051,0.00012315484,0.0004779246],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042343192,0.00038677375,0.0007096837,0.00030865966,0.000107236716,0.000056304754,0.0003615841,0.00024932384,0.00061072625],"category_scores_gemma":[0.000073185634,0.00036094198,0.0004625088,0.0003704208,0.00018258527,0.000096566415,0.0001414914,0.0004854473,0.00021966097],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036052298,0.0011110093,0.00059944653,0.00030348887,0.0003806129,0.0016181713,0.00017844891,0.00015174157,0.98890495,0.000024242338,0.00038760656,0.0027350697],"study_design_scores_gemma":[0.029848576,0.0016666895,0.019555455,0.00020258977,0.0008305906,0.00013357896,0.00003640638,0.00027599282,0.9435554,0.00016625087,0.003268694,0.00045976695],"about_ca_topic_score_codex":0.00023384987,"about_ca_topic_score_gemma":0.000028179467,"teacher_disagreement_score":0.045349523,"about_ca_system_score_codex":0.00042393713,"about_ca_system_score_gemma":0.0009163458,"threshold_uncertainty_score":0.99988425},"labels":[],"label_agreement":null},{"id":"W2562380517","doi":"10.1182/blood.v118.21.1732.1732","title":"Improved Survival with Iron Chelation Therapy for Lower IPSS Risk MDS Appears to Have a Stronger Association in Patients with a Non-RARS Diagnosis","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Hematological disorders and diagnostics","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; Queen's University; University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Myelodysplastic syndromes; Concomitant; International Prognostic Scoring System; Retrospective cohort study; Hematology; Chelation therapy; Gastroenterology; Surgery; Bone marrow; Thalassemia","score_opus":0.012618285964145453,"score_gpt":0.22567452422538448,"score_spread":0.213056238261239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562380517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968825,0.00002638535,0.0008061432,0.00009963956,0.000040383526,0.0016986685,0.000041972293,0.000023926883,0.00038036564],"genre_scores_gemma":[0.99658513,0.0000321657,0.0027309402,0.00018186538,0.000025473344,0.00032329457,0.00005064047,0.00002652125,0.000043970933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901366,0.000031143627,0.00019324872,0.00025768013,0.00022589359,0.00027836626],"domain_scores_gemma":[0.99927783,0.00017012088,0.0001327262,0.0001591602,0.0001516511,0.000108511835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016555074,0.00015086906,0.0002793252,0.00006588413,0.00003696966,0.00001283488,0.00004819255,0.00013175723,0.000034803954],"category_scores_gemma":[0.0003526269,0.00010135279,0.0000456347,0.00013769191,0.000015802429,0.00006507419,0.000011919324,0.00012288755,0.000007179946],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016657367,0.003254424,0.9927376,0.000017271921,0.00008313046,0.000003320746,0.00065770646,0.0000054065486,0.000011399652,0.000008035771,0.00007427443,0.0014816956],"study_design_scores_gemma":[0.015030682,0.005502591,0.9783828,0.00007242715,0.00014431597,1.7282206e-7,0.00017346354,0.00005553051,0.00040519773,0.000027501459,0.00004989579,0.00015542337],"about_ca_topic_score_codex":0.0001895444,"about_ca_topic_score_gemma":0.00026013606,"teacher_disagreement_score":0.014354799,"about_ca_system_score_codex":0.000046031244,"about_ca_system_score_gemma":0.000037773767,"threshold_uncertainty_score":0.41330466},"labels":[],"label_agreement":null},{"id":"W2562386614","doi":"10.1182/blood.v124.21.650.650","title":"Pyrimido-Indole Derivatives Are Novel Agonists of Human Cord Blood Hematopoietic Stem Cell Self-Renewal","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Toronto; Université de Montréal","funders":"","keywords":"Progenitor cell; Cord blood; Haematopoiesis; Stem cell; Transplantation; Cell biology; CD34; Chemistry; Ex vivo; In vivo; In vitro; Biology; Pharmacology; Immunology; Biochemistry; Internal medicine; Medicine; Genetics","score_opus":0.01939758247820208,"score_gpt":0.25389342827831823,"score_spread":0.23449584580011615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562386614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887268,0.00020116095,0.00082636287,0.00008648775,0.0001003987,0.0005443338,0.000023522605,0.00019086422,0.009300104],"genre_scores_gemma":[0.99642843,0.0000258386,0.0027776167,0.00009795294,0.00013604855,0.000035023175,0.000041005027,0.00006795204,0.00039012707],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979233,0.00007972028,0.0006538469,0.0004464214,0.00051064865,0.00038604214],"domain_scores_gemma":[0.99850667,0.00018309591,0.00037690558,0.00054781465,0.00016853215,0.00021697523],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026643544,0.00031443723,0.0007009682,0.00014600565,0.00011188661,0.000021858134,0.00019963426,0.00018863496,0.00005882864],"category_scores_gemma":[0.000018747878,0.00029690654,0.00016845347,0.0002347045,0.00010938996,0.00006157635,0.000038913608,0.00018982733,0.000043184264],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000071029826,0.004247453,0.042703506,0.0033933404,0.00029631774,0.00005308501,0.003145099,0.0000022268553,0.9448168,0.0011440075,0.000031071464,0.0000960473],"study_design_scores_gemma":[0.009986161,0.00090004585,0.014982337,0.0007054032,0.0012619292,0.00029480507,0.00074697257,0.000022683318,0.9705909,0.00010880461,0.000097011594,0.0003029752],"about_ca_topic_score_codex":0.000026915483,"about_ca_topic_score_gemma":0.0000110810115,"teacher_disagreement_score":0.027721167,"about_ca_system_score_codex":0.00001896347,"about_ca_system_score_gemma":0.00008802525,"threshold_uncertainty_score":0.9999483},"labels":[],"label_agreement":null},{"id":"W2562437599","doi":"10.1182/blood.v108.11.629.629","title":"The Management of Anticoagulated Patients Requiring Dental Extraction: A Cross-Sectional Survey of Oral Surgeons and Hematologists.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Warfarin; Cross-sectional study; Family medicine; Emergency medicine; Internal medicine; Atrial fibrillation","score_opus":0.06307241549531879,"score_gpt":0.3508521055147325,"score_spread":0.2877796900194137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562437599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99870265,0.00011748309,0.000043096137,0.000023805389,0.00013170685,0.00022910722,0.000007818048,0.000016623431,0.00072770217],"genre_scores_gemma":[0.99924076,0.00003447956,0.0001653134,0.0000025555419,0.000018405364,9.639185e-7,0.000054495707,0.0000060656953,0.00047697694],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99918157,0.000030944622,0.00035292094,0.00011484676,0.00021851565,0.000101198006],"domain_scores_gemma":[0.99949825,0.00009412754,0.00016511744,0.00011403045,0.000108989596,0.00001946327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030883975,0.00006820012,0.00016484376,0.00004695461,0.000085320804,0.00001697709,0.000034666875,0.000035944267,0.00001709848],"category_scores_gemma":[0.000031202402,0.000050159055,0.00005544832,0.0001512863,0.00010256998,0.000055128916,0.000047957812,0.000033374694,0.0000016415999],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012895202,0.00006911805,0.9985205,0.0000787248,0.00016533917,0.000004486754,0.0000028927855,0.000014141331,0.00016473737,0.00068215316,0.000022896287,0.00014607007],"study_design_scores_gemma":[0.0023623947,0.0000459219,0.99588776,0.000018648794,0.000087171764,0.000007955265,0.000011415803,0.000033874483,0.0013590246,0.00004941344,0.000091794886,0.000044617598],"about_ca_topic_score_codex":0.00035622582,"about_ca_topic_score_gemma":0.00009667475,"teacher_disagreement_score":0.0026327216,"about_ca_system_score_codex":0.000007970385,"about_ca_system_score_gemma":0.0000070382366,"threshold_uncertainty_score":0.2045427},"labels":[],"label_agreement":null},{"id":"W2562443556","doi":"10.1182/blood.v116.21.3273.3273","title":"Phase 2 Study of MLN8237, An Investigational Aurora A Kinase (AAK) Inhibitor In Patients with Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndromes (MDS)","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Common Terminology Criteria for Adverse Events; Medicine; Internal medicine; Neutropenia; Phases of clinical research; Adverse effect; Oncology; Multiple myeloma; Leukemia; Clinical trial; Toxicity","score_opus":0.006878014787305713,"score_gpt":0.23406361344605628,"score_spread":0.22718559865875057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562443556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991515,0.000015272468,0.000026097625,0.000005154071,0.00009636879,0.00054836075,0.00012540346,0.00001163193,0.000020181538],"genre_scores_gemma":[0.99832445,0.000005236245,0.0009579309,0.000053327767,0.00008882678,0.00005342491,0.00042840332,0.000034581375,0.000053792293],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987608,0.000054453267,0.00031363653,0.00041856454,0.00019929398,0.00025325266],"domain_scores_gemma":[0.99914974,0.000013644147,0.00014193403,0.0004242479,0.00013255847,0.00013787876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009156247,0.00022022084,0.00023462343,0.00010049596,0.00006118449,0.000020034015,0.0002299771,0.00016568285,0.000019058967],"category_scores_gemma":[0.000059832128,0.00017781364,0.000034484332,0.00016797904,0.000107273,0.000012750573,0.00009279038,0.00018323051,0.000003148274],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008852194,0.011527819,0.103222094,0.00003375488,0.0002765063,0.000086998894,0.0004015367,0.00003481359,0.88275266,0.000014782169,0.000039890696,0.00072395115],"study_design_scores_gemma":[0.06678567,0.045975216,0.18962699,0.00010615609,0.0009084626,0.00018522903,0.0005052124,0.00017504497,0.69375813,0.00004919109,0.00056042505,0.0013642668],"about_ca_topic_score_codex":0.00008073049,"about_ca_topic_score_gemma":0.001394116,"teacher_disagreement_score":0.1889945,"about_ca_system_score_codex":0.0000140465445,"about_ca_system_score_gemma":0.00039252022,"threshold_uncertainty_score":0.72510296},"labels":[],"label_agreement":null},{"id":"W2562524122","doi":"10.1182/blood.v118.21.1325.1325","title":"A Novel Osteoclastic Network Determines In Vitro Niche for Mouse and Human Hematopoietic Stem Cells","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Haematopoiesis; Cell biology; Biology; Stem cell; In vitro; Retrovirus; Transfection; Transcription factor; Cell culture; Gene; Genetics","score_opus":0.06342018979552234,"score_gpt":0.2858755124935365,"score_spread":0.22245532269801416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562524122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99698377,0.0003212967,0.00019875097,0.000029234649,0.000046689627,0.0009926378,0.0000071513996,0.000034288914,0.0013862083],"genre_scores_gemma":[0.9947385,0.000009486024,0.0024649631,0.000056749144,0.0001344937,0.00012373291,0.0000040581644,0.000039280167,0.002428732],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987022,0.000030112184,0.00028967907,0.00031166413,0.00020155651,0.00046478337],"domain_scores_gemma":[0.9991981,0.00020065674,0.000057432593,0.00029274286,0.00005803132,0.00019307226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031242103,0.00015635142,0.00034530635,0.000093850234,0.00006180349,0.000016585624,0.00010911021,0.0001042202,0.00003591681],"category_scores_gemma":[0.000035429013,0.00013221831,0.00005819741,0.00014831142,0.000066989014,0.000035776855,0.0000893546,0.00015594417,0.000014925243],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029471877,0.0007839284,0.011577512,0.00077611784,0.000050215243,0.00011593265,0.00065289193,9.617559e-7,0.98493034,0.00012952469,0.00014159149,0.0005462701],"study_design_scores_gemma":[0.008899421,0.00092518324,0.0045858147,0.0002337943,0.00018843399,0.00023090342,0.00017369767,0.00027562786,0.9837104,0.00012384137,0.00039971707,0.00025317364],"about_ca_topic_score_codex":0.00006723379,"about_ca_topic_score_gemma":0.000076447956,"teacher_disagreement_score":0.008604703,"about_ca_system_score_codex":0.000017685894,"about_ca_system_score_gemma":0.0000450103,"threshold_uncertainty_score":0.5391706},"labels":[],"label_agreement":null},{"id":"W2562528138","doi":"10.1182/blood.v126.23.174.174","title":"CSF3R Mutations Represent a Novel Therapeutic Target in Pediatric AML with a High Degree of Overlap with CEBPA Mutations: a Report from COG AAML0531 and COG/NCI Target AML Initiative","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"CEBPA; Medicine; Missense mutation; Cohort; Mutation; Oncology; Cog; Myeloid leukemia; Myeloid; Cancer research; Internal medicine; Genetics; Biology; Gene","score_opus":0.053502024397418704,"score_gpt":0.2992414327905266,"score_spread":0.24573940839310793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562528138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908671,0.0014763902,0.0029669388,0.0010023967,0.00003651424,0.0014966354,0.00027664885,0.00006708003,0.0018103028],"genre_scores_gemma":[0.96250796,0.000061515915,0.035952672,0.00020356121,0.00016309203,0.00028157962,0.0005744807,0.00006673052,0.0001884161],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971479,0.0001487634,0.00064044166,0.00067513733,0.0009393637,0.0004483582],"domain_scores_gemma":[0.99727076,0.0005453342,0.0004086588,0.000642621,0.0007927209,0.00033990588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005159112,0.0003111593,0.00065970566,0.00047466793,0.00007101101,0.00003316489,0.0001590483,0.00015514635,0.00005062835],"category_scores_gemma":[0.00076899776,0.00023585245,0.000052366308,0.0011049818,0.00034318023,0.000249587,0.00009895795,0.000529014,0.0000106139],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021371017,0.0029416254,0.9775024,0.00018017509,0.0012383988,0.0040085167,0.008189216,0.00024564148,0.0026330594,0.0002037747,0.0005457506,0.00017433356],"study_design_scores_gemma":[0.05038843,0.0033863431,0.9204263,0.00031741738,0.002508776,0.0023004324,0.006506984,0.0018648406,0.008525774,0.0027390276,0.0003258437,0.0007098069],"about_ca_topic_score_codex":0.0021425146,"about_ca_topic_score_gemma":0.0003995603,"teacher_disagreement_score":0.05707608,"about_ca_system_score_codex":0.00015854005,"about_ca_system_score_gemma":0.0023552312,"threshold_uncertainty_score":0.96177834},"labels":[],"label_agreement":null},{"id":"W2562549173","doi":"10.1182/blood.v114.22.5055.5055","title":"Pediatric Venous Thromboembolism: Redefining Epidemiology.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Diagnosis code; Incidence (geometry); Healthcare Cost and Utilization Project; Epidemiology; Pediatrics; Disease; Psychological intervention; Intensive care medicine; Health care; Internal medicine; Population","score_opus":0.033932852494577094,"score_gpt":0.29963024432340424,"score_spread":0.2656973918288271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562549173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93836033,0.0039157644,0.00008688627,0.0036411833,0.00026997086,0.000443401,0.0000036544213,0.00028456986,0.052994244],"genre_scores_gemma":[0.9867245,0.0017409574,0.0034750414,0.0068466207,0.0009619159,0.000021845588,0.000023466659,0.000024961344,0.0001806682],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983403,0.00006720755,0.00043358828,0.00041320524,0.00018778797,0.00055791426],"domain_scores_gemma":[0.9989877,0.00012648047,0.00014011672,0.000483143,0.000052285042,0.0002103279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005323305,0.00021156196,0.0009276885,0.00016481667,0.00013314377,0.000012546437,0.0001392956,0.00013845947,0.00017154172],"category_scores_gemma":[0.00036394934,0.00018676359,0.00017445427,0.00027243863,0.000033633452,0.000059656268,0.00004645469,0.00023233352,0.00027996922],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017909496,0.05735598,0.46422827,0.0008649778,0.0020228538,0.0021617296,0.003505347,0.00014032576,0.004363876,0.15525053,0.21082523,0.09910176],"study_design_scores_gemma":[0.0022953243,0.0016222992,0.98330563,0.000053235355,0.0014475596,0.00012927123,0.000063548796,0.000014169148,0.00033753703,0.004308479,0.0061649685,0.00025794885],"about_ca_topic_score_codex":0.000030118845,"about_ca_topic_score_gemma":0.0000016016495,"teacher_disagreement_score":0.51907736,"about_ca_system_score_codex":0.000026595553,"about_ca_system_score_gemma":0.00006330988,"threshold_uncertainty_score":0.7615998},"labels":[],"label_agreement":null},{"id":"W2562551519","doi":"10.1182/blood.v110.11.456.456","title":"Red Blood Cell Alloimmunization Is Affected by Depletion of Donor White Cell Subsets.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Red blood cell; CD19; Andrology; Immunology; Antibody; Flow cytometry; Spleen; CD8; Immune system; Medicine; Biology","score_opus":0.004783905552760486,"score_gpt":0.20294798569874917,"score_spread":0.19816408014598869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562551519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99063224,0.0010643917,0.0010740397,0.00021498837,0.000085702675,0.0004965313,0.00003043998,0.00009358189,0.0063080615],"genre_scores_gemma":[0.9964419,0.0003655148,0.0016916484,0.00019802658,0.0000713147,0.0000058396317,0.000338595,0.000045885947,0.0008412746],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99864846,0.000037989936,0.0004076221,0.0002915397,0.00031751074,0.00029689886],"domain_scores_gemma":[0.999127,0.00003419545,0.00015402342,0.00039025926,0.0001628668,0.00013167213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029043446,0.00019138657,0.00031479562,0.00013724189,0.000069227215,0.00001048643,0.00009861587,0.00022192612,0.00023501736],"category_scores_gemma":[0.000014951414,0.00017975787,0.0001195714,0.0004346808,0.000038976013,0.00007235454,0.00002327667,0.00020007325,0.00002063363],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014226763,0.004326633,0.08822892,0.00027896516,0.00008251349,0.000023272501,0.00046536513,8.647566e-7,0.9049731,0.000007813915,0.0011193143,0.00035099825],"study_design_scores_gemma":[0.010535384,0.00063948944,0.09817204,0.0000866842,0.0008895957,0.000028338065,0.00007362762,0.000018743918,0.888332,0.000009862988,0.0010412539,0.00017294714],"about_ca_topic_score_codex":0.000107182495,"about_ca_topic_score_gemma":0.000032555974,"teacher_disagreement_score":0.016641043,"about_ca_system_score_codex":0.000010092896,"about_ca_system_score_gemma":0.000032490196,"threshold_uncertainty_score":0.73303133},"labels":[],"label_agreement":null},{"id":"W2562579323","doi":"10.1182/blood.v120.21.1733.1733","title":"Improvement in Weight and Total Cholesterol and Their Association with Survival in Ruxolitinib-Treated Patients with Myelofibrosis From COMFORT-I","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Internal medicine; Placebo; Gastroenterology; Weight loss; Body mass index; Cachexia; Hypocholesterolemia; Anemia; Cholesterol; Surgery; Obesity; Cancer; Bone marrow; Pathology","score_opus":0.005645359044309663,"score_gpt":0.19691509941011726,"score_spread":0.1912697403658076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562579323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986707,0.00015572758,0.0000012463706,0.0001158334,0.000022428614,0.00069549016,0.00009526273,0.000014167268,0.00022917216],"genre_scores_gemma":[0.99934,0.000052679727,0.00014801318,0.000079041834,0.00004470876,0.00013629251,0.00015218531,0.000018641118,0.000028424472],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990498,0.000044996472,0.0001939717,0.00023500583,0.00019322289,0.0002830406],"domain_scores_gemma":[0.99951494,0.000105325285,0.000096399446,0.00011200054,0.000042625765,0.00012870347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000103791164,0.0001960717,0.00034094608,0.00007091011,0.000033801272,0.00002324961,0.000016951695,0.000075210664,0.00001599568],"category_scores_gemma":[0.000012839025,0.00011889086,0.000014796863,0.00009983015,0.000023121618,0.00013320746,0.000025125313,0.00010506189,0.0000014552185],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023943673,0.001867168,0.9940727,0.000017306638,0.00018882906,0.000004159053,0.00076892617,1.8250284e-7,0.00026554242,0.000014070118,0.0000031484005,0.0025585843],"study_design_scores_gemma":[0.017236013,0.0011293833,0.9652144,0.00017835289,0.00013538942,0.000002356644,0.00012247483,0.0000067663973,0.015821114,0.000005545812,0.000023050608,0.00012515759],"about_ca_topic_score_codex":0.0005991,"about_ca_topic_score_gemma":0.0006769752,"teacher_disagreement_score":0.02885825,"about_ca_system_score_codex":0.00009811536,"about_ca_system_score_gemma":0.000018793093,"threshold_uncertainty_score":0.48482284},"labels":[],"label_agreement":null},{"id":"W2562649751","doi":"10.1182/blood.v110.11.2295.2295","title":"A GMCSF/Interleukin-15 Fusokine Leads to the Generation of a Novel Type of CD2/MHCII Immune Regulatory Cell with Potent Immune Suppressive Properties as Demonstrated in the EAE Mouse Model of Multiple Sclerosis.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Institute for Research in Immunology and Cancer","funders":"","keywords":"FOXP3; IL-2 receptor; Biology; Immunology; Immune system; Experimental autoimmune encephalomyelitis; T cell; Cell biology","score_opus":0.04427977251484514,"score_gpt":0.21751590632067286,"score_spread":0.17323613380582772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562649751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99665654,0.0014300455,0.0006689626,0.00010201204,0.00024638473,0.0005557693,0.000012359032,0.000014181183,0.00031372035],"genre_scores_gemma":[0.99794245,0.000045060333,0.00016202066,0.00008132434,0.000014804879,0.00002316776,0.00005808845,0.000018335511,0.0016547454],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99872756,0.00013173866,0.00064142107,0.00019299146,0.00008827315,0.00021803152],"domain_scores_gemma":[0.99879223,0.00006050024,0.00036587912,0.0004373758,0.00033323537,0.000010794021],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047922792,0.00017387021,0.00030469286,0.00014770977,0.00008551709,0.000007949156,0.00027047313,0.00015225235,0.00004181732],"category_scores_gemma":[0.00006668731,0.00010022296,0.000089593144,0.00023775545,0.00019344759,0.00009522103,0.000057768142,0.0002634682,0.000013003739],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016953326,0.0013999355,0.0003828062,0.000031561627,0.00013384387,3.7958463e-7,0.0029468695,0.0039358297,0.9891616,0.000046229754,0.00015061536,0.00011498107],"study_design_scores_gemma":[0.0031843507,0.0008948585,0.004198114,0.000117931624,0.00010028855,0.000023684022,0.0019626843,0.0006922115,0.98864216,8.148586e-7,0.00006923847,0.00011365301],"about_ca_topic_score_codex":0.00063761434,"about_ca_topic_score_gemma":0.00023078294,"teacher_disagreement_score":0.0038153075,"about_ca_system_score_codex":0.000022959119,"about_ca_system_score_gemma":0.00008980271,"threshold_uncertainty_score":0.4086974},"labels":[],"label_agreement":null},{"id":"W2562656615","doi":"10.1182/blood.v106.11.4639.4639","title":"A Phase I Study of the Histone Deacetylase Inhibitor MGCD0103 (MG-0103) Given as a Three-Times Weekly Oral Dose in Patients with Leukemia or Myelodysplastic Syndromes (MDS).","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pyrogenesis (Canada); Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Pharmacology; Myelodysplastic syndromes; Nausea; Pharmacodynamics; Pharmacokinetics; Adverse effect; Phases of clinical research; Oncology; Gastroenterology; Clinical trial; Bone marrow","score_opus":0.010143622707078043,"score_gpt":0.2777129898355881,"score_spread":0.2675693671285101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562656615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99790865,0.00020088343,0.000006052856,0.0001210022,0.0000935916,0.0013778189,0.00006078291,0.00002090127,0.00021028644],"genre_scores_gemma":[0.99779063,0.0000072582793,0.00021254693,0.00004551179,0.00013453746,0.00014264918,0.000049160863,0.00006955414,0.0015481451],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973598,0.00021929562,0.0005026688,0.00066869997,0.00070473383,0.0005448046],"domain_scores_gemma":[0.99850243,0.000049643306,0.00021237091,0.00084927975,0.00020615665,0.00018009641],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002574343,0.00037604355,0.0004458224,0.00018066722,0.000149591,0.0000285171,0.00052731705,0.00020643344,0.00010187896],"category_scores_gemma":[0.00030341517,0.00025642943,0.00011089271,0.0004876312,0.000275243,0.000020958163,0.00032866755,0.00035321948,0.000040329804],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027690243,0.13061376,0.1472404,0.0005205705,0.0023086779,0.0007472013,0.0048679737,0.0011635048,0.6518294,0.000036603396,0.016191542,0.016790105],"study_design_scores_gemma":[0.17040344,0.046487298,0.0728276,0.0005018616,0.0006895399,0.00019353363,0.0010361148,0.00023419767,0.69773567,0.000016457836,0.008044963,0.001829307],"about_ca_topic_score_codex":0.00032564,"about_ca_topic_score_gemma":0.0030481296,"teacher_disagreement_score":0.14271319,"about_ca_system_score_codex":0.00017727555,"about_ca_system_score_gemma":0.00069357187,"threshold_uncertainty_score":0.9999888},"labels":[],"label_agreement":null},{"id":"W2562661376","doi":"10.1182/blood.v108.11.1169.1169","title":"Dynamic Change in the Stochiometry of ETO2 and SCL Governs the Transition to Terminal Differentiation in Erythroid Progenitors.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Biology; Cell biology; Chromatin; Transcription factor; Cellular differentiation; Chromatin remodeling; Corepressor; Progenitor cell; Genetics; Molecular biology; Stem cell; Gene; Repressor","score_opus":0.012531592538049727,"score_gpt":0.2558800432669123,"score_spread":0.2433484507288626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562661376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979149,0.00018522354,0.000065926324,0.0011455718,0.000056949426,0.00051613955,0.000011633904,0.0000071962486,0.00009646198],"genre_scores_gemma":[0.99930924,0.000023666587,0.000057005174,0.00038029908,0.000112283495,0.000062958716,0.00003308335,0.0000058434384,0.000015588676],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9994554,0.00006995667,0.0001473376,0.00011258002,0.000115747585,0.00009900217],"domain_scores_gemma":[0.9997798,0.00003912092,0.00003898433,0.00011226476,0.000015142722,0.000014653729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000119883225,0.00006689609,0.00012515213,0.000116046685,0.000024385052,0.000004539384,0.00003719435,0.00005275245,0.0000116418705],"category_scores_gemma":[0.000011613604,0.000040030878,0.000027926264,0.0002799522,0.00003322177,0.000030274165,0.000008386611,0.00010695615,0.0000022758],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001314949,0.0061550955,0.36955553,0.00075214147,0.00008849909,0.00012245376,0.025904998,0.000023156144,0.57239735,0.0007120866,0.00019245151,0.022781301],"study_design_scores_gemma":[0.0015775186,0.000361944,0.99576145,0.00005734715,0.00005141792,0.00006451577,0.0004111047,0.0002887797,0.001261774,0.0000774191,0.000041865125,0.0000448659],"about_ca_topic_score_codex":0.00022129554,"about_ca_topic_score_gemma":0.0008135076,"teacher_disagreement_score":0.6262059,"about_ca_system_score_codex":0.000015555239,"about_ca_system_score_gemma":0.000011535884,"threshold_uncertainty_score":0.16324118},"labels":[],"label_agreement":null},{"id":"W2562680644","doi":"10.1182/blood.v108.11.2613.2613","title":"Estimating the Prevalence of Myelodysplasia: A Retrospective Review of Bone Marrow Histopathology in 322 Cases of Unexplained Cytopenia(s) in a Teaching Hospital.","year":2006,"lang":"en","type":"review","venue":"Blood","topic":"Hematological disorders and diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Cytopenia; Medicine; Mean corpuscular volume; Internal medicine; Anemia; Retrospective cohort study; Bone marrow; Myelodysplastic syndromes; Population; Incidence (geometry); Pediatrics; Complete blood count; Bone marrow examination; Red blood cell distribution width; Hematologic disease; Disease; Hemoglobin","score_opus":0.020925279583395604,"score_gpt":0.31478404187316456,"score_spread":0.2938587622897689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562680644","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008778929,0.98775685,0.000015089262,0.00010700551,0.000047112488,0.001987732,0.00009643159,0.000010278759,0.0012005577],"genre_scores_gemma":[0.014186749,0.98309225,0.0023622098,0.00004169419,0.000024391054,0.00017936686,0.0000341801,0.000027972048,0.000051209252],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9967294,0.00045133106,0.0018713572,0.00039209746,0.0002953917,0.0002604761],"domain_scores_gemma":[0.9966744,0.0013024134,0.0013457305,0.00052137114,0.00011506843,0.000040992745],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0011767943,0.00032749068,0.003670594,0.0002129734,0.000022437927,0.0000022149545,0.00023413805,0.00026369334,0.000034993987],"category_scores_gemma":[0.014045476,0.00021082899,0.00037111508,0.000508148,0.00022916374,0.00003144327,0.00012541996,0.0006899994,0.0000015103418],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024459945,0.003428926,0.022043139,0.9262551,0.0000647714,0.0018229735,0.0002528803,0.0000015591097,0.000007589008,0.0011073338,0.00032122794,0.044670038],"study_design_scores_gemma":[0.0028096617,0.002206955,0.015210302,0.9634269,0.005009512,0.0016922363,0.000059627157,0.000020965319,0.000015827241,0.00036205634,0.008672662,0.0005132978],"about_ca_topic_score_codex":0.00017081284,"about_ca_topic_score_gemma":0.000035838188,"teacher_disagreement_score":0.044156738,"about_ca_system_score_codex":0.00007169384,"about_ca_system_score_gemma":0.0002599178,"threshold_uncertainty_score":0.99425966},"labels":[],"label_agreement":null},{"id":"W2562699034","doi":"10.1182/blood.v124.21.4897.4897","title":"Hydroxyurea for Non-Transfusion-Dependent β-Thalassemias: A Meta-Analysis","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Medicine; Thalassemia; Blood transfusion; Anemia; Observational study; Ineffective erythropoiesis; Internal medicine; Beta thalassemia; Meta-analysis; Pediatrics; Randomized controlled trial; Clinical trial; Erythropoiesis","score_opus":0.01823450395174763,"score_gpt":0.2604473082297779,"score_spread":0.24221280427803027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562699034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9261982,0.0028296628,0.02622705,0.0056357747,0.00022378155,0.0020879155,0.000070838076,0.00024732997,0.036479462],"genre_scores_gemma":[0.99507815,0.00014692689,0.0013553796,0.0007239871,0.00008650095,0.00012374177,0.00005331551,0.000029503173,0.0024025235],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9987089,0.000033863133,0.00031647529,0.00035398945,0.00028562208,0.00030115567],"domain_scores_gemma":[0.99909145,0.000112771835,0.000070463844,0.00044891468,0.000093118644,0.0001833041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037594867,0.00019296634,0.0008612854,0.00018371969,0.000101070065,0.000018736111,0.00010196982,0.0001975185,0.00036016008],"category_scores_gemma":[0.000091392685,0.00013128537,0.0014745477,0.00038010173,0.00003125071,0.000034110624,0.000019594001,0.00016857727,0.00005133318],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004258072,0.0074156933,0.02103924,0.00080384687,0.91204023,0.00014097379,0.0020398456,0.0007260219,0.04542209,0.0013637329,0.0051800315,0.0034024955],"study_design_scores_gemma":[0.008012879,0.0007181437,0.0014376963,0.00001334113,0.9605946,0.000056080033,0.00024313203,0.0027811448,0.014349634,0.00035923184,0.011053801,0.00038033238],"about_ca_topic_score_codex":0.00008407678,"about_ca_topic_score_gemma":0.000052561754,"teacher_disagreement_score":0.06887994,"about_ca_system_score_codex":0.000010170866,"about_ca_system_score_gemma":0.000041000494,"threshold_uncertainty_score":0.53536624},"labels":[],"label_agreement":null},{"id":"W2562713493","doi":"10.1182/blood.v126.23.419.419","title":"Dynamin 2 (DNM2) and PACSIN2 Regulate Megakaryocyte Demarcation Membrane System Formation and Platelet Production in Concert","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Dynamin; Cell biology; Endocytic cycle; Platelet; Megakaryocyte; Endocytosis; Clathrin; Biology; Chemistry; Receptor; Biochemistry; Immunology; Haematopoiesis","score_opus":0.015828689170556506,"score_gpt":0.23652136252395314,"score_spread":0.22069267335339665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562713493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965419,0.0011368904,0.000012661562,0.00046696997,0.00006676298,0.00052982965,0.0000041753688,0.0000491032,0.001191688],"genre_scores_gemma":[0.9992192,0.00017395847,0.00022849192,0.00002224896,0.000033960936,0.000028557999,0.00009629447,0.000010876686,0.00018644195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993172,0.000032051135,0.00019173352,0.00019175348,0.00013633446,0.00013092694],"domain_scores_gemma":[0.999654,0.00001152059,0.000070232236,0.00011890298,0.000052555075,0.00009281636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019142935,0.00010552825,0.00021846802,0.00009854735,0.000036774396,0.000017880608,0.000016020358,0.00007119378,0.0000012607186],"category_scores_gemma":[0.000040509363,0.00008899891,0.000012018118,0.00011541639,0.00003086424,0.0002450208,0.000013977072,0.000058799815,0.000005377896],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009903255,0.00935109,0.5010041,0.014810524,0.0026706902,0.0066113314,0.035323616,0.00031891238,0.109425314,0.0056216666,0.003434878,0.30152464],"study_design_scores_gemma":[0.12897176,0.0035802838,0.46896252,0.0040015574,0.0022148679,0.030568069,0.010607898,0.035412308,0.30843267,0.002172195,0.0033811093,0.001694763],"about_ca_topic_score_codex":0.00008324428,"about_ca_topic_score_gemma":0.00009096554,"teacher_disagreement_score":0.29982987,"about_ca_system_score_codex":0.000063824154,"about_ca_system_score_gemma":0.000031094543,"threshold_uncertainty_score":0.36292702},"labels":[],"label_agreement":null},{"id":"W2562770396","doi":"10.1182/blood.v118.21.2736.2736","title":"Targeting Rac2 - Mitochondrial Respiratory Chain Complex III Signaling to Prevent Genomic Instability in Leukemia Stem and Progenitor Cells","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"CD38; Leukemia; Biology; Cancer research; Myeloid leukemia; Stem cell; Progenitor cell; CD34; Molecular biology; Immunology; Cell biology","score_opus":0.03771426220807529,"score_gpt":0.254789813261864,"score_spread":0.21707555105378873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562770396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99663484,0.0005633617,0.000026627335,0.00001743723,0.00018230491,0.0021803938,0.00001646632,0.00007139159,0.00030720397],"genre_scores_gemma":[0.9929176,0.000008047042,0.0062178914,0.00015548004,0.00037534756,0.0001676385,0.000011687504,0.00004594492,0.00010033679],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99794835,0.00015607446,0.00060011505,0.0005958017,0.00024475428,0.00045489593],"domain_scores_gemma":[0.99905074,0.00007256246,0.00013423468,0.00040566095,0.000052789397,0.00028399285],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004019158,0.00026762552,0.00047538878,0.00014038342,0.00007901514,0.00001565551,0.00012914995,0.00013882185,0.00012541129],"category_scores_gemma":[0.000055683216,0.00025438663,0.00007510949,0.0001711294,0.00006141666,0.00006645122,0.00015403038,0.00025017318,0.00003588854],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005812307,0.0011700072,0.038341366,0.00022470787,0.0001500512,0.00018136077,0.0057190666,0.000022104048,0.9519151,0.000010648669,0.000119427285,0.0015649358],"study_design_scores_gemma":[0.02938904,0.0014142347,0.06278256,0.00039961055,0.0004447683,0.00005226721,0.0012874327,0.00024045829,0.9012412,0.000036352798,0.0020455911,0.00066647853],"about_ca_topic_score_codex":0.0003379319,"about_ca_topic_score_gemma":0.0000659312,"teacher_disagreement_score":0.05067389,"about_ca_system_score_codex":0.0011495389,"about_ca_system_score_gemma":0.00064241665,"threshold_uncertainty_score":0.9999908},"labels":[],"label_agreement":null},{"id":"W2562782982","doi":"10.1182/blood.v106.11.2817.2817","title":"Survival of Limited Stage Peripheral T-Cell Lymphoma Is Similar To Diffuse Large B-Cell Lymphoma.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Anaplastic large-cell lymphoma; Lymphoma; Peripheral T-cell lymphoma; CHOP; Stage (stratigraphy); Gastroenterology; Chemotherapy; Diffuse large B-cell lymphoma; T-cell lymphoma; Cancer; Not Otherwise Specified; Chemotherapy regimen; Oncology; T cell; Immunology","score_opus":0.013269817168679211,"score_gpt":0.2467155649051114,"score_spread":0.2334457477364322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562782982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840469,0.0013766575,0.000016961325,0.0010595972,0.00013532772,0.0006135915,0.0003091517,0.00010621742,0.012335641],"genre_scores_gemma":[0.9878063,0.0002850654,0.0015277459,0.0023353444,0.00027283988,0.00006926328,0.00007796954,0.00007316961,0.007552309],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99768203,0.00006168359,0.0005108681,0.0005467287,0.00056429364,0.0006344024],"domain_scores_gemma":[0.9983698,0.00009245731,0.0001485329,0.00078307284,0.00014299274,0.00046315353],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015586804,0.00039482632,0.00067255064,0.00015502052,0.00009719543,0.000032914224,0.0001952916,0.00017503154,0.0005070706],"category_scores_gemma":[0.00003585069,0.00033614077,0.00031602388,0.0003224501,0.000043040287,0.00009085864,0.00012623587,0.000045254375,0.0002794877],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014212113,0.44203496,0.44868582,0.0007869055,0.0013532562,0.0013326129,0.006717608,0.000017042767,0.04882552,0.00039588413,0.01990416,0.028525028],"study_design_scores_gemma":[0.18245666,0.0017855223,0.108831435,0.00013709864,0.0010326342,0.000046366808,0.0005695609,0.0002500173,0.49787384,0.000006177524,0.20637399,0.000636705],"about_ca_topic_score_codex":0.0001363266,"about_ca_topic_score_gemma":0.00006620297,"teacher_disagreement_score":0.4490483,"about_ca_system_score_codex":0.00022338043,"about_ca_system_score_gemma":0.00021742073,"threshold_uncertainty_score":0.99990904},"labels":[],"label_agreement":null},{"id":"W2562819987","doi":"10.1182/blood.v120.21.2645.2645","title":"Mutations of STAT6 DNA Binding Domain Are Characteristic of PMBL and Belong to the Genetic Signature of This Entity.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lymphoma; Biology; Primary immunodeficiency; Pathology; Molecular biology; Cancer research; Medicine","score_opus":0.009947555100507273,"score_gpt":0.24130619415743457,"score_spread":0.2313586390569273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562819987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979201,0.0012717868,0.000008163474,0.00022969847,0.000042716478,0.00028853046,0.000118743614,0.0000041405456,0.000116149466],"genre_scores_gemma":[0.9990066,0.00006827114,0.00077085465,0.000032385466,0.000040697927,0.000021805407,0.00001704065,0.0000063397747,0.000036002555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994625,0.00002982426,0.00018051294,0.00007755782,0.00013972397,0.000109920526],"domain_scores_gemma":[0.99948734,0.00010401966,0.00013343281,0.00015602993,0.00005373128,0.00006545582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010002904,0.00006903773,0.00020059117,0.00006190731,0.000030446612,0.0000031038305,0.000036732188,0.000035982623,0.000054385197],"category_scores_gemma":[0.00006326278,0.00004479032,0.00004237432,0.0001130614,0.00003945257,0.000024594536,0.000026388157,0.000030673033,0.0000040794807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003624134,0.0017853369,0.9217673,0.00026251914,0.0003421269,0.000013924877,0.004411857,7.5744083e-7,0.069316216,0.00020778376,0.00013932452,0.0017165944],"study_design_scores_gemma":[0.0013217153,0.00017411256,0.9130389,0.000163439,0.00046366884,0.000017643564,0.00035101912,9.820532e-7,0.0842205,0.000015701053,0.00019380897,0.000038479982],"about_ca_topic_score_codex":0.000042978034,"about_ca_topic_score_gemma":0.000010133065,"teacher_disagreement_score":0.014904286,"about_ca_system_score_codex":0.00001203873,"about_ca_system_score_gemma":0.00002455781,"threshold_uncertainty_score":0.18264961},"labels":[],"label_agreement":null},{"id":"W2562855965","doi":"10.1182/blood.v116.21.2204.2204","title":"Ideal Amphipathic Peptdes Coupled to Nanofibrous Micropheres Reduce Hemorrhage In Vivo","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hemostasis and retained surgical items","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"In vivo; Hemostasis; Chemistry; Liver injury; Amphiphile; Pharmacology; Biomedical engineering; Biophysics; Surgery; Medicine; Biology","score_opus":0.01351402699545452,"score_gpt":0.2719135572544991,"score_spread":0.2583995302590446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562855965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940996,0.00031719293,0.000012706844,0.001429745,0.0002302377,0.0004054605,0.000011922358,0.00007235087,0.003420763],"genre_scores_gemma":[0.9943281,0.000017139075,0.0027938238,0.0005416193,0.0003519279,0.000025989259,0.000007613394,0.000034928828,0.0018988672],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986147,0.0000368833,0.00034510207,0.0003432066,0.0002467714,0.00041329185],"domain_scores_gemma":[0.9990878,0.00008166288,0.000046302906,0.0003723095,0.00007453039,0.0003373779],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032698156,0.00018308012,0.00040553242,0.0001153282,0.000057002508,0.000031739586,0.00012582423,0.00019989653,0.00070220116],"category_scores_gemma":[0.00023605477,0.00014005382,0.00010594713,0.00033371226,0.000068399044,0.00003526631,0.000055663735,0.00038879263,0.00013388743],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013662354,0.00096834125,0.0045625996,0.00007600113,0.000022159595,0.0007849864,0.0002717804,7.292568e-7,0.9887531,0.00008795815,0.0004155754,0.003920192],"study_design_scores_gemma":[0.016566807,0.0012780374,0.011886418,0.000292775,0.00018339256,0.0013887397,0.00046240416,0.00044048272,0.921556,0.00013181979,0.045132007,0.0006811167],"about_ca_topic_score_codex":0.00023355318,"about_ca_topic_score_gemma":0.00016965918,"teacher_disagreement_score":0.067197055,"about_ca_system_score_codex":0.000015021348,"about_ca_system_score_gemma":0.000105744475,"threshold_uncertainty_score":0.768861},"labels":[],"label_agreement":null},{"id":"W2562903607","doi":"10.1182/blood-2016-05-718494","title":"Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institutes of Health; Norges Forskningsråd; National Cancer Institute; Kreftforeningen","keywords":"Syk; Bruton's tyrosine kinase; breakpoint cluster region; Cancer research; B-cell receptor; Chronic lymphocytic leukemia; Signal transduction; Phosphorylation; Biology; Ibrutinib; Cell signaling; B cell; Receptor; Immunology; Leukemia; Cell biology; Tyrosine kinase; Genetics; Antibody","score_opus":0.016204084570724118,"score_gpt":0.2555248375093678,"score_spread":0.23932075293864366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562903607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99632835,0.00028872272,0.00036283373,0.000073242765,0.0001178153,0.00061433035,0.000063841675,0.000045985544,0.002104889],"genre_scores_gemma":[0.9953044,0.00003865513,0.00079113955,0.000028305512,0.0001493669,0.00004553157,0.00004580779,0.000065540335,0.0035312332],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99755156,0.00009095392,0.0006347364,0.0005049064,0.0006291995,0.00058864226],"domain_scores_gemma":[0.99855554,0.00039943997,0.0001892305,0.00053026696,0.0001267735,0.000198767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053876126,0.0002315243,0.00046496987,0.0001852081,0.00003586911,0.00002131841,0.00025527057,0.00016791021,0.00034128517],"category_scores_gemma":[0.00024590595,0.00017115433,0.00012731817,0.00026637997,0.00008878601,0.00009750967,0.00014302335,0.00014702188,0.00012606388],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001788123,0.0022272996,0.026747407,0.0006523414,0.00003541032,0.00010300508,0.00019239385,4.300893e-7,0.9685006,0.000003921591,0.00025953597,0.0010988332],"study_design_scores_gemma":[0.04982404,0.0002865228,0.00050944684,0.00080487394,0.00007637595,0.000027211463,0.00013279545,0.00009101277,0.9478653,0.0000145136955,0.00016974975,0.0001981496],"about_ca_topic_score_codex":0.00043834813,"about_ca_topic_score_gemma":0.000026246034,"teacher_disagreement_score":0.049645226,"about_ca_system_score_codex":0.0023011083,"about_ca_system_score_gemma":0.0013932119,"threshold_uncertainty_score":0.6979471},"labels":[],"label_agreement":null},{"id":"W2562916116","doi":"10.1182/blood.v126.23.5361.5361","title":"Patterns of Relapse and Progression in Multiple Myeloma Patients Treated with Conventional and Novel Agent-Based Therapy: A Single Centre Experience","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Queen's University","funders":"","keywords":"Medicine; Thalidomide; Lenalidomide; Multiple myeloma; Internal medicine; Bortezomib; Plasma cell leukemia; Oncology; Progression-free survival; Cancer; Surgery; Gastroenterology; Overall survival","score_opus":0.04444903979363133,"score_gpt":0.28795949045913716,"score_spread":0.24351045066550583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562916116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99905854,0.00018159559,0.000018899394,0.00004426912,0.000007774235,0.00060419214,0.000042208667,0.000013907689,0.000028626935],"genre_scores_gemma":[0.99897426,0.000009596201,0.00078362005,0.00001693817,0.000006982983,0.00004132533,0.000116561416,0.000012364619,0.000038364902],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991252,0.00003308992,0.00014706353,0.00021475587,0.0003031684,0.00017671326],"domain_scores_gemma":[0.99946785,0.000037774873,0.00006345949,0.00011674219,0.00011386192,0.0002003124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000049878698,0.000113197246,0.00017377004,0.000085395,0.000025427293,0.000010118528,0.00002824508,0.000043021377,0.000012245733],"category_scores_gemma":[0.00006777245,0.0000758634,0.000017507837,0.000091649825,0.000069224814,0.00005828403,0.000022502914,0.00005457606,6.4328174e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015547789,0.0049465573,0.9839604,0.00004461097,0.00004808194,0.00006773679,0.00050929876,3.0477077e-7,0.0048891935,0.0000017057906,0.0000028343165,0.0039744964],"study_design_scores_gemma":[0.05099002,0.0016630406,0.9176312,0.00033244753,0.000021846847,0.000009457902,0.00021267985,0.00025656048,0.028778868,0.0000010607082,0.00003121327,0.00007157759],"about_ca_topic_score_codex":0.000143827,"about_ca_topic_score_gemma":0.00007550076,"teacher_disagreement_score":0.066329174,"about_ca_system_score_codex":0.00002381214,"about_ca_system_score_gemma":0.000050482973,"threshold_uncertainty_score":0.30936196},"labels":[],"label_agreement":null},{"id":"W2562944267","doi":"10.1182/blood.v116.21.4300.4300","title":"NK-92 Preferentially Targets Acute Myeloid Leukemia Stem Cells","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Myeloid leukemia; CD38; Leukemia; Stem cell; Cell culture; Cancer research; Cytotoxicity; Biology; K562 cells; CD34; Immunology; Molecular biology; In vitro; Cell biology; Biochemistry","score_opus":0.0075827311894118505,"score_gpt":0.2046280087861537,"score_spread":0.19704527759674184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562944267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96993196,0.00037739417,0.00014147347,0.000066483095,0.013701505,0.0001988098,0.00001072327,0.00018627616,0.015385375],"genre_scores_gemma":[0.9023144,0.00011261369,0.000080694364,0.0002065931,0.00011904847,0.00001954849,0.00011267288,0.000023551725,0.09701086],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990871,0.00006907797,0.00024736463,0.000268594,0.000031600284,0.00029627583],"domain_scores_gemma":[0.9994262,0.00003613277,0.00011061248,0.00032762217,0.00007524065,0.000024212688],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00010065028,0.00017092915,0.00018344526,0.00007892451,0.0001749693,0.000029118235,0.00019716636,0.00032392133,0.0053542685],"category_scores_gemma":[0.0000077193135,0.00015267995,0.000113092225,0.00006274016,0.00006655442,0.00013795718,0.000067577,0.0006413496,0.005741527],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008450633,0.00018915166,0.00012069624,0.000007785703,0.00035832715,0.0000026900002,0.00013378724,5.882698e-7,0.9743781,0.00019992379,0.022926677,0.0015977514],"study_design_scores_gemma":[0.001316752,0.00010932278,0.00049814006,0.0000063064103,0.00013335519,0.000057468213,0.000037408725,0.0000011766913,0.73058414,0.000012972144,0.267111,0.00013196569],"about_ca_topic_score_codex":0.000041382642,"about_ca_topic_score_gemma":0.00002971854,"teacher_disagreement_score":0.24418432,"about_ca_system_score_codex":0.00001974231,"about_ca_system_score_gemma":0.00007541155,"threshold_uncertainty_score":0.995555},"labels":[],"label_agreement":null},{"id":"W2562958684","doi":"10.1182/blood.v118.21.2207.2207","title":"Interaction of Multimerin 1 with Collagens: Role in Platelet Adhesion","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Regional Laboratory Medicine Program; McMaster University","funders":"","keywords":"Platelet; Adhesion; Von Willebrand factor; Extracellular matrix; Chemistry; Platelet adhesiveness; Ex vivo; In vivo; Collagen receptor; Cell adhesion; Type I collagen; Platelet activation; Molecular biology; Integrin; In vitro; Biochemistry; Immunology; Cell biology; Biology; Endocrinology; Cell","score_opus":0.019009082864454505,"score_gpt":0.2431015504557033,"score_spread":0.2240924675912488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562958684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919708,0.0001253449,0.0000025544366,0.0000092376895,0.000014879247,0.0001858901,0.0000027829506,0.000013135638,0.0076753753],"genre_scores_gemma":[0.9986148,0.00003313763,0.0012064112,0.000017665681,0.0000051772836,0.000010961937,0.000010917016,0.000008640766,0.00009232645],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99962926,0.000008502304,0.00010866844,0.00009847593,0.00006849452,0.00008660628],"domain_scores_gemma":[0.99980026,0.00000916822,0.00004465566,0.00009573346,0.000020130301,0.000030033376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000024456263,0.000064122665,0.00015962339,0.00006810017,0.000008589541,0.0000012102405,0.000019781623,0.00003579078,0.00010833226],"category_scores_gemma":[0.000007738005,0.000046998477,0.00002008052,0.00009029134,0.000013805772,0.00004208799,0.000007500034,0.00004431395,0.000021776752],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004138757,0.013952594,0.84370923,0.00014980804,0.0006272991,0.0035661282,0.005533449,0.000005484011,0.10467049,0.000040050225,0.00008465752,0.023522053],"study_design_scores_gemma":[0.015979327,0.0020516454,0.3242366,0.00028676816,0.00017848425,0.00037833743,0.00093394617,0.00009903687,0.6553394,0.000054351,0.00033467976,0.00012741453],"about_ca_topic_score_codex":0.00038139246,"about_ca_topic_score_gemma":0.00012380762,"teacher_disagreement_score":0.5506689,"about_ca_system_score_codex":0.000008518605,"about_ca_system_score_gemma":0.000017881328,"threshold_uncertainty_score":0.19165422},"labels":[],"label_agreement":null},{"id":"W2562961935","doi":"10.1182/blood.v110.11.3214.3214","title":"Incidence of HPA-9b in Testing for Neonatal Alloimmune Thrombocytopenia.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Neonatal alloimmune thrombocytopenia; Antigen; Immunology; Population; Antibody; Biology; Allele frequency; Fetus; Medicine; Genotype; Gene; Pregnancy; Genetics","score_opus":0.024722543817946505,"score_gpt":0.2944425924211554,"score_spread":0.26972004860320886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562961935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967639,0.0006682255,0.00016972615,0.000049768067,0.00002604915,0.00034411033,0.000006003553,0.00001538966,0.001956826],"genre_scores_gemma":[0.99192226,0.000009726322,0.007851618,0.00005523298,0.000017858432,0.000008670421,0.00001523537,0.000010393724,0.000109001856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99936914,0.0000038193166,0.00021065329,0.00012556725,0.000102283055,0.00018852726],"domain_scores_gemma":[0.9995839,0.000148582,0.000058910748,0.00012282688,0.000048739406,0.000037050293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018041262,0.00007582043,0.00025304244,0.00006354272,0.000020222229,0.0000027164251,0.000053164218,0.0000472187,0.000011436206],"category_scores_gemma":[0.00020839942,0.000065915505,0.000038414037,0.00015796523,0.000025994337,0.00004658727,0.000023296052,0.0000580223,0.0000048995794],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003134179,0.0017816745,0.86969715,0.00017737756,0.0001583993,0.001318357,0.0005048978,0.0000028794818,0.080197334,0.00022909319,0.000033420798,0.045585986],"study_design_scores_gemma":[0.015475486,0.0010643381,0.8680853,0.00033663775,0.00019466774,0.00039664513,0.00024214305,0.00006806193,0.11316009,0.00039802905,0.00042605944,0.00015249547],"about_ca_topic_score_codex":0.0002142975,"about_ca_topic_score_gemma":0.00017410601,"teacher_disagreement_score":0.04543349,"about_ca_system_score_codex":0.000014417783,"about_ca_system_score_gemma":0.000047938294,"threshold_uncertainty_score":0.2687956},"labels":[],"label_agreement":null},{"id":"W2562964272","doi":"10.1182/blood.v108.11.3140.3140","title":"Hematopoietic Stem Cell Transplantation (SCT) for Hematologic Malignancy from 10/10 Matched Unrelated Donors (MUD) with a Myeloablative Once Daily IV Fludarabine (Flu)/Busulfan Based Regimen (FLUBUP) with Thymoglobulin: Outcomes According to Stem Cell Source.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre","funders":"","keywords":"Medicine; Thymoglobulin; Busulfan; Internal medicine; Fludarabine; Transplantation; Gastroenterology; Surgery; Folinic acid; Regimen; Mucositis; Total body irradiation; Chemotherapy; Hematopoietic stem cell transplantation; Cyclophosphamide; Tacrolimus; Fluorouracil","score_opus":0.013045653217476236,"score_gpt":0.2365764519191797,"score_spread":0.22353079870170345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562964272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96455264,0.00039693463,0.027131084,0.0012585003,0.000042143416,0.0038232806,0.00021891823,0.0004351356,0.002141335],"genre_scores_gemma":[0.9677495,0.00002031739,0.020502752,0.00034846226,0.00010201398,0.0005913655,0.0005943461,0.0002316934,0.009859559],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99518377,0.00022606342,0.0010153797,0.0013622973,0.0010155432,0.0011969754],"domain_scores_gemma":[0.9966272,0.00092197704,0.00051201857,0.0010056136,0.00047606713,0.00045713378],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045529814,0.00088644976,0.0015453137,0.00042161596,0.0003272634,0.00013062646,0.00050636206,0.00041188567,0.00018144741],"category_scores_gemma":[0.000017624256,0.0006457217,0.0002459006,0.0010927989,0.0001647342,0.00026849896,0.00007141719,0.0005634458,0.00017000278],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05827511,0.010659997,0.49415272,0.012057028,0.0040499535,0.007951169,0.023574483,0.014352469,0.36542538,0.00039341935,0.0062169638,0.0028912853],"study_design_scores_gemma":[0.0722929,0.0058727046,0.023485905,0.0029491975,0.003896666,0.00045542736,0.011787272,0.0032719187,0.8731509,0.00012598907,0.00050068815,0.0022104213],"about_ca_topic_score_codex":0.0005651786,"about_ca_topic_score_gemma":0.00011342903,"teacher_disagreement_score":0.50772554,"about_ca_system_score_codex":0.0003981373,"about_ca_system_score_gemma":0.000654835,"threshold_uncertainty_score":0.9995994},"labels":[],"label_agreement":null},{"id":"W2563054377","doi":"10.1182/blood.v120.21.3739.3739","title":"Sabutoclax, a Novel Pan BCL2 Family Inhibitor, Sensitizes Dormant Blast Crisis Chronic Myeloid Leukemia Stem Cells to Dasatinib","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"Dasatinib; Myeloid leukemia; Cancer research; Stem cell; Population; Biology; Haematopoiesis; Immunology; Myeloid; Medicine; Imatinib; Cell biology","score_opus":0.019584618279888277,"score_gpt":0.25045505481255137,"score_spread":0.2308704365326631,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563054377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923788,0.0016894814,0.000141269,0.00031287273,0.00073726056,0.001462818,0.00012586036,0.00034547568,0.0028061734],"genre_scores_gemma":[0.9914358,0.00015751399,0.0025730955,0.0013505765,0.002249638,0.00014918469,0.00007027443,0.00015140958,0.0018625017],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996216,0.00007225648,0.0007483554,0.00074376824,0.0008163381,0.0014032996],"domain_scores_gemma":[0.9974481,0.00014208526,0.00021070559,0.0011355937,0.00015094402,0.00091260305],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00036820344,0.00064898556,0.00085734896,0.00025729422,0.0001840864,0.000059419748,0.00022828314,0.0003186034,0.00013774143],"category_scores_gemma":[0.000032977838,0.0005747839,0.00028156894,0.0004904288,0.000084491614,0.00024794106,0.00027292734,0.00049485656,0.0019474636],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026991992,0.0020119601,0.005560158,0.0004288642,0.00096813426,0.00020514095,0.0030681563,0.000039848917,0.95994246,0.00007136676,0.018441442,0.008992532],"study_design_scores_gemma":[0.027408013,0.0017209195,0.03674812,0.0007500348,0.0017383642,0.0007958364,0.0019718679,0.00015342489,0.8846676,0.000004365729,0.042898364,0.0011431149],"about_ca_topic_score_codex":0.0005034538,"about_ca_topic_score_gemma":0.000070572874,"teacher_disagreement_score":0.0752749,"about_ca_system_score_codex":0.0034460605,"about_ca_system_score_gemma":0.0014021293,"threshold_uncertainty_score":0.9996704},"labels":[],"label_agreement":null},{"id":"W2563069972","doi":"10.1182/blood.v112.11.4666.4666","title":"The Use of IVIG for Solid Organ Transplantation: An Evidence Based Practice Guideline","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital of Winnipeg; University of Manitoba; Centre Hospitalier Universitaire Sainte-Justine; Queen's University; Dalhousie University; University Health Network; University of Toronto; Canadian Blood Services; University of Alberta; St. Michael's Hospital","funders":"","keywords":"Guideline; Medicine; Intensive care medicine; Transplantation; Family medicine; MEDLINE; Evidence-based medicine; Alternative medicine; Internal medicine; Pathology","score_opus":0.08404538768310009,"score_gpt":0.346649179912592,"score_spread":0.2626037922294919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563069972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98892224,0.00088711287,0.004278783,0.00504048,0.00004907767,0.0006371943,0.00004367365,0.000032354623,0.00010906392],"genre_scores_gemma":[0.9683092,0.0015632923,0.028274229,0.0014958876,0.00005344209,0.000030885963,0.000088887246,0.000015574491,0.00016855725],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993691,0.00002975204,0.00021047346,0.000116506664,0.00014909368,0.00012510519],"domain_scores_gemma":[0.99885386,0.0005813967,0.00008582449,0.00020362965,0.00022213931,0.00005313865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013460657,0.00007099028,0.00013601,0.000019719582,0.00012936663,0.000007780634,0.000047088768,0.000032512246,0.000012775975],"category_scores_gemma":[0.0005062798,0.000045965306,0.000044868288,0.00007631912,0.000039491813,0.00023278748,0.0000028733941,0.000037761445,0.000003433005],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06141468,0.093308896,0.24221592,0.003585535,0.010410706,0.028155481,0.01726181,0.0022188148,0.29573688,0.0023034243,0.11631704,0.12707081],"study_design_scores_gemma":[0.087270185,0.014297165,0.050876036,0.0015803578,0.0117814755,0.010022978,0.0008308803,0.0119707165,0.5125756,0.00026238465,0.2975078,0.0010244343],"about_ca_topic_score_codex":0.00006392444,"about_ca_topic_score_gemma":0.000029305073,"teacher_disagreement_score":0.21683872,"about_ca_system_score_codex":0.0000053043204,"about_ca_system_score_gemma":0.00012583542,"threshold_uncertainty_score":0.18744107},"labels":[],"label_agreement":null},{"id":"W2563121153","doi":"10.1182/blood.v110.11.4767.4767","title":"Aggregation of Serum Free Light Chains (FLC) Causes Overestimation of FLC Nephelometric Results as Compared to Serum Protein Electrophoresis (SPE) While Preserving Clinical Usefulness.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Nephelometry; Serum protein electrophoresis; Chromatography; Immunoglobulin light chain; Size-exclusion chromatography; Capillary electrophoresis; Kappa; Chemistry; Multiple myeloma; Immunofixation; Molecular biology; Sephadex; Antibody; Monoclonal; Medicine; Immunology; Monoclonal antibody; Biology; Biochemistry; Mathematics","score_opus":0.026025738507092097,"score_gpt":0.30012021803277444,"score_spread":0.27409447952568233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563121153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966543,0.0006925273,0.0003585851,0.0004921156,0.000082909115,0.00096076966,0.00023895627,0.000031600674,0.00048827485],"genre_scores_gemma":[0.99609846,0.0001809674,0.0029139416,0.000102083475,0.00016436697,0.00007040016,0.00011917942,0.00004191809,0.00030869668],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974803,0.00015226453,0.0009966631,0.00056038226,0.00039545365,0.00041494257],"domain_scores_gemma":[0.9977758,0.00018043467,0.0006174515,0.0009436946,0.0003130892,0.00016951673],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006492694,0.0002735815,0.000468101,0.00029737092,0.00007924212,0.000022527489,0.0004556643,0.00028527906,0.000032091983],"category_scores_gemma":[0.0028425043,0.0002644886,0.00019360488,0.0007595866,0.00006055044,0.000017609906,0.00029374452,0.000112997805,0.000011621409],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001256267,0.0033249692,0.4869491,0.00029754097,0.00096353516,0.000023503486,0.00028059093,0.00029230828,0.49991423,0.00017684375,0.0031779085,0.0033432033],"study_design_scores_gemma":[0.0025216201,0.0008227816,0.3256081,0.00010762529,0.00011578275,0.000003476787,0.000043229833,0.000016031525,0.67016673,0.000044673463,0.00037424627,0.000175696],"about_ca_topic_score_codex":0.00019866487,"about_ca_topic_score_gemma":0.0008591389,"teacher_disagreement_score":0.17025252,"about_ca_system_score_codex":0.000037896058,"about_ca_system_score_gemma":0.00015397585,"threshold_uncertainty_score":0.99998075},"labels":[],"label_agreement":null},{"id":"W2563147873","doi":"10.1182/blood.v110.11.2853.2853","title":"Membrane Type-Matrix Metalloproteinases (MT-MMPs) Are Expressed in Acute Myeloid Leukemia Cells and Are Upregulated by TNF-α.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Alberta","funders":"","keywords":"Matrix metalloproteinase; Jurkat cells; Cell culture; U937 cell; Myeloid; Myeloid leukemia; Biology; Cancer research; Blot; Cell; Molecular biology; Chemistry; Immunology; T cell; Biochemistry; Genetics; Gene","score_opus":0.005101450030016156,"score_gpt":0.21659974016431752,"score_spread":0.21149829013430135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563147873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957133,0.003284626,0.00015905465,0.00003911627,0.000092252456,0.00037584268,0.0000960252,0.000030121526,0.00020969364],"genre_scores_gemma":[0.9973704,0.000495084,0.00062257284,0.00014357698,0.00012673088,0.00002346342,0.00012929107,0.00003662547,0.0010522361],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99870557,0.00004770355,0.00026339345,0.00046136326,0.00015380183,0.00036815298],"domain_scores_gemma":[0.9992996,0.00001084547,0.0001409772,0.00035168492,0.00006276657,0.00013415281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022205443,0.00023776414,0.0002530097,0.00006149978,0.00006228366,0.000030123674,0.00017102298,0.00029310302,0.000024626508],"category_scores_gemma":[0.00004024728,0.0002287196,0.000065198845,0.00014489975,0.000048359354,0.000010331175,0.00011857508,0.0001310914,0.000010838548],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013731362,0.00014364776,0.0001467,0.00003779485,0.000097248325,0.00007748057,0.000017583352,0.0000043120467,0.9983305,0.000008296346,0.00086244004,0.00013672178],"study_design_scores_gemma":[0.0018201635,0.00017691405,0.00014813627,0.000057663266,0.00008371815,0.00002285304,0.0000627324,0.000011038854,0.99229634,0.000049514867,0.004982685,0.00028826756],"about_ca_topic_score_codex":0.000040281408,"about_ca_topic_score_gemma":0.000034498134,"teacher_disagreement_score":0.0060341484,"about_ca_system_score_codex":0.000015875885,"about_ca_system_score_gemma":0.00004945149,"threshold_uncertainty_score":0.93269145},"labels":[],"label_agreement":null},{"id":"W2563154257","doi":"10.1182/blood.v126.23.2736.2736","title":"Five-Year Survival Data Demonstrating Durable Responses from a Pivotal Phase 2 Study of Brentuximab Vedotin in Patients with Relapsed or Refractory Hodgkin Lymphoma","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Brentuximab vedotin; Medicine; Internal medicine; Chemotherapy regimen; Oncology; Refractory (planetary science); Clinical endpoint; Lymphoma; Chemotherapy; Surgery; CD30; Clinical trial","score_opus":0.045830691656711095,"score_gpt":0.3027311426956338,"score_spread":0.2569004510389227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563154257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99818933,0.00014256593,0.0000012034923,0.000031743803,0.00008510018,0.0008612941,0.00038690292,0.000035365145,0.0002664685],"genre_scores_gemma":[0.9984382,0.000006765298,0.00091352256,0.00001801482,0.00005081891,0.000038570775,0.00042235656,0.00003122398,0.00008056703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99788976,0.00024721725,0.00047837934,0.0005213758,0.00060052105,0.00026276524],"domain_scores_gemma":[0.9982096,0.00033734407,0.00022759462,0.00090862426,0.00013212828,0.00018469366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003204928,0.0002295353,0.000549936,0.000121792924,0.00004563965,0.000023444796,0.000204968,0.000074534866,0.00003520969],"category_scores_gemma":[0.0005152595,0.00015844738,0.000030488709,0.00026492556,0.000052388892,0.00019216555,0.00014126224,0.000082424485,0.000011698605],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012298116,0.06873896,0.91330063,0.000016210637,0.00038127525,0.0005241168,0.0011224824,9.842936e-7,0.00009514098,0.0000016179348,0.00018450075,0.003335989],"study_design_scores_gemma":[0.19226955,0.01200019,0.79104346,0.00022239146,0.0005192829,0.0000087181115,0.003093856,0.000034007808,0.0005937082,0.0000025101072,0.000053827836,0.00015847562],"about_ca_topic_score_codex":0.0023448085,"about_ca_topic_score_gemma":0.0010268426,"teacher_disagreement_score":0.17997143,"about_ca_system_score_codex":0.00010840074,"about_ca_system_score_gemma":0.00056200585,"threshold_uncertainty_score":0.64612967},"labels":[],"label_agreement":null},{"id":"W2563163800","doi":"10.1182/blood.v120.21.1372.1372","title":"Clinical Proof of Concept Trial of Oral Ciclopirox Olamine in Patients with Relapsed/Refractory Hematologic Malignancy","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University Health Network; University of British Columbia; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cmax; Hematologic malignancy; Dosing; Pharmacokinetics; Clinical trial; Pharmacology; Internal medicine; Refractory (planetary science); Adverse effect; Oncology; Gastroenterology","score_opus":0.026736390045451745,"score_gpt":0.3068203971167599,"score_spread":0.28008400707130815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563163800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978914,0.00068408705,0.0000026943885,0.00001538937,0.00011171854,0.0008840108,0.000027058495,0.0000098820565,0.00037374417],"genre_scores_gemma":[0.9993315,0.000011707028,0.0004202342,0.000023426614,0.000046253695,0.00002305434,0.00005158013,0.000013410065,0.00007885488],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880123,0.000074928,0.0005259458,0.00015275952,0.00024382447,0.00020132324],"domain_scores_gemma":[0.99922365,0.00006327403,0.00025799155,0.0002547388,0.00007694757,0.00012337024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001267093,0.00011976993,0.0005402716,0.00005457327,0.000008870381,0.0000010748014,0.000051354004,0.000097975644,0.000064473315],"category_scores_gemma":[0.00013280229,0.00007819968,0.00010700866,0.00012407445,0.000100500896,0.00007195779,0.000024956636,0.00009379903,0.0000030838314],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011596349,0.028061911,0.9579356,0.00008655729,0.00017343492,0.00001782157,0.000053776723,7.230148e-8,0.000007718623,0.000051127896,0.000039104994,0.0019765429],"study_design_scores_gemma":[0.1987916,0.0064404216,0.7925018,0.00017986938,0.00044930258,0.0000024261735,0.000017848526,3.1507236e-7,0.0014751776,0.000016569278,0.000054913977,0.0000697325],"about_ca_topic_score_codex":0.000015829522,"about_ca_topic_score_gemma":0.0000020980995,"teacher_disagreement_score":0.18719524,"about_ca_system_score_codex":0.000011812845,"about_ca_system_score_gemma":0.000072110044,"threshold_uncertainty_score":0.31888902},"labels":[],"label_agreement":null},{"id":"W2563183951","doi":"10.1182/blood.v108.11.1823.1823","title":"Twenty Year Follow up of Survivors of Childhood Acute Lymphoid Leukemia: A Report from the Childhood Cancer Survivor Study (CCSS).","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Cohort; Pediatrics; Confidence interval; Population; Cancer; Radiation therapy; Internal medicine; Surgery","score_opus":0.010020424504528957,"score_gpt":0.2623026597175157,"score_spread":0.25228223521298676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563183951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940884,0.0007918958,0.000040349907,0.0002625845,0.00043732816,0.0016946935,0.00043439592,0.00008276496,0.0021675532],"genre_scores_gemma":[0.9971602,0.00013294983,0.0002460153,0.00008658821,0.000629792,0.0001291118,0.0001800535,0.00009829668,0.0013370244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99559677,0.0002284321,0.0011535545,0.0007305528,0.0016640994,0.00062660646],"domain_scores_gemma":[0.99674284,0.0005040409,0.00059373537,0.001548755,0.00042667324,0.00018394493],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008334509,0.00040911348,0.0010488303,0.00015924378,0.0001228267,0.000024748504,0.00060982053,0.00023316428,0.00026166838],"category_scores_gemma":[0.00039026307,0.00028407056,0.0003695708,0.000793488,0.00025250608,0.000100113466,0.00032616733,0.000402634,0.000026733274],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041841183,0.005478442,0.9780848,0.000051622555,0.003193076,0.0006701705,0.0021760804,0.000022975673,0.0052770018,0.00003487872,0.0041029537,0.00048957823],"study_design_scores_gemma":[0.030466616,0.00070715556,0.9386088,0.00018497993,0.0026057635,0.00038578676,0.0012109746,0.000033278386,0.024936663,0.00012972945,0.00041554577,0.00031465734],"about_ca_topic_score_codex":0.07906526,"about_ca_topic_score_gemma":0.0068104393,"teacher_disagreement_score":0.07225482,"about_ca_system_score_codex":0.00041701534,"about_ca_system_score_gemma":0.0028572797,"threshold_uncertainty_score":0.99996114},"labels":[],"label_agreement":null},{"id":"W2563214243","doi":"10.1182/blood.v104.11.3124.3124","title":"Who Actually Detects Relapse in Hodgkin Lymphoma: Patient or Physician?.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Medicine; Asymptomatic; Internal medicine; Chemotherapy regimen; Surgery; Chest radiograph; B symptoms; Radiological weapon; Lymphoma; Cancer; Lung","score_opus":0.010922055954945841,"score_gpt":0.23675074411869718,"score_spread":0.22582868816375135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563214243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99528474,0.0005542438,0.000003283553,0.00036645264,0.00007849805,0.0004329474,0.00000777805,0.000061643026,0.003210433],"genre_scores_gemma":[0.9974964,0.0001303794,0.0006938515,0.0013124819,0.00009135934,0.000112693924,0.000012165543,0.000027121367,0.00012351776],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988841,0.000020767988,0.00024008391,0.00029969495,0.00024750087,0.00030788087],"domain_scores_gemma":[0.9993949,0.00005049415,0.00006628871,0.00031977997,0.000035157147,0.00013335682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004202081,0.00019226318,0.00032250964,0.000096275486,0.00004322527,0.000016608512,0.000060842398,0.00008752132,0.000028922796],"category_scores_gemma":[0.00006381627,0.00013584392,0.00009783791,0.0002500495,0.00002835431,0.000065639666,0.000039784776,0.000050321563,0.00014407143],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002712517,0.10132217,0.11844848,0.0004126575,0.0016035655,0.02705348,0.016342327,0.00014865272,0.010875214,0.0024415702,0.002329571,0.7163098],"study_design_scores_gemma":[0.09106744,0.005745415,0.512804,0.001231229,0.00067054905,0.0004476227,0.0006634078,0.000009819115,0.38187805,0.0006253727,0.0042874496,0.00056967215],"about_ca_topic_score_codex":0.00014687088,"about_ca_topic_score_gemma":0.00018542602,"teacher_disagreement_score":0.71574014,"about_ca_system_score_codex":0.0002488314,"about_ca_system_score_gemma":0.00026036732,"threshold_uncertainty_score":0.5539554},"labels":[],"label_agreement":null},{"id":"W2563219666","doi":"10.1182/blood.v116.21.2402.2402","title":"Autologous Stem Cell Transplantion for Adolescents and Young Adults with Relapsed and Refractory Hodgkin Lymphoma","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Medicine; Etoposide; Internal medicine; Surgery; Autologous stem-cell transplantation; Salvage therapy; Melphalan; Ifosfamide; Oncology; Hematopoietic stem cell transplantation; Progression-free survival; Cyclophosphamide; Chemotherapy regimen; Population; Transplantation; Chemotherapy","score_opus":0.005745132555379219,"score_gpt":0.2060522370650419,"score_spread":0.20030710450966266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563219666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99831146,0.0005311335,0.000014598483,0.00008574577,0.000100423014,0.00062460674,0.000032284785,0.000047765472,0.00025197913],"genre_scores_gemma":[0.9986215,0.00023810174,0.0007797186,0.000064995875,0.000054557102,0.00007283308,0.000030520427,0.000019914984,0.000117856885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993244,0.000011939132,0.00012501935,0.00026633398,0.00010480608,0.00016751714],"domain_scores_gemma":[0.9996009,0.000030839827,0.000057474106,0.00015225403,0.000036926318,0.000121633835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000052962736,0.00013928876,0.00020113058,0.000043015523,0.00007061079,0.000016671942,0.000024189563,0.00011279915,0.000002727533],"category_scores_gemma":[0.000003531618,0.00009897974,0.000031803746,0.00003355831,0.0000465143,0.000048053447,0.000006727674,0.00005125121,0.0000023294485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001835292,0.0033371826,0.9288617,0.0008005718,0.00012656959,0.00025244878,0.0009261625,3.672096e-8,0.011430116,0.000050918905,0.00009721726,0.052281793],"study_design_scores_gemma":[0.038465213,0.001610081,0.9310245,0.00040512308,0.00067745254,0.00065531046,0.00008948768,0.000025120387,0.026342709,0.0000062362014,0.00055722904,0.00014155018],"about_ca_topic_score_codex":0.00005589517,"about_ca_topic_score_gemma":0.00010974959,"teacher_disagreement_score":0.052140243,"about_ca_system_score_codex":0.000012946527,"about_ca_system_score_gemma":0.00004203628,"threshold_uncertainty_score":0.4036277},"labels":[],"label_agreement":null},{"id":"W2563234423","doi":"10.1182/blood.v124.21.57.57","title":"Leukemia-Initiating Activity in T-ALL Requires Active Hif1a and Wnt Signaling","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Wnt signaling pathway; Leukemia; Cancer research; Haematopoiesis; Biology; Progenitor cell; Chronic myelogenous leukemia; Stem cell; Notch signaling pathway; Bone marrow; Signal transduction; Immunology; Cell biology","score_opus":0.0129560211135475,"score_gpt":0.24962681419661703,"score_spread":0.23667079308306954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563234423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984367,0.00025587247,0.00038714238,0.000060246406,0.00004535236,0.00009387118,0.0000031681707,0.00001050614,0.0007071298],"genre_scores_gemma":[0.99931157,0.00005516693,0.00028180933,0.000048960195,0.00022603833,0.000010007978,0.000020962436,0.000014202367,0.00003128962],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993526,0.000064116706,0.00010764193,0.00025040467,0.00006954742,0.00015569481],"domain_scores_gemma":[0.9997105,0.000024647887,0.000072704344,0.0001302148,0.000023506294,0.00003841786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014656628,0.000094385374,0.000097915334,0.0000346347,0.000036382826,0.000014680308,0.000049431488,0.0001314748,0.0000037485859],"category_scores_gemma":[0.00008614089,0.00010159552,0.000028244818,0.000050660026,0.000030037805,0.000006138833,0.000056759305,0.00008336227,0.0000014096671],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004305101,0.00003422069,0.0017299567,0.000012522081,0.000032379725,9.0516386e-7,0.00007104697,0.0003306235,0.9834518,0.000027040958,0.000013331009,0.014253149],"study_design_scores_gemma":[0.0011307298,0.0001319423,0.015048037,0.00002839273,0.000026947444,0.0000063830457,0.000026981928,0.00056015817,0.9821763,0.0001588513,0.0005648863,0.0001404067],"about_ca_topic_score_codex":0.00006366813,"about_ca_topic_score_gemma":0.00014763341,"teacher_disagreement_score":0.014112742,"about_ca_system_score_codex":0.00002973696,"about_ca_system_score_gemma":0.000048462916,"threshold_uncertainty_score":0.4142945},"labels":[],"label_agreement":null},{"id":"W2563263681","doi":"10.1182/blood.v116.21.4954.4954","title":"Do the SLC25A38 or ALAS2 Genes Play a Role In the Phenotypic Expression of Ringed Sideroblasts In Acquired Myelodysplastic Syndrome?","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Metabolism and Genetic Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University; Izaak Walton Killam Health Centre","funders":"","keywords":"Sideroblastic anemia; Biology; Myelodysplastic syndromes; Genetics; Exon; Gene; Gene mutation; Pathology; Mutation; Medicine; Bone marrow; Immunology","score_opus":0.006037179731195168,"score_gpt":0.22276850202152126,"score_spread":0.2167313222903261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563263681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99751294,0.0015581425,0.000024596413,0.000066716355,0.00011466319,0.00027063847,0.0000075102494,0.000003971539,0.00044084762],"genre_scores_gemma":[0.9992676,0.00014948778,0.00027817616,0.00007477698,0.000061892126,0.000068390465,0.000011807117,0.000015461139,0.00007245312],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99895877,0.00012431937,0.00025909833,0.00026203264,0.00015963883,0.00023613773],"domain_scores_gemma":[0.9992737,0.00006766607,0.000085450614,0.00051825005,0.00002273228,0.00003220025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030836713,0.0001478582,0.000166113,0.00005163808,0.00004989678,0.000021412709,0.00045046932,0.00013150413,0.00005174799],"category_scores_gemma":[0.00015401318,0.00008166509,0.00005220432,0.00015745018,0.000100365614,0.0000035073163,0.00011586717,0.0001094577,0.0000060654993],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010491839,0.00034558642,0.016911825,0.000023890861,0.00001796234,0.000008300744,0.00067676086,0.00009486046,0.9807954,0.000045590226,0.000062109815,0.00091280375],"study_design_scores_gemma":[0.0036682372,0.0002398422,0.33662167,0.00007269005,0.00006609688,0.00009880165,0.0013551852,0.00004298618,0.65423495,0.0005457026,0.0027653796,0.0002884634],"about_ca_topic_score_codex":0.000025948873,"about_ca_topic_score_gemma":0.0012642608,"teacher_disagreement_score":0.32656044,"about_ca_system_score_codex":6.1234886e-7,"about_ca_system_score_gemma":0.000057702888,"threshold_uncertainty_score":0.33302057},"labels":[],"label_agreement":null},{"id":"W2563275962","doi":"10.1182/blood.v124.21.355.355","title":"Deletion of Sbds from Hematopoietic Progenitors Causes Neutropenia in a Mouse Model of Shwachman-Diamond Syndrome By Specifically Blocking Myeloid Lineage Progression at Late Differentiation Stages","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Biology; Haematopoiesis; Bone marrow; Cancer research; Myeloid; Immunology; Molecular biology; Stem cell; Cell biology","score_opus":0.007662526906821374,"score_gpt":0.22185037929420554,"score_spread":0.21418785238738416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563275962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99847347,0.0007447069,0.00026818598,0.000012525759,0.000023907298,0.00030732795,0.00012871911,0.0000107923815,0.000030350815],"genre_scores_gemma":[0.9984501,0.00016747574,0.0006928514,0.000008038579,0.000021286321,0.00003609833,0.00046515424,0.000028479972,0.00013051656],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988948,0.000066032255,0.0003561746,0.00032866807,0.00017243504,0.00018187457],"domain_scores_gemma":[0.9993814,0.000011635792,0.0002263972,0.0002756821,0.0000514745,0.000053390373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006831153,0.00017866607,0.0002679284,0.000049642953,0.00003774029,0.000012052734,0.0001250191,0.00016244919,0.000007884181],"category_scores_gemma":[0.000018422885,0.00015812778,0.00008010692,0.000060751474,0.000049252423,0.000007427207,0.00010192279,0.000058511352,0.0000014452519],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007746851,0.0012589623,0.1109067,0.00005595821,0.00010065739,0.0000019154863,0.00007893356,0.0001944457,0.8870718,0.000008666297,0.000013707958,0.0002307974],"study_design_scores_gemma":[0.002518702,0.00037205586,0.006274076,0.00005659142,0.00010231942,0.0000021005585,0.000013655148,0.0008620774,0.98957795,0.000053884854,0.000014407922,0.000152196],"about_ca_topic_score_codex":0.000047677357,"about_ca_topic_score_gemma":0.00009597452,"teacher_disagreement_score":0.10463262,"about_ca_system_score_codex":0.000008903967,"about_ca_system_score_gemma":0.000019537616,"threshold_uncertainty_score":0.64482635},"labels":[],"label_agreement":null},{"id":"W2563324741","doi":"10.1182/blood.v124.21.402.402","title":"Integrin-Linked Kinase As a Key Mediator of Stromal Cell-Enhanced Resistance of Primitive CML Cells to Tyrosine Kinase Inhibitors","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Stem cell; Integrin-linked kinase; Cancer research; CD34; Imatinib mesylate; Biology; Progenitor cell; Tyrosine kinase; CD38; Cell biology; Side population; Protein kinase B; Myeloid leukemia; Imatinib; Kinase; Signal transduction; Cancer stem cell; Protein kinase A; Cyclin-dependent kinase 2","score_opus":0.007134724326067442,"score_gpt":0.2358817679389637,"score_spread":0.22874704361289627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563324741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99184054,0.00038883576,0.000119048236,0.00017194051,0.00022333543,0.00088654965,0.00007798869,0.000056949557,0.006234838],"genre_scores_gemma":[0.99198157,0.000042453867,0.0058176247,0.000118162025,0.00024330273,0.00006304005,0.000041386033,0.000055605506,0.001636856],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99772596,0.0000951097,0.00067441136,0.00050867326,0.00058381347,0.00041202304],"domain_scores_gemma":[0.99801,0.00022349476,0.0003628018,0.00072520174,0.00031026654,0.00036823115],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023766464,0.00032536272,0.00075734424,0.00019120383,0.000036205773,0.000007214833,0.00019678392,0.00017515721,0.00014062572],"category_scores_gemma":[0.0005122903,0.00028962985,0.00017970035,0.00037299294,0.00014006042,0.000061404746,0.00011019169,0.000248479,0.00009123997],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081760826,0.0019482858,0.0012352412,0.0004943087,0.00014868629,0.00006864571,0.0012562254,0.0000056106524,0.99262106,0.00015969454,0.0006865017,0.000558103],"study_design_scores_gemma":[0.012480804,0.0017169913,0.0046538427,0.0007869824,0.00045077514,0.000005245224,0.00025147301,0.000009977094,0.97861445,0.00003338168,0.000784423,0.00021162894],"about_ca_topic_score_codex":0.00014984146,"about_ca_topic_score_gemma":0.00007613178,"teacher_disagreement_score":0.014006613,"about_ca_system_score_codex":0.00027242085,"about_ca_system_score_gemma":0.0005098787,"threshold_uncertainty_score":0.9999556},"labels":[],"label_agreement":null},{"id":"W2563337857","doi":"10.1182/blood.v126.23.170.170","title":"Comprehensive Genomic and Transcript Profiling of CBL Gene in Childhood AML: A Report from Children's Oncology Group Studies AAML03P1, AAML0531 and COG/NCI Target AML Initiative","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Biology; Exon; Genetics; Gene; Alternative splicing; Cancer research; Molecular biology","score_opus":0.0552990024581399,"score_gpt":0.3227903526443341,"score_spread":0.2674913501861942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563337857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9738069,0.023477668,0.000050667073,0.0006798196,0.000081481674,0.0013515195,0.00015836461,0.000048257338,0.00034530694],"genre_scores_gemma":[0.9830997,0.0014514837,0.014495442,0.0003314424,0.00021649087,0.000082647915,0.00024986718,0.000051270952,0.000021660177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975677,0.00024769508,0.0007117025,0.00065875985,0.00036497504,0.00044913308],"domain_scores_gemma":[0.99844116,0.000296374,0.0002533134,0.00035605658,0.00035818256,0.0002948913],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00050203875,0.00031214522,0.0011217896,0.00027707775,0.00006381353,0.0000132551695,0.00012617011,0.00022084385,0.000007639725],"category_scores_gemma":[0.00043927605,0.00027866082,0.00007006367,0.00025514208,0.00050528016,0.00012128285,0.00021810416,0.00058505294,0.0000033892106],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001535894,0.0027996278,0.7058512,0.00037256101,0.0044950703,0.0044977926,0.040740788,0.000009285144,0.23623571,0.00008713745,0.0008123819,0.0025625518],"study_design_scores_gemma":[0.031062903,0.0025307217,0.8952688,0.00022705928,0.0008518351,0.0024536918,0.009149897,0.00010678855,0.05661414,0.0007567327,0.0005474857,0.0004299783],"about_ca_topic_score_codex":0.00045518563,"about_ca_topic_score_gemma":0.00007006928,"teacher_disagreement_score":0.18941757,"about_ca_system_score_codex":0.00019869355,"about_ca_system_score_gemma":0.00075789104,"threshold_uncertainty_score":0.99996656},"labels":[],"label_agreement":null},{"id":"W2563345922","doi":"10.1182/blood.v126.23.3120.3120","title":"Population Pharmacokinetics of Fludarabine and Treosulfan in Patients with Thalassemia Undergoing Hematopoietic Stem Cell Transplantation","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Treosulfan; Fludarabine; Medicine; ThioTEPA; Busulfan; Pharmacokinetics; Transplantation; Hematopoietic stem cell transplantation; Population; Internal medicine; Regimen; Oncology; Pharmacology; Cyclophosphamide; Chemotherapy","score_opus":0.012159599144915932,"score_gpt":0.24830274516579207,"score_spread":0.23614314602087613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563345922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987965,0.00008705338,0.00018134905,0.000048109174,0.000017846793,0.0003389748,0.000007860809,0.000015643654,0.00050665654],"genre_scores_gemma":[0.9991404,0.00003444221,0.00062932266,0.000016197875,0.000017639928,0.0000063180505,0.00006987815,0.000019169554,0.00006667026],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990289,0.000038570823,0.0002247981,0.00016030631,0.00039195205,0.00015544628],"domain_scores_gemma":[0.999528,0.00007454314,0.00007248888,0.00011289758,0.00009436993,0.000117697884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011503271,0.000100585436,0.00020442525,0.00012802427,0.000012460352,0.0000065772206,0.00003770186,0.00005340642,0.0000048969755],"category_scores_gemma":[0.000011881548,0.00008032805,0.000013853878,0.0001974207,0.00003076494,0.00007864686,0.000012624977,0.000089197376,0.0000020161651],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068166264,0.00060837803,0.9943946,0.0006707449,0.00003106516,0.000040326497,0.0011191196,0.0000686414,0.0017834307,0.000016248516,0.000028811706,0.0005569664],"study_design_scores_gemma":[0.0479181,0.0012094255,0.91783905,0.00040141222,0.00034103985,0.000049316135,0.00027570064,0.0006939483,0.031093072,0.000033200362,0.0000054848642,0.00014024718],"about_ca_topic_score_codex":0.00004724519,"about_ca_topic_score_gemma":0.000018459794,"teacher_disagreement_score":0.07655555,"about_ca_system_score_codex":0.00009840399,"about_ca_system_score_gemma":0.00016044035,"threshold_uncertainty_score":0.32756826},"labels":[],"label_agreement":null},{"id":"W2563430010","doi":"10.1182/blood.v118.21.4207.4207","title":"The Inappropriate Use of the SimpliRed D-Dimer Assay in the Diagnosis of Venous Thromboembolism,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; St. Joseph's Hospital","funders":"","keywords":"Medicine; Pre- and post-test probability; Pulmonary embolism; Concordance; Deep vein; Venous thromboembolism; Malignancy; Thrombosis; D-dimer; Internal medicine; Radiology; Surgery","score_opus":0.056974144040302446,"score_gpt":0.25765657064333936,"score_spread":0.20068242660303692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563430010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99302554,0.00063621183,0.0000046523332,0.0010135537,0.000201103,0.001177897,0.000011565744,0.000016433918,0.0039130533],"genre_scores_gemma":[0.99798757,0.00088235404,0.0001313634,0.000660348,0.000057823763,0.00019842494,0.000002475505,0.000025720128,0.000053914584],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99826294,0.0002742322,0.0004820045,0.00021398783,0.00044527263,0.00032154509],"domain_scores_gemma":[0.99811804,0.00042005547,0.00027419362,0.001045406,0.00010101726,0.000041275205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088960223,0.00017449343,0.000530075,0.000060526985,0.00013657697,0.000019282252,0.00052367244,0.00008702917,0.00005308561],"category_scores_gemma":[0.0003458916,0.00007924282,0.00020370886,0.00039980334,0.0002624048,0.00006916872,0.00019143856,0.00022127776,0.000008423806],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031006645,0.052057683,0.7748828,0.0008208173,0.0036092717,0.00010918864,0.057989914,0.00004166932,0.005217965,0.05417778,0.020994069,0.029788753],"study_design_scores_gemma":[0.0013028374,0.00039341205,0.9728027,0.00016189447,0.0008829149,0.000009097498,0.00089239614,0.000008456128,0.016999902,0.000939882,0.0054997895,0.0001067419],"about_ca_topic_score_codex":0.0014322464,"about_ca_topic_score_gemma":0.00027432147,"teacher_disagreement_score":0.19791986,"about_ca_system_score_codex":0.000015287997,"about_ca_system_score_gemma":0.000065905115,"threshold_uncertainty_score":0.32314286},"labels":[],"label_agreement":null},{"id":"W2563458611","doi":"10.1182/blood.v106.11.154.154","title":"AMD3100 Plus G-CSF Use in Proven Poor Mobilizers in a Compassionate Use Protocol (CUP).","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity Western University","funders":"","keywords":"Medicine; Apheresis; Transplantation; Internal medicine; Evening; Granulocyte colony-stimulating factor; Creatinine; Urology; Surgery; Chemotherapy; Platelet","score_opus":0.035512206749781054,"score_gpt":0.3037260904228016,"score_spread":0.2682138836730205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563458611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9429927,0.0000067369474,0.000040749324,0.0005609702,0.000024983072,0.0553875,0.000014312312,0.00007395658,0.0008980904],"genre_scores_gemma":[0.9494354,0.0000041197954,0.0048720455,0.00042569972,0.00005857729,0.04427983,0.000035720368,0.00004287878,0.0008457333],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840593,0.0000841831,0.00051421055,0.00034076802,0.00031917304,0.00033570259],"domain_scores_gemma":[0.9992865,0.00015974288,0.00007942017,0.0002877277,0.000051253268,0.0001354097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002243758,0.00018662884,0.00035888134,0.00024439412,0.000021260823,0.000035640845,0.000086878026,0.00013201195,0.00015716814],"category_scores_gemma":[0.00010914061,0.0001616925,0.000059080237,0.00030757883,0.00004228702,0.00031323696,0.000020003537,0.00025162788,0.00009672961],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00306769,0.009067124,0.8891992,0.0023891898,0.00013324643,0.0017806722,0.0053650034,0.00085691834,0.083203234,0.0004799275,0.0011833136,0.0032744776],"study_design_scores_gemma":[0.106021024,0.0008618678,0.72468936,0.0044607185,0.00027154808,0.00065268466,0.0004416612,0.008617836,0.12241817,0.000096035285,0.030521099,0.0009479644],"about_ca_topic_score_codex":0.00036633757,"about_ca_topic_score_gemma":0.0009651815,"teacher_disagreement_score":0.1645098,"about_ca_system_score_codex":0.00013722476,"about_ca_system_score_gemma":0.0001954022,"threshold_uncertainty_score":0.65936285},"labels":[],"label_agreement":null},{"id":"W2563459892","doi":"10.1182/blood.v126.23.5164.5164","title":"Compliance with Guidelines for Management of Chronic Myeloid Leukemia in Saskatchewan, Canada","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Saskatchewan; Royal University Hospital","funders":"","keywords":"Medicine; Myeloid leukemia; Clinical trial; Intensive care medicine; Oncology; Internal medicine","score_opus":0.06068286338946651,"score_gpt":0.30555610565897284,"score_spread":0.24487324226950632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563459892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99291086,0.0023154253,0.00023653111,0.0005899655,0.00010452531,0.0012211716,0.000038347378,0.000030527575,0.0025526222],"genre_scores_gemma":[0.97552335,0.000047242876,0.01992705,0.0002736993,0.0001321083,0.00016223996,0.00006788848,0.000036642563,0.0038297724],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99868715,0.00001050442,0.00037008425,0.0002741624,0.00034973555,0.00030835794],"domain_scores_gemma":[0.99903977,0.000026713758,0.00011337753,0.0003949552,0.0002794487,0.0001457321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013897325,0.00017513867,0.00036632887,0.000047155856,0.000016997785,0.0000037328937,0.000119790966,0.000045029257,0.000014828908],"category_scores_gemma":[0.000023976801,0.00014024843,0.00003569773,0.00018959484,0.000038795504,0.000033183274,0.000038864127,0.00007593623,0.0000033178521],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008373187,0.007410505,0.32571986,0.027009325,0.012114735,0.008956829,0.003972976,0.017279577,0.008470479,0.0014997567,0.3298351,0.24935769],"study_design_scores_gemma":[0.469855,0.0104998555,0.14554185,0.017909404,0.0055683698,0.0013381706,0.026287606,0.013407854,0.13252462,0.00054313964,0.17372645,0.0027976616],"about_ca_topic_score_codex":0.20927884,"about_ca_topic_score_gemma":0.73617184,"teacher_disagreement_score":0.526893,"about_ca_system_score_codex":0.003648855,"about_ca_system_score_gemma":0.007173971,"threshold_uncertainty_score":0.99845445},"labels":[],"label_agreement":null},{"id":"W2563462486","doi":"10.1182/blood.v124.21.5050.5050","title":"A Case Series Evaluating the Use of a Von Willebrand Factor/Factor VIII Concentrate (Wilate®) for Immune Tolerance Induction (ITI) in Children with Severe Factor VIII Deficiency","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Von Willebrand factor; Factor IX; Coagulopathy; Hemarthrosis; Internal medicine; Von Willebrand disease; Gastroenterology; Immunology; Surgery; Platelet","score_opus":0.060773699152038896,"score_gpt":0.30792873698679113,"score_spread":0.24715503783475223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563462486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99723464,0.0003117524,0.000032629137,0.00024686023,0.00005340661,0.0019114792,0.0001445287,0.000032149695,0.000032528886],"genre_scores_gemma":[0.9990053,0.00005820247,0.00043280274,0.000025882407,0.00008981021,0.000087546876,0.000039217994,0.0000314977,0.000229709],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998356,0.00013858001,0.00037013047,0.0003331591,0.00038833547,0.00041378857],"domain_scores_gemma":[0.9990115,0.00019470027,0.00015565525,0.00035125995,0.00018955179,0.00009730367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019949656,0.0002349191,0.00041389465,0.00009227679,0.00020122714,0.0000463951,0.00009257455,0.00012107218,0.00006142667],"category_scores_gemma":[0.00023955246,0.00013535182,0.0000923817,0.00026691763,0.00016498468,0.000279045,0.000031739164,0.0002455233,0.000003064624],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013837883,0.0010303165,0.91060805,0.0002356918,0.00033760353,0.00007059153,0.0041292785,0.00010410003,0.069500394,0.000036603116,0.000008932871,0.012554633],"study_design_scores_gemma":[0.029434375,0.008276002,0.8185091,0.0007253426,0.0005160371,0.0058168606,0.00063301733,0.0016419739,0.13364908,0.00004600158,0.00015520965,0.0005969977],"about_ca_topic_score_codex":0.00020267589,"about_ca_topic_score_gemma":0.00007479555,"teacher_disagreement_score":0.092098966,"about_ca_system_score_codex":0.000047171434,"about_ca_system_score_gemma":0.0001731749,"threshold_uncertainty_score":0.55194867},"labels":[],"label_agreement":null},{"id":"W2563472576","doi":"10.1182/blood.v114.22.3414.3414","title":"Interim Restaging FDG-PET/CT to Guide Use of High Dose Sequential Induction Therapy with Rituximab-Dose-Intensive Cyclophosphamide, Etoposide, Cisplatin (RDICEP) and Rituximab-Carmustine, Etoposide, Cytarabine, Melphalan (RBEAM) and Autologous Stem Cell Transplantation (ASCT) for Poor Prognosis Diffuse Large B-Cell Lymphoma (DLBCL). ClinicalTrials. Gov Identifier: NCT00530179.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Foothills Medical Centre; University of Saskatchewan; University of Calgary","funders":"","keywords":"Medicine; Rituximab; Etoposide; Internal medicine; Nuclear medicine; Chemotherapy; Lymphoma","score_opus":0.028751004194950577,"score_gpt":0.29048243621206593,"score_spread":0.26173143201711535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563472576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99095595,0.0015666614,0.0003522794,0.0014095723,0.0003231117,0.004790038,0.0003631107,0.00017668332,0.000062595034],"genre_scores_gemma":[0.9874692,0.0028222564,0.006993359,0.0013698433,0.00019041418,0.00051978434,0.0003583324,0.00010769399,0.00016911588],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99544346,0.00025410202,0.0015920115,0.0013179719,0.0005972913,0.0007951693],"domain_scores_gemma":[0.99667215,0.0006946631,0.0007535251,0.00058756355,0.00078311027,0.0005089658],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005842794,0.00077706255,0.0016346205,0.00040387147,0.00028514766,0.00022988462,0.00018706034,0.00015851941,0.000013061412],"category_scores_gemma":[0.00014306261,0.0006297476,0.00029976456,0.0004257058,0.00018198864,0.00051947846,0.00006795074,0.00022174387,0.000008340274],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05446075,0.2000404,0.2964895,0.0042987736,0.005001243,0.012128946,0.007229949,0.000055348686,0.24587974,0.0006166794,0.0067991028,0.16699953],"study_design_scores_gemma":[0.25444707,0.007935913,0.3217998,0.0010351969,0.0037250277,0.0024752095,0.00074724277,0.0001998438,0.40604898,0.00012878905,0.00052815326,0.00092876464],"about_ca_topic_score_codex":0.0018994587,"about_ca_topic_score_gemma":0.00021907638,"teacher_disagreement_score":0.19998631,"about_ca_system_score_codex":0.00017027298,"about_ca_system_score_gemma":0.0002794157,"threshold_uncertainty_score":0.9996154},"labels":[],"label_agreement":null},{"id":"W2563483539","doi":"10.1182/blood.v106.11.2547.2547","title":"Bortezomib Continues Demonstrates Superior Efficacy Compared with High-Dose Dexamethasone in Relapsed Multiple Myeloma: Updated Results of the APEX Trail.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Bortezomib; Medicine; Multiple myeloma; Dexamethasone; Internal medicine; Clinical endpoint; Adverse effect; Progressive disease; Surgery; Refractory (planetary science); Gastroenterology; Clinical trial; Chemotherapy","score_opus":0.019943816147831583,"score_gpt":0.2671768286086359,"score_spread":0.2472330124608043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563483539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965301,0.00036128133,0.000003282886,0.0008604217,0.000027332708,0.0013897205,0.00015113788,0.00006943991,0.00060726586],"genre_scores_gemma":[0.9932727,0.000026659114,0.005933798,0.000045497185,0.00006413144,0.00005476091,0.0001791046,0.000037749644,0.00038558347],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977752,0.00019230433,0.0005950849,0.00042429662,0.00049487466,0.0005182153],"domain_scores_gemma":[0.9984235,0.0003986137,0.00016657168,0.00063640124,0.0001591205,0.0002157762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028083782,0.000277974,0.0006308291,0.00015383943,0.000088737965,0.00002333823,0.0002344334,0.0001234032,0.000052560674],"category_scores_gemma":[0.0005282952,0.00017060841,0.00011436406,0.0005485174,0.00030214316,0.000081934486,0.000058748974,0.00034355622,0.000022531987],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017814543,0.011244067,0.79877526,0.00009811393,0.0011393409,0.00048770796,0.0015098538,0.00015603635,0.15387745,0.000028991106,0.00047463115,0.014394038],"study_design_scores_gemma":[0.08814713,0.000556681,0.7613952,0.00022708166,0.0002020644,0.00007163661,0.00019553542,0.0005379247,0.14816104,0.0000030933722,0.00035056405,0.00015201814],"about_ca_topic_score_codex":0.00071584637,"about_ca_topic_score_gemma":0.0020245526,"teacher_disagreement_score":0.070332594,"about_ca_system_score_codex":0.00005466383,"about_ca_system_score_gemma":0.00022180284,"threshold_uncertainty_score":0.6957209},"labels":[],"label_agreement":null},{"id":"W2563488799","doi":"10.1182/blood.v118.21.254.254","title":"CPX-351: A Randomized Phase 2b Study of CPX-351 v. Intensive Salvage Therapy in '65 Yo First Relapse AML Patients: Initial Efficacy and Safety Report","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Regimen; Cytarabine; Salvage therapy; Gastroenterology; Randomized controlled trial; Phases of clinical research; Surgery; Leukemia; Clinical trial; Chemotherapy","score_opus":0.035677114588055434,"score_gpt":0.3225631896485131,"score_spread":0.28688607506045766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563488799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919907,0.0003010433,0.00002116356,0.0001875336,0.00013492908,0.0051786755,0.000025998297,0.00006221291,0.0020977415],"genre_scores_gemma":[0.9983712,0.00043722577,0.00029131942,0.00027536563,0.00011722696,0.00022014669,0.00008417852,0.00006748182,0.00013590093],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9963639,0.0004973769,0.0013277539,0.0006546257,0.00067076646,0.00048557698],"domain_scores_gemma":[0.9968825,0.00075338,0.00043696575,0.0008691589,0.0007944611,0.0002635157],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015020537,0.0003577756,0.0014849666,0.0004277386,0.00009593908,0.000015527601,0.00022096827,0.00019925322,0.00021225364],"category_scores_gemma":[0.0047138734,0.00027314678,0.0001692579,0.00047679484,0.00037675118,0.00014739893,0.00021137702,0.0006851938,0.000014686052],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7149354,0.05245232,0.13351479,0.00022153147,0.0029299823,0.0109973885,0.07267784,9.848533e-7,0.0020557872,0.000045781886,0.001293693,0.008874454],"study_design_scores_gemma":[0.9015172,0.0069037713,0.08354698,0.00025064603,0.00051101705,0.00025380144,0.002759719,0.00003145221,0.0036209116,0.00003732261,0.00027148463,0.00029568968],"about_ca_topic_score_codex":0.0011803262,"about_ca_topic_score_gemma":0.00012245866,"teacher_disagreement_score":0.18658178,"about_ca_system_score_codex":0.000112062604,"about_ca_system_score_gemma":0.00027820576,"threshold_uncertainty_score":0.99997205},"labels":[],"label_agreement":null},{"id":"W2563521219","doi":"10.1182/blood.v114.22.303.303","title":"PX-171-004, An Ongoing Open-Label, Phase II Study of Single-Agent Carfilzomib (CFZ) in Patients with Relapsed or Refractory Myeloma (MM); Updated Results From the Bortezomib-Treated Cohort.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Royal Victoria Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Carfilzomib; Medicine; Tolerability; Bortezomib; Clinical endpoint; Phases of clinical research; Refractory (planetary science); Internal medicine; Multiple myeloma; Proteasome inhibitor; Oncology; Pharmacology; Adverse effect; Gastroenterology; Clinical trial","score_opus":0.047830979505024226,"score_gpt":0.3235842274055434,"score_spread":0.27575324790051914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563521219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937177,0.00007531042,8.246486e-7,0.00014379591,0.000041688538,0.0048262416,0.0004846369,0.00008298646,0.0006268678],"genre_scores_gemma":[0.9963639,0.000020124487,0.00042852617,0.0001265318,0.00005692899,0.00008599067,0.0025331418,0.00005762761,0.00032725243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99610364,0.00044207557,0.000926311,0.00090190064,0.000991703,0.00063438667],"domain_scores_gemma":[0.99719626,0.00020340887,0.00041300186,0.0014103842,0.00036810484,0.00040887026],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043797144,0.0004459811,0.0008514282,0.0002128531,0.00028416995,0.000079829864,0.0005352955,0.00015039941,0.00009803065],"category_scores_gemma":[0.000440077,0.0002615623,0.00004360392,0.0007769118,0.000092160124,0.0003401081,0.00019043163,0.0004257326,0.000012457706],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07541765,0.2410725,0.64494365,0.000013669217,0.001835566,0.0017451814,0.0034015812,0.0000057197076,0.008562979,0.0000015840606,0.0005718673,0.02242803],"study_design_scores_gemma":[0.238172,0.06352893,0.6924041,0.00024431682,0.0006304652,0.0000060670313,0.0005692276,0.000067632616,0.003994948,0.000003227399,0.00013177663,0.00024730002],"about_ca_topic_score_codex":0.0049972283,"about_ca_topic_score_gemma":0.0030469445,"teacher_disagreement_score":0.17754358,"about_ca_system_score_codex":0.00019751657,"about_ca_system_score_gemma":0.0002694104,"threshold_uncertainty_score":0.99998367},"labels":[],"label_agreement":null},{"id":"W2563524816","doi":"10.1182/blood.v126.23.4462.4462","title":"The Quality, Content, Accuracy and Readability of Information about Sickle Cell Anemia on the Internet","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Health Literacy and Information Accessibility","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children; University of Toronto; McMaster University","funders":"","keywords":"Readability; Medicine; Information quality; The Internet; Quality Score; Information retrieval; Computer science; World Wide Web; Information system","score_opus":0.13967942430136834,"score_gpt":0.4369292634626243,"score_spread":0.2972498391612559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563524816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96140563,0.00010760058,0.00015191255,0.002297654,0.00024292107,0.00096398004,0.000039017294,0.00003648288,0.03475477],"genre_scores_gemma":[0.99531835,0.00003991862,0.00009885696,0.0039475854,0.00005257632,0.000077649755,0.000022543967,0.0000037990803,0.00043873963],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99687195,0.00095670787,0.0015174656,0.00009612186,0.00030093917,0.0002567906],"domain_scores_gemma":[0.99492896,0.0028923273,0.00095387833,0.0005411265,0.00054542493,0.00013831277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006941394,0.000102481805,0.00017252582,0.000029543206,0.0004152363,0.00004200563,0.00027896956,0.000110248686,0.00006431884],"category_scores_gemma":[0.0047925888,0.000050576797,0.000033731027,0.00011609593,0.00013402698,0.00093467,0.00015408524,0.00047979617,0.0001491193],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009224243,0.0005851379,0.77432674,0.0030393673,0.000034274944,2.2504304e-7,0.09284593,0.0000033177696,0.00007466811,0.05967099,0.03962992,0.028867023],"study_design_scores_gemma":[0.0038571614,0.00042834008,0.6250466,0.00041708932,0.00003939503,0.00000177474,0.035763375,0.0007202911,0.0036111386,0.0050931,0.32471406,0.0003076734],"about_ca_topic_score_codex":0.00090037595,"about_ca_topic_score_gemma":0.00008774959,"teacher_disagreement_score":0.28508416,"about_ca_system_score_codex":0.00004818126,"about_ca_system_score_gemma":0.000296232,"threshold_uncertainty_score":0.5737523},"labels":[],"label_agreement":null},{"id":"W2563535457","doi":"10.1182/blood.v120.21.1138.1138","title":"Temporal Incidence Trends of Pediatric Venous Thromboembolism: A Population-Based Cohort Study","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Incidence (geometry); Poisson regression; Confidence interval; Rate ratio; Population; Pediatrics; Cohort; Demography; Retrospective cohort study; Cohort study; Surgery; Internal medicine; Environmental health","score_opus":0.017254084751727808,"score_gpt":0.28475296594395366,"score_spread":0.26749888119222587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563535457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99637306,0.00051584496,0.00001795445,0.000083835184,0.00023879328,0.00081202463,0.000008389025,0.00008333225,0.0018667445],"genre_scores_gemma":[0.9985404,0.0000305186,0.00043868335,0.00015276628,0.0005663427,0.00011068158,0.00005785254,0.000033461714,0.000069306225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982964,0.00006572985,0.00044447053,0.0002604218,0.0005561582,0.0003768599],"domain_scores_gemma":[0.9989733,0.000053330354,0.00021483487,0.0005015227,0.00007230438,0.00018469337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048744574,0.0001946108,0.00076558464,0.00032949224,0.000079798934,0.000011350595,0.00012781947,0.000071431874,0.0002733991],"category_scores_gemma":[0.000066504406,0.0001729351,0.00012824654,0.00056097814,0.000023047365,0.00011753861,0.00005985577,0.00011859781,0.000028117049],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014330132,0.019191554,0.97882193,0.00009418387,0.00024862532,0.000015994086,0.00047503703,0.0000116439305,0.000036397927,0.00009377104,0.00055012497,0.00044637965],"study_design_scores_gemma":[0.0021860665,0.00091392687,0.99369484,0.000021703843,0.0025952032,0.0000057838747,0.00013991416,0.0000130530125,0.00016949947,0.000012198013,0.00008528101,0.00016250735],"about_ca_topic_score_codex":0.0015144174,"about_ca_topic_score_gemma":0.0000624413,"teacher_disagreement_score":0.018277628,"about_ca_system_score_codex":0.00004073124,"about_ca_system_score_gemma":0.00006564748,"threshold_uncertainty_score":0.7052089},"labels":[],"label_agreement":null},{"id":"W2563578391","doi":"10.1182/blood.v108.11.2049.2049","title":"Clinicopathologic Subtypes of Mantle Cell Lymphoma (MCL) Show Distinct Patterns of Genetic Copy Number Alteration.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Blastoid; Mantle cell lymphoma; Biology; Comparative genomic hybridization; Genome instability; Cancer research; Lymphoma; Chromosomal translocation; Genetics; Gene; Chromosome; Immunology; DNA damage","score_opus":0.010245239823613072,"score_gpt":0.24661229113751718,"score_spread":0.2363670513139041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563578391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99507606,0.0007876273,0.00005688735,0.00004611445,0.00007104697,0.00023506318,0.00008165102,0.000020679443,0.0036248586],"genre_scores_gemma":[0.9981531,0.000097298995,0.0010529428,0.000048782407,0.000090460184,0.000028608534,0.00008136111,0.000015530837,0.00043192983],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899924,0.000036618192,0.0004133308,0.00021327793,0.00018303945,0.00015447137],"domain_scores_gemma":[0.99932665,0.00008143566,0.00018231625,0.0002926573,0.00007680605,0.000040109673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000065051885,0.00013457958,0.00033468843,0.000033941596,0.000025584051,0.0000070089613,0.000060899583,0.00006991236,0.00027433885],"category_scores_gemma":[0.000014370203,0.0001026359,0.00012767443,0.00006678521,0.00004288218,0.000020917669,0.000027586037,0.000021765358,0.000057607424],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036406153,0.005495228,0.99073035,0.00013196479,0.00003761031,0.00013242169,0.000034074077,0.000003121533,0.0017341969,0.0000727324,0.00020040036,0.0013915],"study_design_scores_gemma":[0.0058788005,0.00034393914,0.8119492,0.000062670595,0.0003443954,0.00007544309,0.000014086819,0.000011633612,0.18096244,0.00007244309,0.00020929948,0.000075645024],"about_ca_topic_score_codex":0.00029490533,"about_ca_topic_score_gemma":0.000028856464,"teacher_disagreement_score":0.17922825,"about_ca_system_score_codex":0.000022314332,"about_ca_system_score_gemma":0.000057145946,"threshold_uncertainty_score":0.41853705},"labels":[],"label_agreement":null},{"id":"W2563586884","doi":"10.1182/blood.v104.11.3628.3628","title":"An Animal Model Suitable for Predicting In Vivo Behavior of Platelets in Humans: A Tool for New Product Development.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Platelet; In vivo; Blood product; Platelet transfusion; Animal model; Chemistry; Surgery; Medicine; Immunology; Internal medicine; Biology; Biotechnology","score_opus":0.029590427810861776,"score_gpt":0.286464667471327,"score_spread":0.2568742396604652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563586884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942823,0.00009165127,0.002321478,0.00015438392,0.000028996512,0.002944826,0.000013009089,0.000038535865,0.00012483407],"genre_scores_gemma":[0.94564784,0.000009412371,0.05341086,0.00008088024,0.000049179638,0.00048614593,0.000020448062,0.000025256479,0.00026995165],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988846,0.000005520685,0.00038499956,0.0002971744,0.00014370674,0.00028396831],"domain_scores_gemma":[0.9996529,0.000012703742,0.000049806506,0.00017559098,0.000044957404,0.00006402222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029490178,0.000120075856,0.00026219038,0.00016611426,0.00003436042,0.000008341973,0.000083091865,0.000060278613,0.0000122801275],"category_scores_gemma":[0.00003876667,0.000118195945,0.000044135715,0.0001310596,0.00001132239,0.00011244653,0.00001658871,0.000080243226,4.1499527e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024156536,0.023035612,0.2412613,0.002601114,0.00024162629,0.00009955065,0.014497173,0.002717474,0.6933863,0.0030611223,0.0003589987,0.016324032],"study_design_scores_gemma":[0.073057435,0.0022032054,0.08939247,0.00086046534,0.0006427989,0.000019952753,0.0006589159,0.0013271478,0.8294848,0.00044751025,0.0014039091,0.0005013563],"about_ca_topic_score_codex":0.00012350356,"about_ca_topic_score_gemma":0.0007336939,"teacher_disagreement_score":0.15186884,"about_ca_system_score_codex":0.000035346136,"about_ca_system_score_gemma":0.00027884013,"threshold_uncertainty_score":0.48198906},"labels":[],"label_agreement":null},{"id":"W2563604752","doi":"10.1182/blood.v122.21.3393.3393","title":"Lymphocyte Recovery At Day 28 Post-Transplant Is Predictive Of Relapse In Patients With Acute Myeloid Leukemia Transplanted With Peripheral Blood Stem Cell Grafts","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Transplantation; Univariate analysis; Myeloid leukemia; Population; Lymphocyte; Hematopoietic stem cell transplantation; Gastroenterology; Surgery; Leukemia; Donor lymphocyte infusion; Multivariate analysis","score_opus":0.004266038600922059,"score_gpt":0.19102897523805715,"score_spread":0.18676293663713509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563604752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99456084,0.00023586211,0.000048985523,0.000118825774,0.00005205686,0.0023242065,0.0009816716,0.00009539912,0.0015821331],"genre_scores_gemma":[0.9954862,0.0006325595,0.00074461155,0.0002829616,0.000049581777,0.00019698005,0.00055954774,0.00013543424,0.0019121075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962712,0.00017343464,0.0006736774,0.0008341932,0.0011385577,0.000908934],"domain_scores_gemma":[0.9979025,0.00013781805,0.00024830966,0.00076962315,0.0005192311,0.00042251288],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021241004,0.0005660036,0.0008979591,0.00036339037,0.00010436768,0.000029455294,0.0003537763,0.00033935969,0.00026705986],"category_scores_gemma":[0.000007921455,0.0004023569,0.00015165063,0.000626599,0.00026647848,0.00040201592,0.00006847129,0.00062785245,0.000057037316],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030659767,0.0039000527,0.8839045,0.0012173175,0.003574138,0.0021704594,0.010818706,0.000086245665,0.062156197,0.0000035906123,0.00043309364,0.001075915],"study_design_scores_gemma":[0.09288655,0.014285677,0.66152155,0.0019712872,0.0029047611,0.0006666389,0.00044559885,0.00025885296,0.2241283,0.0000039450438,0.000092976836,0.0008338231],"about_ca_topic_score_codex":0.0010566585,"about_ca_topic_score_gemma":0.00019494104,"teacher_disagreement_score":0.22238293,"about_ca_system_score_codex":0.00088399375,"about_ca_system_score_gemma":0.001309453,"threshold_uncertainty_score":0.9998428},"labels":[],"label_agreement":null},{"id":"W2563647285","doi":"10.1182/blood.v118.21.2084.2084","title":"The Anemia Workup in Current Clinical Practice: Results From a Survey of Primary Care Physicians","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Hematological disorders and diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences","funders":"","keywords":"Medicine; Anemia; Referral; Family medicine; Logistic regression; Pediatrics; Primary care; Internal medicine","score_opus":0.10442650019726422,"score_gpt":0.36409194150015617,"score_spread":0.25966544130289193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563647285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9737357,0.007934208,0.000016337783,0.00020148083,0.00019735172,0.00031063225,0.00014464349,0.00001859709,0.017441062],"genre_scores_gemma":[0.9969991,0.0016830601,0.00080049975,0.0002639335,0.000057823883,0.000008151467,0.00016902109,0.000008391893,0.000010006532],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867064,0.0002383792,0.0005386031,0.00020400416,0.00018279205,0.00016556995],"domain_scores_gemma":[0.99608266,0.0031539688,0.00018105473,0.0003398921,0.0001802688,0.00006214236],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00054188457,0.00008685899,0.00032070797,0.000015294312,0.000027498545,0.0000051845172,0.00010993635,0.00009975294,0.0000066335647],"category_scores_gemma":[0.009643396,0.000054764318,0.000065688044,0.00015731233,0.000112259826,0.00002774522,0.00005330334,0.00030546778,0.0000169636],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001805439,0.005182512,0.92351323,0.000069302005,0.000052403688,0.00011192427,0.0014176272,1.8883665e-7,0.000007885395,0.00012494164,0.001969217,0.06574532],"study_design_scores_gemma":[0.0039900145,0.00031728979,0.9926193,0.00024272205,0.00012522168,0.0000017412649,0.00054206874,0.0000028962245,0.000069800495,0.0001241714,0.001897943,0.00006687896],"about_ca_topic_score_codex":0.000826724,"about_ca_topic_score_gemma":0.0005552086,"teacher_disagreement_score":0.06910601,"about_ca_system_score_codex":0.000009520135,"about_ca_system_score_gemma":0.00013735202,"threshold_uncertainty_score":0.9986988},"labels":[],"label_agreement":null},{"id":"W2563655481","doi":"10.1182/blood.v106.11.3739.3739","title":"Folate Assays Are No Longer Useful Diagnostic Tools in Medical Practice.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Boniface Hospital","funders":"","keywords":"Mean corpuscular volume; Medicine; Macrocytosis; Anemia; Medical record; Pediatrics; Gastroenterology; Internal medicine; Hematocrit","score_opus":0.03250319483033118,"score_gpt":0.33655581382822614,"score_spread":0.30405261899789493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563655481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9620035,0.0014145364,0.000009714681,0.010782707,0.00009056331,0.00040216997,0.0000072721673,0.000059930997,0.025229583],"genre_scores_gemma":[0.9934463,0.0010746039,0.0004972247,0.0022353246,0.0007561028,0.000043675056,0.000020782465,0.000030756903,0.0018952681],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99789375,0.000108836444,0.00031332966,0.00030477683,0.0009145654,0.0004647683],"domain_scores_gemma":[0.9972142,0.0018653632,0.000060540504,0.0003545347,0.00017510976,0.00033022912],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00077633304,0.00014490933,0.000292439,0.00014989903,0.000039178944,0.000043583917,0.00015755008,0.00022864214,0.0017241249],"category_scores_gemma":[0.019146666,0.00011738901,0.00007374343,0.0002862926,0.000059427413,0.00031226876,0.00009481984,0.0006504043,0.0025793198],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009082492,0.020363864,0.726227,0.0005329853,0.00091773085,0.035120457,0.0011862072,0.000007774355,0.004443219,0.00034913555,0.046397194,0.16354622],"study_design_scores_gemma":[0.019277465,0.0016664141,0.58997846,0.001168338,0.0004898578,0.001813014,0.00029555155,0.00062249205,0.005215711,0.000046604673,0.3788612,0.0005649114],"about_ca_topic_score_codex":0.00005122515,"about_ca_topic_score_gemma":0.00015885451,"teacher_disagreement_score":0.33246398,"about_ca_system_score_codex":0.000054056818,"about_ca_system_score_gemma":0.00022672406,"threshold_uncertainty_score":0.9991884},"labels":[],"label_agreement":null},{"id":"W2563723973","doi":"10.1182/blood.v114.22.1415.1415","title":"Critical Values in the Coagulation Laboratory: Results of a Survey of the North American Specialized Coagulation Laboratory Association.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Clinical Laboratory Practices and Quality Control","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Documentation; Medicine; Coagulation testing; Family medicine; Medical laboratory; Medical education; Coagulation; Nursing; Internal medicine; Computer science","score_opus":0.04953923978105807,"score_gpt":0.3635609565722828,"score_spread":0.31402171679122476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563723973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916859,0.00011272703,0.000008794372,0.0068341866,0.00009188037,0.00041775423,0.0005710664,0.000014850097,0.00026282098],"genre_scores_gemma":[0.99810725,0.000026728136,0.00012964799,0.0014839516,0.00017022372,0.000004848379,0.00005330033,0.000008028204,0.000016031754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99592626,0.0021228166,0.0008823794,0.00020665923,0.00068675797,0.00017514899],"domain_scores_gemma":[0.9931785,0.004080804,0.00084027427,0.00049287925,0.0013517691,0.00005578026],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0043048877,0.00011792685,0.00048750342,0.00005723662,0.00006376481,0.000022953118,0.00015669425,0.000090182,0.000009514819],"category_scores_gemma":[0.029282931,0.000076513716,0.00007987039,0.001561491,0.00014688805,0.00013885337,0.000015548007,0.00028560794,0.0000026968835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008443468,0.0014980668,0.9939119,0.000022839673,0.00006309237,0.0000029638902,0.0005323584,0.000015103859,0.001332937,0.00063468766,0.00079524313,0.0003464512],"study_design_scores_gemma":[0.0041085505,0.0003807751,0.99321634,0.00003907294,0.00024530388,3.5874777e-7,0.00013135829,0.000094735486,0.0005845573,0.00007819849,0.0010434358,0.00007734161],"about_ca_topic_score_codex":0.0005868083,"about_ca_topic_score_gemma":0.0024490245,"teacher_disagreement_score":0.024978044,"about_ca_system_score_codex":0.00004652381,"about_ca_system_score_gemma":0.00033348319,"threshold_uncertainty_score":0.9788938},"labels":[],"label_agreement":null},{"id":"W2563726270","doi":"10.1182/blood.v126.23.650.650","title":"\"Post-Pulmonary Embolism Syndrome\" after a First Episode of PE: Results of the E.L.O.P.E. Study","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Western University; Jewish General Hospital; University of Ottawa; University of Toronto; Dalhousie University; McGill University","funders":"","keywords":"Medicine; Pulmonary embolism; Contraindication; Quality of life (healthcare); Prospective cohort study; Internal medicine; Physical therapy; Observational study; Cohort; Pediatrics","score_opus":0.01631722025078443,"score_gpt":0.24673828559262986,"score_spread":0.23042106534184542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563726270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99118,0.00054632407,0.0000011265338,0.0014179638,0.00022776597,0.0012074265,0.00006117536,0.000025020865,0.0053332066],"genre_scores_gemma":[0.9986807,0.00003796152,0.00008466352,0.00024272416,0.00006808746,0.000112867674,0.00000729411,0.000024419778,0.00074125454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984387,0.00006896642,0.00048689742,0.0002612842,0.000527849,0.0002162845],"domain_scores_gemma":[0.9985945,0.000051531715,0.00019441,0.0008114574,0.00022880067,0.00011925997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040004237,0.00015903966,0.00055653753,0.000094903065,0.000037371607,0.000006318919,0.0002267593,0.00006148769,0.000034687353],"category_scores_gemma":[0.000224296,0.00010556593,0.00014805864,0.0002440792,0.00008888261,0.00004760989,0.00026757244,0.00011613958,0.000021514721],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024021503,0.10607203,0.82866305,0.0018233344,0.0027415468,0.0023489704,0.028885776,0.00008660921,0.0011170947,0.0005102375,0.022349257,0.0029999344],"study_design_scores_gemma":[0.0061791744,0.0016289736,0.9844797,0.0002797436,0.0011020692,0.00009793277,0.0018420925,0.000010021345,0.0012299292,0.00006612678,0.0029587226,0.00012551472],"about_ca_topic_score_codex":0.0008116615,"about_ca_topic_score_gemma":0.00032885594,"teacher_disagreement_score":0.15581664,"about_ca_system_score_codex":0.000019049952,"about_ca_system_score_gemma":0.00006374827,"threshold_uncertainty_score":0.43048537},"labels":[],"label_agreement":null},{"id":"W2563726985","doi":"10.1182/blood.v108.11.2250.2250","title":"G125A Single Nucleotide Polymorphism (SNP) in 5′-UTR of the Tumor Suppressor Gene Bax Affects Its Transcriptional Regulation.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Saskatchewan Health Authority","funders":"","keywords":"Electrophoretic mobility shift assay; Molecular biology; Chromatin immunoprecipitation; Single-nucleotide polymorphism; Promoter; Biology; Transcription factor; Gene expression; DNA methylation; Transcription (linguistics); Gene; Genetics; Genotype","score_opus":0.022038063409363057,"score_gpt":0.2509470139809447,"score_spread":0.22890895057158164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563726985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895013,0.001627249,0.000005150065,0.0027261178,0.00013086562,0.0004042077,0.00007636646,0.000020698497,0.0055080736],"genre_scores_gemma":[0.99325526,0.000013629175,0.00032244154,0.00018252061,0.0004233443,0.000016265401,0.000040894876,0.000022022461,0.005723604],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99852246,0.00008281043,0.00029415058,0.00022784398,0.0005576877,0.00031504416],"domain_scores_gemma":[0.99944043,0.000093149276,0.00007355903,0.0002321347,0.000082363236,0.0000783765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001507816,0.0001460131,0.00026368833,0.00011992297,0.00007567039,0.0000116671445,0.00016158083,0.00006303868,0.00038621065],"category_scores_gemma":[0.00003999758,0.000102612394,0.0001661823,0.0002886299,0.00013109161,0.00006659611,0.000046166166,0.00019051367,0.000027612108],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019343088,0.0011895214,0.031639256,0.00012749086,0.000038893053,0.000063897765,0.00007141078,0.000036247206,0.9635046,0.002040475,0.0009979984,0.00009678314],"study_design_scores_gemma":[0.001962681,0.00012529697,0.52501863,0.000108864755,0.00004841643,0.000110624904,0.000007857591,0.00012152664,0.46926183,0.0003347577,0.0028146026,0.000084904634],"about_ca_topic_score_codex":0.00032537297,"about_ca_topic_score_gemma":0.000104638384,"teacher_disagreement_score":0.4942428,"about_ca_system_score_codex":0.000028046517,"about_ca_system_score_gemma":0.00009203106,"threshold_uncertainty_score":0.4228736},"labels":[],"label_agreement":null},{"id":"W2563730090","doi":"10.1182/blood.v124.21.713.713","title":"Phase 2 Trial of PRM-151, an Anti-Fibrotic Agent, in Patients with Myelofibrosis: Stage 1 Results","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Myelofibrosis; Bone marrow; Essential thrombocythemia; Internal medicine; Gastroenterology; Fibrosis; Anemia; Ruxolitinib; Clinical endpoint; Polycythemia vera; Clinical trial","score_opus":0.01691741954328189,"score_gpt":0.27841635164952866,"score_spread":0.26149893210624675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563730090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969109,0.00002339971,0.000012488499,0.00008187255,0.000068669244,0.0015744212,0.00012672793,0.000029408713,0.0011720804],"genre_scores_gemma":[0.9982921,0.000016978243,0.0010240285,0.00006469687,0.00010236115,0.000101270554,0.00025044286,0.000027343007,0.000120790886],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983224,0.00012881059,0.0004897405,0.0003992514,0.00039855854,0.00026123927],"domain_scores_gemma":[0.9989347,0.00008628797,0.00021148978,0.0004794601,0.000116543975,0.00017155368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023916326,0.0002146295,0.000531911,0.00014216616,0.000039450522,0.000015306714,0.000074288975,0.00007808286,0.000040678435],"category_scores_gemma":[0.00015976594,0.00015008393,0.00006515486,0.0002022433,0.000054242268,0.000104815954,0.000022726212,0.00010184545,0.000012916892],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10957472,0.0982145,0.77922857,0.00030542893,0.00046371517,0.00006659434,0.0011291717,0.000016951306,0.0008981689,0.00034754985,0.00020045231,0.009554209],"study_design_scores_gemma":[0.51774853,0.032228097,0.42924476,0.00038924455,0.00027950003,0.0000016721913,0.000031600033,0.00003069641,0.019503467,0.000009842717,0.00036993463,0.00016268679],"about_ca_topic_score_codex":0.000051505478,"about_ca_topic_score_gemma":0.000039843097,"teacher_disagreement_score":0.4081738,"about_ca_system_score_codex":0.000026120524,"about_ca_system_score_gemma":0.000071472336,"threshold_uncertainty_score":0.61202455},"labels":[],"label_agreement":null},{"id":"W2563735324","doi":"10.1182/blood.v112.11.4912.4912","title":"Allergen-Specific B Cell Quantity Is Similar in Allergic and Nonallergic Individuals, Whereas Allergen-Specific T Cells May Be Increased in Allergic Individuals","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; Alberta Health Services; University of Calgary","funders":"","keywords":"Immunology; Allergen; Immunoglobulin E; Allergy; Peripheral blood mononuclear cell; Asthma; Flow cytometry; Allergic inflammation; Medicine; Biology; Antibody; In vitro","score_opus":0.03233497341647435,"score_gpt":0.23991478414408074,"score_spread":0.2075798107276064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563735324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9754271,0.013360554,0.000031339274,0.0017267695,0.0003180741,0.0015418577,0.0001764428,0.00018946342,0.007228397],"genre_scores_gemma":[0.9140038,0.07924455,0.0026595101,0.0016572827,0.00034602295,0.0000930391,0.0006717948,0.00020343094,0.0011205976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9925562,0.0005591557,0.0019765752,0.0018340903,0.0016279063,0.0014460566],"domain_scores_gemma":[0.99692607,0.0003164787,0.0005259418,0.0011698426,0.00027208056,0.0007895633],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011588996,0.001119524,0.0017462538,0.0011634452,0.00037132212,0.00011184021,0.0005245394,0.0008942941,0.0024703294],"category_scores_gemma":[0.000055937864,0.0011414587,0.00036349197,0.0013436273,0.00041477283,0.00043725868,0.00034054063,0.0011676028,0.00024732878],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011252648,0.017857125,0.74252486,0.0005776014,0.0014026987,0.010937041,0.023139507,0.00072017254,0.03721759,0.0016475202,0.16210675,0.00074389455],"study_design_scores_gemma":[0.033563208,0.00084843155,0.76447207,0.0005349189,0.00014967898,0.0009966525,0.0016561603,0.00045815945,0.008633275,0.00031675573,0.18613158,0.0022391474],"about_ca_topic_score_codex":0.0005468168,"about_ca_topic_score_gemma":0.0006328625,"teacher_disagreement_score":0.065883994,"about_ca_system_score_codex":0.00017387285,"about_ca_system_score_gemma":0.00034752884,"threshold_uncertainty_score":0.99910355},"labels":[],"label_agreement":null},{"id":"W2563748074","doi":"10.1182/blood.v106.11.4132.4132","title":"Cerebral Sinovenous Thrombosis Post Head Injury - 10 Year Experience in Children.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Cerebral Venous Sinus Thrombosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Surgery; Thrombosis; Head injury; Irritability; Vomiting; Internal medicine","score_opus":0.018863626596595972,"score_gpt":0.28837927718214523,"score_spread":0.26951565058554927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563748074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99200404,0.00020262877,0.000001724901,0.00091908773,0.00006267279,0.0005055162,0.000045419078,0.0001626474,0.0060962574],"genre_scores_gemma":[0.99630165,0.000027150376,0.0016408288,0.0009676405,0.00043060354,0.000029364091,0.0000512131,0.00006086983,0.0004907072],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981037,0.000037464524,0.00039605374,0.0004941962,0.00038038936,0.000588239],"domain_scores_gemma":[0.9990265,0.000023841943,0.00008021837,0.0005802175,0.00007948139,0.00020975085],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000112856236,0.00026655782,0.00048882124,0.00020990522,0.0000910181,0.000033619257,0.00021199776,0.00017608261,0.0026627681],"category_scores_gemma":[0.00009045991,0.00026012165,0.00013904969,0.00042490437,0.0001339774,0.00021402627,0.000108753935,0.00030989948,0.00097579206],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012648049,0.006953924,0.9462736,0.00003535437,0.00017170262,0.000017290824,0.0029520753,0.0000026739078,0.03794149,0.00022509316,0.001023214,0.004277065],"study_design_scores_gemma":[0.003816498,0.0009667359,0.9584162,0.00010759512,0.00013646262,0.00017406516,0.00026102163,0.000008300964,0.034775857,0.000014437121,0.0009980478,0.0003247269],"about_ca_topic_score_codex":0.00063942396,"about_ca_topic_score_gemma":0.00034822448,"teacher_disagreement_score":0.0121426135,"about_ca_system_score_codex":0.00014132634,"about_ca_system_score_gemma":0.00014246874,"threshold_uncertainty_score":0.9999851},"labels":[],"label_agreement":null},{"id":"W2563750297","doi":"10.1182/blood.v120.21.486.486","title":"A Long Acting Polymeric Iron Chelator for the Treatment of Transfusion Associated Iron Overload","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Partial thromboplastin time; Thromboelastography; Excretion; Chemistry; Pharmacology; Deferoxamine; Platelet; Lactate dehydrogenase; Platelet activation; Medicine; Internal medicine; Immunology; Biochemistry","score_opus":0.011748035548832648,"score_gpt":0.24987828206067778,"score_spread":0.23813024651184514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563750297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877672,0.010159141,0.000057699068,0.00044444544,0.0001769919,0.0006626556,0.000011242558,0.000035061643,0.0006855303],"genre_scores_gemma":[0.99734694,0.0019144154,0.000050762792,0.000054319684,0.00012019653,0.000036318954,0.00001729428,0.000021688347,0.00043809318],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992658,0.000020688443,0.00018499569,0.00010809603,0.0001349975,0.0002854286],"domain_scores_gemma":[0.99952936,0.000121316334,0.00008998152,0.00015444214,0.000022299268,0.00008262085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010456593,0.00012101995,0.00021658144,0.00003124904,0.00011067456,0.0000040412388,0.000035063676,0.00013495934,0.000050602626],"category_scores_gemma":[0.000041247262,0.00007106372,0.00017785154,0.00012436362,0.000032968994,0.00003897101,0.0000046557484,0.00007123331,0.000004642862],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011046374,0.024594037,0.42660788,0.0005128802,0.0019290883,0.000016302398,0.024160903,0.000020452624,0.24539639,0.0000885408,0.00025240862,0.27531648],"study_design_scores_gemma":[0.06682297,0.009855705,0.49357435,0.0006713842,0.012450075,0.00012410826,0.0092755,0.0007178967,0.38940817,0.0000137040815,0.016251039,0.00083507353],"about_ca_topic_score_codex":0.00018305996,"about_ca_topic_score_gemma":0.000012256848,"teacher_disagreement_score":0.2744814,"about_ca_system_score_codex":0.00004668522,"about_ca_system_score_gemma":0.000033070144,"threshold_uncertainty_score":0.2897894},"labels":[],"label_agreement":null},{"id":"W2563788622","doi":"10.1182/blood.v116.21.532.532","title":"Impact of Minimal Residual Disease at Unrelated Cord Blood Transplantation In Children with Acute Lymphoblastic Leukemia In Remission: a Study on Behalf of Eurocord-EBMT and EBMT-PDWP","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Minimal residual disease; Internal medicine; Hematopoietic stem cell transplantation; Transplantation; Oncology; Cumulative incidence; Cord blood; Leukemia","score_opus":0.009077526122134886,"score_gpt":0.2832076892005873,"score_spread":0.27413016307845245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563788622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99811584,0.000049152477,0.0000028638246,0.00003405165,0.000017992323,0.0014588073,0.00016160063,0.000027506023,0.00013215972],"genre_scores_gemma":[0.9994413,0.000068638474,0.00017732715,0.00001172143,0.000042418276,0.00004323994,0.00010207855,0.00005526483,0.000057969104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99748033,0.00014384509,0.0006318872,0.0005622945,0.0007495288,0.00043211278],"domain_scores_gemma":[0.998502,0.000301517,0.00020839827,0.00047872387,0.00011826242,0.00039108226],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029100754,0.00032997574,0.0006145266,0.0005134782,0.000043516266,0.00001068219,0.00017964603,0.0001770857,0.00004830917],"category_scores_gemma":[0.00023147058,0.0002452929,0.00007648244,0.0006446665,0.0002218738,0.00010705474,0.00007521327,0.0004766958,0.0000035857086],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018980814,0.0033660126,0.9104233,0.00011083135,0.0006034198,0.0018435356,0.0009366614,0.000036644742,0.063525155,0.000005792284,0.000014814465,0.00015301311],"study_design_scores_gemma":[0.047952134,0.008784017,0.9305229,0.00047135833,0.0016012483,0.0010278259,0.00006492617,0.00020288503,0.009163675,0.0000056782715,3.3512993e-7,0.00020302438],"about_ca_topic_score_codex":0.0010105651,"about_ca_topic_score_gemma":0.00031304857,"teacher_disagreement_score":0.05436148,"about_ca_system_score_codex":0.00030809687,"about_ca_system_score_gemma":0.0018342368,"threshold_uncertainty_score":0.99999994},"labels":[],"label_agreement":null},{"id":"W2563836428","doi":"10.1182/blood.v104.11.3333.3333","title":"Favourable Impact on Acute and Chronic Graft-Versus-Host Disease with Cyclophosphamide and In-Vivo Anti-CD52 Monoclonal Antibodies for Marrow Transplantation from HLA-Identical Sibling Donors for Acquired Aplastic Anaemia.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"CD52; Alemtuzumab; Medicine; Immunology; Aplastic anemia; Cyclophosphamide; Bone marrow; Graft-versus-host disease; Transplantation; Antibody; Internal medicine; Chemotherapy","score_opus":0.011886316144430448,"score_gpt":0.2705266166602784,"score_spread":0.25864030051584797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563836428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98985827,0.0005447242,0.0070169377,0.00020991209,0.000100376354,0.0014117972,0.00078048813,0.000053454223,0.000024044346],"genre_scores_gemma":[0.9943933,0.0010486244,0.0038276988,0.000044124,0.00009771485,0.00011964283,0.00039995604,0.000052345848,0.000016578895],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998445,0.000027614318,0.00037732912,0.0004708411,0.00024910632,0.0004301611],"domain_scores_gemma":[0.9987529,0.0006321191,0.00009845726,0.00016734311,0.000060729013,0.00028843325],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015804898,0.00031859253,0.0004759947,0.00020458897,0.00016353198,0.00006296739,0.000060203507,0.00011664526,0.000011745744],"category_scores_gemma":[0.00005305711,0.000259305,0.00009547233,0.00016969228,0.000117509044,0.00021182252,0.000006520895,0.00011762751,0.000001563029],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.057293143,0.0021012775,0.53386647,0.006729828,0.002341532,0.0013505288,0.0034299165,0.0037588354,0.38833213,0.0004818987,0.000040439623,0.00027402418],"study_design_scores_gemma":[0.08951089,0.003937261,0.6235695,0.0031555817,0.005935776,0.00021020346,0.0003501536,0.0021811672,0.26972097,0.00069176056,0.0000097686125,0.0007269743],"about_ca_topic_score_codex":0.00017523956,"about_ca_topic_score_gemma":0.000352093,"teacher_disagreement_score":0.11861117,"about_ca_system_score_codex":0.000099283156,"about_ca_system_score_gemma":0.00023988548,"threshold_uncertainty_score":0.99998593},"labels":[],"label_agreement":null},{"id":"W2563856048","doi":"10.1182/blood-2016-09-728006","title":"Risk of venous thromboembolism in pregnant women with essential thrombocythemia: a systematic review and meta-analysis","year":2017,"lang":"en","type":"review","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"National Cancer Institute; Università degli Studi di Padova; Università degli Studi di Pavia; University of Ottawa; Heart and Stroke Foundation of Canada","keywords":"Medicine; Essential thrombocythemia; Meta-analysis; Venous thromboembolism; Obstetrics; Absolute risk reduction; Low molecular weight heparin; Pregnancy; Relative risk; Heparin; Thrombosis; Confidence interval; Internal medicine; Polycythemia vera","score_opus":0.07269527291146743,"score_gpt":0.3431705396273679,"score_spread":0.27047526671590044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563856048","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007272795,0.9949263,0.0000206892,0.000020527747,0.000018295741,0.004560298,0.00012307205,0.000030768915,0.00022734706],"genre_scores_gemma":[0.0012913925,0.9970161,0.00026387747,0.000050993163,0.000022494125,0.0010626144,0.000047120873,0.00007094855,0.00017450681],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99634135,0.0005393342,0.0015289644,0.0006763059,0.0005414331,0.0003726422],"domain_scores_gemma":[0.99521995,0.00014632865,0.0025138361,0.0017911962,0.00014295407,0.00018573662],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.001180598,0.0006511114,0.02172315,0.00046886524,0.00008623806,0.000040407725,0.00033374163,0.000344017,0.00020295371],"category_scores_gemma":[0.00019644882,0.00036901163,0.0015429312,0.0006485698,0.00012399133,0.00007570937,0.00012082875,0.0004830141,0.000011912064],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000026620546,0.00080120016,0.0000019866354,0.7012624,0.2971501,0.00003649532,0.00014168628,8.3897326e-8,5.1149414e-7,0.000077622666,0.0000018039573,0.0005234004],"study_design_scores_gemma":[0.0007384995,0.00031928247,0.000021948925,0.12639923,0.87162495,0.00016866297,0.000020461288,6.98046e-7,0.000006946169,0.000040773146,0.0003702315,0.00028833814],"about_ca_topic_score_codex":0.0000523982,"about_ca_topic_score_gemma":0.000036698795,"teacher_disagreement_score":0.5748632,"about_ca_system_score_codex":0.00004717278,"about_ca_system_score_gemma":0.00030077173,"threshold_uncertainty_score":0.9998762},"labels":[],"label_agreement":null},{"id":"W2563858698","doi":"10.1182/blood.v120.21.3417.3417","title":"A Systematic Review Evaluating the Effects of Treatment Duration on Bleeding Due to Factor-specific Oral Anticoagulant Therapy","year":2012,"lang":"en","type":"review","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Western University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Medicine; Rivaroxaban; Edoxaban; Apixaban; Dabigatran; Randomized controlled trial; Pulmonary embolism; Internal medicine; Intensive care medicine; Warfarin; Atrial fibrillation","score_opus":0.24660848691078946,"score_gpt":0.4336353134376727,"score_spread":0.18702682652688324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563858698","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006391154,0.9861565,0.000014105445,0.000103556195,0.00031704156,0.012641102,0.000004358565,0.000036975198,0.00008724466],"genre_scores_gemma":[0.0006037671,0.9980403,0.000089684596,0.00007761602,0.0005933143,0.00018136449,0.00004292098,0.000044281962,0.00032674865],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9975563,0.00048773855,0.001047021,0.00025261036,0.00044431584,0.00021197292],"domain_scores_gemma":[0.997527,0.0009821755,0.00078290456,0.0005641068,0.00006807896,0.00007575653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007343341,0.00039108342,0.0029683572,0.00015169063,0.00007612266,0.000025923924,0.00012001224,0.00009566621,0.000038955237],"category_scores_gemma":[0.00038414742,0.00018120308,0.0007104765,0.00033589848,0.000012174806,0.000038791324,0.000028824927,0.000093784634,0.000105963256],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013243803,0.000059092647,0.00004060621,0.8185287,0.0013603974,0.000007306925,0.00012958354,1.04668835e-7,0.000036785732,0.00011978487,0.00002443806,0.17967996],"study_design_scores_gemma":[0.0017141759,0.0024177942,0.00013920694,0.9114616,0.025474072,0.000053438238,0.0000134659895,0.000002786454,0.00007364996,0.000002392192,0.058352716,0.00029470882],"about_ca_topic_score_codex":0.000004464568,"about_ca_topic_score_gemma":3.3476425e-7,"teacher_disagreement_score":0.17938526,"about_ca_system_score_codex":0.0001273006,"about_ca_system_score_gemma":0.000065265536,"threshold_uncertainty_score":0.73892474},"labels":[],"label_agreement":null},{"id":"W2563868741","doi":"10.1182/blood.v118.21.2278.2278","title":"An Increase in Factor VIII Levels with Increasing Age in a Subgroup of Individuals with Mild Hemophilia A","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Paul's Hospital; University of Calgary; BC Children's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Cohort; Medical record; Internal medicine; Retrospective cohort study; Pediatrics; Thrombosis","score_opus":0.054666943550479886,"score_gpt":0.29531684995382185,"score_spread":0.24064990640334197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563868741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997058,0.000107894215,0.0000026790708,0.00004864865,0.0000051288607,0.0007152511,0.00003102313,0.000028356904,0.0020030583],"genre_scores_gemma":[0.99569446,0.000012229349,0.0040321997,0.000040588224,0.000029524073,0.000041050942,0.000028795936,0.000035907782,0.00008523085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835074,0.00016409617,0.00030101146,0.0003395563,0.0004343082,0.00041028394],"domain_scores_gemma":[0.99912995,0.000080671125,0.000075309996,0.00040326227,0.000059383776,0.00025143134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003994019,0.0002140256,0.0004895159,0.0004748681,0.000028594259,0.000011192245,0.0001407408,0.000120289355,0.00012523495],"category_scores_gemma":[0.000068145324,0.00013830741,0.00003634225,0.00058493053,0.00015974068,0.0001577189,0.00003827721,0.00027095777,0.000006121637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001229679,0.0038548678,0.97720057,0.00012259703,0.00011817451,0.0018820533,0.0037428977,2.0487953e-7,0.011381135,0.00003274049,0.0000012986383,0.00043376477],"study_design_scores_gemma":[0.012363095,0.0021858506,0.94778925,0.00059000513,0.00010058498,0.00014088208,0.0003838542,0.0000050188205,0.03622692,0.000042842483,0.0000067960796,0.00016489164],"about_ca_topic_score_codex":0.0035458186,"about_ca_topic_score_gemma":0.0017305657,"teacher_disagreement_score":0.029411329,"about_ca_system_score_codex":0.000044444667,"about_ca_system_score_gemma":0.00023552075,"threshold_uncertainty_score":0.56400126},"labels":[],"label_agreement":null},{"id":"W2563880171","doi":"10.1182/blood.v114.22.3829.3829","title":"Two-Year Analysis of Efficacy and Safety of Deferasirox (Exjade®) Treatment in Myelodysplastic Syndrome Patients Enrolled in the US03 Study.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Deferasirox; Medicine; Tolerability; Myelodysplastic syndromes; International Prognostic Scoring System; Internal medicine; Creatinine; Adverse effect; Anemia; Ferritin; Gastroenterology; Pediatrics; Surgery; Thalassemia; Bone marrow","score_opus":0.013413101692993075,"score_gpt":0.28984071861084504,"score_spread":0.27642761691785195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563880171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99784386,0.00009233959,0.0000010574537,0.00010041652,0.000006451127,0.0013310134,0.000016152171,0.0000062075715,0.0006025145],"genre_scores_gemma":[0.9997236,0.000059569502,0.0000865547,0.000022434357,0.0000075242638,0.000024432136,0.000026336957,0.000008920364,0.00004062092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829125,0.00023875722,0.00051297754,0.0002655684,0.00044921093,0.00024223517],"domain_scores_gemma":[0.9989296,0.00043732268,0.00010188353,0.00040098702,0.00006286421,0.00006733421],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040944226,0.00015700585,0.00074537535,0.0007133958,0.000023426912,0.00000607874,0.0001345581,0.00005755578,0.000038482685],"category_scores_gemma":[0.00022677933,0.00010045191,0.00009417912,0.001521537,0.000056489032,0.00003074662,0.00003358738,0.00016600722,0.0000025131399],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011743221,0.01023668,0.98305863,0.000021242575,0.0010423582,0.00013995856,0.0030104956,0.000118440264,0.00036244094,0.000027402399,0.0000028194672,0.00080521114],"study_design_scores_gemma":[0.038882993,0.0040143747,0.95404273,0.000045739067,0.001731499,0.000010222885,0.00092944794,0.00012551658,0.00013807214,0.0000060569582,0.0000036346323,0.000069703405],"about_ca_topic_score_codex":0.0002563806,"about_ca_topic_score_gemma":0.00017086472,"teacher_disagreement_score":0.03770867,"about_ca_system_score_codex":0.00011879223,"about_ca_system_score_gemma":0.000100589554,"threshold_uncertainty_score":0.40963098},"labels":[],"label_agreement":null},{"id":"W2563902799","doi":"10.1182/blood.v106.11.2736.2736","title":"Autologous Bone Marrow Transplant after Failed Peripheral Blood Stem Cell Mobilization Does Not Adversely Affect Engraftment or Transplant Related Toxicity.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Multiple myeloma; Bone marrow; Chemotherapy; Stem cell; Surgery; Internal medicine; Plerixafor; Transplantation; Haematopoiesis; CD34; Gastroenterology; CXCR4; Biology","score_opus":0.009017683114902428,"score_gpt":0.2240245223598555,"score_spread":0.2150068392449531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563902799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942939,0.00048506,0.0007051474,0.00058791,0.00022600559,0.0019345246,0.00026262406,0.00045553778,0.0010492463],"genre_scores_gemma":[0.99335307,0.0005193383,0.0019211879,0.00034034837,0.00014226651,0.00031709587,0.0002587069,0.000103956794,0.003044001],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99663115,0.00023047428,0.0009606508,0.00079248194,0.00068577036,0.00069949846],"domain_scores_gemma":[0.9986971,0.00017953302,0.00018346336,0.000507813,0.00008493029,0.0003471713],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003696087,0.0005669854,0.0008018088,0.00021832828,0.00013237465,0.000042484484,0.00015130725,0.00044689863,0.0012099432],"category_scores_gemma":[0.0000066308394,0.00039992805,0.00030120087,0.00030243,0.000093999035,0.00020120623,0.000010429898,0.00038524423,0.000118555094],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009511762,0.011088066,0.078465246,0.005209327,0.0016630108,0.010327986,0.030178465,0.00045286166,0.8502241,0.00015630599,0.0000679192,0.002655001],"study_design_scores_gemma":[0.02460727,0.0016807668,0.029091612,0.001100537,0.00485379,0.0021083578,0.00042320968,0.0010261742,0.9339513,0.000006548676,0.00032512654,0.00082531077],"about_ca_topic_score_codex":0.000024709347,"about_ca_topic_score_gemma":0.0002395798,"teacher_disagreement_score":0.08372725,"about_ca_system_score_codex":0.000101281104,"about_ca_system_score_gemma":0.00017239881,"threshold_uncertainty_score":0.99984527},"labels":[],"label_agreement":null},{"id":"W2563937209","doi":"10.1182/blood.v104.11.3761.3761","title":"Prevelence of α-Globin Deletions in β-Thalassemia Minor Patients and Differences in Erythrocyte Indices.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Biology; Gene; Genetics; Molecular biology; Thalassemia; Gene mutation; Mutation; Minor allele frequency; Hemoglobin; Hemoglobinopathy; Genotype; Allele frequency; Hemolytic anemia; Immunology; Biochemistry","score_opus":0.006819327748148705,"score_gpt":0.2145450692269082,"score_spread":0.2077257414787595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563937209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977425,0.0010376582,0.0000037075094,0.00017277227,0.000028457289,0.0002793959,0.000006531702,0.000009872798,0.0007191346],"genre_scores_gemma":[0.9988996,0.00074517156,0.00024400491,0.00005052341,0.000006164296,0.000013170955,0.000007593926,0.0000062402955,0.000027579039],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992465,0.000017552238,0.00026033574,0.00016781304,0.00013572889,0.00017210213],"domain_scores_gemma":[0.9997342,0.000022780121,0.000063813204,0.000092274975,0.000027385124,0.00005951264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000060405822,0.00009295942,0.00022322245,0.00014853614,0.000018283214,0.0000040620425,0.000049715534,0.00011412601,0.000011994451],"category_scores_gemma":[0.00006751488,0.00007630404,0.00002351726,0.0002794774,0.00008310629,0.00004852547,0.000029095974,0.00016014723,0.000002828673],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023745391,0.0012899183,0.9957769,0.00013212232,0.000016915254,0.000021008023,0.0009205066,0.0000031424167,0.00085238327,0.00005328758,0.000006268944,0.0009038171],"study_design_scores_gemma":[0.0072496086,0.00028319086,0.98881596,0.0005542966,0.00004077172,0.000012512197,0.00033842368,0.00000691832,0.0024166682,0.00018075683,0.000016414015,0.000084492814],"about_ca_topic_score_codex":0.00033527278,"about_ca_topic_score_gemma":0.00020553454,"teacher_disagreement_score":0.007225863,"about_ca_system_score_codex":0.00002432756,"about_ca_system_score_gemma":0.00008161302,"threshold_uncertainty_score":0.31115884},"labels":[],"label_agreement":null},{"id":"W2563947761","doi":"10.1182/blood.v116.21.1963.1963","title":"Hematological Testing Is Not Required with Every Dose of Bortezomib In Patients with Adequate Blood Counts at the Start of Each Cycle","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Bortezomib; Medicine; Neutropenia; Multiple myeloma; Absolute neutrophil count; Dexamethasone; Complete blood count; Internal medicine; Blood count; Platelet; Toxicity; Surgery; Gastroenterology","score_opus":0.02698907948293442,"score_gpt":0.26695772677026663,"score_spread":0.23996864728733222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563947761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978532,0.00003959571,7.0075885e-7,0.000064702734,0.000012964697,0.00044076124,0.000043713342,0.000011710622,0.0015326533],"genre_scores_gemma":[0.9988671,0.0000024433828,0.00084305595,0.00003481078,0.000011822205,0.000022750104,0.000022008859,0.00001355294,0.0001824638],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892145,0.00002759826,0.00020358404,0.00018300868,0.00043629893,0.00022805553],"domain_scores_gemma":[0.9992037,0.0001335245,0.00010850088,0.0003262498,0.00014310027,0.00008493838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012408374,0.00010894193,0.00025430167,0.000049821127,0.00003444048,0.0000041959147,0.000082254504,0.000057686444,0.00015272372],"category_scores_gemma":[0.00016216551,0.000055754106,0.000027217915,0.00018236708,0.0001494307,0.000037654398,0.00004753911,0.00016652928,0.000016698066],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090838043,0.0019526319,0.99336874,0.000054544333,0.0001812665,0.00008876444,0.00012187152,3.887315e-7,0.0025251608,0.000012346637,0.000030754247,0.00075512443],"study_design_scores_gemma":[0.013336902,0.0012504081,0.95693326,0.00012381405,0.00016141677,0.000032836266,0.000024486208,0.000030126683,0.028007807,0.000009726108,0.000019707468,0.00006951629],"about_ca_topic_score_codex":0.00012580119,"about_ca_topic_score_gemma":0.000060445578,"teacher_disagreement_score":0.036435515,"about_ca_system_score_codex":0.000009480089,"about_ca_system_score_gemma":0.00008679515,"threshold_uncertainty_score":0.22735865},"labels":[],"label_agreement":null},{"id":"W2563955151","doi":"10.1182/blood.v126.23.4870.4870","title":"Two Cases of Pediatric Acute Lymphoblastic Leukemia with t(5;14): a Challenging and Unique Entity","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Medicine; Hypereosinophilia; Asymptomatic; Eosinophilia; Petechial rash; Pediatrics; Abdominal pain; Hepatosplenomegaly; Leukocytosis; Chest pain; Rash; Internal medicine; Disease; Surgery","score_opus":0.02222107968969573,"score_gpt":0.2795372547312939,"score_spread":0.2573161750415982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563955151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957611,0.001013308,0.0006877741,0.000095247015,0.00004244625,0.00036314712,0.000018062276,0.00007248693,0.0019464286],"genre_scores_gemma":[0.99654883,0.00042696108,0.002347042,0.00005465214,0.00025638664,0.000025584313,0.000011440725,0.00004090202,0.00028821416],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983759,0.000057761077,0.00026623684,0.00033386983,0.0005775797,0.0003886719],"domain_scores_gemma":[0.99853224,0.00025048974,0.00010836694,0.00035822607,0.00031568648,0.0004350168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029017258,0.00020637743,0.00041765012,0.00024729015,0.00005084297,0.000018414321,0.00012009788,0.000095154755,0.000017671484],"category_scores_gemma":[0.0003693389,0.0001577513,0.00004637916,0.00041479646,0.00015664229,0.00011305246,0.00014509715,0.00018249132,0.000016213835],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009291069,0.006517963,0.8831941,0.005941194,0.0066633434,0.040155493,0.008572886,0.00048398724,0.02073459,0.0057851584,0.008060635,0.0045995642],"study_design_scores_gemma":[0.47577265,0.037070155,0.15646537,0.0031514945,0.034328792,0.109302975,0.0062699346,0.021990154,0.14654678,0.0017684981,0.0023866855,0.0049465112],"about_ca_topic_score_codex":0.0003662173,"about_ca_topic_score_gemma":0.00004169564,"teacher_disagreement_score":0.72672874,"about_ca_system_score_codex":0.00035527497,"about_ca_system_score_gemma":0.0020433923,"threshold_uncertainty_score":0.6432912},"labels":[],"label_agreement":null},{"id":"W2563958277","doi":"10.1182/blood.v124.21.284.284","title":"Self-Enforcing Feedback Activation Between BCL6 and Tonic Pre-B Cell Receptor Signaling in Acute Lymphoblastic Leukemia","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"breakpoint cluster region; BCL6; Cancer research; B-cell receptor; Biology; Signal transduction; B cell; PI3K/AKT/mTOR pathway; Transcription factor; Cell biology; Immunology; Receptor; Genetics; Germinal center; Antibody","score_opus":0.008787858095081884,"score_gpt":0.24511683848472,"score_spread":0.2363289803896381,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563958277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947792,0.0000656059,0.0018472815,0.00015514158,0.00005246231,0.0005951115,0.0000066099224,0.00014191348,0.0023566568],"genre_scores_gemma":[0.99250996,0.00006615079,0.006226241,0.00013673338,0.0004006303,0.00004064379,0.000051235595,0.000065894455,0.0005025227],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977475,0.00011394984,0.0004676165,0.0005223014,0.00052736694,0.0006212698],"domain_scores_gemma":[0.9983511,0.0007416996,0.00014231607,0.00036768295,0.00010401676,0.00029316611],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005403908,0.00027984352,0.00050868443,0.0002916742,0.000109563785,0.000061018298,0.00017475917,0.0002636365,0.000060755276],"category_scores_gemma":[0.00029590313,0.00025857156,0.00006762842,0.00044593276,0.00007135797,0.00022771995,0.00015304446,0.00038485354,0.000094603376],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092085206,0.00087977166,0.18364666,0.0021905222,0.00086002,0.00008687824,0.0041342033,0.00031808406,0.79625124,0.00020397853,0.00082369114,0.009684102],"study_design_scores_gemma":[0.042312756,0.001813807,0.08429087,0.0013027225,0.0012706856,0.0001478488,0.0003133443,0.020692443,0.84444475,0.00021856428,0.0022791428,0.0009130617],"about_ca_topic_score_codex":0.00013420946,"about_ca_topic_score_gemma":0.000004204463,"teacher_disagreement_score":0.099355794,"about_ca_system_score_codex":0.0011411308,"about_ca_system_score_gemma":0.0008165356,"threshold_uncertainty_score":0.99998665},"labels":[],"label_agreement":null},{"id":"W2563961854","doi":"10.1182/blood.v120.21.694.694","title":"Switching to Nilotinib Is Associated with Continued Deeper Molecular Responses in CML-CP Patients with Minimal Residual Disease After ≥ 2 Years On Imatinib: Enestcmr 2-Year Follow-up Results","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Nilotinib; Imatinib; Medicine; Internal medicine; Imatinib mesylate; Myeloid leukemia; Population; Minimal residual disease; Oncology; Gastroenterology; Leukemia","score_opus":0.00883477986199611,"score_gpt":0.23853790824656565,"score_spread":0.22970312838456955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563961854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977198,0.00009772247,0.000002432887,0.0002685608,0.00007161308,0.0011533474,0.00025489126,0.00008594933,0.00034567752],"genre_scores_gemma":[0.99648345,0.0000022066095,0.0013801723,0.00088467234,0.000084166146,0.00016889597,0.00018329074,0.000109203276,0.00070392765],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972059,0.00019848853,0.00044026432,0.000565476,0.0008460074,0.0007438654],"domain_scores_gemma":[0.99828833,0.00022789167,0.00017596949,0.00062399893,0.00013392637,0.0005498866],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033727154,0.00037683386,0.0004928796,0.0002458833,0.000050304276,0.000033564098,0.0001228734,0.00012587504,0.00005491035],"category_scores_gemma":[0.0010702556,0.00029606675,0.000082200386,0.00037148563,0.000041985455,0.00014513107,0.00006782388,0.00027256782,0.00010158173],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0426879,0.0027044355,0.94874364,0.000030504,0.00037609367,0.000987938,0.0033092652,0.0000031974475,0.0005156002,0.000007046916,0.00036005312,0.0002743348],"study_design_scores_gemma":[0.053798232,0.0017701058,0.93928796,0.0009625452,0.000578116,0.000007302183,0.000113651426,0.0000017053127,0.0029206907,0.0000036427157,0.00020957574,0.0003464444],"about_ca_topic_score_codex":0.000092492126,"about_ca_topic_score_gemma":0.00009447068,"teacher_disagreement_score":0.01111033,"about_ca_system_score_codex":0.00036418534,"about_ca_system_score_gemma":0.0003423805,"threshold_uncertainty_score":0.99994916},"labels":[],"label_agreement":null},{"id":"W2563965053","doi":"10.1182/blood.v126.23.2416.2416","title":"Copy Number Variants Underlying Inherited Bone Marrow Failure Syndromes","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Janeway Children's Health and Rehabilitation Centre; London Health Sciences Centre; McMaster University; University of Alberta; Centre hospitalier universitaire de Québec; Centre Hospitalier Universitaire de Sherbrooke; Centre Hospitalier Universitaire Sainte-Justine; CancerCare Manitoba; Population Health Research Institute; Children's Hospital of Eastern Ontario; BC Children's Hospital; Royal University Hospital; Montreal Children's Hospital; University of Toronto; SickKids Foundation; Princess Margaret Cancer Centre; Kingston General Hospital; University of Manitoba; Alberta Children's Hospital; Izaak Walton Killam Health Centre; Hospital for Sick Children","funders":"","keywords":"Copy-number variation; Exact test; SNP array; Genetics; Biology; Genotype; Genotype-phenotype distinction; Genetic testing; Bone marrow failure; SNP; Copy number analysis; Single-nucleotide polymorphism; Bioinformatics; Medicine; Gene; Genome; Internal medicine; Haematopoiesis","score_opus":0.06830775344702059,"score_gpt":0.3305787179845353,"score_spread":0.26227096453751475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563965053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97890997,0.00029867544,0.0001299472,0.0031852701,0.00010554048,0.00041603055,0.000011743411,0.00019934266,0.016743502],"genre_scores_gemma":[0.9859674,0.000023754566,0.007296415,0.00045968272,0.00016820717,0.00002968091,0.000049841914,0.00006112735,0.005943868],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822813,0.00008697934,0.0002520878,0.00033860136,0.00059808104,0.0004961278],"domain_scores_gemma":[0.99867404,0.00006877287,0.000057826484,0.00048867223,0.00022195569,0.0004887163],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004050352,0.00019008594,0.00037379077,0.000112817055,0.00006800782,0.000049602862,0.00015603236,0.00019869645,0.00063319696],"category_scores_gemma":[0.0003856221,0.00016768233,0.00007296083,0.00046872988,0.000087513596,0.00014090376,0.00012455447,0.00045366504,0.0013823122],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008064599,0.0028768298,0.6344813,0.0006225115,0.0016966664,0.013549797,0.0027479087,0.0000056789595,0.062415317,0.001682992,0.27588245,0.0032320737],"study_design_scores_gemma":[0.19919327,0.00490091,0.35084,0.002556715,0.0037537531,0.07739618,0.012636357,0.0018902088,0.05607519,0.0065584304,0.2798565,0.0043424987],"about_ca_topic_score_codex":0.00012990486,"about_ca_topic_score_gemma":0.000020802767,"teacher_disagreement_score":0.2836413,"about_ca_system_score_codex":0.00017148783,"about_ca_system_score_gemma":0.00057300704,"threshold_uncertainty_score":0.99939525},"labels":[],"label_agreement":null},{"id":"W2563967614","doi":"10.1182/blood.v114.22.934.934","title":"A Phase I Study of GA101 (RO5072759) Monotherapy Followed by Maintenance in Patients with Multiply Relapsed/Refractory CD20+ Malignant Disease.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University Health Network; University of British Columbia; London Health Sciences Centre; Jewish General Hospital; Princess Margaret Cancer Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Tolerability; Maintenance therapy; Rituximab; Internal medicine; Dosing; Neutropenia; Refractory (planetary science); Follicular lymphoma; Cohort; Clinical trial; Phases of clinical research; Surgery; Adverse effect; Oncology; Gastroenterology; Lymphoma; Toxicity; Chemotherapy","score_opus":0.011653176776381313,"score_gpt":0.28416125518456703,"score_spread":0.2725080784081857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563967614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973577,0.00058116356,0.000007683126,0.0003603677,0.000026649008,0.0012378132,0.000082112805,0.000025063286,0.0003214238],"genre_scores_gemma":[0.99791217,0.00011009025,0.0001512301,0.00031202007,0.000036543795,0.00003824563,0.00006501108,0.000025251482,0.0013494522],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805343,0.00008310643,0.0003922486,0.00038716997,0.0006691993,0.00041482836],"domain_scores_gemma":[0.99903154,0.000059212103,0.000118942735,0.0003738858,0.0001400247,0.00027641733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001433674,0.00022937692,0.0004475593,0.00014420631,0.000050892108,0.000009794977,0.00015929675,0.00004592423,0.0000593771],"category_scores_gemma":[0.000052030566,0.00015428614,0.00008625711,0.00026466892,0.00007106328,0.00007571094,0.000024378072,0.0002462461,0.000009414819],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018247226,0.07920839,0.8881309,0.00006219946,0.00019391484,0.00036060374,0.00071199686,0.0000021350086,0.006782936,0.000018222292,0.0011521035,0.005129352],"study_design_scores_gemma":[0.09670536,0.019614184,0.87946,0.00031813912,0.00013389892,0.0000032593732,0.00019732951,0.00005002867,0.0016735676,0.00003217037,0.0015451974,0.00026686318],"about_ca_topic_score_codex":0.00018722776,"about_ca_topic_score_gemma":0.000028744447,"teacher_disagreement_score":0.07845813,"about_ca_system_score_codex":0.000031752697,"about_ca_system_score_gemma":0.000092669325,"threshold_uncertainty_score":0.6291606},"labels":[],"label_agreement":null},{"id":"W2564032891","doi":"10.1182/blood.v110.11.1977.1977","title":"Elevated CD56dimCD16neg NK Cells on Day 28 after HCT: Role in Immunity Against Viral Infections or Residual Tumor Cells?.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"NK-92; CD16; Interleukin 21; Immunology; Natural killer cell; Interleukin 12; Biology; CD14; Cytolysis; Lymphokine-activated killer cell; CD3; Immune system; Cytotoxic T cell; T cell; CD8; In vitro","score_opus":0.0064206824521795556,"score_gpt":0.21823274698283346,"score_spread":0.2118120645306539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564032891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98615915,0.00033318272,0.000029869736,0.000039693346,0.0031958907,0.0003028613,0.000018009214,0.00014015016,0.009781207],"genre_scores_gemma":[0.9833728,0.00008979844,0.000022367862,0.000696968,0.000091111535,0.000035128654,0.00016587846,0.000032716664,0.015493205],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99824584,0.00032284952,0.0005022744,0.00033763077,0.00005516802,0.00053621916],"domain_scores_gemma":[0.99910325,0.00023693661,0.00014280065,0.0004048936,0.000076949254,0.000035153],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005331009,0.00026841107,0.0002717073,0.0003913582,0.00023387065,0.000029365512,0.0001642279,0.0003030497,0.0022486786],"category_scores_gemma":[0.00008842666,0.0002370455,0.00011509889,0.00030786105,0.00010746584,0.00016977488,0.000075103475,0.00092875055,0.0027722786],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012330209,0.0019197093,0.0010524986,0.000011294582,0.00012791606,0.00005068127,0.00053067267,0.000017435983,0.99133164,0.000023033715,0.0030310242,0.00067109294],"study_design_scores_gemma":[0.003167413,0.0007092118,0.009011764,0.000059403927,0.00005812542,0.00004755335,0.00058099104,0.0000029484002,0.8849419,0.0000097037955,0.10113286,0.00027812403],"about_ca_topic_score_codex":0.00028616542,"about_ca_topic_score_gemma":0.00036326452,"teacher_disagreement_score":0.10638972,"about_ca_system_score_codex":0.000093358394,"about_ca_system_score_gemma":0.00006990818,"threshold_uncertainty_score":0.9986634},"labels":[],"label_agreement":null},{"id":"W2564033819","doi":"10.1182/blood.v124.21.1052.1052","title":"An Adverse Prognostic Effect of Homozygous TET2 Mutational Status on the Relapse Risk of Acute Myeloid Leukemia Patients of Normal Karyotype","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"CEBPA; NPM1; Internal medicine; Myeloid leukemia; Frameshift mutation; Medicine; Missense mutation; Oncology; Gastroenterology; Mutation; Leukemia; Nonsense mutation; Karyotype; Cancer research; Immunology; Biology; Genetics; Gene; Chromosome","score_opus":0.005191108252441897,"score_gpt":0.24640715071108205,"score_spread":0.24121604245864015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564033819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970801,0.000030080315,0.000023551092,0.000027261516,0.000062035324,0.0010092389,0.00025034437,0.000024342184,0.001493086],"genre_scores_gemma":[0.99902993,0.0000429329,0.00047859162,0.0000336882,0.00006803149,0.000042494412,0.0001956252,0.00003691398,0.000071789815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99753904,0.00048909936,0.00048218243,0.00026889078,0.0008604573,0.00036034387],"domain_scores_gemma":[0.9970581,0.0013573798,0.00038510145,0.00062347244,0.00040249096,0.00017346985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007963534,0.00020498887,0.00047450888,0.00018824109,0.00006646007,0.0000037656,0.00024981983,0.00012919179,0.000081518],"category_scores_gemma":[0.0018188134,0.0001310626,0.0001542717,0.00033889784,0.00031026208,0.000086364926,0.000074539224,0.00043638368,0.000031231622],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036330232,0.0015510157,0.97208893,0.00045644675,0.0011017768,0.000054097618,0.00080142514,0.00019190171,0.014311032,0.00021928453,0.00029133074,0.0052997214],"study_design_scores_gemma":[0.013221501,0.014332385,0.8325624,0.00020702582,0.0015511953,0.000030632033,0.000058232054,0.0010146457,0.13675061,0.000058227695,0.000063100284,0.00015007664],"about_ca_topic_score_codex":0.0002195974,"about_ca_topic_score_gemma":0.0000075808084,"teacher_disagreement_score":0.13952658,"about_ca_system_score_codex":0.000111694506,"about_ca_system_score_gemma":0.00045270156,"threshold_uncertainty_score":0.53445774},"labels":[],"label_agreement":null},{"id":"W2564044047","doi":"10.1182/blood.v116.21.4836.4836","title":"Competition In Engraftment of Normal Hematopoietic Stem Cells and Leukemic Stem Cells","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Stem cell; Haematopoiesis; Homing (biology); Bone marrow; Transplantation; Cancer research; Immunology; Leukemia; Biology; Medicine; Cell biology; Internal medicine","score_opus":0.01008312596389889,"score_gpt":0.22230938537189168,"score_spread":0.21222625940799278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564044047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973648,0.00011093848,0.00008357285,0.000049765895,0.00016372574,0.00051245675,0.000019771789,0.000032651198,0.0016623148],"genre_scores_gemma":[0.9987707,0.00008849206,0.00073304726,0.000039376,0.000037875412,0.00002135654,0.00000906564,0.00002087765,0.00027919293],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988343,0.000040671875,0.00042553333,0.00023187256,0.00025707824,0.00021055462],"domain_scores_gemma":[0.9993833,0.00010809071,0.00010313278,0.00024361341,0.000047094756,0.00011478722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002378617,0.00015010868,0.0003359085,0.00013217072,0.000023672004,0.000009592321,0.00006147709,0.000129887,0.00010170135],"category_scores_gemma":[0.0000012940902,0.00014151116,0.00005088582,0.00012631512,0.000068868714,0.000051843264,0.000017384173,0.00022949175,0.000043775788],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004857085,0.0005146209,0.009333394,0.001165921,0.000032062202,0.00007184456,0.0017189505,0.000004176304,0.9861362,0.0005527338,0.000012880427,0.00040864773],"study_design_scores_gemma":[0.0046832287,0.00018706487,0.004736527,0.00035366658,0.00016880145,0.00024064186,0.00045140233,0.00008869145,0.9888341,0.00001818982,0.00011189575,0.00012581787],"about_ca_topic_score_codex":0.00003171991,"about_ca_topic_score_gemma":0.000031017247,"teacher_disagreement_score":0.004634658,"about_ca_system_score_codex":0.000019598132,"about_ca_system_score_gemma":0.00006952176,"threshold_uncertainty_score":0.57706577},"labels":[],"label_agreement":null},{"id":"W2564067147","doi":"10.1182/blood.v108.11.1191.1191","title":"Silencing of Genes Required for Glycosylphosphatidylinositol Biosynthesis in a Burkitts’ Lymphoma Cell Line (Ramos) and Hematopoietic Stem Cells (HSC).","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Transgenic Plants and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"","keywords":"Cell culture; Biology; Gene silencing; Haematopoiesis; Molecular biology; Stem cell; Paroxysmal nocturnal hemoglobinuria; Gene; Cell biology; Biochemistry; Immunology; Genetics","score_opus":0.007988287059105963,"score_gpt":0.2074513208065286,"score_spread":0.19946303374742264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564067147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943153,0.00411253,0.00095193426,0.000030874435,0.000026133957,0.00031774907,0.00015352109,0.000008827619,0.000083090104],"genre_scores_gemma":[0.997678,0.00037353026,0.0016318363,0.000020666179,0.00008209029,0.000058435628,0.00003715284,0.000017735063,0.00010056581],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991889,0.00001302417,0.0002782583,0.00027439735,0.000063122665,0.00018228382],"domain_scores_gemma":[0.9995944,0.00003614576,0.000090138434,0.00020979463,0.000031701835,0.000037858743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007894621,0.00012521681,0.00017577504,0.000033461936,0.000040218434,0.000010567798,0.00011113303,0.00011712961,0.0000018612704],"category_scores_gemma":[0.0000027713695,0.00012083412,0.00006274948,0.00007084107,0.000039313676,0.0000028375032,0.000026443644,0.000017297663,9.088134e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030986284,0.00037382077,0.0011612884,0.00011024178,0.000016016194,0.0000014107133,0.000030391626,0.000030442983,0.9968317,0.000058167007,0.000052520183,0.0013030204],"study_design_scores_gemma":[0.0015987278,0.0001003338,0.0008411487,0.000029589854,0.000058581623,0.000007629466,0.00006703046,0.00008127676,0.9958962,0.000060025082,0.001120462,0.0001389809],"about_ca_topic_score_codex":0.00008419168,"about_ca_topic_score_gemma":0.00007145657,"teacher_disagreement_score":0.0037389998,"about_ca_system_score_codex":0.0000038243493,"about_ca_system_score_gemma":0.000040113602,"threshold_uncertainty_score":0.49274725},"labels":[],"label_agreement":null},{"id":"W2564114794","doi":"10.1182/blood.v118.21.546.546","title":"Conservative Peri-Procedural Anticoagulation Management in Patients with Venous Thromboembolic Disease Results in a Low Proportion of Thrombosis and Bleeding","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Hospital; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Warfarin; Thrombosis; Compression stockings; Surgery; Low molecular weight heparin; Ambulatory; Venous thrombosis; Cohort; Retrospective cohort study; Venous thromboembolism; Pulmonary embolism; Heparin; Fondaparinux; Internal medicine; Atrial fibrillation","score_opus":0.025874254081346915,"score_gpt":0.25234461331077174,"score_spread":0.22647035922942482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564114794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99705654,0.000041126543,0.0000072613457,0.00012290254,0.00002643628,0.0014916538,0.000009472371,0.000022334914,0.0012222931],"genre_scores_gemma":[0.99892753,0.00012468811,0.0006952874,0.00010008538,0.000011444563,0.00007457335,0.000040020557,0.000019608784,0.0000067318756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987131,0.00002699685,0.0004099934,0.00032735593,0.00028822807,0.0002343317],"domain_scores_gemma":[0.99938333,0.0000108435925,0.00023045632,0.00020018617,0.000088150235,0.000087060274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016503668,0.00016044905,0.00043610687,0.00025190346,0.000034529414,0.000009235914,0.000052027503,0.000040462284,0.00001211551],"category_scores_gemma":[0.00003522149,0.00013404668,0.000028275756,0.0003182375,0.00008832599,0.0001571293,0.00005801745,0.00007803663,0.0000015875092],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049000833,0.008810246,0.98491275,0.0007789973,0.0002099278,0.000031748197,0.0034329358,0.0000086293785,0.000055118908,0.0007926959,0.000015425572,0.00046148844],"study_design_scores_gemma":[0.008406191,0.0008979425,0.9879234,0.0010325239,0.0004502068,6.160442e-7,0.0005103523,0.00008373024,0.00040931825,0.00013988953,0.0000029436917,0.00014290275],"about_ca_topic_score_codex":0.00022547721,"about_ca_topic_score_gemma":0.00006864012,"teacher_disagreement_score":0.007916183,"about_ca_system_score_codex":0.000040581286,"about_ca_system_score_gemma":0.00003548014,"threshold_uncertainty_score":0.5466265},"labels":[],"label_agreement":null},{"id":"W2564171273","doi":"10.1182/blood.v112.11.3299.3299","title":"Tandem Autologous-Nonmyeloablative (NMA) Allogeneic(Allo) Transplant (Tx) in Newly Diagnosed Multiple Myeloma (MM) Leads to Improved Survival When Compared to Conventional Allogeneic Transplant","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Charles-Le Moyne; Hôpital Fleurimont; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Melphalan; Multiple myeloma; Internal medicine; Fludarabine; Surgery; Bortezomib; Transplantation; Cyclophosphamide; Graft-versus-host disease; Oncology; Gastroenterology; Chemotherapy","score_opus":0.03943246113642086,"score_gpt":0.28376938112596095,"score_spread":0.2443369199895401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564171273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99314785,0.00033706412,0.0007663084,0.001201077,0.00019984179,0.0029760792,0.00067592255,0.00017702028,0.00051884097],"genre_scores_gemma":[0.9907927,0.00015741584,0.0061206985,0.0004947953,0.00017572436,0.00060080015,0.0008527302,0.00008620886,0.0007189398],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99547756,0.00031035024,0.00086537877,0.0010838518,0.0009254844,0.0013373978],"domain_scores_gemma":[0.997409,0.00052002433,0.00011345671,0.0005719022,0.00020537333,0.0011802762],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040181793,0.0006298412,0.0011695417,0.00051707984,0.0002624429,0.000030622046,0.00041038214,0.00028505744,0.0003454534],"category_scores_gemma":[0.0002132021,0.0005663636,0.0003449639,0.0005105213,0.0001758279,0.000121281606,0.000074342344,0.00043893888,0.00023900604],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040207403,0.0031659515,0.87521344,0.000083151856,0.0007952827,0.006134716,0.0036154573,0.00015107717,0.105195954,0.000021730215,0.00023692488,0.0013655768],"study_design_scores_gemma":[0.035033517,0.0014938832,0.9252909,0.00025510482,0.00025101606,0.0005013222,0.0001355821,0.00074334105,0.034850363,0.000018086033,0.000833828,0.00059306825],"about_ca_topic_score_codex":0.0011581097,"about_ca_topic_score_gemma":0.006469714,"teacher_disagreement_score":0.07034559,"about_ca_system_score_codex":0.00022360448,"about_ca_system_score_gemma":0.00051499694,"threshold_uncertainty_score":0.9996788},"labels":[],"label_agreement":null},{"id":"W2564173457","doi":"10.1182/blood.v116.21.4194.4194","title":"Functional Role of BAALC In Leukemogenesis","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Bone marrow; Biology; Myeloid; Cancer research; Transplantation; Haematopoiesis; Retinoic acid; Leukemia; Myeloid leukemia; Immunology; Molecular biology; Stem cell; Cell culture; Cell biology; Medicine; Genetics; Internal medicine","score_opus":0.012358175209991905,"score_gpt":0.2550206340140814,"score_spread":0.24266245880408951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564173457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98823905,0.00012134062,0.000006437509,0.0002876747,0.000052917407,0.00013230996,0.0000047141493,0.000018031795,0.011137496],"genre_scores_gemma":[0.99765676,0.000012870287,0.0010890748,0.000073177725,0.00017781703,0.000015052516,0.000012108107,0.000013783923,0.00094934966],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9992686,0.0000148647905,0.00015451854,0.00014158592,0.0002469296,0.0001734889],"domain_scores_gemma":[0.99951965,0.000055847177,0.000026193806,0.00023981044,0.00007701323,0.00008148499],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001904124,0.00006417455,0.00015356747,0.00015527432,0.000015279238,0.0000029932285,0.000071606904,0.00009324472,0.0007408382],"category_scores_gemma":[0.0001547446,0.0000562136,0.000051327577,0.00022037154,0.000058890215,0.000031589512,0.000042922624,0.00028056538,0.000099790486],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008437441,0.0003704528,0.20304182,0.000024068291,0.000036321304,0.000027136051,0.000051675044,0.0000012807589,0.79216194,0.00046086634,0.00046272037,0.003277328],"study_design_scores_gemma":[0.0041480702,0.000102129314,0.5813101,0.000015162942,0.00004456169,0.00011585006,0.00007694695,0.00010563972,0.40987533,0.0001779473,0.00396451,0.000063772495],"about_ca_topic_score_codex":0.00014246804,"about_ca_topic_score_gemma":0.00008052361,"teacher_disagreement_score":0.3822866,"about_ca_system_score_codex":0.000028336706,"about_ca_system_score_gemma":0.00033271,"threshold_uncertainty_score":0.8111658},"labels":[],"label_agreement":null},{"id":"W2564174607","doi":"10.1182/blood.v104.11.4622.4622","title":"High Dose Celecoxib and Metronomic ‘Low-Dose’ Cyclophosphamide Is Effective Therapy in Patients with Relapsed and Refractory Aggressive Histology NHL.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Chemotherapy; Cyclophosphamide; Gastroenterology; Chemotherapy regimen; Oncology","score_opus":0.002706982460976538,"score_gpt":0.1986527501397365,"score_spread":0.19594576767875996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564174607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887405,0.01071799,0.000010144802,0.00004511269,0.00006910547,0.00034484692,0.000020615062,0.0000061904652,0.000045512505],"genre_scores_gemma":[0.997292,0.0018904837,0.0002945863,0.000301219,0.00005658758,0.00006642254,0.000039282662,0.000026483993,0.000032929893],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991222,0.00004220527,0.00014381035,0.00041652718,0.00006430887,0.00021096013],"domain_scores_gemma":[0.9995361,0.000016184533,0.00014233767,0.00019797434,0.00004332934,0.00006405962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000579308,0.0001827336,0.00021326114,0.00004916217,0.00005453585,0.000010175555,0.00007197394,0.00016185021,0.000008579135],"category_scores_gemma":[0.000016707172,0.00015004505,0.000044222794,0.00005749602,0.00012209518,0.0000061921096,0.000046347242,0.00008002627,0.0000016575467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032608996,0.0017929736,0.8808927,0.00005080937,0.0007694827,0.000042003394,0.0005111432,0.00006351865,0.084219016,0.00006550764,0.00022998694,0.02810194],"study_design_scores_gemma":[0.017671507,0.0022694669,0.85455024,0.000042522224,0.00005248615,0.0000068997633,0.00002116425,5.0111595e-7,0.12385474,0.00007144625,0.0011684169,0.00029058452],"about_ca_topic_score_codex":0.0001451798,"about_ca_topic_score_gemma":0.00005656747,"teacher_disagreement_score":0.03963572,"about_ca_system_score_codex":0.000036541966,"about_ca_system_score_gemma":0.000058638212,"threshold_uncertainty_score":0.61186594},"labels":[],"label_agreement":null},{"id":"W2564227909","doi":"10.1182/blood.v124.21.722.722","title":"Interim Analysis of the Mmrf Commpass Trial: Identification of Novel Rearrangements Potentially Associated with Disease Initiation and Progression","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Multiple myeloma; Interim analysis; Exome; Medicine; Clinical trial; Oncology; Exome sequencing; Cancer research; Internal medicine; Biology; Genetics; Gene; Phenotype","score_opus":0.037333814764416856,"score_gpt":0.3341505778331718,"score_spread":0.29681676306875493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564227909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99861497,0.000031911237,0.0004143704,0.00016260736,0.000017839953,0.0006192358,0.00004258615,0.000009060942,0.000087437875],"genre_scores_gemma":[0.9995798,0.000009049472,0.00010879937,0.000011892462,0.000010182722,0.00003363766,0.00019393806,0.0000068235,0.000045897814],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99906325,0.000104422346,0.0002420308,0.00012670949,0.00037795963,0.000085652384],"domain_scores_gemma":[0.99915266,0.000053835436,0.00028885243,0.00024821892,0.00018463022,0.000071783084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028757105,0.00006456961,0.00020448158,0.00013192951,0.000042478558,0.000011156569,0.000057439796,0.000028095958,0.000008497567],"category_scores_gemma":[0.0005040936,0.000037978363,0.000068816866,0.00036887208,0.000065390464,0.000044566736,0.000034848043,0.00004376957,2.7035435e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008618059,0.0060834526,0.9393157,0.00011731129,0.0039052018,0.000003116331,0.00020268591,0.0000103619195,0.037524134,0.000042407675,0.00001151055,0.0041660722],"study_design_scores_gemma":[0.03649705,0.00040737638,0.9511363,0.00018295091,0.0032721716,3.4474564e-7,0.000018012068,0.002201353,0.0062418487,0.000006199882,0.000003682421,0.00003273118],"about_ca_topic_score_codex":0.000030949763,"about_ca_topic_score_gemma":0.000037134807,"teacher_disagreement_score":0.031282283,"about_ca_system_score_codex":0.000013712031,"about_ca_system_score_gemma":0.000037091817,"threshold_uncertainty_score":0.15487127},"labels":[],"label_agreement":null},{"id":"W2564263166","doi":"10.1182/blood.v114.22.2522.2522","title":"Estimating the Replication Rate of Hematopoietic Stem Cells (HSC) In Vivo.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Biology; Stem cell; Haematopoiesis; Transplantation; In vivo; Phenotype; Genetics; Immunology; Andrology; Internal medicine; Gene; Medicine","score_opus":0.017904268821280777,"score_gpt":0.2672023612650073,"score_spread":0.24929809244372653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564263166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939772,0.000106897285,0.0013482785,0.00080324727,0.00004544517,0.0004946303,0.0000023922905,0.000038052167,0.0031838755],"genre_scores_gemma":[0.99667126,0.00001267575,0.0028407038,0.0002089327,0.000035461337,0.000015212247,0.0000030659364,0.000010327674,0.00020237232],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990423,0.0000598529,0.00039647013,0.0002067386,0.00015060787,0.00014403886],"domain_scores_gemma":[0.99914956,0.00013391257,0.00012947893,0.00049949216,0.000047352478,0.00004022898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005105118,0.00009337246,0.0002128205,0.00005899047,0.000027602133,0.0000074561276,0.000086773274,0.000056892128,0.000026716212],"category_scores_gemma":[0.000025458627,0.000068406865,0.00004708472,0.00023029123,0.00002709299,0.000035772366,0.000005374394,0.000100177036,0.000015376054],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059719627,0.0007437296,0.0070833485,0.0006438972,0.000034103286,0.00004860296,0.0042521856,0.00022530912,0.9826876,0.0014235359,0.000109834895,0.0026881543],"study_design_scores_gemma":[0.0019099996,0.00014335585,0.0103831515,0.00049854955,0.00014314454,0.00012479181,0.00019522097,0.0016501942,0.9843966,0.00043583228,0.00003811768,0.00008106656],"about_ca_topic_score_codex":0.000012656261,"about_ca_topic_score_gemma":0.0000025091324,"teacher_disagreement_score":0.0040569645,"about_ca_system_score_codex":0.000013233835,"about_ca_system_score_gemma":0.000044468183,"threshold_uncertainty_score":0.2789551},"labels":[],"label_agreement":null},{"id":"W2564282668","doi":"10.1182/blood.v116.21.1222.1222","title":"The BCR-ABL1-Regulated hnRNP A1, hnRNP E2, and hnRNP K Are Differentially Expressed Between CD34+ and CD34+/CD38- Ph+ Cells, and After Blastic Transformation of CML.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"CD38; Chronic myelogenous leukemia; Biology; Molecular biology; Myeloid; Leukemia; breakpoint cluster region; K562 cells; Myeloid leukemia; Progenitor cell; CD34; Cancer research; Stem cell; Immunology; Cell biology; Genetics; Receptor","score_opus":0.006312495415965988,"score_gpt":0.2107061530749103,"score_spread":0.20439365765894432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564282668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99715513,0.0010023421,0.000057820238,0.000410055,0.00012902716,0.00083222776,0.00015370574,0.00006084111,0.0001988264],"genre_scores_gemma":[0.9986375,0.00047993436,0.00021820297,0.000036690148,0.00017115212,0.000055596465,0.000074915864,0.00004623284,0.0002797583],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99826264,0.000066346736,0.00050191977,0.00041131314,0.00036359162,0.00039418906],"domain_scores_gemma":[0.9987309,0.00025192826,0.00020355775,0.0004599338,0.000102494814,0.00025118864],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016627082,0.00035278936,0.0005429525,0.000106960004,0.00017264753,0.0000735464,0.000111784226,0.00025754073,0.0000679486],"category_scores_gemma":[0.00006045398,0.00024732773,0.000076902004,0.00012516206,0.00031729482,0.00016080814,0.00007571105,0.0003569435,0.000006508977],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014800044,0.0016397136,0.21270862,0.0023162933,0.0022191165,0.00013573507,0.0065268488,0.000002745583,0.7376397,0.00012757801,0.00043982905,0.034763806],"study_design_scores_gemma":[0.023363601,0.0006625667,0.7526114,0.00053245533,0.0026678836,0.00010353368,0.0003260196,0.00037292027,0.2168197,0.00030277763,0.0017845326,0.0004526098],"about_ca_topic_score_codex":0.000073399766,"about_ca_topic_score_gemma":0.00017020965,"teacher_disagreement_score":0.53990275,"about_ca_system_score_codex":0.00003665309,"about_ca_system_score_gemma":0.00010213481,"threshold_uncertainty_score":0.9999979},"labels":[],"label_agreement":null},{"id":"W2564295907","doi":"10.1182/blood.v116.21.1072.1072","title":"High Mortality In Extreme Hyperleukocytosis In Pediatric Acute Myeloid Leukemia: A Report From the Children's Oncology Group.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hematological disorders and diagnostics","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Hospital for Sick Children","funders":"","keywords":"Medicine; Internal medicine; Cytarabine; Induction chemotherapy; Gemtuzumab ozogamicin; Tumor lysis syndrome; Leukostasis; Common Terminology Criteria for Adverse Events; Idarubicin; White blood cell; Chemotherapy regimen; Myeloid leukemia; Leukemia; Oncology; Adverse effect; Chemotherapy","score_opus":0.027796858052210088,"score_gpt":0.2691828491778095,"score_spread":0.24138599112559941,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564295907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962486,0.00038875273,0.000012085104,0.0012895325,0.00020666592,0.00048102342,0.000025984558,0.000050312796,0.0012970391],"genre_scores_gemma":[0.9967544,0.0007006803,0.00097407633,0.00094690046,0.0003595194,0.0000789184,0.00014795602,0.000017633993,0.000019918425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983522,0.00007444006,0.00055545307,0.00042433926,0.00024269368,0.00035085971],"domain_scores_gemma":[0.9985816,0.0005728644,0.00013721212,0.00053982,0.000036033776,0.00013247505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003684936,0.00018712506,0.0005304411,0.000077744844,0.000044146123,0.000014368039,0.00018883037,0.00038676144,0.00015818418],"category_scores_gemma":[0.0013629164,0.00012374177,0.00010007883,0.000377929,0.00009237849,0.000047179426,0.000101541904,0.00087247894,0.000035389236],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041393185,0.0013069218,0.9936471,0.000007904385,0.000053660893,0.0028575838,0.00008264558,8.3148376e-7,0.0005950809,0.00029690587,0.0005372953,0.0005726845],"study_design_scores_gemma":[0.004146798,0.00017580723,0.99268925,0.0000117372765,0.00045173048,0.00038621548,0.000037010377,0.000008486918,0.00027427805,0.0013965301,0.00027895623,0.00014321008],"about_ca_topic_score_codex":0.0042230953,"about_ca_topic_score_gemma":0.005868785,"teacher_disagreement_score":0.004105405,"about_ca_system_score_codex":0.000052991556,"about_ca_system_score_gemma":0.0002619868,"threshold_uncertainty_score":0.6384085},"labels":[],"label_agreement":null},{"id":"W2564300256","doi":"10.1182/blood.v116.21.1497.1497","title":"A Systematic Review of Diagnostic Features and Treatment Outcomes In Hemophagocytic Syndromes In the Adult Population","year":2010,"lang":"en","type":"review","venue":"Blood","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; Macrophage activation syndrome; Population; Immunosuppression; Pediatrics; MEDLINE; Hemophagocytosis; Hemophagocytic lymphohistiocytosis; Lymphoma; Intensive care medicine; Internal medicine; Disease","score_opus":0.025588779737804438,"score_gpt":0.34350778529260134,"score_spread":0.3179190055547969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564300256","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031376944,0.9911388,3.5226552e-8,0.00009884874,0.000020563855,0.005479751,0.000009806275,0.000008102203,0.00010639213],"genre_scores_gemma":[0.0011073444,0.9975054,0.000011071801,0.00007049749,0.000010365881,0.0010470451,0.00008626058,0.000023822256,0.00013816521],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99775887,0.00039722142,0.0011023614,0.00022246875,0.0003266874,0.00019241194],"domain_scores_gemma":[0.99764663,0.0013554645,0.00035744687,0.0005641653,0.000041775973,0.000034527824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005523634,0.00029534978,0.0034014008,0.00026519556,0.000022080498,0.000013414984,0.00015850965,0.00020312036,0.000011312886],"category_scores_gemma":[0.0036700882,0.00014374104,0.0002999862,0.00031230698,0.00004205218,0.000037004444,0.00003077433,0.00038740915,0.000009112644],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000014619574,0.0004498236,0.0022283732,0.973526,0.00016783422,0.00014698734,0.00010871717,6.345852e-9,5.6129007e-8,0.000047410893,0.000007572398,0.023315752],"study_design_scores_gemma":[0.0013286315,0.00023598761,0.009279905,0.9828422,0.0039634877,0.0006369584,0.00006271741,4.4885454e-7,3.2986563e-7,0.000012287869,0.0014885615,0.00014849048],"about_ca_topic_score_codex":0.00017907907,"about_ca_topic_score_gemma":0.000115746785,"teacher_disagreement_score":0.023167262,"about_ca_system_score_codex":0.000059032704,"about_ca_system_score_gemma":0.00017667515,"threshold_uncertainty_score":0.58615893},"labels":[],"label_agreement":null},{"id":"W2564321532","doi":"10.1182/blood.v114.22.4022.4022","title":"Procoagulant Platelet Subpopulation Formation in Whole Blood: Correlation with Whole Blood Clotting Time and 5-Year Mean Bleeding Score in Individuals with Factor VIII Deficiency.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Prothrombinase; Platelet; Hemostasis; Whole blood; Tissue factor; Coagulation; Thrombin; Medicine; Factor V; Bleeding time; Internal medicine; Clotting time; Partial thromboplastin time; Thrombosis; Immunology; Gastroenterology","score_opus":0.0205314536192857,"score_gpt":0.25839346453775003,"score_spread":0.23786201091846432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564321532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977052,0.00017175994,0.000019532976,0.00034380626,0.000007448771,0.0012430542,0.00001346495,0.000061000013,0.0004347035],"genre_scores_gemma":[0.9984966,0.000016725124,0.0009660248,0.0000236115,0.00004908118,0.000025494524,0.0002469925,0.000022461729,0.00015298864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832934,0.000049084054,0.00035847482,0.00033512132,0.0005233412,0.00040463562],"domain_scores_gemma":[0.99947244,0.000046022815,0.0001367025,0.00015603867,0.00007463573,0.00011413164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031954222,0.00021295543,0.000322187,0.0004556069,0.000115682175,0.00006508417,0.00006049484,0.00014311138,0.000012096439],"category_scores_gemma":[0.000045266253,0.00015162631,0.000023198616,0.0005800461,0.0000424167,0.00045830506,0.000020605707,0.00029264812,0.000015091709],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014054727,0.0010497556,0.9691894,0.00009806429,0.00004562297,0.00015106474,0.0030455296,0.00014480873,0.02447821,0.00002778035,0.0000041108174,0.0016250846],"study_design_scores_gemma":[0.018865507,0.002729964,0.9393341,0.0013395469,0.00029617068,0.00048740918,0.0005375884,0.0026917823,0.033324167,0.000065627275,0.000014934986,0.0003132097],"about_ca_topic_score_codex":0.00006250753,"about_ca_topic_score_gemma":0.00017444609,"teacher_disagreement_score":0.02985533,"about_ca_system_score_codex":0.00004706889,"about_ca_system_score_gemma":0.00007295712,"threshold_uncertainty_score":0.61831415},"labels":[],"label_agreement":null},{"id":"W2564322603","doi":"10.1182/blood.v104.11.3991.3991","title":"Novel and Clinically Significant Factors Influencing the Pharmacokinetic Variability of Recombinant Factor VIII (Kogenate-FS) in Children.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Hospital for Sick Children","funders":"","keywords":"Pharmacokinetics; Medicine; Dosing; Haemophilia; Factor IX; Clotting factor; Internal medicine; Pharmacology; Gastroenterology; Pediatrics","score_opus":0.030631561005028504,"score_gpt":0.31353483575946284,"score_spread":0.28290327475443433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564322603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984251,0.00009162096,0.00001147643,0.00046797033,0.00005362315,0.0007777691,0.000016872023,0.000019008115,0.00013652013],"genre_scores_gemma":[0.99946284,0.00017422046,0.00021489413,0.000045250596,0.000035280358,0.000013556177,0.000008514897,0.000014684129,0.0000307344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99860406,0.00007308717,0.00047168502,0.00029391688,0.00027677952,0.000280452],"domain_scores_gemma":[0.99914986,0.00026716312,0.00008526489,0.00028886105,0.00006729477,0.00014154153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005265152,0.0001545899,0.00033504967,0.00008802776,0.000053459964,0.000010321685,0.00012206147,0.00009743428,0.000048675298],"category_scores_gemma":[0.00035554206,0.000085646585,0.000085924046,0.00023246036,0.00017949416,0.000039951636,0.00007032242,0.00032030506,0.00000374025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000723056,0.0020116286,0.8937381,0.00004576197,0.00013538478,0.000009927592,0.0005688977,0.000004935936,0.10266252,0.000029476476,0.0000011430849,0.00071992114],"study_design_scores_gemma":[0.008213944,0.00047500618,0.9357177,0.000083974184,0.00013313991,0.000019085503,0.0000834301,0.000008790768,0.055027287,0.00014043752,0.00000803899,0.0000891512],"about_ca_topic_score_codex":0.0003563656,"about_ca_topic_score_gemma":0.0000059600234,"teacher_disagreement_score":0.047635227,"about_ca_system_score_codex":0.00004608037,"about_ca_system_score_gemma":0.00019861555,"threshold_uncertainty_score":0.34925663},"labels":[],"label_agreement":null},{"id":"W2564332170","doi":"10.1182/blood.v126.23.3569.3569","title":"Post-Transfusion Fevers and Post-Reaction Culture Practices at a Large Academic Hospital Transfusion Service: Quality of Information and Calculated Bacterial Contamination Event Rates","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Canadian Blood Services; University of Toronto; Health Sciences Centre; University Health Network","funders":"","keywords":"Medicine; Cryoprecipitate; Blood product; Transfusion medicine; Adverse effect; Emergency medicine; Blood transfusion; Fresh frozen plasma; Intensive care medicine; Medical emergency; Pediatrics; Surgery; Internal medicine; Platelet","score_opus":0.01525293403027113,"score_gpt":0.3003840394659869,"score_spread":0.2851311054357158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564332170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99405456,0.0002699272,0.00011964331,0.003739077,0.00021738156,0.0012649075,0.00008335474,0.000063766434,0.00018740159],"genre_scores_gemma":[0.9967612,0.0016958755,0.00013805486,0.0005238547,0.000051231164,0.000021565567,0.0007209693,0.0000118551825,0.00007538482],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99853647,0.00012185298,0.0005070618,0.00023095125,0.0004244166,0.00017924965],"domain_scores_gemma":[0.99869865,0.000037820628,0.0003853535,0.00013849647,0.00054893596,0.00019074301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068149035,0.00018769242,0.00029946407,0.000133432,0.000108404565,0.000024095352,0.000047691043,0.00027373302,0.000030951425],"category_scores_gemma":[0.00019262404,0.00015657267,0.00005485682,0.00018274294,0.00003458345,0.00087329367,0.000043270113,0.00024146143,0.000006055363],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033176807,0.0012104429,0.03656152,0.0010728582,0.00025405077,0.0000063233406,0.02907085,0.0000010597441,0.92359686,0.0002231523,0.00008302283,0.0046021636],"study_design_scores_gemma":[0.034150176,0.0021593715,0.8837837,0.00029631553,0.0012807414,0.00010676555,0.0121099,0.00021166964,0.058466323,0.000020377824,0.0070412504,0.00037340465],"about_ca_topic_score_codex":0.0013904008,"about_ca_topic_score_gemma":0.0006727425,"teacher_disagreement_score":0.86513054,"about_ca_system_score_codex":0.00004708389,"about_ca_system_score_gemma":0.000070566355,"threshold_uncertainty_score":0.63848484},"labels":[],"label_agreement":null},{"id":"W2564348684","doi":"10.1182/blood.v116.21.3798.3798","title":"ESAS (Edmonton Symptom Assessment System) as An Effective Outpatient Serial-Longitudinal Symptom Assessment Tool In Patients with Sickle Cell Disease.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Palliative care; Disease; Outpatient clinic; Population; Disease management; Quality of life (healthcare); Sickle cell anemia; Physical therapy; Pediatrics; Internal medicine","score_opus":0.0023922893689289743,"score_gpt":0.2285258411792198,"score_spread":0.22613355181029085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564348684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99118054,0.00006592064,0.000034619345,0.00009205872,0.00065745594,0.0031093217,0.00004832097,0.00016293698,0.0046488326],"genre_scores_gemma":[0.9983406,0.0000110092715,0.0005868843,0.00008283815,0.0001428471,0.00035813384,0.00028495822,0.00007731352,0.00011541246],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969687,0.00018659518,0.0005412593,0.00078093424,0.0008953614,0.0006271627],"domain_scores_gemma":[0.9981958,0.00007466351,0.00023803613,0.0007734208,0.00025226,0.00046577028],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035489994,0.00046860965,0.0006288295,0.00019551565,0.00018044154,0.00008026092,0.0001854242,0.00028199577,0.00009323828],"category_scores_gemma":[0.00003747568,0.00035181025,0.0001356474,0.0003034105,0.00009715203,0.00024605522,0.00009496891,0.00081840437,0.000040400246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065147306,0.009347325,0.9861704,0.00046747798,0.00022180597,0.00020638178,0.0003609101,0.000074251584,0.00092449225,0.0006310141,0.000030849387,0.0009135789],"study_design_scores_gemma":[0.018467192,0.0043649245,0.9737489,0.00053032435,0.00083845377,0.00001354064,0.0004834231,0.0003630913,0.0005600496,0.000022686574,0.00013468276,0.00047271233],"about_ca_topic_score_codex":0.0003505714,"about_ca_topic_score_gemma":0.00010243816,"teacher_disagreement_score":0.017815718,"about_ca_system_score_codex":0.00028527126,"about_ca_system_score_gemma":0.00045634332,"threshold_uncertainty_score":0.99989337},"labels":[],"label_agreement":null},{"id":"W2564349576","doi":"10.1182/blood.v108.11.4224.4224","title":"PBI-1402: A Non-Toxic Immunorestorative Small Molecule for the Treatment of Anemia.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Erythropoiesis; Bone marrow; Haematopoiesis; Anemia; Hemoglobin; Progenitor cell; Cancer research; Phenylhydrazine; In vivo; Red blood cell; Immunology; Medicine; Stem cell; Biology; Chemistry; Internal medicine; Cell biology","score_opus":0.017822170160266035,"score_gpt":0.2518601265158894,"score_spread":0.23403795635562336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564349576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994372,0.0018470456,0.00063276256,0.00023922622,0.00012975404,0.0006053488,0.000020208172,0.000021565565,0.0021321012],"genre_scores_gemma":[0.9958588,0.00019573732,0.0008233841,0.00016273314,0.00030259733,0.00014047074,0.0000554627,0.000014811222,0.002445986],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995312,0.000016322007,0.00014754021,0.0001265668,0.000052616306,0.00012576315],"domain_scores_gemma":[0.99950635,0.000111028145,0.00006690653,0.00022342865,0.00006801911,0.00002426867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000025868783,0.00009806257,0.00019554552,0.000031276657,0.00005512489,0.000002839382,0.000038321934,0.000059633276,0.00003958446],"category_scores_gemma":[0.000011365155,0.000058330606,0.00012178144,0.000076891854,0.00006235907,0.000009232345,0.000005536995,0.000036529193,0.000014618205],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019456329,0.007138064,0.006683268,0.0001255798,0.0006546663,0.000050367606,0.0013362789,0.000052777872,0.9747376,0.0007909683,0.0033031232,0.0031816778],"study_design_scores_gemma":[0.020220445,0.0128263915,0.13030273,0.000054272867,0.0017273945,0.00009198156,0.00040713453,0.000285124,0.80894256,0.00025719992,0.02465999,0.00022479924],"about_ca_topic_score_codex":0.00012443024,"about_ca_topic_score_gemma":0.00005602866,"teacher_disagreement_score":0.16579506,"about_ca_system_score_codex":0.000018519593,"about_ca_system_score_gemma":0.00005806334,"threshold_uncertainty_score":0.23786531},"labels":[],"label_agreement":null},{"id":"W2564377031","doi":"10.1182/blood.v110.11.5178.5178","title":"Medical Costs of Adverse Events in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors: Canadian Perspective.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Nilotinib; Dasatinib; Medicine; Imatinib; Myeloid leukemia; Internal medicine; Adverse effect; Context (archaeology); Chronic myelogenous leukemia; Imatinib mesylate; Oncology; Leukemia","score_opus":0.006123493295899442,"score_gpt":0.23869893077015675,"score_spread":0.2325754374742573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564377031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950815,0.0004462048,0.0000027538917,0.000108513705,0.00006568501,0.0009022974,0.000036607555,0.00004424629,0.0033121842],"genre_scores_gemma":[0.9991414,0.000053914846,0.00010591855,0.00010824194,0.00016489258,0.000024814564,0.0001680932,0.000056436988,0.00017630651],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99737465,0.000050714723,0.0005225503,0.00048613286,0.0008319928,0.0007339401],"domain_scores_gemma":[0.99823046,0.00007177451,0.00015340482,0.00044090184,0.00026390696,0.0008395531],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030058774,0.00032723037,0.0005102283,0.00052345387,0.000054116783,0.0000015454099,0.00015499123,0.00028179117,0.0002854657],"category_scores_gemma":[0.00025783925,0.00027215978,0.000093070965,0.00072770746,0.00014704294,0.00009839961,0.00004182902,0.00038075921,0.000045199453],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00048384344,0.001364839,0.99369663,0.000068565445,0.00025877715,0.0013988748,0.0003610025,0.000006857819,0.00087945163,0.00007108913,0.000075652715,0.0013344458],"study_design_scores_gemma":[0.048443917,0.0019238783,0.9226435,0.0015305524,0.00033407385,0.00012113217,0.00033403633,0.000045797256,0.024120726,0.0000067525607,0.00018398855,0.00031164198],"about_ca_topic_score_codex":0.25468963,"about_ca_topic_score_gemma":0.38969514,"teacher_disagreement_score":0.13500549,"about_ca_system_score_codex":0.018332817,"about_ca_system_score_gemma":0.0063687167,"threshold_uncertainty_score":0.99997306},"labels":[],"label_agreement":null},{"id":"W2564408894","doi":"10.1182/blood.v104.11.2064.2064","title":"A Role for IL-1Receptor Antagonist in the Acute Therapeutic Effects of IVIg?.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; St. Michael's Hospital","funders":"","keywords":"Receptor antagonist; Interleukin 1 receptor antagonist; Medicine; Antibody; Antagonist; Nitric oxide; Immunology; Pharmacology; Platelet; Receptor; Interleukin; Internal medicine; Cytokine","score_opus":0.007883566099320373,"score_gpt":0.2593651069402368,"score_spread":0.2514815408409164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564408894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99420005,0.0008526953,0.00013795537,0.0018922128,0.000082181716,0.0015564288,0.000009367786,0.000021041044,0.0012480695],"genre_scores_gemma":[0.9976032,0.00024372058,0.0003488258,0.0013840554,0.00009238737,0.00025925363,0.000011032321,0.000015360487,0.000042202646],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993619,0.00001998294,0.00014966856,0.00013780258,0.00014241146,0.00018828058],"domain_scores_gemma":[0.9995891,0.00007974587,0.00004881665,0.0002310295,0.00002245398,0.000028842791],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014894632,0.00009517314,0.0002731077,0.00005114806,0.00003945728,0.000011007283,0.000113870796,0.000040408187,0.000008804209],"category_scores_gemma":[0.000020366835,0.00006183087,0.0000964579,0.000119765326,0.00003496136,0.000024398238,0.000019487285,0.000064414286,0.000008823349],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074445835,0.07059658,0.018561302,0.005376979,0.006459677,0.00037605542,0.03248796,0.00009884165,0.7098436,0.09131421,0.005120889,0.059019487],"study_design_scores_gemma":[0.036666762,0.006442569,0.4177579,0.0008139568,0.0050337794,0.000059573413,0.001505704,0.000024004012,0.49533686,0.008165541,0.027763482,0.00042988476],"about_ca_topic_score_codex":0.000067913796,"about_ca_topic_score_gemma":0.000028786786,"teacher_disagreement_score":0.3991966,"about_ca_system_score_codex":0.000016250202,"about_ca_system_score_gemma":0.000038115755,"threshold_uncertainty_score":0.25213897},"labels":[],"label_agreement":null},{"id":"W2564417513","doi":"10.1182/blood.v112.11.2460.2460","title":"New Candidate Regulators of Hematopoietic Stem Cells Identified from Transcriptional Comparisons of Highly Purified Populations of Longterm Repopulating Cells with Markedly Different in Vivo Self-Renewal Activities","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada; Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"","keywords":"Biology; Haematopoiesis; Stem cell; In vivo; BMI1; Bone marrow; Immunology; Molecular biology; Cell biology; Cancer research; Genetics","score_opus":0.02257887963297128,"score_gpt":0.23504879423227829,"score_spread":0.212469914599307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564417513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972886,0.00012067764,0.0013825643,0.000026783237,0.00013600368,0.0005940884,0.00017592963,0.000041434832,0.00023393251],"genre_scores_gemma":[0.9926406,0.000029951274,0.0069141686,0.0000044225358,0.00003345718,0.000014274892,0.0000725459,0.00003783498,0.000252722],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974059,0.00011161037,0.0012101444,0.00035101734,0.0006731525,0.00024820925],"domain_scores_gemma":[0.9985814,0.00016752994,0.0005935494,0.00043146592,0.00008437849,0.00014164689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011874065,0.00026875563,0.00093631056,0.00028109463,0.00005047186,0.0000070919127,0.0001247359,0.00014242009,0.00010754339],"category_scores_gemma":[0.0000036936333,0.00023979029,0.00016022699,0.00028957918,0.00010574379,0.00010117753,0.000014474322,0.00015096547,7.753313e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037804845,0.000961885,0.33328754,0.00083482056,0.00026309112,0.00004788241,0.005771868,0.00018333443,0.6580117,0.00020450335,0.000041789204,0.000013539777],"study_design_scores_gemma":[0.004777176,0.0001628907,0.18230751,0.0009692654,0.00063761545,0.00007047117,0.00070000615,0.00009816269,0.81005806,0.000049835588,0.0000015653815,0.00016743153],"about_ca_topic_score_codex":0.0021235968,"about_ca_topic_score_gemma":0.0008064547,"teacher_disagreement_score":0.15204637,"about_ca_system_score_codex":0.00004339265,"about_ca_system_score_gemma":0.00020026989,"threshold_uncertainty_score":0.97783643},"labels":[],"label_agreement":null},{"id":"W2564425494","doi":"10.1182/blood.v124.21.1311.1311","title":"Quality of Care in Blood and Marrow Transplantation – a Systematic Review in Order to Define a Quality Framework and Develop Quality Indicators","year":2014,"lang":"en","type":"review","venue":"Blood","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Leukemia & Lymphoma Society of Canada; Princess Margaret Cancer Centre","funders":"","keywords":"Accreditation; Medicine; Quality management; Quality assurance; Benchmarking; Quality (philosophy); Health care; CINAHL; Delphi method; Process management; Nursing; Operations management; Medical education; Computer science; Psychological intervention; Business; External quality assessment; Management system; Engineering; Pathology","score_opus":0.18659856349308745,"score_gpt":0.5256591068022932,"score_spread":0.33906054330920576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564425494","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02261789,0.97050875,0.00026328972,0.00033977992,0.00004473454,0.005984362,0.00017794936,0.000023567884,0.000039687613],"genre_scores_gemma":[0.0063086525,0.98525715,0.0065481,0.0007909775,0.000039417086,0.0005016768,0.00050352514,0.000045700723,0.0000048158067],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9873499,0.004047905,0.006906599,0.0007431312,0.0006564235,0.00029600813],"domain_scores_gemma":[0.9893434,0.0066523175,0.0025622924,0.0007326633,0.00048393937,0.00022537327],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.011615576,0.00047508214,0.0057151816,0.00045837776,0.000029771858,0.00001927162,0.00016455281,0.00048909656,0.000022219849],"category_scores_gemma":[0.0556611,0.0003922113,0.00016785272,0.0022167019,0.00006761093,0.000089644156,0.00008173682,0.0007377885,0.0000054776415],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006828544,0.00035425866,0.010703749,0.95258695,0.00020344346,0.000012659915,0.0007319894,3.16657e-8,0.0000014283396,0.0002471572,0.0000040770274,0.035085987],"study_design_scores_gemma":[0.0049324296,0.00037361222,0.01859898,0.96021813,0.012480729,0.00012579371,0.0005021702,2.0010621e-7,0.0000041533144,0.000094829855,0.0019777536,0.0006912129],"about_ca_topic_score_codex":0.00088164915,"about_ca_topic_score_gemma":0.003112675,"teacher_disagreement_score":0.044045523,"about_ca_system_score_codex":0.00008438667,"about_ca_system_score_gemma":0.0007626702,"threshold_uncertainty_score":0.99985296},"labels":[],"label_agreement":null},{"id":"W2564476146","doi":"10.1182/blood.v114.22.4190.4190","title":"A Canadian Prospective, Observational, Open-Label, Pharmacovigilance Study to Assess the Safety of Humate-P® Injection Volume Reduced (ivr) in Patients with Von Willebrand Disease.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Regina General Hospital; Hospital for Sick Children","funders":"","keywords":"Medicine; Tolerability; Adverse effect; Prospective cohort study; Internal medicine; Pediatrics; Surgery","score_opus":0.05509037381173904,"score_gpt":0.3438312259799218,"score_spread":0.28874085216818274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564476146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939166,0.00003506921,7.431459e-7,0.0017654446,0.000027954844,0.0035379143,0.000037968937,0.000012231344,0.00066611404],"genre_scores_gemma":[0.9988058,0.000006580555,0.00006626221,0.00021180006,0.000034873323,0.00010486941,0.00006116676,0.000012484731,0.00069613225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880296,0.00007976319,0.00021196109,0.00026544876,0.00039713387,0.00024272042],"domain_scores_gemma":[0.9992171,0.000024596515,0.00004923613,0.00024642688,0.00022602291,0.00023663088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002343951,0.00012344979,0.00022592781,0.00013890381,0.00014540553,0.000033440814,0.00017045335,0.000023425357,0.00004298071],"category_scores_gemma":[0.00007126089,0.00007727107,0.000014964468,0.0005884749,0.000024419307,0.00014173274,0.000030224177,0.0001348446,0.0000065762297],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015571786,0.005132672,0.9918267,0.000016146198,0.00009857051,0.000023968865,0.00043140393,0.000015095501,0.00032684783,0.000018037352,0.00024058367,0.0003127803],"study_design_scores_gemma":[0.011321815,0.0023362099,0.9854494,0.00010628351,0.00010370479,9.668596e-7,0.00009833585,0.000019778488,0.00036618672,0.000019187566,0.00008896662,0.00008918677],"about_ca_topic_score_codex":0.0020262094,"about_ca_topic_score_gemma":0.0029027115,"teacher_disagreement_score":0.009764637,"about_ca_system_score_codex":0.00020423146,"about_ca_system_score_gemma":0.00052609656,"threshold_uncertainty_score":0.31510228},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W2564480549","doi":"10.1182/blood.v112.11.804.804","title":"Lymphomas with Concurrent T(14;18) and 8q24 Translocations Are Under- Reported and Clinical Outcome Depends on the MYC Partner","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Fluorescence in situ hybridization; Lymphoma; Chromosomal translocation; Follicular lymphoma; Diffuse large B-cell lymphoma; Lymphoblastic lymphoma; Gene rearrangement; Internal medicine; Karyotype; Medicine; Biology; Oncology; Pathology; Cancer research; Immunology; T cell; Chromosome; Gene; Genetics","score_opus":0.14020481656034703,"score_gpt":0.35274478670883863,"score_spread":0.2125399701484916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564480549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99216664,0.0009274899,0.000012254669,0.004537926,0.00005656944,0.00038875052,0.000012574576,0.00004112176,0.0018566962],"genre_scores_gemma":[0.997876,0.0006615935,0.00006775957,0.0008923257,0.00006498141,0.00007088183,0.000018439587,0.000015849397,0.0003321845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891794,0.000049908896,0.00034556066,0.00030877526,0.00021567002,0.00016212268],"domain_scores_gemma":[0.9990638,0.00027816594,0.000112236805,0.00031963017,0.00005655768,0.0001696446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013549316,0.00015944039,0.00030875555,0.00003141745,0.00017312654,0.000016482185,0.000034213244,0.00007331646,0.00004425789],"category_scores_gemma":[0.000062417384,0.000083628576,0.000068921945,0.00008597313,0.00020822829,0.000026770582,0.000014001494,0.00008986469,0.000009131857],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049547572,0.0022711465,0.99347997,0.000014344645,0.00043674698,0.0004207028,0.00011510945,4.3466346e-7,0.000005369407,0.00084265746,0.00046847714,0.0018954942],"study_design_scores_gemma":[0.010667672,0.0007135169,0.9839207,0.00008620452,0.0009399897,0.0013393656,0.00012775153,0.000013604363,0.00041859533,0.00002931354,0.00163275,0.00011056177],"about_ca_topic_score_codex":0.000036833022,"about_ca_topic_score_gemma":0.00008461368,"teacher_disagreement_score":0.010618124,"about_ca_system_score_codex":0.000022610411,"about_ca_system_score_gemma":0.00010019947,"threshold_uncertainty_score":0.34102744},"labels":[],"label_agreement":null},{"id":"W2564514339","doi":"10.1182/blood.v110.11.1093.1093","title":"Stem Cell Transplantation (SCT) Improves Survival in Acute Biphenotypic (ABL) and Acute Undifferentiated Leukemia (AUL): A Single Centre Experience.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Imatinib mesylate; Internal medicine; Transplantation; Gastroenterology; Population; Surgery; Vincristine; Chemotherapy regimen; Autologous stem-cell transplantation; Chemotherapy; Oncology; Imatinib; Myeloid leukemia; Cyclophosphamide","score_opus":0.011427683246522572,"score_gpt":0.24009789355894848,"score_spread":0.2286702103124259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564514339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99754834,0.00046997925,0.00017105858,0.000042339252,0.00018170069,0.00058906054,0.000035737467,0.00010601529,0.00085576886],"genre_scores_gemma":[0.9977111,0.0003091473,0.0006365485,0.000049544742,0.00006424081,0.000015211102,0.0001725373,0.000043553704,0.0009980949],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981628,0.00004516892,0.00042608794,0.00049234944,0.000313296,0.0005602985],"domain_scores_gemma":[0.99924815,0.00008523824,0.00011581956,0.0002885998,0.00004262861,0.00021955147],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001263503,0.0003025336,0.00041355938,0.00019236616,0.00007102337,0.00003328696,0.000097589,0.00019001265,0.000053885335],"category_scores_gemma":[0.000003929088,0.0002678007,0.00007240216,0.0003134075,0.000076123964,0.00014367948,0.00003236284,0.00021921631,0.000019883975],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015305098,0.0019300652,0.2025569,0.00038885354,0.000742024,0.0025895392,0.014133924,0.000002555414,0.7643399,0.00005387374,0.000023983805,0.011707881],"study_design_scores_gemma":[0.031930104,0.00068935356,0.41618288,0.000258399,0.0018080759,0.00027293724,0.0020369533,0.00013526362,0.54611796,0.000033406457,0.00008084763,0.00045379827],"about_ca_topic_score_codex":0.00027031646,"about_ca_topic_score_gemma":0.00047432055,"teacher_disagreement_score":0.21822192,"about_ca_system_score_codex":0.0006003499,"about_ca_system_score_gemma":0.00020576578,"threshold_uncertainty_score":0.9999774},"labels":[],"label_agreement":null},{"id":"W2564540330","doi":"10.1182/blood.v116.21.5117.5117","title":"Chemotherapy, but Not Bevacizumab, Increases Tissue Factor Activity Levels In Endothelial Cells, Blood Monocytes, and Non-Small Cell Lung Cancer Cells","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University","funders":"","keywords":"Lung cancer; Medicine; Carboplatin; Gemcitabine; Bevacizumab; Chemotherapy; Angiogenesis; Tissue factor; Paclitaxel; Cisplatin; Cancer research; Cancer cell; Cancer; Oncology; Pharmacology; Immunology; Internal medicine; Coagulation","score_opus":0.017043797399942454,"score_gpt":0.2901981074395221,"score_spread":0.2731543100395797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564540330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996198,0.0008676153,0.0000048091765,0.00020748867,0.0004243322,0.00098967,0.00070048583,0.000057318597,0.00055026636],"genre_scores_gemma":[0.99500334,0.0011750213,0.00048632393,0.00035786032,0.00055270875,0.00013733131,0.000011541245,0.00005913721,0.0022167303],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985708,0.000046868183,0.00024171887,0.00050770544,0.0001701126,0.00046277707],"domain_scores_gemma":[0.99911356,0.00016572705,0.00012323879,0.00029229652,0.000046653277,0.00025853456],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008586765,0.0003507005,0.0005318152,0.0001372564,0.00007297838,0.000029762989,0.00012812357,0.0002410811,0.0010996604],"category_scores_gemma":[0.0000079476085,0.00032059156,0.00008137061,0.00012397,0.00008597424,0.00008504982,0.00006467676,0.00047984874,0.000015351616],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045690287,0.0029442718,0.040418018,0.00019580663,0.00020082053,0.00015298203,0.000483863,8.5400796e-7,0.9512412,0.000001431831,0.0001482239,0.003755622],"study_design_scores_gemma":[0.020702526,0.00038689276,0.06301988,0.00003864684,0.00068309193,0.000033370612,0.0000147553255,0.00003971836,0.9131353,0.0000041546136,0.0016630238,0.0002786489],"about_ca_topic_score_codex":0.008112271,"about_ca_topic_score_gemma":0.0027758377,"teacher_disagreement_score":0.038105913,"about_ca_system_score_codex":0.000055116554,"about_ca_system_score_gemma":0.00031105446,"threshold_uncertainty_score":0.9999246},"labels":[],"label_agreement":null},{"id":"W2564550290","doi":"10.1182/blood.v126.23.4734.4734","title":"Dabigatran Pharmacokinetics and Pharmacodynamics during Renal Replacement Therapy","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Dabigatran; Medicine; Dialysis catheter; Hemodialysis; Dialysis; Prothrombin complex concentrate; Anesthesia; Renal replacement therapy; Context (archaeology); Pharmacodynamics; Anticoagulant; Acute kidney injury; Warfarin; Pharmacokinetics; Surgery; Internal medicine; Atrial fibrillation","score_opus":0.07198061046218253,"score_gpt":0.3431025339173878,"score_spread":0.2711219234552053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564550290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99474484,0.0006996939,0.000060464117,0.0014493028,0.00014136654,0.000317246,0.0000022106524,0.00007928548,0.0025055895],"genre_scores_gemma":[0.9952287,0.0007745068,0.00090585835,0.00023196451,0.0007342446,0.0000021300214,0.000014758869,0.00001747352,0.0020903542],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99930876,0.000019819048,0.00016781554,0.00015837305,0.00020718884,0.00013803909],"domain_scores_gemma":[0.99962276,0.000014185964,0.00004793141,0.00012211839,0.000041006686,0.00015201439],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014980647,0.00010166301,0.00014527791,0.0000604191,0.000040650542,0.000017882528,0.000034289464,0.00002715635,0.00005665897],"category_scores_gemma":[0.000017442047,0.00008509529,0.000043113905,0.00008846029,0.00002531843,0.00005290352,0.00003497013,0.000066435925,0.000009955014],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022864947,0.0001536509,0.6852933,0.00013103525,0.00075555436,0.00013262755,0.00078581495,0.000091499045,0.2998614,0.00026646387,0.0013436624,0.0088984845],"study_design_scores_gemma":[0.16079526,0.0014674884,0.21982123,0.00011987762,0.0018557747,0.00037848135,0.0004661951,0.004660894,0.43132883,0.00031537164,0.17790069,0.00088990276],"about_ca_topic_score_codex":0.0000038166845,"about_ca_topic_score_gemma":4.798473e-7,"teacher_disagreement_score":0.46547207,"about_ca_system_score_codex":0.00001460169,"about_ca_system_score_gemma":0.000020741376,"threshold_uncertainty_score":0.34700853},"labels":[],"label_agreement":null},{"id":"W2564582829","doi":"10.1182/blood.v116.21.3486.3486","title":"Spleen Status and Engraftment After Allogeneic Hematopoietic Stem Cell Transplantation (HCT).","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Transplantation; Splenectomy; Internal medicine; Gastroenterology; Bone marrow; Cumulative incidence; Stem cell; Total body irradiation; Hematopoietic stem cell transplantation; Surgery; Spleen; Chemotherapy; Cyclophosphamide; Biology","score_opus":0.010203386256106289,"score_gpt":0.25308053919838286,"score_spread":0.24287715294227658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564582829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978343,0.0006786018,0.000011652513,0.00010378485,0.00004239099,0.00046221056,0.000057426343,0.00003411534,0.00077549904],"genre_scores_gemma":[0.9981606,0.0004200911,0.000756339,0.000054626995,0.00004294996,0.00009850776,0.00007688739,0.000014197761,0.00037579043],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990954,0.00002318304,0.00013071342,0.00021920455,0.00022635117,0.00030515136],"domain_scores_gemma":[0.999414,0.000036246573,0.000023527713,0.00019481884,0.000031628257,0.00029973473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006407615,0.00012379553,0.00015204422,0.000065978595,0.000043227814,0.000021074256,0.000030449979,0.000066183646,0.00017716183],"category_scores_gemma":[0.0000034986217,0.000095391675,0.000043559274,0.00005171482,0.000039374347,0.000040106195,0.000014383449,0.00014148917,0.00008342588],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049386243,0.0015782323,0.88678366,0.00055204844,0.0002366458,0.0012109743,0.0014212617,1.6069905e-7,0.09888634,0.000034776327,0.00003646405,0.0087656],"study_design_scores_gemma":[0.010797605,0.00046932555,0.7558416,0.000037802292,0.0004095511,0.00025364294,0.00008963449,0.000007751512,0.23095569,0.00003015165,0.0009616123,0.00014562401],"about_ca_topic_score_codex":0.00005460563,"about_ca_topic_score_gemma":0.000086381646,"teacher_disagreement_score":0.13206935,"about_ca_system_score_codex":0.000010030482,"about_ca_system_score_gemma":0.00005071912,"threshold_uncertainty_score":0.38899598},"labels":[],"label_agreement":null},{"id":"W2564604721","doi":"10.1182/blood.v124.21.1397.1397","title":"Macrophage NADPH Oxidase Activation and ROS Production Is Positively Regulated By Shp2 Phosphatase Function","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University Health Network","funders":"","keywords":"Zymosan; NADPH oxidase; MAPK/ERK pathway; Cell biology; Protein tyrosine phosphatase; Phosphorylation; Biology; Protein kinase B; Phosphatase; Signal transduction; Reactive oxygen species; Molecular biology; Biochemistry","score_opus":0.004567772998095442,"score_gpt":0.2177045084820705,"score_spread":0.21313673548397508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564604721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969245,0.00037155912,0.0015946997,0.00045529424,0.000048459886,0.00029421964,0.0000341278,0.000020931731,0.0002561675],"genre_scores_gemma":[0.9963673,0.000055973687,0.00017052214,0.0002629608,0.00013731334,0.000027808455,0.0005372042,0.000016985901,0.0024239393],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99913347,0.0000699814,0.00011982907,0.00035910722,0.00015152007,0.00016609523],"domain_scores_gemma":[0.99952173,0.0000049473715,0.000057117642,0.00021771123,0.00011455567,0.0000839517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017505414,0.00011198467,0.00007531816,0.000038915157,0.00013130278,0.000043941876,0.000052320323,0.00012353594,0.0000404561],"category_scores_gemma":[0.00012542692,0.00010972129,0.000026870559,0.00010663065,0.000046787565,0.000013912208,0.000041716743,0.00007959431,0.000015664053],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017840581,0.0001432955,0.0005147331,0.000017328966,0.000032563446,5.5996804e-7,0.000018288365,0.000002674443,0.9846649,0.000035692137,0.0060902876,0.008301231],"study_design_scores_gemma":[0.0011581422,0.0003255754,0.0079451185,0.00001031544,0.000018815019,0.000010662013,0.00001114073,0.00008647985,0.9657169,0.000037016718,0.024556104,0.00012375688],"about_ca_topic_score_codex":0.000047094578,"about_ca_topic_score_gemma":0.0000041171397,"teacher_disagreement_score":0.018948067,"about_ca_system_score_codex":0.0000074948534,"about_ca_system_score_gemma":0.000019566074,"threshold_uncertainty_score":0.44743043},"labels":[],"label_agreement":null},{"id":"W2564627979","doi":"10.1182/blood.v112.11.4662.4662","title":"Novel Dissemination Efforts for Hematology-Related Serious Adverse Drug Reactions (sADRs): Findings from the Research on Adverse Drug Events and Reports Project (RADAR)","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacovigilance; Medicine; Expanded access; Medical education; Family medicine; Adverse effect; Internal medicine; Oncology","score_opus":0.10340757094669442,"score_gpt":0.44112807564473805,"score_spread":0.3377205046980436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564627979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926025,0.00031014506,0.000012541016,0.0016463468,0.0011747188,0.0021041902,0.0003655468,0.00016834382,0.0016156217],"genre_scores_gemma":[0.9931157,0.0005163143,0.00017065275,0.00034014843,0.00022040257,0.0005674859,0.00032696247,0.000049868093,0.004692423],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973118,0.00032818664,0.0006136246,0.0007068248,0.00037001408,0.0006695807],"domain_scores_gemma":[0.9966608,0.0022329933,0.0002864677,0.00041004308,0.00020318633,0.0002064766],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0013970912,0.00032436277,0.0003537172,0.00025266907,0.0018750804,0.000012465814,0.0002461686,0.000299355,0.00012510411],"category_scores_gemma":[0.000385705,0.00027161755,0.00018645084,0.0005288322,0.00037570993,0.0003230348,0.00011059305,0.0013797032,0.000058040467],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034933204,0.01689495,0.21474367,0.00041991926,0.004372761,0.0029147826,0.02519071,0.00086330104,0.33567342,0.0037139975,0.38930124,0.0024179057],"study_design_scores_gemma":[0.020776115,0.00044776718,0.09712954,0.00059932895,0.0021216257,0.005284936,0.0055509466,0.0010378374,0.32081342,0.001891978,0.54266167,0.0016848709],"about_ca_topic_score_codex":0.00025864618,"about_ca_topic_score_gemma":0.000093613045,"teacher_disagreement_score":0.1533604,"about_ca_system_score_codex":0.000104947794,"about_ca_system_score_gemma":0.00022583053,"threshold_uncertainty_score":0.9999736},"labels":[],"label_agreement":null},{"id":"W2564655019","doi":"10.1182/blood.v108.11.1597.1597","title":"A Multicentre Trial of the Effectiveness of ζ Globin Enzyme Linked Immunosorbent Assay (ELISA) and Hb H Inclusion Body Screening for the Detection of α Thalassemia Trait.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hamilton Regional Laboratory Medicine Program; University of Toronto; McMaster University","funders":"","keywords":"Microcytosis; Hydrops fetalis; Medicine; Thalassemia; Molecular biology; Internal medicine; Immunology; Gastroenterology; Biology; Anemia; Genetics; Fetus; Iron deficiency; Pregnancy","score_opus":0.00685144653876027,"score_gpt":0.2381447994059434,"score_spread":0.23129335286718314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564655019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99405634,0.0020385156,0.0014480273,0.000113654954,0.00016722783,0.0019968108,0.00002230387,0.000012371752,0.00014472414],"genre_scores_gemma":[0.99966514,0.000087376495,0.00010332928,0.0000087762555,0.00006213915,0.00003199652,0.000007469646,0.000014842187,0.00001892],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99883914,0.00024331168,0.00037119436,0.00014466835,0.00025737914,0.00014430149],"domain_scores_gemma":[0.9985362,0.0008373949,0.00025177366,0.00022626277,0.00012453037,0.000023791948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095825904,0.000119842545,0.00032000022,0.00004547253,0.00015964266,0.000004084142,0.00009828902,0.00017240166,0.0000023573054],"category_scores_gemma":[0.0003907768,0.000065666056,0.00019341159,0.0001855335,0.000117849944,0.000027524005,0.00012710958,0.0001575774,6.550698e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015737943,0.0010798152,0.0025777293,0.00052170514,0.0002505333,0.0000010100853,0.00045150932,0.0001359261,0.9730573,0.000070133916,0.000005241129,0.0061111255],"study_design_scores_gemma":[0.10154152,0.0011847012,0.11821834,0.0009045151,0.0013351409,0.00001804362,0.000532271,0.0025866833,0.7732562,0.0001358294,0.00017992283,0.000106845364],"about_ca_topic_score_codex":0.0005875032,"about_ca_topic_score_gemma":0.00003674492,"teacher_disagreement_score":0.19980113,"about_ca_system_score_codex":0.000016181071,"about_ca_system_score_gemma":0.000052265026,"threshold_uncertainty_score":0.2677784},"labels":[],"label_agreement":null},{"id":"W2564657504","doi":"10.1182/blood.v110.11.348.348","title":"Gene Expression Signatures Predict Overall Survial in Diffuse Large B Cell Lymphoma Treated with Rituximab and Chop-Like Chemotherapy.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Rituximab; CHOP; Lymphoma; Oncology; Chemotherapy regimen; Medicine; Internal medicine; Chemotherapy; Cancer research; Biology","score_opus":0.004820381490119565,"score_gpt":0.21267674191847852,"score_spread":0.20785636042835895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564657504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99594283,0.0024132726,0.000015638478,0.000061028248,0.000035382516,0.0005283423,0.000035679717,0.00007542928,0.00089242123],"genre_scores_gemma":[0.9980547,0.00045666803,0.00057795877,0.00039664228,0.00012360852,0.000036103585,0.0000770632,0.000040595372,0.00023668552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986466,0.00003159823,0.00022946218,0.0004007723,0.0002815876,0.00040996217],"domain_scores_gemma":[0.99933636,0.000077479956,0.000073397656,0.0002801747,0.000036585396,0.0001959999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014656722,0.0002637973,0.00038313144,0.00012747974,0.00006165213,0.000024078021,0.000048665705,0.00017275361,0.000032895652],"category_scores_gemma":[0.000008111327,0.0001777936,0.000057499976,0.00013487929,0.000038195536,0.000069286514,0.000031281925,0.000075137235,0.0000056574404],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022645656,0.06339521,0.88921386,0.00007996275,0.00017126942,0.0020262692,0.0005039975,4.137115e-7,0.039290328,0.000009632475,0.00032819656,0.0027162817],"study_design_scores_gemma":[0.15560985,0.00061834144,0.5704884,0.000118672004,0.00013656962,0.00007922239,0.000025923388,0.000014131424,0.27212968,0.0000037102984,0.00062447763,0.00015105428],"about_ca_topic_score_codex":0.00020344346,"about_ca_topic_score_gemma":0.00011190606,"teacher_disagreement_score":0.3187255,"about_ca_system_score_codex":0.000076073506,"about_ca_system_score_gemma":0.00005387758,"threshold_uncertainty_score":0.72502124},"labels":[],"label_agreement":null},{"id":"W2564661908","doi":"10.1182/blood.v126.23.111.111","title":"Genetic Alterations of Gα13 Signaling Pathway with BCL2 over-Expression Confers Lymphoma Dissemination and Inferior Outcome in Germinal Center B Cell Diffuse Large B Cell Lymphoma","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Simon Fraser University; BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Germinal center; Biology; BCL6; Cancer research; Follicular lymphoma; Gene expression profiling; Lymphoma; Genetics; B cell; Gene; Immunology; Gene expression","score_opus":0.012870875767063797,"score_gpt":0.2552794388710029,"score_spread":0.2424085631039391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564661908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99824226,0.00046736348,0.00005885558,0.000047602367,0.00004393818,0.00045989986,0.00006575957,0.00002242179,0.00059189217],"genre_scores_gemma":[0.9986082,0.00003802645,0.00095149636,0.00006709854,0.000042294443,0.000075792756,0.00007280359,0.000027324668,0.00011700112],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986665,0.00005376822,0.000402762,0.00030386224,0.00031180668,0.0002612898],"domain_scores_gemma":[0.99918324,0.0000825593,0.00016718077,0.00024786795,0.000101552534,0.0002176246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010647563,0.00022076696,0.0003626368,0.00015116065,0.000050642644,0.000034919853,0.000055238877,0.00009329371,0.000018489343],"category_scores_gemma":[0.00002554605,0.00016456579,0.000056987956,0.000121528006,0.00004428696,0.00010743107,0.0000509647,0.00003444824,0.0000052929745],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015402658,0.014963681,0.94782513,0.00014753944,0.000028010154,0.00023078549,0.0013962556,0.0000037988539,0.034265473,0.000021048449,0.00003033827,0.0009338955],"study_design_scores_gemma":[0.05418075,0.00071871694,0.65507275,0.00034748498,0.00020269526,0.00006719862,0.0003677343,0.00019925764,0.2884751,0.000008752781,0.00016925615,0.00019028586],"about_ca_topic_score_codex":0.000074676704,"about_ca_topic_score_gemma":0.00002902037,"teacher_disagreement_score":0.29275236,"about_ca_system_score_codex":0.000105422965,"about_ca_system_score_gemma":0.00015823562,"threshold_uncertainty_score":0.6710798},"labels":[],"label_agreement":null},{"id":"W2564678983","doi":"10.1182/blood.v104.11.884.884","title":"High Risk AML Outpatient Management: A Retrospective Analysis of Bacteremia Incidence Following Chemotherapy.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Medicine; Bacteremia; Fluconazole; Chemotherapy; Incidence (geometry); Internal medicine; Chemotherapy regimen; Intensive care medicine; Antibiotics","score_opus":0.005883418390737432,"score_gpt":0.24471001853283927,"score_spread":0.23882660014210183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564678983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959246,0.00006748646,0.00046227334,0.00008480651,0.00010356328,0.00026594172,0.000015192891,0.000047363214,0.0030287772],"genre_scores_gemma":[0.99812496,0.00015584366,0.0013008219,0.00013589757,0.000044729193,0.000029120498,0.0000125855,0.000014200075,0.00018184476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991094,0.00001676389,0.0002267545,0.00024567058,0.00024735433,0.00015405443],"domain_scores_gemma":[0.9993893,0.000011175842,0.00013585307,0.0003391077,0.000060234976,0.00006431281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000094730494,0.00011115862,0.00036029337,0.0002486585,0.00006468409,0.000009867894,0.00007173991,0.000046366902,0.00014581945],"category_scores_gemma":[0.0000162776,0.00009964819,0.00029886118,0.0010162551,0.000028092383,0.00006186464,0.000028426683,0.00013324825,0.000011367839],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057651814,0.00074946735,0.988103,0.000029372612,0.00616467,0.000050374456,0.0005513408,0.00015863497,0.0023659344,0.00075942796,0.000017703589,0.0009924206],"study_design_scores_gemma":[0.004332593,0.00034587836,0.96833235,0.00008337209,0.009110737,0.0000040162263,0.00008100855,0.000002320207,0.017163496,0.0003365353,0.0001074759,0.00010024317],"about_ca_topic_score_codex":0.00065141416,"about_ca_topic_score_gemma":0.00015576552,"teacher_disagreement_score":0.019770678,"about_ca_system_score_codex":0.0001294286,"about_ca_system_score_gemma":0.000030786425,"threshold_uncertainty_score":0.40635353},"labels":[],"label_agreement":null},{"id":"W2564681745","doi":"10.1182/blood.v110.11.3152.3152","title":"The Use of Ideal Amphipathic Helical Peptides To Reduce Hemorrhage In Vivo.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"In vivo; Factor IXa; Biophysics; Chemistry; Peptide; Phospholipid; Biochemistry; Factor X; Amino acid; Membrane; Cell biology; Biology; Platelet; Immunology; Thrombin","score_opus":0.05627249179593387,"score_gpt":0.3062251409584853,"score_spread":0.24995264916255144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564681745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99729604,0.000090051515,0.00046674724,0.00095255754,0.00010065253,0.00030471548,0.0000029402077,0.000034605782,0.0007516649],"genre_scores_gemma":[0.9938554,0.000012054959,0.00475151,0.0008232023,0.000105836465,0.000008848387,0.0000016245812,0.000016117852,0.00042539174],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998922,0.000038475013,0.00034147257,0.00017360102,0.000273114,0.00025135514],"domain_scores_gemma":[0.9992129,0.00019351159,0.000057778358,0.00031512114,0.00007411355,0.00014657507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005759361,0.00009814496,0.00021157668,0.00010440735,0.00005082237,0.00001536961,0.00008655934,0.00008372105,0.000039607596],"category_scores_gemma":[0.00033454926,0.00007168021,0.00006506279,0.00031242394,0.000041738193,0.000040635954,0.00004457487,0.00014765406,0.000027340291],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003640213,0.0015033011,0.01489018,0.000079933336,0.0000719308,0.0001570524,0.00086477044,0.0000121472485,0.95895046,0.00995967,0.00051959674,0.012626914],"study_design_scores_gemma":[0.0031753718,0.00049448415,0.11485871,0.00015480601,0.000120800614,0.000114919116,0.00028126026,0.00010857902,0.87549824,0.00042822512,0.004605552,0.00015905152],"about_ca_topic_score_codex":0.00007191648,"about_ca_topic_score_gemma":0.00019706396,"teacher_disagreement_score":0.09996853,"about_ca_system_score_codex":0.00001516478,"about_ca_system_score_gemma":0.000044708646,"threshold_uncertainty_score":0.2923034},"labels":[],"label_agreement":null},{"id":"W2564696975","doi":"10.1182/blood.v110.11.4550.4550","title":"Should the Initial Starting Dose of Imatinib for Treatment of Some Patients with Chronic Myelocytic Leukemia (CML) Be Lower Than 400 mg Daily?.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; St. Boniface Hospital","funders":"","keywords":"Medicine; Imatinib mesylate; Imatinib; Fusion gene; Gastroenterology; Internal medicine; Bone marrow; breakpoint cluster region; ABL; Philadelphia chromosome; Chromosomal translocation; Myeloid leukemia; Biology","score_opus":0.033644825586234356,"score_gpt":0.3011877963220362,"score_spread":0.2675429707358018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564696975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99616045,0.00064396963,0.00005064241,0.0001165615,0.00012590818,0.0020544073,0.00013075717,0.00004198757,0.0006752972],"genre_scores_gemma":[0.9979748,0.000038568756,0.0010585195,0.0001065775,0.00029694836,0.00011119712,0.00015398278,0.000066777146,0.00019262133],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99778795,0.000033340773,0.0006980861,0.00036480257,0.00055034406,0.0005654906],"domain_scores_gemma":[0.9981774,0.00035638185,0.00044020242,0.0006911503,0.00019023259,0.0001446188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002482972,0.00034279496,0.0006436102,0.000110927416,0.00010131195,0.000009416178,0.00015064434,0.00013632835,0.00005926173],"category_scores_gemma":[0.00007627754,0.00020576992,0.00021898776,0.0002000475,0.00020433907,0.00010599116,0.000041287127,0.00008741941,0.0000050956974],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036160056,0.044683635,0.6575402,0.00490111,0.015844183,0.0006583225,0.020161916,0.00044192694,0.046361566,0.0022452679,0.00087101036,0.17013083],"study_design_scores_gemma":[0.24574164,0.041948058,0.27752247,0.0013529722,0.0067617865,0.00006535145,0.0008120597,0.000650071,0.42184004,0.000231926,0.0021823838,0.0008912451],"about_ca_topic_score_codex":0.00033004314,"about_ca_topic_score_gemma":0.00025058584,"teacher_disagreement_score":0.3800177,"about_ca_system_score_codex":0.0016357284,"about_ca_system_score_gemma":0.001238603,"threshold_uncertainty_score":0.83910537},"labels":[],"label_agreement":null},{"id":"W2564732019","doi":"10.1182/blood.v110.11.400.400","title":"NR2F6, the Mammalian Homologue of Drosophila Seven Up, Can Initiate Myelodysplasia and Acute Leukemia.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Sunnybrook Hospital; University of Toronto","funders":"","keywords":"Biology; Haematopoiesis; Bone marrow; Stem cell; clone (Java method); Cancer research; Myelodysplastic syndromes; Leukemia; Cell culture; Immunology; Gene; Genetics","score_opus":0.01689573403599705,"score_gpt":0.28065460324198593,"score_spread":0.2637588692059889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564732019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875374,0.00030504348,0.000041873594,0.0022610442,0.000093739414,0.00050875376,0.000063975946,0.000051337767,0.009136863],"genre_scores_gemma":[0.99587274,0.00018427632,0.0005275334,0.00078640523,0.0002708513,0.000017103035,0.000040892613,0.000045348894,0.0022548737],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99819034,0.000073768904,0.00039052148,0.00032851822,0.00044195246,0.00057490246],"domain_scores_gemma":[0.99866414,0.0002224665,0.00012182319,0.00057143014,0.00015365978,0.00026646472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008410942,0.00021681133,0.00040573307,0.00017773297,0.00012896875,0.000019355239,0.0002690986,0.00020498045,0.000056816232],"category_scores_gemma":[0.00015254617,0.00015171006,0.00009180406,0.00038196173,0.00043561973,0.000058882008,0.00019258517,0.0005115183,0.000022505294],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056296405,0.0023068236,0.24212274,0.0020848368,0.008611324,0.03048891,0.026394345,0.000012475926,0.573007,0.020537756,0.03212796,0.05667619],"study_design_scores_gemma":[0.02461681,0.002207394,0.5634891,0.00034650764,0.0024007868,0.010510826,0.0022352869,0.0001044477,0.37982368,0.0027744279,0.010670889,0.0008198598],"about_ca_topic_score_codex":0.00045305584,"about_ca_topic_score_gemma":0.00022707274,"teacher_disagreement_score":0.32136634,"about_ca_system_score_codex":0.00015347746,"about_ca_system_score_gemma":0.00054905616,"threshold_uncertainty_score":0.6186557},"labels":[],"label_agreement":null},{"id":"W2564738594","doi":"10.1182/blood.v104.11.653.653","title":"Role for p40phox in Fcγ-Receptor-Induced NADPH Oxidase Activation.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"NADPH oxidase; Cell biology; P22phox; Rac GTP-Binding Proteins; Superoxide; Biology; Phosphatidylinositol; Cytosol; Oxidase test; Biochemistry; Kinase; Signal transduction; Reactive oxygen species; Enzyme","score_opus":0.01401180931536361,"score_gpt":0.23164514367503342,"score_spread":0.2176333343596698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564738594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99759305,0.00024700625,0.00033709404,0.00042796085,0.00023537622,0.0005505897,0.0000423158,0.0000803556,0.00048624718],"genre_scores_gemma":[0.9979082,0.000013268284,0.0007702067,0.00040699553,0.0000702023,0.00018122837,0.00015265514,0.000030398103,0.00046686968],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99883425,0.000068976326,0.00026688297,0.0003707611,0.000034677414,0.0004244512],"domain_scores_gemma":[0.9994777,0.00008192593,0.00008737697,0.00025504993,0.00006776221,0.000030218132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015644183,0.00020925622,0.00026831092,0.00015587787,0.00015048306,0.000015426589,0.0002083845,0.00024409723,0.00023299182],"category_scores_gemma":[0.00007846095,0.00019460093,0.00009561622,0.00019516077,0.000044670953,0.00015162236,0.000051692925,0.00023409649,0.00051128265],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010078511,0.00063810096,0.00010385858,0.000010411815,0.000081458784,0.000003202464,0.00026856156,0.000005351498,0.9909875,0.0063914387,0.00009991549,0.0013094327],"study_design_scores_gemma":[0.007822244,0.0003507047,0.0012979885,0.000048172078,0.00002902267,0.000012787792,0.00023925072,1.8393698e-7,0.98137015,0.0028876555,0.005705914,0.00023591176],"about_ca_topic_score_codex":0.0001491332,"about_ca_topic_score_gemma":0.00006183946,"teacher_disagreement_score":0.009617318,"about_ca_system_score_codex":0.000055535253,"about_ca_system_score_gemma":0.000100998135,"threshold_uncertainty_score":0.79355955},"labels":[],"label_agreement":null},{"id":"W2564745782","doi":"10.1182/blood.v108.11.752.752","title":"Chronic Myeloid Leukemia Stem Cells Possess Unique Properties That Predict Intrinsic and Acquired Resistance to Imatinib Mesylate.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Imatinib mesylate; Myeloid leukemia; Tyrosine kinase; Cancer research; CD38; Stem cell; Biology; Haematopoiesis; Side population; clone (Java method); Population; Imatinib; Leukemia; Myeloid; CD34; Chemistry; Cell biology; Immunology; Cancer stem cell; Medicine; Signal transduction; Genetics; Gene","score_opus":0.015010967907248644,"score_gpt":0.22290690074657749,"score_spread":0.20789593283932883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564745782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98673666,0.0077342177,0.00003262387,0.0005988674,0.000116859446,0.0015727738,0.00003320245,0.00028657756,0.0028882306],"genre_scores_gemma":[0.9865415,0.00032207288,0.001055398,0.00019216162,0.00035105317,0.00018777941,0.000032039927,0.00008467313,0.011233337],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99770355,0.00008249662,0.00046643006,0.0006656011,0.00046328575,0.00061864866],"domain_scores_gemma":[0.9986896,0.0000658563,0.0001552081,0.00072171865,0.0001088574,0.0002587851],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019447441,0.0004170864,0.00058989425,0.00015253901,0.00014843288,0.00007640786,0.00019205036,0.0001912409,0.000055675308],"category_scores_gemma":[0.00001816016,0.00033907208,0.000090974936,0.0002887294,0.00014989162,0.00017735323,0.00014176288,0.0001820781,0.00007952146],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023361365,0.0019867471,0.06681726,0.005940311,0.0017881835,0.0021936314,0.002961449,0.00017483262,0.8610177,0.0011631456,0.01899682,0.034623787],"study_design_scores_gemma":[0.014135708,0.0008077936,0.04361545,0.0015343876,0.0006379805,0.00024175592,0.0001679933,0.00007213418,0.92707264,0.00009624513,0.011044973,0.00057295774],"about_ca_topic_score_codex":0.0003181869,"about_ca_topic_score_gemma":0.00036041945,"teacher_disagreement_score":0.066054925,"about_ca_system_score_codex":0.0016438665,"about_ca_system_score_gemma":0.0011402249,"threshold_uncertainty_score":0.9999061},"labels":[],"label_agreement":null},{"id":"W2564775260","doi":"10.1182/blood.v116.21.726.726","title":"A Randomized, Double-Blind, Placebo-Controlled, Clinical Outcome Study of ARC1779 In Patients with Thrombotic Thrombocytopenic Purpura (TTP)","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Thrombotic thrombocytopenic purpura; Platelet; Placebo; Gastroenterology; Internal medicine; Microangiopathic hemolytic anemia; Schistocyte; Surgery; Pathology","score_opus":0.04212823482441793,"score_gpt":0.32981261033613424,"score_spread":0.28768437551171633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564775260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894976,0.00014659553,0.0000040329023,0.0000341963,0.00082480686,0.008855421,0.00002158724,0.00005571643,0.0005600245],"genre_scores_gemma":[0.9989912,0.0000025886584,0.000039238228,0.000028325352,0.00003620222,0.00066463975,0.00005193355,0.000032375217,0.00015352062],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9959054,0.0010503511,0.001889811,0.0005515285,0.00015524369,0.00044769354],"domain_scores_gemma":[0.9970486,0.0011945826,0.00068328186,0.00085936143,0.00016336553,0.00005080175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001779077,0.0003415142,0.0023513818,0.0002253858,0.00009459044,0.000023055727,0.0005636042,0.00022204203,0.00083575357],"category_scores_gemma":[0.0003960241,0.00023198963,0.0003137242,0.00021952161,0.00035451673,0.00011310505,0.00021132812,0.000602717,0.00018263001],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.38527313,0.010111586,0.6027398,0.000021060525,0.0012652443,0.0000047573894,0.00020324263,0.0000024180088,0.00018286676,0.00013857905,0.000027120686,0.000030158884],"study_design_scores_gemma":[0.7692967,0.0010140339,0.22803669,0.000033435277,0.00097005593,0.000004534848,0.0002665048,9.2864826e-7,0.0001302082,0.000022783192,0.000016926115,0.00020722003],"about_ca_topic_score_codex":0.00019283354,"about_ca_topic_score_gemma":0.0011257061,"teacher_disagreement_score":0.38402355,"about_ca_system_score_codex":0.000013895084,"about_ca_system_score_gemma":0.000096183896,"threshold_uncertainty_score":0.94602627},"labels":[],"label_agreement":null},{"id":"W2564817673","doi":"10.1182/blood.v118.21.2022.2022","title":"Chemoresistance Can Be Reliably Overcome with High-Dose Therapy and Autologous Stem Cell Transplantation (HDT/ASCT) for Relapsed and Refractory Hodgkin's Lymphoma","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Autologous stem-cell transplantation; ABVD; Internal medicine; Salvage therapy; Oncology; Chemotherapy; Chemotherapy regimen; Surgery; Progressive disease; Cyclophosphamide; Vincristine","score_opus":0.019383074225277915,"score_gpt":0.21488925732839664,"score_spread":0.19550618310311874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564817673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953793,0.0028372332,0.000011195834,0.0002367923,0.00004407902,0.0007196033,0.00007835419,0.000064568994,0.00062882743],"genre_scores_gemma":[0.99313956,0.0032411031,0.002663806,0.0003467432,0.00003580428,0.0001758951,0.000051654664,0.000035954487,0.0003094894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905276,0.00002423855,0.00018294578,0.0003640532,0.00015069687,0.00022529447],"domain_scores_gemma":[0.999368,0.000096152806,0.00010549478,0.00023987198,0.000053652355,0.0001367981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000075256925,0.00021393877,0.000327079,0.000054995817,0.00009552777,0.00001705214,0.000042589672,0.00010912923,0.000009153117],"category_scores_gemma":[0.0000029848059,0.00015278975,0.00004093728,0.00006429702,0.000078880206,0.00007034919,0.0000063180937,0.000039201997,9.2604944e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033378728,0.019866707,0.70586795,0.003024272,0.0025990233,0.0039899917,0.025189871,0.0000012382397,0.03977877,0.0031573125,0.0016020382,0.16154408],"study_design_scores_gemma":[0.03972878,0.0030055244,0.8405233,0.0001334928,0.0006482163,0.00023549056,0.00014519406,0.0000036953365,0.11437067,0.00007220171,0.00091484445,0.00021860139],"about_ca_topic_score_codex":0.0003774394,"about_ca_topic_score_gemma":0.00011348984,"teacher_disagreement_score":0.16132548,"about_ca_system_score_codex":0.000052262647,"about_ca_system_score_gemma":0.00009998365,"threshold_uncertainty_score":0.62305856},"labels":[],"label_agreement":null},{"id":"W2564820253","doi":"10.1182/blood.v104.11.3356.3356","title":"Inhibition of Wnt Pathway Signaling by Thalidomide and Revlimid: Studies in a Drosophila Model System.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"","keywords":"Wnt signaling pathway; Biology; Signal transduction; LRP5; Cell biology; Downregulation and upregulation; Cancer research; Genetics; Gene","score_opus":0.020695775199938073,"score_gpt":0.26379082805663384,"score_spread":0.24309505285669578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564820253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962926,0.0030918699,0.00016850897,0.00005348116,0.000023306731,0.00017687284,0.000020438802,0.0000053434414,0.00016761663],"genre_scores_gemma":[0.9991359,0.0001760232,0.0005301771,0.000023772905,0.000029342205,0.000058608974,0.000015831023,0.0000096729755,0.000020675356],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99941504,0.000027609922,0.00021262682,0.00018349191,0.00005749351,0.00010376279],"domain_scores_gemma":[0.9997583,0.000008323625,0.000067993285,0.00010689651,0.000038724877,0.000019773783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012986184,0.00008105988,0.00013472284,0.000046348498,0.000019607447,0.000004917167,0.000033556924,0.00007193453,3.1047182e-7],"category_scores_gemma":[0.000056236688,0.000080447695,0.00002741663,0.000051940475,0.000042846976,0.0000044709636,0.000046403013,0.00005956615,5.496118e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022231301,0.00012179956,0.0003023461,0.00010927815,0.00002497559,0.000008288318,0.00026949367,0.0016269493,0.99726856,0.000226488,0.000008684955,0.000010892346],"study_design_scores_gemma":[0.0015452378,0.00009637836,0.000031229567,0.0003712293,0.000013102389,0.000024770703,0.0006389022,0.000044507873,0.99647236,0.00067036593,0.000007465366,0.00008445011],"about_ca_topic_score_codex":0.00005385435,"about_ca_topic_score_gemma":0.00005604569,"teacher_disagreement_score":0.0029158469,"about_ca_system_score_codex":0.000021770318,"about_ca_system_score_gemma":0.000029860741,"threshold_uncertainty_score":0.3280562},"labels":[],"label_agreement":null},{"id":"W2564835505","doi":"10.1182/blood.v112.11.31.31","title":"Randomized Double-Blind Comparison of Apixaban with Enoxaparin for Thromboprophylaxis after Knee Replacement: The ADVANCE-1 Trial","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Apixaban; Venography; Pulmonary embolism; Surgery; Placebo; Randomized controlled trial; Deep vein; Rivaroxaban; Thrombosis; Warfarin; Internal medicine; Atrial fibrillation","score_opus":0.044066388416332695,"score_gpt":0.314331983321273,"score_spread":0.2702655949049403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564835505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98528135,0.0011812815,0.00057990954,0.0003624462,0.0002017715,0.008923571,0.000008153312,0.00004220991,0.0034193192],"genre_scores_gemma":[0.9943654,0.00017993819,0.0015461174,0.00019509753,0.00028861858,0.0027069773,0.000025598003,0.000037420672,0.0006548596],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982482,0.00006752176,0.00060947787,0.0003441275,0.0004257959,0.00030487406],"domain_scores_gemma":[0.998648,0.0002261126,0.00030099615,0.00060480245,0.00013855068,0.00008152933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005065162,0.00022829729,0.0013334524,0.00008963225,0.00014674175,0.000014783061,0.00012806308,0.00007045304,0.00010848896],"category_scores_gemma":[0.000063765096,0.0001290153,0.00028353967,0.0001725595,0.000280896,0.00006281629,0.000057232006,0.00013620223,0.00000905142],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98796856,0.004920768,0.0016888862,0.00018914783,0.0012413617,0.00001005509,0.0018127846,0.000013025921,0.00009311398,0.0008642809,0.00087571156,0.00032231942],"study_design_scores_gemma":[0.9798804,0.0049194703,0.0016424918,0.00010438332,0.0018005907,0.000014034882,0.00019662465,0.0000306231,0.0071085775,0.000062042585,0.004071537,0.00016920906],"about_ca_topic_score_codex":0.00007252589,"about_ca_topic_score_gemma":0.000032527227,"teacher_disagreement_score":0.009084035,"about_ca_system_score_codex":0.000019746783,"about_ca_system_score_gemma":0.00007894507,"threshold_uncertainty_score":0.52610916},"labels":[],"label_agreement":null},{"id":"W2564839290","doi":"10.1182/blood.v126.23.2251.2251","title":"Thymic-Derived Tolerizing Dendritic Cells Are up-Regulated upon Treatment with Intravenous Immunoglobulin or Splenectomy in a Murine Model of Immune Thrombocytopenia","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Splenectomy; Medicine; Immunology; Antibody; Spleen; Platelet; Rituximab; Immunoglobulin G; Immune system; Splenocyte","score_opus":0.03030292216445828,"score_gpt":0.2514141313920547,"score_spread":0.22111120922759642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564839290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99694306,0.001589621,0.00003989923,0.00009523096,0.000049688395,0.000895345,0.000043043226,0.000056027246,0.00028810237],"genre_scores_gemma":[0.9967846,0.00030209435,0.0023414127,0.000027978565,0.000015970034,0.000064051135,0.00008133022,0.00005159509,0.00033091917],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984678,0.00004106859,0.00046948768,0.00035508026,0.00025740478,0.0004091306],"domain_scores_gemma":[0.999083,0.00002802793,0.0001869091,0.0004369732,0.00010878819,0.00015629962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000078333665,0.00033604825,0.0010504287,0.00014477734,0.000040006085,0.000016108283,0.00010963747,0.0001168701,0.00004157859],"category_scores_gemma":[0.000014882503,0.0002280595,0.00009023674,0.00027427406,0.000055916345,0.00008770463,0.00004517381,0.0001155265,0.00001722578],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011363499,0.022584904,0.015991485,0.00042998802,0.002919063,0.008601283,0.0069873263,0.0030493871,0.923439,0.000029841434,0.000021707521,0.0045824866],"study_design_scores_gemma":[0.09182036,0.008297256,0.015444822,0.0012137415,0.0014586714,0.0011226273,0.0016984831,0.005875217,0.87233603,0.00012302004,0.000039325434,0.0005704474],"about_ca_topic_score_codex":0.00094710174,"about_ca_topic_score_gemma":0.0006420422,"teacher_disagreement_score":0.08045686,"about_ca_system_score_codex":0.00017208082,"about_ca_system_score_gemma":0.00036416276,"threshold_uncertainty_score":0.9299997},"labels":[],"label_agreement":null},{"id":"W2564863890","doi":"10.1182/blood.v110.11.5156.5156","title":"Medical Visit Patterns in Cancer Chemotherapy Patients Receiving Erythropoiesis-Stimulating Agents in a Managed Care Setting.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Darbepoetin alfa; Chemotherapy; Epoetin alfa; Cancer; Internal medicine; Observational study; Medical record; Population; Emergency medicine","score_opus":0.014169704139281371,"score_gpt":0.31342756467254684,"score_spread":0.2992578605332655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564863890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99606806,0.00042370602,0.000016844506,0.00111056,0.00012764118,0.00048598906,0.0000076154274,0.00005549461,0.0017040962],"genre_scores_gemma":[0.9975418,0.0002762203,0.00071668014,0.0010627038,0.00016419748,0.000026786576,0.000059867354,0.0000446929,0.00010709522],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99799687,0.00004949788,0.0004839656,0.00039281684,0.00057087454,0.0005059502],"domain_scores_gemma":[0.9993357,0.00010237275,0.00009622661,0.00022721881,0.000055670524,0.00018277817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000339029,0.00022309955,0.00034752887,0.00020077109,0.000060480703,0.000013086643,0.000102918195,0.00018181845,0.00053198513],"category_scores_gemma":[0.00013481843,0.00020000064,0.000079365855,0.00027581348,0.000038662114,0.00004796153,0.000056509733,0.00034583785,0.000011645658],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000617566,0.0011722049,0.945715,0.00022961793,0.000049942286,0.0005533139,0.0036524353,0.000004662391,0.00007753808,0.0000011594869,0.00007292048,0.048409462],"study_design_scores_gemma":[0.015049323,0.00021189528,0.9791613,0.001880663,0.000052442476,0.000010365645,0.0015985604,0.00006472867,0.0016255626,0.0000036232934,0.0001528644,0.00018862639],"about_ca_topic_score_codex":0.0010210843,"about_ca_topic_score_gemma":0.0028112119,"teacher_disagreement_score":0.048220836,"about_ca_system_score_codex":0.0003007445,"about_ca_system_score_gemma":0.00007796675,"threshold_uncertainty_score":0.81557894},"labels":[],"label_agreement":null},{"id":"W2564864293","doi":"10.1182/blood.v124.21.268.268","title":"Inhibition of Fatty Acid Oxidation with Avocatin B Selectively Targets AML Cells and Leukemia Stem Cells","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Leukemia & Lymphoma Society of Canada; University Health Network; Princess Margaret Cancer Centre; University of Waterloo","funders":"","keywords":"Leukemia; Stem cell; Myeloid leukemia; Cancer research; Clonogenic assay; Haematopoiesis; Biology; Bone marrow; Progenitor cell; Apoptosis; Immunology; Cell biology; Biochemistry","score_opus":0.010313414577760669,"score_gpt":0.23136432079772623,"score_spread":0.22105090621996556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564864293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934201,0.000082004975,0.003918029,0.00010823537,0.000019949975,0.00050725095,0.000012815356,0.00004768242,0.0018839188],"genre_scores_gemma":[0.99351627,0.000045048306,0.0056613195,0.000101784935,0.00009329088,0.000024943558,0.000025217116,0.000031782543,0.00050033705],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987234,0.000106530126,0.00023384264,0.0003151347,0.00035880663,0.00026231247],"domain_scores_gemma":[0.9991385,0.00008922904,0.00013757849,0.0002454298,0.00024743332,0.00014183226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035764583,0.0001579272,0.0002940205,0.0001364762,0.00006082261,0.000015927304,0.00005812149,0.000117582545,0.00002848321],"category_scores_gemma":[0.000032368098,0.0001273998,0.00003154337,0.00025904956,0.00011694887,0.00010781352,0.00004565623,0.00025656648,0.000032921467],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001793414,0.00015826736,0.0030852864,0.000254838,0.000067116314,0.000010195244,0.00039089326,0.0000060804578,0.99301535,0.00006031433,0.00040177556,0.002370541],"study_design_scores_gemma":[0.0047083246,0.0008875283,0.00964954,0.000116928306,0.000117842326,0.00003900835,0.00013754086,0.0003485226,0.98355055,0.000027540813,0.00029041225,0.00012624207],"about_ca_topic_score_codex":0.00006452653,"about_ca_topic_score_gemma":0.0000146510065,"teacher_disagreement_score":0.009464783,"about_ca_system_score_codex":0.00015296222,"about_ca_system_score_gemma":0.00027775025,"threshold_uncertainty_score":0.5195213},"labels":[],"label_agreement":null},{"id":"W2564866573","doi":"10.1182/blood.v120.21.1468.1468","title":"YB-1 Is Activated by IL-7 and Is Overexpressed in Pediatric Pre-B Acute Lymphoblastic Leukemia","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of Calgary; Child and Family Research Institute","funders":"","keywords":"CD19; B cell; Cancer research; Flow cytometry; CD20; Survivin; Bone marrow; Leukemia; Medicine; Molecular biology; Immunology; Lymphoma; Biology; Antibody; Internal medicine; Cancer","score_opus":0.009191864974723142,"score_gpt":0.2602709083898166,"score_spread":0.25107904341509346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564866573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961666,0.00095288566,0.000062059895,0.00032399845,0.00008186566,0.0005691395,0.00014656714,0.00009036823,0.0016065456],"genre_scores_gemma":[0.99503905,0.00082867406,0.00036415033,0.0009227645,0.0004008609,0.000067038236,0.000044515342,0.000075523094,0.0022574088],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99740183,0.000068818066,0.0003981944,0.0004961892,0.00066878065,0.00096615666],"domain_scores_gemma":[0.99841374,0.00032117986,0.00011134936,0.0004999385,0.000085932865,0.0005678824],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023282439,0.00033590698,0.000502569,0.00029112498,0.000074175245,0.000038843267,0.00019575242,0.00032279358,0.0003511814],"category_scores_gemma":[0.00023131326,0.00029512108,0.000077178796,0.0006456948,0.00010366493,0.00031539946,0.00021816263,0.00037473164,0.00014955616],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011590833,0.0023752733,0.45668563,0.00069889287,0.00070694956,0.00018194382,0.004150366,0.0000013640323,0.4059237,0.000033806595,0.1270129,0.0010701176],"study_design_scores_gemma":[0.049041275,0.0009354125,0.32576847,0.00026113226,0.0019425225,0.00085214875,0.00017369763,0.0010946451,0.6097546,0.000077637924,0.009086931,0.0010114999],"about_ca_topic_score_codex":0.00021037606,"about_ca_topic_score_gemma":0.0000017319813,"teacher_disagreement_score":0.20383094,"about_ca_system_score_codex":0.0006623821,"about_ca_system_score_gemma":0.0007110797,"threshold_uncertainty_score":0.9999501},"labels":[],"label_agreement":null},{"id":"W2564914855","doi":"10.1182/blood.v118.21.1919.1919","title":"Screen for Small Molecules Capable of Expanding Human Hematopoietic Stem Cell Ex Vivo","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Stem cell; Stem cell factor; Haematopoiesis; CD34; Ex vivo; Transplantation; Cord blood; Population; Thrombopoietin; Cell biology; Hematopoietic stem cell; Chemistry; Progenitor cell; Biology; Molecular biology; Immunology; Internal medicine; Biochemistry; In vitro; Medicine","score_opus":0.0490236581281072,"score_gpt":0.2613461706423318,"score_spread":0.21232251251422457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564914855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9544341,0.00022937931,0.008693404,0.000012740221,0.00004406329,0.0007564397,0.00002845763,0.00006521969,0.035736207],"genre_scores_gemma":[0.98547465,0.000013497412,0.013292283,0.00003250309,0.000041011608,0.00004577784,0.000022351784,0.000043851443,0.0010340525],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99891037,0.000024112156,0.00038837982,0.00024107887,0.0001738631,0.0002622153],"domain_scores_gemma":[0.9992979,0.0000653618,0.00013178756,0.0003040101,0.00008585718,0.00011508998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018585303,0.00015532265,0.00035368907,0.000106476684,0.00005377481,0.000006295749,0.00010873575,0.00010250249,0.00015612881],"category_scores_gemma":[0.000005127009,0.00014540125,0.00012446815,0.00009544432,0.000046148405,0.000035063054,0.000014478605,0.00006777583,0.000017647088],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013708558,0.0013712024,0.013763396,0.0042218613,0.00017443323,0.00007302939,0.009495918,0.0000012089365,0.96700126,0.003529419,0.00012152823,0.00010963598],"study_design_scores_gemma":[0.0041207946,0.00042703078,0.00093220704,0.00040525096,0.00055636425,0.00007547925,0.0014808155,0.000021221516,0.9915489,0.0002460689,0.000038624523,0.00014725693],"about_ca_topic_score_codex":0.000078634956,"about_ca_topic_score_gemma":0.000012954253,"teacher_disagreement_score":0.034702152,"about_ca_system_score_codex":0.000011446942,"about_ca_system_score_gemma":0.000040534625,"threshold_uncertainty_score":0.5929291},"labels":[],"label_agreement":null},{"id":"W2564969979","doi":"10.1182/blood.v104.11.1179.1179","title":"Expression of the Human ATP-Binding Cassette Transporter Superfamily in Acute Myeloid Leukemia.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"ATP-binding cassette transporter; Daunorubicin; Myeloid leukemia; Leukemia; Multiple drug resistance; Biology; Cancer research; Pharmacology; Medicine; Immunology; Drug resistance; Transporter; Internal medicine; Gene; Genetics","score_opus":0.011823446259944834,"score_gpt":0.2365012375739696,"score_spread":0.22467779131402477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564969979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99799615,0.00013451818,0.000057153757,0.0002878584,0.00011106103,0.00029970173,0.000017312543,0.000031325486,0.0010649359],"genre_scores_gemma":[0.9986892,0.00004197247,0.00045428256,0.00014160173,0.000052265186,0.000012862597,0.0000247028,0.000025816478,0.0005573242],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998905,0.000011670039,0.00032367793,0.00021606994,0.00029639454,0.00024719504],"domain_scores_gemma":[0.9995181,0.00000640513,0.00006206164,0.00032496828,0.0000244745,0.00006398856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011877164,0.00014588726,0.00029736667,0.000082220846,0.00007393553,0.0000044679255,0.00014916391,0.00012019683,0.00003594719],"category_scores_gemma":[0.000002285949,0.000093598916,0.00014979682,0.00020470051,0.000060496735,0.000058743426,0.000010531946,0.00024199039,0.0000047026656],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038284976,0.0002573396,0.04045952,0.000085148466,0.000034794542,0.00020715427,0.0013453023,0.000012003362,0.95735586,0.00015504501,0.000009836617,0.000039691105],"study_design_scores_gemma":[0.005096166,0.00006865344,0.17583539,0.00067293155,0.00023143091,0.00002677545,0.00019538344,3.671314e-7,0.8174345,0.00014379024,0.00019107887,0.00010356625],"about_ca_topic_score_codex":0.0000644631,"about_ca_topic_score_gemma":0.00011844378,"teacher_disagreement_score":0.1399214,"about_ca_system_score_codex":0.000060462768,"about_ca_system_score_gemma":0.00011941815,"threshold_uncertainty_score":0.38168532},"labels":[],"label_agreement":null},{"id":"W2564973962","doi":"10.1182/blood.v114.22.639.639","title":"Erythropoietin Is Equally Effective as Blood Transfusion at Reducing Infarct Size in Anemic Rats.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Erythropoietin; Anemia; Saline; Myocardial infarction; Anesthesia; Blood transfusion; Internal medicine; Ischemia; Hemoglobin; Cardiology","score_opus":0.006783021970471784,"score_gpt":0.2607828408882988,"score_spread":0.253999818917827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564973962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.977554,0.0017767448,0.0000026823784,0.006095245,0.0000960993,0.0011387046,0.000008537321,0.00014460417,0.013183361],"genre_scores_gemma":[0.9935438,0.001275496,0.0012359488,0.0019786528,0.00020208741,0.000047888137,0.00002814518,0.000042079646,0.001645875],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99776614,0.000116434654,0.00045868757,0.00066568446,0.00044673326,0.00054630253],"domain_scores_gemma":[0.99888074,0.00025271287,0.00009811631,0.00046994298,0.000066060646,0.00023241054],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029628613,0.0003773676,0.00057909614,0.00013944,0.00014843732,0.000021697519,0.00011122629,0.00024648168,0.0010355938],"category_scores_gemma":[0.0001831859,0.0003240743,0.00022318511,0.00038519505,0.000100045145,0.00007450916,0.00003989732,0.0004040694,0.0002033017],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009016147,0.0074726115,0.02812777,0.00022417601,0.000284401,0.0023335617,0.00742397,0.000005459648,0.9321634,0.000089677844,0.0013444292,0.0196289],"study_design_scores_gemma":[0.02347426,0.0056248223,0.067247115,0.001034736,0.00092812633,0.0016056325,0.0004177378,0.000008252761,0.89813286,0.00035392624,0.0006617006,0.0005108404],"about_ca_topic_score_codex":0.00030361075,"about_ca_topic_score_gemma":0.00003705024,"teacher_disagreement_score":0.039119348,"about_ca_system_score_codex":0.00015322161,"about_ca_system_score_gemma":0.00012833286,"threshold_uncertainty_score":0.99992114},"labels":[],"label_agreement":null},{"id":"W2565007565","doi":"10.1182/blood.v108.11.832.832","title":"Obatoclax (GX15-070) Is a Potent Antagonist of Constitutive Mcl-1/Bak Interactions in Intact Mitochondrial Membrane and Synergizes with Bortezomib in Mantle Cell Lymphoma.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Biotechnology Research Institute; McGill University","funders":"","keywords":"Bcl-2 family; Effector; Biology; Programmed cell death; Small molecule; Chemistry; Pharmacology; Apoptosis; Biochemistry","score_opus":0.0035672322929422105,"score_gpt":0.19913227393830024,"score_spread":0.19556504164535804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565007565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959697,0.000437423,0.00022272162,0.00004402241,0.00009928855,0.00024445736,0.000040400013,0.000004816749,0.002937184],"genre_scores_gemma":[0.9984369,0.00016647541,0.0008229589,0.000024283674,0.00008156029,0.000018334615,0.00009210092,0.000011966086,0.00034540266],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99921465,0.000028604902,0.00023644135,0.00027723666,0.00008702169,0.00015604841],"domain_scores_gemma":[0.99966687,0.00001040598,0.000093829745,0.00015779972,0.000037826936,0.00003328572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000044837394,0.00013600221,0.00017689825,0.00008770867,0.000037193247,0.000016572485,0.00005809565,0.000088971545,0.0000106405605],"category_scores_gemma":[0.000005276348,0.000117528834,0.00004088468,0.00010022285,0.00009485864,0.000007827935,0.000042247862,0.000050895145,0.0000011703246],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023538398,0.0006693083,0.0042255674,0.000036746635,0.000029348586,0.000024576595,0.000064949985,0.00008738984,0.99395263,0.00030986886,0.00005255354,0.00031170304],"study_design_scores_gemma":[0.005957518,0.00021952068,0.008635829,0.00006280542,0.000051560266,0.00006496446,0.00015521022,0.0001346241,0.98270303,0.000095507145,0.0017413073,0.00017813566],"about_ca_topic_score_codex":0.00087571534,"about_ca_topic_score_gemma":0.0014235404,"teacher_disagreement_score":0.011249586,"about_ca_system_score_codex":0.00001775473,"about_ca_system_score_gemma":0.00008893727,"threshold_uncertainty_score":0.47926867},"labels":[],"label_agreement":null},{"id":"W2565017341","doi":"10.1182/blood.v108.11.3159.3159","title":"Transplant-Related Mortality in Patients ≥50 Years of Age Is No Lower after Transplantation from Young Fully Matched Unrelated Donors (MUD) Than from Matched Siblings When All Patients Are Given the FLUBUP Regimen with Thymoglobulin.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre","funders":"","keywords":"Thymoglobulin; Medicine; Busulfan; Fludarabine; Folinic acid; Transplantation; Surgery; Internal medicine; Regimen; Gastroenterology; Pediatrics; Hematopoietic stem cell transplantation; Cyclophosphamide; Chemotherapy; Tacrolimus; Fluorouracil","score_opus":0.007579465816897611,"score_gpt":0.21405921148461432,"score_spread":0.2064797456677167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565017341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99557143,0.00011292751,0.00004087131,0.00010994753,0.00014266235,0.0010855182,0.0025715437,0.000058958387,0.00030612524],"genre_scores_gemma":[0.9930547,0.00019352756,0.00064572995,0.00016301856,0.00003329867,0.000055158853,0.0056469603,0.000059824146,0.00014778071],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99746954,0.00011620204,0.0008116164,0.0005368055,0.00070441567,0.0003614266],"domain_scores_gemma":[0.9988391,0.00010887125,0.00036600677,0.00043298063,0.00013986872,0.00011317523],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009518859,0.00038769055,0.0006488632,0.00014606206,0.000043333454,0.000034710403,0.00018275043,0.00026925176,0.00021337591],"category_scores_gemma":[0.00000500555,0.0002785498,0.00019691388,0.0002554637,0.00008927336,0.0001933561,0.000010459652,0.00028742498,0.000054030763],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036596593,0.0021074777,0.9857316,0.00011552485,0.0012228418,0.00048427228,0.0061724503,0.000025035613,0.000427796,0.0000020202535,0.000015260692,0.000036037774],"study_design_scores_gemma":[0.025766408,0.0004783413,0.9680148,0.0011873606,0.0023328827,0.0000044415992,0.00008663974,0.00001695508,0.0015874797,0.00022831559,0.000013260271,0.0002831301],"about_ca_topic_score_codex":0.012436391,"about_ca_topic_score_gemma":0.0018484152,"teacher_disagreement_score":0.02210675,"about_ca_system_score_codex":0.00005484996,"about_ca_system_score_gemma":0.000039507046,"threshold_uncertainty_score":0.9999667},"labels":[],"label_agreement":null},{"id":"W2565019685","doi":"10.1182/blood.v120.21.1414.1414","title":"Outcome of Pediatric Patients with Acute Myeloid Leukemia and -5/5q-Abnormalities Enrolled On Five Children's Oncology Group Acute Myeloid Leukemia Treatment Protocols","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Medicine; Internal medicine; Myeloid leukemia; Acute promyelocytic leukemia; Cog; Leukemia; Myeloid; Hematology; Chromosome abnormality; Cancer; Bone marrow; Oncology; Gastroenterology; Chromosome; Karyotype; Biology","score_opus":0.01751639390199533,"score_gpt":0.29904683518655556,"score_spread":0.28153044128456023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565019685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97766536,0.00017019456,0.000013106211,0.00013955605,0.0000848149,0.019192485,0.00031626676,0.00013234296,0.0022858456],"genre_scores_gemma":[0.9851666,0.00034005393,0.0022183144,0.00032559093,0.0008569556,0.008226801,0.0004033733,0.00014727158,0.0023150223],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99560624,0.00033391302,0.00096345134,0.0007459952,0.0010307175,0.0013197066],"domain_scores_gemma":[0.9972048,0.00033605986,0.0005194243,0.0009130534,0.00028670614,0.0007399807],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000566999,0.0007639021,0.0015523387,0.00058415864,0.00022836222,0.000039139428,0.00034068237,0.00047164925,0.00011282177],"category_scores_gemma":[0.000111317015,0.0005298878,0.00025115052,0.0005507847,0.00033662046,0.00038177153,0.00026108627,0.00072378723,0.00007876619],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041222326,0.0028075327,0.98328733,0.00020138345,0.0028183912,0.00015963412,0.0016490057,0.0000041192575,0.0004167562,0.00016104316,0.0004021609,0.003970422],"study_design_scores_gemma":[0.061629813,0.019162146,0.9084591,0.000102886646,0.0036990342,0.00032667257,0.00022642034,0.000014017975,0.0046080654,0.00001469867,0.0010829598,0.00067417684],"about_ca_topic_score_codex":0.0003245475,"about_ca_topic_score_gemma":0.000023541545,"teacher_disagreement_score":0.07482821,"about_ca_system_score_codex":0.0024455036,"about_ca_system_score_gemma":0.0012787138,"threshold_uncertainty_score":0.99971527},"labels":[],"label_agreement":null},{"id":"W2565035265","doi":"10.1182/blood.v120.21.2445.2445","title":"Next-Generation STAT3 Inhibitors As Targeted Therapeutics in Chronic Myeloid Leukemia.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Imatinib; Myeloid leukemia; Cancer research; STAT3; Tyrosine-kinase inhibitor; K562 cells; Imatinib mesylate; Medicine; Leukemia; Pharmacology; Biology; Immunology; Signal transduction; Internal medicine; Cancer; Cell biology","score_opus":0.03915596805188665,"score_gpt":0.2826460204642045,"score_spread":0.24349005241231786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565035265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98788023,0.009007346,0.000013818414,0.00024953313,0.00034244035,0.00059854385,0.0000067646683,0.00010608723,0.0017952342],"genre_scores_gemma":[0.9957281,0.0006503862,0.00044930275,0.0004800803,0.0014872364,0.00007308329,0.0002010467,0.00006012722,0.0008706868],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982399,0.00007273643,0.00038826824,0.00029802174,0.00036056014,0.0006405364],"domain_scores_gemma":[0.9991785,0.000044056273,0.00010188663,0.00042108807,0.000039811497,0.00021465322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002208197,0.00026661126,0.00033218093,0.00016761711,0.000066983375,0.000025916594,0.00008582976,0.00020526032,0.0003208513],"category_scores_gemma":[0.00004100804,0.00023853396,0.00009175466,0.0003288653,0.000052014508,0.00028893992,0.000043663676,0.00031595025,0.00040541365],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013412417,0.002143532,0.1233013,0.00017556804,0.0006470544,0.00015535612,0.0027350064,0.00011566791,0.847716,0.0003598838,0.0011755103,0.021341035],"study_design_scores_gemma":[0.028477322,0.0012104533,0.06250282,0.00023537276,0.00090691884,0.00032651296,0.00030184744,0.0015805595,0.8717948,0.00008109154,0.031884324,0.0006979502],"about_ca_topic_score_codex":0.0003633111,"about_ca_topic_score_gemma":0.00014229114,"teacher_disagreement_score":0.06079848,"about_ca_system_score_codex":0.0033118988,"about_ca_system_score_gemma":0.0014718309,"threshold_uncertainty_score":0.97271323},"labels":[],"label_agreement":null},{"id":"W2565056379","doi":"10.1182/blood.v124.21.2121.2121","title":"Pharmacokinetic (PK) and Pharmacodynamic (PD) Results of a Novel, First-in-Class Modulator of Eukaryotic Translation Initiation Factor 5A (eIF5A) in Patients (pts) with Relapsed or Refractory B-Cell Malignancies: Data from a Phase 1-2 Study","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Polyamine Metabolism and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Medicine; Cancer research; Apoptosis; In vivo; Molecular biology; Pharmacology; Biology; Immunology","score_opus":0.02630048746202491,"score_gpt":0.2814800260140191,"score_spread":0.2551795385519942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565056379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958322,0.00022637089,0.0005299976,0.00001712107,0.000031018,0.0007392,0.0025711334,0.0000061324404,0.00004683951],"genre_scores_gemma":[0.9975296,0.00010179506,0.0005195014,0.000019144785,0.000034865036,0.0000393185,0.0017271561,0.000018722947,0.000009879904],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99862,0.0000836709,0.00050025625,0.0004620988,0.00017650961,0.00015748087],"domain_scores_gemma":[0.9990269,0.000066027336,0.00027912174,0.00051032135,0.00006318754,0.000054444754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016432315,0.00017171407,0.00026151247,0.000104645434,0.000023333916,0.0000070273004,0.00023914398,0.00007600821,0.00000619208],"category_scores_gemma":[0.00006724227,0.00014831532,0.00002054341,0.00020038104,0.000050272763,0.000024081555,0.00006817616,0.000084760446,5.948882e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002411924,0.015018987,0.04033795,0.000113870716,0.00009084119,0.0000018851028,0.00071526825,0.000150481,0.9378341,0.000001376422,0.0000262204,0.0032970973],"study_design_scores_gemma":[0.21487415,0.004649262,0.43528363,0.00017957755,0.00067604723,0.0000020793798,0.00024590257,0.023453882,0.3188267,0.000009093705,0.0010898975,0.00070977793],"about_ca_topic_score_codex":0.00014952572,"about_ca_topic_score_gemma":0.00032798338,"teacher_disagreement_score":0.6190074,"about_ca_system_score_codex":0.000006392014,"about_ca_system_score_gemma":0.00005731493,"threshold_uncertainty_score":0.6048123},"labels":[],"label_agreement":null},{"id":"W2565087503","doi":"10.1182/blood.v108.11.3359.3359","title":"Total Annual Costs of Infused Iron Chelation Therapy in the United States.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Association of Radiation Oncology","funders":"","keywords":"Medicine; Life expectancy; Emergency medicine; Pediatrics; Intensive care medicine; Population; Environmental health","score_opus":0.0060070802599902625,"score_gpt":0.22605976226840552,"score_spread":0.22005268200841527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565087503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962884,0.00047210586,0.0000073495903,0.00071092014,0.00002425644,0.00026813167,0.000010792458,0.000017490502,0.0022005576],"genre_scores_gemma":[0.99919826,0.00022292651,0.000025829608,0.000247393,0.000030730545,0.000005313515,0.00017640639,0.000007972573,0.00008514305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994373,0.000043667642,0.00017636304,0.00007735105,0.00014931982,0.00011603036],"domain_scores_gemma":[0.99973005,0.00003787963,0.000047944213,0.000121223005,0.000045705943,0.000017170061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012969569,0.00006750779,0.00010465772,0.00009252006,0.000021063324,0.000004084752,0.000038438542,0.00008412433,0.000023425315],"category_scores_gemma":[0.000015938767,0.000042107895,0.000032631393,0.00034845105,0.00004218592,0.000027731556,0.0000055199575,0.000131625,0.0000046930895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018066103,0.020095767,0.82716936,0.00027375622,0.0003705685,0.0003609741,0.030868867,0.008048243,0.060861133,0.004635138,0.009050035,0.036459535],"study_design_scores_gemma":[0.026971215,0.0014939316,0.9510404,0.00016576391,0.00013702826,0.00008982453,0.005704894,0.0011749353,0.007346445,0.00031080274,0.005328093,0.00023665883],"about_ca_topic_score_codex":0.0013230481,"about_ca_topic_score_gemma":0.000031813222,"teacher_disagreement_score":0.12387103,"about_ca_system_score_codex":0.000011676338,"about_ca_system_score_gemma":0.000026557875,"threshold_uncertainty_score":0.20000619},"labels":[],"label_agreement":null},{"id":"W2565088959","doi":"10.1182/blood.v110.11.3303.3303","title":"Bone Marrow Cells from Patients with Shwachman-Diamond Syndrome Abnormally Express Ribosomal Protein and Ribosomal Biogenesis-Related Genes.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Ribosomal protein; Biology; Ribosomal RNA; Gene; Ribosome biogenesis; Molecular biology; RNA; Genetics; Ribosome","score_opus":0.002806609350673061,"score_gpt":0.17291033688756186,"score_spread":0.1701037275368888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565088959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942432,0.0043749055,0.00005740122,0.000015424654,0.00006435637,0.0006404632,0.00028399628,0.000031253163,0.00028901457],"genre_scores_gemma":[0.9972144,0.00009276466,0.0015327347,0.000048111226,0.000048774687,0.00004604956,0.00077417283,0.0000583146,0.00018471651],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983134,0.000040472907,0.00031041083,0.00062413386,0.00023407064,0.000477485],"domain_scores_gemma":[0.9991593,0.000009511037,0.00014604279,0.00039747448,0.00007543685,0.00021228196],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000081386104,0.00034798746,0.00026934122,0.0000721105,0.0001342614,0.000042563428,0.00016378275,0.00029017485,0.000028082653],"category_scores_gemma":[0.0000063239313,0.000299758,0.00007967892,0.000120695666,0.000116214935,0.000013993059,0.00013563692,0.00008884019,0.000015287127],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040092526,0.002745338,0.41242793,0.000034538974,0.00084228936,0.00031778752,0.000057149104,0.000005191964,0.5799905,0.000011204097,0.000050915693,0.003116259],"study_design_scores_gemma":[0.010246286,0.0011468624,0.15346478,0.000040375766,0.00028488762,0.0000337296,0.00002947781,0.0000021576282,0.8333357,0.0000341867,0.0008678121,0.0005137725],"about_ca_topic_score_codex":0.00017191037,"about_ca_topic_score_gemma":0.00018002519,"teacher_disagreement_score":0.25896314,"about_ca_system_score_codex":0.000006663544,"about_ca_system_score_gemma":0.000040192786,"threshold_uncertainty_score":0.99994546},"labels":[],"label_agreement":null},{"id":"W2565093580","doi":"10.1182/blood.v104.11.1797.1797","title":"Variant Forms of Human Interleukin-3 (IL-3) Linked to Truncated Diphtheria Toxin (DT388), Have Enhanced Cytotoxicity Against Acute Myeloid Leukemia (AML) Progenitors.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diphtheria toxin; Cytotoxicity; Myeloid leukemia; Biology; Fusion protein; Leukemia; Haematopoiesis; Toxin; Progenitor cell; Immunology; Molecular biology; Stem cell; Microbiology; In vitro; Biochemistry; Recombinant DNA; Cell biology","score_opus":0.009428141731809243,"score_gpt":0.23434136211362835,"score_spread":0.2249132203818191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565093580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947475,0.00019583937,0.0015979597,0.00006796606,0.0005798548,0.0012787874,0.00025428255,0.00022163003,0.0010561427],"genre_scores_gemma":[0.99697906,0.0000458169,0.0010957004,0.00027122156,0.000085835876,0.00019613479,0.00027681873,0.00008421072,0.00096521917],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997142,0.00013064784,0.0010324896,0.0007149233,0.0001202636,0.00085967913],"domain_scores_gemma":[0.99842274,0.00003861566,0.00042013155,0.00085004256,0.00016311278,0.000105341205],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003600513,0.0005428029,0.0008354439,0.00024295921,0.00033851425,0.000044201926,0.0007946445,0.0006553433,0.00027349204],"category_scores_gemma":[0.000085975546,0.00047125656,0.0003237388,0.00031155755,0.00020274718,0.00019147451,0.0003155737,0.0005753616,0.00034317328],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030783436,0.0009369713,0.000049684313,0.000029653,0.00091995165,0.00003970455,0.0020003784,0.000017366592,0.9933373,0.0013315715,0.000041635107,0.0009879741],"study_design_scores_gemma":[0.007636878,0.0019048392,0.0015280736,0.00016185295,0.00022257335,0.00010369011,0.00037222615,8.890971e-7,0.9860512,0.00088654656,0.00057189475,0.0005593075],"about_ca_topic_score_codex":0.00019390123,"about_ca_topic_score_gemma":0.00016040765,"teacher_disagreement_score":0.007329044,"about_ca_system_score_codex":0.00027252355,"about_ca_system_score_gemma":0.00028731144,"threshold_uncertainty_score":0.9997739},"labels":[],"label_agreement":null},{"id":"W2565114624","doi":"10.1182/blood.v118.21.3366.3366","title":"HLA- and HPA-Alloimmunization Rate In the Setting of Refractoriness to Platelet Transfusion: A Single Center Study,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Platelet; Human leukocyte antigen; Immunology; Platelet transfusion; Isoantibodies; ABO blood group system; Population; Antibody; Internal medicine; Single Center; Antigen; Gastroenterology","score_opus":0.026585405611781954,"score_gpt":0.2431659171549127,"score_spread":0.21658051154313074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565114624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976982,0.000071974006,0.000050979186,0.0002523498,0.000046634348,0.0006621506,0.0000031249097,0.000014277052,0.0012003384],"genre_scores_gemma":[0.99946666,0.000055482094,0.00026899637,0.0001300448,0.000033856348,0.00001385994,0.000006797939,0.000012775855,0.000011544769],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99929136,0.00007720978,0.00022197513,0.00015708571,0.00013094774,0.00012142757],"domain_scores_gemma":[0.99964535,0.000034701803,0.000034788936,0.00020018192,0.00004771625,0.000037265043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034358542,0.00009200954,0.00018636847,0.000078163415,0.00004236835,0.0000076083493,0.00006982059,0.00004456352,0.000027168759],"category_scores_gemma":[0.000020891412,0.000061583654,0.0000252145,0.00027657955,0.000013958888,0.000055392808,0.000019878225,0.000115899624,0.0000014327491],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044214528,0.009255169,0.83266205,0.00014033329,0.00009118373,0.00012324592,0.06708078,8.4891354e-7,0.07718471,0.000057318946,0.0000068791196,0.012955338],"study_design_scores_gemma":[0.007610237,0.0014356578,0.96957254,0.0001845472,0.00016651556,0.00007466284,0.0037966894,0.0000064185415,0.016643044,0.00001919515,0.0003918102,0.00009868822],"about_ca_topic_score_codex":0.00027567535,"about_ca_topic_score_gemma":0.00030903108,"teacher_disagreement_score":0.13691048,"about_ca_system_score_codex":0.000003953046,"about_ca_system_score_gemma":0.0000098199225,"threshold_uncertainty_score":0.25113085},"labels":[],"label_agreement":null},{"id":"W2565123974","doi":"10.1182/blood.v116.21.415.415","title":"A Randomized Phase III Trial of ABVD Vs. Stanford V +/− Radiation Therapy In Locally Extensive and Advanced Stage Hodgkin's Lymphoma: An Intergroup Study Coordinated by the Eastern Cooperatve Oncology Group (E2496)","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency","funders":"","keywords":"ABVD; Medicine; Regimen; Chemotherapy regimen; Internal medicine; Radiation therapy; Randomized controlled trial; Hazard ratio; Surgery; Oncology; Chemotherapy; Vincristine; Confidence interval; Cyclophosphamide","score_opus":0.012605152545392805,"score_gpt":0.30830502666910675,"score_spread":0.29569987412371396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565123974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99219346,0.0006890509,0.00005238523,0.0002798366,0.00027152064,0.006359662,0.000039295275,0.000032768694,0.00008199897],"genre_scores_gemma":[0.9979539,0.00052100414,0.00006894308,0.00031943692,0.000078528436,0.00083501526,0.00010086674,0.000029481827,0.000092809605],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9978191,0.0005131819,0.00071350386,0.00042817811,0.00025730417,0.00026868988],"domain_scores_gemma":[0.9984009,0.00048934383,0.00034804354,0.00042049662,0.00020350794,0.00013769441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089358236,0.00029342386,0.0011809516,0.00012628778,0.00007314902,0.000043952605,0.00013140349,0.0001489737,0.000023251669],"category_scores_gemma":[0.0002159583,0.00017889314,0.00011150441,0.00020951287,0.00019717684,0.00019715473,0.000044838285,0.00014885615,0.0000013290339],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8073017,0.0404938,0.005067667,0.000013320831,0.00077417545,0.00023439291,0.0041045602,0.0000010036982,0.009365017,0.00009938461,0.00003542915,0.13250954],"study_design_scores_gemma":[0.9648025,0.02403503,0.0027879125,0.000034021745,0.000431388,0.000037594844,0.0017205597,0.00029398382,0.00528362,0.0000116661595,0.00039765626,0.00016409256],"about_ca_topic_score_codex":0.0009229332,"about_ca_topic_score_gemma":0.00079794845,"teacher_disagreement_score":0.15750076,"about_ca_system_score_codex":0.00007684273,"about_ca_system_score_gemma":0.00017803373,"threshold_uncertainty_score":0.72950506},"labels":[],"label_agreement":null},{"id":"W2565133281","doi":"10.1182/blood.v112.11.2767.2767","title":"Phase II Testing of Lenalidomide Plus Melphalan for Previously Untreated Older Patients with Multiple Myeloma: The NCIC CTG MY.11 Trial","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Juravinski Cancer Centre; Victoria Hospital; University of Calgary; Queen's University; McMaster University; Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Lenalidomide; Neutropenia; Multiple myeloma; Melphalan; Internal medicine; Toxicity; Phases of clinical research; Gastroenterology; Febrile neutropenia; Tolerability; Surgery; Adverse effect","score_opus":0.04342470690850933,"score_gpt":0.2986483750118101,"score_spread":0.25522366810330077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565133281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944277,0.00020141962,0.000045282544,0.00007977788,0.000045412267,0.0048110597,0.00013078217,0.000067191184,0.00019139262],"genre_scores_gemma":[0.9964603,0.000011244408,0.002143748,0.000034005727,0.00017149263,0.00043962424,0.0002683215,0.000049253955,0.000421969],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980346,0.00008465002,0.00042925382,0.0003598302,0.00055114966,0.00054049655],"domain_scores_gemma":[0.9980606,0.000604214,0.00021737597,0.00045917163,0.00042210252,0.000236556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019910756,0.00026323897,0.000527235,0.000105230036,0.00037916342,0.000011170873,0.00015626334,0.00008174739,0.0000328211],"category_scores_gemma":[0.0012636482,0.00014785498,0.00014396367,0.00030990085,0.00016807517,0.000077898396,0.00006214619,0.00013501954,0.0000063828975],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14778145,0.035589997,0.79283375,0.00041427804,0.0021951825,0.00049150817,0.002658125,0.000014309976,0.0026670913,0.000010458727,0.0007100218,0.014633836],"study_design_scores_gemma":[0.85837674,0.01822094,0.099211864,0.00028681563,0.0009228981,0.00010958364,0.00007578916,0.00067491765,0.021619357,0.000005696404,0.00026935287,0.00022601246],"about_ca_topic_score_codex":0.00036623754,"about_ca_topic_score_gemma":0.000093493494,"teacher_disagreement_score":0.7105953,"about_ca_system_score_codex":0.000060109105,"about_ca_system_score_gemma":0.00034000495,"threshold_uncertainty_score":0.6029351},"labels":[],"label_agreement":null},{"id":"W2565136629","doi":"10.1182/blood.v120.21.3274.3274","title":"Ivig Negatively Regulates LPS-Induced Monocytes Activation Through a Microrna-146a Related Mechanism","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Héma-Québec","funders":"","keywords":"Innate immune system; Biology; Cell biology; Gene silencing; Immune system; Acquired immune system; microRNA; Inflammation; RNA interference; Signal transduction; Proinflammatory cytokine; Immunology; RNA; Gene; Genetics","score_opus":0.016497662198757593,"score_gpt":0.2469848713279726,"score_spread":0.230487209129215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565136629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99718815,0.00069569785,0.0005851211,0.00015244598,0.00013720061,0.0003266126,0.00001193937,0.000054524633,0.00084828684],"genre_scores_gemma":[0.9966968,0.000041995758,0.0022626512,0.00010648057,0.0002863646,0.00003564955,0.00021259466,0.000047427395,0.00031001077],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988034,0.00009531306,0.00026096552,0.00033573824,0.00014016753,0.00036442833],"domain_scores_gemma":[0.99920434,0.000017264641,0.0001940839,0.000388546,0.000094423536,0.00010135303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000153926,0.00022143553,0.00015545553,0.000043102526,0.00011777226,0.000027641281,0.00015370794,0.0002835984,0.0000475041],"category_scores_gemma":[0.00010998273,0.00022244123,0.000111373774,0.00014795209,0.000039531576,0.000032192136,0.000099252626,0.00009443433,0.000046427776],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003503852,0.0002806254,0.00057427585,0.000016202457,0.0001629114,6.842679e-7,0.00023463057,0.000006029956,0.9972012,0.0009219552,0.00028526227,0.00028118314],"study_design_scores_gemma":[0.0011593108,0.00009291329,0.01060731,0.000030133911,0.00009104735,0.000017272772,0.000067837645,0.000018523813,0.9847773,0.0015185414,0.0013491284,0.00027073396],"about_ca_topic_score_codex":0.00002451659,"about_ca_topic_score_gemma":0.0000027273409,"teacher_disagreement_score":0.012423954,"about_ca_system_score_codex":0.000026568912,"about_ca_system_score_gemma":0.00005374896,"threshold_uncertainty_score":0.907089},"labels":[],"label_agreement":null},{"id":"W2565149220","doi":"10.1182/blood.v104.11.1413.1413","title":"Aberrant Intronic Splicing of the Hyaluronan Synthase 1 Gene (HAS1) in Multiple Myeloma: A Biologically Relevant Marker That Predicts for Poor Survival.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Proteoglycans and glycosaminoglycans research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Hyaluronan synthase; Biology; Intron; Exon; RNA splicing; Gene; Phenotype; Cancer research; Gene expression profiling; Gene expression; Molecular biology; Genetics; RNA","score_opus":0.02115889300758473,"score_gpt":0.2505410183545712,"score_spread":0.2293821253469865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565149220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995961,0.0009222556,0.0011472782,0.0004711036,0.000100307836,0.0010677245,0.00018148706,0.0000102542035,0.00013857384],"genre_scores_gemma":[0.99755836,0.0002047919,0.0016051149,0.00008254018,0.000111471076,0.00021062107,0.00006593885,0.000027770247,0.00013339074],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983787,0.00010424636,0.00032065282,0.00046590978,0.00021910892,0.0005113622],"domain_scores_gemma":[0.9991381,0.000061171966,0.000113131486,0.00051835587,0.000082771025,0.00008646007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005282287,0.00020172521,0.00025911425,0.000056059318,0.00009711332,0.000015547,0.0004604411,0.00020743808,0.000009258197],"category_scores_gemma":[0.0004351279,0.00013621204,0.00017429206,0.00014649796,0.00017695331,0.0000045946726,0.0002545717,0.00016649501,0.0000017133028],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046517444,0.00056315295,0.016139748,0.00006583953,0.000091836155,0.00001000189,0.000034836175,0.00019452652,0.97972924,0.000066167726,0.00003291395,0.002606587],"study_design_scores_gemma":[0.00711133,0.0010661514,0.052835297,0.00009364491,0.000041873358,0.000028004797,0.00005693846,0.0001707233,0.93618363,0.0002219696,0.0019558447,0.00023459709],"about_ca_topic_score_codex":0.00028619115,"about_ca_topic_score_gemma":0.0010257175,"teacher_disagreement_score":0.043545593,"about_ca_system_score_codex":0.000031304455,"about_ca_system_score_gemma":0.00024924948,"threshold_uncertainty_score":0.5554566},"labels":[],"label_agreement":null},{"id":"W2565199921","doi":"10.1182/blood.v110.11.4611.4611","title":"Drug Utilization and Cost Considerations of Erythropoiesis-Stimulating Agents in Patients with Myelodysplastic Syndromes.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Darbepoetin alfa; Dosing; Epoetin alfa; Myelodysplastic syndromes; Anemia; Erythropoiesis; Drug holiday; Internal medicine; Retrospective cohort study; Pediatrics; Family medicine; Bone marrow","score_opus":0.031136159369644898,"score_gpt":0.2861349683215925,"score_spread":0.2549988089519476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565199921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983469,0.0001082386,0.00007694041,0.000104005325,0.000027291664,0.00045369775,0.000008477066,0.000019165574,0.00085527607],"genre_scores_gemma":[0.99739367,0.00001989731,0.0023793583,0.00005323348,0.0000114245695,0.0000052136697,0.000052950105,0.000013729493,0.000070495786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992311,0.000015381473,0.00025518687,0.00016072701,0.00018431954,0.00015325735],"domain_scores_gemma":[0.9995093,0.00013840747,0.0000786102,0.0001119552,0.000087990564,0.00007377869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009644864,0.0001056519,0.00020163566,0.000107260326,0.000057032088,0.0000072810967,0.000013158418,0.00003978191,0.00007116901],"category_scores_gemma":[0.0001039276,0.00008457365,0.000016774258,0.00014084367,0.00009307252,0.000046918023,0.000015470017,0.000066208566,0.000002733948],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055225584,0.0010790305,0.9975328,0.00008885697,0.00005339592,0.00005257675,0.0004049924,0.000016227274,0.000063132306,0.000112534595,0.000051856437,0.0004893909],"study_design_scores_gemma":[0.009968278,0.0003862607,0.9868521,0.00035107366,0.00017899099,0.00003264442,0.0002274411,0.000063962165,0.0018006999,0.000027985132,0.000024122854,0.0000864545],"about_ca_topic_score_codex":0.00003210109,"about_ca_topic_score_gemma":0.00008919628,"teacher_disagreement_score":0.010680694,"about_ca_system_score_codex":0.000028190576,"about_ca_system_score_gemma":0.000041065403,"threshold_uncertainty_score":0.34488136},"labels":[],"label_agreement":null},{"id":"W2565202172","doi":"10.1182/blood.v120.21.2085.2085","title":"Eculizumab Is an Effective Treatment for Atypical Hemolytic Uremic Syndrome in Patients with or without Identified Genetic Complement Mutations or Complement Factor H Auto-Antibodies.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Eculizumab; Atypical hemolytic uremic syndrome; Thrombotic microangiopathy; Factor H; Complement system; Medicine; Complement component 5; Immunology; Alternative complement pathway; Complement factor I; Complement factor B; Internal medicine; Antibody; Disease","score_opus":0.03609565215740576,"score_gpt":0.30387846709711985,"score_spread":0.2677828149397141,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565202172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909438,0.00026385716,0.00033132313,0.000033536435,0.0003077505,0.0062317047,0.0017834376,0.00009102077,0.000013555819],"genre_scores_gemma":[0.9956585,0.0000034082761,0.00076063216,0.00006618645,0.000030931595,0.0015673295,0.0016358389,0.000049935028,0.0002272269],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975562,0.000292217,0.00064504484,0.0005522642,0.00013443142,0.0008198471],"domain_scores_gemma":[0.9987363,0.00027390837,0.00024044244,0.0005171329,0.00011676632,0.000115457005],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011009108,0.0004379423,0.0006755934,0.00019327959,0.0002849997,0.00003723151,0.0002539941,0.00010346854,0.0019250934],"category_scores_gemma":[0.00003460239,0.00029626803,0.000121091216,0.00015897326,0.00012451195,0.0001576478,0.000090648406,0.00009525377,0.0001363348],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031435906,0.008173953,0.9818909,0.00015197473,0.0014128494,0.000012838797,0.0023445874,0.0000057412863,0.0012372147,0.00005871091,0.00031015003,0.0012574553],"study_design_scores_gemma":[0.028785042,0.0049268375,0.95967865,0.00015373714,0.0007369972,0.000069419,0.00048157029,0.000021385405,0.0036455153,0.000017961998,0.0010407817,0.00044209237],"about_ca_topic_score_codex":0.00015083743,"about_ca_topic_score_gemma":0.0006748035,"teacher_disagreement_score":0.025641453,"about_ca_system_score_codex":0.0003265717,"about_ca_system_score_gemma":0.0001163038,"threshold_uncertainty_score":0.9999489},"labels":[],"label_agreement":null},{"id":"W2565288421","doi":"10.1182/blood.v128.22.6.6","title":"Obinutuzumab-Based Induction and Maintenance Prolongs Progression-Free Survival (PFS) in Patients with Previously Untreated Follicular Lymphoma: Primary Results of the Randomized Phase 3 GALLIUM Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre","funders":"","keywords":"Obinutuzumab; Follicular lymphoma; Internal medicine; Medicine; Oncology; Progression-free survival; Phases of clinical research; Overall survival; Cancer research; Lymphoma; Chemotherapy; Rituximab","score_opus":0.006445635397728135,"score_gpt":0.22960351266996096,"score_spread":0.22315787727223282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565288421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99343,0.00019354193,0.0000048891175,0.00042461965,0.0000586293,0.0057260315,0.000044117383,0.000033466637,0.000084680374],"genre_scores_gemma":[0.9990476,0.000027266668,0.00016538773,0.00003379398,0.000022837665,0.00058825774,0.00003683376,0.000022873322,0.000055146014],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99789584,0.00038472647,0.00050212094,0.00042084235,0.00053531147,0.00026117853],"domain_scores_gemma":[0.9985102,0.00021747628,0.0003399113,0.0006399213,0.00020200736,0.000090530295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006341726,0.00024168495,0.000711542,0.00008529776,0.000056699097,0.000012182135,0.00011988919,0.000078573445,0.0000029868086],"category_scores_gemma":[0.00043755988,0.00009771058,0.00009572902,0.00026043522,0.000164419,0.00007766675,0.00006835563,0.000044745924,0.0000011183189],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14746101,0.022872483,0.82084805,0.000084581014,0.00052040844,0.00008721512,0.00037360334,9.877399e-7,0.00019040496,0.000008189041,0.000055461656,0.0074976194],"study_design_scores_gemma":[0.54556704,0.002102985,0.44863793,0.00067255524,0.0005628549,0.0000050056847,0.000020425374,0.0000049920327,0.0023259586,0.000008158925,0.0000119146525,0.00008020817],"about_ca_topic_score_codex":0.00019001504,"about_ca_topic_score_gemma":0.00007394343,"teacher_disagreement_score":0.398106,"about_ca_system_score_codex":0.00023963505,"about_ca_system_score_gemma":0.0003269252,"threshold_uncertainty_score":0.39845216},"labels":[],"label_agreement":null},{"id":"W2565322871","doi":"10.1182/blood.v126.23.3189.3189","title":"Bortezomib and High Dose Melphalan (Bor-HDM) Compared to HDM Conditioning for the Treatment of Transplant Eligible Multiple Myeloma: Report from a Single Center","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; Alberta Health Services; University of Calgary","funders":"","keywords":"Medicine; Melphalan; Bortezomib; Single Center; Internal medicine; Multiple myeloma; Regimen; Oncology; Surgery; Urology; Gastroenterology","score_opus":0.06284492650403548,"score_gpt":0.3152140233770871,"score_spread":0.25236909687305165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565322871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99521804,0.000857356,0.00037822805,0.00052054244,0.0000883302,0.0016841891,0.0010057252,0.0000407355,0.00020684635],"genre_scores_gemma":[0.9937626,0.00007738894,0.0041783275,0.000048834012,0.00014625773,0.00030521274,0.0012583305,0.000025859388,0.0001971962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986607,0.00003442943,0.00033928073,0.00033641545,0.00030753098,0.00032166255],"domain_scores_gemma":[0.9986874,0.00030417542,0.000094396346,0.00038301936,0.00015186679,0.00037915542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011152548,0.00019373272,0.00043170978,0.000078315425,0.00009933014,0.000029610277,0.00006911674,0.00005650733,0.000022391754],"category_scores_gemma":[0.00008995772,0.00012236937,0.00010152195,0.00009113373,0.00006452482,0.000048827515,0.000017014856,0.000046437184,0.0000085224865],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058538774,0.012508774,0.9154341,0.000104871746,0.003248419,0.0017085429,0.004652801,0.000025593414,0.04646446,0.000026341444,0.0015359949,0.008436222],"study_design_scores_gemma":[0.13659655,0.00704233,0.5561154,0.000387854,0.0020944919,0.00086765445,0.0009824064,0.0014390115,0.27921933,0.0001877973,0.014634498,0.00043270944],"about_ca_topic_score_codex":0.0024610697,"about_ca_topic_score_gemma":0.0005407962,"teacher_disagreement_score":0.35931873,"about_ca_system_score_codex":0.00007371469,"about_ca_system_score_gemma":0.00009554141,"threshold_uncertainty_score":0.4990078},"labels":[],"label_agreement":null},{"id":"W2565326130","doi":"10.1182/blood.v106.11.4590.4590","title":"Additive Interaction between Oxaliplatin and DMAG in Pediatric Acute Lymphoblastic Leukemia (ALL) Cells. Evidence for Interference with Multiple Signaling Pathways.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Oxaliplatin; Survivin; Cancer research; Leukemia; Signal transduction; Cytotoxicity; Apoptosis; Acute lymphocytic leukemia; Biology; Cell signaling; Cell culture; Immunology; Cancer; Cell biology; Biochemistry; Lymphoblastic Leukemia; In vitro; Genetics","score_opus":0.039666512020934554,"score_gpt":0.2984606968650057,"score_spread":0.25879418484407113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565326130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99313754,0.00022354629,0.0051685977,0.00015968722,0.00004643721,0.0009649467,0.000111752124,0.00007194106,0.00011557722],"genre_scores_gemma":[0.9894379,0.00033045784,0.009018658,0.0001613532,0.00066047354,0.0001882989,0.0000717938,0.000053936164,0.00007713473],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978623,0.00007268453,0.00048340473,0.00062618405,0.0003997014,0.00055576774],"domain_scores_gemma":[0.99638903,0.0026931379,0.00018117366,0.00027230082,0.00020297115,0.00026137364],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033213478,0.0003035049,0.00046186012,0.000351195,0.00007584179,0.000057933208,0.00017797903,0.0001659582,0.000033711418],"category_scores_gemma":[0.0007045371,0.00025248187,0.00006603411,0.00036909088,0.000098270626,0.00042548912,0.00012490014,0.00037035823,0.00003477836],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012491707,0.0017638969,0.5823841,0.001933087,0.0016829779,0.0009994296,0.008430058,0.0008370035,0.3208063,0.000058483696,0.0022149747,0.06639795],"study_design_scores_gemma":[0.08218707,0.009334293,0.20488068,0.0054222574,0.00542055,0.000882577,0.0011735698,0.0765254,0.6111929,0.000111973735,0.0008811109,0.0019876417],"about_ca_topic_score_codex":0.0001097033,"about_ca_topic_score_gemma":0.00010813569,"teacher_disagreement_score":0.37750342,"about_ca_system_score_codex":0.00088858674,"about_ca_system_score_gemma":0.0008368416,"threshold_uncertainty_score":0.9999927},"labels":[],"label_agreement":null},{"id":"W2565332683","doi":"10.1182/blood.v124.21.983.983","title":"Establishment and Drug Sensitivity, Gene Expression and Epigenetic Characterization of a Pediatric Leukemia Cell Line (POETIC1) with Primary Resistance to Decitabine","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Lethbridge; University of Calgary","funders":"","keywords":"Decitabine; DNA methylation; Epigenetics; Cancer research; Leukemia; Gene silencing; Biology; Azacitidine; Population; Medicine; Gene expression; Immunology; Gene; Genetics","score_opus":0.003819335627978461,"score_gpt":0.1902349239956254,"score_spread":0.18641558836764693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565332683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841483,0.0011871117,0.014221928,0.000047305417,0.000023053084,0.00021769377,0.000020813693,0.00000577735,0.00012800042],"genre_scores_gemma":[0.9887831,0.0012638584,0.009418156,0.00004565498,0.00017158462,0.000011642071,0.00011924612,0.000020044094,0.00016667158],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999132,0.00008325964,0.00018720578,0.00032545568,0.0001332929,0.00013881188],"domain_scores_gemma":[0.9994314,0.000025913852,0.0001180375,0.00022868664,0.000095498945,0.0001005054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025944828,0.00013100142,0.00015319255,0.00005646641,0.000048223366,0.000020646836,0.000042580203,0.00006949559,9.401131e-7],"category_scores_gemma":[0.00003826458,0.000117571886,0.00001581442,0.00009100064,0.000030651,0.000005111704,0.000101410995,0.000038692542,3.7523904e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006929467,0.000081413295,0.019435398,0.00008714334,0.000006265072,0.0000011130483,0.000070674025,0.000037000456,0.9796643,0.000002156481,0.0000059191802,0.00053928193],"study_design_scores_gemma":[0.0009542537,0.00027320118,0.08999711,0.000019885258,0.000055456225,0.0000015917742,0.0000053203034,0.000020004129,0.90814406,0.000015270947,0.00037485,0.00013901961],"about_ca_topic_score_codex":0.00000509354,"about_ca_topic_score_gemma":0.00002063149,"teacher_disagreement_score":0.071520306,"about_ca_system_score_codex":0.0000064866217,"about_ca_system_score_gemma":0.000039618648,"threshold_uncertainty_score":0.47944424},"labels":[],"label_agreement":null},{"id":"W2565340679","doi":"10.1182/blood.v118.21.2311.2311","title":"Clinical Performance of Bleeding Risk Scores for Predicting Major and Clinically Relevant Non-Major Bleeding Events in Patients Receiving Oral Anticoagulant Therapy","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Medicine; Atrial fibrillation; Internal medicine; Rivaroxaban; Retrospective cohort study; Incidence (geometry); Major bleeding; Apixaban; Thrombosis; Chest pain; Framingham Risk Score; Physical therapy; Warfarin","score_opus":0.07611609062560037,"score_gpt":0.34519417116070145,"score_spread":0.26907808053510107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565340679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981263,0.0000785751,0.00007490623,0.000039163675,0.0003476974,0.0011069006,0.0000056480335,0.000035015364,0.00018575383],"genre_scores_gemma":[0.99036777,0.00087148044,0.008270583,0.00003602355,0.00035441082,0.0000067576366,0.000009674229,0.000029307266,0.000054000924],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99789137,0.00006198226,0.0011698577,0.0003380081,0.00024999597,0.00028876867],"domain_scores_gemma":[0.99858063,0.00046933975,0.00054461637,0.000186238,0.00012258135,0.000096579795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018767341,0.000169639,0.0005936413,0.00016538231,0.000093678434,0.0000081416665,0.00010113469,0.00012824709,0.000011926777],"category_scores_gemma":[0.0010562629,0.00013628248,0.00016002149,0.0001622642,0.000059329584,0.00017879267,0.00009326765,0.0001877096,0.0000020509922],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015342088,0.00018953315,0.9854051,0.00016545808,0.00021769182,0.0000011943431,0.0003714774,0.0000011904574,0.00018291242,0.000007673849,0.000007970931,0.011915573],"study_design_scores_gemma":[0.015951995,0.0021617124,0.9782439,0.0005906941,0.0003609413,0.0000010821784,0.000083363855,0.001759609,0.00064572884,0.000049322505,0.000014928271,0.00013671593],"about_ca_topic_score_codex":0.00004477488,"about_ca_topic_score_gemma":0.0000070059295,"teacher_disagreement_score":0.014417786,"about_ca_system_score_codex":0.000011451038,"about_ca_system_score_gemma":0.000031693195,"threshold_uncertainty_score":0.5557439},"labels":[],"label_agreement":null},{"id":"W2565383729","doi":"10.1182/blood.v118.21.2617.2617","title":"Merging of Children's Oncology Group and Pediatric Health Information Systems Data to Determine Resource Utilization and Treatment Costs on AAML0531: A Report From the Children's Oncology Group","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Cog; Clinical trial; Chemotherapy regimen; Cost database; Oncology; Randomized controlled trial; Activity-based costing; Cancer; Internal medicine; Pediatrics; Database","score_opus":0.12431781080670501,"score_gpt":0.36833695841383157,"score_spread":0.24401914760712656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565383729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909912,0.0046029724,0.00005615966,0.0015391317,0.000100442594,0.001213193,0.00014535419,0.00002808898,0.001323496],"genre_scores_gemma":[0.9926764,0.0050346474,0.0004551492,0.0009368068,0.000280257,0.000033662956,0.00056827464,0.000009931114,0.000004899798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986749,0.00020245943,0.0004790262,0.00027160608,0.00017242545,0.00019957566],"domain_scores_gemma":[0.9984323,0.00053807173,0.0004407907,0.00038603283,0.00003211647,0.00017071192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006099236,0.00014690903,0.00039597723,0.00007098116,0.00015683404,0.0000151456225,0.00010241794,0.00008057575,0.000007249517],"category_scores_gemma":[0.00031706388,0.00009541358,0.000020691563,0.00014529441,0.000051997682,0.00017512916,0.00018088495,0.00013296098,0.0000024278233],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013773949,0.0019961062,0.62533337,0.00009614217,0.0007413875,0.00006720074,0.0046580676,0.0000012831734,0.000063150204,0.00023833531,0.0014898238,0.36393774],"study_design_scores_gemma":[0.0054055206,0.0055705537,0.9201925,0.00007387001,0.0011333529,0.00068710675,0.00057956454,0.0001483372,0.00006134098,0.000004272905,0.06600755,0.0001360296],"about_ca_topic_score_codex":0.00413771,"about_ca_topic_score_gemma":0.00024902684,"teacher_disagreement_score":0.36380172,"about_ca_system_score_codex":0.00009233551,"about_ca_system_score_gemma":0.000064546315,"threshold_uncertainty_score":0.62550074},"labels":[],"label_agreement":null},{"id":"W2565395747","doi":"10.1182/blood.v106.11.882.882","title":"A Report of the Event-Free Survival (EFS) and Neurotoxicity for Children with Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia (ALL) on Pediatric Oncology Group (POG) Protocol 9405.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Children's Hospital","funders":"","keywords":"Medicine; Gastroenterology; Internal medicine; Methotrexate; Dosing; Mercaptopurine; Surgery","score_opus":0.011308268341035932,"score_gpt":0.29126148684421765,"score_spread":0.2799532185031817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565395747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92412394,0.000016941205,0.0011064869,0.0006663549,0.00006550565,0.073243536,0.00034079046,0.00008057647,0.00035586377],"genre_scores_gemma":[0.92611,0.00007027908,0.006739033,0.0006190568,0.001314092,0.06455951,0.000056099518,0.00017427125,0.0003576072],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99634176,0.00026498546,0.00076757284,0.00076336396,0.0011737396,0.00068854657],"domain_scores_gemma":[0.9964701,0.0009968812,0.0006565539,0.0012539309,0.00027912718,0.0003433994],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008838071,0.00041098992,0.0007878457,0.0001880868,0.00020126585,0.00003173734,0.00051789,0.00026457588,0.00003215488],"category_scores_gemma":[0.0019452728,0.00025825688,0.00020103468,0.00044854233,0.00029824633,0.00010735296,0.00034864154,0.0004950462,0.0000048079214],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03170426,0.0069099944,0.92044634,0.0009754901,0.0035846762,0.0022271879,0.00070151576,0.0005530345,0.0031618783,0.00033399597,0.017090783,0.012310833],"study_design_scores_gemma":[0.16029292,0.021268327,0.7943521,0.00016627349,0.0043598795,0.004606675,0.00004445179,0.0010108965,0.008571765,0.00017245123,0.0045233443,0.0006308699],"about_ca_topic_score_codex":0.00020816985,"about_ca_topic_score_gemma":0.00030557616,"teacher_disagreement_score":0.12858866,"about_ca_system_score_codex":0.00092995877,"about_ca_system_score_gemma":0.0029771293,"threshold_uncertainty_score":0.99998695},"labels":[],"label_agreement":null},{"id":"W2565430251","doi":"10.1182/blood.v104.11.3695.3695","title":"Chronic Aluminum Toxicity Due to Intravenous Substance Abuse Managed with Deferoxamine Chelation Therapy: Case Report.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Aluminum toxicity and tolerance in plants and animals","field":"Agricultural and Biological Sciences","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Toxicity; Deferoxamine; Medicine; Encephalopathy; Deferasirox; Myoclonus; Anemia; Gastroenterology; Surgery; Internal medicine; Anesthesia; Thalassemia","score_opus":0.016641203806309672,"score_gpt":0.20527735688293294,"score_spread":0.18863615307662326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565430251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982021,0.00034092373,0.00008603082,0.000488327,0.000046175035,0.00034683957,0.000046459354,0.00008566188,0.00035752277],"genre_scores_gemma":[0.99865884,0.00009857251,0.00027974884,0.00024130681,0.00046575244,0.000026046557,0.00004980892,0.0000023874152,0.00017754397],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987714,0.000028158482,0.00023808402,0.0003896787,0.00020038386,0.00037229055],"domain_scores_gemma":[0.9995438,0.000046686913,0.00011298747,0.000101726306,0.000053536893,0.00014127897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019487066,0.00018900045,0.00022409066,0.000013065744,0.00030960084,0.00007185527,0.00014807841,0.000095327545,0.0001477966],"category_scores_gemma":[0.000009120439,0.00007566381,0.00005425383,0.0003131576,0.00005210642,0.00014732778,0.000009812672,0.00013681987,0.000030303141],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048123437,0.0029283368,0.007869781,0.000050634568,0.0002796406,0.17880268,0.0038854,0.00078360055,0.7189402,0.0007407876,0.00008414754,0.08515353],"study_design_scores_gemma":[0.007185461,0.008833307,0.31110758,0.00053156714,0.00019202416,0.14382224,0.0014371766,0.000038803275,0.5058498,0.001434168,0.017142871,0.0024250015],"about_ca_topic_score_codex":0.00046780653,"about_ca_topic_score_gemma":0.014056843,"teacher_disagreement_score":0.3032378,"about_ca_system_score_codex":0.000037833823,"about_ca_system_score_gemma":0.000015084766,"threshold_uncertainty_score":0.7844048},"labels":[],"label_agreement":null},{"id":"W2565471235","doi":"10.1182/blood.v124.21.2364.2364","title":"Differences of Somatic Mutations and Gene Expression in Blasts of Transient Leukemia and Acute Myeloid Leukemia of Down Syndrome","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute of Cancer Research; Ontario Institute for Cancer Research; Hospital for Sick Children","funders":"","keywords":"GATA1; Myeloid leukemia; Leukemia; clone (Java method); Exome sequencing; Cancer research; Myeloid; Bone marrow; Biology; Down syndrome; Mutation; Medicine; Haematopoiesis; Immunology; Gene; Genetics; Stem cell","score_opus":0.011146298884666804,"score_gpt":0.2516582278345652,"score_spread":0.2405119289498984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565471235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987127,0.00034362523,0.00020395817,0.000067196146,0.000014711606,0.00038035022,0.000030452664,0.000010905229,0.00023609294],"genre_scores_gemma":[0.99606955,0.00029221777,0.0035075538,0.000010705946,0.000011856879,0.000021267237,0.000015057455,0.000015770196,0.0000560108],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99856603,0.00009392628,0.0005190487,0.00024369157,0.00036417556,0.00021313802],"domain_scores_gemma":[0.999098,0.00025175087,0.00017140842,0.0002735115,0.00008026338,0.0001250702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026353248,0.00014970571,0.0006076448,0.00028877618,0.000026563699,0.00000502867,0.00010695594,0.000119974095,0.00002498106],"category_scores_gemma":[0.000115492054,0.000118058364,0.00004989095,0.00021637736,0.00031166573,0.000072855364,0.000069305584,0.00017920409,0.0000010162053],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013306213,0.00021375311,0.04662354,0.000983156,0.00013418718,0.00003344444,0.002060857,0.000011570575,0.94848347,0.00003705253,0.000013980544,0.0012719026],"study_design_scores_gemma":[0.0055819363,0.0007087354,0.55718625,0.00062805373,0.00023543126,0.0002211223,0.00024797703,0.0010721338,0.43387374,0.00014692992,0.0000036572346,0.00009404934],"about_ca_topic_score_codex":0.00012831046,"about_ca_topic_score_gemma":0.00002140762,"teacher_disagreement_score":0.51460975,"about_ca_system_score_codex":0.00007145331,"about_ca_system_score_gemma":0.0002917734,"threshold_uncertainty_score":0.48142803},"labels":[],"label_agreement":null},{"id":"W2565511778","doi":"10.1182/blood.v104.11.2192.2192","title":"The Effect of Prophylactic Administration of Myeloid Growth Factors Following Autologous Stem Cell Transplantation for Patients with Hematological Malignancies: A Systematic Review.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Transplantation; Granulocyte colony-stimulating factor; Internal medicine; Placebo; Neutropenia; Myeloid; Clinical trial; Stem cell; Randomized controlled trial; Oncology; Gastroenterology; Chemotherapy; Pathology; Biology","score_opus":0.00686634291445491,"score_gpt":0.23874909452330947,"score_spread":0.23188275160885458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565511778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952034,0.0008228071,0.00029524887,0.000032090335,0.000048749647,0.0035076414,0.000012915082,0.000021704936,0.00005547176],"genre_scores_gemma":[0.99942374,0.0000837765,0.000073392475,0.000010726413,0.000005312655,0.00036340853,0.00001917811,0.000010742322,0.000009691554],"study_design_codex":"systematic_review","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99907863,0.00007086342,0.00039028245,0.00012894924,0.00021295856,0.00011830524],"domain_scores_gemma":[0.9991779,0.00024902765,0.00028369328,0.00015087887,0.00010311596,0.000035387726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015932348,0.000116651216,0.0005139101,0.000027785685,0.0000796974,0.0000061152405,0.000055655815,0.000044750843,7.126258e-7],"category_scores_gemma":[0.00006081093,0.00005902566,0.00015819285,0.00013463991,0.00003538912,0.000048925736,0.0000029788455,0.00005517557,6.594083e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013951517,0.0011943277,0.12349092,0.8662501,0.0004674498,0.00004034284,0.0005161043,0.0000046009004,0.0062337755,0.0003598968,0.0000030676485,0.000044284472],"study_design_scores_gemma":[0.014240792,0.026676841,0.05842915,0.056127556,0.012841464,0.00020912426,0.0001859944,0.00000100537,0.8309865,0.00004651587,0.0000012783038,0.00025375464],"about_ca_topic_score_codex":0.0000053638278,"about_ca_topic_score_gemma":0.000004261521,"teacher_disagreement_score":0.82475275,"about_ca_system_score_codex":0.000023046077,"about_ca_system_score_gemma":0.000085636704,"threshold_uncertainty_score":0.24069966},"labels":[],"label_agreement":null},{"id":"W2565516285","doi":"10.1182/blood.v106.11.2165.2165","title":"Inhibition of Immune Thrombocytopenic Purpura (ITP) by an Orally Bioavailable Inhibitor of Syk Kinase Activity.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; St. Michael's Hospital","funders":"","keywords":"Syk; Pharmacology; Platelet; Thrombocytopenic purpura; Immunology; Medicine; Immune system; Bruton's tyrosine kinase; Fc receptor; Chemistry; Tyrosine kinase; Receptor; Internal medicine","score_opus":0.012341640131812154,"score_gpt":0.2511355307972625,"score_spread":0.23879389066545031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565516285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99617577,0.0012013868,0.000007734077,0.0002389616,0.000029492452,0.00037901968,0.000075524935,0.000033741795,0.0018583592],"genre_scores_gemma":[0.9985783,0.00017002388,0.00054869626,0.000048659113,0.000041631312,0.000014722418,0.00013466626,0.000023283521,0.00044002183],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99899685,0.000028507939,0.00031663585,0.00022317024,0.00022679119,0.00020804605],"domain_scores_gemma":[0.9993019,0.000016546392,0.00018473773,0.00032154968,0.00008410102,0.00009117238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000985158,0.00015741035,0.00047998255,0.00008800211,0.000037231344,0.000008331152,0.000057857054,0.00010752685,0.00022794252],"category_scores_gemma":[0.000022213144,0.00013629858,0.00010148791,0.00019302111,0.00007759163,0.0002664014,0.000033538447,0.00009821387,0.000039986935],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020781976,0.007172244,0.0032672316,0.00010052646,0.00018170345,0.000066699344,0.00012746836,0.0000011301496,0.9822545,0.00002047739,0.000518315,0.0060818824],"study_design_scores_gemma":[0.007868829,0.0013372551,0.0053104647,0.00013955445,0.0002889853,0.000050214658,0.000057557914,0.000022159891,0.98421496,0.000031879823,0.0005576834,0.00012045649],"about_ca_topic_score_codex":0.00025300286,"about_ca_topic_score_gemma":0.000043748267,"teacher_disagreement_score":0.007661009,"about_ca_system_score_codex":0.000028017503,"about_ca_system_score_gemma":0.00007750526,"threshold_uncertainty_score":0.5558095},"labels":[],"label_agreement":null},{"id":"W2565568829","doi":"10.1182/blood.v104.11.3619.3619","title":"Phase III Evaluation of Once-Daily, Oral Therapy with ICL670 (Exjade®) Versus Deferoxamine in Patients with β-Thalassemia and Transfusional Hemosiderosis.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Deferasirox; Hemosiderosis; Medicine; Deferoxamine; Thalassemia; Randomized controlled trial; Liver biopsy; Beta thalassemia; Pediatrics; Internal medicine; Gastroenterology; Surgery; Biopsy","score_opus":0.019177397101298392,"score_gpt":0.2702377027777295,"score_spread":0.2510603056764311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565568829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99789536,0.0006292783,0.000016645588,0.0002519106,0.00003200296,0.0007848862,0.000008438487,0.000018327868,0.00036314173],"genre_scores_gemma":[0.9992796,0.00019372047,0.0003459627,0.00004785161,0.000012177382,0.000025744648,0.00006274968,0.000021251975,0.000010938746],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998688,0.000039611838,0.00023303008,0.00024338426,0.00060353545,0.00019247322],"domain_scores_gemma":[0.99947715,0.000021484271,0.000073471194,0.00015365434,0.0001809993,0.00009324076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019046165,0.00016423235,0.00029046013,0.0000937856,0.000043463555,0.0000067133647,0.000038338374,0.00011166315,0.000056940113],"category_scores_gemma":[0.000019662295,0.0001079144,0.000030436657,0.00026700352,0.00011009111,0.000086665204,0.0000073975107,0.00016497848,9.3701306e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08214801,0.060544737,0.7209815,0.00027131054,0.0014734011,0.0000762874,0.008429149,0.0014596398,0.024888273,0.0002051188,0.00008090521,0.0994417],"study_design_scores_gemma":[0.71687865,0.017068807,0.2454578,0.0005276169,0.00093495543,0.000024396832,0.00072659104,0.00013853944,0.01783935,0.000040308852,0.00006633652,0.0002966451],"about_ca_topic_score_codex":0.00014300596,"about_ca_topic_score_gemma":0.00014965206,"teacher_disagreement_score":0.63473064,"about_ca_system_score_codex":0.000049132326,"about_ca_system_score_gemma":0.00024867296,"threshold_uncertainty_score":0.44006217},"labels":[],"label_agreement":null},{"id":"W2565593002","doi":"10.1182/blood.v110.11.128.128","title":"Factors Predictors of Vascular Events with Antiphospholipids Antibodies.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University Health Network; McGill University Health Centre; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Lupus anticoagulant; Internal medicine; Antiphospholipid syndrome; Univariate analysis; Von Willebrand factor; Gastroenterology; Fibrinogen; C-reactive protein; Immunology; Thrombosis; Multivariate analysis; Platelet","score_opus":0.019337898883035023,"score_gpt":0.27902014035542827,"score_spread":0.25968224147239327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565593002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947268,0.00065707695,0.0001859912,0.0000124548005,0.00014535635,0.0005150018,0.000008794471,0.000067376866,0.003681199],"genre_scores_gemma":[0.9989388,0.00007063031,0.00029650156,0.0000109838165,0.00012672585,0.0000038347634,0.000016647396,0.000040667474,0.00049518043],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804556,0.000027499727,0.00035858504,0.00025752975,0.000892719,0.00041809116],"domain_scores_gemma":[0.9988747,0.00009513135,0.00010812731,0.00051133573,0.000197042,0.00021361388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056556996,0.00017699714,0.0004582821,0.00020180162,0.00003916959,0.0000043719447,0.00014443423,0.00011294621,0.000082532475],"category_scores_gemma":[0.0001355021,0.00011443828,0.00013121721,0.00038181077,0.000112015696,0.000053146177,0.000050518673,0.00016404268,0.000014165059],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008545272,0.0005415571,0.9904301,0.00049158826,0.00054991705,0.00004929264,0.0007571336,3.0106625e-7,0.006878162,0.000019680456,0.00014432694,0.000052479918],"study_design_scores_gemma":[0.0061503933,0.0006047076,0.81991434,0.00079980097,0.00032845262,0.0006678563,0.0010750915,0.0000034090983,0.16961868,0.0000070936926,0.00067277584,0.00015741309],"about_ca_topic_score_codex":0.00006672667,"about_ca_topic_score_gemma":0.000011194458,"teacher_disagreement_score":0.17051579,"about_ca_system_score_codex":0.00003571795,"about_ca_system_score_gemma":0.00013263163,"threshold_uncertainty_score":0.46666574},"labels":[],"label_agreement":null},{"id":"W2565604933","doi":"10.1182/blood.v126.23.1846.1846","title":"Bortezomib-Containing Regimens (BCR) for the Treatment of Non-Transplant Eligible Multiple Myeloma","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Bortezomib; Medicine; Multiple myeloma; Internal medicine; Dexamethasone; Melphalan; Regimen; Oncology; Cyclophosphamide; Surgery; Gastroenterology; Chemotherapy","score_opus":0.053807694201940745,"score_gpt":0.32443622344406003,"score_spread":0.2706285292421193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565604933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937209,0.0017787438,0.0006040517,0.0004182784,0.000090646725,0.0018541241,0.000122564,0.00003634342,0.001374352],"genre_scores_gemma":[0.9957273,0.00041525587,0.0023138989,0.00003790067,0.00018029976,0.00037944497,0.000102018894,0.000029918538,0.00081396586],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987573,0.000021035337,0.00025667986,0.00024922666,0.00030872674,0.00040701067],"domain_scores_gemma":[0.9986778,0.00035320056,0.00007657562,0.0004431895,0.00016368057,0.00028557485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017099164,0.00018668381,0.00036965028,0.0000784565,0.000096590506,0.00001384232,0.00010008279,0.00006829258,0.000012498123],"category_scores_gemma":[0.00009149842,0.00010783349,0.00018671312,0.00011246631,0.000067227076,0.000040591298,0.000012517182,0.000056462803,0.000023014923],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009556803,0.010408431,0.9008695,0.00023668657,0.004705029,0.00053660583,0.0067835157,0.00004719067,0.03187566,0.00013410005,0.0013691275,0.033477392],"study_design_scores_gemma":[0.14684674,0.025143223,0.22859782,0.00032457706,0.0027914334,0.0003219412,0.0018026929,0.006416833,0.5619273,0.00013751368,0.025234904,0.0004550041],"about_ca_topic_score_codex":0.0005808494,"about_ca_topic_score_gemma":0.0001515007,"teacher_disagreement_score":0.67227167,"about_ca_system_score_codex":0.00007338881,"about_ca_system_score_gemma":0.00022546003,"threshold_uncertainty_score":0.43973222},"labels":[],"label_agreement":null},{"id":"W2565605910","doi":"10.1182/blood.v110.11.5054.5054","title":"Allogeneic Stem Cell Transplantation for Relapsed Follicular Non-Hodgkin’s Lymphoma: Single Centre Experience.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Follicular lymphoma; Hematopoietic stem cell transplantation; Internal medicine; Surgery; Transplantation; Lymphoma; Gastroenterology; Radiation therapy","score_opus":0.013679472382362407,"score_gpt":0.243065971826445,"score_spread":0.22938649944408257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565605910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99528986,0.00077942875,0.0008315379,0.0001259774,0.00017185275,0.0008500598,0.000024321118,0.000063695574,0.0018632874],"genre_scores_gemma":[0.9963663,0.00008885671,0.002357767,0.00021940208,0.00013053085,0.0000986747,0.00011508924,0.00003067009,0.00059270085],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987845,0.000012533929,0.00028374745,0.00032958385,0.00022337055,0.0003662699],"domain_scores_gemma":[0.99934816,0.00009171956,0.000080435326,0.0002394936,0.00006701624,0.00017318309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011247756,0.00018714943,0.00025256662,0.000070465765,0.000095990574,0.000018553821,0.000063717154,0.00011924199,0.000026513444],"category_scores_gemma":[0.0000044951266,0.00015511614,0.00018685097,0.000117129435,0.000024979532,0.000055875113,0.00000762779,0.000021724813,0.000028991248],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016391476,0.030619372,0.4798988,0.0009380325,0.0008942732,0.0034077035,0.017620927,0.000013045623,0.3726207,0.00033256723,0.0013746511,0.09064077],"study_design_scores_gemma":[0.02348205,0.00064972014,0.097901344,0.00009493856,0.0007860141,0.00010665506,0.0008086215,0.000011112288,0.87174547,0.000010757503,0.0042076395,0.00019567138],"about_ca_topic_score_codex":0.000031136267,"about_ca_topic_score_gemma":0.000027806438,"teacher_disagreement_score":0.49912477,"about_ca_system_score_codex":0.000114577124,"about_ca_system_score_gemma":0.000059265607,"threshold_uncertainty_score":0.6325453},"labels":[],"label_agreement":null},{"id":"W2565606062","doi":"10.1182/blood.v110.11.734.734","title":"Efficacy of Dasatinib in Patients with Chronic-Phase Chronic Myelogenous Leukemia with Resistance or Intolerance to Imatinib: 2-Year Follow-Up Data from START-C (CA180-013).","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Dasatinib; Imatinib; Medicine; Chronic myelogenous leukemia; Internal medicine; Imatinib mesylate; Gastroenterology; Pharmacology; Oncology; Leukemia; Myeloid leukemia","score_opus":0.022522741568587655,"score_gpt":0.2861795180592287,"score_spread":0.26365677649064106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565606062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947235,0.00083641795,0.0003494746,0.0000611683,0.00010250881,0.002490553,0.0007335734,0.00009859472,0.0006042034],"genre_scores_gemma":[0.982512,0.000041857442,0.014848558,0.00010862519,0.00025638836,0.000059605503,0.0015655055,0.00013186302,0.0004756289],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958892,0.00006961584,0.0009551084,0.0011820707,0.0009847541,0.0009192413],"domain_scores_gemma":[0.99597055,0.00033862953,0.00042873886,0.0026497967,0.00022286945,0.00038940302],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039133622,0.00055153295,0.001020206,0.00023736368,0.00009469888,0.000026104959,0.0006967142,0.00018425648,0.00032420352],"category_scores_gemma":[0.000284034,0.00040374472,0.0000622514,0.0009078472,0.00018359306,0.00023522628,0.00023696496,0.00043675373,0.000079692996],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18273136,0.020456836,0.7156959,0.0022586412,0.0045132507,0.0031392346,0.0073748217,0.0003466561,0.011864766,0.00008488676,0.0035015654,0.048032083],"study_design_scores_gemma":[0.35582748,0.012504582,0.60122305,0.0042041102,0.0012003379,0.000023764507,0.00019859846,0.00012008327,0.0197594,0.000009761922,0.003947354,0.0009814915],"about_ca_topic_score_codex":0.0011545612,"about_ca_topic_score_gemma":0.024678828,"teacher_disagreement_score":0.17309614,"about_ca_system_score_codex":0.0026586067,"about_ca_system_score_gemma":0.0034989128,"threshold_uncertainty_score":0.99984145},"labels":[],"label_agreement":null},{"id":"W2565648194","doi":"10.1182/blood.v118.21.5297.5297","title":"The Effect of Comprehensive Care and Degree of Iron Overload on Maternal and Fetal Outcomes in Pregnancies of Transfusion-Dependent Beta-Thalassemia Patients","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Mount Sinai Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Pregnancy; Thalassemia; Obstetrics; Miscarriage; Pediatrics; Prenatal care; Blood transfusion; Population; Internal medicine","score_opus":0.008941114595833834,"score_gpt":0.2179435845080575,"score_spread":0.20900246991222368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565648194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99614847,0.002734138,2.547998e-7,0.000008852874,0.00004502831,0.00041033153,0.00002410679,0.000003625774,0.00062521774],"genre_scores_gemma":[0.99904287,0.0009023095,0.000020744137,0.0000043741265,0.0000019825677,0.0000051567886,0.000002391446,0.000007473127,0.000012688091],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993234,0.000044299417,0.00023629506,0.00010975501,0.00018206229,0.00010413988],"domain_scores_gemma":[0.9996056,0.00009513888,0.00009359042,0.00012169995,0.000049111506,0.00003488625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000044707467,0.00010632937,0.00032653334,0.000047143374,0.000023633855,0.0000016448693,0.000041875668,0.00007977791,0.000003886745],"category_scores_gemma":[0.000016997808,0.000058671274,0.00005457872,0.00003624476,0.00012710849,0.000018340888,0.00002697469,0.00009510974,2.2179694e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038598283,0.00017694941,0.9842523,0.0006118093,0.000084821106,0.000007170237,0.0018332495,6.1624394e-7,0.0030196013,0.000009112238,0.0000011174149,0.009617326],"study_design_scores_gemma":[0.0063245525,0.002756562,0.8791537,0.00048719748,0.00019505157,0.000005601719,0.00067779596,0.0000016946916,0.11034768,0.0000037895836,0.0000022234306,0.00004410032],"about_ca_topic_score_codex":0.0003410966,"about_ca_topic_score_gemma":0.00006290291,"teacher_disagreement_score":0.10732808,"about_ca_system_score_codex":0.000006110064,"about_ca_system_score_gemma":0.000011582183,"threshold_uncertainty_score":0.23925452},"labels":[],"label_agreement":null},{"id":"W2565658402","doi":"10.1182/blood.v114.22.949.949","title":"Integrin β7-Mediated Regulation of Multiple Myeloma Cell Adhesion, Migration and Survival.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Fibronectin; Molecular biology; Small hairpin RNA; Stromal cell; Flow cytometry; Cell culture; Integrin; Cell adhesion; Bortezomib; Biology; MTT assay; Cell migration; Cell biology; Cancer research; Cell; Chemistry; Gene knockdown; Immunology; Multiple myeloma; Extracellular matrix; Biochemistry","score_opus":0.018340776049804147,"score_gpt":0.26590957784494856,"score_spread":0.24756880179514443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565658402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976161,0.00035221933,0.000039848943,0.00033584205,0.000022688833,0.00036789442,0.0000138813375,0.000038304766,0.0012131804],"genre_scores_gemma":[0.9979477,0.00014055295,0.0012342064,0.00002727993,0.00004795287,0.000007831665,0.00019379565,0.000008963069,0.00039173363],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999121,0.00005068815,0.0002110011,0.00018438458,0.00026870315,0.00016420857],"domain_scores_gemma":[0.99935585,0.0001122233,0.0000708845,0.00019090135,0.00013055737,0.00013956419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011705946,0.0001058559,0.0002014685,0.00011356058,0.000038178234,0.000008684642,0.000035039422,0.00007823231,0.000044180644],"category_scores_gemma":[0.00027717283,0.00008348925,0.000043857162,0.00015649057,0.0000324182,0.000067133755,0.000013195405,0.000085100546,0.00001955141],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036001837,0.0012371531,0.46176687,0.00006998201,0.00005244512,0.000025428071,0.00021031211,8.827239e-7,0.52443534,0.000028973798,0.00014844112,0.011664167],"study_design_scores_gemma":[0.005497229,0.0005569304,0.7459627,0.000047209687,0.000054477652,0.000008227396,0.000047735783,0.0005768074,0.24698831,0.000048354443,0.00015864897,0.000053395932],"about_ca_topic_score_codex":0.0001424406,"about_ca_topic_score_gemma":0.00010515564,"teacher_disagreement_score":0.28419578,"about_ca_system_score_codex":0.00001563448,"about_ca_system_score_gemma":0.000034444554,"threshold_uncertainty_score":0.3404593},"labels":[],"label_agreement":null},{"id":"W2565662787","doi":"10.1182/blood.v116.21.3337.3337","title":"Prevalence of Risk Factors for VTE In Hospitalized Medical and Surgical Patients. Data From the Comparison of Methods for Thromboembolic Risk Assessment with Clinical Perceptions and AwareneSS In Real Life Surgical and Medical Patients (COMPASS) Study","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton General Hospital","funders":"","keywords":"Medicine; Observational study; Comorbidity; Risk assessment; Emergency medicine; Intensive care medicine; Informed consent; Risk factor; Internal medicine; Alternative medicine","score_opus":0.06821953959364738,"score_gpt":0.45211045819935397,"score_spread":0.38389091860570657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565662787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995922,0.00019413055,0.00025785068,0.00012609248,0.00013243685,0.0027005759,0.00064376637,0.0000125618935,0.0000105752815],"genre_scores_gemma":[0.99324,0.0028537067,0.0033931588,0.000015818574,0.00007743233,0.00016116825,0.00023425363,0.00002397769,5.112867e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962892,0.00080945255,0.0012190391,0.0007123622,0.0006843736,0.00028560153],"domain_scores_gemma":[0.9927292,0.0056759994,0.0004449737,0.00062326895,0.00015771521,0.00036887958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035477302,0.0002509184,0.0014844675,0.000090152185,0.00010895365,0.000020912765,0.0003540637,0.00025635448,0.00006147364],"category_scores_gemma":[0.0029071167,0.00015368388,0.00007402193,0.00013866341,0.0005625861,0.00010122691,0.00049677433,0.00058894645,7.666615e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031159338,0.01690636,0.97572786,0.00016951194,0.00033202398,0.0000031411973,0.001243579,5.529549e-7,6.645613e-7,0.00006977446,0.000053015887,0.0051819417],"study_design_scores_gemma":[0.028567279,0.002410796,0.9634788,0.00021266608,0.0013713432,0.0000011085529,0.0010888306,0.0025833948,0.0000036049964,0.000049497015,0.00007503955,0.0001576161],"about_ca_topic_score_codex":0.002903812,"about_ca_topic_score_gemma":0.0025759342,"teacher_disagreement_score":0.028255686,"about_ca_system_score_codex":0.000010634303,"about_ca_system_score_gemma":0.00020327755,"threshold_uncertainty_score":0.6267047},"labels":[],"label_agreement":null},{"id":"W2565676304","doi":"10.1182/blood.v114.22.3059.3059","title":"Type 3 Von Willebrand Disease: Plasma Versus Platelets.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; SickKids Foundation; Dalhousie University; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Von Willebrand disease; Von Willebrand factor; Platelet; Missense mutation; Chemistry; Internal medicine; Molecular biology; Compound heterozygosity; Immunology; Endocrinology; Mutation; Medicine; Biology; Gene; Biochemistry","score_opus":0.014006043040541387,"score_gpt":0.25755980585446303,"score_spread":0.24355376281392163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565676304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834495,0.0014385947,8.14071e-7,0.0006599869,0.00015812043,0.00017659056,0.000009659922,0.00007885678,0.014027883],"genre_scores_gemma":[0.9982011,0.0002475748,0.00013432621,0.00021361336,0.00007305979,0.0000030034898,0.00008318934,0.000011856018,0.001032313],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99934804,0.000007035185,0.00010092341,0.00018395962,0.00015514535,0.00020489507],"domain_scores_gemma":[0.9995439,0.000019999834,0.00002503104,0.0001918887,0.000026930014,0.00019224067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00002049555,0.0001225802,0.00019294291,0.000044276938,0.000052273237,0.000012101526,0.000042318505,0.000053104795,0.00014226932],"category_scores_gemma":[0.000041184063,0.000099436285,0.000059570928,0.00011777358,0.000017705715,0.000047170848,0.000007895826,0.00007560183,0.00023752693],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.070381686,0.045706827,0.25239727,0.0005015716,0.006984347,0.09184962,0.0013302548,0.00006218959,0.014512828,0.0054103914,0.058749672,0.45211333],"study_design_scores_gemma":[0.2089777,0.010852853,0.6202996,0.00043988068,0.005034116,0.0009017953,0.00011405603,0.00036790714,0.018176656,0.0022414345,0.13119233,0.0014017351],"about_ca_topic_score_codex":0.0000036504853,"about_ca_topic_score_gemma":0.0000022135623,"teacher_disagreement_score":0.4507116,"about_ca_system_score_codex":0.000012735673,"about_ca_system_score_gemma":0.000042866326,"threshold_uncertainty_score":0.4054894},"labels":[],"label_agreement":null},{"id":"W2565720890","doi":"10.1182/blood.v120.21.361.361","title":"Outpatient Treatment of Symptomatic Pulmonary Embolism: A Systematic Review and Meta-Analysis","year":2012,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Pulmonary embolism; Low molecular weight heparin; Randomized controlled trial; Internal medicine; Prospective cohort study; Meta-analysis; Cohort study; Surgery; Pediatrics; Emergency medicine; Intensive care medicine; Thrombosis","score_opus":0.09111214506807118,"score_gpt":0.33700796488850704,"score_spread":0.24589581982043585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565720890","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000046873047,0.99028134,0.000003173008,0.000064699954,0.000029821498,0.008888451,0.000102359125,0.0000377993,0.0005876416],"genre_scores_gemma":[0.00010195561,0.9948998,0.00013283707,0.00015559475,0.000038117156,0.0036918796,0.00018977343,0.0000625664,0.0007274537],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99649566,0.00038467924,0.0018359623,0.00049112766,0.00044617476,0.00034638654],"domain_scores_gemma":[0.99686986,0.00018422985,0.0012993942,0.0013176795,0.000087516026,0.00024129932],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00044262048,0.00071694714,0.022339419,0.00047746403,0.00004339113,0.000016297989,0.0001557444,0.00018549505,0.00036389785],"category_scores_gemma":[0.00004518287,0.00039587956,0.0047679152,0.000680825,0.00004628148,0.00004370875,0.0000918281,0.00009353188,0.00006130903],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[2.6837623e-7,0.002933968,0.000001774996,0.6451174,0.34938732,0.0000196459,0.00006418542,1.9894403e-8,8.536263e-9,0.0000529769,0.000015131059,0.0024073012],"study_design_scores_gemma":[0.00020280993,0.00030663973,0.000009789965,0.059498042,0.9153642,0.000103888844,0.000014609837,4.8261114e-7,3.2330115e-7,0.0000021392939,0.024239233,0.00025785615],"about_ca_topic_score_codex":0.0000451396,"about_ca_topic_score_gemma":0.0000033143613,"teacher_disagreement_score":0.58561933,"about_ca_system_score_codex":0.00007824392,"about_ca_system_score_gemma":0.00006922527,"threshold_uncertainty_score":0.9998493},"labels":[],"label_agreement":null},{"id":"W2565735109","doi":"10.1182/blood.v108.11.5463.5463","title":"The Influence of Age on Outcomes in Patients Who Receive Autologous Stem Cell Transplantation.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Multiple myeloma; Autologous stem-cell transplantation; Transplantation; Neutropenia; Hematopoietic stem cell transplantation; Internal medicine; Surgery; Toxicity","score_opus":0.006879592354667192,"score_gpt":0.23274344832357177,"score_spread":0.22586385596890457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565735109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934012,0.00002796788,8.433326e-7,0.000098529745,0.000044228942,0.00022569075,0.000013102488,0.0000138688465,0.0061745173],"genre_scores_gemma":[0.99901444,0.000036963538,0.00001158084,0.00008513148,0.00001065069,0.0000220793,0.0000056062777,0.0000057988887,0.0008077268],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99950427,0.000024707935,0.00017037337,0.000088377594,0.0001157127,0.00009654174],"domain_scores_gemma":[0.9996986,0.00007081286,0.000052339623,0.00012640518,0.000034654073,0.000017181253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003625571,0.00005934899,0.0001293775,0.000039583752,0.000042463962,0.000004853614,0.000045278543,0.00003045215,0.0000037466361],"category_scores_gemma":[0.0000033952326,0.000038776267,0.00003489215,0.00009700486,0.00003329811,0.000024426156,0.0000035167127,0.00008314151,0.000009176351],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007765876,0.0005852795,0.9972002,0.00003696471,0.000013918403,0.000020872587,0.0001786209,0.00019849582,0.0007950932,0.00016940902,0.00006992877,0.00065357867],"study_design_scores_gemma":[0.002470208,0.00029769147,0.97955173,0.000045628956,0.000058535847,0.0000023864118,0.000016146967,2.6457613e-7,0.01725456,0.000037855018,0.00022697992,0.000038020462],"about_ca_topic_score_codex":0.00017728345,"about_ca_topic_score_gemma":0.00016711702,"teacher_disagreement_score":0.017648457,"about_ca_system_score_codex":0.000014991286,"about_ca_system_score_gemma":0.00002083422,"threshold_uncertainty_score":0.15812503},"labels":[],"label_agreement":null},{"id":"W2565738506","doi":"10.1182/blood.v116.21.1600.1600","title":"Endoglin Identifies the First Wave of Hematopoietic Progenitors During Embryogenesis.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Neonatal Respiratory Health Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Endoglin; Hemangioblast; Biology; Haematopoiesis; Yolk sac; Progenitor cell; Cell biology; Embryo; Embryonic stem cell; Population; Immunology; CD34; Molecular biology; Stem cell; Genetics; Gene; Medicine","score_opus":0.027797075339307413,"score_gpt":0.3064647081513765,"score_spread":0.2786676328120691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565738506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99611616,0.001673969,8.4556314e-7,0.00068558345,0.0002122174,0.0006611541,0.0000056193135,0.000039256578,0.00060521386],"genre_scores_gemma":[0.9984571,0.000056968434,0.000103411345,0.00008982237,0.00028820615,0.0000875736,0.0000015408518,0.00002857364,0.00088681845],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985355,0.000033146054,0.0003317405,0.00021486248,0.00054812105,0.00033663868],"domain_scores_gemma":[0.9988373,0.00015985417,0.000087166656,0.00058815966,0.00016067472,0.00016687295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004097621,0.00011694591,0.00022860583,0.00010286726,0.0001684447,0.000015907894,0.00017968369,0.0000917663,0.00018537467],"category_scores_gemma":[0.00051136455,0.000078333294,0.000103408594,0.00022800083,0.0002093217,0.00004479891,0.00011347251,0.00039637866,0.00007899322],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020196081,0.00073339726,0.039093625,0.0035441979,0.00015101845,0.00034011403,0.0006149492,2.6827962e-7,0.9528458,0.00025428704,0.000104351064,0.0021160094],"study_design_scores_gemma":[0.0016184935,0.000098722885,0.051324084,0.0000752425,0.00007626153,0.00030870174,0.00011944449,0.0000037678317,0.9419729,0.000042516967,0.004285683,0.000074200165],"about_ca_topic_score_codex":0.00004652795,"about_ca_topic_score_gemma":0.00011428987,"teacher_disagreement_score":0.012230457,"about_ca_system_score_codex":0.000013686323,"about_ca_system_score_gemma":0.00023105058,"threshold_uncertainty_score":0.3194339},"labels":[],"label_agreement":null},{"id":"W2565750806","doi":"10.1182/blood.v126.23.4402.4402","title":"Cytomegalovirus (CMV) Serostatus: High Importance of Choosing Seropositive Donors for Seropositive Patients When Using Rabbit Antithymocyte Globulin (ATG)","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Serostatus; Cumulative incidence; Internal medicine; Gastroenterology; Immunology; Cyclophosphamide; Myeloid leukemia; Viremia; Proportional hazards model; Transplantation; Chemotherapy; Viral load; Antibody; Virus","score_opus":0.04242899754294855,"score_gpt":0.3133569241658141,"score_spread":0.2709279266228656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565750806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99446815,0.00072918134,0.0004664099,0.00016156396,0.0002141828,0.0018556757,0.000748064,0.000082178456,0.0012746087],"genre_scores_gemma":[0.98765635,0.000090199814,0.010851246,0.00035665024,0.00032244116,0.000043867836,0.0002672864,0.000117019605,0.00029491368],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965729,0.000114824936,0.00081077387,0.0007151291,0.0009105611,0.0008758265],"domain_scores_gemma":[0.99678224,0.00014013515,0.0004045956,0.0005672946,0.001486159,0.00061958516],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005714277,0.00043433937,0.0009383679,0.00033354343,0.00020795262,0.00007717628,0.00025515613,0.00026287703,0.000074618285],"category_scores_gemma":[0.00030063387,0.00040516345,0.0002683403,0.0005305037,0.00029833178,0.00043460808,0.0001906187,0.00038962413,0.00004102515],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007369622,0.0037744401,0.89868164,0.0007278171,0.0013992412,0.00023302645,0.0039771916,0.000076914046,0.07982492,0.0005162911,0.0014883027,0.0019306192],"study_design_scores_gemma":[0.075540274,0.0068765236,0.22367401,0.0017939842,0.002366104,0.00019190402,0.0023831269,0.0014768537,0.678028,0.001505496,0.004321838,0.001841886],"about_ca_topic_score_codex":0.0022672068,"about_ca_topic_score_gemma":0.00022543446,"teacher_disagreement_score":0.6750076,"about_ca_system_score_codex":0.0004061204,"about_ca_system_score_gemma":0.0007648441,"threshold_uncertainty_score":0.99984},"labels":[],"label_agreement":null},{"id":"W2565751798","doi":"10.1182/blood.v116.21.742.742","title":"Tyrosine Phosphorylation of Runx1 In Megakaryocytes by Src Family Kinases","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Ontario Institute for Cancer Research","funders":"","keywords":"Tyrosine phosphorylation; Phosphorylation; Protein tyrosine phosphatase; Biology; Tyrosine; Receptor tyrosine kinase; Haematopoiesis; Proto-oncogene tyrosine-protein kinase Src; Cancer research; Cell biology; Molecular biology; Stem cell; Biochemistry","score_opus":0.011373860712128883,"score_gpt":0.26745458241470643,"score_spread":0.25608072170257756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565751798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993807,0.0010519021,0.000009809572,0.0004182899,0.00006229797,0.00029331946,0.00002091371,0.0000338571,0.0043025822],"genre_scores_gemma":[0.9977101,0.00013477493,0.001185843,0.00014416693,0.00008711674,0.000019143645,0.000060374285,0.000022384054,0.00063610746],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989925,0.000022116094,0.00024870195,0.00019590209,0.00030789894,0.00023285317],"domain_scores_gemma":[0.9993172,0.000112966685,0.00005905935,0.00030977532,0.000106328414,0.000094625684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024327011,0.00010741697,0.0002434624,0.00014171921,0.00002240353,0.000007900914,0.00011360173,0.00012493049,0.000129729],"category_scores_gemma":[0.0003353196,0.00009413426,0.000048656595,0.00031904917,0.00009869337,0.00007236002,0.000048391834,0.00037528796,0.00003122367],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011082875,0.00056212407,0.08078401,0.000053131702,0.00002707146,0.00003061902,0.00008705674,5.6326826e-7,0.91226214,0.00016445115,0.004097576,0.001820414],"study_design_scores_gemma":[0.004531478,0.00022668309,0.20348184,0.00005544147,0.0000518952,0.000022643373,0.00006530922,0.00012614724,0.7880175,0.00006635381,0.003261108,0.00009357229],"about_ca_topic_score_codex":0.00053101976,"about_ca_topic_score_gemma":0.000058029524,"teacher_disagreement_score":0.12424462,"about_ca_system_score_codex":0.00003509936,"about_ca_system_score_gemma":0.00017287316,"threshold_uncertainty_score":0.38386837},"labels":[],"label_agreement":null},{"id":"W2565786275","doi":"10.1182/blood.v124.21.6004.6004","title":"Identification and Management of Glucocorticoid-Induced Hyperglycemia on an Inpatient Malignant Hematology Ward: A Quality Improvement Initiative","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hyperglycemia and glycemic control in critically ill and hospitalized patients","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Hematology; Internal medicine; Glycemic; Discontinuation; Adverse effect; Diabetes mellitus; Emergency medicine; Insulin; Endocrinology","score_opus":0.024447386621563382,"score_gpt":0.3048138537753913,"score_spread":0.2803664671538279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565786275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960607,0.000052016403,0.00030433142,0.00029761667,0.00017015268,0.00081525196,0.000014552825,0.000035699024,0.0022496406],"genre_scores_gemma":[0.9987144,0.00007544368,0.00034189023,0.00059661776,0.000036672278,0.000112104295,0.00004329878,0.000018585111,0.000061007486],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981221,0.000100142286,0.00069137476,0.00045322088,0.00036511352,0.00026804983],"domain_scores_gemma":[0.9988703,0.00009129125,0.00020773913,0.0004903512,0.00016904647,0.0001712827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002846236,0.00019681611,0.000495054,0.00009944103,0.000060670514,0.00001363033,0.000089882094,0.00011921612,0.00002130573],"category_scores_gemma":[0.00008313481,0.00016452938,0.00008324644,0.00010314272,0.000071007635,0.00006797498,0.000062943785,0.0001258442,0.000016713902],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067192735,0.020714426,0.11165271,0.0053983075,0.002013186,0.00014939906,0.0039309873,0.0000074864856,0.55846024,0.17241657,0.000055459077,0.11848197],"study_design_scores_gemma":[0.08300179,0.035901643,0.3256942,0.001918353,0.002991511,0.00012602308,0.0038096695,0.0016014398,0.5385476,0.0042500077,0.0008012879,0.0013564894],"about_ca_topic_score_codex":0.000032813547,"about_ca_topic_score_gemma":0.0000040208147,"teacher_disagreement_score":0.2140415,"about_ca_system_score_codex":0.000027942586,"about_ca_system_score_gemma":0.000029786785,"threshold_uncertainty_score":0.67093134},"labels":[],"label_agreement":null},{"id":"W2565808132","doi":"10.1182/blood.v120.21.596.596","title":"Trends in Utilization and Outcomes of Autologous Hematopoietic Cell Transplantation (AHCT) in the Upfront Management of Patients with Multiple Myeloma: A Cibmtr Analysis","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Multiple myeloma; Lenalidomide; Population; Thalidomide; Hematopoietic cell; Bortezomib; Hematopoietic stem cell transplantation; Internal medicine; Transplantation; Oncology; Surgery; Stem cell; Haematopoiesis","score_opus":0.018723871920987786,"score_gpt":0.2797567782569659,"score_spread":0.2610329063359781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565808132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99887735,0.0002643632,0.0000788122,0.00002448929,0.000004911225,0.00035968277,0.000024972585,0.0000046522982,0.00036078904],"genre_scores_gemma":[0.9989782,0.00008318098,0.0006515859,0.0000064163264,0.000001722851,0.00003698544,0.00020213556,0.0000057636225,0.00003402187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991442,0.00006411763,0.00023007969,0.00011812718,0.0002723251,0.00017112821],"domain_scores_gemma":[0.9996396,0.000056214343,0.000074945034,0.00015988393,0.000026684076,0.000042709722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013759911,0.000091013106,0.00026957176,0.0003817624,0.000013958066,0.0000027725087,0.00004320399,0.000032351672,0.000015457314],"category_scores_gemma":[0.000006271708,0.000054251686,0.00004492702,0.0005730985,0.000033907996,0.00005357446,0.000009594472,0.000045414134,5.016652e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023584135,0.0028550113,0.9895894,0.00025860505,0.00039409738,0.000022264876,0.0018054806,0.000007313489,0.000021323855,0.000018442039,8.141786e-7,0.0047914316],"study_design_scores_gemma":[0.009613324,0.0001823643,0.9876986,0.00003804762,0.0010393044,0.0000018762544,0.00031512292,0.000106240164,0.00095709274,0.0000023304683,0.0000015883962,0.000044109463],"about_ca_topic_score_codex":0.00014643821,"about_ca_topic_score_gemma":0.00027515087,"teacher_disagreement_score":0.009377483,"about_ca_system_score_codex":0.000014331862,"about_ca_system_score_gemma":0.0000061598057,"threshold_uncertainty_score":0.22123195},"labels":[],"label_agreement":null},{"id":"W2565816025","doi":"10.1182/blood.v122.21.sci-27.sci-27","title":"Novel Targeting Strategies for Leukemia-Initiating Cells in Myeloid Neoplasms","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Leukemia & Lymphoma Society of Canada; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Myeloid leukemia; Leukemia; Personalized medicine; Myeloid; Computational biology; Medicine; Bioinformatics; Biology; Cancer research; Immunology","score_opus":0.02240041980591328,"score_gpt":0.2745181585874696,"score_spread":0.2521177387815563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565816025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869199,0.00014305244,0.0019788325,0.00045759242,0.00009632377,0.0013170398,0.000020553032,0.00010494658,0.008961753],"genre_scores_gemma":[0.9531314,0.000029032228,0.044939224,0.00042779508,0.00041179842,0.00033130418,0.000052545063,0.00006360989,0.00061329757],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981672,0.00002914487,0.000430405,0.00037455113,0.00029430745,0.00070438103],"domain_scores_gemma":[0.9988476,0.00041711505,0.00009606439,0.00026545825,0.00019963383,0.00017415282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041837944,0.00020861567,0.00035612864,0.00019381374,0.00009630062,0.000104172024,0.00018010952,0.00016881805,0.00017327865],"category_scores_gemma":[0.00035523265,0.00018840184,0.00009882825,0.00028601976,0.00006437124,0.00031416168,0.00008981201,0.0004490731,0.00016558841],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053302596,0.00031448176,0.0029460322,0.00035117342,0.000077746176,0.00003876139,0.0008692155,0.0001261397,0.9894595,0.00049818144,0.0034562005,0.0018092371],"study_design_scores_gemma":[0.047493033,0.0016143274,0.020155195,0.00080111047,0.00031004456,0.00030989022,0.021038687,0.03466357,0.8638734,0.0022009583,0.0061789397,0.001360809],"about_ca_topic_score_codex":0.00081133994,"about_ca_topic_score_gemma":0.000042721724,"teacher_disagreement_score":0.12558609,"about_ca_system_score_codex":0.00024996366,"about_ca_system_score_gemma":0.0009838669,"threshold_uncertainty_score":0.76828045},"labels":[],"label_agreement":null},{"id":"W2565819103","doi":"10.1182/blood.v120.21.3403.3403","title":"Cocaine-Levamisole Thrombovasculopathy: A Report From the Southern Network On Adverse Reactions (SONAR) Project","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Levamisole; Neutropenia; Vasculitis; Rash; Internal medicine; Thrombosis; Systemic lupus erythematosus; Purpura (gastropod); Surgery; Leukopenia; Gastroenterology; Dermatology; Chemotherapy","score_opus":0.014035993533884137,"score_gpt":0.24519880441382017,"score_spread":0.23116281087993604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565819103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899214,0.0026468586,0.00006785766,0.00014166345,0.00020342981,0.0003460159,0.00006859727,0.000030000945,0.006574206],"genre_scores_gemma":[0.996488,0.00013761058,0.0003607577,0.00033919638,0.0010253701,0.00008046122,0.00041919484,0.00003188337,0.0011175767],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99901915,0.000070884365,0.00017608584,0.00027925664,0.00013760343,0.0003169996],"domain_scores_gemma":[0.9991938,0.000025324865,0.00010636668,0.0005811773,0.000033342196,0.000059986298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017146792,0.00016872704,0.0001269982,0.00000976688,0.00018575937,0.000013376892,0.00012825716,0.00011739828,0.000026991507],"category_scores_gemma":[0.000049047587,0.00011534559,0.00014905063,0.000086112304,0.000044494125,0.0000043081436,0.0000645575,0.00009309179,0.00008403782],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003475433,0.009593641,0.8855359,0.000025208315,0.0046691447,0.00016110616,0.0019629663,0.00014482382,0.033533458,0.00031618183,0.057494614,0.0062154233],"study_design_scores_gemma":[0.010416533,0.0011104862,0.12771411,0.00012806644,0.0019949141,0.00046300236,0.0035425106,0.000019782843,0.0492364,0.0006083152,0.8035106,0.0012552935],"about_ca_topic_score_codex":0.00043920928,"about_ca_topic_score_gemma":0.00014336518,"teacher_disagreement_score":0.7578218,"about_ca_system_score_codex":0.000005401932,"about_ca_system_score_gemma":0.000058554557,"threshold_uncertainty_score":0.47036564},"labels":[],"label_agreement":null},{"id":"W2565823447","doi":"10.1182/blood.v112.11.2401.2401","title":"Cost-Effectiveness of Adding Imatinib to Chemotherapy in Adult Patients with Chromosom-Positive Acute Lymphoblastic Leukemia (Ph+ALL): A Canadian Perspective","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Imatinib; Medicine; Internal medicine; Imatinib mesylate; Oncology; Disease; Chemotherapy; Intensive care medicine; Myeloid leukemia","score_opus":0.012860557787126137,"score_gpt":0.2742051226941706,"score_spread":0.26134456490704444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565823447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936301,0.000023089788,0.00020508509,0.00014365824,0.000040196446,0.002907322,0.00026624376,0.00003884616,0.0027454267],"genre_scores_gemma":[0.997285,0.000024667142,0.001586264,0.00048935256,0.000060488663,0.00031972883,0.00009947898,0.00008603622,0.000048994945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997339,0.00015106761,0.00035868844,0.0006148746,0.0007230593,0.00081332814],"domain_scores_gemma":[0.9973215,0.0004313648,0.00011162031,0.0004148477,0.0010494483,0.00067120773],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019417037,0.00035773843,0.00071527547,0.0006144629,0.00010577353,0.000014033089,0.00023650097,0.00017471997,0.00005835332],"category_scores_gemma":[0.00041972226,0.0003047004,0.0000957419,0.0009948935,0.0002198548,0.00013812903,0.00006039152,0.00028596292,0.000044818098],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029376691,0.007667718,0.8531089,0.0010076166,0.0073929895,0.008667736,0.04711487,0.00067138823,0.04006012,0.0013497263,0.0010549275,0.002527351],"study_design_scores_gemma":[0.061805334,0.0038582026,0.87353814,0.0019825934,0.00040112098,0.00056468224,0.00082655303,0.0005456938,0.05583803,0.000025507534,0.000038009177,0.00057613535],"about_ca_topic_score_codex":0.056974452,"about_ca_topic_score_gemma":0.00824219,"teacher_disagreement_score":0.048732262,"about_ca_system_score_codex":0.0069813277,"about_ca_system_score_gemma":0.0046160673,"threshold_uncertainty_score":0.9999405},"labels":[],"label_agreement":null},{"id":"W2565896303","doi":"10.1182/blood.v104.11.591.591","title":"The ICOS:ICOSL Costimulatory Pathway Plays an Important Role in GVHD and Bone Marrow (BM) Graft Rejection.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Xenotransplantation and immune response","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"CD28; T cell; CD8; Immunology; Blockade; Cytotoxic T cell; CD40; Graft-versus-host disease; T-cell receptor; IL-2 receptor; Bone marrow; Biology; Medicine; Cancer research; Immune system; Cell biology; Receptor; Stem cell; Internal medicine; In vitro; Biochemistry","score_opus":0.008369153659625882,"score_gpt":0.2364513406650149,"score_spread":0.22808218700538901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565896303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945507,0.0036965783,0.000017043918,0.00049212016,0.000076482494,0.00031150295,0.000013272373,0.00005596614,0.00078634697],"genre_scores_gemma":[0.99850273,0.00070277107,0.00013413894,0.00031985846,0.000046589914,0.000020900763,0.000024979228,0.00002112646,0.00022692519],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990293,0.00006451647,0.00030481644,0.00020197914,0.00017758511,0.0002217943],"domain_scores_gemma":[0.9994448,0.000076217206,0.00006185576,0.00025769568,0.000034089906,0.00012534625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037065256,0.00012569629,0.00017911938,0.00009357485,0.00013883082,0.000028132854,0.00005249649,0.00008492173,0.00003706736],"category_scores_gemma":[0.00007025564,0.000092279566,0.00004297999,0.00014824234,0.00006968638,0.00008847968,0.00001102066,0.00021200797,0.000014552949],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043000802,0.003982648,0.15160303,0.00016592498,0.00024987134,0.001580777,0.0052892803,0.00012221168,0.81734484,0.0032077543,0.00012639878,0.012027211],"study_design_scores_gemma":[0.02343491,0.0014095642,0.8070373,0.0001696451,0.00021378821,0.001681051,0.001247135,0.00018164482,0.15603285,0.00085790025,0.007351483,0.00038273179],"about_ca_topic_score_codex":0.00012278059,"about_ca_topic_score_gemma":0.00022132903,"teacher_disagreement_score":0.661312,"about_ca_system_score_codex":0.000033047476,"about_ca_system_score_gemma":0.00016114366,"threshold_uncertainty_score":0.37630513},"labels":[],"label_agreement":null},{"id":"W2565899626","doi":"10.1182/blood.v126.23.2562.2562","title":"Phase I Study of Non-Engrafting Allogeneic, Mismatched, Unmanipulated Peripheral Blood Mononuclear Cell Infusions to Treat Poor-Prognosis Acute Myeloid Leukemia","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Internal medicine; Myeloid leukemia; Oncology; Myeloid; Gastroenterology; Leukemia; Immunology","score_opus":0.03356059748126945,"score_gpt":0.3130414238184905,"score_spread":0.27948082633722104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565899626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993466,0.00016580912,0.00003398455,0.00038606566,0.00007875386,0.0025839354,0.000048969516,0.00021721036,0.0030192775],"genre_scores_gemma":[0.9927085,0.000053768705,0.0044549517,0.00031418173,0.00026216102,0.00017268588,0.00007938186,0.00017159498,0.0017827909],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9959489,0.00019890658,0.000914894,0.0008886611,0.0010725242,0.00097609113],"domain_scores_gemma":[0.99683505,0.00009908185,0.00022973602,0.0009626414,0.0006411961,0.0012322675],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00061130465,0.0005623215,0.0010847567,0.00049209,0.00021075098,0.00006608482,0.0005967589,0.00032219986,0.00015440544],"category_scores_gemma":[0.00021318799,0.0005043191,0.00023971086,0.0012134742,0.00010035026,0.00016515976,0.0005585748,0.0007228084,0.00013096789],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015841658,0.019058222,0.022222027,0.00015760063,0.0013850577,0.0017207442,0.014485075,0.0002942315,0.93383557,0.000002041538,0.003080913,0.0021743337],"study_design_scores_gemma":[0.14210767,0.026879225,0.004974627,0.0002202298,0.0066400324,0.0004721236,0.017182907,0.0028801684,0.79688424,0.0000103833345,0.0006714061,0.0010769705],"about_ca_topic_score_codex":0.001719495,"about_ca_topic_score_gemma":0.000073751784,"teacher_disagreement_score":0.1405235,"about_ca_system_score_codex":0.00043454772,"about_ca_system_score_gemma":0.00096459367,"threshold_uncertainty_score":0.99974084},"labels":[],"label_agreement":null},{"id":"W2565902495","doi":"10.1182/blood.v106.11.2180.2180","title":"The HPA-15 (Gov) Platelet Alloantigen System: Allele Frequencies in the Canadian Population.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Neonatal alloimmune thrombocytopenia; Allele; Immunology; Antigen; Population; Single-nucleotide polymorphism; Allele frequency; Biology; Platelet membrane glycoprotein; Platelet; Transplantation; Molecular biology; Medicine; Genetics; Gene; Internal medicine; Pregnancy; Genotype; Fetus","score_opus":0.01239848811579408,"score_gpt":0.23128877448979354,"score_spread":0.21889028637399946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565902495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97331417,0.0021060712,4.9946624e-7,0.0045082415,0.000042739066,0.00044486937,0.000013814208,0.00002889498,0.019540697],"genre_scores_gemma":[0.99853224,0.00009258775,0.000115266776,0.00057998585,0.00009830135,0.000037811897,0.00007242141,0.0000128662095,0.00045852878],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990485,0.00004411152,0.0001941481,0.00014510512,0.0002401837,0.0003280052],"domain_scores_gemma":[0.99950325,0.000049798044,0.000042499694,0.00028188742,0.000026792244,0.00009578555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022244961,0.000117047595,0.00016857682,0.000061770435,0.0003342141,0.00005591133,0.00014933167,0.00007518173,0.000028047047],"category_scores_gemma":[0.00003362414,0.00006353092,0.00005242044,0.00014362327,0.000031405223,0.00005640195,0.000008966348,0.00013077846,0.00010408844],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015596201,0.0022282698,0.89039725,0.00022484793,0.0017335818,0.009190365,0.008474168,0.00020280121,0.00047305468,0.0211288,0.030490335,0.035300553],"study_design_scores_gemma":[0.008110852,0.00023934759,0.80826163,0.00014519219,0.00035267195,0.0018640206,0.0030870286,0.0003523101,0.00050108175,0.00042265403,0.17628852,0.0003746778],"about_ca_topic_score_codex":0.15503502,"about_ca_topic_score_gemma":0.725436,"teacher_disagreement_score":0.5704009,"about_ca_system_score_codex":0.00012096341,"about_ca_system_score_gemma":0.00014379852,"threshold_uncertainty_score":0.85059166},"labels":[],"label_agreement":null},{"id":"W2565923193","doi":"10.1182/blood.v116.21.1346.1346","title":"Population-Based Study of the Outcomes of Primary Central Nervous System Lymphoma (PCNSL) In the Era of Autologous Stem Cell Transplantation (ASCT)","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Primary central nervous system lymphoma; Autologous stem-cell transplantation; Diffuse large B-cell lymphoma; Oncology; Radiation therapy; Lymphoma; Internal medicine; Transplantation; Population; Follicular lymphoma; Cancer registry; Surgery; Cancer","score_opus":0.00849741904376466,"score_gpt":0.22200589500351367,"score_spread":0.213508475959749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565923193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983844,0.000087322405,0.0000015943717,0.00010289419,0.00012563574,0.0010794593,0.00004037006,0.000013230392,0.00016509889],"genre_scores_gemma":[0.9997962,0.0000037079228,0.00006108879,0.000035872305,0.000013732125,0.000049716306,0.000022723876,0.000011097281,0.0000058646897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998769,0.00012496198,0.0004794866,0.00014230456,0.0003499138,0.000134353],"domain_scores_gemma":[0.9990201,0.00022908754,0.000259022,0.00041678053,0.000047741592,0.000027287988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001607289,0.00012418305,0.00042142667,0.000055167748,0.000033677108,0.0000040205505,0.00014000013,0.000065366105,0.000003836926],"category_scores_gemma":[0.000007129332,0.0000661901,0.00013379459,0.00016920669,0.000026481188,0.000020705918,0.000009170954,0.0000718266,4.6981597e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000871825,0.007128547,0.98284024,0.00040361422,0.000108184526,0.00003468378,0.0022544467,0.000066937355,0.0014560245,0.0000633134,0.0000018781735,0.0055549615],"study_design_scores_gemma":[0.008320254,0.00038063928,0.9756657,0.000104100094,0.00078005204,0.000026109567,0.0010815022,0.000041992687,0.01354626,0.0000017000192,9.949689e-7,0.00005071564],"about_ca_topic_score_codex":0.0022406478,"about_ca_topic_score_gemma":0.00087481213,"teacher_disagreement_score":0.012090236,"about_ca_system_score_codex":0.00004465193,"about_ca_system_score_gemma":0.00012454753,"threshold_uncertainty_score":0.3387204},"labels":[],"label_agreement":null},{"id":"W2565926798","doi":"10.1182/blood.v124.21.884.884","title":"Hoxa9/Meis1 Mediate Leukemic Programming through Microrna-155","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Cancer research; microRNA; Leukemia; Myeloid leukemia; miR-155; Biology; Downregulation and upregulation; Bone marrow; In vivo; Myeloid; Immunology; Gene; Genetics","score_opus":0.008786257257661662,"score_gpt":0.2292821661172123,"score_spread":0.22049590885955064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565926798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99593306,0.00076320826,0.0010901414,0.00009230151,0.00018391473,0.00010865287,0.000006181194,0.000026626827,0.0017959273],"genre_scores_gemma":[0.9960222,0.00025818116,0.0017874805,0.000495237,0.0005639081,0.000024680938,0.00008798749,0.000023348372,0.0007369622],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99906677,0.000039873827,0.00017199095,0.00033173105,0.00009383223,0.00029581843],"domain_scores_gemma":[0.99946153,0.000008093228,0.000064899716,0.0003473902,0.000057617322,0.000060463866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011412312,0.00015381952,0.0001318586,0.000020008873,0.00006406443,0.000033343244,0.00024549122,0.00014404091,0.000018570572],"category_scores_gemma":[0.000052901545,0.00014144593,0.000098281074,0.000054171433,0.000058895304,0.0000048527463,0.00010049359,0.00008687729,0.00011221777],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021419091,0.00012367935,0.0032458801,0.000016771011,0.00007764151,0.0000032441237,0.00008420833,0.0000039477545,0.9888538,0.000050111194,0.0019828472,0.005536466],"study_design_scores_gemma":[0.001181762,0.00045007365,0.0017832499,0.000023788047,0.00005978319,0.000042956115,0.0000567697,0.00001033778,0.8431194,0.00015464156,0.1528382,0.00027902864],"about_ca_topic_score_codex":0.000026187274,"about_ca_topic_score_gemma":0.000029380986,"teacher_disagreement_score":0.15085536,"about_ca_system_score_codex":0.000005190668,"about_ca_system_score_gemma":0.000043188265,"threshold_uncertainty_score":0.57679975},"labels":[],"label_agreement":null},{"id":"W2566007460","doi":"10.1182/blood.v118.21.573.573","title":"Reinduction Chemoimmunotherapy with Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL) in Children, Adolescents and Young Adults: Results From Children's Oncology Group (COG) Study ADVL04P2","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Cog; Medicine; Chemoimmunotherapy; Oncology; Internal medicine; Clinical endpoint; Chemotherapy; Clinical trial; Cyclophosphamide","score_opus":0.01370997402574401,"score_gpt":0.25402331629479874,"score_spread":0.24031334226905474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566007460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99586546,0.00033332314,0.000021874861,0.00005756493,0.000120952354,0.0030490276,0.00007610872,0.000114911745,0.00036078936],"genre_scores_gemma":[0.99743325,0.0003492455,0.0012132822,0.00015595464,0.00018946036,0.00020170874,0.00026961195,0.000118068136,0.0000694037],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958326,0.0003169448,0.000972877,0.0013238073,0.00070482586,0.00084891915],"domain_scores_gemma":[0.9982357,0.000111292116,0.00032247842,0.0009244761,0.00012564461,0.00028039055],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00055313064,0.0005467751,0.0009083924,0.0005852064,0.0000911147,0.00003443687,0.00036363237,0.00047700846,0.00003117234],"category_scores_gemma":[0.00022665982,0.0004598134,0.000071178845,0.0007967823,0.0002546294,0.00023840906,0.00018210597,0.0009772123,0.00003143146],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032925073,0.0075312275,0.94044673,0.00003056376,0.0015565947,0.0012576941,0.008940105,0.000004674698,0.0030002892,0.000006525088,0.000053456355,0.0042470344],"study_design_scores_gemma":[0.14763331,0.00554669,0.84180015,0.00075966155,0.000646666,0.001139308,0.0008301661,0.00017262356,0.0010487797,0.000021025508,0.000004582128,0.00039701143],"about_ca_topic_score_codex":0.016627688,"about_ca_topic_score_gemma":0.0022306987,"teacher_disagreement_score":0.11470824,"about_ca_system_score_codex":0.001715912,"about_ca_system_score_gemma":0.00096376974,"threshold_uncertainty_score":0.99978536},"labels":[],"label_agreement":null},{"id":"W2566019957","doi":"10.1182/blood.v104.11.4225.4225","title":"CERA (Continuous Erythropoietin Receptor Activator): Dose-Response Trial of Subcutaneous (SC) Administration Once Every 3 Weeks (Q3W) to Patients with Aggressive Non-Hodgkin’s Lymphoma and Anemia Receiving Chemotherapy.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Anemia; Internal medicine; Gastroenterology; Chemotherapy; Chemotherapy regimen; Surgery","score_opus":0.007099199901736731,"score_gpt":0.2591046772744383,"score_spread":0.25200547737270157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566019957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996709,0.00010247001,0.000030752482,0.00053429307,0.00016042215,0.002170317,0.000034399392,0.000065421445,0.00019293616],"genre_scores_gemma":[0.99677193,0.00011949556,0.0021774212,0.00013348107,0.00026829488,0.00007532487,0.000033484175,0.00008830375,0.0003322854],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9971529,0.0001517928,0.0005581867,0.0006656065,0.0009112003,0.0005603022],"domain_scores_gemma":[0.99783623,0.00039782733,0.00043322207,0.00062002207,0.00033135485,0.000381342],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004336004,0.00036169766,0.00063826266,0.00018844953,0.00013432211,0.000054626376,0.0001954801,0.00025831396,0.00009000035],"category_scores_gemma":[0.0006817691,0.0003063286,0.00009628409,0.00040295912,0.00022387384,0.00016144585,0.00006977024,0.00021210071,0.000021441916],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8749608,0.008104865,0.0055212667,0.00047277493,0.00056734704,0.0016210316,0.0056181853,0.000023410897,0.06446647,0.0000073972865,0.0004110506,0.038225446],"study_design_scores_gemma":[0.68842334,0.027153417,0.04342738,0.001950305,0.00027368224,0.0012248419,0.00038466844,0.000018785275,0.23586173,0.000017526794,0.00058427796,0.00068005593],"about_ca_topic_score_codex":0.0006228671,"about_ca_topic_score_gemma":0.00008898131,"teacher_disagreement_score":0.18653743,"about_ca_system_score_codex":0.0029300882,"about_ca_system_score_gemma":0.007190821,"threshold_uncertainty_score":0.9999389},"labels":[],"label_agreement":null},{"id":"W2566072162","doi":"10.1182/blood.v108.11.628.628","title":"Safety and Efficacy of Anti-Fibrinolytics in Orthopedic Surgery: A Meta-Analysis of Randomized Trials.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto","funders":"","keywords":"Medicine; Tranexamic acid; Jadad scale; Randomized controlled trial; Perioperative; Cochrane Library; Relative risk; Meta-analysis; Surgery; Orthopedic surgery; Placebo; Blood transfusion; Internal medicine; Blood loss; Confidence interval","score_opus":0.05960581887583015,"score_gpt":0.30224877309929626,"score_spread":0.2426429542234661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566072162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99054176,0.0054826406,0.00045073038,0.00063090306,0.000027144573,0.0011192871,0.000029036659,0.000019255047,0.0016992672],"genre_scores_gemma":[0.99752086,0.0017163833,0.00041035478,0.00006737479,0.000018223904,0.000013032048,0.000033970417,0.000009737437,0.00021005186],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9974904,0.00041482315,0.001457512,0.00020336644,0.0002985069,0.00013539293],"domain_scores_gemma":[0.99744165,0.0018164113,0.00035350787,0.0002732377,0.00006768407,0.000047523972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040471423,0.00013377298,0.0053816587,0.0007041737,0.000012136274,0.0000043806176,0.000037638634,0.00006157148,0.00019953049],"category_scores_gemma":[0.0006498893,0.0000902998,0.0020899626,0.00083683216,0.00009532174,0.000020297983,0.000025304988,0.000066495515,6.2679317e-7],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05793295,0.011003818,0.08011069,0.001021663,0.8330118,0.00017547589,0.0004656815,0.0003743149,0.0049299044,0.006776025,0.00040968508,0.0037879578],"study_design_scores_gemma":[0.19289075,0.000039257142,0.063389964,0.000019984645,0.7402064,0.0000034556704,0.000020193875,0.00011129739,0.0027393375,0.000023105118,0.00046059213,0.00009562427],"about_ca_topic_score_codex":0.00056707865,"about_ca_topic_score_gemma":0.0001231061,"teacher_disagreement_score":0.1349578,"about_ca_system_score_codex":0.0000030844485,"about_ca_system_score_gemma":0.000037833222,"threshold_uncertainty_score":0.3682319},"labels":[],"label_agreement":null},{"id":"W2566075579","doi":"10.1182/blood.v104.11.5230.5230","title":"Rituximab + ESHAP as Salvage Chemotherapy for Relapsed/Refractory Aggressive Non-Hodgkins Lymphoma: A Phase II Trial.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; University of Toronto; Western University; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Rituximab; Internal medicine; Etoposide; Salvage therapy; Oncology; Aggressive lymphoma; Autologous stem-cell transplantation; Chemotherapy; Gastroenterology; Lymphoma; Surgery","score_opus":0.01465447122387212,"score_gpt":0.3036123395581574,"score_spread":0.2889578683342853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566075579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899736,0.0021507957,0.000074336946,0.0018825646,0.00035458777,0.0027050762,0.000087277906,0.00014546035,0.0026262682],"genre_scores_gemma":[0.99208504,0.0006980712,0.0021630076,0.002179611,0.00077004713,0.0009985277,0.00014909836,0.00009034335,0.0008662547],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9981216,0.000021929727,0.0004413059,0.00057236064,0.0003499633,0.0004927935],"domain_scores_gemma":[0.9985324,0.00013177526,0.00032991846,0.00058819907,0.00012276096,0.0002949486],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014539837,0.00038010598,0.00073912775,0.00013629647,0.00026550598,0.000037283793,0.00014465602,0.00022767618,0.00015096484],"category_scores_gemma":[0.00018768529,0.00030452074,0.00044340218,0.00017792801,0.000083357496,0.00011491734,0.000042648153,0.00008130448,0.00015718014],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10077081,0.60772395,0.0010289428,0.00041665314,0.005151859,0.005284808,0.0050423075,0.000003534087,0.01751132,0.0030373363,0.013276897,0.24075156],"study_design_scores_gemma":[0.84561145,0.021093829,0.0008767742,0.0003510733,0.0010184356,0.0002533415,0.00007248313,0.00000557777,0.09542042,0.00063336734,0.03433032,0.0003329],"about_ca_topic_score_codex":0.00012499942,"about_ca_topic_score_gemma":0.0000106032885,"teacher_disagreement_score":0.7448407,"about_ca_system_score_codex":0.00030506463,"about_ca_system_score_gemma":0.0006121266,"threshold_uncertainty_score":0.9999407},"labels":[],"label_agreement":null},{"id":"W2566134917","doi":"10.1182/blood.v126.23.877.877","title":"Cognitive, Behavior and Academic Problems in Adolescent Survivors of Childhood Acute Lymphoblastic Leukemia (ALL): A Report from the Childhood Cancer Survivor Study","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Neurocognitive; Medicine; Cognition; Sibling; Pediatrics; Cohort; Quality of life (healthcare); Clinical psychology; Gerontology; Psychology; Psychiatry; Developmental psychology; Internal medicine","score_opus":0.04970438373486885,"score_gpt":0.3326604395482236,"score_spread":0.28295605581335476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566134917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895102,0.0046961107,0.000017530307,0.0006809093,0.00042424712,0.004078599,0.00035124464,0.000115465424,0.00012573485],"genre_scores_gemma":[0.9972669,0.00053121144,0.000066159504,0.0008177263,0.0004616107,0.00056399405,0.00013481294,0.00010662709,0.00005096833],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99483824,0.000518843,0.0015688607,0.0010560325,0.0013610268,0.0006570083],"domain_scores_gemma":[0.9971336,0.00047505557,0.0007196636,0.0008380893,0.00031976396,0.0005138314],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018234234,0.0005712409,0.0012379772,0.0002015746,0.000086485015,0.00003719208,0.00040929858,0.00030226618,0.000032273805],"category_scores_gemma":[0.00084584276,0.0004486845,0.00016830373,0.0006439485,0.00027596776,0.00019002052,0.00034519684,0.0010309768,0.000010864084],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020844133,0.005713656,0.96893173,0.00007625937,0.0009264998,0.00031788004,0.022356143,0.00000804411,0.00027139924,0.0000021463034,0.0001660731,0.0010217368],"study_design_scores_gemma":[0.02007398,0.0007747976,0.9661479,0.0014882437,0.00320974,0.00040031818,0.0064763445,0.000007849123,0.0008437984,0.000047961563,0.000072709205,0.00045637815],"about_ca_topic_score_codex":0.033005215,"about_ca_topic_score_gemma":0.020838287,"teacher_disagreement_score":0.019865539,"about_ca_system_score_codex":0.00024480384,"about_ca_system_score_gemma":0.0015960116,"threshold_uncertainty_score":0.9997965},"labels":[],"label_agreement":null},{"id":"W2566186137","doi":"10.1182/blood.v106.11.251.251","title":"Macrophage Inflammatory Protein (MIP)-1alpha (CCL3) Is a Downstream Target of FGFR3 and RAS Signaling in Multiple Myeloma.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Biology; Fibroblast growth factor receptor; Fibroblast growth factor receptor 3; DUSP6; Tyrosine kinase; Fibroblast growth factor; Cancer research; Molecular biology; Signal transduction; Receptor tyrosine kinase; MAPK/ERK pathway; Oncogene; Kinase; Cell biology; Cell cycle; Gene; Receptor; Biochemistry; Phosphatase; Protein phosphatase 2; Phosphorylation","score_opus":0.007392801319431504,"score_gpt":0.22752917661943017,"score_spread":0.22013637529999866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566186137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998271,0.00092595397,0.000031213574,0.00005846836,0.000010092349,0.00042511546,0.00004591705,0.000011326154,0.00022089995],"genre_scores_gemma":[0.9963926,0.00002735009,0.0031331684,0.000034796314,0.00011045005,0.0000473127,0.000029259614,0.00002965364,0.00019538212],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99873346,0.0000768249,0.00029511447,0.00036191437,0.00019298053,0.00033971955],"domain_scores_gemma":[0.9994357,0.000019616406,0.0000815314,0.0002944749,0.000061006012,0.00010762055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021545852,0.00017201027,0.0001865345,0.00010148247,0.00004033282,0.000017876406,0.00017994625,0.00018198595,0.00006618869],"category_scores_gemma":[0.00013232534,0.00017145844,0.00006029067,0.000114277536,0.00012445633,0.0000092225855,0.0001795005,0.0001554481,0.000011949677],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009005299,0.00019995826,0.06073098,0.000111767455,0.000042011234,0.000014117087,0.00013774568,0.00002215832,0.9377647,0.0000057285424,0.00005428418,0.0008264784],"study_design_scores_gemma":[0.0023414518,0.00020905829,0.012818867,0.000058957583,0.0000075662256,0.000010475926,0.000042474563,0.00008848471,0.9821855,0.000017464403,0.002046727,0.00017296353],"about_ca_topic_score_codex":0.000046939076,"about_ca_topic_score_gemma":0.00007350092,"teacher_disagreement_score":0.047912113,"about_ca_system_score_codex":0.000010793655,"about_ca_system_score_gemma":0.00008360093,"threshold_uncertainty_score":0.6991872},"labels":[],"label_agreement":null},{"id":"W2566259940","doi":"10.1182/blood.v108.11.1464.1464","title":"Control of Platelet Fibronectin Internalization and Cell Surface Retention by Fibrinogen: Lessons from Hypofibrinogemic Patients.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; St. Michael's Hospital","funders":"","keywords":"Platelet; Thrombospondin; Chemistry; Vitronectin; Internalization; Hemostasis; Thrombin; Platelet activation; Fibronectin; Molecular biology; Flow cytometry; Internal medicine; Endocrinology; Medicine; Immunology; Cell; Biology; Biochemistry; Metalloproteinase","score_opus":0.006065464909220823,"score_gpt":0.2066679979296847,"score_spread":0.20060253302046388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566259940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965913,0.0016432861,0.00043025287,0.00005692822,0.000036597256,0.00028664366,0.00031353495,0.000028786764,0.0006126496],"genre_scores_gemma":[0.9985236,0.00009356615,0.00026100138,0.000026030579,0.000019133648,0.0000031522438,0.0008142864,0.000018171238,0.00024109015],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992285,0.00002466826,0.00023681059,0.0002192106,0.00014816933,0.00014264575],"domain_scores_gemma":[0.9995941,0.000037005775,0.00014057306,0.0001294928,0.000050878854,0.00004793926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00002876715,0.00012714836,0.00027039807,0.000032380165,0.00003427339,0.000011178971,0.000032173684,0.00008160397,0.000035393427],"category_scores_gemma":[0.000009010409,0.000117624266,0.00005431209,0.000062391715,0.000030813477,0.00006363114,0.000016625174,0.000050769504,0.000008429168],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019545271,0.0012383205,0.67596614,0.000059716334,0.00015861838,0.000029666517,0.00003677132,0.000016376185,0.3206994,0.000020232175,0.00094547676,0.0006338282],"study_design_scores_gemma":[0.025684135,0.0006207495,0.26295033,0.00014185839,0.0005409521,0.000024994204,0.000022091726,0.0002789084,0.7087038,0.00028403773,0.00054788264,0.00020026354],"about_ca_topic_score_codex":0.0011242003,"about_ca_topic_score_gemma":0.000017475479,"teacher_disagreement_score":0.4130158,"about_ca_system_score_codex":0.000014722068,"about_ca_system_score_gemma":0.000012533418,"threshold_uncertainty_score":0.47965786},"labels":[],"label_agreement":null},{"id":"W2566317865","doi":"10.1182/blood.v114.22.2418.2418","title":"Passive Transfer of Hepatitis B Core Antibody by Intravenous Immune Globulin in Patients with Immune Thrombocytopenic Purpura.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; Queen's University; Hamilton Health Sciences; Hamilton Regional Laboratory Medicine Program; St. Joseph's Hospital","funders":"","keywords":"Medicine; Internal medicine; Rituximab; Thrombocytopenic purpura; Randomized controlled trial; Gastroenterology; Immunology; Hepatitis B; Antibody; Seroprevalence; Confidence interval; Odds ratio; Platelet; Serology","score_opus":0.007205069949488798,"score_gpt":0.23937349004307037,"score_spread":0.23216842009358157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566317865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958697,0.0016238473,0.000048888556,0.0003699169,0.0000537905,0.0010386024,0.00013704498,0.000043382646,0.00081481424],"genre_scores_gemma":[0.9982222,0.0009799481,0.00025483113,0.00015905384,0.000027925505,0.000021204194,0.00024370788,0.000032651187,0.000058479076],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99811715,0.000045017958,0.00064293446,0.00033001672,0.00044133698,0.00042356987],"domain_scores_gemma":[0.99915445,0.00003749486,0.00010704273,0.00040425034,0.00020816426,0.00008857772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009187303,0.0002826612,0.0009314841,0.00011285843,0.00006395576,0.00000982161,0.00015594736,0.00012326745,0.00010910536],"category_scores_gemma":[0.00006552066,0.00023030238,0.00009977506,0.0003814391,0.0001422824,0.000105731815,0.000028407516,0.0002616933,0.00002037003],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043191187,0.004566911,0.95192885,0.00009104855,0.00034784336,0.00013776822,0.0011349919,0.0000010343681,0.035121422,0.00009270535,0.00011381295,0.0060317125],"study_design_scores_gemma":[0.01094378,0.0041117077,0.94983613,0.00042516753,0.00026528203,0.000013631688,0.000028935612,0.000003131697,0.03400525,0.000040596078,0.00009157442,0.00023480321],"about_ca_topic_score_codex":0.0024963627,"about_ca_topic_score_gemma":0.0005736965,"teacher_disagreement_score":0.010511868,"about_ca_system_score_codex":0.000066907465,"about_ca_system_score_gemma":0.00009743341,"threshold_uncertainty_score":0.93914586},"labels":[],"label_agreement":null},{"id":"W2566353152","doi":"10.1182/blood.v116.21.3338.3338","title":"Lack of a Requirement for the Inhibitory Fcγ Receptor In IVIG-Mediated Treatment of ITP","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto","funders":"","keywords":"Knockout mouse; Immunology; Receptor; Antibody; Gene knockout; Medicine; Fc receptor; Immune system; Immunoglobulin Fc Fragments; Platelet; Immunoglobulin G; Biology; Internal medicine; Gene","score_opus":0.0738547111551677,"score_gpt":0.36233752050499035,"score_spread":0.2884828093498226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566353152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955477,0.0006786533,0.0000019620584,0.0019819988,0.000122045174,0.00069001195,0.000069372145,0.0000062555305,0.0009019868],"genre_scores_gemma":[0.99675983,0.00044279892,0.00053645147,0.000058307418,0.00024099932,0.00009501171,0.00003722078,0.000011143378,0.0018182641],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99916446,0.000020364605,0.00027632824,0.00012438904,0.00023403384,0.00018043414],"domain_scores_gemma":[0.9992376,0.00033064582,0.00006776344,0.00020471831,0.00009637596,0.000062902145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020494965,0.00008789524,0.00024864453,0.000067252004,0.000024435221,0.00000222526,0.00007439188,0.0000600698,0.00019061925],"category_scores_gemma":[0.00011486881,0.000049540347,0.00010831167,0.00011210321,0.00013102815,0.000015976093,0.00002325181,0.00009095588,0.000012174522],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010617137,0.0035419976,0.09382543,0.0002790384,0.00026675,0.000010045724,0.00088610157,5.8220434e-7,0.8897763,0.0005010751,0.0013225158,0.008528432],"study_design_scores_gemma":[0.010573018,0.003664296,0.07877607,0.00014773518,0.00017780972,0.000012453669,0.00024207837,0.000114126364,0.80220366,0.00009882288,0.103865884,0.00012406275],"about_ca_topic_score_codex":0.00030278575,"about_ca_topic_score_gemma":0.00022265638,"teacher_disagreement_score":0.10254337,"about_ca_system_score_codex":0.0000144235955,"about_ca_system_score_gemma":0.00011588727,"threshold_uncertainty_score":0.20871471},"labels":[],"label_agreement":null},{"id":"W2566356804","doi":"10.1182/blood.v110.11.3210.3210","title":"Incomplete Platelet Dense Granule Formation in Normal Neonates.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Hospital for Sick Children","funders":"","keywords":"Platelet; Mean platelet volume; Cord blood; Dense granule; Granule (geology); Andrology; Hemostasis; Platelet activation; Medicine; Pathology; Internal medicine; Biology","score_opus":0.006421797702833373,"score_gpt":0.2197269389254396,"score_spread":0.21330514122260621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566356804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99601984,0.0006515932,0.0004410107,0.000027116974,0.00003640842,0.00011421407,0.000008872376,0.000008644708,0.00269229],"genre_scores_gemma":[0.99909014,0.00005747383,0.0004015862,0.00014749324,0.000044168937,0.0000074581685,0.00017347015,0.000009675853,0.00006851013],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994217,0.000011668776,0.0001490619,0.00013885328,0.00006718019,0.0002115177],"domain_scores_gemma":[0.99976283,0.0000047274016,0.000036816957,0.00013223449,0.000019807507,0.00004357116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009341789,0.00009030161,0.0000751172,0.000045035475,0.0000388461,0.000009834047,0.00006878636,0.00008555905,0.000009332613],"category_scores_gemma":[0.000010231953,0.000087026885,0.000038290364,0.000069868634,0.000017741224,0.0000053565536,0.000037539758,0.000043945667,0.000018653762],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008809638,0.0051814555,0.2601745,0.00011752645,0.00042985094,0.00078404753,0.0008349296,0.00012414926,0.6051379,0.00055443996,0.0017497638,0.1240305],"study_design_scores_gemma":[0.0071905223,0.0003112379,0.028950216,0.000010385165,0.00002865258,0.00013638122,0.000082639155,0.000024878098,0.95410246,0.00024753844,0.00869061,0.00022449426],"about_ca_topic_score_codex":0.000059783106,"about_ca_topic_score_gemma":0.00067050377,"teacher_disagreement_score":0.3489646,"about_ca_system_score_codex":0.0000045862635,"about_ca_system_score_gemma":0.000010127308,"threshold_uncertainty_score":0.35488534},"labels":[],"label_agreement":null},{"id":"W2566359172","doi":"10.1182/blood.v126.23.52.52","title":"A New AHI-1-DNM2-BCR-ABL Complex Regulates Leukemic Properties of Primitive CML Cells through Mediation of Cellular Endocytosis and ROS-Induced Autophagy","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Cancer research; Stem cell; CD38; Tyrosine kinase; Biology; Cell biology; Signal transducing adaptor protein; CD34; Endocytosis; Imatinib mesylate; Bosutinib; Chemistry; Molecular biology; Imatinib; Signal transduction; Myeloid leukemia; Nilotinib; Cell; Biochemistry","score_opus":0.056452530433944714,"score_gpt":0.25597004461634304,"score_spread":0.19951751418239833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566359172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950463,0.002850222,0.000049151742,0.00010914603,0.00009183567,0.0007801915,0.000021620985,0.00005888402,0.0009926594],"genre_scores_gemma":[0.9951581,0.00015631087,0.0038884468,0.00004598223,0.00013895638,0.000022774399,0.000050579245,0.00003954642,0.0004993116],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99830025,0.000078151585,0.00051681855,0.00035152028,0.00046860825,0.00028461867],"domain_scores_gemma":[0.9987993,0.00006547546,0.00033223472,0.00041221865,0.00019632679,0.00019443565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014490429,0.00025590314,0.0006668381,0.00009585779,0.000034132,0.000009982645,0.000111845926,0.00015145232,0.00004986706],"category_scores_gemma":[0.00013120942,0.00021045747,0.00009337771,0.0001932862,0.00012685741,0.0001547425,0.0000908503,0.00013051304,0.0000115500225],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018512596,0.00040913702,0.0012628215,0.00028228541,0.00035633377,0.000022401084,0.00436823,0.0000059533377,0.99173516,0.00008620033,0.0003452416,0.0009411142],"study_design_scores_gemma":[0.013716753,0.0008503723,0.0054404656,0.00029640138,0.00066509796,0.00005079714,0.00050118135,0.0001815247,0.9778253,0.00012905542,0.00018061616,0.00016243907],"about_ca_topic_score_codex":0.0012555915,"about_ca_topic_score_gemma":0.000017452503,"teacher_disagreement_score":0.01390986,"about_ca_system_score_codex":0.0003398964,"about_ca_system_score_gemma":0.0011083309,"threshold_uncertainty_score":0.85822064},"labels":[],"label_agreement":null},{"id":"W2566392458","doi":"10.1182/blood.v118.21.4772.4772","title":"Eculizumab (ECU) Significantly Improves Health-Related Quality of Life (HRQoL) in Patients with Atypical Hemolytic Uremic Syndrome (aHUS)","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Atypical hemolytic uremic syndrome; Eculizumab; Medicine; Thrombotic microangiopathy; Dialysis; Internal medicine; Clinical trial; Kidney disease; Gastroenterology; Pediatrics; Complement system; Immunology; Disease; Antibody","score_opus":0.02491320300433999,"score_gpt":0.2314381699479685,"score_spread":0.2065249669436285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566392458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975237,0.0010774868,0.0000049673135,0.000032313787,0.00015742512,0.0008143396,0.00012274644,0.0000658369,0.00020117055],"genre_scores_gemma":[0.9995978,0.0000037386042,0.00006142466,0.000064992724,0.0000036152,0.000040009043,0.00015215133,0.000021746158,0.000054534823],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99754304,0.0004921209,0.001037234,0.000395847,0.00008987976,0.00044188494],"domain_scores_gemma":[0.9987555,0.00012264334,0.0004894422,0.0004790963,0.00007977196,0.00007353857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003269853,0.00022216352,0.0006786191,0.00013733382,0.000064977445,0.0000042472097,0.00030124313,0.0001659635,0.00055623474],"category_scores_gemma":[0.00015589838,0.00018666028,0.00009166674,0.00020880358,0.00019328826,0.000069232345,0.00009060395,0.00021817585,0.00011476522],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026185669,0.005122244,0.98390687,0.00031331263,0.00059828506,0.000011694561,0.0010744198,7.251997e-7,0.005287406,0.00053496944,0.00028449393,0.00024699277],"study_design_scores_gemma":[0.01012542,0.001203668,0.9862795,0.00015911278,0.00006221998,0.000013940387,0.00021643112,3.5152985e-7,0.0015900639,0.00011366442,0.000016999955,0.00021862682],"about_ca_topic_score_codex":0.00097001134,"about_ca_topic_score_gemma":0.00015566817,"teacher_disagreement_score":0.0075068534,"about_ca_system_score_codex":0.00004608778,"about_ca_system_score_gemma":0.00022734108,"threshold_uncertainty_score":0.76117855},"labels":[],"label_agreement":null},{"id":"W2566507382","doi":"10.1182/blood.v114.22.2865.2865","title":"Alkaline Phosphatase (ALP) Variation During Carfilzomib Treatment Is Associated to Best Response in Multiple Myeloma.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Princess Margaret Cancer Centre","funders":"","keywords":"Carfilzomib; Bortezomib; Multiple myeloma; Medicine; Internal medicine; Refractory (planetary science); Proteasome inhibitor; Oncology; Retrospective cohort study; Gastroenterology; Biology","score_opus":0.026152302054536905,"score_gpt":0.30089545400844603,"score_spread":0.27474315195390914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566507382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99615186,0.00027011006,0.0000073974625,0.0014908582,0.000029350178,0.0014959538,0.00030316025,0.00007664226,0.00017468895],"genre_scores_gemma":[0.9966171,0.00007019737,0.0008647711,0.00029788032,0.00007512869,0.00017148111,0.00029005788,0.000025058443,0.0015883294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812794,0.00013899161,0.00034644536,0.00043859833,0.00039967362,0.00054835004],"domain_scores_gemma":[0.99884105,0.00014573244,0.000070589056,0.00043312597,0.0001014464,0.00040805037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025439824,0.00024921345,0.00040478472,0.00030399798,0.000113850925,0.00003148566,0.00008609702,0.00011984149,0.00014677431],"category_scores_gemma":[0.000839243,0.0002152864,0.00010322783,0.0004966207,0.000014930991,0.00009314699,0.0000286988,0.000121328565,0.0003187138],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044971693,0.038834155,0.4458344,0.000066424414,0.0013952854,0.01050494,0.0059648254,0.000098191216,0.429749,0.0000211941,0.00048652888,0.022073355],"study_design_scores_gemma":[0.032255933,0.0031235039,0.82586116,0.00014013356,0.00014164048,0.000039031638,0.00005152959,0.00029801755,0.13745113,0.000010427259,0.00045502116,0.00017249872],"about_ca_topic_score_codex":0.0009336812,"about_ca_topic_score_gemma":0.00026315692,"teacher_disagreement_score":0.38002673,"about_ca_system_score_codex":0.00052341097,"about_ca_system_score_gemma":0.00015228745,"threshold_uncertainty_score":0.87791246},"labels":[],"label_agreement":null},{"id":"W2566511010","doi":"10.1182/blood.v108.11.816.816","title":"Addition of Rituximab (R) to CHOP Improves Survival in the Non-GCB Subtype of Diffuse Large B Cell Lymphoma (DLBCL).","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; CHOP; Rituximab; Lymphoma; Germinal center; Medicine; Internal medicine; Oncology; Vincristine; Chemotherapy; Cancer research; Immunology; B cell; Cyclophosphamide; Antibody","score_opus":0.006027008712655218,"score_gpt":0.22207531473487768,"score_spread":0.21604830602222247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566511010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934445,0.00032430922,0.000005202717,0.00021592365,0.0000642657,0.00045812604,0.00014335554,0.000011355112,0.00533296],"genre_scores_gemma":[0.9992391,0.00004046571,0.00022221872,0.0001260251,0.0001046221,0.00006855208,0.000092034395,0.0000144633395,0.000092523114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898034,0.00003915638,0.00030659616,0.00018581306,0.0002720344,0.00021603606],"domain_scores_gemma":[0.9993303,0.000112180925,0.000108325694,0.00033754556,0.000065003,0.000046650235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016241979,0.00013318681,0.00033145203,0.00009530921,0.000025455201,0.0000072179546,0.00009890348,0.000066783905,0.000031166994],"category_scores_gemma":[0.000029845953,0.00008894219,0.00010698792,0.00023147512,0.000027386986,0.000035110126,0.000030752006,0.00003230488,0.000026854319],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069336145,0.3735952,0.53514767,0.00059220975,0.00024845434,0.0003458763,0.0018172946,0.0000013202239,0.074059546,0.0021261466,0.005567573,0.0058053257],"study_design_scores_gemma":[0.051682737,0.0006296342,0.8413998,0.00008277755,0.00022046192,0.000011447032,0.00018994386,0.000008799201,0.10469093,0.00007387371,0.00091905554,0.000090545516],"about_ca_topic_score_codex":0.0011356273,"about_ca_topic_score_gemma":0.00032392985,"teacher_disagreement_score":0.37296557,"about_ca_system_score_codex":0.00003727002,"about_ca_system_score_gemma":0.00007307719,"threshold_uncertainty_score":0.36269575},"labels":[],"label_agreement":null},{"id":"W2566528426","doi":"10.1182/blood.v104.11.3202.3202","title":"Initial Screening Transferrin Saturations, Serum Ferritin Concentrations, and HFE Genotypes in Whites and Blacks in the Hemochromatosis and Iron Overload Screening (HEIRS) Study.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; Transferrin saturation; Internal medicine; Hereditary hemochromatosis; Hemochromatosis; Ferritin; Gastroenterology; Asymptomatic; Serum ferritin","score_opus":0.014088287940105838,"score_gpt":0.2649539065969938,"score_spread":0.25086561865688795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566528426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917215,0.005505027,0.00018891532,0.0015829985,0.000015380361,0.00073475007,0.000018744753,0.000022745939,0.00020994108],"genre_scores_gemma":[0.99731743,0.00054901326,0.0014378545,0.00057132763,0.000055066317,0.000028086342,0.000021283851,0.000013950089,0.0000059598774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890333,0.00010672653,0.00028266205,0.00028189027,0.0001950384,0.00023037344],"domain_scores_gemma":[0.99965125,0.00009182008,0.000032702002,0.00013466696,0.000018681223,0.00007084806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029123228,0.00016719042,0.00025522496,0.00012945593,0.00014621948,0.00008262472,0.000051153682,0.00008042568,0.000011249718],"category_scores_gemma":[0.00007565234,0.00013610869,0.000020640615,0.0001989766,0.00011430394,0.00018771378,0.000024615347,0.00022048636,5.1831165e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019670837,0.0009119282,0.97022116,0.0001754749,0.00003408984,0.000110090165,0.016908148,0.00007573372,0.002280308,0.0010706721,0.0000137516545,0.008001942],"study_design_scores_gemma":[0.012590467,0.00023478139,0.9706816,0.00013637965,0.00017626102,0.00007447187,0.015049951,0.0000502748,0.000700946,0.00010793469,0.000034894914,0.00016205502],"about_ca_topic_score_codex":0.0007265256,"about_ca_topic_score_gemma":0.002155882,"teacher_disagreement_score":0.012393759,"about_ca_system_score_codex":0.000006569946,"about_ca_system_score_gemma":0.000048119175,"threshold_uncertainty_score":0.5550351},"labels":[],"label_agreement":null},{"id":"W2566532805","doi":"10.1182/blood.v110.11.5173.5173","title":"Acceptability and Validity of Use of a Patient-Reported Cost Diary To Capture Health Resource Utilization and Costs Associated with Deep Venous Thrombosis and Post-Thrombotic Syndrome.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Jewish General Hospital; Université de Montréal; Sanofi (Canada)","funders":"","keywords":"Medicine; Indirect costs; Deep vein; Emergency medicine; Venous thrombosis; Health services research; Thrombosis; Physical therapy; Public health; Surgery; Nursing","score_opus":0.25710381437104196,"score_gpt":0.37835542802287214,"score_spread":0.12125161365183018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566532805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99512964,0.0010726553,0.0007454289,0.0012578358,0.00004447981,0.0012893856,0.0003945814,0.00002282264,0.00004315463],"genre_scores_gemma":[0.99743867,0.00014103654,0.0010330783,0.0012566997,0.0000095501855,0.000016850063,0.00007624435,0.000023710332,0.000004186341],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99650604,0.00036890293,0.0022232456,0.00047959058,0.000114990726,0.00030720682],"domain_scores_gemma":[0.99583286,0.0013382739,0.002067222,0.00034103313,0.00014811482,0.00027250766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0075697484,0.00017212301,0.0010229254,0.00022865727,0.00013118815,0.000034880857,0.000065332686,0.00014334664,0.00002021788],"category_scores_gemma":[0.004155929,0.00019810897,0.000033466476,0.00027281875,0.0001448945,0.000264251,0.000063498526,0.000113434035,0.0000015857481],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028262473,0.00063891243,0.9928718,0.0003478108,0.0001563534,0.0000016082355,0.0048985137,0.00002000847,0.000007797649,0.00032105658,0.00007656649,0.00063126604],"study_design_scores_gemma":[0.00093832554,0.0006661776,0.9962733,0.0001423253,0.000041641488,0.000022009275,0.0012744339,0.00018155816,0.000024869492,0.000099827215,0.00016098445,0.00017458112],"about_ca_topic_score_codex":0.0025807396,"about_ca_topic_score_gemma":0.0018744738,"teacher_disagreement_score":0.00362408,"about_ca_system_score_codex":0.00019903986,"about_ca_system_score_gemma":0.00010426043,"threshold_uncertainty_score":0.80786496},"labels":[],"label_agreement":null},{"id":"W2566600397","doi":"10.1182/blood.v120.21.4372.4372","title":"Seek and You Shall Find – but Then What Do You Do? Cold Agglutinins in Cardiopulmonary Bypass, and a Single Center Experience with Cold Agglutinin Screening Before Cardiac Surgery","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Cold Agglutinin; Medicine; Cardiopulmonary bypass; Single Center; Cohort; Retrospective cohort study; Cardiac surgery; Adverse effect; Surgery; Anesthesia; Internal medicine; Antibody","score_opus":0.016703694492249524,"score_gpt":0.2220320452284416,"score_spread":0.2053283507361921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566600397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97816724,0.020157844,0.00001076097,0.00024643342,0.00016253321,0.0006255871,0.00006436095,0.000054358905,0.000510875],"genre_scores_gemma":[0.9973851,0.0014257951,0.00041724913,0.00017668963,0.00030175498,0.000075832344,0.000038786726,0.00006124478,0.000117577074],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979246,0.00009862232,0.000339608,0.0005363752,0.00040237673,0.00069836614],"domain_scores_gemma":[0.99895924,0.000120665805,0.000106215426,0.00037703823,0.000056756413,0.00038010895],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047995162,0.00034433077,0.0007498396,0.00016140757,0.00014799919,0.00011889502,0.000075885386,0.00019759317,0.000013888505],"category_scores_gemma":[0.000030045234,0.00027534706,0.000121815174,0.00025492252,0.00019569864,0.0006026125,0.00010486944,0.0003136295,0.0000020508742],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022242933,0.00083149516,0.9812567,0.000108460124,0.00018276324,0.00021868138,0.0058496553,4.2853182e-7,0.0048050266,0.000041720185,0.000038876908,0.0064437166],"study_design_scores_gemma":[0.0063537457,0.00082063803,0.96066004,0.0027141902,0.00072982913,0.0009759899,0.011483626,0.000018971336,0.009067185,0.0000062758036,0.0064859814,0.000683536],"about_ca_topic_score_codex":0.00022908676,"about_ca_topic_score_gemma":0.00004733183,"teacher_disagreement_score":0.020596717,"about_ca_system_score_codex":0.000021317683,"about_ca_system_score_gemma":0.00004834885,"threshold_uncertainty_score":0.9999699},"labels":[],"label_agreement":null},{"id":"W2566628598","doi":"10.1182/blood.v104.11.335.335","title":"Results of a Multi-Center Randomized Phase II Trial of Thalidomide and Prednisone Maintenance Therapy for Multiple Myeloma Following Autologous Stem Cell Transplant.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Regional Laboratory Medicine Program; Ontario Institute for Cancer Research; McGill University; Hôpital Maisonneuve-Rosemont; Princess Margaret Cancer Centre; Nova Scotia Cancer Centre; London Health Sciences Centre","funders":"","keywords":"Thalidomide; Medicine; Tolerability; Prednisone; Multiple myeloma; Clinical endpoint; Melphalan; Maintenance therapy; Surgery; Internal medicine; Single Center; Randomized controlled trial; Adverse effect; Chemotherapy","score_opus":0.03109308781095624,"score_gpt":0.3064219060696922,"score_spread":0.27532881825873595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566628598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99108905,0.0010492249,0.0011530902,0.00015465089,0.00009426425,0.0056841117,0.00064644264,0.000037184258,0.000092012146],"genre_scores_gemma":[0.9925269,0.00052932964,0.006133571,0.000019651206,0.00004524401,0.0003632557,0.00011807364,0.00003191862,0.00023207716],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99803585,0.0001315588,0.0007486112,0.00037595507,0.000306743,0.00040128923],"domain_scores_gemma":[0.9985653,0.0005741008,0.00026504725,0.00031693204,0.00010467727,0.00017393532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006297981,0.00024258773,0.0011623175,0.00012741945,0.000086033084,0.000007811439,0.00010432263,0.00012332514,0.0000024745386],"category_scores_gemma":[0.00022997239,0.0001680257,0.0004953143,0.00009682708,0.00015122454,0.00006219983,0.000024398376,0.00010571143,7.113816e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9192143,0.020732468,0.00042987306,0.00021702763,0.0011455253,0.00014829352,0.002119782,0.0000032375704,0.049095146,0.000008061588,0.000009456768,0.0068768286],"study_design_scores_gemma":[0.7787634,0.0057222275,0.00019111458,0.0002638259,0.00034011624,0.000028803237,0.00008162947,0.0003581907,0.21409388,0.000016955073,0.000038026497,0.00010183778],"about_ca_topic_score_codex":0.000145615,"about_ca_topic_score_gemma":0.000024199155,"teacher_disagreement_score":0.16499873,"about_ca_system_score_codex":0.000022832462,"about_ca_system_score_gemma":0.00013499125,"threshold_uncertainty_score":0.68518895},"labels":[],"label_agreement":null},{"id":"W2566693412","doi":"10.1182/blood.v114.22.2960.2960","title":"Differential Expression of Mirna* Species in Cancer and the Contribution of MiR-223* to the Development of Acute Myeloid Leukemia.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Genome British Columbia; BC Cancer Agency; Terry Fox Research Institute","funders":"","keywords":"microRNA; MiRBase; Biology; Duplex (building); Myeloid leukemia; Computational biology; Genetics; Cancer research; Gene; DNA","score_opus":0.006695441932280236,"score_gpt":0.23671649439811793,"score_spread":0.23002105246583768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566693412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983669,0.00080148084,0.00043065022,0.00012291048,0.000018990952,0.00020932473,0.000020316505,8.9847146e-7,0.000028523473],"genre_scores_gemma":[0.9995916,0.00009787957,0.00019870557,0.000015866091,0.000028869179,0.000011262821,0.000027440905,0.000002483227,0.00002589225],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995299,0.00003182208,0.0001962067,0.00008965068,0.00008383708,0.00006858783],"domain_scores_gemma":[0.9996902,0.0000074389623,0.00010611552,0.00012527939,0.000055234545,0.000015742962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008069372,0.000056170447,0.000109636545,0.000017142345,0.000021273183,0.0000026305504,0.00008567836,0.00004405218,0.0000061192636],"category_scores_gemma":[0.000020097701,0.00003309959,0.000029947603,0.000043522203,0.000052284722,0.0000014459988,0.000048394206,0.000022096414,9.295829e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021779173,0.00007637854,0.0015069356,0.000007968355,0.00003438923,7.595121e-8,0.00022085874,0.000010667762,0.99716055,0.000052694384,0.00005379905,0.0006579088],"study_design_scores_gemma":[0.0015786459,0.000030183746,0.17011572,0.00003680245,0.000035067376,4.6088667e-7,0.000019254632,0.0000054016455,0.8278336,0.000025557943,0.0002874235,0.00003188699],"about_ca_topic_score_codex":0.000012109416,"about_ca_topic_score_gemma":0.00005810159,"teacher_disagreement_score":0.16932695,"about_ca_system_score_codex":0.000010019976,"about_ca_system_score_gemma":0.000063550695,"threshold_uncertainty_score":0.13497621},"labels":[],"label_agreement":null},{"id":"W2566694224","doi":"10.1182/blood.v118.21.939.939","title":"Multidimensional Flow Cytometry Significantly Improves Upon the Morphologic Assessment of Post-Induction Marrow Remission Status – Comparison of Morphology and Multidimensional Flow Cytometry; A Report From the Children's Oncology Group AML Protocol AAML0531","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Hospital for Sick Children","funders":"","keywords":"Induction chemotherapy; Medicine; Internal medicine; Chemotherapy; Oncology; Bone marrow; Transplantation; Flow cytometry; Gastroenterology; Immunology","score_opus":0.03407734058277411,"score_gpt":0.3428306592702668,"score_spread":0.3087533186874927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566694224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9750258,0.00014781386,0.0005390829,0.00056223717,0.00017486754,0.02310725,0.00020030752,0.000059501912,0.0001831943],"genre_scores_gemma":[0.9079414,0.000027165665,0.08700811,0.00016748784,0.0001862431,0.0041034194,0.0004635706,0.00005519244,0.00004743079],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99504006,0.0008525057,0.0013248142,0.0009435987,0.0011445845,0.0006944131],"domain_scores_gemma":[0.99569213,0.0011452934,0.0010469429,0.0011114773,0.0006919708,0.00031216352],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019191778,0.00045199686,0.0010926892,0.00037512986,0.00027035855,0.000011344648,0.0003374775,0.00053428754,0.00042449243],"category_scores_gemma":[0.0011829534,0.00025709032,0.00022130096,0.0006739142,0.0007913253,0.0001254404,0.00053977355,0.0013163349,0.000008087419],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021258914,0.0032485386,0.20798114,0.000068932364,0.00052092155,0.0003344215,0.0005535044,0.00001398401,0.778334,0.000022194235,0.0006887896,0.0061076405],"study_design_scores_gemma":[0.009293722,0.004131362,0.81832284,0.000119853226,0.00047472108,0.001591885,0.0009936908,0.0048782993,0.15957165,0.000037560723,0.0003264261,0.00025796006],"about_ca_topic_score_codex":0.0019381708,"about_ca_topic_score_gemma":0.000039578812,"teacher_disagreement_score":0.6187624,"about_ca_system_score_codex":0.00026681097,"about_ca_system_score_gemma":0.0009960855,"threshold_uncertainty_score":0.99998814},"labels":[],"label_agreement":null},{"id":"W2566718115","doi":"10.1182/blood.v106.11.238.238","title":"The First Fully Experimental In Vivo Model of Human Leukemogenesis: Human Hematopoietic Stem Cells Infected with MLL-ENL Induce Pro-B Acute Lymphoblastic Leukemia in NOD/SCID Mice.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Biology; Haematopoiesis; Leukemia; Myeloid; Bone marrow; Severe combined immunodeficiency; Progenitor cell; Immunology; Stem cell; Acute lymphocytic leukemia; Cancer research; Transplantation; CD19; Molecular biology; Antigen; In vivo; Medicine; Cell biology; Internal medicine","score_opus":0.018603602659400677,"score_gpt":0.2674211626186581,"score_spread":0.24881755995925744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566718115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966894,0.00036002762,0.000016359321,0.00018213932,0.000023521798,0.00154513,0.000014239975,0.0000842612,0.0010849488],"genre_scores_gemma":[0.9980683,0.00003730345,0.00030948946,0.00014171815,0.00010463312,0.00034322994,0.000012241367,0.00011422248,0.00086887466],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996522,0.00011869675,0.00092155434,0.0006763101,0.00084793783,0.0009134806],"domain_scores_gemma":[0.9983715,0.00013724931,0.0002589211,0.0008438008,0.00015783805,0.00023068557],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045770407,0.0004791278,0.00075625465,0.0004683783,0.00027081365,0.00005660136,0.00058177573,0.00027655053,0.000063179396],"category_scores_gemma":[0.000017756269,0.00035618004,0.0001223737,0.00081326516,0.00035840165,0.00019626749,0.00027196738,0.00058574206,0.00005049904],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044723556,0.0012384476,0.00674365,0.00022310557,0.0002313206,0.00025572386,0.003257876,0.0013454494,0.9857749,0.00013375786,0.0002785212,0.00007005329],"study_design_scores_gemma":[0.016569085,0.0010865176,0.0021446196,0.0005754819,0.00021177653,0.00018673726,0.00106863,0.0069714566,0.9707053,0.000016336966,0.000058223355,0.00040583534],"about_ca_topic_score_codex":0.0004114871,"about_ca_topic_score_gemma":0.0017481816,"teacher_disagreement_score":0.01612185,"about_ca_system_score_codex":0.0024183083,"about_ca_system_score_gemma":0.0015614752,"threshold_uncertainty_score":0.999889},"labels":[],"label_agreement":null},{"id":"W2566774633","doi":"10.1182/blood.v106.11.1368.1368","title":"Stem Cell Mobilization and Egress of AML Blasts from the Bone Marrow Are Both Regulated by MT-MMP-Mediated Activation of MMP-2.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Canadian Blood Services","funders":"","keywords":"Stromal cell; CD34; Haematopoiesis; Bone marrow; Stem cell; Matrix metalloproteinase; Progenitor cell; Cancer research; Biology; Chemistry; Cell biology; Molecular biology; Immunology; Biochemistry","score_opus":0.004741165558413166,"score_gpt":0.1847811382932312,"score_spread":0.18003997273481803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566774633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974663,0.0015902403,0.00044457975,0.00007078791,0.000022347234,0.00021033516,0.00013947296,0.0000078534085,0.000048083723],"genre_scores_gemma":[0.9991209,0.00015051055,0.00013367647,0.00006774545,0.00008519452,0.000010756869,0.00032940542,0.000013973708,0.00008784976],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993533,0.000056506822,0.00019481078,0.00018759636,0.00011078872,0.00009702676],"domain_scores_gemma":[0.99942553,0.00001565449,0.00022232972,0.00023546044,0.000068061265,0.0000329608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008098236,0.000098410674,0.00012157905,0.000016022124,0.000030871073,0.000007220178,0.000082020146,0.00014098064,0.000010328577],"category_scores_gemma":[0.00001390589,0.00007795993,0.00003211382,0.000065098706,0.000039716615,0.000006937733,0.000036488032,0.000043934855,8.5082326e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005126422,0.0002009219,0.0011030036,0.000018169132,0.000031069074,2.1963e-7,0.000056337416,0.000014676336,0.9971932,0.0000037730524,0.00080591015,0.00052144006],"study_design_scores_gemma":[0.0010905945,0.00014715851,0.0010190215,0.000044876102,0.000037081365,8.7776465e-7,0.000081589096,0.00021486414,0.996629,0.000017956763,0.0006334068,0.00008354923],"about_ca_topic_score_codex":0.000026603868,"about_ca_topic_score_gemma":0.000009003211,"teacher_disagreement_score":0.0016545877,"about_ca_system_score_codex":0.0000037065959,"about_ca_system_score_gemma":0.0000201668,"threshold_uncertainty_score":0.31791136},"labels":[],"label_agreement":null},{"id":"W2566780365","doi":"10.1182/blood.v126.23.2301.2301","title":"Hematuria Is Not a Risk Factor for the Hypertension of Hemophilia","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Urinalysis; Blood pressure; Microscopic hematuria; Risk factor; Internal medicine; Cohort; Population; Renal function; Prospective cohort study; Surgery; Pediatrics; Urinary system; Kidney; Proteinuria","score_opus":0.0863979471448312,"score_gpt":0.31895627420479694,"score_spread":0.23255832705996574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566780365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936644,0.000881955,0.00001515685,0.0040651713,0.00009203238,0.0006899158,0.0001097787,0.000022300641,0.0004593152],"genre_scores_gemma":[0.9965539,0.0001395557,0.0006828502,0.00019595353,0.00019676136,0.000024785008,0.0000057711577,0.00001569549,0.0021847417],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992061,0.000019682653,0.00014338698,0.0001459566,0.00030642506,0.00017840129],"domain_scores_gemma":[0.9990731,0.0002090481,0.00004769864,0.00032709926,0.00021271176,0.00013033059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018640654,0.00009107721,0.00021825897,0.00004174126,0.00005606051,0.0000063722136,0.00007973565,0.00007466162,0.00006972053],"category_scores_gemma":[0.0003592886,0.000045029014,0.00012522639,0.00009365731,0.000057800553,0.000022059467,0.00003346829,0.00010408535,0.000039038834],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009707314,0.0150627,0.274851,0.0018429238,0.0064576804,0.00044938907,0.014124943,0.0000043342925,0.4149418,0.0007294178,0.105495386,0.15633313],"study_design_scores_gemma":[0.024543554,0.002420274,0.06957289,0.00015531165,0.0014380767,0.00016542028,0.00043816603,0.0007361897,0.8772858,0.00064693403,0.022379395,0.00021798954],"about_ca_topic_score_codex":0.000030375022,"about_ca_topic_score_gemma":0.000002147019,"teacher_disagreement_score":0.46234402,"about_ca_system_score_codex":0.000011744744,"about_ca_system_score_gemma":0.00010255687,"threshold_uncertainty_score":0.18362299},"labels":[],"label_agreement":null},{"id":"W2566813663","doi":"10.1182/blood.v120.21.4701.4701","title":"Effectiveness and Cost of Rituximab for CLL in the Province of Manitoba Prior to Its Approval As Part of First Line Treatment","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Medicine; Formulary; Rituximab; Regimen; Population; Cohort; Internal medicine; Oncology; Family medicine; Lymphoma","score_opus":0.03269511178432509,"score_gpt":0.3218280623678805,"score_spread":0.28913295058355537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566813663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951296,0.000912942,0.000031329186,0.000090835725,0.000025517707,0.0035411525,0.000038793314,0.0000041546073,0.00022571244],"genre_scores_gemma":[0.9992034,0.00006423068,0.0002223529,0.000011306188,0.00007958721,0.00034390404,0.000006811356,0.0000127869935,0.000055634995],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990868,0.00006455898,0.0002388284,0.000144235,0.00023635657,0.0002292313],"domain_scores_gemma":[0.99890673,0.0005851134,0.00007412977,0.00026118435,0.00009954184,0.00007331727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005600097,0.00009981694,0.00036225648,0.000063636326,0.000018536908,0.0000025506067,0.00008821285,0.000054949534,0.0000038803437],"category_scores_gemma":[0.00032469738,0.00006295993,0.000053024476,0.00012757088,0.000070197166,0.000034499037,0.00004587832,0.000045719986,0.000002539767],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044220623,0.18471217,0.26871943,0.077259175,0.0036668903,0.0004068714,0.022408826,0.00012400986,0.110958986,0.0048362757,0.0007302202,0.2819565],"study_design_scores_gemma":[0.13836557,0.006110876,0.043963365,0.0009885144,0.0005018035,0.00017096986,0.00047039185,0.0003203138,0.80566317,0.00002830927,0.00327376,0.00014293134],"about_ca_topic_score_codex":0.000527779,"about_ca_topic_score_gemma":0.00046331916,"teacher_disagreement_score":0.69470423,"about_ca_system_score_codex":0.0006401556,"about_ca_system_score_gemma":0.00087300234,"threshold_uncertainty_score":0.25674313},"labels":[],"label_agreement":null},{"id":"W2566835558","doi":"10.1182/blood-2016-10-747915","title":"Alteration of blood clotting and lung damage by protamine are avoided using the heparin and polyphosphate inhibitor UHRA","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of British Columbia","funders":"Canadian Institutes of Health Research; Michael Smith Health Research BC; Centre for Blood Research, University of British Columbia; National Institutes of Health; University of British Columbia; National Heart, Lung, and Blood Institute; Heart and Stroke Foundation of Canada","keywords":"Heparin; Antidote; Protamine; Pharmacology; Medicine; Polyphosphate; Lung; Protamine sulfate; Activated clotting time; Chemistry; Internal medicine; Biochemistry; Toxicity","score_opus":0.016660782012654706,"score_gpt":0.2625384238583386,"score_spread":0.2458776418456839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566835558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99716717,0.001015365,0.00009046248,0.00078285096,0.000052323412,0.0007172685,0.000019705942,0.00003373003,0.000121104014],"genre_scores_gemma":[0.9986579,0.00013984977,0.0007776552,0.00009561349,0.00013795398,0.000022247299,0.000004474639,0.000028964538,0.00013537846],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988516,0.00007424581,0.0003442561,0.00030125724,0.00018078068,0.0002478669],"domain_scores_gemma":[0.9992145,0.00010628474,0.0002008652,0.00027926054,0.00007800231,0.00012109542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028701843,0.00018082156,0.00037884022,0.00005366868,0.00016041497,0.00003789425,0.00006249826,0.000093828,0.000017891596],"category_scores_gemma":[0.00016238635,0.00010782012,0.00003988317,0.00012681393,0.00013475523,0.00017780079,0.00010632874,0.00012472045,0.0000013447369],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028638191,0.00021979661,0.12747772,0.00012915261,0.00014311101,0.000009704684,0.00027184424,1.0686894e-7,0.8708658,0.00009906355,0.000029411318,0.0007256424],"study_design_scores_gemma":[0.005304733,0.00021980418,0.06550388,0.0007634863,0.0008479895,0.000101679,0.00013542411,0.00023372195,0.92662656,0.000036043177,0.00006253761,0.00016411219],"about_ca_topic_score_codex":0.00016542945,"about_ca_topic_score_gemma":0.000015090094,"teacher_disagreement_score":0.061973836,"about_ca_system_score_codex":0.0000144183805,"about_ca_system_score_gemma":0.000048901537,"threshold_uncertainty_score":0.43967766},"labels":[],"label_agreement":null},{"id":"W2566853909","doi":"10.1182/blood.v112.11.3956.3956","title":"Treatment of Adult T-ALL with a Pediatric Asparaginase-Intensive Protocol Results in Survival Benefit When Compared to Other Adult Based Protocols","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Asparaginase; Regimen; Chemotherapy regimen; Chemotherapy; Transplantation; Acute lymphocytic leukemia; Internal medicine; Surgery; Pediatrics; Lymphoblastic Leukemia; Leukemia","score_opus":0.04340239687229744,"score_gpt":0.32456628095631357,"score_spread":0.28116388408401616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566853909","genre_codex":"empirical","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"protocol","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.597016,0.0000026932912,0.00009388006,0.0010952926,0.000011211055,0.3996321,0.00014893153,0.0000772428,0.0019226819],"genre_scores_gemma":[0.33998206,0.000001472933,0.005722698,0.0005172445,0.00020268388,0.6527542,0.00004230889,0.000085437256,0.00069189555],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99706507,0.00009813531,0.00067404605,0.0006281959,0.00092202664,0.0006125024],"domain_scores_gemma":[0.99682355,0.00022730524,0.00021339895,0.0007597319,0.0016032599,0.0003727805],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011035087,0.00036668318,0.0008111888,0.00040302298,0.00004450293,0.000012202014,0.00020876383,0.00013129956,0.000046298414],"category_scores_gemma":[0.00045252798,0.000256037,0.00010257639,0.00059872185,0.00010686234,0.000055766028,0.000043639306,0.00015661023,0.000059715843],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13940892,0.028981555,0.79512274,0.002229883,0.0009105782,0.010207417,0.012715324,0.0009560339,0.0030708965,0.00012780151,0.005586404,0.00068243267],"study_design_scores_gemma":[0.62954074,0.054983072,0.20156424,0.0023143212,0.0008008509,0.0012803385,0.00095321645,0.0068416684,0.09427498,0.000046193625,0.005858972,0.0015414387],"about_ca_topic_score_codex":0.0021919187,"about_ca_topic_score_gemma":0.00067507033,"teacher_disagreement_score":0.59355855,"about_ca_system_score_codex":0.0004982474,"about_ca_system_score_gemma":0.0013164043,"threshold_uncertainty_score":0.9999892},"labels":[],"label_agreement":null},{"id":"W2566891546","doi":"10.1182/blood.v114.22.4776.4776","title":"Single Agent Metronomic Cyclophosphamide in Refractory,Non-Hodgkin's Lymphoma.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Regional Hospital","funders":"","keywords":"Medicine; Cyclophosphamide; Lymphoma; Internal medicine; Oncology; Chemotherapy; Cancer; Refractory (planetary science); Thymoma; Surgery; Chronic lymphocytic leukemia; Gastroenterology; Nitrogen mustard; Leukemia","score_opus":0.012256973421053028,"score_gpt":0.24721631382339043,"score_spread":0.2349593404023374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566891546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984709,0.001973834,0.000003404086,0.00058568583,0.00011821281,0.00033583422,0.0000044541102,0.0000590364,0.012210538],"genre_scores_gemma":[0.9975596,0.00022936422,0.00087755494,0.0007743155,0.00013346864,0.000033146614,0.000027643897,0.000019070325,0.0003458057],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988095,0.000021670015,0.0002981475,0.0003420487,0.00018310072,0.00034550877],"domain_scores_gemma":[0.999301,0.00004648109,0.00007636457,0.00038469138,0.00002312819,0.00016830527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000095142685,0.00020262512,0.0003654842,0.00013941701,0.000036962712,0.000022718668,0.00008153768,0.000092370916,0.00008853717],"category_scores_gemma":[0.00003523646,0.00017260108,0.0001279666,0.00018162293,0.00002197791,0.000066899804,0.00002038568,0.000050473107,0.0001800339],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039477836,0.04646194,0.60218745,0.00005143487,0.000454371,0.0032927725,0.0006161451,0.000015483083,0.021542123,0.00033142584,0.0029363048,0.32171574],"study_design_scores_gemma":[0.013447799,0.0012969467,0.9162356,0.00010370446,0.000227627,0.0000771423,0.00004424749,0.000009483709,0.055287637,0.00009044276,0.012998325,0.00018100312],"about_ca_topic_score_codex":0.00017545215,"about_ca_topic_score_gemma":0.000024065299,"teacher_disagreement_score":0.32153472,"about_ca_system_score_codex":0.00040974596,"about_ca_system_score_gemma":0.00010877122,"threshold_uncertainty_score":0.70384675},"labels":[],"label_agreement":null},{"id":"W2566911125","doi":"10.1182/blood.v124.21.16.16","title":"Engraftment Patterns in NOD.SCID Mice Predict Outcome in Human AML","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"CD33; Xenotransplantation; Myeloid; Haematopoiesis; Stem cell; Nod; CD19; Biology; Transplantation; Leukemia; Cancer research; CD34; Myeloid leukemia; Immunology; Flow cytometry; Severe combined immunodeficiency; Immunophenotyping; Medicine; In vivo; Internal medicine; Cell biology","score_opus":0.02216890756424876,"score_gpt":0.3090627421746761,"score_spread":0.28689383461042733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566911125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943841,0.00004746182,0.00003988903,0.000997666,0.00004728593,0.00052589516,0.000010305316,0.000052936975,0.003894442],"genre_scores_gemma":[0.9979229,0.000013913998,0.00025341692,0.0005864145,0.00020367169,0.000077709556,0.000052491967,0.00003273047,0.00085678033],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99826854,0.00011661733,0.00040463614,0.00034187283,0.00039302855,0.00047530571],"domain_scores_gemma":[0.99923736,0.00009241869,0.000047600697,0.00042862384,0.00003470777,0.00015928784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006429003,0.00016040198,0.00035041422,0.00031639743,0.000031787844,0.000016040662,0.00020564534,0.00011904703,0.00020431423],"category_scores_gemma":[0.00018691608,0.00014044756,0.000062506726,0.00022843866,0.000041816053,0.00004873445,0.00012605084,0.00051815814,0.00016528186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033900404,0.0007375734,0.9833664,0.00012066817,0.00002970789,0.00022320906,0.00034370023,0.0000023660812,0.014216354,0.000087221146,0.00026459858,0.0005743599],"study_design_scores_gemma":[0.013432792,0.00048904243,0.9686415,0.00018064554,0.000052777417,0.000044544846,0.00011459926,0.00026631312,0.014375859,0.000059857248,0.002165429,0.00017663439],"about_ca_topic_score_codex":0.0007648739,"about_ca_topic_score_gemma":0.0006006632,"teacher_disagreement_score":0.014724836,"about_ca_system_score_codex":0.00023943683,"about_ca_system_score_gemma":0.00007338032,"threshold_uncertainty_score":0.5727285},"labels":[],"label_agreement":null},{"id":"W2566934960","doi":"10.1182/blood.v110.11.3539.3539","title":"The Presence of the JAK2V617F Mutation in Primary Myelofibrosis and Its Allele Burden in Polycythemia Vera Predict Chemosensitivity to Hydroxyurea.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Polycythemia vera; Phlebotomy; Myelofibrosis; Medicine; Essential thrombocythemia; Internal medicine; Univariate analysis; Gastroenterology; Cohort; Bone marrow; Myeloproliferative neoplasm; Multivariate analysis","score_opus":0.007405824369477488,"score_gpt":0.23800485384100395,"score_spread":0.23059902947152647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566934960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947419,0.00042218415,0.0000046161886,0.002275068,0.00003267318,0.00089050166,0.0000095845335,0.000008957171,0.001614488],"genre_scores_gemma":[0.99937063,0.00009819331,0.00011858549,0.00014531669,0.00006790712,0.000052702624,0.000006989634,0.000010891499,0.00012880162],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989221,0.00006254653,0.0002665872,0.00022597025,0.00027870215,0.00024410934],"domain_scores_gemma":[0.9991412,0.00043999383,0.00007177562,0.00021845897,0.000049889364,0.00007865148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004934157,0.00012756977,0.00022594845,0.00005994617,0.00007115935,0.000010369395,0.00007066714,0.00006705367,0.0000035819305],"category_scores_gemma":[0.00026949836,0.00007593476,0.00003984181,0.00026822652,0.000054409775,0.000048569156,0.000077536635,0.00013274,0.0000025185807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056559336,0.00092980976,0.919988,0.00010860629,0.000105613304,0.00010780827,0.004485244,0.000042106658,0.06401668,0.00014989077,0.00010649588,0.009394183],"study_design_scores_gemma":[0.0020834233,0.00018752096,0.75924325,0.00015927672,0.000042650638,0.000031481075,0.00012102692,0.000080305246,0.23786232,0.000027368797,0.000106201456,0.00005518939],"about_ca_topic_score_codex":0.000330036,"about_ca_topic_score_gemma":0.00084161427,"teacher_disagreement_score":0.17384565,"about_ca_system_score_codex":0.000094588504,"about_ca_system_score_gemma":0.00011083346,"threshold_uncertainty_score":0.30965295},"labels":[],"label_agreement":null},{"id":"W2566964764","doi":"10.1182/blood.v112.11.3706.3706","title":"A Phase I MMRC Clinical Trial Testing the Combination of Bortezomib and Tipifarnib in Relapsed/Refractory Multiple Myeloma","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Bortezomib; Medicine; Proteasome inhibitor; Multiple myeloma; Internal medicine; Lenalidomide; Refractory (planetary science); Neutropenia; Oncology; Pharmacology; Toxicity","score_opus":0.13052371614131603,"score_gpt":0.3844697312099192,"score_spread":0.25394601506860315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566964764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99748206,0.00032838047,0.0000040438154,0.00013310784,0.00006458557,0.0010014789,0.0000105521485,0.000024121666,0.00095164677],"genre_scores_gemma":[0.99897397,0.000114213064,0.00057415024,0.000036967813,0.00012197771,0.000051136507,0.00002357919,0.000012808281,0.00009122019],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985438,0.00019179565,0.0004999346,0.00023321858,0.00030953684,0.00022170128],"domain_scores_gemma":[0.99808496,0.0012646702,0.00014563483,0.00026338585,0.000104485334,0.00013683843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059231045,0.000113996786,0.00032869205,0.000102291844,0.00009400037,0.0000061271735,0.000072579955,0.00009792817,0.000014714785],"category_scores_gemma":[0.00390905,0.00007693039,0.0000742472,0.00021406065,0.00020830412,0.000047515987,0.000044626868,0.00030545497,0.000007996393],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017269116,0.019779366,0.90741956,0.00004670929,0.00017336354,0.0005191212,0.00033134318,3.2652446e-7,0.0039335373,0.000020629284,0.0001008338,0.05040609],"study_design_scores_gemma":[0.38684154,0.0054123756,0.6049461,0.00006563203,0.00007977667,0.00010498556,0.0000488451,0.0009039021,0.0012706636,0.000024093672,0.0002359827,0.00006614591],"about_ca_topic_score_codex":0.00014268403,"about_ca_topic_score_gemma":0.000028638635,"teacher_disagreement_score":0.36957243,"about_ca_system_score_codex":0.000019994994,"about_ca_system_score_gemma":0.00016985544,"threshold_uncertainty_score":0.46797803},"labels":[],"label_agreement":null},{"id":"W2566967909","doi":"10.1182/blood.v108.11.4069.4069","title":"Liver Transplantation for Prothrombin Deficiency Causing Life-Threatening Bleeds.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Alberta","funders":"","keywords":"Medicine; Bleeding diathesis; Surgery; Prothrombin complex concentrate; Liver transplantation; Context (archaeology); Transplantation; Coagulation Disorder; Coagulopathy; Inferior vena cava; Factor VII; Coagulation; Internal medicine; Warfarin; Platelet","score_opus":0.010459528791695155,"score_gpt":0.23084562727748567,"score_spread":0.22038609848579052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566967909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874425,0.0025884258,0.0033267748,0.00026805588,0.00007227274,0.00083496014,0.000007963451,0.000100468686,0.0053586103],"genre_scores_gemma":[0.99670184,0.00030787362,0.0023321111,0.00011231059,0.000097315584,0.00004506364,0.00005861497,0.000023289873,0.00032157573],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99925816,0.000010160447,0.00019097842,0.00017991492,0.00012359982,0.00023719051],"domain_scores_gemma":[0.99972755,0.00002192376,0.00004497483,0.00009073496,0.000054967215,0.00005982894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008783194,0.000104477265,0.00014967205,0.0000663121,0.00013014229,0.00001607553,0.000024324185,0.00011099581,0.000024634654],"category_scores_gemma":[0.000013578397,0.000087603825,0.000076863136,0.00013431201,0.00003670474,0.00005399753,0.0000040339064,0.00008869361,0.00001180897],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025323753,0.01786595,0.14701451,0.015242317,0.0013547818,0.0039011517,0.011498033,0.002212041,0.73707956,0.02098068,0.004887371,0.03543119],"study_design_scores_gemma":[0.13242613,0.0064798975,0.22442625,0.004147435,0.020546291,0.008199624,0.0031553444,0.013976246,0.5694962,0.005371187,0.008309557,0.0034658455],"about_ca_topic_score_codex":0.00019054378,"about_ca_topic_score_gemma":0.000014655143,"teacher_disagreement_score":0.16758339,"about_ca_system_score_codex":0.000012398178,"about_ca_system_score_gemma":0.00007423639,"threshold_uncertainty_score":0.35723802},"labels":[],"label_agreement":null},{"id":"W2566969303","doi":"10.1182/blood.v114.22.lba-6.lba-6","title":"Transfusion Trigger Trial for Functional Outcomes in Cardiovascular Patients Undergoing Surgical Hip Fracture Repair (FOCUS): The Principal Results","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Western University","funders":"","keywords":"Medicine; Blood transfusion; Anemia; Diabetes mellitus; Adverse effect; Hemoglobin; Surgery; Coronary artery disease; Disease; Hip fracture; Randomized controlled trial; Internal medicine; Osteoporosis","score_opus":0.019170503016771024,"score_gpt":0.2521402735894486,"score_spread":0.2329697705726776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566969303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839851,0.0004962174,0.0003686622,0.008229097,0.0004187451,0.003938695,0.000017686745,0.00015303567,0.002392752],"genre_scores_gemma":[0.9974946,0.00019279176,0.00016942351,0.0008992333,0.0003612768,0.000115889554,0.0000745073,0.000019229494,0.0006730639],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9979957,0.000107651074,0.0005111865,0.0004407617,0.0006394606,0.0003052792],"domain_scores_gemma":[0.99906194,0.0002504727,0.000056733228,0.0004566819,0.00007438865,0.000099769495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007860712,0.0002078632,0.0004923408,0.000118147844,0.00013834778,0.000017821685,0.000088534434,0.00016519387,0.000032361284],"category_scores_gemma":[0.0001817238,0.00012793645,0.00088988355,0.00019370201,0.000025992305,0.000058674425,0.000014572296,0.0002796839,0.000005397197],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.61985075,0.07489758,0.13500965,0.0008716942,0.012845361,0.0013241126,0.004867682,0.0016197846,0.0001592333,0.0050939773,0.020929532,0.12253067],"study_design_scores_gemma":[0.5510676,0.002295654,0.3114378,0.00009220557,0.0014740834,0.000016987307,0.00008053932,0.000039431434,0.00032328514,0.00017479096,0.13275091,0.0002467531],"about_ca_topic_score_codex":0.00003408209,"about_ca_topic_score_gemma":0.00007333846,"teacher_disagreement_score":0.17642814,"about_ca_system_score_codex":0.000036346617,"about_ca_system_score_gemma":0.000080643484,"threshold_uncertainty_score":0.5217097},"labels":[],"label_agreement":null},{"id":"W2566972574","doi":"10.1182/blood.v120.21.2262.2262","title":"Fondaparinux Versus Argatroban and Danaparoid for the Treatment of Suspected or Confirmed Heparin-Induced Thrombocytopenia: A Propensity Score Analysis.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Hospital; Western University; London Health Sciences Centre","funders":"","keywords":"Argatroban; Fondaparinux; Medicine; Heparin-induced thrombocytopenia; Heparin; Thrombosis; Internal medicine; Anticoagulant; Lepirudin; Subgroup analysis; Population; Surgery; Confidence interval; Platelet; Venous thromboembolism","score_opus":0.1473270314127752,"score_gpt":0.330297001354339,"score_spread":0.18296996994156378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566972574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99461687,0.0006303453,0.000039610717,0.00034566145,0.00026374726,0.0027994574,0.000034615885,0.00008182014,0.0011878934],"genre_scores_gemma":[0.99812907,0.00035192553,0.00051614456,0.0000585592,0.0002953152,0.00026197248,0.0000758844,0.000051171784,0.00025994884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976697,0.00009965991,0.00059189403,0.0005419619,0.00033684954,0.00075992924],"domain_scores_gemma":[0.99750113,0.0005861869,0.00026995153,0.000981492,0.00024483568,0.00041642122],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034026592,0.00044741333,0.0016807219,0.00020816532,0.00031149227,0.00004915682,0.00021240558,0.00020995401,0.0001783512],"category_scores_gemma":[0.00020576004,0.00026247316,0.00043231752,0.0008469138,0.00023026371,0.000171684,0.0000935402,0.00017362303,0.000013358226],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00974284,0.012081723,0.770751,0.00033417478,0.036776166,0.00007745749,0.0043865847,0.000002959274,0.1571945,0.0031373198,0.00018396198,0.005331295],"study_design_scores_gemma":[0.023615297,0.0053277905,0.7520829,0.00003962746,0.022826498,0.00010763935,0.0003501844,0.00007711719,0.19334662,0.000019530791,0.0018290798,0.00037775244],"about_ca_topic_score_codex":0.00090845913,"about_ca_topic_score_gemma":0.0023051694,"teacher_disagreement_score":0.036152124,"about_ca_system_score_codex":0.00013682921,"about_ca_system_score_gemma":0.0003022532,"threshold_uncertainty_score":0.9999828},"labels":[],"label_agreement":null},{"id":"W2566983112","doi":"10.1182/blood.v106.11.3982.3982","title":"Pitfalls in Interpreting Platelet Function Tests in Thrombocytopenic Patients Referred by a Hematologist for Diagnostic Testing: Results from a Single Center Prospective Study.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Regional Laboratory Medicine Program; McMaster University","funders":"","keywords":"Medicine; Platelet; Internal medicine; Ristocetin; Medical record; Gastroenterology; Asymptomatic; Von Willebrand disease; Von Willebrand factor","score_opus":0.024208889900543987,"score_gpt":0.27187091917597506,"score_spread":0.24766202927543107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566983112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960348,0.00016554691,0.00000904968,0.00012676883,0.0000715314,0.0025250858,0.00020264245,0.000058869013,0.00080569764],"genre_scores_gemma":[0.9983782,0.00000541778,0.00064691575,0.000105415485,0.000029125034,0.00030784347,0.00046632855,0.000031335323,0.000029386674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983061,0.000050119044,0.00055414723,0.0005580926,0.00017549528,0.000356021],"domain_scores_gemma":[0.9984257,0.00103068,0.0001714818,0.00022482751,0.00007860384,0.00006869701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013461527,0.00023272185,0.00051133265,0.00011715989,0.000046715613,0.000029369825,0.00008059983,0.00010327572,0.000005849464],"category_scores_gemma":[0.0034524242,0.0002026578,0.00004827884,0.0002458049,0.000027532978,0.00013632727,0.000053744483,0.00018049877,0.00001719449],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013468278,0.024051867,0.9688711,0.00001743628,0.00013214021,0.00017059036,0.0011335233,0.0000044628428,0.000533442,7.705917e-7,0.0002456255,0.0034921907],"study_design_scores_gemma":[0.07988869,0.0046596033,0.91138756,0.00073452084,0.0001799685,0.000027411017,0.0004396386,0.00019341345,0.001929257,0.00015271136,0.00012212724,0.0002851025],"about_ca_topic_score_codex":0.0004983779,"about_ca_topic_score_gemma":0.0021618546,"teacher_disagreement_score":0.07854186,"about_ca_system_score_codex":0.00018626788,"about_ca_system_score_gemma":0.000033686887,"threshold_uncertainty_score":0.8264145},"labels":[],"label_agreement":null},{"id":"W2567041189","doi":"10.1182/blood.v106.11.917.917","title":"Influence of Perceived Risk Factors for Bleeding on Venous Thromboembolism Prophylaxis Practices in Acutely Ill Medical Patients: Findings from IMPROVE.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Hamilton General Hospital","funders":"","keywords":"Medicine; Internal medicine; Medical prescription; Logistic regression; Risk factor","score_opus":0.01545923503982009,"score_gpt":0.28091399440979653,"score_spread":0.2654547593699764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567041189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973948,0.000098701086,0.0000039905212,0.00037590487,0.00014036168,0.0014463358,0.0001260536,0.00005128394,0.00036254205],"genre_scores_gemma":[0.99771744,0.0004956728,0.0007347152,0.0005466006,0.000267046,0.00011899348,0.000059004677,0.00004297873,0.000017552484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99766845,0.00005295619,0.0005968892,0.0005264225,0.00072481745,0.00043045165],"domain_scores_gemma":[0.9981586,0.0005322992,0.00053768983,0.0003544628,0.00022121529,0.00019577239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003590831,0.00027447642,0.0008379352,0.00022056523,0.000099920144,0.000025137977,0.0002653004,0.00023930734,0.00009544061],"category_scores_gemma":[0.0035556708,0.00022231859,0.00014416345,0.00019884309,0.00008875329,0.0002715437,0.000097649776,0.00038483224,0.00001840158],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006578421,0.04868635,0.8718767,0.0008167126,0.0020649398,0.00004980895,0.021961965,0.0004223175,0.019455563,0.0003581283,0.00087232416,0.03277731],"study_design_scores_gemma":[0.00570954,0.003391094,0.9786457,0.00043788206,0.00065311353,9.0235534e-7,0.000515478,0.000097167795,0.009274786,0.00007592799,0.00096562435,0.00023281587],"about_ca_topic_score_codex":0.0017138469,"about_ca_topic_score_gemma":0.0001418617,"teacher_disagreement_score":0.10676893,"about_ca_system_score_codex":0.00009289952,"about_ca_system_score_gemma":0.000114654176,"threshold_uncertainty_score":0.9065889},"labels":[],"label_agreement":null},{"id":"W2567073322","doi":"10.1182/blood.v120.21.1163.1163","title":"Patient-Reported Treatment Satisfaction with Oral Rivaroxaban Versus Standard Therapy in the Treatment of Acute Symptomatic Pulmonary Embolism","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Rivaroxaban; Pulmonary embolism; Deep vein; Vitamin K antagonist; Patient satisfaction; Randomized controlled trial; Thrombosis; Emergency medicine; Physical therapy; Internal medicine; Surgery; Atrial fibrillation; Warfarin","score_opus":0.02321250284569653,"score_gpt":0.2806605815696879,"score_spread":0.25744807872399134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567073322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99610937,0.0007746303,0.0000050637213,0.00023520146,0.00016370403,0.0015988192,0.000018087594,0.000037982623,0.0010571479],"genre_scores_gemma":[0.9961033,0.003028569,0.00027882901,0.000065790024,0.00008329871,0.0003483646,0.000045486173,0.000024773739,0.000021618718],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871004,0.00007616454,0.00031646702,0.00018998918,0.00036178489,0.00034553738],"domain_scores_gemma":[0.9992121,0.0000544086,0.00016757623,0.00043607826,0.000038501254,0.00009135597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010038734,0.00023271874,0.0005180591,0.000108927314,0.00006194559,0.000012861073,0.000041898962,0.000052254458,0.000059249738],"category_scores_gemma":[0.0000036112365,0.00012304889,0.000112168826,0.00019275174,0.00004563471,0.000095780895,0.000007677044,0.000041089937,0.000005834011],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032376512,0.031227794,0.72709984,0.000052467392,0.0064108563,0.0003862284,0.017674373,0.000009031284,0.0011055404,0.00033506125,0.000106436266,0.21235472],"study_design_scores_gemma":[0.017480504,0.023400122,0.9466143,0.00007027727,0.0027915202,0.00009864219,0.0010637917,0.0000069955195,0.0062341844,0.000016128859,0.0020602338,0.00016329889],"about_ca_topic_score_codex":0.00091338536,"about_ca_topic_score_gemma":0.0001510678,"teacher_disagreement_score":0.21951446,"about_ca_system_score_codex":0.00019009734,"about_ca_system_score_gemma":0.000057645553,"threshold_uncertainty_score":0.5017788},"labels":[],"label_agreement":null},{"id":"W2567085528","doi":"10.1182/blood.v114.22.2016.2016","title":"Pulmonary Hypertension in Thalassemia Assessed by Echocardiography: A Report From Baseline Data of the Thalassemia Clinical Research Network Longitudinal Cohort Study.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Medicine; Thalassemia; Internal medicine; Cohort; Univariate analysis; Gastroenterology; Surgery; Multivariate analysis","score_opus":0.07427891548377695,"score_gpt":0.37262388978188754,"score_spread":0.2983449742981106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567085528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916537,0.0029211259,0.000020846157,0.0012368249,0.00028629584,0.0014580439,0.00004808142,0.000049123624,0.0023259888],"genre_scores_gemma":[0.997195,0.0013990287,0.00027617626,0.00017344518,0.00036104265,0.00001679862,0.00046248635,0.000030825508,0.000085177504],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99487025,0.0009641479,0.0012271357,0.0010779615,0.0012364092,0.0006240984],"domain_scores_gemma":[0.9956754,0.00073348504,0.00025428814,0.0028479495,0.00029263817,0.00019625331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0077300696,0.00025480427,0.0009029458,0.00014384685,0.00016516216,0.000023343491,0.00066247076,0.0004107242,0.000026227824],"category_scores_gemma":[0.001467429,0.00016764524,0.00025367778,0.0015756086,0.00021032183,0.00010835485,0.00043712748,0.0015579293,0.0000058484898],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022571954,0.006134364,0.9633233,0.000013030369,0.00040283654,0.0034607216,0.000016897135,0.000014601043,0.0012028003,0.0000017296455,0.023883624,0.0013203897],"study_design_scores_gemma":[0.0031375315,0.00044288376,0.9928655,0.00039439168,0.00075047754,0.00033864015,0.00027297312,0.00070956734,0.000118876225,0.00012283704,0.0006832326,0.00016309971],"about_ca_topic_score_codex":0.00095368404,"about_ca_topic_score_gemma":0.00004518623,"teacher_disagreement_score":0.029542204,"about_ca_system_score_codex":0.000027400783,"about_ca_system_score_gemma":0.00033001252,"threshold_uncertainty_score":0.68363744},"labels":[],"label_agreement":null},{"id":"W2567093270","doi":"10.1182/blood.v116.21.4129.4129","title":"The Prognosis of Limited Stage Peripheral T-Cell Lymphoma (PTCL): A Population-Based Analysis and Comparison to Diffuse Large B-Cell Lymphoma (DLBCL)","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Anaplastic large-cell lymphoma; Lymphoma; Internal medicine; Peripheral T-cell lymphoma; Stage (stratigraphy); T-cell lymphoma; Diffuse large B-cell lymphoma; Gastroenterology; Cancer; Population; Oncology; T cell; Immunology","score_opus":0.009142072904371452,"score_gpt":0.2516117252617827,"score_spread":0.24246965235741127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567093270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974904,0.0005163278,0.000039075865,0.00046017324,0.00007931917,0.0008037789,0.00011810406,0.00006543582,0.00042739822],"genre_scores_gemma":[0.9973197,0.000036550937,0.001533711,0.00026675957,0.00006112421,0.00018942918,0.0001690626,0.000035700537,0.0003879635],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980755,0.000073267714,0.0005329826,0.00045224998,0.00043848073,0.00042755526],"domain_scores_gemma":[0.9983327,0.00028031575,0.00024483807,0.0006574444,0.00015310159,0.00033160363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021219988,0.00030193783,0.00064626604,0.0002399649,0.0002567865,0.00008721456,0.00015406095,0.00014473448,0.00004663862],"category_scores_gemma":[0.000079965896,0.00020649031,0.0003049014,0.0007582962,0.00006112298,0.000048757465,0.00006821591,0.000064536944,0.000010595115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019638918,0.04044015,0.9501927,0.00007642467,0.00060583604,0.000027797358,0.00031113834,0.0000058758883,0.0030980145,0.000056431614,0.00010641967,0.0048828544],"study_design_scores_gemma":[0.04504931,0.00057443575,0.8967125,0.000028196035,0.0030003032,0.0000046457835,0.00017819078,0.0029039062,0.048783325,0.0000031624086,0.0025423954,0.00021965429],"about_ca_topic_score_codex":0.0011400093,"about_ca_topic_score_gemma":0.0017336182,"teacher_disagreement_score":0.053480193,"about_ca_system_score_codex":0.00007348002,"about_ca_system_score_gemma":0.00013087053,"threshold_uncertainty_score":0.84204304},"labels":[],"label_agreement":null},{"id":"W2567098548","doi":"10.1182/blood.v120.21.669.669","title":"Outcome of Treatment for Relapsed Acute Lymphoblastic Leukemia in Children with Down Syndrome","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Internal medicine; Population; Concomitant; Pediatrics; Cohort; Clinical trial","score_opus":0.017406060748669277,"score_gpt":0.28285012438850937,"score_spread":0.2654440636398401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567098548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99741894,0.00016931008,0.0002655153,0.000056765857,0.000044561755,0.0014855386,0.0000796088,0.000047405723,0.0004323371],"genre_scores_gemma":[0.9953245,0.000027710992,0.0032345045,0.000060686107,0.00009427575,0.0002502891,0.00007542949,0.000059609167,0.00087302923],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819106,0.00003338416,0.0004428323,0.00029724528,0.00034668503,0.0006887942],"domain_scores_gemma":[0.99884045,0.00020933461,0.00011304129,0.00047727654,0.00007524718,0.0002846672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000206594,0.0002647408,0.00064685644,0.00025446815,0.00003906223,0.000007986076,0.00014180054,0.00015188682,0.000049298622],"category_scores_gemma":[0.00010698117,0.00017917092,0.0001308332,0.0003333774,0.000115058,0.00011194898,0.00004769453,0.00011048296,0.000043111493],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008982633,0.0011110164,0.99364156,0.00009561932,0.0012891899,0.000077279125,0.00025659666,0.000021898428,0.0020609235,0.00012217519,0.000077847915,0.00034761985],"study_design_scores_gemma":[0.06316664,0.0061040088,0.9113416,0.00019658453,0.0020330255,0.004800304,0.00005639086,0.00027161668,0.011567443,0.000019963378,0.0001319483,0.00031048103],"about_ca_topic_score_codex":0.00033383025,"about_ca_topic_score_gemma":0.00001677955,"teacher_disagreement_score":0.08229998,"about_ca_system_score_codex":0.002186769,"about_ca_system_score_gemma":0.0010154161,"threshold_uncertainty_score":0.7306378},"labels":[],"label_agreement":null},{"id":"W2567123265","doi":"10.1182/blood.v120.21.1153.1153","title":"Clinical Predictors of Confirmed Venous Thromboembolism in Patients with a Suspected Recurrent Venous Thromboembolism: A Retrospective Study of the Reverse I Cohort","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Pulmonary embolism; Deep vein; Thrombosis; Retrospective cohort study; Venous thromboembolism; Pre- and post-test probability; Venous thrombosis; Internal medicine; Cohort; Surgery","score_opus":0.011953511516755314,"score_gpt":0.2652280489494882,"score_spread":0.25327453743273287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567123265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99212164,0.00022073543,0.0000011327863,0.000051338702,0.00091530185,0.005146408,0.000047344056,0.000052886062,0.0014431915],"genre_scores_gemma":[0.9992352,0.00011094813,0.00006909829,0.00009780572,0.00024108819,0.00013815633,0.00002485811,0.00006382271,0.000019007144],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99605185,0.0003760768,0.0012275866,0.0005581929,0.001128787,0.00065748725],"domain_scores_gemma":[0.9973302,0.00010298756,0.00076245965,0.0011446751,0.00042702662,0.00023264176],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00089896994,0.00038761902,0.0022945525,0.0002129461,0.00009798079,0.000010052878,0.0003571504,0.00018817242,0.00008573306],"category_scores_gemma":[0.00033752449,0.0002635933,0.00022849714,0.0008192172,0.00033633428,0.00013418557,0.00025262148,0.00056042365,0.000006924927],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002939916,0.10738387,0.8837165,0.00012817049,0.00187913,0.000010231237,0.0057541234,0.0000023468742,0.000028000553,0.00017752082,0.00041556178,0.00021050649],"study_design_scores_gemma":[0.014098977,0.009465792,0.9707785,0.0004440342,0.0032696626,0.0000049186438,0.0013877063,0.0000016710147,0.00017642434,0.00002544263,0.00010177335,0.0002450724],"about_ca_topic_score_codex":0.00058846374,"about_ca_topic_score_gemma":0.0002637802,"teacher_disagreement_score":0.09791808,"about_ca_system_score_codex":0.0001444392,"about_ca_system_score_gemma":0.00019058632,"threshold_uncertainty_score":0.99998164},"labels":[],"label_agreement":null},{"id":"W2567167795","doi":"10.1182/blood.v106.11.4186.4186","title":"A Comparison of Administration Time between Red Blood Cell Transfusion and Chemotherapy.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; Chemotherapy; Chemotherapy regimen; Blood transfusion; Internal medicine; Phlebotomy; Surgery","score_opus":0.016816044661374423,"score_gpt":0.2994770875544074,"score_spread":0.28266104289303295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567167795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914735,0.00021122115,0.000020320076,0.0010024899,0.0000110684305,0.00022852774,0.0000076248825,0.000033198972,0.007012066],"genre_scores_gemma":[0.99854004,0.00007718131,0.0005708546,0.00006415976,0.00018367708,0.000007681893,0.000014591381,0.000011455696,0.00053032517],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999468,0.000014013781,0.00019592271,0.00012873979,0.00010570478,0.00008761086],"domain_scores_gemma":[0.999711,0.000018216897,0.000055354078,0.00011954355,0.000030314544,0.00006558903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004906178,0.00007531961,0.00022002311,0.000040509367,0.000039325205,0.000005864784,0.000025472324,0.00005994443,0.00020652644],"category_scores_gemma":[0.0000026590938,0.00006931474,0.00004403865,0.0000848848,0.000028305347,0.00002831554,0.000004434325,0.000084087194,0.000010263414],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011724713,0.0020047063,0.39056098,0.00009152059,0.0000999686,0.0000024735875,0.0005112283,0.000001128026,0.5987472,0.000010923164,0.0003475711,0.0075050485],"study_design_scores_gemma":[0.0053944746,0.001120537,0.12118266,0.000039305385,0.00061856257,0.000027124508,0.000023411538,0.000012520521,0.86671877,0.0000076268943,0.004778969,0.0000760163],"about_ca_topic_score_codex":0.000009897406,"about_ca_topic_score_gemma":0.000011567116,"teacher_disagreement_score":0.26937833,"about_ca_system_score_codex":0.0000052141622,"about_ca_system_score_gemma":0.000043343123,"threshold_uncertainty_score":0.28265733},"labels":[],"label_agreement":null},{"id":"W2567173875","doi":"10.1182/blood.v120.21.2771.2771","title":"Three-Dimensional Nuclear Telomeric Organization (3D) of Chronic Myeloid Leukemia Patients Predicts Accelerated Phase and Blast Crisis.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"","keywords":"Telomere; Chromosome instability; Biology; Genome instability; Myeloid leukemia; Aneuploidy; Pathology; Cancer research; DNA damage; Genetics; Medicine; Chromosome; DNA","score_opus":0.012528896483684488,"score_gpt":0.23586389368946445,"score_spread":0.22333499720577996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567173875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99826527,0.0008563288,0.00004717898,0.000056619087,0.00017830623,0.00035557037,0.00003870541,0.00010140888,0.00010064233],"genre_scores_gemma":[0.9985911,0.00012210944,0.0005095111,0.00023018618,0.00026836692,0.0000042055285,0.00019152995,0.000056714558,0.00002626553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985574,0.000028345985,0.00037438973,0.00027799612,0.00038570425,0.00037615467],"domain_scores_gemma":[0.99893045,0.00003397222,0.00017201224,0.00027433693,0.00030534161,0.00028390333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000104991195,0.00021565567,0.00036236047,0.00014560456,0.00011181407,0.0000147400115,0.000086975924,0.0001355226,0.0004899849],"category_scores_gemma":[0.00014188711,0.00019031398,0.000037602695,0.0005563763,0.000107548956,0.00024398639,0.000079520156,0.00016867896,0.000052159383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006682513,0.0131002,0.6353267,0.0009181723,0.0006586571,0.000042177584,0.0027735569,0.00001707739,0.30456772,0.000120807155,0.009946256,0.03186041],"study_design_scores_gemma":[0.024517145,0.002174021,0.8746668,0.00028555913,0.00078790175,0.00014499668,0.00016609092,0.0009317117,0.09397279,0.00000892143,0.0018225672,0.00052150484],"about_ca_topic_score_codex":0.000057811052,"about_ca_topic_score_gemma":0.0000066447874,"teacher_disagreement_score":0.2393401,"about_ca_system_score_codex":0.00009122774,"about_ca_system_score_gemma":0.0001920592,"threshold_uncertainty_score":0.77607787},"labels":[],"label_agreement":null},{"id":"W2567193838","doi":"10.1182/blood.v126.23.2195.2195","title":"Barth Syndrome: An Under-Recognized Cause of Chronic Neutropenia","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Neutropenia; Monocytosis; Medicine; Congenital Neutropenia; Absolute neutrophil count; Cyclic neutropenia; Internal medicine; Immunology; Bone marrow; Gastroenterology; Pediatrics; Chemotherapy","score_opus":0.021422284328498502,"score_gpt":0.2583949259998372,"score_spread":0.23697264167133872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567193838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99631894,0.0021983422,0.000055303437,0.000035460023,0.000070368114,0.00014326205,0.000024066825,0.0000113811275,0.0011428691],"genre_scores_gemma":[0.99897176,0.00008488329,0.00022349044,0.000057192236,0.000052282336,0.000014325358,0.00016250297,0.000020873624,0.00041267116],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993119,0.000040596486,0.00013661475,0.0002408579,0.00009362973,0.00017640012],"domain_scores_gemma":[0.9993947,0.000002523235,0.000058134316,0.00034568712,0.00006312433,0.00013579194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000060776205,0.000121677476,0.00015118571,0.000023292958,0.000026146432,0.00001130184,0.00013113543,0.00009426651,0.000020116782],"category_scores_gemma":[0.000012109887,0.00010876413,0.00005354134,0.000060408645,0.000043335254,0.0000046872765,0.000060847724,0.00003657531,0.00002290508],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010183523,0.03420942,0.17082766,0.00023451197,0.006239678,0.00056592905,0.000514815,0.0006082232,0.75665903,0.0012059873,0.00490607,0.023010338],"study_design_scores_gemma":[0.03440042,0.009701828,0.021065328,0.000038880407,0.00089660526,0.00048858847,0.00024607932,0.000046107405,0.92467165,0.0005958217,0.0071115163,0.00073717703],"about_ca_topic_score_codex":0.000060792718,"about_ca_topic_score_gemma":0.00022519658,"teacher_disagreement_score":0.16801263,"about_ca_system_score_codex":0.000006139363,"about_ca_system_score_gemma":0.00015251728,"threshold_uncertainty_score":0.44352725},"labels":[],"label_agreement":null},{"id":"W2567234666","doi":"10.1182/blood.v124.21.5104.5104","title":"Improving the Appropriate Use of Intravenous Immunoglobulin in the Saskatoon Health Region","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University of Saskatchewan; University of Calgary","funders":"","keywords":"Medicine; Clinical endpoint; Off-label use; Pediatrics; Retrospective cohort study; Adverse effect; Internal medicine; Emergency medicine; Clinical trial","score_opus":0.025083178247644583,"score_gpt":0.25229509321674387,"score_spread":0.2272119149690993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567234666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951303,0.00027703267,0.00039456628,0.003136123,0.00008684382,0.00045868548,0.0000012577879,0.00001871287,0.0004964516],"genre_scores_gemma":[0.998316,0.00007907689,0.00011189096,0.0012505658,0.00012356743,0.000027823051,0.000002692204,0.000009591832,0.00007882367],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99925405,0.00014848485,0.0002061453,0.00011382622,0.0001236169,0.00015390226],"domain_scores_gemma":[0.99938107,0.00007360993,0.000095269774,0.00039587414,0.000028817762,0.000025380092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000387268,0.000068699315,0.00015796605,0.00003410474,0.00008314579,0.000018338511,0.0000965834,0.00003158442,0.0000043272294],"category_scores_gemma":[0.000047850583,0.000036239213,0.00005040832,0.0001727809,0.000053065043,0.000040518942,0.000020732487,0.00020253977,0.0000049248947],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012215734,0.01004897,0.19108877,0.0017168877,0.0005467776,0.00010908478,0.040116634,0.00027742505,0.09404629,0.021413228,0.0044725947,0.63494176],"study_design_scores_gemma":[0.016181078,0.0071754437,0.8889678,0.000852481,0.00073892367,0.0020685855,0.0033278489,0.0004097036,0.023911057,0.0010757952,0.054779228,0.00051206496],"about_ca_topic_score_codex":0.002350047,"about_ca_topic_score_gemma":0.00042351324,"teacher_disagreement_score":0.697879,"about_ca_system_score_codex":0.000021154894,"about_ca_system_score_gemma":0.00010019643,"threshold_uncertainty_score":0.35525838},"labels":[],"label_agreement":null},{"id":"W2567252082","doi":"10.1182/blood.v120.21.1253.1253","title":"Mesenchymal Stem Cells Engineered to Inhibit Complement-Mediated Damage","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Mesenchymal stem cell; CD59; CD46; Complement system; Transplantation; Biology; Stem cell; Cell biology; Anaphylatoxin; Immune system; Molecular biology; Chemistry; Immunology; Medicine; Internal medicine","score_opus":0.04297300800766202,"score_gpt":0.2964966134545415,"score_spread":0.25352360544687946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567252082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832408,0.00036961352,0.00012319996,0.0005325862,0.00022384085,0.0011192271,0.000046698107,0.00014458253,0.014199489],"genre_scores_gemma":[0.99318224,0.000013933456,0.0013198695,0.00032865352,0.00048746663,0.00005993131,0.000053899057,0.00005363908,0.0045003495],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973523,0.00009280716,0.00038159647,0.00031190645,0.00084686896,0.0010144953],"domain_scores_gemma":[0.9979573,0.00018718823,0.00004913802,0.0005427836,0.00013903469,0.0011245415],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00069975085,0.00023504192,0.00038901906,0.0002433298,0.00007498821,0.000029721772,0.00019441459,0.00011113482,0.0017362954],"category_scores_gemma":[0.00009858169,0.00020502946,0.00009601998,0.0005509321,0.000037368656,0.00010856437,0.0002104952,0.00031267112,0.0030214912],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010691858,0.0017152999,0.05204579,0.0002901421,0.00028375827,0.00016767334,0.001074815,0.000004477824,0.92956394,0.00030322495,0.0133623155,0.0010816456],"study_design_scores_gemma":[0.0063212034,0.0007644158,0.03443616,0.00015073798,0.00021666945,0.00007922138,0.00054523215,0.00013428317,0.8660823,0.000003390479,0.09081481,0.00045158633],"about_ca_topic_score_codex":0.000043988664,"about_ca_topic_score_gemma":0.0000071646655,"teacher_disagreement_score":0.07745249,"about_ca_system_score_codex":0.00006908518,"about_ca_system_score_gemma":0.00008883354,"threshold_uncertainty_score":0.99917626},"labels":[],"label_agreement":null},{"id":"W2567256464","doi":"10.1182/blood.v108.11.5507.5507","title":"The Relationship between Anemia and Chronic Kidney Disease (CKD) in Older Nursing Facility (NF) Residents.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Anemia; Renal function; Kidney disease; Odds ratio; Dialysis; Internal medicine; Hemoglobin; Creatinine","score_opus":0.019738718517145874,"score_gpt":0.2864027890660844,"score_spread":0.26666407054893854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567256464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880658,0.0034092802,0.000007353466,0.006467812,0.00003151425,0.00031691894,0.000030092056,0.00003792214,0.001633308],"genre_scores_gemma":[0.9981691,0.000056658908,0.00008162041,0.00004854859,0.00017104577,0.00001569379,0.00012050565,0.000008675437,0.0013281183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99912965,0.0000560922,0.00020716005,0.00021847851,0.00016810591,0.00022054013],"domain_scores_gemma":[0.99929667,0.00020736577,0.000039294096,0.00025557238,0.000017020855,0.00018405689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014045993,0.00011183714,0.00013503917,0.000038246533,0.0001816186,0.000025826663,0.000041490468,0.000061091596,0.000022599674],"category_scores_gemma":[0.0001961715,0.00007912863,0.0000412514,0.00010821307,0.00015300704,0.00004024463,0.000015851814,0.00017004082,0.000019639194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023949358,0.00028131317,0.99681777,0.000075780656,0.000008624887,0.000042553605,0.00007781345,3.17814e-7,0.000065466804,0.0002936034,0.0016428231,0.00066997926],"study_design_scores_gemma":[0.0038031328,0.00005497556,0.9930239,0.0003689361,0.00019123175,0.0000101175165,0.00004300505,0.0000020286539,0.00042574207,0.00163565,0.0003628517,0.000078434154],"about_ca_topic_score_codex":0.00018279189,"about_ca_topic_score_gemma":0.000052045623,"teacher_disagreement_score":0.010103335,"about_ca_system_score_codex":0.00012693764,"about_ca_system_score_gemma":0.00017402417,"threshold_uncertainty_score":0.3226772},"labels":[],"label_agreement":null},{"id":"W2567281975","doi":"10.1182/blood.v104.11.4524.4524","title":"Infectious Morbidity and Hospitalization Requirements of Patients with Acute Myeloid Leukemia Receiving Intensive Outpatient Consolidation.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Cytarabine; Internal medicine; Ambulatory; Chemotherapy; Leukemia; Febrile neutropenia; Bacteremia; Induction chemotherapy; Surgery; Neutropenia; Antibiotics","score_opus":0.011018450452384148,"score_gpt":0.24803721095115502,"score_spread":0.23701876049877088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567281975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998057,0.000029154147,0.0004493084,0.00006274625,0.00012369512,0.000492865,0.000019413448,0.00003928381,0.0007264964],"genre_scores_gemma":[0.9993823,0.00008441748,0.00019024427,0.00017084887,0.00002973854,0.000028818617,0.00007253295,0.000015329812,0.000025760664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993028,0.000014326412,0.00019854344,0.00018081312,0.00018584238,0.0001176616],"domain_scores_gemma":[0.9990522,0.000010503875,0.00014817456,0.00015445781,0.000565714,0.00006889789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000036298654,0.00010578817,0.00018434243,0.000079309226,0.00007465623,0.000011826304,0.000024735487,0.000047860347,0.000017661618],"category_scores_gemma":[0.00006507525,0.000088562316,0.000026511638,0.00017467297,0.00007566172,0.000145809,0.000028307019,0.00008540671,0.00000352349],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009746272,0.00043023712,0.996419,0.00005292378,0.00025810994,0.000007476909,0.000562501,0.00005988483,0.0015567059,0.00016153751,0.000047138023,0.000346986],"study_design_scores_gemma":[0.008796538,0.0017496451,0.96431035,0.00019972306,0.0006082752,0.000030506651,0.000090063666,0.0000018902035,0.023885408,0.00012746651,0.00007539292,0.0001247613],"about_ca_topic_score_codex":0.0001373047,"about_ca_topic_score_gemma":0.000043598993,"teacher_disagreement_score":0.03210871,"about_ca_system_score_codex":0.00013342402,"about_ca_system_score_gemma":0.00014330135,"threshold_uncertainty_score":0.36114666},"labels":[],"label_agreement":null},{"id":"W2567301541","doi":"10.1182/blood.v108.11.1040.1040","title":"The Genetics of Hemophilia: Analysis of Patients at the Hospital for Sick Children, Toronto, Canada.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Concordance; Missense mutation; Disease; Genotype; Coagulopathy; Genetic testing; Pediatrics; Mutation; Genetic counseling; Internal medicine; Genetics; Gene; Biology","score_opus":0.0054214446868396885,"score_gpt":0.23512211622011178,"score_spread":0.2297006715332721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567301541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954956,0.0024098158,0.0000010756985,0.00060206425,0.00004029543,0.0005696065,0.00020617155,0.0000032623395,0.00067207817],"genre_scores_gemma":[0.9977237,0.00013087229,0.00003550332,0.000016589915,0.00007821906,0.000018941617,0.00019970966,0.000009192829,0.0017872591],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990594,0.000018731847,0.00022853688,0.00011965346,0.00038096443,0.00019273629],"domain_scores_gemma":[0.99921256,0.00013570314,0.00008776435,0.00033019585,0.00019126026,0.000042491185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000092908966,0.00008388512,0.00022010175,0.000020910375,0.000115195646,0.0000037928482,0.00011663911,0.000037464946,0.00004167115],"category_scores_gemma":[0.000040817045,0.000040993757,0.0001543845,0.00017148982,0.00009760157,0.000009431834,0.000042537067,0.000035822977,4.2498883e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049668397,0.0006964243,0.992425,0.000015809735,0.0016669158,0.0000012546387,0.000046976682,0.000011112178,0.00019130086,0.000038157188,0.0036154694,0.0012419155],"study_design_scores_gemma":[0.0019053922,0.00034941608,0.9792865,0.0000055320565,0.0021966782,4.831013e-7,0.000033597556,0.0000525976,0.015009168,0.000014341841,0.0010979626,0.000048347178],"about_ca_topic_score_codex":0.083051234,"about_ca_topic_score_gemma":0.42776093,"teacher_disagreement_score":0.3447097,"about_ca_system_score_codex":0.00007766772,"about_ca_system_score_gemma":0.00015469849,"threshold_uncertainty_score":0.9230548},"labels":[],"label_agreement":null},{"id":"W2567313353","doi":"10.1182/blood.v126.23.4674.4674","title":"Evaluation of Triton X-100 Effect on Coagulation Tests","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Blood properties and coagulation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"","keywords":"Triton X-100; Partial thromboplastin time; Chemistry; Prothrombin time; Fibrinogen; Coagulation; Thrombin time; Coagulation testing; Factor X; Phospholipid; Pulmonary surfactant; Chromatography; Thromboplastin; Reagent; Thrombin; Platelet; Internal medicine; Biochemistry; Membrane; Medicine","score_opus":0.08932171786650833,"score_gpt":0.3347865842719695,"score_spread":0.24546486640546117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567313353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99081343,0.00051456166,0.0000108876,0.00020745344,0.00011255547,0.00055757986,0.000001293886,0.000034262266,0.0077479864],"genre_scores_gemma":[0.9994876,0.0000018826836,0.000094938136,0.000048530364,0.00017365684,0.000025424535,0.000027865935,0.000011681474,0.00012841997],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99863625,0.00015266503,0.00017639081,0.00013025262,0.0008164744,0.00008799336],"domain_scores_gemma":[0.99918157,0.000034111246,0.00007788181,0.0002048301,0.00043337562,0.000068242465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013050712,0.00008034974,0.00017446284,0.00007135367,0.000019306664,0.0000058078635,0.000028637605,0.00007173922,0.000031550357],"category_scores_gemma":[0.00044339627,0.000060711543,0.000045817098,0.00013317214,0.000016405818,0.00005035276,0.000008876243,0.00006062324,0.000030771982],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026042357,0.005148651,0.2871958,0.00040613767,0.00067796174,0.000011957587,0.0013394101,0.0020142326,0.17660898,0.00050265726,0.0028567791,0.5206332],"study_design_scores_gemma":[0.029559517,0.010656299,0.4421061,0.00037450914,0.0038426449,0.000043171618,0.00006586083,0.011379717,0.50040114,0.00072114985,0.0006365563,0.00021334967],"about_ca_topic_score_codex":0.00004195349,"about_ca_topic_score_gemma":0.0000051024626,"teacher_disagreement_score":0.52041984,"about_ca_system_score_codex":0.00003824354,"about_ca_system_score_gemma":0.00012274573,"threshold_uncertainty_score":0.2475745},"labels":[],"label_agreement":null},{"id":"W2567424123","doi":"10.1182/blood.v112.11.3890.3890","title":"Body Composition and Its Relationship to Growth and Bone Mass in Patients with Thalassemia","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"Underweight; Medicine; Thalassemia; Lean body mass; Body mass index; Bone mineral; Bone density; Internal medicine; Pediatrics; Physiology; Endocrinology; Osteoporosis; Overweight; Body weight","score_opus":0.0069131979641715606,"score_gpt":0.20469824193946884,"score_spread":0.19778504397529728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567424123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977354,0.00035403698,0.000010099619,0.0005348221,0.000012007941,0.0003022689,0.0000032111855,0.000019278315,0.0010288913],"genre_scores_gemma":[0.99938536,0.00008055276,0.00030518786,0.00013407487,0.000009718401,0.0000066031935,0.000021480275,0.000009599943,0.000047412814],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995227,0.000015875905,0.000104754734,0.00013473831,0.000110430134,0.00011149738],"domain_scores_gemma":[0.99976933,0.000022050805,0.000021716256,0.000057535526,0.00003159103,0.00009779544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000032262098,0.000071840885,0.00011855254,0.00008381648,0.00006426644,0.000004611915,0.000011694355,0.00007092492,0.0000029957832],"category_scores_gemma":[0.000028671575,0.00005597323,0.000007979032,0.00014675446,0.00002261801,0.000055392706,0.000010907196,0.00011895275,0.0000046109685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000103350256,0.00027777138,0.99746025,0.000036834004,0.00001429659,0.00004545779,0.00032718352,0.0000012665344,0.0015600736,0.000108992834,0.000040508578,0.000024034443],"study_design_scores_gemma":[0.0054718247,0.0003807512,0.99289453,0.00012013776,0.000055519686,0.00006324608,0.000038380564,0.000016678881,0.000847594,0.000022001828,0.000013725424,0.00007562707],"about_ca_topic_score_codex":0.000009994664,"about_ca_topic_score_gemma":0.0000016433759,"teacher_disagreement_score":0.0053684744,"about_ca_system_score_codex":0.000008237827,"about_ca_system_score_gemma":0.000017072,"threshold_uncertainty_score":0.2282522},"labels":[],"label_agreement":null},{"id":"W2567438736","doi":"10.1182/blood.v112.11.3427.3427","title":"Autoantibodies in Patients with ITP Do Not Bind to Patient-Specific Epitopes on Platelet Glycoproteins.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Autoantibody; Platelet; Immunology; Platelet membrane glycoprotein; Epitope; Antigen; Antibody; Thrombocytopenic purpura; Glycoprotein; Medicine; Immune thrombocytopenia; Immune system; Molecular biology; Biology","score_opus":0.01053301743158474,"score_gpt":0.2113145108376371,"score_spread":0.20078149340605236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567438736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99649215,0.0001739717,0.0000016478559,0.00020040954,0.00006561542,0.000978364,0.00004707977,0.000050222316,0.0019905625],"genre_scores_gemma":[0.9986062,0.00008730615,0.0006010474,0.00038329745,0.000027701668,0.000051603678,0.00006907518,0.000033003827,0.00014076162],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986091,0.000018475801,0.00023798447,0.0003828533,0.00040045037,0.00035111624],"domain_scores_gemma":[0.9994036,0.000024286399,0.00006040908,0.00030785616,0.00005909027,0.00014477829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000027398135,0.00023662232,0.00039356673,0.00021739832,0.00009601789,0.00001446131,0.00006966281,0.00007801619,0.00006937967],"category_scores_gemma":[0.000021815982,0.00016924502,0.000048337057,0.00025607593,0.000045992452,0.00006936414,0.00003066637,0.00014347259,0.0002743495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036500022,0.011352403,0.9446469,0.000044406166,0.0003152003,0.005101392,0.0019831758,0.000026934102,0.00042407686,0.00005641933,0.0012738525,0.03112524],"study_design_scores_gemma":[0.022063868,0.005758425,0.9486864,0.00031127842,0.00004672396,0.000077929595,0.00006509531,0.000001799205,0.015555031,0.000018555806,0.00708446,0.00033041165],"about_ca_topic_score_codex":0.000060697846,"about_ca_topic_score_gemma":0.000018813254,"teacher_disagreement_score":0.03079483,"about_ca_system_score_codex":0.00003957758,"about_ca_system_score_gemma":0.00003745827,"threshold_uncertainty_score":0.6901611},"labels":[],"label_agreement":null},{"id":"W2567444712","doi":"10.1182/blood.v118.21.3750.3750","title":"The Gads Adaptor Protein Is Required to Mediate Lymphoid Disease Downstream of BCR-ABL,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Ontario Institute for Cancer Research","funders":"","keywords":"Signal transducing adaptor protein; GRB2; Cancer research; Biology; breakpoint cluster region; Bone marrow; ABL; Signal transduction; Leukemia; Immunology; Cell biology; Tyrosine kinase; Receptor; Genetics","score_opus":0.024346671392333635,"score_gpt":0.2444021836191539,"score_spread":0.22005551222682027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567444712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920481,0.00086453767,0.000005884902,0.00062808,0.00008981422,0.0012201783,0.0000889529,0.00006910042,0.0049853846],"genre_scores_gemma":[0.99519026,0.000091753005,0.0009756711,0.00023256,0.00015649552,0.00025873023,0.000017923612,0.00003731194,0.0030392706],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99851674,0.000042112915,0.0003396241,0.00031893048,0.000411361,0.0003712043],"domain_scores_gemma":[0.9983834,0.000045925823,0.00012262817,0.0008933418,0.00009749553,0.00045722054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015290527,0.00020390385,0.00028398103,0.000061076134,0.00008141987,0.000008618779,0.00021423463,0.00006728893,0.00028585814],"category_scores_gemma":[0.0002484377,0.00013199275,0.00013036923,0.00019706249,0.00010750922,0.000053722106,0.00009311704,0.00007466309,0.00019735974],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018525463,0.0279068,0.3815567,0.0021657466,0.00763141,0.0032449835,0.020890553,0.0000023519576,0.39794642,0.0037070343,0.037974663,0.09844789],"study_design_scores_gemma":[0.025404438,0.0019324198,0.08257722,0.0007872816,0.0017828194,0.0000903536,0.00030591476,0.000038945833,0.87481904,0.000545758,0.011220474,0.0004953481],"about_ca_topic_score_codex":0.00028496102,"about_ca_topic_score_gemma":0.000023625567,"teacher_disagreement_score":0.4768726,"about_ca_system_score_codex":0.00017887665,"about_ca_system_score_gemma":0.00067775935,"threshold_uncertainty_score":0.53825086},"labels":[],"label_agreement":null},{"id":"W2567464243","doi":"10.1182/blood.v116.21.4962.4962","title":"Cost-Effectiveness of Deferasirox (Exjade®) Versus No Chelation In Patients with Lower Risk Myelodysplastic Syndromes (MDS): A Canadian Perspective","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Deferasirox; Medicine; Myelodysplastic syndromes; Internal medicine; Cost effectiveness; Clinical trial; International Prognostic Scoring System; Transplantation; Quality of life (healthcare); Pediatrics; Intensive care medicine; Thalassemia","score_opus":0.014585219598852539,"score_gpt":0.27512223370208294,"score_spread":0.2605370141032304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567464243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933968,0.000021901811,0.000011433956,0.000042375,0.00020988828,0.0014691327,0.00007255217,0.000021614298,0.0047542723],"genre_scores_gemma":[0.9994079,0.000005752354,0.00026852477,0.000007257463,0.000052670865,0.000087209446,0.00005762561,0.00003937845,0.00007369648],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985051,0.0001286806,0.00017134033,0.00035700528,0.00041173407,0.00042614824],"domain_scores_gemma":[0.99819195,0.00040048637,0.0000863136,0.00035172925,0.0006605226,0.00030900748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034271582,0.00019131074,0.00034958404,0.0004274559,0.00006540757,0.000014257943,0.00012467426,0.0001889995,0.00021453452],"category_scores_gemma":[0.0013320002,0.00016038088,0.00005339322,0.00048161153,0.00016192628,0.0001268285,0.00003190763,0.0007775306,0.0000800631],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050496827,0.0008321478,0.99183667,0.000094022005,0.00032723043,0.000085023734,0.000392641,0.000019832254,0.00088000094,0.00027610044,0.000024934981,0.00018171871],"study_design_scores_gemma":[0.025319511,0.0018409182,0.97087234,0.0001557069,0.00024095192,0.000014851282,0.00012042582,0.00011147839,0.0010345413,0.00002889239,0.000090685324,0.000169709],"about_ca_topic_score_codex":0.040612247,"about_ca_topic_score_gemma":0.04626484,"teacher_disagreement_score":0.020964338,"about_ca_system_score_codex":0.0006505892,"about_ca_system_score_gemma":0.0010866193,"threshold_uncertainty_score":0.97113836},"labels":[],"label_agreement":null},{"id":"W2567487626","doi":"10.1182/blood.v114.22.4768.4768","title":"Incorporation of ANTI-HHV-8 Agents as Targeted Therapy for the Treatment of HIV-Associated Primary Effusion Lymphoma.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Primary effusion lymphoma; Medicine; Lymphoma; Internal medicine; Pleural effusion; Population; Chemotherapy; Sarcoma; Oncology; Gastroenterology; Surgery; Pathology","score_opus":0.013822105323546696,"score_gpt":0.26021965434236366,"score_spread":0.24639754901881697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567487626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99467516,0.0025800497,0.000026929967,0.00062855275,0.00006468438,0.0009775289,0.000044687094,0.000029861594,0.00097255135],"genre_scores_gemma":[0.9956864,0.0030995407,0.000092528455,0.00044645896,0.00004070983,0.000029332232,0.00027352,0.000013785533,0.00031769217],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991645,0.000032289012,0.00027608272,0.00014554911,0.00022831293,0.00015325582],"domain_scores_gemma":[0.9992871,0.00005363066,0.00030265749,0.00018679137,0.00013165068,0.000038114755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011144238,0.00012782599,0.00033702262,0.000054779655,0.00007163819,0.0000049632927,0.000059485723,0.0001044509,0.00003208633],"category_scores_gemma":[0.000038789804,0.00008261466,0.00017506247,0.00020291701,0.000031168514,0.00003479831,0.0000039258093,0.0000218739,0.000002672749],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050674854,0.0482696,0.23023775,0.00012555835,0.0031714821,0.000023996916,0.0048440965,0.00011543622,0.447949,0.00023282075,0.0095913,0.2503715],"study_design_scores_gemma":[0.052163452,0.008792844,0.8206418,0.00008199981,0.0006954553,0.0000022550353,0.0002289927,0.00022749881,0.114379995,0.00061487104,0.0020169544,0.00015386997],"about_ca_topic_score_codex":0.00012496208,"about_ca_topic_score_gemma":0.000008275576,"teacher_disagreement_score":0.5904041,"about_ca_system_score_codex":0.00010710744,"about_ca_system_score_gemma":0.00017022742,"threshold_uncertainty_score":0.3368928},"labels":[],"label_agreement":null},{"id":"W2567520591","doi":"10.1182/blood.v116.21.565.565","title":"Patterns of Management and Adherence to Venous Thromboembolism (VTE) Treatment Guidelines In a National Prospective Cohort Study of VTE Management In the Canadian Outpatient Setting: Recovery Study","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Trillium Health Centre; Royal Alexandra Hospital; Centre de Santé et de Services Sociaux de Chicoutimi; Hôpital Notre-Dame; Health Sciences Centre; Jewish General Hospital; Sunnybrook Health Science Centre; Université du Québec à Chicoutimi; Royal Columbian Hospital; Sanofi (Canada); Hamilton Health Sciences; Centre Hospitalier de l’Université de Montréal; Université de Sherbrooke; Hôpital Charles-Le Moyne; Hamilton General Hospital; Thunder Bay Regional Research Institute","funders":"","keywords":"Medicine; Warfarin; Prospective cohort study; Low molecular weight heparin; Venous thromboembolism; Observational study; Thrombosis; Venous thrombosis; Pulmonary embolism; Emergency medicine; Internal medicine; Intensive care medicine; Atrial fibrillation","score_opus":0.024352891264542438,"score_gpt":0.30847165036817326,"score_spread":0.2841187591036308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567520591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98522264,0.000040744893,0.000001794819,0.00027144654,0.00013489858,0.010413114,0.000025422667,0.000010165798,0.0038797464],"genre_scores_gemma":[0.99742424,0.00008188849,0.00038949627,0.000256075,0.000041675812,0.0016661668,0.000010977686,0.00001964796,0.00010982601],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99768144,0.00009374967,0.0006989179,0.00050313835,0.0007100189,0.00031274825],"domain_scores_gemma":[0.9990252,0.000043003074,0.000164389,0.00047431403,0.00018678403,0.000106280335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009131405,0.00023816833,0.0006476104,0.00055056927,0.00007599564,0.000027201524,0.00020902378,0.000048781498,0.000023723507],"category_scores_gemma":[0.000045369157,0.00018021266,0.000050434424,0.00036178553,0.000022863976,0.000048670685,0.00013493032,0.00014713193,0.0000032724022],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049867296,0.021742444,0.9563777,0.00012298155,0.0009790428,0.00020114913,0.01463889,0.00006364377,0.000013224181,0.0004558893,0.000118237294,0.005236918],"study_design_scores_gemma":[0.005490333,0.006211948,0.9723656,0.00014815238,0.00066450896,0.0000045053184,0.014637414,0.000010505622,0.00005424999,0.00011842171,0.00014723362,0.00014711932],"about_ca_topic_score_codex":0.12449729,"about_ca_topic_score_gemma":0.57452685,"teacher_disagreement_score":0.45002955,"about_ca_system_score_codex":0.00020196536,"about_ca_system_score_gemma":0.00008759463,"threshold_uncertainty_score":0.88133276},"labels":[],"label_agreement":null},{"id":"W2567569077","doi":"10.1182/blood.v126.23.3117.3117","title":"Reduced Intensity Continuous Infusion Busulfan for Allogeneic Hematopoietic Cell Transplant Patients with Hematologic Disorders Who Are Ineligible or Inappropriate for Treatment with a More Intensive Therapeutic Regimen: LCCC 0306","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saint John Regional Hospital","funders":"","keywords":"Medicine; Alemtuzumab; Busulfan; Fludarabine; Internal medicine; Hematopoietic stem cell transplantation; Transplantation; Gastroenterology; Regimen; Surgery; Graft-versus-host disease; Oncology; Chemotherapy; Cyclophosphamide","score_opus":0.02464829476909165,"score_gpt":0.25507425299227876,"score_spread":0.23042595822318712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567569077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873721,0.00029853047,0.004518196,0.000968266,0.000091841,0.006365491,0.00012813066,0.00015032971,0.00010713973],"genre_scores_gemma":[0.99261457,0.00013937615,0.004690651,0.000506662,0.000040584437,0.0010788946,0.00051905186,0.00011127931,0.00029890676],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99768215,0.00005351054,0.00053420453,0.0007213992,0.00041569013,0.00059302966],"domain_scores_gemma":[0.99731755,0.0001745828,0.00036964772,0.000511074,0.0013120942,0.00031504867],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016706879,0.0005643433,0.0012399864,0.00016943266,0.0001328736,0.000032569904,0.00014320678,0.00022529514,0.000006016095],"category_scores_gemma":[0.0000513585,0.0003276524,0.00014556461,0.00031958806,0.00015406417,0.00008854724,0.000015397842,0.000114624374,0.000005203926],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13737096,0.01914465,0.7227702,0.010913441,0.004629177,0.0008057739,0.07822977,0.00015238418,0.021914475,0.00024094463,0.00087341515,0.0029547955],"study_design_scores_gemma":[0.31683254,0.08504404,0.042932115,0.009168741,0.017193476,0.002874908,0.041857112,0.00083262584,0.4774148,0.0009275102,0.0013735103,0.003548632],"about_ca_topic_score_codex":0.00007219011,"about_ca_topic_score_gemma":0.00012869561,"teacher_disagreement_score":0.6798381,"about_ca_system_score_codex":0.000114019866,"about_ca_system_score_gemma":0.00032820588,"threshold_uncertainty_score":0.99991757},"labels":[],"label_agreement":null},{"id":"W2567577235","doi":"10.1182/blood.v124.21.4036.4036","title":"\"Huthal\": A Survey of North American, Indian and Thai Hematologists Regarding Hydroxyurea Use in Thalassemia","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Children's Hospital","funders":"","keywords":"Medicine; Thalassemia; Blood transfusion; Observational study; Family medicine; Pediatrics; Internal medicine","score_opus":0.014226771779630361,"score_gpt":0.24041692290519304,"score_spread":0.22619015112556268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567577235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988597,0.00020938313,0.000007520716,0.00010728,0.000032113287,0.00017775377,0.00000830369,0.00002785934,0.00057006563],"genre_scores_gemma":[0.9994632,0.00016515705,0.00016959754,0.00010637326,0.000009137118,0.0000051514876,0.000026992966,0.000017431168,0.00003698674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990049,0.00011371917,0.00026630567,0.00022569072,0.00014832358,0.00024105376],"domain_scores_gemma":[0.99926305,0.00020082455,0.00012875115,0.00025293327,0.000036165584,0.000118268305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031203247,0.00013125731,0.00045326666,0.00013542376,0.000026540181,0.000010880502,0.000060706065,0.00008360156,0.0000021852677],"category_scores_gemma":[0.0007648333,0.00010389329,0.000049418468,0.0004401354,0.00014828985,0.000053324948,0.00004282902,0.00021855853,0.0000038122625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034041303,0.00022026658,0.9979527,0.000072122675,0.00006142646,0.00009367813,0.00027652676,0.000003326155,0.000083824714,0.000011534944,0.000048421738,0.0011421351],"study_design_scores_gemma":[0.0022445056,0.00020047346,0.996466,0.00012565592,0.00006600304,0.00010412653,0.00009432624,0.000061898376,0.0004583488,0.0000066085395,0.00006163887,0.00011041146],"about_ca_topic_score_codex":0.004281324,"about_ca_topic_score_gemma":0.007778786,"teacher_disagreement_score":0.0034974623,"about_ca_system_score_codex":0.000009311317,"about_ca_system_score_gemma":0.00004611893,"threshold_uncertainty_score":0.6472109},"labels":[],"label_agreement":null},{"id":"W2567610518","doi":"10.1182/blood.v106.11.4300.4300","title":"The Involvement of Reactive Oxygen Species in Polyploidization of the M-07e Human Megakaryocytic Cell Line.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Héma-Québec","funders":"","keywords":"Biology; Cell biology; Endoreduplication; Reactive oxygen species; Cytokinesis; Cell division; Cell; Cell cycle; Biochemistry","score_opus":0.023302022842813724,"score_gpt":0.27380452119453214,"score_spread":0.2505024983517184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567610518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881497,0.00051867537,0.0000070859724,0.0017091125,0.000022743416,0.00052134815,0.0000063149896,0.000008797181,0.009056244],"genre_scores_gemma":[0.99658483,0.00017183078,0.00015447571,0.00010053077,0.00014044956,0.000016247894,0.00000942799,0.000015508316,0.002806675],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988393,0.00008180541,0.0003388576,0.0001347328,0.00041451355,0.00019075834],"domain_scores_gemma":[0.9991243,0.00011821893,0.00014977071,0.00043393823,0.00013563712,0.000038152983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003745934,0.00009059037,0.00018531253,0.00008572602,0.000075418335,0.0000060964635,0.0002321736,0.00005726584,0.000028387583],"category_scores_gemma":[0.0001336871,0.000051512015,0.00006959023,0.00033563658,0.00014886363,0.000044914104,0.00012273178,0.00022613998,0.0000055380888],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012845741,0.0011071292,0.02773294,0.00012880491,0.000115071096,0.0000053470603,0.002438062,0.000054199732,0.9655191,0.0013757027,0.00090470136,0.00049053965],"study_design_scores_gemma":[0.0032209205,0.0002172897,0.09221396,0.0000875265,0.00008435285,0.0000033376464,0.0009199334,0.0001339921,0.90037245,0.00010720806,0.0025832155,0.000055846813],"about_ca_topic_score_codex":0.00020439138,"about_ca_topic_score_gemma":0.00031486712,"teacher_disagreement_score":0.065146625,"about_ca_system_score_codex":0.00020918211,"about_ca_system_score_gemma":0.00025118145,"threshold_uncertainty_score":0.21005991},"labels":[],"label_agreement":null},{"id":"W2567624910","doi":"10.1182/blood.v114.22.616.616","title":"A Phase II Trial Comparison of Once Versus Twice Weekly Bortezomib in CYBORD Chemotherapy for Newly Diagnosed Myeloma: Identical High Response Rates and Less Toxicity.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Bortezomib; Medicine; Dexamethasone; Multiple myeloma; Regimen; Internal medicine; Cohort; Cyclophosphamide; Surgery; Toxicity; Gastroenterology; Chemotherapy","score_opus":0.054298635492380606,"score_gpt":0.4000287091053771,"score_spread":0.34573007361299646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567624910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958483,0.00040313814,0.000059265138,0.0017868942,0.00007251134,0.0017140775,0.000041894717,0.000028557015,0.00004539285],"genre_scores_gemma":[0.997798,0.000069813934,0.0016735154,0.00007793083,0.00013771802,0.00008942633,0.00004130071,0.00001819201,0.00009405338],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983339,0.00013564677,0.00047618084,0.00033711654,0.00032745893,0.0003897024],"domain_scores_gemma":[0.99831176,0.0010001063,0.00011454762,0.0002574035,0.0000900636,0.00022610961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042954323,0.00019443502,0.0006295475,0.00017272601,0.00008391536,0.000024342084,0.00010359663,0.00011900495,0.000016559188],"category_scores_gemma":[0.001025027,0.00016949137,0.00009667474,0.00022784898,0.00009613376,0.00008752092,0.000026971873,0.00015978228,0.0000016848516],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.82156765,0.029202033,0.0051554935,0.000060069855,0.00028377253,0.00024649483,0.0007379542,7.3950577e-7,0.08798768,0.000097255885,0.00023872568,0.05442214],"study_design_scores_gemma":[0.7395642,0.047624983,0.07779536,0.000119088836,0.00019453217,0.000007599418,0.0002835732,0.00052151375,0.133451,0.00006165794,0.00021807493,0.00015842081],"about_ca_topic_score_codex":0.00015595784,"about_ca_topic_score_gemma":0.00011384881,"teacher_disagreement_score":0.082003444,"about_ca_system_score_codex":0.000052408996,"about_ca_system_score_gemma":0.00017208433,"threshold_uncertainty_score":0.69116575},"labels":[],"label_agreement":null},{"id":"W2567682454","doi":"10.1182/blood.v126.23.4978.4978","title":"Discordance Between Morphologic and Cytogenetic Findings Following Induction Chemotherapy for Acute Myeloid Leukemia Is Prevalent in Patients with Bone Marrow Blasts &gt;2% and Is Associated with Poor Clinical Outcomes","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Induction chemotherapy; Internal medicine; Acute promyelocytic leukemia; Bone marrow; Cytogenetics; Chemotherapy; Leukemia; Myeloid leukemia; Biopsy; Cytarabine; Chemotherapy regimen; Fludarabine; Myeloid; Gastroenterology; Oncology; Surgery; Cyclophosphamide","score_opus":0.03420774971938598,"score_gpt":0.32133016040681844,"score_spread":0.2871224106874325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567682454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966793,0.00013919841,0.000045067816,0.0013500925,0.000038057202,0.0016150562,0.00007586667,0.00003933239,0.0000180379],"genre_scores_gemma":[0.9958345,0.000080811296,0.0024734372,0.0006728942,0.00006521577,0.00009622379,0.00007715937,0.00006315464,0.0006365821],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978056,0.00008326069,0.00045092305,0.00063348626,0.00054341584,0.00048331186],"domain_scores_gemma":[0.9989413,0.00016959342,0.00017445508,0.00026967796,0.00014893814,0.00029603357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006789199,0.00029864023,0.00078997517,0.00015671311,0.000074884025,0.000039978077,0.00010722077,0.0002330523,0.000006159362],"category_scores_gemma":[0.00023090388,0.00020676342,0.000081100734,0.00029220612,0.00017566822,0.00015566546,0.00008192131,0.00038167296,0.000002330505],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010123481,0.0003152078,0.9941529,0.000037251455,0.00094683375,0.000042065014,0.0004510908,2.7567896e-7,0.00035112517,5.078199e-7,0.00045879954,0.0022315702],"study_design_scores_gemma":[0.040852096,0.0036509552,0.952205,0.00021291329,0.00077670254,0.000020395642,0.00006112871,0.00004341706,0.0018433644,0.000034684886,0.00004844115,0.00025091827],"about_ca_topic_score_codex":0.000028546947,"about_ca_topic_score_gemma":0.000015506632,"teacher_disagreement_score":0.041947942,"about_ca_system_score_codex":0.00032491694,"about_ca_system_score_gemma":0.00030246383,"threshold_uncertainty_score":0.84315675},"labels":[],"label_agreement":null},{"id":"W2567702298","doi":"10.1182/blood.v108.11.2027.2027","title":"Correlation of DNA Copy Number, Gene Expression, Protein Expression and Clinical Outcome in a Group of Patients with Diffuse Large B Cell Lymphoma (DLBCL) Treated with CHOP Plus Rituximab (CHOP-R).","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia; BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; BCL6; Comparative genomic hybridization; Biology; Lymphoma; Gene expression profiling; Human genome; Clinical significance; CHOP; Rituximab; Oncology; Gene; Cancer research; Internal medicine; Gene expression; Genetics; Medicine; Genome; Immunology; B cell; Antibody; Germinal center","score_opus":0.007772587053766929,"score_gpt":0.24237743916361876,"score_spread":0.23460485210985182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567702298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979817,0.00018995164,0.00006860094,0.000011433297,0.000019652007,0.0013957217,0.000084147505,0.000030305817,0.00021846985],"genre_scores_gemma":[0.9971514,0.000028310022,0.0023041104,0.000018484821,0.00002908771,0.00012960396,0.00021775012,0.000036565438,0.00008469237],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980403,0.00010352716,0.00076386734,0.00041905406,0.0004157649,0.00025745702],"domain_scores_gemma":[0.9988286,0.00009538166,0.00045140294,0.00036965334,0.00012876911,0.00012619131],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012970682,0.0002656966,0.0007267611,0.00009829704,0.000046046753,0.000009398137,0.000063007465,0.00017915675,0.000019915331],"category_scores_gemma":[0.000029465024,0.00016624136,0.00007767221,0.0001984091,0.0000904085,0.00010850668,0.000050021456,0.00007689272,0.0000040170235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023640902,0.07034883,0.9238394,0.00013126983,0.00005308506,0.000064769185,0.00008254439,0.0000012729646,0.0028696915,0.000009013813,0.000032692515,0.00020335373],"study_design_scores_gemma":[0.20163685,0.00122715,0.73189193,0.00057592714,0.0002664593,0.000007317334,0.00002465955,0.000037039103,0.06416798,0.0000051648954,0.000023186585,0.00013635028],"about_ca_topic_score_codex":0.00042039042,"about_ca_topic_score_gemma":0.00006525955,"teacher_disagreement_score":0.19927275,"about_ca_system_score_codex":0.000076628814,"about_ca_system_score_gemma":0.0000690894,"threshold_uncertainty_score":0.6779126},"labels":[],"label_agreement":null},{"id":"W2567715886","doi":"10.1182/blood.v116.21.2389.2389","title":"Significant Improvement In Overall Survival In Patients Who Underwent Autologous Hematopoietic Cell Transplant In the US or Canada Between 1994 and 2005","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Multiple myeloma; Population; Hematopoietic cell; Hematopoietic stem cell transplantation; Internal medicine; Transplantation; Lymphoma; Statistical significance; Surgery; Oncology; Haematopoiesis; Stem cell","score_opus":0.010717401703579906,"score_gpt":0.23886544637503287,"score_spread":0.22814804467145297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567715886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981013,0.000052985866,0.0000010284697,0.0003784334,0.00007789695,0.0009805236,0.000039428563,0.000006982166,0.00036143776],"genre_scores_gemma":[0.99947315,0.000047027497,0.000024491665,0.00019504869,0.000044401804,0.00004857819,0.000032123728,0.000018296621,0.00011687553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794436,0.00009133187,0.00042743207,0.00033348595,0.0006055841,0.0005978286],"domain_scores_gemma":[0.99916,0.0002806968,0.00005299977,0.00033940666,0.000015834627,0.00015105761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005292475,0.00017950962,0.0003801797,0.00011536577,0.000028449664,0.00001922469,0.00020207548,0.00011676688,0.00003789748],"category_scores_gemma":[0.000037327256,0.00011750634,0.00002562563,0.00016975557,0.00006777589,0.00003088583,0.00005049202,0.0005387629,0.0000017213448],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037765055,0.0020155148,0.99077016,0.00053458626,0.00004554624,0.0016749679,0.002035607,0.00001388937,0.0013790947,0.000045756322,0.00024624408,0.0008609691],"study_design_scores_gemma":[0.06465751,0.00056166353,0.9284673,0.00018039612,0.00007466593,0.00003926362,0.0002936196,0.0003832374,0.00457208,0.000042140025,0.00047125565,0.00025688965],"about_ca_topic_score_codex":0.49972108,"about_ca_topic_score_gemma":0.82245564,"teacher_disagreement_score":0.32273453,"about_ca_system_score_codex":0.0018624086,"about_ca_system_score_gemma":0.005209858,"threshold_uncertainty_score":0.92420644},"labels":[],"label_agreement":null},{"id":"W2567742712","doi":"10.1182/blood.v124.21.685.685","title":"Prospective Study of an Inferior Vena Cava Filter Management Pathway in a Tertiary Care and Trauma Centre","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health; Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Medicine; Inferior vena cava; Inferior vena cava filter; Prospective cohort study; Thrombosis; Medical record; Deep vein; Filter (signal processing); Surgery; Venous thrombosis","score_opus":0.006352301044854211,"score_gpt":0.232528303729229,"score_spread":0.2261760026843748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567742712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939578,0.00016170928,0.0000019284212,0.000049416514,0.000037441423,0.0015207242,0.0000044390654,0.000025332749,0.0042411974],"genre_scores_gemma":[0.99941266,0.000020415771,0.00023971067,0.000119288845,0.00004391908,0.00009351541,0.000008810007,0.000017991124,0.000043706037],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908674,0.000054508055,0.00021268667,0.000290916,0.0001751257,0.000180003],"domain_scores_gemma":[0.9995283,0.00001151356,0.00005154319,0.0002998003,0.000035058594,0.00007378706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001080193,0.0001292962,0.0003202202,0.0001209102,0.000029845962,0.00001242118,0.000063259795,0.000033695498,0.00002481673],"category_scores_gemma":[0.000008821935,0.00011016494,0.000029560966,0.00008534548,0.00002236767,0.000053742064,0.00008442155,0.00007326435,0.0000031680045],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005054822,0.012951875,0.9017343,0.0007002832,0.00031298722,0.00020173119,0.030298011,0.000005713185,0.00023918781,0.00031190098,0.000054836608,0.053138644],"study_design_scores_gemma":[0.0076369746,0.0016835121,0.9761968,0.00017452799,0.00027439202,0.0000036156532,0.011576569,0.000014507701,0.0019822768,0.000043017266,0.0003024738,0.00011128426],"about_ca_topic_score_codex":0.00022971646,"about_ca_topic_score_gemma":0.00067502004,"teacher_disagreement_score":0.07446257,"about_ca_system_score_codex":0.000023733028,"about_ca_system_score_gemma":0.000007215076,"threshold_uncertainty_score":0.4492396},"labels":[],"label_agreement":null},{"id":"W2567750831","doi":"10.1182/blood.v118.21.4734.4734","title":"An Uncommon Presentation of Adult Hemophagocytic Lymphohistiocytosis with Severe Pulmonary Hypertension","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of British Columbia; University of Toronto","funders":"","keywords":"Medicine; Hemophagocytosis; Hemophagocytic lymphohistiocytosis; Pancytopenia; Internal medicine; Gastroenterology; Pediatrics; Bone marrow","score_opus":0.024374888571074952,"score_gpt":0.2537686184662438,"score_spread":0.22939372989516887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567750831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870136,0.00020996091,0.000030305158,0.00003616422,0.000016438913,0.00028943463,0.0000036010008,0.00004816368,0.012352349],"genre_scores_gemma":[0.9986833,0.000074561416,0.0007911232,0.00007995068,0.00002406048,0.00002122981,0.000042622243,0.000024492694,0.0002586594],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990384,0.00004431484,0.00023212579,0.00019294779,0.00031561815,0.00017662365],"domain_scores_gemma":[0.99914926,0.000016570766,0.0000842778,0.00039234787,0.00026491348,0.000092645765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006971225,0.000112521855,0.0002522123,0.00010333971,0.00005582374,0.0000046312102,0.00009689174,0.00007386693,0.00014578504],"category_scores_gemma":[0.00003201502,0.00008522427,0.000046784044,0.00018445376,0.000086444896,0.0001702401,0.000024539602,0.00009163701,0.000022952123],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040292214,0.009387894,0.7243877,0.0010400519,0.00046246496,0.0010968568,0.0029589168,0.000017924067,0.22792807,0.0003796046,0.0002920308,0.028019268],"study_design_scores_gemma":[0.009441736,0.0028738207,0.68794537,0.00032310616,0.00047731044,0.0012096512,0.002256771,0.001590429,0.293397,0.00011615263,0.000080637714,0.00028799765],"about_ca_topic_score_codex":0.0003886269,"about_ca_topic_score_gemma":0.000011804607,"teacher_disagreement_score":0.06546892,"about_ca_system_score_codex":0.000019994604,"about_ca_system_score_gemma":0.00016026804,"threshold_uncertainty_score":0.34753448},"labels":[],"label_agreement":null},{"id":"W2567764101","doi":"10.1182/blood.v106.11.1213.1213","title":"Tel-PDGFβR Specifically Induces Interferon-Stimulated Genes.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Fusion gene; Imatinib mesylate; Myeloid leukemia; Cancer research; Tyrosine kinase; Biology; ABL; Fusion protein; Platelet-derived growth factor receptor; Leukemia; Chromosomal translocation; breakpoint cluster region; Molecular biology; Imatinib; Signal transduction; Immunology; Cell biology; Gene; Growth factor; Receptor; Genetics","score_opus":0.024870028848037393,"score_gpt":0.2704788076366559,"score_spread":0.24560877878861848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567764101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9811525,0.0014990921,0.0000263982,0.00070344127,0.00011385091,0.0003372639,0.000007076869,0.00019177327,0.015968645],"genre_scores_gemma":[0.9930921,0.00014549236,0.0029803605,0.00037141505,0.00073647837,0.000017461309,0.000046230412,0.00004280042,0.002567659],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99867374,0.000023743545,0.00031889664,0.00036110004,0.00027454735,0.0003479874],"domain_scores_gemma":[0.9991499,0.00004627543,0.00006582309,0.00046543777,0.00006373997,0.0002088129],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000082104656,0.00021677594,0.0003124731,0.000097741795,0.000049629707,0.000021568785,0.00013419648,0.0001517649,0.0014389048],"category_scores_gemma":[0.00004520491,0.00018015715,0.00010324807,0.00016829041,0.0000569471,0.00007721419,0.000063537096,0.00023268553,0.001320144],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011225633,0.013642537,0.06600648,0.00026006755,0.0032264516,0.0020403701,0.001891366,0.00017053085,0.49124432,0.00043353386,0.012007259,0.40795454],"study_design_scores_gemma":[0.052844618,0.002457982,0.11950242,0.00051412045,0.0017395477,0.0014965335,0.00016589457,0.00077555154,0.6645388,0.00007458905,0.15489382,0.0009961558],"about_ca_topic_score_codex":0.00003120129,"about_ca_topic_score_gemma":0.000016880993,"teacher_disagreement_score":0.40695837,"about_ca_system_score_codex":0.0003098548,"about_ca_system_score_gemma":0.00021216238,"threshold_uncertainty_score":0.9994739},"labels":[],"label_agreement":null},{"id":"W2567786129","doi":"10.1182/blood.v104.11.1838.1838","title":"Pulmonary Complications Due to Iduronidase Deficiency (Hurler Syndrome) Linked to Active Pro-Inflammatory Status.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Neonatal Respiratory Health Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Mucopolysaccharidosis type I; Mucopolysaccharidosis I; Hurler syndrome; Bronchoalveolar lavage; Immunology; Lung; Medicine; Immune system; CD8; Population; Pathology; Internal medicine; Enzyme replacement therapy; Disease","score_opus":0.037978889739594276,"score_gpt":0.3456790969551264,"score_spread":0.3077002072155321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567786129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862641,0.0005923361,0.000281166,0.003920126,0.000060345323,0.0030783745,0.00007426924,0.00016808101,0.005561212],"genre_scores_gemma":[0.99385333,0.000022987815,0.002431933,0.0025195205,0.00007997243,0.0006704313,0.000029591105,0.000059473194,0.00033278452],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9973035,0.00006153118,0.0004047682,0.00059580285,0.00074521574,0.00088922447],"domain_scores_gemma":[0.9972626,0.000101972175,0.00006303085,0.0008007437,0.00032878877,0.0014428445],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027271564,0.00022098063,0.0003283816,0.00039034375,0.00023543114,0.00002586593,0.00026068042,0.0001164081,0.0001107682],"category_scores_gemma":[0.00053432956,0.0002108542,0.000075144315,0.00079081353,0.00008216589,0.000120121105,0.00019192608,0.0004650622,0.0023347756],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037430492,0.025318714,0.03366647,0.0074844775,0.00051619636,0.032906424,0.008144826,0.00060444244,0.5681612,0.011598576,0.0009330568,0.30692258],"study_design_scores_gemma":[0.003797431,0.0017688388,0.9480327,0.00046894117,0.00007988529,0.0016847773,0.00027094228,0.000008431356,0.012099557,0.0003422742,0.031027563,0.00041870587],"about_ca_topic_score_codex":0.00012406861,"about_ca_topic_score_gemma":0.000034866433,"teacher_disagreement_score":0.9143662,"about_ca_system_score_codex":0.00040930716,"about_ca_system_score_gemma":0.0015536882,"threshold_uncertainty_score":0.998442},"labels":[],"label_agreement":null},{"id":"W2567821876","doi":"10.1182/blood.v118.21.1836.1836","title":"Targeting p53 Via JNK Pathway: A Novel Role of RITA for Apoptotic Signaling in Multiple Myeloma","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Chromatin immunoprecipitation; Phosphorylation; Biology; Signal transduction; c-jun; Cancer research; Apoptosis; Activator (genetics); Molecular biology; Immunoprecipitation; Mdm2; Transcription factor; Promoter; Gene; Gene expression; Cell biology; Genetics","score_opus":0.023698628018680945,"score_gpt":0.22163037564509194,"score_spread":0.197931747626411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567821876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892602,0.0011133654,0.00785985,0.000021315485,0.000095279305,0.00085926586,0.00003752654,0.000062412444,0.0006907709],"genre_scores_gemma":[0.9710711,0.0000058006476,0.028582266,0.00005401768,0.000099299476,0.000080672886,0.000032976408,0.000055246837,0.000018581082],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987095,0.000019754078,0.00043185477,0.00030337632,0.00018715384,0.00034834136],"domain_scores_gemma":[0.99928385,0.00008015608,0.00015128098,0.00026829063,0.000115821116,0.00010058834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002649396,0.00016639529,0.000358908,0.00015704686,0.00003753656,0.000004245742,0.0001058941,0.00014954594,0.00003846108],"category_scores_gemma":[0.00035428372,0.00017076386,0.00013905762,0.00021787234,0.000041420968,0.000046267196,0.000047140198,0.00019043093,0.000008595703],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019297164,0.0010167497,0.0050986954,0.00015519679,0.00009423049,0.000022590602,0.0014817513,0.000037668502,0.9901896,0.00009236513,0.0000069932903,0.0016111581],"study_design_scores_gemma":[0.009362874,0.00049997226,0.0032053054,0.0003379727,0.00018896589,0.000040066225,0.00036907784,0.004380466,0.9809757,0.000224525,0.00021290708,0.000202193],"about_ca_topic_score_codex":0.00019164116,"about_ca_topic_score_gemma":0.00003751497,"teacher_disagreement_score":0.020722415,"about_ca_system_score_codex":0.00003879176,"about_ca_system_score_gemma":0.000117439515,"threshold_uncertainty_score":0.6963548},"labels":[],"label_agreement":null},{"id":"W2567824933","doi":"10.1182/blood.v108.11.5062.5062","title":"New Bioaccumulations of Toxins in Resident Coastal Dolphins Signal Dangers of Human Myeloma.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Marine animal studies overview","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Estuary; Bay; Fishery; Geography; Bioaccumulation; Ecology; Biology; Archaeology","score_opus":0.018810493356235008,"score_gpt":0.25019957612547283,"score_spread":0.23138908276923784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567824933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.968947,0.00008118871,0.00003065319,0.000050511684,0.000009579756,0.0001294718,0.000012386788,0.000009485321,0.030729743],"genre_scores_gemma":[0.99855775,0.000010348958,0.0009273919,0.00001345152,0.00002812236,0.0000031908355,0.000006133076,0.0000066907323,0.0004469466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991408,0.000022921437,0.00029919512,0.00015519267,0.00023451578,0.00014737707],"domain_scores_gemma":[0.999681,0.000026597312,0.00010927216,0.00014371704,0.000005435161,0.000033996028],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0000966832,0.000083922125,0.00016199211,0.000036354835,0.000038844835,0.0000041726935,0.00014878919,0.000029980756,0.0015214169],"category_scores_gemma":[0.000009835678,0.000082378174,0.000052668835,0.00025456666,0.00009025097,0.000071622926,0.0002483492,0.000049239134,0.000019531188],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006125002,0.00033284412,0.94238913,0.000019132034,0.000013280484,0.0000059368026,0.00020806413,0.00036149845,0.05358212,0.00071726524,0.0014415219,0.0009231018],"study_design_scores_gemma":[0.00061945163,0.000104312865,0.98075885,0.000018478095,0.000023471786,0.0000010156589,0.000056465997,0.000012355498,0.017253848,0.00047521823,0.00059339934,0.000083122046],"about_ca_topic_score_codex":0.065797195,"about_ca_topic_score_gemma":0.119138844,"teacher_disagreement_score":0.053341653,"about_ca_system_score_codex":0.000026187883,"about_ca_system_score_gemma":0.000010039702,"threshold_uncertainty_score":0.9993913},"labels":[],"label_agreement":null},{"id":"W2567835463","doi":"10.1182/blood.v116.21.4580.4580","title":"The Use of Novel Agents In Patients with Multiple Myeloma Initially Treated with Allogeneic Stem Cell Transplantation Results In A Significant Prolongation of Post Relapse Survival.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Multiple myeloma; Cohort; Transplantation; Population; Internal medicine; Hematopoietic stem cell transplantation; Surgery; Donor lymphocyte infusion; Progression-free survival; Median follow-up; Oncology; Overall survival","score_opus":0.03746768730328527,"score_gpt":0.2549513480998074,"score_spread":0.21748366079652215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567835463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978205,0.000005854534,0.000010291804,0.000031157695,0.00001375839,0.0016934116,0.0003480592,0.0000108892,0.00006605947],"genre_scores_gemma":[0.9985969,0.000018889685,0.0007762856,0.0000056162075,0.000006187781,0.000069408445,0.00046631662,0.000023260167,0.000037099788],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844927,0.00010907391,0.00045060724,0.00025918958,0.0004813354,0.00025053194],"domain_scores_gemma":[0.99878967,0.0003133648,0.00022476711,0.00026832655,0.00031457932,0.00008929767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023133002,0.00015817942,0.0002644917,0.00018644224,0.000037758968,0.000011607053,0.00008637893,0.00008888412,0.0000020247192],"category_scores_gemma":[0.00010408595,0.00009274159,0.00003118974,0.00034451668,0.00010093082,0.000112068934,0.000011008137,0.00020065173,0.0000010202308],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020774899,0.0045860508,0.9252643,0.00011355416,0.000119332944,0.000113016526,0.0006317678,0.000058418933,0.04699198,0.000002310485,6.422757e-7,0.0013437422],"study_design_scores_gemma":[0.048524864,0.002128885,0.88865954,0.00016592036,0.00010823579,0.0000050658905,0.000060103757,0.00022162097,0.06004244,2.2927682e-7,0.0000026269952,0.00008045537],"about_ca_topic_score_codex":0.0012326587,"about_ca_topic_score_gemma":0.0056190565,"teacher_disagreement_score":0.036604736,"about_ca_system_score_codex":0.000022901257,"about_ca_system_score_gemma":0.00013814702,"threshold_uncertainty_score":0.37818924},"labels":[],"label_agreement":null},{"id":"W2567856485","doi":"10.1182/blood.v116.21.2210.2210","title":"Identification and Cloning of Novel Mutations In a Compound Heterozygous Factor V Deficient Patient","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hemostasis and retained surgical items","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; Providence Health Care; Canadian Blood Services; University of British Columbia","funders":"","keywords":"Compound heterozygosity; Bleeding diathesis; Factor V; Molecular biology; Mutation; Clotting factor; Proband; Medicine; Population; Biology; Internal medicine; Genetics; Gene; Platelet; Thrombosis","score_opus":0.022892592553793927,"score_gpt":0.27790137530344905,"score_spread":0.2550087827496551,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567856485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991187,0.000099227116,0.00013244827,0.00013165505,0.00006797461,0.00019604567,0.000018454626,0.000009861633,0.00022567553],"genre_scores_gemma":[0.99941295,0.0000063515104,0.00049033744,0.000026737489,0.000012816924,0.000007862089,0.000015939318,0.0000058787696,0.000021142088],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99941146,0.000009013207,0.00024588668,0.00011869945,0.00012218693,0.00009276402],"domain_scores_gemma":[0.99965304,0.000053335407,0.00006489349,0.00011232339,0.000057009573,0.00005937618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007478796,0.000053690703,0.00013364015,0.000074004085,0.000027683174,0.000011135469,0.000020714795,0.000048851267,0.000013504962],"category_scores_gemma":[0.0000810953,0.00004202793,0.000029128914,0.000106880565,0.000051841307,0.00002437671,0.000014681641,0.00012143802,0.0000015625359],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015728556,0.0017828742,0.04611753,0.000055814675,0.000022348786,0.000018286244,0.0013789681,0.000008949651,0.9456291,0.00035573923,0.0000034892648,0.0046111727],"study_design_scores_gemma":[0.010421351,0.00057214574,0.629065,0.00023483284,0.00017660484,0.00046280597,0.0010552166,0.004602695,0.35064378,0.00007714858,0.0023768977,0.000311538],"about_ca_topic_score_codex":0.000034744186,"about_ca_topic_score_gemma":0.00003010621,"teacher_disagreement_score":0.5949853,"about_ca_system_score_codex":0.000005167986,"about_ca_system_score_gemma":0.000019625879,"threshold_uncertainty_score":0.17138492},"labels":[],"label_agreement":null},{"id":"W2567897835","doi":"10.1182/blood.v106.11.473.473","title":"Membrane Derived Micorvesicles - Underappreciated Components of the Tumor Microenvironment That Modulate Tumor Growth, Vascularization and Metastasis.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Stromal cell; Tumor microenvironment; Matrigel; Bone marrow; Angiogenesis; Cancer cell; Biology; Cancer research; Cell biology; Chemistry; Cancer; Immunology","score_opus":0.0092429999341047,"score_gpt":0.1932701836375526,"score_spread":0.1840271837034479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567897835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99683154,0.002156885,0.000483516,0.00013099691,0.000033823966,0.0002831722,0.00003791791,0.00000992165,0.000032257652],"genre_scores_gemma":[0.9974972,0.00017493346,0.0018795049,0.00024098321,0.00004214081,0.000012140495,0.00008719344,0.00002861086,0.000037269143],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989472,0.00016076678,0.00022361812,0.00031351956,0.00016931872,0.0001855942],"domain_scores_gemma":[0.99934417,0.000008893508,0.00015659958,0.00039022043,0.000025286718,0.00007481824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013457763,0.00016931459,0.00015912189,0.000025434096,0.00008467273,0.000017871538,0.00021926076,0.000043192296,0.000011310725],"category_scores_gemma":[0.000028035769,0.00014045257,0.00012033275,0.000058864498,0.00015444579,0.000007664461,0.00018609002,0.000059978967,0.0000026607606],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003500629,0.00043744064,0.007255599,0.000038588136,0.00019847012,0.0000032044816,0.00002727505,0.00013366049,0.9915863,0.000014802241,0.000022767523,0.00024688718],"study_design_scores_gemma":[0.001625111,0.000040216506,0.06104282,0.000017408878,0.00020115305,0.000024854622,0.000021230504,0.00017977951,0.93635356,0.000035384048,0.00031249758,0.0001459939],"about_ca_topic_score_codex":0.000011917469,"about_ca_topic_score_gemma":0.000008947526,"teacher_disagreement_score":0.05523275,"about_ca_system_score_codex":0.000008453515,"about_ca_system_score_gemma":0.000019592002,"threshold_uncertainty_score":0.57274896},"labels":[],"label_agreement":null},{"id":"W2567915243","doi":"10.1182/blood.v124.21.1688.1688","title":"Somatic Mutations in E3 Ubiquitin Ligase Deltex 1 Are Associated with Survival in Diffuse Large B-Cell Lymphoma","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Diffuse large B-cell lymphoma; Exome sequencing; Biology; Chemoimmunotherapy; PTEN; Cancer research; Exome; Survival analysis; Cancer; Genetics; Gene; Lymphoma; Mutation; Internal medicine; Medicine; Immunology; Immunotherapy","score_opus":0.009947358832023528,"score_gpt":0.2279877392477599,"score_spread":0.21804038041573637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567915243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971447,0.00013606867,0.000006519273,0.0003120932,0.000029743123,0.00038965305,0.00003566186,0.000057145306,0.0018884005],"genre_scores_gemma":[0.99915427,0.000016468182,0.000120836376,0.00021865386,0.000034221073,0.00014718008,0.00013639704,0.000029656172,0.00014229535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987134,0.000120131255,0.00029600048,0.0002615805,0.00024765846,0.0003612661],"domain_scores_gemma":[0.99916357,0.0002866021,0.00012452764,0.00025289177,0.00004337821,0.00012901274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022595034,0.0001848073,0.0004036019,0.00015534923,0.00004768316,0.000022671704,0.000062690735,0.00009194479,0.00002487392],"category_scores_gemma":[0.00021674154,0.00014528247,0.000059334172,0.00028178995,0.00002543835,0.000054101773,0.000026465445,0.00006148666,0.00006002505],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003947175,0.05174759,0.9460697,0.000061776664,0.00008690681,0.00063897687,0.00060125504,0.00000383665,0.00016319922,0.00014034947,0.000033986405,0.00041292034],"study_design_scores_gemma":[0.091707885,0.0003288532,0.89919984,0.00044152298,0.00025267008,0.0000194593,0.00037856295,0.000449093,0.0069353157,0.00007547563,0.00004991928,0.00016140111],"about_ca_topic_score_codex":0.00021040546,"about_ca_topic_score_gemma":0.003339352,"teacher_disagreement_score":0.09166842,"about_ca_system_score_codex":0.00016177028,"about_ca_system_score_gemma":0.00010295834,"threshold_uncertainty_score":0.5924447},"labels":[],"label_agreement":null},{"id":"W2567923610","doi":"10.1182/blood.v106.11.236.236","title":"SCL Oncogene Perturbs HEB/E2A Function on Thymocyte Differentiation.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Click Chemistry and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer","funders":"","keywords":"Biology; Thymocyte; Transcription factor; Chromatin immunoprecipitation; Repressor; Cellular differentiation; Gene; Molecular biology; Genetics; CD8; Cell biology; Promoter; Gene expression; Antigen","score_opus":0.011973376866318929,"score_gpt":0.22233302445168135,"score_spread":0.2103596475853624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567923610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9342933,0.00017881837,0.0000935758,0.0006974808,0.000030918294,0.00004406701,0.00003629464,0.00016440645,0.06446109],"genre_scores_gemma":[0.9877127,0.0000379315,0.00011741855,0.0002623925,0.0010463329,0.00006373645,0.00019392405,0.000020419524,0.010545177],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991753,0.000005285691,0.00018271909,0.00028687395,0.00016911147,0.00018071679],"domain_scores_gemma":[0.99934274,0.000056381552,0.00007217901,0.00040777144,0.000034699337,0.00008625714],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00003215861,0.00014515607,0.00011014709,0.000017277145,0.00016364032,0.000034846522,0.00014346362,0.0001184374,0.0025214478],"category_scores_gemma":[0.000027683907,0.00014058284,0.00008806134,0.0000787437,0.000022845614,0.000053533746,0.000031034353,0.00016304562,0.0003824257],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029890034,0.0011427073,0.00083428534,0.00003448089,0.00007636427,0.0000013428722,0.0000512321,0.000033850032,0.98612154,0.0005519981,0.0020575572,0.009064771],"study_design_scores_gemma":[0.0010317963,0.000014258538,0.0009769223,0.00002225748,0.00009990925,0.000009927045,0.00002550603,0.000112234,0.9144311,0.00014772888,0.082960464,0.00016791366],"about_ca_topic_score_codex":0.000004526312,"about_ca_topic_score_gemma":0.0000064263713,"teacher_disagreement_score":0.080902904,"about_ca_system_score_codex":0.000038555572,"about_ca_system_score_gemma":0.000020306768,"threshold_uncertainty_score":0.9983904},"labels":[],"label_agreement":null},{"id":"W2567954139","doi":"10.1182/blood.v112.11.2072.2072","title":"Disruption of T Cell Suppression in Chronic Lymphocytic Leukemia by CD200 Blockade.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Therapeutics (Canada)","funders":"","keywords":"CD40; Antigen; Antigen-presenting cell; ELISPOT; FOXP3; Immunology; T cell; Chronic lymphocytic leukemia; IL-2 receptor; Flow cytometry; Biology; Immune system; Cancer research; Cytotoxic T cell; Leukemia; In vitro","score_opus":0.01508472783213163,"score_gpt":0.2702129272114141,"score_spread":0.2551281993792825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567954139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99294466,0.0031642437,0.000018188304,0.00002615337,0.00006510801,0.00047714097,0.000014838658,0.00005688569,0.003232781],"genre_scores_gemma":[0.9953223,0.0012431679,0.0001893798,0.000030142175,0.00015115706,0.000036143538,0.00006591983,0.000043788106,0.002917999],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99781084,0.00007062583,0.00049001805,0.00040556485,0.0006777013,0.00054522883],"domain_scores_gemma":[0.9989079,0.000121503814,0.00011198147,0.00057821494,0.00007650603,0.00020387094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020262576,0.00021087065,0.0004463078,0.00021340464,0.000058896458,0.000005965216,0.00019966881,0.00022636632,0.00024347236],"category_scores_gemma":[0.00009558828,0.0001859575,0.00011710675,0.0004461782,0.00020867558,0.00009705094,0.0001103902,0.00026661681,0.00011295308],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00037894287,0.0007454535,0.0029778178,0.00091068394,0.00005786184,0.0008560116,0.0006546748,0.0003184842,0.9881605,0.0000085257,0.004312066,0.0006189922],"study_design_scores_gemma":[0.074276835,0.0005165615,0.0027368674,0.00038588486,0.000103425125,0.00089505163,0.00005359062,0.013863084,0.9052468,0.000016217158,0.0016799561,0.00022572561],"about_ca_topic_score_codex":0.0016483254,"about_ca_topic_score_gemma":0.00003156679,"teacher_disagreement_score":0.08291368,"about_ca_system_score_codex":0.04303247,"about_ca_system_score_gemma":0.02494277,"threshold_uncertainty_score":0.9805849},"labels":[],"label_agreement":null},{"id":"W2568077771","doi":"10.1182/blood.v122.21.1010.1010","title":"Treatment Patterns and Outcomes Of Sickle Cell Patients With Frequent ER Visits: A Single Center Experience","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Logistic regression; Sickle cell anemia; Anemia; Observational study; Pediatrics; Emergency department; Internal medicine; Retrospective cohort study; Vaso-occlusive crisis; Disease","score_opus":0.005489083476723071,"score_gpt":0.20371713038970105,"score_spread":0.19822804691297796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568077771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99815774,0.00012523956,0.000009285974,0.00014554233,0.00002906692,0.00042148514,0.000015515676,0.000017247576,0.0010788988],"genre_scores_gemma":[0.999237,0.00004627356,0.00019004308,0.00013856245,0.000006879549,0.00002867312,0.000014483586,0.000013150801,0.00032493396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99938995,0.000009579909,0.00014774286,0.0001578189,0.00013518168,0.00015971615],"domain_scores_gemma":[0.99962026,0.000011299744,0.00005445177,0.00016490935,0.000052492705,0.00009657368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000007438921,0.00012138074,0.0002033919,0.000032088206,0.000025801985,0.000009401371,0.000028337769,0.000047826765,0.00014743178],"category_scores_gemma":[0.000004421024,0.000068924775,0.000036661873,0.0000402963,0.00003742844,0.000053954456,0.000017816317,0.000039198432,0.000012751675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017011378,0.0033677227,0.99253213,0.0000390432,0.00007378323,0.000007650467,0.0017140614,2.5724148e-7,0.00083361263,0.0000016617829,0.000015952766,0.0013970986],"study_design_scores_gemma":[0.013014511,0.002334088,0.96880233,0.0000914762,0.00015943855,0.00001102039,0.0012358652,0.0000064945116,0.013760045,0.0000039358847,0.00044241644,0.0001383961],"about_ca_topic_score_codex":0.0003004457,"about_ca_topic_score_gemma":0.000010854188,"teacher_disagreement_score":0.023729833,"about_ca_system_score_codex":0.000016317537,"about_ca_system_score_gemma":0.000011920376,"threshold_uncertainty_score":0.28106707},"labels":[],"label_agreement":null},{"id":"W2568124169","doi":"10.1182/blood.v106.11.374.374","title":"Activated JAK2 Signaling in Primary Human Hematopoietic Cells Drives Erythropoietin-Independent Erythropoiesis and Myelofibrosis.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto; University Health Network","funders":"","keywords":"Erythropoiesis; Myelofibrosis; Haematopoiesis; Erythropoietin; Polycythemia vera; Biology; Context (archaeology); Janus kinase 2; Stem cell; Cancer research; Essential thrombocythemia; Immunology; Bone marrow; Medicine; Signal transduction; Internal medicine; Cell biology; Endocrinology; Anemia","score_opus":0.010475370284824242,"score_gpt":0.2472205926312528,"score_spread":0.23674522234642856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568124169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945406,0.00092773995,0.000009589921,0.0014446345,0.000049857375,0.00075007975,0.0000122368265,0.000077595876,0.002187698],"genre_scores_gemma":[0.99429965,0.00043196869,0.003978983,0.0004477867,0.00019007787,0.00012928122,0.000044765256,0.000057023437,0.00042045722],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99778706,0.000092956005,0.0005500238,0.00064428616,0.00043404082,0.000491634],"domain_scores_gemma":[0.9990093,0.00015509603,0.00014978954,0.00035903387,0.0000777829,0.00024896726],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020000072,0.00039757628,0.0007115994,0.00023144047,0.00020711726,0.00006492187,0.00009071083,0.00018393538,0.00050922466],"category_scores_gemma":[0.000024929968,0.00034146127,0.00013050136,0.00023943833,0.00016629286,0.00016487556,0.00010532829,0.00029399246,0.00008805184],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009075103,0.0037961944,0.21865244,0.00021944742,0.00030332152,0.00020268044,0.0013934328,0.000016386433,0.773863,0.00017710832,0.0002481008,0.0010371296],"study_design_scores_gemma":[0.006561314,0.0004868479,0.19486694,0.0003431913,0.0002902944,0.00013797951,0.0002448975,0.000005645408,0.79634446,0.000056229845,0.00036013089,0.00030208786],"about_ca_topic_score_codex":0.00008616612,"about_ca_topic_score_gemma":0.00009277619,"teacher_disagreement_score":0.023785496,"about_ca_system_score_codex":0.00016297739,"about_ca_system_score_gemma":0.00009260639,"threshold_uncertainty_score":0.99990374},"labels":[],"label_agreement":null},{"id":"W2568212737","doi":"10.1182/blood.v108.11.1466.1466","title":"Atorvastatin Reduced Platelet Accumulation in Arteriolar Thrombi and Increases Platelet S-Nitrosylated N-Ethylmaleimide-Sensitive Factor.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Platelet; Atorvastatin; Thrombus; Cremaster muscle; Chemistry; Internal medicine; Endocrinology; Platelet activation; Medicine; Microcirculation; Andrology","score_opus":0.01806562119665327,"score_gpt":0.2651225651505548,"score_spread":0.24705694395390154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568212737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998054,0.00060382363,0.000026411053,0.000108070235,0.00003746175,0.0007508317,0.000046254183,0.00009518444,0.0002779479],"genre_scores_gemma":[0.9987297,0.000085365486,0.0005779089,0.00014197767,0.00022878095,0.000022022477,0.00014240573,0.0000382134,0.000033604687],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983769,0.00014455267,0.00040172925,0.0003907048,0.00033052784,0.00035557977],"domain_scores_gemma":[0.9993391,0.00006757023,0.00010541453,0.0002617157,0.00008918066,0.0001370268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029450687,0.00022666338,0.0005295744,0.00015694543,0.000085226675,0.000034061373,0.00003717903,0.00017619028,0.00003595664],"category_scores_gemma":[0.00009100489,0.00020760266,0.000108527616,0.00024184457,0.00005676725,0.000104222025,0.000032856307,0.00025794737,0.000015113261],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008728434,0.0022431056,0.20025855,0.00052641815,0.0007574504,0.002723934,0.0014298287,0.000092215065,0.7652038,0.00019386958,0.00018498715,0.025513021],"study_design_scores_gemma":[0.0068641016,0.00024843364,0.871331,0.00016311338,0.000093947536,0.00043396582,0.00013202109,0.00013903873,0.12004974,0.000093952236,0.00022261465,0.00022807054],"about_ca_topic_score_codex":0.004527542,"about_ca_topic_score_gemma":0.00024067343,"teacher_disagreement_score":0.6710725,"about_ca_system_score_codex":0.00005444346,"about_ca_system_score_gemma":0.00011176256,"threshold_uncertainty_score":0.8465791},"labels":[],"label_agreement":null},{"id":"W2568245897","doi":"10.1182/blood.v110.11.4397.4397","title":"Screening for Leptomeningeal Disease by High-Sensitivity Flow Cytometry in High Risk Patients with Aggressive Non-Hodgkin’s Lymphoma.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; Lymphoma; Internal medicine; Pathology; CD5; Non-Hodgkin's lymphoma; Occult; Immunophenotyping; Lumbar puncture; Cytology; Gastroenterology; Flow cytometry; Cerebrospinal fluid; Immunology","score_opus":0.00517362186795269,"score_gpt":0.23269023479435177,"score_spread":0.22751661292639908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568245897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951871,0.00029601387,0.0023417715,0.00008491688,0.000097166274,0.0011455879,0.0007496139,0.000061283274,0.000036521822],"genre_scores_gemma":[0.990608,0.00003810088,0.008046723,0.00015498353,0.00015725575,0.00014537596,0.00075103354,0.00006316185,0.00003538612],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99802625,0.000043802327,0.00033551292,0.0005478684,0.0004614693,0.0005850778],"domain_scores_gemma":[0.9983893,0.00039367157,0.00029343273,0.0003611872,0.00013622035,0.00042618444],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030199642,0.00032487224,0.0005030825,0.00027122546,0.0001412156,0.000029451921,0.000060829385,0.000107343134,0.000016762278],"category_scores_gemma":[0.00019064885,0.00025805293,0.00012528776,0.0003768941,0.000068727124,0.00010610766,0.000052084997,0.00009154751,0.000009184012],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020840452,0.0056123957,0.9168895,0.000048643666,0.00030670565,0.0008069822,0.00009199566,0.00001706662,0.00006791516,0.0000057367406,0.00033069513,0.0737383],"study_design_scores_gemma":[0.04228713,0.001006208,0.9494284,0.00037733227,0.0007915111,0.000012371827,0.00003719043,0.00014268092,0.0055314605,0.000012681354,0.00009798014,0.0002750921],"about_ca_topic_score_codex":0.0007463476,"about_ca_topic_score_gemma":0.00017064366,"teacher_disagreement_score":0.07346321,"about_ca_system_score_codex":0.00020326064,"about_ca_system_score_gemma":0.00009465741,"threshold_uncertainty_score":0.9999872},"labels":[],"label_agreement":null},{"id":"W2568283106","doi":"10.1182/blood.v110.11.5039.5039","title":"Impact of Myeloablative Versus Reduced Intensity Conditioning Regimens on Early Lymphocyte Recovery and Its Impact on Transplant Outcomes after Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients with Hematologic Malignancies.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Alemtuzumab; Busulfan; Transplantation; Internal medicine; Lymphocyte; Fludarabine; Regimen; Surgery; Hematopoietic stem cell transplantation; Gastroenterology; Chemotherapy; Cyclophosphamide","score_opus":0.010973726675141153,"score_gpt":0.25287936878827383,"score_spread":0.24190564211313267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568283106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99833536,0.00006529664,0.00004114319,0.000014299476,0.000072536786,0.00093423197,0.000257635,0.000055695353,0.00022382864],"genre_scores_gemma":[0.9993973,0.000110628185,0.00015377332,0.00006195469,0.00001331258,0.00002916097,0.00016571826,0.000049900264,0.000018289422],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99799734,0.00008565869,0.0005678799,0.00045837217,0.00044322843,0.00044753632],"domain_scores_gemma":[0.99881846,0.00031622525,0.00024641133,0.00021281379,0.00022354868,0.00018251724],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020497582,0.00040735182,0.00070389773,0.00029977498,0.000045740082,0.000015304031,0.00006301265,0.0002040232,0.00002225024],"category_scores_gemma":[0.000013373184,0.0002881246,0.00018458738,0.00024444633,0.00006652363,0.00015262123,0.000004401274,0.00020769704,0.000004630182],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037584834,0.0015140019,0.9348728,0.00045924494,0.00061464997,0.00080800976,0.005708698,0.00012643596,0.018225098,0.00001534091,9.759985e-7,0.00006990626],"study_design_scores_gemma":[0.025718162,0.005110291,0.8186963,0.0010643654,0.0006940636,0.00014570863,0.00015474364,0.0000103340735,0.14815216,0.0000032927417,3.4933006e-8,0.00025051212],"about_ca_topic_score_codex":0.00013216936,"about_ca_topic_score_gemma":0.000049250124,"teacher_disagreement_score":0.12992707,"about_ca_system_score_codex":0.00019831632,"about_ca_system_score_gemma":0.00013659558,"threshold_uncertainty_score":0.9999571},"labels":[],"label_agreement":null},{"id":"W2568299126","doi":"10.1182/blood.v126.23.1087.1087","title":"Long-Term Safety and Efficacy of rFVIIIFc in Adults and Adolescents with Severe Hemophilia A: A Longitudinal Analysis of A-LONG and ASPIRE","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital","funders":"","keywords":"Medicine; Dosing; Interim analysis; Internal medicine; Bristol-Myers; Interim; Pediatrics; Clinical trial","score_opus":0.020380362048365006,"score_gpt":0.2861436538083436,"score_spread":0.2657632917599786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568299126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99760926,0.0017000631,0.0000032257724,0.00015453676,0.000005958968,0.00037547952,0.000013616141,0.0000076139654,0.0001302353],"genre_scores_gemma":[0.9994312,0.00035281523,0.00007743696,0.0000071022123,0.000017328415,0.0000032718258,0.000022399658,0.000011007702,0.000077448705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988942,0.00003870697,0.00025921155,0.00029757345,0.00031338457,0.00019688535],"domain_scores_gemma":[0.99932516,0.000038249753,0.000077890734,0.00020754179,0.00011855046,0.0002326255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018966972,0.00014708091,0.00055604154,0.00031760827,0.00002446151,0.000007585774,0.000042696895,0.000082578736,0.000006429313],"category_scores_gemma":[0.000060292732,0.00010214653,0.00004268888,0.00052163244,0.00020663781,0.00005957715,0.000073229836,0.00012162936,4.1840468e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025100189,0.0009894103,0.99017406,0.0005838811,0.00071821146,0.0003195108,0.00054556475,0.0000020657935,0.00009492598,0.0000028478755,0.0000016061647,0.0040579285],"study_design_scores_gemma":[0.018684987,0.00091601576,0.9767018,0.0012613946,0.0014720309,0.00012986736,0.00008119516,0.00007456759,0.00058152934,0.0000019107383,6.721589e-7,0.00009400551],"about_ca_topic_score_codex":0.00010118592,"about_ca_topic_score_gemma":0.0003717958,"teacher_disagreement_score":0.016174968,"about_ca_system_score_codex":0.000017810498,"about_ca_system_score_gemma":0.00006929963,"threshold_uncertainty_score":0.41654143},"labels":[],"label_agreement":null},{"id":"W2568349188","doi":"10.1182/blood.v114.22.2501.2501","title":"Treatment Does Not Correlate with Quality of Life in Children with Immune Thrombocytopenic Purpura: Results From the KIT International Cross-Cultural Validation Study.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Laurentian University; Hospital for Sick Children; Children's Hospital of Eastern Ontario","funders":"","keywords":"Medicine; Thrombocytopenic purpura; Prednisone; Immune thrombocytopenia; Quality of life (healthcare); Platelet; Pediatrics; Internal medicine; Health related quality of life; Disease","score_opus":0.023101043014031528,"score_gpt":0.31426681706899234,"score_spread":0.2911657740549608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568349188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973807,0.00010166128,0.0000013921036,0.00090851745,0.000031732165,0.0009545176,0.00019134821,0.000021795839,0.00040838073],"genre_scores_gemma":[0.9989529,0.00006653214,0.000100437464,0.00006158993,0.00003668075,0.000024866378,0.00057781936,0.000008737768,0.00017039158],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876773,0.000060542094,0.00042224617,0.000285483,0.00032379114,0.00014019638],"domain_scores_gemma":[0.99924237,0.00006581386,0.00023865605,0.00031203846,0.00009733325,0.00004380341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011463131,0.00017750911,0.00040760377,0.000031308125,0.00006293022,0.000046352816,0.00011758319,0.000046356632,0.000020290741],"category_scores_gemma":[0.000063002444,0.00007476751,0.000055206347,0.00011403602,0.00007005586,0.000160607,0.00001735624,0.000098092874,0.0000061954693],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003309101,0.0047532986,0.9873817,0.0000011640474,0.0013033929,0.00004516493,0.0014178436,0.000033554796,0.00075593,0.000016781167,0.0000022882793,0.0009798062],"study_design_scores_gemma":[0.042959057,0.0018528163,0.950423,0.000042976004,0.0003182912,0.000028035758,0.00038157322,0.000006616436,0.0038636269,0.000024152165,0.000004137325,0.00009573499],"about_ca_topic_score_codex":0.0041255723,"about_ca_topic_score_gemma":0.0005716769,"teacher_disagreement_score":0.039649956,"about_ca_system_score_codex":0.00005248962,"about_ca_system_score_gemma":0.00006576946,"threshold_uncertainty_score":0.62366587},"labels":[],"label_agreement":null},{"id":"W2568354557","doi":"10.1182/blood.v108.11.3536.3536","title":"A Phase I-II Trial of Bortezomib Plus Oral Cyclophosphamide and Prednisone for Relapsed/Refractory Multiple Myeloma.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Neutropenia; Bortezomib; Internal medicine; Gastroenterology; Multiple myeloma; Cyclophosphamide; Lenalidomide; Thalidomide; Toxicity; Febrile neutropenia; Refractory (planetary science); Urology; Surgery; Chemotherapy","score_opus":0.02489002344502734,"score_gpt":0.3103489872472944,"score_spread":0.28545896380226704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568354557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951435,0.0011945415,0.00011109344,0.000108827146,0.000096175245,0.002397305,0.00023307226,0.000061149636,0.00065437896],"genre_scores_gemma":[0.99311423,0.00009069283,0.004370796,0.000022749882,0.00026779564,0.00027301608,0.00026184804,0.000038392805,0.0015604671],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9984336,0.000038244492,0.00042314982,0.00035365633,0.0003364353,0.00041491864],"domain_scores_gemma":[0.99896026,0.00022085942,0.00013999663,0.00033408162,0.00012489529,0.00021990534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020149353,0.00020841265,0.0005205899,0.000120024015,0.00013294065,0.000013523966,0.000075066484,0.00013135285,0.00003074279],"category_scores_gemma":[0.00038063026,0.00017171477,0.00015512749,0.00012783347,0.00012112907,0.00008828798,0.000059984388,0.00012658964,0.0000047033936],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5844186,0.10845627,0.07399164,0.0011232763,0.0024414149,0.0008348377,0.00067052327,0.0000072114212,0.12806417,0.0003587007,0.0057346444,0.0938987],"study_design_scores_gemma":[0.90459305,0.02063855,0.020756803,0.00009576113,0.00055745145,0.000045674667,0.00004160119,0.00065765704,0.04605447,0.00015884575,0.0061925994,0.00020753176],"about_ca_topic_score_codex":0.00044132664,"about_ca_topic_score_gemma":0.00010214202,"teacher_disagreement_score":0.32017443,"about_ca_system_score_codex":0.000047188423,"about_ca_system_score_gemma":0.00020826823,"threshold_uncertainty_score":0.7002325},"labels":[],"label_agreement":null},{"id":"W2568386159","doi":"10.1182/blood.v118.21.556.556","title":"Epigenetic Profiling of Primary DLBCLs Reveals Novel DNA Methylation-Based Clusters and New Underlying Mechanisms of Lymphomagenesis","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Jewish General Hospital","funders":"","keywords":"Epigenetics; Biology; DNA methylation; Gene expression profiling; Genetics; Diffuse large B-cell lymphoma; Methylation; Gene; Computational biology; Cancer research; Gene expression","score_opus":0.08223450647289832,"score_gpt":0.2681047403074706,"score_spread":0.1858702338345723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568386159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98714095,0.0010957145,0.010134202,0.000060910148,0.00004021681,0.00054085086,0.000014776778,0.00002236934,0.0009499999],"genre_scores_gemma":[0.9073404,0.00004304374,0.09238394,0.00012584968,0.000013053395,0.000021835132,0.000015759899,0.000019748923,0.00003633951],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990069,0.000027557842,0.00037391056,0.00022730773,0.00020878887,0.0001554794],"domain_scores_gemma":[0.99920595,0.00012913952,0.00020980631,0.00025611257,0.00007350321,0.00012549001],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016652628,0.00014419439,0.00040659404,0.00011756918,0.000031758147,0.0000041222224,0.00005322305,0.00007706951,0.00002634851],"category_scores_gemma":[0.00004735946,0.00012181807,0.00009528487,0.0001365623,0.000040730833,0.000035380883,0.000028022345,0.000020721644,0.0000015358448],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015443607,0.0026642685,0.111224264,0.00069774204,0.0005149758,0.00001989386,0.00049793377,0.000008513064,0.8710385,0.0010909464,0.0000071870077,0.012081372],"study_design_scores_gemma":[0.006786909,0.00038851053,0.29416466,0.00018633071,0.0007494862,0.000011077564,0.000059719518,0.00004433091,0.69700813,0.00051837537,0.0000012263779,0.000081229286],"about_ca_topic_score_codex":0.00023936675,"about_ca_topic_score_gemma":0.0000055999103,"teacher_disagreement_score":0.18294041,"about_ca_system_score_codex":0.00004426686,"about_ca_system_score_gemma":0.00027629256,"threshold_uncertainty_score":0.49675968},"labels":[],"label_agreement":null},{"id":"W2568392694","doi":"10.1182/blood-2016-10-744219","title":"KMT2E-ASNS: a novel relapse-specific fusion gene in early T-cell precursor acute lymphoblastic leukemia","year":2017,"lang":"en","type":"letter","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Princess Margaret Cancer Centre; Centre Hospitalier Universitaire Sainte-Justine","funders":"National Cancer Institute; Canadian Institutes of Health Research; Centre hospitalier universitaire Sainte-Justine; Université de Montréal; Compute Canada; McGill University","keywords":"Immunophenotyping; Fusion gene; Cancer research; Fusion transcript; Biology; Medicine; Oncology; Gene; Immunology; Genetics; Antigen","score_opus":0.021423503304332115,"score_gpt":0.2574559239462583,"score_spread":0.2360324206419262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568392694","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7766302,0.009208145,0.0025013525,0.15329336,0.0046369154,0.010786383,0.0020189565,0.0010827294,0.039841942],"genre_scores_gemma":[0.18642032,0.012928641,0.029453296,0.34157526,0.06162132,0.0037783133,0.009964869,0.0047815223,0.34947646],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9919377,0.00017171152,0.0012616495,0.0021068181,0.002382315,0.0021398338],"domain_scores_gemma":[0.99438417,0.0006278982,0.0007443288,0.003339945,0.0003985035,0.0005051425],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.00056038954,0.0012837568,0.0019933872,0.0011867842,0.00030704951,0.00030043515,0.0017178734,0.0031924008,0.00029531698],"category_scores_gemma":[0.0004181949,0.0011674181,0.0005667026,0.00053015153,0.00047597341,0.00027867043,0.0008265544,0.004633245,0.0016707662],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074554124,0.0010503173,0.0007007847,0.0011296833,0.00070525333,0.029499376,0.00049090415,0.0000047365947,0.034865588,0.00000939229,0.93047106,0.00032737578],"study_design_scores_gemma":[0.0991535,0.0028458366,0.0062118717,0.0059535108,0.004497552,0.008258448,0.000035086414,0.0012754357,0.024749178,0.00015759675,0.84343266,0.003429305],"about_ca_topic_score_codex":0.00048689058,"about_ca_topic_score_gemma":0.000017232607,"teacher_disagreement_score":0.5902099,"about_ca_system_score_codex":0.0044039055,"about_ca_system_score_gemma":0.0049082693,"threshold_uncertainty_score":0.9999914},"labels":[],"label_agreement":null},{"id":"W2568406639","doi":"10.1182/blood-2016-08-735431","title":"Biallelic mutations in DNAJC21 cause Shwachman-Diamond syndrome","year":2017,"lang":"en","type":"letter","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":142,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Children's Hospital of Western Ontario; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Genetics; Immunology; Biology","score_opus":0.01503605242889995,"score_gpt":0.25409840534060935,"score_spread":0.2390623529117094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568406639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9277292,0.006212361,0.000010365101,0.057077814,0.0005244102,0.0008379129,0.0005097634,0.000038576312,0.0070596198],"genre_scores_gemma":[0.8858351,0.0008415133,0.0003092365,0.082295865,0.0020061985,0.00041965995,0.010767119,0.00021624047,0.017309047],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99855065,0.00005439563,0.00023907873,0.00059647736,0.0001599772,0.0003994139],"domain_scores_gemma":[0.9988367,0.000011172102,0.00016299922,0.0008975943,0.000037244605,0.000054321354],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00005129304,0.00033716083,0.00032016422,0.00011617803,0.00012515356,0.00007577304,0.0003959629,0.000887886,0.00003780766],"category_scores_gemma":[0.000043969474,0.00033800572,0.00016728869,0.000049059945,0.00009023892,0.000004355938,0.00012655318,0.00043219634,0.00008513712],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002703416,0.0021930353,0.021086726,0.00025226286,0.0025480776,0.015294724,0.000113443464,0.000010350929,0.002249213,0.0000121779685,0.9550146,0.0011983631],"study_design_scores_gemma":[0.008436824,0.0007163122,0.010284152,0.00016037533,0.0010907035,0.0008973168,0.000021581227,0.0000024453088,0.006548233,0.0005134426,0.9699961,0.00133254],"about_ca_topic_score_codex":0.00020428658,"about_ca_topic_score_gemma":0.00045340555,"teacher_disagreement_score":0.041894056,"about_ca_system_score_codex":0.000009740037,"about_ca_system_score_gemma":0.00013351007,"threshold_uncertainty_score":0.9999072},"labels":[],"label_agreement":null},{"id":"W2568419443","doi":"10.1182/blood-2016-09-738021","title":"Plasma cell neoplasm with plasmablastic morphology mimicking acute leukemia","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pathology; Bone marrow; Plasma cell; Plasma cell neoplasm; Medicine; Multiple myeloma; Biology; Plasmacytoma; Internal medicine","score_opus":0.018171598724125337,"score_gpt":0.2747689751313528,"score_spread":0.25659737640722746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568419443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98126006,0.000039383838,0.00004003374,0.0002304399,0.00008662789,0.00036601728,0.000026731028,0.00006503854,0.017885655],"genre_scores_gemma":[0.9924883,0.000050965766,0.0032779,0.000060544106,0.00011614828,0.000045254892,0.000034278793,0.00004095064,0.0038856377],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99859256,0.000023097236,0.00015414612,0.00037709583,0.00030651342,0.00054657867],"domain_scores_gemma":[0.9986367,0.00008812489,0.00012554438,0.0007597335,0.00007096561,0.00031891404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000064733875,0.00021465286,0.00034508182,0.00009619826,0.00038696555,0.00007905036,0.00023636465,0.00011246556,0.00010107924],"category_scores_gemma":[0.00009401348,0.00015473251,0.00006969295,0.000044901684,0.00018188903,0.00011109653,0.00011723156,0.00027148586,0.00044795295],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003609692,0.0023132376,0.788998,0.0003171964,0.0030551734,0.03631208,0.00044351385,0.000037107795,0.15614201,0.00008704188,0.0014195555,0.0072653936],"study_design_scores_gemma":[0.06732783,0.0029097572,0.40918377,0.000287021,0.0018344162,0.00523263,0.00007285403,0.0017024643,0.508592,0.000039810187,0.0023252761,0.0004921537],"about_ca_topic_score_codex":0.00016417622,"about_ca_topic_score_gemma":0.00008230036,"teacher_disagreement_score":0.37981424,"about_ca_system_score_codex":0.00008879575,"about_ca_system_score_gemma":0.00033096745,"threshold_uncertainty_score":0.63098085},"labels":[],"label_agreement":null},{"id":"W2568553251","doi":"10.1182/blood.v114.22.1292.1292","title":"Evaluation of Bleeding Symptoms in Children with An Inherited Mucocutaneous Bleeding Disorder.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; Hospital for Sick Children","funders":"","keywords":"Medicine; Pediatrics; Population; Mucocutaneous zone; Internal medicine; Disease","score_opus":0.013629302036589517,"score_gpt":0.26992613879403116,"score_spread":0.25629683675744164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568553251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99709505,0.0006116902,0.0000055049863,0.000069742186,0.000010549871,0.00056367996,0.000004134493,0.000039843493,0.0015998087],"genre_scores_gemma":[0.9994562,0.000039921448,0.00033437955,0.00004096509,0.00002650521,0.00001148619,0.00006323943,0.000014787145,0.000012475138],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99887526,0.00003264274,0.00019531985,0.00021814156,0.00047975226,0.00019887269],"domain_scores_gemma":[0.9995657,0.000009749613,0.00007697957,0.00015925418,0.0001199517,0.000068336456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024401493,0.00013352341,0.00026621492,0.00014768034,0.00003386,0.000010672623,0.00005119066,0.00006767413,0.000032877724],"category_scores_gemma":[0.000035529207,0.00010735333,0.000029442,0.0003030565,0.00002221652,0.0001066588,0.0000069901985,0.000091705326,0.0000023938185],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015040455,0.0036965476,0.9335675,0.000011195712,0.00042651474,0.00010564776,0.00044922708,0.00013736774,0.004386676,0.000034418925,0.0000024584174,0.057031997],"study_design_scores_gemma":[0.019310923,0.0034332187,0.96820617,0.00023301988,0.0017615273,0.0010759529,0.0001886145,0.0028405301,0.0023669219,0.0003873266,0.0000031918582,0.00019261621],"about_ca_topic_score_codex":0.00012444901,"about_ca_topic_score_gemma":0.00006791134,"teacher_disagreement_score":0.05683938,"about_ca_system_score_codex":0.000035992085,"about_ca_system_score_gemma":0.000069014306,"threshold_uncertainty_score":0.43777415},"labels":[],"label_agreement":null},{"id":"W2568612476","doi":"10.1182/blood.v112.11.4720.4720","title":"Improving the Sensitivity and the Specificity of HLA-B27 Typing by Replacing Serological Tests with a TaqMan-PCR Assay","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"TaqMan; Immunophenotyping; Polymerase chain reaction; Gold standard (test); Typing; Biology; Serology; HLA-B27; Molecular biology; Antigen; Human leukocyte antigen; Medicine; Immunology; Antibody; Genetics; Internal medicine; Gene","score_opus":0.011272920834007613,"score_gpt":0.1913760920763963,"score_spread":0.1801031712423887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568612476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953011,0.0027833935,0.0002326828,0.00042616396,0.0001061205,0.00025148765,0.000009527692,0.00005381722,0.0008356713],"genre_scores_gemma":[0.9987999,0.00013687117,0.00007019767,0.00018486196,0.000029755938,0.0000103887505,0.00001227363,0.0000119972465,0.00074373186],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982944,0.0007412213,0.00025447257,0.0003297927,0.00003742687,0.0003426692],"domain_scores_gemma":[0.9984223,0.0009020464,0.00020676051,0.00039411397,0.00006071129,0.000014052228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008853015,0.0001889716,0.00036622258,0.000029230741,0.0005185085,0.000010954204,0.00016657829,0.00022323256,0.00003202319],"category_scores_gemma":[0.00017191515,0.00009181441,0.00006667396,0.00011231742,0.0015328432,0.000050647723,0.00016916746,0.00052442047,0.000023020964],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043262102,0.00024898033,0.01569975,0.000010128041,0.0001937784,0.000024961864,0.00051989185,0.0000013768827,0.9816267,0.00028321103,0.00027503073,0.00068357657],"study_design_scores_gemma":[0.0096448185,0.00068863237,0.01892333,0.000048598125,0.00029914634,0.004908147,0.00075550756,0.00003895923,0.9616309,0.000097666874,0.0026109929,0.0003533408],"about_ca_topic_score_codex":0.00042988535,"about_ca_topic_score_gemma":0.0001207907,"teacher_disagreement_score":0.019995831,"about_ca_system_score_codex":0.000008071131,"about_ca_system_score_gemma":0.00003668828,"threshold_uncertainty_score":0.56478244},"labels":[],"label_agreement":null},{"id":"W2568716025","doi":"10.1182/blood.v126.23.3465.3465","title":"Murine Bone Marrow-Derived Megakaryocytes Are Capable of Antigen Cross-Presentation on Major Histocompatibility Class (MHC) I Molecules","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"MHC class I; Antigen presentation; Cross-presentation; Biology; Major histocompatibility complex; Antigen processing; Cytotoxic T cell; CD8; Antigen; MHC restriction; Antigen-presenting cell; Cell biology; Molecular biology; T cell; Immunology; Immune system; Biochemistry; In vitro","score_opus":0.028392645047503298,"score_gpt":0.29248425148392243,"score_spread":0.26409160643641916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568716025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99431694,0.0008230594,0.000018379273,0.0002132391,0.000066253575,0.0006033946,0.000053720505,0.00005393805,0.0038510766],"genre_scores_gemma":[0.99843824,0.00002460338,0.00069067813,0.00009785752,0.000034871002,0.000034164488,0.00014595733,0.000022717915,0.00051093934],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988037,0.000042132568,0.00030410726,0.00029905676,0.00033191388,0.00021910858],"domain_scores_gemma":[0.9990649,0.000035344747,0.00017625252,0.00038109513,0.0001802524,0.00016214912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011121985,0.000175558,0.000439753,0.000087453765,0.000050056402,0.000014163392,0.00007433279,0.00008203426,0.00006561897],"category_scores_gemma":[0.00012655891,0.00014797451,0.00009336147,0.00012718626,0.00010013388,0.00008153079,0.00003619018,0.00009013507,0.000039228235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012754799,0.006690561,0.9262944,0.00026705395,0.00047649434,0.00092139444,0.00052113994,0.0000925813,0.06118926,0.00009307302,0.0017166302,0.0004619559],"study_design_scores_gemma":[0.019177185,0.0009879268,0.628993,0.00013207711,0.0002849176,0.00008199197,0.00026707252,0.00019706938,0.34848496,0.0007440664,0.00043248944,0.00021725988],"about_ca_topic_score_codex":0.00054608006,"about_ca_topic_score_gemma":0.00011219873,"teacher_disagreement_score":0.2973014,"about_ca_system_score_codex":0.000058374848,"about_ca_system_score_gemma":0.00007984167,"threshold_uncertainty_score":0.6034225},"labels":[],"label_agreement":null},{"id":"W2568716835","doi":"10.1182/blood.v110.11.3958.3958","title":"Reduced Bone Mineral Density in Hemophilia.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Osteopenia; Bone mineral; Osteoporosis; Haemophilia; Arthropathy; Hepatitis C virus; Internal medicine; Surgery; Retrospective cohort study; Haemophilia A; Bone density; Pediatrics; Immunology; Virus; Pathology; Osteoarthritis","score_opus":0.02574407923904825,"score_gpt":0.30746903126142433,"score_spread":0.2817249520223761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568716835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867776,0.00023230966,0.0000021310561,0.0011673323,0.000051353247,0.00024795046,8.94093e-7,0.000038474624,0.011481962],"genre_scores_gemma":[0.9928094,0.000026262614,0.0006361883,0.000118263175,0.00024014793,0.000004143907,0.000015081619,0.000012505949,0.0061379853],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901015,0.000016121081,0.00018143252,0.00019092267,0.0002473027,0.0003540891],"domain_scores_gemma":[0.99951416,0.000042121028,0.000017429182,0.00021081374,0.000046119792,0.00016936453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036345754,0.00009463749,0.0002022925,0.00016835523,0.000031753243,0.0000060602006,0.000040902167,0.000091801056,0.000082093415],"category_scores_gemma":[0.00009850284,0.00007390729,0.000060995713,0.0002631086,0.00004611985,0.000029036666,0.00002950909,0.00018195235,0.00014790287],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036832085,0.0025606353,0.5387096,0.000063980566,0.0000708965,0.00625867,0.0002720045,1.434373e-7,0.44509307,0.00012095083,0.0008604475,0.0056212787],"study_design_scores_gemma":[0.008504665,0.000260158,0.6668527,0.00006786916,0.00007644928,0.0005677311,0.00006249755,0.000009958168,0.32254124,0.00014314472,0.00077544566,0.00013813736],"about_ca_topic_score_codex":0.00004515169,"about_ca_topic_score_gemma":0.000059553273,"teacher_disagreement_score":0.12814312,"about_ca_system_score_codex":0.000041280924,"about_ca_system_score_gemma":0.00006298179,"threshold_uncertainty_score":0.3013852},"labels":[],"label_agreement":null},{"id":"W2568716921","doi":"10.1182/blood.v120.21.3016.3016","title":"Discovering Optimal Targets for Adoptive T-Cell Immunotherapy of Leukemia.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Antigen; Immunology; Adoptive cell transfer; Immunotherapy; CD8; Transplantation; CTL*; Leukemia; Cancer research; Cancer immunotherapy; Minor histocompatibility antigen; Biology; T cell; Major histocompatibility complex; Immune system; Medicine; Internal medicine","score_opus":0.022728131410619568,"score_gpt":0.2976592045055155,"score_spread":0.2749310730948959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568716921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864898,0.0033721314,0.0011653492,0.000043504304,0.00010406532,0.000686549,0.0000246347,0.000027624033,0.008086373],"genre_scores_gemma":[0.98671,0.00020488809,0.0072750687,0.000054685745,0.00036576597,0.00006404109,0.000025362522,0.000050053055,0.005250115],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989891,0.000020983849,0.00019512376,0.000145183,0.00023879725,0.0004107817],"domain_scores_gemma":[0.9993666,0.000089067486,0.00006433794,0.00028316327,0.00008229709,0.000114561306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027519453,0.00012426345,0.00028564376,0.00007585691,0.000038203154,0.000007637368,0.00009921895,0.000074446216,0.00072781614],"category_scores_gemma":[0.000025788739,0.00010688135,0.00016525896,0.0001037204,0.00006293354,0.00010187668,0.000035729176,0.00013837263,0.000013653016],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081926543,0.00088524376,0.008226359,0.00012425907,0.00021817921,0.00000323193,0.0012726295,0.000016523718,0.9847905,0.00009699278,0.00024020813,0.0033065993],"study_design_scores_gemma":[0.008445979,0.00078198744,0.004762812,0.000038654405,0.00009056343,0.000021979613,0.0002705382,0.000073668736,0.9690249,0.000014986983,0.01633813,0.00013582998],"about_ca_topic_score_codex":0.000037981397,"about_ca_topic_score_gemma":8.910862e-7,"teacher_disagreement_score":0.016097924,"about_ca_system_score_codex":0.000074345786,"about_ca_system_score_gemma":0.00012517154,"threshold_uncertainty_score":0.79690766},"labels":[],"label_agreement":null},{"id":"W2568741201","doi":"10.1182/blood.v118.21.545.545","title":"Perioperative Heparin Bridging in Patients Receiving Oral Anticoagulation: Meta-Analysis of Bleeding and Thromboembolic Rates","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hamilton General Hospital; McMaster University","funders":"","keywords":"Medicine; Meta-analysis; Observational study; Perioperative; Heparin; Randomized controlled trial; Internal medicine; Low molecular weight heparin; MEDLINE; Relative risk; Surgery; Anesthesia; Confidence interval","score_opus":0.07506420851146108,"score_gpt":0.29912879820060484,"score_spread":0.22406458968914378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568741201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99578696,0.000467621,0.000035940157,0.00005642015,0.00002612907,0.00035284678,0.000004196106,0.000017949189,0.0032519393],"genre_scores_gemma":[0.99866426,0.00010639168,0.0010177878,0.00011532169,0.000014448838,0.000023778564,0.000016087502,0.000014237777,0.000027674552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99887174,0.00005686259,0.00038693682,0.00028464856,0.00020108005,0.00019870567],"domain_scores_gemma":[0.99946827,0.000032948097,0.00013112492,0.00020261412,0.00010222441,0.00006280035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030153588,0.00015386404,0.0012644122,0.0003990613,0.000055171557,0.000019979425,0.00005797949,0.000045632984,0.00028913977],"category_scores_gemma":[0.000057510228,0.0001260897,0.00022688817,0.0005989259,0.000054069333,0.000146476,0.00008049689,0.00007907284,0.000002226367],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014018789,0.0016167453,0.94736695,0.000058856273,0.04465302,0.0000069582284,0.00464257,0.000032168733,0.00041812213,0.00067044323,0.000013049896,0.00050707033],"study_design_scores_gemma":[0.0011658329,0.00017254688,0.88316697,0.000015549165,0.11188643,6.6598903e-7,0.00023350946,0.00047609702,0.0027535502,0.000016340658,0.000006880738,0.000105624196],"about_ca_topic_score_codex":0.000617251,"about_ca_topic_score_gemma":0.00022538162,"teacher_disagreement_score":0.067233406,"about_ca_system_score_codex":0.000014635035,"about_ca_system_score_gemma":0.00001569882,"threshold_uncertainty_score":0.5141789},"labels":[],"label_agreement":null},{"id":"W2568752198","doi":"10.1182/blood.v114.22.4200.4200","title":"Thromboelastogrpahy Reveals Kinetics of LPS- Induced Coagulopathy and Correlates to Fetal Outcome in a Rat Model of Pregnancy Complications.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Trauma, Hemostasis, Coagulopathy, Resuscitation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Saline; Pregnancy; Fibrinolysis; Hyperfibrinolysis; Hemostasis; Fetus; Eclampsia; Coagulopathy; Systemic inflammation; Thromboelastography; Internal medicine; Gastroenterology; Anesthesia; Inflammation; Surgery; Platelet","score_opus":0.046570652444469965,"score_gpt":0.3067053557286224,"score_spread":0.26013470328415245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568752198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99617964,0.0005419193,0.0008730553,0.0006533872,0.00004334907,0.0009422846,0.000036733705,0.000033808647,0.0006958374],"genre_scores_gemma":[0.9893589,0.000045522313,0.010299126,0.00018800308,0.000011437171,0.000025288546,0.000023674704,0.000019427851,0.000028646611],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99844587,0.00004359903,0.00073234213,0.0002903576,0.00027530186,0.00021255565],"domain_scores_gemma":[0.9989652,0.00009192988,0.00022347622,0.00039652982,0.00019963471,0.00012325183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014258987,0.00017649116,0.0005511165,0.0002683612,0.000020473268,0.0000069845546,0.000108459564,0.00012477573,0.0000032200967],"category_scores_gemma":[0.0002846141,0.0001726196,0.000060869475,0.0004277694,0.000059544553,0.00007389015,0.00003935943,0.00016162897,0.000003920483],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010994841,0.0018803156,0.25713834,0.00026404328,0.00003065115,0.0000072993257,0.0021387236,0.00024227337,0.72739035,0.00083125435,0.000025564841,0.009941216],"study_design_scores_gemma":[0.004803847,0.0013295319,0.8966452,0.0010366625,0.00021194138,0.000029260027,0.00021843049,0.0010536634,0.09315661,0.001311355,0.0000028592397,0.00020062125],"about_ca_topic_score_codex":0.000011335443,"about_ca_topic_score_gemma":0.000024845507,"teacher_disagreement_score":0.6395069,"about_ca_system_score_codex":0.000028778935,"about_ca_system_score_gemma":0.000048900598,"threshold_uncertainty_score":0.70392233},"labels":[],"label_agreement":null},{"id":"W2568770972","doi":"10.1182/blood.v108.11.2566.2566","title":"Comparison of Different Strategies of MSC Isolation Revels Advantage To Expand MSC Directly from Purified CD105+ and CD271+ Cells.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Mesenchymal stem cell; CD34; Bone marrow; CD44; Stem cell; Population; Biology; Immunology; Haematopoiesis; Antigen; Cell biology; Molecular biology; In vitro; Medicine; Genetics","score_opus":0.026451335655406083,"score_gpt":0.3295560352252365,"score_spread":0.30310469956983044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568770972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895868,0.0014935269,0.00033194188,0.00006624792,0.00004846867,0.0005572806,0.000046262478,0.000023198061,0.007846302],"genre_scores_gemma":[0.997806,0.000065561886,0.0011795174,0.000006304444,0.00009068121,0.000013645071,0.000044720546,0.000019046065,0.00077451376],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99846125,0.00007604099,0.0004881899,0.0002789209,0.00046703752,0.00022854362],"domain_scores_gemma":[0.9990968,0.00022272585,0.00014363066,0.00029528685,0.00011198331,0.00012954035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014590003,0.00015774806,0.0005621021,0.00012966017,0.000032772765,0.00002236762,0.00009069274,0.000094914125,0.00015044889],"category_scores_gemma":[0.000044069613,0.00012816093,0.00005639679,0.00015423732,0.00006594239,0.00006469141,0.00006810891,0.0001401674,0.0000073871865],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015612853,0.00073602545,0.1245265,0.0002598851,0.000047337355,0.000008753352,0.00043577887,0.000006668455,0.8727663,0.00015854108,0.00018219005,0.00071588065],"study_design_scores_gemma":[0.0017753203,0.00049447565,0.179567,0.00019430368,0.00010879447,0.0000017510025,0.0006944209,0.000105140614,0.8165632,0.00020552386,0.0001965385,0.00009354448],"about_ca_topic_score_codex":0.0005490576,"about_ca_topic_score_gemma":0.0001521815,"teacher_disagreement_score":0.056203116,"about_ca_system_score_codex":0.00001752148,"about_ca_system_score_gemma":0.000051324376,"threshold_uncertainty_score":0.5226251},"labels":[],"label_agreement":null},{"id":"W2568820663","doi":"10.1182/blood.v104.11.1567.1567","title":"CD63 Modulates Spreading and Tyrosine Phosphorylation of Platelets on Immobilized Fibrinogen.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Cell biology; Integrin; Tyrosine phosphorylation; Tetraspanin; Platelet; Platelet activation; Biology; Cytoskeleton; Phosphatidylinositol; Phosphorylation; Apyrase; Vinculin; Focal adhesion; Chemistry; Biochemistry; Extracellular; Cell; Immunology","score_opus":0.010832159885782636,"score_gpt":0.23923210769474842,"score_spread":0.22839994780896578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568820663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99706304,0.0011219414,0.000008965787,0.00009943244,0.000026326066,0.0002586204,0.0000092778455,0.000031393698,0.001380985],"genre_scores_gemma":[0.99893415,0.00015942498,0.00070226594,0.000040141564,0.000016210604,0.000006221197,0.000033568274,0.000014755297,0.00009328036],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994143,0.000005930449,0.00015566271,0.00017386397,0.00011765872,0.00013253457],"domain_scores_gemma":[0.99969614,0.000023511035,0.000056168377,0.00013588683,0.000026426183,0.000061881554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000040911385,0.000111560075,0.00025270486,0.00006167227,0.00003460117,0.0000073549336,0.000021335654,0.0000614051,0.00002252454],"category_scores_gemma":[0.00002212918,0.00009219749,0.000045172343,0.00008420371,0.00003131875,0.000041466537,0.000012638157,0.000050540013,0.000012604376],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015763469,0.0071961978,0.13054554,0.0004093217,0.0012331092,0.001294479,0.001058716,0.0007139856,0.83601254,0.003608712,0.000049569586,0.016301483],"study_design_scores_gemma":[0.017231097,0.0010340385,0.0872699,0.00029179925,0.00026478112,0.00024095704,0.000030689298,0.00005759642,0.89210194,0.0012783568,0.000066361456,0.00013246282],"about_ca_topic_score_codex":0.0000762115,"about_ca_topic_score_gemma":0.0000031824861,"teacher_disagreement_score":0.056089424,"about_ca_system_score_codex":0.000016292432,"about_ca_system_score_gemma":0.000020323554,"threshold_uncertainty_score":0.37597045},"labels":[],"label_agreement":null},{"id":"W2568895729","doi":"10.1182/blood.v116.21.3897.3897","title":"Clinical Presentation, Treatment and Outcome of HIV-Associated Multicentric Castleman Disease","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Primary effusion lymphoma; Medicine; Plasmablastic lymphoma; Concomitant; Incidence (geometry); Internal medicine; Lymphoma; Castleman disease; Viral load; Coinfection; Immunology; Gastroenterology; Disease; Human immunodeficiency virus (HIV)","score_opus":0.028189460611409478,"score_gpt":0.34802343909669525,"score_spread":0.3198339784852858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568895729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978975,0.00029065515,0.0000028416823,0.0006605537,0.00013245914,0.0003248504,0.00005644911,0.000030760224,0.000603908],"genre_scores_gemma":[0.99859804,0.0001591333,0.00011322256,0.0001241995,0.00006654696,0.000013366978,0.000058526944,0.000013012604,0.00085392623],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99915504,0.000037691978,0.00033804908,0.0001801372,0.00013173574,0.00015734907],"domain_scores_gemma":[0.99929255,0.000086222375,0.00014421302,0.0001699987,0.00007667447,0.00023033634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011843115,0.00009937032,0.00027777607,0.000047419304,0.000040267507,0.000007575537,0.000032436037,0.000083888364,0.00008207648],"category_scores_gemma":[0.00047504198,0.000078865094,0.00011157982,0.00010532349,0.000071191986,0.000032997377,0.000015020903,0.000110612804,0.000009499455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010033498,0.0020454237,0.99562174,0.000024216624,0.00018733692,0.00002223466,0.00012974108,6.0831815e-7,0.00026957848,0.000031882886,0.00027967227,0.0012872178],"study_design_scores_gemma":[0.016309096,0.0003131556,0.98136914,0.000014882927,0.000996347,0.000002169987,0.000114873714,0.00011491042,0.00016224578,0.000045618926,0.00047662176,0.00008095509],"about_ca_topic_score_codex":0.00016986247,"about_ca_topic_score_gemma":0.00017516428,"teacher_disagreement_score":0.01620876,"about_ca_system_score_codex":0.000020090038,"about_ca_system_score_gemma":0.00008395622,"threshold_uncertainty_score":0.32160252},"labels":[],"label_agreement":null},{"id":"W2568914178","doi":"10.1182/blood.v114.22.2826.2826","title":"Impact of Cytogenetic Abnormalities On Outcome Among Patients with Relapsed/Refractory Multiple Myeloma Treated with Bortezomib: Adverse Effect of 1q21 (CKS1B) Amplification.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Bortezomib; Internal medicine; Fluorescence in situ hybridization; Multiple myeloma; Medicine; Gastroenterology; Refractory (planetary science); Adverse effect; Oncology; Biology; Chromosome","score_opus":0.013155834312164931,"score_gpt":0.27787758362329773,"score_spread":0.2647217493111328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568914178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99756473,0.00006222531,0.000006394616,0.0000066598964,0.000008818625,0.0014071543,0.0001629999,0.000053245516,0.0007277866],"genre_scores_gemma":[0.99918723,0.000014119751,0.0002115917,0.0000094365,0.00002062399,0.00005070812,0.000306844,0.000039456398,0.00015998067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980051,0.00012747152,0.00044658736,0.00034921637,0.00066063175,0.0004110203],"domain_scores_gemma":[0.9982288,0.00023987553,0.0003091477,0.00065832946,0.0002744633,0.0002893835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012618344,0.00034804907,0.00067896815,0.00027615132,0.00006374257,0.00000777264,0.000120537974,0.000106574946,0.000056872144],"category_scores_gemma":[0.00017437866,0.00020016046,0.00019376492,0.0003040431,0.00017560166,0.00011676575,0.000014755592,0.00017968217,0.00001347387],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008267182,0.003481156,0.9836074,0.00011400935,0.00085783325,0.00007723975,0.0001118313,0.00004248806,0.001540583,0.0000029164623,0.000011336784,0.0018860264],"study_design_scores_gemma":[0.033132855,0.028037814,0.913868,0.00024548935,0.0004940449,0.00000991231,0.000020364443,0.00002472114,0.024000267,9.851755e-7,0.0000028381016,0.00016267558],"about_ca_topic_score_codex":0.0005086046,"about_ca_topic_score_gemma":0.000032515618,"teacher_disagreement_score":0.069739364,"about_ca_system_score_codex":0.00010433884,"about_ca_system_score_gemma":0.00010423248,"threshold_uncertainty_score":0.81623065},"labels":[],"label_agreement":null},{"id":"W2568922696","doi":"10.1182/blood.v120.21.627.627","title":"Surgical Injury Alone Does Not Provoke the Development of Factor VIII Inhibitors in Mouse Models of Hemophilia A","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Queen's University","funders":"","keywords":"Medicine; Recombinant factor VIIa; Antibody; Immunology; Coagulopathy; Internal medicine; Pharmacology","score_opus":0.037111875666626284,"score_gpt":0.29930842064792146,"score_spread":0.2621965449812952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568922696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99813193,0.00023605236,0.0000019265358,0.00037604553,0.000042698466,0.00060013484,0.000023178187,0.000014708331,0.0005733049],"genre_scores_gemma":[0.99811894,0.000045983772,0.0005755745,0.000011623652,0.000101056125,0.000044970788,0.000009146847,0.000016584236,0.0010761066],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985408,0.00005562882,0.00044324956,0.00014633774,0.0004810325,0.0003329246],"domain_scores_gemma":[0.99937737,0.00008762321,0.00007403261,0.0002539802,0.000072887895,0.00013412761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003765059,0.00013513443,0.00034671673,0.00013641737,0.00003620887,0.0000035504227,0.000102201106,0.0001041144,0.000052015184],"category_scores_gemma":[0.000044628927,0.00006562867,0.00008162525,0.00018633682,0.00011203466,0.0000835232,0.00009112275,0.00017699893,0.000008762615],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011142595,0.0107706245,0.53300375,0.000650982,0.0004791879,0.00004638224,0.013983755,0.000002414625,0.42786923,0.0002869073,0.000054348602,0.011738152],"study_design_scores_gemma":[0.002951473,0.00015163739,0.015160345,0.00009350426,0.000039016475,0.000008111355,0.000182826,0.000019149698,0.9810321,0.000027438546,0.0002489321,0.00008550722],"about_ca_topic_score_codex":0.00003079103,"about_ca_topic_score_gemma":0.000016822121,"teacher_disagreement_score":0.5531628,"about_ca_system_score_codex":0.00003607619,"about_ca_system_score_gemma":0.00019201105,"threshold_uncertainty_score":0.26762593},"labels":[],"label_agreement":null},{"id":"W2568959487","doi":"10.1182/blood.v110.11.953.953","title":"p53 Deletion Yields High Response Rates but Rapid Progression and Poor Overall Survival in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Autologous stem-cell transplantation; Multiple myeloma; Internal medicine; Transplantation; Surgery; Chemotherapy; Stem cell; Oncology; Bortezomib; Progression-free survival; Plasma cell leukemia; Gastroenterology; Biology","score_opus":0.019399777953256613,"score_gpt":0.27700313114526975,"score_spread":0.25760335319201316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568959487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99813557,0.0003727922,0.00012712902,0.00016126678,0.00008029855,0.0008594359,0.000036814494,0.00006478131,0.00016190659],"genre_scores_gemma":[0.9978805,0.00025398354,0.0013576254,0.000044375418,0.00003815916,0.000033391523,0.00017231147,0.000026716809,0.00019293358],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982213,0.00022416167,0.00033766704,0.00035299372,0.00040513263,0.00045875943],"domain_scores_gemma":[0.9986143,0.0008258332,0.00008705824,0.00016074869,0.000089545385,0.00022253009],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053458096,0.00019689304,0.00026975313,0.0002449721,0.00012221112,0.000027336897,0.0000579795,0.00016281437,0.000020591302],"category_scores_gemma":[0.00012794533,0.00016274866,0.000047271307,0.00015588047,0.000053375126,0.00011712031,0.000027121598,0.00019792176,0.000014428871],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013680803,0.0019551385,0.9192905,0.00028942816,0.00007762984,0.0010763113,0.00043491067,0.000003099453,0.027990762,0.000012514442,0.000011550794,0.035177384],"study_design_scores_gemma":[0.023666594,0.0015668813,0.88920957,0.00020092182,0.00006641941,0.000039264727,0.0000983595,0.00011949435,0.08485354,0.000010728858,0.00003110544,0.00013713389],"about_ca_topic_score_codex":0.00014371876,"about_ca_topic_score_gemma":0.00026688335,"teacher_disagreement_score":0.05686278,"about_ca_system_score_codex":0.0000745701,"about_ca_system_score_gemma":0.00010398098,"threshold_uncertainty_score":0.66366976},"labels":[],"label_agreement":null},{"id":"W2568986691","doi":"10.1182/blood.v122.21.847.847","title":"Gray Zone Lymphoma (GZL) With Features Intermediate Between Classical Hodgkin Lymphoma (cHL) and Diffuse Large B-Cell Lymphoma (DLBCL): A Large Retrospective Multicenter Analysis Of Clinical Characteristics, Treatment, Outcomes, and Prognosis In The Current Era","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; B symptoms; Internal medicine; Diffuse large B-cell lymphoma; Univariate analysis; Lymphoma; Hypoalbuminemia; Stage (stratigraphy); Anemia; Gastroenterology; Retrospective cohort study; International Prognostic Index; Proportional hazards model; Oncology; Multivariate analysis","score_opus":0.015409755426859786,"score_gpt":0.2955500179360719,"score_spread":0.2801402625092121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568986691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99559253,0.0010627923,0.000012361684,0.0006007557,0.00009383655,0.0017811131,0.000726102,0.000048282436,0.00008222626],"genre_scores_gemma":[0.99700236,0.0012549936,0.00023947786,0.00023941079,0.00017451598,0.0005567381,0.00041443366,0.00005179035,0.00006628557],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99623007,0.00036752253,0.0011356276,0.00096761854,0.0005668859,0.0007322779],"domain_scores_gemma":[0.99741536,0.00075443543,0.0005724422,0.0006688745,0.00017701935,0.00041183812],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045177346,0.00065638125,0.002138861,0.00042301437,0.00014044814,0.00013261114,0.00020095844,0.00024254255,0.000020025322],"category_scores_gemma":[0.00017004159,0.00036110147,0.0004839225,0.00060537225,0.00032222125,0.00016657477,0.00016564834,0.00016809558,0.000011503841],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031460155,0.062092572,0.86483413,0.00007931433,0.003598564,0.0001875366,0.0010923975,8.3763885e-9,0.000008256209,0.000051138308,0.000071023715,0.06767044],"study_design_scores_gemma":[0.09863386,0.002309387,0.8883432,0.0001678718,0.009183972,0.000026231828,0.000225337,0.000115970266,0.00019870786,0.000008701169,0.0004707298,0.00031602246],"about_ca_topic_score_codex":0.00047403303,"about_ca_topic_score_gemma":0.000690805,"teacher_disagreement_score":0.09831926,"about_ca_system_score_codex":0.00021987651,"about_ca_system_score_gemma":0.00016804611,"threshold_uncertainty_score":0.99988407},"labels":[],"label_agreement":null},{"id":"W2569011903","doi":"10.1182/blood.v124.21.4154.4154","title":"The F-BAR Protein PACSIN2 Regulates Platelet Intracellular Membrane Architecture and in Vivo Hemostatic Functions","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Platelet; Megakaryocyte; Cell biology; Thrombin; GPVI; Ex vivo; Chemistry; Thrombus; P-selectin; Platelet activation; Integrin; Von Willebrand factor; In vivo; Molecular biology; Biology; Biophysics; Internal medicine; Receptor; Immunology; Biochemistry; Medicine; Haematopoiesis","score_opus":0.004965848285390238,"score_gpt":0.20052344168566083,"score_spread":0.1955575934002706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2569011903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994432,0.00088340713,0.000040691506,0.002748104,0.000027571252,0.00057977985,0.0000069996913,0.000038148795,0.001243326],"genre_scores_gemma":[0.9977771,0.000058584115,0.00039761534,0.00011386781,0.000030984986,0.00005422848,0.000015807653,0.000019007832,0.0015328235],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99921966,0.00004686011,0.00016362999,0.0002004356,0.00012946986,0.00023993563],"domain_scores_gemma":[0.9995356,0.00009408597,0.000041750467,0.00022598899,0.000018669902,0.00008387317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013722174,0.00014001058,0.00021903517,0.000053861673,0.0001352913,0.000029802652,0.000043853972,0.00006891005,0.000036601574],"category_scores_gemma":[0.0000900975,0.00008713015,0.000034582798,0.00011734604,0.00008381749,0.000028315852,0.000019514118,0.00016551357,0.000015942216],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026195336,0.007561165,0.033492927,0.0011439475,0.0022109565,0.0037848153,0.0035849805,0.00023204398,0.76760644,0.0025343546,0.002187262,0.17304158],"study_design_scores_gemma":[0.04380779,0.0023478665,0.017916355,0.0008644803,0.00083636504,0.00280539,0.0007782736,0.0014105772,0.80180395,0.012211501,0.11432538,0.000892104],"about_ca_topic_score_codex":0.00004356768,"about_ca_topic_score_gemma":0.000115095514,"teacher_disagreement_score":0.17214948,"about_ca_system_score_codex":0.000009035245,"about_ca_system_score_gemma":0.000028049359,"threshold_uncertainty_score":0.35530645},"labels":[],"label_agreement":null},{"id":"W2569021476","doi":"10.1182/blood.v120.21.3571.3571","title":"Preclinical Evaluation of Oncolytic Reovirus in Targeted Therapeutics for High-Risk Pediatric Leukemia","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Leukemia; Medicine; Oncology; Oncolytic virus; Internal medicine; Childhood leukemia; Immunology; Cancer research; Cancer; Lymphoblastic Leukemia","score_opus":0.05963792880105665,"score_gpt":0.37387213976077655,"score_spread":0.3142342109597199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2569021476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99395275,0.0050436235,0.00007833759,0.00002035626,0.00010484726,0.0006774935,0.000041221487,0.0000061446644,0.000075233445],"genre_scores_gemma":[0.99780905,0.00075220846,0.0005625622,0.000053251795,0.000535486,0.00013288659,0.00008043658,0.0000270557,0.000047054597],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984916,0.00033548844,0.00031933244,0.00022021141,0.00031663687,0.00031673932],"domain_scores_gemma":[0.9991493,0.000090304035,0.0001388079,0.00035325886,0.00020103555,0.00006729843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023969214,0.000113180104,0.00016357469,0.00007544946,0.00003293434,0.0000056666267,0.00017474868,0.00020226593,0.000024794079],"category_scores_gemma":[0.00036172214,0.00010780285,0.00008186387,0.00015126912,0.000038522074,0.000004604857,0.000044347402,0.00012039044,0.0000067800665],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026957225,0.0016356254,0.25237948,0.00006880971,0.00028150133,3.519559e-7,0.00017278478,0.00059379596,0.71789885,0.000029684197,0.00020414579,0.024039224],"study_design_scores_gemma":[0.008113573,0.003296122,0.05976998,0.0000054574753,0.0004627344,0.0000013845997,0.000021645074,0.0005909251,0.9268517,0.00029120548,0.0003917988,0.00020349846],"about_ca_topic_score_codex":0.000027573094,"about_ca_topic_score_gemma":0.00010970052,"teacher_disagreement_score":0.2089528,"about_ca_system_score_codex":0.000044961424,"about_ca_system_score_gemma":0.00045749082,"threshold_uncertainty_score":0.43960726},"labels":[],"label_agreement":null},{"id":"W2569063670","doi":"10.1182/blood.v108.11.1081.1081","title":"PRTX-100 Inhibits Platelet Phagocytosis In Vitro.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"ASTER","funders":"","keywords":"Phagocytosis; Platelet; Biology; Population; Molecular biology; Monocyte; Antigen; Microbiology; Immunology; Medicine","score_opus":0.00934703862432661,"score_gpt":0.23542163722560094,"score_spread":0.22607459860127432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2569063670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98304105,0.00081226305,0.0000025305387,0.0002642614,0.000033918874,0.00026507626,0.00001693933,0.000057842903,0.015506113],"genre_scores_gemma":[0.9982908,0.000036141355,0.00038908093,0.00018696695,0.000069147194,0.000027512302,0.00011311904,0.000019851577,0.0008673833],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991647,0.000012072188,0.00019187789,0.0002119933,0.0001529387,0.00026642674],"domain_scores_gemma":[0.9997134,0.000018882036,0.000036510588,0.00015465,0.000018250157,0.000058303598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004420465,0.00013418979,0.00027414574,0.00011573605,0.000029734774,0.00001105203,0.000038700335,0.00008441367,0.000059435726],"category_scores_gemma":[0.000011139584,0.00011492079,0.00006129529,0.00020582195,0.000020922731,0.00005386064,0.00001773733,0.00010485447,0.0001306624],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00156847,0.03326258,0.31615263,0.00030354538,0.00077215576,0.021461759,0.00052645995,0.00002158577,0.5831319,0.00041384946,0.0063122944,0.036072757],"study_design_scores_gemma":[0.021242138,0.00023959782,0.049047977,0.00007738261,0.00016212153,0.0004990633,0.000029323804,0.000028696202,0.9243416,0.0004310503,0.003689545,0.00021149257],"about_ca_topic_score_codex":0.00036638367,"about_ca_topic_score_gemma":0.00007391077,"teacher_disagreement_score":0.3412097,"about_ca_system_score_codex":0.000026953363,"about_ca_system_score_gemma":0.00003736243,"threshold_uncertainty_score":0.46863338},"labels":[],"label_agreement":null},{"id":"W2569130568","doi":"10.1182/blood.v108.11.4058.4058","title":"Aberration of Coagulation Parameters with a Small Dose of Hydroxyethyl Starch in a Patient with Underlying Factor XII Deficiency: A Case Report.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Hydroxyethyl starch; Partial thromboplastin time; Medicine; Anesthesia; Thrombin time; Activated clotting time; Prothrombin time; Coagulation; Heparin; Coagulopathy; Hemostasis; Surgery; Fibrinogen; Internal medicine","score_opus":0.03574230271073546,"score_gpt":0.2592156483780883,"score_spread":0.22347334566735283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2569130568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99789256,0.0002717662,0.00088555913,0.000049203278,0.000018609839,0.0006249277,0.00001017181,0.000026578591,0.00022065222],"genre_scores_gemma":[0.9939496,0.0000027291499,0.005887404,0.000013097935,0.000011277187,0.000022269209,0.000061318766,0.000020638967,0.000031690455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857885,0.000038764007,0.00057782646,0.00026917903,0.00033417396,0.0002012272],"domain_scores_gemma":[0.99900705,0.00009121898,0.00041507394,0.00027390325,0.00015734609,0.000055407465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013905755,0.0001548378,0.00033164045,0.00021195135,0.00004285504,0.00000987918,0.000031828095,0.00007057174,0.00000991403],"category_scores_gemma":[0.000042478947,0.00011969929,0.000052734904,0.0004095069,0.00009269332,0.000090218,0.000011473041,0.00008387833,3.359093e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012688343,0.0029282006,0.9485463,0.00046227121,0.00012409336,0.010257989,0.0074571106,0.004781099,0.018881513,0.00031890144,0.000004286162,0.0049693957],"study_design_scores_gemma":[0.012915882,0.0059036915,0.8853567,0.0009559619,0.0005735952,0.018158196,0.0018668986,0.0038999363,0.06946559,0.00040229945,0.000018100347,0.00048314797],"about_ca_topic_score_codex":0.0051602214,"about_ca_topic_score_gemma":0.004222051,"teacher_disagreement_score":0.06318961,"about_ca_system_score_codex":0.00003942378,"about_ca_system_score_gemma":0.00020532814,"threshold_uncertainty_score":0.78007454},"labels":[],"label_agreement":null},{"id":"W2569180813","doi":"10.1182/blood.v124.21.4894.4894","title":"Hydroxyurea for β-Thalassemia Major: A Meta-Analysis","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Medicine; Observational study; Thalassemia; Anemia; Clinical trial; Meta-analysis; Randomized controlled trial; Internal medicine; Blood transfusion; Sample size determination; Pediatrics; Intensive care medicine","score_opus":0.022272217565540993,"score_gpt":0.26689308302156295,"score_spread":0.24462086545602196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2569180813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8634142,0.010655423,0.01423493,0.012612518,0.00022903767,0.0020999566,0.000085170155,0.00048452467,0.09618419],"genre_scores_gemma":[0.9929857,0.000027944123,0.0021499828,0.0008560253,0.00007603052,0.000075993434,0.00005434916,0.000022418211,0.003751531],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99907416,0.000029266792,0.00022866276,0.00025261915,0.00017189239,0.00024341652],"domain_scores_gemma":[0.9992682,0.00008618485,0.00006522454,0.0003775093,0.000065824424,0.00013711196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026264763,0.0001412718,0.00070994557,0.00014138484,0.000067840134,0.000014281368,0.00007355062,0.00014579682,0.00030004527],"category_scores_gemma":[0.00012197055,0.0000953353,0.0012722188,0.00036126745,0.00002960914,0.000024566598,0.000017559907,0.00011308553,0.00005663598],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017176129,0.0029850958,0.019048734,0.00039716787,0.9482421,0.000051707964,0.0005390846,0.00016813524,0.009123606,0.0050070817,0.012455094,0.0018103794],"study_design_scores_gemma":[0.0043414123,0.00036567973,0.0011854406,0.0000042224437,0.9414471,0.000029862664,0.00006873125,0.001260761,0.0042258836,0.00054295117,0.046312705,0.0002152897],"about_ca_topic_score_codex":0.000033616187,"about_ca_topic_score_gemma":0.000016806029,"teacher_disagreement_score":0.12957147,"about_ca_system_score_codex":0.0000067058036,"about_ca_system_score_gemma":0.000025779727,"threshold_uncertainty_score":0.38876608},"labels":[],"label_agreement":null},{"id":"W2569186978","doi":"10.1182/blood.v116.21.874.874","title":"Liver Fibrosis In Myeloid Leukemia of Down Syndrome","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Hospital for Sick Children","funders":"","keywords":"Acute megakaryoblastic leukemia; Medicine; Leukemia; Myeloid leukemia; Immunology; Myeloid; Population; GATA1; Cancer research; Pathology; Internal medicine; Anemia","score_opus":0.011227144689095123,"score_gpt":0.2565122409598603,"score_spread":0.24528509627076517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2569186978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924912,0.00013399225,0.0000042430815,0.00023224059,0.00006522765,0.00031659944,0.00001292603,0.000038935872,0.006704642],"genre_scores_gemma":[0.9958337,0.0000773276,0.002499521,0.00009387708,0.00008568615,0.000023977516,0.000014530385,0.000028095074,0.0013433172],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987141,0.000030311761,0.00028680288,0.00026005376,0.00035882177,0.00034989574],"domain_scores_gemma":[0.99906784,0.00011121946,0.00005762305,0.0005110046,0.0000899011,0.00016241724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030061437,0.00013375493,0.00034652566,0.00025912875,0.000024356123,0.000008769812,0.00020093769,0.00020261794,0.0007687456],"category_scores_gemma":[0.0002494519,0.000116265284,0.00008986693,0.0004060767,0.00014426482,0.00007777575,0.00011539227,0.00070807885,0.0002049226],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020666509,0.0006751262,0.11022764,0.0003715574,0.00012123183,0.0013007639,0.00045024938,0.0000017590362,0.8818757,0.00036197467,0.0012480608,0.0031592522],"study_design_scores_gemma":[0.0072639612,0.0005226074,0.7274041,0.00016501758,0.00012001211,0.0013724398,0.000069498055,0.00015547202,0.25961313,0.00007847635,0.0030337786,0.0002015014],"about_ca_topic_score_codex":0.000571413,"about_ca_topic_score_gemma":0.00011948139,"teacher_disagreement_score":0.6222626,"about_ca_system_score_codex":0.00010406127,"about_ca_system_score_gemma":0.00050247443,"threshold_uncertainty_score":0.8417225},"labels":[],"label_agreement":null},{"id":"W2569189109","doi":"10.1182/blood-2016-06-720714","title":"Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":227,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Podoplanin; Medicine; Platelet; Venous thrombosis; Internal medicine; Hazard ratio; Pathology; Hematology; Immunohistochemistry; Oncology; Cancer; Thrombosis; Confidence interval; Gastroenterology","score_opus":0.01192329839516186,"score_gpt":0.2502188702516028,"score_spread":0.2382955718564409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2569189109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965113,0.0015857538,0.0000017498213,0.00005410535,0.00003498608,0.00026417783,0.00003603461,0.000019173729,0.0014927612],"genre_scores_gemma":[0.9994714,0.00011925095,0.00017509866,0.000060205744,0.000096400705,0.000011307282,0.000027880556,0.000011195595,0.000027220083],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992368,0.00006798816,0.00022939044,0.00016684708,0.0001800157,0.00011894144],"domain_scores_gemma":[0.9991365,0.00014454254,0.00028221714,0.0003151566,0.00002847513,0.0000931103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019123554,0.000100124176,0.00036648344,0.00008173058,0.00009691758,0.000023615868,0.000081382925,0.00006845789,0.000013508154],"category_scores_gemma":[0.0007367192,0.00007884786,0.000032233846,0.000031864573,0.00008053594,0.00013192317,0.000058433714,0.000024334702,0.0000030131478],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000160285,0.0016025719,0.94504714,0.0005021116,0.000066694774,0.00019807315,0.0008192737,5.774582e-7,0.042065322,0.000023313742,0.00021234812,0.009302264],"study_design_scores_gemma":[0.004415026,0.00016202012,0.91136307,0.0011241615,0.00010951611,0.00010113588,0.00017594872,0.0000043446703,0.082267135,0.00019042935,0.000009963875,0.000077258315],"about_ca_topic_score_codex":0.00069565175,"about_ca_topic_score_gemma":0.000016482418,"teacher_disagreement_score":0.040201813,"about_ca_system_score_codex":0.0000133613285,"about_ca_system_score_gemma":0.00011576893,"threshold_uncertainty_score":0.32153222},"labels":[],"label_agreement":null},{"id":"W2569224204","doi":"10.1182/blood.v106.11.1720.1720","title":"New Fine Structure within the Adult Hematopoietic Stem Cell Compartment Revealed by Longterm Analysis of Mice Repopulated with Single Cells or Their In Vitro Generated Clonal Progeny.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Haematopoiesis; Biology; Myeloid; Stem cell; Immunology; In vitro; Transplantation; In vivo; Repopulation; Molecular biology; Andrology; Cell biology; Genetics; Internal medicine; Medicine","score_opus":0.011982437898916126,"score_gpt":0.22394923685687368,"score_spread":0.21196679895795756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2569224204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99762243,0.00044822288,0.0003136924,0.00026802398,0.00003121203,0.0010353451,0.0001558485,0.00004798083,0.00007724731],"genre_scores_gemma":[0.99143124,0.000011756516,0.0073186085,0.0001608923,0.000045076467,0.000021489963,0.00049463264,0.00003990392,0.00047640124],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99775904,0.00014062307,0.00089542766,0.00043812784,0.00046391014,0.00030287047],"domain_scores_gemma":[0.99863404,0.00010180086,0.00043659937,0.0005035687,0.00016506489,0.0001589063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001743848,0.00032061912,0.00079419644,0.00019098344,0.000048391154,0.000023552897,0.00016773227,0.00014021549,0.00011896491],"category_scores_gemma":[0.0000054735174,0.00018188081,0.00011937788,0.0012641683,0.000055715096,0.000049872502,0.000016028,0.00022552199,0.0000039681913],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013340652,0.0011497699,0.011838681,0.0003346348,0.0011683088,0.00010707507,0.004106406,0.0013788752,0.9781925,0.0000062867384,0.00017212373,0.0002112415],"study_design_scores_gemma":[0.0058883494,0.0003297394,0.0023389973,0.00020727918,0.0027006294,0.00022532087,0.00037211794,0.0019598468,0.98573405,0.0000027857184,0.000029484025,0.0002113796],"about_ca_topic_score_codex":0.0001208646,"about_ca_topic_score_gemma":0.0007831109,"teacher_disagreement_score":0.009499684,"about_ca_system_score_codex":0.00006632053,"about_ca_system_score_gemma":0.00018283608,"threshold_uncertainty_score":0.74168843},"labels":[],"label_agreement":null},{"id":"W2569267893","doi":"10.1182/blood.v104.11.70.70","title":"Phase III Prospective Randomized Trial of EPO with or without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes (MDS): Results of the ECOG- CLSG Trial(E1996).","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada","funders":"","keywords":"Medicine; Myelodysplastic syndromes; Granulocyte colony-stimulating factor; Internal medicine; Erythropoietin; Anemia; Gastroenterology; Randomized controlled trial; Acute leukemia; Bone marrow; Leukemia; Chemotherapy","score_opus":0.031283388758838515,"score_gpt":0.32502883974144947,"score_spread":0.29374545098261096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2569267893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889858,0.00015810973,0.00001117468,0.0002846756,0.0002810758,0.0088726925,0.00007488099,0.000013809049,0.0013177801],"genre_scores_gemma":[0.99825495,0.00043845654,0.00006091634,0.000017063776,0.00012814757,0.0008822718,0.000012489915,0.000019847112,0.00018584289],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980489,0.0002674998,0.0008107361,0.00027101327,0.0004049885,0.00019688159],"domain_scores_gemma":[0.9979538,0.0007124811,0.0006364374,0.0004918303,0.0001580722,0.00004740307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045904572,0.00022758056,0.0012933067,0.000110304114,0.00005858929,0.00000759951,0.0001313965,0.000072368886,0.000035292443],"category_scores_gemma":[0.00022296037,0.00009373686,0.00030550052,0.000488727,0.0003917916,0.000056088782,0.000010355848,0.0001277656,9.919578e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9738722,0.018327616,0.00018363597,0.000021886297,0.0013695748,0.000036105546,0.004745588,0.000016312099,0.0009525146,0.00010693938,0.0000075942485,0.00036007594],"study_design_scores_gemma":[0.8788264,0.057251498,0.0003422699,0.00014713974,0.0017225357,0.000054562734,0.0005988229,0.0000013395212,0.06084811,0.00007419888,0.000044497552,0.00008862737],"about_ca_topic_score_codex":0.00084902317,"about_ca_topic_score_gemma":0.00066759915,"teacher_disagreement_score":0.09504576,"about_ca_system_score_codex":0.00008924553,"about_ca_system_score_gemma":0.00071832596,"threshold_uncertainty_score":0.3822478},"labels":[],"label_agreement":null},{"id":"W2569292446","doi":"10.1182/blood.v116.21.2454.2454","title":"Fludarabine and Rituximab (FR) Is a Safe and Effective Treatment Alternative for Relapsed or Refractory Hairy Cell Leukemia (HCL)","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Fludarabine; Medicine; Cladribine; Rituximab; Tolerability; Internal medicine; Gastroenterology; Refractory (planetary science); Neutropenia; Surgery; Oncology; Lymphoma; Adverse effect; Chemotherapy; Cyclophosphamide","score_opus":0.014138254240143963,"score_gpt":0.29616663364564494,"score_spread":0.28202837940550096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2569292446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994144,0.0009367719,0.000041528463,0.00024802366,0.00014921454,0.0022259003,0.00008423268,0.000054819277,0.0021155088],"genre_scores_gemma":[0.9903873,0.00053524063,0.0030203147,0.00021742568,0.00043315528,0.0004441718,0.000030685675,0.00006246745,0.004869226],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99833137,0.00005179922,0.0002582062,0.0006146754,0.00029683323,0.00044709074],"domain_scores_gemma":[0.99815667,0.0008159946,0.00009479939,0.00045719233,0.00014553785,0.00032983476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002599166,0.00029909733,0.0005400339,0.00013431624,0.00013735879,0.000037630572,0.00009011052,0.00021879097,0.000095758216],"category_scores_gemma":[0.0003189955,0.00020896106,0.00009426932,0.000115711024,0.0002540402,0.00010188655,0.00008980762,0.00033043034,0.000029926172],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038315285,0.02672368,0.004401934,0.0055735847,0.0051630302,0.0043017566,0.025352094,0.00000271245,0.5566825,0.0007574362,0.011423836,0.32130215],"study_design_scores_gemma":[0.4832844,0.010615515,0.002562645,0.00025089763,0.0012155033,0.0012230386,0.00029718477,0.004332877,0.45363817,0.0003332677,0.04169513,0.000551345],"about_ca_topic_score_codex":0.0007929095,"about_ca_topic_score_gemma":0.00020132425,"teacher_disagreement_score":0.44496912,"about_ca_system_score_codex":0.0027482244,"about_ca_system_score_gemma":0.0027832699,"threshold_uncertainty_score":0.8521185},"labels":[],"label_agreement":null},{"id":"W2569343261","doi":"10.1182/blood.v120.21.432.432","title":"Lille Scoring System Rather Than DIPSS Is a Better Predictive of Overall Mortality After Allogeneic Hematopoietic Cell Transplantation (HCT) for Primary Myelofibrosis Using Reduced Intensity Conditioning: A Report From the Center for International Blood and Marrow Transplant Research (CIBMTR)","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Cumulative incidence; Internal medicine; Busulfan; Fludarabine; Myelofibrosis; Transplantation; International Prognostic Scoring System; Melphalan; Hematopoietic cell; Confidence interval; Hematopoietic stem cell transplantation; Incidence (geometry); Gastroenterology; Surgery; Chemotherapy; Haematopoiesis; Bone marrow; Cyclophosphamide; Stem cell; Myelodysplastic syndromes","score_opus":0.043626951125734184,"score_gpt":0.30639597598328255,"score_spread":0.2627690248575484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2569343261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940247,0.00044185456,0.00084556243,0.0002659363,0.00024397268,0.002014108,0.002032431,0.000021543636,0.00010986833],"genre_scores_gemma":[0.995672,0.000079193785,0.0020393108,0.0001655837,0.00043347204,0.00082069007,0.0007283611,0.00003617339,0.000025239808],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982335,0.00009969151,0.0004925941,0.0004208815,0.00041915322,0.0003341953],"domain_scores_gemma":[0.9985365,0.00033304296,0.00019341843,0.0002744039,0.0005414679,0.0001211573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005409291,0.00021759204,0.00042053696,0.000078545796,0.00016089254,0.00003587579,0.00007751239,0.000114012044,0.000022970547],"category_scores_gemma":[0.00004506171,0.00015631718,0.0001899775,0.00006187053,0.00010265013,0.00015276839,0.000028819384,0.00013663356,6.7031687e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014171214,0.0011874898,0.93227446,0.0007512756,0.0012835227,0.000048106212,0.005340537,0.0000012427964,0.057589423,0.00002150629,0.000067941386,0.00001738588],"study_design_scores_gemma":[0.005467915,0.00029646515,0.6853502,0.0010140652,0.0019687077,0.00025527322,0.0003174805,0.000058508023,0.30505648,0.00004020791,0.000037125425,0.00013757191],"about_ca_topic_score_codex":0.0001406672,"about_ca_topic_score_gemma":0.000017733546,"teacher_disagreement_score":0.24746707,"about_ca_system_score_codex":0.000081451115,"about_ca_system_score_gemma":0.000075456235,"threshold_uncertainty_score":0.637443},"labels":[],"label_agreement":null},{"id":"W2569366072","doi":"10.1182/blood.v116.21.1836.1836","title":"Clioquinol Arrests Cell Cycle at G1 Phase and Triggers Intrinsic Apoptosis In Myeloma and Leukemia Cells by Inhibiting Histone Deacetylases","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Clioquinol; Cancer research; Programmed cell death; Apoptosis; Chemistry; Vorinostat; Histone; Histone deacetylase; Pharmacology; Biology; Biochemistry; DNA","score_opus":0.004808900546495452,"score_gpt":0.2552840271920218,"score_spread":0.25047512664552635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2569366072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99667895,0.0021061164,0.000005521433,0.00006819098,0.00011085248,0.00032096283,0.000073758965,0.000022536726,0.000613139],"genre_scores_gemma":[0.99818534,0.0004755963,0.00032520335,0.000063522755,0.00020169278,0.00004434593,0.00010096737,0.000049523125,0.0005537821],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99818796,0.00008781704,0.000343844,0.0006635915,0.00021136415,0.0005053958],"domain_scores_gemma":[0.9991881,0.00005522665,0.00011005201,0.00032297967,0.000050975217,0.0002726587],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002812864,0.00026622857,0.00026674205,0.00014932887,0.00016463858,0.000046299316,0.00015129059,0.0003107887,0.000023652981],"category_scores_gemma":[0.0001285189,0.00028820417,0.000059499722,0.0001665987,0.00031982077,0.000012641324,0.00028456427,0.0003813888,0.000016277834],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011143228,0.0002966718,0.0006531668,0.0000611278,0.000016227888,0.000021005182,0.00011734256,0.000001543061,0.9910682,0.0000019207343,0.0028064812,0.0048448825],"study_design_scores_gemma":[0.0058668656,0.00030991645,0.00014428192,0.00002486108,0.000026622154,0.0000438522,0.000056857418,0.000024855748,0.98511195,0.000003620827,0.0080640735,0.00032223266],"about_ca_topic_score_codex":0.0001773466,"about_ca_topic_score_gemma":0.00034552164,"teacher_disagreement_score":0.005956238,"about_ca_system_score_codex":0.00006468579,"about_ca_system_score_gemma":0.00012274185,"threshold_uncertainty_score":0.999957},"labels":[],"label_agreement":null},{"id":"W2569410523","doi":"10.1182/blood.v126.23.2252.2252","title":"Eculizumab Prevents Thrombotic Microangiopathy: Long-Term Follow-up Study of Patients with Atypical Hemolytic Uremic Syndrome","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Eculizumab; Thrombotic microangiopathy; Medicine; Discontinuation; Atypical hemolytic uremic syndrome; Renal function; Internal medicine; Gastroenterology; Surgery; Pediatrics; Immunology; Complement system; Antibody","score_opus":0.019260734970458597,"score_gpt":0.24187659801210276,"score_spread":0.22261586304164416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2569410523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971192,0.00076806545,0.0000108827235,0.0000054400884,0.0004502553,0.0014669442,0.00006769259,0.0000647622,0.0000467693],"genre_scores_gemma":[0.99940115,9.2479763e-7,0.00001659935,0.000012556228,0.000011486105,0.00006212068,0.00021935045,0.000031729265,0.00024409493],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983572,0.00026193183,0.00046048695,0.00040563403,0.00014507897,0.00036970008],"domain_scores_gemma":[0.99890834,0.000052838725,0.0002353246,0.0005894717,0.00014539654,0.0000686438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012423588,0.00025725874,0.0005111996,0.000105051615,0.00007356467,0.000011819125,0.00039954646,0.00010436573,0.00017808654],"category_scores_gemma":[0.00005520416,0.00021014725,0.000093072136,0.00015673452,0.00009501057,0.000084915075,0.00019551831,0.0001251582,0.00019508436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007249307,0.008164261,0.98795146,0.00007339895,0.0008911585,0.00005009675,0.000670395,0.0000021322933,0.0010773452,0.000006356605,0.00033574732,0.000052730837],"study_design_scores_gemma":[0.025776241,0.0031351694,0.96779174,0.00017641301,0.00084260013,0.00010532511,0.00030762152,1.9905309e-7,0.0015885518,0.000016273687,0.000012649353,0.0002472107],"about_ca_topic_score_codex":0.000034325265,"about_ca_topic_score_gemma":0.000056291312,"teacher_disagreement_score":0.025051309,"about_ca_system_score_codex":0.000051524235,"about_ca_system_score_gemma":0.00010702034,"threshold_uncertainty_score":0.85695565},"labels":[],"label_agreement":null},{"id":"W2569629089","doi":"10.1182/blood.v104.11.3203.3203","title":"Novel Iron Chelators Alleviate Symptoms of Thalassemia.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University","funders":"","keywords":"Deferiprone; Thalassemia; Deferoxamine; Chemistry; Methemoglobin; Red blood cell; Oxidative stress; Pharmacology; Hemoglobin; Spleen; In vivo; Biochemistry; Internal medicine; Immunology; Medicine; Biology","score_opus":0.006524575535930644,"score_gpt":0.22298560542166662,"score_spread":0.21646102988573598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2569629089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871184,0.001151317,0.00008776802,0.0005122289,0.00009331558,0.0001782437,0.0000050402173,0.000057237594,0.010796409],"genre_scores_gemma":[0.99868184,0.00019279911,0.0005723715,0.00016642336,0.00004587513,0.000004271646,0.000009531968,0.000021428214,0.0003054481],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99922323,0.0000049203863,0.00022138022,0.00016064776,0.00018674646,0.00020308823],"domain_scores_gemma":[0.99954677,0.000011308293,0.00007030981,0.00022303594,0.00004047074,0.00010809395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007136727,0.0001157764,0.00022679676,0.000059978087,0.000029621198,0.0000035871828,0.00006322117,0.00016591394,0.000047364483],"category_scores_gemma":[0.000038073453,0.000090302994,0.00010852725,0.00016141715,0.00006341012,0.000031012572,0.000025873644,0.00017017178,0.00004666692],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024810285,0.013595086,0.12064817,0.0012330816,0.0015372281,0.00028542476,0.0034168034,0.00074686203,0.8399794,0.0087530445,0.0004455876,0.009111178],"study_design_scores_gemma":[0.114740536,0.0054365527,0.2617312,0.003188052,0.004206398,0.001983817,0.0021600735,0.000104202816,0.5914094,0.0013228734,0.012171999,0.0015449186],"about_ca_topic_score_codex":0.00006726968,"about_ca_topic_score_gemma":0.0000028932918,"teacher_disagreement_score":0.24857007,"about_ca_system_score_codex":0.000019704776,"about_ca_system_score_gemma":0.00009724369,"threshold_uncertainty_score":0.36824492},"labels":[],"label_agreement":null},{"id":"W2569641842","doi":"10.1182/blood.v114.22.4270.4270","title":"Non-Adherence to Imatinib in Chronic Myeloid Leukemia Patients Is Associated with a Short Term and Long Term Negative Impact On Healthcare Utilization and Costs.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Imatinib; Discontinuation; Medical prescription; Internal medicine; Imatinib mesylate; Emergency medicine; Nilotinib; Medicare Advantage; Health care; Retrospective cohort study; Emergency department; Myeloid leukemia; Pharmacology","score_opus":0.021770386798016392,"score_gpt":0.3115423220825145,"score_spread":0.2897719352844981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2569641842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976049,0.0002435288,0.000003773309,0.00011926391,0.000015788362,0.0015973598,0.000060703733,0.000040448787,0.00031421744],"genre_scores_gemma":[0.99897003,0.00015328395,0.00008225366,0.00044329462,0.000031810618,0.000050531213,0.00018138568,0.000028062559,0.000059333513],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984289,0.000042308675,0.00029975577,0.00049216306,0.00032483798,0.00041207895],"domain_scores_gemma":[0.99916995,0.00006402175,0.00010934341,0.00026299446,0.00011026464,0.0002834106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009330193,0.00030971554,0.0004505249,0.00016221513,0.00007495509,0.00003387015,0.00006202059,0.00013755569,0.000024239243],"category_scores_gemma":[0.00008239658,0.00023732742,0.000033702774,0.0003493058,0.000047145455,0.00012314405,0.00003120771,0.0002351138,0.00000572478],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034478653,0.00045327478,0.9438685,0.00006122097,0.0001116164,0.000083171195,0.0015641513,0.0000027545434,0.0005480758,0.000001401291,0.00004428584,0.052916724],"study_design_scores_gemma":[0.012876466,0.008866106,0.97158265,0.0019006042,0.00012218425,0.000026020209,0.000038781614,0.0001345822,0.0042407545,0.000005393087,8.983128e-7,0.00020557527],"about_ca_topic_score_codex":0.00037414432,"about_ca_topic_score_gemma":0.0007039177,"teacher_disagreement_score":0.052711148,"about_ca_system_score_codex":0.0041152756,"about_ca_system_score_gemma":0.00075202837,"threshold_uncertainty_score":0.99970776},"labels":[],"label_agreement":null},{"id":"W2569660516","doi":"10.1182/blood.v112.11.1560.1560","title":"The Efficacy and Safety of Lenalidomide Oral Monotherapy in Patients with Mantle Cell Lymphoma Previously Treated with Bortezomib: Pooled Data from Two Phase II Studies (NHL-002 and NHL-003).","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Lenalidomide; Bortezomib; Medicine; Mantle cell lymphoma; Internal medicine; Thalidomide; Gastroenterology; Regimen; Multiple myeloma; Phases of clinical research; Proteasome inhibitor; Progressive disease; Oncology; Surgery; Lymphoma; Clinical trial; Chemotherapy","score_opus":0.030769926103399917,"score_gpt":0.3065380049983145,"score_spread":0.2757680788949146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2569660516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99125487,0.0071485587,0.0000048522747,0.000082107144,0.00001052609,0.0012746368,0.00010270244,0.000026254373,0.000095472635],"genre_scores_gemma":[0.9950265,0.0040679774,0.00039231678,0.000048119335,0.000040136067,0.000021138956,0.00016074919,0.000046186957,0.00019683804],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99811673,0.0001147401,0.00040431682,0.0005183506,0.00046871472,0.0003771594],"domain_scores_gemma":[0.9982486,0.000417525,0.00016178029,0.0008857243,0.00014812633,0.00013826234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027189587,0.00025936225,0.0006015884,0.000082264036,0.00020568531,0.000017537046,0.0002308956,0.000058398236,0.000011244004],"category_scores_gemma":[0.00010798046,0.0001450771,0.000019745909,0.00027739425,0.00050273514,0.00013027548,0.00021776611,0.00010953626,0.0000018935518],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1585,0.02923047,0.7323937,0.0005950756,0.0075957766,0.001690461,0.012749539,0.000031666827,0.0024495858,0.000019229277,0.00186499,0.05287951],"study_design_scores_gemma":[0.8566537,0.0047847503,0.12694357,0.00048793436,0.0008647918,0.00010399752,0.000430746,0.0012219214,0.0076709837,0.0000094598045,0.0005092699,0.0003189044],"about_ca_topic_score_codex":0.0015996237,"about_ca_topic_score_gemma":0.0004890387,"teacher_disagreement_score":0.6981537,"about_ca_system_score_codex":0.0004041774,"about_ca_system_score_gemma":0.0011563555,"threshold_uncertainty_score":0.5916072},"labels":[],"label_agreement":null},{"id":"W2569685357","doi":"10.1182/blood.v104.11.4890.4890","title":"t(11;14) Is Infrequent in Long-Term Myeloma Survivors.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Multiple myeloma; Fluorescence in situ hybridization; Chromosomal translocation; Internal medicine; Median follow-up; Progression-free survival; Medicine; Gastroenterology; Chemotherapy; Surgery; Biology; Chromosome; Gene; Genetics","score_opus":0.022830824758873648,"score_gpt":0.30244504997380117,"score_spread":0.2796142252149275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2569685357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99487585,0.000596534,0.000018789864,0.00083519885,0.000059402562,0.00050691684,0.000016555827,0.00005533968,0.0030354103],"genre_scores_gemma":[0.9981768,0.0001639252,0.00044926206,0.00025449952,0.0000926562,0.000053404758,0.000058955768,0.000024998157,0.00072548294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998586,0.000028360128,0.00023437596,0.00029594605,0.00039801642,0.0004572819],"domain_scores_gemma":[0.99922156,0.000028055636,0.000035896086,0.00037947996,0.000059336446,0.00027569346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000115528244,0.00016564308,0.00026170272,0.0001834696,0.000042629257,0.000021502294,0.00010366774,0.00009358875,0.00031972348],"category_scores_gemma":[0.00007965241,0.00013675359,0.00008859677,0.00025452353,0.00005505722,0.00007613591,0.000054511806,0.00017366766,0.00036649863],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007883367,0.0020138675,0.98903936,0.000091395596,0.00012080442,0.0025501214,0.00026926986,9.834632e-7,0.0016707486,0.00008508325,0.000041922736,0.004037604],"study_design_scores_gemma":[0.0149373235,0.00030348537,0.94964,0.00017984024,0.000055687688,0.00014343088,0.0000159904,0.000002377411,0.03428983,0.00013876123,0.00017323875,0.000120067874],"about_ca_topic_score_codex":0.0013929426,"about_ca_topic_score_gemma":0.0023747354,"teacher_disagreement_score":0.039399397,"about_ca_system_score_codex":0.000117839314,"about_ca_system_score_gemma":0.00017193862,"threshold_uncertainty_score":0.557665},"labels":[],"label_agreement":null},{"id":"W2569734962","doi":"10.1182/blood.v120.21.548.548","title":"Treatment of Stage I-II A Non-Bulky Hodgkin's Lymphoma (HL): An Individual Patient-Data Comparison of German Hodgkin Study Group (GHSG) HD10 and HD11 Combined-Modality Therapy (CMT) and NCIC Clinical Trials Group (NCIC CTG) HD.6 ABVD Alone","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; BC Cancer Agency; Princess Margaret Cancer Centre; Queen's University","funders":"","keywords":"ABVD; Medicine; Internal medicine; Chemotherapy regimen; Stage (stratigraphy); Oncology; Cancer; Chemotherapy; Vincristine","score_opus":0.19612051797201766,"score_gpt":0.45330023208905645,"score_spread":0.25717971411703877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2569734962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988634,0.006228225,0.000006817712,0.00008277784,0.0002438229,0.0038627367,0.00085096323,0.000058295405,0.00003237778],"genre_scores_gemma":[0.99665296,0.0013776447,0.00054297113,0.000085467975,0.00027164415,0.00023643096,0.0007539384,0.00006382539,0.000015113461],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99416167,0.001067156,0.002312651,0.0009712061,0.0008662329,0.0006210642],"domain_scores_gemma":[0.9951382,0.001215979,0.0012340277,0.0016768789,0.00012037582,0.00061450474],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002711402,0.0006480402,0.003015178,0.00020863369,0.0002034753,0.000060485756,0.00030232721,0.00030093346,0.000035806755],"category_scores_gemma":[0.00021037892,0.00046156207,0.0002771311,0.0002393856,0.0003240462,0.00043057874,0.00035955268,0.000120961806,0.000003343629],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022764222,0.12677178,0.7799285,0.00008152422,0.0027507092,0.000061602965,0.0071851104,1.0780812e-7,0.0006895605,0.00005703655,0.000066805755,0.08013083],"study_design_scores_gemma":[0.08100193,0.04510183,0.8639592,0.00007228901,0.0030666483,0.0000453663,0.0013896103,0.00005472234,0.004680717,0.000026249249,0.0002582484,0.00034319505],"about_ca_topic_score_codex":0.001701621,"about_ca_topic_score_gemma":0.000330831,"teacher_disagreement_score":0.08403068,"about_ca_system_score_codex":0.000094627285,"about_ca_system_score_gemma":0.0001410697,"threshold_uncertainty_score":0.99978364},"labels":[],"label_agreement":null},{"id":"W2569736288","doi":"10.1182/blood.v108.11.1392.1392","title":"The Role of Gja1 Gap Junctions in the Bone Marrow Niche.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"dental development and anomalies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"","keywords":"Biology; Bone marrow; Haematopoiesis; Progenitor cell; Cell biology; Haploinsufficiency; Immunology; Phenotype; Stem cell; Pathology; Genetics; Medicine","score_opus":0.0038150948254561594,"score_gpt":0.19053110726722144,"score_spread":0.18671601244176528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2569736288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9680888,0.0024398586,0.0000025030736,0.000179707,0.000051202827,0.000058707636,0.0000030555448,0.000002614721,0.029173573],"genre_scores_gemma":[0.99641883,0.00008933079,0.000043208416,0.000049512473,0.00007383159,0.000013615342,0.000026963371,0.0000040123377,0.003280665],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996507,0.000021297483,0.00009845441,0.000075326716,0.00006225303,0.000091968854],"domain_scores_gemma":[0.9998177,0.0000072168605,0.000027919981,0.00012828996,0.000012331663,0.000006491794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009892199,0.000047371297,0.000039608098,0.000010349247,0.000060211198,0.0000129625105,0.00011081961,0.00003275833,0.0000048694983],"category_scores_gemma":[0.000009875568,0.000028179247,0.000034856912,0.000054653043,0.000045815646,0.0000011060775,0.000033284126,0.000030255811,0.0000057088528],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018664641,0.00032252085,0.12567227,0.0000050298086,0.000027577596,0.0000034234545,0.00005386224,0.0000023361433,0.8656635,0.0023297728,0.0044419514,0.0014590878],"study_design_scores_gemma":[0.00071661116,0.0000774132,0.16740909,0.000007387662,0.000023553317,0.000027576438,0.00056426006,0.0000025754132,0.5888387,0.0023338739,0.23988205,0.00011690616],"about_ca_topic_score_codex":0.000028765015,"about_ca_topic_score_gemma":0.0002881525,"teacher_disagreement_score":0.2768248,"about_ca_system_score_codex":0.0000011287049,"about_ca_system_score_gemma":0.00001489806,"threshold_uncertainty_score":0.11491163},"labels":[],"label_agreement":null},{"id":"W2569739222","doi":"10.1182/blood.v118.21.35.35","title":"Lung Cancer Chemotherapy Agents Increase Procoagulant Activity In Vitro and In Vivo","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University","funders":"","keywords":"Tissue factor; Medicine; Carboplatin; Gemcitabine; Chemotherapy; Lung cancer; Paclitaxel; Cancer; Pharmacology; Cisplatin; Cancer research; Immunology; Internal medicine; Oncology; Coagulation","score_opus":0.021067837021402337,"score_gpt":0.2794258489138086,"score_spread":0.25835801189240626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2569739222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955369,0.00035110168,0.0000028388,0.00017959878,0.000030245517,0.00068331324,0.0000050446765,0.00001916916,0.003191782],"genre_scores_gemma":[0.99807966,0.00081497704,0.00017245839,0.000586113,0.000038004666,0.0001787284,0.0000012039212,0.000015272935,0.00011357072],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993523,0.000022244038,0.00011593872,0.00020668306,0.00010204415,0.00020082432],"domain_scores_gemma":[0.99972683,0.000008600133,0.000037062917,0.0001407363,0.000010724639,0.00007601552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012435157,0.00010336284,0.0002813123,0.00010443513,0.000015824071,0.000005909948,0.000042588574,0.00004537159,0.00023178232],"category_scores_gemma":[0.000010495007,0.000090602916,0.000023283812,0.00010999749,0.000020525433,0.000054105945,0.000037188725,0.00008630029,0.0000018722048],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081004266,0.010487105,0.85355705,0.0006090456,0.00025302864,0.00039642348,0.003939767,8.69107e-7,0.118780404,0.00004700454,0.0012615967,0.009857664],"study_design_scores_gemma":[0.0045547397,0.0000600897,0.8416805,0.00014326315,0.000094499235,0.0000046196737,0.000035422134,0.00011322166,0.15286286,0.000020161737,0.0003318762,0.00009872108],"about_ca_topic_score_codex":0.0052655856,"about_ca_topic_score_gemma":0.0007504875,"teacher_disagreement_score":0.034082465,"about_ca_system_score_codex":0.000038769613,"about_ca_system_score_gemma":0.000034883516,"threshold_uncertainty_score":0.79600257},"labels":[],"label_agreement":null},{"id":"W2569766320","doi":"10.1182/blood.v124.21.4988.4988","title":"Plant Food Anthocyanins Induced Platelet Apoptosis Via BCL-2/BCL-XL Pathway","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hops Chemistry and Applications","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Platelet; Platelet activation; Apoptosis; Phosphatidylserine; Anthocyanin; Chemistry; Cell biology; Biochemistry; Immunology; Biology; Phospholipid; Membrane","score_opus":0.0808566165808757,"score_gpt":0.35747297872041606,"score_spread":0.27661636213954033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2569766320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810105,0.00009531311,0.00026219603,0.0006086077,0.00032651625,0.00030076256,0.00028966367,0.00022695564,0.01687947],"genre_scores_gemma":[0.9970831,0.00005884848,0.00022476458,0.0013076268,0.00059363275,0.00016528841,0.0001782193,0.000033670003,0.00035482968],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983612,0.0001919126,0.00035742606,0.0004301493,0.00014493604,0.00051441713],"domain_scores_gemma":[0.9987866,0.0003128546,0.00014862596,0.00038164522,0.000050768656,0.00031947048],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040372333,0.0002753287,0.0002947015,0.00005290957,0.00038654907,0.000024934508,0.00039175994,0.00051113305,0.00072667206],"category_scores_gemma":[0.000064261265,0.0002699034,0.00011270474,0.00021942589,0.00009883926,0.00007183935,0.00009158174,0.00077247445,0.00044707183],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057517445,0.0015813486,0.0014531806,0.00006090525,0.0002895175,0.000008145947,0.0003704036,0.000018671284,0.981197,0.002227231,0.0025802765,0.010155776],"study_design_scores_gemma":[0.002165347,0.00016114907,0.00020344052,0.000008821271,0.00012373626,0.000047356745,0.000033569468,0.00022956183,0.77055776,0.00041751427,0.2257755,0.00027623435],"about_ca_topic_score_codex":0.0000068869717,"about_ca_topic_score_gemma":0.000008954666,"teacher_disagreement_score":0.22319523,"about_ca_system_score_codex":0.00002128093,"about_ca_system_score_gemma":0.00006017385,"threshold_uncertainty_score":0.9999753},"labels":[],"label_agreement":null},{"id":"W2569817649","doi":"10.1182/blood.v112.11.3717.3717","title":"Random Mutagenesis Reveals Residues of JAK2 Critical in Evading Inhibition by Tyrosine Kinase Inhibitors","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Biology; Janus kinase 2; Myeloid leukemia; Mutation; Tyrosine kinase; Mutagenesis; Polycythemia vera; Protein kinase domain; Point mutation; Cancer research; Molecular biology; Mutant; Genetics; Kinase; Signal transduction; Gene; Immunology","score_opus":0.018512999396775996,"score_gpt":0.27505668358676694,"score_spread":0.25654368418999096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2569817649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99463904,0.002950112,0.000016509388,0.0010237063,0.000053128384,0.00047844808,0.000043128304,0.000030486803,0.0007654356],"genre_scores_gemma":[0.9979174,0.00056316605,0.0009110721,0.00018812304,0.00012241365,0.000090748144,0.00005787279,0.000023259678,0.00012594511],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985502,0.00010906605,0.00048715563,0.00029741786,0.00030770508,0.00024847785],"domain_scores_gemma":[0.9991335,0.00033841113,0.00007476714,0.00019375955,0.00012305478,0.00013646724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002191945,0.00018187359,0.00051737006,0.0001642045,0.00007257867,0.0000073872066,0.000029658318,0.000108780936,0.00011432976],"category_scores_gemma":[0.0006139682,0.0001528923,0.00010594723,0.00025323487,0.00012582567,0.000083585735,0.000024013978,0.00011328745,0.000017944534],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005367038,0.004659712,0.7594422,0.00024174672,0.00010423408,0.0009766814,0.00060700264,0.000002394948,0.22779348,0.00026789797,0.0049998574,0.00036810437],"study_design_scores_gemma":[0.013796353,0.0005944259,0.115802586,0.00063182146,0.00021306965,0.00014838921,0.00006176645,0.000005939598,0.8683998,0.000083242194,0.00011921585,0.00014336598],"about_ca_topic_score_codex":0.0001391682,"about_ca_topic_score_gemma":0.000033995842,"teacher_disagreement_score":0.6436396,"about_ca_system_score_codex":0.0000487095,"about_ca_system_score_gemma":0.00006140965,"threshold_uncertainty_score":0.62347674},"labels":[],"label_agreement":null},{"id":"W2569824063","doi":"10.1182/blood.v106.11.1631.1631","title":"The Risk of Dialysis Access Thrombosis Is Related to Polymorphisms in the Transforming Growth Factor-β1 and Plasminogen Activator Inhibitor-Type 1 Genes.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"","keywords":"Plasminogen activator inhibitor-1; Plasminogen activator; Thrombophilia; Thrombosis; Internal medicine; Transforming growth factor; Haplotype; Medicine; Immunology; Biology; Genotype; Gene; Genetics","score_opus":0.0121592461458543,"score_gpt":0.24765048429235095,"score_spread":0.23549123814649664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2569824063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99717623,0.0016880202,0.000031499578,0.00047536637,0.000058355003,0.00035126728,0.000048422156,0.000006830697,0.00016402105],"genre_scores_gemma":[0.9978401,0.0015825925,0.00010121984,0.00024439624,0.00013889805,0.000034505825,0.000010781161,0.000018741914,0.000028758137],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989173,0.000102181104,0.00027581764,0.00028450208,0.00017986239,0.00024036726],"domain_scores_gemma":[0.99942327,0.000040435472,0.00010134575,0.00031912455,0.00005108421,0.0000647358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025469475,0.00016582399,0.00016692234,0.00005053835,0.00016179027,0.000044860397,0.00034970377,0.00016107009,0.000015009095],"category_scores_gemma":[0.00007572153,0.000103916274,0.00009649764,0.00024215184,0.00005299282,0.000017936489,0.000097842225,0.00012307795,0.0000031566985],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005013302,0.00011845642,0.010316516,0.000006018677,0.00015727441,7.985666e-7,0.00073502556,0.0000028947538,0.9854416,0.000032177344,0.00013622885,0.0030028354],"study_design_scores_gemma":[0.00066656916,0.00019977636,0.0051598577,0.000013908751,0.00010233579,0.000004682478,0.00010543748,0.0000064670194,0.9917965,0.0001348026,0.0016638291,0.0001458122],"about_ca_topic_score_codex":0.000117050935,"about_ca_topic_score_gemma":0.000079024845,"teacher_disagreement_score":0.0063548805,"about_ca_system_score_codex":0.000007933689,"about_ca_system_score_gemma":0.00004608081,"threshold_uncertainty_score":0.42375827},"labels":[],"label_agreement":null},{"id":"W2569876089","doi":"10.1182/blood.v110.11.1731.1731","title":"Podocalyxin Is a Selective Marker of Erythroid Progenitors but Is Dispensable for Anemia Recovery.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Podocalyxin; Erythropoiesis; Haematopoiesis; Erythropoietin; Biology; Progenitor cell; Immunology; Ineffective erythropoiesis; Bone marrow; Stem cell; Cancer research; Cell biology; Anemia; Endocrinology; Medicine; Internal medicine; Kidney; Podocyte","score_opus":0.015147873810288405,"score_gpt":0.269086136271295,"score_spread":0.2539382624610066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2569876089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99195486,0.0002433339,0.0006133746,0.00026497865,0.0002789261,0.00072990154,0.00007362577,0.000048589984,0.0057923864],"genre_scores_gemma":[0.98192215,0.00008380312,0.0052805836,0.0022176101,0.0005969442,0.000045636687,0.000060945364,0.00004776062,0.009744551],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99885404,0.000022016618,0.0003176636,0.00031408365,0.00015587712,0.00033631347],"domain_scores_gemma":[0.9990938,0.00015336479,0.00012915775,0.00025404413,0.00024771673,0.000121973426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022728008,0.0001581479,0.00036508933,0.00010887412,0.000059346192,0.0000045301085,0.000056487097,0.00018566175,0.00048738628],"category_scores_gemma":[0.00012852892,0.00013761209,0.00020001679,0.00025075997,0.000073983836,0.000049250786,0.000022104126,0.00014503206,0.00005333514],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010830322,0.0039046707,0.12677929,0.0012429617,0.0013306113,0.000094079485,0.0023992546,0.0000015303968,0.74071693,0.0001768501,0.10051336,0.01201015],"study_design_scores_gemma":[0.007602425,0.003233869,0.052750837,0.00010396251,0.0005926894,0.00025168416,0.000559673,0.00003047763,0.91563946,0.0005329119,0.018421423,0.00028060307],"about_ca_topic_score_codex":0.000045184297,"about_ca_topic_score_gemma":0.000015943377,"teacher_disagreement_score":0.17492251,"about_ca_system_score_codex":0.000037084912,"about_ca_system_score_gemma":0.00012385641,"threshold_uncertainty_score":0.5611658},"labels":[],"label_agreement":null},{"id":"W2569883412","doi":"10.1182/blood.v120.21.sci-34.sci-34","title":"Molecular Triggers of Granule Formation in Megakaryocytes and Platelets","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Platelet; Hermansky–Pudlak syndrome; Cell biology; Dense granule; Granule (geology); Megakaryocyte; Biology; Platelet activation; Biogenesis; Chemistry; Immunology; Biochemistry; Progenitor cell; Stem cell; Pathology; Gene; Medicine","score_opus":0.00953392639705533,"score_gpt":0.23805284552166178,"score_spread":0.22851891912460645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2569883412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947325,0.003246256,0.000009793522,0.000048673075,0.0000122698675,0.00014205356,0.0000026558544,0.000007735928,0.0017980614],"genre_scores_gemma":[0.9995425,0.00015323205,0.00022613909,0.00003514886,0.000005246013,0.000005976288,0.00001617577,0.0000048295947,0.000010764414],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99966055,0.000008001998,0.00010334905,0.000046805115,0.00006859263,0.000112719084],"domain_scores_gemma":[0.99984753,0.000011889455,0.00002862749,0.00005813197,0.000008855534,0.00004494947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000044360688,0.00005136098,0.00014091753,0.00006409747,0.000008715667,0.0000017808976,0.000011797347,0.00003400758,0.000007469394],"category_scores_gemma":[0.000013914743,0.00004190244,0.00002068033,0.0000662467,0.000013723122,0.000096140335,0.0000066257858,0.000031430845,0.0000036137765],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005377268,0.0085508,0.755416,0.00079205266,0.000588395,0.0014288928,0.0047373828,0.0000067248134,0.18668401,0.0014491024,0.00016458172,0.039644346],"study_design_scores_gemma":[0.017562741,0.00033762344,0.14737555,0.000119194425,0.00029143944,0.000645905,0.00019440748,0.000079004174,0.8325749,0.00033178934,0.00035091894,0.00013652378],"about_ca_topic_score_codex":0.000024761293,"about_ca_topic_score_gemma":0.0000031385246,"teacher_disagreement_score":0.6458909,"about_ca_system_score_codex":0.0000055467244,"about_ca_system_score_gemma":0.0000051928064,"threshold_uncertainty_score":0.1708732},"labels":[],"label_agreement":null},{"id":"W2569899586","doi":"10.1182/blood.v114.22.4630.4630","title":"Fibrosis in Nodular Sclerosis Hodgkin Lymphoma Is Predictive of a Residual Mass Following Therapy.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Biopsy; Lymphoma; Nodular sclerosis; Radiology; Stage (stratigraphy); Fibrosis; Positron emission tomography; Pathology; Hodgkin lymphoma","score_opus":0.018285770705369662,"score_gpt":0.2467269497378719,"score_spread":0.22844117903250225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2569899586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99436647,0.0028256227,0.000006330482,0.0009297805,0.0000433192,0.00045201863,0.000033638968,0.00004145855,0.0013013693],"genre_scores_gemma":[0.99732685,0.0005829343,0.0012242809,0.0006508932,0.00006908644,0.000050486273,0.000016611231,0.000018066103,0.00006076528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986777,0.000043907647,0.00032337088,0.00032432933,0.000356485,0.00027420965],"domain_scores_gemma":[0.99936515,0.000062922576,0.00008514219,0.00034793545,0.000042740714,0.00009612855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012872569,0.00019229716,0.00043974735,0.00015334414,0.00003915084,0.0000135205655,0.00008559909,0.00011650923,0.000043717162],"category_scores_gemma":[0.000032107593,0.00015741639,0.00022667761,0.0003077364,0.000027434578,0.000078114856,0.000016321415,0.000042399162,0.000010496237],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064411864,0.00829,0.859467,0.000033443765,0.0008510602,0.00032575655,0.0020268841,0.000004279005,0.090163365,0.000060298516,0.0007365502,0.03739724],"study_design_scores_gemma":[0.0147559075,0.0014473002,0.6574973,0.00034052038,0.00022200434,0.000008230084,0.00008491199,0.000011588664,0.32531232,0.00010768449,0.00011507932,0.000097163545],"about_ca_topic_score_codex":0.00018546626,"about_ca_topic_score_gemma":0.000004489955,"teacher_disagreement_score":0.23514897,"about_ca_system_score_codex":0.00008864434,"about_ca_system_score_gemma":0.000101395744,"threshold_uncertainty_score":0.64192545},"labels":[],"label_agreement":null},{"id":"W2569946296","doi":"10.1182/blood.v118.21.1219.1219","title":"Co-Administration Therapy Modulates Immunity to FVIII In Hemophilia A Mice","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Titer; Immunology; Antibody; Albumin; Internal medicine; Pharmacology","score_opus":0.06127784228225754,"score_gpt":0.3284104153136911,"score_spread":0.26713257303143356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2569946296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98627824,0.00018512986,0.000002038413,0.00065230066,0.00002363852,0.00050347287,0.0000039309543,0.000035754525,0.012315499],"genre_scores_gemma":[0.99777615,0.00010819279,0.0005867806,0.00014859799,0.000057562527,0.000039840197,0.00002521012,0.0000137905445,0.0012438782],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99924177,0.00004516865,0.00015679366,0.00016533259,0.00017013222,0.00022078802],"domain_scores_gemma":[0.99952793,0.000026677795,0.000018307055,0.0002468962,0.00004754077,0.00013262988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017864078,0.00010336112,0.00016557473,0.00012849036,0.000046998495,0.000009354247,0.00008282647,0.000076223056,0.00028066724],"category_scores_gemma":[0.000038758673,0.000078913086,0.000046326364,0.00020521184,0.00003403846,0.000046097633,0.000012552233,0.00014315905,0.0002399559],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016336587,0.008943265,0.603316,0.0000709907,0.0002157592,0.000603028,0.005548341,3.0193272e-7,0.36992252,0.00021503906,0.00037055623,0.009160552],"study_design_scores_gemma":[0.0044653723,0.0012278347,0.345405,0.00005018668,0.00002425665,0.000051341656,0.000149432,0.000014163065,0.6477821,0.00024053392,0.0004769114,0.00011287856],"about_ca_topic_score_codex":0.00018025216,"about_ca_topic_score_gemma":0.000032959393,"teacher_disagreement_score":0.27785957,"about_ca_system_score_codex":0.000022599525,"about_ca_system_score_gemma":0.00009076328,"threshold_uncertainty_score":0.32179824},"labels":[],"label_agreement":null},{"id":"W2569955892","doi":"10.1182/blood.v104.11.5168.5168","title":"Stem Cell Transplantation from Mismatched Related Donors for Paediatric Haematological Disorders : The Hospital for Sick Children, Toronto, Experience.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Fludarabine; Medicine; Total body irradiation; Busulfan; Cyclophosphamide; ThioTEPA; Melphalan; Transplantation; Internal medicine; Etoposide; Surgery; Hematopoietic stem cell transplantation; Gastroenterology; Chemotherapy","score_opus":0.0075392279374490246,"score_gpt":0.24053598398071482,"score_spread":0.2329967560432658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2569955892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883415,0.0009341369,0.006231902,0.0013998837,0.00016254178,0.00252531,0.00012959121,0.000099618694,0.00017548485],"genre_scores_gemma":[0.99590915,0.00037806833,0.002396589,0.00009564537,0.00023784795,0.00059043174,0.00027033704,0.00003614117,0.00008576125],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998552,0.00003051019,0.0003354942,0.00038652858,0.00028868022,0.0004067449],"domain_scores_gemma":[0.99899024,0.00044443525,0.00009579505,0.0002694929,0.00006454537,0.00013549207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012389546,0.00019578675,0.00029495236,0.000027997698,0.00016386338,0.000025552843,0.00021778133,0.00020461882,0.000046241872],"category_scores_gemma":[0.000042845964,0.00012714033,0.00019874958,0.00012100435,0.00010950539,0.00010486366,0.000020819574,0.00012489816,0.0000133026615],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017181369,0.03730513,0.44040465,0.0037826598,0.0062918956,0.000746595,0.37921926,0.0013723016,0.043417864,0.0060449806,0.014347817,0.049885463],"study_design_scores_gemma":[0.3551582,0.014034773,0.34297022,0.0004995343,0.008331213,0.00077732216,0.0352337,0.0028454608,0.22412106,0.011508041,0.0014963554,0.003024081],"about_ca_topic_score_codex":0.0006364329,"about_ca_topic_score_gemma":0.000100610014,"teacher_disagreement_score":0.34398556,"about_ca_system_score_codex":0.00018696695,"about_ca_system_score_gemma":0.00022264755,"threshold_uncertainty_score":0.51846325},"labels":[],"label_agreement":null},{"id":"W2569973043","doi":"10.1182/blood.v106.11.1949.1949","title":"Human Factor VIIai(K62E) Is a More Effective Inhibitor of Coagulation Than Wild-Type FVIIai.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; McMaster University","funders":"","keywords":"Chemistry; Tissue factor; Recombinant DNA; Factor VII; Recombinant factor VIIa; Affinity chromatography; Factor X; Molecular biology; Monoclonal antibody; Mutant; Antibody; Thrombin; Wild type; Thromboplastin; Biochemistry; Factor IX; Coagulation; Enzyme; Platelet; Biology; Immunology; Gene; Medicine","score_opus":0.02451825332005306,"score_gpt":0.3297990305681437,"score_spread":0.3052807772480906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2569973043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966764,0.00026802608,0.000002153102,0.000817654,0.000040566578,0.00071291893,0.000016016224,0.000046106434,0.0014201949],"genre_scores_gemma":[0.9969323,0.000015176981,0.0001755333,0.00007248491,0.00044980907,0.000018851379,0.00003753777,0.00002287006,0.0022754213],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99895877,0.000037593094,0.00019507352,0.00021815024,0.00036937356,0.00022107254],"domain_scores_gemma":[0.99936736,0.000044811968,0.000059164733,0.00025358354,0.000148538,0.00012655125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008153425,0.00013997438,0.0002786972,0.00013410822,0.000073192634,0.000008479205,0.000057236997,0.00012331038,0.00025878754],"category_scores_gemma":[0.00004942162,0.00010389973,0.000107399,0.00020681214,0.0000803162,0.00007103639,0.000032658434,0.00014647875,0.000079500416],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022118313,0.0026325148,0.53401107,0.00023007148,0.00055661733,0.00004888532,0.0029976997,0.0000017838021,0.44604263,0.000043011198,0.00096301956,0.012251535],"study_design_scores_gemma":[0.004790657,0.001087302,0.47377247,0.00013598919,0.00020056045,0.000014761165,0.000070912305,0.00004410769,0.51882243,0.000025386382,0.0009271682,0.00010828389],"about_ca_topic_score_codex":0.00004829801,"about_ca_topic_score_gemma":0.000012518209,"teacher_disagreement_score":0.07277979,"about_ca_system_score_codex":0.00004808416,"about_ca_system_score_gemma":0.000057764875,"threshold_uncertainty_score":0.4236908},"labels":[],"label_agreement":null},{"id":"W2570015670","doi":"10.1182/blood.v114.22.2998.2998","title":"The GPIIbIIIa Antagonist Drugs Eptifibatide and Tirofiban Inhibit Caspase-3 Activation in Thrombin- and Calcium Ionophore-Stimulated Human Platelets.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Tirofiban; Eptifibatide; Platelet; Platelet activation; Pharmacology; Thrombopoiesis; Apoptosis; Chemistry; Medicine; Immunology; Internal medicine; Cell biology; Biology; Biochemistry; Megakaryocyte; Stem cell; Myocardial infarction; Haematopoiesis","score_opus":0.012949183640524916,"score_gpt":0.2722007830097972,"score_spread":0.2592515993692723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570015670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99637604,0.00049343787,0.0000019411168,0.0012602671,0.000022733668,0.00044396822,0.0000059616427,0.000040966195,0.0013547093],"genre_scores_gemma":[0.9992069,0.00016975564,0.000040657,0.0002306453,0.0000267241,0.0000088607685,0.00008113325,0.000016096848,0.00021921065],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990166,0.000027713251,0.00024921933,0.00028782518,0.00014793332,0.0002707058],"domain_scores_gemma":[0.99953914,0.00006222101,0.00007413791,0.00019056043,0.000029998395,0.00010392524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000112320864,0.00018721037,0.00027418727,0.00008365062,0.00031189204,0.000061011237,0.000039865994,0.000108160595,0.000008335732],"category_scores_gemma":[0.000025522446,0.00013509489,0.00003020075,0.0001587786,0.00009847107,0.000093021394,0.000023846742,0.00017899391,0.000005057387],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012402073,0.008552376,0.144856,0.00020394578,0.0008645739,0.0030585935,0.008231078,0.000021800892,0.762854,0.002997243,0.0019381096,0.06518206],"study_design_scores_gemma":[0.029142728,0.0019621856,0.74561733,0.0003744777,0.0004038493,0.0006404761,0.0007145632,0.00061915594,0.2146786,0.004603956,0.0006674118,0.0005752608],"about_ca_topic_score_codex":0.0003380539,"about_ca_topic_score_gemma":0.00007706718,"teacher_disagreement_score":0.60076135,"about_ca_system_score_codex":0.000032717224,"about_ca_system_score_gemma":0.00002932755,"threshold_uncertainty_score":0.55090094},"labels":[],"label_agreement":null},{"id":"W2570030833","doi":"10.1182/blood.v116.21.3523.3523","title":"Adult Dual Umbilical Cord Blood Transplantation Using Myeloablative Total Body Irradiation (1350cGy) and Fludarabine Conditioning","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Fludarabine; Total body irradiation; Cumulative incidence; Umbilical Cord Blood Transplantation; Transplantation; Cyclophosphamide; Umbilical cord; Tolerability; Internal medicine; Surgery; Immunosuppression; Gastroenterology; Hematopoietic stem cell transplantation; Immunology; Adverse effect; Chemotherapy","score_opus":0.01107625044539482,"score_gpt":0.2620554764938404,"score_spread":0.2509792260484456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570030833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964366,0.000034178545,0.0013786427,0.00017161622,0.00018854113,0.0005429602,0.00010552029,0.00010592446,0.001036003],"genre_scores_gemma":[0.992953,0.000043515633,0.0060162134,0.000103835766,0.0002771213,0.00002645738,0.0004961426,0.000034877878,0.000048804224],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998548,0.000054831224,0.00041135828,0.00037710383,0.00034052596,0.0002682195],"domain_scores_gemma":[0.9991477,0.00016999512,0.00012392414,0.00017882332,0.00018342816,0.0001961261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001771667,0.00020885526,0.0003000625,0.00014067786,0.00016328879,0.000042803575,0.000034037716,0.0002092263,0.00013705197],"category_scores_gemma":[0.0000974447,0.00021188552,0.00006494406,0.00018642962,0.00010035276,0.00021875023,0.000006959731,0.0003525642,0.000014122967],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030664075,0.00056847703,0.041754436,0.00039919768,0.00019422696,0.00025464175,0.0016070458,0.000008940888,0.9524935,0.0020330837,0.000008910949,0.00037088673],"study_design_scores_gemma":[0.017838024,0.0009789983,0.59318244,0.00041528427,0.0032816113,0.012799162,0.00035626226,0.0041940096,0.36611104,0.00031782858,0.000017388444,0.0005079706],"about_ca_topic_score_codex":0.00009560469,"about_ca_topic_score_gemma":0.000044671684,"teacher_disagreement_score":0.58638245,"about_ca_system_score_codex":0.000014539896,"about_ca_system_score_gemma":0.000099399505,"threshold_uncertainty_score":0.8640441},"labels":[],"label_agreement":null},{"id":"W2570090604","doi":"10.1182/blood.v108.11.502.502","title":"Genotype-Phenotype Associations in Patients with Severe Congenital Neutropenia.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Neutropenia; Gastroenterology; Absolute neutrophil count; Congenital Neutropenia; Immunology; Chemotherapy","score_opus":0.002767286345498554,"score_gpt":0.17975941728652134,"score_spread":0.17699213094102278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570090604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937198,0.00027074318,0.000008038676,0.00002000745,0.000025567573,0.00017546587,0.00006761629,0.000008040362,0.0057046823],"genre_scores_gemma":[0.99856305,0.000004199578,0.00024025603,0.000055839373,0.000046262267,0.000014536622,0.00068045483,0.000017043327,0.0003783319],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99942476,0.000018375662,0.000103718216,0.00019449941,0.00008736006,0.00017131155],"domain_scores_gemma":[0.9997234,0.0000031013517,0.00004425913,0.00014945323,0.000053196272,0.000026637463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000019616373,0.00010396027,0.00009011128,0.000022229407,0.000047318532,0.00001633606,0.00006798502,0.00007638363,0.000012996915],"category_scores_gemma":[0.0000062417375,0.00008964523,0.000028570572,0.000075952295,0.00001773873,0.0000037736595,0.000029442683,0.000039956136,0.000018976498],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044605426,0.0013266418,0.9972932,0.0000016706063,0.00009514975,0.0000033018346,0.0000075040557,0.000024753286,0.0006865795,0.00006252964,0.00021788226,0.00023622304],"study_design_scores_gemma":[0.0065583684,0.00031460967,0.9894253,0.0000022468976,0.00007435624,0.0000010141285,0.0000058770343,7.0012453e-7,0.0027410903,0.00006769058,0.0006582431,0.00015049109],"about_ca_topic_score_codex":0.00018414571,"about_ca_topic_score_gemma":0.0011042518,"teacher_disagreement_score":0.007867847,"about_ca_system_score_codex":0.0000072467546,"about_ca_system_score_gemma":0.000035349436,"threshold_uncertainty_score":0.36556265},"labels":[],"label_agreement":null},{"id":"W2570113530","doi":"10.1182/blood-2016-11-746701","title":"Exposing Hodgkin-Reed-Sternberg cells","year":2017,"lang":"en","type":"letter","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Reed–Sternberg cell; Lymphoma; Cancer research; Phenotype; Classical Hodgkin lymphoma; Medicine; Immunology; Biology; Hodgkin lymphoma; Genetics; Gene","score_opus":0.025057916329853727,"score_gpt":0.26164228749370777,"score_spread":0.23658437116385406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570113530","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1733953,0.006034461,0.000007453076,0.7055547,0.0031084265,0.0018067941,0.00025332178,0.0003463007,0.109493196],"genre_scores_gemma":[0.07649963,0.00073221757,0.0019502442,0.8384915,0.025211135,0.0003302289,0.0011250577,0.00033201533,0.055327967],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99830204,0.000025305471,0.00027200163,0.0005292701,0.00042568712,0.0004456847],"domain_scores_gemma":[0.9982884,0.00007942616,0.00024872745,0.0012148992,0.000059618393,0.000108916254],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000058689366,0.00040622838,0.0006593829,0.00010738422,0.00014743485,0.00012689567,0.00023337507,0.00065659126,0.00019811801],"category_scores_gemma":[0.000020932628,0.00031886777,0.0003388637,0.000027849672,0.000068239846,0.00004882253,0.00009300251,0.00051525974,0.0007990995],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010754939,0.00063882937,0.00469767,0.00024889884,0.0007246878,0.015841424,0.00006253225,3.8933518e-8,0.000628611,0.0000036422466,0.9747855,0.0023574124],"study_design_scores_gemma":[0.0055831517,0.0003228504,0.003911035,0.0008357522,0.0023228237,0.00055762293,0.0000033285396,6.1132937e-7,0.031952582,0.000018894258,0.95415205,0.0003393177],"about_ca_topic_score_codex":0.00016736367,"about_ca_topic_score_gemma":0.000004358619,"teacher_disagreement_score":0.13293676,"about_ca_system_score_codex":0.00009353522,"about_ca_system_score_gemma":0.00014597081,"threshold_uncertainty_score":0.9999789},"labels":[],"label_agreement":null},{"id":"W2570167904","doi":"10.1182/blood.v116.21.3781.3781","title":"Reduced Infection and Mucositis In Chemotherapy-Treated Animals Following Innate Defense Modulation Using a Novel Drug Candidate.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Inimex Pharmaceuticals (Canada)","funders":"","keywords":"Innate immune system; Biology; Immunology; Chemokine; Mucositis; Inflammation; Microbiology; Pharmacology; Immune system; Chemotherapy","score_opus":0.013291110477336925,"score_gpt":0.27643986471821796,"score_spread":0.263148754240881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570167904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99872184,0.000042415744,0.000050710383,0.00013599977,0.00016674209,0.0003310971,0.000004147601,0.00006552482,0.00048152017],"genre_scores_gemma":[0.9991024,0.000027184373,0.00057913293,0.000086751286,0.000105690306,0.000021233527,0.000010493616,0.000024994262,0.00004210577],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99933064,0.00001740781,0.0001755249,0.00021766957,0.00009373358,0.00016502239],"domain_scores_gemma":[0.9996781,0.000014705031,0.00005554142,0.00013816227,0.000042266103,0.000071269285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012068829,0.000115825,0.00018655849,0.00017378398,0.00009243639,0.000030972693,0.000017539327,0.00007931185,0.0000304054],"category_scores_gemma":[0.00002442477,0.000114297996,0.00005094402,0.00031435536,0.000021569054,0.00011931858,0.000013374848,0.00020211175,0.0000019476245],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036899,0.00014738516,0.30520657,0.000011821031,0.00004002367,0.000010513915,0.0001858723,0.000008393586,0.69374293,0.000024795278,0.000003332484,0.0005814945],"study_design_scores_gemma":[0.006931786,0.00009394595,0.7761186,0.000113331036,0.00021615083,0.0003448998,0.000018692775,0.0006909954,0.21503346,0.000058341127,0.00020882046,0.00017096949],"about_ca_topic_score_codex":0.0035881489,"about_ca_topic_score_gemma":0.0015649085,"teacher_disagreement_score":0.47870943,"about_ca_system_score_codex":0.000040188585,"about_ca_system_score_gemma":0.000055879158,"threshold_uncertainty_score":0.5424232},"labels":[],"label_agreement":null},{"id":"W2570188740","doi":"10.1182/blood.v108.11.1798.1798","title":"Sequences in Intron 51 of the VWF Gene Target Promoter Activation to a Subset of Lung Endothelial Cells in Transgenic Mice.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Transgene; Biology; Molecular biology; Intron; Exon; Genetically modified mouse; Promoter; Gene; Enhancer; Regulatory sequence; Gene expression; Cell biology; Genetics","score_opus":0.003460673968835769,"score_gpt":0.20249407787926016,"score_spread":0.1990334039104244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570188740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990873,0.00012528215,0.00015226388,0.000116530915,0.000067866706,0.00033512397,0.000046664918,0.0000017994588,0.00006721154],"genre_scores_gemma":[0.9993918,0.000012728353,0.00037272225,0.000012566877,0.00009605661,0.000017540327,0.000040739367,0.000008493887,0.00004734146],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99937034,0.000049722254,0.00022537274,0.00015583723,0.00008967402,0.00010903143],"domain_scores_gemma":[0.9997302,0.0000046467662,0.00008383087,0.00014284291,0.000027483693,0.000010946129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009384518,0.000071251074,0.00009824848,0.000053009673,0.000008779915,0.0000026313971,0.00009955658,0.00009851125,0.0000059449067],"category_scores_gemma":[0.000008129035,0.00006207145,0.000046617846,0.00016299295,0.00002702807,0.000003320024,0.000017738848,0.000044493674,3.1167622e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006219579,0.00011943734,0.0066563156,0.00002032317,0.000012233506,1.1048915e-7,0.00009948116,0.0027948313,0.99010694,0.000010468686,0.000030731167,0.000086936765],"study_design_scores_gemma":[0.000898762,0.00007623728,0.025811458,0.000026507889,0.000012557468,0.0000010656736,0.0000072144458,0.00007071747,0.972766,0.00006077714,0.00020551252,0.00006319583],"about_ca_topic_score_codex":0.00029350017,"about_ca_topic_score_gemma":0.0008835655,"teacher_disagreement_score":0.019155141,"about_ca_system_score_codex":0.000016237569,"about_ca_system_score_gemma":0.00008063778,"threshold_uncertainty_score":0.25312003},"labels":[],"label_agreement":null},{"id":"W2570200366","doi":"10.1182/blood.v126.23.1542.1542","title":"Lymphoma Symptoms: Data from a Phase 3, International, Randomized, Open-Label, Multicenter Study in Patients with Previously Treated Mantle Cell Lymphoma (MCL) Treated with Ibrutinib Vs. Temsirolimus","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Mantle cell lymphoma; Medicine; Internal medicine; Ibrutinib; Temsirolimus; Clinical endpoint; Lymphoma; Phases of clinical research; International Prognostic Index; Oncology; Randomized controlled trial; Gastroenterology; Clinical trial; Rituximab; Leukemia; Chronic lymphocytic leukemia","score_opus":0.0463762389773181,"score_gpt":0.3297237700807319,"score_spread":0.2833475311034138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570200366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98898983,0.00033569697,0.00000845669,0.00005720115,0.00008069061,0.008044522,0.00043754154,0.00012554311,0.0019205073],"genre_scores_gemma":[0.99439484,0.000042971737,0.00042723544,0.00015310786,0.00009477396,0.00047715535,0.0033319118,0.00014035498,0.0009376473],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99500424,0.00051050313,0.0009043536,0.0013589473,0.0014469924,0.000774985],"domain_scores_gemma":[0.9960981,0.0003898039,0.0003603106,0.0021386514,0.00051305175,0.00050009676],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008748406,0.0005957169,0.0014612337,0.00035143626,0.000077087454,0.00025100773,0.0015695611,0.00016501339,0.00014280993],"category_scores_gemma":[0.0003733922,0.0003942722,0.000050212195,0.00060302444,0.0002561631,0.00060745963,0.0010078324,0.00016223015,0.00015362991],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.53246224,0.13779584,0.3183875,0.00007350888,0.0028372062,0.0022076555,0.0019304345,0.000004829648,0.000032787368,0.0000011096315,0.00089215033,0.0033747295],"study_design_scores_gemma":[0.97107524,0.0047473535,0.010649822,0.000500412,0.0016323297,0.000050934854,0.00039724587,0.00921334,0.00069118536,0.0000018725897,0.00056917325,0.00047109643],"about_ca_topic_score_codex":0.01378258,"about_ca_topic_score_gemma":0.00075170514,"teacher_disagreement_score":0.438613,"about_ca_system_score_codex":0.003562921,"about_ca_system_score_gemma":0.0035235065,"threshold_uncertainty_score":0.9998509},"labels":[],"label_agreement":null},{"id":"W2570263213","doi":"10.1182/blood.v116.21.1519.1519","title":"A Randomized Controlled Trial of Spiritually-Focused Meditation In Patients Newly Diagnosed with Acute Leukemia.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Religion, Spirituality, and Psychology","field":"Social Sciences","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Meditation; Medicine; Randomized controlled trial; Quality of life (healthcare); Cancer; Myeloid leukemia; Internal medicine; Physical therapy","score_opus":0.012079748675855824,"score_gpt":0.29820705863499747,"score_spread":0.28612730995914165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570263213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982269,0.000027517352,0.00006210627,0.0006742015,0.0012252507,0.0035565773,0.00000492039,0.00003402526,0.012146385],"genre_scores_gemma":[0.99845564,0.00006256117,0.00041457143,0.00018003178,0.00039631312,0.00036154635,0.000013084939,0.00001186785,0.0001043626],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972154,0.0010552069,0.0006653186,0.0002460763,0.00054269325,0.00027528658],"domain_scores_gemma":[0.99752194,0.0015714585,0.0004055299,0.00021525717,0.00018260466,0.0001031847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030223066,0.00014223937,0.00102331,0.00015319361,0.0001034357,0.000032619962,0.0002403856,0.00024491432,0.000062640014],"category_scores_gemma":[0.00213809,0.00010321574,0.00019285626,0.0002742166,0.00050836895,0.0001266962,0.000011801869,0.0002166609,0.0000087151975],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9643344,0.0016250001,0.008638229,0.0000061299197,0.0002904884,0.000012919399,0.017859466,0.0000014268941,0.000079675934,0.006259057,0.00056493457,0.0003282242],"study_design_scores_gemma":[0.9929874,0.00039211503,0.0029560702,0.000014782351,0.00024000417,2.5987006e-7,0.0003524009,0.0000040143113,0.00002992839,0.002755006,0.00013819285,0.00012981452],"about_ca_topic_score_codex":0.005542289,"about_ca_topic_score_gemma":0.021798922,"teacher_disagreement_score":0.028652964,"about_ca_system_score_codex":0.000026670012,"about_ca_system_score_gemma":0.0003893234,"threshold_uncertainty_score":0.9960507},"labels":[],"label_agreement":null},{"id":"W2570279763","doi":"10.1182/blood.v114.22.4133.4133","title":"Transfusional Iron Overload: An Underappreciated Danger in AML Patients?","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Dexrazoxane; Anthracycline; Medicine; Doxorubicin; Cardiotoxicity; Cancer; Cardiomyopathy; Population; Internal medicine; Adverse effect; Toxicity; Oncology; Chemotherapy; Breast cancer; Heart failure","score_opus":0.013917132430472394,"score_gpt":0.2769227942229623,"score_spread":0.2630056617924899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570279763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99282366,0.00008026131,0.000011758365,0.00065137364,0.00003385408,0.00038877295,0.000011380502,0.00005685828,0.005942105],"genre_scores_gemma":[0.9978597,0.000053247375,0.00042125766,0.00093320664,0.000117446085,0.000009794989,0.00016145654,0.000017729853,0.00042612923],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986942,0.0000634959,0.0002046819,0.00028525846,0.00041522153,0.00033718866],"domain_scores_gemma":[0.9994359,0.000032409367,0.000023771228,0.0002643439,0.00006442497,0.00017915023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014482549,0.00012853666,0.0002043934,0.0001760449,0.00003981443,0.0000132909945,0.00010740013,0.00013214865,0.00033817426],"category_scores_gemma":[0.00004943584,0.00011254358,0.000052242656,0.0003028937,0.000031924887,0.00011762257,0.000013860867,0.00033520654,0.00004580386],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028015105,0.030836718,0.6120495,0.00014269994,0.00017823609,0.0008549324,0.0038684516,0.000034741624,0.2013693,0.0008035796,0.0066872463,0.14037305],"study_design_scores_gemma":[0.013498711,0.0013282162,0.9783723,0.000053215666,0.000046461137,0.000018525187,0.000052338262,0.00015178796,0.0049400134,0.00016002434,0.001225769,0.00015264754],"about_ca_topic_score_codex":0.000088053006,"about_ca_topic_score_gemma":0.000058043533,"teacher_disagreement_score":0.36632276,"about_ca_system_score_codex":0.00013086616,"about_ca_system_score_gemma":0.00015651352,"threshold_uncertainty_score":0.4589394},"labels":[],"label_agreement":null},{"id":"W2570308107","doi":"10.1182/blood.v114.22.2576.2576","title":"Neuropathic Vs. Nociceptive Pain in Adolescent Sickle Cell Disease (SCD) Evaluated by a Computer-Based Self-Assessment Pain Tool.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Neuropathic pain; Nociception; Pain assessment; Quantitative sensory testing; McGill Pain Questionnaire; Disease; Physical therapy; Chronic pain; Quality of life (healthcare); Sickle cell anemia; Internal medicine; Anesthesia; Pain management; Sensory system; Psychology; Visual analogue scale","score_opus":0.006711160170530988,"score_gpt":0.23983633085930317,"score_spread":0.23312517068877217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570308107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839125,0.0012400952,0.0073175197,0.0048486097,0.00013359629,0.0017145984,0.000029583236,0.0003610378,0.00044242057],"genre_scores_gemma":[0.98776853,0.00013379617,0.0013230222,0.010419319,0.00008570062,0.000035344798,0.0001434218,0.00003967737,0.00005117818],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99665636,0.0012149794,0.00048906315,0.0005572698,0.0005268238,0.00055552385],"domain_scores_gemma":[0.99880487,0.00014671226,0.00012759809,0.00042309455,0.00011237028,0.00038538346],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019748127,0.00034380058,0.00043397734,0.0001470279,0.00009358621,0.000036269343,0.00014838437,0.0001739321,0.00005855049],"category_scores_gemma":[0.0001095912,0.0003005863,0.00017372903,0.00044605078,0.00004337237,0.000050983657,0.000030554264,0.00060189085,0.00003381543],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041224645,0.1665507,0.3466522,0.0038249774,0.0005064495,0.009000292,0.0028475104,0.006933139,0.038161114,0.00011609477,0.07646733,0.3448177],"study_design_scores_gemma":[0.050444815,0.01260609,0.30068105,0.0022077484,0.0014780646,0.000020429114,0.0004435676,0.62081045,0.0018767519,0.000113098184,0.0077469624,0.0015709961],"about_ca_topic_score_codex":0.000022937638,"about_ca_topic_score_gemma":0.0000024685073,"teacher_disagreement_score":0.6138773,"about_ca_system_score_codex":0.00015820016,"about_ca_system_score_gemma":0.0005377565,"threshold_uncertainty_score":0.9999446},"labels":[],"label_agreement":null},{"id":"W2570321729","doi":"10.1182/blood.v126.23.769.769","title":"Tissue Oxygenation By Transfusion in Severe Anemia with Lactic Acidosis (TOTAL): A Prospective, Randomized, Non-Inferiority Trial of Blood Storage Duration","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Lactic acidosis; Anemia; Acidosis; Randomized controlled trial; Blood transfusion; Adverse effect; Hemolysis; Anesthesia; Surgery; Internal medicine","score_opus":0.008229656836560807,"score_gpt":0.24033539816567753,"score_spread":0.23210574132911674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570321729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883285,0.0002570959,0.0013957574,0.0006481995,0.00013228899,0.0050830897,0.000012853175,0.000064646796,0.0040775733],"genre_scores_gemma":[0.9977192,0.00023169383,0.0009758939,0.00006186966,0.00008155123,0.00030862764,0.000056160967,0.00002861893,0.00053635915],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998032,0.00016657515,0.00060379866,0.00037029586,0.00061578123,0.00021160189],"domain_scores_gemma":[0.99910545,0.0000650174,0.00019559644,0.00027974995,0.00019913443,0.00015504031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008710878,0.00022729569,0.0007633319,0.00020547475,0.000043223063,0.000020668833,0.000069565314,0.00015410341,0.00005891852],"category_scores_gemma":[0.00014657089,0.00017958581,0.00010051676,0.00044514498,0.00007145564,0.00020184,0.000017547769,0.00023330224,0.0000065995487],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8679405,0.014324108,0.0063918014,0.0008016591,0.00074400316,0.00014746135,0.004201005,0.00002438076,0.100354925,0.00033191638,0.00023432537,0.004503948],"study_design_scores_gemma":[0.9142306,0.0024505476,0.004432934,0.00015425574,0.0016525337,0.00006577821,0.0002648899,0.000056052395,0.07630874,0.00005199475,0.00010792472,0.00022373915],"about_ca_topic_score_codex":0.00057924,"about_ca_topic_score_gemma":0.00033426902,"teacher_disagreement_score":0.046290144,"about_ca_system_score_codex":0.00004894781,"about_ca_system_score_gemma":0.00015949259,"threshold_uncertainty_score":0.73232967},"labels":[],"label_agreement":null},{"id":"W2570330626","doi":"10.1182/blood.v116.21.2203.2203","title":"The Role of Amino Acids 700–701 of the Factor Va Heavy Chain During Prothrombin Activation by Factor Xa","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Prothrombinase; Thrombin; Chemistry; Factor V; Recombinant DNA; Cofactor; Biochemistry; Cleavage (geology); Amino acid; Stereochemistry; Enzyme; Platelet; Biology; Immunology; Internal medicine","score_opus":0.0030687710834391853,"score_gpt":0.1992096212260491,"score_spread":0.1961408501426099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570330626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99904406,0.00019933889,0.000024432946,0.00009859713,0.000112724236,0.00037473088,0.00004490523,0.0000065839054,0.0000946346],"genre_scores_gemma":[0.999498,0.000028534787,0.000030695526,0.000005336747,0.000106393,0.000025246507,0.00002041561,0.000016412643,0.00026895024],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993211,0.00003745309,0.00019133257,0.00016553316,0.00014735287,0.0001372043],"domain_scores_gemma":[0.99931234,0.000012142979,0.00018725531,0.00039713635,0.0000692522,0.000021863258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000060236707,0.00010048776,0.00009223349,0.000014496067,0.0000898555,0.000009710874,0.00018363158,0.00016657497,0.000014801381],"category_scores_gemma":[0.00006855124,0.000068029614,0.00007766216,0.0000770815,0.00008786832,0.000004610458,0.00006801673,0.000115453404,7.153011e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003509183,0.000084098465,0.0072703916,0.00001275506,0.000053065545,1.3883267e-8,0.00007829425,0.00000503358,0.99100614,0.000023534565,0.000023033563,0.0014085436],"study_design_scores_gemma":[0.0005302819,0.00006964365,0.08417064,0.000010579259,0.000012236615,0.0000018061228,0.000025731963,0.000016141239,0.91302234,0.000042025793,0.0020265256,0.00007202926],"about_ca_topic_score_codex":0.000024934225,"about_ca_topic_score_gemma":0.000034251505,"teacher_disagreement_score":0.07798379,"about_ca_system_score_codex":0.000008454248,"about_ca_system_score_gemma":0.000057563844,"threshold_uncertainty_score":0.2774167},"labels":[],"label_agreement":null},{"id":"W2570331680","doi":"10.1182/blood.v124.21.2490.2490","title":"Selective Depletion of Recipient-Alloreactive T-Cells While Retaining Viral-Specific and Memory T-Cells Enables Safe and Efficacious Haplo-Identical HSCT","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Immunology; Antigen; Cancer immunotherapy; Cancer research; Immunotherapy; Medicine; Biology; Immune system","score_opus":0.016833925913653618,"score_gpt":0.25102648556191937,"score_spread":0.23419255964826574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570331680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862652,0.00065696513,0.00020529787,0.00011999952,0.000083214116,0.0006789369,0.000008889169,0.000050008315,0.011931534],"genre_scores_gemma":[0.99674064,0.00089255656,0.00083160435,0.000057988604,0.00018742122,0.00002412677,0.00001419451,0.00005259915,0.0011988448],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979336,0.00022408563,0.0003832924,0.00054418435,0.00050086743,0.00041396765],"domain_scores_gemma":[0.9985191,0.0005236899,0.00013232118,0.00036100295,0.00022340433,0.00024048798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008351278,0.00022963037,0.0005356853,0.00022650289,0.000109503584,0.00004238144,0.00009316888,0.00017668282,0.00019706445],"category_scores_gemma":[0.00017726765,0.00021117598,0.00008805389,0.00022929886,0.00031799896,0.00009622447,0.00009970699,0.00040284492,0.000020722893],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078624807,0.00057113357,0.0038602245,0.0001169303,0.00021003989,0.000024769526,0.001266779,0.0000027172207,0.9778645,0.00015896652,0.000323874,0.014813789],"study_design_scores_gemma":[0.007575357,0.0016088908,0.012404271,0.00020308935,0.00021077236,0.000110060704,0.00041818747,0.00024108101,0.973055,0.00027098006,0.0036469637,0.00025533614],"about_ca_topic_score_codex":0.00006941807,"about_ca_topic_score_gemma":0.000018057874,"teacher_disagreement_score":0.014558453,"about_ca_system_score_codex":0.000061901235,"about_ca_system_score_gemma":0.000060119375,"threshold_uncertainty_score":0.8611507},"labels":[],"label_agreement":null},{"id":"W2570610553","doi":"10.1182/blood.v118.21.3582.3582","title":"Image-Guided Therapy May Reduce the Risk of Traumatic or Failed Lumbar Punctures in Children with Acute Lymphoblastic Leukemia,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Traumatic Brain Injury and Neurovascular Disturbances","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Medicine; Lumbar; Lumbar puncture; Chemotherapy; Cerebrospinal fluid; Chemotherapy regimen; Acute lymphocytic leukemia; Lymphoblastic Leukemia; Pediatrics; Leukemia; Surgery; Internal medicine","score_opus":0.025508468002761343,"score_gpt":0.25475509572947336,"score_spread":0.229246627726712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570610553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99727166,0.00057067,0.000044606837,0.000070450165,0.000040180093,0.0009834416,0.000017440261,0.000049526225,0.00095205544],"genre_scores_gemma":[0.9966298,0.0005667197,0.0023110835,0.00017500695,0.000054488573,0.00008995485,0.0000068970903,0.00003512431,0.00013092939],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851847,0.00017895286,0.0004140817,0.00030860273,0.00031803644,0.0002618403],"domain_scores_gemma":[0.99890393,0.00010731266,0.00021822656,0.0006473695,0.00005071143,0.00007246882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031842614,0.00024890844,0.00049861905,0.00008374104,0.00007102185,0.00001463273,0.00027041638,0.000078701414,0.0002021022],"category_scores_gemma":[0.00012782827,0.00011459193,0.00015360369,0.00031117405,0.00027467715,0.000083220686,0.00002093003,0.00022331647,0.000011537141],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062904074,0.007631352,0.88253534,0.0006768695,0.01783264,0.0005557867,0.031721387,0.00002721315,0.028464347,0.0003640871,0.0022069067,0.021693649],"study_design_scores_gemma":[0.009221667,0.00087435363,0.95032644,0.00017364898,0.0011670359,0.00058544194,0.0002507605,0.000026163374,0.0370838,0.00011874044,0.000014866752,0.00015704964],"about_ca_topic_score_codex":0.00028938954,"about_ca_topic_score_gemma":0.000070527334,"teacher_disagreement_score":0.06779111,"about_ca_system_score_codex":0.000021807296,"about_ca_system_score_gemma":0.00020851151,"threshold_uncertainty_score":0.46729234},"labels":[],"label_agreement":null},{"id":"W2570613797","doi":"10.1182/blood.v106.11.4379.4379","title":"Effect of Bax G125A Single Nucleotide Polymorphism (SNP) on Bax Gene Expression in Diffuse Large Cell Lymphoma.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Royal University Hospital","funders":"","keywords":"Mantle cell lymphoma; Single-nucleotide polymorphism; Lymphoma; SNP; Biology; Follicular lymphoma; Molecular biology; Allele; Cancer research; Genotype; Gene; Genetics; Immunology","score_opus":0.008276828658188571,"score_gpt":0.23680512472471318,"score_spread":0.2285282960665246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570613797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936679,0.0017418144,0.0000022359322,0.00019326876,0.0001092743,0.00049041666,0.000031770647,0.000053563585,0.0037097374],"genre_scores_gemma":[0.99836755,0.0001447454,0.00046709063,0.0002720262,0.00025610428,0.000058790978,0.000038273636,0.000043619766,0.00035182218],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984846,0.0001049844,0.00034346024,0.00036430074,0.0003229539,0.00037968886],"domain_scores_gemma":[0.99899966,0.0002044072,0.000118516175,0.00048364804,0.000022077758,0.00017169218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017190605,0.00026419412,0.00049061165,0.00016570579,0.000047034628,0.000011324842,0.000097376775,0.00012785777,0.00009483651],"category_scores_gemma":[0.000042966123,0.00019414493,0.00017139043,0.00014953001,0.00002890863,0.000061611456,0.00006150886,0.000060349677,0.00015656033],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011084451,0.13672836,0.19125551,0.0002828207,0.00014926984,0.0009068691,0.00062292005,0.0000063985945,0.64183,0.00003853559,0.0015474888,0.025523333],"study_design_scores_gemma":[0.06861565,0.002044039,0.043052256,0.00033064568,0.00022924285,0.000030135105,0.00001164093,0.000025713756,0.88361114,0.0000033949987,0.0018989386,0.0001472219],"about_ca_topic_score_codex":0.000069525144,"about_ca_topic_score_gemma":0.000015739724,"teacher_disagreement_score":0.24178107,"about_ca_system_score_codex":0.00016231037,"about_ca_system_score_gemma":0.000042646938,"threshold_uncertainty_score":0.79170007},"labels":[],"label_agreement":null},{"id":"W2570630399","doi":"10.1182/blood.v112.11.456.456","title":"Pregnancy after Allogeneic Hematopoietic Stem Cell Transplantation in Fanconi Anemia Patients: Multi-Institution Cases Report of Female Fertility Recovery","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Prenatal Screening and Diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Fanconi anemia; Transplantation; Hematopoietic stem cell transplantation; Cyclophosphamide; Total body irradiation; Surgery; Aplastic anemia; Pregnancy; Bone marrow failure; Internal medicine; Stem cell; Bone marrow; Haematopoiesis; Chemotherapy; Biology","score_opus":0.023202316919271503,"score_gpt":0.24584421988181998,"score_spread":0.2226419029625485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570630399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976631,0.0011537329,0.00035185285,0.000006710764,0.0000822603,0.00037567044,0.000049427832,0.000034126035,0.00028314482],"genre_scores_gemma":[0.99838555,0.00025725013,0.0010065078,0.000020494686,0.000011919275,0.000043586002,0.00013013689,0.000010113313,0.00013445181],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895984,0.000036040296,0.00041762213,0.00023960733,0.0001878477,0.0001590601],"domain_scores_gemma":[0.9994091,0.00007680471,0.00011976364,0.0002449015,0.00007767002,0.00007178443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006916754,0.00011792425,0.00023407959,0.000067744535,0.000029153132,0.000002724752,0.00003898532,0.00010471525,0.000011277263],"category_scores_gemma":[0.00009567763,0.00010844284,0.00006915296,0.00011846455,0.000056536126,0.00009661324,0.0000125291035,0.00009534718,0.0000058030614],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031440123,0.0016710784,0.99066263,0.00059263554,0.000011791493,0.005084176,0.00054920645,0.000024373123,0.0005084929,6.3388904e-7,0.0000057943525,0.0005747882],"study_design_scores_gemma":[0.003679534,0.0002896787,0.92664975,0.0008884412,0.00013300488,0.00077541225,0.00003612189,0.000005936893,0.06743068,0.000002410401,0.000004996965,0.00010401231],"about_ca_topic_score_codex":0.0002483565,"about_ca_topic_score_gemma":0.00013159627,"teacher_disagreement_score":0.06692219,"about_ca_system_score_codex":0.000029901981,"about_ca_system_score_gemma":0.00009303784,"threshold_uncertainty_score":0.44221705},"labels":[],"label_agreement":null},{"id":"W2570654636","doi":"10.1182/blood.v120.21.685.685","title":"Addition of Rituximab Improves Outcome of HIV Negative Patients with Burkitt Lymphoma Treated with the Lmba Protocol: Results of the Randomized Intergroup (GRAALL-Lysa) LMBA02 Protocol. (IGR sponsored LMBA02, NCT00180882)","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rituximab; Medicine; Internal medicine; Regimen; Cytarabine; Chemotherapy regimen; Randomization; Cyclophosphamide; Randomized controlled trial; Gastroenterology; Surgery; Chemotherapy; Lymphoma; Oncology","score_opus":0.008948696926539802,"score_gpt":0.24784237510676627,"score_spread":0.23889367818022647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570654636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6650526,0.0000073082906,0.000005863517,0.00020503867,0.000019783354,0.33350426,0.0002879237,0.000034131775,0.0008831127],"genre_scores_gemma":[0.628435,6.3550334e-7,0.00036007536,0.00003881571,0.000038646656,0.3708759,0.00006206826,0.0000354644,0.00015336294],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9966152,0.0005324709,0.0011902205,0.00038883102,0.0008466489,0.00042663747],"domain_scores_gemma":[0.99595195,0.00067398977,0.0016648942,0.00092978193,0.00063576346,0.00014359254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063427386,0.00047986727,0.0014367049,0.00013912441,0.00010247472,0.000016574471,0.00028118218,0.00014224634,0.000040884934],"category_scores_gemma":[0.0004980696,0.00019662708,0.00037571715,0.0005126777,0.0007268529,0.00019547371,0.00010613881,0.000117346404,0.0000043726213],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.41021824,0.038598116,0.5395744,0.00080891995,0.0032483754,0.000011870155,0.002323741,0.0000015184071,0.001569719,0.00023451277,0.0006729728,0.002737666],"study_design_scores_gemma":[0.49058744,0.0025852916,0.403839,0.00078248134,0.001414006,0.0000142072,0.00018535256,0.000011468748,0.10003216,0.000015209874,0.00036080327,0.00017260383],"about_ca_topic_score_codex":0.00033826602,"about_ca_topic_score_gemma":0.000046611665,"teacher_disagreement_score":0.13573538,"about_ca_system_score_codex":0.0001110881,"about_ca_system_score_gemma":0.00017390902,"threshold_uncertainty_score":0.80182195},"labels":[],"label_agreement":null},{"id":"W2570700343","doi":"10.1182/blood.v104.11.4788.4788","title":"Lysophosphatidic Acid (LPA) Protects Primary Chronic Lymphocytic Leukemia (CLL) Cells from Apoptosis: Role for LPA as a Survival Factor in CLL.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Lysophosphatidic acid; Apoptosis; Chronic lymphocytic leukemia; Cancer research; Biology; Protein kinase B; Endocrinology; Receptor; Internal medicine; Leukemia; Immunology; Medicine; Biochemistry","score_opus":0.014293771041563538,"score_gpt":0.2615403819868656,"score_spread":0.24724661094530204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570700343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887329,0.0046929196,0.00020402159,0.00017571915,0.0003444789,0.0042749224,0.00014342954,0.000252395,0.0011792404],"genre_scores_gemma":[0.9952697,0.0003558934,0.0014741255,0.00034569897,0.0008092055,0.0008650129,0.00022343287,0.000187333,0.00046960355],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99513596,0.00011481533,0.00084994576,0.0012014743,0.0011958702,0.0015019047],"domain_scores_gemma":[0.9975876,0.00034613485,0.00022703543,0.0010792674,0.00018441587,0.0005755521],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048076015,0.0006222762,0.0011133292,0.00032795724,0.00018419462,0.00013026531,0.0006019012,0.00053796434,0.00028204796],"category_scores_gemma":[0.00041890444,0.00058712956,0.00036477405,0.0007480459,0.0002460324,0.00024734743,0.00028923835,0.0005658255,0.00055022],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0039310483,0.002568865,0.0006534799,0.0034176297,0.0014462938,0.0009555508,0.0031551926,0.0012800487,0.9678359,0.00024442904,0.00026952385,0.014242035],"study_design_scores_gemma":[0.14233744,0.0013189723,0.0012746078,0.00081173104,0.00029324563,0.000102053724,0.00017272294,0.0014062418,0.84957635,0.0011871153,0.0009088918,0.0006106264],"about_ca_topic_score_codex":0.0121838525,"about_ca_topic_score_gemma":0.00072377635,"teacher_disagreement_score":0.1384064,"about_ca_system_score_codex":0.10831736,"about_ca_system_score_gemma":0.092342064,"threshold_uncertainty_score":0.999658},"labels":[],"label_agreement":null},{"id":"W2570707413","doi":"10.1182/blood.v114.22.2429.2429","title":"Human Cord Blood Cells with Rapid In Vivo Platelet Regenerating Activity in NOD/SCID-IL-2Rγc-/- Mice Show Variable Aldehyde Dehydrogenase Activity.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Haematopoiesis; Cord blood; Nod; Stem cell; Biology; Immunology; Aldehyde dehydrogenase; Platelet; Transplantation; Severe combined immunodeficiency; In vivo; Cancer research; Molecular biology; Cell biology; Biochemistry; Medicine; Internal medicine; Enzyme; Genetics","score_opus":0.02294746339654937,"score_gpt":0.27814508449240166,"score_spread":0.2551976210958523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570707413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98674506,0.00027269011,0.00003633762,0.00034601573,0.000049315746,0.0013422812,0.000029052377,0.00010312155,0.011076099],"genre_scores_gemma":[0.9953526,0.00005422571,0.0024806024,0.00024107669,0.00023360348,0.00006885149,0.000013053366,0.00007347843,0.0014824917],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958761,0.00038394175,0.00049932156,0.0010156186,0.00096344325,0.0012616139],"domain_scores_gemma":[0.9981282,0.00023005306,0.00021102243,0.00084119616,0.00011799055,0.00047155365],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001284126,0.00050025637,0.00089954253,0.00050899497,0.00019927262,0.00009450538,0.00034531753,0.00033739017,0.0004131193],"category_scores_gemma":[0.00016955612,0.00045295808,0.000102243306,0.0012746094,0.00010407303,0.00032386126,0.00011872012,0.0011646999,0.000028656168],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065665896,0.0045455606,0.005688608,0.00018574491,0.00010663702,0.0019988162,0.0001862306,0.00017731363,0.98388827,0.000068137444,0.00020414699,0.0022938945],"study_design_scores_gemma":[0.010840659,0.0024364155,0.0043671783,0.00045380022,0.00013382033,0.00028978207,0.000046097026,0.00087073847,0.97974163,0.000025179166,0.00032560862,0.00046907127],"about_ca_topic_score_codex":0.0013630053,"about_ca_topic_score_gemma":0.0012206127,"teacher_disagreement_score":0.010184,"about_ca_system_score_codex":0.00017137647,"about_ca_system_score_gemma":0.00042325645,"threshold_uncertainty_score":0.9997922},"labels":[],"label_agreement":null},{"id":"W2570718628","doi":"10.1182/blood.v112.11.3811.3811","title":"IGF Signaling Is Critical for Growth and Survival of T-Cell Acute Lymphoblastic Leukemia Cells and Is Potentiated by Notch Upregulation of IGF1R","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; BC Cancer Agency","funders":"","keywords":"Notch signaling pathway; PI3K/AKT/mTOR pathway; Protein kinase B; PTEN; Cancer research; Wnt signaling pathway; Biology; Signal transduction; Cell biology; Hes3 signaling axis; Insulin-like growth factor 1 receptor; Growth factor; Receptor; Genetics","score_opus":0.013299210939684754,"score_gpt":0.2573103618964949,"score_spread":0.24401115095681017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570718628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99415505,0.0003176178,0.0043088724,0.00017677638,0.000042644006,0.0004183762,0.00035515896,0.000022944083,0.00020253858],"genre_scores_gemma":[0.99562424,0.00022569488,0.0036582816,0.000111492474,0.0000599176,0.000012834863,0.000047307352,0.000042053336,0.00021819025],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99822944,0.00004649383,0.00046670676,0.0003855525,0.00051168684,0.00036009692],"domain_scores_gemma":[0.99832255,0.0007596526,0.00011726195,0.0002155331,0.00036497365,0.00022006196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017924949,0.0002042717,0.00051779434,0.00013103987,0.00009270574,0.000011204024,0.00009431524,0.00020003396,0.000041724248],"category_scores_gemma":[0.00022170134,0.00018873469,0.0000909283,0.0002107253,0.00039372573,0.00009431767,0.00008490416,0.00010596982,0.0000017266038],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044877204,0.00036621446,0.0031371284,0.00088000065,0.00023228361,0.00003114499,0.00051335484,0.0000021874073,0.99290717,0.000046381825,0.0013750951,0.000060266793],"study_design_scores_gemma":[0.0124108745,0.00076859054,0.002860215,0.00014606841,0.00084564416,0.00014851778,0.000102663136,0.0063923756,0.9760151,0.00012135284,0.000018198649,0.00017040934],"about_ca_topic_score_codex":0.00012402762,"about_ca_topic_score_gemma":7.581659e-7,"teacher_disagreement_score":0.01689208,"about_ca_system_score_codex":0.00008594211,"about_ca_system_score_gemma":0.000495226,"threshold_uncertainty_score":0.7696377},"labels":[],"label_agreement":null},{"id":"W2570744704","doi":"10.1182/blood.v106.11.907.907","title":"Low Molecular Weight Heparin and Bleeding in Patients with Severe Renal Failure: A Meta-Analysis.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Low molecular weight heparin; Renal function; Relative risk; Confidence interval; Number needed to harm; Internal medicine; Heparin; Cochrane Library; Urology; Surgery; Number needed to treat","score_opus":0.023178607270000776,"score_gpt":0.25739528515973337,"score_spread":0.2342166778897326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570744704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99603325,0.00024716186,0.00013360925,0.002149599,0.0000055683763,0.00028957124,0.0000022605498,0.00002419604,0.0011147811],"genre_scores_gemma":[0.9957066,0.0000052911023,0.0033696755,0.00021166139,0.00007808124,0.0000026578937,0.000026397907,0.000010117166,0.00058951037],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991802,0.000022991553,0.00019786203,0.00020582974,0.00025306857,0.00014004427],"domain_scores_gemma":[0.99966246,0.000020741603,0.00006639361,0.00015175175,0.000035620014,0.000063062354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011637802,0.00011726467,0.00047435655,0.00021482054,0.000024844716,0.00002049504,0.000033725453,0.000039674505,0.00019368227],"category_scores_gemma":[0.000018430415,0.00008013222,0.00019289389,0.00042336216,0.000015176796,0.00009579738,0.000033590517,0.00006524186,0.0000086660675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009244085,0.00006229246,0.970291,0.000019515312,0.02853823,0.000016599697,0.00006110777,0.00020281138,0.00011274214,0.0002807507,0.00007393576,0.00024857122],"study_design_scores_gemma":[0.011508193,0.00019270553,0.78143764,0.00001248102,0.19972631,0.0000041214244,0.000022387745,0.00025779614,0.0016452332,0.00003654753,0.004878306,0.00027830695],"about_ca_topic_score_codex":0.000009110857,"about_ca_topic_score_gemma":0.000059297392,"teacher_disagreement_score":0.18885338,"about_ca_system_score_codex":0.000011510264,"about_ca_system_score_gemma":0.000009402099,"threshold_uncertainty_score":0.3267697},"labels":[],"label_agreement":null},{"id":"W2570792206","doi":"10.1182/blood-2016-09-741298","title":"Platelets and neutrophil extracellular traps collaborate to promote intravascular coagulation during sepsis in mice","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":649,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Heart, Lung, and Blood Institute","keywords":"Neutrophil extracellular traps; Sepsis; Disseminated intravascular coagulation; Platelet; Coagulation; Medicine; Extracellular; Immunology; Intensive care medicine; Inflammation; Internal medicine; Chemistry; Biochemistry","score_opus":0.011174839998505603,"score_gpt":0.22779693536065676,"score_spread":0.21662209536215116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570792206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972383,0.0014283778,0.000036251397,0.0004290037,0.00018040258,0.0005253998,0.000026157913,0.000040941937,0.00009516818],"genre_scores_gemma":[0.9988338,0.00013607292,0.00032164197,0.000050519717,0.000040536488,0.00003911115,0.00002478751,0.000026259284,0.00052729173],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987433,0.00011488744,0.0002666968,0.000454393,0.000042898406,0.00037785404],"domain_scores_gemma":[0.99932563,0.00001782734,0.0001289386,0.00041314878,0.00006408543,0.000050379036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021571202,0.00021983309,0.00032307688,0.00014826453,0.00044841805,0.000079432735,0.00024825113,0.00020755717,0.000063651285],"category_scores_gemma":[0.00005015919,0.00021487263,0.000042867418,0.00011225425,0.00009497024,0.00020227044,0.00012716201,0.00022369799,0.00012399143],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000102472084,0.00017286037,0.0014306522,0.000028352051,0.00010868504,0.00015402398,0.00046889315,0.000008668612,0.99580437,0.00033222692,0.000011256284,0.0013775157],"study_design_scores_gemma":[0.003715421,0.00016760678,0.06835122,0.00007541268,0.00006609044,0.00007788958,0.00006477602,0.000003105513,0.92507386,0.00015292357,0.002001576,0.0002501385],"about_ca_topic_score_codex":0.0000797526,"about_ca_topic_score_gemma":0.00009170619,"teacher_disagreement_score":0.07073055,"about_ca_system_score_codex":0.000019820192,"about_ca_system_score_gemma":0.000028296066,"threshold_uncertainty_score":0.8762252},"labels":[],"label_agreement":null},{"id":"W2570876655","doi":"10.1182/blood.v112.11.853.853","title":"Identification of Mir-145 and Mir-146a as Micrornas Involved in the Pathogenesis of 5q- Syndrome","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Health Sciences Centre; Sunnybrook Health Science Centre; BC Cancer Agency","funders":"","keywords":"Haematopoiesis; Bone marrow; Cancer research; Biology; microRNA; Myeloid leukemia; Immunology; Leukemia; Thrombocytosis; Megakaryocytopoiesis; Myeloid; Medicine; Stem cell; Megakaryocyte; Gene; Genetics; Platelet","score_opus":0.02366835082884752,"score_gpt":0.2738834227437285,"score_spread":0.250215071914881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570876655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99738914,0.0013864331,0.000005624059,0.0005060727,0.000016542679,0.00044774174,0.000016812859,0.000009633058,0.00022201342],"genre_scores_gemma":[0.9989186,0.00045406836,0.00021727782,0.00008875512,0.000019765706,0.000028934934,0.000015763178,0.00001577267,0.00024107732],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987308,0.0001158273,0.0004087045,0.00020356431,0.0003628227,0.0001783211],"domain_scores_gemma":[0.9991545,0.00010923172,0.00013161951,0.0004285683,0.00011967854,0.000056381145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005286801,0.00009956703,0.00028723103,0.00018398638,0.000039673916,0.0000049571063,0.0001793669,0.0000945361,0.000020877766],"category_scores_gemma":[0.00023817827,0.00007408263,0.000058673264,0.0003974603,0.00021179813,0.000050075098,0.000052533054,0.00015238357,0.000017815375],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000890181,0.00054411095,0.070987284,0.00020973297,0.000058475573,0.0002852076,0.0015092975,2.36799e-7,0.9258734,0.00004299755,0.00022684097,0.00017339148],"study_design_scores_gemma":[0.0026766479,0.00022571595,0.7357694,0.000084180174,0.00010380447,0.0010134015,0.0005627325,0.00001744037,0.25927186,0.00006212484,0.00014354255,0.00006918972],"about_ca_topic_score_codex":0.000272279,"about_ca_topic_score_gemma":0.000026406926,"teacher_disagreement_score":0.66660154,"about_ca_system_score_codex":0.00002910581,"about_ca_system_score_gemma":0.00018237569,"threshold_uncertainty_score":0.30210018},"labels":[],"label_agreement":null},{"id":"W2570891389","doi":"10.1182/blood.v124.21.3013.3013","title":"Perifollicular Variant of Peripheral T-Cell Lymphoma, UNS: A Distinct Lymphoma Type with Cytogenetic andcytogenetic and Clinical Findings Different from Those of Angio-Immunoblastic Lymphoma","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Lymphoma; Immunophenotyping; Peripheral T-cell lymphoma; Medicine; Follicular lymphoma; Pathology; Not Otherwise Specified; T-cell lymphoma; T cell; Immunology; Antigen","score_opus":0.01706293461568995,"score_gpt":0.27598030822949643,"score_spread":0.25891737361380646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570891389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949509,0.0032089578,0.00042703399,0.00004013928,0.00007468998,0.0007557357,0.00008314589,0.00003781281,0.0004215926],"genre_scores_gemma":[0.9977394,0.0005090422,0.0012134768,0.000051424176,0.000108115884,0.00003319749,0.000086651984,0.000094303025,0.00016442392],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967187,0.00034137873,0.00087157945,0.0007666269,0.00075493817,0.0005467747],"domain_scores_gemma":[0.9977264,0.00047699444,0.00026165516,0.0008086237,0.0003720049,0.00035432528],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029928895,0.00048144933,0.0012164637,0.00017377597,0.00011581474,0.000042316304,0.00028339305,0.0002479581,0.00015310962],"category_scores_gemma":[0.00034962315,0.00036013618,0.00026165246,0.00037179474,0.0006687343,0.000040208655,0.0001967545,0.00008471772,0.000010437326],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004369274,0.009190905,0.8935642,0.00049193285,0.0014768448,0.00036999414,0.0009847817,0.000008332763,0.07517741,0.00004652348,0.000020703423,0.014299049],"study_design_scores_gemma":[0.03838341,0.008172095,0.9064624,0.00059916766,0.0018968355,0.0011430405,0.00028985558,0.0027576194,0.03951465,0.00009589478,0.00016264486,0.00052241836],"about_ca_topic_score_codex":0.0003775865,"about_ca_topic_score_gemma":0.00008272834,"teacher_disagreement_score":0.035662763,"about_ca_system_score_codex":0.00009081237,"about_ca_system_score_gemma":0.00048677908,"threshold_uncertainty_score":0.9998851},"labels":[],"label_agreement":null},{"id":"W2570893191","doi":"10.1182/blood.v108.11.2406.2406","title":"The Tumor Microenvironment Measured by Flow Cytometry Predicts Overall Survival (OS) and Transformation Risk (TR) in Follicular Lymphoma.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"CD19; CD5; Immunoglobulin light chain; Follicular lymphoma; CD20; Lymphoma; CD8; Flow cytometry; CD3; CD23; Immunophenotyping; CD38; Biology; Antibody; Pathology; Immunology; Medicine; Antigen; CD34; Stem cell","score_opus":0.004652618496617838,"score_gpt":0.1911235884170518,"score_spread":0.18647096992043397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570893191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99186665,0.00627557,0.000043339474,0.00043514432,0.00005714519,0.00058461993,0.00008581815,0.000029179164,0.00062255014],"genre_scores_gemma":[0.99799263,0.0014261083,0.00016122524,0.00008402,0.000060781913,0.00009637668,0.000095993295,0.000017800421,0.00006507919],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987303,0.000097187694,0.0002994472,0.00023287802,0.0003664433,0.00027374082],"domain_scores_gemma":[0.9995089,0.00009195019,0.00007464711,0.00022174795,0.000014366702,0.00008839184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003237059,0.00017989466,0.0002406663,0.000056225774,0.00014876758,0.000039744533,0.000054340635,0.000062026884,0.000009650365],"category_scores_gemma":[0.000026708633,0.00012084066,0.0000822512,0.00010279267,0.000050682007,0.00007267031,0.00001573388,0.000062296516,0.00001381754],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003037891,0.005709057,0.96787024,0.00008003104,0.00042620726,0.00019228284,0.00039436886,0.000039031802,0.008725499,0.0000928648,0.001809233,0.014357381],"study_design_scores_gemma":[0.0219747,0.00023830644,0.93822783,0.00006355929,0.00042069535,0.000076166616,0.000065344655,0.00029956372,0.030997047,0.000077335135,0.00741709,0.00014235718],"about_ca_topic_score_codex":0.00050040433,"about_ca_topic_score_gemma":0.0001253303,"teacher_disagreement_score":0.02964242,"about_ca_system_score_codex":0.00015004925,"about_ca_system_score_gemma":0.00003329357,"threshold_uncertainty_score":0.49277392},"labels":[],"label_agreement":null},{"id":"W2570921152","doi":"10.1182/blood.v114.22.861.861","title":"Safety and Efficacy of Subcutaneous-Administered Omacetaxine Mepesuccinate in Chronic Myeloid Leukemia (CML) Patients Who Are Resistant or Intolerant to Two or More Tyrosine Kinase Inhibitors – Results of A Multicenter Phase 2/3 Study.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Dasatinib; Adverse effect; Gastroenterology; Dosing; Regimen; Clinical trial; Myeloid leukemia; Imatinib","score_opus":0.015939251782126147,"score_gpt":0.30403649885043266,"score_spread":0.28809724706830653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570921152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994837,0.00052982033,0.0000019708518,0.00034130178,0.00007219705,0.0036639906,0.00040936115,0.000047516252,0.00009688464],"genre_scores_gemma":[0.998508,0.00015129028,0.00043489542,0.00012136183,0.000091616625,0.000035600242,0.00012278336,0.000057784968,0.00047671946],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9958426,0.00016569822,0.0017768007,0.0008970419,0.0007056727,0.0006122202],"domain_scores_gemma":[0.9974609,0.00023693015,0.00066462473,0.0009631917,0.00027958362,0.00039479267],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036044087,0.0005611001,0.0014868431,0.0004446426,0.00007226518,0.000018649202,0.00022370729,0.00014832059,0.00004767784],"category_scores_gemma":[0.000791481,0.0004039376,0.00013223685,0.000777867,0.000113516915,0.00010057732,0.00014926789,0.00030905285,0.0000045443235],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7025066,0.05802778,0.035926186,0.001743775,0.0012702387,0.013775848,0.014973963,0.00015509746,0.090102136,0.0000055931564,0.0003634818,0.08114933],"study_design_scores_gemma":[0.4770002,0.059984583,0.36476627,0.0052175666,0.0011634893,0.00015059534,0.000894677,0.00042436924,0.089321874,0.0000014475796,0.00044380876,0.0006311288],"about_ca_topic_score_codex":0.00058873557,"about_ca_topic_score_gemma":0.0019849078,"teacher_disagreement_score":0.32884008,"about_ca_system_score_codex":0.0017102546,"about_ca_system_score_gemma":0.0008544034,"threshold_uncertainty_score":0.9998413},"labels":[],"label_agreement":null},{"id":"W2570930624","doi":"10.1182/blood.v112.11.707.707","title":"The Voltage-Gated Proton Channel HVCN1 Co-Localizes with B Cell Receptor and Is Involved in Class Switch Recombination in Vivo","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Ion channel regulation and function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; B-cell receptor; Molecular biology; Germinal center; MHC class II; B cell; Chronic lymphocytic leukemia; Cell biology; Antigen; Major histocompatibility complex; Leukemia; Antibody; Immunology","score_opus":0.010642639045374554,"score_gpt":0.21442543097699557,"score_spread":0.20378279193162102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570930624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981736,0.0001881932,0.00015866388,0.00028588955,0.00008183747,0.0005200596,0.0000048041125,0.000010509588,0.0005764519],"genre_scores_gemma":[0.9977646,0.0005539787,0.000028728115,0.00013084999,0.00006766309,0.000092668335,0.000057416826,0.0000140923685,0.001290034],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993078,0.000049549762,0.00016061154,0.00023068444,0.00010013807,0.00015121447],"domain_scores_gemma":[0.9996939,0.000010799523,0.00006588722,0.00013008274,0.00006422556,0.000035115234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015929394,0.00010607451,0.00008815229,0.000055016782,0.00009880872,0.000015593396,0.00005746976,0.00013176432,0.000012010691],"category_scores_gemma":[0.000021837483,0.00007888697,0.000018500963,0.00014286223,0.000063737374,0.000006767554,0.000019840041,0.000079774494,0.0000031891896],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001109076,0.001130784,0.09270994,0.0001062611,0.00005483045,0.000011311862,0.001646217,0.00015904452,0.8945844,0.000058281566,0.0074320324,0.0009977918],"study_design_scores_gemma":[0.0038090243,0.00041835997,0.003196706,0.000023697266,0.0000057454204,0.0000086574655,0.00031509882,0.0012062306,0.96224767,0.00004800697,0.028555907,0.00016491642],"about_ca_topic_score_codex":0.000043199165,"about_ca_topic_score_gemma":0.00013940362,"teacher_disagreement_score":0.089513235,"about_ca_system_score_codex":0.00001227815,"about_ca_system_score_gemma":0.000040279192,"threshold_uncertainty_score":0.32169175},"labels":[],"label_agreement":null},{"id":"W2570969063","doi":"10.1182/blood.v108.11.1403.1403","title":"Nuclear Localization of the NuMA-RARα/RXRα Complex Is Necessary for Leukemogenesis in hCG-NuMA-RARα Transgenic Mice.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Biology; Cancer research; Retinoic acid receptor; Acute promyelocytic leukemia; Retinoic acid; Leukemia; Myeloid; Myeloid leukemia; Fusion gene; Retinoid X receptor; Promyelocytic leukemia protein; Transcription factor; Immunology; Nuclear receptor; Genetics; Gene","score_opus":0.008533669854448669,"score_gpt":0.21630024398755443,"score_spread":0.20776657413310576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570969063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99351406,0.001595539,0.0023816053,0.00015289431,0.00011313681,0.00035810724,0.00005962455,0.000013413151,0.0018116317],"genre_scores_gemma":[0.99822456,0.00017062681,0.000459852,0.00032017071,0.00025482697,0.00002679547,0.00015258304,0.000042440122,0.0003481256],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998837,0.00006144793,0.00036218407,0.00034148942,0.00015141079,0.00024648648],"domain_scores_gemma":[0.99937385,0.000015768546,0.00013798208,0.00035096533,0.00009080908,0.000030612908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012645281,0.00017894474,0.00020139187,0.000038711194,0.00010384951,0.00001871043,0.00036896288,0.00021526705,0.00004101826],"category_scores_gemma":[0.000024332412,0.00015120015,0.0001856844,0.0001941917,0.00012205892,0.000005331081,0.00005788335,0.00006447161,0.0000031824884],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011416235,0.0003158337,0.01039934,0.00027937355,0.000064666354,9.460382e-7,0.00012534826,0.00055042683,0.9827798,0.00024964564,0.00472337,0.00039711522],"study_design_scores_gemma":[0.002173709,0.00013140628,0.0031596073,0.000036160534,0.00009613713,0.000010830778,0.000109102075,0.00036403077,0.97155064,0.0006809794,0.021456575,0.0002307906],"about_ca_topic_score_codex":0.00008970824,"about_ca_topic_score_gemma":0.00006784192,"teacher_disagreement_score":0.016733205,"about_ca_system_score_codex":0.00001587156,"about_ca_system_score_gemma":0.000116071715,"threshold_uncertainty_score":0.6165763},"labels":[],"label_agreement":null},{"id":"W2570979556","doi":"10.1182/blood.v118.21.344.344","title":"Heme Oxygenase 1 Plays An Unexpected Role During Erythroid Differentiation","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Heme Oxygenase-1 and Carbon Monoxide","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Heme; Erythropoiesis; Heme oxygenase; Catabolism; Biochemistry; Red blood cell; Chemistry; Biology; Cell biology; Enzyme; Internal medicine; Anemia","score_opus":0.010360388729433005,"score_gpt":0.20175398162485492,"score_spread":0.1913935928954219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570979556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99700844,0.00035124263,0.000082405626,0.000006476215,0.000060347804,0.00011499923,0.000018124418,0.00004821944,0.0023097617],"genre_scores_gemma":[0.9986521,0.000050560568,0.0004159836,0.000053342843,0.00026349645,0.00002946241,0.00020949353,0.000033449975,0.00029208764],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990218,0.000048184163,0.00018377723,0.00036196833,0.00010768504,0.00027652876],"domain_scores_gemma":[0.99931294,0.000001778111,0.00006507832,0.00042612047,0.000047287926,0.00014682293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000053166124,0.00016598841,0.00011938706,0.000041146006,0.00008494155,0.000018599962,0.00016713438,0.00014484991,0.00010332618],"category_scores_gemma":[0.000020547748,0.0001656054,0.00008050887,0.00006777823,0.000027269803,0.000007580098,0.000069042624,0.00007046767,0.000023126793],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052428895,0.00041875424,0.0064663067,0.000010041828,0.000063844935,0.000010437415,0.00019911426,0.000001140939,0.9926173,0.000034258406,0.000030571435,0.00009578336],"study_design_scores_gemma":[0.0011434504,0.00018892337,0.06933729,0.00000557014,0.000038926202,0.00001957649,0.00016317017,0.000017729646,0.92859524,0.000054465567,0.00021890918,0.00021674295],"about_ca_topic_score_codex":0.000047857946,"about_ca_topic_score_gemma":0.00009654684,"teacher_disagreement_score":0.06402207,"about_ca_system_score_codex":0.0000062342774,"about_ca_system_score_gemma":0.000030115541,"threshold_uncertainty_score":0.6753192},"labels":[],"label_agreement":null},{"id":"W2571019625","doi":"10.1182/blood.v116.21.4008.4008","title":"Loss of the Y Chromosome in MDS - Age-Related Phenomenon or Clonal Abnormality?","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"clone (Java method); Karyotype; Chromosome abnormality; Internal medicine; Myelodysplastic syndromes; Univariate analysis; Multivariate analysis; Abnormality; Cytopenia; Biology; Bone marrow; Gastroenterology; Oncology; Medicine; Pathology; Chromosome; Genetics","score_opus":0.014968318209936193,"score_gpt":0.2803139900972123,"score_spread":0.2653456718872761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571019625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873302,0.00006206588,7.110996e-7,0.0011568082,0.00013418123,0.00040641704,0.000015444868,0.000025909863,0.010868236],"genre_scores_gemma":[0.9960264,0.000023017425,0.00024070081,0.00016325232,0.00014902119,0.000018866374,0.000013540544,0.00002340739,0.003341814],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99863946,0.000066387875,0.0003406009,0.00020516948,0.0004160614,0.00033232203],"domain_scores_gemma":[0.9990923,0.00009778836,0.000078361256,0.0005504906,0.00007146889,0.0001096252],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00047129794,0.00012179205,0.0002768067,0.00010485569,0.000041919193,0.000008802415,0.0003011466,0.00017404204,0.00092658383],"category_scores_gemma":[0.00023492398,0.00007301608,0.00008079512,0.0005445479,0.0003178456,0.00006103083,0.00016193156,0.00091637403,0.000056176694],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00097163994,0.004194306,0.37366173,0.00057655445,0.0005433921,0.003338636,0.0030104448,0.000007377778,0.6043838,0.0056672925,0.0012300512,0.002414771],"study_design_scores_gemma":[0.025152365,0.0007862354,0.8502615,0.0002659505,0.00026775626,0.0018023206,0.00017833895,0.00017500222,0.11249944,0.0012096035,0.007040604,0.0003608505],"about_ca_topic_score_codex":0.0002362203,"about_ca_topic_score_gemma":0.00022089064,"teacher_disagreement_score":0.49188438,"about_ca_system_score_codex":0.00005826782,"about_ca_system_score_gemma":0.00053464784,"threshold_uncertainty_score":0.9999867},"labels":[],"label_agreement":null},{"id":"W2571061525","doi":"10.1182/blood.v118.21.2107.2107","title":"Iron Dextran Versus Iron Sucrose for Non-Hemodialysis Adult Outpatients with Iron Deficiency Anemia: Assessment of Safety and Feasibility for A Randomized Controlled Trial","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Victoria Hospital; London Health Sciences Centre; Western University","funders":"","keywords":"Iron sucrose; Medicine; Anemia; Hemodialysis; Randomized controlled trial; Iron-deficiency anemia; Iron deficiency; Adverse effect; Internal medicine; Pediatrics; Surgery; Intravenous iron","score_opus":0.04997864673674715,"score_gpt":0.36050766914446813,"score_spread":0.31052902240772096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571061525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98228174,0.0003239175,0.0015165127,0.00019100842,0.00020826458,0.013000414,0.0000676928,0.000018058894,0.0023923826],"genre_scores_gemma":[0.99315524,0.00026879713,0.0054368456,0.000058954975,0.00008437022,0.00090944406,0.000026728412,0.000017900906,0.00004171819],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9981539,0.00015571427,0.00068962434,0.00038949627,0.0002938727,0.00031739598],"domain_scores_gemma":[0.99629563,0.0026058366,0.00044567222,0.00023094534,0.00026660718,0.00015528925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013279114,0.00023267914,0.0015495507,0.000045849847,0.00016510319,0.000012406583,0.000076460055,0.000107950815,0.000031041945],"category_scores_gemma":[0.0016409149,0.00014477267,0.0003555686,0.000083472725,0.00020620914,0.00009275499,0.000032413176,0.00013336957,3.1667622e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98958623,0.0033362296,0.0042762705,0.0005935691,0.00029502998,0.0000018194027,0.0004970722,0.0000012523521,0.00044410746,0.000094892486,0.0000068529985,0.0008666433],"study_design_scores_gemma":[0.9794921,0.0067509166,0.002837294,0.00004066075,0.009280854,0.0000018297437,0.00019906281,0.0005392355,0.0006375204,0.00003195909,0.000028011242,0.00016049901],"about_ca_topic_score_codex":0.00011770457,"about_ca_topic_score_gemma":0.00007136919,"teacher_disagreement_score":0.01209097,"about_ca_system_score_codex":0.000044844186,"about_ca_system_score_gemma":0.00009917448,"threshold_uncertainty_score":0.5903658},"labels":[],"label_agreement":null},{"id":"W2571078417","doi":"10.1182/blood.v114.22.3855.3855","title":"Activity with Thalidomide-Based Therapy Following Lenalidomide Plus Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Lenalidomide; Thalidomide; Pomalidomide; Medicine; Multiple myeloma; Dexamethasone; Internal medicine; Autologous stem-cell transplantation; Oncology; Refractory (planetary science); Combination therapy; Progressive disease; Maintenance therapy; Transplantation; Gastroenterology; Surgery; Chemotherapy","score_opus":0.019466180485118355,"score_gpt":0.26720748448673587,"score_spread":0.2477413040016175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571078417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99695355,0.00025294872,0.00014467156,0.00023884806,0.0000270408,0.001642433,0.000016065775,0.00010761288,0.000616853],"genre_scores_gemma":[0.996286,0.000019396135,0.003054462,0.00024732473,0.000048710124,0.00009359851,0.000084416046,0.000057350455,0.0001087851],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973817,0.0001778535,0.0002612102,0.00058542937,0.00089215196,0.00070164667],"domain_scores_gemma":[0.9984673,0.00031837553,0.00013359544,0.0006152921,0.00011658961,0.0003488033],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026723248,0.00039529603,0.00065346994,0.00028740268,0.00012115003,0.0000411635,0.00014427582,0.0001407888,0.00003681252],"category_scores_gemma":[0.00018931329,0.0002586646,0.00014659237,0.00046416756,0.00007404567,0.00025285155,0.000017781602,0.00044408924,0.000018837092],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022162024,0.006743634,0.94863266,0.000023385071,0.00042575455,0.00077570725,0.00012495782,0.000036813388,0.0028945603,0.0000017423152,0.000015308324,0.018163437],"study_design_scores_gemma":[0.14424205,0.0047384356,0.82795924,0.00026337625,0.000120798606,0.000007697375,0.00002061424,0.00013858394,0.022176148,0.000006131205,0.000065248634,0.000261712],"about_ca_topic_score_codex":0.0003012601,"about_ca_topic_score_gemma":0.00016980142,"teacher_disagreement_score":0.12208002,"about_ca_system_score_codex":0.00022594821,"about_ca_system_score_gemma":0.0004005857,"threshold_uncertainty_score":0.9999865},"labels":[],"label_agreement":null},{"id":"W2571086415","doi":"10.1182/blood.v110.11.3688.3688","title":"Four Novel Mutations in the Ferrochelatase (FECH) Gene in Patients with Erythropoietic Protoporphyria (EPP).","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Porphyrin Metabolism and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Family Medicine","funders":"","keywords":"Ferrochelatase; Erythropoietic protoporphyria; Biology; Genetics; Molecular biology; Gene; Porphyria; Porphobilinogen deaminase; Penetrance; Allele; Mutation; Protoporphyrin; Heme; Phenotype; Biochemistry; Enzyme; Acute intermittent porphyria; Endocrinology","score_opus":0.006787349487833632,"score_gpt":0.22013150530356215,"score_spread":0.21334415581572852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571086415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99745876,0.0002040346,0.0008162146,0.00006139965,0.000031348125,0.00070154975,0.00003012579,0.0000055636706,0.0006910326],"genre_scores_gemma":[0.99776924,0.000013311279,0.0015174199,0.0002384751,0.00004871502,0.00007783252,0.00029103144,0.00001536242,0.000028627353],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909794,0.00003469262,0.00019662084,0.0002438331,0.00016047712,0.0002664063],"domain_scores_gemma":[0.99952537,0.000011770575,0.000059329268,0.0003139947,0.000047519505,0.00004204241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029770588,0.00013058432,0.000102621925,0.0000687819,0.000047562844,0.000015212563,0.00019272423,0.00008912372,0.000007274424],"category_scores_gemma":[0.000068603214,0.000094064235,0.000030650444,0.00026601064,0.00006862473,0.000005594678,0.00003962043,0.00010294006,0.000006826958],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042632787,0.005447757,0.92386115,0.000039541253,0.00006966323,0.00004797901,0.00062774844,0.00013158393,0.067720026,0.00029935045,0.00028757087,0.0010412823],"study_design_scores_gemma":[0.006889508,0.00018894262,0.9753177,0.000010427213,0.000033150256,0.0000103819775,0.00018746463,0.0000016030534,0.015431339,0.00011942912,0.0016189828,0.00019104523],"about_ca_topic_score_codex":0.000055935587,"about_ca_topic_score_gemma":0.0003338343,"teacher_disagreement_score":0.052288685,"about_ca_system_score_codex":0.0000042598863,"about_ca_system_score_gemma":0.000054053602,"threshold_uncertainty_score":0.3835828},"labels":[],"label_agreement":null},{"id":"W2571114168","doi":"10.1182/blood.v106.11.2665.2665","title":"Purified Peritoneal Macrophages Do Not Promote Angiogenesis In Vivo.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Matrigel; Angiogenesis; Neovascularization; In vivo; Pathology; Medicine; Macrophage; Immunology; Bone marrow; Biology; Cancer research; In vitro","score_opus":0.008965052185671023,"score_gpt":0.2447312224571213,"score_spread":0.23576617027145028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571114168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99389756,0.004380491,0.000031361957,0.00024705374,0.0000700048,0.00014593909,0.000039484647,0.000014428758,0.0011736712],"genre_scores_gemma":[0.995428,0.0005291343,0.0013660279,0.0003109439,0.00074681506,0.00005001216,0.000017095264,0.00003032693,0.0015216167],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990166,0.000030557025,0.00018940638,0.00036191792,0.00011632971,0.00028518485],"domain_scores_gemma":[0.99954677,0.0000038019964,0.00004630689,0.00029801088,0.000036126145,0.000068982816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011432553,0.00015642725,0.00014329981,0.00004622336,0.000051425854,0.000026016696,0.00017784988,0.00015540882,0.00014318641],"category_scores_gemma":[0.000013724384,0.00013295318,0.00013580904,0.00009616252,0.000042826137,0.0000037985824,0.00007601135,0.00004149137,0.000025690151],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048138405,0.00026140004,0.010751392,0.000010305086,0.00005399547,0.00001274142,0.000051946492,0.000022173635,0.9806074,0.000018593848,0.0008987379,0.0072632036],"study_design_scores_gemma":[0.0009196927,0.000101174395,0.0076606455,0.000009496134,0.000028145796,0.000021854783,0.000018969275,0.000008787972,0.90861857,0.000003609519,0.082413115,0.00019593944],"about_ca_topic_score_codex":0.0000257819,"about_ca_topic_score_gemma":0.00007225184,"teacher_disagreement_score":0.08151437,"about_ca_system_score_codex":0.000010690935,"about_ca_system_score_gemma":0.000048667032,"threshold_uncertainty_score":0.54216737},"labels":[],"label_agreement":null},{"id":"W2571162532","doi":"10.1182/blood.v118.21.2562.2562","title":"GATA1 mutations Outside the Blast Cell Population in Transient Leukemia of Down Syndrome","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"GATA1; Haematopoiesis; Biology; Population; Molecular biology; Myeloid; clone (Java method); Leukemia; Myelopoiesis; CD34; Precursor cell; Myeloid leukemia; Immunology; Stem cell; Cell; Cell biology; Genetics; Medicine","score_opus":0.023754427226991087,"score_gpt":0.256570534527671,"score_spread":0.2328161073006799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571162532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900824,0.00007638518,0.000057595356,0.00021430354,0.000032494918,0.00048790613,0.000015299041,0.000023591907,0.009010045],"genre_scores_gemma":[0.9984615,0.000014792109,0.0008785086,0.00006640413,0.000023316741,0.00003424107,0.00004513466,0.000018899653,0.00045721256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989185,0.000063244945,0.00032114217,0.00017850156,0.0002887299,0.00022991194],"domain_scores_gemma":[0.99936813,0.00007398494,0.00006760214,0.0003500035,0.00006319747,0.000077071585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025129705,0.000099924044,0.0002094046,0.00016499117,0.000039737282,0.0000049734904,0.00013811236,0.00007803872,0.00017279222],"category_scores_gemma":[0.00006155064,0.00007101717,0.000069506495,0.00034178083,0.000082992534,0.00006342308,0.000027109978,0.00026815603,0.000053859592],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013972969,0.00777466,0.74563456,0.0017555197,0.0007522672,0.0030805322,0.055921428,0.00065264147,0.16966216,0.0022008724,0.0023867283,0.008781349],"study_design_scores_gemma":[0.0039046563,0.00030877872,0.9667938,0.00008342343,0.00016413472,0.00023495361,0.00070240116,0.00032245347,0.027135698,0.00017180934,0.00008232637,0.00009556538],"about_ca_topic_score_codex":0.0017946166,"about_ca_topic_score_gemma":0.00023356167,"teacher_disagreement_score":0.22115926,"about_ca_system_score_codex":0.00016074858,"about_ca_system_score_gemma":0.00024734458,"threshold_uncertainty_score":0.28959963},"labels":[],"label_agreement":null},{"id":"W2571163265","doi":"10.1182/blood.v124.21.5471.5471","title":"Phase I Study of 131-I-Tositumomab Radioimmunotherapy (RIT) in Patients with Relapsed or Residual CD20 Antigen-Expressing B Cell Lymphomas Following Autologous Hematopoietic Stem Cell Transplantation","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Radioimmunotherapy; Medicine; Ibritumomab tiuxetan; CD20; Hematopoietic stem cell transplantation; Transplantation; Diffuse large B-cell lymphoma; Rituximab; Internal medicine; Lymphoma; Oncology; Cancer research; Gastroenterology; Immunology; Monoclonal antibody; Antibody","score_opus":0.013099212266145906,"score_gpt":0.2731688981796613,"score_spread":0.26006968591351537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571163265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99807864,0.00018300205,0.00019443565,0.000026200936,0.000025294188,0.00085647986,0.000008903093,0.000060444883,0.00056661974],"genre_scores_gemma":[0.99915016,0.000019792538,0.0005372327,0.0000350789,0.000029444851,0.00005597023,0.00004126262,0.000035940953,0.00009514346],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99848735,0.000092846734,0.0004789372,0.0003524523,0.00033358982,0.0002547939],"domain_scores_gemma":[0.99921274,0.000117210686,0.00016028508,0.00036532606,0.000041590676,0.00010287355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016736017,0.00020749208,0.00043847965,0.00007678005,0.000101741796,0.00001630602,0.00012365781,0.00009597457,0.000016165002],"category_scores_gemma":[0.0000054016864,0.0001648718,0.000061441955,0.00027585815,0.000046121942,0.00007617082,0.000009202658,0.00017200937,0.000002687188],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066873,0.06343034,0.2667243,0.001308878,0.00028657576,0.00037236622,0.009955355,0.00008281329,0.6484549,0.000010416995,0.0000240309,0.0026627185],"study_design_scores_gemma":[0.11877207,0.0033191163,0.056167766,0.00030686427,0.0006675671,0.00004272946,0.0006777519,0.0001209102,0.8196046,0.000005518242,0.000037878013,0.00027725863],"about_ca_topic_score_codex":0.000013744126,"about_ca_topic_score_gemma":0.000001720984,"teacher_disagreement_score":0.2105565,"about_ca_system_score_codex":0.00002878963,"about_ca_system_score_gemma":0.0000741398,"threshold_uncertainty_score":0.6723277},"labels":[],"label_agreement":null},{"id":"W2571206642","doi":"10.1182/blood.v114.22.69.69","title":"Parental Views On Consent, Tissue Taking and Tissue Banking in Pediatric Oncology Patients.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Ethics and Legal Issues in Pediatric Healthcare","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Medicine; Confidentiality; Pediatric oncology; Family medicine; Cancer; Internal medicine","score_opus":0.060923950388239646,"score_gpt":0.39579465012822934,"score_spread":0.3348706997399897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571206642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96946275,0.0038421236,0.000003825827,0.0023018871,0.0002665584,0.00053031667,0.000007637104,0.000041712,0.02354321],"genre_scores_gemma":[0.99439156,0.0019316328,0.00051412324,0.0022427593,0.00074467855,0.000010725731,0.000033451386,0.000016595386,0.00011446541],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847955,0.00012371391,0.00042746463,0.0003516754,0.00026475522,0.00035283383],"domain_scores_gemma":[0.9991114,0.0002654841,0.00016668883,0.0002015697,0.000068508445,0.00018632399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037708215,0.00017144972,0.00038906105,0.00021832096,0.00007891693,0.000016698945,0.0000718695,0.0002663391,0.00007896183],"category_scores_gemma":[0.0004355462,0.00015676994,0.00002845774,0.00026548823,0.00003803576,0.000044381784,0.000033335236,0.0006515353,0.00003056483],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009220255,0.002044075,0.88081604,0.0003410889,0.000012215256,0.00062510296,0.0034290836,0.0000011396855,0.00015988578,0.0013179565,0.0006873702,0.11047386],"study_design_scores_gemma":[0.008349713,0.006291635,0.9016812,0.00024744237,0.00025503786,0.00011481222,0.0002082501,0.000010142562,0.0007080728,0.00071986933,0.08101966,0.00039418254],"about_ca_topic_score_codex":0.00015321864,"about_ca_topic_score_gemma":0.00017810581,"teacher_disagreement_score":0.110079676,"about_ca_system_score_codex":0.000073516654,"about_ca_system_score_gemma":0.00017434987,"threshold_uncertainty_score":0.63928926},"labels":[],"label_agreement":null},{"id":"W2571213554","doi":"10.1182/blood.v120.21.3776.3776","title":"High Risk of Error in Categorizing Treatment Response in Individual CML Patients by Standard Cytogenetic Analysis or PCR Assay with High CV: A Bayesian Analysis","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Imatinib; Nilotinib; Oncology; Dasatinib; Internal medicine; Medicine; Imatinib mesylate; Statistics; Myeloid leukemia; Mathematics","score_opus":0.018499044465678856,"score_gpt":0.27368544468186706,"score_spread":0.2551864002161882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571213554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99769264,0.00047372302,0.00014387064,0.00005717324,0.000025416113,0.00072527764,0.0008339058,0.000027594484,0.000020417137],"genre_scores_gemma":[0.99560416,0.0001016138,0.003155808,0.000020696234,0.000028362594,0.00013908463,0.00075508485,0.000044243796,0.00015092397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99654716,0.0006790254,0.0007635171,0.0005473895,0.00079641154,0.00066648034],"domain_scores_gemma":[0.99808353,0.0003686403,0.00042021996,0.0007413043,0.00009254633,0.00029375037],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008515739,0.0004190982,0.00138688,0.0015759267,0.000053639003,0.000017403,0.00014448773,0.00018150108,0.00025370123],"category_scores_gemma":[0.00021077562,0.00028961178,0.00026351857,0.0039179157,0.00007478023,0.00011042433,0.000052785388,0.0001959705,0.0000061555797],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064981184,0.0043588597,0.9697309,0.000023040322,0.01566105,0.00010574395,0.0018339407,0.00040470352,0.00020924787,0.0000019015245,0.000012209711,0.00116025],"study_design_scores_gemma":[0.029111946,0.003466923,0.916874,0.000057245412,0.039917465,0.0000050656413,0.00027600976,0.00008096109,0.0099202655,0.0000034598568,0.000028171333,0.00025849213],"about_ca_topic_score_codex":0.009456734,"about_ca_topic_score_gemma":0.00770719,"teacher_disagreement_score":0.05285694,"about_ca_system_score_codex":0.0016238112,"about_ca_system_score_gemma":0.00051471614,"threshold_uncertainty_score":0.9999556},"labels":[],"label_agreement":null},{"id":"W2571231715","doi":"10.1182/blood.v116.21.2527.2527","title":"Myh9 Q1443L Is a Novel Mouse Model of MYH9-Related Disorders","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; Hospital for Sick Children; St. Michael's Hospital; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Canadian Blood Services; University of Toronto","funders":"","keywords":"Platelet disorder; Biology; Genetics; Phenotype; Molecular biology; Megakaryocyte; Haematopoiesis; Immunology; Gene; Stem cell; Platelet","score_opus":0.009963217208319233,"score_gpt":0.23379834584317521,"score_spread":0.223835128634856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571231715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99214137,0.00010395055,0.00009999817,0.0005449576,0.000059694983,0.00027881234,0.00008606647,0.000059575297,0.0066255867],"genre_scores_gemma":[0.99441034,0.00008266253,0.0020112318,0.0002079436,0.000012830424,0.000014667462,0.00003799301,0.000032156153,0.0031901582],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990976,0.0000043993064,0.00023765059,0.00023121337,0.00019875518,0.00023037233],"domain_scores_gemma":[0.99936634,0.000026003114,0.00008278221,0.00035782298,0.00004995145,0.000117067735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000053645836,0.00016059524,0.00031585532,0.00008393123,0.00004183512,0.000005914689,0.00008652644,0.00015922725,0.00015165514],"category_scores_gemma":[0.000054330303,0.00013301977,0.00013095036,0.00012736814,0.00007163748,0.000056543537,0.000031036798,0.00022019731,0.000052224404],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023330786,0.017852383,0.039492227,0.00016398181,0.0017396082,0.00004919853,0.002532641,0.000088370245,0.9301007,0.0017268074,0.001226232,0.0047945874],"study_design_scores_gemma":[0.1701222,0.002989803,0.025360454,0.00033626484,0.006348908,0.00050066586,0.00089515117,0.069203824,0.70069116,0.014855802,0.006424345,0.0022714233],"about_ca_topic_score_codex":0.000120867306,"about_ca_topic_score_gemma":0.000084526124,"teacher_disagreement_score":0.2294095,"about_ca_system_score_codex":0.0000052521227,"about_ca_system_score_gemma":0.00007150918,"threshold_uncertainty_score":0.5424389},"labels":[],"label_agreement":null},{"id":"W2571269762","doi":"10.1182/blood.v126.23.1098.1098","title":"Delayed Major Bleeding in Critically Ill Trauma Patients","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Trauma and Emergency Care Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Incidence (geometry); Hazard ratio; Major trauma; Trauma center; Injury Severity Score; Emergency department; Aspirin; Retrospective cohort study; Coagulopathy; Clopidogrel; Confidence interval; Surgery; Emergency medicine; Internal medicine; Poison control; Injury prevention","score_opus":0.030211096057579993,"score_gpt":0.28471307560734493,"score_spread":0.25450197954976495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571269762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94586325,0.00042114296,0.00001042226,0.0005959555,0.0002779688,0.00014880342,0.000006623424,0.000048316266,0.052627515],"genre_scores_gemma":[0.9983205,0.000014499185,0.0007883253,0.00051941717,0.0001343145,0.000015787247,0.000011066423,0.000014705717,0.00018135349],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991297,0.00001347655,0.00021306743,0.00016578265,0.00022565329,0.00025231187],"domain_scores_gemma":[0.9992548,0.000016823267,0.000015272673,0.000113427785,0.00044626344,0.00015338165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009277627,0.00010067067,0.00019625625,0.0000740122,0.000026977408,0.0000050313784,0.00004800386,0.000053915974,0.000043501383],"category_scores_gemma":[0.00045448705,0.00008596901,0.00004965443,0.00014414261,0.00003185793,0.000048902657,0.000027589118,0.00010612916,0.000055919107],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023175024,0.0022055204,0.97127694,0.00009022078,0.0002086613,0.00016172384,0.0033437945,7.394513e-7,0.0006497261,0.00034586622,0.0069460887,0.014538954],"study_design_scores_gemma":[0.015513702,0.0011966383,0.9717082,0.0001255209,0.0003713456,0.000023020855,0.0021544085,0.000014658592,0.0022686766,0.00036809465,0.005990925,0.00026481267],"about_ca_topic_score_codex":0.0001158644,"about_ca_topic_score_gemma":0.00011065432,"teacher_disagreement_score":0.05245728,"about_ca_system_score_codex":0.000026096926,"about_ca_system_score_gemma":0.000030147557,"threshold_uncertainty_score":0.35057145},"labels":[],"label_agreement":null},{"id":"W2571301763","doi":"10.1182/blood.v114.22.1839.1839","title":"Extracellular Metabolite Biomarkers of Bortezomib Resistance in Multiple Myeloma Indicate Involvement of Unexpected Metabolic Pathways.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Bortezomib; Metabolite; Metabolomics; Extracellular; Metabolic pathway; Multiple myeloma; Proteasome inhibitor; Cell growth; Cell culture; Chemistry; Pharmacology; Biology; Proteasome; Cancer research; Biochemistry; Metabolism; Chromatography; Immunology","score_opus":0.02916951317365667,"score_gpt":0.2666788154445136,"score_spread":0.23750930227085693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571301763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9641841,0.03387082,0.000031405238,0.00013670247,0.000024373674,0.0008777766,0.00009675007,0.00003609147,0.0007419979],"genre_scores_gemma":[0.9936799,0.00069880567,0.0051959837,0.000025026186,0.000026855438,0.00004793858,0.00013071667,0.000022361975,0.00017245863],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975626,0.00013460351,0.0007699852,0.00039729182,0.00064602215,0.0004894949],"domain_scores_gemma":[0.9986743,0.0000872123,0.00029665616,0.0005360198,0.00016006693,0.00024576407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038009995,0.00024689373,0.0007748697,0.0005606531,0.000036703368,0.000007430193,0.00017557241,0.000114305454,0.00004406423],"category_scores_gemma":[0.00028578,0.00021022113,0.00019477945,0.0009105946,0.00013442057,0.000088508634,0.00004119841,0.00016591222,0.0000072116122],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013208997,0.0050142207,0.26094025,0.00019362065,0.00096645614,0.00037365555,0.0006498393,8.59208e-7,0.72191447,0.0009303304,0.000025984573,0.00766939],"study_design_scores_gemma":[0.011006033,0.00021777842,0.60346097,0.000119870274,0.00021269928,0.0000039151005,0.000102222686,0.000037530535,0.38413423,0.00015173979,0.00044629356,0.000106747044],"about_ca_topic_score_codex":0.00020118098,"about_ca_topic_score_gemma":0.00014153177,"teacher_disagreement_score":0.34252068,"about_ca_system_score_codex":0.000033681717,"about_ca_system_score_gemma":0.00018172065,"threshold_uncertainty_score":0.8572569},"labels":[],"label_agreement":null},{"id":"W2571311836","doi":"10.1182/blood.v126.23.2587.2587","title":"ASXL1 and ASXL2 Mutations in Childhood AML Are Strongly Associated with t(8;21) but Do Not Independently Impact on Prognosis: A Report from the Children's Oncology Group and NCI/COG Target Initiative","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Biology; Gene; Epigenetics; Mutation; Genetics; Nonsense mutation; Cancer research; Missense mutation","score_opus":0.02415841168431884,"score_gpt":0.296528748715443,"score_spread":0.2723703370311242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571311836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944611,0.0006370812,0.000008570527,0.0018757753,0.000026947113,0.0015957541,0.00045657862,0.000064651045,0.000873502],"genre_scores_gemma":[0.99810207,0.000042117816,0.00043382467,0.000373132,0.00017187299,0.00020663222,0.0005819981,0.0000519082,0.000036458012],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973796,0.00039304994,0.00041256423,0.0006041042,0.0007036303,0.00050706096],"domain_scores_gemma":[0.99805874,0.0006036131,0.00036541006,0.00035872596,0.00024422928,0.00036928625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008949708,0.00031905415,0.0005976145,0.0001992524,0.00013344658,0.00008208882,0.00015813367,0.00027870157,0.00002133729],"category_scores_gemma":[0.001782719,0.00020023406,0.000058835543,0.00041034422,0.00025715303,0.00018319568,0.00014060613,0.001100292,0.000006934706],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060100364,0.0019379995,0.9898094,0.0000069554894,0.001205581,0.0016753767,0.0037140523,0.000012831034,0.000054051376,0.0000114778395,0.0005224494,0.00044880217],"study_design_scores_gemma":[0.016463267,0.0029575913,0.97512174,0.00025821305,0.00046367053,0.0007787535,0.0031214973,0.00005227041,0.000398116,0.00013964728,0.00003197004,0.00021328586],"about_ca_topic_score_codex":0.0010235244,"about_ca_topic_score_gemma":0.0005779081,"teacher_disagreement_score":0.015862262,"about_ca_system_score_codex":0.000416947,"about_ca_system_score_gemma":0.0013639976,"threshold_uncertainty_score":0.8165308},"labels":[],"label_agreement":null},{"id":"W2571322676","doi":"10.1182/blood.v110.11.4661.4661","title":"A Rare Case of JAK2 V617F Positive Polycythemia Vera in a Child with Neurofibromatosis Type I.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Juvenile myelomonocytic leukemia; Polycythemia vera; Medicine; Neurofibromatosis; Pathology; Immunology; Gastroenterology; Haematopoiesis; Stem cell; Biology; Genetics","score_opus":0.007231242780039169,"score_gpt":0.2473051650984693,"score_spread":0.24007392231843014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571322676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916223,0.00037741964,0.000004968134,0.00034725576,0.000024013116,0.00045304408,0.000023452856,0.0000214288,0.0071260845],"genre_scores_gemma":[0.99883616,0.00003509826,0.00078219955,0.0001896949,0.00004616238,0.000018254852,0.000020861093,0.000023209866,0.000048368005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913394,0.000024494051,0.00022365704,0.00023766691,0.00015334065,0.00022686973],"domain_scores_gemma":[0.9994122,0.00010257194,0.00007317194,0.00020881474,0.00008268085,0.00012055384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008105242,0.00016370689,0.00032245117,0.00013524128,0.0000416264,0.000006398177,0.000032407832,0.00006371269,0.000051098366],"category_scores_gemma":[0.00003724911,0.000118546894,0.000051182273,0.0003339181,0.000044147022,0.000038875623,0.000020297835,0.0001308189,0.00001153325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018614171,0.004350032,0.9268998,0.00013055991,0.00047217114,0.057289295,0.0018458101,0.0000021152198,0.0050539705,0.0005948495,0.000083908315,0.001416076],"study_design_scores_gemma":[0.01225194,0.0036250888,0.51205367,0.00075142924,0.00050369755,0.030089986,0.00038470686,0.000005663569,0.44005415,0.000014372889,0.00006008063,0.00020519289],"about_ca_topic_score_codex":0.00025438514,"about_ca_topic_score_gemma":0.00023321706,"teacher_disagreement_score":0.43500018,"about_ca_system_score_codex":0.00002965821,"about_ca_system_score_gemma":0.00006469019,"threshold_uncertainty_score":0.48342022},"labels":[],"label_agreement":null},{"id":"W2571409851","doi":"10.1182/blood.v110.11.5136.5136","title":"Mesenchymal Stromal Cells Gene-Enhanced To Express Human Factor IX and Their In Vivo Use for Correction of Hemophilia B Phenotype in R333Q Mice.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Jewish General Hospital; McGill University","funders":"","keywords":"Factor IX; Mesenchymal stem cell; Genetic enhancement; Medicine; In vivo; Immunology; Cell therapy; Pharmacology; Cancer research; Stem cell; Pathology; Internal medicine; Biology; Gene; Biotechnology; Genetics","score_opus":0.01814316009132306,"score_gpt":0.2862565669745742,"score_spread":0.26811340688325114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571409851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985656,0.000113358314,0.0006358895,0.0000075006587,0.000082796425,0.0004725878,0.00007131191,0.0000050006556,0.000045920555],"genre_scores_gemma":[0.99908805,0.000028058666,0.00050233176,0.000032652504,0.000092669616,0.000027579099,0.00002022291,0.000022183227,0.00018624336],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99904025,0.000044431636,0.00022026595,0.00031076386,0.000087390974,0.00029688963],"domain_scores_gemma":[0.9995585,0.00003568147,0.000049075355,0.00021681271,0.00006521896,0.0000747255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022552875,0.00013301088,0.00016783534,0.00011383918,0.00003075305,0.000012962662,0.0001286172,0.00012708154,0.000013315413],"category_scores_gemma":[0.000038109392,0.00012945275,0.000043739863,0.000110174486,0.0000376789,0.0000058655273,0.00006198781,0.00007560243,5.974822e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000991184,0.0002351767,0.00290475,0.000017655775,0.000022028049,9.495868e-7,0.0002757541,0.00006133111,0.99439555,0.000001047894,0.000030347534,0.0010641948],"study_design_scores_gemma":[0.0017401243,0.0017288929,0.0068405825,0.00001480782,0.0000040121813,7.4484e-7,0.00009488629,0.000016748578,0.9892341,0.000009450649,0.00018339934,0.00013223864],"about_ca_topic_score_codex":0.00008230087,"about_ca_topic_score_gemma":0.0019679694,"teacher_disagreement_score":0.0051614684,"about_ca_system_score_codex":0.000013787931,"about_ca_system_score_gemma":0.00003542959,"threshold_uncertainty_score":0.527893},"labels":[],"label_agreement":null},{"id":"W2571432015","doi":"10.1182/blood.v108.11.721.721","title":"High Efficiency Clinical Scale Selective Depletion of Alloreacting T Cells Using Expanded T Lymphocytes as Antigen-Presenting Cells and a TH9402-Based Photodepletion Technique in HLA-Mismatched and Matched Donor-Recipient Pairs.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Leukapheresis; IL-2 receptor; Flow cytometry; Immunology; Peripheral blood mononuclear cell; Antigen; Lymphocyte; Molecular biology; Chemistry; Biology; T cell; Stem cell; In vitro; Biochemistry; Cell biology; Immune system","score_opus":0.01374397635391449,"score_gpt":0.2879793427163764,"score_spread":0.2742353663624619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571432015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99735385,0.0003622594,0.0013664375,0.000016257034,0.00004355047,0.00077777996,0.000014578637,0.000025051517,0.000040252857],"genre_scores_gemma":[0.99503744,0.000190513,0.004499321,0.000032649736,0.00009154634,0.000054300337,0.000044797132,0.00004088193,0.000008556923],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977732,0.00034365742,0.0005951216,0.0006320429,0.00025010423,0.000405932],"domain_scores_gemma":[0.99909675,0.00010652148,0.0002765001,0.00029684414,0.00013805392,0.000085352876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011853656,0.00023888987,0.00037502992,0.00016718371,0.00010861963,0.00004004024,0.0001347721,0.00028890366,0.0000052928344],"category_scores_gemma":[0.00006867391,0.00024520973,0.000097663855,0.00026120408,0.00018095842,0.00001085931,0.00012110814,0.0001733484,8.6495623e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006696946,0.00062280445,0.04921772,0.000054104974,0.000030943916,0.000009019724,0.00006051097,0.00046813884,0.94861215,8.9842433e-7,0.000003814761,0.00025020808],"study_design_scores_gemma":[0.0035995026,0.000834785,0.0082029365,0.00007055001,0.000030679086,0.000018661038,0.00009561255,0.0014853086,0.985348,0.000060621645,0.000009937898,0.0002434297],"about_ca_topic_score_codex":0.0012573528,"about_ca_topic_score_gemma":0.00037621008,"teacher_disagreement_score":0.041014783,"about_ca_system_score_codex":0.000037329457,"about_ca_system_score_gemma":0.00019799631,"threshold_uncertainty_score":0.9999362},"labels":[],"label_agreement":null},{"id":"W2571440094","doi":"10.1182/blood.v112.11.905.905","title":"Predictors of Osteopenia/Osteoporosis in Children with Acute Lymphoblastic Leukemia.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Osteopenia; Medicine; Osteoporosis; Bone mineral; Population; Pediatrics; Standard score; Internal medicine; Dual-energy X-ray absorptiometry; Physical therapy","score_opus":0.011586833422837416,"score_gpt":0.2549935655947057,"score_spread":0.24340673217186828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571440094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996992,0.0003971604,0.0000028217335,0.00012070483,0.000029660552,0.0008548238,0.00003383876,0.000045561726,0.0015234657],"genre_scores_gemma":[0.99813837,0.00043541516,0.0005421969,0.00015469291,0.00008037968,0.000060781196,0.00005189098,0.000037404625,0.0004988992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99806577,0.000049623894,0.00043826507,0.0003320913,0.0006025975,0.0005116355],"domain_scores_gemma":[0.9989461,0.00006233703,0.00010795126,0.00041407498,0.00012228779,0.0003472844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016916088,0.00018713679,0.00052393676,0.00026466115,0.00007346316,0.0000051827838,0.00014311136,0.00013937909,0.00008543911],"category_scores_gemma":[0.00007898393,0.00014283661,0.00006982414,0.0006033043,0.00021307329,0.000087671164,0.00006075915,0.0002690689,0.00003690048],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046160456,0.00056114676,0.9953052,0.00007971946,0.00019039866,0.00016773678,0.0003976254,0.0000040019922,0.0023043319,0.0000046613823,0.00025985332,0.0002637135],"study_design_scores_gemma":[0.012379697,0.0019198497,0.96473736,0.00015817766,0.0002276701,0.0020352246,0.00006285693,0.000013122728,0.018257776,0.00000225577,0.000072056595,0.00013393114],"about_ca_topic_score_codex":0.0006862635,"about_ca_topic_score_gemma":0.00011451078,"teacher_disagreement_score":0.030567823,"about_ca_system_score_codex":0.00011288453,"about_ca_system_score_gemma":0.0013655825,"threshold_uncertainty_score":0.5824708},"labels":[],"label_agreement":null},{"id":"W2571440990","doi":"10.1182/blood.v124.21.3421.3421","title":"The International Multiple Myeloma Research (IMMEnSE) Consortium: Genetics of Multiple Myeloma Risk and Prognosis","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Odds ratio; Genome-wide association study; Context (archaeology); Single-nucleotide polymorphism; Multiple myeloma; SNP; Internal medicine; Oncology; Genetic association; Biology; Medicine; Genotype; Genetics; Gene","score_opus":0.043361884258914046,"score_gpt":0.3270510127439485,"score_spread":0.28368912848503447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571440990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99484545,0.0011718575,0.000048041726,0.00091610185,0.000090995825,0.00093275105,0.00007129887,0.000037423833,0.0018860688],"genre_scores_gemma":[0.99533904,0.0011786562,0.002532117,0.000033960463,0.00018770363,0.00015762965,0.00003824587,0.000033629953,0.0004990118],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973314,0.00030774684,0.0004007772,0.00040687394,0.0009958221,0.0005574229],"domain_scores_gemma":[0.99662554,0.0018461854,0.00013181617,0.0005115853,0.0005829406,0.00030191557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012564599,0.00018195268,0.0002843705,0.0001801607,0.00037691384,0.000071263945,0.00028344788,0.00010913209,0.000037721155],"category_scores_gemma":[0.0035589042,0.00012343039,0.00009757475,0.00022317868,0.0005343804,0.000049613045,0.00027505847,0.00037623697,0.00004451296],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046347454,0.00080712535,0.9104965,0.000052697404,0.00046024504,0.000029171493,0.00020905606,0.0000010402689,0.013541447,0.00010976994,0.0005051151,0.07332439],"study_design_scores_gemma":[0.011225122,0.00092221296,0.8732934,0.00008629446,0.00013397254,0.00006562603,0.0002789569,0.0055195154,0.09494835,0.00020429408,0.013186235,0.00013603397],"about_ca_topic_score_codex":0.00027734108,"about_ca_topic_score_gemma":0.0003581482,"teacher_disagreement_score":0.081406906,"about_ca_system_score_codex":0.000040399475,"about_ca_system_score_gemma":0.00012335839,"threshold_uncertainty_score":0.5033345},"labels":[],"label_agreement":null},{"id":"W2571445838","doi":"10.1182/blood.v118.21.265.265","title":"Identification of Patient Subgroups Demonstrating Longer Progression-Free Survival (PFS) Benefit with Bortezomib-Rituximab Versus Rituximab in Patients with Relapsed or Refractory Follicular Lymphoma (FL): Biomarker Analyses of the Phase 3 LYM3001 Study","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Rituximab; Medicine; Internal medicine; Bortezomib; Oncology; Follicular lymphoma; Refractory (planetary science); Progression-free survival; Phases of clinical research; Biomarker; Population; Lymphoma; Clinical trial; Multiple myeloma; Chemotherapy; Biology","score_opus":0.03461630046728208,"score_gpt":0.2997340328390153,"score_spread":0.2651177323717332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571445838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972865,0.0003180418,0.0000047505746,0.000015197235,0.000116338495,0.0020494575,0.00006334651,0.000027659687,0.00011869393],"genre_scores_gemma":[0.99910295,0.000011476804,0.0005309707,0.000007815634,0.000013025404,0.00023005264,0.00005348425,0.000041883526,0.000008319978],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997017,0.00016229477,0.00093019934,0.00052869716,0.0010488863,0.00031291172],"domain_scores_gemma":[0.99733585,0.00013823413,0.00086811907,0.0011509102,0.00038902744,0.000117842996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000273306,0.00034677636,0.0007225389,0.0002043893,0.00012106192,0.000018510611,0.0002521343,0.00010766598,0.000030909756],"category_scores_gemma":[0.00015553762,0.00018193426,0.00014250693,0.0007200077,0.00019027208,0.00018126739,0.000102750084,0.00007853884,0.000002001364],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012910947,0.12944031,0.842867,0.00007925681,0.0013686396,0.00014115988,0.0011630845,9.838412e-7,0.000685624,0.000011934593,0.000004869933,0.011326155],"study_design_scores_gemma":[0.17112678,0.007949668,0.7849102,0.00040653913,0.0019849716,0.000007815508,0.001210662,0.00001964921,0.032191444,0.0000048146503,0.0000014884388,0.00018598624],"about_ca_topic_score_codex":0.00052705035,"about_ca_topic_score_gemma":0.0004798224,"teacher_disagreement_score":0.15821584,"about_ca_system_score_codex":0.00012964278,"about_ca_system_score_gemma":0.00022863189,"threshold_uncertainty_score":0.74190634},"labels":[],"label_agreement":null},{"id":"W2571474109","doi":"10.1182/blood.v118.21.42.42","title":"Intravenous Gammaglobulin (IVIg) Therapy Prevents Antibody-Mediated Transfusion Related Acute Lung Injury (TRALI) by Directly Inhibiting Recipient Neutrophil Activation in a Murine Model","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; St. Michael's Hospital","funders":"","keywords":"Medicine; Transfusion-related acute lung injury; Immunology; Pulmonary edema; Antibody; Lung; In vivo; Edema; Shock (circulatory); Pharmacology; Internal medicine","score_opus":0.00809151950937808,"score_gpt":0.23502998590913413,"score_spread":0.22693846639975604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571474109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99753314,0.00073184614,0.0002539887,0.000051528117,0.00004818889,0.00057585817,0.000068034184,0.00003677278,0.0007006401],"genre_scores_gemma":[0.9951898,0.003134075,0.0003157822,0.00009681055,0.00002584141,0.00006390646,0.0010082286,0.000047463862,0.00011810662],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985405,0.000084870626,0.00037106872,0.00049677544,0.00014851769,0.00035822354],"domain_scores_gemma":[0.9994806,0.000006010621,0.000133255,0.0002479841,0.00004278856,0.000089331006],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011829093,0.00026845065,0.00022911631,0.00008091105,0.000079376565,0.000014643192,0.00014039113,0.00026126346,0.000018431114],"category_scores_gemma":[0.000013703682,0.00025273542,0.00009714788,0.00020754786,0.000036433295,0.000016812497,0.000045116965,0.00016134999,0.0000040326618],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046536452,0.0033835433,0.009030378,0.000012694525,0.00030864196,0.000014167817,0.00048453358,0.000023919083,0.98154587,0.000005685523,0.00008630097,0.0046389312],"study_design_scores_gemma":[0.006827236,0.00081262324,0.0044669607,0.000071858565,0.00009958754,0.000009727165,0.000023095829,0.00045049263,0.9867264,0.00014335658,0.00004516024,0.0003234697],"about_ca_topic_score_codex":0.00019680109,"about_ca_topic_score_gemma":0.000022050157,"teacher_disagreement_score":0.0063618715,"about_ca_system_score_codex":0.000018096158,"about_ca_system_score_gemma":0.000053104883,"threshold_uncertainty_score":0.9999925},"labels":[],"label_agreement":null},{"id":"W2571497853","doi":"10.1182/blood.v112.11.2899.2899","title":"Oct4 Expression and Mesenchymal Stromal Cell Plasticity","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Homeobox protein NANOG; SOX2; Mesenchymal stem cell; CD44; Biology; Stromal cell; Flow cytometry; Embryonic stem cell; Molecular biology; Stem cell; Immunocytochemistry; Cell biology; Cancer research; Andrology; Cell; Medicine; Endocrinology; Induced pluripotent stem cell; Gene","score_opus":0.02996778825540197,"score_gpt":0.26662100593219823,"score_spread":0.23665321767679626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571497853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97252744,0.00039866846,0.00006548188,0.000075845994,0.000036159723,0.00025959685,0.000005323991,0.000053457727,0.02657802],"genre_scores_gemma":[0.99396586,0.00010882491,0.0016563967,0.0000384742,0.00018798128,0.0000113122915,0.0000057365337,0.000018923996,0.0040064924],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985764,0.000051298204,0.00018007601,0.00030654424,0.00052328873,0.00036237072],"domain_scores_gemma":[0.99920124,0.00013726306,0.00003758871,0.00019812245,0.00006608567,0.0003597066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011473044,0.00013648726,0.0002359329,0.000078703364,0.00014996175,0.0000113698425,0.00007910624,0.00010547957,0.0004201467],"category_scores_gemma":[0.00014902487,0.00010794921,0.000048347843,0.000117556054,0.00012856338,0.00006172825,0.00012475575,0.00026862734,0.0001035475],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016721111,0.0008480649,0.16802853,0.00017152833,0.000023269029,0.001064419,0.00027652964,9.626204e-7,0.82753193,0.000024366582,0.0016445764,0.000218569],"study_design_scores_gemma":[0.0061915778,0.00091384497,0.24510013,0.00009810102,0.00007510286,0.0010451414,0.000093536924,0.00013959449,0.7440666,0.000017153885,0.0020660819,0.00019316359],"about_ca_topic_score_codex":0.000031480453,"about_ca_topic_score_gemma":0.0000018712417,"teacher_disagreement_score":0.08346538,"about_ca_system_score_codex":0.000014180489,"about_ca_system_score_gemma":0.00010392108,"threshold_uncertainty_score":0.46003118},"labels":[],"label_agreement":null},{"id":"W2571506331","doi":"10.1182/blood.v118.21.sci-35.sci-35","title":"Functions of Platelet Microparticles in Inflammatory Arthritis","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Platelet; Synovitis; Immunology; Medicine; Inflammation; Arthritis; Prostacyclin; Inflammatory arthritis; Platelet activation; Internal medicine","score_opus":0.009156839319795685,"score_gpt":0.19703984448180736,"score_spread":0.18788300516201167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571506331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963662,0.0020458854,0.000059050904,0.0000045478173,0.000034458393,0.00007143628,0.000012836331,0.00000703659,0.0013985483],"genre_scores_gemma":[0.9991388,0.000068185815,0.000617023,0.000019659274,0.00003515479,0.000011879277,0.000014259303,0.000010873934,0.00008418347],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995019,0.000027983495,0.00016721996,0.00013837987,0.00004337117,0.000121154204],"domain_scores_gemma":[0.999658,0.0000031457325,0.00004201905,0.00022840447,0.000023179924,0.000045256314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000717703,0.00006281287,0.00006609041,0.000030089619,0.000014200869,0.0000030267734,0.000090012094,0.00006096915,0.000047536138],"category_scores_gemma":[0.00003351762,0.00006928211,0.00004335091,0.000046057856,0.000071665905,0.0000023908524,0.000049066308,0.00003854083,0.000017873426],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033204156,0.00037346128,0.0760336,0.000010627515,0.000022381015,0.000025517791,0.000075924574,0.0000021609476,0.9219459,0.00006532877,0.0001259052,0.001285946],"study_design_scores_gemma":[0.0009329666,0.000082659,0.03344313,0.00001240854,0.000010165757,0.000014829129,0.00006830931,0.0000018595704,0.9643648,0.000105223815,0.0008835169,0.00008008623],"about_ca_topic_score_codex":0.000010726777,"about_ca_topic_score_gemma":0.00004246559,"teacher_disagreement_score":0.04259047,"about_ca_system_score_codex":0.0000015346147,"about_ca_system_score_gemma":0.00003529163,"threshold_uncertainty_score":0.28252426},"labels":[],"label_agreement":null},{"id":"W2571511731","doi":"10.1182/blood.v120.21.2197.2197","title":"Health-Related Quality of Life in Children with Chronic Immune Thrombocytopenia Treated with Eltrombopag in the PETIT Study.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Eltrombopag; Medicine; Thrombopoietin receptor; Immune thrombocytopenia; Quality of life (healthcare); Cohort; Incidence (geometry); Internal medicine; Placebo; Pediatrics; Romiplostim; Thrombopoietin; Platelet","score_opus":0.019983432412630956,"score_gpt":0.28415574432991453,"score_spread":0.2641723119172836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571511731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993843,0.0036754473,3.507634e-7,0.0003465633,0.0000065667377,0.0016943497,0.000009501118,0.000020836202,0.00040339268],"genre_scores_gemma":[0.9996389,0.00007535161,0.000031209798,0.00005968909,0.000014050631,0.0000626129,0.00006528958,0.000021118356,0.000031783296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983944,0.00024165148,0.00049875665,0.00020248117,0.0002852742,0.0003774249],"domain_scores_gemma":[0.9992425,0.000043404158,0.00020936379,0.0003931374,0.000024137315,0.000087485416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005309996,0.00018955067,0.00086923555,0.00009651938,0.000043491316,0.000006649959,0.00011052367,0.00005386657,0.0000421503],"category_scores_gemma":[0.000020715714,0.00010147868,0.000038455153,0.0004870263,0.00006466556,0.00008660736,0.000019197261,0.00022474398,0.000010881656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034960112,0.009565814,0.9876276,0.00003158119,0.00057105924,0.0000347225,0.0015121315,0.0000028454967,0.00008752976,0.000022527984,0.0000046436962,0.00018992461],"study_design_scores_gemma":[0.028109217,0.0027795618,0.9678952,0.00011713946,0.00018578157,0.00013627774,0.000507594,0.0000010929301,0.00015773969,0.0000036390106,0.0000021221965,0.00010461526],"about_ca_topic_score_codex":0.01375261,"about_ca_topic_score_gemma":0.0047505684,"teacher_disagreement_score":0.027759615,"about_ca_system_score_codex":0.000067025714,"about_ca_system_score_gemma":0.00020405551,"threshold_uncertainty_score":0.9928149},"labels":[],"label_agreement":null},{"id":"W2571522394","doi":"10.1182/blood.v112.11.3201.3201","title":"Identification of AHI-1 Involvement in Mediating Cellular Resistance to Imatinib Mesylate in Chronic Myeloid Leukemia Cells","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; BC Cancer Agency","funders":"","keywords":"Imatinib mesylate; Cancer research; Myeloid leukemia; Tyrosine kinase; Biology; Progenitor cell; K562 cells; Haematopoiesis; Imatinib; Stem cell; breakpoint cluster region; Myeloid; Protein kinase B; Leukemia; Signal transduction; Immunology; Cell biology; Receptor","score_opus":0.01551737333334093,"score_gpt":0.24862020094174092,"score_spread":0.23310282760839998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571522394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99658626,0.0014602091,0.00004123614,0.00011333082,0.000089013876,0.0009649682,0.000015141242,0.000035177753,0.00069466693],"genre_scores_gemma":[0.9969271,0.0003588451,0.0013596126,0.000064713146,0.0000951845,0.00013318127,0.000051875588,0.00003631769,0.0009731954],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99756557,0.00007222711,0.0010069829,0.0004559443,0.0004904312,0.00040882474],"domain_scores_gemma":[0.99885774,0.00008475266,0.00028280565,0.000580637,0.000065761655,0.00012829059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046758942,0.00021720995,0.0004771542,0.00033062522,0.00004281869,0.0000060679204,0.00017290897,0.000114813294,0.00005577109],"category_scores_gemma":[0.00013006572,0.00022371372,0.00007534235,0.00065291376,0.000060203303,0.00009153441,0.00007034935,0.00022178584,0.00007332262],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000077358374,0.0004486876,0.023503289,0.00042965566,0.000055014687,0.00026253465,0.0031592792,0.0003567149,0.97120726,0.000034266304,0.00012950061,0.00033643178],"study_design_scores_gemma":[0.008631895,0.00015697234,0.04395971,0.00047761988,0.00006807078,0.000008227515,0.00015036805,0.00040020794,0.9456864,0.000040131006,0.00023911454,0.00018127663],"about_ca_topic_score_codex":0.00034513,"about_ca_topic_score_gemma":0.0007308871,"teacher_disagreement_score":0.025520863,"about_ca_system_score_codex":0.00301718,"about_ca_system_score_gemma":0.0011375973,"threshold_uncertainty_score":0.9122781},"labels":[],"label_agreement":null},{"id":"W2571570876","doi":"10.1182/blood.v104.11.2979.2979","title":"No Fibrinolytic Benefit of Adjunctive Anticoagulation during Arterial Thrombolysis Induced by tPA Combined with TAFIa Inhibitor in a Rabbit Arterial Thrombosis Model.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Bolus (digestion); Medicine; Thrombosis; Conventional PCI; Thrombus; Thrombolysis; Heparin; Anticoagulant; Pharmacology; Anesthesia; Cardiology; Internal medicine; Myocardial infarction","score_opus":0.026939791221516414,"score_gpt":0.26515572051513686,"score_spread":0.23821592929362045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571570876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982023,0.00001125523,0.00008607447,0.00024269751,0.00017552223,0.00084038876,0.000018271721,0.000063293264,0.00036019745],"genre_scores_gemma":[0.99864143,0.0000099438375,0.00066096167,0.000024747842,0.00043697562,0.000009297536,0.000095644755,0.0000353839,0.000085591906],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99846196,0.000021841384,0.0005084727,0.00034837253,0.00038757257,0.0002718037],"domain_scores_gemma":[0.999285,0.000026781576,0.00022786311,0.00027770523,0.00010542921,0.00007722764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000082362836,0.00024451295,0.00067290926,0.00022207409,0.000061607774,0.00002867085,0.000069069385,0.00013118946,0.00005879957],"category_scores_gemma":[0.00003772498,0.00021320167,0.00012580382,0.00036988666,0.000051066287,0.00025156754,0.000053744323,0.00008322096,0.000013490048],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002219678,0.00026982697,0.050153,0.00013185688,0.00034068798,0.000006165108,0.0004642624,0.0013205942,0.9447803,0.00027153845,0.00000906495,0.00003302883],"study_design_scores_gemma":[0.045537442,0.001213497,0.6706371,0.0003655456,0.00087723933,0.0000043970504,0.0000928265,0.0008888033,0.27968174,0.00032828213,0.0000060391385,0.0003671345],"about_ca_topic_score_codex":0.000121613644,"about_ca_topic_score_gemma":0.000041527514,"teacher_disagreement_score":0.66509855,"about_ca_system_score_codex":0.00007956354,"about_ca_system_score_gemma":0.0000770303,"threshold_uncertainty_score":0.8694112},"labels":[],"label_agreement":null},{"id":"W2571593283","doi":"10.1182/blood.v110.11.303.303","title":"Is Differential Activity of Enoxaparin and Unfractionated Heparin According to the Location of Deep-Vein Thrombosis in Acute Ischemic Stroke Patients Driven by Different Pathogenic Mechanisms?.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Venography; Deep vein; Pulmonary embolism; Thrombosis; Stroke (engine); Asymptomatic; Surgery; Heparin; Venous thrombosis; Internal medicine; Cardiology","score_opus":0.009759609859705608,"score_gpt":0.2536480274932254,"score_spread":0.2438884176335198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571593283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942802,0.000053738182,0.004427362,0.00018669743,0.00008802646,0.00079593254,0.000038050228,0.000015022382,0.00011495198],"genre_scores_gemma":[0.99939024,0.00015152576,0.00020101362,0.000113446295,0.000020066629,0.00004043615,0.00004056673,0.00001984487,0.000022876295],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987037,0.000040716866,0.0003670156,0.00029051505,0.00034954652,0.00024846414],"domain_scores_gemma":[0.99923337,0.000069467715,0.0002117107,0.0002769162,0.00012092699,0.000087613436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016244921,0.00017794843,0.00048087633,0.00016024504,0.000050268252,0.000010050577,0.00011858508,0.00009276677,0.000029036044],"category_scores_gemma":[0.00004461341,0.00013604756,0.00006960576,0.00027222195,0.000031403448,0.000070415874,0.00016182144,0.00014562953,0.0000017255308],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014631057,0.004688773,0.23210621,0.00014965175,0.0005794006,0.0000014166419,0.00084606063,0.000005415305,0.7497239,0.00009534089,0.00019361037,0.011463904],"study_design_scores_gemma":[0.0017372711,0.00030319873,0.6553168,0.00007533871,0.0004389911,6.741448e-7,0.00017442583,0.000119464654,0.34172046,0.000012951057,0.000016800519,0.00008358161],"about_ca_topic_score_codex":0.00035687105,"about_ca_topic_score_gemma":0.00028003874,"teacher_disagreement_score":0.42321062,"about_ca_system_score_codex":0.0000623861,"about_ca_system_score_gemma":0.00001882541,"threshold_uncertainty_score":0.55478585},"labels":[],"label_agreement":null},{"id":"W2571611675","doi":"10.1182/blood.v116.21.4342.4342","title":"Preclinical Studies of Cytotoxicity, Drug Synergy and Biological Correlates of Clofarabine Against Infant Leukemia Cells","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Children's Hospital","funders":"","keywords":"Clofarabine; Leukemia; Cancer research; Cell culture; Transplantation; Medicine; Immunology; Biology; Cytarabine; Internal medicine; Genetics","score_opus":0.028546202061472244,"score_gpt":0.31689961218981355,"score_spread":0.2883534101283413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571611675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977261,0.00079553074,0.000007774826,0.0001444038,0.00014631638,0.000339329,0.000029100083,0.00003474159,0.0007767423],"genre_scores_gemma":[0.9966699,0.0015435852,0.0013087186,0.00008682827,0.0001264126,0.000016522994,0.000011120535,0.000018103803,0.00021881454],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998287,0.000078031146,0.00064864074,0.00033763738,0.0003516717,0.0002969954],"domain_scores_gemma":[0.99756813,0.0013884853,0.00019786763,0.0003847706,0.00027677303,0.0001839757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061383034,0.00018815958,0.0007522144,0.00011112743,0.000040349376,0.0000050934395,0.00017370586,0.00025212017,0.000033826112],"category_scores_gemma":[0.001954653,0.000125757,0.00011472211,0.00018173222,0.0010952717,0.0000357371,0.0003678457,0.0005055239,0.000008367272],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041356505,0.00090617035,0.16793425,0.0003468901,0.00058789755,0.00009914817,0.00046588486,0.000007205129,0.8273474,0.00037024767,0.0006568211,0.0008645412],"study_design_scores_gemma":[0.013186435,0.0016951164,0.10084585,0.00039303474,0.0003989803,0.00017951497,0.0004005423,0.00083908194,0.8810878,0.00032248234,0.0003751247,0.00027607175],"about_ca_topic_score_codex":0.000060945295,"about_ca_topic_score_gemma":0.000024169418,"teacher_disagreement_score":0.0670884,"about_ca_system_score_codex":0.0000483794,"about_ca_system_score_gemma":0.00039779773,"threshold_uncertainty_score":0.51282215},"labels":[],"label_agreement":null},{"id":"W2571616205","doi":"10.1182/blood.v120.21.2687.2687","title":"A Phase II Trial of R-CHOP Followed by Zevalin Radioimmunotherapy for Patients with Previously Untreated Stages I and II CD20+ Diffuse Large Cell Non-Hodgkin's Lymphoma: an Eastern Cooperative Oncology Group Study (E3402).","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Radioimmunotherapy; Medicine; Diffuse large B-cell lymphoma; Internal medicine; Rituximab; Ibritumomab tiuxetan; Follicular lymphoma; CHOP; Oncology; Gastroenterology; Lymphoma; Immunology","score_opus":0.010813288822096244,"score_gpt":0.29107461148762936,"score_spread":0.2802613226655331,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571616205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909654,0.0013465425,0.00002665228,0.000032768166,0.00013087365,0.007073334,0.00033170654,0.000040860632,0.000051851086],"genre_scores_gemma":[0.997508,0.00018645803,0.00032758314,0.00010303958,0.00011331553,0.0009933338,0.00041976542,0.000066577115,0.00028191978],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980112,0.00020996247,0.00049934397,0.0004530586,0.00030565815,0.0005207982],"domain_scores_gemma":[0.99863344,0.0001634728,0.00031346822,0.0004278955,0.00018427613,0.000277437],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030392944,0.0004005747,0.00096023554,0.000096953416,0.0002661485,0.000021988204,0.00009537278,0.00014757989,0.000024289851],"category_scores_gemma":[0.00003235957,0.00027112057,0.00010891095,0.00014627124,0.00007638987,0.00019798623,0.000062395964,0.00005700885,0.000001613796],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07059011,0.6693347,0.236423,0.000052804113,0.0016027746,0.000032044343,0.012873071,6.8435845e-8,0.001549287,0.0000056747735,0.00026066188,0.007275775],"study_design_scores_gemma":[0.7440456,0.23626427,0.011175307,0.000055122007,0.0018935539,0.0000064729547,0.00063191546,0.0000140634575,0.004264848,7.1791726e-7,0.0014121276,0.00023600907],"about_ca_topic_score_codex":0.00015467656,"about_ca_topic_score_gemma":0.00005712159,"teacher_disagreement_score":0.6734555,"about_ca_system_score_codex":0.000115429815,"about_ca_system_score_gemma":0.000153534,"threshold_uncertainty_score":0.9999741},"labels":[],"label_agreement":null},{"id":"W2571617651","doi":"10.1182/blood.v106.11.101.101","title":"A Lymphoid Progenitor Propagates AML in a Mouse Model of CALM/AF10 Positive Leukemia.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Myeloid; Bone marrow; Myeloid leukemia; Leukemia; Progenitor cell; Population; Transplantation; Spleen; Biology; Cancer research; Stem cell; Immunology; Molecular biology; Pathology; Medicine; Internal medicine; Cell biology","score_opus":0.016598570107957508,"score_gpt":0.2720131212767919,"score_spread":0.2554145511688344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571617651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99561894,0.00032368285,0.00006274595,0.0006186735,0.000009657915,0.0010074847,0.00006934904,0.00006291392,0.0022265625],"genre_scores_gemma":[0.98921746,0.00006786394,0.006944883,0.00021966718,0.00018345552,0.00013356927,0.000025617519,0.000049134902,0.0031583242],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998278,0.000056639197,0.0003953262,0.0003388885,0.00045405456,0.00047706216],"domain_scores_gemma":[0.99908906,0.000058588143,0.00008241563,0.00037731204,0.00019515964,0.00019747409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024328707,0.00019573596,0.00042531913,0.00025928408,0.000033248874,0.000011289562,0.00018617403,0.00016421558,0.000028189099],"category_scores_gemma":[0.0001806159,0.00016660262,0.000101324724,0.0003107256,0.00013683934,0.00012471624,0.00011123554,0.00032874595,0.00006379208],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007460621,0.0020099864,0.017226025,0.00023414874,0.00021164189,0.00014536509,0.0017344471,0.0005248383,0.9726286,0.0001583786,0.00046096605,0.0039195227],"study_design_scores_gemma":[0.009405663,0.00034980435,0.0007827134,0.00011874424,0.000103930055,0.00020684316,0.00013247866,0.04245494,0.9461403,0.000033744924,0.00009212358,0.00017871638],"about_ca_topic_score_codex":0.00025933702,"about_ca_topic_score_gemma":0.00005880857,"teacher_disagreement_score":0.0419301,"about_ca_system_score_codex":0.0007219613,"about_ca_system_score_gemma":0.0016038872,"threshold_uncertainty_score":0.6793858},"labels":[],"label_agreement":null},{"id":"W2571618967","doi":"10.1182/blood.v108.11.997.997","title":"Long-Term Follow up of Children with Apalstic Anemia Treated with Immunosuppressive Therapy.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Discontinuation; Prednisone; Anemia; Surgery; Aplastic anemia; Gastroenterology; Internal medicine; Pediatrics","score_opus":0.007593899503803021,"score_gpt":0.22153718347309467,"score_spread":0.21394328396929166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571618967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99661785,0.0005406918,0.00018265434,0.000022394826,0.000013575665,0.00065323134,0.00002160678,0.000059615188,0.0018883639],"genre_scores_gemma":[0.9986862,0.000050901857,0.0004226859,0.000019336238,0.000046276986,0.00002743925,0.0002519388,0.000037198777,0.00045800398],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990676,0.00002593096,0.00022121888,0.00021801316,0.00027509464,0.00019216322],"domain_scores_gemma":[0.9993908,0.00004649648,0.00012268551,0.00029736702,0.00009160483,0.000051082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004051596,0.00017833835,0.00031635593,0.0000720543,0.000031706975,0.000008958819,0.00006890314,0.00007509222,0.00009252008],"category_scores_gemma":[0.0000032898197,0.00011449954,0.000047653648,0.00017682032,0.00008076886,0.000042263844,0.000003793451,0.00008721541,0.000008414485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007887804,0.00058263046,0.9488655,0.00012010622,0.00034748617,0.00013488135,0.00021675226,0.0000057317525,0.048700076,0.000014362901,0.000014808335,0.00020892809],"study_design_scores_gemma":[0.014210483,0.0007382642,0.66172117,0.00035135078,0.0005862014,0.0006943753,0.000012510201,0.0000012399389,0.321579,0.000002783024,7.1585873e-7,0.00010190636],"about_ca_topic_score_codex":0.00020741424,"about_ca_topic_score_gemma":0.000031533196,"teacher_disagreement_score":0.2871443,"about_ca_system_score_codex":0.000009839536,"about_ca_system_score_gemma":0.0000663509,"threshold_uncertainty_score":0.46691558},"labels":[],"label_agreement":null},{"id":"W2571622608","doi":"10.1182/blood.v104.11.1848.1848","title":"Reaction of Fibrin-Bound Thrombin with a Covalent Antithrombin-Heparin Complex Results in an Anticoagulant Surface.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Thrombin; Fibrin; Antithrombin; Chemistry; Discovery and development of direct thrombin inhibitors; Hirudin; Heparin; Biochemistry; Immunology; Platelet; Biology","score_opus":0.05210155480555912,"score_gpt":0.2989706402273359,"score_spread":0.24686908542177677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571622608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974392,0.000045215776,0.000095772724,0.0004162473,0.0000749149,0.0005858408,0.000022266771,0.00009113498,0.0012293733],"genre_scores_gemma":[0.99554604,0.000048477956,0.004065599,0.00009216025,0.000036385853,0.0000050094595,0.00013083158,0.000034812994,0.000040683044],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99823856,0.00006317415,0.0005311697,0.00042440798,0.0004447435,0.00029791176],"domain_scores_gemma":[0.99894166,0.000026808968,0.00021542993,0.0005323083,0.00013655359,0.0001472335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029555845,0.00021479375,0.0005769654,0.00015336546,0.00005732392,0.000022814753,0.000098582044,0.000120837045,0.000030515748],"category_scores_gemma":[0.000026577009,0.00018589002,0.00006667983,0.00041687605,0.000110126464,0.00016763895,0.00003305422,0.00017836464,0.000019167737],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056123664,0.004800716,0.027860384,0.00012074423,0.00014208551,0.00009349646,0.0005556327,0.00024326936,0.961775,0.0037239094,0.000014597922,0.00010893448],"study_design_scores_gemma":[0.019076519,0.0023031249,0.56588626,0.0003935345,0.0002205132,0.00023649183,0.00020504494,0.00011500271,0.41074073,0.0005849974,0.00003701686,0.00020078912],"about_ca_topic_score_codex":0.00092264503,"about_ca_topic_score_gemma":0.0008212447,"teacher_disagreement_score":0.5510343,"about_ca_system_score_codex":0.000056421915,"about_ca_system_score_gemma":0.00017498089,"threshold_uncertainty_score":0.7580375},"labels":[],"label_agreement":null},{"id":"W2571684968","doi":"10.1182/blood.v114.22.558.558","title":"Adherence with Injectibal Prophylaxis for Venous Thromboembolism (VTE) Following Total Hip (THR) and Total Knee (TKR) Replacement Surgery: Complete Registry.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Trillium Health Centre; Sanofi (Canada); The Scarborough Hospital; Lakeridge Health; University of Toronto; Regina Qu'Appelle Health Region","funders":"","keywords":"Medicine; Knee replacement; Arthroplasty; Venous thromboembolism; Prospective cohort study; Rehabilitation; Cohort; Total hip replacement; Total knee replacement; Emergency medicine; Physical therapy; Surgery; Internal medicine; Thrombosis","score_opus":0.018941191299725102,"score_gpt":0.2523399802636262,"score_spread":0.2333987889639011,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571684968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99335855,0.0007350786,0.00022373695,0.0006130858,0.00030269814,0.0022490483,0.00002646999,0.00016537294,0.0023259602],"genre_scores_gemma":[0.9964335,0.000058112873,0.0020562115,0.00051446137,0.0003391284,0.00022038663,0.00006544119,0.000051830542,0.00026092536],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975577,0.00005384255,0.00046430406,0.0007454283,0.00049872504,0.00067998026],"domain_scores_gemma":[0.998661,0.00016111672,0.00021493585,0.00062081125,0.0000837697,0.00025841154],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038529088,0.00039705617,0.0011593119,0.00014197243,0.00032355744,0.00010034746,0.00009291758,0.00013082087,0.000036972473],"category_scores_gemma":[0.0001520285,0.0003357821,0.0002405518,0.00024514837,0.00008874877,0.00014564868,0.00007082864,0.00024631087,0.000009680056],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0117037315,0.10212192,0.27960137,0.009370477,0.02174693,0.0064248936,0.022196284,0.00024841801,0.11953485,0.018814893,0.03793405,0.3703022],"study_design_scores_gemma":[0.015918411,0.035018485,0.9323936,0.0013210076,0.0028574825,0.0010649748,0.0010970209,0.00011666442,0.005152302,0.00046286473,0.0032719837,0.0013251674],"about_ca_topic_score_codex":0.00015568554,"about_ca_topic_score_gemma":0.000013334197,"teacher_disagreement_score":0.6527923,"about_ca_system_score_codex":0.00005736248,"about_ca_system_score_gemma":0.00016750484,"threshold_uncertainty_score":0.9999094},"labels":[],"label_agreement":null},{"id":"W2571729208","doi":"10.1182/blood.v124.21.5787.5787","title":"Prior Granulocyte Colony-Stimulating Factor Treatment Enhances the Immediate and Transient Output of Primitive Hematopoietic Cells in the Blood of Normal Adult Human Donors Treated with Plerixafor","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of British Columbia; BC Children's Hospital; BC Cancer Agency","funders":"","keywords":"Plerixafor; Medicine; Granulocyte colony-stimulating factor; Haematopoiesis; CD34; Bone marrow; Pharmacology; Stem cell; Immunology; Internal medicine; Andrology; CXCR4; Chemotherapy; Biology; Inflammation","score_opus":0.012549166065516678,"score_gpt":0.2410213060592258,"score_spread":0.22847213999370913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571729208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99761623,0.000066264896,0.00009291799,0.00010184096,0.000016012269,0.0015057606,0.00004750355,0.000016882324,0.0005365893],"genre_scores_gemma":[0.99932724,0.000088151224,0.00033868826,0.000035277357,0.00002486504,0.00010015538,0.000024624742,0.000021933869,0.000039085768],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984552,0.00015618549,0.00053239946,0.00026078077,0.00034154253,0.00025383983],"domain_scores_gemma":[0.99884015,0.00047425507,0.0002459907,0.00027402278,0.00010099319,0.00006456039],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022411138,0.0002402465,0.0005296731,0.00008477383,0.00008493018,0.000011269185,0.000105376486,0.00006899292,0.000011404622],"category_scores_gemma":[0.000019154608,0.00012269533,0.000084726285,0.00018080957,0.00021504662,0.00004370933,0.0000070514116,0.00011020494,0.0000010218644],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010045812,0.0036279894,0.22407846,0.001926005,0.00072773587,0.00008485148,0.079864524,0.00007870292,0.68743896,0.0002599044,0.0000019371773,0.0009063273],"study_design_scores_gemma":[0.011607288,0.0030811876,0.19043842,0.00051300693,0.00120906,0.00008919363,0.0014787036,0.000099447425,0.79134285,0.0000049144364,0.0000056624617,0.00013022962],"about_ca_topic_score_codex":0.00035233208,"about_ca_topic_score_gemma":0.0003067432,"teacher_disagreement_score":0.10390391,"about_ca_system_score_codex":0.000014740459,"about_ca_system_score_gemma":0.000050508588,"threshold_uncertainty_score":0.500337},"labels":[],"label_agreement":null},{"id":"W2571839020","doi":"10.1182/blood.v104.11.3227.3227","title":"Activation of Stem-Cell Specific Genes by HOXA9 and HOXA10 Homeodomain Proteins in CD34+ Human Cord Blood Cells.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Medicinal Plant Pharmacodynamics Research","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; Haematopoiesis; Transcriptome; CD34; Stem cell; Hox gene; Gene; Microarray analysis techniques; Gene expression; Molecular biology; Cell biology; Genetics","score_opus":0.07741799925413428,"score_gpt":0.3868160624077635,"score_spread":0.3093980631536292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571839020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943861,0.0026360715,0.00007616215,0.00022165843,0.00015229522,0.0011478415,0.00016827995,0.000041846517,0.0011697935],"genre_scores_gemma":[0.9964812,0.0022203776,0.00025954502,0.0001477767,0.000121666235,0.00007906754,0.00009361348,0.000038006314,0.00055874075],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99769807,0.00037879654,0.0005288401,0.00046046166,0.00038044035,0.000553385],"domain_scores_gemma":[0.9989564,0.0002508216,0.00021725385,0.00022984334,0.00008013011,0.00026554975],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009214058,0.00027657588,0.0003993755,0.0003193939,0.00015830794,0.000021508607,0.00034248448,0.0003233304,0.00022236824],"category_scores_gemma":[0.000009579743,0.000279513,0.000056229277,0.0003921976,0.00029799002,0.00013635629,0.00011858142,0.0009794869,0.000030655126],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034634708,0.0029498078,0.0072602956,0.00029952882,0.00010980917,0.00010119176,0.00039683664,0.00011031979,0.985774,0.00030616389,0.0006100292,0.0017357161],"study_design_scores_gemma":[0.012557658,0.0006464781,0.0014162057,0.00006116987,0.00013201415,0.000030406265,0.00016716414,0.00008044794,0.9794496,0.0002816153,0.0048975893,0.0002796043],"about_ca_topic_score_codex":0.00010702086,"about_ca_topic_score_gemma":0.000030321098,"teacher_disagreement_score":0.012211311,"about_ca_system_score_codex":0.00005792514,"about_ca_system_score_gemma":0.00010825586,"threshold_uncertainty_score":0.9999657},"labels":[],"label_agreement":null},{"id":"W2571881266","doi":"10.1182/blood.v108.11.3139.3139","title":"Long Term Results of Myeloablative Allogeneic Stem Cell Transplantation Using Related and Unrelated Donors in Patients with Relapsed Composite Low and Intermediate Grade (Including Transformed) Lymphoma.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Vancouver Hospital and Health Sciences Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Transplantation; Stem cell; Univariate analysis; Gastroenterology; Lymphoma; Multivariate analysis; Surgery; Oncology; Biology","score_opus":0.008731107297371723,"score_gpt":0.2149846374896232,"score_spread":0.20625353019225148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571881266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99853635,0.00047060775,0.000011659546,0.0000219817,0.000024014667,0.0006802355,0.000084118234,0.000024592735,0.00014642622],"genre_scores_gemma":[0.9990603,0.00031820338,0.0001992466,0.000009723316,0.0000069370017,0.000010600775,0.00035602562,0.000024449992,0.000014532984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868244,0.00006140634,0.00051943527,0.00032063955,0.00019499406,0.00022109918],"domain_scores_gemma":[0.9994628,0.00009452664,0.0001987653,0.00011224732,0.000049177197,0.000082487866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000095403506,0.00022045248,0.0003825093,0.00020540383,0.0000638874,0.000013973846,0.00003179198,0.00012767092,9.531282e-7],"category_scores_gemma":[0.0000020909918,0.00017194948,0.000040356455,0.0002325365,0.00010344275,0.00012897229,0.0000103069515,0.00006924972,3.5605882e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015613172,0.0018581767,0.9875432,0.00028158008,0.00018249937,0.00018885237,0.002165339,0.00006534019,0.0045059156,0.000004800045,4.729306e-7,0.0016424764],"study_design_scores_gemma":[0.059998445,0.0006555032,0.8805135,0.0012159523,0.00073052227,0.000046684938,0.000047884343,0.000119153556,0.05651034,0.000008533809,3.2669396e-7,0.0001531494],"about_ca_topic_score_codex":0.00043496277,"about_ca_topic_score_gemma":0.00018945344,"teacher_disagreement_score":0.10702973,"about_ca_system_score_codex":0.00009637744,"about_ca_system_score_gemma":0.00004411077,"threshold_uncertainty_score":0.70118964},"labels":[],"label_agreement":null},{"id":"W2571940780","doi":"10.1182/blood.v114.22.2980.2980","title":"The Epidemiology of Venous Thromboembolism in the Elderly: a Population-Based Study.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Healthcare Systems and Practices","field":"Health Professions","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Incidence (geometry); Cohort; Population; Epidemiology; Diagnosis code; Census; Medical prescription; Demography; Cohort study; Pediatrics; Venous thromboembolism; Internal medicine; Thrombosis; Environmental health","score_opus":0.14637872470259242,"score_gpt":0.4973849152023127,"score_spread":0.35100619049972026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571940780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9782797,0.00095062156,0.000008270184,0.017041108,0.0002709705,0.0013369413,0.0000044936905,0.00001957453,0.0020882813],"genre_scores_gemma":[0.9976916,0.000020068013,0.000059918937,0.001859908,0.00022303438,0.00009296605,0.0000039447855,0.0000063591633,0.000042219042],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99109,0.007450254,0.00078650203,0.00015153753,0.00015547383,0.00036620395],"domain_scores_gemma":[0.9892951,0.009699627,0.00044570226,0.00045145844,0.00006876458,0.000039339167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0075590373,0.000087637505,0.0003666021,0.000043702905,0.00063788035,0.0000029077805,0.00025318272,0.00013180723,0.00002432647],"category_scores_gemma":[0.0023177362,0.000044556935,0.000042545842,0.00020610774,0.000016196305,0.00004403927,0.000012125368,0.0005383767,0.000022186423],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027718783,0.00090871175,0.9741079,0.00005848613,0.00002014864,0.000005760341,0.0082039265,0.000010119003,0.0000050364674,0.0068247477,0.00027734725,0.009550052],"study_design_scores_gemma":[0.0007887419,0.000791686,0.9851592,0.00006397815,0.000024464225,0.0000011603079,0.0056658788,0.000012881388,4.879657e-7,0.0027574461,0.004687883,0.00004618526],"about_ca_topic_score_codex":0.0064434796,"about_ca_topic_score_gemma":0.0049658357,"teacher_disagreement_score":0.019411843,"about_ca_system_score_codex":0.000019450203,"about_ca_system_score_gemma":0.00023420755,"threshold_uncertainty_score":0.97406566},"labels":[],"label_agreement":null},{"id":"W2572005821","doi":"10.1182/blood.v112.11.5434.5434","title":"Development of a Modified Skin Explant Assay to Study Treg Suppression of Th17 Cell Mediated GvHD in the Skin","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"FOXP3; Immunology; Cytotoxic T cell; CD8; Adoptive cell transfer; Immune system; T cell; Graft-versus-host disease; IL-2 receptor; Haematopoiesis; Immune tolerance; Biology; Proinflammatory cytokine; Cytokine; Transplantation; Stem cell; Medicine; In vitro; Inflammation; Cell biology; Internal medicine","score_opus":0.020970098289225803,"score_gpt":0.22695239989054625,"score_spread":0.20598230160132044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2572005821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99729455,0.0006748208,0.000022928534,0.000037362835,0.00017770032,0.0005378119,0.000017303022,0.000017882343,0.0012196209],"genre_scores_gemma":[0.99919057,0.000037115053,0.00023502555,0.00003958689,0.0000075295993,0.00007061364,0.00006265525,0.000011464837,0.0003454178],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99822515,0.0005342693,0.0005800331,0.00026861392,0.00007655688,0.00031535607],"domain_scores_gemma":[0.9991135,0.00026894224,0.00018347861,0.00037200382,0.000046485988,0.000015594997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005032145,0.0001851819,0.0004137689,0.00017676887,0.00011644133,0.0000021510511,0.00047121485,0.0002095186,0.00018075114],"category_scores_gemma":[0.000048584687,0.000121768484,0.00006156105,0.00023802374,0.00010428939,0.000026269923,0.00014700304,0.0002411196,0.00009262263],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018952324,0.006214323,0.00430243,0.000013029722,0.00013363987,0.000033817516,0.03044435,0.000003029338,0.9572224,0.000011150281,0.0003391271,0.0010932034],"study_design_scores_gemma":[0.0053183967,0.0004096033,0.050084867,0.000015679698,0.00004317077,0.00004087559,0.0038220515,4.807701e-7,0.93865836,0.000006340435,0.00145964,0.00014053927],"about_ca_topic_score_codex":0.00013559105,"about_ca_topic_score_gemma":0.00010636585,"teacher_disagreement_score":0.04578244,"about_ca_system_score_codex":0.000010835306,"about_ca_system_score_gemma":0.00009769453,"threshold_uncertainty_score":0.49655747},"labels":[],"label_agreement":null},{"id":"W2572023600","doi":"10.1182/blood.v106.11.3362.3362","title":"LS104, a Novel Kinase Inhibitor, Induces Apoptosis, Synergizes with Cytostatic Drugs and Is Targeting the Receptor Tyrosine Kinase FLT3.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Click Chemistry and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Fms-Like Tyrosine Kinase 3; Myeloid leukemia; Tyrosine kinase; Biology; Cancer research; Molecular biology; Tyrosine-kinase inhibitor; Annexin; Cytotoxic T cell; Receptor tyrosine kinase; Kinase; Cell biology; Signal transduction; Flow cytometry; Biochemistry; Mutation; Cancer","score_opus":0.008659193478486765,"score_gpt":0.2217861616129125,"score_spread":0.21312696813442575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2572023600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993135,0.00081348146,0.000012701233,0.0036626025,0.000013010846,0.00011098385,0.0001370631,0.00009971211,0.0020154954],"genre_scores_gemma":[0.9957685,0.000121599245,0.0020094614,0.00029698174,0.0005797343,0.0001450653,0.000085516505,0.000037170055,0.00095597934],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99875855,0.000009012931,0.00028374186,0.00041547994,0.00022738882,0.00030582526],"domain_scores_gemma":[0.9990573,0.00017004527,0.0001563551,0.00041173567,0.00006881984,0.00013577328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011094623,0.00025468407,0.00019580938,0.00002026674,0.00036090738,0.00010534519,0.00022686426,0.00011385156,0.00031754968],"category_scores_gemma":[0.00007314571,0.0001846169,0.0000505758,0.00020653645,0.00017424648,0.00011526592,0.00009794607,0.00028501078,0.00002262827],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002270884,0.00057577767,0.00023263184,0.00011297708,0.000061067825,8.078021e-7,0.0009946714,0.0000044221956,0.9948643,0.000090982816,0.0019303177,0.0011093591],"study_design_scores_gemma":[0.0015234945,0.000017291593,0.000020231495,0.00014070467,0.00013292849,0.00001314248,0.0011287739,0.000026352616,0.9731054,0.00002014387,0.023602797,0.00026876145],"about_ca_topic_score_codex":0.00003722044,"about_ca_topic_score_gemma":0.000004609315,"teacher_disagreement_score":0.021758897,"about_ca_system_score_codex":0.00002368687,"about_ca_system_score_gemma":0.000049786475,"threshold_uncertainty_score":0.7528459},"labels":[],"label_agreement":null},{"id":"W2572038227","doi":"10.1182/blood.v116.21.4626.4626","title":"Effect of Valproic Acid (VPA) on Fludarabine Activity In Chronic Lymphocytic Leukemia (CLL) Patients","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Research Manitoba; CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Apoptosis; Chronic lymphocytic leukemia; Fludarabine; Cancer research; Programmed cell death; Chemistry; Histone deacetylase; Leukemia; Cell culture; Histone deacetylase inhibitor; Histone; Biology; Immunology; Biochemistry; Chemotherapy","score_opus":0.0037017163676691125,"score_gpt":0.25490969922148693,"score_spread":0.2512079828538178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2572038227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99865097,0.00009721824,0.0000024589187,0.0000052080727,0.00013940995,0.00036359503,0.000020094754,0.000010464972,0.00071055756],"genre_scores_gemma":[0.99952555,0.000016715867,0.000017729484,0.000009216148,0.00015922783,0.00004983294,0.00004997455,0.00002877501,0.00014297562],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99872345,0.00014825117,0.000176247,0.00037156767,0.0002626191,0.00031784756],"domain_scores_gemma":[0.9992273,0.000036570065,0.000072984316,0.0005205752,0.0000564854,0.000086102365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034057553,0.00017565655,0.00021952197,0.00010049368,0.000038286198,0.000007924592,0.00022133392,0.00022820767,0.000019479623],"category_scores_gemma":[0.00033531766,0.00015990942,0.00009695984,0.0001484453,0.0001083691,0.000004056507,0.00010957703,0.00027511572,0.000041128795],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026904378,0.00015739074,0.0025590518,0.00009230508,0.000023712968,0.0000063250077,0.00001126564,0.000034647936,0.99310815,0.0000020952248,0.00011659142,0.003619443],"study_design_scores_gemma":[0.005418054,0.0028869067,0.0050786803,0.000030001978,0.000016168264,0.0000040959762,5.366113e-7,0.00009205824,0.9859196,0.0000016630675,0.00041044984,0.0001417903],"about_ca_topic_score_codex":0.000105400235,"about_ca_topic_score_gemma":0.00020008202,"teacher_disagreement_score":0.0071885325,"about_ca_system_score_codex":0.0004417122,"about_ca_system_score_gemma":0.00077549374,"threshold_uncertainty_score":0.6520917},"labels":[],"label_agreement":null},{"id":"W2572113748","doi":"10.1182/blood.v118.21.2619.2619","title":"Significance of Prior HSCT on the Outcome of Salvage Therapy with CPX-351 or Conventional Chemotherapy Among First Relapse AML Patients","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Salvage therapy; Internal medicine; Regimen; Chemotherapy regimen; Clinical endpoint; Cytarabine; Surgery; Chemotherapy; Randomized controlled trial; Gastroenterology","score_opus":0.042431709011144035,"score_gpt":0.2743322192836887,"score_spread":0.23190051027254469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2572113748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957317,0.000046929003,0.000020324887,0.00034405896,0.000032972603,0.0012245473,0.000030331214,0.000024026438,0.002545071],"genre_scores_gemma":[0.9975372,0.000097021795,0.0006323369,0.00033625556,0.000043928343,0.00007895049,0.000012504773,0.00004389934,0.0012179223],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984136,0.00006745227,0.0003932361,0.00025432082,0.00062375894,0.00024762703],"domain_scores_gemma":[0.9986197,0.00023260053,0.0002673872,0.00055687706,0.00023437217,0.00008910022],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032176712,0.00017828222,0.00037066638,0.00008874912,0.00006282338,0.0000048996085,0.00027129042,0.00008986585,0.0009355834],"category_scores_gemma":[0.00012899641,0.00009160517,0.00011501428,0.00025762228,0.0003833355,0.000054263586,0.000027760147,0.00027455387,0.000017247005],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004383303,0.0029756788,0.9871594,0.00012095464,0.00044364418,0.000025674733,0.0011141659,4.3786048e-7,0.0019626406,0.00036050193,0.00062021223,0.00083339785],"study_design_scores_gemma":[0.0132087385,0.0029843138,0.9017329,0.00016528404,0.000060981376,0.0000049615314,0.00010578904,0.000009705994,0.08110791,0.000024722733,0.00048321066,0.000111471905],"about_ca_topic_score_codex":0.00017227809,"about_ca_topic_score_gemma":0.000031224372,"teacher_disagreement_score":0.08542647,"about_ca_system_score_codex":0.00005021975,"about_ca_system_score_gemma":0.00017254884,"threshold_uncertainty_score":0.9999777},"labels":[],"label_agreement":null},{"id":"W2572151484","doi":"10.1182/blood.v122.21.1481.1481","title":"Inhibition Of Inflammation Driven Leukemia Stem Cell Self-Renewal With a Selective JAK2 Antagonist","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"RNA regulation and disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; BC Cancer Agency","funders":"","keywords":"Biology; Cancer research; Stem cell; Myeloid leukemia; STAT5; K562 cells; Leukemia; Cell biology; Molecular biology; Signal transduction; Immunology","score_opus":0.0031337032396702965,"score_gpt":0.18342694249218486,"score_spread":0.18029323925251456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2572151484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960607,0.00004650898,0.00015175757,0.000023430595,0.000011692074,0.0002245694,0.000007831494,0.000017210592,0.003456294],"genre_scores_gemma":[0.9990066,0.000011795109,0.0004853189,0.000027727836,0.000077410485,0.00003169208,0.00011144545,0.000011039719,0.00023695124],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994907,0.000030076637,0.00012848477,0.00015668472,0.00009539759,0.00009866418],"domain_scores_gemma":[0.99955577,0.0000033590027,0.00010220914,0.00013902549,0.00013811617,0.00006152001],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00002537896,0.00008648123,0.00007557208,0.00002810119,0.000038826558,0.000017735252,0.00004038287,0.00007261517,0.000014068668],"category_scores_gemma":[0.0000028773084,0.00007546524,0.000035772948,0.000068556044,0.000029151164,0.000007685595,0.000020500916,0.000027570322,0.000012907964],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004185467,0.00012717859,0.01265863,0.000031605257,0.00004138379,0.0000012137801,0.00010040593,0.00014717852,0.98637265,0.00003734626,0.00018821469,0.00025231208],"study_design_scores_gemma":[0.0018100684,0.00025575238,0.014643838,0.000010800412,0.000051302442,0.000005588405,0.0000903441,0.00017007919,0.98267883,0.000037036847,0.00013308185,0.00011329941],"about_ca_topic_score_codex":0.000028215598,"about_ca_topic_score_gemma":0.000015707305,"teacher_disagreement_score":0.003693868,"about_ca_system_score_codex":0.000013966861,"about_ca_system_score_gemma":0.00012958086,"threshold_uncertainty_score":0.30773833},"labels":[],"label_agreement":null},{"id":"W2572199427","doi":"10.1182/blood.v112.11.3490.3490","title":"Hepatocyte-Like Cells Can Be Derived from Human Umbilical Cord Blood and Embryonic Stem Cells: Tested in a Novel Mouse Model","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Liver physiology and pathology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials","funders":"","keywords":"Stem cell; Biology; Transplantation; Amniotic epithelial cells; Embryonic stem cell; Molecular biology; Progenitor cell; Pathology; Haematopoiesis; Adult stem cell; Immunology; Andrology; Cell biology; Medicine; Internal medicine; Biochemistry","score_opus":0.045948445297719895,"score_gpt":0.2519767931137211,"score_spread":0.2060283478160012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2572199427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99878025,0.00022071363,0.000024271261,0.00010511748,0.00006170295,0.0004509985,0.00015908854,0.00008801155,0.00010982204],"genre_scores_gemma":[0.9967487,0.00009558594,0.0010688913,0.0009766446,0.00008019732,0.00004070072,0.000065635766,0.00003752724,0.0008861512],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99845725,0.00009302196,0.00033310114,0.00057171576,0.00014127124,0.00040365342],"domain_scores_gemma":[0.9990584,0.00013536598,0.000093308015,0.00045491787,0.000051761548,0.0002062226],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000086373926,0.0002590341,0.0005800452,0.0001029117,0.00012871277,0.000005998004,0.00014119768,0.00033855677,0.000024718152],"category_scores_gemma":[0.000010228573,0.0002454577,0.000077998695,0.00012146678,0.00029222286,0.000047136284,0.00011427628,0.0004575954,0.000011656302],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019980967,0.002014822,0.040545095,0.000037056052,0.000120078075,0.00038388016,0.0015208295,0.000022700817,0.95506245,0.000021640093,0.00005152275,0.000020089352],"study_design_scores_gemma":[0.021633698,0.0014930026,0.078530714,0.000071713504,0.00067169406,0.00041700466,0.00017808762,0.001947413,0.894441,0.00010640276,0.0000308596,0.00047841613],"about_ca_topic_score_codex":0.00064990675,"about_ca_topic_score_gemma":0.000549686,"teacher_disagreement_score":0.060621485,"about_ca_system_score_codex":0.000026687972,"about_ca_system_score_gemma":0.00022554032,"threshold_uncertainty_score":0.99999976},"labels":[],"label_agreement":null},{"id":"W2572245593","doi":"10.1182/blood.v114.22.2085.2085","title":"Targeting the Oncogene eIF4E with Ribavirin: A Novel Therapeutic Avenue in Acute Myeloid Leukemia.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Hôpital Maisonneuve-Rosemont; Université de Montréal; McMaster University Medical Centre; Institute for Research in Immunology and Cancer; Jewish General Hospital","funders":"","keywords":"Ribavirin; Myeloid leukemia; EIF4E; Medicine; Immunology; Leukemia; Internal medicine; Oncology; Cytarabine; Cancer research; Virology; Translation (biology); Biology; Virus; Hepatitis C virus; Messenger RNA","score_opus":0.018203294085038693,"score_gpt":0.28087988638565126,"score_spread":0.2626765923006126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2572245593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99278957,0.0020269079,0.00017192434,0.001721061,0.00003946463,0.00069382344,0.0000071554746,0.00006346713,0.002486601],"genre_scores_gemma":[0.9963109,0.0002108107,0.0008218312,0.0014476643,0.00027156447,0.00004144807,0.000016756825,0.000036881924,0.00084214297],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99812317,0.000052263607,0.00028377128,0.00036593142,0.00057374244,0.0006011463],"domain_scores_gemma":[0.9990329,0.00012635149,0.00007485384,0.0005589587,0.00007659227,0.00013034634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045288733,0.00021325717,0.00033377367,0.00010389054,0.00010369621,0.00003748075,0.0002805486,0.000114615716,0.00003325814],"category_scores_gemma":[0.00007167248,0.0001304406,0.00007282083,0.0005153893,0.0001249412,0.00006902493,0.00005703996,0.00048580905,0.00006171767],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035419413,0.005922741,0.008180208,0.00029831546,0.0019671703,0.006305185,0.0068877055,0.000936536,0.89874405,0.0013078796,0.0015251541,0.06438312],"study_design_scores_gemma":[0.4584565,0.007320617,0.10581332,0.002111352,0.003126607,0.015285251,0.0016683844,0.030034943,0.3273676,0.0011010392,0.045339953,0.0023744348],"about_ca_topic_score_codex":0.00022101968,"about_ca_topic_score_gemma":0.000042631298,"teacher_disagreement_score":0.57137644,"about_ca_system_score_codex":0.0031056707,"about_ca_system_score_gemma":0.0044046077,"threshold_uncertainty_score":0.8121221},"labels":[],"label_agreement":null},{"id":"W2572250031","doi":"10.1182/blood-2016-10-746933","title":"International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":624,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institutes of Health; Janssen Pharmaceuticals; National Cancer Institute; National Heart, Lung, and Blood Institute; University of Pennsylvania","keywords":"Histopathology; Medicine; Pathology; Disease; Internal medicine","score_opus":0.058390119026580964,"score_gpt":0.34804638189473286,"score_spread":0.2896562628681519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2572250031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9750692,0.0033219354,0.00020090218,0.017715078,0.0010335828,0.0013134374,0.00022271913,0.0000903242,0.001032815],"genre_scores_gemma":[0.9975695,0.0003528842,0.00044660928,0.0007568467,0.00038499705,0.00016794495,0.000027652468,0.000028324563,0.00026525478],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988413,0.00004523712,0.0002413329,0.00031827678,0.00026890243,0.00028496355],"domain_scores_gemma":[0.99816614,0.0005990788,0.00024397759,0.00045936383,0.00027879246,0.0002526544],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00023283572,0.00016540379,0.00025953134,0.00008269447,0.00031484367,0.00012061382,0.00021526737,0.000072176925,0.00014321978],"category_scores_gemma":[0.017700266,0.00015222645,0.00016489213,0.000047606034,0.0001361844,0.00010988776,0.000041521344,0.00011060848,0.00003038871],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059277248,0.0054205516,0.9373807,0.0018205135,0.0011539939,0.002015579,0.0008349212,0.00008295774,0.0068540107,0.00048657082,0.02591577,0.01210672],"study_design_scores_gemma":[0.073866986,0.0014706214,0.88625157,0.00582419,0.00409909,0.000028098182,0.00047341784,0.010733278,0.0069130473,0.0012084476,0.0081304675,0.0010007626],"about_ca_topic_score_codex":0.00016261252,"about_ca_topic_score_gemma":0.000031305215,"teacher_disagreement_score":0.06793926,"about_ca_system_score_codex":0.000081832804,"about_ca_system_score_gemma":0.00031918762,"threshold_uncertainty_score":0.99057406},"labels":[],"label_agreement":null},{"id":"W2572279408","doi":"10.1182/blood.v116.21.3342.3342","title":"The Attitude of Canadian University Students towards a Behaviour-Based Blood Donor Health Assessment Questionnaire","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Blood donation and transfusion practices","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Likert scale; Medicine; Risk perception; Blood donor; Demography; Family medicine; Human immunodeficiency virus (HIV); Men who have sex with men; Psychology; Perception; Gerontology; Immunology; Developmental psychology","score_opus":0.015096216593320782,"score_gpt":0.268124578362048,"score_spread":0.25302836176872723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2572279408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9778045,0.000050087558,0.00003867885,0.014559389,0.00043366695,0.000325549,0.000014436937,0.00006548881,0.006708214],"genre_scores_gemma":[0.998355,0.000038653856,0.00039623404,0.00090676046,0.00012649373,0.0000046852924,0.000018453335,0.00001184382,0.00014192192],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99894613,0.00003083927,0.00020530149,0.0001946392,0.00038640227,0.0002366782],"domain_scores_gemma":[0.9991931,0.000034453966,0.0002380224,0.0002589228,0.00021935585,0.000056187044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007207347,0.000117898475,0.0001344162,0.00036607328,0.00061950233,0.00021143944,0.00043988877,0.00006340193,0.00014273847],"category_scores_gemma":[0.000050808325,0.00009893611,0.000068500594,0.0005583577,0.000068751855,0.00042824246,0.00005457506,0.00026351813,0.00001852285],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017129016,0.0016415291,0.96124274,0.00007643728,0.00012720535,0.000025432711,0.00004740269,0.0000053446024,0.00020415125,0.032077007,0.00046810877,0.0040675225],"study_design_scores_gemma":[0.002967905,0.000032824715,0.9316634,0.000041112347,0.00033292017,0.0000026048162,0.00021946922,0.00004623236,0.00015726949,0.00007637389,0.06430249,0.00015740555],"about_ca_topic_score_codex":0.21684584,"about_ca_topic_score_gemma":0.6156654,"teacher_disagreement_score":0.39881957,"about_ca_system_score_codex":0.000017135204,"about_ca_system_score_gemma":0.00057138014,"threshold_uncertainty_score":0.78836924},"labels":[],"label_agreement":null},{"id":"W2572346362","doi":"10.1182/blood.v116.21.4416.4416","title":"EspP, An Extracellular Serine Protease From Enterohemorrhagic E. Coli, Induces Coagulopathy In Human Whole Blood and Plasma","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Escherichia coli research studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Ontario Institute for Cancer Research; University of Toronto; Health Sciences Centre; University Health Network","funders":"","keywords":"Serine protease; Biology; Proteases; Escherichia coli; Serine; Microbiology; Molecular biology; Extracellular; Virulence factor; Coagulation; Biochemistry; Protease; Phosphorylation; Virulence; Enzyme; Internal medicine; Medicine","score_opus":0.011028813272861898,"score_gpt":0.2564252797285531,"score_spread":0.24539646645569121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2572346362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99827856,0.00083009,0.0000035133692,0.000086360495,0.000056658206,0.00044799034,0.00005916758,0.00002114045,0.00021649477],"genre_scores_gemma":[0.99797857,0.0000648026,0.0010279261,0.000042281987,0.00026965226,0.00015185954,0.00013280676,0.000030110783,0.0003019772],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99864185,0.0000927941,0.00021920192,0.0005246789,0.00017062164,0.00035082857],"domain_scores_gemma":[0.9992461,0.000013845958,0.000068031666,0.00042829732,0.00006346334,0.00018026975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022561965,0.00021642713,0.000212554,0.00005781498,0.00012328186,0.00006431738,0.00025480724,0.00018652991,0.000027413731],"category_scores_gemma":[0.00012629222,0.00021092751,0.000038338985,0.00009196077,0.00015844018,0.000012400171,0.0003005029,0.00034910362,0.0000044580124],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042952477,0.0009173036,0.05042705,0.000025539259,0.000061223065,0.00008149101,0.00014176768,6.7340477e-7,0.94796693,0.000015381223,0.00002208891,0.0002975871],"study_design_scores_gemma":[0.003562641,0.0007043083,0.041994635,0.000019914838,0.000053395448,0.0000239899,0.00018764783,0.000036330566,0.95097446,0.00008708178,0.002057651,0.0002979522],"about_ca_topic_score_codex":0.00021225147,"about_ca_topic_score_gemma":0.0013834304,"teacher_disagreement_score":0.008432414,"about_ca_system_score_codex":0.0000031081443,"about_ca_system_score_gemma":0.00005559941,"threshold_uncertainty_score":0.8601374},"labels":[],"label_agreement":null},{"id":"W2572395858","doi":"10.1182/blood.v126.23.175.175","title":"Prediction of Primary Treatment Outcome Using Gene Expression Profiling of Pre-Treatment Biopsies Obtained from Childhood and Adolescent Hodgkin Lymphoma Patients","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Oncology; Internal medicine; Clinical trial; Lymphoma; Chemotherapy","score_opus":0.042400746508425714,"score_gpt":0.25966351958422174,"score_spread":0.21726277307579603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2572395858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960009,0.0020761753,0.000019896968,0.000020535843,0.00011087074,0.0012151522,0.00043938303,0.00004299032,0.000074095246],"genre_scores_gemma":[0.99034315,0.00028417466,0.0086797625,0.00001979174,0.00009210461,0.00006413735,0.00047450693,0.00002740964,0.000014986563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844724,0.00005954568,0.0005598681,0.00037347595,0.00035467223,0.0002052231],"domain_scores_gemma":[0.998952,0.00004227159,0.00030453847,0.00035899103,0.00014058308,0.00020165429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000059922528,0.00029033297,0.0006509276,0.00011525277,0.000048342336,0.000009756369,0.000042840657,0.00011074317,0.0000042541396],"category_scores_gemma":[0.00003283111,0.00019731131,0.0001315957,0.00009510261,0.00005630532,0.00008016549,0.000058111505,0.000019816827,0.0000012213673],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042017797,0.017806493,0.9387953,0.00008116441,0.00047528648,0.000018323854,0.0008654117,0.000013242952,0.03426323,0.000001495848,0.0000063739794,0.007253495],"study_design_scores_gemma":[0.020155713,0.0020633459,0.56511635,0.00024713544,0.00086744525,0.000010335341,0.00007532794,0.00004174252,0.41133264,0.000007570681,0.00001044587,0.000071962924],"about_ca_topic_score_codex":0.00036149478,"about_ca_topic_score_gemma":0.000002521349,"teacher_disagreement_score":0.3770694,"about_ca_system_score_codex":0.0005533942,"about_ca_system_score_gemma":0.00022515602,"threshold_uncertainty_score":0.80461216},"labels":[],"label_agreement":null},{"id":"W2572403463","doi":"10.1182/blood.v118.21.4046.4046","title":"Systematic Review of Randomized Controlled Trials of Hematopoietic Stem Cell Mobilization Strategies for Autologous Transplantation for Hematologic Malignancies,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Transplantation; Hematopoietic stem cell transplantation; Stem cell; Internal medicine; Oncology; Cyclophosphamide; Neutropenia; Febrile neutropenia; Autologous stem-cell transplantation; Clinical endpoint; Randomized controlled trial; Chemotherapy; Biology","score_opus":0.03991133675412549,"score_gpt":0.28785056891806043,"score_spread":0.24793923216393493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2572403463","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19079477,0.12593023,0.56232226,0.0001087279,0.00039791554,0.11707312,0.0005398659,0.00025003453,0.0025830567],"genre_scores_gemma":[0.97136784,0.010353242,0.00999108,0.000074879026,0.000018000132,0.007827124,0.00021929281,0.00004534518,0.000103212245],"study_design_codex":"systematic_review","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9934253,0.00093782466,0.0047614914,0.0002859053,0.0003563094,0.00023316579],"domain_scores_gemma":[0.9903035,0.0056776754,0.0029262963,0.0003457755,0.0006801808,0.00006654826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008046619,0.00029795605,0.008925493,0.00018888462,0.000037516267,0.000008558625,0.00012890525,0.00018977658,0.000045876568],"category_scores_gemma":[0.0012931527,0.00019155214,0.0016293593,0.00016925749,0.000108747976,0.00008387204,0.0000036818985,0.000049025046,0.0000017048935],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026204795,0.00065974623,0.000016179749,0.9444689,0.0011082103,0.0000068053155,0.0024226294,0.0000022663448,0.014376441,0.010719045,0.000011597526,0.0000033823985],"study_design_scores_gemma":[0.39396346,0.0007246458,0.000007087638,0.21202403,0.049613956,0.00026760495,0.0016484119,0.00026520496,0.33920896,0.00204222,3.3894926e-7,0.00023405196],"about_ca_topic_score_codex":0.000007090878,"about_ca_topic_score_gemma":0.0000014311539,"teacher_disagreement_score":0.78057307,"about_ca_system_score_codex":0.000013674296,"about_ca_system_score_gemma":0.00027223252,"threshold_uncertainty_score":0.7811269},"labels":[],"label_agreement":null},{"id":"W2572443205","doi":"10.1182/blood.v120.21.1279.1279","title":"Collaboration Between RUNX and NOTCH Pathways in T-Cell Acute Lymphoblastic Leukemia","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Notch signaling pathway; Biology; Genetics; Haematopoiesis; Insertional mutagenesis; Cancer research; Gene; Progenitor cell; Molecular biology; Stem cell","score_opus":0.015939701706688767,"score_gpt":0.26559612790815024,"score_spread":0.24965642620146147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2572443205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946242,0.00048657064,0.00018220498,0.000262328,0.00008460563,0.0004948273,0.00004210507,0.00006441149,0.0037587206],"genre_scores_gemma":[0.9972827,0.00011578038,0.0012850042,0.00015736825,0.0004917677,0.000047576792,0.00006822793,0.00004385885,0.00050770777],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820215,0.00006832614,0.00033517688,0.0002970838,0.00045533135,0.000641955],"domain_scores_gemma":[0.9988274,0.0002788261,0.00007377717,0.00031406755,0.00010424373,0.0004016599],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003659968,0.0002086398,0.0003908853,0.00022786448,0.00006830481,0.000039942697,0.00010529864,0.00021813264,0.000051186988],"category_scores_gemma":[0.00018987567,0.0001864841,0.000038155827,0.0005669493,0.000092837494,0.0002614287,0.00011854212,0.00022533347,0.00020321176],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032913723,0.0011226275,0.78350395,0.0004136811,0.00029842596,0.00035194712,0.0033636175,0.000005679089,0.20412281,0.00023053138,0.0032997825,0.0029578013],"study_design_scores_gemma":[0.05143556,0.001243051,0.6998091,0.00034122585,0.0015748084,0.00056404923,0.0009649966,0.0012015711,0.23715556,0.00016994686,0.0046975617,0.00084257615],"about_ca_topic_score_codex":0.00008174099,"about_ca_topic_score_gemma":0.000010220299,"teacher_disagreement_score":0.08369487,"about_ca_system_score_codex":0.0007407746,"about_ca_system_score_gemma":0.0010117086,"threshold_uncertainty_score":0.7604601},"labels":[],"label_agreement":null},{"id":"W2572471102","doi":"10.1182/blood.v110.11.5027.5027","title":"Should Patients with Myelodysplasia and/or Acute Myeloid Leukemia (MDS/AML) Be Screened for Inherited RUNX1 Mutations Prior to Sibling Donor Allografting?.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"RUNX1; Medicine; Proband; Sibling; Platelet disorder; CEBPA; Myeloid leukemia; Leukemia; Bone marrow; Myeloid; Internal medicine; Oncology; Genetics; Immunology; Mutation; Haematopoiesis; Biology; Stem cell; Gene; Platelet","score_opus":0.02949248383752329,"score_gpt":0.3122175405950061,"score_spread":0.28272505675748283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2572471102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898855,0.00006337762,0.0038894624,0.0016605372,0.00006112647,0.003402209,0.0001669014,0.00024043297,0.0006304574],"genre_scores_gemma":[0.88948524,0.000042435986,0.1042764,0.0029580714,0.00034631917,0.00034991407,0.00057024596,0.0001832632,0.0017881402],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966878,0.00004264912,0.00062412734,0.000779751,0.00076912984,0.0010964997],"domain_scores_gemma":[0.99730676,0.00052530895,0.00016402904,0.00053977803,0.0006738177,0.00079028314],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007013213,0.0004344212,0.0006001304,0.0007330805,0.0003951502,0.00010224439,0.00027756434,0.00030407493,0.000047173573],"category_scores_gemma":[0.0007114354,0.00033496728,0.00011453085,0.0013080833,0.00017226778,0.00022517199,0.00018342918,0.00053269387,0.000016102971],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043562934,0.004560849,0.6876499,0.0014570552,0.0065578423,0.001536369,0.008051031,0.000105537845,0.1421819,0.00048449897,0.0075389566,0.0963131],"study_design_scores_gemma":[0.07536642,0.010405388,0.8179661,0.0007832101,0.003161868,0.0004027689,0.001717634,0.00079193054,0.052972008,0.000045722965,0.03476347,0.0016234543],"about_ca_topic_score_codex":0.00015199148,"about_ca_topic_score_gemma":0.00038725816,"teacher_disagreement_score":0.1303162,"about_ca_system_score_codex":0.00037695357,"about_ca_system_score_gemma":0.0007472888,"threshold_uncertainty_score":0.99991024},"labels":[],"label_agreement":null},{"id":"W2572477394","doi":"10.1182/blood.v114.22.1434.1434","title":"A Potent Stimulator of Self-Renewal in Combination with MEIS1 Overexpression Allows the Transformation of Late Committed Myeloid Progenitors.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Progenitor cell; Haematopoiesis; Stem cell; Myeloid; Biology; Myeloid leukemia; CD34; Bone marrow; Cancer research; Cell biology; Leukemia; Molecular biology; Immunology","score_opus":0.009976627904671069,"score_gpt":0.24204814292715776,"score_spread":0.23207151502248669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2572477394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99822646,0.00003784794,0.00010912225,0.00045144564,0.000020379097,0.000491948,0.000007798751,0.00002593605,0.00062906137],"genre_scores_gemma":[0.99947584,0.000009798343,0.0003902651,0.000047024445,0.000020557078,0.000009662775,0.00002903131,0.0000065219388,0.000011312904],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992756,0.00003535989,0.00029924314,0.00008071569,0.00022134063,0.0000877013],"domain_scores_gemma":[0.9995489,0.00002943117,0.00013341694,0.00013906686,0.00011963025,0.000029521898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000114625764,0.000081575825,0.00017488172,0.000089355264,0.000031032632,0.0000046865257,0.000048693415,0.000045147142,0.000013920328],"category_scores_gemma":[0.00001472267,0.000050306124,0.000054893073,0.00017382695,0.000017749997,0.00007923455,0.0000046005794,0.000112194466,7.6573184e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050009805,0.0037437933,0.007376462,0.00009751951,0.00010552662,0.000003794106,0.0034476146,0.00040988676,0.9823233,0.0003577903,0.000028304426,0.0016059143],"study_design_scores_gemma":[0.008573467,0.0021180448,0.07298912,0.0006623853,0.00022751112,0.000027418633,0.00020461524,0.0034130532,0.9113986,0.00013485958,0.00016296975,0.00008798597],"about_ca_topic_score_codex":0.000063781714,"about_ca_topic_score_gemma":0.000008994994,"teacher_disagreement_score":0.07092473,"about_ca_system_score_codex":0.000017795206,"about_ca_system_score_gemma":0.00004938012,"threshold_uncertainty_score":0.20514241},"labels":[],"label_agreement":null},{"id":"W2572521436","doi":"10.1182/blood.v116.21.238.238","title":"Clinical Efficacy and Safety Versus Biological Response of Desmopressin (DDAVP) In Inherited Von Willebrand Disease (VWD) Types 1 and 2: Initial Results From the International Study Group on DDAVP In VWD In a Cohort of 229 Patients","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Desmopressin; Medicine; Von Willebrand disease; Von Willebrand factor; Internal medicine; Prospective cohort study; Clinical trial; Gastroenterology; Coagulopathy; Platelet","score_opus":0.03106463254456221,"score_gpt":0.32686446202989866,"score_spread":0.29579982948533645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2572521436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99871945,0.00008313753,8.202746e-8,0.00013424258,0.00009992728,0.0006982921,0.00019118871,0.000005042731,0.00006864058],"genre_scores_gemma":[0.99963427,0.00009525333,0.000040100378,0.000041948482,0.000020448624,0.000013118927,0.00014591085,0.0000068557265,0.0000020847153],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985935,0.00028165014,0.0005337415,0.0002982261,0.00018101637,0.0001118414],"domain_scores_gemma":[0.9980695,0.0015313535,0.00011557877,0.00018241213,0.000031133666,0.00006997525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005971661,0.000118705546,0.0003541562,0.00009925086,0.000016897806,0.0000067375095,0.000082251834,0.000108810214,0.000010339199],"category_scores_gemma":[0.0023099456,0.00007779133,0.00002901202,0.000118646836,0.00016103854,0.000035895344,0.000081184706,0.00026212967,6.032402e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11813623,0.0084910095,0.87068486,0.0000031288962,0.00010826674,0.00020183652,0.00040416617,5.743165e-7,0.0002451891,0.0000034233933,0.000004786048,0.0017165085],"study_design_scores_gemma":[0.07604453,0.0017670001,0.9217199,0.00011989007,0.00007506256,0.0000010362269,0.00008307769,0.000029631416,0.000055468397,0.000026488768,0.00001675712,0.00006114161],"about_ca_topic_score_codex":0.00035681817,"about_ca_topic_score_gemma":0.00091295724,"teacher_disagreement_score":0.05103503,"about_ca_system_score_codex":0.000010699268,"about_ca_system_score_gemma":0.000038169954,"threshold_uncertainty_score":0.31722385},"labels":[],"label_agreement":null},{"id":"W2572545790","doi":"10.1182/blood.v112.11.3077.3077","title":"Regulation of the Gene Encoding Human Thrombin-Activable Fibrinolysis Inhibitor by Female Sex Steroids","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor; Queen's University","funders":"","keywords":"Endocrinology; Fibrinolysis; Internal medicine; Estrogen; Population; Medicine; Raloxifene; Hormone replacement therapy (female-to-male); Thrombomodulin; Hormone; Tamoxifen; Thrombin; Platelet; Testosterone (patch); Cancer","score_opus":0.03268812689972554,"score_gpt":0.2559647190933329,"score_spread":0.22327659219360735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2572545790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99617696,0.00014753142,0.00009126003,0.00011596475,0.000095343814,0.0002735507,0.00000709147,0.000055762033,0.0030365286],"genre_scores_gemma":[0.9971156,0.000026503927,0.00044656647,0.000122034355,0.000117988515,0.00001010448,0.00002266183,0.000023517072,0.0021149989],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99891233,0.000050452672,0.00029007316,0.00022259104,0.00035119633,0.00017335745],"domain_scores_gemma":[0.9992565,0.000019213578,0.00015940884,0.00043174272,0.000067456655,0.00006567248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009842141,0.00012962591,0.0002884014,0.00005766851,0.00023333749,0.000008563284,0.000094287716,0.00008514934,0.00018611667],"category_scores_gemma":[0.000017457605,0.000101242375,0.00013018382,0.0002414715,0.0000709106,0.00008798794,0.000060843002,0.000103637736,0.0000097790635],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000065235454,0.00043309777,0.01842904,0.000026205073,0.000098664925,0.000001543684,0.0003919303,0.0000036840345,0.9797367,0.00017809181,0.0006153959,0.00007911447],"study_design_scores_gemma":[0.001927828,0.00016744,0.06461771,0.000057126683,0.00018184521,0.000062491905,0.000082610066,0.000021096841,0.9324965,0.00010240517,0.0001872782,0.0000956865],"about_ca_topic_score_codex":0.000034568136,"about_ca_topic_score_gemma":0.0000026589128,"teacher_disagreement_score":0.047240227,"about_ca_system_score_codex":0.000022566719,"about_ca_system_score_gemma":0.000040422736,"threshold_uncertainty_score":0.4128544},"labels":[],"label_agreement":null},{"id":"W2572556722","doi":"10.1182/blood.v112.11.4052.4052","title":"An Assessment of Surgical Thromboprophylaxis in a Tertiary Care Center","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Sherbrooke; Jewish General Hospital","funders":"","keywords":"Medicine; Odds ratio; Confidence interval; Retrospective cohort study; Medical prescription; Incidence (geometry); Logistic regression; Cohort; Pediatrics; Emergency medicine; Surgery; Internal medicine","score_opus":0.011489512041567784,"score_gpt":0.30567807187134305,"score_spread":0.29418855982977526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2572556722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99147236,0.00027111176,0.0000063684984,0.0001402751,0.000056084,0.00036143672,0.00000774952,0.000026788739,0.0076578273],"genre_scores_gemma":[0.99838287,0.00041480726,0.00089158106,0.00013105106,0.0000746208,0.00003165212,0.00003651736,0.00001562327,0.00002127042],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990576,0.000037341193,0.0002448669,0.00021927136,0.00024787974,0.00019302504],"domain_scores_gemma":[0.99948746,0.000011984637,0.000045136272,0.00032006612,0.00004859822,0.00008677169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006885548,0.00010607117,0.00035219648,0.00010865488,0.000029980447,0.0000037396856,0.000080433834,0.000053945292,0.00014580206],"category_scores_gemma":[0.0000032910198,0.00008796913,0.00008006615,0.00011101795,0.00005263079,0.000052826577,0.00004233636,0.00010301225,0.0000057181305],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009255563,0.00695015,0.9884302,0.0001734031,0.00007632501,0.0008154085,0.0010095697,0.000004701958,0.0013058152,0.00020001318,0.00018737133,0.00083779],"study_design_scores_gemma":[0.004114808,0.0006470628,0.99133503,0.00009110138,0.00006808814,0.000078504076,0.00028180738,0.000017681024,0.0024021626,0.0000091799375,0.0008659712,0.00008860939],"about_ca_topic_score_codex":0.00016086882,"about_ca_topic_score_gemma":0.000035405294,"teacher_disagreement_score":0.007636557,"about_ca_system_score_codex":0.00003142866,"about_ca_system_score_gemma":0.000063708736,"threshold_uncertainty_score":0.3587277},"labels":[],"label_agreement":null},{"id":"W2572605004","doi":"10.1182/blood.v116.21.3345.3345","title":"Recombinant Human Erythropoietin (rHuEPO) In Combination with Chemotherapy Increases Breast Cancer Metastasis In Pre-Clinical Mouse Models","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Erythropoietin; Medicine; Breast cancer; Cancer; Erythropoiesis; Metastatic breast cancer; Metastasis; Cancer research; Internal medicine; Erythropoietin receptor; Chemotherapy; Anemia; Immunology; Oncology","score_opus":0.02106911082768984,"score_gpt":0.31860390950955697,"score_spread":0.2975347986818671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2572605004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99519193,0.00015273591,0.000007729693,0.0032948488,0.000082831546,0.0006981163,0.00002316489,0.00006647978,0.0004821433],"genre_scores_gemma":[0.9962775,0.0006708241,0.0018659293,0.0002807963,0.0000959884,0.00015270285,0.000059709884,0.000054201002,0.00054231274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824,0.00010638488,0.00054615975,0.00047572557,0.00028814108,0.0003435947],"domain_scores_gemma":[0.9990946,0.000076356395,0.00015160705,0.00041993472,0.000091375674,0.00016609413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044261324,0.00026413324,0.00057208294,0.00017282196,0.00006121005,0.000022344915,0.000111523594,0.00018347398,0.00042106453],"category_scores_gemma":[0.000025628577,0.00019762004,0.00010095219,0.00027527357,0.00018831716,0.00012354589,0.00003282074,0.000541893,0.000008042828],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008328598,0.029245533,0.9533819,0.00013244632,0.00027710386,0.0002529903,0.00071168406,0.000021292752,0.006446973,0.0007216032,0.0005344126,0.0074412096],"study_design_scores_gemma":[0.0696378,0.0023230193,0.9023478,0.000761192,0.0004957238,0.0004949531,0.00031800315,0.00041602307,0.021061815,0.0011813982,0.00031814384,0.00064410607],"about_ca_topic_score_codex":0.007938229,"about_ca_topic_score_gemma":0.007176248,"teacher_disagreement_score":0.068804935,"about_ca_system_score_codex":0.00006892277,"about_ca_system_score_gemma":0.00016300648,"threshold_uncertainty_score":0.998668},"labels":[],"label_agreement":null},{"id":"W2572608040","doi":"10.1182/blood.v120.21.3646.3646","title":"Results of a Phase 1 Dose-Escalation Study of Once-Weekly MLN9708, an Investigational Proteasome Inhibitor, in Patients with Relapsed/Refractory Lymphoma","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Proteasome inhibitor; Bortezomib; Adverse effect; Pharmacodynamics; Refractory (planetary science); Cmax; Pharmacokinetics; Lymphoma; Internal medicine; Pharmacology; Multiple myeloma","score_opus":0.016544718486692308,"score_gpt":0.2501366491684977,"score_spread":0.2335919306818054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2572608040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99869144,0.00006738635,0.000004686425,0.000007032961,0.00004127189,0.0008576636,0.0000911366,0.000007519281,0.00023188336],"genre_scores_gemma":[0.9989273,0.0000020118857,0.00046600043,0.000014029318,0.00012278285,0.000068916874,0.00035558484,0.000018982868,0.000024417253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871004,0.00016196127,0.00040037528,0.00024957632,0.0002848267,0.00019324946],"domain_scores_gemma":[0.9991207,0.000013222812,0.00029009525,0.00031817952,0.0001480215,0.000109793975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030569168,0.00014353433,0.00017696412,0.00007875671,0.000030739404,0.0000054847956,0.000117028736,0.00012328353,0.000004331894],"category_scores_gemma":[0.00012494286,0.00012664079,0.000029147712,0.00015124223,0.0000748292,0.000026871581,0.000048741837,0.00006487144,0.0000013471191],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026862593,0.038084522,0.64196366,0.000057923622,0.00009505171,0.0000012757039,0.0019852724,0.000015707239,0.31137228,0.000029400988,0.00003745573,0.003671208],"study_design_scores_gemma":[0.034238484,0.009969432,0.55351394,0.00005680307,0.000041936055,0.0000013826321,0.00020974783,0.000008382511,0.40156737,0.000016562068,0.0001861278,0.00018982528],"about_ca_topic_score_codex":0.000058201636,"about_ca_topic_score_gemma":0.000035400077,"teacher_disagreement_score":0.090195075,"about_ca_system_score_codex":0.000012282984,"about_ca_system_score_gemma":0.00012480882,"threshold_uncertainty_score":0.51642615},"labels":[],"label_agreement":null},{"id":"W2572661861","doi":"10.1182/blood.v118.21.966.966","title":"Molecular and Structural Characterization of the SH3 Domain of AHI-1 in Regulation of Cellular Resistance of BCR-ABL+ Chronic Myeloid Leukemia Cells to Tyrosine Kinase Inhibitors","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Dasatinib; Tyrosine kinase; Cancer research; Nilotinib; Imatinib mesylate; Myeloid leukemia; K562 cells; Stem cell; SH3 domain; Biology; Progenitor cell; Philadelphia chromosome; Imatinib; ABL; breakpoint cluster region; Leukemia; Cell biology; Signal transduction; Immunology; Receptor; Genetics; Gene; Chromosomal translocation","score_opus":0.006730726741856921,"score_gpt":0.2000704274830921,"score_spread":0.19333970074123516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2572661861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985574,0.0004381348,0.00005967957,0.000026351561,0.000058029218,0.0006685507,0.000044137523,0.0000055158084,0.00014218391],"genre_scores_gemma":[0.99885684,0.000025356365,0.000939958,0.000009669103,0.000026030817,0.000008859014,0.000034029395,0.000021224312,0.00007803907],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985243,0.000081336315,0.0006837576,0.00023162697,0.00032239067,0.00015656702],"domain_scores_gemma":[0.9987889,0.00002103952,0.00051388436,0.0005088509,0.00011373816,0.000053590098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018087158,0.00015693514,0.00044204417,0.00013958392,0.000015676998,0.0000017209886,0.00011113417,0.000105413594,0.00004112791],"category_scores_gemma":[0.000042826065,0.00012379458,0.00007909794,0.00038809224,0.00014366624,0.00006054465,0.00006766362,0.000084451036,4.4797264e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020942796,0.00013048183,0.015836107,0.0005540146,0.000053057778,0.0000060604134,0.0009470234,0.000018077324,0.9818112,0.00019917339,0.0000035975618,0.00023173795],"study_design_scores_gemma":[0.003202245,0.0002151737,0.2388978,0.0005332869,0.00011255591,0.0000025603927,0.000031024334,0.000040546827,0.7568,0.00009122009,0.000009172095,0.00006443922],"about_ca_topic_score_codex":0.00018724105,"about_ca_topic_score_gemma":0.000063557534,"teacher_disagreement_score":0.22501127,"about_ca_system_score_codex":0.0002673655,"about_ca_system_score_gemma":0.00029960708,"threshold_uncertainty_score":0.50481963},"labels":[],"label_agreement":null},{"id":"W2572746867","doi":"10.1182/blood.v106.11.500.500","title":"Circulating B Lymphocytes from Patients with Multiple Myeloma Harbour T(4;14) Translocations and Chromosome 13 Deletions.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Chromosomal translocation; Peripheral blood mononuclear cell; Multiple myeloma; Pathology; Bone marrow; Lymphocyte; Biology; Breakpoint; Molecular biology; Chromosome abnormality; Chromosome; Karyotype; Immunology; Medicine; Genetics; Gene","score_opus":0.011855052042191443,"score_gpt":0.23805096777404247,"score_spread":0.22619591573185102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2572746867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976005,0.00066146645,0.00014522426,0.00034463615,0.000015292784,0.0005808817,0.00013650229,0.00008265102,0.0004328641],"genre_scores_gemma":[0.992072,0.000041823336,0.0070557897,0.000097324526,0.00013948332,0.00009054888,0.00039334415,0.000031969765,0.000077706536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987813,0.000032066193,0.00020343346,0.00032649335,0.0003416433,0.00031506133],"domain_scores_gemma":[0.99913853,0.00012549714,0.000050712148,0.00026988256,0.00013920985,0.00027619395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000042788455,0.00017499218,0.00022642408,0.00009487824,0.000198527,0.000037843976,0.000058639307,0.00006668779,0.00013299812],"category_scores_gemma":[0.00008154932,0.00013822794,0.000047241705,0.00015631191,0.000075177835,0.00014608882,0.000021021548,0.00010635735,0.000058986872],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013231976,0.0015665588,0.974015,0.00003231449,0.00037806766,0.00005356402,0.00034945193,0.000012514523,0.003592432,0.000012030974,0.000023532584,0.0198322],"study_design_scores_gemma":[0.021941453,0.00025048846,0.9667865,0.00011948987,0.00023905179,0.000031674346,0.00004390921,0.0011652973,0.008900878,0.00001104948,0.00035309652,0.0001570955],"about_ca_topic_score_codex":0.00035413174,"about_ca_topic_score_gemma":0.00030228414,"teacher_disagreement_score":0.021809133,"about_ca_system_score_codex":0.000066865694,"about_ca_system_score_gemma":0.000108894455,"threshold_uncertainty_score":0.5636772},"labels":[],"label_agreement":null},{"id":"W2572754608","doi":"10.1182/blood.v120.21.2258.2258","title":"Positive Predictive Value of Progressively Elevated D-Dimer Levels in Patients with a Suspected First Deep Vein Thrombosis.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Hospital; McMaster University","funders":"","keywords":"Medicine; D-dimer; Deep vein; Thrombosis; Predictive value; Predictive value of tests; Emergency department; Triage; Venous thrombosis; Pre- and post-test probability; Internal medicine; Radiology; Surgery; Emergency medicine","score_opus":0.00985222463049165,"score_gpt":0.24002383680329448,"score_spread":0.23017161217280283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2572754608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99612737,0.00030551493,0.000043618293,0.00013669716,0.000064412685,0.0016392138,0.000043032214,0.00005219457,0.0015879703],"genre_scores_gemma":[0.9988139,0.000020728628,0.0007132372,0.00013104377,0.000065329994,0.0001248396,0.0000740952,0.000039384846,0.000017404618],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984372,0.00006356436,0.00032702755,0.00027261456,0.00043086678,0.00046869952],"domain_scores_gemma":[0.99907774,0.00005877667,0.00020158719,0.00026503287,0.00024701434,0.00014983884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014886678,0.0002227348,0.0005740717,0.00017572624,0.000053896252,0.000008871844,0.00009556532,0.0000959123,0.00009706295],"category_scores_gemma":[0.000070026006,0.00017196809,0.00006153458,0.00043372798,0.00010241501,0.00017576668,0.00007359838,0.00016210567,0.000013701073],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020653012,0.015417233,0.97913617,0.00011832477,0.00096960925,0.000009709842,0.002895803,0.00001414299,0.00038752396,0.0005249572,0.0001397033,0.00018030945],"study_design_scores_gemma":[0.008295864,0.0019513423,0.97842807,0.00051516003,0.00083585747,0.0000019392899,0.00018241243,0.00002473408,0.00953194,0.000016396405,0.000036860183,0.00017943143],"about_ca_topic_score_codex":0.00013809885,"about_ca_topic_score_gemma":0.00003624467,"teacher_disagreement_score":0.013465891,"about_ca_system_score_codex":0.000075630654,"about_ca_system_score_gemma":0.000052897834,"threshold_uncertainty_score":0.7012655},"labels":[],"label_agreement":null},{"id":"W2572765820","doi":"10.1182/blood.v110.11.1201.1201","title":"Migration of Donor Cells from the Yolk Sac to Fetal Tissues after In Utero Transplantation of Early to Mid-Gestation Canine Fetuses.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Organ and Tissue Transplantation Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Transplantation; Yolk sac; Fetus; Andrology; In utero; Progenitor cell; Stem cell; Biology; Pathology; Medicine; Embryo; Internal medicine; Pregnancy; Cell biology","score_opus":0.013714645454507974,"score_gpt":0.28523469025718184,"score_spread":0.2715200448026739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2572765820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964624,0.00010943754,0.0017138255,0.0007611988,0.00005150989,0.00060859515,0.00018391249,0.00001197706,0.00009714422],"genre_scores_gemma":[0.99707353,0.00009429626,0.0023371067,0.00015079064,0.00006575985,0.000015878313,0.000099669945,0.000013946363,0.00014904772],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998955,0.00004168664,0.00034843234,0.00016262657,0.0003325279,0.00015969636],"domain_scores_gemma":[0.99945825,0.0001400547,0.000050781033,0.0001543115,0.00010158008,0.00009503074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022947254,0.00009283118,0.00018154652,0.0001780912,0.000015234447,0.0000094059,0.00007165356,0.000056685833,0.00013494461],"category_scores_gemma":[0.000015576985,0.00007379884,0.000033875953,0.0003401552,0.000026442178,0.000065988694,0.000005277649,0.00008550092,0.000033822784],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022431242,0.00044532356,0.28342173,0.0002225277,0.000058624893,0.00015459425,0.023716295,0.000025243544,0.6861934,0.00001533214,0.00005604709,0.0034477208],"study_design_scores_gemma":[0.0013141108,0.00028953954,0.5135751,0.000119338576,0.000067233756,0.000004425327,0.00018000443,0.0000027905537,0.48432365,0.0000049815544,0.0000761014,0.000042750133],"about_ca_topic_score_codex":0.00818084,"about_ca_topic_score_gemma":0.016097806,"teacher_disagreement_score":0.23015335,"about_ca_system_score_codex":0.000016310005,"about_ca_system_score_gemma":0.0000428335,"threshold_uncertainty_score":0.99842376},"labels":[],"label_agreement":null},{"id":"W2572789227","doi":"10.1182/blood.v126.23.1859.1859","title":"The Novel Leukemia Stem Cell Marker GPR56 Discriminates Leukemic Subclones with Divergent Stem Cell Properties in Human Acute Myeloid Leukemia","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital de l'Enfant-Jésus; Leukemia & Lymphoma Society of Canada; Hôpital Maisonneuve-Rosemont; Centre hospitalier universitaire de Québec; Université Laval; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Myeloid leukemia; CD34; CD38; Biology; Haematopoiesis; Stem cell; Leukemia; Molecular biology; Myeloid; Population; Cancer research; Immunology; Cell biology; Medicine","score_opus":0.034916840566066185,"score_gpt":0.2517710068041954,"score_spread":0.2168541662381292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2572789227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987348,0.0027533544,0.000035330137,0.000488479,0.0001875004,0.0017649488,0.00003813582,0.00020061198,0.0071836277],"genre_scores_gemma":[0.9603887,0.0005262056,0.0002949513,0.00017769924,0.00025279305,0.00033761602,0.000053154006,0.00018874393,0.0377801],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99484813,0.00024380628,0.00088172354,0.0010154792,0.0015108703,0.00149998],"domain_scores_gemma":[0.9969824,0.00017468595,0.00030063553,0.0013784122,0.00046775246,0.0006961045],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011241975,0.00076419645,0.00090875896,0.00032888027,0.0004930625,0.00020916024,0.0009925675,0.00033561478,0.000023701155],"category_scores_gemma":[0.000024665429,0.00045620048,0.00020134571,0.0006980456,0.00058595015,0.00036248798,0.0006813998,0.0012917195,0.00015266307],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006100688,0.0027375869,0.09514956,0.0016906017,0.0013356729,0.002425072,0.0144066615,0.00040861891,0.857812,0.0003343474,0.013600908,0.0039982926],"study_design_scores_gemma":[0.043606304,0.0033594181,0.037624836,0.0009322824,0.0018372852,0.0008800144,0.023213416,0.0018576807,0.8744913,0.000054960852,0.010283923,0.0018586358],"about_ca_topic_score_codex":0.0013235653,"about_ca_topic_score_gemma":0.0003463143,"teacher_disagreement_score":0.057524726,"about_ca_system_score_codex":0.0036326197,"about_ca_system_score_gemma":0.0034734926,"threshold_uncertainty_score":0.999789},"labels":[],"label_agreement":null},{"id":"W2572821833","doi":"10.1182/blood.v126.23.2850.2850","title":"Tet2-Deficient Bone Marrow Progenitors Have a Proliferative Advantage in the Presence of TNF-Alpha and IFN-Gamma: Implications for Clonal Dominance in Inflammaging and MDS","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Biology; Bone marrow; Haematopoiesis; Progenitor cell; Myeloid; Stem cell; Cancer research; Immunology; Molecular biology; Genetics","score_opus":0.028382483631900053,"score_gpt":0.323324025954704,"score_spread":0.29494154232280395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2572821833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99363315,0.0010475507,0.00006629563,0.002507949,0.000012253358,0.0022927504,0.000026062937,0.000007781675,0.00040621177],"genre_scores_gemma":[0.99672073,0.00003995444,0.0021907892,0.00005187225,0.000052962198,0.0007394596,0.000009511423,0.0000130198305,0.00018168047],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988281,0.00008049628,0.0002962239,0.00028183984,0.00023057492,0.00028277186],"domain_scores_gemma":[0.9991414,0.00026900865,0.000084039275,0.00024389211,0.00016689017,0.00009475033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008553945,0.000120969664,0.00024935917,0.000152548,0.000045893816,0.000020040812,0.00010411093,0.000060358278,0.0000010196176],"category_scores_gemma":[0.0005815579,0.00008701718,0.000024796229,0.00022594228,0.00021792194,0.00010720648,0.00009512747,0.0002593756,4.3933585e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000610371,0.0006371115,0.9584547,0.00022974648,0.000032475946,0.000058619178,0.015030026,0.000005401204,0.02013419,0.000894132,0.00020366073,0.0037095633],"study_design_scores_gemma":[0.02441821,0.0013640086,0.9228743,0.00039988232,0.00014915499,0.0007848554,0.007889315,0.001460545,0.03684497,0.001576521,0.0019236124,0.0003146471],"about_ca_topic_score_codex":0.0002617383,"about_ca_topic_score_gemma":0.00095068227,"teacher_disagreement_score":0.035580423,"about_ca_system_score_codex":0.00009490464,"about_ca_system_score_gemma":0.0005059498,"threshold_uncertainty_score":0.35484576},"labels":[],"label_agreement":null},{"id":"W2572902268","doi":"10.1182/blood.v118.21.3001.3001","title":"Automation of the Hematopoietic CFC Assay for Human Cord Blood, Bone Marrow and Mobilized Peripheral Blood Samples","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stemcell Technologies","funders":"","keywords":"Cord blood; Bone marrow; Haematopoiesis; Peripheral blood mononuclear cell; Transplantation; Enumeration; Colony-forming unit; Blood cell; Umbilical cord; Biology; CD34; Immunology; Medicine; Andrology; Stem cell; Internal medicine; In vitro","score_opus":0.033636801931627776,"score_gpt":0.2672775389708445,"score_spread":0.23364073703921673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2572902268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99576116,0.00033135357,0.00083686394,0.000096106014,0.00008514854,0.0013403514,0.000038818645,0.00008145027,0.0014287352],"genre_scores_gemma":[0.9894071,0.000029739196,0.009882397,0.00006666708,0.000054807177,0.00013999442,0.00003690071,0.00003828989,0.00034406426],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99854106,0.000092758746,0.00052598625,0.00029790998,0.00029104296,0.00025127252],"domain_scores_gemma":[0.99897873,0.00016089021,0.00021962155,0.00041693775,0.00012375947,0.00010002866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042427066,0.0002034254,0.0004435686,0.000071834824,0.0001387089,0.000014085623,0.00011425651,0.00014211674,0.00022249031],"category_scores_gemma":[0.00010129508,0.00015257618,0.00015401072,0.00013691722,0.00015459603,0.0000633265,0.000026274558,0.00010945364,0.00000299219],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030998848,0.0027164577,0.1482044,0.0033800327,0.00060598715,0.000029829522,0.0055023883,5.3328705e-7,0.832507,0.00621363,0.000072372255,0.00045736856],"study_design_scores_gemma":[0.018401893,0.0012083958,0.13505569,0.0007296694,0.0043723145,0.0010785378,0.0005167248,0.00007186791,0.83593136,0.00225742,0.00006534046,0.000310775],"about_ca_topic_score_codex":0.00006450221,"about_ca_topic_score_gemma":0.000035566933,"teacher_disagreement_score":0.018091906,"about_ca_system_score_codex":0.000008441855,"about_ca_system_score_gemma":0.00005511386,"threshold_uncertainty_score":0.62218755},"labels":[],"label_agreement":null},{"id":"W2572930538","doi":"10.1182/blood.v112.11.4100.4100","title":"Use of Amphipathic Helical Peptides as An Anticoagulant","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Defence Research and Development Canada; Jewish General Hospital","funders":"","keywords":"Prothrombinase; Phospholipid; Chemistry; Factor X; Coagulation; Tissue factor; Biochemistry; Thromboplastin; Phosphatidylserine; Membrane; Factor IXa; Thrombin; Partial thromboplastin time; Biophysics; Platelet; Biology; Immunology; Internal medicine","score_opus":0.09836150443472153,"score_gpt":0.30391516088534587,"score_spread":0.20555365645062434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2572930538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99883276,0.000067362555,0.000118447424,0.00017937006,0.000058177437,0.00017940135,0.000004520088,0.00008901407,0.00047097035],"genre_scores_gemma":[0.9955287,0.00008095194,0.0034224307,0.00057057856,0.00010221795,0.0000055123373,0.00001896771,0.000021649046,0.0002489688],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990105,0.000049628088,0.00025324555,0.00020811081,0.0003059648,0.00017254073],"domain_scores_gemma":[0.9992288,0.00003841994,0.0000700488,0.00036948983,0.00010918254,0.00018406381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000099173965,0.00011565832,0.0003151812,0.00009110495,0.000062957784,0.000007956129,0.0000619472,0.00010530704,0.0001406864],"category_scores_gemma":[0.00011608605,0.00009918417,0.00009232227,0.0001448129,0.000086060994,0.00011065412,0.000026687569,0.0001141633,0.00007855028],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016371366,0.0071942983,0.13486671,0.000134161,0.00031355149,0.00043814725,0.0012379292,0.0000049730124,0.83443123,0.019818038,0.0002087666,0.0011885102],"study_design_scores_gemma":[0.003974937,0.0017203554,0.34363037,0.00015177707,0.00043053695,0.0016381729,0.00009074424,0.00026916605,0.6462665,0.0007848198,0.00080488145,0.00023773448],"about_ca_topic_score_codex":0.00007494597,"about_ca_topic_score_gemma":0.000006320166,"teacher_disagreement_score":0.20876366,"about_ca_system_score_codex":0.0000048972383,"about_ca_system_score_gemma":0.00008341933,"threshold_uncertainty_score":0.40446132},"labels":[],"label_agreement":null},{"id":"W2572933940","doi":"10.1182/blood.v126.23.4297.4297","title":"NK-92 Therapy Is Well Tolerated, Has Minimal Toxicity and Shows Efficacy in a Phase I Trial of Patients with Relapsed/Refractory Hematological Malignancies Relapsing after Autologous Stem Cell Transplantation","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Transplantation; Internal medicine; Regimen; Hematopoietic stem cell transplantation; Clinical trial; Oncology; Refractory (planetary science); Immunotherapy; Gastroenterology; Cancer; Immunology; Biology","score_opus":0.022640214582891883,"score_gpt":0.2327597248295704,"score_spread":0.21011951024667852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2572933940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967552,0.001659008,0.00004279999,0.000040532268,0.0006264942,0.0005202264,0.000018592515,0.000037361442,0.00029982693],"genre_scores_gemma":[0.99905753,0.00015563743,0.000044517896,0.000109384215,0.000012109078,0.000031232714,0.00008419777,0.000013644733,0.00049172674],"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987264,0.00026141477,0.0004395105,0.00028987392,0.00006336998,0.00021940841],"domain_scores_gemma":[0.99941546,0.00010420678,0.00020625531,0.00015014847,0.000095601725,0.000028303799],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016860943,0.00019431043,0.00036172304,0.000117479656,0.000066026376,0.000019450354,0.000069130656,0.00029286576,0.0001954513],"category_scores_gemma":[0.000012774054,0.00014719281,0.000057280526,0.00010069419,0.00015773633,0.0001731571,0.000014089781,0.00026750314,0.00003277654],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5758086,0.03770988,0.031219559,0.00016858871,0.00041480127,0.00011613213,0.016611677,0.00000761239,0.33074751,0.000022707254,0.0020729513,0.005100021],"study_design_scores_gemma":[0.37014085,0.012768579,0.016806144,0.00016664609,0.00018673151,0.00008312539,0.00077594223,0.000008927184,0.593018,0.000007057494,0.005626395,0.0004115832],"about_ca_topic_score_codex":0.000023418304,"about_ca_topic_score_gemma":0.000010586242,"teacher_disagreement_score":0.2622705,"about_ca_system_score_codex":0.0000218747,"about_ca_system_score_gemma":0.00006228683,"threshold_uncertainty_score":0.60023487},"labels":[],"label_agreement":null},{"id":"W2572994125","doi":"10.1182/blood.v118.21.1105.1105","title":"The Cellular and Molecular Mechanisms of Neutropenia in Barth Syndrome","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Cardiolipin; Biology; Cell biology; Mitochondrion; Myeloid; Progenitor cell; Annexin A5; Haematopoiesis; Apoptosis; Molecular biology; Cancer research; Annexin; Stem cell; Biochemistry; Phospholipid","score_opus":0.008699042438444318,"score_gpt":0.190091570717162,"score_spread":0.18139252827871769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2572994125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952693,0.0005923873,0.0020389762,0.000020598805,0.00010950572,0.00010492683,0.0000027640917,0.0000029917928,0.0018585272],"genre_scores_gemma":[0.9986755,0.00007989203,0.00094560254,0.00008028039,0.000012336066,0.000009639575,0.0000059889744,0.000008009674,0.00018271767],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99952394,0.000058787944,0.000118646414,0.00014849375,0.000040483472,0.000109641725],"domain_scores_gemma":[0.9997086,0.0000048534807,0.000036104124,0.00020114212,0.000018040102,0.00003128885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010775459,0.0000646804,0.00008095039,0.00001890023,0.000026657757,0.000003955846,0.00009104501,0.000077509794,0.00002392056],"category_scores_gemma":[0.000021870737,0.000048979044,0.00002920704,0.000039297694,0.000048447986,0.0000010511307,0.000057703415,0.000044673772,0.0000041571197],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003562362,0.000063830084,0.0005270986,0.0000041940234,0.000015493331,0.000034930756,0.000031020372,3.8516393e-7,0.99520504,0.003999552,0.000017475773,0.00006533312],"study_design_scores_gemma":[0.00071528484,0.00037252204,0.0019876321,0.0000036001018,0.000017058408,0.00006821435,0.00003301082,0.0000020108978,0.99427885,0.0012466838,0.0012080614,0.00006710167],"about_ca_topic_score_codex":0.000015594624,"about_ca_topic_score_gemma":0.000026100486,"teacher_disagreement_score":0.0034062108,"about_ca_system_score_codex":7.035313e-7,"about_ca_system_score_gemma":0.000014046328,"threshold_uncertainty_score":0.19973074},"labels":[],"label_agreement":null},{"id":"W2573030531","doi":"10.1182/blood.v124.21.2821.2821","title":"A Systematic Review of Definitions and Reporting of Bleeding Outcome Measures in Hemophilia","year":2014,"lang":"en","type":"review","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Bleed; Quartile; Randomized controlled trial; MEDLINE; Observational study; Cohort study; Bleeding diathesis; Pediatrics; Surgery; Internal medicine; Confidence interval","score_opus":0.2429010418159024,"score_gpt":0.4192491614443977,"score_spread":0.1763481196284953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573030531","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000176729,0.9957801,7.92723e-7,0.00004535416,0.000019865325,0.0022516751,0.000010473184,0.000011713196,0.0017032599],"genre_scores_gemma":[0.0006052987,0.99876994,0.0002085414,0.000014199811,0.000033760327,0.00018195102,0.000031656975,0.000028845627,0.00012583073],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9945985,0.00021428967,0.004302688,0.00024654882,0.00044192138,0.00019602942],"domain_scores_gemma":[0.99607867,0.00042286783,0.002791942,0.0004472566,0.00016772629,0.000091534566],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0031566087,0.00024317212,0.0059500844,0.00034906974,0.000022011322,0.00000478661,0.00009259637,0.000166666,0.000013859324],"category_scores_gemma":[0.008834737,0.00014919191,0.0005344836,0.00040833853,0.00006585965,0.000019003659,0.00005833606,0.00027414187,0.000007425324],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[8.683688e-7,0.0001902533,0.0010056288,0.9948398,0.00039898872,0.00007426607,0.000017239056,1.6690817e-9,0.0000025173838,0.00008380704,0.000007645509,0.0033789708],"study_design_scores_gemma":[0.0004573529,0.0000730745,0.000020859674,0.9884679,0.009374905,0.0005307772,0.000010043786,3.1019377e-7,0.000009590826,0.00002123156,0.0009320889,0.00010187037],"about_ca_topic_score_codex":0.0000119439355,"about_ca_topic_score_gemma":0.000002053679,"teacher_disagreement_score":0.008975917,"about_ca_system_score_codex":0.000032031825,"about_ca_system_score_gemma":0.000208896,"threshold_uncertainty_score":0.9995143},"labels":[],"label_agreement":null},{"id":"W2573055599","doi":"10.1182/blood.v108.11.2218.2218","title":"Acetylation of a Conserved Lysine Residue within Activation Domain One of E2A Transcription Factors Plays a Role in Transcriptional Regulation.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Acetylation; Histone; Lysine; Transcription factor; Chromatin; Biology; P300-CBP Transcription Factors; Bromodomain; Histone H3; Transcriptional regulation; Transcription (linguistics); Activator (genetics); Cell biology; Molecular biology; Chemistry; Genetics; Gene; Histone Acetyltransferases; Amino acid","score_opus":0.008289422073080581,"score_gpt":0.2001217193366046,"score_spread":0.19183229726352402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573055599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950944,0.0002780679,0.0039397464,0.00009867812,0.000036840564,0.00031491867,0.000044822973,0.000010484228,0.00018201886],"genre_scores_gemma":[0.99724054,0.000012176686,0.0014385191,0.000005171785,0.00008832371,0.00001637107,0.0011020901,0.000018274572,0.000078545585],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987776,0.00009103274,0.0005326489,0.00024566744,0.00023034656,0.0001226475],"domain_scores_gemma":[0.9993632,0.000014012584,0.0002857639,0.00019101078,0.00012339688,0.00002261835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002010568,0.00013139208,0.00019382281,0.00015550938,0.00003136242,0.0000059236017,0.00006670524,0.00023131727,0.00002663681],"category_scores_gemma":[0.000021322257,0.00014814214,0.00009175944,0.0002479147,0.000067605186,0.000019116824,0.0000072446383,0.00006695245,3.7120185e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032998234,0.000381638,0.014130839,0.000040761504,0.000050783554,8.593433e-8,0.00022945154,0.010778983,0.9731683,0.0008189343,0.000015479369,0.0000547226],"study_design_scores_gemma":[0.0020307067,0.000114808965,0.3246964,0.000049242022,0.000037286438,0.0000014707986,0.00006132659,0.00024063572,0.6715827,0.0010586558,0.000034717206,0.00009207426],"about_ca_topic_score_codex":0.00040315566,"about_ca_topic_score_gemma":0.0008969761,"teacher_disagreement_score":0.31056556,"about_ca_system_score_codex":0.000031893305,"about_ca_system_score_gemma":0.00009444381,"threshold_uncertainty_score":0.60410607},"labels":[],"label_agreement":null},{"id":"W2573069183","doi":"10.1182/blood.v114.22.1.1","title":"Dabigatran Etexilate Versus Warfarin in the Treatment of Venous Thromboembolism.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Dabigatran; Warfarin; Hazard ratio; Confidence interval; Direct thrombin inhibitor; Internal medicine; Randomized controlled trial; Adverse effect; Surgery; Anesthesia; Atrial fibrillation","score_opus":0.0319964771225246,"score_gpt":0.2986380199348272,"score_spread":0.26664154281230257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573069183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9781792,0.0011170392,0.000002118562,0.0015630032,0.00013570077,0.0006912191,0.0000045324023,0.000032931937,0.018274233],"genre_scores_gemma":[0.99738955,0.0017585336,0.0001818902,0.00043084167,0.00013457629,0.00003292006,0.000014616867,0.000012426781,0.00004464437],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989194,0.00004122126,0.00027581028,0.00022236884,0.00025370292,0.00028747285],"domain_scores_gemma":[0.99932134,0.000056182456,0.00006754894,0.0004728109,0.000024494093,0.000057639692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001346413,0.00016801065,0.000554367,0.00009530694,0.00004679341,0.0000127910225,0.00013994124,0.000064647524,0.000048146227],"category_scores_gemma":[0.0000129772,0.00010926449,0.0001446008,0.0002227876,0.000044405526,0.000036018395,0.000008731709,0.00007893239,0.000023245851],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019361936,0.32825106,0.015774319,0.0005073574,0.0036178618,0.0031275318,0.07306472,0.00024934893,0.038066037,0.042831503,0.003477351,0.48909673],"study_design_scores_gemma":[0.018643728,0.018028075,0.9267796,0.00011973738,0.0017377582,0.000042380874,0.0009116548,0.000018880663,0.02014254,0.0007812356,0.012543435,0.00025093817],"about_ca_topic_score_codex":0.00020662718,"about_ca_topic_score_gemma":0.000071699666,"teacher_disagreement_score":0.9110053,"about_ca_system_score_codex":0.00004020556,"about_ca_system_score_gemma":0.000038948932,"threshold_uncertainty_score":0.44556767},"labels":[],"label_agreement":null},{"id":"W2573072332","doi":"10.1182/blood.v106.11.948.948","title":"Meta-Analysis of Impact of Epoetin Alfa Versus Darbepoetin Alfa on Blood Transfusion Requirements.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Darbepoetin alfa; Medicine; Epoetin alfa; Odds ratio; Blood transfusion; Meta-analysis; Anemia; Internal medicine; Population; Random effects model; Surgery","score_opus":0.1045789416323136,"score_gpt":0.35762325737606776,"score_spread":0.2530443157437542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573072332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98438007,0.0022199654,0.000008490555,0.0009860012,0.000035664852,0.00038290428,0.00012190512,0.00003516115,0.011829866],"genre_scores_gemma":[0.9966161,0.0005325042,0.0019146774,0.00007032259,0.00007026418,0.00001995034,0.00012523751,0.000028759117,0.00062216667],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9978488,0.00009503559,0.0007147524,0.00040540565,0.00063640665,0.00029960202],"domain_scores_gemma":[0.99857354,0.00014963669,0.00029375002,0.0006901955,0.00012456604,0.00016832627],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033609214,0.0003032065,0.001429639,0.00035813721,0.000045748788,0.0000065195536,0.00012474794,0.00012743598,0.0029760737],"category_scores_gemma":[0.000060470382,0.00020684842,0.0023824195,0.0006423212,0.00009970405,0.000046920915,0.000025446605,0.00014703923,0.000024248198],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023059023,0.022475032,0.014913017,0.00016722744,0.7712503,0.00010859567,0.0012309019,0.0003799181,0.18290487,0.00018513197,0.0009436573,0.003135427],"study_design_scores_gemma":[0.014471138,0.0053427224,0.0074120895,0.00003697387,0.66307,0.000014622429,0.00011307879,0.0000308273,0.30895802,0.0000067309143,0.00033936618,0.00020441097],"about_ca_topic_score_codex":0.00048044816,"about_ca_topic_score_gemma":0.00010138586,"teacher_disagreement_score":0.12605314,"about_ca_system_score_codex":0.00005142256,"about_ca_system_score_gemma":0.000088596644,"threshold_uncertainty_score":0.99793535},"labels":[],"label_agreement":null},{"id":"W2573121943","doi":"10.1182/blood.v120.21.3496.3496","title":"Kruppel-Like Factor, Klf9, Promotes Proliferation of Notch-Independent Precursor T-Cell Lymphoblastic Lymphomas","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Institute for Clinical Evaluative Sciences; SickKids Foundation; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Chemistry; Cancer research; Transcription factor; Notch signaling pathway; Receptor; Gene; Medicine; Biochemistry","score_opus":0.0074962931151959025,"score_gpt":0.21897366290361203,"score_spread":0.21147736978841614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573121943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958969,0.0017622376,0.0007212016,0.000023857221,0.0003878269,0.00043758444,0.000033294924,0.000022109536,0.00071501953],"genre_scores_gemma":[0.9981505,0.000061338345,0.0004184694,0.000021699761,0.0004852649,0.000041305808,0.00012685021,0.00003524548,0.00065927213],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99884087,0.00005649582,0.0002824162,0.00027730613,0.00023451138,0.00030838576],"domain_scores_gemma":[0.99924976,0.000011063129,0.00018502872,0.0003383093,0.000107096355,0.00010875638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011040218,0.00018582887,0.00015957117,0.00005525759,0.000050257724,0.000015584901,0.00012481309,0.00024628773,0.00004324727],"category_scores_gemma":[0.00003943798,0.00018186898,0.00009803819,0.00009566762,0.000042160143,0.000013001876,0.000067321474,0.00004888689,0.000026905103],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007061205,0.00076682615,0.028195886,0.00007282444,0.00008655429,3.56774e-7,0.00016335111,0.00007265158,0.9693708,0.000021501592,0.0002070516,0.00097162754],"study_design_scores_gemma":[0.0019259847,0.00029397226,0.026354134,0.000021575432,0.00009936959,0.000024686376,0.000015454609,0.000081422004,0.9694099,0.000015807582,0.0015499995,0.00020772767],"about_ca_topic_score_codex":0.000011310254,"about_ca_topic_score_gemma":0.000018260722,"teacher_disagreement_score":0.0022536858,"about_ca_system_score_codex":0.000034137738,"about_ca_system_score_gemma":0.00015296215,"threshold_uncertainty_score":0.74164015},"labels":[],"label_agreement":null},{"id":"W2573160593","doi":"10.1182/blood.v106.11.5534.5534","title":"Dexamethasone Promotes Transgene Expression and Supresses the Early Immune /Inflammatory Response in Adenovirus- Mediated Gene Delivery to Hemophilic Mice.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Dexamethasone; Genetic enhancement; Immune system; Immunology; Adenoviridae; Gene delivery; Viral vector; Inflammation; Transgene; Biology; Medicine; Internal medicine; Gene","score_opus":0.011359495002303238,"score_gpt":0.2518046289315114,"score_spread":0.24044513392920816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573160593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98580575,0.012601829,0.000012989673,0.000901962,0.000020230731,0.0005881416,0.00003468404,0.000021162634,0.000013252972],"genre_scores_gemma":[0.9979071,0.0008967159,0.0004670267,0.00027412354,0.00016256972,0.00011863554,0.000027092809,0.0000469279,0.000099799385],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980724,0.00048166697,0.00030437403,0.0004640256,0.0002580662,0.0004195084],"domain_scores_gemma":[0.9990541,0.00012930515,0.000053227493,0.0005405243,0.00007479716,0.00014806143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008874068,0.00022276395,0.00019467586,0.00012764907,0.000112133544,0.000040765197,0.00039276504,0.00018311915,0.00003348939],"category_scores_gemma":[0.00020016017,0.00017851932,0.00006310043,0.00020492089,0.00012189591,0.000011221276,0.00016055942,0.00018900487,0.000023009386],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007563994,0.00022713549,0.0011641247,0.000013099582,0.000052653115,0.000015240885,0.0005390367,0.000052458105,0.9884147,1.5828932e-7,0.00003809336,0.0019193073],"study_design_scores_gemma":[0.0022772884,0.0016076529,0.01939712,0.000030211631,0.000015211246,0.000019073357,0.00004890623,0.00000990766,0.9755203,0.000004829596,0.00085160637,0.00021785527],"about_ca_topic_score_codex":0.000026028925,"about_ca_topic_score_gemma":0.0002684625,"teacher_disagreement_score":0.018232996,"about_ca_system_score_codex":0.000014761339,"about_ca_system_score_gemma":0.00012824869,"threshold_uncertainty_score":0.7279807},"labels":[],"label_agreement":null},{"id":"W2573191114","doi":"10.1182/blood.v116.21.2643.2643","title":"Academic Community Standards for Chronic Transfusion Therapy In Children with Sickle Cell Anemia and Abnormal Transcranial Doppler Velocities","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Transfusion therapy; Stroke (engine); Transcranial Doppler; Pediatrics; Anemia; Sickle cell anemia; Blood transfusion; Physical therapy; Surgery; Internal medicine; Disease","score_opus":0.006247680393288588,"score_gpt":0.23565878494787887,"score_spread":0.2294111045545903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573191114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99623466,0.0018122301,0.00007061323,0.00029811764,0.000040308183,0.0009380733,0.00010612534,0.000045092722,0.00045477378],"genre_scores_gemma":[0.99572223,0.0036869734,0.00019785258,0.00012886114,0.00009840807,0.000035062658,0.00004964096,0.000029352183,0.000051605526],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991731,0.000040146417,0.00018072755,0.00014742333,0.00018687492,0.00027174107],"domain_scores_gemma":[0.9996277,0.000038201237,0.00003105812,0.00016231304,0.000048482965,0.00009222373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033799084,0.00016171852,0.00023812131,0.000066457105,0.00017164546,0.000009373332,0.000083321815,0.00029794427,0.00006745142],"category_scores_gemma":[0.000006728581,0.0001162338,0.000048117898,0.0001010805,0.00017654769,0.000067244066,0.000007611986,0.0012784925,5.338778e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004669238,0.002694647,0.41900504,0.0008921806,0.00032653156,0.000021027497,0.022029186,0.00003421691,0.48329732,0.0001485938,0.00039165618,0.066490375],"study_design_scores_gemma":[0.14115307,0.010493949,0.71200067,0.00036682643,0.0006045051,0.00091099757,0.002507116,0.00013738038,0.12645012,0.00023630017,0.0042541665,0.0008849199],"about_ca_topic_score_codex":0.00041600742,"about_ca_topic_score_gemma":0.0005340783,"teacher_disagreement_score":0.3568472,"about_ca_system_score_codex":0.000019864181,"about_ca_system_score_gemma":0.00027460765,"threshold_uncertainty_score":0.55544853},"labels":[],"label_agreement":null},{"id":"W2573219103","doi":"10.1182/blood.v112.11.3323.3323","title":"Evaluation of Serum Free Light Chains and Outcome in Multiple Myeloma Patients with an Intact Monoclonal Immunoglobulin Treated with Autologous Stem Cell Transplantation.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Multiple myeloma; Autologous stem-cell transplantation; Medicine; Transplantation; Immunoglobulin light chain; Monoclonal gammopathy of undetermined significance; Internal medicine; Monoclonal; Immunoglobulin D; Gastroenterology; Melphalan; Plasma cell; Kappa; Antibody; Monoclonal antibody; Immunology; B cell","score_opus":0.03372988955375703,"score_gpt":0.26828393581235965,"score_spread":0.23455404625860263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573219103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99818766,0.00017539578,0.00000950701,0.00003816307,0.000007493762,0.0011675766,0.00017924322,0.000031845106,0.00020309129],"genre_scores_gemma":[0.99861044,0.000038966533,0.0009860449,0.000009345612,0.000009760614,0.00007089343,0.00019962608,0.000023967097,0.000050979852],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819475,0.00016011897,0.00029752462,0.00029821598,0.00078804255,0.00026133016],"domain_scores_gemma":[0.99907875,0.0000534233,0.00010655107,0.0003073475,0.0003013855,0.00015256029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020708234,0.00019468156,0.0003377936,0.00019038522,0.00007729102,0.00000704634,0.00007927768,0.0000802821,0.000024790188],"category_scores_gemma":[0.000022253122,0.00013150538,0.00002852028,0.00021604421,0.00007145282,0.00013826179,0.00001399065,0.00012654447,0.0000029359776],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001989521,0.0024366768,0.98748034,0.00008465531,0.00020172741,0.00025769285,0.0008477844,0.000024720954,0.0005797084,0.0000011808156,9.372791e-7,0.006095046],"study_design_scores_gemma":[0.049177025,0.0030089181,0.92805594,0.00007997274,0.00040881007,0.000096605145,0.000085391664,0.0011830658,0.017777245,0.0000019601089,9.924712e-7,0.00012409588],"about_ca_topic_score_codex":0.0003406922,"about_ca_topic_score_gemma":0.0005570755,"teacher_disagreement_score":0.059424434,"about_ca_system_score_codex":0.0000721257,"about_ca_system_score_gemma":0.00017330234,"threshold_uncertainty_score":0.5362634},"labels":[],"label_agreement":null},{"id":"W2573243718","doi":"10.1182/blood.v106.11.1234.1234","title":"Towards a Conceptual Framework for Diagnosis of Heparin-Induced Thrombocytopenia (HIT).","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Heparin-induced thrombocytopenia; Platelet factor 4; Heparin; Medicine; Antibody; Thrombosis; Clinical significance; Confounding; Platelet; Immunology; Internal medicine","score_opus":0.05758008947598982,"score_gpt":0.3313096394436934,"score_spread":0.2737295499677036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573243718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881176,0.00030085308,0.0004896687,0.0021263328,0.00026620162,0.0015128793,0.0000676575,0.0001611004,0.006957728],"genre_scores_gemma":[0.9617462,0.00015883247,0.035773195,0.00081200094,0.00077575434,0.00044670684,0.000038972943,0.00009158302,0.00015671953],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997341,0.00006548362,0.00079187006,0.00064504973,0.00045665042,0.000699967],"domain_scores_gemma":[0.9978139,0.0003877812,0.00026304642,0.0008529079,0.00029179465,0.00039060306],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003277287,0.0004202733,0.0013873104,0.00016690942,0.00014588206,0.000033871136,0.0003563492,0.00046980675,0.00081271084],"category_scores_gemma":[0.00068963366,0.00038377527,0.0004645507,0.00040717426,0.00021678187,0.00020376877,0.00015405603,0.00042137646,0.00014120818],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012162627,0.018028766,0.32342666,0.0011338573,0.005489747,0.00009852158,0.009983065,0.000011143157,0.2795846,0.27731207,0.0036734322,0.0800419],"study_design_scores_gemma":[0.010077497,0.0021016458,0.08420059,0.0004739475,0.001707924,0.000083581814,0.00048285458,0.000037443355,0.8821681,0.0024738929,0.015555477,0.00063704595],"about_ca_topic_score_codex":0.00014453476,"about_ca_topic_score_gemma":0.00006341417,"teacher_disagreement_score":0.6025835,"about_ca_system_score_codex":0.00009509166,"about_ca_system_score_gemma":0.000417746,"threshold_uncertainty_score":0.9998614},"labels":[],"label_agreement":null},{"id":"W2573270370","doi":"10.1182/blood.v126.23.2140.2140","title":"Spectrum of Mutations Associated with Hereditary Erythrocytosis","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Erythropoietin receptor; Sanger sequencing; Exon; Biology; Erythropoietin; Molecular biology; Compound heterozygosity; Mutation; Genetics; Gene","score_opus":0.014510221582972193,"score_gpt":0.22901726318763552,"score_spread":0.21450704160466333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573270370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838183,0.0004894016,0.000025947535,0.0010658526,0.000057178066,0.00014004804,0.00001177781,0.000056060042,0.014335434],"genre_scores_gemma":[0.9991885,0.000019311083,0.00026262808,0.00009119558,0.00003734912,0.0000042987817,0.000046585395,0.000013751774,0.00033641045],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994251,0.00001592686,0.00013429561,0.00009776372,0.00019298847,0.00013391272],"domain_scores_gemma":[0.99959475,0.000022657345,0.00005692985,0.00012310063,0.00008625964,0.00011629219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007377131,0.000071508504,0.00017227228,0.000051453397,0.000024348865,0.0000028435552,0.00003193914,0.000079241305,0.000040799565],"category_scores_gemma":[0.000111235764,0.00005184366,0.00003929749,0.00024230206,0.00006930374,0.000031269905,0.000010518408,0.000105201696,0.000015933609],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001033063,0.019685302,0.9185071,0.0003843264,0.0067415386,0.0023892757,0.010631985,0.0005767964,0.006184419,0.0014628777,0.030317808,0.0020855104],"study_design_scores_gemma":[0.16002744,0.022570089,0.5952373,0.0033023492,0.013745886,0.0031946884,0.034055762,0.0011591831,0.15179224,0.0064646103,0.006367992,0.0020824189],"about_ca_topic_score_codex":0.000060950988,"about_ca_topic_score_gemma":0.000046387377,"teacher_disagreement_score":0.32326975,"about_ca_system_score_codex":0.000018655654,"about_ca_system_score_gemma":0.00016417679,"threshold_uncertainty_score":0.21141231},"labels":[],"label_agreement":null},{"id":"W2573281085","doi":"10.1182/blood.v106.11.4142.4142","title":"Self-Managed Long-Term Low-Molecular-Weight Heparin Therapy Compared with Usual-Care Anticoagulation for the Treatment of Patients with Proximal Venous Thrombosis: Harm Associated with Thrombocytopenia.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Low molecular weight heparin; Confidence interval; Thrombosis; Deep vein; Vitamin K antagonist; Randomized controlled trial; Context (archaeology); Heparin; Internal medicine; Surgery; Warfarin","score_opus":0.01628907317841553,"score_gpt":0.2620981225415465,"score_spread":0.245809049363131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573281085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918948,0.0008530263,0.00027802528,0.00023151084,0.000034984303,0.006302914,0.000046857458,0.00012516843,0.00023274664],"genre_scores_gemma":[0.99667567,0.0004169383,0.0014341436,0.00018046201,0.00008153934,0.0006507834,0.00044507155,0.000093144656,0.000022230832],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980473,0.00006377858,0.0003589993,0.0004880184,0.00059135054,0.00045055812],"domain_scores_gemma":[0.9984724,0.00008225617,0.00035596895,0.0005882455,0.00039750015,0.00010361401],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009051652,0.00042000326,0.0009552971,0.0000961092,0.00024485524,0.000059007165,0.00017013685,0.00008513007,0.000027592958],"category_scores_gemma":[0.0000062133595,0.0002255924,0.00013297581,0.00028161128,0.0001150189,0.00013288663,0.0000235329,0.00008758475,0.00000312854],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021858017,0.06828238,0.9032375,0.00045804045,0.012075291,0.000042719712,0.00810342,0.00038281284,0.00039504212,0.00013365914,0.000057694302,0.004645596],"study_design_scores_gemma":[0.03182855,0.013141787,0.93676406,0.0003809502,0.0042387866,0.0000028639845,0.00019986255,0.00014451332,0.012749862,0.0000019792174,0.00022824622,0.00031852737],"about_ca_topic_score_codex":0.00003312062,"about_ca_topic_score_gemma":0.0002443817,"teacher_disagreement_score":0.055140596,"about_ca_system_score_codex":0.00018754955,"about_ca_system_score_gemma":0.00011786159,"threshold_uncertainty_score":0.91993916},"labels":[],"label_agreement":null},{"id":"W2573320550","doi":"10.1182/blood.v126.23.3535.3535","title":"Hemophilia Prophylaxis No Longer Just for Children without Inhibitors - Increasing Use of Prophylaxis in Other Groups (children with inhibitors and adults with and without inhibitors)","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Pediatrics; Regimen; Pre-exposure prophylaxis; Young adult; Internal medicine; Immunology; Human immunodeficiency virus (HIV)","score_opus":0.021123578354592634,"score_gpt":0.2602333387407746,"score_spread":0.23910976038618195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573320550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943337,0.00060735625,0.0000061912456,0.00014290265,0.00004930684,0.0046355077,0.000071551876,0.00007846677,0.00007502551],"genre_scores_gemma":[0.994245,0.000042375235,0.0044969753,0.00003971715,0.00051848416,0.00018826783,0.00008045079,0.00015455653,0.00023415385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968085,0.00015645722,0.00059303734,0.00093429745,0.0008271019,0.0006805633],"domain_scores_gemma":[0.9980841,0.000097220225,0.00024773157,0.0005180358,0.00046882997,0.0005840284],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005801187,0.000585987,0.0009152682,0.0005248086,0.00012261716,0.00008331083,0.00010695315,0.00033001558,0.0000058776486],"category_scores_gemma":[0.00030889906,0.0003740881,0.000080506456,0.00059383345,0.00067024806,0.00043619485,0.00013147284,0.0004737338,0.0000048520665],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061158743,0.001480294,0.98600835,0.0003440479,0.00042166465,0.000027096006,0.0017262511,0.0000018481156,0.001805636,0.00001155495,0.000064632724,0.0019927653],"study_design_scores_gemma":[0.048999496,0.020250196,0.8900017,0.0029774727,0.00069211784,0.0009623323,0.00054121076,0.000049588263,0.034478012,0.000020564807,0.0000861743,0.0009411288],"about_ca_topic_score_codex":0.001577559,"about_ca_topic_score_gemma":0.00040018093,"teacher_disagreement_score":0.096006624,"about_ca_system_score_codex":0.00008373692,"about_ca_system_score_gemma":0.00033298388,"threshold_uncertainty_score":0.99987113},"labels":[],"label_agreement":null},{"id":"W2573399798","doi":"10.1182/blood.v126.23.4228.4228","title":"Ricolinostat (ACY-1215), the First Selective HDAC6 Inhibitor, Combines Safely with Pomalidomide and Dexamethasone and Shows Promosing Early Results in Relapsed-and-Refractory Myeloma (ACE-MM-102 Study)","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Calgary; University of Alberta","funders":"","keywords":"Pomalidomide; Medicine; Lenalidomide; Tolerability; Internal medicine; Clinical endpoint; Progressive disease; Dexamethasone; Refractory (planetary science); Neutropenia; Gastroenterology; Phases of clinical research; Population; Urology; Bortezomib; Multiple myeloma; Pharmacology; Oncology; Clinical trial; Adverse effect; Toxicity; Chemotherapy","score_opus":0.01544769349969395,"score_gpt":0.2545100883772734,"score_spread":0.23906239487757946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573399798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955968,0.0023952252,0.000004524165,0.00038943265,0.000051889885,0.0011345883,0.000027071574,0.00002067474,0.0003797661],"genre_scores_gemma":[0.998999,0.00009677914,0.00028056375,0.000051381277,0.000148488,0.00010150532,0.000016540285,0.00004730857,0.00025840482],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978215,0.00033087475,0.0003545072,0.0007215469,0.0003494481,0.0004220927],"domain_scores_gemma":[0.9988586,0.00015791928,0.00013524937,0.00041659002,0.00021291692,0.00021877562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009067743,0.0002998169,0.00031788758,0.0001206178,0.00022306238,0.00011054907,0.0001722509,0.00019019557,6.520713e-7],"category_scores_gemma":[0.00062002597,0.00022220849,0.000028645838,0.00027948766,0.00039107143,0.000020234744,0.00032487296,0.00039518642,0.0000019147599],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011361037,0.0047186767,0.4732491,0.00017374172,0.00069899147,0.00052485924,0.028771404,0.000031285304,0.4737531,0.00002451906,0.0030870927,0.0036062007],"study_design_scores_gemma":[0.048208944,0.015314811,0.23946714,0.00033154897,0.0002703583,0.0005588404,0.00504073,0.000089110064,0.6837565,0.00006969048,0.005652136,0.0012402013],"about_ca_topic_score_codex":0.0004960609,"about_ca_topic_score_gemma":0.002613898,"teacher_disagreement_score":0.23378195,"about_ca_system_score_codex":0.000044093606,"about_ca_system_score_gemma":0.0001788426,"threshold_uncertainty_score":0.9061399},"labels":[],"label_agreement":null},{"id":"W2573497597","doi":"10.1182/blood.v106.11.2561.2561","title":"Maintenance Therapy with Thalidomide/Prednisone Post Autologous Stem-Cell Transplant for Patients with Multiple Myeloma Elevates D-Dimer and Possibly Factor VIII Levels.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hamilton Regional Laboratory Medicine Program; Queen's University; London Health Sciences Centre","funders":"","keywords":"Medicine; Thalidomide; Prednisone; Multiple myeloma; Internal medicine; Surgery; Maintenance therapy; Autologous stem-cell transplantation; Transplantation; Gastroenterology; Oncology; Chemotherapy","score_opus":0.016275738304112986,"score_gpt":0.24370058362956948,"score_spread":0.22742484532545648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573497597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99533314,0.0007851242,0.00014263648,0.00039308358,0.000015342532,0.0022695453,0.0008247223,0.000091472684,0.0001449199],"genre_scores_gemma":[0.9940815,0.00013720854,0.004259483,0.00021729908,0.00005828234,0.0002079649,0.0001815684,0.00007262636,0.0007840884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980881,0.000043134096,0.00026431133,0.0005221698,0.0004101384,0.0006721471],"domain_scores_gemma":[0.9987337,0.00021688627,0.00011221247,0.00032676855,0.00027753355,0.00033291717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007060448,0.00037204725,0.0004820287,0.00011400094,0.00017327229,0.00004547893,0.00011430242,0.00011336291,0.00004735297],"category_scores_gemma":[0.000017130053,0.00021556205,0.00007604218,0.000119945515,0.00014196637,0.00015821529,0.000016582753,0.00016207258,0.000014859112],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015038342,0.005015505,0.9219616,0.0002033272,0.0010396395,0.00015274067,0.0014213509,0.0000025643872,0.014768306,0.000009240776,0.00007708355,0.040310316],"study_design_scores_gemma":[0.08179899,0.00698874,0.8435046,0.00020016712,0.00020140104,0.000090084264,0.0001046668,0.00018174724,0.06603417,0.0000040674468,0.00055719726,0.00033416165],"about_ca_topic_score_codex":0.000092730195,"about_ca_topic_score_gemma":0.00013831025,"teacher_disagreement_score":0.07845698,"about_ca_system_score_codex":0.000042170595,"about_ca_system_score_gemma":0.00013481759,"threshold_uncertainty_score":0.87903655},"labels":[],"label_agreement":null},{"id":"W2573557015","doi":"10.1182/blood.v126.23.1853.1853","title":"Investigating Efficacy, Safety, and Biomarkers in a Phase 2 Trial of Pomalidomide + Low-Dose Dexamethasone (POM + LoDEX) Following Second-Line Lenalidomide-Based Therapy (Tx) in Relapsed or Refractory Multiple Myeloma (RRMM)","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; McGill University; Vancouver General Hospital","funders":"","keywords":"Medicine; Pomalidomide; Lenalidomide; Internal medicine; Tolerability; Population; Neutropenia; Clinical endpoint; Discontinuation; Progressive disease; Oncology; Phases of clinical research; Multiple myeloma; Surgery; Adverse effect; Clinical trial; Chemotherapy","score_opus":0.07505917762754469,"score_gpt":0.35174125258759537,"score_spread":0.2766820749600507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573557015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99494386,0.0014334772,0.00003016406,0.00027543004,0.0001252732,0.0029412247,0.000057710044,0.00006255404,0.00013031646],"genre_scores_gemma":[0.9934207,0.00009045325,0.0057983436,0.00015097181,0.00011183992,0.0001328505,0.0001433152,0.00007972498,0.000071794166],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9958653,0.0006952544,0.0012704093,0.0006972115,0.0007548928,0.00071692816],"domain_scores_gemma":[0.9963042,0.0019335046,0.00035723008,0.00059583946,0.0001243059,0.00068492565],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002202657,0.00045020515,0.0012252324,0.0007445666,0.000068828886,0.00003440487,0.00019529455,0.00027241267,0.000058589416],"category_scores_gemma":[0.0060030306,0.0003578659,0.0002301297,0.0008813407,0.00023562943,0.00016617468,0.00008899278,0.00048022726,0.000006654478],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5964127,0.02018533,0.15021305,0.00034604617,0.0014973228,0.0033060783,0.0017125767,0.000071576775,0.16946977,0.0000042205065,0.000047677186,0.056733638],"study_design_scores_gemma":[0.8814358,0.0070244353,0.028435532,0.0009724143,0.0001489233,0.000039189435,0.00032761728,0.0031685901,0.07791676,0.000031144027,0.00012905164,0.0003705154],"about_ca_topic_score_codex":0.00079948525,"about_ca_topic_score_gemma":0.0012670747,"teacher_disagreement_score":0.28502312,"about_ca_system_score_codex":0.00021534984,"about_ca_system_score_gemma":0.001164857,"threshold_uncertainty_score":0.99988735},"labels":[],"label_agreement":null},{"id":"W2573680614","doi":"10.1182/blood.v108.11.3910.3910","title":"Protease-Activated Receptors 1 and 4 Mediate the Synergistic Effect of Thrombin on Collagen-Stimulated Phosphatidylserine Expression, That Occurs on the Smallest Platelets.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Hospital for Sick Children","funders":"","keywords":"Thrombin; Platelet; Phosphatidylserine; Chemistry; Annexin A5; Platelet activation; Protease-activated receptor; Receptor; Annexin; Cell biology; Hemostasis; Thrombin receptor; Molecular biology; Biophysics; Biochemistry; Internal medicine; Immunology; Biology; Medicine; Cell; Membrane; Phospholipid","score_opus":0.017342529335353022,"score_gpt":0.24016024610430528,"score_spread":0.22281771676895226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573680614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99580455,0.00019738695,0.00001051206,0.00076337083,0.00019161061,0.0017727027,0.000015793325,0.000094122406,0.0011499395],"genre_scores_gemma":[0.9992048,0.000043897864,0.000045305504,0.00024268379,0.00007062011,0.000118075906,0.000051402985,0.0000427897,0.00018039413],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983339,0.00027004335,0.0003247802,0.00033783415,0.00047019921,0.00026327037],"domain_scores_gemma":[0.99830836,0.0007793174,0.0002434656,0.00050288724,0.0000683452,0.000097645105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004561386,0.00030640746,0.00046309782,0.00007652946,0.0002188166,0.000026722892,0.00014987489,0.00014975446,0.00034626384],"category_scores_gemma":[0.00025656217,0.00015313552,0.000089686975,0.00030862424,0.00015512414,0.000031048938,0.000050062117,0.00020712816,0.000021274162],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014061349,0.001371371,0.008302837,0.00017927938,0.00036877312,0.000060252907,0.00021276632,0.0002515556,0.9824669,0.0028719413,0.0020587095,0.00044953247],"study_design_scores_gemma":[0.0049956585,0.0017301142,0.017639825,0.0004333824,0.00025867356,0.000018695757,0.000044411456,0.00012831423,0.9741734,0.00021665837,0.00019938713,0.00016144662],"about_ca_topic_score_codex":0.000065898996,"about_ca_topic_score_gemma":0.000006225948,"teacher_disagreement_score":0.009336988,"about_ca_system_score_codex":0.000019001494,"about_ca_system_score_gemma":0.000038223156,"threshold_uncertainty_score":0.6244685},"labels":[],"label_agreement":null},{"id":"W2573703208","doi":"10.1182/blood.v110.11.2536.2536","title":"JAK2 617V&amp;gt;F Mutation Correlates with Arterial Thrombosis in Essential Thrombocythemia.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Essential thrombocythemia; Bone marrow; Internal medicine; Medicine; Exact test; Gastroenterology; Odds ratio; Chromosome abnormality; Pathology; Immunology; Biology; Polycythemia vera; Genetics; Chromosome; Karyotype","score_opus":0.014924077069046839,"score_gpt":0.28026888743361683,"score_spread":0.26534481036456997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573703208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99392754,0.00011470659,0.00030275912,0.00027609995,0.00015985628,0.00055393286,0.000009190296,0.00005884664,0.004597094],"genre_scores_gemma":[0.9969868,0.000056287492,0.0021777218,0.00013826186,0.00032314265,0.000059032347,0.00012206056,0.000030039826,0.00010667178],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869734,0.00002773486,0.00031262147,0.0003349201,0.00029899887,0.00032836228],"domain_scores_gemma":[0.9993757,0.000105616484,0.00009597882,0.00022006272,0.00008165504,0.00012099455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017249404,0.00021705953,0.00038200116,0.00013256763,0.00007711924,0.000028866882,0.000046425786,0.00012210883,0.0004145218],"category_scores_gemma":[0.00004070202,0.0001604352,0.00006497388,0.00024134527,0.00007257644,0.00008902053,0.000018310267,0.00015431819,0.000111655754],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010595566,0.007234151,0.926149,0.00009835368,0.00073142804,0.0008037993,0.0029904493,0.000022172087,0.056940205,0.0013871595,0.0005958724,0.0019878515],"study_design_scores_gemma":[0.019977776,0.0011746365,0.7862405,0.0003735778,0.00075391686,0.00036458133,0.00028127438,0.000020843221,0.18979862,0.000196706,0.0004922066,0.00032532314],"about_ca_topic_score_codex":0.000051166564,"about_ca_topic_score_gemma":0.00041514714,"teacher_disagreement_score":0.13990846,"about_ca_system_score_codex":0.000062059495,"about_ca_system_score_gemma":0.00007849712,"threshold_uncertainty_score":0.6542358},"labels":[],"label_agreement":null},{"id":"W2573707939","doi":"10.1182/blood.v112.11.861.861","title":"Effects of the Mcl-1/Bcl-2 Inhibitor GX015-070 (Obatoclax®) on Growth and Viability of Canine and Human Neoplastic Mast Cells","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Systemic mastocytosis; Mastocytoma; Transfection; Cell culture; Molecular biology; Mast cell; Biology; Apoptosis; Myeloid; Cancer research; Growth inhibition; Cell growth; Midostaurin; Immunology; Myeloid leukemia; Biochemistry","score_opus":0.0038407289578702747,"score_gpt":0.16961876871555948,"score_spread":0.1657780397576892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573707939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997781,0.00082980894,0.000002519762,0.00003339716,0.00017375872,0.00029456106,0.000033328204,0.000010892859,0.0008407651],"genre_scores_gemma":[0.9992624,0.000052637024,0.000015505619,0.000025999598,0.00002252172,0.0000073379465,0.0000054617244,0.000009605082,0.0005985529],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992402,0.000114987124,0.0002280794,0.00021381264,0.000037137852,0.00016575467],"domain_scores_gemma":[0.9993895,0.00023152876,0.00012477979,0.00019496446,0.000036492875,0.00002269759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000076744174,0.00013750617,0.0002912809,0.00004285018,0.00014756096,0.0000022987895,0.000093934956,0.00012773932,0.000051198233],"category_scores_gemma":[0.00005196672,0.00009564144,0.000045689656,0.00007202171,0.00056151126,0.000019311283,0.000090482405,0.0001538554,0.0000051995376],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053851938,0.0005620377,0.021302104,0.0003855086,0.000065234184,0.0000038961753,0.00036783164,5.2446427e-7,0.9762519,0.00075197715,0.0002186671,0.00003643841],"study_design_scores_gemma":[0.0028317692,0.00060360885,0.105903216,0.00006174218,0.00010278314,0.000041338277,0.000018582976,3.966937e-7,0.8897997,0.00004921935,0.000491043,0.00009661084],"about_ca_topic_score_codex":0.00028867697,"about_ca_topic_score_gemma":0.00007112561,"teacher_disagreement_score":0.08645224,"about_ca_system_score_codex":0.000005413295,"about_ca_system_score_gemma":0.000027735663,"threshold_uncertainty_score":0.39001447},"labels":[],"label_agreement":null},{"id":"W2573715876","doi":"10.1182/blood.v126.23.3675.3675","title":"Generation of Synthetic T-ALL By De Novo Transformation of Human Cord Blood Progenitors with a 4-Oncogene Cocktail","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; Progenitor cell; Haematopoiesis; Population; CD34; Stem cell; Viral vector; Cord blood; Transduction (biophysics); Immunology; Virology; Cancer research; Molecular biology; Cell biology; Genetics; Medicine; Gene","score_opus":0.047915832601103665,"score_gpt":0.3043219001626635,"score_spread":0.2564060675615598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573715876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968365,0.00018332376,0.0012362882,0.000136732,0.000018586443,0.0005721137,0.000029679613,0.000030352703,0.0009564592],"genre_scores_gemma":[0.99784607,0.000015741884,0.0017240884,0.00003305454,0.000093335744,0.000044931436,0.00010349606,0.000029117842,0.00011018715],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99854636,0.000060211332,0.0003695419,0.00016942646,0.0006081475,0.00024628444],"domain_scores_gemma":[0.9990119,0.000032015407,0.00013661935,0.00024789877,0.00036904245,0.00020257801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003139387,0.00013433301,0.00029596168,0.00011554381,0.000029232468,0.000007811058,0.000106174324,0.00011003803,0.000019338524],"category_scores_gemma":[0.000081693106,0.000106688174,0.000050940205,0.00021441815,0.00012354429,0.00007907726,0.000015655087,0.00010249816,0.0000047281146],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040174875,0.001548532,0.006872983,0.00028441218,0.00036176265,0.00003339074,0.0013530572,0.0000121376015,0.9879163,0.000072206094,0.00038482266,0.0007586472],"study_design_scores_gemma":[0.012794211,0.003686051,0.00016846764,0.00010892751,0.0008677536,0.000500259,0.00024577082,0.0006621598,0.98070633,0.000018033637,0.00013339698,0.00010865418],"about_ca_topic_score_codex":0.000111635796,"about_ca_topic_score_gemma":0.000026791387,"teacher_disagreement_score":0.012392461,"about_ca_system_score_codex":0.000120540106,"about_ca_system_score_gemma":0.0007600227,"threshold_uncertainty_score":0.43506175},"labels":[],"label_agreement":null},{"id":"W2573736064","doi":"10.1182/blood.v124.21.3955.3955","title":"Multiple CMV Reactivations Are Associated with Lower Risk of Relapse Following Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Transplantation; Internal medicine; Hematopoietic stem cell transplantation; Gastroenterology; Graft-versus-host disease; Viremia; Stem cell; Betaherpesvirinae; Immunology; Surgery; Herpesviridae; Viral disease; Virus","score_opus":0.019014574589767175,"score_gpt":0.2531610907668536,"score_spread":0.23414651617708643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573736064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977562,0.00003705481,0.000279478,0.000066847024,0.000064091066,0.00032194154,0.000061229046,0.0000573513,0.0013558144],"genre_scores_gemma":[0.9990772,0.000034178905,0.0002271058,0.000042725733,0.000053135627,0.000019507197,0.00015274252,0.000027802393,0.0003656048],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886715,0.00010777709,0.00023155738,0.00023609986,0.00034079698,0.00021659165],"domain_scores_gemma":[0.99882984,0.000266385,0.0002202245,0.00023031679,0.00034851398,0.000104693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039924448,0.00012470342,0.00032689224,0.00013218282,0.00015985242,0.0000139644,0.00005832936,0.00011401534,0.00002602814],"category_scores_gemma":[0.00034050478,0.000105498075,0.0001212596,0.00026600074,0.000056051886,0.00009564715,0.000011783002,0.00029557484,0.000010858935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081028364,0.0013635585,0.6993927,0.00012526683,0.0006772377,0.00008279547,0.0013639671,0.00007253446,0.29557142,0.000016512811,0.00016302873,0.0003606946],"study_design_scores_gemma":[0.010141649,0.00063254836,0.66103905,0.0005935079,0.0011417589,0.000015581863,0.0005381464,0.00038529807,0.32505783,0.000018881468,0.00022577847,0.00020997155],"about_ca_topic_score_codex":0.00018698306,"about_ca_topic_score_gemma":0.00024591747,"teacher_disagreement_score":0.03835367,"about_ca_system_score_codex":0.000046515677,"about_ca_system_score_gemma":0.00007662359,"threshold_uncertainty_score":0.43020865},"labels":[],"label_agreement":null},{"id":"W2573844241","doi":"10.1182/blood.v112.11.1297.1297","title":"Comparison of Epoetin Alfa and Darbepoetin Alfa Dosing and Costs in an Inpatient Population with Myelodysplastic Syndromes","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Darbepoetin alfa; Epoetin alfa; Dosing; Anemia; Cumulative incidence; Myelodysplastic syndromes; Population; Incidence (geometry); Erythropoietin; Pediatrics; Emergency medicine; Intensive care medicine; Internal medicine; Cohort","score_opus":0.027560566403844945,"score_gpt":0.29967115732248906,"score_spread":0.2721105909186441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573844241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998506,0.00081972574,0.0000073945857,0.00011790282,0.000016581596,0.00026079177,0.0000034870131,0.000018003922,0.00025011043],"genre_scores_gemma":[0.99726754,0.00011163113,0.0024970213,0.000020489642,0.000015569847,0.000007760773,0.000049363585,0.000013876832,0.00001671783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999189,0.000038541257,0.00025066812,0.00021037145,0.00017332942,0.00013809309],"domain_scores_gemma":[0.99960256,0.000053658092,0.00009702178,0.00012098668,0.000030024441,0.000095763535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005760268,0.00012524263,0.00032410168,0.000094308256,0.000057684985,0.0000067922956,0.000019003643,0.000054447835,0.0000076628685],"category_scores_gemma":[0.00002481279,0.00009689362,0.000012647561,0.000103032406,0.000108078406,0.00005195055,0.000018872111,0.000089674206,7.434702e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117991105,0.0010333345,0.9938791,0.00008657951,0.000025570127,0.00008357986,0.001159392,0.000006379217,0.0015207056,0.00002173319,0.000010420183,0.0020552294],"study_design_scores_gemma":[0.0052263425,0.001981003,0.98566854,0.0005607228,0.00013941813,0.0005905952,0.0004868592,0.00017443436,0.0050402377,0.000006223694,0.000015029835,0.00011060415],"about_ca_topic_score_codex":0.00025084152,"about_ca_topic_score_gemma":0.00017426678,"teacher_disagreement_score":0.008210557,"about_ca_system_score_codex":0.000027824723,"about_ca_system_score_gemma":0.000022993741,"threshold_uncertainty_score":0.39512074},"labels":[],"label_agreement":null},{"id":"W2573857210","doi":"10.1182/blood.v124.21.1091.1091","title":"Influence of Production Affecting Cytokine Genetic Variants on Allogeneic Hematopoietic Cell Transplantation Outcomes","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; Calgary Laboratory Services; University of Calgary","funders":"","keywords":"Cytokine; Immunology; Human leukocyte antigen; Single-nucleotide polymorphism; Biology; Immune system; Transplantation; Hematopoietic stem cell transplantation; Cytokine receptor; Medicine; Gene; Antigen; Genetics; Internal medicine; Genotype","score_opus":0.015304415377597884,"score_gpt":0.27792827864944264,"score_spread":0.2626238632718448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573857210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99828076,0.00006496932,0.000084431835,0.00018430577,0.000039586943,0.0003927303,0.0000050587237,0.000036536218,0.00091159734],"genre_scores_gemma":[0.9989636,0.00010147535,0.0005093064,0.00009350394,0.000092195696,0.0000163649,0.0000070225524,0.000021970618,0.00019454684],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99884075,0.00007100953,0.0002568794,0.0002650082,0.00035186496,0.00021449967],"domain_scores_gemma":[0.9993464,0.00009306457,0.00008336731,0.00029379962,0.00010026101,0.000083160405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003011525,0.00012494247,0.00026790836,0.00014986077,0.00006360801,0.000009311521,0.00007447182,0.000070330796,0.000030334064],"category_scores_gemma":[0.00015429998,0.000102359714,0.000068132256,0.00018952407,0.00004160868,0.000043538435,0.000012648988,0.00014902042,0.00005231965],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018345677,0.0010158839,0.28457135,0.0010037443,0.000071413386,0.00002994897,0.00053501973,0.0010967264,0.70908946,0.000066071574,0.000015621052,0.0023213068],"study_design_scores_gemma":[0.0015883121,0.00039270968,0.6316471,0.00011333899,0.00013420632,0.000060328293,0.0000122993715,0.000021668773,0.36584514,0.00004585646,0.0000615708,0.0000774736],"about_ca_topic_score_codex":0.00007809422,"about_ca_topic_score_gemma":0.000019742685,"teacher_disagreement_score":0.34707573,"about_ca_system_score_codex":0.000013967635,"about_ca_system_score_gemma":0.000052797284,"threshold_uncertainty_score":0.4174108},"labels":[],"label_agreement":null},{"id":"W2573896831","doi":"10.1182/blood.v114.22.510.510","title":"Comparative in Vitro Cellular Data Alone Is Insufficient to Predict Clinical Responses and Guide Choice of BCR-ABL Inhibitor to Treat Imatinib-Resistant Chronic Myeloid Leukemia.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Nilotinib; Imatinib; Dasatinib; Bosutinib; Cmax; Imatinib mesylate; Medicine; Pharmacology; In vivo; Tyrosine-kinase inhibitor; Oncology; Cancer research; Myeloid leukemia; Pharmacokinetics; Internal medicine; Biology; Cancer; Genetics","score_opus":0.05735597344942199,"score_gpt":0.3607660134032223,"score_spread":0.3034100399538003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573896831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992526,0.0028099448,0.00003675625,0.0012737341,0.00008394734,0.0017039707,0.00066438154,0.00006486456,0.0008364335],"genre_scores_gemma":[0.99096924,0.00017875456,0.006536613,0.0008114979,0.00035038477,0.000044156037,0.00025205547,0.000034768214,0.00082253333],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9960481,0.00024420186,0.0013936093,0.0010952608,0.00062715914,0.00059165945],"domain_scores_gemma":[0.99633497,0.0006118381,0.00024761038,0.0021215992,0.00013548136,0.00054847664],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008156109,0.00042368635,0.001321411,0.0003459545,0.000072817056,0.00002852424,0.00053958024,0.00019658674,0.00005274508],"category_scores_gemma":[0.0012045292,0.00036995986,0.00010582594,0.0006283424,0.00014413033,0.0001298638,0.00049806153,0.0003485404,0.000057629884],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007942347,0.005733499,0.0100887595,0.0003001994,0.00036556536,0.0004905077,0.0026649965,0.00004034179,0.9476292,0.000011933169,0.017143048,0.0075895754],"study_design_scores_gemma":[0.033358924,0.008889747,0.14087227,0.0011397871,0.00088892493,0.00006498828,0.00029500813,0.0009027083,0.7970783,0.000011088439,0.015949754,0.00054852315],"about_ca_topic_score_codex":0.00057466293,"about_ca_topic_score_gemma":0.00017076195,"teacher_disagreement_score":0.15055095,"about_ca_system_score_codex":0.0011732138,"about_ca_system_score_gemma":0.0017197464,"threshold_uncertainty_score":0.99987525},"labels":[],"label_agreement":null},{"id":"W2573913157","doi":"10.1182/blood.v118.21.4525.4525","title":"Allogeneic Stem Cell Transplantation Is Associated with Prolonged Disease Control in Chemosensitive Aggressive Histology Lymphoma Patients When Done Early","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Alemtuzumab; Transplantation; Internal medicine; Fludarabine; Follicular lymphoma; Surgery; Lymphoma; Diffuse large B-cell lymphoma; Autologous stem-cell transplantation; Gastroenterology; Chemotherapy; Cyclophosphamide","score_opus":0.010517424436819833,"score_gpt":0.188283065968567,"score_spread":0.17776564153174718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573913157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99784243,0.00040099557,0.000005099811,0.00010475649,0.00003401714,0.000973519,0.0001550734,0.000036451096,0.0004476707],"genre_scores_gemma":[0.9988787,0.000044870423,0.000054375247,0.0005291528,0.0000135726505,0.0002019159,0.00016066927,0.000024357616,0.000092348244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988619,0.0000965503,0.00022555821,0.00033234395,0.00021072978,0.00027291913],"domain_scores_gemma":[0.9992153,0.000059791062,0.00023967338,0.00017014937,0.00014190305,0.00017315315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000048986774,0.00020009818,0.0003688184,0.000084714215,0.000041743308,0.0000059414183,0.000045994017,0.00010411587,0.000024435061],"category_scores_gemma":[0.000012994564,0.00015236312,0.000067713714,0.00008600257,0.000058165835,0.000057849415,0.0000067037017,0.00004549583,0.000019359442],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027233835,0.007882166,0.97772855,0.00004005571,0.0004100208,0.0035775476,0.005828839,1.5707599e-7,0.00020491707,0.000004398171,0.000034113567,0.0015658736],"study_design_scores_gemma":[0.0511248,0.0012267054,0.9296889,0.0001977764,0.0014678277,0.000023229228,0.000041861815,0.000005824482,0.016052859,0.000015445008,0.000004306097,0.00015047975],"about_ca_topic_score_codex":0.00025368124,"about_ca_topic_score_gemma":0.00013180045,"teacher_disagreement_score":0.04840142,"about_ca_system_score_codex":0.00016265239,"about_ca_system_score_gemma":0.00012642033,"threshold_uncertainty_score":0.62131876},"labels":[],"label_agreement":null},{"id":"W2573946350","doi":"10.1182/blood.v116.21.2217.2217","title":"Association of Quantitative and Qualitative Abnormalities of Von Willebrand Factor and Risk of Death In Hemodialysis Patients","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Von Willebrand factor; Medicine; Dialysis; Thrombotic thrombocytopenic purpura; Internal medicine; Hemodialysis; Gastroenterology; Kidney disease; Diabetes mellitus; Vascular disease; Risk factor; Immunology; Endocrinology; Platelet","score_opus":0.013511542450191906,"score_gpt":0.27488792050761934,"score_spread":0.2613763780574274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573946350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981314,0.0005173686,0.000004179875,0.000006029336,0.000052451735,0.00016883263,0.0010442218,0.0000033174324,0.00007223156],"genre_scores_gemma":[0.9997279,0.00007019527,0.000110234345,0.0000012047126,0.000001878695,0.0000066964026,0.000042550597,0.0000035953824,0.000035738387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900734,0.00040564095,0.00035088454,0.00010541281,0.000042283722,0.00008845414],"domain_scores_gemma":[0.9983887,0.00089012546,0.00049133605,0.00008356634,0.0001377118,0.000008531087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003243794,0.000073219715,0.0003094479,0.00010887953,0.000022998589,0.0000019026743,0.000044108583,0.00007680626,0.000057094305],"category_scores_gemma":[0.0006418813,0.00006556346,0.00003661002,0.00005977455,0.00010026848,0.000063124644,0.00003566166,0.000071197035,6.68926e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008095249,0.0003000312,0.9564425,0.00008837275,0.00045025192,5.229179e-8,0.015886994,1.9154696e-7,0.026164614,0.00050281093,0.000012821981,0.00007045245],"study_design_scores_gemma":[0.0031083338,0.00021007049,0.9343939,0.000036862875,0.00020262138,1.9004064e-7,0.0034214705,8.4989205e-7,0.05820725,0.00034567085,0.000013001795,0.00005980206],"about_ca_topic_score_codex":0.00076412054,"about_ca_topic_score_gemma":0.00061647024,"teacher_disagreement_score":0.032042637,"about_ca_system_score_codex":0.000005703523,"about_ca_system_score_gemma":0.000015570276,"threshold_uncertainty_score":0.26736003},"labels":[],"label_agreement":null},{"id":"W2573951820","doi":"10.1182/blood.v116.21.229.229","title":"MN1 Inhibits Myeloid Differentiation by Transcriptional Repression of EGR2","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; BC Cancer Agency","funders":"","keywords":"Psychological repression; Retinoic acid; Myeloid; Myeloid leukemia; Cancer research; Biology; Transcription factor; Downregulation and upregulation; Cellular differentiation; Molecular biology; Bone marrow; Leukemia; Cell biology; Cell culture; Gene expression; Gene; Immunology; Genetics","score_opus":0.0033570743116013335,"score_gpt":0.20422641111302572,"score_spread":0.20086933680142438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573951820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966863,0.00075179327,0.0009427673,0.000031528827,0.00013349247,0.000064150656,0.000021848937,0.000008468567,0.0013596837],"genre_scores_gemma":[0.99842656,0.000112570415,0.0003851335,0.000026644257,0.00015019828,0.000010196985,0.00029177993,0.0000113176675,0.0005856044],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999391,0.000019207075,0.00015681067,0.00020818193,0.00012277423,0.000101984544],"domain_scores_gemma":[0.9996211,0.0000046789755,0.00007328502,0.00019754485,0.00006546416,0.000037955666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007319443,0.00008527652,0.000080276084,0.000016615877,0.000038717633,0.000008671282,0.00011207347,0.00016027821,0.00005633992],"category_scores_gemma":[0.000047948364,0.00007579718,0.000058282498,0.00003846744,0.000051823943,0.0000034144884,0.000026124897,0.00009898958,0.000002814369],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018188732,0.0001837979,0.004316322,0.000029649624,0.00001940273,2.564017e-7,0.000023202323,0.0000012196452,0.9941115,0.000099170706,0.00049261126,0.00070469466],"study_design_scores_gemma":[0.00071429915,0.00007649629,0.0028322684,0.0000103003995,0.000026237523,0.0000087102435,0.000008748186,0.000006036684,0.99115556,0.00011457519,0.0049564308,0.000090355374],"about_ca_topic_score_codex":0.0000036642475,"about_ca_topic_score_gemma":0.000003926605,"teacher_disagreement_score":0.0044638193,"about_ca_system_score_codex":0.0000012770228,"about_ca_system_score_gemma":0.000036693178,"threshold_uncertainty_score":0.30909193},"labels":[],"label_agreement":null},{"id":"W2573963464","doi":"10.1182/blood.v116.21.1091.1091","title":"Non-Pathogenic Anti-Heparin/PF4 Antibodies Generated by Low Molecular Weight Heparins Mediate Procoagulant Effects.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Heparin; Medicine; Low molecular weight heparin; Antibody; Coagulation; Anticoagulant; Thrombosis; Internal medicine; Platelet; Gastroenterology; Immunology; Deep vein; Pharmacology","score_opus":0.006062613402816613,"score_gpt":0.2424389565973155,"score_spread":0.2363763431944989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573963464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926318,0.00035652542,0.000056146328,0.0002465607,0.0007480169,0.0012438707,0.000042215055,0.0002838739,0.0043909894],"genre_scores_gemma":[0.9968135,0.00025565503,0.0012730755,0.0004193785,0.00039725058,0.00012963226,0.00029407474,0.00013541548,0.0002820135],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99698836,0.000074918935,0.00056930044,0.0008896121,0.00055011053,0.0009276845],"domain_scores_gemma":[0.9979406,0.000058075544,0.00018143555,0.0010357873,0.00019718421,0.0005869393],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003073303,0.0005840057,0.0011253571,0.00020713982,0.00022325308,0.00008967576,0.00037174823,0.00047533255,0.00020978396],"category_scores_gemma":[0.00014410609,0.0005079707,0.0002995098,0.00048026515,0.00019023402,0.00016307646,0.0002121161,0.00083367876,0.0004345328],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037103222,0.0014373177,0.11527595,0.00026478744,0.0006375443,0.000411036,0.00011256389,5.532421e-7,0.88063437,0.00012662365,0.0006676519,0.00039447064],"study_design_scores_gemma":[0.0051460033,0.0004128133,0.18515928,0.000119591925,0.0009351389,0.00016511441,0.0000075912885,0.00014045698,0.80637956,0.000030747047,0.0009906436,0.0005130356],"about_ca_topic_score_codex":0.00013791963,"about_ca_topic_score_gemma":0.0000595102,"teacher_disagreement_score":0.07425482,"about_ca_system_score_codex":0.000032376214,"about_ca_system_score_gemma":0.00030224738,"threshold_uncertainty_score":0.9997372},"labels":[],"label_agreement":null},{"id":"W2573996312","doi":"10.1182/blood.v110.11.3328.3328","title":"Cost-Effectiveness Analysis in Canada of Dasatinib Versus Imatinib for the Treatment of Chronic Myelogenous Leukemia in Patients with Imatinib Resistance.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Bristol-Myers Squibb (Canada)","funders":"","keywords":"Dasatinib; Medicine; Chronic myelogenous leukemia; Imatinib; Internal medicine; Cost effectiveness; Oncology; Imatinib mesylate; Leukemia; Myeloid leukemia","score_opus":0.020920169824421454,"score_gpt":0.27869984494827155,"score_spread":0.2577796751238501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573996312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952064,0.0009184413,0.000106673964,0.0000120098875,0.00006628799,0.0032472732,0.00018157509,0.0000075488906,0.0002537941],"genre_scores_gemma":[0.99855405,0.00006994559,0.0007854616,0.000006631227,0.000026382488,0.00032118458,0.00018218097,0.000028269083,0.000025873867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805665,0.00006822386,0.00066195324,0.0003378191,0.00042884864,0.00044653376],"domain_scores_gemma":[0.9973749,0.0014387888,0.00035568397,0.0005912312,0.00015879599,0.00008063042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033358234,0.00026066636,0.0008558935,0.00024547035,0.000041627307,0.000003304979,0.00013012782,0.000072192684,0.000029347264],"category_scores_gemma":[0.0000897401,0.00017282803,0.00014196493,0.0009865861,0.00008332274,0.000034926783,0.000015138844,0.00009060442,4.591411e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009557332,0.0022549618,0.96958244,0.00040189188,0.003321923,0.000055399792,0.0008789209,0.0018458042,0.00016626366,0.00002268293,0.0000061854166,0.011906176],"study_design_scores_gemma":[0.07390082,0.0026194023,0.90752524,0.00020504178,0.002398286,0.0000010533357,0.00030053174,0.00030064746,0.012500189,0.0000036437618,0.00010001311,0.00014513376],"about_ca_topic_score_codex":0.37776738,"about_ca_topic_score_gemma":0.92910755,"teacher_disagreement_score":0.55134016,"about_ca_system_score_codex":0.0119833555,"about_ca_system_score_gemma":0.004595087,"threshold_uncertainty_score":0.9918095},"labels":[],"label_agreement":null},{"id":"W2573999905","doi":"10.1182/blood.v104.11.818.818","title":"The SCL Transcription Factor Supports Erythroid Cell Survival and Differentiation Downstream of the Erythropoietin Receptor.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Erythropoietin receptor; Biology; Erythropoiesis; Erythropoietin; Transcription factor; Cell biology; Signal transduction; Gene; Genetics; Internal medicine; Medicine","score_opus":0.010717607628793698,"score_gpt":0.2182822674074111,"score_spread":0.2075646597786174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573999905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99620223,0.0003507026,0.00010900116,0.0013319034,0.00080323603,0.00030657978,0.000023596947,0.000031898937,0.00084086426],"genre_scores_gemma":[0.9984863,0.0006511623,0.000065453925,0.0000816977,0.00015641154,0.000008570153,0.000034222394,0.000014339763,0.00050187856],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991127,0.00008103803,0.00024397313,0.00018943577,0.00020212602,0.00017073158],"domain_scores_gemma":[0.9994121,0.00005285995,0.00012312176,0.00027886545,0.000071675924,0.00006135318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000096588534,0.00012869507,0.00019541051,0.000028045148,0.00018274332,0.000012225,0.00006210276,0.00010591087,0.00015124641],"category_scores_gemma":[0.000034501896,0.000070954804,0.0001142498,0.00011311632,0.00019508686,0.000041644347,0.000021467784,0.00016927229,0.000012847699],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019706321,0.0008107714,0.025752412,0.00012435258,0.000076791526,0.0000019059592,0.0009056085,0.0000034541843,0.9693787,0.00037331803,0.0002928825,0.0020827143],"study_design_scores_gemma":[0.0072610504,0.00078856037,0.53443694,0.00009582193,0.00028551416,0.000049870134,0.0006882051,0.0000034204108,0.45160577,0.0005412538,0.004071934,0.00017163943],"about_ca_topic_score_codex":0.000046953013,"about_ca_topic_score_gemma":0.00006328089,"teacher_disagreement_score":0.517773,"about_ca_system_score_codex":0.000019121582,"about_ca_system_score_gemma":0.00007084699,"threshold_uncertainty_score":0.2893453},"labels":[],"label_agreement":null},{"id":"W2574020042","doi":"10.1182/blood.v112.11.3041.3041","title":"Hematologic Findings and Transfusion Therapy in Severe Pediatric Plasmodium Falciparum Malaria: Results from a Prospective Observational Study in Uganda","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Malaria Research and Control","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Malaria; Medicine; Plasmodium falciparum; Case fatality rate; Prospective cohort study; Cerebral Malaria; Observational study; Plasmodium vivax; Internal medicine; Immunology; Transfusion therapy; Blood transfusion; Pediatrics; Epidemiology","score_opus":0.04701482443266139,"score_gpt":0.28187518853394555,"score_spread":0.23486036410128416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574020042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955514,0.00035091196,0.0000033708484,0.0018936862,0.000025058163,0.0018099922,0.00005011159,0.00002648421,0.00028898407],"genre_scores_gemma":[0.9988519,0.000529573,0.00013793769,0.00007914656,0.000083979874,0.00016889085,0.000036621772,0.000011495668,0.0001004787],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984839,0.000096464326,0.00033939915,0.00041753554,0.00037417526,0.0002885475],"domain_scores_gemma":[0.99941,0.00022659425,0.00004055815,0.0001637397,0.000061991646,0.00009714827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031003403,0.00014931937,0.00035970146,0.00020051871,0.000073353694,0.000014027374,0.00008102468,0.00012071187,0.000049891405],"category_scores_gemma":[0.00025956117,0.00011912219,0.00003724263,0.0003957047,0.000032205284,0.000096244396,0.000028302777,0.00036696787,0.000005397783],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039556623,0.002582845,0.98893553,0.000011462887,0.000046532597,0.00073080044,0.0028802955,0.0000023132159,0.000706132,0.000060039198,0.00003805333,0.00005034452],"study_design_scores_gemma":[0.051927257,0.0011903545,0.94561356,0.000020593418,0.000031325726,0.0000708029,0.00034509497,0.00008250967,0.0003494025,0.00025262136,0.000006029574,0.00011041993],"about_ca_topic_score_codex":0.0008002457,"about_ca_topic_score_gemma":0.0006256865,"teacher_disagreement_score":0.047971595,"about_ca_system_score_codex":0.000035766217,"about_ca_system_score_gemma":0.00019209903,"threshold_uncertainty_score":0.48576617},"labels":[],"label_agreement":null},{"id":"W2574098295","doi":"10.1182/blood.v120.21.2388.2388","title":"Elevated Expression of miR-181a and miR-155 Identify Pediatric AML Patients at High Risk of Induction Failure, A Report from Children's Oncology Group.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Hospital for Sick Children","funders":"","keywords":"microRNA; Biology; Oncology; Bone marrow; Internal medicine; Myeloid leukemia; Disease; miR-155; Cancer; Cancer research; Medicine; Immunology; Genetics; Gene","score_opus":0.00519699540010693,"score_gpt":0.22712194666529753,"score_spread":0.2219249512651906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574098295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983425,0.0010035048,0.000052068404,0.0000044672533,0.0001481014,0.00025683478,0.00017326327,0.000008568496,0.000010688664],"genre_scores_gemma":[0.99663424,0.00014014094,0.0012733496,0.0000042116103,0.00027287847,0.000013911394,0.001631578,0.000018917739,0.000010776802],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988737,0.0001244287,0.0003913047,0.00028617473,0.00015731512,0.0001670812],"domain_scores_gemma":[0.9988159,0.000014696508,0.0006419863,0.00032599553,0.00011298745,0.00008842968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014505065,0.00013378827,0.00019536178,0.00006488183,0.000044529483,0.0000039863,0.00008074639,0.00027727475,0.000024638513],"category_scores_gemma":[0.00012281901,0.00012828736,0.00006706264,0.00009134612,0.000053904736,0.000013000447,0.00015835172,0.00006712476,0.0000018766327],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049014172,0.00040601986,0.4801782,0.0000127061685,0.000050928913,6.167237e-7,0.000020776546,6.1130714e-7,0.5189158,6.6191325e-7,0.0002785089,0.000086176144],"study_design_scores_gemma":[0.0010363628,0.00009329006,0.54487616,0.000006216592,0.00019165284,0.000010122012,0.0000038654516,2.5726285e-7,0.4535764,0.000017420645,0.00011828817,0.00006996834],"about_ca_topic_score_codex":0.0001444631,"about_ca_topic_score_gemma":0.00001662699,"teacher_disagreement_score":0.06533938,"about_ca_system_score_codex":0.000016066697,"about_ca_system_score_gemma":0.000024816256,"threshold_uncertainty_score":0.52314067},"labels":[],"label_agreement":null},{"id":"W2574134106","doi":"10.1182/blood.v112.11.950.950","title":"QLT0267, a Small Molecule Inhibitor of ILK and FLT3 Is Cytotoxic to Acute Myeloid Leukemia (AML) ‘Stem Cells’ Detected in Immunodeficient Mice.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Integrin-linked kinase; Cancer research; Protein kinase B; Fms-Like Tyrosine Kinase 3; CD34; Myeloid leukemia; Leukemia; Biology; Myeloid; Kinase; CD38; Cytotoxic T cell; Stem cell; Molecular biology; Chemistry; Signal transduction; Immunology; In vitro; Cell biology; Protein kinase A; Biochemistry; Mutation; Cyclin-dependent kinase 2","score_opus":0.01616144116951526,"score_gpt":0.24045743195559433,"score_spread":0.22429599078607906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574134106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99684536,0.0009464461,0.00007761683,0.00026878976,0.00006914598,0.001128809,0.00006430792,0.000074890755,0.0005246126],"genre_scores_gemma":[0.99584496,0.00041486163,0.0018622399,0.00040748905,0.000073706644,0.00008570873,0.00001242663,0.00007518339,0.0012233977],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973666,0.00009462329,0.0006344234,0.0006369152,0.0005599732,0.0007074327],"domain_scores_gemma":[0.9985491,0.00009788472,0.00012357609,0.0006634352,0.00022674786,0.00033923824],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027977466,0.00033531483,0.00065605756,0.00056375755,0.00009526072,0.000017768418,0.00028487656,0.0002574878,0.000043842298],"category_scores_gemma":[0.00006458793,0.00031494684,0.00012002135,0.0010475513,0.00017609165,0.00006253964,0.0003425859,0.000559897,0.00009291547],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004972286,0.00040276747,0.0027349996,0.00015699973,0.00015844067,0.000777334,0.002245232,0.0000061875526,0.9920039,0.0000055176592,0.0005764204,0.00043493797],"study_design_scores_gemma":[0.007772822,0.00090643036,0.010528279,0.0002223527,0.00015194509,0.00066991424,0.00028248562,0.00028010117,0.9785056,0.0000035735543,0.00038864336,0.00028784922],"about_ca_topic_score_codex":0.0004447854,"about_ca_topic_score_gemma":0.00004543608,"teacher_disagreement_score":0.01349833,"about_ca_system_score_codex":0.00046657491,"about_ca_system_score_gemma":0.00082927506,"threshold_uncertainty_score":0.99993026},"labels":[],"label_agreement":null},{"id":"W2574148738","doi":"10.1182/blood.v108.11.3200.3200","title":"In Utero Transplantation of Stem Cells to the Yolk Sac of Early to Mid Gestation Canine Fetuses.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Organ and Tissue Transplantation Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Yolk sac; Fetus; Transplantation; In utero; Stem cell; Bone marrow; Andrology; Transplacental; Medicine; Pathology; Biology; Pregnancy; Internal medicine; Placenta; Embryo","score_opus":0.015379339044837457,"score_gpt":0.2731077971354195,"score_spread":0.25772845809058204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574148738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972824,0.00005260184,0.00051148486,0.0011019143,0.00004080473,0.0005159936,0.00008840435,0.000009163268,0.00039726179],"genre_scores_gemma":[0.9985247,0.000044647146,0.0005108445,0.0000931103,0.000041234478,0.000013623064,0.000019312056,0.000011207513,0.0007413209],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99916893,0.000039859468,0.00026379563,0.00011639881,0.0002826088,0.0001284035],"domain_scores_gemma":[0.99963385,0.000058138994,0.000039194347,0.0001323554,0.0000821033,0.000054376516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001425957,0.00006627721,0.00015085479,0.0001661466,0.000014047293,0.0000053169038,0.000068179244,0.000034535413,0.00006453968],"category_scores_gemma":[0.000002525275,0.00005164086,0.000025542431,0.00034901712,0.000017440734,0.000039728126,0.0000036568727,0.00006631357,0.00003252369],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072724244,0.0007260778,0.051330086,0.00077714515,0.000043232667,0.00017012331,0.008164125,0.00038367618,0.93549496,0.0002649461,0.0003878577,0.0015305311],"study_design_scores_gemma":[0.0019316158,0.0003618642,0.2593536,0.000100747064,0.00006150217,0.000015206338,0.00009624187,0.0000043580844,0.73787075,0.0000074107697,0.00015374676,0.000042933734],"about_ca_topic_score_codex":0.002481782,"about_ca_topic_score_gemma":0.001263485,"teacher_disagreement_score":0.20802352,"about_ca_system_score_codex":0.000011524857,"about_ca_system_score_gemma":0.000048898717,"threshold_uncertainty_score":0.37517288},"labels":[],"label_agreement":null},{"id":"W2574226053","doi":"10.1182/blood.v126.23.3971.3971","title":"Prevalence and Prognostic Value of BCL2 and MYC Protein Expression within ABC and GCB Subtypes in Patients with Previously Untreated, Diffuse Large B-Cell Lymphoma: Analysis from the Phase III MAIN Study","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Tissue microarray; Diffuse large B-cell lymphoma; Lymphoma; Oncology; Medicine; clone (Java method); CHOP; Internal medicine; Immunohistochemistry; Pathology; Cancer research; Biology","score_opus":0.007591549933702428,"score_gpt":0.22901253228905588,"score_spread":0.22142098235535346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574226053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99434847,0.0027590564,0.0000031421937,0.00002885561,0.000006498793,0.0027373147,0.00008515395,0.000015622054,0.0000158825],"genre_scores_gemma":[0.9993532,0.00006911154,0.0002484404,0.000018838238,0.000013051292,0.00021034888,0.000040558883,0.000015999396,0.000030466332],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985943,0.00017646373,0.0003059224,0.000424319,0.00030163868,0.00019734769],"domain_scores_gemma":[0.99911207,0.00012776774,0.00018211837,0.00033401165,0.00007325747,0.00017077339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026074608,0.0002197963,0.00045692894,0.00009224544,0.000062840525,0.000031743584,0.00006177872,0.00005752135,0.0000034787183],"category_scores_gemma":[0.00007990394,0.00011910857,0.000027262595,0.00026387552,0.00008443237,0.00008441487,0.000090886155,0.00004871608,5.180952e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011253586,0.03830207,0.9546646,0.000088277964,0.00046963737,0.000064207474,0.0048818253,7.741341e-7,0.00010436744,0.0000037983646,0.0000063727225,0.00028869614],"study_design_scores_gemma":[0.14541437,0.0029005085,0.84422666,0.00038433677,0.0037705062,0.000003749393,0.00066860364,0.00008464086,0.0024122905,0.000015020436,0.0000020031782,0.00011732949],"about_ca_topic_score_codex":0.00076344836,"about_ca_topic_score_gemma":0.00020172108,"teacher_disagreement_score":0.144289,"about_ca_system_score_codex":0.00003109663,"about_ca_system_score_gemma":0.00007351248,"threshold_uncertainty_score":0.48571065},"labels":[],"label_agreement":null},{"id":"W2574261368","doi":"10.1182/blood.v126.23.649.649","title":"Brain Natriuretic Peptide, Troponin and D-Dimer Levels in Relation to Long-Term Functional Outcome after a First Episode of Pulmonary Embolism: Results from the E.L.O.P.E. Study","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Western University; Jewish General Hospital; University of Ottawa; University of Toronto; Dalhousie University; McGill University","funders":"","keywords":"Medicine; Internal medicine; Pulmonary embolism; Troponin T; Cardiology; Contraindication; Brain natriuretic peptide; Prospective cohort study; Troponin; Natriuretic peptide; Biomarker; Cohort; Myocardial infarction; Heart failure; Pathology","score_opus":0.042236455509526205,"score_gpt":0.2834533388047194,"score_spread":0.2412168832951932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574261368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909357,0.0005369243,0.000042604788,0.006475712,0.00016043971,0.001349719,0.00006154582,0.000022911085,0.0004144356],"genre_scores_gemma":[0.9981757,0.000011344012,0.00014631593,0.00082629756,0.0001801195,0.00015280204,0.000041495885,0.00002466103,0.00044129012],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982578,0.000116045914,0.0005648998,0.0003926813,0.0004499862,0.00021855177],"domain_scores_gemma":[0.9989491,0.00028900997,0.0001178018,0.00041405275,0.00008668527,0.00014335355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066146575,0.00018142023,0.00044623006,0.00014847652,0.00005416424,0.00002130953,0.00009974044,0.00007912347,0.000058222624],"category_scores_gemma":[0.00045296864,0.00013306538,0.000061920095,0.00025123433,0.000050498493,0.00008818182,0.000150234,0.000182446,0.000032932017],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005253191,0.002530677,0.99144244,0.000030758027,0.00012646166,0.00013690966,0.0031210585,0.000042051255,0.0000868952,0.000032732405,0.0015192652,0.0004054295],"study_design_scores_gemma":[0.0056629013,0.00043962614,0.9923214,0.0001267315,0.00040236412,0.000012825276,0.0004938979,0.000031346517,0.000053614105,0.00008182734,0.00023766351,0.00013581432],"about_ca_topic_score_codex":0.000969243,"about_ca_topic_score_gemma":0.001797792,"teacher_disagreement_score":0.007239966,"about_ca_system_score_codex":0.000047963462,"about_ca_system_score_gemma":0.00003683064,"threshold_uncertainty_score":0.5426249},"labels":[],"label_agreement":null},{"id":"W2574286700","doi":"10.1182/blood.v126.23.955.955","title":"Serum Ferritin Is Not Sensitive or Specific for the Diagnosis of Iron Deficiency in Patients with Normocytic Anemia","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; McMaster University","funders":"","keywords":"Medicine; Ferritin; Iron deficiency; Gastroenterology; Anemia; Internal medicine; Iron-deficiency anemia; Transferrin saturation; Concomitant; Iron sucrose","score_opus":0.025278267253985146,"score_gpt":0.248425871493252,"score_spread":0.22314760423926683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574286700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99762577,0.00036885045,0.00003085924,0.0004051844,0.000058556016,0.0007614221,0.00007913476,0.000010184874,0.00066005223],"genre_scores_gemma":[0.9988061,0.00005437952,0.00045808483,0.00043256924,0.00004310454,0.000042063184,0.000015150158,0.000016933338,0.00013159252],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991393,0.00002156454,0.00018468795,0.0001789515,0.00026423484,0.00021126262],"domain_scores_gemma":[0.99936694,0.00012673395,0.00006725905,0.00022810369,0.00014118709,0.00006975458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014443777,0.00011266835,0.00021687856,0.00006304,0.00003213406,0.0000065144686,0.00006547074,0.000049327773,0.000029342329],"category_scores_gemma":[0.000115127565,0.000063595784,0.00003713453,0.00019079064,0.00007535738,0.000043076954,0.000020863627,0.00007638718,0.000009226478],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026119526,0.0023029281,0.9837755,0.00027987588,0.00001406893,0.000020673591,0.0034897227,0.000015836462,0.00007144331,0.0001597186,0.0024232343,0.0048350566],"study_design_scores_gemma":[0.021095732,0.001154943,0.965026,0.000074616124,0.00029086924,0.0000056043373,0.0021268544,0.000010616198,0.009405537,0.0000176416,0.0006513681,0.00014022204],"about_ca_topic_score_codex":0.000074447635,"about_ca_topic_score_gemma":0.00006458405,"teacher_disagreement_score":0.018749492,"about_ca_system_score_codex":0.000018911884,"about_ca_system_score_gemma":0.00010847816,"threshold_uncertainty_score":0.25933608},"labels":[],"label_agreement":null},{"id":"W2574289250","doi":"10.1182/blood.v126.23.3950.3950","title":"Maintenance Rituximab Following R-CHOP Chemotherapy in Patients with Composite or Discordant, Indolent and Aggressive, B-Cell Non-Hodgkin Lymphomas","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Rituximab; Internal medicine; CHOP; Lymphoma; Follicular lymphoma; Diffuse large B-cell lymphoma; Mantle cell lymphoma; Chemotherapy; B symptoms; Aggressive lymphoma; Gastroenterology; Oncology","score_opus":0.007914555491966384,"score_gpt":0.2283367514092352,"score_spread":0.22042219591726883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574289250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974032,0.00065684447,0.000010425118,0.00018938012,0.00007321027,0.0006976168,0.000012228045,0.000026737098,0.0009303557],"genre_scores_gemma":[0.9970703,0.00011865303,0.0020508165,0.00041650428,0.0000345659,0.00007672093,0.000028639284,0.000035564346,0.00016820933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873495,0.000026222693,0.00023449892,0.00036332506,0.00031763013,0.00032337758],"domain_scores_gemma":[0.9992637,0.00003866602,0.00014483131,0.0002692187,0.000058022943,0.00022558053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007611841,0.00024673215,0.0004561431,0.00008944318,0.000044352186,0.000034148,0.00007010492,0.000049916856,0.0000071748354],"category_scores_gemma":[0.000020232585,0.00015032857,0.000059995764,0.0001763756,0.000048928956,0.00009998215,0.00004596579,0.00006772397,0.0000123693235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016842249,0.009674536,0.9821083,0.000041852432,0.00016181852,0.0013347166,0.00051337975,7.4690996e-7,0.00009818829,0.0000045680563,0.00018948031,0.004188165],"study_design_scores_gemma":[0.17937991,0.0018975155,0.8116618,0.0008667123,0.00021442283,0.000082128216,0.00011813731,0.000021880485,0.005222216,0.000011116161,0.00030040726,0.00022378023],"about_ca_topic_score_codex":0.00014327554,"about_ca_topic_score_gemma":0.000040796593,"teacher_disagreement_score":0.17769568,"about_ca_system_score_codex":0.0001337577,"about_ca_system_score_gemma":0.00013840609,"threshold_uncertainty_score":0.61302215},"labels":[],"label_agreement":null},{"id":"W2574380159","doi":"10.1182/blood.v126.23.329.329","title":"Tosedostat Plus Low Dose Cytarabine Induces a High Rate of Responses That Can be Predicted By Genetic Profiling in Elderly AML","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Cytarabine; Medicine; Internal medicine; Myeloid leukemia; Chemotherapy; Prospective cohort study; Gastroenterology; Induction chemotherapy; Oncology; Surgery","score_opus":0.0299385948849215,"score_gpt":0.26792082056320743,"score_spread":0.23798222567828592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574380159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99748635,0.00022221428,0.000019182402,0.0014713848,0.000020674925,0.0003173501,0.00030154604,0.000054418728,0.000106884436],"genre_scores_gemma":[0.9978275,0.00003990986,0.0006751576,0.00044077987,0.000057393918,0.000032371376,0.00028896265,0.0000208505,0.00061709184],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99865335,0.0001651931,0.0003658041,0.0002699828,0.0002965831,0.00024908583],"domain_scores_gemma":[0.99915534,0.00007298989,0.00014008167,0.0002668166,0.00014098577,0.00022377832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002803121,0.00016446036,0.00040240475,0.0002708539,0.000025088033,0.000016021693,0.00008257948,0.000105896215,0.00005501375],"category_scores_gemma":[0.00028910767,0.00014088184,0.000070545546,0.00043996275,0.000084996725,0.00005969216,0.00003144658,0.00017567915,0.0000027914405],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017386936,0.0020010376,0.035197005,0.00026113173,0.00031968785,0.0006284059,0.002095818,0.00008352109,0.95472574,0.000021888163,0.0020156002,0.0009114616],"study_design_scores_gemma":[0.01767883,0.001192096,0.025923109,0.0007435575,0.0003224438,0.000047081565,0.0010468389,0.00033677008,0.9522729,0.00008214051,0.000120805526,0.00023346143],"about_ca_topic_score_codex":0.00075025455,"about_ca_topic_score_gemma":0.00017924195,"teacher_disagreement_score":0.015940137,"about_ca_system_score_codex":0.000050481212,"about_ca_system_score_gemma":0.00039677686,"threshold_uncertainty_score":0.5744994},"labels":[],"label_agreement":null},{"id":"W2574437684","doi":"10.1182/blood.v126.23.3365.3365","title":"Deferiprone Pharmacokinetics with and without Iron Overload and in Special Patient Populations","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Deferiprone; Thalassemia; Medicine; Bioavailability; Deferasirox; Pharmacokinetics; Deferoxamine; Dosing; Pharmacology; Renal function; Hemoglobinopathy; Internal medicine; Pediatrics; Disease","score_opus":0.01799796590938976,"score_gpt":0.2556139669931514,"score_spread":0.23761600108376166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574437684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933867,0.0011724904,0.0000043140935,0.00032578447,0.000058636128,0.00023078022,0.000003362744,0.000012554961,0.004805385],"genre_scores_gemma":[0.99881876,0.0001794768,0.0006999852,0.000086209286,0.00009869817,0.0000048868974,0.0000075607486,0.000009777679,0.000094676376],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995457,0.00001041584,0.0000981763,0.00012330509,0.00011042989,0.000111988134],"domain_scores_gemma":[0.99972713,0.0000026197845,0.000033061406,0.000088266876,0.00002396817,0.00012494638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000036057318,0.00007626453,0.00012300981,0.000040703217,0.000035416986,0.000013254012,0.0000132610185,0.000048917747,0.000008353521],"category_scores_gemma":[0.000021074617,0.00005646922,0.0000074190307,0.000051201372,0.00006330549,0.000035630972,0.000021585825,0.00010107135,0.0000019085219],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034191925,0.00048091283,0.9882291,0.000041777734,0.000028360932,0.00006312457,0.0014577282,0.000024688445,0.00060784287,0.00006369574,0.00029963747,0.00836121],"study_design_scores_gemma":[0.04340929,0.002262516,0.93374914,0.00036756712,0.0007892488,0.00065939286,0.0020219362,0.0005540308,0.0012418729,0.00028693944,0.014199898,0.00045815032],"about_ca_topic_score_codex":0.00006409385,"about_ca_topic_score_gemma":0.00008685355,"teacher_disagreement_score":0.05447995,"about_ca_system_score_codex":0.000009345382,"about_ca_system_score_gemma":0.000033741384,"threshold_uncertainty_score":0.2302748},"labels":[],"label_agreement":null},{"id":"W2574458984","doi":"10.1182/blood.v110.11.1633.1633","title":"Risk Factors Predisposing to Thromboembolism in Children with Cancer.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Cancer; Epidemiology; Risk factor; Pediatrics; Sarcoma; Internal medicine; Retrospective cohort study; Pediatric cancer; Disease; Surgery; Pathology","score_opus":0.014481485698389125,"score_gpt":0.2968168873935464,"score_spread":0.28233540169515725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574458984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969833,0.00043496868,0.00017340636,0.00042367642,0.0001268492,0.00073882216,0.000051955565,0.00011522204,0.0009518187],"genre_scores_gemma":[0.99755806,0.00005062161,0.0010641227,0.00072037795,0.0004766866,0.000014013384,0.000020140349,0.00004569207,0.000050263574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983006,0.00004205385,0.00034326944,0.0003970317,0.00045105463,0.00046595943],"domain_scores_gemma":[0.9990788,0.00007723362,0.00010840376,0.0003786989,0.000049092625,0.00030774283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004648799,0.00021466182,0.00044767652,0.00018449589,0.000068749505,0.000018753233,0.00012919352,0.00009447576,0.000058968097],"category_scores_gemma":[0.000109927525,0.00017677854,0.000060625636,0.00046402626,0.000048371792,0.00008120298,0.00004549984,0.00032115984,0.0000124084745],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008787161,0.00047055175,0.99352235,0.000021361415,0.00022222885,0.000010197247,0.0041550356,0.000021271766,0.00033948186,0.000019721469,0.000120405384,0.0010095189],"study_design_scores_gemma":[0.0033792192,0.00031101663,0.9834934,0.0002732988,0.0002687231,0.00003014486,0.00042230746,0.0000014910898,0.011404637,0.000020302425,0.00017432233,0.00022114917],"about_ca_topic_score_codex":0.012746795,"about_ca_topic_score_gemma":0.0072335615,"teacher_disagreement_score":0.011065155,"about_ca_system_score_codex":0.00008463173,"about_ca_system_score_gemma":0.00014044927,"threshold_uncertainty_score":0.9938274},"labels":[],"label_agreement":null},{"id":"W2574480355","doi":"10.1182/blood.v114.22.1676.1676","title":"Durable Responses After Lenalidomide Oral Monotherapy in Patients with Relapsed or Refractory (R/R) Aggressive Non-Hodgkin's Lymphoma (a-NHL): Results From An International Phase 2 Study (CC-5013-NHL-003).","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Lenalidomide; Medicine; Internal medicine; Mantle cell lymphoma; Lymphoma; Neutropenia; Diffuse large B-cell lymphoma; Oncology; Gastroenterology; Follicular lymphoma; Aggressive lymphoma; Rituximab; Chemotherapy; Multiple myeloma","score_opus":0.01289076447935709,"score_gpt":0.30015439284438994,"score_spread":0.28726362836503283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574480355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99708235,0.00016032303,0.0000022451861,0.0004511796,0.00016774036,0.0014179484,0.00039438324,0.00007308411,0.00025076888],"genre_scores_gemma":[0.9969113,0.0001151049,0.0008333773,0.0009386598,0.00017249848,0.00021294151,0.00047079247,0.00005169233,0.00029364624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972465,0.00021593613,0.000663879,0.0007994678,0.0006830773,0.00039116162],"domain_scores_gemma":[0.9981453,0.00021959087,0.0004147487,0.0007637903,0.00021665727,0.00023994094],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022537065,0.0004153599,0.0005982102,0.0002944275,0.00008375644,0.00008562258,0.00021562348,0.00014074521,0.00013673386],"category_scores_gemma":[0.00024406798,0.00028020111,0.0000870601,0.00028476163,0.00004811412,0.0004497546,0.00003155387,0.00012492437,0.000030888903],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18823111,0.1467138,0.6303259,0.0000043640275,0.0007378468,0.0046831216,0.0027266836,0.0000026941793,0.00021562866,0.000001650746,0.00039391083,0.02596327],"study_design_scores_gemma":[0.2963481,0.0123247225,0.6878402,0.00027148536,0.0002592068,0.000013934092,0.00024250486,0.000016012222,0.0020124356,0.00001137786,0.00041238277,0.00024760753],"about_ca_topic_score_codex":0.0007901036,"about_ca_topic_score_gemma":0.0003145163,"teacher_disagreement_score":0.13438907,"about_ca_system_score_codex":0.00027900914,"about_ca_system_score_gemma":0.0002974042,"threshold_uncertainty_score":0.999965},"labels":[],"label_agreement":null},{"id":"W2574485272","doi":"10.1182/blood.v112.11.665.665","title":"Comparison of Infection-Related Hospitalization Risk and Associated Costs among Patients Receiving Sargramostim (Leukine®), Filgrastim (Neupogen®), and Pegfilgrastim (Neulasta®) for Chemotherapy-Induced Neutropenia","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Filgrastim; Pegfilgrastim; Medicine; Neutropenia; Granulocyte colony-stimulating factor; Febrile neutropenia; Internal medicine; Granulocyte macrophage colony-stimulating factor; Chemotherapy; Immunology; Surgery; Cytokine","score_opus":0.014554765967124796,"score_gpt":0.2743723533667793,"score_spread":0.2598175873996545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574485272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99764484,0.00012654021,0.00026841537,0.0000472567,0.0002065567,0.0013144197,0.00006480658,0.00011352298,0.00021361565],"genre_scores_gemma":[0.99896467,0.0003157548,0.00020786267,0.000038639584,0.000050727933,0.00008653967,0.00020383945,0.000052814896,0.00007917301],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840003,0.00008150613,0.0005611696,0.0004207133,0.00023667504,0.00029988133],"domain_scores_gemma":[0.99856895,0.00018729678,0.00047734703,0.00020609688,0.00038271226,0.00017758508],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013239332,0.00027771486,0.0005965974,0.00018480209,0.0003605421,0.000029457759,0.000048021524,0.00021170393,0.000028676308],"category_scores_gemma":[0.00037117206,0.0002706154,0.00011468051,0.00043468754,0.00012995077,0.00016845479,0.000039499915,0.0002512667,0.0000018756073],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013128083,0.0011263789,0.99031246,0.00006119771,0.0003052067,0.000002144557,0.0005114852,0.000037447542,0.004235426,0.000007980887,0.00025985017,0.0030091645],"study_design_scores_gemma":[0.01060985,0.0019060189,0.9746016,0.00018436408,0.00066313345,0.000018452658,0.000023805631,0.0008884179,0.010721501,0.000021170315,0.000114836635,0.0002468191],"about_ca_topic_score_codex":0.0006226873,"about_ca_topic_score_gemma":0.00028774666,"teacher_disagreement_score":0.015710806,"about_ca_system_score_codex":0.000095562624,"about_ca_system_score_gemma":0.00006836582,"threshold_uncertainty_score":0.9999746},"labels":[],"label_agreement":null},{"id":"W2574508043","doi":"10.1182/blood.v112.11.4303.4303","title":"Survival Outcome of Hematopoietic Stem Cell Transplant Recipients Admitted to the Intensive Care Unit: A Single-Center Report of 53 Patients","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital; Leukemia & Lymphoma Society of Canada; University of British Columbia","funders":"","keywords":"Medicine; Hematopoietic stem cell transplantation; Intensive care unit; Transplantation; Retrospective cohort study; Cohort; Single Center; Mechanical ventilation; Stem cell; Surgery; Internal medicine","score_opus":0.04625428895119274,"score_gpt":0.267853176170237,"score_spread":0.22159888721904428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574508043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966483,0.00006642094,0.00016338279,0.00011599044,0.00035954098,0.0010543419,0.00016421879,0.0000311347,0.0013966626],"genre_scores_gemma":[0.99909836,0.000014060647,0.00022121692,0.00015845976,0.000026494201,0.00002504281,0.00017835243,0.000037641657,0.00024036174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976477,0.000096592805,0.000981768,0.0003106901,0.00069696916,0.0002663027],"domain_scores_gemma":[0.99766046,0.00013053414,0.00031146896,0.0005707132,0.001163469,0.00016334835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015646352,0.00021864183,0.0005994073,0.00013886984,0.000054522705,0.0000033441825,0.00016766785,0.00010895615,0.000028799148],"category_scores_gemma":[0.000054654527,0.00015881543,0.0001796807,0.00032705086,0.00008109813,0.00003370361,0.000025900072,0.00015293663,0.00002029855],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025279805,0.0010534024,0.9662765,0.00075129204,0.00010632904,0.00048485197,0.025922138,0.0000023617567,0.005073357,0.000004229074,0.000032412157,0.000040315586],"study_design_scores_gemma":[0.012962321,0.0014861999,0.5929641,0.0015620444,0.0010291827,0.0021310681,0.008169724,0.0000032952883,0.37908277,0.0000018972003,0.00027889127,0.00032849397],"about_ca_topic_score_codex":0.00004660019,"about_ca_topic_score_gemma":0.000024976665,"teacher_disagreement_score":0.3740094,"about_ca_system_score_codex":0.000029576227,"about_ca_system_score_gemma":0.00007953359,"threshold_uncertainty_score":0.6476305},"labels":[],"label_agreement":null},{"id":"W2574555970","doi":"10.1182/blood.v114.22.2873.2873","title":"Final Results of the First Randomized Trial Comparing Balloon Kyphoplasty (BKP) to Non-Surgical Management Among Cancer Patients with Vertebral Compression Fractures: Marked Improvement in Back Function, Quality of Life and Pain in the BKP Arm.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital","funders":"","keywords":"Medicine; Randomized controlled trial; Surgery; Quality of life (healthcare); Performance status; Cancer; Internal medicine; Overall survival","score_opus":0.01421361090245924,"score_gpt":0.2628563266165523,"score_spread":0.24864271571409305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574555970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936059,0.000047152185,0.00008468198,0.0007628572,0.00007249356,0.004508853,0.000016994312,0.000005624399,0.0008954263],"genre_scores_gemma":[0.998851,0.000016213862,0.0001585649,0.00072464574,0.000028237555,0.00013773408,0.000027153368,0.000007818016,0.000048650832],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9972063,0.0005699105,0.00094539707,0.00031148674,0.0007544374,0.00021251803],"domain_scores_gemma":[0.99873465,0.0003354188,0.00039930965,0.00038117572,0.0000590146,0.00009043988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027577842,0.0001938753,0.00073632685,0.000114328504,0.000045085344,0.000015974341,0.00016711302,0.000042496515,0.000047682166],"category_scores_gemma":[0.0002983411,0.000102755424,0.00010605268,0.0002703532,0.000085864034,0.00005275894,0.000092901115,0.000170462,4.4794518e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7873335,0.00526416,0.20285971,0.00043161542,0.0002486857,0.000008046432,0.00057440693,0.00026756752,0.000009678412,0.000025308234,0.0010360717,0.001941243],"study_design_scores_gemma":[0.4666539,0.00065315573,0.53128684,0.00040593828,0.00020388504,5.437986e-8,0.00014981648,0.0004674529,0.00001778717,0.000014975628,0.00007837919,0.00006780329],"about_ca_topic_score_codex":0.0004707759,"about_ca_topic_score_gemma":0.0004980494,"teacher_disagreement_score":0.32842714,"about_ca_system_score_codex":0.000029552524,"about_ca_system_score_gemma":0.000033293305,"threshold_uncertainty_score":0.41902444},"labels":[],"label_agreement":null},{"id":"W2574564768","doi":"10.1182/blood.v126.23.3637.3637","title":"NOTCH1 Induces Differential Epigenomic Patterning and Genomic Organization in Fetal Liver- and Adult Bone Marrow-Derived Hematopoietic Progentiors","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Progenitor cell; Cancer research; Haematopoiesis; Immunophenotyping; Biology; Bone marrow; Myelopoiesis; Immunology; Leukemia; Stem cell; Cell biology; Flow cytometry","score_opus":0.014969894687419088,"score_gpt":0.23540680118271937,"score_spread":0.2204369064953003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574564768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998397,0.00048941583,0.0003022838,0.00019280196,0.000044041688,0.0004846696,0.0000057188936,0.000041160893,0.00004293344],"genre_scores_gemma":[0.9990184,0.0001355367,0.0004896766,0.00005936073,0.000113948816,0.000016012105,0.00005351469,0.000043682183,0.000069904774],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99878216,0.000062163504,0.00026878595,0.00033804108,0.00025500223,0.0002938202],"domain_scores_gemma":[0.99930733,0.00003739025,0.00009602036,0.00015588694,0.00015888305,0.00024446298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001268275,0.00016907709,0.00029597813,0.0001661433,0.000055404267,0.00005204262,0.000067779576,0.0001226758,0.00006430104],"category_scores_gemma":[0.00028110182,0.00015447113,0.00001805578,0.00020209211,0.0001030006,0.00008703786,0.00018460647,0.00017996063,0.000029771933],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017011908,0.00051874825,0.4381254,0.00037423286,0.00013248235,0.0004995069,0.005158376,0.0000014960972,0.5518442,0.000028972838,0.00004403687,0.0031024513],"study_design_scores_gemma":[0.036494933,0.0007844082,0.8175947,0.0004023473,0.00055792974,0.002606249,0.0021753109,0.0019384007,0.13670076,0.00010148692,0.000029044546,0.00061441195],"about_ca_topic_score_codex":0.00016174695,"about_ca_topic_score_gemma":0.000037740305,"teacher_disagreement_score":0.41514343,"about_ca_system_score_codex":0.00016691428,"about_ca_system_score_gemma":0.00029419616,"threshold_uncertainty_score":0.62991494},"labels":[],"label_agreement":null},{"id":"W2574567064","doi":"10.1182/blood.v112.11.3413.3413","title":"The Efficacy of H. pylori Eradication Therapy in H. pylori-Infected and Uninfected Patients with Immune Thrombocytopenic Purpura: A Systematic Review.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; St. Joseph's Hospital; McMaster University","funders":"","keywords":"Medicine; Helicobacter pylori; Thrombocytopenic purpura; Internal medicine; Splenectomy; Gastroenterology; Urea breath test; Immunology; Platelet; Helicobacter pylori infection","score_opus":0.011215369812376827,"score_gpt":0.23728448945097597,"score_spread":0.22606911963859913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574567064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9796362,0.016500333,0.0000049769483,0.0006767496,0.00005159784,0.0030100832,0.000004156399,0.00005705924,0.000058831956],"genre_scores_gemma":[0.97847503,0.021002958,0.00004963094,0.00016982922,0.000019587671,0.00019565958,0.00003758806,0.000029253088,0.00002044558],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980622,0.00027030913,0.00077732635,0.00027953638,0.00029943793,0.00031119958],"domain_scores_gemma":[0.9982933,0.000295531,0.00040912154,0.0005787137,0.0003508034,0.00007253168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031497958,0.00024378316,0.0009834657,0.00012050203,0.0001523548,0.0000071368554,0.00014058183,0.00008816344,0.000004445263],"category_scores_gemma":[0.00062729756,0.00014323292,0.00007121536,0.0006050261,0.00031910534,0.00008652161,0.00005130107,0.0002938948,0.0000069406256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042671978,0.0015213467,0.9882027,0.0066121574,0.0012890768,0.00002495588,0.0007655526,3.6990133e-7,0.0009580635,0.00001692111,0.00003479023,0.00014735284],"study_design_scores_gemma":[0.012950516,0.0015703841,0.9737092,0.010343812,0.0007311823,0.000099890516,0.00002110383,0.0000033786782,0.00044635878,0.000002273917,0.000016344447,0.00010555444],"about_ca_topic_score_codex":0.000037737133,"about_ca_topic_score_gemma":0.000023031005,"teacher_disagreement_score":0.014493492,"about_ca_system_score_codex":0.0000422069,"about_ca_system_score_gemma":0.000069606715,"threshold_uncertainty_score":0.58408684},"labels":[],"label_agreement":null},{"id":"W2574630961","doi":"10.1182/blood.v110.11.2405.2405","title":"The Identification and Characterization of Zebrafish Mast Cells.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Zebrafish; Biology; GATA1; Tryptase; Cell biology; Haematopoiesis; Morpholino; Degranulation; Progenitor cell; Gene knockdown; Mast cell; Molecular biology; Immunology; Stem cell; Cell culture; Genetics; Gene","score_opus":0.004785797443085428,"score_gpt":0.1868446962115147,"score_spread":0.18205889876842926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574630961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979311,0.00040707274,0.00025162296,0.00006461151,0.00022212235,0.000069970774,0.00001127742,0.000009962915,0.0010322572],"genre_scores_gemma":[0.9950465,0.00011807547,0.0000096779195,0.00001455719,0.00001608098,0.0000014470561,0.000054179724,0.000003613606,0.004735859],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99964964,0.000016844917,0.00016257493,0.00007299004,0.00001209185,0.00008585663],"domain_scores_gemma":[0.9997382,0.00003206532,0.000094277246,0.000099991616,0.000029924153,0.0000055337787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022317993,0.000037380873,0.00005353494,0.000021357953,0.00009923126,0.000007731041,0.000051374736,0.00005094243,0.0000516871],"category_scores_gemma":[0.0000073462165,0.000027646696,0.000013014277,0.00003980583,0.00008779589,0.000021922702,0.00001674347,0.00004135801,0.000027084045],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013131494,0.00006213186,0.00072844175,0.000008159776,0.000016865273,2.8263128e-7,0.00012409293,8.236682e-9,0.9944399,0.00082339987,0.000048943388,0.0037346142],"study_design_scores_gemma":[0.00038576327,0.00002275651,0.08360935,0.0000033915044,0.00002054693,0.000005846537,0.000038819668,3.385695e-7,0.8697411,0.000018927982,0.046122756,0.000030423067],"about_ca_topic_score_codex":0.0000082847055,"about_ca_topic_score_gemma":0.000017266846,"teacher_disagreement_score":0.12469885,"about_ca_system_score_codex":0.0000015637087,"about_ca_system_score_gemma":0.000004422238,"threshold_uncertainty_score":0.11273996},"labels":[],"label_agreement":null},{"id":"W2574647756","doi":"10.1182/blood.v110.11.4952.4952","title":"Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM) Patients over Age 70.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Melphalan; Transplantation; Internal medicine; Multiple myeloma; Surgery; Gastroenterology; Autologous stem-cell transplantation; Creatinine; Hematopoietic stem cell transplantation","score_opus":0.019790775230668228,"score_gpt":0.2708152651092209,"score_spread":0.25102448987855264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574647756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99484825,0.00013515232,0.00006282301,0.000019149855,0.00007158119,0.0007336814,0.000042799893,0.00006420327,0.0040223654],"genre_scores_gemma":[0.99838036,0.00005925115,0.00056623115,0.00006727698,0.000048038753,0.000027085109,0.0002535549,0.000026551907,0.00057165703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984316,0.00004744213,0.0003082003,0.00029969166,0.00040898967,0.0005040333],"domain_scores_gemma":[0.999292,0.00014600878,0.000056670735,0.00022752625,0.00004936289,0.00022843835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017816972,0.0001714947,0.00024981884,0.00021806278,0.000057880767,0.000013738463,0.00007805136,0.00012584857,0.00006418495],"category_scores_gemma":[0.00002695115,0.00014706657,0.00007887453,0.00021456213,0.000039627343,0.00007978783,0.000017941444,0.00018935637,0.00011092111],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076011673,0.0027009605,0.9621047,0.00016847212,0.00006361627,0.0033015728,0.00066626415,0.0000013920231,0.0053239996,0.000006127009,0.000045638208,0.024857135],"study_design_scores_gemma":[0.021457879,0.00044740125,0.9258082,0.000063897314,0.00007758503,0.000026336782,0.0000543418,0.000052048137,0.051679876,0.0000072040893,0.00020478418,0.000120454926],"about_ca_topic_score_codex":0.00025903212,"about_ca_topic_score_gemma":0.0005358853,"teacher_disagreement_score":0.046355877,"about_ca_system_score_codex":0.000079794874,"about_ca_system_score_gemma":0.000046969086,"threshold_uncertainty_score":0.59972006},"labels":[],"label_agreement":null},{"id":"W2574661935","doi":"10.1182/blood.v106.11.315.315","title":"Reversive Loss of Pulmonary Function Induced by Acute Chest Syndrome: A Report from the National Acute Chest Syndrome Study Group (NACSG).","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Vital capacity; Acute chest syndrome; Cardiology; Internal medicine; Pulmonary function testing; Lung volumes; Lung; Lung function; Sickle cell anemia; Diffusing capacity; Disease","score_opus":0.010798443887874546,"score_gpt":0.24081523731778784,"score_spread":0.2300167934299133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574661935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99408,0.0005894796,0.000017713222,0.0025778299,0.0002166616,0.0009868487,0.00013768268,0.00007248878,0.0013213097],"genre_scores_gemma":[0.9976446,0.00014796111,0.00010410625,0.0005348332,0.0001251392,0.00005949681,0.00047388766,0.000040442294,0.0008695444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99769753,0.00007792574,0.00060771755,0.0005046928,0.00080878893,0.00030333604],"domain_scores_gemma":[0.99879223,0.000096261676,0.0003319273,0.0004391245,0.0001970007,0.00014346397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038788392,0.0002748246,0.00048119167,0.00009380132,0.0001734386,0.00001882441,0.00020223182,0.00028152548,0.00016693573],"category_scores_gemma":[0.00009784686,0.00020077692,0.00017514241,0.00044934047,0.00011121084,0.0001827036,0.00010128089,0.000532028,0.00007496365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034867525,0.07124923,0.45496985,0.00039884401,0.05056156,0.060753737,0.011070026,0.000040636834,0.29019785,0.00012690765,0.046886392,0.010258212],"study_design_scores_gemma":[0.010067861,0.0022917795,0.9487725,0.00027248077,0.0062672296,0.02159977,0.0029098485,0.000050038063,0.0012993445,0.000109154455,0.005850725,0.00050925673],"about_ca_topic_score_codex":0.00023371147,"about_ca_topic_score_gemma":0.000014442116,"teacher_disagreement_score":0.49380267,"about_ca_system_score_codex":0.0000957679,"about_ca_system_score_gemma":0.00017129559,"threshold_uncertainty_score":0.81874454},"labels":[],"label_agreement":null},{"id":"W2574683350","doi":"10.1182/blood.v116.21.2346.2346","title":"Anti-GvHD Effect of Antithymocyte Globulin Is Mediated by Antibodies Binding to T Cells and Regulatory NK Cells, and Less So or Not at All by Antibodies Binding to Other Mononuclear Cell Subsets","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Immunology; Antibody; Polyclonal antibodies; Flow cytometry; Graft-versus-host disease; Peripheral blood mononuclear cell; Pathogenesis; Biology; Cytotoxic T cell; T cell; Immune system; Stem cell; Cell biology; In vitro","score_opus":0.006812360158115075,"score_gpt":0.21971376986208307,"score_spread":0.212901409703968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574683350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98683125,0.010610286,0.000005307358,0.000114329814,0.00062864256,0.00059140363,0.00094863353,0.00008854826,0.00018161921],"genre_scores_gemma":[0.99669176,0.0010656721,0.00006149059,0.00031278515,0.0000062061226,0.000009518567,0.0001109561,0.00007317269,0.0016684639],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997646,0.0001941376,0.00053163245,0.0007311872,0.00011110862,0.0007859445],"domain_scores_gemma":[0.99888057,0.00029127486,0.00024869782,0.0004709569,0.000053422977,0.00005508015],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005595125,0.0005154099,0.0008594496,0.00026877038,0.0005351444,0.00007091732,0.0003838402,0.00048327306,0.0002776208],"category_scores_gemma":[0.000054848155,0.0004292143,0.000109526896,0.00026020873,0.0005589469,0.00014859959,0.00037827235,0.00039292852,0.00027003168],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003921815,0.00030205015,0.0073297773,0.00020850243,0.00022139256,0.000007870072,0.0022480367,0.00000220028,0.9845293,0.0000030498202,0.0038602496,0.0008953585],"study_design_scores_gemma":[0.003222255,0.00050706015,0.0035108074,0.00008329004,0.00018061388,0.000021707718,0.0004387982,0.0000041139597,0.9717501,6.65957e-7,0.019741626,0.00053899863],"about_ca_topic_score_codex":0.0003190718,"about_ca_topic_score_gemma":0.000022521654,"teacher_disagreement_score":0.015881376,"about_ca_system_score_codex":0.00001573102,"about_ca_system_score_gemma":0.000036419282,"threshold_uncertainty_score":0.99981594},"labels":[],"label_agreement":null},{"id":"W2574756832","doi":"10.1182/blood.v104.11.1845.1845","title":"Argatroban Inhibits Human Factor Xa at Therapeutic Drug Levels: An Explanation for Its Prolongation of the INR.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; McMaster University","funders":"","keywords":"Lepirudin; Argatroban; Discovery and development of direct thrombin inhibitors; Bivalirudin; Prothrombinase; Pharmacology; Partial thromboplastin time; Thrombin; Medicine; Direct thrombin inhibitor; Antithrombin; Chemistry; Heparin; Platelet; Internal medicine; Warfarin; Dabigatran","score_opus":0.08220899549551088,"score_gpt":0.32355562420656686,"score_spread":0.241346628711056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574756832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973018,0.000060891874,0.000035052093,0.0007957983,0.00009649014,0.0012324725,0.000038648,0.000049462917,0.00038937043],"genre_scores_gemma":[0.9992051,0.000004066772,0.00016184992,0.00019248447,0.00012281405,0.0000726359,0.0000545578,0.000029880157,0.00015661948],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989667,0.000050361294,0.00029410186,0.00024330184,0.00023972704,0.00020584205],"domain_scores_gemma":[0.99926054,0.000029640489,0.00016519515,0.00032016297,0.00014540835,0.00007906132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015385936,0.00014896676,0.00026717957,0.00006861259,0.00019573024,0.000013964724,0.00013029738,0.00010460453,0.00004210063],"category_scores_gemma":[0.00005293158,0.00010641562,0.000105040686,0.00016002348,0.00004306418,0.00016046807,0.00003778475,0.00011734212,0.000011459064],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003422627,0.00075813476,0.016000776,0.0001132023,0.00013508205,7.0541967e-7,0.0025617643,0.0000054862658,0.9771357,0.0027881297,0.000007817832,0.00045894543],"study_design_scores_gemma":[0.00363197,0.0003015315,0.251692,0.000084631756,0.00019712234,0.000010057662,0.0000859166,0.0000068221307,0.74297523,0.0008270509,0.00009154324,0.00009613409],"about_ca_topic_score_codex":0.000033561853,"about_ca_topic_score_gemma":0.0003074717,"teacher_disagreement_score":0.23569122,"about_ca_system_score_codex":0.00009709946,"about_ca_system_score_gemma":0.000117952004,"threshold_uncertainty_score":0.4339503},"labels":[],"label_agreement":null},{"id":"W2574761789","doi":"10.1182/blood.v112.11.1711.1711","title":"A Novel Non-Competitive Chemical Proteasome Inhibitor Displays Preclinical Activity in Myeloma and Leukemia.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Proteasome; MG132; Proteasome inhibitor; Biochemistry; Enzyme; Chemistry; Mechanism of action; Proteolysis; Bortezomib; Biology; Molecular biology; Multiple myeloma; In vitro; Immunology","score_opus":0.017281812865349213,"score_gpt":0.25041031657938256,"score_spread":0.23312850371403335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574761789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99684256,0.00013890893,0.00009674915,0.000056042103,0.000036572135,0.0004501896,0.00014294041,0.000014360422,0.00222167],"genre_scores_gemma":[0.99756503,0.000059514874,0.0014651285,0.00008829104,0.00035876993,0.0001773208,0.00007067788,0.000022933778,0.00019232726],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988582,0.00004238172,0.0001984563,0.00048187305,0.0001264884,0.00029259495],"domain_scores_gemma":[0.999481,0.00004217931,0.00006874744,0.00023937508,0.000035549056,0.00013310337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013879764,0.0001887957,0.00023308984,0.00003388083,0.000060678583,0.000012293329,0.00012934793,0.00026913648,0.000029642015],"category_scores_gemma":[0.00020833123,0.0001830971,0.000073115356,0.000084553736,0.00018956604,0.000007250434,0.0001953457,0.00024670895,0.0000108814065],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015700932,0.0005117341,0.007011205,0.0000309114,0.000026543925,0.00002437402,0.00009590639,3.7764622e-7,0.99149853,0.00002991237,0.00012338368,0.0004901089],"study_design_scores_gemma":[0.0027517031,0.0002906918,0.044638008,0.000054233675,0.000012402634,0.00020514661,0.00001642351,0.000029164885,0.9503768,0.00001794071,0.0013565491,0.00025091734],"about_ca_topic_score_codex":0.00002501169,"about_ca_topic_score_gemma":0.000021991727,"teacher_disagreement_score":0.041121714,"about_ca_system_score_codex":0.000018671695,"about_ca_system_score_gemma":0.00019168381,"threshold_uncertainty_score":0.7466483},"labels":[],"label_agreement":null},{"id":"W2574817830","doi":"10.1182/blood.v106.11.4556.4556","title":"Epidemiology of Fungal Infections in Hematological Malignancies in Italy: SEIFEM-2004 Study (Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne).","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Fungal Infections and Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Incidence (geometry); Medicine; Internal medicine; Epidemiology; Fusariosis; Mucormycosis; Population; Mucorales; Aspergillosis; Gastroenterology; Surgery; Fusarium; Immunology; Biology","score_opus":0.048580727332679104,"score_gpt":0.32320254006070626,"score_spread":0.27462181272802716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574817830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907314,0.0043529985,0.00008795761,0.0014513766,0.00012929396,0.0009279209,0.00001638998,0.00010335337,0.0021993031],"genre_scores_gemma":[0.99753666,0.00031885927,0.0010423383,0.00039765437,0.00013767983,0.00022830961,0.00001251367,0.00001941349,0.00030659937],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967176,0.00053147256,0.0014509376,0.0005312287,0.00014728139,0.0006214954],"domain_scores_gemma":[0.99765754,0.0013968076,0.00026176294,0.00042276792,0.00013381841,0.0001273147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015903102,0.00033324267,0.0015244848,0.00048304108,0.000117271826,0.0000029106116,0.00011555037,0.0002763549,0.00016189959],"category_scores_gemma":[0.0035014336,0.00023434019,0.00021956138,0.0008540588,0.00022019564,0.00011051048,0.00015286237,0.00050991017,0.00005224761],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079691206,0.0078586675,0.98860925,0.00007907194,0.00013093921,0.00010961666,0.00039984946,0.0009483183,0.00028934103,0.0008820861,0.0003689503,0.0002442301],"study_design_scores_gemma":[0.0045356033,0.002798342,0.9890371,0.00016811812,0.00015257522,0.00037295642,0.0008851037,0.000242825,0.0004665059,0.00056449696,0.0005130222,0.0002633531],"about_ca_topic_score_codex":0.0005215998,"about_ca_topic_score_gemma":0.0012488365,"teacher_disagreement_score":0.006805226,"about_ca_system_score_codex":0.000101192825,"about_ca_system_score_gemma":0.000085387626,"threshold_uncertainty_score":0.9556116},"labels":[],"label_agreement":null},{"id":"W2574824340","doi":"10.1182/blood.v126.23.4137.4137","title":"Highly Restricted Usage of Immunoglobulin Light Chain IGKV3-20 with Stereotyped Sequence in Primary Cold-Agglutinin Disease (CAD)","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Immunology; Antibody; Immunoglobulin light chain; Bone marrow; Biology; Cold agglutinin disease; Immunoglobulin gene; Immunoglobulin M; Autoimmune hemolytic anemia; Immunoglobulin G; Medicine","score_opus":0.018907187118171246,"score_gpt":0.23369559119664313,"score_spread":0.21478840407847188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574824340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99364454,0.0018846688,0.000028200426,0.0009292487,0.000062434236,0.0006888177,0.000059236827,0.0000709344,0.0026319125],"genre_scores_gemma":[0.99796,0.00010896592,0.0010677078,0.00021861088,0.00007668754,0.00003150807,0.0000855531,0.000034299454,0.00041670253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983574,0.00009171018,0.00041635116,0.00035086647,0.0004701466,0.00031351286],"domain_scores_gemma":[0.99885267,0.000044404384,0.00012856221,0.00048841594,0.00014032278,0.000345643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023589686,0.00021222807,0.0004486106,0.00016776388,0.000028586295,0.000010403968,0.00015200392,0.00011094123,0.000015593985],"category_scores_gemma":[0.00006396027,0.00016394649,0.00006119472,0.0006255661,0.00008498945,0.00010181739,0.000048600155,0.0002573786,0.000014209099],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00933637,0.008643827,0.62733376,0.0010335896,0.00037659967,0.003930965,0.0015836495,0.000024753948,0.34462744,0.0008083959,0.000430198,0.0018704538],"study_design_scores_gemma":[0.037782032,0.0028777516,0.91024524,0.0013891571,0.0008731475,0.000112339476,0.00014217156,0.000081340666,0.04348967,0.0000952616,0.002422186,0.00048971764],"about_ca_topic_score_codex":0.00024098238,"about_ca_topic_score_gemma":0.00006800931,"teacher_disagreement_score":0.30113778,"about_ca_system_score_codex":0.000051177012,"about_ca_system_score_gemma":0.00053702143,"threshold_uncertainty_score":0.66855437},"labels":[],"label_agreement":null},{"id":"W2574858943","doi":"10.1182/blood.v112.11.1291.1291","title":"Cost-Effectiveness of Rivaroxaban as VTE Prophylaxis after Total Hip Replacement in Canada.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bayer (Canada); Ottawa Hospital","funders":"","keywords":"Rivaroxaban; Medicine; Enoxaparin sodium; Pulmonary embolism; Regimen; Thrombosis; Placebo; Knee replacement; Surgery; Deep vein; Anesthesia; Internal medicine; Low molecular weight heparin; Arthroplasty; Warfarin; Atrial fibrillation","score_opus":0.018641613250740367,"score_gpt":0.25303085659997515,"score_spread":0.23438924334923478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574858943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950412,0.0003094382,0.000004857267,0.00009091511,0.00014820955,0.0014655074,0.000009929091,0.00001362832,0.0029163489],"genre_scores_gemma":[0.9990268,0.00009606423,0.000071109935,0.00015978477,0.000051763058,0.00039108476,0.000010815087,0.000018594143,0.00017403401],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998788,0.00007453266,0.0002641868,0.00026388693,0.00034725165,0.0002621666],"domain_scores_gemma":[0.9993904,0.000054185424,0.00006361711,0.0003307481,0.00005754749,0.00010348918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020153288,0.00013900301,0.00043632425,0.00009249535,0.000027998594,0.0000029430068,0.00006238401,0.00004118969,0.00016968063],"category_scores_gemma":[0.00005806102,0.00012397575,0.000056332014,0.00018165835,0.00003822258,0.000034485733,0.00006556034,0.00011073879,0.000015478558],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010418122,0.005590374,0.98174787,0.0013790287,0.0004869945,0.002165257,0.0009272376,0.00006218097,0.0036411805,0.00018409341,0.0012362939,0.001537662],"study_design_scores_gemma":[0.0039939308,0.00090795953,0.9613751,0.00030636726,0.00011327644,0.000084723666,0.00011164574,0.0000047045864,0.03217218,0.000016748112,0.0007790833,0.00013425671],"about_ca_topic_score_codex":0.38716152,"about_ca_topic_score_gemma":0.11156105,"teacher_disagreement_score":0.27560046,"about_ca_system_score_codex":0.0002545507,"about_ca_system_score_gemma":0.0006369403,"threshold_uncertainty_score":0.9046506},"labels":[],"label_agreement":null},{"id":"W2574859067","doi":"10.1182/blood.v124.21.1995.1995","title":"Non-Inferior Pharmacokinetics with Comparable Safety and Response Rates for Subcutaneous (SC), Compared with Intravenous (IV), Rituximab in Combination with Fludarabine and Cyclophosphamide (FC) in Patients (Pts) with Untreated Chronic Lymphocytic Leukemia (CLL): Part 2 of the Phase Ib SAWYER Study (BO25341)","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Rituximab; Medicine; Fludarabine; Internal medicine; Cyclophosphamide; Gastroenterology; Chronic lymphocytic leukemia; CD20; Pharmacokinetics; Pharmacology; Urology; Chemotherapy; Leukemia; Lymphoma","score_opus":0.00815180799116277,"score_gpt":0.2675118212815842,"score_spread":0.2593600132904214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574859067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939822,0.00024058181,0.00006612032,0.000060194558,0.000023037303,0.005481594,0.000050905,0.00003914947,0.000056193738],"genre_scores_gemma":[0.9990758,0.00007857869,0.00027406367,0.000055915734,0.000025119674,0.00022067266,0.000089100075,0.00009254273,0.00008821423],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99684197,0.00029426176,0.00069320237,0.00071692775,0.00074243377,0.00071120705],"domain_scores_gemma":[0.9978444,0.0005751878,0.0003247324,0.00063725846,0.0004141767,0.00020421893],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00070565747,0.0005106233,0.0011666158,0.00027364132,0.00017290097,0.000054028085,0.00021837883,0.00010835295,0.000011156651],"category_scores_gemma":[0.00009182057,0.00030679937,0.000030279944,0.00088840484,0.0005984252,0.00012702907,0.00009035113,0.00032809246,0.0000016191613],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.57593197,0.018866744,0.3839584,0.0014490596,0.0011506068,0.000852093,0.004679786,0.008979084,0.0016685874,0.000015734491,0.00004879132,0.0023991305],"study_design_scores_gemma":[0.71646506,0.05332583,0.14057294,0.0015124344,0.000950502,0.0006947688,0.00042043335,0.07728595,0.008107371,0.000005566411,0.00013314215,0.00052604167],"about_ca_topic_score_codex":0.001575448,"about_ca_topic_score_gemma":0.003371545,"teacher_disagreement_score":0.24338546,"about_ca_system_score_codex":0.008023329,"about_ca_system_score_gemma":0.0069783772,"threshold_uncertainty_score":0.9999384},"labels":[],"label_agreement":null},{"id":"W2574885367","doi":"10.1182/blood-2016-09-742957","title":"Near-triploid B lymphoblastic leukemia with Burkitt-like morphology","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; Ottawa Hospital","funders":"","keywords":"Pancytopenia; Bone marrow; Lymphoblastic Leukemia; Platelet; Biopsy; Pathology; Leukemia; Medicine; Hemoglobin; Immunology; Biology; Internal medicine","score_opus":0.017765884112402573,"score_gpt":0.2805400125723233,"score_spread":0.2627741284599207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574885367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98520404,0.0003110714,0.00006939232,0.00035442773,0.00017784847,0.00044941207,0.0000073683104,0.00012595364,0.013300492],"genre_scores_gemma":[0.9913438,0.00006654842,0.0015063949,0.00034350454,0.00036315303,0.000055032546,0.000015846941,0.000071568684,0.006234129],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.997788,0.00003832489,0.00026186928,0.00055145216,0.000618122,0.0007422095],"domain_scores_gemma":[0.9973421,0.00012490556,0.0001558846,0.0018177271,0.00017075943,0.0003886142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002403755,0.000262274,0.00047284146,0.00008801147,0.0005079826,0.00016237819,0.0005306664,0.00020686726,0.0003087809],"category_scores_gemma":[0.00042790108,0.00019868405,0.00009781454,0.00011275571,0.00076880824,0.00013592506,0.00028110557,0.0003116959,0.00077453366],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023476433,0.016702507,0.38481638,0.005787447,0.011247021,0.16788761,0.0054847077,0.00082002865,0.2513079,0.0047014146,0.07605553,0.051713012],"study_design_scores_gemma":[0.5643373,0.006169572,0.21886636,0.0014201376,0.0030390602,0.048124623,0.0003114117,0.013151555,0.085049756,0.00045245473,0.056971975,0.002105798],"about_ca_topic_score_codex":0.0014115556,"about_ca_topic_score_gemma":0.00007329578,"teacher_disagreement_score":0.5408609,"about_ca_system_score_codex":0.0037400988,"about_ca_system_score_gemma":0.011365648,"threshold_uncertainty_score":0.99553216},"labels":[],"label_agreement":null},{"id":"W2574894363","doi":"10.1182/blood.v110.11.2211.2211","title":"Oral Treatment with PBI-1402 Increases Hemoglobin Level and Red Blood Cell Count: A Novel Approach to Treating Chemotherapy-Induced Anemia.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Tolerability; Medicine; Anemia; Hemoglobin; Chemotherapy; Internal medicine; Gastroenterology; Placebo; Reticulocyte; Red blood cell; Clinical trial; Erythropoiesis; Adverse effect; Pharmacology; Pathology; Chemistry","score_opus":0.029946328214814646,"score_gpt":0.2596094495179228,"score_spread":0.22966312130310818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574894363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836383,0.00037643043,0.00013079829,0.00039336502,0.000017276898,0.0010916226,0.00004671578,0.0001409077,0.014164596],"genre_scores_gemma":[0.94134593,0.00009430303,0.055777576,0.00048417322,0.00018677587,0.00007611963,0.000086806525,0.000077745666,0.0018705511],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99800926,0.000017613154,0.00035295545,0.00067147624,0.00036307483,0.0005856186],"domain_scores_gemma":[0.99878585,0.000083670355,0.000121184006,0.00044594918,0.00008793601,0.00047541977],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020386421,0.0004839709,0.0006132111,0.00013989497,0.00016612801,0.000043244512,0.000081210645,0.00016588818,0.000031634063],"category_scores_gemma":[0.000019226462,0.00033962994,0.00009484183,0.00031566428,0.00007244631,0.000056871464,0.00003292495,0.00013962178,0.000009284557],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027785865,0.060282808,0.21317652,0.00050918,0.0017185038,0.0010418369,0.0047064205,0.0000044604567,0.69748455,0.00011596776,0.00036324916,0.017817926],"study_design_scores_gemma":[0.088151254,0.012700323,0.051437266,0.0004193586,0.0033637104,0.0031298334,0.002300027,0.000037194146,0.8362163,0.000006007979,0.0013166846,0.00092208356],"about_ca_topic_score_codex":0.0012501165,"about_ca_topic_score_gemma":0.0001225249,"teacher_disagreement_score":0.16173926,"about_ca_system_score_codex":0.0001460513,"about_ca_system_score_gemma":0.00015726742,"threshold_uncertainty_score":0.9999056},"labels":[],"label_agreement":null},{"id":"W2574913381","doi":"10.1182/blood.v116.21.3910.3910","title":"Human Metapneumovirus Infection In Children with Cancer","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Respiratory viral infections research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Human metapneumovirus; Medicine; Bronchiolitis; Pediatrics; Pneumonitis; Pneumonia; Metapneumovirus; Cancer; Internal medicine; Respiratory tract infections; Respiratory system; Lung","score_opus":0.02729614088743943,"score_gpt":0.35577935657268583,"score_spread":0.3284832156852464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574913381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954912,0.000043553973,0.000002811812,0.00006167736,0.000040427865,0.00037689606,0.0000022818285,0.000060104598,0.003921043],"genre_scores_gemma":[0.99912673,0.000014363177,0.0000571124,0.000098000244,0.0001866624,0.00012499384,0.0000040142727,0.000019458817,0.00036864178],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992869,0.000029125846,0.00012382837,0.0001843204,0.00018968392,0.00018614398],"domain_scores_gemma":[0.99957377,0.0000062984464,0.000028680182,0.00024731184,0.000060758775,0.00008317367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015342317,0.00008759742,0.00014036904,0.00024692583,0.000069804766,0.000021052829,0.00004178951,0.000076088305,0.0004467393],"category_scores_gemma":[0.000036245936,0.00006644187,0.00003076814,0.0003850512,0.0000666967,0.000095024756,0.000020467563,0.0005301421,0.000052776377],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008747773,0.00038282937,0.836755,0.0000070054766,0.0000732162,0.000008140425,0.000011481546,0.0000034107754,0.16177045,0.00008435149,0.000031803647,0.0008635693],"study_design_scores_gemma":[0.0021257098,0.0003052211,0.93415374,0.000014029482,0.00007136637,0.00009468534,0.0000011295962,0.0000027983344,0.062479857,0.000014999295,0.00066372805,0.000072722265],"about_ca_topic_score_codex":0.0042484864,"about_ca_topic_score_gemma":0.0069897505,"teacher_disagreement_score":0.099290594,"about_ca_system_score_codex":0.000022684664,"about_ca_system_score_gemma":0.00008690177,"threshold_uncertainty_score":0.6422469},"labels":[],"label_agreement":null},{"id":"W2574956176","doi":"10.1182/blood.v112.11.1821.1821","title":"The Relationship Between D-Dimer Level, Venous Valvular Reflux and Development of the Post-Thrombotic Syndrome after Deep Venous Thrombosis.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Post-thrombotic syndrome; Reflux; D-dimer; Venous thrombosis; Warfarin; Internal medicine; Thrombosis; Logistic regression; Thrombus; Deep vein; Gastroenterology; Surgery; Cardiology; Disease; Atrial fibrillation","score_opus":0.05887664971809918,"score_gpt":0.2717203033046121,"score_spread":0.21284365358651292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574956176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949227,0.0029060738,0.000041430183,0.00077889,0.00014212128,0.0008038751,0.000009278684,0.000040174822,0.00035543815],"genre_scores_gemma":[0.9977672,0.00018395716,0.0013581892,0.00031777102,0.00006875105,0.00009394127,0.000014639917,0.00004410564,0.00015143394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981509,0.00010021291,0.0005221487,0.00032087788,0.0005059913,0.00039988017],"domain_scores_gemma":[0.9986265,0.00030400432,0.0001803625,0.0006490245,0.000115599556,0.00012456284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039015518,0.00023577515,0.00056494493,0.0000773522,0.00081520894,0.000021848804,0.0002285501,0.000121997175,0.000033142514],"category_scores_gemma":[0.00017894893,0.00014690805,0.00012143412,0.00023293169,0.00031362858,0.00007022187,0.00021240211,0.0002666844,0.000054094886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002525552,0.0029342587,0.9836248,0.0003004108,0.0013717351,0.0001062596,0.008762947,0.000005445886,0.00045825366,0.00039656006,0.00025595518,0.001758121],"study_design_scores_gemma":[0.0010643654,0.00044941634,0.99484706,0.00017453983,0.00078860164,0.00017235408,0.00021021851,8.1376174e-7,0.0008066278,0.00014258079,0.0011738518,0.00016956078],"about_ca_topic_score_codex":0.00005433656,"about_ca_topic_score_gemma":0.00005365018,"teacher_disagreement_score":0.011222272,"about_ca_system_score_codex":0.000056411824,"about_ca_system_score_gemma":0.00020903704,"threshold_uncertainty_score":0.62700105},"labels":[],"label_agreement":null},{"id":"W2574969036","doi":"10.1182/blood.v110.11.2930.2930","title":"Synergistic Activity of the Novel Src/Abl Inhibitor Bosutinib in Combination with Imatinib.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Bosutinib; Imatinib; Imatinib mesylate; ABL; Dasatinib; Pharmacology; Cancer research; Myeloid leukemia; Chemistry; Nilotinib; Tyrosine kinase; Medicine; Receptor; Biochemistry","score_opus":0.013128247588446251,"score_gpt":0.2557750856804566,"score_spread":0.24264683809201035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574969036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99488914,0.00003480801,0.00022867961,0.00016275434,0.000070982176,0.0004639839,0.0000073751744,0.00002164932,0.004120615],"genre_scores_gemma":[0.9987589,0.0000021575156,0.00086982816,0.000039314615,0.00004759103,0.000011124269,0.000006376324,0.000016369659,0.00024830556],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990947,0.00002013581,0.00021178502,0.00016911293,0.00030229328,0.00020194624],"domain_scores_gemma":[0.9992902,0.00013759114,0.00014428058,0.00031968887,0.00005782719,0.00005038723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025512188,0.00011578983,0.00021647516,0.00007109249,0.00003093436,0.000003978729,0.000070490234,0.00006871966,0.000021000587],"category_scores_gemma":[0.00017216719,0.00007423983,0.000043097756,0.00030297608,0.00007932017,0.00004427469,0.000035342375,0.00016287538,0.0000048193106],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009487321,0.014241641,0.38338464,0.00049266877,0.00034499672,0.00013538968,0.0011093363,0.000022753153,0.5904325,0.0015972899,0.00008927841,0.0072007594],"study_design_scores_gemma":[0.018420957,0.00038379416,0.59787214,0.00033662678,0.00018758059,0.000047828085,0.000053035506,0.00010413736,0.38241374,0.000025905434,0.0000695591,0.00008467746],"about_ca_topic_score_codex":0.00022044152,"about_ca_topic_score_gemma":0.0002223864,"teacher_disagreement_score":0.2144875,"about_ca_system_score_codex":0.00023140616,"about_ca_system_score_gemma":0.00024400496,"threshold_uncertainty_score":0.30274123},"labels":[],"label_agreement":null},{"id":"W2575001609","doi":"10.1182/blood.v126.23.3976.3976","title":"A Phase 1 Study of the Anti-CD37 Antibody-Drug Conjugate AGS67E in Advanced Lymphoid Malignancies. Interim Results","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Neutropenia; Lymphoma; Internal medicine; Gastroenterology; Follicular lymphoma; Mycosis fungoides; Antibody-drug conjugate; Mantle cell lymphoma; Alemtuzumab; Oncology; Immunology; Antibody; Toxicity; Transplantation; Monoclonal antibody","score_opus":0.04012392533851929,"score_gpt":0.360985348569889,"score_spread":0.32086142323136974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2575001609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99519134,0.00050911,0.0000020685213,0.00021043951,0.00021217593,0.001446691,0.000035126403,0.000043499716,0.0023495825],"genre_scores_gemma":[0.9986942,0.000052009662,0.000078075784,0.000106121086,0.00007793958,0.00004096098,0.000017595887,0.000035473142,0.0008976582],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9973559,0.00019493072,0.00069898716,0.00046015566,0.0008090045,0.00048104583],"domain_scores_gemma":[0.99812716,0.00012131016,0.00020108897,0.0010700305,0.00026644563,0.00021398053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091738877,0.00021970719,0.0005663237,0.00016297036,0.00004089805,0.000018205237,0.0004200771,0.00007464981,0.000012074554],"category_scores_gemma":[0.0009926211,0.00015067558,0.00009517041,0.0006791831,0.00019231265,0.000105924824,0.0003482438,0.00022565895,0.000029293717],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023401702,0.16311887,0.07890069,0.0014288169,0.0014354876,0.007765515,0.07148022,0.0003720415,0.63743466,0.00017456629,0.0056290687,0.0088583715],"study_design_scores_gemma":[0.7582542,0.004075382,0.0066957246,0.0010829342,0.0002704085,0.0007486169,0.009036506,0.0015178791,0.21609885,0.000045816098,0.0018155636,0.00035816155],"about_ca_topic_score_codex":0.0016602776,"about_ca_topic_score_gemma":0.00024512064,"teacher_disagreement_score":0.7348525,"about_ca_system_score_codex":0.0016288786,"about_ca_system_score_gemma":0.004441035,"threshold_uncertainty_score":0.7878205},"labels":[],"label_agreement":null},{"id":"W2575002851","doi":"10.1182/blood.v104.11.213.213","title":"Identification of Oncogenic Collaborators Providing Insights into the Tumor Suppressing Function of the Eed Polycomb Group (PcG) Gene.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Institute for Research in Immunology and Cancer","funders":"","keywords":"Biology; Insertional mutagenesis; Carcinogenesis; Polycomb-group proteins; Gene; Cancer research; Mutant; Myeloid; Molecular biology; Genetics; Gene expression; Repressor","score_opus":0.0045058621389893715,"score_gpt":0.20404523955982104,"score_spread":0.19953937742083167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2575002851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99625397,0.0026909772,0.00041916853,0.00007684441,0.0002734764,0.00022937117,0.00001311087,0.0000033066874,0.00003975651],"genre_scores_gemma":[0.99945444,0.00015692011,0.00010984138,0.00008318819,0.00013142335,0.000017670924,0.000019866935,0.000012658094,0.000014005402],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999351,0.00003262938,0.00025188515,0.00016418064,0.000110450484,0.00008984196],"domain_scores_gemma":[0.9992576,0.000013586274,0.00023589599,0.0003623423,0.00010847208,0.000022067157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001074012,0.00008178278,0.00008834725,0.000022424272,0.00011351239,0.000020508927,0.00019181236,0.00005527503,0.0000010186806],"category_scores_gemma":[0.00009273088,0.00005583359,0.000070621885,0.00017547548,0.00008601242,0.000003956045,0.00009102201,0.000044666805,6.3090357e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031032607,0.00012065192,0.0012534688,0.000018242126,0.000050408395,2.6014447e-7,0.00026109186,0.000253617,0.9974146,0.00036515857,0.000025956258,0.00020555161],"study_design_scores_gemma":[0.00073867285,0.000119534816,0.0057282215,0.000017433642,0.0001059296,0.0000023117188,0.0001619574,0.000011965445,0.99153215,0.00049251365,0.0010214641,0.000067846035],"about_ca_topic_score_codex":0.000082991224,"about_ca_topic_score_gemma":0.00016794057,"teacher_disagreement_score":0.0058824117,"about_ca_system_score_codex":0.00001726816,"about_ca_system_score_gemma":0.00018243367,"threshold_uncertainty_score":0.22768277},"labels":[],"label_agreement":null},{"id":"W2575032537","doi":"10.1182/blood.v112.11.387.387","title":"Epithelial Cells of Donor Origin after Allogeneic HCT: Result of Cell Fusion, Transdifferentiation (plasticity) or Transfer of Epithelial Cell Precursors with the Graft?","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Proteoglycans and glycosaminoglycans research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Biology; Transplantation; Stem cell; Transdifferentiation; Pathology; Microchimerism; Immunology; Molecular biology; Cell biology; Medicine; Fetus; Genetics; Internal medicine","score_opus":0.010400282275800225,"score_gpt":0.21495541237401034,"score_spread":0.2045551300982101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2575032537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944082,0.00025831928,0.00378737,0.000033911183,0.00004262581,0.0005904696,0.00068594975,0.000004948297,0.00018823303],"genre_scores_gemma":[0.99799395,0.000582693,0.00049777894,0.00001601543,0.000089114495,0.00006477724,0.000044924243,0.00003199203,0.0006787587],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983248,0.00016464459,0.000445417,0.00035872974,0.00038779955,0.00031859372],"domain_scores_gemma":[0.9991108,0.000052458458,0.0001291694,0.00038034614,0.00024071206,0.00008651378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018058332,0.0002349775,0.00032678727,0.00009631553,0.00006547033,0.000005725299,0.00035582675,0.00019252981,0.00007912088],"category_scores_gemma":[0.0000148685285,0.00014206592,0.00017197772,0.00023018403,0.00035085136,0.000006631976,0.000040807412,0.00014330498,0.0000018576362],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036288677,0.0011512619,0.0009973729,0.00022083928,0.00009697549,0.000011177423,0.00050973333,0.000092081886,0.9931066,0.000005069074,0.00003635912,0.00014368536],"study_design_scores_gemma":[0.0039172047,0.0022245634,0.0035583803,0.000028652654,0.00016082877,0.000010554123,0.000053723445,0.000016325717,0.9888111,0.0000044294584,0.0010331002,0.00018118379],"about_ca_topic_score_codex":0.00014532047,"about_ca_topic_score_gemma":0.000329539,"teacher_disagreement_score":0.004295523,"about_ca_system_score_codex":0.0000052492746,"about_ca_system_score_gemma":0.00026891072,"threshold_uncertainty_score":0.57932806},"labels":[],"label_agreement":null},{"id":"W2575033743","doi":"10.1182/blood.v116.21.1508.1508","title":"Population Based Study on the Utilization and Cost of Azacitidine In a Canadian Province.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Medicine; Population; Azacitidine; Pharmacy; Regimen; Pediatrics; Emergency medicine; Internal medicine; Family medicine; Environmental health","score_opus":0.03449646704828803,"score_gpt":0.3072835384810917,"score_spread":0.2727870714328037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2575033743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99671876,0.0000074034874,0.000002367346,0.001162661,0.000014725582,0.0011593495,0.000009061707,0.000006431934,0.00091923424],"genre_scores_gemma":[0.9996752,0.0000011782126,0.00003931671,0.00013704321,0.000026248454,0.00003127537,0.000026010464,0.00000825698,0.00005543336],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994472,0.00004381711,0.000109281136,0.0001082369,0.00015691516,0.00013449382],"domain_scores_gemma":[0.9995815,0.00007080767,0.000025089998,0.00018587921,0.000045977325,0.0000907455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036246917,0.00005063642,0.00009476058,0.00015992137,0.00003353395,0.0000068800246,0.00004356087,0.00004238235,0.000048518268],"category_scores_gemma":[0.00037390942,0.000034603894,0.000008995761,0.00017672121,0.000020127109,0.000021547683,0.0000090461945,0.00019177704,0.0000024076667],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038997063,0.00031290334,0.9942908,0.000015477655,0.0000083811765,0.000019628022,0.00011923546,0.0000013391901,0.0035717443,0.000326183,0.000037302456,0.0012579832],"study_design_scores_gemma":[0.0024412416,0.00026301542,0.9923225,0.000023344386,0.000022239303,0.0000036602762,0.00013635396,0.0012611961,0.0032442238,0.000013141353,0.00023687555,0.000032229134],"about_ca_topic_score_codex":0.12949131,"about_ca_topic_score_gemma":0.5718389,"teacher_disagreement_score":0.44234762,"about_ca_system_score_codex":0.00005994911,"about_ca_system_score_gemma":0.00044935994,"threshold_uncertainty_score":0.87630546},"labels":[],"label_agreement":null},{"id":"W2575041000","doi":"10.1182/blood.v126.23.1102.1102","title":"Molecular Basis of Von Willebrand Disease in Patients from India","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Von Willebrand disease; Von Willebrand factor; Medicine; Population; Haplotype; Internal medicine; Genetics; Immunology; Gastroenterology; Biology; Genotype; Gene; Platelet","score_opus":0.006997092863765449,"score_gpt":0.21660188285534432,"score_spread":0.20960478999157886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2575041000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983291,0.00051760644,0.0000012362411,0.00004605686,0.000025733365,0.00017065665,0.000056480647,0.0000073615993,0.00084575906],"genre_scores_gemma":[0.999625,0.000010760647,0.00009427749,0.00008197713,0.0000065168592,0.000006554995,0.00015236557,0.000008570898,0.000013925128],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99951607,0.000013787557,0.00010935201,0.00011150894,0.0001589372,0.0000903715],"domain_scores_gemma":[0.9996485,0.000007757794,0.00003151058,0.0001368018,0.000029360064,0.00014607911],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000020489144,0.00006653831,0.00016973482,0.000051780822,0.0000048570237,0.0000022753786,0.000028727849,0.00003099072,0.000018110546],"category_scores_gemma":[0.000053669657,0.000055546265,0.000034302946,0.000080224454,0.000013602506,0.000027776476,0.000015027495,0.00003379371,0.000013332172],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020005609,0.0021072673,0.9963392,0.000010160102,0.00008183893,0.00033832525,0.00012586181,0.000001601727,0.000073662115,0.000004591956,0.000054699834,0.00066272955],"study_design_scores_gemma":[0.017017465,0.00019372927,0.9782997,0.000056063527,0.0002078132,4.0912798e-7,0.000016111015,0.000009009471,0.0037722036,0.0003183199,0.000054529915,0.00005465817],"about_ca_topic_score_codex":0.000146238,"about_ca_topic_score_gemma":0.00000544793,"teacher_disagreement_score":0.018039517,"about_ca_system_score_codex":0.00001014964,"about_ca_system_score_gemma":0.00004383322,"threshold_uncertainty_score":0.22651109},"labels":[],"label_agreement":null},{"id":"W2575159787","doi":"10.1182/blood.v106.11.817.817","title":"Relapse Patterns and Subsequent Outcomes of Patients Treated on the NCIC CTG HD.6 (ECOG JHD06) Randomized Trial Evaluating ABVD Alone in Patients with Limited Stage Hodgkin Lymphoma (HL).","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Princess Margaret Cancer Centre; McMaster University; BC Cancer Agency; Ontario Institute for Cancer Research","funders":"","keywords":"ABVD; Medicine; Randomized controlled trial; Internal medicine; Stage (stratigraphy); Radiation therapy; Chemotherapy regimen; Rituximab; Randomization; Chemotherapy; Surgery; Oncology; Lymphoma; Vincristine","score_opus":0.01926074541019198,"score_gpt":0.26442736224135854,"score_spread":0.24516661683116656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2575159787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950038,0.00009903021,6.368613e-7,0.00032513216,0.000066544315,0.0042077117,0.00012001885,0.000032865395,0.00014424737],"genre_scores_gemma":[0.99864286,0.0000556553,0.00011872829,0.00029704298,0.000039870512,0.0004429691,0.00022864157,0.000040309435,0.00013389385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972449,0.00042713078,0.00082341203,0.0004341595,0.00072844385,0.0003419395],"domain_scores_gemma":[0.9979834,0.0008164292,0.0004449568,0.00047009005,0.00016222059,0.00012292412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060971716,0.000365236,0.0011417129,0.0001928189,0.00007495321,0.000032805638,0.00009563936,0.00011217751,0.00005393521],"category_scores_gemma":[0.0005452201,0.0001947062,0.0001796401,0.00020040506,0.000079361824,0.00010277881,0.00004648455,0.0000889383,0.000008874142],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22510096,0.009871934,0.75986266,0.000023582155,0.0005750803,0.000017797925,0.0003936255,0.0000033451336,0.0000055170517,0.000016843218,0.000011497222,0.0041171866],"study_design_scores_gemma":[0.48862123,0.0024439364,0.50705296,0.0001403877,0.0005572146,6.4028717e-7,0.00002464313,0.000031604675,0.0010152117,0.0000024067854,0.000004843058,0.000104934115],"about_ca_topic_score_codex":0.00049379707,"about_ca_topic_score_gemma":0.00018885832,"teacher_disagreement_score":0.26352027,"about_ca_system_score_codex":0.00019149345,"about_ca_system_score_gemma":0.000087265784,"threshold_uncertainty_score":0.7939888},"labels":[],"label_agreement":null},{"id":"W2575174870","doi":"10.1182/blood.v110.11.2203.2203","title":"G-CSF Induces Expression of Both Hepatocyte Growth Factor (HGF) and Its Receptor (c-Met) in Human Hematopoietic Stem/Progenitor Cells and Mature Myeloid Cells - Novel Evidence That during Mobilization the HGF-c-Met Axis Counterbalances G-CSF-Induced Attenuation of the SDF-1-CXCR4 Axis.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Liver physiology and pathology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Alberta","funders":"","keywords":"Hepatocyte growth factor; CD34; Haematopoiesis; Stromal cell; Stem cell; Progenitor cell; Bone marrow; CXCR4; Stem cell factor; Biology; Stromal cell-derived factor 1; Cell biology; Cancer research; Molecular biology; Immunology; Receptor; Chemokine; Inflammation","score_opus":0.033207609173741555,"score_gpt":0.2662456748866757,"score_spread":0.23303806571293417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2575174870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99732,0.0013792427,0.00001304466,0.00007280391,0.00019336377,0.00093749014,0.000049164784,0.000019117722,0.000015783948],"genre_scores_gemma":[0.99931383,0.0003246723,0.00009283398,0.00007161722,0.00010406325,0.000027894424,0.000009527767,0.00002117135,0.000034402812],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983744,0.0002068157,0.00046235335,0.0003898476,0.00031425105,0.00025234485],"domain_scores_gemma":[0.99857986,0.00033144228,0.00053774816,0.00032675752,0.0001609066,0.000063300075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051314005,0.00023309264,0.00044456992,0.00011658092,0.00015073824,0.000018435496,0.00021586409,0.00031335623,0.000016699425],"category_scores_gemma":[0.00009237489,0.00014413267,0.00006262595,0.0002516938,0.00017615716,0.00031605002,0.00013913737,0.00034681518,0.0000013147903],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018524782,0.00021793238,0.12533142,0.0005925538,0.000033903118,0.0000033037777,0.003477925,9.924438e-7,0.8700794,0.000020461322,0.000006102574,0.000050770257],"study_design_scores_gemma":[0.0013124853,0.0002498902,0.26242876,0.00080484216,0.00007966242,0.000023838575,0.00064139196,0.0000056926942,0.7343274,0.000024391253,0.0000018250377,0.000099849065],"about_ca_topic_score_codex":0.00004784885,"about_ca_topic_score_gemma":0.000025511743,"teacher_disagreement_score":0.13709733,"about_ca_system_score_codex":0.000025639782,"about_ca_system_score_gemma":0.000050153,"threshold_uncertainty_score":0.587756},"labels":[],"label_agreement":null},{"id":"W2575183386","doi":"10.1182/blood.v118.21.1617.1617","title":"Chemosensitization of Diffuse Large B Cell Lymphoma by Demethylating Nucleoside Analogues","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Decitabine; Demethylating agent; Diffuse large B-cell lymphoma; Cancer research; Azacitidine; DNA methylation; Biology; Lymphoma; Cytarabine; Gene; Immunology; Gene expression; Genetics","score_opus":0.007092110995745348,"score_gpt":0.19604981164230598,"score_spread":0.18895770064656062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2575183386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99566185,0.0008549377,0.0017644677,0.0000067322976,0.000046641344,0.0000860031,0.000029923765,0.000014363582,0.0015350905],"genre_scores_gemma":[0.9983069,0.00009774263,0.0010669677,0.000033426477,0.00007530493,0.0000034878403,0.00025942095,0.000021807953,0.00013494419],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99936193,0.000030920863,0.00018262946,0.00019553787,0.00008240003,0.00014655461],"domain_scores_gemma":[0.9995438,0.0000047034555,0.00013395984,0.00020891488,0.000070349226,0.000038299444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008262388,0.00009498316,0.000098892495,0.00002742602,0.000037702182,0.000004348298,0.00006909027,0.00013765859,0.000011140294],"category_scores_gemma":[0.000028089577,0.0001028606,0.000055117802,0.00008764739,0.000026680664,0.0000035250553,0.000045430897,0.000022889215,0.000003858449],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019900732,0.0007444825,0.0040871324,0.000016056658,0.000041244755,5.932378e-7,0.0001293066,0.0000036579656,0.9934594,0.000012910361,0.00038028866,0.0011050298],"study_design_scores_gemma":[0.002723096,0.00009851398,0.0076141157,0.000008581078,0.00005841371,0.000003987618,0.000041530722,0.000102978425,0.9883972,0.000028652083,0.00080871064,0.00011426205],"about_ca_topic_score_codex":0.000036653917,"about_ca_topic_score_gemma":0.000023478582,"teacher_disagreement_score":0.0050622383,"about_ca_system_score_codex":0.0000062149807,"about_ca_system_score_gemma":0.000026019232,"threshold_uncertainty_score":0.41945335},"labels":[],"label_agreement":null},{"id":"W2575280891","doi":"10.1182/blood.v114.22.2462.2462","title":"Systemic Delivery of the Cancer Gene Therapy Biologic, SNS01, Has Significant Anti-Tumoral Activity in a Murine Model of Multiple Myeloma.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Polyamine Metabolism and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Biology; Molecular biology; Apoptosis; Transfection; Messenger RNA; Cancer cell; Small interfering RNA; Cancer research; Polyethylenimine; Cell culture; Gene; Cancer; Biochemistry; Genetics","score_opus":0.02586164940164124,"score_gpt":0.24494290034749125,"score_spread":0.21908125094585001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2575280891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99660456,0.002536775,0.00021410175,0.00010384675,0.000021423113,0.00027113437,0.00021932591,0.000004769149,0.000024061785],"genre_scores_gemma":[0.99832875,0.0012702084,0.00021800223,0.00006060807,0.000042998185,0.000038565828,0.000017040555,0.000005383219,0.000018442914],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993429,0.000046134235,0.00018963961,0.00021110309,0.00006758995,0.00014259864],"domain_scores_gemma":[0.9994157,0.0000076156475,0.00013817006,0.00036802358,0.00004645488,0.000024026307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009080823,0.0001052635,0.00019193269,0.00002606032,0.00003135603,0.0000036016427,0.0002463192,0.00007573866,0.0000015818983],"category_scores_gemma":[0.000014231019,0.0000721939,0.000081138394,0.00010939287,0.000079587335,0.0000025281863,0.000050291845,0.00005259854,2.84355e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003735572,0.00042426918,0.016064797,0.000008697406,0.000020929288,2.615811e-7,0.000023954202,0.0008413669,0.9810095,0.000013959804,0.000019077725,0.001535852],"study_design_scores_gemma":[0.0010052975,0.000059459617,0.07768087,0.000011541717,0.000016614671,0.0000022794309,0.000008934068,0.0006593125,0.9204062,0.000026369049,0.000043695152,0.00007938403],"about_ca_topic_score_codex":0.00017303818,"about_ca_topic_score_gemma":0.000033477772,"teacher_disagreement_score":0.061616074,"about_ca_system_score_codex":0.0000037982234,"about_ca_system_score_gemma":0.00009956915,"threshold_uncertainty_score":0.29439816},"labels":[],"label_agreement":null},{"id":"W2575287594","doi":"10.1182/blood.v104.11.2941.2941","title":"G-CSF as a Potent Mitogen Augments the Elimination of CML Stem Cells by Imatinib Mesylate In Vitro.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Imatinib mesylate; Granulocyte colony-stimulating factor; CD34; Haematopoiesis; Medicine; Molecular biology; Myeloid leukemia; Immunology; Internal medicine; Stem cell; Biology; Imatinib; Chemotherapy","score_opus":0.009398610449783523,"score_gpt":0.24161201657698037,"score_spread":0.23221340612719685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2575287594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964562,0.00071199733,0.000015300338,0.0007479569,0.00010864812,0.0007222293,0.000036074503,0.000025101823,0.0011764999],"genre_scores_gemma":[0.99818647,0.00009111132,0.0003509581,0.00016254003,0.00003482338,0.000051308194,0.00004703374,0.000022937224,0.0010528449],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987693,0.00004335031,0.00034497055,0.0002229203,0.00038146024,0.00023799257],"domain_scores_gemma":[0.9993374,0.000042193496,0.00014887408,0.00034634492,0.00005492707,0.00007031212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015962838,0.00015468101,0.0002577246,0.000068799585,0.000033956545,0.000008785372,0.000118417454,0.00007904428,0.00003699093],"category_scores_gemma":[0.000021872986,0.0001094408,0.00008391141,0.0001710176,0.00004030435,0.0000521692,0.00004498229,0.00012761485,0.00010088208],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034285552,0.002577607,0.0011335213,0.00016684753,0.00042759132,0.00012390196,0.0023512864,0.000049118153,0.978675,0.00006487535,0.0004044033,0.013682999],"study_design_scores_gemma":[0.016173841,0.00028500668,0.002516367,0.00014707183,0.00028756686,0.00004882752,0.00024107439,0.000039275757,0.9797446,0.0000977708,0.00032707292,0.00009150624],"about_ca_topic_score_codex":0.00032548822,"about_ca_topic_score_gemma":0.000009898001,"teacher_disagreement_score":0.015830986,"about_ca_system_score_codex":0.00041724357,"about_ca_system_score_gemma":0.00022569233,"threshold_uncertainty_score":0.44628662},"labels":[],"label_agreement":null},{"id":"W2575293697","doi":"10.1182/blood.v104.11.5092.5092","title":"Daclizumab Therapy Improves Outcome in Steroid Refractory Acute Graft Versus Host Disease (aGVHD).","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Daclizumab; Medicine; Internal medicine; Gastroenterology; Cyclophosphamide; Graft-versus-host disease; Refractory (planetary science); Immunology; Transplantation; Chemotherapy; Tacrolimus; Biology","score_opus":0.027305508634049274,"score_gpt":0.300544415383503,"score_spread":0.2732389067494537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2575293697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99629456,0.0008371352,0.000055480046,0.00068123336,0.00030610862,0.0005937102,0.00003073408,0.00009851675,0.0011025106],"genre_scores_gemma":[0.99814963,0.0005736359,0.0005092103,0.00031629542,0.000104404455,0.000050417773,0.000074657466,0.000041854997,0.00017991087],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986266,0.000033114076,0.00038072452,0.0003293994,0.00032187643,0.00030830066],"domain_scores_gemma":[0.99915767,0.00007323866,0.00007507642,0.00042322313,0.000035495836,0.00023527327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000112985006,0.00020624678,0.00030774248,0.00013646454,0.000038432812,0.000019508689,0.00011141853,0.000098532255,0.00005643926],"category_scores_gemma":[0.00003368283,0.00017746656,0.000107522734,0.00016154567,0.000051915322,0.00011896661,0.000013887766,0.00021042298,0.00010263028],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0158155,0.010971602,0.3227605,0.0012798934,0.0014562017,0.008592296,0.0059462353,0.0000115530265,0.6270233,0.0008684971,0.00008632327,0.0051881317],"study_design_scores_gemma":[0.09165289,0.0014796518,0.85034055,0.00035880966,0.0007905706,0.000110790366,0.0002134823,0.0000056874023,0.05338254,0.00017215936,0.0010056604,0.00048719873],"about_ca_topic_score_codex":0.000059051938,"about_ca_topic_score_gemma":0.000024866627,"teacher_disagreement_score":0.5736407,"about_ca_system_score_codex":0.00007965099,"about_ca_system_score_gemma":0.00016057189,"threshold_uncertainty_score":0.7236876},"labels":[],"label_agreement":null},{"id":"W2575327981","doi":"10.1182/blood.v116.21.1587.1587","title":"Gpx3 Determines Competitiveness of Normal and Leukemic Stem Cells.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Stem cell; Biology; Haematopoiesis; Leukemia; Molecular biology; Cancer research; GPX3; Immunology; Cell biology; Glutathione peroxidase; Oxidative stress; Superoxide dismutase; Biochemistry","score_opus":0.011796505088733766,"score_gpt":0.2548636973507261,"score_spread":0.24306719226199236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2575327981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965365,0.00011958401,0.000013079193,0.00007184185,0.0000863952,0.00019850284,0.000014781389,0.000027474054,0.0029318603],"genre_scores_gemma":[0.99751776,0.000053260042,0.000919702,0.000054034088,0.00014573224,0.000009242363,0.000004660842,0.000019175848,0.0012764466],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992133,0.000023338898,0.00017398906,0.00017850418,0.00019976345,0.00021114515],"domain_scores_gemma":[0.9993348,0.000104432555,0.00005012582,0.00025954586,0.00011767064,0.00013343478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016530581,0.000103694656,0.0002467712,0.000091270835,0.000035289264,0.000009036602,0.00010146449,0.00009614231,0.000118603166],"category_scores_gemma":[0.000022849037,0.00008700945,0.0000422984,0.00010524023,0.00019263758,0.00005207373,0.00009832305,0.00030032333,0.000019902853],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000709651,0.00014139031,0.11308368,0.00020074255,0.000041046165,0.00008417715,0.00012327927,1.5677071e-7,0.8829526,0.00008979673,0.000026582922,0.0031856329],"study_design_scores_gemma":[0.004416714,0.00022404784,0.102356575,0.00006394448,0.000103063096,0.00040283572,0.000109675406,0.00013192417,0.89028364,0.0000078642515,0.0017982825,0.00010144614],"about_ca_topic_score_codex":0.00006216792,"about_ca_topic_score_gemma":0.000030393461,"teacher_disagreement_score":0.01072711,"about_ca_system_score_codex":0.000014939997,"about_ca_system_score_gemma":0.00019332007,"threshold_uncertainty_score":0.35481426},"labels":[],"label_agreement":null},{"id":"W2575338530","doi":"10.1182/blood.v104.11.701.701","title":"Lymphdx: A Custom Microarray for Molecular Diagnosis and Prognosis in Non-Hodgkin Lymphoma.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Follicular lymphoma; Lymphoma; Germinal center; Mantle cell lymphoma; Diffuse large B-cell lymphoma; Microarray; Significance analysis of microarrays; Cancer research; DNA microarray; Biology; Gene expression profiling; Gene; B cell; Gene expression; Immunology; Genetics; Antibody","score_opus":0.009388363780397606,"score_gpt":0.2506048230573112,"score_spread":0.24121645927691357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2575338530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99312717,0.0028571936,0.000049529604,0.0017670434,0.000053603708,0.0016359105,0.000030205134,0.000050466544,0.0004288638],"genre_scores_gemma":[0.9896326,0.0005373097,0.0064261234,0.0006481645,0.00006569458,0.0025839536,0.000034644694,0.00004364426,0.000027867887],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986365,0.000016392529,0.00029306117,0.00047740046,0.00017477713,0.0004018806],"domain_scores_gemma":[0.9993549,0.00008474755,0.00006604408,0.00024572827,0.00005730837,0.00019125012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011416936,0.0002550458,0.00042154235,0.00016713899,0.000061592225,0.00003753421,0.000072469564,0.00013892225,0.000010708194],"category_scores_gemma":[0.00006943318,0.00021841121,0.00015145793,0.00022639625,0.000059649738,0.000064544874,0.000042226882,0.000032231554,0.00001885273],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018248284,0.01290077,0.93720555,0.00031180395,0.00049148564,0.001159071,0.0007197917,0.0000092235005,0.008978686,0.00063066435,0.00028899417,0.03712149],"study_design_scores_gemma":[0.057104502,0.0013841323,0.46605134,0.0006350011,0.0009048498,0.0003404748,0.000117807285,0.0000113987835,0.47036064,0.0004694117,0.002242584,0.00037786682],"about_ca_topic_score_codex":0.00032079214,"about_ca_topic_score_gemma":0.000053382442,"teacher_disagreement_score":0.4711542,"about_ca_system_score_codex":0.00018682487,"about_ca_system_score_gemma":0.00016229144,"threshold_uncertainty_score":0.8906551},"labels":[],"label_agreement":null},{"id":"W2575373447","doi":"10.1182/blood.v104.11.171.171","title":"Proaerolysin Multi Color Flow-Fish Reveals Shortened Telomere Length in GPI− as Compared to GPI+ Granulocytes from Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH).","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"","keywords":"Telomere; Paroxysmal nocturnal hemoglobinuria; Biology; Flow cytometry; Senescence; Telomerase; Fluorescence in situ hybridization; Dyskeratosis congenita; Pancytopenia; Somatic cell; Immunology; Molecular biology; Bone marrow; Gene; Genetics; Chromosome","score_opus":0.009673778452477655,"score_gpt":0.21235548717493835,"score_spread":0.2026817087224607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2575373447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99692684,0.00029545903,0.00010951462,0.00028422262,0.00030001058,0.0014166042,0.0004362547,0.000113101225,0.00011797174],"genre_scores_gemma":[0.9934058,0.000012651144,0.004421743,0.0010063809,0.00006540337,0.00016759898,0.0006446849,0.000059487797,0.00021620444],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972983,0.00026125612,0.0006492638,0.00084218587,0.00014220733,0.00080679194],"domain_scores_gemma":[0.99889714,0.00008938263,0.00019385105,0.0004974691,0.00018881618,0.00013332289],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017580845,0.0005355177,0.0008398612,0.00021601096,0.00023375226,0.00005113215,0.0004742658,0.00033524766,0.00032066123],"category_scores_gemma":[0.000066657754,0.00043001035,0.00011921139,0.00041531323,0.00014935606,0.00019936792,0.00015347109,0.00050988625,0.00054499833],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003239433,0.005082146,0.08072778,0.000034371566,0.00091509713,0.00021718601,0.0018834115,0.00025972674,0.9059438,0.00018325036,0.00031914611,0.0011946445],"study_design_scores_gemma":[0.02835161,0.0014760606,0.19972213,0.00022946055,0.00024072942,0.00003495585,0.00028878805,0.0000024888589,0.76800495,0.00031378577,0.0006218014,0.0007132314],"about_ca_topic_score_codex":0.0005641039,"about_ca_topic_score_gemma":0.0014685957,"teacher_disagreement_score":0.13793884,"about_ca_system_score_codex":0.00011649831,"about_ca_system_score_gemma":0.00015578936,"threshold_uncertainty_score":0.99981517},"labels":[],"label_agreement":null},{"id":"W2575394572","doi":"10.1182/blood.v120.21.3782.3782","title":"Change in Chronic Low-Grade Nonhematologic Adverse Events (AEs) and Quality of Life (QoL) in Adult Patients (pts) with Philadelphia Chromosome–Positive (Ph+) Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Switched From Imatinib (IM) to Nilotinib (NIL)","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Adverse effect; Internal medicine; Common Terminology Criteria for Adverse Events; Quality of life (healthcare)","score_opus":0.03111188851208853,"score_gpt":0.3032667500792633,"score_spread":0.2721548615671748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2575394572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98971474,0.0043172003,0.000010586729,0.00028409966,0.0001596986,0.0049602757,0.00037278023,0.00009425843,0.000086332206],"genre_scores_gemma":[0.9962221,0.0005699836,0.00045372066,0.0003100118,0.00046366543,0.0010585384,0.0007580972,0.00014797552,0.000015930316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9933206,0.00044712203,0.0020297167,0.0013756979,0.0010456692,0.0017812308],"domain_scores_gemma":[0.9966265,0.00037240091,0.00088126474,0.0011218855,0.000164124,0.0008338006],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006094917,0.0010425802,0.0022554982,0.00075967255,0.00008761475,0.000013534048,0.00043458617,0.00056344137,0.00021124019],"category_scores_gemma":[0.0004071998,0.0009371851,0.0002072538,0.0013910595,0.00026022916,0.00068057555,0.00034520015,0.000963363,0.00011561498],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030909926,0.010339167,0.94233,0.0021326288,0.00067946163,0.00023206744,0.009183436,0.00010428777,0.029446885,0.000048425332,0.000024664363,0.002388009],"study_design_scores_gemma":[0.16267061,0.004473047,0.7967863,0.0051481887,0.00042706664,0.000040474322,0.0007113354,0.0007888139,0.027793309,0.000020841675,0.000026738518,0.001113266],"about_ca_topic_score_codex":0.008835172,"about_ca_topic_score_gemma":0.011757273,"teacher_disagreement_score":0.15957962,"about_ca_system_score_codex":0.014805823,"about_ca_system_score_gemma":0.003244465,"threshold_uncertainty_score":0.9993079},"labels":[],"label_agreement":null},{"id":"W2575449152","doi":"10.1182/blood.v110.11.5123.5123","title":"Age under 40 Does Not Confer Superior Prognosis in Patients with Multiple Myeloma Undergoing Upfront Autologous Stem Cell Transplant Despite High Response Rates.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Melphalan; Multiple myeloma; Internal medicine; Surgery; Cyclophosphamide; Autologous stem-cell transplantation; Gastroenterology; Chemotherapy","score_opus":0.015572496499151817,"score_gpt":0.24935596400898272,"score_spread":0.2337834675098309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2575449152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99743813,0.00009146383,0.0001534019,0.0002059297,0.00006537741,0.0017276503,0.00011424484,0.000108926084,0.00009488558],"genre_scores_gemma":[0.9973112,0.000023903569,0.001649714,0.00013204393,0.000030442267,0.000104487684,0.00014088409,0.00006805774,0.0005393053],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99725085,0.00020113772,0.00046434396,0.0005706826,0.00061652635,0.0008964279],"domain_scores_gemma":[0.9983891,0.0006469087,0.00008690735,0.00035336343,0.00012684477,0.00039687287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045239652,0.00036442044,0.00052304234,0.00032368052,0.00012891385,0.000051064573,0.00013629047,0.00018220286,0.000058144684],"category_scores_gemma":[0.000051108553,0.00023471315,0.000091112866,0.0002490238,0.00013356301,0.00012473941,0.00003951118,0.00030341,0.000043121992],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02726306,0.003620726,0.95008343,0.00017816633,0.00029279504,0.003966555,0.0008789054,0.000007712011,0.011664049,0.000008507311,0.0000047859876,0.0020312867],"study_design_scores_gemma":[0.03270421,0.0019757398,0.8266078,0.00024829217,0.00016989476,0.00002722467,0.00024764644,0.000033050015,0.13770245,0.0000033182148,0.000032006457,0.00024834275],"about_ca_topic_score_codex":0.00031526544,"about_ca_topic_score_gemma":0.001964761,"teacher_disagreement_score":0.1260384,"about_ca_system_score_codex":0.00019114843,"about_ca_system_score_gemma":0.0002802866,"threshold_uncertainty_score":0.95713246},"labels":[],"label_agreement":null},{"id":"W2575518031","doi":"10.1182/blood.v126.23.4323.4323","title":"GSTA1 Genotype Influences Performance of Initial Bu Prediction Methods during Conditioning before SCT","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Conditioning; Busulfan; Pharmacokinetics; Conditioning regimen; Nomogram; Internal medicine; Area under the curve; Urology; Gastroenterology; Nuclear medicine; Transplantation; Hematopoietic stem cell transplantation; Mathematics; Statistics","score_opus":0.01525556817711583,"score_gpt":0.30698236445157207,"score_spread":0.29172679627445625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2575518031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99809444,0.0005924023,0.0003097994,0.00000957463,0.00020174193,0.00007516433,0.00006534795,0.000008402719,0.00064315327],"genre_scores_gemma":[0.99529845,0.00010951029,0.0040086913,0.000032167674,0.00040174712,0.000011516808,0.00008962107,0.000010567848,0.000037741756],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999455,0.000025479603,0.00016769081,0.00014867734,0.00008141745,0.00012177179],"domain_scores_gemma":[0.99957603,0.000008222625,0.00008298867,0.00015177033,0.00011898359,0.000062018844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015789774,0.00007667748,0.00009233547,0.000030736763,0.000052487514,0.0000124663975,0.00008578735,0.000078206984,0.0000065469135],"category_scores_gemma":[0.00011887356,0.000078228004,0.000033810335,0.000052011215,0.000058758164,0.000005664249,0.00006726003,0.0000481143,0.0000022058473],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000168424,0.0001575938,0.13575755,0.000086328924,0.00014289527,0.0000038118094,0.00037521662,0.0020534468,0.8585462,0.00008744062,0.00012421719,0.0024969056],"study_design_scores_gemma":[0.0013061338,0.0007002229,0.04513404,0.000022415607,0.000058619877,0.000025495563,0.000072717645,0.00013699994,0.95102566,0.00009274299,0.001320922,0.00010404611],"about_ca_topic_score_codex":0.000024331643,"about_ca_topic_score_gemma":0.000013559248,"teacher_disagreement_score":0.09247947,"about_ca_system_score_codex":0.000009078104,"about_ca_system_score_gemma":0.0001195603,"threshold_uncertainty_score":0.31900454},"labels":[],"label_agreement":null},{"id":"W2575520160","doi":"10.1182/blood.v118.21.4917.4917","title":"Low Blood Counts of Memory/Effector CD8 T Cells, Gamma/Delta T Cells, Memory B Cells and Plasmacytoid Dendritic Cells and High Counts of Th2 Cells in Systemic Sclerosis","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"RPM International (Canada); University of Calgary","funders":"","keywords":"CD8; DLCO; Immunology; Medicine; Cytotoxic T cell; Immune system; Lung; Internal medicine; Biology; Diffusing capacity; In vitro","score_opus":0.0159678823007318,"score_gpt":0.19963291464852928,"score_spread":0.1836650323477975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2575520160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98581564,0.00974,0.0000027715091,0.0000044894305,0.00092589104,0.0008392038,0.00047633794,0.000046608908,0.002149068],"genre_scores_gemma":[0.99213237,0.006724892,0.00015458107,0.000046760793,0.00011978719,0.000025678057,0.000017842125,0.00006897476,0.0007091129],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976883,0.00014088892,0.00078017236,0.00051661074,0.00046645149,0.0004075597],"domain_scores_gemma":[0.9985181,0.00019885977,0.00034407972,0.0005174439,0.00014167851,0.00027981837],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003307124,0.00036552607,0.00088368234,0.00024784982,0.00004788665,0.000019013665,0.00019429778,0.00034276658,0.0003756383],"category_scores_gemma":[0.000020937554,0.00031665887,0.0001364744,0.00024199653,0.0002254764,0.00007100464,0.00008418853,0.00023720911,0.00015252718],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009437771,0.001247692,0.0014912414,0.0027427855,0.00026278192,0.00006757176,0.0005060217,0.0000055943347,0.9911863,0.0000070923115,0.002148054,0.00024048172],"study_design_scores_gemma":[0.005775869,0.00030832778,0.0016851578,0.0047018672,0.0012212788,0.00005592648,0.00039987674,0.00004822042,0.9854511,0.0000050430667,0.000045446155,0.00030189002],"about_ca_topic_score_codex":0.0003238481,"about_ca_topic_score_gemma":0.000008481981,"teacher_disagreement_score":0.0063167415,"about_ca_system_score_codex":0.000033142765,"about_ca_system_score_gemma":0.00013979326,"threshold_uncertainty_score":0.99992853},"labels":[],"label_agreement":null},{"id":"W2575531189","doi":"10.1182/blood.v120.21.902.902","title":"An Open-Label, Randomized Study of Bendamustine and Rituximab (BR) Compared with Rituximab, Cyclophosphamide, Vincristine, and Prednisone (R-CVP) or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in First-Line Treatment of Patients with Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL): The Bright Study","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Capital District Health Authority; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Vincristine; Rituximab; Bendamustine; Internal medicine; CHOP; Prednisone; Gastroenterology; Cyclophosphamide; Regimen; Surgery; Chemotherapy; Lymphoma","score_opus":0.014174613242557789,"score_gpt":0.27005066347700735,"score_spread":0.25587605023444954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2575531189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9756879,0.006562383,0.000018640005,0.00008641992,0.0001104569,0.016913982,0.0004236125,0.00007964804,0.00011695319],"genre_scores_gemma":[0.9917716,0.0021316924,0.0032054048,0.00007117044,0.000074292155,0.0022512309,0.0001900421,0.00017872729,0.00012585317],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9935493,0.0005600054,0.0020789965,0.001574482,0.0011381496,0.001099062],"domain_scores_gemma":[0.99484384,0.001187318,0.0013079321,0.0015055662,0.00051923504,0.00063611224],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0008315763,0.0014224409,0.004509014,0.00037632693,0.00047337325,0.00014543514,0.00047396985,0.00021189399,0.000054037304],"category_scores_gemma":[0.00015543643,0.00075905776,0.000090745896,0.00090436696,0.0007139504,0.00061291043,0.00046279,0.00015425017,0.0000029488747],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19618498,0.30171132,0.48698384,0.00039097236,0.0013824024,0.00029519494,0.005032157,0.000010579243,0.000076421245,0.00000457014,0.000017743452,0.007909843],"study_design_scores_gemma":[0.51816887,0.02777517,0.44580948,0.00043748863,0.0032006255,0.000115672214,0.00183584,0.00017236892,0.0018983126,0.0000036067363,0.000070332666,0.00051222317],"about_ca_topic_score_codex":0.006226383,"about_ca_topic_score_gemma":0.003512064,"teacher_disagreement_score":0.3219839,"about_ca_system_score_codex":0.00030772513,"about_ca_system_score_gemma":0.00035075672,"threshold_uncertainty_score":0.99985254},"labels":[],"label_agreement":null},{"id":"W2575564040","doi":"10.1182/blood.v108.11.1128.1128","title":"Identification of the Mechanisms Responsible for the Increased Megakaryopoiesis at 39°C.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Tissue Engineering and Regenerative Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Héma-Québec","funders":"","keywords":"Doubling time; Mitosis; Cell culture; Cord blood; Ex vivo; Megakaryocyte; In vivo; Andrology; Biology; Cell cycle; Cell biology; Stem cell; Cell; Chemistry; Immunology; Haematopoiesis; Biochemistry; Genetics; Medicine","score_opus":0.008959449544328243,"score_gpt":0.23184986313611403,"score_spread":0.2228904135917858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2575564040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9720312,0.005182508,0.016152726,0.0052088024,0.00043918108,0.0007825458,0.000027076461,0.000049169328,0.00012683224],"genre_scores_gemma":[0.9798849,0.000012022896,0.0007583746,0.000030839827,0.00023264356,0.000056971578,0.000012095784,0.000014138081,0.018997964],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99940145,0.000028497556,0.00019084416,0.000104066596,0.0001777084,0.00009744604],"domain_scores_gemma":[0.9993221,0.00017795124,0.00007465785,0.00032653852,0.00007698552,0.000021769034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032315592,0.00007147565,0.0001265874,0.000037293277,0.00012170785,0.000003973281,0.00008525103,0.000038531933,0.000019152818],"category_scores_gemma":[0.0002076975,0.000034653538,0.00007431012,0.00015705398,0.00005856691,0.000011587249,0.000020914029,0.000049698858,0.0000035358348],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005335631,0.00010449088,0.0004910898,0.000046609443,0.000057560726,0.0000012536561,0.000055140503,0.00006270012,0.9869746,0.009772674,0.0023023123,0.00007822681],"study_design_scores_gemma":[0.0016185279,0.00008273249,0.033103827,0.000041578507,0.000391007,0.00003092472,0.000042145224,0.00052157167,0.9587851,0.0003981608,0.00494168,0.00004273497],"about_ca_topic_score_codex":0.000050641356,"about_ca_topic_score_gemma":0.00002206811,"teacher_disagreement_score":0.032612737,"about_ca_system_score_codex":0.00001703597,"about_ca_system_score_gemma":0.000042286512,"threshold_uncertainty_score":0.14131302},"labels":[],"label_agreement":null},{"id":"W2575606794","doi":"10.1182/blood.v106.11.1285.1285","title":"Long-Term and Sustained Correction of the α-Galactosidase A Deficiency in Fabry Mice and Patient Cells Receiving Lentivirally Transduced Hematopoietic Stem/Progenitor Cells.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Progenitor cell; Haematopoiesis; Genetic enhancement; Stem cell; Viral vector; Context (archaeology); Transplantation; Biology; Bone marrow; Gene delivery; Ex vivo; Fabry disease; Immunology; Cancer research; Cell biology; Medicine; Internal medicine; In vivo; Disease; Recombinant DNA; Gene; Genetics","score_opus":0.006903911366305191,"score_gpt":0.23065844863923915,"score_spread":0.22375453727293396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2575606794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971274,0.00221216,0.000040786534,0.000062186,0.00007618359,0.00041476288,0.000007932989,0.000005658716,0.000052897125],"genre_scores_gemma":[0.99950963,0.0002274958,0.000031108706,0.000038401904,0.00003156436,0.000020542777,0.0000032950988,0.000018332235,0.00011961526],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998965,0.00013440446,0.0002230982,0.00029372107,0.00014986414,0.00023390495],"domain_scores_gemma":[0.99956113,0.00002035941,0.00007702605,0.00023291679,0.000055177305,0.000053400818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016498943,0.00013439925,0.00013075443,0.000053245407,0.000063391664,0.000021981203,0.00012383891,0.00009813572,0.0000055419628],"category_scores_gemma":[0.000010899074,0.000111698406,0.000052414,0.00012518607,0.0000856625,0.0000067879164,0.00007352305,0.000108484055,7.654476e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028409017,0.00033999243,0.0084422445,0.00007843064,0.000018408726,0.0000025738484,0.0006168576,0.000014760521,0.9808839,3.9551978e-7,0.000011606748,0.009306766],"study_design_scores_gemma":[0.0013405429,0.0007701645,0.0040215133,0.000041233772,0.000024953386,0.000014034439,0.00023602006,0.0000344469,0.9933777,0.0000014632416,0.000015557676,0.00012238826],"about_ca_topic_score_codex":0.000012005684,"about_ca_topic_score_gemma":0.0003072612,"teacher_disagreement_score":0.012493808,"about_ca_system_score_codex":0.000013360617,"about_ca_system_score_gemma":0.00007338367,"threshold_uncertainty_score":0.45549285},"labels":[],"label_agreement":null},{"id":"W2575626416","doi":"10.1182/blood.v120.21.2391.2391","title":"Epigenetic Therapy Inhibits NUP98-HOXA9-Mediated Myeloid Disease – Decitabine and Valproic Acid Work Synergistically to Rescue Normal Hematopoiesis in Transgenic Zebrafish.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Atlantic Cancer Research Institute; Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Biology; Cancer research; Myeloid leukemia; Decitabine; Zebrafish; Myeloid; Haematopoiesis; GATA1; Leukemia; Immunology; Stem cell; DNA methylation; Cell biology; Genetics; Gene expression; Gene","score_opus":0.016643509791405907,"score_gpt":0.26286608214303026,"score_spread":0.24622257235162434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2575626416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888856,0.006165294,0.0001741078,0.002813821,0.00008199614,0.0013936494,0.00003544359,0.00011974848,0.0003303328],"genre_scores_gemma":[0.99499947,0.00078028295,0.0020136514,0.0010960147,0.00037502896,0.00027857066,0.000065624365,0.00010872703,0.0002826226],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966139,0.00019560254,0.000614721,0.00059252046,0.00072013604,0.0012631238],"domain_scores_gemma":[0.99709207,0.00029918362,0.000049816736,0.0006716516,0.00013410662,0.0017531487],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007220007,0.00041256644,0.0006395003,0.00044798665,0.000105588275,0.000046557892,0.000263349,0.00021693025,0.00030923737],"category_scores_gemma":[0.00092922273,0.00035490678,0.00013411003,0.0012612162,0.00018136043,0.000184024,0.00014115169,0.00054071564,0.00023396462],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007917062,0.0063906084,0.6643341,0.00074951147,0.0006724229,0.0006523296,0.0044434965,0.000022829792,0.30218115,0.00030642987,0.0015836175,0.010746406],"study_design_scores_gemma":[0.013029966,0.0005475442,0.91350764,0.0003736806,0.0002505473,0.00007362703,0.00012164838,0.00003959609,0.069812275,0.000058449827,0.0015890364,0.0005960088],"about_ca_topic_score_codex":0.000042825133,"about_ca_topic_score_gemma":0.000036106005,"teacher_disagreement_score":0.24917349,"about_ca_system_score_codex":0.0001460217,"about_ca_system_score_gemma":0.00041989403,"threshold_uncertainty_score":0.99989027},"labels":[],"label_agreement":null},{"id":"W2575664361","doi":"10.1182/blood.v120.21.2062.2062","title":"Venous Thromboembolism Prevention Practices Among Health Care Providers Caring for Patients Hospitalized for Hematopoietic Stem Cell Transplantation: A International Web-Based Survey","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Family medicine; Institutional review board; Transplantation; Hematopoietic stem cell transplantation; Venous thromboembolism; Internal medicine; Surgery","score_opus":0.028801242900876524,"score_gpt":0.3085110951772959,"score_spread":0.27970985227641937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2575664361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917965,0.0005478844,0.0012711508,0.00030676823,0.0007319526,0.004719247,0.00020773124,0.00008423754,0.0003345264],"genre_scores_gemma":[0.9947979,0.00012728617,0.0019182113,0.00027953554,0.00019925975,0.001102185,0.0014649464,0.000053663192,0.000056999623],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983948,0.000093029164,0.00042325747,0.00032253106,0.00033610006,0.0004302706],"domain_scores_gemma":[0.99857587,0.00015797673,0.0006098068,0.00021595196,0.00027272117,0.00016769161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049659394,0.00020445493,0.00051162083,0.00011508744,0.00018044254,0.000057171863,0.00012251607,0.00008414837,0.00001387259],"category_scores_gemma":[0.000058784324,0.00019910467,0.00018212516,0.00008985202,0.000027102999,0.00031295573,0.000018711702,0.00007886796,0.000003400429],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007390639,0.025072848,0.92557317,0.012152753,0.0012050142,0.000004814561,0.02521559,0.00004864334,0.00012159377,0.00029370553,0.0036395793,0.0059332205],"study_design_scores_gemma":[0.016921917,0.0022506223,0.9738467,0.00044353324,0.001303622,0.0000026226157,0.001306906,0.000087932756,0.001684897,0.000016877615,0.0018354874,0.00029890414],"about_ca_topic_score_codex":0.0002811792,"about_ca_topic_score_gemma":0.00015058843,"teacher_disagreement_score":0.048273504,"about_ca_system_score_codex":0.0001198773,"about_ca_system_score_gemma":0.00021851924,"threshold_uncertainty_score":0.8119253},"labels":[],"label_agreement":null},{"id":"W2575679046","doi":"10.1182/blood.v120.21.2168.2168","title":"Platelet ERp57 Is Required for Hemostasis and Thrombosis.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Blood properties and coagulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor","funders":"","keywords":"Platelet; Hemostasis; Protein disulfide-isomerase; Thrombus; Platelet activation; Chemistry; Clot retraction; Platelet membrane glycoprotein; Platelet adhesiveness; Thrombosis; GPVI; Cell biology; Biochemistry; Internal medicine; Thrombin; Medicine; Enzyme; Platelet aggregation; Biology","score_opus":0.05410291972591526,"score_gpt":0.29179661079076424,"score_spread":0.237693691064849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2575679046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928586,0.0038314543,0.00005643612,0.001638597,0.000075589785,0.00031877425,0.000012012661,0.000041225758,0.0011673401],"genre_scores_gemma":[0.99575853,0.00013092715,0.002071748,0.0013556115,0.00027100672,0.0000276052,0.000015078709,0.000017377168,0.00035213178],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99949074,0.000006778547,0.00011287854,0.00010902864,0.00008420811,0.00019638351],"domain_scores_gemma":[0.9996829,0.000020191395,0.000030162077,0.00013730873,0.000034045526,0.00009539775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009635104,0.000076636585,0.00015592588,0.00002196688,0.000060568604,0.000010536786,0.000021487529,0.00006674932,0.00007040002],"category_scores_gemma":[0.00002073372,0.000059459187,0.000041471038,0.000045878118,0.000022632858,0.00009823461,0.000018741799,0.00003863407,0.000012680514],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008640601,0.004032967,0.4611067,0.0013908062,0.0018233337,0.000006995935,0.009509381,4.4529997e-7,0.16254339,0.0031164018,0.056164518,0.299441],"study_design_scores_gemma":[0.014302377,0.0011525134,0.2414183,0.0001747993,0.0016677425,0.00018212528,0.00052663643,0.00015445332,0.58691275,0.0005444865,0.15250826,0.00045552524],"about_ca_topic_score_codex":0.00001528687,"about_ca_topic_score_gemma":9.3943504e-7,"teacher_disagreement_score":0.4243694,"about_ca_system_score_codex":0.0000050234426,"about_ca_system_score_gemma":0.000012694567,"threshold_uncertainty_score":0.24246754},"labels":[],"label_agreement":null},{"id":"W2575735043","doi":"10.1182/blood.v110.11.444.444","title":"Phase I/II Study of MGCD0103, an Oral Isotype-Selective Histone Deacetylase (HDAC) Inhibitor, in Combination with 5-Azacitidine in Higher-Risk Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML).","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pyrogenesis (Canada)","funders":"","keywords":"Azacitidine; Medicine; Internal medicine; Myelodysplastic syndromes; Nausea; Phases of clinical research; Histone deacetylase inhibitor; Oncology; Pharmacology; Gastroenterology; Clinical trial; Bone marrow; Histone deacetylase; Biology; DNA methylation","score_opus":0.01101789143580768,"score_gpt":0.28429147623568246,"score_spread":0.2732735847998748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2575735043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983254,0.00040947815,0.00007479769,0.000015857564,0.000077395656,0.0009085413,0.000044976998,0.000021154405,0.0001223871],"genre_scores_gemma":[0.99912333,0.000057042194,0.0002908478,0.000017241453,0.000057791774,0.00006078766,0.00013665271,0.000059155627,0.00019715405],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99748296,0.00025148768,0.0005609245,0.0007275529,0.00041019593,0.0005668636],"domain_scores_gemma":[0.99890625,0.00005475801,0.00020469737,0.00043275338,0.00020150715,0.0002000473],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00075281097,0.0003305999,0.00046940063,0.00047909236,0.00014439598,0.000017389537,0.00021216816,0.000267818,0.0000099454355],"category_scores_gemma":[0.00010281319,0.00033060648,0.000040521645,0.0006631063,0.00022205773,0.000029072668,0.00015657542,0.0004395201,0.0000028953643],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035646537,0.021630341,0.01326085,0.000071182454,0.00027875113,0.0012680907,0.0019783613,0.000083493964,0.9550004,0.00001568618,0.000071841045,0.0027763387],"study_design_scores_gemma":[0.057174746,0.06889101,0.048583865,0.00010322148,0.00026880135,0.00035260848,0.0009063977,0.00010846815,0.82266665,0.00003741772,0.00013466428,0.000772129],"about_ca_topic_score_codex":0.0010498144,"about_ca_topic_score_gemma":0.0077657234,"teacher_disagreement_score":0.13233374,"about_ca_system_score_codex":0.0002342241,"about_ca_system_score_gemma":0.00029398125,"threshold_uncertainty_score":0.9999146},"labels":[],"label_agreement":null},{"id":"W2575850575","doi":"10.1182/blood.v120.21.2624.2624","title":"Glutaminase Inhibition Selectively Slows the Growth of Primary Acute Myeloid Leukemia (AML) Cells with Isocitrate Dehydrogenase (IDH) Mutations.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Glutaminase; Isocitrate dehydrogenase; Glutamine; IDH1; IDH2; Glutaminolysis; Biology; Myeloid leukemia; Enzyme; Glutamate dehydrogenase; Biochemistry; Cancer research; Mutant; Glutamate receptor; Gene; Amino acid","score_opus":0.010948669861248782,"score_gpt":0.23675952498464028,"score_spread":0.2258108551233915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2575850575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99339616,0.00044150205,0.00040473868,0.00040598685,0.00004208948,0.0011203614,0.00008560364,0.00009142698,0.0040121344],"genre_scores_gemma":[0.99500424,0.00014190451,0.002943459,0.00059388974,0.00027226243,0.00014821802,0.00015512836,0.0000761675,0.0006647445],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976806,0.00018851593,0.00039998308,0.0003407862,0.00069649954,0.00069361227],"domain_scores_gemma":[0.9983837,0.00022067373,0.00022311466,0.00044577362,0.00041795813,0.0003088018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006087061,0.00029861342,0.00043748118,0.00019945535,0.00021229316,0.000026066695,0.00015169269,0.00017022649,0.00006220854],"category_scores_gemma":[0.000080837795,0.00019886499,0.00014411511,0.0008849459,0.00037334312,0.00035184243,0.00009100567,0.000598627,0.000101298014],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007520178,0.0011113627,0.0084492415,0.0003061848,0.0009802952,0.00027605513,0.002314195,0.000013343723,0.98318887,0.0003601009,0.0015959255,0.00065241917],"study_design_scores_gemma":[0.006794084,0.0006926366,0.02223953,0.000107638065,0.0011786245,0.0008937738,0.0003421919,0.00009697745,0.9671366,0.000090638445,0.00016968929,0.00025760106],"about_ca_topic_score_codex":0.00016138927,"about_ca_topic_score_gemma":0.00001295712,"teacher_disagreement_score":0.016052244,"about_ca_system_score_codex":0.00059146463,"about_ca_system_score_gemma":0.0012372752,"threshold_uncertainty_score":0.8109479},"labels":[],"label_agreement":null},{"id":"W2575866337","doi":"10.1182/blood.v108.11.341.341","title":"Therapeutic Effect of HOXB4-Expanded Stem Cells in Mice with Beta Thalassemia Given a Non-Myeloablative Conditioning Regimen.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Haematopoiesis; Stem cell; Bone marrow; Biology; Population; Immunology; Genetic enhancement; Myeloid; Cancer research; Transplantation; Ex vivo; In vivo; Virology; Medicine; Cell biology; Internal medicine; Gene; Genetics","score_opus":0.01124314597576006,"score_gpt":0.266839915694691,"score_spread":0.25559676971893097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2575866337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98155385,0.00044602447,0.000054457476,0.000095950425,0.000019865685,0.0011180831,0.0000089565365,0.00002641436,0.016676383],"genre_scores_gemma":[0.99750245,0.000011326313,0.00015647776,0.000016900183,0.000060580776,0.0000702805,0.000018530116,0.0000340417,0.0021293873],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982389,0.00021876552,0.00030503666,0.00033294645,0.00052330934,0.00038102383],"domain_scores_gemma":[0.9987666,0.0005986488,0.00015075109,0.00028770557,0.0001052457,0.000091041584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050837774,0.00020340248,0.00052837626,0.0001939524,0.00004609097,0.000016522477,0.00012421557,0.00011516399,0.00007147822],"category_scores_gemma":[0.000010363558,0.00014615615,0.00007253506,0.00044892443,0.000118804935,0.000071716706,0.000037884358,0.0003061578,0.000031974512],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008416604,0.00063629175,0.2703427,0.0006757404,0.000307405,0.00036150933,0.0005382205,0.000064249005,0.7252853,0.000063321975,0.00017575973,0.000707876],"study_design_scores_gemma":[0.009014994,0.0021027746,0.0869593,0.00068371283,0.00022374983,0.00004482139,0.00017147187,0.00014173432,0.900421,0.000020140584,0.00006920731,0.00014709606],"about_ca_topic_score_codex":0.00035740333,"about_ca_topic_score_gemma":0.000059366048,"teacher_disagreement_score":0.18338339,"about_ca_system_score_codex":0.000067965404,"about_ca_system_score_gemma":0.0001281367,"threshold_uncertainty_score":0.59600747},"labels":[],"label_agreement":null},{"id":"W2575937652","doi":"10.1182/blood.v126.23.3478.3478","title":"Second Line ITP Therapy in the UK: Results from the UK Paediatric ITP Registry","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Medicine; Splenectomy; Rituximab; Pediatrics; Immune thrombocytopenia; Azathioprine; Thrombopoietin; Dapsone; Second line treatment; Quality of life (healthcare); Internal medicine; Platelet; Chemotherapy; Disease; Lymphoma; Immunology","score_opus":0.031479545865430794,"score_gpt":0.2639115044431848,"score_spread":0.232431958577754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2575937652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97899866,0.0064007267,0.0000010101521,0.003953972,0.000109128065,0.00039111305,0.00016329385,0.000021183188,0.009960883],"genre_scores_gemma":[0.99559593,0.00068176136,0.00008209663,0.0019955938,0.00041007777,0.000025120287,0.00023816101,0.00001417337,0.000957096],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897283,0.00007520466,0.00023667667,0.00023648834,0.00026173025,0.00021705002],"domain_scores_gemma":[0.99894017,0.00026499893,0.00009077554,0.0005859254,0.000041546802,0.00007656221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033738744,0.00014863236,0.00022056962,0.0000321844,0.000053486627,0.000028676606,0.00020606435,0.000100013465,0.00010254991],"category_scores_gemma":[0.00019083088,0.00007189723,0.00007027834,0.00023040386,0.000039716313,0.000027094378,0.000026124833,0.00023874079,0.000070552065],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004504534,0.009261888,0.6495341,0.00003062029,0.0015841874,0.007193712,0.022042934,0.000015466048,0.0010183242,0.00014601585,0.2793017,0.025366528],"study_design_scores_gemma":[0.15320915,0.0030264389,0.7017616,0.00016776357,0.00090091577,0.00058446074,0.005397146,0.00007198844,0.003938545,0.0055157654,0.12471516,0.0007110853],"about_ca_topic_score_codex":0.0006419184,"about_ca_topic_score_gemma":0.00068569975,"teacher_disagreement_score":0.15458655,"about_ca_system_score_codex":0.000015115469,"about_ca_system_score_gemma":0.00010788898,"threshold_uncertainty_score":0.2931884},"labels":[],"label_agreement":null},{"id":"W2575952335","doi":"10.1182/blood.v104.11.3220.3220","title":"Age Related Changes in Hoechst 33342 Efflux Dynamics and Side Population Phenotype in Murine Bone Marrow.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Terry Fox Research Institute","funders":"","keywords":"Side population; Biology; Stem cell; Population; Phenotype; Haematopoiesis; Bone marrow; Abcg2; Molecular biology; ATP-binding cassette transporter; Cell biology; Immunology; Transporter; Cancer stem cell; Biochemistry; Medicine","score_opus":0.006054833302881931,"score_gpt":0.2156222739462325,"score_spread":0.2095674406433506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2575952335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99643576,0.00056446105,0.000025841991,0.0010721163,0.0000781591,0.00032091365,0.0000058185556,0.000053715343,0.0014432253],"genre_scores_gemma":[0.9980614,0.00016163969,0.0009537394,0.00008093552,0.000036256446,0.00001083774,0.00016483649,0.000024930898,0.0005053845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99917334,0.000012855645,0.00023385863,0.00022123271,0.0001427815,0.0002159495],"domain_scores_gemma":[0.99971336,0.000010446163,0.00004731268,0.00014810037,0.000013795604,0.00006699016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015044572,0.00012928488,0.00027282914,0.00020119594,0.000023507911,0.0000067916917,0.00003322271,0.00013323322,0.000014569767],"category_scores_gemma":[0.000018297062,0.00011826021,0.000025508052,0.0002786146,0.00002686602,0.000042638057,0.000011628582,0.0001913118,0.0000055912715],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055025035,0.0032981054,0.8585848,0.0011514165,0.00013079902,0.0063286773,0.003231622,0.00026183217,0.094229855,0.023237213,0.000005411857,0.008989984],"study_design_scores_gemma":[0.0100699635,0.00016665926,0.9793243,0.00051979977,0.000105898056,0.000044963806,0.0001251757,0.00011082151,0.005042065,0.0042783697,0.000023255734,0.00018876308],"about_ca_topic_score_codex":0.000432543,"about_ca_topic_score_gemma":0.019771095,"teacher_disagreement_score":0.12073944,"about_ca_system_score_codex":0.000074042844,"about_ca_system_score_gemma":0.000020980613,"threshold_uncertainty_score":0.99811554},"labels":[],"label_agreement":null},{"id":"W2575956561","doi":"10.1182/blood.v120.21.607.607","title":"SNX3 Regulates Recycling of the Transferrin Receptor and Iron Assimilation in Developing Erythrocytes*","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Transferrin receptor; Endosome; Transferrin; Cell biology; Endocytic cycle; Biology; DMT1; Chemistry; Biochemistry; Intracellular; Receptor; Endocytosis; Transporter","score_opus":0.023530014910616726,"score_gpt":0.25508797965030866,"score_spread":0.23155796473969192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2575956561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99763006,0.0007180192,0.00010178553,0.00051465473,0.00018358098,0.0002090437,0.0000014659985,0.000016841746,0.00062455836],"genre_scores_gemma":[0.9974417,0.0002712772,0.0017516636,0.00023263779,0.00016109594,0.000009873881,0.0000069227694,0.00000970534,0.000115109986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994171,0.000056255147,0.00019887547,0.00010462743,0.00007962377,0.00014348821],"domain_scores_gemma":[0.9997149,0.00006244249,0.000047257156,0.00011381968,0.000023939385,0.00003760434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017019514,0.00007462037,0.00016650058,0.000053224445,0.000037059122,0.0000020761051,0.000027058566,0.000091936905,0.00004328517],"category_scores_gemma":[0.000046987883,0.00005297471,0.000034539244,0.00014535358,0.0000468868,0.00006178511,0.000015790292,0.00011056759,0.0000034540853],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020499113,0.0003434002,0.59384096,0.00039168244,0.00004061671,9.678869e-7,0.0020463206,0.000008782779,0.3952995,0.0007928547,0.00009805416,0.006931865],"study_design_scores_gemma":[0.0023147753,0.00010443497,0.78509945,0.00027481272,0.000072400966,0.000035556444,0.00019703756,0.000020809117,0.20805018,0.0000884904,0.003639873,0.00010219411],"about_ca_topic_score_codex":0.000007716743,"about_ca_topic_score_gemma":0.000011468783,"teacher_disagreement_score":0.19125846,"about_ca_system_score_codex":0.00001779669,"about_ca_system_score_gemma":0.000031869302,"threshold_uncertainty_score":0.21602459},"labels":[],"label_agreement":null},{"id":"W2575981235","doi":"10.1182/blood.v126.23.4744.4744","title":"Survey of Red Cell Transfusion Patterns in Patients with Chronic Bone Marrow Failure Disorders in Northern Alberta, Canada","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Hematological disorders and diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Bone marrow; Bone marrow failure; Population; Myeloid leukemia; Anemia; Internal medicine; Surgery; Haematopoiesis; Stem cell; Biology","score_opus":0.007036369844333289,"score_gpt":0.19269662263059792,"score_spread":0.18566025278626463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2575981235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99859595,0.00015679316,0.0000074440695,0.00034218727,0.000021549062,0.000426237,0.000033842367,0.0000042108986,0.0004117938],"genre_scores_gemma":[0.9996772,0.000029632154,0.000017189064,0.000049494145,0.000003884106,0.000011638195,0.00017264378,0.000014585879,0.000023759221],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990334,0.000061651604,0.0002545903,0.000177822,0.00025552462,0.00021700995],"domain_scores_gemma":[0.9994672,0.00011783324,0.000053708285,0.00016281952,0.00007655136,0.000121910794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000932045,0.00011886783,0.0003123663,0.000050412113,0.000008464263,0.000002330345,0.0000560615,0.000077659766,0.000030642383],"category_scores_gemma":[0.00020094527,0.0000889069,0.00001832953,0.00021431601,0.000021718464,0.00002234526,0.000013167443,0.00012827417,0.0000014488543],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016744736,0.0014805829,0.99771047,0.00009760383,0.000008085266,0.000019513087,0.00012177989,0.000036451154,0.0000072895705,7.287943e-7,0.00012463744,0.00022541547],"study_design_scores_gemma":[0.012009478,0.00073511404,0.9867075,0.00012644535,0.000023686815,6.1099837e-7,0.000088436434,0.00002169704,0.00010237867,0.000005930555,0.000069751855,0.000108978034],"about_ca_topic_score_codex":0.86878103,"about_ca_topic_score_gemma":0.9996289,"teacher_disagreement_score":0.13084787,"about_ca_system_score_codex":0.000060356837,"about_ca_system_score_gemma":0.00048188312,"threshold_uncertainty_score":0.3625518},"labels":[],"label_agreement":null},{"id":"W2575984860","doi":"10.1182/blood.v114.22.3115.3115","title":"Prevalence and Clinical Implications of N-RAS Mutations in Childhood AML – A Report From the Children's Oncology Group.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Internal medicine; Oncology; ETV6; Myeloid leukemia; NPM1; Medicine; Incidence (geometry); Cohort; Hepatosplenomegaly; Leukemia; Biology; Karyotype; Genetics; Disease; Chromosome; Gene; Chromosomal translocation","score_opus":0.02207788450904444,"score_gpt":0.3587832996083014,"score_spread":0.33670541509925694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2575984860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98414284,0.000750828,0.000041928608,0.012951835,0.000016669923,0.00070138567,0.000042512922,0.0000239389,0.0013280588],"genre_scores_gemma":[0.99633783,0.00063012965,0.0021724033,0.0005246687,0.00016280354,0.00002978244,0.000078564284,0.000008749975,0.000055065604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986865,0.00013442979,0.00052889675,0.0003096991,0.00015888836,0.00018162126],"domain_scores_gemma":[0.9984915,0.00063799124,0.00015079044,0.00054097833,0.00007512085,0.00010358829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005420588,0.00008745614,0.00026438272,0.00006106972,0.000055230543,0.00000721279,0.00016266137,0.000126084,0.000025225174],"category_scores_gemma":[0.0011077295,0.000063148866,0.00006780821,0.00025028846,0.00021036579,0.000044771747,0.00005924676,0.0004272387,0.0000069730936],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027190357,0.0016816178,0.9852088,0.000005796787,0.000092178205,0.00006475959,0.00025808034,2.9845054e-7,0.0005154942,0.00026535837,0.00048334277,0.011397086],"study_design_scores_gemma":[0.0032084791,0.00050262385,0.9936651,0.000052111827,0.00024523414,0.00065082544,0.000035957924,0.000007675327,0.00012251765,0.0012650229,0.0001893778,0.00005505681],"about_ca_topic_score_codex":0.0001994465,"about_ca_topic_score_gemma":0.00006310471,"teacher_disagreement_score":0.012427167,"about_ca_system_score_codex":0.000041408442,"about_ca_system_score_gemma":0.0004296271,"threshold_uncertainty_score":0.25751358},"labels":[],"label_agreement":null},{"id":"W2575989280","doi":"10.1182/blood.v120.21.529.529","title":"Cryptic NUP98/NSD1 Translocations Are Highly Prevalent in FLT3/ITD-Positive Acute Myeloid Leukemia and Lead to High Rate of Induction Failure. Report From Children's Oncology Group","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Hospital for Sick Children","funders":"","keywords":"Chromosomal translocation; NPM1; Myeloid leukemia; Sanger sequencing; Internal medicine; CEBPA; Fusion transcript; Oncology; Biology; Cancer research; Medicine; Genetics; Mutation; Gene; Karyotype","score_opus":0.013823085785360678,"score_gpt":0.28017487062929103,"score_spread":0.26635178484393035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2575989280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927434,0.0005763642,0.00032797488,0.004301654,0.0001658545,0.0014698778,0.00013338264,0.000059481426,0.00022201896],"genre_scores_gemma":[0.99259627,0.00022562128,0.005475221,0.00025908698,0.0004933995,0.00019853628,0.0004260443,0.000051735995,0.00027406393],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99754053,0.00027441068,0.0006835774,0.00056355435,0.00036048327,0.00057744206],"domain_scores_gemma":[0.99840826,0.00020179851,0.00025839618,0.00055700785,0.0002035216,0.00037101316],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006511088,0.00028721252,0.00069092814,0.0004055845,0.00008533386,0.000016934808,0.00016280617,0.00034396967,0.00006508806],"category_scores_gemma":[0.00022107652,0.00026864262,0.000089514906,0.0005694313,0.00017584019,0.00028191032,0.00010100738,0.00063889875,0.000047155536],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014963901,0.0035157232,0.32955912,0.0002561467,0.0025385618,0.00086760806,0.0077793254,0.000029794362,0.6431119,0.0005870521,0.0028881335,0.0073702643],"study_design_scores_gemma":[0.006227285,0.00073381973,0.90110487,0.0002561038,0.0010577303,0.0007116561,0.00041256731,0.000014734264,0.0886671,0.00010097884,0.00045324018,0.00025992567],"about_ca_topic_score_codex":0.0022054566,"about_ca_topic_score_gemma":0.00035397342,"teacher_disagreement_score":0.5715457,"about_ca_system_score_codex":0.00087586965,"about_ca_system_score_gemma":0.00047353838,"threshold_uncertainty_score":0.9999766},"labels":[],"label_agreement":null},{"id":"W257599619","doi":"10.1182/blood.v122.21.1748.1748","title":"Developing a Two-Sided Intervention To Facilitate Shared Decision Making In Haemophilia: Decision Boxes For Clinicians and Brief Patient Decision Aids For Patients","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; McMaster University","funders":"","keywords":"Decision aids; Haemophilia; Medicine; Psychological intervention; Patient participation; Delphi method; Health care; Intervention (counseling); Patient satisfaction; Decision support system; Observational study; Family medicine; Nursing; Pediatrics; Alternative medicine; Computer science","score_opus":0.07182782681856885,"score_gpt":0.371082283379956,"score_spread":0.29925445656138716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W257599619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96143615,0.00022669774,0.03274849,0.00035239442,0.00020216798,0.004871155,0.00009374548,0.00003725264,0.000031964908],"genre_scores_gemma":[0.83858144,0.00004382021,0.16024753,0.00018393001,0.000051848987,0.00070745585,0.00008861985,0.00003682492,0.000058516613],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9973685,0.000050942443,0.00091120496,0.00065407634,0.0004891273,0.0005261479],"domain_scores_gemma":[0.99685985,0.0019234059,0.00011754801,0.00039173165,0.00049622095,0.00021127315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055769656,0.0002619461,0.00050655444,0.0005154061,0.00016941167,0.00009927624,0.0001668264,0.00015716754,0.00003680165],"category_scores_gemma":[0.0048254216,0.00020607529,0.00021151347,0.0003317673,0.00003381488,0.00024432674,0.0002690859,0.00013185288,0.00002899817],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002047516,0.0011052793,0.1026958,0.00014062301,0.00006587251,0.000012043574,0.0009338983,0.0000063431035,0.00025452173,0.00003210768,0.00092455465,0.89178145],"study_design_scores_gemma":[0.11084816,0.018408233,0.7840133,0.017674893,0.00036431247,0.00003544936,0.0012586837,0.00277005,0.0053810584,0.053010385,0.0051791854,0.0010563215],"about_ca_topic_score_codex":0.000090637484,"about_ca_topic_score_gemma":0.00022938623,"teacher_disagreement_score":0.89072514,"about_ca_system_score_codex":0.0001623444,"about_ca_system_score_gemma":0.00007192102,"threshold_uncertainty_score":0.8403507},"labels":[],"label_agreement":null},{"id":"W2576001050","doi":"10.1182/blood.v110.11.3132.3132","title":"First Clinical Report of Tipifarnib for the Treatment of T-Large Granular Lymphocyte (LGL) Leukemia.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Bone marrow; Neutropenia; Leukemia; Immunology; Anemia; Internal medicine; Gastroenterology; Toxicity","score_opus":0.04392034777098774,"score_gpt":0.3770399509250474,"score_spread":0.33311960315405964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2576001050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99098986,0.004313272,0.0014000669,0.0001814896,0.00025185687,0.0015520658,0.000039366685,0.00003547975,0.001236523],"genre_scores_gemma":[0.9940003,0.002146415,0.0014558055,0.000067069916,0.000537226,0.0000719121,0.000045038105,0.000044792276,0.0016314037],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99731916,0.00003623042,0.0011575002,0.00037436132,0.00058864045,0.0005241091],"domain_scores_gemma":[0.9963464,0.0017213835,0.00034279027,0.0011050389,0.00029278395,0.00019159897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002055945,0.000192593,0.0007006354,0.000094729774,0.00009630038,0.000005401779,0.00020215708,0.00020575599,0.000058037815],"category_scores_gemma":[0.0007586129,0.00012025279,0.0005409229,0.00024479965,0.0002826027,0.000027342283,0.000049107635,0.00009813983,0.00001235773],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043634243,0.1294271,0.42363688,0.010988483,0.024420286,0.031443562,0.012309345,0.00033285122,0.017041098,0.0072192512,0.020632373,0.2789145],"study_design_scores_gemma":[0.30137488,0.0074146716,0.0396692,0.00038285405,0.0033500802,0.0038636853,0.0005021457,0.004897004,0.19263375,0.0001599185,0.44535068,0.00040113085],"about_ca_topic_score_codex":0.00061215804,"about_ca_topic_score_gemma":0.00020425157,"teacher_disagreement_score":0.4247183,"about_ca_system_score_codex":0.0033974887,"about_ca_system_score_gemma":0.005606211,"threshold_uncertainty_score":0.9945177},"labels":[],"label_agreement":null},{"id":"W2576042684","doi":"10.1182/blood.v104.11.2200.2200","title":"Prospective Cohort Study of the Incidence, Risk Factors and Long-Term Sequelae of Symptomatic Catheter-Related Thrombosis in Adults with Cancer.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Central Venous Catheters and Hemodialysis","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"","keywords":"Medicine; Prospective cohort study; Catheter; Surgery; Thrombosis; Cohort; Incidence (geometry); Cancer; Complication; Parenteral nutrition; Internal medicine","score_opus":0.014494072700245123,"score_gpt":0.3036345800634932,"score_spread":0.2891405073632481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2576042684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968653,0.00011128961,0.0000016283867,0.000020582042,0.00006149399,0.0028021613,0.000045916044,0.000018556715,0.0000730961],"genre_scores_gemma":[0.999571,0.0001944525,0.000012215778,0.000008037603,0.000009704831,0.00017291469,0.0000029576747,0.000018737934,0.000009960576],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984484,0.0002177364,0.0005204072,0.00027078518,0.00026980246,0.00027292527],"domain_scores_gemma":[0.9988615,0.00011893905,0.00052753236,0.00033990585,0.00009446969,0.00005768561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002273747,0.00016690184,0.00050715246,0.000086154556,0.00022351653,0.0000034128866,0.00015918481,0.000106725536,0.0000335839],"category_scores_gemma":[0.00003986553,0.000095660864,0.00006401824,0.00041994167,0.00011547725,0.00006789803,0.000086029824,0.00034589297,0.000001003106],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000345116,0.0020614606,0.92532384,0.00017508557,0.00034023158,0.0000017438464,0.071909025,0.00005211283,0.00007005441,0.000010808428,4.472752e-7,0.000020654918],"study_design_scores_gemma":[0.0047761896,0.000660412,0.9870492,0.0011252015,0.00062041223,8.450367e-7,0.005045084,0.000005886074,0.00051583524,0.00009371253,3.2176132e-8,0.00010717857],"about_ca_topic_score_codex":0.024191549,"about_ca_topic_score_gemma":0.046786673,"teacher_disagreement_score":0.06686394,"about_ca_system_score_codex":0.00014300598,"about_ca_system_score_gemma":0.00020165695,"threshold_uncertainty_score":0.9823064},"labels":[],"label_agreement":null},{"id":"W2576052929","doi":"10.1182/blood.v110.11.1095.1095","title":"Impact of Conditioning on the Outcome of Allografting in Myelofibrosis with Myeloid Metaplasia: Better Survival with Reduced Intensity Approach in Patients ≥50 Years.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Hamilton Health Sciences; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Myelofibrosis; Internal medicine; Fludarabine; Gastroenterology; Transplantation; Surgery; Myeloid; Bone marrow; Cyclophosphamide; Chemotherapy","score_opus":0.020401874767260887,"score_gpt":0.2681464875268918,"score_spread":0.24774461275963092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2576052929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99843633,0.000013349119,0.000015335438,0.00007655749,0.000013632851,0.00062207045,0.000017569506,0.000008718986,0.0007964593],"genre_scores_gemma":[0.99801695,0.0000022853012,0.0017922092,0.00006544564,0.000016368313,0.000031535656,0.00004947393,0.000020190386,0.000005546063],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865407,0.000066591485,0.00041829576,0.00024887518,0.0003574954,0.00025465674],"domain_scores_gemma":[0.999137,0.00022531519,0.00021312971,0.00023463032,0.00013045092,0.000059470887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004279437,0.00018894247,0.00057010195,0.00020569934,0.000026508102,0.00000722403,0.00006272482,0.000064896194,0.000017576975],"category_scores_gemma":[0.000075192795,0.00010185181,0.00009034957,0.00035552963,0.00009670778,0.00004760408,0.000023983986,0.00022195785,0.0000011910686],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010307886,0.002620822,0.99424046,0.000032919073,0.00037771263,0.000025931262,0.00068483764,0.000030645777,0.00072420656,0.000045132398,0.000004531027,0.00018203452],"study_design_scores_gemma":[0.0068142284,0.0023854473,0.97751784,0.00022318568,0.00017806188,0.000008923169,0.00026062995,0.000006407232,0.0125049595,0.000004210914,8.9469756e-7,0.000095229225],"about_ca_topic_score_codex":0.00038484612,"about_ca_topic_score_gemma":0.00013994989,"teacher_disagreement_score":0.016722616,"about_ca_system_score_codex":0.00007480439,"about_ca_system_score_gemma":0.000045171095,"threshold_uncertainty_score":0.41533962},"labels":[],"label_agreement":null},{"id":"W2576178003","doi":"10.1182/blood.v112.11.3260.3260","title":"Outcomes of Second Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Children.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Medicine; Malignancy; Hematopoietic stem cell transplantation; Univariate analysis; Transplantation; Internal medicine; Pediatrics; Surgery; Multivariate analysis","score_opus":0.01337777924538609,"score_gpt":0.23028005848378602,"score_spread":0.21690227923839994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2576178003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959478,0.0003353542,0.0001303178,0.000039212806,0.000040808172,0.00053765945,0.000034365825,0.000042938485,0.0028915699],"genre_scores_gemma":[0.9984166,0.00028806165,0.00065604993,0.00007628559,0.000017812423,0.000023602832,0.000067739005,0.000028245971,0.0004256076],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986398,0.000048817394,0.0005308628,0.00025227547,0.0003011617,0.0002270791],"domain_scores_gemma":[0.9994249,0.00008345288,0.00010930192,0.00025275772,0.00003923829,0.00009036883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012727156,0.00017611777,0.0004529055,0.00018896737,0.000030610543,0.0000027976487,0.00008427642,0.00012433856,0.00015128111],"category_scores_gemma":[0.0000028320496,0.00016085996,0.0001140841,0.0002081343,0.000057697504,0.000058875095,0.000005053778,0.0001278734,0.000040458373],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044198092,0.00078823406,0.96225494,0.00063726504,0.00007625426,0.00016030381,0.0026008147,0.0000064343176,0.033315234,0.000049578117,0.000009272141,0.000057455887],"study_design_scores_gemma":[0.005337352,0.00009817461,0.7051942,0.00008640302,0.00019499163,0.0012905238,0.00008395795,0.00000215386,0.28758815,0.000011283608,0.0000044367816,0.00010841063],"about_ca_topic_score_codex":0.00002654222,"about_ca_topic_score_gemma":0.000023826542,"teacher_disagreement_score":0.2570608,"about_ca_system_score_codex":0.000015400949,"about_ca_system_score_gemma":0.00008431032,"threshold_uncertainty_score":0.6559679},"labels":[],"label_agreement":null},{"id":"W2576191581","doi":"10.1182/blood.v106.11.5578.5578","title":"Canadian Variation in Blood Product Demand Is Influenced by Provincial Rates of Coronary Artery Bypass Graft Surgery.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Blood donation and transfusion practices","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Univariate; Population; Univariate analysis; Multivariate statistics; Blood product; Multivariate analysis; Regression analysis; Statistical significance; Demography; Linear regression; Coronary artery bypass surgery; Surgery; Artery; Internal medicine; Statistics; Environmental health; Mathematics","score_opus":0.009781257319662952,"score_gpt":0.21409947137861976,"score_spread":0.2043182140589568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2576191581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916938,0.00027662003,0.0000066779444,0.0052245986,0.00012591726,0.00035656296,0.000020111229,0.000040872335,0.0022548544],"genre_scores_gemma":[0.9973089,0.000040535208,0.000092033086,0.0019948771,0.0003321034,0.000029808605,0.000052342028,0.000018376142,0.00013100517],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987152,0.000026260124,0.0004337744,0.00030175594,0.0002549829,0.00026799238],"domain_scores_gemma":[0.9993036,0.00007852458,0.0002524317,0.00017335093,0.00016266324,0.000029427332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005063325,0.00015770097,0.00021841905,0.00043976994,0.00011142722,0.00012887843,0.00014406625,0.00007995458,0.00041382154],"category_scores_gemma":[0.00016049863,0.00015973908,0.000053365544,0.0005325172,0.00002822265,0.0017121044,0.000023893077,0.00012911536,0.00006369066],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006966536,0.001823068,0.9720932,0.00019227427,0.00020124094,0.00003794315,0.00035470095,0.000027937393,0.013320581,0.0010214623,0.0049799727,0.0058779432],"study_design_scores_gemma":[0.004445029,0.000025145788,0.9362741,0.000092564376,0.00057155505,0.000024153069,0.0000976542,0.00034350893,0.017953724,0.00054540014,0.039035164,0.000591974],"about_ca_topic_score_codex":0.053846005,"about_ca_topic_score_gemma":0.13158344,"teacher_disagreement_score":0.077737436,"about_ca_system_score_codex":0.000016419868,"about_ca_system_score_gemma":0.00019313043,"threshold_uncertainty_score":0.9524545},"labels":[],"label_agreement":null},{"id":"W2576199044","doi":"10.1182/blood.v108.11.2878.2878","title":"Single Nucleotide Polymorphism of CC Chemokine Ligand 5 Promoter Gene in Recipient May Affect on the Development of Chronic Graft-Versus-Host Disease and Its Severity after Allogeneic Transplantation.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Single-nucleotide polymorphism; CCL5; Immunology; Graft-versus-host disease; Transplantation; Genotype; Hematopoietic stem cell transplantation; Haplotype; Medicine; Biology; Internal medicine; Gene; Genetics; Immune system; T cell; IL-2 receptor","score_opus":0.015866566557778405,"score_gpt":0.2337227537095541,"score_spread":0.21785618715177568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2576199044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99782366,0.0007177297,0.00004227981,0.00032616407,0.00005831272,0.00077321363,0.000048034017,0.000014206891,0.00019641432],"genre_scores_gemma":[0.99912083,0.000090525115,0.00051310577,0.000031964668,0.00005241591,0.00006120181,0.000058216992,0.000022091026,0.000049672355],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99879473,0.00005160335,0.00041738644,0.00024687985,0.0002951525,0.00019423757],"domain_scores_gemma":[0.9994978,0.0001031047,0.000101553975,0.00017909975,0.000041807434,0.00007667071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021647762,0.0001692272,0.000256038,0.0001013302,0.00002996196,0.000005508862,0.000058565714,0.00006219788,0.000031016843],"category_scores_gemma":[0.000012387594,0.00012717208,0.000054004195,0.0001512944,0.000055010525,0.000037179285,0.000010632584,0.00008264075,0.000004499951],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026455277,0.0065743737,0.038746655,0.0021887699,0.00019285727,0.00022013646,0.0023162744,0.0000041405924,0.94659483,0.00005015689,0.0000073139067,0.00045894738],"study_design_scores_gemma":[0.0077025276,0.00019161914,0.32422462,0.0005268366,0.00025353252,0.000019669866,0.000011329651,0.000015546215,0.6669377,0.00000652494,0.000016197566,0.000093879025],"about_ca_topic_score_codex":0.000018107523,"about_ca_topic_score_gemma":0.00012999223,"teacher_disagreement_score":0.28547797,"about_ca_system_score_codex":0.000055254473,"about_ca_system_score_gemma":0.0001236709,"threshold_uncertainty_score":0.5185927},"labels":[],"label_agreement":null},{"id":"W2576221289","doi":"10.1182/blood.v106.11.2632.2632","title":"Heparin Synergistically Enhances Interleukin-11 Signaling through Upregulation of the Map Kinase Pathway.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Heparin; MAPK/ERK pathway; Kinase; Chemistry; STAT3; p38 mitogen-activated protein kinases; Cell biology; Signal transduction; Protein kinase C; Molecular biology; Protein kinase A; Biology; Biochemistry","score_opus":0.017780607842930556,"score_gpt":0.263189928976005,"score_spread":0.24540932113307445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2576221289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925131,0.00018327491,0.001740113,0.0010078277,0.0002342676,0.00021231524,0.000015615955,0.00005257529,0.0040408964],"genre_scores_gemma":[0.9952754,0.0000068984077,0.0033456353,0.00025376107,0.00046239054,0.000015021838,0.00001322891,0.000018421722,0.00060927466],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998941,0.000039997078,0.00039041034,0.00020389576,0.00025067438,0.00017404748],"domain_scores_gemma":[0.9992373,0.00009561398,0.0001521428,0.0003304024,0.00013322088,0.000051312472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000117305295,0.00013228181,0.00022289612,0.0000397554,0.00008702198,0.000017579949,0.00012213559,0.00006683599,0.0003921155],"category_scores_gemma":[0.00014198116,0.00009151806,0.00017667524,0.00013840632,0.00008512663,0.00010754403,0.00005333539,0.00016017914,0.000028644774],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048521568,0.00069898955,0.0013767971,0.00006875362,0.000074845404,0.0000063414,0.00048378084,0.00017956736,0.9910038,0.004247496,0.00029998427,0.0015111231],"study_design_scores_gemma":[0.00094103377,0.00016380053,0.0023529527,0.00042442608,0.00018565776,0.000037659727,0.000103750346,0.00046394466,0.98054296,0.00032234122,0.014360143,0.000101342506],"about_ca_topic_score_codex":0.0000984534,"about_ca_topic_score_gemma":0.00008488526,"teacher_disagreement_score":0.014060158,"about_ca_system_score_codex":0.000030546682,"about_ca_system_score_gemma":0.00008333824,"threshold_uncertainty_score":0.429339},"labels":[],"label_agreement":null},{"id":"W2576268074","doi":"10.1182/blood.v114.22.784.784","title":"Schedule Dependent Effects of Adoptively Transferred Autologous T Cells After AutoSCT for Myeloma: Accelerated Immune Recovery Is Associated with Improved Event-Free Survival.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Ex vivo; Immunology; CD8; Adoptive cell transfer; Multiple myeloma; Immune system; T cell; Transplantation; Internal medicine; Gastroenterology; In vivo; Biology","score_opus":0.007947066621452125,"score_gpt":0.21718593015681378,"score_spread":0.20923886353536167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2576268074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855819,0.0106847575,0.00090636837,0.00023712536,0.00062743755,0.001438301,0.00028820577,0.00016101077,0.000074939744],"genre_scores_gemma":[0.9966769,0.00020099276,0.00029402866,0.00022787253,0.000019309635,0.00017770004,0.00013289682,0.000054842556,0.0022154571],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99755883,0.0004737289,0.00066040293,0.00050302997,0.00008683461,0.0007171828],"domain_scores_gemma":[0.99812776,0.0005991482,0.00031962723,0.00067384104,0.00025021785,0.000029417848],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043519627,0.00046451043,0.0009065524,0.00018581947,0.00019994093,0.000030366855,0.00053891365,0.0005980971,0.00016751558],"category_scores_gemma":[0.00022321085,0.0003910809,0.0003474062,0.0002888476,0.00016849452,0.00019464597,0.000044777917,0.0003668062,0.000020279986],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01068554,0.0022882049,0.000074641575,0.000064118896,0.0021535782,0.000021930577,0.000485232,0.0000036729875,0.98029494,0.00001851796,0.00013654259,0.003773105],"study_design_scores_gemma":[0.021453528,0.005707731,0.042348392,0.00022366975,0.0005147808,0.000032453594,0.00006041078,0.000006365011,0.9288098,0.00007739666,0.00031130374,0.00045415695],"about_ca_topic_score_codex":0.000040998395,"about_ca_topic_score_gemma":0.000016217793,"teacher_disagreement_score":0.051485103,"about_ca_system_score_codex":0.00005190341,"about_ca_system_score_gemma":0.0002352866,"threshold_uncertainty_score":0.9998541},"labels":[],"label_agreement":null},{"id":"W2576302258","doi":"10.1182/blood.v126.23.4464.4464","title":"A Systematic Review of Ultrasound Imaging As a Tool for Evaluating Hemophilic Arthropathy in Children and Adults","year":2015,"lang":"en","type":"review","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Radiological weapon; Cochrane Library; MEDLINE; Diagnostic accuracy; Quality assessment; Medical physics; Ultrasound; External quality assessment; Radiology; Meta-analysis; Pathology","score_opus":0.03789302490473081,"score_gpt":0.3852457754242752,"score_spread":0.3473527505195444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2576302258","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030187292,0.98282605,5.5199285e-7,0.000035457266,0.000019873394,0.01390692,0.00006537016,0.000019480085,0.00010759205],"genre_scores_gemma":[0.00014958621,0.9977493,0.00028975517,0.00004163772,0.00009321957,0.0011929305,0.00030909374,0.000059255523,0.000115177056],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9970674,0.00033007943,0.0012358758,0.00046754905,0.00056333875,0.000335787],"domain_scores_gemma":[0.99806106,0.000550204,0.00045311154,0.00052957336,0.00026504634,0.00014101679],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00244546,0.0003800126,0.003614721,0.00026037009,0.000034965207,0.00001780333,0.00013716961,0.0001329749,0.000016285485],"category_scores_gemma":[0.003963099,0.00024559832,0.00042214245,0.00036141946,0.00006860998,0.00004663511,0.000059727226,0.00025594965,0.00002118717],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000102924605,0.0002986409,0.00036731674,0.93104035,0.00042303253,0.00002362979,0.000058894904,2.0040989e-9,9.3781e-7,0.00000489969,0.000032693115,0.0677393],"study_design_scores_gemma":[0.0033282659,0.00043176604,0.00003081971,0.9836586,0.00955488,0.0022239846,0.0000184688,0.0000032187654,0.000002853683,0.000027050866,0.0005081148,0.00021198101],"about_ca_topic_score_codex":0.000016297992,"about_ca_topic_score_gemma":7.4237795e-7,"teacher_disagreement_score":0.06752732,"about_ca_system_score_codex":0.00008144631,"about_ca_system_score_gemma":0.00070125633,"threshold_uncertainty_score":0.99999964},"labels":[],"label_agreement":null},{"id":"W2576367104","doi":"10.1182/blood.v106.11.1438.1438","title":"Expression of Interleukin-7 Receptor and Activation Markers on Central Memory CD8 Cells in HIV-Infected Individuals Treated with Antiretrovirals.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University Health Centre","funders":"","keywords":"Interleukin-7 receptor; CD38; C-C chemokine receptor type 7; CD8; IL-2 receptor; Immunology; Interleukin 2; Flow cytometry; Aldesleukin; Receptor; Biology; Internal medicine; Molecular biology; Medicine; T cell; Immune system; Cell biology","score_opus":0.0069545813202933305,"score_gpt":0.2183143593771121,"score_spread":0.21135977805681877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2576367104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986304,0.00013611082,0.0000030415533,0.00006880905,0.000018308987,0.0003057078,0.0001035739,0.00002565265,0.0007084142],"genre_scores_gemma":[0.99892175,0.0000656912,0.00016068335,0.0000162035,0.000010715274,0.000018855935,0.00029207574,0.000010909105,0.0005030957],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99908704,0.00018705979,0.00017341506,0.0002181168,0.000047840298,0.00028654965],"domain_scores_gemma":[0.9996272,0.000097572265,0.00008164051,0.00013974113,0.00002288096,0.000031012016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008697929,0.0001350172,0.00019994873,0.00017453181,0.00004324622,0.000007757925,0.00006645531,0.00012547888,0.0002992058],"category_scores_gemma":[0.000024757175,0.000096691,0.000025612419,0.00012157917,0.0000982453,0.00008819903,0.000028941635,0.00016415222,0.00008343184],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065162295,0.00096911786,0.17132463,0.000014077199,0.000109588,0.0000041620565,0.00034481514,0.0000033641902,0.82193756,0.0000041635426,0.0007753071,0.0038616054],"study_design_scores_gemma":[0.00596798,0.00086827105,0.14299946,0.00014386365,0.000022114038,0.000004147731,0.0000970125,4.6801426e-7,0.8491897,7.8614073e-7,0.0006248343,0.0000813702],"about_ca_topic_score_codex":0.00007499239,"about_ca_topic_score_gemma":0.000018746532,"teacher_disagreement_score":0.028325172,"about_ca_system_score_codex":0.00003805222,"about_ca_system_score_gemma":0.000034388977,"threshold_uncertainty_score":0.39429447},"labels":[],"label_agreement":null},{"id":"W2576492167","doi":"10.1182/blood.v126.23.3290.3290","title":"Measuring Quality of End-of-Life Care for Blood Cancers: A National Survey of Hematologic Oncologists","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences","funders":"","keywords":"Medicine; Hematologic Neoplasms; Hematology; Family medicine; Internal medicine; Cancer; Oncology","score_opus":0.5199358173688648,"score_gpt":0.4811171949357485,"score_spread":0.038818622433116345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2576492167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876623,0.009100024,0.00009479284,0.00003991362,0.00008822743,0.00033119082,0.0005209367,0.000014695839,0.0021479307],"genre_scores_gemma":[0.9957374,0.00011431037,0.0039066477,0.000030935487,0.000051983076,0.000027511482,0.00010402228,0.000010397456,0.000016810223],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982918,0.00015920012,0.0006642425,0.0001827855,0.0005471312,0.000154829],"domain_scores_gemma":[0.9959112,0.00079334003,0.0005337135,0.00019597949,0.0024596408,0.00010614708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00112125,0.00012185074,0.00082086585,0.000090830654,0.000014411742,0.000001393808,0.00012915507,0.00011757594,0.000012528349],"category_scores_gemma":[0.007881544,0.00010412967,0.00013651761,0.00019977818,0.00017112085,0.000035750214,0.000038674305,0.000070809176,5.8085845e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053545693,0.0007621681,0.98690784,0.0021691702,0.00052157504,0.0000029259309,0.003099326,0.000029308523,0.005099671,0.00050159055,0.000188967,0.00018199613],"study_design_scores_gemma":[0.019913267,0.002084278,0.451683,0.0015787017,0.0006431652,0.000008978658,0.0053656506,0.000021568336,0.517264,0.00041460225,0.0007311145,0.00029166188],"about_ca_topic_score_codex":0.004479364,"about_ca_topic_score_gemma":0.0022610698,"teacher_disagreement_score":0.5352248,"about_ca_system_score_codex":0.000071860064,"about_ca_system_score_gemma":0.0015838579,"threshold_uncertainty_score":0.94355136},"labels":[],"label_agreement":null},{"id":"W2576559614","doi":"10.1182/blood.v112.11.3843.3843","title":"A Closer Look at Cellular Iron Metabolism in IRP2 Deficient Erythroblasts.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Transferrin receptor; Ferritin; Erythropoiesis; Soluble transferrin receptor; Iron deficiency; Hemoglobin; Biology; Anemia; Transferrin; Serum iron; Iron-deficiency anemia; Transferrin saturation; Endocrinology; Internal medicine; Immunology; Biochemistry; Medicine; Iron status; Serum ferritin","score_opus":0.01140257487372776,"score_gpt":0.21778018073730684,"score_spread":0.2063776058635791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2576559614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97648734,0.009575504,0.000025750805,0.00024400066,0.00019652829,0.00035492764,0.0000071554828,0.000064672226,0.013044135],"genre_scores_gemma":[0.99413586,0.0006697254,0.0006945723,0.0006814702,0.00017101165,0.000026886737,0.000032684875,0.000038958005,0.0035488184],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842334,0.000048848247,0.0003193356,0.0003748268,0.00037746975,0.0004561698],"domain_scores_gemma":[0.9992664,0.000021940179,0.00006409666,0.00044141265,0.000038317336,0.0001678539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014481209,0.00021556366,0.00040970545,0.00018897945,0.00009965897,0.00000654481,0.0001052911,0.0001283927,0.00044777722],"category_scores_gemma":[0.00005433733,0.00018829614,0.00013933217,0.00027469013,0.00012950563,0.00006534914,0.0000867412,0.00019285735,0.0005277942],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012693021,0.018096931,0.46922973,0.0010303124,0.00017463604,0.004336589,0.012744872,0.00019682395,0.46349043,0.005244289,0.021541439,0.0026446471],"study_design_scores_gemma":[0.039794907,0.00036537336,0.6797315,0.00012470756,0.0011061928,0.00083544076,0.0007862862,0.00006018386,0.16923691,0.00025469405,0.106638096,0.001065724],"about_ca_topic_score_codex":0.000098577904,"about_ca_topic_score_gemma":0.00004559445,"teacher_disagreement_score":0.2942535,"about_ca_system_score_codex":0.00002656925,"about_ca_system_score_gemma":0.000093593655,"threshold_uncertainty_score":0.7678493},"labels":[],"label_agreement":null},{"id":"W2576601447","doi":"10.1182/blood.v112.11.686.686","title":"Comprehensive Genomic Screens Reveal Multiple Modes of Action of the PLZF-RAR-α Oncoprotein","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto General Hospital","funders":"","keywords":"Biology; Promoter; Acute promyelocytic leukemia; Gene; Transcription factor; Molecular biology; Genetics; Gene expression; Retinoic acid","score_opus":0.02444172262291396,"score_gpt":0.23564593722360572,"score_spread":0.21120421460069175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2576601447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99760604,0.0011231642,0.00022526034,0.000014251373,0.00003802435,0.00016369774,0.000018810057,0.0000047257913,0.0008060554],"genre_scores_gemma":[0.9979772,0.00027628138,0.0012601573,0.00003614966,0.00008168719,0.0000086350865,0.000018963061,0.000012619448,0.00032829598],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99937814,0.000047470447,0.00018749658,0.0001658667,0.00011026471,0.00011078031],"domain_scores_gemma":[0.9993937,0.000011618905,0.00014836038,0.0003119899,0.00011045604,0.00002388143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004027899,0.000093304785,0.00013288732,0.000015338259,0.00006542734,0.0000019289105,0.00019444249,0.00010869781,0.000004487007],"category_scores_gemma":[0.000045617388,0.000072080074,0.00010187781,0.000060116865,0.00017291619,0.0000022892934,0.000091678055,0.00006908669,0.0000014314837],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004556956,0.00010911923,0.010818291,0.0000691992,0.000051627125,0.0000011481121,0.00004799835,0.00014895247,0.9884076,0.000009219833,0.00010825371,0.00018301347],"study_design_scores_gemma":[0.000848992,0.00013020782,0.0093708895,0.000018549263,0.0000276922,0.00003385994,0.000080880396,0.00003348713,0.9880705,0.000022899225,0.0012834545,0.000078622514],"about_ca_topic_score_codex":0.000055791515,"about_ca_topic_score_gemma":0.0000085419115,"teacher_disagreement_score":0.0014474017,"about_ca_system_score_codex":0.0000054294346,"about_ca_system_score_gemma":0.000105572995,"threshold_uncertainty_score":0.29393402},"labels":[],"label_agreement":null},{"id":"W2576605376","doi":"10.1182/blood.v112.11.2468.2468","title":"Comprehensive Profiling of Micrornas in Murine Hematopoietic Stem Cells and Lineages Using a Microfluidics Approach","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency; Terry Fox Research Institute","funders":"","keywords":"Biology; Haematopoiesis; Stem cell; Progenitor cell; microRNA; Gene expression profiling; Computational biology; Hematopoietic stem cell; Myeloid; Immunology; Cell biology; Genetics; Gene; Gene expression","score_opus":0.02324291715338998,"score_gpt":0.23555382620434093,"score_spread":0.21231090905095096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2576605376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991343,0.007765707,0.000580072,0.0000033162457,0.000019038434,0.00024088756,0.000017977323,0.000005407466,0.000024588171],"genre_scores_gemma":[0.9906957,0.00036099242,0.008810033,0.000016279017,0.000044954693,0.0000050826766,0.000029887975,0.000018697709,0.00001836097],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992568,0.000044043092,0.00023688654,0.00024938319,0.00006946167,0.00014343412],"domain_scores_gemma":[0.9995901,0.0000077460345,0.000095127034,0.00019757319,0.00006628481,0.000043150587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005236386,0.00012084661,0.00017283195,0.000053735337,0.0000340491,0.0000048078305,0.00007326297,0.000101234786,9.0140435e-7],"category_scores_gemma":[0.0000043479026,0.00012620456,0.000044964167,0.00008389346,0.00010341924,0.00000279035,0.000090869034,0.000051254236,4.3414536e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022661234,0.00023787467,0.009131897,0.00022784936,0.00003406074,0.000008340247,0.0001035768,0.000082601735,0.9901066,0.000004026779,0.000013843773,0.000026656015],"study_design_scores_gemma":[0.0011088209,0.000043019292,0.0021801342,0.000033508415,0.00003144981,0.00015972617,0.000104633305,0.00017952557,0.9959291,0.0000033642025,0.00010325384,0.00012346763],"about_ca_topic_score_codex":0.000010496521,"about_ca_topic_score_gemma":4.3013284e-7,"teacher_disagreement_score":0.008229961,"about_ca_system_score_codex":0.0000057404004,"about_ca_system_score_gemma":0.000051885185,"threshold_uncertainty_score":0.51464725},"labels":[],"label_agreement":null},{"id":"W2576634252","doi":"10.1182/blood.v106.11.2249.2249","title":"Outcome of Patients with Secondary Leukemias Managed with Different Treatment Strategies at a Single Center.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Cohort; Internal medicine; Leukemia; Transplantation; Surgery; Gastroenterology; Pediatrics","score_opus":0.01569958775115167,"score_gpt":0.24902361613494373,"score_spread":0.23332402838379207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2576634252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924609,0.00006181123,0.000050102914,0.00012470764,0.00001577475,0.0006316771,0.0000678628,0.000053244607,0.006533904],"genre_scores_gemma":[0.9969535,0.000010268729,0.0007858066,0.00007526136,0.000060023976,0.000037312773,0.00012849752,0.00004406115,0.0019052749],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984323,0.000033675202,0.0002964991,0.00031474067,0.0005464656,0.0003763137],"domain_scores_gemma":[0.9991105,0.00006528102,0.00011154301,0.00042579175,0.000105302846,0.00018155668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000034063196,0.0002631002,0.0004563474,0.00011084907,0.000059694587,0.000020430656,0.00010364958,0.00006810287,0.00022937005],"category_scores_gemma":[0.000009852764,0.00014728337,0.00007021466,0.00011730215,0.00014119635,0.00010462308,0.00007012008,0.00012392829,0.000022341275],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002701481,0.008279523,0.98168135,0.00029007072,0.0009905595,0.0003301054,0.00062581454,0.000025483292,0.0011491195,0.0000393308,0.0001304883,0.0037566635],"study_design_scores_gemma":[0.10263852,0.012602935,0.8440622,0.00029975627,0.00095561286,0.00030378034,0.0005302664,0.00009082315,0.03605891,0.000007636583,0.0020381329,0.0004113998],"about_ca_topic_score_codex":0.0000567732,"about_ca_topic_score_gemma":0.00036281196,"teacher_disagreement_score":0.13761914,"about_ca_system_score_codex":0.0011493019,"about_ca_system_score_gemma":0.00026805338,"threshold_uncertainty_score":0.6006042},"labels":[],"label_agreement":null},{"id":"W2576728170","doi":"10.1182/blood.v118.21.3092.3092","title":"Is There a Role for ASCT in Patients with Desmoplastic Small Round Cell Tumor of the Peritoneum?","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; ThioTEPA; Etoposide; Surgery; Cohort; Cyclophosphamide; Carboplatin; Internal medicine; Plerixafor; Melphalan; Busulfan; Oncology; Autologous stem-cell transplantation; Chemotherapy; Cisplatin","score_opus":0.01767392826803969,"score_gpt":0.2045303778013949,"score_spread":0.18685644953335523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2576728170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977499,0.00032628432,0.0000016662691,0.000030863175,0.00002200634,0.0005854697,0.000020381804,0.000005783816,0.0012575994],"genre_scores_gemma":[0.9991146,0.0000030923973,0.0005972485,0.000101640464,0.000010650339,0.00010373709,0.000003454146,0.000015541907,0.000050084105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995319,0.000012108417,0.00011236481,0.00012528602,0.000093300354,0.00012504507],"domain_scores_gemma":[0.99962246,0.000043045035,0.000058713926,0.00020033288,0.000042352218,0.000033108627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000027199843,0.00008739294,0.00015507093,0.000023966839,0.00002213691,0.000003243081,0.00005833638,0.000023531498,0.000043904533],"category_scores_gemma":[0.0000119021815,0.000046960355,0.000060493352,0.000062351035,0.00002444921,0.000014791349,0.000017592616,0.000041416602,0.0000039597285],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015426599,0.0049344483,0.9939097,0.000044009204,0.0000620929,0.0000073488163,0.0006341217,1.5528781e-7,0.00006683343,0.000018025697,0.000012216007,0.00015677765],"study_design_scores_gemma":[0.0070839697,0.00089867716,0.9576575,0.00009627225,0.00028955218,0.0000033157514,0.000128581,0.000004710145,0.03368143,0.000037621845,0.00006720037,0.000051143827],"about_ca_topic_score_codex":0.00012086061,"about_ca_topic_score_gemma":0.00008933091,"teacher_disagreement_score":0.03625218,"about_ca_system_score_codex":0.000012946021,"about_ca_system_score_gemma":0.000038420454,"threshold_uncertainty_score":0.19149877},"labels":[],"label_agreement":null},{"id":"W2576736597","doi":"10.1182/blood.v114.22.2073.2073","title":"Lack of Inhibition of AKT Predicts Clinical Resistance to Therapy with Imatinib + Reinduction Chemotherapy in Relapsed/Refractory c-Kit+ Acute Myeloid Leukemia.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cytarabine; Internal medicine; Imatinib; Myeloid leukemia; Imatinib mesylate; Gastroenterology; Etoposide; Mitoxantrone; Chemotherapy","score_opus":0.0315470808838495,"score_gpt":0.31778597889663485,"score_spread":0.28623889801278535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2576736597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954463,0.00049256615,0.000028943889,0.00096893567,0.00006048187,0.0009901717,0.00001688197,0.00005678643,0.0019389327],"genre_scores_gemma":[0.9925566,0.00104179,0.0049069854,0.0005933542,0.00017034427,0.000029603245,0.000045378216,0.000037385387,0.0006185721],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99780655,0.00009866367,0.0008929866,0.00044864404,0.00047334327,0.0002798224],"domain_scores_gemma":[0.998572,0.00008962946,0.0004197641,0.00061628607,0.0001598958,0.00014242053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042422308,0.0002433333,0.0007171026,0.00019354722,0.00002535367,0.0000050458143,0.00009812673,0.00023787202,0.000043882443],"category_scores_gemma":[0.00009035034,0.00019696061,0.000119283824,0.00049636705,0.00011097992,0.00010487015,0.0000125725555,0.00033662547,0.000008818899],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041013233,0.019287186,0.13310415,0.00057752203,0.0020510058,0.00057152426,0.0052650925,0.00007626149,0.7084796,0.00040559343,0.0059208605,0.083248],"study_design_scores_gemma":[0.06531156,0.009755633,0.44829187,0.0016894686,0.0002866559,0.00007119033,0.00010970546,0.000014408039,0.47252885,0.00023607783,0.0014046256,0.00029995112],"about_ca_topic_score_codex":0.000049052764,"about_ca_topic_score_gemma":0.000052944517,"teacher_disagreement_score":0.31518772,"about_ca_system_score_codex":0.00041516675,"about_ca_system_score_gemma":0.00063257135,"threshold_uncertainty_score":0.80318207},"labels":[],"label_agreement":null},{"id":"W2576778863","doi":"10.1182/blood.v114.22.2990.2990","title":"The CDC Hemostasis and Thrombosis Centers (HTC) Pilot Sites: Data From the Pediatric Registry.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cohort; Incidence (geometry); Pediatrics; Thrombosis; Venous thrombosis; Surgery; Internal medicine","score_opus":0.06183668550684634,"score_gpt":0.29838428206815226,"score_spread":0.23654759656130592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2576778863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9654011,0.0069228453,0.000017778108,0.023850467,0.00012633413,0.00058129797,0.00012943315,0.0000752111,0.0028955105],"genre_scores_gemma":[0.9805969,0.013774984,0.00026222537,0.004479639,0.0005961285,0.000012282196,0.00015920664,0.000018763185,0.00009985094],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9986826,0.000052040938,0.00023583985,0.00041486765,0.00030536047,0.00030929552],"domain_scores_gemma":[0.99795383,0.00026265715,0.00011034232,0.0015292332,0.000033633525,0.00011031703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002957138,0.00017750032,0.00028246653,0.000025229256,0.00036364,0.00015120365,0.0005376214,0.000040855262,0.00006289414],"category_scores_gemma":[0.00016998225,0.00009876005,0.000049432765,0.00017917834,0.00008030815,0.00009140942,0.00028002792,0.00016394029,0.000039752755],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010832041,0.0048470413,0.38217598,0.00008345948,0.0010042688,0.00006700935,0.0007504298,0.0000011423156,0.0011580118,0.0014354747,0.5944089,0.0139599545],"study_design_scores_gemma":[0.0023121058,0.0005653746,0.95020646,0.00005499268,0.0021244297,0.000012162405,0.0005041733,0.000029327406,0.00018452591,0.00031681595,0.043514896,0.00017472432],"about_ca_topic_score_codex":0.00028703627,"about_ca_topic_score_gemma":0.00007765298,"teacher_disagreement_score":0.5680305,"about_ca_system_score_codex":0.000013808338,"about_ca_system_score_gemma":0.000034672827,"threshold_uncertainty_score":0.4027318},"labels":[],"label_agreement":null},{"id":"W2576868645","doi":"10.1182/blood.v104.11.1736.1736","title":"Several Mechanisms Contribute to the Basic Carboxypeptidase Mediated Downregulation of Fibrinolysis.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Alberta Health Services","funders":"","keywords":"Plasmin; Aprotinin; Fibrinolysis; Antifibrinolytic; Carboxypeptidase; Fibrin; Chemistry; Biochemistry; Lysis; Zymogen; Thrombin; Platelet; Enzyme; Biology; Immunology; Internal medicine; Medicine; Tranexamic acid","score_opus":0.004737653462575955,"score_gpt":0.19866998280561085,"score_spread":0.1939323293430349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2576868645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874613,0.0001920188,0.011193919,0.00045373218,0.00006986664,0.00035075162,0.000079378704,0.000015623827,0.00018337635],"genre_scores_gemma":[0.9981376,0.000012437717,0.0010248813,0.00039618879,0.00017015604,0.00003412808,0.0001432014,0.00001310386,0.00006833498],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992267,0.00003660596,0.00017612062,0.00021504486,0.00015744909,0.00018806633],"domain_scores_gemma":[0.99942875,0.0000060203156,0.0000709864,0.0003334554,0.00008510415,0.00007568901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001525252,0.00011430719,0.00012370158,0.000029580242,0.000057035635,0.000010477014,0.0001546887,0.00009982614,0.0000123245545],"category_scores_gemma":[0.00007696696,0.00008628324,0.00008671903,0.000114673356,0.000018516512,0.0000034369436,0.00008348171,0.00004627635,0.000020437154],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003336824,0.000082394865,0.000012780087,0.000005158678,0.00005843502,0.0000023934572,0.000039452705,0.00030049295,0.99818194,0.00110153,0.00009755611,0.0000845249],"study_design_scores_gemma":[0.001436184,0.00033728566,0.00041386342,0.000016351656,0.000051807434,0.0000098332775,0.00001645391,0.000013602891,0.9958167,0.00086491765,0.0009083372,0.000114637274],"about_ca_topic_score_codex":0.00005006202,"about_ca_topic_score_gemma":0.000039235838,"teacher_disagreement_score":0.010676236,"about_ca_system_score_codex":0.000008040731,"about_ca_system_score_gemma":0.00006320617,"threshold_uncertainty_score":0.35185283},"labels":[],"label_agreement":null},{"id":"W2576909123","doi":"10.1182/blood.v104.11.4939.4939","title":"The Effect of Increasing Zoledronic Acid Dose and Infusion Rate on Pharmacokinetics, Pharmacodynamics, and Renal Function in Patients with Multiple Myeloma.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Medicine; Zoledronic acid; Pharmacokinetics; Cmax; Multiple myeloma; Regimen; Renal function; Adverse effect; Pharmacodynamics; Internal medicine; Urology; Surgery","score_opus":0.005394093303611121,"score_gpt":0.24895226954896796,"score_spread":0.24355817624535683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2576909123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985637,0.00041888328,0.0000062404292,0.000054134238,0.00002851729,0.00084758236,0.00001215058,0.00001591447,0.000052846448],"genre_scores_gemma":[0.99952054,0.00026131576,0.00007877421,0.000021980268,0.000026083171,0.000025124686,0.000041590458,0.000017586906,0.000007024701],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998997,0.00014388273,0.00017140385,0.00021182442,0.00023906166,0.00023685428],"domain_scores_gemma":[0.9994104,0.00021087007,0.000070020695,0.00013388653,0.00004724556,0.00012756714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003097865,0.00015516194,0.00019952774,0.000106830215,0.000104666666,0.000016984495,0.000036310114,0.000039836515,0.0000035832784],"category_scores_gemma":[0.00013558396,0.0000895043,0.00002258827,0.00012530126,0.000107345935,0.00006140855,0.000046370908,0.00018242112,0.0000021384867],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016379021,0.00052709196,0.91385746,0.00009300569,0.00018868528,0.00003376766,0.000053566266,0.00002978093,0.037635393,0.000003486175,0.000001461848,0.031197272],"study_design_scores_gemma":[0.06986811,0.004237856,0.86946887,0.0002134729,0.00018923107,0.000008770414,0.0000060586844,0.00041849035,0.05549378,0.000007464123,0.000015861659,0.000072049384],"about_ca_topic_score_codex":0.0001376223,"about_ca_topic_score_gemma":0.000067432775,"teacher_disagreement_score":0.05348909,"about_ca_system_score_codex":0.000048195394,"about_ca_system_score_gemma":0.000034758898,"threshold_uncertainty_score":0.3649879},"labels":[],"label_agreement":null},{"id":"W2576914903","doi":"10.1182/blood.v120.21.1637.1637","title":"Subcutaneous Rituximab in Combination with Fludarabine and Cyclophosphamide for Patients with CLL: Initial Results of a Phase Ib Study (SAWYER [BO25341]) Show Non-Inferior Pharmacokinetics and Comparable Safety to That of Intravenous Rituximab","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Rituximab; Medicine; Tolerability; Fludarabine; Cyclophosphamide; Internal medicine; Population; Phases of clinical research; Pharmacokinetics; Oncology; Gastroenterology; Adverse effect; Pharmacology; Clinical trial; Chemotherapy; Lymphoma","score_opus":0.016747515598104817,"score_gpt":0.30809539563626565,"score_spread":0.2913478800381608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2576914903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99498737,0.00024474578,0.00015205599,0.00006530071,0.000041976287,0.004129734,0.00023291794,0.000017356579,0.00012852292],"genre_scores_gemma":[0.9979142,0.0000566245,0.0016744296,0.000043079388,0.000041101313,0.000102213955,0.00009775062,0.000047359477,0.000023266226],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99783707,0.000069809954,0.00057537114,0.00037851828,0.00062267156,0.0005165482],"domain_scores_gemma":[0.9985322,0.00030883425,0.00020983632,0.00033394716,0.00036617048,0.0002490263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005025526,0.0002714276,0.00083686644,0.00023618889,0.000064812724,0.00001635055,0.0001079206,0.000082273174,0.00000711454],"category_scores_gemma":[0.00012472089,0.00021174755,0.000028884462,0.00034656454,0.00020672518,0.00013859934,0.00009341056,0.00018435638,0.0000010529783],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29283684,0.29852617,0.34639046,0.0033481831,0.0015605015,0.00065090426,0.025429908,0.00007926888,0.0049957316,0.00005468121,0.00017761666,0.025949737],"study_design_scores_gemma":[0.85964614,0.031430397,0.07920543,0.0005312338,0.00085177814,0.00030364923,0.00071269943,0.0016003652,0.025162814,0.000009589857,0.00016789699,0.0003780015],"about_ca_topic_score_codex":0.0004846729,"about_ca_topic_score_gemma":0.00015234342,"teacher_disagreement_score":0.5668093,"about_ca_system_score_codex":0.00047331498,"about_ca_system_score_gemma":0.0006539923,"threshold_uncertainty_score":0.86348146},"labels":[],"label_agreement":null},{"id":"W2576941554","doi":"10.1182/blood.v118.21.702.702","title":"ENDOTHELIAL GAS6 Contributes to Thrombogenesis and Promotes TISSUE FACTOR Upregulation DURING Vessel Injury","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Thrombus; Platelet; GAS6; Tissue factor; Platelet activation; Endothelium; Inferior vena cava; Biology; Internal medicine; Endocrinology; Pathology; Immunology; Medicine; Receptor; Coagulation; Receptor tyrosine kinase","score_opus":0.01674271504223417,"score_gpt":0.2300034636167815,"score_spread":0.21326074857454733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2576941554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99720466,0.0018212167,0.00010552454,0.000054080345,0.0001961411,0.00033247602,0.000060394214,0.000068869704,0.00015666113],"genre_scores_gemma":[0.99931675,0.000044333396,0.00014504851,0.00002193195,0.000030093206,0.000028807386,0.000027055863,0.0000158738,0.0003701155],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992437,0.00006933298,0.00020524889,0.000231017,0.00002325451,0.00022746243],"domain_scores_gemma":[0.99965316,0.000026909256,0.00007016509,0.00018004839,0.00004843081,0.000021296768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006768657,0.00013883553,0.00021294682,0.00008882627,0.00016132671,0.000015589789,0.000089893,0.00014851583,0.00020996889],"category_scores_gemma":[0.000044870696,0.00012519628,0.000031985976,0.00008271053,0.00006232706,0.000121714285,0.00006967831,0.00006231183,0.000095549854],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008591029,0.00017477143,0.015779149,0.00001550249,0.00013147845,5.893806e-7,0.0006004965,1.00103506e-7,0.9798532,0.00025436233,0.00003170424,0.0030727214],"study_design_scores_gemma":[0.0008313207,0.000108355685,0.39038658,0.000019183817,0.00004411115,0.000011071178,0.000018252626,2.6314655e-7,0.6077707,0.00011013617,0.0006134576,0.00008659438],"about_ca_topic_score_codex":0.000057664023,"about_ca_topic_score_gemma":0.000005204408,"teacher_disagreement_score":0.3746074,"about_ca_system_score_codex":0.000012175535,"about_ca_system_score_gemma":0.000015753989,"threshold_uncertainty_score":0.5105356},"labels":[],"label_agreement":null},{"id":"W2576945848","doi":"10.1182/blood.v118.21.3185.3185","title":"Single-Centre, North American Experience with Compassionate Use of Deferiprone in Patients with Beta-Thalassemia Major,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Deferiprone; Deferasirox; Medicine; Thalassemia; Pediatrics; Adverse effect; Beta thalassemia; Internal medicine","score_opus":0.01668985169914168,"score_gpt":0.19764922569600926,"score_spread":0.18095937399686757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2576945848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988987,0.00003634505,0.0000134321845,0.000028032166,0.000017333758,0.00038865683,0.000008824762,0.000028213235,0.0005804635],"genre_scores_gemma":[0.99719167,0.0000095239675,0.0025937052,0.00007991608,0.000004299017,0.000012891111,0.000025881685,0.00002448312,0.000057610312],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989347,0.000025771216,0.00024395845,0.0002426015,0.0002821506,0.00027081044],"domain_scores_gemma":[0.9993065,0.000016834023,0.00015617406,0.0002675771,0.000114518414,0.00013836993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000020957043,0.0001632048,0.00033721354,0.000093037,0.000029719326,0.0000055294036,0.00007018141,0.00004198934,0.000038834085],"category_scores_gemma":[0.000015059906,0.00010305129,0.000030061985,0.0005138206,0.00025375906,0.00009457229,0.000028156572,0.00015155063,0.000004483081],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007079809,0.0035139741,0.9925664,0.000029738387,0.00008282014,0.000050853152,0.001632634,0.0000036933886,0.00012981625,0.000007165455,0.000019835425,0.0012550654],"study_design_scores_gemma":[0.0063598654,0.0015835279,0.98817825,0.00018926486,0.00014487804,0.0000066994376,0.0005260155,0.000006936795,0.0026864726,5.454235e-7,0.00016776496,0.00014979843],"about_ca_topic_score_codex":0.00037892847,"about_ca_topic_score_gemma":0.00039386726,"teacher_disagreement_score":0.0056518842,"about_ca_system_score_codex":0.000020465659,"about_ca_system_score_gemma":0.000049784067,"threshold_uncertainty_score":0.42023095},"labels":[],"label_agreement":null},{"id":"W2576948015","doi":"10.1182/blood.v112.11.80.80","title":"Impact of Autologous Dendritic Cell Immunotherapy (Arcelis™) on B Cell Subsets in HIV-1-Infected Subjects Receiving Antiretroviral Therapy","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; Centre Hospitalier de l’Université de Montréal; Université de Montréal; McGill University Health Centre","funders":"","keywords":"CD38; CD40; CD8; Immunology; Immunoglobulin D; Dendritic cell; CD19; B cell; CD154; Immunophenotyping; CD23; CD20; Immune system; Immunotherapy; CD5; Flow cytometry; Cytotoxic T cell; Antigen; Medicine; Biology; Antibody; CD34; Immunoglobulin E; Cell biology; In vitro","score_opus":0.013884362814459946,"score_gpt":0.2569916181653187,"score_spread":0.24310725535085873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2576948015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99153733,0.0057351305,0.000003204323,0.00001723519,0.000098492426,0.00041314453,0.000113147275,0.00006882994,0.0020135015],"genre_scores_gemma":[0.9965108,0.0023548598,0.00004627112,0.000019726056,0.000014858064,0.00002876448,0.00019775551,0.000034728775,0.00079222204],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99808776,0.00040901866,0.00034461415,0.00035972413,0.000080135425,0.0007187246],"domain_scores_gemma":[0.9990897,0.00026570278,0.000118336684,0.0004200834,0.000060595958,0.000045564706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014810679,0.0002878661,0.0004685491,0.0003262867,0.00014772432,0.0000086222835,0.0002505416,0.0002565314,0.00054135104],"category_scores_gemma":[0.000035013796,0.00022774664,0.00023636177,0.00030960471,0.00021809123,0.00006917952,0.000030818053,0.00040989468,0.0007527216],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000482515,0.003264758,0.47713044,0.000010984428,0.00015725684,0.00020703865,0.00062923034,0.000005031973,0.5169247,0.0000028444392,0.00029570996,0.00088952313],"study_design_scores_gemma":[0.01117937,0.0033197491,0.58976716,0.000025250118,0.000010669277,0.0001092707,0.000019010027,9.4278596e-7,0.39532384,0.0000064012534,0.000075792945,0.00016251035],"about_ca_topic_score_codex":0.00086538313,"about_ca_topic_score_gemma":0.000032769593,"teacher_disagreement_score":0.1216008,"about_ca_system_score_codex":0.00008172381,"about_ca_system_score_gemma":0.00024141086,"threshold_uncertainty_score":0.96749645},"labels":[],"label_agreement":null},{"id":"W2576963054","doi":"10.1182/blood.v118.21.5280.5280","title":"Successful Tolerance of Deferasirox Following Desensitization for Significant Skin Rash","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia; Providence Health Care","funders":"","keywords":"Deferasirox; Medicine; Rash; Tolerability; Adverse effect; Deferiprone; Deferoxamine; Gastroenterology; Internal medicine; Surgery; Dermatology; Thalassemia","score_opus":0.015333867110591284,"score_gpt":0.21682655204774906,"score_spread":0.20149268493715777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2576963054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98971134,0.004737558,0.003193357,0.000009130416,0.00040982914,0.00028409052,0.000015965617,0.000044390355,0.0015943109],"genre_scores_gemma":[0.99934477,0.00002349357,0.00029567743,0.000037446418,0.00000277197,0.000027359109,0.00006209689,0.000015056963,0.00019134364],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99918044,0.000060230945,0.00028420438,0.00019213278,0.000024948064,0.00025804498],"domain_scores_gemma":[0.9995393,0.000070414615,0.00011827666,0.00020459415,0.000063648295,0.0000037213117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018353824,0.000120305,0.0002300682,0.00006359509,0.00014063662,0.0000047068456,0.00017318281,0.00013024644,0.000091456335],"category_scores_gemma":[0.00006264884,0.00011427778,0.0001603949,0.000119470285,0.00009060201,0.000078455116,0.000024635374,0.00007923015,0.00002988164],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001192572,0.000987379,0.013074453,0.00005415456,0.0002556212,0.000002859088,0.0028365639,0.000009644895,0.9757851,0.002479991,0.000037835707,0.004357191],"study_design_scores_gemma":[0.003281554,0.00014376671,0.024652395,0.00004628497,0.00015355648,0.000008004677,0.00096187607,0.00000827304,0.96906495,0.00055521907,0.0009259011,0.00019820326],"about_ca_topic_score_codex":0.00009714474,"about_ca_topic_score_gemma":0.0000025788347,"teacher_disagreement_score":0.011577942,"about_ca_system_score_codex":0.0000043027544,"about_ca_system_score_gemma":0.00003479536,"threshold_uncertainty_score":0.46601126},"labels":[],"label_agreement":null},{"id":"W2576993890","doi":"10.1182/blood.v112.11.237.237","title":"Investigating the Mechanisms Underlying FVIII Antibody Production in Hemophilic Mice Following Recombinant and Plasma-Derived FVIII Infusion","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Recombinant DNA; Antibody; Immunology; Medicine; Titer; Cytokine; Antigen; Immune system; Antibody titer; Interleukin 10; Chemistry; Gene; Biochemistry","score_opus":0.05254624178278281,"score_gpt":0.3079764839959799,"score_spread":0.25543024221319705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2576993890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99413115,0.00035352982,0.000008126927,0.004163593,0.0001969095,0.00079185347,4.6367944e-7,0.00006406447,0.00029032183],"genre_scores_gemma":[0.9975781,0.000379106,0.0013836976,0.00010698911,0.000060867176,0.00003379413,0.000019570505,0.000027762577,0.0004101569],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985157,0.00010879897,0.00027821315,0.00038256534,0.00035495713,0.00035975504],"domain_scores_gemma":[0.9994153,0.00010502858,0.00006489297,0.00024994352,0.00004178841,0.00012304746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046491093,0.00017864381,0.00027736812,0.00017048696,0.000492281,0.00002265448,0.00008192995,0.00010721113,0.0000066752787],"category_scores_gemma":[0.00036242735,0.00011893415,0.00007122995,0.00041873672,0.000115520765,0.00013444072,0.00009299209,0.0003398567,0.000011096405],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026898259,0.00038586665,0.065603435,0.000083093364,0.00007747036,0.00024587908,0.0020928541,0.000002850489,0.9298017,0.000052232364,0.000021049531,0.0016066509],"study_design_scores_gemma":[0.013545012,0.0011734848,0.33988476,0.0014722925,0.0003514088,0.0020632278,0.0026257085,0.0009904496,0.6345427,0.0027500475,0.000090722075,0.0005101858],"about_ca_topic_score_codex":0.00011824396,"about_ca_topic_score_gemma":0.000031000105,"teacher_disagreement_score":0.295259,"about_ca_system_score_codex":0.000047646365,"about_ca_system_score_gemma":0.00012616195,"threshold_uncertainty_score":0.4849994},"labels":[],"label_agreement":null},{"id":"W2577036545","doi":"10.1182/blood.v114.22.3576.3576","title":"Generation and Implementation of a Novel Murine Xenograft Model for Evaluating Human Hematopoietic Cell-Targeted Gene Therapies for Fabry Disease.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; University Health Network; Ontario Institute for Cancer Research","funders":"","keywords":"Severe combined immunodeficiency; Nod; Globotriaosylceramide; Fabry disease; Biology; Spleen; Transplantation; Sandhoff disease; Krabbe disease; Genetic enhancement; Immunology; Internal medicine; Medicine; Endocrinology; In vivo; Gene; Disease; Leukodystrophy; Diabetes mellitus; Genetics","score_opus":0.0885928812565905,"score_gpt":0.3976911981508325,"score_spread":0.309098316894242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2577036545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9380582,0.0014464373,0.058197923,0.00036787533,0.000008640807,0.0018117981,0.000076975804,0.000021903648,0.000010245149],"genre_scores_gemma":[0.9727075,0.000025515821,0.026387246,0.000098900826,0.00007719471,0.00024637493,0.00035373363,0.000020603851,0.00008293274],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99904805,0.000014194957,0.0002612822,0.00021911332,0.00025440272,0.00020297903],"domain_scores_gemma":[0.9994292,0.000028689152,0.000091164744,0.00014915239,0.00021567068,0.000086082735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022977214,0.00011050236,0.00018764124,0.00008704592,0.0001335029,0.000017639963,0.00004708552,0.0000369277,0.000015754007],"category_scores_gemma":[0.00004162168,0.000101335,0.000077004275,0.00007079127,0.00002429351,0.00006446657,0.000014172042,0.0000382615,1.4568863e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013201093,0.00089106325,0.0029191375,0.00036471017,0.00006851039,6.474488e-7,0.001237331,0.0001515604,0.9905487,0.00022618158,0.000073706,0.0033864882],"study_design_scores_gemma":[0.03550412,0.0030793971,0.025959881,0.00006757927,0.00085043814,0.000008546806,0.00093564583,0.48417082,0.4470099,0.002076169,0.0000135762975,0.00032391484],"about_ca_topic_score_codex":0.000013871624,"about_ca_topic_score_gemma":0.00001211592,"teacher_disagreement_score":0.54353875,"about_ca_system_score_codex":0.000016561771,"about_ca_system_score_gemma":0.00008720442,"threshold_uncertainty_score":0.41323212},"labels":[],"label_agreement":null},{"id":"W2577122677","doi":"10.1182/blood.v110.11.775.775","title":"Missplicing of Glycogen Synthase Kinase 3β: A Potential Mechanism of Blast Crisis Chronic Myeloid Leukemia Stem Cell Generation.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cancer research; Biology; Stem cell; Myeloid leukemia; Progenitor cell; Immunology; Cell biology","score_opus":0.012448884815565359,"score_gpt":0.23715488911954571,"score_spread":0.22470600430398036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2577122677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99247825,0.0018067,0.0037185194,0.000048216076,0.00017608392,0.0006449983,0.00005732143,0.000062625804,0.001007303],"genre_scores_gemma":[0.9958546,0.00013670715,0.002608587,0.000066756875,0.0005112516,0.000018052953,0.00006771312,0.000067017405,0.000669272],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975512,0.000049054815,0.0008163945,0.00048658173,0.00059073494,0.0005060278],"domain_scores_gemma":[0.99835014,0.00006353261,0.00039398458,0.0007262394,0.00020411333,0.00026197892],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038100698,0.00032334338,0.00062438374,0.0002551515,0.00008322802,0.000010301017,0.00017727248,0.00022327495,0.00023091379],"category_scores_gemma":[0.000024054783,0.00030874606,0.00026486412,0.00031304735,0.000066667555,0.000080832775,0.00009144629,0.00020849363,0.000038963542],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018277088,0.00096111913,0.00020918847,0.0005232722,0.00038765874,0.00048304608,0.00038256994,0.00012937142,0.99379617,0.00016542803,0.00029594701,0.0024834522],"study_design_scores_gemma":[0.011763766,0.0009407647,0.00031573843,0.00019239372,0.0013526848,0.00021913109,0.00037581837,0.0011620262,0.98332316,0.000017078066,0.0001179659,0.00021949154],"about_ca_topic_score_codex":0.00052174344,"about_ca_topic_score_gemma":0.00006624239,"teacher_disagreement_score":0.011580995,"about_ca_system_score_codex":0.0010398943,"about_ca_system_score_gemma":0.001116206,"threshold_uncertainty_score":0.99993646},"labels":[],"label_agreement":null},{"id":"W2577148464","doi":"10.1182/blood.v120.21.846.846","title":"Identification of a Two-Step Mechanism Responsible for Antibody-Mediated Transfusion Related Acute Lung Injury (TRALI)","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Transfusion-related acute lung injury; Lung; Antibody; Immunology; In vivo; Medicine; Monoclonal antibody; Complement system; Pulmonary edema; Biology; Internal medicine","score_opus":0.005927822872874017,"score_gpt":0.2772657463331274,"score_spread":0.27133792346025337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2577148464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994687,0.0010384972,0.0032196988,0.000056788616,0.00014783799,0.00049410097,0.00020139833,0.00001737972,0.00013729974],"genre_scores_gemma":[0.99761003,0.00038031058,0.00074822595,0.000029557981,0.000040729108,0.00005692743,0.00079912425,0.00002530327,0.00030981272],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99913573,0.00004859469,0.00027560422,0.00021456038,0.000093798066,0.00023173902],"domain_scores_gemma":[0.9994706,0.000012156907,0.00012185431,0.0002595149,0.00006901947,0.0000668512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021139259,0.0001269864,0.00014381837,0.000056431552,0.000067214525,0.00000813878,0.000094975854,0.00015991816,0.00000952008],"category_scores_gemma":[0.000030628304,0.00011978609,0.00011402026,0.000116517425,0.000025342426,0.0000095568585,0.00002425589,0.000039991,0.0000064549195],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017551692,0.0008162218,0.0036186825,0.000024492738,0.00037305942,6.481048e-7,0.00006866106,6.105149e-7,0.9936281,0.0008481941,0.00012213897,0.00032367412],"study_design_scores_gemma":[0.0036655464,0.00030874196,0.0011534353,0.0000120078175,0.0004822906,0.000008763462,0.000025058634,0.00005948375,0.99359834,0.00033286738,0.00022120962,0.0001322664],"about_ca_topic_score_codex":0.000015458763,"about_ca_topic_score_gemma":0.0000067087612,"teacher_disagreement_score":0.0034900294,"about_ca_system_score_codex":0.000003935014,"about_ca_system_score_gemma":0.0000409135,"threshold_uncertainty_score":0.4884735},"labels":[],"label_agreement":null},{"id":"W2577204667","doi":"10.1182/blood.v126.23.3760.3760","title":"Re-Induction Outcome for Pediatric Patients with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia: A Retrospective Cohort Study of the Therapeutic Advances in Childhood Leukemia Consortium","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Internal medicine; Retrospective cohort study; Cohort; Clinical endpoint; Hematopoietic stem cell transplantation; Transplantation; Clinical trial; Oncology; Pediatrics","score_opus":0.015073015654292558,"score_gpt":0.2756505150572282,"score_spread":0.2605774994029357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2577204667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922441,0.00030576868,0.00006011401,0.000039777202,0.00035072086,0.0063097565,0.000057940826,0.00006901671,0.00056275923],"genre_scores_gemma":[0.9980827,0.00007549669,0.0002654653,0.00008077692,0.0002054234,0.00060208305,0.000026453417,0.00009819803,0.0005633788],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960361,0.00023112167,0.000876171,0.00078867766,0.001454484,0.00061340746],"domain_scores_gemma":[0.9970574,0.00043893015,0.0006212139,0.00089925306,0.0007419488,0.00024126255],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00062925706,0.00042350194,0.0009156766,0.0003247325,0.000121571924,0.000022532306,0.00039667828,0.00025566044,0.000014842607],"category_scores_gemma":[0.0009996289,0.00024859898,0.00012702312,0.0011384464,0.00017152613,0.000312785,0.00013536825,0.0005840349,0.0000096460935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040615066,0.0052669384,0.98789483,0.00016831404,0.00036835164,0.00002992426,0.0017507398,0.00007803818,0.000049976057,0.0000046422842,0.00015095375,0.00017580848],"study_design_scores_gemma":[0.073519245,0.010379317,0.9105319,0.00009266737,0.0027760472,0.00002416828,0.0015536852,0.00014660662,0.00056875905,0.000044751272,0.000055692624,0.00030716325],"about_ca_topic_score_codex":0.000099319346,"about_ca_topic_score_gemma":0.0002211653,"teacher_disagreement_score":0.07736291,"about_ca_system_score_codex":0.003893146,"about_ca_system_score_gemma":0.0039074733,"threshold_uncertainty_score":0.9999966},"labels":[],"label_agreement":null},{"id":"W2577216908","doi":"10.1182/blood.v124.21.1357.1357","title":"Edx-17: A Novel, Safe and Efficacious Treatment for Sickle Cell Disease","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Fetal hemoglobin; Globin; Erythroblast; Hemoglobin; Fetus; Peripheral blood mononuclear cell; Ferritin; Immunology; Transgene; Biology; Molecular biology; In vitro; Medicine; Gene; Anemia; Internal medicine; Erythropoiesis; Biochemistry; Genetics; Pregnancy","score_opus":0.008215379845151775,"score_gpt":0.22602700558731037,"score_spread":0.2178116257421586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2577216908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883861,0.0023474677,0.00049248186,0.0015191823,0.00008519798,0.00074327405,0.00005140208,0.00006582964,0.0063090865],"genre_scores_gemma":[0.9955708,0.00019636149,0.00066637015,0.00042640354,0.00014196074,0.000048586837,0.000040685034,0.000022237375,0.0028866432],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994003,0.000008037284,0.000116515934,0.00020209291,0.00007531068,0.0001976975],"domain_scores_gemma":[0.9994525,0.00005406799,0.00002938167,0.00018556899,0.000023995906,0.00025448788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000045968147,0.00012294465,0.00018487855,0.000031967764,0.000072793315,0.000010042215,0.000025735184,0.00006675157,0.000022363784],"category_scores_gemma":[0.000041296855,0.00008704507,0.00008021669,0.00004305502,0.00003801679,0.000013701272,0.000012402671,0.00004580392,0.00001351253],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010915721,0.12089587,0.13288787,0.006385858,0.0039657196,0.00070657005,0.00953009,0.00049978186,0.24460986,0.008061219,0.04588666,0.41565475],"study_design_scores_gemma":[0.116270594,0.008095135,0.018768497,0.00032304117,0.0052196705,0.0001230668,0.00037247798,0.0034507243,0.021652645,0.00048320173,0.82436043,0.00088054466],"about_ca_topic_score_codex":0.000010002904,"about_ca_topic_score_gemma":0.0000030068172,"teacher_disagreement_score":0.77847373,"about_ca_system_score_codex":0.000012329969,"about_ca_system_score_gemma":0.000046680452,"threshold_uncertainty_score":0.3549595},"labels":[],"label_agreement":null},{"id":"W2577280378","doi":"10.1182/blood.v108.11.581.581","title":"The Pathogen Inactivation of Platelets: Studies of the Possible Mechanisms of the Platelet Dysfunction Seen Following Photochemical Treatment.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; McMaster University","funders":"","keywords":"Platelet; In vivo; DNA damage; Biology; Chemistry; DNA; Biochemistry; Molecular biology; Immunology; Genetics","score_opus":0.01609941877565611,"score_gpt":0.253618855863149,"score_spread":0.23751943708749287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2577280378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99779236,0.00025596947,0.00015561102,0.00016161054,0.00013415838,0.000733358,0.000020160589,0.000011953458,0.00073479535],"genre_scores_gemma":[0.9994565,0.00004396878,0.00022619065,0.000012266299,0.000028849283,0.000038076323,0.000011990438,0.000012555597,0.00016957762],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99896824,0.00006736156,0.00039247298,0.00012195926,0.00033227258,0.00011768231],"domain_scores_gemma":[0.99908274,0.00025469437,0.0002597679,0.0003019949,0.00008740467,0.000013400893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020358135,0.00011225644,0.00026500702,0.000027559794,0.0001002037,0.0000032552878,0.00009482316,0.00007607332,0.0000042473594],"category_scores_gemma":[0.00006410247,0.000051679137,0.00018070811,0.000222577,0.00007907701,0.000032532793,0.000019753466,0.000065868495,6.031122e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009656315,0.00028590744,0.006686795,0.00013748532,0.00033662588,0.000002640914,0.0006428311,0.000011447406,0.99105275,0.00051305024,0.00001631557,0.00021758438],"study_design_scores_gemma":[0.002616495,0.00018440095,0.0115177715,0.0002855127,0.00046557057,0.000029926998,0.0007577205,0.000021358099,0.982699,0.0013540802,0.00002439598,0.000043789234],"about_ca_topic_score_codex":0.00010373086,"about_ca_topic_score_gemma":0.000020365107,"teacher_disagreement_score":0.008353775,"about_ca_system_score_codex":0.000044834727,"about_ca_system_score_gemma":0.00006435276,"threshold_uncertainty_score":0.2107414},"labels":[],"label_agreement":null},{"id":"W2577289848","doi":"10.1182/blood.v112.11.865.865","title":"Initial Results of PX-171-004, An Open-Label, Single-Arm, Phase II Study of Carfilzomib (CFZ) in Patients with Relapsed Myeloma (MM)","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Carfilzomib; Bortezomib; Medicine; Multiple myeloma; Proteasome inhibitor; Population; Lenalidomide; Phases of clinical research; Internal medicine; Adverse effect; Gastroenterology; Toxicity","score_opus":0.0779266594997658,"score_gpt":0.3478634319597014,"score_spread":0.2699367724599356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2577289848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949195,0.000042225827,7.0002204e-7,0.00002440988,0.00003006828,0.0025674105,0.00017276601,0.000025404759,0.0022175086],"genre_scores_gemma":[0.9986039,0.000008048985,0.0006693357,0.000019307437,0.000037490656,0.000073547526,0.000306103,0.000041473275,0.00024078607],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9973244,0.00020214537,0.0006979069,0.0004948769,0.00082907063,0.00045159628],"domain_scores_gemma":[0.99823934,0.000082056154,0.00026775818,0.0007229839,0.0003892314,0.00029862608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023645378,0.00025394405,0.0006950218,0.00030622608,0.00013571892,0.000011769605,0.000306873,0.00009459999,0.000039682243],"category_scores_gemma":[0.00031642383,0.000195434,0.000029367684,0.00053025136,0.00015421856,0.00025972375,0.00023897116,0.00022761204,0.0000051761813],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055361126,0.52640575,0.39586148,0.000104046514,0.00084126944,0.0023553616,0.005951662,0.0000027791982,0.005234661,0.000007482255,0.00014647961,0.0077279187],"study_design_scores_gemma":[0.438069,0.17372963,0.36800417,0.0001870831,0.00023199669,0.000025969926,0.00054930424,0.000017251792,0.018940963,0.000004996499,0.000042945983,0.00019670524],"about_ca_topic_score_codex":0.0017779986,"about_ca_topic_score_gemma":0.0004858103,"teacher_disagreement_score":0.38270786,"about_ca_system_score_codex":0.00005728119,"about_ca_system_score_gemma":0.00024264911,"threshold_uncertainty_score":0.7969567},"labels":[],"label_agreement":null},{"id":"W2577318470","doi":"10.1182/blood.v104.11.900.900","title":"Hematopoietic Stem Cell Transplant (HSCT) as Primary Treatment for T-Cell Lymphobastic Lymphoma (T-LBL) : An Intention to Treat Analysis.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Bone marrow; Cyclophosphamide; Etoposide; Fludarabine; Cytarabine; Internal medicine; Gastroenterology; Surgery; Total body irradiation; Hematopoietic stem cell transplantation; Chemotherapy; Transplantation","score_opus":0.018602419170159284,"score_gpt":0.2764058195543053,"score_spread":0.25780340038414606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2577318470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98985666,0.0006845146,0.0033411656,0.00018205922,0.00007086978,0.0019223092,0.000075952725,0.00015628216,0.0037101717],"genre_scores_gemma":[0.99262357,0.00016314142,0.0014917237,0.00030494682,0.00011519214,0.00043495116,0.0003948436,0.00008381875,0.0043878206],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99703676,0.00006598933,0.0005806053,0.0008587492,0.0006600308,0.0007978951],"domain_scores_gemma":[0.99794257,0.00014685356,0.00010427888,0.0009127546,0.00015383966,0.0007396872],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002470953,0.00044106587,0.00085859525,0.000512729,0.0001421383,0.000061912746,0.00024033243,0.00019474451,0.000060764673],"category_scores_gemma":[0.000012540087,0.00035765418,0.00057499186,0.0007982035,0.000068319314,0.00011010755,0.000038217127,0.000061341685,0.00024052974],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027979506,0.20440814,0.010161483,0.016815152,0.013613149,0.014593183,0.054332722,0.0049463315,0.54884785,0.0023684632,0.00050448603,0.10142953],"study_design_scores_gemma":[0.29698935,0.011975204,0.0023416393,0.00042576136,0.018671485,0.0016448356,0.0012857864,0.0016570601,0.6629534,0.0002604963,0.0008321945,0.00096280285],"about_ca_topic_score_codex":0.0016744601,"about_ca_topic_score_gemma":0.0001966758,"teacher_disagreement_score":0.26900986,"about_ca_system_score_codex":0.012915733,"about_ca_system_score_gemma":0.005134867,"threshold_uncertainty_score":0.9998875},"labels":[],"label_agreement":null},{"id":"W2577361732","doi":"10.1182/blood.v112.11.189.189","title":"Activation of PP2A by FTY720 Inhibits Survival and Self-Renewal of the Ph(+) Chronic Myelogenous Leukemia (CML) CD34+/CD38− Stem Cell through the Simultaneous Suppression of BCR/ABL and BCR/ABL– independent Signals","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"CD38; Dasatinib; Progenitor cell; Cancer research; Chronic myelogenous leukemia; Stem cell; Biology; Clonogenic assay; Haematopoiesis; CD34; Imatinib; Imatinib mesylate; Leukemia; Immunology; Myeloid leukemia; Cell biology; Cell; Biochemistry","score_opus":0.01192342116242778,"score_gpt":0.222397065891162,"score_spread":0.21047364472873423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2577361732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933321,0.0041834465,0.000018520219,0.00010815997,0.000095954296,0.0011729131,0.00009558231,0.000032731987,0.000960619],"genre_scores_gemma":[0.99744964,0.0017340386,0.000106716965,0.000034948407,0.00009795787,0.000020356187,0.000033217446,0.000051532064,0.00047158933],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972941,0.00025074623,0.0007336872,0.00047847306,0.0008447942,0.0003981811],"domain_scores_gemma":[0.9976375,0.00070866966,0.00066146144,0.0006859075,0.00019697609,0.00010947049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025916932,0.0003768934,0.0007359432,0.0000637156,0.00019079859,0.000009632523,0.00025041917,0.0002884415,0.000047764468],"category_scores_gemma":[0.00008009777,0.0002351395,0.00013852668,0.0002906132,0.0003490714,0.00012395982,0.00025079102,0.0003515284,0.0000025615623],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004752175,0.0021753267,0.017065622,0.0010864455,0.0007992848,0.000053077638,0.008477198,0.00078881154,0.9670556,0.000029146024,0.00028480226,0.0017094727],"study_design_scores_gemma":[0.011873039,0.0010759337,0.004024615,0.00042013245,0.0006789893,0.00024110421,0.00059242087,0.00035709454,0.98018396,0.000038342085,0.00030360624,0.00021073749],"about_ca_topic_score_codex":0.0011311244,"about_ca_topic_score_gemma":0.000060100734,"teacher_disagreement_score":0.01312839,"about_ca_system_score_codex":0.00048194762,"about_ca_system_score_gemma":0.0010439899,"threshold_uncertainty_score":0.95887107},"labels":[],"label_agreement":null},{"id":"W2577435390","doi":"10.1182/blood.v122.21.1856.1856","title":"Using RNA-Seq, SNP-CN and Targeted Deep Sequencing To Improve The Diagnostic Paradigm In Multiple Myeloma","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Ion semiconductor sequencing; Genetics; Biology; SNP array; DNA sequencing; Computational biology; Deep sequencing; Bioinformatics; Single-nucleotide polymorphism; Gene; Genome; Genotype","score_opus":0.04256819058609661,"score_gpt":0.29376159585607914,"score_spread":0.2511934052699825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2577435390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962939,0.00087764265,0.00012300073,0.00066901295,0.00005251938,0.0017235342,0.000010541283,0.000036312103,0.00021351672],"genre_scores_gemma":[0.99608403,0.000049726197,0.0031327466,0.00027490265,0.00010860754,0.00024287358,0.000012922558,0.000029290315,0.00006491867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998546,0.000075614815,0.00024146511,0.00033269473,0.00026603448,0.0005382066],"domain_scores_gemma":[0.99859625,0.000614608,0.00004476644,0.00034391796,0.000056864606,0.00034359976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015694594,0.0001865434,0.0002623566,0.00013312035,0.00013380483,0.00006165487,0.00010232891,0.000073246374,0.000080640406],"category_scores_gemma":[0.0014913507,0.00012374076,0.000047855814,0.00025436436,0.0000698376,0.00012067306,0.000099467354,0.0002096171,0.000099260855],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012579009,0.0006285092,0.7544451,0.00013036755,0.00030254642,0.00078369945,0.0019198869,0.00006479536,0.21143226,0.000047517828,0.000059348447,0.030060219],"study_design_scores_gemma":[0.010243664,0.00050114637,0.9174831,0.0002057418,0.0001534231,0.00017414546,0.0005668162,0.017575564,0.052405555,0.0003455724,0.00007920532,0.00026609836],"about_ca_topic_score_codex":0.003927832,"about_ca_topic_score_gemma":0.0004914298,"teacher_disagreement_score":0.163038,"about_ca_system_score_codex":0.00011286944,"about_ca_system_score_gemma":0.000106238054,"threshold_uncertainty_score":0.59377337},"labels":[],"label_agreement":null},{"id":"W2577455346","doi":"10.1182/blood.v104.11.1189.1189","title":"Unexpectedly High Self-Renewal Capacity Demonstrable by Serial Transplantation Is a Property of a Subset of Normal Adult Mouse Hematopoietic Stem Cells.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Stem cell; Haematopoiesis; Transplantation; Biology; Bone marrow; Cell division; Progenitor cell; In vivo; Immunology; Cell biology; Cell; Molecular biology; Genetics; Internal medicine; Medicine","score_opus":0.009055340071642853,"score_gpt":0.1992778448461379,"score_spread":0.19022250477449504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2577455346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99702346,0.000054725624,0.0006788,0.000121322635,0.00009201823,0.00080011756,0.00056543265,0.00011125279,0.00055285293],"genre_scores_gemma":[0.9944216,0.0001558357,0.004986605,0.000052620595,0.000041240193,0.00003827737,0.00013298617,0.000041789386,0.00012903544],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978874,0.00006848784,0.0007815198,0.0003549662,0.00057004334,0.00033761802],"domain_scores_gemma":[0.9989348,0.000046115132,0.000254453,0.00032624757,0.0002690404,0.00016932994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014715493,0.0002726427,0.0005939175,0.00011229364,0.000052563937,0.00001058217,0.0001338,0.00023271194,0.00008772929],"category_scores_gemma":[0.0000053923595,0.00021585499,0.00014725272,0.0003058648,0.0001084669,0.00012703864,0.0000074002387,0.00016846642,0.000015153975],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061647146,0.0025484473,0.004956473,0.0043104156,0.00031585456,0.000056254787,0.011537245,0.000042085136,0.9752873,0.00023013937,0.000067618836,0.00003167471],"study_design_scores_gemma":[0.012859695,0.000621242,0.0003449114,0.00049911806,0.0009912472,0.0003848022,0.00039585237,0.000017456588,0.9836096,0.00005001577,0.0000075968906,0.00021844538],"about_ca_topic_score_codex":0.0013097614,"about_ca_topic_score_gemma":0.00009561499,"teacher_disagreement_score":0.012243223,"about_ca_system_score_codex":0.000044677196,"about_ca_system_score_gemma":0.00024701128,"threshold_uncertainty_score":0.88023114},"labels":[],"label_agreement":null},{"id":"W2577541416","doi":"10.1182/blood.v106.11.1543.1543","title":"Analysis of Validated Clonotypic Igh VDJ Sequences from a Large Cohort of MM Patients.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Isotype; Biology; Immunoglobulin gene; Molecular biology; Antibody; Chronic lymphocytic leukemia; Immunology; Leukemia; Monoclonal antibody","score_opus":0.012921530007855628,"score_gpt":0.2856867852749593,"score_spread":0.27276525526710366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2577541416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976495,0.00037709967,0.000030318206,0.000052478685,0.000023083363,0.00027651305,0.00024028191,0.000024615432,0.0013261052],"genre_scores_gemma":[0.9984297,0.00007253421,0.00069134525,0.00005976868,0.0000619766,0.0000115998255,0.00047379106,0.000013713441,0.00018558455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99826795,0.00006251346,0.00047528138,0.0002766057,0.0006422745,0.00027538673],"domain_scores_gemma":[0.9987749,0.00014403558,0.00016868116,0.0005263281,0.00026943238,0.00011662597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002637704,0.000119396485,0.0005936311,0.0002917142,0.000023143102,0.000005565288,0.00017422948,0.0001077891,0.0009016483],"category_scores_gemma":[0.00020897535,0.0000979923,0.00020179886,0.00095190847,0.00010327903,0.000056935496,0.00007495566,0.00010814125,0.000029390914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017027982,0.002558077,0.98383117,0.00007492276,0.0056828153,0.000022482647,0.0004897626,0.00005172245,0.006054084,0.000058810194,0.00019381737,0.00081204233],"study_design_scores_gemma":[0.042929836,0.0003801684,0.7151788,0.0001260098,0.010785193,0.0000046882383,0.00011028701,0.0071862424,0.22187167,0.00003600251,0.0011752524,0.00021584902],"about_ca_topic_score_codex":0.0027795446,"about_ca_topic_score_gemma":0.00026191256,"teacher_disagreement_score":0.26865238,"about_ca_system_score_codex":0.0007566736,"about_ca_system_score_gemma":0.0013115451,"threshold_uncertainty_score":0.9872416},"labels":[],"label_agreement":null},{"id":"W2577571378","doi":"10.1182/blood.v126.23.2321.2321","title":"Thromboprophylaxis in Multiple Myeloma Patients Treated with Lenalidomide - a Systematic Review","year":2015,"lang":"en","type":"review","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Lenalidomide; Internal medicine; Multiple myeloma; Randomized controlled trial; Thalidomide; Rivaroxaban; Surgery; Oncology; Warfarin","score_opus":0.060038938495165534,"score_gpt":0.33287393689190553,"score_spread":0.27283499839673997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2577571378","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007627045,0.9843502,3.2326992e-7,0.0000074187255,0.000021728263,0.014098091,0.00015455749,0.00007670148,0.0005282428],"genre_scores_gemma":[0.00042775797,0.9948043,0.00016308593,0.00003843752,0.000046220222,0.0026372029,0.0013274227,0.00013997492,0.0004155982],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9956099,0.0005941475,0.0013164207,0.0007456172,0.0010690233,0.00066490215],"domain_scores_gemma":[0.9971538,0.00023817846,0.00056497165,0.001161027,0.0003716971,0.0005103323],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004889824,0.00077504746,0.0064097517,0.00043512366,0.000051652176,0.000033593104,0.00028967712,0.00027961304,0.000046215304],"category_scores_gemma":[0.0010858948,0.00044367142,0.000509843,0.0010162693,0.000080073274,0.000084166946,0.00009741103,0.0005123395,0.00050306704],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006406207,0.0022269464,0.0034490372,0.9506107,0.0016796654,0.0010672469,0.00001554768,6.3258097e-9,7.7616946e-8,7.8867646e-7,0.00009029072,0.040795647],"study_design_scores_gemma":[0.011923649,0.001385252,0.00049943256,0.9594867,0.012083693,0.00032451504,0.00000492968,0.0000013294575,0.000002236382,9.933617e-7,0.013839417,0.00044784485],"about_ca_topic_score_codex":0.00016867834,"about_ca_topic_score_gemma":0.00005983588,"teacher_disagreement_score":0.0403478,"about_ca_system_score_codex":0.00039656984,"about_ca_system_score_gemma":0.0006822835,"threshold_uncertainty_score":0.9998015},"labels":[],"label_agreement":null},{"id":"W2577615809","doi":"10.1182/blood.v112.11.864.864","title":"Initial Results of PX-171-003, An Open-Label, Single-Arm, Phase II Studyof Carfilzomib (CFZ) in Patients with Relapsed and Refractory Multiple Myeloma (MM)","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Carfilzomib; Medicine; Bortezomib; Lenalidomide; Multiple myeloma; Refractory (planetary science); Proteasome inhibitor; Internal medicine; Thalidomide; Progressive disease; Phases of clinical research; Dexamethasone; Gastroenterology; Oncology; Pharmacology; Toxicity; Chemotherapy; Biology","score_opus":0.06796061892251935,"score_gpt":0.33243604603545795,"score_spread":0.2644754271129386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2577615809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962691,0.00016371527,0.0000012892459,0.000048043687,0.000041854742,0.001842109,0.00031944434,0.00003997171,0.0012744534],"genre_scores_gemma":[0.9972885,0.000050713355,0.0017031747,0.00005022048,0.000057210404,0.000068422596,0.00053029635,0.000053308715,0.00019811725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974089,0.00019186028,0.00058932963,0.0006260269,0.000679053,0.00050478446],"domain_scores_gemma":[0.9982764,0.00015966827,0.00021974987,0.00064364023,0.0002588249,0.000441722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002420725,0.00030829656,0.0006494088,0.00027081007,0.00021596637,0.00002302109,0.00023324032,0.00013818296,0.000028401493],"category_scores_gemma":[0.000549447,0.00024168585,0.000026978763,0.0003555379,0.00025303537,0.000381489,0.0002520155,0.00031432498,0.0000058149817],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05990254,0.22872148,0.6662097,0.0001318809,0.00072648184,0.0022124497,0.0036033408,0.0000012147834,0.015049406,0.0000046282476,0.00030246118,0.023134418],"study_design_scores_gemma":[0.39774644,0.067639165,0.51682407,0.00026208666,0.00017340978,0.000053313892,0.00018084193,0.000057766534,0.016387666,0.00000536205,0.000373186,0.0002967106],"about_ca_topic_score_codex":0.0008028706,"about_ca_topic_score_gemma":0.00049106445,"teacher_disagreement_score":0.3378439,"about_ca_system_score_codex":0.00007962702,"about_ca_system_score_gemma":0.00024049357,"threshold_uncertainty_score":0.9855663},"labels":[],"label_agreement":null},{"id":"W2577667369","doi":"10.1182/blood.v104.11.3512.3512","title":"Factor XIII Val34Leu Polymorphism Is Protective Against Venous Thromboembolism; a Meta-Analysis.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Blood properties and coagulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Odds ratio; Meta-analysis; Confidence interval; Internal medicine; Study heterogeneity; Venous thrombosis; Thrombosis; Factor XIII; Surgery","score_opus":0.061381637324570255,"score_gpt":0.27115649634108574,"score_spread":0.2097748590165155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2577667369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98644906,0.0053723464,0.00058331405,0.0033424036,0.00006294415,0.0014121084,0.000061412786,0.00016961855,0.0025467705],"genre_scores_gemma":[0.9960426,0.000028635854,0.0007424209,0.0023341167,0.00016694097,0.00017092956,0.000025576377,0.000036633977,0.00045214692],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9984414,0.000045119046,0.00033097353,0.00043374224,0.00042332936,0.00032545204],"domain_scores_gemma":[0.99901056,0.000013824547,0.00013754479,0.0005373079,0.00014437539,0.00015637884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010539507,0.00025742277,0.0011677023,0.00018928893,0.00014003649,0.00003653875,0.000113836206,0.00015267091,0.00051663804],"category_scores_gemma":[0.00003103559,0.00018311452,0.0010369965,0.00057657197,0.00005592543,0.00010976909,0.000046947334,0.00023439268,0.00012197134],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036134978,0.011909751,0.0026499385,0.00026964062,0.8872943,0.0003550455,0.015031087,0.000514346,0.07382968,0.0011604637,0.00020947114,0.0064149066],"study_design_scores_gemma":[0.008511476,0.001638979,0.06919948,0.000031242722,0.71446234,0.00010040192,0.00032894008,0.0000756261,0.20133385,0.0018227795,0.0017242916,0.00077059306],"about_ca_topic_score_codex":0.00045169695,"about_ca_topic_score_gemma":0.000033821507,"teacher_disagreement_score":0.17283198,"about_ca_system_score_codex":0.000044504606,"about_ca_system_score_gemma":0.00014486138,"threshold_uncertainty_score":0.74671936},"labels":[],"label_agreement":null},{"id":"W2577683663","doi":"10.1182/blood.v120.21.3265.3265","title":"Metabolomic Biomarkers As Predictors of Iron Load and Oxidative Damage in Iron Overloaded Thalassemia Patients","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Metabolomics; Thalassemia; Oxidative stress; Metabolite; Lipid peroxidation; Hemochromatosis; DNA damage; Medicine; Oxidative phosphorylation; Internal medicine; Hereditary hemochromatosis; Biochemistry; Bioinformatics; Biology","score_opus":0.006602687172838737,"score_gpt":0.23595915965585784,"score_spread":0.2293564724830191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2577683663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883637,0.0028847773,0.0000011869743,0.00003153091,0.00017413778,0.00041052443,0.000027867036,0.000020646079,0.008085635],"genre_scores_gemma":[0.9991675,0.00025461338,0.00019988538,0.00007717221,0.000053850115,0.000012135645,0.000045300916,0.000020623258,0.00016893694],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988077,0.00007717683,0.0002787925,0.00020721271,0.0003101552,0.00031894137],"domain_scores_gemma":[0.99938613,0.000052904546,0.00012456394,0.00022845647,0.00004188219,0.00016607674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022842934,0.00017503624,0.00034569745,0.00014918114,0.000023193938,0.000005214928,0.00006642811,0.00012199861,0.000089208785],"category_scores_gemma":[0.00023159158,0.00014854159,0.000053649695,0.00018936956,0.000120994126,0.00020734941,0.000058147478,0.00012328754,0.00001911618],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025068558,0.001339255,0.958356,0.00014261545,0.000047438974,0.0000026560479,0.001477603,2.1835538e-7,0.037414107,0.00008060438,0.00036144193,0.00052733463],"study_design_scores_gemma":[0.0085784495,0.00018453808,0.9532318,0.00004266222,0.00040277088,0.0000029669825,0.0006010682,0.000001428496,0.03634966,0.000014846404,0.0004618029,0.00012801272],"about_ca_topic_score_codex":0.00020659126,"about_ca_topic_score_gemma":0.000014156436,"teacher_disagreement_score":0.010803788,"about_ca_system_score_codex":0.000022494947,"about_ca_system_score_gemma":0.00006737962,"threshold_uncertainty_score":0.605735},"labels":[],"label_agreement":null},{"id":"W2577706754","doi":"10.1182/blood.v126.23.1995.1995","title":"Long-Term Results of Cytarabine-Containing Induction Followed By Consolidation with Autologous Stem Cell Transplant and Rituximab Maintenance As Primary Treatment for Mantle Cell Lymphoma","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Mantle cell lymphoma; Cytarabine; Rituximab; Internal medicine; CHOP; Surgery; Induction chemotherapy; Autologous stem-cell transplantation; Chemotherapy; Oncology; Lymphoma","score_opus":0.018229834114505242,"score_gpt":0.23787264047757842,"score_spread":0.21964280636307318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2577706754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99549526,0.0013407636,0.00009663357,0.00019344957,0.000058983518,0.0011066851,0.00020697874,0.000042668762,0.0014585848],"genre_scores_gemma":[0.99758995,0.00028114687,0.000717116,0.000054697623,0.00003224196,0.00019405443,0.00047789034,0.000024786188,0.00062813],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998862,0.000032822198,0.00031931076,0.0003622207,0.00018492203,0.00023870339],"domain_scores_gemma":[0.9992369,0.000083774314,0.00020284607,0.00021944987,0.00010217912,0.00015487777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011571144,0.00022173354,0.00045759333,0.00006231988,0.000052388383,0.000015517346,0.000038662536,0.00010099791,0.0000013880019],"category_scores_gemma":[0.000004914315,0.00015486556,0.00006701265,0.00006524835,0.000056930305,0.00007873705,0.000008634548,0.000025706635,0.000004306003],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07433164,0.09980357,0.6099354,0.0024410428,0.002910142,0.0030789413,0.016444407,0.000021071344,0.07812516,0.00020602616,0.0033818423,0.109320775],"study_design_scores_gemma":[0.28805536,0.0170536,0.064261116,0.0004392197,0.0022987544,0.00088047737,0.0005139161,0.000045677512,0.6256033,0.000013822353,0.0005059036,0.0003288395],"about_ca_topic_score_codex":0.00018836201,"about_ca_topic_score_gemma":0.000027235088,"teacher_disagreement_score":0.54747814,"about_ca_system_score_codex":0.00021892702,"about_ca_system_score_gemma":0.00026316784,"threshold_uncertainty_score":0.63152343},"labels":[],"label_agreement":null},{"id":"W2577722903","doi":"10.1182/blood.v114.22.3091.3091","title":"Report On Excessive Induction Toxicity in Infants with ALL Enrolled On COG Protocol AALL0631: A Children's Oncology Group Study.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Induction chemotherapy; Mucositis; Cohort; Internal medicine; Chemotherapy; Cog; Pediatrics; Randomization; Asparaginase; Clinical trial; Surgery; Leukemia; Lymphoblastic Leukemia","score_opus":0.01791310408068826,"score_gpt":0.3385384412993033,"score_spread":0.3206253372186151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2577722903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9219417,0.0000017548705,0.000014409668,0.00063961826,0.000032734075,0.07126259,0.0000026154798,0.0000846909,0.006019876],"genre_scores_gemma":[0.9727416,0.0000012686183,0.00027514485,0.00083830656,0.00029531284,0.025546728,0.00002675811,0.000031131323,0.00024375397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970391,0.00028267686,0.0005362488,0.0007103336,0.0009228138,0.00050884386],"domain_scores_gemma":[0.9986064,0.00014558413,0.00027256913,0.00062073907,0.00013109368,0.00022365327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075495476,0.00029430646,0.00060992874,0.00038590538,0.00007042364,0.00002196349,0.00017365075,0.00025104944,0.000055673103],"category_scores_gemma":[0.00049617985,0.00020835742,0.000056195,0.0004986495,0.00007939489,0.00009605912,0.000052653748,0.00074398844,0.000037106172],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.061241157,0.14610533,0.6624904,0.00016060098,0.0021514099,0.06516897,0.004724958,0.00011641046,0.015703125,0.00017823963,0.002730351,0.039228994],"study_design_scores_gemma":[0.07256953,0.046687208,0.87123847,0.0002824121,0.00018160751,0.0025687816,0.00017804706,0.000028989374,0.005623127,0.00005790216,0.0003067781,0.00027713372],"about_ca_topic_score_codex":0.00018309284,"about_ca_topic_score_gemma":0.00015068434,"teacher_disagreement_score":0.20874804,"about_ca_system_score_codex":0.00067682983,"about_ca_system_score_gemma":0.0007851539,"threshold_uncertainty_score":0.8496569},"labels":[],"label_agreement":null},{"id":"W2577782297","doi":"10.1182/blood.v116.21.4204.4204","title":"A Large, Population Based Study of Sex Differences In the Risk of Recurrent Venous Thromboembolism","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Jewish General Hospital","funders":"","keywords":"Medicine; Pulmonary embolism; Deep vein; Cohort; Confidence interval; Retrospective cohort study; Population; Incidence (geometry); Medical record; Pediatrics; Cohort study; Thrombosis; Internal medicine; Surgery","score_opus":0.016265480502169357,"score_gpt":0.2723687248469285,"score_spread":0.2561032443447591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2577782297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99822646,0.00008026394,0.0000067415885,0.0000755985,0.00014523933,0.001004213,0.000015273323,0.000013345796,0.00043287227],"genre_scores_gemma":[0.99967325,0.0000363401,0.000086169915,0.000054146727,0.000062987565,0.000059378242,0.0000136878225,0.000009904617,0.0000041384255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988058,0.00013317383,0.00035047482,0.00018111368,0.00036346033,0.00016592964],"domain_scores_gemma":[0.9991874,0.00010461338,0.00020686867,0.00042301737,0.00004679585,0.000031281892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005509345,0.00011354625,0.0005392783,0.00012450611,0.000047471833,0.0000073647975,0.00015498017,0.000053545184,0.000055983244],"category_scores_gemma":[0.00010311819,0.00007288177,0.00007061365,0.0002110097,0.000019410243,0.000026196307,0.000035638408,0.00022557373,0.0000017231953],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001902571,0.036411244,0.95422864,0.00010162157,0.00014913811,0.000007246456,0.006996514,0.0000036374474,0.00035718494,0.00032223266,0.000037361595,0.0013661786],"study_design_scores_gemma":[0.003180374,0.001576916,0.9907946,0.000058884696,0.0006566637,0.0000011385029,0.0030226833,0.00007534421,0.00034708122,0.00017721028,0.0000413429,0.000067762594],"about_ca_topic_score_codex":0.0011151794,"about_ca_topic_score_gemma":0.0019180577,"teacher_disagreement_score":0.03656598,"about_ca_system_score_codex":0.000005413148,"about_ca_system_score_gemma":0.000026364767,"threshold_uncertainty_score":0.2972032},"labels":[],"label_agreement":null},{"id":"W2577813779","doi":"10.1182/blood.v112.11.2031.2031","title":"Age-Related Differences in the Glycosylation of Anticoagulant Protein C.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Coagulation; Thrombin; Population; Protein C; Alkaline phosphatase; Immunology; Glycosylation; Chemistry; Polyclonal antibodies; Internal medicine; Endocrinology; Medicine; Antibody; Biochemistry; Platelet; Enzyme","score_opus":0.045833557669348365,"score_gpt":0.25795654657194306,"score_spread":0.21212298890259468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2577813779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968065,0.00009436021,0.000054378776,0.00036472318,0.000027714128,0.00046113427,0.0000011561461,0.000024914007,0.0021651022],"genre_scores_gemma":[0.9994043,0.000018621118,0.0003370646,0.00006900146,0.000020791722,0.000016786536,0.000009880407,0.000006475357,0.00011706663],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9992228,0.00006625379,0.00024403086,0.000112289395,0.00024878187,0.000105838815],"domain_scores_gemma":[0.9996535,0.000027845594,0.00007767712,0.00018374641,0.000031474643,0.00002572135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015033108,0.000075053955,0.00020825838,0.000079952806,0.00004023771,0.0000038661674,0.00007189438,0.00006535127,0.000058004644],"category_scores_gemma":[0.000042455395,0.0000475626,0.00004828275,0.00024916718,0.000058258862,0.00003129591,0.00001094102,0.00010393224,0.000011438096],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000112384034,0.0058194925,0.3316563,0.00018027789,0.0002462057,0.00044628838,0.007768918,0.0000035539263,0.614362,0.038035534,0.000049186925,0.0013198131],"study_design_scores_gemma":[0.0032459148,0.00033033898,0.91432464,0.00013106182,0.00009286514,0.00012451307,0.00012215036,0.0001609602,0.07978476,0.0015823357,0.000024010373,0.00007643002],"about_ca_topic_score_codex":0.000051768977,"about_ca_topic_score_gemma":0.000009546784,"teacher_disagreement_score":0.58266836,"about_ca_system_score_codex":0.0000037015263,"about_ca_system_score_gemma":0.00003240568,"threshold_uncertainty_score":0.19395466},"labels":[],"label_agreement":null},{"id":"W2577827433","doi":"10.1182/blood.v124.21.5641.5641","title":"Clinical Impact of Telomere Shortening in Normal and Leukemia Cells in Chronic Lymphocytic Leukemia","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Chronic lymphocytic leukemia; Telomere; Buccal swab; Leukemia; Immunosuppression; Medicine; Cancer; Immunology; Oncology; Internal medicine; Biology; Genetics; Gene","score_opus":0.015369143478947791,"score_gpt":0.29856002437391865,"score_spread":0.28319088089497085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2577827433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977377,0.00092681515,0.000017216955,0.00000791293,0.00007951474,0.00025093905,0.000005680693,0.00003322441,0.00094101334],"genre_scores_gemma":[0.9986229,0.00050245103,0.000456445,0.00006899214,0.0002201828,0.0000074484897,0.000008442694,0.000029319703,0.00008381712],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979456,0.00011700172,0.0008032565,0.0004111382,0.00023823667,0.00048474057],"domain_scores_gemma":[0.99894005,0.00025953862,0.00014421126,0.00038286202,0.00004368761,0.00022966004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006842663,0.00023383606,0.00078568474,0.00028320882,0.000026505404,0.00001229587,0.00013769956,0.00023283047,0.000053174066],"category_scores_gemma":[0.00016357085,0.00020016922,0.00015800555,0.00037918123,0.0001833307,0.00010767633,0.00007276424,0.0004009622,0.000016163269],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024242268,0.00014452549,0.93444216,0.00028029896,0.00007605493,0.00017212614,0.00034979917,0.0004919256,0.039542038,0.000026449874,0.00007077392,0.02416145],"study_design_scores_gemma":[0.012689108,0.0012208696,0.95760906,0.0005572542,0.00012158711,0.00014506368,0.00008229729,0.012681644,0.014471808,0.000024741224,0.00012129218,0.000275253],"about_ca_topic_score_codex":0.0020930346,"about_ca_topic_score_gemma":0.0004801741,"teacher_disagreement_score":0.025070228,"about_ca_system_score_codex":0.0018365235,"about_ca_system_score_gemma":0.0030035651,"threshold_uncertainty_score":0.8162664},"labels":[],"label_agreement":null},{"id":"W2577857478","doi":"10.1182/blood.v118.21.5170.5170","title":"A Ruxolitinib Individual Supply Program for Patients with Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Discontinuation; International Prognostic Scoring System; Internal medicine; Anemia; Adverse effect; Clinical endpoint; Placebo; Polycythemia vera; Essential thrombocythemia; Clinical trial; Gastroenterology; Surgery; Myelodysplastic syndromes; Bone marrow; Pathology","score_opus":0.01629583205061588,"score_gpt":0.2501240779281107,"score_spread":0.23382824587749482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2577857478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868909,0.00029490388,0.000031816548,0.0003745953,0.00024110166,0.0072338735,0.002863883,0.0004051581,0.0016637853],"genre_scores_gemma":[0.9403128,0.00013053854,0.047328297,0.0011861583,0.00049620663,0.0044157994,0.005334085,0.00028146605,0.00051462604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947431,0.000108650274,0.0010140043,0.0014396147,0.0012004238,0.0014941829],"domain_scores_gemma":[0.99627274,0.00033385752,0.00049379683,0.0010238291,0.0011070464,0.00076874497],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022730068,0.0011154163,0.0014614699,0.00033460418,0.0004992441,0.00019015612,0.0004486699,0.00047328862,0.0011720721],"category_scores_gemma":[0.00017043165,0.00077659363,0.0005267649,0.0005173463,0.00038599438,0.00047305116,0.00024618025,0.00040452572,0.00013005859],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01929073,0.034611788,0.90303403,0.0013099555,0.00432505,0.00014918044,0.0038550184,2.5061624e-7,0.0074532474,0.0005256765,0.0024976996,0.022947362],"study_design_scores_gemma":[0.02855075,0.025824495,0.8397575,0.00072439795,0.0033253373,0.00015611811,0.00025731773,0.0000025825304,0.09807254,0.00003858631,0.0023109126,0.0009794785],"about_ca_topic_score_codex":0.00021511783,"about_ca_topic_score_gemma":0.00009707596,"teacher_disagreement_score":0.09061929,"about_ca_system_score_codex":0.00019579958,"about_ca_system_score_gemma":0.0009682692,"threshold_uncertainty_score":0.999741},"labels":[],"label_agreement":null},{"id":"W2577872721","doi":"10.1182/blood.v120.21.3897.3897","title":"Comprehensive Assessment of Clinical Outcomes for CLL Patients with Trisomy 12 (+12): Results of a Population-Based Analysis of 822 CLL Patients in British Columbia (BC), Canada","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Paul's Hospital; Royal Columbian Hospital; Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Population; Internal medicine; Cohort; Oncology; Hazard ratio; Exact test; Proportional hazards model; Clinical trial; Confidence interval","score_opus":0.02991756457431923,"score_gpt":0.34473883324647664,"score_spread":0.31482126867215743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2577872721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99719733,0.000022065176,0.000015404852,0.000015467609,0.00008764582,0.0013771498,0.0012032539,0.0000059792656,0.00007572458],"genre_scores_gemma":[0.99644756,0.000005397514,0.0016767439,0.00006502495,0.000022389066,0.000047355115,0.001647506,0.00002309231,0.0000649356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963512,0.00017338034,0.0016435091,0.0003164309,0.0011235649,0.00039193686],"domain_scores_gemma":[0.9962564,0.0014141276,0.0007871951,0.0005026178,0.00082825037,0.00021140905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004821153,0.00013522674,0.0013335778,0.00018859946,0.000029568351,0.000008962281,0.00014944529,0.00012797199,0.000032760603],"category_scores_gemma":[0.00094391796,0.0001509784,0.0002616398,0.0005475769,0.00009533552,0.0000633591,0.00005247683,0.0001547089,1.18438585e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058789406,0.005171018,0.99114484,0.0003404581,0.0013639579,0.0000044812737,0.000035676443,0.00018396713,0.0000013915662,9.146466e-7,0.00042366437,0.0007417515],"study_design_scores_gemma":[0.103487246,0.0007892359,0.8914651,0.00017645932,0.0014195843,3.3186285e-7,0.000051710955,0.002371062,0.000028270619,0.0000012611262,0.00009364902,0.00011606391],"about_ca_topic_score_codex":0.9316512,"about_ca_topic_score_gemma":0.9471464,"teacher_disagreement_score":0.10289935,"about_ca_system_score_codex":0.0015549867,"about_ca_system_score_gemma":0.005186872,"threshold_uncertainty_score":0.9201289},"labels":[],"label_agreement":null},{"id":"W2577904658","doi":"10.1182/blood.v104.11.1782.1782","title":"Can We Do Better? Identifying Orthopedic Surgery Patients at High Risk for Venous Thromboembolism Despite Thromboprophylaxis.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Orthopedic surgery; Surgery; Venous thromboembolism; Arthroplasty; Incidence (geometry); Regimen; Population; Thrombosis","score_opus":0.01649650793357758,"score_gpt":0.24443855787134783,"score_spread":0.22794204993777026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2577904658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993565,0.0013614602,0.0001696682,0.0008715735,0.001396847,0.002005883,0.00016929753,0.00021330942,0.00024695255],"genre_scores_gemma":[0.9941015,0.0019713764,0.0012923557,0.0010112331,0.0006990961,0.00041194292,0.00026109806,0.00014806315,0.00010332206],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99679023,0.000060196184,0.0007027392,0.00082994625,0.0006836506,0.0009332628],"domain_scores_gemma":[0.9980642,0.00015481592,0.00040375235,0.00080254284,0.0002230603,0.00035160166],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003767674,0.00047033856,0.001300491,0.00032527815,0.0005351987,0.00009778661,0.00021337418,0.00020701438,0.00015024736],"category_scores_gemma":[0.00015277593,0.0004318271,0.00046910695,0.00036461963,0.00011715469,0.00015571475,0.0002331797,0.00026243326,0.00012910004],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026907548,0.030795028,0.82770604,0.0028063569,0.0055536344,0.0006507089,0.0073600123,0.000084159,0.0014360484,0.003392133,0.0077461805,0.11220062],"study_design_scores_gemma":[0.007989814,0.0013326975,0.9760521,0.0005931346,0.002498191,0.000025464837,0.00014326865,0.0000011191722,0.0036118773,0.004604306,0.0025308656,0.0006171694],"about_ca_topic_score_codex":0.0009299242,"about_ca_topic_score_gemma":0.00021345024,"teacher_disagreement_score":0.14834605,"about_ca_system_score_codex":0.0002729982,"about_ca_system_score_gemma":0.00015708868,"threshold_uncertainty_score":0.9998134},"labels":[],"label_agreement":null},{"id":"W2578010896","doi":"10.1182/blood.v116.21.3223.3223","title":"Longer Time to the Start of Continuation Therapy Is Associated with Improved Survival In High Risk Pediatric Acute Lymphoblastic Leukemia (ALL): A Report From the Children's Oncology Group (COG)","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Maintenance therapy; Internal medicine; Hematology; Oncology; Randomized controlled trial; Leukemia; Pediatrics; Chemotherapy","score_opus":0.00777143765716343,"score_gpt":0.2456197355331145,"score_spread":0.23784829787595108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2578010896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956976,0.000074179035,0.00012796318,0.0014490008,0.00016656781,0.001943488,0.00028833657,0.00005937377,0.00019344762],"genre_scores_gemma":[0.99718356,0.000096817355,0.00046322795,0.0006571578,0.00061952055,0.00016628703,0.00032759045,0.000069582136,0.00041625684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969104,0.00037263086,0.00068890146,0.0005901775,0.0008672118,0.0005706837],"domain_scores_gemma":[0.99587727,0.0020068514,0.00057879474,0.00096965156,0.00038282055,0.000184609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016165675,0.00031810979,0.0006846353,0.00015227297,0.00011240768,0.000037798647,0.0004767499,0.0003440457,0.00035134322],"category_scores_gemma":[0.00158835,0.00017177765,0.000121967234,0.0007845614,0.00019118148,0.00008720508,0.00014712985,0.0008035022,0.000091145186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055542104,0.003035987,0.9000256,0.000013833798,0.0056494256,0.000992326,0.003958694,0.000026674647,0.064651735,0.000017143731,0.009521209,0.006553183],"study_design_scores_gemma":[0.023584424,0.0019106457,0.9682259,0.000032483455,0.0016898039,0.00019950494,0.000059848502,0.0009123186,0.0027278424,0.000046352605,0.00035848247,0.00025240632],"about_ca_topic_score_codex":0.006034403,"about_ca_topic_score_gemma":0.0022254172,"teacher_disagreement_score":0.06820031,"about_ca_system_score_codex":0.00047186043,"about_ca_system_score_gemma":0.0018399421,"threshold_uncertainty_score":0.91222525},"labels":[],"label_agreement":null},{"id":"W2578015983","doi":"10.1182/blood.v110.11.3986.3986","title":"Increased Incidence of Venous Thromboembolism Following Allogeneic Compared with Autologous Hematopoietic Stem Cell Transplantation.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Transplantation; Pulmonary embolism; Hematopoietic stem cell transplantation; Incidence (geometry); Cumulative incidence; Thrombosis; Surgery; Deep vein; Retrospective cohort study; Central venous catheter; Internal medicine; Catheter","score_opus":0.012782138488540528,"score_gpt":0.23743835146534784,"score_spread":0.2246562129768073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2578015983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99241495,0.005513393,0.00027019728,0.000016191452,0.0000859722,0.00040056458,0.000010541659,0.00008650077,0.0012016683],"genre_scores_gemma":[0.9991963,0.00012357523,0.00047488144,0.000077697805,0.000039904313,0.0000099816025,0.000023595732,0.000025022919,0.000029048435],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986692,0.000042516403,0.0004241017,0.0002357901,0.00036660983,0.00026176052],"domain_scores_gemma":[0.9991799,0.00013352015,0.00016568374,0.00026944402,0.00007308886,0.0001783509],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023756947,0.00016173162,0.0005461912,0.00010373861,0.00006674009,0.000007476464,0.000103867416,0.0001193423,0.000017871285],"category_scores_gemma":[0.0000073221745,0.00012004339,0.00013477766,0.00023464332,0.00006349441,0.000039749088,0.000009816187,0.00010225418,0.000011773645],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008604501,0.005493481,0.45221904,0.0021417406,0.001361638,0.0029239664,0.007631252,0.00009747494,0.5261162,0.00009275229,0.00007667018,0.000985372],"study_design_scores_gemma":[0.009101701,0.0006169494,0.7057701,0.00247611,0.0031859877,0.0011610923,0.0017689653,0.000017466473,0.2756253,0.000012835498,0.0000073909464,0.00025613385],"about_ca_topic_score_codex":0.00013956935,"about_ca_topic_score_gemma":0.000015069103,"teacher_disagreement_score":0.25355107,"about_ca_system_score_codex":0.000020456155,"about_ca_system_score_gemma":0.00014878831,"threshold_uncertainty_score":0.48952273},"labels":[],"label_agreement":null},{"id":"W2578034297","doi":"10.1182/blood.v108.11.4667.4667","title":"Improvement in Outcome of Patients with CD30+ HIV-Related Systemic B-Cell Non-Hodgkin’s Lymphoma (NHL) Providing HIV Infection Is Adequately Controlled.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"AIDS Vancouver; BC Cancer Agency; University of British Columbia","funders":"","keywords":"CD30; Medicine; Anaplastic large-cell lymphoma; Lymphoma; CHOP; Diffuse large B-cell lymphoma; Internal medicine; T-cell lymphoma; Oncology; Rituximab; B symptoms; Pathology; Immunology","score_opus":0.005286514178820113,"score_gpt":0.20920402721297465,"score_spread":0.20391751303415454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2578034297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953961,0.00028927863,0.000016372287,0.00009064559,0.00009674278,0.002427597,0.000039281575,0.000053906035,0.0015900737],"genre_scores_gemma":[0.99872863,0.000024341989,0.00009725789,0.00007814631,0.000038069324,0.00036330568,0.00011418778,0.00003874201,0.0005173397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979216,0.000040709405,0.00089314237,0.00039122044,0.0004108908,0.0003424377],"domain_scores_gemma":[0.9989371,0.00006837762,0.0004440443,0.00031420105,0.00014958056,0.00008672402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016126408,0.00030181828,0.0007982155,0.00023175066,0.00005066958,0.000020172818,0.00006048719,0.00014270828,0.000026619839],"category_scores_gemma":[0.000018833969,0.00021138597,0.0001714223,0.00025771683,0.000030785286,0.00009470166,0.000033396318,0.0000680576,0.000046973713],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061059074,0.009539582,0.9862892,0.00034309187,0.00027482185,0.000054373475,0.00016607462,0.000021526417,0.0013449073,0.000026875503,0.00011058515,0.001218386],"study_design_scores_gemma":[0.15957147,0.001772929,0.80691636,0.0005616843,0.000978543,0.000016900813,0.000044707176,0.00027250318,0.029562013,0.000009790788,0.000061697974,0.00023139287],"about_ca_topic_score_codex":0.0012941193,"about_ca_topic_score_gemma":0.000059573744,"teacher_disagreement_score":0.17937282,"about_ca_system_score_codex":0.00037880873,"about_ca_system_score_gemma":0.000115328614,"threshold_uncertainty_score":0.86200696},"labels":[],"label_agreement":null},{"id":"W2578051459","doi":"10.1182/blood.v106.11.2568.2568","title":"Outcomes of Previously Untreated Older Patients with Multiple Myeloma (MM) over Time: An Analysis of 3 Consecutive Trials Conducted by the NCIC CTG, 1983–2003.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; McGill University; Queen's University","funders":"","keywords":"Medicine; Internal medicine; Population; Melphalan; Multiple myeloma; Randomization; Dexamethasone; Lenalidomide; Transplantation; Surgery; Randomized controlled trial","score_opus":0.02077457200410801,"score_gpt":0.30534009570836096,"score_spread":0.2845655237042529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2578051459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99638087,0.000306513,0.00000740799,0.00007847467,0.0000128933025,0.0019286287,0.0010897313,0.000036224515,0.00015924989],"genre_scores_gemma":[0.997125,0.000022560062,0.00041584807,0.0000885542,0.000018138973,0.00006612093,0.0014141267,0.000030628675,0.0008189695],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99726456,0.00047942516,0.0007436966,0.00037713192,0.0007395204,0.00039568567],"domain_scores_gemma":[0.99720854,0.0005958196,0.0004864028,0.00066663924,0.00079744076,0.00024515737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004406534,0.00029248788,0.0014009916,0.00029599952,0.00007262942,0.000014768888,0.00016997616,0.00011527395,0.00087448995],"category_scores_gemma":[0.001351282,0.00015456545,0.00023168795,0.001222672,0.00025012865,0.000115640505,0.00003974208,0.00013760474,0.000017968341],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015272811,0.004812589,0.97367036,0.00002901852,0.013781213,0.000012781325,0.0005739718,0.0000072610164,0.003292743,0.0000036710048,0.0004729844,0.0018161252],"study_design_scores_gemma":[0.032016832,0.0009973642,0.92275226,0.000050238057,0.007666741,0.000002637652,0.000084647254,0.0006496908,0.03555256,6.7293223e-7,0.00008600817,0.0001403382],"about_ca_topic_score_codex":0.0009514072,"about_ca_topic_score_gemma":0.00027240824,"teacher_disagreement_score":0.050918095,"about_ca_system_score_codex":0.00005431066,"about_ca_system_score_gemma":0.00019415145,"threshold_uncertainty_score":0.9575052},"labels":[],"label_agreement":null},{"id":"W2578080654","doi":"10.1182/blood.v114.22.855.855","title":"Suppression of RISC-Independent Decoy and RISC-Mediated mRNA Base-Pairing Activities of MicroRNA-328 Is Required for Differentiation-Arrest and Enhanced Survival of Blast Crisis CML Progenitors.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Biology; CEBPA; Molecular biology; Gene silencing; Myeloid leukemia; microRNA; Progenitor cell; Ectopic expression; Cell biology; Cancer research; breakpoint cluster region; Stem cell; Transcription factor; Genetics; Gene","score_opus":0.013029467973255963,"score_gpt":0.25933981210786206,"score_spread":0.2463103441346061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2578080654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99793124,0.00071102905,0.0001170285,0.000112008776,0.00011188368,0.000723399,0.00021617267,0.00002367947,0.000053576023],"genre_scores_gemma":[0.99859923,0.00018621198,0.00093672395,0.000012373547,0.00007113737,0.000027601327,0.00007845,0.000024657718,0.00006362934],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99852246,0.00005458765,0.0005184674,0.00033210433,0.00033484655,0.00023754704],"domain_scores_gemma":[0.9988017,0.00023933622,0.00040197122,0.00030063814,0.0001422597,0.00011407747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001523523,0.00022048321,0.00062201574,0.00014987007,0.000052082654,0.000009137057,0.000075335694,0.00014298758,0.000041381074],"category_scores_gemma":[0.00014675848,0.00018824784,0.0001100914,0.00010698307,0.000085735504,0.00010993787,0.000050846054,0.000093507064,7.1090335e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005707257,0.0011526482,0.061036196,0.0006065514,0.0004255649,0.00000437817,0.0012380574,9.162095e-7,0.9337534,0.0000035048258,0.00018218567,0.0010259006],"study_design_scores_gemma":[0.010914089,0.00071634795,0.12471298,0.0003737794,0.0006134854,0.000007856446,0.00052150176,0.00007976055,0.8618945,0.000036105834,0.000009901088,0.000119685355],"about_ca_topic_score_codex":0.000085704356,"about_ca_topic_score_gemma":0.000036851383,"teacher_disagreement_score":0.07185886,"about_ca_system_score_codex":0.00006587293,"about_ca_system_score_gemma":0.00014117594,"threshold_uncertainty_score":0.7676524},"labels":[],"label_agreement":null},{"id":"W2578172276","doi":"10.1182/blood.v118.21.1876.1876","title":"Integrated Safety From Phase 2 Studies of Monotherapy Carfilzomib in Patients with Relapsed and Refractory Multiple Myeloma (MM): An Updated Analysis","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Carfilzomib; Bortezomib; Multiple myeloma; Medicine; Proteasome inhibitor; Internal medicine; Refractory (planetary science); Clinical trial; Renal function; Adverse effect; Phases of clinical research; Urology; Pharmacology; Oncology; Biology","score_opus":0.035636662927110256,"score_gpt":0.3026075490250956,"score_spread":0.26697088609798536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2578172276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99839985,0.00044951992,0.000019123128,0.000009262569,0.00001251092,0.0005482676,0.00044497746,0.000032659602,0.00008382783],"genre_scores_gemma":[0.9950785,0.00014708613,0.0029995856,0.000021350803,0.0000097932425,0.000025473879,0.001660497,0.00002370905,0.00003397629],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986042,0.00013778913,0.00036304584,0.0003771258,0.00027448998,0.00024335414],"domain_scores_gemma":[0.9989405,0.00007191103,0.00013257252,0.0004077519,0.00025804076,0.0001892185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011663898,0.00021011011,0.0006457007,0.0003653296,0.000046139383,0.0000058895275,0.00007744075,0.00008319894,0.00018273013],"category_scores_gemma":[0.000083296414,0.000140541,0.00006167028,0.00060412416,0.00014151138,0.00013459807,0.000027490825,0.00015773797,0.0000022500067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012193121,0.007162366,0.96166646,0.000012521615,0.005697882,0.000088953806,0.0023781364,5.9215307e-7,0.0019802165,0.0000013546794,0.000008349581,0.00881007],"study_design_scores_gemma":[0.06355729,0.0028804569,0.92180246,0.0000536748,0.0010518119,6.059875e-7,0.00062017137,0.00022106832,0.009631299,0.000009310781,0.000043173844,0.00012868196],"about_ca_topic_score_codex":0.0026780493,"about_ca_topic_score_gemma":0.0017301477,"teacher_disagreement_score":0.05136417,"about_ca_system_score_codex":0.00005190111,"about_ca_system_score_gemma":0.000059217513,"threshold_uncertainty_score":0.57310957},"labels":[],"label_agreement":null},{"id":"W2578216260","doi":"10.1182/blood.v118.21.986.986","title":"ERN1/IRE1 and XBP1 Are Dispensable for Myeloma Cell Survival but Are Required for the Anti-Myeloma Activity of Bortezomib","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"XBP1; Bortezomib; Unfolded protein response; Gene silencing; ATF6; Endoplasmic reticulum; Biology; RNA interference; Gene knockdown; Cancer research; Molecular biology; Small interfering RNA; Cell biology; Transfection; Cell culture; Multiple myeloma; Immunology; Gene; Genetics; RNA","score_opus":0.061933096656635114,"score_gpt":0.2925165551521706,"score_spread":0.23058345849553552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2578216260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99519414,0.0006461292,0.00048526982,0.00027781448,0.00015935506,0.001959494,0.00023160702,0.000045107074,0.0010011024],"genre_scores_gemma":[0.9963426,0.00013808892,0.0010048602,0.00004904666,0.00025134132,0.00018113635,0.000013190809,0.0000619981,0.0019577106],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99822515,0.000053715365,0.00030836,0.00044849917,0.00039458528,0.00056966924],"domain_scores_gemma":[0.9977504,0.0007814663,0.00026267406,0.0007429679,0.0002782087,0.00018429177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005412661,0.00023173411,0.0005992893,0.00006931142,0.00017124692,0.00002274543,0.00025732396,0.00016988248,0.00004608711],"category_scores_gemma":[0.00047246378,0.00016310078,0.00019030637,0.00015485157,0.00027461917,0.00011207331,0.00015114651,0.00014849404,0.0000068806894],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029049568,0.01961552,0.21007988,0.027085222,0.006261536,0.0013159467,0.0074958038,0.00001731497,0.6156379,0.0019765033,0.022742394,0.058722407],"study_design_scores_gemma":[0.07870053,0.0011702611,0.20653938,0.00039119393,0.0012346741,0.00020511016,0.0011898058,0.004901648,0.70129573,0.00028817123,0.0036172036,0.0004662614],"about_ca_topic_score_codex":0.0005064413,"about_ca_topic_score_gemma":0.00022718543,"teacher_disagreement_score":0.08565786,"about_ca_system_score_codex":0.00041787678,"about_ca_system_score_gemma":0.0011854833,"threshold_uncertainty_score":0.66510564},"labels":[],"label_agreement":null},{"id":"W2578256945","doi":"10.1182/blood.v104.11.3511.3511","title":"Evidence on Chromosome 11 for a Quantitative Trait Locus Influencing Levels of Activated Protein C-Protein C Inhibitor Complex.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Genetics; Biology; Locus (genetics); Identity by descent; Protein S; Allele; Linkage disequilibrium; Gene; Protein C; Haplotype","score_opus":0.12499733754173185,"score_gpt":0.3314367110434075,"score_spread":0.20643937350167563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2578256945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99410766,0.00008937598,0.00204204,0.0008698455,0.000038467533,0.0025867727,0.00006454991,0.00010000253,0.000101286365],"genre_scores_gemma":[0.9815818,0.00000106147,0.017793672,0.00021366545,0.000080423386,0.00022172261,0.000011272947,0.00004034996,0.000056009354],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984302,0.000053749034,0.00045986072,0.0003617104,0.00040512212,0.00028935474],"domain_scores_gemma":[0.9989162,0.000098610035,0.00025936888,0.00031071962,0.00028106643,0.00013404168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025852182,0.00022683278,0.00049951655,0.00016701987,0.00009217963,0.00001656429,0.00012016871,0.00013617874,0.00009217381],"category_scores_gemma":[0.0005176607,0.00020315024,0.00014818726,0.0003519081,0.00008070798,0.00017103548,0.000029336241,0.00015685253,0.000016099684],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024233267,0.00093882094,0.000030402183,0.00032483906,0.00012174185,0.0000086256405,0.00072463945,0.000027862194,0.97991854,0.017366793,0.0000052744517,0.00029011653],"study_design_scores_gemma":[0.00802381,0.0032185211,0.004102383,0.0037499855,0.00015508058,0.000012549425,0.00020154876,0.000021034188,0.97778976,0.0024916928,0.000030492714,0.00020314778],"about_ca_topic_score_codex":0.00008608617,"about_ca_topic_score_gemma":0.000029856998,"teacher_disagreement_score":0.015751634,"about_ca_system_score_codex":0.00007014243,"about_ca_system_score_gemma":0.00025701473,"threshold_uncertainty_score":0.82842267},"labels":[],"label_agreement":null},{"id":"W2578262996","doi":"10.1182/blood.v122.21.3161.3161","title":"Lenalidomide Induces A Ribosomal Stress Response In Multiple Myeloma (MM) Cells","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Cereblon; Ribosome biogenesis; Ribosomal protein; Ubiquitin ligase; Biology; Cell biology; Ribosome; Molecular biology; Ubiquitin; Mdm2; Cell culture; Genetics; RNA","score_opus":0.017345463738473264,"score_gpt":0.24538883676656068,"score_spread":0.22804337302808741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2578262996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997503,0.000054070028,0.000007691082,0.001164833,0.000015483754,0.00022495439,0.000023490069,0.00005427446,0.0009521943],"genre_scores_gemma":[0.99762434,0.0000066607654,0.00042536552,0.0005212456,0.000105998326,0.000050700306,0.000022569453,0.00001556567,0.0012275776],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988987,0.00012732975,0.0002764329,0.00023365063,0.0002118201,0.00025205922],"domain_scores_gemma":[0.99930793,0.00015956127,0.00006306239,0.0002405904,0.00006733316,0.00016154711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017751401,0.00013091203,0.00025745455,0.00024717013,0.000043289947,0.000032151627,0.00007097862,0.00009550413,0.00068554253],"category_scores_gemma":[0.00021710635,0.00011151166,0.00011295243,0.00028497833,0.0000526028,0.000105527906,0.000034711036,0.00017933139,0.00042792043],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040202428,0.0011065498,0.02956961,0.000036732432,0.00006971319,0.00019803553,0.00034408495,0.000009232645,0.9671838,0.0000072272233,0.00062380376,0.00044916855],"study_design_scores_gemma":[0.0065987837,0.00015660292,0.22305849,0.000415547,0.00007376576,0.00003105345,0.000529248,0.0001717547,0.768558,0.000027958187,0.00022054838,0.00015821146],"about_ca_topic_score_codex":0.00027430765,"about_ca_topic_score_gemma":0.000076443335,"teacher_disagreement_score":0.19862577,"about_ca_system_score_codex":0.000022663664,"about_ca_system_score_gemma":0.00006306959,"threshold_uncertainty_score":0.750621},"labels":[],"label_agreement":null},{"id":"W2578330893","doi":"10.1182/blood.v120.21.2106.2106","title":"Final Results From the Multicenter Compact Study of Complications in Patients with Sickle Cell Disease and Utilization of Iron Chelation Therapy: A Retrospective Medical Records Review.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Cohort; Medical record; Retrospective cohort study; Cohort study; Complication; Blood transfusion; Anemia; Pediatrics; Disease; Internal medicine","score_opus":0.02130361612213343,"score_gpt":0.2746457735295318,"score_spread":0.25334215740739835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2578330893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955897,0.002648812,0.0000071790864,0.00040848894,0.00001694829,0.0010592493,0.000050497718,0.000005727264,0.00021343605],"genre_scores_gemma":[0.9985193,0.001179793,0.000023895238,0.0001051021,0.0000136738545,0.000007491569,0.00013855094,0.0000070194496,0.0000051875118],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991482,0.00009395147,0.00028174368,0.00011745195,0.0002739247,0.00008471051],"domain_scores_gemma":[0.99938893,0.00007442851,0.00016414889,0.00020185788,0.00009103604,0.00007962043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018440532,0.00007109798,0.00018019037,0.000025328314,0.00002897881,0.000001661959,0.000041041883,0.00003723712,0.000020535323],"category_scores_gemma":[0.00016437043,0.000042061896,0.00001954365,0.0001502981,0.00005700424,0.000045458015,0.000012592652,0.00011449597,8.184148e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069900445,0.006681348,0.9897465,0.000055400185,0.000038261,3.6630814e-7,0.0020166251,0.0000014650258,0.000017959968,0.000002799635,0.00006853469,0.00067172543],"study_design_scores_gemma":[0.014442982,0.0005045767,0.983671,0.0006081258,0.00021682441,1.7943194e-7,0.00034287406,0.000105087645,0.000033341974,0.000004438918,0.00002863282,0.000041919855],"about_ca_topic_score_codex":0.00026525836,"about_ca_topic_score_gemma":0.000036585843,"teacher_disagreement_score":0.013743978,"about_ca_system_score_codex":0.000012481443,"about_ca_system_score_gemma":0.00003086803,"threshold_uncertainty_score":0.17152344},"labels":[],"label_agreement":null},{"id":"W2578336722","doi":"10.1182/blood.v114.22.3207.3207","title":"Stem Cell Transplantation for Fanconi Anemia: A Survey of Decision-Making among Families in the US and Canada.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Fanconi anemia; Medicine; Transplantation; Respondent; Spouse; Hematopoietic stem cell transplantation; Internal medicine; Oncology; Surgery; Family medicine; Genetics; DNA repair","score_opus":0.007343029003267109,"score_gpt":0.24285141735287938,"score_spread":0.23550838834961227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2578336722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980801,0.00070051505,0.00076438254,0.000018461216,0.000030383451,0.00016326501,0.00010058408,0.0000010991623,0.00014121416],"genre_scores_gemma":[0.999115,0.00015984803,0.0005440424,0.00010151334,0.000016242715,0.000013377107,0.00003858424,0.000004297476,0.0000070800793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995672,0.000036353744,0.0001250573,0.00012326281,0.000066814784,0.000081313585],"domain_scores_gemma":[0.9997,0.00008775426,0.000045032924,0.0001111458,0.000046234498,0.000009829651],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017366305,0.000055191915,0.0000658685,0.000018634926,0.000029458757,0.0000072806974,0.00008157203,0.000051296134,4.692651e-7],"category_scores_gemma":[0.000016718746,0.000045679117,0.000012864043,0.000056405,0.000020376357,0.0000019018293,0.0000046707305,0.000029246577,2.2488166e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004989065,0.00035946717,0.74093616,0.0002545695,0.000067087174,0.0000301909,0.0023960508,0.0025844083,0.17398684,0.000035742127,0.001979516,0.076871045],"study_design_scores_gemma":[0.00082466373,0.00011032324,0.88672626,0.000023181656,0.000027036102,0.000009859507,0.00025693007,0.000028163522,0.11173908,0.000034544933,0.00014034385,0.00007958624],"about_ca_topic_score_codex":0.021152303,"about_ca_topic_score_gemma":0.6507247,"teacher_disagreement_score":0.6295724,"about_ca_system_score_codex":0.000008835506,"about_ca_system_score_gemma":0.00017622519,"threshold_uncertainty_score":0.9853659},"labels":[],"label_agreement":null},{"id":"W2578427280","doi":"10.1182/blood.v126.23.1355.1355","title":"Efficacy and Safety of Allogeneic Double Negative T Cell As a Cellular Therapy for AML and Its Underlying Mechanism","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Chemotherapy; Myeloid leukemia; Leukemia; CD8; Minimal residual disease; Medicine; Immunology; Hematopoietic stem cell transplantation; Chemotherapy regimen; Transplantation; Haematopoiesis; Stem cell; Cancer research; Oncology; Internal medicine; Immune system; Biology","score_opus":0.08970118677423887,"score_gpt":0.3391773637705651,"score_spread":0.24947617699632624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2578427280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915924,0.0037544302,0.00018603451,0.00023438263,0.000034861507,0.001674413,0.000008400223,0.00002430727,0.0024907645],"genre_scores_gemma":[0.9958401,0.00084198575,0.00080156256,0.000079326244,0.00006325182,0.000045568653,0.000009992519,0.00003672133,0.0022815233],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989821,0.00004628067,0.00018886168,0.00027292583,0.00026202408,0.00024784755],"domain_scores_gemma":[0.99915814,0.00018045622,0.00006594414,0.00019718209,0.00017386994,0.00022438426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042249207,0.00014174532,0.0003076792,0.0000833486,0.000056865367,0.000016515052,0.000071220216,0.000099279976,0.00012640955],"category_scores_gemma":[0.000046114455,0.00011891185,0.000051551106,0.00010624641,0.00005660215,0.000043953245,0.000049010963,0.0001176619,0.0000058742603],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003907137,0.0004725737,0.00019970103,0.00010723791,0.00019345996,0.000014760868,0.0016961667,0.0000013438743,0.9900457,0.0010138957,0.000018715287,0.002329264],"study_design_scores_gemma":[0.045548987,0.0024770007,0.00028575468,0.000043957632,0.00010812258,0.0000308091,0.0003636903,0.00009350969,0.9476754,0.002223527,0.0010254981,0.00012371838],"about_ca_topic_score_codex":0.00004664573,"about_ca_topic_score_gemma":0.0000040269338,"teacher_disagreement_score":0.04237032,"about_ca_system_score_codex":0.000020640282,"about_ca_system_score_gemma":0.0001524692,"threshold_uncertainty_score":0.48490846},"labels":[],"label_agreement":null},{"id":"W2578488834","doi":"10.1182/blood.v126.23.3397.3397","title":"Transfusion Therapy and Hydroxyurea Improves Cerebrovascular Reserve and Perfusion in Children with Sickle Cell Anemia: An MRI Study","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Cerebral blood flow; Sickle cell anemia; Stroke (engine); Fetal hemoglobin; Anemia; Hemodynamics; Internal medicine; Pediatrics; Cardiology; Pregnancy; Disease; Fetus","score_opus":0.009149176673489265,"score_gpt":0.2178194632096406,"score_spread":0.20867028653615133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2578488834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99432915,0.0038211204,0.0000027141627,0.00018764751,0.000013705036,0.0011851398,0.000001721092,0.00003914032,0.00041964508],"genre_scores_gemma":[0.99705505,0.0025928991,0.0001427535,0.00006573528,0.000034020817,0.000014018439,0.000015779047,0.000027071697,0.0000526817],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897426,0.000075371194,0.00015794091,0.0003536524,0.00023695029,0.00020182887],"domain_scores_gemma":[0.99944186,0.00000848464,0.000030469446,0.00026495237,0.00004117194,0.00021306642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028608393,0.00017078903,0.0002565097,0.00008984358,0.0000673026,0.000022504166,0.00005221743,0.00014299313,0.0000066657635],"category_scores_gemma":[0.000007216168,0.000111558846,0.000023731754,0.00016487658,0.00006483257,0.00010006046,0.000027362097,0.0002633191,0.0000011226633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003263212,0.0029968934,0.97726893,0.00002612854,0.000060087594,0.00003408835,0.0067926757,0.0000081896,0.009020611,0.0000015913704,0.000015967853,0.0034484896],"study_design_scores_gemma":[0.05160825,0.01114654,0.92095804,0.00007870476,0.0003332303,0.00024902617,0.008781282,0.00016971806,0.006251369,0.000026374988,0.000091399554,0.00030606872],"about_ca_topic_score_codex":0.0018795978,"about_ca_topic_score_gemma":0.00037937614,"teacher_disagreement_score":0.056310922,"about_ca_system_score_codex":0.0000097454695,"about_ca_system_score_gemma":0.00006878561,"threshold_uncertainty_score":0.45492378},"labels":[],"label_agreement":null},{"id":"W2578504611","doi":"10.1182/blood.v114.22.556.556","title":"Quality of Life in Adolescents and Adults with Thalassemia: A Report of the Thalassemia Longitudinal Cohort.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Quality of life (healthcare); Medicine; Cohort; Thalassemia; Life expectancy; Gerontology; Longitudinal study; Population; Psychological intervention; Cohort study; SF-36; Mental health; Demography; Health related quality of life; Psychiatry; Internal medicine; Environmental health; Disease; Pathology","score_opus":0.009162705696652467,"score_gpt":0.2515566384525431,"score_spread":0.24239393275589063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2578504611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99666053,0.0008773619,0.0000031426237,0.0004638802,0.000025383497,0.0003974524,0.0000031612894,0.000011214545,0.0015578475],"genre_scores_gemma":[0.9996561,0.00013742098,0.00005728277,0.00007818936,0.000014746739,0.0000031979516,0.0000028541292,0.0000073983724,0.00004281913],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879485,0.000044963468,0.00046776162,0.00021898908,0.0003140092,0.00015945076],"domain_scores_gemma":[0.9991916,0.000017752845,0.00027049362,0.0003480387,0.000089488436,0.00008265562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028900677,0.000114530856,0.0003929282,0.000045994806,0.000021563728,0.000002824459,0.000066120905,0.00013410488,0.000003989457],"category_scores_gemma":[0.00023264602,0.00006662652,0.000061833576,0.00024664326,0.00010833324,0.000032049174,0.00002582225,0.00024221205,3.2700535e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031158133,0.0009583444,0.9962265,0.0002840394,0.0000631565,0.000102134756,0.00020727301,0.0000018684981,0.0015209051,0.000029011311,0.00004266718,0.00025251336],"study_design_scores_gemma":[0.0050799088,0.00027153816,0.99045044,0.0014457271,0.00012419866,0.00028121631,0.0002908855,0.000006292985,0.0019473332,0.00002430017,0.0000067468386,0.00007139088],"about_ca_topic_score_codex":0.0002665997,"about_ca_topic_score_gemma":0.00010214399,"teacher_disagreement_score":0.005776044,"about_ca_system_score_codex":0.000011086042,"about_ca_system_score_gemma":0.00014980324,"threshold_uncertainty_score":0.27169505},"labels":[],"label_agreement":null},{"id":"W2578506856","doi":"10.1182/blood.v104.11.4696.4696","title":"Philadelphia-Negative Clonal Hematopoiesis Following Imatinib Therapy in Patients with Chronic Myeloid Leukemia (CML).","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada; BC Cancer Agency; Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Imatinib; Medicine; Internal medicine; Imatinib mesylate; Myeloid leukemia; Cytarabine; Gastroenterology; Transplantation; Median follow-up; Surgery; Oncology; Immunology; Chemotherapy","score_opus":0.009918820047680492,"score_gpt":0.23906104265185985,"score_spread":0.22914222260417935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2578506856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964539,0.00060496497,0.000023383278,0.00041896055,0.00009762182,0.0012771284,0.000019600015,0.00012630936,0.0009781475],"genre_scores_gemma":[0.9964971,0.00006979361,0.0025825487,0.00025857828,0.00016459975,0.00015841515,0.000106175656,0.00008673924,0.0000760328],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99755776,0.000043071246,0.00047388388,0.0005857784,0.00070735795,0.0006321418],"domain_scores_gemma":[0.99891907,0.00009378679,0.0001697746,0.00053763145,0.000085199244,0.0001945394],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013065092,0.00043338936,0.00064108986,0.00020267958,0.000112377966,0.000027047694,0.000173766,0.00016896859,0.00015603505],"category_scores_gemma":[0.00006891534,0.0003364347,0.00019574293,0.00050138094,0.00010004869,0.00022368714,0.00005498736,0.00037736338,0.00009509139],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023709766,0.008587631,0.9693802,0.00037264975,0.0034933866,0.0012710878,0.004607186,0.00059594074,0.0035671187,0.0003582231,0.00018000316,0.005215599],"study_design_scores_gemma":[0.18221544,0.0039826646,0.77128625,0.0013705908,0.00045187812,0.000086669424,0.0001467313,0.000025253068,0.03902153,0.0005228444,0.0001861616,0.0007039766],"about_ca_topic_score_codex":0.0004264752,"about_ca_topic_score_gemma":0.00016948069,"teacher_disagreement_score":0.19809394,"about_ca_system_score_codex":0.0031987026,"about_ca_system_score_gemma":0.001818657,"threshold_uncertainty_score":0.99990875},"labels":[],"label_agreement":null},{"id":"W2578524701","doi":"10.1182/blood.v126.23.3219.3219","title":"Outcome of Allogeneic Stem Cell Transplantation for Thalassemia Major in India","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Busulfan; Fludarabine; ThioTEPA; Transplantation; Thalassemia; Surgery; Graft-versus-host disease; Internal medicine; Treosulfan; Regimen; Hematopoietic stem cell transplantation; Cyclophosphamide; Pediatrics; Chemotherapy","score_opus":0.01877762632041726,"score_gpt":0.26043355041559935,"score_spread":0.24165592409518208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2578524701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954264,0.0006795102,0.000075199234,0.000093514514,0.000074747266,0.00039281714,0.000018421742,0.000015402313,0.0032239493],"genre_scores_gemma":[0.9989814,0.00007801763,0.00046416753,0.00007320832,0.000017984194,0.000018684468,0.000030270323,0.0000126346085,0.00032364472],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99939644,0.000014949735,0.00024139014,0.00010614085,0.00010822317,0.00013284235],"domain_scores_gemma":[0.9997131,0.000027215981,0.000051120256,0.00009651093,0.00003854889,0.00007348626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014818346,0.00007139479,0.00018557203,0.00007561943,0.000008810637,0.0000021771436,0.000040324165,0.00012220163,0.0000064452147],"category_scores_gemma":[0.00000917146,0.0000575173,0.000055052435,0.00009533846,0.000015463842,0.0000227716,0.0000042608663,0.000077295146,0.00000944734],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024862625,0.00078601437,0.978266,0.0007820566,0.000057645877,0.000068321635,0.0019165534,0.000021379828,0.016517915,0.00009967606,0.0001597711,0.0010760332],"study_design_scores_gemma":[0.05997454,0.0018193449,0.66376054,0.00036923238,0.0014472336,0.00017561675,0.0042891228,0.00012106428,0.2659113,0.00025478064,0.0014439406,0.00043326346],"about_ca_topic_score_codex":0.000023628798,"about_ca_topic_score_gemma":0.000008159681,"teacher_disagreement_score":0.31450546,"about_ca_system_score_codex":0.000012780038,"about_ca_system_score_gemma":0.000063196516,"threshold_uncertainty_score":0.23454875},"labels":[],"label_agreement":null},{"id":"W2578525969","doi":"10.1182/blood.v124.21.4519.4519","title":"Synthetic Anti-IL3 Receptor Antibodies As Therapeutics to Block Innate Imatinib Resistance in Chronic Myelogenous Leukemia","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Chronic myelogenous leukemia; Imatinib mesylate; Biology; Antibody; Cancer research; Immunology; Imatinib; Leukemia; Myeloid leukemia","score_opus":0.013783822288686602,"score_gpt":0.2682412677283323,"score_spread":0.2544574454396457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2578525969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98551244,0.003001009,0.000015938953,0.00091762305,0.00016735768,0.000865361,0.000018137831,0.00016168795,0.0093404595],"genre_scores_gemma":[0.99274886,0.00069076,0.003037218,0.0007964004,0.000268587,0.00007658968,0.000028049559,0.00008915314,0.002264392],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99750245,0.00012826973,0.00054498,0.00065323885,0.00043065628,0.00074041024],"domain_scores_gemma":[0.99841666,0.00017859602,0.00014767017,0.0009429141,0.00010276035,0.0002113975],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003569852,0.00039288055,0.0007107754,0.00023784404,0.000116309755,0.000035002566,0.00026766147,0.00019955459,0.00013596677],"category_scores_gemma":[0.00022857441,0.00035140026,0.000118423566,0.0004565463,0.00011472608,0.00006276616,0.000102961065,0.00034225636,0.0009036745],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001250575,0.0038134754,0.08004779,0.0024172019,0.0023270873,0.0009911649,0.01060131,0.00038103873,0.86187845,0.0027502272,0.0026210765,0.03092062],"study_design_scores_gemma":[0.05012642,0.0044785426,0.13763216,0.005545872,0.0020817749,0.00072353194,0.00043414024,0.0006540442,0.6115583,0.0012153359,0.18309806,0.0024517819],"about_ca_topic_score_codex":0.00017758281,"about_ca_topic_score_gemma":0.0003787172,"teacher_disagreement_score":0.2503201,"about_ca_system_score_codex":0.0019092748,"about_ca_system_score_gemma":0.0011093059,"threshold_uncertainty_score":0.9998938},"labels":[],"label_agreement":null},{"id":"W2578546793","doi":"10.1182/blood.v108.11.351.351","title":"Carboxypeptidase M Cleaves the C-Terminal Lysine of Stromal Cell-Derived Factor-1α and Is Expressed by Human Bone Marrow Cells.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Canadian Blood Services","funders":"","keywords":"Stromal cell; Haematopoiesis; Bone marrow; CD34; Molecular biology; Progenitor cell; Stem cell; Cell biology; Chemistry; Proteases; Mesenchymal stem cell; Biology; Biochemistry; Immunology; Cancer research","score_opus":0.012018340298005723,"score_gpt":0.23225281203272008,"score_spread":0.22023447173471436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2578546793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99765414,0.0003994825,0.000025980858,0.0002589279,0.000037921975,0.00026496753,0.00007507939,0.000042719563,0.0012407799],"genre_scores_gemma":[0.9982845,0.000017953585,0.00034108982,0.00016566527,0.00011161356,0.000009618114,0.000044671615,0.000027984139,0.0009968559],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99888444,0.0000475425,0.0003102416,0.00026201393,0.00028156867,0.00021418187],"domain_scores_gemma":[0.9993162,0.00003263867,0.00015793124,0.00033694142,0.00006474405,0.00009155182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007203517,0.0001885892,0.00033974982,0.00005594357,0.000109843924,0.000025997811,0.00008653641,0.00009956178,0.00022750384],"category_scores_gemma":[0.000004711006,0.00014062639,0.00009060891,0.00009329594,0.000113185524,0.000049556424,0.00004746142,0.00013010069,0.0000056345507],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025520605,0.00072515366,0.001621566,0.000075210446,0.000047246212,0.0000187395,0.0002557144,2.8572686e-7,0.9959204,0.000080450205,0.0011131885,0.00011652342],"study_design_scores_gemma":[0.004060993,0.0003395513,0.024084989,0.00004649575,0.0003334005,0.000022327484,0.000166207,0.000036129877,0.9703969,0.00007938086,0.00029396822,0.00013966303],"about_ca_topic_score_codex":0.00015902077,"about_ca_topic_score_gemma":0.000012054965,"teacher_disagreement_score":0.025523508,"about_ca_system_score_codex":0.000006564325,"about_ca_system_score_gemma":0.000022295599,"threshold_uncertainty_score":0.5734578},"labels":[],"label_agreement":null},{"id":"W2578622261","doi":"10.1182/blood.v108.11.5233.5233","title":"Cyclosporine-Induced Nephrotoxicity and Dose Adjustments in Bone Marrow Transplantation.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto","funders":"","keywords":"Medicine; Nephrotoxicity; Creatinine; Transplantation; Internal medicine; Gastroenterology; Chemotherapy; Urology; Renal function; Bone marrow; Surgery; Toxicity","score_opus":0.012218496602621327,"score_gpt":0.2456258808359522,"score_spread":0.23340738423333085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2578622261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99427056,0.00021473446,0.000060255323,0.0001809064,0.00004097664,0.0006387728,0.00001446613,0.000055587803,0.004523742],"genre_scores_gemma":[0.99805176,0.00013458483,0.0013068866,0.000107225176,0.00007384282,0.000049922855,0.000083783605,0.000019252922,0.00017271865],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989875,0.000030107225,0.00031326327,0.00024108181,0.00021792461,0.00021015079],"domain_scores_gemma":[0.9996608,0.000043883254,0.00004846214,0.00014257313,0.000024041316,0.00008024656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012179635,0.00013995015,0.00023594755,0.00012354484,0.000029794237,0.000009989777,0.000030880667,0.00009742973,0.00005125368],"category_scores_gemma":[0.000006399544,0.00013482393,0.00003526782,0.00017188347,0.000023131412,0.00007486752,0.000004252515,0.00011487528,0.000019488352],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003106168,0.0014656077,0.42847747,0.00091360504,0.00004703328,0.001875743,0.0006687433,0.0000046340556,0.5647765,0.0005286193,0.00004060355,0.00089083525],"study_design_scores_gemma":[0.010828124,0.000120609526,0.809673,0.00020266717,0.000218829,0.0007259684,0.000044441487,0.000028652945,0.17779465,0.00017618857,0.000044889992,0.0001419369],"about_ca_topic_score_codex":0.0003321455,"about_ca_topic_score_gemma":0.00016146257,"teacher_disagreement_score":0.38698182,"about_ca_system_score_codex":0.000020686479,"about_ca_system_score_gemma":0.000037574104,"threshold_uncertainty_score":0.54979604},"labels":[],"label_agreement":null},{"id":"W2578678001","doi":"10.1182/blood.v116.21.4036.4036","title":"Prognostic Relevance of Genomic Aberrations In Light Chain Only Multiple Myeloma","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Multiple myeloma; Internal medicine; Gastroenterology; Fluorescence in situ hybridization; Medicine; Progression-free survival; Immunoglobulin light chain; Autologous stem-cell transplantation; Monoclonal; Confidence interval; Oncology; Plasma cell; Chemotherapy; Antibody; Biology; Monoclonal antibody; Immunology","score_opus":0.01468643369673203,"score_gpt":0.27305550158228953,"score_spread":0.2583690678855575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2578678001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99553806,0.00019911773,0.000009999173,0.0004463452,0.0000631888,0.00072803313,0.000020118783,0.000030077465,0.00296508],"genre_scores_gemma":[0.99502516,0.000031607513,0.0038710132,0.000024184312,0.00008236946,0.00007648214,0.000032490658,0.000019042636,0.00083767733],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990416,0.000026159536,0.0002440965,0.00021302683,0.00020242594,0.00027268403],"domain_scores_gemma":[0.99922585,0.00016893113,0.000056105633,0.0003304934,0.00007484395,0.0001437873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011491153,0.00010948298,0.00021564217,0.00014887139,0.00003894879,0.000007493455,0.000087275046,0.00007882309,0.00009124358],"category_scores_gemma":[0.0008729777,0.00009234737,0.00005559161,0.00016942504,0.000053631582,0.00004642363,0.000033986642,0.00025389067,0.00009352226],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007931845,0.0014562523,0.66733444,0.000056522083,0.00006190458,0.00012017837,0.00019717104,8.9555374e-7,0.32585323,0.00015001505,0.0000433133,0.0046467506],"study_design_scores_gemma":[0.006205331,0.0002634418,0.9483166,0.000062565225,0.00005072178,0.000073069525,0.00002696676,0.00037389892,0.043572158,0.00006268096,0.00091294345,0.00007965062],"about_ca_topic_score_codex":0.00011597897,"about_ca_topic_score_gemma":0.0020508158,"teacher_disagreement_score":0.28228107,"about_ca_system_score_codex":0.00001715751,"about_ca_system_score_gemma":0.00020157151,"threshold_uncertainty_score":0.37658164},"labels":[],"label_agreement":null},{"id":"W2578704408","doi":"10.1182/blood.v126.23.3439.3439","title":"Natural Killer Cells Activated By Oncolytic Reovirus Enhance Cetuximab Mediated Antibody Dependent Cellular Cytotoxicity in an in Vitro and In Vivo Model of Colorectal Cancer","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Antibody-dependent cell-mediated cytotoxicity; Cetuximab; Cytotoxicity; Oncolytic virus; Interleukin 12; Immune system; Cytotoxic T cell; Cancer research; Natural killer cell; Antibody; Interleukin 21; Biology; Chemistry; Immunology; In vitro; Monoclonal antibody; T cell; Biochemistry","score_opus":0.01351801123874271,"score_gpt":0.2968146190110096,"score_spread":0.2832966077722669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2578704408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979221,0.0014509648,0.000010300854,0.000020960444,0.00005634329,0.00042279382,0.00007991087,0.000006559132,0.000030017496],"genre_scores_gemma":[0.99928904,0.00030720053,0.00009984656,0.00004964713,0.000021581694,0.000053058557,0.000095461066,0.00002845685,0.00005571317],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983812,0.00020457036,0.00030625606,0.00045465337,0.0002645598,0.0003887631],"domain_scores_gemma":[0.9994496,0.000019829264,0.000087167726,0.00022935447,0.00008231044,0.00013170668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039021226,0.00019302139,0.0003019821,0.00013847917,0.00001594483,0.000012642437,0.00022786051,0.00022310736,0.000007187755],"category_scores_gemma":[0.000050384686,0.00019455855,0.000029139977,0.00024760375,0.00009181597,0.00001474962,0.00010592381,0.00026332343,8.54723e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049002273,0.00092081696,0.002916882,0.000018415185,0.00002518979,0.000018141449,0.00018216539,0.00076622394,0.99015766,9.8210236e-8,0.000022944207,0.000071225375],"study_design_scores_gemma":[0.0050796517,0.0008293701,0.00021704395,0.000019374087,0.0000069014786,0.0000013113494,0.00005504123,0.00682624,0.9867405,0.000007704121,0.000005433202,0.00021140225],"about_ca_topic_score_codex":0.000615577,"about_ca_topic_score_gemma":0.0047974903,"teacher_disagreement_score":0.0060600163,"about_ca_system_score_codex":0.00008578026,"about_ca_system_score_gemma":0.00033143902,"threshold_uncertainty_score":0.79338676},"labels":[],"label_agreement":null},{"id":"W2578791119","doi":"10.1182/blood.v110.11.1019.1019","title":"Cbl-b Deficiency Enhances Motility and Impairs Leukemogenesis by Bcr-Abl.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Bone marrow; Ubiquitin ligase; Biology; Haematopoiesis; Cancer research; Philadelphia chromosome; breakpoint cluster region; Chronic myelogenous leukemia; Myeloid; ABL; Immunology; Leukemia; Ubiquitin; Tyrosine kinase; Signal transduction; Stem cell; Cell biology; Chromosomal translocation; Receptor; Genetics","score_opus":0.009114481552950941,"score_gpt":0.2540121762098526,"score_spread":0.24489769465690167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2578791119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870954,0.0063220765,0.00012947254,0.00009151529,0.00007327136,0.0003179501,0.000017642913,0.000102473365,0.005850188],"genre_scores_gemma":[0.9974708,0.00023961527,0.001069949,0.00013546212,0.000085541855,0.0000108934355,0.000020403564,0.000021433596,0.0009458821],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985763,0.00002119535,0.0002756388,0.00040546313,0.00028719197,0.0004342277],"domain_scores_gemma":[0.9991946,0.000100014695,0.000069077454,0.00035499348,0.000046752943,0.00023452811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003371197,0.00019629614,0.00028262532,0.00006632059,0.00009876464,0.000013641291,0.000080432736,0.00011164854,0.00013968417],"category_scores_gemma":[0.00010102793,0.00016463488,0.000071317736,0.00019230423,0.00011543952,0.000049000948,0.00004790192,0.00011230492,0.000051465147],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019426314,0.0031901645,0.7920104,0.00035942806,0.00032638505,0.00031653643,0.0006917268,7.7202935e-7,0.14878346,0.000049722014,0.0019730825,0.052104037],"study_design_scores_gemma":[0.010523206,0.0007587151,0.49009112,0.000083025414,0.00065005315,0.0003983522,0.00032653293,0.000033049448,0.49384788,0.00007881734,0.002925432,0.0002838277],"about_ca_topic_score_codex":0.00028660425,"about_ca_topic_score_gemma":0.000059681333,"teacher_disagreement_score":0.3450644,"about_ca_system_score_codex":0.00023914607,"about_ca_system_score_gemma":0.00019032726,"threshold_uncertainty_score":0.67136157},"labels":[],"label_agreement":null},{"id":"W2578807992","doi":"10.1182/blood.v110.11.4150.4150","title":"Decreased Expression of the Histone Methyltransferase SUV39H1 in AML Cells Reactivates Hypermethylated Tumor Suppressor p15INK4B in the Absence of Promoter Demethylation.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Decitabine; Trichostatin A; Methyltransferase; DNA methylation; Molecular biology; Methylation; Chromatin immunoprecipitation; Cancer research; Biology; Histone methyltransferase; EZH2; DNA methyltransferase; Epigenetics; DNA demethylation; Chemistry; Histone; Histone deacetylase; Promoter; Gene expression; Biochemistry; DNA; Gene","score_opus":0.009190101039867464,"score_gpt":0.2533464193212188,"score_spread":0.24415631828135134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2578807992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974043,0.0012417148,0.000525065,0.000048683534,0.000069391186,0.0004568918,0.000018106295,0.000003427055,0.00023242125],"genre_scores_gemma":[0.99857926,0.00007955206,0.0011942921,0.000033383545,0.00003176395,0.000016134694,0.000026913656,0.000017023604,0.000021692913],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984295,0.00030162622,0.0005190485,0.00027223313,0.00025123442,0.00022637076],"domain_scores_gemma":[0.9990123,0.00017216176,0.00019710591,0.00048116848,0.00009831622,0.000038929928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012062067,0.0001526281,0.00020239402,0.00009788556,0.000038774324,0.0000067890355,0.00032541857,0.00014621507,0.000010638902],"category_scores_gemma":[0.00026821098,0.000100329984,0.00009778494,0.00032969177,0.00011758544,0.0000074551317,0.000050381102,0.00015965487,4.4544137e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009895489,0.0004928146,0.020082131,0.00003370298,0.0000110565,0.0000036947492,0.0003753977,0.00009050804,0.9785061,0.000009165159,0.000004135842,0.00029235063],"study_design_scores_gemma":[0.0010836914,0.00011543958,0.10324871,0.00005188349,0.000019990706,0.0000016113339,0.000089684094,0.00001601625,0.8949313,0.00018171618,0.00015395296,0.000105975494],"about_ca_topic_score_codex":0.00021378681,"about_ca_topic_score_gemma":0.00017267231,"teacher_disagreement_score":0.08357476,"about_ca_system_score_codex":0.000009803455,"about_ca_system_score_gemma":0.00006459666,"threshold_uncertainty_score":0.4091338},"labels":[],"label_agreement":null},{"id":"W2578812948","doi":"10.1182/blood.v114.22.1994.1994","title":"Both Nramp1 and Dmt1 Are Necessary for Efficient Macrophage Iron Recycling.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"DMT1; Macrophage; Ferroportin; Transporter; Hemoglobin; Biochemistry; Ferrous; Downregulation and upregulation; Transfection; Biology; Chemistry; Hepcidin; Cell biology; Inflammation; Immunology; In vitro; Gene","score_opus":0.010005335247378202,"score_gpt":0.2580407954919815,"score_spread":0.2480354602446033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2578812948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868904,0.007674831,0.00028510482,0.0010840255,0.000114516144,0.00042945394,0.000016067319,0.00006265909,0.003442948],"genre_scores_gemma":[0.9947889,0.00021777205,0.0023240957,0.0015909016,0.00021360522,0.000010606421,0.000020004352,0.00001653315,0.00081759656],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99923104,0.000013880178,0.00015224576,0.00023394583,0.00013155886,0.00023732906],"domain_scores_gemma":[0.9995659,0.000031861888,0.00005617901,0.00019845672,0.000025773881,0.00012185477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012582506,0.00012105396,0.00022053905,0.000056518977,0.00007947739,0.00001746732,0.000048050835,0.0000780595,0.000026543532],"category_scores_gemma":[0.000091733535,0.00010152184,0.000059515205,0.0000772332,0.000034236116,0.000023733426,0.000013475625,0.000087896595,0.000009293321],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005158691,0.027636176,0.14120016,0.005602594,0.00028041066,0.001019459,0.007166501,0.000402575,0.1976042,0.009178006,0.052942306,0.55180895],"study_design_scores_gemma":[0.051221028,0.0022422115,0.86741537,0.00037794482,0.0019451117,0.00020489197,0.0018957874,0.00067615294,0.02865226,0.0015302178,0.042825665,0.0010133602],"about_ca_topic_score_codex":0.0000069186754,"about_ca_topic_score_gemma":0.0000016567978,"teacher_disagreement_score":0.7262152,"about_ca_system_score_codex":0.000004533077,"about_ca_system_score_gemma":0.000023012859,"threshold_uncertainty_score":0.41399404},"labels":[],"label_agreement":null},{"id":"W2578820165","doi":"10.1182/blood.v112.11.3626.3626","title":"Targeting the Bcl-2 Family of Proteins in Hodgkin Lymphoma: In Vitro Cytotoxicity, Target Modulation and Drug Combination Studies of the BH3 Mimetic ABT-737","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"","keywords":"Cytotoxicity; Cancer research; Lymphoma; Pharmacology; Apoptosis; Stromal cell; Medicine; Growth inhibition; Bone marrow; Annexin A5; In vitro; Immunology; Annexin; Biology; Flow cytometry","score_opus":0.03013737377222814,"score_gpt":0.28719304370355225,"score_spread":0.2570556699313241,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2578820165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99532056,0.0025410603,0.000010449136,0.001059038,0.000026189591,0.0008330147,0.00000935378,0.000006025808,0.00019431129],"genre_scores_gemma":[0.99873716,0.0004943071,0.00047414217,0.000055253062,0.000030385238,0.000039804036,0.0000070728365,0.000008984668,0.00015290173],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987248,0.00016944823,0.00037121156,0.00015330697,0.00040423262,0.00017700944],"domain_scores_gemma":[0.9993847,0.00019584392,0.00012703807,0.00014872383,0.000117666495,0.000026012796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056059775,0.00010688947,0.00030754512,0.00012255441,0.00009143072,0.0000032214803,0.00010985118,0.000042972602,0.0000019298584],"category_scores_gemma":[0.0002458176,0.00006086865,0.000054008233,0.00035925634,0.00028440027,0.00004811115,0.00012760903,0.0001341958,7.749835e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026823653,0.0011311505,0.3010253,0.00036955366,0.00007911475,0.000021022854,0.0039130296,0.0000606661,0.6924031,0.00010420013,0.00008025807,0.0005443821],"study_design_scores_gemma":[0.002882146,0.000117024654,0.7521732,0.0001701406,0.00002073554,0.00001806377,0.0006350137,0.002599606,0.24079797,0.0005040887,0.000019265199,0.00006273941],"about_ca_topic_score_codex":0.00069492875,"about_ca_topic_score_gemma":0.00003714464,"teacher_disagreement_score":0.4516051,"about_ca_system_score_codex":0.000027662063,"about_ca_system_score_gemma":0.00007288011,"threshold_uncertainty_score":0.24821514},"labels":[],"label_agreement":null},{"id":"W2578863070","doi":"10.1182/blood.v110.11.2138.2138","title":"Applying Diagnostic Criteria for Type 1 von Willebrand Disease to a Pediatric Population.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Von Willebrand disease; Population; Platelet disorder; Pediatrics; Retrospective cohort study; Internal medicine; Von Willebrand factor; Platelet","score_opus":0.022420232664243436,"score_gpt":0.31573373879064626,"score_spread":0.29331350612640283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2578863070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997089,0.0008271449,0.0003119636,0.00014518517,0.00013114166,0.001224659,0.000024002547,0.000041744555,0.00020510465],"genre_scores_gemma":[0.9975333,0.00004095674,0.001365383,0.00033685306,0.0002706471,0.00014285545,0.00012852944,0.000019072673,0.00016237744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993987,0.000004328107,0.00013126459,0.00016422334,0.00010161831,0.0001998584],"domain_scores_gemma":[0.9994405,0.00014490193,0.00002440999,0.000121607714,0.00004233172,0.0002262633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007176875,0.000090288755,0.00014827252,0.00009171977,0.0000631974,0.000011957233,0.000027221029,0.00003180837,0.00003772152],"category_scores_gemma":[0.0004448893,0.00007805941,0.000046290916,0.00016723994,0.000003655087,0.000033873923,0.000011402993,0.000027921571,0.000037949118],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042535178,0.000866712,0.99317527,0.0001330162,0.000057743793,0.0003605018,0.000059668673,0.0000023761297,0.00015481144,0.0000436847,0.0011800164,0.0035408665],"study_design_scores_gemma":[0.0055892365,0.00035552186,0.98991853,0.00004195397,0.0009026322,0.00002303667,0.000017383545,0.00001941078,0.00014762618,0.00041330684,0.002422749,0.00014859375],"about_ca_topic_score_codex":0.000017151531,"about_ca_topic_score_gemma":0.0000076266506,"teacher_disagreement_score":0.0051638847,"about_ca_system_score_codex":0.000012924375,"about_ca_system_score_gemma":0.000021665262,"threshold_uncertainty_score":0.31831703},"labels":[],"label_agreement":null},{"id":"W2578878754","doi":"10.1182/blood.v106.11.870.870","title":"Important Role of Routine Cerebrospinal Fluid Examination in Diagnosing Central Nervous System Relapse during Maintenance Therapy in Pediatric Acute Lymphoblastic Leukemia.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Cerebrospinal fluid; Lumbar puncture; Acute lymphocytic leukemia; Maintenance therapy; Bone marrow; Central nervous system; Pediatrics; Internal medicine; Chemotherapy; Leukemia; Lymphoblastic Leukemia","score_opus":0.006117851129794871,"score_gpt":0.22817041541573008,"score_spread":0.2220525642859352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2578878754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99693805,0.0016506093,0.00004827733,0.00008717353,0.00008122401,0.00075655343,0.000015509282,0.00007627726,0.00034634903],"genre_scores_gemma":[0.99710584,0.0016036823,0.0005560056,0.000029477087,0.0004433225,0.00008198202,0.00002196656,0.00006387957,0.00009383783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966531,0.00013244974,0.0010661739,0.00052493036,0.0006908076,0.0009325483],"domain_scores_gemma":[0.9987625,0.00017915966,0.00028751537,0.00042134567,0.00013450357,0.0002150049],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005629366,0.00030680708,0.0006275674,0.00057657936,0.000055546487,0.000022808876,0.00023636744,0.00021119638,0.000020055499],"category_scores_gemma":[0.0002764955,0.00027581188,0.000110718014,0.00093676604,0.00007029912,0.00021164467,0.00009570303,0.00034301236,0.000014317953],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012142922,0.00150381,0.91906804,0.0007062571,0.00012267396,0.0017934268,0.0015994011,0.0009176893,0.06874733,0.00019893612,0.000030407824,0.0040977327],"study_design_scores_gemma":[0.022129675,0.00051117694,0.91955495,0.00067574077,0.0001420265,0.00081586995,0.00037056798,0.015486994,0.040046304,0.000006764975,0.000009961812,0.0002499725],"about_ca_topic_score_codex":0.0004100876,"about_ca_topic_score_gemma":0.0001050504,"teacher_disagreement_score":0.028701022,"about_ca_system_score_codex":0.003405656,"about_ca_system_score_gemma":0.00095784874,"threshold_uncertainty_score":0.9999694},"labels":[],"label_agreement":null},{"id":"W2578880538","doi":"10.1182/blood.v116.21.5147.5147","title":"Rates of Non-Transfusional Iron Accumulation (NTIA) In Hemoglobin E Thalassemia","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"Thalassemia; Hemoglobin; Internal medicine; Gastroenterology; Serum ferritin; Medicine; Blood transfusion; Ferritin; Anemia; Surgery; Chemistry","score_opus":0.011395310615730339,"score_gpt":0.2889055869789496,"score_spread":0.27751027636321923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2578880538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944013,0.00011587987,0.000024013283,0.0004657981,0.0001672603,0.000250569,0.0000042733163,0.00002006818,0.004550874],"genre_scores_gemma":[0.9988729,0.000082585866,0.0007132555,0.00007016009,0.000056677545,0.00000617703,0.000030038958,0.000014356935,0.0001538736],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99921477,0.000013198866,0.00025228268,0.00016664916,0.00018228553,0.0001708139],"domain_scores_gemma":[0.9996099,0.000040414343,0.000051858588,0.0001794617,0.000049485927,0.00006889248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014142104,0.00010225629,0.00020105281,0.00010865948,0.000026722444,0.0000050583926,0.00005899209,0.00022043005,0.00020999475],"category_scores_gemma":[0.000057165576,0.00008541124,0.00007085367,0.00022109285,0.000054731292,0.000054018616,0.000016704167,0.00034084992,0.000019741465],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006966311,0.0007714472,0.31819883,0.000094909185,0.00002190239,0.000025516625,0.0002407839,0.000031830823,0.67876554,0.00009768452,0.00011366932,0.0015682296],"study_design_scores_gemma":[0.008104526,0.00021592368,0.765618,0.00018788711,0.00013592292,0.00008476972,0.00019348052,0.0011223386,0.22354029,0.00016370634,0.00046356738,0.00016954828],"about_ca_topic_score_codex":0.00011541578,"about_ca_topic_score_gemma":0.00009256191,"teacher_disagreement_score":0.45522526,"about_ca_system_score_codex":0.000006732025,"about_ca_system_score_gemma":0.000090621164,"threshold_uncertainty_score":0.3482969},"labels":[],"label_agreement":null},{"id":"W2578914617","doi":"10.1182/blood.v110.11.84.84","title":"10 Year Musculoskeletal Outcomes with Tailored Primary Prophylaxis: The Canadian Hemophilia Prophylaxis Study.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; CancerCare Manitoba; McMaster University; Centre Hospitalier Universitaire Sainte-Justine; Regional Municipality of Niagara; Hospital for Sick Children","funders":"","keywords":"Medicine; Ankle; Hemarthrosis; Haemophilia; Surgery; Incidence (geometry); Cohort; Arthropathy; Osteoarthritis; Internal medicine","score_opus":0.013876916332793273,"score_gpt":0.2723216876933107,"score_spread":0.25844477136051747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2578914617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9712417,0.00015536988,8.4587174e-7,0.0012587789,0.000049255625,0.0024491746,0.0000070663677,0.000074720396,0.024763094],"genre_scores_gemma":[0.9779594,0.0000044461367,0.00023573714,0.000109979424,0.00023521156,0.000082969425,0.00003175005,0.00005124154,0.021289296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99757856,0.000071588154,0.0002709949,0.0004196266,0.0009185051,0.00074073614],"domain_scores_gemma":[0.99842566,0.000082155006,0.00005180534,0.0007143762,0.00020995898,0.00051606423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000672404,0.00027737895,0.00037394796,0.00026893106,0.00038646342,0.00005806019,0.00024350901,0.0001464135,0.0005120211],"category_scores_gemma":[0.00011803889,0.00013662202,0.00013837015,0.00056432636,0.00024028838,0.00006736737,0.000060424012,0.00048584837,0.00058955874],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004906855,0.0028628458,0.98048353,0.00014173328,0.00084374496,0.002169761,0.0007305872,2.977044e-7,0.00045434307,0.000035386784,0.0003202963,0.011466758],"study_design_scores_gemma":[0.0075849616,0.010297675,0.97570395,0.000038951643,0.00033559828,0.000097991986,0.00083687156,7.839561e-7,0.00097373436,0.000016486634,0.0038447003,0.00026827678],"about_ca_topic_score_codex":0.00823544,"about_ca_topic_score_gemma":0.04485609,"teacher_disagreement_score":0.03662065,"about_ca_system_score_codex":0.00020256249,"about_ca_system_score_gemma":0.0008697806,"threshold_uncertainty_score":0.9983688},"labels":[],"label_agreement":null},{"id":"W2578976908","doi":"10.1182/blood.v104.11.3253.3253","title":"Transformed Lymphoma: Incidence and Long-Term Outcome.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Follicular lymphoma; Lymphoma; Lymphoplasmacytic Lymphoma; Internal medicine; Population; Incidence (geometry); Gastroenterology; Marginal zone; Immunology; Waldenstrom macroglobulinemia; B cell; Antibody","score_opus":0.01699762616396155,"score_gpt":0.27650044243866967,"score_spread":0.2595028162747081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2578976908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960917,0.0014094969,0.000023560584,0.0009174658,0.00004588272,0.000270234,0.000004401126,0.000052922514,0.0011843003],"genre_scores_gemma":[0.9986803,0.00031987904,0.00034947623,0.00043591732,0.000054492906,0.000039980918,0.000009640541,0.000011684141,0.00009860852],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993021,0.0000054009397,0.00016707173,0.00019191418,0.00015283853,0.00018069895],"domain_scores_gemma":[0.9996134,0.000023938264,0.000025825484,0.0001674541,0.000021703125,0.00014767525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000042592514,0.00012107749,0.00021392122,0.000042074404,0.000051837033,0.000016492337,0.000036481542,0.0000558605,0.000026959578],"category_scores_gemma":[0.000019094654,0.00008950394,0.000064825945,0.00007060875,0.000047316964,0.00006050665,0.00001424879,0.000024882895,0.00004725445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027663482,0.0017002455,0.985416,0.000065128654,0.0000989295,0.0007397681,0.00019755853,1.7787735e-7,0.0003586124,0.00029783743,0.0000067988935,0.011091309],"study_design_scores_gemma":[0.018613275,0.00030220795,0.9614879,0.00010118353,0.00036665704,0.0007276561,0.000013976449,2.451169e-7,0.018138899,0.00008942589,0.00006634774,0.00009223478],"about_ca_topic_score_codex":0.000068156136,"about_ca_topic_score_gemma":0.000060906856,"teacher_disagreement_score":0.02392808,"about_ca_system_score_codex":0.00006927558,"about_ca_system_score_gemma":0.000085678046,"threshold_uncertainty_score":0.36498648},"labels":[],"label_agreement":null},{"id":"W2578988297","doi":"10.1182/blood.v120.21.1088.1088","title":"Thrombopoietin Can Induce Tolerogenic Responses Via the Modulation of Thymic and Splenic T Lymphocyte Populations in a Murine Model of Immune Thrombocytopenia (ITP)","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; St. Michael's Hospital","funders":"","keywords":"FOXP3; Thrombopoietin; IL-2 receptor; Medicine; Immunology; Splenocyte; Spleen; Platelet; Immune system; Internal medicine; CD8; Endocrinology; T cell; Biology; Stem cell; Haematopoiesis","score_opus":0.04842082961157763,"score_gpt":0.29335234424490836,"score_spread":0.24493151463333074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2578988297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99665993,0.0024912688,0.000024915993,0.00018950165,0.000025672636,0.00043396698,0.00002966777,0.000011092618,0.00013396968],"genre_scores_gemma":[0.999049,0.00019541623,0.00058751245,0.00002574877,0.0000132248315,0.00002047933,0.00003597666,0.000017204578,0.000055414355],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990621,0.000057647103,0.00037704455,0.00013644216,0.00016441979,0.00020234185],"domain_scores_gemma":[0.9994011,0.00004796215,0.00015796114,0.000302041,0.000039760984,0.000051163897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020273367,0.00013086073,0.0004066392,0.000106194726,0.000047487756,0.000003567483,0.00006485999,0.00007556421,0.000016902426],"category_scores_gemma":[0.00004344393,0.00009473501,0.000068815476,0.00020239597,0.000073073534,0.00008936836,0.00005175711,0.00007786986,0.0000017813566],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061181205,0.0030546067,0.48859078,0.00013708002,0.00040625315,0.000012351907,0.0039274404,0.0006876715,0.49973807,0.0006900071,0.0000067058195,0.002137246],"study_design_scores_gemma":[0.0059142327,0.00015538622,0.94586957,0.000093783565,0.0003463064,0.0000993228,0.00012928905,0.0051988126,0.041344795,0.00074476795,0.0000024960902,0.00010122919],"about_ca_topic_score_codex":0.00090258237,"about_ca_topic_score_gemma":0.00027387418,"teacher_disagreement_score":0.45839325,"about_ca_system_score_codex":0.000036273384,"about_ca_system_score_gemma":0.000089445304,"threshold_uncertainty_score":0.38631818},"labels":[],"label_agreement":null},{"id":"W2578991141","doi":"10.1182/blood.v104.11.4026.4026","title":"An Attempt to Reach Consensus Regarding Management of Neonatal Renal Vein Thrombosis: The Canadian Pediatric Hemostasis and Thrombosis Network Experience.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Vascular anomalies and interventions","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; Stollery Children's Hospital; Children's Hospital of Winnipeg; McMaster Children's Hospital; Centre Hospitalier Universitaire Sainte-Justine; BC Children's Hospital","funders":"","keywords":"Medicine; Thrombosis; Venography; Thrombophilia; Renal vein thrombosis; Thrombus; Hemostasis; Concomitant; Surgery; Inferior vena cava; Venous thrombosis; Internal medicine","score_opus":0.02729589098362687,"score_gpt":0.29227963127019446,"score_spread":0.26498374028656757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2578991141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942819,0.001149711,0.000090922964,0.0020622616,0.000089087356,0.0004065883,0.00001908472,0.000023593107,0.0018768482],"genre_scores_gemma":[0.9958057,0.00018318756,0.0033664468,0.0003441862,0.00017549806,0.00003831994,0.000015707403,0.000017942437,0.00005304346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988967,0.000036171736,0.00026257313,0.0002645934,0.0002255319,0.00031439058],"domain_scores_gemma":[0.99917597,0.000012761831,0.000057830366,0.00042645965,0.0000642575,0.0002627206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023295997,0.0001303852,0.00022845293,0.00008528009,0.00029214207,0.000039481853,0.00013070763,0.00005824542,0.00007184503],"category_scores_gemma":[0.0000150041105,0.000100244804,0.00013432287,0.00033083747,0.00007846381,0.000044364162,0.000057516874,0.000104761755,0.0000059976182],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002731978,0.0035297438,0.86964446,0.0017026672,0.008089541,0.000957315,0.035172373,0.0022541438,0.0029330032,0.029372932,0.028544385,0.017526252],"study_design_scores_gemma":[0.0074639623,0.0018727315,0.95585495,0.0010233023,0.0035140247,0.00035102986,0.015905524,0.0000393695,0.0039923727,0.00038882613,0.008974465,0.0006194219],"about_ca_topic_score_codex":0.01925978,"about_ca_topic_score_gemma":0.027262626,"teacher_disagreement_score":0.08621053,"about_ca_system_score_codex":0.000050973147,"about_ca_system_score_gemma":0.00007877022,"threshold_uncertainty_score":0.9904873},"labels":[],"label_agreement":null},{"id":"W2578993682","doi":"10.1182/blood.v108.11.5537.5537","title":"Effect of Mild Hemophilia A on Quality of Life Using the SF-36.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. John’s Health Sciences Centre; Memorial University of Newfoundland","funders":"","keywords":"Medicine; Quality of life (healthcare); Body mass index; Internal medicine; Population; Demography","score_opus":0.053547993256960386,"score_gpt":0.3609021718092465,"score_spread":0.3073541785522861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2578993682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946265,0.0004586684,0.0000023912569,0.00055413303,0.000029637169,0.00040959762,0.000008700614,0.00001240135,0.0038979757],"genre_scores_gemma":[0.9991761,0.000010261668,0.00008180062,0.00004180079,0.00013728443,0.000005888598,0.000006950994,0.000010855432,0.00052905414],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998866,0.00019229736,0.00025856443,0.00012933643,0.00038948163,0.00016430567],"domain_scores_gemma":[0.99909025,0.00039000122,0.000078531404,0.0003305276,0.000055608903,0.000055075903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063812,0.00009783461,0.00033161335,0.000059989638,0.00004284846,0.0000031063144,0.000074261065,0.00006396198,0.00003963651],"category_scores_gemma":[0.00021301808,0.000050720937,0.00014548525,0.00017383236,0.00011551698,0.000012753791,0.000025811765,0.000114727496,0.000007984501],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023103084,0.003397437,0.7093277,0.0013152487,0.0004684181,0.000036987854,0.00017262682,0.000022053837,0.28040877,0.000524243,0.0007788897,0.0012373193],"study_design_scores_gemma":[0.010220606,0.002499306,0.15525661,0.00026922955,0.00037276873,0.000010420268,0.000035256588,0.00008446947,0.83088565,0.00009161229,0.00017194179,0.0001021225],"about_ca_topic_score_codex":0.00048605018,"about_ca_topic_score_gemma":0.000007705094,"teacher_disagreement_score":0.55407107,"about_ca_system_score_codex":0.000014136333,"about_ca_system_score_gemma":0.0000706577,"threshold_uncertainty_score":0.20683397},"labels":[],"label_agreement":null},{"id":"W2579000866","doi":"10.1182/blood.v114.22.3140.3140","title":"A Polymorphism in the XPNPEP2 Gene Is Associated with the Development of Hypotensive Transfusion Reactions without ACE Inhibitors.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Bradykinin; Medicine; Angiotensin-converting enzyme; Genotype; Pharmacology; Gene; Immunology; Internal medicine; Gastroenterology; Chemistry; Biochemistry; Blood pressure","score_opus":0.015561963487202804,"score_gpt":0.23338508113772327,"score_spread":0.21782311765052048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2579000866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9744018,0.0001639266,0.00015046763,0.021954853,0.000031223262,0.0008893837,0.0000032742462,0.00003348442,0.002371618],"genre_scores_gemma":[0.9950027,0.00008311286,0.0009437967,0.003441122,0.00003495906,0.000032979584,0.000010880982,0.000012167735,0.00043831134],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988076,0.000066497,0.00029541986,0.00020061739,0.00043058873,0.00019926517],"domain_scores_gemma":[0.9994386,0.000047698864,0.000090640846,0.000283765,0.00009170577,0.00004760253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003640123,0.00014699566,0.00023515681,0.000099206605,0.00013835682,0.000010158412,0.00011707011,0.00006986358,0.00002518199],"category_scores_gemma":[0.00002419299,0.00007599536,0.000065808636,0.0004415504,0.000052050887,0.000034660145,0.00001043409,0.00022946567,0.0000040894647],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017418361,0.024514327,0.017310327,0.00020651777,0.0026583557,0.0007321448,0.17844833,0.00002666656,0.7081408,0.00072496023,0.010183397,0.055312313],"study_design_scores_gemma":[0.023032175,0.0015157828,0.574723,0.00085830624,0.0019948476,0.00031281737,0.007418163,0.00003926985,0.3731036,0.00011870092,0.016395139,0.00048819615],"about_ca_topic_score_codex":0.00006454702,"about_ca_topic_score_gemma":0.00035450901,"teacher_disagreement_score":0.5574127,"about_ca_system_score_codex":0.000022151235,"about_ca_system_score_gemma":0.00010666222,"threshold_uncertainty_score":0.30990008},"labels":[],"label_agreement":null},{"id":"W2579019697","doi":"10.1182/blood.v116.21.4254.4254","title":"Studies on Heme Oxygenase 1 During Erythroid Differentiation","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Heme Oxygenase-1 and Carbon Monoxide","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Heme; Heme oxygenase; Biochemistry; Dehydratase; Chemistry; Catabolism; Hemoglobin; HMOX1; Biology; Cell biology; Enzyme","score_opus":0.009664910166648168,"score_gpt":0.24618648387308548,"score_spread":0.2365215737064373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2579019697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99849445,0.00030298217,0.00000647816,0.00008038537,0.0003064907,0.000095127754,0.000009672254,0.000024970015,0.0006794246],"genre_scores_gemma":[0.99831414,0.00009955268,0.00015001053,0.00013331405,0.0005295785,0.000027146927,0.0000430252,0.00002122201,0.0006820003],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992357,0.000021642583,0.00015409985,0.00028542813,0.00010863897,0.00019449412],"domain_scores_gemma":[0.999474,0.000006416735,0.00005582617,0.0003403166,0.000049828537,0.00007361505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000077879144,0.00013938488,0.00011271202,0.000031785665,0.000088473775,0.000016585876,0.00010527462,0.00010826232,0.000019810213],"category_scores_gemma":[0.00010335445,0.00012421577,0.00007873858,0.000042741478,0.0000383048,0.0000023291839,0.000067112225,0.000117298696,0.000029632447],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021938074,0.00017753035,0.0018218504,0.000016945169,0.00009698098,0.000006589016,0.000045140932,0.00000292201,0.99743086,0.000077585544,0.00021111546,0.00009053526],"study_design_scores_gemma":[0.000926297,0.00011701799,0.010606383,0.0000075919984,0.000029595158,0.000012035206,0.00006988193,0.0000032652945,0.98686045,0.00004715582,0.001161093,0.00015923145],"about_ca_topic_score_codex":0.0000021425838,"about_ca_topic_score_gemma":0.00006849809,"teacher_disagreement_score":0.010570414,"about_ca_system_score_codex":0.0000037464856,"about_ca_system_score_gemma":0.0000200172,"threshold_uncertainty_score":0.5065372},"labels":[],"label_agreement":null},{"id":"W2579077000","doi":"10.1182/blood.v114.22.3580.3580","title":"PD-L1 Immuno-Gene Therapy Under Cell Fate Control: Persistence of Cellular Delivery Vehicle and Transgene Expression.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research","funders":"","keywords":"Biology; Jurkat cells; Genetic enhancement; CD19; Gene delivery; T cell; Cell biology; Transgene; Viral vector; Transfection; Cell therapy; Ex vivo; Molecular biology; Flow cytometry; Immune system; In vivo; Gene; Stem cell; Immunology; Genetics; Recombinant DNA","score_opus":0.02661883014036972,"score_gpt":0.2510072339640696,"score_spread":0.22438840382369987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2579077000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800045,0.017313434,0.00020465345,0.00045062034,0.000029398521,0.00047242825,0.000013366582,0.000036998623,0.0014745829],"genre_scores_gemma":[0.99380916,0.0036477472,0.00037139657,0.00041067015,0.00007720761,0.000009130826,0.000009488064,0.000027570399,0.0016376297],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985778,0.00009366108,0.0002719768,0.00031303882,0.0004089404,0.00033460557],"domain_scores_gemma":[0.999125,0.000077381155,0.000066690016,0.00043414213,0.00013395703,0.00016280734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024341625,0.00018287743,0.00038030616,0.000097711396,0.00007866547,0.000017597353,0.00015074444,0.00012020223,0.0005699286],"category_scores_gemma":[0.0000070312485,0.00013722638,0.00016293884,0.00015666946,0.00012221053,0.000065768654,0.00001552069,0.00020861221,0.000008392687],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011625001,0.0008807711,0.00081926107,0.00003441427,0.0001026585,0.000037160877,0.00041913823,0.000011509844,0.9912014,0.000004385469,0.000024343166,0.0053024786],"study_design_scores_gemma":[0.013643253,0.0012090638,0.011546348,0.000054490265,0.00010318471,0.00002463708,0.000173523,0.000080687176,0.9725204,0.000067435845,0.00043148792,0.00014546922],"about_ca_topic_score_codex":0.00002975131,"about_ca_topic_score_gemma":8.9322674e-7,"teacher_disagreement_score":0.018680958,"about_ca_system_score_codex":0.000018262237,"about_ca_system_score_gemma":0.00007838496,"threshold_uncertainty_score":0.62403184},"labels":[],"label_agreement":null},{"id":"W2579114106","doi":"10.1182/blood.v118.21.2299.2299","title":"Family History of Venous Thromboembolism (VTE) and the Risk of VTE Recurrence in Patients with a First Unprovoked VTE: A Multicenter Prospective Cohort Study","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; London Health Sciences Centre; McMaster University; St. Joseph’s Healthcare Hamilton; McGill University Health Centre; Victoria Hospital; St. Joseph's Hospital; University of Ottawa; Jewish General Hospital; Dalhousie University","funders":"","keywords":"Medicine; Family history; Venous thromboembolism; Prospective cohort study; Cohort; Thrombosis; Internal medicine; Pediatrics; Pulmonary embolism; Cohort study; Medical history","score_opus":0.009451267463142836,"score_gpt":0.20042655788941938,"score_spread":0.19097529042627653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2579114106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99156463,0.0007609382,0.0000051159964,0.000012843805,0.00012703099,0.004591542,0.000014083313,0.000016975728,0.002906829],"genre_scores_gemma":[0.99898374,0.0003809177,0.00020863388,0.000053631527,0.000016991702,0.00029098833,0.0000038111748,0.000024088236,0.000037196587],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849224,0.00012049683,0.00041638996,0.00036816983,0.0003789749,0.00022374149],"domain_scores_gemma":[0.99883217,0.00008132773,0.0003542907,0.0004796057,0.00019196763,0.000060669438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004526272,0.00020145166,0.00088713056,0.000113882365,0.00004316245,0.0000038572493,0.00014469198,0.000048468693,0.00002202819],"category_scores_gemma":[0.00012066325,0.00012676223,0.000062614345,0.00015060819,0.0003452399,0.000067795845,0.000111476606,0.00018826885,0.0000024181845],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008022834,0.020991683,0.9483211,0.00016803166,0.00087315764,0.000010137868,0.02832823,8.35871e-7,0.000006538701,0.000088508335,0.00012071338,0.00028875985],"study_design_scores_gemma":[0.02128334,0.0027020096,0.972459,0.00029662412,0.0019050342,6.966338e-7,0.0010614876,0.000010256647,0.000065415814,0.000040440427,0.000047842786,0.00012786062],"about_ca_topic_score_codex":0.0038835777,"about_ca_topic_score_gemma":0.00069156714,"teacher_disagreement_score":0.027266743,"about_ca_system_score_codex":0.00009388913,"about_ca_system_score_gemma":0.00008851445,"threshold_uncertainty_score":0.58708334},"labels":[],"label_agreement":null},{"id":"W2579125732","doi":"10.1182/blood.v120.21.4941.4941","title":"Interlaboratory Validation of a 3-Tube 10-Color Antibody Flow Cytometry Panel for Diagnosis of Myelodysplastic Syndromes","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cytometry; CD34; Medicine; Flow cytometry; CD33; Antigen; Antibody; Immunology; Pathology; Biology; Stem cell","score_opus":0.039722465870081054,"score_gpt":0.329344464250231,"score_spread":0.28962199838014996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2579125732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99728644,0.00061127124,0.00068303506,0.0001038602,0.00013496204,0.0007368151,0.00018364876,0.000035586418,0.00022437698],"genre_scores_gemma":[0.9947994,0.00008965012,0.004321444,0.000034744775,0.00018757307,0.00017232381,0.00014674717,0.000041157793,0.00020695977],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985173,0.00006554791,0.0004334147,0.00020342127,0.00038975768,0.0003905658],"domain_scores_gemma":[0.99814,0.00070551265,0.00017568772,0.00035373928,0.00044522478,0.00017983723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053702586,0.00016135743,0.0005032167,0.00040638217,0.00003351083,0.00000697768,0.00015694943,0.00015267324,0.000311071],"category_scores_gemma":[0.0016489365,0.00013979615,0.00013168108,0.00061031495,0.00012168544,0.00017233918,0.000080270904,0.0001443479,0.000041245876],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074116094,0.003951632,0.683519,0.003073277,0.0010690191,0.000025138528,0.0010329504,0.000009371552,0.30093294,0.00013570365,0.0031997303,0.0023100688],"study_design_scores_gemma":[0.006546124,0.0016220638,0.11803107,0.00039472472,0.0009128882,0.00007609881,0.00032716896,0.00034790128,0.870428,0.000015647627,0.001105486,0.00019277389],"about_ca_topic_score_codex":0.000011082518,"about_ca_topic_score_gemma":6.098394e-7,"teacher_disagreement_score":0.56949514,"about_ca_system_score_codex":0.00008182545,"about_ca_system_score_gemma":0.00024650505,"threshold_uncertainty_score":0.5700721},"labels":[],"label_agreement":null},{"id":"W2579174581","doi":"10.1182/blood.v124.21.2286.2286","title":"Patient Factors Associated with Enrollment on an Acute Myeloid Leukemia Phase III Clinical Trial: A Report from the Children’s Oncology Group","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Cog; Clinical trial; Cohort; Internal medicine; Logistic regression; Retrospective cohort study; Pediatrics; Oncology","score_opus":0.050373065321398715,"score_gpt":0.36612845171257496,"score_spread":0.31575538639117623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2579174581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948004,0.000047299734,0.000056138273,0.0016229793,0.0007686142,0.0017706628,0.00011399237,0.00020635422,0.00061358727],"genre_scores_gemma":[0.99129575,0.000023124121,0.00015184248,0.005719569,0.0013324387,0.00009431235,0.0012698736,0.00006309012,0.000049994775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952445,0.0011913668,0.00137732,0.0008322787,0.0009179056,0.0004366371],"domain_scores_gemma":[0.99568224,0.0015353821,0.0010164272,0.0012297226,0.00010462237,0.0004316266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021758645,0.00037306434,0.0011284953,0.000055318345,0.0001832318,0.000036638896,0.00025688595,0.00033158695,0.00008637191],"category_scores_gemma":[0.0014411445,0.00022977557,0.00029915714,0.00016470822,0.00018338821,0.00007445507,0.00008380808,0.00077251164,0.000013367945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15205243,0.09232801,0.63985264,0.00002346004,0.020435175,0.0012549742,0.022477895,0.000012489131,0.00083930383,0.00021165478,0.017686957,0.052824974],"study_design_scores_gemma":[0.39407888,0.06294359,0.5291026,0.00025691217,0.0032644279,0.00008767386,0.00059812685,0.000023777,0.0011207527,0.000083485415,0.007886026,0.00055372174],"about_ca_topic_score_codex":0.0016133209,"about_ca_topic_score_gemma":0.0012904104,"teacher_disagreement_score":0.24202645,"about_ca_system_score_codex":0.00032687443,"about_ca_system_score_gemma":0.00055692886,"threshold_uncertainty_score":0.93699753},"labels":[],"label_agreement":null},{"id":"W2579233025","doi":"10.1182/blood.v114.22.2426.2426","title":"Multiple Human Progenitor Lineages Mediate the Endogenous Regeneration of Beta Cells Via Pro-Angiogenic and Putative Neogenic Function.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Progenitor cell; Stem cell; Biology; Haematopoiesis; Population; Transplantation; Cell biology; Bone marrow; Mesenchymal stem cell; Immunology; Endothelial stem cell; Molecular biology; Internal medicine; In vitro; Medicine; Biochemistry","score_opus":0.022162743178646416,"score_gpt":0.23686539682138272,"score_spread":0.2147026536427363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2579233025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947609,0.003363527,0.00019026008,0.00028088375,0.00014811533,0.0007975083,0.000018177203,0.00006405799,0.00037661195],"genre_scores_gemma":[0.9982458,0.00006233836,0.0005114524,0.0002651646,0.00037926855,0.000048695892,0.0000727028,0.000015664427,0.000398915],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989605,0.00007540318,0.00031026333,0.00023384113,0.00022664866,0.00019334508],"domain_scores_gemma":[0.9992343,0.00011357307,0.00015073486,0.0002491663,0.00014902405,0.000103194434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019420957,0.00015801942,0.00027553627,0.00008053374,0.0001709465,0.00001636972,0.000056356548,0.000081360165,0.000033737957],"category_scores_gemma":[0.000067271096,0.000106731524,0.000116482166,0.0001774091,0.00008721845,0.00005954247,0.000016113807,0.00010069917,0.000015411086],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008924185,0.0004969888,0.011200818,0.00003960157,0.00035180678,0.0000070567635,0.00047038522,0.0000111838945,0.98461384,0.000044193286,0.00012977631,0.0025451134],"study_design_scores_gemma":[0.00334457,0.0012878675,0.024868911,0.000019780358,0.0012645822,0.00005972184,0.00011848524,0.00032576348,0.96824163,0.00014789273,0.00020368712,0.000117109106],"about_ca_topic_score_codex":0.000016631384,"about_ca_topic_score_gemma":0.0000033336423,"teacher_disagreement_score":0.016372206,"about_ca_system_score_codex":0.000012214113,"about_ca_system_score_gemma":0.000049571885,"threshold_uncertainty_score":0.43523854},"labels":[],"label_agreement":null},{"id":"W2579237696","doi":"10.1182/blood.v104.11.4525.4525","title":"Septicemia in Chemotherapy Induced Neutropenic Acute Myeloid Leukemia (AML) Inpatients and Outpatients: A 5 Year Retrospective Experience.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Cytarabine; Medicine; Neutropenia; Internal medicine; Regimen; Empiric therapy; Febrile neutropenia; Chemotherapy regimen; Chemotherapy; Induction chemotherapy; Incidence (geometry); Surgery; Gastroenterology; Pathology","score_opus":0.011119700938383287,"score_gpt":0.2678095402230317,"score_spread":0.25668983928464845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2579237696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951839,0.000051437302,0.0000066792572,0.00016768115,0.00015369279,0.00057900086,0.000007106926,0.000058661164,0.0037918636],"genre_scores_gemma":[0.9985117,0.00016332384,0.00022850622,0.00066133484,0.00009196621,0.0001241101,0.000008662198,0.000034058656,0.0001763634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998821,0.000019039111,0.00025307338,0.000386358,0.00023018598,0.00029032058],"domain_scores_gemma":[0.999416,0.000007857557,0.000081151695,0.0002818373,0.000070828784,0.0001423234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000048127597,0.00018497027,0.0003088527,0.00014135927,0.00007766011,0.000028333545,0.00008484926,0.000111228386,0.0000945672],"category_scores_gemma":[0.000020861673,0.00016947166,0.00006010249,0.0004059656,0.00007068334,0.00019031044,0.000049898677,0.00030721977,0.00003916695],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050239166,0.0010763118,0.87040955,0.000035058616,0.00022205868,0.00010053673,0.008283617,0.0000043262394,0.11773094,0.0003557374,0.000050887957,0.0012286064],"study_design_scores_gemma":[0.023430957,0.0016988553,0.89616585,0.00017247866,0.0001654061,0.0000962424,0.00057544996,0.0000011985032,0.07684456,0.00021458817,0.00035988062,0.00027455247],"about_ca_topic_score_codex":0.00034379447,"about_ca_topic_score_gemma":0.00009527697,"teacher_disagreement_score":0.04088638,"about_ca_system_score_codex":0.00045436664,"about_ca_system_score_gemma":0.00020651976,"threshold_uncertainty_score":0.6910854},"labels":[],"label_agreement":null},{"id":"W2579369645","doi":"10.1182/blood.v118.21.4777.4777","title":"Usability Testing of An Online Transition Program for Adolescents with Hemophilia","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; McMaster University; Hospital for Sick Children","funders":"","keywords":"Usability; Thematic analysis; The Internet; Medical education; Psychology; Multimedia; Medicine; Applied psychology; World Wide Web; Computer science; Qualitative research; Human–computer interaction","score_opus":0.08927768795186496,"score_gpt":0.3278194382473564,"score_spread":0.2385417502954914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2579369645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99820745,0.000020553602,0.00002925257,0.00006470628,0.000009098897,0.001317022,0.000022311771,0.00006509012,0.00026452352],"genre_scores_gemma":[0.95793784,0.0000016628755,0.041814957,0.000015900634,0.00007113504,0.000057839912,0.000057704758,0.000014638589,0.000028351382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99927956,0.000020139814,0.00015367054,0.00018783998,0.00017040086,0.00018841279],"domain_scores_gemma":[0.9994389,0.000015089681,0.000033756212,0.00020455528,0.00018825181,0.00011945724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012884734,0.00008800806,0.00017808579,0.00004298856,0.000036367615,0.0000029566881,0.00004746684,0.000053020114,0.000011959818],"category_scores_gemma":[0.00005664174,0.000058510162,0.000046006095,0.00014552087,0.00009051313,0.0000515111,0.0000060915204,0.000074867334,0.0000011463127],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019091998,0.04513274,0.8204314,0.0018687596,0.00013246182,0.00006777387,0.001023446,6.0644265e-7,0.018711548,0.000009121283,0.0000031324187,0.1107098],"study_design_scores_gemma":[0.013151359,0.015265576,0.82905143,0.0007786188,0.00053464796,0.0000875527,0.00020752943,0.0006769455,0.13989922,0.00017272303,0.000022190545,0.00015219171],"about_ca_topic_score_codex":0.000041543706,"about_ca_topic_score_gemma":0.000021493617,"teacher_disagreement_score":0.12118768,"about_ca_system_score_codex":0.0000104815845,"about_ca_system_score_gemma":0.00007407329,"threshold_uncertainty_score":0.23859753},"labels":[],"label_agreement":null},{"id":"W2579376283","doi":"10.1182/blood.v106.11.1860.1860","title":"A Phase II Study of Temozolomide Therapy for Poor Risk Patients Age ≥ 60 Years with Acute Myeloid Leukemia (AML) - Low Levels of MGMT May Predict for Response.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Myeloid leukemia; Leukemia; Cytarabine; Nausea; Decitabine; Temozolomide; Induction chemotherapy; Surgery; Phases of clinical research; Gastroenterology; Oncology; Chemotherapy","score_opus":0.021989801246705583,"score_gpt":0.315142500201624,"score_spread":0.2931526989549184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2579376283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908804,0.00010498719,0.0002283913,0.00016802871,0.00004010362,0.006679529,0.0017781084,0.000058520345,0.000061923696],"genre_scores_gemma":[0.99057245,0.0000708363,0.0066574845,0.0001245332,0.000176052,0.0005974963,0.000093599614,0.000111566915,0.0015959524],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972263,0.00019381708,0.00071523944,0.0005453061,0.0007384806,0.0005808442],"domain_scores_gemma":[0.9975849,0.0005484316,0.00042922504,0.0007422855,0.0004734605,0.00022172755],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010402972,0.00032096813,0.0008272266,0.00034314,0.00013462972,0.000012982287,0.0003708305,0.00017736797,0.000037399364],"category_scores_gemma":[0.00047571605,0.00024873728,0.00020515503,0.00037108056,0.00018264141,0.00013349498,0.00010237692,0.00030773765,0.000003819319],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37398046,0.07606967,0.04371079,0.0006294726,0.010600898,0.0006974869,0.015005865,0.00010788618,0.3412617,0.000017634495,0.009967317,0.12795079],"study_design_scores_gemma":[0.3994377,0.1584873,0.19333935,0.00029575982,0.0020495737,0.000043326778,0.00101479,0.0005907388,0.23756568,0.000026109336,0.0066207163,0.0005289455],"about_ca_topic_score_codex":0.00009568354,"about_ca_topic_score_gemma":0.00004749195,"teacher_disagreement_score":0.14962856,"about_ca_system_score_codex":0.00027770668,"about_ca_system_score_gemma":0.0009920571,"threshold_uncertainty_score":0.9999965},"labels":[],"label_agreement":null},{"id":"W2579417875","doi":"10.1182/blood.v126.23.3682.3682","title":"A Novel Isoflavone, ME-344, Targets the Cytoskeleton in Acute Myeloid Leukemia","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Myeloid leukemia; Leukemia; Cancer research; HL60; Haematopoiesis; Cell culture; Biology; Cytotoxic T cell; Cancer cell; Apoptosis; Cancer; Medicine; Immunology; In vitro; Stem cell; Internal medicine; Cell biology; Biochemistry; Genetics","score_opus":0.014922441602588783,"score_gpt":0.2471523919367222,"score_spread":0.2322299503341334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2579417875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98989254,0.0027042148,0.003628361,0.00057106104,0.0003301876,0.00028566018,0.000037132886,0.00001802924,0.0025328195],"genre_scores_gemma":[0.99598056,0.00041990477,0.0009673428,0.001154954,0.00028815336,0.000049908424,0.00005214188,0.000029361676,0.0010576647],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99915904,0.000024184154,0.00015077186,0.00026382305,0.00013707428,0.0002650798],"domain_scores_gemma":[0.9994394,0.000005147789,0.000053057687,0.0003619263,0.000053114876,0.000087341956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021317365,0.00014072869,0.00012739854,0.000027801694,0.00004182527,0.000023495635,0.00025082254,0.00012605451,0.0000068574377],"category_scores_gemma":[0.000017664028,0.0001080006,0.00006690754,0.00009694599,0.00003680754,0.0000027353342,0.000117161086,0.00011019041,0.0000135700175],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005838176,0.000115158866,0.00011107678,0.0000033273384,0.00009347283,0.0000053956505,0.00014760386,0.000023371094,0.99734473,0.00033975497,0.00064592,0.0011118182],"study_design_scores_gemma":[0.0030501517,0.00034628567,0.00037388765,0.000008143451,0.00007123623,0.000051473515,0.00012751775,0.000058079546,0.8897436,0.0004723279,0.10548152,0.0002157289],"about_ca_topic_score_codex":0.00012717221,"about_ca_topic_score_gemma":0.0002678417,"teacher_disagreement_score":0.10760107,"about_ca_system_score_codex":0.000031096777,"about_ca_system_score_gemma":0.00023656384,"threshold_uncertainty_score":0.44041365},"labels":[],"label_agreement":null},{"id":"W2579497162","doi":"10.1182/blood.v114.22.sci-12.sci-12","title":"Telomere Dysfunction in Bone Marrow Failure.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute","funders":"","keywords":"Telomerase; Telomere; Dyskeratosis congenita; Biology; Telomerase reverse transcriptase; Telomerase RNA component; Cancer research; Genetics; Somatic cell; Molecular biology; Gene","score_opus":0.00993416630170507,"score_gpt":0.2308519187991731,"score_spread":0.22091775249746803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2579497162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98970425,0.0012526959,0.00003234934,0.0032325443,0.00012304624,0.0002720071,0.000003059732,0.00014394986,0.005236087],"genre_scores_gemma":[0.99601656,0.000103864826,0.0011791885,0.0010990847,0.00025017676,0.000008668544,0.000020143185,0.000016257332,0.0013060613],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99877876,0.00002831896,0.00028176152,0.00030874068,0.00026442562,0.00033799064],"domain_scores_gemma":[0.9993941,0.0000242213,0.000054935896,0.00032811283,0.000049539707,0.00014908539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014300829,0.0001675211,0.00030519327,0.00022383586,0.000046708512,0.000017415487,0.000069795904,0.00012811851,0.0002109204],"category_scores_gemma":[0.00009289249,0.00015142384,0.000076281816,0.00043660178,0.000034721543,0.00010854713,0.000012616488,0.0002517025,0.00016254952],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006205393,0.0054700663,0.32834807,0.00023703552,0.000109748864,0.0017973866,0.0012226399,0.0000069029784,0.5218412,0.0017893497,0.01072131,0.12783574],"study_design_scores_gemma":[0.0102710575,0.0010110907,0.91346574,0.00029090777,0.00018114089,0.0007300655,0.00041392207,0.000034816134,0.044868752,0.00064023107,0.027634686,0.00045756268],"about_ca_topic_score_codex":0.00004866261,"about_ca_topic_score_gemma":0.00009777623,"teacher_disagreement_score":0.5851177,"about_ca_system_score_codex":0.000034674413,"about_ca_system_score_gemma":0.00006607209,"threshold_uncertainty_score":0.6174885},"labels":[],"label_agreement":null},{"id":"W2579581480","doi":"10.1182/blood.v120.21.2318.2318","title":"GATA1s Induces Hyperproliferation of Eosinophil Precursors.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"GATA1; Progenitor cell; Haematopoiesis; Myeloid; Cancer research; Eosinophilia; Biology; Gene knockdown; Myeloid leukemia; Cellular differentiation; Immunology; Molecular biology; Stem cell; Cell culture; Cell biology; Genetics","score_opus":0.02743425637401255,"score_gpt":0.2949856177065621,"score_spread":0.2675513613325496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2579581480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98943394,0.0008609664,0.000016431783,0.00046239776,0.00006931584,0.0002710637,0.0000067150154,0.000034218127,0.008844926],"genre_scores_gemma":[0.9973741,0.0000554969,0.0013610218,0.00012823891,0.00051133614,0.000020170073,0.00002498214,0.000017566334,0.0005070796],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991168,0.000039367947,0.00017513796,0.00011241691,0.0002949183,0.00026140484],"domain_scores_gemma":[0.9994011,0.000045410856,0.00005112889,0.00025191635,0.000098394186,0.00015204969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026210293,0.00008349859,0.00018284333,0.00009652119,0.000031150976,0.0000060077923,0.000075132266,0.000093752,0.00012281095],"category_scores_gemma":[0.00020064316,0.00006812753,0.000044854874,0.0001706195,0.000057743066,0.00014463872,0.00004136673,0.00017579156,0.00009422718],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021473752,0.0023790968,0.26889437,0.00028749686,0.00025888468,0.000014961384,0.0015965472,7.5439505e-7,0.7156969,0.0013315354,0.0032953185,0.00602941],"study_design_scores_gemma":[0.0032517002,0.00035540774,0.14154367,0.000070329006,0.00021397194,0.00016701248,0.00011075017,0.000021673995,0.8514746,0.00005794585,0.0026158765,0.000117056814],"about_ca_topic_score_codex":0.000030805382,"about_ca_topic_score_gemma":9.4954714e-7,"teacher_disagreement_score":0.13577771,"about_ca_system_score_codex":0.000033394972,"about_ca_system_score_gemma":0.0001489946,"threshold_uncertainty_score":0.277816},"labels":[],"label_agreement":null},{"id":"W2579645011","doi":"10.1182/blood.v108.11.558.558","title":"Safety and Efficacy of Peginterferon Alfa-2a and Ribavirin for Hepatitis C in Thalassemia.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Ribavirin; Internal medicine; Gastroenterology; Thalassemia; Hepatitis C; Adverse effect; Pegylated interferon; Peginterferon alfa-2a; Hepatitis C virus; Surgery; Immunology; Virus","score_opus":0.005092839885691956,"score_gpt":0.22655477213081984,"score_spread":0.2214619322451279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2579645011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942302,0.0023969722,0.00004968743,0.00052171276,0.000027501532,0.0003408149,0.000013813037,0.000013117161,0.0024061727],"genre_scores_gemma":[0.99827695,0.001044858,0.00030510526,0.00003711464,0.000028672375,0.000005999466,0.00001884636,0.0000112292955,0.0002712324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99945337,0.000011479038,0.00019911313,0.0001439809,0.000057937992,0.00013412639],"domain_scores_gemma":[0.99974275,0.0000684099,0.000039228016,0.000090021465,0.000019934705,0.000039634702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008374487,0.0000802969,0.0002105606,0.00005619808,0.000021446747,0.000004559736,0.000020664625,0.00009103803,0.000007614073],"category_scores_gemma":[0.000040585935,0.00006692545,0.00003119796,0.00006202623,0.00005895257,0.000022722963,0.000019140456,0.0000797785,7.3173743e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006903359,0.0015742539,0.9603465,0.00055521016,0.00010911775,0.00005327162,0.000516472,0.000015287544,0.014022708,0.0012514652,0.00075856515,0.020106768],"study_design_scores_gemma":[0.021220246,0.00081813347,0.96361285,0.00040050154,0.0002308097,0.00010438875,0.0001426893,0.0002745391,0.00744379,0.00025967925,0.005334731,0.00015763738],"about_ca_topic_score_codex":0.0004576912,"about_ca_topic_score_gemma":0.00016380489,"teacher_disagreement_score":0.02052991,"about_ca_system_score_codex":0.000007941699,"about_ca_system_score_gemma":0.000018668537,"threshold_uncertainty_score":0.27291408},"labels":[],"label_agreement":null},{"id":"W2579658674","doi":"10.1182/blood.v116.21.3344.3344","title":"the Efficacy and Safety of Prothrombin Complex Concentrate In Patients Requiring Urgent Reversal of Warfarin, A Retrospective Canadian Experience","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Medicine; Prothrombin complex concentrate; Warfarin; Adverse effect; Retrospective cohort study; Gastrointestinal bleeding; Surgery; Emergency medicine; Internal medicine; Atrial fibrillation","score_opus":0.0311090368874171,"score_gpt":0.29317505923785964,"score_spread":0.2620660223504425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2579658674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978919,0.000018602988,0.0000015176457,0.00031543858,0.00007531583,0.0007483032,0.0000045176066,0.0000050734993,0.0009393362],"genre_scores_gemma":[0.999733,0.000017654264,0.00013093374,0.000021460437,0.000032619402,0.0000021212286,0.0000040250475,0.0000049962655,0.000053189466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993531,0.000018165156,0.0002448075,0.000111264235,0.00013606416,0.00013657942],"domain_scores_gemma":[0.99957603,0.00004484424,0.00009859757,0.00012609115,0.00006637632,0.00008808551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001408667,0.000060263657,0.00017529036,0.000044373603,0.000053704767,0.0000056238023,0.000049909613,0.00003067933,0.00004171579],"category_scores_gemma":[0.00031358426,0.000044637913,0.00002563969,0.00011874273,0.00012950126,0.00003726766,0.0000309294,0.00007576006,6.267768e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014049068,0.000022140111,0.9921944,0.000016999435,0.00002733041,0.0000013011186,0.0008379838,5.73152e-7,0.0046333307,0.0017475084,0.000015090528,0.00036281315],"study_design_scores_gemma":[0.004282204,0.00011978428,0.99221134,0.000032001266,0.00002770729,4.9258307e-7,0.00014364012,0.000018439356,0.0022424008,0.000031262047,0.00084763643,0.000043069056],"about_ca_topic_score_codex":0.002964679,"about_ca_topic_score_gemma":0.0047899988,"teacher_disagreement_score":0.0041417135,"about_ca_system_score_codex":0.000024028828,"about_ca_system_score_gemma":0.000064948785,"threshold_uncertainty_score":0.44817272},"labels":[],"label_agreement":null},{"id":"W2579680972","doi":"10.1182/blood.v126.23.2737.2737","title":"Retrospective Analysis of Lymphomas in the Setting of Autoimmune Disease and the Impact of Immunosuppression","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Rituximab; Immunosuppression; Internal medicine; Lymphoma; Oncology; Univariate analysis; Lymphoproliferative disorders; Proportional hazards model; Retrospective cohort study; International Prognostic Index; Immunology; Multivariate analysis","score_opus":0.008752508202525626,"score_gpt":0.27610452864727475,"score_spread":0.26735202044474915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2579680972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99436486,0.0040379423,0.000001915647,0.00021311094,0.000008264426,0.00017107234,0.000029264504,0.0000032400792,0.0011703402],"genre_scores_gemma":[0.99981564,0.000119843105,0.0000093362905,0.000016942342,0.000005718023,0.000005586506,0.0000118059315,0.0000042961515,0.000010814993],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99928325,0.00010579868,0.0002305568,0.00008041492,0.00021278858,0.00008715867],"domain_scores_gemma":[0.9993581,0.00006187899,0.00022449656,0.00023784462,0.00008846735,0.000029168155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005200328,0.000064685795,0.00037074808,0.00009714518,0.000018221612,0.0000031915265,0.00007458633,0.000031313666,0.000011221747],"category_scores_gemma":[0.00035691969,0.00003093554,0.0001892891,0.0006190781,0.000115409246,0.000027864042,0.000028233046,0.000060778126,7.250372e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008073432,0.0004127733,0.9882597,0.000021587148,0.0013522726,0.0000023544053,0.0063937334,0.00015592112,0.0022180981,0.00010034548,0.00006603419,0.00020987204],"study_design_scores_gemma":[0.009483426,0.00017491609,0.98385376,0.00006401015,0.0022912952,7.3353846e-7,0.0022058391,0.0011249622,0.00036433898,0.0004051451,7.73709e-7,0.0000308211],"about_ca_topic_score_codex":0.002173518,"about_ca_topic_score_gemma":0.000026692176,"teacher_disagreement_score":0.008676082,"about_ca_system_score_codex":0.000036460962,"about_ca_system_score_gemma":0.00013304845,"threshold_uncertainty_score":0.32857236},"labels":[],"label_agreement":null},{"id":"W2579719571","doi":"10.1182/blood.v104.11.5071.5071","title":"Pseudomembranous Colitis Following Autologous Stem Cell Transplantation.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Pseudomembranous colitis; Clostridium difficile; Diarrhea; Internal medicine; Clostridium difficile toxin A; Transplantation; Metronidazole; Autologous stem-cell transplantation; Hematopoietic stem cell transplantation; Population; Gastroenterology; Surgery; Antibiotics; Microbiology; Biology","score_opus":0.016597843147775647,"score_gpt":0.26219004597917767,"score_spread":0.245592202831402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2579719571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854154,0.0007527954,0.000078601,0.00058274675,0.00014062061,0.00045235615,0.00003279964,0.0001811108,0.012363591],"genre_scores_gemma":[0.99757147,0.00032389635,0.00033710778,0.00014716893,0.00016309072,0.000039875253,0.00004395534,0.000038891612,0.0013345282],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983514,0.000029555302,0.00028986935,0.0003447947,0.00047854372,0.0005058244],"domain_scores_gemma":[0.9992642,0.00006204359,0.00004038579,0.00031371613,0.000063844585,0.00025583012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001269065,0.00018677475,0.00032832354,0.00014514274,0.00014541253,0.000034531437,0.00012566749,0.00014114642,0.00008805686],"category_scores_gemma":[0.000013147206,0.00017709557,0.00024067599,0.0003273623,0.00004656646,0.00006014548,0.000022049559,0.000272362,0.00026610284],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012487934,0.008261466,0.008918802,0.0020746263,0.00089868496,0.026276797,0.003914709,0.00027278086,0.9326434,0.0010045395,0.0005167298,0.013968686],"study_design_scores_gemma":[0.014270315,0.0007409613,0.010765405,0.00015571379,0.00059252843,0.0013000229,0.00030000572,0.0000070140927,0.9708094,0.000052871095,0.00073604885,0.00026970607],"about_ca_topic_score_codex":0.00014512906,"about_ca_topic_score_gemma":0.000020156305,"teacher_disagreement_score":0.038166024,"about_ca_system_score_codex":0.00009052747,"about_ca_system_score_gemma":0.0003734487,"threshold_uncertainty_score":0.72217476},"labels":[],"label_agreement":null},{"id":"W2579757892","doi":"10.1182/blood.v120.21.414.414","title":"Results From the Dose Escalation Phase of a Randomized Phase 1–2 First-in-Human (FIH) Study of SGI-110, a Novel Low Volume Stable Subcutaneous (SQ) Second Generation Hypomethylating Agent (HMA) in Patients with Relapsed/Refractory MDS and AML","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Decitabine; Tolerability; Medicine; Hypomethylating agent; Regimen; Neutropenia; Phases of clinical research; Pharmacodynamics; Pharmacokinetics; Internal medicine; Nausea; Adverse effect; Febrile neutropenia; Pharmacology; Oncology; Clinical trial; Toxicity; Chemistry","score_opus":0.024895926030192483,"score_gpt":0.28826588558876093,"score_spread":0.26336995955856846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2579757892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959869,0.00029645854,0.000056209854,0.000038756367,0.000047208385,0.0032329354,0.00022428037,0.000014286133,0.000102981554],"genre_scores_gemma":[0.998633,0.000017546503,0.00057451625,0.0000200642,0.00011587615,0.000087569104,0.00040148245,0.000038506074,0.00011142793],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99706644,0.00041503794,0.0010794192,0.00038127275,0.00068043574,0.00037739397],"domain_scores_gemma":[0.99775684,0.0008012167,0.00056547014,0.00050654175,0.00022707519,0.00014286718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018918478,0.00023656547,0.00085970346,0.0002796564,0.00009708026,0.000022347886,0.00012031122,0.00012443698,0.000069335845],"category_scores_gemma":[0.0010476111,0.00016568752,0.00006463273,0.0004202877,0.00013255792,0.00026107175,0.00008073201,0.00041221845,0.0000014255289],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29994828,0.095792614,0.3322416,0.00032139805,0.0013069857,0.00012167707,0.05326417,0.00035535818,0.21052928,0.000011410348,0.0002588296,0.005848419],"study_design_scores_gemma":[0.8841583,0.0049631754,0.09629239,0.00022857975,0.00047039703,0.000007445924,0.0010348865,0.0062748687,0.00631641,0.0000047123335,0.000034684013,0.00021414529],"about_ca_topic_score_codex":0.001882171,"about_ca_topic_score_gemma":0.0012612226,"teacher_disagreement_score":0.58421004,"about_ca_system_score_codex":0.00017609035,"about_ca_system_score_gemma":0.00012405534,"threshold_uncertainty_score":0.6756542},"labels":[],"label_agreement":null},{"id":"W2579778415","doi":"10.1182/blood.v112.11.2241.2241","title":"Deregulation of Transcription Factors GATA-1, GATA-2 and C/EBPa in Acute Promyelocytic Leukemia.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Acute promyelocytic leukemia; Biology; Myeloid; Cancer research; Haematopoiesis; Retinoic acid; Leukemia; Transcription factor; Myelopoiesis; GATA1; Myeloid leukemia; Transgene; Cell biology; Molecular biology; Immunology; Genetics; Gene; Stem cell","score_opus":0.010676081065061295,"score_gpt":0.21423895590583783,"score_spread":0.20356287484077654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2579778415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99784476,0.0012106309,0.00036762387,0.000012460489,0.000031389027,0.0001390715,0.000009665153,0.000007788227,0.00037664227],"genre_scores_gemma":[0.99822354,0.00079050433,0.0005637527,0.000013672141,0.000038692702,0.000011056215,0.00013000764,0.000013580695,0.000215169],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992746,0.000032286473,0.00020947667,0.00023900281,0.00010007408,0.00014456316],"domain_scores_gemma":[0.99967504,0.000006661483,0.000068614296,0.00016960359,0.00004034734,0.000039751736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000067542045,0.000119751174,0.00015158963,0.000048043323,0.000042489977,0.000005580019,0.000087004446,0.00014751752,0.000007665353],"category_scores_gemma":[0.000026315298,0.00011090122,0.000043159373,0.00009079864,0.00010860627,0.000007970286,0.000023682505,0.000065013155,7.703406e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035447687,0.00006892707,0.035707064,0.00007302764,0.00004437147,0.00000819903,0.00024588642,0.000020459482,0.96342844,0.000017103997,0.000034804096,0.00031624554],"study_design_scores_gemma":[0.0013213807,0.00015987232,0.030933678,0.000020533647,0.00005609013,0.00007169387,0.000054032153,0.00004301176,0.96686506,0.000060795926,0.00028338222,0.00013044545],"about_ca_topic_score_codex":0.000025381936,"about_ca_topic_score_gemma":0.000010970015,"teacher_disagreement_score":0.0047733863,"about_ca_system_score_codex":0.000014103812,"about_ca_system_score_gemma":0.0001299361,"threshold_uncertainty_score":0.45224205},"labels":[],"label_agreement":null},{"id":"W2579787262","doi":"10.1182/blood.v126.23.1772.1772","title":"Bone Marrow Stromal Cells Induce Bortezomib Resistance in Multiple Myeloma Cells through Downregulation of miRNA-101-3p Targeting Survivin","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Bortezomib; Stromal cell; Cancer research; Panobinostat; Bone marrow; Survivin; Downregulation and upregulation; Cell culture; Biology; Multiple myeloma; microRNA; Tetherin; Stem cell; Molecular biology; Immunology; Cell biology","score_opus":0.03844603199944534,"score_gpt":0.28120865730410355,"score_spread":0.2427626253046582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2579787262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950233,0.0011266252,0.000054354914,0.00017166752,0.00010007606,0.00083059486,0.00008393846,0.00004848723,0.0025609236],"genre_scores_gemma":[0.9813776,0.0000468621,0.017262945,0.000022913822,0.00013196366,0.00004303864,0.00014406527,0.00004216442,0.000928438],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973632,0.00020685571,0.00061340234,0.000457793,0.0007679074,0.00059083675],"domain_scores_gemma":[0.9985519,0.00020085988,0.00023048367,0.00047134148,0.00024802514,0.0002973651],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006292837,0.00025961906,0.0005461512,0.00017031237,0.000059663307,0.000022120603,0.0001450966,0.00017216982,0.000059593745],"category_scores_gemma":[0.0003871917,0.0002372193,0.000107853164,0.000428221,0.00010489996,0.0002168675,0.00008485866,0.0002668269,0.000050183055],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013028652,0.0023097794,0.2014483,0.00026077923,0.00017553556,0.000417451,0.0011827067,0.000033779357,0.79081976,0.000051695635,0.0013782409,0.0006190714],"study_design_scores_gemma":[0.018630985,0.00039429718,0.30234832,0.00025565526,0.00009432251,0.0000117838335,0.0004103592,0.00026808988,0.6762656,0.00013725791,0.0009359288,0.0002473863],"about_ca_topic_score_codex":0.00096783007,"about_ca_topic_score_gemma":0.001160562,"teacher_disagreement_score":0.11455416,"about_ca_system_score_codex":0.00012683631,"about_ca_system_score_gemma":0.00025471734,"threshold_uncertainty_score":0.9673523},"labels":[],"label_agreement":null},{"id":"W2579787791","doi":"10.1182/blood.v104.11.3904.3904","title":"Microvesicles Derived from Activated Platelets Enhance the Invasive Potential of Breast Cancer Cells.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Canadian Blood Services","funders":"","keywords":"Cancer cell; Microvesicles; Platelet; Cancer research; Metastasis; Cancer; Platelet activation; Matrigel; Metastatic breast cancer; Immunology; Stromal cell; Biology; Breast cancer; Chemistry; Medicine; Angiogenesis; Internal medicine; microRNA","score_opus":0.003654152733380092,"score_gpt":0.21037232094330738,"score_spread":0.20671816820992728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2579787791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968314,0.0021285845,0.00023042632,0.00019336263,0.00009353884,0.00015797983,0.00031104777,0.000010508517,0.000043122116],"genre_scores_gemma":[0.99867,0.00034260532,0.00046472726,0.00016556989,0.00020161629,0.000016885166,0.00007656065,0.000024938121,0.00003710879],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99919367,0.0000421745,0.00017383596,0.00028897732,0.000111131914,0.0001902049],"domain_scores_gemma":[0.99933887,0.00001246104,0.0001319566,0.00037789583,0.00007365833,0.00006514297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003729176,0.00014428055,0.00011963936,0.000013861151,0.00006324005,0.000015196916,0.00030490692,0.00011080711,0.000040194063],"category_scores_gemma":[0.0000191309,0.00011680303,0.000097805,0.00006246977,0.00015205033,0.0000045312036,0.00011836528,0.00008136807,0.00000836577],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011244451,0.0003180174,0.00022552571,0.000012620164,0.000189314,0.000019405323,0.00007456209,0.0001970603,0.99828106,0.0000032038686,0.00007842177,0.00048836105],"study_design_scores_gemma":[0.0012545531,0.000038940434,0.008424372,0.000030345711,0.00009923845,0.000013144484,0.00006787249,0.0000011128733,0.98974216,0.00012955013,0.000055548735,0.00014318885],"about_ca_topic_score_codex":0.0002923345,"about_ca_topic_score_gemma":0.0000791613,"teacher_disagreement_score":0.008538932,"about_ca_system_score_codex":0.000008485116,"about_ca_system_score_gemma":0.00018035111,"threshold_uncertainty_score":0.47630894},"labels":[],"label_agreement":null},{"id":"W2579821503","doi":"10.1182/blood.v112.11.3315.3315","title":"Steroid Refractoriness, but Not Rapidity of Response, to Induction Therapy Predicts for Outcome Post-Autologous Stem Cell Transplant (ASCT) in Patients (Pts) with Multiple Myeloma (MM)","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Salvage therapy; Dexamethasone; Internal medicine; Oncology; Multiple myeloma; Maintenance therapy; Autologous stem-cell transplantation; Vincristine; Surgery; Chemotherapy; Cyclophosphamide","score_opus":0.03956711233836863,"score_gpt":0.273261040609517,"score_spread":0.23369392827114838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2579821503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99629617,0.00008661896,0.00004203076,0.00017001072,0.0001010628,0.0026959288,0.0005313162,0.00005286053,0.000024031844],"genre_scores_gemma":[0.9983197,0.00007594375,0.0006908921,0.000083236155,0.000055721477,0.0002588031,0.00017425237,0.00004516244,0.00029628348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978243,0.00016663155,0.0005151841,0.00043781247,0.00058699143,0.00046907662],"domain_scores_gemma":[0.9985184,0.00029981174,0.00015352378,0.0004353663,0.00033089172,0.0002619869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002793987,0.00026920956,0.0005675881,0.00030897663,0.000093285424,0.0000073388987,0.00013979615,0.00015193605,0.00001109866],"category_scores_gemma":[0.000114368224,0.00019510134,0.00010306064,0.00026259298,0.000068721965,0.00012236032,0.000022928185,0.00020157165,0.000009527327],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.061989978,0.0044671674,0.85443455,0.00015880975,0.00015887817,0.00015321671,0.0010420785,0.000004215838,0.07162942,2.9212126e-7,0.000020385703,0.0059410296],"study_design_scores_gemma":[0.038248353,0.0067358757,0.7616086,0.0000731962,0.000041677875,0.00002582641,0.000059611335,0.000011871702,0.19293153,4.7205796e-7,0.0001282173,0.0001347643],"about_ca_topic_score_codex":0.00025737044,"about_ca_topic_score_gemma":0.000105441584,"teacher_disagreement_score":0.12130211,"about_ca_system_score_codex":0.000098280834,"about_ca_system_score_gemma":0.00019218757,"threshold_uncertainty_score":0.7956002},"labels":[],"label_agreement":null},{"id":"W2579935847","doi":"10.1182/blood.v104.11.1458.1458","title":"The Severe Chronic Neutropenia International Registry - 10 Years of Follow-Up.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Hospital for Sick Children","funders":"","keywords":"Medicine; Neutropenia; Congenital Neutropenia; Internal medicine; Febrile neutropenia; Leukopenia; Gastroenterology; Chemotherapy","score_opus":0.00492195025676559,"score_gpt":0.22011493401111118,"score_spread":0.2151929837543456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2579935847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99323744,0.0025688487,0.00001173304,0.00017851013,0.00015586652,0.00007803219,0.000020647734,0.0000048333554,0.003744063],"genre_scores_gemma":[0.99696726,0.00044538514,0.00008525973,0.00003351951,0.00010141173,0.000009768781,0.00006319344,0.000009904146,0.0022843191],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99956673,0.000008499406,0.000095428186,0.00013813764,0.0000831306,0.0001080777],"domain_scores_gemma":[0.9996262,0.000003662607,0.000055937988,0.00025626816,0.00003297816,0.00002494057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000030101588,0.000065078995,0.000057906058,0.000007977741,0.000042821743,0.0000152572,0.00021317476,0.000057725498,0.000019978355],"category_scores_gemma":[0.000020965172,0.00005226545,0.00006992633,0.000029429872,0.00004926891,0.0000019766417,0.00006976397,0.000033054137,0.000016856005],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013893015,0.006159522,0.056688655,0.00011000025,0.0076280627,0.00018295497,0.00038260393,0.00084217155,0.75503457,0.007177147,0.024489705,0.13991533],"study_design_scores_gemma":[0.030752445,0.0014217459,0.025788577,0.00005942156,0.00031517562,0.0001427893,0.00014723257,0.0000037218197,0.61068106,0.0016706769,0.3285266,0.0004905959],"about_ca_topic_score_codex":0.000035622656,"about_ca_topic_score_gemma":0.00012708975,"teacher_disagreement_score":0.3040369,"about_ca_system_score_codex":0.0000073008364,"about_ca_system_score_gemma":0.00009007502,"threshold_uncertainty_score":0.21313232},"labels":[],"label_agreement":null},{"id":"W2579961262","doi":"10.1182/blood.v120.21.910.910","title":"Combined JAK/STAT5A and BCR-ABL Inhibition Impairs Blast Crisis Chronic Myeloid Leukemia Stem Cell Self-Renewal","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"CD38; Cancer research; Dasatinib; Stem cell; Myeloid leukemia; STAT5; Haematopoiesis; Biology; Tyrosine kinase; Imatinib mesylate; Janus kinase; Myeloid; Immunology; Imatinib; CD34; Signal transduction; Cytokine; Cell biology","score_opus":0.008321276368305514,"score_gpt":0.22148471468510003,"score_spread":0.21316343831679452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2579961262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99128395,0.0034837753,0.000017049304,0.00020214074,0.00023103958,0.0007892716,0.000037688045,0.00034731906,0.003607764],"genre_scores_gemma":[0.9965926,0.00059371593,0.00072290265,0.00021252838,0.0006203602,0.00009052164,0.00013934096,0.00009296097,0.00093510665],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99756736,0.00008999182,0.00047649592,0.00051207136,0.0004507757,0.0009033357],"domain_scores_gemma":[0.99845266,0.00009367152,0.0001913629,0.0005831612,0.00008108889,0.0005980356],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002652228,0.0004493778,0.00055845495,0.00017504446,0.00017296782,0.0000427939,0.000090766924,0.0002640003,0.00020288893],"category_scores_gemma":[0.000013106144,0.00041045892,0.00015337422,0.00027746035,0.000078799705,0.00028623283,0.00013720347,0.00034152792,0.00026401653],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020836098,0.02440022,0.5733128,0.007934362,0.0061396984,0.0015466996,0.02349464,0.000052727857,0.2904315,0.0009114337,0.05084218,0.018850092],"study_design_scores_gemma":[0.13400593,0.0072330213,0.10117587,0.00091522536,0.0073230164,0.0018613002,0.0037162479,0.0004905434,0.73039794,0.00016183368,0.010520401,0.0021986726],"about_ca_topic_score_codex":0.00025806035,"about_ca_topic_score_gemma":0.00003717473,"teacher_disagreement_score":0.47213697,"about_ca_system_score_codex":0.0022467866,"about_ca_system_score_gemma":0.0008365175,"threshold_uncertainty_score":0.9998347},"labels":[],"label_agreement":null},{"id":"W2579967746","doi":"10.1182/blood.v112.11.2375.2375","title":"Economic Analysis of Alemtuzumab in Fludarabine-Refractory and Relapsed Chronic Lymphocytic Leukemia in Canada","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Fludarabine; Alemtuzumab; Medicine; Chronic lymphocytic leukemia; Rituximab; Internal medicine; Population; Cyclophosphamide; Oncology; Surgery; Leukemia; Transplantation; Chemotherapy; Lymphoma","score_opus":0.011123878659167119,"score_gpt":0.239181564093093,"score_spread":0.22805768543392588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2579967746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99626034,0.00245924,8.5919334e-7,0.000024452509,0.00004322683,0.0002888651,0.000020541567,0.000012272721,0.00089019927],"genre_scores_gemma":[0.9984762,0.0010712431,0.00004378195,0.000049546063,0.00004422801,0.000023888813,0.000033244458,0.000024973,0.00023290765],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980455,0.00006536268,0.0006377673,0.00042621588,0.000343629,0.00048153254],"domain_scores_gemma":[0.99889004,0.0002450156,0.00011715565,0.00052744494,0.000034741963,0.0001856221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023154487,0.00019218522,0.00081182574,0.0007449512,0.000028712695,0.000004279134,0.00015490658,0.000114834525,0.00017394323],"category_scores_gemma":[0.0001086578,0.0001912006,0.000094697716,0.0008049512,0.00015300713,0.000076022254,0.00008153679,0.00023822406,0.000009083529],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0016485673,0.00063275546,0.87503946,0.0015539904,0.005333714,0.012488208,0.0025462864,0.0837788,0.0112818815,0.00013307355,0.0013434336,0.004219837],"study_design_scores_gemma":[0.11847427,0.0003843183,0.5826836,0.00027374097,0.001190234,0.0007102977,0.00023484085,0.28574198,0.009410425,0.000013142726,0.00042755043,0.00045555638],"about_ca_topic_score_codex":0.9600099,"about_ca_topic_score_gemma":0.96004987,"teacher_disagreement_score":0.2923558,"about_ca_system_score_codex":0.2583994,"about_ca_system_score_gemma":0.21646157,"threshold_uncertainty_score":0.7879804},"labels":[],"label_agreement":null},{"id":"W2580021359","doi":"10.1182/blood.v120.21.1123.1123","title":"Immune Tolerance Induction (ITI) in Adults with Congenital Hemophilia: A Multicenter Experience","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pediatrics; Retrospective cohort study; Population; Multicenter study; Young adult; Internal medicine; Randomized controlled trial","score_opus":0.018347125460374078,"score_gpt":0.2795424247192046,"score_spread":0.2611952992588305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580021359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99649334,0.0010595906,0.0000020117682,0.00026040763,0.000114370945,0.00049027806,0.0000018777234,0.000031783977,0.0015463217],"genre_scores_gemma":[0.998455,0.00006148112,0.00035246657,0.000041703854,0.00023373048,0.00010846878,0.000013704492,0.000016006175,0.0007174452],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900424,0.000024345052,0.00016020749,0.00018102341,0.00024775084,0.00038239974],"domain_scores_gemma":[0.9995442,0.00001992793,0.000027247599,0.0002060169,0.000055539705,0.0001470842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008208271,0.000120899145,0.00017898798,0.000085582076,0.00004295475,0.000008764315,0.00005191824,0.00007184503,0.00011101435],"category_scores_gemma":[0.000031894335,0.000083515806,0.000036093646,0.00019940191,0.00009102323,0.00020985749,0.000025026951,0.0001865649,0.00007072128],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084443163,0.0029957439,0.96881396,0.00007602605,0.00008104472,0.00018671631,0.0074121174,3.5432407e-7,0.017285753,0.000015305925,0.000014159144,0.0022744113],"study_design_scores_gemma":[0.017577088,0.0005884222,0.8733064,0.00038771436,0.00007633991,0.0003162313,0.0020234885,0.000044517685,0.10510973,0.000002272552,0.00037324187,0.00019454882],"about_ca_topic_score_codex":0.00007091247,"about_ca_topic_score_gemma":0.000017626035,"teacher_disagreement_score":0.09550753,"about_ca_system_score_codex":0.000036689493,"about_ca_system_score_gemma":0.000033103523,"threshold_uncertainty_score":0.34056756},"labels":[],"label_agreement":null},{"id":"W2580033002","doi":"10.1182/blood.v110.11.2114.2114","title":"Loss of Imprinting of DLK1 Due to Promoter Hypermethylation Accounts Frequently for Its Overexpression in AML.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Genomic imprinting; Biology; Methylation; CpG site; Molecular biology; Nonsense-mediated decay; DNA methylation; Promoter; Gene; Cancer research; Genetics; Gene expression; RNA splicing; RNA","score_opus":0.009770959978103963,"score_gpt":0.2663225112312445,"score_spread":0.25655155125314055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580033002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99832654,0.00018372816,0.00075691333,0.000013902525,0.000021856615,0.00034751205,0.000027769238,0.000002224963,0.00031956474],"genre_scores_gemma":[0.99828357,0.000005757951,0.0015588294,0.000022884098,0.000033080993,0.000015564936,0.000036923608,0.000011118499,0.000032247193],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993947,0.0000098880055,0.0002090696,0.0001701423,0.00007229536,0.00014389867],"domain_scores_gemma":[0.99965703,0.000009997548,0.000092641865,0.00013768475,0.0000735259,0.000029130757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014716906,0.00007795227,0.00011954065,0.000047545516,0.000014545095,0.0000030499584,0.00007099911,0.00009592069,0.0000035083428],"category_scores_gemma":[0.00006122492,0.000071658644,0.000049328286,0.000062904604,0.000010516693,0.0000039703923,0.000045708002,0.000023040013,8.3297476e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007549104,0.0005278414,0.03455303,0.000058457557,0.000034258148,0.0000019057672,0.00005599405,0.0000070927954,0.9621539,0.000025969899,0.0000070628994,0.002498965],"study_design_scores_gemma":[0.0019509828,0.00024730546,0.02882385,0.00006413329,0.000018221956,0.0000030372012,0.000021563545,0.000006001051,0.9686354,0.00008310226,0.00007807736,0.00006834206],"about_ca_topic_score_codex":0.000023379107,"about_ca_topic_score_gemma":0.00002814231,"teacher_disagreement_score":0.006481451,"about_ca_system_score_codex":0.0000034108184,"about_ca_system_score_gemma":0.000018555731,"threshold_uncertainty_score":0.29221547},"labels":[],"label_agreement":null},{"id":"W258004195","doi":"10.1182/blood.v122.21.1149.1149","title":"Reversal Of Dabigatran By Recombinant Factor VIIa Is Dependent On The Amount Of Tissue-Factor","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; McMaster University; University of Manitoba; Shared Health; University of British Columbia; McMaster University Medical Centre","funders":"","keywords":"Dabigatran; Recombinant factor VIIa; Tissue factor; Medicine; Prothrombin complex concentrate; Pharmacology; Pharmacokinetics; Antidote; Thrombin; Anticoagulant; Pharmacodynamics; Clotting time; Coagulation; Factor IX; Recombinant DNA; Anesthesia; Factor VIIa; Idarucizumab; Warfarin; Surgery; Internal medicine; Platelet; Chemistry; Biochemistry; Atrial fibrillation; Toxicity","score_opus":0.027775969994223305,"score_gpt":0.28674009871129247,"score_spread":0.25896412871706914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W258004195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941754,0.00022856648,0.0000010374278,0.003362977,0.00007037104,0.00070200354,0.000065461834,0.0000121498615,0.0013820649],"genre_scores_gemma":[0.9943172,0.00013716282,0.000042044616,0.000086136344,0.0000362196,0.000022568016,0.000011422729,0.000016434748,0.0053308303],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988771,0.00004758459,0.00023401064,0.00017434121,0.0004481801,0.00021876403],"domain_scores_gemma":[0.9992201,0.00011872032,0.00007282334,0.0003792673,0.000095886724,0.00011321055],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0000832291,0.0001232176,0.000267011,0.00005087458,0.00003761948,0.000007698816,0.00013476626,0.00008674222,0.0026992653],"category_scores_gemma":[0.000060109323,0.00006459743,0.000087033244,0.000091380796,0.00008353913,0.00003473738,0.000032238775,0.00016019239,0.00016234293],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008468491,0.002556155,0.055089023,0.0001878988,0.00039718213,0.000023455512,0.0010652252,2.8691032e-8,0.9238473,0.000066448505,0.010839452,0.005843141],"study_design_scores_gemma":[0.002207587,0.0011764347,0.03711322,0.000103922146,0.00008437326,0.000007951054,0.00011439935,0.0000027587669,0.9575222,0.00004449632,0.001551919,0.00007071988],"about_ca_topic_score_codex":0.00041363685,"about_ca_topic_score_gemma":0.0000058282867,"teacher_disagreement_score":0.03367491,"about_ca_system_score_codex":0.00002505441,"about_ca_system_score_gemma":0.0000587093,"threshold_uncertainty_score":0.9982124},"labels":[],"label_agreement":null},{"id":"W2580156340","doi":"10.1182/blood.v128.22.5986.5986","title":"A Distributed International Patient Data Registry for Hairy Cell Leukemia","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"","keywords":"Medicine; Data quality; Electronic data capture; Health informatics; Disease registry; Computer science; Disease; Family medicine; Pathology; Public health; Business; Clinical trial","score_opus":0.03544397970725752,"score_gpt":0.3052788525166183,"score_spread":0.2698348728093608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580156340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9749143,0.00046086012,0.0087565705,0.0031407466,0.00057086354,0.0011957578,0.004942394,0.00017624887,0.005842245],"genre_scores_gemma":[0.9924899,0.00006957091,0.0022810667,0.00016333553,0.0004607685,0.00006949728,0.0014546133,0.00003066311,0.0029805969],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99862057,0.000015444597,0.00023778062,0.00040947826,0.00040746527,0.00030926225],"domain_scores_gemma":[0.998293,0.00020667072,0.00007720327,0.0011129405,0.00014851995,0.00016169978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016410614,0.00011395788,0.00017091203,0.000047563964,0.000040372754,0.000020100915,0.00046807082,0.00009160939,0.00014276779],"category_scores_gemma":[0.0006848129,0.00007528638,0.0000613374,0.00007534534,0.00008169852,0.000103316204,0.0003767102,0.000081514154,0.00008612113],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030613707,0.00511879,0.0045056017,0.0010585076,0.0013666875,0.0014017274,0.00035314116,0.0000065595978,0.11833086,0.0007287172,0.7679434,0.09612464],"study_design_scores_gemma":[0.15780458,0.000709801,0.0010583623,0.0005922977,0.00040027688,0.00076061836,0.00015435574,0.0060666674,0.16243345,0.00028159175,0.66928005,0.00045796632],"about_ca_topic_score_codex":0.00008209737,"about_ca_topic_score_gemma":0.000010790991,"teacher_disagreement_score":0.15474321,"about_ca_system_score_codex":0.0036335532,"about_ca_system_score_gemma":0.004127803,"threshold_uncertainty_score":0.9501615},"labels":[],"label_agreement":null},{"id":"W2580170403","doi":"10.1182/blood.v104.11.369.369","title":"Regulation of Oxidative Stress by ATM Is Required for the Self-Renewal of Haematopoietic Stem Cells.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Haematopoiesis; Stem cell; Biology; Bone marrow; Telomere; Stromal cell; Progenitor cell; Immunology; Senescence; Cell biology; Hematopoietic stem cell; Cancer research; Genetics","score_opus":0.008311562879247671,"score_gpt":0.22127342368130448,"score_spread":0.2129618608020568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580170403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945367,0.0005327893,0.0042004767,0.00007642401,0.000056753957,0.0003741349,0.0001232574,0.000010340259,0.000089112706],"genre_scores_gemma":[0.99541664,0.0000467579,0.004155521,0.000023232504,0.000033530592,0.000029036997,0.000033890272,0.000015765787,0.0002456017],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993675,0.00002254398,0.00019656346,0.00018453458,0.0001141858,0.0001146818],"domain_scores_gemma":[0.9993611,0.00001777666,0.00016715124,0.00032928074,0.00010034404,0.000024341874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010025392,0.00009291712,0.000126272,0.000012311185,0.00003204426,0.0000045982056,0.00015779787,0.00010096226,0.0000043373066],"category_scores_gemma":[0.000009178856,0.00007350093,0.00009267742,0.00004931269,0.000043695556,0.0000025258146,0.00004872927,0.000020979975,7.253114e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031016974,0.00024196786,0.000054984972,0.000064745094,0.00014587678,1.7647035e-7,0.00022000534,0.00004809215,0.99840397,0.00047418,0.00017922992,0.00013576132],"study_design_scores_gemma":[0.0013492097,0.00035618534,0.00004201062,0.000024127432,0.00012003359,0.000002468984,0.00012715044,0.000017395492,0.99694055,0.0007154903,0.00022834848,0.000077013174],"about_ca_topic_score_codex":0.00001589042,"about_ca_topic_score_gemma":0.0000066348184,"teacher_disagreement_score":0.0014633966,"about_ca_system_score_codex":0.0000058390715,"about_ca_system_score_gemma":0.000052940828,"threshold_uncertainty_score":0.2997281},"labels":[],"label_agreement":null},{"id":"W2580216323","doi":"10.1182/blood.v120.21.4052.4052","title":"Improvement in Clinical Benefit Parameters with Pomalidomide (POM) in Combination with Low-Dose Dexamethasone (LoDEX) in Patients with Relapsed and Refractory Multiple Myeloma (RRMM): Results From a Phase 2 Study","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Calgary","funders":"","keywords":"Medicine; Pomalidomide; Tolerability; Internal medicine; Population; Neutropenia; Surgery; Creatinine; Gastroenterology; Multiple myeloma; Adverse effect; Lenalidomide; Toxicity","score_opus":0.025041961596287986,"score_gpt":0.3076681686536303,"score_spread":0.2826262070573423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580216323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957307,0.00010704502,0.0000082709075,0.00005582527,0.000030283325,0.0038994425,0.00011137579,0.000031010877,0.00002603881],"genre_scores_gemma":[0.99573946,0.000018703222,0.003361015,0.000053709253,0.00002330347,0.00029933229,0.00042469052,0.000051527724,0.000028249433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967594,0.00027913667,0.0008420623,0.00071951404,0.0007323045,0.0006675638],"domain_scores_gemma":[0.99789226,0.00072917185,0.00027685188,0.0005674175,0.0001185954,0.00041572144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008968009,0.00035720546,0.0007224582,0.0003967116,0.000046395257,0.000029419227,0.00010466456,0.00013802024,0.0000063712496],"category_scores_gemma":[0.00054117554,0.00024270227,0.000035055862,0.00047505426,0.0001290716,0.0003304497,0.00007184416,0.00054584345,0.00000456907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.059528604,0.058263563,0.8603389,0.000027455293,0.00031022396,0.00039754776,0.0013510084,0.000006635662,0.00016212392,7.367788e-7,0.000001622003,0.019611582],"study_design_scores_gemma":[0.30424133,0.01645942,0.67739516,0.0003086377,0.00012567829,0.0000029076261,0.0004816148,0.00012846696,0.00065742055,0.000003087539,0.000003476207,0.00019276775],"about_ca_topic_score_codex":0.0037135584,"about_ca_topic_score_gemma":0.0060231523,"teacher_disagreement_score":0.24471274,"about_ca_system_score_codex":0.00019896639,"about_ca_system_score_gemma":0.0001236974,"threshold_uncertainty_score":0.98971117},"labels":[],"label_agreement":null},{"id":"W2580228760","doi":"10.1182/blood.v108.11.3191.3191","title":"UGT1A8 and UGT1A9 as Molecular Determinants of Mycophenolate Mofetil (MMF) Pharmacokinetics.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"UGT2B7; Pharmacokinetics; Mycophenolate; Mycophenolic acid; Pharmacology; Glucuronidation; Metabolite; Medicine; Active metabolite; Transplantation; Prodrug; Internal medicine; Chemistry; Microsome; Biochemistry; Enzyme","score_opus":0.008523031187066965,"score_gpt":0.28005379040899414,"score_spread":0.27153075922192715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580228760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99365157,0.00087027455,0.000026722508,0.000042259482,0.000035844674,0.0001861195,0.000017192362,0.000020302534,0.005149741],"genre_scores_gemma":[0.99780643,0.00023227192,0.0011897482,0.000102872655,0.000026887876,0.000006913459,0.00001840088,0.00001671281,0.00059977156],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99929845,0.000014091706,0.0002204801,0.00015611516,0.00016370903,0.00014712392],"domain_scores_gemma":[0.99967784,0.000021013087,0.00006580891,0.00012282972,0.000038407947,0.000074128395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000033680804,0.0001173239,0.00022310625,0.000058257083,0.000022719343,0.000006696238,0.000034475044,0.00003566627,0.00005881546],"category_scores_gemma":[0.000005045317,0.0000951667,0.000059834594,0.00007487326,0.000035906287,0.000027259226,0.000010555802,0.000048288977,0.000019683064],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002392936,0.0012311676,0.8511188,0.00057912327,0.00030050558,0.0020521323,0.0001223968,0.000013969715,0.13958225,0.0001970948,0.000011737281,0.004551551],"study_design_scores_gemma":[0.012645383,0.00038511096,0.32697994,0.00024526776,0.0009991642,0.00058634323,0.000011212866,0.000047178477,0.6573008,0.0005206325,0.00014542091,0.0001336094],"about_ca_topic_score_codex":0.0001293804,"about_ca_topic_score_gemma":0.0000034320717,"teacher_disagreement_score":0.52413887,"about_ca_system_score_codex":0.0000045677007,"about_ca_system_score_gemma":0.00002080409,"threshold_uncertainty_score":0.38807854},"labels":[],"label_agreement":null},{"id":"W2580290952","doi":"10.1182/blood.v118.21.500.500","title":"Interim Restaging PET/CT-Guided High Dose Sequential Induction Therapy with Autologous Stem Cell Transplantation (ASCT) Does Not Improve Outcome for Poor Prognosis Diffuse Large B-Cell Lymphoma (DLBCL). ClinicalTrials.Gov Identifier: NCT00530179","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; Foothills Medical Centre; University of Saskatchewan; University of Calgary","funders":"","keywords":"Medicine; Rituximab; Autologous stem-cell transplantation; Diffuse large B-cell lymphoma; Internal medicine; Etoposide; Melphalan; Oncology; Transplantation; Nuclear medicine; Surgery; Lymphoma; Chemotherapy","score_opus":0.06271588304624544,"score_gpt":0.3080659076009948,"score_spread":0.24535002455474936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580290952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942174,0.00017512971,0.00020609908,0.00033174732,0.001174003,0.0031860922,0.00029325383,0.0002609417,0.00015536454],"genre_scores_gemma":[0.9946594,0.00052504323,0.0019796554,0.00039813013,0.00036399925,0.0011211459,0.0002393386,0.00010767077,0.0006056066],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966135,0.00019268066,0.0011653551,0.00093234447,0.00044452935,0.00065160857],"domain_scores_gemma":[0.9981297,0.0002301016,0.00061456306,0.00054732227,0.00021527942,0.00026301295],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00060778455,0.00052052614,0.00088509114,0.00020749407,0.00024548455,0.00010818077,0.00021233207,0.00010928727,0.000049330203],"category_scores_gemma":[0.000028041033,0.00033669916,0.0004064459,0.00015840835,0.00010093052,0.0002883754,0.000041187282,0.000144994,0.00003170925],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022350794,0.18688254,0.519183,0.002887522,0.003816882,0.007437293,0.0059901956,0.0000012215434,0.2016828,0.00060831493,0.00044542243,0.048714068],"study_design_scores_gemma":[0.13457662,0.0026268335,0.07824392,0.00013009194,0.0023457478,0.0004776018,0.00036186137,0.00002389522,0.780524,0.000046093523,0.0002043764,0.00043895032],"about_ca_topic_score_codex":0.000657893,"about_ca_topic_score_gemma":0.00009419431,"teacher_disagreement_score":0.5788412,"about_ca_system_score_codex":0.00016706246,"about_ca_system_score_gemma":0.00023279728,"threshold_uncertainty_score":0.9999085},"labels":[],"label_agreement":null},{"id":"W2580326514","doi":"10.1182/blood.v104.11.2718.2718","title":"The Use of Aprotinin to Reduce Transfusion Requirements in Children Undergoing Cardiac Surgery: A Meta-Analysis.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; McMaster University","funders":"","keywords":"Aprotinin; Medicine; Antifibrinolytic; Cardiac surgery; Blood transfusion; Tranexamic acid; Cardiopulmonary bypass; Relative risk; Cochrane Library; Anesthesia; Meta-analysis; Randomized controlled trial; Surgery; Internal medicine; Blood loss; Confidence interval","score_opus":0.09716347775981556,"score_gpt":0.2969437677499172,"score_spread":0.19978028999010167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580326514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923213,0.0006820542,0.0004060195,0.004484444,0.00005338857,0.0017199292,0.000015382655,0.000036361656,0.0002811336],"genre_scores_gemma":[0.99723434,0.00061571173,0.0012343002,0.00050243054,0.000023260796,0.00011503079,0.000021199972,0.000019059447,0.00023469036],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.99833584,0.0001210111,0.0005099605,0.0003245766,0.00044359502,0.00026503802],"domain_scores_gemma":[0.9990983,0.00014335613,0.000077850214,0.0005120372,0.000053490785,0.000114964365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076440326,0.00015986929,0.00088332896,0.00033631298,0.00007610453,0.000024085046,0.00010025732,0.000051625226,0.00003893008],"category_scores_gemma":[0.00010127684,0.00010644713,0.0009951356,0.0011145145,0.000031767995,0.00006917848,0.00003620733,0.00011376974,0.0000075698626],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009799771,0.00903055,0.36569062,0.00030607323,0.5718791,0.000099303565,0.0030805513,0.0028546168,0.031424284,0.0031732311,0.0019442402,0.009537482],"study_design_scores_gemma":[0.007062038,0.0004617511,0.4526432,0.00012455907,0.44867343,0.000013608266,0.00027378678,0.000006214063,0.08672433,0.00014487104,0.0033880267,0.0004841958],"about_ca_topic_score_codex":0.0010409658,"about_ca_topic_score_gemma":0.0008033226,"teacher_disagreement_score":0.12320565,"about_ca_system_score_codex":0.00002360843,"about_ca_system_score_gemma":0.00009333743,"threshold_uncertainty_score":0.43407878},"labels":[],"label_agreement":null},{"id":"W2580337570","doi":"10.1182/blood.v124.21.3579.3579","title":"Modeling the Multi-Step Pathogenesis of Acute Myeloid Leukemia of Down Syndrome","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; University Health Network","funders":"","keywords":"Acute megakaryoblastic leukemia; GATA1; Down syndrome; Population; Myeloid leukemia; Leukemia; Medicine; Immunology; Trisomy; Acute leukemia; Cancer research; Myeloid; Biology; Internal medicine; Genetics; Erythropoiesis; Anemia","score_opus":0.02229596918701218,"score_gpt":0.2758438360047926,"score_spread":0.25354786681778047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580337570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99199086,0.00029343704,0.006127145,0.00026708876,0.000046431407,0.00043790293,0.00003978961,0.00004111612,0.0007561964],"genre_scores_gemma":[0.9883699,0.00017549764,0.01065785,0.00011914706,0.00007590992,0.000030656043,0.000018834206,0.000044466295,0.00050772884],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99817413,0.00012369743,0.00048932125,0.0002953141,0.00054963795,0.00036787777],"domain_scores_gemma":[0.9984657,0.00014724107,0.00012592587,0.00086591695,0.00025712943,0.00013806789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007294182,0.00018683191,0.0005343693,0.0001487397,0.000069622874,0.000007915223,0.00038102272,0.00015404697,0.000054698707],"category_scores_gemma":[0.00022041888,0.00012335081,0.00020483097,0.00033559557,0.00015808968,0.00005404335,0.0001831079,0.00029953968,0.000035534566],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048043733,0.0010528285,0.014669814,0.00087830005,0.0022098704,0.00024457538,0.0011176342,0.0016472695,0.9643426,0.0005498325,0.00031034907,0.012496517],"study_design_scores_gemma":[0.026603164,0.0020624418,0.06405116,0.00075416843,0.0044862563,0.0024572294,0.0007725791,0.6565143,0.24047694,0.00013888288,0.00095328473,0.0007295856],"about_ca_topic_score_codex":0.00037277088,"about_ca_topic_score_gemma":0.000014003544,"teacher_disagreement_score":0.7238656,"about_ca_system_score_codex":0.000092455186,"about_ca_system_score_gemma":0.0003676252,"threshold_uncertainty_score":0.50301},"labels":[],"label_agreement":null},{"id":"W2580375015","doi":"10.1182/blood.v108.11.5496.5496","title":"The Experiences and Challenges of Pregnant Women Coping with Thrombophilia.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Thrombophilia; Medicine; Pregnancy; Obstetrics; Placental abruption; Antiphospholipid syndrome; Referral; Preeclampsia; Thrombosis; Gestation; Family medicine; Surgery","score_opus":0.02431986475276851,"score_gpt":0.24283931985896143,"score_spread":0.21851945510619292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580375015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883729,0.008282131,0.00001582957,0.00091450074,0.000031287105,0.00016750669,3.882582e-7,0.000025433515,0.002190015],"genre_scores_gemma":[0.99841255,0.0011454619,0.00022173906,0.00004482188,0.00004421311,0.00005316124,5.6312103e-7,0.000007548401,0.00006995796],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994471,0.00001641776,0.00012130445,0.00012204144,0.00015770971,0.00013542463],"domain_scores_gemma":[0.9996784,0.00003792923,0.000058682625,0.00015181501,0.000035919198,0.000037282167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009907877,0.000070127055,0.0001564044,0.000020323621,0.00008240339,0.000010344872,0.00004130123,0.000029356905,0.000013522121],"category_scores_gemma":[0.000007474251,0.000038359547,0.000014314578,0.00005466439,0.00011183071,0.000032148626,0.000018074563,0.00003637837,8.830842e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006343782,0.0076155653,0.039875124,0.0021667657,0.001741341,0.00010168306,0.16372983,0.000010004552,0.17043714,0.56766653,0.00031219234,0.04570941],"study_design_scores_gemma":[0.01894582,0.007530819,0.27664208,0.0017787535,0.0006434498,0.00040064857,0.101525955,0.0000751561,0.56878436,0.013742058,0.009173596,0.00075730745],"about_ca_topic_score_codex":0.000008019163,"about_ca_topic_score_gemma":0.000013433779,"teacher_disagreement_score":0.5539245,"about_ca_system_score_codex":0.000004033591,"about_ca_system_score_gemma":0.000023801846,"threshold_uncertainty_score":0.1564257},"labels":[],"label_agreement":null},{"id":"W2580384782","doi":"10.1182/blood.v126.23.4334.4334","title":"Intrabone Infusion of Umbilical Cord Blood Stem Cells to Improve Hematopoietic Recovery after Allogeneic Umbilical Cord Blood Transplantation in Children","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Umbilical Cord Blood Transplantation; Umbilical cord; Hematopoietic stem cell transplantation; Transplantation; Cord blood; CD34; Stem cell; Haematopoiesis; Internal medicine; Gastroenterology; Surgery; Immunology; Biology","score_opus":0.012463122598751401,"score_gpt":0.24412533965161667,"score_spread":0.23166221705286527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580384782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958815,0.0003553606,0.00054123165,0.0001781402,0.00023501026,0.0022395838,0.00015903493,0.0001078494,0.0003023046],"genre_scores_gemma":[0.99591666,0.00028351176,0.0027976413,0.0002897026,0.00015275028,0.00022600706,0.00012740867,0.00008656262,0.00011972521],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99606645,0.00021267009,0.0013435109,0.0008664954,0.0008797259,0.00063113787],"domain_scores_gemma":[0.9979985,0.00021562995,0.00022149578,0.00070785964,0.00022475173,0.0006318013],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00068247085,0.000460881,0.0009731269,0.00039192973,0.00003415551,0.000029700783,0.00024193554,0.00045648738,0.000100722515],"category_scores_gemma":[0.000058553647,0.00044869678,0.0002183851,0.0006443349,0.000115253526,0.00014819988,0.000054229855,0.00042293273,0.00009478243],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009191974,0.008471537,0.2968672,0.0018754413,0.00057145976,0.00076851447,0.0028859607,0.000042532916,0.6746076,0.000063086336,0.000056912035,0.0045978534],"study_design_scores_gemma":[0.022830138,0.006456127,0.12645064,0.0010153649,0.0026883567,0.0027989205,0.0002158311,0.000026832959,0.8367811,0.00010561227,0.000019409923,0.0006117037],"about_ca_topic_score_codex":0.00019308338,"about_ca_topic_score_gemma":0.00012396711,"teacher_disagreement_score":0.17041655,"about_ca_system_score_codex":0.00005781869,"about_ca_system_score_gemma":0.00029169192,"threshold_uncertainty_score":0.99979645},"labels":[],"label_agreement":null},{"id":"W2580443921","doi":"10.1182/blood.v124.21.4027.4027","title":"Oxidative Stress and Increased Destruction of Red Blood Cells Contribute to the Pathophysiology of Anemia Caused By DMT1 Deficiency","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Oxidative stress; DMT1; Biology; Erythropoiesis; Red blood cell; Reactive oxygen species; GATA1; Erythroblast; Apoptosis; Anemia; Cell biology; Molecular biology; Haematopoiesis; Immunology; Internal medicine; Biochemistry; Stem cell; Transporter; Medicine","score_opus":0.007105757000375106,"score_gpt":0.2206508021563944,"score_spread":0.2135450451560193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580443921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99863374,0.00020005957,0.0001935964,0.00019165975,0.00011368935,0.00034436712,0.00013490718,0.000019822686,0.0001681301],"genre_scores_gemma":[0.9989779,0.00009644709,0.0003683767,0.00033406873,0.00008129987,0.000015499952,0.00007317519,0.000011204563,0.000042003634],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989324,0.00021087266,0.0002983322,0.00024969713,0.00012651169,0.00018218634],"domain_scores_gemma":[0.9989956,0.00021521955,0.00020250559,0.00030682245,0.00018033145,0.000099529105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018046543,0.00013294232,0.00039852902,0.00006641941,0.000056902565,0.0000027435478,0.000077048186,0.00012320453,0.000034399593],"category_scores_gemma":[0.00024061928,0.000093345974,0.000053645,0.00018631958,0.00016170646,0.000024140727,0.000042075084,0.00012548227,0.0000042387373],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023084012,0.00040821874,0.0040491424,0.00011433113,0.000047401718,0.0000023916987,0.00017645254,0.0000051820903,0.994114,0.0000895851,0.00035545425,0.00040701663],"study_design_scores_gemma":[0.004781548,0.0023553974,0.055221952,0.00006798757,0.00041871888,0.000016934517,0.00016254747,0.00002526878,0.9364558,0.00017977828,0.00021093315,0.00010311606],"about_ca_topic_score_codex":0.00012024546,"about_ca_topic_score_gemma":0.000016558526,"teacher_disagreement_score":0.05765817,"about_ca_system_score_codex":0.0000059271724,"about_ca_system_score_gemma":0.000043754444,"threshold_uncertainty_score":0.38065386},"labels":[],"label_agreement":null},{"id":"W2580459064","doi":"10.1182/blood.v126.23.3469.3469","title":"Testing for Heparin Induced Thrombocytopenia: Comparison of Practice at an Academic Center with Choosing Wisely Guidelines","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Heparin-induced thrombocytopenia; Intraclass correlation; Internal medicine; Pre- and post-test probability; Retrospective cohort study; Emergency medicine; Thrombosis","score_opus":0.2895316147204578,"score_gpt":0.4408006334271036,"score_spread":0.15126901870664583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580459064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928263,0.00021618762,0.00011678205,0.0012767143,0.0001612263,0.001229242,0.00002212012,0.00012805253,0.0040233885],"genre_scores_gemma":[0.95333165,0.000008099699,0.045415107,0.0005586479,0.00038384352,0.000066696935,0.00008012982,0.00009111564,0.00006471221],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99713874,0.00012241983,0.0009913573,0.00061073364,0.00057196314,0.00056475954],"domain_scores_gemma":[0.99624854,0.00035665277,0.0005986039,0.00062803086,0.001644221,0.0005239516],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008825261,0.00037307476,0.0011762537,0.0001440348,0.00016831487,0.00003620126,0.00028605675,0.00030830383,0.000013039199],"category_scores_gemma":[0.0028354859,0.00030306005,0.00009576797,0.0004357499,0.00009979806,0.00060364493,0.00017809555,0.0004946569,0.00002429181],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092749175,0.0021250388,0.5559338,0.00017227417,0.00049536244,0.000021932725,0.0021946114,0.000017557153,0.434329,0.00012258145,0.0010407385,0.0026196055],"study_design_scores_gemma":[0.039469328,0.011673182,0.21015747,0.0017000857,0.004531796,0.0015123086,0.004619827,0.0013415347,0.71234107,0.00018183845,0.011203629,0.0012679197],"about_ca_topic_score_codex":0.00034881607,"about_ca_topic_score_gemma":0.00009255316,"teacher_disagreement_score":0.34577635,"about_ca_system_score_codex":0.00015020411,"about_ca_system_score_gemma":0.0005289911,"threshold_uncertainty_score":0.9999421},"labels":[],"label_agreement":null},{"id":"W2580492859","doi":"10.1182/blood-2016-07-729400","title":"The integrin PSI domain has an endogenous thiol isomerase function and is a novel target for antiplatelet therapy","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health; Canadian Institutes of Health Research; Ohio State University; China Scholarship Council; Canadian Blood Services; National Natural Science Foundation of China; National Heart, Lung, and Blood Institute; Heart and Stroke Foundation of Canada","keywords":"Integrin; Antithrombotic; Endogeny; Thiol; Platelet; Platelet adhesion; Function (biology); Isomerase; Chemistry; Biochemistry; Medicine; Cell biology; Immunology; Biology; Enzyme; Internal medicine; Receptor","score_opus":0.05554882467499414,"score_gpt":0.27907628063587264,"score_spread":0.2235274559608785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580492859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99488366,0.0016428408,0.00032700365,0.0015306392,0.00012140942,0.0007839173,0.00007712662,0.000031514115,0.0006019071],"genre_scores_gemma":[0.99726266,0.0006851283,0.001105178,0.00045900757,0.00011371631,0.000086579676,0.000044649754,0.000025033993,0.00021807474],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99924684,0.000012993092,0.00013435876,0.00025041495,0.00011037819,0.0002450049],"domain_scores_gemma":[0.9992427,0.00005168,0.00009840775,0.00046244223,0.00004893406,0.000095787684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001634074,0.0001565726,0.0002253739,0.000029584395,0.00096829457,0.00015856732,0.00010628562,0.00008371045,0.000023729805],"category_scores_gemma":[0.000036397305,0.000093559014,0.00007154056,0.000022857954,0.00010461878,0.00014677257,0.000023004048,0.00009851616,0.000009148111],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011488484,0.019674698,0.174981,0.00018845512,0.0064139334,0.00091171,0.006692091,0.0000011114697,0.48013943,0.0032289897,0.0040241615,0.29225594],"study_design_scores_gemma":[0.25108168,0.020683588,0.23084651,0.0003000773,0.0016935208,0.0035242299,0.0022433756,0.00059714774,0.14709969,0.04294156,0.29747844,0.0015102058],"about_ca_topic_score_codex":0.00012774988,"about_ca_topic_score_gemma":0.0000472322,"teacher_disagreement_score":0.33303973,"about_ca_system_score_codex":0.000008081986,"about_ca_system_score_gemma":0.000047354704,"threshold_uncertainty_score":0.7447437},"labels":[],"label_agreement":null},{"id":"W2580495053","doi":"10.1182/blood.v114.22.1046.1046","title":"Modulation of Histone H3K4 and H3K27 Methylation Levels Via Pharmacological Inhibition of LSD1 and Degradation of the EZH2-Containing Polycomb Repressive Complex 2 Stimulates ATRA-Mediated Differentiation of AML Cells.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"EZH2; Cellular differentiation; Retinoic acid; Cancer research; Tretinoin; Biology; Acute promyelocytic leukemia; Haematopoiesis; Retinoid; Retinoic acid receptor; Gene silencing; Stem cell; Cell biology; Epigenetics; Cell culture; Biochemistry; Genetics","score_opus":0.03744741966734066,"score_gpt":0.3270388937491313,"score_spread":0.28959147408179065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580495053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972502,0.0002416286,0.0015864572,0.00019917486,0.000020952813,0.00059345405,0.000050544786,0.000012139595,0.00004546456],"genre_scores_gemma":[0.9990346,0.000052523137,0.0007172146,0.000020551486,0.000021514914,0.0000041337494,0.00012917694,0.0000081748285,0.0000121311405],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998625,0.00017076901,0.0005476431,0.00019860613,0.00034136185,0.00011663909],"domain_scores_gemma":[0.99866766,0.00025101422,0.0005757591,0.0001589101,0.0002991264,0.000047541223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029994542,0.00011488984,0.00037276454,0.00015870424,0.000042285155,0.0000032597384,0.00004765981,0.00011888396,0.00002675609],"category_scores_gemma":[0.00023225568,0.00008796752,0.000056556964,0.00024180375,0.0001744527,0.00011094636,0.000040210234,0.00013932934,1.2236949e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037422674,0.0003216818,0.010341297,0.00012478228,0.00008202066,0.0000010334281,0.0005370977,0.00016713983,0.9831736,0.000056869354,0.0000078526,0.004812399],"study_design_scores_gemma":[0.002911936,0.00039813135,0.4090191,0.00006902339,0.00020866864,0.0000043000937,0.000034624136,0.018320376,0.568707,0.0002862351,3.903352e-7,0.000040218227],"about_ca_topic_score_codex":0.000093049886,"about_ca_topic_score_gemma":0.0000034688612,"teacher_disagreement_score":0.41446662,"about_ca_system_score_codex":0.000054356035,"about_ca_system_score_gemma":0.000053545802,"threshold_uncertainty_score":0.35872114},"labels":[],"label_agreement":null},{"id":"W2580547579","doi":"10.1182/blood.v118.21.3982.3982","title":"Bortezomib-Based Therapy without Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma Patients with t(4;14): A Canadian National Trial,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; McGill University; Queen Elizabeth II Health Sciences Centre; University of Saskatchewan; McGill University Health Centre; Princess Margaret Cancer Centre; University of Manitoba; London Health Sciences Centre; CancerCare Manitoba; University Health Network","funders":"","keywords":"Medicine; Bortezomib; Multiple myeloma; Internal medicine; Surgery; Melphalan; Transplantation; Autologous stem-cell transplantation; Dexamethasone; Maintenance therapy; Lenalidomide; Gastroenterology; Chemotherapy","score_opus":0.03567060873495256,"score_gpt":0.2660870695991821,"score_spread":0.23041646086422954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580547579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99375266,0.00006674062,0.0002525308,0.00006645327,0.00007124199,0.004054405,0.0005315856,0.000067946494,0.0011364415],"genre_scores_gemma":[0.99283093,0.000020697491,0.0048208213,0.00023664802,0.000064844535,0.0008874636,0.00094455516,0.000048262005,0.0001457954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836886,0.00006489466,0.00025333828,0.00035508192,0.00047926715,0.0004785758],"domain_scores_gemma":[0.998661,0.00018482753,0.00009947256,0.00020966867,0.00038592136,0.00045912087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013757762,0.0002280466,0.00029752494,0.00024168339,0.00017069986,0.00002202447,0.00010269894,0.000119965895,0.00007407413],"category_scores_gemma":[0.00004398586,0.00016993468,0.000103481354,0.00014801753,0.00005700204,0.00008779137,0.0000030975834,0.00010966508,0.000020496902],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08596653,0.005130574,0.8929721,0.00012760781,0.0004769018,0.00023637795,0.0008341397,0.000006038648,0.00017281192,0.000014468119,0.00021137398,0.013851047],"study_design_scores_gemma":[0.32702833,0.0042662327,0.65709746,0.000047338017,0.0001776006,0.00000639888,0.000029456314,0.00025910584,0.010526285,0.000008994882,0.00036432184,0.00018849767],"about_ca_topic_score_codex":0.010163542,"about_ca_topic_score_gemma":0.024137545,"teacher_disagreement_score":0.2410618,"about_ca_system_score_codex":0.000109693945,"about_ca_system_score_gemma":0.0011389123,"threshold_uncertainty_score":0.9964279},"labels":[],"label_agreement":null},{"id":"W2580574144","doi":"10.1182/blood.v116.21.3846.3846","title":"Mesenchymal Stromal Cells Accelerate Hematopoietic Reconstitution and Mediate An IL6-Dependent Regeneration of the Intestinal Epithelium of Lethally Irradiated Mice.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Bone marrow; Mesenchymal stem cell; Haematopoiesis; Regeneration (biology); Stem cell; Paracrine signalling; Stromal cell; Biology; Intestinal epithelium; Pathology; Immunology; Cancer research; Medicine; Epithelium; Cell biology; Internal medicine","score_opus":0.02118795751762449,"score_gpt":0.2676740384870547,"score_spread":0.2464860809694302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580574144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99722284,0.00014835481,0.00004166139,0.00035596633,0.00026176256,0.0005738678,0.00002073744,0.000023086468,0.0013517082],"genre_scores_gemma":[0.99796164,0.00005827814,0.0015402428,0.000023626115,0.00014478514,0.000014696123,0.000015564443,0.000018471057,0.00022267076],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981885,0.00017668353,0.00049114047,0.00031061182,0.00056310167,0.00026999097],"domain_scores_gemma":[0.9986563,0.000111463254,0.00024729376,0.0004522426,0.0003286674,0.0002040359],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008236368,0.00016539166,0.00033101585,0.000118674725,0.0000854093,0.000022396724,0.00020893644,0.00015532738,0.0001766619],"category_scores_gemma":[0.00031740713,0.00011721719,0.00006899948,0.00021522463,0.00036813412,0.00012853366,0.000100008154,0.00046233117,0.000008248706],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009742469,0.0004238114,0.017523443,0.00018994733,0.00004334792,0.000020009267,0.00023749727,0.000009760892,0.98047316,0.0004664933,0.000022353875,0.0004927386],"study_design_scores_gemma":[0.0019613698,0.00053133577,0.038820073,0.0001208142,0.0001514055,0.000347855,0.00010328304,0.0005973431,0.957134,0.0001008221,0.000024721134,0.00010698849],"about_ca_topic_score_codex":0.0002080092,"about_ca_topic_score_gemma":0.0002622867,"teacher_disagreement_score":0.023339184,"about_ca_system_score_codex":0.000015207242,"about_ca_system_score_gemma":0.0003527462,"threshold_uncertainty_score":0.47799784},"labels":[],"label_agreement":null},{"id":"W2580610101","doi":"10.1182/blood.v116.21.3170.3170","title":"Systematic Review of the Surgical Treatment of Moderate to Severe Post-Thrombotic Syndrome","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Medicine; Post-thrombotic syndrome; Surgery; Retrospective cohort study; Percutaneous; Venous thrombosis; Prospective cohort study; Thrombosis","score_opus":0.00932589907465638,"score_gpt":0.25449363183969476,"score_spread":0.24516773276503837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580610101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98918384,0.005007189,0.0000014594794,0.0015048747,0.0001314917,0.0026750553,0.000016867769,0.000016490365,0.0014627374],"genre_scores_gemma":[0.9966772,0.0021820245,0.00015701758,0.00047125586,0.000022068903,0.00012605284,0.0000050787016,0.000015842108,0.00034343379],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99887794,0.000057507754,0.00046829964,0.00016138508,0.00028154106,0.00015329741],"domain_scores_gemma":[0.99889386,0.000059865393,0.00015918072,0.0006713333,0.0001238499,0.000091905094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018856488,0.00013518774,0.0010946622,0.000041562496,0.000030394845,0.000004675752,0.00012430473,0.000043364525,0.00016013926],"category_scores_gemma":[0.000102062775,0.000073224335,0.00023253508,0.00015865681,0.000033740875,0.00001877053,0.000050405208,0.00005688191,0.000030126754],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053149302,0.015142276,0.0013472415,0.9689132,0.0028966435,0.00032971182,0.0010262054,0.000013372309,0.0051239077,0.004355304,0.000623648,0.00017534225],"study_design_scores_gemma":[0.015810432,0.011209417,0.15234338,0.73426294,0.04064602,0.005765838,0.00042920987,0.000068468646,0.03706766,0.0002326765,0.001170225,0.000993754],"about_ca_topic_score_codex":0.0000653964,"about_ca_topic_score_gemma":0.000018362925,"teacher_disagreement_score":0.23465028,"about_ca_system_score_codex":0.000016318656,"about_ca_system_score_gemma":0.00005691735,"threshold_uncertainty_score":0.29860017},"labels":[],"label_agreement":null},{"id":"W2580648890","doi":"10.1182/blood.v116.21.1403.1403","title":"Report of a Case of Heyde's Syndrome Diagnosed by Abnormal Closure Times Despite Normal Von Willebrand's Activity","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Angiodysplasia; Gastrointestinal bleeding; Bleeding diathesis; Von Willebrand disease; Von Willebrand factor; Bleed; Internal medicine; Hematochezia; Stenosis; Cardiology; Surgery; Aortic valve stenosis; Gastroenterology; Colonoscopy; Platelet","score_opus":0.004804631338790882,"score_gpt":0.2352672186640964,"score_spread":0.2304625873253055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580648890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99782467,0.00021175412,0.0000053656745,0.00008402151,0.00008206293,0.00033441026,0.00010452569,0.000028674736,0.0013245197],"genre_scores_gemma":[0.99919814,0.00002864562,0.00030136306,0.000015961023,0.000020288995,0.000018111665,0.000059680195,0.000019826148,0.0003379986],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99903524,0.000021034812,0.0002999984,0.00021832463,0.00020327275,0.00022211806],"domain_scores_gemma":[0.9991294,0.00006773927,0.00022795318,0.00036800245,0.00007830146,0.00012856135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015015945,0.00016566121,0.0005029693,0.00007289089,0.000044541062,0.0000052188493,0.000054582517,0.00015220024,0.00017624476],"category_scores_gemma":[0.00009377419,0.00013573562,0.00014460755,0.00013012726,0.00009291497,0.000121681376,0.000031929492,0.000204569,0.000006593243],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038336267,0.0075199115,0.6610467,0.0002589067,0.0010490092,0.24470471,0.0002482009,0.0000010265994,0.081182785,0.000015071944,0.00082542375,0.0027649046],"study_design_scores_gemma":[0.02355931,0.0025027592,0.3231761,0.00015924568,0.0017767426,0.2666673,0.00007219877,0.000031887277,0.3805726,0.000051443294,0.0010303298,0.00040006102],"about_ca_topic_score_codex":0.0006457606,"about_ca_topic_score_gemma":0.000159808,"teacher_disagreement_score":0.33787057,"about_ca_system_score_codex":0.0000054690363,"about_ca_system_score_gemma":0.00008012672,"threshold_uncertainty_score":0.5535138},"labels":[],"label_agreement":null},{"id":"W2580699895","doi":"10.1182/blood.v112.11.5339.5339","title":"The Risk of Venous Thrombosis among Women with Thrombophilia and Oral Contraceptive Use: A Meta-Analysis","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Thrombophilia; Odds ratio; Factor V Leiden; Meta-analysis; Pulmonary embolism; Venous thrombosis; Confidence interval; Lupus anticoagulant; Internal medicine; Risk factor; Thrombosis; Prothrombin G20210A; Obstetrics; Gynecology","score_opus":0.05279830978327282,"score_gpt":0.26581184174636413,"score_spread":0.2130135319630913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580699895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983083,0.000635874,0.00019218137,0.0001414071,0.00001528603,0.00041086378,0.00003636515,0.000042495743,0.00021721187],"genre_scores_gemma":[0.9981114,0.0004157151,0.0010467403,0.000099315286,0.000018836214,0.00006581809,0.0000057284647,0.000022934892,0.00021350154],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.99852204,0.00016355934,0.0003224247,0.00030424213,0.00040501647,0.00028269243],"domain_scores_gemma":[0.9986291,0.00024514197,0.00028410534,0.00048574974,0.00020023623,0.00015565765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003702591,0.00020908553,0.001207043,0.00011148986,0.00030253097,0.000026175194,0.000089011075,0.00008795539,0.00017603877],"category_scores_gemma":[0.00008164662,0.00011430488,0.00033059015,0.0005706924,0.0004199644,0.00011964103,0.000037867598,0.00017793695,0.0000040222344],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002695317,0.0024261929,0.42549133,0.000032247935,0.5604554,0.00004310176,0.0066075325,0.00004190951,0.0033198071,0.0010867626,0.000055728462,0.000170459],"study_design_scores_gemma":[0.0021246334,0.0010549282,0.775609,0.000004348058,0.21706891,0.000028537057,0.0005385241,0.000058686317,0.0031479634,0.00019430234,0.000040057206,0.00013012506],"about_ca_topic_score_codex":0.00028407562,"about_ca_topic_score_gemma":0.00023306723,"teacher_disagreement_score":0.35011765,"about_ca_system_score_codex":0.000014888406,"about_ca_system_score_gemma":0.000054906635,"threshold_uncertainty_score":0.46612176},"labels":[],"label_agreement":null},{"id":"W2580750635","doi":"10.1182/blood.v106.11.217.217","title":"Immune Thrombocytopenia Mediated by Anti-GPIbα Antibodies May Occur Via an FcR-Independent Pathway: A Potential Explanation for Refractory Cases to IVIG Therapy.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Antibody; Platelet; Immunology; Platelet Glycoprotein GPIb-IX Complex; Medicine; Monoclonal antibody; Immune thrombocytopenia; Refractory (planetary science); Platelet membrane glycoprotein; Receptor; Immune system; Blockade; Internal medicine; Biology","score_opus":0.019612546889175332,"score_gpt":0.2834152192845572,"score_spread":0.26380267239538185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580750635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99455035,0.002542262,0.00016944612,0.0007552559,0.0001366335,0.0011549388,0.00039668442,0.00012139331,0.00017304787],"genre_scores_gemma":[0.99604607,0.0006175293,0.0006877032,0.0005241572,0.00016465344,0.000096389056,0.0015385748,0.000049992042,0.00027492788],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984293,0.00004613511,0.00035232786,0.0004287244,0.00034638678,0.00039711574],"domain_scores_gemma":[0.99915737,0.000059783386,0.00012688772,0.00033158294,0.0001292879,0.00019510761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015199537,0.00028410897,0.000552418,0.0001349367,0.0001675584,0.000047410653,0.00012394083,0.00015005902,0.00013959158],"category_scores_gemma":[0.000053297244,0.00023298779,0.00012552869,0.00011960717,0.000031160143,0.00028105621,0.000030504514,0.0001146063,0.00007753143],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013505683,0.0117758075,0.013039483,0.00006908292,0.0012914321,0.0015234451,0.001276706,0.000010706639,0.9147726,0.000020650123,0.0033292817,0.051540203],"study_design_scores_gemma":[0.061485227,0.00948012,0.15118788,0.00022754449,0.0011211684,0.0018995572,0.00095921796,0.00048857735,0.71798766,0.00009935491,0.05356728,0.0014964239],"about_ca_topic_score_codex":0.00027236165,"about_ca_topic_score_gemma":0.00015122522,"teacher_disagreement_score":0.19678497,"about_ca_system_score_codex":0.00004877212,"about_ca_system_score_gemma":0.00008226439,"threshold_uncertainty_score":0.9500966},"labels":[],"label_agreement":null},{"id":"W2580759700","doi":"10.1182/blood.v104.11.1926.1926","title":"Herpes Simplex Virus Infection of Endothelial Cells Is Enhanced by Thrombin.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services","funders":"","keywords":"Herpes simplex virus; Tissue factor; Thrombin; Virus; Biology; Umbilical vein; Virology; Cell culture; In vitro; Microbiology; Immunology; Coagulation; Medicine; Biochemistry; Platelet; Internal medicine","score_opus":0.010292696776090066,"score_gpt":0.2649247740487735,"score_spread":0.25463207727268344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580759700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993497,0.000077049845,0.00049168733,0.000047095757,0.00013867731,0.00025473582,0.00012361184,0.00006662696,0.005303496],"genre_scores_gemma":[0.9986883,0.00035558952,0.0002811959,0.00015906346,0.00007671541,0.000021870703,0.000016727328,0.000020167381,0.0003803718],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992916,0.000014478346,0.0002013698,0.00017959184,0.00014405955,0.00016889522],"domain_scores_gemma":[0.99958277,0.000016454293,0.000073155694,0.0002046665,0.000048169808,0.000074756965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000041016978,0.00012571855,0.00022322003,0.000058308142,0.00006129186,0.000007628612,0.000026491623,0.00009259392,0.00039411482],"category_scores_gemma":[0.000011583523,0.00010852816,0.00010836388,0.00013446613,0.00004703243,0.000057350113,0.000013421394,0.00006799308,0.00018020609],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055477554,0.0064509553,0.0017333056,0.00006197897,0.00051226787,0.000010907181,0.00038642762,0.0000086941445,0.95611393,0.00007785539,0.0007452477,0.033842962],"study_design_scores_gemma":[0.0062090713,0.00044623297,0.0012296918,0.0000402395,0.00024462034,0.000012525555,0.0000072303133,5.5490386e-7,0.9580179,0.00026082247,0.033448383,0.000082757],"about_ca_topic_score_codex":0.0028694754,"about_ca_topic_score_gemma":0.000101353966,"teacher_disagreement_score":0.033760205,"about_ca_system_score_codex":0.000042054708,"about_ca_system_score_gemma":0.000064388376,"threshold_uncertainty_score":0.442565},"labels":[],"label_agreement":null},{"id":"W2580771489","doi":"10.1182/blood.v110.11.50.50","title":"Major Histocompatibility Class II (MHCII) and Germinal Center Associated Gene Expression Correlate with Overall Survival in Ritiximab and CHOP-Like Treated Diffuse Large B Cell Lymphoma (DLBCL) Patients Using Formalin Fixed Paraffin Embedded (FFPE) Tissues.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Germinal center; Gene; Proportional hazards model; Biology; Oncology; Cancer research; Lymphoma; Internal medicine; Immunology; Medicine; B cell; Genetics; Antibody","score_opus":0.009677157934338883,"score_gpt":0.23769951852909055,"score_spread":0.22802236059475167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580771489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977702,0.000524707,0.000020470712,0.000023024479,0.000091449336,0.0011970808,0.00015873839,0.000067080466,0.00014726032],"genre_scores_gemma":[0.9984517,0.000054648935,0.0007501324,0.00010927367,0.00003274121,0.000039145594,0.00037438964,0.000048700498,0.00013925247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997544,0.0001247871,0.000593029,0.0006345817,0.00042548447,0.00067812664],"domain_scores_gemma":[0.99884015,0.000109257766,0.0002762033,0.00033319634,0.00012061619,0.00032055186],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031500336,0.00042841968,0.0007139528,0.00016374179,0.0002269165,0.00003859652,0.000068102636,0.00025174342,0.000017772052],"category_scores_gemma":[0.000031932897,0.00033690076,0.0000789609,0.00017597705,0.00007622748,0.00018611498,0.00013435491,0.00013199073,0.0000025835466],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014660889,0.0434899,0.9498766,0.00008131473,0.0001245374,0.0005076753,0.0009395572,8.0224424e-7,0.0027033999,0.0000036720267,0.00004201285,0.00076442957],"study_design_scores_gemma":[0.16432066,0.00094703824,0.8139604,0.00032208677,0.00039986245,0.0000555859,0.0000616435,0.00054419256,0.01896569,0.0000044825174,0.0000979478,0.0003204442],"about_ca_topic_score_codex":0.00058135396,"about_ca_topic_score_gemma":0.000535983,"teacher_disagreement_score":0.16285457,"about_ca_system_score_codex":0.00043900692,"about_ca_system_score_gemma":0.00007002898,"threshold_uncertainty_score":0.9999083},"labels":[],"label_agreement":null},{"id":"W2580774047","doi":"10.1182/blood.v106.11.923.923","title":"Bendamustine HCl (TREANDATM) Treatment in Combination with Rituximab Results in Objective Responses in Patients with Refractory/Relapsed Indolent B-Cell and Mantle Cell Non-Hodgkin’s Lymphoma: Results from Phase II Multicenter Study (SDX-105-02).","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Northeast Cancer Centre; Hôpital Notre-Dame; Ottawa Public Health; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Bendamustine; Mantle cell lymphoma; Medicine; Rituximab; Internal medicine; Follicular lymphoma; Gastroenterology; Non-Hodgkin's lymphoma; Population; Lymphoma; Oncology","score_opus":0.008431412163650037,"score_gpt":0.24654799173247222,"score_spread":0.23811657956882218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580774047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99464214,0.00022555204,6.7491584e-7,0.00022302417,0.000040048133,0.003534445,0.00075428927,0.000034956964,0.0005448731],"genre_scores_gemma":[0.99761444,0.00011338691,0.0006606382,0.000057897974,0.000037476388,0.00034332584,0.0009245516,0.000052362782,0.00019589183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99690974,0.00024867663,0.00084923307,0.0010182724,0.00050157635,0.00047252566],"domain_scores_gemma":[0.99841046,0.0003707545,0.0003446477,0.0005650151,0.00012472756,0.00018438703],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027597594,0.000527405,0.0007947013,0.0005182938,0.00010078708,0.00003839165,0.0000922837,0.0001426937,0.000011530932],"category_scores_gemma":[0.00007307494,0.00037209172,0.000048862657,0.00038897173,0.00006682448,0.00022658975,0.00007752685,0.00015488676,0.000011783005],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07355038,0.31411615,0.5877661,0.000019750132,0.00016431398,0.0009855292,0.012265477,0.0000151326085,0.000094399606,2.806036e-7,0.000026788905,0.010995701],"study_design_scores_gemma":[0.42164347,0.02172136,0.547593,0.00025836978,0.00028058173,0.000002518515,0.00097539683,0.00007559282,0.0071378434,7.6189826e-7,0.00009310854,0.00021801436],"about_ca_topic_score_codex":0.0050823013,"about_ca_topic_score_gemma":0.008603286,"teacher_disagreement_score":0.34809306,"about_ca_system_score_codex":0.000979568,"about_ca_system_score_gemma":0.0002241347,"threshold_uncertainty_score":0.9998731},"labels":[],"label_agreement":null},{"id":"W2580786046","doi":"10.1182/blood.v104.11.4522.4522","title":"Risk Stratification in Acute Promyelocytic Leukemia Based on Elevated White Cell Count and Reduced Platelet Count Does Not Identify Subsequent Relapses: A Retrospective Review of 60 Patients.","year":2004,"lang":"en","type":"review","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Acute promyelocytic leukemia; Medicine; Internal medicine; Daunorubicin; Gastroenterology; White blood cell; Anthracycline; Platelet; Leukemia; Tretinoin; Cytarabine; Retinoic acid; Cancer; Biology","score_opus":0.008469621684377496,"score_gpt":0.2603386682013335,"score_spread":0.251869046516956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580786046","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0922234,0.9043145,0.000022376258,0.000009713087,0.00013485052,0.0023737338,0.0006990131,0.000018528483,0.0002038634],"genre_scores_gemma":[0.046312418,0.95035344,0.00017602717,0.000050564468,0.000054879027,0.0003345236,0.0025319818,0.000076226155,0.00010991065],"study_design_codex":"systematic_review","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965697,0.00031049954,0.0012315343,0.0010555609,0.00048496158,0.00034776],"domain_scores_gemma":[0.9972346,0.000035808564,0.0014141937,0.0008427763,0.00037642586,0.00009624004],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006246285,0.00062328286,0.0013602687,0.00014723337,0.00007362598,0.00004748963,0.00038865377,0.0006444513,0.000015427615],"category_scores_gemma":[0.00029198945,0.0004736934,0.0002910717,0.000375126,0.00014195609,0.000011198398,0.00007465217,0.0005629371,0.0000059633117],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006682659,0.004536,0.0023869043,0.89478177,0.002360004,0.00030451556,0.000320171,0.000083417726,0.047036394,0.00010969707,0.00059775804,0.04681513],"study_design_scores_gemma":[0.01591845,0.0051555843,0.0025617843,0.35311463,0.014057349,0.00010283353,0.000063628395,0.00004780226,0.528544,0.00022786952,0.07573491,0.0044711344],"about_ca_topic_score_codex":0.00003271505,"about_ca_topic_score_gemma":0.0000093999315,"teacher_disagreement_score":0.5416671,"about_ca_system_score_codex":0.0005289257,"about_ca_system_score_gemma":0.0018763497,"threshold_uncertainty_score":0.9997715},"labels":[],"label_agreement":null},{"id":"W2580802175","doi":"10.1182/blood.v106.11.3990.3990","title":"Hemolytic Uremic Syndrome Is an Immune Mediated Disease: Role of Anti-CD36 Antibodies.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; Children's Hospital of Eastern Ontario; St. Joseph's Hospital; McMaster University; London Health Sciences Centre; Western University; Ottawa Hospital","funders":"","keywords":"Antibody; Platelet; CD36; Pathogenesis; Monoclonal antibody; Immune system; Antigen; Western blot; Biology; Immune complex; Platelet activation; Immunology; Peritubular capillaries; Molecular biology; Chemistry; Kidney; Biochemistry; Receptor; Endocrinology","score_opus":0.009630629949223665,"score_gpt":0.23384395048729772,"score_spread":0.22421332053807405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580802175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97296304,0.0254627,0.0000020788016,0.00016420499,0.00015330726,0.0003346931,0.0005369976,0.00013058195,0.00025242154],"genre_scores_gemma":[0.99879706,0.000101951446,0.000032860586,0.00009941507,0.000032337262,0.000020234558,0.00059236295,0.000027619553,0.00029617077],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99852985,0.00014148072,0.0005062661,0.0003483449,0.000078002435,0.00039606568],"domain_scores_gemma":[0.99890125,0.000078864134,0.0002015406,0.00067356345,0.00007422091,0.00007056557],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014162403,0.00022176653,0.00043869345,0.00013674586,0.00010724106,0.000010539066,0.00041434434,0.000114834125,0.0026303844],"category_scores_gemma":[0.00006668763,0.00021241879,0.00015058329,0.00014875649,0.00016154196,0.00013906616,0.00012523292,0.00012088946,0.00070107804],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007309799,0.0022420085,0.14712152,0.00010970708,0.00057403324,0.00002758674,0.0003452269,0.0000054503744,0.84786075,0.00015553334,0.0011384812,0.0003466054],"study_design_scores_gemma":[0.0063126814,0.00029318826,0.68063825,0.00028770015,0.00079688855,0.0002772954,0.0004014646,0.000036067788,0.2993112,0.0001664836,0.010880464,0.0005983344],"about_ca_topic_score_codex":0.00007652823,"about_ca_topic_score_gemma":0.000010419063,"teacher_disagreement_score":0.5485496,"about_ca_system_score_codex":0.000019575175,"about_ca_system_score_gemma":0.000088848334,"threshold_uncertainty_score":0.99828136},"labels":[],"label_agreement":null},{"id":"W2580842912","doi":"10.1182/blood.v106.11.2651.2651","title":"Fibrinogen and von Willebrand Factor-Independent Platelet Aggregation: The Essential Roles of β3 Integrin, Thrombin, and Divalent Ca2+ Cations.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Thrombin; Chemistry; Platelet; Ristocetin; Adenosine diphosphate; Platelet activation; Von Willebrand factor; Divalent; Fibrinogen; Integrin; Biochemistry; Platelet membrane glycoprotein; Platelet-rich plasma; Hirudin; Coagulation; Biophysics; Receptor; Internal medicine; Platelet aggregation; Medicine; Biology","score_opus":0.008929561949047453,"score_gpt":0.23869693102985526,"score_spread":0.2297673690808078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580842912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938699,0.0042683454,0.000012739679,0.0009714081,0.000028282662,0.00034303477,0.000034549535,0.00001754882,0.0004542083],"genre_scores_gemma":[0.9981627,0.0013717072,0.00010959427,0.00006106766,0.000062901294,0.000012479663,0.000032504362,0.0000111278705,0.0001759081],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999278,0.000020633035,0.00019130133,0.00018729693,0.00018919611,0.00013357608],"domain_scores_gemma":[0.9995859,0.000041725118,0.00008021039,0.00017499828,0.000047026057,0.00007011866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005069881,0.00012894474,0.00022645078,0.00004462192,0.000094428644,0.000021972424,0.000046872698,0.000065360844,0.00006198976],"category_scores_gemma":[0.000019030495,0.00008410665,0.00004157878,0.00005611801,0.00009016631,0.000079728445,0.000045272518,0.0000888688,0.00000530176],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054749823,0.0048327413,0.7260977,0.00050332164,0.0035533605,0.00034669926,0.012376003,0.000028731263,0.058756907,0.0017506066,0.0011627062,0.19004373],"study_design_scores_gemma":[0.016661515,0.00058466394,0.46256498,0.00026434232,0.0009337626,0.0014313038,0.00081651384,0.00013727669,0.51300704,0.0005032209,0.0027729478,0.00032243063],"about_ca_topic_score_codex":0.00007986432,"about_ca_topic_score_gemma":0.00020466192,"teacher_disagreement_score":0.45425016,"about_ca_system_score_codex":0.000011739586,"about_ca_system_score_gemma":0.00003378218,"threshold_uncertainty_score":0.34297696},"labels":[],"label_agreement":null},{"id":"W2580846872","doi":"10.1182/blood.v112.11.3926.3926","title":"C57BL/6JOlaHsd Mice with Tandem Deletion of the Multimerin 1 and Alpha-Synuclein Genes Have Impaired Platelet Function in Vivo and in Vitro That Can Be Corrected by Multimerin 1","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; McMaster University","funders":"","keywords":"Platelet; Thrombus; Fibrinogen; In vivo; Biology; Hemostasis; Serum amyloid P component; Immunology; Molecular biology; Pathology; Chemistry; Internal medicine; Inflammation; Medicine; Biochemistry","score_opus":0.008481272132935936,"score_gpt":0.18589110471149248,"score_spread":0.17740983257855655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580846872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983451,0.001073939,0.00007533888,0.000053146337,0.000034847057,0.0003407935,0.000052859665,0.000007710754,0.000016260024],"genre_scores_gemma":[0.9991237,0.00025524167,0.00034276937,0.00009573972,0.000024605482,0.000036886187,0.00004526895,0.000017903387,0.00005791558],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992204,0.00007285607,0.00015702847,0.00027737702,0.00009792541,0.00017441661],"domain_scores_gemma":[0.999675,0.000009331157,0.00009114654,0.00015096719,0.000026813503,0.00004673625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008009892,0.00014948942,0.00016267221,0.00003963493,0.00005659453,0.000006813566,0.00006292585,0.00013544815,0.00000442988],"category_scores_gemma":[0.000017767701,0.00011732303,0.00002637236,0.00007587299,0.000082892926,0.000007655099,0.00005684639,0.000084795596,1.1228515e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036000146,0.0001475652,0.015159721,0.000010547426,0.000028887283,0.00000660139,0.000113164235,0.000006249902,0.98348004,2.808083e-7,0.00009213747,0.00059478794],"study_design_scores_gemma":[0.002947089,0.0002789679,0.008849694,0.000025391882,0.00002253595,0.00007311394,0.00011422241,0.00040378954,0.9867656,0.0000022192628,0.00036937406,0.00014800404],"about_ca_topic_score_codex":0.00073217094,"about_ca_topic_score_gemma":0.00073890365,"teacher_disagreement_score":0.0063100257,"about_ca_system_score_codex":0.00000878979,"about_ca_system_score_gemma":0.00003502168,"threshold_uncertainty_score":0.4784294},"labels":[],"label_agreement":null},{"id":"W2580892635","doi":"10.1182/blood.v104.11.4459.4459","title":"Effects of Arsenic Trioxide on Megakaryocytic Cell Lines: Apoptosis, Cell Cycle Dysfunction and Signaling Pathways.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Arsenic trioxide; Apoptosis; Acute promyelocytic leukemia; Cell cycle; Flow cytometry; Annexin; Cell culture; Cell cycle checkpoint; Molecular biology; Cancer research; Leukemia; Biology; Cell growth; Chemistry; Immunology; Biochemistry; Genetics","score_opus":0.0036042373569293838,"score_gpt":0.18269644998535156,"score_spread":0.17909221262842218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580892635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99417305,0.0038817716,0.00085635285,0.00000965644,0.0000942292,0.00018281917,0.0000034304626,0.000016468282,0.0007822334],"genre_scores_gemma":[0.9981999,0.0007287841,0.00066860183,0.000079867335,0.00015823514,0.00001893473,0.000026087091,0.000026210855,0.00009337228],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99911046,0.000035940186,0.00020706397,0.0003276314,0.00012873957,0.00019017335],"domain_scores_gemma":[0.9995307,0.000033966935,0.00011493439,0.00020549506,0.000047268382,0.00006767558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000923905,0.0001722737,0.00017016694,0.000042532647,0.000057538444,0.00001482468,0.00010729843,0.00017176343,0.0000019042611],"category_scores_gemma":[0.0000549028,0.0001589987,0.00008324048,0.00008287194,0.00005286639,0.000004135488,0.000045393197,0.00009960556,0.0000059117565],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005602843,0.0003957394,0.00010347622,0.00044020676,0.00002546405,0.000005050149,0.000060376107,0.0005112523,0.99818546,0.000021706492,0.000011916679,0.00018334748],"study_design_scores_gemma":[0.0036161444,0.0008021045,0.000074013544,0.000068494686,0.00011946271,0.0000074806994,0.00005439005,0.000008950951,0.99469817,0.00024234349,0.00013225993,0.00017618747],"about_ca_topic_score_codex":0.000011824121,"about_ca_topic_score_gemma":8.2085705e-7,"teacher_disagreement_score":0.004026868,"about_ca_system_score_codex":0.000011956454,"about_ca_system_score_gemma":0.00010170214,"threshold_uncertainty_score":0.64837784},"labels":[],"label_agreement":null},{"id":"W2580892928","doi":"10.1182/blood.v114.22.3699.3699","title":"Identification of Potential Surrogate Endpoints in Randomized Clinical Trials of Aggressive Non-Hodgkin Lymphoma: Correlation of Complete Response, Time-to-Event and Overall Survival Data.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Surrogate endpoint; Medicine; Internal medicine; Clinical endpoint; Randomized controlled trial; Mantle cell lymphoma; Progression-free survival; Oncology; Aggressive lymphoma; Lymphoma; Clinical trial; Rituximab; Overall survival","score_opus":0.046596878227355976,"score_gpt":0.3686681641389251,"score_spread":0.32207128591156914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580892928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970786,0.00040878367,0.00031141544,0.00033619933,0.00011997597,0.0013844453,0.00030740912,0.0000070027236,0.000046174137],"genre_scores_gemma":[0.9989109,0.00024695764,0.00041293915,0.000024698673,0.000044518292,0.0000161176,0.00027215693,0.000009142788,0.000062568564],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99464434,0.002102006,0.0024054975,0.00034211855,0.00037035625,0.00013567583],"domain_scores_gemma":[0.99402654,0.0029874374,0.0022166127,0.0005089897,0.00016642107,0.00009399496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011024451,0.00014704584,0.0018061509,0.00021162408,0.000017057393,0.000007352459,0.00011682408,0.00011124067,0.00003799365],"category_scores_gemma":[0.0076957135,0.00011657531,0.00024717313,0.00014936004,0.000107027445,0.00007292053,0.00006579311,0.000043380885,0.000010020749],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6582418,0.022530407,0.060954694,0.00024338135,0.0022075772,0.00025785042,0.000870769,0.00020529846,0.20412907,0.00023502544,0.00060001947,0.04952408],"study_design_scores_gemma":[0.34151557,0.00072276074,0.6319554,0.00045246747,0.0011538399,0.000018802059,0.000021748254,0.0031880108,0.02075295,0.00011421974,0.00001350623,0.00009075755],"about_ca_topic_score_codex":0.000076016484,"about_ca_topic_score_gemma":0.000005199378,"teacher_disagreement_score":0.5710007,"about_ca_system_score_codex":0.000027569089,"about_ca_system_score_gemma":0.00015860454,"threshold_uncertainty_score":0.92130435},"labels":[],"label_agreement":null},{"id":"W2580944945","doi":"10.1182/blood.v104.11.102.102","title":"Outcome of Stem Cell Transplantation for Pediatric Acute Lymphoblastic Leukemia. A Comparison of Cyclophosphamide and Total Body Irradiation Versus VP16 and Total Body Irradiation Conditioning Regimens.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Total body irradiation; Medicine; Transplantation; Cyclophosphamide; Surgery; Internal medicine; Gastroenterology; Chemotherapy","score_opus":0.014593438648129302,"score_gpt":0.28463067270436154,"score_spread":0.27003723405623226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580944945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99538624,0.0007011597,0.002297373,0.00006288127,0.00017101201,0.0009809029,0.00021998397,0.000044089997,0.0001363723],"genre_scores_gemma":[0.9974682,0.00027385514,0.0016354948,0.000015550617,0.0001471663,0.00006307591,0.00028268708,0.000041299663,0.00007271434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979312,0.000044149987,0.000770269,0.00040000372,0.0005052636,0.00034910341],"domain_scores_gemma":[0.99840546,0.00057231344,0.00042480818,0.00020715756,0.0001933135,0.00019694661],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022475081,0.0002504871,0.00060331903,0.00029887233,0.00011730955,0.000024968953,0.000068515976,0.00020895447,0.0000063471557],"category_scores_gemma":[0.00007655377,0.0002525558,0.00009952196,0.0002983268,0.00011765257,0.00022356333,0.000027983593,0.00015242411,0.0000033161687],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021233711,0.0040413104,0.6427962,0.013900901,0.0024326418,0.00031077434,0.014502969,0.009221367,0.28474775,0.003198217,0.0004019235,0.0032122175],"study_design_scores_gemma":[0.1012553,0.0052364445,0.79079956,0.00024017013,0.0054321256,0.00043964683,0.00090172514,0.012612533,0.08241095,0.00012222795,0.000007908734,0.00054140517],"about_ca_topic_score_codex":0.00014062978,"about_ca_topic_score_gemma":0.000006727619,"teacher_disagreement_score":0.2023368,"about_ca_system_score_codex":0.0005103119,"about_ca_system_score_gemma":0.0005980833,"threshold_uncertainty_score":0.99999267},"labels":[],"label_agreement":null},{"id":"W2580964459","doi":"10.1182/blood.v116.21.2359.2359","title":"Disease Status Is the Major Prognosis Factor for Allogenic Transplantation Outcome for Hodgkin Lymphoma: a Retrospective Study From the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC)","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Cumulative incidence; Transplantation; Internal medicine; Surgery; Hematopoietic stem cell transplantation; Incidence (geometry); Retrospective cohort study; Autologous stem-cell transplantation; Gastroenterology","score_opus":0.018982690318023628,"score_gpt":0.2647679251694675,"score_spread":0.24578523485144388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580964459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98603565,0.0015036688,0.00026768717,0.0014592877,0.00009768748,0.0052423496,0.0053608706,0.000029163175,0.0000036673655],"genre_scores_gemma":[0.9952955,0.0007986929,0.0012799993,0.0003018881,0.00011757999,0.0017583107,0.0003911674,0.00003312624,0.000023736666],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986267,0.000053343723,0.00036570034,0.00039810565,0.00029605176,0.00026010568],"domain_scores_gemma":[0.9988561,0.00042346944,0.00017050348,0.00030569846,0.00012907572,0.0001151209],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019271922,0.00024413202,0.00036434556,0.000026013564,0.00022833762,0.000038674916,0.00008829354,0.000089616406,0.000031668522],"category_scores_gemma":[0.000023956656,0.00013352199,0.00036288172,0.00009598839,0.000095323056,0.00006650495,0.0000070760684,0.00007095353,6.211055e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007113722,0.0037407868,0.9633405,0.00014213104,0.001303509,0.000009957914,0.011952627,8.649152e-8,0.016279258,0.0000299078,0.00010722045,0.0023826335],"study_design_scores_gemma":[0.027982289,0.0009679799,0.924276,0.00003058416,0.0034819455,0.00000555485,0.00049710873,0.000047526213,0.042193692,0.00023627383,0.0001402902,0.00014078521],"about_ca_topic_score_codex":0.0006905399,"about_ca_topic_score_gemma":0.00044561402,"teacher_disagreement_score":0.039064538,"about_ca_system_score_codex":0.00003519343,"about_ca_system_score_gemma":0.0000999324,"threshold_uncertainty_score":0.5444869},"labels":[],"label_agreement":null},{"id":"W2580972669","doi":"10.1182/blood.v116.21.790.790","title":"Small Molecule RITA Induces Apoptosis In Multiple Myeloma Cells through Activation of the p53 Pathway and Induction of ER-Stress response","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Apoptosis; Mdm2; Bone marrow; Cancer research; Multiple myeloma; Programmed cell death; Biology; Peripheral blood mononuclear cell; Cell culture; Null cell; Molecular biology; Immunology; In vitro; Biochemistry","score_opus":0.02084597959363737,"score_gpt":0.2289059988359614,"score_spread":0.20806001924232403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580972669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987179,0.00008133411,0.000029421259,0.00026493502,0.00017465609,0.0004647583,0.000029752582,0.000016020062,0.00022122305],"genre_scores_gemma":[0.9990057,0.000019319546,0.00081755075,0.000038832863,0.00003986617,0.000022416254,0.0000076772585,0.000021539403,0.000027106847],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99902177,0.00011614533,0.00029059444,0.0002222008,0.0002064564,0.00014284762],"domain_scores_gemma":[0.9991517,0.000113275724,0.0002030162,0.0003904813,0.000102655125,0.000038886792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023228952,0.00012252753,0.0002201071,0.000108427696,0.00003607632,0.000005907933,0.00009577772,0.00022089956,0.000008988598],"category_scores_gemma":[0.00044354668,0.000099209836,0.00006221519,0.00034526642,0.0001291343,0.00006980284,0.00006502922,0.0003859411,7.8440144e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041236155,0.0004994814,0.0041229744,0.000073829615,0.000041092964,0.0000021165301,0.0013507514,0.0000070230626,0.9923959,0.000032051677,0.000008062328,0.0010544034],"study_design_scores_gemma":[0.002867788,0.00019069729,0.067369424,0.00022101644,0.00006532541,0.000011165483,0.0002808829,0.000018179027,0.9287888,0.000034119526,0.00007108634,0.00008152226],"about_ca_topic_score_codex":0.00032999914,"about_ca_topic_score_gemma":0.00013824494,"teacher_disagreement_score":0.06360706,"about_ca_system_score_codex":0.000019478763,"about_ca_system_score_gemma":0.00013723841,"threshold_uncertainty_score":0.40456596},"labels":[],"label_agreement":null},{"id":"W2581002727","doi":"10.1182/blood.v124.21.1009.1009","title":"The Prognostic Impact of High MEL1 Gene Expression in Pediatric Acute Myeloid Leukemia","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Myeloid leukemia; Fusion gene; NPM1; Cancer research; Gene expression; Biology; Gene; Acute promyelocytic leukemia; Gene expression profiling; Leukemia; Haematopoiesis; Immunology; Stem cell; Genetics; Retinoic acid; Karyotype","score_opus":0.010257205961350196,"score_gpt":0.2780282461467004,"score_spread":0.2677710401853502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581002727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997564,0.0006365501,0.00008535717,0.0002067693,0.00005867469,0.00060465466,0.000011292478,0.000043095886,0.00078957906],"genre_scores_gemma":[0.99681425,0.0009376672,0.0013288002,0.00003196093,0.0004294419,0.0000626823,0.00002627771,0.00004077102,0.00032817526],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980663,0.00016536775,0.0004018127,0.00030641124,0.0005313149,0.0005287806],"domain_scores_gemma":[0.9983334,0.0005462654,0.00013935009,0.0006426986,0.00014324223,0.00019504575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006873668,0.0001967307,0.0003990188,0.00021472086,0.00008716756,0.000020962769,0.00032092413,0.00015344199,0.00003941732],"category_scores_gemma":[0.000830383,0.000115055744,0.00015107033,0.0005437975,0.000092988696,0.0000716352,0.00017064443,0.00046056003,0.000054239536],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006882678,0.0006095762,0.71981394,0.0001784236,0.00026797602,0.00016844418,0.00031416575,0.000067985646,0.26985776,0.000091970534,0.0033006924,0.0046407706],"study_design_scores_gemma":[0.007093979,0.0010717325,0.8683057,0.00007350149,0.00036123383,0.00012143247,0.000019727779,0.00034350983,0.12209727,0.00021612192,0.00013244724,0.00016337412],"about_ca_topic_score_codex":0.00022301197,"about_ca_topic_score_gemma":0.000014033503,"teacher_disagreement_score":0.1484917,"about_ca_system_score_codex":0.00029101514,"about_ca_system_score_gemma":0.00079220714,"threshold_uncertainty_score":0.4691837},"labels":[],"label_agreement":null},{"id":"W2581018647","doi":"10.1182/blood.v110.11.4898.4898","title":"IFN-g-Stimulated Mesenchymal Stromal Cells Acquire the Ability To Cross-Present Exogenous Soluble Antigens and Lead to an Effective Immune Response.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Antigen processing; Antigen presentation; MHC class I; Antigen; Cytotoxic T cell; Biology; CD8; Antigen-presenting cell; Immune system; Immunology; Major histocompatibility complex; Cross-presentation; T cell; MHC restriction; MHC class II; Cell biology; In vitro; Biochemistry","score_opus":0.010835130749726031,"score_gpt":0.2806432877075073,"score_spread":0.26980815695778126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581018647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917681,0.004964134,0.00023902167,0.00033557403,0.00077275233,0.001622673,0.000052022115,0.00013719485,0.000108525695],"genre_scores_gemma":[0.9972503,0.000027934746,0.00016003799,0.00027823978,0.00006255307,0.000053949785,0.000021982458,0.0000466356,0.0020983298],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964568,0.0012005698,0.000558667,0.0006595215,0.0001015561,0.001022899],"domain_scores_gemma":[0.99729466,0.0012777289,0.000115188326,0.0010358355,0.00018315102,0.00009341246],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0027213711,0.0003989502,0.00049144245,0.00019392579,0.0009594012,0.00010071807,0.00058545516,0.00037261954,0.00020934505],"category_scores_gemma":[0.00031891107,0.0003040373,0.00015843929,0.00037094,0.00050309004,0.00017696866,0.00032380523,0.00041394215,0.00033098945],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017370371,0.0008087424,0.0019645502,0.000012308858,0.0003104859,0.00003700423,0.004871808,0.00006627908,0.9682546,0.000013231397,0.000094840325,0.006195733],"study_design_scores_gemma":[0.0023728977,0.0023889686,0.35749242,0.000020392441,0.000052268864,0.00013055926,0.00042542908,0.0000023627285,0.63131046,0.000010012748,0.005525232,0.0002689853],"about_ca_topic_score_codex":0.0005941385,"about_ca_topic_score_gemma":0.000060731607,"teacher_disagreement_score":0.35552788,"about_ca_system_score_codex":0.00006586736,"about_ca_system_score_gemma":0.00009579375,"threshold_uncertainty_score":0.9999412},"labels":[],"label_agreement":null},{"id":"W2581037794","doi":"10.1182/blood.v112.11.3386.3386","title":"Monocyte-Derived Microparticles Improve Hemostasis in Factor VIIIDeficient Mice: Exploring the Role of PSGL-1/P-Selectin.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Hemostasis; Platelet; Chemistry; Intravital microscopy; In vivo; Fibrin; Thrombus; Tissue factor; Venule; Immunology; Andrology; Molecular biology; Endocrinology; Internal medicine; Medicine; Microcirculation; Biology; Coagulation","score_opus":0.056198680449148185,"score_gpt":0.28309420771849025,"score_spread":0.22689552726934206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581037794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974448,0.0012481585,0.0000014450485,0.00046707605,0.000039452232,0.00043486466,0.000008004665,0.000028509192,0.0003276614],"genre_scores_gemma":[0.9990405,0.00041188506,0.00023442032,0.000025256653,0.000057410816,0.000063011736,0.0000032931198,0.00001964615,0.0001445934],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99886024,0.000047827278,0.00025533044,0.00021842074,0.0002675602,0.00035060802],"domain_scores_gemma":[0.9994167,0.000103859296,0.000047247715,0.00026634132,0.00007333825,0.0000924907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010939198,0.0001280785,0.00024240627,0.0001035625,0.00010077565,0.000007709867,0.000106519234,0.00004423056,0.000037611113],"category_scores_gemma":[0.000088076056,0.00007244304,0.00009344694,0.0003162607,0.00010947356,0.00005462883,0.000057373407,0.00019976441,0.000029461231],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000107869455,0.0008533801,0.169688,0.000025109688,0.00006824683,0.000057656656,0.0021114345,0.0000017109173,0.81939834,0.0000054465468,0.000008843789,0.0076739676],"study_design_scores_gemma":[0.002170744,0.0002563421,0.098042205,0.000033288416,0.00004602215,0.00004931844,0.0009565168,0.000064087435,0.89807016,0.000017982145,0.00022162801,0.00007171475],"about_ca_topic_score_codex":0.0002202747,"about_ca_topic_score_gemma":0.000023907858,"teacher_disagreement_score":0.07867183,"about_ca_system_score_codex":0.000044797616,"about_ca_system_score_gemma":0.00011512387,"threshold_uncertainty_score":0.29541415},"labels":[],"label_agreement":null},{"id":"W2581040141","doi":"10.1182/blood.v124.21.2075.2075","title":"Inherited Loss of Samsn1 Contributes to Increased Risk of MGUS and MM through Effects on Multiple Cell Types, Including B-Cells, Transformed Myeloma Cells, and Macrophages","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Monoclonal gammopathy of undetermined significance; Biology; Plasma cell; Multiple myeloma; Plasma cell dyscrasia; Cancer research; Immunology; B cell; T cell; Molecular biology; Immune system; Monoclonal; Antibody; Immunoglobulin light chain; Monoclonal antibody","score_opus":0.011576200661810178,"score_gpt":0.257458820482916,"score_spread":0.24588261982110585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581040141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965467,0.0016205894,0.00012731456,0.00007406268,0.000038005986,0.0010772888,0.00021168892,0.000030343606,0.00027402013],"genre_scores_gemma":[0.9971102,0.0007485332,0.0018739422,0.0000787267,0.00004071129,0.000033596254,0.000038509985,0.000031917058,0.000043855962],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985168,0.00019393457,0.0003113674,0.00033586987,0.00028929466,0.00035275082],"domain_scores_gemma":[0.99800813,0.0012338836,0.00011577688,0.00027668552,0.0001112622,0.0002542658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002698543,0.00023902416,0.00061227434,0.00014452559,0.000091082045,0.000013746166,0.000080236154,0.00012380141,0.000009065766],"category_scores_gemma":[0.00050141383,0.00018861571,0.00007198378,0.00021545238,0.00012589275,0.00004797661,0.0000624093,0.0001662683,0.0000067856763],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020178196,0.0016654867,0.219411,0.0014706759,0.0005278253,0.00008348144,0.00051159714,0.000003238057,0.766974,0.000017568509,0.00007657772,0.0072407676],"study_design_scores_gemma":[0.022055343,0.0018721317,0.16072822,0.00030264244,0.0003701715,0.000006976419,0.000037082824,0.00018744095,0.8140188,0.000043599488,0.00025681898,0.00012077729],"about_ca_topic_score_codex":0.0011824789,"about_ca_topic_score_gemma":0.00008553404,"teacher_disagreement_score":0.058682796,"about_ca_system_score_codex":0.000022932063,"about_ca_system_score_gemma":0.000042098483,"threshold_uncertainty_score":0.7691526},"labels":[],"label_agreement":null},{"id":"W2581073930","doi":"10.1182/blood.v120.21.4064.4064","title":"Botezomib Containing Regimens Provide a Rapid Hematological and Cardiac Response in Patients with AL Amyloidosis","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; AL amyloidosis; Internal medicine; Cardiac amyloidosis; Melphalan; Gastroenterology; Amyloidosis; Oncology; Multiple myeloma; Immunology; Antibody","score_opus":0.007860505022234161,"score_gpt":0.23098674605501185,"score_spread":0.2231262410327777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581073930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968329,0.0021934807,0.000006796344,0.00031026502,0.000044366505,0.00045828748,0.00002511167,0.000020451815,0.000108304775],"genre_scores_gemma":[0.9983003,0.00012428388,0.0008383232,0.00039769596,0.000041844836,0.0001679769,0.000050437095,0.00002916301,0.000049956376],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99860567,0.00022471437,0.00020770522,0.0003730786,0.00014530936,0.00044352785],"domain_scores_gemma":[0.9993001,0.00009008853,0.000099023724,0.00031441587,0.000037410253,0.000158935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029569434,0.00023255989,0.00031271446,0.0000573951,0.00006497205,0.000020947049,0.00009253035,0.00015387806,0.000008209846],"category_scores_gemma":[0.00021671879,0.00018101945,0.000069482296,0.00008311305,0.00009588295,0.000012105447,0.000121029836,0.00009381424,0.0000061999895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017161446,0.00076244446,0.99079394,0.000008353015,0.00018209785,0.000006706019,0.00013922346,4.9035594e-7,0.005774479,0.000022291728,0.00026073013,0.00033306665],"study_design_scores_gemma":[0.005692302,0.0016443381,0.95091534,0.000030181509,0.00012665447,0.000008819349,0.00015580672,4.4649303e-7,0.037363205,0.0000025568004,0.0037739836,0.0002863627],"about_ca_topic_score_codex":0.000016795022,"about_ca_topic_score_gemma":0.000004852476,"teacher_disagreement_score":0.03987863,"about_ca_system_score_codex":0.000021878672,"about_ca_system_score_gemma":0.00004157313,"threshold_uncertainty_score":0.7381759},"labels":[],"label_agreement":null},{"id":"W2581094758","doi":"10.1182/blood.v106.11.438.438","title":"Leukemic Stem Cells of Chronic Phase CML Patients Possess Uniquely Elevated BCR-ABL Kinase Activity and Acquire Spontaneous BCR-ABL Kinase Domain Mutations at a High Frequency.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; BC Cancer Agency","funders":"","keywords":"CD38; Tyrosine kinase; Imatinib mesylate; Biology; Cancer research; Stem cell; ABL; Molecular biology; breakpoint cluster region; Haematopoiesis; Progenitor cell; CD117; CD34; Imatinib; Myeloid leukemia; Cell biology; Signal transduction; Genetics; Gene","score_opus":0.00918812710597172,"score_gpt":0.24648312898287658,"score_spread":0.23729500187690486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581094758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99576974,0.0011338801,0.000030734747,0.00011077463,0.00014669939,0.0016440646,0.0006661211,0.00018342223,0.00031457696],"genre_scores_gemma":[0.9967377,0.00022422621,0.0014132708,0.00009541174,0.00013524338,0.000111018526,0.00043834193,0.00010737295,0.00073738425],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967826,0.00022440359,0.0007381799,0.0008472178,0.0006278343,0.00077978225],"domain_scores_gemma":[0.9974923,0.000345341,0.00048727464,0.0009340753,0.00026379872,0.00047716772],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020563377,0.0006030541,0.00086953375,0.00027588164,0.00025097287,0.000032483735,0.00022589375,0.0003290086,0.00043892817],"category_scores_gemma":[0.00007341397,0.00057693943,0.00017899655,0.00047700302,0.00029122175,0.00029938787,0.00015184205,0.00035582908,0.00007152956],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014968191,0.012718741,0.0056315297,0.0007825443,0.0008718564,0.0051559038,0.001317971,0.00006646721,0.9526075,0.00015737185,0.00021056528,0.018982725],"study_design_scores_gemma":[0.0818979,0.0035505365,0.015127804,0.00081187824,0.0019152599,0.0017535108,0.00014363111,0.00039306443,0.8929737,0.00015355874,0.0004161873,0.0008629393],"about_ca_topic_score_codex":0.0012584934,"about_ca_topic_score_gemma":0.0013688446,"teacher_disagreement_score":0.08040108,"about_ca_system_score_codex":0.0041217827,"about_ca_system_score_gemma":0.0015036919,"threshold_uncertainty_score":0.9997012},"labels":[],"label_agreement":null},{"id":"W2581122960","doi":"10.1182/blood.v104.11.943.943","title":"Outcome after Second Autologous Stem Cell Transplantation as Salvage Therapy in Patients with Relapsed Multiple Myeloma.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Melphalan; Multiple myeloma; Salvage therapy; Surgery; Transplantation; Median follow-up; Internal medicine; Etoposide; Regimen; Autologous stem-cell transplantation; Gastroenterology; Chemotherapy","score_opus":0.012340145528378869,"score_gpt":0.24934638105985235,"score_spread":0.23700623553147349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581122960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99770474,0.00015362779,0.000015053267,0.000060513932,0.0000333436,0.0011171359,0.000059400023,0.000061172395,0.00079502293],"genre_scores_gemma":[0.9984057,0.000027081394,0.00066288176,0.00017172279,0.000018209606,0.00013289321,0.00013890507,0.00003656789,0.00040602937],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863094,0.000048433994,0.0002646694,0.0003196865,0.00036394334,0.00037233098],"domain_scores_gemma":[0.9994045,0.000049108952,0.00005355328,0.00026378303,0.000056431527,0.00017260965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007003827,0.00020282727,0.00028066026,0.00015664165,0.00004357221,0.000017064607,0.00006850032,0.00010531834,0.00014648275],"category_scores_gemma":[0.000007795156,0.00014416307,0.00006235535,0.00016492285,0.000040542356,0.000107214844,0.000008936867,0.00020550843,0.00013437228],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003827933,0.0026000848,0.9873281,0.00011196405,0.00009377482,0.0011964948,0.0007940112,0.0000049045802,0.00070587476,0.0000026915902,0.0000016609062,0.003332508],"study_design_scores_gemma":[0.0674269,0.0019813313,0.9092118,0.000057073794,0.00005550899,0.000024063043,0.00003587397,0.000002673884,0.021025104,0.000011254246,0.000030506082,0.00013787074],"about_ca_topic_score_codex":0.000117521246,"about_ca_topic_score_gemma":0.00029246413,"teacher_disagreement_score":0.07811625,"about_ca_system_score_codex":0.000074826945,"about_ca_system_score_gemma":0.00009220724,"threshold_uncertainty_score":0.58787996},"labels":[],"label_agreement":null},{"id":"W2581159256","doi":"10.1182/blood.v116.21.986.986","title":"Elotuzumab In Combination with Lenalidomide and Dexamethasone In Patients with Relapsed Multiple Myeloma: Interim Results of a Phase 2 Study","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Lenalidomide; Dexamethasone; Medicine; Multiple myeloma; Regimen; Internal medicine; Adverse effect; Interim analysis; Premedication; Phases of clinical research; Nausea; Bortezomib; Oncology; Gastroenterology; Clinical trial; Surgery","score_opus":0.016248758170867097,"score_gpt":0.29246174735512265,"score_spread":0.2762129891842556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581159256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979249,0.000017312057,0.000004820374,0.00004588104,0.00001314882,0.0017815724,0.000028589908,0.00001577424,0.00016799454],"genre_scores_gemma":[0.9983005,0.0000030020024,0.0014658484,0.0000066375387,0.0000064838946,0.00008552735,0.00008081338,0.000021241993,0.000029973768],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986251,0.00009279986,0.00033809626,0.00032327528,0.0003803709,0.00024034397],"domain_scores_gemma":[0.99913853,0.00017389374,0.000118896445,0.0003022105,0.00014123949,0.00012521574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030550084,0.0001594208,0.00036848045,0.00031741348,0.000025204314,0.000011572023,0.00006292143,0.00005909047,0.0000071388267],"category_scores_gemma":[0.000489824,0.00010884787,0.00001650804,0.00033181955,0.00009610911,0.00010922527,0.00004056114,0.00029797145,0.0000016416532],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027014919,0.02797285,0.9355391,0.000043866716,0.00013962854,0.00020684984,0.0010281287,4.8640214e-7,0.0028643904,0.000003626925,0.000002024342,0.0051840795],"study_design_scores_gemma":[0.28490797,0.009835429,0.6996926,0.00012727207,0.00005932809,0.000008075311,0.00023536733,0.00008176755,0.0049669705,0.0000037626953,0.0000044768294,0.00007698318],"about_ca_topic_score_codex":0.0008599181,"about_ca_topic_score_gemma":0.0037762846,"teacher_disagreement_score":0.25789303,"about_ca_system_score_codex":0.000034502948,"about_ca_system_score_gemma":0.000083612205,"threshold_uncertainty_score":0.44386873},"labels":[],"label_agreement":null},{"id":"W2581166283","doi":"10.1182/blood.v110.11.4457.4457","title":"Single Institution Outcomes for Early Stage Follicular Lymphomas Treated with Radiation Therapy Alone as Initial Therapy.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; CancerCare Manitoba","funders":"","keywords":"Medicine; Radiation therapy; Stage (stratigraphy); Follicular lymphoma; Surgery; Lymphoma; Internal medicine; Gastroenterology","score_opus":0.024778155724331213,"score_gpt":0.2857142948610816,"score_spread":0.26093613913675034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581166283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99543816,0.001036945,0.00015486983,0.00021399299,0.00006309217,0.0013431953,0.000022233738,0.00011327185,0.0016142343],"genre_scores_gemma":[0.9979332,0.00026731414,0.0004980598,0.0005235559,0.00014722053,0.00015520767,0.00015433962,0.0000321692,0.00028893835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989447,0.000019748899,0.00022911138,0.00026645727,0.00026161768,0.00027833637],"domain_scores_gemma":[0.9993541,0.000084611274,0.00010346301,0.000238629,0.00009800148,0.0001211981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013407145,0.0002157565,0.00031225506,0.00011514047,0.00012224627,0.000036158825,0.00004463855,0.00010897642,0.000036354555],"category_scores_gemma":[0.000023682542,0.00014039646,0.00013490353,0.00016737085,0.000046682755,0.00012217424,0.0000052491773,0.000032064265,0.000016628848],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002057925,0.006884078,0.9172117,0.000013372483,0.001110746,0.00034044342,0.00042673838,0.0000020720056,0.004067342,0.0005372245,0.000025958137,0.067322396],"study_design_scores_gemma":[0.04672129,0.0038925628,0.63654095,0.000027196143,0.00019478353,0.000047233905,0.000032627067,0.000002660682,0.30675498,0.000022046936,0.0056157582,0.00014789993],"about_ca_topic_score_codex":0.000697809,"about_ca_topic_score_gemma":0.00003966616,"teacher_disagreement_score":0.30268764,"about_ca_system_score_codex":0.0001358203,"about_ca_system_score_gemma":0.00012185858,"threshold_uncertainty_score":0.57252014},"labels":[],"label_agreement":null},{"id":"W2581181313","doi":"10.1182/blood.v110.11.2515.2515","title":"Evaluation of XL999, a Potent Inhibitor of FGFR3, for the Potential Treatment of t(4;14) Positive Multiple Myeloma.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Cancer research; Receptor tyrosine kinase; Angiogenesis; Fibroblast growth factor receptor 3; Multiple myeloma; Biology; Tyrosine kinase; Cancer; Fibroblast growth factor; Receptor; Kinase; Medicine; Immunology; Internal medicine; Cell biology; Biochemistry","score_opus":0.021477983403966394,"score_gpt":0.3023060069135144,"score_spread":0.280828023509548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581181313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996162,0.0009117244,0.0017250186,0.000032224252,0.00005681598,0.0008678645,0.00014544521,0.0000020198138,0.00009688994],"genre_scores_gemma":[0.999076,0.000034563847,0.0006112664,0.0000032543264,0.00011640577,0.000036672383,0.0000720776,0.000013396694,0.000036368736],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988878,0.00007388265,0.00026709875,0.00017328122,0.00042448414,0.00017345158],"domain_scores_gemma":[0.99878484,0.000074859454,0.0001487769,0.000253435,0.0007023215,0.000035793237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006705565,0.00009718865,0.00014366161,0.000047873862,0.00003358249,0.0000029291762,0.00010676272,0.00009171453,0.000006744657],"category_scores_gemma":[0.00021385336,0.00006963566,0.00015863981,0.00007091962,0.00010289855,0.0000022805616,0.000043310833,0.00002442575,5.155084e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004551415,0.0007684559,0.0017776801,0.00002853321,0.00033881716,5.03923e-7,0.0001077911,0.000092358285,0.9863063,0.000010102927,0.000023085338,0.010091198],"study_design_scores_gemma":[0.0039501716,0.0021554886,0.0442763,0.00001664108,0.00027794624,0.000003854344,0.00011761355,0.00029576474,0.9487508,0.000021537006,0.000075210424,0.000058665046],"about_ca_topic_score_codex":0.00007933658,"about_ca_topic_score_gemma":0.00006652456,"teacher_disagreement_score":0.042498622,"about_ca_system_score_codex":0.000020171043,"about_ca_system_score_gemma":0.000130088,"threshold_uncertainty_score":0.28396598},"labels":[],"label_agreement":null},{"id":"W2581181917","doi":"10.1182/blood.v108.11.3375.3375","title":"Mobilization Studies in Immunodeficient Mice Support a Role of Complement in Modulating the Trafficking of Hematopoietic Stem Cells (HSC) - A Pivotal Role of C3 Cleavage Fragments in Retention and C5 Fragments in Mobilization/Egress of HSC.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Mobilization; Complement system; Haematopoiesis; Immune system; Chemokine; Alternative complement pathway; Severe combined immunodeficiency; Cell biology; Classical complement pathway; Stem cell; Homing (biology); Complement component 5; Immunology; Biology; Chemistry; Biochemistry","score_opus":0.013547318903792335,"score_gpt":0.2391962070002152,"score_spread":0.22564888809642286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581181917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9780016,0.021083169,0.000019808876,0.0000049689897,0.00006218382,0.00071502186,0.000027188278,0.0000060662924,0.00007997182],"genre_scores_gemma":[0.99964696,0.00020072488,0.000028170736,0.0000032363305,6.1236835e-7,0.00004459786,0.000054416512,0.000012886965,0.00000840425],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976318,0.0003015797,0.0013938781,0.0002725932,0.00011716478,0.00028300658],"domain_scores_gemma":[0.99885327,0.00011571658,0.0006185826,0.00033159633,0.000077978795,0.0000028484205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007626154,0.0001828847,0.0005683449,0.00036146943,0.000049240803,0.0000039950787,0.0002775233,0.0001259865,0.000010562328],"category_scores_gemma":[0.000029907906,0.0001661245,0.00006565758,0.00053384725,0.00025740545,0.000094687464,0.00017114298,0.00016201608,5.168586e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010622004,0.0029182478,0.12878072,0.00034898447,0.000056273224,0.0000011775435,0.015466266,0.022312306,0.82896024,0.00027444816,6.3896863e-7,0.00077447726],"study_design_scores_gemma":[0.006585211,0.0003404885,0.2034218,0.0012309516,0.00006100858,0.0000053820004,0.06879452,0.0022661632,0.7166415,0.00044339063,0.000004638014,0.0002049607],"about_ca_topic_score_codex":0.0010455863,"about_ca_topic_score_gemma":0.00019748135,"teacher_disagreement_score":0.112318754,"about_ca_system_score_codex":0.000042410276,"about_ca_system_score_gemma":0.00003774827,"threshold_uncertainty_score":0.6774361},"labels":[],"label_agreement":null},{"id":"W2581187342","doi":"10.1182/blood.v104.11.5203.5203","title":"A Simplified Real-Time PCR Method for the Quantification of Minimal Residual Disease in Follicular Lymphoma.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Minimal residual disease; Follicular lymphoma; Polymerase chain reaction; clone (Java method); Real-time polymerase chain reaction; Medicine; Internal medicine; Molecular biology; Biology; Oncology; Lymphoma; Bone marrow; DNA","score_opus":0.02464778563486529,"score_gpt":0.30591447122937876,"score_spread":0.28126668559451345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581187342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99513775,0.0007291787,0.00047893927,0.0023237574,0.000025378205,0.0010463907,0.000061792736,0.000024933734,0.00017189288],"genre_scores_gemma":[0.9900458,0.000115064904,0.009175792,0.000086772176,0.00006708141,0.00033781538,0.000076302895,0.00001695587,0.00007842698],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99910474,0.00003789027,0.0002747988,0.00023299867,0.00018019919,0.00016934687],"domain_scores_gemma":[0.9990657,0.00031210046,0.00009169131,0.0003821322,0.000060210397,0.00008814552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025365042,0.00011335547,0.0002403113,0.00006162459,0.000046559744,0.000009556399,0.000073548494,0.00004976445,0.000010408428],"category_scores_gemma":[0.00016922868,0.000073888026,0.00013243713,0.00014614167,0.000033300694,0.00002801525,0.000017469914,0.000016912474,0.000011490782],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013301969,0.08314675,0.3844964,0.001663497,0.004776644,0.0012726363,0.00512466,0.0021245456,0.35646793,0.07267556,0.0030378231,0.0719116],"study_design_scores_gemma":[0.025759019,0.00044959635,0.84429985,0.00015403701,0.0015312033,0.000017935416,0.00010087073,0.00033467275,0.12570144,0.0010036984,0.000516238,0.00013145067],"about_ca_topic_score_codex":0.00057301397,"about_ca_topic_score_gemma":0.00002677156,"teacher_disagreement_score":0.45980346,"about_ca_system_score_codex":0.00006390589,"about_ca_system_score_gemma":0.00022991773,"threshold_uncertainty_score":0.30130664},"labels":[],"label_agreement":null},{"id":"W2581240848","doi":"10.1182/blood.v118.21.1892.1892","title":"Distinct Human Cell Populations Produce Rapidly Detectable Levels of Neutrophils and Platelets in NOD/SCID-IL-2Receptor Gamma Chain Null Mice Transgenically Engineered to Produce Human Myeloid Growth Factors","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"CD34; Clonogenic assay; Haematopoiesis; Immunology; Myeloid; Progenitor cell; CD33; Biology; Stem cell; Transplantation; Cord blood; Andrology; Cancer research; Cell; Medicine; Cell biology; Internal medicine; Biochemistry","score_opus":0.032780206250143884,"score_gpt":0.23503561337051565,"score_spread":0.20225540712037177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581240848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968043,0.0010017753,0.000053309428,0.00006297181,0.0004156942,0.0010185281,0.00015104681,0.00008301735,0.00040938903],"genre_scores_gemma":[0.9983566,0.000012251589,0.0006745902,0.00002435962,0.000049599144,0.00007674603,0.00007528382,0.00006411662,0.0006664785],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976613,0.00020457881,0.00071863766,0.00071865035,0.00007301603,0.00062382733],"domain_scores_gemma":[0.9990181,0.00007304998,0.0001974915,0.0005215375,0.00012841013,0.00006144306],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035719216,0.00038315085,0.0005758033,0.00028165837,0.00020832935,0.000013090024,0.00044211463,0.00030838785,0.00036318],"category_scores_gemma":[0.00010792422,0.00037594547,0.0001028013,0.00034336533,0.0001859392,0.00012503183,0.0001052962,0.00044067262,0.000030835585],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000091008995,0.0007185837,0.00999196,0.00013386302,0.00008763119,0.000004491413,0.0036383495,0.000003810581,0.984995,0.00011757773,0.000073348725,0.0001443594],"study_design_scores_gemma":[0.0021533633,0.00043077386,0.19476238,0.000052864314,0.00008595364,0.000012748983,0.00007970894,2.917896e-7,0.8018234,0.000077093726,0.00018195275,0.00033951915],"about_ca_topic_score_codex":0.00049022684,"about_ca_topic_score_gemma":0.00037103784,"teacher_disagreement_score":0.18477042,"about_ca_system_score_codex":0.000045203928,"about_ca_system_score_gemma":0.00006256313,"threshold_uncertainty_score":0.9998692},"labels":[],"label_agreement":null},{"id":"W2581270594","doi":"10.1182/blood.v104.11.4581.4581","title":"Evaluation of Early Stage Hodgkin’s Lymphoma Treatment: Two Decades of Progress.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Medicine; Radiation therapy; Stage (stratigraphy); Chemotherapy; Lymphoma; Surgery; Survival rate; Chemotherapy regimen; Internal medicine; Oncology","score_opus":0.04432307033459863,"score_gpt":0.3355037672619981,"score_spread":0.29118069692739945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581270594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940697,0.0034090406,0.0000020197483,0.000116576935,0.000030546755,0.000710842,0.00003263316,0.000024107025,0.0016045604],"genre_scores_gemma":[0.99818236,0.00012867962,0.0013982907,0.0000110680085,0.000040812898,0.0001529882,0.000023225568,0.000014968751,0.00004758759],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987358,0.00004564651,0.00026655017,0.00018914459,0.00061309297,0.00014980906],"domain_scores_gemma":[0.9991964,0.000022600701,0.00015823508,0.00028735708,0.00025994953,0.00007543677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021797954,0.0001361799,0.00030481128,0.000092333525,0.000023958952,0.000006413586,0.000044064196,0.000051553518,0.000047154197],"category_scores_gemma":[0.000033740263,0.000098827426,0.00012711942,0.00014240122,0.00006396826,0.000049930917,0.000012962123,0.000012030671,0.00001304002],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016602669,0.017829815,0.78353196,0.00008219714,0.0014975922,0.00007657409,0.0012197632,0.000031245472,0.002172066,0.0013186861,0.000006173331,0.1920679],"study_design_scores_gemma":[0.042985275,0.0025393239,0.56878275,0.00015282763,0.0027022387,0.000025428491,0.00006774151,0.000011341232,0.38230377,0.000275426,0.00008309227,0.00007079293],"about_ca_topic_score_codex":0.0007081358,"about_ca_topic_score_gemma":0.000049617058,"teacher_disagreement_score":0.3801317,"about_ca_system_score_codex":0.00023562199,"about_ca_system_score_gemma":0.0004824012,"threshold_uncertainty_score":0.40300652},"labels":[],"label_agreement":null},{"id":"W2581312672","doi":"10.1182/blood.v114.22.3295.3295","title":"Nilotinib Responses and Tolerability Confirmed in North American Patients with Chronic Myeloid Leukemia (CML) From ENACT (Expanding Nilotinib Access in Clinical Trials).","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Nilotinib; Medicine; Tolerability; Imatinib; Internal medicine; Adverse effect; Imatinib mesylate; Myeloid leukemia","score_opus":0.0551837068716041,"score_gpt":0.3749707380968654,"score_spread":0.31978703122526125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581312672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99686986,0.00041435476,0.000004268755,0.00025555928,0.00010499365,0.001978748,0.00010417647,0.0000916261,0.00017642685],"genre_scores_gemma":[0.9982514,0.00029106624,0.0003836661,0.00040620478,0.00027276683,0.0000716345,0.00024271029,0.000044989,0.000035561232],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9946057,0.0011847664,0.0019009889,0.0010917027,0.0005220617,0.00069473847],"domain_scores_gemma":[0.9956234,0.0024449439,0.000687599,0.00076888286,0.000091377195,0.00038381634],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017551652,0.00048410505,0.0020172962,0.00030882767,0.0000741185,0.000075154785,0.0002688353,0.00017325554,0.00008226661],"category_scores_gemma":[0.0029901615,0.00037885993,0.00015699945,0.0007737529,0.00032177047,0.0002621326,0.000102283906,0.0007824879,0.000010792254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062453807,0.00216835,0.9434132,0.000035620596,0.00016270897,0.00015707083,0.0003758071,0.000007776434,0.00013242291,0.0000018014974,0.000022445905,0.047277436],"study_design_scores_gemma":[0.057041764,0.0034592603,0.9374341,0.00030611863,0.0002985003,0.00000963402,0.00005191416,0.00006682242,0.00083328586,0.000016918098,0.00013839288,0.00034334],"about_ca_topic_score_codex":0.0031457965,"about_ca_topic_score_gemma":0.010803981,"teacher_disagreement_score":0.050796382,"about_ca_system_score_codex":0.0016131724,"about_ca_system_score_gemma":0.0018574566,"threshold_uncertainty_score":0.9998663},"labels":[],"label_agreement":null},{"id":"W2581337487","doi":"10.1182/blood.v118.21.4751.4751","title":"A Tertiary Care University Hospital Thrombosis Consultation Service: Patient Volume and Characteristics, Requesting Service and Reason for Consult","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Medicine; Thrombosis; Service (business); Family medicine; Psychological intervention; Emergency medicine; Medical emergency; Emergency department; Nursing; Internal medicine","score_opus":0.07782034050850299,"score_gpt":0.3322563792796588,"score_spread":0.2544360387711558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581337487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99668807,0.0000897925,0.00012130873,0.0018644846,0.000080161706,0.0008230448,0.00017366289,0.00005254857,0.000106918116],"genre_scores_gemma":[0.9874123,0.00007548926,0.01094855,0.0011737554,0.000056217683,0.000008022944,0.00030029935,0.000015868089,0.000009522856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99912125,0.00004683128,0.0003308884,0.00026275896,0.000101203914,0.00013707648],"domain_scores_gemma":[0.9983296,0.0003291241,0.0002444959,0.00013468506,0.0008463553,0.00011578756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014980473,0.00011163197,0.0001830843,0.000037245023,0.00010856649,0.000015653957,0.000032607033,0.00007902408,0.000019885443],"category_scores_gemma":[0.0013778402,0.00011726732,0.000020154626,0.000094365365,0.000037294616,0.00020719517,0.000059241425,0.000097150085,0.000004455479],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003712712,0.00053023756,0.9468101,0.0009131803,0.00019627323,0.000031442127,0.022661917,5.5929878e-8,0.002242288,0.00006396131,0.00019560424,0.025983648],"study_design_scores_gemma":[0.0069504324,0.00069387263,0.96896213,0.00021368645,0.0012653195,0.000037970465,0.019567227,0.00045222646,0.0006294344,0.000033796485,0.00100036,0.00019354105],"about_ca_topic_score_codex":0.0010997835,"about_ca_topic_score_gemma":0.00018942014,"teacher_disagreement_score":0.025790108,"about_ca_system_score_codex":0.000027666869,"about_ca_system_score_gemma":0.00007801978,"threshold_uncertainty_score":0.47820225},"labels":[],"label_agreement":null},{"id":"W2581343726","doi":"10.1182/blood.v116.21.204.204","title":"Stromal Cell-Derived Secreted Factors Contribute to the Innate Imatinib Resistance of Leukemia Stem Cells In a Genetically Defined Murine Model of Chronic Myeloid Leukemia Blast Crisis","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Royal University Hospital; University of Saskatchewan","funders":"","keywords":"Myeloid leukemia; Cancer research; Dasatinib; Biology; Stem cell; Imatinib; Bone marrow; Leukemia; Haematopoiesis; Immunology; CD117; Nilotinib; Imatinib mesylate; CD34; Cell biology","score_opus":0.011018198858723547,"score_gpt":0.22677607630232796,"score_spread":0.21575787744360442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581343726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965854,0.00032746373,0.00056136976,0.00017335458,0.00011819999,0.0014172854,0.00048019714,0.000052157964,0.00028456113],"genre_scores_gemma":[0.9947172,0.00009273124,0.004350126,0.00007676768,0.00008515158,0.0000938442,0.00006635326,0.00007849229,0.00043935303],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99679524,0.00009971375,0.0011080584,0.0006269418,0.0006625404,0.0007075255],"domain_scores_gemma":[0.99752444,0.00022685486,0.00044924827,0.0011853303,0.00031275104,0.00030135468],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034201174,0.00047411287,0.00096514024,0.00022105104,0.0000677516,0.000017376511,0.00048391664,0.00028992895,0.000081517064],"category_scores_gemma":[0.00011892774,0.00036240063,0.0002226575,0.00052196835,0.00017053727,0.000056736986,0.00021877632,0.0006260222,0.000016781698],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005677632,0.00041560392,0.0017597567,0.00039057125,0.0002203248,0.000031390886,0.00087881496,0.0030273348,0.99226356,0.0000746864,0.00024545589,0.00012471303],"study_design_scores_gemma":[0.016936438,0.0007405849,0.014383751,0.0002547691,0.0004556489,0.000010751522,0.00021532037,0.012541485,0.9540291,0.000025814423,0.000097193995,0.00030918806],"about_ca_topic_score_codex":0.00042340934,"about_ca_topic_score_gemma":0.0016459334,"teacher_disagreement_score":0.03823453,"about_ca_system_score_codex":0.001169442,"about_ca_system_score_gemma":0.0026791994,"threshold_uncertainty_score":0.9998828},"labels":[],"label_agreement":null},{"id":"W2581357176","doi":"10.1182/blood.v126.23.371.371","title":"Spatiotemporal Analysis of Intraclonal Heterogeneity in Multiple Myeloma: Unravelling the Impact of Treatment and the Propagating Capacity of Subclones Using Whole Exome Sequencing","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Exome sequencing; Somatic evolution in cancer; Multiple myeloma; Exome; Biology; Plasma cell leukemia; Genetic heterogeneity; CDKN2A; Cancer research; Neuroblastoma RAS viral oncogene homolog; Bone marrow; Mutation; Pathology; Cancer; Genetics; Immunology; Medicine; Phenotype; Gene; KRAS","score_opus":0.12111700236964291,"score_gpt":0.33999963766570507,"score_spread":0.21888263529606217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581357176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99890035,0.00030998202,0.00007977302,0.00003452297,0.0000067664128,0.0005747155,0.000075372445,0.0000046181217,0.000013879495],"genre_scores_gemma":[0.99852467,0.000017294758,0.0013887746,0.0000016653138,0.000018348948,0.000013395994,0.000024329991,0.0000091970605,0.000002349909],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986586,0.00022942654,0.0004557808,0.000175399,0.00027191488,0.0002088951],"domain_scores_gemma":[0.99885064,0.00029128924,0.00029328995,0.00027887346,0.0001869788,0.00009893299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000712796,0.0001476992,0.0006124826,0.00020945657,0.000053055355,0.000008476445,0.00007258297,0.000048787067,0.0000030060116],"category_scores_gemma":[0.00033990343,0.00007195323,0.00022231622,0.0005533393,0.00032257018,0.000057655678,0.000042048076,0.00009493486,1.3543641e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005027883,0.00042826033,0.9257797,0.000049536477,0.0020898387,0.0000124780745,0.0022483345,0.0036522723,0.06480253,0.000008372932,7.383565e-8,0.0004258162],"study_design_scores_gemma":[0.010609969,0.00065212534,0.6873781,0.00008159025,0.0012540929,0.0000292498,0.00062584947,0.13117345,0.16809537,0.000032811276,1.4260824e-7,0.00006723376],"about_ca_topic_score_codex":0.03359137,"about_ca_topic_score_gemma":0.0019486545,"teacher_disagreement_score":0.23840158,"about_ca_system_score_codex":0.00019646414,"about_ca_system_score_gemma":0.00032964235,"threshold_uncertainty_score":0.972844},"labels":[],"label_agreement":null},{"id":"W2581366736","doi":"10.1182/blood.v120.21.4493.4493","title":"Functional Hyposplenism in Pediatric Chronic Graft-Versus-Host Disease","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Hematological disorders and diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia; Child and Family Research Institute","funders":"","keywords":"Medicine; Graft-versus-host disease; Gastroenterology; Bone marrow; Internal medicine; Spleen; Immunology; Disease; Pathology","score_opus":0.027271002045945646,"score_gpt":0.2602059957537591,"score_spread":0.23293499370781343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581366736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865073,0.008872396,0.00004419546,0.00069366436,0.00032420235,0.00020717482,0.000010323111,0.000052319047,0.0032884409],"genre_scores_gemma":[0.9980609,0.0005953389,0.00011073621,0.0002702892,0.0007272296,0.000035234105,0.000042983906,0.000012158855,0.00014516703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991509,0.000018076746,0.00016088763,0.0001445177,0.00018952711,0.00033612127],"domain_scores_gemma":[0.9992659,0.00018375154,0.000027758926,0.00015132978,0.000024033743,0.00034719775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007514472,0.000105943815,0.00015895127,0.000069866364,0.00003431797,0.0000062587437,0.00003900702,0.000072251096,0.00058036525],"category_scores_gemma":[0.0005315519,0.00008600201,0.00007280185,0.00018533853,0.000029018694,0.00006490267,0.00003339686,0.00013962471,0.0004264323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018324939,0.0024487714,0.9912545,0.00010884113,0.000017470586,0.00008012556,0.000023919305,0.000001864703,0.000041169846,0.002811052,0.0028943312,0.00013471753],"study_design_scores_gemma":[0.006010849,0.00020110927,0.99104035,0.00001541409,0.00027771856,0.000010109986,0.000016697819,0.000011836198,0.00006192451,0.00015425857,0.0020837917,0.00011593224],"about_ca_topic_score_codex":0.0000062727845,"about_ca_topic_score_gemma":0.0000070922883,"teacher_disagreement_score":0.011553578,"about_ca_system_score_codex":0.000026906268,"about_ca_system_score_gemma":0.00011653404,"threshold_uncertainty_score":0.63545924},"labels":[],"label_agreement":null},{"id":"W2581372286","doi":"10.1182/blood.v116.21.655.655","title":"Phase 2B Randomized Study of CPX-351 Vs. Cytarabine (CYT) + Daunorubicin (DNR) (7+3 Regimen) In Newly Diagnosed AML Patients Aged 60–75","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Cytarabine; Regimen; Internal medicine; Clinical endpoint; Daunorubicin; Gastroenterology; Chemotherapy regimen; Randomization; Febrile neutropenia; Phases of clinical research; Leukemia; Neutropenia; Chemotherapy; Surgery; Randomized controlled trial","score_opus":0.012903436643663032,"score_gpt":0.29914894753650567,"score_spread":0.2862455108928426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581372286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926557,0.00009750581,0.00001166827,0.00033484207,0.00023191562,0.0054149562,0.000028912555,0.00008875894,0.0011357741],"genre_scores_gemma":[0.9971559,0.00006751023,0.0007577196,0.00020091824,0.0002149065,0.00040191508,0.00011950188,0.0000880244,0.000993612],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99568737,0.0006351604,0.0011840655,0.00070922915,0.0010650611,0.0007191383],"domain_scores_gemma":[0.9966785,0.0010233945,0.00035609695,0.0012439024,0.00031881995,0.0003793154],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018786367,0.00042195249,0.0017535178,0.00061732973,0.00008926318,0.000028068222,0.00047060053,0.0002595312,0.00038189735],"category_scores_gemma":[0.0032996947,0.0003394431,0.00023757266,0.000815812,0.00027585687,0.0001737827,0.00021663858,0.0013271756,0.00007377869],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26735497,0.13296995,0.32847375,0.00040968516,0.0018307314,0.0030842926,0.011528849,0.000012741784,0.24005394,0.00005173534,0.0072571384,0.006972234],"study_design_scores_gemma":[0.8820079,0.004415135,0.09134009,0.00012887192,0.0006321348,0.000017131482,0.00047150653,0.00021003356,0.020187663,0.000029823073,0.00025566283,0.0003040684],"about_ca_topic_score_codex":0.0019234366,"about_ca_topic_score_gemma":0.0006716964,"teacher_disagreement_score":0.61465293,"about_ca_system_score_codex":0.00012165747,"about_ca_system_score_gemma":0.00034969352,"threshold_uncertainty_score":0.99990577},"labels":[],"label_agreement":null},{"id":"W2581376100","doi":"10.1182/blood.v118.21.3217.3217","title":"Growth Factor Independence 1 (Gfi1) Regulates Cell-Fate Decision of the Bipotential Granulocytic-Monocytic Precursors Defined by Expression of CD48 As a New Marker,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Integrin alpha M; Biology; Haematopoiesis; Myeloid; Bone marrow; Population; Myelopoiesis; Immune system; Cell biology; Granulopoiesis; Cancer research; Immunology; Molecular biology; Stem cell; Medicine","score_opus":0.00803494156179272,"score_gpt":0.20491750746202267,"score_spread":0.19688256590022996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581376100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961671,0.0024908422,0.00021326306,0.000009838011,0.0000957263,0.00026431595,0.000058513204,0.0000073057176,0.0006931018],"genre_scores_gemma":[0.99802804,0.00033078154,0.0011906857,0.00002070669,0.000017669561,0.000009543773,0.000030332983,0.000023010462,0.00034925694],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99885345,0.00005989056,0.00029337377,0.0003344303,0.0002491067,0.00020974365],"domain_scores_gemma":[0.9990858,0.000019978695,0.00023840854,0.00046694413,0.00008039789,0.00010851451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000060911545,0.00019886982,0.00020513214,0.000034975626,0.000058020076,0.00000833679,0.0003584785,0.00021062804,0.000064427295],"category_scores_gemma":[0.00011012904,0.00013785728,0.0001700632,0.0001096123,0.00008348994,0.000008122936,0.00019865966,0.0000719957,0.000004674353],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049716653,0.0014927108,0.029944995,0.000046581354,0.00013882607,0.0000028757747,0.0001843953,0.0000020215477,0.9646629,0.000019125173,0.001114585,0.0018938077],"study_design_scores_gemma":[0.003425348,0.00044946672,0.008731641,0.000065572494,0.00015858233,0.0000072362895,0.00003131405,0.0000032914672,0.9857869,0.0011058311,0.00009184995,0.00014295039],"about_ca_topic_score_codex":0.0004163561,"about_ca_topic_score_gemma":0.00002395507,"teacher_disagreement_score":0.021213355,"about_ca_system_score_codex":0.0000047077924,"about_ca_system_score_gemma":0.00014044526,"threshold_uncertainty_score":0.5621657},"labels":[],"label_agreement":null},{"id":"W2581377786","doi":"10.1182/blood.v120.21.998.998","title":"A Randomized, Open-Label, Multicenter, Dose Escalation Study of HQK-1001 (2,2-Dimethylbutyrate, Sodium Salt) in Sickle Cell Disease","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Tolerability; Pharmacokinetics; Pharmacodynamics; Gastroenterology; Internal medicine; Fetal hemoglobin; Placebo; Pharmacology; Interim analysis; Clinical trial; Adverse effect; Fetus; Pathology","score_opus":0.02148063235436918,"score_gpt":0.2919601810685933,"score_spread":0.2704795487142241,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581377786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905775,0.0030780544,0.000014725227,0.00015860457,0.00021028654,0.0033612915,0.000008310816,0.000036398884,0.0025548202],"genre_scores_gemma":[0.99842256,0.00022888173,0.00027220443,0.00015651062,0.00006325083,0.00013127044,0.00003100792,0.00003470157,0.00065962673],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99807787,0.000330473,0.0006268752,0.00026967985,0.00028873174,0.00040637236],"domain_scores_gemma":[0.9988281,0.00016165948,0.00019777274,0.00039312372,0.000082690676,0.0003366584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085666025,0.00021362968,0.00070640526,0.00016258292,0.00005733126,0.000021760397,0.00016559009,0.00011785403,0.00009404017],"category_scores_gemma":[0.00023886407,0.00016417484,0.000078592195,0.00032191924,0.000074615644,0.00021649983,0.00015137235,0.00025505334,0.000051720996],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1920273,0.26525033,0.50099915,0.0009520255,0.0008471137,0.00022754548,0.014563636,0.00007260503,0.021885991,0.00012321003,0.0006855082,0.0023655558],"study_design_scores_gemma":[0.96982306,0.00063391513,0.020993281,0.00018442534,0.0014682343,0.0000047049693,0.0021573708,0.0007660262,0.0034777476,0.000033705302,0.00018790964,0.00026961384],"about_ca_topic_score_codex":0.0005234668,"about_ca_topic_score_gemma":0.000028459177,"teacher_disagreement_score":0.7777958,"about_ca_system_score_codex":0.000027339918,"about_ca_system_score_gemma":0.00009503371,"threshold_uncertainty_score":0.66948557},"labels":[],"label_agreement":null},{"id":"W2581380240","doi":"10.1182/blood.v114.22.3536.3536","title":"MT1-MMP Associates with Membrane Lipid Rafts and Is Required for G-CSF-Induced Hematopoietic Stem/Progenitor Cell Mobilization.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Canadian Blood Services","funders":"","keywords":"Cell biology; Stromal cell; Progenitor cell; Biology; Stem cell; CD34; Haematopoiesis; Chemistry; Cancer research","score_opus":0.01571001651643169,"score_gpt":0.24340427869214093,"score_spread":0.22769426217570923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581380240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969884,0.0008064563,0.00010746189,0.0007536356,0.00005815011,0.0007809032,0.000010206954,0.00008832525,0.000406439],"genre_scores_gemma":[0.997231,0.000059544094,0.0010329848,0.0003755995,0.00038001672,0.0000398117,0.000025721954,0.000036160283,0.00081918034],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988774,0.000018191922,0.00026272627,0.0003277943,0.00023544003,0.0002784181],"domain_scores_gemma":[0.99925363,0.000088979185,0.00012036571,0.00020784633,0.0001751597,0.00015401612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015802158,0.0001965106,0.00040565495,0.00006150644,0.0001043866,0.00004131782,0.000058240625,0.00013299366,0.000044963],"category_scores_gemma":[0.00003877899,0.00015453098,0.00008823321,0.00018102129,0.000019225437,0.000074150834,0.000013228469,0.00009268255,0.000004803788],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020822066,0.0010876365,0.009606675,0.00049935374,0.00018213838,0.000014259505,0.0014439892,0.0000014380227,0.98508537,0.000027954087,0.0007367338,0.0011062423],"study_design_scores_gemma":[0.0074214414,0.0010167274,0.00034790847,0.00018685378,0.00052468287,0.00006104831,0.0002771535,0.00018796278,0.9892133,0.000053272226,0.000491334,0.00021830814],"about_ca_topic_score_codex":0.000004972856,"about_ca_topic_score_gemma":0.000001592574,"teacher_disagreement_score":0.009258767,"about_ca_system_score_codex":0.000026289053,"about_ca_system_score_gemma":0.00007790762,"threshold_uncertainty_score":0.630159},"labels":[],"label_agreement":null},{"id":"W2581395724","doi":"10.1182/blood.v120.21.1076.1076","title":"Comparative Cellular Studies of the VWF Exon 4–5 Deletion Mutation Using Patient-Derived Blood Outgrowth Endothelial Cells (BOEC) and Megakaryocytes","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; McMaster University; Hospital for Sick Children; Queen's University","funders":"","keywords":"Von Willebrand factor; Exon; Von Willebrand disease; Population; Mutation; Platelet; Molecular biology; Immunology; Andrology; Chemistry; Internal medicine; Medicine; Biology; Genetics; Gene","score_opus":0.04077851864825587,"score_gpt":0.2808160906227046,"score_spread":0.2400375719744487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581395724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948522,0.004241897,0.000023391694,0.000029442885,0.00012545702,0.00046608286,0.000028626046,0.000015588806,0.00021730052],"genre_scores_gemma":[0.9990432,0.0001298115,0.0006811045,0.000038554226,0.00005481112,0.000011957325,0.000013625205,0.0000121550465,0.000014778948],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992001,0.00006785239,0.0002152526,0.00013930343,0.00018703815,0.00019046312],"domain_scores_gemma":[0.9995067,0.000063532265,0.00016398798,0.00012721779,0.00008249599,0.000056069137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006209461,0.0001455887,0.00034433542,0.000047397425,0.00011663214,0.000006792856,0.000031723066,0.000049861956,0.0000061361325],"category_scores_gemma":[0.00002460485,0.0000979786,0.000064924825,0.000089716996,0.00010960166,0.0001016934,0.00003992451,0.0000686637,0.0000029387354],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000085850654,0.0016327831,0.023858666,0.00009607191,0.000889367,0.00003151771,0.007421875,0.000008076074,0.96568716,0.00006974421,0.00001175641,0.0002071462],"study_design_scores_gemma":[0.004317655,0.00031809552,0.0059964485,0.00008807922,0.0013331725,0.00007654558,0.0019193874,0.000053873217,0.9857059,0.00007109523,0.000025489975,0.00009424745],"about_ca_topic_score_codex":0.000051030536,"about_ca_topic_score_gemma":0.000009534724,"teacher_disagreement_score":0.020018766,"about_ca_system_score_codex":0.000013762687,"about_ca_system_score_gemma":0.000027095552,"threshold_uncertainty_score":0.39954513},"labels":[],"label_agreement":null},{"id":"W2581441713","doi":"10.1182/blood.v114.22.4125.4125","title":"Modest Prolongation of Survival for Patients 60-80 Year at Time of Acute Myelogenous Leukemia (AML) Diagnosis Who Are Treated with Conventional AML Therapy: A Provincial Cohort Analysis.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Medicine; Cohort; Incidence (geometry); Transplantation; Pediatrics; Cancer registry; Surgery; Chemotherapy regimen; Induction chemotherapy; Chemotherapy; Cancer; Internal medicine","score_opus":0.011104037831921678,"score_gpt":0.2530085981590873,"score_spread":0.2419045603271656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581441713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996441,0.000049573908,0.00008965404,0.000105176296,0.0000097951315,0.0022877376,0.00066944544,0.00003654523,0.00031105353],"genre_scores_gemma":[0.996947,0.000078206765,0.00046280475,0.000045952307,0.00007495042,0.0002379033,0.0015927438,0.000032698583,0.0005277207],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980279,0.000091659116,0.00044634816,0.00039193334,0.00071931916,0.00032284507],"domain_scores_gemma":[0.998223,0.00010500884,0.00037948208,0.000354969,0.0008134555,0.00012410372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027741367,0.0002193531,0.0008212706,0.00029407558,0.00008154831,0.000009608799,0.00015508414,0.00016650031,0.00008196994],"category_scores_gemma":[0.00008128646,0.00017121287,0.00025863264,0.000632775,0.0001302464,0.00007805026,0.000032417127,0.00013609776,0.000007636878],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038399375,0.002203885,0.98390573,0.000070538845,0.004435879,0.000023171347,0.00018745889,0.000049722254,0.0043667806,0.000017461794,0.0003460299,0.00055340136],"study_design_scores_gemma":[0.014011158,0.004024354,0.9390306,0.000079111,0.003659172,0.0000055533997,0.000015848786,0.001016968,0.03793159,0.000017321228,0.00004012934,0.00016819098],"about_ca_topic_score_codex":0.00015279086,"about_ca_topic_score_gemma":0.00005581598,"teacher_disagreement_score":0.04487513,"about_ca_system_score_codex":0.00036795312,"about_ca_system_score_gemma":0.00047124072,"threshold_uncertainty_score":0.6981858},"labels":[],"label_agreement":null},{"id":"W2581457556","doi":"10.1182/blood.v126.23.2069.2069","title":"A Systematic Review of the Classification, Diagnosis, Treatment and Outcome of Osteonecrosis of the Hips in Sickle Cell Disease","year":2015,"lang":"en","type":"review","venue":"Blood","topic":"Bone and Joint Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Randomized controlled trial; Avascular necrosis; Disease; MEDLINE; Systematic review; Sickle cell anemia; Surgery; Physical therapy; Pediatrics; Internal medicine; Femoral head","score_opus":0.0772941877080234,"score_gpt":0.3380463783126581,"score_spread":0.2607521906046347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581457556","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011051599,0.9939976,5.1243102e-8,0.00019034295,0.000029929031,0.0042989794,0.00027226872,0.000004173848,0.00010154982],"genre_scores_gemma":[0.006927734,0.9920314,0.0000065030113,0.00006154096,0.000008045157,0.0007497711,0.000023996407,0.00002019473,0.00017080069],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99768066,0.00041486166,0.0013337972,0.00018906586,0.00028227654,0.00009932279],"domain_scores_gemma":[0.99728876,0.00025442784,0.001191997,0.0010361496,0.00012447583,0.000104192666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035214928,0.00023146895,0.0026344827,0.000058286758,0.00001573187,0.0000028347677,0.00017025301,0.00007186099,0.000011226345],"category_scores_gemma":[0.0006705255,0.00009846694,0.0006861625,0.0003219006,0.00010694375,0.00001586086,0.00006796928,0.00008489304,0.000002479985],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000033732474,0.0012027177,0.0124759395,0.9844336,0.00016312102,0.0000015960095,0.000036589303,5.8581895e-9,8.6298286e-7,0.00001902564,0.00014663479,0.0015165341],"study_design_scores_gemma":[0.00095966837,0.00009333141,0.0043674516,0.94827956,0.037143663,0.000006932246,0.000039909508,2.1846647e-7,0.000024563122,0.000010063982,0.008970345,0.00010428529],"about_ca_topic_score_codex":0.000057012014,"about_ca_topic_score_gemma":0.0000117574955,"teacher_disagreement_score":0.036980543,"about_ca_system_score_codex":0.00005052843,"about_ca_system_score_gemma":0.00045255135,"threshold_uncertainty_score":0.40153652},"labels":[],"label_agreement":null},{"id":"W2581473011","doi":"10.1182/blood.v114.22.3032.3032","title":"Superior Cytotoxicity of Clonal Versus Polyclonal Gamma Delta T Cells against Philadelphia Chromosome Positive and B-CLL Derived Leukemic Cells.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Biology; Immunology; Flow cytometry; Molecular biology; Cancer research","score_opus":0.019217311547471562,"score_gpt":0.2717472288953481,"score_spread":0.2525299173478765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581473011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954489,0.0008684597,0.000009555953,0.00064831885,0.00011941196,0.0006473716,0.00017929217,0.00005739444,0.0020212992],"genre_scores_gemma":[0.99764967,0.0005574162,0.00044654813,0.0005750528,0.00036794785,0.000011208322,0.000078973964,0.000043527165,0.00026967024],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99773556,0.000081249986,0.00041853514,0.00051743654,0.0006607776,0.0005864225],"domain_scores_gemma":[0.9987772,0.00016993204,0.00010499794,0.00040844918,0.00018275598,0.00035662614],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021141049,0.00032023963,0.0005920023,0.00020477701,0.00010041229,0.000030197361,0.00020302116,0.00022029971,0.00060485053],"category_scores_gemma":[0.000034674667,0.00031034107,0.00020595186,0.00029682796,0.0003195055,0.000102787744,0.0000905485,0.00045691684,0.000024255962],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028010728,0.00088257843,0.00063044124,0.00005742466,0.00025018334,0.00027492252,0.00035558848,0.0000037904342,0.992743,0.000018413142,0.00013411556,0.0018484683],"study_design_scores_gemma":[0.014307762,0.0021622947,0.024650974,0.00010835448,0.00019542867,0.00013239413,0.000072611016,0.000098751225,0.95770985,0.000022188198,0.0002669972,0.00027241293],"about_ca_topic_score_codex":0.00007984522,"about_ca_topic_score_gemma":0.000015562966,"teacher_disagreement_score":0.03503317,"about_ca_system_score_codex":0.00013606445,"about_ca_system_score_gemma":0.00035185448,"threshold_uncertainty_score":0.99993485},"labels":[],"label_agreement":null},{"id":"W2581516280","doi":"10.1182/blood.v106.11.1427.1427","title":"HIV-1 Proviral Integration Is Blocked by Agonists to the VpPAC2 Neuroendocrine Receptor.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Canadian Blood Services; University of Toronto","funders":"","keywords":"Receptor; Biology; Transfection; Immunology; Virology; Cell culture","score_opus":0.008708092147910984,"score_gpt":0.24415819276912532,"score_spread":0.23545010062121433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581516280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9593271,0.0016744505,0.000060536913,0.03527577,0.00018003795,0.00068497204,0.00043397915,0.00009136283,0.0022718054],"genre_scores_gemma":[0.9677218,0.0000719384,0.000102168866,0.00077455596,0.00007889887,0.00011414254,0.0004725184,0.000012800201,0.030651178],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.999109,0.0001172399,0.00014178088,0.00023170747,0.000044819386,0.0003553999],"domain_scores_gemma":[0.99958324,0.00003727197,0.000029752302,0.00027396163,0.000035909303,0.000039843428],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000060460774,0.0001283255,0.00011788046,0.000039749426,0.00019338091,0.00002754142,0.00019542391,0.000037738475,0.00093523524],"category_scores_gemma":[0.000051367868,0.00008006854,0.000055044482,0.000103217724,0.00006500157,0.000049174134,0.00006279815,0.00019982796,0.013248136],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010705183,0.0008157617,0.0012467382,0.0000029466644,0.00016408942,0.000008438965,0.0005024291,7.153405e-7,0.32026023,0.00006689299,0.6336558,0.04316896],"study_design_scores_gemma":[0.0013039908,0.000289007,0.0004273454,0.0000042601755,0.00002317039,0.000040955667,0.000030141577,7.1565086e-7,0.39408502,0.0000038179996,0.6037295,0.00006211354],"about_ca_topic_score_codex":0.000068736954,"about_ca_topic_score_gemma":0.00007583481,"teacher_disagreement_score":0.0738248,"about_ca_system_score_codex":0.000024408297,"about_ca_system_score_gemma":0.00003709372,"threshold_uncertainty_score":0.99997807},"labels":[],"label_agreement":null},{"id":"W2581553487","doi":"10.1182/blood.v114.22.396.396","title":"ETO2 Controls Hematopoietic Stem Cell Expansion.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Biology; Stem cell; CD34; Haematopoiesis; Cancer research; Progenitor cell; Hematopoietic stem cell; Transcription factor; Cell biology; Genetics; Gene","score_opus":0.015132631446027433,"score_gpt":0.26831886580877246,"score_spread":0.253186234362745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581553487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96479964,0.0014120602,0.00012571437,0.003013128,0.000043322332,0.00054892024,0.000004295077,0.00015268166,0.029900238],"genre_scores_gemma":[0.9904776,0.00007534354,0.00063789473,0.0018924235,0.00020179387,0.000017499407,0.000007981025,0.000022988974,0.0066664494],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986227,0.00004578972,0.00023392972,0.00027310374,0.0004128093,0.00041165025],"domain_scores_gemma":[0.9990171,0.00008162126,0.00004544578,0.00049942575,0.00009308038,0.00026331152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020241107,0.00014899025,0.00033223612,0.000095566334,0.00006185601,0.000022595674,0.00014520554,0.00012044154,0.00017872696],"category_scores_gemma":[0.00002752312,0.000119481076,0.00010601657,0.00019285339,0.000039699156,0.000052981024,0.00003277747,0.00032048882,0.000595312],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051347696,0.004016305,0.004078467,0.0003149013,0.00019271747,0.002688189,0.0015446419,0.000005008513,0.9307118,0.0017295544,0.032313652,0.021891277],"study_design_scores_gemma":[0.047918465,0.0035153497,0.020622311,0.0003537891,0.0007589368,0.0016117839,0.0012008082,0.0003460671,0.8933916,0.00091321586,0.02863542,0.00073221675],"about_ca_topic_score_codex":0.000006731673,"about_ca_topic_score_gemma":4.883225e-7,"teacher_disagreement_score":0.04740499,"about_ca_system_score_codex":0.0000619389,"about_ca_system_score_gemma":0.0002248749,"threshold_uncertainty_score":0.76517296},"labels":[],"label_agreement":null},{"id":"W2581583940","doi":"10.1182/blood.v126.23.53.53","title":"Role of the MSC-Derived Exosomal and Endogenous JAK2-SET/PP2A-Beta Catenin-Modulator Mir-300 in Leukemic Stem/Progenitor Proliferation and Survival in CML","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"CD38; Progenitor cell; Ectopic expression; Cancer research; Biology; Stem cell; Haematopoiesis; CD34; Imatinib mesylate; Cell biology; Cell culture; Molecular biology; Imatinib; Myeloid leukemia; Genetics","score_opus":0.03148552727015677,"score_gpt":0.23968508549445475,"score_spread":0.20819955822429798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581583940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995162,0.0032497349,4.0426147e-7,0.00011454535,0.00008148707,0.0011028731,0.000022617294,0.000023120445,0.00024318436],"genre_scores_gemma":[0.99949217,0.000045109504,0.00012523543,0.000024361223,0.00010499254,0.00007927275,0.000019449679,0.000030815205,0.00007860789],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985225,0.00013035064,0.0003880516,0.0003509683,0.00031361598,0.00029450544],"domain_scores_gemma":[0.9992767,0.000052382315,0.00011960785,0.0003302736,0.00006977541,0.00015123373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024587353,0.00021236241,0.00042058868,0.00010532269,0.000036687517,0.000016168433,0.00009862399,0.000140276,0.0000053365693],"category_scores_gemma":[0.000058373153,0.00016025426,0.000042140913,0.00018826345,0.00009228727,0.00008989,0.00010404733,0.00019261871,0.0000043781065],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021823081,0.00040748998,0.68970877,0.0000867444,0.00010186934,0.000052329447,0.0025455668,0.000006187599,0.30625153,0.000025655085,0.0000061440633,0.0005895026],"study_design_scores_gemma":[0.028643059,0.00051811093,0.5059486,0.00019454154,0.00032038195,0.00058622786,0.0010814124,0.00050655927,0.46183008,0.00007701401,0.000054984503,0.00023901965],"about_ca_topic_score_codex":0.0010779785,"about_ca_topic_score_gemma":0.00093822414,"teacher_disagreement_score":0.18376014,"about_ca_system_score_codex":0.0003417349,"about_ca_system_score_gemma":0.00066275906,"threshold_uncertainty_score":0.6534979},"labels":[],"label_agreement":null},{"id":"W2581610696","doi":"10.1182/blood.v116.21.4181.4181","title":"The WD40-Repeats of Ahi-1 Oncogene Critical for Protein Interaction Between Ahi-1 and BCR-ABL Modulates Imatinib-Induced Apoptosis In BCR-ABL-Transduced Cells","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Cancer research; Fusion protein; Biology; SH3 domain; Progenitor cell; ABL; breakpoint cluster region; Tyrosine kinase; Philadelphia chromosome; Myeloid leukemia; Stem cell; K562 cells; Haematopoiesis; Leukemia; Cell biology; Signal transduction; Immunology; Receptor; Chromosomal translocation; Genetics; Recombinant DNA","score_opus":0.020925623757325637,"score_gpt":0.3038845966690858,"score_spread":0.28295897291176014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581610696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962507,0.00013108765,0.000047155583,0.00097552966,0.00021851844,0.0019580731,0.000055971297,0.000051140854,0.00031186105],"genre_scores_gemma":[0.9950543,0.000032582182,0.0040485584,0.00003742156,0.00023492433,0.00034438592,0.000043712378,0.000055306537,0.00014878671],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980246,0.00008093928,0.0006564928,0.00046498782,0.00030106844,0.0004719414],"domain_scores_gemma":[0.99833363,0.0006645095,0.00015757863,0.00053398433,0.00012360064,0.00018668456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043898655,0.00029275837,0.0005591396,0.00013128197,0.00013384395,0.000039058235,0.00015531368,0.00026304025,0.000054834047],"category_scores_gemma":[0.00047825178,0.00022168692,0.00014596416,0.00015786267,0.00014129003,0.00014591611,0.000053635213,0.00044448057,0.000010428595],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021835201,0.00067336764,0.005743234,0.00032082354,0.00022112556,0.000006464765,0.00044115703,6.9538635e-7,0.9817232,0.00008409291,0.00003310375,0.010534402],"study_design_scores_gemma":[0.0084617,0.00076147635,0.0074811243,0.00031333076,0.00047818563,0.000026668557,0.00014136973,0.00026041616,0.9813138,0.000301912,0.0002624956,0.00019747904],"about_ca_topic_score_codex":0.00029221666,"about_ca_topic_score_gemma":0.00014009407,"teacher_disagreement_score":0.010336923,"about_ca_system_score_codex":0.00011427682,"about_ca_system_score_gemma":0.00020410406,"threshold_uncertainty_score":0.90401304},"labels":[],"label_agreement":null},{"id":"W2581712213","doi":"10.1182/blood.v112.11.4479.4479","title":"Snk/Plk2 Methylation Is a Frequent Event in Patients with Multiple Myeloma","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Methylation; DNA methylation; Monoclonal gammopathy of undetermined significance; CpG site; Biology; Cancer research; Epigenetics; Molecular biology; Gene; Genetics; Gene expression; Monoclonal","score_opus":0.020006478693872613,"score_gpt":0.2686162346726264,"score_spread":0.2486097559787538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581712213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99816626,0.00010327503,0.0000392994,0.0001278605,0.000021168002,0.00084351934,0.000026896712,0.000035539884,0.0006361568],"genre_scores_gemma":[0.99775064,0.000027548305,0.0015637621,0.00010310694,0.000034358443,0.000079605044,0.00013615485,0.000022981185,0.0002818173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985954,0.00004522315,0.00021480188,0.00027903158,0.0005367567,0.0003287694],"domain_scores_gemma":[0.9993029,0.000047944286,0.000054881733,0.00028525942,0.00011352027,0.00019548125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007078138,0.00015197396,0.00023179343,0.00016450552,0.00007178868,0.000006463942,0.000057028123,0.0000633027,0.00017376892],"category_scores_gemma":[0.000098159944,0.00011061831,0.00005959662,0.00023401587,0.000044782755,0.000084794345,0.000028007664,0.00014049372,0.00013428341],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047812975,0.0028765618,0.99194807,0.000025694055,0.00015792961,0.00023683596,0.00038877034,0.0000026257217,0.00035184,0.000003645879,0.00007769199,0.0034522216],"study_design_scores_gemma":[0.024186786,0.00088345364,0.9648191,0.00006927137,0.00005147069,0.000018301447,0.000016423968,0.000112284,0.009436655,0.000012606618,0.0002869876,0.000106695734],"about_ca_topic_score_codex":0.0003192192,"about_ca_topic_score_gemma":0.00008984763,"teacher_disagreement_score":0.027128989,"about_ca_system_score_codex":0.00009076022,"about_ca_system_score_gemma":0.00010072333,"threshold_uncertainty_score":0.4510884},"labels":[],"label_agreement":null},{"id":"W2581765864","doi":"10.1182/blood.v104.11.4351.4351","title":"Identification of Target Genes for the Tumor Suppressor RIZ1 Using Gene Expression Profiling.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Biology; Chromatin; K562 cells; DNA methylation; Regulation of gene expression; Gene; Gene expression; Gene expression profiling; Repressor; Psychological repression; Chromatin immunoprecipitation; Chromatin remodeling; Cancer research; Genetics; Promoter","score_opus":0.011523201774092707,"score_gpt":0.2561087764754366,"score_spread":0.2445855747013439,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581765864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9535376,0.0028838709,0.042838246,0.00005119153,0.0001609507,0.00045867648,0.00005606363,0.000007866499,0.0000055532305],"genre_scores_gemma":[0.9888567,0.000044803393,0.010543296,0.0000121569765,0.00030726515,0.00005834052,0.00011785759,0.000019735327,0.00003989256],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993383,0.00001782669,0.0002204399,0.00020765039,0.00009635506,0.000119380915],"domain_scores_gemma":[0.99938846,0.000008888977,0.00017107997,0.00029965243,0.000110646804,0.000021248463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013477953,0.00008419086,0.00007921408,0.000022834596,0.00009112027,0.000011727741,0.00012285351,0.00007768083,0.0000029166947],"category_scores_gemma":[0.000047634145,0.000067627676,0.00007534858,0.000057599194,0.00004197253,0.000004161957,0.00003908336,0.000027852548,8.0483045e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045890603,0.00008447994,0.00021571598,0.000025053328,0.000038009654,1.4026163e-7,0.000021963064,0.013186451,0.9862386,0.000017645312,0.000022581673,0.00010348361],"study_design_scores_gemma":[0.0011006078,0.00005969756,0.00047658067,0.000013719059,0.00007681532,0.000010411405,0.000020627149,0.0006899915,0.9969554,0.00015811392,0.00035483896,0.00008320782],"about_ca_topic_score_codex":0.000007661456,"about_ca_topic_score_gemma":0.0000023861217,"teacher_disagreement_score":0.03531907,"about_ca_system_score_codex":0.000010085259,"about_ca_system_score_gemma":0.00007800907,"threshold_uncertainty_score":0.27577767},"labels":[],"label_agreement":null},{"id":"W2581803614","doi":"10.1182/blood.v114.22.sci-42.sci-42","title":"Manipulating Stem Cells for Therapeutic Expansion.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Stem cell; Haematopoiesis; Transplantation; Biology; Hematopoietic stem cell; Immunology; Cancer research; Fusion protein; Hematopoietic stem cell transplantation; Ex vivo; Cord blood; In vivo; Medicine; Cell biology; Recombinant DNA; Internal medicine; Gene; Genetics","score_opus":0.07824636812199563,"score_gpt":0.33084599775203677,"score_spread":0.2525996296300411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581803614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984869,0.0011158284,0.00094977,0.00081683014,0.000081088525,0.0011079524,0.0000023195316,0.00009326156,0.010963936],"genre_scores_gemma":[0.99237317,0.000025077112,0.0016309131,0.00046305175,0.00019280968,0.000020602685,0.000003352371,0.00001802232,0.0052730003],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998977,0.000025212523,0.00018059352,0.00021041612,0.00029176506,0.00031502434],"domain_scores_gemma":[0.99938387,0.000109220666,0.00003539371,0.00026342127,0.00007687679,0.00013120688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002359205,0.000098129945,0.0001860124,0.000057010377,0.000073465206,0.000018483386,0.000080745944,0.00006705839,0.00009575298],"category_scores_gemma":[0.000012557519,0.00007749441,0.0000846315,0.000113233466,0.000012638652,0.000030827334,0.0000142440995,0.00011209836,0.00006913134],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012797356,0.00072348304,0.0035368504,0.00019066215,0.00007184782,0.000071827024,0.00018460675,0.0000057758816,0.8926881,0.00071458064,0.00062544603,0.10105885],"study_design_scores_gemma":[0.007719213,0.0024082037,0.020873673,0.00022505109,0.00026024407,0.00010550628,0.00028827757,0.0015695505,0.95479363,0.0005771308,0.010887757,0.000291751],"about_ca_topic_score_codex":0.000004143405,"about_ca_topic_score_gemma":6.93121e-7,"teacher_disagreement_score":0.1007671,"about_ca_system_score_codex":0.00001838324,"about_ca_system_score_gemma":0.00005027348,"threshold_uncertainty_score":0.31601304},"labels":[],"label_agreement":null},{"id":"W2581816360","doi":"10.1182/blood.v116.21.4671.4671","title":"The Role of ABO Blood Group In TTP Prevalence and Disease Outcome","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"ADAMTS13; Medicine; ABO blood group system; Internal medicine; Microangiopathic hemolytic anemia; Plasmapheresis; Gastroenterology; Von Willebrand factor; Thrombotic thrombocytopenic purpura; Surgery; Pediatrics; Platelet; Immunology","score_opus":0.004935510445073559,"score_gpt":0.22847198578790573,"score_spread":0.22353647534283216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581816360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995539,0.0029632975,0.0000016261637,0.00043106076,0.000063089385,0.00028195357,0.0000110766605,0.000017135633,0.000691759],"genre_scores_gemma":[0.9991729,0.00037569652,0.00018658624,0.0000654078,0.000067316054,0.000017655027,0.0000025014576,0.0000113715805,0.00010056472],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99927145,0.000018302866,0.00021361213,0.00017206706,0.00016448901,0.00016008355],"domain_scores_gemma":[0.99939626,0.00007250089,0.000039876177,0.00029943805,0.000025356454,0.00016654952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020060554,0.00009080387,0.00015540405,0.000036268873,0.000053043663,0.000009921829,0.00008358551,0.00005493487,0.000025300407],"category_scores_gemma":[0.000105094994,0.000058393503,0.000048344205,0.00009074962,0.00009986908,0.00004227368,0.000031404077,0.00023230717,0.0000026650512],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000068704605,0.00091085036,0.9524406,0.00014879287,0.000027205671,0.00002817561,0.00009853125,2.4793605e-8,0.041565716,0.0021302968,0.0000018176642,0.002579278],"study_design_scores_gemma":[0.003789273,0.00015647733,0.98737985,0.00007596121,0.00046665725,0.00003342788,0.00003237919,0.000022654534,0.006212663,0.0011498843,0.00060619094,0.000074554875],"about_ca_topic_score_codex":0.00004663707,"about_ca_topic_score_gemma":0.00015017686,"teacher_disagreement_score":0.035353053,"about_ca_system_score_codex":0.0000010698358,"about_ca_system_score_gemma":0.000026222346,"threshold_uncertainty_score":0.2381218},"labels":[],"label_agreement":null},{"id":"W2581827757","doi":"10.1182/blood.v116.21.3063.3063","title":"The Combination of Cyclophosphamide-Bortezomib-Dexamethasone (CYBOR-D) Is a Highly Effective and Well Tolerated Regimen that Produces Rapid and Complete Hematological Response In Patients with AL Amyloidosis","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; AL amyloidosis; Bortezomib; Internal medicine; Cyclophosphamide; Gastroenterology; Multiple myeloma; Dexamethasone; Amyloidosis; Regimen; Neutropenia; Surgery; Chemotherapy; Immunology; Immunoglobulin light chain","score_opus":0.005340306155243384,"score_gpt":0.21979506043857236,"score_spread":0.21445475428332897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581827757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99673754,0.0011618425,0.0000034658146,0.0010364733,0.000043273623,0.0009372168,0.00003092653,0.000012742593,0.00003654631],"genre_scores_gemma":[0.99885404,0.00045444316,0.00024756318,0.00019284815,0.000008348697,0.00016136747,0.000037552538,0.000021149619,0.000022686296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986306,0.00024753105,0.00022772347,0.00048396894,0.00017648448,0.00023370818],"domain_scores_gemma":[0.998952,0.0003024005,0.0002070745,0.0003524198,0.00011491077,0.000071210605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036931882,0.00023214692,0.0003141372,0.00005417682,0.00011696678,0.000035253113,0.00012945462,0.00015064524,0.0000055703404],"category_scores_gemma":[0.00022584926,0.00015207326,0.0000390219,0.00013702683,0.000328059,0.000011595907,0.00011219184,0.00014315051,0.0000012519383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028870697,0.00095724716,0.9328938,0.000019624982,0.00023615055,0.0000045482966,0.00018147661,3.9595096e-7,0.061416965,0.00003425942,0.00015058246,0.0012178763],"study_design_scores_gemma":[0.0052846274,0.001467163,0.70388347,0.00002171307,0.00006728872,0.00000635455,0.000055852088,0.0000042627203,0.28862923,0.00002014002,0.00041685943,0.00014300956],"about_ca_topic_score_codex":0.000040799277,"about_ca_topic_score_gemma":0.00003388323,"teacher_disagreement_score":0.22901031,"about_ca_system_score_codex":0.000008716072,"about_ca_system_score_gemma":0.000029148267,"threshold_uncertainty_score":0.6201368},"labels":[],"label_agreement":null},{"id":"W2581838199","doi":"10.1182/blood.v118.21.3261.3261","title":"The F-BAR Protein PACSIN 2 Specifically Coats the Anastomosing Intracellular Membrane Systems of Platelets and Megakaryocytes,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Platelet; Cell biology; Colocalization; Biology; FLNA; Filamin; Megakaryocyte; Platelet activation; Thrombopoiesis; LAMP1; Intracellular; Molecular biology; Cytoskeleton; Endosome; Immunology; Biochemistry; Cell","score_opus":0.020024712807517202,"score_gpt":0.21164542259843855,"score_spread":0.19162070979092136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581838199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98735917,0.008336298,0.000016449396,0.00020271678,0.000064645676,0.00091563223,0.000008435692,0.000028084301,0.0030685456],"genre_scores_gemma":[0.9988813,0.0004210122,0.00021006487,0.000020166435,0.000044964443,0.000032337273,0.0000068196864,0.000021120884,0.00036225063],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989764,0.00006682124,0.00028503584,0.00019332315,0.0002328037,0.00024560426],"domain_scores_gemma":[0.9993072,0.00007467266,0.0001255496,0.0003450041,0.000059532606,0.00008801586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027069458,0.00015521121,0.0003012791,0.000029878214,0.00017575479,0.000030280791,0.00011154727,0.0000781442,0.000018350256],"category_scores_gemma":[0.000046087454,0.00007868747,0.000052860305,0.00010215351,0.00018620843,0.000044331417,0.000034601107,0.00014809995,0.000011305722],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004760813,0.012495094,0.055481177,0.0020369436,0.0073974896,0.013789279,0.010775991,0.000009156238,0.8141714,0.030666158,0.0010634919,0.047353014],"study_design_scores_gemma":[0.016419215,0.0021278807,0.02831424,0.0010173506,0.0014939859,0.0029401984,0.0020082844,0.00033564804,0.9330385,0.000682889,0.011079048,0.0005427836],"about_ca_topic_score_codex":0.00021110769,"about_ca_topic_score_gemma":0.000024179135,"teacher_disagreement_score":0.118867084,"about_ca_system_score_codex":0.000009972783,"about_ca_system_score_gemma":0.00004245331,"threshold_uncertainty_score":0.3208782},"labels":[],"label_agreement":null},{"id":"W2581869914","doi":"10.1182/blood.v110.11.396.396","title":"Genomc-Wide Profiling of Gene Expression and DNA Copy Number Alterations in Multiple Myeloma.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Comparative genomic hybridization; Genomics; Computational biology; Copy-number variation; Gene expression profiling; Biology; Genetics; Multiple myeloma; Gene; Copy number analysis; Genome; Gene deletion; Gene expression; Immunology","score_opus":0.027231807226767712,"score_gpt":0.3099051586046558,"score_spread":0.28267335137788807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581869914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969215,0.0002683179,0.00047624498,0.000041058687,0.00001891706,0.0005038672,0.000015545147,0.000018249008,0.001736294],"genre_scores_gemma":[0.96749705,0.000044828244,0.032150365,0.000027678774,0.00005097788,0.000024742465,0.0000610423,0.000013802895,0.00012953907],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990744,0.000026714686,0.00024747208,0.0001937871,0.00020340412,0.0002542185],"domain_scores_gemma":[0.99938345,0.00017000447,0.00004598164,0.00018222789,0.00006191057,0.00015640743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019835745,0.000096707896,0.00018720984,0.000099262834,0.000052852924,0.000007906634,0.00003665509,0.000060062554,0.000049946997],"category_scores_gemma":[0.00021946168,0.0000794855,0.000032339074,0.00012375115,0.000044489552,0.000057794565,0.000031669424,0.00010046095,0.000015304495],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016649436,0.00046618265,0.6120087,0.00004126162,0.00002801697,0.00011333882,0.00016188585,7.010556e-7,0.38615668,0.000009347579,0.000008182595,0.000839206],"study_design_scores_gemma":[0.0052209753,0.00007752145,0.3277773,0.00006773256,0.00002144108,0.00003163415,0.00007162879,0.00006107491,0.66657126,0.000016162667,0.00003671951,0.000046524314],"about_ca_topic_score_codex":0.000081273814,"about_ca_topic_score_gemma":0.00007649078,"teacher_disagreement_score":0.28423142,"about_ca_system_score_codex":0.000022127611,"about_ca_system_score_gemma":0.000049891605,"threshold_uncertainty_score":0.32413247},"labels":[],"label_agreement":null},{"id":"W2581871698","doi":"10.1182/blood.v108.11.4665.4665","title":"Fludarabine and Mitoxantrone for the Refractory Relapse Treatment of B-Cell Low-Grade Non-Hodgkin Lymphoma (NHL): LACOHG First Interim Report (Latin American Cooperative Oncology Hematology Group).","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Mitoxantrone; Internal medicine; Fludarabine; International Prognostic Index; Oncology; Follicular lymphoma; Hematology; Transplantation; Performance status; Cyclophosphamide; Rituximab; Surgery; Lymphoma; Chemotherapy","score_opus":0.012416748922372383,"score_gpt":0.2753732552975033,"score_spread":0.2629565063751309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581871698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921603,0.0034609148,0.000114900846,0.0018456533,0.00014643212,0.0014140257,0.00005740996,0.0000361285,0.00076424284],"genre_scores_gemma":[0.9950341,0.00095012825,0.0022387959,0.00012816871,0.00020398838,0.00069325365,0.00015764129,0.0000392318,0.0005546943],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983039,0.00006569571,0.00064688205,0.00048677236,0.00015327688,0.00034347465],"domain_scores_gemma":[0.9980284,0.00080673373,0.00045657094,0.0004882769,0.00010870831,0.00011131285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011960841,0.0003236496,0.00094945397,0.00008733865,0.00015100525,0.0000129478685,0.00007484463,0.00012706127,0.000019536743],"category_scores_gemma":[0.00005540597,0.00020059843,0.00018950934,0.00015186078,0.00041184918,0.00003736389,0.000042133826,0.000049029964,0.00000601375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006749316,0.18296021,0.5936952,0.0008246329,0.005924692,0.010791486,0.0050202417,0.00003273273,0.12090142,0.0018801974,0.013542534,0.0576773],"study_design_scores_gemma":[0.091844484,0.039521497,0.42737216,0.00027676066,0.004256361,0.0038833863,0.0012966044,0.0003213526,0.35737965,0.00005632207,0.07316811,0.0006233087],"about_ca_topic_score_codex":0.0018630257,"about_ca_topic_score_gemma":0.00092415774,"teacher_disagreement_score":0.23647822,"about_ca_system_score_codex":0.0002780495,"about_ca_system_score_gemma":0.00018512685,"threshold_uncertainty_score":0.81801665},"labels":[],"label_agreement":null},{"id":"W2581872566","doi":"10.1182/blood.v124.21.2785.2785","title":"CD20 B Cell Depleting Therapy Is Associated with up-Regulation of CD8+CD25highFoxp3+ T Regulatory Cells in a Murine Model of Immune Thrombocytopenia (ITP)","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"CD8; Immunology; CD19; B cell; T cell; Immune system; Cytotoxic T cell; CD20; Rituximab; Biology; Antibody; In vitro","score_opus":0.01276169966669067,"score_gpt":0.2195293619561586,"score_spread":0.20676766228946794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581872566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978568,0.00033797964,0.00005490724,0.000055607732,0.000021145275,0.0003979684,0.000019338922,0.000024747284,0.0012315188],"genre_scores_gemma":[0.99860054,0.00007515937,0.000735167,0.00006336318,0.0000108086515,0.000011116838,0.00005009417,0.000035777528,0.00041795563],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99875295,0.00005206181,0.0004396308,0.0002376618,0.00029716114,0.00022050504],"domain_scores_gemma":[0.9991124,0.000059836402,0.0003398815,0.00033098078,0.000106961044,0.000049892085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002414831,0.0001847026,0.00067799253,0.000119741926,0.000030331246,0.0000046339437,0.000083897,0.00011883548,0.000050329705],"category_scores_gemma":[0.000019063087,0.00014599258,0.00009257453,0.00021334016,0.00005753939,0.00006178854,0.00002458063,0.00010318883,0.0000034203385],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005309767,0.0036657928,0.061889462,0.00013391732,0.00041478156,0.000016949121,0.0013621689,0.00078836264,0.9304328,0.00005879833,0.00008536935,0.0006206554],"study_design_scores_gemma":[0.021167435,0.0007369469,0.14547831,0.00028049905,0.00021399402,0.0000066037765,0.000054195585,0.007499541,0.82417566,0.0002070027,0.000014113176,0.00016568485],"about_ca_topic_score_codex":0.00017305346,"about_ca_topic_score_gemma":0.000045410437,"teacher_disagreement_score":0.106257096,"about_ca_system_score_codex":0.000027861208,"about_ca_system_score_gemma":0.00007039672,"threshold_uncertainty_score":0.5953405},"labels":[],"label_agreement":null},{"id":"W2581873141","doi":"10.1182/blood.v110.11.2299.2299","title":"Genetic Disruption of the SH3 and SAM Domains of HACS1 Enhances Adaptive Immunity.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Immune responses and vaccinations","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Biology; Bone marrow; Immunology; B cell; Population; Immune system; Antigen; Molecular biology; B-1 cell; Spleen; T cell; Antibody; Antigen-presenting cell; Medicine","score_opus":0.009202837331452735,"score_gpt":0.2430574477701097,"score_spread":0.23385461043865696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581873141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935852,0.0052289655,0.00036089172,0.000033597946,0.00011061058,0.000120876975,0.000012611228,0.0000062624904,0.0005409442],"genre_scores_gemma":[0.9991999,0.00019459058,0.00017279803,0.000008704001,0.000007133211,0.0000027441724,0.0000031838265,0.000004187489,0.0004067115],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999495,0.000104609004,0.00019196446,0.00007256574,0.0000196464,0.00011616541],"domain_scores_gemma":[0.9994736,0.00017251495,0.00012247027,0.0001750776,0.000051156876,0.0000051796765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018835906,0.00006137839,0.00011903649,0.00004972337,0.000109212546,0.000001845943,0.00011027057,0.00007221967,0.000039574385],"category_scores_gemma":[0.00005172485,0.000042827687,0.000051241357,0.00010115182,0.00015441424,0.00002416094,0.00006529409,0.00009329751,0.000004655162],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012298785,0.0002548452,0.006381917,0.000009723768,0.00012513154,3.7459088e-7,0.00074603944,7.2707815e-7,0.98356116,0.0019057277,0.000013226637,0.006878131],"study_design_scores_gemma":[0.00073575816,0.0001332381,0.5360319,0.000018635996,0.000059459304,0.00002315426,0.00037265033,3.86277e-7,0.46210027,0.00019110639,0.00029737348,0.000036047117],"about_ca_topic_score_codex":0.00009720938,"about_ca_topic_score_gemma":0.00012092076,"teacher_disagreement_score":0.52965003,"about_ca_system_score_codex":0.0000041806884,"about_ca_system_score_gemma":0.000029899307,"threshold_uncertainty_score":0.17464623},"labels":[],"label_agreement":null},{"id":"W2581979725","doi":"10.1182/blood.v126.23.3900.3900","title":"Expression of B and T Lymphocyte Attenuator (BTLA) Correlates with CNS Metastasis and Adverse Prognosis in Activated B-Cell Lymphoma and Acute Lymphoblastic Leukemia","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"BTLA; Lymphoma; Cancer research; Lymphoblastic lymphoma; Biology; Comparative genomic hybridization; Metastasis; Hematology; Immunology; Medicine; Pathology; T cell; Cancer; Internal medicine; Immune system; Chromosome","score_opus":0.012942658459170529,"score_gpt":0.2301693935255132,"score_spread":0.21722673506634266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581979725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958842,0.003250268,0.0000034261573,0.00006462166,0.000020064179,0.00055325706,0.000038749116,0.000034712175,0.00015070598],"genre_scores_gemma":[0.9974581,0.0011100024,0.0011691295,0.00004110712,0.000015466563,0.00010188287,0.000024554713,0.000035938607,0.000043822685],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986949,0.000048833506,0.00029349746,0.00043695216,0.00026152303,0.00026427937],"domain_scores_gemma":[0.999073,0.00013933814,0.0001587302,0.00020441833,0.000089147994,0.00033533832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011298907,0.00028663926,0.00057507557,0.00018494515,0.0000474073,0.000018773762,0.0000431643,0.00012007253,0.0000053785034],"category_scores_gemma":[0.000046510133,0.00020490088,0.000039271796,0.00023885237,0.00016852902,0.00014210532,0.00010017588,0.000044326644,0.0000023327443],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018596026,0.0031854608,0.93521184,0.00025907686,0.0005596141,0.00075414305,0.0012698848,0.000007411879,0.041321013,0.0000125404495,0.000095497635,0.015463916],"study_design_scores_gemma":[0.07271269,0.00213735,0.35642847,0.0009803459,0.0025041534,0.0011626417,0.0009527757,0.00038640766,0.5622597,0.000017119197,0.00012289832,0.00033548044],"about_ca_topic_score_codex":0.00023364913,"about_ca_topic_score_gemma":0.000029012217,"teacher_disagreement_score":0.57878333,"about_ca_system_score_codex":0.00019105626,"about_ca_system_score_gemma":0.00033538294,"threshold_uncertainty_score":0.8355615},"labels":[],"label_agreement":null},{"id":"W2581999742","doi":"10.1182/blood.v120.21.16.16","title":"Genetic Variability of the CLEC4M Endothelial Lectin Receptor Modulates Binding and Internalization of Von Willebrand Factor and Contributes to Variance in Plasma VWF Levels","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Queen's University","funders":"","keywords":"Von Willebrand factor; Von Willebrand disease; Genetics; Biology; Allele; Genotyping; Single-nucleotide polymorphism; Immunology; Genotype; Molecular biology; Gene; Platelet","score_opus":0.012443400409092328,"score_gpt":0.24033917827675244,"score_spread":0.2278957778676601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581999742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987932,0.00024603156,0.00032888903,0.00006597455,0.00008001254,0.00036817347,0.0000671077,0.000004293834,0.00004630345],"genre_scores_gemma":[0.99945575,0.000036809102,0.0004339556,0.000018683737,0.000014430782,0.0000070939805,0.0000021853987,0.0000069453795,0.000024134346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994499,0.00004912786,0.00019075081,0.00011394182,0.00007456621,0.000121734374],"domain_scores_gemma":[0.99965805,0.00010351247,0.00007306439,0.00009431699,0.000028929493,0.000042135613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000113066344,0.00007726234,0.00022593353,0.000050154147,0.000022052434,0.0000050771164,0.000031173662,0.000050435527,0.000014786289],"category_scores_gemma":[0.0002311177,0.000054774566,0.000019839345,0.00011421164,0.00003884416,0.00004391315,0.000031728967,0.000043905104,4.8633314e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009619081,0.0002980854,0.8843583,0.000054608066,0.000075386735,6.621821e-7,0.00051304355,0.0000025716138,0.113627836,0.00008499451,0.0000022551042,0.000886058],"study_design_scores_gemma":[0.0042044944,0.00011392546,0.80680037,0.00014256213,0.00008011414,0.000013274637,0.000019847077,0.00007052968,0.1882644,0.0002031924,0.000039228806,0.00004807927],"about_ca_topic_score_codex":0.000078884084,"about_ca_topic_score_gemma":0.000029032915,"teacher_disagreement_score":0.077557966,"about_ca_system_score_codex":0.000012969191,"about_ca_system_score_gemma":0.000020311092,"threshold_uncertainty_score":0.2233642},"labels":[],"label_agreement":null},{"id":"W2582009911","doi":"10.1182/blood.v126.23.3961.3961","title":"Long-Term Outcomes, Secondary Malignancies, and Stem Cell Collection Following Bendamustine in Patients with Previously Treated Indolent Non-Hodgkin Lymphoma","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Regional Health Centre; Sudbury Regional Hospital; Centre Hospitalier de l’Université de Montréal; Ottawa Hospital; Dalhousie University","funders":"","keywords":"Bendamustine; Medicine; Lymphoma; Stem cell; Oncology; Internal medicine; Pathology; Rituximab; Biology","score_opus":0.012580554309340616,"score_gpt":0.2254333859239497,"score_spread":0.2128528316146091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582009911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99719965,0.0007638524,0.0000020254229,0.000051272724,0.00009414908,0.0011830439,0.000017218515,0.000049482755,0.0006393191],"genre_scores_gemma":[0.9988732,0.00003384695,0.00015416346,0.00012751238,0.00002201888,0.0001328483,0.00012956455,0.00003534599,0.000491523],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986054,0.000042579435,0.0003203019,0.00038139973,0.0003257175,0.00032463518],"domain_scores_gemma":[0.99926466,0.000034443703,0.0001150496,0.000252208,0.000080078105,0.00025353898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011826254,0.0002743524,0.0005007569,0.0001651524,0.00006111234,0.00003488869,0.000048835107,0.000101429425,0.000009321804],"category_scores_gemma":[0.000009530136,0.00019716499,0.0000720375,0.00027279797,0.000024219353,0.00010720417,0.000046709963,0.000059630387,0.000008556954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031764814,0.0042323014,0.98930323,0.00009439554,0.00022077013,0.00044088904,0.0005832172,7.8275104e-7,0.00002325326,5.786256e-7,0.00015915986,0.0046237516],"study_design_scores_gemma":[0.06703299,0.002185118,0.9262248,0.00034074893,0.0005525721,0.00004052094,0.00006002062,0.0000044875546,0.0033274153,6.9193226e-7,0.0000410405,0.0001895751],"about_ca_topic_score_codex":0.00026083455,"about_ca_topic_score_gemma":0.00020899353,"teacher_disagreement_score":0.066715345,"about_ca_system_score_codex":0.00032166293,"about_ca_system_score_gemma":0.0002805508,"threshold_uncertainty_score":0.80401546},"labels":[],"label_agreement":null},{"id":"W2582023351","doi":"10.1182/blood.v120.21.3025.3025","title":"Association of Cth Genetic Variant with Veno-Occlusive Disease in Children Receiving Intravenous Busulfan Before Hematopoietic Stem Cell Transplantation.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Glutathione Transferases and Polymorphisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Toxicity; Busulfan; Transplantation; Medicine; Hematopoietic stem cell transplantation; Internal medicine; Glutathione; Pharmacology; Hepatic veno-occlusive disease; Gastroenterology; Oncology; Biology; Biochemistry","score_opus":0.0025372796610189825,"score_gpt":0.17724498031207672,"score_spread":0.17470770065105773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582023351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99727595,0.0013269659,0.00083661056,0.000055232802,0.000039866558,0.0002683685,0.00012533407,0.0000075598186,0.00006410529],"genre_scores_gemma":[0.9989186,0.00026071587,0.00039939408,0.000039960527,0.000108611304,0.000020098438,0.00015942204,0.000025089324,0.00006813611],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990816,0.0000678326,0.00022094285,0.00019123113,0.00015478113,0.00028360455],"domain_scores_gemma":[0.9995481,0.000011038698,0.00010201499,0.00018203908,0.00003815955,0.00011865953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011612704,0.00014315404,0.00015470198,0.00004433707,0.000044832977,0.000009235904,0.00009902972,0.00009693268,0.000012694788],"category_scores_gemma":[0.0000042088163,0.00013027295,0.000056546403,0.000097009084,0.000021289758,0.000007032232,0.0000125979595,0.000077778794,0.0000031743878],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014348695,0.000979118,0.95161676,0.00013797365,0.00015863012,0.000023794884,0.0021533412,0.00033929537,0.043826032,0.00003731983,0.000010295659,0.00057394826],"study_design_scores_gemma":[0.0021460142,0.0003634822,0.9181916,0.00006196773,0.00037160513,0.0000813146,0.00006090106,0.000008199296,0.07846253,0.000020555097,0.00002257181,0.00020924548],"about_ca_topic_score_codex":0.000070795075,"about_ca_topic_score_gemma":0.000066171335,"teacher_disagreement_score":0.0346365,"about_ca_system_score_codex":0.00001483909,"about_ca_system_score_gemma":0.00006987544,"threshold_uncertainty_score":0.53123766},"labels":[],"label_agreement":null},{"id":"W2582044360","doi":"10.1182/blood.v116.21.3110.3110","title":"The Pandemic H1N1 Influenza Vaccine Results In Low Rates of Seroconversion In Patients with Hematological Malignancies","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; London Health Sciences Centre","funders":"","keywords":"Medicine; Vaccination; Seroconversion; Titer; Influenza vaccine; Internal medicine; Pandemic; Population; Immunology; Antibody; Coronavirus disease 2019 (COVID-19); Disease; Infectious disease (medical specialty)","score_opus":0.031055326348702252,"score_gpt":0.3195957541015355,"score_spread":0.2885404277528333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582044360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99873394,0.00021755684,2.037112e-7,0.00018298559,0.000026723412,0.00056770316,0.0000096002395,0.000017575194,0.00024368548],"genre_scores_gemma":[0.999576,0.00008212308,0.00010862418,0.00013515317,0.000015958465,0.00003245857,0.0000054344514,0.000009195427,0.00003508096],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986484,0.00005546293,0.0004069245,0.00020719864,0.00035056125,0.00033145622],"domain_scores_gemma":[0.9990024,0.0003247112,0.0001072964,0.0002968248,0.00021225344,0.000056521596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048603083,0.00013214408,0.00032498696,0.00012153064,0.00006255353,0.000008284599,0.0001397961,0.000101857564,0.000010057701],"category_scores_gemma":[0.0012221524,0.0000692444,0.00003091036,0.00032157952,0.00013831812,0.00006834769,0.00011529799,0.0004317227,0.000011443497],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025235252,0.00053609966,0.99334764,0.00008661742,0.000033738062,0.000020357587,0.00031392396,0.0000028290206,0.0028396419,0.00003133393,0.00006701192,0.00019729357],"study_design_scores_gemma":[0.017344762,0.0004852806,0.96807307,0.00026375274,0.00001801122,0.0000042577817,0.00016238315,0.000010914858,0.013186411,0.000035241308,0.000337199,0.00007869628],"about_ca_topic_score_codex":0.00009581065,"about_ca_topic_score_gemma":0.00063562527,"teacher_disagreement_score":0.025274538,"about_ca_system_score_codex":0.000018787063,"about_ca_system_score_gemma":0.00007209012,"threshold_uncertainty_score":0.28237048},"labels":[],"label_agreement":null},{"id":"W2582171842","doi":"10.1182/blood.v126.23.737.737","title":"Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome with Multi-Organ Dysfunction: Final Results from a Pivotal, Historically Controlled, Phase 3 Trial","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Defibrotide; Hepatic veno-occlusive disease; Medicine; Internal medicine; Ascites; Creatinine; Organ dysfunction; Gastroenterology; Dialysis; Hematopoietic stem cell transplantation; Hepatorenal syndrome; Transplantation; Surgery; Sepsis","score_opus":0.04923349367987831,"score_gpt":0.28366159231891885,"score_spread":0.23442809863904054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582171842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98594487,0.0006101336,0.008007608,0.0003067691,0.00046251476,0.0041370913,0.0004251874,0.000052759937,0.000053049305],"genre_scores_gemma":[0.99361247,0.000037707763,0.0047943257,0.000019904704,0.0003307249,0.00048166365,0.0003757587,0.00003283676,0.00031460397],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99843353,0.00007720018,0.000555457,0.00032733296,0.00041345457,0.00019305172],"domain_scores_gemma":[0.99823844,0.0006264137,0.0002920387,0.00036723196,0.00023756459,0.00023829227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000148812,0.00021993625,0.0005861301,0.00006600501,0.00009829403,0.000014651559,0.000062101346,0.000073922994,0.000014445515],"category_scores_gemma":[0.00024846345,0.00013475433,0.00018131988,0.00012941936,0.00008020607,0.00005746212,0.000004571494,0.00006227395,0.000008234309],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97217923,0.014444885,0.0023240524,0.00022135007,0.0018795391,0.00064796483,0.00409133,0.00015577262,0.0025754059,0.000033800643,0.0001650568,0.0012816061],"study_design_scores_gemma":[0.96344185,0.020831738,0.0032168177,0.00025828887,0.0065165604,0.0003822183,0.00031909105,0.0014019824,0.002854313,0.000057798152,0.0005202952,0.00019905898],"about_ca_topic_score_codex":0.00025755924,"about_ca_topic_score_gemma":0.000051700794,"teacher_disagreement_score":0.008737398,"about_ca_system_score_codex":0.00022279659,"about_ca_system_score_gemma":0.0004160937,"threshold_uncertainty_score":0.5495122},"labels":[],"label_agreement":null},{"id":"W2582186273","doi":"10.1182/blood.v112.11.3785.3785","title":"Molecular Dissection of Nup98-HoxA9 Oncogenic Activity Using Drosophila","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Insect Resistance and Genetics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Biology; Gene; Transcription factor; Hox gene; Genetics; Phenotype; Chromosomal translocation; Cell biology; Cancer research","score_opus":0.012565771008039435,"score_gpt":0.24419277703009806,"score_spread":0.23162700602205863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582186273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977444,0.0007762258,0.0008087326,0.000009496371,0.00006695573,0.00008922078,0.000008846243,0.0000074684094,0.00048869586],"genre_scores_gemma":[0.99892974,0.0001813018,0.00060271454,0.00003136911,0.00013260733,0.0000038978137,0.000013988574,0.000018333536,0.00008605644],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993559,0.000033161818,0.00012341558,0.00020865625,0.00011775411,0.00016107595],"domain_scores_gemma":[0.9995364,0.0000030935846,0.0000759035,0.00027915757,0.00006374688,0.000041707885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000045624434,0.00010889803,0.00011921694,0.000029128356,0.00007395708,0.0000037591726,0.00009395512,0.0001241134,0.000005128853],"category_scores_gemma":[0.000019040373,0.0001144531,0.00011089985,0.000090152105,0.00007272902,0.000002373707,0.000042599535,0.000056332825,0.0000019155646],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045483022,0.00021931926,0.0045455764,0.000015581567,0.000059499365,0.000013627619,0.00002650461,0.000118071104,0.994827,0.000012060939,0.000018466882,0.00009882978],"study_design_scores_gemma":[0.00054003554,0.00018844877,0.010058689,0.0000072019275,0.000047167832,0.00009520618,0.0000068557288,0.000027675525,0.98852813,0.00003709341,0.00033554755,0.0001279689],"about_ca_topic_score_codex":0.00001804686,"about_ca_topic_score_gemma":0.000011702128,"teacher_disagreement_score":0.00629887,"about_ca_system_score_codex":0.000006567655,"about_ca_system_score_gemma":0.00008113536,"threshold_uncertainty_score":0.46672618},"labels":[],"label_agreement":null},{"id":"W2582195065","doi":"10.1182/blood.v120.21.1490.1490","title":"Comparison of Sensitivity of Low-Dose CT Scan and Serum Galactomannan in Patients with Hematologic Malignancies and Positive Bronchoalveolar Lavage for Invasive Pulmonary Aspergillosis","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Galactomannan; Medicine; Bronchoalveolar lavage; Aspergillosis; Gastroenterology; Hematopoietic stem cell transplantation; Internal medicine; Retrospective cohort study; Acute leukemia; Leukemia; Radiology; Transplantation; Pathology; Lung; Immunology","score_opus":0.012338779808772219,"score_gpt":0.2600840035547155,"score_spread":0.2477452237459433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582195065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983903,0.0007106904,0.000009433225,0.000034320885,0.000010765151,0.00060222915,0.00012505634,0.0000076147803,0.00010954892],"genre_scores_gemma":[0.99960375,0.000026100866,0.0002726059,0.000031729352,0.000008548789,0.00000673846,0.000027575023,0.000010846991,0.000012093938],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908185,0.00007675801,0.0002521809,0.00019916025,0.00016364643,0.00022641098],"domain_scores_gemma":[0.99924695,0.00021681469,0.00014837441,0.00015533871,0.0001395298,0.000093016315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002599733,0.00013852847,0.0005445602,0.00006407682,0.00003660122,0.0000033139995,0.000023055043,0.00005465584,0.000003028338],"category_scores_gemma":[0.00016429991,0.00010580804,0.000043716485,0.00008389246,0.00021080776,0.0001311325,0.000038208946,0.000083731495,2.2166411e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006850472,0.0019661102,0.9765292,0.0007808192,0.00006886889,0.000012780467,0.00068174966,1.6335524e-7,0.019075459,0.00003119793,0.0000068230756,0.00016181511],"study_design_scores_gemma":[0.0021791777,0.0006027144,0.8586686,0.0004446951,0.00014096162,0.000014390525,0.00052835414,0.000010279247,0.13730855,0.00001008222,6.286098e-7,0.000091525835],"about_ca_topic_score_codex":0.00007124083,"about_ca_topic_score_gemma":0.00023717257,"teacher_disagreement_score":0.1182331,"about_ca_system_score_codex":0.000016589334,"about_ca_system_score_gemma":0.00003873026,"threshold_uncertainty_score":0.43147263},"labels":[],"label_agreement":null},{"id":"W2582225016","doi":"10.1182/blood.v126.23.4804.4804","title":"Gene-Expression for Prediction of Disease Progression Following Initial Management of Follicular Lymphoma","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary; Foothills Medical Centre","funders":"","keywords":"Follicular lymphoma; Medicine; Chemoimmunotherapy; Watchful waiting; Oncology; Internal medicine; Progression-free survival; Bioinformatics; Lymphoma; Cancer; Rituximab; Chemotherapy; Biology; Prostate cancer","score_opus":0.027676001665709656,"score_gpt":0.3006476489902151,"score_spread":0.27297164732450546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582225016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99668986,0.0012688548,0.00021811608,0.00005481823,0.00015505377,0.0010043606,0.0000820188,0.000031085005,0.0004958476],"genre_scores_gemma":[0.9918605,0.00004115288,0.007488377,0.000013953692,0.000079781035,0.00028881725,0.00017781212,0.000015378168,0.000034199686],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990533,0.000018725177,0.00026020352,0.00018752713,0.0003502918,0.00012992515],"domain_scores_gemma":[0.9993648,0.000017011107,0.00011339078,0.00024198125,0.00008164563,0.00018120348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011763061,0.00010679088,0.00022572387,0.000057215417,0.000029496523,0.000004231242,0.000045598612,0.000046489626,0.0000029581975],"category_scores_gemma":[0.000023637092,0.00007917454,0.00019799116,0.000077834564,0.000018712555,0.000053387106,0.00004397375,0.000010157827,0.0000013643933],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004191825,0.02735985,0.87081015,0.002281222,0.0025575676,0.0007854335,0.00056188786,0.00002843406,0.026974022,0.0005040353,0.001612003,0.06233354],"study_design_scores_gemma":[0.04194316,0.0016186631,0.20048533,0.0017675189,0.0029641392,0.00000977154,0.00013473503,0.000098931174,0.7499799,0.00020968782,0.000681004,0.000107110085],"about_ca_topic_score_codex":0.000004332851,"about_ca_topic_score_gemma":1.1514245e-7,"teacher_disagreement_score":0.7230059,"about_ca_system_score_codex":0.00004301629,"about_ca_system_score_gemma":0.000078393525,"threshold_uncertainty_score":0.32286438},"labels":[],"label_agreement":null},{"id":"W2582234884","doi":"10.1182/blood.v114.22.2064.2064","title":"Elemental Arsenic Levels in Plasma, Cellular and Tissue Compartments After Oral Arsenic Trioxide Maintenance Treatment: Implications On Long-Term Safety.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Arsenic trioxide; Medicine; Bone marrow; Arsenic; Acute promyelocytic leukemia; Gastroenterology; Internal medicine; Surgery; Chemistry","score_opus":0.012338368569328214,"score_gpt":0.26389530219497004,"score_spread":0.2515569336256418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582234884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969117,0.0013886552,0.00018165464,0.00011176832,0.00003650635,0.00036333632,0.000065745866,0.0000134653665,0.00092716643],"genre_scores_gemma":[0.9977308,0.00040451495,0.0002826997,0.00018424705,0.00007609056,0.0000633289,0.00021756551,0.000018704635,0.0010220599],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987797,0.000047101883,0.00028090779,0.00046338252,0.00009346352,0.00033544117],"domain_scores_gemma":[0.9994568,0.000010705647,0.000077696335,0.00034087177,0.000023020488,0.000090853646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006884271,0.00023736089,0.00021066636,0.000051526775,0.0000677791,0.000029088036,0.0001353317,0.000123784,0.00002791989],"category_scores_gemma":[0.000011198408,0.00021464798,0.00006249212,0.00008583313,0.00006313695,0.000007207184,0.000036629932,0.00008005194,0.000019895091],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033787466,0.0014468963,0.069424376,0.000026845204,0.00012093876,0.000116890056,0.00009778515,0.000013940749,0.91537964,0.00012248197,0.00006981991,0.012842535],"study_design_scores_gemma":[0.004742741,0.0010691979,0.1302271,0.000039166804,0.00007182511,0.000067652625,0.000018314198,0.000006130692,0.8613399,0.00010347866,0.0020395953,0.00027485332],"about_ca_topic_score_codex":0.000005163216,"about_ca_topic_score_gemma":0.000055442266,"teacher_disagreement_score":0.06080273,"about_ca_system_score_codex":0.00004810719,"about_ca_system_score_gemma":0.000058376718,"threshold_uncertainty_score":0.87530905},"labels":[],"label_agreement":null},{"id":"W2582263258","doi":"10.1182/blood.v114.22.1202.1202","title":"Impact of the Intensity of Conditioning Therapy On the Outcomes of Patients Aged 40 to 60 Years with Acute Myeloid Leukemia/Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; St. Joseph's Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Transplantation; Myeloid leukemia; Hematopoietic stem cell transplantation; Alemtuzumab; Population; Leukemia; Myelodysplastic syndromes; Oncology; Graft-versus-host disease; Acute leukemia; Surgery; Bone marrow","score_opus":0.012251677819701906,"score_gpt":0.2599270747477609,"score_spread":0.24767539692805898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582263258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99855876,0.000025097446,0.0000677812,0.00023159957,0.000025977568,0.00084346323,0.00008101554,0.000016091364,0.00015018576],"genre_scores_gemma":[0.99927354,0.00007087522,0.00023011897,0.00028355693,0.00000830536,0.000011761837,0.000027573757,0.000025241468,0.000069003305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983646,0.000106689855,0.00039566358,0.00022379107,0.0006334148,0.00027583347],"domain_scores_gemma":[0.99850094,0.00044580814,0.00024970275,0.0004905827,0.0002184478,0.00009452129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020781042,0.0002047072,0.00051263184,0.000156483,0.0000770396,0.000008651189,0.00028554676,0.00007954804,0.000045054],"category_scores_gemma":[0.00010031185,0.00010671934,0.0002102412,0.00044068415,0.00015449124,0.00004861508,0.000027758046,0.000288541,0.000005555662],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00465845,0.0021608563,0.7988383,0.0002926525,0.002899688,0.00041120502,0.007021697,0.001618393,0.18147434,0.00010825807,0.00026829334,0.0002478318],"study_design_scores_gemma":[0.005026032,0.0028483062,0.9254939,0.0002615629,0.00033989982,0.00010204571,0.00010628472,0.000007715517,0.06566933,0.000045762277,5.0783336e-7,0.00009863932],"about_ca_topic_score_codex":0.0000776544,"about_ca_topic_score_gemma":0.0000125373535,"teacher_disagreement_score":0.12665558,"about_ca_system_score_codex":0.00015842462,"about_ca_system_score_gemma":0.0005147985,"threshold_uncertainty_score":0.43518883},"labels":[],"label_agreement":null},{"id":"W2582281568","doi":"10.1182/blood.v120.21.3659.3659","title":"Outcomes in Adolescents and Young Adults with Hodgkin Lymphoma Treated with and without Radiation Therapy On CCG 5942: A Report From the Children's Oncology Group","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Radiation therapy; Population; Randomization; Young adult; Internal medicine; Pediatrics; Cohort; Chemotherapy; Chemotherapy regimen; Disease; Stage (stratigraphy); Randomized controlled trial; Surgery; Oncology","score_opus":0.008468161456805063,"score_gpt":0.24476378645050642,"score_spread":0.23629562499370135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582281568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970454,0.001592325,0.0000010546663,0.0002945978,0.000029195762,0.00086592516,0.000011478097,0.000032037216,0.00012795956],"genre_scores_gemma":[0.99871993,0.00045039877,0.00013475648,0.00037771487,0.00008908205,0.00011564701,0.00007282865,0.00002437496,0.000015253386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99903756,0.00006925186,0.00018212099,0.000292489,0.0001889023,0.00022969714],"domain_scores_gemma":[0.9994216,0.000054427877,0.00013562152,0.00025307387,0.000020629968,0.00011465674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010838018,0.00021052292,0.0003515688,0.00005391368,0.00006539033,0.000020015248,0.00003314596,0.0000831134,0.0000031650054],"category_scores_gemma":[0.000019332287,0.000101476064,0.000024177642,0.000091649956,0.00006620341,0.00007736583,0.000013705152,0.000058028025,0.0000018244918],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014095019,0.0037612254,0.96575886,0.0000054241636,0.0003698451,0.00013892699,0.0011698446,7.464711e-8,0.0000209117,0.000006624715,0.000009536691,0.027349204],"study_design_scores_gemma":[0.044286776,0.0017728015,0.951689,0.0003019277,0.00029827433,0.00079719507,0.00010420405,0.000002975509,0.00057658076,0.0000019077636,0.000046082863,0.00012224134],"about_ca_topic_score_codex":0.0028896194,"about_ca_topic_score_gemma":0.0006401209,"teacher_disagreement_score":0.04287727,"about_ca_system_score_codex":0.000081665035,"about_ca_system_score_gemma":0.000041723946,"threshold_uncertainty_score":0.43682596},"labels":[],"label_agreement":null},{"id":"W2582289152","doi":"10.1182/blood.v126.23.177.177","title":"Disruption of Direct 3-Dimensional (3D) Telomere-TRF2 (Telomere Related Factor 2) Interaction Is a Hallmark of Primary Hodgkin (H) and Reed-Sternberg (RS) Cells","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; McGill University; Jewish General Hospital","funders":"","keywords":"Telomere; Biology; Germinal center; Molecular biology; Pathology; Immunology; Genetics; B cell; Antibody; Medicine; DNA","score_opus":0.025563982867299124,"score_gpt":0.2589512014879832,"score_spread":0.23338721862068404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582289152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929156,0.0015240017,0.000008615926,0.00027753477,0.00036526573,0.00043793462,0.0001011546,0.00007811587,0.004291808],"genre_scores_gemma":[0.9969952,0.00028293757,0.0011371025,0.00017900334,0.000095072355,0.00001003997,0.00006998852,0.00004657197,0.0011840763],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99762034,0.00012444129,0.00078757305,0.0005020672,0.00065314135,0.00031242633],"domain_scores_gemma":[0.9982513,0.00017718607,0.00045708532,0.00047003131,0.0003355024,0.00030888198],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003059771,0.0003149437,0.00079080975,0.0003145807,0.000047809455,0.000014503589,0.00011964044,0.00024430113,0.00017720429],"category_scores_gemma":[0.00016010935,0.0002730241,0.00015186731,0.00038126326,0.00019240627,0.00024386216,0.000109327426,0.00030380397,0.00003247076],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019289792,0.002941753,0.14158739,0.0011756788,0.0007668529,0.00013835389,0.0050515328,0.00001166273,0.8177726,0.000056886085,0.002402749,0.02616551],"study_design_scores_gemma":[0.012355988,0.0022250833,0.35369277,0.0016012641,0.0009800158,0.0005517066,0.0007004152,0.00032079205,0.6227065,0.00013807975,0.003951109,0.00077628146],"about_ca_topic_score_codex":0.00032735482,"about_ca_topic_score_gemma":0.000024394902,"teacher_disagreement_score":0.21210538,"about_ca_system_score_codex":0.000077355784,"about_ca_system_score_gemma":0.00018864982,"threshold_uncertainty_score":0.9999722},"labels":[],"label_agreement":null},{"id":"W2582300054","doi":"10.1182/blood.v112.11.4142.4142","title":"Non-Random Telomere Lengthening at Specific Chromosome Ends as a Novel Clonal Event in Chronic Myeloid Leukemia","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Sherbrooke","funders":"","keywords":"Telomere; Subtelomere; Biology; Molecular biology; Metaphase; Chromosome; Southern blot; Myeloid leukemia; DNA; Genetics; Gene; Cancer research","score_opus":0.019973425825177808,"score_gpt":0.2477447948598784,"score_spread":0.2277713690347006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582300054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900445,0.0044645607,0.000045738983,0.00021727622,0.00027751608,0.00059581845,0.000021901436,0.00013126052,0.004201434],"genre_scores_gemma":[0.9928158,0.0020569696,0.0006021552,0.00024954622,0.0010887481,0.00007382402,0.00007258148,0.00008371233,0.0029566572],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9968279,0.00003914671,0.0007317291,0.00077289925,0.0007479283,0.0008804169],"domain_scores_gemma":[0.9985806,0.0001408596,0.00017216489,0.00065563014,0.00008511066,0.00036568078],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027046894,0.00045869398,0.0008395929,0.00036307884,0.00025923084,0.000019420511,0.0002817503,0.00025164525,0.00082899776],"category_scores_gemma":[0.00007773851,0.00042577178,0.00027456842,0.0006271183,0.0002409293,0.00015702954,0.00014625782,0.0006257604,0.0005692298],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011994109,0.0017588,0.06286388,0.00033917237,0.0002799434,0.0038066858,0.0036149735,0.00013425475,0.9197589,0.00017138022,0.0012514583,0.00482113],"study_design_scores_gemma":[0.07712444,0.0019410722,0.5343279,0.0014819333,0.0003090083,0.012626911,0.00040474237,0.000773544,0.31451204,0.00005683926,0.05476031,0.0016812218],"about_ca_topic_score_codex":0.00023444014,"about_ca_topic_score_gemma":0.00011414586,"teacher_disagreement_score":0.60524684,"about_ca_system_score_codex":0.0011591195,"about_ca_system_score_gemma":0.0010978145,"threshold_uncertainty_score":0.9998194},"labels":[],"label_agreement":null},{"id":"W2582311578","doi":"10.1182/blood.v110.11.183.183","title":"High Frequency of 1p36.32 Deletion or Loss of Heterozygosity in Follicular Lymphoma (FL).","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia; BC Cancer Agency","funders":"","keywords":"Loss of heterozygosity; Uniparental disomy; Biology; Comparative genomic hybridization; SNP array; Follicular lymphoma; Genetics; Single-nucleotide polymorphism; Chromosomal translocation; Molecular biology; Chromosome; Allele; Lymphoma; Gene; Karyotype; Genotype","score_opus":0.01186004379127759,"score_gpt":0.252662106105563,"score_spread":0.24080206231428541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582311578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99847144,0.00059269305,0.000041275827,0.000094293544,0.000059915285,0.00029664452,0.000015406273,0.000017126866,0.0004112239],"genre_scores_gemma":[0.9979992,0.00011189956,0.0016857039,0.00007219739,0.000047756483,0.000014564697,0.00002493837,0.000012178652,0.00003158072],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892426,0.000023390161,0.00041258402,0.00018890556,0.00024718858,0.00020366783],"domain_scores_gemma":[0.99935687,0.00006729603,0.00013431805,0.00028087117,0.00008056504,0.00008007651],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019496902,0.00012574908,0.00037942172,0.00012350972,0.00001666679,0.0000025510913,0.000060510778,0.000104079954,0.00006180035],"category_scores_gemma":[0.000050657123,0.00009283592,0.00011180402,0.0002291293,0.00004991919,0.000040080955,0.000022527318,0.000028392786,0.000009462268],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021388876,0.006522813,0.9743304,0.00014696976,0.00019718015,0.0009357887,0.00014177561,0.0000014358725,0.012003975,0.00065436505,0.000024202485,0.0048271907],"study_design_scores_gemma":[0.009833181,0.00046034672,0.7043172,0.00016028601,0.00019812625,0.00009423499,0.00002204534,0.0000013664672,0.28470638,0.00009835806,0.000043038137,0.000065443564],"about_ca_topic_score_codex":0.0017130894,"about_ca_topic_score_gemma":0.00036446052,"teacher_disagreement_score":0.2727024,"about_ca_system_score_codex":0.000095705815,"about_ca_system_score_gemma":0.00008078641,"threshold_uncertainty_score":0.3785739},"labels":[],"label_agreement":null},{"id":"W2582318610","doi":"10.1182/blood.v110.11.692.692","title":"CARD11 as an Oncogene in Diffuse Large B Cell Lymphoma.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; Diffuse large B-cell lymphoma; Germinal center; Cancer research; Lymphoma; BCL10; B cell; Genetics; Antibody; Immunology","score_opus":0.009707787612356423,"score_gpt":0.2663298896683076,"score_spread":0.2566221020559512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582318610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9766894,0.0010413979,0.0000034224993,0.000086034,0.00007735279,0.00025032836,0.000011564175,0.000050860264,0.021789646],"genre_scores_gemma":[0.99815017,0.00012397607,0.0003201473,0.00061583007,0.00015897794,0.000021852295,0.00004647545,0.000023247952,0.00053932285],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989305,0.00001969198,0.0002075838,0.0002631956,0.00020829665,0.00037070658],"domain_scores_gemma":[0.9993133,0.00004161309,0.000037982278,0.00034063065,0.000028861019,0.00023760641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019122097,0.00014367909,0.00024079572,0.000103959006,0.000037198286,0.000011558974,0.0000605595,0.00009567246,0.000059179045],"category_scores_gemma":[0.000019262463,0.00011775569,0.00007929424,0.00015213464,0.000015491967,0.000046066216,0.000029081073,0.000036263766,0.00020458718],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018358568,0.121263966,0.85388273,0.000046620895,0.00011804113,0.0054953913,0.00090883864,1.3299301e-7,0.00487398,0.000508448,0.0002497635,0.012468529],"study_design_scores_gemma":[0.09549262,0.00089920656,0.6536328,0.000053721367,0.00030955984,0.00020529339,0.00029368122,0.0000050264625,0.23499078,0.00006235185,0.013854894,0.00020005075],"about_ca_topic_score_codex":0.00045726344,"about_ca_topic_score_gemma":0.0004027351,"teacher_disagreement_score":0.2301168,"about_ca_system_score_codex":0.00011660456,"about_ca_system_score_gemma":0.00010236242,"threshold_uncertainty_score":0.48019376},"labels":[],"label_agreement":null},{"id":"W2582318813","doi":"10.1182/blood.v114.22.50.50","title":"Tandem Autologous-Allogeneic Nonmyeloablative Sibling Transplant in Relapsed Follicular Lymphoma Leads to Impressive Progression Free Survival with Minimal Toxicity.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Fludarabine; Internal medicine; Regimen; Cyclophosphamide; Follicular lymphoma; Transplantation; Surgery; Gastroenterology; Chemotherapy; Progression-free survival; Oncology; Urology; Lymphoma","score_opus":0.012121351958159355,"score_gpt":0.2619618747990991,"score_spread":0.24984052284093974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582318813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950144,0.0008502796,0.00004825562,0.0013472395,0.0000562284,0.0011204433,0.000028419827,0.00010282143,0.0014319095],"genre_scores_gemma":[0.9958821,0.000055753575,0.0032791363,0.0004051385,0.00010005722,0.00014212684,0.000040691782,0.000029453995,0.000065535554],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99787396,0.000084894455,0.00038368217,0.00059198844,0.0005166421,0.0005488014],"domain_scores_gemma":[0.9989679,0.000110641406,0.00011817016,0.00044059448,0.00008255291,0.00028013735],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018075798,0.00035505125,0.00064083375,0.00024131924,0.000103092476,0.000029089942,0.00016934448,0.00019842238,0.000022256298],"category_scores_gemma":[0.000064019936,0.00024579573,0.000130882,0.00048783264,0.00004769981,0.00006723841,0.000033173495,0.000103555336,0.000014523627],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015758858,0.007448882,0.9172666,0.00004487463,0.00037481723,0.0073925676,0.0019528787,0.000083798965,0.047721967,0.00017801575,0.00007939764,0.015880328],"study_design_scores_gemma":[0.025152108,0.004445948,0.78174263,0.00079431216,0.00048655196,0.0003138632,0.00012467557,0.000059165082,0.18645489,0.00004452216,0.00006764434,0.0003136633],"about_ca_topic_score_codex":0.00004613295,"about_ca_topic_score_gemma":0.00014613984,"teacher_disagreement_score":0.13873293,"about_ca_system_score_codex":0.0001622898,"about_ca_system_score_gemma":0.00021679854,"threshold_uncertainty_score":0.9999994},"labels":[],"label_agreement":null},{"id":"W2582331875","doi":"10.1182/blood.v116.21.2886.2886","title":"Evaluation of CPX-351 (cytarabine:daunorubicin) Liposome Injection Anti-Leukemic Activity Against Primary Patient Leukemia Cells","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celator Pharmaceuticals (Canada)","funders":"","keywords":"Leukemia; Cytarabine; Medicine; Daunorubicin; Myeloid leukemia; Acute lymphocytic leukemia; Chronic lymphocytic leukemia; Bone marrow; Immunology; Myeloid; Pharmacology; Internal medicine","score_opus":0.017768961389472825,"score_gpt":0.27705234054049777,"score_spread":0.25928337915102495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582331875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99094653,0.00021132972,0.000020000818,0.000055472905,0.0006397916,0.0014281025,0.000021628157,0.00010596148,0.006571201],"genre_scores_gemma":[0.9986123,0.00010801241,0.00037691812,0.00011662852,0.0003833633,0.00008020903,0.000063096646,0.0000631025,0.00019639773],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99568945,0.000255545,0.00056142255,0.0006009075,0.0023393617,0.000553339],"domain_scores_gemma":[0.99726623,0.00018121087,0.00031517027,0.0010097097,0.0009704529,0.00025723004],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017453453,0.00031042987,0.0005801551,0.0003413941,0.00010890626,0.000026622703,0.00021481953,0.00035962745,0.00017078155],"category_scores_gemma":[0.0005541909,0.00028381476,0.00020352694,0.0005512782,0.0002147118,0.00024368092,0.00016475856,0.00081190263,0.00010703411],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00020661643,0.0012331802,0.0008026634,0.0002926056,0.00021722601,0.000032036492,0.00036696796,0.00042167568,0.9454068,0.000008417115,0.000318426,0.050693378],"study_design_scores_gemma":[0.034510292,0.0007857673,0.023611182,0.00018966045,0.0009383349,0.00026301,0.0000621448,0.020027349,0.9189366,0.000058668928,0.00030402053,0.00031297145],"about_ca_topic_score_codex":0.00087513844,"about_ca_topic_score_gemma":0.00008833836,"teacher_disagreement_score":0.050380405,"about_ca_system_score_codex":0.00982643,"about_ca_system_score_gemma":0.017091595,"threshold_uncertainty_score":0.9999614},"labels":[],"label_agreement":null},{"id":"W2582339932","doi":"10.1182/blood.v124.21.3520.3520","title":"Addressing the Quality Gap: An Order Set and Checklist to Improve Red Blood Cell Transfusion Ordering Practices on the Internal Medicine Ward","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Checklist; Audit; Emergency medicine; Transfusion medicine; Blood transfusion; Surgery","score_opus":0.08920587226197062,"score_gpt":0.3598615281821823,"score_spread":0.2706556559202117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582339932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92617625,0.00017601454,0.0009916946,0.05133249,0.00026712622,0.0010554676,0.000005378459,0.000090160305,0.019905444],"genre_scores_gemma":[0.9907979,0.00030604211,0.0007320808,0.006774534,0.00043463864,0.00005694715,0.000009832332,0.000035221885,0.00085283304],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980125,0.00031794084,0.00039164574,0.0004769609,0.00050963473,0.00029135242],"domain_scores_gemma":[0.99852496,0.0002838891,0.00021064321,0.00065730297,0.000112041576,0.00021117741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018749983,0.0002430087,0.0003324697,0.0000808521,0.0003098648,0.00007561767,0.00024091675,0.00008126433,0.00015717506],"category_scores_gemma":[0.0005772627,0.00012513001,0.00005524187,0.00023226604,0.000120497774,0.00009857362,0.00007816845,0.00043172174,0.000007750084],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026585595,0.005833648,0.010422495,0.0014462139,0.001036518,0.00010438311,0.024976328,0.000016388654,0.86426014,0.0035774054,0.0069934824,0.07867443],"study_design_scores_gemma":[0.07405251,0.017791394,0.13102485,0.0032892593,0.010448598,0.00041836762,0.02882605,0.0019520408,0.3922316,0.0010680814,0.33683884,0.00205837],"about_ca_topic_score_codex":0.0009191332,"about_ca_topic_score_gemma":0.0004262275,"teacher_disagreement_score":0.47202852,"about_ca_system_score_codex":0.000008526955,"about_ca_system_score_gemma":0.000028424442,"threshold_uncertainty_score":0.5102654},"labels":[],"label_agreement":null},{"id":"W2582390665","doi":"10.1182/blood.v110.11.369.369","title":"Treatment Decisions for Young Women with Supra-Diaphragmatic, Limited-Stage Hodgkin Lymphoma: Exploration of Options Using a Markov Decision Analysis.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto; St. Michael's Hospital","funders":"","keywords":"ABVD; Medicine; Oncology; Radiation therapy; Breast cancer; Internal medicine; Stage (stratigraphy); Relative risk; Surgery; Cancer; Chemotherapy; Cyclophosphamide","score_opus":0.03893762170799528,"score_gpt":0.30937328451227425,"score_spread":0.270435662804279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582390665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.961495,0.00036653582,0.03650821,0.00006392611,0.000044501805,0.0011114986,0.000107079286,0.000043551776,0.00025971077],"genre_scores_gemma":[0.9180169,0.00025701185,0.08102907,0.00002601122,0.00005559706,0.0002956005,0.00014875468,0.00003009612,0.00014096688],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820507,0.000032572316,0.0005815951,0.0003838169,0.00040026632,0.00039670288],"domain_scores_gemma":[0.99807763,0.00064984587,0.00024511377,0.00054391904,0.00023827472,0.00024522797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033601312,0.00026357995,0.0006511363,0.000630562,0.00016722469,0.000034997636,0.00006944646,0.00010303777,0.000041266227],"category_scores_gemma":[0.00014265372,0.00018219752,0.00026102495,0.001001753,0.00004267377,0.0002041933,0.000024475745,0.000023622415,0.0000049689197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011235109,0.06504117,0.6303973,0.00021379831,0.026007364,0.0011436751,0.010746729,0.0033710515,0.01823113,0.0023709892,0.00017274778,0.23106892],"study_design_scores_gemma":[0.08371309,0.010771188,0.7963876,0.0005832576,0.027626218,0.0003473062,0.0075766975,0.00504721,0.065236956,0.00043218565,0.0014508098,0.0008274498],"about_ca_topic_score_codex":0.000161479,"about_ca_topic_score_gemma":0.00042965118,"teacher_disagreement_score":0.23024146,"about_ca_system_score_codex":0.0005376755,"about_ca_system_score_gemma":0.00019820318,"threshold_uncertainty_score":0.7429799},"labels":[],"label_agreement":null},{"id":"W2582429085","doi":"10.1182/blood.v104.11.1945.1945","title":"Detailed Biosynthethic Analysis of the Y1584C and R924Q Von Willebrand Factor Variants.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Von Willebrand factor; Von Willebrand disease; ER retention; Chemistry; Endoplasmic reticulum; Recombinant DNA; Golgi apparatus; Intracellular; Population; Platelet; Molecular biology; Gene; Cell biology; Biology; Biochemistry; Immunology; Mutant; Medicine","score_opus":0.010296815433500342,"score_gpt":0.2353180598066838,"score_spread":0.22502124437318347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582429085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99807304,0.00056769594,0.00002263142,0.00047336053,0.000024729457,0.00016590589,0.00003989825,0.000013082964,0.0006196323],"genre_scores_gemma":[0.99955654,0.00012405831,0.00011153385,0.00010989854,0.000007989042,0.0000033160582,0.000008725013,0.000007788244,0.000070171816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99942946,0.000018739634,0.00013872632,0.00015231578,0.0001428771,0.0001178623],"domain_scores_gemma":[0.99959546,0.00003197799,0.00006146683,0.00023024873,0.000026986672,0.000053838536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000046561054,0.00009561751,0.00032027756,0.000098897835,0.00005245644,0.000007157107,0.00004799409,0.0000711018,0.00006976194],"category_scores_gemma":[0.000052173553,0.000055265016,0.00012893007,0.0003842411,0.00007839556,0.000028145167,0.000022967277,0.00007340379,0.000004133882],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009310466,0.0018370507,0.9649182,0.000053566862,0.008129823,0.00013336135,0.0008493301,0.000014047061,0.022373095,0.00031847451,0.0000070862293,0.0012728575],"study_design_scores_gemma":[0.0071053323,0.00013715067,0.9595221,0.000059612386,0.007030103,0.000040473504,0.000051187417,0.00002737485,0.025423372,0.00046524437,0.00005020025,0.00008782923],"about_ca_topic_score_codex":0.000079031684,"about_ca_topic_score_gemma":0.00015831429,"teacher_disagreement_score":0.0070122276,"about_ca_system_score_codex":0.000008563896,"about_ca_system_score_gemma":0.000041450843,"threshold_uncertainty_score":0.2253642},"labels":[],"label_agreement":null},{"id":"W2582434768","doi":"10.1182/blood.v116.21.2981.2981","title":"Second Clones In Molecularly-Defined Biclonal Multiple Myeloma Are Derived From Unrelated B Cells, Can Be Present at High Frequency and Exhibit Chromosomal Abnormalities","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"clone (Java method); Isotype; Biology; Molecular biology; Immunoglobulin class switching; Monoclonal; Somatic hypermutation; Complementarity determining region; Immunoglobulin light chain; Genetics; Virology; Antibody; Monoclonal antibody; Gene; B cell","score_opus":0.013334391013900713,"score_gpt":0.23086424719896112,"score_spread":0.2175298561850604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582434768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996182,0.00087927544,0.0000018922849,0.0007198264,0.00013644264,0.00075590314,0.0009186283,0.00008313896,0.00032288855],"genre_scores_gemma":[0.9961755,0.000078808145,0.0020126274,0.00011380022,0.00016017849,0.00012132348,0.00074898184,0.00005282797,0.0005359311],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99780214,0.00010475108,0.00039490484,0.0005830028,0.00047903392,0.0006361796],"domain_scores_gemma":[0.9985802,0.00024598045,0.00011824321,0.00047103575,0.00011101104,0.00047350518],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009626263,0.00034834933,0.00049059436,0.0001860743,0.00015473072,0.00005303871,0.0001394616,0.0002706712,0.0012149642],"category_scores_gemma":[0.00015900937,0.00030417598,0.00009520628,0.00017502185,0.00020598437,0.00011758028,0.00018469425,0.0005044748,0.00003145152],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023056722,0.00064806745,0.49625853,0.00006627062,0.00027086562,0.0020133364,0.00035480584,5.688959e-7,0.4999625,0.000020550797,0.000037793827,0.00013613395],"study_design_scores_gemma":[0.011172051,0.0001707349,0.5864454,0.00006175655,0.00008727691,0.000099308665,0.00008153778,0.000072280585,0.4014502,0.00007692264,0.00009856158,0.00018398433],"about_ca_topic_score_codex":0.008468646,"about_ca_topic_score_gemma":0.02069864,"teacher_disagreement_score":0.09851231,"about_ca_system_score_codex":0.00006928895,"about_ca_system_score_gemma":0.00015337422,"threshold_uncertainty_score":0.99994105},"labels":[],"label_agreement":null},{"id":"W2582469586","doi":"10.1182/blood.v112.11.4957.4957","title":"Sezary Syndrome and Combination Immunomodulatory Therapy: Improving Clinical Outcomes","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Health Sciences Centre; Sunnybrook Hospital; University of Toronto; University Health Network; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Mycosis fungoides; Erythroderma; Chlorambucil; Internal medicine; Cutaneous T-cell lymphoma; Peripheral T-cell lymphoma; Dermatology; Lymphoma; Chemotherapy; Surgery; Cyclophosphamide; Immunology; T cell","score_opus":0.04596285576582766,"score_gpt":0.3319117581799852,"score_spread":0.28594890241415755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582469586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966459,0.0017027096,0.000013570821,0.00035645047,0.0000636674,0.00047871462,0.0000029539353,0.00006994925,0.0006660442],"genre_scores_gemma":[0.9977283,0.0007155652,0.00019954695,0.0003975062,0.00002919668,0.000019929814,0.000013151275,0.000026895508,0.0008699149],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988282,0.00008569842,0.00028780487,0.00027265926,0.00030766957,0.00021799836],"domain_scores_gemma":[0.99928004,0.00015899492,0.00005343309,0.00027303075,0.0001146198,0.00011986659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028807786,0.00013003475,0.00033501687,0.000099237775,0.0001507779,0.000013348119,0.00006730975,0.00010430568,0.00006031698],"category_scores_gemma":[0.00023811132,0.00010682972,0.00010405588,0.00009880198,0.0002072141,0.00007258962,0.000057808313,0.00022417637,0.000031223484],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000903839,0.0012591569,0.98955065,0.000025930094,0.00020680449,0.00065745023,0.00019321062,6.916647e-8,0.0022833245,0.00003102257,0.00005493391,0.005647071],"study_design_scores_gemma":[0.0075907395,0.0009851059,0.9840091,0.000014394693,0.000034522523,0.0063915728,0.000058952064,0.00008977791,0.00051349157,0.00006766398,0.00012972318,0.00011494569],"about_ca_topic_score_codex":0.000060495073,"about_ca_topic_score_gemma":0.0000029469588,"teacher_disagreement_score":0.0075003556,"about_ca_system_score_codex":0.000023810797,"about_ca_system_score_gemma":0.00017856128,"threshold_uncertainty_score":0.43563893},"labels":[],"label_agreement":null},{"id":"W2582502952","doi":"10.1182/blood.v104.11.2479.2479","title":"Targeting FGFR3 in t(4;14) Mutiple Myeloma: Pre-Clinical Studies of PRO-001, a Novel Anti-FGFR3 Neutralizing Antibody.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Chromosomal translocation; Cancer research; Biology; Antibody; Multiple myeloma; Molecular biology; Fibroblast growth factor receptor 3; Cyclin D1; Phage display; Receptor tyrosine kinase; Receptor; Cancer; Fibroblast growth factor; Gene; Genetics; Immunology; Cell cycle","score_opus":0.0834791114309878,"score_gpt":0.41368897569308216,"score_spread":0.33020986426209437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582502952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950046,0.0027963417,0.000039765564,0.00035740758,0.00012804978,0.0011109946,0.000031265303,0.00007061447,0.00046095],"genre_scores_gemma":[0.9924396,0.00080085866,0.0061434037,0.00006443519,0.00020026905,0.000055669727,0.00009263073,0.000040803923,0.00016228993],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99728644,0.00009183522,0.0008947867,0.00053180585,0.0005124017,0.00068275805],"domain_scores_gemma":[0.998683,0.00025107551,0.00020347955,0.00038999322,0.00023304755,0.00023941738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074967084,0.0002773529,0.00088533596,0.00023024311,0.00009674588,0.000016772192,0.00016427819,0.0001550233,0.000028285014],"category_scores_gemma":[0.001336642,0.00022297139,0.00017812362,0.0004192091,0.00024270818,0.00013578328,0.00016818591,0.00040608237,0.000031264823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050577987,0.011106909,0.8970138,0.00073325797,0.0010618416,0.0008102182,0.0010602291,0.000053998734,0.086138,0.00014892813,0.000083972875,0.0012830838],"study_design_scores_gemma":[0.045951627,0.0015890198,0.9179327,0.0010239662,0.0003163376,0.00010889693,0.00056137616,0.00011134418,0.03164957,0.00010972692,0.00034703303,0.00029840757],"about_ca_topic_score_codex":0.00043085386,"about_ca_topic_score_gemma":0.000099273406,"teacher_disagreement_score":0.05448843,"about_ca_system_score_codex":0.000067827226,"about_ca_system_score_gemma":0.00024748011,"threshold_uncertainty_score":0.9092509},"labels":[],"label_agreement":null},{"id":"W2582546462","doi":"10.1182/blood.v120.21.595.595","title":"Monoclonal and Oligoclonal Bands After Single Autologous Stem Cell Transplantation in Patients with Multiple Myeloma: Impact On Overall Survival and Progression-Free Survival","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Autologous stem-cell transplantation; Multiple myeloma; Monoclonal gammopathy of undetermined significance; Medicine; clone (Java method); Monoclonal; Hazard ratio; Immunoglobulin light chain; Transplantation; Monoclonal antibody; Oncology; Isotype; Plasma cell; Progression-free survival; Malignancy; Internal medicine; Immunology; Antibody; Chemotherapy; Biology; Confidence interval","score_opus":0.013320627009963485,"score_gpt":0.25964524467942063,"score_spread":0.24632461766945715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582546462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982747,0.00035935853,0.000005359278,0.000038885602,0.000052300617,0.0006461354,0.00018107737,0.00003010103,0.00041211312],"genre_scores_gemma":[0.9990404,0.00003118044,0.0005536636,0.000014691586,0.00006260341,0.00006052088,0.00016595017,0.000029909987,0.0000410674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836254,0.00010034703,0.00019446817,0.0002962033,0.0005327235,0.00051372935],"domain_scores_gemma":[0.9991356,0.00018058403,0.00005623635,0.00020171233,0.000050705366,0.00037514977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015909367,0.00025308577,0.00032056024,0.00013744095,0.000060598613,0.000028690882,0.000050892322,0.000104124454,0.000024859537],"category_scores_gemma":[0.000017672046,0.00016398825,0.000042886888,0.00009022035,0.0000733294,0.00017472467,0.000036543785,0.00018024692,0.000004806318],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077432743,0.003609766,0.98315156,0.00012832296,0.000116156174,0.00016456237,0.00034482652,0.0000013016893,0.00029392398,0.000005309169,0.000005397685,0.0044355947],"study_design_scores_gemma":[0.02944866,0.0023621204,0.9655126,0.00013254008,0.000105328225,0.000035671917,0.00002421099,0.000045110588,0.0021560122,0.0000044887424,0.00000811393,0.0001651813],"about_ca_topic_score_codex":0.000082456674,"about_ca_topic_score_gemma":0.00007389078,"teacher_disagreement_score":0.021705385,"about_ca_system_score_codex":0.000055614575,"about_ca_system_score_gemma":0.000049258535,"threshold_uncertainty_score":0.6687247},"labels":[],"label_agreement":null},{"id":"W2582553426","doi":"10.1182/blood.v106.11.1793.1793","title":"DDAVP at a Maximal Dose of 15 ug Administered Subcutaneously Is a Safe and Effective Alternative to 20 ug IV for Patients &gt; 50 kg with von Willebrand Disease or Mild Hemophilia A.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Desmopressin; Dosing; Regimen; Von Willebrand factor; Von Willebrand disease; Surgery; Gastroenterology; Internal medicine; Platelet","score_opus":0.008856085228356646,"score_gpt":0.24792703269754832,"score_spread":0.23907094746919166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582553426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948738,0.00031810836,0.000010717126,0.00060605595,0.00002999416,0.0028123436,0.0010335301,0.000019517014,0.00029593657],"genre_scores_gemma":[0.99616253,0.000042842472,0.0012240096,0.0005546377,0.000053326596,0.00022335749,0.00014131996,0.000040858733,0.0015571351],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871033,0.000024704306,0.000238786,0.0004486214,0.00027166537,0.0003058779],"domain_scores_gemma":[0.9990271,0.000113251794,0.000121173616,0.00023528798,0.00012154051,0.00038168867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003726816,0.0002811551,0.0005055603,0.00009430096,0.000083438164,0.000012965128,0.000065647575,0.00005965369,0.00006779366],"category_scores_gemma":[0.00006642142,0.00019253655,0.00009013105,0.00010841209,0.00006903951,0.00006870927,0.000055646553,0.000058448415,0.000018086015],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24987298,0.023037503,0.67159736,0.0014660301,0.004681144,0.0038017605,0.007415961,0.000010782335,0.0024492678,0.0000249129,0.0040687816,0.03157349],"study_design_scores_gemma":[0.33339775,0.10006224,0.49017254,0.002841893,0.009226608,0.0013470051,0.00035060933,0.0005951792,0.036565784,0.0004377687,0.022791043,0.0022115796],"about_ca_topic_score_codex":0.000024894058,"about_ca_topic_score_gemma":0.00015703517,"teacher_disagreement_score":0.18142486,"about_ca_system_score_codex":0.000060629274,"about_ca_system_score_gemma":0.00006297651,"threshold_uncertainty_score":0.7851413},"labels":[],"label_agreement":null},{"id":"W2582570920","doi":"10.1182/blood.v120.21.931.931","title":"High Cereblon Protein Expression Correlates with Improved Response and Survival in Myeloma Patients Treated with Lenalidomide","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Cereblon; Lenalidomide; Tissue microarray; Medicine; Multiple myeloma; Bone marrow; Dexamethasone; Oncology; Internal medicine; Cancer research; Immunohistochemistry; Biology; Ubiquitin ligase; Ubiquitin","score_opus":0.010698988344171174,"score_gpt":0.24075602917138492,"score_spread":0.23005704082721373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582570920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99818814,0.00017349535,0.000004064627,0.00006700832,0.000013535686,0.0013710731,0.000017966953,0.000046277783,0.000118466756],"genre_scores_gemma":[0.9981594,0.0000100506295,0.0010693097,0.000011376397,0.000033920813,0.00018331812,0.000057761496,0.000037866404,0.00043699445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852276,0.00020433673,0.00018283984,0.00027752438,0.00032580202,0.00048675353],"domain_scores_gemma":[0.9991383,0.00011793442,0.000075231364,0.00025202121,0.0000863677,0.00033016875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022618087,0.0002206176,0.00031571055,0.00014861283,0.00006776673,0.000019459889,0.00004591573,0.000091313574,0.000031718122],"category_scores_gemma":[0.00014098166,0.00012866645,0.000021640835,0.00019250324,0.000077072735,0.00016773658,0.000041773477,0.0001858098,0.000010504038],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030295186,0.002012147,0.9040632,0.000047610247,0.00011583256,0.000121868696,0.00018365982,1.859113e-7,0.06200305,0.0000027918293,0.000004172093,0.0011502717],"study_design_scores_gemma":[0.033858884,0.0024824578,0.7893746,0.0003983976,0.00007966413,0.000032523298,0.0000556367,0.000012102813,0.1735591,0.0000016985739,0.000014690053,0.00013025128],"about_ca_topic_score_codex":0.0003597106,"about_ca_topic_score_gemma":0.00006866496,"teacher_disagreement_score":0.114688635,"about_ca_system_score_codex":0.000049983253,"about_ca_system_score_gemma":0.00006460162,"threshold_uncertainty_score":0.5246865},"labels":[],"label_agreement":null},{"id":"W2582582530","doi":"10.1182/blood.v112.11.2829.2829","title":"Neuroinflammatory and Neurodegenerative Markers in Non-Hodgkin’s Lymphoma and Hematologic Malignancies with Central Nervous System Involvement","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Western University","funders":"","keywords":"Medicine; Pathology; Lymphoma; Leukemia; Chemotherapy; Internal medicine; Gastroenterology; Oncology","score_opus":0.010833764366105223,"score_gpt":0.1951033476112465,"score_spread":0.18426958324514128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582582530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978204,0.0011640764,0.00001758261,0.00015962053,0.00003676011,0.0005648245,0.000007001397,0.000038979997,0.00019078176],"genre_scores_gemma":[0.9984019,0.00021088627,0.0010344142,0.00019022696,0.000027612057,0.000055163317,0.000009070618,0.00001941185,0.00005133343],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989411,0.00006885701,0.00020576712,0.00033110954,0.00016440035,0.00028874862],"domain_scores_gemma":[0.9995347,0.00003692987,0.000066424065,0.00018137724,0.000025697114,0.0001548744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007938591,0.000200547,0.00034899174,0.00007395947,0.000090587855,0.000014053121,0.000030831077,0.000042432985,0.000003307074],"category_scores_gemma":[0.000009274523,0.00013987784,0.000030040539,0.0000951538,0.00012681005,0.00004980968,0.000039651444,0.000056618926,0.0000015710012],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046897086,0.00093395845,0.97261983,0.00071826903,0.00027494426,0.019174399,0.0013345669,0.000021971384,0.0025285499,0.0005358267,0.00015896467,0.0012297182],"study_design_scores_gemma":[0.008280405,0.001031824,0.9783935,0.00020918755,0.00020035639,0.006036443,0.00075639156,0.0002007338,0.004668088,0.0000032757187,0.000065482025,0.0001543215],"about_ca_topic_score_codex":0.00010497479,"about_ca_topic_score_gemma":0.000075394346,"teacher_disagreement_score":0.013137955,"about_ca_system_score_codex":0.00003850912,"about_ca_system_score_gemma":0.00007149352,"threshold_uncertainty_score":0.57040524},"labels":[],"label_agreement":null},{"id":"W2582592336","doi":"10.1182/blood.v124.21.5927.5927","title":"Evidence of Effect Modification of Graft-Versus-Leukemia Effect of Cytomegalovirus By Alemtuzumab in Myeloid Malignancies Undergoing Unrelated Donor Transplantation","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Alemtuzumab; Medicine; Serostatus; Hazard ratio; Transplantation; Internal medicine; Cytomegalovirus; Oncology; Myeloid; Myeloid leukemia; Immunology; Gastroenterology; Viral disease; Viral load; Herpesviridae; Confidence interval; Virus","score_opus":0.022627565527083712,"score_gpt":0.30078228721888695,"score_spread":0.2781547216918032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582592336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99654955,0.0017215993,0.00026423857,0.0000383789,0.000047471807,0.00080615457,0.000029822811,0.000026707929,0.00051610323],"genre_scores_gemma":[0.9981684,0.0015170675,0.00011095683,0.000006569926,0.000023417735,0.000047743204,0.000047742968,0.000028278158,0.000049841194],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977219,0.00039174844,0.0006942785,0.0003281933,0.0005653791,0.0002984657],"domain_scores_gemma":[0.996733,0.002336717,0.00030178833,0.00039514067,0.00013912572,0.00009422331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014570549,0.00021819802,0.00074316317,0.0003897885,0.000034516142,0.000008746225,0.00017839728,0.00020074491,0.00003489245],"category_scores_gemma":[0.00069679844,0.00018456,0.00016666927,0.0006442537,0.00016534702,0.0001772277,0.000025715017,0.0002524059,0.000011431224],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008067518,0.00023129037,0.05646138,0.0051196828,0.00018001636,0.000009692356,0.00044363094,0.00017439846,0.92429245,0.000111429,0.00003125426,0.004877247],"study_design_scores_gemma":[0.015064672,0.004909891,0.037642162,0.0023837304,0.00046297512,0.000012910796,0.000020775562,0.00089380506,0.9384212,0.000014010423,0.000026382353,0.00014747938],"about_ca_topic_score_codex":0.0011002327,"about_ca_topic_score_gemma":0.00021757936,"teacher_disagreement_score":0.01881922,"about_ca_system_score_codex":0.00014258215,"about_ca_system_score_gemma":0.00021665127,"threshold_uncertainty_score":0.75261384},"labels":[],"label_agreement":null},{"id":"W2582617652","doi":"10.1182/blood.v104.11.852.852","title":"Proteomics Used To Identify the Target of a Platelet Aggregating Antibody in a Patient with HUS.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Platelet; Antibody; Western blot; Antigen; Chemistry; Immunology; Molecular biology; Thrombotic thrombocytopenic purpura; Epitope; Fibrinogen; Isoelectric point; Medicine; Biology; Biochemistry; Enzyme","score_opus":0.01359176994665391,"score_gpt":0.27374760013282046,"score_spread":0.26015583018616656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582617652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99787223,0.00070744485,0.00007903592,0.00015028875,0.00007904038,0.001002022,0.00003789146,0.000022245105,0.0000497945],"genre_scores_gemma":[0.9989777,0.0000022410711,0.0008027031,0.0000531903,0.000008129823,0.000100395344,0.000033280656,0.000010751755,0.000011575502],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99916744,0.0000975337,0.00030220096,0.00017650228,0.000044975193,0.00021132309],"domain_scores_gemma":[0.99945384,0.00006300138,0.0001589416,0.00026348687,0.00004765928,0.000013070291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014849694,0.00010649867,0.0002084319,0.00007619323,0.000057401012,0.000007861629,0.00018283266,0.000044811597,0.000052022602],"category_scores_gemma":[0.00009471444,0.00007020645,0.000036994352,0.00018288073,0.00006339803,0.000036993963,0.000082987346,0.000094801806,0.000049655773],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016764828,0.00081878813,0.056014568,0.00010224313,0.00031601053,0.00006731656,0.006126392,0.0005034158,0.9354112,0.00025289,0.00007010915,0.00014939973],"study_design_scores_gemma":[0.0053477213,0.0005908765,0.021167535,0.0007225807,0.000050684383,0.00014299178,0.0018918323,7.0596883e-7,0.96924806,0.00033064254,0.00033214287,0.00017425865],"about_ca_topic_score_codex":0.00016086224,"about_ca_topic_score_gemma":0.00013288988,"teacher_disagreement_score":0.03484703,"about_ca_system_score_codex":0.000022993729,"about_ca_system_score_gemma":0.00006972421,"threshold_uncertainty_score":0.2862936},"labels":[],"label_agreement":null},{"id":"W2582639740","doi":"10.1182/blood.v118.21.1016.1016","title":"Global Use and Trends in Hematopoietic Stem Cell Transplantation Analyzed by the Worldwide Network of Blood and Marrow Transplantation WBMT: A Targeted Approach for a Widening Gap","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Transplantation; Medicine; Hematopoietic stem cell transplantation; Internal medicine","score_opus":0.02537993826812037,"score_gpt":0.2494778940483865,"score_spread":0.22409795578026612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582639740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99041784,0.0010124432,0.0072306944,0.000044025306,0.000012712023,0.00061994506,0.00012281662,0.000024012917,0.00051551516],"genre_scores_gemma":[0.9919954,0.00025996857,0.007313517,0.000036283243,0.000027570048,0.000086007916,0.00016926281,0.00002223953,0.0000897607],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985772,0.000114243674,0.0003873916,0.00032439778,0.00025984878,0.000336914],"domain_scores_gemma":[0.99930125,0.00023802629,0.00011805356,0.0001547158,0.00007402079,0.00011393735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036802748,0.00018130141,0.00034915464,0.00010470034,0.00006490467,0.000024608953,0.000089044384,0.00011450688,0.000008721731],"category_scores_gemma":[0.000015736357,0.00013731293,0.00005815826,0.00064527564,0.00009706591,0.0001274652,0.000012382022,0.00011592714,1.8046065e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017785378,0.004667574,0.82089776,0.009287136,0.00205056,0.0006885967,0.040037446,0.0004027876,0.09320521,0.00094990176,0.0010793402,0.008948314],"study_design_scores_gemma":[0.1591949,0.003265622,0.6464033,0.0016117293,0.017337035,0.006219026,0.0033618158,0.035783608,0.12465082,0.0007440324,0.000024849589,0.001403276],"about_ca_topic_score_codex":0.0002927327,"about_ca_topic_score_gemma":0.00013742455,"teacher_disagreement_score":0.17449448,"about_ca_system_score_codex":0.000033395343,"about_ca_system_score_gemma":0.0000677819,"threshold_uncertainty_score":0.5599459},"labels":[],"label_agreement":null},{"id":"W2582640753","doi":"10.1182/blood.v126.23.3313.3313","title":"The Healthcare Resource Utilization, Costs, and Predictors of Progression Among Relapsed and Refractory CLL Patients","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Chronic lymphocytic leukemia; Internal medicine; Refractory (planetary science); Health care; Pediatrics; Leukemia","score_opus":0.028163136077747997,"score_gpt":0.3098915925780989,"score_spread":0.2817284565003509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582640753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937937,0.0046365964,0.0000012119336,0.00023695083,0.000048087702,0.0005977379,0.0000066826665,0.000027582139,0.0006513984],"genre_scores_gemma":[0.99912834,0.0004304829,0.00004396266,0.000035295816,0.00006129446,0.000017722416,0.00003413151,0.00001841591,0.00023036505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987204,0.00011988207,0.0002434608,0.00019702941,0.000517817,0.00020143064],"domain_scores_gemma":[0.99888575,0.00014663581,0.00011211573,0.00029239216,0.00028066777,0.00028241274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004352461,0.00008934808,0.00015965305,0.00004912003,0.00009621409,0.00001502698,0.00006685951,0.00010359797,0.0000014329148],"category_scores_gemma":[0.00083336217,0.000056513632,0.000016126301,0.0001387021,0.00030190102,0.000054402757,0.000108375476,0.00014955287,9.302517e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052676076,0.0004626445,0.97565126,0.00027417555,0.00006417103,0.000014797467,0.0015852452,1.9365001e-7,0.00004123109,0.00006024035,0.003805429,0.017513834],"study_design_scores_gemma":[0.08253577,0.00320115,0.8743582,0.001274923,0.00021976697,0.00007092766,0.00188151,0.00075229973,0.0031878916,0.00008382475,0.03221701,0.00021671958],"about_ca_topic_score_codex":0.00017005326,"about_ca_topic_score_gemma":0.000040838873,"teacher_disagreement_score":0.10129307,"about_ca_system_score_codex":0.0006730391,"about_ca_system_score_gemma":0.0011539998,"threshold_uncertainty_score":0.2304559},"labels":[],"label_agreement":null},{"id":"W2582642816","doi":"10.1182/blood.v116.21.968.968","title":"MicroSPECT/CT Imaging of Human Leukemia Engraftment In NOD-Scid Mice Using [111In]-Labeled 7G3 Anti-CD123 Antibodies","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Radioimmunotherapy; Cancer research; Leukemia; Stem cell; Haematopoiesis; Nod; Monoclonal antibody; Immunology; Bone marrow; Interleukin-3 receptor; Antibody; Medicine; Biology; Chemistry; Molecular biology; In vivo; Cell biology","score_opus":0.020293095632853534,"score_gpt":0.3326001338249264,"score_spread":0.3123070381920729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582642816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99763006,0.00025002757,0.000007598473,0.0002073777,0.00004295181,0.000254029,0.00001557875,0.000044038105,0.0015483595],"genre_scores_gemma":[0.99752784,0.00002828934,0.0020574457,0.000086707245,0.00014297572,0.000010540558,0.00002832618,0.000021097016,0.00009679789],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99894065,0.000012004721,0.00033636912,0.00028616545,0.00015155651,0.0002732845],"domain_scores_gemma":[0.9993818,0.000040120274,0.000096186326,0.00030841574,0.00006254318,0.000110939414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015427239,0.00015807654,0.0003138634,0.00006698629,0.00010042076,0.000016492162,0.00012916318,0.000029582488,0.000084235886],"category_scores_gemma":[0.00003919163,0.00015253143,0.0000783817,0.00021346343,0.00017452725,0.000049808838,0.000047396334,0.00038740603,0.0000125733395],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007910407,0.0005136828,0.089968346,0.00012608015,0.000036762096,0.0000809374,0.0000635296,0.0000017835715,0.90900815,0.00011054811,0.00002795613,0.00005434142],"study_design_scores_gemma":[0.0029602929,0.000016866039,0.020731186,0.00010262556,0.00020049268,0.00029680599,0.000062630614,0.00024616913,0.97485423,0.00006372087,0.00032216153,0.0001428255],"about_ca_topic_score_codex":0.00008601043,"about_ca_topic_score_gemma":0.0000092732125,"teacher_disagreement_score":0.06923716,"about_ca_system_score_codex":0.00004771477,"about_ca_system_score_gemma":0.00008570154,"threshold_uncertainty_score":0.6220051},"labels":[],"label_agreement":null},{"id":"W2582657643","doi":"10.1182/blood.v114.22.2978.2978","title":"Post-Thrombotic Syndrome (PTS) in Children: A Systematic Review of Prevalence, Validity of Outcome Measures, and Prognostic Factors.","year":2009,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; St. Joseph's Hospital; Jewish General Hospital","funders":"","keywords":"Medicine; Observational study; Post-thrombotic syndrome; Cohort; Pediatrics; Cohort study; Quality of life (healthcare); Clinical trial; Prospective cohort study; Venous thrombosis; Thrombosis; Internal medicine","score_opus":0.04988601027684127,"score_gpt":0.3155399345023208,"score_spread":0.26565392422547957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582657643","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0071199206,0.98047155,0.0000011592208,0.000016983786,0.000050788512,0.012077111,0.00013061997,0.000032827,0.00009901883],"genre_scores_gemma":[0.011692012,0.9876548,0.00006658551,0.00007703073,0.000019007297,0.0002746018,0.00011986515,0.000056024186,0.000040058232],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9951429,0.0005257052,0.002638369,0.0005713442,0.00075360795,0.00036807722],"domain_scores_gemma":[0.99692625,0.0002955946,0.0014886156,0.00095717504,0.00017522102,0.00015712522],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013510966,0.0006314742,0.009689224,0.0004523799,0.000025951877,0.000012768566,0.00034000567,0.00026068048,0.00004171537],"category_scores_gemma":[0.0016657782,0.0004378777,0.0007420394,0.00050972425,0.000092354494,0.000061381106,0.00012940755,0.00036099914,0.000009792342],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[7.179038e-7,0.0023229376,0.0111334985,0.98378205,0.0009979237,0.000042648393,0.000031386255,2.1008892e-8,1.8366578e-7,0.000042629737,0.000018442803,0.0016275627],"study_design_scores_gemma":[0.00064187945,0.00086067215,0.068069585,0.8814366,0.047865856,0.00051610795,0.000006327242,8.162202e-8,9.748245e-7,0.0000060476136,0.00028535083,0.00031054398],"about_ca_topic_score_codex":0.000056741363,"about_ca_topic_score_gemma":0.000005249595,"teacher_disagreement_score":0.102345474,"about_ca_system_score_codex":0.000066164845,"about_ca_system_score_gemma":0.0001914918,"threshold_uncertainty_score":0.9998073},"labels":[],"label_agreement":null},{"id":"W2582659172","doi":"10.1182/blood.v106.11.2696.2696","title":"Iron Chelation Therapy with Deferasirox (Exjade®, ICL670) or Deferoxamine Is Effective in Reducing Iron Overload in Patients with Advanced Fibrosis and Cirrhosis.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Deferasirox; Deferoxamine; Chelation therapy; Cirrhosis; Medicine; Deferiprone; Gastroenterology; Internal medicine; Liver biopsy; Thalassemia; Fibrosis; Biopsy","score_opus":0.00364895563155928,"score_gpt":0.2078911203683671,"score_spread":0.2042421647368078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582659172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996713,0.00132392,0.0000062588265,0.0002977186,0.000015521468,0.0012641876,0.000006532514,0.00003531106,0.0003375479],"genre_scores_gemma":[0.99803424,0.000641038,0.00089558144,0.00016968707,0.000024815747,0.000070279835,0.000031300224,0.00004001667,0.00009307159],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998742,0.000048529433,0.00025265614,0.00040990664,0.00023613601,0.00031078293],"domain_scores_gemma":[0.9995004,0.00005952423,0.00009625578,0.00020395912,0.000046087418,0.00009377479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009352419,0.00024271775,0.00034455955,0.00018033115,0.000047709003,0.000015595491,0.00004010013,0.00016775953,0.000046670815],"category_scores_gemma":[0.00002996312,0.00015724759,0.000026868438,0.0004041888,0.000060290826,0.0001899873,0.000016429223,0.00028389503,0.0000040386503],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00516534,0.0019034445,0.9028244,0.00012119414,0.00006357195,0.000011544899,0.004140953,0.0003159671,0.0034783257,0.0000034368516,0.000012836056,0.08195897],"study_design_scores_gemma":[0.03591407,0.0039630714,0.9523912,0.0008304821,0.0000987927,0.000013097805,0.0003083166,0.00009708691,0.0059530954,0.0000033669194,0.00017094432,0.00025648405],"about_ca_topic_score_codex":0.00012672514,"about_ca_topic_score_gemma":0.00013919997,"teacher_disagreement_score":0.08170249,"about_ca_system_score_codex":0.00009221222,"about_ca_system_score_gemma":0.00003562792,"threshold_uncertainty_score":0.6412371},"labels":[],"label_agreement":null},{"id":"W2582670998","doi":"10.1182/blood-2016-09-738005","title":"S100A9 induces differentiation of acute myeloid leukemia cells through TLR4","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"S100 Proteins and Annexins","field":"Biochemistry, Genetics and Molecular Biology","cited_by":151,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital de l'Enfant-Jésus; Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Myeloid leukemia; Medicine; Cancer research; Leukemia; Myeloid; Myeloid cells; Immunology","score_opus":0.01269789145927907,"score_gpt":0.2495983856824797,"score_spread":0.23690049422320061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582670998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99609965,0.00018237886,0.00023168944,0.00004323788,0.00013105194,0.000101595884,0.000036214107,0.000006832951,0.003167323],"genre_scores_gemma":[0.99816906,0.00028778584,0.0005553924,0.00004735479,0.00023219155,0.000009679351,0.000051123177,0.000013320116,0.00063407427],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99942183,0.000015032789,0.0001330728,0.0002026214,0.000087463166,0.00013998337],"domain_scores_gemma":[0.99925333,0.000002379006,0.00017458519,0.00049224833,0.00004763372,0.000029828352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004559521,0.000103369755,0.00011844801,0.00001220293,0.00013688767,0.000037393416,0.0002758811,0.00012952366,0.000022312133],"category_scores_gemma":[0.000017788867,0.000090809815,0.00008221894,0.000014912475,0.000067611305,0.000007742755,0.00013297936,0.000053452717,0.000008684264],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000139307085,0.00009216018,0.0015786483,0.000012353509,0.00012861015,0.0000018777963,0.00003912602,8.0031964e-7,0.99713945,0.00010842947,0.00021417682,0.0006704441],"study_design_scores_gemma":[0.0007855893,0.00016110824,0.01731782,0.000014143626,0.00007653837,0.0000028015352,0.000015368267,0.0000028223653,0.97936314,0.00015466956,0.001994096,0.00011188086],"about_ca_topic_score_codex":0.000070487855,"about_ca_topic_score_gemma":0.000014597939,"teacher_disagreement_score":0.01777628,"about_ca_system_score_codex":0.000003945697,"about_ca_system_score_gemma":0.00004890835,"threshold_uncertainty_score":0.37031168},"labels":[],"label_agreement":null},{"id":"W2582671744","doi":"10.1182/blood.v104.11.4192.4192","title":"Antagonistic Roles of the ERK and p38 Pathways in Chemically Induced Erythroid Differentiation of Murine Erythroleukemia Cells.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Porphyrin Metabolism and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"MAPK/ERK pathway; p38 mitogen-activated protein kinases; Cell biology; Heme; Kinase; Globin; Signal transduction; Protein kinase A; Biology; Molecular biology; Chemistry; Biochemistry; Hemoglobin; Enzyme","score_opus":0.004930551356979995,"score_gpt":0.190151207972829,"score_spread":0.185220656615849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582671744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99865687,0.0008952397,0.00004131079,0.000025256788,0.000041719995,0.0001042203,0.000023295222,0.0000029823436,0.00020912253],"genre_scores_gemma":[0.99941146,0.00031922365,0.0001588862,0.000034303943,0.000031842137,0.000005452571,0.000024022458,0.000008821387,0.000006007217],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993929,0.000021535037,0.00020680178,0.00016818583,0.00009235952,0.00011817708],"domain_scores_gemma":[0.9996085,0.0000045066677,0.000110253415,0.00022043101,0.00002897805,0.000027324988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006145946,0.00009759014,0.00014696945,0.000025084573,0.000020043019,0.000004318333,0.0001235483,0.00009917415,0.000002511356],"category_scores_gemma":[0.000042676034,0.000076181874,0.00005102669,0.00007500225,0.00008011166,0.0000024652197,0.00009615787,0.000059272894,3.0600117e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020331698,0.0002652927,0.006179488,0.000040062405,0.000018492983,4.716101e-7,0.0000948777,0.000025246958,0.99299234,0.0001347634,0.000004096138,0.00022455666],"study_design_scores_gemma":[0.0021500336,0.00006354258,0.08074001,0.000021861953,0.00003425487,0.0000029454243,0.000045961704,0.0000032582302,0.91627043,0.00056359736,0.00002750822,0.00007660498],"about_ca_topic_score_codex":0.00004196278,"about_ca_topic_score_gemma":0.0000611976,"teacher_disagreement_score":0.0767219,"about_ca_system_score_codex":0.0000036258054,"about_ca_system_score_gemma":0.00007173162,"threshold_uncertainty_score":0.31066066},"labels":[],"label_agreement":null},{"id":"W2582699834","doi":"10.1182/blood.v118.21.3020.3020","title":"Reduction in Incidence of Severe Infections by Transplantation of High Doses of Haploidentical T Cells Selectively Depleted of Alloreactive Units","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Hôpital Maisonneuve-Rosemont; Université de Montréal","funders":"","keywords":"Medicine; Fludarabine; Transplantation; Alemtuzumab; Graft-versus-host disease; Cumulative incidence; Internal medicine; Hematopoietic stem cell transplantation; Immunology; Leukemia; Gastroenterology; Myeloid leukemia; Stem cell; Cyclophosphamide; Chemotherapy; Biology","score_opus":0.018667856754634667,"score_gpt":0.23649157734229076,"score_spread":0.2178237205876561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582699834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99763846,0.000033403885,0.0011306575,0.0000059600693,0.000043766624,0.0003745726,0.000094396004,0.000012385697,0.0006663708],"genre_scores_gemma":[0.9985724,0.00014080285,0.001192707,0.0000018086856,0.0000065323766,0.000012201693,0.00004986721,0.000012762189,0.000010901169],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988212,0.000090562375,0.0005696175,0.00015594509,0.00025589744,0.00010677109],"domain_scores_gemma":[0.99898875,0.00014957145,0.00029561817,0.00012401656,0.0004015044,0.00004052575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001593748,0.00010208381,0.0003632467,0.00023936795,0.000010642977,7.5684994e-7,0.00005240768,0.00011403376,0.00003551097],"category_scores_gemma":[0.00006551427,0.00010314706,0.00004693045,0.00063001935,0.0001271238,0.00011581666,0.000004553308,0.00010906943,8.342778e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047081738,0.0014737634,0.047474157,0.0010306329,0.00013189999,0.0000059216504,0.0073770937,0.000012874505,0.94161886,0.00033699282,0.0000045790575,0.00006243001],"study_design_scores_gemma":[0.0023949095,0.0005535429,0.18261524,0.0004998219,0.00047865484,0.00011552736,0.00047944934,0.000010124115,0.812615,0.00017794427,2.6974263e-7,0.00005953327],"about_ca_topic_score_codex":0.002451823,"about_ca_topic_score_gemma":0.00009804996,"teacher_disagreement_score":0.13514109,"about_ca_system_score_codex":0.000019117027,"about_ca_system_score_gemma":0.00013279646,"threshold_uncertainty_score":0.42062148},"labels":[],"label_agreement":null},{"id":"W2582768542","doi":"10.1182/blood.v114.22.4557.4557","title":"Erythropoietin Treatment Leads to Reduced Blood Glucose Levels and Body Mass: Insights From Murine Models.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Erythropoietin; Endocrinology; Internal medicine; Genetically modified mouse; Transgene; Diabetes mellitus; Medicine; Erythropoietin receptor; Hemoglobin; Biology; Biochemistry","score_opus":0.020329175528134187,"score_gpt":0.256508231383387,"score_spread":0.23617905585525284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582768542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860383,0.006486756,0.00007259073,0.0019601318,0.00014159913,0.0005928507,0.000044288536,0.00013431485,0.004529127],"genre_scores_gemma":[0.99205035,0.0006998656,0.004702469,0.0010766066,0.00053228927,0.000029381097,0.00006472838,0.000032084256,0.0008122317],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998513,0.00003921127,0.000308089,0.00053368893,0.00026627735,0.00033975905],"domain_scores_gemma":[0.998922,0.000032153275,0.00005725386,0.0005195079,0.000060867394,0.00040823923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000044701515,0.0003126504,0.00053004286,0.0001389752,0.00008631168,0.00003507671,0.00008783741,0.00012577994,0.00008776556],"category_scores_gemma":[0.00004473838,0.00024322546,0.000100645746,0.00019460995,0.000045038396,0.00012926801,0.000030570125,0.00010497058,0.00005156319],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046134752,0.0072081895,0.0027379456,0.000038122504,0.00048280798,0.00026919993,0.0030595872,0.000030097477,0.9735485,0.0016055184,0.0007044026,0.00985431],"study_design_scores_gemma":[0.039442826,0.0039997837,0.10196843,0.00018976121,0.0033200537,0.00008570922,0.0004736992,0.00014272239,0.83509046,0.00772158,0.0067620655,0.0008028875],"about_ca_topic_score_codex":0.00020392645,"about_ca_topic_score_gemma":0.000020091427,"teacher_disagreement_score":0.13845798,"about_ca_system_score_codex":0.000019251249,"about_ca_system_score_gemma":0.000096543496,"threshold_uncertainty_score":0.9918446},"labels":[],"label_agreement":null},{"id":"W2582786483","doi":"10.1182/blood.v126.23.2168.2168","title":"Quantitative MRI of Hemodynamic Compromise in Children with Sickle Cell Disease: New Insights into Pathophysiology","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Medicine; Pathophysiology; Stroke (engine); Cerebral blood flow; Stenosis; Cardiology; Internal medicine; Magnetic resonance imaging; Acute chest syndrome; Hemodynamics; Population; Disease; Sickle cell anemia; Radiology","score_opus":0.007297445188582315,"score_gpt":0.2279036935838153,"score_spread":0.220606248395233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582786483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994394,0.0040716953,0.00011912214,0.00023708379,0.000028125476,0.0004356972,0.0000040090817,0.000026507936,0.0006837568],"genre_scores_gemma":[0.99736506,0.00019199497,0.0020902888,0.00010340534,0.000022174981,0.000007254544,0.000060378425,0.000019853549,0.0001396185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991971,0.00004758502,0.00020281223,0.00023037814,0.00015211901,0.0001700086],"domain_scores_gemma":[0.99933887,0.000018587325,0.00008208644,0.00022971584,0.00005902647,0.00027172946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000041653006,0.00013939285,0.00031980593,0.00010102376,0.000018463696,0.0000029534108,0.00007602981,0.000085845175,0.000009046265],"category_scores_gemma":[0.000026836053,0.00009798326,0.000045788347,0.00023525195,0.000113405265,0.000043043397,0.00003471412,0.0001680125,0.00002169313],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007552172,0.016878627,0.84359926,0.0007785906,0.0010100865,0.00065186614,0.02470444,0.00512927,0.09248594,0.0024018616,0.002135973,0.002671895],"study_design_scores_gemma":[0.110798344,0.012558786,0.82493436,0.0011888425,0.0019140779,0.00007927597,0.0059485915,0.010668826,0.013668677,0.016409304,0.0004778151,0.0013531074],"about_ca_topic_score_codex":0.00048800063,"about_ca_topic_score_gemma":0.000052040807,"teacher_disagreement_score":0.10324617,"about_ca_system_score_codex":0.000020455938,"about_ca_system_score_gemma":0.00032944334,"threshold_uncertainty_score":0.39956415},"labels":[],"label_agreement":null},{"id":"W2582787413","doi":"10.1182/blood.v114.22.4892.4892","title":"Relationship of Treatment Effects On Hemoglobin and M-Protein Levels in Relapsed or Refractory Multiple Myeloma: Final Analysis of a Retrospective Chart Review Study.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Thalidomide; Multiple myeloma; Serum protein electrophoresis; Bortezomib; Gastroenterology; Refractory (planetary science); Lenalidomide; Univariate analysis; Oncology; Surgery; Immunology; Antibody; Monoclonal; Multivariate analysis; Monoclonal antibody","score_opus":0.058756396469428034,"score_gpt":0.34224736938640216,"score_spread":0.2834909729169741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582787413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945052,0.0024612914,0.0000017121853,0.00016481233,0.0000061461083,0.00255037,0.0000475213,0.000015984033,0.0002469224],"genre_scores_gemma":[0.99880946,0.00022402435,0.0003711585,0.000033920576,0.000014971478,0.00013319771,0.000033241937,0.000010664307,0.0003693743],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983345,0.00024855873,0.0004555836,0.00037401877,0.00036480906,0.00022251815],"domain_scores_gemma":[0.9987444,0.00038849155,0.0001896381,0.00044826866,0.000100037665,0.0001291441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003278438,0.00020481592,0.00095996,0.0004813988,0.00004056514,0.0000038501544,0.00005610762,0.00007346828,0.00004013633],"category_scores_gemma":[0.0013247572,0.000140459,0.00015598687,0.0010727589,0.00003943144,0.000038541482,0.000016226502,0.0001569913,0.0000042215306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015738448,0.007887157,0.9755591,0.0004257784,0.0013562179,0.00036425987,0.00038629246,0.0000013975722,0.004400121,0.000023622526,0.00001015285,0.008012021],"study_design_scores_gemma":[0.019058688,0.0147787025,0.954762,0.0012653277,0.0020072674,0.0000063135058,0.000044217664,0.00005040042,0.00790901,0.000018460816,0.000007038784,0.00009261984],"about_ca_topic_score_codex":0.0001746876,"about_ca_topic_score_gemma":0.00022421035,"teacher_disagreement_score":0.020797182,"about_ca_system_score_codex":0.00021856843,"about_ca_system_score_gemma":0.00011990728,"threshold_uncertainty_score":0.5727752},"labels":[],"label_agreement":null},{"id":"W2582845668","doi":"10.1182/blood.v120.21.4223.4223","title":"Combination Therapy with Novel Nanoparticle, SNS01-T, and Lenalidomide Triggers Synergistic Cytotoxicity in Vitro and in Vivo in Multiple Myeloma and Mantle Cell Lymphoma","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Polyamine Metabolism and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Lenalidomide; Multiple myeloma; In vivo; Cancer research; Apoptosis; Mantle cell lymphoma; Pharmacology; Medicine; Lymphoma; Biology; Immunology; Biochemistry","score_opus":0.008928585926283695,"score_gpt":0.21073120932943593,"score_spread":0.20180262340315222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582845668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99765474,0.0019212316,0.00006883243,0.000031196923,0.000007845619,0.00021677604,0.000032230044,0.0000033322135,0.00006379229],"genre_scores_gemma":[0.99910206,0.00038762193,0.00033359887,0.000053942636,0.000017492483,0.00005662898,0.000014612152,0.000008321268,0.000025745503],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99943143,0.000029910614,0.00012784234,0.0001827622,0.00004502103,0.00018302654],"domain_scores_gemma":[0.99976903,0.000024461258,0.000038306865,0.00010310053,0.0000089629075,0.000056164426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013398202,0.000097622345,0.00012168557,0.000056404446,0.000027231357,0.000012818585,0.000037577443,0.000057556175,8.511887e-7],"category_scores_gemma":[0.000018189758,0.00008608923,0.000007924841,0.00009785775,0.00006763143,0.000010409332,0.000032084983,0.00003175022,2.1787808e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015611773,0.00070808077,0.062451743,0.000010189286,0.0000047174885,0.0000011281307,0.00008795814,0.0000014479829,0.93578017,0.0000308692,0.0000017966868,0.0007658022],"study_design_scores_gemma":[0.007939898,0.0000407805,0.22212489,0.0000048966767,0.000006797132,0.000008220134,0.00004239046,0.00010231652,0.7694926,0.0000111755135,0.00013260891,0.000093407834],"about_ca_topic_score_codex":0.000119624594,"about_ca_topic_score_gemma":0.00014459234,"teacher_disagreement_score":0.16628754,"about_ca_system_score_codex":0.000004568086,"about_ca_system_score_gemma":0.0000145351705,"threshold_uncertainty_score":0.3510617},"labels":[],"label_agreement":null},{"id":"W2582847085","doi":"10.1182/blood.v108.11.4449.4449","title":"Percent of Peripheral Blood Leukemic Blasts (PPBLB) at Diagnosis as a Predictor of Short- and Long-Term Survival in Acute Myeloid Leukemia (AML).","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Univariate analysis; Acute promyelocytic leukemia; Internal medicine; Myeloid leukemia; Leukemia; Bone marrow; Surgery; Population; Multivariate analysis; Gastroenterology","score_opus":0.012634142514567898,"score_gpt":0.26848169079500367,"score_spread":0.25584754828043577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582847085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953787,0.0021581452,0.000006438068,0.00016343905,0.00009675083,0.0010351331,0.00013948607,0.000062852036,0.00095909735],"genre_scores_gemma":[0.99579227,0.0020025037,0.00027745118,0.000065504144,0.00027635795,0.0001359827,0.00013882028,0.00009089075,0.0012202295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996374,0.00015296928,0.0009603265,0.0007200119,0.0010023159,0.00079036487],"domain_scores_gemma":[0.99835044,0.00023621132,0.00018506622,0.0006947472,0.00021849094,0.0003150371],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041449603,0.00044398694,0.0010753811,0.0003911512,0.000069268244,0.000021512224,0.00032742418,0.00035266965,0.00042099526],"category_scores_gemma":[0.00014508043,0.0004090268,0.00022724114,0.00049436756,0.00048077275,0.0001498,0.00041956545,0.0005529153,0.000013296412],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081540353,0.0011904587,0.8214263,0.0004689709,0.0004888138,0.0007185817,0.00040116452,0.00001138164,0.17371875,0.000035742825,0.0002205406,0.00050391775],"study_design_scores_gemma":[0.012992428,0.0014275735,0.8558916,0.0004512569,0.0009317906,0.00057321065,0.00007312158,0.00008326838,0.12716883,0.000018233277,0.00008249468,0.00030618533],"about_ca_topic_score_codex":0.000997746,"about_ca_topic_score_gemma":0.0008185804,"teacher_disagreement_score":0.046549916,"about_ca_system_score_codex":0.00083995936,"about_ca_system_score_gemma":0.0008979932,"threshold_uncertainty_score":0.99983615},"labels":[],"label_agreement":null},{"id":"W2582849955","doi":"10.1182/blood.v104.11.3325.3325","title":"Acceptable Outcomes for Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) for Relapsed Aggressive Non-Hodgkin’s Lymphoma (NHL).","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Vancouver General Hospital","funders":"","keywords":"Medicine; Transplantation; Lymphoma; Internal medicine; Cyclophosphamide; Hematopoietic stem cell transplantation; Gastroenterology; Bone marrow; Median follow-up; Diffuse large B-cell lymphoma; Surgery; Chemotherapy","score_opus":0.011361254335391596,"score_gpt":0.25018305627935494,"score_spread":0.23882180194396335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582849955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99535555,0.00035666057,0.0005700126,0.00026646143,0.00026491235,0.0025802169,0.0001513252,0.00005718597,0.00039767765],"genre_scores_gemma":[0.99236405,0.0002588625,0.0050587263,0.0002603782,0.00006883995,0.0011895521,0.00036803854,0.00006246648,0.00036911154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983957,0.000017438886,0.00043353543,0.00045142774,0.00026320165,0.00043874272],"domain_scores_gemma":[0.9988465,0.0002244267,0.00029140429,0.00030622055,0.00016473979,0.00016670921],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009552191,0.00029959576,0.00050856586,0.000102971164,0.00018178835,0.000037144764,0.00011224097,0.00015470102,0.000019492201],"category_scores_gemma":[0.00003297348,0.00024139907,0.00032549747,0.00010483974,0.000024655908,0.0001211114,0.000015778267,0.00003219023,0.000027395417],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010437268,0.017163256,0.93977743,0.0019570685,0.0012251039,0.00019991853,0.0039037399,0.00006662421,0.0022517492,0.00018512708,0.00053764944,0.031688575],"study_design_scores_gemma":[0.11460138,0.0029576698,0.7031446,0.0007146513,0.00297867,0.00006529036,0.0003180316,0.0000118156995,0.17393935,0.00031315972,0.00045638316,0.0004990268],"about_ca_topic_score_codex":0.00003944728,"about_ca_topic_score_gemma":0.00003203379,"teacher_disagreement_score":0.23663288,"about_ca_system_score_codex":0.00022248503,"about_ca_system_score_gemma":0.00018288507,"threshold_uncertainty_score":0.9843969},"labels":[],"label_agreement":null},{"id":"W2582868265","doi":"10.1182/blood-2004-10-3996","title":"Accelerated telomere shortening in glycosylphosphatidylinositol (GPI)–negative compared with GPI-positive granulocytes from patients with paroxysmal nocturnal hemoglobinuria (PNH) detected by proaerolysin flow-FISH","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"Deutsche Forschungsgemeinschaft","keywords":"Paroxysmal nocturnal hemoglobinuria; Telomere; Internal medicine; Flow cytometry; CD59; Biology; Medicine; Immunology; Genetics; Gene; Immune system","score_opus":0.011219288599682945,"score_gpt":0.2426051506236579,"score_spread":0.23138586202397496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582868265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99610424,0.00039739904,0.00006696596,0.0002025112,0.000029342962,0.0019491473,0.0006152282,0.0001341745,0.00050099374],"genre_scores_gemma":[0.99355024,0.000021215545,0.004798695,0.00028097394,0.00018923818,0.00015610589,0.0008142235,0.000101509715,0.000087808476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99628276,0.00015050352,0.00066486653,0.0008680967,0.0010982674,0.0009355276],"domain_scores_gemma":[0.99805987,0.00019902093,0.00022710595,0.0004150016,0.00061621453,0.000482792],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001494598,0.0005907777,0.0009568887,0.00025822836,0.0002540451,0.00018729671,0.00028055746,0.00024844712,0.00041834355],"category_scores_gemma":[0.000057589292,0.00043942517,0.00009924007,0.0010816052,0.00022355319,0.0004343097,0.00008750745,0.0009781447,0.0000352775],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020259667,0.005862571,0.9339014,0.00007747913,0.0015947768,0.00046123486,0.0034124553,0.00016434267,0.018621504,0.0000025955846,0.00084252097,0.014799424],"study_design_scores_gemma":[0.04016743,0.0018937289,0.61161757,0.00066087436,0.0004803401,0.00003645039,0.00035144674,0.0031172992,0.34072417,0.000006878716,0.0002460197,0.0006977736],"about_ca_topic_score_codex":0.0015406975,"about_ca_topic_score_gemma":0.00402847,"teacher_disagreement_score":0.32228383,"about_ca_system_score_codex":0.0002859596,"about_ca_system_score_gemma":0.00035950547,"threshold_uncertainty_score":0.99980575},"labels":[],"label_agreement":null},{"id":"W2582897585","doi":"10.1182/blood.v114.22.2253.2253","title":"Expansion of Large Granular Lymphocytes Following Allogeneic Stem Cell Transplantation: Its Association with Graft-Versus-Host Disease and Graft-Versus-Leukemia Effect.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Hematopoietic stem cell transplantation; Transplantation; Population; Leukemia; Gastroenterology; Graft-versus-host disease; Internal medicine; Incidence (geometry); Immunology; Surgery","score_opus":0.00803562144245822,"score_gpt":0.23565204821904498,"score_spread":0.22761642677658675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582897585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961457,0.0016782295,0.00034678742,0.00010532626,0.00019475266,0.0008850125,0.00006905552,0.0001093867,0.000465726],"genre_scores_gemma":[0.99840736,0.00064609904,0.00040197765,0.00007126026,0.00007034624,0.000033098644,0.00023087097,0.000038559145,0.000100435216],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978145,0.0001504273,0.00042023478,0.0004462619,0.0007651316,0.00040348602],"domain_scores_gemma":[0.9987095,0.000410638,0.00021416083,0.00026758743,0.00010905108,0.0002890355],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041382998,0.00032289574,0.0005211272,0.00015213508,0.0001315832,0.000025644209,0.00008713143,0.00018799287,0.000016810656],"category_scores_gemma":[0.000027697284,0.00027911374,0.00017646338,0.00030589662,0.000021252163,0.00020097742,0.0000072516896,0.00013825194,0.000012410359],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022885019,0.0014838107,0.46881393,0.0060788984,0.0013722774,0.0022046196,0.0057322094,0.00006236945,0.4897659,0.00031345943,0.00006349179,0.0012239938],"study_design_scores_gemma":[0.08139612,0.0029759097,0.22952834,0.0011851817,0.00865693,0.00005579878,0.0003317705,0.00013929787,0.6751425,0.000009758118,0.000050269406,0.0005281052],"about_ca_topic_score_codex":0.0000110987385,"about_ca_topic_score_gemma":0.0000126513405,"teacher_disagreement_score":0.23928559,"about_ca_system_score_codex":0.00017871558,"about_ca_system_score_gemma":0.00022522085,"threshold_uncertainty_score":0.9999661},"labels":[],"label_agreement":null},{"id":"W2582935536","doi":"10.1182/blood.v108.11.3297.3297","title":"Hospital Mortality Due to Pulmonary Embolism (PE) and an Evaluation of the Usefulness of Preventative Interventions.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Autopsy; Pulmonary embolism; Cause of death; Pediatrics; Retrospective cohort study; Mortality rate; Emergency medicine; Intensive care medicine; Disease; Internal medicine","score_opus":0.04380055125365478,"score_gpt":0.33284568543961357,"score_spread":0.2890451341859588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582935536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970199,0.00024458076,0.00007013781,0.00024214255,0.00009741461,0.0010769243,0.000022465783,0.000008999397,0.0012174665],"genre_scores_gemma":[0.9995791,0.00000873047,0.00014536976,0.000035461173,0.00006192071,0.00009727466,0.000016904454,0.000008767606,0.00004647059],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898094,0.00011718122,0.00028627456,0.00016314082,0.00036208334,0.00009036472],"domain_scores_gemma":[0.9993482,0.000014548048,0.00014318341,0.00027323357,0.00018300692,0.00003783458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005200063,0.000079449455,0.00026166483,0.00005268418,0.000035518085,0.0000058431374,0.00007591664,0.000030294645,0.000051188617],"category_scores_gemma":[0.000049772254,0.0000593179,0.00009892028,0.00013347346,0.000058907575,0.00007021874,0.00007929913,0.00004088373,9.818647e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009789671,0.06842293,0.8168553,0.0033802558,0.0021105078,0.000048729016,0.01075267,0.0004428436,0.016097609,0.027903209,0.002012358,0.05187571],"study_design_scores_gemma":[0.0009967069,0.00030608743,0.9773224,0.00025853756,0.0013990657,0.000004570433,0.0005078178,0.000058820053,0.017443912,0.001626917,0.000015513766,0.000059622504],"about_ca_topic_score_codex":0.00056204776,"about_ca_topic_score_gemma":0.00014638777,"teacher_disagreement_score":0.16046715,"about_ca_system_score_codex":0.000014572409,"about_ca_system_score_gemma":0.000033849316,"threshold_uncertainty_score":0.24189137},"labels":[],"label_agreement":null},{"id":"W2582950935","doi":"10.1182/blood.v120.21.1222.1222","title":"Role of the Ether-a-go-go-Related Gene 1B Isoform in Hematopoiesis","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Haematopoiesis; Cell biology; Biology; Gene isoform; Progenitor cell; Stem cell; Cellular differentiation; Immunology; Gene; Biochemistry","score_opus":0.011286782264141372,"score_gpt":0.2605635075694387,"score_spread":0.24927672530529732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582950935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909506,0.0013273084,2.4871878e-7,0.00024692868,0.000032981898,0.0002912237,0.000006365532,0.00001803565,0.0071263523],"genre_scores_gemma":[0.9987381,0.000029428345,0.000113157366,0.000055252192,0.000025947307,0.00001932161,0.000003233091,0.00001647766,0.0009990467],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99913335,0.000042106603,0.00016938262,0.00009932239,0.0002459355,0.0003098999],"domain_scores_gemma":[0.9994647,0.000043783384,0.000046649246,0.00030083684,0.000030015164,0.00011403825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011995725,0.00008860516,0.00017226378,0.00006663365,0.000028545612,0.0000031724505,0.00008748784,0.000060312883,0.00015639623],"category_scores_gemma":[0.000077540295,0.000054295226,0.0000814534,0.00024465832,0.000050099214,0.000056352914,0.000063878215,0.00014738768,0.00012959745],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012310894,0.0059807813,0.6847266,0.000087003966,0.00034001263,0.000043900418,0.0010161187,5.4974794e-7,0.30537608,0.00038355676,0.00022169188,0.0017006077],"study_design_scores_gemma":[0.0043289997,0.00018059627,0.31599855,0.00007190886,0.000094751544,0.0001165034,0.00007388922,0.000006255225,0.67831403,0.00025836824,0.0005026449,0.000053476037],"about_ca_topic_score_codex":0.0000589622,"about_ca_topic_score_gemma":0.000025884898,"teacher_disagreement_score":0.37293795,"about_ca_system_score_codex":0.00002063816,"about_ca_system_score_gemma":0.00004561324,"threshold_uncertainty_score":0.2214095},"labels":[],"label_agreement":null},{"id":"W2582965137","doi":"10.1182/blood.v104.11.1783.1783","title":"Effect of Covalently-Bound Heparin on Insertion of the Reactive Centre Loop in Antithrombin.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Chemical Synthesis and Analysis","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Antithrombin; Chemistry; Heparin; Covalent bond; Peptide; Thrombin; Stereochemistry; Biochemistry; Organic chemistry; Immunology; Biology","score_opus":0.0032861474577298567,"score_gpt":0.2176164710603997,"score_spread":0.21433032360266985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582965137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99933976,0.000107382024,0.0000022846975,0.000052922733,0.000013318296,0.00007491573,0.0000066735874,0.0000012609163,0.0004015077],"genre_scores_gemma":[0.99987024,0.00004327819,0.000008687459,0.000015014347,0.000016039916,0.0000019349075,0.000009503476,0.00000486351,0.000030464902],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99953526,0.00004736206,0.0001253238,0.00013163773,0.0000837427,0.00007669498],"domain_scores_gemma":[0.99969137,0.000016158134,0.0000754251,0.00018364874,0.000018515306,0.0000149128045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000094170246,0.00006586626,0.00013354929,0.00001603822,0.000012118719,0.0000023250398,0.00008759802,0.00006500143,0.000005512119],"category_scores_gemma":[0.0000929219,0.00004391733,0.000110025394,0.00009504088,0.000046651705,0.0000011181396,0.00003586455,0.000041188232,0.0000012198605],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006219184,0.00037022462,0.034426678,0.00002490079,0.000054363805,5.036648e-7,0.000013354705,0.000026580321,0.96461374,0.000023487628,0.0000057761345,0.0003781886],"study_design_scores_gemma":[0.0010437906,0.00018409718,0.015597756,0.00006159398,0.00006104813,7.862284e-7,0.000008379688,0.0000015456947,0.982921,0.000036504567,0.000038880666,0.000044608463],"about_ca_topic_score_codex":0.00014147346,"about_ca_topic_score_gemma":0.00007149007,"teacher_disagreement_score":0.018828923,"about_ca_system_score_codex":0.0000080769805,"about_ca_system_score_gemma":0.000016261909,"threshold_uncertainty_score":0.17908968},"labels":[],"label_agreement":null},{"id":"W2583012624","doi":"10.1182/blood.v114.22.2105.2105","title":"RAP Trial: Ringer's Lactate and Packed Red Blood Cell Transfusion, An in Vitro Study and Chart Review.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Royal University Hospital; University of Saskatchewan","funders":"","keywords":"Medicine; Packed red blood cells; Coagulopathy; Anesthesia; Red blood cell; Whole blood; Saline; Blood transfusion; Surgery; Red Cell; Fresh frozen plasma; Platelet; Internal medicine","score_opus":0.01602418819392819,"score_gpt":0.2722825308058589,"score_spread":0.2562583426119307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583012624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986866,0.005055999,0.000001849633,0.0030398797,0.000060583963,0.0036043243,0.0000035960718,0.00009054307,0.0012772178],"genre_scores_gemma":[0.9747918,0.022603469,0.00020618894,0.0020226415,0.00007382063,0.000063934116,0.000014966942,0.000022767304,0.00020039051],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983826,0.00014440602,0.00044413834,0.0004938411,0.0002610012,0.00027398815],"domain_scores_gemma":[0.9992677,0.0000224125,0.0000604076,0.00037584774,0.000035820794,0.00023783368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006336127,0.00022287168,0.0005861461,0.0001631056,0.00006798932,0.000024190065,0.00007376823,0.000067852656,0.00004238849],"category_scores_gemma":[0.000023219645,0.00019547623,0.000060453785,0.0002451423,0.000029203686,0.000093747025,0.000019337082,0.00021725308,0.000003033305],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033178672,0.095433705,0.012242285,0.0036214215,0.00075204973,0.0026459638,0.013739013,1.11907106e-7,0.70469534,0.000069156944,0.0013887982,0.13223346],"study_design_scores_gemma":[0.7407679,0.02004946,0.13083446,0.001621455,0.007779972,0.00020669693,0.0018279684,0.000025259507,0.08844293,0.00021150835,0.0071637584,0.0010686419],"about_ca_topic_score_codex":0.00004408899,"about_ca_topic_score_gemma":0.00006047189,"teacher_disagreement_score":0.7075892,"about_ca_system_score_codex":0.000004718848,"about_ca_system_score_gemma":0.00002267199,"threshold_uncertainty_score":0.7971289},"labels":[],"label_agreement":null},{"id":"W2583015793","doi":"10.1182/blood.v126.23.5530.5530","title":"Myeloablative Allogeneic Stem Cell Transplantation in CLL: A Single Centre Retrospective Study","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Alberta; University of Calgary","funders":"","keywords":"Medicine; Fludarabine; Thymoglobulin; Cumulative incidence; Internal medicine; Transplantation; Busulfan; Oncology; Chronic lymphocytic leukemia; Hematopoietic stem cell transplantation; Surgery; Graft-versus-host disease; Leukemia; Cyclophosphamide; Chemotherapy; Tacrolimus","score_opus":0.036322149226960386,"score_gpt":0.2835768403285401,"score_spread":0.2472546911015797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583015793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908714,0.00026541942,0.000017705408,0.00007870535,0.00005585522,0.0010831235,0.000010465551,0.0000524517,0.0075648157],"genre_scores_gemma":[0.99836385,0.000017083381,0.00013899525,0.000033369768,0.00008636014,0.00002767924,0.000018295468,0.000028138975,0.0012862204],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983017,0.00014921917,0.00025691194,0.00036737928,0.0005774276,0.00034736414],"domain_scores_gemma":[0.9992483,0.0000551294,0.000056695746,0.0002734015,0.00016379736,0.00020267173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036363484,0.00014911755,0.0002923536,0.00014995813,0.000026232801,0.000017221659,0.00009700877,0.000085661,0.000027552624],"category_scores_gemma":[0.000039122177,0.00013231888,0.00004606339,0.00040127905,0.00004443357,0.000079340854,0.000031702024,0.00020152966,0.000083640145],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029745554,0.028149132,0.8134017,0.00045246797,0.0005143592,0.008869787,0.12273214,0.00012441482,0.019435016,0.00007790472,0.00052440347,0.0027441005],"study_design_scores_gemma":[0.4168766,0.007072294,0.37503353,0.00042307944,0.001079813,0.0005668366,0.045123048,0.0012227311,0.1511982,0.00028127135,0.00030260926,0.00081998005],"about_ca_topic_score_codex":0.00046767233,"about_ca_topic_score_gemma":0.0007354187,"teacher_disagreement_score":0.43836817,"about_ca_system_score_codex":0.00501903,"about_ca_system_score_gemma":0.0019737363,"threshold_uncertainty_score":0.9988005},"labels":[],"label_agreement":null},{"id":"W2583021479","doi":"10.1182/blood.v120.21.2567.2567","title":"Quality of Life Following Completion of Treatment for Adult Acute Lymphoblastic Leukemia with a Pediatric-Based Protocol.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Quality of life (healthcare); Population; Pediatrics; Physical therapy; Cancer; Internal medicine","score_opus":0.03671083446747013,"score_gpt":0.33728031586231,"score_spread":0.30056948139483985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583021479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9579168,0.000023619428,0.0074570966,0.00006141877,0.000037243284,0.03407544,0.0000960452,0.0000474464,0.00028491177],"genre_scores_gemma":[0.9590721,0.0000021588196,0.010817939,0.000086545086,0.000257113,0.029589662,0.00005806073,0.000044516928,0.00007190482],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99793905,0.00009134275,0.00062598713,0.00025530808,0.0006095485,0.00047873906],"domain_scores_gemma":[0.9978103,0.00059642096,0.00034923703,0.00041709328,0.00051332463,0.00031360844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039293317,0.00023416296,0.00073144154,0.00016194116,0.00005542421,0.000006113192,0.000111727575,0.000121457735,0.00002227983],"category_scores_gemma":[0.0006613644,0.00016321044,0.0002687918,0.00030584997,0.000079825884,0.00008313864,0.000028255557,0.000066040004,0.0000060971115],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018295838,0.008539043,0.91476613,0.0055187256,0.0027596457,0.000025619247,0.00079182314,0.00012420503,0.04730452,0.00053072226,0.0007025356,0.0006412114],"study_design_scores_gemma":[0.43375242,0.03276598,0.2897371,0.0009858113,0.009220008,0.00010311379,0.0005123841,0.0071480135,0.22362007,0.0000579397,0.0009203043,0.0011768705],"about_ca_topic_score_codex":0.00025977465,"about_ca_topic_score_gemma":0.000011652236,"teacher_disagreement_score":0.625029,"about_ca_system_score_codex":0.0008602106,"about_ca_system_score_gemma":0.0030908973,"threshold_uncertainty_score":0.66555285},"labels":[],"label_agreement":null},{"id":"W2583039933","doi":"10.1182/blood-2016-10-739656","title":"Antenatal management in fetal and neonatal alloimmune thrombocytopenia: a systematic review","year":2017,"lang":"en","type":"review","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McMaster University; Centre Hospitalier Universitaire Sainte-Justine; University of Toronto; SickKids Foundation; University Health Network; Hospital for Sick Children; St. Michael's Hospital; Canadian Blood Services; Mount Sinai Hospital","funders":"Barts Health NHS Trust; Universität Greifswald; University of Toronto; University of Alberta; Monash University; Canadian Blood Services; University of Oxford; NHS Blood and Transplant; University of Ottawa; Dartmouth College","keywords":"Neonatal alloimmune thrombocytopenia; Medicine; Intensive care medicine; Obstetrics; Systematic review; Fetus; Pregnancy; Pediatrics; MEDLINE","score_opus":0.04766385440130243,"score_gpt":0.34423921965007037,"score_spread":0.29657536524876793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583039933","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000033301505,0.9923055,0.0000010519947,0.000032749922,0.000055669374,0.0056315274,0.00003767774,0.000024606792,0.0018778942],"genre_scores_gemma":[0.000042308002,0.99785125,0.00010816315,0.00006012547,0.000016251237,0.0005057964,0.00026162734,0.00004765842,0.0011067919],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99815685,0.00007561346,0.0007642977,0.00045709612,0.00025156466,0.00029459043],"domain_scores_gemma":[0.998504,0.000035693425,0.00053327164,0.0008147275,0.00001882821,0.0000934676],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025877697,0.00044496247,0.0052794814,0.00015737224,0.000065751694,0.00004420251,0.00024187555,0.0001610678,0.000019757645],"category_scores_gemma":[0.000076119555,0.00030565166,0.00038201344,0.00010846742,0.000052954438,0.00007837377,0.00021585617,0.00027268656,0.00012299896],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000025869092,0.00026385227,0.0000036728381,0.77821624,0.0015629253,0.018541595,0.0000072125313,2.4973462e-10,8.959195e-9,0.000018982044,0.000019504441,0.20136341],"study_design_scores_gemma":[0.0028324863,0.00008969688,0.000024249592,0.89189386,0.024294924,0.011178072,0.000009591528,3.0692877e-7,9.7146916e-8,0.000005447944,0.06940834,0.0002629368],"about_ca_topic_score_codex":0.000022814302,"about_ca_topic_score_gemma":0.000012953857,"teacher_disagreement_score":0.20110048,"about_ca_system_score_codex":0.00004636206,"about_ca_system_score_gemma":0.00006887031,"threshold_uncertainty_score":0.99993956},"labels":[],"label_agreement":null},{"id":"W2583067962","doi":"10.1182/blood.v104.11.4075.4075","title":"Anti-Xa Levels in Critically Ill Patients Receiving Dalteparin for Thromboprophylaxis.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Université de Montréal; Université Laval; Dalhousie University; University of Toronto; McMaster University","funders":"","keywords":"Medicine; Creatinine; Heparin; Low molecular weight heparin; Anesthesia; Renal function; Internal medicine","score_opus":0.020916470155955116,"score_gpt":0.2808044959200315,"score_spread":0.2598880257640764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583067962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99179476,0.000098233635,0.0004107826,0.0015005671,0.00021422283,0.0011880891,0.00001644046,0.00006212181,0.004714803],"genre_scores_gemma":[0.99004835,0.000063494,0.0063626,0.0031684218,0.0001249138,0.00011874843,0.000025841564,0.00003751131,0.000050117127],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985975,0.000015645091,0.00033869737,0.00035345522,0.00026641978,0.00042827666],"domain_scores_gemma":[0.9990753,0.000044222626,0.000049584076,0.00029032794,0.0004229417,0.00011762979],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002028332,0.00016557082,0.00048466364,0.00012777727,0.00007517243,0.000027091128,0.00011001409,0.00009480944,0.000043070206],"category_scores_gemma":[0.0007185294,0.0001530994,0.00009838004,0.00017326247,0.00004264146,0.00007225968,0.00007164594,0.00013110423,0.000034440236],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017749441,0.075038075,0.7635188,0.0040724,0.0013405313,0.00047124788,0.004580912,0.00024212647,0.024225065,0.06357806,0.0055163167,0.05723896],"study_design_scores_gemma":[0.008719106,0.00095381954,0.9796439,0.00031851858,0.00017083407,0.0000038855756,0.000084787076,0.0000052413284,0.006527773,0.0021637422,0.0012067732,0.00020162265],"about_ca_topic_score_codex":0.00012346917,"about_ca_topic_score_gemma":0.00008750441,"teacher_disagreement_score":0.21612509,"about_ca_system_score_codex":0.00007181097,"about_ca_system_score_gemma":0.000074755626,"threshold_uncertainty_score":0.6243212},"labels":[],"label_agreement":null},{"id":"W2583180477","doi":"10.1182/blood.v114.22.2737.2737","title":"ARNT Mediates Chemotherapy Resistance by Modulating the Response to Oxidative Stress in AML Cells.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Aryl hydrocarbon receptor nuclear translocator; Apoptosis; Cancer research; Haematopoiesis; Etoposide; Biology; Chemistry; Transcription factor; Cell biology; Internal medicine; Stem cell; Medicine; Chemotherapy; Biochemistry","score_opus":0.009977501110921898,"score_gpt":0.2786471813479287,"score_spread":0.2686696802370068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583180477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.976549,0.00050204893,0.000041877753,0.02101159,0.00001962159,0.00063255243,0.00002671906,0.00004363932,0.0011729123],"genre_scores_gemma":[0.99317926,0.00009824293,0.0018329314,0.0021869875,0.000114199574,0.00003528533,0.000011765306,0.000021336666,0.0025199857],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983745,0.00020974605,0.0002507247,0.00032380348,0.0004291018,0.0004120927],"domain_scores_gemma":[0.9987968,0.00044696307,0.000058875008,0.00046586787,0.00008041606,0.00015103437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077594223,0.00015852871,0.00024712936,0.00011820379,0.00007376815,0.00002777079,0.00025129548,0.00008350348,0.00004597353],"category_scores_gemma":[0.00052186433,0.00011114791,0.0000443967,0.0005177147,0.000059700218,0.00005089067,0.000036929334,0.00037918857,0.000033364442],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002682078,0.00052896806,0.0025375343,0.000019896444,0.00004399911,0.00011139924,0.0038965356,0.000022940856,0.97786015,0.000027640543,0.009233309,0.0030355414],"study_design_scores_gemma":[0.005602149,0.0004739494,0.04931873,0.00020210176,0.000024424715,0.000006381668,0.0007544289,0.00017867667,0.9369704,0.00015443974,0.0061251093,0.00018919042],"about_ca_topic_score_codex":0.000055425637,"about_ca_topic_score_gemma":0.00006094118,"teacher_disagreement_score":0.046781197,"about_ca_system_score_codex":0.0001601645,"about_ca_system_score_gemma":0.00015392381,"threshold_uncertainty_score":0.45324802},"labels":[],"label_agreement":null},{"id":"W2583226182","doi":"10.1182/blood.v104.11.3616.3616","title":"Biotin-Labeled RBC Survival in Thalassemia and Impact of Treatment.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Biotinylation; Fetal hemoglobin; Biotin; Hemoglobin; Thalassemia; Hemolysis; Medicine; Red blood cell; Ex vivo; Andrology; Immunology; Gastroenterology; Internal medicine; Chemistry; Molecular biology; Biology; Biochemistry; Fetus; In vitro","score_opus":0.013105403268418244,"score_gpt":0.27520983705708907,"score_spread":0.2621044337886708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583226182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981006,0.0005255783,0.0000034047407,0.00010689578,0.00002420417,0.00019312282,0.000009376171,0.000015962994,0.0010208773],"genre_scores_gemma":[0.999384,0.00030612253,0.00020622597,0.000008166191,0.000035133155,0.0000028906543,0.000009926958,0.000010968673,0.000036573252],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994946,0.0000120821205,0.00013964418,0.00013782932,0.0000750854,0.00014076324],"domain_scores_gemma":[0.9997342,0.000022034448,0.000026279076,0.00012665313,0.000017437538,0.00007335089],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000056378598,0.000100970385,0.0002567087,0.000073768955,0.000014044653,0.0000037897337,0.0000206224,0.000068010864,0.000023343924],"category_scores_gemma":[0.0000100224115,0.000069242415,0.00006861425,0.00014239781,0.000028674825,0.00002811769,0.0000070966103,0.000060083756,0.0000028900254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000116422605,0.0021367378,0.84615797,0.000039009814,0.00017224145,0.00007789267,0.00032069784,0.0000037026343,0.14943439,0.00013269782,0.0000017930005,0.0014064555],"study_design_scores_gemma":[0.025292924,0.0028929708,0.9018147,0.00012221916,0.0002728561,0.00008452875,0.000046332905,0.0000049219852,0.069254115,0.00011927069,0.000013707221,0.00008146147],"about_ca_topic_score_codex":0.0016841997,"about_ca_topic_score_gemma":0.00027093646,"teacher_disagreement_score":0.08018027,"about_ca_system_score_codex":0.00003650548,"about_ca_system_score_gemma":0.00009357214,"threshold_uncertainty_score":0.28236237},"labels":[],"label_agreement":null},{"id":"W2583251953","doi":"10.1182/blood.v106.11.547.547","title":"Use of Low Dose Oral Vitamin K in the Treatment of Patients with INR Values of More Than 10.0.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Vitamin K Research Studies","field":"Nursing","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of Toronto; Dalhousie University; Western University; McGill University; McMaster University","funders":"","keywords":"Medicine; Warfarin; Atrial fibrillation; Venous thrombosis; Internal medicine; Thrombosis; Surgery; Gastroenterology","score_opus":0.028416205549058205,"score_gpt":0.2925170103415175,"score_spread":0.2641008047924593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583251953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990138,0.0001651705,5.1538956e-7,0.00018514103,0.000014799425,0.00046100546,0.00007448406,0.0000065661798,0.00007852781],"genre_scores_gemma":[0.9992045,0.00003331446,0.0005994261,0.000010599929,0.00001959053,0.000024387142,0.000013497445,0.000012389336,0.000082258994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884087,0.00012659184,0.00024526962,0.00014060746,0.0004397571,0.0002068889],"domain_scores_gemma":[0.9991961,0.00020798895,0.00012225672,0.00031670654,0.00013207653,0.000024845074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001091549,0.00012527902,0.00028372268,0.000109205655,0.000028728182,0.000007381572,0.00014008186,0.000033954893,0.000012475087],"category_scores_gemma":[0.00009938109,0.000070711394,0.000058071997,0.00023247104,0.00021032366,0.000114340524,0.000028028391,0.000046578694,0.000001980707],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069310307,0.013413164,0.9547493,0.0001282219,0.00022325416,0.0000058711057,0.01688543,0.00008290602,0.0011814672,0.000007663832,0.00029509928,0.0123345265],"study_design_scores_gemma":[0.004761568,0.0033884144,0.9266303,0.00012124742,0.00010038395,4.3632943e-7,0.0007566455,0.0000366986,0.063949734,0.0000099308645,0.00016659492,0.00007804917],"about_ca_topic_score_codex":0.00024091899,"about_ca_topic_score_gemma":0.00027479892,"teacher_disagreement_score":0.062768266,"about_ca_system_score_codex":0.000037789257,"about_ca_system_score_gemma":0.00001542865,"threshold_uncertainty_score":0.2883527},"labels":[],"label_agreement":null},{"id":"W2583294536","doi":"10.1182/blood.v126.23.3402.3402","title":"Impact of TCD Screening Protocol on the Incidence of Hemorrhagic Stroke in Children and Young Adults with Sickle Cell Disease","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Transcranial Doppler; Stroke (engine); Pediatrics; Sickle cell anemia; Incidence (geometry); Anemia; Cohort; Disease; Internal medicine","score_opus":0.007221818081483196,"score_gpt":0.24210420751528272,"score_spread":0.23488238943379952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583294536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98493284,0.00010559676,0.000004915678,0.00006085807,0.000003198823,0.014101313,0.000017700444,0.00000875923,0.00076481234],"genre_scores_gemma":[0.998823,0.000005223982,0.0001259474,0.000020746616,0.0000121703915,0.00096194487,0.000004681686,0.000011201007,0.00003506898],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99930114,0.000032771557,0.00016911146,0.00013641048,0.0002215283,0.00013904204],"domain_scores_gemma":[0.9994671,0.000021228454,0.000101733436,0.00020589886,0.00006203356,0.00014204647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013565377,0.000103587736,0.00017854254,0.000057224042,0.000017384244,0.000004368419,0.00006273896,0.00004215665,0.000010102047],"category_scores_gemma":[0.000070559916,0.00005388228,0.00004107056,0.00014206165,0.00008815362,0.000036549303,0.000028868597,0.00015165385,0.0000010931174],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013966339,0.0007061559,0.9963537,0.00008314909,0.000052182688,0.000021170603,0.00054280367,0.00008360993,0.00031986347,0.00000517359,0.00003147154,0.00040411926],"study_design_scores_gemma":[0.0126814125,0.0022168013,0.98043054,0.0006390124,0.00012945673,0.000041342286,0.00051438215,0.00038396972,0.002857802,0.0000112858315,0.0000014807864,0.00009250473],"about_ca_topic_score_codex":0.0006413394,"about_ca_topic_score_gemma":0.000015954438,"teacher_disagreement_score":0.015923116,"about_ca_system_score_codex":0.000009726513,"about_ca_system_score_gemma":0.00014775919,"threshold_uncertainty_score":0.21972556},"labels":[],"label_agreement":null},{"id":"W2583344781","doi":"10.1182/blood.v110.11.1636.1636","title":"Twenty-Seven Percent of Children with Congenital Heart Disease Have a Thrombotic Event Detected in the Post Operative Period: A Prospective Cohort Study.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Congenital Heart Disease Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Stollery Children's Hospital","funders":"","keywords":"Medicine; Thrombosis; Prospective cohort study; Cohort; Heart disease; Pediatrics; Venous thrombosis; Incidence (geometry); Cohort study; Surgery; Internal medicine","score_opus":0.007592283915640927,"score_gpt":0.2735060995994626,"score_spread":0.26591381568382166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583344781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920658,0.00056592684,0.0000038096898,0.00024426196,0.00002382961,0.0066775186,0.0000850623,0.000037072197,0.00029674356],"genre_scores_gemma":[0.9993276,0.000003974713,0.00005764882,0.00014114821,0.00007058579,0.00028269936,0.000024225094,0.00003156662,0.00006055973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979685,0.0001350403,0.0003797389,0.00045240074,0.00067252707,0.00039177935],"domain_scores_gemma":[0.99886787,0.00007682032,0.00005652147,0.00043737152,0.00035428026,0.00020715108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036250174,0.00028131963,0.00050076423,0.0001317653,0.0001463757,0.000022264314,0.00011813625,0.000036479607,0.00005391792],"category_scores_gemma":[0.00017522811,0.00017791442,0.00010947885,0.00034771304,0.00025641127,0.00007699168,0.00009488638,0.000258411,0.000011249837],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012266607,0.0064286967,0.9766481,0.00002373038,0.001099227,0.0003321568,0.013831964,9.990666e-7,0.00031915092,0.000003919109,0.00000796457,0.00007743893],"study_design_scores_gemma":[0.0064017647,0.0025980657,0.9722031,0.000076736644,0.001633481,0.0001590273,0.0164746,0.000010622572,0.0002386249,0.000004662915,0.0000014558146,0.00019789614],"about_ca_topic_score_codex":0.00034342307,"about_ca_topic_score_gemma":0.0027881407,"teacher_disagreement_score":0.0072618164,"about_ca_system_score_codex":0.00009586179,"about_ca_system_score_gemma":0.00028063674,"threshold_uncertainty_score":0.725514},"labels":[],"label_agreement":null},{"id":"W2583382445","doi":"10.1182/blood.v108.11.703.703","title":"IVIg-Primed Leukocytes Offer Longer Protection in the Amelioration of ITP Than IVIg.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Canadian Blood Services; St. Michael's Hospital","funders":"","keywords":"Medicine; Immunology; Antibody; Platelet; CD11c; Monoclonal antibody; Biology; Phenotype","score_opus":0.01399109793944824,"score_gpt":0.2353909805861872,"score_spread":0.22139988264673896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583382445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995904,0.00031469355,0.000044852044,0.00036928948,0.000024604507,0.0005698409,0.0000027564856,0.000018141616,0.0027518144],"genre_scores_gemma":[0.99951077,0.000016175924,0.00008036465,0.0000466014,0.00005198825,0.000059501683,0.00003432186,0.000008490604,0.00019177602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994168,0.00003592396,0.00015419097,0.00011575206,0.00016481742,0.000112472684],"domain_scores_gemma":[0.9997319,0.000018662275,0.000056517987,0.00015142249,0.000028237273,0.000013236893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000098381766,0.00008122466,0.00015351547,0.000071696064,0.000027979691,0.000008434952,0.000037274953,0.000056724875,0.000017493627],"category_scores_gemma":[0.0000205267,0.000051836156,0.000044675922,0.0001871394,0.000024693345,0.000050093615,0.0000066265884,0.00007829486,0.00001643655],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007390874,0.016292902,0.73513484,0.00031576364,0.00041730204,0.0006991977,0.0025060305,0.00004698383,0.22052522,0.0005990595,0.001038205,0.021685397],"study_design_scores_gemma":[0.006755569,0.0005300323,0.80963284,0.00009292726,0.00022658378,0.000096971125,0.0001944242,0.00010418832,0.18086095,0.0010556426,0.00034245054,0.0001074476],"about_ca_topic_score_codex":0.0010061286,"about_ca_topic_score_gemma":0.00047216326,"teacher_disagreement_score":0.074497975,"about_ca_system_score_codex":0.000014355654,"about_ca_system_score_gemma":0.000024983723,"threshold_uncertainty_score":0.2113817},"labels":[],"label_agreement":null},{"id":"W2583383492","doi":"10.1182/blood.v108.11.1954.1954","title":"Phase I/II Study of the Oral Isotype-Selective Histone Deacetylase (HDAC) Inhibitor MGCD0103 in Combination with Azacitidine in Patients (pts) with High-Risk Myelodysplastic Syndrome (MDS) or Acute Myelogenous Leukemia (AML).","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pyrogenesis (Canada)","funders":"","keywords":"Azacitidine; Medicine; Internal medicine; Myelodysplastic syndromes; Leukemia; Gastroenterology; Oncology; Pharmacology; Bone marrow; DNA methylation; Biology","score_opus":0.004730626248085849,"score_gpt":0.23500564337710644,"score_spread":0.2302750171290206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583383492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980103,0.00007308063,0.000027701892,0.000016573229,0.00007495841,0.0016084185,0.00011003247,0.000017180373,0.000061762505],"genre_scores_gemma":[0.9989352,0.000010403831,0.00015778038,0.000013058832,0.000045066106,0.00018056565,0.000188567,0.00006870037,0.00040062686],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997306,0.00033807795,0.00054141175,0.0006746239,0.0006147335,0.0005251928],"domain_scores_gemma":[0.9986961,0.000044160974,0.00030590306,0.00055919815,0.00030646278,0.000088177214],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026980523,0.0003685176,0.00046540116,0.00028043563,0.00020034224,0.00001867788,0.00033308807,0.00020532068,0.00000975445],"category_scores_gemma":[0.00011249837,0.00025607616,0.000054470525,0.00093711127,0.00023781336,0.00002181101,0.00018944583,0.00043452735,0.0000047114777],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028531414,0.1409017,0.26213354,0.00027141513,0.0013720746,0.0014566334,0.0028242685,0.0029320014,0.55582297,0.000036498215,0.0012567848,0.0024606814],"study_design_scores_gemma":[0.11180054,0.08193059,0.13824505,0.00020608284,0.00044890083,0.00016172754,0.00033471003,0.00008222728,0.6658389,0.000019334177,0.00010173199,0.0008301886],"about_ca_topic_score_codex":0.002729787,"about_ca_topic_score_gemma":0.01567129,"teacher_disagreement_score":0.1238885,"about_ca_system_score_codex":0.00036535878,"about_ca_system_score_gemma":0.00051950006,"threshold_uncertainty_score":0.99998915},"labels":[],"label_agreement":null},{"id":"W2583386249","doi":"10.1182/blood.v110.11.1469.1469","title":"Improved Leukemia-Free and Overall Survival in Patients with Myelodysplastic Syndrome Receiving Iron Chelation Therapy: A Subgroup Analysis.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Univariate analysis; International Prognostic Scoring System; Myelodysplastic syndromes; Anemia; Gastroenterology; Multivariate analysis; Neutropenia; Subgroup analysis; Bone marrow; Chemotherapy; Confidence interval","score_opus":0.008335129943534018,"score_gpt":0.23434987927183684,"score_spread":0.22601474932830282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583386249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983306,0.00013347153,0.00031883217,0.00006534424,0.0000318106,0.00062598404,0.0000082082,0.00005059953,0.00043513087],"genre_scores_gemma":[0.99851304,0.000049152313,0.0009825715,0.000069653295,0.00004991319,0.000014000599,0.00009418835,0.00004049442,0.00018699591],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99807715,0.000068776724,0.00035424475,0.0004520303,0.0005335364,0.0005142596],"domain_scores_gemma":[0.99882936,0.00025150122,0.0001132428,0.0004883191,0.000119090306,0.00019849035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078990596,0.00022588647,0.00047563267,0.00057507714,0.00006376518,0.00003340768,0.0001420014,0.0001646433,0.000043778942],"category_scores_gemma":[0.00023789477,0.00017957702,0.000062944615,0.0009318282,0.00007795486,0.00017198652,0.0000888563,0.0004363449,0.000004544592],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012352978,0.0003790956,0.9936474,0.000054056523,0.00047357258,0.000114161165,0.00024016913,0.00001717785,0.0025771188,0.000015859423,0.0000071883337,0.0012388936],"study_design_scores_gemma":[0.021368966,0.0009979635,0.97583735,0.00005801934,0.00039873194,0.000021875845,0.000036002515,0.0007679367,0.00028927327,0.000017952885,0.000013803876,0.00019212783],"about_ca_topic_score_codex":0.0004834235,"about_ca_topic_score_gemma":0.0005322222,"teacher_disagreement_score":0.020133667,"about_ca_system_score_codex":0.0004203389,"about_ca_system_score_gemma":0.00017674475,"threshold_uncertainty_score":0.73229384},"labels":[],"label_agreement":null},{"id":"W2583428393","doi":"10.1182/blood.v114.22.1916.1916","title":"Trends in the Incidence of HIV-Related Hematologic Malignancies in the Era of Combination Antiretroviral Therapy and Predictors of HIV-Related Non-Hodgkin's Lymphoma Development and Survival.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Cart; Incidence (geometry); Internal medicine; Hazard ratio; Proportional hazards model; Poisson regression; Lymphoma; Survival analysis; Multiple myeloma; Cohort; Oncology; Immunology; Population; Confidence interval","score_opus":0.011970394924396804,"score_gpt":0.23928175250731257,"score_spread":0.22731135758291576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583428393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99668306,0.0019761045,6.805829e-7,0.0005608228,0.000022688251,0.0003498551,0.000007118661,0.000008179445,0.00039150126],"genre_scores_gemma":[0.9991995,0.0005704003,0.000099131175,0.000056389625,0.0000030769336,0.00002032157,0.000032651667,0.000005621433,0.000012913296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986749,0.0001373778,0.0005404655,0.00018233822,0.0003126939,0.00015217703],"domain_scores_gemma":[0.99929446,0.00019541103,0.000237531,0.00019777661,0.000051174782,0.000023657136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005102559,0.00015677843,0.0004293312,0.0001734153,0.000033171924,0.0000076209767,0.00011397892,0.000103595565,0.0000056741355],"category_scores_gemma":[0.000039859773,0.000086064145,0.00004719962,0.00051419425,0.00013995546,0.00006151595,0.00001972938,0.00006990666,3.3729367e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008425121,0.0028298781,0.9736049,0.00003696244,0.000091157264,0.000055167617,0.008334573,0.0000013509086,0.0011832748,0.0008500644,0.000021439535,0.012906947],"study_design_scores_gemma":[0.010390545,0.0011158955,0.9687215,0.0003015408,0.00008140925,0.00006870515,0.00072285184,0.00003935909,0.018333,0.00014494892,0.0000073512783,0.00007286524],"about_ca_topic_score_codex":0.00010903776,"about_ca_topic_score_gemma":0.000021039348,"teacher_disagreement_score":0.017149724,"about_ca_system_score_codex":0.00002663698,"about_ca_system_score_gemma":0.00006772359,"threshold_uncertainty_score":0.3509594},"labels":[],"label_agreement":null},{"id":"W2583428451","doi":"10.1182/blood.v104.11.1969.1969","title":"Generation of a Pre-Leukemic, Transplantable Cell Line from the AML-Associated NUP98-TOP1 Fusion Gene as a New Model To Test Potential Collaborating Genes.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"DNA and Nucleic Acid Chemistry","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; Fusion gene; Haematopoiesis; Cell culture; Molecular biology; Transplantation; Stem cell; Bone marrow; Cancer research; Chromosomal translocation; Progenitor cell; Cell biology; Gene; Immunology; Genetics; Medicine","score_opus":0.009710767940772249,"score_gpt":0.2143480067862502,"score_spread":0.20463723884547796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583428451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913642,0.0009093902,0.0067659128,0.00020435493,0.000051134022,0.00020826233,0.00030197235,0.000016246564,0.00017852522],"genre_scores_gemma":[0.9921322,0.00026899372,0.0048761056,0.00036463016,0.00048903964,0.000012498957,0.0007987457,0.000028498398,0.0010293182],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99899817,0.00001783963,0.0002686984,0.00032767706,0.00017485394,0.00021275149],"domain_scores_gemma":[0.9993244,0.000009288758,0.00012277495,0.0003090969,0.000105641055,0.00012881859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007850635,0.00017020552,0.00015931764,0.000012455566,0.00010728953,0.000034657493,0.0002311304,0.00021412739,0.0000131443185],"category_scores_gemma":[0.000071343355,0.00014650951,0.00007533719,0.0001199727,0.000017559776,0.000006763908,0.00006912822,0.000081226855,0.000004485763],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006235978,0.00038769428,0.00016719298,0.000008335999,0.00005190579,0.0000040718032,0.00019170623,0.019069634,0.9794731,0.0000012423206,0.00047235627,0.000110405315],"study_design_scores_gemma":[0.002150713,0.00024279274,0.0000546613,0.000024602648,0.00015884438,0.000007728971,0.00003416736,0.0018543698,0.9951058,0.000043851513,0.00014730394,0.0001751866],"about_ca_topic_score_codex":0.0004123659,"about_ca_topic_score_gemma":0.00016389319,"teacher_disagreement_score":0.017215265,"about_ca_system_score_codex":0.000026580603,"about_ca_system_score_gemma":0.00046577613,"threshold_uncertainty_score":0.59744847},"labels":[],"label_agreement":null},{"id":"W2583428454","doi":"10.1182/blood.v104.11.709.709","title":"Clinical Outcomes with Unfractionated Heparin or Low-Molecular-Weight Heparin as Bridging Therapy in Patients on Long-Term Oral Anticoagulants: Results from the REGIMEN Registry.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Joseph's Hospital; Hamilton General Hospital","funders":"","keywords":"Medicine; Perioperative; Regimen; Heparin; Low molecular weight heparin; Adverse effect; Surgery; Tolerability; Prospective cohort study; Anticoagulant; Anesthesia; Internal medicine","score_opus":0.05085307861227575,"score_gpt":0.3514106695167056,"score_spread":0.30055759090442985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583428454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99348885,0.000034117154,0.00004415395,0.004277053,0.0002195248,0.00094080996,0.000018529408,0.00009506615,0.00088192226],"genre_scores_gemma":[0.99626917,0.00015550842,0.00029984696,0.0016181512,0.0002966685,0.000005218508,0.00032753788,0.000038387807,0.0009894852],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977765,0.00014329299,0.0006964778,0.00052077015,0.0005626722,0.00030029935],"domain_scores_gemma":[0.9984386,0.0003576498,0.0003272719,0.0006854356,0.000082783474,0.000108255364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003557968,0.00027284073,0.00056461856,0.00009770494,0.00009585704,0.00006243863,0.00019458217,0.00013648257,0.000048510592],"category_scores_gemma":[0.00053786405,0.00015294546,0.00016409896,0.00032541156,0.000088237,0.00011607435,0.000063101834,0.0003031772,0.00007149845],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068903575,0.00050642947,0.98780346,0.00000771488,0.00051771343,0.00031132044,0.000087653556,0.000050717186,0.000020741521,0.000081917366,0.00013171694,0.0035902448],"study_design_scores_gemma":[0.04070674,0.00080523547,0.95670366,0.00026487277,0.00018783784,0.000005898294,0.00001999531,0.000009265513,0.0006018469,0.000056067936,0.00043259317,0.00020596868],"about_ca_topic_score_codex":0.0008047717,"about_ca_topic_score_gemma":0.00027657667,"teacher_disagreement_score":0.03381638,"about_ca_system_score_codex":0.00006418897,"about_ca_system_score_gemma":0.00012694283,"threshold_uncertainty_score":0.6236935},"labels":[],"label_agreement":null},{"id":"W2583481401","doi":"10.1182/blood.v108.11.877.877","title":"Evaluation of a VENOus-Return Assist Device (Venowave™) To Treat Severe Post-Thrombotic Syndrome (VENOPTS): A Randomized Controlled Trial.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Stroke Rehabilitation and Recovery","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McMaster University","funders":"","keywords":"Medicine; Post-thrombotic syndrome; Randomized controlled trial; Quality of life (healthcare); Physical therapy; Clinical trial; Internal medicine; Venous thrombosis; Thrombosis","score_opus":0.014609920796257784,"score_gpt":0.28209329907269853,"score_spread":0.26748337827644075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583481401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9784653,0.0013934871,0.000053080184,0.00077208836,0.00034863548,0.009641895,0.00002247669,0.000060975442,0.009242039],"genre_scores_gemma":[0.99617624,0.000011257438,0.0007453884,0.00015004749,0.00017993618,0.0010454388,0.000052331474,0.000033717668,0.0016056144],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9963302,0.0009314199,0.000998296,0.0003375942,0.0011364807,0.00026598817],"domain_scores_gemma":[0.99683875,0.0012603246,0.0003500706,0.0003792536,0.0010352128,0.00013641897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033799645,0.00024673177,0.002166084,0.0003343139,0.00006500957,0.000022696984,0.00008482498,0.00015737402,0.00042782456],"category_scores_gemma":[0.0036209642,0.00017719185,0.00077944587,0.00032733878,0.00008683367,0.000064765714,0.0000193564,0.00012745515,0.000066956156],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97099197,0.009153294,0.0007027374,0.0003673583,0.0017603509,0.000047109068,0.00048923504,0.00018191757,0.013999757,0.00013287195,0.00032048288,0.0018529212],"study_design_scores_gemma":[0.9760067,0.0026511475,0.009941892,0.0002808088,0.009081579,0.00020774214,0.00013899445,0.0002944333,0.00091464387,0.00024715145,0.000050416653,0.0001844855],"about_ca_topic_score_codex":0.00018443368,"about_ca_topic_score_gemma":0.000039814535,"teacher_disagreement_score":0.017710945,"about_ca_system_score_codex":0.00014668763,"about_ca_system_score_gemma":0.00056049705,"threshold_uncertainty_score":0.7225674},"labels":[],"label_agreement":null},{"id":"W2583481547","doi":"10.1182/blood.v116.21.2740.2740","title":"Flow Cytometric Assessment of Post Induction Response In Patients with Sub-Optimal Morphologic Response to Induction Chemotherapy- A Report From the Children's Oncology Group AML Protocol AAML0531","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Hospital for Sick Children","funders":"","keywords":"Induction chemotherapy; Medicine; Internal medicine; Chemotherapy; Cohort; Refractory (planetary science); Induction therapy; Chemotherapy regimen; Oncology; Bone marrow; Complete response; Gastroenterology; Cytarabine; Surgery; Biology","score_opus":0.011811866891324864,"score_gpt":0.3150428928005589,"score_spread":0.30323102590923406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583481547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9560191,0.0000019082909,0.000074221316,0.0025722089,0.000094528754,0.041105296,0.000042709205,0.00005196806,0.000038030063],"genre_scores_gemma":[0.97109455,9.886583e-7,0.012525666,0.00033161853,0.0001945659,0.015623141,0.0001297509,0.000052818872,0.0000468994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965446,0.0008655902,0.00063679606,0.0006483199,0.0008689949,0.0004356748],"domain_scores_gemma":[0.9975143,0.0004879063,0.00036647334,0.00096689234,0.0004762661,0.00018812556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003372027,0.00026924428,0.00049612526,0.0009356335,0.000096919066,0.000025732457,0.0002882633,0.00038903428,0.00012386817],"category_scores_gemma":[0.00222262,0.00017665845,0.00007965963,0.0020612238,0.00020364062,0.00014446852,0.00013682505,0.0013676324,0.000012692765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0783399,0.0037218693,0.53736895,0.000011425841,0.00016829795,0.00026004884,0.00036711674,0.000018344988,0.3742791,0.0000011530228,0.00026683393,0.005196963],"study_design_scores_gemma":[0.017637769,0.010828254,0.95122,0.00004831104,0.00007407647,0.0004425078,0.00009704441,0.000031659674,0.018823557,0.0000034224688,0.000618139,0.00017525771],"about_ca_topic_score_codex":0.00043971054,"about_ca_topic_score_gemma":0.00005824271,"teacher_disagreement_score":0.41385105,"about_ca_system_score_codex":0.000535528,"about_ca_system_score_gemma":0.0012568042,"threshold_uncertainty_score":0.7203922},"labels":[],"label_agreement":null},{"id":"W2583518335","doi":"10.1182/blood.v116.21.1704.1704","title":"Human Leukemia Xenotransplantation Into Zebrafish Embryos as An In Vivo Assay for Chemotherapy Drug Response","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Zebrafish Biomedical Research Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Zebrafish; Biology; Cancer research; Leukemia; In vivo; Cancer; Xenotransplantation; Cancer cell; Cell culture; Immunology; Transplantation; Medicine; Genetics; Internal medicine","score_opus":0.007221797776056202,"score_gpt":0.3017126740959472,"score_spread":0.294490876319891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583518335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99759614,0.000018756176,0.0005349813,0.0007740847,0.00003673691,0.00058265444,0.000049579845,0.000024925333,0.0003821307],"genre_scores_gemma":[0.9954945,0.000018095387,0.0025177205,0.00053604547,0.00023205929,0.00036176192,0.00025764323,0.000030606763,0.000551581],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987726,0.00011131029,0.00021437451,0.00041136853,0.00019406319,0.00029624702],"domain_scores_gemma":[0.99915665,0.00006585807,0.000050841823,0.0004447151,0.00008678664,0.00019516994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009476452,0.00013280792,0.0001166076,0.00008593627,0.000119452256,0.00004081513,0.00035249552,0.00021880321,0.000080441154],"category_scores_gemma":[0.00031369383,0.00013560096,0.00006109189,0.00013618554,0.00012980116,0.000009180967,0.000029754792,0.0001982952,0.000010399419],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033396928,0.00030812094,0.00045005602,0.000018591076,0.000021689588,0.0000026996806,0.00015029058,6.188343e-7,0.9962172,0.00028468642,0.0013157234,0.00089635816],"study_design_scores_gemma":[0.002980321,0.00033318004,0.0049426216,0.000008104105,0.0000117602995,0.000008834791,0.000043795804,0.00003421735,0.9638986,0.0014383624,0.026127229,0.00017295155],"about_ca_topic_score_codex":0.0001638134,"about_ca_topic_score_gemma":0.0016043561,"teacher_disagreement_score":0.032318573,"about_ca_system_score_codex":0.000019875086,"about_ca_system_score_gemma":0.0002708564,"threshold_uncertainty_score":0.5529646},"labels":[],"label_agreement":null},{"id":"W2583600258","doi":"10.1182/blood.v118.21.3545.3545","title":"Presence of Residual Disease Detected by Multidimensional Flow Cytometry Identifies Patients with AML At High Risk of Relapse – a Report From the Children's Oncology Group,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Hospital for Sick Children","funders":"","keywords":"Gemtuzumab ozogamicin; Internal medicine; Medicine; Minimal residual disease; Induction chemotherapy; Chemotherapy; Oncology; Cohort; Gastroenterology; Bone marrow; Biology; Stem cell","score_opus":0.008735062536538957,"score_gpt":0.2341179727407999,"score_spread":0.22538291020426093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583600258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975353,0.0003174849,0.000037445803,0.000072500225,0.00006627947,0.0008139484,0.0010719647,0.000034913024,0.000050145933],"genre_scores_gemma":[0.99393815,0.000062713894,0.00484852,0.00002879609,0.00006389601,0.000041862688,0.0007688052,0.000035233177,0.00021200585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974627,0.00029766274,0.0005193548,0.00046661147,0.0009528729,0.00030081003],"domain_scores_gemma":[0.9972849,0.00064684945,0.0004855181,0.000931676,0.00041498814,0.00023605839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000375748,0.00019378083,0.00041110543,0.00011470644,0.00010762629,0.0000038182006,0.0002589719,0.00013790124,0.00020147617],"category_scores_gemma":[0.0020135897,0.000119709635,0.000089031615,0.0003265847,0.0005329289,0.00008673762,0.00035644745,0.0003925817,0.000012101401],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004447536,0.0019851392,0.9802768,0.00002806936,0.0007886438,0.0003318917,0.00042363076,0.000001379401,0.007567154,0.0000030190363,0.003873115,0.00027359935],"study_design_scores_gemma":[0.008587549,0.00085643766,0.9496146,0.00010216241,0.00089240586,0.000040703988,0.00004615576,0.000024091894,0.039654102,0.0000337349,0.000031642845,0.000116424344],"about_ca_topic_score_codex":0.0037943549,"about_ca_topic_score_gemma":0.00017020213,"teacher_disagreement_score":0.032086946,"about_ca_system_score_codex":0.00009244337,"about_ca_system_score_gemma":0.000305655,"threshold_uncertainty_score":0.57359546},"labels":[],"label_agreement":null},{"id":"W2583625678","doi":"10.1182/blood.v112.11.1045.1045","title":"Frequency and Natural History of Inherited Bone Marrow Failure Syndromes: The Israeli Inherited Bone Marrow Failure Registry","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Bone marrow failure; Fanconi anemia; Diamond–Blackfan anemia; Pediatrics; Bone marrow; Internal medicine; Aplastic anemia; Congenital Neutropenia; Incidence (geometry); Surgery; Neutropenia","score_opus":0.01241087291709197,"score_gpt":0.2118885139838906,"score_spread":0.19947764106679863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583625678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9479748,0.050234027,0.000024073786,0.00094099913,0.00012925558,0.0002108533,0.000047588976,0.000022732263,0.00041566222],"genre_scores_gemma":[0.9920963,0.0011752646,0.0010839525,0.0003191032,0.00014532999,0.00005361935,0.00015240534,0.000034234632,0.0049397955],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987597,0.000077340264,0.00032014083,0.00040750712,0.00018590208,0.0002494219],"domain_scores_gemma":[0.9988255,0.000011672128,0.00020666808,0.0007225112,0.0001519966,0.00008163496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011905275,0.00022275923,0.00024368844,0.00005175757,0.00011975802,0.000013529299,0.00024555888,0.00025090802,0.000053698608],"category_scores_gemma":[0.00006648369,0.0001807269,0.00011189545,0.0001526555,0.0004236375,0.000011369394,0.00008299872,0.00023343103,0.0000039726256],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025714226,0.0001535914,0.0036378026,0.000058846363,0.00011136762,0.000037579313,0.00021123159,0.0000011951503,0.96215886,0.00007426859,0.033301607,0.00022790712],"study_design_scores_gemma":[0.007834684,0.0008030573,0.09155457,0.00024395216,0.00047169736,0.0052217627,0.001780008,0.00005940395,0.12984714,0.00021269638,0.7602019,0.0017691519],"about_ca_topic_score_codex":0.00014056417,"about_ca_topic_score_gemma":0.00015925251,"teacher_disagreement_score":0.83231175,"about_ca_system_score_codex":0.000036782894,"about_ca_system_score_gemma":0.00020430426,"threshold_uncertainty_score":0.7369829},"labels":[],"label_agreement":null},{"id":"W2583651793","doi":"10.1182/blood.v108.11.2140.2140","title":"Imatinib in Children with Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CP CML): AAML0123 COG Study.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Imatinib; Imatinib mesylate; Chronic myelogenous leukemia; Internal medicine; Gastroenterology; Absolute neutrophil count; Phases of clinical research; Leukemia; Chemotherapy; Surgery; Neutropenia; Myeloid leukemia","score_opus":0.008364758774985158,"score_gpt":0.25655507079033585,"score_spread":0.2481903120153507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583651793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98767835,0.006164267,0.000023789831,0.00008004335,0.000070614,0.003940448,0.000059033835,0.00027916624,0.0017042755],"genre_scores_gemma":[0.9965621,0.00014308252,0.0005367914,0.0000863604,0.0009174898,0.0004957072,0.0004555093,0.00014978362,0.0006531535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963397,0.00012088222,0.00077142176,0.00096644973,0.0006988808,0.0011026791],"domain_scores_gemma":[0.99814975,0.00011342528,0.00026941064,0.0011279299,0.00008334323,0.0002561458],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024488123,0.00065368816,0.00094140886,0.0003095546,0.00016229339,0.000052713563,0.00031822236,0.0002169368,0.00038292707],"category_scores_gemma":[0.000046210364,0.0005449396,0.00015371833,0.00071142666,0.00016910858,0.00016260752,0.00010738496,0.0005816724,0.00027516828],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006304145,0.024305006,0.93336666,0.00022052719,0.0024452333,0.004452663,0.0008260944,0.0008266283,0.007473755,0.000048984028,0.00097007875,0.02443398],"study_design_scores_gemma":[0.23768668,0.009681951,0.73800266,0.00039500152,0.0025913198,0.0013887874,0.00013765905,0.00026151186,0.008573147,0.000026804399,0.0004942707,0.00076022674],"about_ca_topic_score_codex":0.0065322346,"about_ca_topic_score_gemma":0.005570598,"teacher_disagreement_score":0.23705627,"about_ca_system_score_codex":0.004176517,"about_ca_system_score_gemma":0.0037630387,"threshold_uncertainty_score":0.9997002},"labels":[],"label_agreement":null},{"id":"W2583725139","doi":"10.1182/blood.v106.11.3118.3118","title":"Dosing Patterns and Transfusion Use in Cancer Patients Treated with Erythropoietic Agents: Results of an Observational Study of over 8,000 Patients.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Epoetin alfa; Dosing; Darbepoetin alfa; Anemia; Observational study; Cancer; Internal medicine; Erythropoietin; Cumulative dose; Pediatrics","score_opus":0.049912485274118144,"score_gpt":0.3017985016429369,"score_spread":0.2518860163688188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583725139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99895304,0.000025524252,3.986515e-7,0.00006044689,0.000014900408,0.0007370648,0.0001667002,0.000011390498,0.00003054981],"genre_scores_gemma":[0.99932945,0.000120922334,0.00019602942,0.000047737376,0.000019757388,0.000021752716,0.0002115598,0.000018419405,0.000034376633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988006,0.00005008826,0.00040670877,0.0002649356,0.00033971842,0.00013799561],"domain_scores_gemma":[0.9994118,0.000033328506,0.00013666449,0.00017687441,0.00017013426,0.00007114961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004906654,0.00014809822,0.00027958115,0.000094980154,0.000030155796,0.0000062320446,0.000032796994,0.000050715855,0.00005027122],"category_scores_gemma":[0.000018502878,0.000108459695,0.000022084938,0.00018561969,0.000045490968,0.00014906116,0.0000135438095,0.000070735434,2.0616449e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008468035,0.023795603,0.9703475,0.00006601284,0.00009019088,0.000009609036,0.002701388,0.000022601822,0.00026204676,4.3860246e-7,0.000013175974,0.0018446147],"study_design_scores_gemma":[0.04416,0.0042344527,0.9472629,0.0004301992,0.00027787083,0.0000012068207,0.0003167378,0.00002988352,0.003176268,3.399176e-7,0.00001526769,0.000094917494],"about_ca_topic_score_codex":0.0069039217,"about_ca_topic_score_gemma":0.0042895526,"teacher_disagreement_score":0.043313198,"about_ca_system_score_codex":0.00004884292,"about_ca_system_score_gemma":0.000028891614,"threshold_uncertainty_score":0.9997092},"labels":[],"label_agreement":null},{"id":"W2583747254","doi":"10.1182/blood.v108.11.459.459","title":"Fracture Prevalence and Relationship to Endocrinopathy in Iron Overloaded Patients with Sickle Cell Disease and Thalassemia.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Thalassemia; Ferritin; Gastroenterology; Sickle cell anemia; Incidence (geometry); Prospective cohort study; Pediatrics; Osteoporosis; Disease","score_opus":0.002904863821748871,"score_gpt":0.1913925935633012,"score_spread":0.18848772974155234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583747254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956282,0.0019400335,0.00000570977,0.00042360974,0.000013649936,0.0005333633,0.000013401476,0.000025448673,0.0014166079],"genre_scores_gemma":[0.9990036,0.000084877924,0.00015219243,0.00022826003,0.00002245585,0.000016702963,0.00002413699,0.000015281232,0.00045249297],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99924386,0.000022898514,0.00013572532,0.00024633977,0.00016106345,0.00019012857],"domain_scores_gemma":[0.9995709,0.000044908837,0.000036963524,0.00014942065,0.000025382218,0.00017244219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000033026405,0.00012409946,0.0001300684,0.00007276417,0.000050673956,0.0000148911595,0.000027071783,0.000064261905,0.000010975316],"category_scores_gemma":[0.000042558062,0.00009299871,0.000014463792,0.00013258083,0.000037568178,0.000067045905,0.00002335176,0.00017896685,0.000005874012],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013605335,0.000617973,0.9982986,0.0002256976,0.0000042300608,0.000055468732,0.00018099073,0.000030674866,0.00016163902,0.00002224849,0.00018632067,0.00008014443],"study_design_scores_gemma":[0.0047597657,0.0002366491,0.99380326,0.00018967193,0.00016397494,0.0000065430067,0.000047015736,0.000010448764,0.00032739533,0.0000677856,0.00026788717,0.000119577875],"about_ca_topic_score_codex":0.00005797535,"about_ca_topic_score_gemma":0.000013217506,"teacher_disagreement_score":0.0046237125,"about_ca_system_score_codex":0.000013259792,"about_ca_system_score_gemma":0.000033469576,"threshold_uncertainty_score":0.3792377},"labels":[],"label_agreement":null},{"id":"W2583767956","doi":"10.1182/blood.v110.11.213.213","title":"FDG-PET Guided Consolidative Radiotherapy in Patients with Advanced Stage Hodgkin Lymphoma with Residual Abnormalities on Post Chemotherapy CT Scan.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"ABVD; Medicine; Stage (stratigraphy); Chemotherapy; Lymphoma; Radiation therapy; Radiology; Nuclear medicine; Positron emission tomography; Progressive disease; Dacarbazine; Internal medicine; Vincristine; Cyclophosphamide","score_opus":0.006887419519681552,"score_gpt":0.24891706256382792,"score_spread":0.24202964304414637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583767956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99542177,0.0002758324,0.0000075039175,0.00036301828,0.000034406883,0.0011202168,0.0001010328,0.00006834695,0.00260785],"genre_scores_gemma":[0.9950735,0.0001074196,0.0024988186,0.0015332176,0.00006267402,0.00006992263,0.00014606249,0.00006452552,0.00044383275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981509,0.000052710384,0.000348504,0.00043593472,0.0005169532,0.0004950319],"domain_scores_gemma":[0.99893385,0.00013698933,0.00017085094,0.00042560397,0.00016584243,0.00016688215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001848207,0.0003612072,0.00050829956,0.00021407763,0.00007550935,0.000028494997,0.00009465037,0.00004278636,0.00011651869],"category_scores_gemma":[0.000021625425,0.0002381243,0.00004970358,0.00026174268,0.00012467915,0.00012937727,0.000011528828,0.00007487401,0.0000093010085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0091054225,0.007820475,0.9675835,0.00004399461,0.0007071093,0.0014949271,0.0010976196,0.00001762693,0.00018065612,0.0003243349,0.0002301505,0.011394233],"study_design_scores_gemma":[0.08507539,0.0075416714,0.86137617,0.00033932604,0.00009202887,0.0001034759,0.0005747925,0.0000010114493,0.043598965,0.0000041031954,0.0010001861,0.0002929032],"about_ca_topic_score_codex":0.0003990414,"about_ca_topic_score_gemma":0.00023718244,"teacher_disagreement_score":0.10620731,"about_ca_system_score_codex":0.00034249635,"about_ca_system_score_gemma":0.00024190196,"threshold_uncertainty_score":0.9710427},"labels":[],"label_agreement":null},{"id":"W2583791366","doi":"10.1182/blood.v124.21.2799.2799","title":"Thromboembolic Events, Recurrent Gastrointestinal Bleeding and Mortality after Resuming Anticoagulant Following Gastrointestinal Bleeding: A Systematic Review and Meta-Analysis","year":2014,"lang":"en","type":"review","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; St. Joseph's Hospital; McMaster University","funders":"","keywords":"Medicine; Warfarin; Gastrointestinal bleeding; Anticoagulant; Internal medicine; Cohort study; Surgery; Randomized controlled trial; Lower gastrointestinal bleeding; Atrial fibrillation; Colonoscopy","score_opus":0.14337346385879765,"score_gpt":0.39096237112673243,"score_spread":0.24758890726793478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583791366","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00050023256,0.9951874,0.0003318217,0.00013338555,0.00005394954,0.0035791472,0.000029053044,0.0000967016,0.000088294415],"genre_scores_gemma":[0.0025180709,0.99357027,0.002834085,0.00012434673,0.00033792807,0.00015666509,0.00012267644,0.00009099235,0.00024494666],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9949831,0.0004763809,0.0022169559,0.0010041607,0.00074425846,0.0005751514],"domain_scores_gemma":[0.9969862,0.00043346654,0.0013664168,0.00075069006,0.00012064084,0.00034257068],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002469001,0.0009361661,0.012357524,0.00059381995,0.00015436126,0.00013062029,0.0001941589,0.00009972477,0.00008332833],"category_scores_gemma":[0.0011862622,0.0006343827,0.003993985,0.0008305342,0.000065856,0.00014748558,0.00031162117,0.00044130173,0.00001583092],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006169286,0.000040312087,0.011452144,0.89882696,0.08926895,0.00014603205,0.000017084449,1.4755108e-7,8.958987e-7,0.00005072106,0.00001690195,0.00017371227],"study_design_scores_gemma":[0.0005021418,0.00011886913,0.0014399127,0.15190183,0.84364074,0.0011461041,0.000014552742,0.000021464984,8.892985e-8,0.000009965851,0.00080246583,0.00040188193],"about_ca_topic_score_codex":0.000015428426,"about_ca_topic_score_gemma":0.0000058234277,"teacher_disagreement_score":0.75437176,"about_ca_system_score_codex":0.00005511216,"about_ca_system_score_gemma":0.00007356956,"threshold_uncertainty_score":0.9996107},"labels":[],"label_agreement":null},{"id":"W2583798742","doi":"10.1182/blood.v104.11.2889.2889","title":"Upregulation of MT1-MMP Expression by Hyaluronic Acid Enhances Homing-Related Responses of Hematopoietic CD34+ Cells to an SDF-1 Gradient.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Canadian Blood Services","funders":"","keywords":"CD34; Homing (biology); CD44; Matrix metalloproteinase; Chemistry; Chemotaxis assay; Stem cell; Progenitor cell; Cell biology; Haematopoiesis; Molecular biology; Biology; Chemotaxis; Cell; Receptor; Biochemistry","score_opus":0.005301487733537981,"score_gpt":0.22344331966638376,"score_spread":0.21814183193284578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583798742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974214,0.0010658397,0.0010230603,0.00002423943,0.00008430512,0.00025496594,0.0000313814,0.00001291696,0.000081926046],"genre_scores_gemma":[0.9982859,0.00003609278,0.0013914589,0.000025579184,0.000038084545,0.000021341073,0.00006145689,0.000018660354,0.000121448575],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990049,0.000072644056,0.00029204646,0.00029470294,0.00015502745,0.00018068218],"domain_scores_gemma":[0.99933076,0.0000062339827,0.0001563613,0.00035650423,0.00006339319,0.0000867461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014967419,0.00013598807,0.0001721502,0.00005149646,0.000043145432,0.00000694057,0.00016334749,0.00015284587,0.00001699291],"category_scores_gemma":[0.000039686707,0.00012824874,0.00007726626,0.00009853592,0.000043277876,0.000009387001,0.000065990214,0.000048553928,0.0000048711313],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013077525,0.00039344083,0.00003482273,0.000032306012,0.000023727509,0.000001147739,0.00018640042,0.000037669048,0.99892575,0.00006696244,0.00007021867,0.00009677693],"study_design_scores_gemma":[0.0011370756,0.0013547953,0.000070601745,0.000112533715,0.000035936424,0.000006177458,0.000061822786,0.0000029348907,0.9964243,0.0005514988,0.00009812178,0.00014416587],"about_ca_topic_score_codex":0.000013536387,"about_ca_topic_score_gemma":0.0000041606636,"teacher_disagreement_score":0.0025014167,"about_ca_system_score_codex":0.0000074032214,"about_ca_system_score_gemma":0.000062276136,"threshold_uncertainty_score":0.5229832},"labels":[],"label_agreement":null},{"id":"W2583834953","doi":"10.1182/blood.v120.21.2333.2333","title":"Identification of a Novel Protein-Coding Gene (TIHL) and Its Functional Relevance in Myeloid Cells.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; Molecular biology; Haematopoiesis; Myeloid leukemia; CIITA; Myeloid; Leukemia; Gene expression; Bone marrow; Stem cell; Cancer research; Gene; T cell; Cell biology; Immunology; Genetics; Immune system; MHC class II","score_opus":0.020084399462255497,"score_gpt":0.25597672552031925,"score_spread":0.23589232605806376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583834953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996941,0.0011010068,0.001461013,0.000037230056,0.00003795802,0.00025402644,0.000012695655,0.000003574417,0.0001515412],"genre_scores_gemma":[0.9985219,0.00008758286,0.00052618195,0.000013135619,0.00009520405,0.000045780063,0.000023617155,0.000008227699,0.0006783258],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99938446,0.000021111899,0.00016811682,0.00015026127,0.00012392989,0.00015211441],"domain_scores_gemma":[0.99969035,0.0000072664293,0.00006138201,0.00011993357,0.00007282658,0.000048253816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024655613,0.00006147874,0.00006354442,0.000052215833,0.000029480998,0.000008074596,0.000053662283,0.00007001441,0.0000129434975],"category_scores_gemma":[0.00013946753,0.00006238187,0.000021056234,0.000090732705,0.000022445716,0.000008161276,0.000049677612,0.000056461944,0.000006161305],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031173324,0.00024498304,0.0012282496,0.00003404691,0.000009692469,2.2759852e-7,0.000028082819,0.000009198708,0.99779946,0.00024275211,0.000012396284,0.00035973915],"study_design_scores_gemma":[0.00089459616,0.000038309212,0.009840626,0.0000105090285,0.0000042198394,0.0000073720794,0.000011685901,0.00017548297,0.9881195,0.000007942779,0.00082352664,0.00006626917],"about_ca_topic_score_codex":0.000005452371,"about_ca_topic_score_gemma":0.000006540085,"teacher_disagreement_score":0.009679997,"about_ca_system_score_codex":0.000005021473,"about_ca_system_score_gemma":0.00002706886,"threshold_uncertainty_score":0.2543859},"labels":[],"label_agreement":null},{"id":"W2583856608","doi":"10.1182/blood.v108.11.3251.3251","title":"Ex Vivo Gene Trasfer for Hemophilia A That Enhances Safety and Results in Sustained In Vivo Factor VIII Expression from Lentivirally-Engineered Endothelial Progenitors.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Queen's University","funders":"","keywords":"Matrigel; Genetic enhancement; Ex vivo; In vivo; Progenitor cell; Viral vector; Transgene; Molecular biology; Medicine; Immunology; Biology; Stem cell; Gene; Recombinant DNA; Cell biology","score_opus":0.010572929454701736,"score_gpt":0.25013895094200556,"score_spread":0.23956602148730383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583856608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964426,0.0011910842,0.00021537948,0.000079092344,0.000060910996,0.00083962164,0.0010580005,0.000016151225,0.0000971491],"genre_scores_gemma":[0.9978652,0.0002645449,0.0006141785,0.000020161455,0.0003072299,0.00010648196,0.00022403504,0.000039862,0.0005582861],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99831796,0.00011225798,0.0003810018,0.00056368863,0.00019292573,0.00043218044],"domain_scores_gemma":[0.99945724,0.00005417052,0.000073559044,0.00030118861,0.00004839218,0.00006542967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025189054,0.00023358747,0.00025350795,0.000106418775,0.000053898286,0.000034745775,0.00019577489,0.00021508035,0.0000216164],"category_scores_gemma":[0.00007272903,0.0002175324,0.000078612036,0.000100467245,0.000056738747,0.000011417031,0.00007436345,0.00011360723,9.736634e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067300797,0.00034881593,0.0016971576,0.000023026327,0.000030404697,0.00001176059,0.000104511,0.000023380358,0.9905163,0.0000017891089,0.00008342113,0.00042934946],"study_design_scores_gemma":[0.009300155,0.00078144995,0.0022097589,0.000029168787,0.000010158291,0.0000018635004,0.000059488088,0.000041773714,0.9857228,0.00007265095,0.0015256645,0.00024506665],"about_ca_topic_score_codex":0.00014106552,"about_ca_topic_score_gemma":0.0011905647,"teacher_disagreement_score":0.0047935015,"about_ca_system_score_codex":0.000024491372,"about_ca_system_score_gemma":0.000090563866,"threshold_uncertainty_score":0.8870714},"labels":[],"label_agreement":null},{"id":"W2583981099","doi":"10.1182/blood.v124.21.1712.1712","title":"Addition of Rituximab to Salvage Chemotherapy in Aggressive CD20+ Lymphoma Prior to Autologous Stem Cell Transplant (ASCT): A Cohort Comparison from the NCIC CTG Study LY.12","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Princess Margaret Cancer Centre; University of Toronto; Juravinski Cancer Centre; Sunnybrook Health Science Centre; McMaster University; London Health Sciences Centre; Queen's University; Juravinski Hospital; Queen Elizabeth II Health Sciences Centre; Health Sciences Centre","funders":"","keywords":"Medicine; Internal medicine; DHAP; Salvage therapy; Regimen; Chemotherapy regimen; Rituximab; Oncology; Autologous stem-cell transplantation; Febrile neutropenia; Chemotherapy; Gemcitabine; Progressive disease; Surgery; Gastroenterology; Neutropenia; Lymphoma","score_opus":0.010487158471967274,"score_gpt":0.2493796478773854,"score_spread":0.23889248940541813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583981099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954083,0.0004932337,0.000057579884,0.0007059204,0.000093287425,0.0026042657,0.00019258165,0.00005309319,0.00039175703],"genre_scores_gemma":[0.99796677,0.000046266803,0.00040176307,0.00084904965,0.00010202948,0.00047971535,0.00008461993,0.000033124546,0.000036651894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99810326,0.00017777766,0.00051387877,0.0004716175,0.0004243051,0.00030917462],"domain_scores_gemma":[0.9986304,0.00034651926,0.00021967392,0.0005748826,0.00005779843,0.00017069558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024074664,0.0002724995,0.00081123423,0.00010215438,0.00007111739,0.000021233407,0.00019537595,0.00010195341,0.00007015071],"category_scores_gemma":[0.00002290322,0.00018432061,0.000118605814,0.00020985673,0.000033811004,0.000032451913,0.000032124306,0.00007500569,0.00008029172],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010915772,0.030032465,0.89741033,0.000048612073,0.0005354704,0.0002823857,0.014266279,0.000013272769,0.0017165998,0.000014542029,0.0012594089,0.05332905],"study_design_scores_gemma":[0.028017936,0.002467233,0.9218247,0.00038776404,0.0006874687,0.000024589985,0.00089220644,0.000055359353,0.04460217,0.000007776454,0.0008501275,0.00018264866],"about_ca_topic_score_codex":0.0013584765,"about_ca_topic_score_gemma":0.0009058192,"teacher_disagreement_score":0.053146403,"about_ca_system_score_codex":0.00013341298,"about_ca_system_score_gemma":0.00009200937,"threshold_uncertainty_score":0.75163764},"labels":[],"label_agreement":null},{"id":"W2583999202","doi":"10.1182/blood.v106.11.492.492","title":"Revised International Prognostic Index (R-IPI) Is a Better Predictor of Outcome Than the Standard IPI for Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Rituximab and CHOP (R-CHOP).","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Rituximab; International Prognostic Index; Diffuse large B-cell lymphoma; Internal medicine; CHOP; Population; Chemotherapy regimen; Oncology; Lymphoma; Cancer; Surgery","score_opus":0.006231290860206991,"score_gpt":0.22351511049676276,"score_spread":0.21728381963655577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583999202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956125,0.00026657555,0.000037035094,0.0011481474,0.000028591909,0.001852792,0.0008137128,0.00004035779,0.00020026552],"genre_scores_gemma":[0.99786025,0.000055036515,0.0006201614,0.00062757946,0.00011863623,0.0003598568,0.0001407097,0.00004286519,0.0001749151],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984817,0.000025796588,0.00034803196,0.00035388715,0.0005002387,0.00029033562],"domain_scores_gemma":[0.99894476,0.00013538272,0.00020700398,0.00032713966,0.00025478742,0.00013093847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007821526,0.00027381082,0.00044692485,0.00008640463,0.000085845924,0.00003987655,0.0001137071,0.00007642195,0.00003860243],"category_scores_gemma":[0.00003760527,0.0001419336,0.00009442211,0.00011226706,0.00008559299,0.00010220025,0.00004380251,0.000054220614,0.0000040364826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017756979,0.023425898,0.97127837,0.00011930229,0.0006710822,0.000015860118,0.00029744007,1.1137343e-7,0.0000072726198,0.000014638494,0.00030253534,0.002091801],"study_design_scores_gemma":[0.19720733,0.0019929842,0.7942356,0.00024264255,0.0010461584,0.000016497406,0.00003138053,0.00006736745,0.0009264646,0.000003400083,0.004085508,0.00014465144],"about_ca_topic_score_codex":0.000025573167,"about_ca_topic_score_gemma":0.000027425098,"teacher_disagreement_score":0.19543163,"about_ca_system_score_codex":0.00009408302,"about_ca_system_score_gemma":0.00007321477,"threshold_uncertainty_score":0.5787884},"labels":[],"label_agreement":null},{"id":"W2584019337","doi":"10.1182/blood.v108.11.4916.4916","title":"In Vitro Erythroid Cell Expansion Analysis in Polycythemia Vera.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Polycythemia vera; Erythropoiesis; Biology; Transferrin receptor; Immunology; Erythropoietin; Population; Peripheral blood mononuclear cell; Reticulocyte; Stem cell; Cell biology; Andrology; Transferrin; Medicine; Internal medicine; In vitro; Endocrinology; Genetics; Anemia","score_opus":0.005810812428491745,"score_gpt":0.2336819355414297,"score_spread":0.22787112311293795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584019337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940247,0.0007692288,0.000009276333,0.0006217835,0.000027913258,0.00024702118,0.0000103171915,0.000017978942,0.0042717876],"genre_scores_gemma":[0.9980929,0.00008148331,0.00075871695,0.00023153335,0.000090487876,0.000067195855,0.00008659308,0.000013405566,0.00057772256],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989668,0.000035705747,0.00027786926,0.00029158025,0.00018898548,0.00023903546],"domain_scores_gemma":[0.99957997,0.00005923458,0.000048311955,0.00023069516,0.00002277769,0.00005900906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000084398,0.00015062178,0.00039647287,0.0003652799,0.00002391673,0.000010957489,0.0000383972,0.00007795674,0.00015845227],"category_scores_gemma":[0.000011063747,0.00012435297,0.00012198471,0.00069274387,0.000018074614,0.000049712664,0.00001879388,0.000120615485,0.000048352995],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019958882,0.005527612,0.87711674,0.000028736538,0.00016158103,0.00072703516,0.00021978373,0.000060972852,0.115216844,0.000045330125,0.00039953593,0.00029624777],"study_design_scores_gemma":[0.006304067,0.0001231813,0.3711083,0.000026334457,0.0005158112,0.0000116883275,0.000038378326,0.00009763254,0.6212463,0.000059041846,0.00035799944,0.000111320565],"about_ca_topic_score_codex":0.0010094417,"about_ca_topic_score_gemma":0.00059805985,"teacher_disagreement_score":0.5060294,"about_ca_system_score_codex":0.00007687525,"about_ca_system_score_gemma":0.000050360875,"threshold_uncertainty_score":0.5070967},"labels":[],"label_agreement":null},{"id":"W2584019474","doi":"10.1182/blood.v106.11.4140.4140","title":"Anti-Haemostatic Properties of Diverse Haematophagous Hirudinea from around the World Could Have New Therapeutic Potentials.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Leech Biology and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Leech; Biology; Clotting time; Context (archaeology); Platelet; Andrology; Immunology; Medicine","score_opus":0.04540010667565395,"score_gpt":0.2833673119177133,"score_spread":0.23796720524205936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584019474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98556536,0.0037961002,0.00016486694,0.009298089,0.000044959088,0.00045480678,0.000019765806,0.000045739747,0.0006103099],"genre_scores_gemma":[0.99351025,0.00010128326,0.00064216566,0.0016321533,0.00029207955,0.00002118546,0.000016299642,0.000012799852,0.003771769],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99927074,0.000034550685,0.00022652195,0.00017539789,0.00013267348,0.0001601188],"domain_scores_gemma":[0.9993647,0.000060428578,0.000099498786,0.00036322436,0.00005085538,0.00006133256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007918348,0.00011849024,0.00025930622,0.00004040651,0.0001095456,0.000010476855,0.00014364868,0.00006440009,0.0001818143],"category_scores_gemma":[0.00002228361,0.00006837308,0.0000776707,0.00011421442,0.00018982055,0.000044583507,0.00004036142,0.00015626632,0.00009759373],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041396442,0.0046009445,0.118934296,0.00018226558,0.0029727926,0.00009305059,0.005729431,0.00005538036,0.8122339,0.0031855549,0.010116704,0.041481696],"study_design_scores_gemma":[0.0073355506,0.00021194163,0.07373767,0.0002782648,0.0027724172,0.00015193102,0.0016144062,0.00038087546,0.8926573,0.0024313752,0.018079279,0.00034903816],"about_ca_topic_score_codex":0.00029556698,"about_ca_topic_score_gemma":0.00017306501,"teacher_disagreement_score":0.080423325,"about_ca_system_score_codex":0.000010923788,"about_ca_system_score_gemma":0.00008477181,"threshold_uncertainty_score":0.27881736},"labels":[],"label_agreement":null},{"id":"W2584053817","doi":"10.1182/blood.v112.11.1833.1833","title":"Complement Factor H in Human Platelets: Implications for Atypical HUS.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Platelet; Complement system; Atypical hemolytic uremic syndrome; Alternative complement pathway; Platelet activation; Colocalization; Molecular biology; Immunostaining; Von Willebrand factor; Factor H; Biology; Immunology; Pathology; Cell biology; Antibody; Medicine; Immunohistochemistry","score_opus":0.06435248797965383,"score_gpt":0.3143486495012145,"score_spread":0.24999616152156068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584053817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971435,0.0010660893,0.000094915085,0.00027275702,0.00012780302,0.0006941354,0.0003666681,0.00006333332,0.00017077639],"genre_scores_gemma":[0.9987729,0.000012270655,0.00010725313,0.00008217442,0.00003338481,0.0003192438,0.00038790127,0.000011135638,0.0002737209],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909675,0.000059134203,0.00032957565,0.00022537143,0.000017127273,0.00027201802],"domain_scores_gemma":[0.9994493,0.000151441,0.00006835547,0.0002666948,0.000044305216,0.000019900242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000055839053,0.00010876997,0.00021038462,0.000077169774,0.00021436378,0.0000036938475,0.00018632582,0.000064385946,0.00064799],"category_scores_gemma":[0.000041587155,0.00010432765,0.00007494778,0.000062978645,0.0000803518,0.00003134981,0.000057924113,0.000068130554,0.00012792749],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010288367,0.00309914,0.5191576,0.00009123764,0.0004747012,0.000008663191,0.00066844106,0.0000026440098,0.42165002,0.016839063,0.037435487,0.00047014037],"study_design_scores_gemma":[0.008170327,0.0003001816,0.8840253,0.00004987163,0.00006286651,0.00012415476,0.00015438005,6.611719e-7,0.039258875,0.0013785041,0.06618705,0.00028788418],"about_ca_topic_score_codex":0.00001771997,"about_ca_topic_score_gemma":0.000065740525,"teacher_disagreement_score":0.38239115,"about_ca_system_score_codex":0.00003372727,"about_ca_system_score_gemma":0.000031405365,"threshold_uncertainty_score":0.70950353},"labels":[],"label_agreement":null},{"id":"W2584084443","doi":"10.1182/blood.v108.11.288.288","title":"FTY720, a New and Alternative Strategy for Treating Blast Crisis CML and Ph1 ALL Patients.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Cancer research; Chronic myelogenous leukemia; Progenitor cell; Myeloid; Philadelphia chromosome; Dasatinib; Immunology; Imatinib; Megakaryocytopoiesis; Leukemia; CD34; Medicine; Myeloid leukemia; Biology; Stem cell; Megakaryocyte; Chromosomal translocation; Cell biology","score_opus":0.01786129546141479,"score_gpt":0.27060594563445467,"score_spread":0.2527446501730399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584084443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961082,0.0007086293,0.00005869246,0.00019080359,0.000025757865,0.0005633556,0.00004611949,0.000035651276,0.0022628126],"genre_scores_gemma":[0.9961127,0.00005663981,0.0021909494,0.00013005284,0.00024216781,0.000032305452,0.000104608574,0.000027240718,0.001103305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913824,0.000012330745,0.00018833314,0.00029929154,0.00012959367,0.0002322318],"domain_scores_gemma":[0.9995412,0.00007504436,0.000078702666,0.00013088771,0.000047566133,0.00012657729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000037434762,0.00016641489,0.00023752164,0.000052315634,0.00005105266,0.000027506354,0.00003036078,0.000058626003,0.000024601994],"category_scores_gemma":[0.000032987453,0.00013985774,0.000042483985,0.00004868539,0.000028562888,0.00006783273,0.000027060642,0.000063173014,0.0000036923375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012544452,0.0070215194,0.81370676,0.00089778507,0.0032152347,0.000284895,0.0047080354,0.000062509556,0.006284804,0.0015998875,0.029594887,0.13136923],"study_design_scores_gemma":[0.3186259,0.01218975,0.55362034,0.0008342202,0.0074203582,0.0004388125,0.0017387423,0.0028054183,0.07890112,0.006819351,0.0149935745,0.0016124463],"about_ca_topic_score_codex":0.0019774132,"about_ca_topic_score_gemma":0.00016580668,"teacher_disagreement_score":0.31737146,"about_ca_system_score_codex":0.00008994289,"about_ca_system_score_gemma":0.00009472521,"threshold_uncertainty_score":0.57032335},"labels":[],"label_agreement":null},{"id":"W2584085060","doi":"10.1182/blood.v106.11.2243.2243","title":"The Diagnosis of Venous Thromboembolism (VTE) in the Emergency Room: Poor Compliance with Recommended Diagnostic Algorithms.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Pulmonary embolism; Venous thromboembolism; Algorithm; Thrombosis; Venous thrombosis; Emergency department; Deep vein; Emergency medicine; Pediatrics; Internal medicine","score_opus":0.03037605300641579,"score_gpt":0.28805262886539756,"score_spread":0.2576765758589818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584085060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9401331,0.008390012,0.000064994514,0.036451153,0.000386277,0.0025986827,0.000034767174,0.000084527645,0.011856475],"genre_scores_gemma":[0.986991,0.009157262,0.0007827364,0.0017911261,0.00035655173,0.00072814146,0.00001715237,0.000043754084,0.00013225894],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99784684,0.00013984478,0.000578187,0.000365154,0.0005241846,0.0005457919],"domain_scores_gemma":[0.99813324,0.0006784785,0.00022572571,0.0007525187,0.00011468027,0.00009535448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059690035,0.00027732333,0.0006683507,0.00008901701,0.00024787398,0.000030640647,0.0004906303,0.00007666407,0.00015840787],"category_scores_gemma":[0.0002497536,0.00015476746,0.00013484331,0.0004864302,0.00008315536,0.00009510106,0.00009259209,0.00029869724,0.000051213752],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003463264,0.09059193,0.28124,0.001348699,0.0040838392,0.00073720946,0.018410882,0.00040707464,0.00040206063,0.018800525,0.2770651,0.30656636],"study_design_scores_gemma":[0.0058137164,0.0019844596,0.88036656,0.0005985565,0.0014894332,0.00010027719,0.001553421,0.00012139798,0.0025600598,0.0008740115,0.10407294,0.00046518567],"about_ca_topic_score_codex":0.0003191723,"about_ca_topic_score_gemma":0.000878784,"teacher_disagreement_score":0.5991266,"about_ca_system_score_codex":0.00004331849,"about_ca_system_score_gemma":0.000060324688,"threshold_uncertainty_score":0.63112336},"labels":[],"label_agreement":null},{"id":"W2584115654","doi":"10.1182/blood.v126.23.1120.1120","title":"Bleeding in Patients Receiving Low-Molecular-Weight Heparin for Cancer-Associated Thrombosis","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Joseph’s Healthcare Hamilton; St. Joseph's Hospital; McMaster University","funders":"","keywords":"Medicine; Concomitant; Incidence (geometry); Surgery; Low molecular weight heparin; Thrombosis; Cancer; Retrospective cohort study; Internal medicine","score_opus":0.025174051292830395,"score_gpt":0.28558267735881543,"score_spread":0.260408626065985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584115654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938906,0.00031153564,0.000023528079,0.0004775835,0.000338421,0.0009278794,0.000011447961,0.00006547334,0.00395352],"genre_scores_gemma":[0.9983098,0.00016663421,0.00038561053,0.00059538987,0.00009909547,0.00026191951,0.00005253079,0.0000402032,0.00008879849],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868643,0.000028541672,0.0002902442,0.00030007967,0.00029709787,0.00039759246],"domain_scores_gemma":[0.99932766,0.000035596837,0.000109896646,0.00019254022,0.00017161369,0.00016266473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030677117,0.00016093493,0.00046584354,0.00012757514,0.0000460172,0.000025523614,0.00010223289,0.000093810806,0.000025056805],"category_scores_gemma":[0.00023998988,0.00015477673,0.00009092404,0.00026034255,0.000017852426,0.00007865475,0.00007530227,0.00010197409,0.000010736095],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048378384,0.0069849445,0.97783566,0.00019500451,0.0005470057,0.000013886281,0.0009681992,0.00003232867,0.0014346965,0.0003247897,0.007747302,0.0038678285],"study_design_scores_gemma":[0.013880927,0.0006615503,0.97231615,0.0006976652,0.00070917234,3.8207995e-7,0.00012910673,0.00012424716,0.009540456,0.00023628512,0.0014280124,0.0002760562],"about_ca_topic_score_codex":0.0004501887,"about_ca_topic_score_gemma":0.0003017342,"teacher_disagreement_score":0.013832549,"about_ca_system_score_codex":0.00020584282,"about_ca_system_score_gemma":0.00008772454,"threshold_uncertainty_score":0.6311612},"labels":[],"label_agreement":null},{"id":"W2584121116","doi":"10.1182/blood.v114.22.244.244","title":"The Quality and Accuracy of Hemophilia Information on the Internet.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Health Literacy and Information Accessibility","field":"Health Professions","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Readability; The Internet; Medicine; Checklist; Quality (philosophy); Information quality; Factor IX; Pediatrics; Information system; Computer science; Psychology; Internal medicine; World Wide Web","score_opus":0.07104823788971469,"score_gpt":0.452121430174861,"score_spread":0.3810731922851463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584121116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96290517,0.0000501066,0.000106276275,0.011771396,0.00013670289,0.0005988028,0.000010052736,0.000028595143,0.024392918],"genre_scores_gemma":[0.98557127,0.00005769025,0.000062966785,0.01408228,0.000046938014,0.00002362017,0.0000069887446,0.0000014321384,0.00014679262],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9980468,0.0004157072,0.0011162645,0.00005666848,0.00018176892,0.0001827462],"domain_scores_gemma":[0.99705136,0.0017536889,0.00063089834,0.00033581984,0.00017582139,0.000052407366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030848775,0.000067157394,0.00010726171,0.000025438689,0.00055006886,0.00002488571,0.00018277463,0.00006986618,0.00007847431],"category_scores_gemma":[0.0026012037,0.000031685395,0.000026322923,0.00010475861,0.000049587303,0.000710969,0.000042160184,0.00035345348,0.00009385764],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004980787,0.00037728675,0.122234784,0.0010337337,0.00003790131,1.5525302e-7,0.044662446,0.000001623499,0.00006571058,0.58055735,0.019029468,0.23150149],"study_design_scores_gemma":[0.0009941667,0.0001252505,0.88002807,0.00016066691,0.000007357588,5.5159967e-7,0.0017949726,0.00028746447,0.0003471347,0.006762147,0.10941685,0.00007536005],"about_ca_topic_score_codex":0.000058287023,"about_ca_topic_score_gemma":0.000007703591,"teacher_disagreement_score":0.7577933,"about_ca_system_score_codex":0.000016153996,"about_ca_system_score_gemma":0.000091247384,"threshold_uncertainty_score":0.42307404},"labels":[],"label_agreement":null},{"id":"W2584175763","doi":"10.1182/blood.v112.11.4705.4705","title":"Immune Globulin for Patients with Primary Immune Deficiency: An Evidence Based Practice Guideline","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; University of Alberta; Université de Montréal; University of Saskatchewan; Dalhousie University; University of Toronto; Canadian Blood Services; McGill University; University of Calgary; St. Michael's Hospital","funders":"","keywords":"Guideline; Medicine; Family medicine; Evidence-based practice; MEDLINE; Advisory committee; Grading (engineering); Intensive care medicine; Alternative medicine; Pathology; Management","score_opus":0.01163579939648176,"score_gpt":0.24016772036163228,"score_spread":0.22853192096515051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584175763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89925903,0.09215459,0.0044177203,0.000673733,0.00056093326,0.0014221431,0.00008277826,0.00026005233,0.0011690045],"genre_scores_gemma":[0.9923448,0.00026903275,0.0048007676,0.0011431732,0.00000878342,0.00012231545,0.0009158294,0.000050569324,0.0003447499],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99747247,0.00026217615,0.0008195788,0.00059987896,0.00014229173,0.0007036262],"domain_scores_gemma":[0.99749756,0.0005335927,0.0004396504,0.0008615368,0.0006503861,0.000017247656],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007440036,0.0003705977,0.00049880176,0.00012778289,0.0008623836,0.000025210087,0.00065085245,0.00024821173,0.00014331154],"category_scores_gemma":[0.00089363055,0.00030867444,0.00016930714,0.00035547823,0.00042726158,0.0008442718,0.000088108136,0.00032366297,0.00013897111],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017294146,0.064169586,0.024470732,0.0004969121,0.0013146141,0.00010007408,0.004215072,0.0011019742,0.834266,0.0015717098,0.0020601016,0.04893909],"study_design_scores_gemma":[0.08834789,0.019461008,0.4018538,0.0010855848,0.002417278,0.00072593865,0.001856892,0.00018563261,0.17851618,0.0001617026,0.30100974,0.0043783346],"about_ca_topic_score_codex":0.00019545958,"about_ca_topic_score_gemma":0.0000013083652,"teacher_disagreement_score":0.6557498,"about_ca_system_score_codex":0.00004094952,"about_ca_system_score_gemma":0.00043921836,"threshold_uncertainty_score":0.9999365},"labels":[],"label_agreement":null},{"id":"W2584246182","doi":"10.1182/blood.v128.22.1108.1108","title":"Pembrolizumab in Patients with Classical Hodgkin Lymphoma after Brentuximab Vedotin Failure: Long-Term Efficacy from the Phase 1b Keynote-013 Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Brentuximab vedotin; Pembrolizumab; Medicine; Oncology; Internal medicine; Cohort; Transplantation; Phases of clinical research; Autologous stem-cell transplantation; Lymphoma; Clinical trial; Cancer; Immunotherapy; Hodgkin lymphoma","score_opus":0.007994738585659232,"score_gpt":0.2436282702871269,"score_spread":0.23563353170146767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584246182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965664,0.0002250134,0.000007545989,0.0012200329,0.00009100301,0.001678529,0.0000961942,0.000061517996,0.000053756914],"genre_scores_gemma":[0.9989245,0.00001352013,0.000059105292,0.00024904692,0.00020010676,0.0003655427,0.00006729137,0.000051953826,0.000068955735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99773896,0.00015242353,0.0004012645,0.0006332846,0.0006071817,0.00046688522],"domain_scores_gemma":[0.9984534,0.00033582828,0.000119036864,0.00080477295,0.00007768369,0.000209286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008630405,0.00037759883,0.0005181669,0.00007942831,0.00007387193,0.00005673802,0.00020050022,0.00010540683,0.00022183805],"category_scores_gemma":[0.00006851243,0.0001736687,0.00013122555,0.00019970736,0.000115026945,0.000109849956,0.00010993597,0.00008928685,0.00019850634],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003859667,0.09081899,0.8641478,0.000006813003,0.00045143728,0.00066243875,0.00044674863,4.437494e-8,0.000028871113,0.000004229188,0.00020366427,0.039369326],"study_design_scores_gemma":[0.25024086,0.00334128,0.74456364,0.00026604562,0.0006604869,0.000011707025,0.000030814095,8.01008e-7,0.00053934054,0.0000041223443,0.00015434083,0.0001865777],"about_ca_topic_score_codex":0.00012478424,"about_ca_topic_score_gemma":0.0003509055,"teacher_disagreement_score":0.24638121,"about_ca_system_score_codex":0.00020173355,"about_ca_system_score_gemma":0.0001411657,"threshold_uncertainty_score":0.7082004},"labels":[],"label_agreement":null},{"id":"W2584253891","doi":"10.1182/blood.v120.21.4501.4501","title":"CMV Reactivations and Their Impact On Outcomes in Patients After Hematopoietic Cell Transplantation","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Univariate analysis; Transplantation; Internal medicine; Methotrexate; Gastroenterology; Hematopoietic cell; Graft-versus-host disease; Immunology; Surgery; Haematopoiesis; Multivariate analysis; Stem cell; Biology","score_opus":0.01574040747925599,"score_gpt":0.28943732739499073,"score_spread":0.27369691991573475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584253891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977666,0.00009798991,0.000003134393,0.00010786259,0.000017707549,0.00026827087,0.000032552456,0.000011689117,0.001694151],"genre_scores_gemma":[0.99960005,0.000047943464,0.000026108033,0.00011213778,0.000028535604,0.00002830009,0.000023093111,0.000012876702,0.000120930104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99941707,0.0000224184,0.000118780095,0.00009832161,0.00013388452,0.00020951564],"domain_scores_gemma":[0.99965364,0.00007337127,0.000019839232,0.0001196458,0.000021367026,0.000112140435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000927505,0.000097903256,0.00016035479,0.00013191633,0.000024428798,0.000009713678,0.00002150843,0.000050770035,0.0001026747],"category_scores_gemma":[0.00001372171,0.000059636153,0.000046406538,0.00009272461,0.000020790307,0.00009654364,0.0000074438362,0.00013252234,0.00003811897],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002291796,0.001624938,0.9947001,0.000055686916,0.00002239954,0.0000034175714,0.0018041593,1.4925797e-7,0.00094403303,0.000010229455,0.000018825089,0.0005869289],"study_design_scores_gemma":[0.0029052775,0.00020739286,0.98723745,0.000038227936,0.000027992011,0.0000031829754,0.000058108955,0.000001526894,0.009337056,0.000017528193,0.0001037526,0.00006251985],"about_ca_topic_score_codex":0.00007259107,"about_ca_topic_score_gemma":0.000012143457,"teacher_disagreement_score":0.008393023,"about_ca_system_score_codex":0.000025357578,"about_ca_system_score_gemma":0.000019534675,"threshold_uncertainty_score":0.24318919},"labels":[],"label_agreement":null},{"id":"W2584330546","doi":"10.1182/blood.v114.22.156.156","title":"Apolipoprotein AIV (ApoA-IV) Is a Novel Ligand of Platelet β3 Integrin That Negatively Regulates Platelet Adhesion, Aggregation, and Thrombosis.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada; University of Toronto; Canadian Blood Services; St. Michael's Hospital","funders":"","keywords":"Platelet; Integrin; Chemistry; Fibrinogen; Von Willebrand factor; Adhesion; Platelet activation; Platelet adhesiveness; Collagen receptor; Apolipoprotein B; Molecular biology; Biochemistry; Internal medicine; Receptor; Platelet aggregation; Medicine; Biology; Cholesterol","score_opus":0.022104505593657856,"score_gpt":0.259993996513629,"score_spread":0.23788949091997114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584330546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99450237,0.0019478884,0.000027021404,0.001721549,0.000036052108,0.0007367648,0.00008865782,0.00007173304,0.00086799037],"genre_scores_gemma":[0.996224,0.00070430007,0.0018134917,0.00074150064,0.00005226812,0.00002009751,0.00007513906,0.00003140443,0.0003378304],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99834937,0.000022735923,0.0004321167,0.00046759562,0.00035978688,0.000368399],"domain_scores_gemma":[0.998985,0.00006953357,0.00026060798,0.00035735688,0.00013737213,0.00019013237],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013800064,0.00035110928,0.0007461084,0.00018232178,0.00011359785,0.000033738837,0.000112758986,0.00023169385,0.00006181788],"category_scores_gemma":[0.000084422085,0.00027808707,0.00012131476,0.00028217482,0.00013851383,0.0002006526,0.000041261716,0.00021179763,0.000016258276],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021656135,0.017699338,0.085402295,0.00093303894,0.004688455,0.0009835201,0.013842881,0.000007695778,0.6895457,0.0030774663,0.009112439,0.17254156],"study_design_scores_gemma":[0.012517088,0.001219894,0.11346592,0.0005853087,0.00032252047,0.00044048234,0.0002495394,0.000057651017,0.8670958,0.002932347,0.0008002859,0.0003131393],"about_ca_topic_score_codex":0.00024462707,"about_ca_topic_score_gemma":0.000025918229,"teacher_disagreement_score":0.17755014,"about_ca_system_score_codex":0.000025593323,"about_ca_system_score_gemma":0.00008099153,"threshold_uncertainty_score":0.99996716},"labels":[],"label_agreement":null},{"id":"W2584399332","doi":"10.1182/blood.v114.22.3492.3492","title":"Population Pharmacokinetic Model of ADVATE in Pediatric and Adult Patients with Hemophilia A.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Population; Covariate; Pharmacokinetics; Volume of distribution; Mixed model; Internal medicine; Statistics; Mathematics","score_opus":0.010872534061236852,"score_gpt":0.2660150333549748,"score_spread":0.25514249929373795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584399332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989246,0.00012104519,0.0000028735099,0.00021831966,0.0000044608273,0.00030612218,0.0000040213145,0.000010386649,0.00040815206],"genre_scores_gemma":[0.99912244,0.0001805331,0.0004627106,0.00004190615,0.000028409586,0.0000039953293,0.000036694786,0.0000064964115,0.00011683904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99940556,0.000010444212,0.00013073147,0.00012552609,0.00019960196,0.00012811754],"domain_scores_gemma":[0.999742,0.000008347994,0.00003021331,0.000083577455,0.000070840455,0.00006506009],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000035461806,0.00007240849,0.00014306697,0.00013515541,0.0000131623765,0.0000024216652,0.000022131484,0.00003313139,0.0000054198263],"category_scores_gemma":[0.000016535623,0.00005005801,0.000014913506,0.00017617457,0.000011637171,0.00004321452,0.0000073152974,0.000068988644,0.0000014660088],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018002222,0.0010339201,0.99539846,0.0000681133,0.000009958518,0.000008747614,0.00006240569,0.000064486034,0.00051171833,0.000017681363,0.0000074689783,0.0026370187],"study_design_scores_gemma":[0.009561057,0.00056433247,0.98585135,0.000030310732,0.0001268632,0.0000019052214,0.000002482967,0.0024401564,0.0012345563,0.0001324383,6.215416e-7,0.00005391721],"about_ca_topic_score_codex":0.000009519593,"about_ca_topic_score_gemma":0.000002422684,"teacher_disagreement_score":0.0095471,"about_ca_system_score_codex":0.000009171771,"about_ca_system_score_gemma":0.000018094099,"threshold_uncertainty_score":0.20413063},"labels":[],"label_agreement":null},{"id":"W2584406289","doi":"10.1182/blood.v120.21.1266.1266","title":"Outcome and Clinical Characteristics of Clonal and Malignant Myeloid Transformation in Inherited Bone Marrow Failure Syndromes","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; Janeway Children's Health and Rehabilitation Centre; McMaster University; University of Toronto; Montreal Children's Hospital; Centre hospitalier universitaire de Québec; Centre Hospitalier Universitaire de Sherbrooke; Dalhousie University; Centre Hospitalier Universitaire Sainte-Justine; CancerCare Manitoba; Children's Hospital of Western Ontario; Children's Hospital of Eastern Ontario; BC Children's Hospital; SickKids Foundation; Princess Margaret Cancer Centre; Kingston General Hospital; University of Manitoba; Alberta Children's Hospital; Izaak Walton Killam Health Centre; University of Saskatchewan; Hospital for Sick Children","funders":"","keywords":"Bone marrow failure; Fanconi anemia; Medicine; Myeloid leukemia; Myeloid; Bone marrow; Population; Internal medicine; Oncology; Immunology; Biology; Haematopoiesis; Genetics; Stem cell; Environmental health","score_opus":0.016060053952822412,"score_gpt":0.27021440528346913,"score_spread":0.25415435133064673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584406289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998114,0.0015477707,0.000018389908,0.0000807728,0.000031428823,0.00011298688,0.000041770436,0.000002864643,0.000050020295],"genre_scores_gemma":[0.99893457,0.00053846586,0.0003258575,0.000044050117,0.00002927303,0.00000620165,0.00009475589,0.000007729796,0.000019070509],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99938375,0.000031591982,0.00028617427,0.000115186194,0.00005121067,0.00013210138],"domain_scores_gemma":[0.99976957,0.0000078162875,0.00006199809,0.00008525463,0.00001534994,0.000060016442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013462284,0.00008811853,0.00017500206,0.000026275897,0.000017193604,0.0000064195933,0.000026787468,0.000121639045,0.000004049614],"category_scores_gemma":[0.000019516337,0.000076401295,0.000034429962,0.000032395415,0.000051332983,0.000007266845,0.000025082334,0.000047597783,7.5419194e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031082684,0.0005416763,0.9859068,0.000044854667,0.00006481806,0.000002871149,0.00006404037,2.061781e-8,0.010451855,0.00004421711,0.000006431993,0.002841376],"study_design_scores_gemma":[0.0028073774,0.00024979434,0.9894741,0.000017123228,0.00009305751,0.000066843735,0.00007190272,0.0000039426254,0.0065476554,0.000015177579,0.00054519007,0.00010782479],"about_ca_topic_score_codex":0.000008506149,"about_ca_topic_score_gemma":0.000025878879,"teacher_disagreement_score":0.0039041997,"about_ca_system_score_codex":0.0000012065354,"about_ca_system_score_gemma":0.000009429462,"threshold_uncertainty_score":0.31155542},"labels":[],"label_agreement":null},{"id":"W2584416641","doi":"10.1182/blood.v120.21.lba-1.lba-1","title":"Two Doses of Apixaban for the Extended Treatment of Venous Thromboembolism","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Apixaban; Medicine; Placebo; Stroke (engine); Randomized controlled trial; Regimen; Internal medicine; Surgery; Myocardial infarction; Anticoagulant; Warfarin; Atrial fibrillation; Rivaroxaban","score_opus":0.0325648414204759,"score_gpt":0.3138172204741338,"score_spread":0.2812523790536579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584416641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867787,0.0077453125,0.00008572219,0.00033437173,0.00028377117,0.0013926658,0.00003124936,0.000027988373,0.0033202656],"genre_scores_gemma":[0.9971251,0.0010629332,0.00097093655,0.00010498246,0.00037331565,0.00018393376,0.000012372686,0.000024335632,0.00014212115],"study_design_codex":"nonrandomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99910104,0.000019472183,0.00027538,0.00013075538,0.00018236654,0.0002909548],"domain_scores_gemma":[0.99911803,0.00016210673,0.00014566637,0.00042491686,0.0000705908,0.000078684556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015514418,0.00014143181,0.00061057205,0.000056780704,0.00006247144,0.000004318555,0.000091396796,0.000038521557,0.00007503172],"category_scores_gemma":[0.000032076958,0.00008537384,0.00021490749,0.00009114337,0.00008315288,0.000041342206,0.000028102764,0.00002827831,0.0000063983016],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008414949,0.29132232,0.07480888,0.0030645665,0.020895788,0.000033005268,0.040025532,0.000069248556,0.14323021,0.13425814,0.008673123,0.2827777],"study_design_scores_gemma":[0.014533563,0.0059210192,0.64887774,0.00016187863,0.008539334,0.000038716767,0.0016726025,0.000019274428,0.293983,0.0007586768,0.025233964,0.00026020926],"about_ca_topic_score_codex":0.00020299088,"about_ca_topic_score_gemma":0.000012861735,"teacher_disagreement_score":0.5740689,"about_ca_system_score_codex":0.000021036501,"about_ca_system_score_gemma":0.0000380975,"threshold_uncertainty_score":0.3481444},"labels":[],"label_agreement":null},{"id":"W2584476963","doi":"10.1182/blood.v114.22.1997.1997","title":"Investigation of the Role of Heme Oxygenase 1 During Erythroid Differentiation.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Heme Oxygenase-1 and Carbon Monoxide","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Heme; Heme oxygenase; Biochemistry; Chemistry; Red blood cell; Catabolism; Cell biology; Biology; Metabolism; Enzyme","score_opus":0.00453693263404402,"score_gpt":0.18417586264688537,"score_spread":0.17963893001284134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584476963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986757,0.00058967894,0.000010448163,0.00005710003,0.000022067004,0.000082394065,0.000009771443,0.0000045762026,0.0005482664],"genre_scores_gemma":[0.99959886,0.00003407584,0.00010976971,0.00005342645,0.00006789704,0.0000033131494,0.000016083923,0.0000060973,0.00011045288],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99947923,0.000030559084,0.00017210291,0.0001233294,0.00009994282,0.00009483452],"domain_scores_gemma":[0.9995441,0.000002440392,0.00010610763,0.000267433,0.00004602782,0.000033917233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004689336,0.000071502174,0.000083643296,0.000017618695,0.000029844712,0.0000035882383,0.00011967693,0.000064129,0.000009150607],"category_scores_gemma":[0.000030117417,0.000056238434,0.00007991332,0.000069022666,0.000036064026,0.0000022388276,0.000033453336,0.000034813515,9.1640396e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008662314,0.00005141728,0.014500067,0.000009887173,0.000021842787,1.5320425e-7,0.00004431427,0.0000054415164,0.9851304,0.00007606496,0.000021214695,0.0001304819],"study_design_scores_gemma":[0.00040856947,0.000055551394,0.15803178,0.000010586198,0.000021939386,0.0000024368053,0.000030227715,0.0000063828093,0.8410185,0.0002671882,0.00009483195,0.000052002622],"about_ca_topic_score_codex":0.00000644743,"about_ca_topic_score_gemma":0.0000065140807,"teacher_disagreement_score":0.14411195,"about_ca_system_score_codex":0.000002513501,"about_ca_system_score_gemma":0.000032449745,"threshold_uncertainty_score":0.22933368},"labels":[],"label_agreement":null},{"id":"W2584492434","doi":"10.1182/blood.v104.11.2331.2331","title":"SDF-1-CXCR4 and HGF-c-met Axes Regulate Mobilization/Recruitment to Injured Tissue of Human Mesenchymal Stem Cells.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Alberta","funders":"","keywords":"Matrigel; Hepatocyte growth factor; Biology; Stem cell; Mesenchymal stem cell; Homing (biology); Cell biology; CXCR4; Stromal cell; Bone marrow; Immunology; Cancer research; Angiogenesis; Chemokine; Receptor; Inflammation","score_opus":0.06164868695443037,"score_gpt":0.3469157531048203,"score_spread":0.28526706615038994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584492434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933774,0.0006658515,0.00006937261,0.00035545847,0.00006894947,0.0020612394,0.000022003715,0.000057627913,0.0033221121],"genre_scores_gemma":[0.9922561,0.00006751183,0.0017024622,0.00007557371,0.0001068222,0.000109040935,0.000020176394,0.00004212939,0.0056201774],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99783915,0.00008197095,0.00048289317,0.0004695585,0.00070583273,0.00042059436],"domain_scores_gemma":[0.99866015,0.000053718824,0.00010321046,0.00054850965,0.0002087736,0.00042561893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043714477,0.00022288473,0.00048298363,0.00025980602,0.00010701914,0.000029615718,0.00016533937,0.00013540151,0.0002482899],"category_scores_gemma":[0.00004377157,0.00019405056,0.00006276614,0.0004675876,0.00011707633,0.000066109336,0.0001778262,0.00016305402,0.00006774165],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009941643,0.0009991516,0.00528275,0.00046920768,0.00014719613,0.00010653885,0.0014409191,0.000047101592,0.98373616,0.0012154138,0.00029487396,0.006161301],"study_design_scores_gemma":[0.0043123746,0.0025859622,0.010517878,0.00027465474,0.0001533463,0.00005029333,0.00030387947,0.000005285046,0.9783985,0.00024468993,0.0029557124,0.00019740529],"about_ca_topic_score_codex":0.00017617772,"about_ca_topic_score_gemma":0.000057884932,"teacher_disagreement_score":0.0059638955,"about_ca_system_score_codex":0.00007372958,"about_ca_system_score_gemma":0.00013635206,"threshold_uncertainty_score":0.79131526},"labels":[],"label_agreement":null},{"id":"W2584502320","doi":"10.1182/blood.v116.21.680.680","title":"Cytogenetics Abnormalities Predict the Outcome of Allogeneic Transplantation In AML: A CIBMTR Study","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; Foothills Medical Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Cytogenetics; Internal medicine; Oncology; Transplantation; Medicine; Proportional hazards model; Hematopoietic stem cell transplantation; Leukemia; Biology; Chromosome","score_opus":0.02660478337144088,"score_gpt":0.3131698445044549,"score_spread":0.286565061133014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584502320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976769,0.000073540636,0.000013917882,0.00027368107,0.000064406726,0.0008185023,0.000026647569,0.000022848015,0.0010295695],"genre_scores_gemma":[0.99915016,0.00007372239,0.00025776125,0.000080395446,0.000098904886,0.00006126852,0.000015321792,0.000018902243,0.00024353963],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876535,0.000089988825,0.0003649825,0.0001624794,0.00039114547,0.0002260551],"domain_scores_gemma":[0.9992666,0.00014274441,0.000056633766,0.00039429156,0.000077298115,0.00006238799],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006226972,0.00010682126,0.00022545009,0.00012353226,0.000035988873,0.000008985096,0.00019939423,0.0000823386,0.000080248166],"category_scores_gemma":[0.00010841241,0.00007122451,0.00005599771,0.00019363842,0.000114783164,0.00003295897,0.00003459834,0.00041482144,0.000012477225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001216212,0.00073455885,0.9673251,0.000099061865,0.0000897366,0.000114077586,0.0028366982,0.000006362318,0.02834903,0.000060506532,0.000019286792,0.00024397999],"study_design_scores_gemma":[0.0060424237,0.0005643521,0.9553042,0.000018882713,0.0002684848,0.00015263031,0.0013780894,0.000044546774,0.036011703,0.000026894204,0.00011252867,0.000075243785],"about_ca_topic_score_codex":0.00030774073,"about_ca_topic_score_gemma":0.00091234624,"teacher_disagreement_score":0.012020857,"about_ca_system_score_codex":0.000017004195,"about_ca_system_score_gemma":0.00013936288,"threshold_uncertainty_score":0.29044512},"labels":[],"label_agreement":null},{"id":"W2584502966","doi":"10.1182/blood.v120.21.235.235","title":"Quality of Life Results From Eastern Cooperative Oncology Group Protocol E4402 (RESORT): A Randomized Phase III Study Comparing Two Different Rituximab Dosing Strategies for Indolent Non-Hodgkin's Lymphoma","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Anxiety; Rituximab; Randomization; Randomized controlled trial; Internal medicine; Hospital Anxiety and Depression Scale; Follicular lymphoma; Quality of life (healthcare); Coping (psychology); Physical therapy; Lymphoma; Psychiatry; Nursing","score_opus":0.07198776164159298,"score_gpt":0.39594213869872813,"score_spread":0.32395437705713515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584502966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89986354,0.00016752929,0.00058990385,0.000052541956,0.0001319375,0.098359495,0.000114111215,0.000053760756,0.00066717394],"genre_scores_gemma":[0.9093316,0.000005070962,0.00073128456,0.00007999127,0.00033950192,0.0893228,0.00014313204,0.00003382844,0.000012768439],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9960352,0.0007595208,0.0016588859,0.00055027584,0.00047222566,0.00052385643],"domain_scores_gemma":[0.9965932,0.0014704632,0.0008345534,0.0005327588,0.00021710285,0.00035195946],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011467795,0.00046587604,0.002747646,0.00011714312,0.00014286111,0.00006195122,0.00015199625,0.00012599805,0.00002296348],"category_scores_gemma":[0.00029222533,0.00031773705,0.00037752322,0.000113203496,0.00016206763,0.00019517381,0.00013660656,0.00010594483,0.000007729987],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5851098,0.24664891,0.13227849,0.00024384363,0.0051570004,0.00004850277,0.019298451,0.000011543547,0.0017095406,0.0003484012,0.00007112371,0.009074435],"study_design_scores_gemma":[0.93363667,0.004797793,0.048436835,0.00028644098,0.0015267387,0.0000058234873,0.0049387976,0.0005462726,0.005415122,0.000037236226,0.00008447531,0.00028778863],"about_ca_topic_score_codex":0.0031633084,"about_ca_topic_score_gemma":0.0006594656,"teacher_disagreement_score":0.3485269,"about_ca_system_score_codex":0.00020691284,"about_ca_system_score_gemma":0.00038281354,"threshold_uncertainty_score":0.99992746},"labels":[],"label_agreement":null},{"id":"W2584550066","doi":"10.1182/blood.v104.11.3022.3022","title":"Laboratory Testing for Hit Antibodies: How Much Class Do We Need?.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Antibody; Serology; Medicine; Immunology; Immunoassay; Immunoglobulin M; Platelet factor 4; Heparin; Interquartile range; Immunoglobulin G; Platelet; Internal medicine","score_opus":0.044439962623256835,"score_gpt":0.29027376324009374,"score_spread":0.2458338006168369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584550066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861634,0.0006455613,0.00008439492,0.0076678493,0.00023194752,0.0006680199,0.000047206697,0.0002289872,0.0042626658],"genre_scores_gemma":[0.9885562,0.000080177,0.010041076,0.0004434986,0.00051604933,0.000061299,0.000015453512,0.00006273119,0.00022351711],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986162,0.00002286682,0.00024288686,0.0003978663,0.0002268577,0.0004932922],"domain_scores_gemma":[0.99879736,0.00015416306,0.00010182136,0.0004247735,0.00029104552,0.00023086171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020785851,0.00024258644,0.00051373075,0.00012255786,0.00018325755,0.00007033935,0.0001429884,0.00018936329,0.00002747331],"category_scores_gemma":[0.00058536837,0.00021909311,0.00011901891,0.00044360527,0.00007799029,0.00014649799,0.000057817004,0.0002352406,0.00007148647],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006149816,0.0019061017,0.08708668,0.0007771901,0.0006804749,0.00016041753,0.0013023639,0.0000033957297,0.8957127,0.006984188,0.0018264824,0.0034985568],"study_design_scores_gemma":[0.033535574,0.0030158432,0.07073492,0.002059502,0.00227891,0.0002727549,0.0037725358,0.000036140777,0.81128234,0.005831791,0.065832555,0.0013471292],"about_ca_topic_score_codex":0.000038380556,"about_ca_topic_score_gemma":0.00001745523,"teacher_disagreement_score":0.08443031,"about_ca_system_score_codex":0.000078505924,"about_ca_system_score_gemma":0.0004039454,"threshold_uncertainty_score":0.8934358},"labels":[],"label_agreement":null},{"id":"W2584566446","doi":"10.1182/blood.v118.21.4101.4101","title":"Outcome of Children Who Experience Disease Relapse Following Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Hematopoietic stem cell transplantation; Transplantation; Internal medicine; Juvenile myelomonocytic leukemia; Leukemia; Myeloid leukemia; Oncology; Pediatrics; Stem cell; Haematopoiesis","score_opus":0.035588721607233,"score_gpt":0.2818038307582915,"score_spread":0.24621510915105851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584566446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964598,0.000901578,0.0008994257,0.000037220343,0.0000681696,0.0011112365,0.000048950835,0.00006535103,0.00040826743],"genre_scores_gemma":[0.9965438,0.000083284554,0.002454667,0.00010081725,0.000032521846,0.00021213,0.000046095764,0.000036949197,0.00048973213],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99842256,0.000044951532,0.000464883,0.00036124792,0.000327266,0.00037906293],"domain_scores_gemma":[0.9990252,0.00007907326,0.0001151743,0.0004366628,0.0000997194,0.0002441489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020766901,0.00019020677,0.00044302334,0.00011159761,0.00007561708,0.000007412695,0.00022619612,0.00010411808,0.00003855151],"category_scores_gemma":[0.00006676131,0.00015855092,0.0002634611,0.00017910433,0.00008364609,0.00009564717,0.000036213176,0.00012218622,0.000013964144],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043694963,0.00072532496,0.9733315,0.0011577131,0.0001294362,0.00031709313,0.0057760724,9.986438e-7,0.017623516,0.00035478608,0.000069360285,0.00007726613],"study_design_scores_gemma":[0.011226203,0.00063222717,0.38902792,0.00043447406,0.0014473146,0.000247283,0.0010590758,0.000027357648,0.5952444,0.00017724073,0.0000348832,0.0004416384],"about_ca_topic_score_codex":0.00003506902,"about_ca_topic_score_gemma":0.000002447152,"teacher_disagreement_score":0.58430356,"about_ca_system_score_codex":0.000040046903,"about_ca_system_score_gemma":0.00014361969,"threshold_uncertainty_score":0.6465519},"labels":[],"label_agreement":null},{"id":"W2584580642","doi":"10.1182/blood.v104.11.4553.4553","title":"Gene Expression Profiling, Frozen and Paraffin Section Immunohistochemistry, and In Situ Hybridization for Determination of Monoclonality in Diffuse Large B-Cell Lymphoma.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Immunohistochemistry; Tissue microarray; In situ hybridization; Immunoglobulin light chain; Hematopathology; Pathology; Molecular biology; Biology; Monoclonal; Streptavidin; Frozen section procedure; Gene expression profiling; Monoclonal antibody; Gene expression; Antibody; Medicine; Biotin; Gene; Genetics; Cytogenetics","score_opus":0.009513318920748363,"score_gpt":0.2626384238780327,"score_spread":0.25312510495728435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584580642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980938,0.0009997156,0.00024367998,0.000028577726,0.000018795356,0.0005370941,0.00001660697,0.000010241796,0.00005148158],"genre_scores_gemma":[0.99553835,0.00018359546,0.003967594,0.000012237968,0.00002390704,0.00013384754,0.00011990139,0.00000868097,0.0000118852495],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993899,0.000014410512,0.00021408698,0.00019847139,0.00007935739,0.000103814295],"domain_scores_gemma":[0.9997125,0.000028881774,0.000089544665,0.00010092354,0.000034187804,0.000033947537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000104827996,0.000090222056,0.00017187597,0.00006202905,0.000025965674,0.000006677809,0.000017037404,0.00007250478,6.6108225e-7],"category_scores_gemma":[0.000041618925,0.000083231476,0.00002363331,0.00006205385,0.000016028305,0.00005394055,0.00001911713,0.000021431668,1.4972618e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020391207,0.009215414,0.17710617,0.00023792543,0.000007869313,0.000014687206,0.00030027027,0.000002264763,0.81152064,0.0000070876868,0.0000017076455,0.0013820342],"study_design_scores_gemma":[0.039837778,0.00012082072,0.16687056,0.000121542704,0.000049284816,0.000018245597,0.000034878383,0.000074417876,0.7927361,0.0000732708,0.000005212614,0.00005789169],"about_ca_topic_score_codex":0.000077373996,"about_ca_topic_score_gemma":0.0000346443,"teacher_disagreement_score":0.039633866,"about_ca_system_score_codex":0.00010456938,"about_ca_system_score_gemma":0.000049056453,"threshold_uncertainty_score":0.3394081},"labels":[],"label_agreement":null},{"id":"W2584597757","doi":"10.1182/blood.v116.21.392.392","title":"Understanding Treatment Preferences In Patients with Primary Immune Thrombocytopenia Contemplating Splenectomy: A Qualitative Study","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Splenectomy; Medicine; Interquartile range; Immune thrombocytopenia; Inter-rater reliability; Internal medicine; Pediatrics; Surgery; Platelet; Psychology; Spleen; Rating scale","score_opus":0.07177529755104808,"score_gpt":0.3168521692523225,"score_spread":0.24507687170127443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584597757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99507093,0.00004808462,0.0000054397165,0.0000311548,0.000040753577,0.0014493641,0.000017451328,0.00003585108,0.003300975],"genre_scores_gemma":[0.9993234,0.000004779951,0.00040591139,0.000016108792,0.000010724085,0.00008037382,0.00008216823,0.000019966974,0.000056543304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989086,0.000070315524,0.00025457854,0.0002939078,0.0002373523,0.0002352729],"domain_scores_gemma":[0.9994598,0.00011447919,0.000106714164,0.00021101898,0.000039940885,0.00006805867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012701841,0.00020675409,0.00058754155,0.000100761594,0.000091017624,0.000024851379,0.000052401305,0.00005334377,0.000041614025],"category_scores_gemma":[0.000022279715,0.00013349194,0.000039121467,0.00016213943,0.00004707275,0.0001150004,0.000022499242,0.00015164986,0.00000791212],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005389462,0.010905767,0.9598767,0.000020505353,0.0006221469,0.00017244855,0.027013944,2.8275412e-7,0.00038166656,0.000058688827,0.0000016492826,0.00040722682],"study_design_scores_gemma":[0.04720503,0.006498056,0.92512935,0.000106588464,0.00036442827,0.00000943204,0.019850662,0.0000021058033,0.00043406282,0.00021215886,0.0000053694143,0.0001827387],"about_ca_topic_score_codex":0.000476422,"about_ca_topic_score_gemma":0.0016026396,"teacher_disagreement_score":0.046666082,"about_ca_system_score_codex":0.00012681508,"about_ca_system_score_gemma":0.00011110827,"threshold_uncertainty_score":0.5443643},"labels":[],"label_agreement":null},{"id":"W2584614183","doi":"10.1182/blood.v120.21.178.178","title":"Phase I/II Study of CYT387, a JAK1/JAK2 Inhibitor for the Treatment of Myelofibrosis","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Myelofibrosis; Medicine; Constitutional symptoms; Internal medicine; Gastroenterology; Polycythemia vera; Phases of clinical research; Anemia; Essential thrombocythemia; Surgery; Clinical trial; Bone marrow; Disease","score_opus":0.03913227367097902,"score_gpt":0.327461189414224,"score_spread":0.28832891574324493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584614183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947214,0.0019099449,0.000012575469,0.00022481127,0.000117426294,0.0026728394,0.00010533806,0.000012273638,0.00022335042],"genre_scores_gemma":[0.9974074,0.00023570043,0.0006183839,0.000030164056,0.0003079117,0.0010921515,0.000019098254,0.00002137424,0.0002678436],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989509,0.000035292047,0.00036563395,0.00017926023,0.00022813224,0.00024076086],"domain_scores_gemma":[0.99894017,0.0002990448,0.00015580944,0.00037388847,0.00011810862,0.000113001],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001166272,0.00019143232,0.00048474252,0.000061633735,0.00011765403,0.000004506765,0.000052005737,0.000048658527,0.0000994625],"category_scores_gemma":[0.000038610815,0.000103960956,0.00018871977,0.00012440271,0.000045714165,0.000043220643,0.000020684836,0.00003083017,0.00000602984],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015358279,0.4334216,0.48920777,0.00014626085,0.0038558005,0.000008520797,0.018859742,0.0000017910446,0.021169025,0.00028574013,0.0007270287,0.030780893],"study_design_scores_gemma":[0.08299181,0.115220055,0.086295776,0.00009410796,0.0052479994,0.000018127992,0.0022357209,0.000015840747,0.6959269,0.000009236967,0.011773606,0.00017080798],"about_ca_topic_score_codex":0.00009936309,"about_ca_topic_score_gemma":0.000045830537,"teacher_disagreement_score":0.6747579,"about_ca_system_score_codex":0.00003686756,"about_ca_system_score_gemma":0.000045726978,"threshold_uncertainty_score":0.42394048},"labels":[],"label_agreement":null},{"id":"W2584624237","doi":"10.1182/blood.v118.21.96.96","title":"Survival of Peripheral T-Cell Lymphomas (PTCLs) Patients Following Relapse: Spectrum of Disease and Rare Long-Term Survivors","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Lymphoma; Anaplastic large-cell lymphoma; Not Otherwise Specified; Population; Anaplastic lymphoma kinase; Oncology; B symptoms; Gastroenterology; Lung cancer","score_opus":0.013514180569326645,"score_gpt":0.2229407522020368,"score_spread":0.20942657163271014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584624237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962076,0.0012137833,0.0000022553215,0.000022230137,0.00019152481,0.00035062604,0.000046597706,0.000021670678,0.0019436954],"genre_scores_gemma":[0.99946463,0.00013354595,0.00012424662,0.000017008459,0.00003330863,0.000017083856,0.00005376256,0.000026061212,0.00013033209],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886614,0.000043645105,0.00031834544,0.00026334837,0.00029160755,0.00021692472],"domain_scores_gemma":[0.9992205,0.000039746978,0.00013385082,0.00032560548,0.000048615035,0.00023170409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000728589,0.00018505067,0.00041769887,0.000067306624,0.00003813975,0.000005824376,0.00007145107,0.000059822298,0.000116112016],"category_scores_gemma":[0.00003097803,0.00015045186,0.00019859595,0.00010358593,0.000063901716,0.0000679847,0.00006324375,0.00003486725,0.0000037408745],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029893345,0.005906843,0.9916036,0.00023159533,0.0003196951,0.0002067426,0.000510266,6.620589e-8,0.00025435537,0.000092746486,0.000008401339,0.00056676375],"study_design_scores_gemma":[0.010161876,0.00077243085,0.96666986,0.00017454465,0.00094587874,0.0000040347677,0.00005582746,0.0000013703842,0.021030728,0.000051368763,0.0000046417786,0.00012742812],"about_ca_topic_score_codex":0.00030333834,"about_ca_topic_score_gemma":0.000063878084,"teacher_disagreement_score":0.02493372,"about_ca_system_score_codex":0.00003527576,"about_ca_system_score_gemma":0.00008695379,"threshold_uncertainty_score":0.61352485},"labels":[],"label_agreement":null},{"id":"W2584660382","doi":"10.1182/blood.v116.21.5054.5054","title":"LY2784544, a Novel JAK2 Inhibitor, Decreases In Vitro Growth of Hematopoietic Human Progenitors From JAK2 V617F Positive Polycythemia Vera Patients","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Polycythemia vera; Peripheral blood mononuclear cell; Haematopoiesis; In vitro; Myeloid; Immunology; Progenitor cell; Medicine; CFU-GM; Pharmacology; Biology; Molecular biology; Andrology; Internal medicine; Stem cell; Biochemistry","score_opus":0.007086816488903168,"score_gpt":0.2374670101542736,"score_spread":0.23038019366537044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584660382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997704,0.00012779316,0.0000029727344,0.00015371447,0.0001624571,0.0009792418,0.00025411023,0.00003864823,0.0005770435],"genre_scores_gemma":[0.9970772,0.000009325753,0.0018831005,0.00013479554,0.00023807629,0.00020271701,0.00038488267,0.00004717784,0.000022724062],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981548,0.00004086519,0.00052400754,0.00048055913,0.00044795725,0.00035176644],"domain_scores_gemma":[0.9987763,0.00018560844,0.00019854933,0.00035164482,0.00023130733,0.00025658065],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00007713406,0.00033747448,0.0006178639,0.00018561774,0.00008576042,0.000022021733,0.000117185904,0.00018675234,0.000104920065],"category_scores_gemma":[0.00019416874,0.0002813793,0.00017454091,0.00022913414,0.000120148536,0.00009424166,0.00007454384,0.0003126618,0.000022285338],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031302177,0.010404939,0.6230116,0.000048390597,0.00026268902,0.000062822466,0.00072516425,3.3006344e-8,0.36469984,0.00023267805,0.00004904698,0.00018980804],"study_design_scores_gemma":[0.009404695,0.00051881274,0.3200718,0.00020719029,0.00029498604,0.00001922708,0.000053575877,0.0000020992743,0.6691308,0.00011835874,0.000013890892,0.0001645404],"about_ca_topic_score_codex":0.0010094636,"about_ca_topic_score_gemma":0.00014550371,"teacher_disagreement_score":0.304431,"about_ca_system_score_codex":0.000057923542,"about_ca_system_score_gemma":0.00013946068,"threshold_uncertainty_score":0.9999638},"labels":[],"label_agreement":null},{"id":"W2584695957","doi":"10.1182/blood.v112.11.794.794","title":"Second Unrelated Donor (URD) Transplant as a Rescue Strategy for 122 Patients with Primary Non Engraftment: Results from the CIBMTR","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Transplantation; Internal medicine; Aplastic anemia; Gastroenterology; Surgery; Bone marrow","score_opus":0.015459588638221571,"score_gpt":0.22100081602838112,"score_spread":0.20554122739015954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584695957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98997355,0.00012277393,0.00019432674,0.00020850317,0.000070864065,0.0019226102,0.0012195319,0.00007072625,0.0062171184],"genre_scores_gemma":[0.9946814,0.000101203244,0.00085691176,0.00036176274,0.0000973956,0.00009461729,0.0030952937,0.00004729305,0.00066411396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99834234,0.000057121848,0.00046290553,0.00042918746,0.0003876623,0.00032081254],"domain_scores_gemma":[0.9988114,0.00040056577,0.00010966171,0.0004187916,0.000117519376,0.00014201977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014996839,0.0002442082,0.00034009665,0.000050970648,0.00017685891,0.000016326698,0.00012737345,0.00015804682,0.000084932435],"category_scores_gemma":[0.000021996642,0.00015488199,0.000094681425,0.000151726,0.000075940334,0.00007939411,0.0000063104812,0.00022294103,0.000040784882],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13631374,0.049241655,0.5291667,0.005499207,0.015579602,0.0065459204,0.1536053,0.0003750398,0.08109623,0.00093699613,0.012361607,0.009278035],"study_design_scores_gemma":[0.12559102,0.003240777,0.78566986,0.0011450188,0.0020606571,0.00033877572,0.0002621761,0.00007848413,0.07915825,0.00008284707,0.0018383601,0.0005337912],"about_ca_topic_score_codex":0.00019959082,"about_ca_topic_score_gemma":0.00016319394,"teacher_disagreement_score":0.25650316,"about_ca_system_score_codex":0.000027105705,"about_ca_system_score_gemma":0.00022920477,"threshold_uncertainty_score":0.63159037},"labels":[],"label_agreement":null},{"id":"W2584753464","doi":"10.1182/blood.v110.11.1827.1827","title":"The Presence of Central Nervous System Disease at Diagnosis in Pediatric Acute Myeloid Leukemia Does Not Affect Outcome.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Medicine; Internal medicine; Myeloid leukemia; Disease; Myeloid; Univariate analysis; Central nervous system; Gastroenterology; Immunology; Multivariate analysis","score_opus":0.013911644536992233,"score_gpt":0.28257905180232945,"score_spread":0.2686674072653372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584753464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99574876,0.0011060204,0.000018270419,0.00084339466,0.00028065225,0.0012237615,0.00007032307,0.00008990631,0.0006189127],"genre_scores_gemma":[0.9965494,0.0015074377,0.00013971055,0.00008490506,0.00051763095,0.00013552773,0.000016413765,0.000048164493,0.0010008101],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966899,0.00016683109,0.0007036913,0.00046036125,0.0009263104,0.001052895],"domain_scores_gemma":[0.99669385,0.0015813101,0.00019603652,0.00083859474,0.00011866346,0.00057156204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011732148,0.0002721221,0.0004987818,0.00024698433,0.00016561076,0.000028259003,0.00048655184,0.00014431878,0.000019551915],"category_scores_gemma":[0.00094735896,0.00015874604,0.00022795322,0.0006563269,0.00017316207,0.00011017173,0.0003396486,0.0004813485,0.000046287973],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009868774,0.00025120605,0.99248296,0.0007642843,0.00012412187,0.0016839398,0.00019092359,0.000013254851,0.0016314953,0.00017330618,0.0005942087,0.0011034295],"study_design_scores_gemma":[0.0040527713,0.0001664816,0.97028,0.000116081996,0.0006456402,0.00006196826,0.00013820465,0.00016822392,0.023813073,0.000005004569,0.00036523043,0.00018735297],"about_ca_topic_score_codex":0.00040670217,"about_ca_topic_score_gemma":0.00033489364,"teacher_disagreement_score":0.022202985,"about_ca_system_score_codex":0.0011089254,"about_ca_system_score_gemma":0.0005292578,"threshold_uncertainty_score":0.64734757},"labels":[],"label_agreement":null},{"id":"W2584781338","doi":"10.1182/blood.v114.22.4285.4285","title":"Lower Healthcare Resource Utilization Associated with Managing Nilotinib Related Adverse Events in Chronic Myeloid Leukemia (CML) Patients – Evidence From a Clinical Practice Setting Study.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Nilotinib; Dasatinib; Medicine; Adverse effect; Imatinib; Internal medicine; Clinical trial; Myeloid leukemia; Oncology","score_opus":0.036676422257919485,"score_gpt":0.3391300849218322,"score_spread":0.3024536626639127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584781338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949207,0.0008799301,0.000008916253,0.0009746785,0.0001329729,0.0024153155,0.000013791495,0.00021989578,0.00043383212],"genre_scores_gemma":[0.99771434,0.0001909454,0.0005884474,0.0007235471,0.0001315227,0.000042464253,0.00035628112,0.000069736234,0.00018272112],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99490625,0.0009721276,0.0013309924,0.0010580886,0.0010491962,0.000683337],"domain_scores_gemma":[0.99671555,0.001013563,0.00087463163,0.00079633313,0.00031421302,0.00028569796],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014085107,0.00042502856,0.0007185702,0.00019931527,0.00016665862,0.000013922299,0.00023121104,0.00031474937,0.000042553595],"category_scores_gemma":[0.00425282,0.0003872224,0.00012662212,0.00090724026,0.00004907501,0.0004977072,0.00009940747,0.0010009421,0.000053838976],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013854362,0.0049997983,0.9816959,0.000043648317,0.0005602789,0.00077729,0.001781532,0.00016573606,0.00003404123,0.0000021721792,0.00008617274,0.008467983],"study_design_scores_gemma":[0.035666835,0.005411138,0.95150423,0.0041176747,0.001085733,0.000022157492,0.0007812897,0.0008880136,0.00004030455,0.000022607572,0.00013215996,0.0003278561],"about_ca_topic_score_codex":0.00090064004,"about_ca_topic_score_gemma":0.0006053715,"teacher_disagreement_score":0.0342814,"about_ca_system_score_codex":0.005013775,"about_ca_system_score_gemma":0.0016688876,"threshold_uncertainty_score":0.99985796},"labels":[],"label_agreement":null},{"id":"W2584835682","doi":"10.1182/blood.v120.21.555.555","title":"Enforced Expression of the Toll/Interleukin-1 Receptor Associated Protein in Murine Marrow Results in MDS-Like Bone Marrow Failure Mediated by Interferon Gamma","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"","keywords":"Bone marrow; Immunology; Haematopoiesis; Medicine; Bone marrow failure; Cancer research; Myeloid; Innate immune system; Stem cell; Biology; Immune system; Cell biology","score_opus":0.011175606717066192,"score_gpt":0.24778937374714702,"score_spread":0.23661376703008083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584835682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99396694,0.00035632076,0.0000021419448,0.0023408358,0.00013487008,0.0018150555,0.00014698658,0.00006575136,0.0011710714],"genre_scores_gemma":[0.9931208,0.00002968674,0.00031568494,0.00012504075,0.00010809348,0.00019899626,0.0003259478,0.00006893422,0.0057068546],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99631476,0.0005352231,0.0010030404,0.0004411036,0.00081578305,0.0008901095],"domain_scores_gemma":[0.9982381,0.00022599891,0.00037874636,0.00075007265,0.00014801905,0.000259049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015504924,0.00033777245,0.00068177545,0.00034890868,0.000044174634,0.000016540565,0.00043819728,0.00044279845,0.00029846877],"category_scores_gemma":[0.0022388455,0.00024066326,0.00013957656,0.00086863403,0.00014069024,0.00021974833,0.00037229908,0.0011213571,0.00005480051],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002121361,0.0012789645,0.024429388,0.00014031606,0.000057226167,0.000029348668,0.0015298616,6.664377e-7,0.94916284,0.0000054438196,0.0210139,0.00023068118],"study_design_scores_gemma":[0.023928432,0.00063400663,0.016417988,0.0021402254,0.000050661944,0.0000254297,0.00063292385,0.00007576613,0.9494789,0.0000068437075,0.006306207,0.0003025896],"about_ca_topic_score_codex":0.0005991642,"about_ca_topic_score_gemma":0.00054107344,"teacher_disagreement_score":0.02180707,"about_ca_system_score_codex":0.0005986464,"about_ca_system_score_gemma":0.00024240537,"threshold_uncertainty_score":0.98139626},"labels":[],"label_agreement":null},{"id":"W2584837919","doi":"10.1182/blood.v110.11.3872.3872","title":"Clinical Significance of Cytocentrifuge Preparation Analysis of Low-Cell-Count Cerebrospinal Fluid Specimens.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Cerebrospinal fluid and hydrocephalus","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; Université de Montréal","funders":"","keywords":"Cerebrospinal fluid; Flow cytometry; Pathology; Medicine; Cytometry; Immunology","score_opus":0.02369760887452402,"score_gpt":0.3133794741646178,"score_spread":0.28968186529009377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584837919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99336606,0.00013862755,0.0010237099,0.000013182968,0.00017669312,0.0003292676,0.00005542181,0.000036304773,0.0048607592],"genre_scores_gemma":[0.99904835,0.00011589561,0.00030283208,0.00010654163,0.00015163598,0.00000445919,0.0000088422385,0.000015962722,0.00024546814],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971773,0.000094201496,0.0011566431,0.0005804815,0.0006222426,0.00036913969],"domain_scores_gemma":[0.998415,0.0003135378,0.00047126898,0.0005170219,0.00013806517,0.0001451109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007976793,0.00018900406,0.00060049735,0.00028640838,0.00007170296,0.000018728355,0.00035041597,0.00012744263,0.0002368391],"category_scores_gemma":[0.00029447087,0.00018242224,0.00040160495,0.0014159089,0.00023494368,0.00013007488,0.00006825886,0.00016056861,0.00003456728],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039695765,0.002221103,0.048348464,0.000078025354,0.00012425083,0.00001831082,0.00012651483,0.000177138,0.9468092,0.0014408189,0.00008301743,0.00017620718],"study_design_scores_gemma":[0.0013805531,0.00061716215,0.13623992,0.000022856239,0.0007457356,0.0000041846074,0.000020822514,0.0010343791,0.8594013,0.000049434908,0.00030781742,0.00017581899],"about_ca_topic_score_codex":0.000035465517,"about_ca_topic_score_gemma":0.000028998507,"teacher_disagreement_score":0.08789146,"about_ca_system_score_codex":0.000028812112,"about_ca_system_score_gemma":0.00009862293,"threshold_uncertainty_score":0.7438963},"labels":[],"label_agreement":null},{"id":"W2584844568","doi":"10.1182/blood.v112.11.5105.5105","title":"Improvement of Myelodysplasia and Partial Correction of panhypogammaglobulinemia after IV IgG Infusions and Splenectomy","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Hematological disorders and diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Boniface Hospital","funders":"","keywords":"Medicine; Pancytopenia; Bone marrow; Bone marrow examination; Biopsy; Anemia; Surgery; Gastroenterology; Pathology; Internal medicine","score_opus":0.00985458466431781,"score_gpt":0.22802663962638894,"score_spread":0.21817205496207112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584844568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984863,0.00047568185,0.00005596799,0.000097317235,0.000056006127,0.00019683549,0.000011177875,0.000012161353,0.0006085718],"genre_scores_gemma":[0.9986059,0.0008166022,0.00038504743,0.00008796324,0.000027707103,0.000015638021,0.000005812146,0.000005172195,0.000050135568],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99944115,0.0000082648785,0.00021808594,0.00012338687,0.00010604974,0.0001030585],"domain_scores_gemma":[0.9996092,0.00009093415,0.000060105187,0.00009790668,0.00005662466,0.0000852689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003852353,0.00007696735,0.00023172775,0.000035759058,0.000026384276,0.0000016780134,0.000015496254,0.00007154442,0.00006761512],"category_scores_gemma":[0.00025616496,0.000059066388,0.000030368343,0.00006953666,0.00011901725,0.000019458641,0.000038451963,0.00006207584,0.0000013952406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003842212,0.0014691338,0.9487497,0.00027068416,0.000075479686,0.000105537656,0.00041585983,0.0000016418186,0.04228534,0.0000998353,0.0005719443,0.0055705863],"study_design_scores_gemma":[0.005234446,0.0017728036,0.90908664,0.0001504213,0.00030767388,0.00019054036,0.00014662738,0.00023185056,0.08181497,0.000063701984,0.0008808638,0.00011944786],"about_ca_topic_score_codex":0.000049970648,"about_ca_topic_score_gemma":0.000011477915,"teacher_disagreement_score":0.03966308,"about_ca_system_score_codex":0.000002406392,"about_ca_system_score_gemma":0.00003286108,"threshold_uncertainty_score":0.24086574},"labels":[],"label_agreement":null},{"id":"W2584868908","doi":"10.1182/blood.v106.11.3447.3447","title":"TNF-α Stimulates Matrix Metalloproteinase Expression in Myelodysplastic Syndromes (MDS): Therapeutic Potential for Inhibitors of TNF-α and MMPs.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Alberta","funders":"","keywords":"Tumor necrosis factor alpha; Matrigel; Matrix metalloproteinase; Cancer research; Biology; Zymography; Secretion; Internal medicine; Immunology; Endocrinology; Angiogenesis; Medicine","score_opus":0.01445540135918462,"score_gpt":0.29314660856734076,"score_spread":0.27869120720815616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584868908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939307,0.0035718952,0.00045732365,0.00058802887,0.000048466416,0.0012755936,0.00002135688,0.000044310687,0.000062313346],"genre_scores_gemma":[0.990971,0.00016828356,0.008016193,0.000046649206,0.00018404289,0.00010745072,0.000023376899,0.000049576884,0.00043338168],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99825406,0.00006767434,0.0004900466,0.00037671314,0.00038515104,0.00042635904],"domain_scores_gemma":[0.99908614,0.00022972567,0.00011760649,0.00029360305,0.000106540916,0.00016639366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038915774,0.00022752826,0.0005033329,0.00035360947,0.000061266896,0.000020985124,0.00012815358,0.00018162117,0.0000801002],"category_scores_gemma":[0.00020975224,0.00018265881,0.00011329215,0.00024423783,0.0001359725,0.0001477095,0.000108051696,0.00026651725,0.000011482212],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013334544,0.00138595,0.0051425155,0.00095710944,0.00031449035,0.00020232046,0.000417225,0.0003310297,0.97513074,0.000112000715,0.00023407981,0.014439098],"study_design_scores_gemma":[0.03222091,0.0021264472,0.025745247,0.00094788213,0.0009122109,0.00057502766,0.0003781844,0.0082017975,0.92645955,0.00051987445,0.0013828666,0.0005300091],"about_ca_topic_score_codex":0.000035801215,"about_ca_topic_score_gemma":0.00000757164,"teacher_disagreement_score":0.048671182,"about_ca_system_score_codex":0.000073405965,"about_ca_system_score_gemma":0.00018045808,"threshold_uncertainty_score":0.744861},"labels":[],"label_agreement":null},{"id":"W2584875660","doi":"10.1182/blood.v120.21.4132.4132","title":"Factors Predictive for Graft Failure Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia in a Population-Based Provincial Transplant Cohort","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Transplantation; Gastroenterology; Cohort; Population; Hematopoietic stem cell transplantation; Leukemia; Chronic lymphocytic leukemia; Graft-versus-host disease","score_opus":0.016796364268190696,"score_gpt":0.26737291703621,"score_spread":0.2505765527680193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584875660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98731333,0.0006351077,0.005777706,0.000022531913,0.00020132953,0.005600078,0.00029016036,0.00012409528,0.000035651603],"genre_scores_gemma":[0.9961426,0.000017973929,0.0005185917,0.00004047995,0.00032341687,0.0015257485,0.0012376634,0.00010260926,0.00009088463],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971507,0.00007607246,0.000626283,0.0005312065,0.000601165,0.0010145383],"domain_scores_gemma":[0.9985374,0.0006046391,0.00013410373,0.00033483046,0.00008159855,0.0003073986],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00054255244,0.00038942762,0.0006503149,0.00029103085,0.00015316949,0.00002789791,0.00017511118,0.00033335362,0.000013111109],"category_scores_gemma":[0.000040813648,0.0003420808,0.00043038835,0.00028371162,0.0000424091,0.00020921952,0.000010706248,0.00017962774,0.0000046438013],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0035708935,0.0012861203,0.9440327,0.014509821,0.0010502707,0.00016511792,0.008489713,0.0064178514,0.019622184,0.0001600342,0.000103059414,0.0005922174],"study_design_scores_gemma":[0.29660213,0.0030387403,0.31359982,0.0023470924,0.007793094,0.00029763184,0.0008794441,0.08721273,0.2860739,0.00010912678,0.0002671581,0.0017791293],"about_ca_topic_score_codex":0.000931434,"about_ca_topic_score_gemma":0.00076770654,"teacher_disagreement_score":0.6304329,"about_ca_system_score_codex":0.03799454,"about_ca_system_score_gemma":0.017771728,"threshold_uncertainty_score":0.99990314},"labels":[],"label_agreement":null},{"id":"W2584894973","doi":"10.1182/blood.v112.11.3016.3016","title":"Prospective Evaluation of An Argatroban Dosing Nomogram Using the Ecarin Chromogenic Assay at a Tertiary Institution","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; McMaster University Medical Centre; University Health Network","funders":"","keywords":"Argatroban; Partial thromboplastin time; Dosing; Medicine; Bivalirudin; Nomogram; Pharmacology; Prothrombin time; Internal medicine; Thrombin; Coagulation","score_opus":0.07080723701091898,"score_gpt":0.3235103122991432,"score_spread":0.2527030752882242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584894973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960038,0.0001510836,0.0000824518,0.00007253164,0.00012313933,0.0010920693,0.000005512442,0.00005600845,0.0024133998],"genre_scores_gemma":[0.99861836,0.00001593625,0.0010133922,0.000053114596,0.00019212127,0.000038852755,0.00002718118,0.000024531479,0.000016529702],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99825656,0.00024805052,0.00033057816,0.0003319207,0.0005785375,0.0002543249],"domain_scores_gemma":[0.9989342,0.000032809337,0.00015951283,0.0004884899,0.00027876536,0.000106193525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083077897,0.00017595664,0.00033020636,0.00010353616,0.00036768525,0.000013310928,0.000113079725,0.00012521162,0.00006799977],"category_scores_gemma":[0.00013818043,0.00013081536,0.00013131906,0.0003349374,0.0002113212,0.00021528173,0.00007611061,0.00019066484,0.000012771942],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059505142,0.0012217878,0.3357898,0.00003497382,0.00037303154,0.000027636577,0.001610777,0.00011020786,0.6590803,0.00013434223,0.000004521914,0.0015530909],"study_design_scores_gemma":[0.0039017124,0.0002693308,0.6327324,0.00010263969,0.0015470631,0.0008702818,0.00007755212,0.0037916908,0.35639948,0.00013593821,0.00002138297,0.00015052523],"about_ca_topic_score_codex":0.000331119,"about_ca_topic_score_gemma":0.00018355045,"teacher_disagreement_score":0.30268082,"about_ca_system_score_codex":0.00034065725,"about_ca_system_score_gemma":0.00050360715,"threshold_uncertainty_score":0.5334496},"labels":[],"label_agreement":null},{"id":"W2584897115","doi":"10.1182/blood.v112.11.1748.1748","title":"Improved Survival in Red Blood Cell Transfusion Dependent Patients with Primary Myelofibrosis (PMF) Receiving Iron Chelation Therapy.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; St. Paul's Hospital","funders":"","keywords":"Medicine; Deferasirox; Myelofibrosis; Internal medicine; Gastroenterology; Myelodysplastic syndromes; Blood transfusion; Thalassemia; Bone marrow; International Prognostic Scoring System; Surgery; Pediatrics","score_opus":0.010570215473079589,"score_gpt":0.2029129414743136,"score_spread":0.192342726001234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584897115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99576575,0.0003928505,0.000021623458,0.00017580645,0.000075857795,0.0014121161,0.00001663706,0.000060539478,0.0020787944],"genre_scores_gemma":[0.99624604,0.0017213075,0.0012230559,0.0001023423,0.000072638744,0.00016845514,0.00020671479,0.00005022395,0.00020923385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820703,0.000101586425,0.00038276374,0.00050060364,0.0004773712,0.00033065825],"domain_scores_gemma":[0.9992308,0.0000898147,0.00012735152,0.00030006698,0.00011622156,0.00013573084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013777861,0.00029999725,0.00044545403,0.00013796441,0.00014588726,0.000014938799,0.0000665607,0.00014670672,0.00009510065],"category_scores_gemma":[0.000018260516,0.00022356726,0.00008799268,0.00023601623,0.000037137754,0.0001372048,0.000020167849,0.00021306341,0.000007547787],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081197685,0.0077368673,0.9524666,0.00006567736,0.000113150585,0.000061646184,0.0008371715,0.0000066172815,0.03555917,0.0000016869798,0.000008724936,0.002330698],"study_design_scores_gemma":[0.028423078,0.002100947,0.8533194,0.00012422452,0.00019911192,0.000017413431,0.000026100586,0.000012546358,0.11553819,0.0000025437855,0.0000272014,0.00020924999],"about_ca_topic_score_codex":0.00020736115,"about_ca_topic_score_gemma":0.00016818376,"teacher_disagreement_score":0.099147215,"about_ca_system_score_codex":0.00008952849,"about_ca_system_score_gemma":0.00011698554,"threshold_uncertainty_score":0.9116808},"labels":[],"label_agreement":null},{"id":"W2585019257","doi":"10.1182/blood.v112.11.703.703","title":"The POZ/BTB Domain Transcription Factor Miz-1 (Zbtb17) Is Required during Early B Cell Development for the Survival of B-Cell Progenitors and Is Essential for the Formation of Mature Follicular B Cells","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Biology; B cell; CD19; PAX5; Transcription factor; Lymphopoiesis; Cell biology; Progenitor cell; Bone marrow; Haematopoiesis; Stromal cell; Molecular biology; Immunology; Stem cell; Antibody; Cancer research; Gene; Genetics","score_opus":0.010922818071011404,"score_gpt":0.19996869224180805,"score_spread":0.18904587417079666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585019257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916277,0.0025322284,0.0031000113,0.00019254455,0.0013101479,0.0011476609,0.00003972756,0.000013875909,0.00003609035],"genre_scores_gemma":[0.99686813,0.00038139074,0.0001503531,0.000029551324,0.00004410356,0.00011190327,0.00003522954,0.000015192551,0.002364143],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991247,0.000079413905,0.0003843927,0.00014715709,0.000062564446,0.00020179027],"domain_scores_gemma":[0.9991819,0.00021329195,0.00026132292,0.00019362458,0.0001400892,0.000009767095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020711786,0.00014159332,0.00016550458,0.00003892272,0.0007250371,0.000017315942,0.00015219214,0.00015915248,0.000032425105],"category_scores_gemma":[0.000010108133,0.00007914294,0.00017097361,0.00006576226,0.00011718726,0.00012360625,0.000020450947,0.0001263191,0.0000058135834],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062475645,0.00018168394,0.00006697435,0.00010347808,0.00021034865,1.0823608e-7,0.0070244814,0.0000012578752,0.9909219,0.000014625894,0.0006806358,0.00016973224],"study_design_scores_gemma":[0.0032232367,0.00015739037,0.0017064809,0.000015320524,0.00015115071,0.000012722662,0.0013527048,0.0000113609385,0.9706947,0.000010190977,0.022573588,0.000091153095],"about_ca_topic_score_codex":0.000023501132,"about_ca_topic_score_gemma":0.0000074247528,"teacher_disagreement_score":0.021892954,"about_ca_system_score_codex":0.000014543328,"about_ca_system_score_gemma":0.00003728406,"threshold_uncertainty_score":0.5576473},"labels":[],"label_agreement":null},{"id":"W2585025605","doi":"10.1182/blood.v114.22.2397.2397","title":"BIK (Bcl2-Interacting Killer) CpG Methylation Status in Multiple Myeloma Patients: a Potential Predictor of Relapsed/Refractory Disease.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"CpG site; DNA methylation; Methylation; Epigenetics; Cancer research; Multiple myeloma; Biology; Bone marrow; Gene silencing; Molecular biology; Immunology; Genetics; Gene; Gene expression","score_opus":0.015491181669064177,"score_gpt":0.2760061180421629,"score_spread":0.26051493637309875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585025605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978589,0.00036405955,0.00008313697,0.00011368486,0.00015896178,0.0008107932,0.0000994149,0.00005690958,0.00045413247],"genre_scores_gemma":[0.99828285,0.000085686814,0.0008336926,0.000042003212,0.00010975409,0.000042645483,0.00041847516,0.00002496485,0.0001599571],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979213,0.00012264818,0.00049086165,0.0003590212,0.0006122128,0.0004939684],"domain_scores_gemma":[0.9986772,0.00018149485,0.0001849503,0.00034449706,0.00019096867,0.00042089523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013499515,0.00020523043,0.00034997205,0.0003422813,0.000064275155,0.000016972086,0.00008725569,0.00009082594,0.00014198471],"category_scores_gemma":[0.00143476,0.00017697648,0.00014427277,0.00026940493,0.000043359738,0.00024395446,0.000041360752,0.00025669916,0.00002386955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024181958,0.006747983,0.9531103,0.00009459194,0.0001668763,0.00022421757,0.0003121044,0.000023059922,0.008261484,0.000009844198,0.00011125021,0.028520107],"study_design_scores_gemma":[0.02075383,0.0011845465,0.9725151,0.0002671748,0.00014870515,0.0000032855314,0.00007482509,0.0012504507,0.003259552,0.00005214853,0.00035928446,0.00013108963],"about_ca_topic_score_codex":0.00014331193,"about_ca_topic_score_gemma":0.00002282862,"teacher_disagreement_score":0.028389018,"about_ca_system_score_codex":0.000119020515,"about_ca_system_score_gemma":0.0001597713,"threshold_uncertainty_score":0.7216891},"labels":[],"label_agreement":null},{"id":"W2585047090","doi":"10.1182/blood.v108.11.3067.3067","title":"Rituximab Increases Response to ESHAP in Relapsed, Refractory, and Transformed Aggressive B-Cell Lymphoma.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Etoposide; Internal medicine; Rituximab; Cytarabine; Salvage therapy; Autologous stem-cell transplantation; Oncology; Gastroenterology; Progression-free survival; Transplantation; Surgery; Chemotherapy; Lymphoma","score_opus":0.006022726009628075,"score_gpt":0.23060519740513613,"score_spread":0.22458247139550805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585047090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99123186,0.0046868497,0.0000011156806,0.0008271751,0.000027984981,0.0005570474,0.000039320854,0.000050437066,0.0025782108],"genre_scores_gemma":[0.9982417,0.00019558604,0.00044706804,0.00038977162,0.000069128255,0.00014039417,0.000028329156,0.00002604391,0.0004619613],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876285,0.00008141178,0.0002836697,0.0003496059,0.00021987701,0.0003025812],"domain_scores_gemma":[0.9991791,0.0002577413,0.00007521162,0.00025349387,0.000039281826,0.0001951293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001621963,0.0002043848,0.00037818047,0.0002063065,0.00005668077,0.00002310304,0.000053618896,0.00010871954,0.00003521628],"category_scores_gemma":[0.00012876498,0.00016747703,0.00007158885,0.00020044966,0.00004540958,0.000049768558,0.000023506222,0.00005004086,0.00006575821],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019378329,0.10884058,0.7889978,0.00030418497,0.00026118688,0.014750712,0.0013873996,0.0000037197615,0.031532608,0.00025784515,0.004594469,0.02969117],"study_design_scores_gemma":[0.096339226,0.0016519019,0.8424956,0.00041233195,0.0003337304,0.000427288,0.00012872068,0.0000053105923,0.050744876,0.00008793473,0.0071068867,0.00026614516],"about_ca_topic_score_codex":0.001602597,"about_ca_topic_score_gemma":0.0003021262,"teacher_disagreement_score":0.10718867,"about_ca_system_score_codex":0.00013379006,"about_ca_system_score_gemma":0.00016658349,"threshold_uncertainty_score":0.6829515},"labels":[],"label_agreement":null},{"id":"W2585087416","doi":"10.1182/blood.v108.11.1094.1094","title":"Thrombin Is Able To Trigger Apoptosis of Human Platelets.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Apoptosis; Thrombin; Phosphatidylserine; Platelet; Flow cytometry; Biology; Platelet activation; Molecular biology; Cell biology; Immunology; Biochemistry","score_opus":0.021732780716765692,"score_gpt":0.27608733248373546,"score_spread":0.25435455176696975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585087416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97692883,0.00008493347,0.000088594636,0.0007452446,0.00007626958,0.00030076967,0.000008416249,0.00007274302,0.021694213],"genre_scores_gemma":[0.99468744,0.0000047669428,0.0010394285,0.00065076177,0.00010633063,0.000015312049,0.000019765148,0.000024977791,0.0034512477],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998987,0.000015203271,0.00030639474,0.00021883665,0.0002669715,0.00020555193],"domain_scores_gemma":[0.99941856,0.000014267674,0.00007481109,0.0003151399,0.00008177265,0.00009543918],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000107875356,0.00012511802,0.00035064612,0.00013094262,0.00005983407,0.000010621041,0.00007671183,0.0000977732,0.0009762889],"category_scores_gemma":[0.0000098250375,0.000114766335,0.000107327076,0.00026728262,0.000022290085,0.000039551687,0.000029713914,0.000076714394,0.00013708898],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018621955,0.0023844165,0.0027263088,0.00006367686,0.00012367716,0.000004421284,0.0001765896,0.000001925247,0.9726658,0.010236043,0.011313087,0.00028546655],"study_design_scores_gemma":[0.0032899824,0.00048945163,0.011408395,0.00006677228,0.00024583715,0.00001272654,0.00003257518,0.0000068201994,0.98045087,0.0017283765,0.0021457793,0.00012240044],"about_ca_topic_score_codex":0.00020362948,"about_ca_topic_score_gemma":0.000009384651,"teacher_disagreement_score":0.018242966,"about_ca_system_score_codex":0.000011082355,"about_ca_system_score_gemma":0.000027256514,"threshold_uncertainty_score":0.99993694},"labels":[],"label_agreement":null},{"id":"W2585127179","doi":"10.1182/blood.v116.21.961.961","title":"Complete Remissions with Brentuximab Vedotin (SGN-35) in Patients with Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Brentuximab vedotin; Medicine; Anaplastic large-cell lymphoma; CD30; Tolerability; Internal medicine; Oncology; Antibody-drug conjugate; Lymphoma; Gastroenterology; Adverse effect; Immunology; Antibody","score_opus":0.0065421425777565795,"score_gpt":0.20742874197655595,"score_spread":0.20088659939879938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585127179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975684,0.00013142724,0.0000048092625,0.00005674337,0.00013124761,0.0008018386,0.000105207655,0.000077658355,0.0011226231],"genre_scores_gemma":[0.9984085,0.000018642524,0.00071955874,0.0001176655,0.00006049207,0.00009414406,0.00017306536,0.000055111555,0.00035282184],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824274,0.000049524424,0.00034985333,0.00046253082,0.00043569953,0.00045964925],"domain_scores_gemma":[0.9986768,0.0001575333,0.00018122024,0.0005801822,0.00011060944,0.00029370675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000933876,0.0003030042,0.0004940726,0.00015195226,0.00011202168,0.000024685885,0.00011594356,0.00013820973,0.00012375244],"category_scores_gemma":[0.00006142618,0.00017514333,0.00005557146,0.0002938849,0.000054252727,0.00007869402,0.000043247146,0.00018390428,0.00007243415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021512753,0.023242794,0.971141,0.00019671416,0.0001579096,0.0006660014,0.00022728113,0.0000012311983,0.0011438966,0.00002580564,0.0003724151,0.00067366695],"study_design_scores_gemma":[0.12722336,0.0045164386,0.861643,0.0012016731,0.0005907164,0.00020234752,0.00011481687,0.00003638299,0.0012071644,0.0000016507379,0.0029463642,0.000316054],"about_ca_topic_score_codex":0.000082629915,"about_ca_topic_score_gemma":0.0003708327,"teacher_disagreement_score":0.12507209,"about_ca_system_score_codex":0.0001283711,"about_ca_system_score_gemma":0.00036447312,"threshold_uncertainty_score":0.7142138},"labels":[],"label_agreement":null},{"id":"W2585136044","doi":"10.1182/blood.v126.23.534.534","title":"Sharing Post-AML Consolidation Supportive Therapy with Local Centers Reduces Patient Travel Burden without Compromising Safety and Efficacy of Care","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Febrile neutropenia; Consolidation (business); Ambulatory; Neutropenia; Chemotherapy; Emergency medicine; Internal medicine","score_opus":0.01902259234045547,"score_gpt":0.2737282955614709,"score_spread":0.25470570322101543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585136044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99727315,0.00029815227,0.00014202275,0.00015545361,0.000047377947,0.00047667502,0.00001902239,0.000021753873,0.0015663736],"genre_scores_gemma":[0.9995896,0.000039902458,0.00017389824,0.00005750246,0.000047772246,0.0000083113655,0.000048374543,0.0000151141885,0.00001952191],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993309,0.00002032445,0.00018280087,0.0001888664,0.0001573088,0.000119825454],"domain_scores_gemma":[0.9994131,0.000014954416,0.000099124125,0.00012461965,0.00023276909,0.00011545217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004334824,0.000101117184,0.00022290614,0.00004901823,0.00005058513,0.000012821131,0.00003216447,0.00003259297,0.000012676764],"category_scores_gemma":[0.000009412386,0.00007609073,0.000028472248,0.000072394905,0.00011195228,0.000060460494,0.000018153278,0.00008593759,0.0000010093879],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022436125,0.0026264295,0.52534544,0.0004203797,0.001579997,0.00011929874,0.11643673,0.00044679936,0.22472288,0.00023209647,0.00006992707,0.10556392],"study_design_scores_gemma":[0.037961256,0.009178998,0.37485653,0.0008153147,0.00063793035,0.0004147351,0.034238208,0.0000588579,0.54093075,0.000007829815,0.00055341335,0.00034617056],"about_ca_topic_score_codex":0.00029458274,"about_ca_topic_score_gemma":0.000027455957,"teacher_disagreement_score":0.3162079,"about_ca_system_score_codex":0.00003968418,"about_ca_system_score_gemma":0.00013567183,"threshold_uncertainty_score":0.310289},"labels":[],"label_agreement":null},{"id":"W2585146168","doi":"10.1182/blood.v120.21.3333.3333","title":"Human and Murine Immune Thrombocytopenia (ITP) Is Associated with a Peripheral Deficiency of CD4- T Regulatory Cells (Tc-regs)","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; St. Michael's Hospital","funders":"","keywords":"FOXP3; IL-2 receptor; CD8; Immunology; Population; Regulatory T cell; Immune system; Flow cytometry; Peripheral tolerance; Peripheral blood mononuclear cell; T cell; Medicine; Immune tolerance; Biology; In vitro","score_opus":0.011163402575106977,"score_gpt":0.23769252388489018,"score_spread":0.2265291213097832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585146168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935856,0.0028323345,9.162548e-7,0.0000508113,0.000027640166,0.00026869253,0.000017090339,0.0000308051,0.0031861085],"genre_scores_gemma":[0.9987725,0.00003817946,0.00014844764,0.00008097561,0.000021216394,0.000009000378,0.00002443819,0.000024499781,0.000880744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990833,0.000021322858,0.0002052356,0.00017421907,0.00021336964,0.00030256837],"domain_scores_gemma":[0.99946046,0.000012904497,0.000120959376,0.00024453396,0.00004987331,0.00011126426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010666025,0.00016505216,0.00047313643,0.00004862118,0.0000881865,0.000008416756,0.000052746338,0.00008246087,0.00018657043],"category_scores_gemma":[0.00000930574,0.00012193789,0.000056790082,0.00012355026,0.000108060914,0.00009415738,0.000035555946,0.00009165477,0.000007003754],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017642336,0.012419961,0.69516486,0.00023826264,0.0014792522,0.0003117122,0.0042260136,0.0000012360258,0.28432694,0.00035080174,0.0005962347,0.0007082943],"study_design_scores_gemma":[0.012716664,0.0011016596,0.88711953,0.00018132228,0.0008516387,0.00016561995,0.00020468542,0.000005820744,0.097256154,0.000043473377,0.000135548,0.00021785521],"about_ca_topic_score_codex":0.00008927206,"about_ca_topic_score_gemma":0.000016968932,"teacher_disagreement_score":0.19195469,"about_ca_system_score_codex":0.000024799781,"about_ca_system_score_gemma":0.000033569875,"threshold_uncertainty_score":0.4972483},"labels":[],"label_agreement":null},{"id":"W2585171566","doi":"10.1182/blood.v118.21.61.61","title":"Lysosomal Disruption Selectively Targets Leukemia Cells and Leukemia Stem Cells Through A Mechanism Related to Increased Reactive Oxygen Species Production","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; University of Toronto; University Health Network","funders":"","keywords":"Mefloquine; Leukemia; Pharmacology; Haematopoiesis; Cytotoxic T cell; Myeloid leukemia; Stem cell; Cancer research; Immunology; Medicine; Biology; Chloroquine; In vitro; Cell biology; Malaria; Biochemistry","score_opus":0.012688706040504644,"score_gpt":0.2078158370523498,"score_spread":0.19512713101184515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585171566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963062,0.00014739079,0.0006016391,0.00003538406,0.00023732352,0.0006249832,0.000029002254,0.00004979679,0.0019683137],"genre_scores_gemma":[0.99508864,0.000112208494,0.00251855,0.00009617916,0.00016952313,0.00006063022,0.000077014316,0.000033089374,0.0018441409],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986544,0.0001072701,0.0002470322,0.0005824177,0.00015292689,0.0002559425],"domain_scores_gemma":[0.9993405,0.0000057133607,0.00013699295,0.0002751859,0.00012953317,0.00011207654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016263434,0.00022250126,0.0001720652,0.000059126494,0.0001450595,0.000025153602,0.00011419412,0.00022184207,0.000019286643],"category_scores_gemma":[0.000035166435,0.00021643215,0.0000617384,0.00016560925,0.000055229357,0.000028154325,0.00009786247,0.0001306552,0.000032040803],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013833163,0.000109815424,0.0001388942,0.000014193784,0.000090015186,0.0000044230696,0.00073104905,0.0000028268937,0.9976374,0.00040242943,0.0005490804,0.00018153933],"study_design_scores_gemma":[0.0008207119,0.00045535286,0.0023419564,0.000020504758,0.00006223573,0.000027324419,0.00028154845,0.000008631534,0.99268335,0.000467496,0.0025562826,0.00027461775],"about_ca_topic_score_codex":0.00011365041,"about_ca_topic_score_gemma":0.000020330428,"teacher_disagreement_score":0.004954064,"about_ca_system_score_codex":0.00009633448,"about_ca_system_score_gemma":0.00013866818,"threshold_uncertainty_score":0.8825847},"labels":[],"label_agreement":null},{"id":"W2585251126","doi":"10.1182/blood.v116.21.3855.3855","title":"Mesenchymal Stem Cells Express the Surface Receptor Calreticulin (cC1qR) and Complement C1q Chemoattracts Them.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hematological disorders and diagnostics","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Canadian Blood Services","funders":"","keywords":"Mesenchymal stem cell; Stem cell; Cell biology; Complement system; Biology; Haematopoiesis; Complement receptor; Cord blood; Immunology; Chemistry; Antibody","score_opus":0.029548854993277862,"score_gpt":0.25831012257903513,"score_spread":0.22876126758575727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585251126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991853,0.00024100643,0.00003336158,0.0030296159,0.0001607621,0.00046583585,0.000025235795,0.000040017825,0.004151156],"genre_scores_gemma":[0.99679357,0.00012640834,0.0019230857,0.00063825486,0.00008958447,0.000014201381,0.000008444421,0.000014968777,0.00039148369],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99899226,0.000036288606,0.00022185562,0.0002345649,0.00023545255,0.00027960073],"domain_scores_gemma":[0.99893236,0.0004387937,0.000060181595,0.00030677352,0.0000656357,0.00019626583],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002075964,0.00015290406,0.0002598664,0.000009127441,0.000113629896,0.00003487895,0.0001152435,0.00011644015,0.0009491793],"category_scores_gemma":[0.0001229821,0.000087799584,0.000054754328,0.0000673204,0.00016208585,0.000025403366,0.00008388619,0.00032913676,0.00016582005],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019444994,0.005510012,0.12018167,0.00043614183,0.0002733835,0.0002040891,0.0022148283,0.0000070550195,0.80746275,0.010585568,0.049803965,0.0031260848],"study_design_scores_gemma":[0.0072445483,0.00058741163,0.022525428,0.00014721869,0.00044723207,0.00020507291,0.0020724,0.0001844687,0.8535937,0.00043814167,0.1120415,0.00051283685],"about_ca_topic_score_codex":0.00002425302,"about_ca_topic_score_gemma":0.000011866843,"teacher_disagreement_score":0.09765624,"about_ca_system_score_codex":0.000003620175,"about_ca_system_score_gemma":0.000034137287,"threshold_uncertainty_score":0.9999641},"labels":[],"label_agreement":null},{"id":"W2585253753","doi":"10.1182/blood.v124.21.770.770","title":"High Resolution Imaging Reveals Hematopoietic Stem Cells in the Perivascular Niche Are Anchored to Mesenchymal Stromal Cells That Orient Their Divisions","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Zebrafish Biomedical Research Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Stem cell; Biology; Cell biology; Mesenchymal stem cell; Progenitor cell; Population; Zebrafish; Hematopoietic stem cell; Haematopoiesis; Transplantation; Stromal cell; Endothelial stem cell; Immunology; Cancer research; Genetics; Medicine; Internal medicine","score_opus":0.011177626332139494,"score_gpt":0.2436185346178372,"score_spread":0.2324409082856977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585253753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924925,0.00028655163,0.004133426,0.0020951387,0.00006792918,0.00065301615,0.000071003706,0.000018560268,0.0001818512],"genre_scores_gemma":[0.9981219,0.00006442424,0.0007017131,0.0005095479,0.00020189039,0.00022545208,0.00005561687,0.000024736493,0.000094702686],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99787736,0.0003406324,0.0002599446,0.00054023194,0.00046183585,0.00052001426],"domain_scores_gemma":[0.9985622,0.00008555951,0.000082149156,0.0009639145,0.000078125806,0.0002280318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093314546,0.00019221549,0.00019900854,0.00007273806,0.00016762238,0.000072086295,0.0006664188,0.000114047456,0.000016506565],"category_scores_gemma":[0.0001261047,0.00013715358,0.00012168583,0.00029680427,0.0001226746,0.000006327667,0.00032738276,0.00020886664,0.0000369358],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016003696,0.00039714682,0.0025619,0.000025350073,0.000031707175,0.0000070432848,0.00022448973,0.00003164239,0.99037796,0.0002676106,0.005217737,0.0008413773],"study_design_scores_gemma":[0.0013905182,0.0002793391,0.026827471,0.00008227443,0.000043487787,0.00001981186,0.0010230282,0.00017359633,0.94244945,0.00037891956,0.026992386,0.00033970346],"about_ca_topic_score_codex":0.000032715943,"about_ca_topic_score_gemma":0.000027143216,"teacher_disagreement_score":0.047928527,"about_ca_system_score_codex":0.0000216545,"about_ca_system_score_gemma":0.00005062044,"threshold_uncertainty_score":0.559296},"labels":[],"label_agreement":null},{"id":"W2585293092","doi":"10.1182/blood.v116.21.2781.2781","title":"Differential Genomic and Proteomic Signatures In Cord Blood (CB) Vs Peripheral Blood (PB) CD56+Dim NK Cells: Over Expression of CD34 In CB Vs PB CD56+Dim NK Cells","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Immunology; Transplantation; Haematopoiesis; CD34; Bone marrow; Hematopoietic stem cell transplantation; Stem cell; Biology; Cord blood; Population; NKG2D; Hematology; Graft-versus-host disease; Medicine; Cytotoxic T cell; Internal medicine; In vitro; Cell biology","score_opus":0.006909773675247468,"score_gpt":0.23096315569288167,"score_spread":0.2240533820176342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585293092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960586,0.00041778278,0.00011429622,0.000059074493,0.00053265295,0.0021741993,0.000095974254,0.000079344536,0.00046809312],"genre_scores_gemma":[0.99404204,0.00027633418,0.0045616743,0.000094734874,0.00032997286,0.00014190827,0.00007998577,0.000114439965,0.00035889595],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964535,0.00020466771,0.0010797561,0.00089868234,0.0006261471,0.00073722465],"domain_scores_gemma":[0.998378,0.00019241223,0.0003499317,0.0006933636,0.00008526078,0.00030104772],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032842453,0.0005935224,0.0010532449,0.00041995547,0.000083312865,0.00005730965,0.00032301145,0.00069648755,0.0008301573],"category_scores_gemma":[0.000045670997,0.0005386761,0.00018731934,0.00028159676,0.0002099374,0.00016006517,0.00011503848,0.0011285078,0.000021437987],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012307477,0.0025265338,0.04218899,0.0015213116,0.00011027859,0.00027184383,0.0019655959,0.000018384446,0.94996107,0.00003831808,0.00007960673,0.00008730686],"study_design_scores_gemma":[0.020930499,0.0008752614,0.081236325,0.0011118363,0.00070997345,0.00012240282,0.00013799616,0.00018511714,0.89405537,0.000078344856,0.000061903665,0.0004949851],"about_ca_topic_score_codex":0.00028966018,"about_ca_topic_score_gemma":0.00029169713,"teacher_disagreement_score":0.055905726,"about_ca_system_score_codex":0.000036205598,"about_ca_system_score_gemma":0.00020014102,"threshold_uncertainty_score":0.9997065},"labels":[],"label_agreement":null},{"id":"W2585310577","doi":"10.1182/blood.v106.11.3841.3841","title":"Application of the Luminex Platform for Multiplexed Genotyping of Non-Deletional Alpha Thalassemia Mutations.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Genotyping; Alpha-thalassemia; Amplicon; Molecular biology; Genotype; Point mutation; Allele; Biology; Thalassemia; Polymerase chain reaction; Genetics; Mutation; Gene","score_opus":0.013863331712221323,"score_gpt":0.30335027855715513,"score_spread":0.2894869468449338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585310577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98525363,0.0002347719,0.012338363,0.0005662285,0.000021956546,0.0011169116,0.00006296805,0.000013785425,0.00039137356],"genre_scores_gemma":[0.9524854,0.0000072385087,0.047059156,0.00002759457,0.00011691568,0.00013905231,0.000058537484,0.000010990533,0.00009515117],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992109,0.0000058306273,0.00025546664,0.00012218062,0.00027394635,0.00013167718],"domain_scores_gemma":[0.9991531,0.00023706941,0.0001302635,0.00021739026,0.00022241464,0.000039802428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001350612,0.000064682456,0.00014866357,0.000055280183,0.00004737738,0.0000027290312,0.00010421927,0.000039706538,0.000015550071],"category_scores_gemma":[0.00034990505,0.00004733186,0.00008480756,0.00015166993,0.000099365614,0.00006070129,0.000028040495,0.00006542732,0.0000041376557],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011590747,0.0003714769,0.011872012,0.00021929614,0.0000619926,1.2219866e-7,0.00013439554,0.00019851947,0.9750301,0.00043297556,0.0001298913,0.011433301],"study_design_scores_gemma":[0.004342873,0.00016216573,0.23041548,0.00011580858,0.000116146424,0.000015911932,0.00009442909,0.018675532,0.7429697,0.0003220156,0.0026989228,0.00007104032],"about_ca_topic_score_codex":0.000019044852,"about_ca_topic_score_gemma":0.000019136223,"teacher_disagreement_score":0.23206043,"about_ca_system_score_codex":0.000027147416,"about_ca_system_score_gemma":0.00010313777,"threshold_uncertainty_score":0.19301373},"labels":[],"label_agreement":null},{"id":"W2585368272","doi":"10.1182/blood.v112.11.1699.1699","title":"Analysis of Protein Biology to Increase Efficacy of Aurora Kinase Inhibitors for Multiple Myeloma Therapy.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"SUMO protein; Biology; Interactome; Kinase; Cancer research; Multiple myeloma; Cancer; Targeted therapy; Cancer cell; Computational biology; Aurora inhibitor; Function (biology); Bioinformatics; Ubiquitin; Cell cycle; Cell biology; Genetics; Immunology; Gene","score_opus":0.010973348629448298,"score_gpt":0.24440322361004516,"score_spread":0.23342987498059686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585368272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976806,0.0005318657,0.0009604079,0.00001835285,0.000020496796,0.00056694093,0.00018484265,0.0000059691465,0.000030514091],"genre_scores_gemma":[0.99699914,0.00007022087,0.00237006,0.000059362646,0.00006572905,0.00007131564,0.00027947637,0.000015613341,0.00006910684],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99919933,0.000041766452,0.00027491132,0.00026666847,0.00005092432,0.00016639248],"domain_scores_gemma":[0.99930835,0.000026399985,0.00012479564,0.00034782026,0.00012467806,0.000067946465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000092368085,0.00012261116,0.00027558266,0.00014722998,0.00003673485,0.0000017720904,0.0001552101,0.00013190343,0.0000060032344],"category_scores_gemma":[0.00018164283,0.00011195776,0.00024642397,0.00027394126,0.00007187214,0.0000014047723,0.00006239367,0.00003002908,7.355081e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002917357,0.00066863187,0.02798059,0.000014179812,0.00064586045,0.00000105817,0.000060666727,0.000040368366,0.968409,0.00001578498,0.00005247718,0.0018196201],"study_design_scores_gemma":[0.0023093424,0.0007296046,0.01221981,0.0000071975633,0.00020252008,0.0000018274771,0.0000110803,0.000042760283,0.9809311,0.0000035633202,0.0034127547,0.00012845692],"about_ca_topic_score_codex":0.00015969496,"about_ca_topic_score_gemma":0.00008126998,"teacher_disagreement_score":0.015760781,"about_ca_system_score_codex":0.000002989558,"about_ca_system_score_gemma":0.000057263256,"threshold_uncertainty_score":0.45655048},"labels":[],"label_agreement":null},{"id":"W2585386763","doi":"10.1182/blood.v106.11.4255.4255","title":"Gene Regulation during the Erythrocytic Differentiation of Embryonic Stem Cells.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biology; Stem cell factor; Haematopoiesis; Embryoid body; Embryonic stem cell; Stem cell; Cellular differentiation; Erythropoiesis; Molecular biology; Globin; Downregulation and upregulation; Cell biology; Internal medicine; Gene; Induced pluripotent stem cell; Genetics; Medicine; Anemia","score_opus":0.008612236714539118,"score_gpt":0.22095460194549899,"score_spread":0.21234236523095987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585386763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99854404,0.0007331835,0.00019271785,0.000092246766,0.000036083173,0.00016198008,0.0000066518237,0.000007246999,0.00022586687],"genre_scores_gemma":[0.9970442,0.0001875005,0.00010506283,0.00001076503,0.00017959528,0.000010309436,0.00002231588,0.000012902393,0.0024273533],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99928516,0.000054967262,0.00014625194,0.00017686174,0.00017606816,0.0001606922],"domain_scores_gemma":[0.99951303,0.000007808246,0.00007707917,0.00031761557,0.000054495373,0.000029962332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010380849,0.00007809404,0.00007582787,0.000029115216,0.00006931534,0.000012178993,0.00015578217,0.00007052442,0.00001856777],"category_scores_gemma":[0.000005312192,0.000060410675,0.000060073122,0.00006458658,0.000035388224,0.0000033692131,0.00009014712,0.000052521616,0.000016680267],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019143888,0.000093346,0.0010364123,0.00003318476,0.000043406646,3.7715685e-7,0.000023604165,0.00034642318,0.9978512,0.0000068362797,0.00005059667,0.0004954814],"study_design_scores_gemma":[0.00075133314,0.00004707569,0.02333526,0.000006960697,0.000025049705,0.00000865053,0.000011708028,0.00025260274,0.97494304,0.0000049350806,0.0005483668,0.000065022214],"about_ca_topic_score_codex":0.0000031660472,"about_ca_topic_score_gemma":0.000013827928,"teacher_disagreement_score":0.022908151,"about_ca_system_score_codex":0.000013958816,"about_ca_system_score_gemma":0.0000294318,"threshold_uncertainty_score":0.24634758},"labels":[],"label_agreement":null},{"id":"W2585403279","doi":"10.1182/blood.v112.11.1811.1811","title":"VIDAS D-Dimer in Combination with Clinical Pre-Test Probability to Rule out Pulmonary Embolism. A Systematic Review of the Management Outcome Studies.","year":2008,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; D-dimer; Pulmonary embolism; Confidence interval; Randomized controlled trial; Clinical trial; Meta-analysis; Internal medicine; Pre- and post-test probability; Surgery","score_opus":0.08273071241766125,"score_gpt":0.3944623833345467,"score_spread":0.3117316709168855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585403279","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018502104,0.97291446,0.0000039306533,0.00048367435,0.00023648608,0.02484205,0.000016722812,0.000042979424,0.0012746931],"genre_scores_gemma":[0.00010863785,0.9936975,0.00043121178,0.00093131,0.000060618117,0.0039147604,0.000028897826,0.00006555853,0.0007614894],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99426955,0.0006270244,0.0031258562,0.000756475,0.0008557138,0.00036537368],"domain_scores_gemma":[0.9962527,0.00041481038,0.0012082944,0.0017588419,0.00023137894,0.00013394449],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018718797,0.0005749512,0.007024565,0.00020014276,0.00006753379,0.000010012425,0.0005105975,0.0001755831,0.000013963831],"category_scores_gemma":[0.00090533093,0.00030762484,0.00085694646,0.00071042124,0.00013840334,0.00004700041,0.0005441707,0.00042968462,0.000054818032],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005023652,0.007851964,0.0010026986,0.9750378,0.0019860792,0.00009028826,0.000107576045,2.1074018e-7,1.1070543e-8,0.0001790396,0.00066401856,0.013075274],"study_design_scores_gemma":[0.001108395,0.0003919429,0.0061651617,0.9169438,0.023484012,0.00007870396,0.000044456086,4.3358816e-7,2.630254e-7,0.000023721725,0.051432665,0.00032642632],"about_ca_topic_score_codex":0.000013316117,"about_ca_topic_score_gemma":0.000020359743,"teacher_disagreement_score":0.058094,"about_ca_system_score_codex":0.00019963017,"about_ca_system_score_gemma":0.0001529999,"threshold_uncertainty_score":0.9999376},"labels":[],"label_agreement":null},{"id":"W2585432338","doi":"10.1182/blood.v112.11.2420.2420","title":"Microenvironment Determines Myeloid-Erythroid Lineage Switch in MN1 Leukemia","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Haematopoiesis; Biology; Myeloid; Leukemia; Bone marrow; Cancer research; Phenotype; Stem cell factor; Myeloid leukemia; Cell biology; Lineage (genetic); Stem cell; Immunology; Genetics; Gene","score_opus":0.0200376804355847,"score_gpt":0.2580991761476483,"score_spread":0.23806149571206361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585432338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948576,0.0009045503,0.000031018055,0.00063554494,0.000062868465,0.0005588717,0.000008535106,0.00008097377,0.0028600278],"genre_scores_gemma":[0.9887726,0.0015031853,0.0028795488,0.0007058935,0.00042900967,0.00007227514,0.000037507543,0.00006777219,0.0055322535],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9978506,0.000057183708,0.0004519698,0.0005078549,0.00047734362,0.00065506704],"domain_scores_gemma":[0.998887,0.00009377571,0.000071152666,0.0006460113,0.00003881759,0.0002632597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002282623,0.0002711469,0.0004838982,0.00025715661,0.00010086111,0.0000120927625,0.00023639301,0.00018907692,0.00024796295],"category_scores_gemma":[0.00013435975,0.00024330107,0.0001277564,0.00033568763,0.00021232314,0.00009825667,0.00018383763,0.0005664598,0.0005192748],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003632148,0.0017293497,0.42722067,0.00024009559,0.00018459577,0.010187903,0.0013288014,0.000024002378,0.54774857,0.0000137562665,0.006991936,0.0039670905],"study_design_scores_gemma":[0.01841971,0.0007260046,0.48628235,0.00021140024,0.00015498791,0.004984779,0.00020358032,0.0004443823,0.4578104,0.000018259474,0.03017591,0.00056823436],"about_ca_topic_score_codex":0.00021383475,"about_ca_topic_score_gemma":0.00005185784,"teacher_disagreement_score":0.08993818,"about_ca_system_score_codex":0.00063652877,"about_ca_system_score_gemma":0.00052072294,"threshold_uncertainty_score":0.992153},"labels":[],"label_agreement":null},{"id":"W2585466194","doi":"10.1182/blood.v114.22.704.704","title":"Next Generation Transcriptomic Resequencing Identifies Novel Genetic Alterations in High-Risk (HR) Childhood Acute Lymphoblastic Leukemia (ALL): A Report From the Children's Oncology Group (COG) HR ALL TARGET Project.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Genome British Columbia","funders":"","keywords":"Biology; RefSeq; Genetics; Gene; Oncology; Bioinformatics; Genome; Medicine","score_opus":0.027679341565036136,"score_gpt":0.2873964798037109,"score_spread":0.25971713823867476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585466194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867932,0.00087274757,0.006904312,0.0017643555,0.00035288176,0.0027067994,0.00024429092,0.00017267837,0.00018873336],"genre_scores_gemma":[0.97744834,0.00053325755,0.016323322,0.0017101652,0.0015788263,0.00033002818,0.0018314957,0.0000924095,0.00015216989],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99499714,0.0003971918,0.0013689807,0.0012242486,0.0009961426,0.0010162891],"domain_scores_gemma":[0.9974829,0.00042476822,0.00043001302,0.0011868632,0.00020903,0.00026645444],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007934006,0.0005546134,0.00080846425,0.00042939247,0.00035237434,0.00025891862,0.00058318005,0.00045932663,0.000085304615],"category_scores_gemma":[0.0007711478,0.00043744067,0.00024362322,0.00071781484,0.00021868148,0.00044026165,0.000111682435,0.0009328066,0.000053045947],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008878727,0.004463353,0.015463842,0.00004438775,0.0035159166,0.004743104,0.009955756,0.0019242537,0.9456908,0.0002491963,0.008236852,0.004824651],"study_design_scores_gemma":[0.0459127,0.0034480032,0.8622042,0.0004484054,0.005781907,0.010819682,0.00054750673,0.031460617,0.035850268,0.0014391184,0.0007482963,0.0013392809],"about_ca_topic_score_codex":0.01234406,"about_ca_topic_score_gemma":0.0036510236,"teacher_disagreement_score":0.9098405,"about_ca_system_score_codex":0.002005517,"about_ca_system_score_gemma":0.0034751953,"threshold_uncertainty_score":0.9998077},"labels":[],"label_agreement":null},{"id":"W2585495775","doi":"10.1182/blood.v118.21.4752.4752","title":"Gaps in Access to Patient Care for Patients with Rare Hematological Disorders","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Roche (Canada)","funders":"","keywords":"Medicine; Rituximab; Reimbursement; Thrombocytopenic purpura; Medicaid; Pediatrics; Family medicine; Intensive care medicine; Health care; Internal medicine","score_opus":0.009224143674270702,"score_gpt":0.21422689754371627,"score_spread":0.20500275386944555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585495775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99301034,0.003806395,0.00004646658,0.000026540489,0.0001984024,0.0009667229,0.000043565255,0.00004757622,0.0018539702],"genre_scores_gemma":[0.99927604,0.000013312042,0.00009975814,0.00015390803,6.793081e-7,0.00025683557,0.00015744125,0.000015988157,0.00002602999],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989734,0.00004954407,0.00023386936,0.0003077441,0.0000318355,0.0004035488],"domain_scores_gemma":[0.99958587,0.000038636368,0.00006595987,0.00023243726,0.00006850143,0.000008611582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000036584453,0.00017433484,0.00024384905,0.00010374468,0.0001478798,0.000011459498,0.00032295624,0.0001427504,0.00013971992],"category_scores_gemma":[0.00005101747,0.00013168948,0.00006265705,0.0001776799,0.00008339498,0.00010414054,0.000105536405,0.00012880516,0.00005357406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022122546,0.010019214,0.8963832,0.00020727076,0.00023742397,0.000008741644,0.033053655,0.000020125288,0.0016756785,0.0011455871,0.00023795273,0.054798875],"study_design_scores_gemma":[0.020114698,0.005988932,0.90032226,0.0002359908,0.00013910753,0.000010079541,0.009567187,5.014494e-7,0.03449621,0.0005400803,0.027496494,0.0010884409],"about_ca_topic_score_codex":0.000102980564,"about_ca_topic_score_gemma":0.00007306996,"teacher_disagreement_score":0.053710435,"about_ca_system_score_codex":0.0000114243685,"about_ca_system_score_gemma":0.000028105886,"threshold_uncertainty_score":0.5370141},"labels":[],"label_agreement":null},{"id":"W2585576019","doi":"10.1182/blood.v112.11.3023.3023","title":"The Impact of Deep Vein Thrombosis on Outcomes in Critically Ill Patients: A Systematic Review and Meta-Analysis","year":2008,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; St. Joseph's Hospital; McMaster University","funders":"","keywords":"Medicine; Mechanical ventilation; Intensive care unit; Confidence interval; Meta-analysis; Deep vein; Thrombosis; Relative risk; Intensive care medicine; Emergency medicine; Internal medicine","score_opus":0.05646313949268332,"score_gpt":0.36952237272072186,"score_spread":0.3130592332280385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585576019","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004037584,0.9941422,0.0000017488028,0.00025110377,0.000013500605,0.004986529,0.00007154826,0.000014107506,0.00047889777],"genre_scores_gemma":[0.00028089524,0.99750024,0.000044396773,0.00103622,0.000007419304,0.0009845826,0.000047446225,0.00004218705,0.000056632336],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9964971,0.00051206624,0.0017189904,0.00043610102,0.0005075223,0.00032823876],"domain_scores_gemma":[0.9968071,0.000866044,0.0006583886,0.0011042177,0.00043796335,0.00012627935],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0005578173,0.0005541523,0.014852219,0.00036549947,0.00006781929,0.000026192369,0.00027127206,0.00014027435,0.00010552007],"category_scores_gemma":[0.0023387412,0.00024076803,0.004895575,0.00076524436,0.000086977474,0.00003455219,0.000104811246,0.00024808486,0.000019490502],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[8.740546e-7,0.003095301,0.00014332932,0.6107604,0.38462523,0.000014324056,0.00004146261,2.741039e-7,3.043553e-9,0.00010276709,0.0002862716,0.0009298086],"study_design_scores_gemma":[0.00037701006,0.00044892362,0.0017812066,0.032306172,0.9636895,0.000006362225,0.00001127429,6.261915e-7,4.264498e-8,0.0000067488772,0.0011611517,0.0002109912],"about_ca_topic_score_codex":0.00011846059,"about_ca_topic_score_gemma":0.000034994446,"teacher_disagreement_score":0.57906425,"about_ca_system_score_codex":0.00008398841,"about_ca_system_score_gemma":0.00006801232,"threshold_uncertainty_score":0.9997733},"labels":[],"label_agreement":null},{"id":"W2585591789","doi":"10.1182/blood-2016-09-742387","title":"Decreasing TfR1 expression reverses anemia and hepcidin suppression in β-thalassemic mice","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute","keywords":"Hepcidin; Erythropoiesis; Ineffective erythropoiesis; Transferrin receptor; Anemia; Transferrin; Beta thalassemia; Enucleation; Internal medicine; Thalassemia; Endocrinology; Medicine; Biology; Genetics","score_opus":0.01121744570727416,"score_gpt":0.2632048849333728,"score_spread":0.2519874392260986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585591789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903066,0.0019060484,0.0000033900092,0.00045826973,0.00010812213,0.0001979499,0.0000021809976,0.00003245953,0.0069849403],"genre_scores_gemma":[0.99747586,0.0012330331,0.00080590596,0.00008289989,0.000052097475,0.000005154253,0.00000767627,0.000017338674,0.0003200315],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991893,0.000033221833,0.0001716485,0.00025014227,0.0001343427,0.00022135429],"domain_scores_gemma":[0.9993601,0.000039088805,0.00009305958,0.00035107307,0.000022920643,0.00013374402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013449426,0.00012436823,0.00020804594,0.00006885813,0.00021724399,0.000041677522,0.00009317281,0.00019267225,0.000030136287],"category_scores_gemma":[0.00031470312,0.000096807984,0.000035700807,0.000038044116,0.00007789552,0.00013890123,0.00010016545,0.00023566595,0.000009105697],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014217038,0.00035323936,0.301231,0.00016696086,0.000013389722,0.00023847065,0.0004329436,6.1229457e-7,0.6930543,0.000013529726,0.0013691819,0.0029841836],"study_design_scores_gemma":[0.01646661,0.00027783785,0.4126561,0.0053951284,0.00030128818,0.00088018924,0.0014552638,0.00013304848,0.5572137,0.00025298775,0.0045177904,0.0004500613],"about_ca_topic_score_codex":0.00020395964,"about_ca_topic_score_gemma":0.000016822267,"teacher_disagreement_score":0.13584062,"about_ca_system_score_codex":0.000014578539,"about_ca_system_score_gemma":0.00004236706,"threshold_uncertainty_score":0.39477152},"labels":[],"label_agreement":null},{"id":"W2585628954","doi":"10.1182/blood.v104.11.3377.3377","title":"Mesenchymal Stem Cells Promote Survival of Leukemic Cells Via Integrin-Linked Kinase (ILK)-Dependent Akt and STAT3 Activation: Implications for Leukemia Therapy.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Protein kinase B; Stromal cell; PI3K/AKT/mTOR pathway; Mesenchymal stem cell; Cancer research; Cell biology; Signal transduction; Biology; Stem cell; Chemistry","score_opus":0.015382074480751578,"score_gpt":0.24651614074110817,"score_spread":0.2311340662603566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585628954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97590864,0.0007876498,0.022132974,0.000092111455,0.000121848825,0.0006650655,0.00008687366,0.000022446398,0.00018237543],"genre_scores_gemma":[0.9969255,0.00058232027,0.0015871971,0.000054532138,0.00018570309,0.000117126416,0.00011166017,0.000041990712,0.00039401368],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99865067,0.0000441796,0.00036824442,0.00049770763,0.00014821049,0.00029097794],"domain_scores_gemma":[0.99898046,0.000034550852,0.00021552733,0.00044429535,0.00022327938,0.00010187292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021652019,0.0002467744,0.0002485326,0.00004892095,0.00011553097,0.000030951105,0.0002755134,0.00024009244,0.0000057699867],"category_scores_gemma":[0.000017482791,0.00022635004,0.0001120664,0.0001066995,0.00012369531,0.0000124908875,0.00009216746,0.00013664154,0.0000021421758],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001003393,0.000265654,0.000241452,0.00011223979,0.00010712402,0.0000011556887,0.000118399614,0.00014636434,0.99525744,0.00024111038,0.0000348325,0.0033738946],"study_design_scores_gemma":[0.0034415694,0.00063423894,0.0002974851,0.000029548168,0.000053800475,0.000015539892,0.00011127219,0.000011185468,0.9931386,0.00080653053,0.0012052279,0.00025500887],"about_ca_topic_score_codex":0.000042660115,"about_ca_topic_score_gemma":0.000009315895,"teacher_disagreement_score":0.021016803,"about_ca_system_score_codex":0.00006172053,"about_ca_system_score_gemma":0.0004222858,"threshold_uncertainty_score":0.92302865},"labels":[],"label_agreement":null},{"id":"W2585665669","doi":"10.1182/blood.v116.21.1191.1191","title":"Molecular Characterization of a Chromosomal Translocation Linking CDK6 to the IGK Locus In CD5- Monoclonal B-Cell Lymphocytosis (MBL).","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation; Mount Sinai Hospital","funders":"","keywords":"Biology; Lymphocytosis; Breakpoint; Chromosomal translocation; Comparative genomic hybridization; Molecular biology; Locus (genetics); Genetics; CD5; Gene rearrangement; Chromosome abnormality; Fluorescence in situ hybridization; Karyotype; Chromosome; Gene; Immunology; Antibody","score_opus":0.007778699166129864,"score_gpt":0.2478790830427772,"score_spread":0.24010038387664734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585665669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99726975,0.000115396884,0.0004896171,0.0007678078,0.00009936614,0.00076643017,0.00001246717,0.00002911487,0.00045005314],"genre_scores_gemma":[0.9987352,0.00004658434,0.0005201499,0.00023695064,0.00019405856,0.00009416685,0.00007334044,0.000035631743,0.00006394698],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983859,0.000058697125,0.00038802493,0.00030625548,0.0005295948,0.0003314964],"domain_scores_gemma":[0.9990765,0.0000642238,0.00008622692,0.0005034613,0.00013743962,0.00013215907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037558837,0.0001539844,0.00026383216,0.00018738088,0.000045970995,0.00002248804,0.00024154576,0.00016170969,0.000058264162],"category_scores_gemma":[0.00009144419,0.00012323087,0.000087510685,0.00056345336,0.00006746644,0.00007016434,0.00005732366,0.0002728125,0.000044997327],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013304687,0.00067539193,0.00077731576,0.00014136003,0.00003448183,0.00009160139,0.0009978748,0.00003506441,0.99086285,0.00007808936,0.0000036939741,0.0061692363],"study_design_scores_gemma":[0.018012034,0.0001719299,0.004639597,0.00017505485,0.00008396112,0.00018117887,0.000036119865,0.0050869705,0.9709952,0.00001729057,0.00046872467,0.00013194767],"about_ca_topic_score_codex":0.000374208,"about_ca_topic_score_gemma":0.00015307448,"teacher_disagreement_score":0.019867653,"about_ca_system_score_codex":0.00072465726,"about_ca_system_score_gemma":0.0027013677,"threshold_uncertainty_score":0.5025209},"labels":[],"label_agreement":null},{"id":"W2585783048","doi":"10.1182/blood.v108.11.3696.3696","title":"Overcoming Self-Tolerance: Long-Term Protection Against Specific erbB2-Expressing Prostate Tumors Using Low Doses of Lentivirus-Transduced DCs.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Immunotherapy; Cancer research; Medicine; Bone marrow; Viral vector; Immune tolerance; Antigen; CD86; Prostate cancer; Dendritic cell; Genetic enhancement; CD80; Immunology; Cancer; Biology; Cytotoxic T cell; T cell; Immune system; CD40; Internal medicine; In vitro; Recombinant DNA","score_opus":0.013076422055698932,"score_gpt":0.22594064928436702,"score_spread":0.2128642272286681,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585783048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877574,0.01014056,0.0005625992,0.000011220929,0.00044649196,0.0006879119,0.00002307857,0.00015261165,0.00021814786],"genre_scores_gemma":[0.99886626,0.00027517954,0.00030668773,0.000018090874,0.00009277529,0.00003246924,0.000045561235,0.000051833544,0.00031112248],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981036,0.00032089444,0.0006142611,0.00038297364,0.000075608776,0.00050266925],"domain_scores_gemma":[0.99910975,0.00006583308,0.00035702757,0.0003653192,0.000089767644,0.000012324059],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000256411,0.00031328085,0.00045174648,0.00020866722,0.0003983964,0.000050806986,0.00020781238,0.00023098565,0.00007345934],"category_scores_gemma":[0.000010960712,0.0003047518,0.00019991377,0.00024242786,0.00021459121,0.00030902645,0.00004088058,0.00033189837,0.000028442353],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082796084,0.0009927286,0.005836505,0.00015877307,0.00019162266,0.000017544491,0.00075922464,0.00006358672,0.9887642,0.000009365594,0.000018675393,0.0023597605],"study_design_scores_gemma":[0.004650299,0.00013105957,0.031805716,0.0006548234,0.00007276829,0.00012554045,0.0000734361,0.000008232736,0.96164984,0.00001688619,0.00048525195,0.00032616174],"about_ca_topic_score_codex":0.00010481634,"about_ca_topic_score_gemma":0.000006427929,"teacher_disagreement_score":0.02711443,"about_ca_system_score_codex":0.0000459503,"about_ca_system_score_gemma":0.000099411634,"threshold_uncertainty_score":0.99994045},"labels":[],"label_agreement":null},{"id":"W2585907801","doi":"10.1182/blood.v108.11.344.344","title":"The Potential for Lost Productivity and Daily Activity Impairment in Patients with Follicular (FL) and Other Indolent Non-Hodgkin’s Lymphoma (NHL).","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Follicular lymphoma; Internal medicine; Cancer; Hematology; Stage (stratigraphy); Lymphoma","score_opus":0.0035466345246427285,"score_gpt":0.2030042947814467,"score_spread":0.19945766025680395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585907801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99728125,0.00031232173,0.000016577429,0.00043891865,0.00004202013,0.0017797711,0.0000329116,0.00001255555,0.00008369623],"genre_scores_gemma":[0.9993586,0.000014846482,0.00018129329,0.000052836953,0.00009096548,0.00021615799,0.000010433908,0.00002209319,0.00005279496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989858,0.000031447587,0.00014226479,0.000356892,0.00021932878,0.0002642276],"domain_scores_gemma":[0.99951273,0.000043902026,0.000080357684,0.00024439712,0.00004780762,0.00007079766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014261849,0.00018581102,0.00024135715,0.00004315135,0.00013837495,0.00004304799,0.000034728237,0.000054663753,0.0000016709666],"category_scores_gemma":[0.000011062485,0.00010744044,0.000045804158,0.00007155794,0.00007773837,0.00006525909,0.000041894793,0.000033882967,0.0000013993005],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009406122,0.0066502877,0.9791881,0.00004817682,0.00016531072,0.000021673386,0.00009370702,0.0000020877326,0.00021191672,0.000024525985,0.00007140011,0.01258223],"study_design_scores_gemma":[0.027904587,0.0014910409,0.96358484,0.00006319085,0.0002662035,0.000021305916,0.000023544162,0.000026474065,0.006018773,0.00003834174,0.0004369791,0.0001247237],"about_ca_topic_score_codex":0.00077527197,"about_ca_topic_score_gemma":0.0005022883,"teacher_disagreement_score":0.026963973,"about_ca_system_score_codex":0.000093221766,"about_ca_system_score_gemma":0.00006960955,"threshold_uncertainty_score":0.43812943},"labels":[],"label_agreement":null},{"id":"W2585946924","doi":"10.1182/blood.v120.21.4272.4272","title":"Hospital Demand for Blood Components in Ontario Correlates with Selected Diagnostic and Procedural Activities","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Blood donation and transfusion practices","field":"Business, Management and Accounting","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Cryoprecipitate; Medicine; Apheresis; Blood management; Blood product; Health care; Emergency medicine; Platelet; Blood transfusion; Transfusion medicine; Internal medicine; Surgery","score_opus":0.011996718959710623,"score_gpt":0.19594937235509066,"score_spread":0.18395265339538003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585946924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976033,0.00018713517,0.000026639667,0.00041248137,0.00012698762,0.00052740466,0.0000018799691,0.0000626875,0.0010514637],"genre_scores_gemma":[0.9990313,0.0000117012205,0.00022085206,0.00032056347,0.00014240271,0.00010167343,0.000036403664,0.000019958967,0.00011512729],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99925923,0.00000700022,0.00015053246,0.00017421256,0.00013639446,0.00027263502],"domain_scores_gemma":[0.99946874,0.00025743514,0.000117371055,0.00006482214,0.00007174299,0.000019900157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013522292,0.00014992617,0.00015990817,0.00013186607,0.00013264985,0.0001617053,0.000065409426,0.00005597065,0.000055645272],"category_scores_gemma":[0.0001427125,0.00012502534,0.000019997022,0.00019181769,0.000036496185,0.001820672,0.000030038265,0.00014284159,0.000008102911],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006369679,0.0015528188,0.9961876,0.000098481316,0.000092551905,0.0000045545657,0.00043079548,0.0000019533134,0.00022788008,0.0011135289,0.00008165669,0.0001444527],"study_design_scores_gemma":[0.005963392,0.00007171392,0.9893096,0.00008317326,0.00051609846,0.000017973742,0.00026885155,0.000054136955,0.000532358,0.00014441322,0.0027792112,0.00025909225],"about_ca_topic_score_codex":0.003366642,"about_ca_topic_score_gemma":0.023268864,"teacher_disagreement_score":0.019902222,"about_ca_system_score_codex":0.000007043027,"about_ca_system_score_gemma":0.00002776424,"threshold_uncertainty_score":0.9945539},"labels":[],"label_agreement":null},{"id":"W2585952718","doi":"10.1182/blood.v120.21.3785.3785","title":"Bosutinib As Therapy for Chronic Phase Chronic Myeloid Leukemia Following Failure with Imatinib Plus Dasatinib and/or Nilotinib: 24-Month Minimum Follow-up Update","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Nilotinib; Bosutinib; Dasatinib; Medicine; Internal medicine; Imatinib; Gastroenterology; Discontinuation; Myeloid leukemia; Interquartile range; Surgery","score_opus":0.021190996040951808,"score_gpt":0.29488857032200017,"score_spread":0.27369757428104835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585952718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98052055,0.011502481,0.0002047626,0.000676424,0.0007203642,0.0046493327,0.00013718614,0.00043790136,0.0011510034],"genre_scores_gemma":[0.98395604,0.00085585064,0.006781692,0.000641112,0.0019767284,0.001202672,0.0006731631,0.000346461,0.0035662649],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9949625,0.00012403513,0.00095866766,0.0011564823,0.0008235746,0.0019746996],"domain_scores_gemma":[0.9967546,0.00042069168,0.00050113705,0.0013046501,0.00014301226,0.000875936],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006666086,0.0010585597,0.0014735062,0.00024825192,0.0004786918,0.00011712217,0.00037714973,0.00043337134,0.000676978],"category_scores_gemma":[0.00024835658,0.0007732069,0.00050167955,0.00048489685,0.00022253198,0.0006169407,0.00014656105,0.0005934983,0.00020053376],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08235971,0.027452609,0.07616587,0.010003482,0.04538696,0.0032694212,0.035095904,0.000111007204,0.28813407,0.0028719448,0.060103532,0.3690455],"study_design_scores_gemma":[0.6541456,0.029200595,0.0036620137,0.0023446192,0.0065712323,0.0026383859,0.00165474,0.0014680276,0.115092315,0.00010581859,0.18021592,0.0029007306],"about_ca_topic_score_codex":0.00012996246,"about_ca_topic_score_gemma":0.00025606347,"teacher_disagreement_score":0.5717859,"about_ca_system_score_codex":0.0026395472,"about_ca_system_score_gemma":0.005245726,"threshold_uncertainty_score":0.9994719},"labels":[],"label_agreement":null},{"id":"W2585959001","doi":"10.1182/blood.v124.21.5067.5067","title":"Tonsillectomy in a Patient with Type 3 Von Willebrand Disease","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Manitoba; CancerCare Manitoba","funders":"","keywords":"Von Willebrand disease; Tranexamic acid; Tonsillectomy; Cryoprecipitate; Medicine; Von Willebrand factor; Bleeding diathesis; Hemostasis; Desmopressin; Bleeding time; Surgery; Platelet; Fresh frozen plasma; Clotting factor; Gastroenterology; Internal medicine; Pediatrics; Blood loss; Platelet aggregation","score_opus":0.004670706607933678,"score_gpt":0.20774775752716623,"score_spread":0.20307705091923256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585959001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931631,0.00031875982,0.0000029780786,0.00016159922,0.000018173449,0.00019152157,0.0000018882143,0.000019740348,0.006122256],"genre_scores_gemma":[0.9993891,0.000019227977,0.00013910094,0.00023817166,0.000012416284,0.0000128385755,0.000018835546,0.000009907941,0.00016037644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995817,0.000011604729,0.00006705836,0.0001244573,0.000094327675,0.00012084734],"domain_scores_gemma":[0.99972117,0.00001325293,0.000016437765,0.00012836738,0.00001919607,0.000101547026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00001671554,0.00007249562,0.00013465011,0.0000446902,0.000018163359,0.000004870281,0.000016043023,0.000019210796,0.000040557792],"category_scores_gemma":[0.000028305123,0.000048228525,0.000017402552,0.00011678447,0.000014053548,0.0000209073,0.000007339199,0.000042635525,0.000030069532],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001115777,0.003201868,0.9839049,0.0000588514,0.00014660784,0.0031214529,0.00034507437,0.00000733861,0.00025734396,0.0000642807,0.00040851173,0.0073679932],"study_design_scores_gemma":[0.061139364,0.0062332395,0.8999626,0.00065753993,0.001036171,0.0006302441,0.00013488728,0.00035601624,0.0038557411,0.00071511796,0.024698323,0.0005807404],"about_ca_topic_score_codex":0.00002412673,"about_ca_topic_score_gemma":0.000035407214,"teacher_disagreement_score":0.08394229,"about_ca_system_score_codex":0.00000781166,"about_ca_system_score_gemma":0.000037730057,"threshold_uncertainty_score":0.19667022},"labels":[],"label_agreement":null},{"id":"W2585970811","doi":"10.1182/blood.v114.22.2772.2772","title":"Cytogenetic Risk Features in MDS-Update and Present State.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"International Prognostic Scoring System; Multivariate analysis; Univariate analysis; Myelodysplastic syndromes; Univariate; Medicine; Internal medicine; Oncology; Bone marrow; Cytogenetics; Multivariate statistics; Computer science; Biology","score_opus":0.009596251328094545,"score_gpt":0.27898288625285367,"score_spread":0.2693866349247591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585970811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99127847,0.0041322974,0.000011595127,0.0024259735,0.000013667537,0.000367432,0.000013085579,0.00003453164,0.0017229484],"genre_scores_gemma":[0.9945393,0.0030422134,0.0011096307,0.00043447252,0.00011126094,0.0000098908695,0.00001169776,0.000014041962,0.00072748784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897176,0.000064305874,0.00014852858,0.00025117822,0.00024328052,0.00032092247],"domain_scores_gemma":[0.9994615,0.000040782368,0.0000307454,0.00027054886,0.000034905162,0.00016153228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019313763,0.000112853464,0.00019482117,0.00013923121,0.000035145364,0.000021944266,0.00008299074,0.000067964735,0.00003765991],"category_scores_gemma":[0.00009285738,0.000091622445,0.000028748083,0.00018656785,0.00004924531,0.000035534144,0.000051747185,0.00035221354,0.000035839537],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013661248,0.0029743938,0.6010697,0.00023471563,0.00039608762,0.0037253813,0.0019645824,0.00008289988,0.0526891,0.00038710452,0.026811417,0.3082985],"study_design_scores_gemma":[0.006782194,0.0005242948,0.9576762,0.000048704645,0.00008874701,0.00021265452,0.00004866212,0.000086100954,0.028016549,0.0011262601,0.00525477,0.0001349029],"about_ca_topic_score_codex":0.00015202105,"about_ca_topic_score_gemma":0.000045905257,"teacher_disagreement_score":0.35660645,"about_ca_system_score_codex":0.000040257626,"about_ca_system_score_gemma":0.00009852516,"threshold_uncertainty_score":0.3736255},"labels":[],"label_agreement":null},{"id":"W2585980921","doi":"10.1182/blood.v106.11.3817.3817","title":"Prevalence of Frequent α-Globin Gene Deletions in Neonates with HbH in Cord Blood.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"Genotype; Cord blood; Thalassemia; Biology; Fetal hemoglobin; Medicine; Genetics; Gene; Fetus; Pregnancy","score_opus":0.006964290983692631,"score_gpt":0.22729425211240084,"score_spread":0.2203299611287082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585980921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925013,0.0042460063,0.000030000941,0.00090480316,0.000018042729,0.00035811315,0.000011847792,0.00002502479,0.0019048343],"genre_scores_gemma":[0.9937553,0.0015023567,0.004157074,0.0001762729,0.000026754125,0.00002462325,0.000008426083,0.000015289965,0.00033394198],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901545,0.000028810933,0.00031763242,0.00021447738,0.00017925528,0.00024437852],"domain_scores_gemma":[0.9995657,0.000027867018,0.000065343265,0.00021577475,0.00004903393,0.000076284676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001240795,0.00012181401,0.00022708805,0.00015154705,0.000018580002,0.0000035594644,0.00008052848,0.00010885364,0.00011056721],"category_scores_gemma":[0.000034137727,0.00009556757,0.000040896153,0.0003493366,0.00006835565,0.000045292432,0.00002127445,0.00021892296,0.0000134566435],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032853827,0.006357876,0.93370104,0.0006192099,0.0001777546,0.00041757658,0.0010729318,0.0013075678,0.045978986,0.00045843783,0.00012341127,0.009456666],"study_design_scores_gemma":[0.043441813,0.0033584086,0.7633055,0.0030844791,0.0013306427,0.0013613614,0.00092526834,0.001323312,0.17823379,0.00021717754,0.0026333749,0.00078490016],"about_ca_topic_score_codex":0.00033627602,"about_ca_topic_score_gemma":0.00030376346,"teacher_disagreement_score":0.17039557,"about_ca_system_score_codex":0.000025268819,"about_ca_system_score_gemma":0.00011093807,"threshold_uncertainty_score":0.38971323},"labels":[],"label_agreement":null},{"id":"W2585996601","doi":"10.1182/blood.v118.21.2233.2233","title":"Bone Marrow Specimens From Patients with Immune Thrombocytopenia (ITP) Demonstrate Increased Megakaryocyte-Bound IgG and Increased T-Helper Cells","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Bone marrow; Megakaryocyte; Medicine; Pathology; Haematopoiesis; Immunology; Biology; Stem cell","score_opus":0.011010943164106814,"score_gpt":0.1957604892469821,"score_spread":0.1847495460828753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585996601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917961,0.0009791616,0.000002797746,0.000025595373,0.000057993544,0.00077575765,0.00021192663,0.00007827162,0.0060724225],"genre_scores_gemma":[0.99630123,0.00010824609,0.0026878815,0.00019320124,0.000041684914,0.000028717282,0.00041674197,0.00006121064,0.00016106493],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983083,0.00006198732,0.00035550905,0.0005185575,0.00032787916,0.0004277639],"domain_scores_gemma":[0.9988832,0.00005755451,0.00015873546,0.000490051,0.0000766523,0.00033384078],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000088448905,0.0003858696,0.00077299075,0.00009918729,0.00014735348,0.000043545562,0.000102577455,0.0001473696,0.0007595478],"category_scores_gemma":[0.000015352349,0.00029003143,0.000082947845,0.00015405123,0.00017733946,0.00018334136,0.00007083013,0.0001929994,0.00010127266],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026828079,0.0076674847,0.8858301,0.000057034867,0.0018296953,0.0024521288,0.00064280315,4.7346322e-8,0.097668655,0.000026137837,0.00019312165,0.00094995846],"study_design_scores_gemma":[0.029415142,0.0010216485,0.8308635,0.00013775367,0.0014885695,0.00007503575,0.000096883254,0.0000045724555,0.13625097,0.00016816448,0.00011809201,0.0003596696],"about_ca_topic_score_codex":0.0039709806,"about_ca_topic_score_gemma":0.00023280723,"teacher_disagreement_score":0.05496663,"about_ca_system_score_codex":0.000033869626,"about_ca_system_score_gemma":0.000109374494,"threshold_uncertainty_score":0.9999552},"labels":[],"label_agreement":null},{"id":"W2586004935","doi":"10.1182/blood.v114.22.1503.1503","title":"Clonal Analysis of the Human Hematopoietic Hierarchy Reveals An Early Lymphoid Progenitor with Extensive Monocytic Potential.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto General Hospital","funders":"","keywords":"Myeloid; Progenitor cell; Biology; Haematopoiesis; Lineage (genetic); Immunology; Cord blood; Stem cell; Cell biology; Genetics; Gene","score_opus":0.008227304235713377,"score_gpt":0.23545934464428458,"score_spread":0.2272320404085712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586004935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996839,0.0022037572,0.000026607533,0.00008328089,0.00015414273,0.00031419797,0.00002260179,0.00003678526,0.00031966306],"genre_scores_gemma":[0.9982509,0.000014410926,0.00015685303,0.00018380707,0.00003160811,0.000018987399,0.000038400653,0.000016555132,0.0012884751],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986772,0.00022723398,0.00034287872,0.00033309325,0.000085374115,0.00033424277],"domain_scores_gemma":[0.9987768,0.000032490254,0.00024035042,0.00074309,0.00018447627,0.00002277482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014571662,0.00019364935,0.00044087175,0.0001654401,0.00021848713,0.00001542507,0.0004493671,0.00016839239,0.00016883975],"category_scores_gemma":[0.000015815485,0.00013130695,0.0002246195,0.0005476503,0.00031880516,0.00007292673,0.000057702327,0.00020052075,0.000023331955],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010522576,0.00071547995,0.02665528,0.000014105774,0.002570546,0.000016625941,0.00070575776,0.000053744687,0.96817964,0.00052256155,0.000096808995,0.00036424605],"study_design_scores_gemma":[0.003166434,0.0008092428,0.3551473,0.000055377714,0.0049005486,0.00021049206,0.00018080752,0.0000034806574,0.6345797,0.0005350614,0.000111545785,0.00029995455],"about_ca_topic_score_codex":0.00007593687,"about_ca_topic_score_gemma":0.000010109772,"teacher_disagreement_score":0.33359987,"about_ca_system_score_codex":0.000034164408,"about_ca_system_score_gemma":0.00009077974,"threshold_uncertainty_score":0.5354542},"labels":[],"label_agreement":null},{"id":"W2586048965","doi":"10.1182/blood.v116.21.2001.2001","title":"Single Nucleotide Polymorphism Array (SNP-A) Genomic Profiling of Mantle Cell Lymphoma (MCL) Against a Large Control Database Reveals Recurring Copy Number Alterations (CNAs) and Copy Neutral Loss of Heterozygosity (CN-LOH)","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"SNP array; Loss of heterozygosity; Copy number analysis; Uniparental disomy; Biology; Molecular Inversion Probe; Copy-number variation; SNP genotyping; SNP; Genetics; Single-nucleotide polymorphism; Genotyping; Genotype; Chromosome; Karyotype; Genome; Gene; Allele","score_opus":0.006961417909067422,"score_gpt":0.21368405365644305,"score_spread":0.20672263574737562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586048965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997076,0.00025711628,0.0006272847,0.000024799672,0.00016892058,0.00026925353,0.0010914002,0.00001080632,0.00047444654],"genre_scores_gemma":[0.99549115,0.00006483793,0.0037973225,0.00009170384,0.00016284833,0.000017008297,0.00028039468,0.00002818494,0.000066553475],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988291,0.00006380972,0.0004138341,0.00032170516,0.00008600843,0.00028552106],"domain_scores_gemma":[0.9991424,0.000021571283,0.0002497928,0.00040658226,0.00009479564,0.00008482176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019891013,0.00018503977,0.00026817253,0.000030410918,0.00013874618,0.000030035384,0.00016906438,0.00011592936,0.000022397991],"category_scores_gemma":[0.000023532066,0.00019456197,0.00009559605,0.000050816314,0.00010331364,0.000017430753,0.000096203024,0.000089497276,0.0000044602984],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004658053,0.00061434286,0.07645558,0.000086706066,0.00007095826,0.0000037532352,0.00010988944,0.000010013602,0.9223367,0.00021736423,0.000017565224,0.000030538748],"study_design_scores_gemma":[0.0033079858,0.0001010637,0.0045295004,0.00002791606,0.00009485137,0.00004633553,0.00007640554,0.000028164388,0.99121153,0.000027463031,0.00034647496,0.00020228853],"about_ca_topic_score_codex":0.00006468517,"about_ca_topic_score_gemma":0.00006041827,"teacher_disagreement_score":0.07192608,"about_ca_system_score_codex":0.000008446256,"about_ca_system_score_gemma":0.000059193164,"threshold_uncertainty_score":0.7934007},"labels":[],"label_agreement":null},{"id":"W2586067937","doi":"10.1182/blood.v116.21.4374.4374","title":"Incidence and Clinical Features of Acute Promyelocytic Leukemia In a Population-Based Canadian Cohort","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Incidence (geometry); Population; Medicine; Epidemiology; Acute promyelocytic leukemia; Cohort; Pediatrics; Acute leukemia; Internal medicine; Leukemia; Biology; Genetics","score_opus":0.004417463365787112,"score_gpt":0.2556652752941425,"score_spread":0.2512478119283554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586067937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99905926,0.00016613088,0.000009278059,0.000031058502,0.0000687248,0.00015243536,0.00001048071,0.0000037603181,0.000498854],"genre_scores_gemma":[0.9987789,0.000058081718,0.000814342,0.000095497504,0.00007710426,0.000012758232,0.00007784792,0.000009912037,0.00007559036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992838,0.000030309864,0.00021462273,0.0002400367,0.0000793434,0.00015190765],"domain_scores_gemma":[0.99953765,0.000018470982,0.00006484629,0.00022223593,0.000051316012,0.000105485604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022877357,0.00008884212,0.00013470855,0.000048377016,0.00003064211,0.000011475147,0.00013322523,0.00022383721,0.00000696505],"category_scores_gemma":[0.00018772535,0.00008358141,0.00003892306,0.00007361645,0.00008374862,0.0000027415388,0.000026747159,0.0001814862,7.135321e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014483083,0.00002312309,0.9254563,0.000021810312,0.00003507334,0.000011962076,0.0000070059186,0.000003630262,0.07397674,0.000032967924,0.000032850992,0.00038406876],"study_design_scores_gemma":[0.00076385075,0.00010440135,0.87503225,0.000017030596,0.000068128356,0.000026979074,0.0000040558607,0.00004594769,0.12356008,0.00005914757,0.00020364807,0.00011447047],"about_ca_topic_score_codex":0.014239647,"about_ca_topic_score_gemma":0.06785315,"teacher_disagreement_score":0.053613503,"about_ca_system_score_codex":0.000018147852,"about_ca_system_score_gemma":0.0009932858,"threshold_uncertainty_score":0.9923246},"labels":[],"label_agreement":null},{"id":"W2586093081","doi":"10.1182/blood.v110.11.3693.3693","title":"Adult Human Stem Cells Exert Therapeutic Effects To Repair Damaged Tissues in Xenograft Systems through Secretion of Trophic Factors Rather Than Direct Incorporation and Expansion.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Tissue Engineering and Regenerative Medicine","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials","funders":"","keywords":"Stem cell; Homing (biology); Transplantation; Paracrine signalling; Biology; Immunology; Regeneration (biology); Cell biology; Adult stem cell; Cancer research; Pathology; Cellular differentiation; Medicine; Internal medicine; Receptor","score_opus":0.015406706921965434,"score_gpt":0.260542436265294,"score_spread":0.24513572934332856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586093081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900112,0.0073390068,0.0013149156,0.00004415582,0.00027983842,0.0008187096,0.0000020837754,0.00012557048,0.00006452214],"genre_scores_gemma":[0.9985848,0.00007658541,0.00034434735,0.000014581752,0.00018124972,0.00002201432,0.000015523481,0.00003417327,0.00072671514],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988457,0.00010646925,0.00034560915,0.0002592295,0.0002494179,0.0001935503],"domain_scores_gemma":[0.99939156,0.000089787034,0.00009427323,0.00024122192,0.00008306792,0.00010011191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033886547,0.00019624535,0.0004536665,0.00019375257,0.000050096547,0.000008354725,0.000040151637,0.00011379008,0.0000025910692],"category_scores_gemma":[0.000023645565,0.00014070935,0.000047544978,0.00029418588,0.000042077827,0.000059773884,0.00001425565,0.0001455542,0.0000017649268],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005997889,0.00027134284,0.043637358,0.0005618118,0.000087699635,0.00007099675,0.004793942,0.000065748936,0.94985974,0.00020359675,0.00002723264,0.0003605407],"study_design_scores_gemma":[0.0037220996,0.0022636221,0.12251739,0.0016598303,0.0002472398,0.000025449039,0.001535792,0.00017009048,0.8671726,0.000009265101,0.00042963415,0.00024698366],"about_ca_topic_score_codex":0.00022800779,"about_ca_topic_score_gemma":0.00006117176,"teacher_disagreement_score":0.08268715,"about_ca_system_score_codex":0.000030366595,"about_ca_system_score_gemma":0.000015023059,"threshold_uncertainty_score":0.5737961},"labels":[],"label_agreement":null},{"id":"W2586116509","doi":"10.1182/blood.v114.22.3522.3522","title":"Time to Splenectomy Failure in Patients with Recurrent or Refractory Chronic Immune Thrombocytopenic Purpura.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Splenectomy; Medicine; Thrombocytopenic purpura; Concomitant; Eltrombopag; Surgery; Refractory (planetary science); Discontinuation; Internal medicine; Platelet; Immune thrombocytopenia; Spleen","score_opus":0.006405692798160614,"score_gpt":0.2321961633477782,"score_spread":0.2257904705496176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586116509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967954,0.0005283595,7.055972e-7,0.000567345,0.000023158833,0.0009397944,0.000013592243,0.000047288944,0.0010843262],"genre_scores_gemma":[0.99845517,0.000037813443,0.00029281343,0.00018976303,0.00003474616,0.00002834979,0.0001347497,0.000022008135,0.0008046165],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99884754,0.000021009593,0.0002266037,0.00031098255,0.00024931406,0.00034457428],"domain_scores_gemma":[0.99940616,0.0000148740455,0.000061326406,0.00033746738,0.00004752403,0.00013262345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000044448825,0.00020835752,0.00044722593,0.0001211278,0.000039567596,0.0000143331545,0.00009674927,0.00007628767,0.00073227484],"category_scores_gemma":[0.00002347011,0.00013689951,0.000050055594,0.00030108794,0.000018835906,0.00010058857,0.000024241534,0.00016427778,0.00059241266],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022250459,0.11225185,0.32520232,0.0005723178,0.003332661,0.009247279,0.0027695764,0.00004369308,0.020731423,0.000055505956,0.015212654,0.48833027],"study_design_scores_gemma":[0.032569822,0.013544794,0.94196725,0.0005483496,0.00027445314,0.000053206513,0.000020125733,0.0000061972823,0.0012242537,0.000013844127,0.009444829,0.00033286927],"about_ca_topic_score_codex":0.000016155922,"about_ca_topic_score_gemma":0.000096649004,"teacher_disagreement_score":0.61676496,"about_ca_system_score_codex":0.00014551236,"about_ca_system_score_gemma":0.00015626817,"threshold_uncertainty_score":0.8017896},"labels":[],"label_agreement":null},{"id":"W2586123530","doi":"10.1182/blood.v114.22.3078.3078","title":"AT9283, A Novel Aurora Kinase/Jak2 Inhibitor Demonstrates Activity against Refractory Infant Leukemia Cells: Studies On Growth Inhibition, Biological Correlates, Drug Synergy and Effects On Leukemia Stem-Like Cells.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"","keywords":"Leukemia; Stem cell; Cancer research; Cancer stem cell; Cell culture; Growth inhibition; Cell growth; Bone marrow; Stromal cell; Biology; Chemistry; Immunology; Cell biology; Biochemistry","score_opus":0.00860582074969928,"score_gpt":0.21575539804433963,"score_spread":0.20714957729464034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586123530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967872,0.0018801288,0.00004146694,0.00006229084,0.00040214078,0.00043750985,0.00008158178,0.00006664317,0.00024101789],"genre_scores_gemma":[0.9946022,0.003135484,0.00019764672,0.0013644542,0.00032798274,0.00003977253,0.0001238898,0.000038820737,0.00016972532],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978403,0.00016411723,0.000388967,0.00091796956,0.00019391584,0.00049476424],"domain_scores_gemma":[0.99885535,0.00015225369,0.0002463486,0.00042801356,0.00012372053,0.00019430317],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024205912,0.0005450685,0.0004844184,0.00010889461,0.00023716575,0.0000575626,0.00017006234,0.00048780517,0.0000010545145],"category_scores_gemma":[0.00007884946,0.0004547652,0.00016270058,0.00014883734,0.00019892569,0.000016196887,0.00014919759,0.0004474655,0.000012392118],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024228114,0.00069219683,0.00034873013,0.0000859831,0.00016284712,0.00006001606,0.000089373185,0.000082706116,0.99450237,0.000100798374,0.0018766361,0.0017560424],"study_design_scores_gemma":[0.002537796,0.0020190391,0.0011637973,0.00026730733,0.000092859176,0.00001916314,0.00008735383,0.000052285915,0.9916987,0.000037599464,0.0014610591,0.0005630838],"about_ca_topic_score_codex":0.000026030211,"about_ca_topic_score_gemma":0.00004011242,"teacher_disagreement_score":0.0028037336,"about_ca_system_score_codex":0.00014502299,"about_ca_system_score_gemma":0.00019021037,"threshold_uncertainty_score":0.99979043},"labels":[],"label_agreement":null},{"id":"W2586129086","doi":"10.1182/blood.v116.21.499.499","title":"Acute Myeloid Leukemia Stem Cells Escape Innate Immune Surveillance by Macrophages through Interaction with SIRPα","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children; University Health Network","funders":"","keywords":"Nod; Homing (biology); CD47; Severe combined immunodeficiency; Haematopoiesis; Innate immune system; Immunology; Cancer research; Immune system; Bone marrow; Leukemia; Biology; Stem cell; Myeloid; NOD mice; Cell biology; In vivo; Autoimmunity","score_opus":0.0047146878255615475,"score_gpt":0.21662583017217843,"score_spread":0.21191114234661687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586129086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99755293,0.0005602415,0.00020040275,0.00005937571,0.0003817025,0.00012068654,0.00006542451,0.000023449958,0.0010357869],"genre_scores_gemma":[0.996008,0.0007093524,0.00028915016,0.00016149128,0.0001726873,0.000018554774,0.00012350534,0.00002892155,0.0024883866],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990419,0.000033939497,0.00019187463,0.00037384167,0.00010766082,0.00025078465],"domain_scores_gemma":[0.99930596,0.000009102064,0.000118704214,0.0004175424,0.000100024154,0.0000486343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000076918295,0.00019983029,0.00016711421,0.000019352796,0.00007469888,0.000054493954,0.00025017431,0.00016644706,0.00004151405],"category_scores_gemma":[0.000004070896,0.00016653775,0.00006933456,0.00006932806,0.00006892745,0.000014101663,0.00008796612,0.00022293165,0.00005881483],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013196617,0.00008315865,0.00069923233,0.000009728597,0.00018533661,0.000013504806,0.000047924437,0.0000067376604,0.99543643,0.000003530805,0.0022724636,0.0011099901],"study_design_scores_gemma":[0.0009202052,0.0004198607,0.0006056219,0.00001174663,0.000036997666,0.00006769258,0.000067303714,0.000009931368,0.9826021,0.0000049906753,0.01502293,0.00023061466],"about_ca_topic_score_codex":0.00006719749,"about_ca_topic_score_gemma":0.00009890988,"teacher_disagreement_score":0.012834321,"about_ca_system_score_codex":0.000007991719,"about_ca_system_score_gemma":0.000057435256,"threshold_uncertainty_score":0.67912126},"labels":[],"label_agreement":null},{"id":"W2586152906","doi":"10.1182/blood.v112.11.5414.5414","title":"Relevance of α-Globin Genotyping in Patients Expressing HbH in Cord Blood: Prevalence of α-Globin Gene Deletions and α2-Globin Termination Codon Mutations in a Neonatal Hemoglobinopathy Screening Program","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Hemoglobinopathy; Thalassemia; Genetics; Biology; Alpha-thalassemia; Genotyping; Globin; Molecular biology; Genotype; Gene; Hemolytic anemia; Immunology","score_opus":0.011453888895993289,"score_gpt":0.24751041222715245,"score_spread":0.23605652333115917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586152906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99475545,0.0029884726,0.00025001398,0.00006355149,0.00004993999,0.001613004,0.00006688132,0.00005075683,0.00016195452],"genre_scores_gemma":[0.9834505,0.0011171958,0.015100941,0.000031957672,0.000017112732,0.000110538356,0.00010028899,0.0000366647,0.00003483915],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99720573,0.00015911256,0.0011413995,0.00055551296,0.0004442757,0.0004939428],"domain_scores_gemma":[0.9988073,0.00012719436,0.00040610874,0.00032892235,0.00020614929,0.00012430106],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035758916,0.00029636585,0.00059697474,0.00063857314,0.00010022902,0.000012124446,0.00015666275,0.00026423688,0.0000096773965],"category_scores_gemma":[0.00041026226,0.000314683,0.00008951236,0.0011684357,0.0002758347,0.00027669553,0.00010733692,0.00044149716,0.0000012199681],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042825218,0.003588449,0.9144401,0.0009574887,0.0000498075,0.0002402271,0.0034369985,0.00064740074,0.021391,0.000029268002,0.0000059749113,0.05478505],"study_design_scores_gemma":[0.017290328,0.001219539,0.9480858,0.0032476557,0.00021697769,0.00028538407,0.00068151456,0.0030399913,0.025454085,0.000047993093,0.00004363867,0.0003871217],"about_ca_topic_score_codex":0.0004486256,"about_ca_topic_score_gemma":0.00010915999,"teacher_disagreement_score":0.054397926,"about_ca_system_score_codex":0.00008337549,"about_ca_system_score_gemma":0.00018718018,"threshold_uncertainty_score":0.9999305},"labels":[],"label_agreement":null},{"id":"W2586168500","doi":"10.1182/blood.v110.11.2735.2735","title":"Early Normalization of Serum Free Light Chain Is Associated with Prolonged Time to Progression Following Bortezomib ± Pegylated Liposomal Doxorubicin Treatment of Relapsed/Refractory Multiple Myeloma.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Bortezomib; Multiple myeloma; Internal medicine; Gastroenterology; Refractory (planetary science); Urology","score_opus":0.011025037036368276,"score_gpt":0.2648498630517679,"score_spread":0.25382482601539963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586168500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99628925,0.00034236917,0.000026782714,0.00019783623,0.000033376095,0.0022506022,0.000109665394,0.000104764265,0.0006453565],"genre_scores_gemma":[0.99728674,0.000011662516,0.0010436958,0.00002368678,0.000054119624,0.00006968052,0.00017729096,0.0000634575,0.0012696966],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99742484,0.00010244285,0.000588099,0.00042633247,0.0008534701,0.00060479436],"domain_scores_gemma":[0.99826986,0.0001506112,0.00032426257,0.00056321005,0.00031616897,0.00037586302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034245403,0.00032457506,0.00068445015,0.00036971396,0.000106222506,0.000013190577,0.00013957825,0.00022950211,0.00009082985],"category_scores_gemma":[0.0003598918,0.00023170336,0.00018812978,0.0006824054,0.000047631205,0.00013683141,0.00005544157,0.0001271644,0.000031188956],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003644849,0.009099251,0.7776343,0.00007714481,0.0020094388,0.0007336389,0.002327074,0.000002480509,0.19412492,0.0000014077306,0.00005282859,0.010292665],"study_design_scores_gemma":[0.026313767,0.008898926,0.5637405,0.0005158595,0.0004526693,0.0000142305325,0.00003932265,0.00013800486,0.39966372,0.0000015589983,0.00006980499,0.00015165302],"about_ca_topic_score_codex":0.00015272634,"about_ca_topic_score_gemma":0.00014909166,"teacher_disagreement_score":0.21389382,"about_ca_system_score_codex":0.00017885378,"about_ca_system_score_gemma":0.00017439765,"threshold_uncertainty_score":0.9448589},"labels":[],"label_agreement":null},{"id":"W2586193278","doi":"10.1182/blood.v110.11.2896.2896","title":"Impact of Limiting Erythropoiesis-Stimulating Agent Use for Chemotherapy-Induced Anemia on the United States Blood Supply.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Economic shortage; Limiting; Anemia; Erythropoiesis; Blood supply; Population; Blood transfusion; Chemotherapy; Emergency medicine; Intensive care medicine; Surgery; Internal medicine; Environmental health","score_opus":0.04905912856651845,"score_gpt":0.3335899483316472,"score_spread":0.28453081976512873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586193278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983944,0.00002758816,0.00009067268,0.00036488735,0.000056855697,0.000702046,0.000035846853,0.00006169811,0.0002659936],"genre_scores_gemma":[0.99872404,0.000034922232,0.00034311833,0.00048977457,0.00020406458,0.000023704466,0.000079194135,0.00003715533,0.0000640002],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989585,0.00002721531,0.00031138092,0.00019228348,0.0001794091,0.00033118908],"domain_scores_gemma":[0.99862194,0.00064325373,0.00015193691,0.00031011764,0.00017486555,0.00009786775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002857788,0.00017117761,0.00024470303,0.00014155208,0.00017292445,0.00002693816,0.00007310927,0.000070622234,0.00010976411],"category_scores_gemma":[0.00017255459,0.0001123679,0.00021337433,0.00036550954,0.000047326892,0.00004955469,0.000016267848,0.00017877328,0.0000028572665],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082232524,0.0025395725,0.42811403,0.00014197925,0.0011666787,0.000037091908,0.0015729619,0.00052558386,0.56116986,0.0003590462,0.0005877363,0.0029631143],"study_design_scores_gemma":[0.011572919,0.004968711,0.3270988,0.0005174016,0.0011168025,0.000110307024,0.0007004348,0.00023204755,0.65265954,0.000068251305,0.0006529198,0.00030185573],"about_ca_topic_score_codex":0.0004997377,"about_ca_topic_score_gemma":0.0000322664,"teacher_disagreement_score":0.101015225,"about_ca_system_score_codex":0.000051102998,"about_ca_system_score_gemma":0.00007832574,"threshold_uncertainty_score":0.45822302},"labels":[],"label_agreement":null},{"id":"W2586194045","doi":"10.1182/blood.v124.21.2815.2815","title":"Comparison of Procoagulant and Proinflammatory Effects of Nuclear, Mitochondrial, and Bacterial DNA","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Neutrophil extracellular traps; Propidium iodide; Mitochondrial DNA; Nuclear DNA; Proinflammatory cytokine; Biology; Molecular biology; DNA; Immunology; Inflammation; Apoptosis; Biochemistry; Programmed cell death; Gene","score_opus":0.007064633912223119,"score_gpt":0.22261086767093954,"score_spread":0.21554623375871643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586194045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987275,0.0005532403,0.00001726725,0.000015768863,0.00022177483,0.0003392571,0.0000062194545,0.000018759429,0.000100216814],"genre_scores_gemma":[0.999523,0.000024750983,0.00032802124,0.000011573556,0.000038470855,0.000010224747,0.000009529809,0.000012376156,0.000042070667],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992788,0.0001423612,0.00023296033,0.00018326387,0.000024491525,0.00013812695],"domain_scores_gemma":[0.99955326,0.000099143675,0.00015028754,0.00014406705,0.000033887503,0.000019375553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000074533804,0.00011805797,0.0003891759,0.000051865663,0.000051445815,0.000005318999,0.0000735201,0.00012273416,0.000025395595],"category_scores_gemma":[0.000055262793,0.000097074124,0.000029307663,0.00003145905,0.00018018633,0.00004126503,0.000077518336,0.000088496716,0.000009702231],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015322462,0.00024552052,0.0012282568,0.00021447073,0.0000973946,0.0000011608489,0.00039887315,2.643306e-8,0.9942736,0.002279212,0.00009623717,0.0010120277],"study_design_scores_gemma":[0.0032813214,0.0008390523,0.008205215,0.000095212854,0.000106404805,0.000016352524,0.000045721445,0.0000010084143,0.9849523,0.00009318585,0.0022654813,0.000098782795],"about_ca_topic_score_codex":0.0000074404948,"about_ca_topic_score_gemma":0.000002879171,"teacher_disagreement_score":0.009321334,"about_ca_system_score_codex":0.0000017717858,"about_ca_system_score_gemma":0.000012621362,"threshold_uncertainty_score":0.3958568},"labels":[],"label_agreement":null},{"id":"W2586216319","doi":"10.1182/blood.v116.21.2560.2560","title":"The Association Between Smoking and Hodgkin Lymphoma","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Funnel plot; Medicine; Observational study; Odds ratio; Confidence interval; Publication bias; Hazard ratio; Relative risk; Meta-analysis; MEDLINE; Prospective cohort study; Internal medicine; Demography","score_opus":0.008445733565004875,"score_gpt":0.240761830238193,"score_spread":0.23231609667318812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586216319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935163,0.00028692518,5.163071e-7,0.0013952145,0.00010151288,0.000114600196,0.0000041310022,0.00002680252,0.004553981],"genre_scores_gemma":[0.999031,0.00008601967,0.00009859256,0.00010214544,0.00027366073,0.000018752618,0.0000067426467,0.0000068932886,0.00037618517],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999525,0.000012818392,0.000087261666,0.00009909932,0.00014691347,0.00012891022],"domain_scores_gemma":[0.999492,0.00023894785,0.000050699968,0.00013182976,0.000028736318,0.000057808917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001784744,0.000059182003,0.00009716859,0.000014734036,0.00013648973,0.000039257677,0.000028149276,0.000068501155,0.00000770834],"category_scores_gemma":[0.00012306299,0.00003587629,0.000032569278,0.000041977662,0.000016663806,0.000022270113,0.00002026155,0.00004601203,0.000012699083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000029259395,0.00013939098,0.95332175,0.0000030050326,0.000206744,0.000008371663,0.00004933427,2.6255362e-9,0.00035306136,0.00038050066,0.00024936607,0.045285538],"study_design_scores_gemma":[0.003332,0.00006675644,0.9642323,0.0000102253625,0.00043964596,0.00001778032,0.000013954418,0.0000010341088,0.008515531,0.00013289753,0.023198891,0.000038945716],"about_ca_topic_score_codex":0.00004891716,"about_ca_topic_score_gemma":0.00003391745,"teacher_disagreement_score":0.04524659,"about_ca_system_score_codex":0.000033429795,"about_ca_system_score_gemma":0.000030808118,"threshold_uncertainty_score":0.14629927},"labels":[],"label_agreement":null},{"id":"W2586235704","doi":"10.1182/blood.v112.11.2293.2293","title":"Distinct Mechanisms of Idiopathic and Thienopyridine-Assocaited Thrombotic Thrombocytopenia Purpura: Final Results from the Surveillance, Epidemiology, and Risk Factors for Thrombotic Thrombocytopenic Purpura (SERF-TTP) Study.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Apheresis Group; London Health Sciences Centre","funders":"","keywords":"ADAMTS13; Thienopyridine; Medicine; Thrombotic thrombocytopenic purpura; Rituximab; Internal medicine; Gastroenterology; Platelet; Clopidogrel; Aspirin","score_opus":0.06393305497492555,"score_gpt":0.2816590500326754,"score_spread":0.21772599505774984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586235704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856826,0.00640135,0.00033647264,0.0003551095,0.00061187043,0.003170451,0.0032568711,0.00013733788,0.000047905305],"genre_scores_gemma":[0.9981724,0.00064233516,0.00022786693,0.00005169695,0.00007723891,0.00016572134,0.00053908525,0.00006276444,0.00006089655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.993789,0.0023248363,0.0015491591,0.0012674554,0.00016464313,0.00090488256],"domain_scores_gemma":[0.9895333,0.007678855,0.0012700888,0.0011904035,0.00022228206,0.000105070394],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025156213,0.0006989666,0.0021793696,0.00012914526,0.0012320544,0.000035771205,0.00081751536,0.00036248172,0.000085328815],"category_scores_gemma":[0.004266499,0.00048216543,0.00027210786,0.00032612507,0.0010806709,0.00019582579,0.0006042738,0.0005304928,0.000023994484],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062178384,0.0014284883,0.9739444,0.00008640747,0.002467687,0.000016392058,0.0022706087,0.000007771187,0.016707208,0.00091190543,0.0014397246,0.000097614866],"study_design_scores_gemma":[0.012433882,0.001978849,0.9749519,0.00013228027,0.0011945397,0.0001086834,0.0019777126,0.000030790554,0.003786942,0.002758645,0.000112384725,0.00053338066],"about_ca_topic_score_codex":0.0019062064,"about_ca_topic_score_gemma":0.0011419599,"teacher_disagreement_score":0.012920266,"about_ca_system_score_codex":0.00004733927,"about_ca_system_score_gemma":0.00014706938,"threshold_uncertainty_score":0.999763},"labels":[],"label_agreement":null},{"id":"W2586243815","doi":"10.1182/blood.v108.11.3334.3334","title":"Follow-Up of Patients with Curable Lymphomas Ouside of Clinical Trials: A National Survey of Practice Patterns.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Lymphoma; Limiting; Clinical trial; Cancer; Internal medicine; Family medicine; Pediatrics","score_opus":0.0893511662953068,"score_gpt":0.38727667990010683,"score_spread":0.2979255136048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586243815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99662393,0.00022734728,0.000010648661,0.00006855637,0.00009541623,0.00043303648,0.0003973947,0.000007423906,0.002136254],"genre_scores_gemma":[0.9987374,0.000044520893,0.0007194286,0.000055834204,0.000052572203,0.000020557245,0.00028567362,0.000013580194,0.0000704383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99730897,0.00048473658,0.0012215973,0.00019681215,0.0006687586,0.00011910061],"domain_scores_gemma":[0.9946549,0.0028338889,0.0011130709,0.0002181269,0.0011231648,0.000056872454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023584065,0.00011853417,0.00085417135,0.00006785776,0.000015039627,0.0000033738554,0.000058372916,0.00008299471,0.0000552835],"category_scores_gemma":[0.004867015,0.00007967514,0.00017470695,0.00015938608,0.00006631206,0.000075683,0.000021794594,0.000039655646,0.0000030217475],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016307597,0.014886001,0.9807309,0.00007538388,0.0007087842,0.000010252868,0.00003400449,0.0000030896647,0.000022404034,0.00012258846,0.00062904204,0.0011467932],"study_design_scores_gemma":[0.043098826,0.0011977764,0.9487853,0.00015181882,0.00089899194,0.0000052797645,0.000020140678,0.0000050742838,0.005532772,0.000023793491,0.00021558661,0.00006463382],"about_ca_topic_score_codex":0.004814281,"about_ca_topic_score_gemma":0.0003129256,"teacher_disagreement_score":0.04146807,"about_ca_system_score_codex":0.000027636137,"about_ca_system_score_gemma":0.0004617269,"threshold_uncertainty_score":0.7277785},"labels":[],"label_agreement":null},{"id":"W2586248620","doi":"10.1182/blood.v128.22.3865.3865","title":"Sphingolipids Regulate Myeloid-Erythroid Fate Determination in Human Hematopoiesis","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Biology; Cell biology; Myeloid; Haematopoiesis; GATA1; Myelopoiesis; Sphingolipid; Progenitor cell; Lymphopoiesis; Population; Stem cell; Cell fate determination; Transcription factor; Immunology; Genetics; Gene","score_opus":0.008248664119427335,"score_gpt":0.23856644277976852,"score_spread":0.23031777866034117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586248620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99779195,0.00036295858,0.00072414975,0.00011245528,0.00012422354,0.0001124302,0.000006803118,0.000024337647,0.00074066914],"genre_scores_gemma":[0.99796736,0.00011447342,0.0005587506,0.000097964024,0.00048743468,0.000022066368,0.00001726223,0.00002851998,0.0007061395],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989102,0.00005162131,0.00026764424,0.00035409594,0.00012589274,0.0002905532],"domain_scores_gemma":[0.9994322,0.0000133813555,0.000087541506,0.00035529258,0.000045521225,0.00006606845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026242866,0.0001577225,0.00017520237,0.000089418885,0.0000750922,0.00002306402,0.0001861673,0.00014273536,0.000034466284],"category_scores_gemma":[0.00009685548,0.00012389907,0.00008200944,0.00009846315,0.000057349233,0.000010367013,0.000091406015,0.00004758292,0.000012876524],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012856621,0.000085449385,0.0049726227,0.000019255984,0.000015438398,0.000005289484,0.000061436345,0.0000018090117,0.99268717,0.0002479868,0.00005776819,0.0018329277],"study_design_scores_gemma":[0.0021479635,0.00006272136,0.011580848,0.000053526575,0.000025610827,0.000022092974,0.000024551406,0.000004563217,0.98133415,0.0004461991,0.0040738294,0.00022393736],"about_ca_topic_score_codex":0.000022814622,"about_ca_topic_score_gemma":0.00004324625,"teacher_disagreement_score":0.011353004,"about_ca_system_score_codex":0.000009406875,"about_ca_system_score_gemma":0.000027315198,"threshold_uncertainty_score":0.50524575},"labels":[],"label_agreement":null},{"id":"W2586251854","doi":"10.1182/blood.v118.21.4328.4328","title":"Should Generic Versions of Low Molecular Weight Heparins Be Considered As Generic or Biosimilar Drugs. A Regulatory Dilemma","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Biosimilar; Medicine; Pharmacology; Pharmacodynamics; Clinical trial; Low molecular weight heparin; Discovery and development of direct thrombin inhibitors; Heparin; Pharmacokinetics; Thrombin; Internal medicine","score_opus":0.0504492835119005,"score_gpt":0.2621472131924217,"score_spread":0.21169792968052117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586251854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840753,0.00087031454,0.000036864072,0.00063173455,0.00020513425,0.0006501295,0.000022748807,0.00010103457,0.013406719],"genre_scores_gemma":[0.9921669,0.0006942309,0.003062035,0.0034639596,0.000088437635,0.00007172771,0.000028700755,0.00005871807,0.00036530415],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982791,0.000056697667,0.00040858638,0.0004283906,0.00043099493,0.00039623573],"domain_scores_gemma":[0.9986077,0.00003076156,0.00016362812,0.00081153965,0.00012235381,0.0002640193],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014113983,0.00026772267,0.00064476614,0.00020192047,0.00009078349,0.000009964026,0.00019728113,0.00015113785,0.0014260018],"category_scores_gemma":[0.00006783354,0.00021801652,0.00022704074,0.00034205444,0.00016077998,0.00006254501,0.00019458262,0.00013316266,0.000056658097],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015728484,0.06666809,0.039946236,0.0041587567,0.014835288,0.0107263895,0.016414674,0.0000847516,0.48948058,0.0482123,0.30023536,0.0076647224],"study_design_scores_gemma":[0.010522314,0.002313739,0.066255085,0.00047236824,0.004948199,0.00017663359,0.0008745508,0.00009683734,0.8645898,0.00042483307,0.048452113,0.00087350846],"about_ca_topic_score_codex":0.00024195616,"about_ca_topic_score_gemma":0.000023845158,"teacher_disagreement_score":0.37510926,"about_ca_system_score_codex":0.00003577359,"about_ca_system_score_gemma":0.00020759247,"threshold_uncertainty_score":0.9994868},"labels":[],"label_agreement":null},{"id":"W2586259866","doi":"10.1182/blood.v116.21.1113.1113","title":"SAFETY of PROTHROMBIN COMPLEX CONCENTRATES IN PATIENTS REQUIRING RAPID REVERSAL of ANTICOAGULANT TREATMENT with the VITAMIN K ANTAGONISTS: a Systematic Review and a Meta-Analysis of the Literature.","year":2010,"lang":"en","type":"review","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph's Hospital","funders":"","keywords":"Medicine; Warfarin; Prothrombin complex concentrate; Concomitant; Internal medicine; Meta-analysis; Incidence (geometry); Coagulopathy; Fresh frozen plasma; Population; Vitamin K antagonist; Surgery; Complication; Atrial fibrillation","score_opus":0.08356736140687229,"score_gpt":0.3386702739045945,"score_spread":0.2551029124977222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586259866","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000479237,0.9903918,0.0000012762663,0.00019482189,0.000011679348,0.008702427,0.00017844801,0.0000041929034,0.000036149966],"genre_scores_gemma":[0.006988929,0.9925384,0.00011588855,0.000030691943,0.000011073733,0.000058670597,0.00013918913,0.000017981465,0.00009917698],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9974697,0.00047562792,0.0013436278,0.00024069994,0.00034406024,0.00012625934],"domain_scores_gemma":[0.99711066,0.00028671185,0.0017509769,0.00068668806,0.00013599887,0.000028933566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056721375,0.00031555354,0.006830672,0.00016647272,0.00003162024,0.000012268102,0.00015854211,0.0000907033,0.00002832365],"category_scores_gemma":[0.0001042063,0.000116068586,0.0013152412,0.0010171249,0.00015301532,0.000033998935,0.000060154427,0.00012440179,2.2965087e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004022892,0.00018067483,0.0031955324,0.8559511,0.13960613,0.0000030456943,0.00029296576,2.7591884e-7,0.000007768353,0.000167227,0.000006758706,0.00054834376],"study_design_scores_gemma":[0.0016043234,0.00030287093,0.0010914907,0.06338403,0.9307955,0.000005165766,0.000025867084,0.000001951929,0.00001723637,7.587978e-7,0.0026549944,0.00011583249],"about_ca_topic_score_codex":0.0000151957665,"about_ca_topic_score_gemma":0.00001410586,"teacher_disagreement_score":0.792567,"about_ca_system_score_codex":0.000026639125,"about_ca_system_score_gemma":0.00007089631,"threshold_uncertainty_score":0.47331396},"labels":[],"label_agreement":null},{"id":"W2586268812","doi":"10.1182/blood.v110.11.3529.3529","title":"Effects of Integrin-Linked Kinase (ILK) Inhibitor QLT0267 on Multiple Myeloma Cells and Evaluation of ILK as a Therapeutic Target in Multiple Myeloma.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Integrin-linked kinase; Cancer research; Protein kinase B; Multiple myeloma; Cell culture; Bone marrow; Medicine; Cancer; Biology; Cell cycle; Signal transduction; Immunology; Internal medicine; Cell biology","score_opus":0.02792794630012822,"score_gpt":0.3102332232520119,"score_spread":0.2823052769518837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586268812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99518394,0.0014670502,0.000032375116,0.000052833875,0.00011183784,0.0025663308,0.000026225889,0.000033485125,0.0005259445],"genre_scores_gemma":[0.9983945,0.00008104134,0.001097586,0.00006043715,0.0000932885,0.000092671864,0.000051668736,0.000044318178,0.000084487736],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970732,0.00027180123,0.0005941675,0.00046449996,0.0010844134,0.00051192526],"domain_scores_gemma":[0.9972933,0.0014744336,0.00020746012,0.00040659163,0.0003377513,0.00028046424],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012543026,0.00030737693,0.000596765,0.0005031146,0.00005305012,0.000011145383,0.00011707039,0.00020802191,0.000052778545],"category_scores_gemma":[0.0015793592,0.00025014993,0.0001322273,0.00040170093,0.0001588841,0.00008478513,0.0000693686,0.0003204182,0.000028686294],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029416536,0.00531863,0.2196836,0.0006331006,0.00036530403,0.00026754732,0.0009585624,0.00001537874,0.7249625,0.000032230368,0.000014611162,0.04480691],"study_design_scores_gemma":[0.023678878,0.0013546845,0.41408607,0.00036046535,0.00020064914,0.000011423268,0.00013233325,0.0015966292,0.558349,0.00007246512,0.000041492694,0.00011588977],"about_ca_topic_score_codex":0.00039430236,"about_ca_topic_score_gemma":0.00025251124,"teacher_disagreement_score":0.19440247,"about_ca_system_score_codex":0.00012255368,"about_ca_system_score_gemma":0.00024134926,"threshold_uncertainty_score":0.99999505},"labels":[],"label_agreement":null},{"id":"W2586271283","doi":"10.1182/blood-2016-12-754515","title":"Major vs minor histocompatibility antigens","year":2017,"lang":"en","type":"letter","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Minor histocompatibility antigen; Histocompatibility; Immunology; Human leukocyte antigen; Histocompatibility Testing; Antigen; Graft-versus-host disease; Sibling; Medicine; Major histocompatibility complex; Biology; Transplantation; Internal medicine","score_opus":0.028207137814229212,"score_gpt":0.2777071743381443,"score_spread":0.2495000365239151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586271283","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25879163,0.0009224211,0.00022387359,0.6455843,0.0019775329,0.004788878,0.00052861124,0.00048369466,0.08669909],"genre_scores_gemma":[0.13101187,0.00014082699,0.010725814,0.72956264,0.019896211,0.00046986315,0.0063123046,0.0005381861,0.10134228],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980261,0.00006357356,0.00042433236,0.0005846351,0.000508775,0.00039259295],"domain_scores_gemma":[0.99797875,0.00010900315,0.00026417285,0.0014325648,0.00011193442,0.00010357579],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018024404,0.00033882153,0.0007501366,0.0001180265,0.0001268046,0.000036788344,0.000265584,0.0007886717,0.000595996],"category_scores_gemma":[0.00006685274,0.00030666043,0.00024984952,0.000038423765,0.00012705364,0.00003979267,0.000023901963,0.0010099784,0.0005958178],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050365998,0.00034508543,0.0273757,0.0045039104,0.00032488108,0.0054169986,0.00025497563,1.655656e-8,0.001345151,0.0000037612099,0.9602146,0.00016451337],"study_design_scores_gemma":[0.005600563,0.0002827407,0.046791665,0.0012377778,0.0030053067,0.001563992,0.0000065167087,0.000003605245,0.011084161,0.00006622541,0.92977846,0.0005789929],"about_ca_topic_score_codex":0.00013526356,"about_ca_topic_score_gemma":0.000013970415,"teacher_disagreement_score":0.12777975,"about_ca_system_score_codex":0.000056552406,"about_ca_system_score_gemma":0.00022142167,"threshold_uncertainty_score":0.99993855},"labels":[],"label_agreement":null},{"id":"W2586275027","doi":"10.1182/blood.v126.23.3806.3806","title":"AGS62P1, a Novel Anti-FLT3 Antibody Drug Conjugate, Employing Site Specific Conjugation, Demonstrates Preclinical Anti-Tumor Efficacy in AML Tumor and Patient Derived Xenografts","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Tyrosine kinase; Cancer research; Cytotoxic T cell; Monoclonal antibody; Receptor tyrosine kinase; Antibody-drug conjugate; Antibody; Biology; Medicine; In vitro; Immunology; Receptor; Internal medicine; Biochemistry","score_opus":0.047491707089885794,"score_gpt":0.32869511155459974,"score_spread":0.2812034044647139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586275027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99590206,0.0016055675,0.000018695799,0.00026764304,0.00011923264,0.0015332185,0.0000946181,0.000114982206,0.00034395084],"genre_scores_gemma":[0.9968268,0.00018623467,0.0023750933,0.00015790589,0.00013002644,0.00005159477,0.000195494,0.000054133856,0.000022673454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99707323,0.00015989666,0.0007661079,0.0007278947,0.0005717367,0.000701134],"domain_scores_gemma":[0.9979645,0.00035933615,0.00020486861,0.00043668563,0.00029309213,0.00074150064],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040457965,0.00037115076,0.0007743768,0.00026884492,0.00013110296,0.00011617218,0.00012798411,0.00008843506,0.000034281737],"category_scores_gemma":[0.0006666834,0.00031478953,0.00011054554,0.0003829718,0.00030801335,0.0001771698,0.00014149357,0.00037783157,0.000099017074],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004316006,0.0050712563,0.8787473,0.00008825724,0.00019064656,0.0013047466,0.0008148407,0.0000074329478,0.11234565,0.000019001804,0.00019719177,0.00078208366],"study_design_scores_gemma":[0.032612853,0.0009069364,0.91509694,0.0005014489,0.00014633629,0.00046444242,0.0004621528,0.0003121065,0.04852137,0.000019309751,0.00059204135,0.00036407253],"about_ca_topic_score_codex":0.00020736753,"about_ca_topic_score_gemma":0.00006103945,"teacher_disagreement_score":0.06382428,"about_ca_system_score_codex":0.000053856103,"about_ca_system_score_gemma":0.0002820215,"threshold_uncertainty_score":0.99993044},"labels":[],"label_agreement":null},{"id":"W2586281078","doi":"10.1182/blood.v126.23.3858.3858","title":"Myeloid-Related Protein S100A9 Induces Cellular Differentiation in Acute Myeloid Leukemia through TLR2 and TLR4 Receptors","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"S100 Proteins and Annexins","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"S100A8; S100A9; Myeloid leukemia; Myeloid; Leukemia; Immunology; TLR2; Integrin alpha M; Biology; CD33; Calprotectin; Receptor; Cancer research; Population; Molecular biology; Medicine; Flow cytometry; CD34; Inflammation; TLR4; Internal medicine; Cell biology; Stem cell; Biochemistry","score_opus":0.012008926633817819,"score_gpt":0.22361482668999527,"score_spread":0.21160590005617747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586281078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970143,0.0012321917,0.000115475756,0.000102666214,0.0001237219,0.00042005477,0.000009805002,0.000026594535,0.00095521525],"genre_scores_gemma":[0.9977066,0.0001821857,0.0006215397,0.0000622789,0.00013873701,0.000063329026,0.00017785038,0.000030543793,0.0010169261],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988062,0.00008403982,0.00026522484,0.00041583227,0.00015261392,0.00027613723],"domain_scores_gemma":[0.9994716,0.0000039350994,0.000108025,0.00025488256,0.000059708076,0.000101820326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016789825,0.00020781968,0.0001895502,0.000053036005,0.000058999336,0.00004258949,0.00014920946,0.00030597698,0.000023514041],"category_scores_gemma":[0.00005797137,0.00019060138,0.00005304039,0.00015101585,0.00006761993,0.000016442522,0.00012824399,0.00016522997,0.000016131697],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044580014,0.00015240155,0.0030751822,0.000015754089,0.00009454847,0.000010340172,0.00030213714,0.0000052090677,0.994837,0.00016491638,0.00019511423,0.0011028511],"study_design_scores_gemma":[0.0026469282,0.00039354138,0.0041345954,0.000044840806,0.000049349317,0.000011500061,0.00018657985,0.000021138165,0.9879016,0.0006026151,0.003708081,0.00029918418],"about_ca_topic_score_codex":0.00016051315,"about_ca_topic_score_gemma":0.00005417702,"teacher_disagreement_score":0.006935319,"about_ca_system_score_codex":0.000026878632,"about_ca_system_score_gemma":0.00011894877,"threshold_uncertainty_score":0.7772499},"labels":[],"label_agreement":null},{"id":"W2586285374","doi":"10.1182/blood.v114.22.4459.4459","title":"Spectral Analysis of Platelet Oscillations in Cyclic Thrombocytopenia.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; McMaster University","funders":"","keywords":"Eltrombopag; Platelet; Thrombopoietin; Medicine; Internal medicine; Mean platelet volume; Gastroenterology; Immune thrombocytopenia; Biology","score_opus":0.013056566693097342,"score_gpt":0.2674982583663682,"score_spread":0.25444169167327085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586285374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99202955,0.00015605906,0.000031912412,0.0005291845,0.0000144265905,0.00013930356,0.0000080796535,0.000019689562,0.007071811],"genre_scores_gemma":[0.99914056,0.00007254693,0.00055854075,0.000114229166,0.000031417407,0.0000012521517,0.000030308822,0.0000043594227,0.000046774785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993497,0.000012398294,0.0002206504,0.00014481923,0.00013943411,0.00013299026],"domain_scores_gemma":[0.99968725,0.000018566285,0.00003417523,0.00018858188,0.000021105798,0.000050317016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007511575,0.00007174704,0.00036481154,0.0003108522,0.000019919034,0.000004075689,0.00004133341,0.000057164394,0.00015863277],"category_scores_gemma":[0.000010846088,0.00006123888,0.00013116196,0.0010145964,0.00001816771,0.000037106085,0.000004510583,0.00009547143,0.000005458159],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013112681,0.0042324844,0.8166508,0.000032447042,0.0015412166,0.00017982276,0.0010833121,0.00023996028,0.16730161,0.00366975,0.000044109336,0.00489333],"study_design_scores_gemma":[0.0025953553,0.00024236133,0.97429746,0.0000226365,0.0016467726,0.000013031606,0.000027309037,0.00017679771,0.020646198,0.00020462298,0.00006573298,0.00006171708],"about_ca_topic_score_codex":0.00009787361,"about_ca_topic_score_gemma":0.00027796676,"teacher_disagreement_score":0.15764663,"about_ca_system_score_codex":0.000007764482,"about_ca_system_score_gemma":0.000021376194,"threshold_uncertainty_score":0.24972492},"labels":[],"label_agreement":null},{"id":"W2586288138","doi":"10.1182/blood.v120.21.3003.3003","title":"PI3K-Independent Signaling Pathways Contribute to ICOS-Mediated T-Cell Costimulation in Acute Graft-Versus-Host Disease in Mice.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"T cell; CD8; Cytotoxic T cell; T-cell receptor; PI3K/AKT/mTOR pathway; Immunology; CD28; Biology; Cell biology; Immune system; Chemistry; Signal transduction; In vitro; Biochemistry","score_opus":0.013245850211075575,"score_gpt":0.22364532449194133,"score_spread":0.21039947428086575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586288138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929477,0.0044787587,0.00006922357,0.00018779308,0.0011859192,0.0006543017,0.00018019983,0.00009156209,0.00020456796],"genre_scores_gemma":[0.9985347,0.00009040878,0.000045334196,0.00021655404,0.00005910199,0.00008109283,0.0006602947,0.0000317851,0.00028072827],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976733,0.00031599958,0.0005378893,0.00042816842,0.000070873124,0.00097381533],"domain_scores_gemma":[0.99899995,0.00036061433,0.00014632138,0.00030232896,0.000063900094,0.0001268884],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041688344,0.00031143936,0.0004300836,0.0003405919,0.000113246824,0.000018364655,0.00029063,0.00039688405,0.0002433516],"category_scores_gemma":[0.00014477967,0.00030771823,0.00010290459,0.0003538419,0.000076950506,0.000188175,0.00016779051,0.00050692185,0.0016960312],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011953504,0.0019020787,0.07901589,0.000011945803,0.0001250199,0.00006745744,0.0005454977,0.00006019739,0.9167649,0.00012524368,0.00009585893,0.000090536894],"study_design_scores_gemma":[0.035212383,0.0005835005,0.088738725,0.00009957908,0.00037949657,0.000021576905,0.00030864397,0.00002643375,0.8669769,0.000061356615,0.006778464,0.00081289955],"about_ca_topic_score_codex":0.0002538066,"about_ca_topic_score_gemma":0.00018320918,"teacher_disagreement_score":0.049787983,"about_ca_system_score_codex":0.00010392573,"about_ca_system_score_gemma":0.00009306814,"threshold_uncertainty_score":0.9999375},"labels":[],"label_agreement":null},{"id":"W2586292161","doi":"10.1182/blood.v128.22.3850.3850","title":"The Effect of Platelet Transfusion on Death in the Intensive Care Unit","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Waterloo; McMaster University; Canadian Blood Services","funders":"","keywords":"Medicine; Intensive care unit; Platelet transfusion; Mechanical ventilation; Internal medicine; Proportional hazards model; Blood transfusion; Complication; Platelet; Risk factor; Surgery; Intensive care medicine","score_opus":0.013372377580186749,"score_gpt":0.2579195882400781,"score_spread":0.24454721065989135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586292161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887383,0.0003295291,0.0000124391445,0.0037062806,0.00006743446,0.0007740327,0.0000040029163,0.000015466981,0.0063525247],"genre_scores_gemma":[0.99842083,0.0007520522,0.0000044171716,0.0006318801,0.000027620405,0.00003478047,0.0000023666921,0.000008683314,0.000117390504],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993028,0.00010883865,0.00013252994,0.00011970117,0.0002042471,0.00013189696],"domain_scores_gemma":[0.9992663,0.0003355682,0.000022266868,0.00028059873,0.00006838311,0.000026853993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023909152,0.00009136717,0.00015042492,0.000049659004,0.000053728218,0.0000043589307,0.0001124103,0.000041032406,0.000026044461],"category_scores_gemma":[0.000077743316,0.00003169001,0.0000730058,0.000106534404,0.000041401516,0.000012041222,0.000011646703,0.00010594116,0.000016338232],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007638667,0.0013895881,0.23266217,0.0010536795,0.00092807325,0.0009845444,0.025843458,0.0000037300642,0.06502748,0.012216322,0.0021683327,0.65008396],"study_design_scores_gemma":[0.059045017,0.01326666,0.28565902,0.0019562268,0.0011867629,0.00011367465,0.011601979,0.000003360311,0.5481693,0.00012683477,0.07856943,0.00030176237],"about_ca_topic_score_codex":0.00005202615,"about_ca_topic_score_gemma":0.00011292085,"teacher_disagreement_score":0.6497822,"about_ca_system_score_codex":0.000006304675,"about_ca_system_score_gemma":0.000011192646,"threshold_uncertainty_score":0.12922812},"labels":[],"label_agreement":null},{"id":"W2586305743","doi":"10.1182/blood.v106.11.3887.3887","title":"Involvement of Fps/Fes and Fer Kinases in c-Kit Signalling in Mast Cells and Mast Cell Leukemias.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Stem cell factor; Mast cell; Kinase; Cancer research; Tyrosine kinase; Cell biology; Proto-oncogene tyrosine-protein kinase Src; Receptor tyrosine kinase; Phosphorylation; Biology; Signal transduction; Chemistry; Molecular biology; Haematopoiesis; Immunology; Stem cell","score_opus":0.008639253837672282,"score_gpt":0.18800054097436086,"score_spread":0.17936128713668859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586305743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892908,0.008938447,0.000004546357,0.000057809182,0.00004198868,0.00013443136,0.000018756346,0.0000076049,0.0015056629],"genre_scores_gemma":[0.99742573,0.00072370283,0.0002040596,0.000059466623,0.000017173847,0.0000070949372,0.000017072882,0.000009363701,0.0015363399],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99921966,0.00004691788,0.0002758948,0.0002170367,0.000022913819,0.00021758753],"domain_scores_gemma":[0.9997439,0.000057184872,0.000069486116,0.000097342425,0.000014578357,0.000017517434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014346502,0.00012426429,0.00023721521,0.00013198036,0.000031293774,0.000007492766,0.00006745806,0.00012071981,0.00024963345],"category_scores_gemma":[0.0000042705938,0.000117406016,0.000020803542,0.000070114394,0.000109880784,0.000043757558,0.00007325537,0.00014732721,0.000015801244],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004928636,0.00061412604,0.022759354,0.00013302772,0.000020760615,0.000012564984,0.0009776731,0.000023635937,0.9732011,0.00011022778,0.000166929,0.0019313104],"study_design_scores_gemma":[0.0054068696,0.00020338614,0.015578815,0.00010761779,0.000039714298,0.0000098664505,0.0006140808,0.000014250732,0.96426183,0.00003194273,0.013535058,0.00019657795],"about_ca_topic_score_codex":0.00034441164,"about_ca_topic_score_gemma":0.0011923336,"teacher_disagreement_score":0.013368129,"about_ca_system_score_codex":0.000016029466,"about_ca_system_score_gemma":0.000022529302,"threshold_uncertainty_score":0.47876784},"labels":[],"label_agreement":null},{"id":"W2586312643","doi":"10.1182/blood.v106.11.4136.4136","title":"Factor VIII Levels Measured at the Time of Diagnosis of Acute Idiopathic Venous Thromboembolism Are Higher Then When Measured Six-Months Post Diagnosis.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; Thrombophilia; Venous thromboembolism; Internal medicine; Factor V Leiden; Gastroenterology; Factor V; Etiology; Surgery; Venous thrombosis; Thrombosis","score_opus":0.025744129095144962,"score_gpt":0.25191347162743205,"score_spread":0.2261693425322871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586312643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97666824,0.009742518,0.0000048418715,0.00826607,0.00033225125,0.0021317746,0.00069829344,0.00014286076,0.0020131397],"genre_scores_gemma":[0.99504757,0.0013635143,0.00018665679,0.001653791,0.000515041,0.00047610718,0.000043192635,0.00013489739,0.0005792557],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957117,0.0002884439,0.0010989927,0.0007078018,0.001438788,0.0007542783],"domain_scores_gemma":[0.99651533,0.00027195975,0.00084168394,0.0014683136,0.00061876426,0.0002839699],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007376332,0.00060462323,0.0021651275,0.00021687383,0.00023694625,0.000038015398,0.00067732955,0.0003233447,0.0020583875],"category_scores_gemma":[0.0002551471,0.00043082272,0.0006415579,0.00033202735,0.00031993346,0.00020082928,0.00038101926,0.0003598111,0.0002962081],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001332071,0.099836156,0.33242238,0.0037331167,0.0480988,0.0007206834,0.052969635,0.00023602378,0.2993357,0.001759161,0.11286613,0.04669014],"study_design_scores_gemma":[0.004880875,0.0012771775,0.807635,0.0009446683,0.006156452,0.000026247037,0.00016499222,0.000007989375,0.16725777,0.00012840693,0.0109913945,0.000528984],"about_ca_topic_score_codex":0.0003589455,"about_ca_topic_score_gemma":0.00025225838,"teacher_disagreement_score":0.47521263,"about_ca_system_score_codex":0.0001760066,"about_ca_system_score_gemma":0.00016497196,"threshold_uncertainty_score":0.99981433},"labels":[],"label_agreement":null},{"id":"W2586313031","doi":"10.1182/blood.v126.23.3983.3983","title":"Updated Results of a Phase I Study of Ibrutinib and Lenalidomide in Patients with Relapsed and Refractory B-Cell Non-Hodgkin's Lymphoma","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Lenalidomide; Medicine; Ibrutinib; Mantle cell lymphoma; Neutropenia; Internal medicine; Febrile neutropenia; Gastroenterology; Rituximab; Tumor lysis syndrome; Lymphoma; Oncology; Multiple myeloma; Toxicity; Chemotherapy; Leukemia; Chronic lymphocytic leukemia","score_opus":0.017122600569353594,"score_gpt":0.284229050499581,"score_spread":0.2671064499302274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586313031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979607,0.0001552477,6.2821243e-7,0.000015462121,0.000016867794,0.0009594588,0.000027478727,0.000011228767,0.00085291715],"genre_scores_gemma":[0.99958855,0.000015286714,0.00018193996,0.000013357143,0.000015849128,0.000011756051,0.000038004673,0.000023704279,0.00011156639],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99827397,0.000103251026,0.0004929971,0.00033301383,0.00056316884,0.00023357698],"domain_scores_gemma":[0.9987654,0.00012224402,0.00020950074,0.00043238126,0.00025780115,0.0002126872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053263933,0.0001520299,0.00047892987,0.0002080865,0.000015620883,0.000006813708,0.00008329218,0.000086925764,0.000003469426],"category_scores_gemma":[0.00026736542,0.00011506048,0.000017059823,0.00030607198,0.00015018728,0.00007895254,0.000105159204,0.000106944644,0.0000013315756],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1992011,0.19092153,0.54611415,0.0014420251,0.0012129283,0.0015272009,0.034327563,0.000016201046,0.010486651,0.0000068769154,0.0024328965,0.012310852],"study_design_scores_gemma":[0.89605707,0.016033899,0.07458335,0.00023785487,0.0002487084,0.000026330175,0.0015681717,0.0002543226,0.010721041,0.0000045283223,0.00011745298,0.00014725643],"about_ca_topic_score_codex":0.0012930386,"about_ca_topic_score_gemma":0.00007182847,"teacher_disagreement_score":0.69685596,"about_ca_system_score_codex":0.0004555422,"about_ca_system_score_gemma":0.0017677699,"threshold_uncertainty_score":0.469203},"labels":[],"label_agreement":null},{"id":"W2586319235","doi":"10.1182/blood.v108.11.2990.2990","title":"Predictors of Blood Transfusion Requirements in Patients Undergoing Autologous Stem Cell Transplantation for Multiple Myeloma.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Multiple myeloma; Transplantation; Platelet transfusion; Autologous stem-cell transplantation; Blood transfusion; Population; Univariate analysis; Hematopoietic stem cell transplantation; Surgery; Internal medicine; Multivariate analysis; Platelet","score_opus":0.01652051748870765,"score_gpt":0.2538974040890719,"score_spread":0.23737688660036427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586319235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99708915,0.00014762564,0.00019780947,0.000018586252,0.00006955529,0.0016931978,0.00015597312,0.000044858887,0.0005832337],"genre_scores_gemma":[0.9979875,0.000100621815,0.0010710136,0.0000075699363,0.000040250157,0.00010566531,0.0005009485,0.000029378385,0.00015701962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998416,0.000052692467,0.0004632302,0.0003051576,0.00039578538,0.00036712445],"domain_scores_gemma":[0.99935186,0.00016879912,0.00010500842,0.00018310465,0.00009629238,0.00009491337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012341909,0.00017244257,0.00030448078,0.0002121466,0.00006159734,0.0000075237003,0.00007375277,0.000114081326,0.000010419531],"category_scores_gemma":[0.000021974836,0.00015406893,0.000110864356,0.00017548824,0.00003455315,0.00009481868,0.000009496786,0.00008694616,0.0000032122161],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010595389,0.0050200773,0.96912575,0.00076768413,0.00014076909,0.00004690132,0.00023123552,0.000019344478,0.021244664,0.000008373057,0.00001356039,0.0023221208],"study_design_scores_gemma":[0.04344495,0.0015941523,0.7762461,0.00018640232,0.00042610161,0.0000051863367,0.00003555349,0.00011399803,0.17782275,0.000017106118,0.000010054758,0.00009768994],"about_ca_topic_score_codex":0.00023207725,"about_ca_topic_score_gemma":0.00043476757,"teacher_disagreement_score":0.19287968,"about_ca_system_score_codex":0.000039377737,"about_ca_system_score_gemma":0.000092031914,"threshold_uncertainty_score":0.62827486},"labels":[],"label_agreement":null},{"id":"W2586319383","doi":"10.1182/blood.v116.21.2784.2784","title":"IDO Expression In Human Mesenchymal Stromal Cells Mediates T Cell Suppression and Leads to Monocyte Differentiation Into IL-10 Secreting Immunosuppressive CD206+ M2 Macrophages","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University","funders":"","keywords":"Mesenchymal stem cell; Immunology; CD14; Immune system; Monocyte; Stromal cell; Biology; Cancer research; Bone marrow; Haematopoiesis; Cell biology; Stem cell","score_opus":0.009519918207556669,"score_gpt":0.27922228163732876,"score_spread":0.2697023634297721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586319383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99619424,0.00058413984,0.00003243126,0.00018422688,0.0002559011,0.0010182005,0.00002215504,0.00007728996,0.0016314036],"genre_scores_gemma":[0.9954812,0.0000910059,0.002393,0.00003396643,0.0003496278,0.00010121479,0.0001166889,0.00007132585,0.0013619935],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99669814,0.00024048341,0.00063005177,0.0007995845,0.00087082625,0.0007609426],"domain_scores_gemma":[0.99814975,0.00030791975,0.00019686644,0.0006356767,0.00017391918,0.00053584727],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00056706584,0.00040267606,0.0005679733,0.00043585108,0.000284041,0.0001308443,0.00030549144,0.00037513484,0.0012292091],"category_scores_gemma":[0.0003118443,0.0003372166,0.00009782194,0.00029331853,0.00013133035,0.0002832301,0.0006035797,0.000987628,0.0000741176],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024252765,0.0005140308,0.032466616,0.00032521423,0.000017780567,0.00014035525,0.001575697,0.0000053372064,0.96364754,0.000009526129,0.00030587387,0.0007494823],"study_design_scores_gemma":[0.004120132,0.00055468176,0.06853563,0.00035437642,0.00006841103,0.000019410169,0.00034738335,0.00022092227,0.9251377,0.000056336336,0.0002860537,0.0002989389],"about_ca_topic_score_codex":0.00019509916,"about_ca_topic_score_gemma":0.000071587245,"teacher_disagreement_score":0.038509835,"about_ca_system_score_codex":0.000047573834,"about_ca_system_score_gemma":0.00007769764,"threshold_uncertainty_score":0.999908},"labels":[],"label_agreement":null},{"id":"W2586331836","doi":"10.1182/blood.v120.21.202.202","title":"A Phase 2 Study of Elotuzumab (Elo) in Combination with Lenalidomide and Low-Dose Dexamethasone (Ld) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (R/R MM): Updated Results","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Lenalidomide; Dexamethasone; Medicine; Regimen; Population; Phases of clinical research; Internal medicine; Neutropenia; Gastroenterology; Urology; Pharmacology; Chemotherapy","score_opus":0.019072128144097235,"score_gpt":0.28473297022815425,"score_spread":0.265660842084057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586331836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99710125,0.00015928932,0.000003686492,0.000028515895,0.000018840674,0.0024378556,0.000048442605,0.000030634303,0.00017145938],"genre_scores_gemma":[0.99882746,0.000023833785,0.0005802279,0.000014509148,0.000016065223,0.00013749818,0.00030414917,0.000043083888,0.000053171934],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975819,0.00026414252,0.00053907215,0.00042116386,0.0006637239,0.00052998104],"domain_scores_gemma":[0.9986179,0.00023359698,0.00023048102,0.000428832,0.00019572709,0.0002934731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004672758,0.00027965257,0.00056003674,0.0004906898,0.000051980525,0.000014199887,0.00008882112,0.00010094479,0.000012920231],"category_scores_gemma":[0.00039584748,0.00020096498,0.000025599305,0.0006119767,0.00010099333,0.00032419874,0.00005990937,0.00032268264,0.000006452182],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031521183,0.09847808,0.859466,0.00007996909,0.00028552304,0.00021617748,0.0024650912,0.0000035700834,0.0009169687,0.0000025189615,0.000013367972,0.006551562],"study_design_scores_gemma":[0.31579727,0.014708645,0.664834,0.00024608214,0.0001255486,0.000013447372,0.0006338432,0.000107691376,0.00337054,0.0000015022947,0.000016028074,0.00014539417],"about_ca_topic_score_codex":0.0010371008,"about_ca_topic_score_gemma":0.0011095221,"teacher_disagreement_score":0.2842761,"about_ca_system_score_codex":0.0001378766,"about_ca_system_score_gemma":0.000119729746,"threshold_uncertainty_score":0.8195114},"labels":[],"label_agreement":null},{"id":"W2586342586","doi":"10.1182/blood.v108.11.4609.4609","title":"Genetic Polymorphisms of Methylenetetrahydrofolate Reductase Genes and Diffuse Large B-Cell Lymphoma Risk in Middle Eastern Population.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Methylenetetrahydrofolate reductase; Genotype; Genotyping; Internal medicine; Oncology; Diffuse large B-cell lymphoma; Population; Medicine; Lymphoma; Gastroenterology; Biology; Genetics; Cancer research; Gene","score_opus":0.012539283561186824,"score_gpt":0.24008544847592495,"score_spread":0.2275461649147381,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586342586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98680145,0.012434526,0.000011071831,0.000035376852,0.00003097548,0.0002614843,0.000050162354,0.000019511694,0.00035544435],"genre_scores_gemma":[0.9973068,0.0005727567,0.0010479386,0.00001705231,0.00009788517,0.000009859072,0.000040235467,0.00002836062,0.0008790998],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986579,0.00008389399,0.00035988982,0.00028580936,0.00027480556,0.00033768997],"domain_scores_gemma":[0.9994076,0.00004152989,0.00009470501,0.00030757475,0.00004170223,0.0001068868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018113325,0.00015044167,0.00029837264,0.0002767082,0.000045895675,0.000013593049,0.000076275275,0.000109444925,0.000026458903],"category_scores_gemma":[0.000025991067,0.00013212358,0.00006646398,0.00027641983,0.00004966006,0.000053553216,0.00005988575,0.000094464405,0.000014214695],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000089272486,0.0053240065,0.87587875,0.00012671658,0.000045685378,0.00015303059,0.00011888745,0.0000042842066,0.11458997,0.000013628439,0.000019707228,0.0036360403],"study_design_scores_gemma":[0.019889962,0.000293423,0.88874006,0.00006738094,0.00019245784,0.00006831722,0.000047447134,0.0010286527,0.08923343,0.00013896886,0.0001428672,0.00015703237],"about_ca_topic_score_codex":0.0045224535,"about_ca_topic_score_gemma":0.0002674061,"teacher_disagreement_score":0.025356537,"about_ca_system_score_codex":0.00001825057,"about_ca_system_score_gemma":0.00003880022,"threshold_uncertainty_score":0.68366265},"labels":[],"label_agreement":null},{"id":"W2586349952","doi":"10.1182/blood.v104.11.1968.1968","title":"The Leukemogenic Potential of the NUP98-PMX1 Fusion Protein Is Independent of the Known Binding Properties of PMX1 to the Serum Response Factor and the Serum Response Element and Requires the NUP98 Sequences.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; Hox gene; Homeobox; Haematopoiesis; Fusion gene; Fusion protein; Molecular biology; Serum Response Element; Cancer research; Green fluorescent protein; Transplantation; Reporter gene; Gene; Stem cell; Cell biology; Serum response factor; Genetics; Transcription factor; Gene expression; Internal medicine; Medicine","score_opus":0.01391004035657501,"score_gpt":0.24952096577325752,"score_spread":0.23561092541668252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586349952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799384,0.003485452,0.0000056438075,0.014104862,0.00007749889,0.0022441528,0.00012403067,0.0000049846467,0.000014965572],"genre_scores_gemma":[0.99851805,0.00046105857,0.000012684612,0.00026707118,0.00006689046,0.00012963785,9.545242e-7,0.000027684031,0.00051596295],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99605423,0.0019786705,0.0004748406,0.00036393967,0.000733215,0.00039509393],"domain_scores_gemma":[0.9980658,0.00012727838,0.00031341225,0.0012528982,0.00018365611,0.0000569438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034712586,0.00024416498,0.00022358113,0.000044112203,0.00075131096,0.00007062104,0.0012222027,0.00013400661,0.000013889058],"category_scores_gemma":[0.0004718086,0.00008522683,0.00019183202,0.00023917668,0.0011710579,0.000010222207,0.000984845,0.00027412458,0.0000015306451],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014871534,0.00008800212,0.0004849334,0.00003129443,0.00020960391,0.0000010487826,0.0016953213,0.00009108864,0.98162395,0.000047127,0.0000269089,0.00082919124],"study_design_scores_gemma":[0.0024393052,0.001152951,0.008297691,0.00011842426,0.00007018625,0.000023598095,0.0015165427,0.000016183876,0.985241,0.00015708306,0.0008453388,0.00012169094],"about_ca_topic_score_codex":0.00016819654,"about_ca_topic_score_gemma":0.0005586611,"teacher_disagreement_score":0.018579647,"about_ca_system_score_codex":0.000039050123,"about_ca_system_score_gemma":0.00064234034,"threshold_uncertainty_score":0.5778552},"labels":[],"label_agreement":null},{"id":"W2586355691","doi":"10.1182/blood.v108.11.183.183","title":"Telomere Length Measurement by Flow-FISH Distinguishes Dyskeratosis Congenita from Other Bone Marrow Failure Syndromes.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute","funders":"","keywords":"Dyskeratosis congenita; Telomere; Bone marrow failure; Dyskeratosis; Medicine; Pathology; Anemia; Gastroenterology; Immunology; Internal medicine; Biology; Hyperkeratosis; Genetics; Stem cell; Haematopoiesis","score_opus":0.015550842337400495,"score_gpt":0.21017744687206613,"score_spread":0.19462660453466563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586355691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98494464,0.006310615,0.00008927813,0.0017559081,0.00029278896,0.00063996523,0.0006052145,0.00037975752,0.0049818084],"genre_scores_gemma":[0.9945108,0.00005517309,0.0017866072,0.0009991745,0.00069200585,0.0000644278,0.000250993,0.00011294546,0.0015278519],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967674,0.00009064183,0.0006313392,0.00076269486,0.0010669862,0.00068092515],"domain_scores_gemma":[0.99838483,0.00008251772,0.00017578132,0.00074486306,0.00030300565,0.00030898864],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027966977,0.00049346854,0.0007493933,0.00012289848,0.00022149063,0.00010585626,0.00023440222,0.00024930388,0.00086591643],"category_scores_gemma":[0.00022901848,0.00044347017,0.00021478797,0.00034389753,0.00015612193,0.00012410541,0.000063480424,0.00035831853,0.00015642874],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002231061,0.0046244985,0.43957055,0.0003696724,0.0013016984,0.000928414,0.0006911455,0.000004060812,0.19954392,0.00009821536,0.34600398,0.006640734],"study_design_scores_gemma":[0.023214694,0.00088535465,0.1546905,0.0013727712,0.003435778,0.00066040235,0.0011279095,0.00022525602,0.29737666,0.0004211055,0.5137547,0.002834818],"about_ca_topic_score_codex":0.0016890762,"about_ca_topic_score_gemma":0.0017558924,"teacher_disagreement_score":0.28488004,"about_ca_system_score_codex":0.00010535009,"about_ca_system_score_gemma":0.00013911707,"threshold_uncertainty_score":0.9998017},"labels":[],"label_agreement":null},{"id":"W2586364323","doi":"10.1182/blood.v116.21.1526.1526","title":"Investigating the Experiences and Educational Needs of Adolescents with Hemophilia Prior to Transition of Care: A Website Development Project.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Haemophilia; Preparedness; Medical education; Medicine; Qualitative research; Psychology; The Internet; Perception; Nursing; Family medicine; Pediatrics","score_opus":0.02995841033346638,"score_gpt":0.3504568099872778,"score_spread":0.32049839965381144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586364323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973024,0.0001121418,0.000017288292,0.0013645544,0.00013812643,0.00093678816,0.0000062044155,0.000010102816,0.00011238814],"genre_scores_gemma":[0.9966818,0.000005538104,0.0025707572,0.00033326543,0.00021078053,0.00014821012,0.000007416578,0.000008443851,0.000033755114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908596,0.00009074671,0.00032576642,0.00010765668,0.00020680335,0.00018305154],"domain_scores_gemma":[0.9993706,0.00006230339,0.00015757843,0.00011843251,0.00019814058,0.00009296656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021905116,0.000084910454,0.00013574063,0.00008541268,0.00032066187,0.0000030307228,0.000094812174,0.00007664696,0.000014412726],"category_scores_gemma":[0.00006755779,0.00005510757,0.0000130688995,0.00029271576,0.000078012665,0.000044918997,0.000029445911,0.0002654227,0.0000024323656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002706771,0.00008223945,0.5222844,0.0013195567,0.000005500645,1.0209612e-7,0.47397882,1.6892842e-7,0.0012325984,0.0000751935,0.000055762644,0.0009385992],"study_design_scores_gemma":[0.0017369753,0.00021684133,0.74733835,0.001862488,0.00005277029,0.000004492028,0.2435003,0.0000040208965,0.004174456,0.000027752449,0.0008905359,0.00019100752],"about_ca_topic_score_codex":0.0001334036,"about_ca_topic_score_gemma":0.0003900634,"teacher_disagreement_score":0.23047851,"about_ca_system_score_codex":0.000010972802,"about_ca_system_score_gemma":0.0013057576,"threshold_uncertainty_score":0.24663043},"labels":[],"label_agreement":null},{"id":"W2586374027","doi":"10.1182/blood.v112.11.3850.3850","title":"Disease Specific Modulation of Serum Hepcidin: Impact of GDF-15 and Iron Metabolism Markers in Thalassemia Major, Thalassemia Intermedia and Sickle Cell Disease: A Univariate and Multivariate Analysis.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Hepcidin; Transferrin saturation; Thalassemia; Internal medicine; Ineffective erythropoiesis; Anemia; Medicine; Ferritin; Endocrinology; Transferrin; Immunology; Erythropoiesis; Gastroenterology; Iron deficiency","score_opus":0.008626250892101799,"score_gpt":0.23977325473626138,"score_spread":0.23114700384415957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586374027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99018234,0.00878408,0.000056045716,0.00006134995,0.000040248542,0.00043867508,0.0002131314,0.000014957806,0.00020918666],"genre_scores_gemma":[0.9966664,0.0026585108,0.00035939398,0.000017222812,0.00004161641,0.000008939767,0.000091634975,0.00003016887,0.00012611806],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983218,0.00013948242,0.00048243994,0.0004644526,0.00028657494,0.0003052858],"domain_scores_gemma":[0.99869716,0.000119984375,0.0002493169,0.00039991015,0.00006590737,0.00046774844],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021886811,0.00030177704,0.0007664884,0.0005165776,0.0000505097,0.000013957279,0.00007557292,0.000101694524,0.000067388406],"category_scores_gemma":[0.00010322074,0.00025520075,0.0001816911,0.00054430106,0.00025630844,0.00021124518,0.00009875964,0.0001561141,8.0267955e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009801664,0.0006488549,0.9784485,0.00037706966,0.00022992423,0.00006466561,0.0009077151,0.00010733808,0.01775343,0.0000772315,0.000025502233,0.00037962085],"study_design_scores_gemma":[0.007801605,0.00007780704,0.9869194,0.000069775386,0.0023091717,0.000008048014,0.00014372682,0.0016773703,0.0006538575,0.000118020944,0.00001219313,0.00020899424],"about_ca_topic_score_codex":0.00046188786,"about_ca_topic_score_gemma":0.000036720838,"teacher_disagreement_score":0.017099572,"about_ca_system_score_codex":0.000018465664,"about_ca_system_score_gemma":0.00012665658,"threshold_uncertainty_score":0.99999005},"labels":[],"label_agreement":null},{"id":"W2586394078","doi":"10.1182/blood.v114.22.4003.4003","title":"The Association Between Anti-beta2 Glycoprotein 1 Antibodies and Adverse Pregnancy Outcomes.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Placental abruption; Medicine; Pregnancy; Obstetrics; Preeclampsia; Odds ratio; Intrauterine growth restriction; Gestation; Population; HELLP syndrome; Prospective cohort study; Antiphospholipid syndrome; Antibody; Immunology; Internal medicine; Biology","score_opus":0.017787998188996755,"score_gpt":0.2927247627097646,"score_spread":0.2749367645207679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586394078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896022,0.0027145233,0.0000068634545,0.0022294077,0.000056494937,0.00078360236,0.0000079575575,0.0000788505,0.004520089],"genre_scores_gemma":[0.9942904,0.00042792578,0.00014499847,0.00005689181,0.00010646568,0.000011038456,0.000007381944,0.000014431676,0.004940467],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850374,0.000080387355,0.00028441288,0.00021836317,0.00054897,0.00036411986],"domain_scores_gemma":[0.99902225,0.000274539,0.00013081735,0.00034518642,0.00012197104,0.00010521996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049592607,0.00013629369,0.00035519735,0.000066362234,0.00019237735,0.000035724635,0.00010983294,0.000116792915,0.000008424884],"category_scores_gemma":[0.0006299416,0.00008443295,0.00008225811,0.00014810113,0.000043294556,0.000074457545,0.000042950523,0.00019614323,0.00005474459],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000045652137,0.00008748606,0.99533796,0.00008572902,0.00021239911,0.000025416615,0.00029421854,2.8233394e-8,0.0010629696,0.00010422415,0.00018856433,0.002596427],"study_design_scores_gemma":[0.0037188537,0.00016708112,0.9904983,0.00060346926,0.00022147124,0.0001523781,0.00022219094,0.0000030086633,0.0034558882,0.00020031277,0.00065022,0.000106801876],"about_ca_topic_score_codex":0.00001826411,"about_ca_topic_score_gemma":0.000004549046,"teacher_disagreement_score":0.004839648,"about_ca_system_score_codex":0.000060885275,"about_ca_system_score_gemma":0.000063373154,"threshold_uncertainty_score":0.34430757},"labels":[],"label_agreement":null},{"id":"W2586430923","doi":"10.1182/blood.v112.11.346.346","title":"Non-Myeloablative Hematopoietic Stem Cell Transplantation in Older Patients with AML and MDS: Results from the Center for International Blood and Marrow Transplant Research (CIBMTR)","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Fludarabine; Internal medicine; Transplantation; Univariate analysis; Hematopoietic stem cell transplantation; Incidence (geometry); Graft-versus-host disease; Surgery; Oncology; Multivariate analysis; Chemotherapy; Cyclophosphamide","score_opus":0.02177960655277359,"score_gpt":0.26957434509862266,"score_spread":0.24779473854584907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586430923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99573743,0.00013414558,0.00006390244,0.0007793994,0.000043835378,0.0015465984,0.0010141256,0.000014303438,0.00066623447],"genre_scores_gemma":[0.9975476,0.00066777033,0.00053696416,0.00010020834,0.00011666755,0.000116693394,0.0006337075,0.000031936408,0.00024842808],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981019,0.00010711781,0.0003275528,0.00047079756,0.0006268284,0.00036583724],"domain_scores_gemma":[0.99849904,0.0006933331,0.00006254372,0.00022746621,0.0003897677,0.0001278622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004408128,0.00017307521,0.00024144008,0.00016526098,0.00015844479,0.000030854364,0.00015180431,0.00010780233,0.000012637501],"category_scores_gemma":[0.00004697841,0.000113860835,0.00003322959,0.00019135818,0.00023418415,0.00013015428,0.0000314253,0.00042249772,0.000003768022],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007756792,0.0019974315,0.940807,0.0003089095,0.00032490835,0.0003707127,0.04464912,0.000002901937,0.0022901357,0.000016414022,0.0008579079,0.0006177768],"study_design_scores_gemma":[0.070882924,0.0009252174,0.9083645,0.00071099855,0.00021265526,0.00012627058,0.0011266642,0.00019627431,0.016940983,0.000034707584,0.0002641401,0.0002146821],"about_ca_topic_score_codex":0.0002328428,"about_ca_topic_score_gemma":0.00014431916,"teacher_disagreement_score":0.06312613,"about_ca_system_score_codex":0.000046462796,"about_ca_system_score_gemma":0.00012906556,"threshold_uncertainty_score":0.46431103},"labels":[],"label_agreement":null},{"id":"W2586434177","doi":"10.1182/blood.v112.11.4332.4332","title":"Analysis of the Clinical Impact of the Use of Palifermin in Patients Undergoing Autologous Peripheral Blood Progenitor Cell Transplantation for Multiple Myeloma and Relapsed Lymphoma","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Mucositis; Melphalan; Multiple myeloma; Internal medicine; Transplantation; Surgery; Population; Autologous stem-cell transplantation; Lymphoma; Gastroenterology; Total body irradiation; Chemotherapy; Cyclophosphamide","score_opus":0.048266432900576944,"score_gpt":0.3171237236990749,"score_spread":0.26885729079849796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586434177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99860865,0.000063578766,0.000009141017,0.00001254409,0.000024728388,0.00103091,0.00023941124,0.0000050691247,0.000005980017],"genre_scores_gemma":[0.99896765,0.00008768108,0.00081026315,0.0000071976856,0.000010846511,0.000027460044,0.000048625076,0.000012253943,0.000028006101],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858975,0.00020286728,0.000545135,0.00019155079,0.00028235654,0.00018832397],"domain_scores_gemma":[0.99863994,0.00060248753,0.00025764995,0.0002948871,0.00013251313,0.00007249282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013574777,0.00012054876,0.0004580203,0.0001193389,0.000057945545,0.0000032504954,0.00009298972,0.00009920053,0.0000043853374],"category_scores_gemma":[0.00045806935,0.00006674006,0.00044152237,0.00040951083,0.00017356596,0.000046796038,0.000026084397,0.00006686023,8.3729034e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013279455,0.0033340277,0.9897123,0.00014942231,0.0015328899,0.000010673073,0.00059226755,0.0000515796,0.002020804,6.1643436e-7,0.000003016212,0.001264442],"study_design_scores_gemma":[0.02502985,0.0011788694,0.9525413,0.00006841689,0.0020914143,0.000011030319,0.000023421831,0.0013721047,0.01762945,0.0000015609884,7.7719915e-7,0.00005182969],"about_ca_topic_score_codex":0.0003565659,"about_ca_topic_score_gemma":0.0003351413,"teacher_disagreement_score":0.03717104,"about_ca_system_score_codex":0.000026192452,"about_ca_system_score_gemma":0.00025944063,"threshold_uncertainty_score":0.27215806},"labels":[],"label_agreement":null},{"id":"W2586449045","doi":"10.1182/blood.v106.11.2412.2412","title":"Gene Expression Analysis Uncovers Possible Resistance Mechanisms to Bortezomib in Mantle Cell Lymphoma That Differ from Mechanisms Identified in Other Lymphoid Malignancies.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Bortezomib; Mantle cell lymphoma; Proteasome inhibitor; Cancer research; Multiple myeloma; Cell culture; Chemistry; IC50; Lymphoma; Medicine; Biology; Immunology","score_opus":0.010758879382520984,"score_gpt":0.22680788922229,"score_spread":0.21604900983976902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586449045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99507713,0.0010625445,0.001281577,0.00033079935,0.000111521615,0.000647815,0.00016910516,0.00006281071,0.0012566815],"genre_scores_gemma":[0.98055506,0.00013849951,0.015466099,0.0010745144,0.000069695096,0.00023286766,0.000109642286,0.000055852117,0.0022977965],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99739575,0.000082398,0.0005168031,0.0008425879,0.0006003544,0.000562091],"domain_scores_gemma":[0.9986867,0.00007939927,0.00015365235,0.00078321097,0.00004226844,0.0002547985],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020954863,0.00038199383,0.00075165235,0.00057149614,0.00006949188,0.00006803228,0.00022002109,0.00020425569,0.00040629486],"category_scores_gemma":[0.000018971235,0.00032532885,0.00026202796,0.0008881014,0.000019451729,0.00015564598,0.00010807145,0.000057189296,0.00014791409],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071402034,0.008689633,0.28100845,0.000053132848,0.000663589,0.001075956,0.0012476175,0.00016483352,0.70436555,0.0003283647,0.0008170467,0.00087177905],"study_design_scores_gemma":[0.013944392,0.000079696896,0.14979836,0.00021246694,0.00074825814,0.00000618479,0.0002240487,0.000043756118,0.8336528,0.00073293585,0.0002599152,0.0002971848],"about_ca_topic_score_codex":0.0015519535,"about_ca_topic_score_gemma":0.0045266454,"teacher_disagreement_score":0.13121009,"about_ca_system_score_codex":0.0005944637,"about_ca_system_score_gemma":0.0001220174,"threshold_uncertainty_score":0.9999199},"labels":[],"label_agreement":null},{"id":"W2586451500","doi":"10.1182/blood.v106.11.2451.2451","title":"Infusion Speed-Escalation Trial To Give Full-Dose Rituximab in One Hour without Steroids Pre-Medication.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Rituximab; Adverse effect; Cohort; Anesthesia; Internal medicine; Lymphoma","score_opus":0.018739291878907587,"score_gpt":0.32345383506984593,"score_spread":0.3047145431909383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586451500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99150336,0.00015647472,0.0003125872,0.003891301,0.00013773543,0.0015269767,0.000014720504,0.000062666935,0.0023941768],"genre_scores_gemma":[0.9928587,0.000033122276,0.004286968,0.000475721,0.0007095432,0.000107329666,0.00011155376,0.00001975999,0.0013972681],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989052,0.000031949752,0.0003139827,0.00025380254,0.00030812487,0.00018696452],"domain_scores_gemma":[0.99941146,0.000028461944,0.00007864545,0.00024565263,0.00007634815,0.00015942426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012944237,0.00012245496,0.00023693645,0.00017344345,0.000053726555,0.000018953937,0.000057263274,0.000083608626,0.00014799036],"category_scores_gemma":[0.000089495916,0.00010741363,0.00004549308,0.00022819267,0.000020443653,0.0001288469,0.000026928104,0.00011622781,0.00016030899],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0712612,0.091455765,0.29890752,0.00035671997,0.0017027913,0.000120954,0.038148526,0.00059667823,0.06399889,0.0005957406,0.007467485,0.4253877],"study_design_scores_gemma":[0.4667076,0.003531522,0.51181465,0.0004420034,0.0011475328,0.000041462332,0.00026257767,0.0005626454,0.004873992,0.00007859559,0.0101969,0.00034055675],"about_ca_topic_score_codex":0.00014666724,"about_ca_topic_score_gemma":0.00028439576,"teacher_disagreement_score":0.42504716,"about_ca_system_score_codex":0.00015236254,"about_ca_system_score_gemma":0.00016420527,"threshold_uncertainty_score":0.43802005},"labels":[],"label_agreement":null},{"id":"W2586457484","doi":"10.1182/blood.v120.21.770.770","title":"Mutated IDH1 Has 2-Hydroxyglutarate-Independent Functions in Leukemogenesis","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; University of British Columbia","funders":"","keywords":"IDH1; Biology; Cancer research; CTL*; Bone marrow; Molecular biology; Mutation; Immunology; CD8; Genetics; Immune system","score_opus":0.01827588053739694,"score_gpt":0.24052430633279862,"score_spread":0.22224842579540166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586457484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99342185,0.003647165,0.00075343397,0.000044846987,0.00019546146,0.00012226438,0.000010777284,0.000012942361,0.0017912835],"genre_scores_gemma":[0.9987084,0.00010776729,0.00025070613,0.000037084665,0.0002541799,0.000026256363,0.0001256605,0.000020799092,0.0004691014],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991504,0.000058653808,0.0001872756,0.00020634805,0.00010649072,0.00029084863],"domain_scores_gemma":[0.9995645,0.000008255607,0.00004920603,0.00024130562,0.000036879424,0.000099796474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020988249,0.000119554184,0.00009985151,0.00006315112,0.00007206181,0.000021132932,0.00008448746,0.00014459863,0.000047157788],"category_scores_gemma":[0.00004114789,0.00012080923,0.00005905491,0.00012431228,0.00002990904,0.0000050073104,0.000052932548,0.00006498114,0.000068606205],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013927026,0.00032358518,0.12580004,0.0000050697263,0.000035948244,0.0000020853852,0.00005702115,0.00026084794,0.87286216,0.000011626469,0.000048693302,0.0005790217],"study_design_scores_gemma":[0.0010709015,0.00010301129,0.08084038,0.000004532643,0.00004079828,0.000007259057,0.000045610177,0.000036101643,0.9066446,0.000039904946,0.010981712,0.00018518695],"about_ca_topic_score_codex":0.0000694662,"about_ca_topic_score_gemma":0.00013587506,"teacher_disagreement_score":0.044959664,"about_ca_system_score_codex":0.000014483717,"about_ca_system_score_gemma":0.00006327159,"threshold_uncertainty_score":0.4926457},"labels":[],"label_agreement":null},{"id":"W2586464258","doi":"10.1182/blood.v108.11.2561.2561","title":"An In Vitro and In Vivo Evidence That Downregulation of Leukemia Inhibitory Factor (LIF) Receptor (LIF-R) Decreases the Metastatic Potential of Human Rhabdomyosarcoma (RMS) Cells.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Leukemia inhibitory factor; Hepatocyte growth factor; Rhabdomyosarcoma; Cancer research; Cell culture; In vivo; Biology; Bone marrow; Internal medicine; Receptor; Molecular biology; Chemistry; Medicine; Pathology; Immunology; Sarcoma; Cytokine; Interleukin 6","score_opus":0.02442066545395226,"score_gpt":0.27412385081703655,"score_spread":0.24970318536308428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586464258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99888545,0.00051740644,0.00006661105,0.00005398715,0.00004922765,0.0003211045,0.00004286858,0.000013361276,0.00004998447],"genre_scores_gemma":[0.99926287,0.000029316654,0.000516095,0.000020464815,0.000092223374,0.000014620492,0.000023724346,0.0000144786945,0.000026207494],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988515,0.00012107385,0.00043258234,0.00020165791,0.00024702566,0.00014616446],"domain_scores_gemma":[0.9992321,0.0001676422,0.00024399643,0.00023651097,0.000069821646,0.000049920734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020599017,0.00013045607,0.00030236813,0.00021203939,0.000042713826,0.000014201954,0.00007883578,0.000050242972,0.00013164282],"category_scores_gemma":[0.0000710884,0.00009780833,0.000075179865,0.00017518149,0.00011138683,0.00018733674,0.000024545088,0.0001452239,9.0500765e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020405855,0.0005766415,0.010665585,0.00009273948,0.000021527294,0.000009732276,0.00024473714,0.00008781693,0.98767906,0.000017946311,0.000054740576,0.00034538624],"study_design_scores_gemma":[0.0016440606,0.0002509698,0.08898557,0.00041128517,0.00011744825,0.000019374327,0.000248956,0.00033321942,0.90782404,0.000055014323,0.000028305223,0.0000817878],"about_ca_topic_score_codex":0.0022725621,"about_ca_topic_score_gemma":0.0003675635,"teacher_disagreement_score":0.07985508,"about_ca_system_score_codex":0.0000495802,"about_ca_system_score_gemma":0.000099028824,"threshold_uncertainty_score":0.39885083},"labels":[],"label_agreement":null},{"id":"W2586467807","doi":"10.1182/blood.v108.11.4618.4618","title":"Chlorambucil Induced Angioedema of the Tongue in a Patient with Lymphoma.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Chlorambucil; Medicine; Pancytopenia; Surgery; Gastroenterology; Respiratory distress; Tongue; Prednisone; Internal medicine; Chemotherapy; Pathology; Bone marrow; Cyclophosphamide","score_opus":0.009971939716354515,"score_gpt":0.23396865183425702,"score_spread":0.2239967121179025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586467807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991148,0.00019684035,0.0000011680517,0.00019197249,0.000027499002,0.0004657874,0.0000031235797,0.00001715183,0.007948469],"genre_scores_gemma":[0.9994467,0.000003000107,0.00010041736,0.000081323495,0.000057924557,0.000032353015,0.0000038614553,0.00001873612,0.00025566912],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99875855,0.000036023,0.00023994934,0.00019078041,0.00050234905,0.00027236113],"domain_scores_gemma":[0.99927986,0.000051765797,0.00007008286,0.00046547715,0.000081318605,0.000051519673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011816664,0.00010613891,0.00021709663,0.000081321356,0.000024521567,0.0000070277324,0.0001243804,0.000076561926,0.000024145906],"category_scores_gemma":[0.00006563695,0.000061796694,0.000062012565,0.0004891921,0.00008734199,0.000029052777,0.0000787035,0.00008123135,0.0000088841225],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006578117,0.058202557,0.50089365,0.0031647407,0.0016642387,0.017078025,0.011571316,0.0005880636,0.30723944,0.0066172504,0.0059479172,0.080454685],"study_design_scores_gemma":[0.1174026,0.0011717356,0.24244022,0.00086650305,0.00021515656,0.0023262282,0.00040695787,0.00062287407,0.63293755,0.00018310527,0.0011258773,0.00030118745],"about_ca_topic_score_codex":0.0045673847,"about_ca_topic_score_gemma":0.00071797206,"teacher_disagreement_score":0.3256981,"about_ca_system_score_codex":0.001347997,"about_ca_system_score_gemma":0.0031078449,"threshold_uncertainty_score":0.69045496},"labels":[],"label_agreement":null},{"id":"W2586470852","doi":"10.1182/blood.v114.22.3611.3611","title":"Mutagenesis of Erythropoietin Receptor Cytoplasmic Lysines Uncouples Erythropoietin-Dependent Growth From Downstream Signal Transduction Cascades.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Erythropoietin; Ubiquitin ligase; Cell biology; Erythropoiesis; Ubiquitin; Signal transduction; Erythropoietin receptor; Proteasome; Biology; Endocrinology; Biochemistry; Internal medicine","score_opus":0.009305498176837172,"score_gpt":0.2311864846937528,"score_spread":0.22188098651691562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586470852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903403,0.0020724658,0.00015393572,0.004981254,0.00029451246,0.00056059693,0.00017425824,0.00023304993,0.00118966],"genre_scores_gemma":[0.99012643,0.0020097878,0.005923528,0.00019817126,0.0007160399,0.000024779072,0.00035655455,0.000060232473,0.0005844515],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99708503,0.00009405756,0.0008005365,0.0007622861,0.00074347144,0.00051463745],"domain_scores_gemma":[0.99851084,0.00011411904,0.00029432424,0.0005372764,0.00026035844,0.00028306828],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019083552,0.0005273329,0.0008892252,0.00021125312,0.000167946,0.000032456348,0.00018592313,0.00042720925,0.0028824497],"category_scores_gemma":[0.000045493696,0.00044298382,0.00043780345,0.0004099504,0.00029181925,0.00013473065,0.000028481045,0.00037763355,0.00013372945],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008622416,0.009387816,0.02662704,0.00029014557,0.0010758423,0.00033727495,0.0018788576,0.000027513135,0.93607295,0.00014215335,0.00416003,0.01913813],"study_design_scores_gemma":[0.008745942,0.0017998413,0.011519941,0.00040034237,0.0016687413,0.00042138324,0.0016581631,0.000015406813,0.97246146,0.00028813287,0.000538081,0.0004825497],"about_ca_topic_score_codex":0.0008351059,"about_ca_topic_score_gemma":0.00005311229,"teacher_disagreement_score":0.03638852,"about_ca_system_score_codex":0.0001195775,"about_ca_system_score_gemma":0.00019964272,"threshold_uncertainty_score":0.9998022},"labels":[],"label_agreement":null},{"id":"W2586481139","doi":"10.1182/blood.v124.21.5134.5134","title":"Physiologically-Based Mathematical Modelling of Neutrophil Dynamics during Concurrent Chemotherapy and Filgrastim Support","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal","funders":"","keywords":"Filgrastim; Myelopoiesis; Chemotherapy; Teniposide; Neutropenia; Dosing; Granulocyte; Granulocyte colony-stimulating factor; Medicine; Immunology; Oncology; Biology; Pharmacology; Progenitor cell; Internal medicine; Stem cell; Etoposide","score_opus":0.01780269878031885,"score_gpt":0.24609621119061376,"score_spread":0.2282935124102949,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586481139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9804733,0.00002184981,0.018194275,0.00020302007,0.000029497574,0.00016009313,0.0000072727034,0.00004046518,0.0008702461],"genre_scores_gemma":[0.9982937,0.00003581378,0.0013850069,0.00012242781,0.00007369906,0.000016210908,0.000012027566,0.000014093583,0.000046995243],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9993944,0.000015469537,0.00018628515,0.0001624027,0.00010442051,0.00013698229],"domain_scores_gemma":[0.9996205,0.000040187835,0.000058903654,0.00015254499,0.00004544295,0.000082399085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000055635905,0.0001013215,0.0002681532,0.000035584173,0.00004141501,0.0000061645183,0.00003806361,0.000050969196,0.00012652374],"category_scores_gemma":[0.000009820989,0.000079102516,0.00006905735,0.000059739003,0.000079538746,0.000017425307,0.000014167738,0.00010644539,0.0000056179447],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014272808,0.0148751205,0.13612029,0.0073326393,0.0011328012,0.00009230104,0.00078229705,0.02021289,0.7513451,0.05115588,0.00023445082,0.015288922],"study_design_scores_gemma":[0.05651649,0.00795905,0.13946553,0.0013711356,0.0021579945,0.00060823816,0.00012308074,0.4039165,0.37596756,0.009642301,0.0008338208,0.0014382881],"about_ca_topic_score_codex":0.0000031397128,"about_ca_topic_score_gemma":6.7424276e-7,"teacher_disagreement_score":0.38370362,"about_ca_system_score_codex":0.000012105553,"about_ca_system_score_gemma":0.000027579366,"threshold_uncertainty_score":0.3225707},"labels":[],"label_agreement":null},{"id":"W2586486445","doi":"10.1182/blood.v114.22.4447.4447","title":"Cerebral Venous Thrombosis During Pregnancy in the Setting of Type I Antithrombin Deficiency: Case Report and Literature Review.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; St. Joseph's Hospital; McMaster University","funders":"","keywords":"Antithrombin; Medicine; Pregnancy; Antithrombin III deficiency; Heparin; Thrombosis; Venous thrombosis; Asymptomatic; Low molecular weight heparin; Surgery; Internal medicine","score_opus":0.018482711846829113,"score_gpt":0.28705273246236346,"score_spread":0.26857002061553437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586486445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96653605,0.031077564,0.000003100702,0.00093107467,0.00004604818,0.00046281627,0.0000026215798,0.000027237036,0.0009134965],"genre_scores_gemma":[0.9957966,0.003194937,0.00061013974,0.00032250007,0.000029979396,0.0000048464594,0.000011969893,0.000009580568,0.000019443976],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9989695,0.00006290586,0.0003544794,0.0002333981,0.00020327748,0.00017645191],"domain_scores_gemma":[0.99934965,0.000021836142,0.00014579576,0.000356992,0.0000828557,0.000042866006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025720862,0.000119411015,0.00033782388,0.00007614801,0.000075577605,0.000017983259,0.0000630919,0.000075395394,0.000012403832],"category_scores_gemma":[0.00012951312,0.0000880655,0.00005395925,0.0005528265,0.000022243315,0.00007823007,0.000020427357,0.00018572132,0.0000014143525],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013001174,0.022358766,0.28048936,0.024334127,0.00054718566,0.35872954,0.04184642,0.000007207468,0.24070798,0.014576939,0.000514529,0.015757948],"study_design_scores_gemma":[0.0043519735,0.0015932708,0.61284775,0.02979198,0.0010263165,0.32494247,0.0005568967,0.000034760145,0.023503007,0.0009691137,0.000018343035,0.00036410446],"about_ca_topic_score_codex":0.000010816072,"about_ca_topic_score_gemma":0.0000084527555,"teacher_disagreement_score":0.3323584,"about_ca_system_score_codex":0.0000069105827,"about_ca_system_score_gemma":0.000035807694,"threshold_uncertainty_score":0.35912067},"labels":[],"label_agreement":null},{"id":"W2586490996","doi":"10.1182/blood.v114.22.809.809","title":"Hematopoietic Stem Cell Transplantation: a Global Perspective From the Worldwide Network of Blood and Marrow Transplantation.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Transplantation; Hematopoietic stem cell transplantation; Medicine; Gross national income; Health care; Demography; Pediatrics; Gross domestic product; Internal medicine; Economic growth","score_opus":0.010390192268096787,"score_gpt":0.23871014788110742,"score_spread":0.22831995561301063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586490996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9806068,0.005051776,0.0018575456,0.0018752288,0.00008969212,0.00078095583,0.00022999907,0.00008825048,0.009419766],"genre_scores_gemma":[0.99533105,0.0013345296,0.0024888725,0.00046492156,0.00017624123,0.000018241002,0.000081982755,0.000019226112,0.00008493183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982243,0.00011845715,0.00050320633,0.00040860605,0.00043186682,0.00031353603],"domain_scores_gemma":[0.9988946,0.00034029555,0.00015675985,0.00032547087,0.00013364428,0.00014925895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020250095,0.00026432212,0.0004391654,0.00002985878,0.00011751758,0.000028340566,0.00014044947,0.00013066761,0.0000703193],"category_scores_gemma":[0.0000056064223,0.00020643942,0.00013463493,0.00038162476,0.00010726422,0.00008897364,0.000004694422,0.00018140009,0.000011508138],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071556848,0.009062602,0.59158343,0.0064914483,0.003983089,0.0057003666,0.14064364,0.00048732423,0.16021661,0.06714723,0.0012833747,0.006245159],"study_design_scores_gemma":[0.036828775,0.0017615976,0.6971668,0.0031126568,0.021697177,0.006123237,0.008341895,0.00008359722,0.21068512,0.013020684,0.00010554279,0.0010729103],"about_ca_topic_score_codex":0.00012402573,"about_ca_topic_score_gemma":0.000072139694,"teacher_disagreement_score":0.13230175,"about_ca_system_score_codex":0.000025935547,"about_ca_system_score_gemma":0.000115121096,"threshold_uncertainty_score":0.8418355},"labels":[],"label_agreement":null},{"id":"W2586496161","doi":"10.1182/blood.v112.11.3305.3305","title":"Impact of Comorbidity Index on Outcome with Allogeneic Hematopoetic Stem Cell Transplantation for Chronic Lymphocytic Leukemia","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; BC Cancer Agency; Leukemia & Lymphoma Society of Canada","funders":"","keywords":"Medicine; Fludarabine; Chronic lymphocytic leukemia; Hematopoietic stem cell transplantation; Internal medicine; Transplantation; Surgery; Leukemia; Refractory (planetary science); Gastroenterology; Chemotherapy; Cyclophosphamide","score_opus":0.03776748838264262,"score_gpt":0.31299995685496473,"score_spread":0.27523246847232213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586496161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99712974,0.0003477445,0.00051155523,0.000009993402,0.000036894417,0.0012219978,0.00005988149,0.000069345646,0.0006128362],"genre_scores_gemma":[0.9986536,0.00024583767,0.00020574761,0.000035041656,0.0001079965,0.00009456931,0.00006700453,0.00006549569,0.00052469556],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99789417,0.00004884928,0.0004740589,0.00040318767,0.00064273184,0.00053699454],"domain_scores_gemma":[0.9985825,0.00027156266,0.00016923685,0.00057921524,0.00016214297,0.00023534684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001957908,0.0002895509,0.00063646847,0.00019373832,0.000097790326,0.000008226323,0.00018653467,0.00016971157,0.0000550232],"category_scores_gemma":[0.00001808648,0.00020976881,0.00027823757,0.00027934957,0.0001956292,0.00006246844,0.0000193881,0.00017926695,0.000032813252],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.037506238,0.00989026,0.68352485,0.037363004,0.00620659,0.01069756,0.009778597,0.060317017,0.13598137,0.00042053522,0.0020943228,0.006219692],"study_design_scores_gemma":[0.3523904,0.016081093,0.24073696,0.0009644511,0.001743424,0.010781248,0.0001266733,0.023606433,0.35246813,0.000034064877,0.00009848287,0.000968633],"about_ca_topic_score_codex":0.0008201943,"about_ca_topic_score_gemma":0.000054763183,"teacher_disagreement_score":0.44278786,"about_ca_system_score_codex":0.028557561,"about_ca_system_score_gemma":0.026510004,"threshold_uncertainty_score":0.9790088},"labels":[],"label_agreement":null},{"id":"W2586504089","doi":"10.1182/blood.v108.11.2269.2269","title":"Long Term Follow-Up Results for Patients with Hodgkin Lymphoma after First Remission of Longer Than Ten Years: A Population Based Study of 954 Patients from the British Columbia Cancer Agency.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Cohort; Internal medicine; Malignancy; Population; Cancer; Lymphoma; Stage (stratigraphy); Gastroenterology; Proportional hazards model; Pediatrics; Surgery","score_opus":0.007000475242966353,"score_gpt":0.21871586829889897,"score_spread":0.21171539305593262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586504089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968804,0.00014929577,0.0000010123766,0.000016478549,0.00009006169,0.001977365,0.00084867777,0.000014202293,0.000022489428],"genre_scores_gemma":[0.9983553,0.000006170364,0.00012143967,0.000026989628,0.00006335499,0.00037275918,0.000893252,0.000027524145,0.00013318984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863183,0.00003873501,0.00041384847,0.0003176288,0.00042902541,0.00016890939],"domain_scores_gemma":[0.9990137,0.0001023954,0.00028621175,0.00034484017,0.00020019253,0.000052633168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000059178168,0.00012622835,0.00030830942,0.000024265508,0.00009779576,0.00005169611,0.000076566175,0.000069010304,0.000030107522],"category_scores_gemma":[0.000047992213,0.000106715495,0.000097164324,0.00012573824,0.000019252007,0.000056349923,0.000026769245,0.000022738914,5.5240656e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011922144,0.0119005125,0.9785446,0.000042249,0.0001564353,0.000021320295,0.0003450487,0.000002133616,0.000004580506,1.9424746e-8,0.00065077085,0.0071401116],"study_design_scores_gemma":[0.05639631,0.0016973416,0.93990946,0.0008679117,0.00083731615,3.7698763e-7,0.000021842407,0.00000505758,0.0001279031,0.0000035662313,0.000023174021,0.00010973443],"about_ca_topic_score_codex":0.12527788,"about_ca_topic_score_gemma":0.19258328,"teacher_disagreement_score":0.0673054,"about_ca_system_score_codex":0.00009303009,"about_ca_system_score_gemma":0.000062194005,"threshold_uncertainty_score":0.880547},"labels":[],"label_agreement":null},{"id":"W2586515949","doi":"10.1182/blood.v106.11.4332.4332","title":"Overexpression of MEL1 as a Novel Fusion Partner of AML1 in the Blastic Phase of Chronic Myeloid Leukemia with the Recurrent Cryptic Translocation t(1;21)(p36.3;q22).","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Chromosomal translocation; Biology; Myeloid leukemia; Molecular biology; Fusion gene; Gene; Intron; RNA splicing; Genetics; Cancer research; RNA","score_opus":0.008980958979688263,"score_gpt":0.26066920322976617,"score_spread":0.2516882442500779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586515949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99601614,0.0020846133,0.0011955677,0.00016644849,0.000022060194,0.00036562886,0.000015817417,0.0000029101461,0.00013081427],"genre_scores_gemma":[0.99931186,0.00028386826,0.00014597662,0.0000173465,0.0001138632,0.000029989646,0.000056917557,0.000012809089,0.000027394386],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990752,0.00006703392,0.00030466914,0.00019024746,0.00023241577,0.0001304646],"domain_scores_gemma":[0.9992689,0.000028892866,0.0002484357,0.00034897847,0.00008382471,0.000020988482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020107256,0.00011957117,0.00014751525,0.000043390457,0.000029605892,0.0000038317635,0.000171423,0.00010765182,0.000019046458],"category_scores_gemma":[0.00002595432,0.00007244601,0.00006304445,0.0001700328,0.000110724744,0.0000060169286,0.000024265664,0.00009034065,7.88063e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034999152,0.0005864751,0.00004164642,0.000060313592,0.000042248146,1.3011712e-7,0.0004293632,0.0054464657,0.9840604,0.000052241696,0.00006637574,0.00886436],"study_design_scores_gemma":[0.004653016,0.0011457533,0.0019408168,0.00026892728,0.00011003484,0.000011289527,0.0000917308,0.0019054316,0.988757,0.000015901282,0.001005086,0.000095015195],"about_ca_topic_score_codex":0.00004351381,"about_ca_topic_score_gemma":0.00016800045,"teacher_disagreement_score":0.008769345,"about_ca_system_score_codex":0.000035031346,"about_ca_system_score_gemma":0.00022929617,"threshold_uncertainty_score":0.29542625},"labels":[],"label_agreement":null},{"id":"W2586541672","doi":"10.1182/blood.v112.11.4351.4351","title":"Hypogammaglobulinemia Following Rituximab and High-Dose Therapy and Autologous Stem-Cell Transplant: Incidence and Predictors of Prolonged Immunoglobulin Deficiencies","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; St. Michael's Hospital; Sunnybrook Hospital; University of Toronto","funders":"","keywords":"Rituximab; Hypogammaglobulinemia; Medicine; Internal medicine; Regimen; Autologous stem-cell transplantation; Salvage therapy; Lymphoma; Transplantation; Gastroenterology; Oncology; Surgery; Immunology; Chemotherapy; Antibody","score_opus":0.017288657268934533,"score_gpt":0.2390230450724723,"score_spread":0.22173438780353777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586541672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97208494,0.026913933,0.000010787745,0.00008641468,0.000052520307,0.0006376245,0.000019101888,0.000064402986,0.0001302888],"genre_scores_gemma":[0.9921231,0.0069553647,0.0006586544,0.000041010084,0.00004061628,0.000025645526,0.0000072742787,0.00002490114,0.00012342936],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982532,0.00007328983,0.00037603464,0.0004316134,0.00047070457,0.00039512015],"domain_scores_gemma":[0.9990945,0.0002547906,0.00009430006,0.0003063506,0.00006852247,0.00018153645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034053402,0.00023176009,0.00055776566,0.00012398766,0.00016822979,0.00001760747,0.00012424971,0.0001715234,0.000005962927],"category_scores_gemma":[0.000050413004,0.00018687715,0.00006181391,0.00020670502,0.0005625276,0.0001147928,0.000083225714,0.00022918129,0.000002080509],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005158979,0.005249228,0.7054186,0.0026669498,0.0011642583,0.007457726,0.030398143,0.000012986189,0.21903227,0.00011305527,0.00014215671,0.023185687],"study_design_scores_gemma":[0.2217172,0.0037656908,0.5996222,0.00070324354,0.00085307116,0.0135144405,0.00082520914,0.0017954526,0.15620066,0.000077038014,0.00020087499,0.00072495017],"about_ca_topic_score_codex":0.00041357506,"about_ca_topic_score_gemma":0.000016900096,"teacher_disagreement_score":0.2165582,"about_ca_system_score_codex":0.00020587129,"about_ca_system_score_gemma":0.0013072777,"threshold_uncertainty_score":0.7620629},"labels":[],"label_agreement":null},{"id":"W2586556162","doi":"10.1182/blood.v112.11.170.170","title":"Alignment to ACCP Prophylaxis Guidelines and VTE Outcomes in THR and TKR Patients","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Sunnybrook Health Science Centre; McMaster University; St. Joseph's Hospital; St. Joseph’s Healthcare Hamilton; Bayer (Canada)","funders":"","keywords":"Medicine; Pulmonary embolism; Guideline; Incidence (geometry); Arthroplasty; Knee replacement; Venous thromboembolism; Deep vein; Retrospective cohort study; Thrombosis; Emergency medicine; Internal medicine; Surgery","score_opus":0.03204569671265337,"score_gpt":0.2851211728310996,"score_spread":0.2530754761184462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586556162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99632937,0.0003031545,0.0000045375186,0.001720709,0.00006177961,0.0007043669,0.000004563909,0.000020809046,0.00085069],"genre_scores_gemma":[0.9956247,0.000908225,0.0012200486,0.0018687795,0.00004087779,0.000057450747,0.000004443385,0.000013067485,0.0002624119],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991493,0.000012202055,0.00023624989,0.00023152374,0.00019481975,0.00017585859],"domain_scores_gemma":[0.9996184,0.000015836455,0.000031948523,0.00016655462,0.000052613883,0.000114642346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008685863,0.00011795908,0.00031924422,0.0000947023,0.000047825695,0.000009869834,0.000038983017,0.000036357487,0.00001693015],"category_scores_gemma":[0.00007812958,0.00008948235,0.000023256858,0.000080918544,0.000025399113,0.000038267608,0.00011217346,0.000044299213,0.000011972577],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011209978,0.0013955453,0.988048,0.00005369043,0.00006470706,0.000041758434,0.00068918825,0.0000010823773,0.00014183296,0.00005428508,0.0018450445,0.0076536643],"study_design_scores_gemma":[0.0026159957,0.0007003256,0.98952127,0.000059962218,0.00006362017,0.0000066586476,0.00007274616,0.0000023669018,0.000512387,0.000036424095,0.0063049844,0.00010327917],"about_ca_topic_score_codex":0.00015955955,"about_ca_topic_score_gemma":0.000044023862,"teacher_disagreement_score":0.007550385,"about_ca_system_score_codex":0.000013898772,"about_ca_system_score_gemma":0.00001332605,"threshold_uncertainty_score":0.36489847},"labels":[],"label_agreement":null},{"id":"W2586559902","doi":"10.1182/blood.v120.21.3753.3753","title":"Blast Phase Chronic Myeloid Leukemia: A Pooled Analysis of Subcutaneous Omacetaxine Mepesuccinate in Treatment-Resistant Patients","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Neutropenia; Tolerability; Myeloid leukemia; Leukemia; Gastroenterology; Adverse effect; Oncology; Pharmacology; Immunology; Chemotherapy","score_opus":0.011099158388696065,"score_gpt":0.26919389661000453,"score_spread":0.25809473822130846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586559902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99418694,0.0031818545,0.0000057576613,0.00003812416,0.000085856365,0.0008934428,0.00020652535,0.00006727669,0.0013342288],"genre_scores_gemma":[0.9979545,0.00031198244,0.00019677858,0.00003380972,0.000118939155,0.000090579095,0.0005461802,0.00005540212,0.0006918619],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99722755,0.00010720269,0.00080840575,0.00049229735,0.00050584,0.0008587057],"domain_scores_gemma":[0.9982748,0.00012520936,0.00033130674,0.0007873983,0.00011717151,0.00036411834],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017837078,0.00045942157,0.0012681534,0.0008433479,0.00005656412,0.000010781629,0.0001445811,0.00019998659,0.0005644474],"category_scores_gemma":[0.00008896897,0.0003753589,0.00045267693,0.0015365409,0.000080755766,0.0001337121,0.000057382604,0.00019310547,0.00006055203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052948873,0.05279175,0.740345,0.00045209753,0.03612486,0.0019786442,0.0029841247,0.00024748346,0.12338772,0.00008360817,0.00009172924,0.036218088],"study_design_scores_gemma":[0.21840285,0.01521405,0.5246174,0.00040087922,0.07329734,0.00024696626,0.00021427337,0.0020521833,0.16287753,0.000009489169,0.001623321,0.0010437727],"about_ca_topic_score_codex":0.00095750205,"about_ca_topic_score_gemma":0.00090109324,"teacher_disagreement_score":0.21572767,"about_ca_system_score_codex":0.0043603354,"about_ca_system_score_gemma":0.00067059847,"threshold_uncertainty_score":0.9998698},"labels":[],"label_agreement":null},{"id":"W2586573535","doi":"10.1182/blood.v126.23.4175.4175","title":"Ikaros-Dependent Downregulation of MYC with IMiDs in Myeloma (MM) Cells Is Mediated through the Depletion of the Acetylated Chromatin Reader BRD4 at Super-Enhancer Loci","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Enhancer; Biology; Downregulation and upregulation; BRD4; Molecular biology; Chromatin; KLF4; Cancer research; Transcription factor; Bromodomain; Histone; Gene; Genetics; SOX2","score_opus":0.02899555465763853,"score_gpt":0.27523507798788704,"score_spread":0.2462395233302485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586573535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99652165,0.00043739149,0.000022032858,0.0010019745,0.000030179755,0.0010324979,0.000050873612,0.000021934502,0.000881482],"genre_scores_gemma":[0.9988059,0.00006751427,0.000287511,0.00007372075,0.000037587426,0.000053364543,0.000092263595,0.00002579971,0.00055634056],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980181,0.00017140413,0.00039479285,0.00025120837,0.0008734975,0.0002909915],"domain_scores_gemma":[0.9988253,0.00010039105,0.00019101986,0.00054852816,0.00023900173,0.00009577107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027770564,0.00017900037,0.0003361049,0.00006132335,0.00005835698,0.000008689483,0.00016194885,0.00012810976,0.000191904],"category_scores_gemma":[0.00010435509,0.000090089656,0.000074247764,0.0004144821,0.00021178093,0.00009569173,0.0000929951,0.00016768867,0.000030149942],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017683438,0.0018797803,0.22531505,0.00023528932,0.0006730727,0.000047965274,0.0106363,0.00011457295,0.7572243,0.00002290209,0.0011748384,0.00090755493],"study_design_scores_gemma":[0.00937195,0.00039933057,0.3347151,0.00016549033,0.0001314677,0.000029899049,0.00048166272,0.00030364215,0.65419286,0.000032286374,0.00009495884,0.00008134751],"about_ca_topic_score_codex":0.0010456998,"about_ca_topic_score_gemma":0.00059943734,"teacher_disagreement_score":0.10940004,"about_ca_system_score_codex":0.00013535518,"about_ca_system_score_gemma":0.00019308152,"threshold_uncertainty_score":0.36737496},"labels":[],"label_agreement":null},{"id":"W2586578392","doi":"10.1182/blood.v128.22.151.151","title":"The Clinical Impact of the Cell-of-Origin Classification and the MYC+/BCL2+ Double Expresser Status in DLBCL Treated within Prospective Clinical Trials of the Dshnhl","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"BCL6; Fluorescence in situ hybridization; Diffuse large B-cell lymphoma; Internal medicine; Oncology; Lymphoma; Clinical trial; Immunohistochemistry; Medicine; Cancer research; Pathology; Biology; B cell; Immunology; Gene; Germinal center; Antibody; Genetics","score_opus":0.11520768825068846,"score_gpt":0.43345536407772817,"score_spread":0.3182476758270397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586578392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952022,0.00077626965,0.0000012049738,0.0010994157,0.00016142098,0.0019788453,0.000053241227,0.0000073244714,0.00072012347],"genre_scores_gemma":[0.99836034,0.0011609757,0.000027353739,0.000027968474,0.00008612388,0.00012286515,0.000001765218,0.000013270278,0.0001993173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996258,0.0014096226,0.0015794948,0.00026536876,0.00029086747,0.000196597],"domain_scores_gemma":[0.9926232,0.0051816734,0.0011356742,0.00082978373,0.00015801741,0.0000716437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043860683,0.00016140252,0.0007926913,0.000025829462,0.00007647274,0.00001201992,0.00021494915,0.00014794506,0.00001390593],"category_scores_gemma":[0.0020692267,0.000042426396,0.00056464266,0.00020373864,0.0008746535,0.000039429768,0.000082048806,0.0001572951,0.0000018808371],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032023438,0.002945763,0.98782235,0.000013335236,0.00046669116,0.0000011337772,0.0004244159,6.289094e-7,0.0020323545,0.0011832245,0.00021838542,0.0016893735],"study_design_scores_gemma":[0.050627165,0.0005685185,0.9058203,0.00018304047,0.0006956529,0.0000036893916,0.00016471726,0.00001315743,0.04136677,0.00040369434,0.00010413362,0.000049166345],"about_ca_topic_score_codex":0.0005374082,"about_ca_topic_score_gemma":0.000109779685,"teacher_disagreement_score":0.08200206,"about_ca_system_score_codex":0.00005925071,"about_ca_system_score_gemma":0.00043078308,"threshold_uncertainty_score":0.32226974},"labels":[],"label_agreement":null},{"id":"W2586586516","doi":"10.1182/blood.v114.22.2741.2741","title":"Characterization of Bortezomib (Velcade ™) Resistance in a New Set of Human Cell Lines Obtained by Stepwise Selection.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University","funders":"","keywords":"Bortezomib; Cell culture; Proteasome inhibitor; Proteasome; Carfilzomib; HeLa; Deubiquitinating enzyme; Ixazomib; Cancer research; Pharmacology; Chemistry; Multiple myeloma; Biology; Medicine; Ubiquitin; Biochemistry; Immunology; Gene; Genetics","score_opus":0.008831444124134698,"score_gpt":0.2323642178064535,"score_spread":0.2235327736823188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586586516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99826133,0.00044661658,0.00015410154,0.000078268036,0.000011650965,0.00016253791,0.00005736419,0.000006788335,0.00082136627],"genre_scores_gemma":[0.99772173,0.00008168432,0.00038842665,0.000059432354,0.0001000454,0.000004473188,0.0002800534,0.0000085500615,0.0013556277],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993729,0.000036308447,0.00023750105,0.00016621774,0.000071836024,0.000115238996],"domain_scores_gemma":[0.99962914,0.0000029228759,0.00014522726,0.00013369974,0.00005225177,0.000036781046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000080776,0.00008779415,0.00013289151,0.000038650745,0.000019193067,0.000004570822,0.000093100665,0.00010652209,0.000010057663],"category_scores_gemma":[0.000020271402,0.00009294467,0.000037897902,0.00012558096,0.000016165546,0.0000035669336,0.000013254943,0.00004819006,5.4340586e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051441377,0.00017932267,0.001975951,0.000036181184,0.0000080964755,4.5685312e-7,0.000093866416,5.4242173e-7,0.99711543,0.000044183955,0.00033176554,0.00016277158],"study_design_scores_gemma":[0.001190637,0.0003010154,0.007887505,0.00002660484,0.000013708777,8.470588e-7,0.000009838051,0.0000021251076,0.98791105,0.000083620325,0.0024821134,0.0000909363],"about_ca_topic_score_codex":0.000016070677,"about_ca_topic_score_gemma":0.00005846317,"teacher_disagreement_score":0.009204372,"about_ca_system_score_codex":0.0000032739144,"about_ca_system_score_gemma":0.0000686661,"threshold_uncertainty_score":0.37901735},"labels":[],"label_agreement":null},{"id":"W2586625123","doi":"10.1182/blood.v112.11.1281.1281","title":"Mandatory Clinical Pre-Test Probability Assessment Combined with D-Dimer Testing in Outpatients Did Not Result in a Reduction in Radiological Test Utilization for Investigation of VTE","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Pulmonary embolism; Pre- and post-test probability; D-dimer; Deep vein; Radiological weapon; Emergency department; Thrombosis; Radiology; Venous thromboembolism; Venous thrombosis; Emergency medicine; Internal medicine","score_opus":0.13797042276025093,"score_gpt":0.35112128110688445,"score_spread":0.21315085834663353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586625123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968673,0.000016669035,0.00004456099,0.00032764403,0.00005508624,0.0025352708,0.00000854665,0.000027670178,0.000117245865],"genre_scores_gemma":[0.9918205,0.000036532623,0.0075479504,0.00007777189,0.000039014125,0.00035628825,0.00009757613,0.000013452378,0.000010910638],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981256,0.0001417712,0.00089075114,0.00040922896,0.00022725332,0.00020538246],"domain_scores_gemma":[0.99884164,0.00045253788,0.00026809608,0.00022997994,0.00014295803,0.00006477809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010720846,0.0001367554,0.0005233631,0.000158618,0.000035504418,0.0000048858133,0.00006447129,0.00012014543,0.0000030582835],"category_scores_gemma":[0.0021848807,0.00011268511,0.000038961727,0.00040675842,0.00016057458,0.000100093755,0.00003758716,0.00019744586,4.077095e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025488532,0.008407733,0.9887211,0.00020011963,0.000017083172,0.000010086088,0.00039481252,0.00014586365,0.001318589,0.00006742768,0.000049874416,0.00041246807],"study_design_scores_gemma":[0.0105262855,0.0045333714,0.9810065,0.0004122383,0.0000755061,0.000007840578,0.000070186514,0.0016858887,0.0013997375,0.00016317928,0.000010679867,0.00010860274],"about_ca_topic_score_codex":0.000152447,"about_ca_topic_score_gemma":0.00016526383,"teacher_disagreement_score":0.0102714,"about_ca_system_score_codex":0.00010650813,"about_ca_system_score_gemma":0.00016962361,"threshold_uncertainty_score":0.45951656},"labels":[],"label_agreement":null},{"id":"W2586629413","doi":"10.1182/blood.v104.11.2417.2417","title":"t(4;14) Positive Multiple Myeloma Is Chemosensitive to Dexamethasone and/or Thalidomide but Not Alkylating Agents: Rapid Relapse and Not Primary Drug Resistance Explains Poor Outcomes.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Melphalan; Medicine; Internal medicine; Dexamethasone; Chemotherapy; Multiple myeloma; Vincristine; Autologous stem-cell transplantation; Oncology; Gastroenterology; Chemotherapy regimen; Surgery; Cyclophosphamide","score_opus":0.027376332065746967,"score_gpt":0.2867280161057858,"score_spread":0.25935168404003883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586629413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98887664,0.0005004083,0.0000902982,0.00711447,0.000057525795,0.0017402286,0.0003721396,0.000103075894,0.0011452334],"genre_scores_gemma":[0.9641323,0.00025857837,0.025939524,0.0055383267,0.00009703581,0.00012205998,0.00009425588,0.00007663327,0.003741305],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9970267,0.00013353038,0.0004892173,0.00088550453,0.0007126649,0.000752406],"domain_scores_gemma":[0.9975079,0.00087946374,0.00015796913,0.0004718581,0.00022999532,0.00075280014],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042198843,0.00046409364,0.00083488284,0.00021655925,0.000323728,0.00007158031,0.00011220076,0.00014396934,0.000039559647],"category_scores_gemma":[0.0016741294,0.00036880447,0.00014152084,0.00028757678,0.00017857635,0.00021841435,0.0002433116,0.0003635073,0.00004323971],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041055366,0.0068573467,0.29621896,0.0015843139,0.0066638286,0.018461652,0.031223813,0.000006139615,0.547483,0.00018747145,0.0023287244,0.047929324],"study_design_scores_gemma":[0.036196437,0.00046410822,0.59195274,0.00058236223,0.00031679397,0.00021967806,0.00083864736,0.000022694194,0.36873782,0.000026106922,0.00021481042,0.00042783227],"about_ca_topic_score_codex":0.00048885524,"about_ca_topic_score_gemma":0.0003201182,"teacher_disagreement_score":0.29573375,"about_ca_system_score_codex":0.00023906176,"about_ca_system_score_gemma":0.00019000602,"threshold_uncertainty_score":0.9998764},"labels":[],"label_agreement":null},{"id":"W2586664351","doi":"10.1182/blood.v108.11.3941.3941","title":"TDAG51 Deficiency Promotes Migration and Proliferation of Mouse Embryonic Fibroblasts.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University Medical Centre","funders":"","keywords":"Focal adhesion; Cell biology; Cell migration; Vinculin; Fibronectin; Actin; Actin cytoskeleton; Extracellular matrix; Biology; Cytoskeleton; Molecular biology; Signal transduction; Cell culture; Cell","score_opus":0.010666229089522689,"score_gpt":0.2531064203285172,"score_spread":0.24244019123899452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586664351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973176,0.00044117612,0.000109465764,0.0003701539,0.0000058906744,0.00041868523,0.0000031559928,0.000027755232,0.0013061222],"genre_scores_gemma":[0.9965692,0.000030445002,0.0010414908,0.000014183455,0.000037660757,0.000015504555,0.000033126234,0.000011792912,0.002246557],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992181,0.000027878392,0.00017099052,0.00016586651,0.00026421782,0.00015291628],"domain_scores_gemma":[0.99961597,0.000024290928,0.000049123784,0.00015421803,0.00010927475,0.000047152134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011707065,0.000072562616,0.00012206214,0.00010302883,0.00004065918,0.000015493293,0.000032962296,0.000053761592,0.000027445674],"category_scores_gemma":[0.00008547079,0.000061202896,0.000029816429,0.00015020797,0.000050111557,0.000049071827,0.00002765347,0.00007504534,0.000012724714],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033666198,0.0005879109,0.03877183,0.00019673478,0.0000067041155,0.0000060579314,0.00005233346,0.0000059567046,0.95943034,0.000273218,0.00019031804,0.00044493843],"study_design_scores_gemma":[0.0015651693,0.00060587877,0.0599732,0.000045845896,0.0000468408,0.00004664619,0.000021847483,0.0006902357,0.93670166,0.00011185382,0.00012346644,0.000067388275],"about_ca_topic_score_codex":0.000072099116,"about_ca_topic_score_gemma":0.00007454533,"teacher_disagreement_score":0.0227287,"about_ca_system_score_codex":0.00001064409,"about_ca_system_score_gemma":0.00007676218,"threshold_uncertainty_score":0.24957818},"labels":[],"label_agreement":null},{"id":"W2586674273","doi":"10.1182/blood.v124.21.3521.3521","title":"Difficulties in Establishing the Cause of Thrombocytopenia Among Ambulatory Patients Referred to Hematology: An Agreement Study","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; St. Joseph's Hospital; McMaster University","funders":"","keywords":"Medicine; Pediatrics; Hematology; Internal medicine; Thrombotic microangiopathy; Medical diagnosis; Referral; Etiology; Ambulatory; Disease; Family medicine; Pathology","score_opus":0.023159619081572054,"score_gpt":0.2839802824027618,"score_spread":0.26082066332118975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586674273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979525,0.000040400002,0.0000022252475,0.00015450423,0.0000851342,0.0014369513,0.0000063982375,0.000018159333,0.0003036907],"genre_scores_gemma":[0.9993853,0.000005489452,0.00013962176,0.00014661961,0.000036133802,0.00021751357,0.000020111514,0.000015584666,0.000033645214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998591,0.0001896923,0.00037445425,0.00030486824,0.00032476886,0.00021523099],"domain_scores_gemma":[0.99902344,0.00017139637,0.000109841705,0.00047117058,0.00011104368,0.00011313476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002917726,0.00017345558,0.0004802921,0.000096786505,0.00007414934,0.000025774207,0.00012874392,0.000051146006,0.000029271669],"category_scores_gemma":[0.00025348828,0.00010495892,0.000041485604,0.00015596836,0.0000476287,0.000102520564,0.00009082854,0.00011820695,0.00001035894],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006064381,0.0077082342,0.98614407,0.00002304995,0.00016792199,0.00002237441,0.0051998426,0.000013285912,0.000106801934,0.00013490267,0.00013083627,0.00028801456],"study_design_scores_gemma":[0.006021658,0.0021892989,0.98437166,0.000103876075,0.00022894552,0.000002678536,0.0016688979,0.000014608494,0.005252772,0.000009214444,0.00003623568,0.000100154524],"about_ca_topic_score_codex":0.0004443722,"about_ca_topic_score_gemma":0.003279632,"teacher_disagreement_score":0.005961014,"about_ca_system_score_codex":0.000040627794,"about_ca_system_score_gemma":0.000026085927,"threshold_uncertainty_score":0.42801005},"labels":[],"label_agreement":null},{"id":"W2586680445","doi":"10.1182/blood.v110.11.434.434","title":"Liver Engraftment by Transplanted Human Progenitor Cells with High Aldehyde Dehydrogenase Activity in a Novel Model, NOD/SCID/MPSVII Mice.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials","funders":"","keywords":"Haematopoiesis; Stem cell; Biology; Nod; Bone marrow; Progenitor cell; Transplantation; Molecular biology; Cord blood; Immunology; Pathology; Cell biology; Medicine; In vivo; Internal medicine","score_opus":0.021328942072006953,"score_gpt":0.27028736329476327,"score_spread":0.24895842122275633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586680445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951107,0.00023822267,0.001523795,0.000082978404,0.000027639222,0.001725358,0.00009438091,0.000086734966,0.0011102081],"genre_scores_gemma":[0.9958686,0.00004246388,0.002537946,0.00008580342,0.00010011671,0.00009438891,0.00006551824,0.00007032825,0.0011348098],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970551,0.00006091274,0.000372321,0.0006465049,0.00094613794,0.0009190027],"domain_scores_gemma":[0.99872726,0.000106150976,0.00009430055,0.00044949804,0.00010956104,0.0005132414],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00064073916,0.00035334245,0.00047639472,0.0002530107,0.00011906476,0.00002661645,0.00021711686,0.00021526731,0.00010205129],"category_scores_gemma":[0.000014621674,0.00028686677,0.000100049234,0.00043602972,0.000115774346,0.000109792505,0.000048037804,0.0005475478,0.00004553463],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009704692,0.0057582045,0.0025603569,0.00033200294,0.00018567072,0.0011127404,0.0005734942,0.00003428401,0.98809475,0.000016232418,0.000076996665,0.0002848143],"study_design_scores_gemma":[0.01088819,0.0009313737,0.0021499242,0.00024228875,0.00022585908,0.0001305268,0.000045317334,0.0016443838,0.98323166,0.000003390114,0.00019264982,0.00031443377],"about_ca_topic_score_codex":0.0010369908,"about_ca_topic_score_gemma":0.001353368,"teacher_disagreement_score":0.00991772,"about_ca_system_score_codex":0.000213566,"about_ca_system_score_gemma":0.00027684975,"threshold_uncertainty_score":0.99995834},"labels":[],"label_agreement":null},{"id":"W2586681626","doi":"10.1182/blood.v114.22.3984.3984","title":"A Randomized, Controlled Two-Center Pilot Trial of a 6-Month Exercise Training Program to Treat the Post-Thrombotic Syndrome: The EXPO Pilot Trial.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Peripheral Artery Disease Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; Ottawa Hospital; Jewish General Hospital; University of Ottawa; London Health Sciences Centre; McMaster University","funders":"","keywords":"Medicine; Randomized controlled trial; Physical therapy; Post-thrombotic syndrome; Quality of life (healthcare); Hamstring; Randomization; Aerobic exercise; Repeated measures design; Internal medicine; Venous thrombosis; Thrombosis","score_opus":0.029449962592294016,"score_gpt":0.2963356448075828,"score_spread":0.26688568221528874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586681626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9482609,0.0004344609,0.00002312458,0.0090906825,0.00029079273,0.036925085,0.000013288605,0.00017104708,0.0047906158],"genre_scores_gemma":[0.9916955,0.000048111724,0.00020039882,0.0019378399,0.00030878512,0.0047248127,0.000022227563,0.00003812472,0.0010241787],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99656254,0.000631222,0.0010904125,0.00044610602,0.0007172743,0.0005524286],"domain_scores_gemma":[0.9980133,0.00042517998,0.00031268908,0.0008678915,0.0001238871,0.00025705036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001693179,0.0004096767,0.0022868065,0.00014058467,0.00015743598,0.00010313638,0.00038224322,0.0000395197,0.00016119021],"category_scores_gemma":[0.00059155363,0.0001943037,0.0007720278,0.00031567842,0.00017783248,0.00008177654,0.00006923342,0.00020031758,0.00003200961],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96925956,0.014374734,0.0000059700037,0.000038350703,0.0007108606,0.00012590263,0.0010016429,0.000008800156,0.00034246486,0.000077001096,0.00032037415,0.013734343],"study_design_scores_gemma":[0.9639055,0.029628806,0.00028114056,0.00029285185,0.0048198667,0.00006349425,0.00036183014,0.00012927144,0.000044254382,0.00010016919,0.0001748353,0.00019798681],"about_ca_topic_score_codex":0.000049538412,"about_ca_topic_score_gemma":0.000012549394,"teacher_disagreement_score":0.04343462,"about_ca_system_score_codex":0.000041533876,"about_ca_system_score_gemma":0.00012574923,"threshold_uncertainty_score":0.7923475},"labels":[],"label_agreement":null},{"id":"W2586682261","doi":"10.1182/blood.v108.11.2672.2672","title":"Erythroid Response (ER) Rates in Myelodysplastic Syndromes (MDS) Patients Treated with Epoetin Alfa (EPO) or Darbepoetin Alfa (DARB) Using International Working Group Response Criteria (IWGc): Comparative Meta-Analysis.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Darbepoetin alfa; Medicine; Internal medicine; Epoetin alfa; Anemia; Meta-analysis; Myelodysplastic syndromes; Subgroup analysis; International Prognostic Scoring System","score_opus":0.08887509152284004,"score_gpt":0.3531866603420115,"score_spread":0.2643115688191715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586682261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99650437,0.00050993694,0.00022491388,0.00078333827,0.000069280184,0.0011738082,0.0001506265,0.00011389348,0.00046983015],"genre_scores_gemma":[0.99053,0.000015138761,0.0067408793,0.00018941195,0.00010832199,0.00016953688,0.00052010117,0.000098915945,0.0016276776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9928232,0.0023934527,0.0013222733,0.0011619929,0.0013692569,0.00092981197],"domain_scores_gemma":[0.9952246,0.0026772122,0.0005229849,0.0007797989,0.0005218787,0.00027352478],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023894438,0.0007121781,0.0021354465,0.0020303056,0.00022648198,0.00022073952,0.00047137245,0.000250731,0.00091133645],"category_scores_gemma":[0.0011320786,0.00050979713,0.0005212497,0.0030119678,0.0003785226,0.00029583828,0.0002378384,0.0007038732,0.000053990712],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24979779,0.008487874,0.52589035,0.00014494879,0.10890397,0.009492968,0.0023800493,0.0017720206,0.09105105,0.00006753264,0.0018902159,0.000121246194],"study_design_scores_gemma":[0.03176987,0.0035311729,0.84967667,0.00039963634,0.085934475,0.0010472834,0.0010586175,0.00822846,0.014928446,0.000049383012,0.0019228127,0.0014531713],"about_ca_topic_score_codex":0.0010421106,"about_ca_topic_score_gemma":0.00075194344,"teacher_disagreement_score":0.32378635,"about_ca_system_score_codex":0.0007293408,"about_ca_system_score_gemma":0.0006507058,"threshold_uncertainty_score":0.99973536},"labels":[],"label_agreement":null},{"id":"W2586695453","doi":"10.1182/blood.v118.21.4288.4288","title":"Unusual Response of Acute Monocytic Leukemia to Dandelion Root Extract","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Regional Hospital; University of Windsor; Western University","funders":"","keywords":"Bone marrow; Medicine; Pancytopenia; Acute leukemia; Population; Minimal residual disease; Leukemia; Pathology; Cytarabine; Internal medicine","score_opus":0.022296284528720515,"score_gpt":0.247199741403851,"score_spread":0.2249034568751305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586695453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930807,0.00021298899,0.00037645697,0.000024352687,0.001250434,0.00013164814,0.0000044856793,0.00005156428,0.004867381],"genre_scores_gemma":[0.98718154,0.000014475545,0.00010100361,0.00009059912,0.000014695435,0.000011550566,0.000021518912,0.000011964809,0.0125526255],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999225,0.00015351619,0.000249722,0.00017144028,0.000022995051,0.00017728434],"domain_scores_gemma":[0.999526,0.000058125093,0.000089336994,0.000241973,0.00006531094,0.00001920296],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00021601906,0.00010714306,0.00015859824,0.00015543267,0.000060928243,0.00000405631,0.00012179132,0.0001463327,0.0012973228],"category_scores_gemma":[0.00006264685,0.00009732899,0.00007849209,0.00011429001,0.00003909144,0.00009228556,0.000043694265,0.00016182555,0.0012156938],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004043933,0.00025794448,0.0006409824,0.0000038394173,0.00030034594,0.000006546122,0.0007573574,0.0000010238083,0.98953086,0.00007538303,0.003705547,0.0006762324],"study_design_scores_gemma":[0.0016137435,0.00088775443,0.03520183,0.000021208536,0.0001762883,0.00012556325,0.00014372196,0.0000017343197,0.9514429,0.000015310778,0.010258677,0.000111262794],"about_ca_topic_score_codex":0.00010667737,"about_ca_topic_score_gemma":0.0000056972754,"teacher_disagreement_score":0.03808796,"about_ca_system_score_codex":0.00004141041,"about_ca_system_score_gemma":0.00006726179,"threshold_uncertainty_score":0.9996156},"labels":[],"label_agreement":null},{"id":"W2586696194","doi":"10.1182/blood.v110.11.1350.1350","title":"Marrow-Derived Mesenchymal Stromal Cells Can Block an Antigen-Driven Humoral Response by Suppressing Plasma Cell Activity Via Production of CCL2.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Mesenchymal stem cell; Immune system; Ovalbumin; Immunology; Antigen; ELISPOT; Plasma cell; Biology; Antibody; Humoral immunity; T cell; Cell biology","score_opus":0.02032952720530818,"score_gpt":0.28478126540485965,"score_spread":0.2644517381995515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586696194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99734604,0.000082796636,0.00005697898,0.00030972756,0.0002673801,0.0009574241,0.0000405888,0.00009380945,0.0008452636],"genre_scores_gemma":[0.9953452,0.000014759458,0.0025507119,0.000017744527,0.0002233962,0.000011318866,0.000039494404,0.00007224441,0.0017251687],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9961457,0.00049535715,0.0005269222,0.0007724535,0.0011217322,0.0009378046],"domain_scores_gemma":[0.99784285,0.0002115995,0.00027531598,0.0007993216,0.00028718376,0.00058375427],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016170829,0.00034823033,0.0005856454,0.0003142281,0.00020572492,0.00003842522,0.00027660892,0.0002623671,0.00014488073],"category_scores_gemma":[0.00021199885,0.00033434236,0.00014386067,0.00045789406,0.00027957401,0.00021303646,0.00013613653,0.0005837874,0.000019359577],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004189406,0.002458701,0.019307002,0.00018557142,0.00007578206,0.0002770143,0.00074261037,0.000015164155,0.9714921,4.9628295e-7,0.0004317159,0.0008244004],"study_design_scores_gemma":[0.0032052782,0.0016553662,0.05891877,0.000077548444,0.00010952382,0.00017149429,0.0003026116,0.00027521088,0.9345766,0.000001967246,0.00043536318,0.00027029356],"about_ca_topic_score_codex":0.000331042,"about_ca_topic_score_gemma":0.00015348634,"teacher_disagreement_score":0.03961177,"about_ca_system_score_codex":0.00013473678,"about_ca_system_score_gemma":0.00039183107,"threshold_uncertainty_score":0.99991083},"labels":[],"label_agreement":null},{"id":"W2586708780","doi":"10.1182/blood.v120.21.1944.1944","title":"Higher Proportions of IFNg-Producing T Cells, CD56bright NK Cells and Immature B Cells in the Lymphocytes of G-CSF Stimulated Donor Grafts Are Associated with Less Chronic Gvhd After HSCT: Results From the Canadian BMT Group 0601 Randomized, Phase III Trial","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; Vancouver General Hospital; Princess Margaret Cancer Centre; Leukemia & Lymphoma Society of Canada; Queen Elizabeth II Health Sciences Centre; Child and Family Research Institute; Public Health Ontario; Hamilton Health Sciences; University of Toronto; BC Children's Hospital","funders":"","keywords":"Medicine; Immunology; Graft-versus-host disease; Bone marrow; Transplantation; Population; Internal medicine; Lymphocyte; Gastroenterology","score_opus":0.015045658908708775,"score_gpt":0.2377028714002232,"score_spread":0.22265721249151443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586708780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99289227,0.0013150183,0.000010509102,0.0003025401,0.00028796948,0.0033603339,0.0015385327,0.000022863993,0.00026996876],"genre_scores_gemma":[0.9984999,0.00009725673,0.00012235498,0.000113938135,0.00025561114,0.0001586383,0.0005936617,0.000040202136,0.000118447206],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99721915,0.00047959233,0.0009396583,0.0003883108,0.00048976234,0.0004835322],"domain_scores_gemma":[0.99707395,0.0014015932,0.0006134489,0.0005575192,0.00016814019,0.00018535851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014464012,0.00030775715,0.00090431544,0.00014379375,0.00012625966,0.00003488643,0.00017348003,0.00027103748,0.0001768313],"category_scores_gemma":[0.00013331424,0.00016839238,0.00013744144,0.00042340442,0.00019772995,0.00011663899,0.00001572618,0.0003199259,0.0000037724435],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.80875754,0.008130064,0.007550444,0.0012953589,0.0032304402,0.00058598106,0.049949862,0.00014928236,0.117399596,0.000065839784,0.002351011,0.0005345794],"study_design_scores_gemma":[0.78625935,0.00042063868,0.01198666,0.0013238303,0.0026043595,0.000017664519,0.0005072035,0.00007789326,0.19633809,0.000015164957,0.00016253337,0.00028662995],"about_ca_topic_score_codex":0.03471286,"about_ca_topic_score_gemma":0.052592333,"teacher_disagreement_score":0.07893849,"about_ca_system_score_codex":0.00015448061,"about_ca_system_score_gemma":0.0004698334,"threshold_uncertainty_score":0.9717151},"labels":[],"label_agreement":null},{"id":"W2586710373","doi":"10.1182/blood.v104.11.1724.1724","title":"Studies into the Mechanism by Which Glycosaminoglycans Potentiate Protein C Activation by Factor Xa.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Sulfation; Chemistry; Heparin; Glycosaminoglycan; Chondroitin sulfate; Biophysics; Phospholipid; Phosphatidylcholine; Biochemistry; Dextran; Biology; Membrane","score_opus":0.024028180317469016,"score_gpt":0.2757487387406322,"score_spread":0.2517205584231632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586710373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985031,0.00051907374,0.0050824555,0.007847246,0.00013698265,0.0010084718,0.00001721761,0.00016358944,0.00019398211],"genre_scores_gemma":[0.9968027,0.00007828515,0.0011419472,0.0009011089,0.00009362131,0.00013895953,0.000064281434,0.000037580467,0.0007415523],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986123,0.000054092834,0.00028501454,0.00033155328,0.00044792323,0.00026913217],"domain_scores_gemma":[0.99918604,0.00002555427,0.00013573187,0.00035938044,0.00020459881,0.000088697525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015856362,0.0002267049,0.0002958995,0.000057302932,0.00026094195,0.000037746348,0.00013247826,0.00013091428,0.00006448027],"category_scores_gemma":[0.00012730533,0.00015622303,0.00007767295,0.000307133,0.000042103406,0.00013500835,0.00005993391,0.00022250244,0.000054950273],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002935267,0.0006945562,0.000043020635,0.000051290655,0.0004186985,0.000002557043,0.0014803472,0.0000012306297,0.988175,0.007983433,0.00036632104,0.0007542145],"study_design_scores_gemma":[0.0042297575,0.0004124132,0.0003692644,0.00014151381,0.00024873027,0.0000097698685,0.0007269019,0.0000100139005,0.9813548,0.011369803,0.00093539257,0.00019165785],"about_ca_topic_score_codex":0.00009868486,"about_ca_topic_score_gemma":0.00003732872,"teacher_disagreement_score":0.011771682,"about_ca_system_score_codex":0.00006772626,"about_ca_system_score_gemma":0.00008580398,"threshold_uncertainty_score":0.63705903},"labels":[],"label_agreement":null},{"id":"W2586722062","doi":"10.1182/blood.v106.11.905.905","title":"Does Thromboprophylaxis Reduce Mortality in Medical Patients? A Systematic Review and Meta-Analysis of Randomized Cntrolled Tials.","year":2005,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Population Health Research Institute; McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Medicine; Fondaparinux; Randomized controlled trial; Placebo; Meta-analysis; Odds ratio; Anticoagulant; Internal medicine; Surgery; Intensive care medicine; Venous thromboembolism; Thrombosis","score_opus":0.04638966154816773,"score_gpt":0.3620098707002806,"score_spread":0.31562020915211286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586722062","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008151514,0.9845425,0.0000021044793,0.00020787222,0.00004835132,0.014682076,0.000096449876,0.000025650297,0.00031350477],"genre_scores_gemma":[0.000497039,0.9950014,0.00007445435,0.0004758789,0.0000447082,0.0035341426,0.00018450915,0.00004651565,0.00014136604],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.991527,0.001887678,0.00421239,0.0007499002,0.0012971228,0.0003259004],"domain_scores_gemma":[0.9955494,0.0008210452,0.0020127706,0.0011932268,0.00019280959,0.00023078822],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0051551447,0.0006751019,0.050253928,0.000737686,0.00003138559,0.000022359247,0.0003224785,0.00034148793,0.0016390699],"category_scores_gemma":[0.002898065,0.00029198127,0.0066736494,0.0012365566,0.00018233208,0.00004793675,0.00018061236,0.00034789403,0.000011404024],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037480273,0.0018884604,0.000003898224,0.60354894,0.39319873,0.000019248371,0.000030348865,4.3769973e-8,5.363506e-9,0.00005423148,0.000030182237,0.0011884284],"study_design_scores_gemma":[0.022496397,0.00006611777,0.000034392553,0.06696292,0.9084118,0.000003846796,0.0000045040215,0.000002186702,1.5474465e-7,0.0000078646535,0.0017593801,0.0002504371],"about_ca_topic_score_codex":0.00017530675,"about_ca_topic_score_gemma":0.000091264614,"teacher_disagreement_score":0.536586,"about_ca_system_score_codex":0.00005289316,"about_ca_system_score_gemma":0.0001918333,"threshold_uncertainty_score":0.9999532},"labels":[],"label_agreement":null},{"id":"W2586727891","doi":"10.1182/blood.v110.11.2999.2999","title":"Short and Long Term Efficacy of Autologous Bone Marrow Cells To Support Intensive Chemotherapy in Patients Failing Peripheral Blood Stem Cell Mobilization.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Etoposide; Bone marrow; Chemotherapy; Melphalan; Internal medicine; Stem cell; Surgery; CD34; Oncology; Progression-free survival; Urology; Biology","score_opus":0.010629464834721125,"score_gpt":0.2516239475364776,"score_spread":0.24099448270175647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586727891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980133,0.00009976492,0.00043140474,0.000032809592,0.00008324695,0.001075122,0.000009076871,0.000038751896,0.00021649306],"genre_scores_gemma":[0.99846447,0.000035455334,0.000997252,0.00024785727,0.000029038565,0.0000100367415,0.000047216054,0.00003865551,0.00013002867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984449,0.000027076603,0.00059097295,0.00034568796,0.00028219944,0.00030916877],"domain_scores_gemma":[0.99919605,0.00009230082,0.00008814508,0.0002364622,0.00021999369,0.00016706125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026023903,0.00019286443,0.00043030712,0.00019898839,0.000025247547,0.00001018611,0.000065221415,0.00013710312,0.00005233688],"category_scores_gemma":[0.000016258871,0.00018837639,0.000057021287,0.00023656269,0.000050093546,0.000051138348,0.000018774812,0.00012554374,0.0000049470896],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039620837,0.0015581223,0.8553619,0.00051835837,0.000060653732,0.0001987813,0.0045106555,0.000014945047,0.13333629,0.0000029922442,0.000009714552,0.004031394],"study_design_scores_gemma":[0.007160179,0.00069557125,0.61922807,0.00018812547,0.00016342907,0.00005632732,0.0003118331,0.00000913745,0.3720511,6.225967e-7,0.0000045193397,0.00013110039],"about_ca_topic_score_codex":0.00000758621,"about_ca_topic_score_gemma":0.000015617143,"teacher_disagreement_score":0.2387148,"about_ca_system_score_codex":0.000030144967,"about_ca_system_score_gemma":0.000046834277,"threshold_uncertainty_score":0.7681766},"labels":[],"label_agreement":null},{"id":"W2586746414","doi":"10.1182/blood.v106.11.1281.1281","title":"Use of Engineered Autologous BOEC for Gene Therapy of Canine Hemophilia A.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Ex vivo; Genetic enhancement; Therapeutic effect; Transfection; Andrology; In vivo; Internal medicine; Immunology; Gene; Biology; Genetics","score_opus":0.05060868693672383,"score_gpt":0.30457906687771485,"score_spread":0.25397037994099103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586746414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99685323,0.0012307619,0.000031107695,0.0010871359,0.000027217646,0.00055951346,0.000050406426,0.000026789514,0.00013386097],"genre_scores_gemma":[0.9886084,0.0004576525,0.008674934,0.00004854412,0.00015587224,0.000028736407,0.000044854787,0.000020236204,0.0019607765],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992561,0.0000123349455,0.00022269004,0.00013326458,0.00017635268,0.00019929769],"domain_scores_gemma":[0.9993837,0.000096492,0.000047095313,0.00025046294,0.00013957282,0.000082714556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008965326,0.000099433324,0.00030596278,0.00009941289,0.00001831775,0.00000256778,0.000058861326,0.00008108492,0.00007722951],"category_scores_gemma":[0.00007833987,0.00007132268,0.00011348355,0.00011483961,0.000052400213,0.000032036784,0.000012672244,0.00005876548,0.0000043991163],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067097176,0.003431567,0.028352326,0.00019028789,0.0008405472,0.00003754422,0.00038173236,0.000060009064,0.93641543,0.00016740311,0.0014523868,0.027999768],"study_design_scores_gemma":[0.0069541177,0.0012021555,0.02042014,0.000035292785,0.00010656405,0.00003415064,0.000008593582,0.00039670704,0.9650172,0.000018582024,0.0057297936,0.00007668686],"about_ca_topic_score_codex":0.0000418432,"about_ca_topic_score_gemma":0.0000072000266,"teacher_disagreement_score":0.02860176,"about_ca_system_score_codex":0.000015016833,"about_ca_system_score_gemma":0.00010263346,"threshold_uncertainty_score":0.29084542},"labels":[],"label_agreement":null},{"id":"W2586751572","doi":"10.1182/blood.v118.21.198.198","title":"Laboratory HIT Testing in Critically Ill Patients","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; St. Joseph's Hospital","funders":"","keywords":"Medicine; Thrombosis; Heparin; Heparin-induced thrombocytopenia; Deep vein; Critically ill; Low molecular weight heparin; Venous thrombosis; Complete blood count; Internal medicine; Surgery; Emergency medicine","score_opus":0.026710730312633414,"score_gpt":0.24287285896513627,"score_spread":0.21616212865250287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586751572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94532275,0.000066785185,0.000004998569,0.00014393544,0.00007528851,0.00023425426,0.0000038203984,0.00004885934,0.054099306],"genre_scores_gemma":[0.9918958,0.000011234509,0.003883614,0.0040658796,0.000051323943,0.000028895518,0.0000039684182,0.000016017872,0.000043248034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99931103,0.000017271444,0.00016975452,0.00015935214,0.00013379047,0.00020877701],"domain_scores_gemma":[0.99928534,0.000027101547,0.000024669087,0.00016712035,0.00041234825,0.00008342637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010087582,0.00007905248,0.00018785367,0.00007086928,0.000023435632,0.0000057336138,0.000055510824,0.000039575705,0.00014885687],"category_scores_gemma":[0.00084953336,0.00007276788,0.000021995085,0.00017036026,0.000024595505,0.00004414252,0.000044325297,0.00008188332,0.00008434945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009610576,0.0072362516,0.9857406,0.000114927956,0.000049219943,0.000152805,0.0006074093,1.0929213e-7,0.00044160246,0.0011447935,0.0014315112,0.0030711673],"study_design_scores_gemma":[0.0019341593,0.00034777235,0.99452186,0.00011492556,0.00011630898,0.000001107464,0.000093675975,0.0000034072875,0.0014991444,0.0001415185,0.0011380326,0.00008811346],"about_ca_topic_score_codex":0.00009760073,"about_ca_topic_score_gemma":0.000017242764,"teacher_disagreement_score":0.054056056,"about_ca_system_score_codex":0.000015965283,"about_ca_system_score_gemma":0.000032066655,"threshold_uncertainty_score":0.29673877},"labels":[],"label_agreement":null},{"id":"W2586756870","doi":"10.1182/blood.v118.21.985.985","title":"MARCKS Confers Resistance to Velcade Through Skp2/p27-Mediated Pathway in Multiple Myeloma","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"MARCKS; Cell culture; Cancer research; Apoptosis; Proteasome; Chemistry; Bortezomib; Viability assay; Drug resistance; Multiple myeloma; Protein kinase C; Medicine; Biology; Kinase; Biochemistry; Immunology","score_opus":0.027646679448843005,"score_gpt":0.2292441863531458,"score_spread":0.2015975069043028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586756870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97698826,0.00062660646,0.00020562176,0.00009588544,0.00009467508,0.0003971002,0.000108338005,0.000031782864,0.021451715],"genre_scores_gemma":[0.99496126,0.000059066308,0.0032773006,0.000659424,0.00011711823,0.00010976076,0.000100045654,0.00003152272,0.00068449334],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987624,0.00007568522,0.00023533775,0.00042117725,0.00012391372,0.00038143824],"domain_scores_gemma":[0.99936336,0.00001792438,0.000058947688,0.00038763997,0.000052325275,0.00011978452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001665799,0.00018330303,0.00017001058,0.000042755768,0.000054228643,0.0000129240325,0.00026644603,0.00020219905,0.00007616264],"category_scores_gemma":[0.00021599207,0.0001855967,0.000064707456,0.00014200043,0.000060764745,0.000005079902,0.00012129945,0.00012705933,0.00009748386],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028780414,0.00038764052,0.017231435,0.00003979942,0.00005061446,0.000060284587,0.0011552874,8.841224e-7,0.97897404,0.00035805622,0.000865969,0.0005881963],"study_design_scores_gemma":[0.0016896573,0.000208303,0.014431153,0.00003542382,0.0000075006824,0.0000058821374,0.00012815316,0.0000012590324,0.9250137,0.00018213819,0.05803192,0.00026490272],"about_ca_topic_score_codex":0.00006573752,"about_ca_topic_score_gemma":0.00048255472,"teacher_disagreement_score":0.05716595,"about_ca_system_score_codex":0.000009003814,"about_ca_system_score_gemma":0.00008058296,"threshold_uncertainty_score":0.75684136},"labels":[],"label_agreement":null},{"id":"W2586788951","doi":"10.1182/blood.v110.11.5142.5142","title":"Mesenchymal Stromal Cells Engineered To Express IL-12 for Breast Cancer Cellular Immunotherapy.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Université de Montréal; McGill University","funders":"","keywords":"Mesenchymal stem cell; Matrigel; Cancer research; Breast cancer; Medicine; Stromal cell; Immunotherapy; Bone marrow; Immune system; Cancer; Cell therapy; Cytokine; Cancer immunotherapy; Cancer cell; Immunology; Angiogenesis; Biology; Stem cell; Pathology; Internal medicine; Cell biology","score_opus":0.018870345575374783,"score_gpt":0.2922493576446257,"score_spread":0.2733790120692509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586788951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98650354,0.0007012071,0.007188289,0.0005289351,0.00034823388,0.0018557415,0.00030406818,0.00010903777,0.0024609682],"genre_scores_gemma":[0.98551995,0.000042418284,0.005512504,0.00020769722,0.0010134302,0.00017742308,0.00002042812,0.00009610293,0.007410021],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99738055,0.00003349807,0.0004084481,0.00048684617,0.00069498015,0.0009956699],"domain_scores_gemma":[0.9983888,0.00017487427,0.000060136183,0.0005660253,0.00024080677,0.0005693213],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00073721405,0.0002799485,0.00043279058,0.00023118475,0.000101466714,0.000037942857,0.00028215296,0.00017655599,0.0011210509],"category_scores_gemma":[0.000045559816,0.00024859884,0.00019603646,0.00028545552,0.000046948622,0.00006526707,0.00007573184,0.00026070364,0.000083640276],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080979924,0.00050131633,0.0031621733,0.00017990655,0.00020508292,0.00012641409,0.00034651562,0.00002009388,0.98739415,0.000050850864,0.00113756,0.0060661323],"study_design_scores_gemma":[0.0065904385,0.00064446934,0.022023197,0.00013391333,0.000118475175,0.000077811485,0.00016148045,0.00009737092,0.94893503,0.000008038854,0.020885361,0.0003243949],"about_ca_topic_score_codex":0.0001881133,"about_ca_topic_score_gemma":0.000031484004,"teacher_disagreement_score":0.038459107,"about_ca_system_score_codex":0.000094869836,"about_ca_system_score_gemma":0.00016755667,"threshold_uncertainty_score":0.9999966},"labels":[],"label_agreement":null},{"id":"W2586805308","doi":"10.1182/blood.v118.21.1179.1179","title":"Inhibition of Red Blood Cell-Prothrombinase by Heparin and a Covalent Antithrombin-Heparin Complex","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Prothrombinase; Heparin; Phosphatidylserine; Chemistry; Thrombin; Antithrombin; Pharmacology; Anticoagulant; Discovery and development of direct thrombin inhibitors; Immunology; Biochemistry; Internal medicine; Platelet; Medicine; Phospholipid; Membrane","score_opus":0.035146399189708855,"score_gpt":0.24244559415372557,"score_spread":0.20729919496401672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586805308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888288,0.00032628395,0.00003305598,0.000065607645,0.00008525674,0.00046394631,0.00003098232,0.00006921605,0.010096897],"genre_scores_gemma":[0.99740446,0.0003437906,0.0013550358,0.00026675555,0.00004336395,0.00002562549,0.0001237239,0.000024328669,0.00041293682],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99888283,0.0000683204,0.00034079043,0.00033034882,0.00015464191,0.00022303993],"domain_scores_gemma":[0.99926466,0.000023149112,0.00015318934,0.00030391425,0.00010997398,0.00014512277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011411289,0.00017598452,0.00042932483,0.00008903581,0.00006072634,0.0000048517063,0.000044316894,0.00013630763,0.0006230167],"category_scores_gemma":[0.00003104379,0.00016441965,0.000072159164,0.0001710637,0.00019285841,0.000053873173,0.00006118071,0.00015238496,0.000030822877],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026012835,0.0038514202,0.023263216,0.00031141302,0.00010794087,0.000056637924,0.0003594399,5.1548515e-8,0.96809715,0.00019932285,0.0033864987,0.000106767126],"study_design_scores_gemma":[0.012872043,0.0032054451,0.11828775,0.0001154254,0.00059183186,0.00023098131,0.00015406653,0.00001947776,0.8632409,0.00030047988,0.0007584596,0.00022314563],"about_ca_topic_score_codex":0.00019427962,"about_ca_topic_score_gemma":0.00001228333,"teacher_disagreement_score":0.10485627,"about_ca_system_score_codex":0.000008020589,"about_ca_system_score_gemma":0.000047726196,"threshold_uncertainty_score":0.68215954},"labels":[],"label_agreement":null},{"id":"W2586817637","doi":"10.1182/blood.v106.11.4263.4263","title":"Pegfilgrastim and Daily Granulocyte Colony-Stimulating Factor (G-CSF) Patterns of Use and Neutropenia-Related Outcomes in Cancer Patients in Spain: Results of the Learn Study.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Berger (Canada)","funders":"","keywords":"Pegfilgrastim; Medicine; Filgrastim; Febrile neutropenia; Neutropenia; Internal medicine; Granulocyte colony-stimulating factor; Chemotherapy; Surgery","score_opus":0.02346058810496125,"score_gpt":0.28536948743004065,"score_spread":0.2619088993250794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586817637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985786,0.000058091566,2.8605862e-7,0.0002642061,0.000057799007,0.0008852319,0.000094838964,0.00000967853,0.000051238247],"genre_scores_gemma":[0.99964136,0.000059677717,0.000016587459,0.000056991925,0.000013399887,0.000027512164,0.000004516323,0.00001560394,0.00016436458],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988123,0.000100935424,0.0004970124,0.00023372103,0.00019009352,0.00016589857],"domain_scores_gemma":[0.9993463,0.00014090957,0.00018232496,0.00019909468,0.00008008654,0.00005125808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011176337,0.00013733849,0.00039523927,0.000117055286,0.00004090506,0.000012233879,0.000061080194,0.000058633825,0.000016520415],"category_scores_gemma":[0.00014124397,0.00009613774,0.00004048946,0.00021698402,0.000054540975,0.00011573878,0.00008081337,0.00022597556,4.3505818e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020239704,0.0012215358,0.99449813,0.00004269763,0.000061916006,0.0000045957145,0.0016601944,0.00016753463,0.0012887825,0.0000018049226,0.0000042217903,0.0008461801],"study_design_scores_gemma":[0.01696616,0.00054646004,0.9807738,0.00019534139,0.00012407321,0.0000024790013,0.00013779015,0.00006104924,0.001080147,0.0000012959748,0.000026567417,0.00008482328],"about_ca_topic_score_codex":0.005957381,"about_ca_topic_score_gemma":0.01384011,"teacher_disagreement_score":0.016763764,"about_ca_system_score_codex":0.00003675926,"about_ca_system_score_gemma":0.00004412743,"threshold_uncertainty_score":0.9005818},"labels":[],"label_agreement":null},{"id":"W2586822406","doi":"10.1182/blood.v116.21.3794.3794","title":"Neutropenia In Infants with Hemolytic Disease of the Newborn.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Medicine; Neutropenia; Pediatrics; Anemia; Gestational age; Hematology; Hydrops fetalis; Pregnancy; Internal medicine; Gestation; Chemotherapy","score_opus":0.0022659144491620565,"score_gpt":0.18948340658795354,"score_spread":0.1872174921387915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586822406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983369,0.00018821917,0.0000028490372,0.00009021381,0.000038382204,0.00013587321,0.00001063688,0.0000021483168,0.0011947594],"genre_scores_gemma":[0.9995282,0.000012269439,0.00017040384,0.000085089916,0.000024988576,0.000012142138,0.0000093977405,0.000009347874,0.00014814883],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996078,0.000011787704,0.00007526834,0.0001379724,0.00006183554,0.000105347324],"domain_scores_gemma":[0.99957514,0.0000025735258,0.00003594393,0.00032416242,0.000017285864,0.000044875964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000021686872,0.00007330616,0.00006675338,0.000011622893,0.000021192745,0.0000053973386,0.00013024596,0.00003928798,0.000008999056],"category_scores_gemma":[0.00001720026,0.000044401764,0.000033495857,0.000066384324,0.00005433594,0.0000015654313,0.000054807755,0.0000567317,0.0000018743578],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000108619846,0.000870632,0.87711257,0.000010860894,0.000055878845,0.000009544262,0.000017104143,0.000008758312,0.12054852,0.000066555025,0.000058496596,0.0011324523],"study_design_scores_gemma":[0.0048095593,0.00016350871,0.7366922,0.000017869743,0.00010064242,0.000010002135,0.000013099931,0.0000053899257,0.25609925,0.00010702409,0.0018599672,0.00012149529],"about_ca_topic_score_codex":0.000039559956,"about_ca_topic_score_gemma":0.00050884706,"teacher_disagreement_score":0.14042039,"about_ca_system_score_codex":6.428744e-7,"about_ca_system_score_gemma":0.000065145854,"threshold_uncertainty_score":0.18106514},"labels":[],"label_agreement":null},{"id":"W2586836514","doi":"10.1182/blood.v108.11.4941.4941","title":"Cytogenetic Aberrations and Ig VH Gene Mutations of Clinically Benign CD5-Monoclonal B-Cell Lymphocytosis (MLUS).","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Lymphocytosis; Biology; CD5; Isochromosome; Chromosome abnormality; Population; Gene rearrangement; Immunology; Lymphocyte; Karyotype; Genetics; Chromosome; Lymphoma; Gene; Medicine","score_opus":0.015142396905851223,"score_gpt":0.27926449262207836,"score_spread":0.26412209571622713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586836514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899593,0.0013666775,0.00031090394,0.00023271979,0.000046514462,0.00046205684,0.000057752077,0.0000469293,0.0075171664],"genre_scores_gemma":[0.9855168,0.00021164877,0.012105322,0.00010810018,0.00024202908,0.00005489376,0.00012823711,0.000037292135,0.00159568],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979234,0.000067616886,0.0007565859,0.00039640645,0.00049277954,0.00036325373],"domain_scores_gemma":[0.99858385,0.00035840107,0.00015864149,0.00047058304,0.00022544869,0.00020305092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030873256,0.0001792376,0.000377009,0.00016029112,0.00011841166,0.000025323165,0.00013490093,0.00016687236,0.00013614245],"category_scores_gemma":[0.00017220191,0.00017042912,0.00013665977,0.00031651484,0.0002817928,0.000051107058,0.00009072285,0.00014280144,0.00005252862],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000989141,0.01726443,0.09187824,0.0013231526,0.0012062936,0.00087039167,0.0015158011,0.0012393217,0.86877084,0.0021464438,0.0051562553,0.0076396666],"study_design_scores_gemma":[0.17437139,0.0023779098,0.072556,0.00025602162,0.0026615486,0.002537638,0.00033466818,0.010787216,0.7284588,0.0022233017,0.002530276,0.000905235],"about_ca_topic_score_codex":0.0008229658,"about_ca_topic_score_gemma":0.00010533268,"teacher_disagreement_score":0.17338225,"about_ca_system_score_codex":0.00074889534,"about_ca_system_score_gemma":0.00458156,"threshold_uncertainty_score":0.812749},"labels":[],"label_agreement":null},{"id":"W2586848871","doi":"10.1182/blood.v112.11.3733.3733","title":"Expression of Leukemogenic Ptpn11 Causes a Fatal Myeloproliferative Disorder by Affecting Multiple Stages of Hematopoiesis","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Biology; Haematopoiesis; Myeloid; Progenitor cell; PTPN11; Megakaryocyte; Cancer research; Juvenile myelomonocytic leukemia; Bone marrow; Stem cell; Protein tyrosine phosphatase; Immunology; Molecular biology; Cell biology; Signal transduction","score_opus":0.008687464138152842,"score_gpt":0.22696533088002147,"score_spread":0.2182778667418686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586848871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98438424,0.014515275,0.0004857184,0.000009270594,0.000020168884,0.00024089277,0.0003091746,0.000011554113,0.000023721277],"genre_scores_gemma":[0.9978322,0.00024539212,0.0015868199,0.000012655468,0.00003424664,0.00003315814,0.00017330096,0.00002124931,0.000060997074],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99914837,0.000052133615,0.00023576588,0.00025235533,0.00014124604,0.00017013549],"domain_scores_gemma":[0.9993686,0.00003509697,0.00017856955,0.00029483228,0.00007987779,0.000043037024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006368802,0.00014915176,0.00021781986,0.00002728395,0.00007525602,0.0000035389812,0.00014489898,0.000091279886,0.000012362041],"category_scores_gemma":[0.0003201981,0.00013483403,0.00008590389,0.000076499535,0.00013127034,0.0000072369903,0.00015429895,0.000050738214,0.0000011027494],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057309437,0.00030451646,0.063684024,0.0000700679,0.000060811348,0.0000033336626,0.00015057456,0.000010079217,0.9350773,0.000007646179,0.0005052617,0.00006907109],"study_design_scores_gemma":[0.0013926065,0.00025728982,0.0027813523,0.000044208362,0.000027838349,0.000022932643,0.0001273655,0.000002072968,0.99502295,0.000006634445,0.00017314503,0.00014158779],"about_ca_topic_score_codex":0.00009038581,"about_ca_topic_score_gemma":0.000026830043,"teacher_disagreement_score":0.06090267,"about_ca_system_score_codex":0.000003849257,"about_ca_system_score_gemma":0.00006192016,"threshold_uncertainty_score":0.5498372},"labels":[],"label_agreement":null},{"id":"W2586851400","doi":"10.1182/blood.v120.21.1401.1401","title":"Clonal Evolution Predicts Poor Prognosis in Chronic Lymphocytic Leukaemia and Is Possibly a Worse Prognostic Factor Than 17p Deletion: A Population Based Cohort study of FISH Testing in British Columbia, Canada","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Royal Columbian Hospital; St. Paul's Hospital; Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Population; Incidence (geometry); Oncology; Cohort; Chronic lymphocytic leukemia; Trisomy; Leukemia; Biology; Genetics","score_opus":0.01701396843390706,"score_gpt":0.24913012061049616,"score_spread":0.2321161521765891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586851400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99578476,0.0005622882,0.0000022598697,0.000031026957,0.000063776824,0.0034260366,0.00006638744,0.0000396324,0.000023855242],"genre_scores_gemma":[0.99902695,0.000008377176,0.00013805105,0.00005625537,0.00014966982,0.00045491094,0.000080881546,0.00004004915,0.000044865377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969042,0.0001736191,0.00069526717,0.00048765546,0.0010126536,0.0007266013],"domain_scores_gemma":[0.998751,0.00032794083,0.00019070032,0.00024075725,0.00020401501,0.00028561993],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005113367,0.00018826575,0.0005148475,0.00019137343,0.00008814139,0.00006580139,0.000116729934,0.00016212724,0.0000515309],"category_scores_gemma":[0.0010534781,0.00026608186,0.00003961846,0.0009803236,0.00006326544,0.00020516386,0.000082457474,0.00026502085,9.555872e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000055179284,0.0012707707,0.99653476,0.00056873565,0.00007192973,0.000214008,0.00021447221,0.000046760877,0.00012637762,1.7005242e-7,0.000087352164,0.0008094833],"study_design_scores_gemma":[0.031030148,0.0007232451,0.94711024,0.00121345,0.00020537205,0.00035642096,0.00020790439,0.018836876,0.00010300816,0.0000029269434,0.0000040707973,0.00020631841],"about_ca_topic_score_codex":0.9628442,"about_ca_topic_score_gemma":0.98113847,"teacher_disagreement_score":0.049424503,"about_ca_system_score_codex":0.03658579,"about_ca_system_score_gemma":0.026236834,"threshold_uncertainty_score":0.99997914},"labels":[],"label_agreement":null},{"id":"W2586859590","doi":"10.1182/blood.v114.22.31.31","title":"Novel Mechanistic Insight Into Mobilization of Hematopoietic Stem/Progenitor Cells (HSPCs): Complement Cascade and Membrane Attack Complex Activated in Bone Marrow Sinusoids During Mobilization Release From Erythrocytes Sphingosine-1 Phosphate – An Underappreciated Chemoattractant Executing Egress of HSPCs.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Haematopoiesis; Bone marrow; Progenitor cell; Complement membrane attack complex; Cell biology; Chemistry; Myelopoiesis; Complement system; Stem cell; Immunology; Biology; Antibody","score_opus":0.029285212486600824,"score_gpt":0.2671580597054164,"score_spread":0.23787284721881558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586859590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973479,0.0005769618,0.0007856307,0.000054192657,0.00010004996,0.00096959143,0.000048770573,0.000083829604,0.000033071698],"genre_scores_gemma":[0.99692005,0.00022344799,0.0021432433,0.00010464063,0.00006590836,0.0000202676,0.00046198463,0.000045559347,0.0000149051375],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99762815,0.00012380107,0.0010103905,0.0005757279,0.00034135795,0.00032056827],"domain_scores_gemma":[0.9984588,0.00012477109,0.0005741692,0.00040609096,0.0002621645,0.00017398849],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018194277,0.00035076,0.0008751404,0.0002443684,0.000113138005,0.00002014841,0.00010952533,0.00021560756,0.000086472966],"category_scores_gemma":[0.000051813575,0.00034316967,0.000078483325,0.0005327766,0.000100804056,0.00016245712,0.000050939652,0.0002139555,0.00000141593],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009513142,0.0027599998,0.0010096207,0.00071257463,0.00010002744,0.00003577569,0.0017025744,0.0006624298,0.99162424,0.00005364326,0.0000042098823,0.00038357478],"study_design_scores_gemma":[0.008697962,0.00082750403,0.019438984,0.0006380788,0.00026467824,0.000071347065,0.00080691127,0.008896443,0.9600181,0.000043443863,0.000011042621,0.00028549542],"about_ca_topic_score_codex":0.00026901724,"about_ca_topic_score_gemma":0.00007397648,"teacher_disagreement_score":0.031606145,"about_ca_system_score_codex":0.00009720165,"about_ca_system_score_gemma":0.000086582564,"threshold_uncertainty_score":0.999902},"labels":[],"label_agreement":null},{"id":"W2586860593","doi":"10.1182/blood.v116.21.sci-9.sci-9","title":"Genetic Characterization of Hemophilia and Implications for Novel Therapies","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Factor IX; Clotting factor; Recombinant DNA; Medicine; Mutation; Coagulation; Computational biology; Genetics; Biology; Immunology; Gene; Internal medicine","score_opus":0.025811246925291898,"score_gpt":0.3005254604293324,"score_spread":0.2747142135040405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586860593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968762,0.000053143747,0.00018157014,0.0022934885,0.000020360598,0.0003839772,0.0000363157,0.000011195699,0.00014376173],"genre_scores_gemma":[0.99602747,0.0001028943,0.0033125333,0.00003073128,0.00009314676,0.000050990886,0.000038030386,0.000008141224,0.00033603894],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99971503,0.000002182446,0.00008005359,0.00008547006,0.000042742176,0.00007454466],"domain_scores_gemma":[0.9997105,0.000025508962,0.000022361473,0.00012721488,0.00007212852,0.00004228581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000036478807,0.00004160256,0.00008357799,0.000039348703,0.000035032786,0.000004752245,0.000024109157,0.000040854058,0.00001590389],"category_scores_gemma":[0.000024907335,0.000030649862,0.000023501616,0.000049098602,0.000046177247,0.000016734391,0.000008557555,0.000038506354,0.0000011525037],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011302005,0.00029195828,0.12890454,0.000038192717,0.000035908073,1.4818906e-7,0.000070766924,3.054395e-9,0.86453164,0.0004476617,0.0000027155518,0.0056651803],"study_design_scores_gemma":[0.0016452089,0.00013700263,0.8916916,0.000007925612,0.00006590923,0.00002160589,0.0000047956028,0.000012418026,0.105363116,0.00018984315,0.00083172927,0.000028801685],"about_ca_topic_score_codex":0.000001862081,"about_ca_topic_score_gemma":0.0000017036991,"teacher_disagreement_score":0.7627871,"about_ca_system_score_codex":0.0000013486175,"about_ca_system_score_gemma":0.000028087563,"threshold_uncertainty_score":0.12498651},"labels":[],"label_agreement":null},{"id":"W2586868361","doi":"10.1182/blood.v106.11.100.100","title":"The AML1-ETO Fusion Gene and the FLT3 Length Mutation Collaborate in Inducing Acute Leukemia in a Murine Bone Marrow Transplantation Model.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Leukemia; Bone marrow; Fusion gene; Cancer research; RUNX1; Biology; Acute leukemia; Neuroblastoma RAS viral oncogene homolog; Transplantation; Mutation; Immunology; Phenotype; Point mutation; Haematopoiesis; Gene; Stem cell; Medicine; Genetics; Internal medicine","score_opus":0.010308944083696679,"score_gpt":0.261547095882428,"score_spread":0.2512381517987313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586868361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922906,0.00093456835,0.0001401255,0.0049965633,0.000023614866,0.0010044543,0.000015937838,0.000029427078,0.0005646894],"genre_scores_gemma":[0.99288094,0.00443771,0.001651391,0.00030108303,0.000118911004,0.000136148,0.000057481688,0.00002898205,0.00038734623],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99836123,0.00018848795,0.0004108786,0.00029971736,0.00037863938,0.00036102335],"domain_scores_gemma":[0.99922156,0.00023602342,0.00008729228,0.00027521397,0.000099299235,0.000080627375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011976188,0.00016706345,0.00027234093,0.00020233227,0.00016168869,0.000050911618,0.00011864445,0.000126936,0.000006706994],"category_scores_gemma":[0.00011294921,0.00010409442,0.000033872988,0.00064185535,0.00013256748,0.00017587295,0.00004672443,0.00050617295,0.0000090362955],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018858407,0.00086732674,0.0133112455,0.00054615556,0.0005773113,0.002924416,0.041618593,0.034913883,0.80067605,0.002219026,0.0007519646,0.0827356],"study_design_scores_gemma":[0.09887665,0.00042154713,0.048924178,0.00046602596,0.0006874562,0.0014397777,0.0015869841,0.68347037,0.16230404,0.00093859195,0.0003501258,0.0005342861],"about_ca_topic_score_codex":0.0003988455,"about_ca_topic_score_gemma":0.0019072761,"teacher_disagreement_score":0.6485565,"about_ca_system_score_codex":0.000470791,"about_ca_system_score_gemma":0.0005699958,"threshold_uncertainty_score":0.42448473},"labels":[],"label_agreement":null},{"id":"W2586876045","doi":"10.1182/blood.v108.11.376.376","title":"Uniform Approach Better Defines Natural History of Transient Myeloproliferative Disorder (TMD) in Down Syndrome (DS) Neonates: Outcomes from Children’ Oncology Group (COG) Study A2971.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Organomegaly; Internal medicine; Gastroenterology; Pediatrics; Surgery; Polyneuropathy","score_opus":0.01315323781331471,"score_gpt":0.2502322310022915,"score_spread":0.23707899318897682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586876045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914569,0.002624567,0.000037671063,0.0008821298,0.00015245186,0.0022709589,0.000059650032,0.00007262924,0.002443036],"genre_scores_gemma":[0.9955824,0.000026178774,0.002351986,0.00042410474,0.00010791176,0.00027660778,0.0004358573,0.000060781957,0.0007341619],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996992,0.00023457872,0.0008039349,0.00068831776,0.0006740018,0.0006071955],"domain_scores_gemma":[0.9987902,0.00024506156,0.00017170509,0.00053703244,0.00013132844,0.00012467508],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036161582,0.00042089762,0.0011308345,0.0004772914,0.000053170992,0.000011062574,0.0003384557,0.00025937945,0.00013580015],"category_scores_gemma":[0.000074240634,0.0003234902,0.00019775562,0.00038198134,0.00028664828,0.00015374857,0.00012082295,0.00091939484,0.000017778506],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005035544,0.011392031,0.97838295,0.000079272344,0.0009729262,0.00044895895,0.0040749377,0.000021017502,0.0013375062,0.000067226545,0.00082530663,0.0018943156],"study_design_scores_gemma":[0.020539617,0.0014086356,0.9751415,0.000043737404,0.0005067214,0.00018796555,0.0008151874,0.00016229914,0.000091394926,0.00006377631,0.0007238302,0.00031529288],"about_ca_topic_score_codex":0.0071207895,"about_ca_topic_score_gemma":0.0019120537,"teacher_disagreement_score":0.020036064,"about_ca_system_score_codex":0.0007890188,"about_ca_system_score_gemma":0.00045319553,"threshold_uncertainty_score":0.99992174},"labels":[],"label_agreement":null},{"id":"W2586880825","doi":"10.1182/blood.v108.11.964.964","title":"Efficacy of Prothrombin Complex Concentrate (PCC) for Reversal of Warfarin Effect.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Traumatic Brain Injury and Neurovascular Disturbances","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Fresh frozen plasma; Warfarin; Prothrombin complex concentrate; Blood product; Clotting factor; Anesthesia; Surgery; PROTHROMBIN COMPLEX; Vitamin; Internal medicine; Coagulation; Atrial fibrillation; Platelet","score_opus":0.023293374008504057,"score_gpt":0.2753357893099551,"score_spread":0.25204241530145105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586880825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99638385,0.00024393163,0.0001353968,0.00009428562,0.0000547543,0.0014731426,0.000027378086,0.000029190038,0.0015580847],"genre_scores_gemma":[0.99822134,0.000004701515,0.0014630053,0.000032472133,0.00006615234,0.000041978376,0.000039755272,0.000013852164,0.0001167336],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99914104,0.00004786915,0.00032208665,0.00016856073,0.00016676799,0.00015367105],"domain_scores_gemma":[0.99929976,0.000235723,0.00014027176,0.00023588142,0.000054058568,0.00003428756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018407746,0.00010639712,0.00041583896,0.000029606152,0.000024485375,0.0000031067027,0.0000758075,0.00004991049,0.000037528946],"category_scores_gemma":[0.00010212948,0.00008571897,0.00018577965,0.000096667194,0.00013873728,0.00002355767,0.00001187003,0.00005833886,0.00000239733],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023989333,0.0061037396,0.05495305,0.0054976325,0.00084753195,0.00002255133,0.0003227505,0.000013588859,0.9128805,0.008516028,0.0043575843,0.0040861424],"study_design_scores_gemma":[0.017829983,0.0015792402,0.27265325,0.00021857911,0.000546691,0.00002200876,0.000011377647,0.000029061843,0.70563483,0.00019609995,0.0011856861,0.00009319476],"about_ca_topic_score_codex":0.000038792947,"about_ca_topic_score_gemma":0.0000032459436,"teacher_disagreement_score":0.2177002,"about_ca_system_score_codex":0.0000049339064,"about_ca_system_score_gemma":0.000033766846,"threshold_uncertainty_score":0.34955186},"labels":[],"label_agreement":null},{"id":"W2586952446","doi":"10.1182/blood.v118.21.4842.4842","title":"The Effect of Comprehensive Care on Maternal and Fetal Outcomes in Sickle Cell Disease Pregnancies","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Mount Sinai Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Placental abruption; Premature rupture of membranes; Obstetrics; Intrauterine growth restriction; Pregnancy; Population; Gestational age; Low birth weight; Oligohydramnios; Small for gestational age; Pediatrics; Eclampsia; Placenta previa; Prenatal care; Fetus; Placenta","score_opus":0.00636405686477706,"score_gpt":0.21309564361238767,"score_spread":0.2067315867476106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586952446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920522,0.005296114,1.8767003e-7,0.000042084917,0.000055448218,0.00029464718,0.000007748513,0.000011444286,0.002240114],"genre_scores_gemma":[0.99955,0.00023154421,0.000011768859,0.000029893241,0.000006259388,0.000009847334,0.0000018958847,0.000008154196,0.00015066093],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99954563,0.000033360302,0.00010822413,0.0000956599,0.000096466116,0.000120641016],"domain_scores_gemma":[0.99968415,0.00006430616,0.00003361683,0.00013384869,0.00001917844,0.00006490005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000025704903,0.000088212844,0.00017026765,0.000026910237,0.000037618367,0.000003922677,0.000039848925,0.000037163718,0.000006798561],"category_scores_gemma":[0.000016120346,0.000045767258,0.00005007272,0.00003328825,0.00008819879,0.000013057432,0.000025956253,0.00008963159,0.0000054747657],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034295343,0.00014029385,0.99560016,0.00033700877,0.000044047127,0.0001001091,0.0010674328,0.0000013311711,0.00044124445,0.000023764667,0.000011854226,0.0018898143],"study_design_scores_gemma":[0.0050899074,0.0010327998,0.9573059,0.00025694421,0.00019271106,0.00000624286,0.000787274,0.0000059556637,0.035157114,0.00001412336,0.00008592904,0.00006510849],"about_ca_topic_score_codex":0.00007510603,"about_ca_topic_score_gemma":0.000008329569,"teacher_disagreement_score":0.038294256,"about_ca_system_score_codex":0.0000052063733,"about_ca_system_score_gemma":0.00001581863,"threshold_uncertainty_score":0.18663345},"labels":[],"label_agreement":null},{"id":"W2586953518","doi":"10.1182/blood.v118.21.2274.2274","title":"Dysregulation of C10orf55 Expression in Megakaryocytic Cell Lineage From Quebec Platelet Disorder Individuals","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Hospital for Sick Children; McMaster University","funders":"","keywords":"Biology; Platelet; Platelet disorder; Gene; Molecular biology; Immunology; Genetics","score_opus":0.014996800304488871,"score_gpt":0.2264282365835639,"score_spread":0.211431436279075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586953518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958245,0.00090240873,0.00004346542,0.000018825172,0.000044066725,0.0003490623,0.000044059674,0.000029755662,0.0027438235],"genre_scores_gemma":[0.99707425,0.00006358559,0.00217338,0.000037640842,0.00002471449,0.000019455512,0.00023072079,0.000022408472,0.0003538312],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990012,0.000035119843,0.00033258615,0.00024081203,0.00020034463,0.00018993203],"domain_scores_gemma":[0.9994564,0.00004726277,0.00013018679,0.0002673893,0.00002709647,0.00007166647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006679963,0.00015682407,0.00036488508,0.00013444884,0.000023373916,0.0000052893947,0.000075314434,0.00014121382,0.00027866606],"category_scores_gemma":[0.000021900305,0.00012840067,0.00006636938,0.00014873226,0.00003405804,0.000108307344,0.00003888162,0.00010844506,0.00003304734],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002809358,0.007746068,0.9480074,0.00011453333,0.00018604987,0.00051392586,0.004227531,0.00000928925,0.03521941,0.000027164138,0.00015526752,0.0035124354],"study_design_scores_gemma":[0.011802462,0.00021588619,0.58139193,0.00019093964,0.00018049234,0.000008911391,0.00020019442,0.000057170066,0.4053165,0.0003169346,0.00017504343,0.00014353606],"about_ca_topic_score_codex":0.005057449,"about_ca_topic_score_gemma":0.0011378751,"teacher_disagreement_score":0.3700971,"about_ca_system_score_codex":0.000019089384,"about_ca_system_score_gemma":0.00005709401,"threshold_uncertainty_score":0.7645384},"labels":[],"label_agreement":null},{"id":"W2586955463","doi":"10.1182/blood.v112.11.3233.3233","title":"Nilotinib in Elderly Chronic Myeloid Leukemia Patients in Chronic Phase (CML-CP) with Imatinib Resistance or Intolerance: Efficacy and Safety Analysis","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Nilotinib; Medicine; Discontinuation; Internal medicine; Imatinib; Adverse effect; Myeloid leukemia; Gastroenterology","score_opus":0.01335522527399351,"score_gpt":0.27032661347821196,"score_spread":0.25697138820421844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586955463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99439096,0.0028888725,0.0000366061,0.00009185922,0.000034911893,0.0014341963,0.00005587866,0.000085946296,0.000980761],"genre_scores_gemma":[0.99553776,0.0017663654,0.0011443929,0.00007075357,0.00012465662,0.00014232966,0.0002791733,0.00006813374,0.0008664373],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966103,0.00012122637,0.00093256484,0.0009466142,0.00059569685,0.00079361035],"domain_scores_gemma":[0.99833107,0.00020301901,0.00028777815,0.0008069322,0.00010468906,0.00026648986],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002256648,0.00051317416,0.0011624293,0.0005909338,0.00014454164,0.000021975737,0.00019879382,0.00020567824,0.00025534135],"category_scores_gemma":[0.0001399773,0.00040440852,0.00011830484,0.0021226702,0.00025833008,0.00021535577,0.000070802205,0.0005505453,0.000026121726],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02130035,0.012069905,0.9017467,0.0017389517,0.0038137035,0.005299678,0.0057477816,0.0014503077,0.0030375211,0.000044114287,0.00040439318,0.043346576],"study_design_scores_gemma":[0.20668635,0.004653038,0.78047353,0.0012658207,0.0014594345,0.00010561721,0.000063321546,0.00078175665,0.0022038852,0.0000063613056,0.001675772,0.00062513514],"about_ca_topic_score_codex":0.0006173795,"about_ca_topic_score_gemma":0.012602173,"teacher_disagreement_score":0.185386,"about_ca_system_score_codex":0.004961874,"about_ca_system_score_gemma":0.0029369406,"threshold_uncertainty_score":0.9998408},"labels":[],"label_agreement":null},{"id":"W2586983104","doi":"10.1182/blood.v124.21.3901.3901","title":"BK Virus Hemorrhagic Cystitis Is Associated with Graft Versus Host Disease and Increased Health Care Resource Utilization in Patients Undergoing Allogeneic Stem Cell Transplantation","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Hemorrhagic cystitis; Medicine; BK virus; Transplantation; Graft-versus-host disease; Hematopoietic stem cell transplantation; Internal medicine; Population; Incidence (geometry); Gastroenterology; Surgery; Immunology; Kidney transplantation","score_opus":0.010684960448991388,"score_gpt":0.22718979259080999,"score_spread":0.2165048321418186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586983104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961601,0.002716182,0.000018265322,0.00007600754,0.00003279827,0.00041721857,0.0002257536,0.00005812954,0.00029555106],"genre_scores_gemma":[0.9981142,0.0003725207,0.000023134247,0.00041100406,0.000021617096,0.000011868048,0.0009859976,0.00002888601,0.0000307288],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998872,0.00013582277,0.00021493179,0.00028080662,0.0002560313,0.00024042692],"domain_scores_gemma":[0.99926823,0.00009168902,0.0001214806,0.00014638952,0.00005134979,0.00032083597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006787683,0.00016087288,0.00022383309,0.00011455027,0.00011571228,0.000018296396,0.000037701237,0.00008271976,0.000007867861],"category_scores_gemma":[0.00003125364,0.00013860816,0.00003566009,0.00019692453,0.000036011956,0.00005762862,0.0000094789975,0.00009923986,0.0000032314776],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004210696,0.0018989693,0.9870396,0.0010976621,0.00019454853,0.00016853557,0.0022039816,0.00003610682,0.00039600444,0.000014470243,0.000090653804,0.002648764],"study_design_scores_gemma":[0.033886023,0.0014815385,0.9602938,0.0007796402,0.001007349,0.0000040529876,0.00028060132,0.00016545255,0.0017995465,0.0000029031617,0.0000667685,0.00023227451],"about_ca_topic_score_codex":0.00027384466,"about_ca_topic_score_gemma":0.00048506897,"teacher_disagreement_score":0.029675327,"about_ca_system_score_codex":0.00008378258,"about_ca_system_score_gemma":0.00019407623,"threshold_uncertainty_score":0.5652277},"labels":[],"label_agreement":null},{"id":"W2587048940","doi":"10.1182/blood.v120.21.1084.1084","title":"CD44 Antibody Mediated Amelioration of Murine ITP: Evidence for a Similar Strain Dependent FcγRIIB Requirement As Compared to Ivig","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services","funders":"","keywords":"Antibody; Monoclonal antibody; Immunology; Receptor; CD44; Medicine; Fc receptor; In vitro; Biology; Internal medicine; Biochemistry","score_opus":0.1309139917206693,"score_gpt":0.42884165664204,"score_spread":0.2979276649213707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587048940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99278617,0.0013898737,0.00047585918,0.0030108627,0.00012206828,0.0014249332,0.00016125056,0.000035139816,0.0005938213],"genre_scores_gemma":[0.9952784,0.00021128541,0.0024941834,0.00047316728,0.00041516262,0.000089386216,0.0002848024,0.000022336004,0.0007312849],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99794716,0.000069945716,0.0004559885,0.00025930486,0.00076573767,0.0005018692],"domain_scores_gemma":[0.99857223,0.0003121093,0.000113557166,0.00029220406,0.00030367554,0.00040623854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007268039,0.000181754,0.00039987318,0.00016034134,0.00007567718,0.0000147992905,0.00015997051,0.00007324823,0.00030137046],"category_scores_gemma":[0.0006923612,0.00014776771,0.00011939739,0.00025275227,0.000060448954,0.00014981886,0.00010123567,0.0001268568,0.000105802224],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016159388,0.0018718874,0.06501148,0.0006228797,0.00027347924,0.00003185395,0.0007549679,0.000013723662,0.9268418,0.00048495058,0.0011991753,0.0012778819],"study_design_scores_gemma":[0.010290711,0.00513511,0.26610065,0.0016670249,0.00075693283,0.00016896278,0.00071713567,0.00061631267,0.6919289,0.00024026261,0.021701343,0.0006766438],"about_ca_topic_score_codex":0.0002037417,"about_ca_topic_score_gemma":0.00004771627,"teacher_disagreement_score":0.23491286,"about_ca_system_score_codex":0.000039646406,"about_ca_system_score_gemma":0.00014212064,"threshold_uncertainty_score":0.60257924},"labels":[],"label_agreement":null},{"id":"W2587075560","doi":"10.1182/blood.v104.11.3278.3278","title":"Antitumor Activity of Bortezomib (PS-341; Velcade) in a Phase II Study of Patients with Previously Untreated or Treated Waldenstrom’s Macroglobulinemia (WM).","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Alberta Hospital; Alberta Hospital Edmonton; Juravinski Cancer Centre; London Health Sciences Centre; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bortezomib; Internal medicine; Rituximab; Waldenstrom macroglobulinemia; Gastroenterology; Macroglobulinemia; Lenalidomide; Chlorambucil; Fludarabine; Cladribine; Thalidomide; Multiple myeloma; Regimen; Lymphoplasmacytic Lymphoma; Chemotherapy; Lymphoma; Cyclophosphamide","score_opus":0.01537208609548834,"score_gpt":0.301797900612425,"score_spread":0.28642581451693666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587075560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969088,0.00006183572,0.000003422457,0.000030586805,0.000017498327,0.0027178852,0.0000799036,0.0000530086,0.00012706265],"genre_scores_gemma":[0.9994085,0.000023492148,0.00018996159,0.000010922406,0.000027611848,0.00006377679,0.000059591795,0.000048986174,0.00016715695],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99738467,0.00009239837,0.00064114615,0.0005133556,0.0008250767,0.0005433462],"domain_scores_gemma":[0.9984114,0.00007350957,0.00029593997,0.0006831742,0.00032434147,0.0002116475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020450194,0.0003124442,0.00095889875,0.00029721324,0.000054121574,0.000008520173,0.0002101192,0.00013616677,0.000088238034],"category_scores_gemma":[0.00021059667,0.00021772561,0.00007679702,0.0010286641,0.00017380521,0.00010858698,0.00012820386,0.00028877848,0.000005206599],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055874933,0.29349732,0.59950566,0.00165833,0.0022796276,0.00589817,0.0075219553,0.00017224975,0.025107106,0.000008833418,0.00008024413,0.008395541],"study_design_scores_gemma":[0.63351107,0.037927195,0.19854675,0.00090627925,0.0010485837,0.00015128963,0.0003440686,0.0001772972,0.12705268,0.0000033672095,0.0000133248395,0.00031809328],"about_ca_topic_score_codex":0.0059762984,"about_ca_topic_score_gemma":0.0015175379,"teacher_disagreement_score":0.5776361,"about_ca_system_score_codex":0.0021258814,"about_ca_system_score_gemma":0.0041147494,"threshold_uncertainty_score":0.90344155},"labels":[],"label_agreement":null},{"id":"W2587085762","doi":"10.1182/blood.v116.21.4413.4413","title":"Impact of Blood Donor Clinic Closures on the Age of Blood Transfused In a Tertiary Care Centre","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Blood donation and transfusion practices","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Demographics; Pediatrics; Blood transfusion; Emergency medicine; Internal medicine; Demography","score_opus":0.013157562175231726,"score_gpt":0.2551106260802756,"score_spread":0.2419530639050439,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587085762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871577,0.00017529847,9.82533e-7,0.00081538,0.00017810123,0.00045435832,0.000026021618,0.00004851083,0.011143646],"genre_scores_gemma":[0.99914515,0.000053701264,0.00005132539,0.00040528612,0.0002159459,0.0000147102055,0.000031324886,0.00003037938,0.000052154282],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998466,0.000050993003,0.0005764205,0.0003009957,0.00034578468,0.00025981298],"domain_scores_gemma":[0.99872667,0.00031681277,0.00033314596,0.00043713217,0.00016824638,0.000018025416],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00045469523,0.0002305146,0.00031716647,0.0002995488,0.00008654709,0.00008357657,0.00039729392,0.00015147282,0.0013199276],"category_scores_gemma":[0.0002164794,0.00015715708,0.0003086549,0.000473508,0.00009873481,0.00044925106,0.00004118723,0.00046024832,0.000037097034],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016843171,0.0057796184,0.92707616,0.00032379944,0.00062639837,0.00005993595,0.0010167717,0.000006846978,0.06075291,0.002513946,0.00013953392,0.0015356299],"study_design_scores_gemma":[0.0137707805,0.00017081283,0.95071924,0.0002076915,0.0025994538,0.000008490418,0.001079435,0.000018661172,0.028413255,0.00051484676,0.002060226,0.00043710897],"about_ca_topic_score_codex":0.0012936566,"about_ca_topic_score_gemma":0.0030274023,"teacher_disagreement_score":0.032339655,"about_ca_system_score_codex":0.000001969328,"about_ca_system_score_gemma":0.00005689815,"threshold_uncertainty_score":0.999593},"labels":[],"label_agreement":null},{"id":"W2587085973","doi":"10.1182/blood.v118.21.1299.1299","title":"Paralog 4 HOX Genes HOXA4 and HOXB4 Expand Pro-B Cells in Vitro","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Biological Activity of Diterpenoids and Biflavonoids","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Biology; Progenitor cell; Haematopoiesis; Stem cell; Myeloid; Bone marrow; Hox gene; Molecular biology; Cell culture; Cell biology; Cancer research; Immunology; Gene; Gene expression; Genetics","score_opus":0.01876734391204546,"score_gpt":0.21381953027820255,"score_spread":0.1950521863661571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587085973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99693966,0.0012380576,0.000047484973,0.000043867924,0.000049489387,0.00015678712,0.000022379878,0.000011577635,0.0014906818],"genre_scores_gemma":[0.99694484,0.00045669408,0.0020571265,0.00016937238,0.000121142075,0.00002298541,0.000027146267,0.000010407147,0.00019025373],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991695,0.000043570588,0.00013492913,0.00035158807,0.00005356584,0.00024681413],"domain_scores_gemma":[0.99967134,0.0000070103824,0.000043977725,0.00018282715,0.00001750401,0.00007732584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010453569,0.00014724917,0.00015978186,0.000028137585,0.000038921673,0.000016912825,0.00012836202,0.00020528302,0.000017538514],"category_scores_gemma":[0.00001236139,0.000115245704,0.000049604634,0.000044519034,0.00010635559,0.00000485975,0.00011950691,0.00008615883,0.000007990974],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009266783,0.0004141276,0.010277286,0.000011880704,0.000018678826,0.000009484633,0.000043497817,7.124223e-8,0.9839455,0.000012765874,0.000057645364,0.0051163854],"study_design_scores_gemma":[0.000875479,0.00045523062,0.02134062,0.0000052372884,0.000015734442,0.000011355924,0.000026945629,0.0000021964527,0.97354376,0.00014659455,0.0033847233,0.00019209867],"about_ca_topic_score_codex":0.00004966852,"about_ca_topic_score_gemma":0.000023168825,"teacher_disagreement_score":0.011063333,"about_ca_system_score_codex":0.0000015181074,"about_ca_system_score_gemma":0.00001470831,"threshold_uncertainty_score":0.46995834},"labels":[],"label_agreement":null},{"id":"W2587109842","doi":"10.1182/blood.v108.11.5369.5369","title":"A Pilot Trial of Two Dose Levels of Rabbit Antithymocyte Globulin, (rATG), Thymoglobulin, as Part of a Myeloablative-Conditioning for a HLA Identical Matched Related Donor Stem Cell Transplant (SCT) with Cyclosporine (CsA) as Graft Versus Host Disease (GvHD) Prophylaxis.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Thymoglobulin; Cumulative incidence; Regimen; Gastroenterology; Internal medicine; Incidence (geometry); Surgery; Graft-versus-host disease; Transplantation; Hematopoietic stem cell transplantation; Randomized controlled trial; Urology; Tacrolimus","score_opus":0.016708916429075567,"score_gpt":0.26514898844383905,"score_spread":0.24844007201476348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587109842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99476194,0.0007949033,0.00039574242,0.00004800355,0.00014351433,0.0020375128,0.0010314177,0.000020769477,0.0007661892],"genre_scores_gemma":[0.997823,0.00011913799,0.00063275377,0.0000071337213,0.00014232787,0.0001304232,0.00043749783,0.000057712143,0.0006500298],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970624,0.0001850137,0.0009836399,0.0006460327,0.0006201781,0.0005027668],"domain_scores_gemma":[0.998164,0.00012333515,0.00052764814,0.0005458185,0.00041890828,0.00022031544],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042982455,0.0003613797,0.00064679544,0.00012537598,0.00008486727,0.000024321831,0.0003576942,0.00016005593,0.000052384315],"category_scores_gemma":[0.00007677205,0.00031531847,0.00029127745,0.00032318578,0.0003493908,0.000020694173,0.00009362883,0.0001858674,0.000006857284],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10956174,0.0038886485,0.0038290403,0.00080091285,0.00067310774,0.00015769448,0.0000930969,0.00022104206,0.88017577,0.00047668547,0.000039274368,0.000082963816],"study_design_scores_gemma":[0.11173011,0.011973461,0.0074535916,0.00019012038,0.00057978916,0.000023606188,0.00005401662,0.00003219012,0.8673067,0.00019474002,0.000088148736,0.0003734863],"about_ca_topic_score_codex":0.00021167017,"about_ca_topic_score_gemma":0.00007079982,"teacher_disagreement_score":0.012869056,"about_ca_system_score_codex":0.000022810676,"about_ca_system_score_gemma":0.000562955,"threshold_uncertainty_score":0.9999299},"labels":[],"label_agreement":null},{"id":"W2587116754","doi":"10.1182/blood.v118.21.4987.4987","title":"A Systematic Review on the Use of Intrathecal Rituximab in CNS Lymphoma","year":2011,"lang":"en","type":"review","venue":"Blood","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Rituximab; Medicine; Ommaya reservoir; Lymphoma; Cytarabine; Oncology; Internal medicine; Primary central nervous system lymphoma; Chemotherapy; Surgery","score_opus":0.10717698055564964,"score_gpt":0.3127493621355043,"score_spread":0.20557238157985466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587116754","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010021662,0.9948818,1.2596404e-7,0.000071807706,0.000036624253,0.0045950837,0.000031889536,0.00001374494,0.00026870158],"genre_scores_gemma":[0.0000808405,0.99815136,0.000044293458,0.0002376572,0.000028261922,0.001356352,0.000026404043,0.00003835504,0.000036449208],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99796534,0.00034672813,0.001010797,0.00026766595,0.00022123056,0.00018823394],"domain_scores_gemma":[0.9978461,0.00060722517,0.00048704934,0.0009452861,0.00004646181,0.00006786076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033875473,0.00034926392,0.0036418806,0.00014066408,0.000017216236,0.0000108643735,0.00016936159,0.00015263939,0.00006299129],"category_scores_gemma":[0.00059622276,0.00015733836,0.0006748036,0.00032128557,0.000038625894,0.000019210864,0.00004036183,0.0001388123,0.0002156501],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000026710513,0.006664322,0.000006054428,0.96294165,0.0008346791,0.0002637093,0.00002566276,1.4545715e-9,3.2608202e-8,0.0009635338,0.00037095032,0.02792675],"study_design_scores_gemma":[0.001612713,0.00020029242,0.0000071163886,0.8895442,0.01733771,0.00037790945,0.0000024244482,1.7513428e-7,0.000003939915,0.000005794974,0.09079436,0.000113397895],"about_ca_topic_score_codex":0.00004449348,"about_ca_topic_score_gemma":0.000008555572,"teacher_disagreement_score":0.09042341,"about_ca_system_score_codex":0.000061527004,"about_ca_system_score_gemma":0.00015933416,"threshold_uncertainty_score":0.6416072},"labels":[],"label_agreement":null},{"id":"W2587128182","doi":"10.1182/blood.v104.11.4987.4987","title":"Specific Elimination of Alloreactive T Lymphocytes Using Photodynamic Therapy Prevents GVHD and Enables Rapid Immune Reconstitution.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Spleen; Transplantation; Immunology; Immune system; Graft-versus-host disease; Bone marrow; Mixed lymphocyte reaction; Stem cell; Medicine; T cell; Major histocompatibility complex; Cancer research; Biology; Internal medicine; Cell biology","score_opus":0.025597183439983663,"score_gpt":0.2872320237110355,"score_spread":0.2616348402710518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587128182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851525,0.012754295,0.00011762575,0.00007480155,0.000067931585,0.0007282521,0.000021423177,0.000035188135,0.0010480261],"genre_scores_gemma":[0.9822647,0.01636373,0.0012035398,0.000020704496,0.000041909247,0.000028608058,0.000021273827,0.00001927324,0.000036278387],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99889153,0.000048510217,0.0002862712,0.0002592161,0.00027234902,0.00024210864],"domain_scores_gemma":[0.9993554,0.000072809285,0.00013897284,0.00023123628,0.00013505905,0.000066574656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025324099,0.00017014025,0.00035399658,0.00018868607,0.0001160059,0.000013147907,0.00007957671,0.000071015565,0.00006160502],"category_scores_gemma":[0.00006412482,0.00014407562,0.00008265037,0.00020242318,0.00033031998,0.00014589392,0.00004298552,0.000109278255,0.0000020364353],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039185063,0.00086614664,0.00040035776,0.000063134954,0.00045104919,0.000023588877,0.0007274673,0.00001892202,0.983636,0.00017380739,0.0000015705338,0.013246105],"study_design_scores_gemma":[0.012039579,0.00059478066,0.046251368,0.00024652472,0.000089593246,0.00017542488,0.0004241452,0.000055446057,0.9391828,0.000658662,0.00012395649,0.00015769986],"about_ca_topic_score_codex":0.0002017535,"about_ca_topic_score_gemma":0.000005643776,"teacher_disagreement_score":0.04585101,"about_ca_system_score_codex":0.00020934874,"about_ca_system_score_gemma":0.00023298322,"threshold_uncertainty_score":0.58752334},"labels":[],"label_agreement":null},{"id":"W2587146175","doi":"10.1182/blood.v126.23.3337.3337","title":"Molecular Characterization of 140 Patients in the Pyruvate Kinase Deficiency (PKD) Natural History Study (NHS): Report of 20 New Variants","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University Health Network; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Missense mutation; Pyruvate kinase deficiency; Sanger sequencing; Compound heterozygosity; Genetics; Biology; Frameshift mutation; Genotype; Mutation; Gene; Medicine; Pyruvate kinase; Glycolysis; Enzyme","score_opus":0.021614396779284513,"score_gpt":0.24429746331582888,"score_spread":0.22268306653654438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587146175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99813706,0.00017227951,0.00003685561,0.000059005728,0.00045223263,0.00041036026,0.000003150887,0.000010289209,0.0007187916],"genre_scores_gemma":[0.9993296,0.0000072560974,0.00007368357,0.00020376655,0.000043628486,0.000006963885,0.00010296779,0.000008448503,0.00022368784],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99901134,0.00010439422,0.000351678,0.0001655433,0.00026459325,0.00010245672],"domain_scores_gemma":[0.99922484,0.000013516778,0.00023642556,0.00030500456,0.00017040169,0.00004979001],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002345015,0.000085609165,0.0002206733,0.00009207295,0.000009656141,0.0000012758878,0.000076269724,0.000049532893,0.000019893912],"category_scores_gemma":[0.00020712576,0.000061661274,0.000041089635,0.0001729807,0.000033935405,0.00004468786,0.000024039136,0.00011022237,0.0000033079386],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000404876,0.006652985,0.22396417,0.0000798862,0.000050515057,0.00048028055,0.00531393,0.0000047233816,0.7620912,0.000051696483,0.00044908875,0.00045665854],"study_design_scores_gemma":[0.007400966,0.0020442999,0.97915643,0.000055767552,0.00018903635,0.000048482012,0.0003820017,0.00003926856,0.010084487,0.000023987499,0.0004728407,0.00010242772],"about_ca_topic_score_codex":0.0001377436,"about_ca_topic_score_gemma":0.00001141868,"teacher_disagreement_score":0.7551923,"about_ca_system_score_codex":0.000032849563,"about_ca_system_score_gemma":0.00020448666,"threshold_uncertainty_score":0.25144738},"labels":[],"label_agreement":null},{"id":"W2587200722","doi":"10.1182/blood.v124.21.1757.1757","title":"Bendamustine Plus Rituximab (BR) in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma of a Phase 2 Study: Multivariate Analysis and Updated Final Results By Subgroup","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Bendamustine; Medicine; Mantle cell lymphoma; Rituximab; Internal medicine; Tolerability; Refractory (planetary science); Progressive disease; Population; Salvage therapy; Phases of clinical research; Gastroenterology; Lymphoma; Surgery; Oncology; Adverse effect; Chemotherapy","score_opus":0.016510344002501908,"score_gpt":0.27811597323357745,"score_spread":0.26160562923107555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587200722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99756503,0.0008478154,0.000010088203,0.0001117001,0.000019502813,0.00069933926,0.00027473806,0.000013559512,0.0004582053],"genre_scores_gemma":[0.99891347,0.0002331065,0.00022525864,0.000027996184,0.000025774942,0.000069085174,0.00035469883,0.000013752148,0.00013686587],"study_design_codex":"nonrandomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99838686,0.00018465564,0.0005603904,0.00037195446,0.00028659654,0.00020954676],"domain_scores_gemma":[0.99879766,0.0002631227,0.00027372863,0.00052116223,0.00006194943,0.000082406346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027569046,0.00022820648,0.00075521634,0.00022032717,0.000045619312,0.000010410318,0.00008822775,0.00007396031,0.00002159947],"category_scores_gemma":[0.00004067069,0.00014060571,0.00015020595,0.0005268722,0.00006580908,0.000037008664,0.000021929018,0.000037183483,0.0000034153368],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008050049,0.59652555,0.32996145,0.0001494201,0.005809787,0.0005971331,0.013271297,0.000014740091,0.013681608,0.000037218724,0.0006185716,0.031283155],"study_design_scores_gemma":[0.36401257,0.016223628,0.57403064,0.00004972455,0.01012254,0.000019327681,0.0008835829,0.00081629475,0.032071523,0.000006793908,0.0015721852,0.0001912367],"about_ca_topic_score_codex":0.00372049,"about_ca_topic_score_gemma":0.00028833587,"teacher_disagreement_score":0.58030194,"about_ca_system_score_codex":0.00008523068,"about_ca_system_score_gemma":0.000055574907,"threshold_uncertainty_score":0.57337344},"labels":[],"label_agreement":null},{"id":"W2587208298","doi":"10.1182/blood.v118.21.2808.2808","title":"T Cells of Patients with Myelodysplastic Syndrome Are Frequently Derived From the Malignant Clone","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital; BC Cancer Agency; Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Biology; Trisomy; Trisomy 8; CD34; CD3; Population; clone (Java method); Molecular biology; Genetics; Cytogenetics; Chromosome; Stem cell; Medicine; Antigen; Gene; CD8","score_opus":0.007973498372529156,"score_gpt":0.1601701434440974,"score_spread":0.15219664507156827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587208298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993763,0.005139151,0.000047740203,0.00001190142,0.00030282437,0.00022489237,0.00016557756,0.000031055402,0.0003138336],"genre_scores_gemma":[0.9996357,0.000029124853,0.00003922988,0.00006314295,0.0000011193247,0.000014525539,0.000103983846,0.000016509002,0.00009668572],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990813,0.000104896986,0.0002620777,0.00022047474,0.000046738816,0.00028448098],"domain_scores_gemma":[0.9992185,0.000095019095,0.00022704067,0.00038645708,0.00006764967,0.000005293152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000068265894,0.00017119711,0.0002594373,0.000032750948,0.00015468833,0.000005184423,0.0003608592,0.000121217694,0.0006095695],"category_scores_gemma":[0.0000206553,0.00010406965,0.00006767135,0.000108284155,0.00031231713,0.00005713312,0.00006617207,0.00017190697,0.00021021496],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006191495,0.005050779,0.25692728,0.000043317574,0.0014758068,0.000042769705,0.005872356,0.0000059249705,0.72879916,0.0002848921,0.000064661624,0.0008138972],"study_design_scores_gemma":[0.0031274743,0.0003117921,0.7952651,0.0000863887,0.00021831269,0.000008271527,0.00055844005,1.642947e-7,0.19998693,0.0000717931,0.00020143327,0.00016391087],"about_ca_topic_score_codex":0.00044887667,"about_ca_topic_score_gemma":0.000009054643,"teacher_disagreement_score":0.5383378,"about_ca_system_score_codex":0.0000046686587,"about_ca_system_score_gemma":0.00003210257,"threshold_uncertainty_score":0.6674358},"labels":[],"label_agreement":null},{"id":"W2587271375","doi":"10.1182/blood.v114.22.4555.4555","title":"From Bench to Bedside: Hematopoietic Growth Factors (HGFs)- a Cause of Serious and Unanticipated Class Toxicities.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Neutropenia; Internal medicine; Anemia; Bone marrow; Oncology; Chemotherapy","score_opus":0.008326274350899892,"score_gpt":0.23731690720173737,"score_spread":0.22899063285083748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587271375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99821156,0.0010371364,0.0000245332,0.00015006142,0.000032671127,0.0001775184,0.00009969396,0.000012223285,0.0002546105],"genre_scores_gemma":[0.9992169,0.000104273924,0.00019392697,0.00023791856,0.000031896972,0.0000070514934,0.00013315516,0.00001406281,0.00006082912],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99922395,0.000020266687,0.00017700688,0.00028838802,0.00008435335,0.00020606548],"domain_scores_gemma":[0.9995399,0.000008321416,0.000055538076,0.00023732141,0.00004580837,0.00011307743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000022542723,0.000168598,0.00021009053,0.000036578887,0.00004157798,0.000016009019,0.00009471687,0.00011693949,0.000010963159],"category_scores_gemma":[0.000028199729,0.00014800775,0.000053246866,0.0000864274,0.000036170804,0.000003392669,0.000051071485,0.00003909856,0.0000025812997],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000139296,0.0033101733,0.19122434,0.000059097612,0.0011275404,0.000063327,0.0020038385,0.00000951327,0.79856634,0.00033283912,0.0012139077,0.0019497791],"study_design_scores_gemma":[0.0022931069,0.0010718699,0.06297943,0.000026546295,0.000256725,0.000010557201,0.00027732205,0.0000024997746,0.93186337,0.0008208546,0.00015548168,0.00024224902],"about_ca_topic_score_codex":0.00028289703,"about_ca_topic_score_gemma":0.000096396856,"teacher_disagreement_score":0.13329701,"about_ca_system_score_codex":0.0000029988066,"about_ca_system_score_gemma":0.000027919528,"threshold_uncertainty_score":0.60355806},"labels":[],"label_agreement":null},{"id":"W2587294303","doi":"10.1182/blood.v128.22.1262.1262","title":"Retrospective Study of High Hemoglobin Levels in 56 Young Adults","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Fleurimont; Université de Sherbrooke; Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Hematocrit; Medicine; Etiology; Retrospective cohort study; Hemoglobin; Population; Pediatrics; Hematology; Observational study; Internal medicine","score_opus":0.014169943929773918,"score_gpt":0.25755261545655445,"score_spread":0.24338267152678053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587294303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974823,0.00008606277,0.0000049316272,0.00031695937,0.00006758949,0.00085869536,0.0000386726,0.000021471036,0.0011233385],"genre_scores_gemma":[0.999282,0.000031271633,0.00015527804,0.000029953875,0.000075590826,0.00012786641,0.000002607769,0.000014803529,0.0002805977],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989388,0.000046766607,0.00027386178,0.00030425028,0.00025593958,0.00018037051],"domain_scores_gemma":[0.99941784,0.000045754412,0.00008290959,0.0002689759,0.00011605901,0.000068444686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000098389704,0.00014130032,0.00039841136,0.000091058166,0.000022516688,0.000003904265,0.0000510465,0.000051755113,0.0001632336],"category_scores_gemma":[0.00010809626,0.00008449936,0.000058004152,0.00016331875,0.000028045848,0.000046983,0.000033465843,0.00006502392,0.000029481587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020248714,0.008092306,0.9870605,0.000016748218,0.00024364894,0.00016474532,0.0012703675,1.2385942e-7,0.0013052495,0.0003666116,0.00005863849,0.0012185731],"study_design_scores_gemma":[0.023825845,0.003085302,0.93971854,0.00027431632,0.00015041229,0.000019763333,0.00032917224,5.0505366e-7,0.032374512,0.00012653637,0.000009204681,0.000085886866],"about_ca_topic_score_codex":0.000511812,"about_ca_topic_score_gemma":0.00093377143,"teacher_disagreement_score":0.047341958,"about_ca_system_score_codex":0.00009169901,"about_ca_system_score_gemma":0.0000441985,"threshold_uncertainty_score":0.3445784},"labels":[],"label_agreement":null},{"id":"W2587295203","doi":"10.1182/blood.v128.22.234.234","title":"Updated Efficacy and Safety from the Phase 3 Resonate-2 Study: Ibrutinib As First-Line Treatment Option in Patients 65 Years and Older with Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre","funders":"","keywords":"Medicine; Ibrutinib; Chronic lymphocytic leukemia; Chlorambucil; Internal medicine; Bendamustine; Oncology; Leukemia; Chemotherapy; Gastroenterology; Cyclophosphamide","score_opus":0.015178035812554546,"score_gpt":0.2728574033801529,"score_spread":0.25767936756759835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587295203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99464446,0.0016504267,0.000011421472,0.000225094,0.00006120563,0.0031422724,0.00008122615,0.00011332927,0.0000705607],"genre_scores_gemma":[0.99693954,0.0016750627,0.00009010449,0.00015597921,0.00020268747,0.00015963681,0.0001606713,0.00009495975,0.0005213643],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9966308,0.00021525392,0.0006427104,0.0010281348,0.00070255325,0.0007805561],"domain_scores_gemma":[0.9976847,0.00066942966,0.00017638375,0.000979585,0.00012417558,0.00036571277],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038791812,0.00051409483,0.00073628296,0.00018358897,0.00019186019,0.000077608565,0.00024545778,0.00022216613,0.000108553366],"category_scores_gemma":[0.0002093475,0.0002905105,0.00006814932,0.00043147113,0.00036606405,0.00015113251,0.00023010066,0.00019347815,0.000079662925],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.1014699,0.019594554,0.23584409,0.0007771281,0.0081029935,0.00919222,0.020274255,0.0018750881,0.004068898,0.00015252359,0.0014424464,0.5972059],"study_design_scores_gemma":[0.727658,0.009751108,0.25075927,0.0010951854,0.0010110022,0.00022685925,0.00020372815,0.0047910647,0.0018586745,0.000030218958,0.002075782,0.000539098],"about_ca_topic_score_codex":0.01453668,"about_ca_topic_score_gemma":0.0022610691,"teacher_disagreement_score":0.6261881,"about_ca_system_score_codex":0.10092366,"about_ca_system_score_gemma":0.018036164,"threshold_uncertainty_score":0.9999547},"labels":[],"label_agreement":null},{"id":"W2587302424","doi":"10.1182/blood.v126.23.579.579","title":"Advanced Stage Classical Hodgkin Lymphoma Patients with a Negative PET-Scan Following Treatment with ABVD Have Excellent Outcomes without the Need for Consolidative Radiotherapy Regardless of Disease Bulk at Presentation","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"ABVD; Medicine; Radiation therapy; Stage (stratigraphy); Chemotherapy; Radiology; Salvage therapy; B symptoms; Lymphoma; Dacarbazine; Chemotherapy regimen; Oncology; Surgery; Internal medicine; Vincristine; Cyclophosphamide","score_opus":0.020611843153929763,"score_gpt":0.2905276796174142,"score_spread":0.26991583646348444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587302424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943227,0.0002732974,0.00017790937,0.0007984591,0.000057032426,0.0039166985,0.00023051468,0.00003445982,0.0001888841],"genre_scores_gemma":[0.99418247,0.00003571803,0.0023321,0.00012087358,0.00003507813,0.0012544125,0.0001930654,0.000053227865,0.0017930856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982922,0.00010248975,0.0003020544,0.0004308097,0.0005650208,0.00030739143],"domain_scores_gemma":[0.99834263,0.00035228668,0.00030420697,0.00044081034,0.00024244965,0.0003175891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000073095885,0.00036498523,0.00064780714,0.000067219946,0.00013088046,0.000032966294,0.000084462896,0.000035475525,0.0000064799287],"category_scores_gemma":[0.000054136417,0.00017850698,0.00019701396,0.00010279724,0.00016929132,0.00013819794,0.000025721294,0.000029589848,0.0000011943296],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012121057,0.006478858,0.9724517,0.000041794647,0.0025306686,0.00008820631,0.0036468334,0.00006336924,0.000057133326,0.00006612765,0.000055549306,0.0023987282],"study_design_scores_gemma":[0.1938553,0.011523759,0.7712525,0.00030601333,0.002835252,0.000009947483,0.0028063904,0.00028792507,0.015987908,0.000025992082,0.0007512837,0.00035770854],"about_ca_topic_score_codex":0.00017378571,"about_ca_topic_score_gemma":0.00017316859,"teacher_disagreement_score":0.20119916,"about_ca_system_score_codex":0.00063246663,"about_ca_system_score_gemma":0.00040782482,"threshold_uncertainty_score":0.7279303},"labels":[],"label_agreement":null},{"id":"W2587320005","doi":"10.1182/blood.v118.21.640.640","title":"A Novel Mutational Mechanism Drives Over-Expression of Ligand-Independent FLT3 in a Murine Model of B-Precursor ALL","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Biology; Receptor tyrosine kinase; Cancer research; Fms-Like Tyrosine Kinase 3; Molecular biology; Chromosomal translocation; Leukemia; CD19; Genetics; Receptor; Mutation; Gene; Cell","score_opus":0.03721329653237497,"score_gpt":0.28235482497198605,"score_spread":0.24514152843961107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587320005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98940855,0.000042265412,0.008381505,0.00003618977,0.000025380072,0.00036609598,0.00004968018,0.000017104936,0.0016732479],"genre_scores_gemma":[0.9756641,0.000018882653,0.023954784,0.000040337378,0.00002799462,0.00003299376,0.000017433993,0.000023403134,0.00022008934],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984408,0.000021355581,0.00039828423,0.00024849686,0.00065216114,0.00023891639],"domain_scores_gemma":[0.9992436,0.00008308692,0.00014311478,0.00027041408,0.00014146858,0.00011827929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020859086,0.00013384261,0.0003304672,0.00023798383,0.000011984721,0.0000023587609,0.00016455835,0.00013136705,0.000098529104],"category_scores_gemma":[0.0001567659,0.00011208849,0.00008335995,0.00013757653,0.000064468215,0.00007387932,0.00014778362,0.00016160874,0.000006166884],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048776605,0.0027664322,0.001450885,0.00018344568,0.00008910939,0.000050619838,0.002458693,0.00007814538,0.9901402,0.00219354,0.00002945637,0.00007170136],"study_design_scores_gemma":[0.01323242,0.0004170099,0.0072982144,0.0003312697,0.000107154316,0.00006382122,0.00011775,0.02661892,0.9490972,0.0026137293,0.000001765874,0.00010071978],"about_ca_topic_score_codex":0.00018991229,"about_ca_topic_score_gemma":0.000020729547,"teacher_disagreement_score":0.04104298,"about_ca_system_score_codex":0.000075113036,"about_ca_system_score_gemma":0.00046038738,"threshold_uncertainty_score":0.4570836},"labels":[],"label_agreement":null},{"id":"W2587347954","doi":"10.1182/blood.v120.21.1793.1793","title":"GSK-3 Spatial Regulation Has an Essential Role in Lenalidomide Activity and Represents a Biomarker of Clinical Response in CLL","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Lenalidomide; Thalidomide; Pomalidomide; Cancer research; Biomarker; Wnt signaling pathway; Multiple myeloma; Cereblon; Biology; Chemistry; Genetics; Immunology; Signal transduction; Gene","score_opus":0.08311589550309026,"score_gpt":0.40432308599183847,"score_spread":0.32120719048874824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587347954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990292,0.00011654358,0.000020461695,0.00021125522,0.000041813026,0.00042371015,0.000009891844,0.000010037287,0.0001370923],"genre_scores_gemma":[0.99942744,0.0000179912,0.00034562024,0.000008007668,0.00010450627,0.000019147543,0.000019617992,0.0000118630915,0.00004582629],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980771,0.00072344986,0.0003750897,0.00024494945,0.00030029533,0.00027914444],"domain_scores_gemma":[0.9990285,0.00030489068,0.000100369165,0.00030342382,0.000037584712,0.00022524122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016762975,0.0000985074,0.00032946494,0.00020494757,0.000023736624,0.000011293989,0.00004733414,0.00012688384,0.000047142337],"category_scores_gemma":[0.0011133944,0.00008456205,0.000055630757,0.00015241197,0.000115152085,0.00019916685,0.00006809837,0.00015348375,0.0000051195207],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024517158,0.004094543,0.8751807,0.000024407538,0.00006599756,0.000060102087,0.00020285376,4.650991e-7,0.084420785,0.000002514981,0.0000065524623,0.011423909],"study_design_scores_gemma":[0.016861958,0.0003868573,0.9469683,0.000057438057,0.000044766013,0.000022070919,0.000028553182,0.0010345526,0.034479413,0.000026829146,0.000028641496,0.000060628943],"about_ca_topic_score_codex":0.0026545322,"about_ca_topic_score_gemma":0.00068769103,"teacher_disagreement_score":0.07178757,"about_ca_system_score_codex":0.000022528922,"about_ca_system_score_gemma":0.00011184578,"threshold_uncertainty_score":0.40128762},"labels":[],"label_agreement":null},{"id":"W2587413817","doi":"10.1182/blood.v116.21.2691.2691","title":"Targeting CLL Cells Using Rituximab-Conjugated Surface Enhanced Raman Scattering (SERS) Gold Nanoparticles","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Advanced biosensing and bioanalysis techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Colloidal gold; Raman scattering; Raman spectroscopy; Chemistry; Rituximab; Nanoparticle; Fluorescence; Conjugated system; Nanotechnology; Biophysics; Materials science; Antibody; Optics; Biology; Immunology","score_opus":0.0071789103806097375,"score_gpt":0.24546024578649003,"score_spread":0.23828133540588028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587413817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985831,0.00011910682,0.00076938584,0.00003467783,0.0001251256,0.00012768223,0.000011861072,0.000100349185,0.00012870651],"genre_scores_gemma":[0.9653371,0.0000529814,0.0340934,0.00012114755,0.00021092287,0.0000022739346,0.000040359417,0.000035077624,0.00010675534],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99870664,0.000044854976,0.0002792616,0.00046672768,0.00012281587,0.00037968252],"domain_scores_gemma":[0.99926025,0.0000105347435,0.00013586292,0.00039039593,0.00010689657,0.000096089134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021677905,0.00022017285,0.00021478272,0.000035416215,0.00013129179,0.00005774825,0.00018969737,0.00020015179,0.0000048905017],"category_scores_gemma":[0.000051715786,0.00020919408,0.0001082425,0.00014314082,0.00012870038,0.000009063953,0.00012940918,0.00018406047,0.000008586265],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002053323,0.00019235759,0.0003979222,0.000011525219,0.000053793134,0.000004927906,0.000015855885,0.00005969565,0.9988953,0.0000033343822,0.00008036277,0.000264434],"study_design_scores_gemma":[0.0006864309,0.00007190618,0.000034708184,0.000018159604,0.00007985409,0.000012362349,0.000046711903,0.00032766076,0.997556,0.000019232237,0.0008482372,0.0002987393],"about_ca_topic_score_codex":0.000035939604,"about_ca_topic_score_gemma":0.000035379602,"teacher_disagreement_score":0.03332401,"about_ca_system_score_codex":0.0000061224705,"about_ca_system_score_gemma":0.00003083672,"threshold_uncertainty_score":0.8530687},"labels":[],"label_agreement":null},{"id":"W2587441226","doi":"10.1182/blood.v106.11.1074.1074","title":"Fully Automated Magnetic Labeling and Separation of Hematopoietic Cells from Multiple Samples.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; Stemcell Technologies","funders":"","keywords":"Automation; Biomedical engineering; Magnetic separation; Separation process; Haematopoiesis; Cord blood; Computer science; Chromatography; Stem cell; Chemistry; Materials science; Immunology; Biology; Engineering; Cell biology","score_opus":0.009982188043345535,"score_gpt":0.22465320181293938,"score_spread":0.21467101376959385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587441226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99706954,0.0020521455,0.00051356736,0.000030140127,0.000050052517,0.00010021345,0.00004848206,0.000032599688,0.000103260216],"genre_scores_gemma":[0.99107105,0.00014879138,0.008428116,0.00007030082,0.00010710116,0.0000041819235,0.00010169757,0.000014352204,0.000054418204],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99940205,0.000022624814,0.0001870548,0.00019933618,0.000068073,0.00012084878],"domain_scores_gemma":[0.9996908,0.00001657649,0.0000501123,0.00015900642,0.000038808135,0.000044701967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000048338934,0.00009974953,0.00012100703,0.000019322888,0.000033806755,0.000014300187,0.000069399335,0.000103970386,0.000018572897],"category_scores_gemma":[0.000018202078,0.000100833866,0.00003648341,0.00003612681,0.00004067709,0.0000029413488,0.000024272667,0.000037840207,0.000005163337],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023049848,0.00016971628,0.0051242304,0.000018503193,0.000024311656,6.525333e-7,0.00010841889,0.00009897161,0.9934703,0.0000045004685,0.00009414977,0.0008631769],"study_design_scores_gemma":[0.0015444395,0.00015501547,0.0022102909,0.000015528574,0.0000578039,0.0000042378815,0.000024042574,0.0026547387,0.99161154,0.000017095821,0.001580627,0.0001246381],"about_ca_topic_score_codex":0.00009469927,"about_ca_topic_score_gemma":0.00014139153,"teacher_disagreement_score":0.007914549,"about_ca_system_score_codex":0.000002390648,"about_ca_system_score_gemma":0.000021074564,"threshold_uncertainty_score":0.41118857},"labels":[],"label_agreement":null},{"id":"W2587441942","doi":"10.1182/blood.v126.23.4041.4041","title":"Predictors of Response Duration and Survival with Second-Line Bosutinib Therapy in Patients (pts) with Chronic Phase Chronic Myeloid Leukemia (CML) Resistant or Intolerant to Prior Imatinib","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Bosutinib; Internal medicine; Imatinib; Cumulative incidence; Proportional hazards model; Gastroenterology; Discontinuation; Tyrosine-kinase inhibitor; Retrospective cohort study; Myeloid leukemia; Oncology; Nilotinib; Cohort; Cancer","score_opus":0.019198493718807292,"score_gpt":0.2742516609083612,"score_spread":0.2550531671895539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587441942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996385,0.00058086176,0.000027352944,0.00016402926,0.00008131916,0.0024565263,0.000109561515,0.00007043433,0.00012493103],"genre_scores_gemma":[0.9979511,0.00008146178,0.0009847506,0.00006165046,0.00014802245,0.0001647404,0.00013941336,0.00008165028,0.00038722806],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9970248,0.00023148923,0.0008452949,0.0006314346,0.0007558054,0.00051117776],"domain_scores_gemma":[0.9980822,0.00017403172,0.0003723445,0.00066166796,0.00029630895,0.00041342937],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00075973704,0.00043472293,0.0007750952,0.00029600394,0.00006363143,0.000027094531,0.00014706189,0.00014825696,0.00012269641],"category_scores_gemma":[0.0002546344,0.0002813038,0.00004589671,0.00057114667,0.00016116498,0.00018750354,0.0000609125,0.00027264652,0.000008502388],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5152499,0.010496376,0.3517187,0.0011742932,0.0020383417,0.000900398,0.011848204,0.00023835636,0.08197888,0.00002532722,0.00039438356,0.023936827],"study_design_scores_gemma":[0.36514646,0.11896569,0.41768822,0.0018087814,0.0005010405,0.00014913436,0.00044542592,0.0004560023,0.091797404,0.0000050496824,0.0023248082,0.0007119637],"about_ca_topic_score_codex":0.00025333214,"about_ca_topic_score_gemma":0.0028991944,"teacher_disagreement_score":0.15010345,"about_ca_system_score_codex":0.0027235989,"about_ca_system_score_gemma":0.005647148,"threshold_uncertainty_score":0.9999899},"labels":[],"label_agreement":null},{"id":"W2587459771","doi":"10.1182/blood.v110.11.175.175","title":"Identification of a New Genetic Determinant Controlling Human Hematopoietic Stem Cell Engraftment.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Diabetes and associated disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children; University Health Network","funders":"","keywords":"Biology; Nod; Stem cell; Transplantation; Haematopoiesis; Hematopoietic stem cell; Immunology; Xenotransplantation; Human leukocyte antigen; Severe combined immunodeficiency; Humanized mouse; Hematopoietic stem cell transplantation; Immune system; Genetics; Antigen; Gene; Medicine","score_opus":0.005698630183008142,"score_gpt":0.2255752420754104,"score_spread":0.21987661189240226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587459771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99617153,0.0018786103,0.0013678289,0.000009213857,0.000044613535,0.00015333961,0.0000054251664,0.0000083389,0.00036107545],"genre_scores_gemma":[0.998856,0.000054723667,0.00013859385,0.000032200445,0.00006290512,0.000004830084,0.000019182118,0.000015867994,0.0008156707],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99915737,0.000016479327,0.00031749887,0.00019503108,0.000101746344,0.00021189266],"domain_scores_gemma":[0.9994885,0.000007751431,0.00018634247,0.00021046473,0.000041744344,0.00006522097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017629915,0.00009958327,0.00012861882,0.00003257054,0.00004821163,0.000015340296,0.00012189399,0.00009193179,0.0000053344183],"category_scores_gemma":[0.0000068486133,0.0001000593,0.00009232148,0.00005774558,0.00002310389,0.0000017482586,0.000029295321,0.0000350053,0.0000052753508],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007120651,0.0002514013,0.004972982,0.000025623947,0.000045476158,0.0000021970304,0.00009092141,0.000011369833,0.99258274,0.000016860424,0.00007451186,0.0019187744],"study_design_scores_gemma":[0.0017705761,0.00015947162,0.0044449368,0.000011767709,0.00009350638,0.0000017939046,0.00017923885,0.000009451616,0.99255216,0.00007704936,0.0005811274,0.000118944125],"about_ca_topic_score_codex":0.000012666414,"about_ca_topic_score_gemma":0.000017413038,"teacher_disagreement_score":0.002684472,"about_ca_system_score_codex":0.0000042651686,"about_ca_system_score_gemma":0.000028243147,"threshold_uncertainty_score":0.40802997},"labels":[],"label_agreement":null},{"id":"W2587477971","doi":"10.1182/blood.v110.11.698.698","title":"A Negative D-dimer Excludes Recurrent Deep Vein Thrombosis: Results of a Multicentre Management Study.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McGill University; University of Toronto; McMaster University","funders":"","keywords":"Medicine; Deep vein; Thrombosis; D-dimer; Prospective cohort study; Internal medicine; Surgery; Confidence interval; Gastroenterology","score_opus":0.022712393765922066,"score_gpt":0.30611313797984585,"score_spread":0.2834007442139238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587477971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9686552,0.0005458669,0.0001170262,0.00028156568,0.00023681294,0.0026087367,0.000010625307,0.00008949006,0.027454626],"genre_scores_gemma":[0.9959554,0.0003291354,0.0030097133,0.00019947243,0.00011539256,0.000078547964,0.000015155239,0.000031419782,0.00026576518],"study_design_codex":"nonrandomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99775153,0.00006253404,0.0006808603,0.00047868994,0.0005771842,0.00044920345],"domain_scores_gemma":[0.99875605,0.00011257134,0.00024134413,0.000580024,0.00014079301,0.00016922274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007284315,0.0002503946,0.00060650473,0.00023794084,0.00007893571,0.000016668646,0.00017224855,0.00006289999,0.00008587185],"category_scores_gemma":[0.00010816635,0.0002124021,0.0001475948,0.00037963415,0.000066499226,0.000066148146,0.00019182247,0.00015145671,0.000052778152],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00774271,0.4316819,0.1351143,0.0050765234,0.034063853,0.003049619,0.14349765,0.00011733685,0.007200616,0.0061384565,0.026988162,0.19932887],"study_design_scores_gemma":[0.02610948,0.002941561,0.9298167,0.00065078196,0.00376393,0.0000056096887,0.022068288,0.00003376855,0.011149326,0.00009498296,0.0030176404,0.00034793495],"about_ca_topic_score_codex":0.0002003322,"about_ca_topic_score_gemma":0.00038488233,"teacher_disagreement_score":0.7947024,"about_ca_system_score_codex":0.000055070705,"about_ca_system_score_gemma":0.000018915227,"threshold_uncertainty_score":0.8661506},"labels":[],"label_agreement":null},{"id":"W2587489031","doi":"10.1182/blood.v108.11.713.713","title":"Prevention of Venous Thromboembolism after Acute Ischemic Stroke with Enoxaparin Versus Unfractionated Heparin and the Impact of Stroke Severity.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Venography; Pulmonary embolism; Stroke (engine); Deep vein; Heparin; Clinical endpoint; Internal medicine; Asymptomatic; Thrombosis; Low molecular weight heparin; Population; Venous thrombosis; Surgery; Randomized controlled trial; Cardiology","score_opus":0.007147574351758093,"score_gpt":0.2561818173815795,"score_spread":0.24903424302982144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587489031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99075204,0.00062328094,0.000036601803,0.00008439107,0.000052711333,0.0007051261,0.00006239833,0.000027631173,0.007655793],"genre_scores_gemma":[0.9986435,0.00030524548,0.00035683642,0.000016338296,0.000075972996,0.000066907734,0.000041128096,0.000024265451,0.00046979755],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988632,0.00004844854,0.00032768628,0.00023043349,0.00030250696,0.00022770118],"domain_scores_gemma":[0.99918646,0.000068147754,0.00024492785,0.00033499624,0.000111366935,0.00005408914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017557884,0.00019190762,0.0006909784,0.00009751961,0.00004843875,0.000014691241,0.00008364085,0.00008303445,0.00009127138],"category_scores_gemma":[0.000014858951,0.000121815836,0.00018199238,0.00014317181,0.00020685782,0.00009831443,0.000068979934,0.0001527655,0.0000029559699],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.073904954,0.10158153,0.3774993,0.0029270956,0.08044376,0.00060200685,0.0076379334,0.0014617702,0.28537154,0.008925617,0.017947393,0.041697074],"study_design_scores_gemma":[0.021048643,0.0022352417,0.94968534,0.00014020831,0.0038174544,0.000053984284,0.00013180145,0.00006848048,0.02231017,0.00010638793,0.00023548353,0.00016678522],"about_ca_topic_score_codex":0.0023596936,"about_ca_topic_score_gemma":0.00014279323,"teacher_disagreement_score":0.57218605,"about_ca_system_score_codex":0.00003783419,"about_ca_system_score_gemma":0.0000989137,"threshold_uncertainty_score":0.49675056},"labels":[],"label_agreement":null},{"id":"W2587491923","doi":"10.1182/blood.v116.21.1318.1318","title":"Cyclophosphamide and Prednisone Induction Effectively Decreased the Incidence of Engraftment Syndrome In Patients with POEMS Syndrome Who Undergo Stem Cell Transplantation.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; POEMS syndrome; Prednisone; Cyclophosphamide; Autologous stem-cell transplantation; Transplantation; Surgery; Internal medicine; Organomegaly; Gastroenterology; Stem cell; Chemotherapy; Polyneuropathy","score_opus":0.0047237940441878495,"score_gpt":0.19427146320136032,"score_spread":0.18954766915717247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587491923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988523,0.00015316234,0.000026160493,0.000072894014,0.000058817663,0.00071682094,0.000012542272,0.000017851547,0.00008942839],"genre_scores_gemma":[0.99966705,0.00007473496,0.000100846,0.0000617318,0.0000045632873,0.00003830557,0.000009622341,0.000015720141,0.000027398128],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99917305,0.000051690004,0.00018449027,0.00020909775,0.00023525022,0.00014644532],"domain_scores_gemma":[0.99955124,0.00007521555,0.000089018475,0.00016914928,0.000039629038,0.00007576134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001038096,0.00013134652,0.0002128369,0.000058183694,0.000053238768,0.00001022128,0.00005684152,0.00006206083,0.000008009367],"category_scores_gemma":[0.0000121633375,0.00008642691,0.000026227512,0.00018117402,0.00009387734,0.00009563552,0.0000122105175,0.00020287385,9.559652e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007963833,0.0014553224,0.98979676,0.0003556778,0.000057303616,0.0001786274,0.0009879902,0.000021308517,0.005606981,0.000036218353,0.0000044609656,0.0007029515],"study_design_scores_gemma":[0.0073665353,0.0015174807,0.9864208,0.00015438035,0.00013721104,0.00018592243,0.00011505958,0.000007962981,0.0039568474,0.000037917507,0.000005830804,0.00009401682],"about_ca_topic_score_codex":0.00026844238,"about_ca_topic_score_gemma":0.00024514465,"teacher_disagreement_score":0.006570152,"about_ca_system_score_codex":0.000011158109,"about_ca_system_score_gemma":0.00004617576,"threshold_uncertainty_score":0.3524387},"labels":[],"label_agreement":null},{"id":"W2587495422","doi":"10.1182/blood.v126.23.3176.3176","title":"Newly Diagnosed Myeloma (MM) Patients (Pts) with High-Risk (HR) Cytogenetics By FISH: Is There a Role for Tandem Autologous Stem Cell Transplantation (ASCT)?","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Autologous stem-cell transplantation; Multiple myeloma; Internal medicine; Bortezomib; Oncology; Transplantation; Median follow-up; Regimen; Surgery; Chemotherapy","score_opus":0.01698268058370789,"score_gpt":0.24718602575450516,"score_spread":0.23020334517079727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587495422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952871,0.00050904916,0.00031828767,0.00015560482,0.000046229063,0.001618141,0.0015107848,0.00007867661,0.00047608122],"genre_scores_gemma":[0.9957411,0.00033704465,0.0018155955,0.00014976317,0.00007036383,0.00026573706,0.0009433832,0.000059849255,0.00061711756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824053,0.000081250495,0.0002577393,0.00040290502,0.0005411683,0.0004763931],"domain_scores_gemma":[0.9987087,0.00015084217,0.00013711792,0.00032029426,0.00025166525,0.00043132872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010620108,0.00026327465,0.0003495533,0.0000714682,0.000113251444,0.000035954014,0.00012641409,0.00013816117,0.00002821554],"category_scores_gemma":[0.000027861146,0.00019379018,0.00008416339,0.0001426601,0.000049766655,0.000070376984,0.000016995686,0.00014346982,0.0000409534],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015599538,0.0030717973,0.95162666,0.00016244865,0.00049512315,0.00021209593,0.0015462223,0.0000089484965,0.00065809157,0.0000027204417,0.00378824,0.036867686],"study_design_scores_gemma":[0.09619193,0.010692586,0.74061716,0.00014477366,0.0015777422,0.00004308904,0.00048096167,0.0002992094,0.1461083,0.00006351003,0.0033408392,0.00043991493],"about_ca_topic_score_codex":0.00044053467,"about_ca_topic_score_gemma":0.00027155774,"teacher_disagreement_score":0.21100953,"about_ca_system_score_codex":0.000070591865,"about_ca_system_score_gemma":0.0001756944,"threshold_uncertainty_score":0.79025346},"labels":[],"label_agreement":null},{"id":"W2587506213","doi":"10.1182/blood.v108.11.2952.2952","title":"Prophylactic Use of Intravenous Immune Globulin in the Management of Patients Undergoing Hematopoietic Stem Cell Transplantation: A Systematic Review of Literature.","year":2006,"lang":"en","type":"review","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Randomized controlled trial; Hematopoietic stem cell transplantation; Context (archaeology); Transplantation; Internal medicine; Clinical trial; Systematic review; MEDLINE; Surgery","score_opus":0.021268841324957224,"score_gpt":0.2625792875384526,"score_spread":0.2413104462134954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587506213","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008052512,0.990065,0.00008709319,0.0000059993286,0.00005363832,0.008430441,0.00014155646,0.000012029472,0.0003990269],"genre_scores_gemma":[0.008325887,0.99003124,0.00068132504,0.000014864246,0.000010448634,0.000301656,0.00052341766,0.000052898395,0.000058264788],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9946747,0.00063615496,0.0032370116,0.0003457337,0.00086875854,0.00023765984],"domain_scores_gemma":[0.9963668,0.00059269875,0.0019435456,0.0008546513,0.0002011999,0.000041082432],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00072413887,0.00045824298,0.0034945898,0.0002813467,0.000019946454,0.00001587073,0.00031837367,0.00021924093,0.000008383547],"category_scores_gemma":[0.000015082582,0.00029610543,0.0005924465,0.0010241778,0.00005491569,0.00006990569,0.000017623552,0.00028885866,0.000005409804],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022566726,0.0016695315,0.000021698443,0.9954365,0.00036108898,0.00021172255,0.0010046458,7.1261996e-7,0.0000016266854,0.00010987109,0.0000016932576,0.0011583267],"study_design_scores_gemma":[0.0018349077,0.000319958,0.00008233158,0.96897495,0.027936557,0.00031921634,0.000095505115,4.9695893e-7,0.00013198974,0.0000056309523,0.000095178904,0.00020330319],"about_ca_topic_score_codex":0.000009603648,"about_ca_topic_score_gemma":0.0000017690492,"teacher_disagreement_score":0.027575469,"about_ca_system_score_codex":0.00005231594,"about_ca_system_score_gemma":0.00017500164,"threshold_uncertainty_score":0.9999491},"labels":[],"label_agreement":null},{"id":"W2587507882","doi":"10.1182/blood.v128.22.869.869","title":"A Single-Arm, Open-Label, Long-Term Efficacy and Safety Study of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Romiplostim; Medicine; Immune thrombocytopenia; Open label; Pediatrics; Adverse effect; Internal medicine; Thrombopoietin; Platelet","score_opus":0.020946883216061096,"score_gpt":0.2708640515756836,"score_spread":0.24991716835962252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587507882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966596,0.000585232,0.000001633197,0.000103550716,0.000013405324,0.002157885,0.000020772692,0.000025168658,0.00043277338],"genre_scores_gemma":[0.99947536,0.00013278189,0.0001331478,0.000021949727,0.00001148962,0.000023789462,0.000020280484,0.00003529582,0.00014591025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876547,0.000046539062,0.0003387014,0.00038522988,0.00019687672,0.000267167],"domain_scores_gemma":[0.99926436,0.00007392942,0.00012454609,0.0003999728,0.000039791215,0.00009740526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008551166,0.00022633093,0.00073590607,0.00008963222,0.00005535218,0.000024078057,0.00017250798,0.000066434346,0.000054950135],"category_scores_gemma":[0.000029204837,0.00013370052,0.000017561177,0.00017337989,0.000081394166,0.00010968306,0.00016219127,0.00009042108,0.000011672034],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029258474,0.049654547,0.92281705,0.000018944991,0.0010868878,0.0020594078,0.00042886095,2.3261809e-7,0.011935298,0.0000058937026,0.0000028888426,0.009064161],"study_design_scores_gemma":[0.09848542,0.01555754,0.8801256,0.00037115862,0.00062177243,0.0017979031,0.000035737085,3.597817e-7,0.0028246718,0.000009547348,0.0000018211464,0.00016851045],"about_ca_topic_score_codex":0.00023887627,"about_ca_topic_score_gemma":0.00032634268,"teacher_disagreement_score":0.09555957,"about_ca_system_score_codex":0.00003163083,"about_ca_system_score_gemma":0.000053374413,"threshold_uncertainty_score":0.5452149},"labels":[],"label_agreement":null},{"id":"W2587518903","doi":"10.1182/blood.v110.11.1198.1198","title":"Erythropoietin (Epo) Secreting Mesenchymal Stromal Cells and Autocrine Signalling Via the Epo Receptor. A Novel, Cell-Based Paracrine Epo Delivery System for Cardiovascular Therapy.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; Université de Montréal; Montreal Heart Institute; McGill University; Jewish General Hospital","funders":"","keywords":"Erythropoietin; Mesenchymal stem cell; Medicine; Paracrine signalling; Autocrine signalling; In vivo; Stromal cell; Erythropoietin receptor; Internal medicine; Cancer research; Pharmacology; Receptor; Pathology; Biology","score_opus":0.024114863043199628,"score_gpt":0.2581921462187034,"score_spread":0.23407728317550378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587518903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9463186,0.008668086,0.039617267,0.00036152924,0.0002856187,0.0032986274,0.000036800822,0.00019859393,0.0012148782],"genre_scores_gemma":[0.9867984,0.00019155662,0.011230839,0.00010282683,0.0009153962,0.00016072515,0.000055077515,0.00012692178,0.00041827263],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9953186,0.0002473954,0.0008722544,0.0009038569,0.0014084512,0.0012494309],"domain_scores_gemma":[0.9966985,0.0012132913,0.0002483418,0.00087303505,0.00048814932,0.00047870085],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0045351507,0.00051224255,0.000913111,0.00020940743,0.0005245622,0.00010530825,0.00034140903,0.00023840205,0.000117601456],"category_scores_gemma":[0.00017045066,0.00037309446,0.0007385088,0.00045368477,0.0002339968,0.0000888219,0.00015271192,0.0006294232,0.000028776889],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012471696,0.0008840949,0.003960398,0.0018007853,0.0014235972,0.0005082182,0.00038054623,0.00058823335,0.9842354,0.00006310575,0.00018379859,0.0047246185],"study_design_scores_gemma":[0.016074747,0.0018920783,0.0015320771,0.0005939386,0.0010429168,0.0005165666,0.0015108204,0.007550981,0.95352453,0.0000059476047,0.015070459,0.0006849655],"about_ca_topic_score_codex":0.0004763284,"about_ca_topic_score_gemma":0.000016087542,"teacher_disagreement_score":0.040479787,"about_ca_system_score_codex":0.00014418951,"about_ca_system_score_gemma":0.00027232905,"threshold_uncertainty_score":0.9998721},"labels":[],"label_agreement":null},{"id":"W2587520109","doi":"10.1182/blood.v120.21.545.545","title":"High Incidence of EZH2 Mutations with Variable Mutation Load in Follicular Lymphoma and Its Consequences for EZH2 Targeted Therapy","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"EZH2; Biology; Genetics; Histone; Histone methyltransferase; Mutation; Cancer research; DNA; Gene","score_opus":0.00738874545718747,"score_gpt":0.2308877728415228,"score_spread":0.22349902738433533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587520109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992281,0.0057578306,0.0014315117,0.0000514136,0.000045579956,0.00037679335,0.000026062515,0.0000063346283,0.000023439143],"genre_scores_gemma":[0.99555737,0.00016337392,0.0039321454,0.000025367777,0.000060281596,0.00008888764,0.00012442275,0.0000117974,0.00003638293],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99940276,0.000033167147,0.00015751389,0.00016149876,0.000097559125,0.00014746984],"domain_scores_gemma":[0.999583,0.000022700384,0.00010824147,0.00010409082,0.00014540518,0.00003656625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015648096,0.000089582616,0.00010636408,0.000038330414,0.000038054564,0.0000073233687,0.000047333084,0.000102603044,0.00000534279],"category_scores_gemma":[0.00005840413,0.00008136907,0.000020275265,0.00013839478,0.000057193738,0.000014552645,0.000011087173,0.000018519038,4.479052e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014237009,0.00016385344,0.0068825716,0.00002590404,0.000090790905,7.8354225e-7,0.00021659004,0.0010901265,0.9899633,0.00044800225,0.000014585546,0.00096110365],"study_design_scores_gemma":[0.0032657546,0.00035306337,0.029105706,0.00002939515,0.00004934028,0.000037184414,0.000058794853,0.0001987542,0.9662141,0.00028847318,0.0002703927,0.00012901078],"about_ca_topic_score_codex":0.0001361541,"about_ca_topic_score_gemma":0.00008553356,"teacher_disagreement_score":0.023749188,"about_ca_system_score_codex":0.000016483673,"about_ca_system_score_gemma":0.0001747244,"threshold_uncertainty_score":0.33181342},"labels":[],"label_agreement":null},{"id":"W2587525150","doi":"10.1182/blood.v106.11.386.386","title":"Characterization of siRNA-Mediated SBDS-Knockdown Cells: Specific Hypersensitivity to Fas Stimulation.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Gene knockdown; Biology; Molecular biology; Propidium iodide; Cancer research; Transfection; Apoptosis; Cell culture; Programmed cell death","score_opus":0.007147390928035185,"score_gpt":0.20655328532239883,"score_spread":0.19940589439436365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587525150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99792683,0.00013344752,0.00050486595,0.00010256971,0.0000562384,0.00019904671,0.00009055846,0.000012326064,0.000974098],"genre_scores_gemma":[0.99820566,0.000093905546,0.00065698713,0.00014764261,0.00015623178,0.000007755171,0.0004845453,0.00001623853,0.00023103534],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993467,0.000026167238,0.00015724207,0.0002307574,0.00009605099,0.00014310339],"domain_scores_gemma":[0.9995707,0.0000066379043,0.000065447835,0.00021797026,0.00007077091,0.000068460366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000041849577,0.000114504335,0.00012171571,0.00003969808,0.00003822477,0.000010172946,0.000059703136,0.00008798171,0.000026579182],"category_scores_gemma":[0.000014054328,0.000112935544,0.00005414541,0.000095574076,0.000020576581,0.0000048308257,0.000038271686,0.000028989542,0.000059975653],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000324877,0.00069266855,0.002536289,0.000004760391,0.00005950624,0.0000019454212,0.000045300334,0.00008488202,0.992115,0.000007421683,0.00010022607,0.0043195155],"study_design_scores_gemma":[0.0014534539,0.00018105842,0.01583692,0.0000060594643,0.000039206792,0.000003163293,0.000012007288,0.00003585046,0.9692453,0.000002780015,0.0130603025,0.0001238893],"about_ca_topic_score_codex":0.000006016216,"about_ca_topic_score_gemma":0.000022684088,"teacher_disagreement_score":0.02286969,"about_ca_system_score_codex":0.000004692422,"about_ca_system_score_gemma":0.000021096506,"threshold_uncertainty_score":0.4605378},"labels":[],"label_agreement":null},{"id":"W2587547371","doi":"10.1182/blood.v106.11.4119.4119","title":"High Prevalence of Antibodies to the Heparin-Platelet Factor 4 Complex in Hemodialysis Patients.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Heparin; Hemodialysis; Platelet factor 4; Thrombosis; Dialysis; Heparin-induced thrombocytopenia; Internal medicine; Venous thrombosis; Platelet activation; Platelet; Antibody; Gastroenterology; Immunology; Surgery","score_opus":0.02960773321439803,"score_gpt":0.2807725684399619,"score_spread":0.2511648352255639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587547371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99711144,0.00005624738,0.0000069029925,0.0012552891,0.000061113264,0.00056648726,0.000075282456,0.000030042302,0.0008372156],"genre_scores_gemma":[0.998082,0.00009544004,0.0011283781,0.00039161666,0.0001052579,0.000021070491,0.000024469851,0.00001891865,0.0001328927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986221,0.000060230243,0.0004237912,0.0002933261,0.0002987619,0.00030179956],"domain_scores_gemma":[0.999112,0.00007919708,0.000096157746,0.0004893026,0.000105951665,0.00011739036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013408052,0.00017666697,0.00052782457,0.00013832701,0.000056740206,0.0000128766305,0.00022576688,0.00007515001,0.00040821033],"category_scores_gemma":[0.00012800474,0.00012454984,0.000104899525,0.0003399195,0.000060318165,0.00008190829,0.00011810099,0.0001511967,0.00014426016],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007169031,0.0018781936,0.9457087,0.00019267779,0.00022332974,0.000006667267,0.0014336616,0.000025261535,0.042470608,0.0001391287,0.00033605887,0.0075140293],"study_design_scores_gemma":[0.0023034548,0.00021103147,0.9063105,0.00007629261,0.00016607331,0.0000039977735,0.000029616633,0.000019913636,0.088820346,0.000016347005,0.0019137579,0.0001286543],"about_ca_topic_score_codex":0.0003362695,"about_ca_topic_score_gemma":0.0002681561,"teacher_disagreement_score":0.046349734,"about_ca_system_score_codex":0.000042210755,"about_ca_system_score_gemma":0.000048285056,"threshold_uncertainty_score":0.50789946},"labels":[],"label_agreement":null},{"id":"W2587561344","doi":"10.1182/blood.v104.11.3273.3273","title":"HLA-DR Protein Status Predicts Survival in Patients with Diffuse Large B Cell Lymphoma (DLBCL) Treated with the MACOP-B Chemotherapy Regimen.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Chemotherapy regimen; Regimen; Internal medicine; Diffuse large B-cell lymphoma; Oncology; Rituximab; Chemotherapy; Lymphoma","score_opus":0.004658303319586693,"score_gpt":0.19594653798043038,"score_spread":0.1912882346608437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587561344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99530303,0.00023196841,0.0000048603074,0.00064755353,0.000016805516,0.0021797328,0.00006876632,0.000091625814,0.0014556726],"genre_scores_gemma":[0.9983807,0.000050944,0.00020723075,0.0002942765,0.000048260947,0.00034277572,0.00013101473,0.00006827789,0.00047651381],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981499,0.000055431836,0.0002226639,0.00043342903,0.00053465395,0.0006039438],"domain_scores_gemma":[0.99900264,0.00003077156,0.00012953737,0.00053771207,0.000090947586,0.00020840808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008646515,0.00034381438,0.00039587516,0.00008545229,0.00009934737,0.000035760975,0.00010888221,0.00009619629,0.000024088698],"category_scores_gemma":[0.000007947774,0.00017717869,0.00006060862,0.00035549406,0.00007615471,0.00007854527,0.000026853024,0.00008650163,0.00002309856],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020354032,0.0673156,0.9280211,0.000055304452,0.00037085038,0.0003913772,0.00069687533,0.0000038387598,0.00013975124,0.0000544317,0.0000967656,0.0008187572],"study_design_scores_gemma":[0.25081664,0.0030058348,0.7216246,0.00023242715,0.0002637192,0.000010279598,0.00011716968,0.0000027233546,0.022770084,0.0000064871538,0.0009524456,0.00019756309],"about_ca_topic_score_codex":0.0006223484,"about_ca_topic_score_gemma":0.00026434648,"teacher_disagreement_score":0.24878125,"about_ca_system_score_codex":0.0002657275,"about_ca_system_score_gemma":0.0002676775,"threshold_uncertainty_score":0.72251374},"labels":[],"label_agreement":null},{"id":"W2587565674","doi":"10.1182/blood.v118.21.224.224","title":"Histone H3 Methylation Mediates All-Trans-Retinoic Acid Responsiveness in Acute Myeloid Leukemia","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Acute promyelocytic leukemia; Biology; Retinoic acid; Cancer research; Retinoic acid receptor; Tretinoin; Myeloid; Myeloid leukemia; Cellular differentiation; Differentiation therapy; Haematopoiesis; Leukemia; Epigenetics; CD33; Stem cell; Cell biology; Immunology; CD34; Biochemistry; Cell culture; Genetics; Gene","score_opus":0.01402914846670297,"score_gpt":0.2536421106881606,"score_spread":0.23961296222145764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587565674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99174565,0.0042971075,0.0006548317,0.00004174991,0.00015834645,0.00018122478,0.0000113159995,0.000029083862,0.0028806916],"genre_scores_gemma":[0.99594486,0.0012930332,0.0016746534,0.00014855307,0.00013501546,0.000060016944,0.00018028262,0.000038636637,0.0005249254],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99856406,0.00013982711,0.0003192318,0.00046319782,0.00017492671,0.00033875598],"domain_scores_gemma":[0.99929863,0.000018801373,0.000110723886,0.0003882674,0.0000929412,0.00009065166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003424633,0.00022550992,0.0002249924,0.000096222255,0.00005465721,0.000014273715,0.00032297117,0.00031043208,0.000069634785],"category_scores_gemma":[0.000116381954,0.00022179369,0.00009535103,0.00016785871,0.00011756825,0.000010636891,0.000075137286,0.00016810282,0.000020575731],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023929168,0.00012058498,0.0040476345,0.000040482613,0.00010793567,0.000049742404,0.00047257138,0.0000049740397,0.99401796,0.000049102775,0.00008682089,0.0007629099],"study_design_scores_gemma":[0.001429085,0.00023877803,0.0054895557,0.00002103706,0.00012730034,0.000038671657,0.00007523753,0.000006406968,0.9883867,0.00030116242,0.0035997666,0.00028631795],"about_ca_topic_score_codex":0.00005032082,"about_ca_topic_score_gemma":0.00003818951,"teacher_disagreement_score":0.005631269,"about_ca_system_score_codex":0.000042996566,"about_ca_system_score_gemma":0.00024660368,"threshold_uncertainty_score":0.9044484},"labels":[],"label_agreement":null},{"id":"W2587613230","doi":"10.1182/blood.v128.22.1760.1760","title":"Burkitt Lymphoma Genome Sequencing Project (BLGSP): Introduction","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency; Simon Fraser University","funders":"","keywords":"Lymphoma; DNA sequencing; Biology; Immunology; Medicine; Oncology; Cancer research; DNA; Genetics","score_opus":0.018389300689762453,"score_gpt":0.24684720902255702,"score_spread":0.22845790833279456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587613230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993218,0.0005233922,0.00002864528,0.0028999345,0.00017085034,0.00038986083,0.000010680527,0.00012636535,0.0026322692],"genre_scores_gemma":[0.99577945,0.00021345713,0.0007036228,0.00018334527,0.0014399614,0.000096492346,0.000017194181,0.00002210761,0.0015443801],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990355,0.000022975943,0.00018335115,0.00032160516,0.00018987068,0.0002467106],"domain_scores_gemma":[0.99941653,0.000032974178,0.000057282607,0.0003445043,0.00006329345,0.00008539641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009533197,0.0001406711,0.00020750734,0.00009405722,0.000060192826,0.000014524431,0.000047926053,0.000062908715,0.00012463107],"category_scores_gemma":[0.00007084499,0.00008155396,0.00008926692,0.00013365106,0.00003782108,0.00008269032,0.000027910959,0.000019243214,0.00025968795],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030632908,0.005486795,0.14675994,0.00018226783,0.0014329995,0.001136111,0.00087066245,7.791285e-7,0.6737496,0.0024723941,0.0068633403,0.16073878],"study_design_scores_gemma":[0.031649463,0.0016640171,0.3362375,0.00025738572,0.0012631832,0.002450387,0.00019437277,0.0000037387463,0.48296806,0.00026328184,0.14256565,0.0004829435],"about_ca_topic_score_codex":0.000094927746,"about_ca_topic_score_gemma":0.0000053078415,"teacher_disagreement_score":0.19078153,"about_ca_system_score_codex":0.0003274391,"about_ca_system_score_gemma":0.00022950038,"threshold_uncertainty_score":0.33378497},"labels":[],"label_agreement":null},{"id":"W2587615733","doi":"10.1182/blood.v126.23.443.443","title":"Targeting MTHFD2 in Acute Myeloid Leukemia","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"","keywords":"Gene knockdown; Myeloid; Cancer research; Myeloid leukemia; Biology; Retinoic acid; Leukemia; Tretinoin; Acute promyelocytic leukemia; Cell growth; Cellular differentiation; Cell culture; Downregulation and upregulation; Molecular biology; Immunology; Biochemistry; Gene; Genetics","score_opus":0.026030473170628274,"score_gpt":0.2961985301848284,"score_spread":0.2701680570142001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587615733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9777326,0.0006601033,0.000058528465,0.0010669028,0.00010069519,0.00038470665,0.0000058402716,0.00011786652,0.019872744],"genre_scores_gemma":[0.9893505,0.00013211652,0.0055330354,0.0006060984,0.00043192864,0.000044507917,0.000056455618,0.000053835374,0.0037914955],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99824256,0.00006737815,0.00030440246,0.000334794,0.00049452105,0.00055636273],"domain_scores_gemma":[0.998993,0.0000594903,0.000050027415,0.00036892065,0.00014415203,0.00038445773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006690324,0.00016739362,0.0003455301,0.00022341336,0.000035189263,0.000023498562,0.00019596344,0.00015363704,0.000087022745],"category_scores_gemma":[0.0005149831,0.00014714133,0.000061189545,0.00048262233,0.00006922123,0.000117468946,0.00015790321,0.00057047734,0.0005416383],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016513168,0.0019884023,0.5120607,0.00035328983,0.0010865703,0.013554339,0.005935436,0.00017547654,0.296371,0.0009662189,0.15352666,0.012330566],"study_design_scores_gemma":[0.18757938,0.005303226,0.18398575,0.0011969014,0.00206862,0.0056684455,0.0071029207,0.014288945,0.326203,0.0028277647,0.2603405,0.0034345442],"about_ca_topic_score_codex":0.00023515549,"about_ca_topic_score_gemma":0.000014814221,"teacher_disagreement_score":0.32807496,"about_ca_system_score_codex":0.0006115752,"about_ca_system_score_gemma":0.0012087156,"threshold_uncertainty_score":0.6961845},"labels":[],"label_agreement":null},{"id":"W2587618690","doi":"10.1182/blood.v112.11.1283.1283","title":"Oral Warfarin Remains An Effective Treatment Option in the Extended Prophylaxis of VTE for Patients with Cancer: The Effectiveness of the CancerCare Manitoba (CCMB) Anticoagulation Clinic (ACC).","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Medicine; Warfarin; Vitamin K antagonist; Cancer; Retrospective cohort study; Internal medicine; Propensity score matching; Adverse effect; Thrombosis; Low molecular weight heparin; Intensive care medicine; Surgery; Atrial fibrillation","score_opus":0.02263754326444142,"score_gpt":0.29465378401392667,"score_spread":0.27201624074948527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587618690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99287355,0.0001385711,0.00003079572,0.00005622755,0.00010419118,0.0066631404,0.0000357939,0.000009243529,0.000088496825],"genre_scores_gemma":[0.9983342,0.00016138914,0.00007097811,0.000033197663,0.000051851515,0.0012973123,0.000025056333,0.000018033223,0.00000796713],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986435,0.0004349471,0.00024445742,0.00023026142,0.0002812221,0.00016559957],"domain_scores_gemma":[0.99889535,0.00027743523,0.00019903512,0.00042768582,0.00017854743,0.000021956137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044114311,0.00015186754,0.00040557724,0.00004938386,0.00013362894,0.000005604104,0.00013777179,0.00005199824,0.000004499249],"category_scores_gemma":[0.000053956348,0.00006570174,0.000108329295,0.00023730482,0.000118402546,0.00005850465,0.000025518051,0.00007836095,4.210745e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014156271,0.0074998746,0.9722508,0.0004924489,0.00043961467,0.0000039793904,0.0023918056,0.00029521904,0.00054947817,0.000219971,0.000010450715,0.014430685],"study_design_scores_gemma":[0.0070354342,0.0061938465,0.97874725,0.00033837344,0.0006329051,0.0000021565954,0.00039431278,0.00004722578,0.0064407876,0.00007033976,0.000022731723,0.000074653944],"about_ca_topic_score_codex":0.0030601802,"about_ca_topic_score_gemma":0.005213004,"teacher_disagreement_score":0.014356031,"about_ca_system_score_codex":0.00017913264,"about_ca_system_score_gemma":0.00008208413,"threshold_uncertainty_score":0.46260974},"labels":[],"label_agreement":null},{"id":"W2587621549","doi":"10.1182/blood.v116.21.1877.1877","title":"Incidence and Characteristics of Secondary Myelodysplastic Syndrome Developing During Lenalidomide-Based Regimens In Relapsed and/or Refractory Multiple Myeloma Patients","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Lenalidomide; Medicine; Multiple myeloma; Internal medicine; Melphalan; Cyclophosphamide; Oncology; Prednisone; Incidence (geometry); Surgery; Gastroenterology; Chemotherapy","score_opus":0.01179877410903639,"score_gpt":0.24880662209415666,"score_spread":0.23700784798512026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587621549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991603,0.000070516675,0.0000067319315,0.00005556221,0.00007021049,0.0005252232,0.00005011777,0.00002783405,0.00003349647],"genre_scores_gemma":[0.9969035,0.00004926462,0.002807439,0.00003484748,0.000022619477,0.00004082085,0.000049374627,0.00002976268,0.00006236227],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849063,0.00005544519,0.00043807985,0.00035725924,0.0003051549,0.00035341203],"domain_scores_gemma":[0.99873567,0.00046809227,0.00016783712,0.00027269445,0.00012586296,0.00022985102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018108432,0.00020742069,0.00045117064,0.0002822748,0.000085670436,0.000017551241,0.00007714601,0.00013868455,0.000039533934],"category_scores_gemma":[0.0015279168,0.0001713527,0.00003368404,0.0001731007,0.00015610269,0.00010174293,0.00009562925,0.00042926666,0.000005329647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011305095,0.0005797358,0.95863944,0.00063492276,0.00007686586,0.00089036126,0.0001490734,1.0421234e-7,0.035391092,0.0000052698942,0.0000014676327,0.0025011478],"study_design_scores_gemma":[0.01964252,0.00055985665,0.96310735,0.0006242918,0.00006365491,0.00022131485,0.000023150378,0.00009803847,0.015473924,0.000006628481,0.000017614999,0.0001616416],"about_ca_topic_score_codex":0.0000724646,"about_ca_topic_score_gemma":0.00018084534,"teacher_disagreement_score":0.01991717,"about_ca_system_score_codex":0.00004906645,"about_ca_system_score_gemma":0.00031922112,"threshold_uncertainty_score":0.69875604},"labels":[],"label_agreement":null},{"id":"W2587629215","doi":"10.1182/blood.v116.21.1357.1357","title":"The Addition of Rituximab and/or Alpha-Interferon to High Dose Chemotherapy and Autologous Stem Cell Transplantation for Patients with Relapsed Follicular Lymphoma Produces Durable Progression Free Survival and Molecular Remissions","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; St. Michael's Hospital; University of Toronto; University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Autologous stem-cell transplantation; Follicular lymphoma; Internal medicine; Oncology; Transplantation; Rituximab; Minimal residual disease; Chemotherapy; Surgery; Gastroenterology; Lymphoma; Leukemia","score_opus":0.005183612643181809,"score_gpt":0.22653661867834285,"score_spread":0.22135300603516103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587629215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971203,0.00031538654,0.000026051039,0.0008427512,0.000049619466,0.0015161214,0.00008268329,0.00002250594,0.000024570385],"genre_scores_gemma":[0.99715227,0.00026405105,0.0021707662,0.0000343106,0.00001764478,0.00023532908,0.000072736446,0.000019071016,0.000033823184],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992107,0.00002734347,0.00016857423,0.0002726103,0.00017665674,0.00014407799],"domain_scores_gemma":[0.99938214,0.00011169682,0.000092428156,0.00021925088,0.00009099651,0.00010351793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010134796,0.00014057719,0.00022087358,0.000035202745,0.00013888394,0.000024209632,0.00004269641,0.00007208486,0.0000029989312],"category_scores_gemma":[0.0000213315,0.000074241536,0.00002492576,0.000058590573,0.000056908746,0.000050596354,0.000013762597,0.000033228767,1.748767e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029608665,0.023341382,0.2229162,0.0021074926,0.0011184382,0.00022178855,0.003593802,0.000001201059,0.2779298,0.0007339305,0.0006988644,0.43772843],"study_design_scores_gemma":[0.053753212,0.0057442286,0.43641397,0.00042424334,0.00061755267,0.000060692575,0.00010616071,0.00002339235,0.50226074,0.00007348391,0.00035825378,0.0001640245],"about_ca_topic_score_codex":0.000023822768,"about_ca_topic_score_gemma":0.000028009725,"teacher_disagreement_score":0.4375644,"about_ca_system_score_codex":0.000010748817,"about_ca_system_score_gemma":0.00004208116,"threshold_uncertainty_score":0.3027482},"labels":[],"label_agreement":null},{"id":"W2587636018","doi":"10.1182/blood.v110.11.3432.3432","title":"Primary Thyroid Lymphoma: A Retrospective IELSG and IIL Analysis of Clinical Characteristics, Prognostic Factors, Treatment Outcome and Somatic Hypermutation for Localized Diffuse Large B-Cell Lymphoma (DLBCL).","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Somatic hypermutation; Internal medicine; Gastroenterology; Chemotherapy; Lymphoma; Progressive disease; Oncology; Surgery; Immunology; B cell; Antibody","score_opus":0.025218768684155384,"score_gpt":0.3180286301361953,"score_spread":0.2928098614520399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587636018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99560106,0.0019355351,0.0004588254,0.000064964464,0.00008268807,0.0012792287,0.0004363566,0.000046871945,0.00009448896],"genre_scores_gemma":[0.99717337,0.00078525563,0.0011355961,0.000102356484,0.00009218629,0.00011935223,0.00047260153,0.00003497203,0.00008429983],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978358,0.00005300328,0.0009843882,0.0005204447,0.00025880415,0.00034754985],"domain_scores_gemma":[0.99808294,0.0007451246,0.00045237414,0.00031806473,0.00013974709,0.00026177996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037302368,0.0003138494,0.001425805,0.00023577556,0.00009355324,0.00002518925,0.00004638645,0.00015923714,0.000006765203],"category_scores_gemma":[0.0002601929,0.0002313772,0.00036478761,0.00026571134,0.00010400813,0.00006172076,0.000035309633,0.000040191877,0.0000011873],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046884487,0.028302362,0.96132207,0.00021148133,0.0024667578,0.000053376374,0.0004919877,5.7949755e-8,0.00034165336,0.000058737904,0.000006907517,0.006275744],"study_design_scores_gemma":[0.069257066,0.0025818609,0.91054326,0.000051920615,0.015325715,0.000012701749,0.0001729641,0.00016725979,0.0015728403,0.000024181154,0.00010861333,0.00018161612],"about_ca_topic_score_codex":0.00007354393,"about_ca_topic_score_gemma":0.00007389594,"teacher_disagreement_score":0.06878822,"about_ca_system_score_codex":0.00021725392,"about_ca_system_score_gemma":0.000116380266,"threshold_uncertainty_score":0.94352883},"labels":[],"label_agreement":null},{"id":"W2587669739","doi":"10.1182/blood.v110.11.5177.5177","title":"Cost of Myelosuppression with the Second Generation Tyrosine Kinase Inhibitors (TKIs) in Imatinib Resistant/Intolerant Chronic Myelogenous Leukemia (CML): An Economic Analysis Using Global Literature.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nilotinib; Medicine; Dasatinib; Neutropenia; Chronic myelogenous leukemia; Imatinib; Internal medicine; Anemia; Leukemia; Myeloid leukemia; Chemotherapy","score_opus":0.01814481978442503,"score_gpt":0.2816822068926222,"score_spread":0.2635373871081972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587669739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952289,0.003010724,0.00023531486,0.000052498443,0.000083219886,0.00084756094,0.0001784368,0.0000339388,0.00032940728],"genre_scores_gemma":[0.9966619,0.000047638747,0.0022205347,0.0000676361,0.0004304608,0.00002099084,0.00045089703,0.000035462006,0.00006445027],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977819,0.00011807422,0.00071648264,0.0005605516,0.0003325844,0.0004904506],"domain_scores_gemma":[0.99850553,0.000059399634,0.0003791104,0.00076451985,0.00011014119,0.00018131074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055000186,0.0003493621,0.000640374,0.0003073332,0.00014375344,0.000058891244,0.00016799086,0.00021104893,0.00016151095],"category_scores_gemma":[0.000018684304,0.00024048702,0.00016293375,0.0009658816,0.00013720634,0.00022241325,0.000053723274,0.0002663508,0.0000047527765],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030268107,0.0020206985,0.1232597,0.0005805655,0.0030742323,0.00133841,0.004035581,0.02056617,0.8320244,0.00016912466,0.0001772418,0.009727092],"study_design_scores_gemma":[0.03867926,0.0027882217,0.2927467,0.001302607,0.006459321,0.0006924206,0.0007390992,0.05024993,0.6047393,0.000025713456,0.0005893265,0.0009881187],"about_ca_topic_score_codex":0.0007635553,"about_ca_topic_score_gemma":0.019081526,"teacher_disagreement_score":0.22728509,"about_ca_system_score_codex":0.003854885,"about_ca_system_score_gemma":0.0011618261,"threshold_uncertainty_score":0.9999691},"labels":[],"label_agreement":null},{"id":"W2587685665","doi":"10.1182/blood.v128.22.lba-5.lba-5","title":"Results of the Persist-2 Phase 3 Study of Pacritinib (PAC) Versus Best Available Therapy (BAT), Including Ruxolitinib (RUX), in Patients (pts) with Myelofibrosis (MF) and Platelet Counts &lt;100,000/µl","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Ruxolitinib; Medicine; Internal medicine; Population; Adverse effect; Myelofibrosis; Clinical endpoint; Randomization; Intention-to-treat analysis; Randomized controlled trial; Gastroenterology; Phases of clinical research; Clinical trial; Bone marrow","score_opus":0.04798725098813239,"score_gpt":0.2931100426966477,"score_spread":0.2451227917085153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587685665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99392426,0.00025714966,2.0510298e-7,0.00015656122,0.00006903769,0.00096542743,0.00033508227,0.000010721191,0.004281539],"genre_scores_gemma":[0.9990965,0.00036828037,0.00006298706,0.000032526852,0.000036790458,0.00006538407,0.000016272315,0.000022996253,0.00029824086],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9985694,0.00008462101,0.0003838767,0.00032693718,0.00040189084,0.00023326257],"domain_scores_gemma":[0.9989208,0.0002744321,0.00019333896,0.00035197355,0.00017743169,0.00008204988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016575654,0.00020198573,0.0004220379,0.00009189149,0.00007812666,0.000010238313,0.00008913597,0.00006511865,0.00014323309],"category_scores_gemma":[0.0001278265,0.00010626975,0.00004895493,0.00019921255,0.00011357641,0.000067919376,0.000054819015,0.00008218943,0.000013357689],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009867222,0.024726728,0.9424865,0.00008910141,0.0007538883,0.000035568137,0.0031931428,4.0498512e-7,0.0018904789,0.00005386088,0.0012036645,0.01569944],"study_design_scores_gemma":[0.4275134,0.04215147,0.38559455,0.0020335235,0.00077620527,0.000015913782,0.0023509443,0.000005982926,0.13228667,0.00001680543,0.006755717,0.00049882557],"about_ca_topic_score_codex":0.00017840242,"about_ca_topic_score_gemma":0.000095544165,"teacher_disagreement_score":0.5568919,"about_ca_system_score_codex":0.000048982387,"about_ca_system_score_gemma":0.000059893646,"threshold_uncertainty_score":0.43335548},"labels":[],"label_agreement":null},{"id":"W2587687687","doi":"10.1182/blood.v108.11.2026.2026","title":"Isolated Brain Parenchyma Relapse of Non-Hodgkin’s Lymphoma (NHL): A Descriptive Analysis from the International Primary CNS Lymphoma Collaborative Group (IPCG).","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Lymphoma; Parenchyma; Biopsy; Brain biopsy; Internal medicine; Pathology; Radiology","score_opus":0.00713531801834996,"score_gpt":0.22517648998635367,"score_spread":0.2180411719680037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587687687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99065477,0.0017028212,0.00032978962,0.0018283101,0.00018701686,0.00064927933,0.00080451294,0.00006490159,0.0037786004],"genre_scores_gemma":[0.9951983,0.00014444726,0.0016077562,0.00066382124,0.00024581933,0.00018440254,0.0015584596,0.000037745318,0.0003592495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997664,0.00012405009,0.0006758858,0.00058144255,0.0006319772,0.00032266224],"domain_scores_gemma":[0.997917,0.00054839964,0.00039834357,0.0006314754,0.00038281217,0.000121952435],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021615917,0.00035693313,0.00075228297,0.0002628095,0.00013891594,0.00006854473,0.00030167153,0.00016958958,0.00021860261],"category_scores_gemma":[0.00010521468,0.00025429766,0.000436664,0.0013847635,0.00017607656,0.00013459063,0.00013473436,0.00006510801,0.000035544388],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014263019,0.016569227,0.8929415,0.000027688091,0.018940499,0.0007947479,0.0038482458,0.000034056357,0.013621503,0.00053672114,0.021397404,0.029862156],"study_design_scores_gemma":[0.014850707,0.00056832517,0.9685179,0.00012458187,0.004982674,0.000043125106,0.00082445657,0.00051695935,0.006419152,0.00019848105,0.0027088139,0.00024483554],"about_ca_topic_score_codex":0.006812473,"about_ca_topic_score_gemma":0.0016843263,"teacher_disagreement_score":0.07557644,"about_ca_system_score_codex":0.00045258307,"about_ca_system_score_gemma":0.00037922445,"threshold_uncertainty_score":0.99999094},"labels":[],"label_agreement":null},{"id":"W2587704547","doi":"10.1182/blood.v118.21.2899.2899","title":"3D Telomeric Profiles of MGUS, MMN and Relapsed MM","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Digital Imaging for Blood Diseases","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Manitoba; CancerCare Manitoba","funders":"","keywords":"Monoclonal gammopathy of undetermined significance; Telomere; Multiple myeloma; Cancer; Plasma cell leukemia; Pathology; Bone marrow; Internal medicine; Medicine; Biology; Oncology; Cancer research; Immunology; Monoclonal; Antibody; Monoclonal antibody; Genetics; DNA","score_opus":0.01658716510048859,"score_gpt":0.20774452592916468,"score_spread":0.19115736082867607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587704547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9508511,0.0013154593,0.0015408058,0.00005678757,0.00013362111,0.00018964028,0.000012504239,0.00026026368,0.045639843],"genre_scores_gemma":[0.9655474,0.000011305814,0.03417877,0.000062981184,0.000013250243,0.000009439859,0.0000011499394,0.000008660288,0.0001670565],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99927056,0.000012208419,0.00015175757,0.00024223464,0.00015119177,0.00017207097],"domain_scores_gemma":[0.9993744,0.000020465375,0.000076259574,0.00039399808,0.000040517116,0.00009436599],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000059316037,0.000097759,0.00013013602,0.00007705862,0.000028726834,0.000054297572,0.0004173097,0.000021496611,0.000008704973],"category_scores_gemma":[0.000055126002,0.00008793978,0.000036962265,0.00022484813,0.00010291901,0.00052928604,0.0002188782,0.00003793502,0.000024810328],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006741443,0.012075646,0.5214794,0.0008088503,0.0006018439,0.00041523745,0.0067053875,0.0000026059902,0.021126986,0.19211434,0.0035647757,0.2410375],"study_design_scores_gemma":[0.0064476277,0.0013774843,0.4752593,0.00037129517,0.0003628914,0.0003079087,0.00014650614,0.0010595085,0.46975812,0.04103439,0.0024766028,0.00139836],"about_ca_topic_score_codex":0.00002737015,"about_ca_topic_score_gemma":7.559003e-7,"teacher_disagreement_score":0.44863114,"about_ca_system_score_codex":0.0000022748052,"about_ca_system_score_gemma":0.000036518475,"threshold_uncertainty_score":0.358608},"labels":[],"label_agreement":null},{"id":"W2587711874","doi":"10.1182/blood.v128.22.3783.3783","title":"Acquired Hemophilia: A Ten Year Population-Based Review of Incidence Rate, Patient Demographics, and Treatment Outcomes in Manitoba, Canada","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba","funders":"","keywords":"Medicine; Population; Incidence (geometry); Medical record; Pediatrics; Internal medicine; Adverse effect","score_opus":0.021216213760439154,"score_gpt":0.2664735071195586,"score_spread":0.24525729335911944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587711874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928375,0.0027918136,4.1668216e-7,0.0034981412,0.000025651396,0.00070699136,0.000033933513,0.00000999745,0.00009558535],"genre_scores_gemma":[0.9953703,0.0039865165,0.00014850407,0.00025313525,0.000014833715,0.000053802003,0.00002305339,0.000011094808,0.0001387072],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897635,0.00006550744,0.00029692045,0.00020054834,0.00026994164,0.00019071276],"domain_scores_gemma":[0.9993149,0.00017569785,0.0000688761,0.0002457915,0.00007710627,0.00011763635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000116761985,0.00013134776,0.0003821617,0.00010699449,0.000026751573,0.0000027959215,0.000044680477,0.000044926386,0.00004053856],"category_scores_gemma":[0.00018272702,0.00007063096,0.000058856844,0.00018376885,0.00004238567,0.000030986408,0.000019105537,0.000028486174,0.000002164913],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003240645,0.00040269815,0.99537367,0.0004221452,0.000070163565,0.00011056689,0.0000098571145,9.568358e-8,0.0002566777,0.000011675094,0.000058762354,0.003251307],"study_design_scores_gemma":[0.0037132318,0.00045127835,0.9904194,0.00285009,0.00012638886,0.0000068189393,0.000025906862,0.0000029252526,0.002170585,0.000016723137,0.00013045635,0.000086227956],"about_ca_topic_score_codex":0.10110434,"about_ca_topic_score_gemma":0.21352828,"teacher_disagreement_score":0.11242394,"about_ca_system_score_codex":0.00015503343,"about_ca_system_score_gemma":0.00038115509,"threshold_uncertainty_score":0.9048815},"labels":[],"label_agreement":null},{"id":"W2587728357","doi":"10.1182/blood.v106.11.1002.1002","title":"Clonotypic IgG B Cells in Waldenstrom Macroglobulinemia Cells Are Derived from Multiple Post-Transformed B Cells That Have Undergone Isotype Switch Recombination.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Immunoglobulin class switching; Biology; Waldenstrom macroglobulinemia; Macroglobulinemia; Isotype; Somatic hypermutation; Molecular biology; Cytidine deaminase; Immunoglobulin M; Antibody; B cell; Immunoglobulin heavy chain; Immunoglobulin gene; Genetics; Immunology; Multiple myeloma; Immunoglobulin G; Monoclonal antibody; Lymphoma","score_opus":0.01643063475570199,"score_gpt":0.25124884265408703,"score_spread":0.23481820789838503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587728357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941011,0.00089020643,0.00020502806,0.0018082501,0.00037134672,0.0014410833,0.00021942383,0.00015701525,0.0008065565],"genre_scores_gemma":[0.99036825,0.0008069177,0.0050585545,0.00070891296,0.0003926703,0.00006991092,0.00029500137,0.00011904206,0.0021807677],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9961821,0.00014407576,0.00076855754,0.0009344716,0.0008853935,0.001085439],"domain_scores_gemma":[0.9975328,0.0005807873,0.00022215242,0.00091695663,0.00027976092,0.00046757655],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003282134,0.00051178294,0.00080938305,0.000321353,0.00012646116,0.00007650297,0.0004503949,0.00050820253,0.0008221676],"category_scores_gemma":[0.00013032908,0.00049309066,0.000248483,0.00037552183,0.00015578666,0.00023864096,0.00014554553,0.0007815639,0.0009621398],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013203793,0.0037335895,0.007978657,0.00030168393,0.00036574685,0.0008140612,0.0016819704,0.00034690523,0.97680706,0.000008452746,0.0016840285,0.004957469],"study_design_scores_gemma":[0.063749924,0.0002690179,0.012913263,0.0003192675,0.00024254303,0.00006427407,0.0008431461,0.0077302614,0.9117264,0.0000661877,0.0015739503,0.00050173025],"about_ca_topic_score_codex":0.0035308194,"about_ca_topic_score_gemma":0.0055080084,"teacher_disagreement_score":0.06508062,"about_ca_system_score_codex":0.0047912057,"about_ca_system_score_gemma":0.0026893057,"threshold_uncertainty_score":0.9998157},"labels":[],"label_agreement":null},{"id":"W2587729638","doi":"10.1182/blood.v122.21.346.346","title":"Characterization Of The Effects Of Mutated EZH2 On Expression and Epigenome In a Mouse Lymphoma Model","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Biology; H3K4me3; Germinal center; Epigenome; Cancer research; Molecular biology; Lymphoma; Carcinogenesis; EZH2; Epigenetics; Gene expression; Gene; B cell; DNA methylation; Genetics; Antibody; Promoter; Immunology","score_opus":0.004139031775691935,"score_gpt":0.19539794545268896,"score_spread":0.19125891367699702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587729638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99930876,0.00021194277,0.00017558238,0.000009357914,0.000017021823,0.000220521,0.000006168981,0.0000015341211,0.000049133494],"genre_scores_gemma":[0.99952716,0.0002185778,0.00010773308,0.0000138618125,0.000009854647,0.000016332606,0.000021587874,0.000007396832,0.00007750784],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996191,0.000037424987,0.000121356316,0.00010510707,0.000055433295,0.00006156802],"domain_scores_gemma":[0.99971145,0.00000882863,0.00008056305,0.00014959827,0.000032804885,0.000016768194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000040764735,0.00005535383,0.00007211622,0.00002424256,0.0000132149735,0.0000033906215,0.000052074272,0.000067269175,9.846939e-7],"category_scores_gemma":[0.000042592445,0.000040686522,0.000020278776,0.000039830757,0.000022607745,0.0000022210127,0.00003892943,0.000015759237,3.0489306e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009584517,0.00014546527,0.0050297785,0.000037946265,0.000005342918,8.213761e-8,0.0000788754,0.00005633592,0.99381876,0.0000064390993,3.575062e-7,0.00081106124],"study_design_scores_gemma":[0.0007449755,0.00011975932,0.068380676,0.000028420738,0.0000056215026,1.1202949e-7,0.000003236358,0.0003855591,0.930208,0.00007733236,0.000005763002,0.00004050477],"about_ca_topic_score_codex":0.000014368126,"about_ca_topic_score_gemma":0.0000024804135,"teacher_disagreement_score":0.06361069,"about_ca_system_score_codex":0.0000019002993,"about_ca_system_score_gemma":0.000013952002,"threshold_uncertainty_score":0.16591482},"labels":[],"label_agreement":null},{"id":"W2587760167","doi":"10.1182/blood.v120.21.2068.2068","title":"Utility of Pre-Induction Cardiac Function Testing in Patients with Newly Diagnosed AML","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Induction chemotherapy; Ejection fraction; Cardiotoxicity; Cardiac function curve; Anthracycline; Internal medicine; Chemotherapy regimen; Cardiac monitoring; Intensive care medicine; Regimen; Chemotherapy; Cardiology; Surgery; Cancer; Heart failure; Breast cancer","score_opus":0.016550819785777104,"score_gpt":0.23072413708446254,"score_spread":0.21417331729868544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587760167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997934,0.00007582175,0.00008276536,0.000014059253,0.0001467849,0.0004821275,0.000005174137,0.00003475122,0.0012245126],"genre_scores_gemma":[0.9991637,0.0000034057837,0.0005060774,0.000031452477,0.00021027033,0.00001687853,0.000036791196,0.0000132554205,0.000018167935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992632,0.00004464172,0.00017505835,0.00013403241,0.00021653014,0.00016651017],"domain_scores_gemma":[0.9995084,0.00004863418,0.00008860425,0.00017877945,0.00010880769,0.000066815446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001935776,0.00009022874,0.00021278013,0.000065079774,0.00002576074,0.0000035110766,0.00001965502,0.000086502674,0.000013077166],"category_scores_gemma":[0.00013396086,0.00007859776,0.000048704518,0.00025620998,0.000027066082,0.0001680101,0.0000077682525,0.00012687067,0.0000021932162],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020906284,0.00086237484,0.9442004,0.000057065263,0.00006403326,2.9495638e-7,0.00033438017,0.000002297378,0.041209392,0.000006179555,0.00001533471,0.0130391875],"study_design_scores_gemma":[0.0038667328,0.00028919976,0.8507078,0.000087408574,0.00014906467,0.0000014840723,0.000070265334,0.000005355089,0.14470033,0.000008986262,0.00004992567,0.000063387386],"about_ca_topic_score_codex":0.00011623006,"about_ca_topic_score_gemma":0.000007021024,"teacher_disagreement_score":0.10349095,"about_ca_system_score_codex":0.000023259105,"about_ca_system_score_gemma":0.000039830793,"threshold_uncertainty_score":0.32051235},"labels":[],"label_agreement":null},{"id":"W2587764677","doi":"10.1182/blood.v112.11.441.441","title":"Fanconi Anemia and the Response of Human Hematopoietic Cells to DNA Damage","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Fanconi anemia; Biology; Haematopoiesis; Stem cell; DNA damage; Cell biology; DNA repair; Progenitor cell; FANCD2; Genome instability; Cancer research; Molecular biology; Genetics; DNA","score_opus":0.007441763793669121,"score_gpt":0.22541427407332226,"score_spread":0.21797251027965314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587764677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989201,0.00017113336,0.000040926716,0.00008475171,0.000027821325,0.000180089,0.000006074738,0.000008805983,0.0005603397],"genre_scores_gemma":[0.99834347,0.000019891337,0.00053643284,0.0001853799,0.000035349247,0.00001336481,0.0000037568018,0.000013401311,0.00084895734],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999372,0.00010110653,0.00013241153,0.00018659406,0.000083854175,0.00012400653],"domain_scores_gemma":[0.9994627,0.00002319609,0.000044382836,0.0003856158,0.000030084024,0.000054023305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002647132,0.000086378386,0.000121763325,0.00002076911,0.000070820024,0.0000066298967,0.00014490317,0.00006811626,0.00001091173],"category_scores_gemma":[0.000058324968,0.00006557088,0.000048693048,0.000047634174,0.00013003149,0.0000013456146,0.00012353844,0.00003886774,0.000006236143],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019641168,0.00006112633,0.00014753421,0.000011895085,0.000016786656,0.000011993987,0.00028493727,9.032103e-7,0.998774,0.00015985823,0.00032444028,0.00001014726],"study_design_scores_gemma":[0.0016052646,0.00029620188,0.001240161,0.0000075502585,0.000023035116,0.00005728408,0.00008325591,9.2813383e-7,0.9959792,0.00008067961,0.00054451596,0.00008191188],"about_ca_topic_score_codex":0.0000075886423,"about_ca_topic_score_gemma":0.0000048802135,"teacher_disagreement_score":0.0027947542,"about_ca_system_score_codex":0.0000017128652,"about_ca_system_score_gemma":0.000027202594,"threshold_uncertainty_score":0.26739028},"labels":[],"label_agreement":null},{"id":"W2587772896","doi":"10.1182/blood.v104.11.608.608","title":"Phase II Trial of Bortezomib in Mantle Cell Lymphoma.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; BC Cancer Agency; Princess Margaret Cancer Centre; University Health Network; Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Medicine; Bortezomib; Mantle cell lymphoma; Nausea; Internal medicine; Surgery; Neutropenia; Adverse effect; Chills; Vomiting; Progressive disease; Phases of clinical research; Gastroenterology; Chemotherapy; Multiple myeloma; Lymphoma","score_opus":0.013791357118979336,"score_gpt":0.2736314929560739,"score_spread":0.2598401358370946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587772896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99136734,0.0005037979,0.0000014621581,0.000223835,0.000084497115,0.00044011892,0.000012698994,0.000017140788,0.0073491205],"genre_scores_gemma":[0.99913764,0.00011265451,0.00032507,0.00008482102,0.00009201252,0.000046143516,0.000019007737,0.000010636909,0.00017202752],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992968,0.000009578536,0.00023714679,0.00015487989,0.00014970156,0.0001519103],"domain_scores_gemma":[0.9996157,0.00001799015,0.00005918565,0.00021540682,0.00001946313,0.00007220008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006241664,0.00009572329,0.00026125548,0.00007456142,0.000021931442,0.0000031947955,0.00004144555,0.000056464385,0.000043150998],"category_scores_gemma":[0.000016465989,0.00007639461,0.00009182108,0.00011605429,0.000023017405,0.000025738464,0.000023287996,0.000021596641,0.000026503625],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031220231,0.87330747,0.020942917,0.00026538578,0.0004909489,0.0030616615,0.0018253486,0.0000098124765,0.026316697,0.001570641,0.0008040317,0.040184855],"study_design_scores_gemma":[0.71686107,0.0064353044,0.0048671695,0.000070396956,0.00023170967,0.000026241638,0.00003550023,0.0000012812143,0.27031448,0.000112349204,0.0009758804,0.00006860915],"about_ca_topic_score_codex":0.00022422263,"about_ca_topic_score_gemma":0.000019960693,"teacher_disagreement_score":0.8668722,"about_ca_system_score_codex":0.00006409906,"about_ca_system_score_gemma":0.00016861492,"threshold_uncertainty_score":0.31152818},"labels":[],"label_agreement":null},{"id":"W2587780046","doi":"10.1182/blood.v120.21.3701.3701","title":"Overall Survival Benefit for Patients with Relapsed Hodgkin Lymphoma Treated with Brentuximab Vedotin After Autologous Stem Cell Transplant","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Brentuximab vedotin; Autologous stem-cell transplantation; Internal medicine; Oncology; Hazard ratio; Univariate analysis; Cohort; Surgery; Transplantation; Lymphoma; Hodgkin lymphoma; Multivariate analysis; Confidence interval","score_opus":0.007492525847188684,"score_gpt":0.1969964912514361,"score_spread":0.1895039654042474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587780046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997015,0.0005287393,0.000019181554,0.000058601934,0.00009364489,0.0012523334,0.0002828018,0.00010584467,0.0006438639],"genre_scores_gemma":[0.99778116,0.000028606635,0.000654018,0.000113845395,0.00008759181,0.0004866228,0.00035154863,0.000070922535,0.00042565702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837255,0.000031194035,0.00026379921,0.00037831682,0.0003462102,0.00060794264],"domain_scores_gemma":[0.9990458,0.00009921621,0.00011641144,0.0003527768,0.00010258259,0.0002832235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000660199,0.00036553992,0.0005181646,0.00007562302,0.000077633995,0.00002267064,0.00006931246,0.00012910434,0.000040129315],"category_scores_gemma":[0.0000018173245,0.00022571681,0.00012388437,0.00010514027,0.000041774016,0.00010989945,0.000012698444,0.000047123678,0.000028077327],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004569617,0.014340198,0.9761149,0.00012327533,0.00053525326,0.00012152752,0.0005175664,0.000001283271,0.000043134467,0.000038121332,0.000044556367,0.0035505178],"study_design_scores_gemma":[0.07057859,0.0042737015,0.9136889,0.00020068475,0.0019830656,0.00006758479,0.000030218062,0.000006796053,0.008339108,0.0000022075592,0.00052683486,0.00030229357],"about_ca_topic_score_codex":0.000104814375,"about_ca_topic_score_gemma":0.00003902416,"teacher_disagreement_score":0.06600897,"about_ca_system_score_codex":0.00011947443,"about_ca_system_score_gemma":0.00007418379,"threshold_uncertainty_score":0.92044646},"labels":[],"label_agreement":null},{"id":"W2587781085","doi":"10.1182/blood.v128.22.987.987","title":"Donor Chip Causes Donor-Derived Clonal Hematopoiesis As an Early Complication of Allogeneic Stem Cell Transplantation","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Stem cell; Transplantation; Haematopoiesis; Hematopoietic stem cell transplantation; Immunology; Leukemia; Myeloid leukemia; Myeloid; Medicine; Biology; Cancer research; Internal medicine; Genetics","score_opus":0.02612325067268327,"score_gpt":0.2787777229280316,"score_spread":0.2526544722553483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587781085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972839,0.0001278908,0.00046946487,0.00061555445,0.000023479335,0.00048385054,0.00007026535,0.000068098794,0.00085751194],"genre_scores_gemma":[0.9978417,0.0002557404,0.0009828719,0.00009576647,0.00009667195,0.0000566244,0.00006486267,0.000033574983,0.0005721784],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99863505,0.000096672804,0.0003238928,0.00031971614,0.00035856242,0.00026607525],"domain_scores_gemma":[0.9989556,0.00014279337,0.00012316016,0.00041625678,0.00017654344,0.0001856432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017432205,0.00015368874,0.00028506757,0.00013131271,0.00005955606,0.000012622008,0.00017391058,0.000119734905,0.00016046323],"category_scores_gemma":[0.000013935095,0.00011024472,0.000081486636,0.00013860848,0.00011016826,0.0001444808,0.000021832298,0.00010227588,0.00016837462],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003871854,0.00047606986,0.050368365,0.00024107666,0.00010050695,0.00003310875,0.0005538467,4.5681773e-7,0.9460856,0.0002975008,0.000044196826,0.0014121223],"study_design_scores_gemma":[0.0043921047,0.000497805,0.2511226,0.0000937057,0.00020583764,0.00011347489,0.000073032126,0.0000039436336,0.743224,0.000070743496,0.00008857903,0.00011417929],"about_ca_topic_score_codex":0.00020498478,"about_ca_topic_score_gemma":0.000033786506,"teacher_disagreement_score":0.20286156,"about_ca_system_score_codex":0.00006469414,"about_ca_system_score_gemma":0.00022128598,"threshold_uncertainty_score":0.44956493},"labels":[],"label_agreement":null},{"id":"W2587785428","doi":"10.1182/blood.v108.11.347.347","title":"Delays in the Cancer Pathway from Symptom Onset to Initiation of Treatment – A Retrospective Study in Patients with Non-Hodgkin’s Lymphoma.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; Hematology; Referral; Cancer; Retrospective cohort study; Stage (stratigraphy); Internal medicine; Biopsy; Lymphoma; Pediatrics; Pathological; Surgery; Family medicine","score_opus":0.00785519564484285,"score_gpt":0.24023190710277345,"score_spread":0.2323767114579306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587785428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973735,0.00008014874,0.0000010368925,0.0000957529,0.000025669375,0.0017936521,0.00020123462,0.000008856685,0.00042012928],"genre_scores_gemma":[0.99880534,0.000008969921,0.000084833955,0.000107500586,0.000037219903,0.0008271022,0.000107686414,0.000014129609,0.000007238664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99894154,0.00006242968,0.0002621222,0.00029231858,0.0002730372,0.00016855121],"domain_scores_gemma":[0.9994514,0.000059344395,0.00008948187,0.000296355,0.000067501176,0.000035929475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007109422,0.00016469425,0.00032248694,0.00011814165,0.000026211088,0.000011208035,0.00006209276,0.000040761875,0.000015688049],"category_scores_gemma":[0.000010196835,0.0000950385,0.00003873594,0.0003122875,0.000014392326,0.000039390474,0.000015696882,0.000026114103,0.0000053358244],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033746,0.022712497,0.97179115,0.0000032962396,0.00015514044,0.00008599797,0.0035983715,0.000019627962,0.000014865701,0.000009782194,0.00002358432,0.0012482379],"study_design_scores_gemma":[0.03286655,0.0048764157,0.9598373,0.00011854691,0.00027518286,0.000001201847,0.00044114728,0.000004593865,0.0014516251,0.000024452012,0.000013167951,0.0000898189],"about_ca_topic_score_codex":0.031137163,"about_ca_topic_score_gemma":0.02045834,"teacher_disagreement_score":0.03252909,"about_ca_system_score_codex":0.0007447467,"about_ca_system_score_gemma":0.00016964524,"threshold_uncertainty_score":0.9974157},"labels":[],"label_agreement":null},{"id":"W2587789435","doi":"10.1182/blood.v116.21.1090.1090","title":"Thromboprophylaxis In Multiple Myeloma Patients Undergoing Immunomodulatory Therapy with Thalidomide and Lenalidomide: A Systematic Review and Meta-Analysis.","year":2010,"lang":"en","type":"review","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McMaster University; University of Ottawa","funders":"","keywords":"Medicine; Lenalidomide; Thalidomide; Internal medicine; Multiple myeloma; Population; Warfarin; Dexamethasone; Surgery","score_opus":0.07006178504004101,"score_gpt":0.32787614210384375,"score_spread":0.25781435706380273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587789435","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004002814,0.9868536,0.0000017458825,0.000028344286,0.000010278836,0.008908486,0.00010345415,0.00003244959,0.00005884967],"genre_scores_gemma":[0.007051252,0.9903174,0.000408579,0.00010496395,0.00001606292,0.0016244835,0.00023308695,0.00010072693,0.00014343498],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9959467,0.00068523013,0.0012701645,0.00093058776,0.00065050996,0.0005168182],"domain_scores_gemma":[0.99682915,0.0007971923,0.00071557,0.0011692246,0.0001726534,0.0003162316],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00075868977,0.0008725625,0.010610029,0.00063870376,0.000118401615,0.00008574541,0.00020705184,0.00031007515,0.00006979902],"category_scores_gemma":[0.0004997579,0.00045977574,0.0012548962,0.00084929616,0.00016748888,0.00012612862,0.000121511766,0.0007190993,0.0000159595],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052177165,0.0010123813,0.0029235017,0.7414549,0.2481467,0.00019743538,0.000043410822,2.9214954e-8,9.110794e-7,0.000004388035,0.0000029991195,0.0061611678],"study_design_scores_gemma":[0.009617868,0.00079250487,0.0024054633,0.058487386,0.9266337,0.00023483044,0.000010692746,0.000002337548,0.000004824111,0.0000060489733,0.0012292615,0.0005750474],"about_ca_topic_score_codex":0.00012766093,"about_ca_topic_score_gemma":0.0002884095,"teacher_disagreement_score":0.68296754,"about_ca_system_score_codex":0.0000738511,"about_ca_system_score_gemma":0.0002947521,"threshold_uncertainty_score":0.9997854},"labels":[],"label_agreement":null},{"id":"W2587791978","doi":"10.1182/blood.v126.23.1244.1244","title":"The Mir-193 Family Antagonizes Stem Cell Pathways and Is a Potent Tumor Suppressor in Childhood and Adult Acute Myeloid Leukemia","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Haematopoiesis; Cancer research; Myeloid; Biology; Stem cell; Progenitor cell; Myeloid leukemia; Leukemia; Immunology; Bone marrow; Context (archaeology); Cell biology","score_opus":0.007114890120533001,"score_gpt":0.1971312501784665,"score_spread":0.1900163600579335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587791978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991992,0.0072674653,0.000008387628,0.00010492557,0.00003896872,0.00025830657,0.00009912467,0.000009741106,0.00022106252],"genre_scores_gemma":[0.99880445,0.0005673736,0.00015636187,0.00023363797,0.000073627096,0.000025684825,0.000047488316,0.000019827577,0.000071543276],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991266,0.000052853913,0.00017347973,0.0003108594,0.00011604739,0.00022013296],"domain_scores_gemma":[0.99944687,0.000009273212,0.000071969436,0.00027749402,0.000065170934,0.0001292086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011748503,0.000149379,0.00012213892,0.000023313942,0.00007045768,0.000053384858,0.00011924975,0.00008779827,6.442716e-7],"category_scores_gemma":[0.000015550126,0.00011566786,0.00003521867,0.000047025736,0.00006994565,0.0000057127536,0.00014555595,0.000067723224,0.0000027118062],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008131789,0.00012313398,0.0032251612,0.000024093442,0.00006332039,0.000017824974,0.00039358257,0.000002693878,0.9939616,0.000014247417,0.0012676636,0.0008253913],"study_design_scores_gemma":[0.003698895,0.00021027311,0.0688472,0.000023290348,0.00009256928,0.00007201264,0.00051165384,0.0000681588,0.92393357,0.00009076118,0.0022224241,0.00022917123],"about_ca_topic_score_codex":0.000025311976,"about_ca_topic_score_gemma":0.000017057262,"teacher_disagreement_score":0.070027985,"about_ca_system_score_codex":0.00001493087,"about_ca_system_score_gemma":0.0001215449,"threshold_uncertainty_score":0.47167987},"labels":[],"label_agreement":null},{"id":"W2587810005","doi":"10.1182/blood.v128.22.2992.2992","title":"Serum Biomarkers Predict Outcomes in Advanced Hodgkin Lymphoma Independent of International Prognostic Score (IPS) and Treatment: Correlative Analysis from a Large North American Cooperative Group Trial","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Internal medicine; Medicine; Oncology; CD163; International Prognostic Index; Chemokine; Nodular sclerosis; Immunology; CXCL9; CD68; Lymphoma; Chemokine receptor; Rituximab; Receptor; Hodgkin lymphoma; Biology; Phenotype; Immunohistochemistry","score_opus":0.011030550047900448,"score_gpt":0.2558911846757545,"score_spread":0.24486063462785407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587810005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968216,0.00019096374,0.00004718109,0.0001790341,0.00009406832,0.0011748979,0.0013666508,0.00002622972,0.000099396784],"genre_scores_gemma":[0.99870664,0.00028768496,0.0002732568,0.000035654728,0.000038337006,0.0003204088,0.00025842927,0.000016149459,0.00006344905],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841595,0.00010661642,0.0004392706,0.00047234143,0.00032640883,0.00023943764],"domain_scores_gemma":[0.99879396,0.00048029795,0.00027030622,0.00023291665,0.000085224434,0.00013726816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007785072,0.00026352392,0.0007816552,0.00033827368,0.00003751998,0.000014601363,0.00007807954,0.000054221557,0.00007164757],"category_scores_gemma":[0.0001820799,0.00015434099,0.00019391577,0.0005073715,0.00013331596,0.00011657409,0.00005690155,0.000029732078,0.000005765219],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064774207,0.0068001994,0.95723474,0.0000033755282,0.008833811,0.00015781424,0.0005892376,0.0000017151481,0.000069269336,0.000021680744,0.0000030375274,0.019807683],"study_design_scores_gemma":[0.15548289,0.002812298,0.8381182,0.00008366235,0.0024004243,0.0000045047436,0.00026043743,0.00006173591,0.0006243746,0.0000051265474,0.000021893618,0.0001244657],"about_ca_topic_score_codex":0.00069429516,"about_ca_topic_score_gemma":0.0038431422,"teacher_disagreement_score":0.14900547,"about_ca_system_score_codex":0.0002538065,"about_ca_system_score_gemma":0.00010997018,"threshold_uncertainty_score":0.6293843},"labels":[],"label_agreement":null},{"id":"W2587819115","doi":"10.1182/blood.v104.11.2580.2580","title":"High Rate of Deep-Vein Thrombosis in Asia after Major Orthopedic Surgery: The AIDA Study Final Results.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Orthopedic surgery; Surgery; Deep vein; Incidence (geometry); Thrombosis; Venous thrombosis; Prospective cohort study","score_opus":0.02102868447921619,"score_gpt":0.26223076417862606,"score_spread":0.24120207969940988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587819115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99440855,0.00035085133,0.0000113963215,0.0031457972,0.00016150858,0.0010911287,0.000015406295,0.000034311037,0.00078103977],"genre_scores_gemma":[0.99856734,0.00019176993,0.00014988588,0.0006049631,0.00013063998,0.0002157972,0.000017361566,0.000028953877,0.000093275456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982483,0.00013221077,0.0006062862,0.00035359417,0.00031748854,0.0003421313],"domain_scores_gemma":[0.99895996,0.00014719466,0.00015727419,0.0005885172,0.000067979134,0.00007906426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010290652,0.00020234897,0.00067521323,0.00018198785,0.00005632055,0.000020722273,0.00014128724,0.00006486273,0.00012912754],"category_scores_gemma":[0.0001716659,0.00013649177,0.00014293204,0.0004583949,0.00007627267,0.000069165944,0.00010777872,0.00019022477,0.000041711537],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016697955,0.06894286,0.89218485,0.000663735,0.0029393197,0.0022629907,0.013474859,0.0002937845,0.00084838236,0.0019710332,0.005667405,0.009081013],"study_design_scores_gemma":[0.008002897,0.0007153991,0.98697937,0.0001931782,0.0007708531,0.0000062749614,0.000994795,0.0000012999367,0.0015235228,0.00020234539,0.0004643632,0.00014571354],"about_ca_topic_score_codex":0.0019775806,"about_ca_topic_score_gemma":0.0020501672,"teacher_disagreement_score":0.094794534,"about_ca_system_score_codex":0.0000391092,"about_ca_system_score_gemma":0.00009939957,"threshold_uncertainty_score":0.5565973},"labels":[],"label_agreement":null},{"id":"W2587827034","doi":"10.1182/blood.v108.11.4839.4839","title":"Comparison of Erythroid Response (ER) Rates in Myelodysplastic Syndromes (MDS) Patients Treated with Different Therapeutic Strategies Using Epoetin Alfa (EPO).","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Internal medicine; Myelodysplastic syndromes; Epoetin alfa; Erythropoietin; Oncology; Anemia; Bone marrow","score_opus":0.031682199334184376,"score_gpt":0.321288315025565,"score_spread":0.2896061156913806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587827034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99825734,0.0005949974,0.00005666253,0.0000756827,0.000021775184,0.00068760646,0.000018864857,0.000052426618,0.00023465161],"genre_scores_gemma":[0.9993731,0.000018930288,0.00026534812,0.000014371801,0.000030569874,0.000028108647,0.00007442329,0.00005575701,0.00013939403],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975992,0.00032548487,0.0006065405,0.00038099685,0.0005770902,0.00051067467],"domain_scores_gemma":[0.998657,0.00047403446,0.00020810052,0.00037155682,0.00018881862,0.00010052619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021617138,0.00032074619,0.0007706862,0.00041908838,0.00006998408,0.00004253893,0.00014987258,0.00014143797,0.000055564626],"category_scores_gemma":[0.00008125172,0.00022786576,0.00006939696,0.0005458016,0.00023880282,0.000109951485,0.0000550946,0.00034976815,0.000007983763],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040683122,0.002972888,0.9190078,0.00016927812,0.00018398842,0.00015914976,0.0003001025,0.00023412111,0.07267187,0.000033502805,0.000026093468,0.00017291243],"study_design_scores_gemma":[0.011175567,0.0022392317,0.9207073,0.00045260027,0.00031695593,0.00007963457,0.0007841338,0.0014814495,0.062467393,0.000043183667,0.000017154529,0.00023543125],"about_ca_topic_score_codex":0.00065298827,"about_ca_topic_score_gemma":0.00014040756,"teacher_disagreement_score":0.010204472,"about_ca_system_score_codex":0.00021788094,"about_ca_system_score_gemma":0.00037038545,"threshold_uncertainty_score":0.92920965},"labels":[],"label_agreement":null},{"id":"W2587835525","doi":"10.1182/blood.v114.22.3861.3861","title":"Bortezomib-Based Therapy, without Stem Cell Transplantation, for Newly Diagnosed Multiple Myeloma Patients with t(4;14).","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; University of Calgary; London Health Sciences Centre; CancerCare Manitoba; Dalhousie University; Royal Victoria Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Bortezomib; Medicine; Multiple myeloma; Internal medicine; Dexamethasone; Melphalan; Transplantation; Maintenance therapy; Surgery; Gastroenterology; Lenalidomide; Autologous stem-cell transplantation; Prednisone; Hematopoietic stem cell transplantation; Cyclophosphamide; Oncology; Chemotherapy","score_opus":0.015246605146950967,"score_gpt":0.2583392451055925,"score_spread":0.2430926399586415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587835525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948925,0.00019512628,0.001229757,0.00019989784,0.000031494863,0.002713277,0.00019641519,0.00011401303,0.00042756068],"genre_scores_gemma":[0.9925559,0.0000583981,0.00565768,0.00042153272,0.0000713068,0.0002438615,0.0006901142,0.000044661494,0.00025653746],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983671,0.000045940644,0.00025292728,0.00039172822,0.00046965317,0.00047267173],"domain_scores_gemma":[0.998804,0.00018754244,0.00009269587,0.00034147673,0.00027012295,0.00030421597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000084378145,0.000266724,0.00034170772,0.0001222139,0.00014197857,0.000033285785,0.00010615309,0.00009084183,0.000028905031],"category_scores_gemma":[0.0000205449,0.00018724446,0.00011918126,0.00016250298,0.000042403393,0.00009410175,0.0000033753186,0.00011469939,0.000019007455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008251255,0.006140548,0.94274205,0.00012877208,0.00021186082,0.00014867542,0.0002950741,0.000017026883,0.0016226765,0.0000040569785,0.00017722596,0.040260762],"study_design_scores_gemma":[0.11003211,0.0044342647,0.82612747,0.00009320026,0.00023531224,0.0000054083584,0.000026645703,0.00021486123,0.05810845,0.0000070421015,0.00050580665,0.00020943426],"about_ca_topic_score_codex":0.00003586834,"about_ca_topic_score_gemma":0.000041635096,"teacher_disagreement_score":0.1166146,"about_ca_system_score_codex":0.000033660206,"about_ca_system_score_gemma":0.00017505241,"threshold_uncertainty_score":0.7635607},"labels":[],"label_agreement":null},{"id":"W2587843948","doi":"10.1182/blood.v116.21.3835.3835","title":"Post-Thrombotic Syndrome: Assessment of Patient and Health Care Provider Knowledge and Awareness.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Deep vein; Family medicine; Health care; Thrombosis; Emergency medicine; Surgery","score_opus":0.01168963232180994,"score_gpt":0.30800886609271283,"score_spread":0.2963192337709029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587843948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940873,0.002864139,0.000006325766,0.0010165045,0.00017416556,0.0008047301,0.000014015595,0.000029368497,0.0010034963],"genre_scores_gemma":[0.99771667,0.00028309826,0.0014887496,0.00036928646,0.000029786017,0.00004654522,0.000022958478,0.00001998109,0.000022956046],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909407,0.000023720544,0.0002540332,0.00026427815,0.00015992342,0.00020400215],"domain_scores_gemma":[0.9993255,0.000023552595,0.000102504986,0.00025716203,0.00012025415,0.00017099117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012538102,0.0001362533,0.00046883296,0.00008775066,0.0000848005,0.000015524809,0.000040894487,0.000056039597,0.000033762914],"category_scores_gemma":[0.000017432154,0.000112904636,0.000036332898,0.00007094901,0.00007544386,0.000044564757,0.00011372788,0.00014338669,0.000001891848],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020352667,0.011966663,0.87858564,0.0112249935,0.0009953472,0.00015921438,0.016852684,0.0000022113027,0.008021048,0.008411705,0.0020802284,0.06167992],"study_design_scores_gemma":[0.00191749,0.0021364172,0.991526,0.00021936835,0.0003063326,0.000116556934,0.001196156,0.000013194819,0.00077718945,0.000026871105,0.0016394549,0.00012498793],"about_ca_topic_score_codex":0.0003294018,"about_ca_topic_score_gemma":0.00034139413,"teacher_disagreement_score":0.11294035,"about_ca_system_score_codex":0.000020338484,"about_ca_system_score_gemma":0.00026460958,"threshold_uncertainty_score":0.46041173},"labels":[],"label_agreement":null},{"id":"W2587866472","doi":"10.1182/blood.v108.11.4664.4664","title":"Fludarabine Monophosphate in Indolent Non Hodgkin’s Lymphoma (NHL) - Clinical Experience (1995–2006).","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Fludarabine; Medicine; Internal medicine; Vincristine; Cyclophosphamide; Gastroenterology; Non-Hodgkin's lymphoma; Prednisone; Performance status; Lymphoma; Surgery; Chemotherapy; Oncology","score_opus":0.02251837139570574,"score_gpt":0.3336341002078854,"score_spread":0.3111157288121797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587866472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928124,0.0014169218,0.000041794243,0.00024769545,0.00027129787,0.0007153395,0.00000842984,0.00009537965,0.0043907263],"genre_scores_gemma":[0.9957482,0.00028204027,0.001036537,0.00033219627,0.0005778271,0.00014507484,0.000034049164,0.000055515975,0.0017885553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965639,0.0001034973,0.000993567,0.00072925695,0.00077105087,0.00083873986],"domain_scores_gemma":[0.9984146,0.00020237175,0.00013869794,0.0008412517,0.000106312975,0.00029679807],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00068390655,0.00029350258,0.00064038363,0.00020818014,0.00006530296,0.000040461095,0.0003231747,0.00028439608,0.000120943],"category_scores_gemma":[0.0002587071,0.00026039645,0.00019380816,0.00056767894,0.0002809446,0.00012686038,0.00020359606,0.00030461478,0.0004416125],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004657851,0.03763324,0.78372216,0.0009231582,0.00044715745,0.019347394,0.003354119,0.0001981745,0.021260412,0.00056849915,0.012781078,0.11510676],"study_design_scores_gemma":[0.22455527,0.0014731428,0.6591341,0.0006729724,0.00018765613,0.0010439911,0.00032298264,0.00715401,0.08998601,0.00030701,0.014353766,0.0008091098],"about_ca_topic_score_codex":0.004368842,"about_ca_topic_score_gemma":0.00024532244,"teacher_disagreement_score":0.21989742,"about_ca_system_score_codex":0.002804629,"about_ca_system_score_gemma":0.0034195955,"threshold_uncertainty_score":0.9999848},"labels":[],"label_agreement":null},{"id":"W2587866926","doi":"10.1182/blood.v108.11.5398.5398","title":"Effect of Donor on Outcomes after Myeloablative Conditioning with Daily IV Busulfan and Fludarabine (FLUBUP) +/− TBI with Thymoglobulin: Transplants from Mismatched Unrelated Donors (MMUD) Have Worse Survival Due to Higher Transplant-Related Mortality (TRM).","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre","funders":"","keywords":"Thymoglobulin; Busulfan; Fludarabine; Medicine; Folinic acid; Internal medicine; Gastroenterology; Transplantation; Surgery; Hematopoietic stem cell transplantation; Chemotherapy; Oncology; Urology; Cyclophosphamide; Kidney transplantation; Fluorouracil","score_opus":0.0069088125238712175,"score_gpt":0.23427517484543883,"score_spread":0.22736636232156762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587866926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99470437,0.00011002604,0.0004805012,0.00026320916,0.0001090248,0.0016867202,0.000879086,0.00016159861,0.0016054919],"genre_scores_gemma":[0.9974939,0.000017931201,0.0006773745,0.0000976024,0.00005114584,0.00013058068,0.0011553785,0.00009475086,0.00028133686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99679756,0.00032964922,0.00084067526,0.000799597,0.0007165928,0.0005159139],"domain_scores_gemma":[0.9980559,0.00079385634,0.00024711495,0.0004787649,0.00012879987,0.00029557166],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004102786,0.00066849805,0.0013684485,0.00022038925,0.000108704575,0.00003527474,0.00012337875,0.0003309939,0.00025920963],"category_scores_gemma":[0.000013164924,0.00046304686,0.00013716027,0.000379215,0.0002231471,0.0001461089,0.000008589443,0.00042116392,0.000024199067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010113068,0.0007825741,0.96903723,0.000692176,0.0019700252,0.002011194,0.003215374,0.0002703572,0.011758501,0.000053267853,0.000006800402,0.00008944169],"study_design_scores_gemma":[0.025808608,0.0020910797,0.8799395,0.0021947976,0.0038391706,0.00018495045,0.00010941093,0.000044782104,0.08523286,0.00003775603,0.000004504007,0.0005125767],"about_ca_topic_score_codex":0.0020161248,"about_ca_topic_score_gemma":0.0010508078,"teacher_disagreement_score":0.08909772,"about_ca_system_score_codex":0.000042768464,"about_ca_system_score_gemma":0.00007472114,"threshold_uncertainty_score":0.99978215},"labels":[],"label_agreement":null},{"id":"W2587873638","doi":"10.1182/blood.v118.21.4479.4479","title":"Safety and Efficacy of Posaconazole for the Treatment of Invasive Fungal Infections After Failure of One Prior Line of Therapy","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre; Leukemia & Lymphoma Society of Canada; Merck Canada Inc. (Canada); University of Alberta; Université de Montréal; University of Toronto; McMaster University","funders":"","keywords":"Posaconazole; Voriconazole; Medicine; Internal medicine; Fluconazole; Population; Amphotericin B; Neutropenia; Refractory (planetary science); Adverse effect; Aspergillosis; Surgery; Toxicity; Antifungal; Immunology; Biology; Dermatology","score_opus":0.03012663026974977,"score_gpt":0.26917122865925824,"score_spread":0.23904459838950848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587873638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968481,0.0019598799,0.00011713124,0.00008041982,0.000013221234,0.000760285,0.00010389355,0.0000037920431,0.00011325293],"genre_scores_gemma":[0.99778455,0.001478088,0.00058989716,0.000011152045,0.000024601553,0.000020330117,0.0000048764396,0.0000068927075,0.00007958611],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99941117,0.00001938839,0.00029555475,0.00010451755,0.00009200751,0.00007738636],"domain_scores_gemma":[0.9991204,0.0002807692,0.00014284979,0.0002457886,0.0001806925,0.000029494362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009265638,0.00007780581,0.00032970548,0.000032332842,0.000020529813,5.923533e-7,0.000032873606,0.00005139399,0.00007556426],"category_scores_gemma":[0.000070295595,0.000046615067,0.00013358275,0.000070718095,0.00017186918,0.000019807854,0.000008017217,0.00003147402,2.2333262e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007907766,0.013281704,0.7994186,0.00043379658,0.0011882357,0.0000018343703,0.005287523,7.586705e-7,0.16319601,0.00023525562,0.0000076312945,0.009040866],"study_design_scores_gemma":[0.005381961,0.0035785076,0.6260978,0.000067683584,0.00035578205,0.000001425726,0.00018891953,0.000001290365,0.36420503,0.000026831274,0.00006756261,0.000027216496],"about_ca_topic_score_codex":0.00010935752,"about_ca_topic_score_gemma":0.0002999853,"teacher_disagreement_score":0.20100904,"about_ca_system_score_codex":0.000006675021,"about_ca_system_score_gemma":0.00008275065,"threshold_uncertainty_score":0.19009073},"labels":[],"label_agreement":null},{"id":"W2587878856","doi":"10.1182/blood.v126.23.2336.2336","title":"Biological Rational for the Use of Heparin in Septic Shock: Translational Data from the Halo Pilot RCT","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Sepsis Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Thrombosis and Atherosclerosis Research Institute; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Septic shock; Heparin; Sepsis; Internal medicine; Gastroenterology; Population; Surgery; Immunology; Anesthesia","score_opus":0.6362235430599562,"score_gpt":0.39777243458735534,"score_spread":0.23845110847260087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587878856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910122,0.0008670131,0.00023695962,0.006725967,0.0000485797,0.00055827183,0.00048958726,0.0000075379353,0.00005384435],"genre_scores_gemma":[0.996168,0.00004849078,0.0020726388,0.00053999055,0.00013305736,0.000073161915,0.0009366026,0.0000051107218,0.000022948476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99940926,0.000041300937,0.00016573952,0.00015139395,0.00015270586,0.00007961724],"domain_scores_gemma":[0.9980199,0.0015506126,0.000033174405,0.000321834,0.00004176912,0.000032763186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001983967,0.00006449891,0.00012648723,0.0000124586095,0.000027989232,0.00001103978,0.0001252276,0.00002588741,0.00007392035],"category_scores_gemma":[0.00029333693,0.000029300481,0.000037207148,0.000053889875,0.000049713788,0.000044174314,0.000029598006,0.000049256414,0.000007619651],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003435419,0.0030679083,0.982414,0.00000397632,0.00036746231,0.0000055835408,0.00023483972,0.00012291243,0.00027900602,0.0011293932,0.010594892,0.0014364808],"study_design_scores_gemma":[0.005792303,0.00042637766,0.9796047,0.000027124725,0.00028012195,0.0000060056495,0.000046447563,0.0030848926,0.00039203372,0.00050247664,0.009790431,0.00004703638],"about_ca_topic_score_codex":0.00030474982,"about_ca_topic_score_gemma":0.0004086869,"teacher_disagreement_score":0.0061859763,"about_ca_system_score_codex":0.000008024107,"about_ca_system_score_gemma":0.000088657776,"threshold_uncertainty_score":0.119483896},"labels":[],"label_agreement":null},{"id":"W2587881875","doi":"10.1182/blood.v126.23.5351.5351","title":"Targeting Cancer Stem Cell Survival in Plasma Cell Leukemia with a Pan-BCL2 Inhibitor","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Plasma cell leukemia; Stem cell; Cancer research; Myeloid leukemia; Leukemia; Multiple myeloma; Plasma cell; Biology; Cancer stem cell; Bone marrow; CD34; Molecular biology; Immunology","score_opus":0.029672801228874408,"score_gpt":0.2736138966412132,"score_spread":0.2439410954123388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587881875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913969,0.0007918939,0.000005275962,0.00008293296,0.000076615936,0.00049514865,0.000023951057,0.000046419824,0.007080864],"genre_scores_gemma":[0.9964271,0.00005926117,0.00070829416,0.000025020092,0.00022118466,0.000098976896,0.000030268548,0.000036881716,0.002392985],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99845827,0.00006956043,0.0001999813,0.00030396396,0.00049441744,0.0004738272],"domain_scores_gemma":[0.99920857,0.00005662503,0.00006023214,0.0002053683,0.000104812796,0.00036440114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019783419,0.0001786601,0.00029155557,0.00010068672,0.000036404315,0.000021622145,0.000079218946,0.00008039275,0.000034301902],"category_scores_gemma":[0.000022700175,0.00012862944,0.000036170433,0.00021792928,0.000044778077,0.0000683415,0.00004996302,0.00024553708,0.00009452979],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013556371,0.0017846363,0.9705735,0.0002922102,0.0001295812,0.0019946776,0.0013234415,0.0001076515,0.01831788,0.000003437418,0.0010049184,0.003112451],"study_design_scores_gemma":[0.1471469,0.0036692414,0.098094426,0.0007097797,0.0004480175,0.00008353653,0.004882662,0.0036641026,0.7333892,0.000012510009,0.0070135123,0.00088611734],"about_ca_topic_score_codex":0.0017295027,"about_ca_topic_score_gemma":0.00064533844,"teacher_disagreement_score":0.872479,"about_ca_system_score_codex":0.00031072128,"about_ca_system_score_gemma":0.0008735941,"threshold_uncertainty_score":0.52453566},"labels":[],"label_agreement":null},{"id":"W2587899419","doi":"10.1182/blood.v114.22.1493.1493","title":"Enhancement of Soluble Transcription Factor (TAT-HOXB4 and TAT-NUP98HOXA10HD) - Mediated Human Hematopoietic Stem Cell Self-Renewal by Minimizing Inhibitory Endogenous Signalling.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heart and Stroke Foundation; University Health Network; BC Cancer Agency; University of Toronto","funders":"","keywords":"Stem cell; Biology; Progenitor cell; Haematopoiesis; Cell biology; Hematopoietic stem cell; Transcription factor; Cell; Fusion protein; Cancer research; Immunology; Genetics; Gene","score_opus":0.023526781295029803,"score_gpt":0.23770834058668022,"score_spread":0.21418155929165042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587899419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99265224,0.0050251856,0.0005003792,0.00065705687,0.0001244726,0.0004496389,0.000015437126,0.00008087728,0.0004947089],"genre_scores_gemma":[0.9984748,0.00036188946,0.0005537895,0.00017202036,0.000104010855,0.0000089357545,0.00010527952,0.00002072075,0.00019856064],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982958,0.00006307241,0.00052146375,0.00030788785,0.00052418414,0.00028762023],"domain_scores_gemma":[0.99928635,0.000054211345,0.00018286424,0.00015407914,0.000096791126,0.0002257051],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002654973,0.00019913727,0.0003814998,0.000103946186,0.00011673844,0.00001661766,0.000066657725,0.0002851059,0.00006186603],"category_scores_gemma":[0.0000045212805,0.00017120123,0.000088737615,0.00013820223,0.00016422286,0.000056184417,0.00001268803,0.00024161312,0.0000036419049],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039372102,0.0015110145,0.00006428515,0.0003960461,0.00007275236,0.000013241219,0.003500635,4.0565234e-7,0.9931421,0.00007629914,0.000083056875,0.0011007476],"study_design_scores_gemma":[0.005139532,0.0014960978,0.0001866192,0.00023838,0.0003329173,0.000025100102,0.00033082874,0.00008747674,0.99117905,0.00026955004,0.00051214715,0.00020227752],"about_ca_topic_score_codex":0.000024430283,"about_ca_topic_score_gemma":0.0000043824793,"teacher_disagreement_score":0.0058225496,"about_ca_system_score_codex":0.000032634674,"about_ca_system_score_gemma":0.00008709569,"threshold_uncertainty_score":0.69813836},"labels":[],"label_agreement":null},{"id":"W2587907968","doi":"10.1182/blood.v116.21.1242.1242","title":"High Alpha-1 Antitrypsin Clearance Predicts Severity of Gut Graft Versus Host Disease (GVHD) In Children","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Medicine; Hematopoietic stem cell transplantation; Graft-versus-host disease; Gastroenterology; Internal medicine; Transplantation; Methotrexate; Immunology","score_opus":0.007524650223128715,"score_gpt":0.23971984586787498,"score_spread":0.23219519564474628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587907968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978565,0.00012802247,0.000018295817,0.00016967778,0.00033048668,0.0004811874,0.00010208196,0.00005432284,0.0008594272],"genre_scores_gemma":[0.9984769,0.000066078166,0.0011351904,0.000043196535,0.00011430736,0.00001298266,0.00008309147,0.000022689941,0.000045519733],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988863,0.000031040356,0.0002933765,0.00025818293,0.0003121841,0.00021891085],"domain_scores_gemma":[0.99925315,0.000058045694,0.00007747018,0.00037388876,0.000052646876,0.00018480526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013684348,0.00013778417,0.0002744359,0.00009012228,0.000025084288,0.000007064975,0.00010837249,0.0001067733,0.00018697782],"category_scores_gemma":[0.00010846241,0.00013421389,0.000065438246,0.00019707523,0.000095331896,0.0000751021,0.000017110458,0.00025540488,0.000037054044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008451457,0.0012345163,0.9716761,0.00030712396,0.00009289864,0.0001021238,0.0001918213,0.0000018006691,0.02489311,0.0002628669,0.00006453324,0.00032795762],"study_design_scores_gemma":[0.011228219,0.00012305676,0.962143,0.00012372478,0.00026903243,0.000037325255,0.000010739234,0.000019478068,0.025867777,0.000031791136,0.000031508283,0.00011431947],"about_ca_topic_score_codex":0.00017389344,"about_ca_topic_score_gemma":0.000057375146,"teacher_disagreement_score":0.010383073,"about_ca_system_score_codex":0.00000876199,"about_ca_system_score_gemma":0.00010969013,"threshold_uncertainty_score":0.5473083},"labels":[],"label_agreement":null},{"id":"W2587924009","doi":"10.1182/blood.v128.22.89.89","title":"The Risk of Major Bleeding with Low-Molecular-Weight-Heparins for Venous Thromboembolism in Dialysis Patients: The Q-VTE Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Vitamin K antagonist; Dialysis; Low molecular weight heparin; Discontinuation; Venous thromboembolism; Hemodialysis; Warfarin; Heparin; Surgery; Internal medicine; Intensive care medicine; Thrombosis","score_opus":0.005186722746411139,"score_gpt":0.22618675101650418,"score_spread":0.22100002827009305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587924009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952871,0.0002388295,0.00017331037,0.00066648587,0.00012849153,0.0026623805,0.00002374516,0.000026580712,0.00079304824],"genre_scores_gemma":[0.9987175,0.0003250413,0.00009588393,0.00013431533,0.00010622612,0.00052492606,0.0000042992756,0.0000423292,0.000049491122],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982997,0.00010689618,0.0004214007,0.00033816567,0.00042668227,0.00040713273],"domain_scores_gemma":[0.9984507,0.00037028064,0.00026444808,0.000670102,0.00017430386,0.0000701866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005986782,0.0002117311,0.0006183409,0.0000996514,0.00023109514,0.000029625548,0.00029028306,0.000048381342,0.00001217167],"category_scores_gemma":[0.00021607021,0.000087059336,0.00015698351,0.00029468944,0.00012099327,0.00006225583,0.000121813195,0.00010989554,0.0000065647555],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004376337,0.02915213,0.93873197,0.0001718652,0.0059060077,0.00004091138,0.004943743,0.000016935339,0.0020914369,0.0027820051,0.00060758984,0.015117776],"study_design_scores_gemma":[0.014040056,0.0030348953,0.97020197,0.00026639653,0.0047563957,0.0000018363545,0.0010046571,0.000009997148,0.005165699,0.00043154106,0.00087932084,0.00020725999],"about_ca_topic_score_codex":0.0003070631,"about_ca_topic_score_gemma":0.0006807723,"teacher_disagreement_score":0.03146998,"about_ca_system_score_codex":0.00004210842,"about_ca_system_score_gemma":0.00005387487,"threshold_uncertainty_score":0.35501766},"labels":[],"label_agreement":null},{"id":"W2587928021","doi":"10.1182/blood.v126.23.2113.2113","title":"Body Composition Predicts Survival in Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Recipients","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Adipose tissue; Hematopoietic stem cell transplantation; Internal medicine; Skeletal muscle; Transplantation; Body mass index; Prospective cohort study; Quartile; Oncology; Confidence interval","score_opus":0.02534583786427776,"score_gpt":0.2601956131390467,"score_spread":0.23484977527476894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587928021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954604,0.0007069278,0.00002870593,0.00019285038,0.00020749365,0.00039498025,0.000024338708,0.000031022744,0.0029533168],"genre_scores_gemma":[0.99914074,0.00028359133,0.00009397953,0.000068702735,0.000074571406,0.00007348904,0.00014738274,0.000014820606,0.00010273681],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913704,0.0000433075,0.00020044645,0.0001983341,0.00026188762,0.00015900326],"domain_scores_gemma":[0.99959767,0.000026492293,0.000045518667,0.00014678958,0.00004287652,0.00014064349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011419827,0.000107462525,0.00020134187,0.000070298534,0.000018841112,0.00001027879,0.000035345467,0.000058708618,0.000016927748],"category_scores_gemma":[0.000001398319,0.000096266485,0.000046238638,0.00011077953,0.000014076166,0.000044836142,0.0000073026827,0.000063227926,0.000051637693],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003851442,0.0055276006,0.98250693,0.00023071391,0.000102675716,0.0005281061,0.0022076603,0.00004936991,0.007289394,0.00007971745,0.00031145127,0.0007812629],"study_design_scores_gemma":[0.022885827,0.0011081625,0.8460856,0.0004293901,0.00070234813,0.00015639796,0.00020111626,0.00003668247,0.12794892,0.0000466653,0.00021839814,0.00018048305],"about_ca_topic_score_codex":0.000099436475,"about_ca_topic_score_gemma":0.00007181748,"teacher_disagreement_score":0.1364213,"about_ca_system_score_codex":0.00009656905,"about_ca_system_score_gemma":0.00006870434,"threshold_uncertainty_score":0.39256334},"labels":[],"label_agreement":null},{"id":"W2587934392","doi":"10.1182/blood.v106.11.1536.1536","title":"Microfluidic Devices for Molecular Monitoring of Clonotypic IgH VDJ Signatures and the T(4;14) Translocation in Multiple Myeloma.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Microfluidic and Capillary Electrophoresis Applications","field":"Engineering","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Microfluidics; Lab-on-a-chip; Materials science; Chip; Molecular biology; Nanotechnology; Biology; Computer science","score_opus":0.005657533495522844,"score_gpt":0.19972261868899646,"score_spread":0.19406508519347362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587934392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6765179,0.32129282,0.0017423102,0.00009183173,0.000015846661,0.00027937294,0.000004962446,0.000025737214,0.000029193972],"genre_scores_gemma":[0.9405124,0.058705375,0.0005338858,0.000018440713,0.000058197737,0.00014160016,0.0000070600745,0.00001837006,0.000004636608],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99945855,0.00001727008,0.00020124477,0.00011756436,0.000060500428,0.00014484701],"domain_scores_gemma":[0.99970937,0.000077766905,0.00002495887,0.00013986207,0.000025942965,0.000022114791],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012006821,0.000097841905,0.0001396338,0.00005301693,0.00004455765,0.00001132179,0.00010789772,0.00006772534,0.0000022779172],"category_scores_gemma":[0.000011177753,0.000081419494,0.00004293599,0.00012305663,0.000041977106,0.00004035052,0.000006626445,0.000081471175,0.0000010101232],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002353615,0.00004073277,0.0009720584,0.00006269579,0.00004574473,2.0892554e-7,0.00033322588,0.00009181301,0.9934041,0.0009264047,0.00039822594,0.0037012661],"study_design_scores_gemma":[0.0020121357,0.000013798715,0.005868514,0.000028017615,0.000051812145,0.0000020754715,0.00006461521,0.0003879999,0.9851196,0.00013929112,0.006215,0.000097175594],"about_ca_topic_score_codex":0.000012573756,"about_ca_topic_score_gemma":0.000008803581,"teacher_disagreement_score":0.26399451,"about_ca_system_score_codex":0.000011373089,"about_ca_system_score_gemma":0.000010624611,"threshold_uncertainty_score":0.33201906},"labels":[],"label_agreement":null},{"id":"W2587935914","doi":"10.1182/blood.v114.22.2154.2154","title":"Stem Cell Mobilization Capacity Is Not a Predictor of Survival in Multiple Myeloma (MM) After Autologous Stem Cell Transplantation (ASCT).","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Multiple myeloma; Leukapheresis; Autologous stem-cell transplantation; Transplantation; Cyclophosphamide; Surgery; CD34; Plerixafor; Stem cell; Regimen; Internal medicine; Mobilization; Chemotherapy; Urology; Oncology","score_opus":0.026747596890697077,"score_gpt":0.2519472397726218,"score_spread":0.2251996428819247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587935914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973661,0.00023282546,0.00019549555,0.000070239876,0.000057707824,0.0010172157,0.0003029846,0.000059678863,0.00069780013],"genre_scores_gemma":[0.9986911,0.00012994756,0.0004974146,0.000060212347,0.00004174502,0.00007124034,0.00009534419,0.000021725129,0.00039130423],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981513,0.0001397552,0.00044082926,0.00037704565,0.0005094892,0.00038155197],"domain_scores_gemma":[0.99914783,0.000115636736,0.00011190787,0.00031949242,0.0001171215,0.00018798046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017477192,0.00021651191,0.00041423106,0.00020189688,0.000039554383,0.000012789563,0.00009409871,0.00017028314,0.00006041558],"category_scores_gemma":[0.000008060903,0.000189749,0.00011198837,0.0002554045,0.000051343784,0.000112404734,0.0000119895685,0.00017703068,0.000027650955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003017824,0.0051478576,0.87364405,0.0010350074,0.00008611656,0.00056163344,0.005238385,0.000028659812,0.09955298,0.0000073331043,0.000024304409,0.011655848],"study_design_scores_gemma":[0.010387855,0.0007378591,0.65335834,0.000092391194,0.00012902309,0.000018226821,0.00012534103,0.0008425487,0.33417594,0.000005974788,0.00001781582,0.00010867997],"about_ca_topic_score_codex":0.00017422457,"about_ca_topic_score_gemma":0.00015222076,"teacher_disagreement_score":0.23462296,"about_ca_system_score_codex":0.000066218796,"about_ca_system_score_gemma":0.00009812453,"threshold_uncertainty_score":0.77377397},"labels":[],"label_agreement":null},{"id":"W2587935932","doi":"10.1182/blood.v104.11.5149.5149","title":"Mixed Donor Chimerism and Low level alpha-L-iduronidase Expression May Be Adequate for Neurodevelopmental Protection in Hurler’s Syndrome.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Neonatal Health and Biochemistry","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Hurler syndrome; Medicine; Busulfan; Pediatrics; Enzyme replacement therapy; Cyclophosphamide; Fludarabine; Lysosomal storage disease; Internal medicine; Gastroenterology; Transplantation; Mucopolysaccharidosis I; Surgery; Immunology; Chemotherapy; Disease","score_opus":0.04077669407217997,"score_gpt":0.27145043598087437,"score_spread":0.23067374190869439,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587935932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972669,0.00028894714,0.00013263973,0.0010132297,0.00012250319,0.0010541439,0.000041015006,0.00004062417,0.000039986633],"genre_scores_gemma":[0.9965992,0.000027042568,0.0023723831,0.00027412144,0.000063367814,0.00024036496,0.00007665011,0.000021532584,0.00032536002],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99899,0.0000120869745,0.00023695303,0.0003250594,0.00014094744,0.00029494544],"domain_scores_gemma":[0.9995862,0.000012876459,0.000062098254,0.00012684877,0.00002237456,0.00018956696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001047817,0.00015051595,0.00019030935,0.00006444733,0.00008264218,0.000010198025,0.000044713695,0.00011641773,0.00001499479],"category_scores_gemma":[0.000040022256,0.0001317901,0.000035467674,0.000095322685,0.000036740068,0.00006301092,0.00003625959,0.0001797511,0.0000047716962],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014582059,0.0023220454,0.003675237,0.002866938,0.00004748585,0.00061211275,0.00052388373,0.0000016821785,0.9594943,0.000024033887,0.00017588302,0.028798183],"study_design_scores_gemma":[0.012181284,0.00059588446,0.13111156,0.00047940866,0.00003386789,0.0010639746,0.00011892023,0.000010778579,0.8538228,0.000048173075,0.00033496213,0.00019835262],"about_ca_topic_score_codex":0.00009751429,"about_ca_topic_score_gemma":0.000014171273,"teacher_disagreement_score":0.12743632,"about_ca_system_score_codex":0.0000455296,"about_ca_system_score_gemma":0.00015366383,"threshold_uncertainty_score":0.53742445},"labels":[],"label_agreement":null},{"id":"W2587952432","doi":"10.1182/blood.v106.11.63.63","title":"Adoptive Transfer of In Vitro Generated T Cell Precursors Enhances Donor T Cell Reconstitution and Graft-Versus-Tumor Activity in Allogeneic Hematopoietic Stem Cell Transplantation Recipients.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Stem cell; Biology; Haematopoiesis; Bone marrow; T cell; Transplantation; Immunology; CD8; Stromal cell; Lymphopoiesis; Adoptive cell transfer; Cancer research; Molecular biology; Cell biology; Antigen; Internal medicine; Immune system; Medicine","score_opus":0.021396971761077764,"score_gpt":0.2620470736761161,"score_spread":0.24065010191503836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587952432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99554074,0.0009270002,0.00012179757,0.000057556088,0.00007847421,0.0009779639,0.00004471356,0.00002256932,0.002229169],"genre_scores_gemma":[0.99748075,0.0015555738,0.00043755007,0.00001803665,0.00004385518,0.00007460731,0.000035568788,0.000024160863,0.00032988898],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982893,0.00021311434,0.00040254992,0.00043631284,0.00030395074,0.00035475538],"domain_scores_gemma":[0.99942,0.0001284386,0.00007261954,0.0001900101,0.00006944366,0.00011950853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038654634,0.00021999142,0.00043227707,0.0003274567,0.00003487972,0.000013111752,0.00009032551,0.00014328047,0.0001384062],"category_scores_gemma":[0.0000045985066,0.00021562408,0.00008163206,0.00043024938,0.00013371043,0.00017647586,0.000010432098,0.00030923876,0.0000073390215],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004771491,0.0018167385,0.004767855,0.00046500601,0.000028886925,0.000048943657,0.0029082722,0.00007993065,0.9807922,0.0000032099447,0.0000024255207,0.0043150065],"study_design_scores_gemma":[0.0134177385,0.0005233282,0.0054274136,0.00011748628,0.0001407544,0.000021197804,0.00027816487,0.00015475934,0.9796748,0.0000028009754,0.000056375815,0.00018513977],"about_ca_topic_score_codex":0.0001459901,"about_ca_topic_score_gemma":0.0005378691,"teacher_disagreement_score":0.008646247,"about_ca_system_score_codex":0.00011604819,"about_ca_system_score_gemma":0.00017526331,"threshold_uncertainty_score":0.8792895},"labels":[],"label_agreement":null},{"id":"W2587966757","doi":"10.1182/blood.v114.22.2842.2842","title":"Splicing Profile of Human Hyaluronan Synthase 1 (HAS1) Is Altered by Mutagenesis of (A/U)GGG Motifs.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Minigene; Exon; Intron; RNA splicing; Biology; Molecular biology; Exon trapping; Genetics; Exonic splicing enhancer; Alternative splicing; Gene; RNA","score_opus":0.011474792909250178,"score_gpt":0.27937994215897316,"score_spread":0.267905149249723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587966757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969365,0.0004773159,0.00011087912,0.00008731879,0.000014539532,0.00025665495,0.00010535264,0.000008094145,0.00200332],"genre_scores_gemma":[0.99793017,0.000024888923,0.0005127424,0.0000929059,0.0000568108,0.000010832091,0.00013166505,0.000014117298,0.0012258644],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998989,0.000045783614,0.00027562934,0.0002661498,0.00021257324,0.00021090356],"domain_scores_gemma":[0.9992848,0.0000056498898,0.00011724552,0.00040017697,0.00011275877,0.000079392754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013867186,0.000120610595,0.00017913616,0.000060592178,0.00005320637,0.000008628615,0.0001975183,0.00011149847,0.00020640325],"category_scores_gemma":[0.000049228347,0.00011774049,0.000096958276,0.000110760186,0.000060417024,0.000003381254,0.000052082338,0.000059693568,0.000007149158],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003125805,0.00046555873,0.001034426,0.000040813684,0.00004113767,0.0000015966469,0.000047718528,0.000002707154,0.9924155,0.000032123455,0.0015305177,0.004356647],"study_design_scores_gemma":[0.001066794,0.0010070328,0.003149027,0.000021201202,0.000023816963,0.0000042252755,0.00002674027,0.00003415445,0.99305636,0.00002723963,0.0014709971,0.000112419475],"about_ca_topic_score_codex":0.00008082907,"about_ca_topic_score_gemma":0.000006831608,"teacher_disagreement_score":0.0042442274,"about_ca_system_score_codex":0.000004006124,"about_ca_system_score_gemma":0.00004149361,"threshold_uncertainty_score":0.4801318},"labels":[],"label_agreement":null},{"id":"W2587975058","doi":"10.1182/blood.v110.11.4105.4105","title":"Enrichment of Mesenchymal Progenitor Cells from Mouse Compact Bone.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Stemcell Technologies","funders":"","keywords":"Mesenchymal stem cell; Haematopoiesis; Progenitor cell; Bone marrow; Stem cell; Population; Biology; Cell biology; Immunology; Molecular biology; Medicine","score_opus":0.026330364602704034,"score_gpt":0.30265817559300245,"score_spread":0.2763278109902984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587975058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98519796,0.00084617926,0.00006894108,0.00011156181,0.00010623608,0.00068259327,0.000030754858,0.000050511924,0.012905283],"genre_scores_gemma":[0.9945328,0.00003562869,0.0017438588,0.000046305493,0.00034017407,0.000005319509,0.00002728427,0.000029046309,0.0032395385],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977949,0.00004997714,0.000453657,0.00030121193,0.00090167194,0.00049854716],"domain_scores_gemma":[0.99861354,0.00021530148,0.00011115005,0.00048754283,0.00015486997,0.000417572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006053061,0.00016868072,0.00041317634,0.0001544929,0.00004130081,0.0000120351515,0.00014967808,0.00012104631,0.0007358047],"category_scores_gemma":[0.00009708152,0.00013849075,0.00014215815,0.00025008796,0.00008818354,0.00003956435,0.00006409311,0.00024474473,0.00021836994],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023631725,0.0016833575,0.06379649,0.00010208299,0.00018320167,0.00032291512,0.00023287772,7.489603e-7,0.9312596,0.000033262935,0.0011545831,0.0009945958],"study_design_scores_gemma":[0.0030700474,0.0004760721,0.03216954,0.000052508596,0.00012971155,0.000026981921,0.0001585987,0.00001610566,0.9600427,0.000015716822,0.0037204085,0.00012157214],"about_ca_topic_score_codex":0.00051975006,"about_ca_topic_score_gemma":0.000026277938,"teacher_disagreement_score":0.03162695,"about_ca_system_score_codex":0.000053667198,"about_ca_system_score_gemma":0.00013562561,"threshold_uncertainty_score":0.8056545},"labels":[],"label_agreement":null},{"id":"W2587976980","doi":"10.1182/blood.v110.11.3886.3886","title":"Intravenous Immunoglobulins Regulation of Human B Cells Is Mediated through Extracellular Signal-Regulated Kinase 1 and 2.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Héma-Québec","funders":"","keywords":"Antibody; Cell biology; B-cell receptor; Flow cytometry; Signal transduction; B cell; Biology; Cell culture; Immunology; Receptor; Biochemistry","score_opus":0.020250428379130617,"score_gpt":0.2859461645753949,"score_spread":0.2656957361962643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587976980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935021,0.0034519222,0.000121953,0.0003025298,0.000032378768,0.00033536673,0.000032276974,0.00003567304,0.0021857978],"genre_scores_gemma":[0.99618864,0.00023248886,0.0009233712,0.0000975529,0.00012725606,0.0000023613804,0.000119405944,0.000022947506,0.0022859562],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99846596,0.000037068345,0.00044924565,0.00025785743,0.00044479893,0.00034505408],"domain_scores_gemma":[0.9992037,0.00011122644,0.00012054315,0.00024182255,0.00017071377,0.00015201683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036408353,0.00016926452,0.00033698048,0.000110510504,0.00011461411,0.000011446192,0.00008633535,0.00015854815,0.00061835756],"category_scores_gemma":[0.00002046247,0.00014294514,0.00008638394,0.00023925224,0.00022809024,0.00006028879,0.00005550014,0.00020536427,0.000027127586],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028823648,0.0007497153,0.0036694237,0.00018172569,0.00017102464,0.00015735824,0.0008893301,8.5502086e-7,0.99157363,0.00051698845,0.00019235331,0.001609344],"study_design_scores_gemma":[0.0024529644,0.0007956326,0.073706605,0.00012497175,0.0001553381,0.000086854525,0.00009692282,0.00007463523,0.9190943,0.00049372035,0.0027694146,0.00014860692],"about_ca_topic_score_codex":0.00043845625,"about_ca_topic_score_gemma":0.000016593895,"teacher_disagreement_score":0.07247931,"about_ca_system_score_codex":0.000016688653,"about_ca_system_score_gemma":0.000048557144,"threshold_uncertainty_score":0.67705816},"labels":[],"label_agreement":null},{"id":"W2587985418","doi":"10.1182/blood.v120.21.30.30","title":"Hematopoietic Stem Cell Expansion, without Exhaustion or Transformation, by Stable Microrna Antagonism in Vivo","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Biology; Haematopoiesis; Stem cell; Hematopoietic stem cell; Cell biology; Transplantation; Progenitor cell; Immunology; Lymphopoiesis; Cancer research; Internal medicine; Medicine","score_opus":0.02418525230495478,"score_gpt":0.2813033302170231,"score_spread":0.2571180779120683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587985418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886761,0.0019087942,0.00038368668,0.00027303843,0.00010151654,0.00088217016,0.000019282756,0.000060531624,0.0076949354],"genre_scores_gemma":[0.9903215,0.0002258938,0.00026500667,0.0001049969,0.000096275005,0.00006197251,0.000028572435,0.00003609139,0.008859692],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980831,0.00008681485,0.0004424976,0.00022278969,0.0005299123,0.00063486875],"domain_scores_gemma":[0.9991436,0.000057259727,0.00007166635,0.00030868835,0.000088525965,0.00033027754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006293505,0.00018452098,0.00033101934,0.00014883689,0.00007989124,0.000026430016,0.00011004984,0.000150162,0.00079286686],"category_scores_gemma":[0.000016227697,0.00014213813,0.000052009025,0.0003464937,0.000041799252,0.00029927155,0.000026811893,0.00026203747,0.000201065],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026902847,0.0019313064,0.04050944,0.0010228818,0.000027097176,0.000032180295,0.004592353,0.0000012877973,0.9466042,0.000035644203,0.0043180743,0.0006565116],"study_design_scores_gemma":[0.004950112,0.00022541276,0.0013997888,0.00016295451,0.000077881974,0.00017310717,0.0015510656,0.000052680956,0.9787864,0.000005797743,0.012427028,0.0001877748],"about_ca_topic_score_codex":0.00010044873,"about_ca_topic_score_gemma":0.0000128516185,"teacher_disagreement_score":0.03910965,"about_ca_system_score_codex":0.00007793252,"about_ca_system_score_gemma":0.00013938986,"threshold_uncertainty_score":0.8681336},"labels":[],"label_agreement":null},{"id":"W2587995109","doi":"10.1182/blood.v116.21.283.283","title":"Results of a Pivotal Phase 2 Study of Brentuximab Vedotin (SGN-35) in Patients with Relapsed or Refractory Hodgkin Lymphoma","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Brentuximab vedotin; Medicine; CD30; Internal medicine; Oncology; Phases of clinical research; Refractory (planetary science); Antibody-drug conjugate; Gastroenterology; Anaplastic large-cell lymphoma; Lymphoma; Chemotherapy; Immunology; Antibody; Monoclonal antibody","score_opus":0.00971226627271056,"score_gpt":0.26128068393581677,"score_spread":0.2515684176631062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587995109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982537,0.000039453465,1.2056907e-7,0.00002592878,0.000092484035,0.0010403811,0.00008648247,0.000020602887,0.0004408639],"genre_scores_gemma":[0.999463,0.0000067607343,0.00026984356,0.000019059704,0.000033214208,0.000058244023,0.00005427839,0.0000252866,0.00007031209],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99834216,0.000056089844,0.0005851446,0.00034135339,0.00045737042,0.00021789194],"domain_scores_gemma":[0.9987441,0.00012464054,0.0003158819,0.0005644991,0.00013810607,0.000112822054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015454314,0.0001998229,0.0005321193,0.00017573738,0.000024137045,0.000005644398,0.00009833063,0.000091983566,0.000036959125],"category_scores_gemma":[0.00018300093,0.00012904966,0.000060085476,0.0002837039,0.0000656298,0.000063322295,0.000042484764,0.00009741612,0.000004970157],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0124243675,0.21468705,0.7548145,0.000056650715,0.00034103586,0.00025459175,0.001468969,4.238254e-7,0.0012742371,0.0000046326913,0.00011271993,0.014560814],"study_design_scores_gemma":[0.24972615,0.020644084,0.7207147,0.00015760955,0.00036549632,0.000010297266,0.00022598874,0.0000033741303,0.007937126,0.0000011557526,0.000111272006,0.000102733546],"about_ca_topic_score_codex":0.0005661982,"about_ca_topic_score_gemma":0.00053950143,"teacher_disagreement_score":0.23730178,"about_ca_system_score_codex":0.000044524466,"about_ca_system_score_gemma":0.00020590708,"threshold_uncertainty_score":0.52624923},"labels":[],"label_agreement":null},{"id":"W2588002066","doi":"10.1182/blood.v118.21.83.83","title":"Late Relapses Following All-Trans Retinoic Acid for Acute Promyelocytic Leukemia Are Uncommon, Respond Well to Salvage Therapy and Occur Independently of Prognostic Factors At Diagnosis: Long-Term Follow-up of North American Intergroup Study I0129","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Acute promyelocytic leukemia; Chemotherapy; Internal medicine; Anthracycline; Chemotherapy regimen; Arsenic trioxide; Surgery; Cumulative incidence; Salvage therapy; Induction chemotherapy; Randomized controlled trial; Oncology; Gastroenterology; Retinoic acid; Cohort; Cancer","score_opus":0.02131233401937273,"score_gpt":0.26240869295893077,"score_spread":0.24109635893955803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588002066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970847,0.0009784246,0.000118503296,0.000009054156,0.000131463,0.0015407326,0.00008245171,0.00002405756,0.00003060772],"genre_scores_gemma":[0.9985402,0.00046115054,0.00026727284,0.000048637783,0.000040111903,0.00033056168,0.00011093601,0.000068465706,0.00013261741],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979729,0.00013328069,0.0005700541,0.0006551539,0.00026419084,0.00040444284],"domain_scores_gemma":[0.9986647,0.000069707494,0.00042500463,0.0005446558,0.00013869801,0.00015726681],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022552717,0.0003889847,0.0005844978,0.00011693611,0.00009204138,0.00002082225,0.00048664186,0.00013183583,0.0000062359345],"category_scores_gemma":[0.00014588617,0.0003351445,0.0002456654,0.00023952445,0.00014533516,0.000017118276,0.00022471642,0.00014291918,9.905488e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010812514,0.0005479307,0.88168496,0.00014924398,0.0012334564,0.000039799073,0.0020914262,0.0000016821896,0.11257121,4.4066735e-7,0.00003143257,0.0005671584],"study_design_scores_gemma":[0.0027343174,0.0033544528,0.4672079,0.00007943508,0.0005381573,0.000006207674,0.00028331633,6.1879456e-7,0.5255016,0.0000034027203,0.00003588607,0.00025466827],"about_ca_topic_score_codex":0.000057603887,"about_ca_topic_score_gemma":0.0007783957,"teacher_disagreement_score":0.41447705,"about_ca_system_score_codex":0.000038648894,"about_ca_system_score_gemma":0.00012033719,"threshold_uncertainty_score":0.99991006},"labels":[],"label_agreement":null},{"id":"W2588026595","doi":"10.1182/blood.v104.11.3935.3935","title":"A Ten Year Survey of Chronic Immune Thrombocytopenic Purpura in Canadian Children, 1984–2003: Report of the Canadian Chronic ITP Working Group.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; McMaster University; University of Ottawa; University of Toronto; Dalhousie University; University of Alberta; Université de Montréal; University of Saskatchewan","funders":"","keywords":"Medicine; Splenectomy; Thrombocytopenic purpura; Pediatrics; Natural history; Hematology; Immune thrombocytopenia; Internal medicine; Retrospective cohort study; Platelet","score_opus":0.013105016635984519,"score_gpt":0.23475940548594212,"score_spread":0.2216543888499576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588026595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920542,0.004233454,2.6916337e-7,0.00033262078,0.0001122456,0.0007731266,0.000067949295,0.000008587753,0.0024175385],"genre_scores_gemma":[0.9993401,0.00016030182,0.000034411845,0.000045102166,0.00003620698,0.000017572387,0.00022862309,0.000031178195,0.00010647284],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983668,0.00004924789,0.0004724067,0.00027624762,0.0002379243,0.00059737416],"domain_scores_gemma":[0.9988348,0.000013045826,0.0001867681,0.0006128552,0.00009384786,0.00025871277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037863187,0.00018348343,0.00052174943,0.00023347889,0.000101888414,0.000011791878,0.00022552667,0.00015161063,0.00007193497],"category_scores_gemma":[0.00013798031,0.00014339988,0.000093525945,0.00095527805,0.00010978867,0.000044287295,0.000035307246,0.00025082534,0.000012084637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011553925,0.0003529396,0.99714154,0.00002891476,0.0003228124,0.000877928,0.000099501136,0.00002244221,0.00025944246,0.000109948145,0.00003399768,0.0007389789],"study_design_scores_gemma":[0.00502874,0.00020777949,0.9919549,0.00034565522,0.00014241075,0.0006188317,0.000010920539,0.0000035917851,0.0013130436,0.00003384276,0.00021426815,0.00012600906],"about_ca_topic_score_codex":0.9949524,"about_ca_topic_score_gemma":0.999534,"teacher_disagreement_score":0.0072859223,"about_ca_system_score_codex":0.0012907337,"about_ca_system_score_gemma":0.00797392,"threshold_uncertainty_score":0.99764997},"labels":[],"label_agreement":null},{"id":"W2588028995","doi":"10.1182/blood.v126.23.3004.3004","title":"Novel Patient Derived Multiple Myeloma Model Reflects Sensitivity Towards Anticancer Treatment in Multiple Myeloma Patients","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Multiple myeloma; Medicine; Dexamethasone; Lenalidomide; Bortezomib; In vivo; Bone marrow; Internal medicine; Cyclophosphamide; Oncology; Cancer research; Chemotherapy; Pathology; Biology","score_opus":0.06958297664270507,"score_gpt":0.3115760193165639,"score_spread":0.24199304267385885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588028995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99567485,0.00015279996,0.00038044705,0.00017130437,0.00012432199,0.0020563616,0.00023187489,0.00013028042,0.0010777762],"genre_scores_gemma":[0.98815894,0.000046071,0.010698726,0.00017271243,0.000089636436,0.00030971508,0.00032107864,0.00007775949,0.0001253638],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99657696,0.0001195705,0.000528046,0.00081027026,0.0009715414,0.0009936221],"domain_scores_gemma":[0.9976629,0.00016999237,0.00014349593,0.0006878101,0.00043640533,0.0008994002],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020912345,0.0005171677,0.0007516028,0.0002969897,0.00012175475,0.00004432524,0.000103229184,0.00020418837,0.00001457036],"category_scores_gemma":[0.0009613265,0.00041734675,0.00019752297,0.00038685504,0.0001235585,0.00023279853,0.00015751098,0.0002445136,0.000084724124],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003396452,0.023251543,0.7971801,0.00009033897,0.0006581885,0.0011827076,0.0028322244,0.0006608366,0.0999206,0.000010459819,0.00010708388,0.07070947],"study_design_scores_gemma":[0.072104216,0.0032884886,0.65158325,0.00017675148,0.0002421044,0.00008315198,0.00026606032,0.068727575,0.20275094,0.00003425319,0.00018839454,0.0005548141],"about_ca_topic_score_codex":0.0023494288,"about_ca_topic_score_gemma":0.002461219,"teacher_disagreement_score":0.14559683,"about_ca_system_score_codex":0.0008064281,"about_ca_system_score_gemma":0.000731264,"threshold_uncertainty_score":0.99982786},"labels":[],"label_agreement":null},{"id":"W2588040117","doi":"10.1182/blood.v120.21.1549.1549","title":"FAS Mutations Are Associated with Therapeutic Resistance in Follicular Lymphoma","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; McGill University","funders":"","keywords":"Biology; Cancer research; Follicular lymphoma; Autoimmune lymphoproliferative syndrome; Fas receptor; Germinal center; Fas ligand; Lymphoma; Immunology; Apoptosis; Programmed cell death; B cell; Genetics; Antibody","score_opus":0.01649894936772708,"score_gpt":0.24601059361369343,"score_spread":0.22951164424596635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588040117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914063,0.0044807843,0.0000041697917,0.00047319103,0.000025167876,0.00026146596,0.000009329143,0.000041868978,0.0032977024],"genre_scores_gemma":[0.9988434,0.000031018888,0.0002091298,0.0002960075,0.000037031372,0.00011857742,0.000035790075,0.000016362881,0.00041272907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993031,0.000034107878,0.00012050977,0.00012644786,0.00017365962,0.00024218069],"domain_scores_gemma":[0.9995645,0.000069133646,0.00006472984,0.00017372667,0.00003946112,0.00008841136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000074800504,0.0001061156,0.00018883073,0.000052619886,0.000045699344,0.0000098060345,0.00003015584,0.000053397693,0.000023574723],"category_scores_gemma":[0.000037963422,0.000075142925,0.000045980792,0.00022641801,0.000025040032,0.000059173566,0.000006679176,0.000027032127,0.000028494582],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031206197,0.0043773865,0.9936361,0.000011591652,0.0003069614,0.00015408719,0.00041452088,5.261061e-7,0.00008600653,0.00052134093,0.000058941783,0.00040138853],"study_design_scores_gemma":[0.009265139,0.00008604891,0.98602206,0.00019721349,0.0004237639,0.000020054058,0.00014065615,0.0000016188568,0.0027619472,0.00006809518,0.0009234558,0.00008995499],"about_ca_topic_score_codex":0.00002887022,"about_ca_topic_score_gemma":0.00030744905,"teacher_disagreement_score":0.009233932,"about_ca_system_score_codex":0.00012821227,"about_ca_system_score_gemma":0.00005595446,"threshold_uncertainty_score":0.30642396},"labels":[],"label_agreement":null},{"id":"W2588057974","doi":"10.1182/blood.v104.11.1032.1032","title":"A Rapid and Sustained Increase in Neutrophil Elastase Levels Correlates Temporally with Decreased Coagulation Factor Activity during E.coli-Sepsis in Baboons.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Fibrinogen; Sepsis; Elastase; Coagulation; Internal medicine; Medicine; Disseminated intravascular coagulation; Protease; Fibrinolysis; Pathophysiology; Factor IX; Alpha (finance); Immunology; Pharmacology; Endocrinology; Chemistry; Biochemistry; Enzyme; Surgery","score_opus":0.019819840359806776,"score_gpt":0.24660411757489942,"score_spread":0.22678427721509264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588057974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998044,0.00014777099,0.000119360826,0.0005802979,0.00002319609,0.00085173687,0.00002187458,0.00008542419,0.00012632701],"genre_scores_gemma":[0.9990064,0.0000251925,0.00066885276,0.00013840296,0.00002635228,0.000046158148,0.000026345739,0.00003813817,0.000024159479],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998563,0.00009694263,0.00032135085,0.0004088794,0.00027109825,0.00033874158],"domain_scores_gemma":[0.99924,0.00006757119,0.0001343297,0.00025884647,0.00007645437,0.00022282315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016876432,0.0002596996,0.00045228205,0.0004130937,0.00007778277,0.000033562825,0.000055008673,0.0001610867,0.00005815474],"category_scores_gemma":[0.00011748264,0.00023406363,0.000047602993,0.00049878156,0.00006041485,0.00025003363,0.000041119445,0.00027464176,0.000004257874],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004028204,0.006736222,0.6548543,0.00047939995,0.00028517758,0.0013520957,0.0017974494,0.00045901345,0.32647514,0.0011402472,0.0000025936783,0.0023901544],"study_design_scores_gemma":[0.029118173,0.00047197123,0.90737253,0.00032627903,0.00013351787,0.00008355594,0.00021846527,0.00021287109,0.061451424,0.00035268103,0.0000048064817,0.0002537242],"about_ca_topic_score_codex":0.00060391746,"about_ca_topic_score_gemma":0.0005070125,"teacher_disagreement_score":0.26502374,"about_ca_system_score_codex":0.00011676789,"about_ca_system_score_gemma":0.00028293,"threshold_uncertainty_score":0.95448375},"labels":[],"label_agreement":null},{"id":"W2588060467","doi":"10.1182/blood.v112.11.4137.4137","title":"Reduced Adverse Effects and Improved Engraftment in the Pediatric Transplant Population upon Dilution of HPC, Cord Blood Products Prior to Infusion","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Children's Hospital; Calgary Laboratory Services","funders":"","keywords":"Cord blood; Medicine; Adverse effect; Transplantation; Population; Surgery; Pharmacology; Internal medicine","score_opus":0.011168036860683395,"score_gpt":0.23680415258994172,"score_spread":0.22563611572925832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588060467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971196,0.00022197819,0.0000412436,0.00021426743,0.000082870625,0.0022303588,0.000007814502,0.000031155436,0.000050733906],"genre_scores_gemma":[0.9982019,0.0003681128,0.0011136223,0.00004958743,0.00008559158,0.000083983534,0.000066194014,0.000015581358,0.000015445687],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987186,0.00010991615,0.0003804108,0.00028663737,0.00031149693,0.00019291749],"domain_scores_gemma":[0.9994136,0.00011575926,0.00010278709,0.00023605277,0.000056764715,0.00007502492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003028919,0.00015412686,0.0002627837,0.000195461,0.00006536403,0.0000033811336,0.00005761154,0.00008905242,0.000003563257],"category_scores_gemma":[0.00008871342,0.00011427363,0.000048073518,0.00039606684,0.000016492499,0.000059061487,0.000008461426,0.0001200532,0.0000037265986],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083230017,0.0018190308,0.27429062,0.0023073487,0.00005854109,0.00017596786,0.009437008,0.0000063360994,0.70995456,0.000032246615,0.000006898491,0.0010791816],"study_design_scores_gemma":[0.006046562,0.0011148595,0.8183852,0.00022717702,0.00078111695,0.0004666509,0.00006891556,0.000029951087,0.17275347,0.000005717123,0.000005571523,0.00011483626],"about_ca_topic_score_codex":0.00014931621,"about_ca_topic_score_gemma":0.000022434668,"teacher_disagreement_score":0.54409456,"about_ca_system_score_codex":0.000018826637,"about_ca_system_score_gemma":0.000057868834,"threshold_uncertainty_score":0.46599433},"labels":[],"label_agreement":null},{"id":"W2588071773","doi":"10.1182/blood.v128.22.117.117","title":"A Survey of Fusion Genes in Myeloma Identifies Kinase Domain Activation Which Could be Targeted with Available Treatments","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Fusion gene; Gene; Biology; DNA sequencing; Molecular biology; RNA; DNA; Genetics","score_opus":0.036764625624315574,"score_gpt":0.2900010109015289,"score_spread":0.2532363852772133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588071773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99825746,0.00029073335,0.000026158832,0.0002144917,0.000018583341,0.00058861857,0.00011904928,0.0000264557,0.00045844872],"genre_scores_gemma":[0.997734,0.00018562152,0.00048854644,0.000012736633,0.000017613223,0.00007483793,0.00024201378,0.000023390583,0.0012212413],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853456,0.00015125996,0.00024732575,0.00030641307,0.00045302452,0.00030743063],"domain_scores_gemma":[0.9989305,0.00021281985,0.00010032276,0.0003348762,0.00028983725,0.00013163002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002761483,0.00016798136,0.00031349235,0.00021934039,0.00005197767,0.000011957052,0.00006970684,0.00008675012,0.00033789274],"category_scores_gemma":[0.00030203455,0.00009595533,0.000031886393,0.00048190833,0.000058991263,0.00014755745,0.00003867741,0.00006146663,0.00004748965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001375863,0.0016873453,0.71150076,0.000045941477,0.0002375027,0.00010163601,0.00010804062,1.8383518e-7,0.28129444,0.0000036362762,0.00012422679,0.003520452],"study_design_scores_gemma":[0.012468135,0.0004580322,0.66830266,0.00021673649,0.00004788388,0.0000075728594,0.000033614117,0.0000060464026,0.31834275,0.000011556002,0.000035062734,0.00006996384],"about_ca_topic_score_codex":0.0024956334,"about_ca_topic_score_gemma":0.0035774002,"teacher_disagreement_score":0.04319809,"about_ca_system_score_codex":0.00008098635,"about_ca_system_score_gemma":0.00020851122,"threshold_uncertainty_score":0.39129448},"labels":[],"label_agreement":null},{"id":"W2588078128","doi":"10.1182/blood.v106.11.1953.1953","title":"A Novel Thrombin Fluorogenic Substrate of High Affinity, Catalytic Efficiency and Selectivity.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Thrombin; Alexa Fluor; Chemistry; Peptide; Förster resonance energy transfer; Substrate (aquarium); Fluorescence; Fluorescein; Biophysics; Stereochemistry; Combinatorial chemistry; Biochemistry; Platelet; Biology","score_opus":0.007449370688341013,"score_gpt":0.21052629811348966,"score_spread":0.20307692742514866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588078128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978966,0.0009308089,0.0006101379,0.00003735671,0.000028447732,0.00013783351,0.000021832448,0.000010490784,0.00032648369],"genre_scores_gemma":[0.9987786,0.000056228353,0.000898372,0.000043022257,0.00011802805,0.000009906534,0.000022183256,0.00001258907,0.00006107962],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999343,0.000015752577,0.00013629784,0.00024335965,0.00008714864,0.00017445604],"domain_scores_gemma":[0.9996355,0.000005698202,0.000059468337,0.00020370708,0.000039781262,0.000055844903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000115344745,0.000108224696,0.00012441861,0.00002638764,0.000042234286,0.000009793254,0.00009768065,0.00009828758,0.000006605443],"category_scores_gemma":[0.000029105939,0.00010511388,0.0000461388,0.0000743013,0.000048495807,0.0000045359543,0.00007664906,0.00005521329,0.0000050043595],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012524906,0.00049047504,0.00017763652,0.000014012928,0.000037623515,8.6307233e-7,0.000019429777,0.0000061232095,0.9986435,0.0003372148,0.000032680207,0.00022791805],"study_design_scores_gemma":[0.0011965472,0.00035366864,0.00064355304,0.000008933508,0.000048575865,0.00006877297,0.000006617302,0.000026780928,0.9973139,0.00013682758,0.000073076604,0.00012275614],"about_ca_topic_score_codex":0.00004507124,"about_ca_topic_score_gemma":0.00005308176,"teacher_disagreement_score":0.0013296078,"about_ca_system_score_codex":0.0000034820064,"about_ca_system_score_gemma":0.000065863685,"threshold_uncertainty_score":0.42864197},"labels":[],"label_agreement":null},{"id":"W2588104813","doi":"10.1182/blood.v116.21.4281.4281","title":"Variability In Hb A2 levels among Individuals with Beta-Thalassemia Trait: Is Iron Deficiency Associated with Abnormally Low Hb A2?","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Hemoglobin A2; Beta thalassemia; Iron deficiency; Ferritin; Hemoglobin; Medicine; Thalassemia; Internal medicine; Serum iron; Alpha-thalassemia; Anemia; Biology; Genetics; Genotype; Gene","score_opus":0.006691567653562518,"score_gpt":0.21554857550453788,"score_spread":0.20885700785097536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588104813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870702,0.00005940214,0.000040346244,0.00057925883,0.00008377753,0.00080956996,0.00008959653,0.00012486086,0.011142978],"genre_scores_gemma":[0.9985383,0.000015698968,0.0006548205,0.00031223526,0.00004154252,0.000041009036,0.000059137466,0.000056063323,0.0002811929],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973176,0.00013598775,0.00052779686,0.0006171382,0.00066601374,0.00073544],"domain_scores_gemma":[0.9985652,0.00018590859,0.00024056119,0.0005559107,0.00016619966,0.00028621807],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001236082,0.00038061317,0.00060506444,0.00018877268,0.00014085144,0.000049403054,0.0002295591,0.0006047093,0.00033767425],"category_scores_gemma":[0.00036204854,0.00026397625,0.00010041415,0.00082239445,0.0003240962,0.00019950345,0.000052805543,0.0012652924,0.000017989096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005900661,0.0026009413,0.9915168,0.00012477548,0.00015791976,0.00015528424,0.002058757,0.000023917866,0.002228841,0.00007512591,0.00010111291,0.0008974989],"study_design_scores_gemma":[0.00835594,0.00073249027,0.9852613,0.00034358917,0.0006195579,0.00010162384,0.00034498665,0.000066647466,0.0036021627,0.000059952392,0.00010457756,0.00040716928],"about_ca_topic_score_codex":0.0002942343,"about_ca_topic_score_gemma":0.0007699709,"teacher_disagreement_score":0.011468091,"about_ca_system_score_codex":0.000057944206,"about_ca_system_score_gemma":0.00045551202,"threshold_uncertainty_score":0.9999812},"labels":[],"label_agreement":null},{"id":"W2588114026","doi":"10.1182/blood.v112.11.3417.3417","title":"Apoptosis in Platelets from Pediatric Patients with Acute Immune Thrombocytopenic Purpura (ITP) Is Ameliorated by IV Ig.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Platelet; Medicine; Phosphatidylserine; Thrombocytopenic purpura; Immunology; Apoptosis; Platelet activation; Antibody; Mean platelet volume; Internal medicine; Gastroenterology; Biology","score_opus":0.007603968470081268,"score_gpt":0.21126289193993997,"score_spread":0.2036589234698587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588114026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970472,0.0012301371,0.0000023195669,0.00015607275,0.000060284234,0.00068862474,0.00027450875,0.00007108501,0.00046980707],"genre_scores_gemma":[0.99683976,0.0012136659,0.00027509942,0.00026582234,0.0000336412,0.00005039022,0.0010395668,0.00005168019,0.00023036762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830747,0.000034030072,0.00037194995,0.0004673146,0.00038774608,0.00043152148],"domain_scores_gemma":[0.99919516,0.000037346646,0.00014631853,0.000386057,0.00008423433,0.00015086899],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000034862576,0.00031876555,0.0006762291,0.00016324088,0.00012223431,0.000018425731,0.00013737907,0.00016462298,0.00024778364],"category_scores_gemma":[0.000014445206,0.0002454233,0.00008381552,0.0006584134,0.000050135193,0.00017329943,0.000047928963,0.00027688063,0.00021303931],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005290238,0.005339558,0.9855439,0.000016771537,0.0009142252,0.0012832342,0.0005742588,5.1221684e-7,0.0028604378,5.220124e-7,0.0024890678,0.0004484809],"study_design_scores_gemma":[0.045622017,0.0013916676,0.90924686,0.00007059608,0.0014328185,0.00008234661,0.0000525863,0.000009521477,0.04127543,0.000029558883,0.00027954637,0.00050705345],"about_ca_topic_score_codex":0.00064917083,"about_ca_topic_score_gemma":0.000018015284,"teacher_disagreement_score":0.07629705,"about_ca_system_score_codex":0.000050248935,"about_ca_system_score_gemma":0.000105646315,"threshold_uncertainty_score":0.9999998},"labels":[],"label_agreement":null},{"id":"W2588118428","doi":"10.1182/blood.v110.11.1062.1062","title":"Late Onset Eosinophilia (beyond Day 100), Rather Than Early Onset Eosinophilia, Has a Significant Prognostic Impact on Transplant Outcomes after Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT).","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Eosinophilia; Medicine; Incidence (geometry); Eosinophil; Transplantation; Internal medicine; Cumulative incidence; Gastroenterology; Graft-versus-host disease; Hematopoietic stem cell transplantation; Immunology","score_opus":0.013122541808661547,"score_gpt":0.24331744296221364,"score_spread":0.2301949011535521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588118428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934636,0.0012231237,0.000097047596,0.00074669224,0.0002989246,0.002040502,0.00096740853,0.00024815337,0.0009145835],"genre_scores_gemma":[0.9957503,0.0002599662,0.0002269911,0.00085807696,0.00014844733,0.00014996763,0.00040196526,0.0001902961,0.0020139944],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99511695,0.00024661393,0.001092953,0.0011263458,0.0010383602,0.0013787991],"domain_scores_gemma":[0.9976432,0.00036864454,0.00026545965,0.0008973309,0.00013887646,0.0006865357],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008157069,0.0010306006,0.00122341,0.00047654365,0.00028101422,0.0001843248,0.00036260515,0.00047898604,0.00040797933],"category_scores_gemma":[0.000018257593,0.0007751215,0.0007457259,0.00045994262,0.00030528157,0.00022172928,0.000025045416,0.0006593747,0.00015047227],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023197178,0.0059465654,0.964282,0.00041110883,0.0010183391,0.0053173467,0.007020878,0.0000217695,0.012784102,0.0000131748775,0.000111081696,0.0007539303],"study_design_scores_gemma":[0.010200016,0.004392515,0.9663368,0.00043134726,0.0028544466,0.00078461325,0.00018292351,0.000017844328,0.013685284,0.00011682314,0.00007650927,0.00092090067],"about_ca_topic_score_codex":0.00032981017,"about_ca_topic_score_gemma":0.0002279333,"teacher_disagreement_score":0.007880298,"about_ca_system_score_codex":0.00008194346,"about_ca_system_score_gemma":0.0003279753,"threshold_uncertainty_score":0.99947},"labels":[],"label_agreement":null},{"id":"W2588130165","doi":"10.1182/blood.v118.21.5006.5006","title":"Pharmacokinetics of Dasatinib in a Patient with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia During Treatment with Anti-Tuberculosis Therapy","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Dasatinib; Medicine; Imatinib; Internal medicine; Concomitant; Cmax; Imatinib mesylate; Gastroenterology; Isoniazid; Tyrosine-kinase inhibitor; Myeloid leukemia; Pharmacology; Tuberculosis; Oncology; Pharmacokinetics; Pathology; Cancer","score_opus":0.015005173936140545,"score_gpt":0.23890642743556095,"score_spread":0.22390125349942042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588130165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99708813,0.00052585406,0.0000042647885,0.000048227368,0.000024197265,0.0011877712,0.00007104183,0.00005367512,0.0009968635],"genre_scores_gemma":[0.99718875,0.0011505766,0.0012317783,0.000057015426,0.000046121313,0.0001712997,0.000048305086,0.00007257567,0.00003360609],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982892,0.00004457717,0.00039249624,0.00047074893,0.00037346155,0.0004295153],"domain_scores_gemma":[0.99904054,0.00004820881,0.00021186868,0.00043019457,0.00009987383,0.0001692943],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000030878324,0.00041310972,0.0006262592,0.00019749367,0.000046264857,0.0000066630423,0.000091058646,0.00008887411,0.00015138826],"category_scores_gemma":[0.0000046394043,0.000268998,0.00008754717,0.00038066908,0.00013276766,0.00008567879,0.000031013,0.0001186197,0.000009254668],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015023245,0.023612035,0.4843574,0.00041634214,0.016441446,0.018111972,0.027244847,0.0002486949,0.40753925,0.000027686336,0.000012078684,0.0069650305],"study_design_scores_gemma":[0.057165794,0.01150372,0.22459608,0.00062158564,0.0016560076,0.0017555263,0.00015535223,0.000082346916,0.7021398,0.0000030157207,0.000016011227,0.0003047495],"about_ca_topic_score_codex":0.0005632783,"about_ca_topic_score_gemma":0.000037055524,"teacher_disagreement_score":0.29460058,"about_ca_system_score_codex":0.0011842386,"about_ca_system_score_gemma":0.00058431964,"threshold_uncertainty_score":0.9999762},"labels":[],"label_agreement":null},{"id":"W2588130364","doi":"10.1182/blood-2016-12-757302","title":"Stopping second-generation TKIs in CML","year":2017,"lang":"en","type":"letter","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Nilotinib; Medicine; Dasatinib; Discontinuation; Imatinib; Tyrosine-kinase inhibitor; Bosutinib; Internal medicine; Oncology; Imatinib mesylate; Myeloid leukemia; Observational study; Cancer","score_opus":0.037087056406952534,"score_gpt":0.2793085231867801,"score_spread":0.2422214667798276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588130364","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5843452,0.0033543669,0.0000071341165,0.36857048,0.0015096334,0.001743389,0.0001282828,0.0001745402,0.040166974],"genre_scores_gemma":[0.16326296,0.0002841384,0.0014032209,0.6361787,0.036603853,0.0003996631,0.006386797,0.00033660544,0.1551441],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99851066,0.000044727185,0.0002967802,0.00048033556,0.00030267844,0.00036484323],"domain_scores_gemma":[0.9988045,0.000035577665,0.00019934023,0.0008663266,0.000041102438,0.00005312856],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010881876,0.0002920239,0.0005148282,0.00019859627,0.000075341515,0.000047601858,0.00016643741,0.000739135,0.00077736145],"category_scores_gemma":[0.000084572355,0.00027602992,0.00012549147,0.000047675057,0.000037138238,0.00007266406,0.000053691307,0.0012061329,0.00025413634],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000069166513,0.0001667123,0.0022368971,0.00034637153,0.00029034875,0.0062912484,0.00012641451,5.4933975e-7,0.0018371175,0.0000025498584,0.9871352,0.0015596951],"study_design_scores_gemma":[0.010112848,0.00015803875,0.004561935,0.0005995044,0.00056607043,0.00055286,0.0000044503,0.000044294502,0.0029824253,0.000013917121,0.9800474,0.0003562285],"about_ca_topic_score_codex":0.00017078136,"about_ca_topic_score_gemma":0.0002829931,"teacher_disagreement_score":0.42108226,"about_ca_system_score_codex":0.000581943,"about_ca_system_score_gemma":0.00056635117,"threshold_uncertainty_score":0.9999692},"labels":[],"label_agreement":null},{"id":"W2588135995","doi":"10.1182/blood.v106.11.2840.2840","title":"CD56+ Monomorphic Enteropathy-Type T-Cell Lymphoma Is a Genetically Distinct Entity Characterized by 8q Gains and Lack of 1q and 5q Gains.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Comparative genomic hybridization; Lymphoma; Biology; Chromosome; Enteropathy; Whole genome sequencing; Genome; Genetics; Molecular biology; Gene; Cancer research; Disease; Pathology; Medicine; Immunology","score_opus":0.02224629212674485,"score_gpt":0.27786247084775106,"score_spread":0.2556161787210062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588135995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965064,0.0022963295,0.00019409509,0.00016141344,0.00001688834,0.00028200506,0.00010534547,0.000007825643,0.00042972542],"genre_scores_gemma":[0.99697834,0.0011242066,0.0005449691,0.00026232607,0.00008526404,0.000017901304,0.00012680796,0.000018408482,0.00084176805],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990002,0.000061381485,0.00022078896,0.00034187848,0.00014526107,0.00023048147],"domain_scores_gemma":[0.9994199,0.000008849695,0.00007647668,0.00025069178,0.00009379076,0.00015027523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001338835,0.00014889419,0.000178016,0.000038299477,0.00005724635,0.000035830348,0.000116536525,0.00012646057,0.00008533931],"category_scores_gemma":[0.000037125264,0.0001438405,0.000045596767,0.00006107683,0.00013415728,0.0000057902416,0.00015367754,0.000055301374,0.000013595578],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015914899,0.00074208353,0.02776729,0.00006597438,0.00004282241,0.0000046009973,0.000047188634,1.5123315e-7,0.9649192,0.00000948877,0.0003987835,0.005843281],"study_design_scores_gemma":[0.0074971234,0.00097225147,0.04514329,0.00001840744,0.000057667537,0.00004784316,0.000018111636,0.00027889092,0.8787041,0.000024045228,0.0669066,0.00033170826],"about_ca_topic_score_codex":0.000024243769,"about_ca_topic_score_gemma":0.000020502994,"teacher_disagreement_score":0.08621513,"about_ca_system_score_codex":0.000005755117,"about_ca_system_score_gemma":0.00004843707,"threshold_uncertainty_score":0.5865646},"labels":[],"label_agreement":null},{"id":"W2588139273","doi":"10.1182/blood.v120.21.1091.1091","title":"An in-Vitro Model Using Thromboelastography to Evaluate the Effects of Anticoagulants On Clot Formation in Plasma Enriched with Autologous Platelets","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute; McMaster University Medical Centre","funders":"","keywords":"Thromboelastography; Platelet; Fondaparinux; Antithrombotic; Rivaroxaban; Platelet-poor plasma; Dabigatran; Tissue factor; Chemistry; Clotting time; Thrombelastography; Recombinant factor VIIa; Pharmacology; Anticoagulant; Platelet-rich plasma; Thromboplastin; Heparin; Medicine; Thrombosis; Anesthesia; Coagulation; Internal medicine; Warfarin; Biochemistry","score_opus":0.02116357318786661,"score_gpt":0.28826611985508716,"score_spread":0.26710254666722055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588139273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987501,0.00012064771,0.00014994357,0.000027640443,0.00003486753,0.0007691819,0.000003922324,0.00001786549,0.0001258542],"genre_scores_gemma":[0.99852204,0.000015730935,0.0013022424,0.00009031136,0.000010089335,0.000026577323,0.000014973232,0.000016893857,0.0000011603051],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990822,0.000058919057,0.00018740416,0.00013901226,0.00022496626,0.0003075148],"domain_scores_gemma":[0.9995608,0.00006799572,0.00005661739,0.00021129468,0.000023818697,0.00007950798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000144186,0.0001468944,0.00034418126,0.00023575424,0.000034328208,0.0000060317384,0.00005986896,0.00006732268,0.0000010458015],"category_scores_gemma":[0.000027395432,0.000090131325,0.00003364028,0.00030271668,0.000025169742,0.00014451244,0.000012774228,0.00010728531,0.0000039220145],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002736129,0.009900233,0.14117914,0.00033399317,0.00036617005,0.00038651304,0.0069633117,0.0066238362,0.8247282,0.00007875673,0.000006628847,0.0066971234],"study_design_scores_gemma":[0.023327718,0.0029378373,0.38588724,0.00046556356,0.0006209526,0.00045641488,0.00022080053,0.066677414,0.5189413,0.00017721843,0.0000014291714,0.000286151],"about_ca_topic_score_codex":0.000065496395,"about_ca_topic_score_gemma":0.000035685858,"teacher_disagreement_score":0.3057869,"about_ca_system_score_codex":0.000026049438,"about_ca_system_score_gemma":0.000026040761,"threshold_uncertainty_score":0.3675449},"labels":[],"label_agreement":null},{"id":"W2588144806","doi":"10.1182/blood.v118.21.3294.3294","title":"Efficacy and Safety of Eltrombopag in Elderly Patients with Chronic Immune Thrombocytopenia: Analysis of Five Clinical Trials,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Eltrombopag; Medicine; Internal medicine; Adverse effect; Placebo; Chronic myelomonocytic leukemia; International Prognostic Scoring System; Immune thrombocytopenia; Myelodysplastic syndromes; Surgery; Platelet; Bone marrow","score_opus":0.0409012256541122,"score_gpt":0.32431566872744655,"score_spread":0.28341444307333435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588144806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99800557,0.00090499467,0.0000059688887,0.000011378913,0.00001734461,0.00056614284,0.00004012178,0.000006047605,0.0004424568],"genre_scores_gemma":[0.99919105,0.00038724684,0.00029499846,0.0000069471207,0.000006991781,0.000006549929,0.00007812804,0.00000961642,0.00001847813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849063,0.0001439371,0.00084596465,0.00021972237,0.00015715235,0.00014261976],"domain_scores_gemma":[0.9990251,0.00022515151,0.00034960007,0.00026724732,0.00007000685,0.00006287776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005066206,0.00012393924,0.0016223532,0.00017698339,0.000014960767,0.0000018653909,0.000059054608,0.000091145404,0.000097644326],"category_scores_gemma":[0.00018456166,0.000083029874,0.00016864606,0.0003908455,0.00010371995,0.00004162665,0.000027928674,0.000107865366,0.0000015737778],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029073798,0.007015074,0.9770393,0.00004498111,0.006571415,0.00004766977,0.00036826957,0.0000013229919,0.00017113147,0.00001950191,0.0000026665914,0.0058113094],"study_design_scores_gemma":[0.042591162,0.003472055,0.94578266,0.00010503214,0.0071071684,0.0000019257252,0.0000307402,0.0000133963495,0.00080910116,0.00001282117,0.0000051790653,0.00006875308],"about_ca_topic_score_codex":0.00041517132,"about_ca_topic_score_gemma":0.00025234534,"teacher_disagreement_score":0.03968378,"about_ca_system_score_codex":0.000013723639,"about_ca_system_score_gemma":0.00008017512,"threshold_uncertainty_score":0.338586},"labels":[],"label_agreement":null},{"id":"W2588150126","doi":"10.1182/blood.v114.22.2338.2338","title":"FC-Gamma Receptor (FCGR) 2A and 3A Polymorphisms Do Not Influence the Outcome of Relapsed or Refractory CLL Patients Treated with Rituximab, Fludarabine, and Cyclophosphamide (R-FC) or Fludarabine, and Cyclophosphamide (FC) Alone.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Health Sciences Centre","funders":"","keywords":"Fludarabine; Rituximab; Internal medicine; Medicine; Cyclophosphamide; Oncology; Progression-free survival; Gastroenterology; Immunology; Chemotherapy; Lymphoma","score_opus":0.01312360996817118,"score_gpt":0.26011895442554994,"score_spread":0.24699534445737875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588150126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930606,0.0033475233,0.000003159877,0.00088365545,0.000083279585,0.0018827161,0.00019356816,0.00013490146,0.0004106327],"genre_scores_gemma":[0.9931886,0.0021318719,0.0011773418,0.0009955944,0.00011819588,0.000078058154,0.000095618336,0.00011186723,0.0021028304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99523807,0.0001852855,0.0011953233,0.0011520284,0.0012290651,0.0010002443],"domain_scores_gemma":[0.99641687,0.0007326547,0.0004839284,0.0012200956,0.0004676134,0.0006788692],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00055498024,0.0007667255,0.0013841378,0.00028353964,0.00030557154,0.00011248915,0.000390463,0.0004150503,0.00015582159],"category_scores_gemma":[0.0011997493,0.0004444564,0.00010786806,0.000875501,0.0010369407,0.0004033486,0.00022927858,0.00072237826,0.000039707906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09148815,0.01015044,0.81350267,0.0019455489,0.0017751822,0.0028774755,0.0041828994,0.000020999843,0.02731096,0.00016488273,0.0036954363,0.042885367],"study_design_scores_gemma":[0.16824579,0.01267818,0.78997344,0.0012235086,0.0010724049,0.0011422144,0.00030068448,0.00019220756,0.021304019,0.00004053448,0.0027505853,0.0010764139],"about_ca_topic_score_codex":0.0013336772,"about_ca_topic_score_gemma":0.00021750027,"teacher_disagreement_score":0.07675765,"about_ca_system_score_codex":0.00097547524,"about_ca_system_score_gemma":0.0017303121,"threshold_uncertainty_score":0.99980074},"labels":[],"label_agreement":null},{"id":"W2588154148","doi":"10.1182/blood.v110.11.3166.3166","title":"Comparative Analysis of Downstream Genetic Targets of the Variant Acute Promyelocytic Leukemia Fusion Proteins NPM-RARA and NuMA-RARA.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Acute promyelocytic leukemia; Biology; Retinoic acid; Retinoic acid receptor alpha; Chromosomal translocation; Gene; Molecular biology; Leukemia; Phenotype; Retinoic acid receptor; Fusion gene; Cancer research; Genetics","score_opus":0.0057304764896618145,"score_gpt":0.23288114041070668,"score_spread":0.22715066392104485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588154148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99502087,0.0017921751,0.001514787,0.000013483655,0.000035468456,0.00038380251,0.000044193494,0.000005854359,0.0011893653],"genre_scores_gemma":[0.9977053,0.00020637682,0.001772234,0.000021714617,0.000045487654,0.000016994638,0.000058516667,0.000008401151,0.00016496562],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987828,0.000064593136,0.00038481684,0.0003361549,0.00020962539,0.0002219816],"domain_scores_gemma":[0.99904114,0.00001974495,0.0002842849,0.0004443503,0.00014643231,0.00006403481],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020999988,0.0001816937,0.0003605858,0.0000848657,0.00007880847,0.00001086438,0.00026553933,0.00016453584,0.000014717247],"category_scores_gemma":[0.000036581645,0.00012800595,0.00016009163,0.0003131533,0.00023877143,0.0000040650502,0.00016152192,0.00010037519,8.367074e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008840073,0.00019456445,0.017997779,0.00008516279,0.0013851064,0.000011146477,0.00043776177,0.0001301581,0.9792052,0.00003658761,0.000029261088,0.0003988653],"study_design_scores_gemma":[0.00088794855,0.00028252002,0.049112767,0.000027202788,0.0014318022,0.000031562184,0.00010362062,0.00011148349,0.9475614,0.000045706453,0.0002513446,0.00015268152],"about_ca_topic_score_codex":0.000040104638,"about_ca_topic_score_gemma":0.00006212862,"teacher_disagreement_score":0.03164385,"about_ca_system_score_codex":0.000017181224,"about_ca_system_score_gemma":0.00021930276,"threshold_uncertainty_score":0.5219931},"labels":[],"label_agreement":null},{"id":"W2588162726","doi":"10.1182/blood.v110.11.3980.3980","title":"D-DImer Dosing for Risk Prediction of Central Venous Catheter Thrombosis (The DIReCT Trial).","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Central Venous Catheters and Hemodialysis","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Medicine; Asymptomatic; Thrombosis; Venous thrombosis; Surgery; Dosing; Central venous catheter; D-dimer; Internal medicine; Catheter","score_opus":0.048447883780748095,"score_gpt":0.3417593519136408,"score_spread":0.2933114681328927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588162726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933254,0.00029862908,0.001294307,0.00012065613,0.0009972194,0.0018142099,0.00022370416,0.00006366552,0.001862175],"genre_scores_gemma":[0.9980308,0.00016910477,0.00042972667,0.00012614622,0.0009209156,0.000091932365,0.000033601737,0.000031328724,0.00016648824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980941,0.00019221239,0.00061003363,0.00023158701,0.00020214173,0.0006699394],"domain_scores_gemma":[0.9983461,0.00072479254,0.0003840185,0.00034448295,0.00010016694,0.00010047453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013705038,0.00013710813,0.00035360153,0.00006950457,0.0007974634,0.000007180742,0.00014637085,0.00017291578,0.00009192472],"category_scores_gemma":[0.0001608102,0.00009542344,0.0003265618,0.00016596394,0.000056733545,0.00005257966,0.000034186884,0.0002753661,0.000015522844],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028066613,0.03288611,0.64167655,0.0012953023,0.0059803748,0.000008548276,0.17189135,0.0001052286,0.057277255,0.0013556989,0.013215423,0.046241533],"study_design_scores_gemma":[0.20909713,0.009261556,0.6037175,0.00082815124,0.014403682,0.000007045318,0.0074740387,0.0006684942,0.05791158,0.0021386838,0.09315172,0.0013404388],"about_ca_topic_score_codex":0.00055513246,"about_ca_topic_score_gemma":0.00018461917,"teacher_disagreement_score":0.18103053,"about_ca_system_score_codex":0.00007041942,"about_ca_system_score_gemma":0.00009547257,"threshold_uncertainty_score":0.6133524},"labels":[],"label_agreement":null},{"id":"W2588169152","doi":"10.1182/blood.v114.22.1995.1995","title":"Deciphering Mitochondrial Iron Metabolism Using a Knockout Mouse.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Frataxin; Aconitase; Ferritin; Biochemistry; Mitochondrion; Biology; Iron–sulfur cluster; Mitochondrial disease; Heme; Cell biology; Chemistry; Enzyme; Mitochondrial DNA","score_opus":0.03176622582429768,"score_gpt":0.2692674920370362,"score_spread":0.23750126621273854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588169152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979396,0.00017553607,0.00043637524,0.00005867118,0.00036965276,0.00022145775,0.0000144439255,0.000115776034,0.0006685027],"genre_scores_gemma":[0.99508035,0.000016549828,0.003427586,0.00074656116,0.00045519127,0.0000075305347,8.1170896e-7,0.000025414438,0.00023999209],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985173,0.00012619303,0.00019790548,0.00050245936,0.00030195815,0.0003541871],"domain_scores_gemma":[0.99936926,0.00004650586,0.00006715501,0.0003455805,0.00002508087,0.00014641567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000027402177,0.0001896881,0.00017964421,0.00006501484,0.0001632273,0.000091436756,0.0002669348,0.000043160235,0.000053904725],"category_scores_gemma":[0.00035046253,0.0001862548,0.000096301934,0.00020447948,0.000045021858,0.00012037063,0.00005599173,0.00009978979,0.000048867885],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015090368,0.0002812253,0.000048151956,0.0000028643428,0.0000021243693,0.00002163055,0.00007936135,0.0006639102,0.9981155,0.00022344831,0.000039663166,0.00050704554],"study_design_scores_gemma":[0.0011249792,0.00005364139,0.0015431958,0.0000065612035,0.00006721154,0.000023034529,0.000007928153,0.00024898833,0.9960845,0.00017340244,0.0004701795,0.00019634969],"about_ca_topic_score_codex":0.000005892009,"about_ca_topic_score_gemma":0.0000019267745,"teacher_disagreement_score":0.002991211,"about_ca_system_score_codex":0.000010741823,"about_ca_system_score_gemma":0.00005004281,"threshold_uncertainty_score":0.759525},"labels":[],"label_agreement":null},{"id":"W2588190560","doi":"10.1182/blood.v128.22.1250.1250","title":"An Essential Erythroid-Specific Enhancer of ATP2B4 Associated with Red Blood Cell Traits and Malaria Susceptibility","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Biology; Genome-wide association study; Genetics; Locus (genetics); Single-nucleotide polymorphism; Expression quantitative trait loci; Gene; Quantitative trait locus; Phenotype; Genetic association; Genotype","score_opus":0.005900844074698883,"score_gpt":0.21291353267739072,"score_spread":0.20701268860269184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588190560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99664485,0.0007388603,0.000056807512,0.00043348933,0.00004689922,0.000366086,0.00003741581,0.00007315972,0.0016024528],"genre_scores_gemma":[0.9986632,0.00047406915,0.00029119648,0.000027662787,0.0000683506,0.000007077366,0.000015896028,0.000033530523,0.00041902694],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99859923,0.0000804525,0.0003192721,0.00042031135,0.0002676131,0.00031311647],"domain_scores_gemma":[0.9991778,0.00005629967,0.00014837895,0.00027656983,0.00015343833,0.0001874728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002254079,0.0001917207,0.00038696098,0.0000620656,0.00006490028,0.00001148716,0.00007880606,0.0002493684,0.0003236958],"category_scores_gemma":[0.00005012706,0.000117222175,0.00007064969,0.000193121,0.00025170846,0.00009320392,0.000022706718,0.00015588697,0.0000056747713],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031469626,0.003388114,0.033159778,0.00008175183,0.0002671625,0.00005380338,0.00041493465,4.8130414e-7,0.96093655,0.000057098423,0.00015731128,0.0011683244],"study_design_scores_gemma":[0.029799905,0.0031023805,0.36522815,0.0005300453,0.0012967166,0.000077108336,0.00041168736,0.000007657244,0.59875715,0.00011633858,0.00027711876,0.00039578907],"about_ca_topic_score_codex":0.00002126872,"about_ca_topic_score_gemma":0.000052136034,"teacher_disagreement_score":0.36217943,"about_ca_system_score_codex":0.000015545576,"about_ca_system_score_gemma":0.00009652267,"threshold_uncertainty_score":0.47801813},"labels":[],"label_agreement":null},{"id":"W2588191822","doi":"10.1182/blood.v112.11.2140.2140","title":"Genomic Instability Is Frequent in Oral and Rare in Nasal Mucosal Cells of Allogeneic HCT Recipients.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baker Hughes (Canada); University of Calgary","funders":"","keywords":"Buccal swab; Microsatellite instability; Microsatellite; Population; Transplantation; Allele; Gastroenterology; Pathology; Biology; Medicine; Internal medicine; Genetics; Gene","score_opus":0.024864328085066157,"score_gpt":0.2548080974356,"score_spread":0.22994376935053384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588191822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979351,0.0009819082,0.0000010295144,0.00006996523,0.00014327726,0.0004103693,0.00002588232,0.00001028784,0.000422192],"genre_scores_gemma":[0.998345,0.00022342673,0.0011896956,0.00014069075,0.000021829752,0.000019276276,0.0000060389552,0.000016031101,0.000037968643],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988794,0.00005487235,0.00034722133,0.00030355708,0.00018914706,0.00022583453],"domain_scores_gemma":[0.99952453,0.00003765181,0.00005780141,0.00025639258,0.000039083952,0.00008451191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016555969,0.00013116052,0.00033255608,0.000117951364,0.000015075127,0.0000021276983,0.00008053699,0.00011437399,0.00019266862],"category_scores_gemma":[0.00005876684,0.0001235539,0.000045763412,0.00017242852,0.00014372081,0.00002394441,0.000072924355,0.00017194284,0.000007243458],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013856748,0.0004924663,0.87773687,0.000054435266,0.000017803672,0.000056514044,0.00092706765,0.000005931993,0.11998152,0.000001160677,0.000049181508,0.000538508],"study_design_scores_gemma":[0.0037110155,0.00034967533,0.83718616,0.000037679467,0.000023825864,0.00003937507,0.00004218325,0.00001227568,0.15831028,0.000036351277,0.00015733516,0.00009385327],"about_ca_topic_score_codex":0.00060940435,"about_ca_topic_score_gemma":0.0006209355,"teacher_disagreement_score":0.040550683,"about_ca_system_score_codex":0.00011639446,"about_ca_system_score_gemma":0.00019346994,"threshold_uncertainty_score":0.5038382},"labels":[],"label_agreement":null},{"id":"W2588205142","doi":"10.1182/blood.v114.22.5068.5068","title":"The Diagnosis of the Antiphospholipid Syndrome in Our Medical University Center for the Year 2007.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Antiphospholipid syndrome; Lupus anticoagulant; Thrombosis; Medical record; Internal medicine; Venous thrombosis; Pediatrics; Surgery","score_opus":0.01622181419256536,"score_gpt":0.27713642619802187,"score_spread":0.2609146120054565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588205142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9764081,0.00069443486,0.000007943006,0.02075611,0.0002081949,0.000852527,0.000018977611,0.0000117515865,0.0010419203],"genre_scores_gemma":[0.99788594,0.000593376,0.00001899835,0.00015382664,0.000086070286,0.000008911522,0.0000012434994,0.00000814684,0.0012435114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988467,0.00008425412,0.00017028596,0.00012927386,0.0005211069,0.00024834706],"domain_scores_gemma":[0.9989485,0.00041162685,0.000054748907,0.0004494333,0.00006648812,0.000069162226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006232996,0.00007295308,0.00017289357,0.00003342841,0.00010632908,0.0000075390744,0.00045069432,0.00008061612,0.000034585075],"category_scores_gemma":[0.0005691661,0.00003278209,0.000121538134,0.00022925583,0.00008014059,0.00001988784,0.00007868283,0.0002020524,0.000014312876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001604521,0.0006668518,0.97442067,0.00009406131,0.00012382597,0.000102281556,0.00039702735,4.6433487e-7,0.000049161503,0.00068328896,0.022277314,0.0010246277],"study_design_scores_gemma":[0.027157957,0.0008163591,0.8513853,0.0024441895,0.00039089823,0.008742206,0.009734509,0.0002157845,0.004479441,0.00025128183,0.09410908,0.00027300284],"about_ca_topic_score_codex":0.000052749136,"about_ca_topic_score_gemma":0.000047602472,"teacher_disagreement_score":0.12303535,"about_ca_system_score_codex":0.000035959107,"about_ca_system_score_gemma":0.00014350818,"threshold_uncertainty_score":0.13368148},"labels":[],"label_agreement":null},{"id":"W2588237687","doi":"10.1182/blood.v116.21.416.416","title":"Randomized Phase III Trial Comparing ABVD + Radiotherapy and the Stanford V Regimen In Patients with Stage I/II Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the US Intergroup Trial E2496","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Calgary; Nova Scotia Cancer Centre","funders":"","keywords":"ABVD; Medicine; Regimen; Radiation therapy; Chemotherapy regimen; Clinical endpoint; Randomized controlled trial; Mediastinum; Surgery; Internal medicine; Stage (stratigraphy); Chemotherapy; Vincristine","score_opus":0.010226310094974654,"score_gpt":0.2610506480138724,"score_spread":0.25082433791889774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588237687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99526966,0.00022926166,0.000015833517,0.00018581013,0.00025621738,0.0038579393,0.000045034783,0.000015449494,0.00012477707],"genre_scores_gemma":[0.99910593,0.00006168008,0.00012857112,0.00008140991,0.00013858666,0.00034183197,0.00005850145,0.000019177027,0.00006433151],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99791884,0.00024010666,0.0007292435,0.00032359915,0.00052809407,0.0002600978],"domain_scores_gemma":[0.9981113,0.00065872126,0.00050030975,0.00054918876,0.00008009207,0.0001004098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011107957,0.00026692462,0.0016418566,0.00022399395,0.00011723022,0.000045916553,0.00018862655,0.00008969771,0.0000427023],"category_scores_gemma":[0.00023055421,0.00012069615,0.00038470063,0.0005346333,0.00043173417,0.00007962606,0.000072184914,0.00014167737,2.5918553e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91320497,0.008089191,0.07133728,0.000010984619,0.0044865175,0.000013654867,0.0016418096,0.000003842569,0.00004623828,0.00016957792,0.000017612983,0.0009782962],"study_design_scores_gemma":[0.94902664,0.001961238,0.04162116,0.000062806,0.005988287,0.0000043652976,0.000065287306,0.000511995,0.00054377376,0.000007270116,0.000083959465,0.00012324238],"about_ca_topic_score_codex":0.0008011911,"about_ca_topic_score_gemma":0.0009893004,"teacher_disagreement_score":0.035821624,"about_ca_system_score_codex":0.00006614765,"about_ca_system_score_gemma":0.00013551995,"threshold_uncertainty_score":0.49218464},"labels":[],"label_agreement":null},{"id":"W2588242563","doi":"10.1182/blood.v118.21.67.67","title":"Novel Chromosomal Rearrangements and Sequence Mutations in High-Risk Ph-Like Acute Lymphoblastic Leukemia","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; PDGFRB; Sanger sequencing; Gene rearrangement; Genetics; Cancer research; Molecular biology; ABL; Frameshift mutation; Mutation; Gene; Tyrosine kinase; Signal transduction","score_opus":0.027659137725761514,"score_gpt":0.269683588221511,"score_spread":0.2420244504957495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588242563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99663556,0.00008360346,0.0005049979,0.000055666333,0.000111206544,0.00051888434,0.00010869503,0.00008456046,0.0018968051],"genre_scores_gemma":[0.99038357,0.00015381425,0.0084716715,0.00017048913,0.0000973726,0.00009254994,0.000057446447,0.00004843032,0.0005246535],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980575,0.000051022926,0.00036625116,0.0005085535,0.00046955107,0.0005471244],"domain_scores_gemma":[0.99892783,0.00014126595,0.000105493215,0.00042303285,0.000112102214,0.00029028373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021364816,0.00024076717,0.00036344508,0.00026673003,0.00010608136,0.000024090448,0.00018676522,0.00016199313,0.00018279694],"category_scores_gemma":[0.00023100394,0.0002184884,0.000051419607,0.0004554071,0.00026678134,0.00017836058,0.0001569643,0.00028274182,0.00013708365],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015163927,0.0041216905,0.4402281,0.0005324162,0.0022140134,0.006420516,0.007679822,0.000037993676,0.52915806,0.001078516,0.0009646555,0.0060478435],"study_design_scores_gemma":[0.054117713,0.0016263339,0.8981361,0.0005513185,0.0019151805,0.003140829,0.00041039457,0.0049837334,0.03357457,0.00065422885,0.00019185207,0.00069774507],"about_ca_topic_score_codex":0.0026040976,"about_ca_topic_score_gemma":0.00015147994,"teacher_disagreement_score":0.49558347,"about_ca_system_score_codex":0.0005978065,"about_ca_system_score_gemma":0.0008849422,"threshold_uncertainty_score":0.8909699},"labels":[],"label_agreement":null},{"id":"W2588274291","doi":"10.1182/blood.v112.11.3039.3039","title":"The Organization of the National Blood Bank for Rare Blood Units in France","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Population; Medicine; Antigen; Donation; Blood bank; Blood transfusion; Immunology; Andrology; Emergency medicine; Environmental health","score_opus":0.014573213604756465,"score_gpt":0.21975978996720094,"score_spread":0.20518657636244447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588274291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968954,0.0005925178,0.00004122846,0.00118377,0.000092874725,0.00057166966,0.00003110413,0.000020937438,0.0005705419],"genre_scores_gemma":[0.99862766,0.00024593074,0.0002040822,0.00021541076,0.00014921665,0.000024753424,0.000025087193,0.00002213057,0.00048573746],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999069,0.000031812317,0.000253839,0.00015789263,0.00033067216,0.00015680859],"domain_scores_gemma":[0.9990678,0.00014270905,0.000078447134,0.00018453936,0.00049260654,0.000033937267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016641105,0.00010003065,0.00015556492,0.00004395137,0.00023857753,0.000006057299,0.00014335055,0.00008671814,0.000021066176],"category_scores_gemma":[0.00036848278,0.000059834838,0.000051944055,0.00076878356,0.00008357533,0.000044647266,0.000023105998,0.00013841674,0.000002009676],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004593712,0.0027710102,0.9413882,0.00016938022,0.0003061233,0.00001673335,0.0012556593,0.000020358606,0.049511354,0.0036371504,0.0004991473,0.00037894363],"study_design_scores_gemma":[0.014459134,0.00025466556,0.7426304,0.00018043173,0.0005311151,0.00029026164,0.000073751326,0.00003811636,0.23869258,0.00025872898,0.002456921,0.00013386301],"about_ca_topic_score_codex":0.000022151009,"about_ca_topic_score_gemma":0.000031927866,"teacher_disagreement_score":0.19875777,"about_ca_system_score_codex":0.0000048262896,"about_ca_system_score_gemma":0.0001949429,"threshold_uncertainty_score":0.24399939},"labels":[],"label_agreement":null},{"id":"W2588276283","doi":"10.1182/blood.v108.11.3940.3940","title":"Deficiency in TDAG51 Decreases Atherosclerotic Lesion Development in ApoE-Deficient Mice.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Kruppel-like factors research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Apolipoprotein E; Endocrinology; Internal medicine; Steatosis; Biology; LDL receptor; Knockout mouse; Apolipoprotein B; Lipoprotein; Receptor; Cholesterol; Medicine","score_opus":0.017073761892715367,"score_gpt":0.2586980463304689,"score_spread":0.24162428443775352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588276283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973251,0.0010095711,0.00009251717,0.000027759983,0.00003518145,0.00025874624,0.0000039494976,0.0000109162165,0.0012362301],"genre_scores_gemma":[0.99880135,0.000041246592,0.0006501601,0.000029537217,0.00003632451,0.000040046314,0.000071805414,0.000021625758,0.00030788264],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99854445,0.00007199434,0.0002936537,0.00040156636,0.0002430511,0.00044528578],"domain_scores_gemma":[0.9995899,0.000016174232,0.000042530442,0.00024488388,0.0000431171,0.00006340104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000244962,0.00015398538,0.00013370624,0.00014830002,0.000048084636,0.00002435397,0.00022703588,0.00013082555,0.000023014269],"category_scores_gemma":[0.00008432845,0.00014789795,0.000042163952,0.00023901738,0.000047921025,0.0000034551051,0.00014778356,0.000106375155,0.000042875887],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025370322,0.0013874777,0.2688934,0.000023671879,0.0000040318955,0.000021806058,0.000041342497,0.00012197587,0.72865057,0.000031341857,0.00010845006,0.0006905985],"study_design_scores_gemma":[0.0015960468,0.000117805605,0.33286986,0.00004740737,0.000004408126,0.000013135352,0.000059899077,0.000017513034,0.66266966,0.000032479886,0.0023468828,0.0002249103],"about_ca_topic_score_codex":0.00040712042,"about_ca_topic_score_gemma":0.0018084153,"teacher_disagreement_score":0.0659809,"about_ca_system_score_codex":0.000051731135,"about_ca_system_score_gemma":0.00020986819,"threshold_uncertainty_score":0.6031104},"labels":[],"label_agreement":null},{"id":"W2588282992","doi":"10.1182/blood.v116.21.1968.1968","title":"Prospective Canadian Trial In Newly Diagnosed Multiple Myeloma Patients with t(4;14): Bortezomib-Based Therapy without ASCT","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; University of Calgary; Victoria Hospital; London Health Sciences Centre; Southlake Regional Health Center; Princess Margaret Cancer Centre; University of Manitoba; CancerCare Manitoba; Queen Elizabeth II Health Sciences Centre; University of Alberta; University Health Network","funders":"","keywords":"Medicine; Bortezomib; Multiple myeloma; Internal medicine; Melphalan; Dexamethasone; Lenalidomide; Maintenance therapy; Surgery; Gastroenterology; Prednisone; Cyclophosphamide; Chemotherapy; Oncology","score_opus":0.011601866194161757,"score_gpt":0.2610627755224404,"score_spread":0.24946090932827863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588282992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99367785,0.000034772347,0.0000026988284,0.00020090697,0.00014456474,0.0044820854,0.00009222692,0.000060107206,0.0013047898],"genre_scores_gemma":[0.9974147,0.0000065602007,0.0011845784,0.00019323122,0.00018706504,0.00062108453,0.00021368454,0.000059645132,0.000119432676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997915,0.00007160558,0.0002642893,0.0004924077,0.0005455133,0.00071116263],"domain_scores_gemma":[0.998299,0.00015106812,0.000078382276,0.0005099509,0.00023039851,0.000731196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001690579,0.00029156593,0.0004259083,0.0003493726,0.00012549217,0.000045300232,0.00014429084,0.00016534411,0.00017944482],"category_scores_gemma":[0.0004576516,0.0002076347,0.00009046768,0.00035245944,0.00011966783,0.00010245034,0.000014099313,0.0005119836,0.000049344846],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03178411,0.0037295984,0.9577376,0.000010737437,0.00019811666,0.00041016605,0.00015584561,0.0000010580818,0.00028952572,0.0000053424474,0.000049566777,0.0056283306],"study_design_scores_gemma":[0.3269762,0.0020826734,0.6671049,0.000035133155,0.00003964015,0.0000032807313,0.000014165097,0.00006038475,0.0031220682,0.0000061911164,0.0003969031,0.00015844038],"about_ca_topic_score_codex":0.058325015,"about_ca_topic_score_gemma":0.41124466,"teacher_disagreement_score":0.35291964,"about_ca_system_score_codex":0.00013575422,"about_ca_system_score_gemma":0.0012679469,"threshold_uncertainty_score":0.94794565},"labels":[],"label_agreement":null},{"id":"W2588291025","doi":"10.1182/blood.v114.22.2582.2582","title":"Sickle Cell Genetic Markers: Geographic Distribution and Relation to Pain Outcomes in Multicenter Study of Hydroxyurea in Sickle Cell Anemia.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sickle cell anemia; Medicine; Vaso-occlusive crisis; Fetal hemoglobin; Genotyping; Anemia; Haplotype; Pediatrics; Internal medicine; Disease; Genotype; Genetics; Biology; Pregnancy; Gene","score_opus":0.004160648989384009,"score_gpt":0.21419748544358858,"score_spread":0.21003683645420457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588291025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997728,0.00046169772,0.000034227647,0.00035085934,0.000023898378,0.0010052325,0.0000065747276,0.000019793402,0.00036973337],"genre_scores_gemma":[0.99946797,0.00009872763,0.00016706435,0.00014644134,0.000008215118,0.000012605589,0.000030599844,0.000010248158,0.000058154095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988203,0.00012386059,0.00039350832,0.00025335274,0.00017845345,0.00023052421],"domain_scores_gemma":[0.9995377,0.00006241735,0.00007529941,0.00020228926,0.000028940436,0.000093331204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030336407,0.00014569149,0.00028764986,0.0001926704,0.00002582459,0.000007783351,0.000049561637,0.00013300707,0.000009607673],"category_scores_gemma":[0.00007240568,0.00012597308,0.00004317892,0.00035688357,0.000021882734,0.000041962176,0.000021581553,0.0002011977,0.0000040255686],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013182273,0.0051108343,0.9896751,0.000073363786,0.000010723743,0.000060315804,0.0012722891,0.0001570916,0.0021818331,0.0000011483331,0.000030374242,0.001295103],"study_design_scores_gemma":[0.0104213795,0.0015688752,0.9843803,0.00008166074,0.000120322664,0.000002256207,0.002050752,0.0006621569,0.00052776764,0.000019680429,0.000037449663,0.0001274092],"about_ca_topic_score_codex":0.0002907506,"about_ca_topic_score_gemma":0.00011488167,"teacher_disagreement_score":0.010289557,"about_ca_system_score_codex":0.000023916855,"about_ca_system_score_gemma":0.00001770918,"threshold_uncertainty_score":0.51370335},"labels":[],"label_agreement":null},{"id":"W2588294477","doi":"10.1182/blood-2016-10-745471","title":"Myelodysplastic syndrome with excess blasts-2 associated with erythroid predominance","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pancytopenia; Bone marrow; Medicine; Hemoglobin; Myelodysplastic syndromes; Bone marrow aspirate; Platelet; White blood cell; Pathology; Internal medicine; Gastroenterology","score_opus":0.014267805545394549,"score_gpt":0.2610625344501995,"score_spread":0.24679472890480494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588294477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904559,0.000102025,0.0001314025,0.0007602604,0.00004723349,0.0006378212,0.000024955902,0.000120829245,0.0077195396],"genre_scores_gemma":[0.99210757,0.00003800838,0.0008282341,0.00007192986,0.000103756625,0.00009023312,0.000024690822,0.00007906178,0.0066565275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978777,0.000044797707,0.00020928889,0.0005063984,0.00071667106,0.0006451053],"domain_scores_gemma":[0.99789435,0.00015320249,0.00025741773,0.0011423841,0.00027946805,0.00027320872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026495117,0.00027896717,0.00053259695,0.000102468,0.00043410144,0.00013246803,0.00045844566,0.00014945543,0.000088049295],"category_scores_gemma":[0.00058855413,0.00019094007,0.00005180007,0.00018017855,0.0005322649,0.00026434803,0.00014481579,0.0005064062,0.000119157536],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006037389,0.0062970594,0.9044796,0.0009784542,0.005570461,0.054458037,0.0011200878,0.00006133388,0.013879979,0.00039230983,0.0043073567,0.0024179325],"study_design_scores_gemma":[0.025107775,0.0037627781,0.95423806,0.0015939827,0.0008602569,0.0051687392,0.0000744751,0.00023044531,0.007959796,0.000030455685,0.00052564236,0.00044758298],"about_ca_topic_score_codex":0.00007872836,"about_ca_topic_score_gemma":0.0001563436,"teacher_disagreement_score":0.04975847,"about_ca_system_score_codex":0.00015481446,"about_ca_system_score_gemma":0.0006328254,"threshold_uncertainty_score":0.77863103},"labels":[],"label_agreement":null},{"id":"W2588294992","doi":"10.1182/blood.v114.22.3967.3967","title":"FAS Mutations in Follicular Lymphoma Are Rare but Associated with Aggressive Clinical Behavior.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Genome British Columbia; BC Cancer Agency","funders":"","keywords":"Follicular lymphoma; Biology; Exon; Fas receptor; Genetics; Cancer research; Diffuse large B-cell lymphoma; Lymphoma; Gene; Immunology; Apoptosis; Programmed cell death","score_opus":0.024119771397125674,"score_gpt":0.30380545477721727,"score_spread":0.2796856833800916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588294992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973506,0.00074037805,0.0000013288939,0.00060647994,0.00003755305,0.00052059756,0.000040077517,0.00006523683,0.00063775847],"genre_scores_gemma":[0.99870896,0.00007059587,0.00019335095,0.0004899996,0.000061021994,0.00012349401,0.0001745972,0.000015053402,0.00016291122],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882334,0.00006539882,0.00032326157,0.00029559177,0.00025164452,0.00024078367],"domain_scores_gemma":[0.99914646,0.00011100627,0.00023491409,0.0002491803,0.00010490474,0.00015355901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008861328,0.00016448386,0.00039648428,0.000077370016,0.00006103558,0.000019819192,0.00005652558,0.00014477182,0.000028765002],"category_scores_gemma":[0.00024848888,0.000120629695,0.00013361369,0.00023193746,0.00004577105,0.000049288854,0.0000116643505,0.00007308897,0.000028996868],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004944391,0.012246535,0.9698583,0.0000034955629,0.00019760402,0.009144084,0.00009807478,0.0000015784661,0.000029322708,0.00003016227,0.00015584633,0.00818554],"study_design_scores_gemma":[0.021780854,0.0010074442,0.9737486,0.0004316124,0.0010322703,0.00018627866,0.00016066618,0.000006677314,0.0014092774,0.00002983978,0.000071741844,0.00013469718],"about_ca_topic_score_codex":0.0000518407,"about_ca_topic_score_gemma":0.00011180816,"teacher_disagreement_score":0.02173141,"about_ca_system_score_codex":0.00011211521,"about_ca_system_score_gemma":0.00015558329,"threshold_uncertainty_score":0.49191365},"labels":[],"label_agreement":null},{"id":"W2588302747","doi":"10.1182/blood.v128.22.707.707","title":"Hemophagocytic Lymphohistiocytosis (HLH) in Langerhans Cell Histiocytosis (LCH): A Multicenter Retrospective Descriptional Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Hemophagocytic lymphohistiocytosis; Langerhans cell histiocytosis; Histiocyte; Histiocytosis; Hemophagocytosis; Medicine; Retrospective cohort study; Incidence (geometry); Pediatrics; Disease; Immunology; Pathology; Pancytopenia; Bone marrow","score_opus":0.011324799505500761,"score_gpt":0.23729179621400312,"score_spread":0.22596699670850237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588302747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99182725,0.0003703365,0.00009313155,0.000223111,0.000155766,0.000910642,0.00007033285,0.00009245471,0.0062569487],"genre_scores_gemma":[0.9944846,0.000047324153,0.0005145393,0.00015221277,0.00008765932,0.00020359541,0.000019357947,0.000046311816,0.004444401],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99813193,0.00006597016,0.00038728944,0.00056732044,0.0004351061,0.00041239033],"domain_scores_gemma":[0.99912304,0.00006660984,0.00009903171,0.00040647824,0.00011762599,0.00018721912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014189487,0.00028217325,0.0004585393,0.00024384145,0.00009075462,0.000019835612,0.00011348738,0.000100141595,0.00052425615],"category_scores_gemma":[0.0001270658,0.00020185483,0.00013789235,0.0002753098,0.00008482328,0.00010995039,0.000051139177,0.0001011056,0.0004316733],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004985764,0.014827241,0.976151,0.000043150645,0.00025818546,0.0006367056,0.0008730778,6.5650204e-7,0.0048596943,0.00004906081,0.00037218776,0.0014304736],"study_design_scores_gemma":[0.06716266,0.0021744666,0.9209418,0.00028213905,0.0010995998,0.00007536577,0.00063735264,0.00004478534,0.006192662,0.00010582216,0.0008461608,0.00043716503],"about_ca_topic_score_codex":0.00037871217,"about_ca_topic_score_gemma":0.00022989609,"teacher_disagreement_score":0.066664085,"about_ca_system_score_codex":0.0009650614,"about_ca_system_score_gemma":0.00017939832,"threshold_uncertainty_score":0.8231401},"labels":[],"label_agreement":null},{"id":"W2588306955","doi":"10.1182/blood.v112.11.1235.1235","title":"Apoptotic-Like Events in Bernard-Soulier Syndrome (BSS) Platelets.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Hospital for Sick Children","funders":"","keywords":"Platelet; Annexin; Phosphatidylserine; Annexin A5; Flow cytometry; Apoptosis; Chemistry; Platelet activation; Thrombin; Mean platelet volume; Molecular biology; Andrology; Biology; Immunology; Medicine; Membrane; Biochemistry; Phospholipid","score_opus":0.013880035103200407,"score_gpt":0.21319853266174785,"score_spread":0.19931849755854744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588306955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99570346,0.002611438,0.000009414184,0.000077662466,0.00040643726,0.00017220162,0.0000074834816,0.000051468294,0.00096046255],"genre_scores_gemma":[0.99619794,0.00022001256,0.00004007297,0.0000733494,0.000014355192,0.000018067076,0.000080760125,0.000018253982,0.003337176],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989774,0.00009736616,0.00029431915,0.00024860405,0.000042622592,0.00033969196],"domain_scores_gemma":[0.9995835,0.000036405167,0.00008108092,0.00025833267,0.00002221618,0.000018491723],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011754991,0.00015483335,0.00027647102,0.000120775665,0.00012628466,0.0000026611265,0.0001733567,0.0002247796,0.00035920017],"category_scores_gemma":[0.000021725351,0.00014546324,0.000086593354,0.000149551,0.00007697614,0.00011840672,0.00006319782,0.00021694801,0.0010680581],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020582222,0.0036975644,0.324422,0.000044865275,0.00077048555,0.0003375518,0.0014793383,0.000054937398,0.6631717,0.00043271013,0.0028754894,0.0025075313],"study_design_scores_gemma":[0.0059207594,0.0001969604,0.86577135,0.0000552573,0.000052634765,0.002759693,0.00003329195,0.0000035267503,0.11190463,0.0001241729,0.01287998,0.00029772258],"about_ca_topic_score_codex":0.000070530135,"about_ca_topic_score_gemma":0.000008698383,"teacher_disagreement_score":0.5512671,"about_ca_system_score_codex":0.000025618347,"about_ca_system_score_gemma":0.000036051963,"threshold_uncertainty_score":0.9997097},"labels":[],"label_agreement":null},{"id":"W2588308748","doi":"10.1182/blood.v120.21.4823.4823","title":"Clinical Course and Pathological Findings in a Series of Patients with Aggressive Natural Killer (NK) Cell Leukemia","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Pancytopenia; Leukemia; Medicine; Immunology; Hemophagocytic lymphohistiocytosis; Pathology; Acute leukemia; Bone marrow; Biology; Disease","score_opus":0.010623633690095549,"score_gpt":0.26422082074030573,"score_spread":0.25359718705021017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588308748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99773747,0.0016115006,9.4464845e-8,0.000046524714,0.00009051416,0.00022801253,0.00000771699,0.000008853206,0.00026930706],"genre_scores_gemma":[0.99894613,0.00017244088,0.0006204497,0.000099260455,0.000040014445,0.000019093663,0.000022265378,0.0000073912734,0.00007298098],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993041,0.000032529104,0.00020129862,0.00014399033,0.00013646792,0.00018159131],"domain_scores_gemma":[0.99956197,0.000079022655,0.00010348778,0.000110473404,0.000042263702,0.00010280107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008818234,0.00010468697,0.0002917408,0.000025918165,0.000018160623,0.0000039525244,0.000025492356,0.00008478399,0.000020560747],"category_scores_gemma":[0.000059377056,0.000060562725,0.000040269628,0.000055194658,0.00011876886,0.00006903562,0.000035100427,0.000093335424,0.0000046085993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025686726,0.0036273366,0.9944281,0.000030088906,0.00004720281,0.00011378307,0.00028473407,4.565193e-8,0.000017561928,0.00002447065,0.00011760588,0.0010521932],"study_design_scores_gemma":[0.011855431,0.0009812878,0.98529255,0.00012682557,0.00021740014,0.000033876597,0.00007578313,6.613437e-7,0.0012153613,0.0000042292554,0.00012556124,0.0000710086],"about_ca_topic_score_codex":0.0000096263775,"about_ca_topic_score_gemma":0.0000051449356,"teacher_disagreement_score":0.011598564,"about_ca_system_score_codex":0.000025534642,"about_ca_system_score_gemma":0.000048607923,"threshold_uncertainty_score":0.24696761},"labels":[],"label_agreement":null},{"id":"W2588314789","doi":"10.1182/blood.v120.21.108.108","title":"Role of Gas6 in Cancer-Induced Venous Thrombosis","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"GAS6; Cancer; Thrombus; Medicine; Thrombosis; Venous thrombosis; Cancer cell; Pathology; Cancer research; Internal medicine; Receptor; Receptor tyrosine kinase","score_opus":0.023872642172642417,"score_gpt":0.2670005505649223,"score_spread":0.24312790839227985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588314789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98357,0.015268103,6.5361724e-7,0.000020064774,0.00017447752,0.0000822562,0.0000063953808,0.000012709894,0.000865379],"genre_scores_gemma":[0.99974865,0.00012577373,0.000012241342,0.000013353461,0.000025773257,0.000016691374,0.000012786298,0.0000070746064,0.00003765167],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99947476,0.000056605844,0.00016109133,0.00007675951,0.000016061513,0.00021469635],"domain_scores_gemma":[0.99975157,0.000021118989,0.00007153301,0.00013034442,0.000016803517,0.000008656936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010108225,0.00006680372,0.00017666652,0.00005574312,0.000028803974,0.0000015040841,0.00007485502,0.00011136783,0.00017333636],"category_scores_gemma":[0.000010428487,0.000061174615,0.000039961677,0.00009122843,0.000026073578,0.00008006457,0.000026390358,0.0000810654,0.00004998175],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007940012,0.0008942194,0.07476013,0.000005907165,0.000062125284,4.126079e-8,0.00050600135,6.443589e-7,0.9191385,0.00023984694,0.000021423897,0.0043632425],"study_design_scores_gemma":[0.00061524153,0.00005693794,0.41090015,0.000015173394,0.000028312283,0.0000030012818,0.000055188455,3.6365432e-7,0.5876015,0.000025018766,0.0006562372,0.000042936543],"about_ca_topic_score_codex":0.0005945808,"about_ca_topic_score_gemma":0.000035712146,"teacher_disagreement_score":0.33614,"about_ca_system_score_codex":0.000015094843,"about_ca_system_score_gemma":0.00002279896,"threshold_uncertainty_score":0.24946283},"labels":[],"label_agreement":null},{"id":"W2588327775","doi":"10.1182/blood.v116.21.1527.1527","title":"Finishing the Picture: Clopidogrel Is Indeed the Most Common Drug Associated with Thrombotic Thrombocytopenic Purpura (TTP) In FDA Databases: Its Mechanism, Laboratory Findings, Clinical Features, and Epidemiology Differ From That Associated with Ticlopidine","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Clopidogrel; Medicine; Thrombotic thrombocytopenic purpura; Ticlopidine; Thienopyridine; Internal medicine; Antiplatelet drug; Epidemiology; Pharmacovigilance; Surgery; Pediatrics; Platelet; Aspirin; Adverse effect","score_opus":0.04157312082578795,"score_gpt":0.29526001433219595,"score_spread":0.253686893506408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588327775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910516,0.0025087849,0.00000833398,0.0027009754,0.0006285189,0.001252752,0.0016824567,0.00012370312,0.00004285598],"genre_scores_gemma":[0.995202,0.000114022565,0.00004112338,0.0028888995,0.000080733,0.00011232779,0.0013766531,0.00006221327,0.000121993435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944177,0.0029083604,0.00085775304,0.0008476381,0.00017157945,0.0007969508],"domain_scores_gemma":[0.9891353,0.008909328,0.0007026578,0.0010309345,0.00014128434,0.000080453596],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0026812113,0.0005380351,0.001221191,0.00008147204,0.0006321653,0.00008180413,0.0009360744,0.00049111544,0.00036473965],"category_scores_gemma":[0.0027615684,0.0002877664,0.00010319961,0.0004492583,0.00067683525,0.00021934799,0.0005040972,0.00208353,0.000028494454],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019914245,0.0008616617,0.98099667,0.00001600739,0.0018731274,0.00003228455,0.0011017837,0.0000013873373,0.0067623504,0.0014696175,0.0066541974,0.000031797055],"study_design_scores_gemma":[0.0073475963,0.00027282696,0.98350096,0.00036634062,0.00089618604,0.00003686646,0.0009280348,0.000016311029,0.005157768,0.0004200134,0.00059380964,0.00046331293],"about_ca_topic_score_codex":0.00042718713,"about_ca_topic_score_gemma":0.013092491,"teacher_disagreement_score":0.012665304,"about_ca_system_score_codex":0.000054705193,"about_ca_system_score_gemma":0.00021190484,"threshold_uncertainty_score":0.99995744},"labels":[],"label_agreement":null},{"id":"W2588333435","doi":"10.1182/blood.v112.11.4459.4459","title":"Autologous Stem Cell Transplantation Is Superior to Myeloablative Allogeneic SCT as a Salvage Therapy for Patients with Refractory/Relapsed Transformed Lymphoma","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Leukemia & Lymphoma Society of Canada; BC Cancer Agency; St. Paul's Hospital","funders":"","keywords":"Medicine; Internal medicine; Salvage therapy; Refractory (planetary science); Cumulative incidence; Transplantation; Surgery; Gastroenterology; Incidence (geometry); Lymphoma; Population; Chemotherapy","score_opus":0.01238958380997837,"score_gpt":0.23278582197242972,"score_spread":0.22039623816245135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588333435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99571985,0.00037847031,0.000071424365,0.0002667037,0.00005594762,0.0026595383,0.00021103614,0.0000842201,0.00055278616],"genre_scores_gemma":[0.9960432,0.0006485061,0.0010224526,0.0010516617,0.000039387436,0.0006508927,0.0002051874,0.000052986565,0.00028574813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998581,0.000034871653,0.00027837438,0.00042855646,0.00032252938,0.00035464737],"domain_scores_gemma":[0.9992252,0.00011234273,0.000070483,0.00023796965,0.00013826424,0.00021576774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004431772,0.0002942226,0.00042313524,0.00011159461,0.00017632477,0.000013320683,0.000076495024,0.00012694167,0.00005240107],"category_scores_gemma":[0.0000038191533,0.00020490619,0.00015532791,0.00017164768,0.000047948506,0.00009400485,0.0000034748275,0.000037758797,0.000044677403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018108126,0.028668066,0.76660436,0.00035284527,0.0021069015,0.0010322825,0.044187438,0.000006200544,0.011668315,0.00003367769,0.0005742256,0.12665758],"study_design_scores_gemma":[0.0562257,0.010875916,0.75394124,0.00008989139,0.0004414149,0.00011074799,0.00012846064,0.0000026456917,0.17534477,0.0000050642043,0.0025601243,0.00027404027],"about_ca_topic_score_codex":0.000075716736,"about_ca_topic_score_gemma":0.000016633985,"teacher_disagreement_score":0.16367644,"about_ca_system_score_codex":0.000119162076,"about_ca_system_score_gemma":0.00026969373,"threshold_uncertainty_score":0.83558315},"labels":[],"label_agreement":null},{"id":"W2588338825","doi":"10.1182/blood.v104.11.5259.5259","title":"Targeting Hematopoietic Cells Using a Blimp-1 Promoter Helper Dependent Adenoviruses.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Luciferase; Genetic enhancement; Molecular biology; Transgene; Biology; Viral vector; Cell culture; Promoter; Virology; Gene; Gene expression; Transfection; Recombinant DNA; Genetics","score_opus":0.019718641870940936,"score_gpt":0.28085400736521177,"score_spread":0.26113536549427085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588338825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970097,0.0013624207,0.00096508366,0.00007295511,0.00007862381,0.0003326339,0.000013078102,0.000026166848,0.00013932418],"genre_scores_gemma":[0.9971183,0.00010426687,0.0019008082,0.00029118237,0.00031602036,0.000023956078,0.000023828476,0.00006237946,0.00015925095],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984476,0.00006812635,0.00023363018,0.00045620845,0.000296051,0.0004983992],"domain_scores_gemma":[0.99927384,0.000005285521,0.00006518558,0.00043517485,0.000082926024,0.0001376196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002670354,0.00020692918,0.00015907543,0.00006666448,0.00012556938,0.00005583545,0.00028956204,0.00016645947,0.0000737257],"category_scores_gemma":[0.00002936942,0.00019943423,0.000098376346,0.00012423575,0.00006839717,0.000005624698,0.00017437221,0.00015683059,0.00008778817],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015245593,0.00038551795,0.00029061624,0.000029425735,0.000085642336,0.00003568324,0.00010265365,0.0006947936,0.9980776,0.000004359727,0.000041614967,0.00009968717],"study_design_scores_gemma":[0.0020871009,0.00084010744,0.000018100183,0.00002258093,0.000035853016,0.0000621578,0.00005414374,0.000016280139,0.9961662,0.00006476296,0.0003803955,0.0002522699],"about_ca_topic_score_codex":0.000031619104,"about_ca_topic_score_gemma":0.000036331603,"teacher_disagreement_score":0.001934645,"about_ca_system_score_codex":0.00002854868,"about_ca_system_score_gemma":0.00021164892,"threshold_uncertainty_score":0.8132692},"labels":[],"label_agreement":null},{"id":"W2588347050","doi":"10.1182/blood.v106.11.1558.1558","title":"Single Nucleotide Polymorphisms (SNPs) and Recurrent Mutations in the Hyaluronan Synthase 1 (HAS1) Gene May Predispose to Multiple Myeloma (MM) and Waldenstrom’s Macroglobulinemia (WM).","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Exon; Biology; RNA splicing; Single-nucleotide polymorphism; Intron; Exonic splicing enhancer; Molecular biology; Gene; Polypyrimidine tract; Genetics; Cancer research; Alternative splicing; Genotype; RNA","score_opus":0.012701671250108742,"score_gpt":0.2547918201655684,"score_spread":0.24209014891545966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588347050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969028,0.0009132663,0.00004155659,0.0012864734,0.000041572788,0.0004909324,0.00016617078,0.000014682594,0.00014249633],"genre_scores_gemma":[0.995916,0.00004483791,0.0032920907,0.00020610215,0.00023141547,0.000059099664,0.00010835592,0.000030052772,0.00011205566],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998576,0.00011098839,0.00024045857,0.00046617803,0.00021021854,0.0003961894],"domain_scores_gemma":[0.9993083,0.00005915261,0.000046159657,0.00036044454,0.000045033314,0.00018092152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019954523,0.00019677219,0.00014390073,0.00008231753,0.00011474964,0.00007614439,0.00022713024,0.00010794707,0.000017205195],"category_scores_gemma":[0.00018680828,0.00016718269,0.00004392997,0.00013652361,0.00013107715,0.000009984913,0.00020760008,0.00015211658,0.00001553357],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013248005,0.00054948416,0.01578792,0.000022111246,0.00003748936,0.00003122984,0.0004006812,0.000020191399,0.96148837,0.000013060051,0.0005141225,0.021002835],"study_design_scores_gemma":[0.003522175,0.0017591093,0.1255785,0.0000692678,0.000066785135,0.00029172288,0.00026588587,0.0002832208,0.8505509,0.000022944374,0.017117824,0.0004716813],"about_ca_topic_score_codex":0.000060275288,"about_ca_topic_score_gemma":0.0005480284,"teacher_disagreement_score":0.1109375,"about_ca_system_score_codex":0.00001837824,"about_ca_system_score_gemma":0.000046752753,"threshold_uncertainty_score":0.68175125},"labels":[],"label_agreement":null},{"id":"W2588355963","doi":"10.1182/blood.v108.11.3911.3911","title":"Phospholipid Components of the Activated Platelet Surface Determine Multimerin 1 and Factor V/Va Binding, and Modulate Thrombin Generation in Plasma.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Phosphatidylserine; Thrombin; Chemistry; Platelet; Phosphatidylcholine; Platelet activation; Phospholipid; Factor V; Biophysics; Phosphatidylethanolamine; Binding site; Sphingomyelin; Molecular biology; Membrane; Biochemistry; Biology; Immunology","score_opus":0.030492152219625077,"score_gpt":0.2460490259782016,"score_spread":0.21555687375857652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588355963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99929696,0.0000705954,0.0000070107394,0.00008642655,0.00007948527,0.00036867367,0.000020688456,0.000021554888,0.00004862378],"genre_scores_gemma":[0.99913794,0.000026737294,0.00062180805,0.000027288794,0.000025635103,0.0000034043894,0.00004265358,0.000017551942,0.00009699405],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991983,0.00003335478,0.00025451515,0.00020848837,0.00016076991,0.00014458109],"domain_scores_gemma":[0.99962395,0.000023542374,0.00011633365,0.00016245244,0.000027766928,0.000045923498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007111843,0.00013593855,0.0002656712,0.000057412344,0.00005354848,0.000012949793,0.000042932807,0.00009639628,0.000026898017],"category_scores_gemma":[0.00001382611,0.00010399899,0.000029037106,0.00014531628,0.00005145158,0.00006371108,0.000045768607,0.00010603419,0.0000018036444],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002467669,0.00035391847,0.039647248,0.000024507926,0.000034334626,0.0000031212235,0.00011198348,0.000063487576,0.9593946,0.00005514687,0.000009992731,0.00027699536],"study_design_scores_gemma":[0.004249918,0.00006650509,0.27591702,0.000045836794,0.000037869708,0.000026898966,0.000009140234,0.0077892113,0.7117405,0.000023438788,0.000017799524,0.00007583865],"about_ca_topic_score_codex":0.0003334382,"about_ca_topic_score_gemma":0.000078771016,"teacher_disagreement_score":0.24765408,"about_ca_system_score_codex":0.00001229064,"about_ca_system_score_gemma":0.000013635414,"threshold_uncertainty_score":0.42409557},"labels":[],"label_agreement":null},{"id":"W2588370718","doi":"10.1182/blood.v122.21.530.530","title":"RNA-Sequencing Of Paired Pre-Treatment and Relapse Samples Reveals Differentially Expressed Genes Associated With Lenalidomide Resistance In Multiple Myeloma","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Cereblon; Lenalidomide; Biology; Pomalidomide; Molecular biology; Exon; Multiple myeloma; Cancer research; Gene; Ubiquitin ligase; Immunology; Genetics; Ubiquitin","score_opus":0.03657468359301485,"score_gpt":0.258404923781669,"score_spread":0.22183024018865416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588370718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99660224,0.0015423963,0.000022333465,0.000135975,0.000011573384,0.0013684938,0.000068395486,0.000049099166,0.00019951187],"genre_scores_gemma":[0.99457437,0.00035188606,0.0037402234,0.000014893365,0.000025274747,0.00032371993,0.00009018159,0.0000343466,0.0008451031],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982594,0.00017370039,0.00041132895,0.00039602947,0.0003317129,0.00042779677],"domain_scores_gemma":[0.9986144,0.00044980954,0.00018510177,0.0003718678,0.00016164254,0.00021721341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014437194,0.00025391864,0.0005845079,0.0001500368,0.00007619695,0.000030209452,0.000082104336,0.00010195301,0.000048223865],"category_scores_gemma":[0.0005355679,0.00017479528,0.000069985974,0.00018162654,0.00012098154,0.00012061657,0.000042934153,0.000096692864,0.0000037357847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007379188,0.0010717256,0.63479435,0.00013361986,0.0005564797,0.00013650772,0.00055912405,0.0000020361492,0.36030465,0.000012205775,0.00002236585,0.0016690049],"study_design_scores_gemma":[0.019113624,0.0006204081,0.82239205,0.0007973539,0.00017937984,0.000008394438,0.00012430603,0.00006432347,0.15640591,0.00013787659,0.0000108617605,0.00014550576],"about_ca_topic_score_codex":0.0018030864,"about_ca_topic_score_gemma":0.0031686537,"teacher_disagreement_score":0.20389873,"about_ca_system_score_codex":0.00016120072,"about_ca_system_score_gemma":0.00014836139,"threshold_uncertainty_score":0.7127944},"labels":[],"label_agreement":null},{"id":"W2588373691","doi":"10.1182/blood.v108.11.3039.3039","title":"Myeloablative Allogeneic Stem Cell Transplantation for Relapsed Composite Low and Intermediate Grade Lymphoma Is Not Superior to Autologous Stem Cell Transplantation - Reduced Relapse Risk Is Offset by Higher Treatment Related Mortality.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Vancouver General Hospital","funders":"","keywords":"Medicine; Transplantation; Cumulative incidence; Internal medicine; Gastroenterology; Surgery; Autologous stem-cell transplantation; Lymphoma; Incidence (geometry)","score_opus":0.013901441978245433,"score_gpt":0.25807124525495906,"score_spread":0.24416980327671362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588373691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913383,0.0006021404,0.00025667885,0.00074599683,0.00015692138,0.0027889782,0.0036900963,0.00017082992,0.00025004288],"genre_scores_gemma":[0.98993737,0.0016418298,0.00086246483,0.00034537617,0.00008203613,0.00037193022,0.002004417,0.000114090646,0.004640465],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99672836,0.00028225197,0.0008689602,0.0009616854,0.0004964998,0.0006622582],"domain_scores_gemma":[0.99848616,0.00029364103,0.0002720953,0.00045071746,0.00014719229,0.00035017467],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002698005,0.00054262084,0.00075327227,0.0002895166,0.00025147112,0.00005946624,0.00016615355,0.00043933326,0.000038582704],"category_scores_gemma":[0.0000027189099,0.00048346084,0.00023030488,0.00036564659,0.00013515068,0.00017671289,0.000019073415,0.00024532163,0.00004946232],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057538506,0.0027081426,0.027964301,0.0014776364,0.0010561222,0.0007872234,0.019605255,0.000060136328,0.9286374,0.00001874207,0.0027288985,0.009202294],"study_design_scores_gemma":[0.028151253,0.0021810026,0.16840266,0.00018759488,0.0026336887,0.00017004757,0.00022919393,0.00047321166,0.79658717,0.000022383258,0.00048784024,0.00047396106],"about_ca_topic_score_codex":0.00086582097,"about_ca_topic_score_gemma":0.000052647123,"teacher_disagreement_score":0.14043835,"about_ca_system_score_codex":0.00046813575,"about_ca_system_score_gemma":0.000225534,"threshold_uncertainty_score":0.9997617},"labels":[],"label_agreement":null},{"id":"W2588373857","doi":"10.1182/blood.v120.21.2149.2149","title":"Expanding Spectrum of Malignancies in ALPS: A Cancer Predisposing Syndrome?.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Cancer; Cohort; Lymphoma; Oncology; Internal medicine; Immunology","score_opus":0.01756122313501451,"score_gpt":0.27842884941103874,"score_spread":0.2608676262760242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588373857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918211,0.006520495,0.0000017527107,0.00017596595,0.00010082394,0.00018741489,0.000008738156,0.00001622082,0.0011674728],"genre_scores_gemma":[0.99929,0.00023051728,0.00019931498,0.00004166913,0.000074443626,0.00006267044,0.0000036473552,0.0000102179265,0.00008753784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99937195,0.00001075012,0.00015896527,0.000096919604,0.00012245477,0.00023893542],"domain_scores_gemma":[0.99972075,0.00002760288,0.00004831921,0.00012272112,0.0000094189845,0.000071166134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007170511,0.00008312934,0.00021935646,0.000077988145,0.000016817563,0.000004142853,0.000026918207,0.00003643907,0.00008144618],"category_scores_gemma":[0.000014491224,0.00006498946,0.000050727656,0.00012291028,0.000020480884,0.000070857466,0.00002006014,0.000030082892,0.0000071582476],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018788312,0.0014704918,0.993102,0.00008240319,0.0000913489,0.0000827303,0.0006819224,7.7748126e-7,0.0038960734,0.00016016248,0.000032899217,0.0003804168],"study_design_scores_gemma":[0.0027620697,0.00012330932,0.8532681,0.00054832647,0.00019551255,0.00017038683,0.00012440766,0.0000018424979,0.14264607,0.000018295043,0.00008414961,0.00005752637],"about_ca_topic_score_codex":0.00035137904,"about_ca_topic_score_gemma":0.000037437447,"teacher_disagreement_score":0.13983388,"about_ca_system_score_codex":0.00007364127,"about_ca_system_score_gemma":0.000042981952,"threshold_uncertainty_score":0.2650193},"labels":[],"label_agreement":null},{"id":"W2588377090","doi":"10.1182/blood.v128.22.90.90","title":"Serial Trough Anti-Xa Levels to Assess Low Molecular Weight Heparin Accumulation in Patients with Chronic Kidney Disease: Analysis of Crcl &lt;30 Ml/Min from the Trivet Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Université de Montréal; St. Joseph’s Healthcare Hamilton; University of Toronto; McMaster University","funders":"","keywords":"Kidney disease; Medicine; Rivaroxaban; Heparin; Internal medicine; Low molecular weight heparin; Gastroenterology; Renal function; Trough level; Trough (economics); Urology; Warfarin; Transplantation","score_opus":0.02203160969831906,"score_gpt":0.2851327764739025,"score_spread":0.26310116677558343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588377090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966172,0.00006267639,0.00059631356,0.0005638852,0.00008728511,0.0017566973,0.00025217747,0.000022148215,0.000041622232],"genre_scores_gemma":[0.9991679,0.000017286593,0.00011253084,0.00029188656,0.0001082238,0.000111982416,0.00014180479,0.000027387798,0.000020996753],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981429,0.00016277065,0.00040400893,0.00044303367,0.00057796703,0.00026930473],"domain_scores_gemma":[0.99873936,0.000086649816,0.00016771245,0.0006972642,0.000114970775,0.0001940276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021481581,0.00020772319,0.0006855248,0.0002135862,0.000047147492,0.00002578438,0.00020862465,0.00004668803,0.0003299726],"category_scores_gemma":[0.00014597178,0.00011852053,0.00012335682,0.0006912505,0.00003221349,0.00010422198,0.00011843356,0.00006205414,0.000013579497],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028911178,0.0073844986,0.9852688,0.000029266139,0.0028026486,0.000033086842,0.00040085582,0.0003171154,0.001983411,0.00004942399,0.00031219542,0.001129617],"study_design_scores_gemma":[0.012645503,0.0007303365,0.978396,0.000223307,0.005910907,3.2095933e-8,0.000032310152,0.00006813704,0.0015886155,0.000013913336,0.0002275442,0.00016337246],"about_ca_topic_score_codex":0.00039055813,"about_ca_topic_score_gemma":0.00029227103,"teacher_disagreement_score":0.01235639,"about_ca_system_score_codex":0.00009412638,"about_ca_system_score_gemma":0.00014336422,"threshold_uncertainty_score":0.4833127},"labels":[],"label_agreement":null},{"id":"W2588380004","doi":"10.1182/blood.v104.11.2050.2050","title":"Silencing of Caspase 8 Expression in Leukemia Cells and Patient Samples.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Jurkat cells; Gene silencing; Biology; Apoptosis; Caspase; Caspase 8; Cancer cell; Leukemia; Molecular biology; Caspase 3; Cancer research; Immunology; Programmed cell death; Cancer; T cell; Gene; Immune system; Biochemistry; Genetics","score_opus":0.00821925551963049,"score_gpt":0.2146781919874538,"score_spread":0.20645893646782332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588380004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99843997,0.0010969328,0.00022304943,0.000010235019,0.000016754257,0.000056355246,0.000010901211,0.0000015059902,0.0001443161],"genre_scores_gemma":[0.99861145,0.0002236703,0.0010879536,0.000029547533,0.00001562115,0.000009285547,0.000007612338,0.0000043956575,0.00001048545],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996817,0.000007722703,0.00009199234,0.000116377334,0.0000371361,0.0000650899],"domain_scores_gemma":[0.99980134,0.0000021005203,0.00003373606,0.00012475117,0.000015495592,0.000022593957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000023535767,0.00004218226,0.000048610356,0.00001641982,0.0000147808705,0.0000030263504,0.000032624484,0.00004169283,0.000003267938],"category_scores_gemma":[0.0000074879954,0.000038605678,0.000014231989,0.000028013823,0.000020032894,0.0000013053694,0.000027302,0.00002319099,4.40061e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006323469,0.00005846694,0.00065684837,0.00000807151,0.0000027476538,0.0000012478073,0.000121068006,0.00031659356,0.99764556,0.0000136334265,0.000024947301,0.0011444865],"study_design_scores_gemma":[0.0006650078,0.00007471452,0.002955937,0.000024152483,0.0000043517794,0.0000026337327,0.00012154555,0.0000018356762,0.99563664,0.00003777025,0.00042799048,0.000047413738],"about_ca_topic_score_codex":0.00011403277,"about_ca_topic_score_gemma":0.000033372737,"teacher_disagreement_score":0.0022990888,"about_ca_system_score_codex":0.000008883515,"about_ca_system_score_gemma":0.000050911312,"threshold_uncertainty_score":0.1574294},"labels":[],"label_agreement":null},{"id":"W2588397113","doi":"10.1182/blood.v114.22.3345.3345","title":"Low Risk of Reactivation of Hepatitis B and Hepatic Injury in Multiple Myeloma (MM) Patients (pts) Undergoing Autologous Stem Cell Transplant (ASCT).","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; HBsAg; Internal medicine; Hepatitis B; Hepatitis B virus; Population; Lymphoma; Gastroenterology; Rituximab; Immunology; Oncology; Virus","score_opus":0.009114183538141217,"score_gpt":0.21714373313259858,"score_spread":0.20802954959445735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588397113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986758,0.00023154721,0.00005747872,0.00003514523,0.000042334,0.00049541803,0.000104010905,0.000029505958,0.00032871377],"genre_scores_gemma":[0.9975037,0.00183027,0.0005413826,0.000041184478,0.00001569469,0.000012028402,0.00002434687,0.000016128264,0.000015279744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986251,0.000101368336,0.0005573206,0.00023901707,0.00026263125,0.0002145642],"domain_scores_gemma":[0.9990879,0.0002477938,0.0002930951,0.00020837408,0.00010191287,0.000060886505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015634063,0.00016727058,0.0005132507,0.00019056443,0.000046070687,0.0000036351664,0.000052773194,0.000105458486,0.0000049932723],"category_scores_gemma":[0.00014848451,0.00015715032,0.000058184065,0.00020508663,0.00006526958,0.00009186653,0.00001833803,0.00015338234,0.000002308572],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014718561,0.0014332307,0.962906,0.0003923069,0.00006655271,0.00001837083,0.0021976177,0.0000036925398,0.013928219,0.000008989574,0.000012928147,0.018884884],"study_design_scores_gemma":[0.0038358588,0.0012681705,0.85199374,0.00056869176,0.00018934415,0.0000036376828,0.000040914452,0.00021580559,0.14171359,0.000051938547,0.000005626644,0.00011265327],"about_ca_topic_score_codex":0.0022256358,"about_ca_topic_score_gemma":0.0024027096,"teacher_disagreement_score":0.12778537,"about_ca_system_score_codex":0.000045280107,"about_ca_system_score_gemma":0.000062481275,"threshold_uncertainty_score":0.6408404},"labels":[],"label_agreement":null},{"id":"W2588410911","doi":"10.1182/blood.v114.22.4844.4844","title":"Red Blood Cell Transfusion Independence Following the Initiation of Iron Chelation Therapy in Myelodysplastic Syndrome.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Myelodysplastic syndromes; Internal medicine; Blood transfusion; Anemia; International Prognostic Scoring System; Gastroenterology; Ferritin; Hemoglobin; Bone marrow; Apheresis; Surgery; Platelet","score_opus":0.00758178236652693,"score_gpt":0.22147082357208078,"score_spread":0.21388904120555385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588410911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994486,0.00096695597,0.00006501974,0.00063483237,0.00006502741,0.0004641463,0.0000010488051,0.000027792967,0.0032891987],"genre_scores_gemma":[0.99861705,0.0010715644,0.000099502104,0.00012628484,0.000015044854,0.000006601313,0.000013593144,0.000010700655,0.00003968294],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990041,0.000056883386,0.0003028705,0.00017022269,0.00029868665,0.00016723423],"domain_scores_gemma":[0.9996185,0.00005437952,0.00008291193,0.00017421838,0.000031118412,0.000038911505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024969998,0.00011385467,0.00019431768,0.00011157784,0.000059704533,0.000007129418,0.000070869806,0.00019140798,0.000029298864],"category_scores_gemma":[0.00004336311,0.000079348196,0.00009166628,0.00035640883,0.0000205792,0.00008520774,0.000005325934,0.0002809879,0.0000041393605],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060007186,0.005955895,0.1232039,0.00018435578,0.00015641555,0.00049626775,0.0059308643,0.00073801825,0.8484115,0.000171537,0.000017756967,0.014133421],"study_design_scores_gemma":[0.026361497,0.0033505405,0.8505353,0.00072698115,0.0006667091,0.0002615543,0.00095335953,0.00051709346,0.115690485,0.0005874033,0.00004276964,0.0003063456],"about_ca_topic_score_codex":0.000035529614,"about_ca_topic_score_gemma":0.000007209927,"teacher_disagreement_score":0.73272103,"about_ca_system_score_codex":0.000012004682,"about_ca_system_score_gemma":0.0000622912,"threshold_uncertainty_score":0.32357258},"labels":[],"label_agreement":null},{"id":"W2588423274","doi":"10.1182/blood.v124.21.4123.4123","title":"Sensory Neuropeptides Prime the Splenic Marginal Zone for Optimal Humoral Immunity","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital; University of Toronto; University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre; Hospital for Sick Children","funders":"","keywords":"Marginal zone; Immunology; Biology; Red pulp; Population; Germinal center; B cell; Lymphocytosis; Immune system; Spleen; Antibody; Medicine","score_opus":0.015391006399226435,"score_gpt":0.22086858103347323,"score_spread":0.2054775746342468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588423274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994389,0.0016878259,0.0004630097,0.00039150892,0.0006401904,0.0003600804,0.000025336856,0.00012607466,0.0019169586],"genre_scores_gemma":[0.9851829,0.000051784136,0.0004324986,0.00027457377,0.00013832017,0.000048468148,0.000089046065,0.000032460655,0.013749967],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99833715,0.0004751421,0.00028743088,0.00031051383,0.000030037281,0.00055971334],"domain_scores_gemma":[0.9987786,0.0003959393,0.00013331807,0.0005971134,0.00007467649,0.00002034679],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043073422,0.00023708037,0.0003122686,0.00005798145,0.000534298,0.00002362277,0.00051691575,0.00021803667,0.00036210575],"category_scores_gemma":[0.00010777737,0.00016641828,0.00017822877,0.00007878817,0.0004884163,0.000058711732,0.0001918975,0.00049138075,0.0008265581],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020648047,0.0004430404,0.00045781257,0.000011649654,0.00020782383,0.0000034000036,0.0001832754,0.0000041508606,0.9942962,0.00095942296,0.0011720516,0.0020547253],"study_design_scores_gemma":[0.0051117325,0.00090664515,0.0028810373,0.0000133336,0.00023922845,0.0004108264,0.00020494706,0.000013175917,0.7931187,0.00011649653,0.19669007,0.00029379883],"about_ca_topic_score_codex":0.00007727387,"about_ca_topic_score_gemma":0.000018173327,"teacher_disagreement_score":0.20117745,"about_ca_system_score_codex":0.000008974569,"about_ca_system_score_gemma":0.000043643427,"threshold_uncertainty_score":0.9999514},"labels":[],"label_agreement":null},{"id":"W2588426502","doi":"10.1182/blood.v116.21.4895.4895","title":"Cytarabine and Etoposide (CYVE) as First-Line Therapy for Primary Central Nervous System Lymphoma","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Cytarabine; ThioTEPA; Etoposide; Primary central nervous system lymphoma; Busulfan; Regimen; Surgery; Cyclophosphamide; Adverse effect; Internal medicine; Urology; Chemotherapy; Gastroenterology","score_opus":0.007984061426459408,"score_gpt":0.23264255930883312,"score_spread":0.22465849788237371,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588426502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99365836,0.0020765613,0.000017005226,0.0013654551,0.00027820392,0.0011580209,0.000041190364,0.00012331299,0.0012818661],"genre_scores_gemma":[0.9965001,0.00057979906,0.0011704392,0.00058549165,0.0005060792,0.0002538244,0.00009003382,0.000044985954,0.0002692911],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988753,0.00001202871,0.00024666206,0.00033842635,0.00017441747,0.00035314093],"domain_scores_gemma":[0.9991418,0.0001248565,0.00007333064,0.00034873493,0.00006721798,0.00024404608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009047625,0.00022210683,0.00038443843,0.000057182537,0.00012876416,0.000036039393,0.000066372064,0.00012713819,0.000033856963],"category_scores_gemma":[0.000030842468,0.000165876,0.00013971921,0.00007065627,0.00005120389,0.000046541158,0.00002856918,0.00005907052,0.000018255296],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019945432,0.012415924,0.33445576,0.0010978415,0.0015818973,0.001051657,0.0006523839,0.0000029584942,0.038058806,0.0044444846,0.0013530572,0.6028907],"study_design_scores_gemma":[0.022874797,0.0015424165,0.91184694,0.00013938548,0.00047639382,0.0013729047,0.000038184047,0.00005422821,0.041936476,0.00006914676,0.01943784,0.00021129208],"about_ca_topic_score_codex":0.00025045968,"about_ca_topic_score_gemma":0.00009741403,"teacher_disagreement_score":0.60267943,"about_ca_system_score_codex":0.000066899804,"about_ca_system_score_gemma":0.00012907288,"threshold_uncertainty_score":0.67642266},"labels":[],"label_agreement":null},{"id":"W2588428507","doi":"10.1182/blood.v116.21.3112.3112","title":"Comparison of Conventional Cytology Vs. High Sensitivity Flow Cytometry for the Diagnosis of Leptomeningeal Involvement by Hematological Lymphoid Malignancies","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Lymphoma; Cytology; Gold standard (test); Flow cytometry; Cerebrospinal fluid; Pathology; Lumbar puncture; Bone marrow; Leukemia; Internal medicine; Gastroenterology; Immunology","score_opus":0.0268993223690798,"score_gpt":0.3059622302246445,"score_spread":0.2790629078555647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588428507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996564,0.0008185773,0.00030645324,0.0011027056,0.00020668424,0.00063564314,0.0003139119,0.000022534216,0.000029526986],"genre_scores_gemma":[0.99650204,0.000081955186,0.0026668324,0.0001326037,0.00006421134,0.00036446535,0.00015646873,0.000013619574,0.000017776787],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998707,0.000047140125,0.0004588315,0.0002521189,0.00029724583,0.00023765316],"domain_scores_gemma":[0.99795705,0.0012569464,0.00024477686,0.00028354488,0.00017647151,0.000081238286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029851773,0.00017255926,0.0006986637,0.00007482219,0.00008526095,0.0000069441185,0.00008254375,0.0001457505,0.00015053904],"category_scores_gemma":[0.00018724447,0.000113611066,0.0002433864,0.0001387167,0.00029576494,0.000024469336,0.00006774357,0.00009032241,0.000004026558],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001994907,0.0072054868,0.94897497,0.00015399589,0.0005682247,0.000014581242,0.000100129284,0.000002856884,0.036349118,0.0016073702,0.0032407006,0.0015830576],"study_design_scores_gemma":[0.0058000186,0.00085471314,0.40025204,0.0000557566,0.0006699714,0.000111825495,0.000116249605,0.0001974642,0.59082884,0.0000625218,0.0009580814,0.000092530594],"about_ca_topic_score_codex":0.00013719266,"about_ca_topic_score_gemma":0.0000678526,"teacher_disagreement_score":0.5544797,"about_ca_system_score_codex":0.000028345194,"about_ca_system_score_gemma":0.000079989164,"threshold_uncertainty_score":0.46329248},"labels":[],"label_agreement":null},{"id":"W2588445917","doi":"10.1182/blood.v108.11.1695.1695","title":"Controlling the Pathway for Prothrombin Activation by Prothrombinase.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Prothrombinase; Thrombin; Chemistry; Cleavage (geology); Biochemistry; Peptide; Thromboplastin; Factor X; Coagulation; Platelet; Biology; Internal medicine; Immunology","score_opus":0.016282375335991923,"score_gpt":0.24655159156604411,"score_spread":0.2302692162300522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588445917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9538882,0.00028195095,0.02561366,0.005473627,0.00018415925,0.00919476,0.00003568868,0.0003184733,0.0050095315],"genre_scores_gemma":[0.9957658,0.0000022256397,0.001206347,0.00055515213,0.00021659237,0.00092380546,0.000099340985,0.000032709944,0.0011980287],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990778,0.00003257043,0.00024001252,0.00021916337,0.00021204518,0.0002184393],"domain_scores_gemma":[0.99942553,0.00007407081,0.00011278762,0.00023671637,0.000108064174,0.000042814972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002342434,0.00013323034,0.00022366538,0.000034633304,0.00018474933,0.000036566955,0.000069128386,0.00009080205,0.00004755778],"category_scores_gemma":[0.00005382899,0.00009142811,0.000102349666,0.00012151829,0.000036245805,0.00007183429,0.000011234118,0.00009734022,0.000013203773],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007433644,0.001510416,0.0006056091,0.00006543052,0.00009536853,8.610464e-7,0.000051440216,0.0000033264378,0.9647029,0.02992694,0.0021872534,0.0007761188],"study_design_scores_gemma":[0.009834919,0.00047533223,0.0023491688,0.00006553125,0.00018425322,0.000010823559,0.000048996288,0.00034019665,0.96940947,0.007228548,0.009918768,0.00013400894],"about_ca_topic_score_codex":0.00003749998,"about_ca_topic_score_gemma":0.000004000143,"teacher_disagreement_score":0.04187765,"about_ca_system_score_codex":0.000017377477,"about_ca_system_score_gemma":0.00005979916,"threshold_uncertainty_score":0.372833},"labels":[],"label_agreement":null},{"id":"W2588447148","doi":"10.1182/blood.v108.11.1038.1038","title":"Galectin-3 Binding Protein Contaminates the Purification of Recombinant Factor IX.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Factor IX; Recombinant DNA; Affinity chromatography; HEK 293 cells; Transfection; Molecular biology; Biology; Chemistry; Biochemistry; Gene; Enzyme","score_opus":0.007064883040698993,"score_gpt":0.2146897192984385,"score_spread":0.2076248362577395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588447148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983226,0.00064494205,0.00013500906,0.000118820164,0.000096609605,0.0003057958,0.0000065492623,0.000008686264,0.00036100004],"genre_scores_gemma":[0.9976054,0.000023764616,0.00013404657,0.000003097541,0.00010510121,0.000034020028,0.000072517956,0.000011619982,0.0020104272],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994698,0.00003679012,0.00015827823,0.00015225027,0.00007703107,0.000105826],"domain_scores_gemma":[0.99958605,0.0000067986034,0.0001273129,0.00020761119,0.00006002055,0.000012189408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008355816,0.00007239552,0.000067588495,0.000024887115,0.000055399687,0.000010102563,0.00008738975,0.00008868205,0.000010235967],"category_scores_gemma":[0.000027940916,0.000056425688,0.00004698202,0.000085800864,0.000036939506,0.0000021540077,0.000019549898,0.00004283811,0.0000039278243],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012486869,0.00008531201,0.0019832288,0.000010169033,0.000022128286,1.5039406e-7,0.000012908946,0.000010052978,0.99628246,0.00008420777,0.0001778838,0.0013190142],"study_design_scores_gemma":[0.0005087555,0.0001111521,0.017688205,0.000016084672,0.000022170081,0.0000056728345,0.000015671592,0.00001257863,0.97836703,0.000066154826,0.0031138381,0.00007267443],"about_ca_topic_score_codex":0.000054099863,"about_ca_topic_score_gemma":0.00004467923,"teacher_disagreement_score":0.017915417,"about_ca_system_score_codex":0.000009265729,"about_ca_system_score_gemma":0.00003410333,"threshold_uncertainty_score":0.23009728},"labels":[],"label_agreement":null},{"id":"W2588455970","doi":"10.1182/blood.v112.11.4258.4258","title":"Retrospective Study of Trough Imatinib Plasma Levels Conducted as Part of the Follow-up of Patients with Chronic Myeloid Leukemia in a Canadian Cohort","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Imatinib; Myeloid leukemia; Medicine; Trough level; Internal medicine; Cohort; Gastroenterology; Oncology","score_opus":0.016316615937859352,"score_gpt":0.23718431651633629,"score_spread":0.22086770057847693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588455970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955319,0.000062473366,1.0621771e-7,0.000015857056,0.0000950546,0.0024439,0.00018192716,0.000012428702,0.0016563509],"genre_scores_gemma":[0.99941266,0.000011915825,0.0000535317,0.00001628208,0.00002631407,0.00008395901,0.00003841176,0.000036486843,0.000320446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99778765,0.00009877253,0.00066016265,0.00036406153,0.0006790427,0.0004102977],"domain_scores_gemma":[0.9983239,0.000046109522,0.00043032208,0.00072249246,0.00031654842,0.00016060607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014066267,0.0002526637,0.00080734654,0.00017274424,0.00006371542,0.000002047512,0.00020770455,0.00011522183,0.00015146156],"category_scores_gemma":[0.00023401584,0.0001762512,0.000096858384,0.0006477494,0.00022280558,0.00007081801,0.000050566585,0.0002579115,0.000004238559],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002961425,0.0013183403,0.99306226,0.00006893822,0.0008323338,0.000051187344,0.003542713,0.000020001662,0.00068573956,0.000016704735,0.000051637373,0.00005400237],"study_design_scores_gemma":[0.047388185,0.0029286363,0.93439347,0.0002700133,0.00053840247,0.000030347543,0.00034578712,0.000018608738,0.01391465,0.0000064924766,0.00003443571,0.00013100424],"about_ca_topic_score_codex":0.21616203,"about_ca_topic_score_gemma":0.2576638,"teacher_disagreement_score":0.058668822,"about_ca_system_score_codex":0.003213599,"about_ca_system_score_gemma":0.006751577,"threshold_uncertainty_score":0.9988792},"labels":[],"label_agreement":null},{"id":"W2588462476","doi":"10.1182/blood.v114.22.622.622","title":"Prediction of Survival in Diffuse Large B-Cell Lymphoma Based On the Expression of Two Genes: Integration of Tumor and Microenvironment Contributions.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; International Prognostic Index; Oncology; Survival analysis; Biology; Gene; Lymphoma; Internal medicine; Medicine; Computational biology; Genetics","score_opus":0.010597088637092978,"score_gpt":0.22748691115468458,"score_spread":0.21688982251759162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588462476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985945,0.00045869898,0.0000956459,0.00017441125,0.000018089528,0.00036584484,0.00015457442,0.0000046337536,0.00013358616],"genre_scores_gemma":[0.9995609,0.00013661865,0.00014767912,0.00006151201,0.000012925619,0.000020814105,0.000049415077,0.000003997196,0.0000061184],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993044,0.00006452741,0.00026185668,0.00011656409,0.00016719397,0.0000854393],"domain_scores_gemma":[0.9995241,0.000096656506,0.00013483608,0.00018452042,0.000029904271,0.00002997837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015542877,0.000083689636,0.0002128728,0.000059135942,0.000019795727,0.0000019693296,0.000028586963,0.000030561918,0.000009013572],"category_scores_gemma":[0.00003412348,0.00005142045,0.000049666614,0.000064958804,0.000033639968,0.000019030656,0.000009450281,0.00002308198,4.554407e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002974825,0.041617736,0.21652904,0.000045902718,0.00002110889,0.0000099769895,0.00020060358,0.000007740883,0.7394811,0.0002843991,0.00003352187,0.0014714177],"study_design_scores_gemma":[0.024472443,0.000570596,0.34272823,0.00019754068,0.00008712163,0.0000019189545,0.000074004725,0.0002685985,0.6315421,0.000018379127,0.00001757509,0.000021523749],"about_ca_topic_score_codex":0.000040794643,"about_ca_topic_score_gemma":0.0000059431018,"teacher_disagreement_score":0.12619919,"about_ca_system_score_codex":0.000044949662,"about_ca_system_score_gemma":0.000030398935,"threshold_uncertainty_score":0.20968652},"labels":[],"label_agreement":null},{"id":"W2588511228","doi":"10.1182/blood.v124.21.576.576","title":"Unveiling the Regulatory Role of CD8+ T-Cells in the Pathogenesis and Effective Steroid Treatment in ITP","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Canadian Blood Services; St. Michael's Hospital","funders":"","keywords":"Immunology; CD8; Cytotoxic T cell; Medicine; Autoantibody; Immune system; Antibody; Platelet; Dexamethasone; Internal medicine; Biology; In vitro","score_opus":0.004962047762048895,"score_gpt":0.21256655982551206,"score_spread":0.20760451206346317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588511228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99703866,0.0014373241,0.0000012100867,0.00008326983,0.000012075023,0.00056633184,0.0000044870017,0.0000045139445,0.00085213716],"genre_scores_gemma":[0.9996773,0.000102250946,0.000029639714,0.00006964755,0.00001531883,0.00006510516,0.0000034883415,0.000007465169,0.00002980783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99943113,0.00011646856,0.00011802513,0.0001305895,0.00008973548,0.0001140406],"domain_scores_gemma":[0.9995521,0.00018563356,0.000037060123,0.00019639984,0.000008621728,0.00002020606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019358052,0.000092200855,0.00020317746,0.000043123368,0.000025138594,0.000004689623,0.000039362967,0.000038152997,0.0000028618376],"category_scores_gemma":[0.000014557162,0.000045598947,0.00003623548,0.0000864973,0.000046753466,0.000015592977,0.0000111297295,0.00004321439,0.000003135712],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028845397,0.005910395,0.700645,0.00009720944,0.0003723125,0.00024794863,0.009537009,0.000028457447,0.17369035,0.00028379913,0.000012764838,0.1088863],"study_design_scores_gemma":[0.011280173,0.0011410394,0.8994195,0.00009860764,0.0003120668,0.000058012592,0.0013084679,0.00013735204,0.08524269,0.0005461878,0.0003635498,0.0000923629],"about_ca_topic_score_codex":0.00013259657,"about_ca_topic_score_gemma":0.00014431369,"teacher_disagreement_score":0.19877449,"about_ca_system_score_codex":0.000017404644,"about_ca_system_score_gemma":0.000015010996,"threshold_uncertainty_score":0.1859471},"labels":[],"label_agreement":null},{"id":"W2588513806","doi":"10.1182/blood.v104.11.528.528","title":"Risk Factors for Bleeding in Patients with Nonvalvular Atrial Fibrillation Who Are Receiving Anticoagulant Therapy with Ximelagatran or Warfarin: Findings from the SPORTIF III and V Trials.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kelowna General Hospital; McMaster University","funders":"","keywords":"Ximelagatran; Medicine; Warfarin; Atrial fibrillation; Stroke (engine); Internal medicine; Cardiology; Hazard ratio; Anticoagulant; Direct thrombin inhibitor; Confidence interval; Dabigatran","score_opus":0.052978762942514884,"score_gpt":0.291074211053172,"score_spread":0.2380954481106571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588513806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99662846,0.00020282799,0.00027926444,0.0004586288,0.00010844886,0.0022228295,0.00004693281,0.000043223205,0.000009351382],"genre_scores_gemma":[0.99793196,0.00033091186,0.00078586675,0.000029747833,0.0007366418,0.0000025603408,0.00010575446,0.000035467398,0.00004109969],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857414,0.00005459347,0.00047865408,0.00032841688,0.0003314394,0.00023275596],"domain_scores_gemma":[0.9986731,0.0006080755,0.0003939789,0.00019189523,0.00006811228,0.00006487001],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055428344,0.0002295976,0.00069310685,0.00010679824,0.00019068472,0.00007276105,0.000060762093,0.00009471567,0.000021154938],"category_scores_gemma":[0.0003728743,0.00011378317,0.00014288691,0.00024802447,0.000042974745,0.0001772383,0.000020384614,0.000120568766,6.5685276e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055580847,0.000017792425,0.9914424,0.000019555073,0.00044496005,0.0000035847686,0.0010391925,0.0003440172,0.000047665613,0.000020117997,0.000005867164,0.0010567915],"study_design_scores_gemma":[0.04458807,0.00079046097,0.95181423,0.00035475366,0.00080097077,8.8336844e-7,0.00041430266,0.000046606816,0.00068690843,0.00006906487,0.00025021718,0.00018350147],"about_ca_topic_score_codex":0.000507182,"about_ca_topic_score_gemma":0.00021536899,"teacher_disagreement_score":0.03962811,"about_ca_system_score_codex":0.000034234676,"about_ca_system_score_gemma":0.000054100863,"threshold_uncertainty_score":0.46399432},"labels":[],"label_agreement":null},{"id":"W2588518146","doi":"10.1182/blood.v114.22.3123.3123","title":"A Cohort Study of Warfarin Administered to Achieve An INR of 2.0 to 3.0 for the Prevention of Recurrent Venous Thrombosis in Patients with An Antiphospholipid Antibody.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; London Health Sciences Centre; McMaster University; St. Joseph's Hospital","funders":"","keywords":"Medicine; Thrombosis; Warfarin; Venous thrombosis; Adverse effect; Surgery; Cohort; Anticoagulant; Antiphospholipid syndrome; Internal medicine; Clinical trial; Atrial fibrillation","score_opus":0.03553622908638727,"score_gpt":0.3626541861199272,"score_spread":0.32711795703353996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588518146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99291474,0.00003319964,0.000057046618,0.0000513941,0.000045161378,0.006810043,0.000031223517,0.0000095859095,0.00004758556],"genre_scores_gemma":[0.9991724,0.0000063352677,0.00060051266,0.000015681833,0.00002243305,0.00011170315,0.000032765864,0.000020443313,0.000017744836],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981239,0.00012614806,0.00058554806,0.00031115153,0.00062377297,0.00022949866],"domain_scores_gemma":[0.99852693,0.00006581593,0.00021657156,0.0007157166,0.00035277547,0.00012216628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006759705,0.00013941273,0.00062195427,0.00020543774,0.000026743404,0.000005941414,0.00024032165,0.000052717736,0.0000056427784],"category_scores_gemma":[0.00013268863,0.000093329494,0.000052969775,0.00047869474,0.000027753606,0.000060549904,0.000047389025,0.00008563715,7.084292e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003661733,0.027603729,0.95350504,0.00028573515,0.00019724088,0.0000013586407,0.008102692,0.0000071817612,0.0040611206,0.000008517573,0.000009750131,0.0025558867],"study_design_scores_gemma":[0.008260987,0.08056284,0.90186685,0.0007528976,0.00024022385,0.000011051768,0.002099246,0.00001767963,0.0060868505,0.000009175885,0.000005272309,0.00008694654],"about_ca_topic_score_codex":0.00019816581,"about_ca_topic_score_gemma":0.00023536388,"teacher_disagreement_score":0.052959107,"about_ca_system_score_codex":0.000034897137,"about_ca_system_score_gemma":0.00011455309,"threshold_uncertainty_score":0.38058662},"labels":[],"label_agreement":null},{"id":"W2588523697","doi":"10.1182/blood.v120.21.1991.1991","title":"Outcome of Transplantation for Acute Leukemia in Down Syndrome","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Montreal Children's Hospital; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Medicine; Internal medicine; Myeloid leukemia; Transplantation; Leukemia; Down syndrome; Acute leukemia; Cohort; Population; Incidence (geometry); Multivariate analysis; Oncology","score_opus":0.022487288145496054,"score_gpt":0.3233769002499278,"score_spread":0.30088961210443177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588523697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99723923,0.00009506382,0.0009965957,0.000094904324,0.00006802272,0.0005320747,0.00005489319,0.00002162579,0.000897581],"genre_scores_gemma":[0.9962077,0.00003924603,0.0030830542,0.00007643079,0.00006224889,0.00006699015,0.00005474931,0.000020070165,0.00038947977],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896693,0.00001857638,0.0003075038,0.0001232695,0.0002442265,0.00033951475],"domain_scores_gemma":[0.99945277,0.00015779569,0.000047988848,0.00017539541,0.00004819178,0.000117845506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002721559,0.00009461626,0.00029122253,0.00015514382,0.000015904736,0.000003104672,0.000078634424,0.00010180335,0.00004563545],"category_scores_gemma":[0.00007186219,0.0000790524,0.00007619387,0.00017590656,0.00004023615,0.00010136881,0.000013221195,0.000105779705,0.000025505988],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015281076,0.0012014249,0.9206397,0.0019194303,0.00073098415,0.00047717764,0.0021013198,0.000013475071,0.06847004,0.0011593367,0.00044615107,0.0013128358],"study_design_scores_gemma":[0.030674255,0.00080896774,0.8837286,0.00022233925,0.0014260634,0.002704742,0.000109869696,0.00038373173,0.079275124,0.000098965975,0.00033437437,0.00023292808],"about_ca_topic_score_codex":0.00007823761,"about_ca_topic_score_gemma":0.000007786024,"teacher_disagreement_score":0.03691108,"about_ca_system_score_codex":0.00028686845,"about_ca_system_score_gemma":0.00023505767,"threshold_uncertainty_score":0.32236633},"labels":[],"label_agreement":null},{"id":"W2588526377","doi":"10.1182/blood.v124.21.2204.2204","title":"Novel Evidence That Pituitary Gonadotropins Directly Stimulate Human Leukemic cells—studies on Myeloid Cell Lines and Primary Patient AML and CML Cells","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Biology; Haematopoiesis; Internal medicine; Endocrinology; Myeloid; Progenitor cell; Luteinizing hormone; Myeloid leukemia; Stem cell; Population; Cancer research; Hormone; Cell biology; Medicine","score_opus":0.03963293132510984,"score_gpt":0.28795475274938254,"score_spread":0.2483218214242727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588526377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905696,0.0064628455,0.000040891457,0.0006156126,0.00019441423,0.00076578534,0.000027017053,0.00011654219,0.0012072767],"genre_scores_gemma":[0.98888713,0.005136418,0.0021232571,0.0018544481,0.00033812973,0.000043344626,0.000019873874,0.00007820584,0.0015192006],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99745816,0.000116977884,0.00043628216,0.00079918833,0.0005977993,0.0005916157],"domain_scores_gemma":[0.99797463,0.00069591316,0.0002088657,0.0005996119,0.00017693208,0.00034405015],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003719894,0.00043597282,0.00069954025,0.00023041878,0.00028382716,0.00005011812,0.00018856312,0.00016794054,0.000016328997],"category_scores_gemma":[0.00019544111,0.00035116944,0.00009178622,0.00017364352,0.00038027344,0.00019878059,0.00042283183,0.00055862236,0.000040587634],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021534282,0.0005348245,0.0024701518,0.0010786578,0.00017651089,0.00008240996,0.0010775913,0.000043359425,0.98871297,0.00002347672,0.002081386,0.003503322],"study_design_scores_gemma":[0.008522953,0.003513815,0.031915627,0.0015300384,0.00058668025,0.00011752607,0.0003266189,0.0005738841,0.9481886,0.000062963896,0.0039651524,0.0006961272],"about_ca_topic_score_codex":0.00016982145,"about_ca_topic_score_gemma":0.00001855232,"teacher_disagreement_score":0.040524356,"about_ca_system_score_codex":0.00023752793,"about_ca_system_score_gemma":0.00017260644,"threshold_uncertainty_score":0.999894},"labels":[],"label_agreement":null},{"id":"W2588538983","doi":"10.1182/blood.v114.22.680.680","title":"A Randomized, Double-Blind, Placebo-Controlled Phase 1/2 Study to Determine the Safety and Efficacy of Romiplostim in Children with Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP).","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Romiplostim; Adverse effect; Thrombocytopenic purpura; Placebo; Randomized controlled trial; Internal medicine; Incidence (geometry); Clinical endpoint; Platelet; Pediatrics; Thrombopoietin","score_opus":0.015088824189044416,"score_gpt":0.28494448241797693,"score_spread":0.26985565822893254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588538983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820448,0.0034234885,0.000013280462,0.0004950927,0.000014939884,0.0137070585,0.0000071736367,0.00002990829,0.00026421814],"genre_scores_gemma":[0.9992592,0.00021563323,0.000055231616,0.00007686675,0.000042929132,0.00024099623,0.00002085828,0.000025008487,0.00006330266],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980471,0.00017690423,0.0007248088,0.00039988267,0.0003070059,0.0003443136],"domain_scores_gemma":[0.9988974,0.0001975945,0.00021917021,0.0005100237,0.000054100263,0.00012171036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008145537,0.0003292725,0.0019735266,0.00016903838,0.00009845612,0.00002958669,0.00016725318,0.00006526116,0.000023052688],"category_scores_gemma":[0.000114011404,0.00017793593,0.00015663916,0.00033337044,0.000096973796,0.000075195225,0.000052164425,0.00023704168,0.000007620984],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9729478,0.013147189,0.006236766,0.000013021481,0.00190591,0.00024694216,0.0010279705,0.000028483306,0.0008010651,0.000014788386,0.0000012103241,0.0036288616],"study_design_scores_gemma":[0.9478878,0.007471888,0.039758634,0.00019200837,0.002650965,0.00037551855,0.00008073834,0.00007745923,0.0013157653,0.000011654499,0.0000015982081,0.00017602283],"about_ca_topic_score_codex":0.00020321779,"about_ca_topic_score_gemma":0.00015842092,"teacher_disagreement_score":0.03352187,"about_ca_system_score_codex":0.000044170698,"about_ca_system_score_gemma":0.00015622312,"threshold_uncertainty_score":0.7256017},"labels":[],"label_agreement":null},{"id":"W2588543869","doi":"10.1182/blood.v126.23.3126.3126","title":"Propensity Score Matching Analysis Comparing Azathioprine Plus Prednisone Vs Prednisone Alone Regimens As First-Line Treatment in Chronic Graft-Versus-Host Disease","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Prednisone; Internal medicine; Propensity score matching; Regimen; Azathioprine; Clinical endpoint; Clinical trial; Gastroenterology; Surgery; Oncology; Disease","score_opus":0.07022890407625802,"score_gpt":0.3088827313527356,"score_spread":0.23865382727647755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588543869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936794,0.0013170758,0.00046953527,0.0012975376,0.0001031999,0.0019539485,0.0000416889,0.00021499637,0.0009226348],"genre_scores_gemma":[0.9960944,0.00028563713,0.00067633874,0.00006979708,0.00038936743,0.00021848449,0.0003926642,0.00008600114,0.0017873102],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958946,0.00015893238,0.0007187674,0.0010273049,0.0012012915,0.0009990997],"domain_scores_gemma":[0.99671125,0.00022414754,0.0002212814,0.0013119489,0.00027394877,0.0012573926],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005460352,0.0005502572,0.0014351296,0.00060732424,0.00018292946,0.00008941006,0.00034768533,0.00017505932,0.000093002054],"category_scores_gemma":[0.00052683614,0.00046002882,0.00030362766,0.0015294941,0.0001995672,0.0002301438,0.0004794489,0.00040882695,0.00020566602],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.056764595,0.016204657,0.8277592,0.001482142,0.015108197,0.017701583,0.007717209,0.050451037,0.004768643,0.0003274254,0.0007667267,0.0009485495],"study_design_scores_gemma":[0.29798314,0.011789287,0.5097513,0.0020481905,0.022774223,0.00045636515,0.0006362375,0.1405771,0.010361925,0.00023126847,0.0014161925,0.0019747715],"about_ca_topic_score_codex":0.0061878543,"about_ca_topic_score_gemma":0.005617425,"teacher_disagreement_score":0.31800795,"about_ca_system_score_codex":0.0061066113,"about_ca_system_score_gemma":0.0035663529,"threshold_uncertainty_score":0.9997851},"labels":[],"label_agreement":null},{"id":"W2588551336","doi":"10.1182/blood.v118.21.3208.3208","title":"Using the Zebrafish As a Tool for Modeling Systemic Mastocytosis,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Zebrafish Biomedical Research Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Atlantic Cancer Research Institute; Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Zebrafish; Biology; Notch signaling pathway; Cell biology; Phenotype; Mast cell; Signal transduction; Immunology; Genetics; Gene","score_opus":0.05280303601802262,"score_gpt":0.3087425654414308,"score_spread":0.2559395294234082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588551336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8823763,0.00040859258,0.11557699,0.000100202975,0.00003220557,0.0007048278,0.00002830695,0.000017363243,0.00075518957],"genre_scores_gemma":[0.9936313,0.000037030233,0.0054156464,0.00022906877,0.00020852832,0.0003225501,0.000030774238,0.000022459039,0.00010261081],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99914926,0.00003209579,0.00016158259,0.00024866682,0.00014211505,0.00026630296],"domain_scores_gemma":[0.9993585,0.000016814767,0.000039670766,0.0004026367,0.0001011941,0.00008119071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026344444,0.00009092776,0.000081858954,0.000023031991,0.00014110148,0.000022077824,0.00032794767,0.00010235229,0.000018036826],"category_scores_gemma":[0.00023525268,0.000067646695,0.00008329927,0.000082570536,0.000066856046,0.0000027621898,0.000118795586,0.00006849855,0.0000121915855],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005025165,0.00018383561,0.0002103872,0.000036680318,0.000108420434,0.000001182487,0.000067394154,0.000024721823,0.99736583,0.0009792601,0.000463698,0.0005083226],"study_design_scores_gemma":[0.003205042,0.00060944766,0.00012546849,0.00009156507,0.00024605563,0.00027446102,0.0004303086,0.017618775,0.9648318,0.003278009,0.008766243,0.00052278733],"about_ca_topic_score_codex":0.000042623888,"about_ca_topic_score_gemma":0.0000066702632,"teacher_disagreement_score":0.11125501,"about_ca_system_score_codex":0.000008366227,"about_ca_system_score_gemma":0.00013029964,"threshold_uncertainty_score":0.2758552},"labels":[],"label_agreement":null},{"id":"W2588556515","doi":"10.1182/blood.v110.11.1255.1255","title":"TIMP-3 Inhibition of Angiopoietin-1 Signaling Recruits Hematopoietic Stem Cells from the Bone Marrow Niche.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Hematological disorders and diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Stem cell; Cell biology; Biology; Haematopoiesis; Bone marrow; Hematopoietic stem cell; Angiogenesis; Progenitor cell; Vascular endothelial growth factor; Angiopoietin; Endothelial stem cell; Immunology; Cancer research; Genetics","score_opus":0.025590333980241055,"score_gpt":0.2529574165789765,"score_spread":0.22736708259873548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588556515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934821,0.002455464,0.00088065513,0.00072341505,0.000073084266,0.00038273307,0.000023661616,0.000051620576,0.0019272778],"genre_scores_gemma":[0.997681,0.00008098855,0.001201758,0.00077088445,0.000107567525,0.000007878569,0.000023853338,0.000018914452,0.00010712117],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987494,0.000042948323,0.00044121058,0.00021139288,0.00028885136,0.0002662082],"domain_scores_gemma":[0.99849296,0.0008662534,0.00014092338,0.00028599068,0.00009059923,0.00012326495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004072372,0.00014009488,0.00033867612,0.00003582766,0.00005672157,0.000011050595,0.000070815586,0.00015385298,0.00019991299],"category_scores_gemma":[0.00017865727,0.00009328033,0.0001373763,0.00020076429,0.00008362241,0.000025051926,0.00004614449,0.0001769883,0.00007025635],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040199948,0.0044683195,0.062557876,0.00051871495,0.00027621049,0.0009929294,0.0027154742,0.000009294065,0.90912855,0.0020885223,0.011616228,0.005225901],"study_design_scores_gemma":[0.0028972328,0.0003444262,0.0047058314,0.00052840105,0.00039511872,0.000054808384,0.0012611904,0.000012578099,0.98736143,0.0013732967,0.0008929048,0.0001727535],"about_ca_topic_score_codex":0.000028178414,"about_ca_topic_score_gemma":0.000014161104,"teacher_disagreement_score":0.07823293,"about_ca_system_score_codex":0.000008804302,"about_ca_system_score_gemma":0.000034452594,"threshold_uncertainty_score":0.38038614},"labels":[],"label_agreement":null},{"id":"W2588557764","doi":"10.1182/blood.v120.21.4034.4034","title":"Activity of Single Agent Drugs in Phase I and II Trials Best Predicts Future Clinical Utility in Multiple Myeloma","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Multiple myeloma; Clinical trial; Pomalidomide; Daratumumab; Etoposide; Oncology; Melphalan; Internal medicine; Phases of clinical research; Lenalidomide; Chemotherapy","score_opus":0.13562963148249854,"score_gpt":0.40737554794224434,"score_spread":0.2717459164597458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588557764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970057,0.0012018307,0.0000032320324,0.00018444461,0.00013357229,0.001018958,0.000108103595,0.000014969023,0.00032917087],"genre_scores_gemma":[0.9988936,0.0002286579,0.00036792213,0.000016708495,0.00034708634,0.000042466978,0.00003454742,0.000012639223,0.000056343062],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978494,0.00050566194,0.0006359918,0.00027461335,0.00032233476,0.00041202037],"domain_scores_gemma":[0.9984986,0.0006243638,0.00015156981,0.0003066188,0.00004329072,0.00037550868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022308975,0.00015592165,0.0007876966,0.00013957325,0.000040368654,0.0000058582946,0.000059244245,0.00017778079,0.00006899322],"category_scores_gemma":[0.0017718509,0.000119787896,0.000120477205,0.00018664768,0.0001186782,0.00013201479,0.0001047832,0.00027450226,0.000005686883],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002347861,0.03368736,0.8415534,0.0001067032,0.00012713911,0.000047610727,0.0007394312,2.93261e-8,0.009332893,0.0000021799242,0.000037797774,0.11201758],"study_design_scores_gemma":[0.051342066,0.0015394372,0.91389924,0.00011947979,0.00013246559,0.000012235888,0.00022318943,0.000104840394,0.031977605,0.000007117244,0.0005580421,0.0000842548],"about_ca_topic_score_codex":0.00027534162,"about_ca_topic_score_gemma":0.00021960426,"teacher_disagreement_score":0.11193333,"about_ca_system_score_codex":0.000038493028,"about_ca_system_score_gemma":0.00009283698,"threshold_uncertainty_score":0.48848087},"labels":[],"label_agreement":null},{"id":"W2588572219","doi":"10.1182/blood.v114.22.1591.1591","title":"Low-Level FLT3-ITD Mutations Do Not Predict for Higher Relapse Rate in AML with Standard Risk Karyotpye.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Cytarabine; Medicine; Internal medicine; Gastroenterology; Chemotherapy regimen; Chemotherapy; Daunorubicin; Oncology; Surgery","score_opus":0.020341190133452137,"score_gpt":0.28770179659600603,"score_spread":0.2673606064625539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588572219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990296,0.00015569,0.0012489238,0.0033426639,0.00007031211,0.0015186616,0.00054355577,0.000118914286,0.0027052704],"genre_scores_gemma":[0.98686767,0.00010062641,0.008242959,0.00050384604,0.00027671378,0.00015527723,0.00014046657,0.000054161585,0.0036582872],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99810565,0.00009423028,0.0003501924,0.00043751145,0.00047773757,0.00053470855],"domain_scores_gemma":[0.9986653,0.00025917304,0.00010278884,0.0004841232,0.00025300647,0.00023561441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006079801,0.00022229049,0.00039740794,0.00025101035,0.00011831173,0.000040775933,0.00016273334,0.00015622596,0.0001252819],"category_scores_gemma":[0.0003691207,0.00017260543,0.00008740356,0.00046372847,0.00009891286,0.00013852883,0.00003027026,0.000537927,0.00004761164],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06794098,0.018325254,0.48960054,0.0021797095,0.0048998552,0.009156992,0.015126619,0.0022741286,0.10839064,0.010826212,0.13535124,0.13592784],"study_design_scores_gemma":[0.08175771,0.008111153,0.82662624,0.0007494215,0.001128057,0.00013688239,0.0003570797,0.0006989608,0.06317734,0.002490755,0.014036816,0.0007296031],"about_ca_topic_score_codex":0.000058176403,"about_ca_topic_score_gemma":0.000048508184,"teacher_disagreement_score":0.3370257,"about_ca_system_score_codex":0.00027978962,"about_ca_system_score_gemma":0.0006272714,"threshold_uncertainty_score":0.7038645},"labels":[],"label_agreement":null},{"id":"W2588577212","doi":"10.1182/blood.v120.21.3399.3399","title":"The Risk of Cancer Following Acute Venous Thromboembolism: A Population-Based Cohort Study","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; McGill University Health Centre","funders":"","keywords":"Medicine; Cancer; Population; Cohort; Incidence (geometry); Retrospective cohort study; Reimbursement; Venous thromboembolism; Health care; Emergency medicine; Pediatrics; Internal medicine; Thrombosis; Environmental health","score_opus":0.010143791389132453,"score_gpt":0.29133045006504354,"score_spread":0.2811866586759111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588577212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99502194,0.0018073702,0.000014320534,0.00017524282,0.00053019985,0.0016026242,0.000014065199,0.000054032014,0.0007802351],"genre_scores_gemma":[0.9987425,0.00030315216,0.00012766817,0.00016154857,0.00024465984,0.00030993382,0.00001410304,0.00003285543,0.000063554755],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985471,0.00008974425,0.00033164409,0.0001943699,0.00045743858,0.00037972347],"domain_scores_gemma":[0.9990035,0.00012138026,0.00019348915,0.00050970033,0.000056702964,0.00011521537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006364499,0.0001622642,0.0006201979,0.000061995874,0.00027195748,0.000019205549,0.00013177007,0.00004901387,0.000051366173],"category_scores_gemma":[0.00007285147,0.000108120745,0.00020577782,0.00019933,0.000025364765,0.00006605781,0.00005154106,0.00013092915,0.000013083323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016403215,0.0060218098,0.98820287,0.00002413239,0.0037022387,0.0000086065065,0.0005654195,0.000025013484,0.00010006249,0.00009686938,0.00026948683,0.0009670997],"study_design_scores_gemma":[0.0020968304,0.00035084283,0.986176,0.000049740775,0.009950402,0.0000012355852,0.00028295297,0.000022549726,0.0005360967,0.000024605417,0.0003945119,0.000114210816],"about_ca_topic_score_codex":0.004161218,"about_ca_topic_score_gemma":0.00035050514,"teacher_disagreement_score":0.0062481635,"about_ca_system_score_codex":0.000045597597,"about_ca_system_score_gemma":0.000058856156,"threshold_uncertainty_score":0.6290545},"labels":[],"label_agreement":null},{"id":"W2588581803","doi":"10.1182/blood.v106.11.1120.1120","title":"Second Solid Cancers after Allogeneic Stem Cell Transplantation: The Vancouver Experience.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Medicine; Transplantation; Stem cell; Surgery; Internal medicine; Hematopoietic stem cell transplantation; Gastroenterology; Graft-versus-host disease; Incidence (geometry); Median follow-up; Chemotherapy","score_opus":0.010781200022447576,"score_gpt":0.24411783222233846,"score_spread":0.23333663219989087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588581803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837935,0.00058222277,0.00031541171,0.00018038928,0.00023487389,0.000412452,0.000026245609,0.00005344912,0.014401454],"genre_scores_gemma":[0.9941717,0.00018493686,0.00055560947,0.001059113,0.00026048167,0.00017486002,0.000011281861,0.000025155006,0.0035568718],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99889964,0.00003417482,0.00028308606,0.00024562137,0.0002802504,0.00025725455],"domain_scores_gemma":[0.9994643,0.00005647944,0.000055299257,0.00027416676,0.000042012245,0.000107756176],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009486601,0.00015558186,0.00018139866,0.00004125181,0.000072020535,0.000011816401,0.00009902177,0.00008152954,0.001837805],"category_scores_gemma":[8.647464e-7,0.00010998631,0.0000866151,0.00011271367,0.00006262112,0.00009065571,0.0000049757773,0.00012341724,0.00012016718],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028960349,0.0030333127,0.21807523,0.0058151195,0.0012474705,0.0031970136,0.32974574,0.000947387,0.40772852,0.00018228502,0.010816549,0.016315315],"study_design_scores_gemma":[0.0060864515,0.00017870459,0.035846706,0.00018225066,0.0007249696,0.00048560684,0.0024343806,0.000066512424,0.9335128,0.000008356439,0.02013418,0.00033908506],"about_ca_topic_score_codex":0.000013012116,"about_ca_topic_score_gemma":0.0007424427,"teacher_disagreement_score":0.52578425,"about_ca_system_score_codex":0.000047419722,"about_ca_system_score_gemma":0.00011947375,"threshold_uncertainty_score":0.99907464},"labels":[],"label_agreement":null},{"id":"W2588586254","doi":"10.1182/blood.v126.23.2360.2360","title":"The Human Blood Hierarchy Is Shaped By Distinct Progenitor Lineages Across Development","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University Health Network; University of Toronto; Ontario Institute for Cancer Research; Hospital for Sick Children; Princess Margaret Cancer Centre","funders":"","keywords":"Progenitor cell; Haematopoiesis; Stem cell; Biology; Myeloid; Hemangioblast; Immunology; Cell biology; Cord blood; Cellular differentiation; Lineage (genetic); Genetics","score_opus":0.023787264242745642,"score_gpt":0.26784106475625047,"score_spread":0.24405380051350484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588586254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971371,0.0018569008,0.00010650242,0.00011646201,0.00019125376,0.00018692372,0.00004716294,0.000025685747,0.00033195005],"genre_scores_gemma":[0.99614686,0.000042790893,0.00045508335,0.0001562207,0.0003903407,0.000047572477,0.00017406876,0.000031095504,0.002555993],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99887276,0.00004015233,0.00024015018,0.00031476488,0.00018126788,0.00035090756],"domain_scores_gemma":[0.9993806,0.000010128783,0.000062891755,0.00029410282,0.00010294836,0.00014936614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022716288,0.0001793992,0.00012058127,0.000008047556,0.00038999534,0.000091558184,0.0003278407,0.00013006991,0.0000049281903],"category_scores_gemma":[0.000048123908,0.0001324568,0.000070924856,0.000053648848,0.000113979535,0.0000027875087,0.00010521166,0.00010245214,0.000012918367],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004423181,0.00073246233,0.037417542,0.000016362992,0.00024288433,0.0000064343812,0.0006269478,2.0982085e-7,0.95476454,0.000008525505,0.0038883924,0.0022514856],"study_design_scores_gemma":[0.0018317798,0.00018574634,0.0012349433,0.000006542209,0.000043511405,0.000011088023,0.000080183105,0.0000035049236,0.8253064,0.000016599444,0.17107071,0.00020896301],"about_ca_topic_score_codex":0.000022456934,"about_ca_topic_score_gemma":0.00007981812,"teacher_disagreement_score":0.16718231,"about_ca_system_score_codex":0.000006551082,"about_ca_system_score_gemma":0.0001028746,"threshold_uncertainty_score":0.54014313},"labels":[],"label_agreement":null},{"id":"W2588616464","doi":"10.1182/blood.v110.11.2876.2876","title":"Predictors of Mortality in Patients Undergoing Autologous Stem Cell Transplant (ASCT) Admitted to the Intensive Care Unit: An Institutional Review of 1013 Transplant Patients over Five Years.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Univariate analysis; Intensive care unit; APACHE II; Sepsis; Mechanical ventilation; Multiple myeloma; Retrospective cohort study; Internal medicine; Surgery; Multivariate analysis","score_opus":0.048056565193527044,"score_gpt":0.331418222085277,"score_spread":0.28336165689174997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588616464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948128,0.0034273718,0.000031125895,0.000014305775,0.00012474185,0.0006907809,0.00063416,0.000011162449,0.0002535813],"genre_scores_gemma":[0.99733406,0.001815649,0.00006699326,0.00032307598,0.000021232468,0.0000072364055,0.0004149618,0.000010559457,0.0000062238723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985102,0.00008455607,0.0005872089,0.0001973822,0.00043444108,0.00018622322],"domain_scores_gemma":[0.9986982,0.00011617645,0.00018803487,0.00023776172,0.0006569999,0.00010285187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018433292,0.00014593794,0.0004615293,0.00011324494,0.000020238756,0.0000013034557,0.00013166397,0.00008490904,0.00001306295],"category_scores_gemma":[0.00007053157,0.00010818043,0.00010238462,0.00027465462,0.00008539646,0.000053930875,0.000017026556,0.00014307542,0.0000013867112],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020741986,0.00053997245,0.9803409,0.0028556373,0.00012797887,0.000027634369,0.015372528,0.00001215228,0.000057333942,0.000018073593,0.000024142842,0.00041621446],"study_design_scores_gemma":[0.0034540861,0.0009266057,0.97582597,0.011828898,0.00043288711,0.0000013083986,0.0016547309,0.0000025929032,0.0054983194,0.0000014023697,0.00027559002,0.00009762385],"about_ca_topic_score_codex":0.00030248132,"about_ca_topic_score_gemma":0.00044480927,"teacher_disagreement_score":0.013717797,"about_ca_system_score_codex":0.000043771943,"about_ca_system_score_gemma":0.0001657427,"threshold_uncertainty_score":0.441147},"labels":[],"label_agreement":null},{"id":"W2588619955","doi":"10.1182/blood.v104.11.3300.3300","title":"Primary Central Nervous System Lymphoma in Children: A Report of 12 Cases.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Primary central nervous system lymphoma; Lymphoma; Chemotherapy; Anaplastic large-cell lymphoma; Large cell; Chemotherapy regimen; Radiation therapy; Internal medicine; Gastroenterology; Pathology; Oncology; Cancer","score_opus":0.007743124824626704,"score_gpt":0.2164080129988162,"score_spread":0.2086648881741895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588619955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99549633,0.0012411386,0.0000023457305,0.00010605383,0.000065518,0.00049737963,0.00001751896,0.000051957562,0.0025217563],"genre_scores_gemma":[0.9992175,0.000045154095,0.00039137836,0.00006858965,0.00009572249,0.000044053937,0.00007918399,0.000019891218,0.000038544447],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988575,0.000013574383,0.00039583302,0.0002459503,0.00022733862,0.00025983408],"domain_scores_gemma":[0.99934864,0.000018787794,0.00012038864,0.0003638799,0.000027546,0.00012073589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000723349,0.00013966045,0.00038418983,0.00009214954,0.00002115863,0.000006111711,0.000046521116,0.00007130777,0.000008439407],"category_scores_gemma":[0.00002738267,0.00011650917,0.0001302338,0.00013513379,0.000031639654,0.00003063277,0.000028689974,0.000032261145,0.000009249079],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058827154,0.005271139,0.9620022,0.00015438082,0.00024638986,0.022431893,0.00011965777,0.000012955634,0.00031193727,0.00020305304,0.00004169491,0.009145832],"study_design_scores_gemma":[0.011020662,0.0002865747,0.9380278,0.0003846837,0.00032396067,0.04068419,0.000043359356,7.3985626e-7,0.009081819,0.0000054713655,0.000051572282,0.00008918072],"about_ca_topic_score_codex":0.0022113016,"about_ca_topic_score_gemma":0.00007113452,"teacher_disagreement_score":0.023974452,"about_ca_system_score_codex":0.0003554904,"about_ca_system_score_gemma":0.00031977377,"threshold_uncertainty_score":0.4751106},"labels":[],"label_agreement":null},{"id":"W2588661613","doi":"10.1182/blood.v124.21.392.392","title":"Phase 2 Trial of Interim PET Scan-Tailored Therapy in Patients with Advanced Stage Diffuse Large B-Cell Lymphoma (DLBCL) in British Columbia (BC)","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Burnaby Hospital; BC Cancer Agency; Spinal Cord Injury BC","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Interim analysis; Interim; Stage (stratigraphy); Internal medicine; Oncology; Nuclear medicine; Clinical trial; Lymphoma; Surgery","score_opus":0.007200698574824707,"score_gpt":0.239697087658289,"score_spread":0.23249638908346432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588661613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978555,0.00011315906,0.0000016837464,0.000014997896,0.00008447908,0.0014061301,0.000106201274,0.000024087556,0.0003937913],"genre_scores_gemma":[0.9990318,0.00013207635,0.00016187211,0.00010880096,0.00003463427,0.000180662,0.0001504728,0.000034377146,0.00016531849],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9985436,0.00008331908,0.00042073007,0.00034042174,0.00029097422,0.0003209288],"domain_scores_gemma":[0.99924976,0.00006093061,0.00016785129,0.00034046665,0.00006712743,0.00011386258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013432319,0.00015512906,0.00055043516,0.00008061307,0.000027516406,0.000042095977,0.00009329872,0.000058298043,0.00007921456],"category_scores_gemma":[0.00004775381,0.00017131885,0.00008246334,0.00019569122,0.000045690176,0.000087081644,0.000031305488,0.00005419324,0.000004710569],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013943208,0.25714475,0.6956682,0.000052258267,0.000077911245,0.00020221013,0.0001966424,2.298889e-7,0.00013266376,0.0000026350076,0.00006530294,0.03251398],"study_design_scores_gemma":[0.6247447,0.010816238,0.3622235,0.00020397195,0.000045176366,0.0000037911188,0.000055844932,0.000011097007,0.0013229516,0.000003844557,0.0004503854,0.00011848505],"about_ca_topic_score_codex":0.0053660693,"about_ca_topic_score_gemma":0.017477838,"teacher_disagreement_score":0.6108015,"about_ca_system_score_codex":0.00010364097,"about_ca_system_score_gemma":0.000099823046,"threshold_uncertainty_score":0.97530437},"labels":[],"label_agreement":null},{"id":"W2588672442","doi":"10.1182/blood-2016-08-737239","title":"IL-4/CXCL12 loop is a key regulator of lymphoid stroma function in follicular lymphoma","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Medical Research Council; Institut National Du Cancer; Versus Arthritis; National Centre for the Replacement, Refinement and Reduction of Animals in Research; Michael Smith Health Research BC","keywords":"Stromal cell; Germinal center; Cancer research; Biology; Bone marrow; Follicular lymphoma; Stroma; Tumor microenvironment; Follicular dendritic cells; CXCL13; Mantle zone; B cell; Cell biology; Lymphoma; Immunology; Chemokine; T cell; Immune system; Chemokine receptor; Antigen-presenting cell; Antibody","score_opus":0.01429776879337591,"score_gpt":0.24906864149858624,"score_spread":0.23477087270521033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588672442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953021,0.0008718169,0.0000035053106,0.0005970646,0.00014340115,0.00037236523,0.00003291615,0.00002943126,0.0026474032],"genre_scores_gemma":[0.9985677,0.0001207098,0.00028064675,0.00018157935,0.000118635275,0.00006751801,0.000019981591,0.000024923194,0.0006182984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99874115,0.000022196555,0.00031752308,0.00033530628,0.00032087704,0.00026294673],"domain_scores_gemma":[0.9985897,0.000026081148,0.00022008564,0.0009490828,0.000081686114,0.0001333964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011439082,0.00019309115,0.00043118568,0.00010731004,0.00010987528,0.00003550647,0.00013705231,0.00013125347,0.0001015848],"category_scores_gemma":[0.00007184407,0.00016018466,0.00019065767,0.00008268752,0.000073840194,0.00012375649,0.00006731694,0.0000288857,0.00005962639],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024504802,0.0042225746,0.9760749,0.000087925444,0.0004413161,0.00028873334,0.00017865657,6.162947e-7,0.0060710073,0.0005381475,0.0006993631,0.011151747],"study_design_scores_gemma":[0.021018375,0.0006336156,0.87991804,0.00022209398,0.00054591574,0.000121226396,0.00004737444,0.000031423675,0.0945833,0.00012354346,0.0026217445,0.00013335639],"about_ca_topic_score_codex":0.0007514572,"about_ca_topic_score_gemma":0.000049222133,"teacher_disagreement_score":0.096156836,"about_ca_system_score_codex":0.00012221909,"about_ca_system_score_gemma":0.00016989655,"threshold_uncertainty_score":0.6532141},"labels":[],"label_agreement":null},{"id":"W2588678135","doi":"10.1182/blood.v112.11.3608.3608","title":"The Impact of Therapeutic Management and Prognostic Factors on the Outcome of Primary Cutaneous B-Cell Lymphomas (PCBCL) (IELSG 11 Study)","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lymphoma; Radiation therapy; Retrospective cohort study; Stage (stratigraphy); Chemotherapy; Internal medicine; Gastroenterology; Surgery; Biology","score_opus":0.044767144029001574,"score_gpt":0.30403173798402683,"score_spread":0.25926459395502527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588678135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99197817,0.0009227742,0.0000024689705,0.00014149585,0.000020550306,0.0024016222,0.000011920334,0.000022020644,0.0044989516],"genre_scores_gemma":[0.9983038,0.00032215996,0.0000139594595,0.00005996127,0.000014861321,0.00005043069,0.000004191799,0.000033191063,0.0011974913],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981415,0.00016281378,0.00040298453,0.00026555944,0.00069149927,0.0003356388],"domain_scores_gemma":[0.99817294,0.0008769234,0.00014342106,0.00058978173,0.00012892263,0.00008804089],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022582572,0.00023844684,0.00042887902,0.00011259902,0.00022464541,0.000015937338,0.00024496648,0.000050516057,0.000044459543],"category_scores_gemma":[0.00012851713,0.00011185164,0.00017979673,0.0002656541,0.0003542256,0.000019922289,0.00011545936,0.00014126727,0.00000563785],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037436688,0.0045674723,0.9894228,0.00011506643,0.0007428023,0.0003267692,0.0023969458,0.0000067891283,0.0012666832,0.00006084645,0.000048150465,0.0006713106],"study_design_scores_gemma":[0.0050988165,0.0048570866,0.9818587,0.00004848644,0.00041753118,0.00091127335,0.0028797677,0.000053325097,0.0035787094,0.00006901171,0.000066549175,0.0001607765],"about_ca_topic_score_codex":0.00022143111,"about_ca_topic_score_gemma":0.000019457248,"teacher_disagreement_score":0.0075641307,"about_ca_system_score_codex":0.00008353548,"about_ca_system_score_gemma":0.00013540586,"threshold_uncertainty_score":0.45611772},"labels":[],"label_agreement":null},{"id":"W2588684164","doi":"10.1182/blood.v114.22.2681.2681","title":"Bendamustine Produces Durable Responses with An Acceptable Long-Term Safety Profile in Patients with Rituximab-Refractory Non-Hodgkin's Lymphoma: A Pooled Analysis.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Bendamustine; Medicine; Rituximab; Internal medicine; Refractory (planetary science); Regimen; Salvage therapy; Population; Follicular lymphoma; Chemotherapy regimen; Oncology; Gastroenterology; Surgery; Chemotherapy; Lymphoma","score_opus":0.006593143173261565,"score_gpt":0.24249322082871366,"score_spread":0.2359000776554521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588684164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99707335,0.00029919922,0.000008143015,0.00028879254,0.000021979266,0.001392315,0.00007723735,0.00009042768,0.00074853],"genre_scores_gemma":[0.99671376,0.000036841873,0.0015892308,0.00021569876,0.00007514969,0.00014057764,0.00070752116,0.000037859667,0.00048338197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975022,0.00009664123,0.00044153075,0.00080599234,0.0005800168,0.0005735938],"domain_scores_gemma":[0.9983908,0.00006175782,0.0002252135,0.0008118482,0.00024069201,0.00026971143],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002103168,0.00041628673,0.00088415394,0.00046456108,0.00014859396,0.00007022543,0.00015800154,0.00011144212,0.00025555107],"category_scores_gemma":[0.000052646486,0.00026987557,0.00010829905,0.0011840491,0.00007046147,0.00041049646,0.000030156592,0.000104994986,0.000022463197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074421326,0.034436524,0.9452506,0.000050145558,0.001313702,0.00047797602,0.00021120397,0.00001244148,0.00014681561,0.000004772382,0.000039439423,0.0106142815],"study_design_scores_gemma":[0.046488903,0.006998759,0.9356955,0.0002091143,0.0042744996,0.000028155204,0.000044891094,0.000016913813,0.0058572986,0.00000180769,0.000057192792,0.00032691043],"about_ca_topic_score_codex":0.00025852586,"about_ca_topic_score_gemma":0.00048735202,"teacher_disagreement_score":0.03904677,"about_ca_system_score_codex":0.0002099775,"about_ca_system_score_gemma":0.00038013293,"threshold_uncertainty_score":0.9999753},"labels":[],"label_agreement":null},{"id":"W2588684606","doi":"10.1182/blood.v126.23.890.890","title":"Low Molecular Weight Heparin for Prevention of Placenta-Mediated Pregnancy Complications: An Individual Patient Data Meta-Analysis","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Centre Hospitalier Universitaire Sainte-Justine; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Placental abruption; Pregnancy; Meta-analysis; Obstetrics; Low molecular weight heparin; Small for gestational age; Gestational age; Internal medicine; Fetus; Heparin","score_opus":0.20328038956226185,"score_gpt":0.3567886577019543,"score_spread":0.15350826813969243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588684606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8764045,0.0087843565,0.10163776,0.0014165526,0.00020996205,0.006644002,0.0033954016,0.00030775284,0.0011997084],"genre_scores_gemma":[0.97154427,0.00001217021,0.019693935,0.00016844737,0.00001624738,0.00019283137,0.008306909,0.00002115366,0.000044024913],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99837303,0.000118749515,0.0004831151,0.00040695947,0.0004595765,0.0001585674],"domain_scores_gemma":[0.99802667,0.000043045846,0.00029647,0.0011546506,0.00028251082,0.00019662653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028596964,0.00014954426,0.000643553,0.0001923053,0.000036703328,0.000016493364,0.0002617303,0.00008919107,0.000090885944],"category_scores_gemma":[0.00011530262,0.00012685602,0.00031994955,0.00044652217,0.00002777629,0.00015579208,0.00011320348,0.00006433684,0.000008576221],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048574546,0.061478987,0.014175076,0.0007884324,0.8198247,0.00003094161,0.003250585,0.00048132657,0.061227027,0.022284297,0.0023149163,0.013657961],"study_design_scores_gemma":[0.01099624,0.0022818206,0.007874625,0.00007450271,0.7652361,0.000015367701,0.00032088673,0.0063730916,0.20276646,0.0027730025,0.00085179094,0.00043612518],"about_ca_topic_score_codex":0.00001878883,"about_ca_topic_score_gemma":0.00003299408,"teacher_disagreement_score":0.14153944,"about_ca_system_score_codex":0.000009692747,"about_ca_system_score_gemma":0.00009291916,"threshold_uncertainty_score":0.51730376},"labels":[],"label_agreement":null},{"id":"W2588698611","doi":"10.1182/blood.v114.22.2916.2916","title":"Thrombotic Complications and Risk of Myeloid Transformation in 164 Elderly Patients with Essential Thrombocythemia.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Essential thrombocythemia; Myelofibrosis; Thrombosis; Internal medicine; Venous thrombosis; Surgery; Myeloid leukemia; Myeloproliferative neoplasm; Polycythemia vera; Pediatrics; Bone marrow","score_opus":0.006320464987302755,"score_gpt":0.23338135870590535,"score_spread":0.22706089371860258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588698611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970258,0.00009859404,0.00014938462,0.00036015562,0.000007487546,0.000605496,0.00002758704,0.000014665853,0.0017108631],"genre_scores_gemma":[0.9985701,0.00024255886,0.0010183151,0.00005163167,0.000009584951,0.000026386955,0.00007186137,0.000006307469,0.0000032812961],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993467,0.00002370941,0.00021344266,0.00014696339,0.00015623994,0.00011294185],"domain_scores_gemma":[0.99961215,0.000038558417,0.00008207261,0.00013712562,0.00007677381,0.000053343298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000044159307,0.00010658109,0.00023687634,0.00006841423,0.000046471225,0.00000795517,0.000025712823,0.000041557003,0.000014100713],"category_scores_gemma":[0.000011882435,0.00007651571,0.00002805296,0.00011803982,0.000041429415,0.000079496494,0.0000033955198,0.00008018593,0.0000032078208],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000077011195,0.0036790362,0.98706144,0.000040642186,0.00015178915,0.0000023349564,0.0012253217,0.00001010786,0.0006726822,0.00082754524,0.000010812308,0.006241305],"study_design_scores_gemma":[0.0077129146,0.0015231341,0.9785917,0.000119960816,0.00034410236,0.0000069822963,0.000055811386,0.000030567713,0.011333879,0.0001954764,0.00001518449,0.00007028771],"about_ca_topic_score_codex":0.0000392779,"about_ca_topic_score_gemma":0.00006828545,"teacher_disagreement_score":0.010661197,"about_ca_system_score_codex":0.000015439424,"about_ca_system_score_gemma":0.000030917974,"threshold_uncertainty_score":0.312022},"labels":[],"label_agreement":null},{"id":"W2588705932","doi":"10.1182/blood.v108.11.3737.3737","title":"Retrospective Review of Patients of Southeast Asian Descent with Persistent Hyperferritinemia Who Are Negative for Hereditary Hemochromatosis.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Hereditary hemochromatosis; Hemochromatosis; Internal medicine; Gastroenterology; Liver biopsy; Population; Liver disease; Hepatitis C; Biopsy; Pathology","score_opus":0.00666462691825064,"score_gpt":0.21049862031257124,"score_spread":0.2038339933943206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588705932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9753,0.013400889,0.000037387686,0.00045802683,0.000056239962,0.0015537243,0.00044679563,0.000023384328,0.008723546],"genre_scores_gemma":[0.997314,0.00039336478,0.0017649224,0.00016904662,0.00008944878,0.000043063847,0.000108572385,0.000026642927,0.00009095202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988983,0.000027677987,0.00034654286,0.00022117904,0.00031967086,0.00018661977],"domain_scores_gemma":[0.9989679,0.000014904677,0.00027384376,0.00023466579,0.0004420766,0.000066615656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000082781306,0.0001609721,0.0006341439,0.00005385422,0.000036954672,0.0000022452268,0.000066053915,0.000052396415,0.00004799062],"category_scores_gemma":[0.00010338264,0.00012169891,0.00020782994,0.00015809161,0.00011259504,0.0000391498,0.000017410523,0.000074168005,0.0000012881375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010622813,0.0067399847,0.9459293,0.03550745,0.000381084,0.000015416073,0.0007187973,0.0000023106907,0.0006627387,0.0006925801,0.007308735,0.0009793284],"study_design_scores_gemma":[0.013026326,0.0014452778,0.9619578,0.012109219,0.0020470708,0.000018752562,0.0022528986,0.0000035220794,0.0066505847,0.00009017408,0.00016982418,0.00022853754],"about_ca_topic_score_codex":0.00005561022,"about_ca_topic_score_gemma":0.000013307298,"teacher_disagreement_score":0.023398232,"about_ca_system_score_codex":0.000021200554,"about_ca_system_score_gemma":0.000070269234,"threshold_uncertainty_score":0.49627376},"labels":[],"label_agreement":null},{"id":"W2588707314","doi":"10.1182/blood.v126.23.3467.3467","title":"Safety and Efficacy of Long-Term Open-Label Dosing of Subcutaneous (SC) Romiplostim in Pediatric Patients with Immune Thrombocytopenia (ITP)","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Romiplostim; Medicine; Dosing; Adverse effect; Splenectomy; Placebo; Internal medicine; Clinical endpoint; Incidence (geometry); Pediatrics; Surgery; Thrombopoietin; Clinical trial","score_opus":0.020500002167422843,"score_gpt":0.26928010311069633,"score_spread":0.2487801009432735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588707314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972686,0.0011258734,0.0000024614753,0.000023098346,0.000025403933,0.000759458,0.000021329684,0.000008973995,0.0007647599],"genre_scores_gemma":[0.9991979,0.0001657184,0.00048252608,0.000010928907,0.000009907278,0.0000037931964,0.000070148315,0.000021629567,0.000037450187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990027,0.00002704378,0.00035333267,0.00021506455,0.00021804594,0.00018378861],"domain_scores_gemma":[0.999328,0.000057687208,0.00017915676,0.00023505175,0.00009698011,0.00010310275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009201502,0.00015199998,0.0006342889,0.00010132877,0.000023075509,0.000011027956,0.000111759626,0.000065245025,0.000009456181],"category_scores_gemma":[0.00005269483,0.00011374463,0.00001898783,0.00023179562,0.000053661977,0.00009641295,0.00011256393,0.000087518165,0.0000034212499],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002853011,0.007528213,0.9862302,0.00010020152,0.0001519181,0.0006093401,0.00033917942,0.0000019875747,0.00026463132,0.000005311194,0.000003306285,0.0019127107],"study_design_scores_gemma":[0.067659,0.0027582347,0.92737216,0.00017774,0.0005481922,0.00011039054,0.000015222423,0.0000052226655,0.0012290439,0.000010794874,0.0000011020686,0.00011290174],"about_ca_topic_score_codex":0.00012791523,"about_ca_topic_score_gemma":0.00004819645,"teacher_disagreement_score":0.06480599,"about_ca_system_score_codex":0.000024437668,"about_ca_system_score_gemma":0.00010735374,"threshold_uncertainty_score":0.46383715},"labels":[],"label_agreement":null},{"id":"W2588721401","doi":"10.1182/blood.v110.11.3887.3887","title":"Influence of mTOR Signalling Pathway on the MHC I Immunopeptidome.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Major histocompatibility complex; PI3K/AKT/mTOR pathway; Biology; MHC class I; Cell biology; Label-free quantification; MHC restriction; Antigen; Signal transduction; Genetics; Proteomics; Quantitative proteomics; Gene","score_opus":0.01317240238304842,"score_gpt":0.24495996292859148,"score_spread":0.23178756054554306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588721401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99257123,0.000063044514,0.000050630664,0.00035124188,0.00000475482,0.00009000657,0.0000046200003,0.000025864261,0.0068386104],"genre_scores_gemma":[0.99828875,0.000009204451,0.00007622479,0.0010287015,0.000081324375,0.0000032067612,0.0000048064203,0.000008137789,0.0004996721],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992632,0.000016292617,0.00023006955,0.000110132314,0.00023699556,0.00014327314],"domain_scores_gemma":[0.9994124,0.00014137899,0.00008109949,0.0002181037,0.00008922716,0.000057756908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039993852,0.000077288074,0.00014962163,0.000082810395,0.00005243414,0.0000059348354,0.00006962962,0.000041785108,0.00018371508],"category_scores_gemma":[0.00013703387,0.000048362464,0.000109559536,0.0002314551,0.00005935981,0.000025511788,0.000015325772,0.00013424766,0.000085914115],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004970643,0.00046943512,0.0019459673,0.00002327641,0.00010062473,0.00004643374,0.00017982602,0.00008165411,0.9957851,0.0008527325,0.000067417874,0.00039782762],"study_design_scores_gemma":[0.0011792667,0.00021281272,0.016460134,0.000552526,0.000094488474,0.000016224696,0.00020428299,0.00001913912,0.98034793,0.000069968155,0.00076451193,0.00007870174],"about_ca_topic_score_codex":0.00001632353,"about_ca_topic_score_gemma":0.0000034865225,"teacher_disagreement_score":0.015437154,"about_ca_system_score_codex":0.000009358523,"about_ca_system_score_gemma":0.000032089443,"threshold_uncertainty_score":0.20115514},"labels":[],"label_agreement":null},{"id":"W2588725667","doi":"10.1182/blood.v114.22.1082.1082","title":"Immunosuppressive Therapy and Future Response to Androgens or Survival After Hematopoietic Stem Cell Transplantation in Fanconi Anemia.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Fanconi anemia; Medicine; Hematopoietic stem cell transplantation; Transplantation; Cancer; Internal medicine; Anemia; Malignancy; Aplastic anemia; Immunology; Oncology; Pediatrics; Bone marrow; Biology","score_opus":0.012162479878342987,"score_gpt":0.2500303941381658,"score_spread":0.23786791425982282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588725667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958435,0.0013929844,0.00007631324,0.0011979804,0.00009711959,0.00085325784,0.000038444985,0.0000542793,0.0004460843],"genre_scores_gemma":[0.9968669,0.0014804186,0.0007401074,0.0004832421,0.00009754469,0.000059111484,0.000022148903,0.000026986643,0.00022358738],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99854213,0.000164804,0.00036160744,0.00035883317,0.00027579127,0.00029684207],"domain_scores_gemma":[0.9993002,0.00016516812,0.000054296965,0.000264749,0.000049918188,0.00016567127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027883632,0.00022990214,0.00036600893,0.00018363744,0.000039830033,0.000027574559,0.00006740176,0.00016910674,0.000097077354],"category_scores_gemma":[0.000004174574,0.00018340688,0.00005444357,0.00027790043,0.000024184455,0.00008404235,0.0000043612317,0.0001657184,0.00002097515],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0790193,0.0025135977,0.060448892,0.0016517477,0.00012873758,0.009307983,0.080157265,0.000010569366,0.7528913,0.000070536305,0.000056572393,0.013743502],"study_design_scores_gemma":[0.019040002,0.0018286684,0.58313537,0.0005436102,0.0002542889,0.0017720341,0.0024933442,0.0000050753733,0.38991126,0.000026490974,0.0005629857,0.0004268434],"about_ca_topic_score_codex":0.000007068922,"about_ca_topic_score_gemma":0.000016933627,"teacher_disagreement_score":0.5226865,"about_ca_system_score_codex":0.000022634444,"about_ca_system_score_gemma":0.00009143576,"threshold_uncertainty_score":0.7479116},"labels":[],"label_agreement":null},{"id":"W2588744190","doi":"10.1182/blood.v116.21.1401.1401","title":"Immune Response Following Exposures to Topical Bovine Thrombin Does Not Impair Hemostasis","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hemostasis and retained surgical items","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Hemostasis; Thrombin; Clinical endpoint; Randomized controlled trial; Thrombin generation; Surgery; Anesthesia; Internal medicine; Platelet","score_opus":0.014145215548813286,"score_gpt":0.2850020940695639,"score_spread":0.27085687852075063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588744190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98211515,0.00016652541,0.000021340522,0.015587777,0.00058750797,0.0004043978,0.000016821234,0.0001506915,0.00094979006],"genre_scores_gemma":[0.99349284,0.000011499502,0.0020589938,0.0013912267,0.00034845015,0.000027478041,0.000012547956,0.000037119124,0.0026198165],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981802,0.00010466847,0.0004478211,0.0003874463,0.00041035778,0.00046947217],"domain_scores_gemma":[0.998481,0.00031725952,0.000048094644,0.00062602415,0.00007497648,0.00045269562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000818518,0.00022530706,0.0005307738,0.00011015747,0.00013490545,0.000048278158,0.00016270706,0.00021900664,0.0004385656],"category_scores_gemma":[0.001158754,0.000138827,0.0003628759,0.00024939075,0.000059425194,0.000062972416,0.00011392202,0.00046218964,0.00010138535],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013276415,0.00082790246,0.01847819,0.000027625663,0.00017415917,0.0006293231,0.00034606195,1.230489e-7,0.9713722,0.00017884259,0.00056247605,0.0060754623],"study_design_scores_gemma":[0.0048514153,0.0013124999,0.14407665,0.00008806884,0.00022391889,0.00020930196,0.00020269552,0.000008692343,0.79686636,0.000055235003,0.051781848,0.00032333378],"about_ca_topic_score_codex":0.0000588029,"about_ca_topic_score_gemma":0.00002062376,"teacher_disagreement_score":0.17450584,"about_ca_system_score_codex":0.00001689291,"about_ca_system_score_gemma":0.000099111705,"threshold_uncertainty_score":0.5661201},"labels":[],"label_agreement":null},{"id":"W2588744976","doi":"10.1182/blood.v108.11.1625.1625","title":"Contribution of Coagulation Pathways and Fibrinolysis in Generation of Kinins.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Centre hospitalier universitaire de Québec; Université de Montréal","funders":"","keywords":"Kallikrein; Kininogen; Kinin; Plasmin; High-molecular-weight kininogen; Fibrinolysis; Chemistry; Kallidin; Factor XII; Prekallikrein; Proteases; Bradykinin; Coagulation; Tissue factor; Tissue plasminogen activator; Thrombin; Biochemistry; Internal medicine; Immunology; Biology; Enzyme; Medicine; Platelet; Receptor","score_opus":0.019393608498365703,"score_gpt":0.23172775330044493,"score_spread":0.21233414480207924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588744976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99788374,0.001294618,0.00024689213,0.00007063977,0.00002762668,0.00017326997,0.000011704453,0.000014011739,0.00027748442],"genre_scores_gemma":[0.9992975,0.00004596512,0.00030359183,0.000011976476,0.00011097234,0.0000045231536,0.00018586936,0.0000063214056,0.00003328581],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992894,0.000020761345,0.00034206698,0.00012018538,0.00013761276,0.00009000639],"domain_scores_gemma":[0.999587,0.000031384276,0.0001415386,0.00010299096,0.00011443531,0.00002267778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011872403,0.00006895979,0.00022710634,0.000114234994,0.000019465037,0.000003975045,0.000015954321,0.00006903778,0.000014990008],"category_scores_gemma":[0.000048461476,0.00006751628,0.000044703895,0.00016532281,0.00003845953,0.00006362426,0.000009504816,0.000028087456,6.504455e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003325873,0.00028300539,0.71539336,0.000040620987,0.000021026084,0.0000023465839,0.00012393092,0.000080618236,0.27798563,0.004134057,0.000028579321,0.0018735508],"study_design_scores_gemma":[0.002250836,0.000096352735,0.68349415,0.000047463014,0.00008703979,0.0000070231376,0.000012372329,0.0019032609,0.31173176,0.00029308247,0.00003215737,0.000044502904],"about_ca_topic_score_codex":0.00036405324,"about_ca_topic_score_gemma":0.00013634408,"teacher_disagreement_score":0.033746116,"about_ca_system_score_codex":0.00001095723,"about_ca_system_score_gemma":0.000030171674,"threshold_uncertainty_score":0.2753234},"labels":[],"label_agreement":null},{"id":"W2588762403","doi":"10.1182/blood.v116.21.290.290","title":"The Anti-Malarial Mefloquine Demonstrates Preclinical Activity In Leukemia and Myeloma, and Is Dependent Upon Toll-Like Receptor Signaling for Its Cytotoxicity","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Mefloquine; Leukemia; Pharmacology; Medicine; Cytotoxic T cell; Bone marrow; Immunology; Biology; Malaria; In vitro; Chloroquine","score_opus":0.012397848949163593,"score_gpt":0.26547209612502715,"score_spread":0.2530742471758636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588762403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985507,0.00036154408,0.00010308169,0.00030287792,0.000192833,0.00040545303,0.000034842822,0.000007844384,0.000040815616],"genre_scores_gemma":[0.99860936,0.00019165293,0.000680685,0.000073096,0.00028611367,0.000043724547,0.000015911284,0.000011192712,0.0000882307],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991763,0.000056795074,0.00018885138,0.00031042378,0.000083265826,0.00018433985],"domain_scores_gemma":[0.9995678,0.00008104455,0.00007728228,0.00015640832,0.000043852586,0.00007358532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046179417,0.000120741126,0.00013087073,0.000018379276,0.00014587992,0.000060070106,0.00009783928,0.00023143706,0.000008590111],"category_scores_gemma":[0.00030391308,0.00009395051,0.00004245403,0.000033577187,0.00007157917,0.000009794228,0.00008577305,0.00017793225,8.4697217e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013865801,0.0000686404,0.005286073,0.00001201701,0.000025503146,5.332248e-7,0.000013964963,7.261148e-7,0.9925288,0.000040208026,0.00008858558,0.0017963035],"study_design_scores_gemma":[0.0016425005,0.00020970772,0.0044331104,0.000009849252,0.00001880784,0.000009712792,0.000014352182,0.00015183451,0.9915264,0.00004359937,0.0018143036,0.00012577142],"about_ca_topic_score_codex":0.000009479241,"about_ca_topic_score_gemma":0.00021446458,"teacher_disagreement_score":0.001725718,"about_ca_system_score_codex":0.000004790937,"about_ca_system_score_gemma":0.00008364098,"threshold_uncertainty_score":0.38311908},"labels":[],"label_agreement":null},{"id":"W2588763838","doi":"10.1182/blood.v110.11.3175.3175","title":"A Distal Single Nucleotide Polymorphism Disrupts Development-Dependent Long-Range Transcriptional Regulation of the PU.1 Gene through the Chromatin-Remodeling Protein SATB1 in Acute Myeloid Leukemia.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Molecular biology; Chromatin; Biology; Chromatin remodeling; Transcription factor; Myeloid; Promoter; Enhancer; Chromatin immunoprecipitation; Chemistry; Cancer research; Gene expression; Cell biology; Gene; Genetics","score_opus":0.010721909718689445,"score_gpt":0.22162072266954969,"score_spread":0.21089881295086024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588763838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902052,0.0011129879,0.0075137154,0.00019783922,0.00013809555,0.0006444265,0.000021778189,0.0000135003975,0.00015240928],"genre_scores_gemma":[0.99759614,0.000024391524,0.0016647135,0.000043573113,0.00020545782,0.000029990113,0.00011868245,0.000031741325,0.0002853265],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985019,0.00006223312,0.00048274916,0.00031906774,0.0003519226,0.00028211522],"domain_scores_gemma":[0.99932015,0.000009766249,0.00020786816,0.0003590671,0.00006757587,0.000035565023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030192983,0.000185052,0.00014783957,0.000039324488,0.00014436038,0.000020340001,0.00023686442,0.00017895325,0.000011611908],"category_scores_gemma":[0.000018937717,0.00013888894,0.00011166133,0.0001926692,0.0001032873,0.000016581624,0.000078090336,0.0001288748,0.0000020695018],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010593804,0.00014304928,0.0013891177,0.000017956769,0.00009265543,0.0000018898937,0.0005234878,0.0010069232,0.9944581,0.000041215993,0.000008416928,0.00221129],"study_design_scores_gemma":[0.0013788458,0.000052729218,0.13154419,0.00006789426,0.00006149051,0.000045700217,0.000047067497,0.000158732,0.86601955,0.00011287512,0.00034194117,0.00016898756],"about_ca_topic_score_codex":0.00009000479,"about_ca_topic_score_gemma":0.0008960974,"teacher_disagreement_score":0.13015507,"about_ca_system_score_codex":0.00013805769,"about_ca_system_score_gemma":0.00020855149,"threshold_uncertainty_score":0.56637263},"labels":[],"label_agreement":null},{"id":"W2588774828","doi":"10.1182/blood.v128.22.2994.2994","title":"Outcome of Hodgkin Lymphoma after Progression Following Autologous Stem Cell Transplantation","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada; BC Cancer Agency","funders":"","keywords":"Medicine; Brentuximab vedotin; Autologous stem-cell transplantation; Internal medicine; Oncology; ABVD; Population; Surgery; Progression-free survival; Transplantation; Chemotherapy regimen; Lymphoma; Chemotherapy; Hodgkin lymphoma; Vincristine; Cyclophosphamide","score_opus":0.01290261446109875,"score_gpt":0.267485376512859,"score_spread":0.2545827620517602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588774828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978339,0.00069423614,0.000045214358,0.00020766041,0.000100803074,0.00029474607,0.000017254324,0.000049099835,0.0007570622],"genre_scores_gemma":[0.998769,0.00006710749,0.0006874914,0.000049399117,0.000029514838,0.0000947872,0.000006100654,0.000014645975,0.00028198803],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99917805,0.000026892501,0.00025233193,0.00018251428,0.00020041154,0.00015982495],"domain_scores_gemma":[0.9995899,0.000062565225,0.0000710214,0.00018221,0.000023003631,0.00007129345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000666309,0.00011647731,0.00024621957,0.000055898603,0.000021723345,0.0000046054165,0.000037047226,0.00007433691,0.000030477026],"category_scores_gemma":[0.0000038444396,0.00006382081,0.00015687438,0.000057709884,0.000019698733,0.000051187526,0.000009795012,0.0000127505455,0.000038883347],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016657698,0.0014525562,0.90538305,0.00013227822,0.00009643375,0.0007036166,0.00019786358,3.283736e-8,0.0090301605,0.000015499358,0.000013151511,0.0828088],"study_design_scores_gemma":[0.010354289,0.00039394578,0.70609796,0.00033926306,0.00056873646,0.00006975671,0.00001484734,6.21055e-7,0.28195855,0.0000081582975,0.00012212268,0.00007173803],"about_ca_topic_score_codex":0.000011078914,"about_ca_topic_score_gemma":0.0000031478044,"teacher_disagreement_score":0.2729284,"about_ca_system_score_codex":0.00003922841,"about_ca_system_score_gemma":0.000036672696,"threshold_uncertainty_score":0.2602537},"labels":[],"label_agreement":null},{"id":"W2588786370","doi":"10.1182/blood.v128.22.327.327","title":"Inhibitor Development in Previously Untreated Patients with Severe Hemophilia a Treated with Nuwiq®, a New Generation Recombinant FVIII of Human Origin","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Institute for Clinical Evaluative Sciences; BC Children's Hospital; SickKids Foundation; Hospital for Sick Children; Translational Research in Oncology","funders":"","keywords":"Immunogenicity; Von Willebrand factor; Medicine; Recombinant DNA; Titer; Incidence (geometry); Cumulative incidence; Immunology; Internal medicine; Antibody; Gastroenterology; Cohort; Biology; Platelet; Biochemistry","score_opus":0.02320265702288769,"score_gpt":0.25980900969250026,"score_spread":0.23660635266961258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588786370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980481,0.000050693212,0.0000034297807,0.00024036477,0.00001532772,0.001230631,0.0000045032016,0.000041224368,0.0003656916],"genre_scores_gemma":[0.9927738,0.00002095687,0.00069117587,0.000013104898,0.000055285982,0.000061639446,0.00013337191,0.000034963854,0.0062157023],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984656,0.000050671762,0.00034792777,0.00035841353,0.00042266826,0.00035469767],"domain_scores_gemma":[0.9992025,0.00002220653,0.00010310378,0.0002717471,0.00019648566,0.00020398469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010014446,0.00023111081,0.00039048778,0.00021869226,0.000062795254,0.000009839917,0.00006720041,0.00009947007,0.00009994995],"category_scores_gemma":[0.000023225299,0.00011231864,0.000032313936,0.00039086165,0.000055880013,0.000093263756,0.000023520824,0.000087860215,0.000021778387],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074483006,0.0027708504,0.9708012,0.000076244694,0.00023754133,0.000121269615,0.00045475998,3.183558e-7,0.016758025,0.000016869955,0.00020729037,0.0078108334],"study_design_scores_gemma":[0.07663079,0.007865609,0.5384579,0.0024597407,0.0003213293,0.00005243396,0.000028286047,0.000004129975,0.37316766,0.000015187138,0.0005767227,0.00042021633],"about_ca_topic_score_codex":0.00018399916,"about_ca_topic_score_gemma":0.00040166557,"teacher_disagreement_score":0.4323433,"about_ca_system_score_codex":0.00017507221,"about_ca_system_score_gemma":0.0005022575,"threshold_uncertainty_score":0.45802212},"labels":[],"label_agreement":null},{"id":"W2588789577","doi":"10.1182/blood.v112.11.4520.4520","title":"Use of Factor VIII/Von Willebrand Factor Complex for Inducing Immune Tolerance in Hemophilia a Patients Who Have Failed with Recombinant Fviii: Recent Canadian Experience","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Foothills Medical Centre; BC Children's Hospital; McMaster University; University of Manitoba; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Von Willebrand factor; Titer; Concomitant; Immune tolerance; Regimen; Internal medicine; Immune system; Gastroenterology; Immunology; Antibody; Platelet","score_opus":0.07300563606911833,"score_gpt":0.28738575035927466,"score_spread":0.21438011429015633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588789577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974447,0.00011774062,0.000003281952,0.00035622335,0.00006690383,0.0017484349,0.000123023,0.00001511827,0.00012459382],"genre_scores_gemma":[0.99821174,0.0002575306,0.00054047164,0.00006552515,0.0000289264,0.00012812123,0.00010745108,0.00003670627,0.0006235207],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981341,0.00004759835,0.00044060833,0.0004037619,0.00038459143,0.0005893339],"domain_scores_gemma":[0.9987756,0.00009849768,0.00011305561,0.0003847844,0.00028137106,0.0003466683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005635628,0.00024788475,0.00059995946,0.00027907066,0.0001667595,0.000017326627,0.00012724838,0.00012442126,0.00015195488],"category_scores_gemma":[0.00016955874,0.00018084174,0.000081643375,0.0003008093,0.00014955526,0.00017913968,0.000028484912,0.00019768398,0.000004391576],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060663425,0.0010967586,0.98470235,0.000098006196,0.00008476431,0.00011062228,0.005932517,0.0000029531182,0.004833229,0.0000024857713,0.000103775725,0.0024258895],"study_design_scores_gemma":[0.012133497,0.0010864807,0.9400188,0.00044671368,0.00002862075,0.000019376675,0.00021789453,0.00015649557,0.04365362,0.000002855082,0.0019985493,0.00023715128],"about_ca_topic_score_codex":0.013669565,"about_ca_topic_score_gemma":0.012042423,"teacher_disagreement_score":0.044683617,"about_ca_system_score_codex":0.00019607821,"about_ca_system_score_gemma":0.00041296185,"threshold_uncertainty_score":0.99289846},"labels":[],"label_agreement":null},{"id":"W2588795721","doi":"10.1182/blood.v128.22.2131.2131","title":"Bortezomib-Containing Regimens for the Treatment of Newly Diagnosed AL Amyloidosis: Experience of Two Centers in Canada","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Leukemia & Lymphoma Society of Canada; University of British Columbia; Institute of Cancer Research; BC Cancer Agency","funders":"","keywords":"Bortezomib; Medicine; Multiple myeloma; AL amyloidosis; Amyloidosis; Internal medicine; Dexamethasone; Surgery; Proteasome inhibitor; Gastroenterology; Oncology; Immunoglobulin light chain; Immunology","score_opus":0.012484558422828598,"score_gpt":0.26109124320062715,"score_spread":0.24860668477779857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588795721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967826,0.0017643567,0.000094251925,0.0005659613,0.000105081286,0.00050815486,0.00013864138,0.0000039899523,0.000036945963],"genre_scores_gemma":[0.9971174,0.0017465212,0.00026890362,0.00021195784,0.000039905844,0.0005223565,0.000016355249,0.00002064315,0.000055935372],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989172,0.000034212917,0.00032720272,0.00030467412,0.00012464426,0.0002920378],"domain_scores_gemma":[0.99904406,0.00021764125,0.00019554926,0.00043285283,0.00004854358,0.00006136394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000056730856,0.00018715743,0.00027222442,0.000030892228,0.00003798566,0.0000042214483,0.00020458613,0.00004355277,0.000009467209],"category_scores_gemma":[0.00007117917,0.00011214603,0.00013254445,0.00006285321,0.00008302668,0.0000047156755,0.000033686458,0.000016484923,3.5342765e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018398325,0.0007070077,0.84435016,0.000008156357,0.00036447914,0.000009050766,0.00048219392,0.00002448184,0.14859012,0.000029433613,0.00037382383,0.0048771147],"study_design_scores_gemma":[0.012029742,0.0011152342,0.08180848,0.000063138075,0.00014563465,0.0000036048593,0.0012636507,0.0000063516886,0.89959145,0.000006554321,0.0037876815,0.00017850677],"about_ca_topic_score_codex":0.25873274,"about_ca_topic_score_gemma":0.47600344,"teacher_disagreement_score":0.7625417,"about_ca_system_score_codex":0.00011715144,"about_ca_system_score_gemma":0.0003293001,"threshold_uncertainty_score":0.7462034},"labels":[],"label_agreement":null},{"id":"W2588799177","doi":"10.1182/blood.v126.23.4898.4898","title":"Acute Myeloid Leukaemia in Children: Preliminary Results of a National Protocol in Casablanca, Morocco","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Cytarabine; Internal medicine; Etoposide; Gastroenterology; Pediatrics; Chemotherapy","score_opus":0.023795827741390933,"score_gpt":0.3152251886148496,"score_spread":0.29142936087345866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588799177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9625959,0.000021215343,0.000001269537,0.00024199404,0.000026335538,0.018815877,0.00004264402,0.000021860427,0.018232953],"genre_scores_gemma":[0.97971547,0.000002982742,0.00019745184,0.00010963828,0.000119222415,0.01936131,0.00003331678,0.000012095166,0.00044850653],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999064,0.000031160853,0.0003157554,0.00018366484,0.00025982817,0.00014554145],"domain_scores_gemma":[0.99956137,0.000018489769,0.00007825724,0.00015593521,0.000112225796,0.0000737039],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002050003,0.000089503876,0.0001991848,0.00017016826,0.00001185829,0.0000043305304,0.000063453524,0.00006824591,0.000016701151],"category_scores_gemma":[0.00008016673,0.00008064924,0.000036839,0.00032174974,0.000033804794,0.00007424563,0.000034114113,0.00017748977,0.000016955886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055989968,0.0028233714,0.97667193,0.000079223806,0.00013807465,0.00013615612,0.0007433728,0.00009831518,0.0054917713,0.00013198392,0.007475615,0.00061115716],"study_design_scores_gemma":[0.045823585,0.00200414,0.91633797,0.00024133637,0.00007415613,0.0006861902,0.00005713409,0.000023260465,0.03252263,0.00021131836,0.0018624578,0.00015581564],"about_ca_topic_score_codex":0.0002968213,"about_ca_topic_score_gemma":0.00013735703,"teacher_disagreement_score":0.06033399,"about_ca_system_score_codex":0.00009180022,"about_ca_system_score_gemma":0.00050396775,"threshold_uncertainty_score":0.32887805},"labels":[],"label_agreement":null},{"id":"W2588808924","doi":"10.1182/blood.v108.11.4603.4603","title":"Identification of Combined Clinical and Biomarker Prognostic Factors in Follicular Lymphoma.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Follicular lymphoma; Medicine; Lymphoma; Univariate analysis; Oncology; Immunohistochemistry; Internal medicine; Pathology; Tissue microarray; Survival analysis; Multivariate analysis","score_opus":0.01987890567061137,"score_gpt":0.2866864409767795,"score_spread":0.26680753530616813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588808924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987116,0.0005552085,0.0000035538226,0.00011322813,0.000044093318,0.00036935278,0.0000067037486,0.000016568312,0.00017972407],"genre_scores_gemma":[0.9997261,0.000052952557,0.000062704494,0.000014504878,0.000017404986,0.000027233444,0.000043272415,0.0000079375895,0.00004787513],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99912995,0.00003567391,0.00043103265,0.0001808293,0.00012135872,0.00010113454],"domain_scores_gemma":[0.9995515,0.000115597875,0.00009254286,0.00015988083,0.000034691948,0.000045815246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001470531,0.00008429104,0.00023783771,0.00007204063,0.000015236865,0.000008327419,0.000025718671,0.000069166585,0.000006164429],"category_scores_gemma":[0.00009329648,0.000063961605,0.0000682765,0.00012513319,0.000066354514,0.000027765827,0.00001539096,0.000016455215,0.000004526797],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033497538,0.0047846306,0.99132824,0.000034755463,0.0000776691,0.000044207467,0.00001938136,1.1561696e-7,0.0022064254,0.0002532373,0.000053383563,0.001164465],"study_design_scores_gemma":[0.010324734,0.00018571447,0.9665663,0.000055681972,0.00028066782,0.000011502321,0.00001742852,0.000033066655,0.022274796,0.00014075282,0.00005539514,0.000053930733],"about_ca_topic_score_codex":0.00018664674,"about_ca_topic_score_gemma":0.000024217901,"teacher_disagreement_score":0.024761902,"about_ca_system_score_codex":0.000014309813,"about_ca_system_score_gemma":0.00003708998,"threshold_uncertainty_score":0.26082784},"labels":[],"label_agreement":null},{"id":"W2588819103","doi":"10.1182/blood.v126.23.5206.5206","title":"Bolivian Aymara Natives with Chronic Mountain Sickness Have Autonomous BFU-E Growth","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; St Mary's Hospital Centre","funders":"","keywords":"Polycythemia vera; Erythropoietin; Erythropoiesis; Polycythemia rubra vera; Biology; Erythropoietin receptor; Effects of high altitude on humans; Internal medicine; Immunology; Medicine; Endocrinology; Anemia","score_opus":0.010365806273213584,"score_gpt":0.23319910637575691,"score_spread":0.22283330010254332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588819103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95170486,0.003168517,0.00011865735,0.0017160447,0.00010963903,0.0004904898,0.000008156758,0.00019028869,0.042493317],"genre_scores_gemma":[0.9967112,0.00010295797,0.00033874126,0.00030310117,0.00020026063,0.000027826125,0.00002504114,0.000043884444,0.002246989],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99877924,0.00004322261,0.00019539036,0.0002939222,0.00030090183,0.00038730487],"domain_scores_gemma":[0.9991674,0.000023963043,0.00007349593,0.00026502414,0.00016755165,0.0003025999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016186661,0.00021179125,0.0003136173,0.00010209892,0.00007930388,0.000026326003,0.00010662878,0.00015214508,0.000060190636],"category_scores_gemma":[0.00007007535,0.00014927001,0.00005606586,0.0002005674,0.00016966257,0.00009673748,0.000041038984,0.00029458234,0.000108273605],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003822089,0.023166852,0.7920754,0.003276696,0.007932315,0.009849051,0.058267854,0.0008661916,0.011732861,0.023481378,0.023639986,0.041889317],"study_design_scores_gemma":[0.3071381,0.045294773,0.2431412,0.005624903,0.010801463,0.013772565,0.06415664,0.007935424,0.118506856,0.009025775,0.16608235,0.008519961],"about_ca_topic_score_codex":0.0002969738,"about_ca_topic_score_gemma":0.0001006472,"teacher_disagreement_score":0.5489342,"about_ca_system_score_codex":0.00012616797,"about_ca_system_score_gemma":0.00063752965,"threshold_uncertainty_score":0.60870546},"labels":[],"label_agreement":null},{"id":"W2588829128","doi":"10.1182/blood.v126.23.762.762","title":"The Hypertension of Hemophilia Is Associated with Vascular Joint Remodeling and Cannot be Explained By the Usual Cardiovascular Risk Factors","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Blood pressure; National Health and Nutrition Examination Survey; Cohort; Population; Internal medicine; Etiology; Cohort study; Prehypertension; Epidemiology; Pediatrics; Environmental health","score_opus":0.05218097075406737,"score_gpt":0.24974793642458065,"score_spread":0.1975669656705133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588829128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915448,0.006582307,0.0000130032795,0.0011479649,0.000031708016,0.00047198142,0.000030908202,0.000026306701,0.00015103615],"genre_scores_gemma":[0.9985337,0.00096122717,0.00004400394,0.00005816578,0.00004715601,0.000012109117,0.00003547757,0.000026756132,0.00028137173],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981405,0.00019571709,0.00021483161,0.00025599322,0.00089590735,0.00029704315],"domain_scores_gemma":[0.9987235,0.00015400293,0.00007506453,0.0005334452,0.00032808457,0.00018591947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010893637,0.00017577014,0.00042388402,0.00004077619,0.00027213633,0.000023188608,0.000092465794,0.000103345265,0.0000033535491],"category_scores_gemma":[0.00054929056,0.00007397447,0.0002059249,0.00019520798,0.00018441057,0.00003916516,0.000062625055,0.00024694114,0.0000012513201],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020915007,0.0069605056,0.7813388,0.00037631864,0.069821,0.001095673,0.033142902,0.0006642966,0.047140423,0.00008283421,0.031874344,0.02541138],"study_design_scores_gemma":[0.14286877,0.012636004,0.21465729,0.0018269088,0.038735386,0.0011561025,0.038743615,0.024625499,0.47983235,0.00076237076,0.04146857,0.00268713],"about_ca_topic_score_codex":0.0009101078,"about_ca_topic_score_gemma":0.000028390363,"teacher_disagreement_score":0.56668156,"about_ca_system_score_codex":0.000042655953,"about_ca_system_score_gemma":0.00014007054,"threshold_uncertainty_score":0.30165914},"labels":[],"label_agreement":null},{"id":"W2588836946","doi":"10.1182/blood.v114.22.1323.1323","title":"Relative Efficacy of Steroid Therapy in Ameliorating Autoimmune Thrombocytopenia Mediated by Anti-Platelet GPIIbIIIa Versus GPIbα Antibodies.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; St. Michael's Hospital","funders":"","keywords":"Medicine; Prednisone; Thrombocytopenic purpura; Platelet; Autoantibody; Antibody; Immunology; Internal medicine; Dexamethasone; Pathogenesis; Autoimmune disease; Gastroenterology","score_opus":0.019499786954702367,"score_gpt":0.28689772544551956,"score_spread":0.26739793849081717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588836946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912396,0.003828175,0.0000037991872,0.000312108,0.0000789151,0.0006068561,0.000032199503,0.00006871432,0.0038295963],"genre_scores_gemma":[0.9979425,0.0012445402,0.0003335931,0.00011778512,0.000017657925,0.0000055341548,0.00024366798,0.00002493682,0.00006975041],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99847275,0.0000634908,0.00049084885,0.0003369347,0.00027658738,0.00035937937],"domain_scores_gemma":[0.9991601,0.00016765487,0.00021412753,0.00030905104,0.00007211589,0.00007695887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014305813,0.00026850213,0.00083248696,0.00014889908,0.00006413445,0.000017033384,0.00011878566,0.00016135804,0.000064230946],"category_scores_gemma":[0.00013009545,0.00022136788,0.00010659019,0.0004487193,0.0000777453,0.00018377659,0.000023487484,0.00025612133,0.0000323526],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040668705,0.016737679,0.093979955,0.00006201383,0.0020848576,0.0022863583,0.004716973,0.000012958066,0.8354934,0.00018561969,0.0006884656,0.03968485],"study_design_scores_gemma":[0.11459294,0.0054568546,0.73025024,0.00038090692,0.00026381676,0.00006446877,0.00025492738,0.00007328405,0.14741606,0.00013582948,0.0006394649,0.00047123586],"about_ca_topic_score_codex":0.00011588798,"about_ca_topic_score_gemma":0.000011898529,"teacher_disagreement_score":0.68807733,"about_ca_system_score_codex":0.000035026176,"about_ca_system_score_gemma":0.00007393949,"threshold_uncertainty_score":0.902712},"labels":[],"label_agreement":null},{"id":"W2588854745","doi":"10.1182/blood.v114.22.1308.1308","title":"The Prevalence of Anti-Factor VIII Antibodies in the Hemophilia A Population of the Quebec Province of Canada: Results of Testing with the Bethesda/Nijmegen Assay and with Three ELISA Assays.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Hôpital Maisonneuve-Rosemont; Centre Hospitalier Universitaire de Sherbrooke; Hôpital de l'Enfant-Jésus; Queen's University; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Haemophilia; Population; Haemophilia A; Antibody; Roche Diagnostics; Recombinant DNA; Titer; Immunology; Internal medicine; Pediatrics; Biology; Genetics","score_opus":0.018965500314424427,"score_gpt":0.2511212331452887,"score_spread":0.2321557328308643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588854745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933258,0.0006023906,0.0000013101351,0.0044398527,0.0000073390183,0.0009572343,0.000052341988,0.0000035399914,0.000610183],"genre_scores_gemma":[0.99945164,0.00004686086,0.000109960005,0.000019189343,0.000023372266,0.0000059128124,0.0000024904307,0.0000073881174,0.0003331962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836737,0.00018892574,0.00034551558,0.0001680123,0.0007287257,0.00020142176],"domain_scores_gemma":[0.9980906,0.00082003896,0.0003403228,0.0005027176,0.00021922245,0.00002709857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009062905,0.0001314566,0.00028059428,0.000035593304,0.00012392866,0.000007950954,0.0002675212,0.000043556825,0.0000010001554],"category_scores_gemma":[0.0005568333,0.000043371954,0.00003206628,0.00033866666,0.00036316854,0.000046977682,0.00003830281,0.00017476098,2.6114533e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037064962,0.000273721,0.9842854,0.00039701673,0.000103447586,0.000010865593,0.0010251543,0.0000188095,0.010199948,0.00012091917,0.00004091901,0.0031531074],"study_design_scores_gemma":[0.0016308776,0.0006130408,0.9712026,0.0006295384,0.00016366036,0.000016966549,0.0002631292,0.00007029897,0.025302783,0.000046089055,0.000010834578,0.000050175626],"about_ca_topic_score_codex":0.104935825,"about_ca_topic_score_gemma":0.40434006,"teacher_disagreement_score":0.29940423,"about_ca_system_score_codex":0.000027512551,"about_ca_system_score_gemma":0.0007019047,"threshold_uncertainty_score":0.90102446},"labels":[],"label_agreement":null},{"id":"W2588856514","doi":"10.1182/blood.v110.11.358.358","title":"The Architecural Pattern of FOXP3+ T Cells Predicts Risk of Transformation in Patients with Follicular Lymphoma (FL).","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Follicular lymphoma; FOXP3; Lymphoma; CD68; Tissue microarray; Internal medicine; Medicine; Oncology; Univariate analysis; Pathology; Cancer research; Immunology; Immunohistochemistry; Multivariate analysis; Immune system","score_opus":0.0032098421261298284,"score_gpt":0.19188410115354965,"score_spread":0.18867425902741983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588856514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986932,0.00015924433,0.00009599601,0.00003210606,0.00002680401,0.00054535334,0.000038636816,0.0000079108495,0.00040072712],"genre_scores_gemma":[0.99974424,0.0000675302,0.00010082816,0.000018702396,0.00001287481,0.000015050827,0.000027153663,0.000008826079,0.0000048138804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990865,0.000026228621,0.00031768897,0.00009718873,0.00030462714,0.00016775333],"domain_scores_gemma":[0.9994628,0.00008924794,0.00014489918,0.00018996366,0.00006124526,0.00005183684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017301159,0.00009652499,0.00018918811,0.000064092215,0.000028609053,0.0000034236284,0.000052169165,0.000039595172,0.0000031857012],"category_scores_gemma":[0.000010443623,0.000053372263,0.00006812288,0.00011949383,0.0000478772,0.0000352374,0.000008133431,0.000030185814,0.0000018095808],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029130175,0.0025954049,0.94449556,0.000055968936,0.00018681999,0.000009416816,0.0010191492,0.0000067780525,0.00010365597,0.000017833743,0.000005179781,0.051212944],"study_design_scores_gemma":[0.017491316,0.000984937,0.8970386,0.00013739093,0.0002796566,0.0000028573736,0.000089988884,0.000016430608,0.083836235,0.00001507006,0.000061075836,0.00004646651],"about_ca_topic_score_codex":0.00029909587,"about_ca_topic_score_gemma":0.00016294133,"teacher_disagreement_score":0.083732575,"about_ca_system_score_codex":0.00002874657,"about_ca_system_score_gemma":0.00003336082,"threshold_uncertainty_score":0.21764576},"labels":[],"label_agreement":null},{"id":"W2588865522","doi":"10.1182/blood.v118.21.634.634","title":"Randomized, Open Label Phase 1/2 Study of Pomalidomide (POM) Alone or in Combination with Low-Dose Dexamethasone (LoDex) in Patients (Pts) with Relapsed and Refractory Multiple Myeloma Who Have Received Prior Treatment That Includes Lenalidomide (LEN) and Bortezomib (BORT): Phase 2 Results","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pomalidomide; Neutropenia; Internal medicine; Clinical endpoint; Population; Phases of clinical research; Lenalidomide; Adverse effect; Dexamethasone; Febrile neutropenia; Regimen; Surgery; Gastroenterology; Randomized controlled trial; Clinical trial; Chemotherapy","score_opus":0.06689704075909599,"score_gpt":0.33766078471489747,"score_spread":0.2707637439558015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588865522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98734194,0.00028220468,0.000008788487,0.000056874967,0.00001540357,0.011917076,0.00015532866,0.000029988192,0.00019238687],"genre_scores_gemma":[0.99507314,0.00039317936,0.0027746463,0.000029358353,0.000012066382,0.0010356405,0.00027501516,0.000074968804,0.0003320138],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99574155,0.0009406888,0.0010794245,0.00096395105,0.0007037963,0.0005705981],"domain_scores_gemma":[0.9969368,0.0010443003,0.00064773357,0.0006837797,0.00027971994,0.0004076898],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012565904,0.0005787991,0.001982391,0.0005997587,0.00013595044,0.00006200966,0.0002066337,0.00016085824,0.000018483623],"category_scores_gemma":[0.0010211392,0.00035856402,0.000048721715,0.00041043284,0.0003372417,0.00056148844,0.0001930496,0.0002936458,0.0000014138948],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6099193,0.08660563,0.280536,0.000093962226,0.0010195752,0.001101537,0.006920872,6.3186593e-7,0.00062762,0.0000011017801,0.0000037003758,0.013170075],"study_design_scores_gemma":[0.7166978,0.03303404,0.23061885,0.00069369806,0.00062927406,0.000030872226,0.0013393144,0.0002769523,0.016386766,0.000007268921,0.0000056858757,0.0002794507],"about_ca_topic_score_codex":0.007965598,"about_ca_topic_score_gemma":0.01042125,"teacher_disagreement_score":0.106778525,"about_ca_system_score_codex":0.00022810919,"about_ca_system_score_gemma":0.00028634715,"threshold_uncertainty_score":0.99988663},"labels":[],"label_agreement":null},{"id":"W2588865636","doi":"10.1182/blood.v116.21.2357.2357","title":"Allogeneic Stem Cell Transplantation Can Overcome the Adverse Prognostic Impact of TP53 Mutation In Chronic Lymphocytic Leukemia (CLL): Results From the GCLLSG CLL3x Trial","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Fludarabine; Transplantation; Medicine; Internal medicine; Chronic lymphocytic leukemia; Oncology; Hematopoietic stem cell transplantation; Leukemia; Gastroenterology; Immunology; Chemotherapy; Cyclophosphamide","score_opus":0.017859198200497053,"score_gpt":0.2864295989912406,"score_spread":0.26857040079074357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588865636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960867,0.0003269299,0.0000069802873,0.000105681676,0.00024115024,0.00249378,0.0003069863,0.00004491737,0.00038684427],"genre_scores_gemma":[0.9985515,0.00018845646,0.000049113256,0.00004852063,0.00051905203,0.00012159954,0.0003409805,0.00004722854,0.00013356218],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99708706,0.0002839927,0.000815272,0.0004811647,0.00078210584,0.00055041385],"domain_scores_gemma":[0.99670666,0.0018036216,0.00030099583,0.00091235415,0.000119880584,0.00015646762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009510207,0.00029053696,0.00043264776,0.0001356679,0.000107867905,0.000030192612,0.0004317129,0.00025966618,0.000064606436],"category_scores_gemma":[0.00031141375,0.0001692439,0.00027305243,0.00052322284,0.00025168908,0.000091152324,0.00005092839,0.00059777335,0.000036817008],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.25442883,0.0035591512,0.020089319,0.0021168606,0.003095591,0.0053195707,0.04565757,0.029906405,0.61532944,0.00020922386,0.0011995882,0.01908844],"study_design_scores_gemma":[0.75534326,0.0029324908,0.15411033,0.00045757552,0.0015995074,0.00062698463,0.000568821,0.024644425,0.05909914,0.000100882615,0.00007748326,0.00043910713],"about_ca_topic_score_codex":0.030978974,"about_ca_topic_score_gemma":0.008701519,"teacher_disagreement_score":0.5562303,"about_ca_system_score_codex":0.018954286,"about_ca_system_score_gemma":0.038941562,"threshold_uncertainty_score":0.9848118},"labels":[],"label_agreement":null},{"id":"W2588869535","doi":"10.1182/blood.v106.11.1430.1430","title":"Novel Mechansims for Pk (Gb3) Inhibition of HIV Infection.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children; Ontario Institute for Cancer Research; Canadian Blood Services; University of Toronto","funders":"","keywords":"Jurkat cells; Peripheral blood mononuclear cell; Biology; In vitro; T cell; Flow cytometry; Globotriaosylceramide; Lipid bilayer fusion; Glycolipid; Antigen; Molecular biology; Immunology; Biochemistry; Immune system; Virus; Medicine","score_opus":0.015989081764343663,"score_gpt":0.25420253616944727,"score_spread":0.2382134544051036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588869535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99105823,0.00062120537,0.0056078373,0.00038982526,0.00008705656,0.00038587977,0.0003593561,0.000045120156,0.0014455061],"genre_scores_gemma":[0.99722975,0.00003540234,0.0008447448,0.000030479483,0.000038047016,0.00006994185,0.00031706574,0.0000066308794,0.0014279562],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999569,0.000019252608,0.000115232375,0.00011039739,0.000018013638,0.00016810189],"domain_scores_gemma":[0.9997483,0.00004685055,0.00003532854,0.00010008033,0.000055822446,0.000013619206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000081610466,0.00006204032,0.000101554404,0.000060296465,0.00006534574,0.0000028407137,0.000028023405,0.00008706676,0.00023014769],"category_scores_gemma":[0.000035469086,0.000052497115,0.000059634018,0.000052073505,0.000039791677,0.000041688447,0.000016671584,0.000058478126,0.00043648467],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000064587366,0.0015964203,0.0013422859,0.000019691706,0.00023089262,6.694429e-7,0.00011170473,0.0000043337213,0.98819965,0.0012950663,0.0027769061,0.0043578],"study_design_scores_gemma":[0.006000265,0.00033991173,0.0023486775,0.000014111926,0.000057648125,0.000027868897,0.000015440348,0.0000023347895,0.9574905,0.00009955769,0.033543065,0.000060598177],"about_ca_topic_score_codex":0.000038307877,"about_ca_topic_score_gemma":0.00006702838,"teacher_disagreement_score":0.030766161,"about_ca_system_score_codex":0.00001262398,"about_ca_system_score_gemma":0.000030476811,"threshold_uncertainty_score":0.5610273},"labels":[],"label_agreement":null},{"id":"W2588876159","doi":"10.1182/blood.v128.22.1110.1110","title":"Checkmate 205 Update with Minimum 12-Month Follow up: A Phase 2 Study of Nivolumab in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Nivolumab; Internal medicine; Brentuximab vedotin; Oncology; Autologous stem-cell transplantation; Cohort; Progression-free survival; Clinical endpoint; Transplantation; Lymphoma; Surgery; Chemotherapy; Clinical trial; Hodgkin lymphoma; Cancer; Immunotherapy","score_opus":0.009844112837785985,"score_gpt":0.2363699067996585,"score_spread":0.2265257939618725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588876159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99782354,0.00010438173,0.0000032589621,0.00017480634,0.00007137986,0.0012882211,0.00004966539,0.000046843903,0.0004378883],"genre_scores_gemma":[0.9990433,0.000025265368,0.00016956369,0.00006472424,0.000040535968,0.00019044874,0.000035774272,0.00005297778,0.000377441],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979289,0.000082292805,0.00044756258,0.00052941433,0.0006064158,0.00040537506],"domain_scores_gemma":[0.99871135,0.00007608429,0.00024168464,0.0006314028,0.00012171049,0.00021778424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000106065185,0.00033221277,0.00067807577,0.00017036237,0.0000466912,0.000013443257,0.00012321096,0.00010282389,0.000072682495],"category_scores_gemma":[0.000037050373,0.0001745896,0.000079130594,0.00021817918,0.00009895804,0.00015195282,0.00005264189,0.00006153876,0.000026743186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008552087,0.08338606,0.8840123,0.000027642613,0.00073843775,0.0004949998,0.00057798944,1.9360965e-7,0.00016485385,0.000010052764,0.00033671004,0.021698704],"study_design_scores_gemma":[0.28666946,0.024719574,0.6841982,0.00038048002,0.00072022306,0.000013016455,0.00017130516,0.0000026002092,0.0022788807,0.000003551393,0.0006325376,0.00021015403],"about_ca_topic_score_codex":0.0001591379,"about_ca_topic_score_gemma":0.00044966722,"teacher_disagreement_score":0.2781174,"about_ca_system_score_codex":0.00018596285,"about_ca_system_score_gemma":0.00020390135,"threshold_uncertainty_score":0.7119557},"labels":[],"label_agreement":null},{"id":"W2588882073","doi":"10.1182/blood.v116.21.4412.4412","title":"Characteristics and Outcomes of Patients Receiving Massive Transfusions at a Tertiary Care Centre","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Trauma and Emergency Care Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Cryoprecipitate; Apheresis; Retrospective cohort study; Blood transfusion; Fresh frozen plasma; Surgery; Platelet transfusion; Hematocrit; Emergency medicine; Platelet; Pediatrics; Internal medicine","score_opus":0.006229361692345561,"score_gpt":0.23141122546592358,"score_spread":0.22518186377357802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588882073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975998,0.00013075491,6.070667e-7,0.00029694944,0.0003065828,0.00016096102,0.000099870056,0.00001952198,0.0013849989],"genre_scores_gemma":[0.99942964,0.00015297103,0.00013986576,0.000046709254,0.000040602827,0.000004223573,0.000033100594,0.0000103705515,0.00014250295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994863,0.0000074273976,0.00015628422,0.0001230745,0.000107440464,0.00011943955],"domain_scores_gemma":[0.99963385,0.000025082538,0.00003831515,0.00012341149,0.00011358969,0.00006576217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000014287027,0.00008968555,0.00020062934,0.0000319657,0.000070318325,0.0000018282385,0.000026308944,0.000050832066,0.00009100771],"category_scores_gemma":[0.00008129597,0.00006811642,0.000058085454,0.0000336992,0.00004546409,0.000018581912,0.00003337961,0.00009696944,0.0000028763855],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012209633,0.00017044572,0.9822478,0.00011312261,0.000083284816,0.000006453568,0.004721154,3.5462326e-9,0.006274885,0.0000053890235,0.00007396958,0.006291226],"study_design_scores_gemma":[0.0013986375,0.0000470422,0.99456984,0.00003831587,0.00029009668,0.0000019962424,0.0005673009,2.9978176e-7,0.002391277,0.0000022747174,0.000626385,0.00006653592],"about_ca_topic_score_codex":0.000021907583,"about_ca_topic_score_gemma":0.00027286756,"teacher_disagreement_score":0.012321982,"about_ca_system_score_codex":0.000005177161,"about_ca_system_score_gemma":0.000012081643,"threshold_uncertainty_score":0.27777067},"labels":[],"label_agreement":null},{"id":"W2588894548","doi":"10.1182/blood.v104.11.3693.3693","title":"Non-Heme Induction of HO-1 in Macrophages Does Not Apparently Alter Cellular Iron Levels.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Heme Oxygenase-1 and Carbon Monoxide","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Heme; Hemin; Heme oxygenase; Biochemistry; Chemistry; Ferritin; Ferrous; Bilirubin; HMOX1; Oxidative stress; Biliverdin; Glutathione; Cytoprotection; Reactive oxygen species; Enzyme; Biology; Endocrinology","score_opus":0.008586654373486189,"score_gpt":0.22543972023716877,"score_spread":0.21685306586368258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588894548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988099,0.00031343751,0.00014202872,0.000075566066,0.00011630603,0.00012700004,0.000025012232,0.0000068422305,0.00038394766],"genre_scores_gemma":[0.99894345,0.00006207266,0.0003872821,0.00008973194,0.00019356965,0.000016744167,0.000046690544,0.000019679184,0.00024079134],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99914277,0.000019664181,0.00022787135,0.00028460013,0.000116406474,0.00020871118],"domain_scores_gemma":[0.99956256,0.0000021332319,0.000071404225,0.00027743695,0.000032250264,0.000054222302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010074098,0.00013635341,0.0001459512,0.000051328887,0.000021239346,0.000009193696,0.00012993094,0.0001512066,0.000016762433],"category_scores_gemma":[0.0000144680935,0.000115352595,0.00007405897,0.00007487812,0.00004760332,0.0000043160735,0.00005962639,0.0000822705,0.000008100384],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022822125,0.00024952542,0.0028777411,0.00003577362,0.000022957922,0.000012908144,0.00007052466,0.00004375753,0.99634606,0.000016397757,0.000022354985,0.00027918664],"study_design_scores_gemma":[0.0016557778,0.00014310307,0.009947758,0.000020039328,0.000021622778,0.00000515274,0.000058033733,0.0000016097677,0.98766464,0.00006726304,0.00026562362,0.00014938305],"about_ca_topic_score_codex":0.00010846178,"about_ca_topic_score_gemma":0.00007230619,"teacher_disagreement_score":0.008681417,"about_ca_system_score_codex":0.000010028548,"about_ca_system_score_gemma":0.00005282088,"threshold_uncertainty_score":0.47039422},"labels":[],"label_agreement":null},{"id":"W2588895154","doi":"10.1182/blood.v108.11.3781.3781","title":"Evaluation of the CapillaryS 2 CE System for Hemoglobinopathy Investigations.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Hemoglobinopathy; High-performance liquid chromatography; Chromatography; Capillary electrophoresis; Isoelectric focusing; Hemoglobin variants; Hemoglobin; Hemoglobin A2; Chemistry; Hemolytic anemia; Medicine; Biochemistry; Internal medicine","score_opus":0.015201269958267342,"score_gpt":0.23870023013160277,"score_spread":0.22349896017333543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588895154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98327017,0.0021696812,0.00005326715,0.00060348486,0.00020516658,0.0011417447,0.000018961839,0.000043060936,0.012494491],"genre_scores_gemma":[0.99914056,0.000009550606,0.00040109176,0.00006959572,0.000095440475,0.000066115004,0.00002513014,0.000013931115,0.00017856101],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989169,0.000073767325,0.0002634325,0.00013438774,0.0004779893,0.00013349677],"domain_scores_gemma":[0.99911165,0.000028662389,0.00011822354,0.00026846176,0.0004350851,0.000037886388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006107812,0.00008562559,0.00015330984,0.0000402677,0.00009907976,0.000006006732,0.000067565,0.00010082546,0.0000099753715],"category_scores_gemma":[0.00018892431,0.000056084413,0.00011032868,0.00021540528,0.00007225905,0.000024925583,0.000015901429,0.00006885629,0.0000050155395],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024985147,0.0067123026,0.27677202,0.0066791736,0.0016799006,0.000025637455,0.002828243,0.006183075,0.58594614,0.05779284,0.036759485,0.018371347],"study_design_scores_gemma":[0.04198052,0.00075112964,0.11640517,0.0019158515,0.014513945,0.0005849674,0.0035243444,0.017530408,0.78531134,0.007584517,0.009246051,0.0006517468],"about_ca_topic_score_codex":0.000109468434,"about_ca_topic_score_gemma":0.000012610938,"teacher_disagreement_score":0.19936523,"about_ca_system_score_codex":0.000053896743,"about_ca_system_score_gemma":0.000310446,"threshold_uncertainty_score":0.2287056},"labels":[],"label_agreement":null},{"id":"W2588916936","doi":"10.1182/blood.v128.22.792.792","title":"Treatment-Free Remission in Patients with Chronic Myeloid Leukemia in Chronic Phase According to Reasons for Switching from Imatinib to Nilotinib: Subgroup Analysis from ENESTop","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Nilotinib; Medicine; Internal medicine; Imatinib; Clinical endpoint; Imatinib mesylate; Interim analysis; Myeloid leukemia; Gastroenterology; Surgery; Clinical trial","score_opus":0.013697153198881004,"score_gpt":0.27771215606763033,"score_spread":0.26401500286874935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588916936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99428684,0.0003407128,0.0014242509,0.00043594211,0.00008419799,0.0026830717,0.0005465722,0.000120153694,0.000078255114],"genre_scores_gemma":[0.9897877,0.000044220847,0.00809131,0.000089056855,0.0003511773,0.0006529444,0.00069968525,0.0001180396,0.0001658627],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996341,0.000096013595,0.0008080365,0.0013106739,0.00051932543,0.0009249653],"domain_scores_gemma":[0.9969414,0.00057704095,0.00025902042,0.001594848,0.00007719714,0.0005505163],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018923018,0.0006166217,0.0012273906,0.0007888737,0.00010923775,0.0000431194,0.0004042483,0.00021708097,0.00013988487],"category_scores_gemma":[0.0004718918,0.00041970494,0.00025318775,0.0012580347,0.00002556682,0.0002469532,0.00017559185,0.00017818197,0.000055520017],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034352122,0.001878539,0.8338159,0.000043002696,0.0015944048,0.0001244777,0.0008897659,0.00015251833,0.07774485,0.0000058032692,0.000068216126,0.08024736],"study_design_scores_gemma":[0.23063548,0.008409856,0.70310634,0.00283978,0.0043402705,0.0000055260693,0.00017047791,0.0008938563,0.04774235,0.000087586566,0.00079551764,0.00097295275],"about_ca_topic_score_codex":0.0120508,"about_ca_topic_score_gemma":0.011880946,"teacher_disagreement_score":0.22720027,"about_ca_system_score_codex":0.017695079,"about_ca_system_score_gemma":0.0019091977,"threshold_uncertainty_score":0.9998255},"labels":[],"label_agreement":null},{"id":"W2588917049","doi":"10.1182/blood.v104.11.777.777","title":"Ship Represses the PI3-Kinase-Mediated Skewing of Myeloid Cell Development towards Alternative (M-2) Macrophages.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Inflammation; Arginase; Macrophage polarization; Macrophage; Immune system; Biology; Cell biology; M2 Macrophage; Nitric oxide synthase; Immunology; Cancer research; Wound healing; Nitric oxide; Arginine; Biochemistry","score_opus":0.014420304310307115,"score_gpt":0.22691981275871187,"score_spread":0.21249950844840476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588917049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97592264,0.01646971,0.00012467298,0.00019783391,0.0009426543,0.00029250883,0.000023970968,0.00006457673,0.0059614065],"genre_scores_gemma":[0.9974673,0.00027947774,0.0005556379,0.00018514243,0.000042749714,0.000045760924,0.00004788564,0.000026527876,0.0013495275],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987272,0.00012064449,0.00039226413,0.0003096533,0.000075571865,0.00037468143],"domain_scores_gemma":[0.99907273,0.00014747772,0.00021957794,0.00043942052,0.00010490427,0.000015886497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002978982,0.00020581917,0.0002690405,0.00006694202,0.00018206274,0.000011648688,0.00052285905,0.00016746328,0.0003622257],"category_scores_gemma":[0.00010802125,0.0001512898,0.000081979415,0.00016687124,0.0002860056,0.000072425406,0.00021752703,0.00033314797,0.00031458167],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007355559,0.00057981093,0.0006529639,0.00007168713,0.00042040163,0.00003177109,0.0053570555,0.00008524885,0.98976713,0.00015189868,0.00027250563,0.0025359609],"study_design_scores_gemma":[0.0029500145,0.00007788648,0.0032431022,0.00006997444,0.00007331225,0.000024921032,0.0003291443,1.0737036e-7,0.978831,0.00016101796,0.0140637895,0.00017575201],"about_ca_topic_score_codex":0.00021767417,"about_ca_topic_score_gemma":0.00001040927,"teacher_disagreement_score":0.021544624,"about_ca_system_score_codex":0.0000642206,"about_ca_system_score_gemma":0.00029743367,"threshold_uncertainty_score":0.61694187},"labels":[],"label_agreement":null},{"id":"W2588930776","doi":"10.1182/blood.v108.11.204.204","title":"Development of Leukemia after HOXB4 Gene Transfer in the Canine Model.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"clone (Java method); Biology; Transplantation; Leukemia; Haematopoiesis; CD34; Molecular biology; Bone marrow; Stem cell; Flow cytometry; Hematopoietic stem cell transplantation; Immunology; Cancer research; Medicine; Gene; Internal medicine; Genetics","score_opus":0.024493460887080626,"score_gpt":0.2616597362218664,"score_spread":0.23716627533478576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588930776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98928386,0.0003765315,0.0004125185,0.0001335616,0.000008201528,0.0003292206,0.0000033205802,0.000007838244,0.009444975],"genre_scores_gemma":[0.9948578,0.000010916026,0.0038763473,0.000080994796,0.000049532176,0.00006914151,0.000010875982,0.000012329693,0.0010320591],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988645,0.000029815505,0.0002692901,0.00014587904,0.00045591724,0.00023461397],"domain_scores_gemma":[0.99966216,0.000026958754,0.000011079639,0.00021034216,0.000045831915,0.00004360453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036040807,0.00008723578,0.00016691834,0.0000756012,0.000019396963,0.0000049786518,0.00010680053,0.000056340537,0.0001262736],"category_scores_gemma":[0.000010814331,0.000055880595,0.00003813718,0.00018572425,0.0000323291,0.000018134,0.000018022323,0.00014411345,0.000016056643],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007267082,0.0030463622,0.098816775,0.0007723396,0.00016782212,0.0009290474,0.008117687,0.00075474946,0.87956995,0.0007672909,0.00085287413,0.0054783765],"study_design_scores_gemma":[0.006875805,0.00016718594,0.27928036,0.00015124865,0.000107053056,0.00008558886,0.00018003785,0.0018085607,0.70862144,0.00009005881,0.0024113727,0.00022123998],"about_ca_topic_score_codex":0.00025988257,"about_ca_topic_score_gemma":0.00068274373,"teacher_disagreement_score":0.1804636,"about_ca_system_score_codex":0.00006198854,"about_ca_system_score_gemma":0.00038461157,"threshold_uncertainty_score":0.22787446},"labels":[],"label_agreement":null},{"id":"W2588946552","doi":"10.1182/blood-2016-12-758185","title":"T regulatory cells and dendritic cells protect against transfusion-related acute lung injury via IL-10","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; Canadian Blood Services; St. Michael's Hospital","funders":"National Institute on Aging; Health Canada; Canadian Blood Services; National Science Foundation; National Institutes of Health; National Heart, Lung, and Blood Institute; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"Transfusion-related acute lung injury; Medicine; Immunology; Lung; Internal medicine; Pulmonary edema","score_opus":0.006719758809235995,"score_gpt":0.2341636093143181,"score_spread":0.2274438505050821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588946552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98513865,0.0003140093,0.00016314843,0.0011277685,0.00040317036,0.0018267247,0.000034191256,0.0001730757,0.010819268],"genre_scores_gemma":[0.9904631,0.0012243658,0.0006600913,0.0005781155,0.00009678355,0.00007262351,0.0000133275935,0.000057626625,0.0068340153],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984061,0.000046797606,0.00034715992,0.00048784324,0.00034066068,0.00037140067],"domain_scores_gemma":[0.9986485,0.000018333545,0.00010516887,0.0008797913,0.000064318425,0.00028383837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025314032,0.0002711018,0.00040292373,0.00013739294,0.00045003832,0.000076955424,0.00021013705,0.0002074541,0.000311497],"category_scores_gemma":[0.000012045209,0.00024279382,0.00014752746,0.00007965472,0.000179114,0.00013607797,0.000089849804,0.0003267403,0.00009451768],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019326776,0.0010448958,0.0004912313,0.0004839535,0.00079925393,0.0005214624,0.00041446133,0.0000011029047,0.97815746,0.00011863319,0.0021958884,0.015578385],"study_design_scores_gemma":[0.015994659,0.0007455537,0.017189197,0.00062004256,0.0035344025,0.00010731465,0.00008049904,0.00036107656,0.9430234,0.0001270335,0.017568987,0.000647863],"about_ca_topic_score_codex":0.000038054834,"about_ca_topic_score_gemma":0.000015115361,"teacher_disagreement_score":0.035134096,"about_ca_system_score_codex":0.000017758442,"about_ca_system_score_gemma":0.0000527599,"threshold_uncertainty_score":0.99008447},"labels":[],"label_agreement":null},{"id":"W2588961417","doi":"10.1182/blood.v112.11.297.297","title":"Growth Factor Independence 1 (Gfi1) Is An Essential Factor for the Development of Lymphoma","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Lymphoma; Cancer research; Biology; Haematopoiesis; Transcription factor; Leukemia; Immunology; Gene; Stem cell; Genetics","score_opus":0.01871332129239153,"score_gpt":0.24631410761666897,"score_spread":0.22760078632427744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588961417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997754,0.0005476396,0.0011489674,0.000022562024,0.000058386006,0.00022773277,0.00014961134,0.0000064293113,0.000084687446],"genre_scores_gemma":[0.99808246,0.000078676036,0.0014758834,0.000067100314,0.000060303726,0.000042262844,0.000060429524,0.00001516514,0.00011772985],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992838,0.000012391914,0.00016265054,0.00023330795,0.00013941596,0.00016845358],"domain_scores_gemma":[0.9995511,0.0000107791875,0.00007215531,0.0002287229,0.00008634737,0.000050892468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000027198594,0.00012572722,0.00010694331,0.00001602203,0.00016037675,0.000008141746,0.00019545795,0.00010492285,0.000030518924],"category_scores_gemma":[0.000017757135,0.00008962649,0.000075206015,0.000038333088,0.000053031305,0.0000045297325,0.00005472002,0.000021253974,0.000003200157],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004861051,0.008982877,0.23362273,0.00014440244,0.0030448614,0.000016365782,0.0069149127,0.0000030085414,0.68645656,0.00012785388,0.00081466883,0.059385646],"study_design_scores_gemma":[0.002354681,0.00021550973,0.055575274,0.0000034471768,0.00004618149,0.00001130218,0.000067529734,0.0000036689871,0.9403337,0.00002228501,0.0012399263,0.00012649599],"about_ca_topic_score_codex":0.000022937546,"about_ca_topic_score_gemma":0.000054252232,"teacher_disagreement_score":0.25387713,"about_ca_system_score_codex":0.0000034189811,"about_ca_system_score_gemma":0.0001702492,"threshold_uncertainty_score":0.3654862},"labels":[],"label_agreement":null},{"id":"W2588964553","doi":"10.1182/blood.v116.21.4187.4187","title":"BCL2 Is Highly Mutated In Diffuse Large B-Cell Lymphoma","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Germinal center; Follicular lymphoma; Lymphoma; Biology; Sanger sequencing; Mantle cell lymphoma; Cancer research; IGHV@; B cell; Gene; Genetics; Chronic lymphocytic leukemia; Mutation; Antibody; Leukemia; Immunology","score_opus":0.00605661490227594,"score_gpt":0.23071091586968784,"score_spread":0.2246543009674119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588964553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910962,0.00027656922,5.08845e-7,0.00074893073,0.00015626501,0.0002651311,0.000031471372,0.000069576694,0.0073553305],"genre_scores_gemma":[0.9974545,0.0000719585,0.0002696937,0.0009930617,0.00009739202,0.000056199053,0.000041731342,0.00002410196,0.000991319],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990316,0.0000140898255,0.00019868751,0.00026597158,0.00017632871,0.00031329307],"domain_scores_gemma":[0.9993539,0.000043097418,0.00004450827,0.0003653182,0.000034940473,0.00015827677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000070059985,0.00015655621,0.00024654242,0.00009583148,0.000038330858,0.000018176323,0.00007038591,0.00012171251,0.00019645417],"category_scores_gemma":[0.00002639137,0.0001221164,0.00008775961,0.00016932213,0.000024041397,0.000041692623,0.000037177324,0.00007946001,0.00042440067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010267628,0.14022817,0.820125,0.00007681512,0.00017891946,0.0023865837,0.0010193374,3.042895e-8,0.026923673,0.0005187096,0.0037053884,0.004734741],"study_design_scores_gemma":[0.13690686,0.0003078074,0.55354655,0.000050799797,0.00029578657,0.00013984839,0.00005594987,0.00003223391,0.2849703,0.00007003116,0.023417702,0.00020612933],"about_ca_topic_score_codex":0.00022439727,"about_ca_topic_score_gemma":0.00014701704,"teacher_disagreement_score":0.26657844,"about_ca_system_score_codex":0.000033935426,"about_ca_system_score_gemma":0.00008697283,"threshold_uncertainty_score":0.54549533},"labels":[],"label_agreement":null},{"id":"W2588972323","doi":"10.1182/blood.v108.11.249.249","title":"Improved Survival in Patients with Myelodysplastic Syndrome (MDS) Receiving Iron Chelation Therapy.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Myelodysplastic syndromes; Internal medicine; International Prognostic Scoring System; Anemia; Ferritin; Gastroenterology; Chelation therapy; Hemoglobin; Bone marrow; Surgery; Pediatrics; Thalassemia","score_opus":0.0073793239404041835,"score_gpt":0.2234912166053888,"score_spread":0.2161118926649846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588972323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99741596,0.00007394701,0.00005915901,0.00011940194,0.000053930657,0.00064862095,0.0000055670357,0.00005995501,0.0015634624],"genre_scores_gemma":[0.99856466,0.000012283083,0.0005129514,0.000030217543,0.000085496606,0.00003108008,0.00010631169,0.000044147713,0.00061282614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861515,0.00006128875,0.00024221005,0.0003003931,0.00040893164,0.0003720487],"domain_scores_gemma":[0.99938416,0.000103262646,0.0000700108,0.00026736895,0.000098290366,0.00007689649],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022081591,0.00016370474,0.00025777746,0.00018515709,0.000048527803,0.000020474115,0.00008919084,0.00011153295,0.0000779521],"category_scores_gemma":[0.00007756625,0.00012723384,0.00003233189,0.0003728939,0.00004682128,0.000117946896,0.0000315718,0.00031462635,0.000032848275],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005379168,0.0009778494,0.9906133,0.00004867786,0.00004453047,0.00007556697,0.00006274789,0.000021521839,0.006019107,0.000017648299,0.000028294542,0.0015528438],"study_design_scores_gemma":[0.015940255,0.0008902696,0.98156154,0.00008941695,0.000038740458,0.000022410726,0.000014261303,0.00027546228,0.0009556206,0.000015270352,0.000052837444,0.00014394162],"about_ca_topic_score_codex":0.00043388343,"about_ca_topic_score_gemma":0.000096531345,"teacher_disagreement_score":0.015402338,"about_ca_system_score_codex":0.00017198788,"about_ca_system_score_gemma":0.0001438129,"threshold_uncertainty_score":0.51884454},"labels":[],"label_agreement":null},{"id":"W2588972403","doi":"10.1182/blood.v108.11.5310.5310","title":"Treatment of Steroid-Resistant Graft-Versus-Host Disease with Monoclonal Antibodies in Children.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Daclizumab; Medicine; Infliximab; Monoclonal antibody; Immunology; Monoclonal antibody therapy; Corticosteroid; Internal medicine; Monoclonal; Hematopoietic stem cell transplantation; Transplantation; Gastroenterology; Antibody; Disease","score_opus":0.01039724492967089,"score_gpt":0.23936508254646244,"score_spread":0.22896783761679154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588972403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975912,0.0006966688,0.000023734276,0.00011138774,0.000018629029,0.00043964596,0.00007515706,0.000025487603,0.0010181211],"genre_scores_gemma":[0.9987176,0.000094480136,0.0008346741,0.000006990479,0.00004329761,0.000022613442,0.0001315919,0.000016413469,0.00013234913],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99918675,0.000020596588,0.00022798179,0.00018891315,0.00021404905,0.0001617326],"domain_scores_gemma":[0.999612,0.00004131273,0.00005680098,0.00018589495,0.0000288185,0.00007517895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000263485,0.00013715743,0.00024714935,0.000093264,0.000019681176,0.0000055213227,0.000030759133,0.000031171516,0.000021817077],"category_scores_gemma":[0.0000033198003,0.00009990089,0.000053791824,0.000112502,0.00005706134,0.000031593718,0.0000034032028,0.00002901303,0.0000060896414],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019835865,0.002365206,0.98560584,0.000116913376,0.0001372176,0.0002327943,0.00014849455,0.000008550181,0.0091458475,0.00019082618,0.000005062177,0.000059647304],"study_design_scores_gemma":[0.01817494,0.00087701366,0.9474301,0.00014305025,0.0005543127,0.000041322535,0.000043220163,0.000009991217,0.032595865,0.000012207543,0.000020842745,0.000097161836],"about_ca_topic_score_codex":0.00034633384,"about_ca_topic_score_gemma":0.00015224602,"teacher_disagreement_score":0.03817578,"about_ca_system_score_codex":0.000029956098,"about_ca_system_score_gemma":0.00007321153,"threshold_uncertainty_score":0.407384},"labels":[],"label_agreement":null},{"id":"W2588975040","doi":"10.1182/blood.v116.21.3214.3214","title":"Phenotypic Evaluation of a Family Cohort with Hemolytic Anemia","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Haptoglobin; Hemolytic anemia; Hemolysis; Erythrocyte fragility; Population; Immunology; Anemia; Reticulocyte; Biology; Reticulocytosis; Internal medicine; Medicine; Genetics","score_opus":0.02180439086441417,"score_gpt":0.2742350794183774,"score_spread":0.2524306885539632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588975040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98517954,0.00006688862,0.000033441156,0.00005546776,0.0001468513,0.0002961203,0.0000016918773,0.000027838145,0.014192148],"genre_scores_gemma":[0.9983864,0.0000054510388,0.0009416599,0.00025306884,0.00013538229,0.000019546707,0.000022498003,0.000009743398,0.00022624167],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99937296,0.000026467209,0.000115272436,0.00013625309,0.00025837065,0.00009068406],"domain_scores_gemma":[0.999395,0.000023776727,0.000055257304,0.00023540373,0.00023922269,0.0000512999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023385721,0.00006698613,0.0001596422,0.000045305627,0.000019875788,0.0000017780933,0.000028563389,0.00007245454,0.000335846],"category_scores_gemma":[0.00007341205,0.000049110422,0.000028291273,0.00010417595,0.000059569556,0.000019705913,0.0000071295135,0.00014730537,0.00004157589],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002218655,0.0004943334,0.11815985,0.000066438384,0.000084806576,0.00000722905,0.00010116112,0.000006031108,0.87775,0.0001739096,0.00025161024,0.002682775],"study_design_scores_gemma":[0.0072552217,0.0007750045,0.94994557,0.000036451842,0.0011913002,0.00015754986,0.00006328143,0.0003148239,0.039609727,0.00015411095,0.00040293628,0.00009399945],"about_ca_topic_score_codex":0.000017630227,"about_ca_topic_score_gemma":0.000017588694,"teacher_disagreement_score":0.83814025,"about_ca_system_score_codex":0.000006532297,"about_ca_system_score_gemma":0.00017778877,"threshold_uncertainty_score":0.36772782},"labels":[],"label_agreement":null},{"id":"W2588986929","doi":"10.1182/blood.v118.21.4268.4268","title":"An Evaluation of Septicemia During Outpatient Consolidation Chemotherapy for Acute Myeloid Leukemia","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Bacteremia; Medicine; Ambulatory; Internal medicine; Ciprofloxacin; Chemotherapy; Myeloid leukemia; Fluconazole; Cohort; Surgery; Antibiotics; Gastroenterology; Microbiology; Biology","score_opus":0.04044547208076241,"score_gpt":0.32462252214099263,"score_spread":0.2841770500602302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588986929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957538,0.0000308575,0.00018762822,0.000022274784,0.0000920722,0.000743621,0.000011184561,0.000032864733,0.0031256774],"genre_scores_gemma":[0.9984728,0.000024973753,0.001041057,0.00006914622,0.000093737275,0.00016058245,0.00003398135,0.000016108208,0.00008762597],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993864,0.000023753575,0.00017045082,0.00013888601,0.00017937097,0.00010112753],"domain_scores_gemma":[0.99934965,0.000008179456,0.000095741365,0.00020310325,0.00029107905,0.00005221843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001694943,0.00007016503,0.00013935773,0.000056080942,0.0000477543,0.000004302616,0.000036799996,0.00005160185,0.0002452694],"category_scores_gemma":[0.000014431827,0.00006502656,0.00005495224,0.000072176976,0.00002361086,0.000088899505,0.0000045911593,0.00004855138,0.000005758523],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085659296,0.0013071193,0.049749766,0.00013480551,0.000646597,0.0000017522548,0.0036552304,0.00003167598,0.93462044,0.00029003219,0.000098366654,0.008607645],"study_design_scores_gemma":[0.008837605,0.00087254983,0.14438826,0.000037116915,0.0015945561,0.000022540113,0.000115210925,0.00017275006,0.8436572,0.00011863699,0.0001034728,0.00008008411],"about_ca_topic_score_codex":0.000029270219,"about_ca_topic_score_gemma":0.000010358689,"teacher_disagreement_score":0.09463849,"about_ca_system_score_codex":0.000086205306,"about_ca_system_score_gemma":0.00017972445,"threshold_uncertainty_score":0.26855278},"labels":[],"label_agreement":null},{"id":"W2588987871","doi":"10.1182/blood.v106.11.3433.3433","title":"Leukemia-Related Gene Expression of Bone Marrow Cells from Patients with Shwachman-Diamond Syndrome at the Pre-Leukemic Phase.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute; Hospital for Sick Children","funders":"","keywords":"Myeloid leukemia; Leukemia; Bone marrow; Microarray analysis techniques; Gene; Gene expression profiling; Biology; Cytopenia; Myelodysplastic syndromes; Microarray; Cancer research; Gene expression; Medicine; Immunology; Genetics","score_opus":0.003054311414120126,"score_gpt":0.19179223627801573,"score_spread":0.1887379248638956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588987871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956584,0.0033368526,0.000017405378,0.000020386564,0.00004497796,0.0003450387,0.00027418282,0.000012550754,0.00029019156],"genre_scores_gemma":[0.9973639,0.00013680194,0.0004669395,0.00005848968,0.000034896613,0.000032733267,0.0009947511,0.000034405366,0.0008770368],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99887806,0.000045824825,0.0002629092,0.00038118873,0.00019685121,0.00023518919],"domain_scores_gemma":[0.99915814,0.000012976199,0.00018546527,0.000521075,0.000046414454,0.00007590012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000043476495,0.00021649341,0.00021206672,0.00002495174,0.00009835156,0.000010876722,0.00016752546,0.00017064776,0.00010758163],"category_scores_gemma":[0.000006313117,0.00014239861,0.00009303489,0.00006893893,0.000089537585,0.0000071497607,0.00013107725,0.00007824439,0.000021920137],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026851852,0.00191873,0.020621756,0.000009865515,0.00032201447,0.000011288307,0.000092741415,0.00013474961,0.9744967,6.836453e-7,0.0009683544,0.0011545938],"study_design_scores_gemma":[0.0124626625,0.0006864481,0.0077372272,0.000030847485,0.00024212399,0.00001116028,0.000011929096,0.000011093988,0.977785,0.000013951946,0.0008223405,0.00018523965],"about_ca_topic_score_codex":0.00006227535,"about_ca_topic_score_gemma":0.000057013687,"teacher_disagreement_score":0.012884529,"about_ca_system_score_codex":0.000025986421,"about_ca_system_score_gemma":0.000057719622,"threshold_uncertainty_score":0.5806847},"labels":[],"label_agreement":null},{"id":"W2588992991","doi":"10.1182/blood.v126.23.3350.3350","title":"Hemin: A Salvage Treatment for a Patient with Severe Auto-Immune Hemolytic Anemia and Reticulocytopenia","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal; Héma-Québec","funders":"","keywords":"Medicine; Reticulocytosis; Chills; Coombs test; Hemolysis; Serology; Haemolysis; Internal medicine; Gastroenterology; Anemia; Immunology; Surgery; Antibody","score_opus":0.015443307802152195,"score_gpt":0.2319276954607592,"score_spread":0.216484387658607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588992991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99471885,0.0013373413,0.00005363375,0.00069707935,0.00003351048,0.0010722562,0.000017994367,0.000056598677,0.0020127234],"genre_scores_gemma":[0.99555624,0.0000424799,0.0034625824,0.00016203495,0.000058696387,0.00011177824,0.000041664473,0.0000286034,0.0005359462],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991862,0.000010694683,0.00016483673,0.0002621756,0.00016393008,0.00021217184],"domain_scores_gemma":[0.9993942,0.00002842048,0.00004221562,0.0002474158,0.00007311024,0.00021466252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000062054125,0.00017182266,0.00030592256,0.00003455825,0.000054649478,0.000017614579,0.000029571696,0.00007398533,0.0000126837],"category_scores_gemma":[0.000014729711,0.00011126579,0.00005201536,0.000080195605,0.000040222603,0.00003918274,0.000016746426,0.00006349038,0.000005288501],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040671285,0.05260545,0.18659489,0.00577163,0.006305856,0.011896006,0.066076644,0.00003422259,0.22972545,0.0027037899,0.0077926237,0.38982216],"study_design_scores_gemma":[0.30986762,0.1052296,0.045080606,0.0022922745,0.012187942,0.024562951,0.0039832126,0.00080672157,0.44558507,0.00057665835,0.047685247,0.002142087],"about_ca_topic_score_codex":0.00007577275,"about_ca_topic_score_gemma":0.000025529864,"teacher_disagreement_score":0.38768005,"about_ca_system_score_codex":0.000040591916,"about_ca_system_score_gemma":0.00010996396,"threshold_uncertainty_score":0.45372874},"labels":[],"label_agreement":null},{"id":"W2589000699","doi":"10.1182/blood.v114.22.528.528","title":"Allogeneic Hematopoietic Cell Transplantation Can Cure Some Patients with Acute Leukemia in Relapse or Primary Induction Failure: A CIBMTR Study.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Internal medicine; Transplantation; Acute leukemia; Leukemia; Myeloid leukemia; Acute lymphocytic leukemia; Hematopoietic stem cell transplantation; Gastroenterology; Surgery; Lymphoblastic Leukemia","score_opus":0.008912289069390116,"score_gpt":0.24219286935502976,"score_spread":0.23328058028563964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589000699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99695545,0.000072246636,0.000019020992,0.00074504904,0.000039281767,0.0018376171,0.000022800195,0.00008330004,0.00022524815],"genre_scores_gemma":[0.99746513,0.00015410532,0.00092310354,0.00046777853,0.00010311832,0.000086029046,0.00028939766,0.00004525879,0.00046610076],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978123,0.00011384485,0.0003870524,0.00051556155,0.00070352206,0.00046777134],"domain_scores_gemma":[0.99911493,0.000037349062,0.00010906393,0.00042401897,0.000119733646,0.0001949329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020563848,0.00027955128,0.0004241758,0.00033953437,0.00008231297,0.000026578664,0.00016695634,0.00019444241,0.00003335527],"category_scores_gemma":[0.000018072518,0.00020454773,0.000053150357,0.0006601434,0.000048362108,0.00022928455,0.000022016344,0.00064196094,0.00002161586],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013201221,0.016602622,0.8579208,0.0012381863,0.0010373358,0.011720504,0.019950865,0.00015574717,0.070033,0.00006489796,0.0027759566,0.0052988585],"study_design_scores_gemma":[0.044063903,0.0066033187,0.9325932,0.00025537386,0.0010358581,0.0005343061,0.00072291965,0.000010186042,0.013547963,0.00006626156,0.0001072959,0.00045937407],"about_ca_topic_score_codex":0.00012310097,"about_ca_topic_score_gemma":0.00025168172,"teacher_disagreement_score":0.07467244,"about_ca_system_score_codex":0.0007867321,"about_ca_system_score_gemma":0.0011324411,"threshold_uncertainty_score":0.83412147},"labels":[],"label_agreement":null},{"id":"W2589020689","doi":"10.1182/blood.v110.11.2468.2468","title":"Coalescence of the German-Austrian and IMRAW Cytogenetic MDS Databases: Modification of Patient Risk Groups.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"International Prognostic Scoring System; Internal medicine; Cohort; Myelodysplastic syndromes; Karyotype; Oncology; Medicine; Bone marrow; Pediatrics; Biology; Chromosome; Genetics","score_opus":0.027504762760764842,"score_gpt":0.31324018193770464,"score_spread":0.2857354191769398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589020689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998299,0.00046878424,0.00034333582,0.00007794397,0.000025733241,0.00045889092,0.000063324944,0.000008449054,0.00025452583],"genre_scores_gemma":[0.9987841,0.00027902977,0.0007935492,0.00003246973,0.000039646467,0.0000056094555,0.000018675033,0.000010983871,0.00003593038],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99894387,0.00005733479,0.0002990071,0.00017488252,0.00034907213,0.00017581812],"domain_scores_gemma":[0.9989652,0.00011191888,0.00017894147,0.0005446877,0.00011383965,0.00008540643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003939941,0.0000817008,0.00016750152,0.00007401618,0.000043349173,0.0000028631066,0.0001233899,0.000047388276,0.000014410107],"category_scores_gemma":[0.0002346992,0.000056806202,0.00004092296,0.00023595273,0.00021348578,0.000032051976,0.00011138339,0.00017423276,0.0000030947062],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026881634,0.0008629288,0.6624208,0.00029274912,0.00012685846,0.000020168518,0.0011786898,0.000005866711,0.323254,0.00040369085,0.00023607133,0.01092934],"study_design_scores_gemma":[0.0026144756,0.00026461703,0.5014466,0.00011633842,0.00020729675,0.00005363524,0.0002778012,0.00018127279,0.49444655,0.000034608707,0.0002837556,0.00007302746],"about_ca_topic_score_codex":0.00026312855,"about_ca_topic_score_gemma":0.0000272962,"teacher_disagreement_score":0.17119256,"about_ca_system_score_codex":0.000032732933,"about_ca_system_score_gemma":0.00011357435,"threshold_uncertainty_score":0.23164897},"labels":[],"label_agreement":null},{"id":"W2589025718","doi":"10.1182/blood.v116.21.2745.2745","title":"Validation of Monosomal Karyotype Based Model In the Risk Stratification of Acute Myeloid Leukemia","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Monosomy; Internal medicine; Cytarabine; Medicine; Myeloid leukemia; Gastroenterology; Chemotherapy regimen; Transplantation; Induction chemotherapy; Chromosome 7 (human); Chemotherapy; Oncology; Karyotype; Biology; Genetics; Chromosome","score_opus":0.017628828577959065,"score_gpt":0.2831599524219569,"score_spread":0.26553112384399785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589025718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99641585,0.000016270227,0.00072403526,0.00034152553,0.00002398045,0.00048350668,0.0000472095,0.000014809627,0.001932803],"genre_scores_gemma":[0.9940707,0.000028791554,0.005601002,0.00004319935,0.00004945433,0.000032172004,0.00009750804,0.000014900554,0.00006226832],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987965,0.000093445255,0.0003503371,0.00018413075,0.00041174536,0.00016380439],"domain_scores_gemma":[0.99886924,0.00014441386,0.00018172446,0.00058100466,0.0001768498,0.000046747246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006401148,0.000100558645,0.00021381216,0.00015595758,0.000031398748,0.000007998957,0.00023088565,0.00013695404,0.000035523088],"category_scores_gemma":[0.000179958,0.0000720653,0.00007081036,0.00033680903,0.00010266337,0.00008236973,0.000021645656,0.00050607853,0.00000805876],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023825782,0.00049581454,0.04687754,0.00007326903,0.00008733674,0.000007786631,0.00051871664,0.000817026,0.9490463,0.0008194885,0.00014387972,0.00087457674],"study_design_scores_gemma":[0.0036639345,0.00025645876,0.1266807,0.000027592412,0.00036226606,0.000013797243,0.00008679406,0.08814595,0.7800782,0.0005880479,0.000013317052,0.000082987244],"about_ca_topic_score_codex":0.00021860519,"about_ca_topic_score_gemma":0.00004733134,"teacher_disagreement_score":0.16896816,"about_ca_system_score_codex":0.000042699972,"about_ca_system_score_gemma":0.00074786844,"threshold_uncertainty_score":0.29387373},"labels":[],"label_agreement":null},{"id":"W2589026218","doi":"10.1182/blood.v126.23.4893.4893","title":"Front-Line FLAG-IDA and Nove-HiDAC Chemotherapy Improves Overall Survival (OS) and Complete Remission Rates (CR) for Patients with Secondary or Therapy-Related AML Compared to 3&amp;7","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; CancerCare Manitoba; University of Toronto","funders":"","keywords":"Medicine; Flag (linear algebra); Cytarabine; Internal medicine; Etoposide; Idarubicin; Mitoxantrone; Salvage therapy; Fludarabine; Refractory (planetary science); Oncology; Surgery; Gemcitabine; Gastroenterology; Chemotherapy; Cyclophosphamide","score_opus":0.04440066489194252,"score_gpt":0.3057987817389067,"score_spread":0.2613981168469642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589026218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953142,0.0005005516,0.00013414102,0.0012682764,0.000076762524,0.002159203,0.00015112241,0.00008137766,0.00031441182],"genre_scores_gemma":[0.9825903,0.00021297146,0.011419053,0.0013323504,0.00021699017,0.000094286406,0.0005526347,0.00013640859,0.0034449976],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981262,0.000058873393,0.00036365647,0.000550701,0.00042471476,0.00047585327],"domain_scores_gemma":[0.9982762,0.00021040498,0.000119788936,0.000392896,0.00041247703,0.0005882717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035674893,0.00033236173,0.0006421222,0.00013123848,0.00012044512,0.00006620104,0.00014048629,0.00015472573,0.00013649186],"category_scores_gemma":[0.00017539588,0.00021650243,0.00004570678,0.0001547536,0.00012715973,0.00013285731,0.00009303466,0.00028973835,0.000013768483],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1001458,0.0055974564,0.24437912,0.00091854506,0.0030094942,0.00008478091,0.009659007,0.000012030719,0.5466736,0.000055171357,0.038110904,0.051354058],"study_design_scores_gemma":[0.36973995,0.019346483,0.4483081,0.0008111714,0.00046878014,0.00015073367,0.00080410356,0.003221954,0.034616392,0.00040290042,0.12034519,0.0017842181],"about_ca_topic_score_codex":0.00016501955,"about_ca_topic_score_gemma":0.000080706144,"teacher_disagreement_score":0.51205724,"about_ca_system_score_codex":0.00008847486,"about_ca_system_score_gemma":0.0003448155,"threshold_uncertainty_score":0.88287127},"labels":[],"label_agreement":null},{"id":"W2589030604","doi":"10.1182/blood.v110.11.lb3.lb3","title":"Loss of Primitive Hematopoietic Cells in Patients with Dyskeratosis Congenita.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Dyskeratosis congenita; CD34; Haematopoiesis; Telomerase; Bone marrow; Bone marrow failure; Telomere; Biology; Stem cell; Immunology; Population; Cancer research; Granulocyte colony-stimulating factor; Medicine; Cell biology; Genetics; Gene","score_opus":0.0060520002378489715,"score_gpt":0.21460580501326146,"score_spread":0.2085538047754125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589030604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99800915,0.000119716315,0.00003884077,0.000026460348,0.0000440311,0.0003809487,0.000014159088,0.000022314971,0.0013443877],"genre_scores_gemma":[0.99899155,0.000014572524,0.0007186178,0.00012561299,0.000025451893,0.0000044793014,0.000012405796,0.000018783574,0.00008851026],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989101,0.000017890176,0.0002937703,0.00020777313,0.0003010074,0.00026941035],"domain_scores_gemma":[0.99933577,0.00007049674,0.00008731912,0.00023111896,0.0001578961,0.00011740475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013275859,0.00013353564,0.00031077027,0.0001387236,0.000020239268,0.0000042396714,0.00006638802,0.00007233735,0.0000477783],"category_scores_gemma":[0.00003151181,0.0001062801,0.000040278668,0.00030400202,0.00011208929,0.000047037112,0.000018807597,0.0001255183,0.000017217762],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034533103,0.0019628413,0.98799944,0.0001329277,0.00006794902,0.000120039,0.000948288,3.0835778e-7,0.007780033,0.000059949074,0.000022483704,0.00056038174],"study_design_scores_gemma":[0.005673983,0.00046080933,0.7323756,0.00016202948,0.000097996686,0.000009716503,0.00021047596,5.9161545e-7,0.26083744,0.000006694027,0.0000552354,0.00010942333],"about_ca_topic_score_codex":0.00003481855,"about_ca_topic_score_gemma":0.00004220661,"teacher_disagreement_score":0.25562385,"about_ca_system_score_codex":0.000020799585,"about_ca_system_score_gemma":0.0000626654,"threshold_uncertainty_score":0.43339768},"labels":[],"label_agreement":null},{"id":"W2589043944","doi":"10.1182/blood.v114.22.1100.1100","title":"MYC Translocations and Expression Are Clinically Important in R-CHOP Treated Patients with De Novo DLBCL.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Chromosomal translocation; Diffuse large B-cell lymphoma; Lymphoma; Medicine; Cancer research; CHOP; Gene expression profiling; Oncology; Internal medicine; Biology; Gene; Gene expression; Genetics","score_opus":0.007797327228993337,"score_gpt":0.25010714161352876,"score_spread":0.24230981438453542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589043944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984744,0.0002657987,0.00000441922,0.0005271256,0.000006673258,0.00034476287,0.000013888905,0.000026471022,0.00033646188],"genre_scores_gemma":[0.9985713,0.00015213579,0.0008206072,0.00033252945,0.000017923205,0.000034087123,0.000038835216,0.000007968132,0.000024617628],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99926203,0.000017630775,0.00026626376,0.00019102912,0.00011404478,0.00014900982],"domain_scores_gemma":[0.99957126,0.000037858015,0.00006983253,0.00015814252,0.000040470124,0.0001224581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005516836,0.000102888436,0.00019340878,0.00004859388,0.000032743945,0.0000091382,0.000024405506,0.000062294544,0.000011552568],"category_scores_gemma":[0.000033244658,0.00006714082,0.000029152106,0.0001013009,0.000018899866,0.000034972887,0.000003721794,0.000051063296,0.0000021908618],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018341401,0.0074323323,0.98871505,0.000008667228,0.0000291609,0.00014168787,0.00017440232,4.0510812e-7,0.00036755626,0.000007611011,0.000028398777,0.002911325],"study_design_scores_gemma":[0.021442847,0.0010524517,0.97374725,0.0002753664,0.0001848965,0.000020282514,0.000031361393,0.0000047226113,0.003082674,0.000023681305,0.000060646154,0.000073831296],"about_ca_topic_score_codex":0.000026344273,"about_ca_topic_score_gemma":0.000040336974,"teacher_disagreement_score":0.021259433,"about_ca_system_score_codex":0.000027756267,"about_ca_system_score_gemma":0.000052367035,"threshold_uncertainty_score":0.27379233},"labels":[],"label_agreement":null},{"id":"W2589050464","doi":"10.1182/blood.v116.21.3518.3518","title":"Related Myeloablative Stem Cell Transplantation (SCT) to Cure Sickle Cell Anemia (SCA): Update of French Results","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Busulfan; Internal medicine; Transplantation; Gastroenterology; Hematopoietic stem cell transplantation; Cyclophosphamide; Anemia; Regimen; Fludarabine; Surgery; Chemotherapy","score_opus":0.004437753079620363,"score_gpt":0.21041581205736234,"score_spread":0.205978058977742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589050464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95717025,0.00026377532,0.000048494392,0.0007859603,0.00023807639,0.0005360124,0.00012646525,0.00007975933,0.040751234],"genre_scores_gemma":[0.9948077,0.0003348707,0.0010792636,0.00012840172,0.000045109595,0.0000067618503,0.00018219788,0.000031707335,0.0033839522],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985336,0.000042948726,0.0005135314,0.00034436444,0.00027242026,0.00029312292],"domain_scores_gemma":[0.99904734,0.000057610418,0.000173186,0.00036157016,0.00014370099,0.00021660399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020704618,0.00020020462,0.00031511634,0.00013176007,0.0000646592,0.000009346461,0.000118111384,0.0003649327,0.00012798059],"category_scores_gemma":[0.000015876081,0.00016516502,0.00010162275,0.0004181726,0.000068159745,0.00006837902,0.000018793435,0.0005772386,0.0001907493],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010552414,0.002774043,0.006064823,0.0011737249,0.00019701548,0.0004382984,0.022339478,0.00035139927,0.95177513,0.00022089818,0.008953774,0.0046561533],"study_design_scores_gemma":[0.019719282,0.0013132266,0.014125457,0.00032420357,0.0011667644,0.00014144983,0.0013882052,0.0001452599,0.95232266,0.00012417803,0.008723225,0.00050607685],"about_ca_topic_score_codex":0.0001227201,"about_ca_topic_score_gemma":0.000045837845,"teacher_disagreement_score":0.037637513,"about_ca_system_score_codex":0.000010843144,"about_ca_system_score_gemma":0.00011649078,"threshold_uncertainty_score":0.6735234},"labels":[],"label_agreement":null},{"id":"W2589050849","doi":"10.1182/blood.v110.11.2579.2579","title":"First Report of a Phase II Clinical Trial of Lenalidomide Oral Therapy for Peripheral T-Cell Lymphoma.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; University of Ottawa; Dalhousie University; University of Calgary; University of Alberta","funders":"","keywords":"Lenalidomide; Medicine; Internal medicine; Rash; Thalidomide; Gastroenterology; Multiple myeloma; Chemotherapy regimen; Regimen; Neutropenia; Phases of clinical research; Clinical endpoint; Surgery; Chemotherapy; Oncology; Clinical trial","score_opus":0.08000429015003754,"score_gpt":0.4267506636782165,"score_spread":0.34674637352817894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589050849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941956,0.0004976162,0.0006313832,0.00025468122,0.00016529554,0.0023667568,0.000026178395,0.000024533992,0.0018379771],"genre_scores_gemma":[0.99493194,0.0001927862,0.0026617192,0.00010578656,0.00038903693,0.00006140217,0.000045804285,0.000040800627,0.0015707283],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99736524,0.000070522765,0.0012835639,0.00036740268,0.0005299071,0.0003833439],"domain_scores_gemma":[0.99800026,0.00044525348,0.00036971,0.0005022259,0.0004999725,0.00018254881],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021250106,0.00018034522,0.0007950711,0.00012693963,0.00008821017,0.000006730365,0.00014879786,0.00017901261,0.00014166062],"category_scores_gemma":[0.0011130462,0.0001482407,0.0005095485,0.00021192017,0.00027208345,0.00003556458,0.00004804558,0.000100201076,0.0000016458167],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7169106,0.13087857,0.03555431,0.00047472128,0.0012659754,0.0017570787,0.0013583077,0.0000024160545,0.06706041,0.00009006736,0.002154293,0.04249323],"study_design_scores_gemma":[0.81386817,0.035512034,0.0007763934,0.00006342818,0.00022949766,0.0011577302,0.00023703049,0.00013382218,0.13494083,0.00009391584,0.012792332,0.00019483961],"about_ca_topic_score_codex":0.000097280266,"about_ca_topic_score_gemma":0.00006636346,"teacher_disagreement_score":0.096957535,"about_ca_system_score_codex":0.00004040938,"about_ca_system_score_gemma":0.0006566936,"threshold_uncertainty_score":0.60450804},"labels":[],"label_agreement":null},{"id":"W2589057659","doi":"10.1182/blood.v104.11.1479.1479","title":"Bortezomib Demonstrates Superior Efficacy to High-Dose Dexamethasone in Relapsed Multiple Myeloma: Final Report of the APEX Study.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hotel Dieu Hospital","funders":"","keywords":"Medicine; Bortezomib; Hazard ratio; Dexamethasone; Internal medicine; Multiple myeloma; Clinical endpoint; Gastroenterology; Oncology; Randomized controlled trial; Surgery; Confidence interval","score_opus":0.03250827096040593,"score_gpt":0.30562658840310425,"score_spread":0.2731183174426983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589057659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964582,0.00013698958,0.000011546375,0.00071458105,0.00007142906,0.0023747936,0.000017724858,0.000041003284,0.00017375936],"genre_scores_gemma":[0.99498034,0.0000058243254,0.004516275,0.000043477507,0.00005758258,0.0001402986,0.000017718277,0.00003113841,0.00020733303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99782574,0.00010813148,0.0005660211,0.00045657106,0.0005998772,0.00044363414],"domain_scores_gemma":[0.99852085,0.00020853624,0.00010604336,0.0007805238,0.0001199396,0.00026413548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003936684,0.00022726262,0.0004988205,0.0001800212,0.00008941024,0.000016493428,0.00021205127,0.0000914068,0.000035553097],"category_scores_gemma":[0.0016543447,0.00015344616,0.00013626162,0.00065704156,0.00011324212,0.00004444947,0.00012882888,0.00029223438,0.000034420056],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009964975,0.011865319,0.9475824,0.000041133768,0.00030398185,0.0048276954,0.0005892377,0.00009634857,0.031072784,0.000018374449,0.000013854194,0.002592336],"study_design_scores_gemma":[0.040916134,0.0012966539,0.9044977,0.00015088348,0.00017339956,0.00042799267,0.00031282016,0.000011502334,0.052038617,0.00002686749,0.00002330113,0.00012417026],"about_ca_topic_score_codex":0.0018142085,"about_ca_topic_score_gemma":0.0010340256,"teacher_disagreement_score":0.04308478,"about_ca_system_score_codex":0.000094024406,"about_ca_system_score_gemma":0.00043035127,"threshold_uncertainty_score":0.6257353},"labels":[],"label_agreement":null},{"id":"W2589058778","doi":"10.1182/blood.v108.11.5459.5459","title":"Combination High-Dose Cyclophosphamide and Bortezomib Is Safe and Effective for Stem Cell Harvesting in Chemotherapy Refractory Multiple Myeloma.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency","funders":"","keywords":"Medicine; Bortezomib; Cyclophosphamide; Stem cell; Autologous stem-cell transplantation; Multiple myeloma; Melphalan; Surgery; Transplantation; Oncology; Internal medicine; Chemotherapy; Biology","score_opus":0.009514570107209444,"score_gpt":0.25420080630768255,"score_spread":0.2446862362004731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589058778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961078,0.0013451856,0.000043284468,0.00020595573,0.000023198829,0.0017377962,0.000031515527,0.000033792963,0.00047147533],"genre_scores_gemma":[0.996558,0.00014807578,0.0017788173,0.00010267144,0.00005406092,0.0001986047,0.00005711942,0.00003099636,0.0010716247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895626,0.000044214015,0.00020801346,0.00033608938,0.0001676129,0.00028778176],"domain_scores_gemma":[0.9991865,0.00040236,0.00007780669,0.00014859765,0.00006786512,0.00011687301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018133804,0.00016882172,0.0002810679,0.00011733204,0.00008750052,0.0000297722,0.00003274152,0.00009160799,0.000006240557],"category_scores_gemma":[0.000051002553,0.00015016686,0.000035257268,0.00010994628,0.000054905966,0.00010983562,0.000021651558,0.00011953083,0.000003094366],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001030275,0.001856599,0.85811746,0.0003622018,0.0001013138,0.00009241552,0.00030329206,8.9924936e-7,0.037071325,0.00004521213,0.00012653848,0.10089249],"study_design_scores_gemma":[0.038259096,0.00066982093,0.8586515,0.00009455505,0.0000536842,0.000013629349,0.000040422397,0.00039952146,0.1010377,0.00013666278,0.000524231,0.00011915374],"about_ca_topic_score_codex":0.001160589,"about_ca_topic_score_gemma":0.00013930563,"teacher_disagreement_score":0.10077334,"about_ca_system_score_codex":0.000063351246,"about_ca_system_score_gemma":0.000036803853,"threshold_uncertainty_score":0.6123627},"labels":[],"label_agreement":null},{"id":"W2589065286","doi":"10.1182/blood.v110.11.4655.4655","title":"Familial Essential Thrombocythemia Showing Spontaneous Megakaryocyte Colony Formation and Acquired JAK2 Mutations without a Germline Mutation in C-MPL or TPO.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Essential thrombocythemia; Megakaryocyte; Thrombopoietin; Thrombopoietin receptor; Polycythemia vera; Germline mutation; Biology; Mutation; Germline; Genetics; Myeloproliferative Disorders; Immunology; Thrombocytosis; Gene; Platelet; Haematopoiesis; Stem cell","score_opus":0.018356280245539213,"score_gpt":0.2928085827134607,"score_spread":0.2744523024679215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589065286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996778,0.0001714601,0.0007809468,0.00025348522,0.00009110156,0.0009863231,0.000018417999,0.000064168766,0.0008560747],"genre_scores_gemma":[0.9958043,0.000082344035,0.0033431752,0.00018531847,0.0001748533,0.00009169992,0.00017554569,0.000025389092,0.000117391966],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985373,0.000043138098,0.00046840266,0.00029427608,0.0003526566,0.00030424792],"domain_scores_gemma":[0.9992535,0.00020543732,0.000120682314,0.00014944254,0.00013847265,0.00013242943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003177978,0.00021116136,0.00037245452,0.00020352619,0.00013713037,0.000037920952,0.00003947396,0.0001220281,0.000064382366],"category_scores_gemma":[0.00018317784,0.00017016823,0.000057511374,0.00023688997,0.000051679082,0.00022142459,0.000026114463,0.000103729966,0.000014844292],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016828211,0.014580026,0.48812938,0.0012827993,0.0019831695,0.04991743,0.041897632,0.00030846227,0.33851108,0.0020417417,0.0003538861,0.044166192],"study_design_scores_gemma":[0.043323085,0.002818625,0.6017686,0.0007164609,0.0016139351,0.015011129,0.002294118,0.004330811,0.3266971,0.00026431747,0.00047035416,0.00069144793],"about_ca_topic_score_codex":0.000116883064,"about_ca_topic_score_gemma":0.0023674306,"teacher_disagreement_score":0.11363923,"about_ca_system_score_codex":0.00013282799,"about_ca_system_score_gemma":0.00013505347,"threshold_uncertainty_score":0.6939259},"labels":[],"label_agreement":null},{"id":"W2589069501","doi":"10.1182/blood.v110.11.892.892","title":"A Phase I Trial of the Small Molecule Pan-Bcl-2 Family Inhibitor Obatoclax Mesylate (GX15-070) Administered by Continuous Infusion for up to Four Days to Patients with Hematological Malignancies.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Chills; Neutropenia; Internal medicine; Febrile neutropenia; Nausea; Tolerability; Gastroenterology; Adverse effect; Leukemia; Chemotherapy","score_opus":0.029615988848254057,"score_gpt":0.29868314500775756,"score_spread":0.2690671561595035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589069501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991822,0.00009491105,0.0005462207,0.00022191406,0.00024449563,0.0064598774,0.00013896199,0.000049601895,0.00042201488],"genre_scores_gemma":[0.99690896,0.000005343392,0.0010257196,0.0007031662,0.00014182844,0.000287941,0.000043351778,0.000052577176,0.0008311125],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99709386,0.00007271266,0.00071783905,0.0005283755,0.00085527916,0.00073192513],"domain_scores_gemma":[0.9979311,0.00029382968,0.00020039336,0.0006949324,0.00043866478,0.00044107967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060742156,0.00029525286,0.0006895451,0.00011891214,0.00010018606,0.000027966835,0.00034753775,0.00020990371,0.000015839425],"category_scores_gemma":[0.0010739657,0.00018113655,0.0001838765,0.00045854502,0.00011226655,0.000034706198,0.00026401592,0.00018163821,0.00001769637],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5304697,0.031943943,0.0072452654,0.0013853726,0.0010332537,0.0007966378,0.0040094084,0.0000029994512,0.37156546,0.0003182688,0.029644711,0.021584976],"study_design_scores_gemma":[0.6766665,0.01916335,0.001034332,0.00052560214,0.00031373926,0.000084594045,0.00023340156,0.000043864802,0.2954584,0.00001398621,0.00610504,0.00035716468],"about_ca_topic_score_codex":0.000116489915,"about_ca_topic_score_gemma":0.00006235914,"teacher_disagreement_score":0.1461968,"about_ca_system_score_codex":0.0008885055,"about_ca_system_score_gemma":0.0019243285,"threshold_uncertainty_score":0.7386534},"labels":[],"label_agreement":null},{"id":"W2589078350","doi":"10.1182/blood.v118.21.385.385","title":"A Functional In Vivo RNAi screen Involving Jumonji C Domain Containing Candidates Unravels Kdm5b As a Negative Modulator of Hematopoietic Stem Cell Self-Renewal","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer; McMaster University; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Biology; Stem cell; Haematopoiesis; Small hairpin RNA; Hematopoietic stem cell; H3K4me3; Molecular biology; Cell biology; Transplantation; RNA interference; Bone marrow; Cell culture; Gene expression; Gene knockdown; Gene; Genetics; Immunology; RNA; Promoter","score_opus":0.01393246731991403,"score_gpt":0.21398138468981245,"score_spread":0.20004891736989844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589078350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99321985,0.0014353398,0.0005753468,0.0000071688205,0.000053121876,0.0002148463,0.000024901681,0.000011750248,0.0044576474],"genre_scores_gemma":[0.9971254,0.00009295396,0.0023800095,0.000025785415,0.00007100487,0.000023574747,0.000024280034,0.000025132578,0.00023186383],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99883044,0.00009301734,0.00034395375,0.00032843594,0.0001669024,0.00023726783],"domain_scores_gemma":[0.9993552,0.000030737592,0.00018519566,0.00023846555,0.00010147183,0.00008895995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024226091,0.00017512169,0.00021737511,0.000086292894,0.000052342144,0.000012726947,0.00012751063,0.00016345002,0.000045909957],"category_scores_gemma":[0.000021377797,0.00017514419,0.00008119288,0.00012435447,0.000051000876,0.000006594937,0.00009430747,0.000083548526,0.0000044977146],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012114908,0.00037133414,0.050486088,0.000046240115,0.00010477127,0.0000093494655,0.0019291436,0.000040389026,0.94634974,0.00047498505,0.000009942798,0.000056886434],"study_design_scores_gemma":[0.0018502627,0.0004845999,0.0052441023,0.00004130944,0.000045813027,0.000005121467,0.00058149593,0.000044333217,0.9886183,0.0028191723,0.00006548449,0.00020000397],"about_ca_topic_score_codex":0.00033944426,"about_ca_topic_score_gemma":0.0002604094,"teacher_disagreement_score":0.045241985,"about_ca_system_score_codex":0.000015199892,"about_ca_system_score_gemma":0.00013604184,"threshold_uncertainty_score":0.7142173},"labels":[],"label_agreement":null},{"id":"W2589081489","doi":"10.1182/blood.v110.11.3380.3380","title":"Independent and Converging Pathways in Leukemia Stem Cells.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Leukemia; Stem cell; NPM1; Transplantation; Bone marrow; Myeloid leukemia; Biology; Cancer research; Immunology; Minimal residual disease; Myeloid; Molecular biology; Medicine; Gene; Internal medicine; Genetics","score_opus":0.01971435543269155,"score_gpt":0.25893892270037083,"score_spread":0.2392245672676793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589081489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920645,0.00049879664,0.000079128426,0.00008986521,0.00005625075,0.00029275654,0.0000027538795,0.000047551268,0.006868409],"genre_scores_gemma":[0.9983366,0.00011796788,0.00038623795,0.00022779188,0.00010644458,0.000006481531,0.0000032481048,0.00002364824,0.00079153856],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987182,0.000026050107,0.00023749011,0.00026839442,0.0003272252,0.00042261902],"domain_scores_gemma":[0.99937475,0.000107976965,0.00003648176,0.00022755237,0.000042744803,0.00021051677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074417674,0.00011904518,0.00021930417,0.00021916699,0.000036420337,0.000016468448,0.000082828235,0.00013073412,0.000042185835],"category_scores_gemma":[0.000022263946,0.00010807042,0.000031252486,0.0002155038,0.00005864504,0.00005457204,0.00010639283,0.00044380134,0.00005548831],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044592726,0.0005676001,0.46396524,0.0004329941,0.00014861822,0.007819567,0.0031013065,0.0000055129744,0.48695862,0.0009798071,0.00074502634,0.0348298],"study_design_scores_gemma":[0.020438498,0.00039695718,0.25350493,0.0002339012,0.000100102436,0.0007054837,0.002205905,0.00044672762,0.7177742,0.0000916926,0.0037547208,0.0003468405],"about_ca_topic_score_codex":0.00013966468,"about_ca_topic_score_gemma":0.00006366137,"teacher_disagreement_score":0.23081562,"about_ca_system_score_codex":0.00033430225,"about_ca_system_score_gemma":0.00029604632,"threshold_uncertainty_score":0.4406984},"labels":[],"label_agreement":null},{"id":"W2589100168","doi":"10.1182/blood.v114.22.3154.3154","title":"Rate of Inhibitor Development in Hemophilia A Patients Treated with Plasma Derived or Recombinant Factor VIII Concentrates. A Systematic Review of the Literature.","year":2009,"lang":"en","type":"review","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Regimen; Cochrane Library; Internal medicine; Meta-analysis; MEDLINE; Pediatrics","score_opus":0.030551519327932524,"score_gpt":0.2935808058028091,"score_spread":0.26302928647487656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589100168","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03841552,0.9520923,3.0644316e-8,0.00003114376,0.000047043755,0.0092885755,0.000059498834,0.000014762697,0.00005114804],"genre_scores_gemma":[0.0022013066,0.9962236,0.00007482089,0.0000333003,0.000016162623,0.00039355297,0.00024251825,0.000047965314,0.0007667195],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99628794,0.0005844598,0.0017654912,0.0004251031,0.0005437581,0.00039324426],"domain_scores_gemma":[0.99763215,0.0002198383,0.00096951716,0.0006329479,0.00039775294,0.0001477923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034025215,0.0005823298,0.0042589563,0.00022745477,0.000042561165,0.000015680776,0.00028395143,0.0002801281,0.000035125217],"category_scores_gemma":[0.00044714127,0.00023177914,0.00039158043,0.0012708743,0.00008837595,0.000042673553,0.00006312607,0.00041145727,0.000011645828],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000112906826,0.002061755,0.0006847242,0.98625076,0.00080431864,0.00015214791,0.00020102994,4.6219113e-9,0.000008392915,0.0000014407345,0.000029006227,0.009693506],"study_design_scores_gemma":[0.004742824,0.0006833273,0.0002721396,0.9866751,0.0030621255,0.00007688628,0.0000062451086,2.4674964e-7,0.0014818907,4.4715816e-7,0.0027604925,0.0002382774],"about_ca_topic_score_codex":0.000004365038,"about_ca_topic_score_gemma":0.0000068851377,"teacher_disagreement_score":0.04413138,"about_ca_system_score_codex":0.00020232635,"about_ca_system_score_gemma":0.0013927998,"threshold_uncertainty_score":0.9451679},"labels":[],"label_agreement":null},{"id":"W2589121350","doi":"10.1182/blood.v108.11.3304.3304","title":"Time Trends in the Usefulness of Pretest Prediction and D-Dimer Testing for the Diagnosis of Venous Thromboembolism (VTE).","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Integre de Sante et de Services Sociaux de Laval; Hôpital Notre-Dame","funders":"","keywords":"Medicine; D-dimer; Context (archaeology); Venous thromboembolism; Cohort; Pre- and post-test probability; Clinical trial; Internal medicine; Emergency medicine; Pediatrics; Thrombosis","score_opus":0.029252814722890312,"score_gpt":0.2530444774877918,"score_spread":0.22379166276490148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589121350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954418,0.0010774664,0.0000147895435,0.0006074592,0.000060187263,0.000762268,0.00005026114,0.000021467582,0.0019643146],"genre_scores_gemma":[0.99899024,0.0000629291,0.00022106316,0.00010340919,0.00016702761,0.0003616416,0.000024215176,0.000019350076,0.00005011757],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900365,0.00004194742,0.0003488604,0.00018689557,0.00022193759,0.00019672824],"domain_scores_gemma":[0.9987789,0.0006645053,0.00015947028,0.00029942268,0.00007678797,0.000020949326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044493593,0.0001264243,0.00042310642,0.00011503457,0.000083648534,0.000012092852,0.00012484042,0.00006116712,0.00002474933],"category_scores_gemma":[0.000121594974,0.00007611168,0.000076327124,0.00033807097,0.0001345618,0.000049438087,0.000040230843,0.00008674572,9.0696534e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016544767,0.031364996,0.8090601,0.0019551644,0.0016408619,0.000033692028,0.010728316,0.00088840164,0.015786901,0.005739119,0.02489644,0.097740576],"study_design_scores_gemma":[0.002079599,0.0009158301,0.98773617,0.00019412005,0.0013161914,0.000014623817,0.0002786881,0.00040860978,0.00599613,0.00025767888,0.00072179025,0.000080570215],"about_ca_topic_score_codex":0.0005315589,"about_ca_topic_score_gemma":0.0000499398,"teacher_disagreement_score":0.17867608,"about_ca_system_score_codex":0.000009053144,"about_ca_system_score_gemma":0.000019871031,"threshold_uncertainty_score":0.31037444},"labels":[],"label_agreement":null},{"id":"W2589149922","doi":"10.1182/blood.v128.22.1073.1073","title":"A Phase I Study of IDH305 in Patients with Advanced Malignancies Including Relapsed/Refractory AML and MDS That Harbor IDH1R132 Mutations","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Isocitrate dehydrogenase; IDH1; Tolerability; Medicine; Population; Myeloid leukemia; Glioma; Myelodysplastic syndromes; Pharmacology; Cancer research; Internal medicine; Oncology; Adverse effect; Biology; Mutation; Enzyme; Genetics","score_opus":0.019679981470810137,"score_gpt":0.2768842672032304,"score_spread":0.25720428573242027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589149922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99879795,0.00028011447,0.0000030403085,0.000088383495,0.000021792142,0.0007098442,0.000023792756,0.000017847853,0.000057216974],"genre_scores_gemma":[0.99958,0.0000339222,0.00020570814,0.000020386491,0.000008129234,0.00011869985,0.0000061584906,0.000015888672,0.000011103605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99923754,0.00002595473,0.00018218053,0.00020547453,0.00020549998,0.00014334459],"domain_scores_gemma":[0.9994735,0.0000930525,0.00010737757,0.000186928,0.00006981898,0.00006933581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000055738536,0.000119981014,0.00024833062,0.00014009638,0.00004104922,0.0000055688297,0.000031418607,0.000029590214,0.000013734949],"category_scores_gemma":[0.00005884109,0.000069790374,0.000020516218,0.00013492924,0.000043725286,0.0001229654,0.00002949144,0.000040314655,0.000002031443],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029648174,0.023671342,0.96471983,0.000024067069,0.00013912703,0.00007475115,0.0010493635,3.8949167e-7,0.005832637,0.000020730587,0.0000068417457,0.0041644536],"study_design_scores_gemma":[0.08485427,0.0070118317,0.89030874,0.00040044196,0.0003007897,0.0000026883647,0.0006543968,6.915112e-7,0.01632645,0.000013419129,0.000033806922,0.000092456365],"about_ca_topic_score_codex":0.000028689949,"about_ca_topic_score_gemma":0.00004561891,"teacher_disagreement_score":0.08455779,"about_ca_system_score_codex":0.000029591361,"about_ca_system_score_gemma":0.000026722917,"threshold_uncertainty_score":0.2845969},"labels":[],"label_agreement":null},{"id":"W2589156608","doi":"10.1182/blood.v126.23.4113.4113","title":"Human Blood Cell Level of 5-Hydroxymethylcytosine (5hmC) Declines Steadily during Aging and Is Multifactorial","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal; Concordia University; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Epigenetics; 5-Hydroxymethylcytosine; DNA methylation; Biology; Population; Andrology; Physiology; Genetics; Internal medicine; Medicine; Gene; Gene expression","score_opus":0.05498044566411464,"score_gpt":0.2911990732029346,"score_spread":0.23621862753881995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589156608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962574,0.0029046065,0.0001639523,0.000020790223,0.00012912598,0.000109623674,0.00004280489,0.000008499925,0.00036317235],"genre_scores_gemma":[0.997145,0.00012544652,0.0017307537,0.000014198348,0.00052597665,0.0000044000317,0.000039086975,0.000024702023,0.00039044707],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99906874,0.000044727127,0.00026503962,0.00029183406,0.00015019979,0.00017946506],"domain_scores_gemma":[0.99934965,0.000009513913,0.00013322562,0.00026064125,0.00013047007,0.000116488016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019458562,0.00014857354,0.000171868,0.000052226376,0.000062948355,0.000019824514,0.00010559508,0.00014272796,0.0000070593896],"category_scores_gemma":[0.000064089596,0.00014796315,0.000055537188,0.000059823615,0.000050353417,0.000004387883,0.00011316184,0.000065404616,0.0000017198794],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012762816,0.00021341824,0.032861874,0.000041276537,0.00004922596,0.000002106578,0.00018013766,0.000016273963,0.9664656,0.0000042126694,0.000013285018,0.0001398625],"study_design_scores_gemma":[0.0037157424,0.000260491,0.0103795,0.00001215486,0.000101943915,0.0000029914709,0.000047027643,0.000009846713,0.98464966,0.00007609762,0.00057277334,0.00017177037],"about_ca_topic_score_codex":0.00009545215,"about_ca_topic_score_gemma":0.000035049725,"teacher_disagreement_score":0.022482373,"about_ca_system_score_codex":0.0000030689816,"about_ca_system_score_gemma":0.000035477948,"threshold_uncertainty_score":0.6033762},"labels":[],"label_agreement":null},{"id":"W2589157782","doi":"10.1182/blood-2016-10-742437","title":"Ventricular arrhythmias and sudden death in patients taking ibrutinib","year":2017,"lang":"en","type":"letter","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":209,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; CancerCare Manitoba","funders":"National Cancer Institute","keywords":"Ibrutinib; Medicine; Bruton's tyrosine kinase; Food and drug administration; Internal medicine; Cardiology; Ventricular fibrillation; Tyrosine kinase; Pharmacology; Leukemia; Receptor","score_opus":0.027904621790663102,"score_gpt":0.291713119591134,"score_spread":0.2638084978004709,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589157782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95992965,0.001741864,0.0000010941214,0.031108405,0.0002542765,0.0011559653,0.000034197587,0.000049811722,0.0057247356],"genre_scores_gemma":[0.8818285,0.0003477908,0.00044885083,0.097745545,0.010665527,0.00017209194,0.0011722079,0.00031308414,0.007306444],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99741524,0.000074582196,0.00034984373,0.0006145812,0.0008393844,0.00070637104],"domain_scores_gemma":[0.9984018,0.00013726624,0.0002809993,0.0009488473,0.00010350866,0.00012757846],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025058215,0.00032127707,0.00065363175,0.0003001111,0.00009420669,0.000089568144,0.00025645335,0.0007788725,0.000090139685],"category_scores_gemma":[0.00069568236,0.0002821752,0.00011674339,0.000093413306,0.00010309122,0.00006644543,0.00026776988,0.0014651235,0.00008388927],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002579086,0.0010737077,0.21062362,0.0036973679,0.0009510334,0.20946135,0.0003885548,8.119014e-7,0.000009898899,0.000015236407,0.5673498,0.0061706873],"study_design_scores_gemma":[0.16385949,0.0007042313,0.14392978,0.004135782,0.0011332545,0.0042992756,0.0000128994525,0.00015697228,0.0005210013,0.0001310195,0.679966,0.0011503291],"about_ca_topic_score_codex":0.00055866764,"about_ca_topic_score_gemma":0.000007858065,"teacher_disagreement_score":0.20516208,"about_ca_system_score_codex":0.0020993997,"about_ca_system_score_gemma":0.002333046,"threshold_uncertainty_score":0.99996305},"labels":[],"label_agreement":null},{"id":"W2589166858","doi":"10.1182/blood.v108.11.21.21","title":"The Specificity and Isotype of Monoclonal Anti-D Antibodies Dictates Their Ability To Inhibit Opsonized Platelet Phagocytosis.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Opsonin; Monoclonal antibody; Phagocytosis; Isotype; Polyclonal antibodies; Antibody; Molecular biology; Platelet; Biology; Immunoglobulin G; Immunology","score_opus":0.008770320020185147,"score_gpt":0.2232795943996017,"score_spread":0.21450927437941655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589166858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950102,0.00230427,0.000029481413,0.0011188424,0.00005648157,0.00042244777,0.000049781465,0.000041246723,0.0009672275],"genre_scores_gemma":[0.99863535,0.00047732648,0.0006083175,0.000067996945,0.00012699407,0.0000071068475,0.00001471018,0.000015588521,0.000046628906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989521,0.000036376783,0.0003224402,0.00026666175,0.00019005011,0.00023235189],"domain_scores_gemma":[0.9993306,0.0001651925,0.00006083515,0.00026600005,0.000097130316,0.00008029012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002685783,0.00016320705,0.00036418706,0.000044727643,0.00016228385,0.000024835312,0.000077377124,0.00007259011,0.000020445787],"category_scores_gemma":[0.00003550703,0.000097774195,0.00008723709,0.0001658207,0.00017655116,0.000044460918,0.000050712093,0.00013671325,0.0000046997097],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006913977,0.0019168085,0.5516661,0.0001750956,0.0001787664,0.00003243993,0.0005495881,0.0000046380605,0.4376051,0.00082314573,0.00040225676,0.0059546796],"study_design_scores_gemma":[0.0030359097,0.0002929675,0.573409,0.000063147294,0.00011695558,0.00004216869,0.00010918778,0.000022539962,0.42094278,0.00068991585,0.0011677347,0.0001076921],"about_ca_topic_score_codex":0.0002939758,"about_ca_topic_score_gemma":0.000113403716,"teacher_disagreement_score":0.021742932,"about_ca_system_score_codex":0.0000065100257,"about_ca_system_score_gemma":0.000028412382,"threshold_uncertainty_score":0.3987116},"labels":[],"label_agreement":null},{"id":"W2589170784","doi":"10.1182/blood.v120.21.467.467","title":"Amino Acid Substitution At Peptide-Binding Pockets of HLA Class I Molecules Adversely Impacts Hematopoietic Cell Transplantation Outcomes","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Human leukocyte antigen; Transplantation; Medicine; Hematopoietic stem cell transplantation; Graft-versus-host disease; Internal medicine; Hazard ratio; Gastroenterology; Proportional hazards model; Immunology; Antigen; Confidence interval","score_opus":0.011818361722414095,"score_gpt":0.23182430690416414,"score_spread":0.22000594518175004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589170784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886203,0.00955438,0.00011064335,0.000032391046,0.00042149887,0.00020960438,0.00005246349,0.000055898145,0.0009428427],"genre_scores_gemma":[0.99756116,0.0006108589,0.00008749757,0.000048799677,0.000012127054,0.000013331059,0.00016466087,0.000021440821,0.001480154],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998696,0.00024104513,0.00036941248,0.00016859344,0.00005995731,0.00046496256],"domain_scores_gemma":[0.99932945,0.00014174877,0.00021391116,0.0002475342,0.00003943881,0.00002793036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025476742,0.00022214124,0.00032598214,0.00014848684,0.00019730811,0.0000074929117,0.00015530385,0.00024773186,0.00023906064],"category_scores_gemma":[0.000034059463,0.00019328708,0.00017666785,0.000109140514,0.00015752114,0.00023114611,0.000027532336,0.00015813933,0.0004096643],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004031382,0.00051321404,0.046170697,0.000103090446,0.00020655965,0.000004295007,0.0021522741,0.0000012484979,0.95003414,0.00025706246,0.000056982506,0.000097268625],"study_design_scores_gemma":[0.0029907099,0.00013027224,0.13938822,0.000056161818,0.00020413226,0.00020449198,0.00021699117,1.0511979e-7,0.8555945,0.000006880582,0.001025355,0.00018215473],"about_ca_topic_score_codex":0.000027129048,"about_ca_topic_score_gemma":0.0000048905063,"teacher_disagreement_score":0.09443964,"about_ca_system_score_codex":0.000038330654,"about_ca_system_score_gemma":0.0000425925,"threshold_uncertainty_score":0.7882018},"labels":[],"label_agreement":null},{"id":"W2589193943","doi":"10.1182/blood.v118.21.2370.2370","title":"Tif1gamma Is Essential for Macrophage Differentiation","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Biology; Haematopoiesis; Progenitor cell; Stem cell; GATA2; Embryonic stem cell; Bone marrow; Molecular biology; Cell biology; CD34; Cancer research; Immunology; Gene; Genetics","score_opus":0.031413714253844975,"score_gpt":0.28726663881848746,"score_spread":0.2558529245646425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589193943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99020416,0.00012620477,0.0027255204,0.00026635133,0.000106537926,0.0005802807,0.000027291204,0.000066600915,0.0058970647],"genre_scores_gemma":[0.9901415,0.000022220605,0.0038610916,0.00023216385,0.0003427922,0.00006933032,0.000051022205,0.000030221516,0.0052496456],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991817,0.000015683396,0.00014650797,0.00020860753,0.00018833215,0.0002591755],"domain_scores_gemma":[0.9994552,0.000026103506,0.000039010396,0.00026019287,0.00010408575,0.00011539983],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000096880205,0.000094467716,0.00015307288,0.00007801246,0.00005717646,0.000011527002,0.00009324619,0.00009185272,0.0010863945],"category_scores_gemma":[0.00006337102,0.000080342725,0.00009620504,0.00009181568,0.00003693569,0.000048079914,0.000040998162,0.00012024007,0.00017715982],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002345806,0.005395095,0.07240764,0.0011708895,0.0016116423,0.00041505886,0.0065273065,1.0448756e-7,0.8152206,0.0037944948,0.056946903,0.034164462],"study_design_scores_gemma":[0.0094432,0.00047317555,0.070031874,0.000032332413,0.0004206107,0.00006642279,0.00006266648,0.00030619616,0.91482025,0.00051837123,0.0036699635,0.00015495365],"about_ca_topic_score_codex":0.00003901339,"about_ca_topic_score_gemma":0.0000033898245,"teacher_disagreement_score":0.09959964,"about_ca_system_score_codex":0.000032528802,"about_ca_system_score_gemma":0.000083622894,"threshold_uncertainty_score":0.9998267},"labels":[],"label_agreement":null},{"id":"W2589200777","doi":"10.1182/blood.v104.11.4978.4978","title":"Protective Effect of Curcumin in an F1-Hybrid Model of Acute Graft-vs.-Host Disease.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Curcumin; Transplantation; Immune system; Medicine; Immunology; Experimental autoimmune encephalomyelitis; CD8; Spleen; Graft-versus-host disease; Pharmacology; Internal medicine","score_opus":0.0065100881684989195,"score_gpt":0.24103817150204032,"score_spread":0.23452808333354142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589200777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99828017,0.00018627354,0.0009966589,0.000018045503,0.00002126003,0.00030403206,0.00012951675,0.0000044109124,0.0000596133],"genre_scores_gemma":[0.99964905,0.00003469131,0.000113194794,0.000025173867,0.000030458166,0.000049258753,0.00006336851,0.000012496871,0.000022280561],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99930733,0.000042848034,0.00017547602,0.00024126573,0.00008883678,0.00014426715],"domain_scores_gemma":[0.99951464,0.000003933537,0.00007347508,0.00028852012,0.00005773796,0.00006169938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008759334,0.00012279677,0.00018013547,0.000048599784,0.000013737395,0.0000042501233,0.00016330155,0.000060547147,0.0000024670453],"category_scores_gemma":[0.000021624139,0.00010886592,0.00009288806,0.000056052013,0.000060566217,0.000005944013,0.00005758369,0.00006009631,0.0000019619183],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056588906,0.00035221962,0.006114053,0.000048755635,0.00009119498,0.000009911534,0.00005344482,0.0009396815,0.99166375,0.000016422684,0.000007720975,0.00013697738],"study_design_scores_gemma":[0.001754319,0.0018104739,0.0050304923,0.000053437543,0.00009678225,0.0000034759523,0.0000074187255,0.00019986309,0.9906711,0.00025205727,0.000003487672,0.00011711175],"about_ca_topic_score_codex":0.000055874974,"about_ca_topic_score_gemma":0.000023457376,"teacher_disagreement_score":0.0014582542,"about_ca_system_score_codex":0.000005731798,"about_ca_system_score_gemma":0.0000819844,"threshold_uncertainty_score":0.44394234},"labels":[],"label_agreement":null},{"id":"W2589202283","doi":"10.1182/blood.v106.11.5085.5085","title":"Use of Echocardiography in the Diagnosis of Cardiac AL Amyloidosis - An Analysis of \"Presumed\" and \"Endomyocardial Biopsy-Proven\" Disease.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cardiac amyloidosis; Amyloidosis; Internal medicine; Biopsy; Amyloid (mycology); Pathology; AL amyloidosis; Creatinine; Amyloid disease; Cardiology; Gastroenterology; Disease; Immunoglobulin light chain; Amyloid fibril; Immunology","score_opus":0.014297822090528713,"score_gpt":0.2589506151401458,"score_spread":0.24465279304961707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589202283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941225,0.0043102875,0.000009430807,0.00018549958,0.00003290726,0.00036304496,0.0009356734,0.000006430516,0.000034239674],"genre_scores_gemma":[0.99326485,0.0054997094,0.000600518,0.00014017096,0.00005984763,0.00019432942,0.00021614364,0.00002129373,0.0000031194327],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982252,0.00028869504,0.00048276252,0.00044317872,0.0002964259,0.0002637001],"domain_scores_gemma":[0.998463,0.00022152523,0.00026132184,0.0008559791,0.00008562572,0.00011257226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029382762,0.00024188364,0.0006664812,0.00036720996,0.000036934234,0.000017386907,0.00027573504,0.00012268807,0.0000067388164],"category_scores_gemma":[0.00019394164,0.0001925636,0.00080607744,0.0007102929,0.00025128384,0.000020071115,0.00012324327,0.000066505105,3.1709098e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010389018,0.0011004786,0.9750035,0.000023145285,0.0037587334,0.0000022550787,0.00016023572,0.00024874997,0.017617328,0.00002410828,0.00013699374,0.0018205995],"study_design_scores_gemma":[0.00088421535,0.00021616241,0.88368183,0.00001646358,0.00471099,6.662526e-7,0.00017067596,0.000023024048,0.109181516,0.000005753236,0.0009375889,0.0001710931],"about_ca_topic_score_codex":0.00040663604,"about_ca_topic_score_gemma":0.000076329125,"teacher_disagreement_score":0.09156419,"about_ca_system_score_codex":0.000007631153,"about_ca_system_score_gemma":0.00003785412,"threshold_uncertainty_score":0.78525156},"labels":[],"label_agreement":null},{"id":"W2589217902","doi":"10.1182/blood.v120.21.1424.1424","title":"Presence of Minimal Residual Disease by Flow Cytometry After Induction Chemotherapy Is Less Predictive of Overall and Progression-Free Survival Compared to Conventional Prognostic Factors Including Cytogenetic Risk and Age","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Calgary Laboratory Services; Princess Margaret Cancer Centre; University of Calgary","funders":"","keywords":"Medicine; Minimal residual disease; Induction chemotherapy; Immunophenotyping; Acute promyelocytic leukemia; Internal medicine; Oncology; Chemotherapy; Leukemia; Chemotherapy regimen; Myeloid leukemia; Bone marrow; Transplantation; Surgery; Immunology; Flow cytometry; Biology","score_opus":0.033555692717299676,"score_gpt":0.31320657855195855,"score_spread":0.27965088583465886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589217902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99642277,0.0014193961,0.00013238851,0.00017806899,0.000050616785,0.0009968379,0.00076000433,0.000018526169,0.000021402568],"genre_scores_gemma":[0.99769974,0.000110915375,0.0018124549,0.000025729309,0.00013203421,0.00007666029,0.00006451132,0.000027591144,0.000050363073],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981799,0.00013974844,0.00031550968,0.00031699476,0.0007272105,0.00032065055],"domain_scores_gemma":[0.9987518,0.00023560393,0.00014650215,0.00027680493,0.00015826906,0.0004309918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034724432,0.00018703839,0.00037629536,0.00019705042,0.000061738494,0.000014448428,0.00011722708,0.000099068144,0.000042483054],"category_scores_gemma":[0.0005797034,0.00015640762,0.000050006453,0.0002308019,0.0003007544,0.00014133092,0.00025935087,0.00020743695,5.9202455e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022783247,0.0008391933,0.97216064,0.0003325639,0.00023149447,0.00000996801,0.0017597263,0.0000010237126,0.021177886,0.0000026383238,0.0005433632,0.0006631839],"study_design_scores_gemma":[0.0050096717,0.00051118544,0.9551699,0.00029685994,0.00026854,0.000009880466,0.00034310814,0.00012932162,0.038060993,0.00002949156,0.00004051606,0.0001305408],"about_ca_topic_score_codex":0.00005354941,"about_ca_topic_score_gemma":0.0000028438415,"teacher_disagreement_score":0.016990744,"about_ca_system_score_codex":0.000046710466,"about_ca_system_score_gemma":0.00012615656,"threshold_uncertainty_score":0.6378118},"labels":[],"label_agreement":null},{"id":"W2589225088","doi":"10.1182/blood.v120.21.1612.1612","title":"Primary Mediastinal B Cell Lymphoma Treated with CHOP-Like Chemotherapy with or without Rituximab: 5-Year Results of the Mabthera International Trial Group (MInT) Study","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Grand River Hospital","funders":"","keywords":"Rituximab; Medicine; Internal medicine; Diffuse large B-cell lymphoma; International Prognostic Index; Lymphoma; CHOP; Oncology; Chemotherapy; Surgery; Gastroenterology","score_opus":0.012838535536045536,"score_gpt":0.24295674212259233,"score_spread":0.2301182065865468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589225088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99421483,0.00010722068,0.0000044240137,0.00020418726,0.00017459171,0.001964249,0.000042807973,0.000049263454,0.0032384333],"genre_scores_gemma":[0.9972992,0.000034135668,0.00085690664,0.0002282981,0.0004617001,0.00021232708,0.00004408298,0.000050332157,0.00081301556],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981575,0.00008750535,0.0003930338,0.00033389236,0.0007200335,0.00030804682],"domain_scores_gemma":[0.99882764,0.000107238615,0.00028454568,0.0005113853,0.00011759222,0.00015159414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000247332,0.00029295147,0.0005146631,0.00007702355,0.00006926238,0.000022087426,0.00019573589,0.00007284818,0.00008721457],"category_scores_gemma":[0.000020823005,0.00013411188,0.000098626086,0.00022661372,0.00011871599,0.00010494067,0.000044513843,0.00007770503,0.000013975414],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14793353,0.05739894,0.7879926,0.00002981294,0.0010617544,0.00006954398,0.0015340674,2.1314324e-7,0.00027909508,0.0000057442817,0.0002290643,0.0034656173],"study_design_scores_gemma":[0.4814553,0.0068967263,0.50348747,0.00012425246,0.0008235524,0.00015011724,0.00037394214,0.0000029931534,0.005717781,5.381735e-7,0.0008204938,0.00014685497],"about_ca_topic_score_codex":0.00028957054,"about_ca_topic_score_gemma":0.00009228441,"teacher_disagreement_score":0.33352178,"about_ca_system_score_codex":0.00014249732,"about_ca_system_score_gemma":0.00022406889,"threshold_uncertainty_score":0.54689234},"labels":[],"label_agreement":null},{"id":"W2589225965","doi":"10.1182/blood.v126.23.5290.5290","title":"Management of T-Cell Large Granular Lymphocyte Leukemia with Methotrexate or Cyclophosphamide","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and Retrovirus Studies","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Victoria Hospital; London Health Sciences Centre","funders":"","keywords":"Methotrexate; Cyclophosphamide; Medicine; Prednisone; Internal medicine; Leukemia; Gastroenterology; Lymphoproliferative disorders; Chemotherapy; Acute lymphocytic leukemia; Immunology; Surgery; Lymphoma","score_opus":0.013326618020678702,"score_gpt":0.22398561977674283,"score_spread":0.21065900175606414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589225965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96037805,0.01733282,0.00019583362,0.000024105691,0.00032527317,0.0002604106,0.000038792325,0.00008100057,0.0213637],"genre_scores_gemma":[0.9744415,0.0012290784,0.0016630492,0.000060280676,0.00001675107,0.000026269616,0.00002709233,0.000023304394,0.022512643],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99899477,0.00008304688,0.00022927325,0.0002616761,0.000058468613,0.00037277176],"domain_scores_gemma":[0.9994447,0.000032991004,0.00012667269,0.000294047,0.00006820238,0.00003333819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022612333,0.00019338312,0.00034127486,0.00005485427,0.00010150924,0.0000048341935,0.00019596804,0.000117686664,0.000083501145],"category_scores_gemma":[0.0000074235313,0.00011922266,0.00006601613,0.00016783092,0.00014438712,0.00003669717,0.00015311534,0.000107618,0.00025962223],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013358368,0.010086121,0.09246488,0.002354518,0.014603488,0.0037345984,0.010856685,0.00016438906,0.80832374,0.008177165,0.020243902,0.01563212],"study_design_scores_gemma":[0.0266146,0.00090203027,0.0033532348,0.00012215677,0.00094796997,0.00010677395,0.002142445,0.0000010176772,0.8496597,0.00012957213,0.11561012,0.00041041325],"about_ca_topic_score_codex":0.00012452372,"about_ca_topic_score_gemma":0.00003433772,"teacher_disagreement_score":0.09536622,"about_ca_system_score_codex":0.000043242544,"about_ca_system_score_gemma":0.0000976638,"threshold_uncertainty_score":0.48617592},"labels":[],"label_agreement":null},{"id":"W2589247971","doi":"10.1182/blood.v128.22.2617.2617","title":"Bleeding in Patients with Atrial Fibrillation Treated with Different Doses of Direct Oral Anticoagulants and Vitamin K Antagonists: A Population-Based Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Dabigatran; Rivaroxaban; Apixaban; Atrial fibrillation; Gastrointestinal bleeding; Population; Stroke (engine); Edoxaban; Internal medicine; Warfarin; Hazard ratio; Incidence (geometry); Randomized controlled trial; Confidence interval","score_opus":0.022392409877515933,"score_gpt":0.27406637095661684,"score_spread":0.2516739610791009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589247971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988645,0.000014568561,0.000015262833,0.00007404323,0.000022294886,0.0009324269,0.00001163938,0.000033171153,0.00003212499],"genre_scores_gemma":[0.9996876,0.0000037741831,0.00011096162,0.00000331762,0.0000939141,9.471372e-7,0.000041939642,0.000015707183,0.000041853767],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990588,0.00005181056,0.0002661321,0.00021130191,0.00028236822,0.00012959426],"domain_scores_gemma":[0.9994938,0.00012985809,0.00014777477,0.0001279656,0.00005654261,0.00004406055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008582598,0.00014375254,0.00042374848,0.00019236527,0.00003639554,0.000014060779,0.000022518716,0.0000336599,0.000011634245],"category_scores_gemma":[0.00005435512,0.00007462021,0.000037335336,0.00019240328,0.0000214323,0.00008813873,0.000014897012,0.000022222495,4.558004e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022685947,0.0000928254,0.99598,0.000035411336,0.00018130829,0.0000043376363,0.000047023408,0.000016100317,0.00022540317,0.0000064058254,6.162006e-7,0.0011419368],"study_design_scores_gemma":[0.029348465,0.0017039065,0.9673695,0.00020966415,0.00049920345,3.6573786e-7,0.00003704691,0.000037557176,0.00067792146,0.0000018724674,0.000004080902,0.00011040431],"about_ca_topic_score_codex":0.00013309605,"about_ca_topic_score_gemma":0.00010420548,"teacher_disagreement_score":0.028610524,"about_ca_system_score_codex":0.00002745235,"about_ca_system_score_gemma":0.00001437329,"threshold_uncertainty_score":0.30429238},"labels":[],"label_agreement":null},{"id":"W2589281829","doi":"10.1182/blood.v128.22.2563.2563","title":"Installing FVIII-Specific Tolerance in Hemophilia Via Engagement of the Aryl Hydrocarbon Receptor By Tryptophan Derivatives","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Aryl hydrocarbon receptor; Chemistry; Tryptophan; Immune tolerance; In vivo; Receptor; Transcription factor; Pharmacology; Immunology; Antigen; Biology; Biochemistry; Amino acid; Gene","score_opus":0.010000251310035272,"score_gpt":0.21924602998918796,"score_spread":0.2092457786791527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589281829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949306,0.003164298,0.0011047419,0.00011741837,0.00009412806,0.00015551301,0.000012116947,0.000003864185,0.0004172947],"genre_scores_gemma":[0.99819416,0.0011845845,0.00034702665,0.000024794203,0.00008150852,0.000015262725,0.000011353846,0.00001343121,0.00012790387],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992425,0.000063442625,0.00021642091,0.00022602674,0.0001111109,0.0001404852],"domain_scores_gemma":[0.9995607,0.000017471102,0.000097847966,0.00026806537,0.000028868995,0.000027015325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016217913,0.00010278728,0.00010341105,0.000020932477,0.00003818272,0.0000054787997,0.00016138055,0.00007933081,0.00001383501],"category_scores_gemma":[0.000035851783,0.00006824023,0.000051947536,0.000087582,0.00005866849,0.0000030853273,0.00007043994,0.000051359384,0.0000022896281],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018337472,0.0001331772,0.012390479,0.0000074600553,0.000013956982,1.8369354e-7,0.0000625648,0.0000139201575,0.9835873,0.00002625759,0.000030923977,0.0037154262],"study_design_scores_gemma":[0.0008915185,0.000073636504,0.007928978,0.000038299855,0.00000440955,1.9835291e-7,0.000012952473,0.0000060517596,0.9826183,0.00022104573,0.008104883,0.000099736244],"about_ca_topic_score_codex":0.0000055018654,"about_ca_topic_score_gemma":0.000007753585,"teacher_disagreement_score":0.008073959,"about_ca_system_score_codex":0.000008117004,"about_ca_system_score_gemma":0.000017863998,"threshold_uncertainty_score":0.27827558},"labels":[],"label_agreement":null},{"id":"W2589347345","doi":"10.1182/blood.v112.11.892.892","title":"The SH2-B Adaptor Protein Negatively Regulates EPO-Dependent Signalling Via Interaction with Erythropoietin Receptor Ptyr-343","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Erythropoietin; Erythropoietin receptor; Signal transducing adaptor protein; Erythropoiesis; SH2 domain; Cell biology; STAT5; Biology; Haematopoiesis; Signal transduction; Janus kinase 2; Chemistry; Tyrosine phosphorylation; Internal medicine; Endocrinology; Stem cell; Anemia; Medicine","score_opus":0.021499278291538842,"score_gpt":0.2402855583950254,"score_spread":0.21878628010348658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589347345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940574,0.00025912185,0.0013152644,0.0016783011,0.00020896624,0.00080425985,0.000012123533,0.00016211225,0.0015024319],"genre_scores_gemma":[0.99404424,0.00006978323,0.0025493088,0.000088489345,0.00056479423,0.00013261575,0.00002329006,0.000053587595,0.002473886],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984152,0.00008196465,0.0003967969,0.00036355818,0.00042096942,0.0003215229],"domain_scores_gemma":[0.99886703,0.00015648593,0.00023962489,0.00031567388,0.00028192048,0.00013926419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002005307,0.00024185295,0.00027190498,0.00008595938,0.00060190895,0.00005268838,0.00011924585,0.00008449721,0.00033850985],"category_scores_gemma":[0.00013174178,0.00015284221,0.00013150151,0.0002069251,0.00016536629,0.00018414024,0.0000385857,0.000474193,0.00011560198],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008159715,0.00078359165,0.00062444,0.000033381435,0.0003240436,0.000081090795,0.0007525198,0.00004683258,0.9939111,0.000102278136,0.0010705388,0.0014542444],"study_design_scores_gemma":[0.0024002965,0.0015115567,0.0009995757,0.0005125787,0.0001666708,0.0007753287,0.00077254826,0.0003147297,0.98092264,0.000046814792,0.011327263,0.00025000892],"about_ca_topic_score_codex":0.00019252564,"about_ca_topic_score_gemma":0.00004959426,"teacher_disagreement_score":0.012988439,"about_ca_system_score_codex":0.00008396141,"about_ca_system_score_gemma":0.0001456829,"threshold_uncertainty_score":0.6232725},"labels":[],"label_agreement":null},{"id":"W2589374434","doi":"10.1182/blood.v104.11.2250.2250","title":"Adult Recipients of Matched Related Donor Blood Cell Transplants (BCT) Given Pretransplant Low-Dose Antithymocyte Globulin (ATG) Have Less Chronic Graft-Versus-Host Disease (cGVHD) and Transplant-Related Mortality (TRM): A Matched Pair Analysis.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre","funders":"","keywords":"Medicine; Thymoglobulin; Internal medicine; Gastroenterology; Cumulative incidence; Graft-versus-host disease; Surgery; Refractory (planetary science); Transplantation; Folinic acid; Chemotherapy; Tacrolimus","score_opus":0.013364698308881127,"score_gpt":0.24575685989140625,"score_spread":0.23239216158252513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589374434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922375,0.0015020755,0.00051599013,0.00029050282,0.00026290416,0.002189002,0.0022491554,0.00031577513,0.0004370699],"genre_scores_gemma":[0.99335766,0.003398748,0.0005839308,0.000049697872,0.00005472204,0.0000942163,0.0021899012,0.00013472654,0.0001364135],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9938574,0.00029883592,0.002095559,0.0014602971,0.0012211053,0.0010668358],"domain_scores_gemma":[0.99674976,0.00021828219,0.0006128833,0.0011250228,0.00028243422,0.0010116308],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00059294485,0.0009592639,0.0019470858,0.00060655177,0.00019758442,0.000052849275,0.0004219241,0.0007011413,0.00018781444],"category_scores_gemma":[0.000031749023,0.00091569417,0.00079112896,0.0013264798,0.00041138072,0.00030117505,0.000027628961,0.0007329485,0.00004124299],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010539327,0.010447443,0.78386974,0.012853633,0.01695012,0.0067221024,0.0123202875,0.001203969,0.14483507,0.00017827394,0.000009686861,0.0000703408],"study_design_scores_gemma":[0.084665895,0.0011612093,0.6554098,0.0042627025,0.05479308,0.00037095495,0.0003940584,0.0007507081,0.19687748,0.000116097726,0.0000033163049,0.0011946687],"about_ca_topic_score_codex":0.001053176,"about_ca_topic_score_gemma":0.0009324423,"teacher_disagreement_score":0.1284599,"about_ca_system_score_codex":0.00015003297,"about_ca_system_score_gemma":0.00056435104,"threshold_uncertainty_score":0.9993294},"labels":[],"label_agreement":null},{"id":"W2589413304","doi":"10.1182/blood.v110.11.1674.1674","title":"Risk of Acute Leukemia Post-Autologous Stem Cell Tranplant (ASCT) for Hodgkin’s Lymphoma (HL) Depends on Choice of Salvage Chemotherapy and Use of Radiation.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Etoposide; Salvage therapy; Internal medicine; Gemcitabine; Oncology; Cytarabine; Chemotherapy; Melphalan; Surgery; Chemotherapy regimen; Regimen","score_opus":0.011712078419037293,"score_gpt":0.25002451767656697,"score_spread":0.23831243925752968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589413304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99735016,0.0009801368,0.0000706264,0.000057157406,0.000044516422,0.00064351363,0.0006664025,0.000018937842,0.00016853676],"genre_scores_gemma":[0.9971672,0.0011984902,0.0012343238,0.00018075174,0.00003864966,0.000021852595,0.00006369404,0.000026713555,0.000068297755],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99888194,0.000027161312,0.00043778797,0.00023459598,0.000211565,0.00020693688],"domain_scores_gemma":[0.9985408,0.0006139286,0.0003526681,0.00029128898,0.00010331097,0.00009796676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017487397,0.00018014088,0.000521587,0.00013552608,0.000030940908,0.0000051151205,0.00006103872,0.00013624251,0.000008875117],"category_scores_gemma":[0.000022919206,0.00014084796,0.0001705699,0.00009958003,0.000055359127,0.000047468493,0.000009920668,0.000035356974,9.113388e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035926318,0.0070311637,0.6180428,0.0005951296,0.0031382053,0.00012097406,0.0014532106,0.000013641804,0.07072798,0.00017991067,0.00040048352,0.29470384],"study_design_scores_gemma":[0.015152368,0.0016372763,0.48906022,0.000059535407,0.0009725024,0.000023860664,0.000029367695,0.000022975055,0.49264312,0.0000043667833,0.00032624585,0.00006816285],"about_ca_topic_score_codex":0.00057071913,"about_ca_topic_score_gemma":0.00004295922,"teacher_disagreement_score":0.42191514,"about_ca_system_score_codex":0.000085774445,"about_ca_system_score_gemma":0.00012413607,"threshold_uncertainty_score":0.5743613},"labels":[],"label_agreement":null},{"id":"W2589417532","doi":"10.1182/blood.v116.21.745.745","title":"3D Telomere Dynamics In Hodgkin's Lymphoma","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Université de Sherbrooke","funders":"","keywords":"ABVD; Nodular sclerosis; Medicine; Telomere; Lymphoma; Biopsy; Internal medicine; Pathology; Gastroenterology; Oncology; Chemotherapy; Cyclophosphamide; Biology; Hodgkin lymphoma","score_opus":0.006895547528057508,"score_gpt":0.23569904952441112,"score_spread":0.2288035019963536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589417532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842983,0.00017984888,0.00001553333,0.0005398823,0.00037997696,0.00023922019,0.000013870349,0.000123295,0.014210068],"genre_scores_gemma":[0.99529725,0.00006530621,0.0029137859,0.00043322679,0.000273054,0.000017275419,0.00003146178,0.00003706692,0.0009315687],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986727,0.000022379583,0.00028408525,0.00034351723,0.0002697106,0.00040759594],"domain_scores_gemma":[0.999094,0.0000613214,0.00006104649,0.000519441,0.00006331257,0.00020087743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016687872,0.00019502913,0.00032849412,0.0002092178,0.00005433849,0.000022340138,0.00016706447,0.00020021618,0.00022205034],"category_scores_gemma":[0.00017441755,0.00017685785,0.00007817195,0.0003853518,0.00010690897,0.00008269854,0.000050173006,0.0003179918,0.00015889708],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012595898,0.002507975,0.8420343,0.00015396245,0.00007612353,0.0010508157,0.00043687658,5.824844e-7,0.036971807,0.003362697,0.00037092547,0.112908006],"study_design_scores_gemma":[0.011714062,0.0003540183,0.949035,0.00016820231,0.00019688648,0.0011672168,0.0005096475,0.001081155,0.020431757,0.00037101045,0.014349967,0.00062111067],"about_ca_topic_score_codex":0.00024922166,"about_ca_topic_score_gemma":0.001539883,"teacher_disagreement_score":0.112286896,"about_ca_system_score_codex":0.00005374656,"about_ca_system_score_gemma":0.00016362862,"threshold_uncertainty_score":0.72120535},"labels":[],"label_agreement":null},{"id":"W2589429206","doi":"10.1182/blood.v112.11.1222.1222","title":"Effect of Normal Variation in Factor VIII Pharmacokinetics on Prophylactic Dosing Requirements in Severe Classical Hemophilia.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Dosing; Pharmacokinetics; Regimen; Percentile; Trough level; Internal medicine; Gastroenterology; Transplantation","score_opus":0.03299890332781334,"score_gpt":0.32593877824434847,"score_spread":0.2929398749165351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589429206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976346,0.000043853535,0.0000017059529,0.0002459972,0.000060179726,0.0007348356,0.0000051226943,0.000015954447,0.0012577341],"genre_scores_gemma":[0.9993913,0.000047689922,0.000083196726,0.000025568523,0.00009155779,0.000024076793,0.000012503925,0.000016675911,0.0003074212],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861866,0.00014876088,0.00027935975,0.00021863224,0.0004599578,0.000274654],"domain_scores_gemma":[0.99951875,0.00013973592,0.000054721426,0.00016335727,0.000034917462,0.0000885346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019354219,0.00014238319,0.00030250053,0.00024562102,0.000032963304,0.000004395422,0.000060076567,0.00010142828,0.00006328976],"category_scores_gemma":[0.000116683936,0.00010556982,0.000058960784,0.00032643773,0.00005095086,0.00007274579,0.000028533517,0.000281115,0.000023230445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002718878,0.0043317205,0.6622573,0.00054199377,0.00013987164,0.001408969,0.0007747273,0.000019620646,0.32197708,0.000009318123,0.000017653196,0.0058028516],"study_design_scores_gemma":[0.025637116,0.005150335,0.5120997,0.0002628583,0.0001565608,0.000108074775,0.0000052331434,0.00051574904,0.4558844,0.0000085153815,0.000024453855,0.00014704699],"about_ca_topic_score_codex":0.000022380418,"about_ca_topic_score_gemma":0.0000025863972,"teacher_disagreement_score":0.15015766,"about_ca_system_score_codex":0.00010885612,"about_ca_system_score_gemma":0.00009204564,"threshold_uncertainty_score":0.43050125},"labels":[],"label_agreement":null},{"id":"W2589446847","doi":"10.1182/blood.v108.11.3501.3501","title":"Diagnostic Evaluation of t[4;14] in Multiple Myeloma.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Multiple myeloma; Bone marrow; Flow cytometry; Biology; Gold standard (test); Pathology; Medicine; Molecular biology; Immunology; Internal medicine","score_opus":0.040885278424064725,"score_gpt":0.3205290946531306,"score_spread":0.27964381622906587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589446847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934579,0.0007874773,0.0000075333264,0.000078076584,0.000022796137,0.00066402124,0.000011107516,0.000015874402,0.004955229],"genre_scores_gemma":[0.99914217,0.000018846446,0.000449846,0.000008398945,0.000061440165,0.000097463686,0.0000830888,0.00001023256,0.00012849567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988377,0.00007317765,0.00020089316,0.00014776565,0.0005504014,0.00019003393],"domain_scores_gemma":[0.999268,0.00028632052,0.0000405502,0.00018631657,0.00016211043,0.000056687644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003304624,0.000076041826,0.00016476857,0.00013492402,0.00001870834,0.0000040631626,0.0000387287,0.000046137895,0.00012400161],"category_scores_gemma":[0.0013911154,0.00006424661,0.000044593315,0.0001847205,0.00003449544,0.00003693679,0.000017156392,0.00006738237,0.000044999193],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059578815,0.0020555537,0.98222846,0.00004370058,0.00004303061,0.00008112213,0.00003269203,0.000031908734,0.0062466078,0.00003400861,0.00009238428,0.009050928],"study_design_scores_gemma":[0.015369577,0.00015070809,0.94849396,0.00008026567,0.00014989794,0.000013966963,0.000015695074,0.001253773,0.034138,0.00023450267,0.00005154338,0.000048127287],"about_ca_topic_score_codex":0.000703142,"about_ca_topic_score_gemma":0.0005519827,"teacher_disagreement_score":0.033734545,"about_ca_system_score_codex":0.000045373097,"about_ca_system_score_gemma":0.00011294445,"threshold_uncertainty_score":0.2619901},"labels":[],"label_agreement":null},{"id":"W2589457544","doi":"10.1182/blood.v126.23.5008.5008","title":"Morphologic Evolution in Post-Transplant Lymphoproliferative Disorders (PTLD): A Clinicopathologic Case Series","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Alberta","funders":"","keywords":"Lymphoproliferative disorders; Pathology; Medicine; Plasmacytoma; Lymphoma; Internal medicine; Multiple myeloma","score_opus":0.01794304025019674,"score_gpt":0.2689907028334592,"score_spread":0.2510476625832625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589457544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925445,0.0019716765,0.000047219848,0.0013608697,0.00016080527,0.00048616726,0.000056326582,0.000112200374,0.0032602332],"genre_scores_gemma":[0.99834555,0.00030046958,0.00024416723,0.0006949327,0.00005836022,0.000081768485,0.00006305428,0.00001954066,0.00019217852],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863493,0.00012411366,0.00032483257,0.00034478054,0.00020066599,0.00037065262],"domain_scores_gemma":[0.9993887,0.000029411283,0.00009679986,0.00020871843,0.000107474145,0.00016890712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035958,0.00020097045,0.00035888198,0.00013398576,0.000069213755,0.0000152099965,0.00006622333,0.00021179205,0.000037119906],"category_scores_gemma":[0.00024662365,0.00016542966,0.00010075834,0.00031273626,0.00011972325,0.00014533337,0.000024261086,0.0002069883,0.00004338762],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016787469,0.0022276735,0.9740505,0.000054962424,0.00010371293,0.014526762,0.004134571,0.00009145104,0.0014907467,0.0003710705,0.00037295927,0.00089680264],"study_design_scores_gemma":[0.15755412,0.02557906,0.6384149,0.0005707291,0.00234028,0.08415526,0.067003995,0.00046484187,0.0020996642,0.01818148,0.0010318605,0.0026037677],"about_ca_topic_score_codex":0.00079793256,"about_ca_topic_score_gemma":0.0025177829,"teacher_disagreement_score":0.3356356,"about_ca_system_score_codex":0.00016662474,"about_ca_system_score_gemma":0.0003784877,"threshold_uncertainty_score":0.67460257},"labels":[],"label_agreement":null},{"id":"W2589488562","doi":"10.1182/blood.v124.21.2650.2650","title":"The Cost-Effectiveness of Clinical Genomic Tests to Aid CR1 Treatment Decisions in Intermediate-Risk AML","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"NPM1; Medicine; Guideline; Oncology; Myeloid leukemia; Internal medicine; Intensive care medicine; Biology","score_opus":0.05482478339056106,"score_gpt":0.4015646334241789,"score_spread":0.34673985003361785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589488562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99690753,0.00013071709,0.00017371577,0.00021297562,0.00014013368,0.0014724738,0.000019044357,0.000019531635,0.00092384865],"genre_scores_gemma":[0.998191,0.0006137906,0.00053097,0.000070865884,0.00019244131,0.00023696735,0.000009928257,0.000026208068,0.00012781168],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978081,0.0007226488,0.00054607244,0.00032616663,0.00025455432,0.0003424855],"domain_scores_gemma":[0.99140286,0.007452702,0.00009792516,0.00067766494,0.000107632244,0.00026122635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025322135,0.0001447374,0.0005141472,0.00013377247,0.000064767315,0.000013193381,0.0002520858,0.00011386922,0.000016565262],"category_scores_gemma":[0.0062415786,0.00008596568,0.00015129066,0.00024419063,0.00014788662,0.000022400855,0.00016094325,0.0003215865,0.00018716292],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015150507,0.0014629959,0.7509395,0.00001859942,0.00018583723,0.000050781033,0.00017928405,0.000022923381,0.0046535144,0.000074066455,0.00018488403,0.24071257],"study_design_scores_gemma":[0.0119951535,0.0026835804,0.9712738,0.00015280966,0.00012796353,0.00001725257,0.00005065329,0.00021498762,0.006744706,0.00012370871,0.0065335636,0.000081826925],"about_ca_topic_score_codex":0.0002717924,"about_ca_topic_score_gemma":0.00041539417,"teacher_disagreement_score":0.24063075,"about_ca_system_score_codex":0.00022052242,"about_ca_system_score_gemma":0.00037860373,"threshold_uncertainty_score":0.74722034},"labels":[],"label_agreement":null},{"id":"W2589502557","doi":"10.1182/blood.v126.23.1109.1109","title":"Risk Factors for Neonatal Thrombosis in the Neonatal Intensive Care Unit -a Case Control Study","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Neonatal intensive care unit; Thrombosis; Pediatrics; Gestational age; Incidence (geometry); Venous thrombosis; Logistic regression; Intensive care unit; Emergency medicine; Intensive care medicine; Pregnancy; Surgery; Internal medicine","score_opus":0.0636548523386627,"score_gpt":0.3188692461576287,"score_spread":0.255214393818966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589502557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959437,0.00033639246,0.00046565317,0.00025786596,0.00022391643,0.0023406371,0.000271677,0.00005926152,0.000100875855],"genre_scores_gemma":[0.9988563,0.0000034463635,0.0001435101,0.00064780057,0.00012061426,0.00012593741,0.00005378283,0.000030771163,0.000017842205],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9985939,0.00019932403,0.00029055006,0.0003040745,0.00033961795,0.00027253083],"domain_scores_gemma":[0.99828565,0.00032155451,0.00011053945,0.00041418802,0.00070759794,0.00016047251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038341573,0.00021721964,0.000409632,0.00012245917,0.00012710078,0.00003443347,0.00014490008,0.00010418084,0.000029299947],"category_scores_gemma":[0.0007240986,0.00014466328,0.00012750868,0.00023801735,0.000045459667,0.00008497227,0.000038968126,0.00026801834,0.000013024738],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003916164,0.0014205249,0.7734382,0.000060682072,0.001110764,0.0017806137,0.2171591,0.000031184696,0.00015347709,0.0007246844,0.00022988887,0.0034992364],"study_design_scores_gemma":[0.03681339,0.0034726947,0.15324266,0.000035968813,0.002424855,0.00075867877,0.8003298,0.00023788956,0.0016734826,0.0002695883,0.00045676736,0.00028422297],"about_ca_topic_score_codex":0.00059109693,"about_ca_topic_score_gemma":0.0009365526,"teacher_disagreement_score":0.62019557,"about_ca_system_score_codex":0.000028706432,"about_ca_system_score_gemma":0.00010582538,"threshold_uncertainty_score":0.58991975},"labels":[],"label_agreement":null},{"id":"W2589537887","doi":"10.1182/blood.v108.11.348.348","title":"Pathology the Gold Standard – A Retrospective Analysis of Discordant “Second-Opinion” Lymphoma Pathology and Its Impact on Patient Care.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lymphoma; Surgical pathology; Retrospective cohort study; Anatomical pathology; Pathological; Pathology; Clinical pathology; Immunohistochemistry","score_opus":0.006002989227844861,"score_gpt":0.2594789498924781,"score_spread":0.25347596066463324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589537887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99316525,0.003938101,0.0000024572937,0.00017393469,0.000078315796,0.0004007869,0.00067189586,0.000018983237,0.0015502877],"genre_scores_gemma":[0.9993108,0.00024743492,0.000043367294,0.0001225336,0.00005176238,0.00006846387,0.00011312697,0.000014557522,0.00002799021],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876004,0.000092792914,0.00030949718,0.00036094154,0.00022967922,0.00024703573],"domain_scores_gemma":[0.9991284,0.000114081115,0.0001793487,0.0003758558,0.0001299987,0.00007232126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000086835724,0.00020914094,0.00064045936,0.00019879235,0.000062646366,0.000011932219,0.00005678197,0.000070876835,0.00006808017],"category_scores_gemma":[0.00003668777,0.00011373693,0.0002812368,0.00034582257,0.00009588888,0.000025444282,0.00004894437,0.00005318252,0.000003824218],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000539864,0.0028702572,0.98016655,0.000042175037,0.0026910636,0.001499104,0.0015204151,0.000024594454,0.0017749176,0.002923419,0.0003477235,0.0055999183],"study_design_scores_gemma":[0.005085185,0.0048558353,0.97421294,0.00003497895,0.0023456009,0.000289992,0.00025676223,0.000015758527,0.01253097,0.000091228925,0.00017187615,0.00010885083],"about_ca_topic_score_codex":0.00013565274,"about_ca_topic_score_gemma":0.00015535396,"teacher_disagreement_score":0.010756053,"about_ca_system_score_codex":0.00018620498,"about_ca_system_score_gemma":0.00008818983,"threshold_uncertainty_score":0.46380574},"labels":[],"label_agreement":null},{"id":"W2589546648","doi":"10.1182/blood.v104.11.4610.4610","title":"Impaired Clonogenic Capacity Contributes to Bone Marrow Hypoplasia and Late Hematological Recovery after Zevalin in the Low-Grade NHL Patients.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bone marrow; Clonogenic assay; Medicine; Erythropoietin; Granulocyte colony-stimulating factor; Peripheral blood mononuclear cell; Haematopoiesis; Erythropoiesis; Pathology; Internal medicine; Anemia; Stem cell; Biology; Chemotherapy; Cell culture; In vitro","score_opus":0.015220309839231224,"score_gpt":0.24859090921058571,"score_spread":0.2333705993713545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589546648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99569374,0.0009794855,0.000009994977,0.0020074632,0.00005743105,0.0010881929,0.00003267485,0.00003804663,0.000092951814],"genre_scores_gemma":[0.9979564,0.00008206661,0.000318398,0.0013407052,0.00005317753,0.00015430803,0.000021536503,0.000020131289,0.0000532541],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981333,0.00012631831,0.00037830655,0.00039193398,0.000419001,0.0005511141],"domain_scores_gemma":[0.9990272,0.00024321761,0.000049486025,0.0004161088,0.00007236644,0.00019164187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005201733,0.00020131348,0.0004294693,0.00012816819,0.000057089463,0.00004240131,0.00014438832,0.00018655465,0.000029490822],"category_scores_gemma":[0.0006595152,0.00013273094,0.00010419609,0.00035189686,0.00015135515,0.00006419367,0.00011586254,0.0003060151,0.00007236895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019235464,0.032003507,0.87236273,0.0026618196,0.0017578019,0.01504339,0.010003937,0.00015347188,0.03583594,0.0014362198,0.004325518,0.005180214],"study_design_scores_gemma":[0.17176268,0.0021541524,0.77160037,0.0007802758,0.0004280035,0.0018136583,0.00022025747,0.00012269523,0.045148678,0.0045609423,0.00079277204,0.000615534],"about_ca_topic_score_codex":0.00033987119,"about_ca_topic_score_gemma":0.00024548263,"teacher_disagreement_score":0.15252721,"about_ca_system_score_codex":0.0015174631,"about_ca_system_score_gemma":0.0007760619,"threshold_uncertainty_score":0.5412611},"labels":[],"label_agreement":null},{"id":"W2589560953","doi":"10.1182/blood.v120.21.3536.3536","title":"Combination of Dexamethasone and Asparaginase Induces Prothrombotic State in Children Receiving Multiagent Chemotherapy for Acute Lymphoblastic Leukemia","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; McMaster Children's Hospital","funders":"","keywords":"Medicine; Dexamethasone; Concomitant; Internal medicine; Asparaginase; Chemotherapy; Gastroenterology; Antithrombin; Oncology; Immunology; Surgery; Leukemia; Lymphoblastic Leukemia; Heparin","score_opus":0.015939741657237418,"score_gpt":0.29639713637797516,"score_spread":0.2804573947207377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589560953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956054,0.00042328946,0.001598432,0.00010514011,0.000041888437,0.0021287277,0.00001988945,0.000033213484,0.00004399482],"genre_scores_gemma":[0.9933548,0.00018875343,0.0059423717,0.0000806786,0.000066790366,0.00020074588,0.00003223531,0.000048762668,0.0000848636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844146,0.00006860338,0.00036855612,0.000281564,0.00033476634,0.00050505897],"domain_scores_gemma":[0.9989744,0.0003161634,0.00015043083,0.00024487358,0.00011477354,0.00019940297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005627684,0.00020025217,0.0004670886,0.00025072365,0.000044085566,0.000015889385,0.000103727914,0.00011623962,0.000017354363],"category_scores_gemma":[0.00034688893,0.00017789804,0.000052771786,0.00029267647,0.00013394146,0.00018842935,0.00005900404,0.00015043645,0.0000045062966],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093167706,0.0037593513,0.77795345,0.00061508914,0.0013952256,0.000017751756,0.0040503736,0.000029023835,0.19506206,0.00011441439,0.00012640528,0.015945163],"study_design_scores_gemma":[0.028542578,0.0007423184,0.77349806,0.00026848543,0.00036752134,0.00019894417,0.00006160291,0.001682815,0.19427048,0.0001590462,0.0000072881353,0.00020088552],"about_ca_topic_score_codex":0.00020388095,"about_ca_topic_score_gemma":0.000005651967,"teacher_disagreement_score":0.027610902,"about_ca_system_score_codex":0.00043886274,"about_ca_system_score_gemma":0.00039712954,"threshold_uncertainty_score":0.7254471},"labels":[],"label_agreement":null},{"id":"W2589588730","doi":"10.1182/blood.v108.11.704.704","title":"Murine Model of Fetal and Neonatal Alloimmune Thrombocytopenia Mediated by Anti-GPIb α Versus Anti-β3 Integrin Antibodies.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Neonatal alloimmune thrombocytopenia; Antibody; Antigen; Immunology; Platelet; Isoantibodies; Fetus; Medicine; Biology; Molecular biology; Pregnancy","score_opus":0.012474239958871276,"score_gpt":0.24239834898729753,"score_spread":0.22992410902842625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589588730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932924,0.003526697,0.00004353639,0.00018884128,0.00007089806,0.00028709872,0.0002098412,0.000056878158,0.0023238107],"genre_scores_gemma":[0.9973594,0.00079363526,0.0006900596,0.000029871517,0.000024372543,0.0000055415567,0.00065442413,0.00003067911,0.0004120409],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988114,0.000014699286,0.00032520233,0.00030479627,0.00024747194,0.0002964073],"domain_scores_gemma":[0.99945444,0.00004496104,0.00010780575,0.00024207275,0.000067255845,0.00008344487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006565504,0.00024293725,0.0006659355,0.00008503364,0.000056720437,0.000015313017,0.00009062805,0.00012348498,0.00004443101],"category_scores_gemma":[0.000031665262,0.0002002871,0.000086974025,0.00013355278,0.00014998617,0.00011867501,0.000083630475,0.00015337662,0.000015398668],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016325492,0.010693031,0.22691143,0.0004718044,0.0030324548,0.0020889342,0.000505419,0.00010093332,0.7431495,0.0005723304,0.0044895834,0.0063520228],"study_design_scores_gemma":[0.16956852,0.0029957274,0.25789037,0.00050938176,0.00345298,0.0008480112,0.0004471524,0.011849416,0.54747665,0.0003246075,0.0031434828,0.0014936503],"about_ca_topic_score_codex":0.000585409,"about_ca_topic_score_gemma":0.00006769072,"teacher_disagreement_score":0.19567284,"about_ca_system_score_codex":0.000014709182,"about_ca_system_score_gemma":0.00005516422,"threshold_uncertainty_score":0.8167471},"labels":[],"label_agreement":null},{"id":"W2589631417","doi":"10.1182/blood.v118.21.3624.3624","title":"Efficacy of SAR302503, a JAK2 Inhibitor, in the Treatment of a Primary Xenograft Model of Human Acute Myeloid Leukemia,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; BC Cancer Agency; Hospital for Sick Children; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Myeloid leukemia; Medicine; Myeloid; Leukemia; Transplantation; Haematopoiesis; Myelofibrosis; Stem cell; Cancer research; Nod; Ruxolitinib; Pharmacology; Bone marrow; Immunology; Internal medicine; Biology; Endocrinology","score_opus":0.044340039342035856,"score_gpt":0.2744695478423681,"score_spread":0.23012950850033226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589631417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930889,0.00060540426,0.000005959401,0.00004965984,0.000016295868,0.0009791455,0.000049925362,0.000010923272,0.005193792],"genre_scores_gemma":[0.9974514,0.0006002416,0.0015525628,0.000055625333,0.000034554614,0.0001500719,0.000039726187,0.000018830337,0.000096976044],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99864846,0.00006176942,0.0005536792,0.00023662933,0.00030060735,0.00019882488],"domain_scores_gemma":[0.99905044,0.00010255812,0.0002262647,0.00047095073,0.000088932386,0.000060881644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012225346,0.00021475615,0.0007151889,0.00015146843,0.00003084153,0.0000025509196,0.00011299551,0.00008955177,0.000033089655],"category_scores_gemma":[0.000012785971,0.00013060891,0.00022871632,0.00019177799,0.00012909462,0.00003608629,0.000024198625,0.00007693089,0.000002781877],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026215194,0.11443838,0.5266151,0.00072953454,0.004493428,0.00031369954,0.085002854,0.000052909072,0.24837302,0.0033595115,0.00027935862,0.0137206875],"study_design_scores_gemma":[0.023472972,0.010469485,0.2315341,0.00030638176,0.0017814415,0.000026523412,0.0002754889,0.00005890598,0.7316703,0.00021009921,0.000044652283,0.00014963337],"about_ca_topic_score_codex":0.0004186426,"about_ca_topic_score_gemma":0.00008415478,"teacher_disagreement_score":0.48329732,"about_ca_system_score_codex":0.000096066105,"about_ca_system_score_gemma":0.00022958602,"threshold_uncertainty_score":0.5326077},"labels":[],"label_agreement":null},{"id":"W2589687802","doi":"10.1182/blood.v118.21.552.552","title":"Calpain Drives Megakaryopoiesis by Targeting the 7SK snRNP Complex: A Connection to Down Syndrome Megakaryocytic Neoplasia","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"snRNP; Biology; Cell biology; Small nuclear RNA; Calpain; P-TEFb; Molecular biology; Biochemistry; RNA; Gene expression; RNA splicing; Non-coding RNA; Enzyme","score_opus":0.026503231563810965,"score_gpt":0.2628492445985824,"score_spread":0.23634601303477143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589687802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893128,0.0005671564,0.00029173045,0.0012413722,0.00017021393,0.0011810602,0.000029223784,0.00022466021,0.006981782],"genre_scores_gemma":[0.9955023,0.0000445361,0.0016722389,0.0009098294,0.00016787453,0.00015935909,0.00005740464,0.00006983598,0.0014166011],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971808,0.00022133606,0.0004865692,0.00058163464,0.0007165773,0.0008130851],"domain_scores_gemma":[0.9981208,0.0004370781,0.000105368905,0.0007482614,0.0001513405,0.0004371824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007896556,0.0003182833,0.0005033895,0.00017625514,0.00033099554,0.000055277254,0.00040932524,0.00015993588,0.00087175774],"category_scores_gemma":[0.0007442798,0.00022680523,0.0001708852,0.00062882865,0.00023142635,0.00012140389,0.00023604305,0.00037391137,0.0005154119],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004371165,0.012066097,0.02985825,0.0026827739,0.007125763,0.0101931095,0.05176926,0.00008180267,0.2968889,0.004381942,0.5715145,0.009066482],"study_design_scores_gemma":[0.23602217,0.012801306,0.11837491,0.0022520998,0.0061850226,0.042290468,0.021978283,0.023357203,0.3873685,0.0027007305,0.14129397,0.0053753345],"about_ca_topic_score_codex":0.002742268,"about_ca_topic_score_gemma":0.00010946021,"teacher_disagreement_score":0.43022048,"about_ca_system_score_codex":0.0020358078,"about_ca_system_score_gemma":0.0014367164,"threshold_uncertainty_score":0.9545136},"labels":[],"label_agreement":null},{"id":"W2589689353","doi":"10.1182/blood.v104.11.153.153","title":"Multi-Log Clonal Ex-Vivo Expansion of Long Term Lympho-Myeloid Hematopoietic Stem Cells by Nup98-Hox Fusion Genes.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer; BC Cancer Agency","funders":"","keywords":"Stem cell; Haematopoiesis; Hox gene; Biology; Myeloid; Fusion gene; Ex vivo; Transplantation; Cancer research; Cell biology; Molecular biology; In vitro; Gene; Genetics; Gene expression; Internal medicine; Medicine","score_opus":0.025001388595357495,"score_gpt":0.27766761297234127,"score_spread":0.2526662243769838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589689353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936315,0.003706869,0.0005122905,0.00015165142,0.00017489551,0.00089356955,0.00002632226,0.00007625018,0.00082668394],"genre_scores_gemma":[0.9933659,0.0006099621,0.0019083585,0.00008845046,0.00013816099,0.000031226366,0.00003143694,0.00006784018,0.0037586757],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968591,0.00009229295,0.0006215535,0.0005912661,0.0012029962,0.0006328341],"domain_scores_gemma":[0.9983859,0.00009708739,0.00017637743,0.0006975627,0.00020262043,0.00044042425],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004524258,0.0003095416,0.0005838678,0.00018249614,0.00010775912,0.000024158897,0.00029975758,0.0002661183,0.00058018434],"category_scores_gemma":[0.000028617835,0.00026002046,0.00019569749,0.00034844648,0.00016874564,0.00008847192,0.00022670442,0.00025182564,0.0002504867],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011914025,0.001621652,0.0140408175,0.0007081093,0.00006389864,0.00039730745,0.00034916998,0.000009211239,0.9784982,0.000012903538,0.000255229,0.003924315],"study_design_scores_gemma":[0.009575829,0.00047234754,0.00895635,0.00054514484,0.00012795463,0.00030224782,0.00014116865,0.00004669125,0.9793173,0.000008701613,0.0002648764,0.00024136997],"about_ca_topic_score_codex":0.00017516648,"about_ca_topic_score_gemma":0.000016204516,"teacher_disagreement_score":0.009456689,"about_ca_system_score_codex":0.00014616059,"about_ca_system_score_gemma":0.00043639244,"threshold_uncertainty_score":0.9999852},"labels":[],"label_agreement":null},{"id":"W2589693443","doi":"10.1182/blood.v120.21.3097.3097","title":"The Benefit of Allogeneic Hematopoietic Cell Transplantation in Older Patients with Acute Myeloid Leukemia Is Restricted to Those in First Complete Remission At the Time of Transplantation.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Cumulative incidence; Transplantation; Internal medicine; Myeloid leukemia; Hematopoietic stem cell transplantation; Gastroenterology; Leukemia; Incidence (geometry); Acute leukemia; Bone marrow; Surgery; Myeloid","score_opus":0.010940924925292876,"score_gpt":0.2454269506333944,"score_spread":0.2344860257081015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589693443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972903,0.0003033758,0.000028019273,0.00063903263,0.00001717612,0.0012130607,0.0001432009,0.000010700103,0.00035513786],"genre_scores_gemma":[0.9979028,0.00085601147,0.00037451988,0.00012750234,0.000018335493,0.00006138119,0.00019469378,0.000030963874,0.0004337664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981803,0.00009393593,0.0005038603,0.0002260196,0.00059460034,0.000401253],"domain_scores_gemma":[0.9988191,0.00036419352,0.00015021268,0.00040715397,0.00012824575,0.00013106382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000269801,0.0001808587,0.00031677852,0.00017212723,0.00009580209,0.0000067158335,0.00022952026,0.00010977895,0.000084593026],"category_scores_gemma":[0.000023026048,0.0001032836,0.00005875895,0.0006280418,0.000093721974,0.00008101805,0.000034454388,0.00023111388,0.000028105533],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057420717,0.0013746055,0.7928131,0.0010445764,0.00020779589,0.00007827917,0.027420633,0.0002132181,0.16963506,0.000025174277,0.00075386575,0.00069161644],"study_design_scores_gemma":[0.008645497,0.00031325786,0.86175436,0.00047861403,0.00027930213,0.000046296267,0.00012446035,0.000046364974,0.12802584,0.000007146865,0.00015363058,0.00012523089],"about_ca_topic_score_codex":0.00022922047,"about_ca_topic_score_gemma":0.00018953964,"teacher_disagreement_score":0.06894126,"about_ca_system_score_codex":0.00020924312,"about_ca_system_score_gemma":0.00015999445,"threshold_uncertainty_score":0.4211783},"labels":[],"label_agreement":null},{"id":"W2589711530","doi":"10.1182/blood.v104.11.1737.1737","title":"Role of Plasminogen-Fibrin Interaction in Plasminogen Activation by t-PA.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Zymogen; Plasmin; Chemistry; Plasminogen activator; Fibrin; Tissue plasminogen activator; Binding site; Fibrinogen; Surface plasmon resonance; Lysine; Biochemistry; Stereochemistry; Enzyme; Molecular biology; Amino acid; Biology","score_opus":0.00566583975918163,"score_gpt":0.21452631976033723,"score_spread":0.2088604800011556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589711530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99865264,0.00023948384,0.00019236041,0.000024061712,0.000038444792,0.00013866163,0.00001508115,0.0000067793044,0.00069246494],"genre_scores_gemma":[0.9993511,0.000032393134,0.00031525653,0.000042277698,0.000079693076,0.000021034348,0.000106540654,0.000011664551,0.000040041792],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994333,0.000017467786,0.00015946369,0.0001843376,0.00008127985,0.00012414569],"domain_scores_gemma":[0.99972445,0.0000033454337,0.000074592004,0.0001442827,0.0000211683,0.000032183794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000531024,0.00008806565,0.00008607951,0.000041879703,0.0000173133,0.0000058168034,0.000075481505,0.00011404095,0.000008542335],"category_scores_gemma":[0.000027097854,0.000092932154,0.000041531785,0.000059439095,0.0000123661,0.000008245505,0.000038123526,0.000056866957,0.000007070224],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057147332,0.0002763659,0.00036236417,0.0000074152827,0.00001985235,7.03482e-7,0.00004675474,0.000040454746,0.9985473,0.00007476384,0.00007093138,0.00049592037],"study_design_scores_gemma":[0.001285593,0.0002667699,0.00020215225,0.000029492914,0.000009246725,0.000008496107,0.000086705346,0.0000064418537,0.9962543,0.0003506262,0.0014027626,0.000097377815],"about_ca_topic_score_codex":0.00007357162,"about_ca_topic_score_gemma":0.00002400472,"teacher_disagreement_score":0.0022929912,"about_ca_system_score_codex":0.000012939818,"about_ca_system_score_gemma":0.000038904578,"threshold_uncertainty_score":0.3789663},"labels":[],"label_agreement":null},{"id":"W2589740173","doi":"10.1182/blood.v106.11.281.281","title":"VENUS - A Study To Validate Centrally Adjudicated Venous Ultrasound Against Venography after Major Orthopaedic Surgery.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton General Hospital","funders":"","keywords":"Venography; Medicine; Gold standard (test); Deep vein; Thrombosis; Radiology; Venous thrombosis; Surgery","score_opus":0.010277548182424457,"score_gpt":0.24299309042591807,"score_spread":0.2327155422434936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589740173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99477917,0.00118042,0.000010442309,0.0008854782,0.0002473962,0.0016718933,0.000033460903,0.00020691326,0.0009848083],"genre_scores_gemma":[0.9951111,0.0003209304,0.00029566264,0.0031583484,0.0005691596,0.0003220963,0.00005647896,0.00007383378,0.000092376526],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99759597,0.0000933609,0.0004995433,0.00055696,0.0005400914,0.0007140875],"domain_scores_gemma":[0.99858946,0.00009019393,0.00011453551,0.0006730326,0.000092616945,0.00044015064],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043430645,0.00031248623,0.0007217991,0.00039335343,0.00012932235,0.00006489403,0.00017228328,0.00006876093,0.00025233388],"category_scores_gemma":[0.00010671554,0.00029719356,0.0003186061,0.0006719238,0.00004613036,0.00008861788,0.00008954628,0.000200012,0.0004708247],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068121497,0.11029929,0.8157166,0.0003662273,0.0043674293,0.0041439836,0.008962074,0.00006339772,0.003403484,0.000028994,0.025051218,0.02691607],"study_design_scores_gemma":[0.0034580033,0.0013091837,0.95899075,0.00022916248,0.0016863086,0.000053264805,0.00034390792,0.0000014952768,0.00093987555,0.000008437438,0.032575447,0.00040413052],"about_ca_topic_score_codex":0.00008518993,"about_ca_topic_score_gemma":0.00013163954,"teacher_disagreement_score":0.14327416,"about_ca_system_score_codex":0.000050869614,"about_ca_system_score_gemma":0.00008990552,"threshold_uncertainty_score":0.999948},"labels":[],"label_agreement":null},{"id":"W2589761919","doi":"10.1182/blood.v116.21.4597.4597","title":"High Dose Melphalan and Autologous Stem Cell Transplantation In Light Chain and Light and Heavy Chain Deposition Disease: Hematologic and Renal Outcomes.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Melphalan; Autologous stem-cell transplantation; Multiple myeloma; AL amyloidosis; Transplantation; Internal medicine; Hematopoietic stem cell transplantation; Bone marrow; Plasma cell dyscrasia; Creatinine; Gastroenterology; Surgery; Urology; Immunoglobulin light chain; Immunology; Antibody","score_opus":0.004448358118912616,"score_gpt":0.21399236181944864,"score_spread":0.20954400370053602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589761919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935786,0.0045829127,0.000024703228,0.0013064968,0.000050937495,0.0003544287,0.00004346075,0.000023219694,0.000035218207],"genre_scores_gemma":[0.99675953,0.0023286536,0.00047371828,0.00017109951,0.00003118039,0.000083399515,0.0000792797,0.000019508168,0.000053599622],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891734,0.000073256335,0.00022157135,0.0004764636,0.0000842436,0.0002271105],"domain_scores_gemma":[0.9995028,0.00004037916,0.00008651077,0.00018335576,0.000015743783,0.00017120299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010981412,0.00024026964,0.00027497683,0.00007559878,0.000092717695,0.000043682714,0.000054616976,0.00020695404,0.0000022384509],"category_scores_gemma":[0.000012449572,0.00020026969,0.000032018113,0.000047675832,0.000070130045,0.00001247741,0.00005224132,0.000108936685,6.9346567e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019370053,0.00043344853,0.6769926,0.00020596763,0.00008262872,0.0002000404,0.00028605654,7.6833743e-7,0.31960908,0.00024490093,0.000024027691,0.0017267831],"study_design_scores_gemma":[0.0038222985,0.00023269262,0.61510867,0.000033176282,0.00019808857,0.0002033767,0.00004879737,0.000014209469,0.37992388,0.000079607904,0.00007695996,0.0002582212],"about_ca_topic_score_codex":0.000041269195,"about_ca_topic_score_gemma":0.00035889584,"teacher_disagreement_score":0.061883923,"about_ca_system_score_codex":0.0000051467596,"about_ca_system_score_gemma":0.000018698858,"threshold_uncertainty_score":0.8166761},"labels":[],"label_agreement":null},{"id":"W2589773089","doi":"10.1182/blood.v106.11.3213.3213","title":"National Responses to HIV Versus HCV-Infection from Virally Contaminated Blood Products among Persons with Hemophilia (PWH): More Different Than Alike.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Blood donation and transfusion practices","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Hepatitis C; Human immunodeficiency virus (HIV); Public health; Blood transfusion; Hepatitis C virus; Hepatitis; Cause of death; Environmental health; Immunology; Pediatrics; Virology; Internal medicine; Virus; Disease; Pathology","score_opus":0.01652358711359329,"score_gpt":0.23470848519964335,"score_spread":0.21818489808605007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589773089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98406905,0.000046297315,0.000051594998,0.008423804,0.00029977426,0.0005241838,0.000041092586,0.00030357557,0.0062406426],"genre_scores_gemma":[0.9952463,0.000010085533,0.0003986343,0.0011043153,0.0012697172,0.000082297345,0.00018968212,0.00004499962,0.0016539517],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981,0.000040356445,0.00028975468,0.00057085557,0.00070046855,0.00029858242],"domain_scores_gemma":[0.9988879,0.00015296416,0.0002257141,0.00025336165,0.00043516618,0.000044878518],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023598805,0.00030713834,0.0002410492,0.00037370794,0.0003300338,0.00039153677,0.00020041627,0.000101013815,0.0004070908],"category_scores_gemma":[0.0003253495,0.0002600629,0.00007310143,0.000587487,0.00006607585,0.0015747081,0.00007586829,0.00021637166,0.000265735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0102821,0.012574179,0.92452055,0.0002994676,0.0027452048,0.00018685019,0.0020723455,0.00035010936,0.021665864,0.008882527,0.008386746,0.008034033],"study_design_scores_gemma":[0.014787646,0.00017937567,0.91685736,0.00013231783,0.0014212722,0.000009583716,0.0003693322,0.0005177515,0.011017079,0.000061770384,0.053874094,0.0007724051],"about_ca_topic_score_codex":0.0007771494,"about_ca_topic_score_gemma":0.0024889747,"teacher_disagreement_score":0.045487348,"about_ca_system_score_codex":0.000027920409,"about_ca_system_score_gemma":0.00006359308,"threshold_uncertainty_score":0.99998516},"labels":[],"label_agreement":null},{"id":"W2589792316","doi":"10.1182/blood.v118.21.3303.3303","title":"Eculizumab Is An Effective Long-Term Treatment In Patients with Atypical Hemolytic Uremic Syndrome (aHUS) Previously Receiving Chronic Plasma Exchange/Infusion (PE/PI): Extension Study Results,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Eculizumab; Atypical hemolytic uremic syndrome; Thrombotic microangiopathy; Dialysis; Clinical endpoint; Internal medicine; Surrogate endpoint; Regimen; Renal function; Gastroenterology; Surgery; Randomized controlled trial; Immunology; Complement system; Antibody","score_opus":0.018602610640520042,"score_gpt":0.24243213995430304,"score_spread":0.223829529313783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589792316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939254,0.00092465006,0.0000026873718,0.000006756494,0.00022679918,0.004656329,0.00007935973,0.00011985681,0.000058192603],"genre_scores_gemma":[0.9989886,0.00003129676,0.000021188516,0.000014192433,0.000023703442,0.00043285207,0.00031966087,0.00004540539,0.00012309592],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971271,0.0006895348,0.00055135053,0.0009040879,0.00012246605,0.0006054632],"domain_scores_gemma":[0.9985872,0.00012926772,0.00025531155,0.0008610565,0.00008823995,0.00007891558],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023951047,0.00043442307,0.0005970949,0.00022008443,0.00018954012,0.000018367442,0.00029322665,0.00018796734,0.00042359094],"category_scores_gemma":[0.000052197192,0.0003337759,0.000090575275,0.000202454,0.0000931275,0.0001660441,0.00018518082,0.00019987974,0.00020239339],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050495625,0.014589519,0.9645451,0.00010929423,0.00055183715,0.00027498798,0.0060613286,0.0000014793973,0.0011208039,0.0000013842844,0.000062170024,0.0076325624],"study_design_scores_gemma":[0.032439377,0.018570779,0.9443414,0.000677795,0.0004755267,0.00012727756,0.00015763991,0.0000024802648,0.0028301137,0.0000037204538,0.000012759288,0.000361128],"about_ca_topic_score_codex":0.000341312,"about_ca_topic_score_gemma":0.0012589833,"teacher_disagreement_score":0.027389815,"about_ca_system_score_codex":0.00044155924,"about_ca_system_score_gemma":0.00008780051,"threshold_uncertainty_score":0.9999114},"labels":[],"label_agreement":null},{"id":"W2589841223","doi":"10.1182/blood.v126.23.3717.3717","title":"Outcomes of Down-Syndrome Associated Acute Lymphoblastic Leukemia in Adults: A Single Center Retrospective Review","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Alberta; Hospital for Sick Children; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Mucositis; Neutropenia; Regimen; Pediatrics; Internal medicine; Down syndrome; Acute lymphocytic leukemia; Retrospective cohort study; Single Center; Cancer; Leukemia; Lymphoblastic Leukemia; Surgery; Chemotherapy","score_opus":0.018046047745107804,"score_gpt":0.27653739152205087,"score_spread":0.25849134377694305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589841223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923281,0.0018906557,0.000019789242,0.000495033,0.00011339466,0.0009725394,0.00012398769,0.00008777629,0.0039687157],"genre_scores_gemma":[0.9973955,0.0007033725,0.00036191635,0.00065509893,0.00003374104,0.00006619673,0.00009661638,0.000055258173,0.00063225976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969938,0.00014104163,0.0007516419,0.0004711354,0.001042422,0.00059999566],"domain_scores_gemma":[0.9981219,0.00017970652,0.0002664145,0.0005635451,0.0005192158,0.0003491723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005718589,0.00028811715,0.0012061028,0.00026180447,0.000023251761,0.000011480735,0.00026799657,0.00020487019,0.00009118001],"category_scores_gemma":[0.0029556307,0.00023927806,0.00019602748,0.00089752383,0.00014720867,0.00013181042,0.00018353372,0.00031272863,0.00013397084],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078529515,0.0046602464,0.97624093,0.0020033072,0.002023345,0.0037224304,0.00087694306,0.000003403159,0.001429973,0.00006932045,0.0077851396,0.0003996473],"study_design_scores_gemma":[0.0929065,0.0047171144,0.87163943,0.021825718,0.0018222943,0.0029864584,0.00022338839,0.0003833931,0.0021929506,0.00022961659,0.0003403697,0.00073276774],"about_ca_topic_score_codex":0.00030581164,"about_ca_topic_score_gemma":0.000066929395,"teacher_disagreement_score":0.10460152,"about_ca_system_score_codex":0.0046163057,"about_ca_system_score_gemma":0.0015929836,"threshold_uncertainty_score":0.9992048},"labels":[],"label_agreement":null},{"id":"W2589885101","doi":"10.1182/blood.v128.22.358.358","title":"IKZF1 Regulates BRD4 Retention and Recruitement at Enhancer in Myeloma Cells: Role of BRD4 in IMiDs Resistance","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Enhancer; BRD4; Biology; Bromodomain; Cell culture; Transcription factor; Enhancer RNAs; RNA polymerase II; Molecular biology; Chromatin; Cancer research; Gene expression; Gene; Promoter; Histone; Genetics","score_opus":0.005765579804463464,"score_gpt":0.20646856614560744,"score_spread":0.20070298634114397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589885101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961013,0.0026388764,0.000015692582,0.00011916887,0.000033707078,0.00016733058,0.00000964538,0.000003985905,0.00091024477],"genre_scores_gemma":[0.99657494,0.000739073,0.00031944638,0.00001962801,0.00003564123,0.000028493272,0.000013139583,0.000008558928,0.0022610957],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992736,0.000047711655,0.00023707144,0.00023438137,0.00008007227,0.00012715609],"domain_scores_gemma":[0.9996616,0.000007042062,0.00008654856,0.0001877727,0.000028591405,0.000028441187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016583192,0.00008017558,0.00010314493,0.000047810747,0.000015799564,0.0000046233945,0.00006371337,0.000094511975,0.000025306268],"category_scores_gemma":[0.000036312544,0.00006498163,0.000027367458,0.000066969,0.000050021325,0.000005782208,0.000066405344,0.000025405534,0.0000025152272],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007397012,0.00006936752,0.006259056,0.000019040586,0.000007729013,8.7136414e-7,0.000032937125,2.4823078e-7,0.9907113,0.000048930084,0.0001842612,0.0025922984],"study_design_scores_gemma":[0.0011920729,0.00007952673,0.01456474,0.00012431722,0.0000049336118,9.289492e-7,0.000024399675,0.000001412651,0.9766511,0.00021109145,0.007054959,0.00009051671],"about_ca_topic_score_codex":0.000014265306,"about_ca_topic_score_gemma":0.00042858446,"teacher_disagreement_score":0.014060189,"about_ca_system_score_codex":0.000017282826,"about_ca_system_score_gemma":0.000017518885,"threshold_uncertainty_score":0.26498738},"labels":[],"label_agreement":null},{"id":"W2589906945","doi":"10.1182/blood.v116.21.4257.4257","title":"Lack of Association between Single Nucleotide Polymorphism rs3811647 in the TF Gene and Iron Status in Patients with Iron Deficiency and Control Subjects","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Total iron-binding capacity; Serum iron; Transferrin saturation; Transferrin; Ferritin; Single-nucleotide polymorphism; Population; Hemochromatosis; Internal medicine; Medicine; Iron deficiency; Immunology; Endocrinology; Genotype; Genetics; Biology; Anemia; Gene","score_opus":0.00738482717382819,"score_gpt":0.21457316252710815,"score_spread":0.20718833535327996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589906945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99851286,0.00048344617,0.0000023327211,0.00016879909,0.000031523054,0.0003833361,0.000025428062,0.000006330353,0.00038591467],"genre_scores_gemma":[0.9996359,0.00003554007,0.00010619717,0.0001391654,0.000036457306,0.000004444942,0.000019351506,0.000010492707,0.000012488709],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991487,0.000057071076,0.00018260407,0.00015185296,0.00023714412,0.00022258438],"domain_scores_gemma":[0.99957985,0.00009483722,0.00011200215,0.0001324656,0.00003140609,0.000049428425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026138555,0.00009443647,0.00021927107,0.000089920264,0.000026942686,0.000011281694,0.000039341452,0.00007657036,0.0000050172875],"category_scores_gemma":[0.0001294089,0.00006539956,0.0000131377565,0.00012850355,0.000056479515,0.000064394924,0.000012398976,0.0001582969,9.3482475e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007725438,0.00057039066,0.99123573,0.000042206364,0.0000040474824,0.0000018822223,0.00080298644,3.2783677e-7,0.0063407347,0.000020921825,0.0000064981805,0.00089701265],"study_design_scores_gemma":[0.013322707,0.0003439841,0.98491293,0.000014425455,0.00017071745,7.681815e-7,0.00014495317,0.0000013596788,0.0009638117,0.00002903706,0.00002416411,0.00007113541],"about_ca_topic_score_codex":0.00037321975,"about_ca_topic_score_gemma":0.00032253837,"teacher_disagreement_score":0.013245452,"about_ca_system_score_codex":0.000011107518,"about_ca_system_score_gemma":0.000031286672,"threshold_uncertainty_score":0.26669168},"labels":[],"label_agreement":null},{"id":"W2589908125","doi":"10.1182/blood.v128.22.2876.2876","title":"Replication of New Genomic Classification System in Acute Myeloid Leukemia with Normal Karyotype","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"CEBPA; Myeloid leukemia; NPM1; Biology; Oncology; Mutation; Genetics; Cancer research; Gene; Internal medicine; Karyotype; Medicine; Chromosome","score_opus":0.021296347538988573,"score_gpt":0.26918356971489055,"score_spread":0.24788722217590198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589908125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99325,0.00010465937,0.00060795556,0.0007918976,0.00002218329,0.00057071296,0.000010095775,0.00006840039,0.0045741065],"genre_scores_gemma":[0.9951282,0.00010282508,0.002145954,0.000038293365,0.00013359524,0.00004281006,0.000027467062,0.000032579424,0.0023482414],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986296,0.00004185576,0.00035698013,0.0004066393,0.000301192,0.00026369106],"domain_scores_gemma":[0.99851257,0.000056172586,0.00016121032,0.0009913074,0.00013271264,0.00014602183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033537226,0.00012738083,0.0002744843,0.00020526139,0.00002465089,0.000006842268,0.0001842739,0.00012091761,0.000030310774],"category_scores_gemma":[0.000073203846,0.00008170402,0.00004090083,0.0003425482,0.00006835817,0.00011658641,0.000046614252,0.00015085455,0.00011806256],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092041114,0.00012576941,0.14404012,0.00016579335,0.00017133888,0.000044908433,0.00019827142,0.0000016568131,0.8382721,0.0013631401,0.00077376614,0.013922703],"study_design_scores_gemma":[0.010980433,0.00061930803,0.78993595,0.0004822764,0.00025454263,0.0003956875,0.0001817892,0.00018482069,0.19552383,0.000018455052,0.0012538775,0.00016905824],"about_ca_topic_score_codex":0.00024049466,"about_ca_topic_score_gemma":0.00003356739,"teacher_disagreement_score":0.6458958,"about_ca_system_score_codex":0.000776138,"about_ca_system_score_gemma":0.0012100181,"threshold_uncertainty_score":0.33317932},"labels":[],"label_agreement":null},{"id":"W2589917306","doi":"10.1182/blood.v104.11.1131.1131","title":"Microrna Expression Profiling in Acute Myelogenous Leukemia.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Biology; microRNA; Gene expression profiling; Haematopoiesis; Leukemia; Gene; Gene expression; Stem cell; Bone marrow; Cellular differentiation; Cancer research; Cell biology; Genetics; Immunology","score_opus":0.006453700722997933,"score_gpt":0.22761712738159817,"score_spread":0.22116342665860023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589917306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99803495,0.0009833768,0.0004061811,0.000028374105,0.000045641467,0.00018863015,0.000011391619,0.000014835748,0.00028659689],"genre_scores_gemma":[0.9949508,0.00006503675,0.004571144,0.000065855114,0.000112859525,0.000021264594,0.00013950573,0.000019203455,0.000054377397],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993076,0.000020510313,0.00014865801,0.00026027937,0.00007161012,0.00019138351],"domain_scores_gemma":[0.9996228,0.0000018876755,0.000049870618,0.00024755576,0.000026485706,0.000051369374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006312217,0.00010521497,0.00008698803,0.000038254617,0.00003775086,0.00001162884,0.00011925629,0.0001283243,0.000005862545],"category_scores_gemma":[0.00001894627,0.000105244944,0.000049325674,0.00006781149,0.000025265404,0.0000030022459,0.00007180865,0.0000591981,0.000016050113],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031241332,0.00012397542,0.0019854978,0.000012156976,0.000022512515,0.000021996153,0.000032177853,0.00026919224,0.9973138,0.00001723646,0.000026365502,0.00014386678],"study_design_scores_gemma":[0.001807163,0.00005612818,0.0047135856,0.000030401734,0.000023996077,0.000037497055,0.000013734084,0.0000024111994,0.99265957,0.00013529997,0.00039066834,0.00012957533],"about_ca_topic_score_codex":0.000011258102,"about_ca_topic_score_gemma":0.000010620066,"teacher_disagreement_score":0.0046542413,"about_ca_system_score_codex":0.000038178252,"about_ca_system_score_gemma":0.0001494215,"threshold_uncertainty_score":0.42917642},"labels":[],"label_agreement":null},{"id":"W2589956626","doi":"10.1182/blood.v118.21.4775.4775","title":"Adverse Events Associated with Bone Marrow Biopsy In A Resident Training Program; First Do No Harm","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Hematological disorders and diagnostics","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Bone marrow; Biopsy; Quality assurance; Complication; Adverse effect; Surgery; Radiology; Internal medicine; Pathology","score_opus":0.04296725962658473,"score_gpt":0.2649472250641648,"score_spread":0.22197996543758006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589956626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883674,0.00014670378,0.0000089325495,0.0001718683,0.000034262473,0.0006025551,0.00000725035,0.000102312064,0.010558729],"genre_scores_gemma":[0.997279,0.000032702785,0.0021545421,0.0001511203,0.000019729754,0.0001088636,0.000023539926,0.000019321233,0.00021118848],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893564,0.000028912402,0.00024671562,0.00023318827,0.00021715066,0.00033841576],"domain_scores_gemma":[0.99943924,0.00008469288,0.000081566686,0.00016462726,0.00007365311,0.000156218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001581055,0.00014124825,0.00031660454,0.00007097939,0.00004051859,0.000004590601,0.00006212429,0.00012395089,0.00031739363],"category_scores_gemma":[0.00091801304,0.00010308821,0.000056994642,0.00024633392,0.000051070867,0.000038659182,0.000027381253,0.00016958878,0.00007135656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038747466,0.0069147334,0.9850121,0.00010307827,0.00014769194,0.0029425696,0.003133854,6.00662e-7,0.000058353016,0.0001592602,0.00038244508,0.0007577964],"study_design_scores_gemma":[0.013202793,0.0021713271,0.9801302,0.001380701,0.00029725785,0.00014784286,0.0013013941,0.00004956283,0.00023395312,0.00034523054,0.00044413493,0.00029562906],"about_ca_topic_score_codex":0.000098660916,"about_ca_topic_score_gemma":0.0001742198,"teacher_disagreement_score":0.012815318,"about_ca_system_score_codex":0.000020413314,"about_ca_system_score_gemma":0.000064735475,"threshold_uncertainty_score":0.42038155},"labels":[],"label_agreement":null},{"id":"W2589976880","doi":"10.1182/blood.v106.11.5576.5576","title":"Estimating the Total Cost of Infused Iron Chelation Therapy.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Association of Radiation Oncology","funders":"","keywords":"Medicine; Deferoxamine; Reimbursement; Clinical trial; Thalassemia; Unit cost; Chelation therapy; Intensive care medicine; Health care; Internal medicine","score_opus":0.010294253051531076,"score_gpt":0.2461036738026714,"score_spread":0.2358094207511403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589976880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99162084,0.00088012364,0.00013331287,0.001531381,0.000048830687,0.00027320135,0.0000012555046,0.0000278913,0.0054831537],"genre_scores_gemma":[0.9981296,0.000051765794,0.001267219,0.00016765772,0.00011934169,0.000006583357,0.0000070593856,0.000008985701,0.00024178268],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9995486,0.000014710743,0.00015092193,0.00007086757,0.000117390744,0.00009751144],"domain_scores_gemma":[0.99971974,0.000028170492,0.000059149108,0.00013546275,0.000028961837,0.00002854527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010289684,0.00005841763,0.00009503656,0.000021526997,0.000049177448,0.0000045205325,0.000032693802,0.00006370153,0.00008818054],"category_scores_gemma":[0.000046505003,0.00003478051,0.00004484029,0.000090913316,0.000040006544,0.00003168192,0.000009390283,0.000114450144,0.000020003803],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003277078,0.0037501366,0.05431041,0.00021116284,0.00048212253,0.000017485725,0.009796146,0.024407355,0.23188324,0.0006005254,0.0012157601,0.67299795],"study_design_scores_gemma":[0.05998173,0.0022188728,0.56739837,0.00086454366,0.0012375229,0.0006319767,0.002218879,0.1770725,0.17383441,0.0002864536,0.013401475,0.00085324096],"about_ca_topic_score_codex":0.000019634286,"about_ca_topic_score_gemma":0.0000012847794,"teacher_disagreement_score":0.6721447,"about_ca_system_score_codex":0.000007011607,"about_ca_system_score_gemma":0.000029145718,"threshold_uncertainty_score":0.14183082},"labels":[],"label_agreement":null},{"id":"W2589983700","doi":"10.1182/blood.v128.22.1891.1891","title":"Patient-Reported Quality of Life before and after Stopping Treatment in the ENESTop Trial of Treatment-Free Remission for Patients with Chronic Myeloid Leukemia in Chronic Phase","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Nilotinib; Internal medicine; Imatinib mesylate; Adverse effect; Imatinib; Gastroenterology; Myeloid leukemia","score_opus":0.02172127991890915,"score_gpt":0.29370315122618446,"score_spread":0.2719818713072753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589983700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99453354,0.0007358378,0.000007685512,0.00011110595,0.00004677347,0.00437236,0.000135729,0.000016805454,0.000040161212],"genre_scores_gemma":[0.9983763,0.00020577588,0.00017925419,0.000016086502,0.00010116274,0.00092401926,0.00008881505,0.00003553016,0.00007304664],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99756074,0.00015487296,0.001017369,0.0004972043,0.00037212804,0.00039769136],"domain_scores_gemma":[0.99796265,0.0003128918,0.0005557603,0.00094111654,0.00009603945,0.00013152251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025237008,0.0003573593,0.00084643223,0.0001820878,0.00003762354,0.0000059750146,0.00011174359,0.00015278338,0.000026496413],"category_scores_gemma":[0.00030377347,0.00017500625,0.00015500064,0.00021594492,0.00012081657,0.00010619666,0.000042982745,0.00006953555,5.796697e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0986811,0.0122588165,0.73920083,0.0006172835,0.0010270874,0.000084092986,0.0034011612,0.000007748538,0.008977642,0.00003031463,0.000012906072,0.13570105],"study_design_scores_gemma":[0.6769295,0.04930573,0.2652155,0.00094791956,0.00063583173,0.000011239702,0.0000990638,0.00003251607,0.0063265515,0.00004766195,0.00024134101,0.0002071687],"about_ca_topic_score_codex":0.0012832019,"about_ca_topic_score_gemma":0.0027441778,"teacher_disagreement_score":0.5782484,"about_ca_system_score_codex":0.006255622,"about_ca_system_score_gemma":0.0032859244,"threshold_uncertainty_score":0.9975592},"labels":[],"label_agreement":null},{"id":"W2589986701","doi":"10.1182/blood.v116.21.2218.2218","title":"Investigation of the Role of Copy Number Variation In the Pathogenesis of Type 1 Von Willebrand Disease","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Multiplex ligation-dependent probe amplification; Von Willebrand disease; Copy-number variation; Von Willebrand factor; Pathogenesis; Genetics; Genotype; Biology; Immunology; Medicine; Gene; Exon; Genome; Platelet","score_opus":0.006707235440340707,"score_gpt":0.21922834715737852,"score_spread":0.2125211117170378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589986701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990802,0.00008926023,5.761609e-7,0.00013032593,0.00002813928,0.00018135794,0.000014865004,0.0000017870013,0.0004734868],"genre_scores_gemma":[0.999826,0.000014776039,0.00008519841,0.00003252769,0.000009503464,0.0000050226263,0.000011598407,0.0000036154602,0.000011752336],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996459,0.000029233548,0.000116172276,0.000051394567,0.00011780642,0.00003953295],"domain_scores_gemma":[0.9996675,0.000029983163,0.000081589096,0.00015926764,0.000044134602,0.000017520417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008058691,0.00003781094,0.00009498925,0.000015603027,0.000011090887,0.0000010873079,0.00004200716,0.000029436518,0.00002435775],"category_scores_gemma":[0.00007228762,0.00002057839,0.000029770199,0.00013605655,0.000035758,0.00001950058,0.000007174981,0.000037709593,0.0000013514987],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050699382,0.0002478518,0.85304326,0.000023888295,0.00002494201,0.0000017872109,0.00047675797,8.315493e-7,0.14566451,0.00024498728,0.000006260287,0.00021424827],"study_design_scores_gemma":[0.0012906282,0.00003594545,0.9550399,0.000028118367,0.00019126566,0.00000317775,0.00003954566,0.000031401763,0.041373927,0.0019231467,0.000025005478,0.000017934186],"about_ca_topic_score_codex":0.00008546696,"about_ca_topic_score_gemma":0.000030869942,"teacher_disagreement_score":0.10429059,"about_ca_system_score_codex":0.0000015813632,"about_ca_system_score_gemma":0.000050089184,"threshold_uncertainty_score":0.08391624},"labels":[],"label_agreement":null},{"id":"W2589997752","doi":"10.1182/blood.v112.11.1724.1724","title":"Treatment of Relapsed and Refractory Multiple Myeloma in Patients with p53 Deletion.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Multiple myeloma; Gastroenterology; Internal medicine; Medicine; Lenalidomide; Transplantation; Concomitant; Beta-2 microglobulin; Median follow-up; Progression-free survival; Refractory (planetary science); Chemotherapy; Biology","score_opus":0.017301992136897554,"score_gpt":0.24472092671450177,"score_spread":0.2274189345776042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589997752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99864453,0.00033925724,0.0000018535101,0.000033976088,0.000008799633,0.00054134504,0.000018789708,0.000013156591,0.0003983083],"genre_scores_gemma":[0.9983704,0.00023637175,0.0010660549,0.000008306513,0.000015367876,0.0000398792,0.000059370985,0.000014678625,0.00018955558],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991855,0.000029421724,0.00016124929,0.00019246506,0.00024054012,0.00019081247],"domain_scores_gemma":[0.9994837,0.00006210586,0.000047603407,0.00020136751,0.000071514456,0.00013370543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000020506335,0.000117465584,0.00024639265,0.000119600336,0.00004147238,0.0000021176,0.000023153254,0.00004967048,0.000021660995],"category_scores_gemma":[0.00005187179,0.00007862131,0.000030733998,0.000113816415,0.00008320683,0.000036340018,0.0000108752865,0.000050937062,0.0000079907695],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012170953,0.005458276,0.98730475,0.000023409864,0.00013975713,0.00025386043,0.00025393022,3.477602e-7,0.0005061997,0.0000021868696,0.000008202646,0.0048319874],"study_design_scores_gemma":[0.0439978,0.00443946,0.9472989,0.000041373292,0.00005456023,0.00003282898,0.000018076045,0.000017581286,0.0037895902,0.0000016195197,0.00024505786,0.00006316269],"about_ca_topic_score_codex":0.00019220613,"about_ca_topic_score_gemma":0.00004342308,"teacher_disagreement_score":0.04278071,"about_ca_system_score_codex":0.000055226123,"about_ca_system_score_gemma":0.000065882276,"threshold_uncertainty_score":0.32060844},"labels":[],"label_agreement":null},{"id":"W2590011141","doi":"10.1182/blood.v108.11.5118.5118","title":"Safety and Efficacy of Bortezomib (VELCADE™) in 104 Patients with Relapsed and/or Refractory Multiple Myeloma Who Have Received at Least Two Previous Lines of Therapy: Impact of Cytogenetics on Response from a Canadian Cohort.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Bortezomib; Medicine; Multiple myeloma; Internal medicine; Refractory (planetary science); Proteasome inhibitor; Neutropenia; Gastroenterology; Progressive disease; Dexamethasone; Surgery; Oncology; Toxicity; Chemotherapy","score_opus":0.013976039929333913,"score_gpt":0.27634865128426556,"score_spread":0.2623726113549316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590011141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969329,0.0006799582,5.276565e-7,0.000040003724,0.0000070875562,0.0014083456,0.00083806284,0.000007126325,0.00008598822],"genre_scores_gemma":[0.99874234,0.0005188919,0.0002983772,0.0000130506705,0.000020324553,0.000016781762,0.00023039733,0.000035098346,0.00012475782],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830174,0.00021267755,0.00048993825,0.00032908455,0.00035358156,0.00031299196],"domain_scores_gemma":[0.9982964,0.0006048237,0.0002447666,0.00038386308,0.00018959299,0.0002805782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019324134,0.00023426807,0.00063573115,0.00028423552,0.000044391047,0.0000051963793,0.00007243834,0.00011823734,0.0000309234],"category_scores_gemma":[0.00045446795,0.00015644479,0.000069566006,0.00017107038,0.0001812691,0.000034561745,0.00002996664,0.00014434355,6.612101e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0693336,0.001721057,0.91491306,0.000033933586,0.00046681677,0.00007538765,0.0003743282,0.000023687393,0.008926585,2.2023309e-7,0.000015216608,0.004116134],"study_design_scores_gemma":[0.05311855,0.0049699508,0.92624044,0.00042371507,0.00012301074,0.000005833408,0.000022364356,0.00010764843,0.0148214465,0.0000015435872,0.00004536456,0.00012012687],"about_ca_topic_score_codex":0.09553504,"about_ca_topic_score_gemma":0.0973795,"teacher_disagreement_score":0.016215047,"about_ca_system_score_codex":0.00015834387,"about_ca_system_score_gemma":0.00043410063,"threshold_uncertainty_score":0.919091},"labels":[],"label_agreement":null},{"id":"W2590021417","doi":"10.1182/blood.v126.23.73.73","title":"Genes Influencing the Development and Severity of Chronic ITP Identified through Whole Exome Sequencing","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Exome sequencing; Immunology; Immune dysregulation; Medicine; Exome; Immune system; Candidate gene; Autoimmunity; Phenotype; Genetics; Biology; Gene","score_opus":0.04512761106817795,"score_gpt":0.27502091714402593,"score_spread":0.229893306075848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590021417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930622,0.0053132335,0.000025725838,0.00009547762,0.000055799803,0.00019996427,0.000002846699,0.00002076209,0.0012240099],"genre_scores_gemma":[0.9986125,0.000045635898,0.0009262519,0.0000693455,0.0000324769,0.000015522257,0.00000920229,0.000009544468,0.00027950888],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99930555,0.00001675125,0.0001875347,0.00014772089,0.00018261737,0.00015985007],"domain_scores_gemma":[0.99962467,0.000018372999,0.00006602374,0.00017090945,0.000058661022,0.00006136869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014025408,0.000098569064,0.00019755505,0.000023056016,0.000067537454,0.000013024801,0.000051643172,0.00004288787,0.000008015249],"category_scores_gemma":[0.000023238514,0.00006560199,0.000025394469,0.00009121281,0.00005060749,0.00009063257,0.000053724638,0.00006286231,0.000015141413],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003266909,0.0035799814,0.6538726,0.0014362001,0.004806399,0.0024445239,0.1260101,0.00008007737,0.12554169,0.00076395134,0.000978117,0.08015969],"study_design_scores_gemma":[0.025378907,0.00091230276,0.3873422,0.00079502515,0.0014834786,0.0017078614,0.014705044,0.00013820706,0.5520362,0.002261281,0.012517255,0.0007222294],"about_ca_topic_score_codex":0.00017650504,"about_ca_topic_score_gemma":0.0001084037,"teacher_disagreement_score":0.4264945,"about_ca_system_score_codex":0.00007670807,"about_ca_system_score_gemma":0.0003217226,"threshold_uncertainty_score":0.26751718},"labels":[],"label_agreement":null},{"id":"W2590044361","doi":"10.1182/blood.v114.22.2471.2471","title":"Adjudicating Bleeding Outcomes in a Large Thromboprophylaxis Trial in Critical Illness.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; St. Joseph’s Healthcare Hamilton; McMaster University; Canadian Blood Services","funders":"","keywords":"Bleed; Medicine; Major bleeding; Adjudication; Psychological intervention; Kappa; Emergency medicine; Intensive care medicine; Internal medicine; Surgery; Atrial fibrillation; Psychiatry","score_opus":0.35994593345718573,"score_gpt":0.5669600663098682,"score_spread":0.20701413285268244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590044361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842755,0.00058814586,0.000007790191,0.007973889,0.0007813519,0.000680648,0.000040474788,0.00009649539,0.005555711],"genre_scores_gemma":[0.99411935,0.000092403025,0.00011713541,0.0050712,0.00041845473,0.00008019007,0.000008889634,0.000016556494,0.000075846525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99698454,0.0005707347,0.0007178114,0.00046100715,0.00021445344,0.0010514355],"domain_scores_gemma":[0.9984767,0.00081457524,0.00008057598,0.0001899043,0.000052058505,0.00038620835],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015728974,0.00025929828,0.0005378158,0.00022060676,0.00023615199,0.000024553523,0.00030666482,0.0007687313,0.0009351792],"category_scores_gemma":[0.0011327108,0.0002521018,0.00010533661,0.00052517216,0.0001244291,0.00019213985,0.00007385631,0.0028020644,0.000083358835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011934328,0.02725249,0.849577,0.00032785628,0.00019718577,0.0017444472,0.0048015052,0.000051418825,0.020734154,0.04687368,0.00051026203,0.03599565],"study_design_scores_gemma":[0.41244557,0.0039115027,0.47634196,0.0004323261,0.00055993453,0.00012404226,0.002721347,0.0036754506,0.05213558,0.026532002,0.018448792,0.0026714779],"about_ca_topic_score_codex":0.00003060338,"about_ca_topic_score_gemma":0.000053224907,"teacher_disagreement_score":0.40051123,"about_ca_system_score_codex":0.000078561614,"about_ca_system_score_gemma":0.0001222006,"threshold_uncertainty_score":0.99999315},"labels":[],"label_agreement":null},{"id":"W2590058432","doi":"10.1182/blood.v114.22.1036.1036","title":"Feasibility of Outpatient Consolidation Chemotherapy and Toxicity in Elderly Patients with AML.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Medicine; Febrile neutropenia; Etoposide; Internal medicine; Chemotherapy; Neutropenia; Cytarabine; Surgery","score_opus":0.013130955693413082,"score_gpt":0.2659127549226171,"score_spread":0.252781799229204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590058432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99827045,0.000024384777,0.00001414434,0.000167618,0.000012992757,0.0003971744,0.0000047405742,0.000010804772,0.0010976988],"genre_scores_gemma":[0.99962056,0.000012289673,0.00013603028,0.00019009669,0.000010293243,0.0000052822515,0.000006791683,0.000003339284,0.000015318645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99958724,0.0000137424995,0.00012115596,0.000115111565,0.000091942915,0.00007080668],"domain_scores_gemma":[0.9997319,0.000008659472,0.000045883055,0.000114329094,0.00006278725,0.000036443555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000040176114,0.000054271863,0.00013143751,0.000037276728,0.000014956671,0.000003459139,0.00001480266,0.00002884813,0.000021358239],"category_scores_gemma":[0.0000109536195,0.000042124862,0.000014494533,0.00009560615,0.000029217665,0.00004093518,0.0000028762495,0.000056910478,5.6503177e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022528344,0.0019396252,0.9905843,0.000016108606,0.000010467049,7.425692e-7,0.00017186487,7.386276e-7,0.00261373,0.000029496821,0.000011544633,0.004396092],"study_design_scores_gemma":[0.0070619453,0.0022843988,0.96782446,0.000040652605,0.000032595908,0.0000024094943,0.0000145693275,9.609344e-7,0.022601934,0.00006100429,0.000032199016,0.000042883843],"about_ca_topic_score_codex":0.000026234322,"about_ca_topic_score_gemma":0.00003418384,"teacher_disagreement_score":0.02275986,"about_ca_system_score_codex":0.000018657607,"about_ca_system_score_gemma":0.000029144054,"threshold_uncertainty_score":0.1717802},"labels":[],"label_agreement":null},{"id":"W2590064272","doi":"10.1182/blood.v118.21.2068.2068","title":"Population-Based Health Care Cost Estimates Related to Non-Hodgkin Lymphoma (NHL)","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; Princess Margaret Cancer Centre; Health Sciences Centre; McMaster University; Cancer Care Ontario; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Cancer registry; Population; Health care; Cancer; Demography; Family medicine; Pediatrics; Emergency medicine; Gerontology; Environmental health; Internal medicine","score_opus":0.02105690599250566,"score_gpt":0.2867025262339326,"score_spread":0.26564562024142696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590064272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988832,0.0005829008,0.00011201359,0.00048263159,0.0002128239,0.00086678483,0.00005179515,0.00015024318,0.008708823],"genre_scores_gemma":[0.9862123,0.000009300299,0.008911815,0.0041060494,0.00004555785,0.000048778475,0.00047797948,0.000036251316,0.00015196642],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99889857,0.000023711607,0.0003116201,0.00028983102,0.00017513301,0.0003011371],"domain_scores_gemma":[0.99914587,0.000036481775,0.000082136714,0.00035337897,0.00007400714,0.000308113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009209266,0.00015971232,0.00032781472,0.00012592555,0.00010709425,0.000009635889,0.000087877255,0.0000843946,0.0004974318],"category_scores_gemma":[0.000041978943,0.00014906879,0.00007928704,0.00019876708,0.000018772009,0.00005266395,0.000019495654,0.00008225383,0.00011196678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060678297,0.00085066486,0.905072,0.0005832583,0.00021442646,0.00015377364,0.0074100746,0.00007559102,0.00095425453,0.00010654272,0.0027766316,0.08119601],"study_design_scores_gemma":[0.009427336,0.0009890817,0.97709817,0.00024558313,0.00013905758,0.00003576139,0.00033394503,0.00039213116,0.0079790065,0.000023777025,0.0030653386,0.00027080093],"about_ca_topic_score_codex":0.0020087094,"about_ca_topic_score_gemma":0.00018438081,"teacher_disagreement_score":0.08092521,"about_ca_system_score_codex":0.00019925574,"about_ca_system_score_gemma":0.0005243851,"threshold_uncertainty_score":0.6078849},"labels":[],"label_agreement":null},{"id":"W2590065183","doi":"10.1182/blood.v112.11.1559.1559","title":"Supportive Efficacy Analyses for the Phase 3 Study of Temsirolimus Versus Investigator’s Choice Therapy for the Treatment of Patients with Relapsed or Refractory Mantle Cell Lymphoma.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Temsirolimus; Medicine; Hazard ratio; Mantle cell lymphoma; Internal medicine; Clinical endpoint; Population; Refractory (planetary science); Progression-free survival; Oncology; Randomized controlled trial; Lymphoma; Confidence interval; Chemotherapy; Discovery and development of mTOR inhibitors; Biology; PI3K/AKT/mTOR pathway","score_opus":0.09279054521882356,"score_gpt":0.3546920991419785,"score_spread":0.26190155392315495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590065183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99316365,0.0014329039,0.0000046409496,0.00007455987,0.00008696461,0.0050176904,0.00016673747,0.000015937389,0.000036923306],"genre_scores_gemma":[0.99767697,0.00073975365,0.00013158462,0.000055708628,0.00007901613,0.0010496838,0.00006748607,0.000032511856,0.00016727149],"study_design_codex":"nonrandomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9988119,0.000044313405,0.00036368557,0.0002727883,0.00029877207,0.0002085367],"domain_scores_gemma":[0.99655235,0.0022285297,0.00034485236,0.00055492326,0.0002128184,0.00010654958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006270408,0.00023728395,0.000475459,0.00005746932,0.00018975214,0.0000056685285,0.00011533717,0.000048232538,0.00001653256],"category_scores_gemma":[0.0001079436,0.00009375215,0.00019200692,0.00017029617,0.00014412281,0.000035430287,0.000009447599,0.000020630887,9.2750673e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06322633,0.46465483,0.41786483,0.000098981545,0.012502679,0.00006307885,0.01197376,0.00002885581,0.0007563757,0.0000065945515,0.0013535888,0.027470093],"study_design_scores_gemma":[0.3653225,0.08747387,0.48482418,0.000023859033,0.0044442513,0.0000022494362,0.0011324224,0.000026212198,0.05168705,8.549917e-7,0.0049403766,0.00012216679],"about_ca_topic_score_codex":0.00037232455,"about_ca_topic_score_gemma":0.00005274325,"teacher_disagreement_score":0.37718096,"about_ca_system_score_codex":0.00008424298,"about_ca_system_score_gemma":0.00031718414,"threshold_uncertainty_score":0.38231018},"labels":[],"label_agreement":null},{"id":"W2590078033","doi":"10.1182/blood.v114.22.1661.1661","title":"The VcR-CVAD Regimen Produces a High Complete Response Rate in Untreated Mantle Cell Lymphoma (MCL): First Analysis of E1405 – A Phase II Study of VcR-CVAD with Maintenance Rituximab for MCL.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Regimen; Mantle cell lymphoma; Vincristine; Rituximab; Bortezomib; Cyclophosphamide; Internal medicine; Surgery; Chemotherapy; Chemotherapy regimen; Phases of clinical research; Gastroenterology; Urology; Lymphoma; Multiple myeloma","score_opus":0.012704438226657754,"score_gpt":0.2603393007549339,"score_spread":0.24763486252827613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590078033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99463564,0.00087999273,0.000004496545,0.0017323169,0.000022066499,0.0023854217,0.00020467101,0.000033009255,0.00010236748],"genre_scores_gemma":[0.99852943,0.00012730742,0.00024470012,0.00009065824,0.000021076145,0.0003399476,0.00007168175,0.000026174745,0.0005489915],"study_design_codex":"nonrandomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9976617,0.00024791536,0.00068697624,0.0005927158,0.0003604954,0.0004502151],"domain_scores_gemma":[0.9976062,0.00062601484,0.00044894428,0.000921814,0.00029995202,0.00009706469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077888905,0.0003337075,0.0010994927,0.0003686066,0.00021691137,0.000023031449,0.0002224285,0.000067715984,0.000012166403],"category_scores_gemma":[0.00018028576,0.00019935785,0.00019795621,0.0012858091,0.0001212368,0.00006369209,0.000047448302,0.00005351273,0.0000025836055],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20343381,0.5686275,0.12972368,0.00054750347,0.0212525,0.0019655218,0.019223757,0.0004020224,0.034748074,0.000375227,0.0021009888,0.017599422],"study_design_scores_gemma":[0.25159264,0.04068618,0.5891878,0.0004989512,0.012489487,0.00003138199,0.0026274547,0.00068584783,0.10035803,0.000048908383,0.0013685899,0.00042474412],"about_ca_topic_score_codex":0.0011811566,"about_ca_topic_score_gemma":0.0012129841,"teacher_disagreement_score":0.5279413,"about_ca_system_score_codex":0.00012981355,"about_ca_system_score_gemma":0.00017743932,"threshold_uncertainty_score":0.8129577},"labels":[],"label_agreement":null},{"id":"W2590096408","doi":"10.1182/blood.v108.11.239.239","title":"Expression of MLL Fusion Genes in Human Hematopoietic Cells Is Sufficient To Induce Both Acute Lymphoid and Acute Myeloid Leukemia In Vivo.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Biology; Haematopoiesis; Lymphopoiesis; Leukemia; Myeloid; Cancer research; Immunology; Bone marrow; clone (Java method); Acute leukemia; Stem cell; Gene; Genetics","score_opus":0.01085910169809486,"score_gpt":0.26926460586991124,"score_spread":0.2584055041718164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590096408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99676067,0.00051445316,0.000020945667,0.00027440846,0.00004493446,0.00086212,0.00003910854,0.000036304922,0.001447083],"genre_scores_gemma":[0.9967556,0.00028117944,0.001095546,0.00026826083,0.00009227238,0.00005592038,0.000019841831,0.000051780476,0.0013796011],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99744344,0.000069295966,0.00064604724,0.00060967286,0.00063921907,0.0005923259],"domain_scores_gemma":[0.9989532,0.000068465946,0.00012663206,0.00055565214,0.00008128025,0.0002147453],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039170255,0.00029222367,0.00060736475,0.0006660293,0.00007330397,0.000024780447,0.00024456062,0.00025097647,0.00011271052],"category_scores_gemma":[0.000019266947,0.00025814597,0.00007637876,0.0006839265,0.00010526573,0.00009203389,0.00037234844,0.0003145194,0.000017564736],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017125724,0.0005855292,0.01971538,0.00014915087,0.000026797396,0.00046981254,0.0012265571,0.000026275766,0.9753609,0.000025613774,0.0019886785,0.0002540554],"study_design_scores_gemma":[0.0067043323,0.00041596685,0.022164404,0.00046714186,0.000102007405,0.00015760263,0.0002609,0.000107659245,0.968751,0.000042054144,0.0005907039,0.00023620023],"about_ca_topic_score_codex":0.0016417113,"about_ca_topic_score_gemma":0.00015329283,"teacher_disagreement_score":0.006609866,"about_ca_system_score_codex":0.00055883126,"about_ca_system_score_gemma":0.00045009595,"threshold_uncertainty_score":0.99998707},"labels":[],"label_agreement":null},{"id":"W2590120838","doi":"10.1182/blood.v108.11.1549.1549","title":"Role of HFE in Hepatic Iron Overload: Novel Findings Demonstrate Direct Effects of Mutant C282Y on Hepcidin and Calreticulin mRNA Expression.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Calreticulin; Hepcidin; Endoplasmic reticulum; Hereditary hemochromatosis; Mutant; Hemochromatosis; Ferroportin; Unfolded protein response; Cell biology; Mutant protein; Transfection; Biology; Chemistry; Molecular biology; Cell culture; Biochemistry; Immunology; Gene; Genetics; Inflammation","score_opus":0.0032586743606413046,"score_gpt":0.20318868502799728,"score_spread":0.19993001066735597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590120838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942644,0.0024191425,0.000008014339,0.000029597457,0.000037584603,0.00036537822,0.000013788071,0.000015129888,0.0028469204],"genre_scores_gemma":[0.99902654,0.00013159626,0.00068648555,0.00003740285,0.00002883714,0.0000134799,0.000008590693,0.000016560796,0.000050491228],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998974,0.00003983451,0.00032430622,0.00021981141,0.00023617619,0.00020584131],"domain_scores_gemma":[0.9994671,0.00015560417,0.00010468143,0.00018539552,0.00002194793,0.00006529114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013085907,0.00015534267,0.00043805,0.0001392141,0.000021305144,0.0000043969653,0.000051592237,0.0000995921,0.00001523745],"category_scores_gemma":[0.00015416586,0.00012529899,0.000058413716,0.00015398281,0.00008622555,0.00003857356,0.000025607429,0.0001136749,0.0000022977058],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013967132,0.001357287,0.0874728,0.0005047724,0.00000736741,0.00001841296,0.00023351512,0.000010120788,0.90962553,0.00022087386,0.000022859076,0.00038676258],"study_design_scores_gemma":[0.0058744205,0.0002653321,0.25934565,0.00046831963,0.00013771327,0.000007647933,0.0000824737,0.00003807225,0.73354095,0.00012171283,0.000020473955,0.000097239485],"about_ca_topic_score_codex":0.0005540905,"about_ca_topic_score_gemma":0.00004003789,"teacher_disagreement_score":0.17608462,"about_ca_system_score_codex":0.000008326148,"about_ca_system_score_gemma":0.000038309863,"threshold_uncertainty_score":0.51095444},"labels":[],"label_agreement":null},{"id":"W2590133597","doi":"10.1182/blood.v114.22.1866.1866","title":"Prolonged Use of Lenalidomide (≥12 Cycles) for Multiple Myeloma (MM) Is Frequently Affected by Dose-Limiting Thrombocytopenia but Is Associated with Improved Quality of Response and Survival.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Lenalidomide; Medicine; Multiple myeloma; Dexamethasone; Internal medicine; Data monitoring committee; Refractory (planetary science); Surgery; Oncology; Randomized controlled trial; Biology","score_opus":0.06479940935999418,"score_gpt":0.32684519123499833,"score_spread":0.26204578187500416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590133597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955886,0.00019100604,0.000045113342,0.0004423833,0.000013180988,0.0023211306,0.001304228,0.000059456503,0.000034871922],"genre_scores_gemma":[0.9966901,0.00003187278,0.0025401528,0.0001489173,0.000020104653,0.00007650632,0.00019543157,0.00004026194,0.00025668406],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99734336,0.0004920961,0.00061444775,0.0004966232,0.00052505947,0.0005284233],"domain_scores_gemma":[0.9966557,0.0016900987,0.0004784837,0.0004733271,0.00044728201,0.00025508233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010360542,0.00030211848,0.0010061907,0.00012772692,0.00011509667,0.000033565695,0.000117070915,0.0001873444,0.000019903347],"category_scores_gemma":[0.003996859,0.00023488655,0.0001576023,0.00022823132,0.0001603866,0.00017295693,0.00004270173,0.00018801451,9.064906e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019036107,0.0021339108,0.22616412,0.00015300959,0.0010544816,0.000028177821,0.00043158943,1.6139747e-7,0.7493458,0.0000034443071,0.00009778738,0.001551443],"study_design_scores_gemma":[0.02978163,0.0021867172,0.5657181,0.00016905104,0.00025884373,0.00000814065,0.00007624995,0.00020569026,0.40143567,0.000011097496,0.00000938809,0.00013938174],"about_ca_topic_score_codex":0.000760816,"about_ca_topic_score_gemma":0.0002747298,"teacher_disagreement_score":0.3479101,"about_ca_system_score_codex":0.00006541506,"about_ca_system_score_gemma":0.00018737232,"threshold_uncertainty_score":0.95783955},"labels":[],"label_agreement":null},{"id":"W2590191054","doi":"10.1182/blood.v104.11.3150.3150","title":"Informed Consent in Pediatric Bone Marrow Transplantation: The Parental Experience.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Ethics and Legal Issues in Pediatric Healthcare","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Informed consent; Feeling; Medicine; Anxiety; Family medicine; Transplantation; Nova scotia; Psychology; Psychiatry; Social psychology; Surgery; Alternative medicine","score_opus":0.03772358095440179,"score_gpt":0.3423249744623387,"score_spread":0.3046013935079369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590191054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876111,0.0022290614,0.000009339929,0.004617208,0.00019426827,0.00033086835,0.00000791526,0.000031693853,0.0049685393],"genre_scores_gemma":[0.9907724,0.0073004835,0.00026417503,0.0010111864,0.00046090485,0.000050608767,0.000024726225,0.000008953735,0.00010653178],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897945,0.000024925057,0.0003139933,0.00014920768,0.00029694114,0.00023549756],"domain_scores_gemma":[0.9993628,0.00024848036,0.000050152215,0.00018077626,0.00004276751,0.00011497716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018100142,0.00009939234,0.00015111748,0.00008101657,0.000078814395,0.0000148146055,0.00007717822,0.000107903004,0.00006821255],"category_scores_gemma":[0.00021411995,0.000069001304,0.00004951775,0.00030209668,0.00007203193,0.00005592544,0.000012664527,0.00035971228,0.000023200431],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016526392,0.00087462144,0.9301553,0.001343714,0.000021155765,0.0014670664,0.06212717,0.000023464785,0.00012276295,0.003036756,0.0002443699,0.00041836972],"study_design_scores_gemma":[0.03058278,0.001211204,0.93552005,0.00058050477,0.0006500695,0.0025277846,0.013709363,0.000009361308,0.0040835696,0.0018496626,0.008551293,0.0007243825],"about_ca_topic_score_codex":0.00046255116,"about_ca_topic_score_gemma":0.0013559301,"teacher_disagreement_score":0.048417807,"about_ca_system_score_codex":0.00004347519,"about_ca_system_score_gemma":0.00088826666,"threshold_uncertainty_score":0.28137916},"labels":[],"label_agreement":null},{"id":"W2590203404","doi":"10.1182/blood.v114.22.987.987","title":"Port-A-Catheter Infection Rate and Associated Risk Factors in Children Diagnosed with Acute Lymphoblastic Leukemia.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Catheter; Neutropenia; Surgery; Absolute neutrophil count; Incidence (geometry); Port (circuit theory); Retrospective cohort study; Internal medicine; Chemotherapy","score_opus":0.005752578254273503,"score_gpt":0.22540486167176002,"score_spread":0.21965228341748652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590203404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99897134,0.000041257623,0.000017153865,0.000036234283,0.0000362684,0.00034717057,0.000017033397,0.00008787371,0.0004456551],"genre_scores_gemma":[0.9992235,0.00038578603,0.00001288802,0.00014552915,0.00005015332,0.000020520509,0.00003990646,0.00001621914,0.00010551964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992615,0.00004709847,0.00015565833,0.00022855794,0.00010282314,0.00020437097],"domain_scores_gemma":[0.99959725,0.00004016902,0.00009356614,0.00013997483,0.00003363078,0.00009541574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007994424,0.0001514037,0.00024128951,0.00012317392,0.00007810871,0.000023660858,0.000024440082,0.0000839892,0.000025817082],"category_scores_gemma":[0.000044651017,0.00011355555,0.000047210593,0.00027128117,0.00003112027,0.000095460666,0.000008744792,0.00018904243,0.0000071456434],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005234549,0.0005166876,0.99736327,0.0000023511707,0.00024075311,0.000041809257,0.00014289744,0.000020004769,0.0012477763,0.0000053281847,0.000036316087,0.0003304468],"study_design_scores_gemma":[0.006480935,0.0011269825,0.9875148,0.000058789516,0.00080503843,0.00013609872,0.0000061317874,0.000008419621,0.0036672316,0.000033556837,0.000027615544,0.0001343952],"about_ca_topic_score_codex":0.0011073421,"about_ca_topic_score_gemma":0.00034555985,"teacher_disagreement_score":0.009848478,"about_ca_system_score_codex":0.00012506408,"about_ca_system_score_gemma":0.00011058118,"threshold_uncertainty_score":0.4630661},"labels":[],"label_agreement":null},{"id":"W2590214910","doi":"10.1182/blood.v114.22.2248.2248","title":"CMV-Specific Immunity and CMV Complications in Seropositive HCT Recipients Depend On Donor Serostatus.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baker Hughes (Canada); University of Calgary","funders":"","keywords":"Medicine; CD8; Immunology; Serostatus; T cell; Thymoglobulin; Cytomegalovirus; Transplantation; Cytotoxic T cell; Foscarnet; Anti-thymocyte globulin; Priming (agriculture); Virology; Immune system; Human cytomegalovirus; Ganciclovir; Internal medicine; Viral load; Virus; Biology; Viral disease; Kidney transplantation; Herpesviridae","score_opus":0.03445288809260412,"score_gpt":0.31847024125733886,"score_spread":0.28401735316473475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590214910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807994,0.0005540151,0.0000055221485,0.0013016217,0.000023777586,0.0005069756,0.000049184207,0.00003385867,0.016725697],"genre_scores_gemma":[0.99802744,0.0006911155,0.00029842978,0.00052427227,0.000053402353,0.000018860992,0.000061693696,0.000014855087,0.00030991744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988458,0.00007025273,0.00021836857,0.0002939231,0.00025119833,0.00032044516],"domain_scores_gemma":[0.9992016,0.00009145535,0.00003909632,0.00038999526,0.00008965704,0.00018822172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020151059,0.00013910196,0.00024035972,0.00020858305,0.00015413959,0.000038597736,0.00008311363,0.00008642248,0.000109773195],"category_scores_gemma":[0.00003622748,0.00012584156,0.000044385783,0.00031993378,0.00009037894,0.00007360828,0.00004536007,0.0004481714,0.00013508637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051345034,0.026262017,0.4685189,0.00018733209,0.00046360516,0.0010988665,0.010704646,0.000019368965,0.2643393,0.010372802,0.0071393773,0.20575926],"study_design_scores_gemma":[0.00442684,0.0006941908,0.9779548,0.00013988107,0.000025321007,0.00005798689,0.00022087627,0.000023111419,0.008510924,0.00018739256,0.0076203286,0.00013837081],"about_ca_topic_score_codex":0.00027303892,"about_ca_topic_score_gemma":0.00022168738,"teacher_disagreement_score":0.50943583,"about_ca_system_score_codex":0.000063343214,"about_ca_system_score_gemma":0.000056143122,"threshold_uncertainty_score":0.51316696},"labels":[],"label_agreement":null},{"id":"W2590229274","doi":"10.1182/blood.v116.21.2922.2922","title":"Will a Peripheral Blood (PB) Sample Yield the Same Diagnostic and Prognostic Cytogenetic Data as the Concomitant Bone Marrow (BM) In Myelodysplasia? An International Study Comparing Cytogenetics and Interphase FISH Using Parallel PB and BM Samples","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North York General Hospital","funders":"","keywords":"Myelodysplastic syndromes; International Prognostic Scoring System; Fluorescence in situ hybridization; Cytogenetics; Bone marrow; Biology; Pathology; Concordance; Leukemia; Oncology; Concomitant; Chromosome; Internal medicine; Medicine; Immunology; Genetics","score_opus":0.06715068969143526,"score_gpt":0.3309408066033175,"score_spread":0.26379011691188226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590229274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99539685,0.00071323843,0.00019258792,0.001382383,0.000109200635,0.0019315608,0.00020354483,0.000033069402,0.000037541577],"genre_scores_gemma":[0.99377006,0.00048322292,0.00472149,0.00045812834,0.00029572996,0.00009065122,0.000110229674,0.000055311233,0.000015149207],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974561,0.0002297402,0.00053078553,0.0007691235,0.0005063775,0.00050791353],"domain_scores_gemma":[0.9955633,0.0028543423,0.00014064931,0.0010410431,0.00011556556,0.0002850834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009245668,0.00035004472,0.0004986678,0.00014671577,0.00027918338,0.00033217084,0.0006544962,0.00012885447,0.000053641277],"category_scores_gemma":[0.0045758463,0.00023877741,0.00003226935,0.00019862367,0.00062757416,0.00028825185,0.0011933662,0.0008727877,0.0000010502457],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029264923,0.0012052492,0.969076,0.000057467307,0.00035469874,0.00036612057,0.0028663059,0.000017564518,0.02447718,0.000065892935,0.000025584794,0.0011953362],"study_design_scores_gemma":[0.019407228,0.0023004017,0.9418602,0.00041422917,0.0017377972,0.0050662598,0.0061180824,0.019727683,0.0018499525,0.000311869,0.00057233905,0.00063396286],"about_ca_topic_score_codex":0.0019217958,"about_ca_topic_score_gemma":0.009459062,"teacher_disagreement_score":0.027215756,"about_ca_system_score_codex":0.000039551596,"about_ca_system_score_gemma":0.0002499043,"threshold_uncertainty_score":0.973706},"labels":[],"label_agreement":null},{"id":"W2590281602","doi":"10.1182/blood.v108.11.3299.3299","title":"Content, Accuracy and Quality of Warfarin Patient Information.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Warfarin; Fact sheet; Medicine; Pharmacy; Reading (process); Scale (ratio); Quality (philosophy); Computer science; Medical physics; Family medicine; Internal medicine; World Wide Web; Geography","score_opus":0.18362342511156773,"score_gpt":0.3862778646192232,"score_spread":0.20265443950765546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590281602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874833,0.00026324068,0.000034688906,0.0003962656,0.000039733564,0.00020880683,0.00001432604,0.00001558921,0.01154404],"genre_scores_gemma":[0.99891907,0.000033982124,0.00035188836,0.0005859501,0.000017491142,0.0000038156354,0.00002111567,0.0000022901324,0.000064383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999379,0.000025319072,0.00031283096,0.000050453236,0.0001508769,0.000081546124],"domain_scores_gemma":[0.9994378,0.00019450825,0.00015523564,0.00009524407,0.00006725009,0.000049973947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010657399,0.00005239794,0.00014052307,0.000028373155,0.00002056655,0.000008021209,0.000020781083,0.000026697084,0.00004607177],"category_scores_gemma":[0.00030590154,0.0000393718,0.00003370908,0.000046861118,0.000030850566,0.00024182063,0.000026262707,0.00007071943,0.000010813319],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020012443,0.0007372264,0.9825527,0.00027429845,0.000060625563,0.000002048011,0.00022070506,0.0000010611175,0.004581397,0.003681953,0.00020914733,0.007478703],"study_design_scores_gemma":[0.006413229,0.00029445565,0.9288142,0.000037624086,0.0001793135,0.000015709189,0.00020693411,0.00006637735,0.02664711,0.00015828403,0.03706226,0.000104516286],"about_ca_topic_score_codex":0.00032718183,"about_ca_topic_score_gemma":0.0000042899746,"teacher_disagreement_score":0.053738527,"about_ca_system_score_codex":0.0000041825615,"about_ca_system_score_gemma":0.000014674233,"threshold_uncertainty_score":0.16055353},"labels":[],"label_agreement":null},{"id":"W2590294446","doi":"10.1182/blood.v126.23.668.668","title":"The Zebrafish Provides Mechanistic Insights into the Role of Poly(A)-Specific Ribonuclease (PARN) in Hematopoietic Stem Cell (HSC) Homeostasis and Bone Marrow Failure","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Dalhousie University; Hospital for Sick Children; Izaak Walton Killam Health Centre","funders":"","keywords":"Zebrafish; Biology; Morpholino; Cell biology; Diamond–Blackfan anemia; Hematopoietic stem cell; Stem cell; GATA1; Haematopoiesis; Genetics; RNA; Gene","score_opus":0.007994697588822505,"score_gpt":0.19785134757799272,"score_spread":0.1898566499891702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590294446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91357666,0.08531892,0.000070898095,0.00041231496,0.00003386166,0.00024157911,0.000008011739,0.0000062382333,0.00033151146],"genre_scores_gemma":[0.9979546,0.0015432276,0.00016541991,0.000043036296,0.000054488668,0.000062021725,0.000011192464,0.000018063616,0.00014791706],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99914104,0.00008442668,0.00022419896,0.0002478722,0.00013867031,0.00016377767],"domain_scores_gemma":[0.99924034,0.000022848482,0.00010850307,0.00046783828,0.00008193558,0.000078557125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018994624,0.00012622352,0.0001297841,0.000029937397,0.000118181866,0.000052118266,0.00021431652,0.00008740808,0.000002756933],"category_scores_gemma":[0.00001718478,0.00007968871,0.000043111213,0.00012176401,0.00013094115,0.000005834465,0.00010123492,0.00008322459,0.0000039981846],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014118366,0.0004810324,0.0008570849,0.00006595502,0.00007009221,0.000006513966,0.003196447,0.000008936818,0.9656001,0.0055798627,0.0012305955,0.022762218],"study_design_scores_gemma":[0.001655968,0.00030394993,0.00053044665,0.000032120617,0.00007084079,0.000021301454,0.00962309,0.0000664746,0.7993682,0.0041273087,0.18393476,0.00026552705],"about_ca_topic_score_codex":0.0000654195,"about_ca_topic_score_gemma":0.0003106185,"teacher_disagreement_score":0.18270417,"about_ca_system_score_codex":0.000010237346,"about_ca_system_score_gemma":0.000081659426,"threshold_uncertainty_score":0.32496113},"labels":[],"label_agreement":null},{"id":"W2590300471","doi":"10.1182/blood.v126.23.4866.4866","title":"A Phase 1b, Open-Label, Dose Escalation and Expansion Study Evaluating the Safety and Efficacy of Entospletinib (GS-9973) with Vincristine and Dexamethasone in Adult Subjects with Relapsed or Refractory Acute Lymphoid Leukemia (ALL)","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Syk; Leukemia; Cancer research; Medicine; B cell; Immunology; Bone marrow; Stem cell; Pharmacology; Internal medicine; Tyrosine kinase; Biology; Receptor; Cell biology","score_opus":0.05963480540907737,"score_gpt":0.3749456455827471,"score_spread":0.3153108401736697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590300471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961421,0.0002768391,0.000092772774,0.00025745612,0.000016958384,0.0030248887,0.000017264098,0.000031024032,0.00014070951],"genre_scores_gemma":[0.994406,0.00019594256,0.0049075894,0.000119508586,0.000048746886,0.00009366326,0.00003524689,0.00005611033,0.00013721769],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9969339,0.00048574945,0.0005629299,0.0006574395,0.0009727476,0.0003872814],"domain_scores_gemma":[0.997142,0.0012527237,0.0003023691,0.0005383004,0.00042769563,0.00033689494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021024102,0.00032288802,0.00067438977,0.00016935312,0.00012665684,0.000071916686,0.00018799245,0.00012499797,0.000008095219],"category_scores_gemma":[0.0019702774,0.00017859387,0.000011609237,0.0005408741,0.00032678046,0.00024793384,0.00033952427,0.00034774753,0.000001114877],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.45577323,0.046057455,0.1984153,0.000833533,0.0026476833,0.0027086793,0.04543752,0.000038052556,0.15260386,0.00006164611,0.0002119523,0.0952111],"study_design_scores_gemma":[0.8083149,0.08450336,0.076809995,0.0013595372,0.002480491,0.0020800305,0.0057674693,0.013922888,0.0041975854,0.000010186903,0.000045930305,0.00050762855],"about_ca_topic_score_codex":0.0010929108,"about_ca_topic_score_gemma":0.00036077842,"teacher_disagreement_score":0.3525417,"about_ca_system_score_codex":0.0003937025,"about_ca_system_score_gemma":0.0016993267,"threshold_uncertainty_score":0.72828466},"labels":[],"label_agreement":null},{"id":"W2590306790","doi":"10.1182/blood.v114.22.3409.3409","title":"Elderly Multiple Myeloma (MM) Patients (≥70 years) Can Safely Undergo Autologous Stem Cell Transplantation (ASCT) but Have Shorter Overall Survival Than Younger Patients (&lt;70 years).","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Melphalan; Surgery; Transplantation; Multiple myeloma; Internal medicine; Gastroenterology","score_opus":0.016602091666397943,"score_gpt":0.24472882946800145,"score_spread":0.2281267378016035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590306790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955767,0.000104000486,0.000035852954,0.00010850738,0.00025091117,0.0013365579,0.0005598112,0.00014604823,0.0018816594],"genre_scores_gemma":[0.99575514,0.000116179384,0.00033308758,0.00019901879,0.00013800425,0.000039576553,0.001679306,0.00007207603,0.0016676264],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965336,0.00018317613,0.0005433099,0.000713173,0.0011227089,0.0009040828],"domain_scores_gemma":[0.9984342,0.00012352718,0.00016670323,0.00053931284,0.00022094014,0.0005153233],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001337694,0.00043909388,0.0005647302,0.00024227622,0.00013660028,0.00007661862,0.00023076951,0.00027869706,0.00009860189],"category_scores_gemma":[0.000032637643,0.00041153614,0.00023777623,0.000160449,0.00006799528,0.00022984445,0.000038206275,0.00035797872,0.00016845063],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014255878,0.005010721,0.9464053,0.00011150471,0.00039730003,0.00090882095,0.0015137253,0.000004328258,0.0028949575,0.000012272199,0.0002865729,0.041028943],"study_design_scores_gemma":[0.022239061,0.0027280778,0.96705604,0.00009322713,0.00035998694,0.000019922074,0.000086878696,0.00007279957,0.0066874507,0.000027590188,0.00025146277,0.0003774804],"about_ca_topic_score_codex":0.0006510824,"about_ca_topic_score_gemma":0.00067407335,"teacher_disagreement_score":0.040651463,"about_ca_system_score_codex":0.00018780939,"about_ca_system_score_gemma":0.00017222058,"threshold_uncertainty_score":0.99983364},"labels":[],"label_agreement":null},{"id":"W2590329281","doi":"10.1182/blood.v128.22.52.52","title":"Longitudinal Tracking of MDS Patients Using Next Generation Sequencing Provides a Predictive Measure for Azacitidine Response and AML Progression","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Azacitidine; Myelodysplastic syndromes; Oncology; Internal medicine; Medicine; Myeloid leukemia; International Prognostic Scoring System; Hypomethylating agent; Bone marrow; Biology; Gene; Genetics","score_opus":0.11538503938323698,"score_gpt":0.3352456667797034,"score_spread":0.21986062739646645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590329281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933634,0.00025869004,0.0047357646,0.00021958153,0.00003290497,0.0013015749,0.00004284065,0.0000314862,0.000013754057],"genre_scores_gemma":[0.99247116,0.00001568047,0.0071477336,0.0000160038,0.0001998603,0.00007225344,0.000014542795,0.00002958713,0.00003318467],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99862224,0.0001271879,0.000278497,0.00031001106,0.00040022845,0.0002618085],"domain_scores_gemma":[0.9987606,0.00020716494,0.00014451946,0.00017778213,0.0006125575,0.00009737858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007190609,0.00013537321,0.00024324912,0.00015738932,0.00011441584,0.000022580081,0.000053351192,0.00010638864,0.000005435995],"category_scores_gemma":[0.0016138653,0.00008829646,0.000052946598,0.00013549028,0.000114006005,0.00030414824,0.000048330534,0.00009553503,4.810226e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030205862,0.00017649675,0.11569163,0.00016089667,0.000086634594,0.000012365852,0.000360033,0.0000017433848,0.86474025,0.000006203284,0.000035599114,0.015707549],"study_design_scores_gemma":[0.013829029,0.0033360098,0.089021236,0.0018697347,0.00038824748,0.000103724116,0.0001291226,0.005986923,0.88508165,0.000031302283,0.00004338994,0.00017962826],"about_ca_topic_score_codex":0.000014904907,"about_ca_topic_score_gemma":0.0000053548324,"teacher_disagreement_score":0.0266704,"about_ca_system_score_codex":0.00027303683,"about_ca_system_score_gemma":0.00047301437,"threshold_uncertainty_score":0.3600625},"labels":[],"label_agreement":null},{"id":"W2590330431","doi":"10.1182/blood.v116.21.800.800","title":"Comparing MicroRNA Expression In Aggressive and Indolent Non-Hodgkin Lymphomas Identifies a Prognostic Signature for Mantle Cell Lymphoma","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Queen's University; Health Sciences Centre; Sunnybrook Health Science Centre; Toronto General Hospital; University Health Network; University of Toronto; Ontario Institute for Cancer Research; BC Cancer Agency; Kingston General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Mantle cell lymphoma; microRNA; Lymphoma; Medicine; Oncology; TaqMan; Transplantation; Cancer research; Gene expression profiling; Real-time polymerase chain reaction; Pathology; Biology; Internal medicine; Gene expression; Gene","score_opus":0.006718646863967504,"score_gpt":0.24297254864015105,"score_spread":0.23625390177618355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590330431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948328,0.0025494967,0.0014010502,0.000027036991,0.00018064934,0.00072445587,0.000024822673,0.00001045868,0.0002492174],"genre_scores_gemma":[0.9977486,0.00015497839,0.0013623061,0.00004057153,0.00012967832,0.00019632683,0.000103868115,0.000040827617,0.00022285673],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987578,0.0000382213,0.00019676195,0.0004911474,0.00015717659,0.0003589078],"domain_scores_gemma":[0.9993576,0.00002688876,0.00012363544,0.00030450823,0.00008470274,0.000102661994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016551884,0.00018758992,0.00018223409,0.00010191503,0.00008946322,0.0000646396,0.00020630086,0.00031998137,0.000008772501],"category_scores_gemma":[0.00012869858,0.00018482463,0.00007001325,0.00009129835,0.00007021359,0.0000062062345,0.00026490382,0.00016908997,0.0000034181892],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013488946,0.00034137993,0.000761386,0.00010032592,0.000025238489,0.000035583864,0.00010170545,0.000010678038,0.9971942,0.00000578148,0.00027063733,0.0010181987],"study_design_scores_gemma":[0.0057750177,0.00018866152,0.002602055,0.00012900303,0.000030273468,0.00005349518,0.000074997755,0.00014575853,0.9897357,0.00007323692,0.00097253255,0.00021922546],"about_ca_topic_score_codex":0.00002150201,"about_ca_topic_score_gemma":0.00018889994,"teacher_disagreement_score":0.0074584526,"about_ca_system_score_codex":0.00001261837,"about_ca_system_score_gemma":0.00011887964,"threshold_uncertainty_score":0.753693},"labels":[],"label_agreement":null},{"id":"W2590334965","doi":"10.1182/blood.v104.11.2059.2059","title":"Triple Immunosuppressive Therapy in Patients with Chronic Resistant Immune Thrombocytopenic Purpura; a Case Series of 11 Patients.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Azathioprine; Splenectomy; Thrombocytopenic purpura; Internal medicine; Immunosuppression; Gastroenterology; Platelet; Spleen; Disease","score_opus":0.006849847765423045,"score_gpt":0.21690019257304502,"score_spread":0.21005034480762197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590334965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966674,0.0018120918,6.0592026e-7,0.000059688726,0.000042073294,0.0011725605,0.00007495551,0.000020517537,0.00015013486],"genre_scores_gemma":[0.9993139,0.00021383706,0.00011561145,0.000020156624,0.0000070722954,0.000063367166,0.00018224909,0.0000306926,0.000053120988],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988292,0.000027553326,0.0003602069,0.0002486425,0.00024832474,0.00028607374],"domain_scores_gemma":[0.9992596,0.00001267028,0.00017272349,0.00037279216,0.0001245873,0.00005761853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004039504,0.00021351036,0.0005286501,0.00010394298,0.000065450164,0.000010916795,0.000081052916,0.00007607327,0.00016884814],"category_scores_gemma":[0.000018578117,0.00014924939,0.00008021555,0.00024682085,0.00009078573,0.00016782076,0.00003164732,0.00010974443,0.0000041886174],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042194743,0.016178545,0.9694881,0.00012661125,0.0005988137,0.004300596,0.00131687,0.000013059641,0.0017929951,0.00007498994,0.00001275531,0.0018772101],"study_design_scores_gemma":[0.09918243,0.008757319,0.8673817,0.00029423166,0.00018792918,0.00026520796,0.0001600741,1.9827921e-7,0.02341717,0.0000751665,0.000079963604,0.00019862484],"about_ca_topic_score_codex":0.001137643,"about_ca_topic_score_gemma":0.00077475735,"teacher_disagreement_score":0.10210639,"about_ca_system_score_codex":0.00010895353,"about_ca_system_score_gemma":0.00018751842,"threshold_uncertainty_score":0.60862136},"labels":[],"label_agreement":null},{"id":"W2590343515","doi":"10.1182/blood.v106.11.3684.3684","title":"Anticoagulant Heparan Sulfate Mediates Antithrombin Amelioration of Leukocyte-Endothelial Interactions in Sepsis.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Cremaster muscle; Intravital microscopy; Inflammation; Sepsis; Antithrombin; Immunology; Microcirculation; Proinflammatory cytokine; Chemistry; Thrombus; Biology; Medicine; Internal medicine; Heparin; Biochemistry","score_opus":0.021156483304471792,"score_gpt":0.29798333655199505,"score_spread":0.27682685324752326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590343515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99515146,0.00029089127,0.00004165179,0.0013233479,0.0001598345,0.0003928593,0.000010851935,0.000044229153,0.0025848667],"genre_scores_gemma":[0.9975899,0.00084383565,0.00091207516,0.00023026926,0.00021054839,0.000028339464,0.000035033692,0.000019129831,0.00013087002],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989189,0.000036672776,0.00040449406,0.00021109452,0.00021301645,0.00021584022],"domain_scores_gemma":[0.9994803,0.000042525804,0.00011910751,0.0002345321,0.000057559042,0.00006598575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016966785,0.00013024105,0.00044865103,0.00025533413,0.00003494786,0.00001522528,0.00007414316,0.00003855786,0.00018288154],"category_scores_gemma":[0.000053724933,0.000118034404,0.00008730391,0.00022771148,0.000049240905,0.00014761118,0.000037315287,0.00011975118,0.00007748075],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033533172,0.02831227,0.3340337,0.00069135823,0.0011072737,0.00022513929,0.004812871,0.00075672497,0.6016461,0.0059057856,0.008918893,0.013254544],"study_design_scores_gemma":[0.007955988,0.00045599125,0.5513712,0.0004120736,0.0006108814,0.000034418314,0.00036698085,0.0008036815,0.4301215,0.00014327728,0.007462055,0.00026190182],"about_ca_topic_score_codex":0.00042516805,"about_ca_topic_score_gemma":0.0008190517,"teacher_disagreement_score":0.21733753,"about_ca_system_score_codex":0.000038696842,"about_ca_system_score_gemma":0.00004807904,"threshold_uncertainty_score":0.48133034},"labels":[],"label_agreement":null},{"id":"W2590368876","doi":"10.1182/blood.v110.11.3307.3307","title":"Predictors of Transformation to Myelodysplasia/Acute Myelogenous Leukemia (MDS/AML) in Severe Congenital Neutropenia (SCN).","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Neutropenia; Congenital Neutropenia; Internal medicine; Promyelocyte; Bone marrow; Myelopoiesis; Absolute neutrophil count; Leukemia; Hematopoietic stem cell transplantation; Gastroenterology; Population; Transplantation; Pediatrics; Haematopoiesis; Chemotherapy; Stem cell","score_opus":0.004130487698422232,"score_gpt":0.21350027924421278,"score_spread":0.20936979154579055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590368876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99431014,0.00030329867,0.00023743087,0.000028524732,0.000086025175,0.0003965676,0.0000807281,0.000011220615,0.0045460546],"genre_scores_gemma":[0.99904937,0.00008649182,0.00031346665,0.00009126984,0.000056358465,0.000018375773,0.00018501708,0.000020549196,0.00017911696],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99899834,0.00002112988,0.0003085179,0.0002444999,0.00013247323,0.0002950503],"domain_scores_gemma":[0.9995626,0.0000069731386,0.00005872824,0.0002159544,0.000051186074,0.000104513696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000117414565,0.00016555347,0.00017970071,0.00008583705,0.000038717615,0.000009682652,0.00014545987,0.00016287623,0.000011576387],"category_scores_gemma":[0.000010288775,0.00015871138,0.00007719375,0.00015508854,0.00003373527,0.00000803298,0.000038489427,0.00006630288,0.000014743943],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011805022,0.0020267693,0.15731972,0.00007891946,0.0016324335,0.00015939013,0.0021242409,0.0002490026,0.81760174,0.00019813911,0.00040496778,0.017024182],"study_design_scores_gemma":[0.008337806,0.0016769589,0.09316296,0.000021444286,0.0003289903,0.0001251637,0.0002765623,0.000006426816,0.89281017,0.000032498094,0.0028614854,0.00035954043],"about_ca_topic_score_codex":0.000108004344,"about_ca_topic_score_gemma":0.000753228,"teacher_disagreement_score":0.07520843,"about_ca_system_score_codex":0.000020018193,"about_ca_system_score_gemma":0.0000928699,"threshold_uncertainty_score":0.64720625},"labels":[],"label_agreement":null},{"id":"W2590416412","doi":"10.1182/blood.v108.11.1048.1048","title":"An Algorithm for “Indeterminate” Test Results in the Platelet Serotonin Release Assay for Heparin-Induced Thrombocytopenia (HIT).","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Platelet; Heparin; Platelet factor 4; Platelet activation; Heparin-induced thrombocytopenia; Chemistry; Pharmacology; Serotonin; Apyrase; Monoclonal antibody; Immunology; Receptor; Antibody; Medicine; Biochemistry","score_opus":0.029276728198965204,"score_gpt":0.30576941669379726,"score_spread":0.27649268849483205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590416412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877051,0.000044729768,0.00048145652,0.0014312518,0.00020296195,0.0057440815,0.00061244477,0.00017056231,0.0036074265],"genre_scores_gemma":[0.9836395,0.000014053416,0.012351269,0.00058627024,0.0007392724,0.0014023975,0.00078987324,0.00012139522,0.0003559782],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963164,0.00019033815,0.00100542,0.0010055724,0.00045139575,0.0010308833],"domain_scores_gemma":[0.9968802,0.0011303755,0.00027901414,0.0012276246,0.00023758793,0.0002451958],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001733082,0.0005406302,0.0010652397,0.00023553729,0.0003499372,0.00016277548,0.0006044426,0.0004505277,0.00002187539],"category_scores_gemma":[0.000525549,0.0004156018,0.00030490814,0.00048654535,0.00009645361,0.00031660183,0.0000659175,0.00049760303,0.00004045614],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025184844,0.0326005,0.035371885,0.00089612516,0.0007901119,0.0014069246,0.003265865,0.000031422333,0.73620254,0.0026059998,0.0077370247,0.17657311],"study_design_scores_gemma":[0.060763337,0.008213272,0.2611098,0.0004000878,0.001027941,0.0008000578,0.0007207271,0.008242753,0.63718617,0.002061512,0.01793913,0.0015351918],"about_ca_topic_score_codex":0.0007200126,"about_ca_topic_score_gemma":0.00079278724,"teacher_disagreement_score":0.22573791,"about_ca_system_score_codex":0.000119417185,"about_ca_system_score_gemma":0.00032836213,"threshold_uncertainty_score":0.9998296},"labels":[],"label_agreement":null},{"id":"W2590468594","doi":"10.1182/blood.v108.11.574.574","title":"A Phase II Randomized, Double-Blind, Eight-Arm, Parallel-Group, Dose-Response Study of Apixaban, a New Oral Factor Xa Inhibitor for the Prevention of Deep Vein Thrombosis in Knee Replacement Surgery - On Behalf of the Apixaban Investigators.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Apixaban; Warfarin; Surgery; Deep vein; Pulmonary embolism; Thrombosis; Venography; Anesthesia; Rivaroxaban; Internal medicine; Atrial fibrillation","score_opus":0.05075478254133818,"score_gpt":0.31666401784081133,"score_spread":0.26590923529947313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590468594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98779726,0.00051250454,0.00011032816,0.00075276365,0.00025870788,0.01046491,0.000029717652,0.00002328245,0.000050532788],"genre_scores_gemma":[0.9979988,0.00006818543,0.00022959214,0.000100810554,0.00013174988,0.0012372598,0.000034012537,0.00004660646,0.00015301377],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99628824,0.0005755575,0.0015724007,0.00045538569,0.00074321177,0.00036520968],"domain_scores_gemma":[0.9968261,0.0011124574,0.0009680387,0.00085762556,0.00012967103,0.000106112544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023443664,0.00035400523,0.001643155,0.00035113917,0.00013190355,0.00001893918,0.00024834444,0.00012668638,0.000082096885],"category_scores_gemma":[0.0003847916,0.00021481278,0.00064234546,0.00053327647,0.00019812201,0.00009763237,0.0001648205,0.00018809256,0.0000011052285],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.71285206,0.2247372,0.021683693,0.0010302615,0.0042807404,0.000012968799,0.010078877,0.00037670057,0.015132612,0.00183521,0.005724326,0.0022553455],"study_design_scores_gemma":[0.89336306,0.014997316,0.040246505,0.00080362434,0.004240054,0.0000029884952,0.0014846355,0.00013183613,0.043529633,0.00038267006,0.000466093,0.00035161394],"about_ca_topic_score_codex":0.0021270963,"about_ca_topic_score_gemma":0.0012365108,"teacher_disagreement_score":0.2097399,"about_ca_system_score_codex":0.00006717797,"about_ca_system_score_gemma":0.00021271301,"threshold_uncertainty_score":0.8759811},"labels":[],"label_agreement":null},{"id":"W2590481202","doi":"10.1182/blood.v112.11.351.351","title":"Decreased Infections in Recipients of Unrelated Donor (URD Hematopoietic Cell Transplantation (HCT) from Donors with An Activating KIR B Genotype (B/x)","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Genotype; Transplantation; Medicine; Immunology; Internal medicine; Hematopoietic stem cell transplantation; Genotyping; Incidence (geometry); Leukemia; Cumulative incidence; Gastroenterology; Biology; Genetics","score_opus":0.010002469844882138,"score_gpt":0.20626265423339601,"score_spread":0.19626018438851386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590481202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997488,0.00016660726,0.0003731842,0.0000113370825,0.00042192088,0.00018633211,0.000008588319,0.000057395326,0.0012865922],"genre_scores_gemma":[0.9986255,0.00016030922,0.00024272884,0.00002769782,0.000011967483,0.000018800096,0.00048084604,0.00001713578,0.00041500802],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990925,0.00016613655,0.00031115572,0.00022333687,0.00003453369,0.00017231972],"domain_scores_gemma":[0.9994505,0.0001115767,0.00016902466,0.0001797738,0.00006851148,0.000020608277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006870275,0.00013727287,0.00019616997,0.00017207261,0.00014044646,0.000005160197,0.0000731632,0.00018259487,0.0005647017],"category_scores_gemma":[0.000021170936,0.00012511757,0.0000453253,0.00023896519,0.00006605363,0.0002133665,0.000007787603,0.00026901107,0.00008563465],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009502018,0.0018523936,0.15010694,0.000019809988,0.00015836416,0.000011421627,0.0028381,0.000102559,0.8436828,0.000017730785,0.00005224516,0.00020742672],"study_design_scores_gemma":[0.0066890675,0.00079365185,0.1863343,0.00010521104,0.00013348041,0.00019251753,0.00038442478,0.00001210624,0.8048551,0.000022321872,0.00027645478,0.00020133969],"about_ca_topic_score_codex":0.002366413,"about_ca_topic_score_gemma":0.00036710087,"teacher_disagreement_score":0.038827676,"about_ca_system_score_codex":0.0000274855,"about_ca_system_score_gemma":0.000071274255,"threshold_uncertainty_score":0.6183088},"labels":[],"label_agreement":null},{"id":"W2590520833","doi":"10.1182/blood.v112.11.920.920","title":"Pediatric Patients with Extramedullary Leukemia Involving the Central Nervous System Have a Superior Outcome.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Medicine; Leukemia; Central nervous system; Bone marrow; Chemotherapy; Pathology; Internal medicine; Oncology","score_opus":0.017220474479343058,"score_gpt":0.23424135509247732,"score_spread":0.21702088061313426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590520833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966789,0.00077721913,0.000025952422,0.00017926774,0.00011759214,0.0010371014,0.000018912275,0.00016514544,0.0009999464],"genre_scores_gemma":[0.99764866,0.000085298874,0.0005872584,0.00028208343,0.00063329155,0.00006629038,0.000040196217,0.00007452686,0.0005823986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99736136,0.00010742515,0.0004155593,0.0003997503,0.0008982812,0.00081760314],"domain_scores_gemma":[0.99850726,0.00014575898,0.00010322767,0.0006677549,0.00021991594,0.00035608222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019818514,0.00027894758,0.0004233406,0.0001501903,0.00034848097,0.00003671695,0.00031503648,0.00015255492,0.000040893043],"category_scores_gemma":[0.0001789918,0.00016439971,0.00012840932,0.00038867124,0.00016642702,0.00011768519,0.00013182641,0.00065194094,0.000078294084],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001697917,0.00025020997,0.99624765,0.00026459064,0.00010782247,0.00095847313,0.00078377326,0.0000071045897,0.00009073614,0.000024884195,0.00090207404,0.00019287491],"study_design_scores_gemma":[0.007653866,0.00050607306,0.9887272,0.00007026933,0.00042544235,0.00077370467,0.00072401273,0.00023093885,0.00029707173,8.041345e-7,0.00035734425,0.00023325122],"about_ca_topic_score_codex":0.0002712329,"about_ca_topic_score_gemma":0.00002262273,"teacher_disagreement_score":0.0075204433,"about_ca_system_score_codex":0.0006766746,"about_ca_system_score_gemma":0.0010060334,"threshold_uncertainty_score":0.6704026},"labels":[],"label_agreement":null},{"id":"W2590527978","doi":"10.1182/blood.v128.22.3705.3705","title":"A Retrospective Analysis of Pneumocystis Jirovecii Pneumonia Infection in Patients Receiving Idelalisib in Clinical Trials","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Pneumocystis jirovecii pneumonia detection and treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Bendamustine; Obinutuzumab; Ofatumumab; Idelalisib; Rituximab; Internal medicine; MedDRA; Lymphoma; Chronic lymphocytic leukemia; Leukemia; Ibrutinib; Adverse effect","score_opus":0.039936413408877346,"score_gpt":0.357492729501198,"score_spread":0.31755631609232066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590527978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976538,0.000039333536,0.00007603833,0.00024047958,0.0002819462,0.0007734992,0.000061008668,0.000059316975,0.0008145758],"genre_scores_gemma":[0.9992036,0.0003449155,0.000081876686,0.00005691836,0.00007087616,0.00007360138,0.000019651912,0.000029480503,0.00011904543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99525845,0.0008824311,0.0023093724,0.00067860814,0.00050249783,0.00036866104],"domain_scores_gemma":[0.9975044,0.0008001286,0.0007701336,0.0005417849,0.00019354638,0.00019002166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028024176,0.00028551515,0.0019360525,0.0015124563,0.00003364321,0.000014234727,0.00008803083,0.000275552,0.00009414201],"category_scores_gemma":[0.0056707906,0.0002013772,0.0006940129,0.0021188029,0.0000863236,0.00016269436,0.000060228165,0.00028984997,0.00002495061],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041731927,0.0033919832,0.9717186,0.00001924831,0.0012865065,0.000054547454,0.0000830094,0.000006613216,0.011259561,0.00004226578,0.00000535792,0.011714959],"study_design_scores_gemma":[0.016181858,0.0012885497,0.97725034,0.00030150943,0.0022428867,0.000009604698,0.000008376874,0.00006112728,0.0023391226,0.000097002434,0.000031677115,0.00018797636],"about_ca_topic_score_codex":0.00046887362,"about_ca_topic_score_gemma":0.001786345,"teacher_disagreement_score":0.015764538,"about_ca_system_score_codex":0.00041441066,"about_ca_system_score_gemma":0.00009777483,"threshold_uncertainty_score":0.82119244},"labels":[],"label_agreement":null},{"id":"W2590530680","doi":"10.1182/blood.v112.11.4185.4185","title":"A Scoring System Based on Clinical, Blood Count and Immunophenotypic Data Can Predict the Risk of Disease Progression in Patients with Chronic Lymphocytic Leukemia","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; St. Paul's Hospital; University of British Columbia Hospital","funders":"","keywords":"Chronic lymphocytic leukemia; Medicine; Univariate analysis; Internal medicine; Oncology; Risk factor; Hematology; Leukemia; Pathological; Univariate; Complete blood count; Immunology; Multivariate analysis","score_opus":0.024312960698751857,"score_gpt":0.28822430141926386,"score_spread":0.26391134072051203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590530680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99600416,0.0018643773,0.0000064022584,0.000019704092,0.00006488926,0.0017348666,0.00016426604,0.000059046142,0.000082290855],"genre_scores_gemma":[0.99896723,0.0004302154,0.00013867051,0.000034318804,0.00013382653,0.00008246694,0.00014349105,0.00005128348,0.00001847026],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967387,0.00032031213,0.00067867176,0.0006825028,0.0011038929,0.00047592746],"domain_scores_gemma":[0.9966353,0.00049799,0.00030942642,0.002113972,0.00014266046,0.0003006122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001006564,0.0002671431,0.00055365026,0.00013912938,0.00018541145,0.000020567417,0.0004820572,0.000111406,0.000006168932],"category_scores_gemma":[0.0005643577,0.00015768992,0.0000623937,0.00037467157,0.0005238414,0.00008533981,0.0002963525,0.00041321982,0.000004482315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.005029708,0.0016637573,0.9883502,0.001549859,0.00040846397,0.00042114482,0.00013967101,0.0006567625,0.000017890612,0.0000075695416,0.00005304231,0.0017018946],"study_design_scores_gemma":[0.1515214,0.0032449076,0.75241834,0.0047466466,0.0012657724,0.000051834977,0.00004405768,0.08626585,0.000177685,0.0000015856415,0.000043638734,0.00021828357],"about_ca_topic_score_codex":0.0013439796,"about_ca_topic_score_gemma":0.00010419499,"teacher_disagreement_score":0.23593189,"about_ca_system_score_codex":0.009922449,"about_ca_system_score_gemma":0.033491798,"threshold_uncertainty_score":0.9938783},"labels":[],"label_agreement":null},{"id":"W2590570686","doi":"10.1182/blood.v120.21.3681.3681","title":"Sustained Immune Competency and Long Term Molecular Remissions in FL Patients with FLIPI Risk Factors &gt;1, Treated Front Line with R-CHOP Followed by Consolidative 90 Y-Radioimmunotherapy and Maintenance Rituximab","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Rituximab; Chemoimmunotherapy; Internal medicine; Follicular lymphoma; Chemotherapy regimen; Surgery; Radioimmunotherapy; Regimen; Fludarabine; Maintenance therapy; Ibritumomab tiuxetan; Clinical endpoint; Progressive disease; Median follow-up; Oncology; Chemotherapy; Gastroenterology; Lymphoma; Clinical trial; Immunology; Cyclophosphamide","score_opus":0.0037553235389250817,"score_gpt":0.21067491337067262,"score_spread":0.20691958983174755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590570686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924555,0.0059840763,0.00004310333,0.00011262826,0.000020729753,0.0010807655,0.00011074984,0.00003986739,0.00015261474],"genre_scores_gemma":[0.9982479,0.00067086203,0.00054402684,0.0000648792,0.000011919726,0.000081555714,0.00021261562,0.000045130317,0.00012111166],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985832,0.00008623305,0.00029946832,0.00035776867,0.00022051237,0.00045280682],"domain_scores_gemma":[0.99905354,0.00009528104,0.00018058789,0.00031854733,0.000108133616,0.00024388301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008302546,0.0003574243,0.0006177567,0.00010069012,0.00011685227,0.000026632883,0.000051301635,0.00009448582,0.000026041456],"category_scores_gemma":[0.0000452223,0.00021417503,0.000048815007,0.0001510729,0.00015392268,0.00013416649,0.000038262733,0.00013749843,0.0000013559926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009905405,0.005552723,0.9889113,0.000030441724,0.00065121276,0.00011521747,0.0010896208,3.1384087e-7,0.0016482399,0.000014521241,0.000028633058,0.000967294],"study_design_scores_gemma":[0.062695764,0.0018196107,0.9234409,0.0004129206,0.00062765565,0.000030968506,0.00027965475,0.0000080919845,0.010338596,0.0000043701475,0.00007490932,0.00026660523],"about_ca_topic_score_codex":0.00038143902,"about_ca_topic_score_gemma":0.000037507485,"teacher_disagreement_score":0.06547039,"about_ca_system_score_codex":0.00011473036,"about_ca_system_score_gemma":0.00007011291,"threshold_uncertainty_score":0.8733804},"labels":[],"label_agreement":null},{"id":"W2590572145","doi":"10.1182/blood.v114.22.4467.4467","title":"Inter-Observer Variability in the Assessment of the 4Ts Score for the Diagnosis of Heparin Induced Thrombocytopenia (HIT) in Patients Undergoing Cardiac Surgery (CS).","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Heparin-induced thrombocytopenia; Medicine; Thrombosis; Population; Complication; Cardiac surgery; Retrospective cohort study; Surgery; Internal medicine; Intensive care medicine","score_opus":0.05872866840451441,"score_gpt":0.3144837963369577,"score_spread":0.2557551279324433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590572145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994799,0.000042026935,0.0000130170465,0.0014197468,0.0003052628,0.002601647,0.000033302116,0.000012907913,0.0007730491],"genre_scores_gemma":[0.9990684,0.000082892104,0.00014074621,0.00035805785,0.000058515794,0.00024233207,0.000018810973,0.000023922406,0.0000063282682],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99685,0.0007652535,0.0009777967,0.00042343995,0.0005537133,0.00042978526],"domain_scores_gemma":[0.9948953,0.003302522,0.0003594492,0.0011952937,0.00018589018,0.000061580584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031530946,0.0002836398,0.0011144608,0.000121699806,0.000110589586,0.00002766187,0.00056102406,0.00020052197,0.00002697553],"category_scores_gemma":[0.0013107153,0.00015437396,0.000462812,0.0007697567,0.00011809609,0.00014378873,0.00017116933,0.0004965067,0.0000011320857],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054839784,0.0027161802,0.9914399,0.00014676103,0.00019516515,0.0000014969748,0.0006623469,0.0000052062455,0.0016582531,0.0005687466,0.00011007635,0.0024410496],"study_design_scores_gemma":[0.0024202766,0.00042561884,0.97920316,0.0005028938,0.00041130098,0.0000012965917,0.00022887602,0.00003197446,0.016132904,0.00043618795,0.000051066912,0.00015441896],"about_ca_topic_score_codex":0.0006368568,"about_ca_topic_score_gemma":0.00072227395,"teacher_disagreement_score":0.014474652,"about_ca_system_score_codex":0.00015737649,"about_ca_system_score_gemma":0.0005263695,"threshold_uncertainty_score":0.62951875},"labels":[],"label_agreement":null},{"id":"W2590631360","doi":"10.1182/blood.v110.11.2431.2431","title":"High-Resolution CGH Analysis of CD34+ Cells from Lower-Risk Myelodysplastic Patients Reveals Cryptic Copy Number Alterations and Predicts Overall and Leukemia-Free Survival.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Myelodysplastic syndromes; Biology; International Prognostic Scoring System; Cytogenetics; Myeloid leukemia; Leukemia; Comparative genomic hybridization; Myeloid; Chromosome abnormality; Internal medicine; Oncology; Karyotype; Bone marrow; CD34; Cancer research; Immunology; Genetics; Chromosome; Medicine; Gene; Stem cell","score_opus":0.008800520466095418,"score_gpt":0.24865166966648686,"score_spread":0.23985114920039144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590631360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99639577,0.00019030589,0.0014319347,0.00006783088,0.00016062865,0.000521382,0.0006763617,0.00004508525,0.00051068014],"genre_scores_gemma":[0.9936479,0.00042308882,0.00486686,0.000086456545,0.00018306663,0.000012760435,0.00040367307,0.00003455682,0.00034168232],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975315,0.00014493916,0.00059065805,0.000529935,0.0007456499,0.00045734335],"domain_scores_gemma":[0.9974117,0.0009601975,0.00026145784,0.00067130197,0.00033737934,0.00035795142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060866156,0.00025675958,0.0006969515,0.00036899062,0.00013831448,0.00003973722,0.00015736224,0.00021962072,0.00020320978],"category_scores_gemma":[0.0008007493,0.00023583649,0.00011420319,0.0006559748,0.00019821388,0.00015511106,0.00019569306,0.00036512362,0.000022570088],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007187663,0.0008064125,0.97145665,0.00013725343,0.0030821397,0.00007256329,0.0004212977,0.00020680095,0.019090526,0.0001914113,0.0033001867,0.00051602075],"study_design_scores_gemma":[0.01193285,0.00052901154,0.9708276,0.00012643768,0.0062763453,0.0000044118638,0.000039790306,0.0027632024,0.0067818533,0.000349797,0.00012612245,0.00024259459],"about_ca_topic_score_codex":0.0017448551,"about_ca_topic_score_gemma":0.0003072685,"teacher_disagreement_score":0.012308673,"about_ca_system_score_codex":0.00022281367,"about_ca_system_score_gemma":0.0001645527,"threshold_uncertainty_score":0.9617133},"labels":[],"label_agreement":null},{"id":"W2590631479","doi":"10.1182/blood.v106.11.1882.1882","title":"Incidence of Aspirin ’Resistance’ as Determined Using the PFA-100 in Pediatric Patients with Arterial Ischemic Stroke.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Aspirin; Internal medicine; Population; Stroke (engine); Hemostasis; Platelet; Pediatric stroke; Regimen; Anesthesia; Surgery; Cardiology; Ischemia; Ischemic stroke","score_opus":0.007012577329677734,"score_gpt":0.22545020193739526,"score_spread":0.21843762460771754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590631479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979764,0.0012070627,0.000035129167,0.000022968492,0.000029607892,0.0002864857,0.000008599725,0.000013430923,0.0004203037],"genre_scores_gemma":[0.99910015,0.00007131008,0.00038823453,0.00008419236,0.00027124208,0.00000845803,0.000007751286,0.0000146374605,0.00005404005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991065,0.00003903811,0.00020523615,0.00016324209,0.00031853336,0.00016744171],"domain_scores_gemma":[0.99950594,0.000021386384,0.00008997852,0.00027058486,0.00006030168,0.000051789317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010357555,0.00011302197,0.00023335742,0.00006255622,0.000034053166,0.000008064954,0.00009360275,0.000048169626,0.000039209408],"category_scores_gemma":[0.00002569287,0.000075499855,0.00010970103,0.00017342443,0.000053312197,0.00008227602,0.000021435662,0.00008768642,0.0000049725168],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001747666,0.0011760116,0.9833778,0.00014358765,0.00026159204,0.00008103617,0.0003040545,0.0000531536,0.009745201,0.000006976317,0.000045970046,0.0030569548],"study_design_scores_gemma":[0.026184427,0.00048545402,0.9270841,0.00030589828,0.0017771279,0.00005298378,0.00012067698,0.000044814176,0.042138755,0.000009730398,0.0014540764,0.00034194154],"about_ca_topic_score_codex":0.000012270131,"about_ca_topic_score_gemma":0.000032632273,"teacher_disagreement_score":0.05629368,"about_ca_system_score_codex":0.000017452165,"about_ca_system_score_gemma":0.00011337595,"threshold_uncertainty_score":0.30787948},"labels":[],"label_agreement":null},{"id":"W2590633005","doi":"10.1182/blood.v128.22.769.769","title":"Chemo-Transcriptomic Analysis of Complex Karyotype AML Reveals Increased Expression of Cell Cycle Components and Exquisite Dependency on Polo-like Kinase 1","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Leukemia & Lymphoma Society of Canada; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Neuroblastoma RAS viral oncogene homolog; Biology; RUNX1; Cancer research; Transcriptome; Myeloid; Internal medicine; Oncology; Haematopoiesis; Gene; Medicine; Genetics; KRAS; Stem cell; Mutation; Gene expression","score_opus":0.020880022443714775,"score_gpt":0.2725980691153113,"score_spread":0.25171804667159653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590633005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978163,0.00021305449,0.00006508246,0.00014209493,0.00001972693,0.00035309474,0.00018030216,0.000027903761,0.0011824117],"genre_scores_gemma":[0.998167,0.00014518817,0.0011528141,0.00013319377,0.000031833668,0.0000089619325,0.00008981288,0.000027889932,0.00024333685],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981441,0.00014713427,0.00047110964,0.00038535654,0.0005428582,0.00030945597],"domain_scores_gemma":[0.9985224,0.0002398256,0.0002048719,0.000631664,0.00015774625,0.00024347502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032309306,0.00019570618,0.00072829064,0.00053988385,0.00004568464,0.000005343953,0.0001990074,0.00013410657,0.00042186267],"category_scores_gemma":[0.00008932184,0.00013569217,0.0001766532,0.0004969287,0.00016504947,0.00006560285,0.00009757189,0.00015187684,0.000018017678],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008367856,0.00087696064,0.10497062,0.00017295039,0.00035831376,0.000039571823,0.00012385189,7.117563e-7,0.89219844,0.00001097709,0.00018568206,0.0002251531],"study_design_scores_gemma":[0.0065290225,0.00031130997,0.38142842,0.00021096219,0.0010179929,0.000006737562,0.000028310966,0.000083946,0.6102237,0.00002866888,0.000027897753,0.000103016035],"about_ca_topic_score_codex":0.00042776932,"about_ca_topic_score_gemma":0.000012824027,"teacher_disagreement_score":0.2819747,"about_ca_system_score_codex":0.00006417604,"about_ca_system_score_gemma":0.00007650903,"threshold_uncertainty_score":0.5533366},"labels":[],"label_agreement":null},{"id":"W2590703941","doi":"10.1182/blood.v116.21.192.192","title":"Apixaban Versus Enoxaparin for Thromboprophylaxis After Joint Replacement Surgery: Pooled Analysis of Major Venous Thromboembolism and Bleeding In 8,464 Patients From the ADVANCE 2 and 3 Trials","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Apixaban; Surgery; Deep vein; Pulmonary embolism; Thrombosis; Knee replacement; Enoxaparin sodium; Myocardial infarction; Placebo; Randomized controlled trial; Stroke (engine); Rivaroxaban; Atrial fibrillation; Internal medicine; Arthroplasty; Warfarin; Low molecular weight heparin","score_opus":0.0255291563354962,"score_gpt":0.2806648741774637,"score_spread":0.25513571784196754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590703941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99598426,0.0011745121,0.000013174181,0.0004400313,0.0004398425,0.0016441672,0.00018588644,0.000020474628,0.00009766958],"genre_scores_gemma":[0.99798805,0.00043963332,0.0007465904,0.00022128336,0.00015714174,0.00030933038,0.00009813713,0.000031177384,0.000008662785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99783254,0.00010025939,0.0008520605,0.0005360953,0.0003330934,0.00034594303],"domain_scores_gemma":[0.99777514,0.0010702753,0.00039329487,0.0005231504,0.00012072537,0.00011744219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013672122,0.0002584518,0.0018993765,0.00030655935,0.00009223278,0.00004462042,0.00009541175,0.00011987728,0.00010732311],"category_scores_gemma":[0.0010038641,0.000186132,0.00026808734,0.00040012223,0.00012150525,0.00007376574,0.00014166303,0.00019055842,0.0000012128689],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039657583,0.01076092,0.900808,0.00059673545,0.021751285,0.000028521927,0.0058165267,0.000009587802,0.024554923,0.0010745109,0.0007379019,0.029895348],"study_design_scores_gemma":[0.008674884,0.0007500758,0.9735507,0.00012543792,0.011266632,6.222537e-7,0.00028968538,0.00007350676,0.0043659024,0.00022165045,0.00047464142,0.00020628845],"about_ca_topic_score_codex":0.000983865,"about_ca_topic_score_gemma":0.0011459816,"teacher_disagreement_score":0.07274269,"about_ca_system_score_codex":0.000028420027,"about_ca_system_score_gemma":0.000045094752,"threshold_uncertainty_score":0.7590243},"labels":[],"label_agreement":null},{"id":"W2590720970","doi":"10.1182/blood.v120.21.394.394","title":"Predicting Venous Thromboembolism Recurrence Risk in Patients with Cancer: A Validation Study","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Ottawa Hospital; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Pulmonary embolism; Thrombosis; Cancer; Clinical prediction rule; Low molecular weight heparin; Venous thrombosis; Warfarin; Malignancy; Venous thromboembolism; Population; Internal medicine; Retrospective cohort study; Surgery; Cohort","score_opus":0.01252402845769624,"score_gpt":0.26167513412680576,"score_spread":0.24915110566910953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590720970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968286,0.00033964327,0.000006629362,0.0000336219,0.0002544132,0.0016010619,0.000015401558,0.00006102507,0.0008595667],"genre_scores_gemma":[0.9991516,0.00014230219,0.00014632427,0.00006195823,0.00020813866,0.00022752953,0.000023316667,0.000026715139,0.000012144659],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998636,0.000078743826,0.00025176033,0.00025584095,0.0003852755,0.0003923695],"domain_scores_gemma":[0.99932194,0.00003069524,0.00015586754,0.00029478074,0.00007473285,0.000121991034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003338563,0.00016082435,0.00042687415,0.00011814073,0.00009381958,0.000018487008,0.00008068163,0.00004449145,0.000060548977],"category_scores_gemma":[0.00006603184,0.00012902464,0.000030640822,0.00027680618,0.000021745776,0.00018976131,0.000057918965,0.00019246977,0.000018061457],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039311297,0.021016838,0.9703314,0.00004522059,0.0002202507,0.0000041975595,0.0038380958,0.000016138572,0.0000049175724,0.000016302465,0.00007076257,0.0043966067],"study_design_scores_gemma":[0.0060065445,0.0014402247,0.9905001,0.0001839725,0.0009401368,0.0000010172713,0.00048642492,0.0000070575843,0.00018267776,0.000008108576,0.0001019886,0.00014173586],"about_ca_topic_score_codex":0.0012329974,"about_ca_topic_score_gemma":0.00014504266,"teacher_disagreement_score":0.020168753,"about_ca_system_score_codex":0.00006343925,"about_ca_system_score_gemma":0.00004202775,"threshold_uncertainty_score":0.5261472},"labels":[],"label_agreement":null},{"id":"W2590724842","doi":"10.1182/blood.v128.22.920.920","title":"An International Assessment of Event-Free Survival at 24 Months (EFS24) and Subsequent Survival in Peripheral T-Cell Lymphoma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Anaplastic large-cell lymphoma; Lymphoma; Internal medicine; Peripheral T-cell lymphoma; Oncology; T-cell lymphoma; Aggressive lymphoma; Not Otherwise Specified; Cancer; B symptoms; Chemotherapy; Pathology; Immunology; T cell; Rituximab","score_opus":0.015359037758739721,"score_gpt":0.28201460952763696,"score_spread":0.26665557176889726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590724842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937171,0.00031713655,0.00001668759,0.0007215598,0.0003994227,0.00028471896,0.00009534748,0.000022297072,0.004425772],"genre_scores_gemma":[0.9982299,0.00044666216,0.0005794622,0.000039981867,0.00011164371,0.00005526602,0.00003891366,0.000020984846,0.00047714316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985571,0.000080555066,0.000337337,0.00034459739,0.00044913922,0.00023125728],"domain_scores_gemma":[0.999116,0.00008943393,0.00010370781,0.00045509855,0.000073639705,0.00016211678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000222503,0.00018226301,0.00034132105,0.00008776142,0.00003277578,0.000015435118,0.00016251963,0.00007603684,0.00019489207],"category_scores_gemma":[0.000031669246,0.00012322617,0.000083540464,0.00006564938,0.000067925685,0.0001227848,0.00012573064,0.00002867265,0.000004685143],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014021427,0.0058223894,0.96942747,0.000027045584,0.00015107091,0.00018085225,0.00010386897,0.0000015974518,0.019145615,0.0007051315,0.000042100957,0.004252647],"study_design_scores_gemma":[0.030860845,0.0006614744,0.9472932,0.00010362154,0.000114440125,0.000039027655,0.000071924354,0.00006896194,0.020042438,0.00007444745,0.0005312645,0.00013832553],"about_ca_topic_score_codex":0.00041559117,"about_ca_topic_score_gemma":0.0006516267,"teacher_disagreement_score":0.03072063,"about_ca_system_score_codex":0.0003737807,"about_ca_system_score_gemma":0.0001547973,"threshold_uncertainty_score":0.5025017},"labels":[],"label_agreement":null},{"id":"W2590782066","doi":"10.1182/blood.v118.21.871.871","title":"Conventional Reinduction/Consolidation-Type Therapy Versus Short Course High Intensity Combination Chemotherapy As Post-Induction Treatment for Children with Relapsed Acute Lymphoblastic Leukemia. Early Results of Study ALL-REZ BFM 2002","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Anthracycline; Regimen; Chemotherapy; Idarubicin; Induction chemotherapy; Randomized controlled trial; Chemotherapy regimen; Internal medicine; Surgery; Pediatrics; Cytarabine; Cancer","score_opus":0.038771342064680456,"score_gpt":0.29951436480318694,"score_spread":0.26074302273850647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590782066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952507,0.000038753235,0.000114225026,0.00033852286,0.0004273769,0.0033727211,0.00010474348,0.00010296844,0.00025001544],"genre_scores_gemma":[0.99673384,0.0001256797,0.0009983954,0.00007458058,0.00022051396,0.00017056846,0.00070548087,0.0000734267,0.0008974946],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99751616,0.00010037319,0.0005909932,0.0006535433,0.0007437854,0.0003951443],"domain_scores_gemma":[0.99697787,0.00016045218,0.0002933801,0.0006185473,0.0017526803,0.00019709789],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034768856,0.0003647035,0.0005682229,0.00024340002,0.00016501365,0.000025898691,0.00017458027,0.00021828103,0.00017462843],"category_scores_gemma":[0.00015054262,0.00028744483,0.00014261439,0.0003416828,0.00022570847,0.00023739749,0.00002819255,0.00017958003,0.000051054132],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.612933,0.08173228,0.11371155,0.00010347267,0.067060746,0.00038066358,0.014482771,0.000089861394,0.084484816,0.0015851152,0.004949906,0.018485837],"study_design_scores_gemma":[0.1894127,0.06802048,0.6069111,0.00007605293,0.0028826268,0.00045165356,0.0007097696,0.00011668977,0.13085559,0.000095736876,0.000053801898,0.0004137914],"about_ca_topic_score_codex":0.0019226501,"about_ca_topic_score_gemma":0.000048302183,"teacher_disagreement_score":0.49319956,"about_ca_system_score_codex":0.0009002353,"about_ca_system_score_gemma":0.0016383468,"threshold_uncertainty_score":0.9999578},"labels":[],"label_agreement":null},{"id":"W2590833518","doi":"10.1182/blood.v110.11.3385.3385","title":"High Expression of MDR1 and BCRP1 in Leukemic Stem Cells Correlates with Reversible Drug Resistance Ex Vivo and Predicts Failure of Remission Induction Chemotherapy in Patients with Acute Myeloid Leukemia.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute","funders":"","keywords":"Daunorubicin; Myeloid leukemia; CD38; Ex vivo; CD34; Leukemia; ATP-binding cassette transporter; Stem cell; Chemotherapy; Cancer research; Bone marrow; Pharmacology; Biology; In vivo; Immunology; Medicine; Internal medicine; Transporter; Gene","score_opus":0.0028241559451409573,"score_gpt":0.17480074112300273,"score_spread":0.17197658517786177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590833518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99886113,0.00033418878,0.00008410194,0.000047729995,0.000034712288,0.00052542065,0.000010610556,0.000016741884,0.00008535108],"genre_scores_gemma":[0.99524754,0.00031599542,0.0034254205,0.0000131790375,0.00001367635,0.0000038484472,0.000014222156,0.000025187535,0.00094094186],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987896,0.000019869343,0.00035711663,0.00030603408,0.00032548272,0.00020189013],"domain_scores_gemma":[0.99938226,0.000024207517,0.00022687363,0.0001973969,0.00007995277,0.00008930605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002264227,0.00017788858,0.00041065173,0.00019643911,0.000027313696,0.0000037504751,0.000054132226,0.00015110035,0.0000065366744],"category_scores_gemma":[0.0000022784093,0.00012401833,0.000018340681,0.0003139322,0.00009558959,0.00013084471,0.000011856752,0.00021343469,1.01056635e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007393661,0.00048865733,0.36082613,0.0006903264,0.000055638233,0.000059400543,0.0018696424,0.000011198312,0.6281092,0.0000148276795,0.0001182006,0.0003631123],"study_design_scores_gemma":[0.014384865,0.00035196645,0.17484805,0.0033887834,0.000104213155,0.0000054186917,0.00049527356,0.0000024827862,0.80621386,0.000025056986,0.00005161624,0.00012839543],"about_ca_topic_score_codex":0.00004122061,"about_ca_topic_score_gemma":0.00017139579,"teacher_disagreement_score":0.18597808,"about_ca_system_score_codex":0.00006967812,"about_ca_system_score_gemma":0.00009753382,"threshold_uncertainty_score":0.5057321},"labels":[],"label_agreement":null},{"id":"W2590839479","doi":"10.1182/blood.v108.11.1079.1079","title":"Outcome Measures in Childhood Idiopathic Thrombocytopenic Purpura: Relationship of Bleeding Severity, Quality of Life, and Platelet Count.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; Laurentian University; Izaak Walton Killam Health Centre; Hospital for Sick Children","funders":"","keywords":"Medicine; Hematologist; Thrombocytopenic purpura; Pediatrics; Quality of life (healthcare); Platelet; Population; Grading (engineering); Internal medicine; Disease","score_opus":0.04407649461935241,"score_gpt":0.29531665655033695,"score_spread":0.25124016193098453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590839479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99496245,0.002764925,0.000005515585,0.0001450272,0.000025785668,0.00032667234,0.000026401036,0.000018971887,0.0017242435],"genre_scores_gemma":[0.9996359,0.00008347386,0.00015975354,0.00003136839,0.000021733302,0.00000825443,0.0000172599,0.000013440484,0.00002886286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986199,0.000059408725,0.00065757276,0.00019668505,0.00029574754,0.00017065152],"domain_scores_gemma":[0.99939966,0.00009166408,0.00020577964,0.00018549831,0.00006187532,0.00005551222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004876866,0.00013717955,0.0006828807,0.00011968185,0.000039098803,0.0000072668895,0.000056571644,0.00012286661,0.000009374866],"category_scores_gemma":[0.00027087046,0.00011990079,0.00007095397,0.0002095719,0.00007810437,0.00009288002,0.00003386847,0.0001691059,0.000002507115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062515865,0.0011065718,0.99628204,0.00019118328,0.000096243806,0.00003507126,0.00015230112,0.000003698483,0.0012890014,0.00062140747,0.000008095003,0.00015189177],"study_design_scores_gemma":[0.007734625,0.0001282166,0.9883669,0.0001319966,0.000119952056,0.00005725023,0.00007005003,0.000005649617,0.0017686193,0.0015112746,0.000006946437,0.00009849207],"about_ca_topic_score_codex":0.0009393656,"about_ca_topic_score_gemma":0.0004229732,"teacher_disagreement_score":0.007915092,"about_ca_system_score_codex":0.000019575791,"about_ca_system_score_gemma":0.000084990694,"threshold_uncertainty_score":0.48894125},"labels":[],"label_agreement":null},{"id":"W2590840427","doi":"10.1182/blood.v120.21.3461.3461","title":"Systemic Ceramide Accumulation Causes Dysregulated Hematopoiesis","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Spleen; Bone marrow; Haematopoiesis; Biology; Ceramide; Lymphopoiesis; Peripheral blood cell; Leukocytosis; Lymph; CD8; Internal medicine; Endocrinology; Immunology; Molecular biology; Pathology; Stem cell; Immune system; Cell biology; Medicine; Biochemistry; Apoptosis","score_opus":0.019909885002903135,"score_gpt":0.26494605390436937,"score_spread":0.24503616890146623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590840427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941495,0.004638954,0.0004471856,0.000011774491,0.00025243204,0.000106900836,0.000005870346,0.00003302549,0.00035434778],"genre_scores_gemma":[0.9983558,0.000065590386,0.0003173849,0.00008894626,0.0008595245,0.0000127545345,0.000069067275,0.000022150649,0.00020877943],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992673,0.000043175845,0.00016975657,0.00016026986,0.00010060215,0.0002588941],"domain_scores_gemma":[0.9995333,0.0000095131145,0.000066579574,0.00025920878,0.00004575045,0.000085661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016858552,0.00011627891,0.0001262623,0.000034053093,0.00006897036,0.000020286692,0.00009359034,0.00012053536,0.000023986202],"category_scores_gemma":[0.000070031594,0.00010876572,0.0000632422,0.00007439791,0.000019083796,0.0000079020965,0.000047826314,0.00003971404,0.000026210115],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010955013,0.00009251978,0.03258636,0.000027887765,0.00006711435,6.507013e-7,0.00009315003,0.000045214278,0.9666317,0.00018702047,0.00015439287,0.0001030169],"study_design_scores_gemma":[0.0008416078,0.000020053485,0.01799174,0.000022994807,0.000109393135,0.00009428998,0.00007697887,0.000017584282,0.9771777,0.000017080585,0.003442238,0.00018836878],"about_ca_topic_score_codex":0.000017050734,"about_ca_topic_score_gemma":0.0000021989806,"teacher_disagreement_score":0.01459462,"about_ca_system_score_codex":0.0000039878237,"about_ca_system_score_gemma":0.000019599544,"threshold_uncertainty_score":0.44353375},"labels":[],"label_agreement":null},{"id":"W2590845115","doi":"10.1182/blood.v120.21.3056.3056","title":"The Risk of Organ Specific Graft-Versus-Host Disease Can Be Predicted by the Multiple Single Nucleotide Polymorphism Based Predictive Models.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Single-nucleotide polymorphism; SNP; Genotype; Immunology; Graft-versus-host disease; Medicine; Disease; Internal medicine; Biology; Oncology; Gene; Genetics","score_opus":0.03216372197563532,"score_gpt":0.25241345864345305,"score_spread":0.22024973666781772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590845115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865365,0.0040996084,0.00016706096,0.002492246,0.0002818953,0.0011660703,0.0034963994,0.00010739999,0.0016528316],"genre_scores_gemma":[0.9980608,0.0005392105,0.000068065274,0.0001601569,0.00048256584,0.00006622312,0.00015099267,0.0000708456,0.00040114287],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975165,0.00022525282,0.00036945648,0.00030970358,0.0008697159,0.0007093351],"domain_scores_gemma":[0.9973181,0.00078175723,0.00017357802,0.0009036725,0.00021137348,0.0006115523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053787173,0.00025376587,0.00030078462,0.00008903013,0.00049692893,0.000049754653,0.00035179904,0.00009764683,0.00017810514],"category_scores_gemma":[0.00041538035,0.00014774907,0.0002018198,0.000417969,0.00051773165,0.00013648922,0.00012606966,0.00048314198,0.000011109055],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030973235,0.022399355,0.69155043,0.00031473042,0.0041239443,0.000110223344,0.008094894,0.00020942435,0.1382942,0.0008456605,0.095388554,0.00769532],"study_design_scores_gemma":[0.06620526,0.0033715277,0.46078497,0.00040152558,0.0049766195,0.000028392358,0.0035380686,0.03622264,0.18098919,0.0002737181,0.24186905,0.0013390378],"about_ca_topic_score_codex":0.001029281,"about_ca_topic_score_gemma":0.0002483153,"teacher_disagreement_score":0.23076549,"about_ca_system_score_codex":0.00010098551,"about_ca_system_score_gemma":0.00024821455,"threshold_uncertainty_score":0.60250324},"labels":[],"label_agreement":null},{"id":"W2590891051","doi":"10.1182/blood.v120.21.492.492","title":"Persistent Impairments in Humoral and Cellular Immunity in Patients with Immune Thrombocytopenia Treated with Rituximab: A Sub-Study of a Randomized Controlled Trial","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Rituximab; Immunology; Pneumococcal vaccine; Antibody; Conjugate vaccine; Hib vaccine; Pneumococcal conjugate vaccine; Vaccination; Streptococcus pneumoniae; Internal medicine; Immunization; Microbiology; Biology; Antibiotics","score_opus":0.007665425783257617,"score_gpt":0.21721572308347756,"score_spread":0.20955029730021993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590891051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889527,0.00068651774,2.2063537e-7,0.000007655935,0.000018969993,0.010171719,0.000004887268,0.000012258902,0.00014504897],"genre_scores_gemma":[0.9993762,0.000017428716,0.000033425902,0.0000066760695,0.00000721769,0.00046836998,0.00005013233,0.0000214502,0.000019104937],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99823505,0.0003406104,0.0005892933,0.00019986433,0.00030605678,0.00032914538],"domain_scores_gemma":[0.9992702,0.000087607674,0.00024227484,0.00023992745,0.00006423767,0.000095767275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005083376,0.0002576209,0.0026876454,0.00020111499,0.000043062453,0.000010318499,0.00005282704,0.00006500912,0.000015764594],"category_scores_gemma":[0.000047555,0.0001482736,0.0001441059,0.00021968537,0.00008783919,0.00010926607,0.000032142016,0.00015133263,0.0000014120999],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5134125,0.041157097,0.44293907,0.000015237615,0.0010918664,0.00011379442,0.0011523041,3.8056905e-7,0.00010191779,4.0831944e-7,1.4791479e-7,0.000015318017],"study_design_scores_gemma":[0.70688784,0.006729109,0.28362212,0.00009403019,0.001705576,0.000011829762,0.0006148729,0.000008269287,0.00022181825,9.917385e-7,8.822477e-8,0.00010345498],"about_ca_topic_score_codex":0.001401447,"about_ca_topic_score_gemma":0.00014230296,"teacher_disagreement_score":0.19347538,"about_ca_system_score_codex":0.000042558433,"about_ca_system_score_gemma":0.00004297239,"threshold_uncertainty_score":0.6046422},"labels":[],"label_agreement":null},{"id":"W2590913730","doi":"10.1182/blood.v104.11.4908.4908","title":"Osteonecrosis of the Jaw Associated with Pamidronate Therapy.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Bone health and treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Osteonecrosis of the jaw; Discontinuation; Osteomyelitis; Surgery; Multiple myeloma; Adverse effect; Bisphosphonate; Adjuvant therapy; Osteoporosis; Internal medicine; Chemotherapy","score_opus":0.014853597723907135,"score_gpt":0.24399477270950745,"score_spread":0.22914117498560033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590913730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963588,0.0002349558,8.4709586e-7,0.0011925361,0.000027874912,0.00030287093,0.000009182074,0.000023467852,0.0018494776],"genre_scores_gemma":[0.99890494,0.000052088213,0.000074457865,0.0004946153,0.0000022981476,0.000014224716,0.0000066000653,0.000011449116,0.00043931493],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994877,0.000015700403,0.00010396368,0.00008864392,0.00016196523,0.0001420518],"domain_scores_gemma":[0.99962527,0.000016959388,0.0000700206,0.00018366968,0.00004570197,0.00005838442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000047027035,0.00006963534,0.00014224868,0.000015524685,0.000050706945,0.0000022023542,0.000037184913,0.000044756925,0.000015941283],"category_scores_gemma":[0.000021571152,0.000035179306,0.00004475803,0.00014480903,0.000044818218,0.00001534121,0.000008064825,0.00007174576,0.000007047883],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025411142,0.00387889,0.9880097,0.000035907673,0.00063596613,0.000041964082,0.00055594166,0.0000035494822,0.0033449712,0.00016936004,0.00003157899,0.0030380911],"study_design_scores_gemma":[0.015779464,0.00072027463,0.94053525,0.00016003898,0.00017137243,0.000021890408,0.000017203449,2.97611e-7,0.042273305,0.00012919307,0.00014804228,0.00004366009],"about_ca_topic_score_codex":0.0009738138,"about_ca_topic_score_gemma":0.00041793942,"teacher_disagreement_score":0.047474407,"about_ca_system_score_codex":0.000023991352,"about_ca_system_score_gemma":0.00013732366,"threshold_uncertainty_score":0.14721216},"labels":[],"label_agreement":null},{"id":"W2590932981","doi":"10.1182/blood.v112.11.3695.3695","title":"Balloon Kyphoplasty Improves Both Roland-Morris Disability Scores and Bone Pain among Cancer Patients with Vertebral Compression Fractures: Interim Analysis of Results from a Phase IV Random Trial","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal General Hospital","funders":"","keywords":"Medicine; Interim analysis; Breast cancer; Surgery; Vertebral compression fracture; Quality of life (healthcare); Back pain; Randomized controlled trial; Adverse effect; Osteoporosis; Cancer; Physical therapy; Internal medicine","score_opus":0.011815435645842465,"score_gpt":0.2742595056474366,"score_spread":0.26244407000159414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590932981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968367,0.00026315748,0.00024543324,0.00005826948,0.00006662203,0.0013146019,0.0011433025,0.00003167424,0.000040205952],"genre_scores_gemma":[0.99817693,0.00005012583,0.0003879357,0.00011826652,0.0000654315,0.00006937767,0.0010761872,0.00002036739,0.00003539826],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976618,0.0002978298,0.0006772979,0.0005384501,0.000594055,0.0002305094],"domain_scores_gemma":[0.99830204,0.00045175612,0.00042589786,0.0004942427,0.00008129206,0.0002447535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042248832,0.0002668548,0.00096834486,0.00015732099,0.000083238454,0.00002058743,0.00009497517,0.00007005966,0.00022057902],"category_scores_gemma":[0.00078965124,0.00017895678,0.00019669367,0.00029957885,0.0003133697,0.00014446679,0.0000788796,0.0001533728,4.1123943e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23303719,0.009223204,0.74964,0.0001170798,0.0032091103,0.00003889682,0.0008967337,0.000016211301,0.00070331653,2.518419e-7,0.00047631978,0.0026416737],"study_design_scores_gemma":[0.31691027,0.0014535775,0.6704326,0.00018657699,0.0067245867,2.4592435e-7,0.00008880271,0.003607552,0.0004054731,0.000003294024,0.000032134816,0.0001548672],"about_ca_topic_score_codex":0.002704022,"about_ca_topic_score_gemma":0.00070956396,"teacher_disagreement_score":0.083873086,"about_ca_system_score_codex":0.000025679812,"about_ca_system_score_gemma":0.000053698215,"threshold_uncertainty_score":0.7297646},"labels":[],"label_agreement":null},{"id":"W2590983141","doi":"10.1182/blood.v118.21.811.811","title":"Vantage 088: Vorinostat in Combination with Bortezomib in Patients with Relapsed/Refractory Multiple Myeloma: Results of a Global, Randomized Phase 3 Trial","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Tolerability; Bortezomib; Internal medicine; Multiple myeloma; Clinical endpoint; Panobinostat; Oncology; Progression-free survival; Phases of clinical research; Clinical trial; Surrogate endpoint; Gastroenterology; Adverse effect; Chemotherapy; Histone deacetylase","score_opus":0.019806327992397905,"score_gpt":0.2789102579825956,"score_spread":0.2591039299901977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590983141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939412,0.00005920338,0.00002052052,0.000018798504,0.00005061174,0.0042210873,0.00017587356,0.000028570852,0.0014841299],"genre_scores_gemma":[0.99802005,0.000025437086,0.001335453,0.00001089733,0.000017611306,0.00019660026,0.00032502736,0.000023323473,0.000045580684],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9976814,0.0002661537,0.00066389475,0.0003935885,0.0006084329,0.0003865499],"domain_scores_gemma":[0.99868584,0.0002573007,0.000289486,0.00039326955,0.00019059713,0.00018349245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004986001,0.0002407308,0.00083477667,0.00021607979,0.000028855799,0.000008227598,0.00010283236,0.000105370586,0.000021876533],"category_scores_gemma":[0.0007131969,0.0001590532,0.00008171134,0.0004381122,0.00015981864,0.00017232823,0.000033484852,0.00021283365,0.0000060946213],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5851503,0.020103527,0.3926503,0.0000362221,0.00019681553,0.00025098055,0.0003206504,2.5337718e-7,0.000020609192,0.000017029104,0.000008679596,0.0012446089],"study_design_scores_gemma":[0.64015955,0.007035785,0.35149348,0.00016871109,0.00014092248,0.0000030031376,0.000041814015,0.00004310792,0.00078919274,0.000016236705,0.000008152352,0.00010006719],"about_ca_topic_score_codex":0.0012968953,"about_ca_topic_score_gemma":0.0008516806,"teacher_disagreement_score":0.0550092,"about_ca_system_score_codex":0.00010592136,"about_ca_system_score_gemma":0.00021588546,"threshold_uncertainty_score":0.64860016},"labels":[],"label_agreement":null},{"id":"W2590996367","doi":"10.1182/blood.v106.11.3384.3384","title":"A High Throughput Seeking Myeloma Therapeutics Identifies Glucocorticoids as Inhibitors of c-Maf-Dependent Transactivation of Cyclin D2.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Transactivation; Luciferase; Cyclin; Cancer research; Cyclin D1; Biology; Transcription factor; Chemistry; Molecular biology; Cell cycle; Biochemistry; Cell; Gene; Transfection","score_opus":0.02162061704519746,"score_gpt":0.2997802515673962,"score_spread":0.2781596345221987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590996367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973555,0.00054326805,0.00046454967,0.00041091398,0.00006924457,0.00052928115,0.000019240357,0.00003997022,0.00056798937],"genre_scores_gemma":[0.9973124,0.00019714242,0.0018545164,0.00005599397,0.00015575746,0.000028097365,0.000030119572,0.00002853105,0.0003373904],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99822515,0.000059447277,0.000528582,0.00024331188,0.00067030906,0.00027318456],"domain_scores_gemma":[0.99909437,0.00010764452,0.00019346354,0.00032678136,0.00017749495,0.00010026793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017319627,0.00016945419,0.00038267157,0.00016409974,0.000052085208,0.00001347551,0.00009605603,0.00011077973,0.00013520992],"category_scores_gemma":[0.000064699176,0.00014037352,0.00014872999,0.00021274154,0.00010199999,0.00015021085,0.000024421273,0.00015769049,0.000023333958],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067395484,0.003756315,0.055373706,0.0003103082,0.0013039268,0.000073377065,0.0018711182,0.00003109001,0.86628765,0.00023396949,0.00001033741,0.07007426],"study_design_scores_gemma":[0.0073832166,0.0005698658,0.073859684,0.00019183978,0.0003990297,0.000037041755,0.00024821673,0.000122078,0.91670746,0.00030140238,0.000076397984,0.000103775455],"about_ca_topic_score_codex":0.0003445699,"about_ca_topic_score_gemma":0.000071583025,"teacher_disagreement_score":0.06997049,"about_ca_system_score_codex":0.0000484627,"about_ca_system_score_gemma":0.00012453701,"threshold_uncertainty_score":0.5724266},"labels":[],"label_agreement":null},{"id":"W2591005764","doi":"10.1182/blood.v106.11.5086.5086","title":"Prognostic Relevance of CD56 Expression in Patients with Multiple Myeloma Treated with High-Dose Melphalan-Based Chemotherapy and Autologous Stem Cell Transplant.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Melphalan; Medicine; Multiple myeloma; Internal medicine; Chemotherapy; Gastroenterology; Bone marrow; Autologous stem-cell transplantation; Surgery; Oncology","score_opus":0.0075971534887974415,"score_gpt":0.22114338701166417,"score_spread":0.21354623352286672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591005764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981907,0.00024456336,0.00003627093,0.00006182719,0.0000039862753,0.001292625,0.000060998518,0.000050207724,0.000058802525],"genre_scores_gemma":[0.9945965,0.000035320107,0.005018361,0.00002626003,0.000012384293,0.00008720724,0.000115585244,0.000037110207,0.000071298105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868137,0.000055801964,0.00022747437,0.0003436698,0.00036245058,0.00032923883],"domain_scores_gemma":[0.9992278,0.00017133632,0.000096284944,0.0002539173,0.00008383915,0.000166771],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000051588562,0.00022426201,0.00038409003,0.00013482079,0.000038578306,0.000007639173,0.00006312328,0.000084461455,0.000016529273],"category_scores_gemma":[0.000011832919,0.00013987537,0.00002625841,0.00018598966,0.00008795437,0.0000672504,0.000006740149,0.00013099531,0.00000309438],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007534935,0.004222293,0.9677023,0.000215226,0.00008475447,0.00016989675,0.0002572413,0.000032023316,0.007207936,3.9495566e-7,0.000003450973,0.012569544],"study_design_scores_gemma":[0.055558156,0.002548896,0.75419116,0.00048059874,0.00009303897,0.0000088956485,0.000015292666,0.00040662364,0.18657202,4.5708958e-7,0.00001080107,0.00011405126],"about_ca_topic_score_codex":0.00007709744,"about_ca_topic_score_gemma":0.000102298596,"teacher_disagreement_score":0.21351114,"about_ca_system_score_codex":0.00003136339,"about_ca_system_score_gemma":0.00007675173,"threshold_uncertainty_score":0.5703952},"labels":[],"label_agreement":null},{"id":"W2591022778","doi":"10.1182/blood.v108.11.3051.3051","title":"Autologous Stem-Cell Transplant with a Rituximab Purge and Maintenance vs. Standard Chemotherapy for Mantle Cell Lymphoma: Extended Follow-Up of a Matched Pair Analysis.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; London Health Sciences Centre; BC Cancer Agency; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Mantle cell lymphoma; Rituximab; Autologous stem-cell transplantation; Surgery; Internal medicine; Vincristine; Cyclophosphamide; Chemotherapy regimen; Transplantation; Regimen; Oncology; Chemotherapy; Lymphoma","score_opus":0.005429387968229044,"score_gpt":0.20775490870634447,"score_spread":0.20232552073811544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591022778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948194,0.0018424096,0.0010172622,0.00045574296,0.000026864904,0.00091047323,0.0003369246,0.000064190404,0.0005267481],"genre_scores_gemma":[0.9949329,0.00023755594,0.0032492226,0.00016117969,0.000027289298,0.00019126853,0.000091315625,0.00003769693,0.0010715533],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99850994,0.000026040603,0.00037819133,0.00044054337,0.00026862905,0.00037666888],"domain_scores_gemma":[0.9991609,0.000084600724,0.00018988294,0.00034538817,0.00010823242,0.00011103925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013829563,0.0002839302,0.0009790607,0.00013839292,0.00006388634,0.00001926739,0.00007340569,0.00009547418,0.00002207554],"category_scores_gemma":[0.0000016365566,0.00019476215,0.0002824507,0.00026727072,0.0000860254,0.000039343595,0.000009478957,0.00003359499,0.0000019773736],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031613726,0.07222608,0.8296888,0.0039319457,0.01119841,0.0026099056,0.0033575548,0.000023440789,0.019296924,0.0009473914,0.005067786,0.020038042],"study_design_scores_gemma":[0.2783125,0.0047467966,0.26496306,0.00028815394,0.013024105,0.00028432126,0.00033328807,0.0003035004,0.4343865,0.00018805833,0.002607573,0.00056214986],"about_ca_topic_score_codex":0.00025287512,"about_ca_topic_score_gemma":0.00015204515,"teacher_disagreement_score":0.56472576,"about_ca_system_score_codex":0.00006761557,"about_ca_system_score_gemma":0.00014006367,"threshold_uncertainty_score":0.794217},"labels":[],"label_agreement":null},{"id":"W2591056031","doi":"10.1182/blood.v128.22.2054.2054","title":"Safety and Efficacy of Venetoclax and Obinutuzumab in Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL) and Coexisting Medical Conditions: Final Results of the Run-in Phase of the Randomized CLL14 Trial (BO25323)","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Venetoclax; Obinutuzumab; Chronic lymphocytic leukemia; Medicine; Internal medicine; IGHV@; Oncology; Randomized controlled trial; Leukemia; Bendamustine","score_opus":0.014868334353418191,"score_gpt":0.28853567708742517,"score_spread":0.273667342734007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591056031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99617684,0.0007449983,0.0000023676068,0.000063423155,0.000032355852,0.0027920206,0.00007628073,0.0000073731308,0.00010432861],"genre_scores_gemma":[0.999441,0.00035441562,0.000021928761,0.000012679995,0.00003574434,0.00003908664,0.000013996315,0.000017261818,0.000063850115],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9971726,0.000491142,0.0010154705,0.0003260866,0.00069743773,0.00029725477],"domain_scores_gemma":[0.99648535,0.0023976543,0.0004351818,0.00044126215,0.00012245399,0.000118082586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013394476,0.00018674764,0.00092352345,0.00011541624,0.000051050447,0.0000058008427,0.00016889567,0.00015276062,0.000018273333],"category_scores_gemma":[0.0047259205,0.00008672253,0.000077368684,0.00034575202,0.0014091345,0.00004810968,0.00016794058,0.00017631763,2.46927e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.9869746,0.0006607055,0.004827221,0.0007747168,0.0003834863,0.000040922998,0.0010906012,0.000050260667,0.0007728393,0.00014125985,0.000022492974,0.004260921],"study_design_scores_gemma":[0.97345334,0.0013083129,0.015457441,0.003925385,0.00034145487,0.00006115726,0.000026341262,0.0028869428,0.0024020243,0.00003515126,0.000009285131,0.00009313425],"about_ca_topic_score_codex":0.0018535636,"about_ca_topic_score_gemma":0.00036683682,"teacher_disagreement_score":0.013521203,"about_ca_system_score_codex":0.008435158,"about_ca_system_score_gemma":0.021154089,"threshold_uncertainty_score":0.9953713},"labels":[],"label_agreement":null},{"id":"W2591075764","doi":"10.1182/blood.v106.11.4180.4180","title":"Predictors of Red Cell Transfusion in Medically III Patients.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Blood transfusion; Blood pressure; Hemoglobin; Creatinine; Diabetes mellitus; Internal medicine; Surgery","score_opus":0.005262153608399638,"score_gpt":0.20464244380221958,"score_spread":0.19938029019381995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591075764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96518886,0.000109541696,0.000060969123,0.001279438,0.00009182347,0.00054251135,0.000003710312,0.000041374817,0.03268176],"genre_scores_gemma":[0.99791056,0.00046622087,0.0005387219,0.00043547712,0.00006771029,0.000014817832,0.00002183506,0.000013655045,0.0005310168],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99889076,0.000022965649,0.00036501166,0.00018510953,0.00036750984,0.00016865386],"domain_scores_gemma":[0.9995861,0.000015669477,0.000042023974,0.00019538266,0.00004187233,0.00011892852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014895463,0.00009965876,0.00023418032,0.00014082043,0.000016145388,0.0000019425665,0.00007572333,0.0000846941,0.0004278925],"category_scores_gemma":[0.00001579428,0.00008366871,0.00007473838,0.00018590555,0.000035324312,0.00003639938,0.000018421842,0.00013518195,0.0000100964235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012024539,0.04544431,0.8022908,0.0010171236,0.00035808308,0.00010381285,0.0051486725,0.000020470135,0.07121941,0.00037715546,0.009267284,0.06355046],"study_design_scores_gemma":[0.07654243,0.0017014774,0.7434342,0.00038915122,0.0008455061,0.0000059704516,0.00022645586,0.0000756149,0.117168546,0.000023641553,0.059300568,0.00028644686],"about_ca_topic_score_codex":0.00005253877,"about_ca_topic_score_gemma":0.0001135078,"teacher_disagreement_score":0.07533997,"about_ca_system_score_codex":0.00001192483,"about_ca_system_score_gemma":0.000035346413,"threshold_uncertainty_score":0.46851227},"labels":[],"label_agreement":null},{"id":"W2591089716","doi":"10.1182/blood.v126.23.2618.2618","title":"High Frequency and Poor Outcome of Ph-like Acute Lymphoblastic Leukemia in Adults","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Philadelphia chromosome; Acute lymphocytic leukemia; Leukemia; Cancer; Oncology; Cohort; Lymphoblastic Leukemia; Pediatrics; Biology; Chromosomal translocation; Genetics; Gene","score_opus":0.01774282261141722,"score_gpt":0.2744041560133935,"score_spread":0.2566613334019763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591089716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99715877,0.00036940412,0.00005880019,0.00026622153,0.00015189305,0.00042813638,0.00003859692,0.00005223912,0.001475941],"genre_scores_gemma":[0.9955429,0.000063403146,0.0033257273,0.00026432722,0.00012406058,0.000031850082,0.00002706061,0.000042386047,0.00057832873],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978493,0.00005969254,0.00057242846,0.00040173013,0.00064134505,0.0004754936],"domain_scores_gemma":[0.99863714,0.00018215015,0.000118439195,0.0004178699,0.00021768145,0.00042669036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003318492,0.00023203048,0.00059708016,0.00029287403,0.000022778639,0.000012548549,0.00019098594,0.00019507253,0.000046302583],"category_scores_gemma":[0.0006040109,0.00019253873,0.000063764346,0.00042057675,0.00019955751,0.00011629568,0.00015811565,0.00023296467,0.000071652204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030667714,0.001633034,0.94943833,0.0014367084,0.00089219754,0.004585655,0.0023933887,0.000035070178,0.029238138,0.0015708357,0.0030658385,0.0026440192],"study_design_scores_gemma":[0.26030877,0.006242961,0.67459154,0.002668389,0.002293345,0.0046913275,0.0014209448,0.0049078474,0.03812405,0.0026635434,0.0005187408,0.0015685046],"about_ca_topic_score_codex":0.0020362998,"about_ca_topic_score_gemma":0.000105210034,"teacher_disagreement_score":0.2748468,"about_ca_system_score_codex":0.0008897476,"about_ca_system_score_gemma":0.0014921724,"threshold_uncertainty_score":0.7851502},"labels":[],"label_agreement":null},{"id":"W2591093400","doi":"10.1182/blood.v118.21.4753.4753","title":"Location, Location, Location: Reassessing Erythropoiesis Stimulating Agents (ESAs) in the United States (US), Canada, and Europe (2007−2011)","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Anemia; Clinical trial; Intensive care medicine; Kidney disease; Dialysis; Internal medicine; Dosing","score_opus":0.028302804878892876,"score_gpt":0.2577396044726097,"score_spread":0.22943679959371682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591093400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99384147,0.0012335845,0.00026334074,0.0022961562,0.00009947765,0.0004094062,0.000004293223,0.00005012367,0.0018021747],"genre_scores_gemma":[0.9959558,0.00025340106,0.0014548077,0.0015148243,0.00010509391,0.000025490692,0.0001846175,0.00003090123,0.0004750444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99856013,0.00013454075,0.0003858809,0.00031168872,0.00032674533,0.0002810133],"domain_scores_gemma":[0.9986164,0.000120143246,0.00013991765,0.0004078608,0.0005968281,0.0001188765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003009552,0.0002057697,0.00021164774,0.00012092073,0.00022884042,0.00003929764,0.000116667616,0.00006068636,0.00018688306],"category_scores_gemma":[0.00019820339,0.00015315595,0.000016554039,0.00078210316,0.00012926655,0.00009499884,0.000034952056,0.00016151654,0.000027254826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059106467,0.0014894775,0.97944236,0.00050547445,0.00018175675,0.0002521941,0.007181264,0.00036419957,0.00006400527,0.00028135386,0.008946919,0.0012318927],"study_design_scores_gemma":[0.003024757,0.00022374379,0.98588544,0.0005535083,0.00035331488,0.00017861754,0.004209675,0.001038178,0.0006566561,0.00007097952,0.003548407,0.00025669837],"about_ca_topic_score_codex":0.3324616,"about_ca_topic_score_gemma":0.08064699,"teacher_disagreement_score":0.2518146,"about_ca_system_score_codex":0.00009353166,"about_ca_system_score_gemma":0.00057336636,"threshold_uncertainty_score":0.9361288},"labels":[],"label_agreement":null},{"id":"W2591115028","doi":"10.1182/blood.v110.11.1870.1870","title":"Extended-Duration Enoxaparin for Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients: An Evaluation of the EXCLAIM Study Based on a Recently Recommended Composite Efficacy Endpoint.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Calgary","funders":"","keywords":"Medicine; Asymptomatic; Placebo; Pulmonary embolism; Clinical endpoint; Relative risk; Randomized controlled trial; Internal medicine; Surgery; Intention-to-treat analysis; Thrombosis; Surrogate endpoint; Deep vein; Confidence interval; Pathology","score_opus":0.03313448768624279,"score_gpt":0.33182857786705766,"score_spread":0.2986940901808149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591115028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907235,0.00003668489,0.0001338491,0.0007130969,0.00037127387,0.0071111014,0.00001859682,0.000043875087,0.00084803783],"genre_scores_gemma":[0.9978147,0.000012309986,0.00040890006,0.0011351656,0.00013149307,0.00030498946,0.00014499706,0.000041366715,0.000006081443],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9961012,0.0004562556,0.00085712195,0.00050915993,0.0016825567,0.0003937349],"domain_scores_gemma":[0.9979993,0.00025953827,0.00033296295,0.00069665577,0.0005487653,0.000162784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037025614,0.0002559448,0.00066626945,0.00027165466,0.0001420155,0.000022180133,0.00027939607,0.000177275,0.000094932366],"category_scores_gemma":[0.00092928595,0.00018952515,0.00014132315,0.0004169761,0.00005418432,0.00009745762,0.00007340745,0.00030029638,0.0000040919213],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033350445,0.41400665,0.075339265,0.0004803687,0.0010301961,0.00004351558,0.011749124,0.00030318834,0.0025797365,0.00073069625,0.000666903,0.4897353],"study_design_scores_gemma":[0.02275057,0.0090769725,0.9581848,0.00025432426,0.0009648727,0.0000019883391,0.0005666417,0.0016109667,0.005980972,0.0001388332,0.00026809133,0.00020100363],"about_ca_topic_score_codex":0.00011966252,"about_ca_topic_score_gemma":0.00043792007,"teacher_disagreement_score":0.8828455,"about_ca_system_score_codex":0.00020445367,"about_ca_system_score_gemma":0.00023025832,"threshold_uncertainty_score":0.7728611},"labels":[],"label_agreement":null},{"id":"W2591120917","doi":"10.1182/blood.v118.21.258.258","title":"Adding Mercaptopurine and Methotrexate to Alternate Week ATRA Maintenance Therapy Does Not Improve the Outcome for Adults with Acute Promyelocytic Leukemia (APL) in First Remission: Results From North American Leukemia Intergroup Trial C9710","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Maintenance therapy; Mercaptopurine; Cytarabine; Acute promyelocytic leukemia; Internal medicine; Hazard ratio; Randomization; Randomized controlled trial; Clinical endpoint; Methotrexate; Leukemia; Cumulative incidence; Gastroenterology; Surgery; Chemotherapy; Confidence interval; Transplantation; Retinoic acid","score_opus":0.016035799010468553,"score_gpt":0.2453781777968862,"score_spread":0.22934237878641764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591120917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99717355,0.00015479181,0.00051216123,0.00020738388,0.00017830195,0.0013179617,0.00025631997,0.000025874733,0.00017365556],"genre_scores_gemma":[0.98974895,0.0008303974,0.007630708,0.00030956903,0.00038139397,0.0003881278,0.00012503783,0.000060377,0.00052540447],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99771047,0.00008555193,0.0005943963,0.00092785084,0.00019060573,0.0004911001],"domain_scores_gemma":[0.9985984,0.00010241789,0.00035986406,0.00064399035,0.0001345395,0.00016079476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003508125,0.00039427393,0.00043738223,0.00005567447,0.00013513978,0.000055178338,0.0005550952,0.00011622723,0.0000039615643],"category_scores_gemma":[0.00025508268,0.00022289598,0.00010617417,0.00019734213,0.00019818258,0.000017016193,0.0001840509,0.00024753282,0.0000016295581],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3674072,0.0006951093,0.017896285,0.00025721596,0.0017292172,0.0003119083,0.009057173,0.000049602815,0.54899853,0.000052140134,0.00029388457,0.053251706],"study_design_scores_gemma":[0.052810572,0.005161519,0.0046981922,0.00019058504,0.00019501927,0.00004173191,0.00053944427,0.00014648476,0.93204623,0.00007028201,0.0033850116,0.000714893],"about_ca_topic_score_codex":0.00116803,"about_ca_topic_score_gemma":0.0016259204,"teacher_disagreement_score":0.3830477,"about_ca_system_score_codex":0.00008899631,"about_ca_system_score_gemma":0.00022502565,"threshold_uncertainty_score":0.9089434},"labels":[],"label_agreement":null},{"id":"W2591137922","doi":"10.1182/blood.v104.11.1363.1363","title":"Polymorphisms in the Hyaluronan Synthase 1 Gene May Be Predisposing Factors for Waldenstrom’s Macroglobulinemia.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Hyaluronan synthase; Biology; Molecular biology; Exon; splice; Intron; Gene; RNA splicing; Genetics; RNA","score_opus":0.03221589051560325,"score_gpt":0.30376390142880244,"score_spread":0.2715480109131992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591137922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99476534,0.00059636834,0.00015515993,0.0024655734,0.00011142112,0.0012630746,0.0000928259,0.000061988205,0.00048824388],"genre_scores_gemma":[0.99612546,0.000021219508,0.0024052197,0.0005370002,0.00032426202,0.000115863964,0.00011859362,0.00005013964,0.0003022225],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979073,0.000047275487,0.0003540993,0.0004108283,0.00059520395,0.00068529794],"domain_scores_gemma":[0.998773,0.00030896295,0.00006625945,0.0006087809,0.000062728446,0.0001803149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039203648,0.00023614382,0.00032139552,0.00013116971,0.00012196873,0.000046271976,0.00032502855,0.00015391393,0.000048563063],"category_scores_gemma":[0.0004020035,0.00016037305,0.000170408,0.0002884022,0.00015399471,0.00006933176,0.00007337752,0.00027551418,0.000016127771],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009453436,0.05355352,0.107498206,0.0044866195,0.00404353,0.027271712,0.06046962,0.0021918048,0.6526109,0.0143413525,0.010302814,0.05377651],"study_design_scores_gemma":[0.25180808,0.0036604693,0.035798434,0.0009310418,0.001388656,0.005552598,0.002562492,0.0013846859,0.6884817,0.0009379689,0.0063686906,0.0011251728],"about_ca_topic_score_codex":0.0010528995,"about_ca_topic_score_gemma":0.00012494616,"teacher_disagreement_score":0.24235465,"about_ca_system_score_codex":0.0024534075,"about_ca_system_score_gemma":0.0029671995,"threshold_uncertainty_score":0.6539823},"labels":[],"label_agreement":null},{"id":"W2591186241","doi":"10.1182/blood.v106.11.3978.3978","title":"Clinical and Laboratory Control of a Man with Chronic Recurrent Thrombotic Thrombocytopenic Purpura (TTP) Since Birth, with Bi-Weekly Infusion of Plasma.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Boniface Hospital","funders":"","keywords":"Medicine; Thrombotic thrombocytopenic purpura; Prednisone; Schistocyte; Internal medicine; Jaundice; Splenectomy; Pediatrics; Gastroenterology; Hemolytic anemia; Dipyridamole; Microangiopathic hemolytic anemia; Surgery; Platelet","score_opus":0.012409176678004851,"score_gpt":0.2590720886435195,"score_spread":0.24666291196551465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591186241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921189,0.0065049506,0.000045232002,0.00017507667,0.00009680422,0.00070595864,0.0001773323,0.00004172873,0.0001340348],"genre_scores_gemma":[0.99942106,0.00019126903,0.00017910016,0.000039378785,0.000044334916,0.00003167967,0.000024732346,0.00002165238,0.000046811063],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832135,0.00029576858,0.0006452444,0.00036300815,0.000089806046,0.0002848442],"domain_scores_gemma":[0.9986759,0.00024066823,0.0004363075,0.00044575188,0.00015723803,0.000044146327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000276782,0.00022070833,0.00068859715,0.00009127356,0.00007721133,0.0000081746575,0.00022542728,0.00012766934,0.00021498936],"category_scores_gemma":[0.000043020398,0.00015782367,0.00006342303,0.00017164179,0.0006519302,0.000104952414,0.00009226783,0.00019168734,0.0000328876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023956338,0.0045426553,0.78360695,0.0007695645,0.0022151046,0.000018619941,0.00034546625,0.000041577317,0.19844154,0.0019929328,0.0005841189,0.005045853],"study_design_scores_gemma":[0.0697041,0.016642915,0.7994099,0.002282481,0.002119095,0.00023113345,0.00047280194,0.000058286863,0.09626319,0.00004169169,0.011849608,0.0009247777],"about_ca_topic_score_codex":0.000023413186,"about_ca_topic_score_gemma":0.00039726662,"teacher_disagreement_score":0.10217834,"about_ca_system_score_codex":0.000024351957,"about_ca_system_score_gemma":0.0003126109,"threshold_uncertainty_score":0.6435862},"labels":[],"label_agreement":null},{"id":"W2591204805","doi":"10.1182/blood.v106.11.3218.3218","title":"Quantitiative Analysis of Roughness of Catheters by Scanning Electron Microscopy (SEM) and Atomic Force Microscopy (AFM).","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Central Venous Catheters and Hemodialysis","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster Children's Hospital","funders":"","keywords":"Materials science; Scanning electron microscope; Surface roughness; Magnification; Surface finish; Biomedical engineering; Microscopy; Forceps; Atomic force microscopy; Catheter; Optics; Composite material; Surgery; Medicine; Nanotechnology; Physics","score_opus":0.015355495597711353,"score_gpt":0.3511323581475354,"score_spread":0.33577686254982403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591204805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962144,0.0021758606,0.00053864653,0.00015662034,0.000048222435,0.00034462492,0.00023846504,0.00002308167,0.00026011837],"genre_scores_gemma":[0.99751365,0.000513855,0.0012509597,0.00022144063,0.00004619444,0.000022541144,0.00008899096,0.000028758337,0.00031361674],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99802935,0.00018164051,0.0006922919,0.00035306197,0.000180778,0.0005628738],"domain_scores_gemma":[0.9986835,0.00020440556,0.00055565336,0.00031710966,0.0001253906,0.00011390323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035105768,0.00020385496,0.0007961164,0.00029553843,0.00027659928,0.000008437728,0.00017839351,0.00017170537,0.00008397196],"category_scores_gemma":[0.000027795573,0.00019360092,0.00026804642,0.0006342245,0.000121914876,0.00011538996,0.00006790263,0.00023875569,0.000006932083],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013529322,0.0005943449,0.2039171,0.0001830951,0.0017384778,6.812018e-7,0.012354332,0.000033875804,0.78006756,0.00016923118,0.00053260004,0.00027341972],"study_design_scores_gemma":[0.004325453,0.0004473563,0.044297375,0.000290007,0.0070989123,0.0000016120609,0.0019038741,0.0009045714,0.9387878,0.00009068477,0.0013315382,0.00052081386],"about_ca_topic_score_codex":0.0008598379,"about_ca_topic_score_gemma":0.00041763554,"teacher_disagreement_score":0.15961972,"about_ca_system_score_codex":0.00008704843,"about_ca_system_score_gemma":0.00013352715,"threshold_uncertainty_score":0.78948164},"labels":[],"label_agreement":null},{"id":"W2591247162","doi":"10.1182/blood.v112.11.4821.4821","title":"Cardiopulmonary Testing and Pulmonary Hypertension in Patients with Sickle Cell Anemia","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Medicine; Cardiology; Internal medicine; Acute chest syndrome; DLCO; Pulmonary hypertension; Pulmonary function testing; Sickle cell anemia; Disease; Lung; Diffusing capacity","score_opus":0.008358100008157131,"score_gpt":0.1738411347784799,"score_spread":0.16548303477032278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591247162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901416,0.0010533398,5.650544e-7,0.00005463996,0.000023062488,0.00024089513,0.0000019836689,0.000040094375,0.00844384],"genre_scores_gemma":[0.99893266,0.00011405617,0.0006232731,0.00013657828,0.00002512629,0.0000041329104,0.000013948764,0.000020706837,0.00012949239],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99927515,0.000015904872,0.00013696817,0.00021051615,0.00016349833,0.00019798554],"domain_scores_gemma":[0.99964184,0.0000321428,0.00003153646,0.00014240066,0.000055060984,0.00009704003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000039099614,0.0001159987,0.00020559314,0.00006716829,0.0000785846,0.0000026779467,0.000025590478,0.00009503858,0.0000042512365],"category_scores_gemma":[0.000033970588,0.00008404715,0.000021043252,0.00020230305,0.00006406912,0.00004386268,0.000028493914,0.00018787562,0.000007264279],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000097039505,0.0008774002,0.99429053,0.000066207096,0.000009708759,0.0014809163,0.00006377729,0.00001246071,0.0014859628,2.3980277e-7,0.00005028454,0.00156545],"study_design_scores_gemma":[0.004553818,0.0004458056,0.9933051,0.0001428364,0.000090951966,0.0006955488,0.00008629023,0.00009679327,0.000358392,0.000004617128,0.00009050288,0.00012935499],"about_ca_topic_score_codex":0.00010635503,"about_ca_topic_score_gemma":9.2190373e-7,"teacher_disagreement_score":0.008791106,"about_ca_system_score_codex":0.000010027926,"about_ca_system_score_gemma":0.00004507718,"threshold_uncertainty_score":0.34273434},"labels":[],"label_agreement":null},{"id":"W2591260446","doi":"10.1182/blood.v108.11.884.884","title":"Use of Therapeutic Dose Low Molecular Weight Heparin in Patients with Renal Insufficiency: Analysis of Anti-Xa Levels and Creatinine Clearance.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Renal function; Low molecular weight heparin; Nomogram; Warfarin; Hemodialysis; Creatinine; Urology; Heparin; Anticoagulant; Internal medicine; Gastroenterology","score_opus":0.0104463230798324,"score_gpt":0.22404881915191485,"score_spread":0.21360249607208245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591260446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99895585,0.00027460215,0.00008177135,0.000037148682,0.000007573917,0.0003202118,0.000018832125,0.0000089341875,0.00029505434],"genre_scores_gemma":[0.9992137,0.000051613246,0.0005808507,0.00008119665,0.0000069663693,0.000008110636,0.000026154348,0.000012982976,0.000018410541],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897426,0.000033010943,0.00032775768,0.00021883985,0.0002825975,0.00016355603],"domain_scores_gemma":[0.9994391,0.000027036149,0.00015120789,0.00026080408,0.00008576429,0.000036060745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009562214,0.00012239322,0.00060517027,0.00033416264,0.00001684141,0.000007999106,0.00005220744,0.00004230543,0.00003296309],"category_scores_gemma":[0.000012031237,0.000092689676,0.00006707332,0.0007314327,0.00008286092,0.0000536925,0.000032153686,0.00005823603,4.4800151e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001131172,0.009390405,0.9833969,0.000088059634,0.0009989775,0.000018767352,0.00014738739,0.0007920878,0.0037148672,0.0005027835,0.000012473012,0.000824178],"study_design_scores_gemma":[0.0036037033,0.0007698886,0.9833901,0.00013430361,0.0023024043,4.243131e-7,0.000009832997,0.00027129936,0.009377197,0.000013016077,0.00003552837,0.000092330425],"about_ca_topic_score_codex":0.000528379,"about_ca_topic_score_gemma":0.00009156331,"teacher_disagreement_score":0.008620516,"about_ca_system_score_codex":0.000009179918,"about_ca_system_score_gemma":0.000024991888,"threshold_uncertainty_score":0.37797752},"labels":[],"label_agreement":null},{"id":"W2591279795","doi":"10.1182/blood.v128.22.5280.5280","title":"Building a Targeted Approach to Assess Risk of Anthracycline Induced Cardiomyopathy Amongst Paediatric Cancer Patients","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cardiotoxicity; Medicine; Pharmacogenomics; Internal medicine; Oncology; Anthracycline; Cancer; Subclinical infection; Cardiomyopathy; ADME; Intensive care medicine; Pharmacology; Bioinformatics; Breast cancer; Drug; Heart failure; Chemotherapy; Biology","score_opus":0.020374062423335126,"score_gpt":0.2721535160418664,"score_spread":0.25177945361853127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591279795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99597985,0.00018198704,0.002101147,0.00009007886,0.00018689717,0.0007379989,0.000116922114,0.00006509045,0.0005400218],"genre_scores_gemma":[0.99618757,0.00018273595,0.002867221,0.00010622068,0.0004733851,0.000096856806,0.000017070332,0.000038922695,0.000030047808],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998494,0.000089070585,0.0003560417,0.00036620896,0.0004140406,0.00028061445],"domain_scores_gemma":[0.9989119,0.00007989305,0.00021416985,0.00033239435,0.0002670227,0.00019458355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002959102,0.0001881895,0.00047619132,0.00020718983,0.000056981455,0.000008952313,0.00010774264,0.000161038,0.000013926521],"category_scores_gemma":[0.00034555767,0.00013574304,0.00020229546,0.0005245949,0.000033174823,0.00010258379,0.00004641295,0.00015269469,0.0000047767767],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007701249,0.0007933629,0.25422207,0.000065315464,0.0002647239,0.0000021029966,0.00018378033,0.000004199818,0.72778124,0.000013414667,0.00007199724,0.016520815],"study_design_scores_gemma":[0.005372535,0.00023398294,0.28171006,0.000109985,0.0004226582,0.0000037992977,0.000029932253,0.000008080324,0.711807,0.000024274894,0.00012451201,0.00015316193],"about_ca_topic_score_codex":0.00016474162,"about_ca_topic_score_gemma":0.000004032104,"teacher_disagreement_score":0.027487991,"about_ca_system_score_codex":0.00007713274,"about_ca_system_score_gemma":0.00010420973,"threshold_uncertainty_score":0.5535441},"labels":[],"label_agreement":null},{"id":"W2591297419","doi":"10.1182/blood.v120.21.69.69","title":"Assessment of Early Molecular Response As a Predictor of Long-Term Clinical Outcomes in the Phase 3 BELA Study","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Bosutinib; Discontinuation; Medicine; Internal medicine; Gastroenterology; Population; Clinical endpoint; Imatinib; Imatinib mesylate; Myeloid leukemia; Clinical trial; Dasatinib","score_opus":0.040900576643565646,"score_gpt":0.423422908470745,"score_spread":0.3825223318271793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591297419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99793833,0.00022092948,0.0000092429755,0.00009074075,0.00007743956,0.0013598016,0.000017740369,0.0000135804075,0.0002722131],"genre_scores_gemma":[0.9994378,0.000010234076,0.00022579062,0.00008025594,0.00004613201,0.00007491079,0.000008151715,0.000018226221,0.00009847995],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99772614,0.00061700295,0.0006661489,0.00019152887,0.00055715174,0.00024199918],"domain_scores_gemma":[0.998301,0.00062187464,0.0002025588,0.00071132777,0.000050983337,0.000112247646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017075913,0.00014961534,0.0005313588,0.00009714938,0.0000149979805,0.0000042294964,0.00017572133,0.000083802646,0.00006574928],"category_scores_gemma":[0.00048121726,0.00009498466,0.00017351616,0.00015876528,0.00008315606,0.000051843977,0.00006848416,0.0002295373,0.000008231744],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008892609,0.036553003,0.9578428,0.00003448832,0.0007013747,0.00039997767,0.0013833604,1.3814353e-7,0.0018300094,0.00002043534,0.000006074398,0.000339048],"study_design_scores_gemma":[0.039046243,0.0065959464,0.95156157,0.00006858019,0.00096997106,0.000040664258,0.00023048355,0.0000017770147,0.0014126445,0.000003327883,0.0000057665634,0.00006302731],"about_ca_topic_score_codex":0.00008901759,"about_ca_topic_score_gemma":0.000008977515,"teacher_disagreement_score":0.038156983,"about_ca_system_score_codex":0.000087312255,"about_ca_system_score_gemma":0.00041378193,"threshold_uncertainty_score":0.3873362},"labels":[],"label_agreement":null},{"id":"W2591299813","doi":"10.1182/blood.v114.22.2983.2983","title":"Incidence and Clinical Outcomes of Occult Malignancies Detected by Computed Tomographic Pulmonary Angiography in Patients with Acute Pulmonary Embolism.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Occult; Pulmonary embolism; Radiology; Malignancy; Lung cancer; Incidence (geometry); Pulmonary angiography; Retrospective cohort study; Cancer; Internal medicine; Pathology","score_opus":0.006482307875977947,"score_gpt":0.24479658666318518,"score_spread":0.23831427878720723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591299813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99776787,0.00086799404,0.00001825892,0.00027364073,0.000045614197,0.00076721754,0.000035330326,0.000065847176,0.00015821666],"genre_scores_gemma":[0.99793637,0.0005084857,0.0008011054,0.00061592035,0.00001871789,0.000017168266,0.00007484843,0.000017517206,0.000009877315],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982556,0.00006479629,0.000564397,0.00041728068,0.0003735486,0.00032433844],"domain_scores_gemma":[0.99910563,0.00007490924,0.00019115694,0.00034112303,0.00013172661,0.00015543174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017771746,0.00024615123,0.000815119,0.00037424662,0.00004878463,0.000014719721,0.00014312474,0.00012477211,0.0000065933987],"category_scores_gemma":[0.000027406075,0.00018877017,0.00021594073,0.0007395377,0.00016449532,0.000119981225,0.00007271742,0.00016769065,0.0000011388199],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016120663,0.0068639256,0.98794633,0.00004224955,0.00062436674,0.00017809683,0.000056903675,6.199446e-7,0.0002150547,0.000035283803,0.00017927852,0.003696661],"study_design_scores_gemma":[0.0033785836,0.0015445076,0.9933605,0.00021402577,0.00097447156,0.000015604388,0.000033287095,0.000018081728,0.00015154546,0.00006628785,0.000037664664,0.00020543234],"about_ca_topic_score_codex":0.000093350565,"about_ca_topic_score_gemma":0.000018740588,"teacher_disagreement_score":0.005414155,"about_ca_system_score_codex":0.000007319887,"about_ca_system_score_gemma":0.000025087158,"threshold_uncertainty_score":0.7697824},"labels":[],"label_agreement":null},{"id":"W2591311294","doi":"10.1182/blood.v118.21.4613.4613","title":"The Saskatchewan Experience for Using FCR in Treatment of CLL – A Comparison of Oral Versus IV Regimens","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Saskatchewan; Saskatchewan Cancer Agency","funders":"","keywords":"Fludarabine; Medicine; Cyclophosphamide; Rituximab; Tolerability; Regimen; Internal medicine; Chronic lymphocytic leukemia; Gastroenterology; Surgery; Chemotherapy; Leukemia; Adverse effect; Lymphoma","score_opus":0.18307658965297108,"score_gpt":0.40551548883019084,"score_spread":0.22243889917721976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591311294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981516,0.0006204174,0.000027240823,0.000017142478,0.00006009635,0.0005344932,0.0000039000647,0.0000067559113,0.00057836703],"genre_scores_gemma":[0.9969461,0.000020339387,0.0028139115,0.0000025757831,0.000021597925,0.000046605976,0.0000021201447,0.000011440168,0.00013530064],"study_design_codex":"qualitative","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99911106,0.000028244314,0.00027834537,0.00014457581,0.00019758994,0.00024017066],"domain_scores_gemma":[0.9992428,0.000188174,0.00009455132,0.00034855973,0.00006990939,0.00005604925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012510657,0.000085062995,0.00029297403,0.000046225054,0.000033802822,0.0000027201484,0.00009878021,0.000051071398,0.000013232307],"category_scores_gemma":[0.000075284726,0.00005592057,0.00007339602,0.00013300737,0.00017488345,0.00002246461,0.000028326745,0.000036742997,0.0000010736757],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.058014326,0.042083483,0.11109205,0.0013823105,0.0026853853,0.00036474265,0.5890742,0.00006828385,0.12860157,0.0025527766,0.0003200129,0.063760854],"study_design_scores_gemma":[0.14000207,0.0055888155,0.0017667317,0.00017554108,0.00035080028,0.000035539822,0.03562251,0.009445342,0.8059284,0.00006562571,0.000870101,0.00014850579],"about_ca_topic_score_codex":0.003842943,"about_ca_topic_score_gemma":0.0011953516,"teacher_disagreement_score":0.67732686,"about_ca_system_score_codex":0.0012908165,"about_ca_system_score_gemma":0.0018171271,"threshold_uncertainty_score":0.5809406},"labels":[],"label_agreement":null},{"id":"W2591377221","doi":"10.1182/blood.v128.22.3280.3280","title":"Mutational Characterisation and Tracking Disease Progression Using Circulating Cell-Free Tumor DNA in Multiple Myeloma Patients","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Collège Boréal","funders":"","keywords":"Neuroblastoma RAS viral oncogene homolog; Monoclonal gammopathy of undetermined significance; Digital polymerase chain reaction; KRAS; Cell-free fetal DNA; Liquid biopsy; Multiple myeloma; Medicine; GNAS complex locus; Cancer research; Bone marrow; Pathology; Monoclonal; Oncology; Internal medicine; Biology; Cancer; Immunology; Polymerase chain reaction; Gene; Colorectal cancer; Monoclonal antibody; Antibody; Genetics","score_opus":0.011275849997938871,"score_gpt":0.23223819152510347,"score_spread":0.2209623415271646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591377221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993104,0.00016138912,0.00019989203,0.000027677417,0.000053944892,0.00015717035,0.00007040238,0.000004099122,0.0000150791275],"genre_scores_gemma":[0.9990742,0.000017923132,0.00062877836,0.00004438819,0.000120222845,0.000013915268,0.000084232954,0.00001340206,0.000002900514],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99944144,0.000017874117,0.00013950298,0.00020249955,0.00007787382,0.000120816934],"domain_scores_gemma":[0.9996664,0.000024211575,0.00008331837,0.0001225427,0.000042674157,0.00006083582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005150865,0.00007752049,0.00005916114,0.000028543789,0.000052611387,0.000020324507,0.00005025983,0.00003326668,0.0000028561271],"category_scores_gemma":[0.00025036506,0.00006618608,0.000021410444,0.000027392347,0.000023274715,0.0000073563915,0.00006980089,0.00002060911,5.9536376e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031806783,0.00013453818,0.5214306,0.000014939003,0.000003634863,0.0000058214437,0.000027833847,0.000009461096,0.47330737,0.0000032130013,0.0000029253779,0.0050278557],"study_design_scores_gemma":[0.0030518733,0.000055218763,0.8691196,0.000078352794,0.000017019935,0.000003235518,0.000010411489,0.0002778358,0.12712087,0.00007175763,0.00006341438,0.00013042429],"about_ca_topic_score_codex":0.000006283479,"about_ca_topic_score_gemma":0.000011872494,"teacher_disagreement_score":0.347689,"about_ca_system_score_codex":0.000013584237,"about_ca_system_score_gemma":0.000050967996,"threshold_uncertainty_score":0.269899},"labels":[],"label_agreement":null},{"id":"W2591384843","doi":"10.1182/blood.v112.11.565.565","title":"Prognostic Factors for Outcome of Nonmyeloablative Allogeneic Stem Cell Transplantation (NST) in Poor-Risk Chronic Lymphocytic Leukemia (CLL): Final Results from a Prospective Multicenter Trial (GCLLSG CLL3X study)","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Fludarabine; Alemtuzumab; Medicine; Internal medicine; Transplantation; Chronic lymphocytic leukemia; Cyclophosphamide; Minimal residual disease; Busulfan; Oncology; Surgery; Hematopoietic stem cell transplantation; Leukemia; Chemotherapy","score_opus":0.0514493279026734,"score_gpt":0.3053333784551641,"score_spread":0.25388405055249075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591384843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98807925,0.0002687719,0.00012062125,0.000010546177,0.0001991235,0.010275857,0.0008117798,0.00007640971,0.00015766363],"genre_scores_gemma":[0.99767375,0.00016329851,0.00045676777,0.000013338724,0.000280063,0.00062062975,0.00028943497,0.000083963976,0.0004187644],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99539626,0.0003025948,0.0015409706,0.0010399666,0.00092981925,0.0007904078],"domain_scores_gemma":[0.99626887,0.002036088,0.0005621562,0.00060938887,0.00028962802,0.00023388836],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00059477426,0.00050071767,0.0011082558,0.00037928665,0.0001501235,0.000019889725,0.0003122179,0.00028958186,0.000020829606],"category_scores_gemma":[0.00058580434,0.00042185723,0.00032681003,0.000519836,0.00022722497,0.00017449746,0.00007074624,0.00043973688,0.000023192792],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.27405718,0.008772626,0.66600627,0.0013153265,0.0016973057,0.0021510192,0.03806186,0.0014322815,0.005834082,0.0000061159953,0.000046768153,0.0006191376],"study_design_scores_gemma":[0.66582143,0.006480896,0.2886458,0.00026949882,0.0012712601,0.000058299745,0.0011618213,0.0069459677,0.028943172,0.000013848775,0.000008653939,0.0003793557],"about_ca_topic_score_codex":0.006761129,"about_ca_topic_score_gemma":0.0014693508,"teacher_disagreement_score":0.39176422,"about_ca_system_score_codex":0.026251834,"about_ca_system_score_gemma":0.014479635,"threshold_uncertainty_score":0.99985296},"labels":[],"label_agreement":null},{"id":"W2591387482","doi":"10.1182/blood.v116.21.3625.3625","title":"The Epstein-Barr Virus (EBV) Encoded Oncoprotein LMP1 Mediates Down Regulation of Shelterin Proteins, Formation of Telomere Aggregates and Multinuclearity.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Université de Sherbrooke","funders":"","keywords":"Shelterin; Telomere; Biology; Transfection; Cell culture; Molecular biology; Lymphoma; Germinal center; Cancer research; Virology; B cell; Immunology; Genetics; DNA; Gene; Antibody; Transcription factor; DNA-binding protein","score_opus":0.006714259740301701,"score_gpt":0.2283339881522238,"score_spread":0.2216197284119221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591387482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99668974,0.0010544878,0.00001508471,0.0004997777,0.00006491692,0.00082131947,0.000022723447,0.000036958925,0.0007950114],"genre_scores_gemma":[0.9984535,0.00030015345,0.0009841976,0.000029446353,0.00005607381,0.00004934254,0.000022444972,0.000017603317,0.00008722344],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989493,0.00004067839,0.00039431758,0.00015109895,0.00028218096,0.00018245021],"domain_scores_gemma":[0.999087,0.00006766847,0.00037140204,0.00025291136,0.00015224438,0.000068796704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003348448,0.00012959437,0.00026393926,0.00006897617,0.00011367522,0.000019463285,0.000088199435,0.00015293778,0.000041357718],"category_scores_gemma":[0.0003658781,0.00009191658,0.00006682566,0.00015587748,0.0002096068,0.0001431798,0.00003776969,0.00020045512,0.000003757021],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002390512,0.00025569374,0.0052749543,0.00024582967,0.00006674639,0.0000014553474,0.0010762117,0.0000029008982,0.9586647,0.00033137898,0.00008388497,0.03375717],"study_design_scores_gemma":[0.0062281257,0.00060621416,0.03303888,0.00021711264,0.00016662954,0.00001219833,0.0006381839,0.00060992467,0.95609605,0.0013763537,0.00085758773,0.00015274603],"about_ca_topic_score_codex":0.00049445225,"about_ca_topic_score_gemma":0.0006735188,"teacher_disagreement_score":0.033604424,"about_ca_system_score_codex":0.000015958381,"about_ca_system_score_gemma":0.00007079396,"threshold_uncertainty_score":0.37482494},"labels":[],"label_agreement":null},{"id":"W2591400841","doi":"10.1182/blood.v106.11.4156.4156","title":"Clopidogrel Use in Children.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Clopidogrel; Medicine; Aspirin; Percutaneous coronary intervention; Population; Warfarin; Thienopyridine; Surgery; Internal medicine; Regimen; Pediatrics; Myocardial infarction; Atrial fibrillation","score_opus":0.009187213803840385,"score_gpt":0.22429996460621582,"score_spread":0.21511275080237544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591400841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99528563,0.003632138,0.000018866807,0.00011923428,0.000014147955,0.00015374598,0.0000034104921,0.00004734137,0.00072550215],"genre_scores_gemma":[0.9979501,0.0004900652,0.0004447289,0.00053584814,0.00026517324,0.0000065280483,0.000016957918,0.000012022235,0.00027861338],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99949807,0.000018758681,0.00009768664,0.00012925395,0.000120499986,0.00013573712],"domain_scores_gemma":[0.999699,0.000008622763,0.000012293103,0.00020123964,0.000012606336,0.00006622817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000060392784,0.00006950103,0.00014614259,0.000051063253,0.000016831134,0.000009050261,0.000034372682,0.000045747838,0.00009558353],"category_scores_gemma":[0.000018794819,0.000060256472,0.00014675992,0.00009396872,0.00002101823,0.00007211264,0.000010192734,0.00007836496,0.00009483596],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048242502,0.0007737272,0.9793887,0.000005605059,0.00028148424,0.000053009288,0.000028623796,0.000008083335,0.00025630125,0.00008981459,0.00018283924,0.018883564],"study_design_scores_gemma":[0.0064807218,0.00005136453,0.97875446,0.00003249302,0.00019047926,0.0002900185,0.000007703404,0.000006364285,0.0027404588,0.000010027513,0.011349002,0.00008692541],"about_ca_topic_score_codex":0.000017101058,"about_ca_topic_score_gemma":0.0000073084534,"teacher_disagreement_score":0.018796638,"about_ca_system_score_codex":0.0000072461594,"about_ca_system_score_gemma":0.000023300046,"threshold_uncertainty_score":0.24571876},"labels":[],"label_agreement":null},{"id":"W2591449905","doi":"10.1182/blood.v124.21.3133.3133","title":"Identification of New microRNA Biomarkers and Candidate Target Genes in Primitive CML Cells Using Global Comparative RNA analyses","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"CD34; Imatinib mesylate; microRNA; Progenitor cell; Biology; Stem cell; Haematopoiesis; Cancer research; MiRBase; Molecular biology; Immunology; Imatinib; Gene; Genetics; Myeloid leukemia","score_opus":0.04231022861407496,"score_gpt":0.33850139428500786,"score_spread":0.2961911656709329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591449905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99749744,0.0014103984,0.0003869813,0.000030479536,0.00004322208,0.00028382207,0.000035862526,0.000010956619,0.00030081847],"genre_scores_gemma":[0.9960972,0.0000637796,0.003696994,0.000020721489,0.000037414222,0.0000027741085,0.00003321551,0.000007104723,0.000040774954],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991025,0.000062483356,0.00030696503,0.00024085387,0.00013370355,0.0001535122],"domain_scores_gemma":[0.999451,0.00003577169,0.0001896846,0.00017990898,0.000051630894,0.00009204753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000108933855,0.00012967072,0.00033192226,0.000084742416,0.000026271167,0.0000114988,0.000049243645,0.000053788597,0.000014131884],"category_scores_gemma":[0.000024183168,0.00011650547,0.00004311499,0.0002317581,0.000076688644,0.000057568428,0.00002924756,0.000043121563,0.0000048002435],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000092738985,0.00022691462,0.0791674,0.00005356042,0.00039850755,0.000010667629,0.00051465956,0.00004553662,0.918562,0.000008610165,0.00006461295,0.0008547692],"study_design_scores_gemma":[0.0056002117,0.00010551684,0.14856689,0.000097000375,0.0004791257,0.000023501703,0.00021594192,0.0016246227,0.8431138,0.0000404605,0.000041113806,0.000091812944],"about_ca_topic_score_codex":0.002189833,"about_ca_topic_score_gemma":0.00017875215,"teacher_disagreement_score":0.075448215,"about_ca_system_score_codex":0.00021814056,"about_ca_system_score_gemma":0.00024081531,"threshold_uncertainty_score":0.4750955},"labels":[],"label_agreement":null},{"id":"W2591461324","doi":"10.1182/blood.v118.21.999.999","title":"Endogenous Ligands Selectively Stimulate Highly Avid Autoreactive Human Invariant Natural Killer T Cells with Distinctive T-Cell Receptor Vβ11 CDR3 Sequence Motifs","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"CD1D; Biology; Natural killer T cell; T-cell receptor; Avidity; Innate immune system; Immune system; Cell biology; Immunology; Antigen; T cell","score_opus":0.024762506929363267,"score_gpt":0.20958383109119513,"score_spread":0.18482132416183186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591461324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97610754,0.0003448521,0.00016225308,0.000020766978,0.0039893505,0.0005758102,0.000020623724,0.00026063126,0.018518172],"genre_scores_gemma":[0.97566164,0.000019437126,0.00019533622,0.00013856977,0.000067542576,0.000054031818,0.00022710956,0.000053982905,0.023582377],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99818814,0.00018903082,0.00036520397,0.00062738074,0.00007675885,0.0005534592],"domain_scores_gemma":[0.99886036,0.00010615985,0.00032171604,0.00035669838,0.00030232684,0.00005274443],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00015166012,0.000414708,0.00039455152,0.00016006397,0.0004925937,0.000032659005,0.00027025235,0.00029142015,0.0013966571],"category_scores_gemma":[0.000030942403,0.0003335865,0.00012720595,0.00022551707,0.00022854209,0.00033690454,0.00008257303,0.0008095758,0.0011790016],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008101131,0.0012718379,0.0004989168,0.000014072079,0.0006156075,0.00003559101,0.0038318923,0.0000048422826,0.99113697,0.00017098077,0.0015172468,0.000091952],"study_design_scores_gemma":[0.003926909,0.0016630073,0.0036250884,0.000047710768,0.00029107963,0.00023321458,0.00041358173,0.0000075007247,0.9858975,0.000029412862,0.0034016985,0.00046329142],"about_ca_topic_score_codex":0.00080349506,"about_ca_topic_score_gemma":0.000032944987,"teacher_disagreement_score":0.0052394425,"about_ca_system_score_codex":0.00013948148,"about_ca_system_score_gemma":0.000119709846,"threshold_uncertainty_score":0.9999116},"labels":[],"label_agreement":null},{"id":"W2591468554","doi":"10.1182/blood.v118.21.2065.2065","title":"Deriving Health Utility Values From a Health-Related Quality of Life Instrument in Non-Hodgkin Lymphoma Patients","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Quality of life (healthcare); EQ-5D; Quality-adjusted life year; Cancer; Health related quality of life; Gerontology; Physical therapy; Internal medicine; Cost effectiveness; Disease; Nursing","score_opus":0.3419676506228307,"score_gpt":0.3840803251919141,"score_spread":0.04211267456908341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591468554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99133986,0.0021364568,0.00032264282,0.0028024672,0.00046332012,0.0010481239,0.00064233097,0.000047687336,0.0011970989],"genre_scores_gemma":[0.99198985,0.00013677213,0.0037692047,0.003835726,0.000054206732,0.00006585303,0.00009640028,0.000033850392,0.000018125918],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9883723,0.0011407746,0.008939624,0.0007598553,0.0001654651,0.00062196644],"domain_scores_gemma":[0.9927241,0.0005401925,0.0054898146,0.0007768335,0.00006704438,0.00040199794],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0179902,0.00026046534,0.0019616836,0.00034302362,0.00015222389,0.000022885673,0.0003692121,0.00018470231,0.00040462278],"category_scores_gemma":[0.0027385263,0.0003442882,0.0001641132,0.00030591956,0.00009198897,0.00035465488,0.00011772707,0.00016334518,0.00026240235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035985297,0.0018149192,0.9820247,0.0003975685,0.00009964631,2.244528e-7,0.011477459,0.0000029975336,5.442552e-7,0.0022142248,0.00050717144,0.0014245531],"study_design_scores_gemma":[0.0045454362,0.00021762618,0.98372513,0.00018194277,0.0000033608587,2.6560974e-7,0.0009138732,0.00042094637,0.000013704841,0.009572419,0.00014616539,0.00025912724],"about_ca_topic_score_codex":0.10609444,"about_ca_topic_score_gemma":0.00296066,"teacher_disagreement_score":0.10313378,"about_ca_system_score_codex":0.0005556678,"about_ca_system_score_gemma":0.0006301836,"threshold_uncertainty_score":0.99990094},"labels":[],"label_agreement":null},{"id":"W2591509707","doi":"10.1182/blood.v114.22.2502.2502","title":"Treatment of Hodgkin Lymphoma without G-CSF Does Not Increase the Risk of Febrile Neutropenia.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Hospital; London Health Sciences Centre","funders":"","keywords":"Medicine; Febrile neutropenia; ABVD; Neutropenia; Absolute neutrophil count; Chemotherapy; Chemotherapy regimen; Internal medicine; Surgery; Granulocyte colony-stimulating factor; Bone marrow suppression; Gastroenterology; Cyclophosphamide; Vincristine","score_opus":0.010742378294662838,"score_gpt":0.2607679571154977,"score_spread":0.25002557882083487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591509707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918476,0.00030186764,0.0000066161097,0.00062774133,0.00007406651,0.00043026634,0.00006373512,0.00003143235,0.006616688],"genre_scores_gemma":[0.9979359,0.0005240688,0.00016924659,0.00016873848,0.00018635788,0.000031357387,0.0000063558523,0.000012831987,0.00096518034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991672,0.00007328605,0.00025676598,0.00017278362,0.0001743852,0.0001555657],"domain_scores_gemma":[0.9991301,0.000060054834,0.00016757741,0.00047175452,0.00008662068,0.000083906845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007253696,0.00013812435,0.00035831626,0.0000546136,0.00007695284,0.000008532079,0.000083271756,0.000044555032,0.000098702425],"category_scores_gemma":[0.00002936713,0.00006913042,0.00017374006,0.0001553562,0.00008526754,0.000041936888,0.000013732267,0.000044197932,0.0000136589315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017886834,0.009125521,0.71828085,0.00006572654,0.0010150488,0.00007654506,0.0010028209,0.000017000848,0.21240403,0.0010828745,0.00043571639,0.054705147],"study_design_scores_gemma":[0.009067529,0.0026315963,0.53981906,0.000042017615,0.0017245656,0.00013217803,0.0000840121,0.0000069431185,0.44137904,0.000096822245,0.0049186624,0.00009753763],"about_ca_topic_score_codex":0.0016255778,"about_ca_topic_score_gemma":0.00012399694,"teacher_disagreement_score":0.22897501,"about_ca_system_score_codex":0.00003375362,"about_ca_system_score_gemma":0.000121778765,"threshold_uncertainty_score":0.28190568},"labels":[],"label_agreement":null},{"id":"W2591560740","doi":"10.1182/blood.v116.21.4253.4253","title":"Intraendosomal Transferrin Saturation Governs Interorganellar Association for Iron Delivery In Erythroid Cells","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Jewish General Hospital; McGill University","funders":"","keywords":"Endosome; Ferrochelatase; Transferrin receptor; Endocytosis; Mitochondrion; Cell biology; DMT1; Transferrin; Pinocytosis; Chemistry; Biochemistry; Protoporphyrin IX; Biology; Heme; Biophysics; Receptor; Transporter; Enzyme","score_opus":0.00717892243870521,"score_gpt":0.22090938744110952,"score_spread":0.2137304650024043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591560740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972036,0.000029560912,0.0001172611,0.0004888841,0.0008693348,0.00041460295,0.000029706876,0.000051882762,0.00079519756],"genre_scores_gemma":[0.99740195,0.00006531638,0.0007342239,0.0004319258,0.00051087857,0.000028195998,0.00010311741,0.000019867668,0.00070453563],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991893,0.000032352746,0.0002302381,0.00021675303,0.00012467658,0.00020664468],"domain_scores_gemma":[0.99955034,0.00011120667,0.00006539334,0.00013895966,0.00007216307,0.000061916726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014483731,0.00011445876,0.00020797201,0.000070738744,0.000036763835,0.000010973324,0.000044496814,0.00024582757,0.00013345943],"category_scores_gemma":[0.000100562705,0.00011028185,0.00008642378,0.000093291594,0.000017703127,0.00007272139,0.000008592688,0.0003241278,0.000050316256],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025149228,0.0004127711,0.010180358,0.000050410465,0.00002684621,0.0000074179297,0.0002995988,0.00000258049,0.9872924,0.00011653267,0.0004638676,0.0008957147],"study_design_scores_gemma":[0.01371737,0.0013262903,0.16307238,0.000053102714,0.00027702827,0.000054747674,0.00021363553,0.00031138974,0.80784905,0.00013309011,0.012700289,0.00029163028],"about_ca_topic_score_codex":0.00003525181,"about_ca_topic_score_gemma":0.00057586137,"teacher_disagreement_score":0.17944336,"about_ca_system_score_codex":0.00006354089,"about_ca_system_score_gemma":0.000055702923,"threshold_uncertainty_score":0.44971633},"labels":[],"label_agreement":null},{"id":"W2591564318","doi":"10.1182/blood.v120.21.1181.1181","title":"Postoperative Blood Use Following Elective Total Hip and Total Knee Arthroplasty","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Surgery; Blood management; Blood transfusion; Perioperative; Univariate analysis; Body mass index; Arthroplasty; Anesthesia; Rivaroxaban; Internal medicine; Multivariate analysis; Warfarin","score_opus":0.012596153284441166,"score_gpt":0.23727683728401996,"score_spread":0.2246806839995788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591564318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994687,0.00084218656,0.000073867755,0.00036424556,0.0003266191,0.0006572777,0.0000077649265,0.000101517275,0.0029394827],"genre_scores_gemma":[0.9956015,0.000047035384,0.0013461283,0.00055390655,0.00018267392,0.00004014851,0.000012616694,0.00003044226,0.0021855482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880725,0.000059932438,0.0001885173,0.00027934907,0.00024430672,0.00042061857],"domain_scores_gemma":[0.9993706,0.000068619025,0.000032889497,0.00020132263,0.000046031437,0.00028058246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016269251,0.0002111445,0.00029385238,0.0000953792,0.00017746663,0.000041540065,0.000019853656,0.00008975908,0.00013097815],"category_scores_gemma":[0.00007958612,0.0001792567,0.00012542344,0.00015595942,0.00005170323,0.00031830507,0.00006227268,0.00025707937,0.000045374054],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096220546,0.0220834,0.6867053,0.00032089071,0.010138801,0.0013410212,0.022135569,0.000004844287,0.21670522,0.008250067,0.0022220234,0.029130677],"study_design_scores_gemma":[0.027150126,0.00263702,0.9058707,0.0001927715,0.00472022,0.0017147431,0.001804088,0.0000219112,0.050029565,0.00002665694,0.005115113,0.000717085],"about_ca_topic_score_codex":0.000055426797,"about_ca_topic_score_gemma":0.000014360013,"teacher_disagreement_score":0.21916543,"about_ca_system_score_codex":0.000012585033,"about_ca_system_score_gemma":0.00003544,"threshold_uncertainty_score":0.7309876},"labels":[],"label_agreement":null},{"id":"W2591576130","doi":"10.1182/blood.v126.23.4608.4608","title":"Application of Spectral Density/Periodogram Analysis to Serial Neutrophil Counts to Diagnose Cyclic Neutropenia","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Neutropenia; Cyclic neutropenia; Medicine; Congenital Neutropenia; Medical diagnosis; Absolute neutrophil count; Internal medicine; Pediatrics; Pathology; Chemotherapy","score_opus":0.007684077832967285,"score_gpt":0.24642074569613354,"score_spread":0.23873666786316625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591576130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99822706,0.00013253173,0.00045785535,0.00008731024,0.000048889553,0.00020022338,0.0000227071,0.0000077829145,0.00081563706],"genre_scores_gemma":[0.9987979,0.000014328896,0.00067983347,0.00014695094,0.000117203665,0.000035135185,0.00010006071,0.000010179081,0.00009842901],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999457,0.00001544223,0.00010521231,0.00021478462,0.00008525144,0.00012229533],"domain_scores_gemma":[0.99950397,0.0000018577241,0.000032878746,0.00027151604,0.000059271668,0.00013050644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000036191625,0.00008568304,0.00013554115,0.000050410177,0.000018871056,0.00001274643,0.00010072622,0.000055329667,0.000007889936],"category_scores_gemma":[0.000015089466,0.00008182501,0.00007317574,0.00023551559,0.000012405366,0.0000016908978,0.00005350467,0.000019486708,0.000059411617],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005018447,0.0036024172,0.46111786,0.000016177208,0.0030082285,0.000023457344,0.00029377275,0.0010405226,0.51428545,0.00031154862,0.0055105025,0.010288202],"study_design_scores_gemma":[0.005691183,0.0021584216,0.1609218,0.0000063741163,0.0025141924,0.0000144229525,0.00009225194,0.00003965587,0.7904555,0.00016267787,0.03734171,0.00060177187],"about_ca_topic_score_codex":0.00014570187,"about_ca_topic_score_gemma":0.00026213395,"teacher_disagreement_score":0.30019605,"about_ca_system_score_codex":0.0000046509094,"about_ca_system_score_gemma":0.000025134434,"threshold_uncertainty_score":0.33367273},"labels":[],"label_agreement":null},{"id":"W2591576904","doi":"10.1182/blood.v106.11.875.875","title":"A Report of the Event Free Survival (EFS) for Children with Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia (ALL) Treated on Pediatric Oncology Group (POG) Protocol 9605.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Children's Hospital","funders":"","keywords":"Medicine; Prednisone; Vincristine; Mercaptopurine; Gastroenterology; Internal medicine; Methotrexate; Randomized controlled trial; Randomization; Surgery; Chemotherapy; Cyclophosphamide","score_opus":0.011214265251753076,"score_gpt":0.2930904087026105,"score_spread":0.28187614345085743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591576904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91570973,0.000020898771,0.0014747322,0.00055556523,0.000086394175,0.080567524,0.0005357967,0.00013857281,0.0009107732],"genre_scores_gemma":[0.8999062,0.000053697302,0.007491862,0.00030485366,0.0017999496,0.08887551,0.00018905729,0.00023472647,0.001144147],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99570423,0.00027119723,0.00097247923,0.00079984806,0.0014155908,0.00083665183],"domain_scores_gemma":[0.9959584,0.000978295,0.00080524886,0.001490561,0.00040654084,0.0003609469],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009182232,0.00048374393,0.00094722485,0.00025375324,0.0001914915,0.000026411466,0.00063072855,0.00034243823,0.000079289726],"category_scores_gemma":[0.0014701994,0.00029266695,0.00033485642,0.0006599179,0.0002379525,0.000092218506,0.00024017337,0.0004797537,0.000016048923],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0459155,0.012490103,0.86662185,0.00082205853,0.008602156,0.0032528357,0.0010063936,0.001485107,0.0021235815,0.00029931832,0.03568392,0.021697147],"study_design_scores_gemma":[0.28716317,0.034933954,0.63045156,0.00034830102,0.010701594,0.00460148,0.000096306365,0.0015498672,0.018376976,0.0001554551,0.010576779,0.0010445393],"about_ca_topic_score_codex":0.00047335765,"about_ca_topic_score_gemma":0.00042338457,"teacher_disagreement_score":0.24124767,"about_ca_system_score_codex":0.0021952642,"about_ca_system_score_gemma":0.004631946,"threshold_uncertainty_score":0.99995255},"labels":[],"label_agreement":null},{"id":"W2591596051","doi":"10.1182/blood.v120.21.1339.1339","title":"Targeting Treatment-Naive CML Stem/Progenitor Cells From Imatinib-Nonresponders with JAK2 (BMS-911543)/ABL Inhibitor Combination Therapy","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Cancer research; Imatinib; Imatinib mesylate; Stem cell; Progenitor cell; Tyrosine kinase; Tyrosine-kinase inhibitor; Haematopoiesis; breakpoint cluster region; Medicine; Myeloid leukemia; Immunology; Biology; Internal medicine; Cell biology; Receptor; Cancer","score_opus":0.021509866091431473,"score_gpt":0.25519863139554966,"score_spread":0.2336887653041182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591596051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99364424,0.00317372,0.000042610456,0.00016663565,0.00038658775,0.0014992915,0.00007487336,0.00019044674,0.0008215725],"genre_scores_gemma":[0.99252564,0.00025562558,0.0040560425,0.00014635875,0.0009032803,0.0002150084,0.00035337772,0.00010980413,0.0014348836],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977682,0.00016132697,0.00041149225,0.00047463088,0.0005153484,0.000668998],"domain_scores_gemma":[0.99851245,0.00026375474,0.00026312287,0.0005206012,0.00009468229,0.00034536648],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001716436,0.0004671149,0.0005440287,0.00013239091,0.00016769317,0.000043147462,0.00011542595,0.00018971856,0.00032369304],"category_scores_gemma":[0.000025138621,0.00033925896,0.00014798668,0.00023734722,0.00007876208,0.0002914982,0.000032523978,0.00018801473,0.00032029938],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036651138,0.018556967,0.34902322,0.00012730899,0.005391456,0.00035316808,0.012320742,0.000010167291,0.58081394,0.000079776684,0.0021229559,0.027535187],"study_design_scores_gemma":[0.055598512,0.0029254206,0.016337704,0.00020773613,0.0011352128,0.000070396185,0.0015159316,0.00009715854,0.91616756,0.0000194751,0.005377549,0.00054732716],"about_ca_topic_score_codex":0.00035104287,"about_ca_topic_score_gemma":0.0000085330985,"teacher_disagreement_score":0.33535364,"about_ca_system_score_codex":0.0007691567,"about_ca_system_score_gemma":0.00030195783,"threshold_uncertainty_score":0.99990594},"labels":[],"label_agreement":null},{"id":"W2591612602","doi":"10.1182/blood.v118.21.3968.3968","title":"Elotuzumab in Combination with Lenalidomide and Low-Dose Dexamethasone in High-Risk and/or Stage 23 Relapsed and/or Refractory Multiple Myeloma: A Retrospective Subset Analysis of the Phase 2 Study,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Lenalidomide; Medicine; Internal medicine; Regimen; Population; Thalidomide; Multiple myeloma; Dexamethasone; Oncology; Phases of clinical research; Gastroenterology; Chemotherapy","score_opus":0.027542022663080094,"score_gpt":0.2935291335301979,"score_spread":0.2659871108671178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591612602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979854,0.00023738563,0.000010410769,0.000024902802,0.000011486819,0.0015484813,0.00013340526,0.000016308102,0.000032190183],"genre_scores_gemma":[0.9988051,0.0002725159,0.000606019,0.000010873876,0.000006439956,0.00010823501,0.000035006742,0.00002232161,0.00013349511],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981389,0.0003609684,0.00037310665,0.00045867346,0.0003904061,0.00027792013],"domain_scores_gemma":[0.9987576,0.00036720344,0.00021701962,0.00040384548,0.00010689244,0.00014744654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005876717,0.00021433563,0.000674156,0.00055614486,0.00007694179,0.000015417154,0.000080262755,0.00008486312,0.00003510441],"category_scores_gemma":[0.0008238376,0.00012126658,0.000044977984,0.0011198479,0.00020359199,0.00013865792,0.000090446636,0.00031367558,5.946661e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014274804,0.009494312,0.96744275,0.000063347965,0.0013225575,0.0004962316,0.003880714,0.000001022254,0.00091432914,0.000014214043,0.000001353091,0.0020943827],"study_design_scores_gemma":[0.09790661,0.005336552,0.8903255,0.00010893284,0.0012416218,0.000012702267,0.0016671851,0.0006936202,0.0025703562,0.000018274688,0.0000015236658,0.00011715941],"about_ca_topic_score_codex":0.0066836653,"about_ca_topic_score_gemma":0.023163777,"teacher_disagreement_score":0.08363181,"about_ca_system_score_codex":0.00010613312,"about_ca_system_score_gemma":0.00011705163,"threshold_uncertainty_score":0.9999309},"labels":[],"label_agreement":null},{"id":"W2591660273","doi":"10.1182/blood.v120.21.470.470","title":"The Relationship of Acute Gvhd and Pre- and Post-Transplant Flow-MRD to the Incidence and Timing of Relapse in Children Undergoing Allogeneic Transplantation for High Risk ALL: Defining a Target Population and Window for Immunological Intervention to Prevent Relapse","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of Manitoba","funders":"","keywords":"Medicine; Cumulative incidence; Internal medicine; Transplantation; Interquartile range; Incidence (geometry); Population; Hazard ratio; Tacrolimus; Alemtuzumab; Cohort; Methotrexate; Oncology; Gastroenterology; Confidence interval","score_opus":0.014085539185336598,"score_gpt":0.28580932851497126,"score_spread":0.27172378932963465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591660273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988982,0.0014629242,0.0071472945,0.0004816619,0.000022857597,0.0017603781,0.00013302744,0.000008083649,0.0000017610496],"genre_scores_gemma":[0.98671085,0.00079083303,0.012158149,0.00003359473,0.000017562445,0.00014800587,0.00011813349,0.000013688671,0.00000921487],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989501,0.00013201182,0.00036433825,0.00019884355,0.00014666941,0.0002080318],"domain_scores_gemma":[0.9981991,0.0014086061,0.00013064094,0.000121133715,0.0000638916,0.00007663013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010580138,0.00011006586,0.00019500808,0.000101948615,0.00014178759,0.000015967611,0.000057327095,0.00009469997,6.6736845e-7],"category_scores_gemma":[0.0007804347,0.00007233872,0.000033554763,0.000096102696,0.00005722829,0.00012482573,0.00004365441,0.00012156325,1.1359274e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021647732,0.00015589473,0.9802139,0.00028878052,0.0002767716,0.0000011943041,0.005263101,0.000077052086,0.0053196936,0.00067398767,0.0000036238614,0.005561249],"study_design_scores_gemma":[0.0039674984,0.00098575,0.99056214,0.00037323957,0.00066224794,0.00015101836,0.00016282343,0.0004785843,0.0021427302,0.00043735185,0.0000011364838,0.00007550782],"about_ca_topic_score_codex":0.0003163907,"about_ca_topic_score_gemma":0.00022757593,"teacher_disagreement_score":0.010348233,"about_ca_system_score_codex":0.00004161175,"about_ca_system_score_gemma":0.000034631892,"threshold_uncertainty_score":0.29498875},"labels":[],"label_agreement":null},{"id":"W2591670734","doi":"10.1182/blood.v104.11.3730.3730","title":"Hydroxyurea Induces Expression of HbF and Increase of P50 in High Oxygen Affinity Hemoglobinopathy.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Hemoglobinopathy; Oxygen–haemoglobin dissociation curve; Fetal hemoglobin; Internal medicine; Medicine; Endocrinology; Hydroxycarbamide; Hemolytic anemia; Biology; Gastroenterology; Hemoglobin; Fetus; Chemotherapy; Genetics","score_opus":0.006943021478310016,"score_gpt":0.21807863132273467,"score_spread":0.21113560984442464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591670734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961529,0.0016868334,0.0000031337217,0.0002185953,0.00003710421,0.0002612045,0.000014214689,0.000021684627,0.0016043698],"genre_scores_gemma":[0.99875456,0.00045583872,0.0006501396,0.00006288809,0.000023029756,0.000006228211,0.000013735855,0.000014277098,0.000019291198],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99899685,0.000036583813,0.0003709104,0.00020284033,0.00020593604,0.00018685526],"domain_scores_gemma":[0.9994233,0.00003330222,0.00013453796,0.0002326848,0.00005056456,0.00012559381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017570244,0.00013854896,0.00039075754,0.00015062572,0.00002595036,0.0000032922742,0.00007199272,0.00020535704,0.000022719705],"category_scores_gemma":[0.00014650075,0.000110020665,0.000053588967,0.000255924,0.00011905797,0.00006209369,0.000069172595,0.0002019835,0.0000026736539],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042092914,0.004350901,0.12511387,0.0006620084,0.000079266705,0.00020500612,0.0019209447,0.00006519718,0.86518574,0.00047118502,0.000040822513,0.0014841025],"study_design_scores_gemma":[0.0153543595,0.0006805051,0.23259464,0.0010556395,0.00019266373,0.00008522246,0.00079595624,0.0000041243916,0.74793124,0.0010758389,0.000045778397,0.00018400395],"about_ca_topic_score_codex":0.001103413,"about_ca_topic_score_gemma":0.000025266565,"teacher_disagreement_score":0.117254496,"about_ca_system_score_codex":0.000015346612,"about_ca_system_score_gemma":0.0001259579,"threshold_uncertainty_score":0.44865125},"labels":[],"label_agreement":null},{"id":"W2591685873","doi":"10.1182/blood.v126.23.5165.5165","title":"Disruption of the Peripheral Lymphoid Niche Contributes to Lymphopenia in CML Patients Undergoing Imatinib Treatments","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Imatinib mesylate; Imatinib; Medicine; Immunology; Myeloid; Myeloid leukemia; Chronic myelogenous leukemia; Bone marrow; CD34; CD8; Haematopoiesis; Progenitor cell; Tyrosine-kinase inhibitor; Stem cell; Internal medicine; Cancer research; Leukemia; Immune system; Biology; Cancer","score_opus":0.01682470344825451,"score_gpt":0.26586622001207955,"score_spread":0.24904151656382503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591685873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99660295,0.00028273687,0.000009469292,0.00027138178,0.00017035157,0.0010037766,0.00002823941,0.000024464427,0.0016066219],"genre_scores_gemma":[0.9985022,0.000016725631,0.00043060485,0.00024049038,0.000033432352,0.00008027133,0.00004980421,0.000025052817,0.0006214517],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986638,0.000078885714,0.00037181308,0.00025721808,0.00034440614,0.00028390557],"domain_scores_gemma":[0.9991325,0.00006987268,0.00012534457,0.00041658917,0.00011389278,0.00014178449],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012981516,0.00018657059,0.00034726874,0.00007777699,0.00003956955,0.000013566525,0.00013428021,0.00008256697,0.000024729941],"category_scores_gemma":[0.00038585387,0.00012647049,0.00009164583,0.00032787418,0.000040149454,0.00007445323,0.000107333646,0.000058767582,0.000034846664],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023525453,0.0017200406,0.99387693,0.000034124678,0.00018996811,0.000011171051,0.0007788947,0.000021470454,0.0012384893,0.000030719722,0.00020421937,0.0016587359],"study_design_scores_gemma":[0.06653765,0.00075785397,0.9155456,0.00041375778,0.0004114854,0.000032696513,0.00025330138,0.00010074979,0.015411743,0.0001108389,0.00028042475,0.00014390134],"about_ca_topic_score_codex":0.00032833978,"about_ca_topic_score_gemma":0.00020243194,"teacher_disagreement_score":0.078331314,"about_ca_system_score_codex":0.0017060231,"about_ca_system_score_gemma":0.0006861549,"threshold_uncertainty_score":0.5157317},"labels":[],"label_agreement":null},{"id":"W2591707817","doi":"10.1182/blood.v114.22.3584.3584","title":"Use of MGMT Resistance to Enrich for Transduced Hematopoietic Cells in Gene Therapy for Fabry Disease.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; University Health Network; Ontario Institute for Cancer Research","funders":"","keywords":"Genetic enhancement; Enzyme replacement therapy; Fabry disease; Cancer research; Haematopoiesis; Globotriaosylceramide; Stem cell; Transgene; Viral vector; Hematopoietic stem cell transplantation; Biology; Krabbe disease; Transduction (biophysics); Immunology; Medicine; Disease; Cell biology; Gene; Pathology; Genetics; Leukodystrophy; Recombinant DNA; Biochemistry","score_opus":0.02658296750918831,"score_gpt":0.2948950111083464,"score_spread":0.2683120435991581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591707817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929112,0.00205774,0.0030201564,0.00046274203,0.000026352778,0.0012917607,0.00020886952,0.000007482822,0.000013703793],"genre_scores_gemma":[0.99461615,0.0003806831,0.0036563724,0.0005159045,0.00008796943,0.00022803657,0.000073142255,0.000029361348,0.00041238533],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989289,0.00004538583,0.00022809776,0.00035414452,0.0001279539,0.0003155394],"domain_scores_gemma":[0.9992691,0.000039444265,0.000042066145,0.00042257766,0.00010487686,0.000121929224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001917961,0.000141454,0.00018574129,0.00006679481,0.000034708577,0.000014810376,0.00021913703,0.00008483864,0.0000047313283],"category_scores_gemma":[0.00004731395,0.0001388629,0.00013678594,0.00013168894,0.000024706884,0.0000035395924,0.000010800286,0.000038634327,0.0000010009877],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006375747,0.0005769201,0.00015963733,0.000043660482,0.000037208876,0.0000016334807,0.000060325387,0.000073403724,0.990556,0.00002533564,0.0005053553,0.0015847515],"study_design_scores_gemma":[0.0028022956,0.0022733472,0.00080414896,0.000017292716,0.000014365269,3.5560114e-7,0.0000074476698,0.0000133882195,0.98996115,0.00031323623,0.0036298211,0.00016317329],"about_ca_topic_score_codex":0.0000017780068,"about_ca_topic_score_gemma":0.000053915533,"teacher_disagreement_score":0.0035734512,"about_ca_system_score_codex":0.0000075496405,"about_ca_system_score_gemma":0.00010741404,"threshold_uncertainty_score":0.5662665},"labels":[],"label_agreement":null},{"id":"W2591709028","doi":"10.1182/blood.v116.21.1762.1762","title":"Pralatrexate Is An Effective Treatment for Heavily Pretreated Patients with Relapsed/Refractory Transformed Mycosis Fungoides (tMF)","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Mycosis fungoides; Medicine; CHOP; Prednisone; Lymphoma; Cyclophosphamide; Refractory (planetary science); Vincristine; Chemotherapy; Internal medicine; Peripheral T-cell lymphoma; T-cell lymphoma; Surgery; Gastroenterology; Dermatology; T cell; Immunology","score_opus":0.01284923716643537,"score_gpt":0.28446490409847114,"score_spread":0.27161566693203576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591709028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924475,0.00010252134,0.00002533629,0.00021264509,0.00005450724,0.005643802,0.0002775366,0.0001249831,0.0011111802],"genre_scores_gemma":[0.99656045,0.000048924336,0.0006947268,0.00014767218,0.00008502603,0.0011885577,0.0004005085,0.00009587922,0.0007782678],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980859,0.000073094765,0.0002563558,0.0005990311,0.0004318815,0.00055373635],"domain_scores_gemma":[0.99837726,0.0002157475,0.000081722756,0.00049865624,0.00046834323,0.00035828762],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000110690235,0.0003705654,0.00048861984,0.00018358331,0.00020020273,0.00004270764,0.00010410508,0.00020060486,0.00022559495],"category_scores_gemma":[0.000119484415,0.00025415167,0.00016510974,0.00024430355,0.00013764267,0.00018371186,0.000011203892,0.00024092455,0.000025572714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077885594,0.0129865315,0.9005867,0.00019257482,0.0013242667,0.000050549337,0.0036573631,8.523862e-7,0.034268387,0.000019275085,0.00014948304,0.038975414],"study_design_scores_gemma":[0.084543094,0.06066105,0.5480537,0.00020155398,0.0018727788,0.00021099465,0.00033388654,0.00023321674,0.29908928,0.000102238075,0.0039027329,0.00079552125],"about_ca_topic_score_codex":0.00020284769,"about_ca_topic_score_gemma":0.0005368912,"teacher_disagreement_score":0.3525331,"about_ca_system_score_codex":0.00014154155,"about_ca_system_score_gemma":0.00023516579,"threshold_uncertainty_score":0.99999106},"labels":[],"label_agreement":null},{"id":"W2591719313","doi":"10.1182/blood.v118.21.4323.4323","title":"Findings of Feasibility Assessment From Multicenter Clinical Trials of Antithrombotic Therapy in Pediatric Venous Thromboembolism","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Randomized controlled trial; Clinical trial; Bivalirudin; Thrombolysis; Antithrombotic; Data monitoring committee; Fibrinolytic agent; Venous thromboembolism; Intensive care medicine; Physical therapy; Surgery; Internal medicine; Thrombosis; Myocardial infarction; Percutaneous coronary intervention","score_opus":0.19650961580916634,"score_gpt":0.4214472024720688,"score_spread":0.22493758666290245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591719313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99570554,0.0007361209,0.000043247514,0.000052852003,0.00036402317,0.0016487191,0.000044029784,0.000027959743,0.0013775008],"genre_scores_gemma":[0.9916033,0.0041875797,0.003786239,0.000142017,0.00019863392,0.00002540633,0.0000197629,0.000030414083,0.000006625204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960611,0.00058218505,0.002137261,0.00049347134,0.00041328644,0.00031273876],"domain_scores_gemma":[0.9978879,0.00056693907,0.00068646076,0.00058814604,0.00013776944,0.0001327865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038844168,0.00023495733,0.0025317785,0.00022505822,0.000023292832,0.000007377716,0.00023634855,0.00019357677,0.0005159647],"category_scores_gemma":[0.0006242192,0.0001880302,0.00048474685,0.0002733244,0.00012985639,0.00008329845,0.000103799204,0.00027344227,0.000013860305],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018063402,0.034843832,0.9596431,0.0001919591,0.00055472954,0.000023422115,0.0010533109,6.8056613e-7,0.0018104087,0.00022822492,0.00014186138,0.0013278265],"study_design_scores_gemma":[0.0120418435,0.001992624,0.97685707,0.00014607869,0.001270766,0.0000010170613,0.00014408953,0.00001686543,0.0068700453,0.0004930142,0.000017481056,0.00014910086],"about_ca_topic_score_codex":0.0010061665,"about_ca_topic_score_gemma":0.000043151533,"teacher_disagreement_score":0.032851208,"about_ca_system_score_codex":0.000032954933,"about_ca_system_score_gemma":0.00015330045,"threshold_uncertainty_score":0.76676494},"labels":[],"label_agreement":null},{"id":"W2591756406","doi":"10.1182/blood.v104.11.3547.3547","title":"Molecular Characterization of a PU.1 Transcription Complex Formed on the IL-1β Proximal Promoter.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada","funders":"","keywords":"Molecular biology; Leucine zipper; Ccaat-enhancer-binding proteins; Transcription (linguistics); Transcription factor; Promoter; Biology; Gene; DNA; Recombinant DNA; Electrophoretic mobility shift assay; Gene expression; Nuclear protein; Chemistry; Genetics","score_opus":0.030748946607621182,"score_gpt":0.25598439167251125,"score_spread":0.22523544506489007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591756406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99327207,0.0000051013553,0.0025535794,0.0024119255,0.000049306935,0.0005817211,0.00004377507,0.000037475023,0.0010450478],"genre_scores_gemma":[0.9991141,0.0000039973343,0.00020461062,0.0003956388,0.000071511146,0.000041666735,0.0001258834,0.0000147782375,0.000027790877],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993819,0.00002201602,0.00019293808,0.000122031845,0.0001699192,0.000111201196],"domain_scores_gemma":[0.9996296,0.000008448045,0.00007627766,0.00017189697,0.000077731864,0.000036051308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008362804,0.00008709156,0.00013290205,0.00005620433,0.00005085952,0.000011067871,0.000048290407,0.000038318416,0.00009243919],"category_scores_gemma":[0.00003039935,0.000058911417,0.00009456188,0.00011697027,0.00003096508,0.000052628136,0.0000056212893,0.00010913658,0.000012166977],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006255452,0.00089555566,0.00006519432,0.0000447668,0.0000496957,0.00000774127,0.0003617541,0.000003494929,0.99545527,0.0025950235,0.0000049533755,0.00045398567],"study_design_scores_gemma":[0.0019967903,0.0009040144,0.013887037,0.00019496743,0.00012368978,0.00005607626,0.0000333603,0.00008390067,0.9817069,0.00020312367,0.0007488773,0.000061221355],"about_ca_topic_score_codex":0.000012342413,"about_ca_topic_score_gemma":0.0000020053938,"teacher_disagreement_score":0.013821842,"about_ca_system_score_codex":0.00001819831,"about_ca_system_score_gemma":0.000047762896,"threshold_uncertainty_score":0.2402338},"labels":[],"label_agreement":null},{"id":"W2591761690","doi":"10.1182/blood.v124.21.4778.4778","title":"Combination Therapy with Reovirus and Immunomodulatory Drugs Induces Direct Oncolytic and Immune-Mediated Killing of Multiple Myeloma Cells and Overcomes Stromal-Mediated Microenvironmental Protection","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Stromal cell; Immune system; Oncolytic virus; Context (archaeology); Immunology; Cancer research; Biology; Medicine","score_opus":0.006797090644802705,"score_gpt":0.21089239987065347,"score_spread":0.20409530922585076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591761690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964948,0.0029234544,0.000012193323,0.000018068902,0.000018853563,0.00047345026,0.000023345465,0.000011393959,0.000024425506],"genre_scores_gemma":[0.9982136,0.0014979633,0.000096764496,0.000023060556,0.00002461153,0.000034840636,0.00005890726,0.00002809235,0.000022177139],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990528,0.00014331375,0.00017681856,0.0003050379,0.00014548318,0.00017650497],"domain_scores_gemma":[0.9995548,0.000049392103,0.000119060634,0.00018838201,0.000028002707,0.000060363975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026887946,0.00016200508,0.00018850251,0.00006896629,0.00009619,0.00002356152,0.00006685873,0.00011490221,0.0000030438619],"category_scores_gemma":[0.000021817337,0.0001421009,0.000022947972,0.000063924104,0.00020772626,0.000011791333,0.000057004967,0.00010084878,6.867031e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009418728,0.0002240043,0.007002883,0.000026121885,0.00012260285,6.56845e-7,0.00016540865,0.0000041112194,0.984735,4.4751644e-7,7.630502e-7,0.006776129],"study_design_scores_gemma":[0.0052238367,0.004201379,0.051382605,0.000024355795,0.000018494788,0.0000086647315,0.000097209326,0.00020634082,0.9385859,0.00000440809,0.0000914916,0.00015535529],"about_ca_topic_score_codex":0.00007264875,"about_ca_topic_score_gemma":0.000021540462,"teacher_disagreement_score":0.046149142,"about_ca_system_score_codex":0.0000113818005,"about_ca_system_score_gemma":0.00002765082,"threshold_uncertainty_score":0.57947063},"labels":[],"label_agreement":null},{"id":"W2591784403","doi":"10.1182/blood.v104.11.527.527","title":"The Risk of Hemorrhage and the Frequency of Vitamin K Use in Asymptomatic Patients with Warfarin-Associated Coagulopathy.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Warfarin; Asymptomatic; Prothrombin complex concentrate; Coagulopathy; Vitamin K antagonist; Emergency medicine; Internal medicine; Pediatrics; Surgery; Atrial fibrillation","score_opus":0.012272618445617733,"score_gpt":0.23017363714487482,"score_spread":0.2179010186992571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591784403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99889255,0.00008544489,0.000016584783,0.0002042235,0.000023347307,0.00053540175,0.000007031114,0.000009979466,0.00022543164],"genre_scores_gemma":[0.9994961,0.000043632426,0.00033289398,0.000019406101,0.0000125909555,0.0000022737058,0.0000067200776,0.000007642635,0.00007876676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99927384,0.00007006949,0.00027118908,0.00008211286,0.00020576695,0.00009700915],"domain_scores_gemma":[0.9991709,0.00033036005,0.00023505278,0.00018285563,0.00006151433,0.000019346811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031362768,0.000075578864,0.00023380287,0.000042634874,0.000047381545,0.0000091068505,0.000051234663,0.000029981225,0.0000029537455],"category_scores_gemma":[0.00055627665,0.000035501947,0.00004536233,0.00018751601,0.00012183218,0.000052700918,0.000028628705,0.000061772516,9.921836e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001075768,0.00006315042,0.9984238,0.000030468651,0.00011150884,0.0000022502236,0.0003226752,0.000013196127,0.000035918383,0.0006267578,0.0000013246064,0.00026137888],"study_design_scores_gemma":[0.018218404,0.00014848378,0.980266,0.000068319845,0.00037918283,6.453339e-7,0.000103594895,0.000031578285,0.0003082616,0.00043193335,0.0000027920867,0.000040854142],"about_ca_topic_score_codex":0.00040004813,"about_ca_topic_score_gemma":0.0002872745,"teacher_disagreement_score":0.018157844,"about_ca_system_score_codex":0.000014088254,"about_ca_system_score_gemma":0.000022618568,"threshold_uncertainty_score":0.14477274},"labels":[],"label_agreement":null},{"id":"W2591806628","doi":"10.1182/blood.v112.11.3101.3101","title":"Characterization of Novel Natural Mutations in Telomere Binding Protein Factor (TIN2) Identified in Patients with Bone-Marrow Failure Syndromes","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; Telomere; Chromatin immunoprecipitation; Gene; Shelterin; Promoter; Dyskeratosis congenita; Molecular biology; Mutation; Genetics; Cancer research; Gene expression; DNA-binding protein; Transcription factor","score_opus":0.014520529778204965,"score_gpt":0.22344703126221122,"score_spread":0.20892650148400624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591806628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99874026,0.000025921177,0.000013675823,0.000095519026,0.000056522764,0.0009392992,0.000069880916,0.000038378887,0.000020542628],"genre_scores_gemma":[0.9986373,0.0000047749836,0.00061954116,0.000017082113,0.000019402009,0.000041285562,0.00032692222,0.00002756172,0.0003060899],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859095,0.000029817675,0.00043770485,0.00029391306,0.00037875527,0.0002688384],"domain_scores_gemma":[0.99935985,0.0000259327,0.00019907209,0.00020755029,0.00013409974,0.00007351286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000058352798,0.00018467674,0.0003825367,0.00050791603,0.000056289984,0.000011939007,0.00008580556,0.00009868306,0.000032541222],"category_scores_gemma":[0.00010389913,0.00015796979,0.00004609075,0.0007611922,0.00008385508,0.00028698996,0.000022822485,0.00024333359,0.000006667011],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000096689655,0.0011055749,0.5731953,0.00011950792,0.000026074957,0.00006235516,0.0009970929,5.710005e-7,0.42421266,0.000009147166,0.000001193575,0.00017383584],"study_design_scores_gemma":[0.0067527383,0.0001625008,0.89638937,0.00051818514,0.000027186166,0.000045697052,0.00015746802,0.000019377274,0.09574652,0.0000010880062,0.000008944528,0.00017092485],"about_ca_topic_score_codex":0.00006198404,"about_ca_topic_score_gemma":0.00015334929,"teacher_disagreement_score":0.32846615,"about_ca_system_score_codex":0.00004635109,"about_ca_system_score_gemma":0.000115764036,"threshold_uncertainty_score":0.6441821},"labels":[],"label_agreement":null},{"id":"W2591821521","doi":"10.1182/blood.v106.11.1450.1450","title":"Secondary Cytogenetic Abnormalities and Outcome in Children with TEL-AML1-Positive Acute Lymphoblastic Leukemia.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"ETV6; Chromosomal translocation; Karyotype; Biology; Cytogenetics; Acute lymphocytic leukemia; Leukemia; Internal medicine; Gastroenterology; Chromosome; Oncology; Medicine; Immunology; Lymphoblastic Leukemia; Genetics; Gene","score_opus":0.008387921869581915,"score_gpt":0.25006881964543076,"score_spread":0.24168089777584884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591821521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945707,0.0007189193,0.0000886715,0.00033499638,0.000018513872,0.0006901262,0.00008363554,0.00007958591,0.0034148546],"genre_scores_gemma":[0.9950742,0.00014469377,0.0022865443,0.00080730615,0.0002541689,0.00006404698,0.000059864815,0.00006626446,0.0012429159],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977793,0.00006637841,0.00043549493,0.0005193509,0.0005141497,0.00068531727],"domain_scores_gemma":[0.9989471,0.00017098083,0.000081922524,0.0003909484,0.00008962428,0.00031945773],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020312954,0.00033849437,0.00055249577,0.00031710058,0.00009362528,0.00005124718,0.0001719315,0.00017162868,0.00013592839],"category_scores_gemma":[0.00006470909,0.00026691664,0.00006213528,0.0003177537,0.0003204015,0.00019129355,0.00016351815,0.0003918548,0.00008750189],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005010179,0.00043532279,0.9902051,0.0000976369,0.0009439721,0.0006032023,0.0008423582,0.00005009087,0.0017580435,0.00011334593,0.00018182662,0.0042680684],"study_design_scores_gemma":[0.02388214,0.0010032508,0.949969,0.0001890794,0.0007276398,0.008370344,0.00017581455,0.00041860942,0.014683062,0.00002446121,0.00015034468,0.0004062856],"about_ca_topic_score_codex":0.00024693456,"about_ca_topic_score_gemma":0.000085316104,"teacher_disagreement_score":0.040236145,"about_ca_system_score_codex":0.000708658,"about_ca_system_score_gemma":0.0011614567,"threshold_uncertainty_score":0.9999783},"labels":[],"label_agreement":null},{"id":"W2591823319","doi":"10.1182/blood.v118.21.4944.4944","title":"Outcome of Patients with Newly Diagnosed Diffuse Large B-Cell Non-Hodgkin Lymphomas (DLBCL) Receiving Initial Therapy in Hospital Compared with An Out-Patient Setting","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Logistic regression; Population; Pediatrics; Retrospective cohort study; Lymphoma; Internal medicine; Surgery","score_opus":0.016120373190133545,"score_gpt":0.24374436762886545,"score_spread":0.2276239944387319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591823319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997436,0.0000731407,0.000011406038,0.000024265648,0.00009857384,0.0012646485,0.000074019496,0.00005127024,0.00096669636],"genre_scores_gemma":[0.9964639,0.000019677578,0.0029396866,0.00016646755,0.000041612737,0.00015558719,0.000139893,0.00006493759,0.000008237221],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99796796,0.00007714639,0.0005535367,0.000464136,0.00045812532,0.00047909503],"domain_scores_gemma":[0.99870956,0.00009086715,0.0003201201,0.0005006915,0.00015825746,0.00022052755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000108195134,0.00036298003,0.0006429783,0.00016142438,0.0000705007,0.000020363786,0.0001359868,0.000097412856,0.00004634348],"category_scores_gemma":[0.000027778235,0.00024404339,0.0000901327,0.00019774128,0.00006640146,0.00018423487,0.000050998096,0.00010856069,0.000008684366],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010273086,0.08965301,0.8960322,0.00004352133,0.00017580492,0.00034838068,0.010711221,9.3532844e-7,0.000024097117,0.0000057679226,0.000014228359,0.0019635332],"study_design_scores_gemma":[0.12975533,0.009713678,0.8510286,0.0002416263,0.00018182496,0.0000045470324,0.00079113495,0.00002117562,0.007946948,0.0000038553685,0.000027574035,0.00028370458],"about_ca_topic_score_codex":0.0005140981,"about_ca_topic_score_gemma":0.00047062538,"teacher_disagreement_score":0.12872802,"about_ca_system_score_codex":0.00009907066,"about_ca_system_score_gemma":0.0001147174,"threshold_uncertainty_score":0.9951801},"labels":[],"label_agreement":null},{"id":"W2591831116","doi":"10.1182/blood.v116.21.5120.5120","title":"Seasonal Variation In the Occurrence of Venous Thromboembolism In Canada","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Pulmonary embolism; Deep vein; Cohort; Thrombosis; Retrospective cohort study; Population; Venous thrombosis; Venous thromboembolism; Cohort study; Pediatrics; Demography; Internal medicine","score_opus":0.008920719921797554,"score_gpt":0.23159489639039288,"score_spread":0.22267417646859533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591831116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962025,0.00008281936,0.000002892052,0.0007332078,0.00021238872,0.00032353695,0.000015851778,0.000004642644,0.0024221197],"genre_scores_gemma":[0.9992213,0.000038376413,0.00010310332,0.0005255671,0.000062257925,0.000030473439,0.000010965145,0.000004509113,0.0000034199422],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99917215,0.00003164542,0.00020182674,0.00013637323,0.00027998514,0.00017800552],"domain_scores_gemma":[0.9995664,0.000068906746,0.00006202684,0.00023858398,0.000030421681,0.000033712975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002750408,0.00007669518,0.00027104482,0.000057090372,0.000018977178,0.0000059566555,0.00013695644,0.000034918452,0.00008628673],"category_scores_gemma":[0.000075880045,0.00005747896,0.000024900264,0.0002163939,0.000021288304,0.00003269679,0.000025242494,0.00022458562,0.0000032488565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005973885,0.020180738,0.8856815,0.0006679827,0.00028882545,0.000613047,0.013052437,0.00011662779,0.022873381,0.026527733,0.007862454,0.022075552],"study_design_scores_gemma":[0.0010760481,0.00007209391,0.9969817,0.000044645225,0.000074990516,0.000012389999,0.0002039517,0.000059077895,0.00046724663,0.00018245979,0.00076722394,0.000058194102],"about_ca_topic_score_codex":0.56431055,"about_ca_topic_score_gemma":0.8247401,"teacher_disagreement_score":0.26042953,"about_ca_system_score_codex":0.000036329908,"about_ca_system_score_gemma":0.0006003188,"threshold_uncertainty_score":0.43859074},"labels":[],"label_agreement":null},{"id":"W2591845364","doi":"10.1182/blood.v110.11.1102.1102","title":"Early Recovery of Absolute Lymphocyte Count (ALC) Is a Predictor of Long-Term Outcome Following Related Allogeneic Peripheral Blood Stem Cell Transplantation in Adults with AML/MDS.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Busulfan; Transplantation; Internal medicine; Incidence (geometry); Stem cell; Cohort; Cumulative incidence; Hematopoietic stem cell transplantation; Lymphocyte; Donor lymphocyte infusion; Total body irradiation; Surgery; Gastroenterology; Cyclophosphamide; Chemotherapy","score_opus":0.01082810601048695,"score_gpt":0.24991298511161678,"score_spread":0.23908487910112983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591845364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99682164,0.0010044691,0.000116908705,0.000032035874,0.000087332766,0.0009857543,0.00008996057,0.000050868643,0.00081101165],"genre_scores_gemma":[0.99773735,0.000482473,0.00068673945,0.00006264382,0.000048307258,0.000023830235,0.00008149819,0.00007083611,0.0008063176],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99703515,0.00007278282,0.0010216058,0.0004607349,0.0008343856,0.0005753711],"domain_scores_gemma":[0.99874943,0.00013200918,0.000303253,0.00045095236,0.00017167315,0.00019270199],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006669681,0.00028945802,0.00069666386,0.00037767095,0.000037188132,0.000011635154,0.0002170284,0.00029198642,0.0000606981],"category_scores_gemma":[0.000016715721,0.00024968153,0.00022773299,0.00057933957,0.00009879624,0.00019186447,0.000031554795,0.00034292985,0.000007080003],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051274975,0.0010921682,0.9323186,0.0016480983,0.0007575024,0.002625148,0.0057277367,0.000020020214,0.049773965,0.0000028907896,0.0000071365903,0.0008992143],"study_design_scores_gemma":[0.037993878,0.0020235688,0.8585908,0.0013369845,0.00094730355,0.000275347,0.00020269293,0.00005179341,0.09833705,0.0000015480266,0.0000032580733,0.00023579976],"about_ca_topic_score_codex":0.0006248443,"about_ca_topic_score_gemma":0.00024633628,"teacher_disagreement_score":0.073727846,"about_ca_system_score_codex":0.0002893428,"about_ca_system_score_gemma":0.00049908063,"threshold_uncertainty_score":0.9999955},"labels":[],"label_agreement":null},{"id":"W2591861675","doi":"10.1182/blood.v114.22.3519.3519","title":"Safety and Efficacy of Romiplostim in Immune Thrombocytopenia (ITP) in the “real-life” : Result of the French Experience in 72 Adults.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Romiplostim; Medicine; Splenectomy; Immune thrombocytopenia; Adverse effect; Eltrombopag; Pediatrics; Thrombopoietin; Internal medicine; Platelet","score_opus":0.013688015287753423,"score_gpt":0.2713373207793664,"score_spread":0.25764930549161297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591861675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957479,0.0009789614,3.0449877e-7,0.0005016349,0.000013482244,0.00052216504,0.000009058807,0.0000037590737,0.0022226966],"genre_scores_gemma":[0.99933946,0.00048501778,0.00004810946,0.00008505672,0.000005400547,0.000008545673,0.000006608976,0.000004638249,0.000017184035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990142,0.000066987785,0.0004027482,0.00016882703,0.00017234772,0.000174861],"domain_scores_gemma":[0.9994231,0.00011201972,0.00009604483,0.00032539567,0.000018190241,0.00002529006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018613035,0.00010680729,0.0003972875,0.00006414494,0.000022054044,0.0000035987273,0.00015561726,0.00006171776,0.000009711544],"category_scores_gemma":[0.00018331008,0.000060250477,0.0000396536,0.0003648166,0.00008284778,0.000043209173,0.000036365418,0.00014137592,8.180831e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015654945,0.00910514,0.92490506,0.0000811337,0.000072580435,0.0003415333,0.0441096,0.000024870416,0.010778747,0.00032945126,0.000021901293,0.008664503],"study_design_scores_gemma":[0.014802883,0.00029395716,0.98015374,0.00033932467,0.0000312539,0.000015902635,0.00091212144,0.000028806602,0.003283421,0.0000759502,0.00000947963,0.000053173215],"about_ca_topic_score_codex":0.002277464,"about_ca_topic_score_gemma":0.00092432613,"teacher_disagreement_score":0.05524868,"about_ca_system_score_codex":0.000013788267,"about_ca_system_score_gemma":0.00005318273,"threshold_uncertainty_score":0.34428596},"labels":[],"label_agreement":null},{"id":"W2591864839","doi":"10.1182/blood.v104.11.367.367","title":"Revealing the Interplay of Extrinsic Versus Intrinsic Regulators of Self-Renewal in Hoxb4-Transduced HSCs.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; BC Cancer Agency; Institute for Research in Immunology and Cancer","funders":"","keywords":"Biology; Haematopoiesis; Stem cell; Clonogenic assay; Cell biology; Progenitor cell; Bone marrow; Myeloid; Molecular biology; In vitro; Immunology; Genetics","score_opus":0.009448490229564144,"score_gpt":0.25993060585627603,"score_spread":0.2504821156267119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591864839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980443,0.00088331493,0.000037862887,0.000092332695,0.000098087905,0.00021651242,0.000008656078,0.0000070748606,0.0006118533],"genre_scores_gemma":[0.9992889,0.00020766852,0.0003485827,0.0000116822275,0.00006479792,0.000009968474,0.000015362972,0.000016779597,0.00003625612],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988993,0.000078786834,0.00032036862,0.00024771295,0.00021519234,0.00023867977],"domain_scores_gemma":[0.9993195,0.000029309922,0.00009924132,0.0004305604,0.000073766154,0.00004763426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000301271,0.00012194539,0.0001846307,0.00008776681,0.000025056604,0.000005976034,0.00034132632,0.00012276208,0.000005403292],"category_scores_gemma":[0.00007758611,0.00009823769,0.000101674814,0.00023290372,0.00009834713,0.000003373607,0.00012561226,0.00012236818,0.000002406873],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002822133,0.000390232,0.001983789,0.000087938184,0.00012692095,0.00000878753,0.00024650947,0.00017074695,0.99582493,0.00016861208,0.000010540296,0.0006988056],"study_design_scores_gemma":[0.0043379026,0.00037239734,0.0035811777,0.000054820972,0.000040102997,0.0000094623465,0.000104538725,0.0000026361283,0.99114263,0.0000592486,0.00019100311,0.000104085666],"about_ca_topic_score_codex":0.0001224089,"about_ca_topic_score_gemma":0.00017453577,"teacher_disagreement_score":0.0046822806,"about_ca_system_score_codex":0.000018702054,"about_ca_system_score_gemma":0.0001509041,"threshold_uncertainty_score":0.40060169},"labels":[],"label_agreement":null},{"id":"W2591871775","doi":"10.1182/blood.v128.22.3110.3110","title":"A Pooled Overall Survival (OS) Analysis of 5-Year Data from the COMFORT-I and COMFORT-II Trials of Ruxolitinib for the Treatment of Myelofibrosis (MF)","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ruxolitinib; Medicine; Myelofibrosis; International Prognostic Scoring System; Internal medicine; Clinical endpoint; Clinical trial; Hazard ratio; Placebo; Surrogate endpoint; Crossover study; Surgery; Confidence interval; Myelodysplastic syndromes; Bone marrow; Pathology","score_opus":0.12174213721891605,"score_gpt":0.35179578534296735,"score_spread":0.2300536481240513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591871775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817152,0.001708556,0.00012568563,0.0014958484,0.000053109936,0.0014028,0.01336805,0.000008541167,0.00012219237],"genre_scores_gemma":[0.9950959,0.0030959498,0.000691211,0.00005470844,0.00011970245,0.00014700771,0.0006395112,0.00001762824,0.00013839858],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804324,0.00018868655,0.0008901885,0.00034894713,0.00033356855,0.00019538437],"domain_scores_gemma":[0.9921237,0.0059404727,0.00059419294,0.0011283623,0.0001354965,0.0000777382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008001067,0.00022042084,0.0015030878,0.000084693645,0.00009673902,0.000009708067,0.00021598589,0.00007456791,0.00030998577],"category_scores_gemma":[0.00042656402,0.00008638428,0.00044204007,0.00018997568,0.00018188421,0.00004797651,0.00009785399,0.000028600902,6.7419546e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002397069,0.0059431423,0.9252108,0.00006819471,0.043502335,0.0000032373887,0.00116354,0.0000040149434,0.008814039,0.0023568075,0.00079634984,0.009740502],"study_design_scores_gemma":[0.042580176,0.004917624,0.7687737,0.00030507642,0.07264254,0.0000025329975,0.00048553463,0.00029096412,0.10146331,0.00033242814,0.007990372,0.00021575148],"about_ca_topic_score_codex":0.0011216588,"about_ca_topic_score_gemma":0.00064667437,"teacher_disagreement_score":0.15643708,"about_ca_system_score_codex":0.000022614091,"about_ca_system_score_gemma":0.000098327546,"threshold_uncertainty_score":0.35226485},"labels":[],"label_agreement":null},{"id":"W2591891548","doi":"10.1182/blood.v128.22.4719.4719","title":"Preclinical Characterization of TTI-281, a Novel, Orally Bioavailable BET Inhibitor: Predictive Biomarker Identification and Combination Treatment Analysis","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Trillium Therapeutics (Canada)","funders":"","keywords":"Biomarker; Medicine; Pharmacology; Vorinostat; Oncology; Biology; Gene; Histone deacetylase","score_opus":0.016287261115846427,"score_gpt":0.2588543542264236,"score_spread":0.24256709311057717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591891548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99070174,0.00008927841,0.008402164,0.00020984742,0.0000615728,0.000273903,0.00017786445,0.00001335439,0.000070291666],"genre_scores_gemma":[0.99800915,0.00024722487,0.00018491823,0.000016458698,0.000057072077,0.000045012355,0.00066591654,0.000009274995,0.0007649764],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99912554,0.00005458826,0.00031550135,0.00029947565,0.000110952155,0.00009393778],"domain_scores_gemma":[0.9993411,0.0000136194985,0.00022298962,0.0002303982,0.00014289145,0.000049020644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016948495,0.00010398378,0.0001428509,0.00010918186,0.000040339117,0.000018580617,0.00005784829,0.00012330605,0.000016027772],"category_scores_gemma":[0.00008880193,0.00007649226,0.00007579241,0.0001877591,0.00008017127,0.000017656388,0.00003556623,0.000015225569,0.0000036758697],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006534956,0.0005859471,0.030919343,0.000006347855,0.0003603997,1.1973461e-7,0.00001893194,1.4969605e-7,0.965115,0.00003749736,0.000033012955,0.002857894],"study_design_scores_gemma":[0.0018336632,0.00045445206,0.1599104,0.00001363863,0.00030502342,0.0000011959643,0.0000057762254,0.00006465411,0.8360416,0.000012694676,0.0012694097,0.00008748561],"about_ca_topic_score_codex":0.000009048741,"about_ca_topic_score_gemma":0.000010343849,"teacher_disagreement_score":0.1290734,"about_ca_system_score_codex":0.000013184837,"about_ca_system_score_gemma":0.000038059316,"threshold_uncertainty_score":0.31192636},"labels":[],"label_agreement":null},{"id":"W2591920743","doi":"10.1182/blood.v108.11.3174.3174","title":"Prevention of Graft-Versus-Host Disease by Selective Depletion of Alloreactive T Cells.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cytotoxic T cell; Granzyme B; Graft-versus-host disease; Immunology; T cell; Transplantation; Biology; Antigen; CD8; Cancer research; Molecular biology; Stem cell; In vitro; Immune system; Medicine; Cell biology; Biochemistry","score_opus":0.008979696185219516,"score_gpt":0.27678777991035586,"score_spread":0.2678080837251363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591920743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969835,0.00070843444,0.00007811857,0.000071630944,0.000032564374,0.00050038914,0.000099436336,0.000022696218,0.0015031752],"genre_scores_gemma":[0.9990678,0.00016669661,0.0001067207,0.0000059590966,0.000037878635,0.000037071346,0.00008068682,0.000013826808,0.00048336625],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991204,0.000053440188,0.00018916617,0.00016896018,0.00030829458,0.00015972165],"domain_scores_gemma":[0.9993926,0.00008097305,0.00012338911,0.00015293212,0.0001882353,0.00006185869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010761279,0.00009759089,0.0002267449,0.000077098994,0.000028200937,0.000002107905,0.000051647537,0.000036538757,0.000022280308],"category_scores_gemma":[0.00007170129,0.000086756896,0.00010426392,0.00018472296,0.000113024485,0.000051565476,0.000025925046,0.00009062395,0.0000023516873],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021606113,0.0024733301,0.007239628,0.00011833203,0.00039561326,0.0000066316975,0.00013321539,0.0000018418242,0.98626536,0.00005808713,0.0009609599,0.00018636697],"study_design_scores_gemma":[0.007016795,0.0010501291,0.16653275,0.000091961425,0.00033566717,0.0000013385388,0.000102769474,0.00002590026,0.824218,0.00033267454,0.00020439153,0.000087633365],"about_ca_topic_score_codex":0.0003082693,"about_ca_topic_score_gemma":0.00005908987,"teacher_disagreement_score":0.1620474,"about_ca_system_score_codex":0.00004869069,"about_ca_system_score_gemma":0.00008339803,"threshold_uncertainty_score":0.35378435},"labels":[],"label_agreement":null},{"id":"W2591940518","doi":"10.1182/blood.v124.21.2415.2415","title":"Longterm Multilineage Human Hematopoietic Repopulation of Untreated KIT-Mutant Immunodeficient Mice","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Haematopoiesis; Biology; Stem cell; Immunology; Bone marrow; Population; Repopulation; Transplantation; Cord blood; Severe combined immunodeficiency; Cell biology; Cancer research; Genetics; Internal medicine; Gene; Medicine","score_opus":0.009838644721052501,"score_gpt":0.23363873741994054,"score_spread":0.22380009269888804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591940518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954686,0.00037878475,0.00032178487,0.000025501144,0.001022396,0.00015489374,0.0000023728708,0.00008126682,0.0025443952],"genre_scores_gemma":[0.995938,0.000008424131,0.000031681335,0.000041018204,0.000019201276,0.000007850332,0.00021980131,0.000015089412,0.0037189466],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989468,0.00014481261,0.0004678484,0.00022179357,0.000035393005,0.00018337181],"domain_scores_gemma":[0.99923825,0.000051892705,0.00026225386,0.00033225608,0.00010516627,0.000010196822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019074744,0.00013689206,0.0002311,0.00010629391,0.00014452057,0.0000098630435,0.00010543245,0.00015766769,0.0006608201],"category_scores_gemma":[0.00007901032,0.00012304688,0.00010374861,0.00009893965,0.00007212754,0.00006596366,0.00003767321,0.0001626798,0.00030355545],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006482877,0.0005467025,0.0018682322,0.000026332891,0.000100889265,0.0000010989469,0.00034887972,0.000012351749,0.9961488,0.0004447579,0.00017080094,0.00026631934],"study_design_scores_gemma":[0.0024362826,0.00027117672,0.009604394,0.000057776633,0.00013550349,0.00011205771,0.00018777537,0.000060441394,0.9828554,0.000023522376,0.004116547,0.0001391693],"about_ca_topic_score_codex":0.00020000119,"about_ca_topic_score_gemma":0.000009524292,"teacher_disagreement_score":0.0132934535,"about_ca_system_score_codex":0.000017559089,"about_ca_system_score_gemma":0.0000093094595,"threshold_uncertainty_score":0.72355163},"labels":[],"label_agreement":null},{"id":"W2592003520","doi":"10.1182/blood.v112.11.249.249","title":"Preclinical Studies Using Polyethylenimine (PEI) Nanoparticles Complexed with Eukaryotic Translation Initiation Factor 5A (eIF5A) siRNA and eIF5AK50R Plasmid DNA Demonstrates Significant Anti-Myeloma Activity in Vitro and in Vivo","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Polyamine Metabolism and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Propidium iodide; Molecular biology; Biology; In vivo; Apoptosis; Initiation factor; In vitro; Annexin; Small interfering RNA; Messenger RNA; Transfection; Translation (biology); Flow cytometry; Cancer research; Programmed cell death; Cell culture; Biochemistry; Gene; Genetics","score_opus":0.06592297567674045,"score_gpt":0.29941162539139177,"score_spread":0.23348864971465133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592003520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978321,0.00155797,0.00008100796,0.00012153972,0.000013333636,0.00028693097,0.00008561558,0.000010489533,0.000011013045],"genre_scores_gemma":[0.9979113,0.00062588416,0.0013380497,0.000024308301,0.000038971542,0.000023724782,0.000023713597,0.0000115410385,0.0000025247978],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990364,0.000090467984,0.00025033744,0.00033214493,0.0000903094,0.00020039176],"domain_scores_gemma":[0.99960613,0.000084323794,0.00009070257,0.00012714326,0.000030778916,0.000060932984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010017063,0.00015902989,0.0002519964,0.00006794881,0.0000918798,0.000014371695,0.00005075279,0.00008838905,0.0000011034496],"category_scores_gemma":[0.00004866547,0.00014153241,0.000022031405,0.00013469906,0.00022770112,0.00002135757,0.00003218238,0.000084152176,2.3202121e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015674149,0.00027153955,0.10016167,0.00002169667,0.000032237273,0.000005809233,0.00016550535,0.000018217828,0.89852107,0.000003421547,0.0000010580072,0.00064101466],"study_design_scores_gemma":[0.0015309498,0.00008659463,0.29899824,0.000013708457,0.00003276121,0.000026094493,0.000068765265,0.0003247215,0.69876844,0.000015013776,0.000007018526,0.00012768585],"about_ca_topic_score_codex":0.000029312983,"about_ca_topic_score_gemma":0.00013597179,"teacher_disagreement_score":0.19975263,"about_ca_system_score_codex":0.0000054676457,"about_ca_system_score_gemma":0.000056783178,"threshold_uncertainty_score":0.5771524},"labels":[],"label_agreement":null},{"id":"W2592005338","doi":"10.1182/blood.v128.22.1680.1680","title":"Genetic Determinants of Response to Guadecitabine (SGI-110) in AML","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Decitabine; Biology; International Prognostic Scoring System; CEBPA; Internal medicine; Genetics; Medicine; Mutation; Myelodysplastic syndromes; Bone marrow; Gene; DNA methylation","score_opus":0.018382417904745516,"score_gpt":0.30619381110834115,"score_spread":0.2878113932035956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592005338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99746853,0.000118512486,0.00003607857,0.0015282532,0.0000311849,0.00041441547,0.0000145307695,0.000020048543,0.0003684553],"genre_scores_gemma":[0.99453163,0.000039655864,0.0027296422,0.00017171784,0.000076714714,0.000035252768,4.821282e-7,0.0000278756,0.0023870408],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99858093,0.00011652115,0.00034043664,0.00026299513,0.00032955437,0.00036953174],"domain_scores_gemma":[0.99884015,0.00029165193,0.000045287834,0.0005247711,0.000095509444,0.00020261612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000511149,0.000114595816,0.00031082807,0.0003427984,0.000013951475,0.000003799458,0.00018686145,0.00008852593,0.00019100768],"category_scores_gemma":[0.0014307665,0.00007632427,0.000051459287,0.000364237,0.000071109476,0.00003645431,0.00012545288,0.00010033756,0.00025146265],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002261758,0.00034965313,0.2984958,0.000044066175,0.000021038497,0.0006101505,0.000201392,2.6742651e-7,0.6716727,0.0000033660426,0.00053721154,0.025802622],"study_design_scores_gemma":[0.0073781344,0.00081876834,0.76659256,0.0002606652,0.000029147239,0.0001322783,0.000027901553,0.0000093147755,0.22292098,0.000026338495,0.0017109499,0.00009292132],"about_ca_topic_score_codex":0.00007237005,"about_ca_topic_score_gemma":0.0000694931,"teacher_disagreement_score":0.4680968,"about_ca_system_score_codex":0.00010882208,"about_ca_system_score_gemma":0.0003106906,"threshold_uncertainty_score":0.32321274},"labels":[],"label_agreement":null},{"id":"W2592049596","doi":"10.1182/blood.v108.11.3551.3551","title":"Lenalidomide (L) in Combination with Dexamethasone (D) Improves Survival and Time to Progression in Elderly Patients (pts) with Relapsed or Refractory (rel/ref) Multiple Myeloma (MM).","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Lenalidomide; Tolerability; Thalidomide; Population; Placebo; Refractory (planetary science); Clinical trial; Combination therapy; Multiple myeloma; Gastroenterology; Surgery; Adverse effect","score_opus":0.011774752614454983,"score_gpt":0.26231165148167435,"score_spread":0.25053689886721936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592049596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99721295,0.00012713906,0.00001290417,0.00017214104,0.000014104522,0.0019043852,0.0000137061525,0.0000643532,0.00047833877],"genre_scores_gemma":[0.9948371,0.000011931874,0.003964569,0.000021249616,0.000028385864,0.00021047099,0.00014750527,0.00005605192,0.00072270684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980159,0.00014821794,0.00032135853,0.0004798479,0.0005740449,0.0004606769],"domain_scores_gemma":[0.9990331,0.00024003431,0.000107577616,0.0002668929,0.00014152285,0.00021087653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026152012,0.00025308167,0.00041649817,0.00034603127,0.00006138112,0.00003376305,0.00007439831,0.00011486835,0.00002609835],"category_scores_gemma":[0.00025394204,0.00015962472,0.000023324868,0.00045676422,0.00007439736,0.00018611585,0.00004792886,0.00024679035,0.000030836545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011890789,0.0070447233,0.9167841,0.00011136844,0.00007963484,0.0005098008,0.00015996522,0.0000030530286,0.009189267,0.000005447279,0.000042346208,0.054179475],"study_design_scores_gemma":[0.06874449,0.009454473,0.9134513,0.00058650697,0.00005699438,0.000021513766,0.000060512786,0.00020133478,0.007055477,0.000011557179,0.00014540328,0.00021043106],"about_ca_topic_score_codex":0.00089788693,"about_ca_topic_score_gemma":0.0026516085,"teacher_disagreement_score":0.056853704,"about_ca_system_score_codex":0.00012439473,"about_ca_system_score_gemma":0.00013669349,"threshold_uncertainty_score":0.6509307},"labels":[],"label_agreement":null},{"id":"W2592055730","doi":"10.1182/blood.v116.21.3094.3094","title":"A Retrospective Study on the Incidence of Rituximab-Related Interstitial Pneumonitis In Patients Undergoing Immunochemotherapy for Non-Hodgkin Lymphoma","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Rituximab; Medicine; Ofatumumab; Internal medicine; Vincristine; Lymphoma; Incidence (geometry); CHOP; Retrospective cohort study; CD20; Concomitant; Diffuse large B-cell lymphoma; Surgery; Cyclophosphamide; Chemotherapy","score_opus":0.007846380834312477,"score_gpt":0.2542861580910291,"score_spread":0.24643977725671665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592055730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99744165,0.000019351364,0.0000022864606,0.00023152717,0.00017386177,0.0016200874,0.00001660115,0.00001576434,0.00047889346],"genre_scores_gemma":[0.9994853,0.00001341539,0.000094559466,0.00011832446,0.000031812855,0.00020876738,0.00000909929,0.000021572156,0.000017156819],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990131,0.000032979427,0.00029853024,0.0002501804,0.00022516647,0.00017999092],"domain_scores_gemma":[0.99919677,0.00019664917,0.00013190042,0.0003279803,0.00010926863,0.00003746245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016865671,0.0001534291,0.00031445638,0.00009165733,0.00006300917,0.000014482451,0.000112256756,0.000072734736,0.0000268072],"category_scores_gemma":[0.00019805373,0.00010429689,0.00010130537,0.00016273926,0.00006175255,0.000042136908,0.000032739572,0.000099266086,0.000008809081],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003350001,0.01796569,0.97449046,0.000013068787,0.00031010766,0.000026356935,0.0019464059,1.5341863e-7,0.0025955192,0.00022581848,0.000022275377,0.0020691375],"study_design_scores_gemma":[0.03744562,0.005620307,0.93489766,0.00020908359,0.00013319377,0.000007610915,0.00041043575,0.000015467667,0.020971049,0.00019572601,0.0000053668036,0.00008845138],"about_ca_topic_score_codex":0.00024565545,"about_ca_topic_score_gemma":0.00017609721,"teacher_disagreement_score":0.039592776,"about_ca_system_score_codex":0.00011929369,"about_ca_system_score_gemma":0.000097389224,"threshold_uncertainty_score":0.42531037},"labels":[],"label_agreement":null},{"id":"W2592081749","doi":"10.1182/blood.v120.21.980.980","title":"Dyskerin Is Upregulated During Erythroid Differentiation of Human Hematopoietic Progenitor Cells and Hyperactivates Telomerase in Erythroid Precursor Cells","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"Telomerase; Telomerase reverse transcriptase; Biology; Telomere; Telomerase RNA component; Haematopoiesis; Cellular differentiation; Molecular biology; Myeloid; Myeloid leukemia; Stem cell; Progenitor cell; CD34; Cancer research; Cell biology; Gene; Genetics","score_opus":0.01105278210481861,"score_gpt":0.24181842156241637,"score_spread":0.23076563945759776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592081749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99741346,0.0014191889,0.0000022380816,0.000078624515,0.00015604927,0.0007395412,0.000024873789,0.00007419233,0.00009180585],"genre_scores_gemma":[0.998787,0.00018235634,0.0003813718,0.000031632335,0.00017848304,0.00003890391,0.00002571484,0.00005317355,0.00032137716],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981262,0.0000719971,0.00056281884,0.0003828423,0.00032984262,0.0005263005],"domain_scores_gemma":[0.99900174,0.00005919179,0.0002184972,0.00039128985,0.000078429766,0.00025083503],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001402366,0.0003069321,0.0005718371,0.00025928195,0.000097864766,0.00002294377,0.00009663962,0.00017116254,0.00016619592],"category_scores_gemma":[0.00003044784,0.00028475138,0.00009458271,0.00032653273,0.00012382414,0.00026373108,0.00007115502,0.00023414244,0.000022334209],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008123089,0.0016908492,0.17758799,0.0006682515,0.0000833925,0.0000144291935,0.002951176,4.6965627e-7,0.81667084,0.0000075342004,0.000025883679,0.00021796672],"study_design_scores_gemma":[0.0028050055,0.00013987516,0.2510901,0.0002590152,0.00015434723,0.00007002293,0.0002767636,0.000011038178,0.7449375,0.000013887271,0.000028813078,0.00021362967],"about_ca_topic_score_codex":0.00005948693,"about_ca_topic_score_gemma":0.00000788355,"teacher_disagreement_score":0.07350212,"about_ca_system_score_codex":0.00004092849,"about_ca_system_score_gemma":0.00003808168,"threshold_uncertainty_score":0.9999605},"labels":[],"label_agreement":null},{"id":"W2592087354","doi":"10.1182/blood.v116.21.2835.2835","title":"HIV-Associated Diffuse Large B Cell Lymphoma: Determinants of Survival In the Era of Rituximab and HAART.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Providence Health Care; University of Toronto; Sunnybrook Health Science Centre; St. Michael's Hospital","funders":"","keywords":"Rituximab; Medicine; International Prognostic Index; Internal medicine; Diffuse large B-cell lymphoma; Lymphoma; Chemotherapy regimen; Univariate analysis; Retrospective cohort study; Oncology; Cohort; Regimen; Chemotherapy; Multivariate analysis","score_opus":0.007876683118470413,"score_gpt":0.2371652752037719,"score_spread":0.22928859208530147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592087354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99859256,0.00026657904,1.5846852e-7,0.00012172301,0.00005900889,0.00021994635,0.000069774476,0.0000075796065,0.0006626796],"genre_scores_gemma":[0.99969214,0.000083801344,0.000066225235,0.000053632495,0.00002146943,0.000017851853,0.000012866479,0.000009760928,0.000042279225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99920267,0.000047634847,0.00024160274,0.00013991774,0.00019095775,0.00017723316],"domain_scores_gemma":[0.99938154,0.00016757734,0.00011336287,0.000248594,0.000042816813,0.000046078458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023596836,0.00010621841,0.00035808273,0.000037429203,0.000027801441,0.0000062362105,0.000073598305,0.00008472612,0.000012091029],"category_scores_gemma":[0.000083760664,0.00006714909,0.000062810104,0.00010220582,0.000054596883,0.000026534804,0.000034465273,0.00007103634,0.0000046458217],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035675246,0.04068836,0.95265824,0.000053030893,0.000039403323,0.000104857834,0.0007199046,4.6556115e-9,0.0045105033,0.000058779333,0.000037785805,0.0010934611],"study_design_scores_gemma":[0.05504261,0.0002165418,0.8842598,0.00006276089,0.00022201544,0.000024027995,0.00013484228,0.000014757291,0.059840105,0.000023646695,0.000101284546,0.00005757719],"about_ca_topic_score_codex":0.00023151652,"about_ca_topic_score_gemma":0.00058348826,"teacher_disagreement_score":0.0683984,"about_ca_system_score_codex":0.00000991535,"about_ca_system_score_gemma":0.000057634777,"threshold_uncertainty_score":0.27382606},"labels":[],"label_agreement":null},{"id":"W2592114706","doi":"10.1182/blood.v110.11.4545.4545","title":"BCR-ABL Induces Autocrine IGF-1 Signaling.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Autocrine signalling; Cancer research; Imatinib mesylate; breakpoint cluster region; Chronic myelogenous leukemia; Biology; Signal transduction; Tyrosine kinase; Imatinib; Cell biology; Leukemia; Immunology; Cell culture; Receptor; Myeloid leukemia; Genetics","score_opus":0.019275800723235655,"score_gpt":0.2817426360693515,"score_spread":0.26246683534611587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592114706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9750848,0.0007420658,0.000049176513,0.00026561518,0.0001319096,0.0003003438,0.000003982597,0.00017955959,0.02324255],"genre_scores_gemma":[0.99290603,0.000022057611,0.0026473461,0.0003890969,0.00047879442,0.000011846433,0.000029638817,0.000032617038,0.0034825448],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987446,0.000013250317,0.00026584772,0.00027436606,0.00029864995,0.00040329574],"domain_scores_gemma":[0.99923015,0.00008937085,0.00006691484,0.0003507823,0.000056865767,0.00020591514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023045881,0.00017037374,0.00025492685,0.00010839874,0.000058830075,0.00001189929,0.000089770896,0.00009910726,0.00059661514],"category_scores_gemma":[0.00010684701,0.00014334674,0.000088190594,0.000204883,0.000043939304,0.00004982389,0.000043712054,0.00020192719,0.0003529528],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007455301,0.00995717,0.19280139,0.0005528097,0.0027227546,0.008962065,0.0021522169,0.000010163374,0.69463086,0.0013559877,0.0072882227,0.078820854],"study_design_scores_gemma":[0.022336267,0.0010223829,0.09900997,0.00024902134,0.0009894425,0.00095785444,0.00019947428,0.000018814402,0.8509249,0.00019946543,0.023694951,0.0003974284],"about_ca_topic_score_codex":0.00012123243,"about_ca_topic_score_gemma":0.000021245938,"teacher_disagreement_score":0.15629409,"about_ca_system_score_codex":0.00021013079,"about_ca_system_score_gemma":0.0002625954,"threshold_uncertainty_score":0.6532517},"labels":[],"label_agreement":null},{"id":"W2592135980","doi":"10.1182/blood.v108.11.975.975","title":"Treatment of Hepatitis-Associated Aplastic Anemia with High Dose Cyclophosphamide.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Medicine; Aplastic anemia; Gastroenterology; Internal medicine; Platelet transfusion; Cyclophosphamide; Hepatitis; Mesna; Anemia; Immunology; Bone marrow; Platelet; Chemotherapy","score_opus":0.00653944721458054,"score_gpt":0.2136410543806569,"score_spread":0.20710160716607634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592135980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99621683,0.00017692609,0.00008008066,0.000060213566,0.000042630953,0.0003522922,0.0000370326,0.00006456146,0.0029694347],"genre_scores_gemma":[0.99784595,0.000099859324,0.0011517502,0.000011826788,0.00004420389,0.000028065426,0.00020018063,0.0000223579,0.00059579284],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991749,0.000019819885,0.0002434828,0.0001630969,0.000227263,0.00017146778],"domain_scores_gemma":[0.9995113,0.0001021196,0.000096355885,0.00016690986,0.00006603777,0.00005727404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000026894173,0.00013502513,0.00029886918,0.00005061221,0.000026188303,0.0000046081445,0.000027084916,0.00007328458,0.00008347238],"category_scores_gemma":[0.000008685307,0.00010004516,0.000044530498,0.00015825934,0.00004031188,0.00002239883,0.000002143502,0.000034651337,0.0000224567],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025951792,0.0033950163,0.97814155,0.00025026096,0.00020314092,0.00069555227,0.00027538647,0.00003246644,0.016072063,0.00040469356,0.00004205546,0.00022831578],"study_design_scores_gemma":[0.01393187,0.0017985132,0.84292984,0.00022246497,0.0009883387,0.00020389589,0.000018888302,0.000016568105,0.13966157,0.000063305786,0.00004722907,0.00011754713],"about_ca_topic_score_codex":0.0018461718,"about_ca_topic_score_gemma":0.00029205126,"teacher_disagreement_score":0.13521172,"about_ca_system_score_codex":0.00005494085,"about_ca_system_score_gemma":0.00007725924,"threshold_uncertainty_score":0.40797234},"labels":[],"label_agreement":null},{"id":"W2592137822","doi":"10.1182/blood.v128.22.1895.1895","title":"Treatment-Free Remission (TFR) in Patients with Chronic Phase Chronic Myeloid Leukemia (CML-CP) and in Stable Deep Molecular Response (DMR) to Dasatinib - the Dasfree Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Dasatinib; Discontinuation; Medicine; Internal medicine; Clinical endpoint; Oncology; Imatinib; Drug holiday; Surrogate endpoint; Myeloid leukemia; Clinical trial; Immunology","score_opus":0.009186561493443199,"score_gpt":0.2607091870981696,"score_spread":0.2515226256047264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592137822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936483,0.0012193492,0.000032799097,0.0006375612,0.00004498944,0.0041411547,0.00004819579,0.00006818577,0.0001594661],"genre_scores_gemma":[0.9981524,0.000106691485,0.00026647517,0.00008056777,0.00007499843,0.0004714208,0.0000326514,0.0000929795,0.0007218695],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966261,0.0003890935,0.0005926202,0.0009353165,0.00063847034,0.00081839156],"domain_scores_gemma":[0.99721867,0.00032460858,0.00016143268,0.0018748065,0.00007747164,0.00034303693],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047295762,0.0005347406,0.0006630682,0.00032992932,0.000120136676,0.00003607915,0.00036056415,0.0001482957,0.00012990269],"category_scores_gemma":[0.0004502691,0.00028929635,0.000066179186,0.0006093504,0.00011801743,0.00017641265,0.000266703,0.00023922652,0.00003700562],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025978979,0.013712959,0.81736845,0.00011634581,0.0007798865,0.0020440046,0.0029986762,0.00008486717,0.07153326,0.0000115904,0.00015926566,0.065211706],"study_design_scores_gemma":[0.30132738,0.02756014,0.6428453,0.00088416296,0.0006016538,0.00006404721,0.000260648,0.0000816982,0.024246814,0.000025724048,0.0015527101,0.00054974825],"about_ca_topic_score_codex":0.000714788,"about_ca_topic_score_gemma":0.0025951865,"teacher_disagreement_score":0.2753484,"about_ca_system_score_codex":0.0074554896,"about_ca_system_score_gemma":0.0018933987,"threshold_uncertainty_score":0.9999559},"labels":[],"label_agreement":null},{"id":"W2592143294","doi":"10.1182/blood.v108.11.388.388","title":"Deregulated Expression of a Novel Oncogene, Ahi-1, in Murine Hematopoietic Cells Confers a Proliferative Advantage In Vitro and Leukemogenic Activity In Vivo and Enhances the Effects of BCR-ABL.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Haematopoiesis; Cancer research; Biology; Myeloid; breakpoint cluster region; CD34; Myeloid leukemia; K562 cells; Leukemia; Stem cell; Immunology; Cell biology; Receptor","score_opus":0.0052313813399006235,"score_gpt":0.232767478647267,"score_spread":0.22753609730736638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592143294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971143,0.001396639,0.000012615155,0.000030486462,0.000017125187,0.0012607473,0.000013777694,0.00000814008,0.00014618672],"genre_scores_gemma":[0.9992708,0.00018533797,0.00036541995,0.000012290468,0.0000109671255,0.00008016773,0.000004415879,0.000015821564,0.000054756078],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988647,0.00009757528,0.00033525823,0.00029364918,0.00018607632,0.00022273361],"domain_scores_gemma":[0.99924296,0.00032013137,0.0001619172,0.00020742894,0.000024212073,0.00004337039],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015234992,0.00019352202,0.0005372773,0.00016325808,0.000017026645,0.0000046425685,0.000054385706,0.00010279081,0.0000060693073],"category_scores_gemma":[0.000055486347,0.00013813587,0.000036401714,0.00023859122,0.0001468303,0.00007291604,0.000063807085,0.00016407369,1.6277116e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060542853,0.001864507,0.013551508,0.0008354453,0.00003496602,0.00007191219,0.00088033814,0.000009027304,0.9818814,0.0000068875715,0.0000024902413,0.0002560835],"study_design_scores_gemma":[0.023406787,0.00031116445,0.036201112,0.0009583333,0.000084458385,0.000043382995,0.00014779961,0.00026868997,0.9384549,0.000022699598,0.0000026314558,0.000098030345],"about_ca_topic_score_codex":0.00079762767,"about_ca_topic_score_gemma":0.00062201265,"teacher_disagreement_score":0.043426495,"about_ca_system_score_codex":0.00013979395,"about_ca_system_score_gemma":0.00022120883,"threshold_uncertainty_score":0.5633018},"labels":[],"label_agreement":null},{"id":"W2592146876","doi":"10.1182/blood.v128.22.4264.4264","title":"Distribution and Impact of Comorbidities on Survival and Leukemic Transformation in Myeloproliferative Neoplasm (MPN)-Associated Myelofibrosis (MF)","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Myelofibrosis; Medicine; Comorbidity; Myeloproliferative neoplasm; Internal medicine; Polycythemia vera; Proportional hazards model; Population; International Prognostic Scoring System; Survival analysis; Cancer; Oncology; Myelodysplastic syndromes; Bone marrow","score_opus":0.01626958853424984,"score_gpt":0.26803980581992337,"score_spread":0.2517702172856735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592146876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976589,0.00013837291,0.00002770549,0.00056122657,0.000029907704,0.0004956878,0.0004975537,0.000024875038,0.0005657797],"genre_scores_gemma":[0.9987799,0.00087106833,0.000023724264,0.00001986855,0.000025473342,0.00006211262,0.00015953547,0.000013224277,0.000045102668],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989082,0.000097316544,0.00032943723,0.00022887407,0.00021480054,0.00022132332],"domain_scores_gemma":[0.9992639,0.00030849522,0.00011341783,0.00011023041,0.00009706385,0.00010690988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000183528,0.00021202337,0.00045230478,0.00010493512,0.00006330754,0.000016415084,0.00002549896,0.00011512678,0.000027113168],"category_scores_gemma":[0.00013408206,0.00013047314,0.00007544159,0.00014126897,0.00010725088,0.00014895659,0.000013466932,0.00009079224,0.0000036259362],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060318416,0.0012608,0.9750765,0.00008440847,0.00043997288,0.000017232465,0.0016482915,0.0000031160137,0.01248638,0.0017481566,0.000075846125,0.006556123],"study_design_scores_gemma":[0.010564628,0.0018964433,0.93413055,0.0004836196,0.0001455558,0.000025253354,0.00019254135,0.000037486392,0.052198756,0.00017504282,0.000014768741,0.00013532818],"about_ca_topic_score_codex":0.0002040259,"about_ca_topic_score_gemma":0.00018357938,"teacher_disagreement_score":0.040945914,"about_ca_system_score_codex":0.00020278858,"about_ca_system_score_gemma":0.00011034395,"threshold_uncertainty_score":0.53205407},"labels":[],"label_agreement":null},{"id":"W2592147653","doi":"10.1182/blood.v126.23.3621.3621","title":"Molecular Analysis of Diamond Blackfan Anemia and Genotype-Phenotype Correlation: Experience from the Canadian Inherited Marrow Failure Registry","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Janeway Children's Health and Rehabilitation Centre; London Health Sciences Centre; McMaster University; University of Alberta; Centre hospitalier universitaire de Québec; Centre Hospitalier Universitaire de Sherbrooke; Centre Hospitalier Universitaire Sainte-Justine; Western University; Royal University Hospital; Montreal Children's Hospital; University of Toronto; BC Children's Hospital; Princess Margaret Cancer Centre; Kingston General Hospital; Alberta Children's Hospital; Izaak Walton Killam Health Centre; University of Manitoba; CancerCare Manitoba; Population Health Research Institute; Children's Hospital of Eastern Ontario; Hospital for Sick Children","funders":"","keywords":"Diamond–Blackfan anemia; Medicine; Bone marrow failure; Internal medicine; Hematopoietic stem cell transplantation; Oncology; Anemia; Cohort; Transplantation; Bioinformatics; Genetics; Biology; Gene; Haematopoiesis; Stem cell","score_opus":0.00836966612507545,"score_gpt":0.2204360046865347,"score_spread":0.21206633856145926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592147653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956712,0.003170823,0.000294659,0.0002758844,0.00006206531,0.000122119,0.00006890889,0.000006548189,0.00032780226],"genre_scores_gemma":[0.9987446,0.000027119308,0.00041701368,0.00009886694,0.00008784284,0.0000089658815,0.000524468,0.000014114835,0.000077000346],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991776,0.00005771266,0.00017519186,0.00028169175,0.00015713311,0.00015070678],"domain_scores_gemma":[0.99910396,0.000011033496,0.00011314592,0.00047484957,0.00014120403,0.00015579333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009107919,0.00011835946,0.00014201306,0.000059007412,0.00006963785,0.00002848516,0.00015703468,0.00021533783,0.000022185084],"category_scores_gemma":[0.00009182126,0.0001067959,0.000058844435,0.00040250475,0.00013564274,0.0000051167904,0.000047583257,0.000081481674,0.0000018547335],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013194817,0.00008250975,0.2940529,0.000012768322,0.0016486255,0.00001889203,0.0030119955,0.0097668795,0.68676835,0.00016770768,0.003011042,0.0013263869],"study_design_scores_gemma":[0.0039004115,0.00036908998,0.6460672,0.000046717716,0.0040032226,0.000028922788,0.0018281634,0.0056923395,0.30953655,0.0003034862,0.027210431,0.0010134837],"about_ca_topic_score_codex":0.022346664,"about_ca_topic_score_gemma":0.15304047,"teacher_disagreement_score":0.3772318,"about_ca_system_score_codex":0.000027168046,"about_ca_system_score_gemma":0.00024272849,"threshold_uncertainty_score":0.98416364},"labels":[],"label_agreement":null},{"id":"W2592151663","doi":"10.1182/blood.v108.11.2539.2539","title":"Characterization of a Hierarchy of Proliferative Ability in AML: Identification of a Role for NR2F6 in the Maintenance of the Undifferentiated State.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Biology; Transcription factor; Cell culture; Cell growth; Cancer research; Genetics; Gene","score_opus":0.004278303194558542,"score_gpt":0.21331624359008416,"score_spread":0.20903794039552562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592151663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986157,0.000088682486,0.0007494858,0.000024196515,0.000011289033,0.00041330353,0.00006732863,6.825435e-7,0.000029328028],"genre_scores_gemma":[0.99975026,0.000025828267,0.000036211328,0.0000044120434,0.000008344721,0.00004649812,0.00009253017,0.000004135961,0.000031781212],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99928814,0.0000925988,0.00036349153,0.000108877306,0.000080139645,0.00006677857],"domain_scores_gemma":[0.99935025,0.000015734522,0.0003025427,0.00019180636,0.00013597278,0.0000036838464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002523308,0.00005155433,0.00011111265,0.00002331162,0.000009209548,0.0000023109023,0.00015295629,0.000047476984,6.928071e-7],"category_scores_gemma":[0.00008714604,0.000033282435,0.00004458611,0.00013851198,0.00010011807,0.000003238729,0.000021163685,0.000031587042,1.9113495e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006972879,0.0003674432,0.047938608,0.00016813165,0.00000974544,3.2666726e-8,0.00034149448,0.000032952856,0.9508563,0.00013819804,0.0000012672937,0.00007607994],"study_design_scores_gemma":[0.0005421657,0.000067360656,0.19793022,0.000026969588,0.000010650313,3.503808e-7,0.00006903692,0.000075940814,0.80053705,0.0007064848,0.000008988348,0.000024774869],"about_ca_topic_score_codex":0.000048014015,"about_ca_topic_score_gemma":0.00007835304,"teacher_disagreement_score":0.15031926,"about_ca_system_score_codex":0.000004231101,"about_ca_system_score_gemma":0.00006625685,"threshold_uncertainty_score":0.13572183},"labels":[],"label_agreement":null},{"id":"W2592188002","doi":"10.1182/blood.v114.22.2989.2989","title":"Incidence and Management of Isolated Subsegmental Pulmonary Embolism.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Pulmonary embolism; Pulmonary angiography; Incidence (geometry); Radiology; Retrospective cohort study; Surgery","score_opus":0.008582054126472591,"score_gpt":0.24651277818741602,"score_spread":0.23793072406094343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592188002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827101,0.0014173039,0.00004968701,0.00072926737,0.000041574647,0.00046267404,0.000002524564,0.000046159566,0.014540691],"genre_scores_gemma":[0.9949664,0.003086044,0.0010284801,0.0006154723,0.0000341961,0.000011359389,0.000009562677,0.000009016601,0.00023946991],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991954,0.000011125913,0.00020905124,0.00020963259,0.0001943008,0.0001804893],"domain_scores_gemma":[0.99959946,0.00000720043,0.0000606046,0.00022000253,0.000025608355,0.000087155495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009192431,0.00011323542,0.00028579962,0.00007452814,0.00003878334,0.000008905354,0.000067706875,0.00003905948,0.000057391815],"category_scores_gemma":[0.000002841729,0.00010272395,0.000047413923,0.00013704269,0.000036596964,0.00006006596,0.000063343454,0.000055089957,0.000011044764],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010396828,0.05951273,0.192555,0.0059703905,0.0050355652,0.009561544,0.00354006,0.000026061205,0.1604995,0.0878439,0.010160653,0.46425492],"study_design_scores_gemma":[0.0020101753,0.0007067631,0.98814034,0.00039616416,0.00076978636,0.000117203555,0.00024675133,0.00006714327,0.006217101,0.00034371155,0.0008384189,0.0001464442],"about_ca_topic_score_codex":0.000023587745,"about_ca_topic_score_gemma":0.0000011238205,"teacher_disagreement_score":0.79558533,"about_ca_system_score_codex":0.00001076423,"about_ca_system_score_gemma":0.0000076542565,"threshold_uncertainty_score":0.41889608},"labels":[],"label_agreement":null},{"id":"W2592196376","doi":"10.1182/blood.v118.21.422.422","title":"Pre-Screening for Low Methyl Guanine Methyltransferase (MGMT) Expression Results in High Response Rates to Temozolomide (TMZ) Therapy in AML and MDS Patients.","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; McMaster University Medical Centre; Merck Canada Inc. (Canada); Hôpital Maisonneuve-Rosemont; Princess Margaret Cancer Centre","funders":"","keywords":"Temozolomide; Methyltransferase; Medicine; O-6-methylguanine-DNA methyltransferase; Oncology; Internal medicine; Induction chemotherapy; Myeloid leukemia; Chemotherapy; Decitabine; DNA methylation; Methylation; Biology; Gene expression","score_opus":0.03785284742677013,"score_gpt":0.31350372330765197,"score_spread":0.27565087588088183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592196376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99551857,0.00029341754,0.00069811346,0.0007657901,0.00003865285,0.002440213,0.00009999126,0.000051099407,0.0000941828],"genre_scores_gemma":[0.96922195,0.00017919527,0.029393092,0.0003985075,0.000060738676,0.0003832833,0.00008026304,0.00006587702,0.00021708442],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972913,0.0004810669,0.00063893886,0.0006517584,0.00034433088,0.0005926009],"domain_scores_gemma":[0.9979769,0.0009931318,0.00007478911,0.0005015489,0.00016718126,0.00028646685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021281338,0.00028448965,0.0005516187,0.0006246784,0.00006589026,0.000020776231,0.00021200159,0.00020949995,0.00003347111],"category_scores_gemma":[0.002017314,0.00022963963,0.00006986278,0.00054046826,0.00007079478,0.00016518754,0.00009380282,0.00041164763,0.0000041128924],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17189616,0.0023687417,0.11093846,0.00014352104,0.00012334972,0.00023513532,0.009251165,0.000014741309,0.67980444,0.000021173368,0.00075801456,0.024445085],"study_design_scores_gemma":[0.036199044,0.0032284227,0.3555506,0.00032350374,0.000027974449,0.0000061186593,0.00019042895,0.00008571254,0.6037254,0.000079545134,0.00037098667,0.00021227701],"about_ca_topic_score_codex":0.0008161817,"about_ca_topic_score_gemma":0.00013879348,"teacher_disagreement_score":0.24461211,"about_ca_system_score_codex":0.000100999074,"about_ca_system_score_gemma":0.00016397706,"threshold_uncertainty_score":0.9364432},"labels":[],"label_agreement":null},{"id":"W2592208651","doi":"10.1182/blood.v112.11.1978.1978","title":"Acute Treatments and Early Outcomes of Childhood Arterial Ischemic Stroke: First Analysis of the International Pediatric Stroke Study.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Antithrombotic; Concomitant; Stroke (engine); Pediatric stroke; Pediatrics; Internal medicine; Ischemic stroke; Ischemia","score_opus":0.014396826440405703,"score_gpt":0.24962563367409996,"score_spread":0.23522880723369424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592208651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99891984,0.000044555494,0.0000069662947,0.00012475383,0.00013392391,0.00030412318,0.00011411221,0.0000137336665,0.00033796224],"genre_scores_gemma":[0.9992613,0.00006263017,0.0001608904,0.000027892554,0.000060526167,0.000010976226,0.000011733046,0.0000092463615,0.00039479168],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899685,0.000019413465,0.00031699662,0.00017850664,0.00039224268,0.00009597344],"domain_scores_gemma":[0.9993752,0.000031540003,0.00020188007,0.00027057546,0.000070124515,0.000050678515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005459813,0.000119365155,0.00043738278,0.00021962037,0.00005769678,0.000005929765,0.00012218245,0.00005010698,0.00007615358],"category_scores_gemma":[0.000025102774,0.000080720274,0.00021270933,0.00028048616,0.000034391644,0.000045977908,0.00007032539,0.00006422139,0.0000013914507],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032843163,0.0026374336,0.97939134,0.000004256797,0.008617927,0.0000045280085,0.0008665044,0.0000011927757,0.0083775,0.000013359059,0.00001968011,0.00003345465],"study_design_scores_gemma":[0.0069805677,0.00031548835,0.9646254,0.00000411533,0.013424185,0.0000093470735,0.00009027092,0.000011391288,0.014473136,0.0000023953617,0.0000075152434,0.00005614663],"about_ca_topic_score_codex":0.00004335495,"about_ca_topic_score_gemma":0.000019610863,"teacher_disagreement_score":0.014765879,"about_ca_system_score_codex":0.000008626908,"about_ca_system_score_gemma":0.000037565354,"threshold_uncertainty_score":0.32916772},"labels":[],"label_agreement":null},{"id":"W2592217503","doi":"10.1182/blood.v108.11.4390.4390","title":"MKC-1 Is a Novel Agent That Induces Cell Cycle Arrest and Disrupts Multiple Survival Pathways in Hematologic Cancers.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Jurkat cells; Cell cycle; Cell cycle checkpoint; Cell culture; Cancer research; In vitro; In vivo; Haematopoiesis; Apoptosis; Cell growth; Biology; Pharmacology; Immunology; T cell; Cell biology; Stem cell; Biochemistry; Immune system","score_opus":0.02979857206763766,"score_gpt":0.24627994290977684,"score_spread":0.21648137084213917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592217503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962112,0.0017274919,0.00006968407,0.00023248218,0.00022837023,0.00029947117,0.000048740556,0.000039185627,0.0011433805],"genre_scores_gemma":[0.9988041,0.00021038335,0.00038839714,0.00028678487,0.0001433292,0.0000401023,0.000013752762,0.000020927755,0.00009221224],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990811,0.00001329257,0.0001698165,0.00029335925,0.00018103766,0.00026140176],"domain_scores_gemma":[0.9996101,0.000038364607,0.00006701432,0.00018706683,0.000017223454,0.0000802331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009388551,0.00015483832,0.0002932436,0.000063633626,0.000046868077,0.000020583439,0.000058334725,0.00009113153,0.000056953595],"category_scores_gemma":[0.000006617677,0.00012945877,0.000051351068,0.000115025825,0.000034094704,0.000044432927,0.000032790398,0.00012942677,0.000005991048],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033842734,0.0041953744,0.3813516,0.00036494754,0.000112161106,0.0005235744,0.0028271698,0.000032234846,0.6064695,0.001617126,0.00031431075,0.0018535828],"study_design_scores_gemma":[0.026668137,0.00050932495,0.35163832,0.00026187405,0.00014586055,0.00009775121,0.0012988666,0.00040755505,0.61465394,0.0017124668,0.0020298953,0.0005760341],"about_ca_topic_score_codex":0.0051415144,"about_ca_topic_score_gemma":0.003540041,"teacher_disagreement_score":0.029713288,"about_ca_system_score_codex":0.000047776757,"about_ca_system_score_gemma":0.00007036755,"threshold_uncertainty_score":0.77724665},"labels":[],"label_agreement":null},{"id":"W2592218248","doi":"10.1182/blood.v112.11.507.507","title":"The Deletion of the Proline-Rich Region of HOXB4 Is Associated with Myeloid Leukemia in a Mouse Model","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; Homeobox; Progenitor cell; Exon; Molecular biology; Haematopoiesis; Cancer research; Mutant; Myeloid; Transplantation; Stem cell; Gene; Transcription factor; Genetics; Medicine; Internal medicine","score_opus":0.011035553903236937,"score_gpt":0.20529093983614047,"score_spread":0.19425538593290353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592218248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99921495,0.00036116762,0.00010054322,0.000036435697,0.000006957478,0.00015368198,0.00001307644,0.0000050133244,0.000108149354],"genre_scores_gemma":[0.99929637,0.00007021405,0.000077853205,0.000049631613,0.000017321563,0.000018280733,0.000012383378,0.00001233015,0.00044561745],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99940103,0.000049671602,0.0001665533,0.00013193056,0.00013678361,0.00011404058],"domain_scores_gemma":[0.9994211,0.0000141623705,0.00015348784,0.00028874387,0.00010479098,0.000017666538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000081297476,0.000077087214,0.000090487054,0.00001498053,0.000058403846,0.0000026011269,0.00018186966,0.000082893086,4.366063e-7],"category_scores_gemma":[0.00012334854,0.000046018646,0.000046656318,0.00009767172,0.00011364941,0.0000017638233,0.00004594492,0.000057010446,1.9148813e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025129408,0.00047217653,0.061565973,0.000029373079,0.0001342976,0.000003960541,0.0004672199,0.007472998,0.9288675,0.000020001586,0.0006388459,0.00007633086],"study_design_scores_gemma":[0.0011317822,0.0001070254,0.010357844,0.00002887599,0.00003267313,0.000008895867,0.000023033666,0.0009671799,0.98719245,0.000029010047,0.00004513081,0.000076104356],"about_ca_topic_score_codex":0.000018632021,"about_ca_topic_score_gemma":0.00005516718,"teacher_disagreement_score":0.058324914,"about_ca_system_score_codex":0.00001622121,"about_ca_system_score_gemma":0.00027530873,"threshold_uncertainty_score":0.1876586},"labels":[],"label_agreement":null},{"id":"W2592234056","doi":"10.1182/blood.v128.22.1107.1107","title":"Pembrolizumab in Relapsed/Refractory Classical Hodgkin Lymphoma: Primary End Point Analysis of the Phase 2 Keynote-087 Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Pembrolizumab; Medicine; Oncology; Internal medicine; Clinical endpoint; Brentuximab vedotin; Phases of clinical research; Refractory (planetary science); Cohort; Chemotherapy regimen; Lymphoma; Chemotherapy; Cancer; Clinical trial; Immunotherapy; Hodgkin lymphoma","score_opus":0.01326816067492311,"score_gpt":0.2703291171265829,"score_spread":0.25706095645165983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592234056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99607396,0.00044577743,0.0000044552708,0.00087636395,0.000080558435,0.000669524,0.000054119908,0.000029592427,0.00176567],"genre_scores_gemma":[0.99917173,0.00006276812,0.000040742165,0.00019732765,0.00006400682,0.00010781799,0.00001348194,0.000022160737,0.00031996565],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997982,0.00018848536,0.0005318481,0.00043394402,0.0005653831,0.00029830245],"domain_scores_gemma":[0.998418,0.00033413555,0.00019598503,0.0008511451,0.00006544816,0.00013530988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002649277,0.00023323124,0.00073806755,0.00031172117,0.000050170547,0.000009843189,0.00017607558,0.000108612556,0.0002181603],"category_scores_gemma":[0.00014824742,0.000116846655,0.00039318245,0.0007253798,0.000121881196,0.000056328085,0.00011818941,0.0000721201,0.000020852005],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001081105,0.069046706,0.8791689,0.000026031761,0.0035794554,0.00046469457,0.00065919734,0.0000012958617,0.005629565,0.0000937944,0.00028320632,0.03996604],"study_design_scores_gemma":[0.077368505,0.0016717948,0.90792924,0.000096282536,0.0056922613,0.000024989777,0.0001225071,0.000011262619,0.006522416,0.000023189494,0.00040628845,0.000131268],"about_ca_topic_score_codex":0.00018232387,"about_ca_topic_score_gemma":0.00019105447,"teacher_disagreement_score":0.0762874,"about_ca_system_score_codex":0.00035384903,"about_ca_system_score_gemma":0.00028224502,"threshold_uncertainty_score":0.47648683},"labels":[],"label_agreement":null},{"id":"W2592247439","doi":"10.1182/blood.v126.23.5057.5057","title":"Enteropathy-Associated T-Cell Lymphoma: A Single Centre Experience","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Celiac Disease Research and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Lymphoma; Perforation; Internal medicine; Incidence (geometry); Hematopathology; Surgery","score_opus":0.026728494666505464,"score_gpt":0.2623648906334918,"score_spread":0.23563639596698632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592247439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96924245,0.0005766703,0.000018572737,0.0002585651,0.00007656569,0.00025506492,0.000006903804,0.00009172036,0.029473469],"genre_scores_gemma":[0.9943291,0.000019537085,0.00006411371,0.00024541686,0.00006673176,0.000018736888,0.00003362444,0.000014746447,0.0052080196],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989286,0.000055709217,0.00011968981,0.00017388062,0.00039461692,0.00032750823],"domain_scores_gemma":[0.9991217,0.000013034034,0.000033059896,0.00023688166,0.0000988487,0.00049645203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014207716,0.00009450074,0.00013813193,0.000056071745,0.000041991367,0.000028408405,0.00008234582,0.0000319913,0.00006208765],"category_scores_gemma":[0.00021219131,0.00008304965,0.00006565263,0.00013985531,0.000035147343,0.000053198844,0.00009586498,0.000053255928,0.00020497642],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019036235,0.24268122,0.3508866,0.0011344262,0.0011793305,0.009639292,0.031280417,0.000004317982,0.14040942,0.00031648786,0.17606172,0.044503126],"study_design_scores_gemma":[0.22297788,0.007789576,0.11177117,0.0010179793,0.0018905954,0.00016284274,0.043893598,0.0004035251,0.3189266,0.0005754165,0.28882208,0.0017687444],"about_ca_topic_score_codex":0.00006123389,"about_ca_topic_score_gemma":0.000014160748,"teacher_disagreement_score":0.23911545,"about_ca_system_score_codex":0.00009945849,"about_ca_system_score_gemma":0.00009986705,"threshold_uncertainty_score":0.33866665},"labels":[],"label_agreement":null},{"id":"W2592264389","doi":"10.1182/blood.v126.23.3404.3404","title":"Red Cell Antigen Genotyping Compared to Standard Serological Phenotyping in Sickle Cell Disease Patients in Canada: Potential for Reducing Alloimmunization","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hamilton Regional Laboratory Medicine Program; Hamilton Health Sciences; McMaster Children's Hospital; Canadian Blood Services; McMaster University","funders":"","keywords":"Genotyping; Medicine; Antigen; Immunology; Leukoreduction; Blood transfusion; Population; Hemoglobinopathy; Genotype; Thalassemia; Serology; Internal medicine; Hemolytic anemia; Antibody; Biology; Genetics","score_opus":0.015125301013657638,"score_gpt":0.22089378022390369,"score_spread":0.20576847921024605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592264389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99689156,0.00021573459,0.0010655328,0.00032482218,0.0001534477,0.0010838284,0.00003818651,0.000022465167,0.0002044515],"genre_scores_gemma":[0.9973293,0.00001994042,0.0020637908,0.0002356825,0.00006359289,0.000027904272,0.00021876438,0.00002588022,0.000015158628],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865085,0.000046035355,0.0003600774,0.0003146092,0.00027991447,0.00034849235],"domain_scores_gemma":[0.99927866,0.000019495199,0.000060829283,0.00019768071,0.00015272376,0.00029062506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020195577,0.00014786994,0.00031400414,0.000111334586,0.000058734702,0.000014388727,0.000093879215,0.00005980592,0.000012027157],"category_scores_gemma":[0.000054561035,0.00014412982,0.000039322764,0.00024301454,0.000010014932,0.000062114974,0.000046011824,0.00013951148,0.0000016605073],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004094674,0.002043847,0.9676632,0.0002717612,0.000029255738,0.00011290943,0.0014126134,0.0125745265,0.010145315,0.000011661347,0.0003479673,0.0012922597],"study_design_scores_gemma":[0.030664071,0.00052811723,0.9480154,0.0003314104,0.00020222359,0.00000189708,0.00051712553,0.00964738,0.009182301,0.000092591225,0.00043393654,0.00038357082],"about_ca_topic_score_codex":0.12426869,"about_ca_topic_score_gemma":0.14234939,"teacher_disagreement_score":0.026569398,"about_ca_system_score_codex":0.00023903417,"about_ca_system_score_gemma":0.0007186488,"threshold_uncertainty_score":0.8815629},"labels":[],"label_agreement":null},{"id":"W2592269524","doi":"10.1182/blood.v112.11.4217.4217","title":"Direct Interaction of Ahi-1 with BCR-ABL Modulates BCR-ABL Transforming Activity and Imatinib Response in a BCR-ABL Inducible Cell Line Model","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Cancer research; Progenitor cell; Biology; ABL; Imatinib mesylate; Chronic myelogenous leukemia; K562 cells; breakpoint cluster region; Stem cell; Tyrosine kinase; Haematopoiesis; Myeloid leukemia; Imatinib; Leukemia; Cell biology; Immunology; Signal transduction; Receptor","score_opus":0.024331189195292816,"score_gpt":0.26476059003146923,"score_spread":0.24042940083617642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592269524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99608445,0.0004603899,0.00026270337,0.00018279467,0.00004029341,0.0008563028,0.000036676487,0.00008475299,0.0019916154],"genre_scores_gemma":[0.9940718,0.0003824256,0.0043731993,0.000041858017,0.000048019527,0.00007847842,0.00002511253,0.00006640531,0.0009127067],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979524,0.00014664674,0.00048841763,0.0005836933,0.0003812241,0.0004475971],"domain_scores_gemma":[0.9986807,0.00031159382,0.00022341791,0.00051619153,0.00008805517,0.00018000185],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004418417,0.00037497285,0.00074882957,0.000367355,0.00010298202,0.000013826526,0.00009820343,0.0002071701,0.00004086995],"category_scores_gemma":[0.00013283345,0.00031531378,0.000100134384,0.00043337094,0.0001283426,0.00041418677,0.00004520117,0.00044411296,0.000006534443],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018243471,0.0068376423,0.022724314,0.00085524353,0.00050807965,0.0005939395,0.00943079,0.004839576,0.9303169,0.0000053914705,0.00006451809,0.005580137],"study_design_scores_gemma":[0.023103893,0.002144836,0.015396226,0.0008109759,0.00045062025,0.00058618205,0.00026093778,0.04153187,0.9152272,0.00002578204,0.00007537024,0.00038615207],"about_ca_topic_score_codex":0.0010269079,"about_ca_topic_score_gemma":0.00018353928,"teacher_disagreement_score":0.03669229,"about_ca_system_score_codex":0.00036810446,"about_ca_system_score_gemma":0.0006264681,"threshold_uncertainty_score":0.9999299},"labels":[],"label_agreement":null},{"id":"W2592287337","doi":"10.1182/blood.v128.22.4194.4194","title":"Polatuzumab Vedotin Combined with Bendamustine (B) and Rituximab (R) or Obinutuzumab (G) in Patients with Relapsed or Refractory (R/R) Follicular Lymphoma (FL) or Diffuse Large B-Cell Lymphoma (DLBCL): Preliminary Results of a Phase Ib/II Dose-Escalation Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont; BC Cancer Agency; Jewish General Hospital","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Internal medicine; Tolerability; Rituximab; Bendamustine; Follicular lymphoma; Oncology; Gastroenterology; Adverse effect; Lymphoma; Surgery","score_opus":0.009850781726426483,"score_gpt":0.23951556851764386,"score_spread":0.22966478679121738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592287337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99533796,0.00025162386,0.000005765535,0.00011913396,0.00006154774,0.003660645,0.00034697252,0.00011252785,0.00010380919],"genre_scores_gemma":[0.99776477,0.000093726565,0.0006492253,0.00007061895,0.000051258146,0.00032135396,0.00024214134,0.0001151827,0.0006917405],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9961207,0.00020583415,0.0010766195,0.001039896,0.00088798447,0.00066899107],"domain_scores_gemma":[0.9972003,0.00046071998,0.00064823614,0.0010170181,0.00030550527,0.00036823723],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027158434,0.0006845749,0.0012336969,0.00038643795,0.00020960082,0.00003015704,0.00018388357,0.00023707139,0.00003802],"category_scores_gemma":[0.00030135553,0.0003265329,0.000101097045,0.000674884,0.00014721965,0.00031441788,0.00018087716,0.000093946415,0.000008923395],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3597594,0.44314027,0.18102281,0.00024612618,0.00081239536,0.0024721113,0.0021066277,4.7750837e-7,0.00032217824,0.000009488846,0.0001360695,0.009972065],"study_design_scores_gemma":[0.5320613,0.096323445,0.3665319,0.00089304836,0.0011583612,0.00007577454,0.00033387737,0.000040901476,0.002048023,0.0000015731742,0.00019645561,0.00033535907],"about_ca_topic_score_codex":0.00032280147,"about_ca_topic_score_gemma":0.0005009292,"teacher_disagreement_score":0.34681684,"about_ca_system_score_codex":0.0006696071,"about_ca_system_score_gemma":0.001007002,"threshold_uncertainty_score":0.9999187},"labels":[],"label_agreement":null},{"id":"W2592306659","doi":"10.1182/blood.v120.21.2341.2341","title":"Short Term Signalling Responses of the Most Primitive Subsets of Human Hematopoietic Cells Stimulated in Vitro Correlate with Their Subsequent Self-Renewal Behaviour.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; Haematopoiesis; CD34; Stem cell; CD38; Immunology; Cell biology; Transplantation; Molecular biology; CD90; Andrology; Internal medicine; Medicine","score_opus":0.030312147554381556,"score_gpt":0.2885456305251492,"score_spread":0.25823348297076765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592306659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977963,0.00038839187,0.000006011972,0.00002387542,0.000039667982,0.0010655095,0.000026721817,0.000027061431,0.00062644953],"genre_scores_gemma":[0.99952024,0.000017894337,0.00014201703,0.0000107982905,0.000028002238,0.000026475069,0.000018001345,0.00004183134,0.00019474921],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99777347,0.00027475975,0.0005250911,0.00024721192,0.0006714821,0.00050800474],"domain_scores_gemma":[0.99868727,0.00028817213,0.00017006068,0.00046385213,0.00020435227,0.00018628663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007559231,0.00022441379,0.0005072346,0.00016747776,0.00006593859,0.000008166433,0.00023131835,0.00014116049,0.0000546896],"category_scores_gemma":[0.000051259412,0.00013864358,0.00010329427,0.00045288407,0.00019623025,0.00005956491,0.00011409556,0.00038986228,0.0000030353383],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045370343,0.0013626539,0.35394967,0.00013153722,0.00010555441,0.00004420197,0.0018535018,0.000012276964,0.6420455,0.000009760406,0.0000017682734,0.00002986104],"study_design_scores_gemma":[0.0017454547,0.0003074523,0.2616536,0.00038791413,0.00023589846,0.00005872606,0.00025547342,0.00003097715,0.7352145,0.0000040209184,0.0000010232815,0.000104990795],"about_ca_topic_score_codex":0.00013398279,"about_ca_topic_score_gemma":0.000023637776,"teacher_disagreement_score":0.093168944,"about_ca_system_score_codex":0.00007666879,"about_ca_system_score_gemma":0.00019871688,"threshold_uncertainty_score":0.5653721},"labels":[],"label_agreement":null},{"id":"W2592332357","doi":"10.1182/blood.v128.22.2248.2248","title":"Radius: A Phase 2, Randomized Trial of Standard of Care (SOC) with or without Midostaurin to Prevent Relapse Following Allogeneic Hematopoietic Stem Cell Transplant (alloHSCT) in Patients (pts) with FLT3-Itd-Mutated Acute Myeloid Leukemia (AML)","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Midostaurin; Medicine; Internal medicine; Oncology; Adverse effect; Maintenance therapy; Clinical endpoint; Phases of clinical research; Randomized controlled trial; Clinical trial; Chemotherapy; Leukemia","score_opus":0.008505898755819464,"score_gpt":0.2653194782138638,"score_spread":0.25681357945804434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592332357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894258,0.000300912,0.0004761506,0.00011647661,0.000089914574,0.008999483,0.00034830734,0.000069483795,0.00017348611],"genre_scores_gemma":[0.99625516,0.00022237282,0.0020608928,0.000039258943,0.000052329488,0.0005408548,0.00008882576,0.0001442324,0.00059609604],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9947092,0.0005713267,0.0014375189,0.0008271972,0.0016250104,0.00082973344],"domain_scores_gemma":[0.99712807,0.00046131547,0.00048877776,0.00088515115,0.000546054,0.000490636],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010231211,0.00061016355,0.0028253326,0.0005471354,0.000062524334,0.000017469341,0.0004095259,0.00025316578,0.000050784125],"category_scores_gemma":[0.00013753952,0.0003274934,0.0003968648,0.0007847642,0.00025167613,0.00015962006,0.00008554992,0.00037784106,0.000006606901],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.949281,0.002816277,0.0049730707,0.00090927206,0.0018487602,0.00075080217,0.009490928,0.000014215227,0.028718168,0.0000040662367,0.00004226807,0.0011512185],"study_design_scores_gemma":[0.6942453,0.017927451,0.000050255738,0.002689356,0.0021936523,0.000039129645,0.00069427706,0.000006717209,0.28176695,0.0000021163498,0.00004703959,0.0003377695],"about_ca_topic_score_codex":0.00012842682,"about_ca_topic_score_gemma":0.00018891667,"teacher_disagreement_score":0.25503567,"about_ca_system_score_codex":0.00089367566,"about_ca_system_score_gemma":0.0025527682,"threshold_uncertainty_score":0.9999177},"labels":[],"label_agreement":null},{"id":"W2592337213","doi":"10.1182/blood-2016-10-741207","title":"Leveraging increased cytoplasmic nucleoside kinase activity to target mtDNA and oxidative phosphorylation in AML","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Occupational Cancer Research Centre; Princess Margaret Cancer Centre; University of Toronto","funders":"National Institute of General Medical Sciences; National Human Genome Research Institute; Canadian Institutes of Health Research","keywords":"Oxidative phosphorylation; Nucleoside; Mitochondrial DNA; Nucleoside analogue; Biology; Kinase; Phosphorylation; Mitochondrion; Gene; Cell biology; Molecular biology; Biochemistry","score_opus":0.02878178271001089,"score_gpt":0.30778799977558374,"score_spread":0.2790062170655728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592337213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99478954,0.00009446121,0.000046553432,0.00075809145,0.000026637608,0.00044984458,0.000019834642,0.000026705999,0.0037883113],"genre_scores_gemma":[0.9983248,0.000041676227,0.0010561836,0.00018076405,0.00007521444,0.00002709898,0.000007613308,0.000021250102,0.0002653982],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989713,0.000044078995,0.00013517273,0.00031817495,0.00023970757,0.0002915879],"domain_scores_gemma":[0.9991682,0.000068234884,0.000066440196,0.00040915943,0.00005540304,0.00023254691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034505228,0.00013220112,0.00026300922,0.0001694442,0.000242845,0.0001049598,0.00010944334,0.000074316806,0.00013475347],"category_scores_gemma":[0.000389741,0.0001264982,0.00003658566,0.000094195166,0.00006699284,0.00020876268,0.00014332849,0.00026083778,0.00007772865],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084191817,0.0006647274,0.4815013,0.00006782743,0.00006147723,0.0004099115,0.0008798115,0.0000022747238,0.5036803,0.00004670515,0.0001506038,0.011693159],"study_design_scores_gemma":[0.003467401,0.00013105973,0.72988296,0.000090439324,0.000026764477,0.000021275097,0.000049894625,0.00023692673,0.26378527,0.00009392941,0.0020948078,0.00011925561],"about_ca_topic_score_codex":0.0037048447,"about_ca_topic_score_gemma":0.00039594658,"teacher_disagreement_score":0.24838166,"about_ca_system_score_codex":0.00006976939,"about_ca_system_score_gemma":0.00009525649,"threshold_uncertainty_score":0.5600642},"labels":[],"label_agreement":null},{"id":"W2592364037","doi":"10.1182/blood.v118.21.4670.4670","title":"Acute Hemolytic Reactions Reported in ITP Patients Treated with Rho (D) Immune Globulin: Symptom Onset and Does Prior Exposure Lessen the Risk?","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Hemolysis; Haptoglobin; Pediatrics; Relative risk; Internal medicine; Confidence interval","score_opus":0.009118756824834357,"score_gpt":0.20911695450157455,"score_spread":0.1999981976767402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592364037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980105,0.00021347342,0.0000034472414,0.00019970411,0.00004514721,0.00069806614,0.000033358334,0.00006522042,0.00073103764],"genre_scores_gemma":[0.99895185,0.00039615628,0.00022067352,0.000049647795,0.000025202133,0.00003987007,0.000053709988,0.00002673864,0.00023616203],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988718,0.000056509427,0.00036132388,0.00030315007,0.00019032304,0.00021687537],"domain_scores_gemma":[0.99915355,0.000046217334,0.00016033869,0.00046116227,0.000087858636,0.000090896814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014770422,0.00018402403,0.00029332735,0.00007588961,0.00014512759,0.000015143426,0.00006587755,0.000110504974,0.000037183614],"category_scores_gemma":[0.00003638118,0.00009259501,0.00005419935,0.00026454273,0.00009181194,0.00007705042,0.00002441341,0.00027816455,0.0000044834587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004985161,0.0016305103,0.99393123,0.00003205637,0.00048918364,0.00025087295,0.0011480872,7.805604e-8,0.0008730482,0.000006466823,0.0000090337435,0.0011308994],"study_design_scores_gemma":[0.009161033,0.0008419339,0.97692156,0.00020216734,0.0018117133,0.00037485393,0.00022700231,0.0000065662784,0.010221598,0.000034975325,0.00006302304,0.00013359364],"about_ca_topic_score_codex":0.0014568055,"about_ca_topic_score_gemma":0.00049594877,"teacher_disagreement_score":0.017009707,"about_ca_system_score_codex":0.000012923909,"about_ca_system_score_gemma":0.000045660578,"threshold_uncertainty_score":0.3775915},"labels":[],"label_agreement":null},{"id":"W2592365743","doi":"10.1182/blood.v106.11.688.688","title":"Uptake of Factor V by Megakaryocytes Requires a Specific Factor V Receptor Linked to a Low-Density Lipoprotein Receptor-Related Protein.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Endocytosis; Biology; Tissue factor; Receptor; Factor V; LDL receptor; Cell biology; Molecular biology; Chemistry; Biochemistry; Internal medicine; Lipoprotein; Coagulation; Cholesterol","score_opus":0.021870873482832513,"score_gpt":0.25186595250457233,"score_spread":0.22999507902173982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592365743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933859,0.00061147026,0.00018854653,0.0020389324,0.00023789774,0.002414753,0.00017416273,0.0003396377,0.000608714],"genre_scores_gemma":[0.984467,0.00006233284,0.011688287,0.00029905356,0.00036980046,0.00010874693,0.00011077932,0.000091438866,0.0028025073],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969601,0.0001055868,0.00097576657,0.00068982795,0.0007414678,0.00052722293],"domain_scores_gemma":[0.9980248,0.00004698405,0.00033168157,0.00077345304,0.0003221018,0.0005009724],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00022469668,0.00043471836,0.0008470414,0.0002405648,0.00011767331,0.000044266646,0.00025484362,0.0004114273,0.0039450875],"category_scores_gemma":[0.00024640237,0.0003961492,0.00026767617,0.0005269411,0.00008308711,0.00020261343,0.00010270135,0.00040052124,0.00081853056],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025527118,0.0017105214,0.0002465421,0.000095949996,0.00027562826,0.0000042085526,0.0007776865,7.2582236e-7,0.9765323,0.0004149276,0.0021080375,0.017578231],"study_design_scores_gemma":[0.004913788,0.0009930972,0.009649372,0.0004910032,0.00010463863,0.000011193509,0.00009648082,0.0000149870175,0.95312667,0.0000740215,0.030110221,0.00041451582],"about_ca_topic_score_codex":0.00007008949,"about_ca_topic_score_gemma":0.00002233417,"teacher_disagreement_score":0.028002184,"about_ca_system_score_codex":0.00009324125,"about_ca_system_score_gemma":0.00012997274,"threshold_uncertainty_score":0.99995947},"labels":[],"label_agreement":null},{"id":"W2592367016","doi":"10.1182/blood.v124.21.2305.2305","title":"CPX-351 Markedly Reduces Renal and Hepatic Clearance Rates for Cytarabine (Cyt) and Daunorubicin (Daun) in Rats with an Associated Decrease in Excretory and Metabolic Burden Despite Providing Dramatic Increases in Systemic Drug Exposure Compared to Conventional Cyt+Daun","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celator Pharmaceuticals (Canada)","funders":"","keywords":"Excretion; Pharmacology; Pharmacodynamics; Pharmacokinetics; Saline; Drug; Medicine; Internal medicine; Chemistry","score_opus":0.010704430733058485,"score_gpt":0.2679464237572189,"score_spread":0.2572419930241604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592367016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948425,0.002578375,0.000054567816,0.00018478892,0.000014406633,0.0022392855,0.000029624309,0.000037202994,0.000019224737],"genre_scores_gemma":[0.99750674,0.0001254821,0.0015758297,0.000116370225,0.00007788491,0.0003951526,0.00008796212,0.00005228756,0.00006228875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99691385,0.0007877968,0.0006812479,0.00064935704,0.00042245278,0.0005452774],"domain_scores_gemma":[0.99792916,0.0010215081,0.00019069365,0.00025212843,0.00015410279,0.00045241113],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021059706,0.00033471937,0.0009459481,0.000555238,0.00009276575,0.000095646414,0.00013871271,0.00012607903,0.000008340219],"category_scores_gemma":[0.001887297,0.0002861286,0.00003155233,0.00053119316,0.00018823579,0.00028619161,0.000091904454,0.0002594283,0.0000012306481],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074920524,0.0012292683,0.88556796,0.0020722477,0.00031321135,0.00027488155,0.0035958553,0.00017889144,0.09758525,0.00008472304,0.00006115115,0.0015445172],"study_design_scores_gemma":[0.04513145,0.0015479634,0.883929,0.0070059462,0.00040843428,0.00039568634,0.0015188403,0.05058825,0.008729002,0.00017223235,0.000015722542,0.0005574604],"about_ca_topic_score_codex":0.0021898716,"about_ca_topic_score_gemma":0.0019018259,"teacher_disagreement_score":0.08885625,"about_ca_system_score_codex":0.00023024279,"about_ca_system_score_gemma":0.00052730524,"threshold_uncertainty_score":0.9999591},"labels":[],"label_agreement":null},{"id":"W2592372550","doi":"10.1182/blood.v128.22.3821.3821","title":"Warfarin Resumption after Intracranial Hemorrhage: A Systematic Review and Meta-Analysis","year":2016,"lang":"en","type":"review","venue":"Blood","topic":"Intracerebral and Subarachnoid Hemorrhage Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; St. Joseph's Hospital; McMaster University","funders":"","keywords":"Medicine; Warfarin; Stroke (engine); Relative risk; Retrospective cohort study; Cohort study; Surgery; Atrial fibrillation; Internal medicine; Confidence interval","score_opus":0.05977610712587624,"score_gpt":0.35229652084673974,"score_spread":0.2925204137208635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592372550","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000066929238,0.9940989,0.000067255685,0.00047376697,0.000022245547,0.004791598,0.00018821679,0.000072169874,0.0002791553],"genre_scores_gemma":[0.000022245747,0.9874393,0.0012262632,0.0003423213,0.0001659753,0.002206998,0.00009998146,0.000076502205,0.008420414],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99563813,0.0006837702,0.0015592403,0.0008401906,0.00073533267,0.00054332585],"domain_scores_gemma":[0.9974673,0.00024740596,0.00048276014,0.0012613817,0.00021719022,0.00032395966],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0015204893,0.00071361853,0.011878402,0.0005597722,0.00008399332,0.00007231993,0.00025997625,0.00047683562,0.0032425325],"category_scores_gemma":[0.0005037042,0.00035276465,0.003990645,0.0008899216,0.000095274634,0.000101341044,0.00016878957,0.0007517493,0.0008382942],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000080395,0.00015979286,6.8479216e-7,0.88020164,0.09401272,0.0010775869,0.0000061741994,8.646675e-10,1.8302828e-7,0.000010478717,0.000021740454,0.024500968],"study_design_scores_gemma":[0.00034941168,0.00007171346,7.47642e-7,0.04632268,0.9485172,0.0021309603,0.0000016987151,0.000009826163,6.666889e-7,0.000008837681,0.002230391,0.0003558446],"about_ca_topic_score_codex":0.000010883986,"about_ca_topic_score_gemma":0.000006057537,"teacher_disagreement_score":0.8545045,"about_ca_system_score_codex":0.00007508196,"about_ca_system_score_gemma":0.00018545814,"threshold_uncertainty_score":0.9999397},"labels":[],"label_agreement":null},{"id":"W2592373261","doi":"10.1182/blood.v104.11.370.370","title":"p120E4F-1: A Novel Candidate Factor for Mediating Bmi-1 Function in Hematopoietic Stem Cells.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Biology; Stem cell; Haematopoiesis; Cell growth; Cell biology; Small interfering RNA; BMI1; Cell culture; Gene knockdown; Endogeny; Immunoprecipitation; Molecular biology; Transfection; Genetics; Endocrinology","score_opus":0.013614765044382129,"score_gpt":0.23647965748644917,"score_spread":0.22286489244206703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592373261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9781833,0.0010080495,0.020155502,0.00004426247,0.00017589236,0.00026850952,0.00005687242,0.0000102571785,0.00009731981],"genre_scores_gemma":[0.9978621,0.00009834688,0.0016179086,0.000042245643,0.00018024114,0.000048386693,0.000064626016,0.000022222825,0.000063899],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992273,0.000012229834,0.00020841775,0.00026021604,0.000089247,0.00020259636],"domain_scores_gemma":[0.99963313,0.00001383353,0.00007991227,0.00017357396,0.000045428165,0.000054135435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000118314936,0.00011464594,0.00011182917,0.000042820546,0.000047654255,0.000019070289,0.00007433873,0.00013055402,0.0000037276955],"category_scores_gemma":[0.000023794799,0.00011427144,0.00006057964,0.000071366914,0.000015262365,0.0000031649424,0.00003104568,0.000052335115,0.0000034095233],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025403628,0.0001604877,0.0016338901,0.00003447433,0.000020680398,6.0486923e-7,0.00012428209,0.00042398766,0.9963778,0.00005526681,0.0000023791747,0.0011407138],"study_design_scores_gemma":[0.0028343285,0.00026220555,0.0022112092,0.000015416283,0.000025327525,0.000001359576,0.000057646605,0.000032848104,0.9929932,0.00023595408,0.0011781876,0.0001523638],"about_ca_topic_score_codex":0.000028769155,"about_ca_topic_score_gemma":0.00012893992,"teacher_disagreement_score":0.019678788,"about_ca_system_score_codex":0.000013662334,"about_ca_system_score_gemma":0.00006597815,"threshold_uncertainty_score":0.4659854},"labels":[],"label_agreement":null},{"id":"W2592403451","doi":"10.1182/blood.v124.21.1337.1337","title":"NR2F6 (EAR-2) Is a Novel Leukemia Oncogene Whose Cellular Function Is to Regulate Terminal Differentiation of Erythrocytes at the Proerythroblast Stage","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Biology; Leukemia; Stem cell; Bone marrow; Progenitor cell; Haematopoiesis; Myeloid; Cancer research; Immunology; Cellular differentiation; Myeloid leukemia; Cell biology; Genetics; Gene","score_opus":0.016123039467541293,"score_gpt":0.2550693821930926,"score_spread":0.23894634272555132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592403451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99313104,0.00013577213,0.0031751338,0.001711911,0.00008521635,0.0009531356,0.000055511675,0.000057335827,0.0006949593],"genre_scores_gemma":[0.97954583,0.00003329112,0.00067134155,0.00096841407,0.0004062102,0.00006856659,0.0000730444,0.000062552775,0.018170733],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976672,0.000080789505,0.00045794673,0.00051900436,0.0008092888,0.00046575602],"domain_scores_gemma":[0.9983803,0.000107746775,0.00021346279,0.00079853,0.0002785313,0.00022143484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044118703,0.0002730878,0.0004254627,0.0001800912,0.00019248463,0.000037393827,0.00021284021,0.00017970538,0.00068056997],"category_scores_gemma":[0.00014294984,0.00019489563,0.00013351404,0.00039774712,0.00014917654,0.00010321137,0.0002830185,0.0002991478,0.00021438158],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006485624,0.0004094678,0.004955738,0.00027574805,0.0002462495,0.000008650644,0.0010629109,0.000019621732,0.9842613,0.000040738007,0.004515102,0.003555911],"study_design_scores_gemma":[0.005872451,0.0018507718,0.045959607,0.00020861694,0.00050533,0.000055699704,0.00015697743,0.0028021692,0.92598367,0.000029824761,0.016332204,0.00024267824],"about_ca_topic_score_codex":0.00019446493,"about_ca_topic_score_gemma":0.000060864983,"teacher_disagreement_score":0.05827763,"about_ca_system_score_codex":0.00045058626,"about_ca_system_score_gemma":0.0003019402,"threshold_uncertainty_score":0.79476136},"labels":[],"label_agreement":null},{"id":"W2592462257","doi":"10.1182/blood.v120.21.1641.1641","title":"Final Results of the BP22333 Study Demonstrate Non-Inferior Pharmacokinetics (PK) and Safety of Subcutaneous (SC) Administration of Rituximab Compared with Intravenous (IV) Administration As Maintenance Therapy in Patients with Follicular Lymphoma (FL)","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital de l'Enfant-Jésus","funders":"","keywords":"Rituximab; Medicine; Tolerability; Dosing; Pharmacokinetics; CD20; Internal medicine; Follicular lymphoma; Confidence interval; Oncology; Adverse effect; Gastroenterology; Urology; Surgery; Lymphoma","score_opus":0.011247776682651513,"score_gpt":0.24537154497197097,"score_spread":0.23412376828931947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592462257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976796,0.0001284033,0.000005609518,0.00006742882,0.00002747055,0.0017665835,0.00009328111,0.0000068526665,0.00022475427],"genre_scores_gemma":[0.9994431,0.000082883555,0.00032485317,0.000020692825,0.000017880755,0.000040877905,0.000044357366,0.000016326067,0.00000900416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984912,0.00007974576,0.000582896,0.00021980076,0.00040913615,0.000217189],"domain_scores_gemma":[0.99886715,0.00006853249,0.00045512913,0.00030816914,0.00021409866,0.00008693009],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016191888,0.00021304116,0.000489211,0.000056845784,0.000042805947,0.000008140887,0.00008075735,0.00005655895,0.0000041128183],"category_scores_gemma":[0.000021897627,0.00012588833,0.00004814475,0.00021814948,0.00014907576,0.0000656,0.000018095932,0.000054947614,4.3131632e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028603874,0.033733428,0.93047357,0.000076176875,0.000424146,0.000110469926,0.0013337521,0.000008608122,0.00086849934,0.000024091669,0.0000033151207,0.004340092],"study_design_scores_gemma":[0.06906729,0.016283128,0.8434046,0.0002635367,0.0004528842,0.00019877013,0.0002610794,0.000019738678,0.06992509,0.0000034486204,0.000009723491,0.00011072928],"about_ca_topic_score_codex":0.0001411896,"about_ca_topic_score_gemma":0.00015199448,"teacher_disagreement_score":0.08706897,"about_ca_system_score_codex":0.000045500346,"about_ca_system_score_gemma":0.00031033473,"threshold_uncertainty_score":0.5133577},"labels":[],"label_agreement":null},{"id":"W2592546469","doi":"10.1182/blood.v120.21.3324.3324","title":"A Retrospective Single-Centre Cohort Study Comparing Lower-Dose Intravenous Immune Globulin (IVIg) (1 g/kg) to Higher-Dose Ivig (2 g/kg) in Adult Immune Thrombocytopenia","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Medicine; Dosing; Immune thrombocytopenia; Platelet; Retrospective cohort study; Internal medicine; Cohort; Pediatrics; Guideline; Antibody; Immunology","score_opus":0.017782738501803456,"score_gpt":0.25937513288768077,"score_spread":0.24159239438587732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592546469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98817086,0.001424962,0.00000530363,0.000333248,0.00065267575,0.003833451,0.000027964448,0.00017213795,0.005379387],"genre_scores_gemma":[0.9980849,0.000054261036,0.0004141359,0.00018171275,0.00021511002,0.00014715081,0.00008813072,0.000102815335,0.00071177306],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99626034,0.00014703216,0.00089222676,0.00079153344,0.0006819466,0.0012269235],"domain_scores_gemma":[0.9980991,0.00005973401,0.00023854173,0.00093529787,0.00020631654,0.00046104833],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042361897,0.0006222157,0.0018178482,0.0002463299,0.00018603279,0.00007741062,0.00031099105,0.00020469839,0.00029352837],"category_scores_gemma":[0.00014654588,0.00057189603,0.00020799132,0.00078595796,0.00007731646,0.00026531797,0.0002843982,0.00054589217,0.00052030664],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009385672,0.040438976,0.9438976,0.000049104772,0.0012025272,0.001648568,0.0036789898,0.0000048526103,0.007112921,0.00007218195,0.000096305324,0.00085940387],"study_design_scores_gemma":[0.022957468,0.0023389345,0.9691456,0.0003322743,0.0009597098,0.00014867118,0.00092315674,0.000014093543,0.0024362088,0.00003418693,0.0001780466,0.000531643],"about_ca_topic_score_codex":0.0019949765,"about_ca_topic_score_gemma":0.0008673684,"teacher_disagreement_score":0.03810004,"about_ca_system_score_codex":0.0005666382,"about_ca_system_score_gemma":0.000098405144,"threshold_uncertainty_score":0.99967325},"labels":[],"label_agreement":null},{"id":"W2592554342","doi":"10.1182/blood.v106.11.2242.2242","title":"The Worcester Venous Thromboembolism Study: A Population Based Perspective of Venous Thromboembolism Attack Rates.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Medicine; Pulmonary embolism; Population; Deep vein; Venous thromboembolism; Venous thrombosis; Census; Thrombosis; Medical record; Demography; Emergency medicine; Surgery; Environmental health","score_opus":0.021074211163972796,"score_gpt":0.31162486336611944,"score_spread":0.29055065220214665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592554342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98636496,0.0020103035,0.000029152925,0.0024072013,0.00032172247,0.0023804032,0.0000142270765,0.00014635481,0.006325675],"genre_scores_gemma":[0.99721074,0.00019768454,0.00041838957,0.0010346737,0.00065625063,0.00016643795,0.000028176446,0.00008783094,0.0001998426],"study_design_codex":"nonrandomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9970621,0.00018518986,0.0007208013,0.0006147227,0.00077484763,0.0006423467],"domain_scores_gemma":[0.99784356,0.0001971077,0.00036373883,0.0010627264,0.00035257885,0.00018029772],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00060417684,0.00040956942,0.0012966141,0.00020216369,0.0004436169,0.00008999029,0.00036278466,0.00014471148,0.00015304687],"category_scores_gemma":[0.00013945857,0.00030495168,0.00028411305,0.0004498667,0.00014438557,0.00017807065,0.00013874656,0.0003393631,0.00009731409],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017574329,0.41025412,0.30771053,0.0016226971,0.021118876,0.00079881813,0.098070584,0.005408688,0.0076458873,0.038500212,0.025719438,0.08139272],"study_design_scores_gemma":[0.006331907,0.0026460725,0.97775906,0.0001820879,0.002372865,0.000026300215,0.0039608455,0.00023508414,0.0015441097,0.00039711274,0.004140416,0.00040411417],"about_ca_topic_score_codex":0.0010320225,"about_ca_topic_score_gemma":0.00054451596,"teacher_disagreement_score":0.67004853,"about_ca_system_score_codex":0.00020479955,"about_ca_system_score_gemma":0.00017461239,"threshold_uncertainty_score":0.9999403},"labels":[],"label_agreement":null},{"id":"W2592573887","doi":"10.1182/blood.v118.21.3365.3365","title":"Can Heparin-Based Therapy in Children Be Monitored on Samples Drawn Through Ports? An Analysis From Clinical Trials Data,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Venipuncture; Heparin; Medicine; Phlebotomy; Thrombosis; Anticoagulant; Serial dilution; Internal medicine; Surgery; Pathology","score_opus":0.2707128743817153,"score_gpt":0.4197765040926562,"score_spread":0.1490636297109409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592573887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970207,0.0003178468,0.0000599058,0.0005196494,0.00014022978,0.0009770767,0.000458708,0.00007697219,0.00042889293],"genre_scores_gemma":[0.9901502,0.00078759977,0.0029232488,0.0025556257,0.00053235237,0.000059189184,0.0029452026,0.00003576419,0.000010833559],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99685174,0.0005886983,0.0010471077,0.0008168328,0.0003744965,0.00032114395],"domain_scores_gemma":[0.9972534,0.0003412691,0.00033205273,0.0018436626,0.000041004972,0.00018858568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00201383,0.00025889793,0.001579767,0.00021046695,0.00008404133,0.000053014544,0.00043115078,0.00016517803,0.0005497892],"category_scores_gemma":[0.00034415073,0.00020170554,0.0003247521,0.0003549728,0.00010335227,0.00009678463,0.00008266361,0.00022179761,0.000010212243],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026183273,0.011354405,0.97610635,0.0000038792878,0.0037559655,0.000046226352,0.00059943885,0.000011726512,0.000028454557,0.00012566651,0.000746657,0.00695938],"study_design_scores_gemma":[0.0075806356,0.0010647622,0.9843149,0.00003492643,0.0043733744,6.097222e-7,0.00013513307,0.00008370915,0.0013006884,0.00027390232,0.00062308507,0.00021425358],"about_ca_topic_score_codex":0.047941368,"about_ca_topic_score_gemma":0.0035627484,"teacher_disagreement_score":0.04437862,"about_ca_system_score_codex":0.00002299877,"about_ca_system_score_gemma":0.00015475712,"threshold_uncertainty_score":0.95839846},"labels":[],"label_agreement":null},{"id":"W2592583156","doi":"10.1182/blood.v126.23.1600.1600","title":"Circulating Cytokines and Markers of Iron Metabolism in Myelofibrosis Patients Treated with Momelotininb: Correlatives from the Ym-387-II Study","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Myelofibrosis; Internal medicine; Anemia; Gastroenterology; Thrombocytosis; Cytokine; Wilcoxon signed-rank test; Bone marrow; Proinflammatory cytokine; Ruxolitinib; Immunology; Mann–Whitney U test; Platelet; Inflammation","score_opus":0.01807539859597501,"score_gpt":0.23955891928596687,"score_spread":0.22148352068999186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592583156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99768007,0.0005328845,0.0000011794598,0.00012551314,0.000029140994,0.0010896099,0.000044231663,0.000020508047,0.00047688896],"genre_scores_gemma":[0.9993357,0.000028085211,0.0003419757,0.000038024897,0.000036209163,0.000110065164,0.000050595572,0.00002288233,0.000036480305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986975,0.00015533996,0.000320907,0.00031770047,0.00033285958,0.00017568831],"domain_scores_gemma":[0.999092,0.00025489458,0.00016936105,0.00023223447,0.00014533327,0.000106182015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016046896,0.0002209912,0.00048889976,0.00007083666,0.000079434154,0.000015041422,0.000055743112,0.000051867803,0.000016519904],"category_scores_gemma":[0.00016694036,0.00012161847,0.000036906516,0.00025488157,0.00008258097,0.00008040853,0.000064664186,0.000107405525,0.0000016629947],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054095645,0.003155978,0.9882322,0.000010137359,0.00040228554,0.000027579968,0.00653994,0.00001089567,0.00011304117,0.000010492959,0.000024023471,0.0009325026],"study_design_scores_gemma":[0.01729437,0.0028688272,0.97444516,0.00016041908,0.0007683553,0.0000051614074,0.0028357843,0.000047235153,0.0014250763,0.000012484882,0.000019117837,0.00011798494],"about_ca_topic_score_codex":0.0010836469,"about_ca_topic_score_gemma":0.00023568668,"teacher_disagreement_score":0.016753413,"about_ca_system_score_codex":0.000023532442,"about_ca_system_score_gemma":0.00004938252,"threshold_uncertainty_score":0.49594572},"labels":[],"label_agreement":null},{"id":"W2592595418","doi":"10.1182/blood.v106.11.1876.1876","title":"Biochemical and Pharmacologic Profiling of a Novel Dual Acting Antithrombin Agent with Antiprotease and Antiplatelet Actions. Hematologic Implications.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Medicure (Canada)","funders":"","keywords":"Antithrombotic; Pharmacology; Antithrombin; Argatroban; Platelet; Chemistry; Anticoagulant; Thrombin; Medicine; Heparin; Immunology; Biochemistry; Internal medicine","score_opus":0.05432742738575021,"score_gpt":0.3155505527129445,"score_spread":0.2612231253271943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592595418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99697655,0.00030054516,0.00085684354,0.00096497784,0.000016917298,0.00057008676,0.000010839638,0.00007635713,0.00022685442],"genre_scores_gemma":[0.9661126,0.000103247075,0.033470847,0.0001978546,0.000046054618,0.000030280493,0.000014490726,0.000014684805,0.000009909302],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99912626,0.000017577964,0.00024983953,0.00029728084,0.00012862339,0.00018039522],"domain_scores_gemma":[0.99945253,0.000042973155,0.0001490607,0.00015230844,0.00007940848,0.00012372377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001331734,0.00014592963,0.0003090433,0.00009440096,0.000102184495,0.00001604732,0.00003379102,0.000094472336,0.000024082105],"category_scores_gemma":[0.000043012893,0.000114969436,0.000031275784,0.00018846968,0.000111446934,0.000092174974,0.00003736582,0.00015027997,0.0000017928622],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006242326,0.001309681,0.018645924,0.00012596618,0.00012966178,0.0000073097035,0.000065781285,0.0000016413634,0.97771865,0.00118147,0.000014340106,0.00073716155],"study_design_scores_gemma":[0.006085446,0.00028513608,0.01830103,0.00009442048,0.00040655542,0.0011180872,0.0001426156,0.00040582375,0.9729418,0.00003206415,0.00004919251,0.00013779265],"about_ca_topic_score_codex":0.0000048159027,"about_ca_topic_score_gemma":8.202191e-7,"teacher_disagreement_score":0.032614004,"about_ca_system_score_codex":0.000009412857,"about_ca_system_score_gemma":0.00004675804,"threshold_uncertainty_score":0.46883178},"labels":[],"label_agreement":null},{"id":"W2592656165","doi":"10.1182/blood.v114.22.4688.4688","title":"Diagnostic Cytogenetic Analysis in Pediatric Acute Myeloid Leukemia (AML): Evaluation of Methodological Issues with a Special Focus On Missing Data.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Oncology; Cytogenetics; Internal medicine; Myeloid leukemia; Clinical trial; Risk stratification; Pediatrics; Biology","score_opus":0.1146270348921136,"score_gpt":0.40265905793702234,"score_spread":0.2880320230449087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592656165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99391985,0.0012385097,0.00049707224,0.0015159731,0.000025526591,0.0008126551,0.000031286014,0.00003276076,0.001926383],"genre_scores_gemma":[0.9808746,0.00085455173,0.016744616,0.00009487066,0.0011573886,0.000022239094,0.00017669746,0.000020723945,0.00005434531],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960667,0.0007955243,0.00052045565,0.0006999275,0.0014804008,0.00043699986],"domain_scores_gemma":[0.99711245,0.0012304614,0.0001861558,0.0010175101,0.00027356675,0.00017986896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025870332,0.0002477224,0.0007965719,0.0009026455,0.000052774532,0.000027069915,0.00038877083,0.00018320656,0.00021123135],"category_scores_gemma":[0.0039104647,0.00018507295,0.00011204461,0.0023617987,0.00008332357,0.00009859076,0.00010028887,0.0004331654,0.00002247033],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048755305,0.0053218924,0.7058286,0.00024033623,0.00470917,0.0032555894,0.0016445273,0.004252487,0.03053658,0.00020520609,0.002462903,0.2366672],"study_design_scores_gemma":[0.009825421,0.0022767703,0.9471018,0.00008950402,0.017830903,0.00011427055,0.00006681836,0.0045356653,0.017150912,0.0006716498,0.000051181454,0.00028515168],"about_ca_topic_score_codex":0.000114364026,"about_ca_topic_score_gemma":0.00010593455,"teacher_disagreement_score":0.24127316,"about_ca_system_score_codex":0.00037494733,"about_ca_system_score_gemma":0.00094907795,"threshold_uncertainty_score":0.75470555},"labels":[],"label_agreement":null},{"id":"W2592678340","doi":"10.1182/blood.v120.21.1478.1478","title":"Effectiveness of Supportive Care Measurements to Reduce Infections During Induction for Children with Acute Myeloid Leukemia: A Report From the Children's Oncology Group","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Gemtuzumab ozogamicin; Medicine; Induction chemotherapy; Cytarabine; Febrile neutropenia; Neutropenia; Internal medicine; Etoposide; Daunorubicin; Chemotherapy regimen; Randomized controlled trial; Intensive care; Chemotherapy; Intensive care medicine","score_opus":0.01770065370938092,"score_gpt":0.29244983120220525,"score_spread":0.27474917749282435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592678340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99623066,0.00014324176,0.00031272348,0.00007935289,0.00033277483,0.0024096828,0.000086662054,0.000058494687,0.00034640348],"genre_scores_gemma":[0.99788135,0.000013399389,0.00028709325,0.000034649307,0.0005947032,0.000887283,0.00024537736,0.000034514527,0.000021644202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988171,0.00011076061,0.0002602303,0.0003048815,0.00022086255,0.0002861574],"domain_scores_gemma":[0.99896866,0.000073364725,0.00019269803,0.00036855857,0.0002567204,0.00013998551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000271331,0.00017286534,0.00033681045,0.00008472954,0.00024056305,0.000009561271,0.00007439506,0.00011244839,0.000014792099],"category_scores_gemma":[0.000075294796,0.00012158519,0.00011680226,0.0002964846,0.00006417963,0.00014479712,0.000043769767,0.00023116633,0.0000043193077],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055657653,0.00063755957,0.8688927,0.000039664897,0.0017801725,0.0000055513483,0.0007398143,0.000012145179,0.12671745,0.0000128605525,0.00006314343,0.00054232974],"study_design_scores_gemma":[0.0037032661,0.0009785538,0.7399527,0.00010271627,0.0018716408,0.0013330672,0.0001382386,1.4678865e-8,0.25174412,0.0000060133393,0.00006860524,0.000101102916],"about_ca_topic_score_codex":0.0011228265,"about_ca_topic_score_gemma":0.00017160347,"teacher_disagreement_score":0.12894008,"about_ca_system_score_codex":0.0003839853,"about_ca_system_score_gemma":0.0003155614,"threshold_uncertainty_score":0.49581},"labels":[],"label_agreement":null},{"id":"W2592679594","doi":"10.1182/blood.v108.11.3338.3338","title":"The Use of Erythropoietic Agents in Patients with Non-Myeloid Hematological Malignancies.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; McMaster University; Cancer Care Ontario; Queen's University; McMaster University Medical Centre; Ontario Institute for Cancer Research; Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Guideline; Randomized controlled trial; MEDLINE; Cochrane Library; Hematocrit; Clinical trial; Intensive care medicine; Internal medicine","score_opus":0.01923726513339219,"score_gpt":0.23273003537803413,"score_spread":0.21349277024464194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592679594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99831223,0.00013069528,0.0000060856,0.00040924447,0.00003222094,0.00038974857,0.0000054703014,0.000018042514,0.00069626956],"genre_scores_gemma":[0.9979696,0.000042374053,0.0013265279,0.00008285278,0.000020760952,0.00002000736,0.00002475215,0.000014023292,0.0004990469],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99902326,0.00002300421,0.00026339284,0.00017818986,0.00027365252,0.00023850097],"domain_scores_gemma":[0.99945885,0.00007166905,0.000084999265,0.00026800283,0.00006947741,0.00004703096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000493917,0.00013273375,0.00024998657,0.00003479756,0.00005855605,0.00001215382,0.000059089147,0.00006347415,0.000036117144],"category_scores_gemma":[0.00002980977,0.0000688817,0.000055752345,0.00015429217,0.00019041107,0.000032456344,0.0000304284,0.00009101401,0.000015420374],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011702794,0.0029122694,0.9949947,0.000044263048,0.0000397986,0.0000915635,0.00004177319,0.000004614134,0.00011140435,0.000116476585,0.0013250677,0.00020104475],"study_design_scores_gemma":[0.00797491,0.00072805386,0.9852483,0.00020234307,0.00011601782,0.000025229458,0.00004429412,0.0000061147607,0.0042659766,0.000034008946,0.0012616934,0.00009304409],"about_ca_topic_score_codex":0.0001301686,"about_ca_topic_score_gemma":0.000041648585,"teacher_disagreement_score":0.009746383,"about_ca_system_score_codex":0.000025024521,"about_ca_system_score_gemma":0.000037438895,"threshold_uncertainty_score":0.28089142},"labels":[],"label_agreement":null},{"id":"W2592688761","doi":"10.1182/blood.v128.22.5838.5838","title":"Outcome Following Second Allogeneic Hematopoietic Cell Transplantation: A Single Centre Experience","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Transplantation; Surgery; Internal medicine; Hematopoietic stem cell transplantation; Regimen; Gastroenterology; Median follow-up; Aplastic anemia; Hematopoietic cell; Bone marrow; Stem cell; Haematopoiesis; Chemotherapy","score_opus":0.021795657079270205,"score_gpt":0.25793569257117516,"score_spread":0.23614003549190496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592688761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98889977,0.00021227245,0.0021684421,0.00037410518,0.00022069001,0.00038585984,0.000021651284,0.0001385547,0.0075786794],"genre_scores_gemma":[0.994589,0.000025102046,0.0019825874,0.00023793391,0.00007209337,0.000028922257,0.000016983353,0.000040027502,0.0030073647],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983606,0.000043082462,0.00046731293,0.00039144955,0.0003629971,0.0003745943],"domain_scores_gemma":[0.99918693,0.00015205574,0.00007625976,0.00033572144,0.00004114268,0.00020787658],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011527909,0.00021717174,0.0003340411,0.00008516512,0.000070054186,0.000019216184,0.00011419571,0.00011815348,0.0010936253],"category_scores_gemma":[0.000019334302,0.00015696375,0.000196408,0.00014898619,0.00004633855,0.00012816749,0.00000916697,0.000074204116,0.00027400252],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004733846,0.00055403495,0.313159,0.0006231952,0.00006271494,0.0008279144,0.004576547,1.9794001e-7,0.67980176,0.000061870014,0.00003120916,0.0002542132],"study_design_scores_gemma":[0.0082242405,0.00015147754,0.024290245,0.00052219594,0.0005369034,0.00071689935,0.00060240744,8.675891e-7,0.96390194,0.00004786034,0.00068574346,0.00031924248],"about_ca_topic_score_codex":0.0000028712923,"about_ca_topic_score_gemma":0.0000128957545,"teacher_disagreement_score":0.28886873,"about_ca_system_score_codex":0.000033566434,"about_ca_system_score_gemma":0.00004819669,"threshold_uncertainty_score":0.9998195},"labels":[],"label_agreement":null},{"id":"W2592691487","doi":"10.1182/blood.v104.11.2573.2573","title":"Forced Overexpression of Ahi-1 Confers a Proliferative Advantage on Primitive Murine Hematopoietic Cells and Enhances the Effects of BCR-ABL.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; Haematopoiesis; Cancer research; Bone marrow; CD34; Transduction (biophysics); breakpoint cluster region; Stem cell; Myeloid; Molecular biology; Virology; Immunology; Cell biology; Gene; Genetics","score_opus":0.005244031291528187,"score_gpt":0.24380019077078874,"score_spread":0.23855615947926057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592691487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962907,0.00041251583,0.000022915205,0.000069352034,0.000037646696,0.0013720524,0.000015114958,0.00001735496,0.0017623699],"genre_scores_gemma":[0.9990733,0.00020836211,0.0003250378,0.000080489124,0.000030097719,0.00006736341,0.000007974714,0.000017184257,0.00019017296],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99905413,0.000046708818,0.0002344139,0.00022939565,0.0002625341,0.0001727956],"domain_scores_gemma":[0.99912035,0.00030521932,0.00018421437,0.00026536317,0.000055809847,0.00006905074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000065968015,0.0001762834,0.0003867568,0.000048379134,0.000041568932,0.0000041555186,0.000062176594,0.000066305896,0.00001864989],"category_scores_gemma":[0.000116990996,0.00010581973,0.00006865942,0.00007686972,0.00016843055,0.00004505406,0.000045565175,0.00012318093,0.000003355818],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037933845,0.0010455672,0.00051603804,0.0010889113,0.0002531235,0.00003890903,0.0029158269,0.000005545819,0.99283373,0.0007313864,0.00001638902,0.00017524564],"study_design_scores_gemma":[0.01558051,0.0024046986,0.002632285,0.0024221314,0.00029929122,0.00003305498,0.00038637358,0.0000054794546,0.9759778,0.00016015074,0.00001531319,0.00008295682],"about_ca_topic_score_codex":0.000031225503,"about_ca_topic_score_gemma":0.0000028241634,"teacher_disagreement_score":0.016855964,"about_ca_system_score_codex":0.00007511748,"about_ca_system_score_gemma":0.00018517666,"threshold_uncertainty_score":0.43152034},"labels":[],"label_agreement":null},{"id":"W2592695527","doi":"10.1182/blood.v110.11.428.428","title":"Neuropsychological (NP) Dysfunction and Neuroimaging Abnormalities in Neurologically Intact Adult Patients with Sickle Cell Disease (SCD).","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Rainbow Health Ontario","funders":"","keywords":"Wechsler Adult Intelligence Scale; Population; Neuropsychology; Pediatrics; Asymptomatic; Medicine; Psychology; Executive dysfunction; Internal medicine; Psychiatry; Cognition","score_opus":0.0040358855971433846,"score_gpt":0.20095104389754026,"score_spread":0.19691515830039688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592695527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99454665,0.00016949514,0.0000466709,0.00069484505,0.00009629083,0.00033617302,0.0000041388557,0.00008796773,0.00401776],"genre_scores_gemma":[0.99616075,0.000118049116,0.000091197275,0.0034761194,0.000039451596,0.0000056507693,0.000020173118,0.000020964508,0.00006766353],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987532,0.00005627759,0.0002550354,0.00036080636,0.00021987033,0.0003548311],"domain_scores_gemma":[0.99937,0.000062078994,0.00006224028,0.00018243137,0.00007030969,0.0002529705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001257059,0.00017937679,0.00019301496,0.000111477304,0.00006722,0.000021850889,0.000053291627,0.00008624017,0.0000299739],"category_scores_gemma":[0.00010325722,0.00012062037,0.000039054426,0.00019267196,0.00011741646,0.00009065795,0.00004038568,0.00040479586,0.000010472781],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001736266,0.0017004254,0.9932065,0.00005766506,0.000009699189,0.00089703215,0.00011459135,0.00000950348,0.0002992015,0.00003433266,0.000051401796,0.0018833952],"study_design_scores_gemma":[0.007448383,0.0013827696,0.99029654,0.00003032133,0.00010255737,0.0000530619,0.00009427711,0.000038429756,0.000054075073,0.000039406583,0.0003164777,0.00014366898],"about_ca_topic_score_codex":0.000026042995,"about_ca_topic_score_gemma":0.0000067323926,"teacher_disagreement_score":0.005712117,"about_ca_system_score_codex":0.0000077731975,"about_ca_system_score_gemma":0.000020102401,"threshold_uncertainty_score":0.4918756},"labels":[],"label_agreement":null},{"id":"W2592713142","doi":"10.1182/blood.v116.21.5116.5116","title":"A Randomized, Controlled Trial of Varying D-Dimer Cutpoints According to Clinical Pretest Probability Compared with a Uniform D-Dimer Cutpoint for Diagnosis of Deep Vein Thrombosis","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hamilton Health Sciences; Hamilton General Hospital; University of Calgary; Jewish General Hospital; McMaster University","funders":"","keywords":"D-dimer; Medicine; Deep vein; Pre- and post-test probability; Randomized controlled trial; Internal medicine; Clinical trial; Thrombosis; Surgery; Nuclear medicine","score_opus":0.03757810014776154,"score_gpt":0.329721641372838,"score_spread":0.29214354122507646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592713142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9737547,0.00008070527,0.0007473122,0.0006153423,0.00056813715,0.022710755,0.000023324797,0.0000639299,0.001435783],"genre_scores_gemma":[0.97581965,0.000084696636,0.017271798,0.00026521,0.000308452,0.0061542876,0.000020866932,0.000057721,0.00001731463],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99591553,0.00026295194,0.0021238753,0.00063949585,0.00056879973,0.0004893277],"domain_scores_gemma":[0.99427086,0.0030605847,0.000923286,0.0008571643,0.00058604986,0.00030207192],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0038623048,0.00039137376,0.0048205364,0.00022591093,0.000096934746,0.000028213752,0.00028324965,0.000206223,0.00012982867],"category_scores_gemma":[0.003596686,0.00026618983,0.00110133,0.00031646714,0.0003364453,0.000114331946,0.00015478989,0.00033550203,0.0000060756533],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9233278,0.020191196,0.045621037,0.0007029971,0.0054097516,0.000003962704,0.0008003225,0.000049884045,0.0014131828,0.0009127024,0.00020740354,0.0013597423],"study_design_scores_gemma":[0.9731861,0.004006472,0.0050598187,0.00044345544,0.007644169,0.000004005264,0.00015660991,0.00049276336,0.008234866,0.00039027774,0.00008232095,0.00029917003],"about_ca_topic_score_codex":0.00021985355,"about_ca_topic_score_gemma":0.00015333464,"teacher_disagreement_score":0.049858253,"about_ca_system_score_codex":0.000026232594,"about_ca_system_score_gemma":0.00016653881,"threshold_uncertainty_score":0.999979},"labels":[],"label_agreement":null},{"id":"W2592731744","doi":"10.1182/blood.v106.11.3713.3713","title":"Relationships of Serum Ferritin, Transferrin Saturation, and HFE Mutations and Self-Reported Diabetes Mellitus in the Hemochromatosis and Iron Overload Screening (HEIRS) Study.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Diabetes mellitus; Medicine; Transferrin saturation; Internal medicine; Hemochromatosis; Hereditary hemochromatosis; Type 2 Diabetes Mellitus; Ferritin; Endocrinology; Gastroenterology; Serum ferritin","score_opus":0.016264527044566424,"score_gpt":0.24571581893063196,"score_spread":0.22945129188606553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592731744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926197,0.005481121,0.000021194837,0.0010029131,0.000009022285,0.0005713011,0.000013813968,0.000028342834,0.0002526001],"genre_scores_gemma":[0.9981395,0.00040703328,0.0012544777,0.00010507994,0.000029595849,0.00002405239,0.000017244627,0.000010775064,0.000012228921],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99902344,0.00013126592,0.0003250961,0.00019974814,0.00017998651,0.00014048128],"domain_scores_gemma":[0.9995262,0.00016008307,0.000060474627,0.00015443997,0.000038471593,0.0000603164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040952573,0.000118578624,0.00021518144,0.00011010831,0.00014211256,0.000027117176,0.000031398467,0.000065184955,0.000009665838],"category_scores_gemma":[0.00011476154,0.00009294461,0.00002097263,0.0001923282,0.00007407519,0.00014906401,0.000012278061,0.00015745027,3.8462198e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001671951,0.0008711326,0.98309296,0.00011225175,0.00006657625,0.000006439931,0.010349952,0.000010761672,0.0009002388,0.00028138814,0.000013643324,0.004277953],"study_design_scores_gemma":[0.004426482,0.00012496107,0.98745126,0.000041224364,0.0006564756,0.000034663823,0.006104831,0.00016477544,0.0007755497,0.00007416886,0.00005159572,0.000093994684],"about_ca_topic_score_codex":0.000064510146,"about_ca_topic_score_gemma":0.00034550228,"teacher_disagreement_score":0.005519822,"about_ca_system_score_codex":0.0000034128295,"about_ca_system_score_gemma":0.000023481729,"threshold_uncertainty_score":0.3790171},"labels":[],"label_agreement":null},{"id":"W2592733586","doi":"10.1182/blood.v108.11.3183.3183","title":"Ectopic Expression of Mutated HOXB4 Proteins with Increased Intracellular Stability Affects Both Long and Short Term Hematopoietic Reconstitution.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Haematopoiesis; Transplantation; Cancer research; Biology; Progenitor cell; In vivo; Ectopic expression; Stem cell; Molecular biology; Cell culture; Medicine; Internal medicine; Cell biology; Genetics","score_opus":0.006338730457111111,"score_gpt":0.1965991348706748,"score_spread":0.19026040441356368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592733586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902063,0.008366449,0.0004157019,0.000015150317,0.00005510974,0.0006323285,0.00001373504,0.00006405517,0.00023119638],"genre_scores_gemma":[0.99949676,0.00005241149,0.00019320409,0.0000069893886,0.000010339732,0.0000462954,0.000061614635,0.000013647078,0.00011874052],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99888587,0.00029971456,0.00026223672,0.00026562857,0.00004053754,0.00024603785],"domain_scores_gemma":[0.99939406,0.00011853034,0.000104418315,0.0003256997,0.00004251521,0.000014804021],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023298005,0.00018650947,0.00032083513,0.00008035691,0.00015746037,0.000013696406,0.0001055425,0.00018181327,0.00016862358],"category_scores_gemma":[0.000033672743,0.00014116833,0.000049050992,0.00010760286,0.0004973721,0.00010197386,0.000036362595,0.00017699401,0.000005910824],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005510692,0.00069239945,0.07309075,0.000101053105,0.00008486188,0.000018805104,0.00013747757,7.607438e-7,0.9248895,0.00007059354,0.000009108768,0.00035359504],"study_design_scores_gemma":[0.0027199958,0.0003992009,0.11682338,0.00019873792,0.000072466995,0.0002512992,0.000050711984,4.1750192e-7,0.8792049,0.000030049778,0.00009358347,0.00015525367],"about_ca_topic_score_codex":0.00019758094,"about_ca_topic_score_gemma":0.000033178243,"teacher_disagreement_score":0.04568463,"about_ca_system_score_codex":0.000013989298,"about_ca_system_score_gemma":0.000097962475,"threshold_uncertainty_score":0.5756678},"labels":[],"label_agreement":null},{"id":"W2592759934","doi":"10.1182/blood.v104.11.1975.1975","title":"The Oncogenic Potential of the Homeobox Gene Cdx2 Is Depending on the MAPK Pathway and Can Be Antagonized by the MEK1/2 Inhibitor PD98059 in a Mouse Model of t(12;13)(p13;q12) Positive AML.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"CDX2; Ectopic expression; Biology; Homeobox; Progenitor cell; Cancer research; Molecular biology; Mutant; Fusion gene; Cell biology; Gene expression; Stem cell; Gene; Genetics","score_opus":0.00801813846626139,"score_gpt":0.20276551594551678,"score_spread":0.19474737747925538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592759934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966703,0.0009719173,0.000056377732,0.0013819305,0.00005494156,0.00034157082,0.00040228074,0.0000030606484,0.00011759911],"genre_scores_gemma":[0.9981131,0.00072850066,0.000025374651,0.0006969339,0.000063781,0.000026126521,0.000021091777,0.000018641695,0.0003064531],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988771,0.00010935597,0.00027914598,0.00027104208,0.00021128311,0.0002520834],"domain_scores_gemma":[0.9992156,0.000035332323,0.00016512403,0.0004770343,0.00007119489,0.000035701836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024752255,0.00017929802,0.00016968414,0.000023598852,0.00018991243,0.000030094136,0.00044160674,0.0001268044,0.00000319488],"category_scores_gemma":[0.00004013385,0.000087442866,0.00014644975,0.00007807632,0.00021154514,0.0000048043566,0.00021621624,0.00016767404,6.48539e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015736754,0.00015050758,0.00012409058,0.000005510325,0.0001313257,0.0000015848777,0.00044230014,0.00020830626,0.9981495,0.000057527886,0.00014832999,0.00042363745],"study_design_scores_gemma":[0.0013700644,0.00028821072,0.00033251249,0.000029274313,0.000059048198,0.000014294886,0.0005574511,0.00015310913,0.99689794,0.00013773928,0.000045500045,0.00011485982],"about_ca_topic_score_codex":0.00040650635,"about_ca_topic_score_gemma":0.00059230346,"teacher_disagreement_score":0.0014427752,"about_ca_system_score_codex":0.000015670359,"about_ca_system_score_gemma":0.00013389785,"threshold_uncertainty_score":0.35658166},"labels":[],"label_agreement":null},{"id":"W2592808937","doi":"10.1182/blood.v112.11.4676.4676","title":"Review of Current Patterns of Treatment and Costs in Follicular Non-Hodgkin’s Lymphoma","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Follicular lymphoma; Medicine; Lymphoma; Incidence (geometry); Malignancy; Demography; Disease; Oncology; Internal medicine","score_opus":0.024672004009994593,"score_gpt":0.2904089879460761,"score_spread":0.26573698393608153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592808937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87404525,0.12511645,0.0000013375803,0.000073687654,0.000026036922,0.000497991,0.00002525207,0.000004986154,0.00020901226],"genre_scores_gemma":[0.7907798,0.20895731,0.00005799141,0.00007522521,0.000015976517,0.00007463717,0.000021498701,0.000007206623,0.0000103031525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992627,0.000024686628,0.00031085065,0.00017111232,0.00010891933,0.000121721685],"domain_scores_gemma":[0.9995082,0.00003582671,0.00010167404,0.00023529705,0.00004337169,0.000075616175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005177737,0.0001298861,0.0004955308,0.00006171233,0.000012639325,9.828562e-7,0.000029202136,0.000030762447,0.000021138176],"category_scores_gemma":[0.000016387852,0.000091098635,0.0001103788,0.00008860773,0.000027639042,0.000018922943,0.000019693643,0.000014142778,0.0000033515798],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021275126,0.0053897887,0.9409594,0.0018753294,0.00016231506,0.00013852712,0.0001579553,5.801395e-8,0.00019846571,0.00002460345,0.00010067724,0.050971612],"study_design_scores_gemma":[0.01699208,0.0014792266,0.93345416,0.014654888,0.00063288206,0.0002583465,0.000015983042,0.0000028141276,0.029466406,0.0000026343314,0.0029385106,0.00010204784],"about_ca_topic_score_codex":0.00046088753,"about_ca_topic_score_gemma":0.000026397249,"teacher_disagreement_score":0.08384086,"about_ca_system_score_codex":0.00012764022,"about_ca_system_score_gemma":0.000112612026,"threshold_uncertainty_score":0.37148944},"labels":[],"label_agreement":null},{"id":"W2592865172","doi":"10.1182/blood.v126.23.4470.4470","title":"Appropriateness of Thrombophilia Testing in Tertiary Care Centers in Edmonton","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of Alberta Hospital; Alberta Hospital Edmonton; University of British Columbia","funders":"","keywords":"Medicine; Thrombophilia; Factor V Leiden; Venous thromboembolism; Emergency department; Family history; Pediatrics; Emergency medicine; Internal medicine; Thrombosis; Venous thrombosis","score_opus":0.0435619231651981,"score_gpt":0.27790032496892264,"score_spread":0.23433840180372453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592865172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99661416,0.00032412546,0.000016793905,0.00009845214,0.00010148383,0.00028757704,0.0000021951976,0.00003106198,0.0025241377],"genre_scores_gemma":[0.9982282,0.000003881926,0.0015774331,0.00009780768,0.000039024686,0.000012770267,0.000013638824,0.000015837773,0.000011430054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99910605,0.000042568885,0.00029091653,0.00018441802,0.00020477634,0.0001712958],"domain_scores_gemma":[0.9995242,0.000020547042,0.00006825981,0.00019844384,0.0001012638,0.00008731348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017883819,0.000101027385,0.00026807247,0.00015348033,0.000008695189,0.0000044676217,0.00006901244,0.00008339655,0.0000075516487],"category_scores_gemma":[0.00011798842,0.0000925179,0.00003286626,0.00028150654,0.00002209,0.000056999022,0.000039782662,0.000113174545,0.000005040611],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025770341,0.00075179787,0.93813384,0.0001508215,0.00001925016,0.000038801696,0.0020087152,0.000025298255,0.057348385,0.00013889743,0.000005572313,0.0013528613],"study_design_scores_gemma":[0.008130342,0.00020909216,0.9242173,0.00048795145,0.00007031117,0.000018471512,0.0019778,0.00022872262,0.06411756,0.00041179563,0.00001068756,0.00011996519],"about_ca_topic_score_codex":0.00039037404,"about_ca_topic_score_gemma":0.00015022856,"teacher_disagreement_score":0.013916528,"about_ca_system_score_codex":0.000037902802,"about_ca_system_score_gemma":0.00010167851,"threshold_uncertainty_score":0.37727705},"labels":[],"label_agreement":null},{"id":"W2592892140","doi":"10.1182/blood.v116.21.lba-6.lba-6","title":"A Randomized Phase II Trial of Dasatinib 100 Mg Vs Imatinib 400 Mg In Newly Diagnosed Chronic Myeloid Leukemia In Chronic Phase (CML-CP): The S0325 Intergroup Trial","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Dasatinib; Internal medicine; Clinical endpoint; Imatinib; Imatinib mesylate; Randomized controlled trial; Gastroenterology; Nilotinib; Myeloid leukemia; Surgery","score_opus":0.018861270659581344,"score_gpt":0.32013891735561084,"score_spread":0.3012776466960295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592892140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98347425,0.0011103468,0.00002846445,0.0005559653,0.0014297938,0.011933537,0.00009574399,0.00012513614,0.0012467597],"genre_scores_gemma":[0.99288803,0.0005435379,0.00037729056,0.000156105,0.0025981318,0.0025382526,0.00030702286,0.00012994393,0.0004616699],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9932855,0.0008369422,0.0027612587,0.0010321763,0.0009296178,0.0011545464],"domain_scores_gemma":[0.9945042,0.0022706126,0.0010283865,0.0017506168,0.0001181283,0.00032805657],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0030398073,0.0008375531,0.0029011993,0.0006061143,0.00016599536,0.00005810443,0.0007606432,0.00058644515,0.0014944223],"category_scores_gemma":[0.0031430803,0.0006028276,0.00087047135,0.00093973393,0.00067407585,0.0002653637,0.0003061941,0.0018485485,0.000056440178],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9193755,0.011997088,0.000034357065,0.00022611122,0.00068269635,0.00038756756,0.002418818,0.000021433547,0.046751082,0.00014688532,0.00036927537,0.017589185],"study_design_scores_gemma":[0.95956725,0.015696995,0.000050418043,0.00066131237,0.0011957745,0.0000815226,0.00012042259,0.003292745,0.017177537,0.00013194754,0.0015471355,0.0004769125],"about_ca_topic_score_codex":0.0024399136,"about_ca_topic_score_gemma":0.0047821775,"teacher_disagreement_score":0.040191777,"about_ca_system_score_codex":0.003512717,"about_ca_system_score_gemma":0.008119891,"threshold_uncertainty_score":0.9996423},"labels":[],"label_agreement":null},{"id":"W2592897778","doi":"10.1182/blood.v128.22.5176.5176","title":"Outcome of Acute Myeloid Leukemia in Children and Young Adults Treated with an Uniform Protocol in Casablanca, Morocco","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; McMaster Children's Hospital","funders":"","keywords":"Medicine; Pediatrics; Acute promyelocytic leukemia; Myeloid leukemia; Young adult; Internal medicine","score_opus":0.010350883642442278,"score_gpt":0.2812372507731492,"score_spread":0.2708863671307069,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592897778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97150123,0.0000073583947,0.000003976896,0.00008065983,0.0000033679498,0.02767868,0.000053295444,0.00003878897,0.0006326538],"genre_scores_gemma":[0.9904188,0.000018282102,0.0005575324,0.000035944096,0.000042551455,0.00834729,0.000029478297,0.000043286014,0.00050685543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983007,0.000060251525,0.00044925124,0.00041183102,0.00032979727,0.0004481915],"domain_scores_gemma":[0.9991216,0.000035387922,0.000102776656,0.0004549792,0.000094953306,0.00019026751],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027792234,0.00022861062,0.00050552445,0.00035435465,0.000022336078,0.00000997307,0.00016225946,0.00015691399,0.000039571438],"category_scores_gemma":[0.000052588293,0.00013376007,0.000031819756,0.00043607506,0.00015179446,0.00021540043,0.00007693538,0.00027554008,0.00000902705],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002465465,0.000298675,0.98879224,0.000082754676,0.00013191008,0.00027704527,0.00021243923,3.8366957e-7,0.005546051,0.000013609675,0.000017558816,0.0021618505],"study_design_scores_gemma":[0.04354608,0.0016009097,0.93506366,0.00041873433,0.00008476317,0.00062336354,0.00005661506,0.00006436125,0.018339608,0.000010088412,0.000013237575,0.00017855444],"about_ca_topic_score_codex":0.00454123,"about_ca_topic_score_gemma":0.0023104195,"teacher_disagreement_score":0.053728573,"about_ca_system_score_codex":0.0004267994,"about_ca_system_score_gemma":0.00038997797,"threshold_uncertainty_score":0.68650115},"labels":[],"label_agreement":null},{"id":"W2592898871","doi":"10.1182/blood.v128.22.4162.4162","title":"A Phase I Study of Romidepsin, Gemcitabine, Dexamethasone and Cisplatin Combination Therapy in the Treatment of Peripheral T-Cell and Diffuse Large B-Cell Lymphoma: Canadian Cancer Trials Group Study LY.15","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Partnership Against Cancer; Queen's University; Queen Elizabeth II Health Sciences Centre; Sunnybrook Health Science Centre; University of British Columbia; Princess Margaret Cancer Centre; BC Cancer Agency; Health Sciences Centre; Saint John Regional Hospital; Dalhousie University; University of New Brunswick","funders":"","keywords":"Romidepsin; Gemcitabine; Medicine; Internal medicine; Oncology; Regimen; Diffuse large B-cell lymphoma; Chemotherapy regimen; Lymphoma; Cancer; Histone deacetylase","score_opus":0.02472410259735151,"score_gpt":0.3165873725998048,"score_spread":0.29186327000245327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592898871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952929,0.002798264,0.0000044459357,0.000043816162,0.00002832287,0.0016770259,0.000118821314,0.0000022234449,0.000034155582],"genre_scores_gemma":[0.99852544,0.0010234447,0.000020982041,0.000011911396,0.0000390061,0.00023635554,0.0000155014,0.000018423058,0.00010894405],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99822664,0.00066314195,0.0003722921,0.00031454625,0.0001924044,0.00023095733],"domain_scores_gemma":[0.9992737,0.00011093699,0.0001464126,0.0003072902,0.00007251406,0.00008913732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007799454,0.00016668468,0.00036328787,0.00011125043,0.00006734057,0.000015188339,0.00011381785,0.000080787744,0.000009769462],"category_scores_gemma":[0.00006784612,0.000100212455,0.000046687834,0.00012232817,0.000068227055,0.0000062721433,0.000023371798,0.00002891833,2.2210114e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006401202,0.11423106,0.055979885,0.000016801969,0.00016133943,0.000023841027,0.006029866,2.555751e-7,0.8117537,0.000002700373,0.000042669788,0.011117748],"study_design_scores_gemma":[0.37100735,0.035419084,0.03366934,0.00002261735,0.00017571237,0.000006297479,0.0045376355,0.000018203058,0.554153,0.0000069665807,0.00070571963,0.0002780466],"about_ca_topic_score_codex":0.022716075,"about_ca_topic_score_gemma":0.10296455,"teacher_disagreement_score":0.37036723,"about_ca_system_score_codex":0.000050482595,"about_ca_system_score_gemma":0.00013189123,"threshold_uncertainty_score":0.98379177},"labels":[],"label_agreement":null},{"id":"W2592915896","doi":"10.1182/blood.v126.23.1948.1948","title":"Prolonged Duration of Systemic Immunosuppression after Allogeneic Hematopoietic Cell Transplantation Associates with the Use of Peripheral Blood Stem Cells, Severe Grade of Chronic Gvhd, Progressive Type Onset of Chronic Gvhd, Grade 2-4 Acute Gvhd and Older Age, but Not with T-Cell Depletion or Conditioning Regimen","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Discontinuation; Cumulative incidence; Univariate analysis; Immunosuppression; Internal medicine; Transplantation; Hematopoietic stem cell transplantation; Incidence (geometry); Risk factor; Multivariate analysis; Surgery; Gastroenterology","score_opus":0.0259240838220665,"score_gpt":0.258603069176533,"score_spread":0.23267898535446646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592915896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935971,0.0035992954,0.00005882599,0.000054662367,0.000039043003,0.0024868879,0.00012052298,0.000022934433,0.000020758505],"genre_scores_gemma":[0.99823153,0.00044525714,0.0004481861,0.00000832653,0.000031052197,0.00018459331,0.00017505922,0.000055801116,0.00042016993],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971989,0.0004244454,0.0006896429,0.00039665305,0.000935005,0.00035536347],"domain_scores_gemma":[0.9976682,0.0002127936,0.0009845943,0.000437672,0.00057225185,0.00012447113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040130477,0.00030629183,0.0007033517,0.00014121625,0.00007609959,0.000028233739,0.00016088448,0.00021580378,0.000066203385],"category_scores_gemma":[0.00001829639,0.0001865028,0.00007721533,0.00035480745,0.0003253874,0.00019992405,0.000044509317,0.00028497062,0.000001087788],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004264124,0.0019932154,0.035836104,0.009193045,0.001011066,0.00046324608,0.0073234397,0.0003374484,0.9393984,0.000004252258,0.000061291525,0.00011437358],"study_design_scores_gemma":[0.012759495,0.0060716067,0.023181768,0.0016230135,0.0023889292,0.00073092047,0.001208153,0.00014038185,0.9516621,0.0000015578936,0.000003419485,0.00022862904],"about_ca_topic_score_codex":0.00009205292,"about_ca_topic_score_gemma":0.00007177798,"teacher_disagreement_score":0.012654338,"about_ca_system_score_codex":0.00012747428,"about_ca_system_score_gemma":0.0007252405,"threshold_uncertainty_score":0.7605363},"labels":[],"label_agreement":null},{"id":"W2593010135","doi":"10.1182/blood.v128.22.2272.2272","title":"Autologous Stem Cell Transplantation (ASCT) As Upfront Treatment in Primary Central Nervous System Lymphoma (PCNSL): A Systematic Review and Comparative Analysis in Clinical Trials Setting","year":2016,"lang":"en","type":"review","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"ThioTEPA; Medicine; Primary central nervous system lymphoma; Oncology; Internal medicine; Autologous stem-cell transplantation; Regimen; Hazard ratio; Clinical trial; Transplantation; Confidence interval; Surgery; Chemotherapy; Cyclophosphamide","score_opus":0.07924015972048083,"score_gpt":0.3847847973442299,"score_spread":0.30554463762374906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593010135","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0064792293,0.9798844,0.0000057408256,0.000041134477,0.000086908556,0.012610895,0.0003304836,0.00006802587,0.0004932043],"genre_scores_gemma":[0.010953745,0.98506045,0.00008850844,0.00006221127,0.0000795559,0.0029195456,0.0006595238,0.00004210763,0.00013432877],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9869754,0.005410538,0.005557867,0.0010779124,0.00039472492,0.0005835681],"domain_scores_gemma":[0.9933878,0.003208272,0.0022917194,0.0007267346,0.000060513783,0.0003249386],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.003207249,0.00093341543,0.016810358,0.0006610871,0.000056598652,0.00004918578,0.00015797751,0.00048816754,0.00001450909],"category_scores_gemma":[0.000098487646,0.0005356691,0.002157784,0.00073373853,0.00005778329,0.0000663581,0.00003328391,0.00015946462,0.00006201982],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006411574,0.0026185205,0.0018046122,0.71858317,0.007155218,0.0022140578,0.00030037813,4.0431394e-7,1.1682479e-7,0.000019175026,0.000012381018,0.26722786],"study_design_scores_gemma":[0.012031096,0.0008509432,0.018124279,0.6890749,0.27602527,0.0014821196,0.00016533777,0.000011531141,0.00000441104,5.723421e-7,0.0016632462,0.0005663329],"about_ca_topic_score_codex":0.00027355237,"about_ca_topic_score_gemma":0.00016246756,"teacher_disagreement_score":0.26887006,"about_ca_system_score_codex":0.001954149,"about_ca_system_score_gemma":0.0009672681,"threshold_uncertainty_score":0.9997095},"labels":[],"label_agreement":null},{"id":"W2593028116","doi":"10.1182/blood.v120.21.4255.4255","title":"Cost-Effectiveness of Ruxolitinib Versus Best-Available Therapy for Medical Treatment of Myelofibrosis: Canadian Societal Perspective","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Ruxolitinib; Medicine; Myelofibrosis; Reimbursement; Cohort; Internal medicine; Cost effectiveness; Health care","score_opus":0.08230238664045916,"score_gpt":0.36072881519931166,"score_spread":0.27842642855885247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593028116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98370665,0.0065424666,0.000013085798,0.00034001068,0.00022297374,0.0026582256,0.0003692387,0.000017424518,0.0061299093],"genre_scores_gemma":[0.99639374,0.0011795782,0.00067808334,0.000045085653,0.00023539811,0.0012023152,0.00009494285,0.000031444222,0.00013939948],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99856955,0.00009962645,0.00027171784,0.0002623063,0.0003252291,0.00047157527],"domain_scores_gemma":[0.998116,0.000689031,0.00010230194,0.00024064702,0.00031968422,0.0005323234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002943049,0.00023383649,0.0006314615,0.000096753356,0.00008453011,0.000004217582,0.00006368665,0.00016975348,0.0005412076],"category_scores_gemma":[0.00016188469,0.0001731964,0.00029766932,0.000132811,0.00013546334,0.00006427053,0.000009782977,0.000058200007,0.000024424484],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0083254175,0.041493636,0.8931712,0.0005817946,0.010171805,0.000048896283,0.008138152,0.0000028552356,0.0053573227,0.019920247,0.00079598866,0.011992689],"study_design_scores_gemma":[0.096827485,0.025290957,0.18038495,0.00057022774,0.0023412295,0.00007061216,0.003446059,0.000028417875,0.6759999,0.00011825011,0.0144609045,0.00046106498],"about_ca_topic_score_codex":0.016830955,"about_ca_topic_score_gemma":0.0022280116,"teacher_disagreement_score":0.71278626,"about_ca_system_score_codex":0.00041656173,"about_ca_system_score_gemma":0.0009897351,"threshold_uncertainty_score":0.98971605},"labels":[],"label_agreement":null},{"id":"W2593028431","doi":"10.1182/blood.v126.23.1368.1368","title":"TET2 Mutations Are Highly Associated with RUNX1-RUNX1T1 Translocations and NPMc+ in Childhood AML: a Report from Children's Oncology Group AAML03P1, AAML0531 and NCI/COG Target AML Initiative","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Missense mutation; Gemtuzumab ozogamicin; Medicine; Frameshift mutation; Nonsense mutation; Oncology; Hepatoblastoma; Mutation; Pediatric cancer; Genetics; Internal medicine; Cancer research; Biology; Cancer; Gene","score_opus":0.021305409382570122,"score_gpt":0.2764131315293978,"score_spread":0.25510772214682764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593028431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98899925,0.0011941597,0.00019911537,0.00525855,0.000045951332,0.001348047,0.00038532747,0.00015797134,0.0024116468],"genre_scores_gemma":[0.992659,0.00009494862,0.0045754495,0.0004127052,0.00015813246,0.00024298346,0.001649769,0.00007231208,0.00013472063],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973041,0.0002958363,0.0005834403,0.0007390342,0.0005257699,0.00055185775],"domain_scores_gemma":[0.9978868,0.00047203407,0.00030721928,0.0004202143,0.00038087557,0.00053286925],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006325565,0.00034193974,0.00074236153,0.00039559524,0.00016454319,0.000051339193,0.00014376527,0.0003401525,0.000026654821],"category_scores_gemma":[0.0013495041,0.0003002968,0.00005621743,0.00078565517,0.0004066178,0.00026698882,0.00008426635,0.00083911617,0.0000094768675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003984003,0.004760319,0.9722263,0.00003941016,0.001882637,0.00347971,0.013297203,0.00001635283,0.0010327481,0.00019222351,0.0013223353,0.0013523585],"study_design_scores_gemma":[0.020149838,0.001175594,0.972031,0.00022342631,0.0007464718,0.0010717697,0.002092445,0.00013370613,0.00083114405,0.000722063,0.00046622514,0.00035634873],"about_ca_topic_score_codex":0.0008700483,"about_ca_topic_score_gemma":0.0015725376,"teacher_disagreement_score":0.019751437,"about_ca_system_score_codex":0.0003351265,"about_ca_system_score_gemma":0.001522171,"threshold_uncertainty_score":0.9999449},"labels":[],"label_agreement":null},{"id":"W2593072228","doi":"10.1182/blood.v106.11.4215.4215","title":"Granulocyte-Colony Stimulating Factor Decreases Angina and Improves Exercise Capacity in Patients with Chronic Refractory ‘No Option’ Ischemic Heart Disease.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Granulocyte colony-stimulating factor; Internal medicine; Angina; Myocardial infarction; Troponin T; Canadian Cardiovascular Society; Cardiology; Gastroenterology; Surgery; Chemotherapy","score_opus":0.010525687458331882,"score_gpt":0.22143890891120688,"score_spread":0.210913221452875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593072228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998216,0.00076405867,0.000011551616,0.00008992137,0.000023983508,0.00072505645,0.000023489089,0.00006044749,0.00008553612],"genre_scores_gemma":[0.9986342,0.000072057905,0.0007592151,0.00016079374,0.0001827175,0.000040055947,0.00006306913,0.000026636506,0.00006124996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990336,0.000022410371,0.00018170918,0.0002929255,0.00023196636,0.0002374172],"domain_scores_gemma":[0.9994018,0.000037684724,0.0000643077,0.00021385221,0.00008173584,0.00020062513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006105888,0.00017540074,0.0002747091,0.000083949766,0.000067626825,0.000019505083,0.000035216723,0.00008888956,0.000026374453],"category_scores_gemma":[0.00006698101,0.00015430356,0.000054865155,0.00010648808,0.00006630964,0.00022710381,0.000015831733,0.00018231974,0.000007600175],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007817519,0.001285487,0.6652602,0.0002933582,0.000065107124,0.0000064629944,0.00027244116,0.000020364907,0.32381156,0.000003723563,0.00008422945,0.008115305],"study_design_scores_gemma":[0.008279248,0.00042802223,0.9104479,0.0004724609,0.00014546045,0.000004729105,0.000008666594,0.00014277003,0.07937686,0.0000075267794,0.00048443137,0.0002019291],"about_ca_topic_score_codex":0.00005490115,"about_ca_topic_score_gemma":0.000021139662,"teacher_disagreement_score":0.2451877,"about_ca_system_score_codex":0.00014660977,"about_ca_system_score_gemma":0.00011263425,"threshold_uncertainty_score":0.6292317},"labels":[],"label_agreement":null},{"id":"W2593077845","doi":"10.1182/blood.v104.11.318.318","title":"E2F4 Plays a Critical Role in Early B-Cell Development.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; Cell biology; B cell; Cell cycle; Cell growth; Cancer research; Cell; Immunology; Genetics; Antibody","score_opus":0.005435479376329426,"score_gpt":0.20435542701269913,"score_spread":0.1989199476363697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593077845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97450286,0.016464207,0.000058500176,0.0000842066,0.00017885135,0.000098401986,0.0000032334285,0.0000586875,0.00855106],"genre_scores_gemma":[0.9993054,0.000014001064,0.00014173934,0.00010789741,0.0000019504243,0.00002301669,0.000022258753,0.000012582706,0.0003711426],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989991,0.000044054603,0.00025724532,0.00022823074,0.00002960067,0.0004417281],"domain_scores_gemma":[0.9997236,0.00004764261,0.000028459584,0.00017290236,0.000021349522,0.000006004636],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013209024,0.00013888648,0.0001716993,0.0000994241,0.0001582232,0.000014257826,0.00021429815,0.00018685462,0.00014621197],"category_scores_gemma":[0.000054387143,0.00013727306,0.000048938447,0.00014822972,0.00013599067,0.00008705346,0.000060500308,0.00028892123,0.0014781032],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009948257,0.0062772254,0.010566852,0.000041779247,0.00008151326,0.000060433536,0.0115081435,0.00003480429,0.96062845,0.0071531856,0.000020871366,0.003527255],"study_design_scores_gemma":[0.011361477,0.00018197868,0.076359965,0.00008656064,0.000039120183,0.000071467985,0.0013547648,3.326632e-7,0.8920167,0.0015953039,0.016445998,0.00048633936],"about_ca_topic_score_codex":0.00017035473,"about_ca_topic_score_gemma":0.000011131929,"teacher_disagreement_score":0.06861176,"about_ca_system_score_codex":0.000018644378,"about_ca_system_score_gemma":0.00013103751,"threshold_uncertainty_score":0.99929935},"labels":[],"label_agreement":null},{"id":"W2593091403","doi":"10.1182/blood.v104.11.1765.1765","title":"Ximelagatran Versus Warfarin: A Comparison of Bleeding Outcomes in Patients with Nonvalvular Atrial Fibrillation.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kelowna General Hospital; McMaster University","funders":"","keywords":"Ximelagatran; Medicine; Warfarin; Atrial fibrillation; Stroke (engine); Internal medicine; Cardiology; Direct thrombin inhibitor; Anticoagulant; Embolism; Anesthesia; Dabigatran","score_opus":0.044388331034519765,"score_gpt":0.31664640262191324,"score_spread":0.27225807158739346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593091403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99797887,0.000093713854,0.0000632988,0.00031855176,0.00021874899,0.0005905024,0.0000035894493,0.00004355765,0.00068918726],"genre_scores_gemma":[0.9979168,0.000005022052,0.0016817363,0.000009115699,0.00028294063,4.524901e-7,0.000034490975,0.000018314957,0.000051116996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877703,0.000015232925,0.00042452096,0.00019143785,0.0004066766,0.00018512904],"domain_scores_gemma":[0.9994328,0.00008270054,0.00016296178,0.00018831242,0.00007233397,0.000060859744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000099253644,0.00014695348,0.00049599825,0.00019212131,0.000039271115,0.000011593087,0.00005592759,0.00007260835,0.000031554795],"category_scores_gemma":[0.0000958249,0.000116337455,0.00017204958,0.00029829444,0.0000343033,0.000114672126,0.000032055956,0.0000832107,0.000013235026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001382632,0.00005609943,0.99496156,0.00004290428,0.00029332866,0.0000031663735,0.00023833977,0.0021974551,0.00003885938,0.00035680513,0.000002260075,0.00042661524],"study_design_scores_gemma":[0.051384598,0.0008837413,0.9459644,0.00006864612,0.00049369375,3.3997262e-7,0.00010594068,0.00003252286,0.00069262274,0.000041028215,0.00019893759,0.00013352123],"about_ca_topic_score_codex":0.000058639776,"about_ca_topic_score_gemma":0.000025783966,"teacher_disagreement_score":0.050001968,"about_ca_system_score_codex":0.000042637166,"about_ca_system_score_gemma":0.000046139823,"threshold_uncertainty_score":0.47441038},"labels":[],"label_agreement":null},{"id":"W2593116899","doi":"10.1182/blood.v112.11.2824.2824","title":"Assessment of Microrna Expression in Mantle Cell Lymphoma Using High Throughput Techniques","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Mantle cell lymphoma; microRNA; Follicular lymphoma; Blastoid; Lymphoma; Biology; Cancer research; Population; Gene expression; Gene expression profiling; Pathology; Gene; Medicine; Immunology; Genetics","score_opus":0.020834626419359747,"score_gpt":0.2857635119999962,"score_spread":0.2649288855806365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593116899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953317,0.00055035576,0.00005521299,0.000036228277,0.00003356778,0.00029301946,0.000008108767,0.000034371922,0.0036574067],"genre_scores_gemma":[0.9568491,0.000377164,0.04254873,0.0000623188,0.000044080633,0.000027053993,0.000014441787,0.000015678079,0.00006142126],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99918246,0.000025055217,0.00024577798,0.00020122387,0.00018473378,0.00016076094],"domain_scores_gemma":[0.9995407,0.000027899541,0.0000948825,0.0002517658,0.000035316458,0.000049437094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005480756,0.00012249788,0.00028882877,0.00008820332,0.000038808394,0.0000034283967,0.000051831677,0.00007743509,0.000029132632],"category_scores_gemma":[0.000003897224,0.00009569399,0.000069618814,0.00011299761,0.000039288258,0.000046958354,0.000048001242,0.00003315095,0.0000031342581],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020185886,0.008015523,0.49190253,0.000100921534,0.000033692766,0.00057423435,0.00013630922,0.0000013470827,0.4981368,0.000038485934,0.00012771474,0.0009122803],"study_design_scores_gemma":[0.0043993094,0.00018043727,0.3306002,0.00023995631,0.00006475756,0.00011717766,0.000021325131,0.000010003629,0.6640976,0.000015499154,0.00019236878,0.00006135936],"about_ca_topic_score_codex":0.00034338742,"about_ca_topic_score_gemma":0.0000036438073,"teacher_disagreement_score":0.1659608,"about_ca_system_score_codex":0.00011443187,"about_ca_system_score_gemma":0.00014398024,"threshold_uncertainty_score":0.39022878},"labels":[],"label_agreement":null},{"id":"W2593121552","doi":"10.1182/blood.v128.22.3.3","title":"Spk-9001: Adeno-Associated Virus Mediated Gene Transfer for Hemophilia B Achieves Sustained Mean Factor IX Activity Levels of &gt;30% without Immunosuppression","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Factor IX; Capsid; Immunosuppression; Medicine; Genetic enhancement; Antibody; Immunology; Single Center; Virus; Virology; Internal medicine; Molecular biology; Gene; Biology; Genetics","score_opus":0.02101662145472926,"score_gpt":0.2852542696577755,"score_spread":0.26423764820304624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593121552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954673,0.0005144244,0.00094400614,0.00022168522,0.00006999132,0.00077082845,0.0019274771,0.000038273593,0.0000460223],"genre_scores_gemma":[0.9982494,0.00020893951,0.00008760512,0.000044341792,0.00013025312,0.00007987218,0.00014002013,0.00008063256,0.0009788985],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978685,0.00025501105,0.00034980613,0.0005512055,0.00037519264,0.00060030125],"domain_scores_gemma":[0.9986999,0.00010348634,0.00011841144,0.00061150064,0.00030282128,0.0001639004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040304128,0.00032295534,0.00041143678,0.00009061787,0.00012292145,0.00001801709,0.00044117967,0.00038501876,0.00022572972],"category_scores_gemma":[0.00029346772,0.00023692146,0.00023752538,0.00013049372,0.00016270799,0.000013754711,0.0000998836,0.000121370846,0.000009687387],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035021105,0.0007438264,0.0010964596,0.000033220636,0.00050967815,0.000003005204,0.000110467256,0.0000010759077,0.9913979,0.0000036912654,0.00005877935,0.002539751],"study_design_scores_gemma":[0.008032366,0.0029276966,0.0065618097,0.0000387647,0.0000768043,0.0000026672108,0.000019582629,0.000009161365,0.9816003,0.000047673915,0.00036134935,0.00032182067],"about_ca_topic_score_codex":0.000021261849,"about_ca_topic_score_gemma":0.0001547798,"teacher_disagreement_score":0.009797631,"about_ca_system_score_codex":0.00003833,"about_ca_system_score_gemma":0.00025055968,"threshold_uncertainty_score":0.9661377},"labels":[],"label_agreement":null},{"id":"W2593185963","doi":"10.1182/blood.v110.11.16.16","title":"Constitutional Loss-of-Function Mutations in Telomerase Are Genetic Risk Factors for Acute Myeloid Leukemia.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Dyskeratosis congenita; Telomerase; Myeloid leukemia; Telomerase RNA component; Telomere; Biology; Leukemia; Acute leukemia; Bone marrow failure; Aplastic anemia; Immunology; Gene mutation; Cancer research; Mutation; Internal medicine; Genetics; Medicine; Telomerase reverse transcriptase; Gene; Bone marrow; Haematopoiesis; Stem cell","score_opus":0.01810054676921367,"score_gpt":0.2767724778386817,"score_spread":0.258671931069468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593185963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895955,0.00040314117,0.008618667,0.000048658043,0.00024908758,0.00056637824,0.0002183702,0.00005491475,0.00024530647],"genre_scores_gemma":[0.99581176,0.00014497338,0.0034800672,0.000089448695,0.0001590487,0.00002686766,0.00016377996,0.000014716654,0.00010933551],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986013,0.000021924556,0.00048821897,0.00029790666,0.0002645949,0.0003260189],"domain_scores_gemma":[0.99893636,0.00028998425,0.00020902576,0.00022877027,0.00017783082,0.00015802328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020742044,0.00018034974,0.00034251,0.00024485457,0.00011655714,0.000009086512,0.00007637767,0.00013922314,0.000060685772],"category_scores_gemma":[0.0003328435,0.00016541887,0.00012952456,0.0003927474,0.00034863234,0.00008238417,0.00001562024,0.00019485682,0.000013452658],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033472723,0.0006180863,0.9833288,0.000092843846,0.00026166823,0.00012467039,0.00035483198,0.0001181628,0.010509517,0.0006470057,0.000077607285,0.0035320558],"study_design_scores_gemma":[0.0049693137,0.00029696253,0.9559824,0.000098776705,0.0007364471,0.00009919739,0.0005065123,0.00007101514,0.035596427,0.00027436536,0.0011671106,0.0002014823],"about_ca_topic_score_codex":0.00016517247,"about_ca_topic_score_gemma":0.00020122051,"teacher_disagreement_score":0.027346432,"about_ca_system_score_codex":0.000103581166,"about_ca_system_score_gemma":0.00029609294,"threshold_uncertainty_score":0.6745586},"labels":[],"label_agreement":null},{"id":"W2593216503","doi":"10.1182/blood.v114.22.1140.1140","title":"High Dose Valacyclovir Is Highly Effective to Prevent Cytomegalovirus and Other Herpes Viruses Viremia After Allogeneic Stem Cell Transplantation.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Viremia; Transplantation; Valaciclovir; Foscarnet; Cytomegalovirus; Viral load; Betaherpesvirinae; Hematopoietic stem cell transplantation; Immunology; Valganciclovir; Internal medicine; Human cytomegalovirus; Herpesviridae; Ganciclovir; Gastroenterology; Viral disease; Virus","score_opus":0.013117538243408035,"score_gpt":0.2782498634006556,"score_spread":0.26513232515724755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593216503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99272084,0.002370354,0.000064630076,0.00071809546,0.00007153531,0.0018163876,0.0002218217,0.00013001285,0.0018863399],"genre_scores_gemma":[0.98958486,0.0004563134,0.0006098306,0.007262854,0.00028407725,0.0002342214,0.000007725958,0.000073809824,0.0014862755],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99738765,0.0001423071,0.000449246,0.00076308864,0.00060849456,0.0006492179],"domain_scores_gemma":[0.99860793,0.00014353705,0.00008288482,0.0005075271,0.00010384259,0.0005542829],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031298408,0.00043730752,0.0006089792,0.00034952952,0.0001389258,0.00010550818,0.0001805609,0.00023580417,0.00036875994],"category_scores_gemma":[0.000010599844,0.00036971597,0.0001863995,0.00042138304,0.000082223385,0.00016175004,0.000051239524,0.00028986417,0.000444209],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013637409,0.011393457,0.06509193,0.0014104863,0.0013514699,0.0022815175,0.01146554,0.00004045586,0.653891,0.00030483017,0.003241306,0.23589057],"study_design_scores_gemma":[0.009031478,0.0023606606,0.3077993,0.00028872915,0.0007590251,0.00015534608,0.00008310002,0.000009358769,0.62863064,0.00014539069,0.050049536,0.0006874386],"about_ca_topic_score_codex":0.00037303998,"about_ca_topic_score_gemma":0.000096973294,"teacher_disagreement_score":0.24270737,"about_ca_system_score_codex":0.00009374058,"about_ca_system_score_gemma":0.0001134432,"threshold_uncertainty_score":0.9998755},"labels":[],"label_agreement":null},{"id":"W2593224771","doi":"10.1182/blood.v112.11.1702.1702","title":"Loss of Chromosome 1p21 Band Is Associated with Disease Progression and Poor Survival in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Monoclonal gammopathy of undetermined significance; Multiple myeloma; Plasma cell leukemia; Fluorescence in situ hybridization; Transplantation; Biology; Plasma cell; Pathology; Stem cell; Bone marrow; Chromosome 13; Medicine; Internal medicine; Monoclonal; Immunology; Chromosome; Monoclonal antibody; Antibody; Gene; Genetics","score_opus":0.0187909325527553,"score_gpt":0.25285232032357596,"score_spread":0.23406138777082067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593224771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99859834,0.00032205696,0.0000052717105,0.00005278651,0.000016008336,0.0006689739,0.000168696,0.000028391965,0.00013949492],"genre_scores_gemma":[0.9992341,0.00024094696,0.00013433093,0.000014699379,0.000009998871,0.000034521046,0.00020187498,0.000021398806,0.00010816845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868506,0.0000864045,0.00023004091,0.0002687302,0.00044306432,0.0002866813],"domain_scores_gemma":[0.999226,0.00019843537,0.000099437944,0.000132655,0.000096392345,0.00024708576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006566512,0.00015558199,0.0003025451,0.00011269318,0.000091794216,0.0000068933027,0.000045900586,0.000066673856,0.000013691017],"category_scores_gemma":[0.000053546533,0.000115144954,0.000038285252,0.00018400732,0.000111872,0.00008272812,0.000014449848,0.00010422178,0.0000029108098],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012918233,0.0028354123,0.9912316,0.0003260647,0.00012796058,0.0018598516,0.0006024394,0.0000018546733,0.0005849676,7.4956637e-7,0.0000051448287,0.001132096],"study_design_scores_gemma":[0.029057443,0.0009152831,0.9544867,0.00047950773,0.0001369861,0.000032732576,0.000035449084,0.00012732524,0.014617188,0.0000026536686,0.0000019571178,0.00010674138],"about_ca_topic_score_codex":0.00004072176,"about_ca_topic_score_gemma":0.00011687836,"teacher_disagreement_score":0.036744904,"about_ca_system_score_codex":0.00003951499,"about_ca_system_score_gemma":0.0001816384,"threshold_uncertainty_score":0.4695475},"labels":[],"label_agreement":null},{"id":"W2593232986","doi":"10.1182/blood.v112.11.51.51","title":"Obesity Does Not Preclude Safe and Effective Myeloablative Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia (AML) in Adults","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Underweight; Internal medicine; Overweight; Transplantation; Body mass index; Population; Surgery; Leukemia","score_opus":0.008823736359961256,"score_gpt":0.2603788038322051,"score_spread":0.2515550674722438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593232986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99412215,0.0001830596,0.00063058967,0.0002668404,0.000056312387,0.0031399366,0.00018401077,0.000070743845,0.0013463871],"genre_scores_gemma":[0.99310875,0.0014990116,0.003504172,0.00017616423,0.00014044734,0.00046295754,0.00014335192,0.000052061772,0.000913057],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99790776,0.00013415134,0.00038988845,0.00062956754,0.00039171558,0.0005469479],"domain_scores_gemma":[0.99855375,0.00063698855,0.00010868464,0.00029623372,0.00017204256,0.00023230024],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033921478,0.0003142574,0.00059086597,0.0002512062,0.0001863535,0.00001558667,0.0001363736,0.00025125258,0.000028798991],"category_scores_gemma":[0.00012440729,0.00024703477,0.00011923939,0.00029520466,0.00020998764,0.00020509172,0.000050823215,0.00048453338,0.000026131896],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029090805,0.003874034,0.41773146,0.0097566005,0.0017188204,0.004352092,0.071608424,0.000050290186,0.45177945,0.00038465206,0.00084037083,0.008812986],"study_design_scores_gemma":[0.024457589,0.0010572101,0.34143564,0.00043369655,0.00051765266,0.0006576819,0.0003222777,0.0002882775,0.6302306,0.00017947225,0.000080983096,0.00033889184],"about_ca_topic_score_codex":0.0002564997,"about_ca_topic_score_gemma":0.00016842966,"teacher_disagreement_score":0.17845117,"about_ca_system_score_codex":0.00038814146,"about_ca_system_score_gemma":0.00040643028,"threshold_uncertainty_score":0.9999982},"labels":[],"label_agreement":null},{"id":"W2593255647","doi":"10.1182/blood.v114.22.410.410","title":"Activation of Chloride Channels with the Anti-Parasitic Agent Ivermectin Induces Membrane Hyperpolarization and Cell Death in Leukemia Cells.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Parasites and Host Interactions","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Leukemia; Clonogenic assay; Viability assay; Niclosamide; Trypan blue; Biology; Pharmacology; Immunology; Chemistry; Cancer research; Apoptosis; Biochemistry","score_opus":0.010985790972261688,"score_gpt":0.23328568219920084,"score_spread":0.22229989122693916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593255647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998498,0.00022682191,0.00007154228,0.00013717273,0.00007989242,0.00016246272,0.000005705324,0.000012793528,0.0008055591],"genre_scores_gemma":[0.9994416,0.00010646487,0.000017160157,0.000084555264,0.00001787585,0.0000052716005,0.000025433306,0.0000050309545,0.00029655691],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995314,0.000049285867,0.00012439938,0.00013801361,0.000023498467,0.00013342567],"domain_scores_gemma":[0.99969524,0.00006846832,0.00009506351,0.00010164032,0.000030406914,0.000009189049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006701554,0.00009103234,0.00013513172,0.000082571576,0.00009295229,0.000011433109,0.00006597757,0.00008724476,0.000025433825],"category_scores_gemma":[0.000008860931,0.00006365555,0.0000194111,0.00012202759,0.000037059497,0.0000978867,0.0000079134,0.00016243866,0.0000107952455],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005874486,0.00022668284,0.0049427995,0.0000070148735,0.00003268724,0.0000018919478,0.0006871688,0.00010821758,0.9936638,0.00013382554,0.000014747191,0.00012244089],"study_design_scores_gemma":[0.0009972923,0.00018183919,0.119805135,0.000028142218,0.000052099742,0.000024958323,0.00016459492,0.0000099485715,0.8784814,0.000019162737,0.00016694155,0.000068518646],"about_ca_topic_score_codex":0.00020437936,"about_ca_topic_score_gemma":0.000013614806,"teacher_disagreement_score":0.115182415,"about_ca_system_score_codex":0.000017970158,"about_ca_system_score_gemma":0.000033611414,"threshold_uncertainty_score":0.2595798},"labels":[],"label_agreement":null},{"id":"W2593255690","doi":"10.1182/blood.v120.21.3807.3807","title":"MCL-1 and Mir-181c in GATA2 Mutation Associated Monomac and Familial Myelodysplastic Syndrome","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"GATA2; Haploinsufficiency; Biology; Cancer research; Myeloid; RUNX1; Mutation; CEBPA; Immunology; Genetics; Stem cell; Haematopoiesis; Phenotype; Gene","score_opus":0.014673774856724088,"score_gpt":0.2664312987781708,"score_spread":0.2517575239214467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593255690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980609,0.0006423444,0.000010580293,0.0002044942,0.000053364278,0.0003304878,0.000015765992,0.000037801117,0.0006442567],"genre_scores_gemma":[0.9990845,0.0000763367,0.000297716,0.000083440675,0.00005787457,0.000026162903,0.000046718505,0.00002237784,0.0003048746],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989345,0.00006646477,0.0001937401,0.00019807855,0.00021351012,0.00039367372],"domain_scores_gemma":[0.9993915,0.0001839753,0.000042553525,0.00012376891,0.000039127357,0.00021909067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034062244,0.00012388134,0.00025216318,0.00017014831,0.000046092504,0.0000169914,0.00004121639,0.00013463528,0.00002888536],"category_scores_gemma":[0.00045195044,0.0001151356,0.000019082598,0.000202226,0.000078698744,0.00015440621,0.00006361476,0.00026264024,0.000036679365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023020254,0.0010397544,0.9723571,0.00021803744,0.00024233112,0.0007323359,0.0016785398,0.0000013768203,0.020712888,0.00013567711,0.00039874302,0.0022530179],"study_design_scores_gemma":[0.006576184,0.00027855753,0.989924,0.00008160449,0.00014042851,0.0008244405,0.00018778954,0.000432956,0.0012752654,0.00004619564,0.00010709012,0.00012548867],"about_ca_topic_score_codex":0.00020310635,"about_ca_topic_score_gemma":0.00004024562,"teacher_disagreement_score":0.019437622,"about_ca_system_score_codex":0.000107122636,"about_ca_system_score_gemma":0.00008157114,"threshold_uncertainty_score":0.46950933},"labels":[],"label_agreement":null},{"id":"W2593273640","doi":"10.1182/blood.v126.23.sci-10.sci-10","title":"Clonal Events in Normal Aging Hematopoiesis","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Myeloid; Biology; Population; Haematopoiesis; Somatic evolution in cancer; Bone marrow failure; Bone marrow; Immunology; Genetics; Internal medicine; Stem cell; Cancer; Medicine","score_opus":0.03199805272937629,"score_gpt":0.30788577468454303,"score_spread":0.27588772195516675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593273640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98702234,0.00021998509,0.000026665159,0.0012695974,0.00004698396,0.00016771619,0.0000020341768,0.000037823047,0.011206865],"genre_scores_gemma":[0.9967582,0.000009497697,0.0012364861,0.00027513425,0.00018674454,0.000017826687,0.000012506853,0.000017554805,0.0014860323],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893343,0.000038274313,0.00016249916,0.00016143636,0.00039616742,0.00030816096],"domain_scores_gemma":[0.9994468,0.000035768917,0.00002282466,0.00020824699,0.00006834642,0.00021800894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003977099,0.00008396875,0.0001767245,0.00014509473,0.000018900795,0.0000047804983,0.00010268961,0.00006129232,0.000080216945],"category_scores_gemma":[0.00020496424,0.00007481611,0.000039843955,0.0002398929,0.000026689384,0.00007467005,0.00009838974,0.00024474738,0.00025850607],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017515243,0.0009105024,0.987137,0.000113424285,0.00010014311,0.00091356965,0.001006856,0.0000057776665,0.003522327,0.00025251965,0.004760854,0.0011018383],"study_design_scores_gemma":[0.061717547,0.0008831375,0.79407144,0.0006218749,0.00028232278,0.0029492124,0.0019694697,0.00071845204,0.117741674,0.0013319841,0.016976645,0.0007362585],"about_ca_topic_score_codex":0.00013856344,"about_ca_topic_score_gemma":0.000023875322,"teacher_disagreement_score":0.19306561,"about_ca_system_score_codex":0.00012795007,"about_ca_system_score_gemma":0.00036103968,"threshold_uncertainty_score":0.33226588},"labels":[],"label_agreement":null},{"id":"W2593299098","doi":"10.1182/blood.v114.22.1230.1230","title":"The Impact of Prior Exposure to Rituximab On Autologous Stem Cell Transplantation in Patients with Follicular and Transformed Follicular Lymphoma.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Rituximab; Medicine; Follicular lymphoma; Autologous stem-cell transplantation; Internal medicine; Lymphoma; CD20; Transplantation; Oncology; Single Center; Gastroenterology; Immunology; Surgery","score_opus":0.004597439398691838,"score_gpt":0.21953297853284512,"score_spread":0.21493553913415328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593299098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980303,0.0005329531,0.0000056925214,0.00015689981,0.000009872903,0.0010430642,0.000024624434,0.000016097976,0.00018046885],"genre_scores_gemma":[0.999603,0.00013459103,0.000104598534,0.00006400826,0.000007472149,0.00004200266,0.000022976781,0.000010649286,0.000010748521],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991117,0.000031848384,0.00021555611,0.0002008612,0.00023182265,0.00020818025],"domain_scores_gemma":[0.9995658,0.000049328886,0.000052582207,0.00018874256,0.00004084327,0.00010274117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000066206274,0.00016556444,0.00029450175,0.00007251032,0.00005606841,0.000013208763,0.000045259112,0.000063768945,0.0000017180789],"category_scores_gemma":[0.0000029077833,0.000087208326,0.000090217836,0.00014752155,0.000018613093,0.00003728734,0.0000020887146,0.000031041018,0.0000024352842],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035914143,0.014179715,0.8455443,0.000086545035,0.0003256274,0.00026477128,0.002208986,0.00006119465,0.0005624066,0.000044781278,0.00001812894,0.13311215],"study_design_scores_gemma":[0.03838541,0.00898901,0.9313834,0.00014625341,0.0002908168,0.000019776011,0.000038902628,0.0000041004264,0.020631878,0.000008109647,0.000010222627,0.000092159265],"about_ca_topic_score_codex":0.000068767135,"about_ca_topic_score_gemma":0.000023395245,"teacher_disagreement_score":0.13301998,"about_ca_system_score_codex":0.00007317941,"about_ca_system_score_gemma":0.00007219875,"threshold_uncertainty_score":0.35562524},"labels":[],"label_agreement":null},{"id":"W2593329670","doi":"10.1182/blood.v118.21.1271.1271","title":"Early Appearance and Rapid, Selective Expansion of Lymphoid-Deficient Fetal HSCs Associated with Their Preferential Localization in the Marrow","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Haematopoiesis; Stem cell; Bone marrow; Biology; Lymphopoiesis; Myeloid; Progenitor cell; Fetus; clone (Java method); Immunology; Cell biology; Genetics; Gene","score_opus":0.03005126138675631,"score_gpt":0.23626426566886238,"score_spread":0.20621300428210607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593329670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99460274,0.00041874376,0.00031391217,0.000018535258,0.000013553588,0.0005907551,0.0000038598687,0.000013721973,0.00402415],"genre_scores_gemma":[0.9997721,0.000044161203,0.000035764213,0.000024964618,0.0000147736755,0.000023594323,0.000008996964,0.000013066625,0.00006260844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882257,0.00019376256,0.00017088401,0.00020137134,0.00040273555,0.00020867311],"domain_scores_gemma":[0.9994937,0.000053998574,0.00007952128,0.00017513143,0.00014855772,0.000049064405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044261193,0.0001031966,0.00019219561,0.00008358559,0.000047711135,0.000009601983,0.0000844139,0.000076278266,0.000026873646],"category_scores_gemma":[0.00010711688,0.00005949843,0.000025901501,0.0003932435,0.000100876314,0.000047654343,0.000030069677,0.00013082522,0.0000020840869],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020514259,0.0035442824,0.9152437,0.0002863636,0.00029860478,0.00006374324,0.026387973,0.000017430368,0.046786543,0.0002396533,0.000055019354,0.005025287],"study_design_scores_gemma":[0.007341243,0.002244735,0.86206836,0.00050124305,0.00012250242,0.000055369288,0.0010719224,0.0012466738,0.12511967,0.000067238805,0.00001995496,0.00014108176],"about_ca_topic_score_codex":0.00023682466,"about_ca_topic_score_gemma":0.00007758835,"teacher_disagreement_score":0.07833313,"about_ca_system_score_codex":0.000025954918,"about_ca_system_score_gemma":0.000093537754,"threshold_uncertainty_score":0.24262756},"labels":[],"label_agreement":null},{"id":"W2593333702","doi":"10.1182/blood.v116.21.1153.1153","title":"Herpesviruses Enhance Fibrinogen Clot Lysis.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services","funders":"","keywords":"Plasmin; Plasminogen activator; Annexin A2; Herpes simplex virus; Virus; Biology; Coagulation; Fibrin; Fibrinolysis; Protease; Fibrinogen; Molecular biology; Virology; Chemistry; Annexin; Immunology; Biochemistry; Medicine; Flow cytometry; Enzyme","score_opus":0.008203399578816368,"score_gpt":0.2579798200422639,"score_spread":0.24977642046344753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593333702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90819865,0.00015644237,0.00008633602,0.00070110644,0.0001732337,0.00019402681,0.0000042094925,0.00012393373,0.09036208],"genre_scores_gemma":[0.9852373,0.000025338888,0.0059800963,0.0010335481,0.0005185886,0.00002547435,0.0000096449985,0.00002429546,0.0071456945],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99916476,0.0000069359444,0.00015806424,0.00024293711,0.00020843445,0.00021889198],"domain_scores_gemma":[0.99929136,0.000026244958,0.000049569215,0.00049137545,0.00003797081,0.00010350027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000085050895,0.00011777797,0.0001856141,0.00005067475,0.000033421627,0.000012554408,0.00012428225,0.00006879517,0.0006542313],"category_scores_gemma":[0.00008727103,0.000103498234,0.00008185221,0.00011368005,0.000048634283,0.00004066521,0.00009320467,0.00019802751,0.0005011514],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032989807,0.0005093017,0.039624255,0.000064350905,0.00035532107,0.00011365555,0.00009552697,1.6390801e-7,0.9035074,0.00021400789,0.044944,0.0105389925],"study_design_scores_gemma":[0.0009797093,0.000059760943,0.011946076,0.000017181423,0.00030292393,0.000050237646,0.000021313306,0.0000041758726,0.63603705,0.000011361267,0.35046706,0.00010314051],"about_ca_topic_score_codex":0.000031044787,"about_ca_topic_score_gemma":0.000015266194,"teacher_disagreement_score":0.30552307,"about_ca_system_score_codex":0.000007349651,"about_ca_system_score_gemma":0.000028318744,"threshold_uncertainty_score":0.7163374},"labels":[],"label_agreement":null},{"id":"W2593342731","doi":"10.1182/blood.v128.22.4307.4307","title":"The Clonal Origins of Leukemic Progression of Myelodysplasia","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Exome sequencing; Deep sequencing; Oncology; Biology; Exome; Internal medicine; Medicine; Mutation; Genetics; Gene; Genome","score_opus":0.014063405181400469,"score_gpt":0.30235367060497886,"score_spread":0.2882902654235784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593342731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99521744,0.00040414286,0.000037885336,0.0013059628,0.000050057733,0.000289594,0.000013125295,0.000021233667,0.0026605306],"genre_scores_gemma":[0.99750566,0.0003230881,0.0007201249,0.000018656152,0.00012432244,0.00001830115,0.000002751521,0.000016622127,0.0012704883],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988309,0.000045463563,0.00026999807,0.00014652636,0.0004633098,0.00024379928],"domain_scores_gemma":[0.99894506,0.0002794228,0.00011782098,0.00039118566,0.00017790851,0.000088627574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033426,0.00008764095,0.00020258705,0.00006272725,0.00004741816,0.000003143078,0.0001919593,0.00007600362,0.00006476491],"category_scores_gemma":[0.00027722507,0.00003834468,0.00007906748,0.00016726764,0.00030173958,0.000036653433,0.0000823498,0.00012864063,0.000034856293],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004858081,0.00034885237,0.05163413,0.0001156113,0.00017676476,0.00003354127,0.00008529702,7.2428705e-8,0.8928282,0.005484386,0.0017646626,0.047042638],"study_design_scores_gemma":[0.007337179,0.00086009735,0.056015782,0.00051074964,0.00013098885,0.00015291672,0.000050689083,0.00001541776,0.90830487,0.0002536985,0.026282692,0.00008489385],"about_ca_topic_score_codex":0.000022962806,"about_ca_topic_score_gemma":0.0000034911195,"teacher_disagreement_score":0.046957746,"about_ca_system_score_codex":0.00013995521,"about_ca_system_score_gemma":0.00059287803,"threshold_uncertainty_score":0.15636507},"labels":[],"label_agreement":null},{"id":"W2593352694","doi":"10.1182/blood.v104.11.3085.3085","title":"Survival of HIV Infected Individuals with Hemophilia after 20 Years: From the Canadian Hemophilia Registry.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Human immunodeficiency virus (HIV); Cause of death; Cohort; Mortality rate; Pediatrics; Internal medicine; Surgery; Immunology; Disease","score_opus":0.01601164867097944,"score_gpt":0.25323618209433557,"score_spread":0.23722453342335614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593352694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98968095,0.0003415059,0.0000013461956,0.0059916787,0.000052170202,0.0005396769,0.0003116999,0.000036370686,0.003044632],"genre_scores_gemma":[0.9973647,0.000030221378,0.00044686804,0.00022966015,0.00028425764,0.000036712674,0.00023658856,0.000036164,0.0013348277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983316,0.000056355155,0.000237701,0.00031276708,0.00061255984,0.00044901588],"domain_scores_gemma":[0.9986548,0.00008997577,0.000066305096,0.00068427325,0.00013516736,0.0003695147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019246418,0.00020168218,0.00034153106,0.000118427604,0.000095433184,0.000037302332,0.00020998434,0.00016937206,0.0003696563],"category_scores_gemma":[0.00010752022,0.00012375739,0.000096369695,0.00040590047,0.00027412234,0.00005634675,0.000049420763,0.00032636808,0.00012760864],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014162662,0.00055312406,0.99533546,0.000028423561,0.00062246347,0.0008553836,0.00080011523,0.00000308281,0.0008107232,0.000109697205,0.00049807597,0.00024179985],"study_design_scores_gemma":[0.0077948994,0.00037984384,0.9790055,0.00023869131,0.0004186582,0.00006534549,0.000101136124,8.6721553e-7,0.0063712634,0.00037372136,0.0050691497,0.00018093236],"about_ca_topic_score_codex":0.041000195,"about_ca_topic_score_gemma":0.11602362,"teacher_disagreement_score":0.07502343,"about_ca_system_score_codex":0.00010483456,"about_ca_system_score_gemma":0.0011710417,"threshold_uncertainty_score":0.96538585},"labels":[],"label_agreement":null},{"id":"W2593360865","doi":"10.1182/blood.v128.22.4434.4434","title":"Multiple Myeloma Cancer Stem Cells: Immunophenotypic and Functional Characterization, Gene Expression Profiling and Therapeutic Targets","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CD34; CD19; Stem cell; Flow cytometry; Cancer stem cell; Cancer research; Multiple myeloma; Bone marrow; CD20; Medicine; Molecular biology; Biology; Antibody; Immunology; Genetics","score_opus":0.02461289194391677,"score_gpt":0.25612523782062036,"score_spread":0.23151234587670358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593360865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994953,0.003635264,0.00053582905,0.00021648023,0.00007979589,0.00044745815,0.00006969981,0.000042179207,0.000020289306],"genre_scores_gemma":[0.9972813,0.0008792506,0.00062823284,0.00005772862,0.0001340671,0.00012617117,0.00004322545,0.00002284647,0.0008271662],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991184,0.000039622577,0.00014471637,0.00027719507,0.00019392918,0.00022616108],"domain_scores_gemma":[0.99950266,0.000063894324,0.000051658473,0.00015254258,0.00008287477,0.00014637045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006592321,0.00013317229,0.00016172882,0.00006053403,0.00013077841,0.0000186046,0.000026945467,0.000060967115,0.00013135107],"category_scores_gemma":[0.000013677444,0.00007986812,0.000023867817,0.000053357293,0.00006918834,0.000081132755,0.000045666595,0.0000595042,0.000015247894],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026425513,0.00016141558,0.20934829,0.000043378415,0.000109975765,0.000012301439,0.000061271,7.749208e-8,0.7595718,0.0000068392105,0.000003851905,0.030416552],"study_design_scores_gemma":[0.004981716,0.00009270548,0.3778935,0.000085372885,0.000049741262,0.000018228373,0.000014442476,0.000048060265,0.6165304,0.000011863636,0.00020558202,0.00006836369],"about_ca_topic_score_codex":0.000009818025,"about_ca_topic_score_gemma":0.0000024019673,"teacher_disagreement_score":0.16854523,"about_ca_system_score_codex":0.000024757126,"about_ca_system_score_gemma":0.000059753595,"threshold_uncertainty_score":0.32569277},"labels":[],"label_agreement":null},{"id":"W2593373924","doi":"10.1182/blood.v108.11.1256.1256","title":"Expression of Immune Memory Markers CD8 α α and Interleukin−7 Receptor on CD8+ T Cell Subsets among HIV−1 Infected Patients.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"CD38; CD8; Immunology; Biology; Interleukin-7 receptor; Cytotoxic T cell; Memory T cell; Immune system; T cell; Memory cell; IL-2 receptor; Cell biology; CD34","score_opus":0.0032920108051921466,"score_gpt":0.17450214503919872,"score_spread":0.17121013423400658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593373924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98755604,0.00051879225,0.000011536386,0.000014651155,0.0014760159,0.00021700302,0.000011094786,0.0000599545,0.010134937],"genre_scores_gemma":[0.9902917,0.00004664715,0.000026943162,0.00003032746,0.00002403723,0.000013549201,0.00050027407,0.000019874418,0.009046647],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99892926,0.00017416841,0.00040471426,0.000245222,0.000040996478,0.00020563355],"domain_scores_gemma":[0.99931395,0.00008900641,0.00026005652,0.00023361319,0.000088661924,0.000014688712],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00010473273,0.00017955976,0.00023246637,0.00015373713,0.00010284893,0.000010926561,0.000093467184,0.00022336456,0.0014109691],"category_scores_gemma":[0.000043465796,0.00015848324,0.000093004186,0.00008587859,0.00012378948,0.00012954853,0.00006195032,0.0002675457,0.00026411517],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047566954,0.0010086378,0.029327922,0.000027509106,0.00004521524,5.424182e-7,0.00012627807,0.0000018200952,0.95224786,0.000008161461,0.016359402,0.00037101348],"study_design_scores_gemma":[0.003701249,0.0004138016,0.109340414,0.00010407749,0.000049472357,0.000003337472,0.0001241831,8.4456263e-7,0.8785892,0.000004020333,0.0075202174,0.00014915141],"about_ca_topic_score_codex":0.0001728436,"about_ca_topic_score_gemma":0.00000693809,"teacher_disagreement_score":0.080012485,"about_ca_system_score_codex":0.00002201162,"about_ca_system_score_gemma":0.0000121626845,"threshold_uncertainty_score":0.9995019},"labels":[],"label_agreement":null},{"id":"W2593404771","doi":"10.1182/blood.v114.22.393.393","title":"Histone Demethylases as Modulators of Hematopoietic Cell Fate.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Biology; Stem cell; Molecular biology; Gene knockdown; Haematopoiesis; H3K4me3; Hematopoietic stem cell; Gene expression; Gene; Cell biology; Genetics; Promoter","score_opus":0.0046759403592214034,"score_gpt":0.23682938729687114,"score_spread":0.23215344693764975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593404771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99361277,0.0039454224,0.00024449005,0.000073582494,0.00006888413,0.000104358944,0.000004643657,0.000013149412,0.0019327309],"genre_scores_gemma":[0.99851555,0.00013375233,0.0004947169,0.0000561084,0.00009949451,0.000003339088,0.000038574686,0.000012521649,0.0006459406],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99934727,0.000021076074,0.00017979319,0.00020629773,0.00011074446,0.00013479097],"domain_scores_gemma":[0.9995202,0.000004020371,0.00009340552,0.00028045158,0.000052062132,0.000049867594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000053351712,0.00010289498,0.00011984929,0.000037955688,0.000026291227,0.0000041841454,0.00009293791,0.00013093225,0.000026888729],"category_scores_gemma":[0.000021930777,0.00010772376,0.00008066661,0.000088158806,0.000034886143,0.0000019702213,0.0000216552,0.00004024115,0.000011438241],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021045153,0.00022026042,0.00035235583,0.000014601655,0.000024753197,0.0000013268118,0.000027948588,0.00028744698,0.9973531,0.000057823316,0.00046499338,0.001174361],"study_design_scores_gemma":[0.0007687179,0.00035318127,0.0029466755,0.000010217433,0.00005920878,0.00001690569,0.000012181738,0.0000148992385,0.9933238,0.0002961153,0.002077814,0.00012027358],"about_ca_topic_score_codex":0.000012892229,"about_ca_topic_score_gemma":0.0000032844835,"teacher_disagreement_score":0.004902814,"about_ca_system_score_codex":0.000008501782,"about_ca_system_score_gemma":0.000051248986,"threshold_uncertainty_score":0.43928474},"labels":[],"label_agreement":null},{"id":"W2593437745","doi":"10.1182/blood-2016-09-742148","title":"Activation of the LMO2 oncogene through a somatically acquired neomorphic promoter in T-cell acute lymphoblastic leukemia","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Hospital for Sick Children; University College London; Leukaemia and Lymphoma Research; Alex's Lemonade Stand Foundation for Childhood Cancer; National Institute for Health and Care Research; National Cancer Institute; National Institutes of Health; Hope Funds for Cancer Research; Cancer Research UK","keywords":"Cancer research; MYB; Biology; RUNX1; Mutant; Leukemia; Mutation; Transcription factor; Molecular biology; Gene; Cell biology; Genetics","score_opus":0.020629491302079445,"score_gpt":0.280517488381667,"score_spread":0.25988799707958754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593437745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906004,0.000031294076,0.00049392926,0.0013326689,0.00010310935,0.00091544224,0.000013770566,0.000030649964,0.006478741],"genre_scores_gemma":[0.9964491,0.000028955454,0.0019340117,0.00025697215,0.00014939548,0.00006316106,0.000010295859,0.00004709163,0.0010609855],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978112,0.00009034053,0.0004993217,0.00037398288,0.0007548174,0.00047035102],"domain_scores_gemma":[0.9977772,0.00019441897,0.00034324938,0.0013966596,0.00017364758,0.00011480853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027428445,0.00023382196,0.0004848145,0.00008586311,0.00019522058,0.00005462966,0.00067620724,0.00022483636,0.000090251946],"category_scores_gemma":[0.0008046003,0.00015755494,0.00014828017,0.00021239856,0.0003969085,0.00024285889,0.00038905558,0.00019639388,0.000056775218],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073949294,0.0018536975,0.020907553,0.00065601716,0.00043351544,0.00033402795,0.0014602888,0.00002971476,0.97143936,0.00028088345,0.00060694147,0.0012584935],"study_design_scores_gemma":[0.027014319,0.00061844545,0.10198269,0.0011142106,0.0006187391,0.0003382192,0.000086246284,0.0043829908,0.8623102,0.0010588743,0.0001851781,0.000289895],"about_ca_topic_score_codex":0.0002581722,"about_ca_topic_score_gemma":0.000021306445,"teacher_disagreement_score":0.10912918,"about_ca_system_score_codex":0.00062999025,"about_ca_system_score_gemma":0.0019936822,"threshold_uncertainty_score":0.6424904},"labels":[],"label_agreement":null},{"id":"W2593439184","doi":"10.1182/blood.v124.21.1295.1295","title":"Targeting Patient at High Risk of Thrombocytopenia and Neutropenia with Cybord, Vel-Dex and VMP: Time to Decrease the Number of Blood Tests ?","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Neutropenia; Medicine; Bortezomib; McNemar's test; Retrospective cohort study; Internal medicine; Absolute neutrophil count; Complete blood count; Surgery; Multiple myeloma; Toxicity","score_opus":0.005989839501110271,"score_gpt":0.23969021144305458,"score_spread":0.23370037194194432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593439184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981652,0.00019891615,0.000002774993,0.00016247283,0.0000058423957,0.0006618243,0.000056632147,0.000013041634,0.00073327724],"genre_scores_gemma":[0.99647105,0.000061683895,0.003110299,0.000065065724,0.000029283663,0.000029389274,0.000021702128,0.000023533301,0.00018801012],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998825,0.00011527546,0.00022703616,0.00026518916,0.00031507763,0.0002524327],"domain_scores_gemma":[0.99876326,0.00025820904,0.00013390149,0.00032245708,0.00013264215,0.00038951632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018871746,0.00016192417,0.00038264447,0.000038405928,0.00010271693,0.000013140098,0.00007405596,0.000041702813,0.00023890367],"category_scores_gemma":[0.00051941536,0.00009014891,0.000030024723,0.00012208936,0.00013328923,0.000040857212,0.00016260373,0.00009959306,0.000039115246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090103626,0.0009818372,0.96230906,0.00009905964,0.00056652224,0.000053557455,0.00036478613,0.0000030542371,0.03054114,0.000021159478,0.00013740094,0.0040213754],"study_design_scores_gemma":[0.012848861,0.0026456064,0.900751,0.00021675556,0.0012208701,0.00019407265,0.000051873154,0.000108356435,0.08135097,0.000027524678,0.0004187642,0.00016537671],"about_ca_topic_score_codex":0.00082466396,"about_ca_topic_score_gemma":0.000056205565,"teacher_disagreement_score":0.0615581,"about_ca_system_score_codex":0.000009110075,"about_ca_system_score_gemma":0.00005489991,"threshold_uncertainty_score":0.3676166},"labels":[],"label_agreement":null},{"id":"W2593443444","doi":"10.1182/blood.v128.22.194.194","title":"Molecular Predictors of Outcome and Drug Response in Multiple Myeloma: An Interim Analysis of the Mmrf CoMMpass Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Interim analysis; Interquartile range; Cohort; Multiple myeloma; Exome sequencing; Univariate analysis; Clinical trial; Regimen; Bortezomib; Exome; Oncology; Surgery; Multivariate analysis; Mutation; Biology; Genetics","score_opus":0.029945130256521853,"score_gpt":0.3243466149619323,"score_spread":0.29440148470541044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593443444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99898124,0.000070817485,0.00000830739,0.00022049536,0.000016877917,0.00059587025,0.0000691268,0.000010075224,0.000027209127],"genre_scores_gemma":[0.999805,0.000004996131,0.000059299913,0.000013273607,0.000005415898,0.000028856028,0.0000043794507,0.000011268133,0.000067522065],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984439,0.0004662487,0.0003615205,0.00021157498,0.0003418089,0.00017493354],"domain_scores_gemma":[0.99879414,0.00032587437,0.00010370349,0.0005832388,0.00007469935,0.00011836706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005497519,0.00011361643,0.00044059675,0.0003393785,0.000023930139,0.000004299338,0.00014658317,0.000035298788,0.000018690738],"category_scores_gemma":[0.000710839,0.000058199366,0.000111582514,0.00048667964,0.00013283164,0.000046253204,0.00012914906,0.00007553614,8.145673e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018200182,0.0031275698,0.9547672,0.00001929499,0.0015088898,0.0000795244,0.000991587,0.0000018034262,0.03727696,0.000002431602,0.0000021898275,0.00040247603],"study_design_scores_gemma":[0.010586745,0.00089874415,0.96269846,0.0000482965,0.0009939693,0.0000024647052,0.0006080611,0.00010062845,0.02400567,0.0000023462892,0.000005035029,0.000049568793],"about_ca_topic_score_codex":0.00043228522,"about_ca_topic_score_gemma":0.0008332193,"teacher_disagreement_score":0.013271293,"about_ca_system_score_codex":0.000027342605,"about_ca_system_score_gemma":0.000039327493,"threshold_uncertainty_score":0.23733012},"labels":[],"label_agreement":null},{"id":"W2593447424","doi":"10.1182/blood.v108.11.3383.3383","title":"AMD3100 with G-CSF for Autologous Peripheral Blood Progenitor Cell (PBPC) Mobilization in Non-Hodgkin’s Lymphoma (NHL) and Multiple Myeloma (MM): Mobilization, Engraftment, and Pharmacokinetics (PK).","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Leukapheresis; Apheresis; Filgrastim; Urology; CD34; Transplantation; Multiple myeloma; Progenitor cell; Granulocyte colony-stimulating factor; Internal medicine; Chemotherapy; Stem cell; Platelet","score_opus":0.005669353608637306,"score_gpt":0.22627583363586476,"score_spread":0.22060648002722746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593447424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940106,0.0021152901,0.00017826424,0.00010131594,0.00006153061,0.003192205,0.00006264057,0.00008991902,0.00018821424],"genre_scores_gemma":[0.99256027,0.000322116,0.0051594707,0.000114980096,0.0001609725,0.0011890206,0.0002368083,0.00006381828,0.00019257516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983625,0.00004041782,0.00040258083,0.000579175,0.00021804123,0.00039729418],"domain_scores_gemma":[0.9991896,0.00010982213,0.0001433266,0.00023842417,0.00016551166,0.00015330882],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009498534,0.00035023078,0.00042339842,0.0001384693,0.00013529428,0.00006823116,0.000059053982,0.00014299764,0.000011846443],"category_scores_gemma":[0.000023883002,0.0002839062,0.000058511436,0.000228238,0.000107496104,0.00011554785,0.00003843893,0.00004736173,0.0000016617902],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043149627,0.008612484,0.9703975,0.00039316402,0.00022297078,0.0001711608,0.00045845745,0.00017723395,0.013379737,0.000047746456,0.00016314615,0.0055449368],"study_design_scores_gemma":[0.07556322,0.0029968407,0.63296366,0.00015993381,0.0016794377,0.00043709195,0.00022582668,0.005955608,0.2779054,0.000049017166,0.0015704774,0.0004934613],"about_ca_topic_score_codex":0.00020109053,"about_ca_topic_score_gemma":0.00019544575,"teacher_disagreement_score":0.3374338,"about_ca_system_score_codex":0.00009034519,"about_ca_system_score_gemma":0.000120056844,"threshold_uncertainty_score":0.9999613},"labels":[],"label_agreement":null},{"id":"W2593453782","doi":"10.1182/blood.v106.11.3120.3120","title":"Trend of Drug Approval on Hematological Malignancies in the U.S. and Japan.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Clinical trial; Drug; Drug approval; Approved drug; Drug development; Clinical research; Internal medicine; Pharmacology","score_opus":0.021966871190867134,"score_gpt":0.2824456067603153,"score_spread":0.26047873556944817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593453782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99133515,0.00080952,4.011358e-7,0.0011822564,0.000007398767,0.00019621538,0.0000024602803,0.000010721572,0.0064558554],"genre_scores_gemma":[0.9990982,0.00006528307,0.00021885897,0.00023025827,0.00006574903,0.000016707152,0.0000030733872,0.0000056821914,0.00029619783],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99917984,0.00004488316,0.00015940308,0.00014542922,0.00028723685,0.00018320119],"domain_scores_gemma":[0.99950826,0.000199539,0.000025760253,0.00021607976,0.000009377387,0.000041008603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030070663,0.00007261379,0.00018962282,0.000058520636,0.000018407309,0.000006490445,0.000092103706,0.00004818153,0.00002949242],"category_scores_gemma":[0.00010556212,0.000040272134,0.00003448645,0.00012917237,0.00014222339,0.00001927488,0.000036490463,0.00013061674,0.000009630318],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007935462,0.07843642,0.17387897,0.00863899,0.0016025482,0.007910219,0.14043513,0.0001520329,0.0723591,0.17774515,0.05695648,0.2739495],"study_design_scores_gemma":[0.33951217,0.0039709317,0.24325925,0.0018671759,0.0007717962,0.01526785,0.014140109,0.005530935,0.33510402,0.0019739587,0.03747383,0.0011279712],"about_ca_topic_score_codex":0.00006305992,"about_ca_topic_score_gemma":0.00006808188,"teacher_disagreement_score":0.3315767,"about_ca_system_score_codex":0.00018407161,"about_ca_system_score_gemma":0.00027139063,"threshold_uncertainty_score":0.164225},"labels":[],"label_agreement":null},{"id":"W2593462836","doi":"10.1182/blood.v128.22.619.619","title":"Phase 1b Study of Pembrolizumab in Patients with Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma: Results from the Ongoing Keynote-013 Trial","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pembrolizumab; Tolerability; Refractory (planetary science); Internal medicine; Oncology; Population; Lymphoma; Phases of clinical research; Clinical trial; Surgery; Adverse effect; Cancer; Immunotherapy","score_opus":0.011302247285985749,"score_gpt":0.2363130380389587,"score_spread":0.22501079075297295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593462836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967365,0.00020266096,0.0000016154486,0.0001450739,0.00015287106,0.0017112832,0.0003102414,0.00003012203,0.0007095815],"genre_scores_gemma":[0.99924743,0.00003352203,0.000065580556,0.000104622195,0.00021167971,0.00011355593,0.00012411669,0.000032215194,0.00006727021],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9977359,0.00016896079,0.0006197765,0.0004641323,0.00067564717,0.00033555157],"domain_scores_gemma":[0.99793196,0.0008509278,0.00033366217,0.0006498553,0.000105193634,0.0001284084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026547586,0.00025546257,0.00051730353,0.000088018234,0.00007172922,0.000012128641,0.00015935818,0.00009018029,0.000025103951],"category_scores_gemma":[0.00024320124,0.00012193151,0.000087937864,0.00016970582,0.000056188066,0.00010368557,0.00008331108,0.000082010025,0.000022021426],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16988748,0.45191485,0.36224216,0.000021697495,0.0004216059,0.00029766356,0.0024573233,1.4664748e-7,0.0001882562,0.0000038493117,0.0004815653,0.012083423],"study_design_scores_gemma":[0.57338595,0.011672412,0.41317785,0.00019122307,0.00042084136,0.0000018044379,0.00016085543,6.029948e-7,0.0006934676,0.0000024562007,0.00019812782,0.00009442573],"about_ca_topic_score_codex":0.00037416338,"about_ca_topic_score_gemma":0.0001542475,"teacher_disagreement_score":0.44024244,"about_ca_system_score_codex":0.00017912856,"about_ca_system_score_gemma":0.0002853926,"threshold_uncertainty_score":0.49722227},"labels":[],"label_agreement":null},{"id":"W2593462923","doi":"10.1182/blood.v126.23.4387.4387","title":"Influence of Matched Sibling Donor's Availability and Stem Cell Transplantation on Treatment Outcome for Acute Lymphoblastic Leukemia; Study on 294 Patients","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Hematopoietic stem cell transplantation; Transplantation; Internal medicine; Sibling; Leukemia; Acute lymphocytic leukemia; Acute leukemia; Surgery; Lymphoblastic Leukemia","score_opus":0.03558754654130561,"score_gpt":0.31008698950512914,"score_spread":0.27449944296382356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593462923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99713826,0.000017372444,0.000085085805,0.00003353059,0.00004610014,0.0023389035,0.00013219185,0.000042152304,0.00016637196],"genre_scores_gemma":[0.9991963,0.000020433137,0.00024534584,0.000060975337,0.00003518797,0.00017476405,0.000042086343,0.000033703152,0.00019121259],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99801475,0.00008305229,0.00052468455,0.00046986184,0.00059090037,0.0003167307],"domain_scores_gemma":[0.9983277,0.0005539079,0.00015536134,0.00040802205,0.0002851583,0.00026990732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030725356,0.0002677205,0.0005394258,0.00018982601,0.000056346526,0.000018171715,0.00010802782,0.000106736166,0.0000023681794],"category_scores_gemma":[0.00009905279,0.00019521233,0.00007593863,0.00019012649,0.000068854104,0.00008314291,0.000026621281,0.00009159929,0.000021791595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00767463,0.009105658,0.9691689,0.00060310407,0.00059247424,0.000093506016,0.006289886,0.0012494507,0.004075321,0.000011356712,0.000031517447,0.0011041745],"study_design_scores_gemma":[0.11565412,0.035952475,0.7447313,0.00023325179,0.0027969396,0.00002719901,0.0012290756,0.00089501106,0.09805852,0.000035344605,0.000020623615,0.00036610683],"about_ca_topic_score_codex":0.00013767679,"about_ca_topic_score_gemma":0.000012541857,"teacher_disagreement_score":0.2244376,"about_ca_system_score_codex":0.0011605127,"about_ca_system_score_gemma":0.0005362315,"threshold_uncertainty_score":0.79605275},"labels":[],"label_agreement":null},{"id":"W2593487892","doi":"10.1182/blood.v128.22.5975.5975","title":"Characterization and Management of Synchronous Dual Hematological Malignancies","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Regional Health Centre","funders":"","keywords":"Medicine; Concomitant; Multiple myeloma; Internal medicine; Malignancy; Lymphoma; Lymphoproliferative disorders; Monoclonal gammopathy of undetermined significance; Hematology; Asymptomatic; Pediatrics; Immunology; Monoclonal","score_opus":0.014183194939847037,"score_gpt":0.23338348081457963,"score_spread":0.2192002858747326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593487892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975372,0.0001734913,0.00045715438,0.0003540371,0.000028743618,0.00014345963,0.0000118347025,0.000018526518,0.001275542],"genre_scores_gemma":[0.99798506,0.0007657908,0.0005348092,0.000121933714,0.000023681496,0.000009673736,0.000010750008,0.000004398665,0.0005439218],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9996257,0.0000071307454,0.00011245139,0.0001039717,0.00007102547,0.00007972554],"domain_scores_gemma":[0.9998091,0.000011837007,0.00003594797,0.00009114469,0.00001617589,0.000035819838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000035748584,0.000050093306,0.00013122836,0.000021892216,0.000013742573,0.0000021818064,0.000016902311,0.000028393888,0.00015745741],"category_scores_gemma":[0.0000046977875,0.000030307,0.000019777844,0.000027051537,0.000048232465,0.000037908787,0.00002394166,0.000015002288,0.000005895635],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013885343,0.000341213,0.06538732,0.0007542969,0.00021713143,0.00022740188,0.00013047102,2.2070546e-8,0.88081485,0.0028502285,0.00006811686,0.049070068],"study_design_scores_gemma":[0.0062804385,0.00040429248,0.7796464,0.00042876744,0.00023154954,0.00029423382,0.00006166237,0.0000038786775,0.20722523,0.00003499295,0.005266909,0.0001216518],"about_ca_topic_score_codex":0.0000010190184,"about_ca_topic_score_gemma":3.337997e-7,"teacher_disagreement_score":0.7142591,"about_ca_system_score_codex":0.000007649407,"about_ca_system_score_gemma":0.0000136037115,"threshold_uncertainty_score":0.17240481},"labels":[],"label_agreement":null},{"id":"W2593488431","doi":"10.1182/blood.v112.11.3559.3559","title":"Zebrafish Mast Cells Demonstrate Conserved Innate and Adaptive Immune Responses","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Zebrafish; Biology; Innate immune system; Cell biology; Immune system; Tryptase; Acquired immune system; Degranulation; TLR2; Immunology; Mast cell; Receptor","score_opus":0.015831793911755244,"score_gpt":0.19546668345737506,"score_spread":0.17963488954561982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593488431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98924536,0.005957848,0.000014268285,0.00010757279,0.00019620245,0.00015065148,0.0000778872,0.00006572142,0.004184507],"genre_scores_gemma":[0.98545164,0.0004572972,0.00023125831,0.00011005991,0.000017696802,0.000009835619,0.000026193266,0.00001590239,0.013680137],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99900097,0.00016707456,0.00024708748,0.0002643458,0.00002420855,0.0002963368],"domain_scores_gemma":[0.99948406,0.00012703637,0.00009570091,0.00020841381,0.000054039203,0.00003073945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013450565,0.00016986186,0.00027056673,0.00007767147,0.00028034308,0.000010070398,0.000115781324,0.00017213047,0.00049861585],"category_scores_gemma":[0.00002401247,0.0001565361,0.00005547846,0.00008687558,0.00053331355,0.00005397637,0.00007839848,0.00021401198,0.00026918936],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049153005,0.0002988958,0.0023665342,0.000012478016,0.0001691221,0.00013503878,0.00037152835,1.9441856e-7,0.9944522,0.00029844034,0.0010494172,0.00035466868],"study_design_scores_gemma":[0.004962246,0.0004469497,0.043359064,0.000030030704,0.00009893241,0.000870299,0.0002170717,0.0000018584268,0.9242333,0.000051731262,0.025425723,0.0003027612],"about_ca_topic_score_codex":0.00014327186,"about_ca_topic_score_gemma":0.000038004204,"teacher_disagreement_score":0.070218824,"about_ca_system_score_codex":0.0000053480912,"about_ca_system_score_gemma":0.0000654596,"threshold_uncertainty_score":0.6383357},"labels":[],"label_agreement":null},{"id":"W2593506840","doi":"10.1182/blood.v114.22.549.549","title":"Loss of Tafazzin (TAZ) Function and Accelerated Apoptosis of Human Bone Marrow Stem and Myeloid Progenitors in Barth Syndrome.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Progenitor cell; Bone marrow; Biology; Cardiolipin; Stem cell; Haematopoiesis; Myeloid; Cell biology; Immunology; Cancer research; Genetics","score_opus":0.012161379096048964,"score_gpt":0.22666406263209726,"score_spread":0.2145026835360483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593506840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989813,0.0005417999,0.000023998748,0.00003412839,0.00007136102,0.00016860521,0.000010778257,0.000005688246,0.00016233958],"genre_scores_gemma":[0.99954134,0.00007512522,0.00009725703,0.00004405737,0.000041838455,0.00000699563,0.000043829907,0.0000070786,0.00014246195],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99932426,0.000057164394,0.00022980709,0.00021725854,0.00005858796,0.00011289964],"domain_scores_gemma":[0.99967,0.000004776672,0.00008946196,0.0001355482,0.00005612711,0.00004405182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000097770295,0.00009882036,0.00018616377,0.00007193742,0.000027186408,0.0000057613215,0.00003814725,0.00015042843,0.000013929461],"category_scores_gemma":[0.000015320837,0.00009647631,0.00002934353,0.00009818356,0.00005823424,0.000004123415,0.000025361342,0.00005541145,5.1936155e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012236336,0.00018092366,0.029077819,0.000031481388,0.000024697874,0.0000032990479,0.000032397893,9.2384124e-7,0.96955186,0.0000560547,0.000038864604,0.0008793273],"study_design_scores_gemma":[0.002430604,0.0019863585,0.07610002,0.000023330693,0.000054464344,0.00009497012,0.0000709747,0.0000023786686,0.9188149,0.00006484013,0.00022530007,0.00013184185],"about_ca_topic_score_codex":0.000010016148,"about_ca_topic_score_gemma":0.000016993963,"teacher_disagreement_score":0.05073693,"about_ca_system_score_codex":0.000002043331,"about_ca_system_score_gemma":0.000015984495,"threshold_uncertainty_score":0.39341897},"labels":[],"label_agreement":null},{"id":"W2593523011","doi":"10.1182/blood.v118.21.4319.4319","title":"The Prevalence of Cardiovascular Risk Factors in Individuals with Hemophilia","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Medicine; Risk factor; Dyslipidemia; Population; Pediatrics; Internal medicine; Medical record; Diabetes mellitus; Disease","score_opus":0.030840209589490755,"score_gpt":0.25817109005352545,"score_spread":0.2273308804640347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593523011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99428415,0.0026800327,0.0000015755468,0.000026490228,0.000014074115,0.00040599794,0.000012868082,0.000012555729,0.0025622644],"genre_scores_gemma":[0.9974895,0.0016384983,0.00019481669,0.0000021936473,0.000019869007,0.00001978021,0.000001829746,0.000010950026,0.0006225574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900264,0.000079308804,0.00014527907,0.00016182315,0.00040033308,0.00021063781],"domain_scores_gemma":[0.99931955,0.00007687885,0.00003940597,0.0004437579,0.000050352148,0.00007006047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040783494,0.00009298793,0.0002124427,0.000065548535,0.00005342402,0.0000040293644,0.00012217961,0.00005124913,0.00004806682],"category_scores_gemma":[0.00009184752,0.000044116994,0.0001160742,0.00019565495,0.00014280567,0.00003080414,0.000033419503,0.0001552584,0.00000852447],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029873885,0.00041134589,0.99693316,0.00011650541,0.00077803066,0.00003624418,0.0008756089,7.769374e-7,0.000046014247,0.000021650918,0.000006684435,0.000744079],"study_design_scores_gemma":[0.0023340345,0.00047141837,0.9575376,0.00008699816,0.0006877385,0.000012393402,0.0001382936,0.0000014032436,0.038220882,0.00006845386,0.0003839575,0.000056841913],"about_ca_topic_score_codex":0.00024001657,"about_ca_topic_score_gemma":0.0000094995285,"teacher_disagreement_score":0.0393956,"about_ca_system_score_codex":0.00001028284,"about_ca_system_score_gemma":0.00006931943,"threshold_uncertainty_score":0.17990388},"labels":[],"label_agreement":null},{"id":"W2593530729","doi":"10.1182/blood.v108.11.684.684","title":"Rapid and Irreversible Alteration of the Ability of Hematopoietic Stem Cells To Execute Both Symmetric and Asymmetric Self-Renewal Divisions by Exposure to Reduced Steel Factor Concentrations with No Effect on Their Survival or Mitogenesis.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Haematopoiesis; Bone marrow; Stem cell; Biology; Population; Transplantation; Stromal cell; Myeloid; Immunology; Cell biology; Andrology; Molecular biology; Chemistry; Internal medicine; Cancer research; Medicine","score_opus":0.010715560156080052,"score_gpt":0.22356453585702604,"score_spread":0.212848975700946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593530729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99674964,0.0002525501,0.00027720266,0.00011106578,0.00011032804,0.0018671271,0.00020568287,0.00002953002,0.00039686286],"genre_scores_gemma":[0.99903756,0.000040735333,0.00066503685,0.000038027734,0.000030509407,0.000041329764,0.00001620363,0.000022701413,0.00010791872],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983159,0.00022649665,0.00043904752,0.00037435786,0.00042633442,0.00021790157],"domain_scores_gemma":[0.9983105,0.00084723753,0.00015162259,0.000382818,0.00014185409,0.00016596622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028536192,0.00022986326,0.00048823957,0.00021224483,0.00009432355,0.000021904427,0.0000928858,0.0000909808,0.000011644834],"category_scores_gemma":[0.000043554977,0.00013739475,0.00006496484,0.0010277134,0.00005133186,0.000050905877,0.000025599607,0.00008400986,0.0000023668294],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000498036,0.0010023895,0.055578437,0.0010020258,0.00017737692,0.0000039312113,0.0011504574,0.000019541749,0.93948704,0.00006455477,0.00014454317,0.0008716793],"study_design_scores_gemma":[0.0036976507,0.0032427153,0.09326458,0.00031785853,0.00042720887,0.000023479437,0.00014928637,0.000021583797,0.89864993,0.0000029421806,0.00004828932,0.00015449358],"about_ca_topic_score_codex":0.000078759665,"about_ca_topic_score_gemma":0.000023613695,"teacher_disagreement_score":0.040837113,"about_ca_system_score_codex":0.000033749333,"about_ca_system_score_gemma":0.00010172648,"threshold_uncertainty_score":0.5602795},"labels":[],"label_agreement":null},{"id":"W2593544935","doi":"10.1182/blood-2016-12-753830","title":"Perforin and CD107a testing is superior to NK cell function testing for screening patients for genetic HLH","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Manitoba","keywords":"Perforin; Genetic testing; Immunology; Medicine; Biology; Internal medicine; Immune system; CD8","score_opus":0.05584757049644236,"score_gpt":0.29571947426444817,"score_spread":0.23987190376800582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593544935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957396,0.00021368703,0.0013802146,0.00010662178,0.000055815904,0.0013034292,0.000014950944,0.000034311786,0.0011513807],"genre_scores_gemma":[0.9607902,0.0000043849764,0.03784932,0.00015736067,0.00017728185,0.00019888938,0.00001183584,0.000039396717,0.00077129266],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898124,0.000008225597,0.00022863658,0.0002799263,0.00016376539,0.00033821425],"domain_scores_gemma":[0.99901617,0.0001465337,0.0000919506,0.00030739466,0.00031986448,0.00011811893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018639555,0.00012530971,0.00021438053,0.00007150858,0.00074633106,0.000094630515,0.00010401679,0.00006498958,0.000011986257],"category_scores_gemma":[0.0017125896,0.00011755482,0.000048033446,0.000054762448,0.000037220667,0.00011198727,0.00009506628,0.000092033166,0.000008152348],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015558134,0.00015054879,0.8405616,0.00045836307,0.000031077318,0.0000014030401,0.00021210467,0.0000029055311,0.030717563,0.0000016032644,0.0003401911,0.12736703],"study_design_scores_gemma":[0.00899431,0.003434362,0.96027076,0.00027465113,0.00020449201,0.0000066344346,0.00021207733,0.0034294268,0.017528588,0.00003218004,0.005395644,0.00021688794],"about_ca_topic_score_codex":0.00005252794,"about_ca_topic_score_gemma":0.0000030663987,"teacher_disagreement_score":0.12715015,"about_ca_system_score_codex":0.000009966335,"about_ca_system_score_gemma":0.00005779454,"threshold_uncertainty_score":0.57402503},"labels":[],"label_agreement":null},{"id":"W2593597398","doi":"10.1182/blood.v110.11.4867.4867","title":"A Rapid Automated Method for the Sequential Isolation of CD19, CD3 and Myeloid Cells from One Tube of Whole Blood.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; Stemcell Technologies","funders":"","keywords":"Myeloid; CD19; Biology; Immunomagnetic separation; Immunology; Transplantation; Haematopoiesis; Immune system; Leukapheresis; T cell; Molecular biology; CD34; Stem cell; Medicine; Cell biology; Internal medicine","score_opus":0.023076499224552606,"score_gpt":0.29005577225603774,"score_spread":0.2669792730314851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593597398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8870051,0.0005734165,0.11093183,0.00015301327,0.00008716118,0.0007976892,0.000119233366,0.00006575108,0.00026679164],"genre_scores_gemma":[0.89501655,0.0000729416,0.104606345,0.00005134537,0.00009230385,0.000012212015,0.00007866182,0.000020644324,0.00004900932],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99894905,0.000051179588,0.00044290078,0.0001778832,0.00022389801,0.00015510894],"domain_scores_gemma":[0.9986698,0.0007672215,0.00017155345,0.00021451767,0.00011944479,0.000057482503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006945132,0.00010674969,0.00030566775,0.00007626979,0.000037754857,0.000005813674,0.00005841818,0.00011351829,0.00005276784],"category_scores_gemma":[0.000045015833,0.0000838741,0.00007644525,0.0001352426,0.00005531245,0.000037111906,0.000010739994,0.0000711825,0.0000023122755],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021289926,0.00036984688,0.0016006546,0.00037588316,0.00036090857,0.0000037299203,0.0013282893,0.0000052520586,0.9941178,0.000054890505,0.000029263289,0.0015405782],"study_design_scores_gemma":[0.006113534,0.000301302,0.018275868,0.00019565331,0.0021009564,0.000027501816,0.0002273915,0.0033190206,0.96919155,0.00007572077,0.00009491104,0.00007659211],"about_ca_topic_score_codex":0.00019988946,"about_ca_topic_score_gemma":0.00002818523,"teacher_disagreement_score":0.024926256,"about_ca_system_score_codex":0.0000056900094,"about_ca_system_score_gemma":0.00004858679,"threshold_uncertainty_score":0.34202868},"labels":[],"label_agreement":null},{"id":"W2593611659","doi":"10.1182/blood.v118.21.233.233","title":"Inhibition of Mitochondrial Translation As a Therapeutic Strategy for Acute Myeloid Leukemia (AML)","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Click Chemistry and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; University of Toronto; University Health Network; Princess Margaret Cancer Centre; BC Cancer Agency; Ontario Institute for Cancer Research","funders":"","keywords":"Myeloid leukemia; Stem cell; Biology; Cancer research; Haematopoiesis; Clonogenic assay; Hematopoietic stem cell; Cell culture; Molecular biology; Cell biology; Genetics","score_opus":0.041975670294542605,"score_gpt":0.28069639920805856,"score_spread":0.23872072891351595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593611659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.965084,0.00009678596,0.001345637,0.000030639174,0.000020943628,0.00017226172,0.0001377836,0.00006275435,0.03304917],"genre_scores_gemma":[0.9973371,0.000024091707,0.0015840763,0.000017560955,0.00019148762,0.00017018225,0.00018571987,0.000017239137,0.00047256154],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993429,0.0000041032417,0.00023438175,0.0001943963,0.000089457,0.00013476306],"domain_scores_gemma":[0.99953055,0.00004407884,0.00011015273,0.00022027975,0.000051233877,0.000043702024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000026695727,0.00010881824,0.00012804578,0.00001469723,0.0000584161,0.000009109138,0.00009323726,0.0001416313,0.00047982883],"category_scores_gemma":[0.000006476956,0.00011259533,0.00010832884,0.00006768956,0.000043011587,0.000062669584,0.000007092179,0.000082943385,0.000009797486],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010051281,0.0002546691,0.000031502837,0.00007117513,0.000110614776,8.2182976e-7,0.00034911186,0.0000018385941,0.99509937,0.00088444276,0.000027716109,0.0030682203],"study_design_scores_gemma":[0.0020094598,0.000044929162,0.000023617331,0.00002422024,0.00032428236,0.000011506015,0.00010749498,0.000031777894,0.98988444,0.0068189558,0.00060027296,0.0001190342],"about_ca_topic_score_codex":0.000026503165,"about_ca_topic_score_gemma":0.0000058643227,"teacher_disagreement_score":0.03257661,"about_ca_system_score_codex":0.000015412059,"about_ca_system_score_gemma":0.000077207835,"threshold_uncertainty_score":0.52537894},"labels":[],"label_agreement":null},{"id":"W2593642777","doi":"10.1182/blood.v110.11.1862.1862","title":"The Effects of the Degree of Mobility Reduction and Prespecified Risk Factors on Venous Thromboembolism Rates in Acutely Ill Medical Patients in the EXCLAIM Study.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Calgary","funders":"","keywords":"Medicine; Incidence (geometry); Placebo; Internal medicine; Pulmonary embolism; Thrombosis; Deep vein; Venous thrombosis; Venous thromboembolism; Surgery; Pathology","score_opus":0.02084452233642817,"score_gpt":0.27924253327729254,"score_spread":0.25839801094086434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593642777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964142,0.00030062842,9.1117414e-7,0.00014429548,0.00027940047,0.002411044,0.0000039329607,0.000007799777,0.00043779475],"genre_scores_gemma":[0.9992456,0.00057525106,0.000004810374,0.000060736616,0.000048425034,0.000046035526,0.0000020090106,0.00001149788,0.0000056583835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979919,0.000378197,0.00046266377,0.00024182365,0.00068545225,0.00023994477],"domain_scores_gemma":[0.99816746,0.0009859743,0.00020917434,0.00051776186,0.00006959905,0.000050031154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016001951,0.00015251272,0.0004492945,0.0000812402,0.00011023326,0.000009855584,0.00026400213,0.000097915516,0.000005321969],"category_scores_gemma":[0.0011918952,0.00006983578,0.00007104973,0.00029262528,0.0002127924,0.000033379,0.00010784041,0.00034474925,5.5523367e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002643164,0.032156605,0.9307176,0.00021123992,0.0003404448,0.000019257754,0.019753538,0.000004846377,0.00031540974,0.00029399485,0.00022282281,0.015699947],"study_design_scores_gemma":[0.0033807089,0.0017876351,0.98526525,0.00016214032,0.00025772402,0.0000016189473,0.003090598,0.0000024337517,0.0057485956,0.0001870914,0.000055082877,0.00006113518],"about_ca_topic_score_codex":0.0011615683,"about_ca_topic_score_gemma":0.0008764825,"teacher_disagreement_score":0.05454766,"about_ca_system_score_codex":0.00003086032,"about_ca_system_score_gemma":0.000037594433,"threshold_uncertainty_score":0.28478205},"labels":[],"label_agreement":null},{"id":"W2593644059","doi":"10.1182/blood.v126.23.4073.4073","title":"Impact of Disease Duration upon Symptom Burden Amongst Patients with Myeloproliferative Neoplasms (MPNs)","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Myeloproliferative neoplasm; Myelofibrosis; Polycythemia vera; Essential thrombocythemia; Internal medicine; Cohort; Anemia; Disease; Leukopenia; Pediatrics; Bone marrow","score_opus":0.012136897239527105,"score_gpt":0.2598161557736921,"score_spread":0.247679258534165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593644059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971039,0.00015897398,0.000024387416,0.00025735056,0.00006208199,0.0012142622,0.00013395741,0.000054152577,0.0009908939],"genre_scores_gemma":[0.9985859,0.000028727234,0.00040394635,0.000045656434,0.00015879002,0.00016571238,0.00043569517,0.000038721686,0.00013685346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982482,0.00007405534,0.0003825253,0.0003831907,0.00061670877,0.00029527867],"domain_scores_gemma":[0.9980014,0.000070146394,0.00023209682,0.00037279955,0.0006995996,0.00062393484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009758935,0.00032206654,0.00048779938,0.00012914218,0.000069408125,0.000032531658,0.000072208204,0.00007848502,0.00009423394],"category_scores_gemma":[0.00014248144,0.00020414469,0.00014713487,0.00024473463,0.00006914618,0.00020098027,0.00003447937,0.00012197655,0.000048984974],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018966445,0.0032753085,0.9917867,0.00004134819,0.0007631146,0.000052718333,0.0010254391,0.00009698843,0.000089168105,0.00020499973,0.0003685215,0.00039903098],"study_design_scores_gemma":[0.015947796,0.0053561977,0.9728965,0.00019382781,0.00078078645,0.000009992797,0.00007761237,0.00012930491,0.004273964,0.000049500995,0.000060234488,0.00022429191],"about_ca_topic_score_codex":0.00015202964,"about_ca_topic_score_gemma":0.000037027985,"teacher_disagreement_score":0.018890228,"about_ca_system_score_codex":0.00014796284,"about_ca_system_score_gemma":0.000548289,"threshold_uncertainty_score":0.83247787},"labels":[],"label_agreement":null},{"id":"W2593660667","doi":"10.1182/blood.v128.22.2778.2778","title":"Use of Tyrosine Kinase Inhibitors Post-Allogeneic Stem Cell Transplant in Patients with Philadelphia or BCR-ABL Positive Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis","year":2016,"lang":"en","type":"review","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Alberta","funders":"","keywords":"Medicine; Internal medicine; Transplantation; Oncology; Systematic review; Philadelphia chromosome; Meta-analysis; Hematopoietic stem cell transplantation; Pediatrics; MEDLINE","score_opus":0.031879298493492594,"score_gpt":0.2647455008461922,"score_spread":0.2328662023526996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593660667","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021990198,0.9853979,0.0000064784094,0.000041167717,0.000021045864,0.008391654,0.0039016737,0.00003318637,0.000007872551],"genre_scores_gemma":[0.005421769,0.9918563,0.00014392822,0.0001501956,0.000018468947,0.0008399974,0.0009453904,0.00014865205,0.0004752956],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99448454,0.0006348807,0.002423674,0.0010978224,0.0008009883,0.0005580789],"domain_scores_gemma":[0.9955783,0.00071319885,0.0017639407,0.0012689404,0.0003457715,0.00032983455],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032343421,0.0012628871,0.01380683,0.0008598942,0.000048062535,0.000028650597,0.00025635274,0.00044249737,0.00011181341],"category_scores_gemma":[0.000061010407,0.0006020991,0.0019514174,0.0014569235,0.00012938645,0.00015856995,0.00008975837,0.00032980565,0.000024005965],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018028727,0.0010985576,0.0001033976,0.75365704,0.24366833,0.000759228,0.0000800371,4.5721052e-7,0.0000032078485,0.0000012125257,0.000012819221,0.0004354446],"study_design_scores_gemma":[0.0048051486,0.0009877264,0.000067004956,0.20272599,0.79053706,0.00023850823,0.0000038372127,6.0542993e-7,0.000037930295,9.5064465e-8,0.00013070545,0.00046538663],"about_ca_topic_score_codex":0.00010901313,"about_ca_topic_score_gemma":0.000056664856,"teacher_disagreement_score":0.55093104,"about_ca_system_score_codex":0.0013250523,"about_ca_system_score_gemma":0.0015803612,"threshold_uncertainty_score":0.999643},"labels":[],"label_agreement":null},{"id":"W2593675088","doi":"10.1182/blood.v128.22.241.241","title":"Final Analysis of Overall Survival from the First Trial","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Princess Margaret Cancer Centre; Institute of Cancer Research; University of Calgary","funders":"","keywords":"Lenalidomide; Medicine; Clinical endpoint; Multiple myeloma; Thalidomide; Internal medicine; Progression-free survival; Melphalan; Intention-to-treat analysis; Oncology; Surgery; Randomized controlled trial; Chemotherapy","score_opus":0.05529072315189045,"score_gpt":0.31385951154189523,"score_spread":0.2585687883900048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593675088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99712485,0.00011388127,0.000024280867,0.0013224205,0.00004686344,0.00022224584,0.00015482583,0.000010587698,0.0009800318],"genre_scores_gemma":[0.9990375,0.000050328694,0.000082684135,0.00004299701,0.0001829937,0.000014839174,0.00003677914,0.0000054519096,0.0005464289],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99921525,0.000040015162,0.00014648147,0.0001386021,0.0003117512,0.00014792164],"domain_scores_gemma":[0.9990553,0.0004595015,0.000045155062,0.00032277123,0.000045657805,0.000071590024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011444402,0.00006782334,0.0002485882,0.00005750418,0.00003678484,0.0000057893694,0.00008800998,0.00003357026,0.0007715553],"category_scores_gemma":[0.00024115843,0.000029247529,0.00019596762,0.00017173616,0.0000483474,0.00002145873,0.00003276632,0.00004093293,0.000039033355],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016339967,0.0015854283,0.96607995,0.000006218445,0.00884978,0.00007579463,0.00009242938,3.8507383e-7,0.0019942836,0.00010208876,0.00056615897,0.0043074926],"study_design_scores_gemma":[0.10523943,0.000413646,0.88755065,0.000025591233,0.0024873398,7.8992167e-7,0.000007791762,0.000019129582,0.0026428676,0.00004927741,0.0015227844,0.00004070559],"about_ca_topic_score_codex":0.0008471431,"about_ca_topic_score_gemma":0.0005050082,"teacher_disagreement_score":0.08889946,"about_ca_system_score_codex":0.000012984818,"about_ca_system_score_gemma":0.00004835804,"threshold_uncertainty_score":0.8447989},"labels":[],"label_agreement":null},{"id":"W2593706908","doi":"10.1182/blood.v110.11.2587.2587","title":"Long-Term Phenotypic Correction of Hemophilia A Mice Following Intravenous Injection of miRNA-Regulated Lentiviral Vectors.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Transgene; Genetic enhancement; Viral vector; Transduction (biophysics); Immune system; Gene delivery; Biology; Immunology; Immune tolerance; Virology; Cancer research; Medicine; Gene; Recombinant DNA; Genetics","score_opus":0.00956697146541638,"score_gpt":0.2654593673439676,"score_spread":0.25589239587855117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593706908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997916,0.00069751206,0.00049070205,0.0000051679967,0.0003775035,0.00021389194,0.0000044312856,0.000013777914,0.0002810392],"genre_scores_gemma":[0.99941,0.00003403217,0.00006523295,0.0000113106125,0.00014849153,0.0000042466795,0.000059503393,0.000025830459,0.00024138957],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99894094,0.00006600432,0.00028821,0.00024973735,0.00019980244,0.0002553242],"domain_scores_gemma":[0.99942684,0.000015848065,0.00013240628,0.0002660339,0.000108138964,0.000050759892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003752335,0.00013051621,0.00018012825,0.00011577094,0.00004782747,0.0000066237767,0.00014371329,0.00016102412,0.000014142038],"category_scores_gemma":[0.000049786482,0.0001384473,0.00014783067,0.00023265646,0.00006626926,0.000005006791,0.000046823126,0.000101632184,0.0000030005606],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013000749,0.00048540835,0.019847794,0.00003616343,0.00022593429,0.000005873453,0.00009293064,0.000041889783,0.968359,0.0000011228361,0.00001778824,0.009586009],"study_design_scores_gemma":[0.0014057233,0.0027895297,0.05400389,0.000032896085,0.00006236779,0.00002092194,0.000023183984,0.000014457368,0.94150984,0.000009327183,0.000011338873,0.000116511656],"about_ca_topic_score_codex":0.000063458065,"about_ca_topic_score_gemma":0.0004519954,"teacher_disagreement_score":0.034156095,"about_ca_system_score_codex":0.000018028435,"about_ca_system_score_gemma":0.00007026965,"threshold_uncertainty_score":0.5645717},"labels":[],"label_agreement":null},{"id":"W2593722226","doi":"10.1182/blood.v126.23.4012.4012","title":"Identification of a New AHI-1-Mediated-PP2A-Beta-Catenin-BCR-ABL-JAK2 Complex Modulating Resistance of CML Stem/Progenitor Cells to Tyrosine Kinase Inhibitors","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Beetle Biology and Toxicology Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Protein phosphatase 2; Cancer research; Imatinib mesylate; Progenitor cell; Stem cell; Tyrosine kinase; Biology; Cell biology; Signal transduction; Imatinib; Phosphatase; Phosphorylation; Myeloid leukemia","score_opus":0.0331472728836247,"score_gpt":0.26182911790257024,"score_spread":0.22868184501894553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593722226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99646866,0.00227814,0.00016724227,0.00022201931,0.00028068412,0.00029693244,0.00011705017,0.000015818425,0.00015346322],"genre_scores_gemma":[0.997282,0.000036094763,0.0012873949,0.00007762988,0.00026475437,0.000024851503,0.00008796412,0.000019321098,0.0009199821],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986236,0.00008928549,0.00053245784,0.0003756219,0.00014136315,0.00023765667],"domain_scores_gemma":[0.99889,0.000026409823,0.00033376788,0.000364186,0.00024613275,0.0001395101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029248174,0.00018031245,0.00031591524,0.00006240003,0.0000631526,0.0000062803897,0.0002170981,0.00023274143,0.0000040581085],"category_scores_gemma":[0.0001308419,0.00017315238,0.00009010117,0.00017876457,0.00016990279,0.000005253311,0.00015272269,0.00007438107,0.000012351481],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014683562,0.00024410758,0.008713401,0.00004174446,0.00016708915,0.0000024861718,0.00016352604,0.000020399446,0.98476636,0.000037624563,0.005508771,0.00018765949],"study_design_scores_gemma":[0.001221424,0.00031635255,0.006087103,0.000021519703,0.00009708179,0.0000027962126,0.00015357234,0.000009772232,0.9884123,0.00003762012,0.003473125,0.00016728387],"about_ca_topic_score_codex":0.000022465834,"about_ca_topic_score_gemma":0.0000774636,"teacher_disagreement_score":0.0036459942,"about_ca_system_score_codex":0.000011215691,"about_ca_system_score_gemma":0.00011491607,"threshold_uncertainty_score":0.7060949},"labels":[],"label_agreement":null},{"id":"W2593743787","doi":"10.1182/blood.v116.21.3830.3830","title":"Primary Care Referrals for Suspected Hematologic Malignancies: Incidence, Factors Affecting Choice of Specialist, and Flow of Referral Information.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Healthcare Systems and Technology","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Referral; Specialty; Family medicine; Incidence (geometry); Pediatrics","score_opus":0.025300043003294078,"score_gpt":0.2571941761446629,"score_spread":0.2318941331413688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593743787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99501973,0.000094992654,0.000041955907,0.00006944798,0.00029190426,0.0005319057,0.000024334826,0.000098846314,0.0038268701],"genre_scores_gemma":[0.998569,0.0000037040065,0.0009866956,0.000075036216,0.00024648273,0.000017736229,0.00007757967,0.000010779074,0.000012955541],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990035,0.000007647666,0.00048715743,0.00014478144,0.00014240523,0.00021449456],"domain_scores_gemma":[0.9987385,0.000105550185,0.0005060342,0.00021796249,0.00041959417,0.000012357105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022373385,0.00013456173,0.00037629556,0.0002583781,0.00010715312,0.000039464234,0.00016501834,0.000200619,0.000021640519],"category_scores_gemma":[0.00066664215,0.00011301924,0.00005781727,0.0002911876,0.00007289817,0.0006621912,0.00010601496,0.00014597656,0.000002240114],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005081168,0.0001832987,0.8884524,0.017506817,0.00010329312,0.0000043111972,0.0018915959,0.0000025995105,0.031548128,0.052349847,0.00068191724,0.00722496],"study_design_scores_gemma":[0.00447004,0.00019913081,0.9064771,0.00072376215,0.00022286469,0.000027768103,0.009632261,0.00009532925,0.024403244,0.0019141547,0.051100645,0.000733723],"about_ca_topic_score_codex":0.0018993878,"about_ca_topic_score_gemma":0.001691517,"teacher_disagreement_score":0.050435692,"about_ca_system_score_codex":0.000011517044,"about_ca_system_score_gemma":0.000044013184,"threshold_uncertainty_score":0.4608791},"labels":[],"label_agreement":null},{"id":"W2593772058","doi":"10.1182/blood.v106.11.604.604","title":"Insights into Disease Evolution of Transformed Follicular Lymphoma Derived from Cytogenetics.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lymphoma; Follicular lymphoma; Biopsy; Diffuse large B-cell lymphoma; Cytogenetics; Pathology; Internal medicine; Medicine; Biology; Chromosome; Genetics","score_opus":0.008312444818462163,"score_gpt":0.22632247508640851,"score_spread":0.21801003026794635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593772058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867958,0.011860004,0.00016839209,0.00039479774,0.000036029727,0.00034004898,0.000018868626,0.00003685247,0.00034924145],"genre_scores_gemma":[0.9974009,0.0003832341,0.0017495947,0.000111561756,0.00017262502,0.00006326907,0.000083164115,0.000016442387,0.000019217185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991453,0.000021333426,0.00023681096,0.00022113493,0.0002355224,0.00013986153],"domain_scores_gemma":[0.99935323,0.00002875622,0.000052480562,0.0002827763,0.000057097226,0.00022566524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000015479738,0.00014193427,0.00024688867,0.000063910455,0.000044049735,0.0000059971885,0.00005543813,0.00006387132,0.000048594167],"category_scores_gemma":[0.00001976491,0.00011181576,0.00016128024,0.00009944447,0.000045229855,0.00004903322,0.000013509767,0.00001745633,0.000040273593],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008212141,0.020328745,0.6798616,0.00018694336,0.0018914609,0.00042208272,0.002365952,0.00004371989,0.22843027,0.0012286695,0.00018083054,0.06423848],"study_design_scores_gemma":[0.011552135,0.00017261603,0.6408067,0.00008848566,0.0010286145,0.0000032596827,0.000037276564,0.00008230897,0.34434423,0.0003528892,0.0014328735,0.000098641096],"about_ca_topic_score_codex":0.00031267203,"about_ca_topic_score_gemma":0.00011678441,"teacher_disagreement_score":0.115913965,"about_ca_system_score_codex":0.00015943617,"about_ca_system_score_gemma":0.00019451781,"threshold_uncertainty_score":0.45597145},"labels":[],"label_agreement":null},{"id":"W2593772298","doi":"10.1182/blood.v114.22.243.243","title":"Safety of Excluding Suspected Deep Vein Thrombosis with a Single Whole-Leg Compression Ultrasound: Systematic Review and Meta-Analysis.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Deep vein; Thrombosis; Pulmonary embolism; Meta-analysis; Surgery; Randomized controlled trial; MEDLINE; Venous thrombosis; Prospective cohort study; Internal medicine","score_opus":0.0354036891553918,"score_gpt":0.28180001876172256,"score_spread":0.24639632960633076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593772298","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40096462,0.5406223,0.004928951,0.013710915,0.000075764234,0.017832123,0.00011948082,0.000616656,0.021129185],"genre_scores_gemma":[0.9943053,0.0026581688,0.0014778692,0.0013195918,0.000013480724,0.000055467634,0.000038732705,0.000017608018,0.000113743146],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99823225,0.00014519638,0.00065244985,0.00034510138,0.00039846209,0.0002265562],"domain_scores_gemma":[0.9986247,0.0001426739,0.00038719416,0.00058710383,0.00014257073,0.00011577479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041654796,0.00024414755,0.0033432117,0.00016722121,0.000085234125,0.000027374463,0.00011113374,0.000051098916,0.00020402708],"category_scores_gemma":[0.0001260033,0.00015030446,0.00041763103,0.00064875884,0.000048131802,0.000081640705,0.000033896922,0.00009884633,0.000004619776],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008717998,0.016735177,0.002116568,0.32716465,0.61673784,0.00011083798,0.0020931144,0.00009795745,0.031043118,0.0022821352,0.0014804966,0.000050926657],"study_design_scores_gemma":[0.0012505465,0.0007182929,0.01787776,0.0051589347,0.9728531,0.000033937402,0.00016882454,0.000014044183,0.001655504,0.000032188404,0.000033958953,0.00020286588],"about_ca_topic_score_codex":0.000034083496,"about_ca_topic_score_gemma":0.00004196163,"teacher_disagreement_score":0.59334075,"about_ca_system_score_codex":0.000024754463,"about_ca_system_score_gemma":0.000014354942,"threshold_uncertainty_score":0.6129238},"labels":[],"label_agreement":null},{"id":"W2593776441","doi":"10.1182/blood.v110.11.472.472","title":"Efficacy and Safety of Dasatinib in Patients with Chronic Myeloid Leukemia in Blast Phase Whose Disease Is Resistant or Intolerant to Imatinib: 2-Year Follow-Up Data from the START Program.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Dasatinib; Imatinib; Medicine; Internal medicine; Imatinib mesylate; Transplantation; Gastroenterology; Myeloid leukemia; Oncology","score_opus":0.022644311821729567,"score_gpt":0.2975425443278579,"score_spread":0.2748982325061284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593776441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99460524,0.00040977955,0.000015065559,0.00025008403,0.00004371497,0.0035110821,0.001049112,0.00004145574,0.00007446735],"genre_scores_gemma":[0.99584967,0.000060576378,0.0025798278,0.0002087013,0.000082103186,0.000070978436,0.0010322413,0.000055314467,0.000060596874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972719,0.00007844716,0.000778515,0.00073234417,0.0006107299,0.00052806217],"domain_scores_gemma":[0.997505,0.00035221718,0.00019867356,0.0015094641,0.000079605576,0.0003550187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000471079,0.0003346606,0.0005727719,0.00013835978,0.000062857056,0.000027298463,0.00036824725,0.000085416556,0.00013264205],"category_scores_gemma":[0.00039407253,0.00020802396,0.00004086166,0.00056914345,0.00014685301,0.0001423938,0.00029551832,0.00029414037,0.00001372683],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13726075,0.010843802,0.7766137,0.00047526314,0.000815194,0.00064606784,0.006231333,0.000013741987,0.0010682208,0.000013603359,0.001121915,0.06489639],"study_design_scores_gemma":[0.15553501,0.0030647547,0.8357704,0.0016550542,0.00048537552,0.0000022210736,0.00025678874,0.00018038925,0.00077850337,0.000005102177,0.0020133208,0.0002530589],"about_ca_topic_score_codex":0.001282933,"about_ca_topic_score_gemma":0.005620255,"teacher_disagreement_score":0.06464333,"about_ca_system_score_codex":0.0009784978,"about_ca_system_score_gemma":0.0015762472,"threshold_uncertainty_score":0.84829706},"labels":[],"label_agreement":null},{"id":"W2593845645","doi":"10.1182/blood.v126.23.3149.3149","title":"The Impact of Graft-Versus-Host Disease on Dendritic Cell Homeostasis and Their Potential Use As Biomarker to Predict the Severity of Chronic Graft-Versus-Host Disease","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Immunology; Graft-versus-host disease; CD8; Transplantation; Dendritic cell; Hematopoietic stem cell transplantation; Medicine; Immune system; T cell; Biology; Internal medicine","score_opus":0.018204435409878945,"score_gpt":0.2575073205683018,"score_spread":0.23930288515842282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593845645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9634975,0.033723436,0.000012115569,0.0003506533,0.000764876,0.00067540427,0.0008756572,0.000038170387,0.00006218771],"genre_scores_gemma":[0.9975332,0.0018592845,0.0000031999514,0.000049079372,0.000038841103,0.000042893756,0.00006873237,0.000038822585,0.00036592866],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9977382,0.00079046877,0.00042157804,0.0003708658,0.00012266998,0.00055624516],"domain_scores_gemma":[0.9974841,0.0009999298,0.00021410338,0.0009622828,0.00017054817,0.00016903544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046241004,0.00038434577,0.00039034456,0.00013085379,0.0004019779,0.00006058564,0.0005416181,0.00013479394,0.00011531525],"category_scores_gemma":[0.00053301145,0.00021474507,0.00038778866,0.00026545403,0.0008364875,0.00017743652,0.000235837,0.00026611343,0.00005949183],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.35228786,0.008994259,0.014506918,0.00024294946,0.009478694,0.000132888,0.003598389,0.00006868976,0.58775914,0.00036034684,0.009268222,0.013301642],"study_design_scores_gemma":[0.041717213,0.010529079,0.7304938,0.00030725665,0.0017194424,0.00007792826,0.002025968,0.000060558967,0.1988993,0.00015143554,0.01297256,0.001045502],"about_ca_topic_score_codex":0.0005567297,"about_ca_topic_score_gemma":0.000034078756,"teacher_disagreement_score":0.71598685,"about_ca_system_score_codex":0.000077917655,"about_ca_system_score_gemma":0.0006042779,"threshold_uncertainty_score":0.87570494},"labels":[],"label_agreement":null},{"id":"W2593862141","doi":"10.1182/blood.v118.21.138.138","title":"Mir-34a Sensitizes Multiple Myeloma (MM) Cells to the Proteasome Inhibitor Bortezomib","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Bortezomib; microRNA; Biology; Cancer research; Proteasome inhibitor; Gene silencing; Demethylating agent; Molecular biology; Epigenetics; DNA methylation; Cell culture; Cell growth; Gene expression profiling; Gene expression; Multiple myeloma; Gene; Genetics; Immunology","score_opus":0.011264950813557514,"score_gpt":0.2054384232008416,"score_spread":0.19417347238728408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593862141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99809015,0.0002756919,0.00021918913,0.00011704806,0.00014153426,0.00064141594,0.000046214383,0.000024654233,0.00044412908],"genre_scores_gemma":[0.9964705,0.000004979107,0.0023289982,0.00028412786,0.0004630597,0.00007256518,0.000047137604,0.00002805838,0.00030058873],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99914306,0.000059116173,0.00015862926,0.00030243138,0.00011140321,0.0002253813],"domain_scores_gemma":[0.99926174,0.000007082749,0.000060742415,0.0004837335,0.00007552895,0.00011118032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010001915,0.00014243243,0.00009460609,0.00002537561,0.00008288397,0.000019449339,0.00017128991,0.000106712396,0.000031529966],"category_scores_gemma":[0.000059578524,0.00011125731,0.00008438654,0.000073451534,0.00004281618,0.0000030197466,0.00012476706,0.000052488485,0.00011531781],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000624983,0.00016698765,0.00049981393,0.000012143933,0.00005250376,0.0000066020393,0.00013185081,0.000006795774,0.99487215,0.000009348746,0.003867391,0.00031192615],"study_design_scores_gemma":[0.00066608016,0.00010696506,0.011585413,0.000011877592,0.000041403644,0.000013813235,0.00003247538,0.000015212264,0.95408154,0.0000122279425,0.03327195,0.00016104004],"about_ca_topic_score_codex":0.000023897335,"about_ca_topic_score_gemma":0.000042139898,"teacher_disagreement_score":0.040790595,"about_ca_system_score_codex":0.00000631238,"about_ca_system_score_gemma":0.000044893415,"threshold_uncertainty_score":0.45369413},"labels":[],"label_agreement":null},{"id":"W2593877575","doi":"10.1182/blood.v128.22.1720.1720","title":"A Novel Role for INPP4B in Haematopoiesis and Leukemia","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Haematopoiesis; Myeloid leukemia; Progenitor cell; Cancer research; Biology; Myeloid; Leukemia; Population; Stem cell; Internal medicine; Oncology; Immunology; Medicine; Cell biology","score_opus":0.0186421034162389,"score_gpt":0.2790129586342145,"score_spread":0.2603708552179756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593877575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99433976,0.0003084538,0.00091331004,0.0023117452,0.000016439533,0.0005074073,0.000022515143,0.000035594043,0.0015447927],"genre_scores_gemma":[0.99025977,0.000080779304,0.006939849,0.00028408298,0.000121800425,0.00013901584,0.000003728648,0.000028509505,0.0021424934],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99917394,0.000010591609,0.00015752672,0.00022690788,0.00014154223,0.00028948838],"domain_scores_gemma":[0.99938184,0.00020486952,0.000025586938,0.00021728045,0.000053389544,0.000117026684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022335509,0.00009434989,0.00023258345,0.00013303486,0.000027928209,0.000009492811,0.000072304836,0.000093373295,0.000034666275],"category_scores_gemma":[0.00038538783,0.00006126322,0.000038269904,0.00011974328,0.00006966247,0.000064414744,0.00006824002,0.00008734811,0.000023689296],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045616023,0.0004714293,0.07324173,0.00027910754,0.00014191966,0.000089179084,0.00053219224,1.726991e-7,0.8905992,0.0018219338,0.0024906974,0.0298763],"study_design_scores_gemma":[0.11894326,0.001579336,0.28010494,0.0013703246,0.00043545818,0.0017148518,0.0008136745,0.0005789772,0.5244198,0.0035547635,0.06565955,0.00082508795],"about_ca_topic_score_codex":0.00009470403,"about_ca_topic_score_gemma":0.0000528392,"teacher_disagreement_score":0.36617938,"about_ca_system_score_codex":0.0001550687,"about_ca_system_score_gemma":0.00027845145,"threshold_uncertainty_score":0.24982418},"labels":[],"label_agreement":null},{"id":"W2593928999","doi":"10.1182/blood.v106.11.4901.4901","title":"Concomitant Administration of Recombinant Human Erythropoietin (rHuEPO) and Oral Iron Chelator Deferiprone May Stabilize Iron Balance in Transfusion Dependent Patients with Early Myelodysplastic Syndrome (MDS).","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Deferiprone; Medicine; Gastroenterology; Internal medicine; Concomitant; Anemia; Adverse effect; Blood transfusion; Ferritin; Deferoxamine","score_opus":0.005304031343726452,"score_gpt":0.21752419412872556,"score_spread":0.2122201627849991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593928999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981917,0.00039251806,0.000012582964,0.0002535396,0.000070813556,0.00084617856,0.0000134273905,0.00003001337,0.0001892282],"genre_scores_gemma":[0.9992022,0.00020763573,0.0003642617,0.000022754153,0.000010830119,0.000022722394,0.000044773533,0.000031435346,0.00009336599],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984476,0.00006063502,0.000506835,0.00035761393,0.00033058264,0.0002967408],"domain_scores_gemma":[0.9994135,0.000030930492,0.00014404683,0.00021158505,0.000060275688,0.00013966185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016814256,0.00022246526,0.00043241528,0.00009257781,0.00007179146,0.000013102282,0.000058335852,0.00019376994,0.000079681195],"category_scores_gemma":[0.000026387552,0.00017224421,0.000041841995,0.00016307025,0.00014232702,0.0001087201,0.000020318113,0.0002740565,0.0000057689417],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001479096,0.004888367,0.9732873,0.00052999903,0.00006784985,0.00016306461,0.0012384328,0.000019180725,0.016499633,0.00006672958,0.000010587374,0.0017497592],"study_design_scores_gemma":[0.023193082,0.00689007,0.9638271,0.0006320234,0.00031210383,0.00017447284,0.00038239837,0.000049827406,0.0041772537,0.000014896949,0.000054793538,0.0002919956],"about_ca_topic_score_codex":0.00014279355,"about_ca_topic_score_gemma":0.000346043,"teacher_disagreement_score":0.021713987,"about_ca_system_score_codex":0.00006484968,"about_ca_system_score_gemma":0.00008362679,"threshold_uncertainty_score":0.7023915},"labels":[],"label_agreement":null},{"id":"W2593953634","doi":"10.1182/blood.v120.21.1558.1558","title":"CD30 Expression in Diffuse Large B-Cell Lymphoma","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"CD30; Diffuse large B-cell lymphoma; CHOP; BCL6; Lymphoma; Immunohistochemistry; Tissue microarray; Brentuximab vedotin; Pathology; Medicine; Cancer research; Large-cell lymphoma; Vincristine; Oncology; Chemotherapy; Internal medicine; Germinal center; B cell; Immunology; Antibody; Cyclophosphamide","score_opus":0.011306287013033654,"score_gpt":0.2455517415188752,"score_spread":0.23424545450584155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593953634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878379,0.0028993613,0.000002887936,0.00009742768,0.00009548988,0.00019582633,0.0000070308793,0.00003798058,0.008826089],"genre_scores_gemma":[0.99844295,0.00013834618,0.0003873601,0.00028077228,0.00016306706,0.00006271503,0.000020921736,0.000015954603,0.00048792796],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99921626,0.0000228434,0.00013907513,0.00013840555,0.0001479162,0.00033549708],"domain_scores_gemma":[0.9995097,0.00003597159,0.00003277028,0.0002407642,0.000011654495,0.00016912477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008076018,0.00011180078,0.0001773137,0.00005995776,0.000030811607,0.0000070714664,0.000038573027,0.00007080459,0.000084476895],"category_scores_gemma":[0.00001878998,0.00008108371,0.00006369779,0.00008318453,0.000009348008,0.00007339492,0.000042252286,0.00002921699,0.00024499907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033302767,0.08920119,0.9012266,0.000035482524,0.000021148067,0.00012039273,0.00045394897,1.47162655e-8,0.0062735626,0.000089431574,0.0010202143,0.0015247331],"study_design_scores_gemma":[0.068591714,0.0001177731,0.6830981,0.00010319257,0.00011915489,0.000047203717,0.000088122586,0.000002744824,0.23377323,0.000010037311,0.013942263,0.000106513195],"about_ca_topic_score_codex":0.000023067814,"about_ca_topic_score_gemma":0.0000046723185,"teacher_disagreement_score":0.22749966,"about_ca_system_score_codex":0.000053316806,"about_ca_system_score_gemma":0.000027559752,"threshold_uncertainty_score":0.33064976},"labels":[],"label_agreement":null},{"id":"W2593955222","doi":"10.1182/blood.v106.11.3748.3748","title":"Clinical Relevance of Cytogenetics Abnormalities in Adult Patients with Acquired Aplastic Anaemia.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Prenatal Screening and Diagnostics","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Monosomy; Trisomy 8; Karyotype; Trisomy; Cytogenetics; Internal medicine; Gastroenterology; Chromosome abnormality; Clinical significance; Chromosome 7 (human); Aneuploidy; Medicine; Abnormality; Pathology; Oncology; Biology; Chromosome; Genetics","score_opus":0.014162801524002757,"score_gpt":0.26941343185982697,"score_spread":0.25525063033582424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593955222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982861,0.00022025514,0.00006651407,0.000058941252,0.00003445016,0.00014737569,0.000029726622,0.000024048326,0.0011325871],"genre_scores_gemma":[0.99290884,0.00014486261,0.0065441797,0.00018314773,0.00010618055,0.000005592854,0.00003151664,0.000012825783,0.00006285979],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990379,0.000028933335,0.00037164232,0.00015401158,0.00022648877,0.00018100563],"domain_scores_gemma":[0.99910444,0.0003579399,0.00009477094,0.0002096584,0.00013445948,0.00009873887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000088275454,0.00009524044,0.00025095517,0.000047556303,0.000013351192,0.0000033895683,0.00006927124,0.000083814164,0.00001247677],"category_scores_gemma":[0.0011066488,0.00007534195,0.000036973932,0.000118299016,0.0000980041,0.000041781805,0.000032034033,0.0000964137,0.000010383588],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029692022,0.0010489076,0.99313307,0.000053623688,0.00003259888,0.000018576773,0.00007831764,0.000066889384,0.000014640014,0.00008474195,0.00008973321,0.0050820014],"study_design_scores_gemma":[0.009179407,0.0011771006,0.98531353,0.0004370995,0.00014134652,0.0000071403447,0.000033916964,0.000115696195,0.0032473924,0.000013748418,0.00022614494,0.00010749044],"about_ca_topic_score_codex":0.000033786317,"about_ca_topic_score_gemma":0.00010154433,"teacher_disagreement_score":0.008882486,"about_ca_system_score_codex":0.000010891543,"about_ca_system_score_gemma":0.00005699305,"threshold_uncertainty_score":0.30723554},"labels":[],"label_agreement":null},{"id":"W2593958487","doi":"10.1182/blood.v104.11.831.831","title":"The Mechanism of Transfusion-Related Immunomodulation Is Related to the Transfusion of Dendritic Cells Expressing the CD200 (OX-2) Tolerance Signal and Alloantigen: Evidence from a Murine Tumor Model.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Immunology; CD11c; Medicine; Blood transfusion; Fibrosarcoma; Antibody; Biology; Pathology; Phenotype","score_opus":0.009582662005405581,"score_gpt":0.2180328088724646,"score_spread":0.208450146867059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593958487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9697651,0.024814865,0.0029144606,0.001181224,0.000432639,0.0007595878,0.000038228933,0.000026569918,0.000067284964],"genre_scores_gemma":[0.99637514,0.0028703508,0.00031254187,0.00013215168,0.000010927708,0.00003730152,0.0000075560297,0.000025855976,0.00022815149],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99831057,0.0002609777,0.00065728376,0.00034528133,0.000121662495,0.00030421957],"domain_scores_gemma":[0.9986524,0.00042962775,0.00021157731,0.0005695059,0.00011971062,0.000017161845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050991896,0.00022186649,0.00031613995,0.000046635607,0.00053260924,0.000020667983,0.0005101861,0.00018472684,0.00017354374],"category_scores_gemma":[0.00003119594,0.00012940678,0.00013366026,0.0002237067,0.00033529484,0.000118608164,0.00008009998,0.00040792642,0.000018084322],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002181347,0.00012467819,0.000030719813,0.000020685478,0.00017712252,0.0000022269671,0.008648051,0.0059140516,0.98365664,0.00021642058,0.000027497199,0.0009637521],"study_design_scores_gemma":[0.0022309772,0.00017051227,0.00075512525,0.00065608544,0.0002332967,0.000034303335,0.00033405237,0.00095756707,0.9916026,0.002796895,0.000070943235,0.00015762344],"about_ca_topic_score_codex":0.0006255569,"about_ca_topic_score_gemma":0.000051827898,"teacher_disagreement_score":0.026610022,"about_ca_system_score_codex":0.000023601138,"about_ca_system_score_gemma":0.00010348756,"threshold_uncertainty_score":0.52770555},"labels":[],"label_agreement":null},{"id":"W2593991668","doi":"10.1182/blood.v126.23.1116.1116","title":"Updates on the Risk of Dalteparin Thromboprophylaxis Failure in Hospitalized Acutely Ill Medical Patients with Cancer (ARTIC STUDY)","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Pulmonary embolism; Cancer; Low molecular weight heparin; Retrospective cohort study; Venous thrombosis; Malignancy; Thrombosis; Intensive care medicine; Emergency medicine; Internal medicine","score_opus":0.012713408768041294,"score_gpt":0.2576327428915946,"score_spread":0.2449193341235533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593991668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99628115,0.00010407281,0.0000017824976,0.0014252182,0.000087579756,0.0014219106,0.000016960683,0.000025064952,0.00063625246],"genre_scores_gemma":[0.9990504,0.000111334375,0.00007345645,0.00045742252,0.00005109706,0.00019767393,0.000010893971,0.000024320565,0.00002340033],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981364,0.00011742548,0.00030592375,0.0002814701,0.00090795563,0.00025084254],"domain_scores_gemma":[0.9990026,0.00006231577,0.0001435049,0.0004458438,0.00018360828,0.0001621291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041686243,0.00017568837,0.0005098675,0.00008495862,0.000043962278,0.000012637998,0.00019400696,0.000061114144,0.00021690044],"category_scores_gemma":[0.00033833281,0.00009198647,0.00005116782,0.0002984311,0.000096058866,0.00004738575,0.00010041152,0.00021432145,0.000019710153],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015034752,0.011377619,0.9823055,0.00003222555,0.0006405108,0.000028501841,0.0016444079,0.000011661442,0.0000051760067,0.00013191349,0.0029168213,0.000755316],"study_design_scores_gemma":[0.010639801,0.003985641,0.9825988,0.00017714407,0.000619097,6.336044e-7,0.0009534784,0.000015718797,0.0003329629,0.00007749402,0.00047646943,0.00012278074],"about_ca_topic_score_codex":0.0016807313,"about_ca_topic_score_gemma":0.0012584181,"teacher_disagreement_score":0.010489454,"about_ca_system_score_codex":0.000039205068,"about_ca_system_score_gemma":0.00012222565,"threshold_uncertainty_score":0.37510994},"labels":[],"label_agreement":null},{"id":"W2593997079","doi":"10.1182/blood.v116.21.3710.3710","title":"Characterization of the Impact of Culture on the Thrombopoietic Potential of Cord Blood Progenitors.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Héma-Québec","funders":"","keywords":"Cord blood; Haematopoiesis; Progenitor cell; Megakaryocyte; CD34; Transplantation; Platelet; Andrology; Stem cell; Immunology; Stem cell factor; Bone marrow; Cytokine; Thrombopoietin; Biology; Chemistry; Cell biology; Medicine; Internal medicine","score_opus":0.007260311271715342,"score_gpt":0.24864742461034298,"score_spread":0.24138711333862764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593997079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989057,0.000024330442,8.3915097e-7,0.000107243046,0.00008226162,0.00043244925,0.00006319812,0.000006059252,0.00037791335],"genre_scores_gemma":[0.9997931,0.000021456835,0.000020869107,0.000014173338,0.00004307101,0.000006681484,0.000027719761,0.000009520132,0.00006339592],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994474,0.000021541384,0.00017132191,0.00008643102,0.0001825673,0.00009071322],"domain_scores_gemma":[0.999404,0.0000114121385,0.0001908799,0.00028015825,0.000088127446,0.000025387015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000046741774,0.00009228195,0.00021429345,0.00002115769,0.00003197983,0.0000029619623,0.00009483374,0.00007449756,0.000073519856],"category_scores_gemma":[0.0000376511,0.000040069517,0.00017179985,0.00012228334,0.00008845664,0.000020202526,0.000019583464,0.00012249482,0.0000019217728],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007707323,0.0023092814,0.043060403,0.000028658393,0.00041984575,0.0000054985962,0.00020925282,2.696101e-7,0.9536142,0.00005905469,0.000017733728,0.00019878018],"study_design_scores_gemma":[0.0018962745,0.0008330366,0.3603515,0.000049609887,0.00053327525,0.000051080202,0.000027547241,0.0000055063865,0.63614494,0.000068405316,0.000006466602,0.000032368625],"about_ca_topic_score_codex":0.000044264136,"about_ca_topic_score_gemma":0.0000037543998,"teacher_disagreement_score":0.31746924,"about_ca_system_score_codex":0.0000024614017,"about_ca_system_score_gemma":0.00005809978,"threshold_uncertainty_score":0.16339874},"labels":[],"label_agreement":null},{"id":"W2594014758","doi":"10.1182/blood.v128.22.3529.3529","title":"How Do New Immigrant Families (African Continent) with a Child with Sickle Cell Disease (SCD) Experience the Western Medical System?","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; Stollery Children's Hospital; University of Alberta","funders":"","keywords":"Immigration; Context (archaeology); Medicine; Family medicine; Language barrier; Health care; Disease; Cultural diversity; Gerontology; Psychology; Sociology; Political science; Geography","score_opus":0.003369331659506059,"score_gpt":0.18295972627530616,"score_spread":0.1795903946158001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594014758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9645761,0.003067876,0.00048029947,0.028263904,0.00007940001,0.0006559673,0.000012074044,0.00014821003,0.00271614],"genre_scores_gemma":[0.9959689,0.00039084454,0.00004702578,0.00040728378,0.00018554051,0.00005650301,0.000003465855,0.000035420846,0.002905041],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983164,0.000045300334,0.0001890802,0.000357385,0.0007033602,0.00038846748],"domain_scores_gemma":[0.9986443,0.000060020455,0.00010027945,0.00051686954,0.00005944174,0.0006190789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008864337,0.00024253456,0.00032659972,0.000045280758,0.00014765604,0.000052721873,0.00022228788,0.00008552579,0.000031070267],"category_scores_gemma":[0.00005394126,0.000087944536,0.000076419936,0.0001944104,0.00037680098,0.000079968304,0.00004824619,0.00019096736,0.000022977894],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010832182,0.008958285,0.8374444,0.0029980538,0.0026769333,0.016287487,0.062474463,0.000009421583,0.0059574237,0.0020055182,0.009010706,0.041345097],"study_design_scores_gemma":[0.17421238,0.010318157,0.15699595,0.032439243,0.008272747,0.008972743,0.28187218,0.00013501132,0.024622727,0.00003300383,0.29817158,0.0039542993],"about_ca_topic_score_codex":0.00029135105,"about_ca_topic_score_gemma":0.00008443284,"teacher_disagreement_score":0.6804485,"about_ca_system_score_codex":0.000018824794,"about_ca_system_score_gemma":0.00028352923,"threshold_uncertainty_score":0.3586274},"labels":[],"label_agreement":null},{"id":"W2594024065","doi":"10.1182/blood.v108.11.951.951","title":"Comparative Proteome Analysis To Study Novel Markers of the Blood Platelet Lesion.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Proteome; Platelet; Chemistry; Tandem mass spectrometry; Chromatography; Mass spectrometry; Biochemistry; Blood proteins; Quantitative analysis (chemistry); Proteomics; Computational biology; Biology; Immunology","score_opus":0.025414802591170384,"score_gpt":0.277179144986623,"score_spread":0.2517643423954526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594024065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919461,0.000038850852,0.0003292535,0.0006438427,0.000035881556,0.0023373957,0.000015390848,0.00003398019,0.0046193143],"genre_scores_gemma":[0.9970342,0.0000023562288,0.0013248718,0.00022288691,0.000035132234,0.000091264854,0.0000066938674,0.000010295114,0.0012723235],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987668,0.00004866279,0.0003254501,0.00026882757,0.00041647992,0.0001737908],"domain_scores_gemma":[0.99927276,0.000024871712,0.00008301961,0.00046405845,0.00008290931,0.00007235193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021282438,0.00014406578,0.0004393956,0.00020372143,0.00007840878,0.000010258566,0.00015953479,0.00003679773,0.00014074972],"category_scores_gemma":[0.000010916592,0.0000931004,0.00019471289,0.0011698839,0.00003652381,0.000020839327,0.00008000134,0.000111706206,0.000010844653],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016411152,0.09488348,0.50449103,0.00030615233,0.041947756,0.0002373869,0.005995169,0.00091030495,0.34372395,0.0015780301,0.003238873,0.0010467479],"study_design_scores_gemma":[0.010461755,0.0009542507,0.8580278,0.000035950565,0.010851404,0.000009730695,0.0009875754,0.000027830905,0.117618404,0.00001399059,0.0008618858,0.00014942],"about_ca_topic_score_codex":0.00042535283,"about_ca_topic_score_gemma":0.00038347216,"teacher_disagreement_score":0.35353678,"about_ca_system_score_codex":0.0000069119633,"about_ca_system_score_gemma":0.000026266669,"threshold_uncertainty_score":0.3796524},"labels":[],"label_agreement":null},{"id":"W2594032372","doi":"10.1182/blood.v126.23.1568.1568","title":"Whole Exome Sequencing Reveals That DNMT3A and ASXL1 Mutation Are Involved in the Development of Tyrosine Kinase Inhibitor Resistance in Chronic Myeloid Leukemia Patients without ABL1 Tyrosine Kinase Domain Mutation","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Ponatinib; Dasatinib; Nilotinib; Tyrosine-kinase inhibitor; Medicine; Myeloid leukemia; Mutation; Imatinib; Imatinib mesylate; Exome sequencing; Tyrosine kinase; Resistance mutation; Cancer research; Internal medicine; Biology; Genetics; Cancer; Reverse transcriptase; Gene; Receptor","score_opus":0.02896320036997661,"score_gpt":0.26013344898843765,"score_spread":0.23117024861846105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594032372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99561256,0.0025337224,0.00004028758,0.0001585402,0.00007695614,0.0013571131,0.000039040082,0.000037626025,0.00014415395],"genre_scores_gemma":[0.9925545,0.00003306512,0.0064420486,0.00010808324,0.000090741516,0.00018699463,0.00043855803,0.00004773106,0.000098274184],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971666,0.00023103645,0.00085173215,0.0005409785,0.00076446956,0.00044523043],"domain_scores_gemma":[0.99852914,0.00013639823,0.00049970625,0.00045441304,0.00021397341,0.00016637213],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009859515,0.00035474263,0.0005785706,0.0003215409,0.00008645638,0.000036451198,0.0001497749,0.0001774653,0.0000065207373],"category_scores_gemma":[0.0004000167,0.00028890415,0.000047353795,0.00062838977,0.00012080904,0.00029321684,0.00007376392,0.00029620188,0.000012241655],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015426513,0.0019042055,0.85312206,0.0019397598,0.00019017879,0.0011351766,0.05104309,0.00018243608,0.085390516,0.00009570479,0.00036695923,0.003087295],"study_design_scores_gemma":[0.044433363,0.00045626797,0.8665272,0.0037664971,0.00019084895,0.000037525977,0.005582309,0.0001255741,0.0776588,0.0005172525,0.00023773032,0.00046665495],"about_ca_topic_score_codex":0.00020705874,"about_ca_topic_score_gemma":0.004718685,"teacher_disagreement_score":0.04546078,"about_ca_system_score_codex":0.005730825,"about_ca_system_score_gemma":0.0018594688,"threshold_uncertainty_score":0.9999563},"labels":[],"label_agreement":null},{"id":"W2594040066","doi":"10.1182/blood.v106.11.1208.1208","title":"RIZ1 Tumor Suppressor Regulates IGF-1 Autocrine Loop To Control Cell Proliferation, Apoptosis, and Differentiation in Chronic Myeloid Leukemia Blast Crisis Cell Lines.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Biology; Cancer research; Myeloid leukemia; K562 cells; Tumor suppressor gene; Cell growth; Leukemia; Immunology; Genetics; Cancer; Carcinogenesis","score_opus":0.006151422821804697,"score_gpt":0.2258149700100713,"score_spread":0.2196635471882666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594040066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944928,0.0012907671,0.00012837705,0.001656664,0.00007884261,0.001900922,0.000048478494,0.0001399289,0.00026318472],"genre_scores_gemma":[0.995324,0.00011784064,0.00097311154,0.00061066827,0.0006791412,0.00035652771,0.00016152857,0.00007582591,0.0017013451],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975006,0.00008015519,0.0006876055,0.0007160775,0.00040101475,0.0006145773],"domain_scores_gemma":[0.998698,0.000089068104,0.0001837353,0.0005557401,0.00014589756,0.00032758905],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015871823,0.00043572029,0.0006367134,0.0003097493,0.000106636726,0.00007292535,0.00014430245,0.00015339282,0.00023677121],"category_scores_gemma":[0.00007874087,0.00039553287,0.00010022685,0.00031886675,0.000044044675,0.00020495246,0.000083973355,0.00029810198,0.00013336449],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008666551,0.0037537625,0.04503623,0.0012344006,0.00034990968,0.0000782377,0.0015945514,0.0019137769,0.935018,0.000029815328,0.007909013,0.0022156253],"study_design_scores_gemma":[0.03789236,0.0007768397,0.051651146,0.00018898773,0.00067403744,0.00005596878,0.00007468375,0.008323112,0.8989917,0.000015620433,0.000937976,0.0004175603],"about_ca_topic_score_codex":0.00020969649,"about_ca_topic_score_gemma":0.00031302753,"teacher_disagreement_score":0.037025705,"about_ca_system_score_codex":0.0017900662,"about_ca_system_score_gemma":0.0007756536,"threshold_uncertainty_score":0.9998497},"labels":[],"label_agreement":null},{"id":"W2594080940","doi":"10.1182/blood.v110.11.969.969","title":"A Pilot Study of the Accuracy of Diagnostic Coding for Venous Thromboembolism within an Administrative Dataset of Emergency Department Visits.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Health Sciences Centre; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Emergency department; Diagnosis code; Pulmonary embolism; Population; Medical emergency; Emergency medicine; Health care; Ambulatory care; Ambulatory; Surgery","score_opus":0.07620832414814128,"score_gpt":0.3636587268407932,"score_spread":0.28745040269265193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594080940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950949,0.00020041721,0.00009798032,0.00004040157,0.0003063971,0.0032316525,0.0008508444,0.000013068122,0.00016433415],"genre_scores_gemma":[0.99899906,0.00009521681,0.0004085164,0.000055659053,0.00008498207,0.00010870578,0.0002176384,0.000024729054,0.0000054642087],"study_design_codex":"nonrandomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99804944,0.00006971193,0.0009132825,0.00029338984,0.00041597802,0.00025820735],"domain_scores_gemma":[0.9977275,0.0005785177,0.000699538,0.0007115,0.00018298441,0.00009994491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007220419,0.00019005124,0.0007532663,0.00008598335,0.00008908253,0.000004500751,0.0002863987,0.000030176776,0.00003405429],"category_scores_gemma":[0.0009701598,0.00013770007,0.00008888025,0.00023786063,0.000055694785,0.00008237577,0.00012654898,0.00009427831,8.8193474e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021215493,0.5617553,0.25588435,0.0047263145,0.008592816,0.00015838428,0.051105477,0.00014200786,0.087344795,0.012359589,0.01188418,0.003925234],"study_design_scores_gemma":[0.0059719165,0.034103647,0.8543621,0.00030733264,0.0032964929,0.000008042688,0.005418025,0.000011978406,0.09594805,0.00021267301,0.00016519724,0.00019459322],"about_ca_topic_score_codex":0.0003666724,"about_ca_topic_score_gemma":0.0011327126,"teacher_disagreement_score":0.5984777,"about_ca_system_score_codex":0.000017717914,"about_ca_system_score_gemma":0.000101182726,"threshold_uncertainty_score":0.5615246},"labels":[],"label_agreement":null},{"id":"W2594087813","doi":"10.1182/blood.v128.22.222.222","title":"Health-Related Quality of Life (HRQoL) of Blinatumomab Versus Standard of Care (SOC) Chemotherapy in Patients with Relaspsed or Refractory Philadelphia Negative B-Cell Precursor Acute Lymphoblastic Leukemia in a Randomized, Open-Label Phase 3 Study (TOWER)","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Blinatumomab; Medicine; Internal medicine; Acute lymphocytic leukemia; Oncology; Chemotherapy; Leukemia; Lymphoblastic Leukemia","score_opus":0.028804082293295764,"score_gpt":0.34324321513831907,"score_spread":0.3144391328450233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594087813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911866,0.00040484397,0.000046129724,0.0003054769,0.000086170825,0.007275025,0.00045889505,0.000027608685,0.00020923016],"genre_scores_gemma":[0.9985805,0.00019249276,0.0007346178,0.0000427637,0.000016763404,0.00020522773,0.00004341641,0.000088608096,0.00009560671],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99323124,0.0012474742,0.0026260896,0.0007584185,0.0015067023,0.00063006656],"domain_scores_gemma":[0.99266905,0.003207155,0.0018333994,0.0008976841,0.0010546077,0.00033808927],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001937896,0.00048200705,0.0036642135,0.00061607896,0.000043684788,0.000010944031,0.0005984803,0.00027841143,0.00010131999],"category_scores_gemma":[0.0032694445,0.00029665523,0.00014182589,0.0012402365,0.00062923087,0.00025945506,0.00023307919,0.00040641974,0.000003062768],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9553991,0.019859588,0.01158799,0.00074633403,0.0014820922,0.00006261301,0.008602015,0.000005421425,0.0011702317,0.000011955085,0.00011337024,0.0009593206],"study_design_scores_gemma":[0.9341387,0.047071077,0.008303655,0.0016838885,0.00044465216,0.0000025476415,0.0016531157,0.000060399092,0.006325328,0.000017918797,0.000004930524,0.00029377214],"about_ca_topic_score_codex":0.0014271745,"about_ca_topic_score_gemma":0.00053573126,"teacher_disagreement_score":0.027211487,"about_ca_system_score_codex":0.0027952972,"about_ca_system_score_gemma":0.009677698,"threshold_uncertainty_score":0.99994856},"labels":[],"label_agreement":null},{"id":"W2594102613","doi":"10.1182/blood.v128.22.2625.2625","title":"Anticoagulation Therapy for Thrombotic Events in Paediatric Cancer Patients with Low Platelet Counts","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Central Venous Catheters and Hemodialysis","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Hamilton Health Sciences; McMaster Children's Hospital","funders":"","keywords":"Medicine; MEDLINE; Cancer; Pediatrics; Intensive care medicine; Internal medicine","score_opus":0.02144955720230673,"score_gpt":0.3148511393528696,"score_spread":0.2934015821505629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594102613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99869,0.00009651575,0.000065189655,0.00010255083,0.00018726345,0.00070245727,0.000042825508,0.00001553436,0.000097665274],"genre_scores_gemma":[0.99912685,0.00026432853,0.000049259725,0.00012349349,0.00012757958,0.00009621785,0.000018038727,0.000015554333,0.0001786654],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993434,0.000037781043,0.00015104494,0.00012538163,0.00010610624,0.00023630234],"domain_scores_gemma":[0.99964875,0.000089652865,0.0000810088,0.00008986013,0.00005700887,0.00003371203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008426539,0.00006828473,0.00013358647,0.00004974314,0.00009217134,0.000001323145,0.000047552574,0.000066337736,0.00025926912],"category_scores_gemma":[0.000011151374,0.000039439965,0.000029358438,0.00009123515,0.000007792195,0.00004781429,0.000007734228,0.00005082993,0.000057249235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005126756,0.00039883747,0.9925033,0.000023805802,0.00002745642,2.5208524e-7,0.00024571974,0.0000016862197,0.00006767114,0.000014655454,0.00024615685,0.0064192167],"study_design_scores_gemma":[0.0070252977,0.00010787979,0.99175906,0.000113695234,0.000028826007,3.4856214e-8,0.000010400097,0.000013011192,0.00010759178,0.00016992107,0.0005745776,0.00008972084],"about_ca_topic_score_codex":0.000041553223,"about_ca_topic_score_gemma":0.00008878516,"teacher_disagreement_score":0.00697403,"about_ca_system_score_codex":0.000050965955,"about_ca_system_score_gemma":0.000076581724,"threshold_uncertainty_score":0.28388152},"labels":[],"label_agreement":null},{"id":"W2594107028","doi":"10.1182/blood.v126.23.1532.1532","title":"Primary Results of the Health-Related Quality of Life Assessment from the Phase III Gadolin Study of Obinutuzumab Plus Bendamustine Compared with Bendamustine Alone in Patients with Rituximab-Refractory, Indolent Non-Hodgkin Lymphoma","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Bendamustine; Obinutuzumab; Medicine; Rituximab; Internal medicine; Quality of life (healthcare); Clinical endpoint; Refractory (planetary science); Lymphoma; Phases of clinical research; Oncology; Surgery; Gastroenterology; Clinical trial","score_opus":0.03667813950631183,"score_gpt":0.3057816624668234,"score_spread":0.2691035229605116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594107028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99484223,0.00041357926,0.0000049323794,0.0003313273,0.00008629021,0.0033933164,0.0007450838,0.000020544783,0.00016269667],"genre_scores_gemma":[0.9986651,0.000014586164,0.0004426162,0.00013672467,0.00003571184,0.00010212712,0.00055818114,0.000035918023,0.000009023928],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951143,0.00056931283,0.0020025095,0.0005186744,0.0014439187,0.00035127607],"domain_scores_gemma":[0.99564034,0.00041618277,0.0019754823,0.0011766521,0.00052839424,0.00026294426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009255116,0.00039235284,0.0017844338,0.000112709815,0.00007827729,0.000009686012,0.0003163037,0.000097004646,0.00000999293],"category_scores_gemma":[0.00015992043,0.00020016162,0.00010686105,0.0005857643,0.00021909087,0.00007411843,0.0001792165,0.00020513564,8.9307144e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03385725,0.10318274,0.850747,0.00016436096,0.0014317656,0.000025582258,0.008582852,0.00025781288,0.000071600596,0.000005547378,0.00027560658,0.0013978631],"study_design_scores_gemma":[0.3328539,0.009469518,0.654253,0.0006071392,0.0004801512,0.0000024392104,0.0016978895,0.00006622625,0.00042946474,0.0000019454128,0.000012286182,0.00012605393],"about_ca_topic_score_codex":0.033019,"about_ca_topic_score_gemma":0.002791627,"teacher_disagreement_score":0.29899666,"about_ca_system_score_codex":0.00078977895,"about_ca_system_score_gemma":0.0027936248,"threshold_uncertainty_score":0.9734202},"labels":[],"label_agreement":null},{"id":"W2594120437","doi":"10.1182/blood.v118.21.3307.3307","title":"Activated Protein C and Septic Shock: A Propensity-Matched Cohort Study,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Sepsis Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Brandon Regional Health Authority; Jewish General Hospital; University of Manitoba","funders":"","keywords":"Drotrecogin alfa; Medicine; Septic shock; Propensity score matching; Internal medicine; Hazard ratio; Cohort; Retrospective cohort study; Proportional hazards model; Intensive care; Sepsis; APACHE II; Cohort study; Intensive care unit; Intensive care medicine; Confidence interval; Severe sepsis","score_opus":0.08842954493511432,"score_gpt":0.29023318777424784,"score_spread":0.20180364283913352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594120437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935104,0.00011117189,6.282013e-7,0.00011836188,0.00001537634,0.002788966,0.0000011879683,0.00007413692,0.0033797259],"genre_scores_gemma":[0.9987492,0.000009025235,0.00035279372,0.000100020465,0.000024362076,0.00039181428,0.000004796193,0.000019879333,0.000348127],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99923426,0.000036087826,0.00014032553,0.0002701999,0.0001596176,0.00015951348],"domain_scores_gemma":[0.9995089,0.000012789935,0.000042783333,0.00026694624,0.000052475018,0.00011609932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011296511,0.00013264446,0.00031964117,0.00004530925,0.000048976213,0.00001223378,0.00003449923,0.000046043708,0.0001999199],"category_scores_gemma":[0.000038113365,0.000092627655,0.000036080666,0.000093597344,0.000028631304,0.00004010254,0.000043162854,0.0000816361,0.0000494602],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007531306,0.008186803,0.9773901,0.000026745234,0.000664356,0.00026522524,0.0010134716,5.9637637e-9,0.011950919,0.000014249061,0.00004699441,0.0003658181],"study_design_scores_gemma":[0.0042762533,0.0013005972,0.8654782,0.00006375463,0.0007328712,0.000045599067,0.00019351042,8.671624e-7,0.12775391,0.000020804711,0.000043905802,0.000089713736],"about_ca_topic_score_codex":0.00021245924,"about_ca_topic_score_gemma":0.000027963404,"teacher_disagreement_score":0.115803,"about_ca_system_score_codex":0.000016975688,"about_ca_system_score_gemma":0.00003403458,"threshold_uncertainty_score":0.37772462},"labels":[],"label_agreement":null},{"id":"W2594142637","doi":"10.1182/blood.v116.21.23.23","title":"A Modified Model of Type 2B von Willebrand Disease: Taking ADAMTS13-Mediated Cleavage out of the Equation","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"ADAMTS13; Von Willebrand disease; Recombinant DNA; Molecular biology; Chemistry; Von Willebrand factor; Mutant; Cleavage (geology); Wild type; Platelet; Complementary DNA; Transfection; Gene; Immunology; Biology; Biochemistry","score_opus":0.030920702531932104,"score_gpt":0.26127794261725534,"score_spread":0.23035724008532324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594142637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972103,0.00014432798,0.00006885443,0.00013864727,0.00010363457,0.0002730942,0.000039548228,0.000015500846,0.00200608],"genre_scores_gemma":[0.9994881,0.000024090199,0.00016340041,0.000047733258,0.00001992255,0.000006026797,0.00004138839,0.000012709496,0.00019659563],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9994003,0.000012883854,0.00016824462,0.00011284683,0.00020017513,0.00010555208],"domain_scores_gemma":[0.999443,0.000030005627,0.00014632384,0.00025484507,0.00006628467,0.0000595302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006002213,0.00008247077,0.00018687588,0.000035660552,0.000030088117,0.0000031145419,0.000064401895,0.00005989036,0.000020213081],"category_scores_gemma":[0.0001970367,0.000054078435,0.00006484122,0.00009543192,0.000046646575,0.00003621393,0.000022506752,0.00009921117,0.000005082741],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018415527,0.006847164,0.2504702,0.0005224424,0.0009822903,0.0000848164,0.0022116415,0.0012878794,0.728058,0.0018807908,0.00044196978,0.005371298],"study_design_scores_gemma":[0.04886042,0.00092188176,0.4455997,0.0007934362,0.004655818,0.000024424937,0.00019030755,0.3320227,0.15978993,0.006206557,0.0002530474,0.0006817692],"about_ca_topic_score_codex":0.00002527857,"about_ca_topic_score_gemma":0.00003058081,"teacher_disagreement_score":0.568268,"about_ca_system_score_codex":0.0000042917104,"about_ca_system_score_gemma":0.00009188366,"threshold_uncertainty_score":0.22052546},"labels":[],"label_agreement":null},{"id":"W2594150621","doi":"10.1182/blood.v116.21.4677.4677","title":"Are Communication Tools Effective in Increasing Reporting Rate of Acute Hemolytic Reactions (AHR) In ITP Patients Treated with Rh (D) Immune Globulin?","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Disseminated intravascular coagulation; Internal medicine; Pediatrics","score_opus":0.01072574178929352,"score_gpt":0.2567813950829763,"score_spread":0.24605565329368279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594150621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981978,0.00005100906,0.0000045419943,0.00010846757,0.000025120105,0.0008839046,0.00000966135,0.000032766467,0.0006867542],"genre_scores_gemma":[0.99908805,0.00003401142,0.00065285,0.000028238237,0.000012852792,0.00005133965,0.00009818949,0.000021718892,0.000012769702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99854934,0.00017072313,0.0007629214,0.00021398965,0.0001277354,0.00017525865],"domain_scores_gemma":[0.9982443,0.0002312481,0.00084081077,0.00046984787,0.00016106578,0.000052752745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008542182,0.00013977141,0.00042681798,0.00016166428,0.000059409052,0.000012795309,0.00006966518,0.00012017979,0.00000775174],"category_scores_gemma":[0.0006940503,0.0001147944,0.000056034278,0.0004788735,0.000055809058,0.00015000693,0.000030191184,0.00048306806,0.0000017149198],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006343353,0.0017571275,0.8853303,0.00006940016,0.000115063405,0.000084882486,0.00028570415,0.0000020855177,0.11046159,0.0000120989025,4.88681e-7,0.0012468888],"study_design_scores_gemma":[0.0083709555,0.00028487964,0.9293687,0.0009396717,0.0003767697,0.00010461361,0.000109739805,0.00004649098,0.060270336,0.000021594857,0.000005478709,0.00010078631],"about_ca_topic_score_codex":0.0027378951,"about_ca_topic_score_gemma":0.0010850979,"teacher_disagreement_score":0.050191257,"about_ca_system_score_codex":0.000031197855,"about_ca_system_score_gemma":0.000037302747,"threshold_uncertainty_score":0.46811798},"labels":[],"label_agreement":null},{"id":"W2594151149","doi":"10.1182/blood.v108.11.367.367","title":"Kinetin Riboside Is a Novel Targeted Inhibitor of CCND1 and CCND2 Transactivation with Substantial Preclinical Anti-Myeloma Activity.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Cyclin D2; Cyclin D1; Transactivation; Cancer research; Biology; Cyclin B1; Cyclin D; Cyclin A; Cell cycle; Cyclin; Molecular biology; Biochemistry; Genetics; Gene expression; Cancer; Cyclin-dependent kinase 1; Gene","score_opus":0.021516807086795476,"score_gpt":0.2839931647472843,"score_spread":0.2624763576604888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594151149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977028,0.0001588116,0.00074266887,0.000398897,0.000018835624,0.00058321597,0.00009196204,0.000038337654,0.00026448513],"genre_scores_gemma":[0.99609184,0.000027319322,0.0035029275,0.000023359153,0.00013069596,0.000023629338,0.000050301278,0.000026579297,0.00012333808],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986557,0.000038414226,0.0002652975,0.0003319858,0.00042611995,0.00028251557],"domain_scores_gemma":[0.9992947,0.00012574441,0.00010791055,0.0002119178,0.000121653575,0.00013805096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011195619,0.0001760192,0.0003750887,0.00011556221,0.00005176518,0.000015309619,0.000044718377,0.00011661401,0.00005904122],"category_scores_gemma":[0.000048287395,0.00013259597,0.000070298855,0.00022761867,0.00013465554,0.00010473729,0.000013644554,0.0001753101,0.0000034259842],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021643788,0.004748751,0.2717668,0.00016320907,0.00032189363,0.000068816276,0.00010459519,0.0000017867591,0.7173448,0.000015254169,0.000057010257,0.00324268],"study_design_scores_gemma":[0.012735146,0.0007162984,0.5232205,0.00009198255,0.0001483869,0.000038915416,0.000008613803,0.00011128634,0.46278313,0.000006966607,0.000060711856,0.00007810339],"about_ca_topic_score_codex":0.00045558746,"about_ca_topic_score_gemma":0.00008176517,"teacher_disagreement_score":0.2545617,"about_ca_system_score_codex":0.000015983256,"about_ca_system_score_gemma":0.000106921354,"threshold_uncertainty_score":0.54071075},"labels":[],"label_agreement":null},{"id":"W2594164534","doi":"10.1182/blood.v104.11.1860.1860","title":"Comparison of the Anticoagulant Effect of Melagatran and Lmwh in an Acquired Antithrombin Deficiency in Children with All Treated with L-Asparaginase.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stollery Children's Hospital","funders":"","keywords":"Ximelagatran; Direct thrombin inhibitor; Asparaginase; Anticoagulant; Medicine; Antithrombin; Thrombosis; Population; Low molecular weight heparin; Warfarin; Discovery and development of direct thrombin inhibitors; Pharmacology; Heparin; Internal medicine; Surgery; Immunology; Thrombin; Leukemia; Lymphoblastic Leukemia; Platelet","score_opus":0.014549307280928167,"score_gpt":0.3135924123303691,"score_spread":0.2990431050494409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594164534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99823606,0.00083770225,0.000001020179,0.00009037968,0.000007397447,0.0007427747,0.0000066341936,0.000009471196,0.00006856245],"genre_scores_gemma":[0.9998516,0.00002722083,0.00005634468,0.000016203881,0.000006185371,0.000012457894,0.000015454216,0.000010789712,0.0000037451985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992925,0.00006593659,0.00018156489,0.00017771992,0.00012508556,0.00015717585],"domain_scores_gemma":[0.999673,0.000022981183,0.00008439073,0.00016075329,0.00001630549,0.00004253682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008242095,0.00013025178,0.0004590799,0.000091830625,0.000014570159,0.0000029328385,0.00006052057,0.000044869677,0.000005803518],"category_scores_gemma":[0.0000026197217,0.000070057664,0.000022492188,0.00028247375,0.0001618396,0.0000385142,0.000011213725,0.000069337504,2.2293936e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007630932,0.0024928544,0.9551597,0.000064181884,0.0001113614,0.000023030705,0.0006734762,0.00008614768,0.04051258,0.00001353684,0.0000013588811,0.000098676705],"study_design_scores_gemma":[0.01968837,0.0053489483,0.69471323,0.0001609551,0.0005182137,0.00007743838,0.00002359856,0.000013051526,0.2793986,0.0000032462333,3.3667305e-7,0.000053986434],"about_ca_topic_score_codex":0.0011927326,"about_ca_topic_score_gemma":0.0014967194,"teacher_disagreement_score":0.26044643,"about_ca_system_score_codex":0.00002032886,"about_ca_system_score_gemma":0.00005989181,"threshold_uncertainty_score":0.28568688},"labels":[],"label_agreement":null},{"id":"W2594184912","doi":"10.1182/blood.v128.22.1210.1210","title":"A microRNA Expression-Based Model Predicts Event Free Survival in Pediatric Acute Myeloid Leukemia","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Oncology; Cohort; Medicine; Proportional hazards model; microRNA; Myeloid; Myeloid leukemia; Internal medicine; Biology; Genetics; Gene","score_opus":0.007080998972718572,"score_gpt":0.22176039437995948,"score_spread":0.2146793954072409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594184912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915754,0.000556064,0.00710238,0.000121068544,0.00008045705,0.00021470836,0.00014969317,0.000019656112,0.00018054928],"genre_scores_gemma":[0.9979402,0.00014336228,0.0011821374,0.00005800779,0.00026268102,0.000048388014,0.00007102744,0.000030919335,0.00026327744],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99884486,0.000059912705,0.000241732,0.00039759825,0.00018043246,0.0002754366],"domain_scores_gemma":[0.999143,0.000017642364,0.00009793256,0.0005753393,0.00005220794,0.00011388442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001375618,0.00016950874,0.00013657784,0.00007299781,0.000033764805,0.000010501422,0.00029661294,0.00018213404,0.000019034533],"category_scores_gemma":[0.00009238969,0.00013255334,0.00009660573,0.00008627474,0.00003217086,0.0000054640523,0.00014723603,0.00005324733,0.000014010157],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008909541,0.00017958938,0.01606161,0.000022071381,0.000023898056,0.000008125102,0.000008724263,0.0007171461,0.9815684,0.0000057155826,0.001180164,0.00013548431],"study_design_scores_gemma":[0.005544709,0.0000855843,0.0280142,0.00004947171,0.00010011795,0.0000041168487,0.000002350511,0.00079229026,0.96466833,0.00019454338,0.0002724817,0.00027182387],"about_ca_topic_score_codex":0.0000045942975,"about_ca_topic_score_gemma":0.000026570235,"teacher_disagreement_score":0.016900066,"about_ca_system_score_codex":0.000045014163,"about_ca_system_score_gemma":0.00036014424,"threshold_uncertainty_score":0.5405368},"labels":[],"label_agreement":null},{"id":"W2594215124","doi":"10.1182/blood.v120.21.3143.3143","title":"Global Trends in Hematopoietic Cell Transplantation.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Transplantation; Hematopoietic cell; Medicine; Bone transplantation; Hematopoietic stem cell transplantation; Demography; Internal medicine; Haematopoiesis; Stem cell; Surgery; Biology","score_opus":0.015317858255692636,"score_gpt":0.2687643408650956,"score_spread":0.25344648260940295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594215124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93014294,0.0005485593,0.00050104596,0.00016448119,0.000117787175,0.00015114898,0.00002125726,0.00006874471,0.06828406],"genre_scores_gemma":[0.99749404,0.000067396315,0.0016992483,0.00012813018,0.00009304593,0.0000216885,0.0000863003,0.000015790332,0.00039436936],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892765,0.000034859557,0.00028104815,0.0001623722,0.00024071585,0.00035334635],"domain_scores_gemma":[0.99955255,0.000033948498,0.00003852575,0.00017825939,0.000018080098,0.00017863329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015616488,0.00013570346,0.00021810528,0.00013159022,0.000022538283,0.0000074088002,0.00005286131,0.000101729696,0.0003777949],"category_scores_gemma":[0.0000041545422,0.00012765886,0.00007420152,0.00045872974,0.000023732462,0.000100790436,0.0000039029574,0.00008359347,0.00014590572],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000074537646,0.0017003741,0.9899108,0.00059284054,0.000027884547,0.0001786451,0.0022644137,0.0000036719912,0.0033805368,0.00080957275,0.00015796836,0.00089876796],"study_design_scores_gemma":[0.0073905215,0.00009529969,0.95144475,0.00015429365,0.0004625457,0.0015830186,0.00021036339,0.00000747371,0.03806809,0.0000648125,0.00031060915,0.00020825287],"about_ca_topic_score_codex":0.000029237215,"about_ca_topic_score_gemma":0.000018032828,"teacher_disagreement_score":0.06788968,"about_ca_system_score_codex":0.00003353461,"about_ca_system_score_gemma":0.000028485896,"threshold_uncertainty_score":0.5205777},"labels":[],"label_agreement":null},{"id":"W2594219762","doi":"10.1182/blood.v112.11.3232.3232","title":"Preliminary Clinical Activity in a Phase I Trial of the BCR-ABL/IGF- 1R/Aurora Kinase Inhibitor XL228 in Patients with Ph++ Leukemias with Either Failure to Multiple TKI Therapies or with T315I Mutation","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Dasatinib; Medicine; Nilotinib; Dosing; Adverse effect; Internal medicine; Pharmacology; Imatinib mesylate; Imatinib; Gastroenterology; Myeloid leukemia","score_opus":0.024536031285848286,"score_gpt":0.2890415884862166,"score_spread":0.2645055572003683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594219762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99552196,0.000036237467,0.00001622606,0.0002523708,0.00006007232,0.0039777816,0.000044056374,0.000039786948,0.000051520015],"genre_scores_gemma":[0.9975423,0.000009020968,0.0016389054,0.000121405006,0.00012467553,0.0003014181,0.000034821158,0.00007007862,0.00015734465],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9975124,0.00026975246,0.0005656453,0.0005809222,0.0006833306,0.00038795185],"domain_scores_gemma":[0.9982931,0.00035319582,0.00033994144,0.00070738286,0.00014648343,0.00015991084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002604687,0.00037262714,0.0007308856,0.00017540398,0.000075579715,0.000010719586,0.0001643165,0.00017992171,0.00003273104],"category_scores_gemma":[0.00030906408,0.00019135403,0.00008671544,0.0007577102,0.00024407275,0.0001961618,0.00006235119,0.00046538218,0.0000061669452],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3499812,0.020508373,0.6203965,0.000089746354,0.0003578728,0.00065492396,0.0033764818,0.00007708864,0.00037821065,9.3556037e-7,0.00009908966,0.0040795766],"study_design_scores_gemma":[0.48831573,0.03326655,0.4686427,0.0007752804,0.0003118091,0.00007400492,0.0003462838,0.00007010248,0.0078013227,0.0000015298004,0.0001274148,0.0002672669],"about_ca_topic_score_codex":0.0005013959,"about_ca_topic_score_gemma":0.0022532248,"teacher_disagreement_score":0.1517538,"about_ca_system_score_codex":0.00044969298,"about_ca_system_score_gemma":0.0014757508,"threshold_uncertainty_score":0.7803191},"labels":[],"label_agreement":null},{"id":"W2594234261","doi":"10.1182/blood.v128.22.2814.2814","title":"Long-Term Outcomes of Patients with Acute Myeloid Leukemia Treated with Salvage High-Dose Etoposide and Cyclophosphamide","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Leukemia & Lymphoma Society of Canada; University of British Columbia","funders":"","keywords":"Cytarabine; Medicine; Etoposide; Internal medicine; Cyclophosphamide; Myeloid leukemia; Busulfan; Induction chemotherapy; Regimen; Oncology; Leukemia; Chemotherapy regimen; Salvage therapy; Chemotherapy; Surgery; Gastroenterology","score_opus":0.008111254755101997,"score_gpt":0.24534440161414514,"score_spread":0.23723314685904315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594234261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99801296,0.00010793983,0.000052014813,0.0003680648,0.000019303288,0.00086382625,0.00010606177,0.00009465188,0.00037515312],"genre_scores_gemma":[0.99598753,0.00020265438,0.0012396309,0.00015732701,0.000036843674,0.000047066485,0.000070228845,0.00008181703,0.0021768988],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797577,0.000049518243,0.00034130947,0.0004927499,0.0006296819,0.00051095383],"domain_scores_gemma":[0.9984324,0.00017591169,0.00017322414,0.00064150925,0.00026141392,0.00031553992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011083123,0.00034590115,0.00067952496,0.00018330738,0.00006716964,0.000017927912,0.00017520125,0.00014118265,0.0000817278],"category_scores_gemma":[0.00006554551,0.00017166957,0.00005932223,0.0002858866,0.00036010766,0.00018067323,0.00011651528,0.00021399788,0.000024485254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021969546,0.00043978656,0.98334074,0.00008917783,0.0012376565,0.0006613337,0.00007731397,1.7133922e-7,0.008729928,0.000030513094,0.000081887665,0.0031145094],"study_design_scores_gemma":[0.030436687,0.0017454287,0.9078011,0.00027352848,0.0008397502,0.00008408822,0.0000091079655,6.1132494e-7,0.058544554,0.000008427295,0.000025931577,0.00023077692],"about_ca_topic_score_codex":0.00021720512,"about_ca_topic_score_gemma":0.000059859864,"teacher_disagreement_score":0.075539656,"about_ca_system_score_codex":0.00023097097,"about_ca_system_score_gemma":0.0003864908,"threshold_uncertainty_score":0.7000482},"labels":[],"label_agreement":null},{"id":"W2594239232","doi":"10.1182/blood.v116.21.1444.1444","title":"Identification of a VPS33B-Binding Protein That Facilitates Alpha Granule Formation In Human Megakaryocytes and Platelets.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Hermansky–Pudlak syndrome; Biogenesis; Biology; Cell biology; Multiprotein complex; Stress granule; Granule (geology); Platelet; Golgi apparatus; Gene; Genetics; Immunology","score_opus":0.014419620650307044,"score_gpt":0.2553276071506913,"score_spread":0.24090798650038425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594239232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99894726,0.00015686879,0.0000069128037,0.00007923302,0.000017395389,0.00052079157,0.00001694701,0.00002132666,0.00023328833],"genre_scores_gemma":[0.9995363,0.00002129808,0.00016162299,0.0000045716415,0.0000059707118,0.000048922295,0.000079462276,0.0000073758124,0.00013448206],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99939346,0.000011426688,0.00022245405,0.00013251501,0.000120181925,0.00011994852],"domain_scores_gemma":[0.99970216,0.0000171013,0.000094457915,0.00012396397,0.000024785184,0.000037523903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012402706,0.00008699554,0.00018314974,0.00013428055,0.00005002863,0.000014584404,0.000033889017,0.00006519468,0.000013800457],"category_scores_gemma":[0.000035668025,0.000074459786,0.000027935705,0.000086211374,0.00004125869,0.00019829483,0.000013425257,0.00010017206,0.00000605006],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026523758,0.00046099228,0.03828664,0.00014056578,0.00003450323,0.000046380006,0.00067964697,1.14647634e-7,0.95860547,0.00017388642,0.0000051297684,0.001540147],"study_design_scores_gemma":[0.0041644834,0.00011811921,0.0474887,0.00007624357,0.000061131956,0.000098791104,0.00023552144,0.00005891008,0.9468513,0.0007376065,0.000033336848,0.000075820215],"about_ca_topic_score_codex":0.000069052716,"about_ca_topic_score_gemma":0.00010858978,"teacher_disagreement_score":0.011754133,"about_ca_system_score_codex":0.000007289585,"about_ca_system_score_gemma":0.000008300959,"threshold_uncertainty_score":0.3036382},"labels":[],"label_agreement":null},{"id":"W2594242280","doi":"10.1182/blood.v116.21.2571.2571","title":"The Effects of Azacitidine on Quality of Life Measured Longitudinally In MDS Patients Treated at a Tertiary Care Center","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University Health Network; Sunnybrook Health Science Centre; Western University; University of Toronto","funders":"","keywords":"International Prognostic Scoring System; Medicine; Azacitidine; Myelodysplastic syndromes; Quality of life (healthcare); Internal medicine; Oncology; Randomized controlled trial; Bone marrow","score_opus":0.013834058494775767,"score_gpt":0.28214921894385825,"score_spread":0.2683151604490825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594242280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99804157,0.00018119763,2.9434935e-7,0.00015744075,0.00008157471,0.00074419304,0.00003357019,0.000016149554,0.000743993],"genre_scores_gemma":[0.9996127,0.000029525323,0.0000255481,0.000071592905,0.00004268607,0.000036736743,0.000052749994,0.00002142889,0.00010703792],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830467,0.00019356993,0.0004150278,0.00022170114,0.000591435,0.00027358366],"domain_scores_gemma":[0.9984297,0.00043982943,0.00013743562,0.00052251725,0.0003363483,0.00013415421],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003417115,0.00014408816,0.00036874067,0.00011057101,0.00004509899,0.000004516545,0.00017186462,0.00012575743,0.000015979776],"category_scores_gemma":[0.0019753724,0.000091269205,0.00011058043,0.00019649627,0.00013807726,0.00002689383,0.00009958884,0.0003540571,0.000008856472],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008797728,0.0011125744,0.88917345,0.00050342927,0.00013323402,0.000018625864,0.0004026702,8.5710326e-8,0.106838055,0.000010157126,0.00017673026,0.000751222],"study_design_scores_gemma":[0.011743416,0.00056371075,0.8178286,0.00017017177,0.000054261658,0.0000020003997,0.00002859432,0.000002687746,0.16949101,0.0000024118901,0.000050834595,0.00006232603],"about_ca_topic_score_codex":0.00031717742,"about_ca_topic_score_gemma":0.00072055287,"teacher_disagreement_score":0.07134487,"about_ca_system_score_codex":0.000097445125,"about_ca_system_score_gemma":0.00013920381,"threshold_uncertainty_score":0.37218502},"labels":[],"label_agreement":null},{"id":"W2594280696","doi":"10.1182/blood.v118.21.2359.2359","title":"Deletion of Hoxa Genes in Adult Mice Affects Hematopoietic Stem Cell and B Cell Progenitors","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Biology; Haematopoiesis; Hox gene; Stem cell; Hematopoietic stem cell; Progenitor cell; Cell biology; Gene; Cancer research; Molecular biology; Genetics; Gene expression","score_opus":0.010424631750133686,"score_gpt":0.2182595236475901,"score_spread":0.2078348918974564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594280696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967858,0.0012070956,0.00003585821,0.0000083961795,0.00002047026,0.00028001907,0.000004231657,0.0000049596247,0.0016531427],"genre_scores_gemma":[0.9989121,0.0002105531,0.00055137393,0.0000126974,0.000025578931,0.000028716418,0.000010422117,0.000012002167,0.00023653667],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999371,0.000055651748,0.00012378737,0.00019713047,0.0001000782,0.00015237568],"domain_scores_gemma":[0.99966687,0.0000052399996,0.000051620435,0.00015317238,0.0000675135,0.000055574797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000094374205,0.00008632591,0.000093516464,0.00005503075,0.000020459129,0.000005981719,0.000083297564,0.00010654773,0.000010984377],"category_scores_gemma":[0.000007205339,0.00008209105,0.000031883406,0.00008010071,0.000039030896,0.0000028599754,0.00005639697,0.000051820218,0.0000058521214],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047870857,0.00034699592,0.02094287,0.00018360486,0.000008276106,0.00000564886,0.00020447392,9.321912e-7,0.9774187,0.000027427186,0.000025347446,0.0007878445],"study_design_scores_gemma":[0.0011048485,0.00027630883,0.0029707935,0.0000135114815,0.000010572198,0.00000889991,0.00014408145,0.000013888069,0.9951655,0.000012097002,0.00019020216,0.00008925895],"about_ca_topic_score_codex":0.00004778777,"about_ca_topic_score_gemma":0.000046412777,"teacher_disagreement_score":0.017972078,"about_ca_system_score_codex":0.0000026052628,"about_ca_system_score_gemma":0.000031955384,"threshold_uncertainty_score":0.33475757},"labels":[],"label_agreement":null},{"id":"W2594280921","doi":"10.1182/blood.v116.21.3812.3812","title":"Cost-Effectiveness of Zoledronic Acid Versus Clodronate In Patients with Multiple Myeloma From a Canadian Healthcare System Perspective.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Zoledronic acid; Multiple myeloma; Incidence (geometry); Bisphosphonate; Adverse effect; Internal medicine; Osteonecrosis of the jaw; Spinal cord compression; Surgery; Urology; Osteoporosis","score_opus":0.0157276648467145,"score_gpt":0.27440588885353717,"score_spread":0.25867822400682267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594280921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996906,0.00026410454,9.797515e-7,0.00011033146,0.00026833534,0.0017577258,0.00026333536,0.00003136619,0.0003978174],"genre_scores_gemma":[0.9994439,0.0000030261217,0.00018196428,0.000028052267,0.000024280183,0.00013662448,0.00014839292,0.000028702767,0.000005073652],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878776,0.00009326837,0.0002000388,0.00030618708,0.00021083518,0.0004018948],"domain_scores_gemma":[0.99880993,0.000102390884,0.00008309441,0.0003209771,0.00021517526,0.00046840362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011517425,0.00016395295,0.00038228242,0.00015637814,0.00006354347,0.0000047266212,0.00006411781,0.00013942947,0.000012012695],"category_scores_gemma":[0.0000648999,0.00013578711,0.000041045576,0.00019567828,0.00004379283,0.000049436796,0.000012658158,0.0003077339,0.000018651917],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028171898,0.00064920133,0.994663,0.00026546465,0.00015320141,0.00008813945,0.00032336966,5.1174493e-7,0.00010840194,0.00017102067,0.0000011694023,0.0007593021],"study_design_scores_gemma":[0.040630523,0.0010886162,0.95551103,0.0003827782,0.00012849625,0.0000058482383,0.00031861127,0.000014679281,0.0017719544,0.0000062915105,0.00003803233,0.00010311506],"about_ca_topic_score_codex":0.46464673,"about_ca_topic_score_gemma":0.6621391,"teacher_disagreement_score":0.1974924,"about_ca_system_score_codex":0.00056543713,"about_ca_system_score_gemma":0.0009456514,"threshold_uncertainty_score":0.55372375},"labels":[],"label_agreement":null},{"id":"W2594291948","doi":"10.1182/blood.v104.11.1223.1223","title":"Ferritin Heavy Chain, a Repressor of the Human β-Globin Gene That Binds a Conserved Cagtgc Motif, Is Bound to the Repressed β-Globin Promoter In Vivo in K562 Cells and Specifically Binds an Analogous Site in the Mouse βMajor-Globin Promoter.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Molecular biology; Biology; Globin; Chromatin immunoprecipitation; Promoter; Repressor; Chromatin; Locus control region; Binding site; Gene; Gene expression; Genetics","score_opus":0.018713525113247934,"score_gpt":0.248172112602591,"score_spread":0.22945858748934306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594291948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98447156,0.00068681256,0.000011691877,0.010014453,0.00008167309,0.003935908,0.00017814353,0.00005353283,0.0005662093],"genre_scores_gemma":[0.99654305,0.00017925994,0.00020897601,0.002260593,0.00007891746,0.00019704815,0.000032078355,0.00007765021,0.00042241233],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9951471,0.000810873,0.0011934665,0.0011550493,0.00075469556,0.0009387956],"domain_scores_gemma":[0.99725616,0.00009973629,0.0003173956,0.0019615616,0.000119318465,0.0002458225],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020466445,0.0005752676,0.0009006394,0.00039244338,0.00025338418,0.00015622105,0.00082289084,0.0004899051,0.00006647886],"category_scores_gemma":[0.00014204229,0.000338317,0.00022367875,0.0014908753,0.00043544456,0.00014798866,0.00025334675,0.0010813166,0.0000093823355],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087122264,0.008091361,0.09471221,0.00040506665,0.00022353244,0.0013365584,0.047672242,0.0006883031,0.84421504,0.00014192158,0.0010814847,0.00056104927],"study_design_scores_gemma":[0.031423036,0.0026855778,0.21758412,0.0017905893,0.0004331475,0.0009074425,0.006501016,0.0005917934,0.7351406,0.00069884397,0.0010897586,0.0011540236],"about_ca_topic_score_codex":0.006804029,"about_ca_topic_score_gemma":0.008703094,"teacher_disagreement_score":0.12287191,"about_ca_system_score_codex":0.00016065422,"about_ca_system_score_gemma":0.00025727722,"threshold_uncertainty_score":0.9999069},"labels":[],"label_agreement":null},{"id":"W2594319486","doi":"10.1182/blood.v128.22.347.347","title":"Results of a Phase II Study of Guadecitabine (SGI-110) in Higher Risk MDS, CMML or Low Blast Count AML Patients Refractory to or Relapsing after Azacitidine (AZA) Treatment","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Decitabine; Azacitidine; Internal medicine; Medicine; Gastroenterology; Hypomethylating agent; International Prognostic Scoring System; Myelodysplastic syndromes; Phases of clinical research; Refractory (planetary science); Neutropenia; Bone marrow; Oncology; Clinical trial; DNA methylation; Toxicity; Biology","score_opus":0.030230985891311204,"score_gpt":0.31391851202022725,"score_spread":0.28368752612891607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594319486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963067,0.0000916794,0.000005300317,0.00033251013,0.00012515028,0.0021219715,0.0007232384,0.000034962264,0.00025849158],"genre_scores_gemma":[0.99397576,0.00018706034,0.0004521136,0.000066301276,0.00016677886,0.00022557916,0.00003635065,0.00007109037,0.0048189703],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9965224,0.00021772155,0.001112995,0.0006595622,0.00092613354,0.00056115707],"domain_scores_gemma":[0.9975397,0.0003969069,0.00035564433,0.0009906562,0.00040445232,0.0003126431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048635044,0.00036268606,0.000871354,0.000512665,0.000057508,0.000008472111,0.00020785935,0.00016140647,0.00058744627],"category_scores_gemma":[0.0009798465,0.00019727756,0.0001017497,0.00068009313,0.000105012754,0.00015243287,0.000211929,0.00023302124,0.00003896078],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28898054,0.23863374,0.20051032,0.0005090301,0.0024748638,0.003377972,0.02205836,0.0000072167477,0.14478922,0.0000036791303,0.006841479,0.09181356],"study_design_scores_gemma":[0.43309942,0.16621533,0.31509975,0.0029672526,0.0011834044,0.000028403347,0.0014293484,0.000024091518,0.070692465,0.0000065310624,0.008583101,0.0006709287],"about_ca_topic_score_codex":0.0006021534,"about_ca_topic_score_gemma":0.0009810795,"teacher_disagreement_score":0.14411888,"about_ca_system_score_codex":0.0007300381,"about_ca_system_score_gemma":0.000427819,"threshold_uncertainty_score":0.80447453},"labels":[],"label_agreement":null},{"id":"W2594339435","doi":"10.1182/blood-2016-11-750893","title":"Thrombophilia risk is not increased in children after perinatal stroke","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Alberta; University of Calgary","funders":"","keywords":"Thrombophilia; Medicine; Stroke (engine); Pediatrics; Population; Factor V Leiden; Obstetrics; Internal medicine; Thrombosis; Venous thrombosis","score_opus":0.013571447391623201,"score_gpt":0.26242317141846006,"score_spread":0.24885172402683686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594339435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99681455,0.00009055343,0.000008760743,0.00039613855,0.000085509084,0.00033727256,0.00012039495,0.00005036007,0.002096458],"genre_scores_gemma":[0.9982148,0.000046097746,0.0005721386,0.0006149809,0.00017606115,0.00003262271,0.0000144242995,0.000026819538,0.0003020968],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989335,0.000032945034,0.00020619831,0.00031793627,0.00026633887,0.00024310272],"domain_scores_gemma":[0.9988767,0.0000126561235,0.0001240305,0.00080636353,0.000039799947,0.00014045295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016780681,0.00016473095,0.00030956452,0.00009260913,0.00015709834,0.000062464766,0.00017836734,0.00013025495,0.0007538249],"category_scores_gemma":[0.000098343226,0.00015038035,0.0001136007,0.00004075192,0.00006815671,0.00013308112,0.00010960778,0.00024179388,0.00016666677],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008204828,0.00054097467,0.99149567,0.000013663467,0.00015656349,0.0000329884,0.00014546918,6.762349e-8,0.0064438162,0.00017979709,0.000029928698,0.00087903254],"study_design_scores_gemma":[0.0068787285,0.00016965695,0.94575787,0.000055874218,0.00026254877,0.00006132398,0.000014917913,0.000030221085,0.046341896,0.00016755633,0.000107577565,0.0001518358],"about_ca_topic_score_codex":0.0005649403,"about_ca_topic_score_gemma":0.000057149628,"teacher_disagreement_score":0.045737784,"about_ca_system_score_codex":0.000015926571,"about_ca_system_score_gemma":0.000051058665,"threshold_uncertainty_score":0.8253854},"labels":[],"label_agreement":null},{"id":"W2594345661","doi":"10.1182/blood.v112.11.988.988","title":"Use of Pharmacogenetic Factors to Predict Warfarin Dose in Children - a Retrospective Cohort Study","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stollery Children's Hospital","funders":"","keywords":"Warfarin; VKORC1; Medicine; CYP2C9; Vitamin K epoxide reductase; Pharmacogenetics; Retrospective cohort study; Genotyping; Population; Internal medicine; Dosing; Surgery; Pediatrics; Atrial fibrillation; Genotype; Biology","score_opus":0.10408123361477373,"score_gpt":0.3851185748491991,"score_spread":0.28103734123442536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594345661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954233,0.0006068442,0.0000058941,0.000027621694,0.0004996627,0.00265285,0.00030507278,0.000073446376,0.00040530838],"genre_scores_gemma":[0.9982111,0.000674938,0.00012760425,0.00038324602,0.00017167396,0.00016909737,0.000027702168,0.000050410938,0.00018424226],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99706876,0.0005743282,0.000677718,0.0006441738,0.00042326958,0.0006117691],"domain_scores_gemma":[0.99869764,0.00015430473,0.00018003986,0.00037511674,0.0001659266,0.00042697426],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00057341787,0.00038408648,0.0006672192,0.00038176728,0.00016393633,0.000012214966,0.000438385,0.00020028652,0.000472411],"category_scores_gemma":[0.00014796232,0.0003726759,0.00012665965,0.00079944346,0.00015812456,0.00011340049,0.00024059732,0.00068339426,0.000044413322],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019438457,0.0055369283,0.9464446,0.0000064012606,0.0007798915,0.00007259802,0.0017350393,0.0007473157,0.0436009,0.0000063389125,0.00050494325,0.00037067832],"study_design_scores_gemma":[0.005668825,0.0003087991,0.88283384,0.000005163489,0.00062056835,0.000035379744,0.000040992472,0.00010538278,0.10880983,0.000011842268,0.0012400381,0.00031933084],"about_ca_topic_score_codex":0.00034691763,"about_ca_topic_score_gemma":0.00003206935,"teacher_disagreement_score":0.065208934,"about_ca_system_score_codex":0.00005310195,"about_ca_system_score_gemma":0.00013414459,"threshold_uncertainty_score":0.9998725},"labels":[],"label_agreement":null},{"id":"W2594366765","doi":"10.1182/blood.v106.11.2812.2812","title":"Evaluation of a New Prognostic Index for Peripheral T-Cell Lymphoma, Unspecified (PTCL-US).","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"International Prognostic Index; Medicine; Internal medicine; Lymphoma; Peripheral T-cell lymphoma; Proportional hazards model; Stage (stratigraphy); Cancer; Diffuse large B-cell lymphoma; Not Otherwise Specified; Oncology; Gastroenterology; T cell; Immunology; Immune system; Biology","score_opus":0.0354041682120084,"score_gpt":0.29179782440031704,"score_spread":0.25639365618830867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594366765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899253,0.002136473,0.00008044413,0.00053934206,0.00006235956,0.0014042314,0.000011568315,0.0000352177,0.00580504],"genre_scores_gemma":[0.9959495,0.00003744403,0.0023784628,0.00015076919,0.00038811952,0.00024623345,0.000041768926,0.000021567834,0.0007861473],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987653,0.00003062282,0.00025953937,0.00022522156,0.00052232266,0.00019697876],"domain_scores_gemma":[0.9992034,0.000052030602,0.00010047935,0.00023424487,0.0002834453,0.00012639911],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002637954,0.00013956099,0.00024964733,0.000060617163,0.00003623739,0.000012002521,0.00005279724,0.000077061195,0.00020719715],"category_scores_gemma":[0.00011732074,0.00011315424,0.00013507073,0.00010117045,0.000022006385,0.000049541304,0.000013360488,0.000019841938,0.000025138219],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005428081,0.02592238,0.5096923,0.00021971218,0.0009438218,0.000018890127,0.0011925437,0.0001640535,0.0057937996,0.00036528375,0.007645684,0.4474987],"study_design_scores_gemma":[0.11295556,0.0016315463,0.75336105,0.00017284263,0.004963345,0.000055281667,0.00010025856,0.003485707,0.10660781,0.000309089,0.016104287,0.00025319378],"about_ca_topic_score_codex":0.000077550394,"about_ca_topic_score_gemma":0.00004951611,"teacher_disagreement_score":0.4472455,"about_ca_system_score_codex":0.00017852349,"about_ca_system_score_gemma":0.0006185187,"threshold_uncertainty_score":0.4614296},"labels":[],"label_agreement":null},{"id":"W2594379076","doi":"10.1182/blood.v128.22.2800.2800","title":"Remissions after Third Induction Chemotherapy for Primary Non-Responders with Acute Myeloid Leukemia (AML) Are Uncommon and Short-Lived","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Induction chemotherapy; Medicine; Chemotherapy; Internal medicine; Regimen; Chemotherapy regimen; Flag (linear algebra); Cytarabine; Oncology; Bone marrow; Myeloid leukemia; Gastroenterology; Surgery","score_opus":0.017561323064774887,"score_gpt":0.27712744694779723,"score_spread":0.25956612388302236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594379076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899668,0.00018132372,0.0013008752,0.0061219325,0.000050576604,0.0011938895,0.00003618587,0.00010458368,0.0010437941],"genre_scores_gemma":[0.9833762,0.00064057345,0.006411727,0.0012675747,0.00040262655,0.00038064682,0.000037817263,0.00011182493,0.0073710005],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982834,0.00004340108,0.00025451978,0.0005364678,0.00039674927,0.00048545448],"domain_scores_gemma":[0.9987124,0.00014611657,0.00008368472,0.00053788035,0.00018945795,0.0003304307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002764631,0.00028321287,0.00042869122,0.00020005033,0.00013422524,0.000029485147,0.00013898232,0.0002571782,0.00005641293],"category_scores_gemma":[0.000070421935,0.00016704299,0.00009166333,0.00022864254,0.00020587262,0.00019512043,0.00007543279,0.00031448054,0.000011772579],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013791196,0.00038143274,0.048201643,0.00025349535,0.0011029189,0.00034554326,0.0007755227,5.120984e-7,0.8913687,0.000010274753,0.010707267,0.033061486],"study_design_scores_gemma":[0.044957645,0.0033017055,0.56266433,0.0017073222,0.0013336213,0.0013130461,0.0008272777,0.000040157713,0.36088088,0.0002591975,0.021727066,0.0009877116],"about_ca_topic_score_codex":0.000021943602,"about_ca_topic_score_gemma":0.000018404966,"teacher_disagreement_score":0.53048784,"about_ca_system_score_codex":0.00047897644,"about_ca_system_score_gemma":0.0007025322,"threshold_uncertainty_score":0.68118155},"labels":[],"label_agreement":null},{"id":"W2594391356","doi":"10.1182/blood.v116.21.897.897","title":"Risk-Factors for Acute Graft-Versus-Host Disease and Survival After Hematopoietic Cell Transplantation From Siblings and Unrelated Donors – An Analysis of the CIBMTR","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Total body irradiation; Internal medicine; Busulfan; Methotrexate; Graft-versus-host disease; Transplantation; Gastroenterology; Cohort; Hematopoietic stem cell transplantation; Leukemia; Oncology; Immunology; Cyclophosphamide; Chemotherapy","score_opus":0.009130443834846975,"score_gpt":0.2505142091924413,"score_spread":0.2413837653575943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594391356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975484,0.00009567924,0.0004737575,0.0000707775,0.00017448055,0.0005473255,0.0010259124,0.000031808708,0.000031875898],"genre_scores_gemma":[0.99853694,0.0003293993,0.0006157644,0.000019338555,0.000029553945,0.000029269066,0.00039445236,0.000026551412,0.000018699622],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988434,0.00006453496,0.00032041818,0.00035188696,0.00024498414,0.00017480874],"domain_scores_gemma":[0.99872905,0.00047262615,0.00015799244,0.00033030997,0.00007751212,0.00023249676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016748118,0.00019261493,0.00037955176,0.00018305863,0.00008558626,0.000025927426,0.00007674874,0.00013756816,0.000052059426],"category_scores_gemma":[0.00003940028,0.00013933015,0.0001603468,0.00036455583,0.00011826002,0.00010535953,0.000009914142,0.00017684604,7.1768676e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014448537,0.00031995634,0.95143485,0.00026190744,0.0017001237,0.000020579775,0.004176478,0.000006376072,0.040576536,0.000038128066,7.7845857e-7,0.000019417092],"study_design_scores_gemma":[0.0057733436,0.00012894059,0.9062125,0.00005296271,0.046122644,0.0000048310158,0.00034528135,0.0005626608,0.040572874,0.000062850326,0.0000031802388,0.00015789758],"about_ca_topic_score_codex":0.00034356135,"about_ca_topic_score_gemma":0.0006547681,"teacher_disagreement_score":0.04522233,"about_ca_system_score_codex":0.000005250193,"about_ca_system_score_gemma":0.000041252802,"threshold_uncertainty_score":0.56817186},"labels":[],"label_agreement":null},{"id":"W2594407451","doi":"10.1182/blood.v128.22.3164.3164","title":"Microenvironmental Links Between TET2/DNMT3A Mutations and Arginase 1 Overexpression in Human MDS/CMML","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; Queen's University","funders":"","keywords":"Myeloid; Arginase; Immunohistochemistry; Cancer research; Medicine; Haematopoiesis; Biology; Immunology; Molecular biology; Genetics; Arginine; Stem cell","score_opus":0.007159147784256683,"score_gpt":0.21894307442119426,"score_spread":0.21178392663693757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594407451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945618,0.0041906545,0.000023973202,0.00014916022,0.000049044047,0.00015288562,0.00005757672,0.000034376386,0.00078055635],"genre_scores_gemma":[0.9987379,0.0000652269,0.00001394437,0.00003748575,0.0000047366293,0.000017639672,0.00009790241,0.000013560917,0.001011638],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990636,0.00011120213,0.00023912059,0.000263898,0.000025534497,0.00029661864],"domain_scores_gemma":[0.9996284,0.000084149106,0.00007088395,0.00020281223,0.0000059468016,0.000007765009],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012565777,0.00014561863,0.00017599078,0.00009685907,0.00023318827,0.000009489335,0.00013606287,0.00025607576,0.00029624056],"category_scores_gemma":[0.000022549963,0.00011008297,0.000045483484,0.000059906975,0.00028989345,0.000112249785,0.000097388154,0.00024344493,0.00016914259],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008445293,0.00032747167,0.02598248,0.000006807713,0.000032410517,0.000003563552,0.00041689695,2.8784467e-7,0.96797067,0.0001039585,0.00001942533,0.005127558],"study_design_scores_gemma":[0.0057379375,0.00012966972,0.35346135,0.00019771451,0.00004180949,0.000022867624,0.00035545733,1.234258e-7,0.63532984,0.00038111335,0.004110202,0.00023193432],"about_ca_topic_score_codex":0.00005992826,"about_ca_topic_score_gemma":0.000001963804,"teacher_disagreement_score":0.3326409,"about_ca_system_score_codex":0.000015332083,"about_ca_system_score_gemma":0.00001236561,"threshold_uncertainty_score":0.44890532},"labels":[],"label_agreement":null},{"id":"W2594418048","doi":"10.1182/blood.v124.21.1740.1740","title":"Subcutaneous (SQ) Bortezomib (BTZ) in Patients (Pts) with Relapsed Mantle Cell Lymphoma (MCL): Retrospective, Observational Study of Treatment Patterns and Outcomes in US Community Oncology Practices","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Internal medicine; Mantle cell lymphoma; Bortezomib; Adverse effect; Oncology; Neutropenia; Phases of clinical research; Discontinuation; Rituximab; Carfilzomib; Surgery; Clinical trial; Multiple myeloma; Lymphoma; Chemotherapy","score_opus":0.04972315257606459,"score_gpt":0.32868254989258977,"score_spread":0.2789593973165252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594418048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978898,0.000019882775,4.90209e-7,0.00006116394,0.000019540388,0.0012630387,0.000041285948,0.000013757817,0.0006910366],"genre_scores_gemma":[0.9994169,0.00003028346,0.00018655644,0.00003281996,0.00000774345,0.000101411366,0.00008945885,0.00001907524,0.00011573649],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983288,0.0004869862,0.00034025402,0.00025906897,0.0003247592,0.0002601302],"domain_scores_gemma":[0.9986275,0.0004934435,0.00029919035,0.0003757891,0.00010891355,0.000095202966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002461229,0.00019171779,0.000555475,0.00017198118,0.000072157265,0.000011668579,0.00008720489,0.00007967655,0.000017219978],"category_scores_gemma":[0.000234977,0.00013644833,0.000030138908,0.00015292373,0.0000515243,0.00008727865,0.00006236599,0.00017951398,0.000003086116],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017993974,0.049830474,0.94428724,0.000050682316,0.00024480408,0.00024196156,0.0013031934,0.000002359346,0.000059210066,0.0000030147019,0.0000013234933,0.0021763218],"study_design_scores_gemma":[0.067472845,0.027540555,0.9035765,0.00004005953,0.00015164122,0.000024728197,0.00074096065,0.000051263254,0.00027265103,0.000009710328,0.000024285033,0.00009480428],"about_ca_topic_score_codex":0.017656246,"about_ca_topic_score_gemma":0.025413092,"teacher_disagreement_score":0.06567345,"about_ca_system_score_codex":0.00040252958,"about_ca_system_score_gemma":0.00013622698,"threshold_uncertainty_score":0.9923706},"labels":[],"label_agreement":null},{"id":"W2594442364","doi":"10.1182/blood.v128.22.675.675","title":"Final Results of a Phase 2 Trial of Extended Treatment (tx) with Carfilzomib (CFZ), Lenalidomide (LEN), and Dexamethasone (KRd) Plus Autologous Stem Cell Transplantation (ASCT) in Newly Diagnosed Multiple Myeloma (NDMM)","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Carfilzomib; Lenalidomide; Multiple myeloma; Medicine; Autologous stem-cell transplantation; Transplantation; Dexamethasone; Oncology; Internal medicine","score_opus":0.03761855174225196,"score_gpt":0.30014886028019844,"score_spread":0.26253030853794646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594442364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99610436,0.0004950209,0.00014536107,0.00013346238,0.000033236847,0.0022165107,0.00060708856,0.000032815537,0.0002321714],"genre_scores_gemma":[0.99612224,0.00095548347,0.002137293,0.000006541391,0.000051773848,0.00023987476,0.000102439364,0.000031225365,0.0003531261],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9976326,0.00024610842,0.00070468744,0.0005134796,0.00046099751,0.0004420897],"domain_scores_gemma":[0.99786067,0.0010627435,0.0002964184,0.00040356928,0.00012103189,0.00025554898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028411447,0.00031555074,0.0008445547,0.00029666608,0.000042508862,0.000008901651,0.000090306115,0.00014095697,0.00001819431],"category_scores_gemma":[0.00014286612,0.0001885073,0.00012586969,0.00022234529,0.00018926231,0.000106435495,0.000018176137,0.00010151973,0.000003976831],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.69938874,0.013995745,0.02335728,0.00046179575,0.0007692593,0.0034130905,0.002755454,0.000010050853,0.09428513,0.000009034282,0.000015237714,0.16153917],"study_design_scores_gemma":[0.6263187,0.013900459,0.057340976,0.00038857642,0.0005178221,0.000107487685,0.00016219307,0.00011863975,0.3009685,0.0000073123174,0.000022346978,0.00014699982],"about_ca_topic_score_codex":0.0014655152,"about_ca_topic_score_gemma":0.0012128515,"teacher_disagreement_score":0.20668337,"about_ca_system_score_codex":0.00013626963,"about_ca_system_score_gemma":0.0004176544,"threshold_uncertainty_score":0.76871043},"labels":[],"label_agreement":null},{"id":"W2594460255","doi":"10.1182/blood.v108.11.3349.3349","title":"Cost of Current Iron Chelation Infusion Therapy and Cost-Effectiveness of Once-Daily Oral Deferasirox in Transfusion-Dependent Thalassemia Patients in Canada.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Deferasirox; Deferoxamine; Medicine; Deferiprone; Thalassemia; Chelation therapy; Beta thalassemia; Blood transfusion; Cost effectiveness; Internal medicine; Intensive care medicine; Pediatrics","score_opus":0.016180669910763903,"score_gpt":0.2553862684614543,"score_spread":0.2392055985506904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594460255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99714184,0.001247756,0.000011328985,0.000019019,0.00008236952,0.0012338186,0.000020638909,0.000004672018,0.00023856769],"genre_scores_gemma":[0.99819154,0.0016679585,0.000012567726,0.000007491879,0.000006261792,0.000028602479,0.00007105414,0.0000111480795,0.0000033638576],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989394,0.00010812592,0.00035189788,0.00017221303,0.000268021,0.00016032543],"domain_scores_gemma":[0.9996359,0.000060142545,0.00009143167,0.00010206499,0.00006558269,0.00004488384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018325547,0.00012100223,0.0002980591,0.00011652353,0.000017911461,0.000002272407,0.000036880705,0.00009858517,0.000010029936],"category_scores_gemma":[0.000021511067,0.00009964763,0.000028927596,0.00021675568,0.000031415257,0.000042717485,0.000012838985,0.0001863144,2.218189e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000389167,0.0013132246,0.96004915,0.00019213154,0.000007949968,0.000006527431,0.00019683459,0.00022974913,0.009863827,0.000014606096,0.0000057842976,0.027731044],"study_design_scores_gemma":[0.015708456,0.00021768837,0.96920794,0.0005304371,0.000032144173,0.000002497001,0.000120840734,0.00014834355,0.013864969,0.000022718894,0.000054906417,0.0000890389],"about_ca_topic_score_codex":0.38026452,"about_ca_topic_score_gemma":0.38562527,"teacher_disagreement_score":0.027642004,"about_ca_system_score_codex":0.00015375717,"about_ca_system_score_gemma":0.00032159788,"threshold_uncertainty_score":0.62558544},"labels":[],"label_agreement":null},{"id":"W2594464923","doi":"10.1182/blood.v104.11.2245.2245","title":"Cytomegalovirus Infections Following Reduced-Intensity Allogeneic Stem Cell Transplantation.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Fludarabine; Transplantation; Melphalan; Busulfan; Surgery; Serostatus; Internal medicine; Hematopoietic stem cell transplantation; Cyclophosphamide; Chemotherapy; Immunology; Viral load; Human immunodeficiency virus (HIV)","score_opus":0.024422388321204143,"score_gpt":0.28402172290420363,"score_spread":0.2595993345829995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594464923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871253,0.0005423601,0.00031118753,0.00044814014,0.00020192662,0.0004646842,0.00002574563,0.00020260182,0.010678094],"genre_scores_gemma":[0.99748,0.000328704,0.0004663822,0.00033909726,0.00020711507,0.00004050567,0.00003286061,0.000044877623,0.0010604841],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99835986,0.000030546817,0.00031416837,0.00039258966,0.00043132572,0.00047148083],"domain_scores_gemma":[0.9991018,0.000042824482,0.00005129451,0.00037264245,0.0001235994,0.0003078355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022411125,0.00020901713,0.00036626233,0.00026826988,0.0002651213,0.000052997988,0.000114776994,0.00015487178,0.00009236059],"category_scores_gemma":[0.000015253238,0.00019488615,0.0003221965,0.00047460137,0.000056080928,0.00013922768,0.000032260483,0.0003929522,0.00049336976],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054474646,0.005225696,0.07452109,0.00045620126,0.00080932386,0.0031156824,0.0019989507,0.00019299888,0.9090399,0.00045167914,0.00043200198,0.0032117076],"study_design_scores_gemma":[0.016978277,0.0010323756,0.09435084,0.00022975575,0.0012082594,0.0013245253,0.00027140087,0.000010454634,0.87486243,0.00025725726,0.0088965185,0.00057793356],"about_ca_topic_score_codex":0.0004796418,"about_ca_topic_score_gemma":0.00014628888,"teacher_disagreement_score":0.034177523,"about_ca_system_score_codex":0.000121392826,"about_ca_system_score_gemma":0.0003481712,"threshold_uncertainty_score":0.7947227},"labels":[],"label_agreement":null},{"id":"W2594480162","doi":"10.1182/blood.v124.21.5164.5164","title":"Metastatic Breast Cancer in a Patient with Fanconi Anemia","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Fanconi anemia; Metastatic breast cancer; Bone marrow; Breast cancer; Oncology; Cancer; Population; Bone marrow failure; Internal medicine; Biopsy; Trisomy 8; Pathology; Haematopoiesis; Stem cell; Biology; Karyotype","score_opus":0.00386182418159614,"score_gpt":0.21040579108620194,"score_spread":0.2065439669046058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594480162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985534,0.00014868239,0.00024564547,0.00005761732,0.000035234763,0.00011496192,0.000023712144,0.000009964551,0.0008108024],"genre_scores_gemma":[0.9982942,0.000015151864,0.0012872763,0.00018816024,0.00004177944,0.000055885346,0.000012242656,0.000016276183,0.000089059926],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994154,0.000036222867,0.00009344616,0.000212416,0.00008078369,0.00016174154],"domain_scores_gemma":[0.9996756,0.000003641742,0.000039279443,0.00020822929,0.000027574411,0.000045721386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005957144,0.00009238841,0.00009307958,0.000021419357,0.00001478331,0.000008070413,0.00007329185,0.0000369171,0.000030129371],"category_scores_gemma":[0.000009229185,0.00007422072,0.00002349676,0.00005537365,0.000018543964,0.0000015647995,0.00003556253,0.000041715353,0.0000055808555],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010762114,0.00050834764,0.0131612085,0.00005027063,0.000093294795,0.000050431063,0.00012418495,0.00017168836,0.9718303,0.00017765124,0.0001549335,0.013570032],"study_design_scores_gemma":[0.002927867,0.0007631851,0.0072862,0.00005312898,0.00007824144,0.00031861264,0.00007617484,0.00009178041,0.98529565,0.000110930654,0.002696364,0.00030184662],"about_ca_topic_score_codex":0.00006640851,"about_ca_topic_score_gemma":0.00035767787,"teacher_disagreement_score":0.013465332,"about_ca_system_score_codex":0.0000058254054,"about_ca_system_score_gemma":0.000041853404,"threshold_uncertainty_score":0.30266333},"labels":[],"label_agreement":null},{"id":"W2594482699","doi":"10.1182/blood.v128.22.4517.4517","title":"Adjusted Comparisons Suggest Daratumumab Is Associated with Prolonged Survival Compared with Standard of Care Therapies in Patients with Heavily Pre-Treated and Highly Refractory Multiple Myeloma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Daratumumab; Pomalidomide; Medicine; Lenalidomide; Carfilzomib; Internal medicine; Population; Hazard ratio; Multiple myeloma; Oncology; Proportional hazards model; Propensity score matching; Progression-free survival; Confidence interval; Chemotherapy","score_opus":0.015379544027113484,"score_gpt":0.2528049908430324,"score_spread":0.2374254468159189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594482699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965449,0.00037937087,0.0000079281535,0.00011907104,0.000011709845,0.0018198167,0.00089434005,0.000083950086,0.00013893549],"genre_scores_gemma":[0.99887836,0.000024546613,0.0004147088,0.000011469449,0.000010803318,0.0000986108,0.00041548858,0.00005970969,0.00008629711],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99758255,0.00019923865,0.0003421667,0.0005016944,0.00085779803,0.0005165463],"domain_scores_gemma":[0.99807256,0.00025509525,0.00024175966,0.0004382756,0.0007369158,0.00025539476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010707943,0.00037140085,0.0009301651,0.00020363579,0.000112171125,0.000023124978,0.00010810114,0.00012235365,0.00002035361],"category_scores_gemma":[0.00008845245,0.00019043381,0.000038408067,0.00038944598,0.00033274826,0.00014780594,0.000040222607,0.00020899624,0.0000016569436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03512642,0.0025699101,0.9575449,0.00011139745,0.0013280722,0.00012509085,0.0017801002,8.8040343e-7,0.0005455294,0.0000019272225,0.000030548195,0.00083517964],"study_design_scores_gemma":[0.08729582,0.012104918,0.8923191,0.0012339158,0.00030678592,0.0000056463878,0.0005011773,0.000011049512,0.0059313113,4.0194968e-7,0.000056251443,0.00023363734],"about_ca_topic_score_codex":0.00055545475,"about_ca_topic_score_gemma":0.0069665946,"teacher_disagreement_score":0.06522586,"about_ca_system_score_codex":0.00019699293,"about_ca_system_score_gemma":0.0002380193,"threshold_uncertainty_score":0.77656657},"labels":[],"label_agreement":null},{"id":"W2594507558","doi":"10.1182/blood.v112.11.3027.3027","title":"Natural History of Mesenteric Venous Thrombosis: A Large Multicentre Study","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Vascular anomalies and interventions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; St. Joseph's Hospital","funders":"","keywords":"Medicine; Natural history; Thrombosis; Surgery; Laparotomy; Anticoagulant; Mortality rate; Mesenteric Vein; Splanchnic Circulation; Cohort; Internal medicine; Splanchnic","score_opus":0.026719814281614605,"score_gpt":0.26849995088091105,"score_spread":0.24178013659929645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594507558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991717,0.0057792487,0.00000792014,0.000045221695,0.00027399833,0.00030515183,0.000004657332,0.00003335774,0.0018334899],"genre_scores_gemma":[0.99608564,0.00006663507,0.00011145224,0.00007153273,0.000057631885,0.0000117717045,0.000009310306,0.000012632081,0.003573396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99932665,0.000032914213,0.00019457423,0.00013109481,0.00016878595,0.00014600938],"domain_scores_gemma":[0.99958,0.0000069088737,0.000057699413,0.00024043604,0.000066617984,0.000048283673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000056672197,0.00007997915,0.0002415587,0.00005400572,0.00003687847,0.0000012515794,0.00006097269,0.000026658472,0.00028845656],"category_scores_gemma":[0.00003088411,0.00006737301,0.00024682458,0.00006109941,0.000034865312,0.000035492438,0.000037607675,0.00009456035,0.000026790061],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018603972,0.12317278,0.7982521,0.00050605385,0.0048929905,0.0008534879,0.03408479,0.0000010022186,0.016598191,0.00010883765,0.02099027,0.00035347664],"study_design_scores_gemma":[0.014566713,0.0024694635,0.95776343,0.00015830252,0.0013584702,0.00034262636,0.0037508279,0.00007869702,0.00061826064,0.0000016599143,0.018724173,0.00016738649],"about_ca_topic_score_codex":0.00009663594,"about_ca_topic_score_gemma":0.000045560166,"teacher_disagreement_score":0.15951134,"about_ca_system_score_codex":0.000051544175,"about_ca_system_score_gemma":0.000054815948,"threshold_uncertainty_score":0.3158397},"labels":[],"label_agreement":null},{"id":"W2594515180","doi":"10.1182/blood.v104.11.3920.3920","title":"Circulating Endothelial Progenitor Cells (EPCs): Variability between Normal Individuals as Measured by a New Standardized, Functional 5-Day In Vitro Colony Assay.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Stemcell Technologies","funders":"","keywords":"Progenitor cell; Ficoll; Peripheral blood mononuclear cell; Population; Andrology; Immunology; Biology; Stem cell; CD34; Endothelial progenitor cell; In vitro; Differential centrifugation; Molecular biology; Medicine; Pathology; Cell biology; Biochemistry","score_opus":0.012253032848181168,"score_gpt":0.23836171285440172,"score_spread":0.22610868000622056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594515180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878162,0.0006709271,0.009645793,0.00007522465,0.0002081181,0.00042341594,0.00065950514,0.000022796321,0.0004779834],"genre_scores_gemma":[0.99649984,0.00001882103,0.0016855488,0.00013303747,0.0011169802,0.000062173065,0.0003013391,0.00003381208,0.00014843966],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981471,0.0001940863,0.0003723452,0.00050821574,0.00038488183,0.00039342738],"domain_scores_gemma":[0.99928224,0.000046976016,0.0001306375,0.00027986322,0.00009487608,0.0001654137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001000262,0.00022909898,0.00027731713,0.00004051066,0.00010591278,0.00004190979,0.0001782841,0.00028785208,0.00006401763],"category_scores_gemma":[0.00018932486,0.00023161816,0.00018493953,0.00013665573,0.00006239672,0.000009189927,0.000092428556,0.00013537116,0.000013611183],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001280304,0.00023607718,0.037730392,0.000013138979,0.00018734482,0.0000055596965,0.0000492783,0.0000732462,0.9593403,0.000011267327,0.00057115965,0.0016542053],"study_design_scores_gemma":[0.004535632,0.0001684385,0.004722596,0.000013396541,0.00011070396,0.000013957683,0.000016202137,0.00000111772,0.9768032,0.00019708149,0.013134795,0.0002828703],"about_ca_topic_score_codex":0.0001777433,"about_ca_topic_score_gemma":0.000020574735,"teacher_disagreement_score":0.033007793,"about_ca_system_score_codex":0.00007034398,"about_ca_system_score_gemma":0.0007158344,"threshold_uncertainty_score":0.9445115},"labels":[],"label_agreement":null},{"id":"W2594526180","doi":"10.1182/blood.v114.22.3961.3961","title":"NUP98-HOXA9 Reprograms Embryonic Hematopoiesis, Suppresses Cellular Apoptosis, and Causes Malignant Tissue Infiltrates in Transgenic Zebrafish.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Biology; Zebrafish; Myeloid; Cancer research; Myeloid leukemia; Haematopoiesis; GATA1; Downregulation and upregulation; Embryonic stem cell; Cell biology; Stem cell; Genetics; Gene","score_opus":0.014582821848042302,"score_gpt":0.27514301474813085,"score_spread":0.2605601929000885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594526180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98692137,0.0082278345,0.000022782346,0.0029484848,0.00004177085,0.00097582396,0.000015115024,0.00017423372,0.0006725986],"genre_scores_gemma":[0.9960326,0.00160198,0.001074862,0.00034779526,0.00016353403,0.00007458603,0.000067995046,0.0000530734,0.0005835955],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974203,0.00011453429,0.0004932115,0.00070809014,0.0004644228,0.0007994093],"domain_scores_gemma":[0.9986602,0.00013184987,0.00007948492,0.0007187311,0.000093134244,0.00031659726],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003980529,0.00035385744,0.00067225593,0.0002802455,0.00009536105,0.00009914004,0.00024462093,0.0002594503,0.00015608144],"category_scores_gemma":[0.00015620374,0.00030685472,0.00010223816,0.0005956493,0.00017551897,0.00019980001,0.0000574204,0.00048704538,0.00004577402],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019567709,0.0015831859,0.018108876,0.00051363406,0.00018982953,0.00043190323,0.00089780224,0.0000022121556,0.9737204,0.00039030577,0.001509772,0.0024564248],"study_design_scores_gemma":[0.00509057,0.0009012008,0.012883359,0.0003215223,0.00025727917,0.0003336457,0.00037481118,0.000016548885,0.975442,0.00031055562,0.0037194057,0.00034908098],"about_ca_topic_score_codex":0.00020168867,"about_ca_topic_score_gemma":0.00005402527,"teacher_disagreement_score":0.009111223,"about_ca_system_score_codex":0.00007180312,"about_ca_system_score_gemma":0.00026769927,"threshold_uncertainty_score":0.99993837},"labels":[],"label_agreement":null},{"id":"W2594553173","doi":"10.1182/blood.v106.11.2407.2407","title":"Combination Bortezomib (PS341, Velcade) and Rituximab Treatment Affects Multiple Survival and Death Pathways To Promote Apoptosis in Mantle Cell Lymphoma.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Bortezomib; Mantle cell lymphoma; Proteasome inhibitor; Rituximab; Apoptosis; Cancer research; Medicine; Programmed cell death; Proteasome; Lymphoma; Pharmacology; Immunology; Chemistry; Multiple myeloma; Biochemistry","score_opus":0.016339821527128054,"score_gpt":0.23814267788218457,"score_spread":0.22180285635505653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594553173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960074,0.0011044589,0.000004051299,0.0006501064,0.000045268414,0.0011228827,0.000031409683,0.00005153899,0.0009828992],"genre_scores_gemma":[0.9974434,0.00054086105,0.0014522347,0.00010068165,0.00006539442,0.00021813133,0.000047231162,0.00002737783,0.00010473037],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988448,0.00004012514,0.00019765826,0.00042472323,0.0001869374,0.00030577488],"domain_scores_gemma":[0.99938726,0.00008742504,0.00005148601,0.00021313236,0.000026663864,0.00023404957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010414316,0.00024915495,0.00040639157,0.0001379145,0.000075551354,0.000037276663,0.000036436835,0.000098707846,0.0000074688096],"category_scores_gemma":[0.000024629408,0.00020311354,0.00005140683,0.00012128009,0.00001828825,0.00008137474,0.000045735527,0.0000324961,0.000027994429],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002986611,0.047280658,0.8045958,0.00016433676,0.00023827545,0.0002079336,0.002186322,0.000002571843,0.014487688,0.0003988303,0.00008856486,0.1300503],"study_design_scores_gemma":[0.07832096,0.0019155245,0.62873477,0.00012502608,0.00036071736,0.00004663069,0.000116468305,0.00025252663,0.28830048,0.000025393967,0.0015623851,0.00023914744],"about_ca_topic_score_codex":0.0002736238,"about_ca_topic_score_gemma":0.00019692881,"teacher_disagreement_score":0.2738128,"about_ca_system_score_codex":0.00023156236,"about_ca_system_score_gemma":0.000060672326,"threshold_uncertainty_score":0.82827294},"labels":[],"label_agreement":null},{"id":"W2594558897","doi":"10.1182/blood.v108.11.2021.2021","title":"Empirical Versus Pre-Emptive Antifungal Therapy in High-Risk Febrile Neutropenic Patients: An Economic Analysis.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Neutropenia; Febrile neutropenia; Internal medicine; Mucositis; Randomized controlled trial; Pneumonia; Septic shock; Surgery; Intensive care medicine; Chemotherapy; Sepsis","score_opus":0.015585679415264833,"score_gpt":0.29315459732206434,"score_spread":0.2775689179067995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594558897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978629,0.00022393605,0.000017025946,0.000050554787,0.00012657976,0.00041625343,0.00007891913,0.00005352326,0.0011703344],"genre_scores_gemma":[0.9988977,0.00012811834,0.00017210202,0.000081357226,0.00021316142,0.000017821743,0.0002684017,0.000023329769,0.00019801389],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982147,0.00016944473,0.00044779517,0.00058808964,0.00021575978,0.000364193],"domain_scores_gemma":[0.99899,0.00010769871,0.00013762426,0.0005655219,0.00007461054,0.00012457109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025047734,0.00021523958,0.00056414265,0.00020107222,0.000079659265,0.000033768076,0.00013935225,0.0001373228,0.00032322327],"category_scores_gemma":[0.0000447685,0.00018345742,0.00023739884,0.0003794487,0.00009685635,0.00019627517,0.00003127767,0.00026335535,0.00006834928],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020588674,0.0022088955,0.99407685,0.0000063812017,0.00035216947,0.000017559852,0.00009900638,0.00011753594,0.00022198155,0.000039047107,0.00024004918,0.0005616681],"study_design_scores_gemma":[0.011946934,0.0014919412,0.9842545,0.000008497086,0.00063389697,5.139552e-7,0.000056009325,0.00015949608,0.001029939,0.000060521892,0.00017104033,0.00018674866],"about_ca_topic_score_codex":0.0035991068,"about_ca_topic_score_gemma":0.0066350787,"teacher_disagreement_score":0.009888067,"about_ca_system_score_codex":0.00013820456,"about_ca_system_score_gemma":0.00013264833,"threshold_uncertainty_score":0.7481176},"labels":[],"label_agreement":null},{"id":"W2594567415","doi":"10.1182/blood.v108.11.3667.3667","title":"Outcome of Hematopoietic Stem Cell Transplantation for Pediatric Acute Lymphoblastic Leukemia in Third Complete Remission (CR3): A Vital Role for Graft-Versus-Host-Disease/Graft-Versus-Leukemia Effect in Survival.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Hematopoietic stem cell transplantation; Total body irradiation; Transplantation; Cyclophosphamide; Leukemia; Internal medicine; Graft-versus-host disease; Surgery; Acute lymphocytic leukemia; Stem cell; Gastroenterology; Chemotherapy; Lymphoblastic Leukemia","score_opus":0.016193591826444514,"score_gpt":0.27665255095452923,"score_spread":0.2604589591280847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594567415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99169946,0.0005701292,0.002061329,0.00007505174,0.00041466905,0.0039189537,0.00066886115,0.00011961345,0.00047192196],"genre_scores_gemma":[0.99670655,0.00012108722,0.0011134648,0.000030292973,0.0003265851,0.0006701397,0.00058306515,0.00014436332,0.00030446335],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99524486,0.00021991336,0.0014171295,0.0009483138,0.0010411011,0.0011286892],"domain_scores_gemma":[0.99474204,0.0036221645,0.00036918075,0.00062321225,0.00023509099,0.00040832456],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009126329,0.0006308565,0.0012950847,0.0008147678,0.000120556375,0.00004083275,0.0004250154,0.00040725214,0.000016527114],"category_scores_gemma":[0.00024833702,0.00058001204,0.0005151498,0.0009777942,0.0001268034,0.00021642249,0.00008872576,0.00036754512,0.000021528404],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19987367,0.004243711,0.5461479,0.036602657,0.00097043655,0.002078836,0.002016044,0.0039781593,0.20003416,0.0008662752,0.0022987032,0.0008894492],"study_design_scores_gemma":[0.58296806,0.0124072,0.22709262,0.0019024753,0.011355375,0.0001567613,0.00089639187,0.05108853,0.108274065,0.0007357735,0.00032507803,0.0027976616],"about_ca_topic_score_codex":0.00046022751,"about_ca_topic_score_gemma":0.00026405204,"teacher_disagreement_score":0.3830944,"about_ca_system_score_codex":0.0028154722,"about_ca_system_score_gemma":0.0019701594,"threshold_uncertainty_score":0.99966514},"labels":[],"label_agreement":null},{"id":"W2594588826","doi":"10.1182/blood.v120.21.4629.4629","title":"Determining the Correlation Between Antiphospholipid Antibodies and Epilepsy: A Systematic Review","year":2012,"lang":"en","type":"review","venue":"Blood","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Epilepsy; Medicine; Antiphospholipid syndrome; Lupus anticoagulant; Cochrane Library; Internal medicine; Antibody; Pediatrics; Meta-analysis; Immunology; Psychiatry","score_opus":0.07528977952629964,"score_gpt":0.3601810586780045,"score_spread":0.28489127915170487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594588826","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017544077,0.9920468,0.000008303664,0.000029741128,0.00016401956,0.006949817,0.000027393347,0.000066358814,0.00053215254],"genre_scores_gemma":[0.0002454853,0.9980294,0.00005868904,0.000051566723,0.0004800788,0.00042613773,0.00012043848,0.00010128242,0.00048691634],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99640274,0.00066221773,0.0013941911,0.0004079192,0.000653662,0.0004792616],"domain_scores_gemma":[0.9964053,0.0013629817,0.0008556282,0.001022973,0.00015486719,0.00019823792],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021549345,0.00047867512,0.0046873824,0.00016964594,0.00015122154,0.00005344134,0.0002457772,0.00031501794,0.00002088697],"category_scores_gemma":[0.0011962428,0.00025921426,0.0004764041,0.00038171426,0.00012208325,0.00008280887,0.00019919024,0.0006126143,0.00029148778],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[5.641017e-7,0.00004705772,0.018299973,0.9564419,0.0006219635,0.000013785425,0.000097849996,3.6305775e-10,3.2547327e-8,0.000009492688,0.00012136626,0.024346052],"study_design_scores_gemma":[0.0005159474,0.000049970648,0.00020618393,0.9126737,0.03431741,0.008975475,0.000024475656,6.354811e-7,2.8203746e-7,0.0000015752355,0.042992875,0.00024147883],"about_ca_topic_score_codex":0.0000037122736,"about_ca_topic_score_gemma":4.817368e-7,"teacher_disagreement_score":0.04376817,"about_ca_system_score_codex":0.000065348344,"about_ca_system_score_gemma":0.00020344232,"threshold_uncertainty_score":0.999986},"labels":[],"label_agreement":null},{"id":"W2594594009","doi":"10.1182/blood.v116.21.3351.3351","title":"The Role of Recipient Platelets In the Prevention of Antibody-Mediated Transfusion Related Acute Lung Injury (TRALI)","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Transfusion-related acute lung injury; Platelet; Monoclonal antibody; Immunology; Antibody; Platelet transfusion; Lung; Immune system; Diffuse alveolar damage; Blood transfusion; Internal medicine; Pulmonary edema; Acute respiratory distress","score_opus":0.004661327577318892,"score_gpt":0.2613213814019003,"score_spread":0.2566600538245814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594594009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935999,0.00027469755,0.000011365459,0.0010474981,0.00017530273,0.0010073476,0.000010149156,0.000023824829,0.0038499031],"genre_scores_gemma":[0.99804246,0.0015557394,0.00008374,0.00005813461,0.00001985756,0.000024682795,0.00004531612,0.000012926053,0.00015712019],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99875486,0.000092009046,0.00046698377,0.00016556481,0.00034053807,0.00018003165],"domain_scores_gemma":[0.99932474,0.000079005535,0.00011999501,0.0003768106,0.000057552377,0.000041889365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007047417,0.000112356916,0.00022232681,0.000106568485,0.000063246625,0.0000067169726,0.00017776516,0.00012421318,0.00006724322],"category_scores_gemma":[0.000036384063,0.00006418413,0.00012530749,0.00038646482,0.00008482021,0.00004377984,0.00002114055,0.00037078976,0.0000047185154],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003857244,0.0025853522,0.012276729,0.00008176512,0.00033253606,0.000023622682,0.002039555,8.3880474e-7,0.96593595,0.0023162295,0.00011897619,0.013902698],"study_design_scores_gemma":[0.01574707,0.001710469,0.30897927,0.00056233007,0.002227438,0.0001106575,0.0014334342,0.00036749267,0.6537731,0.0013897134,0.013411064,0.00028793362],"about_ca_topic_score_codex":0.000086843735,"about_ca_topic_score_gemma":0.00014925124,"teacher_disagreement_score":0.31216285,"about_ca_system_score_codex":0.00000438329,"about_ca_system_score_gemma":0.000037341404,"threshold_uncertainty_score":0.2617353},"labels":[],"label_agreement":null},{"id":"W2594616381","doi":"10.1182/blood.v118.21.5198.5198","title":"The Relationship Between Obesity and Lymphoma: A Meta-Analysis of Prospective Cohort Studies","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Overweight; Follicular lymphoma; Internal medicine; Body mass index; Lymphoma; Diffuse large B-cell lymphoma; Prospective cohort study; Incidence (geometry); Obesity; Oncology","score_opus":0.18651966057051458,"score_gpt":0.34632949122651135,"score_spread":0.15980983065599677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594616381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914589,0.0072442763,0.000008196798,0.0000652596,0.000009974277,0.000231817,0.00001925859,0.0000111376075,0.0009511865],"genre_scores_gemma":[0.9994591,0.00013487076,0.000088245695,0.000010660275,0.000018331104,0.000027957847,0.0000026358914,0.000004243235,0.00025395944],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994726,0.000028772745,0.0001673339,0.0001289063,0.00012783066,0.00007455065],"domain_scores_gemma":[0.9992749,0.00030927715,0.00008746063,0.00019992978,0.0000926471,0.000035750807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025776352,0.00006759923,0.00052427425,0.000060843366,0.000095945325,0.0000036248316,0.000032434014,0.000028560207,0.000015913678],"category_scores_gemma":[0.00019509792,0.000036319576,0.0002460903,0.00028310058,0.00012724315,0.000023298751,0.000027494665,0.000041384286,0.0000011297802],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012098766,0.00008492962,0.85537994,0.0000078139365,0.14283815,0.0000012387763,0.00109254,2.5044946e-8,0.000001728637,0.000534273,0.000014322216,0.000032961474],"study_design_scores_gemma":[0.00034750294,0.000050723815,0.6924891,0.0000012024908,0.30609694,8.1548166e-7,0.00020703184,3.3260122e-7,0.000249296,0.00051633705,0.000014753712,0.000025985053],"about_ca_topic_score_codex":0.0003868198,"about_ca_topic_score_gemma":0.0002475275,"teacher_disagreement_score":0.16325879,"about_ca_system_score_codex":0.000014951163,"about_ca_system_score_gemma":0.000022715376,"threshold_uncertainty_score":0.14810693},"labels":[],"label_agreement":null},{"id":"W2594637709","doi":"10.1182/blood.v114.22.4689.4689","title":"Familial Platelet Disorder and Predisposition to Myeloid Leukemia (FPD/AML) in the Absence of RUNX1 Mutations- A Report of Three Families.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"RUNX1; Platelet disorder; Haploinsufficiency; Myeloid leukemia; Genetics; Biology; Leukemia; Locus (genetics); Cancer research; Immunology; Gene; Phenotype; Transcription factor; Platelet","score_opus":0.01197889769395351,"score_gpt":0.27211632141780295,"score_spread":0.26013742372384946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594637709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954877,0.00020391312,0.00030076772,0.0009384503,0.000021454229,0.0008814539,0.00002357723,0.000018194529,0.0021244963],"genre_scores_gemma":[0.9980277,0.000103921535,0.0014295096,0.0002047865,0.00006217594,0.000037867063,0.000049373288,0.000011296567,0.000073378294],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984899,0.000044924564,0.00047013542,0.00026811758,0.00049162225,0.00023526484],"domain_scores_gemma":[0.99911463,0.00013058941,0.00011365648,0.00042456083,0.000139958,0.000076584634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004832382,0.00013115388,0.00030497444,0.00021075124,0.000042893244,0.000009107728,0.00015842765,0.00010067437,0.000010010585],"category_scores_gemma":[0.00034742535,0.0000974243,0.000052561216,0.00054027315,0.00013499387,0.00008261267,0.00004432576,0.0002466506,0.0000034574018],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025626123,0.0033608484,0.36657357,0.0008367378,0.00035669963,0.003661519,0.017344575,0.0004565605,0.4958236,0.0019634776,0.0019252169,0.10513459],"study_design_scores_gemma":[0.0041257953,0.0008905372,0.9756972,0.00016962958,0.000071019815,0.0007321367,0.0010179926,0.0003372997,0.016073385,0.00056258484,0.00020199773,0.00012037328],"about_ca_topic_score_codex":0.00062678463,"about_ca_topic_score_gemma":0.0002093465,"teacher_disagreement_score":0.6091237,"about_ca_system_score_codex":0.000079217774,"about_ca_system_score_gemma":0.00033078343,"threshold_uncertainty_score":0.39728478},"labels":[],"label_agreement":null},{"id":"W2594652897","doi":"10.1182/blood.v118.21.4535.4535","title":"Superior Survival of Combined Gastrointestinal and Skin GvHD Compared to Isolated Gastrointestinal GvHD in Children Post Allogeneic Stem Cell Transplantation","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Graft-versus-host disease; Internal medicine; Gastroenterology; Transplantation; Biopsy; Methotrexate; Stem cell; Surgery","score_opus":0.016492624855822258,"score_gpt":0.22210915059478015,"score_spread":0.2056165257389579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594652897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99605435,0.000033395823,0.001859984,0.00003168756,0.000033128712,0.00090113474,0.000098170465,0.00005674615,0.00093140284],"genre_scores_gemma":[0.9884967,0.000009436803,0.011174747,0.00003601988,0.000017333788,0.000019802414,0.00017417494,0.00003718109,0.00003460578],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824536,0.00010982061,0.0006236563,0.00038038136,0.00027645344,0.0003643093],"domain_scores_gemma":[0.9991784,0.00009535155,0.000115869465,0.00022087544,0.00014920074,0.0002403071],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023631315,0.00026106392,0.0005030185,0.00025354448,0.000034776505,0.00001076843,0.0001183631,0.000053501342,0.00019431677],"category_scores_gemma":[0.0000138474115,0.00026057992,0.00006946011,0.00026651722,0.0000744146,0.00006658511,0.000016469367,0.00017851676,0.000018699466],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012491676,0.0009503616,0.88525426,0.0003758948,0.00003189517,0.00021803196,0.0019644513,0.000006005407,0.10969702,0.000028552697,0.0000014410223,0.00022289212],"study_design_scores_gemma":[0.008537599,0.0019604345,0.9217275,0.0003930595,0.00028675265,0.0046438663,0.00042033228,0.000055351273,0.061787214,0.000003995364,2.472124e-7,0.00018365313],"about_ca_topic_score_codex":0.0003766477,"about_ca_topic_score_gemma":0.000116500254,"teacher_disagreement_score":0.047909807,"about_ca_system_score_codex":0.00002156096,"about_ca_system_score_gemma":0.00009539402,"threshold_uncertainty_score":0.9999846},"labels":[],"label_agreement":null},{"id":"W2594664805","doi":"10.1182/blood.v118.21.3304.3304","title":"Identifying Drugs Implicated in Drug-Induced Immune Thrombocytopenia Using Levels of Evidence Applied to Laboratory Tests,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Drug; Internal medicine; Pharmacology","score_opus":0.160905839935582,"score_gpt":0.34563261006159757,"score_spread":0.18472677012601557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594664805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99782926,0.00044946512,0.000012690834,0.00003671431,0.000040563216,0.0006444709,0.000013763137,0.000037837977,0.0009352579],"genre_scores_gemma":[0.9971405,0.000021468202,0.0026488765,0.00008891752,0.000012523158,0.000030155825,0.0000037375394,0.00002852927,0.00002524787],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99878186,0.000028364831,0.0003925229,0.00030955762,0.00020152278,0.00028618105],"domain_scores_gemma":[0.99923295,0.000044312354,0.00012553782,0.00039679237,0.0000941887,0.000106214604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021983405,0.0001728728,0.00054531085,0.00017943484,0.00004265754,0.000009851781,0.00014540534,0.000075272445,0.000059827966],"category_scores_gemma":[0.000059466445,0.00014416433,0.000049549028,0.0006119818,0.000028246093,0.00012139996,0.00008773349,0.00012513586,0.000046265806],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008745105,0.00086321216,0.02204572,0.000088200344,0.00011778248,0.00014888286,0.0027263337,4.369219e-7,0.9727593,0.000049532595,0.00000627906,0.0011068668],"study_design_scores_gemma":[0.0028846236,0.00008285518,0.37370494,0.00044279717,0.00018216213,0.000021463851,0.00040684227,0.0000029257753,0.6220231,0.00010325102,0.0000055829846,0.00013947887],"about_ca_topic_score_codex":0.0009043889,"about_ca_topic_score_gemma":0.00006484036,"teacher_disagreement_score":0.3516592,"about_ca_system_score_codex":0.000050895156,"about_ca_system_score_gemma":0.00015187607,"threshold_uncertainty_score":0.5878851},"labels":[],"label_agreement":null},{"id":"W2594668490","doi":"10.1182/blood.v116.21.452.452","title":"SCID-Synth-Hu: a Novel Multiple Myeloma Model for In Vivo Expansion of Primary Cells","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"In vivo; Stromal cell; Bone marrow; Multiple myeloma; In vitro; Cancer research; Pathology; Chemistry; Medicine; Immunology; Biology; Biochemistry","score_opus":0.032647133983738356,"score_gpt":0.2853032607522818,"score_spread":0.25265612676854343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594668490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954001,0.000056302564,0.002041316,0.0000863246,0.000067228015,0.001127301,0.00017689497,0.000029686069,0.0010148963],"genre_scores_gemma":[0.9547096,0.00001710464,0.044221696,0.00005780619,0.00006333497,0.0001579986,0.000035823457,0.0000307679,0.0007058698],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987082,0.000013321782,0.0002833963,0.0003006141,0.00032287557,0.00037163158],"domain_scores_gemma":[0.99900234,0.0002201112,0.00006819603,0.00039098036,0.00012338192,0.00019497002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024228415,0.00015402469,0.00035337443,0.00018943996,0.000043233827,0.000008038867,0.00011508772,0.00013051298,0.00004528859],"category_scores_gemma":[0.00029095975,0.00012688716,0.00011696543,0.00013959866,0.00007182784,0.000073587194,0.00006348766,0.00019090304,0.000008633122],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005407479,0.0024204368,0.020945342,0.00022665162,0.000062487175,0.000023228144,0.00019698359,0.000020887574,0.97237766,0.000032536573,0.000107229505,0.0030458327],"study_design_scores_gemma":[0.020983765,0.00029558042,0.027898474,0.000108047294,0.00007872324,0.000018612287,0.000028043507,0.06578895,0.8844401,0.000047295864,0.00018381227,0.00012857502],"about_ca_topic_score_codex":0.00013895544,"about_ca_topic_score_gemma":0.0002437545,"teacher_disagreement_score":0.08793751,"about_ca_system_score_codex":0.000028434028,"about_ca_system_score_gemma":0.00026996506,"threshold_uncertainty_score":0.5174308},"labels":[],"label_agreement":null},{"id":"W2594744300","doi":"10.1182/blood.v126.23.4201.4201","title":"Outcomes after Initial Relapse of Multiple Myeloma: An International Myeloma Working Group Study","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Multiple myeloma; Medicine; Regimen; Bortezomib; Internal medicine; Clinical trial; Surgery","score_opus":0.06316883351363833,"score_gpt":0.3488994633154714,"score_spread":0.28573062980183306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594744300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963965,0.000074797055,0.000018392999,0.00008467989,0.0002689812,0.00069809484,0.000026490428,0.000065758424,0.0023663514],"genre_scores_gemma":[0.9972931,0.0000044182766,0.0018864833,0.000057967205,0.0002572958,0.00013266534,0.00008552333,0.000032807293,0.0002497456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981014,0.00010989115,0.00035997102,0.00033739494,0.0007865832,0.0003047668],"domain_scores_gemma":[0.99878764,0.00009954828,0.0000907482,0.00044900333,0.00018858488,0.00038446896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030270804,0.0001913699,0.00035780715,0.0002109737,0.000039005412,0.00002880076,0.00019302465,0.00007688425,0.000105612264],"category_scores_gemma":[0.0004577201,0.00014972579,0.00010330537,0.00015085924,0.00006726295,0.00020329205,0.00014667356,0.00018402716,0.000058638438],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014694491,0.007383055,0.98102874,0.000012820637,0.0006204975,0.0013699774,0.0011627296,5.72351e-7,0.0002111179,0.000017894841,0.000019627194,0.006703523],"study_design_scores_gemma":[0.024889862,0.0014891425,0.9712389,0.00004575343,0.00017354726,0.00005501405,0.000769991,0.0000806955,0.0008700081,0.000029879378,0.00023030881,0.00012687204],"about_ca_topic_score_codex":0.00016304672,"about_ca_topic_score_gemma":0.00022236364,"teacher_disagreement_score":0.023420412,"about_ca_system_score_codex":0.000055954893,"about_ca_system_score_gemma":0.00008610829,"threshold_uncertainty_score":0.61056405},"labels":[],"label_agreement":null},{"id":"W2594750141","doi":"10.1182/blood.v106.11.2296.2296","title":"LIF-LIF-R and SDF-1-CXCR4 Axes Regulate Overlapping and Complementary Steps of Metastasis of Rhabdomyosarcoma - Implication for Developing Better Antimetastatic Therapies.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Leukemia inhibitory factor; Rhabdomyosarcoma; Chemotaxis; Cancer research; CXCR4; Cell culture; Chemistry; Alveolar rhabdomyosarcoma; Receptor; Biology; Immunology; Medicine; Chemokine; Pathology; Cytokine; Sarcoma; Biochemistry","score_opus":0.03043052945779426,"score_gpt":0.29563385859897057,"score_spread":0.2652033291411763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594750141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900855,0.005515132,0.0004220984,0.0030756854,0.000012171615,0.0007365232,0.0001072082,0.000013552102,0.000032149997],"genre_scores_gemma":[0.91196096,0.0005713165,0.08700059,0.00027189657,0.00003580973,0.00006270428,0.00007259113,0.000018468732,0.000005630733],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990101,0.000031647884,0.00040670048,0.00023167548,0.00014497606,0.00017492622],"domain_scores_gemma":[0.9992614,0.00021793647,0.00019692336,0.00020487966,0.00006709901,0.000051769017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018239097,0.00015445543,0.00043362682,0.00011804772,0.0000607102,0.000010702699,0.00004399089,0.000031115036,0.000016958278],"category_scores_gemma":[0.000016664662,0.00012683588,0.00007629574,0.00009751816,0.00007494449,0.000085656065,0.000044009565,0.000036028,6.4032906e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019828012,0.0018391298,0.5400481,0.0011712463,0.0032761502,0.00000615074,0.0015255584,0.0000014434406,0.06844555,0.0022748061,0.00030721413,0.38090634],"study_design_scores_gemma":[0.009800142,0.00047461913,0.81900865,0.00033129074,0.0017154742,0.00006545099,0.0002946988,0.00009456717,0.16412754,0.0008524645,0.0030351633,0.00019994135],"about_ca_topic_score_codex":0.000056126457,"about_ca_topic_score_gemma":0.000025863585,"teacher_disagreement_score":0.3807064,"about_ca_system_score_codex":0.000017265918,"about_ca_system_score_gemma":0.000027611606,"threshold_uncertainty_score":0.5172217},"labels":[],"label_agreement":null},{"id":"W2594796393","doi":"10.1182/blood.v114.22.4436.4436","title":"Results of a World Wide Survey On the Diagnostic Dilemma Between Type 2B Von Willeband Disease and the PT-VWD.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Lawrence College; Laurentian University; Queen's University","funders":"","keywords":"Medicine; Dilemma; Genetic testing; Von Willebrand disease; Diagnostic test; Disease; Family medicine; Pediatrics; Immunology; Internal medicine; Platelet; Von Willebrand factor","score_opus":0.021277751768822763,"score_gpt":0.2562608647938236,"score_spread":0.23498311302500083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594796393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99107915,0.000986862,5.414502e-7,0.0056812647,0.000024139694,0.0004706523,0.00014185558,0.0000134249185,0.001602117],"genre_scores_gemma":[0.9985303,0.00027417773,0.0000059626313,0.00055432983,0.000044578912,0.000006810769,0.00010814991,0.000008649529,0.00046703682],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992177,0.00011349796,0.00017985106,0.00016485811,0.00017620492,0.00014792246],"domain_scores_gemma":[0.9968968,0.0025785533,0.00007225542,0.00031155848,0.000044750697,0.000096104115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029248736,0.00011899712,0.00026031546,0.00003869747,0.000072315466,0.000014019349,0.00007011496,0.000025541145,0.000010405733],"category_scores_gemma":[0.0022815804,0.000055793706,0.0000469866,0.00019402226,0.0001008566,0.000020779336,0.00001743305,0.00009921783,0.000010915711],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003952208,0.00132116,0.9807959,0.000020575928,0.00048715,0.00028056634,0.00024517177,0.000002430227,0.0000144812875,0.00033051096,0.008938517,0.00361129],"study_design_scores_gemma":[0.009680772,0.00038492828,0.9875138,0.00012399141,0.00053087325,0.0000025671816,0.000005711171,0.000003967363,0.00016103264,0.0007675689,0.00076482,0.0000599601],"about_ca_topic_score_codex":0.0002757386,"about_ca_topic_score_gemma":0.00018522858,"teacher_disagreement_score":0.008173698,"about_ca_system_score_codex":0.000005279716,"about_ca_system_score_gemma":0.000032958906,"threshold_uncertainty_score":0.27314296},"labels":[],"label_agreement":null},{"id":"W2594808128","doi":"10.1182/blood.v106.11.496.496","title":"Disease Stage Strongly Modulates Responsiveness to Targeted Agents in Nf1 Mutant Mice with Myeloprolfierative Disease (MPD) and Acute Myeloid Leukemia (AML).","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Cancer research; Myeloid leukemia; Myeloid; Biology; Leukemia; Haematopoiesis; Cre recombinase; Bone marrow; Neuroblastoma RAS viral oncogene homolog; Clonogenic assay; Molecular biology; Immunology; Stem cell; Mutation; Transgene; Genetically modified mouse; Cell culture; Genetics; KRAS; Gene","score_opus":0.014949632427981438,"score_gpt":0.283687685398438,"score_spread":0.2687380529704566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594808128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99333626,0.00068665814,0.00017804814,0.0029961143,0.000033225366,0.002054308,0.00042470053,0.00010805434,0.00018264817],"genre_scores_gemma":[0.9925282,0.00014612699,0.0025824113,0.0009146236,0.00020516383,0.00028367311,0.00017714014,0.00010230357,0.003060369],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966142,0.00022193039,0.00045976668,0.0009872257,0.0008038445,0.00091302977],"domain_scores_gemma":[0.99702007,0.00015668821,0.00010463472,0.00072007894,0.0002798322,0.0017187133],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035434068,0.00048769324,0.0005964513,0.00049743865,0.00016784534,0.000089767665,0.00028131867,0.00011947605,0.00014685278],"category_scores_gemma":[0.0003526653,0.00040004836,0.000081764876,0.0007624133,0.00020355811,0.00035134488,0.00026794733,0.00055765134,0.00007218322],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11347887,0.00499083,0.48776433,0.0013095862,0.0030897511,0.039662592,0.009129331,0.009606058,0.317712,0.00058048195,0.0019712609,0.0107049085],"study_design_scores_gemma":[0.022650678,0.0011319601,0.9158067,0.00060768216,0.0008725967,0.0000887197,0.0007432422,0.0070924703,0.04576068,0.000045918103,0.0042664525,0.0009328869],"about_ca_topic_score_codex":0.00014023451,"about_ca_topic_score_gemma":0.00013534352,"teacher_disagreement_score":0.42804238,"about_ca_system_score_codex":0.0008217726,"about_ca_system_score_gemma":0.0021559251,"threshold_uncertainty_score":0.99984515},"labels":[],"label_agreement":null},{"id":"W2594811309","doi":"10.1182/blood.v106.11.1710.1710","title":"Estimating the Replication Rate of Hematopoietic Stem Cells in Non-Human Primates: A Test of Hayflick’s Hypothesis.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Haematopoiesis; Biology; Stem cell; Transplantation; Hematopoietic stem cell transplantation; Hematopoietic stem cell; Immunology; Andrology; Genetics; Internal medicine; Medicine","score_opus":0.015450606987468958,"score_gpt":0.24068579761626788,"score_spread":0.22523519062879893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594811309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987864,0.0001724017,0.0003559513,0.000081425496,0.000018843011,0.00018871037,0.000009879677,0.0000052406353,0.00038115308],"genre_scores_gemma":[0.9970314,0.000017577479,0.0027041498,0.00006298488,0.000058641384,0.000016531882,0.0000067889546,0.000015319343,0.00008663829],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992522,0.00003189348,0.0003293303,0.0002047609,0.000060604216,0.000121232],"domain_scores_gemma":[0.99927056,0.000045919496,0.00016375644,0.0004537894,0.000045055862,0.000020934081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002759514,0.00009465615,0.00015112861,0.000025662153,0.00003336046,0.0000074868913,0.00018925221,0.00007482742,0.000003235426],"category_scores_gemma":[0.000039072125,0.00007550402,0.000058578582,0.00007450912,0.00006307643,0.0000028432419,0.000028297962,0.000053017993,0.00000206849],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007867381,0.00038375345,0.004973804,0.000091690745,0.000014795949,2.8345323e-7,0.0002119942,0.0002477747,0.9930132,0.00001545712,0.00002563458,0.0010137236],"study_design_scores_gemma":[0.00065908406,0.00011811326,0.002973019,0.000049666938,0.000030787476,0.0000035134717,0.000036071542,0.0006897992,0.9952318,0.000036080684,0.00009247997,0.00007958074],"about_ca_topic_score_codex":0.000039620056,"about_ca_topic_score_gemma":0.00004164678,"teacher_disagreement_score":0.0023481986,"about_ca_system_score_codex":0.000004760755,"about_ca_system_score_gemma":0.0000282921,"threshold_uncertainty_score":0.30789644},"labels":[],"label_agreement":null},{"id":"W2594817066","doi":"10.1182/blood.v120.21.969.969","title":"Combined Modality Therapy Versus Chemotherapy Alone As an Induction Regimen for Primary CNS Lymphoma: A Cost-Effectiveness Analysis","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Primary central nervous system lymphoma; Oncology; Induction chemotherapy; Chemotherapy; Regimen; Chemotherapy regimen; Cost effectiveness; Surgery","score_opus":0.0394932294918329,"score_gpt":0.3239294473007653,"score_spread":0.28443621780893236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594817066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956241,0.000752935,0.0001228487,0.0004806322,0.0002078052,0.0021989367,0.000029514771,0.00010754403,0.0004756658],"genre_scores_gemma":[0.99678844,0.00028449047,0.00053286715,0.00029779083,0.00029138025,0.0012145165,0.00048878737,0.000043579443,0.000058123052],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986306,0.00012299378,0.0002244163,0.00038093657,0.00026071726,0.00038034187],"domain_scores_gemma":[0.99873185,0.00020775571,0.0001206739,0.00056026905,0.00012290431,0.00025655664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004138245,0.0002537425,0.0006075953,0.00016687883,0.00013160663,0.000026571635,0.000075841934,0.0001507076,0.000058942354],"category_scores_gemma":[0.00002948998,0.0002097269,0.00033287844,0.00046906542,0.000051811967,0.00020154104,0.000016298556,0.00004437409,0.000012969395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02378451,0.059461497,0.6102622,0.00012884152,0.019197037,0.000023775305,0.0012078612,0.000008999537,0.012987562,0.0009384721,0.00012810407,0.2718711],"study_design_scores_gemma":[0.06581827,0.0021642332,0.8653562,0.000017281307,0.002921643,0.000017313276,0.00007102652,0.000023192624,0.06216283,0.00011387439,0.0011251105,0.00020904317],"about_ca_topic_score_codex":0.00045825433,"about_ca_topic_score_gemma":0.000012583726,"teacher_disagreement_score":0.27166206,"about_ca_system_score_codex":0.0003319434,"about_ca_system_score_gemma":0.00011943734,"threshold_uncertainty_score":0.85524154},"labels":[],"label_agreement":null},{"id":"W2594828897","doi":"10.1182/blood.v126.23.5573.5573","title":"Descriptive Analysis of Bortezomib Use in Multiple Myeloma in Four Adult University Teaching Hospitals in Quebec, Canada","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Notre-Dame; Centre Hospitalier Universitaire Sainte-Justine; Centre Hospitalier Universitaire de Sherbrooke; McGill University; Centre Hospitalier de l’Université de Montréal; Université Laval","funders":"","keywords":"Bortezomib; Medicine; Multiple myeloma; Proteasome inhibitor; Internal medicine; Adverse effect; Mantle cell lymphoma; Autologous stem-cell transplantation; Oncology; Population; Regimen; Surgery; Lymphoma","score_opus":0.03186814555242502,"score_gpt":0.2510077652511925,"score_spread":0.2191396196987675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594828897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990505,0.00005724194,0.0000069117573,0.0001253326,0.000017496579,0.0003608871,0.0000620748,0.000008277391,0.000311281],"genre_scores_gemma":[0.99882835,0.000014541962,0.00059727253,0.000020297783,0.000007634328,0.00000496276,0.000057086098,0.000009326302,0.00046052548],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859905,0.00019219366,0.00025950946,0.0002654815,0.00035255463,0.00033120907],"domain_scores_gemma":[0.99916035,0.00016168538,0.0000714907,0.00024935714,0.0001253575,0.00023176239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022654503,0.0001310921,0.00047556614,0.0007766692,0.000018956598,0.000008784666,0.00010390699,0.000068238456,0.000008713802],"category_scores_gemma":[0.0011336849,0.00012673771,0.000068658395,0.0009133373,0.000035239256,0.00018357093,0.000058275156,0.00024711838,0.0000012202439],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037406827,0.00065956794,0.99363065,0.000015616915,0.00047050166,0.0026614289,0.0010999158,0.00009354129,0.00021426145,0.000014397296,0.00008060472,0.00068542326],"study_design_scores_gemma":[0.011786667,0.00009007164,0.98213667,0.00009034402,0.0002381308,0.000002165431,0.0027986206,0.0021824532,0.0005281625,0.0000027915878,0.000044240525,0.00009968878],"about_ca_topic_score_codex":0.99002445,"about_ca_topic_score_gemma":0.9990356,"teacher_disagreement_score":0.011494008,"about_ca_system_score_codex":0.0008221153,"about_ca_system_score_gemma":0.0008251196,"threshold_uncertainty_score":0.5168214},"labels":[],"label_agreement":null},{"id":"W2594833014","doi":"10.1182/blood.v112.11.1110.1110","title":"Clinical Relevance of Vascular Endothelial Growth Factor (VEGFA) and VEGF Receptor (VEGFR2) Gene Single Nucleotide Polymorphism on the Treatment Outcomes Following Imatinib Mesylate Therapy.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"","keywords":"Haplotype; Genotype; Imatinib mesylate; Vascular endothelial growth factor A; Vascular endothelial growth factor; Angiogenesis; Biology; Internal medicine; Single-nucleotide polymorphism; Immunology; Myeloid leukemia; Cancer research; Oncology; Medicine; VEGF receptors; Genetics; Imatinib; Gene","score_opus":0.04238334477860886,"score_gpt":0.2849597639319657,"score_spread":0.24257641915335684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594833014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99471825,0.0027909938,0.000004251804,0.0005947356,0.0003478521,0.00094034715,0.000066654204,0.000089904424,0.00044701813],"genre_scores_gemma":[0.99047714,0.006488383,0.0016554503,0.00035985326,0.00024861717,0.00005934282,0.000019813267,0.0000796651,0.0006117475],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976587,0.00018708542,0.00068748597,0.0005435214,0.00051782746,0.00040535445],"domain_scores_gemma":[0.9977545,0.0010020586,0.0002590326,0.0007406965,0.00005602088,0.00018765083],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021171705,0.0004132024,0.0009038744,0.00007895797,0.00018299356,0.000012630022,0.00015982651,0.0001528818,0.000116778094],"category_scores_gemma":[0.00037151866,0.00024720785,0.0006483015,0.00013274161,0.00020807657,0.00006953111,0.000039316565,0.00021293879,0.000053484007],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053159293,0.009919893,0.83112305,0.000054053962,0.006000911,0.00044684016,0.0025572504,8.3374414e-7,0.13025466,0.00008499538,0.00014272223,0.018883185],"study_design_scores_gemma":[0.054291654,0.0074990625,0.46486035,0.00031444267,0.0011209039,0.00010865954,0.00008823244,0.000019809915,0.4653925,0.00008464189,0.005648989,0.0005707464],"about_ca_topic_score_codex":0.00015160309,"about_ca_topic_score_gemma":0.0000049526852,"teacher_disagreement_score":0.3662627,"about_ca_system_score_codex":0.00022432076,"about_ca_system_score_gemma":0.00020431902,"threshold_uncertainty_score":0.99999803},"labels":[],"label_agreement":null},{"id":"W2594851455","doi":"10.1182/blood.v128.22.2053.2053","title":"Interim Analysis of Lenalidomide Consolidation on Minimal Residual Disease in Patients with Chronic Lymphocytic Leukemia Following Initial FCR Chemotherapy - CLL6 Residuum Study of the Australian Leukaemia and Lymphoma Group (ALLG) and the French Innovative Leukemia Organization (FILO)","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Minimal residual disease; Cyclophosphamide; Internal medicine; Interim analysis; Rituximab; Surgery; Fludarabine; Chemotherapy; Melphalan; Bone marrow; Progression-free survival; Chemotherapy regimen; Oncology; Randomized controlled trial; Lymphoma","score_opus":0.011283592042245275,"score_gpt":0.2674695994931097,"score_spread":0.25618600745086445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594851455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980995,0.00005334264,0.000011566785,0.00013162638,0.000037568436,0.0015799516,0.000035209283,0.000019208823,0.000031994565],"genre_scores_gemma":[0.9995964,0.00002512216,0.000025261743,0.00007422619,0.000053699176,0.000049938608,0.00005557483,0.00004484316,0.00007489263],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969887,0.00042167897,0.00079169974,0.0005552395,0.0008841136,0.0003585276],"domain_scores_gemma":[0.99783343,0.0005496896,0.00044415036,0.0006878606,0.00036455176,0.00012028731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006192692,0.0003146498,0.0007717573,0.0004913971,0.00011890734,0.000034891553,0.00026426258,0.00012917157,0.00003059438],"category_scores_gemma":[0.00073342666,0.0001646125,0.00008206762,0.0022884377,0.00065741834,0.0001801177,0.0001811385,0.00014470416,9.090408e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.011372291,0.0011451084,0.97325814,0.00022871708,0.0038083962,0.00006084813,0.004791625,0.00015449522,0.0033927788,0.0001492947,0.00006969593,0.0015685909],"study_design_scores_gemma":[0.17380649,0.0012394858,0.81142783,0.00053553935,0.001589553,0.0000049838486,0.00034533613,0.00034864878,0.010511295,0.000017493425,0.0000023843497,0.00017097611],"about_ca_topic_score_codex":0.0033102767,"about_ca_topic_score_gemma":0.00093100657,"teacher_disagreement_score":0.16243419,"about_ca_system_score_codex":0.0125968605,"about_ca_system_score_gemma":0.008302608,"threshold_uncertainty_score":0.9973194},"labels":[],"label_agreement":null},{"id":"W2594884462","doi":"10.1182/blood.v104.11.2670.2670","title":"SRC within the Lin-CD34+CD38+/Lo Population Possess Heterogeneous Migration, Repopulation, and Self-Renewal Potential.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Population; CD38; CD34; Biology; Haematopoiesis; Stem cell; Bone marrow; Side population; Immunology; Proto-oncogene tyrosine-protein kinase Src; Molecular biology; Cell biology; Medicine; Cancer stem cell; Signal transduction","score_opus":0.008651798473171737,"score_gpt":0.23743815853022707,"score_spread":0.22878636005705533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594884462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958845,0.00030459967,0.0015083897,0.0011669871,0.00020694746,0.0006223261,0.0000068667277,0.00016166139,0.00013771748],"genre_scores_gemma":[0.9949479,0.0000651689,0.004212077,0.00021561013,0.0002352065,0.000027100381,0.00019331762,0.000033044744,0.000070550625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985278,0.000065240594,0.00051142345,0.00032715054,0.0003819073,0.00018644278],"domain_scores_gemma":[0.9992121,0.0000330838,0.00016265568,0.00034782363,0.0001345611,0.00010977748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002453681,0.0001844755,0.00022359798,0.00007936101,0.00020897924,0.000075398384,0.00006753408,0.00013227423,0.000014762],"category_scores_gemma":[0.00004904867,0.00013970198,0.000072002906,0.00018886442,0.000036872858,0.00010639655,0.000013849371,0.00012428383,0.000017552817],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005094472,0.0047343536,0.82313496,0.0017547974,0.001593316,0.0012239572,0.019894717,0.026488079,0.10978428,0.00961725,0.000086569846,0.0011782852],"study_design_scores_gemma":[0.021033801,0.0011296422,0.72388804,0.0009097826,0.0049257977,0.017638497,0.0008030706,0.0032241042,0.21236417,0.012693727,0.00020073293,0.0011886088],"about_ca_topic_score_codex":0.0007228817,"about_ca_topic_score_gemma":0.00044174088,"teacher_disagreement_score":0.10257989,"about_ca_system_score_codex":0.00003975204,"about_ca_system_score_gemma":0.00007805463,"threshold_uncertainty_score":0.56968814},"labels":[],"label_agreement":null},{"id":"W2594902263","doi":"10.1182/blood.v126.23.4736.4736","title":"Use of Rivaroxaban for Prophylaxis of Superficial Venous Thrombosis in Klippel-Trenaunay- Weber Syndrome - Case Report and Systematic Review","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Vascular Malformations and Hemangiomas","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Rivaroxaban; Low molecular weight heparin; Thrombosis; Surgery; Venous thrombosis; Post-thrombotic syndrome; Deep vein; Disseminated intravascular coagulation; Warfarin; Internal medicine","score_opus":0.05441930432460733,"score_gpt":0.2895214227355801,"score_spread":0.23510211841097278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594902263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99077713,0.0070762667,0.000020284835,0.00006946309,0.000027198337,0.0019452191,0.000022023314,0.000010800386,0.000051626503],"genre_scores_gemma":[0.9981073,0.00019243277,0.00148392,0.000021351305,0.000013125613,0.000101170925,0.00002430436,0.000014864432,0.00004150757],"study_design_codex":"systematic_review","study_design_gemma":"case_report","domain_scores_codex":[0.998786,0.00004374858,0.0007196498,0.00013689292,0.00018888131,0.0001248482],"domain_scores_gemma":[0.9990953,0.00005100851,0.00022109304,0.00039591902,0.00015688162,0.00007978252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050507777,0.00010115668,0.0008423614,0.00013898929,0.000019333143,0.0000059801737,0.000035967238,0.000067662586,0.000005343059],"category_scores_gemma":[0.00057784835,0.0000799919,0.00012824904,0.00022557897,0.000039275743,0.00010277798,0.00002750763,0.000054050273,0.0000014186347],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005570242,0.0042054895,0.018525412,0.95317334,0.0010562226,0.018540129,0.0025150885,0.0000027973188,0.001090131,0.00051729905,0.00020134075,0.00011703119],"study_design_scores_gemma":[0.013083716,0.008687565,0.022933591,0.24599291,0.016022418,0.6823579,0.001786398,0.00031874806,0.007570564,0.0002649608,0.00013421348,0.0008470335],"about_ca_topic_score_codex":0.00013197307,"about_ca_topic_score_gemma":0.000032357828,"teacher_disagreement_score":0.70718044,"about_ca_system_score_codex":0.000012849518,"about_ca_system_score_gemma":0.00008357908,"threshold_uncertainty_score":0.3261975},"labels":[],"label_agreement":null},{"id":"W2594914094","doi":"10.1182/blood.v114.22.2106.2106","title":"Robotic High Thoroughput Multiplex PCR Single-Nucleotide Polymorphism Genotyping of Apheresis Platelet Donors.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Canadian Blood Services; St. Michael's Hospital","funders":"","keywords":"Genotyping; Single-nucleotide polymorphism; SNP; Multiplex; Genotype; SNP genotyping; Multiplex polymerase chain reaction; Polymerase chain reaction; Immunology; Typing; Antigen; Medicine; Biology; Genetics; Gene","score_opus":0.018318021796295183,"score_gpt":0.2346195420212579,"score_spread":0.2163015202249627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594914094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99384314,0.0019238675,0.000090695605,0.0007484952,0.000107995314,0.00037816179,0.000013172642,0.00010370693,0.002790781],"genre_scores_gemma":[0.9937248,0.00017842324,0.005014961,0.00048701986,0.00011969028,0.00000529411,0.000055194003,0.000033667155,0.00038092566],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986051,0.000028938915,0.000378682,0.00033815065,0.00024836528,0.00040078943],"domain_scores_gemma":[0.9991964,0.00005555787,0.00015078211,0.0003837798,0.000057944817,0.00015551946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000646102,0.0002522423,0.000596192,0.00012386552,0.000079277095,0.000016285063,0.00011449427,0.00013672019,0.00012704758],"category_scores_gemma":[0.00004860162,0.00021870907,0.00016314238,0.00022386483,0.00005267537,0.000089923284,0.000027329588,0.00013592654,0.00006109453],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016830793,0.028444055,0.06073631,0.00047135356,0.0038211234,0.009127188,0.0017004241,0.0004648886,0.682802,0.0013192059,0.002031593,0.20739874],"study_design_scores_gemma":[0.045856293,0.0043622195,0.49118406,0.0009619031,0.0029801968,0.0013893606,0.00025969069,0.00044668352,0.4462768,0.003353907,0.0016478758,0.0012810025],"about_ca_topic_score_codex":0.0003949648,"about_ca_topic_score_gemma":0.0000417257,"teacher_disagreement_score":0.43044776,"about_ca_system_score_codex":0.00003369478,"about_ca_system_score_gemma":0.000045424244,"threshold_uncertainty_score":0.8918697},"labels":[],"label_agreement":null},{"id":"W2594943400","doi":"10.1182/blood.v120.21.1074.1074","title":"Characterization of the p.A1461D Mutation Causing Von Willebrand's Disease Type 2B with Severe Thrombocytopenia, Circulating Giant Platelets and Defective α -Granule Secretion","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Platelet; Von Willebrand disease; Ristocetin; Von Willebrand factor; Agglutination (biology); Bleeding time; Immunology; Chemistry; Molecular biology; Internal medicine; Medicine; Endocrinology; Antigen; Biology; Platelet aggregation","score_opus":0.009735582806667488,"score_gpt":0.2246483919405117,"score_spread":0.21491280913384422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594943400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988735,0.00020406969,0.000093149414,0.00006742941,0.000051494713,0.00048676567,0.000016081509,0.000018107223,0.000189438],"genre_scores_gemma":[0.99960494,0.000027178443,0.00008587578,0.00004818773,0.000035271303,0.000008231091,0.00015232731,0.00001641561,0.000021595408],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994203,0.00003551405,0.00011900275,0.0001293928,0.00015281954,0.00014301503],"domain_scores_gemma":[0.9996024,0.000018255401,0.00011881165,0.00011579558,0.00006583105,0.00007890236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000058073518,0.00010763441,0.0001854997,0.00003323266,0.00011094208,0.000011648568,0.000015772614,0.000043694617,0.000015480497],"category_scores_gemma":[0.00003027549,0.0000694922,0.000029499843,0.0001462738,0.00003746564,0.00019627843,0.000015533486,0.00006257872,0.0000020375162],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043716785,0.0006963935,0.7728243,0.00019548512,0.0002990366,0.00011974869,0.0022627232,0.00001426549,0.22072734,0.00006423145,0.0000013809395,0.0023579628],"study_design_scores_gemma":[0.0033281741,0.00013366445,0.9797865,0.0002404778,0.0006080679,0.00048538297,0.00009325761,0.00022241227,0.014953844,0.000040010633,0.000009337917,0.00009886847],"about_ca_topic_score_codex":0.000030860185,"about_ca_topic_score_gemma":0.00000967381,"teacher_disagreement_score":0.20696224,"about_ca_system_score_codex":0.000021434758,"about_ca_system_score_gemma":0.000042394575,"threshold_uncertainty_score":0.28338096},"labels":[],"label_agreement":null},{"id":"W2594955024","doi":"10.1182/blood.v128.22.143.143","title":"Reversal of Betrixaban-Induced Anticoagulation in Healthy Volunteers By Andexanet Alfa","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph's Hospital","funders":"","keywords":"Medicine; Intensive care medicine; Anesthesia","score_opus":0.044413436195190635,"score_gpt":0.31866931678415406,"score_spread":0.27425588058896344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594955024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995255,0.0001141421,0.000112173955,0.0033091656,0.00009333953,0.00027701186,0.000006306096,0.000024517978,0.00080834073],"genre_scores_gemma":[0.9987754,0.000058144145,0.00016091435,0.0000972991,0.00013625898,6.701978e-7,0.000017411327,0.000008981436,0.00074491644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992714,0.000026956355,0.00026175976,0.0001329876,0.00017595045,0.00013093925],"domain_scores_gemma":[0.9996337,0.00007287272,0.00007991458,0.00013525564,0.000030233436,0.000048012706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016638242,0.000070532216,0.00021431057,0.00013456181,0.000013696451,0.0000029019761,0.00003283383,0.000058228998,0.00008691925],"category_scores_gemma":[0.00012695574,0.00005058341,0.000048227317,0.00018578146,0.000016965883,0.00007615185,0.000015910047,0.00003286586,0.000017160022],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023283383,0.000039298193,0.88067406,0.00004462097,0.00003916371,0.0000030301896,0.00004790826,5.4872584e-7,0.11471998,0.00016403434,0.0006551441,0.003379399],"study_design_scores_gemma":[0.018050708,0.00084522454,0.9322769,0.00015568262,0.00017592714,0.0000042793195,0.00006424499,0.00005292978,0.04191451,0.00007163572,0.006223411,0.00016452356],"about_ca_topic_score_codex":0.00009473004,"about_ca_topic_score_gemma":0.000016624144,"teacher_disagreement_score":0.07280547,"about_ca_system_score_codex":0.000021923312,"about_ca_system_score_gemma":0.000026137011,"threshold_uncertainty_score":0.20627317},"labels":[],"label_agreement":null},{"id":"W2594964815","doi":"10.1182/blood.v116.21.3509.3509","title":"Significant Improvement In Day 100 and 1-Year Overall Survival In Patients Who Underwent Myeloablative Allogeneic Hematopoietic Cell Transplant In the US or Canada Between 1994 and 2005","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Transplantation; Internal medicine; Hematopoietic stem cell transplantation; Population; Hematopoietic cell; Statistical significance; Disease; Surgery; Pediatrics; Demography; Haematopoiesis; Stem cell","score_opus":0.008981173167389412,"score_gpt":0.21691360767267126,"score_spread":0.20793243450528184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594964815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99815285,0.000093424,8.742277e-7,0.00022422266,0.000057934132,0.0010708898,0.0000956036,0.0000054509637,0.0002987357],"genre_scores_gemma":[0.9994027,0.00012293992,0.000047829337,0.00015381038,0.00003665626,0.000048067508,0.000067940135,0.000020461837,0.0000996102],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835014,0.00009712019,0.00038531603,0.00037685162,0.00036488034,0.0004256782],"domain_scores_gemma":[0.9993094,0.00020467707,0.00007636051,0.0002591001,0.000012098934,0.00013836366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033753912,0.00023265477,0.000402242,0.00009761395,0.000033072036,0.000016354388,0.00010703678,0.00010221866,0.00003949667],"category_scores_gemma":[0.000018208004,0.00015604295,0.000022116285,0.00012453405,0.000056490495,0.000041775555,0.000038640017,0.00037338756,9.473601e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010509309,0.00062083226,0.99548936,0.00009535641,0.0000523514,0.00019692413,0.001878711,0.0000035203232,0.0011776129,0.000014349245,0.000032565844,0.00033334538],"study_design_scores_gemma":[0.017808937,0.00043045334,0.9775257,0.00012103277,0.00011777281,0.0000061965084,0.00027735435,0.000015569382,0.0032991741,0.00002462437,0.00019556217,0.00017763516],"about_ca_topic_score_codex":0.18201566,"about_ca_topic_score_gemma":0.6603116,"teacher_disagreement_score":0.47829592,"about_ca_system_score_codex":0.0003458142,"about_ca_system_score_gemma":0.0006862448,"threshold_uncertainty_score":0.8234314},"labels":[],"label_agreement":null},{"id":"W2594993143","doi":"10.1182/blood.v120.21.1909.1909","title":"Irradiated NK-92 Targets AML Leukemic Stem Cells in Vivo and Gene-Modified CD16+NK-92 Mediates Antibody Dependent Cell Mediated Cytotoxicity (ADCC) Against CD123+ Cells","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Antibody-dependent cell-mediated cytotoxicity; Cancer research; Leukemia; Stem cell; CD38; CD34; Cytotoxic T cell; Biology; Immunology; Antibody; Monoclonal antibody; In vitro; Cell biology","score_opus":0.020130242991296392,"score_gpt":0.27302105172603636,"score_spread":0.25289080873473996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594993143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98678327,0.006048175,0.000021629457,0.00010112132,0.00055273494,0.0021354994,0.00030425037,0.00025209336,0.0038012343],"genre_scores_gemma":[0.98844826,0.006949139,0.00022609967,0.00045659524,0.00061099755,0.00010321286,0.00023538384,0.00020358106,0.0027667154],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99384594,0.0005225439,0.0011181951,0.0010805812,0.0013818422,0.0020508799],"domain_scores_gemma":[0.99646896,0.00063748675,0.000336625,0.000994576,0.00021322444,0.001349129],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015710669,0.00082003867,0.0012909694,0.0007674757,0.00018460811,0.000099514335,0.00052250765,0.0006982788,0.0008802586],"category_scores_gemma":[0.0000862473,0.0007676188,0.00024574203,0.0008680162,0.00028564598,0.00033543725,0.00032179386,0.0011859965,0.00031255058],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046416346,0.002754369,0.032775823,0.00045505754,0.000247265,0.0004029309,0.0015195126,0.000041581883,0.96047604,0.000005345091,0.00055754656,0.00030038244],"study_design_scores_gemma":[0.01442692,0.0004822605,0.010324372,0.00014705656,0.00023153679,0.00006873172,0.00032699728,0.0008423055,0.971427,0.000013802916,0.00095529045,0.0007536996],"about_ca_topic_score_codex":0.000509302,"about_ca_topic_score_gemma":0.00014579782,"teacher_disagreement_score":0.022451451,"about_ca_system_score_codex":0.00044024695,"about_ca_system_score_gemma":0.00045579878,"threshold_uncertainty_score":0.9994775},"labels":[],"label_agreement":null},{"id":"W2595026465","doi":"10.1182/blood.v124.21.1013.1013","title":"Bone Marrow Adipocyte-Derived Free Fatty Acids Induce Gene Signature Linking Transcription with Metabolic Changes That Contribute to Survival of Acute Monocytic Leukemia Cells","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; Downregulation and upregulation; Transcription factor; Stromal cell; Cancer research; Bone marrow; Cell biology; Biochemistry; Immunology; Gene","score_opus":0.020341772598522274,"score_gpt":0.24985592665146558,"score_spread":0.22951415405294331,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595026465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894184,0.0015381901,0.0053440486,0.0014500273,0.00020370023,0.0013702883,0.0002521511,0.00014134274,0.00028183623],"genre_scores_gemma":[0.99022496,0.00048849045,0.0072838,0.00067576376,0.0005222969,0.0001129143,0.00019499272,0.00011499943,0.0003818145],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99677986,0.00025595105,0.00039156753,0.0006796267,0.0010420075,0.00085096795],"domain_scores_gemma":[0.99767184,0.00016152419,0.00020713458,0.001067176,0.00040015246,0.0004921816],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008307258,0.00046501128,0.0011571074,0.00039528555,0.00012034963,0.000047110192,0.00050817814,0.00045371527,0.000057840167],"category_scores_gemma":[0.0001118239,0.0003747773,0.00017365857,0.0006542296,0.00014678459,0.00014797524,0.00015768113,0.00089864194,0.000028104088],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011201681,0.00017654459,0.0019101966,0.00018464978,0.0011517444,0.00014128885,0.0007874862,0.000030432979,0.9926398,0.00007344661,0.00016790512,0.0016163397],"study_design_scores_gemma":[0.014652431,0.0011147385,0.014353533,0.00026309022,0.0020955452,0.00011898754,0.00009879938,0.00026735527,0.9646015,0.00003793235,0.0020145162,0.0003815388],"about_ca_topic_score_codex":0.00019055557,"about_ca_topic_score_gemma":0.00020099283,"teacher_disagreement_score":0.028038265,"about_ca_system_score_codex":0.00027900963,"about_ca_system_score_gemma":0.00047721187,"threshold_uncertainty_score":0.9998704},"labels":[],"label_agreement":null},{"id":"W2595097309","doi":"10.1182/blood.v108.11.4114.4114","title":"Validation of a Weight Based Heparin Nomogram That Utilizes Anti-Factor Xa Levels for Monitoring.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto General Hospital; Toronto Western Hospital","funders":"","keywords":"Nomogram; Medicine; Heparin; Bolus (digestion); Fondaparinux; Thrombosis; Internal medicine; Surgery","score_opus":0.09665982272335966,"score_gpt":0.33387625813522315,"score_spread":0.2372164354118635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595097309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957086,0.00011104309,0.0020462624,0.00036005751,0.00024220599,0.00060369965,0.000026244485,0.00007265979,0.00082922186],"genre_scores_gemma":[0.99371564,0.00000601425,0.0044385414,0.000012653548,0.00076698005,0.0000064983146,0.00005884328,0.000016370848,0.0009784665],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992782,0.000015105535,0.00022315483,0.00014744105,0.00019755813,0.00013854241],"domain_scores_gemma":[0.9994987,0.000110290515,0.00012160614,0.0001680443,0.00006916817,0.000032185522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009651484,0.00010297175,0.00024211791,0.00010718742,0.000039401813,0.000015322557,0.000045733912,0.000058884114,0.00006907163],"category_scores_gemma":[0.00004915365,0.00008757994,0.0001569152,0.00011794937,0.00001889934,0.00006886389,0.000013978539,0.00002916869,0.0000055708883],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005901086,0.00006759412,0.98261625,0.00012721473,0.00006134825,0.0000014008343,0.000014721701,0.000018262934,0.015517723,0.00018294169,0.00013842617,0.0011950813],"study_design_scores_gemma":[0.0033331702,0.00007929139,0.5842978,0.000033677235,0.00020666928,4.899542e-7,0.000009865826,0.00010162706,0.40662417,0.00006589969,0.005176488,0.00007087852],"about_ca_topic_score_codex":0.000031920754,"about_ca_topic_score_gemma":0.0000013246448,"teacher_disagreement_score":0.3983185,"about_ca_system_score_codex":0.000010713538,"about_ca_system_score_gemma":0.000025569594,"threshold_uncertainty_score":0.3571406},"labels":[],"label_agreement":null},{"id":"W2595165795","doi":"10.1182/blood.v106.11.119.119","title":"Characterization of Distinct Molecular Signatures in Myeloproliferative Diseases with the JAK2V617F Mutation and Wild Type JAK2.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Biology; Mutation; Gene; Polycythemia vera; Point mutation; Molecular biology; Gene expression profiling; Myeloproliferative Disorders; Genetics; Allele; Phenotype; Gene expression; Immunology","score_opus":0.005338461280016435,"score_gpt":0.2287456310499443,"score_spread":0.22340716976992786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595165795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964767,0.0006077655,0.000050397815,0.0020085368,0.000009775701,0.00056127174,0.000024826131,0.000013326645,0.00024736658],"genre_scores_gemma":[0.99905896,0.000073422765,0.00022828559,0.000332749,0.000055741104,0.00007963179,0.00010770251,0.00001299944,0.000050525654],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993519,0.000047586887,0.00014507964,0.0001799978,0.00016967671,0.00010576306],"domain_scores_gemma":[0.99958426,0.00006211355,0.00008131422,0.00011690741,0.000103769475,0.000051632043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000448989,0.00012605518,0.00019868884,0.000055625933,0.00004326333,0.00001505055,0.000028082215,0.000039655955,0.000030679053],"category_scores_gemma":[0.000047305497,0.00007214296,0.000021615264,0.00016978142,0.000065453714,0.00007049256,0.000012833992,0.000078569035,0.0000019404736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011035227,0.0034797958,0.8690304,0.00017404906,0.00057455985,0.00031915907,0.0032897126,0.00013207975,0.11063198,0.0021062056,0.00006275103,0.009095748],"study_design_scores_gemma":[0.002933828,0.000650551,0.84813356,0.00012492506,0.00029322164,0.000025293397,0.000065864326,0.00014883456,0.14728373,0.000022971852,0.00022427301,0.00009296212],"about_ca_topic_score_codex":0.000010786888,"about_ca_topic_score_gemma":0.000055896497,"teacher_disagreement_score":0.036651753,"about_ca_system_score_codex":0.000016227235,"about_ca_system_score_gemma":0.000057434703,"threshold_uncertainty_score":0.29419044},"labels":[],"label_agreement":null},{"id":"W2595178400","doi":"10.1182/blood.v128.22.2186.2186","title":"Factors Influencing Long-Term Hematopoietic Function Following Autologous Stem Cell Transplantation","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Blood Services; University of Calgary; University of Ottawa; University of Toronto; University Health Network; Ottawa Hospital","funders":"","keywords":"Plerixafor; Stem cell; CXCR4; Medicine; Hematopoietic stem cell transplantation; Transplantation; CD34; Haematopoiesis; Bone marrow; Immunology; Internal medicine; Biology; Receptor","score_opus":0.020515931691132062,"score_gpt":0.24644325454870306,"score_spread":0.225927322857571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595178400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853261,0.00019328103,0.012177724,0.00007732476,0.00034209312,0.00047401045,0.000011213326,0.00028867827,0.0011095394],"genre_scores_gemma":[0.99908036,0.00006122895,0.00014493905,0.00006444368,0.000065748165,0.000028121314,0.000040931212,0.000048686743,0.00046556396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983222,0.00006263957,0.00045289437,0.00038985192,0.00040737624,0.0003650646],"domain_scores_gemma":[0.9991491,0.00020331358,0.00012267145,0.00029712144,0.0000518417,0.00017599187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016349014,0.00026165473,0.00036577412,0.00016507345,0.000102358455,0.000022468133,0.00008315366,0.00018921327,0.00010887848],"category_scores_gemma":[0.0000080221025,0.0001785368,0.00020830487,0.00017790975,0.000032823667,0.00020987456,0.000007454004,0.00011662819,0.00013372794],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000093955205,0.00025850482,0.68320984,0.0010418021,0.00015036136,0.0003316154,0.0022561585,0.0000011634827,0.31034747,0.000049365575,0.00000657681,0.0022532062],"study_design_scores_gemma":[0.004398142,0.00024754577,0.59885734,0.0007980124,0.0012528059,0.00024017197,0.00020106706,0.0000014958022,0.39375183,0.000025112084,0.000007690992,0.0002188002],"about_ca_topic_score_codex":0.000007657981,"about_ca_topic_score_gemma":0.0000076050997,"teacher_disagreement_score":0.08435249,"about_ca_system_score_codex":0.00006038911,"about_ca_system_score_gemma":0.000086025946,"threshold_uncertainty_score":0.7280519},"labels":[],"label_agreement":null},{"id":"W2595210719","doi":"10.1182/blood.v128.22.2061.2061","title":"Marcks Peptide Inhibitor Displays Synergistic Cytotoxicity with Bortezomib in Drug Resistant Multiple Myeloma Cells but Enhances Autophagic Effect","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto General Hospital; University of Toronto","funders":"","keywords":"MARCKS; Bortezomib; Cytotoxicity; Apoptosis; Cytotoxic T cell; Cancer research; Cell culture; Proteasome inhibitor; Chemistry; Programmed cell death; Viability assay; Pharmacology; Phosphorylation; Molecular biology; Biology; Myristoylation; Multiple myeloma; Biochemistry; Immunology; In vitro","score_opus":0.00743718624176384,"score_gpt":0.24098958539730764,"score_spread":0.2335523991555438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595210719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963495,0.0002646825,0.00006292525,0.00017623937,0.00007069498,0.0013453839,0.00014194698,0.000109383174,0.0014792273],"genre_scores_gemma":[0.9948826,0.00006830117,0.0006666652,0.000032029373,0.00018803116,0.0002972406,0.000030268458,0.00005765845,0.0037772194],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971739,0.00021851946,0.0004115573,0.00068169634,0.0006870437,0.0008272894],"domain_scores_gemma":[0.99785906,0.0008870721,0.00012216884,0.00059145835,0.00008259601,0.00045766137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003680485,0.00039927426,0.00063194724,0.00023153613,0.00012042562,0.000037291764,0.00018449486,0.00011026878,0.0001258944],"category_scores_gemma":[0.0004273398,0.00021993316,0.00012879129,0.00028299267,0.00023648095,0.0001408474,0.00009241482,0.0002479466,0.00020725054],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034925307,0.0013304976,0.16956335,0.000283958,0.00024312406,0.0035415788,0.00008485305,8.2096153e-7,0.8199909,0.0000163382,0.0001846665,0.001267382],"study_design_scores_gemma":[0.017867109,0.0013168568,0.2579819,0.000812375,0.00013980328,0.000040578074,0.000027554595,0.00004300037,0.7214145,0.000013181618,0.00011150121,0.00023164572],"about_ca_topic_score_codex":0.00073083997,"about_ca_topic_score_gemma":0.0014710699,"teacher_disagreement_score":0.098576404,"about_ca_system_score_codex":0.0002042541,"about_ca_system_score_gemma":0.00021533052,"threshold_uncertainty_score":0.8968614},"labels":[],"label_agreement":null},{"id":"W2595228860","doi":"10.1182/blood.v126.23.4234.4234","title":"Insulin Growth Factor 1 Receptor (IGF-1R) Inhibitor, Linsitinib (OSI-906) in Combination with Bortezomib and Dexamethasone Demonstrates Favorable Safety Prolife and Clinical Activity in Patients with Relapsed/Refractory Multiple Myeloma","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Dalhousie University; University Health Network; Jewish General Hospital; Université de Montréal; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Tolerability; Medicine; Bortezomib; Internal medicine; Dexamethasone; Lenalidomide; Dosing; Multiple myeloma; Pharmacology; Refractory (planetary science); Carfilzomib; Oncology; Gastroenterology; Adverse effect; Urology; Biology","score_opus":0.026090857815357395,"score_gpt":0.278428074502276,"score_spread":0.2523372166869186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595228860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973942,0.00021458983,0.000018167872,0.0001858852,0.00004105556,0.0018708502,0.00008312006,0.000052654905,0.00013948971],"genre_scores_gemma":[0.99692047,0.00019114753,0.0024974255,0.000038833274,0.000051910793,0.00007031812,0.00014905179,0.000047933605,0.00003293194],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99733514,0.00038942014,0.00051872554,0.0006646735,0.00059435813,0.00049769186],"domain_scores_gemma":[0.99801034,0.00056948955,0.00021253103,0.00027804746,0.0003140327,0.00061553466],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00063403725,0.00033932523,0.0006805444,0.0002701544,0.000080236015,0.000048248476,0.000073478586,0.00026186893,0.0000070355386],"category_scores_gemma":[0.0012827964,0.00024961174,0.000036037745,0.00039604426,0.00026689193,0.00045040858,0.000081758284,0.0006896251,0.000007842026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012328128,0.008071305,0.96806985,0.00009405174,0.00016937596,0.00008693762,0.00029134587,4.57483e-7,0.0002369289,0.0000053898043,0.000013037245,0.0106331995],"study_design_scores_gemma":[0.08932968,0.006087082,0.9009957,0.00032851638,0.00007330785,0.000011682304,0.00015811659,0.00019698947,0.002527855,0.000012195308,0.000032798205,0.00024610583],"about_ca_topic_score_codex":0.00056120515,"about_ca_topic_score_gemma":0.0010712186,"teacher_disagreement_score":0.07700155,"about_ca_system_score_codex":0.00016174476,"about_ca_system_score_gemma":0.0004776739,"threshold_uncertainty_score":0.9999956},"labels":[],"label_agreement":null},{"id":"W2595243603","doi":"10.1182/blood.v112.11.sci-53.sci-53","title":"Donor T Cell Gene Expression and GVHD.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer","funders":"","keywords":"Immunology; CD8; Biology; Hematopoietic stem cell transplantation; Graft-versus-host disease; Minor histocompatibility antigen; Haematopoiesis; T cell; Transplantation; Major histocompatibility complex; Stem cell; Immune system; Genetics; Medicine; Internal medicine","score_opus":0.016441215039003178,"score_gpt":0.23004671198324544,"score_spread":0.21360549694424227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595243603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857131,0.00048168644,0.00042409988,0.00005724287,0.00004051459,0.00015085652,0.000003158196,0.000042747928,0.013086587],"genre_scores_gemma":[0.99081194,0.0003400733,0.00786606,0.000091312846,0.00006304583,0.0000080717355,0.0000134691845,0.000011744949,0.00079430174],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99952495,0.000012064368,0.0001080465,0.00013493105,0.00011738712,0.000102593185],"domain_scores_gemma":[0.9997206,0.000029257117,0.000022097873,0.00011988439,0.000018347362,0.00008981743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003800516,0.00006600837,0.00011208719,0.00003216093,0.000046874367,0.0000029068133,0.000021092337,0.000051838728,0.00013621875],"category_scores_gemma":[0.0000060612965,0.00005472829,0.000021247493,0.00004100161,0.000026428752,0.000025374195,0.0000072983394,0.000053489362,0.000047952955],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028150807,0.00030504147,0.07938383,0.00019296199,0.000011299645,0.00033528355,0.00091618067,2.7600663e-7,0.9183271,0.000010663846,0.00029488414,0.0001943375],"study_design_scores_gemma":[0.00324383,0.000081001956,0.058845058,0.000034941844,0.0000794742,0.00085286115,0.0000303043,0.000004877495,0.93636256,0.0000082454035,0.00039383906,0.00006298633],"about_ca_topic_score_codex":0.0000054602633,"about_ca_topic_score_gemma":2.9168885e-7,"teacher_disagreement_score":0.020538766,"about_ca_system_score_codex":0.0000035198595,"about_ca_system_score_gemma":0.00002379971,"threshold_uncertainty_score":0.2231755},"labels":[],"label_agreement":null},{"id":"W2595260906","doi":"10.1182/blood.v128.22.1056.1056","title":"PP2A Balances Glucose Metabolism and Foxo Activation to Maintain Cellular Redox Homeostasis in Acute Lymphoblastic Leukemia","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"FOXO transcription factor regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Protein phosphatase 2; Cancer research; Biology; Protein subunit; Protein kinase B; Myeloid leukemia; PI3K/AKT/mTOR pathway; Leukemia; Phosphatase; Myeloid; Dephosphorylation; Cell biology; Phosphorylation; Signal transduction; Immunology; Genetics; Gene","score_opus":0.005412024182122006,"score_gpt":0.20855872601432798,"score_spread":0.20314670183220598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595260906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904788,0.0005037099,0.008375031,0.00026946055,0.00007002627,0.00019534383,0.000035218585,0.000016428923,0.00005593776],"genre_scores_gemma":[0.998595,0.00027625074,0.00075238897,0.000108532906,0.00008709871,0.000028931625,0.000048677983,0.000018360306,0.000084764375],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999127,0.000044568897,0.00017424316,0.00033151257,0.00011783392,0.00020488336],"domain_scores_gemma":[0.999604,0.000014080588,0.000049058253,0.00021088122,0.000038633105,0.00008337013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000111294845,0.00013833975,0.00013773314,0.00008945272,0.000035677298,0.000021297925,0.00009250542,0.00011716173,0.000014356452],"category_scores_gemma":[0.00005588117,0.00011161854,0.000038405135,0.0001168361,0.00004093672,0.0000143536845,0.00003802914,0.000030017665,0.000011367784],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000093416755,0.000044668803,0.0024853707,0.000007728254,0.000046605328,0.0000027781302,0.000036338653,0.000008997921,0.99284035,0.00029745727,0.00005686774,0.004079437],"study_design_scores_gemma":[0.0019374999,0.00010775752,0.07111554,0.000030353443,0.000042465734,0.000006083207,0.000016661688,0.000008429739,0.9213205,0.0002499375,0.00499871,0.00016607756],"about_ca_topic_score_codex":0.000026647496,"about_ca_topic_score_gemma":0.000035347188,"teacher_disagreement_score":0.071519844,"about_ca_system_score_codex":0.00003711699,"about_ca_system_score_gemma":0.00005067045,"threshold_uncertainty_score":0.45516717},"labels":[],"label_agreement":null},{"id":"W2595261433","doi":"10.1182/blood.v120.21.3574.3574","title":"High-Dose Cytarabine-Based Consolidation Shows Superior Results for Elderly AML Patients with Intermediate Risk Cytogenetics in First Complete Remission","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Cytarabine; Medicine; Internal medicine; Regimen; Etoposide; Gastroenterology; Mitoxantrone; Idarubicin; Surgery; Leukemia; Chemotherapy","score_opus":0.0222480989188224,"score_gpt":0.26815559109811926,"score_spread":0.24590749217929686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595261433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964961,0.0000649266,0.00037349714,0.00040161546,0.000106055326,0.001767774,0.0006376368,0.00005245607,0.00009998421],"genre_scores_gemma":[0.9901595,0.000037677823,0.007930775,0.00015507366,0.00022008638,0.00014985989,0.0012313946,0.00004813373,0.00006749237],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797976,0.00010585735,0.00048845046,0.0003673641,0.00044057128,0.00061799673],"domain_scores_gemma":[0.9983841,0.00035931705,0.00017431758,0.00048793358,0.00026685782,0.00032748282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004672629,0.00024338825,0.00038766014,0.00022928692,0.00011575278,0.000025629824,0.00015832236,0.00015911115,0.000030435996],"category_scores_gemma":[0.0007817371,0.00018983726,0.00006652465,0.00025114388,0.00011860313,0.00012106671,0.000045300894,0.0003378869,0.000023801567],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010661375,0.0022560821,0.97057325,0.0002762565,0.0001280057,0.000032209824,0.00073125045,0.000071066046,0.008927715,0.000008721566,0.0015910056,0.0047430536],"study_design_scores_gemma":[0.07593872,0.0036841754,0.87449735,0.0004251431,0.00032271032,0.000013162904,0.00007392964,0.0010965327,0.039326575,0.0000098790415,0.0042538405,0.00035795092],"about_ca_topic_score_codex":0.0001547199,"about_ca_topic_score_gemma":0.00017585834,"teacher_disagreement_score":0.09607588,"about_ca_system_score_codex":0.00021103406,"about_ca_system_score_gemma":0.00028133055,"threshold_uncertainty_score":0.77413386},"labels":[],"label_agreement":null},{"id":"W2595300774","doi":"10.1182/blood.v114.22.1018.1018","title":"A Prospective Study of Voriconazole Therapeutic Drug Monitoring (TDM) in Patients with Acute Leukemia.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Voriconazole; Internal medicine; Therapeutic drug monitoring; Aspergillosis; Gastroenterology; Prospective cohort study; Fluconazole; Neutropenia; Toxicity; Surgery; Pharmacokinetics; Immunology; Antifungal","score_opus":0.00825458677644774,"score_gpt":0.25592648033069443,"score_spread":0.24767189355424668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595300774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984249,0.000119142394,0.0000029994612,0.000015442589,0.000023685223,0.0007973457,0.0000018922557,0.000020917852,0.0005936912],"genre_scores_gemma":[0.999702,0.00000684803,0.00007361007,0.000020044612,0.000031222622,0.000012455837,0.0000015538773,0.000008430464,0.00014383544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990923,0.000025046795,0.00019554398,0.0002239033,0.00029790623,0.00016529398],"domain_scores_gemma":[0.9995097,0.00001801809,0.00006260865,0.00025282428,0.00011220699,0.000044636516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000090841415,0.00010939642,0.00028400563,0.00005766975,0.000028138847,0.000005207141,0.0000603519,0.00003060124,0.0000048490115],"category_scores_gemma":[0.0000134575985,0.00007865088,0.00003036065,0.00023544375,0.00002276855,0.00006551348,0.000010583936,0.00015274445,0.000002326046],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079964986,0.0053679044,0.9902134,0.000014019275,0.00012703157,0.00002743811,0.0019135226,0.0000012386143,0.00072690484,0.000009282741,0.0000019519496,0.00079764234],"study_design_scores_gemma":[0.009767394,0.002344781,0.98208624,0.00007230066,0.0002122432,7.415486e-7,0.0010010164,0.0000015023754,0.004381887,0.00005430003,8.9885276e-7,0.00007669],"about_ca_topic_score_codex":0.000049794657,"about_ca_topic_score_gemma":0.00003549398,"teacher_disagreement_score":0.008967744,"about_ca_system_score_codex":0.0000864502,"about_ca_system_score_gemma":0.00008447859,"threshold_uncertainty_score":0.320729},"labels":[],"label_agreement":null},{"id":"W2595323673","doi":"10.1182/blood.v128.22.904.904","title":"Long Term Survival and Clinical Complete Responses of Various Prognostic Subgroups in 103 Relapsed/Refractory Acute Myeloid Leukemia (r/r AML) Patients Treated with Guadecitabine (SGI-110) in Phase 2 Studies","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Tolerability; Regimen; Clinical endpoint; Gastroenterology; Neutropenia; Phases of clinical research; Decitabine; Adverse effect; Chemotherapy regimen; Febrile neutropenia; Surgery; Clinical trial; Chemotherapy; Biology","score_opus":0.04218165801584925,"score_gpt":0.34323655601432224,"score_spread":0.30105489799847296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595323673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972736,0.0006950349,0.000012393006,0.00023802806,0.00006477282,0.0014192805,0.00013335656,0.00005744993,0.00010607711],"genre_scores_gemma":[0.9973199,0.0016695138,0.00031625194,0.000050625476,0.000080338716,0.00008071234,0.00006956223,0.000071947914,0.00034117463],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99600905,0.00064493634,0.0012119405,0.0007660646,0.00067787705,0.000690143],"domain_scores_gemma":[0.9958109,0.0025884009,0.00031865816,0.00061555946,0.00038465043,0.00028182002],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001157902,0.0004080144,0.0013144676,0.0005841913,0.00005996722,0.000015696125,0.00023672775,0.00025028494,0.00002426364],"category_scores_gemma":[0.0024680214,0.00025706607,0.0000967076,0.0006407059,0.0008377864,0.00021641789,0.0002422681,0.00062110735,0.000013457157],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011314031,0.003552842,0.96503294,0.00016314017,0.0008052907,0.0018077334,0.00034442707,1.2191714e-7,0.010045766,0.0000087273975,0.000044698823,0.006880289],"study_design_scores_gemma":[0.078465536,0.0073820306,0.910511,0.001060522,0.00051371136,0.00008429255,0.00010224398,0.000010189714,0.0015378742,0.000011077,0.0000428842,0.000278641],"about_ca_topic_score_codex":0.00019250734,"about_ca_topic_score_gemma":0.00067475147,"teacher_disagreement_score":0.06715151,"about_ca_system_score_codex":0.0005483371,"about_ca_system_score_gemma":0.00065098435,"threshold_uncertainty_score":0.99998814},"labels":[],"label_agreement":null},{"id":"W2595343754","doi":"10.1182/blood.v114.22.3057.3057","title":"The Role of gas6 in Venous Thrombosis In Vivo.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Platelet; GAS6; Bone marrow; Thrombus; Transplantation; Medicine; Biology; Internal medicine; Immunology; Endocrinology; Receptor; Receptor tyrosine kinase","score_opus":0.00668262750550582,"score_gpt":0.22008187114367259,"score_spread":0.21339924363816676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595343754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880132,0.008854424,6.339773e-7,0.00010638574,0.000048316633,0.00008219409,0.0000021030182,0.000007078924,0.002885661],"genre_scores_gemma":[0.999645,0.00023631414,0.000007141998,0.000019622632,0.0000054932057,0.0000039615466,0.000003438909,0.000002747698,0.00007626541],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995109,0.00006697176,0.00018026786,0.000079636215,0.000014237012,0.00014800769],"domain_scores_gemma":[0.9997503,0.000043022355,0.000051437033,0.00014090654,0.000011209207,0.0000031286675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013931238,0.000052896077,0.00013090218,0.000046772562,0.000038959108,0.0000032527053,0.000104312494,0.00007942329,0.000031150154],"category_scores_gemma":[0.000020336034,0.00003882491,0.00003163445,0.000106857886,0.00003999749,0.000033586017,0.000013546346,0.0000852747,0.000015432228],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020459336,0.0006422807,0.013712384,0.0000011731457,0.000018324536,3.461774e-7,0.00036474047,0.0000039344195,0.97574335,0.0011055135,0.000032774133,0.0083547365],"study_design_scores_gemma":[0.0009752505,0.00016063139,0.36697355,0.00001945812,0.000009654255,0.000004527196,0.00013106797,0.0000026990074,0.62732285,0.0013135639,0.0030435133,0.000043236338],"about_ca_topic_score_codex":0.00009070142,"about_ca_topic_score_gemma":0.000072109186,"teacher_disagreement_score":0.35326114,"about_ca_system_score_codex":0.000009350498,"about_ca_system_score_gemma":0.000016101858,"threshold_uncertainty_score":0.15832339},"labels":[],"label_agreement":null},{"id":"W2595496294","doi":"10.1182/blood.v118.21.3641.3641","title":"Investigating the Potential Use of L-Asparaginase in Myeloid Leukemia,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Propidium iodide; Asparagine synthetase; Myeloid leukemia; Cancer research; Leukemia; Asparaginase; Glutamine; Asparagine; K562 cells; Myeloid; Cell culture; Biology; Programmed cell death; Apoptosis; Chemistry; Biochemistry; Immunology; Enzyme; Amino acid","score_opus":0.05270448775701249,"score_gpt":0.2729060486275812,"score_spread":0.22020156087056875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595496294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99645996,0.0001486618,0.000038879884,0.00029138615,0.000038572558,0.0003612282,0.0000051729157,0.000029867533,0.0026262943],"genre_scores_gemma":[0.9942958,0.000042633816,0.0047160867,0.00035222754,0.000090981666,0.000024933437,0.000007324778,0.000025201944,0.0004448393],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871314,0.00010152028,0.000315001,0.00021442736,0.00032805034,0.00032789382],"domain_scores_gemma":[0.99909794,0.00010255642,0.0000884861,0.0004825695,0.000097456854,0.00013098081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039086203,0.00012363304,0.00024910155,0.00014450142,0.000045576828,0.0000119449505,0.00019968089,0.00009465727,0.00010884972],"category_scores_gemma":[0.0005389029,0.00008606323,0.00007093728,0.00037653564,0.0002704776,0.00012024733,0.00013652931,0.00046189927,0.000037746977],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038248324,0.0015088554,0.5857986,0.0004209267,0.00042658538,0.001618568,0.008473461,0.0000739449,0.38784847,0.0022484988,0.0033765335,0.00782303],"study_design_scores_gemma":[0.008916684,0.0005096594,0.67351055,0.00030595675,0.00029709688,0.00050939294,0.00079256867,0.0018446238,0.31147146,0.00077221805,0.0007978153,0.0002719772],"about_ca_topic_score_codex":0.002165566,"about_ca_topic_score_gemma":0.00005744479,"teacher_disagreement_score":0.087711915,"about_ca_system_score_codex":0.000096420015,"about_ca_system_score_gemma":0.000525558,"threshold_uncertainty_score":0.35095564},"labels":[],"label_agreement":null},{"id":"W2595557001","doi":"10.1182/blood.v128.22.1075.1075","title":"Transcriptional Landscape of APL Identifies Aberrant Podoplanin Expression As a Defining Feature and Missing Link for the Bleeding Disorder of This Disease","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Institute for Research in Immunology and Cancer; Leukemia & Lymphoma Society of Canada; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Cancer research; Podoplanin; GATA1; Medicine; Biology; Immunology; Gene; Gene expression; Genetics; Lymphatic system","score_opus":0.016365107776869163,"score_gpt":0.27466791414130814,"score_spread":0.258302806364439,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595557001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9685237,0.014858185,0.0015401931,0.013944182,0.00006659263,0.0004958638,0.00014095964,0.000029624889,0.0004007083],"genre_scores_gemma":[0.9969768,0.00048546848,0.0011399775,0.000048938167,0.00009613531,0.00002838092,0.00001972829,0.000020209465,0.0011843621],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999134,0.000027307957,0.00018230065,0.00018244676,0.00029493563,0.00017899906],"domain_scores_gemma":[0.9990248,0.000518884,0.00007975889,0.00018012787,0.00010815316,0.000088265544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026929905,0.000102734935,0.00020602334,0.0000800487,0.00010586536,0.00001431379,0.000094663854,0.00007363927,0.000077888966],"category_scores_gemma":[0.00039565665,0.00005236101,0.000088973546,0.00008234194,0.000118435826,0.000079507394,0.000038651982,0.000117230775,0.0000017168151],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013338239,0.00018779591,0.04297317,0.0007416625,0.00020667535,0.000015382355,0.0013663867,8.174439e-7,0.93806607,0.000823738,0.0023972518,0.011887263],"study_design_scores_gemma":[0.060191214,0.0013595961,0.3171499,0.013360218,0.003959536,0.00039016997,0.004443029,0.0024898262,0.57414454,0.006929456,0.01471841,0.0008641023],"about_ca_topic_score_codex":0.000012857457,"about_ca_topic_score_gemma":0.0000022187007,"teacher_disagreement_score":0.36392152,"about_ca_system_score_codex":0.000009808584,"about_ca_system_score_gemma":0.0001420159,"threshold_uncertainty_score":0.213522},"labels":[],"label_agreement":null},{"id":"W2595602033","doi":"10.1182/blood.v104.11.124.124","title":"Identification of the Multimerin Binding Region within the C2 Domain of Human Factor V Using Constructs Generated by Alanine-Scanning and Site-Directed Mutagenesis.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Prothrombinase; Alanine scanning; Thrombin; Recombinant DNA; Molecular biology; Binding site; Factor V; Chemistry; Biology; Biochemistry; Mutagenesis; Platelet; Mutant; Immunology","score_opus":0.030197602138935752,"score_gpt":0.2704304697781947,"score_spread":0.24023286763925894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595602033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988586,0.00014132769,0.00036824218,0.00011070291,0.000081501785,0.0003648594,0.000016668047,0.000042224703,0.000015924654],"genre_scores_gemma":[0.99858075,0.000004524715,0.0012810691,0.00003661495,0.000023574199,0.0000039897213,0.000017828166,0.000019211811,0.00003246166],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99902105,0.000086816646,0.00039652846,0.00018049873,0.0002072781,0.000107809734],"domain_scores_gemma":[0.99913114,0.000022689977,0.00043398043,0.00026303314,0.00010722031,0.000041911575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016653958,0.00011783125,0.00022824114,0.00006986747,0.00017340858,0.000015678219,0.0000763072,0.0000772162,0.0000072312714],"category_scores_gemma":[0.00005247473,0.0000777528,0.00004817219,0.00032302423,0.0001327719,0.000047102712,0.000034134682,0.00009010268,5.089036e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009391125,0.00010862862,0.011284676,0.000034311768,0.00008366401,0.0000014322493,0.0011354975,0.00004900298,0.9868282,0.00041377626,0.0000032804048,0.00004815711],"study_design_scores_gemma":[0.0023961724,0.00005339025,0.02337633,0.00015141809,0.00024143732,0.00005232371,0.00038195527,0.00051659136,0.97264373,0.000106058775,0.0000017528502,0.0000788182],"about_ca_topic_score_codex":0.00014233793,"about_ca_topic_score_gemma":0.000017274724,"teacher_disagreement_score":0.01418443,"about_ca_system_score_codex":0.00002136519,"about_ca_system_score_gemma":0.00005815249,"threshold_uncertainty_score":0.3170667},"labels":[],"label_agreement":null},{"id":"W2595611953","doi":"10.1182/blood.v128.22.489.489","title":"Efficacy of Daratumumab, Lenalidomide and Dexamethasone Versus Lenalidomide and Dexamethasone Alone for Relapsed or Refractory Multiple Myeloma Among Patients with 1 to 3 Prior Lines of Therapy Based on Previous Treatment Exposure: Updated Analysis of Pollux","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec; University of British Columbia","funders":"","keywords":"Lenalidomide; Daratumumab; Dexamethasone; Medicine; Internal medicine; Interim analysis; Clinical endpoint; Multiple myeloma; Refractory (planetary science); Gastroenterology; Intention-to-treat analysis; Oncology; Surgery; Randomized controlled trial; Biology","score_opus":0.03217945903125362,"score_gpt":0.29854864507836426,"score_spread":0.26636918604711063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595611953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99537766,0.0005344084,0.0002213008,0.000094108866,0.000025681196,0.0031375464,0.000568191,0.000026526222,0.000014584702],"genre_scores_gemma":[0.98998463,0.0003088089,0.009087414,0.000019086356,0.000025549274,0.00020596298,0.0001943018,0.00005473708,0.00011952838],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974847,0.00021250066,0.0007114018,0.00061747263,0.000571606,0.00040234873],"domain_scores_gemma":[0.995348,0.002608522,0.00049221574,0.0007216481,0.00046771063,0.0003619392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031183878,0.00040470666,0.0014277269,0.0006812509,0.00007489415,0.000011003556,0.00011539306,0.00014460381,0.000046561978],"category_scores_gemma":[0.0013489092,0.00021668912,0.0002234649,0.0007277434,0.00027828084,0.000092985865,0.000036521695,0.00007452821,6.621659e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20202705,0.007649857,0.6721599,0.000134597,0.008771218,0.000027390328,0.0003283685,0.000023424464,0.042828,0.0000015567069,0.000013141974,0.0660355],"study_design_scores_gemma":[0.1780142,0.02123603,0.62184626,0.00033893972,0.0027567395,0.0000010789745,0.000032828953,0.0001624267,0.17539884,6.15987e-7,0.00004230691,0.00016974985],"about_ca_topic_score_codex":0.0003737587,"about_ca_topic_score_gemma":0.0004239816,"teacher_disagreement_score":0.13257085,"about_ca_system_score_codex":0.00008927406,"about_ca_system_score_gemma":0.00017620604,"threshold_uncertainty_score":0.8836326},"labels":[],"label_agreement":null},{"id":"W2595668491","doi":"10.1182/blood.v104.11.4934.4934","title":"Thalidomide +/− Corticosteroids for the Treatment of Multiple Myeloma Patients ≥ 70 Years of Age.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Thalidomide; Prednisone; Gastroenterology; Internal medicine; Lenalidomide; Thrombocytosis; Multiple myeloma; Surgery; Platelet","score_opus":0.031009496680620266,"score_gpt":0.2960436096393507,"score_spread":0.2650341129587305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595668491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99762386,0.0004367286,0.00006950802,0.00007358454,0.000053999658,0.0014919073,0.00012675182,0.0000131731495,0.000110512716],"genre_scores_gemma":[0.99787045,0.00021117461,0.001465692,0.000018036759,0.00004330523,0.00015021469,0.000079348276,0.000019899784,0.00014187912],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990547,0.000017166449,0.00026491092,0.00016017057,0.00027229413,0.00023076416],"domain_scores_gemma":[0.99907875,0.00025516291,0.000100554185,0.00034973552,0.00011333024,0.000102453734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000048112866,0.000114986186,0.00029490542,0.000059680857,0.000038405833,0.000005333628,0.00007961034,0.000046158464,0.000014738462],"category_scores_gemma":[0.00016795628,0.000072865405,0.00018485864,0.000092004346,0.00009461321,0.000025077587,0.000017244236,0.000031935604,0.00000842044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002624694,0.020310704,0.83927673,0.00018984788,0.002100754,0.00014057876,0.0016651433,0.000021049122,0.01749624,0.000068521396,0.000039273622,0.11606643],"study_design_scores_gemma":[0.04821529,0.0048713065,0.8007741,0.00006415689,0.00042698134,0.0000067775954,0.00006777314,0.000020372807,0.14480415,0.00006094628,0.00062510546,0.00006307767],"about_ca_topic_score_codex":0.00028822842,"about_ca_topic_score_gemma":0.000063900814,"teacher_disagreement_score":0.1273079,"about_ca_system_score_codex":0.000055076503,"about_ca_system_score_gemma":0.00007065631,"threshold_uncertainty_score":0.29713652},"labels":[],"label_agreement":null},{"id":"W2595699847","doi":"10.1182/blood.v108.11.3032.3032","title":"Long-Term Follow-Up of Allogeneic Stem Cell Transplantation for Chronic Lymphocytic Leukemia.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Fludarabine; Transplantation; Busulfan; Internal medicine; Chronic lymphocytic leukemia; Cyclophosphamide; Surgery; Gastroenterology; Alemtuzumab; Rituximab; Chemotherapy; Leukemia; Lymphoma","score_opus":0.016587828997562278,"score_gpt":0.26758239290600494,"score_spread":0.25099456390844266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595699847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99290955,0.0031535784,0.0010597049,0.000015966418,0.00015609086,0.0011995482,0.00005610007,0.00008263326,0.0013668296],"genre_scores_gemma":[0.99356383,0.0003563848,0.000326675,0.000031105115,0.00037633558,0.00013602886,0.00025387472,0.00006678939,0.004888955],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979297,0.00003947275,0.0005308049,0.00041988218,0.0005144747,0.0005656471],"domain_scores_gemma":[0.9988618,0.00020071548,0.00014761978,0.0004873416,0.00016685086,0.00013568962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023900124,0.00023768595,0.00047830297,0.00016286406,0.00006895317,0.00001709502,0.0002044391,0.0002010803,0.00007614822],"category_scores_gemma":[0.000011167951,0.00021869327,0.00027053256,0.0002203334,0.00010878951,0.00007531631,0.000027368791,0.000104998166,0.000058896992],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.005896474,0.002274913,0.022961125,0.036134597,0.0013644159,0.0019309984,0.0013851842,0.0026512307,0.89853895,0.00081393344,0.0026109528,0.023437256],"study_design_scores_gemma":[0.16382775,0.00095510675,0.011696408,0.00040667038,0.001311756,0.0006525708,0.000027227197,0.002778549,0.8177506,0.000054588458,0.00022161457,0.000317199],"about_ca_topic_score_codex":0.00056579424,"about_ca_topic_score_gemma":0.00021075644,"teacher_disagreement_score":0.15793127,"about_ca_system_score_codex":0.019437822,"about_ca_system_score_gemma":0.019057972,"threshold_uncertainty_score":0.98650306},"labels":[],"label_agreement":null},{"id":"W2595729270","doi":"10.1182/blood.v120.21.3267.3267","title":"Diverse Immunophenotypic Abnormalities in Adult Patients with Hemophagocytic Lymphohistiocytosis","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Vancouver General Hospital","funders":"","keywords":"Hemophagocytosis; Hemophagocytic lymphohistiocytosis; Pancytopenia; Medicine; Immunophenotyping; Histiocyte; Gastroenterology; Cytopenia; Immunology; Internal medicine; Pathology; Pediatrics; Bone marrow; Flow cytometry; Disease","score_opus":0.009514473787835397,"score_gpt":0.23301113928569714,"score_spread":0.22349666549786174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595729270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935738,0.00089337793,0.0000040143773,0.000031744257,0.00005226509,0.0003180439,0.000006500047,0.000040879877,0.005079374],"genre_scores_gemma":[0.9987534,0.000062006104,0.00013045881,0.00016681575,0.000045892124,0.000042237505,0.000038940463,0.00002312065,0.0007371258],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987756,0.000039127517,0.00023826907,0.00013708886,0.00034888758,0.0004610094],"domain_scores_gemma":[0.9993975,0.000026850983,0.000053756925,0.00028251397,0.00012955627,0.000109834284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012543044,0.00014163391,0.00025690199,0.00014727181,0.00007885498,0.000012282692,0.00009047503,0.00006932901,0.00027465614],"category_scores_gemma":[0.000078261575,0.00011147044,0.000047120946,0.00021637003,0.00009391829,0.0002695784,0.000059468115,0.00014860056,0.00019279716],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003132566,0.0013839403,0.99460536,0.00012177216,0.00007794342,0.00001591958,0.0010409863,0.000001186885,0.00012256824,0.00023666033,0.00007781177,0.0020025645],"study_design_scores_gemma":[0.012218246,0.0002619195,0.98372966,0.00010769998,0.00009299477,0.0000117665495,0.0011427422,0.000008065875,0.0017290384,0.000007075002,0.00053090183,0.000159905],"about_ca_topic_score_codex":0.00020593191,"about_ca_topic_score_gemma":0.000011591573,"teacher_disagreement_score":0.011904989,"about_ca_system_score_codex":0.000090752816,"about_ca_system_score_gemma":0.00012561408,"threshold_uncertainty_score":0.45456326},"labels":[],"label_agreement":null},{"id":"W2595747511","doi":"10.1182/blood.v128.22.3909.3909","title":"Aplastic Anemia in Pregnancy - a Single Centre, North American Case Series","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Medicine; Pregnancy; Medical record; Pediatrics; Anemia; Obstetrics; Aplastic anemia; Surgery; Bone marrow; Internal medicine","score_opus":0.012419859485490575,"score_gpt":0.2277077158433066,"score_spread":0.21528785635781603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595747511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99801946,0.000073138646,0.00013961311,0.0002671626,0.00004110477,0.00024233495,0.000021495209,0.00005670359,0.0011390013],"genre_scores_gemma":[0.99850035,0.00004305306,0.00087959185,0.000029036451,0.0000345335,0.000013790993,0.000009020906,0.00001816113,0.00047249053],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992382,0.000027679687,0.00019574692,0.00019100003,0.00012485487,0.00022254806],"domain_scores_gemma":[0.9995388,0.000104691,0.00005088056,0.00017617388,0.000028457009,0.00010104423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000025874198,0.00010519245,0.00019045826,0.00007272844,0.000019583362,0.000005750313,0.00003117873,0.000026534808,0.00007326369],"category_scores_gemma":[0.000058115813,0.00007387854,0.000027946264,0.0002126698,0.00007189613,0.00006371163,0.000007281133,0.000050181916,0.00006732898],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010781226,0.00081606687,0.9534687,0.0003898248,0.000031471624,0.020066584,0.0011444143,5.145383e-7,0.016120225,0.000044062926,0.000028712706,0.0077816043],"study_design_scores_gemma":[0.029683024,0.0026652273,0.6603511,0.007609055,0.0011507533,0.07680667,0.0014475177,0.000013782096,0.21839869,0.00007404161,0.0007987248,0.0010013904],"about_ca_topic_score_codex":0.000050602637,"about_ca_topic_score_gemma":0.0015295327,"teacher_disagreement_score":0.29311758,"about_ca_system_score_codex":0.000026256039,"about_ca_system_score_gemma":0.000042961197,"threshold_uncertainty_score":0.30126795},"labels":[],"label_agreement":null},{"id":"W2595753835","doi":"10.1182/blood.v124.21.2447.2447","title":"Contribution of Chemotherapy Mobilization to Disease Control in Multiple Myeloma Treated with Autologous Transplantation","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Multiple myeloma; Lenalidomide; Internal medicine; Melphalan; Thalidomide; Transplantation; Mucositis; Regimen; Plerixafor; Cyclophosphamide; Chemotherapy; Surgery; Oncology; Clinical endpoint; Chemotherapy regimen; Gastroenterology; Randomized controlled trial","score_opus":0.008578086463383719,"score_gpt":0.2565454628737735,"score_spread":0.2479673764103898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595753835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911395,0.00003831225,0.0071997955,0.000283854,0.000005903357,0.0011830248,0.000045666937,0.000039187813,0.000064760105],"genre_scores_gemma":[0.9990983,0.000022660277,0.00033237858,0.0001026849,0.000018001327,0.00012549883,0.00026342357,0.000013604333,0.000023430104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99917465,0.00007225505,0.00017769495,0.0001863902,0.00019731432,0.00019169241],"domain_scores_gemma":[0.9993882,0.00009237174,0.000046266327,0.00015452554,0.00013539504,0.0001832087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000995146,0.000104761544,0.0002362563,0.00013454912,0.000025797159,0.000005233825,0.00003307226,0.00004399277,0.000017220404],"category_scores_gemma":[0.0001476503,0.00007800627,0.00003347859,0.00020741118,0.000031055133,0.00004171891,0.0000020899222,0.00004494773,0.0000073841084],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071339305,0.001261069,0.9573347,0.00007396577,0.00009576996,0.00007146157,0.00010536978,0.0001138738,0.02866024,0.00004514109,0.0000034412449,0.005101063],"study_design_scores_gemma":[0.03927844,0.0010450095,0.9072387,0.000111457324,0.00013752602,0.000012595717,0.000007641351,0.006257577,0.04580626,0.00001200333,0.000024372217,0.00006841461],"about_ca_topic_score_codex":0.00011981114,"about_ca_topic_score_gemma":0.00014343284,"teacher_disagreement_score":0.050095968,"about_ca_system_score_codex":0.000032657343,"about_ca_system_score_gemma":0.000046563433,"threshold_uncertainty_score":0.31810033},"labels":[],"label_agreement":null},{"id":"W2595755981","doi":"10.1182/blood.v110.11.3280.3280","title":"Anti-Chronic Graft Versus Host Disease Activity Though a Regulatory T Cell Dependent Mechanism after Photodynamic Therapy.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"FOXP3; IL-2 receptor; Graft-versus-host disease; Medicine; Immunology; Hematopoietic stem cell transplantation; Transplantation; Photopheresis; Context (archaeology); Regulatory T cell; Photodynamic therapy; T cell; Cancer research; Internal medicine; Biology; Immune system; Lymphoma; Chemistry","score_opus":0.012374906292125098,"score_gpt":0.2815508700487828,"score_spread":0.2691759637566577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595755981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99160033,0.0055015306,0.00012832372,0.00018186937,0.00034522903,0.0012527481,0.00006525931,0.0002015529,0.0007231458],"genre_scores_gemma":[0.99637705,0.0018251339,0.00008505584,0.00014480068,0.00030724824,0.00014111065,0.000014285305,0.00008708397,0.0010182221],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971756,0.00009751018,0.00027507375,0.0006459215,0.0008861855,0.0009197297],"domain_scores_gemma":[0.99820465,0.0001689674,0.00010845874,0.0009004528,0.00010944965,0.00050801045],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00059867545,0.00039796202,0.00048734492,0.00021870364,0.00017393297,0.000030643158,0.00023541067,0.00014251986,0.00021440355],"category_scores_gemma":[0.00005168625,0.00033864428,0.00027286273,0.00027491074,0.00018378948,0.00013780191,0.00016769575,0.00047967723,0.000063766725],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008806412,0.0025243165,0.0016104142,0.00017782052,0.00060857256,0.0015341353,0.00022895118,0.0000011889452,0.9831201,0.000038373448,0.000029783876,0.0013199638],"study_design_scores_gemma":[0.024031736,0.001650474,0.31327787,0.0001281118,0.00038605768,0.00003606104,0.000099771954,0.00008187242,0.6591205,0.00015297644,0.00050188316,0.00053267996],"about_ca_topic_score_codex":0.00009331363,"about_ca_topic_score_gemma":0.0002384552,"teacher_disagreement_score":0.32399958,"about_ca_system_score_codex":0.00036218233,"about_ca_system_score_gemma":0.0003809609,"threshold_uncertainty_score":0.99990654},"labels":[],"label_agreement":null},{"id":"W2595836238","doi":"10.1182/blood.v108.11.1717.1717","title":"Plasmin-Mediated Coagulation Factor Xa Derivative, Xa33/13, Enhances Plasminogen Activation and Fibrin Clot Lysis.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of British Columbia","funders":"","keywords":"Plasmin; Fibrin; Fibrinolysis; Chemistry; Thrombin; Coagulation; Lysis; Tissue plasminogen activator; Plasminogen activator; Molecular biology; Chromogenic; Biochemistry; Platelet; Immunology; Biology; Enzyme; Medicine; Internal medicine; Endocrinology; Chromatography","score_opus":0.0184854912947644,"score_gpt":0.24727478517877882,"score_spread":0.22878929388401442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595836238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949094,0.00013470143,0.0022469894,0.00033269436,0.000090468944,0.00045805462,0.000025744272,0.00017741455,0.0016245395],"genre_scores_gemma":[0.9974954,0.000025686908,0.0012991758,0.00019569448,0.0001737818,0.00003114094,0.00031064538,0.000033530207,0.00043493454],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985371,0.000056317273,0.00038302632,0.00038760185,0.0003748755,0.00026104072],"domain_scores_gemma":[0.9991986,0.00015897916,0.00020359953,0.00021555665,0.00012324002,0.000100037665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000947101,0.00023745162,0.000370663,0.00018520169,0.00013707619,0.000046309626,0.00005890129,0.00017987478,0.00024019147],"category_scores_gemma":[0.00009848526,0.00022140182,0.00007099278,0.0003119983,0.000061436636,0.00022741614,0.00003535785,0.00012970106,0.00005176569],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008654911,0.000595117,0.039532837,0.000070182876,0.00017010017,0.000005452931,0.00023494034,0.000011090614,0.95625377,0.0009080836,0.00019453879,0.0019373426],"study_design_scores_gemma":[0.0029197913,0.0001856954,0.36575478,0.000064973516,0.00015297417,0.000013904203,0.00006012483,0.00043814976,0.629004,0.00036166806,0.00086664484,0.00017728745],"about_ca_topic_score_codex":0.00010718398,"about_ca_topic_score_gemma":0.00005235685,"teacher_disagreement_score":0.32724977,"about_ca_system_score_codex":0.00002919147,"about_ca_system_score_gemma":0.00005845533,"threshold_uncertainty_score":0.9028504},"labels":[],"label_agreement":null},{"id":"W2595865619","doi":"10.1182/blood.v128.22.719.719","title":"Antiphospholipid Syndrome (APS) Patient Plasmas Consistently Activate Complement: A Novel Approach to Detecting a Pathogenic Mechanism for APS","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Complement system; Antiphospholipid syndrome; Alternative complement pathway; Lupus anticoagulant; Complement membrane attack complex; Immunology; Immune system; Systemic lupus erythematosus; Medicine; Thrombosis; Venous thrombosis; Factor H; Complement (music); Antibody; Internal medicine; Biology; Disease; Biochemistry; Gene; Phenotype","score_opus":0.04161488049643803,"score_gpt":0.2723220952765087,"score_spread":0.23070721478007067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595865619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97730815,0.000054723136,0.016966911,0.00028516463,0.00022659906,0.003782075,0.00024103533,0.00014165751,0.0009936531],"genre_scores_gemma":[0.98371375,0.0000068477398,0.014453482,0.00021309231,0.00010065093,0.00092096435,0.000021709964,0.000101356396,0.00046812074],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969836,0.00006242646,0.0006204335,0.000734889,0.0007167103,0.00088193757],"domain_scores_gemma":[0.9980396,0.00030684652,0.00019819554,0.0006942894,0.0003321417,0.00042893624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005253835,0.00032236648,0.0006553947,0.0002530301,0.00018264049,0.000037674155,0.00024077129,0.0001382084,0.00004149784],"category_scores_gemma":[0.00054580654,0.00022427358,0.00024597667,0.00031117685,0.000048132344,0.0000758313,0.0002207034,0.00015063555,0.00009935855],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046499993,0.0016877605,0.0045806635,0.00084189,0.0006483282,0.00007119101,0.0013155348,6.887293e-7,0.9856544,0.0029432052,0.0002282006,0.0015631363],"study_design_scores_gemma":[0.049024396,0.0046394323,0.0007683318,0.0032027394,0.00080232846,0.058014363,0.0041019865,0.0004825185,0.87419736,0.00052247616,0.0030830393,0.0011610544],"about_ca_topic_score_codex":0.000022750663,"about_ca_topic_score_gemma":0.0000050663734,"teacher_disagreement_score":0.111457065,"about_ca_system_score_codex":0.00018240348,"about_ca_system_score_gemma":0.00018022725,"threshold_uncertainty_score":0.91456115},"labels":[],"label_agreement":null},{"id":"W2595917680","doi":"10.1182/blood.v128.22.2271.2271","title":"High-Risk Cytogenetics Multiple Myeloma: Impact of Consolidation and Maintenance","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; Institute of Cancer Research; University of Calgary","funders":"","keywords":"Medicine; Bortezomib; Multiple myeloma; Exact test; Internal medicine; Log-rank test; Oncology; Surgery; Survival analysis","score_opus":0.017593901825313108,"score_gpt":0.28892524358829946,"score_spread":0.27133134176298634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595917680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99882597,0.00020811298,0.00024167966,0.000088276814,0.000015719044,0.0002831947,0.00017965729,0.000018907209,0.00013849325],"genre_scores_gemma":[0.99692416,0.00060700974,0.0021733125,0.0000062299755,0.000042115294,0.000012937391,0.000015365711,0.000012931416,0.00020595436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992672,0.000035459674,0.00015577966,0.0001646957,0.00016103822,0.00021581752],"domain_scores_gemma":[0.99926656,0.00015670313,0.00007874792,0.00022162576,0.00011167466,0.00016471179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000828039,0.00009931375,0.00019803482,0.00006427752,0.000032464723,0.000005187585,0.000036760142,0.000048706686,0.000064862325],"category_scores_gemma":[0.00046325417,0.00005416483,0.00006321823,0.000067166024,0.00010571266,0.00003758315,0.000032328535,0.00004490761,0.00002377438],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026142213,0.00034175056,0.9052766,0.000021367961,0.00027721483,0.000035165835,0.000027141637,4.300887e-7,0.07178026,0.000028812605,0.00007857806,0.02187127],"study_design_scores_gemma":[0.013242941,0.00079031417,0.8526289,0.000075293734,0.00011129095,0.000051234725,0.000007808058,0.000029586743,0.13288328,0.00008772057,0.000035977522,0.00005568692],"about_ca_topic_score_codex":0.00029609198,"about_ca_topic_score_gemma":0.00002827789,"teacher_disagreement_score":0.061103016,"about_ca_system_score_codex":0.000029307304,"about_ca_system_score_gemma":0.00007378644,"threshold_uncertainty_score":0.22087777},"labels":[],"label_agreement":null},{"id":"W2595919366","doi":"10.1182/blood.v118.21.3369.3369","title":"Age of Blood Does Not Affect Quality of Life and Hemoglobin: N– of −1 Trials in Transfusion-Dependent Patients,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Hospital; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Blood transfusion; Hemoglobin; Anemia; Quality of life (healthcare); Adverse effect; Visual analogue scale; Surgery; Internal medicine; Nursing","score_opus":0.056967087771621495,"score_gpt":0.29339812947785593,"score_spread":0.23643104170623444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595919366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963428,0.00026221832,0.000037224207,0.000082878476,0.00009264357,0.0011756037,0.00007716165,0.00001535178,0.0019141182],"genre_scores_gemma":[0.99844235,0.0007434916,0.00058907986,0.00010188329,0.00001732209,0.000020065505,0.000011934301,0.000014033647,0.000059820813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975196,0.00034158325,0.0013054489,0.00025640885,0.00041542482,0.00016151693],"domain_scores_gemma":[0.9988802,0.00022572701,0.00035234104,0.00033669366,0.00008858781,0.000116427014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018839713,0.00015939557,0.0012326564,0.00019446909,0.000013611762,0.000002113609,0.00009991602,0.000105259634,0.00020310044],"category_scores_gemma":[0.0004814405,0.00011051345,0.00021377877,0.00015793448,0.00010394593,0.00004060736,0.00004433108,0.00010818062,6.6587376e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002471231,0.017220182,0.6777379,0.0032869063,0.00089908775,0.000028429567,0.003780488,2.1237081e-7,0.29018658,0.0012996488,0.000016625128,0.0030727065],"study_design_scores_gemma":[0.025464593,0.0009613897,0.56924,0.00020911821,0.0009190962,0.000001156699,0.00027488996,3.130761e-7,0.40271604,0.000091961694,0.00001708065,0.00010441177],"about_ca_topic_score_codex":0.0014537168,"about_ca_topic_score_gemma":0.0006126702,"teacher_disagreement_score":0.112529464,"about_ca_system_score_codex":0.000003468842,"about_ca_system_score_gemma":0.000045991303,"threshold_uncertainty_score":0.45066077},"labels":[],"label_agreement":null},{"id":"W2595988118","doi":"10.1182/blood.v128.22.4632.4632","title":"Myeloma Canada Research Network (MCRN)-001 ASCT Study of Busulfan + Melphalan (BuMel) Conditioning Followed By Lenalidomide (Len) Maintenance: Updated Results Including Serial Minimal Residual Disease (MRD) and Involved Serum Hevylite™ Chain (HLC) Ratio Assessments","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Hôpital Maisonneuve-Rosemont; Université de Montréal; Leukemia & Lymphoma Society of Canada; University of British Columbia; McGill University Health Centre; Saint John Regional Hospital; Ottawa Hospital; Saskatchewan Cancer Agency; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Melphalan; Minimal residual disease; Lenalidomide; Busulfan; Multiple myeloma; Internal medicine; Maintenance therapy; Autologous stem-cell transplantation; Oncology; Thalidomide; Surgery; Urology; Bone marrow; Transplantation; Hematopoietic stem cell transplantation; Chemotherapy","score_opus":0.045154314947404496,"score_gpt":0.3399590849051596,"score_spread":0.29480476995775506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595988118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938976,0.00032683287,0.000008259744,0.0013713656,0.00017681894,0.0022432217,0.0016072632,0.0000613145,0.0003072856],"genre_scores_gemma":[0.99564296,0.00008753801,0.00023424269,0.00007247884,0.00044060376,0.00022197311,0.00134227,0.00007179128,0.0018861716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9935061,0.0011380628,0.0009970472,0.0009910192,0.0018884762,0.001479302],"domain_scores_gemma":[0.9964106,0.00079241314,0.0003248651,0.0007533526,0.00066995,0.0010488257],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00219232,0.00043965204,0.000806024,0.0002600347,0.0006953191,0.00010223443,0.0003045942,0.00014359756,0.00012342936],"category_scores_gemma":[0.0014438701,0.00032496944,0.000076108205,0.0006354877,0.00024904267,0.0003054427,0.00044686112,0.00042158415,0.0000065584186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037579697,0.007243083,0.81753314,0.0003297985,0.0037811534,0.004775754,0.00081093435,0.0000157515,0.045253593,0.00014220315,0.079117924,0.0034169545],"study_design_scores_gemma":[0.17457433,0.0054155192,0.7948168,0.0015637194,0.00079792255,0.000043702017,0.0037536363,0.0003174985,0.016126784,0.00014322119,0.0016504382,0.00079641526],"about_ca_topic_score_codex":0.059739713,"about_ca_topic_score_gemma":0.13114505,"teacher_disagreement_score":0.13699463,"about_ca_system_score_codex":0.00041781488,"about_ca_system_score_gemma":0.0017170757,"threshold_uncertainty_score":0.99992025},"labels":[],"label_agreement":null},{"id":"W2595998300","doi":"10.1182/blood.v120.21.28.28","title":"Time Course Studies of the Progeny of Barcoded CD34+ Human Cord Blood Cells Generated in Transplanted NOD/SCID-IL2Rγ−/− Mice Unveil the Clonal Dynamics of Short Term, Intermediate Term and Long Term Repopulating Cells","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Biology; Haematopoiesis; clone (Java method); Stem cell; Nod; Cord blood; CD34; Immunology; Bone marrow; Transplantation; Cell biology; Molecular biology; In vivo; Andrology; Genetics; Gene; Internal medicine; Medicine","score_opus":0.037029084851994576,"score_gpt":0.32264365911821047,"score_spread":0.2856145742662159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595998300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969698,0.0012047136,0.0000025633008,0.00005037889,0.00011228501,0.001313458,0.00011005939,0.000017529286,0.0002191713],"genre_scores_gemma":[0.99914944,0.00017522601,0.00012637934,0.00001878791,0.00009432924,0.00003058364,0.00005438718,0.000045902696,0.00030497063],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969264,0.00033832827,0.0010959954,0.00035378095,0.00072357134,0.0005619246],"domain_scores_gemma":[0.99825805,0.00028973084,0.0004258444,0.0005981209,0.0002772363,0.00015104115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012262,0.00030759952,0.0008069685,0.0001467992,0.00011317241,0.000011861995,0.00039006086,0.00015723344,0.00003313102],"category_scores_gemma":[0.00009500674,0.00019085662,0.00015682161,0.00039964356,0.00081730535,0.00008141906,0.00023119162,0.00044331027,0.0000015493926],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011276162,0.00088948023,0.4205691,0.00087721326,0.00036232537,0.000039012615,0.0015049798,0.0000027375115,0.5753224,0.0000046555165,0.000005682771,0.00030964342],"study_design_scores_gemma":[0.0022091463,0.0003499319,0.40208635,0.0010308038,0.0007500372,0.00009288127,0.0002827423,0.0003757414,0.59267765,0.000002726631,6.640652e-7,0.0001413638],"about_ca_topic_score_codex":0.00007628707,"about_ca_topic_score_gemma":0.00025624485,"teacher_disagreement_score":0.018482763,"about_ca_system_score_codex":0.000043179163,"about_ca_system_score_gemma":0.00013051095,"threshold_uncertainty_score":0.7782907},"labels":[],"label_agreement":null},{"id":"W2596013139","doi":"10.1182/blood.v106.11.3835.3835","title":"Pregnancy in Thalassemia Patients and Their Partners in a Canadian Population.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network","funders":"","keywords":"Thalassemia; Medicine; Pregnancy; Pediatrics; Population; Beta thalassemia; Intermedia; Incidence (geometry); Obstetrics; Internal medicine; Environmental health","score_opus":0.006318459640186759,"score_gpt":0.23356918223024947,"score_spread":0.2272507225900627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596013139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99243975,0.0016517984,1.149064e-7,0.00065149565,0.000020590822,0.00022741784,0.0000036721833,0.000009693943,0.004995497],"genre_scores_gemma":[0.9993841,0.00021058263,0.000041124968,0.00020716136,0.000012118015,0.000009931694,0.000025189738,0.000008514998,0.00010126008],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994461,0.000013900342,0.00013816475,0.000121892066,0.000049542457,0.00023040514],"domain_scores_gemma":[0.9997405,0.000008773231,0.000017368186,0.00007762221,0.000010882107,0.00014485882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004199028,0.000072409035,0.000114327835,0.000139391,0.000020351465,0.0000052629757,0.000022425635,0.00009425057,0.000017844874],"category_scores_gemma":[0.000038424594,0.00005659247,0.000015557134,0.00014991159,0.000012661861,0.00004378517,0.0000074316686,0.00011748027,0.000005810351],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004284563,0.00018501002,0.9852584,0.000015157773,0.000006964875,0.000014375007,0.0006459597,0.0000092887,0.000014658459,0.000032041076,0.00004860433,0.013765232],"study_design_scores_gemma":[0.0034788626,0.000049631224,0.9941242,0.00031754206,0.000011480691,0.0000065916392,0.00015306528,0.00016779137,0.000061055165,0.000038088107,0.0015169816,0.00007474722],"about_ca_topic_score_codex":0.071183816,"about_ca_topic_score_gemma":0.33536947,"teacher_disagreement_score":0.26418564,"about_ca_system_score_codex":0.000058026664,"about_ca_system_score_gemma":0.000074133284,"threshold_uncertainty_score":0.93500125},"labels":[],"label_agreement":null},{"id":"W2596014825","doi":"10.1182/blood.v120.21.4641.4641","title":"Use of Intravenous Immune Globulin in Patients with Immune Thrombocytopenia Before and After Romiplostim: Real-World Experience","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Windsor; Centre Hospitalier de l’Université de Montréal; Victoria Hospital; Western University; Hamilton Health Sciences; Hôpital Notre-Dame; London Health Sciences Centre; McMaster University","funders":"","keywords":"Romiplostim; Medicine; Interquartile range; Thrombopoietin; Immune thrombocytopenia; Internal medicine; Platelet; Pediatrics","score_opus":0.010571664412557505,"score_gpt":0.23645953999471678,"score_spread":0.22588787558215928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596014825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988098,0.000428637,9.037724e-7,0.000024355084,0.00002861023,0.00045066516,0.000019777872,0.000013433516,0.00022379146],"genre_scores_gemma":[0.99895084,0.0000644178,0.00074230955,0.000029374454,0.00001223717,0.00003477877,0.000042709333,0.00002040807,0.000102931466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911535,0.000017224324,0.00025706727,0.00016358665,0.0001655019,0.00028128363],"domain_scores_gemma":[0.99951255,0.000017655597,0.000082716746,0.00025476818,0.00003895364,0.00009334414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000041424977,0.00015588301,0.00045089293,0.000082406055,0.000024586478,0.000009526859,0.00004312491,0.000051318453,0.000054361688],"category_scores_gemma":[0.000015674776,0.00011176687,0.000028806628,0.00017539214,0.00008589721,0.00022193116,0.00004949582,0.00008691323,0.000006530362],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006043569,0.0029310859,0.99242526,0.00003365177,0.000109615445,0.00008440808,0.002231469,1.8532107e-7,0.00032687,0.0000146026705,0.0000015848752,0.001236899],"study_design_scores_gemma":[0.0065599545,0.0007204303,0.98876494,0.00017572992,0.00015369958,0.00001921893,0.0000653957,0.0000016197251,0.0034005502,0.000008940762,0.000027661612,0.000101828016],"about_ca_topic_score_codex":0.0007718999,"about_ca_topic_score_gemma":0.0003556675,"teacher_disagreement_score":0.0059555974,"about_ca_system_score_codex":0.000024277057,"about_ca_system_score_gemma":0.000022880678,"threshold_uncertainty_score":0.45577207},"labels":[],"label_agreement":null},{"id":"W2596141944","doi":"10.1182/blood.v126.23.1192.1192","title":"Vitamin K2 Supports Hematopoiesis through Acting on Bone Marrow Mesenchymal Stromal/Stem Cells","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Bone and Joint Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CD34; Bone marrow; Haematopoiesis; Mesenchymal stem cell; Stem cell; Vitamin K2; Stromal cell; Cancer research; Transplantation; Leukemia; Medicine; Immunology; Biology; Internal medicine; Pathology; Vitamin; Cell biology","score_opus":0.02966513296850029,"score_gpt":0.26472186592467256,"score_spread":0.23505673295617227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596141944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9777293,0.000373723,0.000017103212,0.0009955069,0.00021646186,0.00028410897,0.000025066754,0.00016084687,0.020197833],"genre_scores_gemma":[0.9939731,0.000015249641,0.0010094017,0.0006505783,0.00033088587,0.000019614363,0.000021192085,0.000043013217,0.0039369855],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984226,0.00004738603,0.00031833435,0.00034393123,0.00047203506,0.00039568587],"domain_scores_gemma":[0.9989295,0.00007766471,0.0001190561,0.00044431948,0.0000832165,0.00034622132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019010632,0.00021926872,0.00043251042,0.00006793191,0.000064171385,0.000028930715,0.000065850574,0.000110483175,0.00021460222],"category_scores_gemma":[0.000066456036,0.00018776025,0.00015952793,0.00015063085,0.000046209625,0.0001463049,0.000056133766,0.0001760601,0.0002948763],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023853132,0.02094738,0.12319403,0.0025986927,0.0019442001,0.023368038,0.01172563,0.000020359024,0.3160933,0.0023418446,0.48225555,0.01312564],"study_design_scores_gemma":[0.011581761,0.0019502568,0.0047675236,0.00073540444,0.0014226589,0.00078140636,0.006858517,0.000024938117,0.9487734,0.00036596492,0.022012146,0.00072605844],"about_ca_topic_score_codex":0.0000523188,"about_ca_topic_score_gemma":0.0000062022477,"teacher_disagreement_score":0.63268006,"about_ca_system_score_codex":0.000035070243,"about_ca_system_score_gemma":0.0001715265,"threshold_uncertainty_score":0.76566404},"labels":[],"label_agreement":null},{"id":"W2596168750","doi":"10.1182/blood.v128.22.1126.1126","title":"Exploring the Potential of JAK1/2 Inhibitor Ruxolitinib with Reduced Intensity Hematopoietic Cell Transplantation (HCT) for Myelofibrosis: Stage I Results of a Prospective Trial Conducted through the Myeloproliferative Disorders - Research Consortium (MPD-RC)","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Internal medicine; Transplantation; Fludarabine; Regimen; Hematopoietic stem cell transplantation; Clinical trial; Surgery; Busulfan; Gastroenterology; Oncology; Bone marrow; Chemotherapy; Cyclophosphamide","score_opus":0.07615313580450668,"score_gpt":0.31191312948285355,"score_spread":0.23575999367834688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596168750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98835003,0.000105289626,0.00022581928,0.0032725225,0.00015974358,0.0067951824,0.0005206533,0.000033768985,0.00053700624],"genre_scores_gemma":[0.9959029,0.0004040966,0.0005630201,0.00003360309,0.00022689381,0.0025287012,0.000054472253,0.000042034637,0.00024429648],"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970229,0.00036500668,0.000802648,0.00057653413,0.00076566846,0.0004672239],"domain_scores_gemma":[0.99645615,0.0012898594,0.00041407332,0.0005287879,0.0012181838,0.00009296076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078506884,0.00030935477,0.00067569537,0.000106090134,0.00033868907,0.000028488348,0.00016925455,0.00009349929,0.00001654658],"category_scores_gemma":[0.0004830911,0.00013817598,0.00019972798,0.00040007732,0.00080850086,0.00023492947,0.000044611184,0.00026884902,0.0000030144422],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5380516,0.012036301,0.010472864,0.0019126219,0.0035152175,0.000080830294,0.07888095,0.000026107906,0.3443118,0.008481719,0.0006094703,0.0016204881],"study_design_scores_gemma":[0.10511736,0.007437999,0.023503521,0.0007118855,0.0007531102,0.000028837034,0.0077786217,0.0000035236442,0.8538784,0.00052966154,0.00007893228,0.00017818209],"about_ca_topic_score_codex":0.00018931314,"about_ca_topic_score_gemma":0.00013443247,"teacher_disagreement_score":0.50956655,"about_ca_system_score_codex":0.00006913137,"about_ca_system_score_gemma":0.0004370792,"threshold_uncertainty_score":0.5634653},"labels":[],"label_agreement":null},{"id":"W2596175104","doi":"10.1182/blood.v126.23.87.87","title":"Discovery and Functional Validation of Novel Pediatric Specific FLT3 Activating Mutations in Acute Myeloid Leukemia: Results from the COG/NCI Target Initiative","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Missense mutation; Mutation; Cog; Biology; Myeloid leukemia; Exome sequencing; Exome; Point mutation; Genetics; Cancer research; Fms-Like Tyrosine Kinase 3; Leukemia; Gene; Oncology; Medicine","score_opus":0.06235173547707459,"score_gpt":0.28867605802401364,"score_spread":0.22632432254693904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596175104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947808,0.0002876147,0.0014635532,0.00095426023,0.00009619888,0.00046084978,0.00065233855,0.00002329859,0.0012811088],"genre_scores_gemma":[0.9938629,0.00014299095,0.0040489365,0.00009309156,0.00058817514,0.000035052628,0.0010656796,0.00002410187,0.0001390661],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982841,0.00010930607,0.00046192703,0.00034219655,0.00056896394,0.00023351691],"domain_scores_gemma":[0.997943,0.001177488,0.0002232249,0.00027459816,0.00027747313,0.00010422327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006151976,0.00015623285,0.0002669006,0.0001864644,0.00008472021,0.0000421472,0.0001017459,0.00011903113,0.000013124198],"category_scores_gemma":[0.001361608,0.00011763987,0.000047619593,0.00062195695,0.00012534326,0.00041368586,0.00011745592,0.0004930567,0.000009940749],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010877468,0.0047375355,0.62631536,0.00022186113,0.0022548868,0.00039255084,0.043219402,0.003256324,0.280982,0.0015711482,0.024028849,0.0021426314],"study_design_scores_gemma":[0.046171155,0.00053283176,0.8377934,0.00014462165,0.0005717711,0.00010177256,0.006798919,0.0016468429,0.10442686,0.0009667209,0.00046813622,0.0003769802],"about_ca_topic_score_codex":0.0002777799,"about_ca_topic_score_gemma":0.000015843114,"teacher_disagreement_score":0.21147804,"about_ca_system_score_codex":0.00027224654,"about_ca_system_score_gemma":0.0011094097,"threshold_uncertainty_score":0.4797215},"labels":[],"label_agreement":null},{"id":"W2596214817","doi":"10.1182/blood.v128.22.663.663","title":"Fludarabine and Busulfan Plus Low Dose TBI Versus Cyclophosphamide Plus TBI in Allogeneic Hematopoietic Cell Transplantation for Adult Acute Lymphoblastic Leukemia: Equivalent Outcomes in a Recent, Large Canadian Multicenter Cohort","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; CancerCare Manitoba; BC Cancer Agency; Foothills Medical Centre; University of Manitoba","funders":"","keywords":"Busulfan; Medicine; Total body irradiation; Regimen; Fludarabine; Transplantation; Cyclophosphamide; Internal medicine; Hematopoietic stem cell transplantation; Oncology; Surgery; Chemotherapy","score_opus":0.011206218686523299,"score_gpt":0.2672239615402363,"score_spread":0.25601774285371304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596214817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99394125,0.000328394,0.00046669302,0.0013697689,0.00030223187,0.0026725116,0.0005279158,0.000056043187,0.00033519912],"genre_scores_gemma":[0.99448884,0.0027921288,0.0007640308,0.00057680736,0.00008246481,0.0004919609,0.00017689049,0.000098817996,0.0005280404],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99626344,0.00009796948,0.0008087461,0.0008436929,0.00056457,0.0014215629],"domain_scores_gemma":[0.9976381,0.00074864586,0.00014240402,0.00048134392,0.0002776422,0.00071182987],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045892104,0.00048176353,0.0008507193,0.0005568235,0.00010445209,0.0000360027,0.00026021135,0.00035367033,0.00008551874],"category_scores_gemma":[0.0006299038,0.00036842024,0.00013141602,0.00040571878,0.00013488784,0.00017009812,0.00007443461,0.00025348188,0.000049950162],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020531626,0.0018995843,0.9241919,0.0031680614,0.0013675254,0.0070029753,0.003766097,0.00015348812,0.034052666,0.00020003402,0.00067157776,0.002994498],"study_design_scores_gemma":[0.3766609,0.0014924412,0.5839553,0.0019633053,0.001802876,0.0004321899,0.0005116993,0.004099908,0.027356712,0.000068054294,0.00046665466,0.0011899498],"about_ca_topic_score_codex":0.011572608,"about_ca_topic_score_gemma":0.07971701,"teacher_disagreement_score":0.3561293,"about_ca_system_score_codex":0.005069157,"about_ca_system_score_gemma":0.0031510228,"threshold_uncertainty_score":0.9998768},"labels":[],"label_agreement":null},{"id":"W2596269791","doi":"10.1182/blood.v106.11.3712.3712","title":"Initial Screening Transferrin Saturation Values, Serum Ferritin Concentrations, and HFE Genotypes in Native Americans and Whites in the Hemochromatosis and Iron Overload Screening (HEIRS) Study.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Transferrin saturation; Hemochromatosis; Hereditary hemochromatosis; Internal medicine; Medicine; Genotype; Ferritin; Transferrin; Endocrinology; Gastroenterology; Serum ferritin; Biology; Genetics","score_opus":0.017623076569537894,"score_gpt":0.2815664372856434,"score_spread":0.2639433607161055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596269791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929974,0.0045366734,0.00021737115,0.0011846465,0.0000110744595,0.000680343,0.000020124782,0.0000200001,0.00033234863],"genre_scores_gemma":[0.9965791,0.0004976908,0.0022534907,0.0005188505,0.00007936415,0.000028887607,0.000021096534,0.000012797557,0.000008728543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988714,0.00018417073,0.00025904167,0.00027029568,0.00020758892,0.00020752203],"domain_scores_gemma":[0.99964815,0.00012569127,0.00004339731,0.000100645324,0.000022770877,0.00005932965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029745683,0.00015889578,0.00025685423,0.00012417237,0.00012517194,0.000060036542,0.000043797576,0.00005829299,0.000012391979],"category_scores_gemma":[0.00007466402,0.00012883008,0.000018045346,0.00020941475,0.00013112965,0.00021842725,0.000019906629,0.0001991721,3.38936e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028101803,0.00087090244,0.8960658,0.0000868596,0.00004487518,0.000041656986,0.036683183,0.00005838242,0.002573324,0.0003498896,0.00002830423,0.06291583],"study_design_scores_gemma":[0.007461792,0.00027092895,0.96541846,0.00008196041,0.00016005208,0.000041339757,0.02511412,0.0004490902,0.00076958933,0.000025656416,0.000053218413,0.00015378946],"about_ca_topic_score_codex":0.00058033236,"about_ca_topic_score_gemma":0.001742841,"teacher_disagreement_score":0.069352694,"about_ca_system_score_codex":0.000007738133,"about_ca_system_score_gemma":0.0000307677,"threshold_uncertainty_score":0.52535385},"labels":[],"label_agreement":null},{"id":"W2596288557","doi":"10.1182/blood.v128.22.1151.1151","title":"Efficacy of Daratumumab, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma Patients with 1 to 3 Prior Lines of Therapy: Updated Analysis of Pollux","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Alberta","funders":"","keywords":"Lenalidomide; Daratumumab; Dexamethasone; Medicine; Oncology; Multiple myeloma; Internal medicine; Thalidomide; Refractory (planetary science); Carfilzomib; Biology","score_opus":0.029548182363770412,"score_gpt":0.2992962749890381,"score_spread":0.26974809262526767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596288557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99777174,0.00066867797,0.000028698094,0.0001006226,0.000021140793,0.0011459804,0.0002126906,0.000016748882,0.00003370762],"genre_scores_gemma":[0.99477124,0.0003322833,0.004648339,0.00001599284,0.000016672679,0.000034375993,0.00005908953,0.00003583745,0.00008617296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976727,0.00021153415,0.0006961609,0.00049238116,0.0005634383,0.0003637942],"domain_scores_gemma":[0.9968276,0.0015672713,0.00036827815,0.00056093035,0.00038635166,0.00028954665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037449974,0.00028840554,0.0011744474,0.0009149765,0.000038709695,0.000007699149,0.00012671712,0.00013370774,0.00008390935],"category_scores_gemma":[0.0018745523,0.00016217298,0.00011410463,0.0012969907,0.0002799478,0.00009809239,0.00008904427,0.0001246214,0.0000013427682],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08796631,0.003165445,0.79527617,0.0000895878,0.0042966185,0.00003916646,0.00041837132,0.0000040404466,0.0686279,0.0000031106558,0.00000907494,0.04010423],"study_design_scores_gemma":[0.123046316,0.0038232326,0.7867437,0.00032425442,0.0010963748,0.0000023088987,0.000075759745,0.000039512517,0.084661014,0.0000013609066,0.000038434082,0.00014772151],"about_ca_topic_score_codex":0.000596584,"about_ca_topic_score_gemma":0.0007779689,"teacher_disagreement_score":0.039956506,"about_ca_system_score_codex":0.00004641923,"about_ca_system_score_gemma":0.00015366805,"threshold_uncertainty_score":0.66132224},"labels":[],"label_agreement":null},{"id":"W2596304870","doi":"10.1182/blood.v128.22.1289.1289","title":"Implications of Low Zinc and Copper Levels As Well As Altered Iron Trafficking Proteins on Oxidant Stress in Patients with Transfusion Dependant Thalassemia","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"","keywords":"Oxidative stress; Hemopexin; Ineffective erythropoiesis; Transferrin; Malondialdehyde; Chemistry; Soluble transferrin receptor; Transferrin receptor; Internal medicine; Pro-oxidant; Hereditary hemochromatosis; Thalassemia; Lipid peroxidation; Inflammation; Beta thalassemia; Endocrinology; Biochemistry; Anemia; Erythropoiesis; Iron deficiency; Medicine; Hemochromatosis; Heme","score_opus":0.006021585603049573,"score_gpt":0.22017274270063242,"score_spread":0.21415115709758284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596304870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99634093,0.00007547186,0.000023959186,0.0006563195,0.000020931473,0.0009832714,0.000038374226,0.000023014136,0.0018377291],"genre_scores_gemma":[0.99958485,0.00013629658,0.00007805886,0.000046454046,0.000011153795,0.00002736258,0.000011095047,0.000023319915,0.0000814036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990528,0.00003240123,0.00023684681,0.00026252118,0.00020553307,0.00020986192],"domain_scores_gemma":[0.9995264,0.000035801797,0.00007572733,0.00020786824,0.000052517476,0.00010168559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006547793,0.00014341046,0.00022061971,0.00009236977,0.000047900303,0.000005743157,0.000054851334,0.00011695049,0.000063069376],"category_scores_gemma":[0.000024481811,0.000082220795,0.000034490018,0.00011045549,0.00006307156,0.000049497223,0.000013854439,0.00012849443,0.000016435319],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011191564,0.0064171273,0.66803914,0.00041395318,0.00012239027,0.000041712996,0.0014307529,0.000022487087,0.29529428,0.00021467012,0.000027681117,0.026856653],"study_design_scores_gemma":[0.017917953,0.0024767714,0.8032766,0.0025811433,0.00013634824,0.000033405915,0.00018781317,0.000006011926,0.17306632,0.000029866009,0.000086316126,0.00020143452],"about_ca_topic_score_codex":0.000081148006,"about_ca_topic_score_gemma":0.000088857436,"teacher_disagreement_score":0.13523749,"about_ca_system_score_codex":0.000025087118,"about_ca_system_score_gemma":0.0000762664,"threshold_uncertainty_score":0.33528668},"labels":[],"label_agreement":null},{"id":"W2596371246","doi":"10.1182/blood.v104.11.3032.3032","title":"Congenital Macrothrombocytopenia and Defective Localization of the Nonmuscle Myosin Heavy Chain IIA in Leukocytes and Megakaryocytes with a Normal MYH9 Gene.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Biology; Myosin; Pathology; Molecular biology; Platelet; Immunofluorescence; Inclusion bodies; Gene; Antibody; Immunology; Cell biology; Medicine; Genetics","score_opus":0.005690820417377537,"score_gpt":0.2049720968608014,"score_spread":0.19928127644342386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596371246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975135,0.0015245681,0.000077562974,0.0000997337,0.000010228159,0.00048664524,0.000013156131,0.000010247424,0.00026438604],"genre_scores_gemma":[0.9994033,0.00012208494,0.00031849864,0.000087399516,0.000009197845,0.000018745719,0.000009128913,0.000013182954,0.000018486146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994185,0.000020905798,0.00012829721,0.00017421087,0.0001145665,0.0001435087],"domain_scores_gemma":[0.9997342,0.000024278399,0.00005036714,0.00011001542,0.000032474658,0.000048614576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004975971,0.0001185567,0.0002408546,0.00004957617,0.00006197577,0.000011768987,0.000030182628,0.00005180047,0.0000049206997],"category_scores_gemma":[0.00001904104,0.000076512355,0.000023006107,0.00015765597,0.00014263793,0.0000756534,0.000036182486,0.000066234796,8.19442e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065220793,0.0014708518,0.98292524,0.00010117012,0.00042006085,0.00030844874,0.0027835602,0.00013634391,0.009886566,0.00020845416,0.000003676687,0.0011034473],"study_design_scores_gemma":[0.023143344,0.0010871278,0.7354995,0.0002019292,0.00039830577,0.00064713793,0.0004436068,0.00016084427,0.23793009,0.00030647466,0.000015480879,0.00016618134],"about_ca_topic_score_codex":0.0005961117,"about_ca_topic_score_gemma":0.0012376605,"teacher_disagreement_score":0.24742573,"about_ca_system_score_codex":0.00002503278,"about_ca_system_score_gemma":0.00007382345,"threshold_uncertainty_score":0.31200835},"labels":[],"label_agreement":null},{"id":"W2596382835","doi":"10.1182/blood.v110.11.4653.4653","title":"Transfusion Dependence in Patients with Primary Myelofibrosis Has a Negative Impact on Survival Independent of Decreased Myelopoiesis.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Myelofibrosis; Internal medicine; Gastroenterology; International Prognostic Scoring System; Bone marrow; Anemia; Splenectomy; Myelodysplastic syndromes; Surgery; Spleen","score_opus":0.012010795410853866,"score_gpt":0.24613943428432689,"score_spread":0.23412863887347302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596382835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966038,0.000065005384,0.000079520585,0.000100174504,0.00003867932,0.001200264,0.000052880154,0.000026801017,0.0018328951],"genre_scores_gemma":[0.9986374,0.0000516035,0.0009899426,0.000112015405,0.000029424733,0.000048455928,0.00007930308,0.0000331435,0.000018726907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977392,0.00008476964,0.00046197136,0.00044228326,0.00087420933,0.00039754223],"domain_scores_gemma":[0.9986494,0.00040383058,0.00016445607,0.00031529943,0.0002132832,0.00025373395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034563476,0.00033461067,0.0006475003,0.00028601452,0.0000740127,0.000016549922,0.00009081998,0.00013372382,0.00011971532],"category_scores_gemma":[0.00008998627,0.00021917683,0.00014180057,0.00042304827,0.000099746336,0.00009834271,0.000024337169,0.00022341598,0.000009436906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006534222,0.008150307,0.9797877,0.00006977188,0.0003302168,0.00010855661,0.00069996313,0.000011984357,0.0011535151,0.000034206543,0.000008689471,0.003110862],"study_design_scores_gemma":[0.019562257,0.0047802036,0.89706063,0.0004334258,0.00023082565,0.000007030144,0.000090066234,0.0000022032455,0.07762167,0.00002072009,0.000006205067,0.00018478805],"about_ca_topic_score_codex":0.0007436148,"about_ca_topic_score_gemma":0.00096858,"teacher_disagreement_score":0.082727104,"about_ca_system_score_codex":0.00022288617,"about_ca_system_score_gemma":0.000309168,"threshold_uncertainty_score":0.89377713},"labels":[],"label_agreement":null},{"id":"W2596426804","doi":"10.1182/blood.v126.23.687.687","title":"Comprehensive Sequence Analysis of Relapse and Refractory Pediatric Acute Myeloid Leukemia Identifies miRNA and mRNA Transcripts Associated with Treatment Resistance - a Report from the COG/NCI-Target AML Initiative","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"microRNA; Myeloid leukemia; Messenger RNA; Biology; Oncology; Transcriptome; Internal medicine; Bioinformatics; Medicine; Cancer research; Gene expression; Genetics; Gene","score_opus":0.0251188126483596,"score_gpt":0.25315181441186124,"score_spread":0.22803300176350164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596426804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892133,0.009703973,0.000055386034,0.000046836918,0.00002350799,0.00020729622,0.00068579783,0.00000929863,0.00005464217],"genre_scores_gemma":[0.9973991,0.00089410046,0.00030944246,0.000039925053,0.000041278035,0.000020384492,0.0011673146,0.00001370628,0.00011478169],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99892247,0.00014187372,0.0002615351,0.0003646642,0.00018030439,0.00012915353],"domain_scores_gemma":[0.9989238,0.00006224046,0.00034092777,0.00032154375,0.00026406097,0.00008746845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000111936235,0.00016657516,0.00027410573,0.00005410772,0.00006847591,0.00002463915,0.00007990799,0.00010555144,0.0000023027176],"category_scores_gemma":[0.00009880176,0.00012166905,0.00007017851,0.00024143983,0.00016663321,0.000013172117,0.000030816416,0.000055423636,1.813716e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069999124,0.00033183064,0.21900274,0.000029232013,0.010548634,0.0002757251,0.0024348283,0.000065222725,0.76555425,0.0000039565525,0.0009932829,0.00006029725],"study_design_scores_gemma":[0.00429516,0.00044768566,0.86805433,0.00004599691,0.0125526,0.00003003883,0.00051627465,0.000066014465,0.11242964,0.00014192644,0.0010573162,0.0003629989],"about_ca_topic_score_codex":0.00014205607,"about_ca_topic_score_gemma":0.0004849058,"teacher_disagreement_score":0.65312463,"about_ca_system_score_codex":0.000051268635,"about_ca_system_score_gemma":0.00022971121,"threshold_uncertainty_score":0.49615198},"labels":[],"label_agreement":null},{"id":"W2596441180","doi":"10.1182/blood.v124.21.4035.4035","title":"Retrospective Evaluation of Patients Referred for Hemochromatosis Genetic Testing","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Joseph’s Healthcare Hamilton; St. Joseph's Hospital; McMaster University","funders":"","keywords":"Transferrin saturation; Phlebotomy; Hemochromatosis; Medicine; Hereditary hemochromatosis; Genetic testing; Internal medicine; Ferritin; Genotype; Serum iron; Genotyping; Gastroenterology; Deferasirox; Anemia; Genetics; Serum ferritin; Biology; Thalassemia; Gene","score_opus":0.029870710795876238,"score_gpt":0.28115763763557255,"score_spread":0.25128692683969633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596441180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948163,0.00013413388,0.00028337713,0.00001798608,0.00008985033,0.00048608403,0.000008795822,0.000018839055,0.004144638],"genre_scores_gemma":[0.99111277,0.000002053082,0.008674331,0.000040818733,0.00007251742,0.000039759172,0.00002670725,0.000012361411,0.000018681772],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992585,0.00003668706,0.00016134277,0.0001361513,0.0003033205,0.00010400138],"domain_scores_gemma":[0.999169,0.00004686041,0.00008990898,0.00016137371,0.0004974093,0.000035465673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029345145,0.00006262642,0.00016088171,0.000045378598,0.00003024396,0.0000029728483,0.000031443764,0.000038037673,0.000021795178],"category_scores_gemma":[0.0023129422,0.000055906923,0.00003966681,0.00010242828,0.000019244957,0.000020785956,0.000009600572,0.000026621648,0.0000036853073],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058311394,0.00086425635,0.96826863,0.00019914948,0.00003221181,9.050113e-8,0.00020751118,0.000011007592,0.008427067,0.00016201165,0.00023273003,0.021537002],"study_design_scores_gemma":[0.00841711,0.00033972866,0.98089224,0.000027813854,0.00075743644,8.252852e-7,0.000023441764,0.00080545305,0.007899641,0.0007284543,0.000049758128,0.000058082875],"about_ca_topic_score_codex":0.000010688935,"about_ca_topic_score_gemma":0.0000016709158,"teacher_disagreement_score":0.02147892,"about_ca_system_score_codex":0.000011628534,"about_ca_system_score_gemma":0.00004077066,"threshold_uncertainty_score":0.2768975},"labels":[],"label_agreement":null},{"id":"W2596445459","doi":"10.1182/blood.v128.22.139.139","title":"Prediction of Bleeding Risk in Patients on Extended Oral Anticoagulation for Venous Thromboembolism","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; University of Ottawa; Jewish General Hospital; McMaster University; London Health Sciences Centre; Ottawa Hospital; Dalhousie University","funders":"","keywords":"Medicine; Major bleeding; Risk assessment; Prospective cohort study; Venous thromboembolism; Cohort; Surgery; Internal medicine; Intensive care medicine; Thrombosis; Atrial fibrillation","score_opus":0.024209910850626626,"score_gpt":0.26022697803247175,"score_spread":0.23601706718184512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596445459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976712,0.000026497368,0.00028480092,0.0001260447,0.00023141658,0.0009765271,0.00006192462,0.000037865775,0.0005837587],"genre_scores_gemma":[0.999198,0.00012002811,0.00039326138,0.000052705076,0.00010733728,0.000056556735,0.000025538166,0.000021658674,0.000024900695],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990105,0.000024897467,0.00030388875,0.00022638732,0.00022625747,0.00020804607],"domain_scores_gemma":[0.9994421,0.000063220934,0.00015247095,0.00020110095,0.00009247414,0.000048629485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021736746,0.00011136552,0.00040267294,0.00017283765,0.000042534797,0.0000052913124,0.00004958202,0.00007196685,0.000020282023],"category_scores_gemma":[0.00014987492,0.00007977759,0.00007569332,0.00010836121,0.00002697124,0.00008118642,0.000021908983,0.00004893548,0.0000068208906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036475752,0.018404458,0.9118365,0.00026864978,0.00042910586,0.00000363675,0.00058264256,0.000022261262,0.008478578,0.0030198253,0.0008620014,0.05572757],"study_design_scores_gemma":[0.009538131,0.0024765595,0.97718877,0.00036283434,0.000427778,4.788654e-7,0.000024666511,0.000053759766,0.009006528,0.00069431524,0.00015254029,0.00007363338],"about_ca_topic_score_codex":0.00004663412,"about_ca_topic_score_gemma":0.000007409849,"teacher_disagreement_score":0.06535226,"about_ca_system_score_codex":0.000044285385,"about_ca_system_score_gemma":0.000019549801,"threshold_uncertainty_score":0.32532355},"labels":[],"label_agreement":null},{"id":"W2596450036","doi":"10.1182/blood.v128.22.4145.4145","title":"Gray Zone Lymphoma (GZL) with Features Intermediate Between Diffuse Large B-Cell Lymphoma (DLBCL) and Classical Hodgkin Lymphoma (cHL): Pathologic Classification and Clinical Outcomes from a Multicenter Consensus Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; BCL6; Lymphoma; Medicine; CD30; Not Otherwise Specified; CD15; Pathology; B cell; Immunology; Biology","score_opus":0.026249397051790153,"score_gpt":0.2906882922959565,"score_spread":0.26443889524416636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596450036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957503,0.0006283282,0.000030142122,0.0012865632,0.0001672296,0.001441523,0.0003856033,0.00017566691,0.00013461895],"genre_scores_gemma":[0.99752146,0.00036185625,0.000768956,0.00047304883,0.00026946238,0.00018430529,0.00008088331,0.00007412472,0.00026589568],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962711,0.00044435862,0.00087031914,0.0012535898,0.0005157109,0.00064495625],"domain_scores_gemma":[0.9962305,0.0018213209,0.00039120042,0.0008233219,0.00012829444,0.0006053795],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040432878,0.00064091035,0.0012655845,0.00016123638,0.00019060262,0.000104583065,0.00017669883,0.00037548816,0.000016047934],"category_scores_gemma":[0.0002924922,0.00034520857,0.00021822247,0.00013843316,0.00053261785,0.00010229389,0.0002473414,0.00009393367,0.00004952063],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095245213,0.04771792,0.88555586,0.00002518485,0.0010301437,0.001407879,0.0003588353,1.5181199e-9,0.00019799848,0.000026827642,0.00016270166,0.0625642],"study_design_scores_gemma":[0.19979855,0.0028914623,0.7928414,0.00016254133,0.002313298,0.00013697421,0.0006980362,0.000007747716,0.0004577723,0.000021233413,0.00030687952,0.000364158],"about_ca_topic_score_codex":0.00020572673,"about_ca_topic_score_gemma":0.0003258441,"teacher_disagreement_score":0.1988461,"about_ca_system_score_codex":0.0001974638,"about_ca_system_score_gemma":0.00014570149,"threshold_uncertainty_score":0.9999},"labels":[],"label_agreement":null},{"id":"W2596479444","doi":"10.1182/blood.v118.21.2051.2051","title":"Pharmacodynamic, Biodistribution and Toxicology Results for SNS01-T, a Nanoparticle That Targets eIF5A for the Treatment of Multiple Myeloma","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Polyamine Metabolism and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Biodistribution; Apoptosis; Small interfering RNA; Biology; Pharmacokinetics; In vivo; Cancer research; Pharmacology; Molecular biology; RNA; Biochemistry; Gene","score_opus":0.029472189191939044,"score_gpt":0.270201903147026,"score_spread":0.24072971395508697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596479444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922191,0.0021585391,0.0029310777,0.00013043944,0.000053178916,0.0007116644,0.0017542624,0.000006369446,0.0000353565],"genre_scores_gemma":[0.99746,0.0005299548,0.0010009435,0.000030603194,0.00006824529,0.0004994024,0.00033731514,0.00000556966,0.000067942296],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99951947,0.000012901462,0.00012261301,0.00017564792,0.000024173942,0.00014519779],"domain_scores_gemma":[0.99964064,0.00004392314,0.00007050011,0.00017356873,0.00003616519,0.000035178415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000069467234,0.00007939131,0.00009118159,0.000010242688,0.000087239074,0.000004008602,0.000074309784,0.000049753267,0.0000011796889],"category_scores_gemma":[0.00003466397,0.00005572276,0.000059165806,0.000025584322,0.00007084767,0.0000021229203,0.00001800184,0.000009348186,6.005747e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031210206,0.00058823306,0.0009376092,0.000007176644,0.000086271124,1.2076801e-7,0.00010159636,5.018757e-7,0.99223065,0.00017295463,0.00023397354,0.005328788],"study_design_scores_gemma":[0.0042554885,0.0005973073,0.008204658,9.082775e-7,0.00014943608,0.0000032354508,0.000031298674,0.00015934945,0.94890934,0.000066067696,0.03755967,0.00006325034],"about_ca_topic_score_codex":0.000014186249,"about_ca_topic_score_gemma":0.000037645736,"teacher_disagreement_score":0.04332134,"about_ca_system_score_codex":0.0000026347084,"about_ca_system_score_gemma":0.000016107075,"threshold_uncertainty_score":0.22723083},"labels":[],"label_agreement":null},{"id":"W2596496142","doi":"10.1182/blood.v128.22.5391.5391","title":"Comparison of Pharmacokinetics and Pharmacodynamics of Two Anti-CD20 Monoclonal Antibodies (Candidate Biosimilar DRL-Rituximab and Innovator Reference Product Rituximab (Mabthera®) in a Randomised, Multi-Centre, Double-Blind, Parallel Group Study of CHOP with Rituximab Chemotherapy in Patients with CD20-Positive Diffuse Large B-Cell Lymphoma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Rituximab; Medicine; Pharmacodynamics; Cmax; Biosimilar; Internal medicine; Pharmacokinetics; Prednisone; Pharmacology; European union; CHOP; Cyclophosphamide; Vincristine; Gastroenterology; Oncology; Lymphoma; Chemotherapy","score_opus":0.02019780311363597,"score_gpt":0.30602112059193826,"score_spread":0.2858233174783023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596496142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956393,0.0016723595,0.00014826926,0.0000779967,0.000045874065,0.0020209716,0.0003654514,0.00001622735,0.000013498767],"genre_scores_gemma":[0.99650323,0.0007512642,0.0025556984,0.000048259197,0.000008951816,0.00003373689,0.000044554843,0.000038607894,0.000015667152],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972008,0.00040566624,0.0010011423,0.0007123781,0.00016432282,0.0005157219],"domain_scores_gemma":[0.9984577,0.0002017198,0.0006533798,0.00033022746,0.00030056984,0.00005644878],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048503015,0.00048762443,0.0015782694,0.0003385526,0.0000611599,0.000013508933,0.00026005413,0.00018240644,0.000017792067],"category_scores_gemma":[0.00002094051,0.00030857802,0.000053991902,0.00048743637,0.00064023904,0.00014838912,0.00014539248,0.00027216115,6.288433e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.064962655,0.11589277,0.7351511,0.00017956665,0.0007322068,0.000008624788,0.0010819045,9.268086e-7,0.080300055,0.000026625725,0.0000050094336,0.0016585706],"study_design_scores_gemma":[0.6873783,0.00151618,0.16501051,0.0002516401,0.0003806781,0.000005090548,0.00021960754,0.000084916435,0.14477864,0.0000051397797,0.000020667288,0.00034861753],"about_ca_topic_score_codex":0.00013445479,"about_ca_topic_score_gemma":0.00023628127,"teacher_disagreement_score":0.62241566,"about_ca_system_score_codex":0.000025866626,"about_ca_system_score_gemma":0.000057482433,"threshold_uncertainty_score":0.99993664},"labels":[],"label_agreement":null},{"id":"W2596571051","doi":"10.1182/blood.v118.21.5146.5146","title":"Clinical Burden and Progression of Myelofibrosis in a Controlled Study Population of Placebo-Treated Patients (COMFORT-I)","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Myelofibrosis; Placebo; Ruxolitinib; Population; Internal medicine; Clinical trial; Surgery; Pathology; Bone marrow","score_opus":0.03565850352619703,"score_gpt":0.32898378470369327,"score_spread":0.29332528117749623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596571051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99696237,0.00009187686,4.381048e-7,0.00001089626,0.000022850032,0.002496355,0.000009712552,0.000010872324,0.00039461468],"genre_scores_gemma":[0.9992135,0.00004089044,0.0004982392,0.0000055195933,0.000021421078,0.00016487687,0.000029865276,0.000010697529,0.000014990968],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863076,0.00014375283,0.00069234666,0.00021577813,0.00020732654,0.00011003307],"domain_scores_gemma":[0.99925804,0.0001286979,0.00027353887,0.00016296898,0.00010597545,0.00007075025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026336478,0.00012510437,0.0007041587,0.000110230234,0.000018274512,0.0000025014924,0.000029912486,0.000077632285,0.00003560962],"category_scores_gemma":[0.00015666337,0.000083886574,0.00007351243,0.00010987507,0.0000378076,0.000036869544,0.000031540727,0.00006556173,8.606993e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043423525,0.010722966,0.97815347,0.000047120255,0.00029260755,0.000011424379,0.0008343729,1.6376339e-7,0.00006921331,0.0000144424175,0.0000026610287,0.005509197],"study_design_scores_gemma":[0.07264692,0.00601115,0.91854763,0.0002327704,0.0005025272,0.0000011950636,0.00011161614,0.000028199618,0.0018457497,0.000013819347,0.0000014482014,0.00005698206],"about_ca_topic_score_codex":0.00043313086,"about_ca_topic_score_gemma":0.00008998009,"teacher_disagreement_score":0.06830457,"about_ca_system_score_codex":0.0000112424505,"about_ca_system_score_gemma":0.000020262962,"threshold_uncertainty_score":0.34207952},"labels":[],"label_agreement":null},{"id":"W2596596216","doi":"10.1182/blood.v128.22.777.777","title":"Targeting NF-KB Activation in Novel Intracranial Models of CNS Lymphoma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Lymphoma; Primary central nervous system lymphoma; Pathology; Parenchyma; Biology; Cancer research; Central nervous system; Diffuse large B-cell lymphoma; Pathogenesis; Medicine; Neuroscience","score_opus":0.018273545695187108,"score_gpt":0.24259698915038008,"score_spread":0.22432344345519298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596596216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99700457,0.00006962697,0.0012706036,0.00060731795,0.00003742029,0.00021352252,0.000011748824,0.00002139543,0.00076379743],"genre_scores_gemma":[0.9980324,0.00004784979,0.0016640838,0.000059056776,0.000096639626,0.00003159938,0.0000089357945,0.000014828305,0.000044637974],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99927396,0.000010378861,0.00023683613,0.00016786763,0.00015582479,0.00015513877],"domain_scores_gemma":[0.99958944,0.0000912747,0.00007649018,0.00014691289,0.000046170077,0.000049738363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000082390405,0.000095399984,0.00020521398,0.0000859971,0.00001682247,0.00000375514,0.000037882648,0.000061033777,0.000038058108],"category_scores_gemma":[0.00007562152,0.000062940344,0.00005397393,0.00010414622,0.000022715025,0.00009698945,0.000021414166,0.000018269791,0.000008674563],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027802697,0.010080255,0.10743389,0.00006789978,0.0001996213,0.00005328997,0.0006184389,0.000032909928,0.75032103,0.0019371118,0.000090691094,0.12888685],"study_design_scores_gemma":[0.0379175,0.00044558904,0.4744944,0.0007348812,0.0002055584,0.000050984723,0.00009364029,0.00077253475,0.48411834,0.0007736449,0.00018923586,0.00020368477],"about_ca_topic_score_codex":0.00017695045,"about_ca_topic_score_gemma":0.000010808181,"teacher_disagreement_score":0.3670605,"about_ca_system_score_codex":0.000102282815,"about_ca_system_score_gemma":0.00010951772,"threshold_uncertainty_score":0.25666326},"labels":[],"label_agreement":null},{"id":"W2596636194","doi":"10.1182/blood.v128.22.1812.1812","title":"A Phase 1 Study of TTI-621, a Novel Immune Checkpoint Inhibitor Targeting CD47, in Patients with Relapsed or Refractory Hematologic Malignancies","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Therapeutics (Canada)","funders":"","keywords":"CD47; Phagocytosis; Immune system; Cancer research; Immunology; Medicine; Pharmacology","score_opus":0.01393267562949513,"score_gpt":0.23404095757486273,"score_spread":0.2201082819453676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596636194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983396,0.00073288166,0.000031248746,0.000025297702,0.00014137346,0.00063255086,0.000024784928,0.00003955371,0.000032730244],"genre_scores_gemma":[0.99953747,0.00001337948,0.00010599098,0.00000799075,0.000010352141,0.00005774068,0.000034721805,0.000020982558,0.00021137673],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99845135,0.00014587163,0.00069735333,0.0003181166,0.000071316965,0.00031598288],"domain_scores_gemma":[0.9989814,0.0001132116,0.00043942573,0.00032813192,0.00012222862,0.000015582029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029314516,0.00021241233,0.0005007789,0.00015173235,0.00008036436,0.000005896088,0.00016545305,0.00016801519,0.00011044131],"category_scores_gemma":[0.0002068879,0.00011707586,0.000061678285,0.00020432628,0.000115516465,0.00017888224,0.00009373617,0.00013841853,0.000020220898],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016776251,0.020519152,0.05078685,0.000027447553,0.00018140674,0.000005760198,0.0008370776,3.9497945e-7,0.92534345,0.000014899571,0.000020444448,0.00058548973],"study_design_scores_gemma":[0.08084562,0.0077791074,0.2254837,0.00039479785,0.00010874981,0.000015108977,0.00081660075,4.962977e-7,0.68404937,0.0000077452705,0.0002226788,0.00027601756],"about_ca_topic_score_codex":0.00005039206,"about_ca_topic_score_gemma":0.000017186972,"teacher_disagreement_score":0.24129407,"about_ca_system_score_codex":0.00003836119,"about_ca_system_score_gemma":0.00006195755,"threshold_uncertainty_score":0.47742152},"labels":[],"label_agreement":null},{"id":"W2596684151","doi":"10.1182/blood.v128.22.1874.1874","title":"An International Collaborative Study of Outcome and Prognostic Factors in Patients with Secondary CNS Involvement By Diffuse Large B-Cell Lymphoma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; CancerCare Manitoba; BC Cancer Agency","funders":"","keywords":"Medicine; Rituximab; Diffuse large B-cell lymphoma; Regimen; Cohort; Natural history; Internal medicine; Retrospective cohort study; Lymphoma; Oncology; Pediatrics","score_opus":0.007960163842466941,"score_gpt":0.24071384594055817,"score_spread":0.23275368209809122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596684151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99845207,0.000051399937,9.1540284e-7,0.000033447894,0.000033441785,0.000996028,0.00035000214,0.00001226846,0.000070437076],"genre_scores_gemma":[0.999683,0.0000137875795,0.000033188993,0.000035959685,0.0000077787645,0.00008546839,0.000094854004,0.000015158532,0.000030807532],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990758,0.00003471008,0.0002449489,0.00024655525,0.0002586873,0.00013930559],"domain_scores_gemma":[0.99945503,0.00006420278,0.00010378502,0.0001767749,0.00010460859,0.00009557711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000047960493,0.000143704,0.00025040886,0.00009238624,0.000023696783,0.000011122046,0.000055840617,0.00003182843,0.00003070938],"category_scores_gemma":[0.00002222481,0.00008031651,0.000016584703,0.00009723134,0.000028156392,0.0001101756,0.000036582325,0.000021677788,0.0000014281705],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013877955,0.11082218,0.88655704,0.000015166169,0.0001813148,0.000015769645,0.0012313314,1.6587311e-8,0.00014742621,0.000005858802,0.00001734987,0.000867794],"study_design_scores_gemma":[0.09717724,0.004275629,0.8947545,0.00005708887,0.00014962356,4.5348312e-7,0.0010807135,5.5723837e-7,0.0023606012,0.0000013145216,0.000056457982,0.00008577143],"about_ca_topic_score_codex":0.00007628044,"about_ca_topic_score_gemma":0.0002747363,"teacher_disagreement_score":0.10654655,"about_ca_system_score_codex":0.00007521349,"about_ca_system_score_gemma":0.000050138595,"threshold_uncertainty_score":0.3275212},"labels":[],"label_agreement":null},{"id":"W2596739573","doi":"10.1182/blood.v128.22.1832.1832","title":"Texture Analysis on Computed Tomography Predicts the Outcome of Patients with Hodgkin Lymphoma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"ABVD; Medicine; Dacarbazine; Procarbazine; Vincristine; Vinblastine; Chemotherapy regimen; Nuclear medicine; Radiology; Oncology; Chemotherapy; Internal medicine; Cyclophosphamide","score_opus":0.005148351974198391,"score_gpt":0.2320694353161337,"score_spread":0.2269210833419353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596739573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99521565,0.000050186234,0.002316101,0.0014966426,0.000048629074,0.0001855951,0.000018644052,0.000040113886,0.0006284471],"genre_scores_gemma":[0.9984934,0.00000419966,0.0006342537,0.0006687718,0.000066560264,0.000004899677,0.00002077096,0.000014256681,0.00009292753],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898237,0.000048943522,0.00021454114,0.00019231296,0.00039803822,0.00016380286],"domain_scores_gemma":[0.9991712,0.00015408068,0.00012602664,0.00036117077,0.00008746924,0.00010004556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016714547,0.00011668792,0.00030696025,0.00019765738,0.00004748485,0.000007798636,0.00013204546,0.0000466928,0.000040166906],"category_scores_gemma":[0.00013291369,0.0000469942,0.00015006727,0.0005795052,0.00013390312,0.000021527176,0.000026349466,0.000099784105,0.0000038190337],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000089016685,0.0005911212,0.98330134,0.000017688733,0.001035981,0.000009403275,0.000061277075,0.000013974593,0.000073122304,0.00007139333,0.00019515521,0.014540515],"study_design_scores_gemma":[0.005810594,0.0004089077,0.9906931,0.000099727724,0.0015147455,0.0000031490058,0.000007123652,0.00034933144,0.00021566826,0.000015377074,0.0008127966,0.00006946778],"about_ca_topic_score_codex":0.00002150028,"about_ca_topic_score_gemma":0.000003163992,"teacher_disagreement_score":0.014471048,"about_ca_system_score_codex":0.000009337634,"about_ca_system_score_gemma":0.000018755452,"threshold_uncertainty_score":0.19163679},"labels":[],"label_agreement":null},{"id":"W2596761532","doi":"10.1182/blood.v110.11.623.623","title":"Successful Engraftment Using Varied Stem Cell Sources, Low Toxicity, and Long-Term Survival Using a Bu/Flu/ATG Reduced Intensity Allogeneic Transplantation in High Risk Pediatric Patients Ineligible for Myelablative Therapy: Results of the Pediatric Blood and Marrow Transplant Consortium (PBMTC) Study ONC0313.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Thymoglobulin; Medicine; Busulfan; Fludarabine; Internal medicine; Transplantation; Gastroenterology; Toxicity; Hematopoietic stem cell transplantation; Surgery; Chemotherapy; Cyclophosphamide; Tacrolimus","score_opus":0.02134487030115428,"score_gpt":0.259129269606165,"score_spread":0.23778439930501072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596761532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99441373,0.0004519893,0.00078251853,0.000011774501,0.0002001228,0.0036900467,0.00040791088,0.00003216267,0.000009752701],"genre_scores_gemma":[0.9980389,0.0010807847,0.0005752196,0.000019998666,0.00011738335,0.000025400155,0.000084670806,0.000052064977,0.000005608399],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967367,0.00034169765,0.0011842265,0.0006722907,0.0005819727,0.00048308066],"domain_scores_gemma":[0.997997,0.0006015625,0.0006404225,0.00031149123,0.00028037158,0.00016916767],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012922252,0.0004135079,0.0007415946,0.00041410432,0.00020102003,0.00003282634,0.00014217553,0.00022301154,0.0000021487444],"category_scores_gemma":[0.000030228844,0.0003316158,0.00010839523,0.0006254154,0.00009477066,0.00012169785,0.0000292287,0.00029423475,1.968056e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034384157,0.0037265387,0.95346665,0.0011471958,0.00020948134,0.00007262844,0.0091844695,0.000083822786,0.028598314,0.0000014338626,2.2965486e-7,0.00007083401],"study_design_scores_gemma":[0.037856594,0.0010665674,0.79738605,0.00017532094,0.0039121727,0.000069897535,0.000634213,0.00011344266,0.15848379,0.000008641198,5.8741225e-8,0.00029326664],"about_ca_topic_score_codex":0.00066915475,"about_ca_topic_score_gemma":0.00034823077,"teacher_disagreement_score":0.1560806,"about_ca_system_score_codex":0.00005718079,"about_ca_system_score_gemma":0.00018377234,"threshold_uncertainty_score":0.9999136},"labels":[],"label_agreement":null},{"id":"W2596837612","doi":"10.1182/blood.v128.22.221.221","title":"Analysis of a Global Registration Trial of the Efficacy and Safety of CTL019 in Pediatric and Young Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL)","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; University of Toronto; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Clinical endpoint; Clinical trial; Internal medicine; Cytokine release syndrome; Adverse effect; Salvage therapy; Oncology; Chimeric antigen receptor; Chemotherapy; Immunotherapy; Cancer","score_opus":0.009385437605929787,"score_gpt":0.2620527594645376,"score_spread":0.2526673218586078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596837612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986573,0.00022792513,0.000017324017,0.000060284052,0.000023436201,0.00052214885,0.000040615676,0.000004541671,0.00044641146],"genre_scores_gemma":[0.99883294,0.0009362623,0.000038571194,0.0000037726074,0.000042901007,0.0000058026076,0.0000045072297,0.0000072321727,0.00012799664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998806,0.00009133231,0.00037844924,0.0002007851,0.00039468723,0.00012876611],"domain_scores_gemma":[0.99903417,0.00023974018,0.00024750075,0.000320382,0.000102548576,0.000055643868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003113002,0.00009601407,0.00039740908,0.00013641248,0.000013071594,0.0000031267505,0.0000767195,0.000082376726,0.000026601496],"category_scores_gemma":[0.0002263258,0.00005251746,0.00007266801,0.0007690954,0.00015847624,0.00004363099,0.000037162717,0.00006765366,1.537205e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11846914,0.00084734097,0.8278735,0.00019829907,0.0016149766,0.0000158244,0.0005161626,0.000007043569,0.045176335,0.000048303464,0.000010035339,0.00522303],"study_design_scores_gemma":[0.12192516,0.001796846,0.8708949,0.00014203643,0.0032149667,0.000018698282,0.000037479753,0.000044794135,0.0018518569,0.000007432431,0.000005713655,0.000060120332],"about_ca_topic_score_codex":0.0002586355,"about_ca_topic_score_gemma":0.0005035395,"teacher_disagreement_score":0.043324478,"about_ca_system_score_codex":0.00009564953,"about_ca_system_score_gemma":0.0003175771,"threshold_uncertainty_score":0.21415998},"labels":[],"label_agreement":null},{"id":"W2597008783","doi":"10.1182/blood.v128.22.2306.2306","title":"Bortezomib Consolidation after Nonmyeloablative Allogeneic Stem Cell Transplantation Leads to a High Incidence of Immunophenotypic Complete Response in Young and/or High-Risk Multiple Myeloma Patients","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University Health Centre; Université de Montréal; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Fludarabine; Transplantation; Internal medicine; Bortezomib; Cyclophosphamide; Multiple myeloma; Gastroenterology; Surgery; Oncology; Immunology; Chemotherapy","score_opus":0.013372511911879423,"score_gpt":0.25065262006571715,"score_spread":0.2372801081538377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597008783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99752265,0.00008621079,0.00032284262,0.000088421395,0.000043731445,0.0012525977,0.000643943,0.000022692768,0.000016895887],"genre_scores_gemma":[0.9974772,0.00018270816,0.0018380614,0.000029254728,0.000017597065,0.00020418485,0.000079698526,0.000027291353,0.00014401328],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980618,0.00034709836,0.00046137167,0.00039726184,0.00038182203,0.00035067566],"domain_scores_gemma":[0.9985269,0.00063304213,0.00016133563,0.00029967623,0.00019282926,0.00018627169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030355624,0.00021503668,0.0003820698,0.00030097598,0.00005873055,0.000012405026,0.000091179245,0.000097346696,0.000049207894],"category_scores_gemma":[0.00019828003,0.0001458265,0.000046526202,0.00024970283,0.000093721515,0.00016584004,0.000048233014,0.00010508954,0.000045200475],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034019496,0.0006803177,0.8181529,0.000093494884,0.00008206346,0.00012076057,0.0011867179,0.0000027941733,0.14096123,0.0000035285082,0.000001766205,0.004694919],"study_design_scores_gemma":[0.020608384,0.0020679235,0.8854575,0.00032201162,0.00013645737,0.000013913388,0.000055519795,0.00002267761,0.09115485,0.000011814719,0.0000038931066,0.00014503121],"about_ca_topic_score_codex":0.00083006884,"about_ca_topic_score_gemma":0.00090630504,"teacher_disagreement_score":0.06730462,"about_ca_system_score_codex":0.000104033476,"about_ca_system_score_gemma":0.00011519514,"threshold_uncertainty_score":0.5946632},"labels":[],"label_agreement":null},{"id":"W2597083162","doi":"10.1182/blood.v128.22.1849.1849","title":"A Phase 1b, Multi-Center, Open-Label Study of Novel Combinations of CC-122, CC-223, CC-292, and Rituximab in Diffuse Large B-Cell Lymphoma: CC-122-DLBCL-001","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Rituximab; Tolerability; Medicine; Diffuse large B-cell lymphoma; Internal medicine; Phases of clinical research; Lymphoma; Ibrutinib; Refractory (planetary science); Pharmacology; Adverse effect; Oncology; Clinical trial; Leukemia; Chronic lymphocytic leukemia","score_opus":0.062468978753671314,"score_gpt":0.36699496717822594,"score_spread":0.30452598842455464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597083162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952727,0.0007282455,0.00011183458,0.00019197709,0.0001050051,0.0024583365,0.00034465862,0.000047284746,0.00073996815],"genre_scores_gemma":[0.99704766,0.00027496874,0.0006910358,0.000082326354,0.000049528073,0.00017730186,0.000057903406,0.00008404068,0.0015352585],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99633336,0.00018403478,0.0010231659,0.0007723065,0.000881643,0.0008054597],"domain_scores_gemma":[0.99730664,0.00047396717,0.00034740198,0.0010926621,0.00040664073,0.00037267743],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008343446,0.00040312984,0.0010613112,0.00047118514,0.000117163276,0.000045915753,0.00068064797,0.00021700995,0.0000016877264],"category_scores_gemma":[0.00058712694,0.00031432672,0.00008251952,0.00063442625,0.00028182357,0.00030972893,0.0008912211,0.0002135056,0.000037239824],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005160743,0.994512,0.00009118831,0.00030314326,0.0002931488,0.00021139003,0.001319236,2.4320396e-10,0.00026858924,0.00018800439,0.0003157953,0.0019814018],"study_design_scores_gemma":[0.99031943,0.0026221657,0.00002630351,0.0004391155,0.00033303731,0.00012120706,0.0008393441,0.0018529138,0.0025045308,0.00002048897,0.00060842815,0.00031303847],"about_ca_topic_score_codex":0.0015914332,"about_ca_topic_score_gemma":0.0007500497,"teacher_disagreement_score":0.99188983,"about_ca_system_score_codex":0.0014831249,"about_ca_system_score_gemma":0.001901911,"threshold_uncertainty_score":0.99993086},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"nonrandomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"split"},{"id":"W2597108928","doi":"10.1182/blood.v116.21.985.985","title":"Results of PX-171-003-A1, An Open-Label, Single-Arm, Phase 2 (Ph 2) Study of Carfilzomib (CFZ) In Patients (pts) with Relapsed and Refractory Multiple Myeloma (MM)","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Calgary; Princess Margaret Cancer Centre","funders":"","keywords":"Carfilzomib; Medicine; Lenalidomide; Thalidomide; Multiple myeloma; Bortezomib; Refractory (planetary science); Internal medicine; Clinical endpoint; Regimen; Phases of clinical research; Progression-free survival; Gastroenterology; Surgery; Oncology; Clinical trial; Chemotherapy","score_opus":0.04297886026335334,"score_gpt":0.3249800669720499,"score_spread":0.28200120670869655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597108928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99607486,0.000054915246,5.0637703e-7,0.000024421557,0.000050382092,0.0026760278,0.00017070094,0.00002606114,0.0009221581],"genre_scores_gemma":[0.9981407,0.000012875287,0.0012831383,0.000015653268,0.00003565097,0.00008175883,0.0001990465,0.00005046119,0.00018073442],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973902,0.00018944389,0.0006770535,0.0006201044,0.0006653063,0.0004578626],"domain_scores_gemma":[0.9978327,0.00020397354,0.00032676596,0.0009028568,0.00033824466,0.00039545997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042679583,0.0002912296,0.0007027619,0.00030410124,0.00008358188,0.000032315318,0.00029521057,0.00014452238,0.0000288389],"category_scores_gemma":[0.000782073,0.00022114071,0.000023906592,0.00038044076,0.000176722,0.0003186473,0.00022004005,0.00042571095,0.000003607541],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023479987,0.22851595,0.6342414,0.00014297145,0.0004657965,0.00042428917,0.002616366,4.612633e-7,0.0956081,0.000005351205,0.000060934035,0.014438356],"study_design_scores_gemma":[0.3560098,0.06598724,0.5428457,0.00017845983,0.0002535323,0.000015044484,0.0009158024,0.00006334133,0.03331574,0.000006020468,0.00017660612,0.00023270262],"about_ca_topic_score_codex":0.0022890107,"about_ca_topic_score_gemma":0.0036390433,"teacher_disagreement_score":0.3325298,"about_ca_system_score_codex":0.000039606253,"about_ca_system_score_gemma":0.00015098965,"threshold_uncertainty_score":0.9017857},"labels":[],"label_agreement":null},{"id":"W2597210174","doi":"10.1182/blood.v114.22.1084.1084","title":"Alemtuzumab Used with Fludarabine and Cyclophosphamide (FCC) for Stem Cell Transplantation in Acquired Aplastic Anemia Is Associated with a Low Risk of Graft Versus Host Disease and Viral Infections and with Sustained Engraftment.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Fludarabine; Alemtuzumab; Medicine; Transplantation; Graft-versus-host disease; Cyclophosphamide; Aplastic anemia; Internal medicine; Gastroenterology; Surgery; Treosulfan; Immunology; Bone marrow; Chemotherapy","score_opus":0.005271456850722984,"score_gpt":0.21307439706372142,"score_spread":0.20780294021299844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597210174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968304,0.000276337,0.001029194,0.00008450969,0.000010786306,0.0014555793,0.00023720642,0.000040624822,0.000035345827],"genre_scores_gemma":[0.9987509,0.0003928749,0.00052304723,0.00002472165,0.0000101283285,0.00006990741,0.0001638971,0.000027833175,0.000036645004],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885005,0.000050845625,0.00026824977,0.0003457205,0.00023380184,0.00025133768],"domain_scores_gemma":[0.9990684,0.00034776056,0.00016174414,0.000131348,0.000102430306,0.0001883206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011689846,0.00024358169,0.00038526783,0.0001557145,0.00009411081,0.000022727512,0.000025250716,0.000082127925,0.0000033970964],"category_scores_gemma":[0.000018944545,0.00018470592,0.000023520159,0.00025372003,0.000114623166,0.00012576694,0.0000029276348,0.00008854859,1.4699035e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04128517,0.0028337373,0.92315036,0.0039654546,0.00078985695,0.0007030558,0.0089133745,0.00013692756,0.017750312,0.00009159402,0.0000074976383,0.0003726477],"study_design_scores_gemma":[0.10064139,0.010406225,0.84822404,0.0013992799,0.005634844,0.00014142059,0.0007772249,0.00056663714,0.03179335,0.000026195985,0.0000026102152,0.00038679794],"about_ca_topic_score_codex":0.000053136366,"about_ca_topic_score_gemma":0.00024748626,"teacher_disagreement_score":0.07492635,"about_ca_system_score_codex":0.000041840285,"about_ca_system_score_gemma":0.00014122832,"threshold_uncertainty_score":0.7532089},"labels":[],"label_agreement":null},{"id":"W2597212957","doi":"10.1182/blood.v128.22.2614.2614","title":"Bleeding and Thrombotic Outcomes Following Perioperative Interruption of Direct Oral Anticoagulants in Patients with Prior Venous Thromboembolic Disease","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Rivaroxaban; Discontinuation; Perioperative; Apixaban; Surgery; Retrospective cohort study; Warfarin; Atrial fibrillation; Internal medicine","score_opus":0.016355689181739807,"score_gpt":0.27011699579199555,"score_spread":0.25376130661025575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597212957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984427,0.00019038886,0.000020202253,0.00017069888,0.000087077766,0.00073277985,0.000011361518,0.00003287628,0.00031187964],"genre_scores_gemma":[0.9995312,0.00007468164,0.00019964544,0.0000868377,0.000016188835,0.000028536908,0.000007236793,0.000027996319,0.000027673628],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988247,0.000040296793,0.00027418544,0.00031131995,0.00027942576,0.00027006664],"domain_scores_gemma":[0.99946314,0.00005145293,0.00009136168,0.00021562852,0.000052109757,0.00012629734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013403122,0.00019405555,0.000809134,0.00015495239,0.000057058252,0.000018588345,0.00006429598,0.000039008424,0.000019410294],"category_scores_gemma":[0.00009740776,0.00011408148,0.000074851385,0.0001274289,0.000076365206,0.00018122583,0.000074997726,0.000057663052,0.0000044744966],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000061146355,0.0034812803,0.9922411,0.00009202892,0.0004638889,0.000032540636,0.0008976899,0.0000014523243,0.00091574626,0.00009821728,0.000004605774,0.0017103185],"study_design_scores_gemma":[0.0075078416,0.00094499043,0.98906815,0.0007018949,0.0009039976,7.7235126e-7,0.00013644382,0.000006643091,0.000548312,0.00001567214,0.000008214608,0.00015704203],"about_ca_topic_score_codex":0.000061476385,"about_ca_topic_score_gemma":0.000036960413,"teacher_disagreement_score":0.007446695,"about_ca_system_score_codex":0.000041148563,"about_ca_system_score_gemma":0.000042339394,"threshold_uncertainty_score":0.46521077},"labels":[],"label_agreement":null},{"id":"W2597239135","doi":"10.1182/blood.v128.22.1377.1377","title":"Thrombocytopenia and Microangiopathic Hemolytic Anemia Precipitated By Acute Pancreatitis: A Single Center Experience of Five Cases","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"ADAMTS13; Microangiopathic hemolytic anemia; Thrombotic thrombocytopenic purpura; Medicine; Gastroenterology; Context (archaeology); Internal medicine; Thrombotic microangiopathy; Acute pancreatitis; Platelet; Disease","score_opus":0.011975796267109158,"score_gpt":0.23852379589808112,"score_spread":0.22654799963097197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597239135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99436957,0.004219574,0.000014714632,0.000050639806,0.00010923181,0.00028446782,0.00075729383,0.00004509272,0.0001494233],"genre_scores_gemma":[0.9986251,0.000092470626,0.00004165744,0.000037747002,0.000009160208,0.00004549106,0.00005743777,0.00001330448,0.001077657],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990302,0.000115965464,0.0002734101,0.0002894093,0.000033782657,0.00025728004],"domain_scores_gemma":[0.9993492,0.00017229865,0.00013155375,0.00026386403,0.000054405453,0.00002869269],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000050899842,0.00015343548,0.00030067583,0.000042868884,0.0000685978,0.000009960159,0.00016349078,0.00007974987,0.00047904748],"category_scores_gemma":[0.00007479509,0.00011049037,0.000051024417,0.000057960326,0.00025795717,0.00009642341,0.00012181632,0.000038581507,0.000060965875],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007317291,0.00042212798,0.05559276,0.00003255973,0.00018295241,0.000033505545,0.00073267764,7.2962125e-9,0.9401074,0.000013265635,0.0025494327,0.00026014625],"study_design_scores_gemma":[0.0049811895,0.00047848956,0.01254364,0.0003821936,0.00025185422,0.0011519302,0.00036995497,8.936022e-8,0.9783314,0.000023498797,0.0012589802,0.0002267718],"about_ca_topic_score_codex":0.000100417965,"about_ca_topic_score_gemma":0.000015149175,"teacher_disagreement_score":0.04304912,"about_ca_system_score_codex":0.000017618175,"about_ca_system_score_gemma":0.000023891609,"threshold_uncertainty_score":0.52452344},"labels":[],"label_agreement":null},{"id":"W2597243443","doi":"10.1182/blood.v106.11.934.934","title":"A Phase II Study of Enzastaurin, a Protein Kinase C-β (PKCβ) Inhibitor, in the Treatment of Relapsed Diffuse Large B-Cell Lymphoma (DLBCL).","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Phases of clinical research; Diffuse large B-cell lymphoma; Neutropenia; Febrile neutropenia; Transplantation; Progressive disease; Toxicity; Oncology; Pharmacology; Surgery; Chemotherapy; Gastroenterology","score_opus":0.018796161994482884,"score_gpt":0.3007050673734482,"score_spread":0.28190890537896535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597243443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944259,0.0011924704,0.0000015610922,0.00013543181,0.000020550284,0.0036565056,0.000028293554,0.000027145063,0.00051213824],"genre_scores_gemma":[0.99839455,0.00008299928,0.00013276494,0.000039373648,0.00016716751,0.00044502423,0.000013956449,0.00003679548,0.000687375],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9974009,0.00022194193,0.0006753089,0.00038802577,0.00081161055,0.00050221285],"domain_scores_gemma":[0.99847454,0.000110675624,0.00018106798,0.0009906573,0.000103974824,0.00013907837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045866973,0.00026659176,0.0005805184,0.00024699443,0.00007413368,0.000009524848,0.00024274948,0.00010962466,0.000035050074],"category_scores_gemma":[0.00009854385,0.00016972185,0.00015557157,0.0005196906,0.000090543705,0.000061585786,0.00009251577,0.000116177674,0.000014975239],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022286063,0.93025804,0.00047714586,0.00026064296,0.00022338597,0.0009490223,0.025031725,0.0000013959112,0.032544725,0.0000338993,0.00015724817,0.007834161],"study_design_scores_gemma":[0.7517664,0.033451654,0.00024223657,0.00015638002,0.00042665168,0.00007059124,0.0033376885,0.00043375706,0.20776585,0.0000068893573,0.0021912735,0.0001506393],"about_ca_topic_score_codex":0.00096525945,"about_ca_topic_score_gemma":0.0005429247,"teacher_disagreement_score":0.89680636,"about_ca_system_score_codex":0.0019703258,"about_ca_system_score_gemma":0.00213599,"threshold_uncertainty_score":0.69210565},"labels":[],"label_agreement":null},{"id":"W2597247499","doi":"10.1182/blood.v108.11.4273.4273","title":"The Ubiquitin Specific Peptidase 42 Gene (USP42) Is Recurrently Involved as a Fusion Gene with RUNX1 in Acute Myeloid Leukemia with the t(7;21)(p22;q22) Cryptic Translocation.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"RUNX1; Fusion gene; Biology; Chromosomal translocation; Myeloid leukemia; Fusion transcript; Karyotype; Molecular biology; Fusion protein; Leukemia; Genetics; Cancer research; Gene; Chromosome; Transcription factor","score_opus":0.011776877344481946,"score_gpt":0.24329501486352648,"score_spread":0.23151813751904454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597247499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9792513,0.005123484,0.000327626,0.011119827,0.00005694841,0.0020735983,0.000035835597,0.00012494363,0.0018864207],"genre_scores_gemma":[0.98725486,0.0037119228,0.0030393738,0.0011547928,0.00065882056,0.00047211323,0.00021944841,0.00015885556,0.0033298421],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99582934,0.00023393368,0.0006866003,0.00084847666,0.001334192,0.0010674627],"domain_scores_gemma":[0.99743944,0.0002980521,0.00024221616,0.0013627379,0.0003855274,0.00027199546],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009155382,0.00054701744,0.00056103733,0.00027259704,0.00058725604,0.00018224733,0.0006798939,0.000218495,0.00017140908],"category_scores_gemma":[0.00003878798,0.00029213508,0.0001484568,0.0014112116,0.0005741982,0.00017933473,0.00009432696,0.0011338583,0.00024637076],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014039696,0.0034593744,0.020030444,0.00041591967,0.001919544,0.004499831,0.012211531,0.00030087394,0.8669966,0.0014012435,0.039951388,0.034773596],"study_design_scores_gemma":[0.044888508,0.003667579,0.05945267,0.0010211386,0.0013177393,0.002087794,0.0029040165,0.0009975843,0.82456285,0.00044557618,0.057201937,0.0014525908],"about_ca_topic_score_codex":0.0008890092,"about_ca_topic_score_gemma":0.0008936053,"teacher_disagreement_score":0.042433694,"about_ca_system_score_codex":0.0006871564,"about_ca_system_score_gemma":0.0016024313,"threshold_uncertainty_score":0.9999531},"labels":[],"label_agreement":null},{"id":"W2597260518","doi":"10.1182/blood.v112.11.33.33","title":"Randomized, Parallel Group, Multicenter, Multinational Study Evaluating Safety of DU-176b Compared with Warfarin in Subjects with Non-Valvular Atrial Fibrillation","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Warfarin; Atrial fibrillation; Internal medicine; Adverse effect; Myocardial infarction; Randomized controlled trial; Stroke (engine); Mace; Data monitoring committee; Cardiology; Surgery; Percutaneous coronary intervention","score_opus":0.05221970175168812,"score_gpt":0.32243199646502496,"score_spread":0.27021229471333685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597260518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939275,0.00009616699,0.001315767,0.00015851576,0.00006774532,0.0040038726,0.0000030024892,0.000043384764,0.00038409207],"genre_scores_gemma":[0.9893807,0.00003465349,0.009864952,0.000014040315,0.0004576071,0.000010583403,0.00008924097,0.000026250354,0.00012193259],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976582,0.00028570485,0.0007354491,0.0003250277,0.0007846445,0.00021100434],"domain_scores_gemma":[0.9985397,0.0005588942,0.00038999144,0.0002277172,0.00021882857,0.00006489006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010588048,0.00022156956,0.0008834566,0.00023233735,0.0001151015,0.0000114309,0.000070393064,0.000054728553,0.000039059294],"category_scores_gemma":[0.00037840285,0.00015823024,0.00018372225,0.00036245247,0.0001017885,0.0001525251,0.000048573846,0.00010497511,0.0000053494723],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1425169,0.00016363137,0.8406499,0.000052059575,0.00051907584,0.000041157724,0.0014840193,0.014255135,0.000113605834,0.000040886363,0.000003207614,0.00016043837],"study_design_scores_gemma":[0.4665692,0.000700694,0.5096731,0.00008778014,0.0005763507,0.000016929622,0.0003407456,0.021836597,0.0000461432,0.0000044876924,0.00001634479,0.0001316061],"about_ca_topic_score_codex":0.00026655087,"about_ca_topic_score_gemma":0.00014039279,"teacher_disagreement_score":0.33097672,"about_ca_system_score_codex":0.000043205626,"about_ca_system_score_gemma":0.00008804625,"threshold_uncertainty_score":0.6452442},"labels":[],"label_agreement":null},{"id":"W2597309066","doi":"10.1182/blood.v128.22.243.243","title":"Higher c-MYC Expression Is Associated with Ixazomib-Lenalidomide-Dexamethasone (IRd) Progression-Free Survival (PFS) Benefit Versus Placebo-Rd: Biomarker Analysis of the Phase 3 Tourmaline-MM1 Study in Relapsed/Refractory Multiple Myeloma (RRMM)","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Medicine; Lenalidomide; Internal medicine; Ixazomib; Placebo; Oncology; Progression-free survival; Clinical endpoint; Interim analysis; Proteasome inhibitor; Dexamethasone; Multiple myeloma; Randomized controlled trial; Carfilzomib; Pathology; Chemotherapy","score_opus":0.04594296410992498,"score_gpt":0.33523731177272736,"score_spread":0.2892943476628024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597309066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99587345,0.0003447642,0.000008916572,0.0005342911,0.00019703263,0.002202609,0.00042203176,0.00008581482,0.0003310636],"genre_scores_gemma":[0.99799883,0.000036661102,0.00031324665,0.000029896128,0.0000847993,0.00028555212,0.00008153286,0.0000796614,0.001089794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949548,0.00068805757,0.00083720067,0.0008641814,0.0018646778,0.00079107756],"domain_scores_gemma":[0.9948599,0.0020995205,0.000568439,0.0016823345,0.00039138895,0.00039842143],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011264636,0.0005162153,0.001170728,0.0006729802,0.00018002217,0.000031497137,0.0005640147,0.00027032933,0.00072574295],"category_scores_gemma":[0.00211131,0.0002582321,0.00039749162,0.0017636886,0.00022870374,0.00017048033,0.00038196304,0.000359701,0.000016628943],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03246186,0.018092666,0.88529086,0.000033073895,0.008491252,0.00045502718,0.00047341335,0.000004745862,0.04794728,0.0000019709398,0.00030605533,0.0064417846],"study_design_scores_gemma":[0.21107247,0.0023946883,0.74577427,0.00068669894,0.003230695,0.000003499351,0.00027401253,0.0001793712,0.03597688,0.0000061043615,0.0000963507,0.00030495544],"about_ca_topic_score_codex":0.00043225568,"about_ca_topic_score_gemma":0.0018014067,"teacher_disagreement_score":0.17861061,"about_ca_system_score_codex":0.00025580724,"about_ca_system_score_gemma":0.00023029024,"threshold_uncertainty_score":0.999987},"labels":[],"label_agreement":null},{"id":"W2597328822","doi":"10.1182/blood.v124.21.3853.3853","title":"Depletion of Red Blood Cells from Cord Blood Using a Simple and Rapid Immunomagnetic Separation Method","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Stemcell Technologies","funders":"","keywords":"Hemolysis; Transplantation; Cord blood; Leukapheresis; Chromatography; Centrifugation; Haematopoiesis; Cryopreservation; Andrology; Progenitor cell; Immunomagnetic separation; CD34; Molecular biology; Immunology; Chemistry; Percoll; Bone marrow; Biology; Stem cell; Medicine; Surgery; Cell biology; Embryo","score_opus":0.020121273195374312,"score_gpt":0.2932627177468118,"score_spread":0.27314144455143746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597328822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838579,0.00047605604,0.0143559575,0.00004257932,0.000075792945,0.00047751665,0.000029619116,0.000053274867,0.00063129846],"genre_scores_gemma":[0.9229432,0.00010020667,0.07660687,0.000060864495,0.00010311388,0.000011780272,0.000116066956,0.00003251662,0.000025417605],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99845296,0.00021583088,0.0005071186,0.00034144157,0.0002752665,0.00020739195],"domain_scores_gemma":[0.99892527,0.0002949752,0.00021470686,0.0003574568,0.000103102844,0.00010448918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003950798,0.00018695364,0.00044110222,0.00011697006,0.000061094426,0.00001938429,0.0000638329,0.00015106308,0.0001384404],"category_scores_gemma":[0.00006134956,0.00018616483,0.00007768137,0.00016743649,0.000048379443,0.000071386225,0.000018374154,0.00011477071,0.0000066702737],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014338303,0.00048419042,0.0069186464,0.0002706291,0.00019847084,0.000013814414,0.0004322558,0.000008811689,0.9901588,0.000038688308,0.000009156698,0.001323153],"study_design_scores_gemma":[0.009843962,0.0011690091,0.020380517,0.0002372062,0.0035975797,0.00027435174,0.0001064522,0.0024652262,0.9613033,0.00031037122,0.00010894313,0.00020311524],"about_ca_topic_score_codex":0.00023159714,"about_ca_topic_score_gemma":0.000013037519,"teacher_disagreement_score":0.06225091,"about_ca_system_score_codex":0.0000071089994,"about_ca_system_score_gemma":0.0000499786,"threshold_uncertainty_score":0.7591582},"labels":[],"label_agreement":null},{"id":"W2597368060","doi":"10.1182/blood.v104.11.1784.1784","title":"PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT): A Pilot Study.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Dalhousie University; University of Ottawa; McMaster University; Université de Sherbrooke; Université de Montréal","funders":"","keywords":"Medicine; Pulmonary embolism; Heparin; Randomized controlled trial; Randomization; Low molecular weight heparin; Surgery","score_opus":0.05348025605175573,"score_gpt":0.3496906282410681,"score_spread":0.2962103721893124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597368060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98791564,0.00041069213,0.00011237819,0.0007774206,0.00036092632,0.008927164,0.000011880392,0.0000978175,0.0013860585],"genre_scores_gemma":[0.9953678,0.0000144836495,0.0013589168,0.00028793878,0.00055047893,0.0023435347,0.000010358053,0.00004489998,0.00002156552],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983103,0.00004419928,0.00038551097,0.00048056315,0.00033263472,0.00044678285],"domain_scores_gemma":[0.99921983,0.000068021174,0.00004281985,0.00041032216,0.00012395649,0.00013501655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025640632,0.00021393198,0.0006932334,0.00017501444,0.00010646197,0.000038220485,0.00013113956,0.00006943518,0.000043257638],"category_scores_gemma":[0.00040902905,0.00018584933,0.00010852035,0.00023060785,0.00005965435,0.00006664087,0.00007454273,0.00020760627,0.000028838733],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0779636,0.7147556,0.01882574,0.010486966,0.0028037895,0.00346839,0.053670105,0.00016854968,0.01370316,0.07489607,0.0014907555,0.027767293],"study_design_scores_gemma":[0.6107061,0.19692412,0.16799821,0.0005063453,0.001952285,0.000032803706,0.00853156,0.0000032793287,0.006117568,0.005310143,0.001121995,0.0007956197],"about_ca_topic_score_codex":0.00048248438,"about_ca_topic_score_gemma":0.00036916617,"teacher_disagreement_score":0.5327425,"about_ca_system_score_codex":0.000093178845,"about_ca_system_score_gemma":0.000163993,"threshold_uncertainty_score":0.7578716},"labels":[],"label_agreement":null},{"id":"W2597397210","doi":"10.1182/blood.v116.21.4924.4924","title":"25 Year Old Female Conceiving 6 Months After Last Dose of Rituximab: a Case Report","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Regional Hospital; Western University","funders":"","keywords":"Rituximab; Medicine; Pregnancy; CD20; Lymphoma; Follicular lymphoma; Fetus; Internal medicine; Biology","score_opus":0.01138891233944219,"score_gpt":0.27196372194715385,"score_spread":0.2605748096077117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597397210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99627686,0.00013894596,0.000004154891,0.00006886254,0.00022270852,0.00018273116,0.000024294326,0.00003130791,0.0030501336],"genre_scores_gemma":[0.99791837,0.000008675951,0.00047898723,0.00006936707,0.000267039,0.000019356112,0.0000047214703,0.000018938264,0.0012145726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99927866,0.000006496415,0.00022807208,0.00018535744,0.00014709488,0.00015432059],"domain_scores_gemma":[0.9993183,0.000023451554,0.00008997694,0.00038907945,0.00006496882,0.00011421674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011313946,0.00009268642,0.00023973505,0.000046286823,0.000022709723,0.000008840503,0.000035441797,0.000080673584,0.00042425806],"category_scores_gemma":[0.00009029968,0.00007837408,0.00009070603,0.000078642996,0.00007010828,0.000041862404,0.000031921572,0.00020514437,0.000022140877],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015248198,0.0012944778,0.8936581,0.00015616963,0.00013605395,0.07916718,0.0014735976,2.1316855e-7,0.022087185,0.000068565794,0.00052437437,0.0012816275],"study_design_scores_gemma":[0.018622966,0.0004918215,0.83766687,0.0003239276,0.0009456315,0.06189591,0.0009345943,0.000021295147,0.05000731,0.00003284137,0.028571717,0.00048512997],"about_ca_topic_score_codex":0.0010259376,"about_ca_topic_score_gemma":0.0014787592,"teacher_disagreement_score":0.05599122,"about_ca_system_score_codex":0.0000075218054,"about_ca_system_score_gemma":0.000070752074,"threshold_uncertainty_score":0.46453282},"labels":[],"label_agreement":null},{"id":"W2597404181","doi":"10.1182/blood.v104.11.3514.3514","title":"Post-Thrombotic Syndrome, Functional Disability and Quality of Life after Upper Extremity Deep Venous Thrombosis in Adults.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Dash; Post-thrombotic syndrome; Quality of life (healthcare); Venous thrombosis; Thrombosis; Rivaroxaban; Physical therapy; Internal medicine; Activities of daily living; Warfarin; Surgery; Atrial fibrillation","score_opus":0.01785284828692471,"score_gpt":0.25592043094045464,"score_spread":0.23806758265352992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597404181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969472,0.0009054889,0.00003900453,0.00088376016,0.00010762355,0.0006518727,0.000031982625,0.00004111116,0.00039191594],"genre_scores_gemma":[0.99848896,0.00019995011,0.0005347976,0.00057455787,0.00005286768,0.00008979117,0.000028231332,0.00002291952,0.0000079498295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816424,0.00007435485,0.0005931261,0.000465393,0.0003829462,0.00031995302],"domain_scores_gemma":[0.99905217,0.00008559139,0.00011985056,0.00045027467,0.000095752446,0.00019635996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038661968,0.00021465225,0.0008202602,0.00008356674,0.00004970387,0.0000124329445,0.00007398316,0.0001230123,0.00034637723],"category_scores_gemma":[0.00023465366,0.0001928231,0.00014594305,0.00019994407,0.00028321077,0.000118645534,0.00011290427,0.00018219487,0.000019192717],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022698725,0.014770912,0.9812119,0.0010864811,0.00025711145,0.000024564455,0.00088514487,0.000023089684,0.00045103004,0.000681266,0.000008142857,0.00037337682],"study_design_scores_gemma":[0.005487049,0.0005916327,0.9921608,0.0002970728,0.00027324728,0.000020472782,0.00044268422,0.000003300759,0.00018133693,0.00034626,0.000010191338,0.00018592771],"about_ca_topic_score_codex":0.0017807354,"about_ca_topic_score_gemma":0.001152138,"teacher_disagreement_score":0.014179279,"about_ca_system_score_codex":0.00009716572,"about_ca_system_score_gemma":0.00008948169,"threshold_uncertainty_score":0.78630984},"labels":[],"label_agreement":null},{"id":"W2597498378","doi":"10.1182/blood.v116.21.82.82","title":"Rate of Late Venous Thromboembolism Events In High-Risk Medical Patients","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Foothills Medical Centre; Sanofi (Canada); Alberta Health; University of Calgary","funders":"","keywords":"Medicine; Incidence (geometry); Medical record; Population; Venous thromboembolism; Emergency department; Pediatrics; Emergency medicine; Intensive care medicine; Internal medicine; Thrombosis","score_opus":0.005105356641888358,"score_gpt":0.2341173661004068,"score_spread":0.22901200945851843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597498378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99698734,0.000051488485,0.0000041417243,0.00033385595,0.00061900896,0.000537863,0.00001581088,0.000038948303,0.0014115686],"genre_scores_gemma":[0.9986744,0.00034646,0.00022165016,0.00044487498,0.00014719469,0.00003555496,0.000037298254,0.000031704032,0.000060847524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983741,0.00007226364,0.00045765567,0.00029456933,0.00045818524,0.00034319743],"domain_scores_gemma":[0.9990391,0.00006813166,0.0001767817,0.00042274751,0.00008841467,0.00020480018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005393045,0.0001730698,0.0007074253,0.00016268752,0.00004288683,0.000004268408,0.0001949484,0.00018786256,0.00048092645],"category_scores_gemma":[0.00038146574,0.00014810203,0.000096154334,0.00021206492,0.00007071192,0.000058833823,0.0001262307,0.00044813473,0.000080835234],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057995876,0.02465387,0.9593839,0.00022166928,0.0004558439,0.00010390379,0.0007391658,0.0000055382966,0.0016862781,0.0018469974,0.000761385,0.010083445],"study_design_scores_gemma":[0.0073418394,0.0005331621,0.9869821,0.00014805183,0.00035603472,0.0000033070164,0.000015877979,0.000018647977,0.0027293228,0.0011009544,0.00063456927,0.00013611767],"about_ca_topic_score_codex":0.0011553342,"about_ca_topic_score_gemma":0.00041533957,"teacher_disagreement_score":0.027598208,"about_ca_system_score_codex":0.000013518376,"about_ca_system_score_gemma":0.0000943692,"threshold_uncertainty_score":0.6039426},"labels":[],"label_agreement":null},{"id":"W2597924550","doi":"10.1182/blood.v128.22.230.230","title":"Results of the Phase 3 Study of Lenalidomide Versus Placebo As Maintenance Therapy Following Second-Line Treatment for Patients with Chronic Lymphocytic Leukemia (the CONTINUUM Trial)","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Internal medicine; Lenalidomide; Bendamustine; Maintenance therapy; Clinical endpoint; Progression-free survival; Oncology; Randomization; IGHV@; Chronic lymphocytic leukemia; Minimal residual disease; Neutropenia; Phases of clinical research; Randomized controlled trial; Clinical trial; Leukemia; Multiple myeloma; Chemotherapy","score_opus":0.0315961884502852,"score_gpt":0.3215981640664695,"score_spread":0.2900019756161843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597924550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99074924,0.00028053642,0.00000858711,0.00011162994,0.00029709598,0.00820098,0.00008895396,0.000023626506,0.00023936496],"genre_scores_gemma":[0.99644816,0.0000680324,0.000028688217,0.00002636635,0.00019002476,0.00057694444,0.0000125730985,0.000050825256,0.0025983613],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9974097,0.00018485059,0.0007332462,0.00045288846,0.00072427175,0.0004950405],"domain_scores_gemma":[0.99632204,0.0016519271,0.00046005327,0.0011793779,0.00028107892,0.000105520696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006151052,0.00029459165,0.00069590914,0.000072466144,0.000117282296,0.000011917208,0.00037066,0.00008611483,0.000032232358],"category_scores_gemma":[0.00078286714,0.00011592166,0.0003232586,0.00026067244,0.00021359371,0.00006705655,0.0000713203,0.0000822187,0.000005702624],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.9640983,0.008303027,0.0003681701,0.000112281356,0.004263145,0.000052184772,0.0019478742,0.00002551148,0.0066298237,0.000017764638,0.0004917543,0.013690196],"study_design_scores_gemma":[0.87549955,0.042143762,0.0001968739,0.00034993008,0.0006812401,0.000008728406,0.00025126315,0.00010377869,0.0792689,0.000011132186,0.0013539272,0.0001309007],"about_ca_topic_score_codex":0.00082138786,"about_ca_topic_score_gemma":0.0007364139,"teacher_disagreement_score":0.088598706,"about_ca_system_score_codex":0.01774352,"about_ca_system_score_gemma":0.015092083,"threshold_uncertainty_score":0.99049145},"labels":[],"label_agreement":null},{"id":"W2597968140","doi":"10.1182/blood.v128.22.5193.5193","title":"In Vitro Comparison of ADCC and CAR Sensitivity of Adult HER-2+ B-ALL Using the NK-92 Human Cell Line Transduced with a Human CD16 (ADCC) or an Anti-HER2 Chimeric Antigen Receptor (CAR)","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Antibody-dependent cell-mediated cytotoxicity; Cytotoxic T cell; Medicine; Chimeric antigen receptor; CD20; Immunology; Antigen; Antibody; Cancer research; Monoclonal antibody; In vitro; Biology; Immunotherapy; Immune system","score_opus":0.04747231502687925,"score_gpt":0.34110462667759395,"score_spread":0.2936323116507147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597968140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99838525,0.00021082337,0.00006167494,0.00020248641,0.000027287264,0.00087605976,0.00005555895,0.000027889644,0.00015296259],"genre_scores_gemma":[0.99867684,0.00010616775,0.0006705305,0.00006270816,0.00014743076,0.000008497855,0.000020974398,0.0000666156,0.0002402102],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997668,0.00044080208,0.0005170597,0.0004431367,0.0004999264,0.0004310465],"domain_scores_gemma":[0.9985988,0.00017496123,0.00022900307,0.0005917741,0.00023964606,0.00016578277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059971295,0.00027389798,0.0008782091,0.00019269797,0.00009667358,0.000014230857,0.00015013132,0.0001365092,0.00023696014],"category_scores_gemma":[0.000030412632,0.00015487005,0.00009828091,0.00037685857,0.0003995246,0.0001164426,0.00004584454,0.0003002539,0.0000013972801],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013337564,0.0018783842,0.03988317,0.00025390342,0.00017858636,0.000043608954,0.002774239,0.0000029046305,0.9523143,0.000004160392,0.0000105090785,0.0013224541],"study_design_scores_gemma":[0.009324865,0.0020569542,0.016027283,0.0003523159,0.00020845002,0.00004950232,0.00073753175,0.00017404841,0.9707726,0.0000041424237,0.00008454417,0.0002077472],"about_ca_topic_score_codex":0.002649848,"about_ca_topic_score_gemma":0.0013421307,"teacher_disagreement_score":0.023855887,"about_ca_system_score_codex":0.0000413158,"about_ca_system_score_gemma":0.00013652683,"threshold_uncertainty_score":0.6315417},"labels":[],"label_agreement":null},{"id":"W2598033418","doi":"10.1182/blood.v128.22.5964.5964","title":"Test-Retest Reliability Analysis of the Patient Reported Outcomes Burdens and Experiences (PROBE)","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Hemophilia Society; McMaster University","funders":"","keywords":"Intraclass correlation; Kappa; Medicine; Cohen's kappa; Quality of life (healthcare); Reliability (semiconductor); Test (biology); Physical therapy; Clinical psychology; Psychometrics; Statistics","score_opus":0.02064752383122629,"score_gpt":0.29343376043158914,"score_spread":0.27278623660036283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2598033418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996876,0.00010444765,0.0000016931298,0.0022241022,0.000023662273,0.00025168204,0.000006656832,0.000015366068,0.0004963964],"genre_scores_gemma":[0.9987748,0.000023994495,0.0001263625,0.000025618494,0.000010544274,0.000030179352,0.0000012846513,0.0000041476774,0.0010030515],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99907863,0.000033021915,0.00024796245,0.00020349014,0.0003018025,0.0001351],"domain_scores_gemma":[0.99898106,0.00029552088,0.00008225697,0.00045965152,0.000106478314,0.000075050855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015358391,0.000077112716,0.00026011883,0.00007435036,0.00005177634,0.000004719783,0.00005524122,0.00004249026,0.00011843572],"category_scores_gemma":[0.0012825254,0.000028842118,0.00013210122,0.00035812237,0.00021903851,0.000022909355,0.00005804527,0.00004132613,0.0000016472992],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009968166,0.00043896592,0.9909383,0.0000112165335,0.0004230673,0.000013934021,0.0011803531,5.5534198e-8,0.0059636543,0.0000038735698,0.00002105667,0.0009955585],"study_design_scores_gemma":[0.000990568,0.00026596838,0.9581704,0.000035790203,0.0011765095,0.000007873187,0.0005802124,0.0000075376643,0.03860783,0.000027777953,0.000084327105,0.000045204648],"about_ca_topic_score_codex":0.000057106146,"about_ca_topic_score_gemma":0.00001013889,"teacher_disagreement_score":0.032767896,"about_ca_system_score_codex":0.0000131866,"about_ca_system_score_gemma":0.000049900864,"threshold_uncertainty_score":0.15353952},"labels":[],"label_agreement":null},{"id":"W2598163766","doi":"10.1182/blood.v124.21.2529.2529","title":"Evaluation of the Disease Risk Index on Outcomes Following Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Myelodysplastic syndromes; Internal medicine; Univariate analysis; Transplantation; Myeloid leukemia; Hematopoietic stem cell transplantation; Surgery; Myeloid; Oncology; International Prognostic Scoring System; Bone marrow; Gastroenterology; Multivariate analysis","score_opus":0.017819161390609142,"score_gpt":0.29588063515144114,"score_spread":0.278061473760832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2598163766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965903,0.00020971593,0.0010434295,0.0002768917,0.00011746328,0.0014385472,0.000063008665,0.000030339474,0.00023030321],"genre_scores_gemma":[0.9990257,0.00009956898,0.00030991528,0.00011268407,0.000041276024,0.00017814469,0.00003820818,0.000039366798,0.00015513675],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99770004,0.0002749622,0.00031955822,0.0003547135,0.001065068,0.00028569033],"domain_scores_gemma":[0.99844843,0.0006032149,0.00015640781,0.00044067178,0.00017894077,0.00017234121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013510957,0.00020795666,0.00037082908,0.00013936171,0.00015971408,0.000019237254,0.00015694444,0.00010382678,0.000012573839],"category_scores_gemma":[0.0007501991,0.00014008442,0.00022497671,0.00016989293,0.00007987568,0.00006605354,0.000034843033,0.0002084975,0.0000066658954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061364286,0.00048634637,0.9742184,0.0010029336,0.0014905606,0.000029517496,0.0008222712,0.0008719634,0.014545403,0.00018204711,0.000079655554,0.0056572426],"study_design_scores_gemma":[0.0134612415,0.00037855076,0.952027,0.00022568917,0.011179664,0.000033210054,0.000059139184,0.0063604102,0.015168102,0.00090759684,0.00001852679,0.00018083594],"about_ca_topic_score_codex":0.000020306843,"about_ca_topic_score_gemma":0.000011020699,"teacher_disagreement_score":0.022191383,"about_ca_system_score_codex":0.00015765194,"about_ca_system_score_gemma":0.0005223734,"threshold_uncertainty_score":0.5712477},"labels":[],"label_agreement":null},{"id":"W2598458092","doi":"10.1182/blood.v126.23.1261.1261","title":"Effective Treatment of Human CML By RNAi In Vivo in a Xenotransplantation Mouse Model","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"In vivo; Small interfering RNA; Xenotransplantation; K562 cells; Transplantation; Transfection; RNA interference; Chemistry; Ex vivo; Cancer research; Medicine; Pharmacology; Leukemia; Immunology; Biology; RNA; Biochemistry","score_opus":0.014251942258396523,"score_gpt":0.2621744784885009,"score_spread":0.24792253623010438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2598458092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99890274,0.00026133165,0.000114865645,0.0000067981296,0.000009764621,0.00015454713,0.000047174384,0.0000023918474,0.0005004005],"genre_scores_gemma":[0.9993657,0.00013214033,0.000056644323,0.000015954578,0.000015584628,0.00004153578,0.00006538154,0.000006331965,0.00030072036],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999575,0.000028373905,0.0001162857,0.0001424986,0.00004629606,0.00009153344],"domain_scores_gemma":[0.99981534,0.0000029191026,0.000028647057,0.00010181583,0.000023872326,0.000027371718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000043173204,0.00007437661,0.00009993524,0.000035702,0.0000063070697,0.0000031006846,0.000049748458,0.00006883799,0.0000015292784],"category_scores_gemma":[0.0000040319414,0.00006879009,0.00002860598,0.0000318496,0.000015345238,0.000002643203,0.0000073726897,0.000019260486,0.0000013394389],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008680487,0.0005881811,0.0066273063,0.0000069794155,0.000021832508,0.000002858331,0.0004948397,0.00073818414,0.99117893,0.000005012947,0.00008155533,0.00016752652],"study_design_scores_gemma":[0.0027094246,0.0011271106,0.0005472797,0.000011093964,0.000015301153,0.0000014595474,0.00005613279,0.00018424823,0.9952025,0.000048620328,0.00002484292,0.000071977534],"about_ca_topic_score_codex":0.00032954008,"about_ca_topic_score_gemma":0.0006028242,"teacher_disagreement_score":0.0060800263,"about_ca_system_score_codex":0.0000139950635,"about_ca_system_score_gemma":0.000025029758,"threshold_uncertainty_score":0.28051785},"labels":[],"label_agreement":null},{"id":"W2598509493","doi":"10.1182/blood.v128.22.5821.5821","title":"Results of Salvage Autologous Stem Cell Transplantation (ASCT) for Relapsed Multiple Myeloma (MM) in the Era of Novel Agents: Outcome of Patients (Pts) Receiving Prior Bortezomib (BTZ)-Based Therapy","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bortezomib; Salvage therapy; Autologous stem-cell transplantation; Regimen; Multiple myeloma; Thalidomide; Surgery; Internal medicine; Lenalidomide; Oncology; Cyclophosphamide; Transplantation; Median follow-up; Chemotherapy","score_opus":0.04255757704501884,"score_gpt":0.298766442566565,"score_spread":0.25620886552154615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2598509493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99544275,0.000085169726,0.0005860612,0.00021990358,0.000050345254,0.0022664648,0.0012311265,0.000018790732,0.00009939963],"genre_scores_gemma":[0.9970728,0.000101172634,0.0023649458,0.0000487873,0.000015774493,0.00012413926,0.00017252802,0.000029584337,0.00007026926],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977809,0.00015064748,0.0009145884,0.0003087759,0.000520063,0.00032499785],"domain_scores_gemma":[0.99753004,0.0012103945,0.00046791468,0.00047537024,0.00024013975,0.00007614772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005656104,0.00019968521,0.0005152844,0.00017034037,0.00004231414,0.00000451329,0.00021065734,0.00012347313,0.000009290671],"category_scores_gemma":[0.0002961433,0.000113480324,0.00019748713,0.00021853093,0.00009150446,0.000077341545,0.000012423914,0.00012406714,0.0000015848864],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012327273,0.008969233,0.8220988,0.0008017034,0.00025235815,0.00003054896,0.0019799063,0.000012510117,0.098792054,0.0000063400225,0.000034752575,0.05469451],"study_design_scores_gemma":[0.08657085,0.0015791545,0.7217604,0.00033808465,0.00010954841,0.000001843106,0.00006703682,0.00022472483,0.18922538,0.000002779187,0.000035640074,0.000084571926],"about_ca_topic_score_codex":0.00020178012,"about_ca_topic_score_gemma":0.0001037439,"teacher_disagreement_score":0.10033843,"about_ca_system_score_codex":0.000044720047,"about_ca_system_score_gemma":0.00011513252,"threshold_uncertainty_score":0.46275932},"labels":[],"label_agreement":null},{"id":"W2598696175","doi":"10.1182/blood-2016-11-747022","title":"Genetic profiling of MYC and BCL2 in diffuse large B-cell lymphoma determines cell-of-origin–specific clinical impact","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Cell of origin; Biology; Gene expression profiling; Lymphoma; Cancer research; Profiling (computer programming); Cell; Computational biology; Genetics; Gene; Immunology; Gene expression","score_opus":0.031713977297532815,"score_gpt":0.3348248998591481,"score_spread":0.30311092256161526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2598696175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99498266,0.0037893164,0.0000018322163,0.000023421855,0.00008907894,0.000357687,0.0000316319,0.000009510135,0.0007148886],"genre_scores_gemma":[0.9963295,0.0020742824,0.0013744296,0.0000145160275,0.0001116099,0.000019613413,0.0000064635296,0.000019373134,0.000050216455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987958,0.000036165937,0.00049473497,0.00027910882,0.0001559606,0.00023822678],"domain_scores_gemma":[0.9987937,0.00013353769,0.0002845938,0.0006014346,0.000048252004,0.00013847717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001711377,0.00016601039,0.0005250365,0.00007610949,0.000053805004,0.00002036199,0.000117231815,0.00010893701,0.000011747674],"category_scores_gemma":[0.00006083347,0.00012079592,0.00016202465,0.000041156385,0.00010199817,0.000046550394,0.000079635785,0.000045353772,0.000006816599],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009749877,0.019258572,0.9707673,0.00014641066,0.000057948197,0.00022803848,0.00008646979,1.0161409e-7,0.0041968753,0.000008648365,0.000033925713,0.005118192],"study_design_scores_gemma":[0.04703838,0.0006719083,0.88063186,0.00012864836,0.00021394169,0.00003421408,0.000024631938,0.000044671724,0.070950665,0.000017642169,0.00014639994,0.00009702044],"about_ca_topic_score_codex":0.000109236345,"about_ca_topic_score_gemma":0.000016860546,"teacher_disagreement_score":0.09013544,"about_ca_system_score_codex":0.000024418785,"about_ca_system_score_gemma":0.000109410226,"threshold_uncertainty_score":0.49259147},"labels":[],"label_agreement":null},{"id":"W2599091064","doi":"10.1182/blood.v120.21.1092.1092","title":"Differential Expression of Markers of Apoptosis in Platelets From Children with Acute Versus Chronic Immune Thrombocytopenia","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Platelet; Medicine; Immunology; Gastroenterology; Flow cytometry; Phosphatidylserine; Thrombopoietin; Internal medicine; Apoptosis; Immune thrombocytopenia; Platelet activation; Biology","score_opus":0.009135889403093081,"score_gpt":0.24022010639764657,"score_spread":0.2310842169945535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2599091064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981569,0.0009893199,0.000005822195,0.000013685844,0.000071854265,0.00032617216,0.000060399663,0.000011675474,0.00036415015],"genre_scores_gemma":[0.99914503,0.00020714992,0.00036240212,0.0000027792323,0.000035553898,0.000012887719,0.00019896853,0.000019223964,0.00001602447],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991619,0.000021923248,0.00023080023,0.00015205443,0.00019545396,0.00023787214],"domain_scores_gemma":[0.9995069,0.000030364843,0.00012897882,0.00024829668,0.000016625361,0.000068853165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000026567954,0.0001500623,0.00052557664,0.0000705958,0.000018361636,0.0000027158799,0.00007696773,0.00008732673,0.00025232276],"category_scores_gemma":[0.000005828246,0.000106620784,0.00007013247,0.00010236929,0.000051432915,0.000090421454,0.000046899633,0.000097341,0.0000060221496],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00470097,0.0037171561,0.44470173,0.000041780964,0.0022077847,0.000032200925,0.00033513282,0.0000010376908,0.54285026,0.0000061038118,0.000027199625,0.0013786625],"study_design_scores_gemma":[0.018438715,0.0006261855,0.46007526,0.00015461986,0.000591887,0.000011168155,0.000022515864,0.0000016002441,0.5200056,0.0000027643598,0.0000024378166,0.000067244095],"about_ca_topic_score_codex":0.00044245494,"about_ca_topic_score_gemma":0.000024493993,"teacher_disagreement_score":0.022844633,"about_ca_system_score_codex":0.000027907698,"about_ca_system_score_gemma":0.000045505007,"threshold_uncertainty_score":0.43478695},"labels":[],"label_agreement":null},{"id":"W2599558025","doi":"10.1182/blood-2017-01-761593","title":"Platelet polyphosphate: the long and the short of it","year":2017,"lang":"en","type":"letter","venue":"Blood","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Polyphosphate; Platelet; Platelet activation; Thrombosis; Medicine; Chemistry; Immunology; Biochemistry; Internal medicine; Phosphate","score_opus":0.020098102519490183,"score_gpt":0.2623652373907548,"score_spread":0.2422671348712646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2599558025","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08628666,0.034186333,0.000014555244,0.86674774,0.0007916153,0.0015818127,0.00008233799,0.00007551541,0.010233443],"genre_scores_gemma":[0.627168,0.0022373858,0.000071865405,0.33211634,0.0077021653,0.0000878971,0.0003141198,0.00014863504,0.030153578],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99825996,0.000070865375,0.0004528727,0.00035945323,0.00049717457,0.00035964852],"domain_scores_gemma":[0.9979765,0.00040997402,0.00030358913,0.0011575889,0.00009154809,0.000060820836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045620557,0.00033774052,0.0007408438,0.0000630892,0.0003083865,0.00008360621,0.0004279303,0.00047910758,0.00014664562],"category_scores_gemma":[0.0001502141,0.00017421175,0.00029349545,0.0000688826,0.00080943055,0.000062612584,0.00013654299,0.00085099216,0.000015503634],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021965645,0.00012425365,0.01940553,0.0004624435,0.0012518512,0.0007433628,0.0010191293,3.7207573e-7,0.000030186995,0.00029852506,0.96757454,0.008870145],"study_design_scores_gemma":[0.009191092,0.0002079155,0.059838247,0.00093626144,0.003220405,0.0013855346,0.00008159033,0.00004751412,0.004788208,0.0005413927,0.9192438,0.0005180016],"about_ca_topic_score_codex":0.00038856454,"about_ca_topic_score_gemma":0.00003411211,"teacher_disagreement_score":0.54088134,"about_ca_system_score_codex":0.000009808004,"about_ca_system_score_gemma":0.00013267063,"threshold_uncertainty_score":0.7104149},"labels":[],"label_agreement":null},{"id":"W2599724895","doi":"10.1182/blood.v128.22.96.96","title":"Dose-Dependent Effect of Stored Red Blood: Results of a Sub-Group Analysis of the Age of Blood Evaluation (ABLE) Trial","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Centre Hospitalier de l’Université de Montréal; Ottawa Hospital; McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Hazard ratio; Proportional hazards model; Randomization; Clinical trial; Randomized controlled trial; Confounding; Internal medicine; Surgery; Confidence interval","score_opus":0.017509973770032376,"score_gpt":0.2744386390495868,"score_spread":0.25692866527955444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2599724895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99545497,0.00026635485,0.00003255142,0.00021804309,0.00016114308,0.0023094749,0.00010511791,0.00002035146,0.0014319787],"genre_scores_gemma":[0.99932325,0.0001641018,0.00009941825,0.000016778913,0.000050400995,0.000060164006,0.000038597977,0.000019760007,0.0002275487],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964578,0.000563204,0.0011296013,0.00035440185,0.0012951527,0.00019982607],"domain_scores_gemma":[0.99754506,0.00034787692,0.0007340459,0.0010225064,0.000283397,0.00006713719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027687773,0.00020014637,0.0010476888,0.00044290407,0.000027707827,0.0000030554154,0.0002511065,0.00013569786,0.00010379827],"category_scores_gemma":[0.0007047742,0.00011128411,0.00064092065,0.0009665107,0.0001422606,0.000042792206,0.000081756996,0.00009557213,9.215658e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023803707,0.0052619083,0.006354506,0.00044981696,0.01076484,0.000012022161,0.00037837625,0.000017841636,0.9490595,0.00008002046,0.00008255669,0.0037349472],"study_design_scores_gemma":[0.21793735,0.003702039,0.04376194,0.00034783126,0.068778105,0.0000022792085,0.00003340398,0.000026670263,0.66525173,0.000017460896,0.00004685772,0.00009433166],"about_ca_topic_score_codex":0.00031492297,"about_ca_topic_score_gemma":0.00030113137,"teacher_disagreement_score":0.28380772,"about_ca_system_score_codex":0.000013820168,"about_ca_system_score_gemma":0.00008469202,"threshold_uncertainty_score":0.45380345},"labels":[],"label_agreement":null},{"id":"W2599824194","doi":"10.1182/blood.v128.22.75.75","title":"Endosome-Mitochondria Interface Controls Intracellular Iron Trafficking in Erythroid Cells","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spartan Bioscience (Canada); Impact; McGill University; Jewish General Hospital","funders":"","keywords":"Endosome; Ferrochelatase; Reticulocyte; Population; Cell biology; Mitochondrion; Transferrin receptor; Biology; Transferrin; Intracellular; Biochemistry; Heme; Medicine","score_opus":0.010639345528117955,"score_gpt":0.2364027709288647,"score_spread":0.22576342540074673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2599824194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944043,0.000877779,0.001062338,0.0009945724,0.0006904036,0.0004193187,0.0000075208145,0.00011065852,0.001433101],"genre_scores_gemma":[0.99647874,0.0001946903,0.00051639706,0.00046641202,0.00041249348,0.000029472481,0.000005429682,0.000030267884,0.00186609],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986994,0.00008899031,0.00034148298,0.00036576076,0.0001436127,0.00036071363],"domain_scores_gemma":[0.99924296,0.0001740418,0.00008770914,0.00032425547,0.00004178884,0.00012924419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012572437,0.00018809535,0.00040234096,0.00013589136,0.000032121665,0.000009453053,0.000088630986,0.00016816333,0.00055118394],"category_scores_gemma":[0.00009500745,0.00012942111,0.00010354867,0.00013327747,0.00008686319,0.00007564351,0.00003341807,0.00021372532,0.0004945171],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028009462,0.00052079186,0.0016329247,0.000038856342,0.000034210425,0.00011036221,0.00021946988,0.000008101338,0.9933694,0.00008374803,0.00045644393,0.0032455907],"study_design_scores_gemma":[0.022311268,0.0011113761,0.004134163,0.00038940692,0.00014444666,0.00018743277,0.00017344706,0.000055697372,0.9466413,0.000094405616,0.02445262,0.00030439117],"about_ca_topic_score_codex":0.000009258714,"about_ca_topic_score_gemma":0.00001702551,"teacher_disagreement_score":0.04672806,"about_ca_system_score_codex":0.00004643283,"about_ca_system_score_gemma":0.00005643835,"threshold_uncertainty_score":0.63561815},"labels":[],"label_agreement":null},{"id":"W2599986771","doi":"10.1182/blood.v108.11.2430.2430","title":"Multicenter Phase I Studies To Evaluate the Safety, Tolerability, and Clinical Response to Intensive Dosing with the Proteasome Inhibitor PR-171 in Patients with Relapsed or Refractory Hematological Malignancies.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Tolerability; Medicine; Dosing; Proteasome inhibitor; Internal medicine; Macroglobulinemia; Adverse effect; Phases of clinical research; Multiple myeloma; Pharmacokinetics; Pharmacology; Clinical trial; Gastroenterology; Oncology","score_opus":0.026225779673567404,"score_gpt":0.3154442726249826,"score_spread":0.28921849295141516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2599986771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941676,0.0002765514,0.00003920219,0.0028749993,0.00004626977,0.0025290477,0.000029888231,0.000013575782,0.00002284493],"genre_scores_gemma":[0.99733764,0.000013382344,0.0007064135,0.0014614199,0.0000988985,0.00025406413,0.0000125621,0.00002244327,0.00009318158],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99779016,0.00067578454,0.00041969502,0.0005377195,0.00025662524,0.00032001294],"domain_scores_gemma":[0.99866784,0.00025723936,0.00010486337,0.0004500106,0.00042377503,0.0000963025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012758975,0.00023739699,0.00032566744,0.00003545864,0.00016608449,0.000039687562,0.00019239036,0.00011535122,0.0000046856526],"category_scores_gemma":[0.0014154545,0.00010392147,0.000047811176,0.000161604,0.00029933243,0.000007861575,0.00029801505,0.00021738032,0.0000045927586],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3367222,0.0095420005,0.45014903,0.00020753482,0.00079808437,0.00020824114,0.0040563797,0.00005102931,0.19058496,0.000044097833,0.0028934283,0.0047429963],"study_design_scores_gemma":[0.060456116,0.054712776,0.60949886,0.0011102123,0.0004667206,0.00010347214,0.003733718,0.00002017381,0.25376713,0.00006634445,0.014713095,0.0013513556],"about_ca_topic_score_codex":0.000012237749,"about_ca_topic_score_gemma":0.00017714806,"teacher_disagreement_score":0.2762661,"about_ca_system_score_codex":0.000023569335,"about_ca_system_score_gemma":0.00009749953,"threshold_uncertainty_score":0.42377946},"labels":[],"label_agreement":null},{"id":"W2600359049","doi":"10.1182/blood.v128.22.617.617","title":"Phase 2 Study of Venetoclax Plus Rituximab or Randomized Ven Plus Bendamustine+Rituximab (BR) Versus BR in Patients with Relapsed/Refractory Follicular Lymphoma: Interim Data","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Bendamustine; Rituximab; Medicine; Venetoclax; Ven; Internal medicine; Chemotherapy regimen; Regimen; Chemotherapy; Chemoimmunotherapy; Follicular lymphoma; Clinical endpoint; Gastroenterology; Oncology; Lymphoma; Leukemia; Randomized controlled trial; Chronic lymphocytic leukemia","score_opus":0.03353409437138315,"score_gpt":0.30083518320600355,"score_spread":0.2673010888346204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2600359049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953336,0.00067291455,0.000014255591,0.00006337669,0.00027301224,0.0031155895,0.00027860876,0.000060470593,0.00018815731],"genre_scores_gemma":[0.99861634,0.00010023663,0.00031835912,0.000040591713,0.00009883057,0.00033886262,0.0003300385,0.00006608516,0.0000906854],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99695927,0.00024041721,0.00084397086,0.000807987,0.00069464225,0.000453686],"domain_scores_gemma":[0.99707156,0.00057911465,0.00039554609,0.0015682487,0.0001702165,0.00021529237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038112738,0.00044350096,0.0017373794,0.0002331089,0.00006473668,0.000022653283,0.00041468593,0.00013991981,0.00012380489],"category_scores_gemma":[0.00054163975,0.00024430378,0.00014432364,0.00029126919,0.00015942173,0.0002546678,0.00031623943,0.00009313045,0.000040887153],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.77884686,0.1675965,0.030037638,0.00018818004,0.004157009,0.001645017,0.0015392444,0.000004885252,0.00015220563,0.00002311673,0.00051357073,0.015295791],"study_design_scores_gemma":[0.96648544,0.012907,0.015174622,0.00066254556,0.0028119984,0.000019419995,0.0002949303,0.000067801724,0.0006505671,0.0000032689802,0.00061779877,0.0003046311],"about_ca_topic_score_codex":0.0009372693,"about_ca_topic_score_gemma":0.00027599197,"teacher_disagreement_score":0.18763858,"about_ca_system_score_codex":0.00090060715,"about_ca_system_score_gemma":0.0009514715,"threshold_uncertainty_score":0.9962419},"labels":[],"label_agreement":null},{"id":"W2600407259","doi":"10.1182/blood.v120.21.sci-12.sci-12","title":"Next-Generation Sequencing of Lymphoid Cancers: From Discovery to Clinical Translation","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; Genetics; Computational biology; Genome; Somatic hypermutation; Germinal center; Exome; Chromatin; Gene; Exome sequencing; Mutation; B cell","score_opus":0.07024164404840032,"score_gpt":0.30401042553002844,"score_spread":0.2337687814816281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2600407259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898834,0.0022112012,0.0070761815,0.000056879697,0.00046269756,0.00014710042,0.00003732318,0.000007053603,0.000118121156],"genre_scores_gemma":[0.99477386,0.00016446435,0.0021736652,0.000076376076,0.0024134717,0.000011783446,0.00032538528,0.000014810728,0.000046192537],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99923456,0.000055360382,0.00027418503,0.00019284723,0.00010346685,0.00013956643],"domain_scores_gemma":[0.9995795,0.000012086534,0.000089935675,0.00021051256,0.000039451752,0.00006851725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016510363,0.00008446674,0.00011364614,0.00002516504,0.000026709875,0.000013662247,0.00006071258,0.00014631303,0.000011144798],"category_scores_gemma":[0.000035223926,0.000088296154,0.000077721634,0.00007016989,0.000021147953,0.000020135529,0.00001836643,0.000034813092,0.0000046205055],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003791729,0.00005157106,0.017847475,0.0000038571357,0.00006322276,7.844901e-8,0.000119042845,0.000776436,0.97248024,0.0000073323185,0.00015020676,0.008462599],"study_design_scores_gemma":[0.000921338,0.00012814406,0.010597043,0.000017030281,0.00009018187,0.0000031080165,0.00003894009,0.00037985627,0.98554057,0.000009752045,0.002141952,0.0001320591],"about_ca_topic_score_codex":0.00024288727,"about_ca_topic_score_gemma":0.00023916327,"teacher_disagreement_score":0.013060334,"about_ca_system_score_codex":0.000041998814,"about_ca_system_score_gemma":0.00014404733,"threshold_uncertainty_score":0.36006126},"labels":[],"label_agreement":null},{"id":"W2600563341","doi":"10.1182/blood.v120.21.2211.2211","title":"Interactions of Heparin and a Covalently Linked Antithrombin Heparin Complex with the Components of the Fibrinolytic Pathway.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Plasmin; Heparin; Antithrombin; Chemistry; Proteases; Serpin; Covalent bond; Serine; Coagulation; Biochemistry; Pharmacology; Enzyme; Medicine; Internal medicine; Organic chemistry","score_opus":0.050133249622271545,"score_gpt":0.2714695198157467,"score_spread":0.22133627019347513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2600563341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971738,0.000108545966,0.000069860405,0.0006817563,0.00008080186,0.00040024903,0.000012191941,0.000018643917,0.0014541807],"genre_scores_gemma":[0.99909,0.000012292774,0.00040061589,0.00019435181,0.000038638387,0.000008940221,0.000009578807,0.000013884924,0.0002316777],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99920624,0.00006814061,0.00022342456,0.0001100069,0.00023351857,0.00015868376],"domain_scores_gemma":[0.99926805,0.000069693,0.00017793666,0.00034599248,0.000070892165,0.000067446395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013282325,0.00010926039,0.00027587885,0.00005310687,0.00008250403,0.0000069992093,0.000096485426,0.00003681618,0.00006839834],"category_scores_gemma":[0.000016697255,0.00005937381,0.000067950605,0.00020006188,0.00016417212,0.00007244828,0.0000923739,0.00013162308,0.000004784775],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011076877,0.0024810971,0.3306,0.00020680635,0.000591843,0.0000014274934,0.001182735,0.0000034007653,0.6489768,0.015232008,0.00014998221,0.0004631256],"study_design_scores_gemma":[0.0027080516,0.00020001404,0.90474117,0.00017177995,0.00042416278,0.00011404535,0.00017525573,0.00018434833,0.09019726,0.000053136628,0.00095767825,0.00007310794],"about_ca_topic_score_codex":0.00011214154,"about_ca_topic_score_gemma":0.00003123921,"teacher_disagreement_score":0.57414114,"about_ca_system_score_codex":0.0000073031188,"about_ca_system_score_gemma":0.000028771947,"threshold_uncertainty_score":0.24211937},"labels":[],"label_agreement":null},{"id":"W2600737182","doi":"10.1182/blood.v120.21.137.137","title":"Continuous Dose Dasatinib Is Safe and Feasible in Combination with Intensive Chemotherapy in Pediatric Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL): Children's Oncology Group (COG) Trial AALL0622","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Dasatinib; Medicine; Cohort; Internal medicine; Imatinib; Acute lymphocytic leukemia; Chemotherapy; Oncology; Clinical endpoint; Surgery; Clinical trial; Leukemia; Lymphoblastic Leukemia; Myeloid leukemia","score_opus":0.012422455077250191,"score_gpt":0.26943409156285975,"score_spread":0.25701163648560954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2600737182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941127,0.0011024633,0.0000089977575,0.0010889141,0.00015566725,0.0030078976,0.000041333977,0.000055256216,0.00042681413],"genre_scores_gemma":[0.9960344,0.0010229968,0.00048615414,0.0013702147,0.00047027052,0.00022287831,0.00025624994,0.000072697156,0.00006414456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99761856,0.00015109075,0.000572207,0.0005797864,0.00036521774,0.00071313913],"domain_scores_gemma":[0.99866813,0.00027219934,0.00031807338,0.00032782144,0.0001426469,0.00027111958],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028091727,0.00043671502,0.00091130164,0.0004342889,0.000054313463,0.000023524994,0.00012411643,0.00034262481,0.000083541934],"category_scores_gemma":[0.00011564118,0.00037603072,0.00008130427,0.0005278198,0.00013919674,0.0002711181,0.00007571081,0.00042710442,0.000027551378],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.070337616,0.014563751,0.88711303,0.00018129227,0.0026603458,0.0012544749,0.0124882255,0.0000054703128,0.004397991,0.00023453699,0.0007160513,0.0060472027],"study_design_scores_gemma":[0.36118135,0.006763049,0.62779313,0.00013618807,0.0012577993,0.00095546717,0.00017977225,0.000051767565,0.0012538458,0.000038240796,0.000049088263,0.0003403042],"about_ca_topic_score_codex":0.0004838596,"about_ca_topic_score_gemma":0.00012557645,"teacher_disagreement_score":0.29084373,"about_ca_system_score_codex":0.0019100093,"about_ca_system_score_gemma":0.0007222967,"threshold_uncertainty_score":0.99986917},"labels":[],"label_agreement":null},{"id":"W2600767020","doi":"10.1182/blood.v128.22.4538.4538","title":"EPCR Guides Hematopoietic Stem Cells Homing to the Bone Marrow Independently of Niche Clearance","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Neonatal Respiratory Health Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Homing (biology); Stem cell; Haematopoiesis; Endothelial protein C receptor; Bone marrow; Immunology; Cell biology; Biology; Transplantation; Cancer research; Hematopoietic stem cell; Medicine; Internal medicine; Thrombin; Platelet","score_opus":0.039059232811358445,"score_gpt":0.3206879953928863,"score_spread":0.28162876258152786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2600767020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98988026,0.003788727,0.00010776614,0.004400963,0.00010387659,0.00077744754,0.000015216017,0.000034143355,0.000891594],"genre_scores_gemma":[0.9948263,0.00015467427,0.00025744273,0.00079047994,0.0001344738,0.000045062072,2.1452672e-7,0.000033768196,0.0037575823],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998,0.00010808632,0.0004132245,0.00028701598,0.0007579304,0.00043370656],"domain_scores_gemma":[0.9984262,0.00031146887,0.00010208837,0.0006988776,0.00017261661,0.00028876038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091536046,0.00012814712,0.00030769806,0.000104706574,0.000070758855,0.000010565214,0.0002769307,0.00008575797,0.00014911174],"category_scores_gemma":[0.00024814814,0.00007050838,0.000078957666,0.00025594997,0.000090479036,0.000052313157,0.0001559642,0.00019938871,0.00049111014],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077239494,0.00064914057,0.0093830675,0.0015740868,0.0001063195,0.0003029524,0.00069665385,0.0000012992664,0.8601933,0.00039300945,0.0031435657,0.12278421],"study_design_scores_gemma":[0.0035819102,0.00068899826,0.00503818,0.000801626,0.00005814485,0.0001057737,0.00022080532,0.0000041315748,0.9313485,0.00005884197,0.0579548,0.00013828288],"about_ca_topic_score_codex":0.000028590524,"about_ca_topic_score_gemma":0.00002613522,"teacher_disagreement_score":0.12264593,"about_ca_system_score_codex":0.000047013593,"about_ca_system_score_gemma":0.00025139496,"threshold_uncertainty_score":0.6312391},"labels":[],"label_agreement":null},{"id":"W2600981619","doi":"10.1182/blood.v120.21.2271.2271","title":"Can Common Coagulation Assays Be Used to Estimate Dabigatran or Rivaroxaban Concentration? An Interlaboratory Comparison of 41 Hospitals in Quebec.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"Dabigatran; Rivaroxaban; Medicine; Partial thromboplastin time; Dosing; Thrombin time; Prothrombin time; Coagulation testing; Warfarin; Coagulation; Thromboelastography; Direct thrombin inhibitor; Pharmacology; Intensive care medicine; Anesthesia; Internal medicine; Atrial fibrillation","score_opus":0.07575264021467597,"score_gpt":0.3950417285102688,"score_spread":0.3192890882955928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2600981619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968276,0.00006495901,0.00011926853,0.0016573641,0.00018094647,0.0007287394,0.000017112858,0.000060996368,0.00034301597],"genre_scores_gemma":[0.99841064,0.0000013495032,0.00087466795,0.00012610761,0.00023297267,0.0000054945654,0.00017441671,0.000019675452,0.00015466871],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871445,0.00009682649,0.0005190194,0.00016018808,0.0002744488,0.00023509625],"domain_scores_gemma":[0.9992341,0.00008437419,0.00017081603,0.00025590576,0.00007326669,0.00018157833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029891415,0.00014426716,0.00044583934,0.00011755332,0.00003965628,0.000024885692,0.00007699839,0.00007956713,0.000079355326],"category_scores_gemma":[0.00010234679,0.00012533236,0.000049782102,0.00031975418,0.000038989238,0.0002932961,0.00002729139,0.00008021581,0.000006926717],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013746489,0.00016772341,0.98271674,0.000057775404,0.00004731513,0.0000028382894,0.004327261,0.00010045511,0.010339746,0.0012205337,0.00014655269,0.0007356181],"study_design_scores_gemma":[0.0031742738,0.00037606418,0.9607788,0.00008607146,0.00019948288,0.0000011579207,0.00086708495,0.00052400504,0.0331859,0.000021861968,0.00062077097,0.00016457886],"about_ca_topic_score_codex":0.001251979,"about_ca_topic_score_gemma":0.010470925,"teacher_disagreement_score":0.022846151,"about_ca_system_score_codex":0.000057998215,"about_ca_system_score_gemma":0.000063746455,"threshold_uncertainty_score":0.5843022},"labels":[],"label_agreement":null},{"id":"W2600984278","doi":"10.1182/blood.v124.21.2818.2818","title":"Systematic Review of the Published Evidence on the Pharmacokinetic Characteristics of Factor VIII and IX Concentrates","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; McMaster University","funders":"","keywords":"Factor IX; Medicine; Pharmacokinetics; Population; MEDLINE; Population pharmacokinetics; Pharmacology; Internal medicine; Chemistry","score_opus":0.034385795962408254,"score_gpt":0.3095173984538517,"score_spread":0.2751316024914434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2600984278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9759993,0.01707871,0.0000010560161,0.005016426,0.000046930865,0.001431914,0.000010994589,0.0000069478574,0.00040770601],"genre_scores_gemma":[0.99106044,0.008266187,0.000004810821,0.00038918311,0.000035969315,0.0000263514,0.0000016797668,0.000006036958,0.00020932191],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9989716,0.00020842518,0.00030144965,0.00009806469,0.0003136049,0.00010688147],"domain_scores_gemma":[0.9986226,0.00068101485,0.00016217452,0.00034871977,0.00013645436,0.00004906475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045682004,0.0000806962,0.000387591,0.000017439294,0.000030967894,0.000010976108,0.00014062562,0.000024175311,0.00011960526],"category_scores_gemma":[0.0026031958,0.00003113512,0.000065656,0.00011776422,0.00011512188,0.000028078655,0.00003591411,0.00009913233,0.0000053984513],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058969734,0.0008056064,0.0716551,0.85832715,0.00062653737,0.0000075768316,0.00041400496,1.693027e-8,0.066222146,0.00069486524,0.0006520663,0.00053596246],"study_design_scores_gemma":[0.0024440002,0.0008207371,0.11210795,0.65541714,0.0029475885,0.000042701853,0.00005832489,0.00009480371,0.22576429,0.000041963758,0.00011635545,0.00014413458],"about_ca_topic_score_codex":0.0000032093462,"about_ca_topic_score_gemma":1.5904985e-7,"teacher_disagreement_score":0.20291,"about_ca_system_score_codex":0.0000063495363,"about_ca_system_score_gemma":0.000042612115,"threshold_uncertainty_score":0.31164566},"labels":[],"label_agreement":null},{"id":"W2601049681","doi":"10.1182/blood.v110.11.1417.1417","title":"Histone Deacetylase Inhibitor Valproic Acid Has Differential Effects on Trafficking of Normal Hematopoietic Stem/Progenitor Cells and Leukemic Blasts.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Alberta","funders":"","keywords":"Cancer research; Haematopoiesis; Progenitor cell; Bone marrow; Stem cell; CD34; Leukemia; Biology; Myeloid; CXCR4; Myeloid leukemia; Stromal cell; Homing (biology); Myelopoiesis; Stem cell factor; Immunology; Cell biology; Chemokine; Inflammation","score_opus":0.013617114109270531,"score_gpt":0.2601441598105263,"score_spread":0.24652704570125578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2601049681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99763757,0.0005875344,0.00012429278,0.00008628034,0.00024164648,0.0009286899,0.000029888233,0.000101729674,0.00026234105],"genre_scores_gemma":[0.99809444,0.000024972325,0.00051393214,0.00006890634,0.0006556293,0.00003405191,0.000027717711,0.00007759488,0.0005027404],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975098,0.000079455225,0.0005178426,0.0004938054,0.0007115427,0.0006875531],"domain_scores_gemma":[0.9984619,0.00038524106,0.00016551997,0.00045148304,0.000111527435,0.00042429977],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033107089,0.00033968367,0.0006242911,0.0003412633,0.00013633145,0.000030326051,0.00016820435,0.00025106632,0.00013380499],"category_scores_gemma":[0.000093403876,0.00029950473,0.00016877514,0.00028154653,0.00024641794,0.00007296303,0.00013201477,0.0005936046,0.00007944373],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008414358,0.0009263257,0.00060354406,0.001264789,0.00019950038,0.00048292705,0.0008042078,9.989891e-7,0.9860195,0.000013905947,0.0012210938,0.007621755],"study_design_scores_gemma":[0.010546412,0.0015299662,0.0019311397,0.00049687247,0.00037822718,0.00035405907,0.0001330124,0.0000801994,0.9840664,0.0000025046195,0.00023543362,0.0002457553],"about_ca_topic_score_codex":0.000021045427,"about_ca_topic_score_gemma":0.000007915852,"teacher_disagreement_score":0.009704976,"about_ca_system_score_codex":0.00028005507,"about_ca_system_score_gemma":0.00032985175,"threshold_uncertainty_score":0.9999457},"labels":[],"label_agreement":null},{"id":"W2601212590","doi":"10.1182/blood.v120.21.4518.4518","title":"Absolute Lymphocyte Count At Day+15 and +30 Post-ASCT As Predictors of Early and 1-Year Mortality for Patients with AL Amyloidosis Treated with a Single Autologous Stem Cell Transplant","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; AL amyloidosis; Autologous stem-cell transplantation; Melphalan; Internal medicine; Multiple myeloma; Univariate analysis; Proportional hazards model; Transplantation; Hazard ratio; Oncology; Survival analysis; Hematopoietic stem cell transplantation; Surgery; Immunology; Confidence interval; Antibody; Multivariate analysis","score_opus":0.006454290962888688,"score_gpt":0.20420701086807064,"score_spread":0.19775271990518195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2601212590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997157,0.0010167193,0.000011146026,0.0000146818975,0.000029297626,0.0008175559,0.000859732,0.000022011458,0.00007187938],"genre_scores_gemma":[0.99895364,0.00022543866,0.0001810951,0.00007608781,0.000025460697,0.00014207822,0.0002772572,0.000044463417,0.00007449829],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987884,0.00004801333,0.00022308441,0.00039372928,0.00018035664,0.0003663924],"domain_scores_gemma":[0.99922466,0.000040170577,0.00017729482,0.00027944334,0.00009970453,0.00017872102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008057981,0.00028703405,0.00032517724,0.00003769429,0.00008630466,0.000017368506,0.00008356991,0.0001469736,0.0000064748033],"category_scores_gemma":[0.0000058650107,0.00020925293,0.000060789745,0.0000512494,0.00015167985,0.0000151738595,0.00004617893,0.000034091358,0.0000017531722],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007403836,0.0011891841,0.9757576,0.000070921924,0.0006982081,0.0000039218808,0.00038996426,0.000001116822,0.020972505,0.0000025303323,0.000030610998,0.00014304773],"study_design_scores_gemma":[0.0077554816,0.0044699796,0.79061043,0.00003719903,0.00091147213,0.000015635578,0.00005643875,0.0000015768344,0.19557378,3.6341467e-7,0.00032072628,0.0002468927],"about_ca_topic_score_codex":0.00019922272,"about_ca_topic_score_gemma":0.000088207766,"teacher_disagreement_score":0.18514715,"about_ca_system_score_codex":0.000034658893,"about_ca_system_score_gemma":0.00005120077,"threshold_uncertainty_score":0.8533087},"labels":[],"label_agreement":null},{"id":"W2601298533","doi":"10.1182/blood.v128.22.527.527","title":"Targeting Pre-Leukemic Stem Cells in T-Acute Lymphoblastic Leukemia","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Cancer research; Stem cell; Stromal cell; Leukemia; Biology; Acute lymphocytic leukemia; Haematopoiesis; Reprogramming; Ex vivo; Minimal residual disease; Immunology; In vivo; Medicine; Cell; Cell biology; Lymphoblastic Leukemia; Genetics","score_opus":0.010623260968671954,"score_gpt":0.24924567615133672,"score_spread":0.23862241518266478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2601298533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99553,0.0002585576,0.0012894048,0.0002568012,0.00020527763,0.00065878883,0.000057273748,0.00018771502,0.0015561868],"genre_scores_gemma":[0.9927273,0.0002847483,0.0009504522,0.00022657246,0.0002594712,0.00009268339,0.000011291064,0.00007518728,0.0053723],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968627,0.00010610081,0.00063199946,0.00068313925,0.00071016053,0.0010058695],"domain_scores_gemma":[0.9981974,0.0005424571,0.00013082408,0.0006140346,0.00012961237,0.0003857114],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041991656,0.0003426374,0.0005773337,0.0003254461,0.00007011505,0.00003021897,0.00033832394,0.00025868,0.0002622312],"category_scores_gemma":[0.00017140525,0.00023369158,0.00012933674,0.0004947721,0.00017314704,0.00017927698,0.0002277893,0.0002657935,0.0009995991],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059017295,0.0003953203,0.015507431,0.00018473576,0.00027769778,0.0016147443,0.00032036903,0.00003416771,0.97092,0.000069314956,0.0051200315,0.004965994],"study_design_scores_gemma":[0.08041181,0.001742554,0.022693062,0.0023344555,0.0009658216,0.0017431695,0.0003022409,0.0039398638,0.8782825,0.00019376393,0.00600217,0.0013886034],"about_ca_topic_score_codex":0.00009254021,"about_ca_topic_score_gemma":0.0000061260407,"teacher_disagreement_score":0.09263753,"about_ca_system_score_codex":0.0026036277,"about_ca_system_score_gemma":0.0020815737,"threshold_uncertainty_score":0.9997782},"labels":[],"label_agreement":null},{"id":"W2601433906","doi":"10.1182/blood.v110.11.4020.4020","title":"A Novel Marker for Blood Platelet Storage Lesion: Newly Synthesized Rap1 in Integrin Signaling.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Canadian Blood Services","funders":"","keywords":"Platelet; Platelet activation; Rap1; Thrombin; Platelet transfusion; P2Y12; Chemistry; Immunology; Biology; Biochemistry; Signal transduction","score_opus":0.02346533808208003,"score_gpt":0.2732001181421121,"score_spread":0.24973478006003205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2601433906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941924,0.0009211617,0.0020634686,0.00023539645,0.00008913162,0.0009045833,0.000035684345,0.00007089694,0.0014872659],"genre_scores_gemma":[0.99038446,0.00005574372,0.0082409335,0.00029553965,0.00010348117,0.00006143481,0.00005765003,0.00004797644,0.00075278117],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985201,0.000017259923,0.0003935093,0.00036843657,0.00021891904,0.0004817775],"domain_scores_gemma":[0.99910635,0.00032246445,0.000093236624,0.0002586208,0.00005658429,0.00016274539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004901389,0.00024731833,0.0005170161,0.00021048274,0.000058852234,0.000017962904,0.00009900535,0.00019156815,0.00011049034],"category_scores_gemma":[0.00018956266,0.00020441502,0.00016379188,0.00022945247,0.000035243633,0.00006324471,0.000028035487,0.00020272007,0.000022464823],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014066464,0.049851287,0.10707679,0.0009335604,0.0041235182,0.023168642,0.0021745553,0.00003419274,0.6888618,0.0006491121,0.0013576321,0.10770244],"study_design_scores_gemma":[0.28153357,0.004213249,0.13079235,0.002068612,0.0033746522,0.0045673875,0.0011926148,0.00046125674,0.54784596,0.0012941592,0.02078815,0.0018680303],"about_ca_topic_score_codex":0.00010799009,"about_ca_topic_score_gemma":0.00011884201,"teacher_disagreement_score":0.2674671,"about_ca_system_score_codex":0.00003391899,"about_ca_system_score_gemma":0.00007673245,"threshold_uncertainty_score":0.83358026},"labels":[],"label_agreement":null},{"id":"W2601651086","doi":"10.1182/blood.v128.22.1173.1173","title":"Development of an Optimized rAAV2/6 Human Factor 8 cDNA Vector Cassette for Hemophilia a Gene Therapy","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Genetic enhancement; Factor IX; Medicine; Vector (molecular biology); Clotting factor; Transgene; Immunology; Recombinant DNA; Biology; Internal medicine; Gene; Genetics","score_opus":0.035727219956170786,"score_gpt":0.31746737436253697,"score_spread":0.2817401544063662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2601651086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981322,0.00035698825,0.00068807113,0.000111761896,0.000039795825,0.00051394594,0.00011468136,0.00001621051,0.000026294289],"genre_scores_gemma":[0.9845711,0.00008946322,0.014232002,0.00010934612,0.0002117084,0.00016354377,0.00011846966,0.000054640714,0.00044972132],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998758,0.00006720055,0.00027115623,0.00038750094,0.00018278374,0.00033336],"domain_scores_gemma":[0.9991423,0.000017381202,0.00009234984,0.0004954762,0.00013362568,0.00011886853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002413772,0.00018270533,0.00020849198,0.000053052827,0.00010259778,0.0000122296415,0.00031981018,0.00013137702,0.000081183134],"category_scores_gemma":[0.000028439961,0.00013146602,0.00010917731,0.000052432795,0.00006375838,0.0000046846853,0.000055863205,0.000037987887,0.000005134015],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001443803,0.00039669697,0.00012272068,0.000010755267,0.00021322221,0.0000016182913,0.00007471943,0.0000010782071,0.9877295,0.0000044741923,0.00007016302,0.009931284],"study_design_scores_gemma":[0.00755171,0.0022479927,0.0007755763,0.000007746336,0.000009845701,0.0000037314303,0.0000062405124,0.0000019113477,0.984516,0.000022397242,0.0046523837,0.00020443687],"about_ca_topic_score_codex":0.000003047748,"about_ca_topic_score_gemma":0.000045287663,"teacher_disagreement_score":0.013561146,"about_ca_system_score_codex":0.00001476655,"about_ca_system_score_gemma":0.00019463664,"threshold_uncertainty_score":0.5361029},"labels":[],"label_agreement":null},{"id":"W2601654193","doi":"10.1182/blood.v126.23.5228.5228","title":"Mechanisms of Resistance to Lenalidomide in Del(5q) Myelodysplastic Syndrome Patients","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lenalidomide; Myelodysplastic syndromes; Neutropenia; Medicine; Bone marrow failure; Bone marrow; Thrombocytosis; Myeloid; Immunology; Internal medicine; Oncology; Stem cell; Cancer research; Haematopoiesis; Biology; Multiple myeloma; Chemotherapy; Genetics","score_opus":0.025241491959236792,"score_gpt":0.2763959753417481,"score_spread":0.2511544833825113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2601654193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99778557,0.00009242181,0.00017215496,0.00011688815,0.00004941651,0.0005365031,0.000030077868,0.000018031473,0.0011989349],"genre_scores_gemma":[0.9956314,0.000004255195,0.0035468377,0.000057172263,0.000009218459,0.000051344072,0.000026522908,0.000017409717,0.0006558716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869865,0.00004530034,0.00025231286,0.00021639727,0.0004905815,0.0002967344],"domain_scores_gemma":[0.9991138,0.000060418715,0.000046844532,0.00025600253,0.00014817034,0.00037477352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016628898,0.00011440173,0.00029078,0.00019706858,0.000015291826,0.000005690455,0.00009189308,0.000049943545,0.000027221033],"category_scores_gemma":[0.00056231185,0.00009549115,0.00004062993,0.00026053042,0.000021338692,0.000045247627,0.00005536384,0.00008467655,0.00011991835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006465958,0.011289341,0.95840526,0.0006536937,0.00066343066,0.004217426,0.0010311297,0.0000443665,0.012624002,0.001301438,0.0014953436,0.0018086173],"study_design_scores_gemma":[0.0369079,0.0024136987,0.9277198,0.0006164065,0.00014087939,0.00005766023,0.00012366856,0.000035397243,0.030264087,0.0012847809,0.0002273134,0.00020841073],"about_ca_topic_score_codex":0.00008678258,"about_ca_topic_score_gemma":0.00016443682,"teacher_disagreement_score":0.030685456,"about_ca_system_score_codex":0.00007425169,"about_ca_system_score_gemma":0.00013503479,"threshold_uncertainty_score":0.3894016},"labels":[],"label_agreement":null},{"id":"W2601668405","doi":"10.1182/blood.v126.23.3770.3770","title":"Pediatric-Based Versus Adult Treatment Protocols in Young Adults (18-40 years) with Standard Risk Acute Lymphoblastic Leukemia: The BC Cancer Agency Experience","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada; University of British Columbia","funders":"","keywords":"Medicine; Etoposide; Cytarabine; Acute lymphocytic leukemia; Pediatrics; Vincristine; Cancer; Chemotherapy regimen; Chemotherapy; Asparaginase; Internal medicine; Leukemia; Surgery; Lymphoblastic Leukemia; Cyclophosphamide","score_opus":0.026857487378155735,"score_gpt":0.3222013380621209,"score_spread":0.2953438506839652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2601668405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98716664,0.00015661988,0.0001354626,0.000117629446,0.00014980968,0.011123293,0.00012812355,0.000101060905,0.00092138397],"genre_scores_gemma":[0.9743225,0.00019925588,0.0008429326,0.00007831909,0.00050211075,0.023712125,0.00002133997,0.00007565678,0.00024577527],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9967129,0.00012604734,0.00042480923,0.0006527038,0.0013094335,0.0007740538],"domain_scores_gemma":[0.9978922,0.00025628347,0.00020858162,0.0007935192,0.00045852878,0.00039089838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002452415,0.00039307226,0.0005000712,0.00019236845,0.000112526504,0.00006541778,0.00036565226,0.00017742431,0.00011127677],"category_scores_gemma":[0.00047008574,0.00023967795,0.00010092735,0.0008160474,0.00020774755,0.00014926735,0.00008696648,0.00032674192,0.00008069247],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.082762875,0.0025056342,0.878018,0.0003188399,0.0008488843,0.004720475,0.021379601,0.0010351357,0.00025895803,0.00002980685,0.0025168255,0.005604948],"study_design_scores_gemma":[0.6145812,0.034795813,0.30260342,0.001807948,0.0048711523,0.0005039626,0.0061177365,0.012745431,0.01667706,0.000051464853,0.0032063224,0.0020384642],"about_ca_topic_score_codex":0.007400346,"about_ca_topic_score_gemma":0.0021045865,"teacher_disagreement_score":0.5754146,"about_ca_system_score_codex":0.00500969,"about_ca_system_score_gemma":0.0077637904,"threshold_uncertainty_score":0.99920946},"labels":[],"label_agreement":null},{"id":"W2601781581","doi":"10.1182/blood.v128.22.2548.2548","title":"Autoantibodies to Thrombopoietin and the Thrombopoietin Receptor in Patients with Immune Thrombocytopenia","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; McMaster University","funders":"","keywords":"Thrombopoietin; Autoantibody; Medicine; Thrombopoietin receptor; Immunology; Thrombocytopenic purpura; Immune system; Eltrombopag; Platelet disorder; Platelet; Immune thrombocytopenia; Antibody; Antiphospholipid syndrome; Internal medicine; Biology","score_opus":0.004986913265765663,"score_gpt":0.2147430160925133,"score_spread":0.20975610282674764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2601781581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922929,0.0003479052,0.000006452988,0.0045493743,0.00004982463,0.00097608624,0.000021454922,0.00004054761,0.00171546],"genre_scores_gemma":[0.99832577,0.0001746438,0.0006977739,0.00029539026,0.00002054529,0.000048294824,0.000014215497,0.000028191987,0.00039517],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988321,0.00005561117,0.00023979219,0.00031668966,0.00024221878,0.0003135994],"domain_scores_gemma":[0.99934185,0.000106375075,0.00006605988,0.00033594668,0.000058362126,0.00009142205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017095273,0.00020931523,0.00058672874,0.00006675992,0.000087830434,0.000021894019,0.0001005943,0.00006329501,0.00016072972],"category_scores_gemma":[0.000081520884,0.00008899895,0.000047971065,0.00016756209,0.00020832205,0.00008604923,0.00008813866,0.00009039769,0.00013453251],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022319378,0.0021808862,0.98383605,0.000040214014,0.00051638467,0.000052235842,0.0014110422,1.4575667e-7,0.0032573775,0.00058724376,0.00070956914,0.005176909],"study_design_scores_gemma":[0.043978002,0.00081370166,0.95028615,0.00033275952,0.00018212602,0.0000135066675,0.000105285995,3.4315937e-7,0.0031824457,0.00019581735,0.00074044993,0.00016942334],"about_ca_topic_score_codex":0.0001095445,"about_ca_topic_score_gemma":0.00006035988,"teacher_disagreement_score":0.04174606,"about_ca_system_score_codex":0.00002490011,"about_ca_system_score_gemma":0.000037823153,"threshold_uncertainty_score":0.3629272},"labels":[],"label_agreement":null},{"id":"W2601935555","doi":"10.1182/blood.v112.11.1810.1810","title":"Levels of Inflammatory Markers and the Development of the Post Thrombotic Syndrome.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Post-thrombotic syndrome; Internal medicine; Gastroenterology; Thrombosis; Population; Incidence (geometry); Thrombus; Venous thrombosis; Cohort; Warfarin; Deep vein; Surgery; Atrial fibrillation","score_opus":0.01527583752349488,"score_gpt":0.219664809160554,"score_spread":0.20438897163705913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2601935555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958559,0.00034982953,0.000006028389,0.0005390362,0.00006103707,0.0005133189,0.0000026626003,0.000008943374,0.0026632247],"genre_scores_gemma":[0.9990311,0.00008909326,0.00051475305,0.00019325396,0.000010913626,0.000016828735,7.3484404e-7,0.000010069,0.000133208],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991777,0.000042797412,0.0003005735,0.00010773091,0.0002496232,0.00012155312],"domain_scores_gemma":[0.9994238,0.00007193013,0.00012668768,0.00028429346,0.00005886074,0.000034416866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029163636,0.00008988962,0.0003330904,0.000036671,0.00010507025,0.000002449039,0.00011644185,0.000032509455,0.000054538752],"category_scores_gemma":[0.000064615066,0.000046849702,0.000070468486,0.000093465445,0.00032706402,0.000022363836,0.0001269654,0.00006827638,0.0000035777314],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071501243,0.010024096,0.8338981,0.005500957,0.010367706,0.00029015035,0.07029853,0.0000382178,0.031394143,0.021332879,0.004013599,0.012126599],"study_design_scores_gemma":[0.002763276,0.00007311226,0.98942393,0.00017271348,0.00028667285,0.00010097725,0.0003443295,0.0000024690498,0.006498165,0.00004151458,0.00024001235,0.000052831634],"about_ca_topic_score_codex":0.000018538287,"about_ca_topic_score_gemma":0.000015260961,"teacher_disagreement_score":0.15552582,"about_ca_system_score_codex":0.000009406449,"about_ca_system_score_gemma":0.00013104374,"threshold_uncertainty_score":0.19104753},"labels":[],"label_agreement":null},{"id":"W2601943785","doi":"10.1182/blood.v128.22.4778.4778","title":"The Efficacy and Cost Effectiveness of Subcutaneous Immunoglobulin (SCIG) Replacement in Patients with Immune Deficiency Secondary to Chronic Lymphocytic Leukemia","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"","keywords":"Hypogammaglobulinemia; Medicine; Chronic lymphocytic leukemia; Population; Internal medicine; Quality of life (healthcare); Ambulatory; Pediatrics; Leukemia; Surgery; Immunology; Antibody","score_opus":0.006313302183648464,"score_gpt":0.24626345919126047,"score_spread":0.23995015700761202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2601943785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99463236,0.0022804907,0.000029554274,0.00004624628,0.00006635589,0.0024160624,0.000015014763,0.000029233093,0.000484678],"genre_scores_gemma":[0.9993616,0.00018339987,0.000046198114,0.000022659882,0.000026657854,0.000121236415,0.000008974355,0.00003914483,0.00019014886],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975645,0.00018563578,0.00047767532,0.00048471952,0.00066761597,0.0006198826],"domain_scores_gemma":[0.9974037,0.0012334508,0.00011891341,0.00084739545,0.0002277441,0.0001687909],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095512473,0.00024099849,0.00047228183,0.00014228164,0.000117264135,0.000025804808,0.00028350914,0.0000934156,0.000033946297],"category_scores_gemma":[0.000495738,0.00012830066,0.000051210354,0.00041462688,0.00032345342,0.000063401174,0.0002503748,0.0001564571,0.000034252727],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.24793491,0.008144152,0.19175798,0.008753621,0.0027581316,0.0027016264,0.002741353,0.0012650763,0.18203431,0.0011192642,0.00035891755,0.35043067],"study_design_scores_gemma":[0.3493083,0.012799009,0.5713826,0.0037783664,0.00026366353,0.0006849658,0.00007758704,0.00015074565,0.060428735,0.000032288022,0.00059776567,0.0004959435],"about_ca_topic_score_codex":0.0005883159,"about_ca_topic_score_gemma":0.00007223964,"teacher_disagreement_score":0.37962463,"about_ca_system_score_codex":0.030772476,"about_ca_system_score_gemma":0.014063874,"threshold_uncertainty_score":0.9915255},"labels":[],"label_agreement":null},{"id":"W2602045657","doi":"10.1182/blood.v112.11.115.115","title":"Heritability of Iron Status Phenotype in the Hemochromatosis and Iron Overload Screening (HEIRS) Family Study","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Hereditary hemochromatosis; Hemochromatosis; Transferrin saturation; Heritability; Genetics; Population; Phenotype; Genotype; Biology; Hepcidin; Ferritin; Internal medicine; Medicine; Anemia; Gene; Serum ferritin","score_opus":0.01986461211169735,"score_gpt":0.25316405366252426,"score_spread":0.2332994415508269,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2602045657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937286,0.0037134017,0.000010998384,0.000064540334,0.000029914405,0.00056288944,0.000008396795,0.000019902016,0.0018613925],"genre_scores_gemma":[0.9989172,0.00025975943,0.00057422346,0.00016617352,0.00003095902,0.000014208971,0.000005831772,0.000012521322,0.000019114408],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988626,0.00011514748,0.000257515,0.0002285311,0.00030242564,0.00023373142],"domain_scores_gemma":[0.9994205,0.00007537097,0.000059061498,0.00035430398,0.000028502021,0.00006225004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002803634,0.00012959099,0.0003009874,0.000057390353,0.000069630994,0.000006053106,0.00007767404,0.000050023744,0.000022772507],"category_scores_gemma":[0.000097725744,0.000092362076,0.000042376734,0.00020018131,0.00012815098,0.000063729574,0.00004263566,0.00013806512,0.0000027178123],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000133084,0.002641003,0.9844968,0.00012761724,0.000013157023,0.000029933848,0.007165167,0.000003244078,0.0035879123,0.000025636558,0.000053727177,0.0017227588],"study_design_scores_gemma":[0.0061802543,0.00037282213,0.98218024,0.000017869892,0.00015367262,0.0000149651205,0.010629827,0.000006637615,0.00025389317,0.000016682536,0.00008476152,0.00008838835],"about_ca_topic_score_codex":0.0012197064,"about_ca_topic_score_gemma":0.0000786325,"teacher_disagreement_score":0.0060471706,"about_ca_system_score_codex":0.0000057488082,"about_ca_system_score_gemma":0.000045818673,"threshold_uncertainty_score":0.3766416},"labels":[],"label_agreement":null},{"id":"W2602169105","doi":"10.1182/blood-2016-11-750158","title":"A phase 1 clinical trial of single-agent selinexor in acute myeloid leukemia","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University of Calgary","funders":"National Cancer Institute; Karyopharm Therapeutics","keywords":"Medicine; Internal medicine; Adverse effect; Myeloid leukemia; Population; Hazard ratio; Toxicity; Phases of clinical research; Refractory (planetary science); Oncology; Cancer; Gastroenterology; Confidence interval; Biology","score_opus":0.1026217167358261,"score_gpt":0.4179450152060915,"score_spread":0.3153232984702654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2602169105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931136,0.00010874533,0.000037631045,0.001223437,0.00033780298,0.0010723589,0.000031449217,0.00003792227,0.0040370985],"genre_scores_gemma":[0.9946389,0.00030679096,0.0021910456,0.00019715706,0.0009859144,0.000049694514,0.000028700537,0.000040413994,0.001561342],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99746484,0.00014283348,0.0009638456,0.00045133295,0.00052493677,0.00045219515],"domain_scores_gemma":[0.9975515,0.00021957167,0.0003648613,0.0014001742,0.00016696593,0.000296914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014252969,0.00019550612,0.00079921214,0.00017845965,0.00009500271,0.00004120062,0.00052560755,0.0002732894,0.00009907626],"category_scores_gemma":[0.002381551,0.00016411106,0.00027332114,0.0001281015,0.00032544514,0.00011872454,0.00026992426,0.0006390015,0.00009474371],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2794412,0.06876911,0.04456968,0.0005033454,0.0029128906,0.0073840534,0.0009344252,0.0000025335203,0.3798719,0.00023144014,0.016006941,0.19937246],"study_design_scores_gemma":[0.8983233,0.013137867,0.011225838,0.00027815774,0.0008828503,0.0001845627,0.00007000392,0.00045080433,0.06340632,0.00008080187,0.011641416,0.00031806694],"about_ca_topic_score_codex":0.00015168828,"about_ca_topic_score_gemma":0.000038527243,"teacher_disagreement_score":0.6188821,"about_ca_system_score_codex":0.00022247671,"about_ca_system_score_gemma":0.0012157111,"threshold_uncertainty_score":0.66922545},"labels":[],"label_agreement":null},{"id":"W2602310116","doi":"10.1182/blood.v128.22.607.607","title":"Frequent Genetic Alterations of PI3K-AKT Pathway and Their Clinical Significance in Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Simon Fraser University; BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; PTEN; Germinal center; PI3K/AKT/mTOR pathway; Cancer research; Biology; Protein kinase B; Lymphoma; B cell; Genetics; Signal transduction; Immunology","score_opus":0.015329869750786982,"score_gpt":0.25679796478888284,"score_spread":0.24146809503809585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2602310116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969449,0.0014047936,0.00006208473,0.00028287122,0.00010219845,0.00042381024,0.0001530352,0.00001799198,0.00060830795],"genre_scores_gemma":[0.99785584,0.00088765385,0.00045538845,0.00029476485,0.00010435233,0.000087631735,0.000014123493,0.000020666332,0.00027955842],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858904,0.00009159317,0.0005244832,0.00036668658,0.00014347382,0.00028469786],"domain_scores_gemma":[0.99905586,0.00021641259,0.00012984916,0.0003722933,0.00005033709,0.00017522786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014346055,0.00018942267,0.00038532674,0.00007022319,0.000038014907,0.000011946328,0.000073715724,0.00009725722,0.00004257719],"category_scores_gemma":[0.00002537332,0.000111449815,0.00012927635,0.000073014955,0.00008944969,0.00004375984,0.000050849365,0.000042457308,0.000026688527],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000095053205,0.05834999,0.9045727,0.00008526935,0.00008952721,0.0002592691,0.00034598913,7.218879e-8,0.021084206,0.00009325412,0.00022769911,0.01479693],"study_design_scores_gemma":[0.10842957,0.0014443618,0.72429925,0.00033723676,0.0001997897,0.0000939894,0.000094152514,0.000027985609,0.16003868,0.00008494138,0.0046966444,0.00025337437],"about_ca_topic_score_codex":0.000038675702,"about_ca_topic_score_gemma":0.00005391209,"teacher_disagreement_score":0.18027347,"about_ca_system_score_codex":0.000047972597,"about_ca_system_score_gemma":0.00014328578,"threshold_uncertainty_score":0.45447916},"labels":[],"label_agreement":null},{"id":"W2602461976","doi":"10.1182/blood.v128.22.731.731","title":"TNF-Alpha Promotes Clonal Expansion of Tet2 Deficient Bone Marrow Progenitors in MDS","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Progenitor cell; Bone marrow; Haematopoiesis; Biology; Tumor necrosis factor alpha; Immunology; Molecular biology; Stem cell; Cancer research; Apoptosis; Cell biology; Genetics","score_opus":0.017285373236599753,"score_gpt":0.27559676202512234,"score_spread":0.2583113887885226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2602461976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99666053,0.00049990584,0.000028447108,0.001143047,0.000056672474,0.0006617283,0.000014776872,0.000041337044,0.0008935258],"genre_scores_gemma":[0.99736804,0.00005276445,0.0015251209,0.000033614033,0.00013340371,0.000061601735,0.000008558896,0.000030222707,0.0007866679],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99827695,0.000067908855,0.00036030772,0.00030904348,0.0005795346,0.00040623083],"domain_scores_gemma":[0.9991457,0.00011210441,0.00007685235,0.00036682523,0.00014531662,0.0001531867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045378943,0.00014514892,0.00031221457,0.00025547337,0.000027525555,0.000005571267,0.00012884951,0.00012586772,0.00014916954],"category_scores_gemma":[0.00039442707,0.00009123775,0.000086095635,0.00034387098,0.00013876492,0.00006317643,0.00010882325,0.00017981652,0.00007175822],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023785139,0.0010578514,0.10744992,0.00015267824,0.000045378052,0.0002262882,0.00021352363,1.5429968e-7,0.8750779,0.0001041582,0.00038023922,0.015054051],"study_design_scores_gemma":[0.007834835,0.0007940778,0.052274168,0.00044674482,0.00006829408,0.00021500251,0.000094693394,0.000020910935,0.93717855,0.00010544052,0.00082402333,0.0001432662],"about_ca_topic_score_codex":0.000054263306,"about_ca_topic_score_gemma":0.000010598513,"teacher_disagreement_score":0.062100638,"about_ca_system_score_codex":0.00013625564,"about_ca_system_score_gemma":0.00046531565,"threshold_uncertainty_score":0.37205675},"labels":[],"label_agreement":null},{"id":"W2602588549","doi":"10.1182/blood.v128.22.2794.2794","title":"Relapse Following Initial Remission and Subsequent Outcome for Children with Relapsed Acute Myeloid Leukemia on the AAML0531 Phase III Study of Gemtuzumab Ozogamicin: A Report from the Children's Oncology Group","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Gemtuzumab ozogamicin; Medicine; Cumulative incidence; Internal medicine; Oncology; Chemotherapy regimen; Induction chemotherapy; Univariate analysis; Chemotherapy; CD33; Surgery; Transplantation; Multivariate analysis; Stem cell","score_opus":0.027817250505030897,"score_gpt":0.33008278561666476,"score_spread":0.30226553511163384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2602588549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99113446,0.00012444584,0.00016891035,0.0027653351,0.00015344426,0.0051437146,0.00012042546,0.00008591781,0.0003033396],"genre_scores_gemma":[0.9975675,0.00006895021,0.0004428707,0.0004972011,0.0005039918,0.00029742828,0.00015641362,0.000096837706,0.0003688476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963183,0.00036077428,0.00095425645,0.0008901313,0.00087684573,0.0005997142],"domain_scores_gemma":[0.9960931,0.0014765009,0.0005263733,0.0014600013,0.00019860458,0.00024539733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015265432,0.00043873757,0.0009377992,0.00014520348,0.00040454292,0.000031162297,0.00048370435,0.00027117663,0.00003508843],"category_scores_gemma":[0.0012510279,0.00018962327,0.00023604828,0.00030078573,0.00029243386,0.0001315564,0.00027136967,0.000728829,0.0000059653357],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035922367,0.010627019,0.8002249,0.000046220823,0.015567587,0.0041724844,0.007547276,0.0000030032022,0.09439075,0.0003309909,0.006644321,0.024523085],"study_design_scores_gemma":[0.35630727,0.037257437,0.5562064,0.0009813877,0.009625432,0.0033405176,0.0023263542,0.00004244785,0.03144147,0.0002346765,0.0012546398,0.0009819538],"about_ca_topic_score_codex":0.000881849,"about_ca_topic_score_gemma":0.00011104499,"teacher_disagreement_score":0.32038492,"about_ca_system_score_codex":0.00061743194,"about_ca_system_score_gemma":0.0007448984,"threshold_uncertainty_score":0.77326125},"labels":[],"label_agreement":null},{"id":"W2602605464","doi":"10.1182/blood-2017-01-761973","title":"Venetoclax and obinutuzumab in chronic lymphocytic leukemia","year":2017,"lang":"en","type":"letter","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Venetoclax; Obinutuzumab; Chronic lymphocytic leukemia; Chlorambucil; Medicine; Internal medicine; Fludarabine; Ibrutinib; Leukemia; IGHV@; Oncology; Bendamustine; Immunology; Chemotherapy; Cyclophosphamide","score_opus":0.023312772086532346,"score_gpt":0.29351931831963235,"score_spread":0.27020654623310003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2602605464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8716228,0.036963865,0.000004169349,0.05063655,0.0010596198,0.0048507047,0.00012768249,0.00045685863,0.034277722],"genre_scores_gemma":[0.56791997,0.008546868,0.0006086742,0.28008235,0.039073996,0.0011821244,0.0016903281,0.0011952203,0.09970046],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962009,0.000096762655,0.0005371397,0.001046758,0.00090877054,0.0012096716],"domain_scores_gemma":[0.99727315,0.00023789748,0.00023474835,0.0019410553,0.0000911165,0.00022201809],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00033281877,0.00058226153,0.0011899828,0.00045046164,0.00013932041,0.00014253154,0.00059110357,0.0015892407,0.00016760091],"category_scores_gemma":[0.0003071134,0.0005436093,0.00019247507,0.0001604391,0.0004637653,0.00010756905,0.00040550414,0.0023970217,0.0003320886],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00018886439,0.000031030726,0.00011542284,0.0064737075,0.00067092857,0.074544996,0.00023299677,0.00007473684,0.00055779354,0.000016676247,0.91420484,0.002888039],"study_design_scores_gemma":[0.109101556,0.0006371606,0.00041326712,0.0033750325,0.00080592016,0.009827473,0.00001073179,0.010165087,0.0013979292,0.0001784984,0.86314875,0.0009385984],"about_ca_topic_score_codex":0.007007636,"about_ca_topic_score_gemma":0.00019882803,"teacher_disagreement_score":0.30370283,"about_ca_system_score_codex":0.4332169,"about_ca_system_score_gemma":0.26141214,"threshold_uncertainty_score":0.9999045},"labels":[],"label_agreement":null},{"id":"W2602635160","doi":"10.1182/blood.v128.22.4236.4236","title":"Drug-Insensitive CML Stem/Progenitor Cells Highly Express Key Regulators of the Hedgehog Pathway and Inhibition of the Hedgehog Pathway Enhances Their Response to TKI Treatment","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Smoothened; Progenitor cell; Stem cell; Cancer research; Hedgehog signaling pathway; Biology; Hedgehog; CD34; Imatinib mesylate; Bone marrow; Haematopoiesis; Immunology; Imatinib; Myeloid leukemia; Cell biology; Signal transduction","score_opus":0.008583970273020653,"score_gpt":0.19967521758280612,"score_spread":0.19109124730978547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2602635160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996987,0.0010493753,0.00003174416,0.00038192497,0.00026869826,0.00070518,0.00046302666,0.000015469352,0.00009760454],"genre_scores_gemma":[0.9985343,0.000101073405,0.00008999179,0.0000702773,0.00016659859,0.000076142416,0.000003741009,0.000035404006,0.0009224242],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99800575,0.00053370686,0.00041535904,0.0005049839,0.00023841477,0.0003017685],"domain_scores_gemma":[0.99843836,0.00017418273,0.0002866589,0.00078257796,0.00022504885,0.00009318125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039123406,0.0003194194,0.0003552626,0.00004966515,0.00017725198,0.000013437857,0.00023979206,0.00014671571,0.0000018339122],"category_scores_gemma":[0.00011900299,0.00015595093,0.00022718331,0.00016192129,0.0003662421,0.000007074785,0.00032008855,0.000054239652,0.0000029962016],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003623613,0.00024983578,0.0010478123,0.000032811884,0.00018106002,0.0000025333918,0.0020471269,0.000003806377,0.9944767,0.00003082977,0.00008138706,0.0014837695],"study_design_scores_gemma":[0.0013841899,0.0005400439,0.003480026,0.00025761934,0.0000636766,0.0000066976368,0.0006795911,4.4505987e-7,0.9900644,0.000033216744,0.0032800983,0.00021004182],"about_ca_topic_score_codex":0.00002230507,"about_ca_topic_score_gemma":0.00005293189,"teacher_disagreement_score":0.0044123125,"about_ca_system_score_codex":0.000032389635,"about_ca_system_score_gemma":0.00017320887,"threshold_uncertainty_score":0.63594943},"labels":[],"label_agreement":null},{"id":"W2602735484","doi":"10.1182/blood.v128.22.5992.5992","title":"CT or CT/PET Surveillance in Asymptomatic Adult and Pediatric Patients Following Curative Intent Therapy for Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphoma: A Systematic Review","year":2016,"lang":"en","type":"review","venue":"Blood","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Medicine; Asymptomatic; Positron emission tomography; Lymphoma; Aggressive lymphoma; MEDLINE; Disease; Pediatrics; Oncology; Internal medicine; Radiology; Rituximab","score_opus":0.02105059497066095,"score_gpt":0.3370804618260396,"score_spread":0.31602986685537865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2602735484","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004934357,0.98097354,0.0001617787,0.00024136437,0.00008372401,0.013323828,0.00016047795,0.00009634697,0.00002458346],"genre_scores_gemma":[0.0010857097,0.98815405,0.0020095448,0.00045239422,0.00010313483,0.007860203,0.00016195865,0.0000987823,0.00007421714],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9964371,0.00032986957,0.001594475,0.0007700018,0.00042275363,0.00044582703],"domain_scores_gemma":[0.9961078,0.0012652959,0.0014586505,0.00067818287,0.00022151698,0.0002685508],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00079524453,0.00065227377,0.0038788524,0.00026797206,0.000095092255,0.000046975598,0.00028471352,0.00009597252,0.000009133805],"category_scores_gemma":[0.0027207942,0.00037087678,0.0004446398,0.00052211975,0.000085480286,0.00008496141,0.00012646025,0.00014712515,0.000009793989],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016992797,0.0008161051,0.0006422577,0.72821826,0.00042374633,0.00025020508,0.000051227176,4.103662e-10,2.697318e-7,0.000020660404,0.0010148362,0.26854542],"study_design_scores_gemma":[0.009189857,0.0005529518,0.0002342212,0.97174627,0.003916318,0.001116037,0.000019533894,0.000026484806,0.0000028685192,0.0000571637,0.01245675,0.0006815708],"about_ca_topic_score_codex":0.000018671739,"about_ca_topic_score_gemma":0.000005510322,"teacher_disagreement_score":0.26786384,"about_ca_system_score_codex":0.00014001758,"about_ca_system_score_gemma":0.00037255374,"threshold_uncertainty_score":0.9998743},"labels":[],"label_agreement":null},{"id":"W2603067755","doi":"10.1182/blood.v110.11.2326.2326","title":"The Role of Bone Marrow Examination in the Initial Evaluation of Pediatric Hodgkin’ Disease: The Canadian Perspective.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Hematological disorders and diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cancer Care Nova Scotia; Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Medicine; Stage (stratigraphy); Bone marrow; Disease; Trephine; Lymphoma; Hematology; Internal medicine; Pediatrics; Surgery","score_opus":0.030171860665429342,"score_gpt":0.3174742624545106,"score_spread":0.2873024017890813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2603067755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97415286,0.005734294,0.000007323476,0.0016175307,0.00002830081,0.0005388595,0.000009084178,0.0000033341364,0.017908428],"genre_scores_gemma":[0.9996372,0.00010788672,0.000011444208,0.00011495167,0.00009179341,0.000019766754,0.000007680922,0.0000040404525,0.00000526216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989459,0.00017187106,0.00019296972,0.00008010992,0.00046765205,0.00014151767],"domain_scores_gemma":[0.99873346,0.00067344,0.00007538116,0.00017708614,0.00028159242,0.000059051563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022477426,0.000053879787,0.000093657094,0.000072077746,0.00009294552,0.000008070256,0.000084455125,0.000045718727,0.000028150485],"category_scores_gemma":[0.0035564688,0.000025888407,0.000040177278,0.0002891259,0.000083514366,0.00001762806,0.000009470122,0.00010349437,0.0000022330414],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024563223,0.0027765299,0.8288734,0.00008888602,0.00008908237,0.00009408868,0.008977053,0.000034350764,0.00020963841,0.11828032,0.0005918054,0.039739206],"study_design_scores_gemma":[0.0010981531,0.000108135,0.9826973,0.000011414184,0.00036921538,0.000004506494,0.0053069293,0.0001794097,0.0002293957,0.009803398,0.00015499984,0.00003713339],"about_ca_topic_score_codex":0.008674439,"about_ca_topic_score_gemma":0.07075789,"teacher_disagreement_score":0.15382391,"about_ca_system_score_codex":0.000038511444,"about_ca_system_score_gemma":0.00033029917,"threshold_uncertainty_score":0.9979269},"labels":[],"label_agreement":null},{"id":"W2603167456","doi":"10.1182/blood.v128.22.1103.1103","title":"Longer Term Efficacy and Safety of Subcutaneous Compared with Intravenous Rituximab: Updated Results of the Phase 3 SABRINA Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Rituximab; Adverse effect; Vincristine; Internal medicine; Regimen; Prednisone; Maintenance therapy; International Prognostic Index; Surgery; Cyclophosphamide; Oncology; Chemotherapy; Lymphoma","score_opus":0.011638767461707184,"score_gpt":0.25444124668042095,"score_spread":0.24280247921871376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2603167456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99811274,0.00015106521,0.0000014165333,0.0002177893,0.000021759852,0.0009325214,0.00012507038,0.000017111734,0.00042054345],"genre_scores_gemma":[0.99975646,0.000038353213,0.000056548157,0.000016104997,0.000019594443,0.000010676291,0.000011160928,0.000012170019,0.00007895422],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99907154,0.000049202914,0.00031412262,0.00021437315,0.00021127624,0.00013946595],"domain_scores_gemma":[0.9991193,0.00012478112,0.00015646481,0.000444443,0.000084398234,0.00007066049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008184512,0.00013160527,0.00039163325,0.00003335884,0.00003875706,0.000004220268,0.00007391028,0.00003102603,0.000020011255],"category_scores_gemma":[0.00003446781,0.000057439083,0.00003813894,0.000102232814,0.00014022115,0.000017921993,0.000042747382,0.000032600285,0.0000030415595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049375173,0.21500027,0.624909,0.00016696024,0.0038635444,0.002901143,0.0065647135,0.0000013762759,0.032751966,0.00006767821,0.0003509328,0.06404727],"study_design_scores_gemma":[0.21377145,0.008782057,0.71932024,0.00037246925,0.0013390529,0.00063697627,0.00016826543,0.00000135114,0.055376742,0.0000033305466,0.00012147312,0.00010662379],"about_ca_topic_score_codex":0.00008493749,"about_ca_topic_score_gemma":0.000046980604,"teacher_disagreement_score":0.20621821,"about_ca_system_score_codex":0.00002422237,"about_ca_system_score_gemma":0.000060863567,"threshold_uncertainty_score":0.23422979},"labels":[],"label_agreement":null},{"id":"W2603204059","doi":"10.1182/blood.v128.22.5852.5852","title":"Outcome of Patients with Peripheral T-Cell Lymphoma Undergoing Allogeneic Stem Cell in British Columbia","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Leukemia & Lymphoma Society of Canada; BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Lymphoma; Peripheral T-cell lymphoma; Internal medicine; Anaplastic large-cell lymphoma; Cancer; Transplantation; Gastroenterology; Not Otherwise Specified; Oncology; Surgery; T cell; Immunology; Immune system","score_opus":0.010401239381902282,"score_gpt":0.22947458122911843,"score_spread":0.21907334184721614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2603204059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973358,0.00024821953,0.000020982852,0.000035283447,0.00002516929,0.0006345959,0.000044831893,0.000025473077,0.0016296565],"genre_scores_gemma":[0.99344814,0.000050811028,0.00019354084,0.00006938823,0.00001783878,0.000029888082,0.000011228706,0.00004650569,0.006132654],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983468,0.000073064184,0.00036013682,0.00033895424,0.00048690572,0.00039411208],"domain_scores_gemma":[0.9991989,0.00010170546,0.00008898919,0.0002830787,0.00019593498,0.00013136187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010468749,0.00012215116,0.00037476837,0.00006738059,0.00004699941,0.000041680887,0.00012821214,0.00008855998,0.00027667178],"category_scores_gemma":[0.000036228666,0.00012465996,0.000070183705,0.00020861109,0.000113211725,0.00006365319,0.000062932646,0.00005845288,0.00001577317],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001342641,0.0031115708,0.9873604,0.00021840398,0.000042326763,0.00021543165,0.00011678897,8.503672e-7,0.00461398,5.2942636e-7,0.00006802227,0.0041173883],"study_design_scores_gemma":[0.03616948,0.0012477102,0.9563382,0.00026696263,0.000059938528,0.000111719826,0.00026653265,0.0000054894826,0.005199826,0.000010697373,0.00010646575,0.00021697038],"about_ca_topic_score_codex":0.0022380336,"about_ca_topic_score_gemma":0.04246591,"teacher_disagreement_score":0.040227875,"about_ca_system_score_codex":0.00015791648,"about_ca_system_score_gemma":0.00029880632,"threshold_uncertainty_score":0.9750066},"labels":[],"label_agreement":null},{"id":"W2603206339","doi":"10.1182/blood.v126.23.4792.4792","title":"Diagnosis of Fanconi Anemia By Chromosome Breakage Tests Using 3 Different Scoring Systems and Whole Genome Sequencing Among Patients with Aplastic Anemia in Korean","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Aplastic anemia; Fanconi anemia; Bone marrow failure; Medicine; Bone marrow; Anemia; Chromosome instability; Gastroenterology; Pathology; Internal medicine; Chromosome; Biology; Genetics; Haematopoiesis; DNA repair; Gene; Stem cell","score_opus":0.010353242127696522,"score_gpt":0.20578270965102502,"score_spread":0.1954294675233285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2603206339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986777,0.00071359024,0.000074570475,0.000001233245,0.000064658,0.000332855,0.00008814854,0.000013902558,0.00003339034],"genre_scores_gemma":[0.9995037,0.0000154015,0.00021525387,0.0000058900323,0.00004737285,0.000036283993,0.00012249639,0.000036650094,0.000016954304],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988438,0.00005275968,0.0002582456,0.00037651614,0.00019350302,0.00027517555],"domain_scores_gemma":[0.9993341,0.000017248123,0.00015617044,0.00026955528,0.00007556076,0.00014736013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000104104125,0.00020590746,0.00026064762,0.00006256702,0.000031021813,0.000028999659,0.00010369216,0.00012735902,0.0000010678074],"category_scores_gemma":[0.000053214324,0.00018148111,0.000024586061,0.000093368544,0.000065357155,0.000012599861,0.00012110289,0.000082629565,5.4880036e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015124834,0.0001295658,0.50023234,0.00010861366,0.00002262361,0.000013541939,0.00008463884,0.00018870657,0.49917206,0.0000011082632,0.0000034273003,0.000028272054],"study_design_scores_gemma":[0.005843867,0.0014202755,0.17594302,0.0006259442,0.00017179544,0.000058475554,0.00029967004,0.0003430428,0.814656,0.000011128562,0.000020169355,0.00060657377],"about_ca_topic_score_codex":0.00026814442,"about_ca_topic_score_gemma":0.00009691317,"teacher_disagreement_score":0.3242893,"about_ca_system_score_codex":0.00006358153,"about_ca_system_score_gemma":0.000059806298,"threshold_uncertainty_score":0.74005854},"labels":[],"label_agreement":null},{"id":"W2603219335","doi":"10.1182/blood.v110.11.3716.3716","title":"Aldehyde Dehydrogenase-Activity Purifies Multiple Hemangiogenic Lineages That Accelerate Vascularization of Ischemic Tissue through Paracrine Support of Neovessel Formation.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials","funders":"","keywords":"Paracrine signalling; Angiogenesis; Biology; Matrigel; CD34; Cell biology; Mesenchymal stem cell; Haematopoiesis; Bone marrow; Population; Stem cell; Stromal cell; Immunology; Cancer research; Biochemistry; Medicine","score_opus":0.051927080536511655,"score_gpt":0.32000188427324144,"score_spread":0.26807480373672976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2603219335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852704,0.0009725894,0.009012293,0.0001217157,0.00004126519,0.000786809,0.00002418617,0.000048862807,0.0037219014],"genre_scores_gemma":[0.9957451,0.00036133875,0.0029351837,0.000042592314,0.00009077357,0.000021984068,0.00014456474,0.000034786943,0.00062367826],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99799323,0.000053240787,0.00053910434,0.00027903917,0.00072313315,0.00041226964],"domain_scores_gemma":[0.99853724,0.00020432122,0.00030582037,0.00051535876,0.00029883598,0.00013843426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006627187,0.00020529366,0.0005033597,0.0001553502,0.00006099913,0.0000129251575,0.00017097969,0.00015866279,0.00024437698],"category_scores_gemma":[0.00027373465,0.00018292763,0.00018409644,0.00044168445,0.00010975809,0.00038086364,0.00010148901,0.0001785387,0.000025971292],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020089043,0.00092323415,0.023061749,0.00091872405,0.00025420988,0.00005796826,0.00048942375,0.000018172355,0.972677,0.000031365624,0.00039633558,0.0009709566],"study_design_scores_gemma":[0.0027467324,0.00029569207,0.011211631,0.00007663314,0.000212748,0.00010665435,0.00011024451,0.00020254549,0.9818282,0.000015106927,0.003049297,0.00014447673],"about_ca_topic_score_codex":0.00020167424,"about_ca_topic_score_gemma":0.00005178352,"teacher_disagreement_score":0.011850118,"about_ca_system_score_codex":0.00003070487,"about_ca_system_score_gemma":0.00010800304,"threshold_uncertainty_score":0.74595726},"labels":[],"label_agreement":null},{"id":"W2603490583","doi":"10.1182/blood.v114.22.3185.3185","title":"The Kinetics of Activated Thrombin-Activatable Fibrinolysis Inhibitor with Respect to Plasminogen Binding Site Removal From Fibrin Degradation Products.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Fibrin; Plasmin; Chemistry; Fibrinolysis; Zymogen; Thrombomodulin; Thrombin; Biochemistry; Kinetics; Carboxypeptidase; Binding site; Tissue plasminogen activator; Biophysics; Molecular biology; Enzyme; Biology; Platelet; Immunology; Medicine; Internal medicine","score_opus":0.010178477044049684,"score_gpt":0.21772602953649714,"score_spread":0.20754755249244747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2603490583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99844533,0.00029659053,0.00019538349,0.00025736375,0.00005496434,0.00036729051,0.00007409739,0.000020012412,0.00028899094],"genre_scores_gemma":[0.99466693,0.000035107438,0.0043836855,0.000048273865,0.00028925558,0.0000117712425,0.00020275175,0.000021447628,0.00034075702],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99887145,0.00005107635,0.00021596855,0.00039039386,0.0002158778,0.00025521632],"domain_scores_gemma":[0.99915284,0.000017108927,0.00013832336,0.0005119247,0.000110880326,0.00006895313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009166414,0.0001727069,0.00016631698,0.000046439174,0.000105560895,0.000039406717,0.00017077732,0.00009723655,0.0000046713662],"category_scores_gemma":[0.00011420823,0.00012704321,0.000048939048,0.00026556503,0.000029848441,0.000009115985,0.00007393656,0.000076267555,0.000008577502],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003196235,0.00015023707,0.0001119966,0.0000050006884,0.000086439,0.0000052533355,0.000035790243,0.000020917116,0.9980123,0.000015565218,0.0004634502,0.00077343686],"study_design_scores_gemma":[0.00077025907,0.0012449465,0.0005615215,0.000053203865,0.00006359243,0.000019260207,0.0000351642,0.0000042424836,0.99424815,0.000038444,0.0027790135,0.00018219411],"about_ca_topic_score_codex":0.000045853096,"about_ca_topic_score_gemma":0.000016052858,"teacher_disagreement_score":0.004188302,"about_ca_system_score_codex":0.0000138952855,"about_ca_system_score_gemma":0.000052999836,"threshold_uncertainty_score":0.5180672},"labels":[],"label_agreement":null},{"id":"W2603510719","doi":"10.1182/blood.v128.22.4362.4362","title":"High Cumulative Illness Rating Scale (CIRS) Score in CLL Correlates with Short CLL Telomere Length and Decreased Survival","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; CancerCare Manitoba; Research Institute in Oncology and Hematology; University of Manitoba","funders":"","keywords":"Chronic lymphocytic leukemia; Internal medicine; Medicine; Telomere; Buccal swab; Gastroenterology; Cancer; Surrogate endpoint; Oncology; Leukemia; Biology; Genetics","score_opus":0.01817511774152435,"score_gpt":0.27059866827796136,"score_spread":0.252423550536437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2603510719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99727577,0.00026160304,0.000074756026,0.00018902072,0.000066936795,0.00063270744,0.00001609432,0.000066721295,0.0014163834],"genre_scores_gemma":[0.9985583,0.00010786936,0.00058471283,0.000039657072,0.0001444767,0.00004809868,0.000016298123,0.000052968855,0.0004476426],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99798054,0.000105548206,0.00032533018,0.00051133096,0.00054553297,0.0005317425],"domain_scores_gemma":[0.99847555,0.00064093876,0.000060814902,0.00038882598,0.00014741432,0.00028644464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043018485,0.00024543056,0.00047727214,0.00015321687,0.000093400966,0.00002659501,0.00012050191,0.00015070401,0.0000898482],"category_scores_gemma":[0.00035760936,0.00014930275,0.00004212406,0.0003264972,0.00031013295,0.00015912598,0.0001121189,0.00024575202,0.000023904066],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018711442,0.0014118693,0.96173257,0.00045721227,0.00046912787,0.0011820906,0.0018285742,0.00002494083,0.01247584,0.00057701877,0.00009594561,0.017873699],"study_design_scores_gemma":[0.30635044,0.0026886074,0.49302563,0.0071561537,0.0011512537,0.0018214735,0.0036757884,0.0049537322,0.17620696,0.0006944679,0.000347873,0.0019276075],"about_ca_topic_score_codex":0.0011165135,"about_ca_topic_score_gemma":0.00092237815,"teacher_disagreement_score":0.4687069,"about_ca_system_score_codex":0.001174992,"about_ca_system_score_gemma":0.0019209994,"threshold_uncertainty_score":0.608839},"labels":[],"label_agreement":null},{"id":"W2603871177","doi":"10.1182/blood.v108.11.727.727","title":"In Vitro Chemotactic Index and Response to CXCR4 Antagonist AMD3100 Correlate with CD34+ Cell Yield from Leukapheresis Products: Implications for Poor Mobilizers.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Canadian Blood Services","funders":"","keywords":"Leukapheresis; CD34; Haematopoiesis; Stromal cell; CXCR4; Progenitor cell; Bone marrow; Chemotaxis; Plerixafor; Immunology; Transplantation; Cell biology; Cancer research; Biology; Andrology; Stem cell; Chemistry; Internal medicine; Receptor; Medicine; Chemokine; Inflammation","score_opus":0.010704374205008934,"score_gpt":0.23866347192919382,"score_spread":0.22795909772418488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2603871177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907301,0.00016850735,0.0008500504,0.0057694754,0.000040072857,0.0016314349,0.00013842045,0.00005283777,0.0006191211],"genre_scores_gemma":[0.99137926,0.000014797458,0.0068787932,0.0004008343,0.000082906394,0.00024808742,0.00008996196,0.000044013337,0.00086133525],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987433,0.000037389225,0.00032227943,0.00047440644,0.00014509287,0.00027750735],"domain_scores_gemma":[0.9988592,0.00047679836,0.000084580686,0.00036765254,0.00009634725,0.00011542263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019745567,0.00018610492,0.00030405118,0.0001333006,0.00007126997,0.000030439523,0.00007174059,0.00011175928,0.00002268986],"category_scores_gemma":[0.00010611937,0.00016677393,0.000034007575,0.0003319749,0.00005090371,0.000080236525,0.000012444932,0.00013142626,0.000014552541],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006157492,0.0007415968,0.02570121,0.00024509142,0.000042012063,0.000036909212,0.00049554073,0.000008996274,0.9658942,0.000010903728,0.00054968055,0.00011636146],"study_design_scores_gemma":[0.008105603,0.00037285633,0.20180854,0.00017607646,0.0004039495,0.00011971716,0.00026976835,0.000039965067,0.78766215,0.00011061975,0.00069592707,0.00023482997],"about_ca_topic_score_codex":0.0007186896,"about_ca_topic_score_gemma":0.00012931804,"teacher_disagreement_score":0.17823206,"about_ca_system_score_codex":0.000054909793,"about_ca_system_score_gemma":0.00017700029,"threshold_uncertainty_score":0.68008435},"labels":[],"label_agreement":null},{"id":"W2604051175","doi":"10.1182/blood.v110.11.587.587","title":"A Multicenter Phase II Study Using a Dose Intensified Pediatric Regimen in Adults with Untreated Acute Lymphoblastic Leukemia.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Hamilton Health Sciences; Health Sciences Centre; CancerCare Manitoba; Queen Elizabeth II Health Sciences Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Vincristine; Regimen; Mercaptopurine; Asparaginase; Internal medicine; Acute lymphocytic leukemia; Dexamethasone; Prednisone; Pediatrics; Chemotherapy regimen; Methotrexate; Chemotherapy; Surgery; Gastroenterology; Leukemia; Cyclophosphamide; Lymphoblastic Leukemia","score_opus":0.016634474596226093,"score_gpt":0.30058355377325574,"score_spread":0.28394907917702966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604051175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965616,0.00010145861,0.0003006471,0.000048027458,0.00007268253,0.002336291,0.0000148351155,0.00014366464,0.00042078388],"genre_scores_gemma":[0.99733084,0.000026065969,0.0016676282,0.00017032561,0.00029010745,0.000050012008,0.00003310504,0.00009976191,0.0003321583],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9964523,0.00009407059,0.00070676906,0.000806409,0.0008720622,0.0010684391],"domain_scores_gemma":[0.9979522,0.00027327694,0.00019074659,0.00069734233,0.00040627673,0.0004801161],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005643888,0.00044638966,0.0007115717,0.0008842616,0.00014640838,0.0000329333,0.00024363797,0.00019573847,0.000046529665],"category_scores_gemma":[0.0003337473,0.00034050216,0.00008571019,0.0016074913,0.00012322533,0.00016111537,0.0002463916,0.00045494328,0.000042888416],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2099376,0.07883759,0.51899236,0.0009936499,0.004177715,0.11250651,0.032282557,0.00012062013,0.035499025,0.000016517377,0.0005840306,0.0060518],"study_design_scores_gemma":[0.7849614,0.045597613,0.107180096,0.0016237063,0.0074974746,0.0041107335,0.010308661,0.025898835,0.011300241,0.000007193462,0.00005449185,0.0014595801],"about_ca_topic_score_codex":0.0010543279,"about_ca_topic_score_gemma":0.00029803597,"teacher_disagreement_score":0.5750238,"about_ca_system_score_codex":0.0016747476,"about_ca_system_score_gemma":0.0013697012,"threshold_uncertainty_score":0.9999047},"labels":[],"label_agreement":null},{"id":"W2604623858","doi":"10.1182/blood.v120.21.2581.2581","title":"AML Cells Have Altered Mitochondrial Biogenesis and Low Spare Reserve Capacity in Their Respiratory Chain That Renders Them Susceptible to Oxidative Metabolic Stress.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Mitochondrial biogenesis; TFAM; Mitochondrion; Oligomycin; Respiratory chain; Cell biology; Mitochondrial respiratory chain; Biology; Oxidative phosphorylation; Stem cell; Myeloid; Chemistry; Biochemistry; Immunology","score_opus":0.05680673279561843,"score_gpt":0.24604027396511027,"score_spread":0.18923354116949184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604623858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99679726,0.0010315184,0.00019722297,0.00007699424,0.0007332292,0.000436219,0.00030022746,0.000015881638,0.00041142674],"genre_scores_gemma":[0.99698174,0.00016600412,0.00087161595,0.0004935261,0.0010818592,0.00007660529,0.00009272702,0.00002952598,0.00020637958],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982885,0.00036096972,0.00023838849,0.0005005221,0.00013247202,0.00047915807],"domain_scores_gemma":[0.999102,0.00003482896,0.000101748934,0.0004817886,0.000056611127,0.00022303892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002542493,0.00026545618,0.00029676882,0.00011323146,0.00008405211,0.000027101896,0.00019023333,0.00028165476,0.000054329164],"category_scores_gemma":[0.00011285526,0.00023277894,0.000095607975,0.00013547248,0.000100608086,0.000013376667,0.00016366578,0.0001397576,0.000022477105],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020318788,0.00023792317,0.046272866,0.000017718938,0.00006980817,0.0000028307713,0.0008034134,0.000010528051,0.95092785,0.00006208272,0.0012171535,0.00017460706],"study_design_scores_gemma":[0.0016198461,0.00024464066,0.0049983673,0.00001797075,0.000036661622,0.000009028785,0.00083610957,0.0000033826393,0.9783425,0.000019910125,0.01360071,0.0002708882],"about_ca_topic_score_codex":0.00019629177,"about_ca_topic_score_gemma":0.0015002105,"teacher_disagreement_score":0.041274503,"about_ca_system_score_codex":0.000010843233,"about_ca_system_score_gemma":0.000043739958,"threshold_uncertainty_score":0.949245},"labels":[],"label_agreement":null},{"id":"W2604684472","doi":"10.1182/blood.v128.22.1852.1852","title":"Biomarkers of Cytokine Release Syndrome and Neurotoxicity after CD19 CAR-T Cells and Mitigation of Toxicity By Cell Dose","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cytokine release syndrome; Medicine; CD8; Toxicity; CD19; Immunology; T cell; Internal medicine; Gastroenterology; Chimeric antigen receptor; Antigen; Immune system","score_opus":0.008121120329729692,"score_gpt":0.23716369371763285,"score_spread":0.22904257338790315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604684472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99828905,0.0003718568,0.000014085718,0.00020776007,0.000021327272,0.0005729093,0.0001964658,0.0000149020725,0.00031163997],"genre_scores_gemma":[0.99852014,0.00037038498,0.00015304342,0.000055598935,0.000017920001,0.00001956962,0.000005346906,0.00002293287,0.00083505694],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99885494,0.000086029526,0.00027359964,0.00027837735,0.00030175224,0.00020529426],"domain_scores_gemma":[0.9991729,0.00014398986,0.00009944294,0.00030321482,0.0000857818,0.00019465505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022013288,0.00013660366,0.00031362308,0.0001108862,0.000018784911,0.000006045583,0.000057117064,0.000097170436,0.0003366875],"category_scores_gemma":[0.000053388816,0.00010025448,0.000059776787,0.00014410743,0.00027472913,0.00006650973,0.00006563634,0.0000864219,0.0000029022399],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061239686,0.0004627284,0.02775605,0.0003252593,0.00007122384,0.000063731306,0.00007125659,2.1817506e-8,0.96932447,0.00000123909,0.00013791877,0.0011736804],"study_design_scores_gemma":[0.005142758,0.0008311335,0.05824124,0.0001268447,0.00010585934,0.000080369005,0.000014543757,0.000007184192,0.93513966,0.000023177852,0.00019372754,0.00009348952],"about_ca_topic_score_codex":0.000072744566,"about_ca_topic_score_gemma":0.000006528388,"teacher_disagreement_score":0.034184825,"about_ca_system_score_codex":0.00001637791,"about_ca_system_score_gemma":0.000043241922,"threshold_uncertainty_score":0.4088259},"labels":[],"label_agreement":null},{"id":"W2604707621","doi":"10.1182/blood.v120.21.699.699","title":"The Independent Effects of Frailty and Comorbidity On the Quality of Life in MDS Patients","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Frailty in Older Adults","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Health Sciences Centre; University Health Network; Sunnybrook Health Science Centre","funders":"","keywords":"Comorbidity; Medicine; Quality of life (healthcare); Univariate analysis; Internal medicine; Multivariate analysis; Univariate; Gerontology; Multivariate statistics","score_opus":0.03678347943477029,"score_gpt":0.30252212432115316,"score_spread":0.2657386448863829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604707621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99770075,0.00042701687,0.0000017391454,0.00043991517,0.00013530858,0.00047742852,0.0000089891555,0.000006275697,0.0008025652],"genre_scores_gemma":[0.9996342,0.000050535833,0.000015323938,0.00019108549,0.000043058764,0.00001523609,0.0000029783498,0.000007036919,0.000040555053],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99889356,0.00020920519,0.00028443267,0.00008841324,0.0003626195,0.00016177844],"domain_scores_gemma":[0.99822897,0.0011483935,0.00014239203,0.00034868708,0.00005508067,0.000076505756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006669856,0.00008229087,0.0002199396,0.000024242618,0.000033589626,0.0000031094248,0.00009462902,0.00006142643,0.00000894625],"category_scores_gemma":[0.0020943633,0.00004343194,0.000038686056,0.00008127659,0.00011829629,0.000029651852,0.00006611393,0.00018349035,0.0000038143887],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008306276,0.0014441212,0.99453884,0.00019057735,0.0000516112,4.7484735e-7,0.0008588965,1.2803575e-7,0.00086134183,0.0003943042,0.00029817352,0.0012784518],"study_design_scores_gemma":[0.003703665,0.00026267508,0.977675,0.00011889422,0.00003696432,6.4745717e-7,0.00007879431,0.0000018856884,0.017887203,0.00006877128,0.00012391405,0.000041565825],"about_ca_topic_score_codex":0.00040966153,"about_ca_topic_score_gemma":0.00013085343,"teacher_disagreement_score":0.017025862,"about_ca_system_score_codex":0.000012022855,"about_ca_system_score_gemma":0.000025868912,"threshold_uncertainty_score":0.25072998},"labels":[],"label_agreement":null},{"id":"W2604892075","doi":"10.1182/blood.v128.22.1841.1841","title":"ZW38, a Novel Azymetric Bispecific CD19-Directed CD3 T Cell Engager Antibody Drug Conjugate with Controlled T Cell Activation and Improved B Cell Cytotoxicity","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"Blinatumomab; CD19; Antibody; T cell; Antibody-drug conjugate; Cancer research; B cell; Immunology; Medicine; Molecular biology; Chemistry; Biology; Immune system; Monoclonal antibody","score_opus":0.013718849653266661,"score_gpt":0.2543328361908271,"score_spread":0.24061398653756041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604892075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98421776,0.00042300846,0.00081169803,0.00034165938,0.00007120589,0.0026818174,0.00005122676,0.00026003222,0.011141576],"genre_scores_gemma":[0.9722502,0.00040813355,0.00090904685,0.00015041932,0.0002416933,0.000109441986,0.000034939778,0.00011518861,0.025780905],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970114,0.00024146013,0.0005076061,0.0008157802,0.0006779793,0.00074572314],"domain_scores_gemma":[0.99716586,0.0010139443,0.0002982607,0.00070439937,0.0004206328,0.00039691475],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00085051643,0.0004539001,0.0009009193,0.00062561355,0.00020614527,0.00009267971,0.00019296075,0.00021027247,0.0008188308],"category_scores_gemma":[0.00020034846,0.00028614237,0.00016763841,0.00095072074,0.00019703903,0.00020064604,0.0000907866,0.00056036207,0.000059485985],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004599571,0.0024905268,0.005082613,0.0001771295,0.00017074894,0.00003915681,0.0002510343,4.2065113e-7,0.98654777,0.0000047227745,0.00018507571,0.00045125524],"study_design_scores_gemma":[0.08751049,0.0010388575,0.0072292145,0.00010971349,0.00026392078,0.0000272954,0.00009845177,0.00022950301,0.90200514,0.0000063198186,0.0011082405,0.0003728338],"about_ca_topic_score_codex":0.00015380334,"about_ca_topic_score_gemma":0.000017319171,"teacher_disagreement_score":0.08454259,"about_ca_system_score_codex":0.00011243364,"about_ca_system_score_gemma":0.000288098,"threshold_uncertainty_score":0.99995905},"labels":[],"label_agreement":null},{"id":"W2605064360","doi":"10.1182/blood-2017-01-764324","title":"Improved outcomes for myeloid leukemia of Down syndrome: a report from the Children’s Oncology Group AAML0431 trial","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Hospital for Sick Children; Izaak Walton Killam Health Centre; Dalhousie University","funders":"National Cancer Institute","keywords":"Medicine; Myeloid leukemia; Oncology; Internal medicine; Leukemia; Pediatrics","score_opus":0.02602040476858037,"score_gpt":0.3267331675037752,"score_spread":0.3007127627351948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605064360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99013275,0.00015894583,0.00011075515,0.0040315907,0.0005079127,0.003425063,0.00019395212,0.00005998581,0.0013790419],"genre_scores_gemma":[0.99321616,0.000053619,0.0030736448,0.0003699808,0.00083225855,0.0004701838,0.00023403327,0.000059174563,0.0016909273],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975888,0.0000943221,0.0007640035,0.0005674591,0.00045583397,0.0005295642],"domain_scores_gemma":[0.99579734,0.00087583886,0.0007242258,0.0022127852,0.00019681707,0.00019302635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011744763,0.00027066117,0.0009857785,0.000079405625,0.00038250073,0.000060093236,0.0008660156,0.00035237946,0.00010210488],"category_scores_gemma":[0.0039542406,0.0001703716,0.00043625096,0.00006881883,0.00041216615,0.00011771479,0.0003639081,0.00054894673,0.000018274235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0716311,0.0059270565,0.7265341,0.00031386683,0.011527513,0.004137386,0.001485185,9.985956e-7,0.09671379,0.0006424839,0.03614176,0.04494471],"study_design_scores_gemma":[0.2059743,0.0037238488,0.77286816,0.000076832446,0.0014296728,0.0017610759,0.00010034073,0.00006161374,0.007012195,0.00033529176,0.006367309,0.00028934696],"about_ca_topic_score_codex":0.0033643085,"about_ca_topic_score_gemma":0.00024454354,"teacher_disagreement_score":0.13434319,"about_ca_system_score_codex":0.00035542733,"about_ca_system_score_gemma":0.0014537642,"threshold_uncertainty_score":0.69475526},"labels":[],"label_agreement":null},{"id":"W2605173819","doi":"10.1182/blood.v106.11.5015.5015","title":"Prognostic Significance of Biochemical Markers of Bone Metabolism in Patients with Bone Lesions from Multiple Myeloma (MM).","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Hôpital Notre-Dame; Juravinski Cancer Centre; McMaster University; University of Waterloo","funders":"","keywords":"Medicine; Deoxypyridinoline; Internal medicine; Bone remodeling; Pyridinoline; N-terminal telopeptide; Creatinine; Univariate analysis; Multiple myeloma; Bone disease; Gastroenterology; Pathology; Multivariate analysis; Alkaline phosphatase; Osteocalcin; Osteoporosis; Chemistry","score_opus":0.009320886981294336,"score_gpt":0.23229804392291564,"score_spread":0.22297715694162132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605173819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99762213,0.0011949502,0.000006010543,0.00014889028,0.000019857953,0.0007642143,0.00012558771,0.000016054806,0.00010227989],"genre_scores_gemma":[0.9918048,0.000024128016,0.007873188,0.000058575228,0.00002309002,0.00004967435,0.00011548659,0.000018197026,0.000032858974],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885297,0.000029392151,0.00040414976,0.00022172564,0.00026443697,0.00022734361],"domain_scores_gemma":[0.9992478,0.00011577669,0.00016063121,0.00024116295,0.00007613816,0.0001585262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000058673442,0.00013010959,0.0004443191,0.00009298114,0.00001668661,0.0000014410967,0.00003771554,0.00008127382,0.00003491556],"category_scores_gemma":[0.0001265109,0.00010075378,0.000048684655,0.00020056468,0.000077689525,0.000037632508,0.000019051959,0.00011024837,0.000006362153],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001340602,0.0053763245,0.9807047,0.0000903432,0.0001163043,0.000016788359,0.00010562155,8.0452395e-7,0.007865876,0.0000032223516,0.00007066071,0.004308747],"study_design_scores_gemma":[0.015876636,0.00038834737,0.93471473,0.00023174814,0.00031864713,0.000002015946,0.00001997361,0.00001570882,0.048256937,0.000007134492,0.000090100875,0.000078043544],"about_ca_topic_score_codex":0.00053809193,"about_ca_topic_score_gemma":0.00010206129,"teacher_disagreement_score":0.045989998,"about_ca_system_score_codex":0.00001917901,"about_ca_system_score_gemma":0.00011275422,"threshold_uncertainty_score":0.41086197},"labels":[],"label_agreement":null},{"id":"W2605266835","doi":"10.1182/blood.v128.22.1008.1008","title":"Physician Factors Determining Treatment Decisions in Selecting Second Line Agents for Pediatric ITP","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Children's Hospital of Eastern Ontario; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Observational study; Preference; Pediatrics; Family medicine; Internal medicine","score_opus":0.042377482123989,"score_gpt":0.30595728514358056,"score_spread":0.26357980301959155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605266835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986169,0.00014813383,0.000063556035,0.000055370932,0.00006518458,0.00046869047,0.000050453087,0.00003347447,0.0004982891],"genre_scores_gemma":[0.9981853,0.00012730242,0.00052486575,0.00006608901,0.0001241638,0.00006403081,0.000027991717,0.000026293372,0.00085399015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991272,0.000011591925,0.00020840061,0.0002555749,0.00009452253,0.00030272757],"domain_scores_gemma":[0.99937284,0.00028700253,0.000069651884,0.0001456883,0.000027711245,0.00009711808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000039689712,0.0001652862,0.00030082758,0.00014016552,0.000071310475,0.000008999986,0.000041210526,0.000061046834,0.00003442074],"category_scores_gemma":[0.000103350125,0.00009927819,0.00010790485,0.0001550485,0.000007742143,0.000062040635,0.000013411949,0.00003578793,0.000019076966],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008708806,0.0031863907,0.9048544,0.00002175093,0.0002491558,0.00028975625,0.0005705733,0.0000010459831,0.0043367594,0.0000057361976,0.00010035095,0.086296976],"study_design_scores_gemma":[0.08250269,0.006305621,0.7934976,0.00040352077,0.0019718339,0.00011091191,0.00046330012,0.00013384336,0.10856177,0.0006442006,0.0046372525,0.00076744],"about_ca_topic_score_codex":0.000014703973,"about_ca_topic_score_gemma":0.00012603449,"teacher_disagreement_score":0.1113568,"about_ca_system_score_codex":0.00006948621,"about_ca_system_score_gemma":0.000062701234,"threshold_uncertainty_score":0.40484473},"labels":[],"label_agreement":null},{"id":"W2605492041","doi":"10.1182/blood.v128.22.3525.3525","title":"Validation of Painreportit Neuropathic Pain Scale in African American Adults with Sickle Cell Disease","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neuropathic pain; Medicine; McGill Pain Questionnaire; Pain scale; Pain assessment; Population; Physical therapy; Disease; Anesthesia; Visual analogue scale; Internal medicine; Pain management","score_opus":0.0038202451340441997,"score_gpt":0.19362821866893654,"score_spread":0.18980797353489234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605492041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970643,0.000116149786,0.00030957928,0.00097109133,0.000016979604,0.0002842012,0.000008085303,0.000038625272,0.001191018],"genre_scores_gemma":[0.9993855,0.00009164499,0.00014449026,0.00012858662,0.000022460263,0.000017426351,0.000008537223,0.000022159835,0.00017924262],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888194,0.00018992434,0.0002731852,0.00023099412,0.00022018609,0.00020379454],"domain_scores_gemma":[0.999224,0.00008526345,0.00017609578,0.00027478443,0.00006434063,0.00017549454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046765222,0.00011117384,0.00021999961,0.00009436958,0.00001931004,0.0000034154014,0.000050475952,0.000033372457,0.000030406683],"category_scores_gemma":[0.00027656622,0.00006599399,0.000050588067,0.0003236768,0.00014901489,0.000038342823,0.000016173311,0.00008769251,0.000009245391],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007311261,0.0020687317,0.9474676,0.0002523323,0.000025479116,0.00032573333,0.00074880215,0.000013188633,0.021359915,0.000008358602,0.00006143359,0.026937246],"study_design_scores_gemma":[0.031392176,0.0068373065,0.80894834,0.0039048998,0.0010952209,0.00009779402,0.006074139,0.00054093346,0.1382035,0.00018236417,0.0016844036,0.0010389184],"about_ca_topic_score_codex":0.00013924684,"about_ca_topic_score_gemma":0.000020765468,"teacher_disagreement_score":0.1385193,"about_ca_system_score_codex":0.00001431132,"about_ca_system_score_gemma":0.000118700074,"threshold_uncertainty_score":0.2691157},"labels":[],"label_agreement":null},{"id":"W2605593254","doi":"10.1182/blood.v106.11.1820.1820","title":"Relationship of Harvest CD34+ and CD3+ Counts To Chronic Graft-Versus-Host Disease (cGVHD), Relapse and Survival Following Sibling Allogeneic Stem Cell Transplant.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Graft-versus-host disease; Hazard ratio; CD34; Internal medicine; Transplantation; Stem cell; Immunology; Confidence interval; Biology","score_opus":0.024597308344823137,"score_gpt":0.2617591890284541,"score_spread":0.23716188068363095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605593254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99454486,0.0021005373,0.00029078237,0.00021878108,0.00016040228,0.00033943445,0.000047336325,0.000039698327,0.0022581841],"genre_scores_gemma":[0.99845916,0.0002411184,0.0005064396,0.000037836282,0.00009591829,0.000010841625,0.000037776008,0.000027093423,0.00058379775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899757,0.000043155072,0.0002679925,0.00024622015,0.00025950483,0.00018553347],"domain_scores_gemma":[0.9992845,0.00021923213,0.00004919154,0.00017806745,0.000027156379,0.00024186843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022633579,0.00013727054,0.00022297564,0.00011662251,0.00006371573,0.000016997135,0.000049617815,0.0000774139,0.000027546716],"category_scores_gemma":[0.000016252488,0.00013616458,0.00005874197,0.00015376335,0.000031468335,0.0000888612,0.000009709726,0.00010643116,0.000027763504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070147414,0.00049568777,0.95084876,0.0022564356,0.00023011571,0.00023718558,0.0028985806,0.00006212877,0.04097911,0.00057493744,0.00013882814,0.0005767338],"study_design_scores_gemma":[0.028638052,0.0008213328,0.92641973,0.001989717,0.004806553,0.000098266944,0.0005849159,0.0004063267,0.031494062,0.00003597814,0.0038595805,0.00084550143],"about_ca_topic_score_codex":0.000009198239,"about_ca_topic_score_gemma":0.000051605155,"teacher_disagreement_score":0.027936578,"about_ca_system_score_codex":0.00002672776,"about_ca_system_score_gemma":0.000095795185,"threshold_uncertainty_score":0.55526304},"labels":[],"label_agreement":null},{"id":"W2605656567","doi":"10.1182/blood-2016-11-752204","title":"MDS with isolated del(5q) and internuclear bridging","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Fetal and Pediatric Neurological Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; Ottawa Hospital","funders":"","keywords":"Medicine; Physics","score_opus":0.011362063341618872,"score_gpt":0.22876237789443662,"score_spread":0.21740031455281775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605656567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889659,0.0001991623,0.000038102895,0.0013178188,0.00002785924,0.00008562957,0.0000016372519,0.000045666635,0.009318172],"genre_scores_gemma":[0.9986222,0.000098704484,0.00010447059,0.0006090575,0.00007720412,0.0000016857989,0.0000014641472,0.000009600852,0.00047563593],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99959445,0.0000066632324,0.00006274026,0.00014541789,0.00006988485,0.000120868885],"domain_scores_gemma":[0.99966943,0.00001176765,0.00003938403,0.00018256619,0.00001621749,0.00008060452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000030319841,0.000069743575,0.000115990435,0.000018768673,0.000109054745,0.000032720396,0.0000621647,0.00003756761,0.000053650958],"category_scores_gemma":[0.000050985615,0.00004537696,0.00002111686,0.000020221249,0.0000796976,0.00004716319,0.000055733322,0.00011603454,0.000026154006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000934159,0.0006647261,0.9652676,0.00013302271,0.00017517664,0.000948074,0.00021268692,8.180878e-7,0.0040474143,0.0001806717,0.0010439897,0.026391655],"study_design_scores_gemma":[0.0065027354,0.0023131086,0.98549724,0.000051446,0.0003354945,0.00043581772,0.000026951695,0.00048757793,0.0003888439,0.00014163734,0.003637937,0.00018120933],"about_ca_topic_score_codex":0.00006169267,"about_ca_topic_score_gemma":0.000007838626,"teacher_disagreement_score":0.026210446,"about_ca_system_score_codex":0.0000011041855,"about_ca_system_score_gemma":0.000007593895,"threshold_uncertainty_score":0.18504187},"labels":[],"label_agreement":null},{"id":"W2605688188","doi":"10.1182/blood.v118.21.1826.1826","title":"p53-Independent Anti-Myeloma Activity of Prima-1met","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Peripheral blood mononuclear cell; Apoptosis; Flow cytometry; Cytotoxic T cell; Cell culture; Viability assay; Biology; Bone marrow; Western blot; Molecular biology; Cancer research; Multiple myeloma; Immunology; In vitro; Biochemistry","score_opus":0.023898158254834434,"score_gpt":0.24018298924017442,"score_spread":0.21628483098534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605688188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97441596,0.00029734874,0.00031847242,0.00004381676,0.00015403597,0.00030075948,0.000013151759,0.00006835257,0.02438813],"genre_scores_gemma":[0.99831194,0.00003844616,0.0012849781,0.000056239296,0.000062633466,0.000010409941,0.0000049403516,0.000029333725,0.00020108672],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99902225,0.00003174229,0.0001844097,0.00024281406,0.00030132398,0.00021745493],"domain_scores_gemma":[0.9991991,0.000013193926,0.00011521804,0.00047378227,0.00008055253,0.000118180986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013405748,0.00012972155,0.00030319704,0.000097522476,0.00002348991,0.0000031975842,0.00009724884,0.00013301226,0.00026417777],"category_scores_gemma":[0.000059845883,0.00012121391,0.00013089595,0.00016367812,0.000058550788,0.000045215013,0.00006304887,0.0002106726,0.00005716261],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017174418,0.002143426,0.014645408,0.00012629348,0.00035731072,0.00030862968,0.00053349446,4.484444e-7,0.9748963,0.00023283107,0.00017239501,0.006411712],"study_design_scores_gemma":[0.0027282122,0.0003523974,0.20782237,0.000067181114,0.00031515837,0.00016048826,0.000018682771,0.0000062245163,0.7879881,0.00003697766,0.00040589357,0.00009827405],"about_ca_topic_score_codex":0.00011604696,"about_ca_topic_score_gemma":0.0000141214805,"teacher_disagreement_score":0.19317697,"about_ca_system_score_codex":0.000030081514,"about_ca_system_score_gemma":0.00015614381,"threshold_uncertainty_score":0.49429598},"labels":[],"label_agreement":null},{"id":"W2605707138","doi":"10.1182/blood.v128.22.1705.1705","title":"CD200 Is a Marker of LSC Activity in Acute Myeloid Leukemia","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of Toronto; Princess Margaret Cancer Centre; McGill University; University Health Network","funders":"","keywords":"CD34; CD38; Stem cell; Population; Myeloid leukemia; Biology; Leukemia; Myeloid; Haematopoiesis; Immunology; Bone marrow; Stem cell marker; Molecular biology; Side population; Cancer research; Medicine; Cancer stem cell; Cell biology","score_opus":0.015627541688724073,"score_gpt":0.2832251319817756,"score_spread":0.2675975902930515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605707138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879529,0.00013776796,0.00004749011,0.0022377863,0.00003585698,0.0003684279,0.000045285866,0.000039159517,0.00913533],"genre_scores_gemma":[0.99033624,0.00034281888,0.000649407,0.00030818893,0.00009468602,0.000032661246,0.0000028132533,0.000034992456,0.008198217],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99841577,0.000075320626,0.0002630923,0.00034864293,0.00044181553,0.00045533362],"domain_scores_gemma":[0.99883837,0.0001716893,0.00008064707,0.00059019367,0.00010361588,0.00021551336],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037664405,0.00016938247,0.0004324824,0.00023979289,0.000022881093,0.000005754061,0.00019072699,0.00017810168,0.0014522296],"category_scores_gemma":[0.00026173948,0.00011245717,0.00011695028,0.0003817351,0.00014282376,0.00011972104,0.00014506796,0.0002821659,0.0002477597],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096197147,0.0005569668,0.15042359,0.00012973396,0.00034264082,0.00039220776,0.00024189908,7.1347316e-8,0.8096876,0.000047808684,0.007587895,0.029627578],"study_design_scores_gemma":[0.014095293,0.0003961766,0.38276342,0.00032029455,0.0001981185,0.0001729966,0.000028445444,0.000052519295,0.5958332,0.00010692115,0.005819849,0.0002128241],"about_ca_topic_score_codex":0.00023166179,"about_ca_topic_score_gemma":0.000028628127,"teacher_disagreement_score":0.23233981,"about_ca_system_score_codex":0.00045412924,"about_ca_system_score_gemma":0.0010051184,"threshold_uncertainty_score":0.9994606},"labels":[],"label_agreement":null},{"id":"W2605710025","doi":"10.1182/blood.v128.22.3796.3796","title":"Perioperative Management for Congenital Factor XI Deficiency; A Systematic Review","year":2016,"lang":"en","type":"review","venue":"Blood","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Tranexamic acid; Perioperative; Surgery; Complication; Recombinant factor VIIa; Fresh frozen plasma; Internal medicine; Platelet","score_opus":0.042194168480608404,"score_gpt":0.33066956964599353,"score_spread":0.2884754011653851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605710025","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000043935506,0.9859449,0.00008899611,0.000049320926,0.00021255243,0.011501306,0.00027488137,0.00008899516,0.0018345987],"genre_scores_gemma":[0.000018494387,0.9861297,0.00024728777,0.00016030291,0.00025444484,0.002460246,0.00016605141,0.000086884545,0.010476612],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99751127,0.00010139582,0.001121922,0.0005579016,0.0003126828,0.00039482088],"domain_scores_gemma":[0.9982983,0.00023027849,0.0004770921,0.00066346215,0.0001636145,0.00016726601],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023127861,0.0005612905,0.0035127718,0.00014791133,0.00012286821,0.000044315624,0.00021397082,0.00018030002,0.00020578735],"category_scores_gemma":[0.00020527458,0.00032922952,0.0011952565,0.00020804774,0.000058218397,0.00006594929,0.00005119828,0.00008751401,0.00031674607],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000029104099,0.00019276496,0.0000017604673,0.90680313,0.0009742291,0.000025807229,0.000065875814,1.3411122e-9,2.3612694e-7,0.0007328454,0.00012737759,0.09107309],"study_design_scores_gemma":[0.0010492052,0.00022956294,0.0000027034803,0.5567202,0.01662808,0.00017688255,0.000017614973,4.9522833e-7,0.000002095699,0.0000045799447,0.4248541,0.00031447163],"about_ca_topic_score_codex":0.0000027382973,"about_ca_topic_score_gemma":0.000002386783,"teacher_disagreement_score":0.42472672,"about_ca_system_score_codex":0.00011709438,"about_ca_system_score_gemma":0.00027092756,"threshold_uncertainty_score":0.99991596},"labels":[],"label_agreement":null},{"id":"W2605720166","doi":"10.1182/blood.v126.23.741.741","title":"Copies of Donor Killer Immunoglobulin-like Receptor Genes and Motifs Titrate Natural Killer (NK) Cells' Functional Response to Epstein - Barr Virus Infections and Influence the Risk of Developing Post-Transplant Lymphoproliferative Disease (PTLD) after Allogeneic Hematopoietic Cell Transplantation","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Immunology; Biology; Human leukocyte antigen; Transplantation; Lymphoproliferative disorders; Virus; Immune system; Antibody; Virology; Epstein–Barr virus; Medicine; Antigen; Lymphoma; Internal medicine","score_opus":0.00644477969014335,"score_gpt":0.20377760343861617,"score_spread":0.19733282374847283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605720166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915597,0.0058304993,0.00031759683,0.0001596584,0.0016077115,0.0003902156,0.00009695305,0.000022739418,0.0000149380185],"genre_scores_gemma":[0.9968309,0.0015517138,0.00013366708,0.00019707021,0.000016692655,0.00007570118,0.00009931705,0.000015299891,0.0010796358],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986195,0.00044038284,0.0004033618,0.0002718274,0.00007388406,0.00019102303],"domain_scores_gemma":[0.99901074,0.00024842424,0.00017133805,0.00017991873,0.00033644444,0.000053136326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029389453,0.00021688195,0.00023876934,0.00014267716,0.00020731956,0.000023482953,0.00007957538,0.0001244604,0.00012398144],"category_scores_gemma":[0.000066515924,0.00016125712,0.000074310345,0.00013497431,0.00022396552,0.00018508636,0.000035475925,0.00017845392,0.00005589137],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008939563,0.00022559697,0.028369084,0.00010758762,0.0003212931,0.0000034415245,0.004397259,0.0002766533,0.9570463,0.00001733174,0.0002081905,0.00008770788],"study_design_scores_gemma":[0.00367767,0.0006543117,0.2844238,0.00018107344,0.00051949586,0.00014565916,0.000969666,0.000006799095,0.70578486,0.000018558363,0.0032941324,0.0003239684],"about_ca_topic_score_codex":0.0002428433,"about_ca_topic_score_gemma":0.00009715646,"teacher_disagreement_score":0.2560547,"about_ca_system_score_codex":0.000028934357,"about_ca_system_score_gemma":0.000176394,"threshold_uncertainty_score":0.65758747},"labels":[],"label_agreement":null},{"id":"W2605735165","doi":"10.1182/blood-2017-02-764662","title":"Multiple myeloma cells sent “PAKing”!","year":2017,"lang":"en","type":"letter","venue":"Blood","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Multiple myeloma; Kinase; Cancer research; Allosteric regulation; Medicine; Biology; Immunology; Internal medicine; Cell biology; Receptor","score_opus":0.017218840950173342,"score_gpt":0.24453290537577477,"score_spread":0.22731406442560143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605735165","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05335671,0.008200333,0.00034648736,0.81831104,0.011044745,0.0050381073,0.0008564935,0.0012658791,0.10158024],"genre_scores_gemma":[0.057022106,0.00039713085,0.0031725608,0.84884846,0.035330538,0.00026570365,0.0020807693,0.0008350457,0.052047674],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99774325,0.00004712829,0.00034010326,0.00067804824,0.00061199465,0.0005794882],"domain_scores_gemma":[0.9975996,0.00006296783,0.00034450393,0.0017432172,0.00011546037,0.00013427048],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00010182563,0.00044734206,0.00067533186,0.0001741655,0.00013658521,0.00006591693,0.00034602554,0.0012903316,0.00022556896],"category_scores_gemma":[0.00013491801,0.00043100017,0.00040669457,0.000061707535,0.00010768123,0.0000313428,0.00014389226,0.002288401,0.0008608566],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022491755,0.00016706636,0.00011677706,0.00037508705,0.0005042027,0.013554388,0.000067028355,7.536353e-7,0.028846147,9.871233e-7,0.9553302,0.001014867],"study_design_scores_gemma":[0.0040764087,0.00016389333,0.00026865525,0.00065766025,0.0011741427,0.0007039439,0.0000031418708,0.0000138182295,0.08015722,0.000008940206,0.91236985,0.00040232643],"about_ca_topic_score_codex":0.00009364782,"about_ca_topic_score_gemma":0.000011642839,"teacher_disagreement_score":0.051311072,"about_ca_system_score_codex":0.00010355259,"about_ca_system_score_gemma":0.00032032965,"threshold_uncertainty_score":0.9999171},"labels":[],"label_agreement":null},{"id":"W2605943665","doi":"10.1182/blood.v128.22.1218.1218","title":"Dynamo: A Phase 2 Study Demonstrating the Clinical Activity of Duvelisib in Patients with Relapsed Refractory Indolent Non-Hodgkin Lymphoma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Cégep de l'Outaouais; Jewish General Hospital","funders":"","keywords":"Medicine; Tolerability; Internal medicine; Adverse effect; Refractory (planetary science); Phases of clinical research; Lymphoma; Clinical endpoint; Oncology; Regimen; Salvage therapy; Clinical trial; Chemotherapy","score_opus":0.024602021958420383,"score_gpt":0.3463210955347562,"score_spread":0.32171907357633583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605943665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99773747,0.000022556827,0.00003481733,0.000119877564,0.00006337815,0.0016028949,0.000012191221,0.000022497046,0.00038432912],"genre_scores_gemma":[0.99957585,0.0000116426145,0.00013366262,0.000041002735,0.00007753007,0.000063529995,0.000002910706,0.000032087155,0.0000617599],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973021,0.0003726814,0.0006401865,0.00043684038,0.0008550995,0.00039310666],"domain_scores_gemma":[0.99762124,0.00095131743,0.00027701285,0.00081213284,0.00017647943,0.00016184583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013411574,0.00019444397,0.00051205023,0.000115480274,0.000057533125,0.000010790358,0.0002381051,0.00013244942,0.000028106],"category_scores_gemma":[0.00092985167,0.000095232754,0.00009364159,0.0003235251,0.00027830922,0.00011575104,0.00014398978,0.0002640289,0.000012499484],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006897584,0.04941848,0.80241597,0.00007372231,0.00039387142,0.00024731943,0.00087692076,5.8142246e-7,0.0013506006,0.0000041289127,0.000053136035,0.13826768],"study_design_scores_gemma":[0.2966404,0.0068959366,0.6932853,0.0003906136,0.00015774155,0.000014441867,0.00024221509,0.00014845627,0.002073642,0.0000032420712,0.000025443642,0.00012260844],"about_ca_topic_score_codex":0.00034404124,"about_ca_topic_score_gemma":0.00019024813,"teacher_disagreement_score":0.2897428,"about_ca_system_score_codex":0.0015315451,"about_ca_system_score_gemma":0.0041264445,"threshold_uncertainty_score":0.7320136},"labels":[],"label_agreement":null},{"id":"W2605986624","doi":"10.1182/blood.v128.22.4752.4752","title":"Comparison of Bleeding Tools in a Cohort of Pediatric Patients with ITP: Data from the Pediatric ITP Consortium of North America ICON1 Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; Centre Hospitalier Universitaire Sainte-Justine; McMaster University","funders":"","keywords":"Medicine; Cohort; Immune thrombocytopenia; Pediatrics; Cohort study; Observational study; Platelet; Internal medicine","score_opus":0.0394665413234035,"score_gpt":0.293945239144649,"score_spread":0.2544786978212455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605986624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976794,0.0004065905,0.0000074983445,0.000023499582,0.000033707583,0.000999684,0.0007378346,0.000009026532,0.0001027204],"genre_scores_gemma":[0.9994499,0.0001593996,0.000107070104,0.000010962792,0.000046340596,0.000017436998,0.00018570061,0.000015404486,0.000007796372],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845415,0.000052050993,0.00058119086,0.00030121993,0.00042691297,0.00018444455],"domain_scores_gemma":[0.99828076,0.0003873419,0.0005005062,0.0006489846,0.00012777677,0.00005461072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000105056606,0.00015523558,0.0007040575,0.000112264985,0.00002195153,0.0000039638066,0.00027140544,0.000034689052,0.000033002514],"category_scores_gemma":[0.0001689868,0.00008120488,0.0000379709,0.00045009298,0.00006846915,0.000106920656,0.00013378155,0.00008644697,0.00000502005],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024745037,0.008662411,0.98910975,0.000035903435,0.00039680034,0.000016836995,0.00037861092,0.0000014128652,0.000021333015,3.0903917e-7,0.00013442208,0.0009947749],"study_design_scores_gemma":[0.011368041,0.0012604209,0.98474604,0.000033593347,0.0020875842,6.094971e-7,0.00030183242,0.000007718913,0.000098784614,0.000001815399,0.000009129895,0.00008443366],"about_ca_topic_score_codex":0.00051001075,"about_ca_topic_score_gemma":0.00026382122,"teacher_disagreement_score":0.01112059,"about_ca_system_score_codex":0.000010671339,"about_ca_system_score_gemma":0.0001030239,"threshold_uncertainty_score":0.3311439},"labels":[],"label_agreement":null},{"id":"W2606117552","doi":"10.1182/blood.v126.23.1398.1398","title":"Mapping Microenvironment-Mediated Signaling Dependency of Targeted Inhibitors: A Mechanism-Based Approach of Selecting Effective Therapy Targeting Drug Resistant AML","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Advanced biosensing and bioanalysis techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Drug Research and Development","funders":"","keywords":"Temsirolimus; Cancer research; Stromal cell; PI3K/AKT/mTOR pathway; Tumor microenvironment; Myeloid leukemia; Drug resistance; Biology; Protein kinase B; Leukemia; Pharmacology; Signal transduction; Immunology; Cell biology","score_opus":0.00781293078646328,"score_gpt":0.21777916670189407,"score_spread":0.2099662359154308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606117552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889666,0.00152271,0.00899708,0.000011526974,0.000021818789,0.0003551175,0.00002290545,0.00004007625,0.00006217016],"genre_scores_gemma":[0.95599085,0.000050192684,0.043607187,0.000028458811,0.00008336057,0.00001862462,0.0001801324,0.000031205556,0.000009973152],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99838257,0.00022266351,0.00045332257,0.00042462331,0.0002513023,0.00026553433],"domain_scores_gemma":[0.9990061,0.000041483065,0.00044463712,0.0002512588,0.00017858011,0.00007797275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007094438,0.00022511992,0.00033488535,0.00012213831,0.000064912594,0.000009100918,0.00015385408,0.00015666978,7.228196e-7],"category_scores_gemma":[0.0002280091,0.00019984401,0.00019421084,0.0002882473,0.00008194586,0.000005535909,0.00006551591,0.00012766222,2.731152e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001524001,0.00039875574,0.0009951418,0.00004755643,0.0002067208,0.0000024431934,0.00017053518,0.0001458055,0.9975905,0.0000022463041,0.000024972194,0.0002629511],"study_design_scores_gemma":[0.0014161351,0.0003873864,0.000033211014,0.00007111769,0.000057352623,0.0000028246013,0.0006594732,0.00034648814,0.996672,0.00006578941,0.00007064925,0.00021757488],"about_ca_topic_score_codex":0.00004516887,"about_ca_topic_score_gemma":0.0000027308126,"teacher_disagreement_score":0.034610108,"about_ca_system_score_codex":0.000022420543,"about_ca_system_score_gemma":0.000072508556,"threshold_uncertainty_score":0.8149402},"labels":[],"label_agreement":null},{"id":"W2606266333","doi":"10.1182/blood.v128.22.1113.1113","title":"Population-Based Survival Outcomes in Adult Patients with Burkitt Lymphoma (BL) Treated with Cyclophosphamide, Vincristine, Doxorubicin, High-Dose Methotrexate (CODOX-M)/Ifosfamide, Etoposide and High-Dose Cytarabine (IVAC) Plus or Minus Rituximab (R) in British Columbia (BC), Canada","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Leukemia & Lymphoma Society of Canada; University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Population; Oncology; Regimen; Vincristine; Hazard ratio; Cytarabine; Etoposide; Cyclophosphamide; Leukemia; Chemotherapy; Confidence interval","score_opus":0.005736648885363281,"score_gpt":0.20236256222605137,"score_spread":0.19662591334068807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606266333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965117,0.00016556954,0.000004627483,0.0005284749,0.00013523053,0.0018032271,0.000694716,0.00010592667,0.000050523828],"genre_scores_gemma":[0.99607515,0.00008536705,0.0014795494,0.00044824608,0.000043728825,0.0003767488,0.0005675265,0.0001278207,0.0007958434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958369,0.00029882416,0.0010036555,0.0010517918,0.00092107226,0.0008877447],"domain_scores_gemma":[0.99724036,0.00084112893,0.0003690246,0.00069058064,0.00038763965,0.00047123284],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022799736,0.00063678954,0.0017381153,0.00021755953,0.0001906831,0.00013168927,0.00018903712,0.0002155202,0.00010476589],"category_scores_gemma":[0.00042469433,0.0004939382,0.00008146752,0.00073468074,0.00013713329,0.00020988104,0.00007008973,0.00016663797,0.0000056312456],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002614917,0.0066987104,0.97805506,0.00014527331,0.0003796912,0.00493762,0.000037435428,0.000018718683,0.000034269528,0.000008140785,0.00019283418,0.006877356],"study_design_scores_gemma":[0.16578858,0.0014590571,0.8295249,0.0011987602,0.0005736655,0.00008315984,0.000048383223,0.000025939575,0.00065370783,0.00001549633,0.00003310298,0.0005952888],"about_ca_topic_score_codex":0.9885318,"about_ca_topic_score_gemma":0.9942248,"teacher_disagreement_score":0.16317366,"about_ca_system_score_codex":0.0014980319,"about_ca_system_score_gemma":0.0013415643,"threshold_uncertainty_score":0.9997512},"labels":[],"label_agreement":null},{"id":"W2606472448","doi":"10.1182/blood-2017-03-691345","title":"Can histologic transformation of follicular lymphoma be predicted and prevented?","year":2017,"lang":"en","type":"review","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; University of British Columbia; University Health Network","funders":"","keywords":"Follicular lymphoma; Transformation (genetics); Liquid biopsy; Disease; Medicine; Lymphoma; Precision medicine; Malignant transformation; Bioinformatics; Biology; Oncology; Pathology; Cancer; Internal medicine; Genetics; Gene","score_opus":0.06144884763105181,"score_gpt":0.3243587914494427,"score_spread":0.2629099438183909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606472448","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002583118,0.9940192,0.0000011197033,0.000113768365,0.000060113547,0.0013794946,0.00034715535,0.000032941727,0.0014631039],"genre_scores_gemma":[0.004701571,0.9940027,0.00007879053,0.000019774443,0.000045878518,0.00024207841,0.0007209156,0.000022701985,0.00016558121],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988448,0.000056245983,0.00048368445,0.00025313563,0.0002001025,0.00016205317],"domain_scores_gemma":[0.9989346,0.000043549393,0.00040740194,0.00045370386,0.00004836037,0.00011238423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009155945,0.0002843459,0.0015129439,0.00011697845,0.000068275775,0.000012848066,0.00009851975,0.00027250018,0.000017707602],"category_scores_gemma":[0.00004798064,0.0001916967,0.0003773871,0.000059821665,0.00007217287,0.00003733228,0.00002380956,0.00005157139,0.0000017940308],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000084897,0.0013837317,0.00037935268,0.017421203,0.0012000405,0.00013388896,0.000116413044,6.559357e-9,4.5337032e-7,0.000120414785,0.00014721944,0.9790888],"study_design_scores_gemma":[0.0054468364,0.0005005945,0.0016162898,0.012586564,0.013957307,0.0007816045,0.0000072984326,0.0000010654096,0.000051285064,0.000014684342,0.96486384,0.00017264797],"about_ca_topic_score_codex":0.00010233117,"about_ca_topic_score_gemma":0.000016200174,"teacher_disagreement_score":0.97891617,"about_ca_system_score_codex":0.000104359126,"about_ca_system_score_gemma":0.00032454325,"threshold_uncertainty_score":0.78171647},"labels":[],"label_agreement":null},{"id":"W2606566776","doi":"10.1182/blood-2017-03-772384","title":"Genomic architecture and treatment outcome in pediatric acute myeloid leukemia: a Children’s Oncology Group report","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute","keywords":"Medicine; Pediatric oncology; Oncology; Myeloid leukemia; Internal medicine; Leukemia; Pediatrics; Cancer","score_opus":0.02062085654835358,"score_gpt":0.31165989809748856,"score_spread":0.29103904154913496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606566776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99170375,0.00059246446,0.000011843868,0.0021089038,0.00009461399,0.0009996569,0.000022858305,0.00005946481,0.004406447],"genre_scores_gemma":[0.9932462,0.0018174779,0.0021461952,0.00019330304,0.00079623214,0.0001338657,0.00006922972,0.000052968528,0.0015445589],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99792546,0.00006939688,0.00049761607,0.0006584411,0.0002606554,0.0005884435],"domain_scores_gemma":[0.99816895,0.00009018706,0.00026199134,0.0011316704,0.000037271275,0.00030990594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039332814,0.0003018596,0.000704973,0.00033177747,0.00023068077,0.000058784084,0.00028357352,0.0003138801,0.00002857129],"category_scores_gemma":[0.00023540943,0.00023472328,0.00013003971,0.000097892414,0.00017250144,0.000075288364,0.0002998711,0.00065613125,0.000044627443],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021550125,0.00045641285,0.97196,0.000031200183,0.0002776399,0.009493679,0.00027559008,0.0000012660034,0.0019510704,0.00001934272,0.00010330358,0.015214982],"study_design_scores_gemma":[0.013787515,0.001246261,0.97088367,0.000012249936,0.000728069,0.0108442055,0.000016784812,0.000011134277,0.000336273,0.00005562658,0.0018738719,0.00020433714],"about_ca_topic_score_codex":0.0010563806,"about_ca_topic_score_gemma":0.00052373996,"teacher_disagreement_score":0.015010646,"about_ca_system_score_codex":0.0012313111,"about_ca_system_score_gemma":0.00080920674,"threshold_uncertainty_score":0.95717376},"labels":[],"label_agreement":null},{"id":"W2606617462","doi":"10.1182/blood.v128.22.2907.2907","title":"Experience with MRD Testing in B- ALL By Flow Cytometry Does Not Prevent Interpretative Discordance","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Minimal residual disease; Medicine; Clinical trial; Flow cytometry; Oncology; Internal medicine; Leukemia; Immunology","score_opus":0.020265335671581414,"score_gpt":0.3038010314626758,"score_spread":0.2835356957910944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606617462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915374,0.00007968202,0.00637777,0.00056406466,0.000034784985,0.00038136923,0.00003083731,0.00005019733,0.00094387366],"genre_scores_gemma":[0.9896041,0.00001930427,0.008705263,0.00027295479,0.00005789148,0.00014391671,0.000003246771,0.000028645916,0.001164664],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99841344,0.000055540724,0.00024533516,0.00041235902,0.00045039557,0.00042293334],"domain_scores_gemma":[0.9987568,0.0006056619,0.0000715337,0.000320744,0.00008307717,0.00016216082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016481864,0.00017046771,0.0002611143,0.00010878824,0.000026553766,0.000016716827,0.00019336415,0.000050518705,0.000055585],"category_scores_gemma":[0.0010474507,0.00008119443,0.000028180275,0.0003455663,0.00020994982,0.00016727013,0.00011998467,0.00015537733,0.00003097096],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087843015,0.0013574383,0.25493953,0.00014438615,0.00017410534,0.000750167,0.0043143407,0.0000023163952,0.72165006,0.000025607875,0.00032116656,0.015442453],"study_design_scores_gemma":[0.01599456,0.0019023364,0.030995544,0.0031499984,0.00011132953,0.000359944,0.001091318,0.0015241378,0.9440249,0.00009183502,0.00028607927,0.00046800773],"about_ca_topic_score_codex":0.00008404601,"about_ca_topic_score_gemma":0.000030615203,"teacher_disagreement_score":0.22394396,"about_ca_system_score_codex":0.00027518233,"about_ca_system_score_gemma":0.0002396435,"threshold_uncertainty_score":0.33110127},"labels":[],"label_agreement":null},{"id":"W2606644796","doi":"10.1182/blood.v128.22.5572.5572","title":"Atypical Chronic Lymphocytic Leukemia with CD200 Expression Shares Similar Outcomes to Classical Chronic Lymphocytic Leukemia","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Chronic lymphocytic leukemia; Immunophenotyping; Mantle cell lymphoma; Hairy cell leukemia; Macroglobulinemia; Medicine; Leukemia; CD5; Prolymphocytic leukemia; Lymphoplasmacytic Lymphoma; Pathology; Splenic marginal zone lymphoma; IGHV@; Immunology; Lymphoma; Waldenstrom macroglobulinemia; B cell; Flow cytometry; Antibody; Multiple myeloma","score_opus":0.015754796762661668,"score_gpt":0.27718427580725186,"score_spread":0.2614294790445902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606644796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99165106,0.0019711275,0.0007447532,0.0009160191,0.0002827711,0.001995214,0.000068885995,0.0007587982,0.0016113466],"genre_scores_gemma":[0.9852655,0.00037061528,0.0013040229,0.00088878087,0.0014754699,0.00047527012,0.000048163394,0.00029507428,0.00987714],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99199516,0.00021539372,0.0010862595,0.0019073476,0.0023335,0.002462327],"domain_scores_gemma":[0.99421376,0.0009755251,0.00023207399,0.0024518343,0.00034414153,0.0017826366],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00049647957,0.0010653482,0.0016284023,0.0005253682,0.00034097172,0.00013550611,0.0010395736,0.0006988322,0.0015759254],"category_scores_gemma":[0.00091231393,0.0006359248,0.00046857915,0.0008894627,0.0006711944,0.00039298562,0.00076393806,0.0005667028,0.0027810761],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.028335568,0.002123337,0.020622715,0.007191316,0.0061894725,0.02410739,0.0019485955,0.009351634,0.7007531,0.0023406816,0.11793336,0.07910283],"study_design_scores_gemma":[0.40451676,0.0103528695,0.02425555,0.011124572,0.0021699443,0.0063614924,0.00015491046,0.025823006,0.43165562,0.0002684375,0.07948739,0.00382946],"about_ca_topic_score_codex":0.00044013097,"about_ca_topic_score_gemma":0.00029379546,"teacher_disagreement_score":0.3761812,"about_ca_system_score_codex":0.46994883,"about_ca_system_score_gemma":0.18435118,"threshold_uncertainty_score":0.99960923},"labels":[],"label_agreement":null},{"id":"W2606650185","doi":"10.1182/blood.v128.22.1091.1091","title":"Divergent Modes of Tumor Evolution Underlie Histological Transformation and Early Progression of Follicular Lymphoma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Canada's Michael Smith Genome Sciences Centre; McGill University; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Follicular lymphoma; Somatic evolution in cancer; Biology; Disease; Lymphoma; Cancer; Deep sequencing; Oncology; Internal medicine; Pathology; Cancer research; Immunology; Medicine; Genome; Gene; Genetics","score_opus":0.008078138659875361,"score_gpt":0.22033127013879136,"score_spread":0.212253131478916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606650185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99339664,0.0020910038,0.0041841227,0.000040453724,0.000023926268,0.000106676074,0.000025250158,0.0000028352035,0.0001291194],"genre_scores_gemma":[0.99918014,0.00036244286,0.00040203874,0.0000065422223,0.000021880656,0.000008370426,0.0000063833313,0.000004288137,0.0000079113115],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995925,0.000013722602,0.00014444732,0.00010718445,0.000067513654,0.00007465242],"domain_scores_gemma":[0.999741,0.0000086174,0.000078102836,0.00009529565,0.000046044843,0.000030936066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005026327,0.000056652,0.00008879733,0.000018660816,0.000019667295,0.0000021702112,0.00004488568,0.000054357806,0.0000025514282],"category_scores_gemma":[0.000029878898,0.000039020364,0.00004228615,0.000021197533,0.000065078966,0.0000028974155,0.000028728313,0.000007602555,3.4889214e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007825792,0.00020186175,0.018614627,0.000030071253,0.000029720943,8.550591e-7,0.00003068619,0.0000046689042,0.973462,0.0016753445,0.000019270403,0.0058526592],"study_design_scores_gemma":[0.0019710013,0.0006838968,0.058207467,0.00003994045,0.0000628369,0.00000887541,0.00001979611,0.00001793658,0.93775845,0.0006158048,0.0005297497,0.000084234875],"about_ca_topic_score_codex":0.000018255905,"about_ca_topic_score_gemma":0.000006128686,"teacher_disagreement_score":0.03959284,"about_ca_system_score_codex":0.000009710063,"about_ca_system_score_gemma":0.000034783225,"threshold_uncertainty_score":0.15912043},"labels":[],"label_agreement":null},{"id":"W2606879060","doi":"10.1182/blood-2016-11-750885","title":"Biological considerations of plasma-derived and recombinant factor VIII immunogenicity","year":2017,"lang":"en","type":"review","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Canadian Institutes of Health Research","keywords":"Immunogenicity; Medicine; Immunology; Recombinant DNA; Adverse effect; Antibody; Complement system; Immune system; Internal medicine; Biology; Genetics","score_opus":0.2557022808620999,"score_gpt":0.4107380104979006,"score_spread":0.1550357296358007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606879060","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029753068,0.96831924,1.9891573e-7,0.00007253141,0.00008291583,0.0009298427,0.00009279309,0.00002015378,0.0007292356],"genre_scores_gemma":[0.0075105466,0.99152386,0.00018534479,0.0000039319193,0.00005923481,0.000049052585,0.00009612142,0.000017389548,0.0005545096],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988592,0.00011489603,0.00039707503,0.00028542682,0.00013745115,0.00020590682],"domain_scores_gemma":[0.99883145,0.00031813415,0.00020673484,0.00044563538,0.00007520698,0.00012286309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013025483,0.00023523213,0.0015310493,0.000101962374,0.0001624788,0.000023587874,0.00008719463,0.00035476903,0.0002062109],"category_scores_gemma":[0.00048895745,0.00013376301,0.00031750597,0.000039311253,0.0002584568,0.000022298866,0.000107236054,0.00029643267,0.000033361892],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005293091,0.0026616217,0.0016204345,0.014226653,0.003740376,0.0006378421,0.00012654324,1.9655597e-9,0.0009991269,0.00024409773,0.00023643608,0.9754539],"study_design_scores_gemma":[0.007745214,0.0020899137,0.002143835,0.016224517,0.0049047875,0.001885786,0.000020816582,0.0000011367061,0.0023907996,0.00020389944,0.9617976,0.00059169106],"about_ca_topic_score_codex":0.00001680782,"about_ca_topic_score_gemma":0.00000312561,"teacher_disagreement_score":0.9748622,"about_ca_system_score_codex":0.000020165477,"about_ca_system_score_gemma":0.00039061432,"threshold_uncertainty_score":0.5454697},"labels":[],"label_agreement":null},{"id":"W2606899793","doi":"10.1182/blood.v128.22.5954.5954","title":"Accredited Interactive Web-Based Application for the 2016 International Clinical Practice Guidelines on Thrombosis in Cancer: Improving Knowledge Transfer in Daily Clinical Practice","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Accreditation; Population; Multidisciplinary approach; Cancer; Intensive care medicine; Best practice; Medical education; Internal medicine","score_opus":0.08807214458631339,"score_gpt":0.46702381984819735,"score_spread":0.37895167526188395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606899793","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4441633,0.0021216527,0.02893084,0.4983529,0.00624568,0.010175297,0.00022470599,0.0002571969,0.009528457],"genre_scores_gemma":[0.9683674,0.005928613,0.0057360246,0.01495929,0.0025341464,0.0021946118,0.00003418453,0.000063891144,0.00018182279],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99704117,0.00027047552,0.0014089113,0.0006392406,0.00034058362,0.0002996191],"domain_scores_gemma":[0.98998994,0.008129521,0.00032326294,0.0004814448,0.00097615644,0.00009968306],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0036447023,0.00021997467,0.00053913175,0.00018148997,0.00006123045,0.000034561075,0.00032287533,0.0001895468,0.00005669988],"category_scores_gemma":[0.013378868,0.0001324341,0.00022109675,0.00023188973,0.000092557464,0.0003960987,0.00007137664,0.00038544432,0.000048814436],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005249631,0.038723815,0.029841313,0.00015970824,0.0017949218,0.000034178895,0.0006173081,0.000056409965,0.0028886518,0.0017181765,0.07778274,0.8411331],"study_design_scores_gemma":[0.030524153,0.0016717527,0.16185397,0.0012093,0.001724889,0.0000069811213,0.0008654191,0.006097645,0.0010528037,0.00004344736,0.79459745,0.0003521854],"about_ca_topic_score_codex":0.00045340174,"about_ca_topic_score_gemma":0.00068646244,"teacher_disagreement_score":0.840781,"about_ca_system_score_codex":0.00017712661,"about_ca_system_score_gemma":0.0005485084,"threshold_uncertainty_score":0.9949319},"labels":[],"label_agreement":null},{"id":"W2607148153","doi":"10.1182/blood.v128.22.605.605","title":"Linking Subclonal Genetic Diversity with Functional Heterogeneity Identifies Diagnosis Subclones Destined to Relapse","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Biology; clone (Java method); Somatic evolution in cancer; SNP array; Disease; Leukemia; Genetics; Genetic heterogeneity; Exome sequencing; Cancer research; Cancer; Immunology; Mutation; Oncology; Phenotype; Medicine; Internal medicine; Genotype; Gene; Single-nucleotide polymorphism","score_opus":0.025859145650564713,"score_gpt":0.25129110736379273,"score_spread":0.22543196171322802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607148153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945954,0.00011481257,0.0030410364,0.001505862,0.00012143358,0.00036742855,0.000027320884,0.00011329443,0.00011340934],"genre_scores_gemma":[0.995025,0.000044890778,0.0032424429,0.00028149446,0.00032610077,0.00008143311,0.000012903784,0.0000311608,0.00095459976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979619,0.00005189547,0.00021100654,0.00048353296,0.00084472727,0.00044693134],"domain_scores_gemma":[0.9985773,0.00032549506,0.000058628146,0.00038366712,0.0002815694,0.00037332083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019201529,0.00020103347,0.000259457,0.00016788092,0.00045411356,0.000025680174,0.00018452357,0.00010236103,0.00022727391],"category_scores_gemma":[0.0003226665,0.00012854907,0.00009124691,0.0002945089,0.00015722154,0.00010829169,0.00069302466,0.00012035087,0.00020023173],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067739515,0.00049396517,0.97782034,0.000052025123,0.00023812607,0.00049404334,0.0001350252,0.000008038525,0.017867627,0.000022607666,0.0010896622,0.0011011489],"study_design_scores_gemma":[0.007863789,0.0009867783,0.91645825,0.00031025425,0.00039251882,0.0005692528,0.0000188746,0.000011827048,0.07261246,0.00008613041,0.00045465102,0.0002351975],"about_ca_topic_score_codex":0.000110085064,"about_ca_topic_score_gemma":0.00014657374,"teacher_disagreement_score":0.061362065,"about_ca_system_score_codex":0.0002345427,"about_ca_system_score_gemma":0.00030691765,"threshold_uncertainty_score":0.5242079},"labels":[],"label_agreement":null},{"id":"W2607182299","doi":"10.1182/blood.v112.11.681.681","title":"MN1 Overexpression Promotes Proliferation and Self-Renewal of Primitive Normal Human Hematopoietic Cells","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Haematopoiesis; Cord blood; Biology; CD34; Cell culture; Molecular biology; Leukemia; Myeloid; Stem cell; Transfection; Immunology; Cancer research; Cell biology; Genetics","score_opus":0.015088923504081751,"score_gpt":0.26427938607163864,"score_spread":0.2491904625675569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607182299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99625313,0.00009962402,0.00001556117,0.00008874214,0.00001082977,0.00063604943,0.0000061907863,0.000055211003,0.002834641],"genre_scores_gemma":[0.99709,0.00005839552,0.0021642789,0.00003167395,0.00011495482,0.000027487415,0.000021034637,0.000020200603,0.00047198837],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989402,0.000051238494,0.00022728209,0.00022109045,0.00034678454,0.00021336401],"domain_scores_gemma":[0.999412,0.0000432145,0.000079796926,0.00020541078,0.00013599935,0.00012357032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012313001,0.00012188817,0.00023977508,0.00009029308,0.00012090182,0.0000076217393,0.000060076094,0.00010418877,0.000045930814],"category_scores_gemma":[0.000047000347,0.00009971304,0.000041211944,0.00010343088,0.000109879315,0.00008908706,0.00008108421,0.0001792869,0.000008906735],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007118926,0.0012025376,0.028893247,0.00034448964,0.000079778736,0.000077930374,0.0024962418,4.412021e-7,0.9663735,0.00012373734,0.00029265124,0.00004425659],"study_design_scores_gemma":[0.0039695916,0.0007052391,0.023959836,0.00017549265,0.000087667184,0.00039048976,0.00006201505,0.00006145193,0.9703948,0.00004832922,0.000047625785,0.00009744862],"about_ca_topic_score_codex":0.000025969344,"about_ca_topic_score_gemma":0.0000016573418,"teacher_disagreement_score":0.004933411,"about_ca_system_score_codex":0.00003504449,"about_ca_system_score_gemma":0.00019849249,"threshold_uncertainty_score":0.40661797},"labels":[],"label_agreement":null},{"id":"W2607410024","doi":"10.1182/blood-2016-11-750729","title":"EPCR expression marks UM171-expanded CD34+ cord blood stem cells","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":225,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Canadian Institutes of Health Research; Stem Cell Network","keywords":"Stem cell; Endothelial protein C receptor; Haematopoiesis; Cord blood; Biology; CD34; Immunology; CD38; Cell biology; Molecular biology; Thrombin","score_opus":0.025302209869459,"score_gpt":0.27699480205420807,"score_spread":0.25169259218474904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607410024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9702981,0.00018236243,0.00030367685,0.00021191686,0.00040374274,0.0005868044,0.000022436001,0.00012660562,0.027864328],"genre_scores_gemma":[0.9928241,0.00017222516,0.002007282,0.00010476247,0.00024845547,0.000038822567,0.00002392039,0.00004849378,0.004531971],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99836564,0.000053862823,0.00036983922,0.00041503974,0.00043505218,0.00036056142],"domain_scores_gemma":[0.9982597,0.00009583614,0.00022811658,0.001084467,0.000085116066,0.00024675427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024035419,0.00023457504,0.00039989597,0.00007532239,0.00031788673,0.0000839598,0.0002757447,0.0002115419,0.00033493244],"category_scores_gemma":[0.000026694821,0.00020066122,0.00012971269,0.000045345434,0.00008270798,0.00013043865,0.000057480716,0.00022427503,0.0002640318],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031381674,0.0012156401,0.046589695,0.0006815001,0.00017933316,0.0007182535,0.0006593565,4.1891371e-7,0.9457607,0.00007843418,0.0009125199,0.002890301],"study_design_scores_gemma":[0.009150534,0.0003236357,0.014437722,0.0007873055,0.0007788725,0.00036219237,0.00016068653,0.00001671755,0.97274995,0.000042311505,0.00095482444,0.00023526471],"about_ca_topic_score_codex":0.000028128325,"about_ca_topic_score_gemma":0.0000062906865,"teacher_disagreement_score":0.032151975,"about_ca_system_score_codex":0.0000129710115,"about_ca_system_score_gemma":0.000079162746,"threshold_uncertainty_score":0.8182727},"labels":[],"label_agreement":null},{"id":"W2607437673","doi":"10.1182/blood.v108.11.5268.5268","title":"Routine Surveillance for Bloodstream Infections in a Pediatric Hematopoietic Stem Cell Transplant (HSCT) Cohort: Do Patients Benefit?.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Medicine; Pediatrics; Population; Cohort; Psychological intervention; Internal medicine","score_opus":0.005183361800126566,"score_gpt":0.21295776200678648,"score_spread":0.2077744002066599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607437673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994194,0.0004894985,0.00007410657,0.00007336646,0.00020833359,0.0011280667,0.00015846948,0.00010011086,0.003574104],"genre_scores_gemma":[0.9983734,0.00021647324,0.000052200157,0.000040589137,0.0003197394,0.00036549103,0.00013250514,0.00003799004,0.00046164187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99864835,0.000024815685,0.0004200152,0.00035470468,0.00019248512,0.0003596403],"domain_scores_gemma":[0.99932295,0.00009135612,0.00010716915,0.00026978325,0.0001113699,0.00009735005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011682656,0.00020378122,0.0003614163,0.00018704114,0.000107278865,0.000024546158,0.00006694411,0.000104011786,0.000032031745],"category_scores_gemma":[0.0000047885205,0.00019077341,0.00015219874,0.00046242657,0.000021954509,0.00005763364,0.000012647432,0.00016317857,0.000021317377],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036138623,0.0034662161,0.9954917,0.00022061389,0.000027644985,0.000010428724,0.00007230415,0.000054356275,0.00017292559,0.00014954449,0.00019510828,0.0001030632],"study_design_scores_gemma":[0.011414414,0.00060544285,0.9831682,0.000052075724,0.00054321106,0.00006582465,0.000018952574,0.000007897926,0.0032224553,0.000075857024,0.0005845508,0.00024114306],"about_ca_topic_score_codex":0.00029231425,"about_ca_topic_score_gemma":0.0006666994,"teacher_disagreement_score":0.01232348,"about_ca_system_score_codex":0.000052350428,"about_ca_system_score_gemma":0.00007866167,"threshold_uncertainty_score":0.7779514},"labels":[],"label_agreement":null},{"id":"W2607531233","doi":"10.1182/blood.v128.22.5017.5017","title":"Lupus Anticoagulant Testing in Patients Receiving Rivaroxaban or Apixaban for the Treatment of Venous Thromboembolism","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Rivaroxaban; Apixaban; Medicine; Anticoagulant; Warfarin; Venous thromboembolism; Edoxaban; Lupus anticoagulant; Intensive care medicine; Internal medicine; Thrombosis; Atrial fibrillation","score_opus":0.038981037742697414,"score_gpt":0.2782142290409197,"score_spread":0.2392331912982223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607531233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99654484,0.00031476785,0.00007063114,0.0004393322,0.00034129008,0.0017827376,0.000023685689,0.000040189647,0.0004425095],"genre_scores_gemma":[0.99769,0.0006307732,0.0009809943,0.000093530325,0.00017018784,0.00018978615,0.0000069605135,0.00003713423,0.00020058535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986851,0.000029562207,0.00039244062,0.00029151942,0.00022026789,0.00038110156],"domain_scores_gemma":[0.99866,0.0005796939,0.00015891495,0.0004278342,0.000102347,0.000071177274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016754375,0.00019599471,0.00065575575,0.00010671541,0.00009341185,0.000012883941,0.00012631249,0.00005969993,0.000030533487],"category_scores_gemma":[0.00028659642,0.0000918165,0.00011566465,0.00019044158,0.00006367533,0.000052340838,0.000036947546,0.00003541367,0.000007993246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002589813,0.028188905,0.75478727,0.00028469713,0.0008818733,0.000040852483,0.002566547,0.000007708838,0.0045409203,0.0002912736,0.0005994921,0.20755151],"study_design_scores_gemma":[0.012387761,0.005444445,0.9713834,0.0005763208,0.0008532475,0.000012263283,0.00011640468,0.00002407242,0.006861999,0.00013336672,0.0020443196,0.0001624176],"about_ca_topic_score_codex":0.0001924173,"about_ca_topic_score_gemma":0.00009407651,"teacher_disagreement_score":0.21659614,"about_ca_system_score_codex":0.00008283538,"about_ca_system_score_gemma":0.000062546984,"threshold_uncertainty_score":0.37441683},"labels":[],"label_agreement":null},{"id":"W2607545593","doi":"10.1182/blood.v128.22.4677.4677","title":"Tandem Autologous Followed By Nonmyeloablative Allogeneic Transplantation in Relapsed High Risk Follicular Lymphoma Leads to Excellent Long Term Progression-Free Survival after 8 Years of Follow-up","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Internal medicine; Oncology; Follicular lymphoma; Transplantation; Chemotherapy; Surgery; Lymphoma","score_opus":0.007555878386590273,"score_gpt":0.24148124231136223,"score_spread":0.23392536392477195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607545593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969427,0.00095824554,0.00008275957,0.00037160542,0.00022477539,0.0010542976,0.00018310263,0.000051188745,0.00013135244],"genre_scores_gemma":[0.9980876,0.00053830026,0.000529878,0.00005514335,0.000044090204,0.00041095936,0.000058496124,0.00004057895,0.00023494764],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997962,0.00014751547,0.0004872601,0.00050377706,0.00050889875,0.00039052477],"domain_scores_gemma":[0.99885434,0.00021291296,0.00017835465,0.000494024,0.00006707672,0.00019327896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002360638,0.00027221095,0.00057336537,0.00016499565,0.00003982948,0.000010245393,0.00015170412,0.00019731517,0.00006547426],"category_scores_gemma":[0.00010077588,0.00018914774,0.00021241205,0.0002369557,0.000062268584,0.0000585763,0.000048552723,0.000049536156,0.0000344379],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011287909,0.002321359,0.94591546,0.000049048176,0.00038560148,0.001195152,0.00064305984,9.377645e-7,0.014930537,0.000018097218,0.00010104036,0.03331091],"study_design_scores_gemma":[0.03881094,0.0010252483,0.8770387,0.0006015911,0.00075946853,0.000032933996,0.000019590907,8.804302e-7,0.08141179,0.00004162674,0.000047407244,0.00020982565],"about_ca_topic_score_codex":0.00019286628,"about_ca_topic_score_gemma":0.00038800796,"teacher_disagreement_score":0.068876766,"about_ca_system_score_codex":0.00017799204,"about_ca_system_score_gemma":0.000120592544,"threshold_uncertainty_score":0.7713221},"labels":[],"label_agreement":null},{"id":"W2607649265","doi":"10.1182/blood.v128.22.906.906","title":"Survival Following Allogeneic Hematopoietic Cell Transplantation in Older High-Risk Acute Myeloid Leukemia Patients Initially Treated with CPX-351 Liposome Injection Versus Standard Cytarabine and Daunorubicin: Subgroup Analysis of a Large Phase III Trial","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cytarabine; Medicine; Daunorubicin; Internal medicine; Induction chemotherapy; Gastroenterology; Leukemia; Transplantation; Surgery; Myeloid leukemia; Chemotherapy regimen; Randomized controlled trial; Chemotherapy; Oncology","score_opus":0.009812300967628565,"score_gpt":0.2733147008563751,"score_spread":0.2635023998887465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607649265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968203,0.00007388502,0.00080375007,0.00003458829,0.00012150277,0.0014019723,0.00057355297,0.00005812294,0.00011235057],"genre_scores_gemma":[0.9983164,0.0005303995,0.00023703295,0.000016384618,0.00008087316,0.00008049471,0.0006235982,0.00005634292,0.000058481342],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9969202,0.00030364844,0.00074651197,0.0006287594,0.0008519782,0.00054889906],"domain_scores_gemma":[0.9985751,0.00033337926,0.00030108314,0.0003562174,0.00021792443,0.00021629389],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00064235093,0.0003589759,0.0011066351,0.0009585844,0.00010455597,0.00002405192,0.0001303858,0.00023682509,0.000064399166],"category_scores_gemma":[0.00008078661,0.0002518087,0.00022259358,0.0015125606,0.00009432082,0.00025446707,0.000040640618,0.00028679002,0.0000030232643],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.51924366,0.004148649,0.3889122,0.00028484693,0.010071088,0.0011321328,0.002495102,0.000051058527,0.07122086,0.000022491486,0.0000150346195,0.0024029075],"study_design_scores_gemma":[0.789249,0.015047831,0.11786172,0.00024963898,0.017760647,0.00001727084,0.00020078846,0.000101652586,0.05909775,0.000005993164,0.000006202124,0.00040147835],"about_ca_topic_score_codex":0.00091510115,"about_ca_topic_score_gemma":0.0009646952,"teacher_disagreement_score":0.27105048,"about_ca_system_score_codex":0.00046146743,"about_ca_system_score_gemma":0.0003848896,"threshold_uncertainty_score":0.99999344},"labels":[],"label_agreement":null},{"id":"W2607663437","doi":"10.1182/blood.v128.22.4241.4241","title":"Combined Targeting of STAT3 and STAT5: A Novel Approach to Overcome Drug Resistance in Ph+ Cml","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Ponatinib; Dasatinib; Nilotinib; Bosutinib; Imatinib; Cancer research; Imatinib mesylate; Tyrosine kinase; Myeloid leukemia; Medicine; Pharmacology; Internal medicine","score_opus":0.012290476567410358,"score_gpt":0.2382235188245373,"score_spread":0.22593304225712693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607663437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951901,0.00048815584,0.00027041914,0.0004901747,0.000023661374,0.00049008813,0.000046992933,0.000026932961,0.0029735111],"genre_scores_gemma":[0.98021364,0.00004323456,0.01714933,0.00008275096,0.000026371066,0.000035224602,0.0000113549595,0.00002364143,0.0024144466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988818,0.000024702118,0.00029743448,0.0003015976,0.00022678997,0.00026766883],"domain_scores_gemma":[0.9993542,0.00012036573,0.00008090399,0.00027128772,0.00004427351,0.00012895747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020886485,0.00013873813,0.00033753106,0.000101978825,0.000019425948,0.000004861119,0.00006886278,0.00004264522,0.00001834468],"category_scores_gemma":[0.00015094229,0.00009836038,0.00003124757,0.00018145468,0.000048434336,0.000057659323,0.000062991,0.00007499254,0.0000064350247],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026521012,0.010471242,0.48199257,0.001723045,0.00063962955,0.0001705422,0.010771662,0.0000036467063,0.48078975,0.0032729225,0.0048589115,0.0026539653],"study_design_scores_gemma":[0.18422556,0.0010203102,0.6720882,0.0031428342,0.00057011395,0.000053939966,0.0010431889,0.00010148397,0.12920815,0.00097499526,0.006593549,0.0009776826],"about_ca_topic_score_codex":0.00016475427,"about_ca_topic_score_gemma":0.00006885358,"teacher_disagreement_score":0.3515816,"about_ca_system_score_codex":0.00019428734,"about_ca_system_score_gemma":0.00015129919,"threshold_uncertainty_score":0.40110198},"labels":[],"label_agreement":null},{"id":"W2607762492","doi":"10.1182/blood-2017-01-764951","title":"Donor-engrafted CHIP is common among stem cell transplant recipients with unexplained cytopenias","year":2017,"lang":"en","type":"letter","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Stem cell; Medicine; Transplantation; Immunology; Internal medicine; Biology; Genetics","score_opus":0.022244495493890164,"score_gpt":0.25529660750469013,"score_spread":0.23305211201079998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607762492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84064114,0.00031576247,0.000014147645,0.13487123,0.00025793514,0.002488738,0.0006396542,0.0002391845,0.020532181],"genre_scores_gemma":[0.6913511,0.00044819195,0.0005625658,0.18338333,0.0052452604,0.00052123156,0.0043804967,0.00071063224,0.113397144],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952387,0.00024332103,0.0006212653,0.0011763166,0.0014721138,0.0012482586],"domain_scores_gemma":[0.99614966,0.00020672186,0.00046956335,0.0025463435,0.00022950221,0.00039822495],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00039418496,0.0008746173,0.0015332727,0.00043953367,0.00038392984,0.00019714113,0.0012168466,0.0015063842,0.00027017723],"category_scores_gemma":[0.000014514044,0.0006579206,0.00031847882,0.00024501857,0.00036900764,0.00017280146,0.00016304992,0.005072888,0.00039021074],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010582592,0.00054662395,0.07214465,0.001246382,0.0013085399,0.030621143,0.00143552,3.7440324e-7,0.0008448793,0.0000010564611,0.89023423,0.00055833126],"study_design_scores_gemma":[0.049785525,0.0033760536,0.050140034,0.0061559617,0.006045921,0.0024695233,0.00012453813,0.00007396845,0.049107965,0.000014651921,0.83004725,0.0026585942],"about_ca_topic_score_codex":0.00078421773,"about_ca_topic_score_gemma":0.00012112295,"teacher_disagreement_score":0.14929003,"about_ca_system_score_codex":0.0002969975,"about_ca_system_score_gemma":0.0006374245,"threshold_uncertainty_score":0.9997899},"labels":[],"label_agreement":null},{"id":"W2607860563","doi":"10.1182/blood.v128.22.3038.3038","title":"Granulocyte Colony-Stimulating Factor (GCSF) Use with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone +/- Rituximab (CHOP±R) Treatment for Aggressive Non-Hodgkin's Lymphoma (aNHL)","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Amgen (Canada); William Osler Health System; Moncton Hospital; BC Cancer Agency; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Neutropenia; Internal medicine; Febrile neutropenia; Rituximab; Vincristine; CHOP; Prednisone; Gastroenterology; Granulocyte colony-stimulating factor; Surgery; Regimen; Pegfilgrastim; International Prognostic Index; Lymphoma; Cyclophosphamide; Chemotherapy","score_opus":0.018634900912338156,"score_gpt":0.2701461459420711,"score_spread":0.25151124502973293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607860563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946597,0.00036250427,0.0019489765,0.00032868952,0.00014918188,0.0018168994,0.00028375658,0.00015684137,0.0002934372],"genre_scores_gemma":[0.993763,0.00028161512,0.0026144325,0.00018386198,0.00026574905,0.0006032862,0.000024928948,0.000085078565,0.0021780143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983594,0.000043349835,0.00034439392,0.00054074975,0.00023073856,0.00048137794],"domain_scores_gemma":[0.998329,0.00044615724,0.00028024983,0.00043361474,0.00023031024,0.0002806891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000066815264,0.00038826044,0.0006281583,0.00010419932,0.00037979268,0.000064531756,0.00007258866,0.00012442312,0.000047307767],"category_scores_gemma":[0.00015061874,0.00023395469,0.00012934548,0.00016855825,0.00015745443,0.00022344054,0.000041191957,0.000079583224,0.000016121174],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063389963,0.005411291,0.76242346,0.00035565524,0.0015205366,0.00039938564,0.0008984425,0.000014101481,0.13888164,0.000108229186,0.00077543774,0.08287284],"study_design_scores_gemma":[0.15056844,0.0144352075,0.608956,0.0016562558,0.0027629791,0.0011769888,0.00011978285,0.00007809576,0.20180728,0.0000783362,0.017435903,0.0009247603],"about_ca_topic_score_codex":0.00074387627,"about_ca_topic_score_gemma":0.00027453847,"teacher_disagreement_score":0.15346746,"about_ca_system_score_codex":0.00020248286,"about_ca_system_score_gemma":0.00024332968,"threshold_uncertainty_score":0.9540395},"labels":[],"label_agreement":null},{"id":"W2608393446","doi":"10.1182/blood.v128.22.1921.1921","title":"Efficacy and Safety Following Bosutinib Dose Reduction in Patients with Philadelphia Chromosome‒Positive Chronic Myeloid Leukemia","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Nilotinib; Bosutinib; Medicine; Dasatinib; Internal medicine; Gastroenterology; Myeloid leukemia; Philadelphia chromosome; Imatinib; Surgery; Chromosomal translocation; Biology","score_opus":0.006967615130548236,"score_gpt":0.2284353939009106,"score_spread":0.22146777877036236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2608393446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99681264,0.0005792514,0.000009825355,0.0005420567,0.00015469138,0.0012169634,0.000024428564,0.000091978036,0.00056816585],"genre_scores_gemma":[0.9988527,0.00016487406,0.00024178503,0.000038123257,0.0003054155,0.000049250793,0.00008333618,0.000059392092,0.00020510351],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99803835,0.000059378486,0.00038107487,0.00062543544,0.0003914735,0.00050426286],"domain_scores_gemma":[0.9990815,0.000093134,0.0001321315,0.00042965935,0.00005788637,0.00020568326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013428366,0.00032674376,0.0004768623,0.0001662677,0.000105950996,0.000016295415,0.000082764636,0.00015871153,0.000076861426],"category_scores_gemma":[0.000071182694,0.00021631476,0.0000790278,0.0002926974,0.00012256688,0.00024095057,0.0000701207,0.00021034671,0.000043950553],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012145148,0.0068617705,0.7931884,0.00041337195,0.003533655,0.0007450018,0.0023616373,0.000026126472,0.08163438,0.00016205467,0.0004204473,0.098508045],"study_design_scores_gemma":[0.11314707,0.0020853418,0.87263924,0.0015745418,0.00055584277,0.00010997727,0.000027428816,0.0000053629915,0.0091852425,0.000013684905,0.00033557435,0.0003207075],"about_ca_topic_score_codex":0.00006726964,"about_ca_topic_score_gemma":0.000020756253,"teacher_disagreement_score":0.101001926,"about_ca_system_score_codex":0.002564388,"about_ca_system_score_gemma":0.0006864278,"threshold_uncertainty_score":0.882106},"labels":[],"label_agreement":null},{"id":"W2608522660","doi":"10.1182/blood.v128.22.4528.4528","title":"Development of Second Primary Malignancies in Multiple Myeloma Patients Treated with Lenalidomide: An Alberta Perspective","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Children's Hospital; University of Alberta; University of Calgary; Alberta Health Services","funders":"","keywords":"Lenalidomide; Multiple myeloma; Medicine; Internal medicine; Oncology; Thalidomide; Cancer; Transplantation","score_opus":0.019374747880028857,"score_gpt":0.2532059949176327,"score_spread":0.23383124703760383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2608522660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965668,0.00005743785,0.0000050097074,0.000045864133,0.000007897208,0.0006590707,0.000035813067,0.000018887446,0.0026032515],"genre_scores_gemma":[0.99531865,0.000007251704,0.0032963715,0.000023627881,0.000014710041,0.00008849191,0.00006526333,0.000026189198,0.0011594505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863046,0.000051340445,0.0002851362,0.00034073633,0.000345053,0.0003472927],"domain_scores_gemma":[0.9990764,0.00012352562,0.00008832508,0.0002719455,0.0002469492,0.0001928075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000873299,0.00018764695,0.00034811505,0.00018069253,0.00004760563,0.0000067136134,0.00008503366,0.00006254381,0.00017206016],"category_scores_gemma":[0.00013643599,0.000105964136,0.000040502902,0.00017641274,0.0000944843,0.00014756618,0.000041417024,0.00006266609,0.00002626465],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015551957,0.0032873633,0.94720066,0.000065752814,0.00030259104,0.000086350825,0.0014562358,4.8507758e-8,0.04018907,0.000021764943,0.0000103440725,0.0058246045],"study_design_scores_gemma":[0.026086336,0.00074409915,0.82500106,0.0002516184,0.000042539712,0.000012178089,0.00022891477,0.0000014917554,0.14737979,0.0000060487864,0.00012573155,0.000120193596],"about_ca_topic_score_codex":0.00042339732,"about_ca_topic_score_gemma":0.0044367025,"teacher_disagreement_score":0.12219962,"about_ca_system_score_codex":0.00021311607,"about_ca_system_score_gemma":0.00028593207,"threshold_uncertainty_score":0.4321092},"labels":[],"label_agreement":null},{"id":"W2608951168","doi":"10.1182/blood.v120.21.2560.2560","title":"A Highly Selective Anti-ROR1 Monoclonal Antibody Inhibits Human Acute Myeloid Leukemia CD34+ Cell Survival and Self-Renewal.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; BC Cancer Agency","funders":"","keywords":"Biology; Myeloid leukemia; Leukemia; Cancer research; Stem cell; CD34; Acute leukemia; Stromal cell; Bone marrow; Population; Myeloid; Immunology; Molecular biology; Medicine; Cell biology","score_opus":0.01692193652536604,"score_gpt":0.29997526656942486,"score_spread":0.2830533300440588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2608951168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97114515,0.0010619105,0.00000843507,0.00011822318,0.00016093379,0.0006472257,0.000027082397,0.00019593493,0.026635092],"genre_scores_gemma":[0.9922611,0.00057657715,0.0005756921,0.00009944542,0.00093244144,0.000028812929,0.00010183301,0.000091838796,0.0053322604],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99738324,0.00015464479,0.00033444155,0.0005098165,0.0006805358,0.0009373511],"domain_scores_gemma":[0.9986218,0.00011535492,0.00010256292,0.0004261731,0.00020098816,0.0005330812],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000567397,0.00035446582,0.0005788225,0.0002484786,0.00022432307,0.00005698153,0.00016128458,0.00023785367,0.0003223361],"category_scores_gemma":[0.000026212554,0.0003249278,0.00014117497,0.0004520718,0.00012962638,0.00020510201,0.00018065148,0.0005704532,0.00009092118],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012770339,0.0013484461,0.12951347,0.000098785444,0.0005999683,0.00008115152,0.0010063675,2.9533908e-7,0.86645454,0.00010538337,0.0003498038,0.00031405478],"study_design_scores_gemma":[0.009534398,0.000925401,0.14048904,0.000060111113,0.0007169416,0.00036099018,0.00012554978,0.000017423257,0.84351933,0.000068815076,0.0037350266,0.0004469489],"about_ca_topic_score_codex":0.00024908522,"about_ca_topic_score_gemma":0.000026289285,"teacher_disagreement_score":0.022935217,"about_ca_system_score_codex":0.00017997446,"about_ca_system_score_gemma":0.00031051465,"threshold_uncertainty_score":0.99992025},"labels":[],"label_agreement":null},{"id":"W2609208895","doi":"10.1182/blood.v128.22.2939.2939","title":"Revealing the Tumor Ecosystem in Follicular Lymphoma By Mass Cytometry","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Mass cytometry; Biology; Immune system; Follicular lymphoma; Population; Somatic evolution in cancer; Immunology; Lymphoma; Cancer research; Phenotype; Cancer; Genetics; Medicine; Gene","score_opus":0.007744966061271533,"score_gpt":0.22605863332457604,"score_spread":0.2183136672633045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2609208895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99410886,0.0022106764,0.000044973032,0.001879277,0.00007425159,0.0003625988,0.000035680758,0.000039847724,0.0012438138],"genre_scores_gemma":[0.9987709,0.00012065243,0.00013793385,0.00037725488,0.00010224519,0.000120605044,0.0000056644753,0.000019064304,0.00034571023],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990225,0.000051074632,0.00023114137,0.0002303646,0.00021569735,0.0002492609],"domain_scores_gemma":[0.9993203,0.00014610408,0.00006371912,0.00035649913,0.000025712341,0.00008766063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020795915,0.00013181727,0.00024510408,0.00006534153,0.00004553392,0.000015545704,0.000091444876,0.00004728337,0.000045601595],"category_scores_gemma":[0.000069191316,0.000060635513,0.000098276665,0.00019517977,0.000016567543,0.000037556732,0.00002535273,0.000022919869,0.0001462978],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000066643835,0.0023966741,0.9146761,0.00010238448,0.0004107871,0.0014126142,0.00010659093,1.9234072e-7,0.06414632,0.00037156825,0.004381022,0.011929139],"study_design_scores_gemma":[0.048601948,0.00059828744,0.3794021,0.0017927883,0.00077508244,0.000901059,0.00024721885,0.000021414176,0.5171853,0.00016774543,0.049863916,0.0004431542],"about_ca_topic_score_codex":0.00005468758,"about_ca_topic_score_gemma":0.000014752854,"teacher_disagreement_score":0.53527397,"about_ca_system_score_codex":0.00015359228,"about_ca_system_score_gemma":0.0000572574,"threshold_uncertainty_score":0.24726444},"labels":[],"label_agreement":null},{"id":"W2609558812","doi":"10.1182/blood.v128.22.899.899","title":"The Addition of Bortezomib to Standard Chemotherapy for Pediatric Acute Myeloid Leukemia Has Increased Toxicity without Therapeutic Benefit: A Report from the Children's Oncology Group","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Cytarabine; Internal medicine; Etoposide; Oncology; Mitoxantrone; Chemotherapy; Bortezomib; Induction chemotherapy; Gemtuzumab ozogamicin; Idarubicin; Leukemia; Minimal residual disease; Myeloid leukemia; Surgery; Multiple myeloma; Stem cell; CD33","score_opus":0.016141066221819492,"score_gpt":0.29011373622437386,"score_spread":0.2739726700025544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2609558812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98150706,0.00048093635,0.002601928,0.011015387,0.00014039822,0.002778188,0.0011594219,0.00008813326,0.0002285202],"genre_scores_gemma":[0.99231833,0.0010528276,0.0022912296,0.0018722839,0.001406904,0.00037414164,0.0002281286,0.00008948261,0.0003666898],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973072,0.0001525386,0.00066687557,0.00057221943,0.00069973303,0.00060146605],"domain_scores_gemma":[0.9962411,0.0015853802,0.0003972666,0.0011239456,0.00040319786,0.00024911025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012722099,0.00030525526,0.0006282614,0.00010496566,0.00038139944,0.000046322442,0.00051405333,0.00025243845,0.00012527966],"category_scores_gemma":[0.0005856004,0.00014622923,0.000264541,0.0003695335,0.0002914032,0.000089882706,0.00011481676,0.0003115431,0.000016019669],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030557858,0.0018194199,0.36129344,0.00008309392,0.007408821,0.0002575944,0.0015415952,0.0000024193823,0.3380642,0.0009283478,0.060779884,0.19726335],"study_design_scores_gemma":[0.050807633,0.006932064,0.7389285,0.00018314559,0.00349829,0.0008379046,0.00018914629,0.00004448539,0.12870899,0.0031767047,0.065997936,0.0006952132],"about_ca_topic_score_codex":0.000440015,"about_ca_topic_score_gemma":0.00023206096,"teacher_disagreement_score":0.37763506,"about_ca_system_score_codex":0.00069409487,"about_ca_system_score_gemma":0.0016007195,"threshold_uncertainty_score":0.5963055},"labels":[],"label_agreement":null},{"id":"W2609654701","doi":"10.1182/blood.v108.11.309.309","title":"Phase I Clinical Study of Donor Lymphocyte Infusion Depleted of Alloreactive T Cells after Haplotype Mismatched Myeloablative Stem Cell Transplantation To Limit Infections and Malignant Relapse without Causing GVHD.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Transplantation; Immunology; CD8; Stem cell; Donor lymphocyte infusion; Hematopoietic stem cell transplantation; Graft-versus-host disease; IL-2 receptor; Lymphocyte; Immune system; Internal medicine; T cell; Biology","score_opus":0.0224805757878834,"score_gpt":0.3201168305975907,"score_spread":0.29763625480970735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2609654701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99757355,0.00018931091,0.0001674478,0.000023884899,0.000054056713,0.0016803691,0.00008304125,0.00003262327,0.00019573157],"genre_scores_gemma":[0.99913234,0.00026931637,0.00031814823,0.000024918323,0.000036764643,0.00008457756,0.00001537162,0.000029497327,0.00008908],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982379,0.00021601385,0.00064789,0.00035237946,0.00032049452,0.00022529546],"domain_scores_gemma":[0.9988176,0.0003136942,0.00022989883,0.0002451327,0.00027131467,0.0001223212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036333138,0.00019886949,0.0005808707,0.00021538601,0.000069713235,0.000008598154,0.000045089324,0.00009605145,0.000011296633],"category_scores_gemma":[0.000028990466,0.00016427266,0.00007542072,0.00032253822,0.000118037606,0.000082383274,0.00004769427,0.00016450594,0.000001973999],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070530456,0.015731359,0.077876985,0.00026005245,0.0005526865,0.00016940456,0.012595798,0.000028150316,0.8838315,0.0000015405487,0.000008179216,0.0018912825],"study_design_scores_gemma":[0.041887347,0.012515455,0.37580824,0.0002822846,0.0013896079,0.000039589497,0.002795775,0.00017278513,0.5648298,0.000015171653,0.000020706435,0.00024319],"about_ca_topic_score_codex":0.00092569983,"about_ca_topic_score_gemma":0.00068718713,"teacher_disagreement_score":0.31900167,"about_ca_system_score_codex":0.000058911155,"about_ca_system_score_gemma":0.00012466109,"threshold_uncertainty_score":0.66988444},"labels":[],"label_agreement":null},{"id":"W2609889780","doi":"10.1182/blood.v106.11.605.605","title":"Towards the Human Cancer Genome Project: A Sequence-Ready Physical Map of a Follicular Lymphoma Genome.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Genomics and Phylogenetic Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Genome; Biology; Reference genome; Genetics; Cancer genome sequencing; Computational biology; Genome project; Bacterial artificial chromosome; Human genome; Whole genome sequencing; Sequence-tagged site; DNA sequencing; Genomics; Gene; Gene mapping; Chromosome","score_opus":0.027191905148859937,"score_gpt":0.28036322747989845,"score_spread":0.2531713223310385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2609889780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919813,0.0058652135,0.0000069397265,0.00030032717,0.00003613329,0.00017657621,0.00014078523,0.0000041785443,0.0014885385],"genre_scores_gemma":[0.99757814,0.00042091595,0.00027219325,0.0001617589,0.00079033565,0.00012504142,0.000040548435,0.000023137833,0.00058794033],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990871,0.000035120076,0.0001859351,0.00029813417,0.00013360019,0.00026012748],"domain_scores_gemma":[0.9993835,0.0000046244645,0.00009642089,0.00038858107,0.00008749956,0.00003935566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009113064,0.00017510813,0.00020001274,0.000022679209,0.00012316299,0.0000143006155,0.00030359378,0.00007166967,0.000009058304],"category_scores_gemma":[0.0000066121956,0.000126037,0.00013735652,0.0000637563,0.00013736071,7.8000176e-7,0.00016777283,0.0000412325,0.0000069100747],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009584081,0.0002883171,0.0005293692,0.00002327153,0.00030298106,0.0000018585503,0.0005055868,0.00006317379,0.99556994,0.00019338452,0.0000739484,0.0024385822],"study_design_scores_gemma":[0.0030296445,0.00060251856,0.03085659,0.000017213062,0.0004354368,0.000033244833,0.00029071144,0.00003736807,0.6166306,0.00021840514,0.34724298,0.0006052532],"about_ca_topic_score_codex":0.00026228337,"about_ca_topic_score_gemma":0.00010604112,"teacher_disagreement_score":0.3789393,"about_ca_system_score_codex":0.0000147373685,"about_ca_system_score_gemma":0.0001339204,"threshold_uncertainty_score":0.513964},"labels":[],"label_agreement":null},{"id":"W2609900216","doi":"10.1182/blood.v128.22.2095.2095","title":"TTI-281, an Orally Bioavailable Bromodomain and Extraterminal Domain (BET) Inhibitor, Is a Promising Candidate for the Treatment of Multiple Myeloma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Trillium Therapeutics (Canada)","funders":"","keywords":"Pharmacology; Bioavailability; In vivo; ADME; Bromodomain; Oral administration; Pharmacokinetics; IC50; Chemistry; In vitro; Biology; Biochemistry; Epigenetics","score_opus":0.03026844614524714,"score_gpt":0.2984379529543976,"score_spread":0.26816950680915047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2609900216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959507,0.0010172408,0.00016691923,0.00064648,0.000033883953,0.0017974683,0.0002645939,0.000032442895,0.00009027843],"genre_scores_gemma":[0.9918944,0.0003622267,0.0059030177,0.00003471569,0.00015814815,0.00028671508,0.000031133743,0.000037110138,0.0012924897],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985172,0.00006508222,0.00028658018,0.0004021162,0.00026307846,0.00046591208],"domain_scores_gemma":[0.99877405,0.0002871937,0.000098126635,0.0004586668,0.000104113155,0.00027784385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019752017,0.00023721937,0.0003658132,0.000092306116,0.00019093479,0.00003838693,0.00009188083,0.000084571235,0.00006695316],"category_scores_gemma":[0.000058657006,0.00011506304,0.000108965345,0.00009885163,0.00020450926,0.00012617414,0.000027317354,0.00003871839,0.000010830598],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037706743,0.0052195797,0.24643116,0.00021706305,0.0010896755,0.00028809425,0.0017975621,7.8468936e-8,0.6091308,0.000055699533,0.00028121294,0.13171838],"study_design_scores_gemma":[0.07537477,0.012894544,0.122331135,0.00042770206,0.00073077437,0.0003283872,0.00036913695,0.0002901706,0.7780476,0.00039644845,0.008454956,0.00035434763],"about_ca_topic_score_codex":0.00039102018,"about_ca_topic_score_gemma":0.0002819857,"teacher_disagreement_score":0.1689168,"about_ca_system_score_codex":0.00007524315,"about_ca_system_score_gemma":0.00016774965,"threshold_uncertainty_score":0.46921346},"labels":[],"label_agreement":null},{"id":"W2610051933","doi":"10.1182/blood.v128.22.868.868","title":"a Randomized, Double-Blinded, Placebo Controlled Study of IVIG Vs. IVIG with High Dose Methylprednisolone in Rapidly Augmenting Platelet Counts in Childhood ITP","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; Université de Montréal; Izaak Walton Killam Health Centre; Kingston General Hospital; Children's Hospital of Eastern Ontario; Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Methylprednisolone; Placebo; Internal medicine; Adverse effect; Clinical endpoint; Sepsis; Splenectomy; Complete blood count; Gastroenterology; Randomized controlled trial","score_opus":0.013546116049634467,"score_gpt":0.2577937414817336,"score_spread":0.24424762543209916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610051933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931574,0.0005425672,0.0000086704795,0.0001700269,0.000056702873,0.0041384003,0.000011350053,0.000032688724,0.0018821993],"genre_scores_gemma":[0.99889135,0.00011661269,0.00014484834,0.000046778525,0.000028064027,0.00040894197,0.000010905455,0.00003280947,0.00031971166],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9981101,0.00016781728,0.0006305216,0.00036612575,0.00036735318,0.00035804033],"domain_scores_gemma":[0.9989393,0.00036703152,0.00025665187,0.00030038564,0.000056002653,0.00008066905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072088314,0.00026605558,0.0016335205,0.00031603876,0.000030779647,0.000012676875,0.000102424165,0.00011080054,0.00012587584],"category_scores_gemma":[0.00010110672,0.00015189785,0.00010776288,0.0002842934,0.0000648162,0.00008408716,0.00003771535,0.00015536712,0.000031854597],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9224445,0.020201564,0.047208074,0.000056392226,0.0032200674,0.0017384441,0.001713554,0.000012429364,0.00059979915,0.00006180489,0.000044159595,0.0026992096],"study_design_scores_gemma":[0.9869086,0.0009540934,0.009224781,0.00031722372,0.00068560214,0.000056970897,0.00021969608,0.000010834725,0.0013590172,0.00007875135,0.000016484602,0.00016792516],"about_ca_topic_score_codex":0.00048658196,"about_ca_topic_score_gemma":0.0004391829,"teacher_disagreement_score":0.06446412,"about_ca_system_score_codex":0.000037378708,"about_ca_system_score_gemma":0.00010769733,"threshold_uncertainty_score":0.6194215},"labels":[],"label_agreement":null},{"id":"W2610140576","doi":"10.1182/blood.v128.22.3037.3037","title":"Differential Expression of TCF3 Target Genes Defines Subclasses of Diffuse Large B-Cell Lymphoma with Striking Differences in Clinical Outcome Following R-CHOP Therapy","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Diffuse large B-cell lymphoma; Vincristine; Lymphoma; Biology; Cancer research; BCL6; Prednisone; CHOP; Rituximab; Oncology; Cyclophosphamide; Medicine; B cell; Internal medicine; Immunology; Genetics; Chemotherapy; Germinal center","score_opus":0.0359742485564188,"score_gpt":0.29630831159421195,"score_spread":0.26033406303779316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610140576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99764997,0.0015630367,0.00009138797,0.00008872286,0.00013175882,0.00034458653,0.000034286415,0.000027144166,0.000069109534],"genre_scores_gemma":[0.99805075,0.0010133996,0.00068140106,0.00003136839,0.00007927874,0.000046904228,0.000009334804,0.00002684604,0.000060746628],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979942,0.000123739,0.00082404626,0.00035629058,0.00039694304,0.00030479676],"domain_scores_gemma":[0.99858063,0.00055818615,0.00033458447,0.00036178262,0.000057715508,0.0001070909],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015686596,0.00025613012,0.0009014467,0.00013021228,0.000037876103,0.000009824346,0.00013441281,0.000115400566,0.000044170978],"category_scores_gemma":[0.000081443904,0.00012443223,0.0002683112,0.00012971288,0.00007417494,0.00009666922,0.00006322427,0.00004255121,0.0000015829396],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055471103,0.026397124,0.91761327,0.000063653206,0.00017367295,0.00007245511,0.000082828185,3.415943e-8,0.05254543,0.000034984412,0.000006471157,0.00245537],"study_design_scores_gemma":[0.064972915,0.0011978784,0.68871754,0.00047818598,0.00016435354,0.00000436183,0.000057256104,0.0000018995281,0.24422932,0.000021524176,0.00003723382,0.00011755147],"about_ca_topic_score_codex":0.00005645784,"about_ca_topic_score_gemma":0.000027141245,"teacher_disagreement_score":0.22889575,"about_ca_system_score_codex":0.00002511611,"about_ca_system_score_gemma":0.000094056246,"threshold_uncertainty_score":0.5074199},"labels":[],"label_agreement":null},{"id":"W2610540653","doi":"10.1182/blood-2016-11-750174","title":"Selective inhibition of nuclear export with selinexor in patients with non-Hodgkin lymphoma","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":157,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Neutropenia; Follicular lymphoma; Lymphoma; Leukopenia; Adverse effect; Gastroenterology; Mantle cell lymphoma; Febrile neutropenia; Oncology; Chemotherapy","score_opus":0.005920226534403244,"score_gpt":0.21683525894195574,"score_spread":0.2109150324075525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610540653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99659705,0.0000130605995,0.000001143352,0.00009920016,0.000013812803,0.00046047894,0.000011143525,0.000014338453,0.0027897612],"genre_scores_gemma":[0.9990635,0.000007773036,0.0007158456,0.00007111069,0.000029192326,0.000038507194,0.000025239939,0.000022459573,0.00002637678],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992556,0.000009373872,0.000156237,0.00020853578,0.00022274793,0.00014749136],"domain_scores_gemma":[0.9992673,0.000011134189,0.00017381736,0.0003434645,0.00013933377,0.00006499435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004465562,0.00012459233,0.00025672177,0.00006381863,0.000068731286,0.000014694731,0.000045184483,0.000050177176,0.000014534375],"category_scores_gemma":[0.000019280265,0.00008080225,0.000030223146,0.00006565125,0.00006149706,0.0001022894,0.000022681581,0.00003107918,0.000010309133],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006757202,0.0056528472,0.99095595,0.00003371133,0.00014994026,0.00009830581,0.00028499987,4.5592725e-7,0.00017406263,0.000020743262,0.000099491874,0.0018537799],"study_design_scores_gemma":[0.031498082,0.0026023532,0.94804263,0.0003709575,0.00019414301,0.000012748939,0.000044535387,0.00000476047,0.017081508,0.0000060444095,0.00005029385,0.00009193473],"about_ca_topic_score_codex":0.00022507232,"about_ca_topic_score_gemma":0.0000646964,"teacher_disagreement_score":0.042913303,"about_ca_system_score_codex":0.00006385961,"about_ca_system_score_gemma":0.00010053343,"threshold_uncertainty_score":0.32950202},"labels":[],"label_agreement":null},{"id":"W2610673450","doi":"10.1182/blood.v128.22.3960.3960","title":"A Novel Oncolytic Reovirus Immune Priming Strategy Dramatically Enhances the Efficacy of Anti-PD-L1 Antibody Therapy Against Multiple Myeloma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Oncolytic virus; Multiple myeloma; Bortezomib; Antibody; Cancer; Immunotherapy; In vivo; Cancer research; Immunology; Immune system; Medicine; Biology; Virology; Internal medicine","score_opus":0.023470025254840505,"score_gpt":0.3110429636234485,"score_spread":0.28757293836860803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610673450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962596,0.0016667609,0.00078616216,0.0002021535,0.000056199813,0.00056357536,0.000032262367,0.000021130734,0.00041209772],"genre_scores_gemma":[0.9975071,0.0015500371,0.00036718283,0.00011117597,0.00019314604,0.00003370449,0.000028120323,0.00004658665,0.00016295451],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99818814,0.00015376395,0.0004438998,0.0004185985,0.00033564327,0.00045998354],"domain_scores_gemma":[0.99851066,0.0002123092,0.0001915511,0.0008418401,0.00015646884,0.00008716859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054521865,0.00024393988,0.0002971597,0.000056773217,0.00014100574,0.00003937879,0.0006520252,0.00015975132,0.00003257767],"category_scores_gemma":[0.00026757515,0.00014185396,0.00018704978,0.0001677888,0.0003244469,0.000008755358,0.00013244383,0.00012478702,0.000019954909],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010815888,0.00087032234,0.0006170905,0.000019445502,0.0002670032,0.0000039820357,0.00008098055,0.000015958276,0.97368497,0.000016248487,0.000010259214,0.023332141],"study_design_scores_gemma":[0.005522237,0.0018726825,0.013152302,0.0000734599,0.000023949506,0.000009078375,0.00005379267,0.000025120995,0.97862697,0.000013693368,0.00041133913,0.00021540107],"about_ca_topic_score_codex":0.000020372388,"about_ca_topic_score_gemma":0.000035080167,"teacher_disagreement_score":0.02311674,"about_ca_system_score_codex":0.000011773141,"about_ca_system_score_gemma":0.0002829264,"threshold_uncertainty_score":0.5784637},"labels":[],"label_agreement":null},{"id":"W2610718437","doi":"10.1182/blood.v128.22.5818.5818","title":"Early Relapse Following ASCT for Patients with MM: Identification of Predictor Factors in the Era of Novel Agents","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; Calgary Laboratory Services; Institute of Cancer Research; University of Calgary","funders":"","keywords":"Medicine; Exact test; Incidence (geometry); Internal medicine; Log-rank test; Oncology; Surgery; Survival analysis","score_opus":0.030951160966747257,"score_gpt":0.31136038284035955,"score_spread":0.2804092218736123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610718437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983071,0.000016491018,0.00047710983,0.00008871708,0.000045169367,0.00085723243,0.000056338613,0.0000050008175,0.00014685794],"genre_scores_gemma":[0.9993432,0.000006241783,0.0003681327,0.000010557403,0.000020918413,0.00005599888,0.00001656039,0.000008970347,0.00016941177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990993,0.000034701952,0.00028947444,0.00012125148,0.00031862615,0.00013663417],"domain_scores_gemma":[0.9991293,0.00033018415,0.00012849072,0.00022713274,0.00015042185,0.000034497556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034596235,0.000064507454,0.00023678836,0.000059275542,0.000023169956,0.0000025580546,0.00010342627,0.00005774345,0.000009856673],"category_scores_gemma":[0.0007144589,0.000030461168,0.000060903705,0.00011432742,0.00006171113,0.000058920334,0.000012763611,0.00006521448,0.0000012278965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018565693,0.0015007845,0.99131733,0.000050937433,0.00014395722,9.439687e-7,0.0010845421,5.5210474e-8,0.0054874998,0.00003506874,0.00003784037,0.00015537548],"study_design_scores_gemma":[0.010592939,0.00097601855,0.9848704,0.00020985959,0.00027072072,3.633237e-7,0.00009398549,0.0000094353145,0.002897476,0.000024865209,0.00002060819,0.00003335791],"about_ca_topic_score_codex":0.000048781178,"about_ca_topic_score_gemma":0.0000075582357,"teacher_disagreement_score":0.010407282,"about_ca_system_score_codex":0.00001744286,"about_ca_system_score_gemma":0.00008417739,"threshold_uncertainty_score":0.12421704},"labels":[],"label_agreement":null},{"id":"W2610723615","doi":"10.1182/blood.v128.22.5404.5404","title":"Clinical Retrospective Analysis of 42 Patients with Primary Bone Lymphoma Treated at Maisonneuve-Rosemont Hospital","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Lymphoma; Diffuse large B-cell lymphoma; Retrospective cohort study; Survival analysis; Biopsy; Surgery; Internal medicine","score_opus":0.006701570003698607,"score_gpt":0.23529407517508294,"score_spread":0.22859250517138432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610723615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977193,0.00015674935,0.0000030273814,0.0001882426,0.00004823377,0.00043334436,0.0002126063,0.00004864085,0.0011898463],"genre_scores_gemma":[0.9987785,0.00012064017,0.00030933702,0.000080563805,0.000039018196,0.000040425457,0.00014847684,0.000024373401,0.0004586715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829274,0.000047330486,0.00048601182,0.00048087983,0.00043400456,0.00025905133],"domain_scores_gemma":[0.9986272,0.00013663397,0.0002780562,0.0005266729,0.00023408457,0.00019738027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009738465,0.00022007477,0.0009120998,0.0001694053,0.000049264778,0.000005279188,0.000059682123,0.000119170254,0.0001182694],"category_scores_gemma":[0.00007446604,0.00011599464,0.00038796986,0.00046504274,0.0001427239,0.000060787002,0.000067355504,0.000027496393,0.000032959968],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052991015,0.013425436,0.9742693,0.000011701377,0.005916408,0.00015246213,0.00008255011,6.4759014e-8,0.00012536068,0.000024288132,0.00021050006,0.005252051],"study_design_scores_gemma":[0.030877773,0.0038730348,0.952776,0.00010682671,0.009157102,0.000005239725,0.000010008431,0.000001178611,0.00294806,0.000004167393,0.00008593512,0.00015466254],"about_ca_topic_score_codex":0.00006136616,"about_ca_topic_score_gemma":0.00004416753,"teacher_disagreement_score":0.030347863,"about_ca_system_score_codex":0.00038055488,"about_ca_system_score_gemma":0.00007185823,"threshold_uncertainty_score":0.47301242},"labels":[],"label_agreement":null},{"id":"W2610790606","doi":"10.1182/blood.v128.22.4095.4095","title":"Comprehensive Genomic Analysis of Adult Burkitt Lymphoma Identifies the B-Cell Receptor Signaling Pathway As a Potential Therapeutic Target","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Burkitt's lymphoma; Medicine; Lymphoma; Oncology; Chromosomal translocation; Gene expression profiling; SNP; Gene; Cancer research; Internal medicine; Biology; Single-nucleotide polymorphism; Genetics; Genotype; Gene expression","score_opus":0.010270463955659939,"score_gpt":0.22857775645666878,"score_spread":0.21830729250100883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610790606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99473715,0.0036332628,0.00007347253,0.0006439659,0.00012576941,0.00035517258,0.000080872276,0.00003623004,0.0003141358],"genre_scores_gemma":[0.99825925,0.00038529903,0.00019990059,0.00042517149,0.00011586649,0.000057675163,0.00003947767,0.000024172838,0.0004931954],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985972,0.00009578748,0.00037917157,0.0003275086,0.00033778453,0.00026255433],"domain_scores_gemma":[0.998743,0.00021612483,0.0002105896,0.00047604518,0.00025868314,0.000095538024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000079542784,0.0002120145,0.00050297193,0.0001715706,0.00010746318,0.000026560318,0.0001545692,0.000082005645,0.00047395704],"category_scores_gemma":[0.000022389411,0.000107895416,0.00048538888,0.00033202392,0.00011940864,0.00004720823,0.000056917706,0.000031238902,0.00014991093],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021085108,0.0025567792,0.032859176,0.000047820227,0.0077273287,0.00008385434,0.0006897349,0.000020233556,0.94817054,0.00020356843,0.00011571905,0.0073144217],"study_design_scores_gemma":[0.009689834,0.0004053436,0.06828925,0.00008551597,0.007928685,0.000029286883,0.00055622077,0.000043012817,0.91117936,0.00016507406,0.0014453093,0.00018309122],"about_ca_topic_score_codex":0.00023341567,"about_ca_topic_score_gemma":0.000007138204,"teacher_disagreement_score":0.03699114,"about_ca_system_score_codex":0.00006859305,"about_ca_system_score_gemma":0.00012853295,"threshold_uncertainty_score":0.51894975},"labels":[],"label_agreement":null},{"id":"W2610868654","doi":"10.1182/blood.v128.22.167.167","title":"Amelioration of Immune Thrombocytopenia in Human CD44 Transgenic Mice By Anti-Human CD44 Antibodies","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto; Canadian Blood Services","funders":"","keywords":"Antibody; Monoclonal antibody; Genetically modified mouse; Immunology; clone (Java method); Immune system; Biology; Platelet; Molecular biology; Transgene; Biochemistry; Gene","score_opus":0.013953071681927437,"score_gpt":0.27937712472675025,"score_spread":0.2654240530448228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610868654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99673945,0.0012296789,0.000011988516,0.00025654447,0.000033906923,0.00033091602,0.000040710893,0.0000299528,0.001326841],"genre_scores_gemma":[0.9989293,0.0003441585,0.00007245681,0.00002813608,0.000023753497,0.000010826144,0.00008942562,0.000021292197,0.00048060308],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989868,0.00003199165,0.00037287787,0.00022834247,0.00016282375,0.00021719783],"domain_scores_gemma":[0.99956495,0.000020133448,0.00010732869,0.0002160597,0.00004626097,0.000045299013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009546095,0.0001578129,0.0005208764,0.00010925309,0.00006379837,0.000008731627,0.00008619785,0.00008914448,0.00011354354],"category_scores_gemma":[0.000012071387,0.00011022558,0.00009324285,0.00013883773,0.00008353715,0.00013146152,0.000016156542,0.00006777943,0.0000240686],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027097538,0.0014527182,0.060405906,0.00005362699,0.00015620198,0.000042351636,0.00025039306,8.3076216e-8,0.9368736,0.00008705818,0.00017676818,0.0004742058],"study_design_scores_gemma":[0.013660463,0.000604858,0.20497683,0.00031052734,0.00028921152,0.000026379526,0.0000801452,4.7681363e-7,0.7793783,0.00027060413,0.00023141195,0.0001707708],"about_ca_topic_score_codex":0.0003013491,"about_ca_topic_score_gemma":0.00017450201,"teacher_disagreement_score":0.15749528,"about_ca_system_score_codex":0.000019578682,"about_ca_system_score_gemma":0.000026787082,"threshold_uncertainty_score":0.44948685},"labels":[],"label_agreement":null},{"id":"W2610875117","doi":"10.1182/blood.v128.22.2108.2108","title":"B-Cell Markers Predict Response to Venetoclax in Multiple Myeloma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Venetoclax; Multiple myeloma; Cancer research; IGHV@; Medicine; Immunology; Oncology; Leukemia; Chronic lymphocytic leukemia","score_opus":0.01874606279069476,"score_gpt":0.272848247350366,"score_spread":0.25410218455967126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610875117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958741,0.00014170422,0.000029276667,0.0010221545,0.000043358505,0.0008455608,0.000048609112,0.00006176446,0.0019334904],"genre_scores_gemma":[0.99392253,0.000029291588,0.0010987873,0.00012250678,0.00006614441,0.00014936978,0.000008206921,0.000029507244,0.004573644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984811,0.00014171927,0.0002086857,0.00033586076,0.00034444165,0.0004881927],"domain_scores_gemma":[0.99864066,0.00041559868,0.000027236081,0.00042420535,0.00004891816,0.00044337098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035849994,0.00014953801,0.00021913949,0.00025182447,0.000038193288,0.000010186845,0.000112948626,0.00007877264,0.00020907777],"category_scores_gemma":[0.00096123834,0.000097957105,0.000070618305,0.00023536313,0.00004319248,0.00005378515,0.00007416605,0.00009137807,0.0005412467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015505126,0.0010786584,0.76640296,0.000042246993,0.0001005032,0.0014132122,0.00012103268,0.0000011221393,0.20035027,0.0000022524823,0.0018923859,0.013090231],"study_design_scores_gemma":[0.026646819,0.0013149463,0.8960658,0.0002166825,0.000034835262,0.000041054667,0.000031979274,0.00003580163,0.06899332,0.000009773387,0.0064845183,0.00012448468],"about_ca_topic_score_codex":0.000090980735,"about_ca_topic_score_gemma":0.00005343092,"teacher_disagreement_score":0.13135695,"about_ca_system_score_codex":0.00019938318,"about_ca_system_score_gemma":0.00026039104,"threshold_uncertainty_score":0.6956812},"labels":[],"label_agreement":null},{"id":"W2610928722","doi":"10.1182/blood.v128.22.3603.3603","title":"Implementation of a Physician-Prescribed Exercise Program As Standard of Care in Allogeneic Stem Cell Transplant (SCT) Patients (pts) in British Columbia: A Pilot Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Cancer survivorship and care","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital; Simon Fraser University; Leukemia & Lymphoma Society of Canada; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Physical therapy; Quality of life (healthcare); Transplantation; Aerobic exercise; Internal medicine","score_opus":0.009687770800004856,"score_gpt":0.26178010793305456,"score_spread":0.2520923371330497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610928722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99632215,0.00049574283,8.6141404e-7,0.0000066110883,0.000059605794,0.0025170106,0.00048247466,0.000019533934,0.000096012554],"genre_scores_gemma":[0.9994074,0.000119589684,0.000013734406,0.000013251258,0.000013672697,0.0003387072,0.00004370724,0.000021607077,0.000028346132],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986255,0.000074772885,0.00043969584,0.00025752163,0.00038697012,0.00021553361],"domain_scores_gemma":[0.9994308,0.000018889024,0.000121760546,0.00020133321,0.00017102233,0.00005624461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010755898,0.0000981865,0.0004447358,0.00007177349,0.00001379255,0.000012982143,0.000087575085,0.00003448566,0.000039655497],"category_scores_gemma":[0.0000022645281,0.000112986156,0.000058711186,0.00024150981,0.000028686281,0.0000563172,0.000022378861,0.000062999265,8.216474e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007605433,0.004752823,0.85053736,0.0004560793,0.000035490262,0.000048716083,0.0074736048,1.3398972e-7,0.002477393,2.1716632e-7,0.000014162999,0.13344349],"study_design_scores_gemma":[0.033907775,0.023942837,0.88742644,0.0014732943,0.0003405956,0.0000016410739,0.02388417,1.4470689e-7,0.028807376,0.0000067914993,0.000042829015,0.00016612059],"about_ca_topic_score_codex":0.058121216,"about_ca_topic_score_gemma":0.75281936,"teacher_disagreement_score":0.69469815,"about_ca_system_score_codex":0.0000820516,"about_ca_system_score_gemma":0.00015015277,"threshold_uncertainty_score":0.9481508},"labels":[],"label_agreement":null},{"id":"W2611012983","doi":"10.1182/blood.v128.22.2573.2573","title":"Safety and Efficacy of Recombinant Factor XIII (FXIII) in Patients with Congenital FXIII A-Subunit Deficiency, Results from the Mentor™2 Trial","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Blood properties and coagulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Pediatrics; Factor XIII deficiency; Factor XIII; Internal medicine; Surgery","score_opus":0.016208606595800337,"score_gpt":0.21719100048473644,"score_spread":0.2009823938889361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611012983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977816,0.00019158487,0.0000069490275,0.0004959376,0.00014874668,0.00083320896,0.00010457722,0.000014810434,0.00042258078],"genre_scores_gemma":[0.9995184,0.00004423453,0.000052387317,0.000038225182,0.000059972826,0.000007431806,0.000036221558,0.000013655371,0.00022949213],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988282,0.00007291455,0.0004013054,0.00024047117,0.00027888652,0.00017825204],"domain_scores_gemma":[0.99915576,0.00024656017,0.00014864172,0.00030278723,0.000084156956,0.00006211793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016392944,0.00012868972,0.00026087073,0.000036738882,0.00005650315,0.000010712891,0.00008420529,0.000070031485,0.00004122401],"category_scores_gemma":[0.0002146172,0.000057699766,0.000037851725,0.00010978394,0.00009226275,0.000073816496,0.0000480141,0.0000846562,0.0000047925246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28851897,0.0065974216,0.6256156,0.000028703696,0.00049143215,0.000010381605,0.0041941353,0.0000010215641,0.0031146575,0.00014067921,0.00015526247,0.07113175],"study_design_scores_gemma":[0.21952553,0.0023525415,0.7755207,0.00014728637,0.00020623353,0.0000011317709,0.00006871641,0.0000032480405,0.001562021,0.000016317583,0.00049626065,0.00010004626],"about_ca_topic_score_codex":0.0003376774,"about_ca_topic_score_gemma":0.00008833946,"teacher_disagreement_score":0.14990507,"about_ca_system_score_codex":0.000019135297,"about_ca_system_score_gemma":0.00006313286,"threshold_uncertainty_score":0.23529282},"labels":[],"label_agreement":null},{"id":"W2611202021","doi":"10.1182/blood.v128.22.4616.4616","title":"Anti-Thymocyte Globulin Kills Leukemic Stem Cells in Vitro","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; Foothills Medical Centre; Alberta Health Services; University of Alberta; University of Calgary","funders":"","keywords":"Anti-thymocyte globulin; Leukemia; Stem cell; Immunology; Myeloid leukemia; Haematopoiesis; Peripheral blood mononuclear cell; Flow cytometry; Transplantation; Hematopoietic stem cell transplantation; Graft-versus-host disease; CD34; Medicine; Biology; Cancer research; In vitro; Internal medicine; Globulin","score_opus":0.01511192327513591,"score_gpt":0.259114402957377,"score_spread":0.24400247968224106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611202021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99435186,0.00059023773,0.000063204556,0.001220535,0.00011527657,0.00049272925,0.000037652153,0.00010240509,0.0030260698],"genre_scores_gemma":[0.9912501,0.00052741077,0.0006790093,0.00036865816,0.0002625316,0.000029143397,0.000005993298,0.000050159244,0.006826987],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99802065,0.00008864071,0.00035764562,0.00044370777,0.0004404217,0.00064894994],"domain_scores_gemma":[0.99880856,0.00019505515,0.00006278092,0.0005967659,0.00008193995,0.00025490366],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003831982,0.00020506638,0.00044818976,0.00023298782,0.000035434463,0.000016568212,0.00025239366,0.00018099094,0.00015748998],"category_scores_gemma":[0.00006841937,0.00013675111,0.000105693114,0.0003602383,0.00010735853,0.00010439818,0.00014033326,0.00030333965,0.0014157548],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021723629,0.00030790246,0.006689156,0.000053244952,0.00006039769,0.000656689,0.0000682973,5.2237044e-7,0.975585,0.000021149071,0.0015840151,0.014756416],"study_design_scores_gemma":[0.012072809,0.0001566449,0.010730101,0.00020354571,0.00006216382,0.00012285436,0.000044792563,0.00002753279,0.96797603,0.000021154594,0.00839319,0.00018919434],"about_ca_topic_score_codex":0.00008858207,"about_ca_topic_score_gemma":0.000005784125,"teacher_disagreement_score":0.014567222,"about_ca_system_score_codex":0.00044943945,"about_ca_system_score_gemma":0.00051322376,"threshold_uncertainty_score":0.99936175},"labels":[],"label_agreement":null},{"id":"W2611533293","doi":"10.1182/blood.v128.22.2790.2790","title":"Excess Treatment-Related Mortality in Obese Children and Adolescents with Acute Myeloid Leukemia on AAML0531: A Report from the Children's Oncology Group","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Internal medicine; Myeloid leukemia; Induction chemotherapy; Hematopoietic stem cell transplantation; Chemotherapy; Transplantation; Underweight; Body mass index; Oncology; Leukemia; Pediatrics; Overweight","score_opus":0.011588120132491867,"score_gpt":0.27981629410621955,"score_spread":0.26822817397372767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611533293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959699,0.00030181638,0.000008806906,0.0012758715,0.00004882436,0.001543769,0.00013449666,0.00009567186,0.0006208301],"genre_scores_gemma":[0.9977351,0.00082944287,0.00011069381,0.00030469507,0.00022449561,0.00010840174,0.00023001939,0.00006208829,0.0003950749],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972334,0.00025039207,0.00050332263,0.0008828866,0.00052148703,0.00060850935],"domain_scores_gemma":[0.99821043,0.000175092,0.00021316583,0.0010500719,0.000063405496,0.00028784448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039267883,0.00039263128,0.00065538357,0.0001382286,0.000117575946,0.00002891592,0.0002731357,0.00030696264,0.000056185527],"category_scores_gemma":[0.00012557485,0.00018845417,0.00009674798,0.0003396771,0.00038208207,0.000126351,0.00014676328,0.0005121652,0.000053617987],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009925395,0.0012037265,0.9809917,0.0000063157245,0.0013935362,0.0033072003,0.00025520075,4.0302368e-7,0.0026652098,0.000016398457,0.00018252371,0.008985206],"study_design_scores_gemma":[0.02861208,0.0016201608,0.962864,0.00051274674,0.0008197113,0.0024765697,0.000026823513,0.000004908414,0.0026774625,0.000066670094,0.000087476496,0.00023139581],"about_ca_topic_score_codex":0.0052871383,"about_ca_topic_score_gemma":0.0011583719,"teacher_disagreement_score":0.027619539,"about_ca_system_score_codex":0.0009956739,"about_ca_system_score_gemma":0.000777061,"threshold_uncertainty_score":0.7992607},"labels":[],"label_agreement":null},{"id":"W2611706829","doi":"10.1182/blood.v128.22.88.88","title":"Association of BW with Thromboembolic and Bleeding Outcomes in Phase III Randomized Controlled Trials of Direct Oral Anticoagulants: Systematic Review and Meta-Analysis","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Randomized controlled trial; Meta-analysis; Internal medicine; Rivaroxaban; Surgery; Warfarin; Atrial fibrillation","score_opus":0.0413653531057872,"score_gpt":0.335109863496641,"score_spread":0.2937445103908538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611706829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8891605,0.09282903,0.00013969807,0.0029195868,0.000024462666,0.014324425,0.00007898669,0.000029471403,0.0004938361],"genre_scores_gemma":[0.98303473,0.015974058,0.00013945244,0.00017862469,0.0000059704494,0.00045583403,0.0000038736293,0.000011101605,0.00019633843],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99587554,0.0011478999,0.0022010782,0.00022718305,0.00038637657,0.0001619439],"domain_scores_gemma":[0.9941619,0.0032336276,0.0021427062,0.0002479199,0.00015662015,0.00005721771],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.011887826,0.00021197354,0.02937297,0.00033870418,0.000019383198,0.000012306916,0.000051467116,0.00005485979,0.00009800056],"category_scores_gemma":[0.0056937817,0.000085185544,0.0011812302,0.0002913734,0.0000562629,0.000072409275,0.000027643579,0.000037221158,3.9006858e-7],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004299736,0.0025770243,0.00933268,0.04906391,0.9331846,0.000007849504,0.00026698547,5.1271326e-7,0.0008631559,0.0003484938,0.000042499374,0.000012521299],"study_design_scores_gemma":[0.29510373,0.00013492526,0.001385025,0.0025249498,0.7002874,0.0000011754538,0.00003357307,0.0000072723283,0.00043190952,0.000018244373,3.6643516e-7,0.00007140223],"about_ca_topic_score_codex":0.00012964918,"about_ca_topic_score_gemma":0.00005332193,"teacher_disagreement_score":0.290804,"about_ca_system_score_codex":0.00001723452,"about_ca_system_score_gemma":0.000021879634,"threshold_uncertainty_score":0.985037},"labels":[],"label_agreement":null},{"id":"W2611734568","doi":"10.1182/blood.v128.22.5550.5550","title":"Comparison of the IPSS and IPSS-R in Predicting Survival and Response of Myelodysplastic Syndrome Patients to 5-Azacitidine","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Azacitidine; International Prognostic Scoring System; Medicine; Myelodysplastic syndromes; Internal medicine; Oncology; Cohort; Decitabine; Bone marrow","score_opus":0.02047426465743408,"score_gpt":0.29904641992612563,"score_spread":0.27857215526869156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611734568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988748,0.000070470924,0.000012462494,0.00044253733,0.000045057568,0.00042375017,0.000045631252,0.000008913319,0.00007642118],"genre_scores_gemma":[0.99968785,0.000010928804,0.00013811496,0.000013077719,0.000014086813,0.0000096375925,0.0000012903704,0.000014504297,0.00011048009],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99872327,0.00017757202,0.00033814728,0.0001964717,0.0003538695,0.00021064973],"domain_scores_gemma":[0.99860597,0.0008431638,0.000090673304,0.0002434038,0.000100995254,0.00011576893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005511795,0.00009851191,0.0003565355,0.0001549681,0.000028267901,0.0000037921254,0.0001002019,0.00006469795,0.000011126987],"category_scores_gemma":[0.002056066,0.000057559137,0.000023541095,0.00025189813,0.00015181948,0.00004196478,0.00021121088,0.00013036176,0.0000018469833],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001232561,0.00027717388,0.9459409,0.00010522765,0.000037309685,0.000011303214,0.0006446822,8.3127924e-7,0.0510086,0.000010395478,0.000026252852,0.00070472795],"study_design_scores_gemma":[0.0062605306,0.001003212,0.9693863,0.00056768325,0.000054024455,0.00003222002,0.00019488015,0.000047615442,0.02236746,0.0000071140284,0.00002181077,0.000057155925],"about_ca_topic_score_codex":0.000048781592,"about_ca_topic_score_gemma":0.000031942152,"teacher_disagreement_score":0.02864114,"about_ca_system_score_codex":0.00004806883,"about_ca_system_score_gemma":0.0001075719,"threshold_uncertainty_score":0.24614514},"labels":[],"label_agreement":null},{"id":"W2612083993","doi":"10.1182/blood.v128.22.3005.3005","title":"Failure to Achieve CR with First-Line Treatment Is the Primary Cause of Treatment Failure in T-Cell Lymphoma: The Princess Margaret Cancer Centre Experience","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Lymphoma; Internal medicine; Anaplastic large-cell lymphoma; Cancer; T-cell lymphoma; Etiology; Progressive disease; Not Otherwise Specified; Stage (stratigraphy); Gastroenterology; Oncology; Chemotherapy","score_opus":0.018006855050988542,"score_gpt":0.28066762846840715,"score_spread":0.2626607734174186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2612083993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9589249,0.000580558,0.000020771957,0.03762924,0.000019267007,0.00227214,0.00013194527,0.00002329883,0.00039789296],"genre_scores_gemma":[0.99324214,0.0012162628,0.00015907075,0.00046889516,0.00007299402,0.0008053533,0.000011049525,0.00004246217,0.0039817635],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980985,0.0001041751,0.0002989597,0.0005057119,0.00048667242,0.0005060077],"domain_scores_gemma":[0.99848855,0.0002735441,0.00010124689,0.00080280885,0.00016677986,0.00016707822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007885768,0.0003425158,0.00044078074,0.00008953241,0.00014184367,0.000024756398,0.000280719,0.00008254794,0.0002670196],"category_scores_gemma":[0.000037794,0.0001291134,0.00010277332,0.00040184453,0.00024123004,0.00006000583,0.00009175016,0.00005847511,0.000020341218],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037425833,0.009365159,0.9005137,0.00019976041,0.00091707165,0.00063449953,0.051861875,0.00005715278,0.01382373,0.00004685499,0.0014031521,0.017434422],"study_design_scores_gemma":[0.12979545,0.025560927,0.15897429,0.0027353584,0.0018330225,0.0016104794,0.024100693,0.00010073435,0.5432196,0.00007985926,0.110308245,0.00168133],"about_ca_topic_score_codex":0.002158332,"about_ca_topic_score_gemma":0.03745766,"teacher_disagreement_score":0.7415395,"about_ca_system_score_codex":0.0008859727,"about_ca_system_score_gemma":0.0008557443,"threshold_uncertainty_score":0.98010623},"labels":[],"label_agreement":null},{"id":"W2612248406","doi":"10.1182/blood.v128.22.2923.2923","title":"Chromosome 9p24.1/PD-L1/PD-L2Alterations and PD-L1 Expression and Treatment Outcomes in Patients with Classical Hodgkin Lymphoma Treated with Nivolumab (PD-1 Blockade)","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"Brentuximab vedotin; Nivolumab; Medicine; Oncology; Internal medicine; Chlorambucil; Blockade; Polysomy; Cohort; Autologous stem-cell transplantation; Reed–Sternberg cell; PD-L1; Transplantation; Lymphoma; Cancer research; Chemotherapy; CD30; Receptor; Cyclophosphamide; Hodgkin lymphoma; Cancer; Biology; Immunotherapy; Chromosome","score_opus":0.007392563174687249,"score_gpt":0.2152760438936839,"score_spread":0.20788348071899665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2612248406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99702096,0.00028974292,0.0000050524154,0.0009419527,0.000029857805,0.0011839523,0.00011953197,0.000087230044,0.00032172902],"genre_scores_gemma":[0.99767864,0.0001977312,0.00058116275,0.0000905561,0.00006727139,0.00038439,0.00009265094,0.000055145818,0.0008524655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979694,0.00008135927,0.00038149042,0.000716588,0.0003938252,0.0004573309],"domain_scores_gemma":[0.9987591,0.00018109215,0.0001406124,0.0004804905,0.00008591006,0.0003527972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004601869,0.0004959574,0.00073813787,0.00019006354,0.0001686476,0.00006389124,0.00006290964,0.00015709428,0.000055435838],"category_scores_gemma":[0.000027390428,0.00024246055,0.000072190756,0.0001786714,0.00017589149,0.00019451504,0.00005495067,0.000051039082,0.000017134415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010668639,0.009352494,0.97805053,0.000023676392,0.00042571532,0.00026668265,0.00030332344,4.227452e-7,0.0011151704,0.000023559809,0.000058518395,0.009313049],"study_design_scores_gemma":[0.07625623,0.006179668,0.89940286,0.0005935902,0.00066255406,0.00008399249,0.000044087574,0.000010306922,0.016041376,0.000008525458,0.0004039793,0.00031285398],"about_ca_topic_score_codex":0.00021529011,"about_ca_topic_score_gemma":0.00025978766,"teacher_disagreement_score":0.07864769,"about_ca_system_score_codex":0.00033152234,"about_ca_system_score_gemma":0.00014265842,"threshold_uncertainty_score":0.9887254},"labels":[],"label_agreement":null},{"id":"W2612422239","doi":"10.1182/blood-2016-12-758383","title":"Safety and tolerability of pembrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphoma","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":295,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; H. Lundbeck A/S; Università di Bologna; Argenx; PharmaMar; Celgene; Gilead Sciences; Servier; Amgen; Pfizer; Bristol-Myers Squibb","keywords":"Pembrolizumab; Medicine; Tolerability; Refractory (planetary science); Internal medicine; Lymphoma; Oncology; Adverse effect; Immunotherapy; Cancer; Biology","score_opus":0.005873927897826031,"score_gpt":0.21331301627289417,"score_spread":0.20743908837506814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2612422239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99310565,0.0003329341,0.0000011265092,0.00008757032,0.00003996507,0.00037627982,0.000052304753,0.000011834611,0.0059923353],"genre_scores_gemma":[0.99945706,0.00008261595,0.00023569047,0.000068920584,0.000026706695,0.000016201431,0.000043748747,0.000013911068,0.0000551694],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989367,0.000030140136,0.00027578737,0.00027543693,0.00026954128,0.00021237963],"domain_scores_gemma":[0.9989874,0.00006738338,0.00020330495,0.00054403086,0.0000766527,0.00012125574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013374243,0.00015072255,0.0004141926,0.00004808776,0.00009631822,0.000012760184,0.00008362253,0.00007555925,0.00002384549],"category_scores_gemma":[0.000073980984,0.00010761395,0.000044595978,0.000032172164,0.00011263005,0.000106268984,0.00008265297,0.00005541027,0.000004026865],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001632539,0.018163718,0.9738851,0.00015420726,0.000058641814,0.00006120398,0.00015260406,6.6140785e-8,0.00003129147,0.000023610133,0.000019903815,0.005817072],"study_design_scores_gemma":[0.095067486,0.0012085857,0.90209204,0.00015105237,0.00017969246,0.000009477174,0.000014126906,0.0000020698678,0.00082193484,0.000007975352,0.00035256424,0.000093007046],"about_ca_topic_score_codex":0.000090493515,"about_ca_topic_score_gemma":0.000040346145,"teacher_disagreement_score":0.093434945,"about_ca_system_score_codex":0.000096738535,"about_ca_system_score_gemma":0.00015750235,"threshold_uncertainty_score":0.43883696},"labels":[],"label_agreement":null},{"id":"W2612511582","doi":"10.1182/blood.v128.22.4414.4414","title":"Natural History of Relapsed Myeloma, Refractory to Immunomodulatory Drugs and Proteasome Inhibitors: A Multicenter IMWG Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Multiple myeloma; Pomalidomide; Lenalidomide; Medicine; Bortezomib; Refractory (planetary science); Ixazomib; Proteasome inhibitor; Internal medicine; Natural history; Oncology; Carfilzomib; Thalidomide; Biology","score_opus":0.012614655181575684,"score_gpt":0.2627553543396567,"score_spread":0.250140699158081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2612511582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948007,0.002296573,0.0000014908196,0.0001831597,0.00020253725,0.0020306553,0.00001204971,0.000052205112,0.00042064436],"genre_scores_gemma":[0.99432606,0.000023616807,0.00035439743,0.000058929923,0.00011387728,0.00017133704,0.000004401996,0.000035357287,0.0049120444],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99832034,0.00011294741,0.00034003117,0.00040240207,0.00048044077,0.00034381586],"domain_scores_gemma":[0.9988218,0.00010318201,0.00010210768,0.00051010115,0.0001579372,0.00030487656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023815036,0.00020806647,0.00037148717,0.00022728754,0.000036899044,0.0000061589462,0.00010117273,0.000070532216,0.00006962767],"category_scores_gemma":[0.00030141775,0.00013117344,0.000087338136,0.000084665546,0.00011736027,0.00013980236,0.00012814038,0.000150182,0.000051799663],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029425425,0.008028245,0.35113865,0.00018543562,0.0009579052,0.00032466944,0.005245058,1.8200556e-8,0.59122103,0.000005499034,0.0012641596,0.038686763],"study_design_scores_gemma":[0.039243244,0.0035241714,0.9241045,0.000544703,0.00024127254,0.000030059673,0.00054893794,0.0000045433935,0.025515473,0.0000050816147,0.0059726136,0.00026537073],"about_ca_topic_score_codex":0.00014216476,"about_ca_topic_score_gemma":0.000017945213,"teacher_disagreement_score":0.57296586,"about_ca_system_score_codex":0.000338824,"about_ca_system_score_gemma":0.00020109859,"threshold_uncertainty_score":0.5349097},"labels":[],"label_agreement":null},{"id":"W2612853764","doi":"10.1182/blood.v128.22.3118.3118","title":"Clinical Outcomes with Ruxolitinib (RUX) in Patients with Myelofibrosis (MF) Stratified By Transfusion Status: A Pooled Analysis of the COMFORT-I and -II Trials","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Myelofibrosis; Ruxolitinib; Anemia; Internal medicine; Placebo; Blood transfusion; Bone marrow","score_opus":0.021164645303813127,"score_gpt":0.29838522585240107,"score_spread":0.27722058054858795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2612853764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99750644,0.00006991924,0.00002609391,0.00065224845,0.00001884039,0.0011685443,0.00040890073,0.000012311168,0.00013671609],"genre_scores_gemma":[0.9989787,0.00021172853,0.00038385086,0.00015205785,0.000011211913,0.00008647436,0.000058093377,0.000015820706,0.00010208891],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978596,0.0002884473,0.0008102785,0.00036932016,0.000425959,0.00024637813],"domain_scores_gemma":[0.9982261,0.00085854676,0.00031141212,0.00034481668,0.000112378984,0.00014676845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047177353,0.00022425425,0.0012746799,0.0001337221,0.00007283542,0.000011773073,0.00006021429,0.0000940909,0.00009728056],"category_scores_gemma":[0.00020805243,0.000083820945,0.0002171916,0.00042930729,0.00014152993,0.00005890324,0.000025179603,0.00009271718,5.07098e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013402426,0.0037076618,0.9862047,0.00001853926,0.0038740365,0.0000027725616,0.00024953636,6.2084945e-7,0.00016931344,0.00004659573,0.00003469168,0.0043513263],"study_design_scores_gemma":[0.031423073,0.0028773092,0.95439476,0.00022711924,0.00793753,5.7426513e-7,0.00006455964,0.0000029056034,0.0028965669,0.000008374816,0.000051662155,0.000115539195],"about_ca_topic_score_codex":0.00016257631,"about_ca_topic_score_gemma":0.0007367645,"teacher_disagreement_score":0.031809878,"about_ca_system_score_codex":0.000023257833,"about_ca_system_score_gemma":0.000101302285,"threshold_uncertainty_score":0.3418119},"labels":[],"label_agreement":null},{"id":"W2612885052","doi":"10.1182/blood-2017-03-742304","title":"How I treat recurrent venous thromboembolism in patients receiving anticoagulant therapy","year":2017,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Medicine; Intensive care medicine; Venous thromboembolism; Regimen; Disease; Dosing; Clinical trial; Anticoagulant; Drug; Anticoagulant therapy; Surgery; Internal medicine; Thrombosis; Pharmacology","score_opus":0.09923626495626652,"score_gpt":0.3514992289107994,"score_spread":0.25226296395453285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2612885052","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0035986088,0.9885559,7.0138276e-7,0.00012855977,0.0007898283,0.003396226,0.00003992885,0.000084760555,0.0034054627],"genre_scores_gemma":[0.0016383269,0.99642396,0.00006944824,0.00007184756,0.0005343001,0.00032526223,0.0003310333,0.0001558464,0.00044995148],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969573,0.00017004066,0.000707348,0.00088549836,0.00054963055,0.0007301666],"domain_scores_gemma":[0.99743474,0.000074446776,0.0006990424,0.0014928689,0.00009016464,0.00020874065],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032100678,0.0007868705,0.0051328805,0.00046808415,0.00018224306,0.0002305036,0.00052469125,0.0004296226,0.000036900543],"category_scores_gemma":[0.00015738876,0.0005893011,0.0007299651,0.00020289504,0.00007954076,0.00013453557,0.00020281623,0.0006596741,0.000074522555],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009260609,0.009290138,0.00066545967,0.008977933,0.00071334396,0.0001523807,0.0001492552,1.9913292e-8,2.2878027e-7,0.000045344936,0.0011885022,0.9788081],"study_design_scores_gemma":[0.004430973,0.0012775259,0.029267676,0.03230144,0.0034798041,0.000026121628,0.000012767083,3.2982373e-7,0.0000041112303,0.000025184212,0.9285534,0.000620637],"about_ca_topic_score_codex":0.000089548535,"about_ca_topic_score_gemma":0.000031518197,"teacher_disagreement_score":0.9781875,"about_ca_system_score_codex":0.0001701369,"about_ca_system_score_gemma":0.00025722675,"threshold_uncertainty_score":0.99965584},"labels":[],"label_agreement":null},{"id":"W2613272044","doi":"10.1182/blood.v128.22.3530.3530","title":"Predictors of Quality of Life, Dyspnea, and Walking Distance during 1 Year Follow-up after a First Episode of Pulmonary Embolism: Extended Results of the E.L.O.P.E. Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Jewish General Hospital; McGill University","funders":"","keywords":"Medicine; Contraindication; Quality of life (healthcare); Pulmonary embolism; Physical therapy; Observational study; Cohort; Prospective cohort study; Comorbidity; Cohort study; Pediatrics; Internal medicine","score_opus":0.01202222576615024,"score_gpt":0.24372085906123853,"score_spread":0.23169863329508827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613272044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976189,0.0004894175,0.000008580638,0.00021845175,0.00012611334,0.00077242526,0.00012580947,0.000011900156,0.0006283721],"genre_scores_gemma":[0.9993982,0.00021689749,0.00004454383,0.000013446937,0.00004993793,0.00004439358,0.0000013719151,0.000018453411,0.00021276779],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981834,0.00010406913,0.00081243366,0.0002707161,0.00044810097,0.00018126969],"domain_scores_gemma":[0.99850345,0.00015033579,0.00051157264,0.0006430936,0.00012159726,0.00006995587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048794484,0.00014468329,0.00073072343,0.0000761085,0.000033981723,0.0000024396859,0.0001599563,0.000055068424,0.000017987959],"category_scores_gemma":[0.00041653996,0.00008708899,0.00013531189,0.00016902294,0.00017831613,0.00005809328,0.00021753814,0.00006164626,4.171134e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013240546,0.004516924,0.9792434,0.0012374007,0.0005564372,0.00000807,0.0028604472,7.341032e-7,0.009461874,0.00015879757,0.00007329554,0.0005585689],"study_design_scores_gemma":[0.007816046,0.00030153425,0.97546434,0.00083776965,0.0004788878,0.0000011965953,0.00071888586,0.0000013622255,0.014197019,0.00005333642,0.00004525974,0.00008436842],"about_ca_topic_score_codex":0.00030730068,"about_ca_topic_score_gemma":0.00042527175,"teacher_disagreement_score":0.006491991,"about_ca_system_score_codex":0.000013359004,"about_ca_system_score_gemma":0.000028931,"threshold_uncertainty_score":0.3551386},"labels":[],"label_agreement":null},{"id":"W2613372458","doi":"10.1182/blood.v128.22.3079.3079","title":"Adherence to Chronic Myeloid Leukemia Monitoring and Treatment Guidelines in Canadian Registries","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Saskatchewan Cancer Agency; Université de Montréal; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Hôpital Maisonneuve-Rosemont; McMaster University","funders":"","keywords":"Medicine; Imatinib mesylate; Disease registry; Imatinib; Family medicine; Myeloid leukemia; Dasatinib; Cancer registry; Clinical trial; Cancer; Internal medicine; Disease","score_opus":0.038302530915274885,"score_gpt":0.3065045354085133,"score_spread":0.2682020044932384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613372458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935007,0.0025663443,0.0000028758416,0.0019070324,0.00011710503,0.00049346604,0.000023011513,0.000045817065,0.001343645],"genre_scores_gemma":[0.99123925,0.001465468,0.00093562447,0.00006330189,0.0004199028,0.000128342,0.00000473356,0.000026690444,0.0057166927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985949,0.000016858998,0.00029343317,0.00039231716,0.0001669634,0.0005355317],"domain_scores_gemma":[0.9988917,0.000054600536,0.000042865973,0.0003991822,0.000067797606,0.0005438144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010191796,0.00021807732,0.00030057004,0.00018079007,0.000056342033,0.000019092795,0.00008508161,0.00009368612,0.00006508248],"category_scores_gemma":[0.00022046386,0.00014574558,0.000039690985,0.00017456,0.00004743366,0.000069285394,0.000034499917,0.000055501972,0.00009488469],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000070326336,0.00009377369,0.7414263,0.0000416483,0.00015509671,0.0006351427,0.00031315343,0.0000037270256,0.020380607,0.000058806614,0.00060410216,0.23621735],"study_design_scores_gemma":[0.038460407,0.0050087287,0.6028092,0.0033680517,0.00045722738,0.0005751018,0.00019512489,0.000021037951,0.20235968,0.00007295858,0.14589003,0.00078247534],"about_ca_topic_score_codex":0.31786582,"about_ca_topic_score_gemma":0.3307095,"teacher_disagreement_score":0.23543487,"about_ca_system_score_codex":0.006824077,"about_ca_system_score_gemma":0.0033656915,"threshold_uncertainty_score":0.99698853},"labels":[],"label_agreement":null},{"id":"W2613385908","doi":"10.1182/blood.v128.22.4652.4652","title":"Fludarabine/Busulfan Plus Low Dose TBI As Reduced Intensity Conditioning in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Myeloid Malignancies","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Fludarabine; Busulfan; Internal medicine; Regimen; Total body irradiation; Myeloid leukemia; Myeloid; Transplantation; Clofarabine; Hematopoietic stem cell transplantation; Population; Gastroenterology; Oncology; Cytarabine; Surgery; Chemotherapy; Cyclophosphamide","score_opus":0.012972409280034156,"score_gpt":0.2527781063836014,"score_spread":0.23980569710356722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613385908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99616826,0.0001528554,0.00039744365,0.0010260915,0.00013782803,0.0014416246,0.00007474657,0.000091998336,0.00050916977],"genre_scores_gemma":[0.99704754,0.00012343876,0.000741892,0.0004664156,0.00011911162,0.00018113836,0.00014839262,0.000071496484,0.0011005942],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99763453,0.00007019528,0.000521068,0.00057691033,0.00044198785,0.0007553141],"domain_scores_gemma":[0.99852175,0.0003683242,0.00012948908,0.00042037887,0.00030805724,0.00025203422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003432013,0.0003013172,0.0005513682,0.0002646464,0.00014109719,0.00002925662,0.00020578525,0.00020672743,0.000116643954],"category_scores_gemma":[0.00035890378,0.00022454625,0.00016376346,0.00025064332,0.00014337397,0.00014940025,0.000070692266,0.00024282277,0.00010287703],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017521974,0.001911824,0.08897836,0.001652334,0.00025473165,0.0005334139,0.0035157932,0.00001692637,0.89878124,0.00025337233,0.0013784622,0.00097131974],"study_design_scores_gemma":[0.048820425,0.0011291906,0.13998036,0.0027245667,0.000300602,0.00026519407,0.0006158783,0.000060422986,0.8050506,0.00038112176,0.00011369012,0.00055790925],"about_ca_topic_score_codex":0.000052384243,"about_ca_topic_score_gemma":0.000047206137,"teacher_disagreement_score":0.09373063,"about_ca_system_score_codex":0.00041030126,"about_ca_system_score_gemma":0.0007310765,"threshold_uncertainty_score":0.9156731},"labels":[],"label_agreement":null},{"id":"W2613487167","doi":"10.1182/blood.v130.suppl_1.14.14","title":"Final Safety and Efficacy Data of Long-Term Open-Label Dosing of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Romiplostim; Medicine; Dosing; Adverse effect; Clinical endpoint; Placebo; Incidence (geometry); Splenectomy; Intention-to-treat analysis; Discontinuation; Surgery; Internal medicine; Pediatrics; Thrombopoietin; Clinical trial","score_opus":0.03971991722092445,"score_gpt":0.3000809287420907,"score_spread":0.26036101152116625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613487167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997747,0.0010042487,0.00001431516,0.000117830496,0.000009091682,0.00066074124,0.00015718196,0.000008992581,0.00028059364],"genre_scores_gemma":[0.99851084,0.0004601291,0.0007569724,0.000012683576,0.000008822341,0.0000024550552,0.00014810127,0.000020254107,0.00007973651],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901056,0.000024353052,0.00031544914,0.0003116207,0.00014896135,0.00018904931],"domain_scores_gemma":[0.99909824,0.00007111544,0.00014584047,0.0005961723,0.0000300884,0.000058547692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010538078,0.00015138822,0.000616287,0.000062062005,0.000031104344,0.000010807913,0.00027856362,0.000057633366,0.00003832423],"category_scores_gemma":[0.000038066508,0.00009148014,0.000014547447,0.000117676114,0.00011888294,0.00014918287,0.000301951,0.00006855338,0.000003749412],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028754661,0.005394279,0.9449462,0.000054736327,0.00076098874,0.0008863531,0.000095641066,2.6359808e-7,0.022804767,0.000020407671,0.000005595629,0.022155257],"study_design_scores_gemma":[0.048138317,0.0014998865,0.93613255,0.00081967475,0.0004971055,0.0019603122,0.0000046654086,0.0000040151276,0.010812208,0.000010878859,0.00000217214,0.00011822232],"about_ca_topic_score_codex":0.00021936218,"about_ca_topic_score_gemma":0.00010030447,"teacher_disagreement_score":0.04526285,"about_ca_system_score_codex":0.000013220041,"about_ca_system_score_gemma":0.00008360776,"threshold_uncertainty_score":0.3730452},"labels":[],"label_agreement":null},{"id":"W2613491192","doi":"10.1182/blood.v128.22.5922.5922","title":"Enhancing Appropriate Utilization of Coagulation Tests at St. Michael's Hospital","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Clinical Laboratory Practices and Quality Control","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Partial thromboplastin time; Emergency department; Coagulation testing; Prothrombin time; Bleed; Emergency medicine; Coagulation; Internal medicine; Surgery","score_opus":0.03981844542915682,"score_gpt":0.3339206112936098,"score_spread":0.294102165864453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613491192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966937,0.00017517521,0.0010120431,0.0014170397,0.00011179938,0.00026791994,0.000024408717,0.000035656944,0.00026230744],"genre_scores_gemma":[0.9987607,0.000044553108,0.00050011504,0.00014128198,0.00016272075,0.000006056532,0.000015328998,0.000012026561,0.00035719603],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99908966,0.00006164649,0.00036416206,0.0001753691,0.0001932202,0.00011594904],"domain_scores_gemma":[0.99887997,0.00036883724,0.0002558397,0.0002232726,0.00019750722,0.00007459264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036888095,0.00007637608,0.0002149558,0.000030025176,0.0000310024,0.0000048269694,0.000036051442,0.000083908475,0.00017658333],"category_scores_gemma":[0.0011331216,0.000050430484,0.000057000318,0.000097891956,0.00003751579,0.00011740065,0.000028825232,0.000047716636,0.000037683225],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003353752,0.0014190507,0.17655598,0.00014632447,0.000160251,0.000010324573,0.000269475,5.342925e-7,0.80700934,0.0012306765,0.000096680276,0.012766015],"study_design_scores_gemma":[0.021218555,0.0019876093,0.49380866,0.00066419615,0.0010848847,0.000015773037,0.00016105945,0.00014257785,0.4673558,0.00072673033,0.012467875,0.0003662915],"about_ca_topic_score_codex":0.000012237993,"about_ca_topic_score_gemma":0.000045657813,"teacher_disagreement_score":0.33965352,"about_ca_system_score_codex":0.000018866915,"about_ca_system_score_gemma":0.00005098271,"threshold_uncertainty_score":0.20564955},"labels":[],"label_agreement":null},{"id":"W2613537197","doi":"10.1182/blood.v128.22.5253.5253","title":"RUNX1 Mutation in Cytogenetically Normal Acute Myeloid Leukemia : Clinical Implications, Co-Mutation Analysis","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"CEBPA; NPM1; Neuroblastoma RAS viral oncogene homolog; RUNX1; Myeloid leukemia; Mutation; Leukemia; Biology; Myeloid; Oncology; Medicine; Cancer research; Internal medicine; Genetics; Karyotype; Gene; Haematopoiesis; Chromosome; Stem cell; KRAS","score_opus":0.02836690807924474,"score_gpt":0.36383829173010257,"score_spread":0.3354713836508578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613537197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98649114,0.000077086544,0.006479202,0.0043650297,0.000033028853,0.00056911877,0.00006346781,0.000090163034,0.0018317801],"genre_scores_gemma":[0.99333787,0.00031659508,0.004593872,0.00044496093,0.00022709974,0.00012355772,0.00026539687,0.000034654815,0.00065599504],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973319,0.0002195351,0.00089595607,0.0005787,0.00047737974,0.00049648574],"domain_scores_gemma":[0.99810046,0.00047746536,0.00016663231,0.000653137,0.00028445615,0.0003178498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095126824,0.00019928976,0.0005091918,0.0006129619,0.000078559584,0.000030509016,0.00022987968,0.00027299186,0.00022373727],"category_scores_gemma":[0.00057837635,0.00014899383,0.00026972333,0.0012445013,0.00018671408,0.00016861607,0.00007326528,0.00032773826,0.00042545956],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048384635,0.00067518407,0.89247286,0.000029565212,0.0021429304,0.0004503595,0.00015030353,0.000029445097,0.047987234,0.0006216945,0.00080927345,0.054147303],"study_design_scores_gemma":[0.008442367,0.00043794198,0.9725473,0.00003350132,0.0020289007,0.00020716869,0.000036129073,0.00045440343,0.014768932,0.00027216066,0.00056145893,0.00020975553],"about_ca_topic_score_codex":0.00007679455,"about_ca_topic_score_gemma":0.000100289755,"teacher_disagreement_score":0.08007442,"about_ca_system_score_codex":0.00047629,"about_ca_system_score_gemma":0.00095010275,"threshold_uncertainty_score":0.6075792},"labels":[],"label_agreement":null},{"id":"W2614321241","doi":"10.1182/blood.v128.22.5010.5010","title":"Rationale and Design of a Phase III Safety Trial of Idarucizumab in Children Receiving Dabigatran Etexilate for the Treatment and Secondary Prevention of Venous Thromboembolism","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Dabigatran; Idarucizumab; Direct thrombin inhibitor; Clinical trial; Intensive care medicine; Antithrombins; Adverse effect; Surgery; Internal medicine; Warfarin; Heparin","score_opus":0.03190393013967593,"score_gpt":0.29252931394305715,"score_spread":0.26062538380338124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2614321241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917947,0.00056743826,0.0050161527,0.00014277219,0.000034119657,0.0023506822,0.000058415084,0.0000058775595,0.000029828698],"genre_scores_gemma":[0.9977738,0.00065173313,0.0014150107,0.000008537545,0.000038134865,0.00005995752,0.000012657267,0.000009637516,0.000030520518],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.999248,0.00006332266,0.00037357054,0.00013877523,0.00009450343,0.00008180163],"domain_scores_gemma":[0.99937516,0.00021261425,0.00019472181,0.00014236127,0.000045628294,0.00002950401],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032954948,0.0000866291,0.00038789632,0.000063459906,0.000034525918,0.000002501882,0.000030772448,0.000057527675,0.000025811652],"category_scores_gemma":[0.000037442678,0.00005196717,0.000061233826,0.000059770464,0.00006727013,0.00005056332,0.000009186422,0.00002816001,7.76983e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025547767,0.011040673,0.0011366643,0.00019481545,0.0015800112,8.786232e-7,0.0035197232,0.000009273926,0.61823034,0.0030723512,0.0000065068416,0.335661],"study_design_scores_gemma":[0.5163452,0.014369114,0.05847155,0.000516963,0.0016137047,0.00003846402,0.00012890839,0.0001843848,0.40374845,0.004421013,0.000026754798,0.0001355048],"about_ca_topic_score_codex":0.000019257139,"about_ca_topic_score_gemma":0.000010348275,"teacher_disagreement_score":0.49079743,"about_ca_system_score_codex":0.000010462912,"about_ca_system_score_gemma":0.00010070747,"threshold_uncertainty_score":0.21191597},"labels":[],"label_agreement":null},{"id":"W2614343481","doi":"10.1182/blood.v128.22.1166.1166","title":"Feasibility of Allogeneic Hematopoietic Cell Transplantation Among High-Risk AML Patients in First Complete Remission: Results of the Transplant Objective from the SWOG (S1203) Randomized Phase III Study of Induction Therapy Using Standard 7+3 Therapy or Idarubicin with High-Dose Cytarabine (IA) Versus IA Plus Vorinostat","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Medicine; Cytarabine; Transplantation; Internal medicine; Idarubicin; Oncology; Hazard ratio; Hematopoietic stem cell transplantation; Leukemia; Surgery; Confidence interval","score_opus":0.03813434342249572,"score_gpt":0.30598481845754855,"score_spread":0.2678504750350528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2614343481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918254,0.00013555388,0.00019315057,0.00012846547,0.00013505184,0.006328232,0.0012257677,0.000018917577,0.000009446789],"genre_scores_gemma":[0.9979635,0.0015167047,0.0002491571,0.000008921163,0.00004906044,0.00007364869,0.00008772335,0.000042803596,0.0000084938065],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9952454,0.00147302,0.0012199495,0.0005802072,0.0011560584,0.0003253585],"domain_scores_gemma":[0.99577326,0.0018524991,0.0009386748,0.0008730372,0.0004629716,0.00009957276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013702097,0.00036215392,0.0013154662,0.00014693971,0.00015506415,0.000009108327,0.0003420421,0.00015083555,0.00003838631],"category_scores_gemma":[0.00018931707,0.00015434828,0.00017564248,0.00057177496,0.0005496735,0.00013108565,0.00003078619,0.00038307207,3.163404e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.78043514,0.0036503735,0.14614497,0.000086204454,0.0006979948,0.000027864644,0.018698195,0.0001366661,0.049435224,0.0000013848072,0.000004379515,0.0006815607],"study_design_scores_gemma":[0.5434577,0.0043080044,0.30031583,0.0005252944,0.0005491388,0.0000037166024,0.00091714936,0.000036326786,0.14974745,0.000016148935,7.605118e-7,0.00012249911],"about_ca_topic_score_codex":0.015529117,"about_ca_topic_score_gemma":0.0028670176,"teacher_disagreement_score":0.2369775,"about_ca_system_score_codex":0.00026609303,"about_ca_system_score_gemma":0.00051443756,"threshold_uncertainty_score":0.9910266},"labels":[],"label_agreement":null},{"id":"W2614562262","doi":"10.1182/blood.v128.22.1211.1211","title":"Prognostic Significance of 11q23/MLL Fusion Partners in Children with Acute Myeloid Leukemia (AML) - Results from the Children's Oncology Group (COG) Trial AAML0531","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Internal medicine; Medicine; Monosomy; Oncology; Gemtuzumab ozogamicin; Myeloid leukemia; Leukemia; Pediatrics; Biology; Chromosome; Genetics; CD33","score_opus":0.017554334581264014,"score_gpt":0.28630986131914776,"score_spread":0.2687555267378837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2614562262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99106836,0.00020156727,0.00005574624,0.0025022316,0.00008180278,0.0044744047,0.00041365257,0.00008872959,0.0011135088],"genre_scores_gemma":[0.99633867,0.0004036529,0.0010920772,0.00027343884,0.000804317,0.0003318914,0.00032962876,0.00007225059,0.00035410264],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963002,0.00035287626,0.00084462034,0.0008966152,0.0008276844,0.0007779663],"domain_scores_gemma":[0.9966589,0.0014502706,0.00041428456,0.0010606373,0.0001571299,0.00025875977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094076176,0.00039032038,0.0008024917,0.00018381249,0.0001095801,0.000021516616,0.0006280313,0.00035477756,0.00007029349],"category_scores_gemma":[0.0011002376,0.00020270706,0.00014749457,0.0006390863,0.00061184686,0.00014559424,0.00023974015,0.0007237498,0.00006137484],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19639882,0.0039762068,0.61277497,0.000035937755,0.0038947598,0.00076763367,0.0015735059,0.000009509156,0.12544408,0.00018945544,0.007223323,0.047711782],"study_design_scores_gemma":[0.25540257,0.0061380905,0.7144946,0.00043249657,0.0012028991,0.00025109647,0.0000810014,0.000013783182,0.020668091,0.0000997634,0.000832094,0.0003835568],"about_ca_topic_score_codex":0.0024659773,"about_ca_topic_score_gemma":0.00048396923,"teacher_disagreement_score":0.104775995,"about_ca_system_score_codex":0.0004808724,"about_ca_system_score_gemma":0.0017868557,"threshold_uncertainty_score":0.8266154},"labels":[],"label_agreement":null},{"id":"W2614976199","doi":"10.1182/blood-2017-02-769240","title":"CD34+ megakaryocytes and megakaryocytic fragments in myelodysplastic syndrome","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Megakaryocyte; Peripheral blood; CD34; Platelet; Hemoglobin; Medicine; Myelodysplastic syndromes; Immunology; Internal medicine; Haematopoiesis; Biology; Bone marrow; Stem cell; Cell biology","score_opus":0.015114092523464198,"score_gpt":0.2720122154795686,"score_spread":0.2568981229561044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2614976199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99329245,0.0009171837,0.0000027272263,0.0010002065,0.00009415447,0.0004886652,0.000011774968,0.00003176502,0.0041610687],"genre_scores_gemma":[0.99801755,0.00040805864,0.00070729817,0.00016761175,0.00005650169,0.00012375905,0.000012656951,0.000024728015,0.00048185812],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987777,0.000027216984,0.00025100802,0.0003914197,0.0002393606,0.00031329584],"domain_scores_gemma":[0.99885654,0.00012220306,0.000105432744,0.00068321853,0.000037102356,0.0001955111],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011713422,0.00022659171,0.00044988963,0.00012200759,0.00023298078,0.00009324502,0.00015806308,0.00009393283,0.000092699716],"category_scores_gemma":[0.00034260683,0.00018091984,0.00005613372,0.000051213057,0.00011052055,0.00015602664,0.00015971961,0.00016051662,0.000083242296],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000085402855,0.0011805372,0.99416196,0.00010576758,0.00024810588,0.0023924385,0.00014972135,0.0000012594336,0.00032815532,0.00045055497,0.00009548832,0.00080058957],"study_design_scores_gemma":[0.009280105,0.0006275604,0.9842259,0.00038253155,0.000315004,0.00077006477,0.000030402416,0.000071447466,0.0035202303,0.00037392328,0.00023026684,0.00017253008],"about_ca_topic_score_codex":0.00011367748,"about_ca_topic_score_gemma":0.00007913309,"teacher_disagreement_score":0.009936045,"about_ca_system_score_codex":0.00004930084,"about_ca_system_score_gemma":0.00007380955,"threshold_uncertainty_score":0.73776966},"labels":[],"label_agreement":null},{"id":"W2615427609","doi":"10.1182/blood.v128.22.5177.5177","title":"Evaluation of Mortality during Treatement of Acute Myeloid Leukemia in Patients According to Morocco National AML-MA-2011 Protocol in Casablanca","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; McMaster Children's Hospital","funders":"","keywords":"Medicine; Mortality rate; Protocol (science); Pediatrics; Emergency medicine; Intensive care medicine; Internal medicine; Alternative medicine","score_opus":0.040404110734306525,"score_gpt":0.3534445816708796,"score_spread":0.31304047093657306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2615427609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98126984,0.000001645603,0.000003119519,0.000030886258,0.00002897668,0.01707219,0.000028096652,0.000007749854,0.0015574988],"genre_scores_gemma":[0.9806675,0.0000014739121,0.000039715207,0.000013242512,0.000032366246,0.019188302,0.000005321765,0.000008677163,0.000043412805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986067,0.000059985046,0.00038907185,0.0001766328,0.0006369482,0.00013065456],"domain_scores_gemma":[0.9992839,0.000014440817,0.00012587215,0.000149395,0.0003833169,0.00004307437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047187952,0.000084839936,0.00020563757,0.00019892104,0.000015917149,0.0000023894925,0.00004858896,0.00003856352,0.0001306451],"category_scores_gemma":[0.000064371445,0.00006426683,0.000040300132,0.00018644524,0.00001568743,0.00010149348,0.000032523152,0.000047950416,0.0000084018375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019181387,0.0005030114,0.93995655,0.00006957715,0.00009893318,0.000001844603,0.000103422644,0.000046867735,0.05778065,0.000013452339,0.00001474802,0.0012191279],"study_design_scores_gemma":[0.011541461,0.0002307023,0.8220201,0.00023268806,0.00015295338,0.0000016374609,0.000018246834,0.000008289043,0.16568145,0.00004674522,0.000010318517,0.00005538306],"about_ca_topic_score_codex":0.00038411596,"about_ca_topic_score_gemma":0.00026639397,"teacher_disagreement_score":0.11793642,"about_ca_system_score_codex":0.0007068127,"about_ca_system_score_gemma":0.00040762383,"threshold_uncertainty_score":0.26207253},"labels":[],"label_agreement":null},{"id":"W2615766380","doi":"10.1182/blood.v128.22.1148.1148","title":"First in Human Study with GSK2857916, an Antibody Drug Conjugated to Microtubule-Disrupting Agent Directed Against B-Cell Maturation Antigen (BCMA) in Patients with Relapsed/Refractory Multiple Myeloma (MM): Results from Study BMA117159 Part 1 Dose Escalation","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Multiple myeloma; Antibody; Pharmacology; Immunology; Pharmacokinetics; Plasma cell; Transplantation; Cancer research; Internal medicine; Oncology","score_opus":0.01609402546199887,"score_gpt":0.2762876653695559,"score_spread":0.260193639907557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2615766380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919158,0.00002352849,0.000005439395,0.00006975754,0.000054588036,0.007365783,0.0002853569,0.00017320621,0.00010649794],"genre_scores_gemma":[0.9970195,0.000009926769,0.00053565943,0.000026037114,0.00007967481,0.00026064427,0.0018576379,0.00009113308,0.00011973385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99579865,0.00051495736,0.0009093335,0.0011666452,0.0009241428,0.0006862995],"domain_scores_gemma":[0.99779516,0.00026786028,0.0003230996,0.0008854329,0.00030821134,0.00042020995],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00050682924,0.0004943733,0.00065609906,0.00051292137,0.0002540987,0.0000869462,0.00020708678,0.00011739793,0.000025508314],"category_scores_gemma":[0.0002960553,0.00032245892,0.000045415738,0.00069594523,0.000059673206,0.00043707475,0.00010631225,0.0003160447,0.00003844773],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013968185,0.0357084,0.92079693,0.000025251436,0.00027043239,0.00063836336,0.005105618,0.000031251115,0.022164848,8.1969326e-8,0.000022523105,0.0012681232],"study_design_scores_gemma":[0.11656972,0.0070379404,0.8691085,0.00068763265,0.000112444286,0.0000010780543,0.0013487078,0.0001426659,0.004585425,5.523949e-7,0.000033848515,0.00037151377],"about_ca_topic_score_codex":0.0029668303,"about_ca_topic_score_gemma":0.019355057,"teacher_disagreement_score":0.102601536,"about_ca_system_score_codex":0.00027827965,"about_ca_system_score_gemma":0.00011131629,"threshold_uncertainty_score":0.99992275},"labels":[],"label_agreement":null},{"id":"W2616327563","doi":"10.1182/blood.v128.22.2336.2336","title":"Low Dose Secondary/Tertiary Prophylaxis Is Feasible and Effective in Resource Limited Setting in South India for Children with Hemophilia","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Cryoprecipitate; Clotting factor; Pediatrics; Population; Factor IX; Hemarthrosis; Surgery; Internal medicine; Environmental health","score_opus":0.007759148569807648,"score_gpt":0.24479059748195547,"score_spread":0.23703144891214784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2616327563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957467,0.00025379134,0.00000311201,0.0010221956,0.000007630978,0.0026412036,0.000053387488,0.000031661195,0.00024033639],"genre_scores_gemma":[0.9985877,0.000011970754,0.0003650571,0.00017716661,0.000085210966,0.00024625123,0.00002662937,0.000036514,0.00046344497],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986556,0.000076580516,0.00019548395,0.00044297246,0.00020278196,0.00042655226],"domain_scores_gemma":[0.9993248,0.00019920703,0.000049154973,0.0002382254,0.000042567597,0.00014602668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030376957,0.00019297889,0.00030696782,0.000340371,0.00005834988,0.000018622864,0.000068785346,0.00014059168,0.00002263775],"category_scores_gemma":[0.00013690037,0.00011046669,0.000046967416,0.00031430833,0.00010199004,0.00008353973,0.000055767272,0.00023063787,0.000009547465],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006958973,0.0006022228,0.9523385,0.00018004852,0.00013249174,0.00010394209,0.001886303,7.5276816e-8,0.004388675,0.0000027333351,0.000048489255,0.0396206],"study_design_scores_gemma":[0.022452425,0.0016997018,0.92353505,0.0006881742,0.00005612796,0.000058293503,0.00009960148,0.0000049219557,0.051169865,0.00005528898,0.000027172024,0.00015336218],"about_ca_topic_score_codex":0.000016007758,"about_ca_topic_score_gemma":0.000017514749,"teacher_disagreement_score":0.04678119,"about_ca_system_score_codex":0.000057767265,"about_ca_system_score_gemma":0.000120242774,"threshold_uncertainty_score":0.4504701},"labels":[],"label_agreement":null},{"id":"W2616394381","doi":"10.1182/blood.v128.22.977.977","title":"Selinexor in Combination with Bortezomib and Dexamethasone (SdB) Demonstrates Significant Activity in Patients with Refractory Multiple Myeloma (MM) Including Proteasome-Inhibitor Refractory Patients: Results of the Phase I Stomp Trial","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec; Queen Elizabeth II Health Sciences Centre; Hôpital Maisonneuve-Rosemont; CancerCare Manitoba; Ottawa Hospital; Juravinski Cancer Centre; Institute of Cancer Research; University of Manitoba; Princess Margaret Cancer Centre; University of Calgary; Vancouver General Hospital; Memorial University of Newfoundland; McGill University Health Centre","funders":"","keywords":"Bortezomib; Tolerability; Refractory (planetary science); Medicine; Dexamethasone; Proteasome inhibitor; Internal medicine; Phases of clinical research; Pharmacology; Multiple myeloma; Oncology; Clinical trial; Gastroenterology; Adverse effect; Biology","score_opus":0.008298695547919364,"score_gpt":0.2210101915872341,"score_spread":0.21271149603931472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2616394381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987394,0.000021924772,0.0000338069,0.000034300378,0.000071875285,0.0010005257,0.000070180635,0.0000067185315,0.000021250527],"genre_scores_gemma":[0.9995955,0.000011689496,0.00022319231,0.000011289442,0.000057050314,0.000032702897,0.000037634294,0.00001991418,0.000011014791],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988594,0.00016343419,0.00026431406,0.00034629845,0.00019933391,0.00016724349],"domain_scores_gemma":[0.9992116,0.00005788386,0.00029607958,0.0002605777,0.00013055946,0.00004327807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020212974,0.00015881809,0.00018351652,0.00006767898,0.000051128754,0.000010241668,0.00008568382,0.00013733795,0.0000012333355],"category_scores_gemma":[0.00030663938,0.00008867926,0.000025804991,0.0001340072,0.00011024651,0.000026748046,0.00005500422,0.0001253174,1.7820926e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05756059,0.0036809936,0.38317543,0.0000250215,0.00005482187,0.0000013792385,0.00010067243,0.0000017082594,0.5334546,0.0000015282163,0.000021145046,0.021922102],"study_design_scores_gemma":[0.17464417,0.0065925308,0.6030793,0.00013126984,0.000035667592,6.164147e-7,0.000037724116,0.000008961591,0.21500105,0.000007919507,0.00025924694,0.0002015231],"about_ca_topic_score_codex":0.000043340024,"about_ca_topic_score_gemma":0.00017107917,"teacher_disagreement_score":0.31845355,"about_ca_system_score_codex":0.000029843064,"about_ca_system_score_gemma":0.000074908305,"threshold_uncertainty_score":0.36162353},"labels":[],"label_agreement":null},{"id":"W2616563766","doi":"10.1182/blood.v108.11.2043.2043","title":"Association between Drug-Metabolizing Enzymes Polymorphisms and Diffuse Large B-Cell Lymphoma Risk in the Middle Eastern Population.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Carcinogens and Genotoxicity Assessment","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"GSTP1; Genotype; Population; Odds ratio; Lymphoma; Biology; Internal medicine; Diffuse large B-cell lymphoma; Oncology; Allele; Genetics; Medicine; Immunology; Gene; Environmental health","score_opus":0.00726355781705448,"score_gpt":0.206945024383115,"score_spread":0.1996814665660605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2616563766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99624425,0.0029861743,0.000069219685,0.000096269156,0.00003276663,0.00015195437,0.00009954213,0.0000065910426,0.00031320265],"genre_scores_gemma":[0.99859256,0.00010853625,0.00012901398,0.00009334386,0.00033362425,0.000014027835,0.00020083327,0.000012403286,0.0005156366],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991038,0.000119686985,0.00018037367,0.00021995843,0.00015458174,0.00022160294],"domain_scores_gemma":[0.999616,0.000025666639,0.00012445431,0.00018714672,0.000020418303,0.000026270354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003085124,0.00011377556,0.00012131894,0.000037275076,0.00011005424,0.000051457147,0.00009637797,0.00009514334,0.000002322406],"category_scores_gemma":[0.000016797218,0.00009490232,0.000059947903,0.00007555831,0.000009813036,0.0000045368292,0.00006168762,0.00005204506,0.0000027936912],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000470282,0.0007404924,0.98189616,0.000006620534,0.00003322796,0.000001887128,0.00011202301,0.0000024422895,0.016701916,0.000047293852,0.0001435794,0.00030965006],"study_design_scores_gemma":[0.0044251913,0.000032867072,0.9441032,0.000005295681,0.0001295332,0.0000026192165,0.0001434361,0.000019649116,0.048243985,0.00010072644,0.0026507261,0.00014280407],"about_ca_topic_score_codex":0.001184807,"about_ca_topic_score_gemma":0.0010122301,"teacher_disagreement_score":0.037792996,"about_ca_system_score_codex":0.000013706807,"about_ca_system_score_gemma":0.00001355743,"threshold_uncertainty_score":0.38700044},"labels":[],"label_agreement":null},{"id":"W2617118699","doi":"10.1182/blood.v128.22.3595.3595","title":"Predictors for ICU Admission and Clinical Outcomes of Malignant Hematology Patients Admitted to Critical Care Units","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Intensive care unit; Comorbidity; Retrospective cohort study; Emergency medicine; Intensive care; Internal medicine; Intensive care medicine","score_opus":0.11667727181762319,"score_gpt":0.44215330477366466,"score_spread":0.32547603295604144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617118699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99802583,0.00049694185,0.00014834061,0.0006026927,0.00015164755,0.00032300578,0.0001518144,0.000017125521,0.00008261548],"genre_scores_gemma":[0.9981052,0.00008890456,0.0014947652,0.000161957,0.000041493113,0.000013670909,0.000017910384,0.000012014475,0.00006408013],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99907315,0.00004440931,0.00039198497,0.0001913914,0.00013988059,0.00015920888],"domain_scores_gemma":[0.9981137,0.00089726754,0.000063268686,0.00016145637,0.00052306394,0.00024126004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008387127,0.00009868055,0.00046218486,0.000062038904,0.000017151166,0.0000011942931,0.00005182696,0.000118532655,0.000018239878],"category_scores_gemma":[0.0062435144,0.000056761954,0.00007394053,0.00007211771,0.00009234634,0.000023207123,0.000046849484,0.000038449456,0.0000021593114],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018706715,0.0002820218,0.99604946,0.00022288044,0.00010217864,0.000005642713,0.0005127272,3.7961163e-9,0.00032522142,0.00022500633,0.00030999503,0.0017777967],"study_design_scores_gemma":[0.007130146,0.0028736088,0.94736534,0.0013451491,0.00048136312,0.0000035448845,0.0005789159,6.761686e-7,0.03574741,0.0000457451,0.004325399,0.00010270566],"about_ca_topic_score_codex":0.000007649042,"about_ca_topic_score_gemma":0.00000533784,"teacher_disagreement_score":0.04868412,"about_ca_system_score_codex":0.000007076186,"about_ca_system_score_gemma":0.00007577621,"threshold_uncertainty_score":0.7474521},"labels":[],"label_agreement":null},{"id":"W2617129843","doi":"10.1182/blood.v128.22.1451.1451","title":"Efficacy and Safety of Direct Oral Anticoagulants: A Systematic Review of Population Based Studies","year":2016,"lang":"en","type":"review","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Apixaban; Dabigatran; Rivaroxaban; Stroke (engine); Context (archaeology); Internal medicine; Edoxaban; Population; Observational study; Intensive care medicine; Bleed; Atrial fibrillation; Surgery; Warfarin","score_opus":0.12509875811954235,"score_gpt":0.4144722928941167,"score_spread":0.28937353477457434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617129843","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000025149551,0.99645203,0.00000590665,0.00005792025,0.000061344144,0.0032086282,0.000026590364,0.00002187689,0.0001405362],"genre_scores_gemma":[0.00017281258,0.99926674,0.00015197766,0.000021726297,0.00008284367,0.000009365393,0.00008158654,0.000020328427,0.00019264409],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9979503,0.00025404335,0.0012589394,0.00018494825,0.00025838218,0.000093352966],"domain_scores_gemma":[0.9977786,0.0007083241,0.0010346824,0.00034011228,0.00010463586,0.000033660115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006788197,0.000221905,0.0049095633,0.00016035694,0.000019384559,0.0000027005628,0.000056176632,0.00007668696,0.000018295208],"category_scores_gemma":[0.0017773566,0.0001196161,0.00039810117,0.00020993654,0.000031101783,0.000027790866,0.00004379803,0.000040389354,0.000005156529],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012827159,0.00001796881,0.00053144165,0.9844169,0.0013559293,0.000002189466,0.000004409244,1.22025465e-8,2.5338835e-7,0.000051132876,0.000021528123,0.013585428],"study_design_scores_gemma":[0.0014035751,0.000078197925,0.00039859247,0.9573484,0.02649757,0.0000059839276,0.0000026493494,3.930342e-7,0.0000011723788,0.0000023676469,0.014150908,0.00011020115],"about_ca_topic_score_codex":0.0000033312301,"about_ca_topic_score_gemma":3.907716e-7,"teacher_disagreement_score":0.027068492,"about_ca_system_score_codex":0.000019738694,"about_ca_system_score_gemma":0.000040110113,"threshold_uncertainty_score":0.4877803},"labels":[],"label_agreement":null},{"id":"W2617533125","doi":"10.1182/blood.v128.22.1572.1572","title":"Inhibition of the Mitochondrial Protein Import Machinery Is Selectively Cytotoxic to Acute Myeloid Leukemia (AML) Cells and Stem Cells","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Biology; DNAJA3; Inner mitochondrial membrane; Gene knockdown; Cell biology; Myeloid leukemia; Small hairpin RNA; Mitochondrion; Stem cell; Mitochondrial apoptosis-induced channel; mitochondrial fusion; Molecular biology; Cancer research; Mitochondrial DNA; Apoptosis; Gene; Biochemistry","score_opus":0.006321740971295182,"score_gpt":0.2054539835372621,"score_spread":0.19913224256596693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617533125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99693024,0.000046156405,0.001308643,0.00017504764,0.00041677477,0.000653823,0.0001716846,0.000011357093,0.0002862954],"genre_scores_gemma":[0.9915021,0.000049604016,0.001039314,0.0005112744,0.00050676207,0.000081331535,0.000008393961,0.000028429142,0.0062727667],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99892974,0.00010267721,0.00024200103,0.00039595013,0.00012487143,0.0002047502],"domain_scores_gemma":[0.9993762,0.000011077874,0.00012598553,0.00032476077,0.00007278637,0.00008922201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008812206,0.00016584824,0.00016931523,0.00004207009,0.00006900586,0.000011225549,0.00011922348,0.00020408754,0.000034190994],"category_scores_gemma":[0.000016758062,0.00010439987,0.00009862487,0.0001029176,0.00007186086,0.000005011032,0.00013659499,0.00007837018,0.000019106295],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019601507,0.000055220706,0.00031313705,0.000012176598,0.000056967016,0.0000031035502,0.00006860366,8.3739803e-7,0.9967268,0.000015557505,0.00207113,0.0004804219],"study_design_scores_gemma":[0.0015931895,0.0004530659,0.00025111498,0.000028671782,0.00005322526,0.000033303888,0.0000109762,6.447272e-7,0.99096686,0.000047245197,0.0064121727,0.000149546],"about_ca_topic_score_codex":0.00001428018,"about_ca_topic_score_gemma":0.00002036672,"teacher_disagreement_score":0.005986471,"about_ca_system_score_codex":0.000016113057,"about_ca_system_score_gemma":0.00012529398,"threshold_uncertainty_score":0.42573032},"labels":[],"label_agreement":null},{"id":"W2617553448","doi":"10.1182/blood.v128.22.1534.1534","title":"The miRNA-193 Family Is a Potent Tumor-Suppressor and a Biomarker for Poor Prognosis in Acute Myeloid Leukemia","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Terry Fox Research Institute","funders":"","keywords":"Ectopic expression; Cancer research; Biology; Myeloid leukemia; microRNA; Gene knockdown; Progenitor cell; Haematopoiesis; Leukemia; Myeloid; STAT5; Stem cell; Cyclin-dependent kinase 6; Immunology; Cell cycle; Signal transduction; Cell culture; Cell; Cyclin-dependent kinase; Cell biology; Genetics; Gene","score_opus":0.009404863809061966,"score_gpt":0.23398834057507226,"score_spread":0.2245834767660103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617553448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962257,0.0019493528,0.00015829608,0.0008811382,0.00004085563,0.00055751967,0.00012106299,0.000008573123,0.00005750522],"genre_scores_gemma":[0.99843365,0.000228263,0.00049333094,0.00022455658,0.000061025738,0.0002605104,0.000020194015,0.000021291604,0.0002571491],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991842,0.000032345622,0.0001689428,0.00029924637,0.00008200613,0.00023325677],"domain_scores_gemma":[0.9995864,0.000025207884,0.000067842615,0.00020618492,0.000053074673,0.0000612986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013180665,0.00012396228,0.00009678562,0.000025846686,0.00007389523,0.000030101937,0.0001320817,0.00008263203,0.000002629113],"category_scores_gemma":[0.000057139423,0.00007544004,0.000073142546,0.0000466648,0.00007680286,0.0000043168743,0.00008974545,0.000022353695,0.0000030267374],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015566393,0.00006310013,0.003465792,0.00001625985,0.0001295063,0.0000036402228,0.00001490312,9.487745e-8,0.98907465,0.000013342961,0.0024798515,0.0045831804],"study_design_scores_gemma":[0.0027583765,0.00012695935,0.09645422,0.000040913274,0.000100276964,0.000025604772,0.000016713884,0.000033383065,0.8845009,0.00013097636,0.015650084,0.00016154665],"about_ca_topic_score_codex":0.000009144028,"about_ca_topic_score_gemma":0.000012335196,"teacher_disagreement_score":0.10457372,"about_ca_system_score_codex":0.00001799411,"about_ca_system_score_gemma":0.00007449647,"threshold_uncertainty_score":0.30763555},"labels":[],"label_agreement":null},{"id":"W2617796537","doi":"10.1182/blood.v128.22.5032.5032","title":"Blood Donation May Not Reduce Risk of Testosterone-Induced Polycythemia","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Victoria Hospital; Western University; London Health Sciences Centre; Canadian Blood Services; University of Toronto","funders":"","keywords":"Medicine; Hematocrit; Phlebotomy; Hemoglobin; Donation; Adverse effect; Blood donor; Internal medicine; Surgery; Immunology","score_opus":0.013523585546752061,"score_gpt":0.24791042570574373,"score_spread":0.23438684015899167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617796537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909828,0.000245939,0.000016466965,0.0035790843,0.00013393912,0.00025323636,0.000022605744,0.00006884492,0.0046971394],"genre_scores_gemma":[0.9976496,0.00029584512,0.0003707425,0.000108012755,0.0001389882,0.000009600239,0.000005472491,0.000027103351,0.0013946212],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99892086,0.000041518935,0.0003064483,0.00023896767,0.0002582949,0.00023389597],"domain_scores_gemma":[0.9991836,0.00008288084,0.00017015469,0.00035499287,0.00008994524,0.00011842948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017576393,0.0001421084,0.00024781894,0.000100894686,0.00004934239,0.0000047137046,0.00008676787,0.00019603055,0.000107696105],"category_scores_gemma":[0.00029484872,0.000088120396,0.000103274506,0.00016622356,0.00006524937,0.00005782482,0.00003342666,0.00015156461,0.00006492196],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012310634,0.00088111096,0.019327538,0.000049399074,0.0002695636,0.000027248483,0.00019975264,1.9444182e-7,0.9644994,0.00012663701,0.00025073663,0.014245295],"study_design_scores_gemma":[0.010708095,0.0006824978,0.030230341,0.0003229551,0.0010409309,0.00016703714,0.00010872357,0.0000029984017,0.955362,0.000076365955,0.0011348526,0.00016316661],"about_ca_topic_score_codex":0.000075932796,"about_ca_topic_score_gemma":0.0000029971247,"teacher_disagreement_score":0.014082128,"about_ca_system_score_codex":0.000014975962,"about_ca_system_score_gemma":0.00009320291,"threshold_uncertainty_score":0.35934454},"labels":[],"label_agreement":null},{"id":"W2617810686","doi":"10.1182/blood-2017-03-771220","title":"A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":122,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Ixazomib; AL amyloidosis; Medicine; Tolerability; Internal medicine; Adverse effect; Nausea; Gastroenterology; Refractory (planetary science); Bortezomib; Amyloidosis; Surgery; Multiple myeloma; Immunology; Carfilzomib; Immunoglobulin light chain; Antibody","score_opus":0.023053167134366278,"score_gpt":0.31488483824743213,"score_spread":0.29183167111306585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617810686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99780715,0.00019133916,7.4237454e-7,0.0003696,0.00017249653,0.001239857,0.000036788635,0.000011729325,0.00017031033],"genre_scores_gemma":[0.99866796,0.00005830711,0.00010778139,0.00016784093,0.000104089806,0.00038320295,0.000009469269,0.000035277244,0.0004660799],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985262,0.00015369176,0.00035888588,0.0004523188,0.00022791661,0.0002809484],"domain_scores_gemma":[0.9981286,0.000025773506,0.0003720483,0.001343321,0.000057070753,0.0000731876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002104612,0.00023972041,0.00031831473,0.00005148001,0.0001999847,0.00004058375,0.00061970635,0.0001530658,0.000026897134],"category_scores_gemma":[0.00051738764,0.00015793415,0.00013565569,0.00007984267,0.00013532686,0.0000097248885,0.00037526555,0.00015089355,0.0000068938066],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007872269,0.026601613,0.6794851,0.000027743145,0.0004374199,0.000048997914,0.000449062,0.0000025600955,0.28847188,0.0000050887165,0.0011907265,0.0024925875],"study_design_scores_gemma":[0.04567537,0.006233681,0.29049063,0.0000870637,0.00030420965,0.00001264619,0.0006315869,0.0000042869883,0.6524394,0.000011458922,0.003710436,0.00039919707],"about_ca_topic_score_codex":0.00025851463,"about_ca_topic_score_gemma":0.0008302009,"teacher_disagreement_score":0.38899446,"about_ca_system_score_codex":0.000024385696,"about_ca_system_score_gemma":0.00012099583,"threshold_uncertainty_score":0.64403677},"labels":[],"label_agreement":null},{"id":"W2618144711","doi":"10.1182/blood.v128.22.402.402","title":"Effects of AG-348, a Pyruvate Kinase Activator, on Anemia and Hemolysis in Patients with Pyruvate Kinase Deficiency: Data from the DRIVE PK Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pyruvate kinase deficiency; Pyruvate kinase; Medicine; Adverse effect; Internal medicine; Hemolysis; Anemia; Endocrinology; Gastroenterology; Glycolysis; Metabolism","score_opus":0.011642946930585579,"score_gpt":0.23199903702725594,"score_spread":0.22035609009667037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2618144711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998623,0.00012393479,0.000008089621,0.00014693935,0.000079464306,0.00083433,0.00009159926,0.000025516392,0.00006709061],"genre_scores_gemma":[0.9994014,0.000035733778,0.00005628676,0.000311059,0.000052069317,0.00002772758,0.00006252799,0.000021363227,0.000031855427],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861246,0.00016178505,0.00022472104,0.0005133953,0.00026893473,0.00021872432],"domain_scores_gemma":[0.9983019,0.00053349853,0.00014329978,0.0008671223,0.00006480387,0.00008934569],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012793735,0.00019914936,0.00037936014,0.00008490621,0.00006318573,0.000007313495,0.00018891817,0.00007444873,0.000034242035],"category_scores_gemma":[0.00027342787,0.000098039,0.000028562928,0.00024955685,0.00013290824,0.00009009923,0.00015985673,0.00015751648,0.000017114593],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002317787,0.0058182976,0.8621519,0.000073279305,0.0001552762,0.00012102218,0.0008984958,7.3293717e-7,0.12513311,0.000012078207,0.00014939738,0.0031685869],"study_design_scores_gemma":[0.019138003,0.0033123484,0.93977034,0.00030480206,0.00040753055,8.58469e-7,0.00019997217,0.000004769832,0.036622874,0.00003414717,0.00006375192,0.00014057117],"about_ca_topic_score_codex":0.00023842869,"about_ca_topic_score_gemma":0.00008808188,"teacher_disagreement_score":0.088510245,"about_ca_system_score_codex":0.000020937312,"about_ca_system_score_gemma":0.00005723382,"threshold_uncertainty_score":0.39979145},"labels":[],"label_agreement":null},{"id":"W2618328561","doi":"10.1182/blood.v128.22.4497.4497","title":"Pomalidomide + Low-Dose Dexamethasone Following Second-Line Lenalidomide-Based Therapy in Relapsed or Refractory Multiple Myeloma: A Phase 2 Study Investigating Efficacy and Safety","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McGill University Health Centre; Leukemia & Lymphoma Society of Canada; University of British Columbia","funders":"","keywords":"Pomalidomide; Medicine; Lenalidomide; Progressive disease; Internal medicine; Regimen; Multiple myeloma; Neutropenia; Population; Phases of clinical research; Clinical endpoint; Dexamethasone; Oncology; Surgery; Gastroenterology; Clinical trial; Chemotherapy","score_opus":0.052097136182529986,"score_gpt":0.34331889794625303,"score_spread":0.29122176176372305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2618328561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955415,0.00069629465,0.000052798565,0.0003862317,0.00006935581,0.0030102152,0.00004920755,0.00013211454,0.00006228601],"genre_scores_gemma":[0.9959852,0.000068435416,0.00287732,0.00023651555,0.00012745406,0.00024722388,0.000036951507,0.00008885079,0.00033203422],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99649525,0.00054572587,0.00080328895,0.00080883066,0.00060016447,0.00074676215],"domain_scores_gemma":[0.99587154,0.0025579082,0.00020191916,0.00067317876,0.00009653191,0.00059890497],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011453374,0.0004530773,0.00086906273,0.00038417138,0.0001888003,0.00004421658,0.00016789367,0.0001612557,0.00022260482],"category_scores_gemma":[0.0038338674,0.00027566866,0.00016294463,0.0004734869,0.0001544104,0.00017926155,0.00008579639,0.00037074648,0.000026069372],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026670216,0.021080969,0.4978618,0.00011596917,0.0010316604,0.0041825245,0.0009773121,0.0000034899954,0.35763195,0.000001990121,0.000019685167,0.09042241],"study_design_scores_gemma":[0.5724087,0.00978039,0.32723334,0.0010763427,0.00024215663,0.00006128232,0.00033784486,0.00033124856,0.087903574,0.000015485482,0.00015171288,0.00045793861],"about_ca_topic_score_codex":0.00019985084,"about_ca_topic_score_gemma":0.00042443053,"teacher_disagreement_score":0.54573846,"about_ca_system_score_codex":0.00015618924,"about_ca_system_score_gemma":0.00045109037,"threshold_uncertainty_score":0.99996954},"labels":[],"label_agreement":null},{"id":"W2618501159","doi":"10.1182/blood.v128.22.2818.2818","title":"Efficacy and Safety of Azacitidine (AZA) Versus Conventional Care Regimens (CCR) in Patients Aged ≥75 Years with Acute Myeloid Leukemia (AML) in the Phase 3 AZA-AML-001 Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Azacitidine; Chemotherapy regimen; Pediatrics; Chemotherapy","score_opus":0.01705127111205544,"score_gpt":0.2930885542918426,"score_spread":0.27603728317978715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2618501159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99714375,0.00010791965,0.0000036921138,0.00020256388,0.00004766916,0.0018599293,0.00013294759,0.000021100444,0.00048044405],"genre_scores_gemma":[0.99927235,0.00008462419,0.00012156946,0.00005084704,0.00006329598,0.00007363681,0.00014335474,0.000034589142,0.00015574846],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976704,0.00025006008,0.00043711415,0.00043663778,0.00079543993,0.00041033415],"domain_scores_gemma":[0.99865854,0.00038077094,0.00013573407,0.0005215273,0.00017362343,0.0001298095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049829733,0.0002232628,0.00044228393,0.00026261777,0.000058878613,0.00001418188,0.0002453533,0.00010394341,0.00006895322],"category_scores_gemma":[0.00019646807,0.00013606851,0.000051403542,0.00045929855,0.00023396553,0.00011231693,0.00012112382,0.0003751767,0.000015947722],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.074308164,0.016830374,0.85909456,0.00024307492,0.0020722514,0.00275028,0.012600405,0.0000056072663,0.012879523,0.0001618947,0.0014718428,0.017582038],"study_design_scores_gemma":[0.27016065,0.0056232475,0.71967226,0.00023942675,0.00035193167,0.000026521067,0.0018135096,0.0000036457086,0.0016243206,0.0000045473844,0.00030163123,0.00017832826],"about_ca_topic_score_codex":0.00016530906,"about_ca_topic_score_gemma":0.00023622578,"teacher_disagreement_score":0.19585249,"about_ca_system_score_codex":0.00039358527,"about_ca_system_score_gemma":0.00041187744,"threshold_uncertainty_score":0.55487126},"labels":[],"label_agreement":null},{"id":"W2618995018","doi":"10.1182/blood.v128.22.2633.2633","title":"Inpatient Non-Hemolytic Delayed Serologic Transfusion Reactions and Hospital Length of Stay: Is There an Association?","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Medicine; Hemolysis; Antibody; Serology; Blood transfusion; Hemolytic disease of the newborn (ABO); Immunology; Emergency medicine; Pregnancy; Biology","score_opus":0.00681254266130423,"score_gpt":0.22463731716503402,"score_spread":0.21782477450372978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2618995018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99668187,0.00013711894,0.00017187191,0.001924477,0.000075287084,0.00037465684,0.0000532294,0.000039898827,0.00054157106],"genre_scores_gemma":[0.9983509,0.00089069,0.00030149354,0.000118728494,0.000058098416,0.000013431293,0.000009966298,0.000017148317,0.00023951067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908626,0.000030724306,0.00024059998,0.00023480832,0.0002347997,0.00017282678],"domain_scores_gemma":[0.9994105,0.00006498059,0.00009739288,0.00020894161,0.00011012897,0.00010803872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015076275,0.00012004248,0.00022691593,0.00005781311,0.00007248376,0.000006211367,0.00004226898,0.0001511004,0.00012602935],"category_scores_gemma":[0.000024780813,0.00007635387,0.0000685363,0.00010317446,0.000032487867,0.00011727134,0.000011555737,0.00010694127,0.00000674338],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026344837,0.0050762603,0.83314,0.00010689348,0.00053568254,0.000022018372,0.002467401,2.3611068e-7,0.14519252,0.00013084878,0.00013947093,0.012925224],"study_design_scores_gemma":[0.013433854,0.006563131,0.89700663,0.00020264354,0.0010521067,0.000031275264,0.00033888256,0.000047514077,0.080078065,0.0004169968,0.0005940146,0.00023486125],"about_ca_topic_score_codex":0.00018422276,"about_ca_topic_score_gemma":0.00006148867,"teacher_disagreement_score":0.06511445,"about_ca_system_score_codex":0.000025832469,"about_ca_system_score_gemma":0.000034584762,"threshold_uncertainty_score":0.31136203},"labels":[],"label_agreement":null},{"id":"W2619158663","doi":"10.1182/blood.v128.22.4122.4122","title":"Identification of TRA-1-60-Positive Cells As a Potent Refractory Population in Follicular Lymphomas","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lymphoma; Follicular lymphoma; Rituximab; Germinal center; Population; Biology; Cancer research; CHOP; Stem cell; Pathology; B cell; Immunology; Molecular biology; Antibody; Medicine; Genetics","score_opus":0.0055711573293389305,"score_gpt":0.21193777386616,"score_spread":0.20636661653682106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619158663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99639136,0.00086906273,0.00021730662,0.00007837267,0.0011458432,0.00018394447,0.000006339504,0.000026695603,0.0010810565],"genre_scores_gemma":[0.99460053,0.00016359187,0.000006074379,0.000037072754,0.000015616653,0.000015108475,0.000058851914,0.000009656389,0.005093515],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99911994,0.00014867107,0.00037375026,0.00018863604,0.000034760636,0.00013426875],"domain_scores_gemma":[0.99948895,0.000046195906,0.00020682585,0.00018383736,0.00006519198,0.00000902276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015919616,0.00009325145,0.00014447053,0.00014678,0.00004354792,0.000005060852,0.000068311856,0.00015851697,0.00037957236],"category_scores_gemma":[0.000052339718,0.000072278344,0.00007900101,0.000091017,0.000036549194,0.0001911401,0.000014750884,0.00006954501,0.0005394902],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013113591,0.00047983162,0.0013196708,0.0000072295197,0.00006591778,0.0000025138966,0.00016490737,0.0000016733792,0.99343765,0.00022750981,0.00017047404,0.0039914977],"study_design_scores_gemma":[0.0021848239,0.00015533219,0.057195485,0.000058549616,0.000051608484,0.000025758003,0.000089789406,0.0000011043625,0.93726045,0.000106935506,0.002779474,0.00009069795],"about_ca_topic_score_codex":0.00019683801,"about_ca_topic_score_gemma":0.000012475624,"teacher_disagreement_score":0.056177195,"about_ca_system_score_codex":0.00006222085,"about_ca_system_score_gemma":0.00002005938,"threshold_uncertainty_score":0.6934235},"labels":[],"label_agreement":null},{"id":"W2619464104","doi":"10.1182/blood.v128.22.2612.2612","title":"Systematic Review of Treatment for Massive and Submassive Pulmonary Embolism","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Pulmonary embolism; Internal medicine; Confidence interval; Randomized controlled trial; Meta-analysis; Surgery; MEDLINE","score_opus":0.014070656465683985,"score_gpt":0.2655734671533986,"score_spread":0.2515028106877146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619464104","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43119603,0.49020016,0.00100349,0.026474362,0.00052929827,0.03605042,0.00039193954,0.0002331814,0.013921117],"genre_scores_gemma":[0.83274305,0.16138238,0.0006128627,0.0011102092,0.00014518198,0.0020092353,0.000019145236,0.000042030097,0.0019359193],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9991823,0.000028757315,0.00033552104,0.0001891125,0.00010871871,0.00015560997],"domain_scores_gemma":[0.9992257,0.00013649829,0.00017884024,0.00028212092,0.00009455012,0.000082314364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013015172,0.00012999462,0.00086553476,0.000049713057,0.00002791217,0.000003501185,0.000043815886,0.000034792403,0.00003594209],"category_scores_gemma":[0.000158215,0.00006821131,0.00013604766,0.00004748844,0.00003633649,0.00003272224,0.000025640013,0.000012764063,0.000008518051],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035351197,0.0026554342,0.0005914398,0.9770878,0.0019961044,0.000075667485,0.00021574782,3.9671534e-8,0.0053424397,0.0075787697,0.0013494985,0.0030716902],"study_design_scores_gemma":[0.011782799,0.004525869,0.010592214,0.920544,0.025551952,0.00018335247,0.00033704817,0.00001024388,0.022311814,0.00094110746,0.002729537,0.0004900236],"about_ca_topic_score_codex":0.0000104899655,"about_ca_topic_score_gemma":0.0000011615547,"teacher_disagreement_score":0.401547,"about_ca_system_score_codex":0.00003989006,"about_ca_system_score_gemma":0.000040415736,"threshold_uncertainty_score":0.27815765},"labels":[],"label_agreement":null},{"id":"W2619467112","doi":"10.1182/blood.v128.22.4016.4016","title":"The Effect of Traumatic Diagnostic Lumbar Puncture in De Novo Pediatric Acute Myeloid Leukemia - a Report from the Children's Oncology Group","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Medicine; Cytarabine; Cerebrospinal fluid; Lumbar puncture; Cohort; Internal medicine; Myeloid leukemia; Chemotherapy; Leukemia; Pediatrics; Oncology; Gastroenterology","score_opus":0.005521341572266158,"score_gpt":0.26248725795278843,"score_spread":0.2569659163805223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619467112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99704117,0.00074673555,0.000010216128,0.0009300692,0.000064616695,0.0009862658,0.00002917916,0.000023663551,0.00016807523],"genre_scores_gemma":[0.998438,0.0009135467,0.000040698633,0.00006620716,0.00022590112,0.0001756927,0.00001801674,0.000022011403,0.000099904326],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984401,0.00031184938,0.0003038548,0.0002496142,0.00031052073,0.00038407888],"domain_scores_gemma":[0.9950938,0.004122392,0.00013164294,0.00050020724,0.000024050445,0.00012791056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043190998,0.00016830408,0.00034202402,0.00005633055,0.0000782636,0.0000106566395,0.00020149643,0.00009865625,0.000031939155],"category_scores_gemma":[0.0021592232,0.000063143874,0.00012273152,0.00020992936,0.00011446616,0.000035469046,0.000067766676,0.0002500211,0.000029404895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027216124,0.0003495295,0.9787112,0.000025064171,0.00044083438,0.004281923,0.00010692964,2.3175771e-7,0.005759094,0.0000051914953,0.0005264945,0.009521344],"study_design_scores_gemma":[0.010337693,0.002229179,0.9772831,0.00007259644,0.0008868851,0.0014426674,0.0000067931824,0.0000011344115,0.007482724,0.00011228473,0.00008221627,0.00006267805],"about_ca_topic_score_codex":0.00025783657,"about_ca_topic_score_gemma":0.00032368503,"teacher_disagreement_score":0.010065531,"about_ca_system_score_codex":0.00014090665,"about_ca_system_score_gemma":0.00025416721,"threshold_uncertainty_score":0.2584948},"labels":[],"label_agreement":null},{"id":"W2619639643","doi":"10.1182/blood.v128.22.1716.1716","title":"Inhibition of c-Myc By Apto-253 As an Innovative Therapeutic Approach to Induce Cell Cycle Arrest and Apoptosis in Acute Myeloid Leukemia","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Insect Resistance and Genetics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aptose Biosciences (Canada)","funders":"","keywords":"Myeloid leukemia; Cell cycle; Cancer research; Apoptosis; Cell cycle checkpoint; Biology; Myeloid; Leukemia; Annexin A5; Oncogene; Programmed cell death; Molecular biology; Immunology; Biochemistry","score_opus":0.006770400588782471,"score_gpt":0.22498066237286832,"score_spread":0.21821026178408584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619639643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99720263,0.0002805987,0.00035162456,0.000044149445,0.00002318645,0.00018977578,0.000048360707,0.000005252663,0.0018544444],"genre_scores_gemma":[0.99860144,0.00023061901,0.00057224644,0.00027436297,0.00004910579,0.000031879154,0.00006242967,0.000018093267,0.00015984631],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991724,0.000044574655,0.00018112733,0.00031261446,0.00009577383,0.00019351661],"domain_scores_gemma":[0.99955994,0.0000067812825,0.000069060545,0.00022943404,0.0000784044,0.000056355333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009677578,0.00013425027,0.00013786164,0.000056185225,0.000030044563,0.000011110212,0.00009633903,0.00015439447,0.0000024563917],"category_scores_gemma":[0.0000105940835,0.00010807053,0.000021121776,0.00018916366,0.000062280764,0.0000069513144,0.000053741463,0.00005783738,0.000002956813],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000077553304,0.00025644928,0.0014503935,0.000015924688,0.00003347942,4.8901603e-7,0.00025736427,0.000002157236,0.9960979,0.000049156442,0.00007380149,0.0016853339],"study_design_scores_gemma":[0.0012402443,0.00046048878,0.003092408,0.000018896424,0.00002139812,0.0000024035166,0.00012009525,0.0000013876205,0.99425125,0.00014580178,0.0004803591,0.00016526008],"about_ca_topic_score_codex":0.000035425197,"about_ca_topic_score_gemma":0.000022714798,"teacher_disagreement_score":0.0018466405,"about_ca_system_score_codex":0.000014158332,"about_ca_system_score_gemma":0.000076722514,"threshold_uncertainty_score":0.44069883},"labels":[],"label_agreement":null},{"id":"W2619745853","doi":"10.1182/blood.v128.22.1441.1441","title":"Pharmacokinetics (PK) and Pharmacodynamics (PD), Safety and Tolerability of a Single-Dose Oral Solution of Dabigatran Etexilate Given after Standard Anticoagulant Therapy in Children from Birth to Less Than One Year Old, with Venous Thromboembolism","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; University of Alberta; Children's Hospital of Eastern Ontario; Hospital for Sick Children; University of Ottawa","funders":"","keywords":"Medicine; Dabigatran; Tolerability; Pharmacodynamics; Pharmacokinetics; Dosing; Gestational age; Anesthesia; Pediatrics; Internal medicine; Adverse effect; Warfarin; Atrial fibrillation; Pregnancy","score_opus":0.03037683305658886,"score_gpt":0.29518334008807556,"score_spread":0.2648065070314867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619745853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996044,0.0014312585,0.00012675147,0.0010923065,0.00003086193,0.000653398,0.0005659138,0.000016269667,0.0000392431],"genre_scores_gemma":[0.9941452,0.0048022135,0.0008242917,0.00013321225,0.000054187938,0.000007953729,0.00000761809,0.000021492577,0.0000038105052],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987481,0.00010078734,0.00033933748,0.0003049175,0.00025973818,0.0002470819],"domain_scores_gemma":[0.9993271,0.00014061903,0.00013007566,0.00016672592,0.00008411391,0.00015134465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026096462,0.00018088905,0.00063729164,0.000056476976,0.000036042187,0.000009741491,0.00006463953,0.00005877619,0.000031252337],"category_scores_gemma":[0.000029525918,0.00011821516,0.000036955622,0.00013217199,0.00022989845,0.0000978756,0.000075284246,0.00013775601,4.8813536e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011094041,0.001889042,0.6282764,0.00011065712,0.0006802848,0.000014242119,0.0011731555,0.0000036191013,0.32725063,0.00000893834,0.0000018092207,0.029497154],"study_design_scores_gemma":[0.0155018205,0.0018696646,0.9064216,0.00030404865,0.0005154146,0.000017397773,0.000054788667,0.000049458038,0.0748265,0.00006152447,0.00019943363,0.00017831712],"about_ca_topic_score_codex":0.00046281636,"about_ca_topic_score_gemma":0.00012961376,"teacher_disagreement_score":0.2781452,"about_ca_system_score_codex":0.000026636357,"about_ca_system_score_gemma":0.000034340632,"threshold_uncertainty_score":0.48206744},"labels":[],"label_agreement":null},{"id":"W2619790460","doi":"10.1182/blood.v128.22.3654.3654","title":"Regional- and Age-Related Differences in Pain in Children with Sickle Cell Anemia: Results from the Multinational DOVE Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Analgesic; Sickle cell anemia; Clinical endpoint; Clinical trial; Physical therapy; Anesthesia; Internal medicine; Disease","score_opus":0.008326315631516491,"score_gpt":0.20297167400463512,"score_spread":0.19464535837311864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619790460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956394,0.00047914972,0.000002532181,0.0028572604,0.000011184833,0.0005831975,0.00002204146,0.000018501236,0.00038673147],"genre_scores_gemma":[0.9993639,0.0001224773,0.0000597045,0.000140064,0.000023352748,0.00001569991,0.000031068477,0.000009821957,0.00023391408],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898416,0.00014544162,0.00024050316,0.0002751014,0.0001984695,0.0001563162],"domain_scores_gemma":[0.99932665,0.0003682247,0.00006743501,0.00016743176,0.000022844777,0.000047425216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037638505,0.0001172805,0.0001798401,0.000057120673,0.000041912663,0.000009859216,0.00007338957,0.000102189675,0.00001508983],"category_scores_gemma":[0.00014938955,0.000052914296,0.000017605198,0.00017624279,0.000113448215,0.00003428813,0.00002885721,0.00021115388,0.000005200735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019005616,0.0014493478,0.99216,0.0000027710514,0.000061890394,0.00007094994,0.0024791784,0.00000195538,0.00028327227,0.000012079172,0.000112974456,0.0031755024],"study_design_scores_gemma":[0.023673918,0.00047501974,0.9737907,0.00015419042,0.000066911845,0.000013198357,0.0015091682,0.000024826979,0.00005641949,0.00011923781,0.000021923797,0.000094464405],"about_ca_topic_score_codex":0.0011159019,"about_ca_topic_score_gemma":0.00055520504,"teacher_disagreement_score":0.023483861,"about_ca_system_score_codex":0.000014058937,"about_ca_system_score_gemma":0.00003835622,"threshold_uncertainty_score":0.21577823},"labels":[],"label_agreement":null},{"id":"W2620176398","doi":"10.1182/blood.v128.22.1016.1016","title":"Pediatric Emergency Department Adherence to the 2014 National Heart, Lung and Blood Institute Guidelines Targeting Analgesic Therapy in the Management of Vaso-Occlusive Pain Episodes in Children with Sickle Cell Disease: a Multicenter Perspective","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Emergency department; Triage; Vaso-occlusive crisis; Acute chest syndrome; Dosing; Guideline; Emergency medicine; Pain assessment; Hydromorphone; Opioid; Sickle cell anemia; Physical therapy; Disease; Pain management; Internal medicine","score_opus":0.00951521213060424,"score_gpt":0.26727786503145773,"score_spread":0.2577626529008535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620176398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98265254,0.010987058,0.00010087006,0.004571029,0.00002851771,0.0014857578,0.00002404823,0.000010143327,0.00014005668],"genre_scores_gemma":[0.9915117,0.0071632513,0.0006585849,0.0003924488,0.00007989204,0.000133759,0.000009612023,0.000011938675,0.000038828584],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987005,0.00013484557,0.00031659828,0.0002841571,0.00034327264,0.00022060843],"domain_scores_gemma":[0.99945444,0.000051803978,0.000090546804,0.00017139419,0.00016238865,0.00006940038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065078674,0.00015659798,0.00016384217,0.0001087927,0.00007596428,0.000007986752,0.00012624501,0.000033517223,0.00003108468],"category_scores_gemma":[0.00007349347,0.00007116631,0.0000504733,0.0003205548,0.00004897762,0.00006169278,0.000051860734,0.00010304971,0.0000032882376],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015590995,0.0012868646,0.99461466,0.00006652418,0.00022499698,0.000027008098,0.0012886398,0.0001489725,0.00015413528,0.0001693691,0.0013362856,0.00052664796],"study_design_scores_gemma":[0.00847991,0.0005947153,0.9870176,0.00022311076,0.00045725994,0.00000981423,0.0023536852,0.00014561588,0.00017622195,0.00012932424,0.0002134304,0.00019931486],"about_ca_topic_score_codex":0.00019938294,"about_ca_topic_score_gemma":0.00010179672,"teacher_disagreement_score":0.008859166,"about_ca_system_score_codex":0.00002755168,"about_ca_system_score_gemma":0.0000740741,"threshold_uncertainty_score":0.29020777},"labels":[],"label_agreement":null},{"id":"W2620267410","doi":"10.1182/blood.v128.22.4728.4728","title":"Risk Stratification for the Development of Venous Thromboembolism in Hospitalized Patients with Cancer","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; BC Cancer Agency; University of British Columbia; University of Calgary; University of Alberta","funders":"","keywords":"Medicine; Internal medicine; Cancer; Medical record; Logistic regression; Pulmonary embolism; Retrospective cohort study; Incidence (geometry); Surgery","score_opus":0.011633668211423276,"score_gpt":0.2545420982864414,"score_spread":0.24290843007501814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620267410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99700004,0.00018189842,0.0007326837,0.00033014434,0.00007223703,0.0014276591,0.000026901836,0.000013876864,0.00021457151],"genre_scores_gemma":[0.9972663,0.00020651915,0.001852653,0.00004495887,0.000033413533,0.00053250435,0.000010539396,0.000016190992,0.000036917372],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999209,0.000013999984,0.00025482164,0.00016952725,0.00018922068,0.00016345858],"domain_scores_gemma":[0.9994025,0.00007096316,0.00015593578,0.00022618708,0.00011237618,0.000032027172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001595208,0.00009600309,0.0002816462,0.000046127952,0.00006268138,0.000005596757,0.00008216032,0.000032735636,0.000040046816],"category_scores_gemma":[0.000038235874,0.000045729324,0.00003339317,0.000090707166,0.00004025802,0.000039974588,0.000017783288,0.00003291229,0.0000029178466],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024678375,0.010846315,0.81071955,0.00025024146,0.0012289191,0.000001214638,0.0047351317,0.000011022069,0.0015862541,0.0012931034,0.00052884466,0.16855265],"study_design_scores_gemma":[0.0058405767,0.0003371248,0.98608434,0.00019713717,0.00038143058,1.0033628e-7,0.00007692211,0.0000026245298,0.006042672,0.000110624576,0.0008471631,0.00007929653],"about_ca_topic_score_codex":0.00009924684,"about_ca_topic_score_gemma":0.00028688126,"teacher_disagreement_score":0.1753648,"about_ca_system_score_codex":0.000036963665,"about_ca_system_score_gemma":0.000110827976,"threshold_uncertainty_score":0.18647876},"labels":[],"label_agreement":null},{"id":"W2620384985","doi":"10.1182/blood.v128.22.4507.4507","title":"Oncolytic Reovirus Immune Priming: A Phase 1b Study of Reolysin with Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Medicine; Pomalidomide; Internal medicine; Refractory (planetary science); Multiple myeloma; Bortezomib; Cohort; Carfilzomib; Gastroenterology; Dexamethasone; Toxicity; Surgery; Biology","score_opus":0.012354445263569708,"score_gpt":0.2679979485087741,"score_spread":0.2556435032452044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620384985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986068,0.00042943552,0.000025454963,0.000016383594,0.000011352221,0.0008412023,0.000019272984,0.000009105949,0.000041001666],"genre_scores_gemma":[0.9994009,0.000055580345,0.0002748102,0.000015907444,0.000025011466,0.00006543419,0.000016302793,0.000044900105,0.00010113769],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984453,0.00017435978,0.00029748576,0.00047021708,0.00030710179,0.00030555183],"domain_scores_gemma":[0.9989221,0.00005923012,0.0001650033,0.00062099885,0.00013343897,0.00009919268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031033048,0.00020525247,0.0002955468,0.00011869751,0.0000476073,0.000010653659,0.00018618032,0.000100101846,0.000008563178],"category_scores_gemma":[0.000111914655,0.00013267368,0.000028441655,0.00018255522,0.00014874559,0.000010460185,0.000095696174,0.00011496994,0.0000016401383],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018815076,0.011312488,0.2962198,0.000018411298,0.00025866218,0.000021935153,0.00025594264,0.0000019711729,0.66040665,3.1571216e-7,0.0000051625075,0.012683589],"study_design_scores_gemma":[0.1051001,0.06444748,0.19160677,0.00010589414,0.00010317888,0.000005293173,0.00021464203,0.0000037620325,0.6379881,0.000002318024,0.00010810766,0.00031436086],"about_ca_topic_score_codex":0.000069664165,"about_ca_topic_score_gemma":0.0007507089,"teacher_disagreement_score":0.10461301,"about_ca_system_score_codex":0.000023480867,"about_ca_system_score_gemma":0.00014515844,"threshold_uncertainty_score":0.5410276},"labels":[],"label_agreement":null},{"id":"W2620458165","doi":"10.1182/blood.v128.22.3330.3330","title":"Selinexor Shows Synergy in Combination with Pomalidomide and Low Dose Dexamethasone in Patients with Relapsed / Refractory Multiple Myeloma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec; Memorial University of Newfoundland; Queen Elizabeth II Health Sciences Centre; Hôpital Maisonneuve-Rosemont; Institute of Cancer Research; University of Manitoba; Juravinski Cancer Centre; McGill University Health Centre; CancerCare Manitoba; Ottawa Hospital; University of Calgary; Princess Margaret Cancer Centre; Vancouver General Hospital","funders":"","keywords":"Pomalidomide; Lenalidomide; Tolerability; Medicine; Refractory (planetary science); Multiple myeloma; Internal medicine; Bortezomib; Dexamethasone; Carfilzomib; Neutropenia; Oncology; Pharmacology; Toxicity; Adverse effect; Biology","score_opus":0.0030965475052035073,"score_gpt":0.1766271670979139,"score_spread":0.1735306195927104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620458165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999518,0.000059187976,0.000107683765,0.0000377383,0.00003056771,0.00016252026,0.000007163277,0.000007469055,0.00006967701],"genre_scores_gemma":[0.9989404,0.000020356363,0.0007677433,0.00006120272,0.000030303963,0.000011832261,0.00003990551,0.000019471094,0.00010877706],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993679,0.000045857283,0.00011726478,0.0002498703,0.000085571875,0.00013353846],"domain_scores_gemma":[0.9996721,0.00001865502,0.000058073616,0.00016615914,0.00004764101,0.00003737524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006960314,0.00010685402,0.000104821396,0.00005598563,0.000019789215,0.000008223513,0.000045057626,0.00010585724,0.0000058712326],"category_scores_gemma":[0.000059938335,0.000067278335,0.000011080528,0.00007202793,0.000041271942,0.000010144701,0.000023981258,0.000054871372,0.0000012269988],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016270891,0.00047597196,0.7550608,0.000012368127,0.00003273417,0.0000075697712,0.000040362596,0.0000055755836,0.2312135,0.000016076217,0.00002544005,0.011482512],"study_design_scores_gemma":[0.019841498,0.0014100327,0.93812877,0.000066021326,0.000017688984,0.0000056506005,0.00002089023,0.00001198133,0.039651215,0.000017716668,0.0006518174,0.0001767388],"about_ca_topic_score_codex":0.000028249167,"about_ca_topic_score_gemma":0.00051647273,"teacher_disagreement_score":0.19156228,"about_ca_system_score_codex":0.000011041324,"about_ca_system_score_gemma":0.00002129654,"threshold_uncertainty_score":0.2743531},"labels":[],"label_agreement":null},{"id":"W2621128125","doi":"10.1182/blood.v110.11.429.429","title":"Candidate Gene Polymorphisms and Their Association with TCD Velocities in Children with Sickle Cell Disease.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Transcranial Doppler; Genotyping; Stroke (engine); Internal medicine; Pediatrics; Genotype; Gene; Genetics; Biology","score_opus":0.002464681469603603,"score_gpt":0.1744344871218227,"score_spread":0.1719698056522191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2621128125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960781,0.0019412248,0.000040191557,0.00036349098,0.000013752497,0.0002705097,0.000019613411,0.000035857156,0.001237258],"genre_scores_gemma":[0.9987502,0.00023254474,0.00013592183,0.0002460013,0.000046598507,0.0000055617506,0.000051940493,0.00002060018,0.000510604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99929017,0.000013146469,0.00011824645,0.0001681031,0.00015031396,0.00025999726],"domain_scores_gemma":[0.99963325,0.000019937666,0.00006321706,0.00011510035,0.00002850825,0.00013999261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000132952,0.00012616489,0.00016607763,0.000076662844,0.00005640165,0.000013090563,0.000029709701,0.00007725407,0.0000125386405],"category_scores_gemma":[0.000008962905,0.00007811876,0.000018867615,0.00015428089,0.000046733036,0.000042045856,0.000012918803,0.00014744389,0.0000034269788],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017977979,0.0002766353,0.9969664,0.0000136144845,0.00012045804,0.000042999178,0.0006976823,0.000005367398,0.0011582463,0.000010386092,0.00004054311,0.00048787188],"study_design_scores_gemma":[0.006567198,0.0003066083,0.97594094,0.00007696643,0.00022513887,0.000057620462,0.00048643467,0.000012826434,0.016032007,0.00002235589,0.00011249702,0.0001594025],"about_ca_topic_score_codex":0.00027373183,"about_ca_topic_score_gemma":0.00015827325,"teacher_disagreement_score":0.021025471,"about_ca_system_score_codex":0.000039089977,"about_ca_system_score_gemma":0.00008935676,"threshold_uncertainty_score":0.31855908},"labels":[],"label_agreement":null},{"id":"W2621281002","doi":"10.1182/blood.v128.22.4526.4526","title":"Biomarker Driven Phase II Clinical Trial of Trametinib in Relapsed/Refractory Multiple Myeloma with Sequential Addition of the AKT Inhibitor, GSK2141795 at Time of Disease Progression to Overcome Treatment Failure: A Trial of the Princess Margaret Phase II Consortium","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; University Health Network; Queen's University; University of Calgary; Princess Margaret Cancer Centre","funders":"","keywords":"Trametinib; Neuroblastoma RAS viral oncogene homolog; Medicine; Protein kinase B; Multiple myeloma; Progressive disease; Oncology; Biomarker; Internal medicine; Clinical trial; PI3K/AKT/mTOR pathway; Lenalidomide; MEK inhibitor; Cancer research; Response Evaluation Criteria in Solid Tumors; Phases of clinical research; MAPK/ERK pathway; Cancer; Disease; Biology; KRAS; Signal transduction","score_opus":0.04344315609987847,"score_gpt":0.36256081193825196,"score_spread":0.3191176558383735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2621281002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99093145,0.000044769964,0.000005053819,0.00056561717,0.0001897396,0.0067098187,0.001501907,0.0000162941,0.000035347766],"genre_scores_gemma":[0.99876004,0.000024515764,0.00029750014,0.000009764509,0.00016105112,0.00038275812,0.00010918931,0.00003393847,0.00022125896],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9960567,0.00072890095,0.001328809,0.0004944628,0.0010274946,0.00036363094],"domain_scores_gemma":[0.99698806,0.0006056307,0.00092115515,0.00092050363,0.00021949291,0.00034515647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054921414,0.00031014756,0.0009155135,0.00017332149,0.00011172443,0.000004724284,0.00026252712,0.00018206623,0.0002346464],"category_scores_gemma":[0.0013063401,0.00013942868,0.00051227695,0.0003831959,0.00065910746,0.000085311985,0.00027817907,0.00014901497,0.0000029135356],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7438061,0.07424679,0.032770958,0.00011448763,0.0007545248,0.000053196374,0.00028960526,7.183481e-7,0.12117648,0.000004634283,0.00016231128,0.02662018],"study_design_scores_gemma":[0.7396483,0.05534356,0.022971814,0.0012169408,0.00070439,0.0000056699814,0.000021297545,0.00004343387,0.17946057,0.000006993758,0.0004410127,0.00013605795],"about_ca_topic_score_codex":0.00006271868,"about_ca_topic_score_gemma":0.00010420398,"teacher_disagreement_score":0.058284085,"about_ca_system_score_codex":0.00015623783,"about_ca_system_score_gemma":0.0007263427,"threshold_uncertainty_score":0.56857365},"labels":[],"label_agreement":null},{"id":"W2622722746","doi":"10.1182/blood.v128.22.1729.1729","title":"Kinase-Activating Fusions in Pediatric High-Risk B-Lineage Acute Lymphoblastic Leukemia (ALL): a Report from the Dana-Farber Cancer Institute (DFCI) ALL Consortium","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Hamilton Health Sciences; Centre hospitalier universitaire de Québec; Université de Montréal; McMaster Children's Hospital","funders":"","keywords":"Medicine; Sanger sequencing; Tyrosine kinase; Cancer research; Fusion transcript; Oncology; Multiplex ligation-dependent probe amplification; Internal medicine; Fusion gene; Biology; Genetics; DNA sequencing; Gene; Exon","score_opus":0.020959760092592646,"score_gpt":0.2900689846454729,"score_spread":0.2691092245528803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2622722746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99310136,0.0005845219,0.0009450152,0.0023502524,0.0006791322,0.0009713541,0.00037172297,0.00018162865,0.0008150008],"genre_scores_gemma":[0.99145454,0.0023370076,0.0014448012,0.0010029622,0.0018425175,0.00034011976,0.00013427298,0.00011290839,0.0013308808],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954973,0.0002154062,0.0010873077,0.0010439508,0.001080761,0.0010752887],"domain_scores_gemma":[0.99552864,0.0018514597,0.000542977,0.0013608277,0.00025385118,0.0004622265],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00067614013,0.0005075284,0.00073758274,0.0002727899,0.00022309601,0.000060659535,0.00055450853,0.0003449606,0.00041224848],"category_scores_gemma":[0.0029777065,0.0002957575,0.00020348936,0.000810791,0.00034641265,0.00031778787,0.00049403176,0.0006733285,0.0001697857],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013431563,0.0015829074,0.83818567,0.00015678372,0.0029202953,0.022740168,0.0012738282,0.00016612177,0.102774456,0.0002074478,0.020185463,0.008463701],"study_design_scores_gemma":[0.06417903,0.0006104571,0.8612785,0.00124594,0.0068260883,0.0019609816,0.00022873202,0.0019610205,0.034928456,0.0003235912,0.02486537,0.0015918529],"about_ca_topic_score_codex":0.018361516,"about_ca_topic_score_gemma":0.0023241122,"teacher_disagreement_score":0.067846,"about_ca_system_score_codex":0.001902957,"about_ca_system_score_gemma":0.004165338,"threshold_uncertainty_score":0.99994946},"labels":[],"label_agreement":null},{"id":"W2622862433","doi":"10.1182/blood.v128.22.4509.4509","title":"A Phase 1/2 Study of the Second Generation Selective Inhibitor of Nuclear Export (SINE) Compound, KPT-8602, in Patients with Relapsed Refractory Multiple Myeloma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University Health Centre","funders":"","keywords":"Tolerability; Pharmacology; Nuclear export signal; Internal medicine; Medicine; Anorexia; Refractory (planetary science); Neutropenia; Chemistry; Endocrinology; Adverse effect; Materials science; Toxicity","score_opus":0.005728787595799582,"score_gpt":0.19951327500295718,"score_spread":0.1937844874071576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2622862433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99942887,0.00001252092,0.000005585593,0.0000061627497,0.000085710155,0.00033212668,0.000021593936,0.000003471581,0.000103985345],"genre_scores_gemma":[0.9997337,0.0000012109349,0.00006603044,0.000023536533,0.00007787044,0.00000534423,0.000016191436,0.000016864922,0.0000592574],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99935764,0.000058914935,0.00018834883,0.00019044273,0.000120276934,0.00008436805],"domain_scores_gemma":[0.99946237,0.0000065201384,0.00015813514,0.00024079444,0.00011286115,0.000019347124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000051134502,0.00008952974,0.000115732895,0.000030506893,0.000034669567,0.0000033418373,0.00007211388,0.00007389552,0.000015555397],"category_scores_gemma":[0.000029703815,0.000052629188,0.00002940156,0.00007947861,0.00004218305,0.0000073542733,0.000036580986,0.000050872062,6.466473e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060151005,0.00235516,0.15923682,0.000006183034,0.00006599685,5.419008e-7,0.00024419898,6.993515e-7,0.83658683,0.0000016985359,0.00020671953,0.00069364486],"study_design_scores_gemma":[0.024875503,0.006591816,0.47882542,0.000021553753,0.000048548914,0.0000019140875,0.00017810008,0.000004332375,0.487963,0.00000337863,0.0013566372,0.0001297976],"about_ca_topic_score_codex":0.000010648069,"about_ca_topic_score_gemma":0.00021296601,"teacher_disagreement_score":0.34862384,"about_ca_system_score_codex":0.000009882674,"about_ca_system_score_gemma":0.000026498225,"threshold_uncertainty_score":0.2146156},"labels":[],"label_agreement":null},{"id":"W2622918134","doi":"10.1182/blood.v128.22.5083.5083","title":"Lef1 Is a Critical Mediator of Wnt/β-Catenin Signaling in T-Cell Acute Lymphoblastic Leukemia (T-ALL)","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and Retrovirus Studies","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Wnt signaling pathway; Leukemia; Cancer research; Biology; Population; LRP6; Beta-catenin; WNT3A; Immunology; Signal transduction; Cell biology; Medicine","score_opus":0.009876881711327822,"score_gpt":0.22741773658111525,"score_spread":0.21754085486978741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2622918134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942803,0.0038297314,0.00004252453,0.00030800738,0.000323653,0.0000951478,0.00006935664,0.00003963047,0.0010116838],"genre_scores_gemma":[0.9977332,0.00031595904,0.000078925405,0.00011958347,0.000042239135,0.000016790862,0.0000049924774,0.000017889146,0.0016704638],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99875623,0.000089054716,0.0003658285,0.000295851,0.000048300546,0.0004447427],"domain_scores_gemma":[0.99920255,0.00048334134,0.00007745042,0.00014774314,0.000058187194,0.00003073063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013417967,0.00018392851,0.0003808126,0.00011396734,0.000063916275,0.0000041520098,0.00020046077,0.00025439888,0.00029686806],"category_scores_gemma":[0.00013807928,0.000117515534,0.00010779622,0.000100245394,0.00037246034,0.000050488637,0.00012346338,0.0001349644,0.0005515392],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008400779,0.00032289297,0.0053073214,0.00003829307,0.00023483323,0.000027698226,0.00038817208,1.6945388e-7,0.9920569,0.00038608658,0.00087434356,0.00027926188],"study_design_scores_gemma":[0.0045667617,0.00023307904,0.0007168158,0.000091577516,0.00023408097,0.000032044718,0.00016406912,3.4686698e-7,0.9927829,0.00016100955,0.00083535473,0.0001819428],"about_ca_topic_score_codex":0.00008181481,"about_ca_topic_score_gemma":0.000015014507,"teacher_disagreement_score":0.0045905057,"about_ca_system_score_codex":0.000046800928,"about_ca_system_score_gemma":0.00011624497,"threshold_uncertainty_score":0.7089104},"labels":[],"label_agreement":null},{"id":"W2623410148","doi":"10.1182/blood-2017-03-735654","title":"The NCI Genomic Data Commons as an engine for precision medicine","year":2017,"lang":"en","type":"review","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":337,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Precision medicine; Big data; Genomics; Cancer; Data sharing; Genome; Computational biology; Commons; Genomic information; Personalized medicine; Genomic medicine; Bioinformatics; Data science; Medicine; Computer science; Biology; Data mining; Genetics; Gene; Alternative medicine; Pathology","score_opus":0.1103278833604714,"score_gpt":0.39892976590636015,"score_spread":0.28860188254588875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2623410148","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000070482274,0.9965236,0.00014688441,0.00008376992,0.0004953078,0.0008338724,0.0012553151,0.000006335773,0.0005844127],"genre_scores_gemma":[0.000041180145,0.989497,0.000265376,0.000050405975,0.0022980107,0.000110643436,0.007139625,0.00006472846,0.0005330038],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998706,0.000047518675,0.00036471203,0.00054232014,0.0000928395,0.0002466542],"domain_scores_gemma":[0.99612623,0.00021389044,0.00031725227,0.0031666176,0.00006368812,0.000112336806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052747544,0.00027532328,0.00059393776,0.000026297499,0.00032469368,0.00008014704,0.001958404,0.00026952437,0.000006183836],"category_scores_gemma":[0.00087443495,0.00017843947,0.00014986133,0.00002185112,0.000114652496,0.0000024488854,0.0007475986,0.00012882144,0.000011913158],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015240364,0.00007764535,0.0000015292089,0.0005158868,0.00023785644,0.0000026764496,0.0000051940397,4.5603306e-7,0.00007211662,0.00011345152,0.014707697,0.98425025],"study_design_scores_gemma":[0.0006410842,0.000419752,0.0000030045849,0.0005728738,0.0010376236,0.000042768574,0.0000036924068,0.0000068933336,0.000035616747,0.000117505304,0.99689853,0.0002206541],"about_ca_topic_score_codex":0.000043984015,"about_ca_topic_score_gemma":0.00030479295,"teacher_disagreement_score":0.9840296,"about_ca_system_score_codex":0.000012062158,"about_ca_system_score_gemma":0.00039994935,"threshold_uncertainty_score":0.72765505},"labels":[],"label_agreement":null},{"id":"W2623919964","doi":"10.1182/blood.v128.22.3192.3192","title":"Quality of Life Scores Improve with Increasing Hemoglobin but Optimal Thresholds Vary According to Transfusion Dependence and Clinical Risk Scores: A Canadian Cross Sectional Study of 689 Patients with 2969 Measurements","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Guelph; Université Laval; University of Saskatchewan; University of British Columbia; CancerCare Manitoba; Health Sciences Centre; Ottawa Hospital; University Health Network; Dr. Georges-L.-Dumont University Hospital Centre; St. Paul's Hospital; McMaster University; Princess Margaret Cancer Centre; Foothills Medical Centre; University of Alberta; McGill University; McGill University Health Centre; Jewish General Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Quality of life (healthcare); Comorbidity; Cohort; Internal medicine; Physical therapy","score_opus":0.05395958110658142,"score_gpt":0.34436892639269584,"score_spread":0.2904093452861144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2623919964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99847406,0.000035163826,0.00009027992,0.000017688943,0.00003622247,0.0011456927,0.00012896284,0.000011571454,0.00006038376],"genre_scores_gemma":[0.99910706,0.000021577864,0.000738591,0.000024860268,0.000051399726,0.000018041683,0.0000053282115,0.00002177616,0.000011362869],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997272,0.00024474284,0.00060872757,0.0004700246,0.0010616002,0.00034288265],"domain_scores_gemma":[0.9981417,0.00022143505,0.0001740266,0.00032579288,0.00060375844,0.0005332559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016192709,0.00017438296,0.000448057,0.00019858488,0.00014681403,0.000025696381,0.000141858,0.000107165586,0.000015474274],"category_scores_gemma":[0.0005925908,0.000103804865,0.000051745665,0.00024153729,0.0002028308,0.00017605202,0.000068527675,0.00021924917,0.0000013143205],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068987077,0.0021373276,0.98187864,0.0000858788,0.00043047042,0.000014937449,0.00022127767,0.0000048579163,0.006855832,9.770812e-7,0.0000014253332,0.0014696654],"study_design_scores_gemma":[0.016985986,0.0070696836,0.97214544,0.00029726938,0.00014795233,0.000010790214,0.00033430767,0.000006424721,0.002863795,0.0000017837174,5.146635e-7,0.00013605675],"about_ca_topic_score_codex":0.16121309,"about_ca_topic_score_gemma":0.111413285,"teacher_disagreement_score":0.049799807,"about_ca_system_score_codex":0.00006849764,"about_ca_system_score_gemma":0.00073240214,"threshold_uncertainty_score":0.90480113},"labels":[],"label_agreement":null},{"id":"W2624315412","doi":"10.1182/blood.v128.22.3976.3976","title":"Outcomes of Adult Philadelphia Positive Acute Lymphoblastic Leukemia Patients Treated with Pediatric Multi-Agent Chemotherapy and Imatinib and the Impact of Residual Disease Monitoring on Survival","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Imatinib; Minimal residual disease; Imatinib mesylate; Chemotherapy; Oncology; Surgery; Leukemia; Myeloid leukemia","score_opus":0.010022237313677169,"score_gpt":0.26519829035814707,"score_spread":0.2551760530444699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2624315412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987443,0.00013188402,0.0000052062255,0.00011948558,0.00002182193,0.00068199716,0.00025706683,0.000019306877,0.000018936385],"genre_scores_gemma":[0.99919873,0.00048530192,0.00012796662,0.0000118626085,0.000057014688,0.000025740996,0.000015577312,0.000033225526,0.000044563425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988365,0.000066447756,0.00029134296,0.00027044435,0.00032104945,0.00021417384],"domain_scores_gemma":[0.998773,0.00037780925,0.00023543622,0.00028365466,0.0001557432,0.00017436461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006129689,0.00026069436,0.00049673027,0.00009098888,0.00004540773,0.000006676788,0.00006202616,0.000052483905,0.000007061542],"category_scores_gemma":[0.00012937609,0.00011266708,0.000091324466,0.00011409681,0.00017789715,0.0000556556,0.000033475146,0.000058438698,0.0000012892194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005311016,0.000808308,0.9911013,0.000053424174,0.0012509704,0.000023796414,0.00038615227,0.0000023482262,0.0005410251,0.0000043365353,0.000005132407,0.00051216036],"study_design_scores_gemma":[0.08212421,0.001323976,0.90839756,0.0002242316,0.001423057,0.0000071067766,0.000025196428,0.00003249371,0.006332452,0.0000033232448,4.2505242e-8,0.00010638205],"about_ca_topic_score_codex":0.00031105513,"about_ca_topic_score_gemma":0.0000025601091,"teacher_disagreement_score":0.08270381,"about_ca_system_score_codex":0.00029508278,"about_ca_system_score_gemma":0.0002533323,"threshold_uncertainty_score":0.45944303},"labels":[],"label_agreement":null},{"id":"W2624452439","doi":"10.1182/blood.v128.22.3947.3947","title":"Novel Fatty Acid Oxidation Inhibitor Avocatinb Induces AMPK-Dependent Apoptosis of AML Cells Co-Cultured with BM-Adipocytes","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Apoptosis; Stromal cell; Bone marrow; Adipocyte; Beta oxidation; Cell culture; Cancer research; Mesenchymal stem cell; AMPK; Biology; Chemistry; Stem cell; Internal medicine; Cell biology; Endocrinology; Fatty acid; Biochemistry; Adipose tissue; Immunology; Medicine; Phosphorylation; Protein kinase A","score_opus":0.018922615781695004,"score_gpt":0.2684599733449065,"score_spread":0.2495373575632115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2624452439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957065,0.00010057714,0.001031824,0.0007592288,0.00006203657,0.00066432817,0.00007695719,0.00006491226,0.0015336644],"genre_scores_gemma":[0.9915206,0.000056466128,0.00676908,0.00009271578,0.0002867102,0.00005719663,0.000047868285,0.00004471953,0.0011246625],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979903,0.000055307046,0.00037448417,0.00041752003,0.00077269285,0.0003896896],"domain_scores_gemma":[0.99856263,0.00012396202,0.0002207474,0.0005020799,0.00037331076,0.00021727153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028558768,0.00023935082,0.0004032465,0.00016924736,0.00006143387,0.000024586321,0.00022017863,0.00019471804,0.00018659484],"category_scores_gemma":[0.00016714259,0.00013820079,0.00007913321,0.00027912576,0.00020508825,0.000192671,0.0000754781,0.00023765855,0.000181555],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002847975,0.00077439134,0.0028658533,0.00012728476,0.00025083937,0.00000836767,0.00037057558,4.287735e-7,0.9930098,0.00003042572,0.00087771623,0.0013995344],"study_design_scores_gemma":[0.008860538,0.00065531424,0.0032928009,0.00032928414,0.00023365083,0.000054626747,0.00026008234,0.0000020804275,0.98583037,0.000007319467,0.00028408528,0.00018984133],"about_ca_topic_score_codex":0.000084252664,"about_ca_topic_score_gemma":0.0000132046935,"teacher_disagreement_score":0.00857574,"about_ca_system_score_codex":0.00015999621,"about_ca_system_score_gemma":0.00032901077,"threshold_uncertainty_score":0.56356645},"labels":[],"label_agreement":null},{"id":"W2624497242","doi":"10.1182/blood.v128.22.5173.5173","title":"Outcome of acute Myeloid Leukemia in Adults Patients Treated According to Morocco National AML-MA-2011 Protocol in Casablanca, Morocco","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; McMaster Children's Hospital","funders":"","keywords":"Medicine; Bone marrow; Internal medicine; Myeloid leukemia; Biopsy; Giemsa stain; Surgery; Pediatrics; Pathology","score_opus":0.021023420167819395,"score_gpt":0.3171388374506465,"score_spread":0.29611541728282714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2624497242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9653199,0.000003578726,0.000009611239,0.00029481392,0.00003332286,0.03191547,0.0001309654,0.000052131036,0.0022402408],"genre_scores_gemma":[0.9740737,0.00000531504,0.00063202955,0.00022450298,0.000102238824,0.023892257,0.000045113753,0.000060405688,0.0009644085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996724,0.00010360213,0.0009489148,0.00059306575,0.0009508826,0.0006795342],"domain_scores_gemma":[0.9984227,0.00018184281,0.00018483451,0.00044215875,0.0005005863,0.00026788464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004874065,0.00031634117,0.00067874766,0.0008781016,0.000035432022,0.000012067062,0.0003441125,0.00022917641,0.00020617135],"category_scores_gemma":[0.0006405002,0.00022791784,0.00011223856,0.00073172303,0.000074094954,0.00024388159,0.00022984964,0.0003493455,0.0002703881],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002189994,0.000678978,0.97956944,0.00018448317,0.00011463026,0.00016343856,0.00024651253,0.0000035853895,0.013598753,0.000023056684,0.00057836075,0.002648776],"study_design_scores_gemma":[0.044411395,0.00086604996,0.91437584,0.00090246124,0.000056126595,0.00003145885,0.00007655035,0.000096129515,0.038487833,0.00003774337,0.0003351207,0.00032327662],"about_ca_topic_score_codex":0.0014571511,"about_ca_topic_score_gemma":0.00029192233,"teacher_disagreement_score":0.06519357,"about_ca_system_score_codex":0.0019596855,"about_ca_system_score_gemma":0.00076605665,"threshold_uncertainty_score":0.929422},"labels":[],"label_agreement":null},{"id":"W2624748903","doi":"10.1182/blood.v128.22.1974.1974","title":"Combined DNA and Transcriptome Sequencing Reveals Discrete Subtypes of Myelodysplasia","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Biology; CD34; Transcriptome; Myelodysplastic syndromes; Proportional hazards model; Myeloid; Survival analysis; Bone marrow; Gene; NPM1; Cancer research; Genetics; Immunology; Gene expression; Molecular biology; Stem cell; Internal medicine; Medicine; Karyotype","score_opus":0.017248883058844342,"score_gpt":0.26582666400589666,"score_spread":0.24857778094705232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2624748903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99464065,0.0002574817,0.0000865346,0.0018247749,0.000034711393,0.00030790857,0.000027918524,0.00004762278,0.0027724125],"genre_scores_gemma":[0.99676466,0.00020427273,0.00065959885,0.00009428768,0.00007722639,0.000012552507,0.00000521035,0.000027097973,0.0021550946],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99886,0.000054494183,0.00026357148,0.0002453998,0.00028171323,0.00029482617],"domain_scores_gemma":[0.9992123,0.00014479882,0.00006017864,0.00031192656,0.000093727394,0.00017705784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003034703,0.00012990502,0.00034666626,0.00012013584,0.000037436097,0.0000073636456,0.000101047706,0.000092372225,0.00010511107],"category_scores_gemma":[0.00019772224,0.00008079158,0.00006206003,0.00015750807,0.000191988,0.00009260372,0.00003948324,0.0001202103,0.000021771619],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019497244,0.000053944896,0.032801285,0.00018000844,0.000124015,0.00006797058,0.0002934942,1.7110368e-8,0.9644772,0.0005617574,0.0002530478,0.0009922867],"study_design_scores_gemma":[0.015149505,0.001165435,0.12376513,0.00076289935,0.00037521168,0.0002574607,0.0001902041,0.000013392124,0.8564753,0.0009338408,0.00067517767,0.00023646088],"about_ca_topic_score_codex":0.0000325373,"about_ca_topic_score_gemma":0.0000039961024,"teacher_disagreement_score":0.108001925,"about_ca_system_score_codex":0.00006648128,"about_ca_system_score_gemma":0.00017576924,"threshold_uncertainty_score":0.3294585},"labels":[],"label_agreement":null},{"id":"W2624994883","doi":"10.1182/blood.v128.22.87.87","title":"Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a Single-Dose Oral Solution of Dabigatran Given after Standard Anticoagulant Therapy in Children (Two Age Groups: 1-&lt;2 and 2-&lt;12 Years Old), with Venous Thromboembolism","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Children's Hospital of Eastern Ontario; University of Ottawa","funders":"","keywords":"Medicine; Dabigatran; Tolerability; Dosing; Pharmacodynamics; Pharmacokinetics; Heparin; Anesthesia; Warfarin; Adverse effect; Internal medicine; Pharmacology; Atrial fibrillation","score_opus":0.022354673897355307,"score_gpt":0.2975474512377221,"score_spread":0.2751927773403668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2624994883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99525076,0.0030873222,0.00006330548,0.0005882631,0.000043758475,0.00065853994,0.0001930319,0.000019357174,0.000095684896],"genre_scores_gemma":[0.99260426,0.006742876,0.0004224767,0.000118763375,0.00006631116,0.000008860954,0.00000825438,0.000022525834,0.0000056817494],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985868,0.00012826677,0.0003986089,0.00032279297,0.00027303703,0.0002905282],"domain_scores_gemma":[0.9993162,0.00014351861,0.00016383978,0.00017237685,0.00006884374,0.00013518476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039607834,0.00019875701,0.0006809864,0.00006468065,0.00003734098,0.000010579354,0.00006839151,0.000057618767,0.00004561682],"category_scores_gemma":[0.000040118128,0.00013134234,0.00005035535,0.00010781108,0.00048097133,0.00013791143,0.00007170673,0.00015314053,3.7765943e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00864994,0.0028628954,0.5348812,0.0002038631,0.0008828275,0.00010371798,0.0013860539,0.0000022386257,0.38294262,0.00003277603,0.000009204471,0.06804272],"study_design_scores_gemma":[0.024980025,0.0019809646,0.95113015,0.0002671677,0.0006449182,0.000104063365,0.000034480337,0.000059774946,0.01996692,0.000097272,0.0005247249,0.00020952057],"about_ca_topic_score_codex":0.00018688361,"about_ca_topic_score_gemma":0.000107789936,"teacher_disagreement_score":0.416249,"about_ca_system_score_codex":0.000031962598,"about_ca_system_score_gemma":0.000033005123,"threshold_uncertainty_score":0.5355986},"labels":[],"label_agreement":null},{"id":"W2625414910","doi":"10.1182/blood-2017-03-737460","title":"How I treat patients with aggressive lymphoma at high risk of CNS relapse","year":2017,"lang":"en","type":"review","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"BC Cancer Agency","keywords":"Medicine; Internal medicine; Lymphoma; Aggressive lymphoma; Oncology; Rituximab","score_opus":0.02568196772515453,"score_gpt":0.2763027689729554,"score_spread":0.2506208012478009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2625414910","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05425552,0.9423602,1.7793076e-7,0.00002251684,0.00011675363,0.0015156943,0.0010020583,0.00003317554,0.00069390686],"genre_scores_gemma":[0.0050454927,0.9906076,0.00013270474,0.000007011074,0.00014806598,0.00032122023,0.0010369989,0.00011042285,0.0025904782],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980663,0.00009445844,0.00042535778,0.0006042486,0.00048158714,0.00032806868],"domain_scores_gemma":[0.9957701,0.00018075277,0.0022453074,0.0014043271,0.0001714692,0.00022806453],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000056726287,0.0006349467,0.0027003014,0.00017138426,0.00017229248,0.000042360312,0.00021788248,0.00034634498,0.000042999814],"category_scores_gemma":[0.0002092172,0.0003631034,0.0007081984,0.00010868356,0.00014770737,0.000058626636,0.00013950796,0.00010559084,0.00006510926],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000068694004,0.0040810127,0.041431412,0.0047812276,0.0028828813,0.0006619154,0.000027994367,1.06344755e-8,2.4076753e-8,0.000015244261,0.0005902981,0.9454593],"study_design_scores_gemma":[0.023984315,0.002309763,0.07575173,0.044582814,0.052708786,0.00033689363,0.0000051794373,6.3424096e-8,0.000059072252,0.000006155078,0.7997203,0.00053491973],"about_ca_topic_score_codex":0.0002530665,"about_ca_topic_score_gemma":0.000054655786,"teacher_disagreement_score":0.94492435,"about_ca_system_score_codex":0.0002976771,"about_ca_system_score_gemma":0.0003248013,"threshold_uncertainty_score":0.9998821},"labels":[],"label_agreement":null},{"id":"W2625429274","doi":"10.1182/blood.v128.22.1686.1686","title":"A Novel Micro RNA Signature Identifies a Patient Subset with Poor Prognosis in Core Binding Factor AML","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Advanced biosensing and bioanalysis techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Core binding factor; Oncology; Myeloid leukemia; Medicine; Internal medicine; NPM1; Cohort; Biomarker; microRNA; Cancer; Bioinformatics; Gene; Biology; Transcription factor; Genetics; Chromosome","score_opus":0.011162080333141271,"score_gpt":0.23930954111983213,"score_spread":0.22814746078669085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2625429274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987266,0.00016432947,0.0005638699,0.00012161449,0.000021852038,0.00018737848,0.0001450076,0.000034896926,0.00003445928],"genre_scores_gemma":[0.9954524,0.000073797986,0.0040840413,0.00008475121,0.000049062903,0.000021048181,0.000056563855,0.000020629152,0.00015767643],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990641,0.00001660586,0.0001757479,0.00037964477,0.00012308023,0.0002408205],"domain_scores_gemma":[0.99956703,0.000010773885,0.00011013892,0.00018431102,0.00007864359,0.000049105223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004820502,0.00017546563,0.00015937864,0.00008312983,0.000049903632,0.000022364931,0.00011396989,0.00016157333,0.000002166641],"category_scores_gemma":[0.000043509404,0.00010382417,0.00007292619,0.00015533336,0.00007795762,0.000005731614,0.000065820685,0.00007374962,0.0000017111381],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005873631,0.00025738226,0.013236956,0.000009174417,0.00007545501,0.000014256194,0.000029082223,2.0985496e-7,0.98446596,0.0000015909428,0.00015080611,0.0017003826],"study_design_scores_gemma":[0.0008044811,0.00034783376,0.0015403742,0.0001209983,0.000038106144,0.0000297172,0.00005199599,9.073794e-7,0.99624205,0.000008440904,0.00060011615,0.00021500574],"about_ca_topic_score_codex":0.000010944215,"about_ca_topic_score_gemma":0.00014551466,"teacher_disagreement_score":0.011776054,"about_ca_system_score_codex":0.0000123471145,"about_ca_system_score_gemma":0.000028038005,"threshold_uncertainty_score":0.42338267},"labels":[],"label_agreement":null},{"id":"W2625742390","doi":"10.1182/blood.v128.22.1379.1379","title":"Megakaryocyte Apoptosis in the Bone Marrow of Patients with Immune Thrombocytopenia","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; McMaster University","funders":"","keywords":"Megakaryocyte; Bone marrow; Medicine; Thrombopoiesis; Immunology; Terminal deoxynucleotidyl transferase; Thrombopoietin receptor; Bone marrow failure; Pathology; Haematopoiesis; Pancytopenia; Thrombopoietin; Biology; TUNEL assay; Immunohistochemistry; Stem cell","score_opus":0.00767744299286085,"score_gpt":0.21549423652882072,"score_spread":0.20781679353595986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2625742390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99697137,0.00023789123,0.0000026998562,0.0004967104,0.000015859529,0.00035058384,0.00001805893,0.000008865958,0.0018979784],"genre_scores_gemma":[0.9995085,0.000060192433,0.0001520038,0.00008348151,0.0000074589448,0.000021908409,0.000016639828,0.000011087415,0.00013872044],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99933183,0.000023477522,0.00016333397,0.00012553726,0.00020424134,0.00015160134],"domain_scores_gemma":[0.99956965,0.000040972773,0.000065107946,0.00026183057,0.000035532135,0.000026915948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000069288595,0.00009683251,0.00029215548,0.000045927012,0.000021586487,0.0000036326107,0.000073178475,0.000035388435,0.00006753877],"category_scores_gemma":[0.000018462322,0.000040291783,0.000041943415,0.00012789661,0.00004803371,0.000055644512,0.000017833521,0.00004367117,0.000018720919],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058980234,0.004564949,0.979623,0.000040171228,0.00029597533,0.000100898134,0.00035924264,7.354805e-8,0.009679287,0.000088501954,0.00013683319,0.004521227],"study_design_scores_gemma":[0.01952817,0.0007494892,0.94183713,0.00015607485,0.00023623348,0.000016019094,0.00004840431,2.0876041e-7,0.037030462,0.00007841784,0.00024053348,0.00007887855],"about_ca_topic_score_codex":0.00005866508,"about_ca_topic_score_gemma":0.000021857353,"teacher_disagreement_score":0.03778593,"about_ca_system_score_codex":0.000010821092,"about_ca_system_score_gemma":0.000024907458,"threshold_uncertainty_score":0.16430512},"labels":[],"label_agreement":null},{"id":"W2625841244","doi":"10.1182/blood.v128.22.2180.2180","title":"Thrombospondin-1-Derived Peptide Rfyvvmwk Improves the Adhesive Phenotype of CD34+ Cells from Atherosclerotic Patients with Type II Diabetes","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal; Montreal Heart Institute","funders":"","keywords":"CD34; Vitronectin; Progenitor cell; Stem cell; Cancer research; Cell biology; Immunology; Chemistry; Extracellular matrix; Molecular biology; Medicine; Biology; Fibronectin","score_opus":0.005904255041056298,"score_gpt":0.19111293289425832,"score_spread":0.18520867785320203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2625841244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998668,0.00066281867,0.000027560392,0.000040460556,0.00013092736,0.00019711198,0.000100860845,0.0000076131582,0.00016462497],"genre_scores_gemma":[0.9989975,0.0001449819,0.0002428085,0.00012839348,0.00015786856,0.0000159731,0.00003333286,0.000030445783,0.00024870815],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992109,0.000035606903,0.00014980698,0.00027155573,0.00012607909,0.00020607459],"domain_scores_gemma":[0.99924815,0.000031445456,0.00013683931,0.00039136596,0.00014873048,0.000043463588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000047543122,0.00015556502,0.00016188582,0.000012118759,0.00008234293,0.000007873495,0.00022226595,0.00008892484,0.00008603073],"category_scores_gemma":[0.00002700277,0.00007883678,0.000079475205,0.000060149872,0.00014279039,0.0000046903333,0.000111433015,0.000029634355,0.00001373422],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060400715,0.00019598617,0.050188214,0.000005641127,0.00022891513,1.2902615e-7,0.000059379086,6.7113353e-7,0.94802976,0.000006616703,0.0003117012,0.0009126101],"study_design_scores_gemma":[0.0011758386,0.000940552,0.14595395,0.00003789111,0.00011478919,4.0437065e-8,0.000028759168,4.4288257e-7,0.8506324,0.000025339772,0.00094906124,0.00014093758],"about_ca_topic_score_codex":0.000020255236,"about_ca_topic_score_gemma":0.000014603854,"teacher_disagreement_score":0.097397335,"about_ca_system_score_codex":0.0000056534764,"about_ca_system_score_gemma":0.00005041669,"threshold_uncertainty_score":0.32148707},"labels":[],"label_agreement":null},{"id":"W2625960167","doi":"10.1182/blood.v128.22.682.682","title":"Long-Term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Chronic Lymphocytic Leukemia (CLL): 10-Year Follow-up of the Gcllsg CLL3X Trial","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Fludarabine; Cumulative incidence; Chronic lymphocytic leukemia; Internal medicine; Hematopoietic stem cell transplantation; Transplantation; Incidence (geometry); Surgery; Oncology; Leukemia; Cyclophosphamide; Chemotherapy","score_opus":0.029967683680596744,"score_gpt":0.29250807591740235,"score_spread":0.2625403922368056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2625960167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99535084,0.0006840812,0.0003420342,0.00006099466,0.00041623408,0.0026209764,0.00010908412,0.000047977468,0.00036776197],"genre_scores_gemma":[0.9930842,0.0002341312,0.000098901335,0.000029081008,0.0002935927,0.00017823381,0.000024132796,0.0000789606,0.0059787994],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9968403,0.00013011668,0.0010541523,0.00049914507,0.00086017617,0.000616127],"domain_scores_gemma":[0.997515,0.0006094641,0.00041398456,0.0010432064,0.00023853677,0.00017977833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005886177,0.00031614583,0.00080879923,0.0001478969,0.000077355275,0.000012526648,0.0005217646,0.00028086285,0.000252066],"category_scores_gemma":[0.0001097583,0.00018875625,0.00062456395,0.0002731705,0.00028815103,0.000087997425,0.00008664825,0.000119534634,0.00007379469],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.21430077,0.0033539063,0.036283426,0.04242884,0.003492226,0.00047116264,0.0039641657,0.000137204,0.6807132,0.0013523934,0.0017824689,0.011720247],"study_design_scores_gemma":[0.5219241,0.0017749738,0.0032847147,0.00080045953,0.001379566,0.00022759898,0.000042623116,0.00010875315,0.4700982,0.000040398987,0.00007293543,0.00024571933],"about_ca_topic_score_codex":0.00010459758,"about_ca_topic_score_gemma":0.000074789976,"teacher_disagreement_score":0.30762327,"about_ca_system_score_codex":0.012312451,"about_ca_system_score_gemma":0.015034739,"threshold_uncertainty_score":0.9914791},"labels":[],"label_agreement":null},{"id":"W2626574197","doi":"","title":"Transcriptional repression of the rara pathyway is crucial for leukemogenesis","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Psychological repression; Biology; Cancer research; Medicine; Genetics; Gene; Gene expression","score_opus":0.022116223042506496,"score_gpt":0.28068675703731577,"score_spread":0.2585705339948093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2626574197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927224,0.00042770364,0.000056134253,0.0018377446,0.000057912937,0.00060367526,0.000087777924,0.000021130896,0.004185504],"genre_scores_gemma":[0.98726994,0.00011197074,0.0011691543,0.00059449935,0.000364587,0.00006943091,0.000015093835,0.00002501394,0.010380297],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998949,0.000040335697,0.00022435831,0.00021881355,0.000364889,0.00020262359],"domain_scores_gemma":[0.9993497,0.000060791157,0.000038503716,0.00038363598,0.00009518338,0.00007215065],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018885086,0.00009287028,0.00019374701,0.000040554496,0.00009598396,0.0000059133013,0.00016971903,0.00010176222,0.0014318685],"category_scores_gemma":[0.00006648194,0.000059620794,0.0002245266,0.00012482052,0.00008639182,0.000038421298,0.000019182384,0.00012223075,0.000022772127],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020894466,0.0012945186,0.016189873,0.0003234453,0.00034416316,0.000021154307,0.0019463059,0.000017686745,0.88235503,0.0003158192,0.021025319,0.07407724],"study_design_scores_gemma":[0.01490854,0.00042037744,0.17054677,0.00022016698,0.00045769732,0.00012645613,0.0000726477,0.0003191047,0.7433186,0.00045885373,0.06897145,0.00017930077],"about_ca_topic_score_codex":0.000034842302,"about_ca_topic_score_gemma":0.0000034585662,"teacher_disagreement_score":0.1543569,"about_ca_system_score_codex":0.00004224246,"about_ca_system_score_gemma":0.0003196155,"threshold_uncertainty_score":0.99948096},"labels":[],"label_agreement":null},{"id":"W2626728407","doi":"10.1182/blood.v128.22.1274.1274","title":"Agreement Between R2 and R2* Liver Iron Estimates Is Independent of the Type of Iron Removal Therapy: Results from the Twitch Trial","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Phlebotomy; Medicine; Midpoint; Confidence interval; Randomization; Nuclear medicine; Clinical trial; Surgery; Internal medicine; Mathematics","score_opus":0.026069399232579674,"score_gpt":0.26002426407341717,"score_spread":0.2339548648408375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2626728407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99262077,0.0024235803,0.0000032292216,0.0034926122,0.00013984178,0.0005451358,0.00007841902,0.0000090339045,0.000687384],"genre_scores_gemma":[0.99746144,0.0018057697,0.00010652974,0.00013917158,0.00014106625,0.0000025633599,0.0000075098787,0.00001180115,0.00032414013],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998963,0.000060254944,0.0003292284,0.00019011302,0.00031696874,0.00014041658],"domain_scores_gemma":[0.99907476,0.00023776932,0.0001819223,0.0004022487,0.000058282498,0.00004503169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002621161,0.00011734234,0.00024102618,0.000019769106,0.00005157307,0.0000052133205,0.00013560688,0.00013587782,0.00008172367],"category_scores_gemma":[0.00015341824,0.0000465421,0.00007866919,0.00008786895,0.00014595318,0.000021916729,0.00007895414,0.000121510595,0.000007914135],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.072600335,0.004652148,0.39125085,0.00027293456,0.003331722,0.00008870118,0.022552093,0.0000055612336,0.22484806,0.00018161406,0.015445874,0.26477012],"study_design_scores_gemma":[0.29987353,0.0054477253,0.5092776,0.0014066708,0.0022862693,0.00003542498,0.0012863595,0.000029947805,0.16655438,0.0006714825,0.012712158,0.00041847856],"about_ca_topic_score_codex":0.00058420707,"about_ca_topic_score_gemma":0.000012665287,"teacher_disagreement_score":0.26435164,"about_ca_system_score_codex":0.000010725742,"about_ca_system_score_gemma":0.00006410986,"threshold_uncertainty_score":0.18979317},"labels":[],"label_agreement":null},{"id":"W2626970433","doi":"10.1182/blood.v128.22.1339.1339","title":"Src-like Adaptor Protein Promotes the CD103+ dendritic Cell Homeostasis in the Lung","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation","funders":"","keywords":"Dendritic cell; Progenitor cell; Biology; Cell biology; Immune system; Immunology; Acquired immune system; Antigen-presenting cell; Stem cell; T cell","score_opus":0.009001423003594989,"score_gpt":0.21269851180152607,"score_spread":0.20369708879793108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2626970433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9683977,0.027570166,0.000032057465,0.0023186014,0.00021697058,0.00085368025,0.00002889372,0.000047538706,0.0005344381],"genre_scores_gemma":[0.99388754,0.00032751984,0.000024445866,0.00031604068,0.000030789008,0.00023098668,0.0000063810558,0.000021951017,0.005154335],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980941,0.0008798842,0.00027549025,0.00023805087,0.00005458568,0.00045789426],"domain_scores_gemma":[0.99878055,0.0005092396,0.00008793762,0.0005802086,0.000033839628,0.00000820906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006152425,0.00019654831,0.00019793642,0.00007608387,0.00028251394,0.000031084557,0.00062682724,0.00017087125,0.0003286019],"category_scores_gemma":[0.000115234245,0.00008506639,0.000110683664,0.00017899931,0.00027758017,0.000099793266,0.000066059045,0.00027041044,0.00034417535],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025710306,0.0006411372,0.0006970692,0.000019486994,0.00012563914,0.000013594798,0.001327119,3.986992e-8,0.99039376,0.00034015457,0.0014946363,0.004690286],"study_design_scores_gemma":[0.0044613136,0.00036471794,0.0089417165,0.00015072768,0.000078375066,0.000153345,0.00064574,2.2765639e-7,0.92345774,0.000158903,0.06133714,0.00025005284],"about_ca_topic_score_codex":0.000069213675,"about_ca_topic_score_gemma":0.000015934673,"teacher_disagreement_score":0.066935994,"about_ca_system_score_codex":0.000017926368,"about_ca_system_score_gemma":0.00008224491,"threshold_uncertainty_score":0.44237927},"labels":[],"label_agreement":null},{"id":"W2627028493","doi":"10.1182/blood.v128.22.4172.4172","title":"Intratumoral Administration of the Immunotherapeutic Combination Anti-ctla4, Anti-cd137 and Anti-ox40: Comparison to Systemic Administration, Peri-Draining Lymph Node Injection, and Cellular Vaccine in a Mouse Lymphoma Model","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Cancer immunotherapy; Immunotherapy; Cancer research; Immune system; Systemic administration; Cancer; CD137; Immunology; Internal medicine; In vivo; Biology","score_opus":0.015068652019173867,"score_gpt":0.2570639547747318,"score_spread":0.24199530275555795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2627028493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960157,0.0011315326,0.0009395683,0.00101107,0.00010936188,0.0006827409,0.000023810497,0.000040933457,0.000045263438],"genre_scores_gemma":[0.99917996,0.0002018904,0.00017963779,0.00019621775,0.000041704854,0.000034622026,0.000014538758,0.00003113783,0.000120317505],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99832684,0.0001034361,0.00069429335,0.00036578524,0.0002671637,0.00024246714],"domain_scores_gemma":[0.9990948,0.00005215058,0.00028219563,0.00034978695,0.00014365278,0.00007741832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038495645,0.00023859314,0.00047996602,0.00019157442,0.00013243503,0.00005130481,0.00011277267,0.00014188098,0.000008890629],"category_scores_gemma":[0.000046398898,0.00016808255,0.00006691336,0.00035893606,0.00010370659,0.00017677456,0.000037568603,0.00007478115,9.2849e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007415743,0.00064922695,0.2629051,0.000157499,0.00009948402,0.000005370544,0.001024754,0.000029067696,0.7322207,0.00008887723,0.000013046262,0.0020653338],"study_design_scores_gemma":[0.019566108,0.00094246137,0.5294723,0.0011472481,0.00022354504,0.00058146374,0.00089187676,0.0038148512,0.44292185,0.000045114397,0.00003324269,0.00035998187],"about_ca_topic_score_codex":0.000082084654,"about_ca_topic_score_gemma":0.000042145784,"teacher_disagreement_score":0.28929883,"about_ca_system_score_codex":0.000097308184,"about_ca_system_score_gemma":0.0003273249,"threshold_uncertainty_score":0.68542075},"labels":[],"label_agreement":null},{"id":"W2628084958","doi":"10.1182/blood.v128.22.4519.4519","title":"A Comparison of Cyclophosphamide, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Transplant Eligible Patients with Newly Diagnosed Multiple Myeloma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Bortezomib; Dexamethasone; Internal medicine; Multiple myeloma; Cyclophosphamide; Autologous stem-cell transplantation; Regimen; Transplantation; Induction chemotherapy; Surgery; Gastroenterology; Oncology; Chemotherapy","score_opus":0.021932576883592965,"score_gpt":0.2921746258348039,"score_spread":0.27024204895121096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2628084958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964265,0.0018020505,0.00011110389,0.00011965729,0.00004099502,0.0011527975,0.00014808154,0.00004062638,0.0001581796],"genre_scores_gemma":[0.9942194,0.0008473685,0.0046520988,0.00001912216,0.000023412647,0.00009816466,0.000058886028,0.000044166387,0.000037352715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977622,0.000095780764,0.00048749574,0.0005549715,0.00052541523,0.0005741388],"domain_scores_gemma":[0.9978063,0.001096226,0.00015759592,0.0003771895,0.0001294693,0.0004332365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019955025,0.00032840428,0.00082129735,0.0002468597,0.00006517674,0.000018537565,0.000098247605,0.00014596699,0.000031671236],"category_scores_gemma":[0.00040276692,0.00021049101,0.000058599875,0.00030333913,0.00025278263,0.00015481694,0.000054613058,0.00018369815,0.0000058606433],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009536341,0.0027973475,0.94734025,0.0001389182,0.00040472546,0.00021636035,0.00045236817,8.9213194e-7,0.0036303105,0.000010141144,0.000017339813,0.035455022],"study_design_scores_gemma":[0.1107357,0.0026704266,0.8595549,0.00048397764,0.00028761794,0.000013554938,0.000095744035,0.000087557884,0.025773762,0.000009488938,0.00006939805,0.00021788769],"about_ca_topic_score_codex":0.0008088972,"about_ca_topic_score_gemma":0.0009426174,"teacher_disagreement_score":0.10119936,"about_ca_system_score_codex":0.00005294251,"about_ca_system_score_gemma":0.00011468852,"threshold_uncertainty_score":0.8583574},"labels":[],"label_agreement":null},{"id":"W2639253133","doi":"10.1182/blood.v128.22.4505.4505","title":"Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to Bortezomib, Thalidomide and Dexamethasone (VTD) As Induction Therapy for the Treatment of Transplant Eligible Multiple Myeloma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Bortezomib; Medicine; Thalidomide; Dexamethasone; Multiple myeloma; Regimen; Cyclophosphamide; Internal medicine; Autologous stem-cell transplantation; Lenalidomide; Gastroenterology; Oncology; Surgery; Chemotherapy","score_opus":0.037364715148987725,"score_gpt":0.31157889982393855,"score_spread":0.27421418467495084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2639253133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861354,0.0078083235,0.000708325,0.0014368524,0.00008289722,0.0034343817,0.00025116338,0.000056790854,0.00008582357],"genre_scores_gemma":[0.9786179,0.015968436,0.00404261,0.00009864592,0.00012657323,0.00071640266,0.000039570463,0.000052963533,0.00033687407],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980007,0.000091641385,0.00042916654,0.000574861,0.00036658734,0.00053708645],"domain_scores_gemma":[0.99739456,0.0013728383,0.00012954549,0.00051912654,0.0001594673,0.00042448248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002983457,0.00036691176,0.0006997713,0.00017077531,0.0001955525,0.000032885277,0.00011101644,0.00013245214,0.00004136076],"category_scores_gemma":[0.00019689059,0.00019180775,0.00015362869,0.00022113867,0.00020699955,0.00010238341,0.000023879857,0.00007591609,0.000008641287],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01206306,0.0034396907,0.37735844,0.00009491249,0.002261674,0.00008431543,0.0015618317,0.000002111305,0.2223704,0.00006312516,0.00009569703,0.38060474],"study_design_scores_gemma":[0.051652946,0.0051486623,0.49079382,0.0001800246,0.00054296246,0.00018478255,0.00022447843,0.00008783612,0.44682527,0.00014359615,0.0039675515,0.0002480558],"about_ca_topic_score_codex":0.0009913053,"about_ca_topic_score_gemma":0.00022680323,"teacher_disagreement_score":0.38035667,"about_ca_system_score_codex":0.000071221475,"about_ca_system_score_gemma":0.00012272308,"threshold_uncertainty_score":0.7821693},"labels":[],"label_agreement":null},{"id":"W2642831584","doi":"10.1182/blood.v128.22.4403.4403","title":"Systemic Exposure of Rituximab Increased By Ibrutinib: Pharmacokinetic Results from the Helios Trial","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Bendamustine; Ibrutinib; Rituximab; Medicine; Tolerability; Internal medicine; Pharmacology; Pharmacokinetics; Oncology; Chronic lymphocytic leukemia; Leukemia; Lymphoma; Adverse effect","score_opus":0.018075422548981607,"score_gpt":0.2785870912286461,"score_spread":0.2605116686796645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2642831584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933669,0.0025795924,0.00001573032,0.00091432995,0.0001871993,0.0012305019,0.00066951895,0.00006742826,0.0009687933],"genre_scores_gemma":[0.9978257,0.0002786912,0.000052866093,0.00014622792,0.0008059729,0.00006548229,0.000064898995,0.000035568602,0.000724583],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9975363,0.00026244216,0.00065959233,0.00039537123,0.0007646486,0.00038162176],"domain_scores_gemma":[0.9969707,0.0016324328,0.00020183445,0.00086427835,0.00014676772,0.00018399584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006949616,0.00018697276,0.0004796282,0.000053841053,0.000051490017,0.000014081574,0.0003592789,0.00013437301,0.00020471409],"category_scores_gemma":[0.0014149667,0.00009521837,0.00014540594,0.00021691935,0.00018269998,0.000046344856,0.000111069676,0.00016617091,0.00017668174],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10629683,0.003978392,0.0006108859,0.00024762415,0.0010027542,0.00025638397,0.00064427045,3.7175434e-7,0.8340851,0.000023296167,0.04490711,0.007946986],"study_design_scores_gemma":[0.7791044,0.0006463846,0.00018472047,0.00072526047,0.00046978693,0.00014385654,0.0000721432,0.00004880847,0.21576025,0.000019608628,0.002697781,0.00012701671],"about_ca_topic_score_codex":0.0015079774,"about_ca_topic_score_gemma":0.000008807453,"teacher_disagreement_score":0.6728076,"about_ca_system_score_codex":0.00071677426,"about_ca_system_score_gemma":0.0022841112,"threshold_uncertainty_score":0.4051915},"labels":[],"label_agreement":null},{"id":"W2642929279","doi":"10.1182/blood.v128.22.1413.1413","title":"Longitudinal Analysis of Long-Term Safety and Efficacy of Recombinant Factor VIII Fc Fusion Protein (rFVIIFc) in Adults/Adolescents with Severe Hemophilia a","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital","funders":"","keywords":"Medicine; Dosing; Interim analysis; Interim; Internal medicine; Factor IX; Pediatrics; Clinical trial","score_opus":0.016434656025791763,"score_gpt":0.27200497449323796,"score_spread":0.2555703184674462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2642929279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984691,0.00019595503,0.000012710341,0.00025857362,0.00001370052,0.0009443467,0.000031838696,0.000013055382,0.00006070085],"genre_scores_gemma":[0.99912775,0.00025891536,0.00009080188,0.0000029634532,0.00001735132,0.000012751491,0.00002173277,0.000016569806,0.00045118542],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984625,0.00006325995,0.0004003932,0.00036719904,0.00042293232,0.0002837191],"domain_scores_gemma":[0.9991592,0.000049607785,0.00014098235,0.00036139658,0.00013440514,0.00015438395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001465781,0.00018549159,0.0006502058,0.0004310465,0.000033199027,0.0000042075426,0.0000904143,0.00010725249,0.000115374256],"category_scores_gemma":[0.000071687,0.00009871587,0.00012262439,0.0006699447,0.0001404046,0.000059551803,0.00007481835,0.00011599014,0.000005160227],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005243472,0.0028775649,0.9657542,0.00058712956,0.0006578023,0.00019089067,0.00019066717,2.8945956e-7,0.013886798,0.0000030327467,0.0000011302302,0.010607021],"study_design_scores_gemma":[0.019661715,0.0016313456,0.95366204,0.004600929,0.000718623,0.000028269133,0.000015489031,0.00000896471,0.019550445,0.0000020658001,0.0000014069828,0.00011873382],"about_ca_topic_score_codex":0.00007665088,"about_ca_topic_score_gemma":0.00020051085,"teacher_disagreement_score":0.014418243,"about_ca_system_score_codex":0.000048124482,"about_ca_system_score_gemma":0.0000898778,"threshold_uncertainty_score":0.40255162},"labels":[],"label_agreement":null},{"id":"W2646599743","doi":"10.1182/blood.v128.22.1212.1212","title":"Expanded Phenotypic and Genetic Heterogeneity in the Clinical Spectrum of FPD-AML: Lymphoid Malignancies and Skin Disorders Are Common Features in Carriers of Germline RUNX1 Mutations","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Platelet disorder; RUNX1; Germline; Germline mutation; Genetics; Leukemia; Biology; Cancer research; Mutation; CEBPA; Medicine; Immunology; Gene; Haematopoiesis; Stem cell; Platelet","score_opus":0.017713579701339015,"score_gpt":0.3114942413868977,"score_spread":0.29378066168555866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2646599743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99534565,0.0022782895,0.000012670622,0.0017989996,0.000017525614,0.0004325243,0.000038192018,0.0000069257812,0.0000692383],"genre_scores_gemma":[0.998174,0.0013621611,0.0002686321,0.00010039771,0.000034161592,0.000024223193,0.000005656062,0.000013805026,0.00001695327],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868363,0.00021965239,0.0004208185,0.00022940125,0.0002209549,0.00022556563],"domain_scores_gemma":[0.99904126,0.00042998174,0.00012234275,0.00030047435,0.000030887975,0.000075076634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039561198,0.00012047944,0.00038702282,0.0001471442,0.000029216033,0.0000061934234,0.00012278873,0.000108156215,0.0000070915507],"category_scores_gemma":[0.00027760022,0.000072752526,0.00005651582,0.0002104957,0.00049123005,0.00003496025,0.000072520044,0.00015273472,4.3577225e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018433972,0.00034002162,0.9881225,0.000097689306,0.000060537324,0.00003325371,0.0007810513,0.000001818604,0.0049034636,0.000033765442,0.00003959733,0.0054019187],"study_design_scores_gemma":[0.0071397764,0.00028361124,0.9783916,0.00014786152,0.00008019133,0.0000791707,0.00066619687,0.000014953855,0.012641214,0.00045443577,0.000025229336,0.00007579695],"about_ca_topic_score_codex":0.00036363088,"about_ca_topic_score_gemma":0.0043796576,"teacher_disagreement_score":0.009730981,"about_ca_system_score_codex":0.00002685848,"about_ca_system_score_gemma":0.00013108006,"threshold_uncertainty_score":0.2966762},"labels":[],"label_agreement":null},{"id":"W266794678","doi":"10.1182/blood.v122.21.514.514","title":"Whole Genome Sequencing Of Chronic Myeloid Leukemia (CML)-Derived Induced Pluripotent Stem Cells (iPSC) Reveals Faithful Genocopying Of Highly Mutated Primary Leukemic Cells","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Induced pluripotent stem cell; Biology; Cancer research; Myeloid leukemia; KLF4; SOX2; Stem cell; Myeloid; Progenitor cell; Genetics; Gene; Embryonic stem cell","score_opus":0.01788640998757009,"score_gpt":0.2193060988833037,"score_spread":0.2014196888957336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W266794678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931931,0.0023247614,0.00005189422,0.00006078137,0.00022649838,0.0029647222,0.00011075838,0.00020003454,0.00086743163],"genre_scores_gemma":[0.99476135,0.0003370269,0.0025326805,0.00016028364,0.00026134934,0.00018543313,0.00017335628,0.00018270452,0.0014058029],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99494743,0.00020516771,0.0017937156,0.001004501,0.0009448884,0.0011042819],"domain_scores_gemma":[0.9962934,0.00019132737,0.0011425257,0.0014307024,0.00047758574,0.00046440784],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037473039,0.00075281214,0.001700899,0.0004361236,0.00012897336,0.000036783505,0.0005332629,0.00047457393,0.0003137413],"category_scores_gemma":[0.000028002785,0.0007023028,0.00041509792,0.0006515126,0.0002219175,0.00031457425,0.00030200105,0.00065256224,0.00037079875],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008763568,0.00042481298,0.00038150308,0.0017487395,0.0008830492,0.00019966766,0.0011821726,0.00063478074,0.9923645,0.0000039254196,0.00010039208,0.001988818],"study_design_scores_gemma":[0.014230703,0.001212936,0.007941246,0.0009905508,0.0009964891,0.00019710243,0.0005239782,0.0004886709,0.9727323,0.000026322916,0.000102284925,0.00055741833],"about_ca_topic_score_codex":0.0016507654,"about_ca_topic_score_gemma":0.000017917302,"teacher_disagreement_score":0.019632205,"about_ca_system_score_codex":0.008339165,"about_ca_system_score_gemma":0.004509395,"threshold_uncertainty_score":0.99954283},"labels":[],"label_agreement":null},{"id":"W2670680731","doi":"10.1182/blood.v128.22.758.758","title":"Minimal Residual Disease Assessment of Remission after Induction Therapy Is Superior to Morphologic Assessment for Risk Stratification in Childhood Acute Lymphoblastic Leukemia: A Report from the Children's Oncology Group (COG)","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Minimal residual disease; Medicine; Internal medicine; Oncology; Population; Cohort; Cog; Bone marrow; Clinical trial; Complete remission; Acute lymphocytic leukemia; Leukemia; Chemotherapy; Lymphoblastic Leukemia","score_opus":0.016517082420828853,"score_gpt":0.32315432944339745,"score_spread":0.3066372470225686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2670680731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98757356,0.00014372978,0.0040825955,0.0042568077,0.0001268558,0.0031291107,0.0005863082,0.000044390417,0.000056661684],"genre_scores_gemma":[0.9850274,0.00030439612,0.012052802,0.00040305546,0.0004399764,0.0013783807,0.0002611197,0.000052352527,0.000080546444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99661857,0.0003221061,0.0008946124,0.0009018838,0.0007710773,0.00049173535],"domain_scores_gemma":[0.9972764,0.0008027719,0.00039177673,0.00097083976,0.00023070847,0.00032748413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000911554,0.00032433003,0.0005543039,0.00019368526,0.00012030321,0.000031083604,0.00029638855,0.00029104733,0.00017962902],"category_scores_gemma":[0.00063387095,0.00018336001,0.00017264795,0.0003347149,0.00017562586,0.00015076603,0.0001369487,0.0003086185,0.0000071849436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057935687,0.0044622147,0.71345866,0.000037879556,0.0011193056,0.00065694354,0.000818284,0.000010479272,0.23539886,0.000052472347,0.0022186954,0.035972655],"study_design_scores_gemma":[0.014838262,0.0023352834,0.9729433,0.0002220822,0.0006943186,0.00020546238,0.00011119173,0.00011788553,0.0077801524,0.00037136883,0.00016547197,0.00021523195],"about_ca_topic_score_codex":0.0003553139,"about_ca_topic_score_gemma":0.000036805366,"teacher_disagreement_score":0.25948465,"about_ca_system_score_codex":0.0014393184,"about_ca_system_score_gemma":0.0034249795,"threshold_uncertainty_score":0.7477204},"labels":[],"label_agreement":null},{"id":"W2683646381","doi":"10.1182/blood.v128.22.708.708","title":"Tet2 Deficiency Leads to an Increased Inflammatory Phenotype in Murine Macrophages","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Phenotype; Biology; Immune system; Knockout mouse; Immunology; Demethylating agent; Gene expression; Cancer research; Gene; Molecular biology; DNA methylation; Genetics","score_opus":0.007051811318661227,"score_gpt":0.240265832019404,"score_spread":0.23321402070074276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2683646381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99755436,0.00077258545,0.0003922884,0.00004932968,0.00004594956,0.00012062121,0.000009299432,0.000011499,0.001044064],"genre_scores_gemma":[0.99871916,0.00010208497,0.00077238114,0.000055792083,0.0001365308,0.000015661835,0.000016381286,0.0000171001,0.0001648925],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992409,0.000053688058,0.00015784334,0.00026646917,0.00008843921,0.00019269859],"domain_scores_gemma":[0.99951667,0.000010153823,0.000033992786,0.0002980285,0.000044492426,0.0000966733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018391806,0.00010040354,0.000082351944,0.000059214293,0.000029138015,0.00001099519,0.00013492552,0.00008591048,0.000025989732],"category_scores_gemma":[0.000113321934,0.00007809765,0.00002631048,0.00007902907,0.000026417107,0.0000037176032,0.000065445594,0.00002902185,0.000031364427],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019759926,0.0001377868,0.106154226,0.0000055588866,0.0000033055412,0.0000044136013,0.000019134006,0.000009606019,0.8902791,0.000045713936,0.0000064471988,0.0033149098],"study_design_scores_gemma":[0.000852182,0.0002527666,0.18303452,0.000009924637,0.0000070509436,8.947984e-7,0.0000057457155,0.0000013875957,0.8142139,0.00011609944,0.001380832,0.00012473654],"about_ca_topic_score_codex":0.000026663782,"about_ca_topic_score_gemma":0.000107863074,"teacher_disagreement_score":0.07688029,"about_ca_system_score_codex":0.000006851368,"about_ca_system_score_gemma":0.00004333549,"threshold_uncertainty_score":0.31847298},"labels":[],"label_agreement":null},{"id":"W2686022823","doi":"10.1182/blood.v128.22.417.417","title":"Post-Thrombotic Syndrome and Functional Disability in Patients with Upper Extremity Deep Vein Thrombosis: A Prospective Cohort Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Dalhousie University; Jewish General Hospital; University of Ottawa; McGill University; Western University","funders":"","keywords":"Medicine; Thrombosis; Warfarin; Surgery; Prospective cohort study; Pulmonary embolism; Deep vein; Low molecular weight heparin; Internal medicine; Cohort; Atrial fibrillation","score_opus":0.006907848311125209,"score_gpt":0.22053224774806582,"score_spread":0.21362439943694062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2686022823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959004,0.000040439525,0.000018074894,0.00031511096,0.000069112284,0.0032151116,0.000014746542,0.00005783855,0.00036918125],"genre_scores_gemma":[0.9993201,0.000012821487,0.00008829408,0.0001109977,0.000029680577,0.00035526408,0.000012467765,0.000027644537,0.000042715656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99823266,0.00007224708,0.00028226955,0.00062665285,0.0004716474,0.00031450787],"domain_scores_gemma":[0.99916756,0.00006937574,0.000072303876,0.00042119564,0.00013415738,0.000135397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002695005,0.00022975539,0.0005883074,0.00007340617,0.000082702936,0.000020779926,0.000059515358,0.000059887683,0.000265861],"category_scores_gemma":[0.00009249486,0.00013880651,0.000047717607,0.00017112643,0.00018478738,0.00018010286,0.00010648087,0.00011652098,0.000025061001],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012499,0.022038754,0.97645545,0.00004901635,0.00054231717,0.000018870756,0.00034533656,4.2869033e-7,0.00003668353,0.00006972951,0.000017910677,0.00030051754],"study_design_scores_gemma":[0.010715775,0.002683734,0.98506296,0.00014938273,0.0007268487,0.000009353228,0.0003418358,0.000001097655,0.000021980126,0.00008463366,0.0000046622404,0.00019773423],"about_ca_topic_score_codex":0.000174757,"about_ca_topic_score_gemma":0.00036190145,"teacher_disagreement_score":0.019355021,"about_ca_system_score_codex":0.00015752853,"about_ca_system_score_gemma":0.000037667065,"threshold_uncertainty_score":0.5660366},"labels":[],"label_agreement":null},{"id":"W2687135656","doi":"10.1182/blood.v128.22.1794.1794","title":"Risk Adjusted Management of Newly Diagnosed High and Intermediate FLIPI Follicular Lymphoma Using (90)Y Ibritumomab Tiuxetan","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Ibritumomab tiuxetan; Follicular lymphoma; Rituximab; Internal medicine; Surgery; Asymptomatic; Lymphoma; Gastroenterology; Radioimmunotherapy; Immunology","score_opus":0.01132159949779818,"score_gpt":0.23088958304358548,"score_spread":0.2195679835457873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2687135656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970149,0.0016524973,0.00006127776,0.00014834077,0.00013999859,0.0005411612,0.000060113965,0.000057818208,0.00032391024],"genre_scores_gemma":[0.99557674,0.0016877404,0.002339797,0.000079818565,0.00010078745,0.00005241221,0.000011979458,0.000033597094,0.00011712601],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99860364,0.000053347885,0.00036764468,0.0003868441,0.00028432955,0.0003041938],"domain_scores_gemma":[0.99901134,0.00010533283,0.00019220232,0.00043631456,0.00006127105,0.00019354434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000101169906,0.0002391613,0.0004579428,0.000114180555,0.000059647464,0.000015821268,0.00008483671,0.00008421103,0.000051207266],"category_scores_gemma":[0.000034440767,0.00015495229,0.00013632627,0.00014911254,0.000100612495,0.00008235464,0.000115256924,0.000026220705,0.00002304713],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029644227,0.0046406155,0.7480652,0.00038292666,0.0029942656,0.0030714553,0.00020275232,0.0000012786096,0.0045406003,0.00074938935,0.00036738627,0.23468773],"study_design_scores_gemma":[0.04187198,0.00058987684,0.9201918,0.0011009487,0.0030276792,0.00014619477,0.00010045198,0.00003808537,0.031912107,0.000108491025,0.0006971673,0.00021516946],"about_ca_topic_score_codex":0.00037495518,"about_ca_topic_score_gemma":0.00001743138,"teacher_disagreement_score":0.23447256,"about_ca_system_score_codex":0.00009588789,"about_ca_system_score_gemma":0.000042037766,"threshold_uncertainty_score":0.63187706},"labels":[],"label_agreement":null},{"id":"W26909110","doi":"10.1182/blood.v122.21.3932.3932","title":"Novel Inhibitors Of CRM1/XPO1 Nuclear Exporter Exhibit Striking Activity Against AML “primagrafts,” Including AML Leukemia Initiating Cells, While Sparing Normal Hematopoietic Cells","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Cancer research; Haematopoiesis; Myeloid leukemia; Leukemia; Nuclear export signal; Bone marrow; Apoptosis; Biology; Myeloid; Cell culture; Immunology; Stem cell; Cell nucleus; Cell biology; Biochemistry; Genetics; Cytoplasm","score_opus":0.012502052051873222,"score_gpt":0.20364761335635825,"score_spread":0.19114556130448504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W26909110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99450403,0.000065349406,0.00041165337,0.000017068402,0.00033220873,0.00024664224,0.00001437137,0.000041093088,0.0043675844],"genre_scores_gemma":[0.99645,0.00003418076,0.0026822363,0.00016443637,0.0004870659,0.000010162458,0.00003329224,0.000071530165,0.00006709398],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99839187,0.000039468556,0.00041768287,0.0004813935,0.00023799563,0.00043157983],"domain_scores_gemma":[0.99898446,0.00001869846,0.00034282173,0.00041970582,0.000111763715,0.00012252624],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015355233,0.00029067937,0.00029919564,0.000088819754,0.00019544264,0.00007794052,0.0002135031,0.00027266142,0.00010003699],"category_scores_gemma":[0.000028338201,0.00029816516,0.00017124465,0.0001447951,0.000080708545,0.000044678487,0.00037288072,0.0002788902,0.00002500573],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022792241,0.00014155578,0.0015347786,0.00009375129,0.000075236705,0.0000036776876,0.00021169128,0.00012373329,0.99494207,0.000010158075,0.00038646703,0.0024541134],"study_design_scores_gemma":[0.0011727229,0.0001696013,0.0025849808,0.00008027792,0.00006670793,0.000021155407,0.00026022544,0.0002956274,0.99363434,0.000007722971,0.0013564535,0.00035020203],"about_ca_topic_score_codex":0.00011617204,"about_ca_topic_score_gemma":0.000012762036,"teacher_disagreement_score":0.0043004905,"about_ca_system_score_codex":0.000039280825,"about_ca_system_score_gemma":0.00007000324,"threshold_uncertainty_score":0.9999471},"labels":[],"label_agreement":null},{"id":"W2691764704","doi":"10.1182/blood-2017-04-778993","title":"Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review","year":2017,"lang":"en","type":"review","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":206,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; McMaster University","funders":"","keywords":"Apixaban; Rivaroxaban; Dabigatran; Medicine; Intensive care medicine; Warfarin; Internal medicine; Atrial fibrillation","score_opus":0.17057866802595864,"score_gpt":0.43795967726245455,"score_spread":0.2673810092364959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2691764704","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025503829,0.994171,7.39133e-7,0.000020146848,0.000107640066,0.00227974,0.0003349572,0.000015383564,0.0005199862],"genre_scores_gemma":[0.0011933405,0.99746746,0.00048689265,0.000021128033,0.00008161621,0.00022888223,0.00026621122,0.000044908844,0.00020957651],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99834234,0.00007745182,0.0007195785,0.00045124185,0.00016356377,0.00024584148],"domain_scores_gemma":[0.9980895,0.000074363415,0.0006682991,0.0009075732,0.00012445345,0.00013578935],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015865713,0.00041489978,0.0054295743,0.0001099378,0.00006000703,0.00001983232,0.00018642902,0.0002682148,0.000017602644],"category_scores_gemma":[0.00011399673,0.00027832008,0.00058221124,0.00013283239,0.000120572986,0.0000669023,0.00004450136,0.000076176024,0.0000047439194],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001965827,0.0010554213,0.00016998904,0.20967288,0.0015213381,0.000082788574,0.00037481321,7.1637773e-10,0.00013623669,0.000047302936,0.00008835042,0.7868312],"study_design_scores_gemma":[0.0015363698,0.000600078,0.00014579398,0.19854446,0.010719273,0.00025589767,0.000003252802,1.579289e-7,0.0014827425,0.0000034444697,0.78647363,0.00023489843],"about_ca_topic_score_codex":0.000018464452,"about_ca_topic_score_gemma":0.000003471265,"teacher_disagreement_score":0.7865963,"about_ca_system_score_codex":0.00002689926,"about_ca_system_score_gemma":0.00018525466,"threshold_uncertainty_score":0.9999669},"labels":[],"label_agreement":null},{"id":"W2692177560","doi":"10.1182/blood.v128.22.2686.2686","title":"DNA Copy Number Gains of TCF4 (E2-2) Are Associated with Poor Outcome in Diffuse Large B-Cell Lymphoma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; Transcription factor; Germinal center; TCF4; B cell; Diffuse large B-cell lymphoma; Genetics; Gene expression profiling; Gene; Cancer research; Gene expression; Enhancer","score_opus":0.009134785827101751,"score_gpt":0.2196407149176553,"score_spread":0.21050592909055355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2692177560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979016,0.00005957848,0.00005462956,0.00007553717,0.000031951244,0.00009285581,0.0002492035,0.000009099963,0.0015255421],"genre_scores_gemma":[0.9970389,0.00002621901,0.00008899094,0.00010588703,0.000041813146,0.00001583656,0.00005525907,0.000019566689,0.0026075037],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999192,0.00004722506,0.0002310273,0.00019726671,0.00009292789,0.00023957867],"domain_scores_gemma":[0.9994998,0.000017291879,0.00015044888,0.00022020677,0.000065768916,0.0000465012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000099560784,0.0001268537,0.00017779687,0.000024681154,0.000032821023,0.000007820628,0.00012659052,0.00012215042,0.000044088065],"category_scores_gemma":[0.000049134465,0.00008788734,0.000059824953,0.0000663015,0.00003682651,0.0000041370463,0.00006326743,0.000024451852,0.000015610896],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037879494,0.0035308602,0.89563614,0.000017841448,0.00007737691,0.000011050082,0.000075251344,4.46345e-7,0.10030527,0.00014445886,0.00013242844,0.00003101415],"study_design_scores_gemma":[0.029861668,0.00026137818,0.29710025,0.00007538761,0.00008069154,0.000016783104,0.000298267,0.0000020234245,0.66967916,0.00005626026,0.002226344,0.00034179227],"about_ca_topic_score_codex":0.000026428599,"about_ca_topic_score_gemma":0.00021376193,"teacher_disagreement_score":0.5985359,"about_ca_system_score_codex":0.000016964334,"about_ca_system_score_gemma":0.000055974604,"threshold_uncertainty_score":0.35839418},"labels":[],"label_agreement":null},{"id":"W2693861306","doi":"10.1182/blood.v128.22.4877.4877","title":"Transformation in Pre-Treatment Presentations of Gaucher Disease during the First Two Decades of Imiglucerase Enzyme Replacement Therapy: A Report from the International Collaborative Gaucher Group Gaucher Registry","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Enzyme replacement therapy; Splenectomy; Cohort; Bone pain; Avascular necrosis; Pediatrics; Internal medicine; Surgery; Disease; Spleen; Femoral head","score_opus":0.018025223812761462,"score_gpt":0.30968069291279793,"score_spread":0.2916554691000365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2693861306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889988,0.0014875199,0.00010684337,0.0068277433,0.000044954486,0.00150204,0.00013479537,0.000016658709,0.00088067487],"genre_scores_gemma":[0.99747896,0.00086138316,0.00007447992,0.00006175171,0.00009324279,0.00048429723,0.000074720854,0.00002085912,0.00085033063],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822634,0.00012475706,0.0005374915,0.00028174135,0.0006383835,0.00019127008],"domain_scores_gemma":[0.99857557,0.0002942723,0.00023946163,0.00057731575,0.00023450826,0.000078846286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002900257,0.00016476442,0.00022138146,0.000075265445,0.0000806598,0.0000218773,0.0002300686,0.000052880176,0.0004155899],"category_scores_gemma":[0.00026013778,0.00008114132,0.00011557522,0.0002850535,0.00018141347,0.00016870549,0.0000434489,0.000101801044,0.000003417256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00415878,0.002934942,0.9401509,0.000051817184,0.0008945911,0.00015000095,0.011675327,0.000027487975,0.038399186,0.00009523862,0.0006135752,0.0008481438],"study_design_scores_gemma":[0.016919665,0.00022479068,0.8591265,0.00025682116,0.00016761934,0.000024708315,0.0018418205,0.00006306283,0.11754132,0.00013574888,0.003567828,0.00013011222],"about_ca_topic_score_codex":0.001892527,"about_ca_topic_score_gemma":0.001611435,"teacher_disagreement_score":0.08102441,"about_ca_system_score_codex":0.00014545592,"about_ca_system_score_gemma":0.0002448915,"threshold_uncertainty_score":0.45504177},"labels":[],"label_agreement":null},{"id":"W2699766133","doi":"10.1182/blood.v128.22.2934.2934","title":"High Frequency of Somatic Mutations of KMT2D and CARD11 Genes in Cold Agglutinin Disease","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Biology; Exome; Sanger sequencing; Missense mutation; Exome sequencing; Lymphoplasmacytic Lymphoma; Somatic evolution in cancer; Bone marrow; Genetics; Mutation; Cancer research; Immunology; Gene; Lymphoma; Waldenstrom macroglobulinemia","score_opus":0.008355205314155624,"score_gpt":0.22066801073533504,"score_spread":0.21231280542117942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2699766133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975315,0.001644599,0.000036391433,0.00038843456,0.000024252133,0.00019982047,0.00005071474,0.000009352232,0.000114972776],"genre_scores_gemma":[0.9989205,0.00018076577,0.0008036435,0.000013949283,0.000021363547,0.000012555262,0.000004671223,0.000007906471,0.00003463007],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99947095,0.000018515364,0.00021458894,0.000102963735,0.00010832477,0.000084639905],"domain_scores_gemma":[0.9996408,0.000058592224,0.00005058071,0.00014096133,0.000035126734,0.000073894385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000058793114,0.00006018835,0.00019588122,0.00007119463,0.000011941701,0.0000011531657,0.000026434062,0.00003220847,0.000035184345],"category_scores_gemma":[0.000038280035,0.000040182193,0.00003524514,0.00008262696,0.00006481135,0.00003260127,0.000008949827,0.000026251802,0.0000018022914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023274784,0.00067153136,0.68132436,0.00030544447,0.000053350614,0.000032866657,0.0001772526,3.439842e-7,0.3130865,0.002660326,0.0000026627415,0.0016620882],"study_design_scores_gemma":[0.0056928913,0.0001458101,0.845483,0.00050175417,0.00041754905,0.000007177563,0.00004239648,0.0000032787207,0.14639328,0.0012445184,0.000007315141,0.000061015635],"about_ca_topic_score_codex":0.00019730504,"about_ca_topic_score_gemma":0.000060611426,"teacher_disagreement_score":0.16669324,"about_ca_system_score_codex":0.0000034405982,"about_ca_system_score_gemma":0.000052824373,"threshold_uncertainty_score":0.16385822},"labels":[],"label_agreement":null},{"id":"W2701594823","doi":"10.1182/blood.v128.22.3430.3430","title":"Post Transplant Cyclophosphamide (PTCy) with Anti-Thymocyte Globulin (ATG) Effectively Reduces the Severe (Grade III-IV) Acute Graft-Versus-Host Disease (GVHD) When Compared to ATG Alone in Matched Unrelated Donor (MUD) Allogeneic Hematopoietic Cell Transplants","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Anti-thymocyte globulin; Graft-versus-host disease; Cyclophosphamide; Immunology; Hematopoietic stem cell transplantation; Internal medicine; Transplantation; Gastroenterology; Incidence (geometry); Calcineurin; Chemotherapy","score_opus":0.010676786891091665,"score_gpt":0.23257209210500696,"score_spread":0.2218953052139153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2701594823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893216,0.0010389215,0.0006462849,0.0032966668,0.00029567198,0.0037664787,0.00093699637,0.00028411258,0.00041327448],"genre_scores_gemma":[0.99652004,0.0009479037,0.00094697165,0.0003999922,0.000082091785,0.0003365345,0.00031386665,0.00016225335,0.00029032605],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9951477,0.00035878172,0.0010689277,0.0012402266,0.0010120124,0.0011723511],"domain_scores_gemma":[0.9969488,0.0008040276,0.00026488988,0.0009040911,0.0001776735,0.0009005361],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048182136,0.0009186101,0.0013682027,0.00030671933,0.0002293274,0.000066887515,0.00059671624,0.00031867213,0.00021055489],"category_scores_gemma":[0.000029953684,0.00056556286,0.0002943349,0.0007424941,0.00027182224,0.00023938075,0.000038464208,0.00045758873,0.00021769236],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033766583,0.004008085,0.18231061,0.0018475177,0.0025239256,0.009397909,0.013976714,0.00014500083,0.7514977,0.000064954686,0.00012805364,0.00033297492],"study_design_scores_gemma":[0.059093446,0.0010346597,0.45896062,0.0031836994,0.0048625823,0.0009609666,0.00048526446,0.000016698154,0.47013402,0.00003996658,0.00007913896,0.0011489312],"about_ca_topic_score_codex":0.00037650697,"about_ca_topic_score_gemma":0.00032617972,"teacher_disagreement_score":0.28136364,"about_ca_system_score_codex":0.00016652611,"about_ca_system_score_gemma":0.00040704545,"threshold_uncertainty_score":0.99967957},"labels":[],"label_agreement":null},{"id":"W2713994360","doi":"10.1182/blood.v128.22.4651.4651","title":"Autologous Transplantation As Consolidation for High Risk Aggressive T-Cell Non-Hodgkin's Lymphoma: A SWOG S9704 Intergroup Trial Subgroup Analysis","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Hospital; Dalhousie University","funders":"","keywords":"Medicine; Autologous stem-cell transplantation; Internal medicine; Aggressive lymphoma; Oncology; Lymphoma; Transplantation; CHOP; Randomized controlled trial; International Prognostic Index; Diffuse large B-cell lymphoma; Regimen; Rituximab","score_opus":0.00745717083887135,"score_gpt":0.25330941368189336,"score_spread":0.245852242843022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2713994360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99342674,0.00021597487,0.0035244853,0.00037888405,0.00028036512,0.0014273424,0.00030500325,0.000085286396,0.0003559198],"genre_scores_gemma":[0.9964261,0.0008339391,0.00089878356,0.000108487955,0.00027502858,0.0007215005,0.0004396276,0.000028631248,0.00026789488],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99840623,0.00006784027,0.00045223153,0.0005002851,0.0002561714,0.00031725081],"domain_scores_gemma":[0.99836737,0.0004976219,0.00049218076,0.00034818499,0.0001409106,0.00015373713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017737398,0.0002615343,0.00058556866,0.00027377444,0.00012261921,0.000033422086,0.00009323696,0.00018163917,0.00011560156],"category_scores_gemma":[0.0001378177,0.00016981583,0.00041228533,0.0002860287,0.00006283416,0.00011109409,0.0000148028175,0.00003472853,0.00008980313],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17299259,0.04722931,0.39583936,0.00080232596,0.03353116,0.0034879365,0.0043572853,0.00002461806,0.032133594,0.0028029406,0.0030235832,0.3037753],"study_design_scores_gemma":[0.5152279,0.0072768116,0.16542304,0.00028319558,0.03530745,0.00016941526,0.00009283341,0.000089725996,0.27476528,0.0006227492,0.00028414768,0.00045743008],"about_ca_topic_score_codex":0.00057114323,"about_ca_topic_score_gemma":0.00013161825,"teacher_disagreement_score":0.34223536,"about_ca_system_score_codex":0.0001501107,"about_ca_system_score_gemma":0.00015330758,"threshold_uncertainty_score":0.6924889},"labels":[],"label_agreement":null},{"id":"W2724175224","doi":"10.1182/blood.v128.22.1949.1949","title":"Effects of Long-Term Ruxolitinib (RUX) on Bone Marrow (BM) Morphology in Patients with Myelofibrosis (MF) Enrolled in the COMFORT-I Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Myelofibrosis; Ruxolitinib; Internal medicine; International Prognostic Scoring System; Population; Bone marrow; Gastroenterology; Essential thrombocythemia; Polycythemia vera; Surgery; Myelodysplastic syndromes","score_opus":0.008084472802540894,"score_gpt":0.23883888654796523,"score_spread":0.23075441374542432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2724175224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99627537,0.00007739138,0.0000012977129,0.00031179583,0.00004018613,0.0029363758,0.00001707071,0.000013352791,0.00032716515],"genre_scores_gemma":[0.9989161,0.000028874994,0.000038391267,0.00024978642,0.00003134819,0.00062712154,0.000017385753,0.000024198931,0.0000668081],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982753,0.0002598802,0.00038643664,0.00036120994,0.0003984124,0.00031876424],"domain_scores_gemma":[0.99864596,0.0006864082,0.00014365966,0.00039317476,0.00005895868,0.00007186508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002207178,0.0002467962,0.00062540977,0.00018913875,0.000034419976,0.000007330389,0.0001067358,0.00007943539,0.00006451602],"category_scores_gemma":[0.00010202501,0.00011488902,0.00006621512,0.00021749291,0.00007456529,0.000039180333,0.00003619395,0.0001284652,0.000018557905],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001618574,0.022479286,0.9718894,0.00008003034,0.00018566482,0.0005735233,0.0006857481,3.111361e-7,0.0005579737,0.000043780026,0.00003133298,0.0018544146],"study_design_scores_gemma":[0.055285174,0.009670483,0.91663456,0.00053277804,0.00023830801,0.00001210154,0.000049218295,1.7890373e-7,0.01745004,0.000009548487,0.0000031302386,0.000114460054],"about_ca_topic_score_codex":0.00005113107,"about_ca_topic_score_gemma":0.00016105328,"teacher_disagreement_score":0.05525478,"about_ca_system_score_codex":0.000050979073,"about_ca_system_score_gemma":0.00004317142,"threshold_uncertainty_score":0.46850383},"labels":[],"label_agreement":null},{"id":"W2724638186","doi":"10.1182/blood-2017-01-762336","title":"Gemtuzumab ozogamicin in infants with AML: results from the Children’s Oncology Group trials AAML03P1 and AAML0531","year":2017,"lang":"en","type":"review","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute","keywords":"Gemtuzumab ozogamicin; Medicine; Oncology; Internal medicine; Myeloid leukemia; Leukemia; Pediatrics; Clinical trial; CD33","score_opus":0.1302847990664755,"score_gpt":0.416543857673311,"score_spread":0.2862590586068355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2724638186","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008120375,0.98202085,0.0000017048017,0.00064273924,0.0001584829,0.004887978,0.0010974573,0.00006877543,0.003001636],"genre_scores_gemma":[0.0007308016,0.9946768,0.0005024899,0.00020711287,0.0014906435,0.00028526044,0.0013605177,0.0001396213,0.0006067411],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938305,0.0017568435,0.001748624,0.0012285047,0.0006595556,0.00077595824],"domain_scores_gemma":[0.9912262,0.0047842786,0.0013876443,0.0022174888,0.00009553718,0.00028885718],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0046049003,0.00075674994,0.005421626,0.00038262364,0.00021079485,0.00012446861,0.0009820617,0.0010296829,0.000050395196],"category_scores_gemma":[0.0055688065,0.00039876797,0.00039200648,0.00031594225,0.00050768064,0.000108867316,0.0005304846,0.0023670916,0.00010079123],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015734377,0.00044813595,0.000635373,0.0010588368,0.0017793397,0.000863856,0.00025361427,4.1571447e-8,0.0000029247688,0.00002612591,0.0033834325,0.98997486],"study_design_scores_gemma":[0.029538881,0.0015229054,0.0077698724,0.01590331,0.005534026,0.0012136261,0.000039670413,0.0000017107766,0.0000057341663,0.000025268866,0.9379516,0.0004933977],"about_ca_topic_score_codex":0.0039852792,"about_ca_topic_score_gemma":0.0014775161,"teacher_disagreement_score":0.9894815,"about_ca_system_score_codex":0.0005256123,"about_ca_system_score_gemma":0.0025625692,"threshold_uncertainty_score":0.9999345},"labels":[],"label_agreement":null},{"id":"W2724904788","doi":"10.1182/blood.v128.22.875.875","title":"Characterization of Bleeding in Hemophilia Carriers and Comparison to Women with Type 1 Von Willebrand Disease, Type 3 Von Willebrand Disease Obligate Carriers and Controls","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Von Willebrand disease; Hemarthrosis; Von Willebrand factor; Pediatrics; Carrier testing; Internal medicine; Surgery; Prenatal diagnosis; Pregnancy; Platelet","score_opus":0.012371659036533884,"score_gpt":0.2594101062623206,"score_spread":0.2470384472257867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2724904788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99692345,0.00055392436,0.0000046025757,0.0013869778,0.000051252784,0.0008904428,0.0000772083,0.000025059066,0.00008711045],"genre_scores_gemma":[0.998749,0.00039838385,0.000028230801,0.00007860232,0.00008372544,0.000041317915,0.00004099152,0.000031147876,0.0005485879],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861294,0.000052060754,0.0002644085,0.00036781412,0.00032214247,0.00038060787],"domain_scores_gemma":[0.9986229,0.00007256125,0.000075304466,0.00021302563,0.00014038432,0.00087583787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017929441,0.00020831435,0.000475783,0.00023042387,0.00007352471,0.00002813241,0.00005769112,0.00006785115,0.000043251937],"category_scores_gemma":[0.00017068035,0.00013063957,0.000023250841,0.00036392914,0.00017694596,0.00015175657,0.000044708275,0.000091337984,0.0000045036427],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064151995,0.00018507299,0.82956475,0.00021732108,0.00016420225,0.00006810213,0.0008295682,0.0000011221134,0.16098888,0.000016485163,0.000023167031,0.0015261514],"study_design_scores_gemma":[0.01702438,0.0014295148,0.9665936,0.0009884088,0.00040416716,0.000008310709,0.00027455974,0.000091847316,0.012025063,0.00005734622,0.0008024069,0.00030035744],"about_ca_topic_score_codex":0.000013429609,"about_ca_topic_score_gemma":0.000009476982,"teacher_disagreement_score":0.14896382,"about_ca_system_score_codex":0.000067799076,"about_ca_system_score_gemma":0.00019479026,"threshold_uncertainty_score":0.5327327},"labels":[],"label_agreement":null},{"id":"W2725206342","doi":"10.1182/blood.v128.22.3457.3457","title":"Single Centre Experience in Treating Newly Diagnosed t(4;14) Multiple Myeloma with and without Planned Front-Line Autologous Stem Cell Transplant","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Multiple myeloma; Bortezomib; Internal medicine; Lenalidomide; Surgery; Dexamethasone; Autologous stem-cell transplantation; Cyclophosphamide; Maintenance therapy; Median follow-up; Prednisone; Oncology; Chemotherapy","score_opus":0.0236939429228463,"score_gpt":0.2597571939518852,"score_spread":0.23606325102903888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2725206342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99775106,0.00045832348,0.00014402896,0.00023852976,0.000022997772,0.00071298215,0.00007415354,0.00008943286,0.0005084842],"genre_scores_gemma":[0.9965939,0.00007545297,0.0020488799,0.00003235621,0.000044224344,0.00007871073,0.000028948962,0.000034872122,0.0010626438],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983096,0.00007479961,0.0002649948,0.00047849884,0.0003003576,0.00057171547],"domain_scores_gemma":[0.9990233,0.00025609072,0.00007468184,0.0002752254,0.00004450935,0.00032618231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007087316,0.00025914892,0.00041438747,0.00011721993,0.0000797501,0.000022293698,0.00008420559,0.000095861775,0.00004520533],"category_scores_gemma":[0.000046759927,0.00014918779,0.00004028261,0.000100655714,0.0001116585,0.00011296257,0.000025559539,0.00011256552,0.000020505518],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019238256,0.0015278611,0.9216917,0.00007358462,0.000080016645,0.0017712612,0.0040131398,0.0000011862198,0.03755028,0.0000010751978,0.000008966394,0.031357083],"study_design_scores_gemma":[0.08938783,0.0035274646,0.6198542,0.0014275641,0.00020375819,0.00036707747,0.0020721562,0.0004702872,0.28201526,0.000003642913,0.00022232931,0.00044838994],"about_ca_topic_score_codex":0.0002619909,"about_ca_topic_score_gemma":0.0016412874,"teacher_disagreement_score":0.30183747,"about_ca_system_score_codex":0.000058875114,"about_ca_system_score_gemma":0.000069500704,"threshold_uncertainty_score":0.6083701},"labels":[],"label_agreement":null},{"id":"W2725301718","doi":"10.1182/blood.v128.22.1407.1407","title":"Clinical and Biological Determinants of Bleeding Manifestation in Congenital Factor XI Deficiency; A Systematic Review","year":2016,"lang":"en","type":"review","venue":"Blood","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Factor XI; Pediatrics; Population; Family history; Gene mutation; Univariate analysis; Internal medicine; Mutation; Multivariate analysis; Genetics","score_opus":0.10310955455568048,"score_gpt":0.3901985815358311,"score_spread":0.2870890269801506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2725301718","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022134053,0.97552294,0.0000024050241,0.0000060534626,0.00010543199,0.0020814103,0.000048852347,0.000023060591,0.00007581534],"genre_scores_gemma":[0.010023706,0.98958063,0.00005998485,0.000024206285,0.000098490076,0.00008722438,0.000021863532,0.000024476534,0.000079395984],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9969866,0.0002395603,0.001959946,0.00040033503,0.00018298622,0.00023053022],"domain_scores_gemma":[0.99798626,0.0007534333,0.00079070946,0.00027828105,0.00007609234,0.0001152483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064860855,0.00030640376,0.0034655186,0.0001480846,0.000026382977,0.000010236124,0.0001095926,0.00030873212,0.000033512926],"category_scores_gemma":[0.0011770781,0.00017673432,0.0004373421,0.00018127607,0.00013368882,0.00005373534,0.000045516645,0.00012955861,0.000024512101],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000052822115,0.00027286247,0.01897825,0.80369025,0.00011398771,0.00006810253,0.00003959691,4.3116563e-10,8.787884e-7,0.000044236775,0.0000029070911,0.17678364],"study_design_scores_gemma":[0.0014178585,0.0005809373,0.0061561964,0.98365694,0.0045346045,0.00075552973,0.000015700176,0.0000027263036,0.0000028522695,0.000016393898,0.0025508811,0.0003093669],"about_ca_topic_score_codex":0.000009316429,"about_ca_topic_score_gemma":0.000008877705,"teacher_disagreement_score":0.17996669,"about_ca_system_score_codex":0.00002659205,"about_ca_system_score_gemma":0.00021810971,"threshold_uncertainty_score":0.72070163},"labels":[],"label_agreement":null},{"id":"W2726667285","doi":"10.1182/blood.v128.22.2137.2137","title":"Pattern of First Relapse in Multiple Myeloma (MM) Patients (Pts) after a Cybord Induction Regimen and Autologous Stem Cell Transplantation (ASCT): Impact of Maintenance Therapy in the Real-World Setting","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lenalidomide; Maintenance therapy; Thalidomide; Regimen; Internal medicine; Autologous stem-cell transplantation; Multiple myeloma; Oncology; Bortezomib; Transplantation; Surgery; Chemotherapy","score_opus":0.015900020236878122,"score_gpt":0.26684772706854054,"score_spread":0.2509477068316624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2726667285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99870265,0.00009938135,0.00001013846,0.00015380025,0.000015631542,0.00081668724,0.000081377846,0.000008826311,0.00011152071],"genre_scores_gemma":[0.99904555,0.00067315885,0.00007271902,0.000012523159,0.000014562964,0.00009451201,0.00002244223,0.000015162455,0.000049357135],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879074,0.00015214713,0.0003395588,0.00022231843,0.0002398178,0.00025543358],"domain_scores_gemma":[0.9992644,0.00023517072,0.00015124204,0.00022988569,0.000064585016,0.000054698292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025075162,0.00013869576,0.00025227564,0.00020893921,0.000024346471,0.0000052131118,0.000069540525,0.000067082045,0.000012239932],"category_scores_gemma":[0.00002641591,0.00007296081,0.00006374356,0.00021134055,0.00006555196,0.00010207732,0.0000127263165,0.000112835274,0.0000017085662],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015340315,0.0009466115,0.9307067,0.00012394122,0.000055994973,0.00008732295,0.0029707819,7.8170194e-7,0.0030684713,4.7638903e-7,0.000008688837,0.060496222],"study_design_scores_gemma":[0.017334322,0.001012099,0.9703874,0.00051123113,0.000028945615,0.0000128033,0.00014360395,0.00003763666,0.010449173,0.000008585662,0.000005352059,0.0000688617],"about_ca_topic_score_codex":0.0025785507,"about_ca_topic_score_gemma":0.0026272526,"teacher_disagreement_score":0.06042736,"about_ca_system_score_codex":0.00007319358,"about_ca_system_score_gemma":0.000040029096,"threshold_uncertainty_score":0.38980147},"labels":[],"label_agreement":null},{"id":"W2726845895","doi":"10.1182/blood.v128.22.901.901","title":"SWOG S1203: A Randomized Phase III Study of Standard Cytarabine Plus Daunorubicin (7+3) Therapy Versus Idarubicin with High Dose Cytarabine (IA) with or without Vorinostat (IA+V) in Younger Patients with Previously Untreated Acute Myeloid Leukemia (AML)","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Idarubicin; Medicine; Internal medicine; Cytarabine; Vorinostat; Oncology; Clinical endpoint; Gastroenterology; Transplantation; Randomized controlled trial; Chemotherapy; Histone deacetylase; Biology","score_opus":0.015487240033292589,"score_gpt":0.2988562247141778,"score_spread":0.28336898468088517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2726845895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834616,0.00026139617,0.0002694447,0.0002760594,0.00009242392,0.014941135,0.00023341179,0.00023882784,0.00022570112],"genre_scores_gemma":[0.99443144,0.00069897756,0.0017100858,0.00012189175,0.00014197917,0.0011232212,0.00023119905,0.00031901966,0.001222178],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9915549,0.0008453161,0.0016291991,0.0016660361,0.0026993982,0.0016051255],"domain_scores_gemma":[0.994231,0.0008865639,0.000903382,0.0019067606,0.0013905029,0.0006818193],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0013299966,0.0013289958,0.004206803,0.0009323589,0.00018932899,0.000072627976,0.00066485815,0.00030617084,0.000320446],"category_scores_gemma":[0.00026455935,0.00062021863,0.0001855275,0.0019781352,0.0009365072,0.0006407801,0.00018951237,0.00087661593,0.000020390302],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9012208,0.007066591,0.07043672,0.00013434318,0.0064550694,0.0018385681,0.0036039343,0.000044787776,0.0055895788,0.000014606167,0.00008000442,0.00351497],"study_design_scores_gemma":[0.891652,0.071487926,0.011664491,0.0013405248,0.0033412145,0.000120064215,0.00095392106,0.000069905764,0.018397627,0.000004483673,0.00007268148,0.0008951545],"about_ca_topic_score_codex":0.0043847766,"about_ca_topic_score_gemma":0.0027306667,"teacher_disagreement_score":0.06442133,"about_ca_system_score_codex":0.0016393468,"about_ca_system_score_gemma":0.0035501027,"threshold_uncertainty_score":0.9999461},"labels":[],"label_agreement":null},{"id":"W2727252409","doi":"10.1182/blood.v128.22.4021.4021","title":"Investigating the Effects of Anti-CD200 Therapy for Childhood ALL","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Inflammation biomarkers and pathways","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Therapeutics (Canada)","funders":"","keywords":"Immunology; Antigen; Immune system; Monoclonal antibody; Bone marrow; Antibody; Minimal residual disease; Cancer research; Lymphocyte; Severe combined immunodeficiency; Medicine; Biology; In vivo","score_opus":0.010077993694487357,"score_gpt":0.21300519151773245,"score_spread":0.2029271978232451,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2727252409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970959,0.0014253181,0.00009680581,0.00038761695,0.00026327514,0.0003853152,0.000021393957,0.000025178893,0.0002992322],"genre_scores_gemma":[0.99921805,0.0001085733,0.000115487615,0.00025431698,0.000039478025,0.000038708065,0.000012709646,0.000008148082,0.00020455629],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99951285,0.00007750543,0.0001453865,0.0001004608,0.000015349116,0.00014843779],"domain_scores_gemma":[0.9992202,0.0004768301,0.000101706246,0.00015856736,0.00003513794,0.0000075735434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017706225,0.000075322605,0.00011213674,0.000021431524,0.00009095593,0.000003606949,0.0001244506,0.00009137286,0.000033617038],"category_scores_gemma":[0.00015771996,0.000035924808,0.00006873302,0.000033925044,0.00011202836,0.000028621616,0.000016275508,0.000036604946,0.00002948613],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008001735,0.000095092284,0.0032106857,0.000016152057,0.00018481255,1.9239265e-7,0.0004691048,2.5069252e-8,0.984364,0.0013833664,0.0008533405,0.009415283],"study_design_scores_gemma":[0.004053052,0.0002014204,0.031918585,0.000055544006,0.00002879632,0.000009015983,0.000016158878,1.2170399e-7,0.9526605,0.0007008995,0.010289697,0.00006622814],"about_ca_topic_score_codex":0.0000049212645,"about_ca_topic_score_gemma":0.0000010947502,"teacher_disagreement_score":0.031703465,"about_ca_system_score_codex":0.0000019127185,"about_ca_system_score_gemma":0.000024259502,"threshold_uncertainty_score":0.14649712},"labels":[],"label_agreement":null},{"id":"W2727738863","doi":"10.1182/blood.v128.22.689.689","title":"Measurement and Prevalence of Cognitive Impairment in Older Patients with Hematologic Malignancies","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cognition; Grip strength; Montreal Cognitive Assessment; Population; Gerontology; Geriatrics; Cognitive impairment; Physical therapy; Psychiatry","score_opus":0.013001418464121626,"score_gpt":0.23309835337251827,"score_spread":0.22009693490839666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2727738863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974112,0.00096316834,0.000038169717,0.00021595114,0.000020906882,0.0010542816,0.000027913067,0.000020073014,0.00024833452],"genre_scores_gemma":[0.999461,0.00022733903,0.000048249585,0.00006854402,0.000008910225,0.00011059943,9.858559e-7,0.000010126939,0.00006424116],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989203,0.00003162764,0.00021521676,0.00023631156,0.0003926073,0.00020393927],"domain_scores_gemma":[0.9993103,0.00006726453,0.000104618855,0.000091483285,0.00037243532,0.000053885175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014508501,0.00013830053,0.00026618477,0.000085905616,0.00002383627,0.0000022858521,0.000027442722,0.00003731364,0.000042055384],"category_scores_gemma":[0.00019272976,0.00007754592,0.000025928399,0.000109269284,0.0001773507,0.000056008776,0.000045822075,0.000048524445,0.000004079002],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039789392,0.0016994794,0.99545944,0.00043531432,0.00017599488,0.000015099114,0.00041186652,1.7124423e-8,0.0006946796,0.0000075307535,0.000025895903,0.00067677314],"study_design_scores_gemma":[0.017416071,0.0018178697,0.9577629,0.0068016057,0.000369611,0.000014867447,0.00018754862,1.5658324e-7,0.015499991,0.00002028871,0.0000025043257,0.00010660279],"about_ca_topic_score_codex":0.0000075259914,"about_ca_topic_score_gemma":0.000011551508,"teacher_disagreement_score":0.037696574,"about_ca_system_score_codex":0.00005888425,"about_ca_system_score_gemma":0.000053981265,"threshold_uncertainty_score":0.31622308},"labels":[],"label_agreement":null},{"id":"W2728217431","doi":"10.1182/blood.v128.22.665.665","title":"Functional GSTA1 Haplotypes Affect Clearance and Toxicity of Busulfan When Administered in 16 Doses to Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation: A Multicenter Prospective Study on Behalf of the Pediatric Disease Working Party of the European Society for Blood and Marrow Transplantation (EBMT)","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Université de Montréal; Alberta Children's Hospital; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Busulfan; Dosing; Hematopoietic stem cell transplantation; Transplantation; Internal medicine; Therapeutic drug monitoring; Haplotype; Gastroenterology; Tacrolimus; Pharmacology; Oncology; Genotype; Pharmacokinetics; Biology; Genetics; Gene","score_opus":0.017463602072664,"score_gpt":0.2298552941189541,"score_spread":0.2123916920462901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2728217431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99665236,0.00012827026,0.00031870173,0.00008628266,0.000074638105,0.0025098564,0.00015688057,0.000012402667,0.000060573828],"genre_scores_gemma":[0.9995069,0.00016354257,0.00013425284,0.000023780893,0.000050019495,0.00006701219,0.0000065764434,0.000028064096,0.000019848932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983833,0.0002282528,0.0004961785,0.0003380683,0.00038583684,0.00016838986],"domain_scores_gemma":[0.9987794,0.00056332204,0.00027994477,0.00020104958,0.000094744246,0.00008154558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032685357,0.00018496049,0.00029108193,0.00007976781,0.000079890066,0.000008820416,0.000091729904,0.000045649376,0.0000033512151],"category_scores_gemma":[0.000029751704,0.00011180726,0.00013629465,0.00021788901,0.000061872364,0.000066324304,0.000017963974,0.00008118181,3.775818e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014557712,0.0018133848,0.9788233,0.003229635,0.000068809386,0.0000035292937,0.009514113,0.0000066704943,0.0049472437,0.0000114528775,0.0000028311506,0.00012327141],"study_design_scores_gemma":[0.013699107,0.0008040884,0.94042003,0.00078570674,0.0018659624,0.00000581587,0.0005356152,0.0000029016721,0.041746832,0.000021451995,1.5771752e-7,0.000112323],"about_ca_topic_score_codex":0.00000454798,"about_ca_topic_score_gemma":0.000046976034,"teacher_disagreement_score":0.03840325,"about_ca_system_score_codex":0.00002121093,"about_ca_system_score_gemma":0.00007282147,"threshold_uncertainty_score":0.45593676},"labels":[],"label_agreement":null},{"id":"W2728241634","doi":"10.1182/blood-2017-04-777029","title":"DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":379,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean; Université de Montréal; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Hôpital Maisonneuve-Rosemont","funders":"Canadian Institutes of Health Research; Concordia University","keywords":"Biology; Haematopoiesis; Epigenetics; Genetics; Gene; Mutation; Myeloid; Population; Phenotype; Immunology; Medicine; Stem cell","score_opus":0.012306119368155576,"score_gpt":0.2669459064091549,"score_spread":0.2546397870409993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2728241634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950541,0.0017475992,0.00004235821,0.0013953175,0.000021775642,0.00032943295,0.00003684755,0.000024983221,0.0013475728],"genre_scores_gemma":[0.9965952,0.0007436389,0.0020954695,0.000049280163,0.00010928573,0.000030043646,0.000008011671,0.000019534002,0.00034952437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990817,0.000032040716,0.00015032449,0.00030536728,0.00017473746,0.00025584898],"domain_scores_gemma":[0.999208,0.000088421446,0.000059425493,0.00033857086,0.000049106955,0.00025647852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009632439,0.00015542621,0.0002661325,0.000066735294,0.00042764045,0.00013437636,0.000087537475,0.00008934627,0.000027725817],"category_scores_gemma":[0.00009043491,0.00012227948,0.000027665505,0.00002364971,0.00043690766,0.00008156257,0.00019409241,0.0001808505,0.000004097964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005892593,0.0009940456,0.7627547,0.0010945952,0.0009839586,0.00083207444,0.001266384,3.3807217e-7,0.18874949,0.0021915345,0.00055931415,0.039984312],"study_design_scores_gemma":[0.005011826,0.00027544622,0.9704861,0.00013307483,0.00047060274,0.0008373801,0.000099603225,0.00025857138,0.020937031,0.0012362882,0.000095101976,0.00015896875],"about_ca_topic_score_codex":0.000046423476,"about_ca_topic_score_gemma":0.00003196024,"teacher_disagreement_score":0.20773141,"about_ca_system_score_codex":0.000016633629,"about_ca_system_score_gemma":0.000056933914,"threshold_uncertainty_score":0.49864122},"labels":[],"label_agreement":null},{"id":"W2728845318","doi":"10.1182/blood.v128.22.1375.1375","title":"Platelet Release from Infused CD34+-Derived Human Megakaryocytes: Lessons from a Natural-Occurring Platelet Bioreactor","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Platelet; Thrombopoiesis; Megakaryocyte; In vivo; In vitro; Cell biology; Bone marrow; Biology; Pathology; Chemistry; Immunology; Haematopoiesis; Stem cell; Medicine; Biochemistry","score_opus":0.020234463053547636,"score_gpt":0.27082466406665673,"score_spread":0.2505902010131091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2728845318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951857,0.0014592534,0.000017428696,0.0008119829,0.00022705249,0.00051121076,0.000936378,0.00033703996,0.0005139855],"genre_scores_gemma":[0.9973063,0.00016961368,0.00062621315,0.0005434031,0.00028539018,0.000053280324,0.00070454914,0.000086437656,0.00022482214],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99767977,0.0000552858,0.00048046143,0.00077378494,0.00039772168,0.0006130016],"domain_scores_gemma":[0.9983093,0.00029212883,0.00021040846,0.00074309227,0.00007597737,0.00036910217],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00006129749,0.00048847176,0.0008015991,0.00016723052,0.00023575673,0.00007235089,0.000244493,0.000274055,0.0006199885],"category_scores_gemma":[0.0001571813,0.00032936962,0.0002445068,0.00017917162,0.00014101337,0.00025567232,0.00011115547,0.0003124292,0.0004171689],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006643465,0.0027853954,0.045725647,0.000033308093,0.0024812373,0.006970486,0.00076973013,2.3058375e-7,0.92064714,0.000077125274,0.0013353815,0.018509991],"study_design_scores_gemma":[0.06883791,0.00065967586,0.15959524,0.0013632437,0.0012719,0.0001783814,0.00020866789,0.000029891045,0.7528861,0.0019308887,0.011850248,0.0011878456],"about_ca_topic_score_codex":0.002051966,"about_ca_topic_score_gemma":0.00032331477,"teacher_disagreement_score":0.16776101,"about_ca_system_score_codex":0.00009127656,"about_ca_system_score_gemma":0.00012910047,"threshold_uncertainty_score":0.99991584},"labels":[],"label_agreement":null},{"id":"W2729220566","doi":"10.1182/blood.v128.22.1453.1453","title":"Anticoagulation Prophylaxis in Asparaginase-Based Therapy in Adults with Acute Lymphoblastic Leukemia","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Dosing; Asparaginase; Induction chemotherapy; Thrombosis; Chemotherapy; Internal medicine; Surgery; Acute lymphocytic leukemia; Pediatrics; Lymphoblastic Leukemia; Leukemia","score_opus":0.01084216172669376,"score_gpt":0.25223232536664203,"score_spread":0.24139016363994828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2729220566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969406,0.00009657496,0.00092232676,0.00053507433,0.000030944226,0.0009975105,0.000010178649,0.000071498216,0.0003953022],"genre_scores_gemma":[0.9983553,0.00007396739,0.00094714365,0.00015900114,0.00007743732,0.00014705135,0.000016621903,0.00005418621,0.00016924174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978799,0.00009145509,0.000350979,0.00050761417,0.0006059562,0.0005640969],"domain_scores_gemma":[0.99887365,0.00027851493,0.00008247704,0.00047054258,0.00012902911,0.00016576296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022528121,0.00025267963,0.0004081891,0.0004857117,0.00002997161,0.00001777623,0.00015924172,0.00017076293,0.00007799488],"category_scores_gemma":[0.00014506615,0.00014785978,0.000049565067,0.00076525734,0.00016072748,0.00014352011,0.000029876614,0.00017471862,0.00008347583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019428564,0.0031817658,0.8173865,0.000374271,0.00030960748,0.0070901182,0.00075436744,0.00018361959,0.110344246,0.00013661342,0.0001409113,0.04066939],"study_design_scores_gemma":[0.15741521,0.007011704,0.71224505,0.0033274,0.00010370165,0.00044427716,0.000055344914,0.005143115,0.11348821,0.00010940685,0.00010803241,0.00054856646],"about_ca_topic_score_codex":0.00031528532,"about_ca_topic_score_gemma":0.00014883303,"teacher_disagreement_score":0.13798665,"about_ca_system_score_codex":0.001116176,"about_ca_system_score_gemma":0.0020520284,"threshold_uncertainty_score":0.6029547},"labels":[],"label_agreement":null},{"id":"W2730325962","doi":"10.1182/blood.v128.22.595.595","title":"Marked Differences in the Genomic Landscape of Pediatric Compared to Adult Acute Myeloid Leukemia: A Report from the Children's Oncology Group and NCI/COG Therapeutically Applicable Research to Generate Effective Treatments (TARGET) Initiative","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Cog; Oncology; Myeloid leukemia; Medicine; Transcriptome; Internal medicine; Clinical trial; Bioinformatics; Gene; Biology; Genetics","score_opus":0.03269638115181099,"score_gpt":0.3212255211498859,"score_spread":0.2885291399980749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2730325962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902199,0.00050469773,0.00013786438,0.0036395516,0.000029645164,0.0041680983,0.00015930884,0.000024322835,0.0011166236],"genre_scores_gemma":[0.9952339,0.0006803159,0.0011525044,0.0009023219,0.00041869277,0.0013872492,0.000058802445,0.000037100333,0.00012910426],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960634,0.0012209605,0.0005220454,0.0007536878,0.00073240785,0.000707465],"domain_scores_gemma":[0.9952192,0.003333339,0.00013832042,0.00072767184,0.00032385648,0.00025762536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016517218,0.0002940482,0.0007133457,0.00029021635,0.00019290583,0.000040358158,0.0005507407,0.00019985042,0.00005518699],"category_scores_gemma":[0.0004820009,0.00013595981,0.00008552315,0.0008834731,0.00024280162,0.00006188381,0.0003727911,0.0005811363,0.000051029514],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036361276,0.0011064876,0.9296688,0.000021372109,0.0016920862,0.0005810843,0.004786082,9.2600476e-7,0.049366817,0.00008728965,0.0022038284,0.006849144],"study_design_scores_gemma":[0.009499776,0.0021496434,0.98255396,0.000047967296,0.0005235672,0.00016171914,0.0005886127,0.000032011932,0.0037720585,0.00032726626,0.00017084643,0.00017259897],"about_ca_topic_score_codex":0.0008884954,"about_ca_topic_score_gemma":0.00022421227,"teacher_disagreement_score":0.052885175,"about_ca_system_score_codex":0.00044449282,"about_ca_system_score_gemma":0.00065502845,"threshold_uncertainty_score":0.55442804},"labels":[],"label_agreement":null},{"id":"W2730377080","doi":"10.1182/blood.v128.22.4990.4990","title":"Elucidating the Thrombogenic Risk of Non-O Blood Groups in Children with Acute Lymphoblastic Leukemia (ALL): Is Von Willebrand Factor a Culprit ?","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton; Université de Montréal","funders":"","keywords":"ABO blood group system; Von Willebrand factor; Medicine; Context (archaeology); Internal medicine; Risk factor; Immunology; Gastroenterology; Lymphoblastic Leukemia; Leukemia; Platelet; Biology","score_opus":0.004180648288886884,"score_gpt":0.20876045172398777,"score_spread":0.20457980343510088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2730377080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997681,0.00062035996,0.00016067161,0.00033356022,0.000035402627,0.0006537689,0.00008484203,0.000039102542,0.00039127137],"genre_scores_gemma":[0.9976579,0.001697284,0.00022306538,0.00017883153,0.00006374275,0.000022142814,0.000010099734,0.000045721605,0.00010124088],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840325,0.000058920108,0.00040685348,0.00037051633,0.00033930657,0.00042115588],"domain_scores_gemma":[0.99898934,0.00011446811,0.00022855903,0.0004910598,0.000057168472,0.000119423756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016344899,0.00026530286,0.0004525542,0.00010481773,0.000089732304,0.000013644104,0.00019732931,0.00019421497,0.00011575905],"category_scores_gemma":[0.000087195345,0.00012425294,0.00014555403,0.00032657819,0.00018632768,0.000092560906,0.000070251794,0.00026215392,0.000027808263],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022447077,0.00075133255,0.92610157,0.00005778656,0.003902611,0.000052661013,0.0019503993,0.000006198844,0.06323463,0.00002045383,0.000094021685,0.0036038512],"study_design_scores_gemma":[0.038122717,0.0015516796,0.8668739,0.0010536868,0.005427037,0.000895768,0.00037137268,0.000100840814,0.08498232,0.00009839778,0.00006504807,0.00045719446],"about_ca_topic_score_codex":0.00030510937,"about_ca_topic_score_gemma":0.00004554565,"teacher_disagreement_score":0.05922764,"about_ca_system_score_codex":0.000050206927,"about_ca_system_score_gemma":0.00023349529,"threshold_uncertainty_score":0.50668883},"labels":[],"label_agreement":null},{"id":"W2730555015","doi":"10.1182/blood.v128.22.5028.5028","title":"Rationale and Design of a Phase III Single-Arm Multicenter Study of Dabigatran Etexilate for the Secondary Prevention of Venous Thromboembolism in Children","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Children's Hospital of Eastern Ontario; Hospital for Sick Children; University of Ottawa; University of Alberta","funders":"","keywords":"Medicine; Dabigatran; Incidence (geometry); Venous thromboembolism; Thrombosis; Clinical trial; Venous thrombosis; Internal medicine; Risk factor; Pediatrics; Warfarin; Atrial fibrillation","score_opus":0.07459493824673243,"score_gpt":0.3594840352820648,"score_spread":0.2848890970353324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2730555015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99638957,0.0011619505,0.00037121508,0.00021818168,0.000020052783,0.0017636864,0.000028891549,0.0000028322609,0.000043634584],"genre_scores_gemma":[0.99945915,0.00019435749,0.00023414537,0.000025937159,0.000026244827,0.000038206763,0.0000021014146,0.000005619869,0.000014226662],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9994102,0.00005945934,0.00025517546,0.00009704554,0.000099528654,0.00007855609],"domain_scores_gemma":[0.99916375,0.0005235289,0.00015040133,0.00008740399,0.000052837622,0.000022075452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029568622,0.00005854712,0.00024026443,0.000025404324,0.000028462176,0.0000018624868,0.000039763072,0.000022141157,0.000031323354],"category_scores_gemma":[0.00010676387,0.00003232341,0.000032875123,0.00004512023,0.000063570114,0.000060830374,0.000022089227,0.00004601287,1.301821e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063957167,0.097485416,0.041970156,0.00043407187,0.003342092,0.000004586324,0.009710813,0.000009525544,0.68081653,0.000075472286,0.000050090643,0.15970552],"study_design_scores_gemma":[0.20176847,0.022640683,0.51790255,0.0005407385,0.0045092283,0.000029240284,0.0018894254,0.00032251803,0.24918808,0.0005459569,0.00045222085,0.00021085831],"about_ca_topic_score_codex":0.00003263853,"about_ca_topic_score_gemma":0.000014004535,"teacher_disagreement_score":0.47593242,"about_ca_system_score_codex":0.0000041144053,"about_ca_system_score_gemma":0.00002209546,"threshold_uncertainty_score":0.13181104},"labels":[],"label_agreement":null},{"id":"W2731034946","doi":"10.1182/blood.v128.22.5117.5117","title":"Using the Zebrafish to Model the Tumour-Suppressor Effects of NUP98 in NUP98-NSD1 mediated AML","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Zebrafish; Cancer research; Myeloid leukemia; Biology; Oncogene; Epigenetics; Leukemia; Cancer; Gene; Genetics; Cell cycle","score_opus":0.025856489904854073,"score_gpt":0.29717197556737307,"score_spread":0.271315485662519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2731034946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98945016,0.00021078034,0.0007803145,0.0071216607,0.000062904735,0.0012602734,0.000020313577,0.000038406815,0.0010552068],"genre_scores_gemma":[0.99747264,0.000034512377,0.0007532958,0.0009333768,0.00015891418,0.00008142541,0.0000028381241,0.000046048404,0.0005169459],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980967,0.00020129266,0.00032290598,0.00029190467,0.0005815581,0.00050566386],"domain_scores_gemma":[0.99784607,0.0010751096,0.000082784994,0.00069987914,0.00013250235,0.00016363118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062547013,0.0001818047,0.0003546467,0.00014619237,0.00007224064,0.0000152017465,0.0004718518,0.00011430196,0.000054109005],"category_scores_gemma":[0.0016825002,0.00007968726,0.00009357677,0.0004812761,0.00017764594,0.00007732269,0.00024903842,0.00032635304,0.000055755958],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020588402,0.0003452079,0.0030405382,0.000119744545,0.000113971684,0.00009404647,0.00111959,0.00009221665,0.99138725,0.00016245451,0.0026887285,0.0006303602],"study_design_scores_gemma":[0.013435146,0.00039830923,0.017561762,0.00093508867,0.00033038965,0.00010135118,0.00021091056,0.014377355,0.95133233,0.00041229613,0.0006381601,0.0002668922],"about_ca_topic_score_codex":0.00015923005,"about_ca_topic_score_gemma":0.00004066652,"teacher_disagreement_score":0.040054917,"about_ca_system_score_codex":0.00012738316,"about_ca_system_score_gemma":0.00034448004,"threshold_uncertainty_score":0.32495522},"labels":[],"label_agreement":null},{"id":"W2732102095","doi":"10.1182/blood.v128.22.3656.3656","title":"Daily Pain Is Associated with Alterations in Functional Connectivity of the Brain on fMRI in Adults with Sickle Cell Disease","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Functional Brain Connectivity Studies","field":"Neuroscience","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chronic pain; Medicine; Functional connectivity; Functional magnetic resonance imaging; Resting state fMRI; Disease; Connectome; Periaqueductal gray; Default mode network; Neuroscience; Psychology; Internal medicine; Physical therapy; Central nervous system","score_opus":0.014889458868882356,"score_gpt":0.20428501872072197,"score_spread":0.18939555985183962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2732102095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847678,0.000008887442,0.0001275069,0.013710312,0.000053305073,0.00037943313,0.00013475647,0.000027520306,0.00079050264],"genre_scores_gemma":[0.99623245,0.0000015708346,0.0000083359155,0.0030917344,0.000024936333,0.00009315831,0.0000017881896,0.000015142319,0.00053090067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982253,0.00052489666,0.00016286783,0.00045969657,0.00041088127,0.00021638184],"domain_scores_gemma":[0.99035376,0.009133082,0.00012230991,0.00027988976,0.00006223915,0.000048709782],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00043707513,0.00015227844,0.0001676735,0.00010039096,0.00012926561,0.00001284564,0.00012597756,0.000034782137,0.00003633774],"category_scores_gemma":[0.00865919,0.00008322406,0.000041655945,0.00053930323,0.00018763951,0.00015881349,0.00004996486,0.00013754363,0.0000074773493],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024066456,0.0055279504,0.9396015,0.00005038731,0.000044265278,0.000059023907,0.0011535621,0.0007323065,0.044173338,0.0021675015,0.003738305,0.00034522166],"study_design_scores_gemma":[0.0071924385,0.0006126716,0.93343097,0.0004995585,0.00001895571,0.0000024376034,0.00009086507,0.00021221602,0.057026442,0.0006089374,0.00009259031,0.0002119397],"about_ca_topic_score_codex":0.00005565737,"about_ca_topic_score_gemma":0.0021113744,"teacher_disagreement_score":0.012853103,"about_ca_system_score_codex":0.00007515142,"about_ca_system_score_gemma":0.00015479296,"threshold_uncertainty_score":0.9996913},"labels":[],"label_agreement":null},{"id":"W2732441612","doi":"10.1182/blood.v128.22.454.454","title":"Genomic Landscape of Pediatric Mixed Phenotype Acute Leukemia","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Myeloid; Leukemia; Myeloid leukemia; Biology; Acute lymphocytic leukemia; Immunology; Cancer research; Medicine; Lymphoblastic Leukemia","score_opus":0.014138770153635048,"score_gpt":0.25932859678282927,"score_spread":0.24518982662919422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2732441612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99265546,0.0006426787,0.000088692344,0.0004416074,0.0000913561,0.0002540673,0.000034918114,0.00006491359,0.0057263393],"genre_scores_gemma":[0.9943114,0.0007113276,0.0011786934,0.000076183336,0.0006898299,0.000014541261,0.000012300139,0.000040527986,0.0029652056],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987434,0.000037830247,0.00027243927,0.00026831258,0.0003143287,0.00036366572],"domain_scores_gemma":[0.9989819,0.00013059143,0.00009085883,0.00048315295,0.00013166467,0.00018182753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020328804,0.00014228372,0.00033634686,0.0002005763,0.000032068827,0.0000057376697,0.0002032109,0.00012540407,0.00047509486],"category_scores_gemma":[0.00013528728,0.000089896224,0.0001070399,0.00028290795,0.000061935985,0.000053373282,0.000120570796,0.000154376,0.0005350656],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054109463,0.00039707762,0.33228543,0.00017388797,0.0007058634,0.00027287495,0.00015062864,5.6915076e-7,0.63654315,0.00034301702,0.021626947,0.0069594905],"study_design_scores_gemma":[0.036732603,0.0015141334,0.7411381,0.00010315905,0.0028828895,0.00033219205,0.00007317155,0.000053916465,0.20976196,0.00037781126,0.006475216,0.00055484654],"about_ca_topic_score_codex":0.000022249948,"about_ca_topic_score_gemma":0.0000035491241,"teacher_disagreement_score":0.42678115,"about_ca_system_score_codex":0.00013683445,"about_ca_system_score_gemma":0.0007991851,"threshold_uncertainty_score":0.68773645},"labels":[],"label_agreement":null},{"id":"W273305725","doi":"10.1182/blood.v124.21.5108.5108","title":"Recombinant Factor VIIa (rFVIIa) Mediated Activation of Prothrombin Complex Concentrates (PCCs). Studies on the Comparison of Novoseven with a Biosimilar Product","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Recombinant factor VIIa; Recombinant DNA; Chemistry; Tissue factor; Thrombin; Chromatography; Factor VIIa; Saline; Medicine; Surgery; Coagulation; Platelet; Biochemistry; Immunology; Internal medicine","score_opus":0.11924758740906442,"score_gpt":0.35951218109509614,"score_spread":0.2402645936860317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W273305725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99384254,0.0001388792,0.0000024097321,0.0041171564,0.00003462795,0.001546111,0.000010939209,0.000025373318,0.00028196577],"genre_scores_gemma":[0.9995331,0.000048452537,0.00014716461,0.00004148261,0.000039157894,0.000057916743,0.00003613757,0.000017257405,0.00007933454],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986552,0.00014464611,0.00033330836,0.00022308977,0.00043779667,0.00020594579],"domain_scores_gemma":[0.9986927,0.000400608,0.0002225208,0.0003206472,0.00030766302,0.000055855366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026504838,0.00015758528,0.0005259418,0.00007450103,0.000077143915,0.000005673671,0.00010111537,0.00003910664,0.00004266955],"category_scores_gemma":[0.00049381965,0.000076672586,0.000049229286,0.00026168293,0.00029818487,0.00003331932,0.000028665285,0.00015068421,0.000006881463],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007800109,0.005633776,0.34862798,0.0006618641,0.0013767042,0.000003948043,0.003987568,0.000004319954,0.6368544,0.00040825256,0.00083515194,0.00082599785],"study_design_scores_gemma":[0.0038371568,0.003040089,0.08188932,0.0005012067,0.00013979983,0.0000026653213,0.0007318004,0.00014041118,0.9093887,0.000048644168,0.00019327237,0.00008694648],"about_ca_topic_score_codex":0.000019327572,"about_ca_topic_score_gemma":0.000009288205,"teacher_disagreement_score":0.27253428,"about_ca_system_score_codex":0.000026752026,"about_ca_system_score_gemma":0.00009617535,"threshold_uncertainty_score":0.31266174},"labels":[],"label_agreement":null},{"id":"W2733127128","doi":"10.1182/blood.v128.22.2576.2576","title":"Modelling FVIII Levels for Prediction of Zero Spontaneous-Joint Bleeding in a Cohort of Severe Hemophilia a Subjects with Target Joints Initiated on Tertiary Prophylaxis","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Cohort; Regimen; Randomization; Surgery; Hemarthrosis; Internal medicine; Post-hoc analysis; Randomized controlled trial","score_opus":0.04812231918492463,"score_gpt":0.26431013347017646,"score_spread":0.21618781428525183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2733127128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99640614,0.000054383145,0.0008429403,0.00016584493,0.00003177255,0.0017170166,0.00019810883,0.00003612815,0.0005476827],"genre_scores_gemma":[0.9969923,0.000035381567,0.0023262815,0.000013932625,0.000055749875,0.000103131955,0.00003493547,0.00003848901,0.00039979912],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99837554,0.000044672437,0.00044888476,0.00034079255,0.00045375733,0.00033634016],"domain_scores_gemma":[0.9991294,0.00014205392,0.00012694561,0.00025361672,0.00023549396,0.000112460184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037247612,0.0001908058,0.0004814394,0.0003363136,0.000037779777,0.000004315189,0.00006577302,0.0001459768,0.000033383152],"category_scores_gemma":[0.00012553728,0.00011223355,0.000093155875,0.00024524314,0.00008758522,0.0000824674,0.000025733656,0.00013745124,0.0000032865341],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056283204,0.0044111763,0.65510845,0.0016971421,0.0009790529,0.0012336606,0.00088876183,0.00096651894,0.3276373,0.000059377468,0.000053450818,0.0013367845],"study_design_scores_gemma":[0.026112022,0.011141688,0.11115817,0.00590932,0.00039391537,0.0008870019,0.000087780856,0.004630873,0.83847857,0.0008799656,0.00001022885,0.00031049206],"about_ca_topic_score_codex":0.000033941073,"about_ca_topic_score_gemma":0.000004578588,"teacher_disagreement_score":0.54395026,"about_ca_system_score_codex":0.000088514746,"about_ca_system_score_gemma":0.00020822376,"threshold_uncertainty_score":0.45767516},"labels":[],"label_agreement":null},{"id":"W2733281141","doi":"10.1182/blood.v128.22.679.679","title":"Comparison of Total Body Irradiation-Based with Intravenous Busulfan-Based Chemotherapy-Only Conditioning Regimens for Myeloablative Hematopoietic Cell Transplantation (HCT) in Adults with Acute Lymphoblastic Leukemia","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Ottawa Hospital","funders":"","keywords":"Medicine; Busulfan; Total body irradiation; Internal medicine; Melphalan; Etoposide; Clofarabine; Transplantation; Oncology; Cyclophosphamide; Surgery; Fludarabine; Hematopoietic stem cell transplantation; Chemotherapy; Acute lymphocytic leukemia; Gastroenterology; Leukemia; Cytarabine; Lymphoblastic Leukemia","score_opus":0.006951006725704243,"score_gpt":0.25530584369443865,"score_spread":0.2483548369687344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2733281141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9159876,0.00003820441,0.081509404,0.00032319207,0.00002131738,0.0016103027,0.00021715416,0.000063423846,0.0002294083],"genre_scores_gemma":[0.9907192,0.000010996531,0.008372896,0.00011380252,0.00005575569,0.00023658338,0.00031193974,0.00008283247,0.00009598991],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99772084,0.000071232214,0.00055798277,0.00050888496,0.00061828597,0.00052280317],"domain_scores_gemma":[0.9976774,0.0010820713,0.00035739245,0.0003368975,0.00036002646,0.00018621096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017386077,0.0003361909,0.0006901053,0.00033345917,0.000090561465,0.000017851611,0.000121785946,0.00017197912,0.00005861551],"category_scores_gemma":[0.000058100137,0.00022747373,0.00008371278,0.00044405196,0.00027316823,0.00011663629,0.0000057285756,0.00015013179,0.00000831881],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16075322,0.012588487,0.28541178,0.011005701,0.00287685,0.0017607262,0.021504173,0.01704457,0.4805772,0.0005878567,0.0005310035,0.005358424],"study_design_scores_gemma":[0.14838399,0.010626488,0.12867267,0.0048566777,0.0012625932,0.0004154629,0.0006594761,0.028180555,0.6762568,0.000039426257,0.000008735948,0.0006371816],"about_ca_topic_score_codex":0.000102037586,"about_ca_topic_score_gemma":0.00007845882,"teacher_disagreement_score":0.19567956,"about_ca_system_score_codex":0.0008093467,"about_ca_system_score_gemma":0.003551685,"threshold_uncertainty_score":0.92761093},"labels":[],"label_agreement":null},{"id":"W2733429355","doi":"10.1182/blood-2017-03-772368","title":"Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":296,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Ottawa Hospital; University of Ottawa","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Medicine; Hematopoietic cell; Transplantation; Comorbidity; Hematopoietic stem cell transplantation; Hematologic Neoplasms; Pediatrics; Gerontology; Stem cell; Internal medicine; Haematopoiesis","score_opus":0.02025034841545103,"score_gpt":0.25117838788276275,"score_spread":0.23092803946731172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2733429355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993288,0.00003188154,0.000022831045,0.00005587388,0.000017356464,0.00044206297,0.00001573991,0.000006938716,0.00007853338],"genre_scores_gemma":[0.999083,0.00025053596,0.00040688415,0.000079620484,0.0000054597067,0.000009904533,0.00014490022,0.000012564452,0.0000071595387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991345,0.00013227649,0.00026426767,0.00014074655,0.00019433412,0.0001339191],"domain_scores_gemma":[0.9993776,0.00021153303,0.00010723442,0.00024147502,0.000028243361,0.000033924156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002998188,0.00009034687,0.00017848528,0.00015160693,0.000039590304,0.000028740104,0.000079024074,0.000064002,0.000008062377],"category_scores_gemma":[0.000044903725,0.0000731383,0.00002226119,0.000091551934,0.000059452264,0.00009189109,0.0000069951484,0.00010324081,0.000002100256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012638004,0.0004635159,0.98593354,0.00047217176,0.00001170578,0.00008441877,0.009113131,0.0000101200285,0.0036940633,0.000008709694,0.00000282935,0.000079406156],"study_design_scores_gemma":[0.0063083926,0.00008192454,0.98362505,0.0004390108,0.00013717989,0.000040954026,0.00029655092,0.000024750634,0.008950978,0.000021356815,0.000004385728,0.000069476664],"about_ca_topic_score_codex":0.0008454266,"about_ca_topic_score_gemma":0.00011330091,"teacher_disagreement_score":0.00881658,"about_ca_system_score_codex":0.000007681706,"about_ca_system_score_gemma":0.00001771327,"threshold_uncertainty_score":0.29824933},"labels":[],"label_agreement":null},{"id":"W2734387382","doi":"10.1182/blood-2017-05-786319","title":"Soluble P-selectin is the smoke, not the fire","year":2017,"lang":"en","type":"letter","venue":"Blood","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Inflammation; P-selectin; Coagulation; Selectin; Immunology; L-selectin; Chemistry; Medicine; Internal medicine; Cell adhesion molecule; Platelet; Platelet activation","score_opus":0.05134576085834346,"score_gpt":0.31631798239854425,"score_spread":0.2649722215402008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2734387382","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010342344,0.0012793265,0.0000013296847,0.9636758,0.0003200482,0.00093341374,0.000021009693,0.00005372135,0.023373025],"genre_scores_gemma":[0.008148686,0.00038786666,0.000035607587,0.71859527,0.0057943612,0.0001266944,0.000084439984,0.00011747359,0.26670957],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99726063,0.0001528566,0.00025192255,0.0004996697,0.001177758,0.0006571885],"domain_scores_gemma":[0.99665004,0.00042251925,0.00017865567,0.0024871165,0.00018445858,0.00007719314],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00044293367,0.0003090555,0.00039960773,0.000064037275,0.00064134906,0.00019516403,0.0011891734,0.0006107968,0.0014829264],"category_scores_gemma":[0.00047481182,0.00015331869,0.00033262116,0.00012904084,0.0002846901,0.000025403619,0.00036970663,0.0038879672,0.0009709169],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020685373,0.00007837798,0.00027047461,0.00012696373,0.0002300391,0.0008127198,0.00011491189,2.7483061e-8,0.0007314239,0.0000020699897,0.99604845,0.0015638554],"study_design_scores_gemma":[0.0010649755,0.00014402527,0.0011063213,0.0001166872,0.00039401397,0.0002703137,0.000011583577,0.000018882576,0.012627431,0.000037988975,0.9840324,0.0001753935],"about_ca_topic_score_codex":0.0004084581,"about_ca_topic_score_gemma":0.000013345762,"teacher_disagreement_score":0.24508049,"about_ca_system_score_codex":0.00003801478,"about_ca_system_score_gemma":0.00037468583,"threshold_uncertainty_score":0.99980694},"labels":[],"label_agreement":null},{"id":"W2734717767","doi":"10.1182/blood.v128.22.1452.1452","title":"Long Term Monitoring of Patients with Positive Lupus Anticoagulant and Antiphospholipid Antibodies. Are All Cases Persistently Positive?","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Medicine; Antiphospholipid syndrome; Thrombosis; Lupus anticoagulant; Internal medicine; Pediatrics; Surgery","score_opus":0.018946058866555225,"score_gpt":0.26800063766038523,"score_spread":0.24905457879383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2734717767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974554,0.001281836,0.000012378518,0.00009990792,0.00014350825,0.00066476077,0.0001448688,0.000033123244,0.00016421426],"genre_scores_gemma":[0.9990331,0.00030301147,0.00017162458,0.000013771105,0.000099912395,0.000009076152,0.00001602814,0.0000415269,0.00031194952],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998297,0.000058374302,0.0002854002,0.00038840013,0.0005648215,0.0004060425],"domain_scores_gemma":[0.99865776,0.00020492155,0.00018705982,0.0003366108,0.00041136015,0.0002022738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012016427,0.00022599135,0.0005205568,0.00015092145,0.00007078885,0.000021291302,0.00009819038,0.00008535975,0.000012208702],"category_scores_gemma":[0.00012205804,0.00013409255,0.000077917306,0.00012157326,0.00022184527,0.00013089538,0.00010378513,0.00009757397,0.000007652986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004889394,0.0006446927,0.9798387,0.0004890428,0.000527135,0.0006814825,0.00073781994,2.1250987e-8,0.016086854,0.000004020442,0.000019411149,0.0004818358],"study_design_scores_gemma":[0.00763195,0.00074985734,0.90119356,0.0047870516,0.00036233463,0.0048335143,0.00049786025,4.3052566e-7,0.07977205,7.3073033e-7,0.000003304179,0.00016732942],"about_ca_topic_score_codex":0.00005412117,"about_ca_topic_score_gemma":0.000005352784,"teacher_disagreement_score":0.078645155,"about_ca_system_score_codex":0.000061363164,"about_ca_system_score_gemma":0.000057548987,"threshold_uncertainty_score":0.54681355},"labels":[],"label_agreement":null},{"id":"W2735841375","doi":"10.1182/blood-2017-05-786004","title":"Novel mechanisms of PIEZO1 dysfunction in hereditary xerocytosis","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health; Yale University; American Society of Hematology","keywords":"Medicine; Genetics; Biology","score_opus":0.02649619426699702,"score_gpt":0.25873714412015214,"score_spread":0.23224094985315513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2735841375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894758,0.00006113928,0.0027549788,0.00040877928,0.00068522355,0.00017092163,0.000009875183,0.000032369673,0.0064009232],"genre_scores_gemma":[0.9970452,0.000027921356,0.0019672136,0.00026648806,0.00019775526,0.000011359851,0.000015469332,0.00001154939,0.00045700787],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9994015,0.000011713583,0.00017854017,0.0001696546,0.00011159079,0.00012701354],"domain_scores_gemma":[0.99935937,0.000021140739,0.00011566037,0.00040156953,0.000050326045,0.000051904386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009646258,0.000084355146,0.00023559129,0.00007971628,0.00006632271,0.000004809564,0.00007573321,0.000112836424,0.00017744338],"category_scores_gemma":[0.00010433125,0.00007488483,0.00006534415,0.000043328768,0.000049434882,0.00006657101,0.00004033596,0.00012340485,0.000037069352],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034528706,0.0012443806,0.010776931,0.00011213191,0.000072909774,0.000049723312,0.0000832768,0.0000031817822,0.9837074,0.0011415174,0.00035513134,0.002108111],"study_design_scores_gemma":[0.016638469,0.0016852068,0.62777925,0.00023877715,0.00026877268,0.0003090851,0.00022888133,0.00014785882,0.34993967,0.0017726673,0.0007791713,0.000212213],"about_ca_topic_score_codex":0.00016565323,"about_ca_topic_score_gemma":0.00006784654,"teacher_disagreement_score":0.6337677,"about_ca_system_score_codex":0.000012126347,"about_ca_system_score_gemma":0.00003971885,"threshold_uncertainty_score":0.30537146},"labels":[],"label_agreement":null},{"id":"W2735853984","doi":"10.1182/blood.v128.22.842.842","title":"Inferior Access to Allogeneic Transplant in Disadvantaged Populations: A CIBMTR Analysis","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Transplantation; Demography; Poisson regression; Disadvantaged; Epidemiology; Population; Internal medicine; Environmental health","score_opus":0.04619539138248598,"score_gpt":0.35564078096030527,"score_spread":0.3094453895778193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2735853984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951028,0.00006353258,0.0030361104,0.0010397069,0.00003256969,0.00034840207,0.00008838175,0.00003280345,0.0002556712],"genre_scores_gemma":[0.9982001,0.0001473584,0.0009025763,0.00030464266,0.000019976254,0.000061590195,0.000081298334,0.00001128215,0.00027114007],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914205,0.0000277638,0.00026073502,0.00022470462,0.00016462797,0.00018012496],"domain_scores_gemma":[0.99955994,0.000047916907,0.00003341609,0.00020212494,0.000022114396,0.00013449621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005702101,0.000117454045,0.00028634124,0.0003677074,0.000028633614,0.000016544582,0.00007790964,0.000041233452,0.00018131953],"category_scores_gemma":[0.000015913281,0.000070140086,0.0001368618,0.0006030059,0.00001109381,0.00010804002,0.0000083468385,0.00003549578,0.00004346008],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011040377,0.0003909049,0.99282837,0.000028896857,0.0005270238,0.00017632548,0.00011630775,0.000020666665,0.0044204677,0.00005920735,0.0000012681409,0.0013201575],"study_design_scores_gemma":[0.0046163867,0.00008463926,0.98898387,0.00020488513,0.0017151025,0.000022431184,0.000005137793,0.0000027479189,0.0041919732,0.000040202376,0.000036921247,0.00009572128],"about_ca_topic_score_codex":0.00011382604,"about_ca_topic_score_gemma":0.0010784802,"teacher_disagreement_score":0.004505983,"about_ca_system_score_codex":0.000026220729,"about_ca_system_score_gemma":0.000025132773,"threshold_uncertainty_score":0.28602296},"labels":[],"label_agreement":null},{"id":"W2735983023","doi":"10.1182/blood.v128.22.3578.3578","title":"Assessment of Value Using the American Society of Clinical Oncology (ASCO) and European Society of Medical Oncology (ESMO) Frameworks for Novel Therapies for the Hematologic Malignancies","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; University of Waterloo; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Oncology; Clinical Oncology; Clinical trial; Hematology; Cancer; Multiple myeloma; Hematologic Neoplasms; Randomized controlled trial","score_opus":0.06265466806402764,"score_gpt":0.4027958830188676,"score_spread":0.34014121495483995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2735983023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.844694,0.0013462646,0.1492885,0.0040211626,0.00012377,0.00035896868,0.00013129185,0.0000025107977,0.000033490393],"genre_scores_gemma":[0.9447945,0.006730825,0.04672112,0.0014488747,0.00024277261,0.000031552307,0.0000060341827,0.000016933687,0.000007392504],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988238,0.000111246736,0.00052968616,0.00022598209,0.00013314714,0.00017611684],"domain_scores_gemma":[0.9968495,0.00202507,0.0006275167,0.0002795193,0.0001765899,0.00004180756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017597636,0.00011255282,0.00043851047,0.0000063014986,0.000076211065,0.0000045793877,0.00030536362,0.00026684586,0.0000029208143],"category_scores_gemma":[0.000396565,0.0000572413,0.00038499167,0.000041866962,0.0013016337,0.0000017286335,0.00021923221,0.00012551974,2.2996332e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029186835,0.00197254,0.033805106,0.00025362475,0.0024314763,6.959898e-7,0.0006659724,0.00006840654,0.9036856,0.009148708,0.0042818612,0.043394137],"study_design_scores_gemma":[0.037901983,0.024563083,0.1964291,0.00061933626,0.003324919,0.00018500329,0.013155318,0.012406216,0.42396724,0.004114365,0.28207728,0.0012561564],"about_ca_topic_score_codex":0.000046505065,"about_ca_topic_score_gemma":0.000020799016,"teacher_disagreement_score":0.47971836,"about_ca_system_score_codex":0.000011086125,"about_ca_system_score_gemma":0.0005181419,"threshold_uncertainty_score":0.47959235},"labels":[],"label_agreement":null},{"id":"W2736085962","doi":"10.1182/blood.v128.22.1795.1795","title":"Is Prior Rituximab Exposure Associated with a Difference in Outcomes in Relapsed Low-Grade Lymphomas Retreated with Rituximab in Comparison to Rituximab NaïVe Patients?","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Rituximab; Medicine; Regimen; Follicular lymphoma; Internal medicine; Progression-free survival; Oncology; Mantle cell lymphoma; Surgery; Lymphoma; Chemotherapy","score_opus":0.01266687284968091,"score_gpt":0.24454450607804867,"score_spread":0.23187763322836777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2736085962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958064,0.00025269567,0.0000038673024,0.0015212437,0.00004740124,0.0019085277,0.000117280964,0.000107679036,0.0002349365],"genre_scores_gemma":[0.9981861,0.000031229054,0.00039684423,0.00044771284,0.000014868377,0.00050558214,0.00006988608,0.00007547707,0.00027228863],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962362,0.00019604331,0.00090490666,0.0009776467,0.0007951291,0.00089009403],"domain_scores_gemma":[0.99818164,0.00037066062,0.00028188736,0.0006918073,0.00017300695,0.00030097453],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021203443,0.00063297653,0.0017638047,0.00060245994,0.00006423608,0.00004448529,0.00022739758,0.00030141577,0.000051188574],"category_scores_gemma":[0.00032977943,0.00037100315,0.0001155204,0.0011624686,0.00010785717,0.00013028586,0.0000859476,0.00023453342,0.00007575112],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013786107,0.0765297,0.9167578,0.000047061723,0.00029467113,0.00075543305,0.0015423978,0.0000010041184,0.00012543655,0.000017383732,0.00005248962,0.0024979718],"study_design_scores_gemma":[0.23329762,0.0028703918,0.756096,0.0025496199,0.00022795376,0.000014615309,0.00012010013,0.00001866435,0.0043594623,0.000018170394,0.000014586373,0.0004128139],"about_ca_topic_score_codex":0.0011410393,"about_ca_topic_score_gemma":0.0064049303,"teacher_disagreement_score":0.231919,"about_ca_system_score_codex":0.0010754971,"about_ca_system_score_gemma":0.00029040792,"threshold_uncertainty_score":0.9998742},"labels":[],"label_agreement":null},{"id":"W2736866953","doi":"10.1182/blood.v128.22.690.690","title":"Impact of Wait Times for Autologous Stem Cell Transplantation in Patients with Aggressive Non-Hodgkin Lymphoma, a Subset Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Clinical Trial","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Dalhousie University; Juravinski Hospital; Queen's University; McMaster University; Sunnybrook Health Science Centre; Juravinski Cancer Centre; Princess Margaret Cancer Centre; Canadian Partnership Against Cancer","funders":"","keywords":"Medicine; Autologous stem-cell transplantation; Internal medicine; Gemcitabine; Oncology; Transplantation; Salvage therapy; Surgery; Chemotherapy; Mitoxantrone","score_opus":0.03304076690110804,"score_gpt":0.33272631868295566,"score_spread":0.29968555178184764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2736866953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957518,0.00011759551,0.0000060935754,0.00007268434,0.00009671336,0.001907189,0.0020041293,0.000004602493,0.00003920681],"genre_scores_gemma":[0.9993644,0.00011459778,0.000055359265,0.00002200205,0.000047969334,0.00023387183,0.00012025263,0.000014525692,0.000027056392],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99818337,0.00023343142,0.0008264373,0.0002625505,0.00025138774,0.00024280086],"domain_scores_gemma":[0.9978238,0.0007478083,0.0008651823,0.00028618606,0.00013235814,0.00014470339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050639495,0.00017142581,0.0010826796,0.00024814403,0.000039579543,0.000006462401,0.00010073163,0.00014829118,0.00005037871],"category_scores_gemma":[0.00009604935,0.00007569268,0.00062523526,0.00032377485,0.00007648218,0.000040215127,0.0000065357503,0.000027259703,6.762214e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02027876,0.0027871642,0.9582009,0.000035483667,0.003493309,0.000015437883,0.0002414488,0.000007981176,0.00003359229,0.0000061414994,0.00007557735,0.014824232],"study_design_scores_gemma":[0.17348546,0.0030190859,0.81297636,0.00022543113,0.008398432,9.641063e-7,0.000009238989,0.00002039869,0.0017782128,0.000003423162,0.0000055463015,0.000077433026],"about_ca_topic_score_codex":0.058206942,"about_ca_topic_score_gemma":0.19447647,"teacher_disagreement_score":0.1532067,"about_ca_system_score_codex":0.00027219058,"about_ca_system_score_gemma":0.0010485107,"threshold_uncertainty_score":0.94806457},"labels":[],"label_agreement":null},{"id":"W2736942508","doi":"10.1182/blood.v128.22.4150.4150","title":"Differential Outcome of Patients with Primary Refractory Vs. Relapsed Peripheral T-Cell Lymphoma: Analysis from a Prospective Multicenter US Cohort Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and Retrovirus Studies","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Prospective cohort study; Peripheral T-cell lymphoma; B symptoms; Lymphoma; Surgery; T cell; Immunology","score_opus":0.004158099599308163,"score_gpt":0.19218239543135776,"score_spread":0.1880242958320496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2736942508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980255,0.0002632985,0.000035900524,0.0000077312125,0.0002832422,0.00069959933,0.0002685594,0.000045777928,0.00037039138],"genre_scores_gemma":[0.9979562,0.000018255596,0.0000339213,0.000020083513,0.000023931178,0.000059375845,0.00009914221,0.000021222624,0.0017678635],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852264,0.000174583,0.00041137837,0.0004901452,0.00010550074,0.00029572495],"domain_scores_gemma":[0.9990605,0.00009777578,0.00027741762,0.00039404555,0.00014509898,0.000025171237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000054606495,0.00026437332,0.000741116,0.000117523734,0.00013819576,0.0000071299105,0.00018531855,0.00014781389,0.0003649025],"category_scores_gemma":[0.000021230588,0.00014175358,0.00019088936,0.00015129242,0.00023595989,0.00006922759,0.00014882465,0.00010781199,0.00004672388],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015308588,0.011947744,0.94236904,0.000009657033,0.0073595163,0.0000054852667,0.00070602354,1.15429266e-7,0.035898194,7.295468e-7,0.000025083871,0.0001475703],"study_design_scores_gemma":[0.029833136,0.001028205,0.95552844,0.000011502365,0.0036482785,2.236855e-7,0.00011999544,8.403276e-8,0.00952357,0.0000015359445,0.000092097915,0.0002129382],"about_ca_topic_score_codex":0.0005437957,"about_ca_topic_score_gemma":0.0002540193,"teacher_disagreement_score":0.028302277,"about_ca_system_score_codex":0.0000759617,"about_ca_system_score_gemma":0.00002512175,"threshold_uncertainty_score":0.5780543},"labels":[],"label_agreement":null},{"id":"W2737230095","doi":"10.1182/blood.v124.21.4245.4245","title":"Evaluating the Need for Anticoagulation Beyond 6 Months for Patients with Cancer-Associated Venous Thromboembolism: A Retrospect of Real Life (EXTEND Study)","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Cancer; Retrospective cohort study; Thrombosis; Low molecular weight heparin; Malignancy; Surgery; Clinical trial; Venous thrombosis; Internal medicine","score_opus":0.027925719043431413,"score_gpt":0.32341759410596294,"score_spread":0.2954918750625315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2737230095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99321055,0.0000809122,0.00013027003,0.0002950957,0.0001708819,0.005648512,0.00006458237,0.0000478851,0.00035131874],"genre_scores_gemma":[0.99797595,0.000028929575,0.00064635277,0.00020440784,0.00021199517,0.0007570916,0.0000885649,0.000052080963,0.000034639812],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983555,0.000077108685,0.00041496064,0.0003271294,0.00049518835,0.0003301323],"domain_scores_gemma":[0.99836093,0.00026419255,0.00040994666,0.00037692123,0.0005087125,0.000079290934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007556539,0.00019339472,0.00078398915,0.00007325286,0.0002386861,0.000026005755,0.00012806585,0.000065329565,0.000011801567],"category_scores_gemma":[0.0005952177,0.00012924788,0.000115853625,0.00020440033,0.000048280097,0.00005971215,0.000040205905,0.0000768571,6.319758e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014001188,0.040169,0.93123376,0.00068191584,0.0045632506,0.0000013172624,0.0067202924,0.000616265,0.0017063108,0.0022140313,0.0016801263,0.009013586],"study_design_scores_gemma":[0.016026173,0.01558219,0.960932,0.00014304195,0.00387324,1.9632057e-7,0.00040017845,0.0022075858,0.00032890553,0.00031494838,0.00003291719,0.00015858516],"about_ca_topic_score_codex":0.00082176714,"about_ca_topic_score_gemma":0.00031604138,"teacher_disagreement_score":0.02969825,"about_ca_system_score_codex":0.000054536613,"about_ca_system_score_gemma":0.00010557435,"threshold_uncertainty_score":0.5270576},"labels":[],"label_agreement":null},{"id":"W2737383904","doi":"10.1182/blood-2017-05-784678","title":"Five-year follow-up of brentuximab vedotin combined with ABVD or AVD for advanced-stage classical Hodgkin lymphoma","year":2017,"lang":"en","type":"letter","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; BC Cancer Agency","keywords":"Brentuximab vedotin; ABVD; Dacarbazine; Medicine; Oncology; Vinblastine; Internal medicine; Classical Hodgkin lymphoma; Lymphoma; Stage (stratigraphy); Bleomycin; Hodgkin lymphoma; Chemotherapy; Vincristine; Cyclophosphamide; Biology","score_opus":0.019684991130865064,"score_gpt":0.26962220136689946,"score_spread":0.2499372102360344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2737383904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7770539,0.0013591794,0.00006705221,0.20160702,0.0018542806,0.007888798,0.003265645,0.00031554294,0.0065886024],"genre_scores_gemma":[0.6037508,0.00062805525,0.012236305,0.11307011,0.006866465,0.0040823827,0.007127741,0.0009110183,0.2513271],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997249,0.000052411677,0.0005404196,0.00084293657,0.0006558557,0.00065937644],"domain_scores_gemma":[0.99719685,0.00039420687,0.0006533084,0.0013405413,0.0002501279,0.00016498956],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010467961,0.00065943133,0.0015983015,0.0001602382,0.00015676451,0.000075057535,0.00037855402,0.00068595016,0.00010771754],"category_scores_gemma":[0.0001783843,0.00043165486,0.00050756696,0.000091409966,0.00021867293,0.00011334936,0.00009906498,0.00029368085,0.00004107975],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011440425,0.008360717,0.009538384,0.0027456046,0.004214853,0.007126682,0.00023553033,6.241097e-7,0.0001919317,0.00023643882,0.94596523,0.009943576],"study_design_scores_gemma":[0.22983003,0.013558235,0.012978951,0.0025338193,0.0051539573,0.0002957327,0.00006148086,0.000012439555,0.009549016,0.000051125768,0.72511506,0.000860168],"about_ca_topic_score_codex":0.00007298961,"about_ca_topic_score_gemma":0.000056858356,"teacher_disagreement_score":0.24473849,"about_ca_system_score_codex":0.00017304569,"about_ca_system_score_gemma":0.0007355737,"threshold_uncertainty_score":0.9998135},"labels":[],"label_agreement":null},{"id":"W2737437839","doi":"10.1182/blood.v112.11.839.839","title":"The Addition of Rituximab Eliminates the Negative Prognostic Impact of PMBCL Compared to DLBCL in Young Patients with CD20-Positive Aggressive Lymphomas Receiving a CHOP-Like Chemotherapy: Results of a Subgroup Analysis of the Mabthera International Trial Group (MInT) Study","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Rituximab; Medicine; Internal medicine; Lymphoma; CHOP; Diffuse large B-cell lymphoma; Stage (stratigraphy); Oncology; Chemotherapy; International Prognostic Index; Radiation therapy; Subgroup analysis; Gastroenterology; Surgery; Confidence interval","score_opus":0.008444756382393205,"score_gpt":0.2549183131276354,"score_spread":0.2464735567452422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2737437839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99619555,0.00008326233,0.0000035202959,0.00010818638,0.000058127516,0.002879717,0.00057375396,0.0000056881463,0.00009217748],"genre_scores_gemma":[0.99947774,0.000047565536,0.00006683872,0.000015959133,0.000024982224,0.00023496561,0.000107335254,0.000016564516,0.000008053301],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977878,0.00027800613,0.0007742804,0.00028000044,0.00069490296,0.00018503456],"domain_scores_gemma":[0.99664956,0.0010637376,0.0012386364,0.00043478826,0.00056831865,0.000044945526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003180012,0.00022053647,0.0007075588,0.00023092148,0.00009786728,0.000010340239,0.0002627995,0.000047777463,0.000013890391],"category_scores_gemma":[0.00054082094,0.00010096196,0.00032228816,0.0010402285,0.0002509261,0.00006587887,0.00006579216,0.00007792083,3.2717148e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03471026,0.023386806,0.91425014,0.000011451932,0.007151882,0.000012070464,0.019039609,0.0000559462,0.00014328468,0.0000066749813,0.000026319562,0.0012055702],"study_design_scores_gemma":[0.12636846,0.0041624233,0.8625696,0.00045215408,0.001855695,0.00000628882,0.0015315852,0.0001483246,0.0028215975,0.000008187215,5.0503985e-7,0.000075218246],"about_ca_topic_score_codex":0.0029637436,"about_ca_topic_score_gemma":0.0014472181,"teacher_disagreement_score":0.091658205,"about_ca_system_score_codex":0.00020428417,"about_ca_system_score_gemma":0.00015292005,"threshold_uncertainty_score":0.44803137},"labels":[],"label_agreement":null},{"id":"W2737966976","doi":"10.1182/blood.v128.22.4359.4359","title":"Incidence and Implications of Skin Cancers in Cancercare Manitoba Chronic Lymphocytic Leukemia (CLL) Clinic Patients","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"","keywords":"Medicine; Chronic lymphocytic leukemia; Hazard ratio; Internal medicine; Population; Confidence interval; Incidence (geometry); Proportional hazards model; Cancer; Cumulative incidence; Cancer registry; Leukemia; Oncology; Cohort","score_opus":0.016714996751474562,"score_gpt":0.2975111773936931,"score_spread":0.2807961806422185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2737966976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966723,0.0015604653,0.00000980867,0.000093389775,0.000063263964,0.0006076226,0.000047168614,0.000028293534,0.0009177302],"genre_scores_gemma":[0.9975519,0.0017708209,0.00010292774,0.00008303225,0.00010537151,0.00012472257,0.000010563318,0.000030047042,0.00022059733],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982341,0.000049037586,0.0004861454,0.00042711492,0.00036015565,0.00044346176],"domain_scores_gemma":[0.99862057,0.00027516356,0.00014061533,0.0005793313,0.00019531281,0.00018901045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002013675,0.00016887399,0.0003722771,0.00017756797,0.000042397507,0.000007916232,0.00020480165,0.00013347059,0.00012107837],"category_scores_gemma":[0.0003047103,0.00012655597,0.00006346816,0.00035779763,0.00026874192,0.00010608388,0.00014834925,0.00012152212,0.000046326033],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0005837642,0.00040757385,0.8593106,0.0015383572,0.00033295839,0.00012630755,0.0009537362,0.00004650033,0.012433333,0.0002201479,0.0013869567,0.12265971],"study_design_scores_gemma":[0.09836516,0.0008520542,0.87774223,0.0019515695,0.00021581387,0.00014497961,0.00018579002,0.00039200825,0.018870674,0.00030011198,0.00062610855,0.00035351212],"about_ca_topic_score_codex":0.018030856,"about_ca_topic_score_gemma":0.021127984,"teacher_disagreement_score":0.1223062,"about_ca_system_score_codex":0.11986487,"about_ca_system_score_gemma":0.03726168,"threshold_uncertainty_score":0.9967339},"labels":[],"label_agreement":null},{"id":"W2738119439","doi":"10.1182/blood.v128.22.4662.4662","title":"Improving Revised International Prognostic Scoring System (IPSS-R) Pre-Allogeneic Stem Cell Transplant Does Not Translate into Better Post-Transplant Outcomes for Patients with Myelodysplastic Syndromes","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dr. Georges-L.-Dumont University Hospital Centre; Vancouver General Hospital; BC Cancer Agency; McMaster University; Leukemia & Lymphoma Society of Canada; University of British Columbia","funders":"","keywords":"Medicine; International Prognostic Scoring System; Cytopenia; Internal medicine; Myelodysplastic syndromes; Univariate analysis; Multivariate analysis; Oncology; Transplantation; Cumulative incidence; Bone marrow","score_opus":0.008626040680261805,"score_gpt":0.23410929524631746,"score_spread":0.22548325456605567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2738119439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98842645,0.00007159929,0.006062798,0.001147053,0.00033808526,0.0029311252,0.00077527465,0.00021361878,0.00003401307],"genre_scores_gemma":[0.99599296,0.000034234912,0.0024427965,0.00015341942,0.0001557848,0.00048990845,0.00015387422,0.00012667729,0.0004503292],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967527,0.00008098241,0.0007200918,0.0008024232,0.0008791587,0.000764658],"domain_scores_gemma":[0.9980636,0.0005792402,0.0002069597,0.00045763212,0.00038108113,0.0003114906],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032084624,0.00049154524,0.00071733916,0.00032338267,0.00015930254,0.00006852256,0.00043495325,0.00018512596,0.000026888412],"category_scores_gemma":[0.000048107057,0.0002566402,0.00023359383,0.00013152801,0.00010717563,0.00032590656,0.000039028193,0.00026499876,0.00002715566],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031676034,0.0007821998,0.81327784,0.005691795,0.0011417462,0.00039888694,0.0012082114,0.000003478087,0.16655107,0.000035200992,0.0000052383893,0.0077367295],"study_design_scores_gemma":[0.07272447,0.005101254,0.70971525,0.011778099,0.0049905432,0.00052063825,0.00028238076,0.00043965178,0.19259465,0.000010560942,0.00017780042,0.0016647154],"about_ca_topic_score_codex":0.000054484066,"about_ca_topic_score_gemma":0.000028371716,"teacher_disagreement_score":0.1035626,"about_ca_system_score_codex":0.00026550202,"about_ca_system_score_gemma":0.00028196644,"threshold_uncertainty_score":0.99998856},"labels":[],"label_agreement":null},{"id":"W2738177970","doi":"10.1182/blood.v128.22.5012.5012","title":"Fixed Doses of Anticoagulants Cause Wide Variation of Thrombin Generation","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Antithrombotic; Discovery and development of direct thrombin inhibitors; Population; Quartile; Anticoagulant; Thrombosis; Heparin; Internal medicine; Thrombin; Pharmacology; Platelet; Confidence interval","score_opus":0.0484758289944872,"score_gpt":0.28222681203459465,"score_spread":0.23375098304010744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2738177970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99461603,0.00005208747,0.0043445867,0.00033227878,0.00012926948,0.000200691,0.000012391321,0.00002973103,0.00028293836],"genre_scores_gemma":[0.99770564,0.000060295344,0.0019294333,0.0000708234,0.000073976546,0.0000048759657,0.000013773791,0.0000127160865,0.00012844053],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991747,0.000042789114,0.0003099758,0.00014267357,0.00022938456,0.00010047674],"domain_scores_gemma":[0.99932015,0.00005721428,0.00018055347,0.00024782753,0.00014676666,0.000047472775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014520709,0.00008344269,0.0002707353,0.00008671069,0.0000211594,0.0000032206244,0.000043265747,0.00007799529,0.00017992673],"category_scores_gemma":[0.00015203997,0.000057916874,0.000057276902,0.00011745102,0.00003152945,0.000078223886,0.000016707532,0.000026781136,0.000012876784],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019017994,0.0005848237,0.021583566,0.000038244616,0.00014877223,0.0000018437373,0.00013127146,7.3594583e-7,0.9731166,0.0039099003,0.000066561115,0.0003986887],"study_design_scores_gemma":[0.0031261463,0.00022711998,0.21954568,0.00009516983,0.0002982661,0.000010097199,0.00000969266,0.000051018298,0.7761705,0.00040066583,0.000011584524,0.000054043143],"about_ca_topic_score_codex":0.000026361164,"about_ca_topic_score_gemma":0.000010581237,"teacher_disagreement_score":0.19796212,"about_ca_system_score_codex":0.000007914348,"about_ca_system_score_gemma":0.000054515283,"threshold_uncertainty_score":0.23617814},"labels":[],"label_agreement":null},{"id":"W2738794292","doi":"10.1182/blood-2017-04-777987","title":"Immunoassay for human serum erythroferrone","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"National Center for Advancing Translational Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute","keywords":"Immunoassay; Pathophysiology; Medicine; Internal medicine; Endocrinology; Immunology; Computational biology; Biology; Antibody","score_opus":0.040919152601107046,"score_gpt":0.3246796236461545,"score_spread":0.2837604710450474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2738794292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98196256,0.00017817134,0.00013141177,0.0013447639,0.0005176352,0.00032558857,0.000017213692,0.000074606905,0.015448044],"genre_scores_gemma":[0.9873697,0.000022452903,0.00062020286,0.00053706364,0.00060989463,0.00003671008,0.000036350877,0.000019677942,0.010747951],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9994284,0.000011765572,0.00012648763,0.00017842253,0.00006670838,0.00018822291],"domain_scores_gemma":[0.99915874,0.000021579635,0.00008900594,0.0005988191,0.00006599687,0.00006588691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009944554,0.00009189424,0.00020970432,0.000030253594,0.00047237476,0.000019800022,0.0001028256,0.00009583967,0.000281594],"category_scores_gemma":[0.0000902809,0.000078503486,0.000105588544,0.000013455863,0.00008228867,0.00004950657,0.000042100306,0.00009785205,0.00010737658],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040437444,0.0016707848,0.053214658,0.00031313175,0.00046435118,0.00006841065,0.00025758994,4.1304875e-7,0.91426706,0.006121921,0.018961564,0.0042557674],"study_design_scores_gemma":[0.020895472,0.00242567,0.7978378,0.0001223653,0.0005596334,0.00019530942,0.00012543575,0.000019008045,0.077480726,0.0025660966,0.09743286,0.0003396534],"about_ca_topic_score_codex":0.000021877919,"about_ca_topic_score_gemma":0.000014194866,"teacher_disagreement_score":0.8367863,"about_ca_system_score_codex":0.000008257796,"about_ca_system_score_gemma":0.000032500368,"threshold_uncertainty_score":0.36331725},"labels":[],"label_agreement":null},{"id":"W2738968294","doi":"10.1182/blood.v128.22.2411.2411","title":"A Rapid Desensitization Program Is a Viable Therapeutic Option in the Management of Immunomodulating Agent-Related Hypersensitivity Reactions in Patients with Plasma Cell Disorders","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Grand River Hospital; Toronto East General Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Pomalidomide; Lenalidomide; Medicine; Discontinuation; Anaphylaxis; Angioedema; Ixazomib; Multiple myeloma; Allergy; Surgery; Dermatology; Internal medicine; Immunology; Carfilzomib","score_opus":0.009707029350178732,"score_gpt":0.2248702124786374,"score_spread":0.21516318312845867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2738968294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99229294,0.000012228297,0.000082626175,0.00024015442,0.000035922163,0.0013582414,0.0000042114198,0.000040511255,0.0059331395],"genre_scores_gemma":[0.998885,0.000059184942,0.0008408772,0.000021283055,0.0000054439415,0.000063892185,0.000022857566,0.000019505787,0.000081962295],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990339,0.00008645113,0.0002523874,0.00020197505,0.0002306377,0.00019462976],"domain_scores_gemma":[0.99946725,0.00005819828,0.00013438055,0.00025839472,0.0000564946,0.000025266141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017952704,0.00011837272,0.00015287808,0.00017039814,0.000052058735,0.000007981189,0.00003768269,0.000058885227,0.0000035401615],"category_scores_gemma":[0.000008763194,0.00007371439,0.000045314348,0.0005310053,0.000044316224,0.00013879572,0.000014811415,0.00012177266,0.000009748663],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018232783,0.014254464,0.12754025,0.00026659077,0.0005891168,0.000038347316,0.0028631054,0.00024985257,0.03595753,0.00025094606,0.000001529498,0.81780595],"study_design_scores_gemma":[0.012180503,0.00025911018,0.9795746,0.0006171687,0.00036570177,0.000014414591,0.0020006094,0.0007823413,0.0033276163,0.00006444574,0.0006590565,0.00015440612],"about_ca_topic_score_codex":0.000102834165,"about_ca_topic_score_gemma":0.00003733182,"teacher_disagreement_score":0.8520344,"about_ca_system_score_codex":0.00009354677,"about_ca_system_score_gemma":0.000027452914,"threshold_uncertainty_score":0.3005986},"labels":[],"label_agreement":null},{"id":"W2739420956","doi":"10.1182/blood.v114.22.1305.1305","title":"Functional Characterization of Three VWF- A1 Domain Mutations Causing Type 2 Von Willebrand Disease.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Paul's Hospital; University of British Columbia; Queen's University","funders":"","keywords":"Von Willebrand disease; Platelet; Von Willebrand factor; Molecular biology; Mutant; Recombinant DNA; Mutation; Ristocetin; Chemistry; Transfection; Complementary DNA; Wild type; Gene; Immunology; Biology; Biochemistry","score_opus":0.013321030833413757,"score_gpt":0.23336561062071995,"score_spread":0.22004457978730618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739420956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99783057,0.00011558344,0.00040377953,0.0005468482,0.000058458318,0.00016962309,0.000026183887,0.000023803757,0.0008251509],"genre_scores_gemma":[0.9987789,0.000020532547,0.00018462469,0.00013642925,0.000053773885,0.0000031028667,0.0006911209,0.0000066634643,0.0001248487],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99956405,0.0000068394206,0.000114312475,0.00010411679,0.00012488973,0.00008577556],"domain_scores_gemma":[0.99973065,0.000008263655,0.000048433452,0.00009382106,0.00005594593,0.000062903026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000021144248,0.00006656165,0.00012362254,0.00005326027,0.000054577282,0.000006126932,0.000011968551,0.000029278475,0.00008934802],"category_scores_gemma":[0.000016027234,0.00005855055,0.000037340844,0.00012996084,0.000017639524,0.00006158312,0.0000036894533,0.00003290825,0.000013358791],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014133563,0.0075171157,0.48872408,0.00013675349,0.0007776997,0.0009417625,0.0004057764,0.000031227566,0.48520148,0.004178728,0.00021026994,0.010461744],"study_design_scores_gemma":[0.0033406776,0.00019341461,0.99162513,0.000053294007,0.0003171263,0.00004377832,0.000008367041,0.000037197315,0.002149795,0.0019487692,0.00021919346,0.00006324133],"about_ca_topic_score_codex":0.0000031866125,"about_ca_topic_score_gemma":0.000004188884,"teacher_disagreement_score":0.5029011,"about_ca_system_score_codex":0.000007827001,"about_ca_system_score_gemma":0.00006686781,"threshold_uncertainty_score":0.23876221},"labels":[],"label_agreement":null},{"id":"W2739450639","doi":"10.1182/blood.v128.22.1831.1831","title":"Patient Subgroup Analysis of Quality-of-Life Outcomes in Checkmate 205, a Phase 2 Study of Nivolumab in Patients with Classical Hodgkin Lymphoma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Nivolumab; Internal medicine; Quality of life (healthcare); Cohort; Brentuximab vedotin; Oncology; Visual analogue scale; Cancer; Lymphoma; Surgery; Hodgkin lymphoma; Immunotherapy","score_opus":0.01904726363066952,"score_gpt":0.29892047991076104,"score_spread":0.27987321628009154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739450639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989734,0.000056139386,0.000002397568,0.00007390435,0.00001755794,0.0007275393,0.000097391516,0.000007938961,0.00004372004],"genre_scores_gemma":[0.9997609,0.000009060597,0.00007689915,0.000025855643,0.0000035982353,0.00007638017,0.000022967857,0.000013309529,0.0000109938455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99776405,0.00015586402,0.0009985582,0.00030258996,0.00057086296,0.00020807267],"domain_scores_gemma":[0.99865675,0.00019987319,0.0004490055,0.00046377917,0.00012716035,0.00010342347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001865866,0.00018726326,0.0012819278,0.0005167744,0.000010156181,0.0000025348775,0.000076933145,0.000063267034,0.00004177777],"category_scores_gemma":[0.00015769924,0.00010597314,0.00016703458,0.0007530395,0.00006897964,0.000052383093,0.000049197133,0.000026986829,0.0000013068748],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014682561,0.112356365,0.8769479,0.00004809421,0.002289349,0.00002253174,0.0011150625,0.0000022932136,0.00013014438,0.000023436056,0.000003445139,0.005593152],"study_design_scores_gemma":[0.10562355,0.0057387496,0.88466895,0.00013016515,0.0014653614,1.8786184e-7,0.0003744849,0.0000074336763,0.0018833256,0.000003051239,0.000003139934,0.000101603604],"about_ca_topic_score_codex":0.0016724274,"about_ca_topic_score_gemma":0.0013683448,"teacher_disagreement_score":0.106617615,"about_ca_system_score_codex":0.000110690395,"about_ca_system_score_gemma":0.00009652776,"threshold_uncertainty_score":0.4321459},"labels":[],"label_agreement":null},{"id":"W2739929101","doi":"10.1182/blood.v128.22.92.92","title":"Interleukin (IL)-10 Is an Effective Therapeutic for Murine Transfusion Related Acute Lung Injury (TRALI)","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Transfusion-related acute lung injury; Medicine; Immunology; Antibody; FOXP3; IL-2 receptor; Cytokine release syndrome; Monoclonal antibody; T cell; Lung; Internal medicine; Pulmonary edema; Chimeric antigen receptor; Immune system","score_opus":0.010074900544126441,"score_gpt":0.27769354380054073,"score_spread":0.26761864325641427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739929101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98430824,0.00016552498,0.003621952,0.0055497224,0.00028122813,0.0031200126,0.00008677898,0.0002839792,0.0025825754],"genre_scores_gemma":[0.99110806,0.0004500413,0.00040845101,0.0014036539,0.00010144015,0.00029635345,0.000029995233,0.000060916875,0.006141117],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985955,0.000064484644,0.00033422193,0.0004608351,0.00021377685,0.00033122895],"domain_scores_gemma":[0.99919665,0.000065986314,0.000058116686,0.00041898453,0.0000866329,0.00017365316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025836457,0.00024053408,0.00034618765,0.00015960018,0.00008761806,0.000015261643,0.0001299727,0.00015176648,0.00089727796],"category_scores_gemma":[0.000011935714,0.0001543061,0.00022039666,0.0001735257,0.000058156238,0.00013280295,0.00002377941,0.00013067097,0.00006296688],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003397215,0.0040081237,0.0025485281,0.00038002955,0.0031099364,0.0000869038,0.0022771931,1.0942118e-7,0.6287388,0.0018841414,0.0035106537,0.35005832],"study_design_scores_gemma":[0.059610087,0.010884154,0.025814181,0.0009584191,0.0079763755,0.00017822984,0.00016033629,0.00013578996,0.8281556,0.0018304467,0.06347063,0.0008257955],"about_ca_topic_score_codex":0.000020121804,"about_ca_topic_score_gemma":0.000016909446,"teacher_disagreement_score":0.34923252,"about_ca_system_score_codex":0.00003581389,"about_ca_system_score_gemma":0.00002381121,"threshold_uncertainty_score":0.98245645},"labels":[],"label_agreement":null},{"id":"W2740436806","doi":"10.1182/blood.v128.22.4124.4124","title":"The Role of UBR5 Mutations in the Pathogenesis of Mantle CELL Lymphoma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Biology; Immunoprecipitation; Mutant; Mantle cell lymphoma; Cancer research; Ubiquitin ligase; Mutation; Proteome; Molecular biology; Genetics; Gene; Ubiquitin; Lymphoma; Immunology","score_opus":0.0059440769770645364,"score_gpt":0.2031671674382162,"score_spread":0.19722309046115166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740436806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936026,0.0016068731,0.000024911405,0.000071185095,0.000013607628,0.00009942964,0.000042349275,0.0000014601316,0.0045375815],"genre_scores_gemma":[0.9995004,0.0001852836,0.00009514317,0.000019855945,0.00003126395,0.000024877105,0.000005511501,0.000005331266,0.00013233234],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995797,0.0000660106,0.00011758292,0.00008149365,0.00006563509,0.000089560446],"domain_scores_gemma":[0.99962825,0.000043256943,0.000059122794,0.00022816713,0.000029806655,0.000011428837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001659847,0.00004632563,0.00005053727,0.000011139238,0.000032898475,0.0000031089476,0.00017519717,0.00004180185,0.000006199269],"category_scores_gemma":[0.00003645392,0.00002239801,0.00004526238,0.000046082263,0.000059498056,9.1559747e-7,0.000032410073,0.00001013886,0.000003643338],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010451487,0.0001562968,0.003606786,0.000005410006,0.000008624325,5.534299e-7,0.000089543195,2.8267618e-7,0.9864731,0.0002664603,0.000016991382,0.009365519],"study_design_scores_gemma":[0.0006223448,0.000086658365,0.0086664725,0.000006900487,0.000013025808,0.000003952987,0.00023166617,9.382689e-7,0.9836744,0.0005087429,0.00614845,0.000036468613],"about_ca_topic_score_codex":0.0000123069,"about_ca_topic_score_gemma":0.000022486745,"teacher_disagreement_score":0.00932905,"about_ca_system_score_codex":0.0000011673759,"about_ca_system_score_gemma":0.000034547647,"threshold_uncertainty_score":0.09133644},"labels":[],"label_agreement":null},{"id":"W2740491057","doi":"10.1182/blood.v128.22.2615.2615","title":"A Retrospective Study of Venous Thromboembolism in Acute Leukemia Patients during Prolonged Hospital Stay. the Princess Margaret Cancer Centre Experience","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Incidence (geometry); Acute leukemia; Venous thromboembolism; Cancer; Retrospective cohort study; Cohort; Internal medicine; Surgery; Pediatrics; Leukemia; Thrombosis","score_opus":0.006850998576370519,"score_gpt":0.2475757965798453,"score_spread":0.24072479800347477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740491057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966013,0.00010535703,8.5492877e-7,0.0003181241,0.00021735278,0.0024669406,0.000025640433,0.00003926413,0.00022517165],"genre_scores_gemma":[0.99907875,0.00026394072,0.000015766826,0.000050047453,0.00007763491,0.00039786732,0.0000023253272,0.00003099442,0.000082683575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99818295,0.000065559536,0.00037118455,0.00045340852,0.0005149541,0.00041191452],"domain_scores_gemma":[0.9990365,0.000018686564,0.00021417177,0.0005018645,0.00014955325,0.00007925884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000113519396,0.00021413587,0.00061939214,0.0000880244,0.0001016936,0.000015181044,0.00026261085,0.00006157914,0.00007869329],"category_scores_gemma":[0.000058600534,0.00012307723,0.00006563914,0.00026078927,0.00010220309,0.0001304335,0.00021832495,0.0001454446,0.0000049920595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000085669286,0.0100601325,0.9562449,0.000051966534,0.0005097216,0.000076553355,0.031389084,0.0000015882971,0.0007609903,0.000050091578,0.000053114876,0.0007162159],"study_design_scores_gemma":[0.008485649,0.0013100685,0.9822548,0.00028842376,0.00039214702,0.0000015126225,0.003009421,0.0000011324909,0.004039447,0.000028258404,0.000027356682,0.00016178137],"about_ca_topic_score_codex":0.0007598484,"about_ca_topic_score_gemma":0.0005861115,"teacher_disagreement_score":0.028379664,"about_ca_system_score_codex":0.00031768752,"about_ca_system_score_gemma":0.0000872715,"threshold_uncertainty_score":0.50189435},"labels":[],"label_agreement":null},{"id":"W2741155318","doi":"10.1182/blood.v128.22.871.871","title":"\"Outgrowing\" the Laboratory Diagnosis of Type 1 Von Willebrand's Disease: A Two Decade Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Von Willebrand disease; Medicine; Von Willebrand factor; Population; Hemostasis; Retrospective cohort study; Internal medicine; Bleeding diathesis; Gastroenterology; Cohort; Pediatrics; Platelet","score_opus":0.011033967393706684,"score_gpt":0.270576930188649,"score_spread":0.25954296279494227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741155318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99613535,0.0021300053,0.0000012205693,0.00086607237,0.00006165411,0.00043191356,0.00005047294,0.000027613176,0.0002957036],"genre_scores_gemma":[0.9992771,0.00024309548,0.000014913624,0.0001494878,0.000048201786,0.000063987456,0.0000044176495,0.000015186853,0.00018360125],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99933743,0.000042648328,0.00013395015,0.00015599346,0.00019097042,0.00013903012],"domain_scores_gemma":[0.99938446,0.000107594504,0.000045917164,0.00029711047,0.00006956322,0.000095361356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008353208,0.00010036616,0.00019938507,0.000034402474,0.000046625442,0.0000050899826,0.00007403998,0.00002231254,0.0001067342],"category_scores_gemma":[0.00013855305,0.000046627352,0.000052519357,0.0001679255,0.00004567906,0.000044363893,0.000027799473,0.00004118581,0.000044029817],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015150978,0.003014937,0.99286026,0.000012876082,0.0003755888,0.00027039312,0.00018452563,1.0924779e-7,0.00057406625,0.000027856853,0.0005515205,0.0019763582],"study_design_scores_gemma":[0.018188832,0.00088623556,0.96930933,0.00018872523,0.0015728478,0.000009213779,0.00020419089,0.0000010757457,0.0056950753,0.00013974383,0.0036718098,0.00013293685],"about_ca_topic_score_codex":0.000020125666,"about_ca_topic_score_gemma":0.0000148798135,"teacher_disagreement_score":0.023550946,"about_ca_system_score_codex":0.0000095199985,"about_ca_system_score_gemma":0.0000704534,"threshold_uncertainty_score":0.19014083},"labels":[],"label_agreement":null},{"id":"W2741695148","doi":"10.1182/blood.v128.22.1403.1403","title":"VWF-FVIII Interactions Influence Hemostatic Thrombus Stability in Murine Models of Hemophilia Α and Type 2N VWD","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Von Willebrand factor; Thrombus; Von Willebrand disease; Bleeding time; Internal medicine; Arteriole; Endogeny; Platelet; Hemostasis; Chemistry; Endocrinology; Medicine; Coagulation; Immunology; Microcirculation; Platelet aggregation","score_opus":0.04609545985065112,"score_gpt":0.32212853968555405,"score_spread":0.27603307983490294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741695148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957535,0.0001899254,0.000013003351,0.0019390252,0.000027573562,0.00034315334,0.000013859662,0.000020772262,0.0016991431],"genre_scores_gemma":[0.9988551,0.0002566431,0.00040332903,0.000039870665,0.00001734551,0.000011022232,0.00000429367,0.000011493125,0.0004009045],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990707,0.000041767584,0.000253185,0.00022764536,0.00019776738,0.00020890513],"domain_scores_gemma":[0.9992142,0.00018594033,0.000040883726,0.00030132668,0.00014322216,0.00011446869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015919394,0.00010629025,0.0002598992,0.00011060829,0.000028918374,0.00000511109,0.00005723987,0.000047517562,0.000157781],"category_scores_gemma":[0.00022459771,0.000066633154,0.00003442521,0.00022411882,0.00016064772,0.00015860748,0.000062166226,0.00011298444,0.000018393515],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046927566,0.0028984202,0.73707855,0.00043089455,0.00017178533,0.0001288885,0.0010915153,0.000006651308,0.25235283,0.0006641436,0.000058112335,0.0046489593],"study_design_scores_gemma":[0.016663367,0.0018364295,0.6151476,0.0013476224,0.0002679596,0.00019373129,0.00037155615,0.00044802623,0.35430884,0.008692409,0.00036138648,0.00036111084],"about_ca_topic_score_codex":0.00009936997,"about_ca_topic_score_gemma":0.00009327624,"teacher_disagreement_score":0.121930964,"about_ca_system_score_codex":0.000036980444,"about_ca_system_score_gemma":0.00013620601,"threshold_uncertainty_score":0.2717221},"labels":[],"label_agreement":null},{"id":"W2742169549","doi":"10.1182/blood.v128.22.3318.3318","title":"An Open-Label, Single-Arm, Phase 1 Study of the Pharmacokinetics (PK) and Safety of Carfilzomib in Patients with Relapsed Multiple Myeloma and End-Stage Renal Disease (ESRD)","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Carfilzomib; Medicine; Pharmacokinetics; Hemodialysis; Cmax; Renal function; Urology; End stage renal disease; Multiple myeloma; Internal medicine; Gastroenterology; Proteasome inhibitor","score_opus":0.03127264767840359,"score_gpt":0.3132466429932698,"score_spread":0.2819739953148662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2742169549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99706495,0.00010109043,0.0000035238577,0.00006036101,0.000013663827,0.0022757186,0.00040920253,0.00000889987,0.00006256621],"genre_scores_gemma":[0.99950004,0.000029029969,0.0002118568,0.000017057886,0.0000129535465,0.00004648945,0.000030444433,0.000024035484,0.00012806834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984861,0.00017266376,0.00032097072,0.00033425225,0.0004232068,0.00026278303],"domain_scores_gemma":[0.9988263,0.00013174464,0.00014379334,0.00044625893,0.00013808368,0.00031381033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016143611,0.0001754767,0.00033490054,0.00009423954,0.000068346424,0.000015064241,0.00017372236,0.00003304072,0.0000375349],"category_scores_gemma":[0.00016542434,0.00009043884,0.000014500096,0.00017911251,0.00018421395,0.00014786262,0.00020711072,0.000093639814,3.9893118e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013712728,0.04782896,0.90508664,0.00008091611,0.00024316162,0.00010384157,0.00043556507,6.054281e-7,0.02424153,0.000006044996,0.0000059107397,0.008254113],"study_design_scores_gemma":[0.20262171,0.0102516115,0.77293235,0.00018705384,0.00025828957,0.0000020938571,0.00012580519,0.00004600423,0.013440686,0.0000033039685,0.00003693223,0.00009417292],"about_ca_topic_score_codex":0.00016887966,"about_ca_topic_score_gemma":0.00013116373,"teacher_disagreement_score":0.18890898,"about_ca_system_score_codex":0.000026336718,"about_ca_system_score_gemma":0.000084364445,"threshold_uncertainty_score":0.3687989},"labels":[],"label_agreement":null},{"id":"W2742432366","doi":"10.1182/blood.v128.22.2430.2430","title":"Iron Overload Is Highly Prevalent in All Disease Severity States in Pyruvate Kinase Deficiency (PKD)","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; University Health Network; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Ferritin; Internal medicine; Gastroenterology; Pyruvate kinase deficiency; Anemia; Chelation therapy; Pyruvate kinase; Thalassemia; Glycolysis; Metabolism","score_opus":0.01797260377570837,"score_gpt":0.260555699143183,"score_spread":0.24258309536747463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2742432366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960943,0.0007495242,0.000009137859,0.0021465844,0.0001439702,0.00029244894,0.00005038042,0.000046875637,0.0004668085],"genre_scores_gemma":[0.99591976,0.0010389494,0.000065200176,0.0016728911,0.00006470027,0.000027382373,0.000023456554,0.000014631794,0.0011730321],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988427,0.00007383956,0.0002592565,0.00034861147,0.00016180122,0.00031377067],"domain_scores_gemma":[0.99936616,0.00006142931,0.0000548654,0.0003072474,0.00003082444,0.00017947063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012663774,0.00014710655,0.00022777733,0.00012116351,0.00001935007,0.000004747309,0.00006658204,0.00007349849,0.000383593],"category_scores_gemma":[0.00009063322,0.00010200799,0.0000633792,0.00014681046,0.00006173942,0.000076410746,0.000046633108,0.00011657772,0.0001802715],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018654367,0.005739052,0.83352953,0.00063341873,0.000031444077,0.00083057187,0.0011227907,0.000010476046,0.1481459,0.00029763227,0.0021536786,0.0056400895],"study_design_scores_gemma":[0.00785288,0.00042975091,0.9783064,0.0002695864,0.00008209016,0.0000072479434,0.00004186848,0.000046627338,0.0063185045,0.00060262886,0.0058383644,0.00020402075],"about_ca_topic_score_codex":0.00015450957,"about_ca_topic_score_gemma":0.00010984953,"teacher_disagreement_score":0.14477693,"about_ca_system_score_codex":0.00006330567,"about_ca_system_score_gemma":0.00010773474,"threshold_uncertainty_score":0.42000744},"labels":[],"label_agreement":null},{"id":"W2742474398","doi":"10.1182/blood-2017-02-749101","title":"Phase 1 study of the anti-CD22 immunotoxin moxetumomab pasudotox for childhood acute lymphoblastic leukemia","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute","keywords":"CD22; Immunotoxin; Medicine; Minimal residual disease; Lymphoblastic Leukemia; Acute lymphocytic leukemia; Leukemia; Immunology; Oncology; Internal medicine; CD20; Antibody; Monoclonal antibody","score_opus":0.010653050824302584,"score_gpt":0.25227846219094324,"score_spread":0.24162541136664065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2742474398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954252,0.00051259424,0.00009832337,0.000066253044,0.0013722708,0.0019827604,0.00025165832,0.000057812485,0.00023311788],"genre_scores_gemma":[0.9984536,0.000033675195,0.0000991288,0.000055652927,0.000057560817,0.0002357283,0.000026532049,0.000049088434,0.000989046],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982528,0.00013762411,0.0005414007,0.00045810093,0.00008288405,0.00052717596],"domain_scores_gemma":[0.997286,0.000104059385,0.0006187111,0.0018609078,0.00010346345,0.000026839158],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.00029449599,0.00033412917,0.00059108005,0.00007625553,0.0014151814,0.00006851227,0.0015351326,0.0002474877,0.000113431175],"category_scores_gemma":[0.0002254505,0.00023884138,0.00029999152,0.00007665924,0.00025045304,0.00016478848,0.000453631,0.0002820112,0.000062844],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019618445,0.008883624,0.00101801,0.000017476079,0.0013777354,0.00000771092,0.0010645699,0.0000024642095,0.98502344,0.0003819577,0.00025760202,0.001769223],"study_design_scores_gemma":[0.054810274,0.0036217028,0.045515966,0.00007812367,0.0010694145,0.00011363123,0.0007523362,0.000007044517,0.891875,0.00025248434,0.0015308749,0.00037311827],"about_ca_topic_score_codex":0.00015267113,"about_ca_topic_score_gemma":0.000025379995,"teacher_disagreement_score":0.09314842,"about_ca_system_score_codex":0.00004031294,"about_ca_system_score_gemma":0.00021307438,"threshold_uncertainty_score":0.99988484},"labels":[],"label_agreement":null},{"id":"W2742882677","doi":"10.1182/blood.v128.22.3617.3617","title":"GNPAT p.D519G is Independently Associated with Markedly Increased Iron Stores in HFE p.C282Y Homozygotes","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Phlebotomy; Hemochromatosis; Hereditary hemochromatosis; Internal medicine; Ferritin; Hepcidin; Medicine; Endocrinology; Transferrin saturation; Iron supplement; Serum iron; Hemoglobin; Iron deficiency; Anemia; Serum ferritin","score_opus":0.005344523098615993,"score_gpt":0.20426762646359745,"score_spread":0.19892310336498145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2742882677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912785,0.00083077006,0.000008361079,0.0016144047,0.000059009075,0.00038021716,0.000034986173,0.00010971119,0.0056840167],"genre_scores_gemma":[0.996654,0.0003003735,0.00006774785,0.0005796794,0.00004736471,0.000021595919,0.000023264558,0.00004646531,0.0022595224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836594,0.00009219031,0.0002963096,0.00036651333,0.0004248515,0.00045416772],"domain_scores_gemma":[0.99913025,0.00014187426,0.000115838455,0.0003276134,0.00008443102,0.00019996722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002700076,0.0002376057,0.00037610118,0.00018827891,0.00006504273,0.000018099667,0.00012127565,0.00031171396,0.0004797434],"category_scores_gemma":[0.000324792,0.00013997934,0.00008353683,0.0003300588,0.00011318753,0.000101608886,0.000046117897,0.00027362877,0.00009208945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004951281,0.0019881236,0.98029023,0.000063418425,0.00032746335,0.00065370847,0.0005592366,7.288451e-7,0.009021332,0.000037146085,0.0022602316,0.004303245],"study_design_scores_gemma":[0.041830394,0.0015333873,0.9325207,0.0020883277,0.00073713344,0.00018121077,0.00071703864,0.000024223067,0.01713569,0.0001943169,0.002360914,0.00067665527],"about_ca_topic_score_codex":0.00044556631,"about_ca_topic_score_gemma":0.00030586738,"teacher_disagreement_score":0.047769528,"about_ca_system_score_codex":0.00009327779,"about_ca_system_score_gemma":0.00017988893,"threshold_uncertainty_score":0.5708192},"labels":[],"label_agreement":null},{"id":"W2743064314","doi":"10.1182/blood-2017-02-767335","title":"Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Burkitt's lymphoma; Lymphoma; Cancer research; Biology; Medicine; Immunology","score_opus":0.006180129369933306,"score_gpt":0.21600429647024255,"score_spread":0.20982416710030924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2743064314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837245,0.012564312,0.000008644832,0.0015096263,0.00019067942,0.0005451544,0.000033841166,0.00008508062,0.0013382083],"genre_scores_gemma":[0.995922,0.0009809867,0.001042767,0.00081557216,0.00036222284,0.00007477604,0.00005453874,0.00006287854,0.00068424357],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840975,0.000033495107,0.00019948347,0.00056303735,0.00034430347,0.00044994272],"domain_scores_gemma":[0.99857694,0.000035999477,0.00020128654,0.00082088064,0.00009661847,0.0002682469],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000058637655,0.00038630495,0.0004631223,0.000077930665,0.00049493596,0.00020179662,0.00022005805,0.00021329687,0.00003334751],"category_scores_gemma":[0.00001512171,0.00026248556,0.00012215102,0.00004496033,0.00019322468,0.00012187944,0.00009730829,0.000073039526,0.000034178094],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004851522,0.05555552,0.5019145,0.0009422113,0.009071802,0.017662644,0.0022998266,0.000013674013,0.15781908,0.005903399,0.0090014,0.23496443],"study_design_scores_gemma":[0.046995692,0.0010158279,0.8678149,0.00009480417,0.0016078741,0.001191956,0.00006326152,0.000012867602,0.07954774,0.00022089196,0.0010879509,0.00034622682],"about_ca_topic_score_codex":0.0004313993,"about_ca_topic_score_gemma":0.00004632065,"teacher_disagreement_score":0.3659004,"about_ca_system_score_codex":0.00008332316,"about_ca_system_score_gemma":0.00016443187,"threshold_uncertainty_score":0.9999827},"labels":[],"label_agreement":null},{"id":"W2743322456","doi":"10.1182/blood.v128.22.3045.3045","title":"Ribavirin, an eIF4E Inhibitor, As a Potential Anti-Lymphoma Therapeutic - Preclinical and Early Clinical Data","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Respiratory viral infections research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Ribavirin; EIF4E; Cancer research; Biology; Lymphoma; Virology; Immunology; Virus; Translation (biology); Pharmacology; Messenger RNA; Gene; Genetics","score_opus":0.15575742119824354,"score_gpt":0.45464086379510166,"score_spread":0.2988834425968581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2743322456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99684024,0.00089979626,0.000108923865,0.0007391632,0.00023875636,0.00047144055,0.000026658448,0.00011968266,0.0005553113],"genre_scores_gemma":[0.99705255,0.0004732511,0.00023283096,0.00043834475,0.0011390827,0.000016496479,0.000011811953,0.000043415926,0.0005922205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972498,0.00044361135,0.00065025105,0.00079405133,0.00047048274,0.00039180828],"domain_scores_gemma":[0.99744517,0.00027923132,0.00009382303,0.0015675907,0.00014570793,0.00046847833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014095587,0.00018552721,0.0004254031,0.00012731589,0.00012417037,0.00008864098,0.00035383765,0.0002823364,0.0001769678],"category_scores_gemma":[0.0009160275,0.000119926575,0.00009685052,0.0001758089,0.00049837405,0.00049889216,0.0004401782,0.0002777007,0.0003691711],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004387582,0.0037625914,0.69511586,0.00002625451,0.00030934022,0.00027058777,0.000017952834,2.9093538e-8,0.039816305,0.00012319243,0.00047648308,0.25964263],"study_design_scores_gemma":[0.012830052,0.00480616,0.9557548,0.000102906335,0.0003353193,0.00039947443,0.000011681795,0.000026415037,0.00486637,0.000238405,0.020402748,0.00022562512],"about_ca_topic_score_codex":0.00006852267,"about_ca_topic_score_gemma":0.000010943228,"teacher_disagreement_score":0.26063898,"about_ca_system_score_codex":0.00001699817,"about_ca_system_score_gemma":0.00031565706,"threshold_uncertainty_score":0.4890464},"labels":[],"label_agreement":null},{"id":"W2743432286","doi":"10.1182/blood-2017-05-782177","title":"Novel nonsense gain-of-function NFKB2 mutations associated with a combined immunodeficiency phenotype","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"NIH Clinical Center; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Penetrance; Nonsense mutation; Phenotype; Gain of function; Severe combined immunodeficiency; Expressivity; Genetics; Nonsense; Biology; Common variable immunodeficiency; Primary immunodeficiency; Medicine; Missense mutation; Gene","score_opus":0.01331467790446874,"score_gpt":0.22399170580460775,"score_spread":0.210677027900139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2743432286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98758703,0.0032171921,0.0010949639,0.000103403116,0.00052755576,0.000279948,0.000057103476,0.00009903967,0.007033737],"genre_scores_gemma":[0.9984568,0.000015373069,0.000043330092,0.000041603682,0.0000020991938,0.000021996178,0.00019705748,0.00002343797,0.0011983418],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998845,0.00007560141,0.00034459005,0.0002815437,0.000067881476,0.00038540032],"domain_scores_gemma":[0.99843895,0.000136885,0.00050071627,0.0007414074,0.00017554694,0.0000064728542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029116747,0.00021151651,0.00032323436,0.00010195117,0.0011845803,0.000042041025,0.00043101507,0.00020084059,0.00013780606],"category_scores_gemma":[0.0004424146,0.00018225651,0.00011097745,0.0001460774,0.0006392078,0.00016701831,0.00008305689,0.00027265502,0.00011227039],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044740294,0.0040525976,0.0029774203,0.000017615506,0.00069877866,0.0000046454506,0.0011818381,0.000072269264,0.9848154,0.003621545,0.000026830723,0.0020836226],"study_design_scores_gemma":[0.039667483,0.003294012,0.78977555,0.00044702756,0.0016821699,0.000109192995,0.0024167341,0.000108102686,0.15834987,0.0010729593,0.0017854227,0.0012914953],"about_ca_topic_score_codex":0.00032502602,"about_ca_topic_score_gemma":0.000020505819,"teacher_disagreement_score":0.82646555,"about_ca_system_score_codex":0.000014616682,"about_ca_system_score_gemma":0.00013759459,"threshold_uncertainty_score":0.9110954},"labels":[],"label_agreement":null},{"id":"W2743835996","doi":"10.1182/blood.v128.22.2037.2037","title":"Chemical Activation of the SHIP1 Inositol Lipid Phosphatase: A Novel Therapeutic Strategy to Suppress B-Cell Receptor Signaling and CXCR4 Expression in Malignant Human B Cells","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Inimex Pharmaceuticals (Canada)","funders":"","keywords":"breakpoint cluster region; Chronic lymphocytic leukemia; Cancer research; Signal transduction; B-cell receptor; Phosphorylation; Biology; Protein kinase B; Tyrosine phosphorylation; Receptor; B cell; Cell biology; Leukemia; Immunology; Biochemistry; Antibody","score_opus":0.023789231452606658,"score_gpt":0.2793902036280285,"score_spread":0.2556009721754219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2743835996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99870384,0.00019550882,0.00006610512,0.00020774202,0.000037421225,0.0006616615,0.000021829375,0.000014597464,0.00009128115],"genre_scores_gemma":[0.99919593,0.000017784289,0.00031099515,0.00007354333,0.00010757338,0.000044880908,0.000007438004,0.000025374395,0.00021649999],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985839,0.000059695707,0.00031124166,0.00032597219,0.00041188725,0.000307288],"domain_scores_gemma":[0.99910796,0.0002140898,0.000090496935,0.00039300066,0.000065852255,0.00012859702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023353047,0.00015024313,0.00024293487,0.00007663973,0.00004287641,0.000016437492,0.0001991229,0.00013196388,0.0000955773],"category_scores_gemma":[0.000056893303,0.000084032814,0.000048775542,0.00019537481,0.00009053301,0.00007837157,0.00015480307,0.00014915307,0.000006785399],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021958418,0.0008244418,0.0005012523,0.00015808544,0.000018298819,0.000003803075,0.0003759212,0.0000032477924,0.99689794,0.000035528683,0.00013239756,0.0008295322],"study_design_scores_gemma":[0.018811537,0.00016491715,0.00037802113,0.0010236029,0.00003557311,0.000010011514,0.00010327228,0.000038852133,0.9791502,0.000016473823,0.00015736138,0.00011022528],"about_ca_topic_score_codex":0.00011700382,"about_ca_topic_score_gemma":0.0000036869803,"teacher_disagreement_score":0.018591952,"about_ca_system_score_codex":0.00065010233,"about_ca_system_score_gemma":0.0006161008,"threshold_uncertainty_score":0.3426759},"labels":[],"label_agreement":null},{"id":"W2743920872","doi":"10.1182/blood-2016-11-754382","title":"The actin-binding protein profilin 2 is a novel regulator of iron homeostasis","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics; Institut de Recerca contra la Leucèmia Josep Carreras; Generalitat de Catalunya; Ministerio de Asuntos Económicos y Transformación Digital, Gobierno de España; Rheinische Friedrich-Wilhelms-Universität Bonn; José Carreras Leukämie-Stiftung; Centro Nacional de Biotecnología; Deutsche Forschungsgemeinschaft","keywords":"Iron homeostasis; Regulator; Untranslated region; Cell biology; Actin; Three prime untranslated region; Biology; Phenotype; Messenger RNA; Biochemistry; Gene","score_opus":0.02064673898797981,"score_gpt":0.2764091456919899,"score_spread":0.25576240670401007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2743920872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933065,0.0005628736,0.000007925446,0.0019220847,0.00008738404,0.0006041191,0.00002123705,0.00001944612,0.0034683857],"genre_scores_gemma":[0.99347794,0.000054065295,0.0011412783,0.00004984604,0.00011361856,0.00003673764,0.0000036187826,0.000019741798,0.0051031765],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991701,0.000012770613,0.00018447032,0.00017005212,0.00024864837,0.00021396377],"domain_scores_gemma":[0.9988618,0.00002150986,0.00021708847,0.0007760757,0.000055780492,0.00006774321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023982112,0.000104857325,0.00019847373,0.000036582234,0.00034022614,0.00003778261,0.00020830151,0.000069835405,0.00004267763],"category_scores_gemma":[0.0003681095,0.00006819884,0.000084728934,0.000045185436,0.00014727477,0.00007059497,0.00006934984,0.00011057368,0.00002216159],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046101087,0.0014605544,0.029759001,0.0006531788,0.00012040623,0.000010044853,0.0010676087,1.0059315e-7,0.93037415,0.0032375758,0.0015178357,0.031338554],"study_design_scores_gemma":[0.007739434,0.00017786295,0.081742704,0.00015203221,0.00035731873,0.000014546089,0.000741899,0.000005684187,0.8988791,0.00009455733,0.009925019,0.0001698326],"about_ca_topic_score_codex":0.00005962244,"about_ca_topic_score_gemma":0.0000074720383,"teacher_disagreement_score":0.0519837,"about_ca_system_score_codex":0.0000055202277,"about_ca_system_score_gemma":0.00008732473,"threshold_uncertainty_score":0.2781068},"labels":[],"label_agreement":null},{"id":"W2744107898","doi":"10.1182/blood.v128.22.2609.2609","title":"Dilute Russell Viper Venom Time Interpretation and Clinical Correlation: A Two-Year Retrospective Institutional Review","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Antiphospholipid syndrome; Lupus anticoagulant; Institutional review board; Retrospective cohort study; Thrombosis; Surgery","score_opus":0.017955891871770605,"score_gpt":0.3261839897100804,"score_spread":0.3082280978383098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2744107898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9524977,0.010626417,0.0013550835,0.002948857,0.0003478454,0.0015023531,0.000031474767,0.00012300252,0.030567229],"genre_scores_gemma":[0.99271077,0.0036140264,0.00059220596,0.00029128868,0.00037628447,0.000031820487,0.000015879787,0.000019223617,0.0023485073],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863577,0.00012887358,0.00041227153,0.0003075144,0.00035419222,0.0001614081],"domain_scores_gemma":[0.99906677,0.00022607783,0.000102208236,0.00027185254,0.00019139238,0.00014171061],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007345518,0.00010417729,0.00035252012,0.000061367886,0.000053295,0.000010877669,0.00006616384,0.00008142557,0.00039318946],"category_scores_gemma":[0.0010124245,0.000069132446,0.000092697366,0.00013434312,0.00017111363,0.00011589681,0.00005687736,0.0001618129,0.0011374234],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029683043,0.00054027385,0.9832181,0.0009530608,0.00040186706,0.00009187558,0.00023929785,1.239919e-7,0.0014853557,0.0032183484,0.003391593,0.0061633117],"study_design_scores_gemma":[0.0667396,0.0036767076,0.7734784,0.09295615,0.00312401,0.031193828,0.00016639482,0.0013920141,0.00077638536,0.0027252843,0.022503233,0.00126804],"about_ca_topic_score_codex":0.0000038877165,"about_ca_topic_score_gemma":0.0000016078632,"teacher_disagreement_score":0.2097397,"about_ca_system_score_codex":0.000093769566,"about_ca_system_score_gemma":0.0001758455,"threshold_uncertainty_score":0.9996403},"labels":[],"label_agreement":null},{"id":"W2744261860","doi":"10.1182/blood-2017-03-769620","title":"Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1683,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"National Cancer Institute","keywords":"Diffuse large B-cell lymphoma; Medicine; Ibrutinib; Lymphoma; Refractory (planetary science); Internal medicine; Leukemia; Chronic lymphocytic leukemia; Biology","score_opus":0.02363812012859347,"score_gpt":0.29211759367235235,"score_spread":0.2684794735437589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2744261860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907908,0.00021677396,1.1777411e-7,0.0023903085,0.00031442908,0.00040865294,0.00019061183,0.00002505733,0.0056632906],"genre_scores_gemma":[0.9982092,0.00007695473,0.000064865744,0.00046309,0.00017273301,0.000057075613,0.000057964786,0.000014223572,0.0008839205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886465,0.000045915072,0.00026475673,0.0003059962,0.0003408814,0.00017778703],"domain_scores_gemma":[0.9985175,0.00022486915,0.0001557053,0.0009905087,0.000042014683,0.000069361355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030670888,0.00014189912,0.00023722132,0.000037408157,0.00023449546,0.00013715608,0.0003783231,0.00005610424,0.000028461494],"category_scores_gemma":[0.00065175473,0.0000831015,0.00008542073,0.000023023096,0.000026136817,0.00013518064,0.00020112826,0.00010515065,0.00012398792],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015445762,0.06634201,0.9301407,0.0000013515835,0.00024751335,0.00045663823,0.0008584035,2.097412e-8,0.00007780234,0.000014695635,0.00057249266,0.0011339338],"study_design_scores_gemma":[0.1228621,0.00016481428,0.8690551,0.000032176937,0.00017634104,0.0000033579959,0.00043919735,0.000003234439,0.000749285,0.000018466157,0.0064224117,0.000073512456],"about_ca_topic_score_codex":0.0017400346,"about_ca_topic_score_gemma":0.0008718834,"teacher_disagreement_score":0.12270764,"about_ca_system_score_codex":0.00009156326,"about_ca_system_score_gemma":0.000067574176,"threshold_uncertainty_score":0.3388781},"labels":[],"label_agreement":null},{"id":"W2744440086","doi":"10.1182/blood.v128.22.3590.3590","title":"Global Prospective Cohort Study of Factors Associated with Venous Thromboembolism in Patients with Lung Cancer Receiving Cancer Therapy","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lung cancer; Internal medicine; Venous thrombosis; Pulmonary embolism; Prospective cohort study; Cancer; Proportional hazards model; Thrombosis; Chemotherapy regimen; Surgery; Cohort","score_opus":0.010533745457820546,"score_gpt":0.2644826125806652,"score_spread":0.25394886712284465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2744440086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956148,0.0002722547,0.0000027645165,0.000058989684,0.00009804381,0.0033883476,0.00006184975,0.000051010433,0.00045191162],"genre_scores_gemma":[0.99912727,0.0002254684,0.0000073006763,0.000053937823,0.000037401678,0.00046558215,0.000008042107,0.000038372564,0.000036641268],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99828297,0.000060327595,0.0002772496,0.00043353098,0.00058053836,0.00036537988],"domain_scores_gemma":[0.99908113,0.000040074192,0.00024488746,0.00029311323,0.00025706599,0.000083704166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012880439,0.00025373435,0.00086604373,0.00008217236,0.00006159488,0.000011210599,0.00011258502,0.00006763541,0.00010642901],"category_scores_gemma":[0.000032646785,0.00013716666,0.000038485075,0.00044103255,0.00006159186,0.00010633538,0.00003944979,0.00008509565,4.6214896e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019733138,0.018345445,0.97569335,0.000024590947,0.0028980176,0.000009690298,0.0019425104,0.000016470902,0.000025172545,0.000012055501,0.0000788714,0.00075648894],"study_design_scores_gemma":[0.018834647,0.0029611257,0.97575474,0.0008195305,0.00089849165,1.6569366e-7,0.0002774207,9.171184e-7,0.00023607774,0.0000073290107,0.000005044201,0.00020451845],"about_ca_topic_score_codex":0.004812275,"about_ca_topic_score_gemma":0.007660624,"teacher_disagreement_score":0.018637316,"about_ca_system_score_codex":0.0004357789,"about_ca_system_score_gemma":0.00015623069,"threshold_uncertainty_score":0.7274753},"labels":[],"label_agreement":null},{"id":"W2745093822","doi":"10.1182/blood.v128.22.5781.5781","title":"Effective Strategy to Prevent Acute Graft-Versus-Host Disease in Unrelated Donor Allogeneic Hematopoietic Cell Transplants By Using a Combination of Anti-Thymocyte Globulin (ATG), Post-Transplant Cyclophosphamide and Cyclosporine","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Anti-thymocyte globulin; Cyclophosphamide; Graft-versus-host disease; Hematopoietic stem cell transplantation; Internal medicine; Transplantation; Calcineurin; Busulfan; Immunology; Cohort; Gastroenterology; Stem cell; Chemotherapy; Biology","score_opus":0.007713573429877061,"score_gpt":0.2469281975690681,"score_spread":0.23921462413919103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2745093822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948221,0.0010801122,0.0006495458,0.00022513431,0.00011569811,0.0022715675,0.0007132042,0.000060493177,0.00006214603],"genre_scores_gemma":[0.99808407,0.0012058674,0.00028888285,0.00004154666,0.000016879314,0.00007041794,0.00019045697,0.000057330213,0.00004452667],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99760944,0.00014615101,0.0007230405,0.00061284576,0.00043664293,0.0004718906],"domain_scores_gemma":[0.9986696,0.000264358,0.0001794313,0.0003178039,0.00012459011,0.00044417413],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027367275,0.00040083783,0.0006766512,0.0002385102,0.000052873744,0.000013714278,0.00012918079,0.00018773638,0.000031811152],"category_scores_gemma":[0.00002275406,0.00032296282,0.000119811746,0.0003825963,0.000092403156,0.00014618074,0.000019253874,0.00015346277,0.000012918486],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035977259,0.0024613808,0.17153634,0.0012737329,0.00034783446,0.00078628864,0.0008929633,0.000040470735,0.8187298,0.000045691104,0.000003023171,0.00028472132],"study_design_scores_gemma":[0.02205392,0.0013967581,0.33378798,0.002386811,0.0019979887,0.00013847506,0.00006203637,0.00004545998,0.63766915,0.000032594864,0.000005636626,0.000423169],"about_ca_topic_score_codex":0.00026812768,"about_ca_topic_score_gemma":0.0000511947,"teacher_disagreement_score":0.18106066,"about_ca_system_score_codex":0.00009285381,"about_ca_system_score_gemma":0.00014826862,"threshold_uncertainty_score":0.9999222},"labels":[],"label_agreement":null},{"id":"W2745961901","doi":"10.1182/blood.v128.22.1231.1231","title":"Umbilical Cord Blood (UCB) Transplantation in Children with Acute Leukemia: Impact of Conditioning Regimen on Transplant Outcomes","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia; Université de Montréal; University of Manitoba; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Regimen; Fludarabine; Transplantation; Internal medicine; Total body irradiation; Randomized controlled trial; Acute leukemia; Clinical trial; Surgery; Cyclophosphamide; Leukemia; Chemotherapy","score_opus":0.010067558529686672,"score_gpt":0.2698634673704835,"score_spread":0.25979590884079684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2745961901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974075,0.000019364817,0.00051377434,0.00018726158,0.000019108938,0.00072909077,0.0003201517,0.00006594053,0.00073780416],"genre_scores_gemma":[0.9988388,0.0001638829,0.0005264821,0.00006304726,0.000027912522,0.000047042337,0.00021843903,0.000038221515,0.00007616239],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983758,0.00006644154,0.00047070498,0.000363209,0.00040648252,0.00031741225],"domain_scores_gemma":[0.9991588,0.00022461299,0.00013650108,0.00028857627,0.00005115975,0.00014036958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015998005,0.00025740438,0.00053077115,0.00022125113,0.000034796056,0.000008029984,0.00009520583,0.00016085393,0.000101190526],"category_scores_gemma":[0.000011769608,0.00015374682,0.00015872697,0.00020206951,0.00009752601,0.000112170295,0.0000027394822,0.00017418791,0.000018612374],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016524341,0.00079074164,0.9386694,0.000119456265,0.0012118631,0.00036866742,0.00059326127,0.000014552007,0.05612358,0.00018787233,0.000007998561,0.00026020923],"study_design_scores_gemma":[0.021487735,0.00224156,0.83099645,0.0010575877,0.0018068078,0.0021448832,0.000015222804,0.0000044244625,0.14002518,0.00003368844,3.83436e-7,0.00018606713],"about_ca_topic_score_codex":0.00015888919,"about_ca_topic_score_gemma":0.00003519017,"teacher_disagreement_score":0.10767291,"about_ca_system_score_codex":0.000079568264,"about_ca_system_score_gemma":0.000225724,"threshold_uncertainty_score":0.62696135},"labels":[],"label_agreement":null},{"id":"W2747656856","doi":"10.1182/blood.v128.22.2042.2042","title":"11q Deletion (del11q) Is Not a Prognostic Factor for Adverse Outcomes for Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Treated with Ibrutinib: Pooled Data from 3 Randomized Phase 3 Studies","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Ibrutinib; Bendamustine; Chlorambucil; Internal medicine; Chronic lymphocytic leukemia; Ofatumumab; Gastroenterology; Chemotherapy; Leukemia; Cyclophosphamide","score_opus":0.0540131814922611,"score_gpt":0.32486603436649475,"score_spread":0.27085285287423366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2747656856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97674733,0.0010123353,0.0030070846,0.00020841463,0.00017434848,0.013431252,0.005008485,0.00038543745,0.000025320642],"genre_scores_gemma":[0.98875475,0.0003982067,0.0037577392,0.00040619573,0.0003703611,0.0030241834,0.001940923,0.00030788194,0.0010397682],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9934249,0.00025384166,0.0013777184,0.0020344357,0.0012914048,0.001617697],"domain_scores_gemma":[0.9884899,0.0063919937,0.00073559704,0.0024129963,0.0013667536,0.0006027372],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00069715566,0.0011330832,0.0029268092,0.00039335474,0.0003395484,0.00008029676,0.00087165023,0.00036312675,0.000107776745],"category_scores_gemma":[0.0043545193,0.0006191848,0.00047691088,0.00047204492,0.0007882957,0.00046902578,0.00035757892,0.00011747945,0.00009270661],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.8929201,0.0067067672,0.018500222,0.004242675,0.03750359,0.00060951087,0.0019731717,0.000045770495,0.0034842722,0.00006847706,0.0012895429,0.03265591],"study_design_scores_gemma":[0.94812614,0.004523053,0.0014157682,0.0019650157,0.009436696,0.00008382351,0.00016530795,0.020161157,0.012602714,0.000037438265,0.00051585236,0.00096703536],"about_ca_topic_score_codex":0.0011619889,"about_ca_topic_score_gemma":0.00031550636,"teacher_disagreement_score":0.055206046,"about_ca_system_score_codex":0.05433458,"about_ca_system_score_gemma":0.036641564,"threshold_uncertainty_score":0.9996259},"labels":[],"label_agreement":null},{"id":"W2747878830","doi":"10.1182/blood.v128.22.1046.1046","title":"Divergent Epigenomes in Pediatric and Adult Acute Myeloid Leukemia Implicate Cell of Origin and Transcriptional Silencing of Immune Responses As Sources of Clinically Relevant Heterogeneity: A Report from the Children's Oncology Group and NCI/COG Therapeutically Applicable Research to Generate Effective Treatments (TARGET) Initiative","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"DNA methylation; Myeloid leukemia; Biology; Methylation; RUNX1; Decitabine; Leukemia; Cancer research; Oncology; Cancer; Myeloid; Internal medicine; Bioinformatics; Medicine; Stem cell; Genetics; Haematopoiesis; DNA; Gene; Gene expression","score_opus":0.03230629537192327,"score_gpt":0.3430110246948542,"score_spread":0.310704729322931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2747878830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922525,0.00452847,0.00009933084,0.00067583896,0.00001603026,0.0020304269,0.00031535272,0.000011057944,0.000070948714],"genre_scores_gemma":[0.98468316,0.012643596,0.002175401,0.00009585307,0.00009035659,0.00020437794,0.0000291457,0.00003277002,0.000045339184],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9962824,0.00087758846,0.0010903481,0.00070958456,0.00057480676,0.00046527642],"domain_scores_gemma":[0.99575675,0.0027807965,0.00036461992,0.00044376517,0.00042173755,0.00023234484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022026387,0.00025814265,0.0008588657,0.00030585565,0.00011558819,0.000011479937,0.00020989156,0.00021239898,0.000013953972],"category_scores_gemma":[0.0004887079,0.00015539918,0.000108619926,0.000417762,0.0006948322,0.00007659978,0.00029874354,0.00037612472,0.000002413631],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004702685,0.0005332599,0.48932397,0.00005935281,0.0007108794,0.00010518974,0.0017708506,8.3962306e-7,0.49879968,0.000051131236,0.0000065204777,0.0039356435],"study_design_scores_gemma":[0.0082164025,0.0042500934,0.78048617,0.00009734057,0.00055034476,0.00017662164,0.0002395552,0.000008715606,0.20535067,0.00045837805,0.00003204429,0.00013367902],"about_ca_topic_score_codex":0.0013944925,"about_ca_topic_score_gemma":0.00005865661,"teacher_disagreement_score":0.293449,"about_ca_system_score_codex":0.0002228711,"about_ca_system_score_gemma":0.0007639496,"threshold_uncertainty_score":0.6336995},"labels":[],"label_agreement":null},{"id":"W2749073211","doi":"10.1182/blood.v128.22.175.175","title":"Randomized Study of Pegasparagase (SS-PEG) and Calaspargase Pegol (SC-PEG) in Pediatric Patients with Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma: Results of DFCI ALL Consortium Protocol 11-001","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Hamilton Health Sciences; Centre hospitalier universitaire de Québec; Université de Montréal; McMaster Children's Hospital","funders":"","keywords":"Medicine; Asparaginase; PEG ratio; Lymphoblastic lymphoma; Gastroenterology; Internal medicine; Pharmacology; Surgery; Leukemia; Lymphoblastic Leukemia; Immunology; T cell","score_opus":0.01279503569065933,"score_gpt":0.2740441363747799,"score_spread":0.2612491006841206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2749073211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9278203,0.000029688752,0.00009850786,0.000089354246,0.00009813797,0.07136115,0.00025882013,0.00010032612,0.0001436636],"genre_scores_gemma":[0.96953034,0.00007110584,0.0004577029,0.000060295974,0.00014505236,0.028736984,0.000058239777,0.00016579991,0.00077445904],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99162304,0.00088951434,0.0025845473,0.001485991,0.0020723003,0.0013446003],"domain_scores_gemma":[0.9895949,0.0057979645,0.001403049,0.0013422999,0.0009954834,0.00086634886],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010747893,0.0009795727,0.002921727,0.0011404372,0.000082519444,0.000044431894,0.0005684624,0.00039135054,0.00008469461],"category_scores_gemma":[0.0056966464,0.000564829,0.00021918381,0.0013393735,0.0009053065,0.0003375906,0.00042513694,0.00022537165,0.0000339287],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7276157,0.036148638,0.22024487,0.0015563505,0.001971102,0.006824035,0.0020252084,0.000057569116,0.00077356084,0.00002826464,0.0018371771,0.0009175258],"study_design_scores_gemma":[0.9055281,0.008113025,0.07863498,0.00077053736,0.0029722236,0.00036799395,0.00016317738,0.0006532978,0.0020719657,0.0000146944285,0.00007431274,0.00063564745],"about_ca_topic_score_codex":0.0015369117,"about_ca_topic_score_gemma":0.00068537256,"teacher_disagreement_score":0.17791244,"about_ca_system_score_codex":0.0013297306,"about_ca_system_score_gemma":0.0049226196,"threshold_uncertainty_score":0.99968034},"labels":[],"label_agreement":null},{"id":"W2749109162","doi":"10.1182/blood-2017-06-788679","title":"Autoimmune HIT due to apheresis catheter heparin flushes for stem cell harvesting before autotransplantation for myeloma","year":2017,"lang":"en","type":"letter","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Regional Laboratory Medicine Program; McMaster University","funders":"","keywords":"Heparin; Apheresis; Medicine; Platelet; Multiple myeloma; Chondroitin sulfate; Heparinoid; Adverse effect; Immunology; Pharmacology; Internal medicine; Glycosaminoglycan","score_opus":0.03962210116969341,"score_gpt":0.28332349709027704,"score_spread":0.24370139592058362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2749109162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7477968,0.00040400156,0.0034968886,0.22446184,0.0019634664,0.013070242,0.0019631053,0.00077588786,0.0060678176],"genre_scores_gemma":[0.65177846,0.000056677778,0.0371934,0.17733833,0.013114909,0.0075513273,0.008618864,0.0015129294,0.102835104],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965775,0.0000700238,0.0008223905,0.0010756721,0.0004140791,0.0010403506],"domain_scores_gemma":[0.99735993,0.00035430017,0.0004978009,0.0012774144,0.00028542636,0.00022515528],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036693868,0.00076253136,0.0016816084,0.00027232373,0.0005848547,0.00024212839,0.00061761506,0.0012520461,0.000055474342],"category_scores_gemma":[0.00008807165,0.00070778833,0.00071126554,0.00011090767,0.00007605759,0.00020304948,0.000088689456,0.0008349708,0.000113591595],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012420708,0.003205819,0.007415479,0.03949298,0.0075410767,0.002812544,0.010775427,0.00001292622,0.12707846,0.00019595264,0.7351452,0.06508204],"study_design_scores_gemma":[0.014313454,0.003741873,0.035079066,0.0036483803,0.009995284,0.00058794016,0.00010994452,0.00019798127,0.10754718,0.0003024093,0.8223536,0.0021228888],"about_ca_topic_score_codex":0.00044660023,"about_ca_topic_score_gemma":0.0002306714,"teacher_disagreement_score":0.096767284,"about_ca_system_score_codex":0.00013856275,"about_ca_system_score_gemma":0.0003862633,"threshold_uncertainty_score":0.99953735},"labels":[],"label_agreement":null},{"id":"W2749521159","doi":"10.1182/blood.v128.22.5206.5206","title":"Ex Vivo High-Throughput Flow Cytometry Screening Identifies Subsets of Responders to Differentiation Agents in Individual AML Patient Samples","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Ex vivo; Acute promyelocytic leukemia; Flow cytometry; Myeloid; Population; Haematopoiesis; Progenitor cell; Immunophenotyping; Biology; Leukemia; Myeloid leukemia; In vivo; CD34; Cancer research; Immunology; Stem cell; Retinoic acid; Medicine; Cell culture; Cell biology","score_opus":0.0566600850589305,"score_gpt":0.3161915275369681,"score_spread":0.2595314424780376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2749521159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995395,0.00008250245,0.002836973,0.0006729848,0.00010949993,0.0005691883,0.0002128913,0.000042429958,0.000078504214],"genre_scores_gemma":[0.994607,0.000047129237,0.0046737604,0.00015412149,0.00008643936,0.000033448774,0.00008624375,0.000035094978,0.00027678427],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99752176,0.00015851515,0.0004990041,0.00041057143,0.00095674524,0.0004534286],"domain_scores_gemma":[0.9987984,0.0002935072,0.00013174805,0.0004443217,0.00014642507,0.00018565716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041509987,0.00018916215,0.00038468937,0.0008537544,0.000049865008,0.0000279486,0.0002250833,0.00013586145,0.00029594733],"category_scores_gemma":[0.0008710484,0.00014134041,0.00008386533,0.00069138163,0.000081279206,0.00017675174,0.0002734877,0.00017142524,0.00005678421],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00162884,0.0015099683,0.5028089,0.00028757594,0.00073438475,0.0002221844,0.0056764125,0.000025415498,0.44027737,0.000084313404,0.009369403,0.037375234],"study_design_scores_gemma":[0.0058863405,0.00038195367,0.7081335,0.00042547873,0.0001068245,0.000011357681,0.00048144965,0.000026936634,0.2840784,0.00007439447,0.000232024,0.00016135338],"about_ca_topic_score_codex":0.00029014616,"about_ca_topic_score_gemma":0.00012162678,"teacher_disagreement_score":0.20532458,"about_ca_system_score_codex":0.00015869123,"about_ca_system_score_gemma":0.00012289401,"threshold_uncertainty_score":0.57636946},"labels":[],"label_agreement":null},{"id":"W2749902584","doi":"10.1182/blood.v128.22.1922.1922","title":"Treatment-Free Remission Accomplished By Dasatinib (TRAD): Preliminary Results of the Pan-Canadian Tyrosine Kinase Inhibitor Discontinuation Trial","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; London Health Sciences Centre; University of Alberta; McGill University Health Centre; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Hôpital de l'Enfant-Jésus; Université de Montréal; Hôpital Maisonneuve-Rosemont; Princess Margaret Cancer Centre; University of Calgary; University of British Columbia; University Health Network; CancerCare Manitoba; Ottawa Hospital; Dalhousie University; University of Toronto","funders":"","keywords":"Discontinuation; Dasatinib; Medicine; Internal medicine; Imatinib; Tyrosine-kinase inhibitor; Imatinib mesylate; Myeloid leukemia; Cancer","score_opus":0.017443082424518697,"score_gpt":0.25378755329799185,"score_spread":0.23634447087347316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2749902584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98856044,0.00034275776,0.0000027309204,0.005723736,0.0002916654,0.0017787005,0.0006306584,0.00004373863,0.002625602],"genre_scores_gemma":[0.99329495,0.00006623923,0.00024567093,0.000049879633,0.00040197273,0.00008953979,0.00020062592,0.000035914443,0.005615205],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982251,0.00010559346,0.00054986426,0.0004181046,0.00035906344,0.0003422538],"domain_scores_gemma":[0.9979461,0.00020169797,0.00027589552,0.0012482038,0.00007475888,0.00025335414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015029244,0.00025333525,0.00037164136,0.000084136474,0.000111311885,0.000014854102,0.00023578014,0.00016396208,0.00007972981],"category_scores_gemma":[0.0009785504,0.00012814335,0.00017441939,0.00018553731,0.00010291273,0.00011983139,0.000072433584,0.00008807879,0.000019210307],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11065282,0.011949463,0.021762691,0.00011392071,0.0009935988,0.00019795746,0.001477781,5.165089e-7,0.57106996,0.00009260372,0.099342205,0.18234648],"study_design_scores_gemma":[0.48370728,0.007377547,0.0370277,0.0008304027,0.0009381226,0.000055422686,0.00006063308,0.000010456555,0.45793435,0.00007191529,0.01173139,0.00025477048],"about_ca_topic_score_codex":0.008370373,"about_ca_topic_score_gemma":0.0023659326,"teacher_disagreement_score":0.37305447,"about_ca_system_score_codex":0.0007225208,"about_ca_system_score_gemma":0.0008245472,"threshold_uncertainty_score":0.99823296},"labels":[],"label_agreement":null},{"id":"W2750504927","doi":"10.1182/blood-2017-05-782060","title":"Management of rivaroxaban- or apixaban-associated major bleeding with prothrombin complex concentrates: a cohort study","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":319,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Rivaroxaban; Apixaban; Medicine; Warfarin; Prothrombin complex concentrate; Cohort; PROTHROMBIN COMPLEX; Internal medicine; Atrial fibrillation; Surgery; Coagulation","score_opus":0.08289482141221749,"score_gpt":0.34959025934743493,"score_spread":0.26669543793521744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2750504927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840029,0.000018993369,0.000030641364,0.00039538473,0.00007513396,0.004116805,0.000006710482,0.00008959283,0.011263879],"genre_scores_gemma":[0.9944558,0.0000192716,0.0007655071,0.000025096391,0.00010918169,0.000033096294,0.00002340459,0.000027997266,0.004540627],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985367,0.00003436546,0.00036991766,0.00030820203,0.00048688301,0.0002639242],"domain_scores_gemma":[0.9987859,0.000036369707,0.00042736268,0.00055289787,0.00011474299,0.00008268613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003478102,0.00019192079,0.00054639525,0.000068472546,0.00026189355,0.00007741517,0.00020544359,0.000045106157,0.00029315948],"category_scores_gemma":[0.000062612795,0.00013317438,0.00008133407,0.00013416908,0.00010607066,0.00012935042,0.00013290225,0.000075801385,0.000015872483],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040345243,0.00046035124,0.9945758,0.00017599144,0.00288356,0.0002034256,0.00021303086,0.0000011662369,0.0004286332,0.0003629319,0.00013949904,0.00015216002],"study_design_scores_gemma":[0.01761406,0.0010060039,0.976392,0.00026930313,0.0023893889,0.0000056022795,0.0010368985,0.000055880253,0.00079452613,0.000021135618,0.00024665773,0.00016858251],"about_ca_topic_score_codex":0.00008967151,"about_ca_topic_score_gemma":0.00003489203,"teacher_disagreement_score":0.018183837,"about_ca_system_score_codex":0.000034568988,"about_ca_system_score_gemma":0.000032389034,"threshold_uncertainty_score":0.5430694},"labels":[],"label_agreement":null},{"id":"W2750537303","doi":"10.1182/blood.v128.22.5212.5212","title":"Discovery of Selective Dual Inhibitors of Bromodomain Protein BRD4 and JAK2 for Treatment of Hematologic Malignancies","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aptose Biosciences (Canada)","funders":"","keywords":"Bromodomain; BRD4; Cancer research; BET inhibitor; Cancer; Oncogene; Epigenetics; Biology; Chemistry; Cell cycle; Biochemistry; Genetics","score_opus":0.008847824752551943,"score_gpt":0.22342414659348675,"score_spread":0.2145763218409348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2750537303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99803984,0.0006099335,0.00060568046,0.00004873296,0.000018348122,0.00049453543,0.00011695643,0.0000031161564,0.00006287854],"genre_scores_gemma":[0.99843025,0.00006806168,0.001072018,0.0000033391789,0.000034967157,0.000076976234,0.000013498787,0.000008194459,0.00029269958],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99940425,0.000030151028,0.00023239123,0.00016761912,0.00006536197,0.00010022258],"domain_scores_gemma":[0.9995667,0.00001980145,0.00018155492,0.00013504358,0.00007675995,0.00002016348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000062658466,0.00009644238,0.0002094212,0.000032163214,0.000016070915,0.0000024389717,0.000038651775,0.00008270406,0.0000012506318],"category_scores_gemma":[0.000089830704,0.00006180044,0.00008011902,0.00004118544,0.00013491815,0.0000061528967,0.000026731046,0.0000066291777,1.2120452e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011598094,0.0003647064,0.0026727715,0.00006301816,0.00007586904,4.1455888e-7,0.00003973351,1.2005314e-7,0.9956351,0.0005519714,0.00004710373,0.00043318924],"study_design_scores_gemma":[0.00213897,0.0020275784,0.0007216772,0.00006654493,0.00003149459,0.0000073835004,0.000043751043,4.194283e-7,0.99437904,0.000338843,0.0001684856,0.00007582429],"about_ca_topic_score_codex":0.000014007353,"about_ca_topic_score_gemma":0.000008675557,"teacher_disagreement_score":0.002022989,"about_ca_system_score_codex":0.0000053772214,"about_ca_system_score_gemma":0.000053518757,"threshold_uncertainty_score":0.25201488},"labels":[],"label_agreement":null},{"id":"W2751006050","doi":"10.1182/blood.v128.22.5874.5874","title":"Allogeneic Stem Cell Transplantation for Multiple Myeloma: a Single Center Experience","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Multiple myeloma; Transplantation; Surgery; Internal medicine; Single Center; Melphalan; Autologous stem-cell transplantation; Stem cell; Median follow-up; Retrospective cohort study; Cohort; Oncology; Chemotherapy","score_opus":0.03554665423340628,"score_gpt":0.2839223300539518,"score_spread":0.2483756758205455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2751006050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960238,0.00014675698,0.0020949973,0.00016516069,0.000052471227,0.0007229392,0.00013198641,0.00005310694,0.000608828],"genre_scores_gemma":[0.99619836,0.00007215836,0.0018426697,0.00005158819,0.00007554406,0.0002513698,0.000048838858,0.000021537533,0.0014379339],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99905884,0.00002172918,0.00015084959,0.00025600087,0.0001905087,0.00032209355],"domain_scores_gemma":[0.99940896,0.00012846733,0.000034784825,0.00019222175,0.00006428467,0.00017129746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000045251523,0.000116423915,0.00014614698,0.00005612104,0.00006219544,0.000010998407,0.00006520561,0.000052486754,0.000050934672],"category_scores_gemma":[0.000020557747,0.00007211184,0.00008747039,0.000052805593,0.00003817918,0.00007660995,0.000010689855,0.0000281195,0.00005875706],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007294418,0.001955775,0.2636287,0.00014615945,0.00008066646,0.00012952858,0.00062253367,8.9621494e-8,0.7009577,0.000007351907,0.00006643796,0.031675592],"study_design_scores_gemma":[0.02577575,0.00077853893,0.06899608,0.000110821384,0.0000938155,0.00011087227,0.00009585139,0.000015596057,0.9018071,0.000008094255,0.0020854594,0.00012200533],"about_ca_topic_score_codex":0.0000096606955,"about_ca_topic_score_gemma":0.000020629957,"teacher_disagreement_score":0.2008494,"about_ca_system_score_codex":0.0000335581,"about_ca_system_score_gemma":0.000033259927,"threshold_uncertainty_score":0.29406357},"labels":[],"label_agreement":null},{"id":"W2751641642","doi":"10.1182/blood.v128.22.3046.3046","title":"Retrospective Study of Intravascular Lymphoma Cases Diagnosed in Quebec","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Jewish General Hospital; Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec; McGill University; Hôpital Charles-Le Moyne; Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean; Université de Montréal; Université Laval; Royal Victoria Hospital; Université de Sherbrooke","funders":"","keywords":"Medicine; Population; Malignancy; Lymphoma; Disease; Hepatosplenomegaly; Hemophagocytosis; Pathology; Bone marrow","score_opus":0.011545872324708786,"score_gpt":0.24830252040375833,"score_spread":0.23675664807904956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2751641642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99840313,0.00047611253,0.0000010307286,0.00012868429,0.00003839666,0.0006461724,0.000010642535,0.00002587739,0.00026994786],"genre_scores_gemma":[0.9994702,0.00013237244,0.000027724345,0.000026063368,0.000048299957,0.00013445015,0.0000023643663,0.000016687294,0.00014186204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99902904,0.00004606432,0.00025327803,0.00026638713,0.00023313306,0.00017207925],"domain_scores_gemma":[0.9993222,0.00010838525,0.00006380479,0.00037083906,0.000061760205,0.00007304011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008434574,0.0001317862,0.00038117566,0.00012331818,0.000018365308,0.000005509683,0.000051492407,0.00004862089,0.00008310425],"category_scores_gemma":[0.0002053023,0.00008106461,0.000084465435,0.00018200028,0.000042207255,0.00004648527,0.00003216195,0.000019657924,0.000019554172],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007663797,0.020220488,0.93498844,0.000012541026,0.0003206138,0.002654224,0.00079294347,1.03397774e-7,0.0010448734,0.00007542867,0.000050635204,0.03976308],"study_design_scores_gemma":[0.027538782,0.0017239333,0.95654625,0.0001752756,0.00032368483,0.00007146442,0.00067042076,2.9318247e-7,0.012746775,0.000018078159,0.00009794469,0.00008712852],"about_ca_topic_score_codex":0.02992043,"about_ca_topic_score_gemma":0.033257876,"teacher_disagreement_score":0.039675955,"about_ca_system_score_codex":0.00020115204,"about_ca_system_score_gemma":0.0000871945,"threshold_uncertainty_score":0.9843826},"labels":[],"label_agreement":null},{"id":"W2751655689","doi":"10.1182/blood-2017-05-784199","title":"Coexistence of multiple myeloma and Paget disease of bone","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Bone health and treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Pelvis; Orthopedic surgery; Multiple myeloma; Femur; Radiography; Bone disease; Hematology; Surgery; Osteoporosis; Internal medicine","score_opus":0.02965272081194593,"score_gpt":0.30127072701707164,"score_spread":0.2716180062051257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2751655689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976394,0.00096285815,0.0000011387532,0.00028779524,0.000021770105,0.00016154778,0.000036013615,0.0000059266035,0.00088350615],"genre_scores_gemma":[0.99899924,0.00009737224,0.0005501403,0.000040165363,0.0000114440745,0.0000058370306,0.0000056628137,0.0000046879604,0.00028547682],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99961853,0.0000061879305,0.00012114554,0.00008562797,0.00008482776,0.000083704705],"domain_scores_gemma":[0.9993575,0.000022288985,0.00011196067,0.00030876222,0.00003379991,0.00016568108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003959056,0.000045963363,0.00016879935,0.000017258382,0.00005057047,0.0000024534793,0.000026197704,0.000020732792,0.0000073254355],"category_scores_gemma":[0.00019219842,0.00003623057,0.000025736834,0.000011062455,0.00009232433,0.000026397343,0.00002471146,0.000026770127,0.0000024955266],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019099482,0.0006253238,0.99502563,0.00035300228,0.000034830366,0.000089727546,0.00006791005,1.1873949e-8,0.0012666032,0.000039865092,0.00002900135,0.002277097],"study_design_scores_gemma":[0.0050858706,0.00018198811,0.98887694,0.00012962034,0.00016207293,0.0000116394585,0.0000102956055,0.0000131125225,0.0053387936,0.000047605958,0.00011565917,0.00002638851],"about_ca_topic_score_codex":0.00017570138,"about_ca_topic_score_gemma":0.000023985178,"teacher_disagreement_score":0.0061486796,"about_ca_system_score_codex":0.0000020704226,"about_ca_system_score_gemma":0.00004352664,"threshold_uncertainty_score":0.14774399},"labels":[],"label_agreement":null},{"id":"W2751873067","doi":"10.1182/blood.v128.22.3873.3873","title":"Chromatin Accessibility Identifies CTCF As a Gatekeeper of Stemness Functions in Human Hematopoietic Development","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Biology; Chromatin; CTCF; Progenitor cell; Stem cell; Cell biology; Multipotent Stem Cell; Genetics; Transcription factor; Gene; Enhancer","score_opus":0.01331672143448706,"score_gpt":0.2738143855416985,"score_spread":0.2604976641072115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2751873067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977328,0.0004918027,0.00073845696,0.000024559893,0.00005437441,0.00014252575,0.0000048881893,0.0000067830397,0.0008037877],"genre_scores_gemma":[0.9989902,0.000022315566,0.00022549194,0.000006270592,0.000032966993,0.000036798992,0.000021730948,0.000010535658,0.00065369764],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99912995,0.00005239396,0.00032306867,0.00024487826,0.000115791554,0.00013391112],"domain_scores_gemma":[0.9995014,0.00001343678,0.00009872886,0.00027698895,0.0000724581,0.000036981244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000244022,0.000093591305,0.00012537395,0.000049112965,0.000050754537,0.00001186719,0.000116889285,0.00009140366,0.00007176321],"category_scores_gemma":[0.000066840665,0.00007170299,0.00004193901,0.00007520408,0.000052338837,0.000004887915,0.00008392273,0.000026423744,0.000011678671],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000070881174,0.00022573593,0.06825921,0.000040826428,0.000022441363,8.4635286e-7,0.00009736467,0.0000017945473,0.93050694,0.000026631336,0.000006445025,0.0008046462],"study_design_scores_gemma":[0.0007122508,0.000052506144,0.14275786,0.000046693993,0.000011032583,0.0000011451503,0.00005404962,2.6282552e-7,0.8555351,0.0004601444,0.0002765745,0.00009240713],"about_ca_topic_score_codex":0.000020368472,"about_ca_topic_score_gemma":0.00015222077,"teacher_disagreement_score":0.07497191,"about_ca_system_score_codex":0.000009233962,"about_ca_system_score_gemma":0.00006994086,"threshold_uncertainty_score":0.2923963},"labels":[],"label_agreement":null},{"id":"W2752524964","doi":"10.1182/blood.v128.22.1873.1873","title":"CD3 T-Cell Infiltrates at Diagnosis Predicts Overall Survival in Solid Organ Transplant Recipients with Post-Transplant Lymphoproliferative Disorders (PTLD)","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Azathioprine; Medicine; Tacrolimus; Lymphoproliferative disorders; Internal medicine; Organ transplantation; Gastroenterology; Biopsy; Immunosuppression; Immune system; Transplantation; Pathology; Immunology; Lymphoma; Disease","score_opus":0.006419773402704069,"score_gpt":0.21373388947253277,"score_spread":0.2073141160698287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752524964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932368,0.0005125066,0.00002968209,0.0018418145,0.00016425308,0.00076446345,0.00052383693,0.00010569667,0.0028209912],"genre_scores_gemma":[0.99375236,0.0045908345,0.00003734682,0.00051320746,0.000073418945,0.00018104451,0.00017520688,0.00007173369,0.0006048362],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997655,0.000098438715,0.0004217841,0.00057867303,0.0005296103,0.00071654766],"domain_scores_gemma":[0.99901676,0.00015796791,0.00013877763,0.0003004436,0.00010295498,0.00028310448],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016210772,0.00040590655,0.0005751543,0.0001647415,0.00012332549,0.000023511015,0.00015951056,0.0002214195,0.00026501797],"category_scores_gemma":[0.00004089528,0.00026108677,0.00012731204,0.00027245082,0.00013175559,0.00018902571,0.000022156593,0.00017040403,0.000043704924],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020232475,0.0018215906,0.98047143,0.00007838215,0.00026428592,0.00014531458,0.0025854758,0.000011843786,0.01189162,0.000021258254,0.0002060903,0.00047943013],"study_design_scores_gemma":[0.07028117,0.0041867946,0.85038346,0.0019650676,0.00088258437,0.00007955492,0.0004581092,0.000011856044,0.07017257,0.00013744822,0.0005189559,0.0009224207],"about_ca_topic_score_codex":0.00071044225,"about_ca_topic_score_gemma":0.0066945916,"teacher_disagreement_score":0.130088,"about_ca_system_score_codex":0.00021307095,"about_ca_system_score_gemma":0.00029979818,"threshold_uncertainty_score":0.99998415},"labels":[],"label_agreement":null},{"id":"W2752715768","doi":"10.1182/blood-2017-07-793398","title":"Balancing the yin and yang of SINE","year":2017,"lang":"id","type":"letter","venue":"Blood","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Sine; Sine qua non; Internal medicine; Cancer research; Pharmacology; Oncology; Political science; Mathematics","score_opus":0.005233126125058232,"score_gpt":0.20227482540585165,"score_spread":0.1970416992807934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752715768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94013834,0.010844298,0.00006394266,0.03330496,0.0014707602,0.0004294338,0.00010847667,0.000010784599,0.013629024],"genre_scores_gemma":[0.97626656,0.00090445706,0.00016571113,0.011999338,0.005242306,0.0000055366263,0.00025579717,0.00005487338,0.0051054237],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99917984,0.000047567148,0.0001733605,0.00030376294,0.00010958617,0.00018587988],"domain_scores_gemma":[0.9990237,0.000014494625,0.0002483682,0.0006309921,0.000055738015,0.000026728405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000109496345,0.00019667795,0.00022141973,0.000020749994,0.00016960691,0.00004605309,0.00023003524,0.0005025524,0.000031170563],"category_scores_gemma":[0.00006459083,0.00013831885,0.00010110318,0.000017514156,0.00017341162,0.0000021483665,0.00016040955,0.00032909622,0.0000061775854],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005891388,0.00006251019,0.0034623928,0.00037996838,0.0006475687,0.000048785892,0.00011658445,4.946525e-7,0.82855636,0.000026069243,0.16149276,0.0051475815],"study_design_scores_gemma":[0.0009693263,0.00031406697,0.007158411,0.00008966463,0.00046640047,0.00016814886,0.000028608652,0.000002975061,0.082942426,0.000040781382,0.90757126,0.00024792104],"about_ca_topic_score_codex":0.000031605323,"about_ca_topic_score_gemma":0.00001321628,"teacher_disagreement_score":0.7460785,"about_ca_system_score_codex":0.000002419252,"about_ca_system_score_gemma":0.000035991896,"threshold_uncertainty_score":0.5640479},"labels":[],"label_agreement":null},{"id":"W2752818287","doi":"10.1182/blood.v118.21.523.523","title":"Thymic Retention of CD4+CD25hi+FoxP3+ T Regulatory (Treg) Cells Is Responsible for Peripheral Treg Deficiency and Platelet and Megakaryocyte Destruction in Active Immune Thrombocytopenia (ITP)","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; St. Michael's Hospital","funders":"","keywords":"FOXP3; Megakaryocyte; Immunology; Platelet; Immune system; IL-2 receptor; Bone marrow; Regulatory T cell; Splenocyte; Adoptive cell transfer; Medicine; Biology; T cell; Stem cell; Cell biology; Haematopoiesis","score_opus":0.021738277857379924,"score_gpt":0.24023763121362016,"score_spread":0.21849935335624024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752818287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964912,0.0019501105,0.000009886719,0.000038798284,0.00006353878,0.0007011479,0.000036422865,0.000020455442,0.0006884293],"genre_scores_gemma":[0.9972577,0.0005381773,0.0018108881,0.000020854477,0.000012398328,0.0000327116,0.000023852466,0.000023406597,0.00027998193],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99895257,0.00003954631,0.00030318488,0.00033929682,0.00013056806,0.00023486305],"domain_scores_gemma":[0.99948657,0.000033642507,0.00014968938,0.00021209428,0.000051427516,0.00006656417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014979969,0.0001808627,0.0004646848,0.00016314742,0.00007891621,0.000010061751,0.00004760504,0.00014249189,0.000042861087],"category_scores_gemma":[0.000018081222,0.00016067433,0.000072612,0.00014140923,0.00012354195,0.00019635903,0.00003195284,0.000098708675,0.000001507693],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0091144,0.0028388756,0.08375988,0.0005827995,0.00058348663,0.00027320153,0.0093942,0.0000015730923,0.8685606,0.00072137755,0.00008688442,0.024082715],"study_design_scores_gemma":[0.010845894,0.0012263273,0.4586334,0.00014478916,0.00029249975,0.00022681462,0.00065646914,0.0000616908,0.52635896,0.0013622312,0.000030433353,0.00016051576],"about_ca_topic_score_codex":0.0002676161,"about_ca_topic_score_gemma":0.000081164515,"teacher_disagreement_score":0.37487352,"about_ca_system_score_codex":0.00004008738,"about_ca_system_score_gemma":0.00007726869,"threshold_uncertainty_score":0.6552109},"labels":[],"label_agreement":null},{"id":"W2753082865","doi":"10.1182/blood.v128.22.4991.4991","title":"Efficacy of Dabigatran Etexilate in a Murine Model of Cancer Associated Thrombosis","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Dabigatran; Cancer; Pulmonary embolism; Rivaroxaban; Direct thrombin inhibitor; Thrombosis; Low molecular weight heparin; Warfarin; Discovery and development of direct thrombin inhibitors; Lung cancer; Apixaban; Intensive care medicine; Internal medicine; Thrombin; Atrial fibrillation","score_opus":0.04375751817295521,"score_gpt":0.3513237967834105,"score_spread":0.3075662786104553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2753082865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978265,0.00047017113,0.0000024926749,0.0005474458,0.000036390276,0.00019632575,0.000063453575,0.000013433287,0.0008437537],"genre_scores_gemma":[0.9986629,0.0007063034,0.000061463536,0.00005172801,0.000025801268,0.000022363593,0.000004676889,0.0000108092145,0.00045394758],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994289,0.000017958122,0.00020865751,0.00011590803,0.00009531897,0.00013320126],"domain_scores_gemma":[0.99965787,0.00006272513,0.00008993683,0.00010519623,0.00004334429,0.00004094685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006005151,0.00007627751,0.0003039152,0.00006668449,0.0000061272453,4.6092782e-7,0.00004186943,0.000058471673,0.00024208945],"category_scores_gemma":[0.000018873216,0.00005034082,0.00007118305,0.00012351642,0.000049435228,0.000020539657,0.000014093444,0.000044849396,0.000001960394],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025304666,0.0022539096,0.2627045,0.000045513974,0.0004050788,0.0000048233233,0.000281973,0.000029382423,0.7320354,0.000023950866,0.000087286244,0.001875126],"study_design_scores_gemma":[0.028400058,0.0003792312,0.4144846,0.00030569907,0.0007749987,0.0000010103406,0.0000042951965,0.00014899597,0.5553181,0.000082891864,0.00002756369,0.00007253719],"about_ca_topic_score_codex":0.0004408064,"about_ca_topic_score_gemma":0.00035075785,"teacher_disagreement_score":0.17671727,"about_ca_system_score_codex":0.000041534528,"about_ca_system_score_gemma":0.00010054498,"threshold_uncertainty_score":0.26507097},"labels":[],"label_agreement":null},{"id":"W2753485911","doi":"10.1182/blood-2017-03-774653","title":"H3 K27M/I mutations promote context-dependent transformation in acute myeloid leukemia with RUNX1 alterations","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"RUNX1; Myeloid leukemia; Context (archaeology); Mutation; Cancer research; Leukemia; Biology; Chromosomal translocation; Myeloid; Genetics; Gene; Transcription factor","score_opus":0.01922175462295055,"score_gpt":0.2968200042722698,"score_spread":0.27759824964931923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2753485911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98278004,0.00009289514,0.0013634373,0.0037904538,0.000053339816,0.0015133687,0.00006131868,0.00008663373,0.010258524],"genre_scores_gemma":[0.99599373,0.000093826755,0.0014894416,0.00018291402,0.00011510413,0.0002512121,0.0001776755,0.000039155737,0.0016569585],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99830043,0.000048669823,0.00037295825,0.00033124312,0.0005188685,0.00042782078],"domain_scores_gemma":[0.9986024,0.000040911345,0.00012777107,0.0007839819,0.0002442803,0.00020065198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033109734,0.00020563006,0.00033729975,0.00023055282,0.0004779227,0.00018308985,0.00028172924,0.00013144851,0.00008643541],"category_scores_gemma":[0.00012974162,0.00016831837,0.00007440889,0.00017895648,0.00016245946,0.0006281872,0.000045948982,0.00050934934,0.0001346369],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006290035,0.009858351,0.16513148,0.0023559972,0.01066537,0.01022915,0.08135379,0.0015107541,0.38611427,0.022308903,0.003951518,0.30023038],"study_design_scores_gemma":[0.11623354,0.004572635,0.4438429,0.0015867173,0.003619805,0.0039706873,0.0033807224,0.014784874,0.3899156,0.0011297625,0.015072673,0.0018901341],"about_ca_topic_score_codex":0.00054324296,"about_ca_topic_score_gemma":0.001127453,"teacher_disagreement_score":0.29834023,"about_ca_system_score_codex":0.00038638586,"about_ca_system_score_gemma":0.0010321421,"threshold_uncertainty_score":0.68638235},"labels":[],"label_agreement":null},{"id":"W2753511274","doi":"10.1182/blood.v128.22.4338.4338","title":"Azacitidine Use in the Real World Does Not Replicate AZA-001 Results in Higher Risk MDS/Low Blast Count AML: An Audit of 1101 Patients in the Cancer Care Ontario Registry","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Cancer Care Ontario; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Population; Proportional hazards model; Cancer registry; Cancer; Confidence interval","score_opus":0.030862540737387246,"score_gpt":0.2858397053328404,"score_spread":0.25497716459545317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2753511274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935358,0.000038066595,2.0956932e-7,0.0027072388,0.00008345308,0.0010102635,0.00069600285,0.000019884767,0.0019090684],"genre_scores_gemma":[0.995747,0.00041735487,0.000055575918,0.0004323864,0.00020567993,0.00023192976,0.00013210987,0.000036063833,0.0027418563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968322,0.00041904123,0.00070126384,0.00064707705,0.00084456924,0.0005558728],"domain_scores_gemma":[0.9971417,0.00054913945,0.0002983457,0.0016793186,0.00023094167,0.000100538135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011469239,0.00024956366,0.0004189838,0.00025597645,0.00005756148,0.00003492365,0.0006665095,0.0001547346,0.00010692061],"category_scores_gemma":[0.0004456396,0.0001135566,0.00006686744,0.00060884695,0.00022343264,0.00019086002,0.00012883278,0.0008353373,0.000012423223],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020742505,0.0012386348,0.9844193,0.00007301258,0.000047880803,0.00022554456,0.0061127213,0.000004757613,0.0014191291,0.00003742499,0.0026309225,0.0017164471],"study_design_scores_gemma":[0.015887322,0.00034506404,0.971939,0.0006050595,0.000074520365,0.000003943135,0.0004886831,0.000004724754,0.0038010762,0.000024076335,0.0066615846,0.00016491805],"about_ca_topic_score_codex":0.42789173,"about_ca_topic_score_gemma":0.8588636,"teacher_disagreement_score":0.4309719,"about_ca_system_score_codex":0.0010503542,"about_ca_system_score_gemma":0.0006028092,"threshold_uncertainty_score":0.57591796},"labels":[],"label_agreement":null},{"id":"W2754217112","doi":"10.1182/blood-2017-05-784413","title":"CK2β regulates thrombopoiesis and Ca2+-triggered platelet activation in arterial thrombosis","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Deutsche Forschungsgemeinschaft","keywords":"Thrombopoiesis; Platelet; Platelet activation; Thrombosis; Chemistry; Cell biology; Biochemistry; Biology; Medicine; Immunology; Internal medicine; Megakaryocyte; Haematopoiesis; Stem cell","score_opus":0.02258531026751697,"score_gpt":0.2769510943775852,"score_spread":0.2543657841100682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754217112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968205,0.0000958797,0.0000015348892,0.0006328166,0.00007019321,0.00027902922,0.000008958946,0.000029029943,0.002062068],"genre_scores_gemma":[0.99928683,0.00020628463,0.00022214103,0.000055191154,0.00006516717,0.000017253618,0.00003390162,0.000015854032,0.00009739737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99928284,0.000013638652,0.00015456138,0.00023435071,0.0001197275,0.0001948815],"domain_scores_gemma":[0.99945146,0.00002913581,0.00009846938,0.00033466052,0.000022072465,0.00006420443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000061373124,0.00013592711,0.00033690708,0.00007088291,0.00017552878,0.00006867968,0.00006436529,0.000110146495,0.00006032051],"category_scores_gemma":[0.000065601205,0.00011431165,0.000038235426,0.000039732964,0.000074997326,0.00019662202,0.00003979291,0.00007486611,0.0000133574995],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009298645,0.005618871,0.49872273,0.0002811476,0.0015908668,0.00079047383,0.0022003737,0.0000010572252,0.4561844,0.00045493868,0.0012632491,0.031962026],"study_design_scores_gemma":[0.0107981125,0.00016855466,0.8877019,0.00013065177,0.00013516097,0.00004111709,0.00006474774,0.000015000308,0.099733286,0.00092472206,0.00015605766,0.00013066456],"about_ca_topic_score_codex":0.00039140703,"about_ca_topic_score_gemma":0.0001046378,"teacher_disagreement_score":0.3889792,"about_ca_system_score_codex":0.000018820117,"about_ca_system_score_gemma":0.000029413408,"threshold_uncertainty_score":0.4661494},"labels":[],"label_agreement":null},{"id":"W2754234593","doi":"10.1182/blood.v128.22.2843.2843","title":"Minimal Residual Disease (MRD) Assessment By Multiparametric Flow Cytometry Is Prognostic for Progression-Free Survival in Phase 1/1b Relapsed/Refractory Acute Myeloid Leukemia (AML) Patients Treated with Idasanutlin MDM2 Antagonist","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Minimal residual disease; Oncology; Cytarabine; Internal medicine; Flow cytometry; Refractory (planetary science); Myeloid leukemia; Leukemia; Clinical trial; Immunology; Biology","score_opus":0.015705951130273153,"score_gpt":0.3182589468307045,"score_spread":0.3025529957004313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754234593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885852,0.0004831279,0.00034880062,0.00087666867,0.0001261673,0.005162237,0.004045113,0.00021676972,0.00015593231],"genre_scores_gemma":[0.98557675,0.0002582453,0.0092617,0.00019512023,0.00028441276,0.0014853614,0.0017145085,0.00022477275,0.0009991234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9937217,0.0003159165,0.0010308509,0.0014791089,0.0019758402,0.0014765394],"domain_scores_gemma":[0.99503314,0.0013998437,0.0004096069,0.0014000474,0.0006026395,0.0011547275],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007933361,0.0007716812,0.0010772293,0.001106643,0.00026048158,0.0001111415,0.0006914798,0.0003887286,0.00011190402],"category_scores_gemma":[0.0023173043,0.00050088455,0.00022500422,0.0017906164,0.00042772832,0.00041999717,0.0003264842,0.0007419622,0.000039974155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018095937,0.020338833,0.90215176,0.00041272194,0.0009192208,0.0011805202,0.00012816205,6.8035047e-7,0.016965251,0.000005119664,0.014503214,0.02529857],"study_design_scores_gemma":[0.32547948,0.01848977,0.60795486,0.0017160105,0.0024079587,0.0000550434,0.00013450996,0.0012533545,0.037869662,0.000027011496,0.0031106118,0.0015017544],"about_ca_topic_score_codex":0.00007540122,"about_ca_topic_score_gemma":0.000017241711,"teacher_disagreement_score":0.30738354,"about_ca_system_score_codex":0.0016796641,"about_ca_system_score_gemma":0.0024394884,"threshold_uncertainty_score":0.9997443},"labels":[],"label_agreement":null},{"id":"W2755976565","doi":"10.1182/blood.v128.22.4406.4406","title":"Bayesian Network Models of Multiple Myeloma: Drivers of High Risk and Durable Response","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Inference; Bayesian network; Bayesian probability; Approximate Bayesian computation; Causal inference; Computational biology; Computer science; Set (abstract data type); Bayesian inference; Biology; Bioinformatics; Machine learning; Artificial intelligence; Statistics; Mathematics","score_opus":0.014132920736549004,"score_gpt":0.24572116729398305,"score_spread":0.23158824655743404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755976565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978123,0.00030505026,0.0009772544,0.00016989702,0.000021094913,0.00032647143,0.00009584006,0.000020541198,0.0002715689],"genre_scores_gemma":[0.9944387,0.0004155491,0.0045699463,0.000007677696,0.00003593041,0.000013460892,0.0000051769707,0.000016686683,0.0004968446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890035,0.00013292595,0.00022210932,0.0002074312,0.00025489094,0.00028230628],"domain_scores_gemma":[0.9987744,0.000500282,0.00010953005,0.0003227589,0.000098451004,0.0001945419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028451998,0.000113468624,0.00031488034,0.00008651002,0.000049683593,0.000003014934,0.00006262382,0.00007079314,0.00005406639],"category_scores_gemma":[0.00034466348,0.00007187645,0.000064948996,0.00012776983,0.0001440591,0.00007705873,0.000053329393,0.00006405072,0.0000060222214],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007822599,0.0009784811,0.9372127,0.00011019007,0.00069448585,0.00015697672,0.00023310128,0.0000910268,0.037174895,0.00020766881,0.0002872328,0.015030656],"study_design_scores_gemma":[0.035206232,0.0016123967,0.8686185,0.00041213285,0.00038600358,0.000045972974,0.000068028465,0.0015272606,0.09000057,0.001815125,0.00015136745,0.0001564046],"about_ca_topic_score_codex":0.0003901056,"about_ca_topic_score_gemma":0.00004881533,"teacher_disagreement_score":0.06859418,"about_ca_system_score_codex":0.00001787944,"about_ca_system_score_gemma":0.0000808721,"threshold_uncertainty_score":0.29310367},"labels":[],"label_agreement":null},{"id":"W2756016513","doi":"10.1182/blood-2017-05-786699","title":"Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Heart, Lung, and Blood Institute","keywords":"Pathophysiology; Phenotype; Medicine; Biology; Immunology; Genetics; Internal medicine","score_opus":0.08534298051233632,"score_gpt":0.35793151194974443,"score_spread":0.27258853143740813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756016513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950913,0.00063151616,0.000051130257,0.00083704473,0.0001304231,0.00016871744,0.0000018852038,0.000015925845,0.0030720118],"genre_scores_gemma":[0.9983849,0.00024516895,0.00052315305,0.0005651435,0.00009135766,0.00000701722,0.0000049088385,0.000010842018,0.00016754553],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9994202,0.00002028783,0.00014888225,0.00020513397,0.00007333637,0.0001321258],"domain_scores_gemma":[0.9993193,0.0000870278,0.00008593523,0.00040937398,0.000027843478,0.000070483984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000075133656,0.000095097144,0.0002423105,0.000015513751,0.00035041585,0.000029501954,0.000100591875,0.00009151637,0.000008763476],"category_scores_gemma":[0.00013883153,0.000056000394,0.000051895215,0.000017444434,0.00017982119,0.00005157804,0.00008173342,0.00013589974,0.000029297875],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089007197,0.01449334,0.2993572,0.0003317882,0.003880547,0.002258909,0.0064895665,0.0000020329046,0.14895143,0.017276678,0.00056349445,0.50550497],"study_design_scores_gemma":[0.009402162,0.00050612143,0.9783045,0.00006479192,0.00031888718,0.000047138892,0.000110166555,0.00005513477,0.00047299563,0.009386857,0.0012097101,0.00012153304],"about_ca_topic_score_codex":0.00009976983,"about_ca_topic_score_gemma":0.000110644774,"teacher_disagreement_score":0.67894727,"about_ca_system_score_codex":0.0000037919554,"about_ca_system_score_gemma":0.0000573879,"threshold_uncertainty_score":0.2695151},"labels":[],"label_agreement":null},{"id":"W2756071038","doi":"10.1182/blood-2017-06-793141","title":"Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor–modified T-cell therapy","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute; Juno Therapeutics; National Institutes of Health","keywords":"Chimeric antigen receptor; Cytokine release syndrome; CD19; Immunology; Receptor; Antigen; Medicine; Cell therapy; Cytokine; Immunotherapy; Cancer research; Biology; Cell; Immune system; Internal medicine; Biochemistry","score_opus":0.021497684031937653,"score_gpt":0.2764908282456986,"score_spread":0.25499314421376096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756071038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98904794,0.0020507283,0.0000043547557,0.00038489376,0.00008760545,0.00058848545,0.00004123591,0.000031533167,0.007763242],"genre_scores_gemma":[0.9920476,0.0036403525,0.0005804933,0.00008704815,0.00009106987,0.000024517549,0.000019167908,0.000055875276,0.003453855],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99859977,0.00005942796,0.00026423822,0.0003518452,0.00038862092,0.00033610844],"domain_scores_gemma":[0.99844927,0.000052546267,0.00015715077,0.0010127325,0.00010541947,0.0002228968],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001916821,0.00020983511,0.00041626787,0.00013694826,0.000093419185,0.000043593787,0.00023138007,0.00013742525,0.0017946182],"category_scores_gemma":[0.00006143269,0.00017790058,0.000116417454,0.00011495026,0.0002948671,0.000071247865,0.000107906235,0.0001899708,0.00002726802],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015982423,0.0010537856,0.06346476,0.00015215957,0.000394395,0.00022883447,0.00018524588,2.8738796e-7,0.92337555,0.0000026121816,0.0003969585,0.009147156],"study_design_scores_gemma":[0.017506862,0.0023228629,0.5160027,0.00020008507,0.00016803057,0.00049829466,0.00007238649,0.00002431619,0.45657474,0.000046599853,0.006198857,0.00038427857],"about_ca_topic_score_codex":0.00013976631,"about_ca_topic_score_gemma":0.0000050147455,"teacher_disagreement_score":0.4668008,"about_ca_system_score_codex":0.000012472466,"about_ca_system_score_gemma":0.000057931848,"threshold_uncertainty_score":0.99911785},"labels":[],"label_agreement":null},{"id":"W2756474686","doi":"10.1182/blood.v128.22.4788.4788","title":"Evaluation of the Impact of Hematopoietic Stem Cell Transplant on the Quality of Life of Elderly Patients Treated for Lymphoma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Family Support in Illness","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Quality of life (healthcare); Transplantation; Depression (economics); Regimen; Hematopoietic stem cell transplantation; Anxiety; Cohort; Internal medicine; Pediatrics; Physical therapy; Psychiatry; Nursing","score_opus":0.061086690736917026,"score_gpt":0.32549297861311804,"score_spread":0.264406287876201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756474686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99729306,0.00003081628,0.0000072713806,0.00006480115,0.000057971232,0.0007559964,0.0003214368,0.0000044606127,0.0014642124],"genre_scores_gemma":[0.9999138,0.0000068556938,0.0000033339163,0.0000048364527,0.000008620021,0.000023802386,0.0000019220724,0.0000062320023,0.000030567335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99773306,0.0006938244,0.0004472949,0.00010255574,0.0008961003,0.00012715861],"domain_scores_gemma":[0.9978544,0.0007736853,0.00054500974,0.00028521667,0.0005105671,0.000031099087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002354414,0.00007588901,0.00023089573,0.00002615621,0.00006166361,0.0000024316141,0.00027884226,0.000068017944,0.000044896045],"category_scores_gemma":[0.0002855296,0.000033967885,0.00020695975,0.00016089759,0.00021555125,0.00004200008,0.000009465079,0.000015074205,6.409662e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004415472,0.005367426,0.88608146,0.0003501881,0.00042426938,7.317275e-8,0.0523662,0.000030443942,0.03770844,0.0032465644,0.00023474307,0.013748674],"study_design_scores_gemma":[0.005960168,0.00073893333,0.6787067,0.0002472803,0.00037331216,6.140155e-8,0.003002533,0.000016601896,0.30956486,0.0012718096,0.000005763051,0.000111956695],"about_ca_topic_score_codex":0.002123967,"about_ca_topic_score_gemma":0.00019404905,"teacher_disagreement_score":0.27185643,"about_ca_system_score_codex":0.000042162494,"about_ca_system_score_gemma":0.00043170102,"threshold_uncertainty_score":0.3210817},"labels":[],"label_agreement":null},{"id":"W2757190301","doi":"10.1182/blood-2017-06-788349","title":"Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":661,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Barncancerfonden; Vetenskapsrådet; Karolinska Institutet; Insamlingsstiftelsen Cancer- och Allergifonden","keywords":"Etoposide; Dexamethasone; Hemophagocytic lymphohistiocytosis; Medicine; Internal medicine; Immunology; Oncology; Chemotherapy; Disease","score_opus":0.03750387943550386,"score_gpt":0.3427169274531296,"score_spread":0.3052130480176257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2757190301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951891,0.000838493,6.265522e-7,0.0002796363,0.000022112943,0.0012818967,0.000013557257,0.0000061704386,0.0023684376],"genre_scores_gemma":[0.99883866,0.00016438121,0.000014548304,0.000010181166,0.000015213102,0.000025023557,0.000004770822,0.000011336289,0.00091587164],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99887604,0.00013108227,0.00039248483,0.00020551453,0.00022461884,0.00017026553],"domain_scores_gemma":[0.9987142,0.00015582936,0.00021607874,0.00076194364,0.000105469284,0.000046472727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003147213,0.00012433124,0.00045321303,0.00006837474,0.00012232129,0.000016760801,0.00018266757,0.00006213034,0.000021256295],"category_scores_gemma":[0.0007336935,0.000076638935,0.00005807292,0.00008525017,0.00035585265,0.00006133728,0.00010540262,0.00013728917,0.000002675726],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011117801,0.00479008,0.9685422,0.00006810594,0.00033026276,0.000082244645,0.005134164,0.000002035715,0.014696115,0.000028576253,0.000013408423,0.0052009933],"study_design_scores_gemma":[0.03282985,0.0016849866,0.89872825,0.00017889371,0.00014705968,0.000008798587,0.00054571516,0.0000061576206,0.06578135,0.000004579749,0.000024187104,0.000060184706],"about_ca_topic_score_codex":0.00068226503,"about_ca_topic_score_gemma":0.0005412236,"teacher_disagreement_score":0.069814,"about_ca_system_score_codex":0.000018698918,"about_ca_system_score_gemma":0.00022202445,"threshold_uncertainty_score":0.3125245},"labels":[],"label_agreement":null},{"id":"W2757194729","doi":"10.1182/blood.v128.22.3824.3824","title":"The Safety and Efficacy of Full Versus Reduced Dose Betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention with Extended Duration Betrixaban (APEX) Trial","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Pulmonary embolism; Dosing; Surgery; Thrombosis; Deep vein; Venous thromboembolism; Anesthesia; Internal medicine","score_opus":0.016338326094113172,"score_gpt":0.28467663295778994,"score_spread":0.26833830686367677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2757194729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98936576,0.00039155618,0.00012345523,0.0058225463,0.00032077188,0.0025920717,0.000014588052,0.00004181519,0.0013274448],"genre_scores_gemma":[0.9965085,0.0025293468,0.00023588227,0.00012802557,0.00031764738,0.00011095023,0.000027251597,0.000029723538,0.0001126966],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975189,0.0002593234,0.00070187944,0.0004016086,0.00072538794,0.0003928948],"domain_scores_gemma":[0.9980547,0.00072940777,0.00035409833,0.0006107545,0.0001367651,0.00011431116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012336477,0.0002454024,0.00065284054,0.00013672952,0.00022467248,0.000042282936,0.00026513208,0.0001274541,0.000036384314],"category_scores_gemma":[0.0005660912,0.0001125428,0.00012840405,0.0003918836,0.00027107776,0.00013154953,0.00008204167,0.00019596796,0.0000072851744],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28931257,0.04521288,0.00092777633,0.000429352,0.009755176,0.00045473606,0.012577816,0.0000063763955,0.06006442,0.02228993,0.003037246,0.5559317],"study_design_scores_gemma":[0.4507195,0.028431261,0.49844232,0.001024121,0.0062787025,0.00014873839,0.0014433473,0.000016373167,0.0065996163,0.0007317816,0.0055642384,0.00059999054],"about_ca_topic_score_codex":0.000049404716,"about_ca_topic_score_gemma":0.00018243387,"teacher_disagreement_score":0.5553317,"about_ca_system_score_codex":0.000053190462,"about_ca_system_score_gemma":0.00016886047,"threshold_uncertainty_score":0.4589362},"labels":[],"label_agreement":null},{"id":"W2757476094","doi":"10.1182/blood.v128.22.sci-1.sci-1","title":"Molecular Events Defining Human Clonal Hematopoiesis at Single Cell Resolution","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Progenitor cell; Biology; Haematopoiesis; Stem cell; Myeloid; Immunology; Cell biology; Megakaryocyte; Lymphopoiesis; Multipotent Stem Cell","score_opus":0.011370910823419081,"score_gpt":0.21192700156185687,"score_spread":0.20055609073843778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2757476094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951607,0.0006689029,0.0012781086,0.00006907229,0.00009187981,0.000076219716,0.000027758006,0.00002248163,0.002604873],"genre_scores_gemma":[0.9981894,0.000028260858,0.0007253819,0.00011022805,0.00009111356,0.000009712889,0.00008091296,0.000030251613,0.0007347538],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990641,0.000043443866,0.00018052182,0.0003156266,0.00013605085,0.00026028443],"domain_scores_gemma":[0.9995401,0.0000084022895,0.000063912106,0.00027009202,0.0000407568,0.00007676438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000084911095,0.00014336083,0.00011377941,0.000028184882,0.00012697058,0.000009750917,0.00014487459,0.0001456728,0.000033215558],"category_scores_gemma":[0.000022630014,0.00011865842,0.000114514216,0.000041267343,0.000046169076,0.0000032806279,0.000083295985,0.000037867198,0.00003691833],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029565177,0.00032027098,0.008763132,0.000014281384,0.000031575608,0.000006796798,0.00001501059,0.000003528091,0.9903296,0.000111180656,0.00024994134,0.00012509886],"study_design_scores_gemma":[0.0016134913,0.00024312428,0.0010465307,0.00002876401,0.00004354883,0.00001740849,0.00000556427,0.0000016239546,0.9929273,0.0001323309,0.0037479778,0.00019234252],"about_ca_topic_score_codex":0.000014226051,"about_ca_topic_score_gemma":0.000029070748,"teacher_disagreement_score":0.007716601,"about_ca_system_score_codex":0.00001986143,"about_ca_system_score_gemma":0.000021485843,"threshold_uncertainty_score":0.48387498},"labels":[],"label_agreement":null},{"id":"W2760740884","doi":"10.1182/blood.v114.22.174.174","title":"A Meta-Analysis of Randomized Controlled Trials of Aspirin in Primary Prevention of Cardiovascular Disease.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Aspirin; Relative risk; Stroke (engine); Myocardial infarction; Internal medicine; Meta-analysis; Cochrane Library; Number needed to harm; Randomized controlled trial; Confidence interval; Surgery; Number needed to treat","score_opus":0.0524765519359269,"score_gpt":0.2951564967381479,"score_spread":0.24267994480222102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2760740884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7492388,0.24652055,0.0012602868,0.00004227461,0.0000127463845,0.002429411,0.000048141817,0.000011240753,0.00043657023],"genre_scores_gemma":[0.99646914,0.0029637048,0.00023764765,0.0000321687,0.00002346095,0.00011019494,0.00008025295,0.000008511995,0.000074937496],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99442834,0.002283934,0.0021480105,0.00023297107,0.0007819802,0.00012473931],"domain_scores_gemma":[0.9976801,0.00057195756,0.0008138279,0.0006617562,0.00019235372,0.0000799759],"candidate_categories":["metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.010388179,0.00017869603,0.016687855,0.00055399875,0.000008733077,0.000002938755,0.000086137356,0.00007325329,0.00015791373],"category_scores_gemma":[0.001181162,0.000112406626,0.042428877,0.0006179277,0.00008595531,0.00004317602,0.000010751097,0.00005868158,3.5539856e-7],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10344405,0.0018994197,0.0004439923,0.00017942164,0.8895823,0.000026798973,0.00004162443,0.0014063923,0.0012177108,0.00009688868,0.0000014356667,0.0016600107],"study_design_scores_gemma":[0.30469027,0.00010211798,0.0062763146,0.0000410894,0.6858882,0.0000011488023,0.000010161461,0.000043413107,0.0026976054,0.00017480881,0.000013824725,0.000061111765],"about_ca_topic_score_codex":0.000024542353,"about_ca_topic_score_gemma":6.3455695e-7,"teacher_disagreement_score":0.24723034,"about_ca_system_score_codex":0.000008064635,"about_ca_system_score_gemma":0.00013783164,"threshold_uncertainty_score":0.99791044},"labels":[],"label_agreement":null},{"id":"W2760837506","doi":"10.1182/blood.v128.22.1183.1183","title":"ABVD Versus Combination Baseline Beacopp/Escalated Beacopp in the Treatment of Newly Diagnosed Advanced-Stage Hodgkin Lymphoma: A Decision Analysis","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre; Barrie Urology Group; University of Toronto","funders":"","keywords":"ABVD; Medicine; Dacarbazine; Procarbazine; Oncology; Internal medicine; Hodgkin's lymphoma; Vincristine; Lymphoma; Chemotherapy; Cyclophosphamide","score_opus":0.016459228457309967,"score_gpt":0.28451435202651354,"score_spread":0.2680551235692036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2760837506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962841,0.0014206287,0.00032097925,0.0006995027,0.00010511229,0.0008084216,0.00009002968,0.00003750064,0.0002336847],"genre_scores_gemma":[0.9970181,0.0015149065,0.00077308196,0.000069801965,0.000036474048,0.00023431581,0.00015640451,0.00001991891,0.00017699564],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981532,0.00013721958,0.00052153977,0.00042493918,0.00047195074,0.00029115754],"domain_scores_gemma":[0.9972518,0.0016854567,0.0001955717,0.00063961936,0.000119390505,0.00010814311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026380474,0.00027095215,0.00061188,0.00037479145,0.000058029833,0.000019089932,0.00012485575,0.00011498617,0.00007858876],"category_scores_gemma":[0.00025627902,0.00013924291,0.00034942402,0.00097468833,0.000051035986,0.000120788274,0.000018917985,0.00002507557,0.00002287157],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003872994,0.062097054,0.32930577,0.00003562387,0.00361633,0.0011566845,0.0012128185,0.0000878748,0.0037750243,0.00064733875,0.0003037634,0.5938887],"study_design_scores_gemma":[0.15796913,0.005577816,0.8054055,0.00021690628,0.0051952465,0.00000951608,0.00024208472,0.00023729184,0.023377407,0.00011568509,0.001422516,0.00023092281],"about_ca_topic_score_codex":0.00031788606,"about_ca_topic_score_gemma":0.0005091125,"teacher_disagreement_score":0.5936578,"about_ca_system_score_codex":0.00036112592,"about_ca_system_score_gemma":0.00010349581,"threshold_uncertainty_score":0.56781614},"labels":[],"label_agreement":null},{"id":"W2761055198","doi":"10.1182/blood-2017-06-793554","title":"AML with myelodysplasia-related changes masquerades as acute panmyelosis with myelofibrosis","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Bone health and treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Osteoclast; Anabolism; Bone marrow; Medicine; RANKL; Mesenchymal stem cell; Bone resorption; Multiple myeloma; Osteoblast; Tartrate-resistant acid phosphatase; Endocrinology; Acid phosphatase; Bone remodeling; Internal medicine; Cancer research; Chemistry; Pathology; In vitro","score_opus":0.012677386555666472,"score_gpt":0.2677753453912137,"score_spread":0.25509795883554726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761055198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97698283,0.00021494488,0.0000024339083,0.0067975097,0.000063581916,0.0006812206,0.00002594304,0.00012074397,0.015110808],"genre_scores_gemma":[0.98923385,0.0003373133,0.0019305571,0.000493701,0.00006403963,0.00014623643,0.000046307156,0.00006396429,0.007684035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848455,0.00002360804,0.00017927891,0.00043290452,0.0003625173,0.00051712774],"domain_scores_gemma":[0.99837524,0.000028027598,0.00022867936,0.0008547539,0.000095751,0.00041754637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000067826586,0.00030570847,0.00046485855,0.00009816431,0.0005323719,0.000078474746,0.00015119767,0.00015919306,0.00017138774],"category_scores_gemma":[0.000023820563,0.0001922869,0.000052857868,0.000111165704,0.00018114505,0.00014340284,0.00004539466,0.00021522805,0.0003005652],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019453891,0.0017778453,0.97190547,0.0002466131,0.0034855884,0.0026644368,0.0007127794,2.8166014e-7,0.0019206789,0.0003238605,0.000322872,0.014694184],"study_design_scores_gemma":[0.018854601,0.0061888862,0.9304634,0.0007753076,0.0034896734,0.0019003236,0.00007708011,0.000005837138,0.03556892,0.00006172886,0.0022441272,0.0003701379],"about_ca_topic_score_codex":0.00063615723,"about_ca_topic_score_gemma":0.000623594,"teacher_disagreement_score":0.041442093,"about_ca_system_score_codex":0.000034585253,"about_ca_system_score_gemma":0.00016995383,"threshold_uncertainty_score":0.7841232},"labels":[],"label_agreement":null},{"id":"W2761236690","doi":"10.1182/blood-2017-07-731588","title":"FCR achieves long-term durable remissions in patients with IGHV-mutated CLL","year":2017,"lang":"en","type":"review","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"","keywords":"IGHV@; Chemoimmunotherapy; Fludarabine; Chronic lymphocytic leukemia; Rituximab; Medicine; Internal medicine; Cyclophosphamide; Oncology; Alemtuzumab; Progression-free survival; Leukemia; Immunology; Chemotherapy; Transplantation; Lymphoma","score_opus":0.06436159046231887,"score_gpt":0.37783677114149145,"score_spread":0.31347518067917257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761236690","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019908058,0.9738628,7.482639e-7,0.000026837606,0.00010957141,0.002595285,0.000060756134,0.00008146273,0.0033544519],"genre_scores_gemma":[0.0012489144,0.98950046,0.0001152897,0.000017486944,0.00017375883,0.00016538921,0.0008674305,0.0001572146,0.0077540264],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967319,0.0001540682,0.0007048636,0.00075308373,0.0008853702,0.00077074306],"domain_scores_gemma":[0.9970977,0.00017862872,0.00041801026,0.0017193435,0.00016500526,0.00042133307],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003294416,0.00055404555,0.0021367508,0.00037599544,0.00015830986,0.00008721243,0.00065856485,0.0005233294,0.00025047752],"category_scores_gemma":[0.00048764763,0.0003550975,0.00027954028,0.00035851315,0.00017546293,0.000107592634,0.0002823817,0.0009808356,0.00034158272],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0004762716,0.0070819166,0.025623856,0.087566935,0.00179443,0.005852062,0.00011736522,2.976151e-7,0.0000013445513,0.000010786819,0.001450119,0.8700246],"study_design_scores_gemma":[0.12816791,0.0014147674,0.025584307,0.18394582,0.0071341023,0.0012367093,0.0000063749685,0.000008118092,0.000026727123,0.000008571841,0.65091723,0.0015493622],"about_ca_topic_score_codex":0.0001468577,"about_ca_topic_score_gemma":0.0000630103,"teacher_disagreement_score":0.86847526,"about_ca_system_score_codex":0.0041474896,"about_ca_system_score_gemma":0.013578586,"threshold_uncertainty_score":0.9998901},"labels":[],"label_agreement":null},{"id":"W2761565001","doi":"10.1182/blood.v128.22.4339.4339","title":"Impact of Bone Marrow Fibrosis in MDS Patients Treated with Azacitidine","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Myelofibrosis; Azacitidine; Internal medicine; International Prognostic Scoring System; Myelodysplastic syndromes; Chronic myelomonocytic leukemia; Bone marrow; Gastroenterology; Surgery; Oncology","score_opus":0.009351642600387447,"score_gpt":0.24635067494992058,"score_spread":0.23699903234953312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761565001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99835026,0.00007398809,0.0000019200188,0.00014326414,0.0000071046093,0.00039474972,0.000098930264,0.000018615707,0.0009111715],"genre_scores_gemma":[0.9993433,0.000075119264,0.00019740684,0.000018399327,0.000020990385,0.0000675793,0.00003943368,0.000019188516,0.00021859501],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991404,0.0000273019,0.00023184206,0.00020678746,0.00018916249,0.00020453843],"domain_scores_gemma":[0.9994173,0.00007031102,0.00008583994,0.00020545503,0.000111753165,0.0001093407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004136204,0.00016380676,0.00038640352,0.00012365512,0.000015764132,0.000003914209,0.000025847214,0.000053414144,0.00029503217],"category_scores_gemma":[0.00004529791,0.00007782315,0.00009200889,0.00018835667,0.000042059582,0.000054715078,0.000013195444,0.000038536735,0.000018556182],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005077604,0.003661383,0.98408175,0.000024083296,0.00025366683,0.000052791027,0.000056073353,3.1268306e-7,0.0094574895,0.00001322012,0.00012339074,0.0017680828],"study_design_scores_gemma":[0.01649818,0.004538862,0.8800459,0.00041180756,0.00016161181,0.00001368001,0.000003268431,9.481519e-7,0.0982126,0.000005806925,0.000022384262,0.00008499008],"about_ca_topic_score_codex":0.00019523552,"about_ca_topic_score_gemma":0.000055817905,"teacher_disagreement_score":0.104035884,"about_ca_system_score_codex":0.0000719775,"about_ca_system_score_gemma":0.000059241298,"threshold_uncertainty_score":0.32303953},"labels":[],"label_agreement":null},{"id":"W2761626975","doi":"10.1182/blood.v128.22.3609.3609","title":"Estimated Late Health Outcomes in Children Newly Diagnosed with Mature B-Cell Non-Hodgkin Lymphoma Treated with Contemporary LMB Chemotherapy Based upon Similarly Treated Participants in the Childhood Cancer Survivor Study (CCSS)","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Common Terminology Criteria for Adverse Events; Hazard ratio; Population; Chemotherapy regimen; Internal medicine; Vincristine; Odds ratio; Etoposide; Regimen; Pediatrics; Cyclophosphamide; Cancer; Surgery; Chemotherapy; Confidence interval; Environmental health","score_opus":0.02063185837029449,"score_gpt":0.29690594363108674,"score_spread":0.2762740852607923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761626975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904838,0.00031404573,0.000021220052,0.0028515062,0.000016439924,0.005828793,0.00018485342,0.0001720503,0.00012729908],"genre_scores_gemma":[0.99665296,0.000098213764,0.00016768191,0.0016978673,0.000049066406,0.0008771032,0.000106516396,0.00016947159,0.00018110646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954152,0.00063220185,0.00076311093,0.0009400789,0.001010503,0.0012388757],"domain_scores_gemma":[0.99757546,0.0005470444,0.00032932428,0.0010103039,0.0001485987,0.00038924534],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008142532,0.00071417674,0.0013251412,0.00044300238,0.0001273805,0.00007527984,0.00047376892,0.00023186774,0.00006054688],"category_scores_gemma":[0.000096580916,0.0003339255,0.000093315466,0.0014150951,0.0001601055,0.00020318142,0.00004425807,0.00038527822,0.000017311824],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00390136,0.013791233,0.9759306,0.00004942929,0.00052958133,0.0010526958,0.002210816,0.0000415673,0.0004792804,3.1854302e-7,0.000176,0.0018371408],"study_design_scores_gemma":[0.15754583,0.004594521,0.8334706,0.00074472,0.00019818581,0.000034938566,0.00030440843,0.00045439176,0.0022707223,0.0000010504953,0.0000076103934,0.00037304228],"about_ca_topic_score_codex":0.023412904,"about_ca_topic_score_gemma":0.008940249,"teacher_disagreement_score":0.15364449,"about_ca_system_score_codex":0.00059546734,"about_ca_system_score_gemma":0.0027845218,"threshold_uncertainty_score":0.99991125},"labels":[],"label_agreement":null},{"id":"W2762190074","doi":"10.1182/blood-2017-08-798520","title":"Maestro tissue factor reaches new hEIGHT","year":2017,"lang":"en","type":"letter","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services","funders":"","keywords":"Tissue factor; Coagulation; Factor IX; Blood coagulation factors; Immunology; Factor (programming language); Repertoire; Clotting factor; Medicine; Biology; Internal medicine; Computer science; Physics","score_opus":0.06779862710084752,"score_gpt":0.33254608959172227,"score_spread":0.2647474624908748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2762190074","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01077952,0.0025261086,0.0000023356226,0.9361588,0.0003751436,0.00082472997,0.00009137794,0.00013754138,0.049104482],"genre_scores_gemma":[0.004223331,0.00048760397,0.0010184003,0.07370378,0.02913438,0.000041407257,0.0013072197,0.00016512042,0.88991874],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99821436,0.00003606685,0.00019195507,0.00045245286,0.0005729794,0.00053218513],"domain_scores_gemma":[0.99848145,0.00006126515,0.00009644091,0.0010732851,0.000054389828,0.00023316832],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000050200997,0.00033384503,0.0005750826,0.00014412423,0.00012152845,0.00007831865,0.00030778188,0.00090933754,0.0012674227],"category_scores_gemma":[0.000093627474,0.00022986442,0.00017966703,0.000039774033,0.000092831964,0.00004798239,0.0000815973,0.0014465633,0.0014573687],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014328952,0.00015940289,0.0030486393,0.00022017068,0.00041697093,0.009746921,0.000066758264,9.0330937e-10,0.0007031884,0.0000011101206,0.97672564,0.008896874],"study_design_scores_gemma":[0.0023729198,0.00036113054,0.0017271449,0.00026698742,0.00047554952,0.000316096,0.0000020341565,1.1390811e-7,0.012115884,0.0000714384,0.98207533,0.00021537578],"about_ca_topic_score_codex":0.00015247476,"about_ca_topic_score_gemma":0.0000043028704,"teacher_disagreement_score":0.86245495,"about_ca_system_score_codex":0.000043148688,"about_ca_system_score_gemma":0.00045340857,"threshold_uncertainty_score":0.99964553},"labels":[],"label_agreement":null},{"id":"W2762616050","doi":"10.1182/blood.v128.22.1638.1638","title":"Azacitidine (AZA) Prolongs Overall Survival in Older Patients with Acute Myeloid Leukemia (AML) with Poor Prognostic Karyotypes Compared with Conventional Care Regimens (CCR)","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Cytarabine; Azacitidine; Gastroenterology; Oncology; Chemotherapy regimen; Leukemia; Chemotherapy; Biology","score_opus":0.008975817158364137,"score_gpt":0.23595505171657424,"score_spread":0.22697923455821012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2762616050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99470884,0.000115101015,0.00014636443,0.0008584161,0.000043485685,0.0026163412,0.00017490829,0.00014167382,0.0011948864],"genre_scores_gemma":[0.9953744,0.000022541164,0.002090469,0.00017675277,0.00013451096,0.0003339808,0.0005260561,0.00012304056,0.0012182944],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964397,0.00012358635,0.00040208126,0.0008363758,0.0013073959,0.0008908911],"domain_scores_gemma":[0.99787426,0.00017995108,0.00020154731,0.0005630976,0.0008126471,0.00036847414],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017538968,0.0004916193,0.0007188022,0.00028551838,0.00011746719,0.00004340091,0.00027224558,0.00016850288,0.00016843755],"category_scores_gemma":[0.00007105122,0.00026983587,0.000072889954,0.00047305785,0.00041303912,0.0002950742,0.000112399444,0.00046579316,0.00006238489],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00805382,0.0010674039,0.98558784,0.00025683866,0.0009532144,0.001153861,0.0004537481,0.0000070689134,0.0014788053,0.00015357604,0.00054035056,0.00029349545],"study_design_scores_gemma":[0.073487945,0.004695978,0.91289306,0.0016548557,0.0007342827,0.00030322996,0.00021185733,0.000023523637,0.004929696,0.000018631852,0.00047371702,0.0005732554],"about_ca_topic_score_codex":0.00017943309,"about_ca_topic_score_gemma":0.00042101715,"teacher_disagreement_score":0.07269479,"about_ca_system_score_codex":0.00065725617,"about_ca_system_score_gemma":0.001597282,"threshold_uncertainty_score":0.9999754},"labels":[],"label_agreement":null},{"id":"W2762629706","doi":"10.1182/blood-2017-05-781849","title":"Immune reconstitution and survival of 100 SCID patients post–hematopoietic cell transplant: a PIDTC natural history study","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":266,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; CancerCare Manitoba","funders":"National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Hematopoietic cell; Medicine; Immunology; Hematopoietic stem cell transplantation; Chemotherapy; Natural history; Internal medicine; Immune system; Haematopoiesis; Transplantation; Hematologic Neoplasms; Chemotherapy regimen; Oncology; Stem cell; Biology","score_opus":0.008435931367009777,"score_gpt":0.20467587134358733,"score_spread":0.19623993997657757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2762629706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96353775,0.031916026,0.0000024168955,0.00002318173,0.0015213892,0.00031057704,0.000023776018,0.000026955984,0.002637906],"genre_scores_gemma":[0.9992103,0.000101155405,0.0000034527584,0.000015013389,0.0000021620085,0.000009721377,0.000057380435,0.0000100850975,0.00059070217],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99897134,0.000120967496,0.0003450424,0.00025991353,0.000049719663,0.00025302285],"domain_scores_gemma":[0.99909353,0.000040738832,0.00027426644,0.00047728905,0.0001079626,0.0000061829846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025103468,0.00017510787,0.00033606388,0.00008191981,0.0004784203,0.000013416726,0.00035075075,0.00012623396,0.00009772877],"category_scores_gemma":[0.00006352351,0.00015946376,0.00008853402,0.000025491216,0.0005881805,0.00016429706,0.00007817367,0.0002375811,0.000040614377],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006847143,0.011320731,0.15283889,0.00024399666,0.0005258969,0.000017872318,0.017539104,9.426293e-7,0.8119086,0.00051760895,0.000043724034,0.0043579196],"study_design_scores_gemma":[0.020475486,0.0012620063,0.88141346,0.00015777195,0.0005189861,0.000046481397,0.0027636618,0.0000011042349,0.09078807,0.000041902083,0.0019617944,0.0005692708],"about_ca_topic_score_codex":0.00042703818,"about_ca_topic_score_gemma":0.000017173703,"teacher_disagreement_score":0.7285746,"about_ca_system_score_codex":0.000017807215,"about_ca_system_score_gemma":0.00007482637,"threshold_uncertainty_score":0.65027434},"labels":[],"label_agreement":null},{"id":"W2763706110","doi":"10.1182/blood.v128.22.3528.3528","title":"Economic Evaluation of the Direct Oral Anticoagulants Compared to Vitamin K Antagonists in the Treatment of Deep Venous Thrombosis and Pulmonary Embolism in the Outpatient Setting: Analysis from the Queen Elizabeth II Health Sciences Centre in Halifax, Nova Scotia","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Apixaban; Rivaroxaban; Pulmonary embolism; Cost-effectiveness analysis; Cost effectiveness; Cost-minimization analysis; Venous thrombosis; Low molecular weight heparin; Dabigatran; Intensive care medicine; Thrombosis; Surgery; Warfarin; Internal medicine; Atrial fibrillation","score_opus":0.04095197551899995,"score_gpt":0.32534449740840066,"score_spread":0.28439252188940073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2763706110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98429,0.0007037387,0.0000022685028,0.01288848,0.000074966956,0.0017925502,0.000104952815,0.000004168611,0.00013886],"genre_scores_gemma":[0.9987736,0.0005978576,0.000059259044,0.00046658347,0.000031163745,0.00003725834,0.000024527812,0.000008084075,0.0000017030953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974157,0.0008886796,0.0005457105,0.00034948433,0.0005040597,0.00029634451],"domain_scores_gemma":[0.99878865,0.00035569703,0.0002687115,0.0005103879,0.000039312108,0.000037248206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002094922,0.00017507064,0.0007286609,0.0001869319,0.00013347527,0.000023894918,0.0003355822,0.000039565708,0.000020173422],"category_scores_gemma":[0.000055239332,0.00007128498,0.000105935935,0.000609356,0.00016958485,0.000048393875,0.00008054925,0.00005800342,0.0000018020394],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025200847,0.0050595636,0.95755124,0.000021113168,0.00033821244,0.000002356436,0.029455047,0.00056235644,0.00020487282,0.00006902631,0.000092462935,0.0066185575],"study_design_scores_gemma":[0.0019859502,0.00052212516,0.9900567,0.00023282148,0.001048627,9.240387e-7,0.0044698277,0.0009003998,0.0005839005,0.00006221568,0.000055836685,0.00008069419],"about_ca_topic_score_codex":0.038549155,"about_ca_topic_score_gemma":0.062940635,"teacher_disagreement_score":0.03250545,"about_ca_system_score_codex":0.00017704091,"about_ca_system_score_gemma":0.00014438559,"threshold_uncertainty_score":0.96785325},"labels":[],"label_agreement":null},{"id":"W2763779520","doi":"10.1182/blood.v108.11.5517.5517","title":"Ten-Year Overall Survival Analysis of Current Treatments of Relapsed or Refractory Multiple Myeloma in Canada.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Bortezomib; Medicine; Thalidomide; Multiple myeloma; Internal medicine; Interim analysis; Lenalidomide; Clinical trial; Oncology; Surgery","score_opus":0.027923415720154172,"score_gpt":0.29332471182485564,"score_spread":0.2654012961047015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2763779520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979546,0.0005078673,0.0000035352775,0.000020923184,0.000049826125,0.00037122218,0.0002963055,0.000009765068,0.0007859336],"genre_scores_gemma":[0.99879587,0.0001118734,0.00025218917,0.0000044585026,0.00002832123,0.000024133495,0.0003477559,0.000016862985,0.00041852932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981923,0.00008572687,0.00049784314,0.00027295624,0.0006181768,0.00033298714],"domain_scores_gemma":[0.99897176,0.00020692777,0.00016796253,0.00039254528,0.0001185916,0.00014220459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000103625694,0.00017319033,0.00068519264,0.0004098391,0.000021432568,0.0000032363848,0.000093757466,0.000053003692,0.00017392261],"category_scores_gemma":[0.00016083682,0.00012620208,0.00015722275,0.00071349175,0.000039957486,0.000041744945,0.00003466778,0.00012284052,0.0000033151111],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094579265,0.0034041924,0.98835933,0.00007761406,0.0018393336,0.00023519149,0.000033873213,0.000027038612,0.002543597,0.0000152798,0.00009210374,0.0024266231],"study_design_scores_gemma":[0.015980426,0.00033077103,0.97411656,0.000076831435,0.0013500886,0.0000022434274,0.000052726125,0.0003510316,0.0074844756,0.0000050061917,0.00015642509,0.00009343628],"about_ca_topic_score_codex":0.7199624,"about_ca_topic_score_gemma":0.842624,"teacher_disagreement_score":0.12266158,"about_ca_system_score_codex":0.00032156924,"about_ca_system_score_gemma":0.0010273999,"threshold_uncertainty_score":0.5146372},"labels":[],"label_agreement":null},{"id":"W2764047877","doi":"10.1182/blood.v128.22.5675.5675","title":"Efficacy of Carfilzomib in the Treatment of Relapsed and (or) Refractory Multiple myeloma: a Meta Analysis of Individual Patient Data from Clinical Trials","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Carfilzomib; Medicine; Multiple myeloma; Lenalidomide; Bortezomib; Meta-analysis; Clinical trial; Oncology; Internal medicine; Thalidomide; Proteasome inhibitor; Cochrane Library; Intensive care medicine","score_opus":0.3327612388515309,"score_gpt":0.4480871288065761,"score_spread":0.11532588995504517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2764047877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924785,0.0030862568,0.000005513263,0.0001167567,0.000015676667,0.0010238686,0.0032353522,0.0000051221027,0.00003294394],"genre_scores_gemma":[0.9972721,0.0013869108,0.00072388304,0.000013023228,0.00003136793,0.00004848318,0.00048421198,0.000009973977,0.00003007536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963157,0.0012484919,0.0012776334,0.00040264285,0.000556645,0.0001988645],"domain_scores_gemma":[0.98801154,0.0099794725,0.00054373255,0.001259689,0.00008347645,0.00012209012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001852186,0.00016803837,0.0019050572,0.00027748875,0.000019256297,0.000005330129,0.00026195563,0.00010886782,0.00015313823],"category_scores_gemma":[0.0042780307,0.00006718056,0.0005073387,0.00039185776,0.00019029267,0.00005981588,0.00011879156,0.000070620066,0.0000015615384],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009410228,0.028005034,0.6792775,0.00004300706,0.20503229,0.00019331515,0.002205314,4.8773103e-7,0.0041907732,0.0000074569703,0.00008623155,0.07154842],"study_design_scores_gemma":[0.04362989,0.004140972,0.83730626,0.000036521862,0.10740384,0.0000018058365,0.00029146968,0.00003315088,0.00680371,0.000006344211,0.0002774793,0.00006853715],"about_ca_topic_score_codex":0.0011077512,"about_ca_topic_score_gemma":0.0005701146,"teacher_disagreement_score":0.15802884,"about_ca_system_score_codex":0.00001671702,"about_ca_system_score_gemma":0.00013523022,"threshold_uncertainty_score":0.5121511},"labels":[],"label_agreement":null},{"id":"W2764339126","doi":"10.1182/blood-2017-05-780049","title":"Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":241,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Takeda Oncology","keywords":"Brentuximab vedotin; Anaplastic large-cell lymphoma; Medicine; Internal medicine; Oncology; Refractory (planetary science); Lymphoma; Hodgkin lymphoma; Biology","score_opus":0.007575507668794034,"score_gpt":0.22328376742191533,"score_spread":0.2157082597531213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2764339126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966555,0.00015292768,4.840961e-7,0.000032663225,0.000101748905,0.000513187,0.0001707816,0.000021431892,0.0023512326],"genre_scores_gemma":[0.9990985,0.000046398512,0.0001366497,0.000021384465,0.00003759156,0.000030332316,0.00008352962,0.000025654974,0.0005199621],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998646,0.00004014458,0.00038208233,0.00032858292,0.00032526368,0.00027792604],"domain_scores_gemma":[0.9985235,0.00010255632,0.00038311345,0.0007726977,0.00010620664,0.000111970265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012004385,0.00018369703,0.0004382443,0.00010090529,0.00008779899,0.000020607245,0.00014654735,0.00009933574,0.00001785478],"category_scores_gemma":[0.00021194112,0.000119984485,0.000060134535,0.00007389817,0.000048448746,0.00008698281,0.000060264738,0.000056764322,0.00004516677],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006221405,0.021435201,0.96994156,0.00028734285,0.0001504884,0.00034018117,0.0003260565,8.132855e-7,0.000075399665,0.000015634329,0.00043787304,0.00076806184],"study_design_scores_gemma":[0.16722861,0.0030502966,0.82620955,0.00094687985,0.00027028646,0.000011982633,0.000080827034,0.0000075106987,0.0018583748,0.0000012731595,0.00021756411,0.000116868534],"about_ca_topic_score_codex":0.00021629171,"about_ca_topic_score_gemma":0.00013195431,"teacher_disagreement_score":0.1610072,"about_ca_system_score_codex":0.00011579348,"about_ca_system_score_gemma":0.00019577901,"threshold_uncertainty_score":0.48928252},"labels":[],"label_agreement":null},{"id":"W2765240381","doi":"10.1182/blood.v128.22.4096.4096","title":"Molecular Subgroups of Peripheral T-Cell Lymphoma Evolve By Distinct Genetic Pathways","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Peripheral T-cell lymphoma; SNP array; Lymphoma; SNP; Comparative genomic hybridization; Biology; Copy-number variation; Single-nucleotide polymorphism; Cancer research; Gene; Genetics; Medicine; Oncology; Chromosome; T cell; Genotype; Immunology","score_opus":0.006730647651362611,"score_gpt":0.20116274142313625,"score_spread":0.19443209377177365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765240381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921852,0.0031688653,0.0001168471,0.00013559873,0.00004675094,0.000238643,0.00007533066,0.000037110836,0.003995698],"genre_scores_gemma":[0.9988594,0.00012274584,0.00057890255,0.00008826506,0.0000474535,0.000053995947,0.000019721941,0.000027506152,0.00020201504],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990072,0.00002589002,0.00022756106,0.00026241236,0.00023851458,0.00023836788],"domain_scores_gemma":[0.9993091,0.000041794076,0.000079554105,0.00036250873,0.000056318615,0.00015070273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003587285,0.00016869624,0.0002762048,0.000030127881,0.000026881182,0.0000068987824,0.0000774597,0.00006987144,0.00014851638],"category_scores_gemma":[0.00002207599,0.000103717786,0.00015114472,0.0000704947,0.00006494322,0.000024127998,0.000047584923,0.000014892446,0.000047282872],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009542839,0.009633144,0.48664618,0.00010293819,0.00030205815,0.00065303984,0.00013486015,2.1236728e-7,0.46691746,0.00013571896,0.0011120951,0.034266848],"study_design_scores_gemma":[0.020113824,0.000928581,0.26390922,0.000112624024,0.00046059708,0.00008922689,0.000018949975,0.0000064467254,0.7130135,0.000102724334,0.0010774839,0.00016679052],"about_ca_topic_score_codex":0.00006695431,"about_ca_topic_score_gemma":0.0000030966908,"teacher_disagreement_score":0.24609607,"about_ca_system_score_codex":0.00007464531,"about_ca_system_score_gemma":0.0000852688,"threshold_uncertainty_score":0.42294887},"labels":[],"label_agreement":null},{"id":"W2765414225","doi":"10.1182/blood-2017-09-804641","title":"Single-agent ibrutinib in relapsed or refractory follicular lymphoma: a phase 2 consortium trial","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":156,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; National Human Genome Research Institute","keywords":"Ibrutinib; Rituximab; Medicine; Follicular lymphoma; Oncology; Refractory (planetary science); Internal medicine; Idelalisib; Phases of clinical research; Clinical trial; Lymphoma; Leukemia; Chronic lymphocytic leukemia; Biology","score_opus":0.06832704270368069,"score_gpt":0.3612379891516637,"score_spread":0.29291094644798304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765414225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905085,0.00048281223,0.000005946406,0.00039141532,0.00043001588,0.0014251092,0.000012886656,0.00007874607,0.006664599],"genre_scores_gemma":[0.99498165,0.00007152566,0.0003070872,0.00016121035,0.00062376994,0.00012313783,0.000021632106,0.00005438087,0.0036555917],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9973622,0.00011788507,0.00058739755,0.00055524014,0.000710501,0.0006667862],"domain_scores_gemma":[0.99743116,0.00023526415,0.00025784198,0.0016275862,0.00010023841,0.0003479034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068760244,0.0002509413,0.0006012762,0.00018004248,0.00021360442,0.00010648178,0.00040993566,0.00026000553,0.0003478888],"category_scores_gemma":[0.003167091,0.00019640889,0.00019137602,0.00014218513,0.00028448793,0.000113821094,0.00020418428,0.0002374198,0.00018465216],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5387154,0.13195781,0.0022969372,0.0012796147,0.0020291554,0.08444756,0.0026029304,0.0000037788143,0.10986399,0.00037545915,0.01148109,0.11494625],"study_design_scores_gemma":[0.9397089,0.0032790683,0.00059633295,0.00027180839,0.00027882063,0.0005796002,0.0000855897,0.00040066332,0.026460323,0.000028760023,0.028045582,0.00026454247],"about_ca_topic_score_codex":0.00057508616,"about_ca_topic_score_gemma":0.00012793501,"teacher_disagreement_score":0.4009935,"about_ca_system_score_codex":0.0036139407,"about_ca_system_score_gemma":0.007564513,"threshold_uncertainty_score":0.99806166},"labels":[],"label_agreement":null},{"id":"W2765798560","doi":"10.1182/blood-2017-06-788935","title":"Novel use Of Hydroxyurea in an African Region with Malaria (NOHARM): a trial for children with sickle cell anemia","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":150,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Malaria; Sickle cell anemia; Medicine; Incidence (geometry); Anemia; Clinical trial; Pediatrics; Placebo; Immunology; Internal medicine; Disease; Alternative medicine; Pathology","score_opus":0.021870624369665238,"score_gpt":0.24386086479117922,"score_spread":0.22199024042151397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765798560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969126,0.000039181636,0.00013756394,0.0004434552,0.000029995736,0.0014844693,0.000018281895,0.000023707926,0.00091073493],"genre_scores_gemma":[0.9973717,0.000018889696,0.0021126224,0.000059822152,0.00008487345,0.00004062351,0.00004099942,0.000034524408,0.00023594926],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9991147,0.000014019755,0.00020154037,0.00026650928,0.00016107413,0.0002421877],"domain_scores_gemma":[0.99899656,0.000023570952,0.00022330382,0.00057338795,0.00006592627,0.00011722808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009524319,0.00015385974,0.00032702353,0.00007773517,0.00009320235,0.000033480144,0.00013192701,0.00014574328,0.0000044653802],"category_scores_gemma":[0.000047739086,0.00010218313,0.00005203919,0.000080359394,0.00012935791,0.0001525618,0.000021984466,0.00017481156,8.568759e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16678722,0.020930931,0.7743531,0.0005348344,0.0007137101,0.00029219454,0.0034386495,0.00024159972,0.028477032,0.00044739747,0.0009843367,0.0027990188],"study_design_scores_gemma":[0.60595375,0.017561479,0.35801563,0.00055082084,0.0017057502,0.00032766646,0.0005093851,0.00029911057,0.013900549,0.00002856322,0.00056433637,0.00058294355],"about_ca_topic_score_codex":0.0005331932,"about_ca_topic_score_gemma":0.0002529834,"teacher_disagreement_score":0.43916655,"about_ca_system_score_codex":0.000011997936,"about_ca_system_score_gemma":0.00014775568,"threshold_uncertainty_score":0.4166907},"labels":[],"label_agreement":null},{"id":"W2765805902","doi":"10.1182/blood.v128.22.2432.2432","title":"Genotype/Phenotype Correlations in 103 Children from 87 Families with Hereditary Spherocytosis","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; St. Michael's Hospital; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Hereditary spherocytosis; Ankyrin; Sanger sequencing; Genetics; Spherocytosis; Spectrin; Genetic testing; Band 3; Penetrance; Medicine; Genetic counseling; Genotype; Phenotype; Biology; Pediatrics; Mutation; Immunology; Gene; Splenectomy; Membrane protein","score_opus":0.009304149994788822,"score_gpt":0.20925842559693333,"score_spread":0.19995427560214452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765805902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99534214,0.0004113187,0.00030911787,0.00041722297,0.00017712906,0.00020878685,0.000047157166,0.000084435065,0.0030026936],"genre_scores_gemma":[0.99649733,0.00013599219,0.0015916245,0.0004727496,0.00042389845,0.000018333638,0.00009701664,0.00002416479,0.0007389086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99921465,0.000037192778,0.00017252091,0.00026525074,0.0001234736,0.00018691765],"domain_scores_gemma":[0.9994405,0.000104466155,0.000047690948,0.00027741364,0.000046252182,0.00008369151],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000033248685,0.00013384467,0.00023544057,0.00007024642,0.000045452904,0.00000381847,0.000056651897,0.00011526964,0.0009828269],"category_scores_gemma":[0.00004170352,0.00008239933,0.000043382955,0.00016552948,0.00007600171,0.000065344066,0.000023616016,0.00012770052,0.00045384438],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005932197,0.0006231862,0.9651038,0.000009983144,0.00022856428,0.00006287284,0.0003096638,0.000009171855,0.026114728,0.00010645703,0.0014366827,0.0054016407],"study_design_scores_gemma":[0.0058635846,0.0004919776,0.98968947,0.00011382542,0.00017535705,0.00004611063,0.00010995343,0.0000053208096,0.0023970006,0.00018678456,0.00077701523,0.00014359255],"about_ca_topic_score_codex":0.00042430876,"about_ca_topic_score_gemma":0.000546015,"teacher_disagreement_score":0.02458565,"about_ca_system_score_codex":0.000023982548,"about_ca_system_score_gemma":0.00008111591,"threshold_uncertainty_score":0.9999304},"labels":[],"label_agreement":null},{"id":"W2765840980","doi":"10.1182/blood-2017-09-805424","title":"Finding active LCH cells in the blood","year":2017,"lang":"en","type":"letter","venue":"Blood","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Thymic stromal lymphopoietin; Langerhans cell histiocytosis; CD14; Immunology; Peripheral blood; Histiocytosis; Biology; Medicine; Pathology; Immune system","score_opus":0.023885420496557827,"score_gpt":0.2753265993141431,"score_spread":0.25144117881758526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765840980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.36687082,0.0011415085,0.000003119561,0.32997152,0.00093760126,0.0025893713,0.0003398837,0.00008536471,0.2980608],"genre_scores_gemma":[0.50597703,0.0003836809,0.00042213817,0.40291244,0.006301203,0.00046059844,0.0013715605,0.00023229876,0.08193906],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99875593,0.000051056555,0.00017694347,0.0003380949,0.00034176113,0.00033622314],"domain_scores_gemma":[0.9989502,0.000107162865,0.00015265793,0.0007316382,0.000026356889,0.00003200284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000925357,0.00025600565,0.000406516,0.00011522754,0.00013960492,0.000050654817,0.000287572,0.00042286766,0.0001259533],"category_scores_gemma":[0.00005471885,0.00016698858,0.00014700298,0.00006248112,0.000069263966,0.000034303503,0.000034547924,0.0010500111,0.00021254404],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004429284,0.0032085802,0.004178364,0.00041099245,0.0016759913,0.036946144,0.002245185,1.937194e-7,0.00012267222,0.000027850596,0.9484667,0.0026730371],"study_design_scores_gemma":[0.013710956,0.0004853452,0.0052197427,0.00073763693,0.0044875713,0.0005055762,0.00013409929,0.000001621377,0.0015658321,0.0002171179,0.97251725,0.00041723618],"about_ca_topic_score_codex":0.00017173108,"about_ca_topic_score_gemma":0.00002051948,"teacher_disagreement_score":0.21612175,"about_ca_system_score_codex":0.0000319325,"about_ca_system_score_gemma":0.00014176252,"threshold_uncertainty_score":0.6809597},"labels":[],"label_agreement":null},{"id":"W2766745670","doi":"10.1182/blood-2017-07-793760","title":"Infectious complications of CD19-targeted chimeric antigen receptor–modified T-cell immunotherapy","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":566,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; Juno Therapeutics; National Institutes of Health; National Institute of Allergy and Infectious Diseases; Washington State University","keywords":"Chimeric antigen receptor; Immunotherapy; Medicine; CD19; Antigen; Immunology; Virology; Cancer research; Immune system","score_opus":0.030049117923058317,"score_gpt":0.31668949529388235,"score_spread":0.28664037737082404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766745670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8989978,0.000643845,0.00010497075,0.0003704591,0.000113904476,0.0006050103,0.000017907962,0.00007313865,0.09907297],"genre_scores_gemma":[0.99392563,0.0010095392,0.0005428556,0.000094385025,0.00012769761,0.00004350717,0.000041707597,0.00004458531,0.00417012],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988654,0.000052152758,0.00026993916,0.00025269188,0.0002884934,0.00027130972],"domain_scores_gemma":[0.99809396,0.000056552257,0.00021552539,0.0013358966,0.0001890324,0.00010904599],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020749624,0.00014440369,0.0003347387,0.00013095088,0.00027908027,0.000038680817,0.0003289296,0.00009741773,0.002044236],"category_scores_gemma":[0.000069951275,0.00013482066,0.00015172218,0.00014018573,0.00020856751,0.000064238986,0.00005869888,0.00022119621,0.0001243641],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010499973,0.0011971319,0.06875755,0.00003732231,0.00021083513,0.0000030389654,0.00018903209,0.0000012402381,0.9228965,0.00006472454,0.0004913266,0.0060463236],"study_design_scores_gemma":[0.008861482,0.0005970226,0.34265468,0.00005028644,0.00006727065,0.000032802738,0.000034727997,0.00004283021,0.63451207,0.0001459162,0.012805718,0.00019519725],"about_ca_topic_score_codex":0.0003987299,"about_ca_topic_score_gemma":0.000010941493,"teacher_disagreement_score":0.2883844,"about_ca_system_score_codex":0.00001791631,"about_ca_system_score_gemma":0.0001258281,"threshold_uncertainty_score":0.99886805},"labels":[],"label_agreement":null},{"id":"W2766948867","doi":"10.1182/blood-2017-06-791228","title":"Ixazomib significantly prolongs progression-free survival in high-risk relapsed/refractory myeloma patients","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Ixazomib; Multiple myeloma; Progression-free survival; Refractory (planetary science); Medicine; Lenalidomide; Oncology; Internal medicine; Pomalidomide; Overall survival; Carfilzomib; Biology","score_opus":0.01918654123332542,"score_gpt":0.2931582333603844,"score_spread":0.27397169212705896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766948867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99480367,0.00014225743,0.0000027158328,0.00032494104,0.0002331864,0.001388041,0.00010694958,0.00007394277,0.002924323],"genre_scores_gemma":[0.9977993,0.00011064112,0.0009244447,0.0000214761,0.00018147635,0.00020047453,0.00011225856,0.00004938245,0.0006005532],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973944,0.00018323965,0.0003619747,0.00054253277,0.0008686229,0.000649223],"domain_scores_gemma":[0.9974393,0.00013254902,0.00029472215,0.0015716155,0.0001638085,0.00039798723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004874105,0.000269964,0.00045616046,0.0001689258,0.0003655908,0.00008907424,0.0005166465,0.00018890962,0.000096433054],"category_scores_gemma":[0.0022633988,0.00020410269,0.00010900285,0.00009457204,0.0001816811,0.0002309365,0.0003009141,0.0004933476,0.00016577696],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007631091,0.00462917,0.94431484,0.00006623256,0.00018442226,0.00068535295,0.00011896145,1.1678704e-7,0.00038418148,0.000025368847,0.00024164189,0.048586592],"study_design_scores_gemma":[0.03460676,0.0015526423,0.9596325,0.00019116534,0.00012661368,0.0000062544304,0.000025941965,0.000016748423,0.0030883946,0.00020358732,0.00036414,0.00018524879],"about_ca_topic_score_codex":0.00075299974,"about_ca_topic_score_gemma":0.00035222873,"teacher_disagreement_score":0.04840134,"about_ca_system_score_codex":0.00007762636,"about_ca_system_score_gemma":0.00017973653,"threshold_uncertainty_score":0.8323066},"labels":[],"label_agreement":null},{"id":"W2767050955","doi":"10.1182/blood-2017-07-797423","title":"How I treat heavy menstrual bleeding associated with anticoagulants","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; McMaster University","funders":"","keywords":"Medicine; Tranexamic acid; Levonorgestrel; Adverse effect; Rivaroxaban; Thrombosis; Progestin; Anticoagulant; Gynecology; Obstetrics; Family planning; Intensive care medicine; Surgery; Population; Warfarin; Internal medicine; Estrogen; Atrial fibrillation","score_opus":0.030279591080540066,"score_gpt":0.269928044045747,"score_spread":0.23964845296520693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767050955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908527,0.00004753684,0.0000034066077,0.0011029892,0.000055276872,0.00015891554,0.000015692149,0.00006108787,0.0077024074],"genre_scores_gemma":[0.99462175,0.000016362435,0.00031313952,0.000036718255,0.0001159981,0.000007823924,0.00002468356,0.0000223094,0.004841236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999298,0.000007903155,0.00007282109,0.0001952192,0.00018664109,0.00023946716],"domain_scores_gemma":[0.99936944,0.000012809121,0.00009869619,0.00035912255,0.00004552783,0.00011440643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003983978,0.00013930243,0.000275275,0.00003357929,0.00023721355,0.00013513346,0.00007716719,0.000055312295,0.00001614733],"category_scores_gemma":[0.00006255611,0.00009316055,0.000045701418,0.00002819234,0.00005569494,0.00011704798,0.000040206312,0.00006673003,0.000010185038],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008245014,0.0009331587,0.9912007,0.000019247946,0.00076949515,0.0012263729,0.00006765493,3.1615965e-8,0.003601178,0.00005212179,0.0001275663,0.0019200487],"study_design_scores_gemma":[0.014917346,0.0010944899,0.94976294,0.00025952968,0.0011136964,0.00033098552,0.000038853974,0.000021768024,0.03198975,0.000017285189,0.00029088533,0.0001624634],"about_ca_topic_score_codex":0.00007419605,"about_ca_topic_score_gemma":0.000034671655,"teacher_disagreement_score":0.041437726,"about_ca_system_score_codex":0.000020325544,"about_ca_system_score_gemma":0.000028130877,"threshold_uncertainty_score":0.37989768},"labels":[],"label_agreement":null},{"id":"W2767413682","doi":"10.1182/blood.v128.22.2963.2963","title":"Results of a Phase 2 Trial Evaluating Efficacy and Safety of Entospletinib (GS-9973) in Patients with Mantle Cell Lymphoma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Royal Victoria Regional Health Centre","funders":"","keywords":"Medicine; Mantle cell lymphoma; Bendamustine; Internal medicine; Ibrutinib; Idelalisib; Tolerability; Gastroenterology; Adverse effect; Oncology; Surgery; Rituximab; Chronic lymphocytic leukemia; Lymphoma; Leukemia","score_opus":0.021673952974636417,"score_gpt":0.31747118032332516,"score_spread":0.29579722734868874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767413682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99737895,0.00007684512,0.0000061165633,0.00004962728,0.000028688322,0.0012106887,0.000075808544,0.000009789189,0.0011634618],"genre_scores_gemma":[0.99919045,0.000029480976,0.00044318364,0.000008052881,0.00005387318,0.000015279822,0.000018818122,0.000020047137,0.00022079599],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980521,0.00010869202,0.000590014,0.00029578406,0.00067972305,0.0002736539],"domain_scores_gemma":[0.99855596,0.00054384925,0.00022811523,0.00039217997,0.00016837419,0.000111545676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071705296,0.00012751183,0.00040052473,0.0001247406,0.000017955485,0.0000035739586,0.00009496835,0.000076431475,0.000039019764],"category_scores_gemma":[0.0009121443,0.00007797655,0.000040126164,0.00020075138,0.00014348642,0.000041807965,0.00008020719,0.00005216284,0.0000052745236],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8510562,0.028157687,0.010981244,0.0006708971,0.00023895205,0.00008346465,0.0014928351,0.00000164772,0.021307347,0.000019779076,0.00014678344,0.085843146],"study_design_scores_gemma":[0.9338932,0.0083754985,0.015833054,0.0006570266,0.00013787881,0.000007313596,0.000029914978,0.000074892596,0.040788505,0.000004151708,0.000107628286,0.000090904425],"about_ca_topic_score_codex":0.00017539125,"about_ca_topic_score_gemma":0.000010372304,"teacher_disagreement_score":0.08575224,"about_ca_system_score_codex":0.00057196885,"about_ca_system_score_gemma":0.0018565301,"threshold_uncertainty_score":0.32934046},"labels":[],"label_agreement":null},{"id":"W2767574526","doi":"10.1182/blood-2017-05-787598","title":"CRISPR-mediated TCR replacement generates superior anticancer transgenic T cells","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":225,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Cancer Research UK; Wellcome Trust","keywords":"T-cell receptor; Transgene; Biology; Cancer research; CRISPR; Immunology; Molecular biology; Cell biology; T cell; Genetics; Gene; Immune system","score_opus":0.034131408438636324,"score_gpt":0.3280309917116137,"score_spread":0.2938995832729774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767574526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880668,0.0006269022,0.000020227286,0.0014264601,0.00024977393,0.00062306743,0.000028951627,0.00006892493,0.008888913],"genre_scores_gemma":[0.97999686,0.0012025544,0.0003702002,0.0003189794,0.00050077593,0.00006308226,0.000025898724,0.000054007072,0.01746766],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998353,0.000045059314,0.00025091367,0.00039719982,0.0004805426,0.00047330986],"domain_scores_gemma":[0.9983956,0.000052634325,0.00006119891,0.0011185528,0.00012296496,0.00024901383],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003226734,0.00018192058,0.00033880267,0.0000776208,0.00025255748,0.00011175925,0.0002768127,0.00010826214,0.009827715],"category_scores_gemma":[0.00008622041,0.0001542194,0.00014348247,0.00007310042,0.00017204351,0.00007762168,0.000058147853,0.00024502093,0.00031727628],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003695012,0.0004898018,0.028478742,0.00007124432,0.00025511725,0.00008610694,0.00024782558,5.1086386e-7,0.9672153,0.000009023142,0.001130881,0.0016459415],"study_design_scores_gemma":[0.007912339,0.0005595975,0.019925667,0.000052628824,0.00020741037,0.000027544247,0.000046322628,0.00008739036,0.9398169,0.000011140204,0.031167101,0.0001859721],"about_ca_topic_score_codex":0.00016235327,"about_ca_topic_score_gemma":0.00006991782,"teacher_disagreement_score":0.03003622,"about_ca_system_score_codex":0.00003396643,"about_ca_system_score_gemma":0.00019303503,"threshold_uncertainty_score":0.9910774},"labels":[],"label_agreement":null},{"id":"W2767633842","doi":"10.1182/blood-2017-08-799080","title":"FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab and chemotherapy","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of British Columbia; BC Cancer Agency","funders":"Terry Fox Research Institute","keywords":"Rituximab; Follicular lymphoma; Oncology; Chemotherapy; Lymphoma; Internal medicine; Medicine; Chemotherapy regimen; Biomarker; Adverse effect; Gene expression; Immunology; Cancer research; Gene; Biology; Genetics","score_opus":0.013824745892446809,"score_gpt":0.25733546440602173,"score_spread":0.24351071851357492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767633842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963222,0.00092556817,0.0000020623477,0.0009104484,0.000010433631,0.0005986475,0.000006937645,0.00003317658,0.0011905308],"genre_scores_gemma":[0.99858314,0.00023750243,0.00058078056,0.00024779106,0.000020244639,0.00015181222,0.000011134504,0.000024081752,0.00014349278],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991611,0.000015473606,0.00013266926,0.00031975604,0.00016162658,0.00020936082],"domain_scores_gemma":[0.99928,0.000027244112,0.00008280888,0.00046598146,0.000031968797,0.0001120465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000051398816,0.00017919824,0.00030438803,0.000065494765,0.00012626252,0.000065256565,0.000064964304,0.00008259708,0.000034456487],"category_scores_gemma":[0.00002681909,0.000113221104,0.000047417976,0.00005388414,0.000073378345,0.00008304962,0.00003057905,0.00002377005,0.0000116678075],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003037876,0.0044028405,0.9721827,0.000039868894,0.00018334393,0.00077992416,0.00016432474,9.704484e-9,0.0030860922,0.0000065323056,0.0001369048,0.018713685],"study_design_scores_gemma":[0.05045948,0.00044949257,0.8838489,0.0004889105,0.00023819524,0.00018815568,0.000019260728,0.000025621785,0.06348703,0.000016341797,0.0006549468,0.00012362935],"about_ca_topic_score_codex":0.00026082635,"about_ca_topic_score_gemma":0.000022330929,"teacher_disagreement_score":0.088333756,"about_ca_system_score_codex":0.00003339223,"about_ca_system_score_gemma":0.000047529527,"threshold_uncertainty_score":0.4617023},"labels":[],"label_agreement":null},{"id":"W2768086932","doi":"10.1182/blood-2017-06-793729","title":"Immunoglobulin G Fc glycans are not essential for antibody-mediated immune suppression to murine erythrocytes","year":2017,"lang":"en","type":"letter","venue":"Blood","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"Canadian Institutes of Health Research; Health Canada; Institut National de la Santé et de la Recherche Médicale","keywords":"Antibody; Immunology; Immunoglobulin G; Immunoglobulin Fc Fragments; Immune system; Glycan; Isoantibodies; Antibody-dependent cell-mediated cytotoxicity; Immunoglobulin M; Biology; Chemistry; Molecular biology; Glycoprotein; Monoclonal antibody","score_opus":0.014579015531096478,"score_gpt":0.3028873878978195,"score_spread":0.288308372366723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768086932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6007707,0.0049661514,0.001920534,0.3731512,0.0026255539,0.0065452335,0.008347203,0.00018056849,0.0014928221],"genre_scores_gemma":[0.6021992,0.0021578323,0.0055481456,0.15558639,0.034238268,0.0022036047,0.1260251,0.0009095874,0.07113188],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973734,0.00009309906,0.0004442744,0.00087776314,0.00046882356,0.000742608],"domain_scores_gemma":[0.99768746,0.00004523049,0.0003433959,0.0013924699,0.00039428694,0.0001371662],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002176081,0.00047011103,0.00052276003,0.00016057261,0.00036960075,0.00018675596,0.00096696,0.0011692287,0.00016731185],"category_scores_gemma":[0.0006309433,0.0004421567,0.0003480794,0.0000794474,0.00011781204,0.0000076232227,0.00052555825,0.00065898267,0.00016574048],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039740017,0.00015545101,0.00008864843,0.00020621525,0.00019772776,0.000113326714,0.000010611507,0.000002130498,0.65102106,7.893592e-7,0.34761012,0.00019654215],"study_design_scores_gemma":[0.0020338076,0.00037485518,0.0005063343,0.00011771337,0.000056666966,0.000026599277,0.000005049239,0.000008509602,0.43911323,0.0000035122964,0.55740416,0.00034954713],"about_ca_topic_score_codex":0.00010473911,"about_ca_topic_score_gemma":0.00003916175,"teacher_disagreement_score":0.21756484,"about_ca_system_score_codex":0.000018563853,"about_ca_system_score_gemma":0.00021312667,"threshold_uncertainty_score":0.999803},"labels":[],"label_agreement":null},{"id":"W2768676673","doi":"10.1182/blood.v128.22.4267.4267","title":"The Impact of Myeloproliferative Neoplasms (MPNs) on Patients' Quality of Life and Productivity: Results from the International MPN Landmark Survey","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Quality of life (healthcare); Polycythemia vera; Essential thrombocythemia; Myelofibrosis; Bristol-Myers; Absenteeism; Demography; Productivity; Myeloproliferative neoplasm; Internal medicine; Bone marrow; Psychology","score_opus":0.034217428626846694,"score_gpt":0.304659878616368,"score_spread":0.2704424499895213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768676673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935329,0.00014976141,0.0000032249798,0.0029610998,0.00011107672,0.0005991048,0.0021311296,0.000009538366,0.000502152],"genre_scores_gemma":[0.9991752,0.00029928543,0.00003867094,0.00007162053,0.00014163941,0.00004160732,0.00010868868,0.000012359628,0.00011093938],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981499,0.00039741784,0.00050603726,0.00033433447,0.00045142087,0.00016093919],"domain_scores_gemma":[0.99417007,0.0044595343,0.00038284226,0.00045347732,0.0004392944,0.000094782525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097526395,0.00018565777,0.00039266906,0.0000319968,0.00010039982,0.000020731912,0.0001337457,0.000057133377,0.00002663139],"category_scores_gemma":[0.0058644055,0.00006944876,0.00011214958,0.000096081276,0.00018750643,0.00006076705,0.00007110633,0.000101389334,0.000005773517],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040024016,0.0016505175,0.98739016,0.0000053054105,0.0010206472,0.0000010302331,0.0005701098,0.0000010447069,0.0006165936,0.00023247035,0.0012183114,0.0032914246],"study_design_scores_gemma":[0.009509053,0.0010792062,0.97421473,0.00009786809,0.000056448105,0.0000010632211,0.000036488513,0.0000039229267,0.014667196,0.00015747349,0.00009784222,0.00007869675],"about_ca_topic_score_codex":0.0019104391,"about_ca_topic_score_gemma":0.001002843,"teacher_disagreement_score":0.014050603,"about_ca_system_score_codex":0.000042472406,"about_ca_system_score_gemma":0.00019091624,"threshold_uncertainty_score":0.7020665},"labels":[],"label_agreement":null},{"id":"W2768756833","doi":"10.1182/blood.v128.22.1438.1438","title":"Subgroup Analysis of Patients with Cancer in Xalia - a Non-Interventional Study of Rivaroxaban in Routine Treatment of Deep Vein Thrombosis","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Rivaroxaban; Medicine; Fondaparinux; Thrombosis; Pulmonary embolism; Deep vein; Surgery; Vitamin K antagonist; Cohort; Heparin; Internal medicine; Warfarin; Anesthesia; Venous thromboembolism; Atrial fibrillation","score_opus":0.013423919670199895,"score_gpt":0.2835568963275443,"score_spread":0.2701329766573444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768756833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99887186,0.00009560539,0.000019608455,0.00004919424,0.00002335352,0.0007612997,0.00007367439,0.0000037707537,0.000101641635],"genre_scores_gemma":[0.9996463,0.00008915287,0.00006992997,0.000004851275,0.000009192201,0.00012466921,0.000022071097,0.000011518608,0.0000222988],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986934,0.000046306563,0.00055791455,0.0002314445,0.00031553608,0.00015539119],"domain_scores_gemma":[0.9992703,0.000036713034,0.00026904538,0.00028474975,0.000100126024,0.00003903339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010897618,0.00013412774,0.00090873096,0.0005135663,0.000007850095,0.0000016105738,0.00007307097,0.000032543678,0.00032708712],"category_scores_gemma":[0.000010826665,0.00008223553,0.00014619343,0.0006902202,0.00003997592,0.000041102867,0.00003355673,0.000022605831,5.7660293e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015120456,0.07000291,0.92241323,0.000076916025,0.003858369,0.000005071009,0.0018122655,0.00005310015,0.0004347397,0.00003952223,0.0000043271307,0.0011483622],"study_design_scores_gemma":[0.016903715,0.006091205,0.96999574,0.0003057576,0.0041560316,4.4982247e-8,0.00041790094,0.00002928965,0.0020159485,0.0000064569135,0.0000022853321,0.000075623546],"about_ca_topic_score_codex":0.0062432173,"about_ca_topic_score_gemma":0.021203022,"teacher_disagreement_score":0.063911706,"about_ca_system_score_codex":0.00009217337,"about_ca_system_score_gemma":0.000028143093,"threshold_uncertainty_score":0.9966575},"labels":[],"label_agreement":null},{"id":"W2768914249","doi":"10.1182/blood-2017-07-798728","title":"Inhibition of heme oxygenase ameliorates anemia and reduces iron overload in a β-thalassemia mouse model","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Heme Oxygenase-1 and Carbon Monoxide","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Thalassemia; Heme oxygenase; Heme; Beta thalassemia; Medicine; Anemia; Pathophysiology; Chemistry; Pharmacology; Internal medicine; Biochemistry; Enzyme","score_opus":0.010230709753543326,"score_gpt":0.24388645770081807,"score_spread":0.23365574794727476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768914249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981909,0.0005418798,0.000012156092,0.0000526108,0.000016293132,0.0001143567,0.000041282277,0.0000067399715,0.0010237736],"genre_scores_gemma":[0.99856925,0.00039918575,0.00044880135,0.000043043885,0.000059957376,0.000017039647,0.000030956537,0.000016993767,0.0004147907],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99921376,0.000022935077,0.00019710351,0.00029169655,0.00009107444,0.00018341676],"domain_scores_gemma":[0.999342,0.0000039506867,0.00013663383,0.00040461923,0.000039186456,0.00007355834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001254512,0.00013503143,0.00015416286,0.000042046562,0.00006397614,0.000034968205,0.00012170463,0.00015611963,0.0000039349247],"category_scores_gemma":[0.000075760785,0.00013472555,0.000044079345,0.000025242687,0.00009558908,0.0000110158035,0.00011280616,0.00007192722,0.0000016950572],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041871477,0.00015412465,0.002997423,0.00003594504,0.000010171362,0.0000074932846,0.000058227735,0.000041152332,0.9962527,0.000018604123,0.00014181726,0.00024044869],"study_design_scores_gemma":[0.001270846,0.00011888991,0.0029400496,0.0000295137,0.000018911182,0.000005560616,0.00006717655,0.00020384445,0.9950811,0.00006944836,0.000040796564,0.00015385199],"about_ca_topic_score_codex":0.00007091457,"about_ca_topic_score_gemma":0.00007106422,"teacher_disagreement_score":0.0012289746,"about_ca_system_score_codex":0.000005483148,"about_ca_system_score_gemma":0.000057271485,"threshold_uncertainty_score":0.54939485},"labels":[],"label_agreement":null},{"id":"W2769574490","doi":"10.1182/blood.v128.22.3402.3402","title":"Red Cell Alloimmunization Rates in Allogeneic Hematopoietic Stem Cell Transplant Recipients","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Calgary Laboratory Services; University of Calgary; University of Saskatchewan; Saskatchewan Health Authority","funders":"","keywords":"Medicine; ABO blood group system; Hematopoietic stem cell transplantation; Cord blood; Human leukocyte antigen; Population; Transplantation; Bone marrow; Internal medicine; Immunology; Antigen","score_opus":0.01063478512365277,"score_gpt":0.21403273178084162,"score_spread":0.20339794665718886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769574490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99592054,0.0006994288,0.00023845091,0.00047984277,0.000105005114,0.00036483278,0.000010062234,0.000052875464,0.0021289566],"genre_scores_gemma":[0.99748474,0.0009703523,0.00020047954,0.00008541124,0.00003744887,0.000020308591,0.000026792408,0.000032461146,0.0011420271],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989057,0.00005351832,0.00030949875,0.00027577401,0.00019559795,0.0002598818],"domain_scores_gemma":[0.99947304,0.000044515262,0.000052596195,0.00029358047,0.000039977305,0.000096293064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014961083,0.0001565185,0.00025384524,0.000110010624,0.000040176317,0.000008166318,0.00009592509,0.00012992778,0.00010874012],"category_scores_gemma":[0.000002341205,0.00010526471,0.0000713709,0.00019643283,0.000025398764,0.00006340163,0.000013461132,0.00009831108,0.000063478445],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014609736,0.0018488874,0.26474252,0.00014765952,0.000028609473,0.00010978203,0.000810932,0.0000013929644,0.7308624,0.0000341206,0.000042251046,0.0012253977],"study_design_scores_gemma":[0.014857177,0.00040550806,0.10998735,0.0006585559,0.00028454742,0.000066213994,0.00007524294,0.000008566916,0.8728731,0.00006622269,0.0004939953,0.00022349169],"about_ca_topic_score_codex":0.00002440005,"about_ca_topic_score_gemma":0.000025642046,"teacher_disagreement_score":0.15475516,"about_ca_system_score_codex":0.000018303075,"about_ca_system_score_gemma":0.000036555604,"threshold_uncertainty_score":0.42925704},"labels":[],"label_agreement":null},{"id":"W2769593282","doi":"10.1182/blood-2017-07-795047","title":"Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":271,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; University of Calgary","funders":"National Cancer Institute; Celgene","keywords":"Multiple myeloma; Medicine; Internal medicine; Oncology; Progression-free survival; Overall survival; Surgery","score_opus":0.12058246848122686,"score_gpt":0.40384146286934536,"score_spread":0.2832589943881185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769593282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971474,0.00006212058,0.00003209502,0.0004121742,0.000076380195,0.0015218293,0.00039365163,0.000005341358,0.00034901677],"genre_scores_gemma":[0.99860275,0.00004207355,0.0003805449,0.0000059694303,0.0000556107,0.00025767196,0.0001254689,0.0000091495685,0.00052075094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987934,0.000057168494,0.00035796428,0.00020391117,0.00034667263,0.00024088613],"domain_scores_gemma":[0.99828166,0.0005609989,0.00021484368,0.00078409736,0.00008204801,0.00007634595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003057735,0.00014450446,0.00076920737,0.00020082774,0.0001240558,0.000016568982,0.0002164769,0.00005345998,0.000046230783],"category_scores_gemma":[0.0008290727,0.00008105117,0.00047688885,0.00009287029,0.00009272406,0.000040445513,0.000030162268,0.0000471039,0.0000023565328],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036398698,0.01586112,0.9298707,0.00006329419,0.005853459,0.00006671471,0.0007821827,0.000003998908,0.0004350338,0.000028774055,0.000024236038,0.010611777],"study_design_scores_gemma":[0.3376709,0.004181255,0.6492098,0.000019461877,0.0029178767,0.0000013324934,0.00012132624,0.00073883595,0.004847403,0.000009444722,0.00022198945,0.000060381983],"about_ca_topic_score_codex":0.0016175687,"about_ca_topic_score_gemma":0.0048501506,"teacher_disagreement_score":0.3012722,"about_ca_system_score_codex":0.00003430481,"about_ca_system_score_gemma":0.0000860743,"threshold_uncertainty_score":0.33051708},"labels":[],"label_agreement":null},{"id":"W2770273110","doi":"10.1182/blood-2017-07-746453","title":"Age-related clonal hematopoiesis","year":2017,"lang":"en","type":"review","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":283,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Haematopoiesis; Biology; Progenitor cell; Stem cell; Somatic cell; Immunology; Stem cell theory of aging; Cancer; Somatic evolution in cancer; Genetics; Stem cell factor; Gene","score_opus":0.10768796225740501,"score_gpt":0.4030714379170683,"score_spread":0.2953834756596633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770273110","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000013818537,0.95284194,9.417414e-7,0.00012122013,0.00016934288,0.0010827548,0.000046602265,0.00012520596,0.045598157],"genre_scores_gemma":[0.0000042675592,0.9668075,0.0003978594,0.000037495483,0.00056980376,0.00013886983,0.00039735466,0.00013544921,0.03151139],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974947,0.00012604822,0.00066738005,0.00057625386,0.00058085285,0.00055474404],"domain_scores_gemma":[0.99740803,0.00018745539,0.0003730197,0.0016010462,0.000098603174,0.0003318617],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00045586465,0.0004802772,0.0027202712,0.0003177313,0.00017712574,0.00007717072,0.0006477625,0.0008098106,0.000711669],"category_scores_gemma":[0.000580529,0.00035345295,0.0009568549,0.00021674378,0.00025094714,0.000052105068,0.00031648806,0.0013998095,0.0027639659],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009724675,0.00044197464,0.000010457933,0.037286457,0.0025396547,0.007101566,0.000033555367,4.4432733e-9,0.0000019981715,0.00038730208,0.016049447,0.93613786],"study_design_scores_gemma":[0.0016274531,0.00008630608,0.000011209064,0.01622563,0.00457148,0.0031492729,0.0000027216565,4.2884608e-7,0.0000055993214,0.000048156315,0.97397834,0.00029340512],"about_ca_topic_score_codex":0.000029160517,"about_ca_topic_score_gemma":0.0000023646035,"teacher_disagreement_score":0.9579289,"about_ca_system_score_codex":0.0002054275,"about_ca_system_score_gemma":0.0017680846,"threshold_uncertainty_score":0.99989176},"labels":[],"label_agreement":null},{"id":"W2770415197","doi":"10.1182/blood.v128.22.5919.5919","title":"Development, Implementation, and Testing of a Web Based Decision Aid for Facilitating Shared Decision Making for Disease Modifying Therapies for Sickle Cell Disease","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Disease; Psychological intervention; Population; Health care; Disadvantage; Patient participation; Intensive care medicine; Nursing; Internal medicine; Environmental health","score_opus":0.03066027092585552,"score_gpt":0.3088686467470523,"score_spread":0.27820837582119673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770415197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78955835,0.00093128375,0.20712583,0.00014371956,0.000040288945,0.0017226452,0.00043255498,0.000036902224,0.000008417099],"genre_scores_gemma":[0.7006073,0.00001352665,0.2988484,0.00007667604,0.000025168716,0.00033796855,0.000049332804,0.00002620379,0.000015416928],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9987346,0.0000128165475,0.00045804388,0.00032691276,0.00017771685,0.0002898919],"domain_scores_gemma":[0.99715805,0.0020836722,0.00017344531,0.00015465432,0.00025347347,0.00017673348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003277167,0.0001650099,0.00022931676,0.00011526912,0.0002591174,0.000023414323,0.00006281154,0.000048467467,0.000016610835],"category_scores_gemma":[0.001315146,0.00011372999,0.00010913897,0.00010077951,0.00003370907,0.000100602265,0.000030624193,0.000028733297,5.682799e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049909493,0.0006803781,0.12307035,0.0028155507,0.00014430062,0.000005146858,0.0016058461,0.00005159253,0.06949468,0.000060878803,0.00037938278,0.79670095],"study_design_scores_gemma":[0.4857849,0.0048438194,0.12342951,0.030743238,0.006082162,0.000014359187,0.024143102,0.13004683,0.11305853,0.02689137,0.051260736,0.0037014598],"about_ca_topic_score_codex":0.0000014841826,"about_ca_topic_score_gemma":0.000004495012,"teacher_disagreement_score":0.7929995,"about_ca_system_score_codex":0.00002649699,"about_ca_system_score_gemma":0.00032308002,"threshold_uncertainty_score":0.46377745},"labels":[],"label_agreement":null},{"id":"W2770772275","doi":"10.1182/blood.v128.22.1623.1623","title":"Genome-Wide Genotype-Based Risk Model for Survival in Core Binding Factor Acute Myeloid Leukemia Patients","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Single-nucleotide polymorphism; SNP; Core binding factor; Internal medicine; Myeloid leukemia; Oncology; Genotype; Medicine; Biology; Genetics; Gene; Transcription factor","score_opus":0.03360631329366281,"score_gpt":0.28385398652205684,"score_spread":0.25024767322839403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770772275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892357,0.00004561658,0.007613453,0.0002116909,0.00010812939,0.0014270013,0.0009985475,0.00009647661,0.00026339607],"genre_scores_gemma":[0.99318063,0.00011362166,0.004216582,0.0001653262,0.00014658367,0.00016153682,0.00021014536,0.00010908205,0.0016964995],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974669,0.00006311428,0.00046078707,0.0005919144,0.0005648674,0.0008523838],"domain_scores_gemma":[0.99813825,0.0005419631,0.00015821749,0.0005784097,0.00026173962,0.00032143612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003738454,0.00031156067,0.00051767763,0.00038363063,0.00011884427,0.000022011587,0.00031269708,0.00024981343,0.00009233648],"category_scores_gemma":[0.00088418304,0.00022052422,0.00018465344,0.00030428972,0.00010164967,0.00012663398,0.00011462692,0.00035229907,0.00016509807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012233312,0.0004976104,0.90926385,0.0001102395,0.0003133803,0.00004448706,0.00029564087,0.00009646254,0.08457963,0.000020241172,0.00028909062,0.0032660256],"study_design_scores_gemma":[0.073174894,0.0013470702,0.8605243,0.0002815222,0.0006559372,0.0000069192183,0.00004998678,0.022467641,0.038878184,0.0002830574,0.0014444645,0.0008860053],"about_ca_topic_score_codex":0.0000697407,"about_ca_topic_score_gemma":0.000074645024,"teacher_disagreement_score":0.07195157,"about_ca_system_score_codex":0.0011634587,"about_ca_system_score_gemma":0.0011397663,"threshold_uncertainty_score":0.89927167},"labels":[],"label_agreement":null},{"id":"W2771219441","doi":"10.1182/blood.v130.suppl_1.1579.1579","title":"Monomorphic Post Transplant Lymphoproliferative Disorder (Diffuse Large B Cell Lymphoma subtype) Successfully Treated without Chemotherapy after Solid Organ Transplant in Children","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Stollery Children's Hospital; Alberta Health Services","funders":"","keywords":"Medicine; Rituximab; Post-transplant lymphoproliferative disorder; Diffuse large B-cell lymphoma; Internal medicine; Lymphoma; Transplantation; Chemotherapy; Organ transplantation; Cyclophosphamide; Lymphoproliferative disorders; Prednisone; Gastroenterology; Oncology; Pathology","score_opus":0.004424094825774727,"score_gpt":0.22483422525854269,"score_spread":0.22041013043276797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2771219441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955273,0.0010488913,0.00002945928,0.0008776322,0.00005904932,0.00098279,0.0005344049,0.00009969208,0.0008407318],"genre_scores_gemma":[0.99637073,0.0013186752,0.000026011427,0.0011391204,0.00009920379,0.00012558485,0.00033029373,0.00010687068,0.0004834911],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978307,0.000066361856,0.00043376803,0.00060884474,0.00031673125,0.0007436346],"domain_scores_gemma":[0.9987736,0.000015397736,0.0002219908,0.00065383705,0.00009519482,0.00023998632],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001538951,0.0004771036,0.0007373989,0.00016458756,0.00029816726,0.000112485264,0.0003106154,0.00031732628,0.00022035108],"category_scores_gemma":[0.000013832265,0.0004036877,0.00020238693,0.00014593072,0.00012665869,0.00022230014,0.000020106769,0.0002031885,0.000044233504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024835847,0.0080942605,0.9827529,0.00005479226,0.00034464343,0.00021434764,0.0026138113,0.0000011049182,0.0029327287,0.000006036939,0.000022839626,0.00047895004],"study_design_scores_gemma":[0.11412408,0.0005278514,0.86710304,0.00018097683,0.0005085026,0.00009894395,0.00012748878,0.000084981475,0.016646594,0.000018501149,0.00008343445,0.00049560086],"about_ca_topic_score_codex":0.0024271973,"about_ca_topic_score_gemma":0.002873944,"teacher_disagreement_score":0.11564986,"about_ca_system_score_codex":0.000106417596,"about_ca_system_score_gemma":0.0003091145,"threshold_uncertainty_score":0.9998415},"labels":[],"label_agreement":null},{"id":"W2771284269","doi":"10.1182/blood-2017-10-812974","title":"Hydroxyurea for SCA in Africa: no malaria harm","year":2017,"lang":"en","type":"letter","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Malaria; Sickle cell anemia; Medicine; Incidence (geometry); Anemia; Placebo; Blood transfusion; Pediatrics; Internal medicine; Immunology; Disease; Pathology; Alternative medicine","score_opus":0.019096790680930505,"score_gpt":0.24873255958747176,"score_spread":0.22963576890654125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2771284269","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033746024,0.003347547,0.00001179104,0.82904357,0.0015345134,0.0022060645,0.00017102108,0.00013077747,0.1601801],"genre_scores_gemma":[0.030109238,0.0015296565,0.0027352758,0.6540737,0.019250752,0.0009396881,0.002728062,0.0006257907,0.28800786],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983457,0.000023760695,0.0003250364,0.0004508498,0.0002539345,0.00060072733],"domain_scores_gemma":[0.9988699,0.00006316318,0.00017239255,0.00071409927,0.00009710093,0.000083330815],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00017625156,0.00031951367,0.00063642894,0.00018530192,0.000104950595,0.000044492128,0.00026203136,0.001590844,0.00014943503],"category_scores_gemma":[0.00026355434,0.00026100097,0.00027000517,0.00006790202,0.00008479295,0.000041162522,0.000057559355,0.0015957454,0.0002971731],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004731621,0.0002661255,0.00033312407,0.000663782,0.00023235497,0.0015891895,0.0001145818,2.1570031e-7,0.00013334396,0.000014959372,0.99630165,0.00030334463],"study_design_scores_gemma":[0.006327198,0.00026011316,0.0002989519,0.0006350454,0.0006917805,0.00010939369,0.000012582959,0.000025614454,0.00009183657,0.00013257943,0.9911117,0.00030318412],"about_ca_topic_score_codex":0.0000601757,"about_ca_topic_score_gemma":0.0000037071247,"teacher_disagreement_score":0.17496988,"about_ca_system_score_codex":0.000034766756,"about_ca_system_score_gemma":0.000188844,"threshold_uncertainty_score":0.9999842},"labels":[],"label_agreement":null},{"id":"W2771490898","doi":"10.1182/blood.v130.suppl_1.2313.2313","title":"Use of Anticoagulation in Patients with Immune Thrombocytopenia","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Immune thrombocytopenia; Internal medicine; Hematology; Thrombosis; Prospective cohort study; Platelet; Pediatrics","score_opus":0.024604524695256803,"score_gpt":0.2597986857373836,"score_spread":0.23519416104212676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2771490898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99926704,0.000023426663,0.0000014922206,0.00003745597,0.000013936,0.00021103771,0.0000047261165,0.0000046259847,0.00043627177],"genre_scores_gemma":[0.99950725,0.000007966079,0.0003806604,0.000008497044,0.0000032180187,0.0000021061094,0.000026708041,0.000006370584,0.000057232413],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99965733,0.0000045101474,0.00009435997,0.000077652396,0.000093260685,0.000072881165],"domain_scores_gemma":[0.9995968,0.000006376947,0.00008326198,0.0002620942,0.000033115884,0.000018367557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000017470375,0.000051315816,0.00020080982,0.000029788745,0.000035309953,0.000011964509,0.00003344122,0.000025797532,0.000012448424],"category_scores_gemma":[0.000026289965,0.000036349084,0.000016833766,0.000021707896,0.000028366207,0.00013151564,0.000015728801,0.00002896294,0.000004734762],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012338502,0.0013133397,0.9970138,0.000011952897,0.00006299481,0.000034997924,0.00003624716,7.1635486e-7,0.0004972449,0.000015114907,0.0000028938896,0.00088730955],"study_design_scores_gemma":[0.009180149,0.00029030713,0.9861871,0.00008095281,0.000094064475,0.0000023649422,0.0000025777204,0.000007894466,0.0040881843,0.000016578138,0.000013747247,0.000036075176],"about_ca_topic_score_codex":0.00022575162,"about_ca_topic_score_gemma":0.000035708727,"teacher_disagreement_score":0.0108266985,"about_ca_system_score_codex":0.000004930441,"about_ca_system_score_gemma":0.000014030946,"threshold_uncertainty_score":0.14822726},"labels":[],"label_agreement":null},{"id":"W2771573185","doi":"10.1182/blood.v128.22.3633.3633","title":"Factors Impacting Quality of Life in Thalassemia Patients; Results from the Intercontinenthal Collaborative Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa; University of Toronto; Toronto General Hospital; University Health Network; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Thalassemia; Quality of life (healthcare); Disease; Blood transfusion; Anemia; Pediatrics; Internal medicine; Nursing","score_opus":0.026777521558322033,"score_gpt":0.2925286185071163,"score_spread":0.2657510969487943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2771573185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99743927,0.00013228745,0.0000018359782,0.0006597484,0.00011410026,0.0005650193,0.00020090392,0.000018405588,0.00086841814],"genre_scores_gemma":[0.99980366,0.000028195209,0.000009569363,0.00004540297,0.000034433688,0.0000057002076,0.00001903674,0.000011027762,0.00004298513],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985441,0.00023000121,0.00059291074,0.00021433918,0.00024337608,0.00017527383],"domain_scores_gemma":[0.9984432,0.00078191014,0.00026327118,0.00028811282,0.0001430924,0.00008041215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038920937,0.00013110385,0.00034800632,0.000041085015,0.000036288828,0.000007546606,0.00009928042,0.000088587185,0.00002551255],"category_scores_gemma":[0.003538938,0.000057340272,0.000064402,0.00024134893,0.000060069473,0.00006258789,0.000056546018,0.00015880006,0.0000040196387],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000446245,0.0018231407,0.98455787,0.0000057333823,0.00017842102,0.0000026849495,0.0105700465,2.7071965e-7,0.001765456,0.0000032568391,0.00018927453,0.00045760744],"study_design_scores_gemma":[0.017039062,0.00044419683,0.95301205,0.00018003187,0.00007547968,9.080243e-8,0.027065389,7.2235594e-7,0.0020509916,0.00000884915,0.00004675008,0.0000763958],"about_ca_topic_score_codex":0.0019183854,"about_ca_topic_score_gemma":0.0005606228,"teacher_disagreement_score":0.03154582,"about_ca_system_score_codex":0.000026930062,"about_ca_system_score_gemma":0.00010427229,"threshold_uncertainty_score":0.42366952},"labels":[],"label_agreement":null},{"id":"W2771670907","doi":"10.1182/blood-2017-05-784975","title":"Fc-independent immune thrombocytopenia via mechanomolecular signaling in platelets","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"National Institute of General Medical Sciences; National Heart, Lung, and Blood Institute","keywords":"Platelet; Antibody; Immune thrombocytopenia; Immunology; Epitope; Immune system; Chemistry; Cell biology; Medicine; Biology","score_opus":0.014926461473260237,"score_gpt":0.2651740937176781,"score_spread":0.2502476322444179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2771670907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935295,0.00080731296,0.00007331803,0.00022538981,0.00009385777,0.00037390465,0.000004763135,0.000031790158,0.004860165],"genre_scores_gemma":[0.9989444,0.000072220246,0.00054865517,0.000081021935,0.000032874555,0.000021988726,0.000028855437,0.000027354601,0.00024262852],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99892336,0.000017849052,0.00023058007,0.00028939347,0.00022778106,0.00031105083],"domain_scores_gemma":[0.99917495,0.000011965771,0.00011552965,0.00057498243,0.000028056724,0.00009452429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013279887,0.00017383786,0.00046629095,0.000079241865,0.00017538047,0.00005622355,0.00018779936,0.00011570323,0.00014163606],"category_scores_gemma":[0.000036234076,0.0001529602,0.000100039695,0.000041494397,0.000030842482,0.00010808672,0.00009147064,0.00017197554,0.0001906209],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033751552,0.0040758355,0.042964663,0.00010053909,0.00090267847,0.038922094,0.0004998539,0.000009266366,0.9024381,0.00020442827,0.000025772899,0.009519223],"study_design_scores_gemma":[0.02846194,0.00077799725,0.116673045,0.0003422289,0.0005173398,0.0013196954,0.00008984245,0.00012480399,0.8490502,0.0017827083,0.00041396698,0.00044621044],"about_ca_topic_score_codex":0.00031172732,"about_ca_topic_score_gemma":0.000071287854,"teacher_disagreement_score":0.073708385,"about_ca_system_score_codex":0.000030080151,"about_ca_system_score_gemma":0.000047729794,"threshold_uncertainty_score":0.62375355},"labels":[],"label_agreement":null},{"id":"W2771680190","doi":"10.1182/blood.v128.22.5676.5676","title":"High-Dose Cyclophosphamide in Highly Refractory Multiple Myeloma Patients As a Bridge to Further Novel Therapies","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Princess Margaret Cancer Centre; Jewish General Hospital; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Multiple myeloma; Lenalidomide; Progression-free survival; Cyclophosphamide; Surgery; Regimen; Refractory (planetary science); Oncology; Chemotherapy","score_opus":0.018339538225723043,"score_gpt":0.27227082968242766,"score_spread":0.2539312914567046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2771680190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99645543,0.00023392215,0.000028433586,0.0014367517,0.00013022871,0.0010503978,0.00009832521,0.00008781577,0.00047869518],"genre_scores_gemma":[0.9962687,0.0001266277,0.0012744085,0.00046110523,0.0001257324,0.00018859607,0.000038142247,0.00006200527,0.0014546772],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797237,0.000052142314,0.00033227677,0.0004910073,0.0005390653,0.0006131196],"domain_scores_gemma":[0.99860805,0.0002209405,0.00007028474,0.000538184,0.00013963164,0.0004229323],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013017005,0.00027059077,0.00037417264,0.00024022836,0.000053519714,0.000020187334,0.00016597568,0.00011323388,0.00021392132],"category_scores_gemma":[0.00057221844,0.00017155528,0.00009591565,0.0002584265,0.00006141288,0.00013634244,0.00010150953,0.00013720391,0.0009675031],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018205309,0.005438212,0.87112916,0.000027791299,0.00027955076,0.00027127183,0.0006449368,2.8557363e-7,0.05752206,0.000038947972,0.00022288709,0.06260438],"study_design_scores_gemma":[0.03658278,0.0011061452,0.9361655,0.00021656604,0.00003669777,0.000010983408,0.000025909721,0.0000014511483,0.021334622,0.00004377749,0.004275936,0.00019961664],"about_ca_topic_score_codex":0.0012964422,"about_ca_topic_score_gemma":0.00028175936,"teacher_disagreement_score":0.06503637,"about_ca_system_score_codex":0.00014331896,"about_ca_system_score_gemma":0.00011800885,"threshold_uncertainty_score":0.99981034},"labels":[],"label_agreement":null},{"id":"W2772214850","doi":"10.1182/blood-2018-09-872549","title":"Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":275,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Center for Research Resources; National Institute of General Medical Sciences; National Cancer Institute; National University of Singapore; University of Nebraska Medical Center","keywords":"Biology; Lymphoma; Genetics; Cancer research; Immunology","score_opus":0.006008785433177785,"score_gpt":0.2009641097093744,"score_spread":0.1949553242761966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2772214850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951524,0.0014334519,0.0000030804279,0.000018009427,0.000041514788,0.00032859907,0.000009836502,0.000008946676,0.0030041442],"genre_scores_gemma":[0.99863374,0.000120208926,0.0010862851,0.000049152983,0.000011138974,0.000014677851,0.000007965294,0.000015353946,0.00006150248],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99918115,0.000022057962,0.00025086713,0.00018469495,0.0002005176,0.00016071627],"domain_scores_gemma":[0.9994971,0.000019647165,0.00008761651,0.00029413894,0.000039145838,0.000062329425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000040525534,0.0001130602,0.00032624495,0.00007437358,0.000005673926,0.000002174412,0.00006697121,0.000067387635,0.0000970639],"category_scores_gemma":[0.000006198002,0.00009809158,0.00014227393,0.00012884285,0.000030853393,0.000017337186,0.000028516279,0.00002262138,0.000023525687],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046826088,0.004075889,0.70971745,0.00013090507,0.00010572749,0.00023089681,0.00034846592,0.000017565064,0.2836198,0.000102678016,0.000007231282,0.0015965999],"study_design_scores_gemma":[0.01715291,0.00077393046,0.49142694,0.00007940033,0.00018959213,0.000029854746,0.000107775544,0.0000341753,0.49003834,0.000025453812,0.000064402724,0.00007721601],"about_ca_topic_score_codex":0.00015790372,"about_ca_topic_score_gemma":0.000008180369,"teacher_disagreement_score":0.21829048,"about_ca_system_score_codex":0.00006503275,"about_ca_system_score_gemma":0.00013441939,"threshold_uncertainty_score":0.40000588},"labels":[],"label_agreement":null},{"id":"W2772775389","doi":"10.1182/blood-2017-05-787929","title":"When can we stop anticoagulation in patients with cancer-associated thrombosis?","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Intensive care medicine; Anticoagulant; Thrombosis; Case fatality rate; Cancer; Anticoagulant therapy; Venous thromboembolism; Risk assessment; Epidemiology; Surgery; Internal medicine","score_opus":0.02119033348921285,"score_gpt":0.27500228584258896,"score_spread":0.2538119523533761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2772775389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952524,0.00008209064,0.0000018009484,0.0023992488,0.00010920221,0.00055520015,0.000014501321,0.000032652213,0.0015529414],"genre_scores_gemma":[0.99918765,0.00019078428,0.00008771865,0.00023818573,0.000051095816,0.000044269018,0.00003586071,0.000021198717,0.0001432521],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991257,0.000017822675,0.0001529827,0.00021341693,0.0002579723,0.00023205695],"domain_scores_gemma":[0.9992875,0.000009562226,0.00016596215,0.00039332407,0.00007664117,0.00006704773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000084261315,0.000118945994,0.000338677,0.00006810172,0.00015349631,0.000049537444,0.00011340947,0.00005710145,0.00008696683],"category_scores_gemma":[0.000041422132,0.00009615733,0.00003132072,0.00004701029,0.00003994863,0.000098269586,0.00005309677,0.00008709621,0.00000690548],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001670427,0.002592069,0.9934823,0.000040929837,0.00019637776,0.000006714941,0.0006104364,0.0000054833818,0.00006321174,0.00009776525,0.00063113484,0.0022569082],"study_design_scores_gemma":[0.0070554987,0.0003262155,0.9909406,0.00039150644,0.00038087458,1.2456007e-7,0.000038506583,0.00001485024,0.00037361734,0.00009797147,0.0002604095,0.000119862],"about_ca_topic_score_codex":0.0029774122,"about_ca_topic_score_gemma":0.003078826,"teacher_disagreement_score":0.0070387945,"about_ca_system_score_codex":0.0000748043,"about_ca_system_score_gemma":0.00005302722,"threshold_uncertainty_score":0.45009765},"labels":[],"label_agreement":null},{"id":"W2772881286","doi":"10.1182/blood-2017-08-797886","title":"Safety and efficacy of selinexor in relapsed or refractory multiple myeloma and Waldenstrom macroglobulinemia","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Multiple myeloma; Medicine; Macroglobulinemia; Refractory (planetary science); Waldenstrom macroglobulinemia; Dexamethasone; Internal medicine; Oncology; Gastroenterology; Lymphoma; Biology","score_opus":0.025158198645819394,"score_gpt":0.3108131917688931,"score_spread":0.2856549931230737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2772881286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978886,0.0006022179,0.0000030709587,0.00037648968,0.000027413676,0.0004880783,0.000052057723,0.000019091998,0.0005429348],"genre_scores_gemma":[0.9960398,0.00060059334,0.0025078885,0.000022139098,0.000065097774,0.000010194901,0.0000226178,0.000018514454,0.00071314286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989067,0.000039435203,0.0002892879,0.0002938788,0.00020658324,0.0002641726],"domain_scores_gemma":[0.99883664,0.0002472976,0.00012504507,0.00050528,0.00006173213,0.00022399504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017578964,0.00014781907,0.00037468743,0.000086840635,0.00012316095,0.000023353976,0.000098482364,0.00010567939,0.00004250438],"category_scores_gemma":[0.0014586309,0.000105889936,0.000038063416,0.000045893747,0.00018923281,0.000059331764,0.00012369374,0.00018694761,0.0000067255796],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051707225,0.0013264051,0.9152636,0.00018131653,0.00019312587,0.0008858353,0.0002023106,2.8684337e-7,0.015641896,0.0000096796575,0.000044781216,0.061080046],"study_design_scores_gemma":[0.040635765,0.0006401561,0.9512058,0.00022122754,0.00009466415,0.00013467016,0.00004332728,0.0002635271,0.006067212,0.000006387441,0.00059433095,0.00009296852],"about_ca_topic_score_codex":0.00034907326,"about_ca_topic_score_gemma":0.0003607099,"teacher_disagreement_score":0.060987078,"about_ca_system_score_codex":0.000022171644,"about_ca_system_score_gemma":0.00009396028,"threshold_uncertainty_score":0.43180662},"labels":[],"label_agreement":null},{"id":"W277399393","doi":"10.1182/blood.v124.21.3064.3064","title":"Efficacy and Safety of Frontline Bortezomib, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (VR-CAP) Vs R-CHOP in a Subset of Newly Diagnosed Mantle Cell Lymphoma (MCL) Patients (Pts) Medically Eligible for Transplantation in the Randomized Phase 3 LYM-3002 Study (NCT00722137)","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Rituximab; Internal medicine; Clinical endpoint; Transplantation; Prednisone; CHOP; Regimen; Bortezomib; Mantle cell lymphoma; Vincristine; Oncology; Autologous stem-cell transplantation; Gastroenterology; Cyclophosphamide; Adverse effect; Urology; Surgery; Lymphoma; Clinical trial; Chemotherapy","score_opus":0.006136237237894708,"score_gpt":0.2507294225807201,"score_spread":0.2445931853428254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W277399393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918677,0.002223643,0.00011914867,0.00017720732,0.000051196977,0.0052090585,0.00018698443,0.000014798026,0.00015025989],"genre_scores_gemma":[0.995803,0.002589319,0.0006188518,0.00015548505,0.00003093675,0.0005322321,0.00023026331,0.00002802908,0.000011857309],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99734247,0.00032754333,0.001118869,0.00045108513,0.0004475632,0.00031247918],"domain_scores_gemma":[0.9971916,0.0019008265,0.00033707658,0.0003377095,0.00011209898,0.00012066905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012109638,0.00030975012,0.0013502768,0.00019467644,0.00005636866,0.000016467799,0.00012705296,0.00012889734,0.00001288058],"category_scores_gemma":[0.00040783302,0.00020612538,0.00012911519,0.00022823093,0.00015982543,0.00008293198,0.00002772914,0.000071550705,0.0000011695555],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2962186,0.17028196,0.46590984,0.0013266245,0.0007410396,0.00018430069,0.015082994,0.000010609502,0.0012033795,0.00008718969,0.00017310155,0.048780367],"study_design_scores_gemma":[0.6820378,0.0028053138,0.30752617,0.00026878607,0.0012858105,0.000008617745,0.00027085832,0.00033927493,0.0052022184,0.000049201528,0.000068086556,0.00013789035],"about_ca_topic_score_codex":0.0010386435,"about_ca_topic_score_gemma":0.0003232359,"teacher_disagreement_score":0.38581917,"about_ca_system_score_codex":0.000038691516,"about_ca_system_score_gemma":0.00008887463,"threshold_uncertainty_score":0.84055483},"labels":[],"label_agreement":null},{"id":"W2774761959","doi":"10.1182/blood.v130.suppl_1.5524.5524","title":"Post-Autologous Stem Cell Transplantation Therapy for Multiple Myeloma Patients: Impact on Clinical Outcomes","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Medicine; Surgery; Multiple myeloma; Transplantation; Autologous stem-cell transplantation; Internal medicine","score_opus":0.05433498657521999,"score_gpt":0.38483227951047844,"score_spread":0.3304972929352584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774761959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968351,0.000055187174,0.000024449328,0.00028255215,0.00015171927,0.0016106492,0.00047734694,0.000051945823,0.00051105506],"genre_scores_gemma":[0.99820644,0.00019802395,0.0004160122,0.00023906282,0.000091409,0.00011301176,0.00029565953,0.000032555286,0.00040784007],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986504,0.000064303094,0.00031298335,0.0003246736,0.00028389355,0.00036374768],"domain_scores_gemma":[0.9983268,0.0005056895,0.00016668637,0.0005764813,0.0001761054,0.00024825596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001796457,0.0002068982,0.00039935668,0.00006981776,0.00027638997,0.000053747186,0.00017243154,0.0001326101,0.000028365585],"category_scores_gemma":[0.00017881744,0.00012803337,0.00038341354,0.000019143643,0.00006554721,0.00009681957,0.000014216841,0.00014514379,0.00007264117],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004068788,0.0039014146,0.90620536,0.0000442734,0.00040702405,0.00007528093,0.00009454807,3.7736731e-7,0.00033485657,0.0000031256536,0.00007300647,0.08479195],"study_design_scores_gemma":[0.043735113,0.007113177,0.941833,0.000029668146,0.00013014502,0.0000049675095,0.000015087125,0.00004009638,0.006883657,0.0000107136075,0.000089715984,0.00011461273],"about_ca_topic_score_codex":0.00012143083,"about_ca_topic_score_gemma":0.000027183849,"teacher_disagreement_score":0.08467734,"about_ca_system_score_codex":0.000028849088,"about_ca_system_score_gemma":0.00008758483,"threshold_uncertainty_score":0.5221049},"labels":[],"label_agreement":null},{"id":"W2775616175","doi":"10.1182/blood-2017-10-807172","title":"The ecosystem of classical Hodgkin lymphoma","year":2017,"lang":"en","type":"letter","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Classical Hodgkin lymphoma; Lymphoma; Reed–Sternberg cell; Cancer research; Tumor microenvironment; Hodgkin lymphoma; Medicine; Immunology; Biology; Tumor cells","score_opus":0.018062467028314003,"score_gpt":0.25526398864059086,"score_spread":0.23720152161227687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2775616175","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09501495,0.0044196118,8.0482204e-7,0.8657013,0.0010412764,0.0010606474,0.00024348381,0.00007312012,0.032444756],"genre_scores_gemma":[0.76885647,0.001429319,0.00024066518,0.18174386,0.016981656,0.00068079296,0.00055508176,0.00022651776,0.029285619],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985248,0.00006434316,0.00033958833,0.00031008504,0.00044765088,0.00031353004],"domain_scores_gemma":[0.99793214,0.00030989863,0.0003566165,0.0012486948,0.000086338114,0.0000662887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012194309,0.0002637353,0.0006272745,0.00004670789,0.00017575533,0.00005617838,0.00030199465,0.0005221649,0.000027312095],"category_scores_gemma":[0.00008964766,0.00014339379,0.00036588885,0.000029216288,0.00010340269,0.000018686294,0.00007782309,0.00021665126,0.0001444451],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023588558,0.00062876684,0.004189565,0.00025092033,0.0009980489,0.002801491,0.000018928635,8.4417815e-9,0.000013551652,0.00008074793,0.98280853,0.008185856],"study_design_scores_gemma":[0.0052921544,0.00032077584,0.012400113,0.00049957715,0.0013946539,0.00051863666,0.000004901684,0.000001950729,0.002015854,0.000034448585,0.9773827,0.00013421601],"about_ca_topic_score_codex":0.00004130285,"about_ca_topic_score_gemma":0.000019557408,"teacher_disagreement_score":0.68395746,"about_ca_system_score_codex":0.000089690024,"about_ca_system_score_gemma":0.0002881294,"threshold_uncertainty_score":0.58474284},"labels":[],"label_agreement":null},{"id":"W2775773970","doi":"10.1182/blood.v130.suppl_1.4427.4427","title":"Actinium Labeled Daratumumab Demonstrates Enhanced Killing of Multiple Myeloma Cells over Naked Daratumumab","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Daratumumab; Antibody-dependent cell-mediated cytotoxicity; Immunogenicity; Antibody; Antigen; Monoclonal antibody; Immunology; Multiple myeloma; Medicine; Cancer research","score_opus":0.025711355486034735,"score_gpt":0.31298040994059184,"score_spread":0.2872690544545571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2775773970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799325,0.0005351507,0.00003239335,0.00030157817,0.00027249157,0.00038984526,0.00006649101,0.000046059853,0.01842352],"genre_scores_gemma":[0.9934211,0.00031419407,0.0016538323,0.000067362744,0.0003242638,0.000019315814,0.000036613896,0.000036511643,0.0041268175],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99797904,0.00005194433,0.0004383163,0.00041917653,0.00056761975,0.00054391235],"domain_scores_gemma":[0.9981869,0.00022627972,0.00029927606,0.0007934674,0.00023838898,0.00025571056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002290415,0.0002703173,0.0005844728,0.000106122316,0.00055170595,0.00007574707,0.00040859188,0.0001789512,0.00029055224],"category_scores_gemma":[0.00023481817,0.00021768418,0.00021648269,0.00010374004,0.00034979358,0.00017258216,0.00019200482,0.00042837719,0.00009392745],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008454905,0.00078946317,0.027895872,0.00025750473,0.000303566,0.0001249925,0.00020110299,0.0000013469621,0.9658428,0.00013544908,0.00036323597,0.003239203],"study_design_scores_gemma":[0.00554783,0.00041604476,0.05392663,0.00024954823,0.00014159938,0.000039765953,0.00008167576,0.0002835984,0.93557113,0.000048012404,0.0034666245,0.00022751327],"about_ca_topic_score_codex":0.0002684291,"about_ca_topic_score_gemma":0.00010995019,"teacher_disagreement_score":0.03027162,"about_ca_system_score_codex":0.00001760832,"about_ca_system_score_gemma":0.00016012232,"threshold_uncertainty_score":0.8876903},"labels":[],"label_agreement":null},{"id":"W2778847088","doi":"10.1182/blood.v128.22.4281.4281","title":"Aside from the Allelic Burden of JAK2-V617F, Acquisition of Mutations in Myeloid Gene Panel Is Associated with the Transformation of Myeloproliferative Neoplasm into Secondary AML","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Myeloid; Myeloproliferative neoplasm; JAK2 V617F; Mutation; Gene; Biology; Allele; Genetics; Medicine; Cancer research; Oncology; Bone marrow; Immunology; Myelofibrosis","score_opus":0.014545971677427504,"score_gpt":0.23782583951757602,"score_spread":0.22327986784014853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2778847088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894449,0.0003294995,0.00018593848,0.008144934,0.000019398352,0.0009217038,0.0003983582,0.000012400634,0.0005428685],"genre_scores_gemma":[0.9986788,0.0002337377,0.00036259487,0.00025814935,0.000047662274,0.0001685516,0.00018528255,0.000017697786,0.000047514124],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985019,0.0001812386,0.00055455824,0.0002092677,0.00038772018,0.00016534394],"domain_scores_gemma":[0.99819255,0.00076312944,0.00037373882,0.0002831438,0.00033992596,0.000047494872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026315523,0.00019172076,0.00046500398,0.00008971497,0.00007856475,0.0000075860207,0.00011375787,0.00010379528,0.00017327564],"category_scores_gemma":[0.00009623237,0.0000889546,0.00010567062,0.0002770709,0.00019405519,0.00013573177,0.000019198555,0.0001251412,0.000005480867],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018246417,0.0051268702,0.28211632,0.00027504147,0.0067611453,0.00005744968,0.24216805,0.0001988354,0.4268134,0.0018850589,0.0005831352,0.032190055],"study_design_scores_gemma":[0.008644627,0.000739513,0.44665188,0.0005187118,0.0005541754,0.000011934728,0.0022944568,0.000054210956,0.539796,0.00056855514,0.00005721747,0.00010871353],"about_ca_topic_score_codex":0.0007550936,"about_ca_topic_score_gemma":0.0009369753,"teacher_disagreement_score":0.2398736,"about_ca_system_score_codex":0.000058640933,"about_ca_system_score_gemma":0.00023406543,"threshold_uncertainty_score":0.36274633},"labels":[],"label_agreement":null},{"id":"W2781509838","doi":"10.1182/blood.v130.suppl_1.4641.4641","title":"A Decision Model to Estimate Risk Thresholds for Guiding Duration of Anticaogulation in Unprovoked Venous Thromboembolism","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Venous thromboembolism; Population; Pulmonary embolism; Case fatality rate; Anticoagulant therapy; Risk assessment; Pediatrics; Intensive care medicine; Internal medicine; Thrombosis","score_opus":0.36690315201120766,"score_gpt":0.46980883820157243,"score_spread":0.10290568619036478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2781509838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8768096,0.00014773343,0.119364694,0.0018022156,0.00022805325,0.0009905797,0.00019567295,0.000018316654,0.00044312887],"genre_scores_gemma":[0.93998975,0.00003126672,0.059471972,0.00022480162,0.00010494387,0.000106774365,0.00001772644,0.000024498468,0.000028275732],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9967132,0.00004702612,0.0024934546,0.00040557442,0.00007514024,0.0002655579],"domain_scores_gemma":[0.99663264,0.00039594792,0.0021228918,0.0006798415,0.00008378885,0.000084864805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007861448,0.00012806388,0.00075590954,0.0002741463,0.00032060806,0.00009904335,0.00029575976,0.0001276222,0.000010548872],"category_scores_gemma":[0.007517895,0.00016536657,0.00008351935,0.000067470886,0.000030346402,0.0005046743,0.00006124564,0.00005547618,0.000070209375],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001823264,0.0016881322,0.5561324,0.00081262924,0.00019436653,0.0000016178277,0.009036153,0.18108536,0.0010618322,0.2446349,0.0019429132,0.0032273892],"study_design_scores_gemma":[0.002361664,0.00013353689,0.27543926,0.00017416806,0.000023669114,0.0000013995468,0.000067490524,0.60691416,0.0003715215,0.11410134,0.00017109037,0.00024072659],"about_ca_topic_score_codex":0.0004982944,"about_ca_topic_score_gemma":0.00032675514,"teacher_disagreement_score":0.42582878,"about_ca_system_score_codex":0.000116558855,"about_ca_system_score_gemma":0.000082383376,"threshold_uncertainty_score":0.90001655},"labels":[],"label_agreement":null},{"id":"W2781514472","doi":"10.1182/blood.v128.22.761.761","title":"Excellent Outcome of Children with Down Syndrome (DS) and Acute Lymphoblastic Leukemia (ALL) Treated on Dana-Farber Cancer Institute (DFCI) ALL Consortium Protocols 00-001 and 05-001","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; McMaster Children's Hospital; Centre Hospitalier Universitaire Sainte-Justine; McMaster University; Hamilton Health Sciences; Université de Montréal","funders":"","keywords":"Medicine; Cumulative incidence; Internal medicine; Population; Cancer; Oncology; Pediatrics; Cohort","score_opus":0.022998027925625015,"score_gpt":0.30023651763600356,"score_spread":0.27723848971037857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2781514472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98808455,0.00013286098,0.000030862626,0.000503356,0.000053141215,0.010125387,0.0003010108,0.00010888218,0.00065994775],"genre_scores_gemma":[0.9922317,0.00030752027,0.0002348966,0.00042927355,0.00010538674,0.0036862153,0.00006569974,0.00009721782,0.0028420687],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967754,0.00008051046,0.00067395985,0.0008611222,0.00081431726,0.00079470774],"domain_scores_gemma":[0.99797106,0.00021860102,0.00027883917,0.00073755963,0.00019937343,0.00059457927],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021744044,0.0005452046,0.0009855969,0.0002914682,0.00009268827,0.000041588875,0.0002475357,0.00026632566,0.00022669758],"category_scores_gemma":[0.00011739764,0.00031823647,0.0000729312,0.00026354406,0.00077939185,0.00020395813,0.00021197769,0.00024691838,0.000045561723],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005735584,0.0047335126,0.923476,0.0011111785,0.009236459,0.0039424505,0.00030325883,0.000016974369,0.041492287,0.00033111125,0.0041553453,0.005465883],"study_design_scores_gemma":[0.20298141,0.009737738,0.73090583,0.004005397,0.004805008,0.008692672,0.000030880314,0.00022228883,0.030497883,0.000043808534,0.006600805,0.0014762839],"about_ca_topic_score_codex":0.001963175,"about_ca_topic_score_gemma":0.00019915077,"teacher_disagreement_score":0.19724582,"about_ca_system_score_codex":0.00074754603,"about_ca_system_score_gemma":0.00081237685,"threshold_uncertainty_score":0.999927},"labels":[],"label_agreement":null},{"id":"W2781578073","doi":"10.1182/blood.v130.suppl_1.5651.5651","title":"Does Venous Thromboembolism Prophylaxis Policy Have Any Impact on Clot Risk Reduction in Hospitalized Solid Tumor Patients at Princess Margaret Cancer Centre: A Longitudinal Study?","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Regimen; Pharmacy; Cancer; Venous thromboembolism; Anticoagulant drug; Emergency medicine; Retrospective cohort study; Pediatrics; Thrombosis; Anticoagulant; Surgery; Internal medicine","score_opus":0.014018667316843711,"score_gpt":0.32206605679926514,"score_spread":0.30804738948242144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2781578073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99439293,0.00009558147,4.6598944e-7,0.0005875075,0.0007259862,0.0033431824,0.00012912434,0.000075785996,0.00064945436],"genre_scores_gemma":[0.9981297,0.0004910117,0.000035999336,0.0000711503,0.00069920527,0.00031096025,0.000031117677,0.00007675332,0.00015409471],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970847,0.00011395094,0.00050743937,0.00083548896,0.00068249257,0.0007759555],"domain_scores_gemma":[0.9977674,0.000018549981,0.0006173329,0.001151234,0.00016992682,0.00027554968],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002709557,0.0004707926,0.0011227021,0.0002966167,0.00058048026,0.00015083105,0.00036876992,0.0001120348,0.00012660057],"category_scores_gemma":[0.00024441333,0.00029587498,0.00021710865,0.00015610764,0.00015140993,0.00022085445,0.00034104567,0.00034214827,0.000037697297],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004459931,0.02370293,0.9696357,0.00015376924,0.0007667733,0.00019126624,0.0029451656,0.000044564556,0.00007812065,0.000040555944,0.00021588038,0.0017792565],"study_design_scores_gemma":[0.01188444,0.004590457,0.97974193,0.00044838706,0.0006835738,0.000006591117,0.0002688804,0.000004342459,0.0016861863,0.0002645934,0.000054700926,0.00036589554],"about_ca_topic_score_codex":0.02912233,"about_ca_topic_score_gemma":0.0027838617,"teacher_disagreement_score":0.02633847,"about_ca_system_score_codex":0.00089927326,"about_ca_system_score_gemma":0.00026581174,"threshold_uncertainty_score":0.99994934},"labels":[],"label_agreement":null},{"id":"W2781648272","doi":"10.1182/blood.v130.suppl_1.1108.1108","title":"Comparison of Bleeding Risk between Rivaroxaban and Apixaban: a Pilot Feasibility Study","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Sherbrooke; University of Alberta; McMaster University; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Apixaban; Rivaroxaban; Medicine; Randomized controlled trial; Randomization; Internal medicine; Surgery; Intensive care medicine; Warfarin; Atrial fibrillation","score_opus":0.10614556250775972,"score_gpt":0.39166198243680933,"score_spread":0.28551641992904964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2781648272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954469,0.00019776454,0.000015425614,0.00015992062,0.0000666937,0.0010701118,0.0000135102155,0.0000345552,0.0029950936],"genre_scores_gemma":[0.99942154,0.000050519397,0.00028194228,0.000013259099,0.00016015214,0.000019466814,0.0000033578153,0.00001541416,0.000034351127],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886,0.000047086985,0.0003300032,0.00031209126,0.00025560733,0.0001951985],"domain_scores_gemma":[0.9986841,0.00006273227,0.0003229691,0.0007487875,0.000058079688,0.00012333032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005403141,0.00013832911,0.00071418163,0.000061018953,0.000308983,0.000050254977,0.00017216294,0.000036179288,0.000025067868],"category_scores_gemma":[0.00023099336,0.000118746124,0.000055753884,0.000037797527,0.000111734196,0.00007835213,0.00024712062,0.00015346425,0.000006202158],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028708198,0.0079908855,0.9879793,0.00011287329,0.00045585644,0.000007026071,0.001189316,2.5271535e-7,0.00036773377,0.00006348516,0.00016507752,0.0016394781],"study_design_scores_gemma":[0.00509486,0.0032508455,0.9862098,0.00008089048,0.0019850088,0.0000013010099,0.00079394545,0.000011061761,0.002275833,0.00011556792,0.000075497745,0.00010538242],"about_ca_topic_score_codex":0.0008402356,"about_ca_topic_score_gemma":0.00010349993,"teacher_disagreement_score":0.0050661517,"about_ca_system_score_codex":0.000013684034,"about_ca_system_score_gemma":0.00001775338,"threshold_uncertainty_score":0.48423266},"labels":[],"label_agreement":null},{"id":"W2781880236","doi":"10.1182/blood-2017-07-796151","title":"ABO zygosity, but not secretor or Fc receptor status, is a significant risk factor for IVIG-associated hemolysis","year":2018,"lang":"en","type":"letter","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Hôpital de l'Enfant-Jésus; St. Michael's Hospital; Sunnybrook Health Science Centre; Mount Sinai Hospital; Canadian Blood Services; Health Sciences Centre; University Health Network; University of Toronto","funders":"Health Canada; Knut och Alice Wallenbergs Stiftelse; Vetenskapsrådet; Government of Canada; Canadian Blood Services; Australian Government","keywords":"Hemolysis; ABO blood group system; Zygosity; Medicine; Antibody; Immunology; Internal medicine; Gastroenterology; Biology; Genetics","score_opus":0.025335983650230577,"score_gpt":0.2582547411259198,"score_spread":0.23291875747568921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2781880236","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7651648,0.00045114098,0.00033025828,0.15246087,0.0019225174,0.005026129,0.07371118,0.0006095815,0.00032354426],"genre_scores_gemma":[0.17203166,0.0043711956,0.009004013,0.687869,0.04262584,0.0012012778,0.018212963,0.0014836488,0.0632004],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950069,0.00018672174,0.0009095494,0.0013797262,0.001108709,0.001408361],"domain_scores_gemma":[0.99668914,0.0005627858,0.0006367331,0.0010632153,0.00062222953,0.0004259042],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003509217,0.00093292317,0.0017612543,0.0003216451,0.00035757342,0.0001211909,0.00038815624,0.0021855424,0.0040493635],"category_scores_gemma":[0.0004668003,0.0007120771,0.0009531243,0.00043315362,0.00016948934,0.00009693254,0.00010101749,0.002048752,0.00034187184],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014033291,0.001747207,0.005253844,0.0012040808,0.004606165,0.0003534267,0.0009962879,2.2897515e-8,0.010825041,8.3494666e-7,0.9709638,0.002645982],"study_design_scores_gemma":[0.017499298,0.0048580356,0.0045803133,0.00087846984,0.011172631,0.000039814604,0.00007866592,0.000033189135,0.055619147,0.000029802328,0.90379393,0.0014167285],"about_ca_topic_score_codex":0.00089632306,"about_ca_topic_score_gemma":0.00016303018,"teacher_disagreement_score":0.5931331,"about_ca_system_score_codex":0.00017911462,"about_ca_system_score_gemma":0.00056592445,"threshold_uncertainty_score":0.99953306},"labels":[],"label_agreement":null},{"id":"W2781917933","doi":"10.1182/blood-2017-09-742353","title":"Splenectomy for immune thrombocytopenia: down but not out","year":2018,"lang":"en","type":"review","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":197,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Heart, Lung, and Blood Institute","keywords":"Splenectomy; Medicine; Rituximab; Thrombopoietin; Romiplostim; Immune thrombocytopenia; Fulminant; Refractory (planetary science); Intensive care medicine; Pediatrics; Internal medicine; Surgery; Platelet; Spleen; Lymphoma","score_opus":0.06206140102980273,"score_gpt":0.3487699583796061,"score_spread":0.2867085573498034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2781917933","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00053664425,0.99176824,0.000009903091,0.000042445296,0.0003550853,0.0026833185,0.00040720144,0.00008128676,0.0041158865],"genre_scores_gemma":[0.000085272586,0.991329,0.0008172109,0.000080645936,0.0004641127,0.0004972269,0.0010305756,0.00010937226,0.0055865804],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99823064,0.000030798234,0.00055984413,0.00053795165,0.00020439108,0.0004363519],"domain_scores_gemma":[0.99873614,0.00011882178,0.00026561477,0.00065988983,0.000086738284,0.00013276571],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001303018,0.0005121083,0.0031853726,0.00011951441,0.00010329023,0.00003180013,0.00020744184,0.00040510806,0.00020460026],"category_scores_gemma":[0.000078331075,0.000353609,0.0009438792,0.000107008964,0.000063133666,0.000042164018,0.00007878697,0.00021446975,0.00096506544],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013029893,0.004080814,0.000021102516,0.047257677,0.009457338,0.0013851555,0.00012901574,4.5644986e-9,0.000025118401,0.00011041452,0.0073546385,0.9300484],"study_design_scores_gemma":[0.0055522453,0.0005784327,0.00001414813,0.0067400085,0.011256663,0.00054533896,0.000005809784,2.0833357e-7,0.00020284487,0.00003265279,0.9747453,0.0003263857],"about_ca_topic_score_codex":0.000028695595,"about_ca_topic_score_gemma":0.0000145370195,"teacher_disagreement_score":0.9673906,"about_ca_system_score_codex":0.00005250218,"about_ca_system_score_gemma":0.0003396998,"threshold_uncertainty_score":0.9998916},"labels":[],"label_agreement":null},{"id":"W2781920357","doi":"10.1182/blood.v130.suppl_1.1497.1497","title":"Metformin and the Incidence of Lymphoid Malignancies in Patients with Type 2 Diabetes","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Metformin; Internal medicine; Hazard ratio; Population; Type 2 diabetes; Cohort; Proportional hazards model; Cumulative incidence; Diabetes mellitus; Cancer; Incidence (geometry); Oncology; Confidence interval; Insulin; Endocrinology","score_opus":0.004082092596751908,"score_gpt":0.20038347010269686,"score_spread":0.19630137750594495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2781920357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9542693,0.045351025,7.8847705e-7,0.0000047986987,0.000039356826,0.000091601214,0.0000063370053,0.0000010637391,0.00023570894],"genre_scores_gemma":[0.99526674,0.0045025935,0.000080242186,0.00006610792,0.00003172719,0.000011052803,0.000005751244,0.0000056710705,0.00003013818],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996023,0.000019728965,0.00008508056,0.00011329921,0.00007297571,0.00010662111],"domain_scores_gemma":[0.9995282,0.000007746632,0.00009201281,0.00029563563,0.000058024038,0.000018325001],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013969203,0.000062094885,0.0001180788,0.0000109622715,0.000051531413,0.00001627907,0.00015954171,0.000036803296,0.0000037613424],"category_scores_gemma":[0.00011168731,0.000037824568,0.000016168893,0.000020216508,0.00019627361,0.0000051476036,0.000078137666,0.000020674728,5.189358e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009946261,0.00007449609,0.98138875,0.000022513737,0.00004611714,2.7559267e-7,0.000064137734,7.426969e-7,0.006393327,0.00010450238,0.000035705667,0.011769997],"study_design_scores_gemma":[0.006423797,0.00022589965,0.61172014,0.00004437321,0.00006884134,5.652448e-7,0.000025697069,0.0000029239668,0.37678924,0.00018846599,0.0043785907,0.00013143569],"about_ca_topic_score_codex":0.00002891681,"about_ca_topic_score_gemma":0.000048340855,"teacher_disagreement_score":0.37039593,"about_ca_system_score_codex":0.0000012579434,"about_ca_system_score_gemma":0.000030851414,"threshold_uncertainty_score":0.15424411},"labels":[],"label_agreement":null},{"id":"W2782099884","doi":"10.1182/blood.v130.suppl_1.1812.1812","title":"Pomalidomide (POM) + Low-Dose Dexamethasone (LoDEX) Safety and Efficacy in Patients (pts) with Relapsed and/or Refractory Multiple Myeloma (RRMM) Previously Treated with a Proteasome Inhibitor (PI) and in Whom Last Prior Therapy with Lenalidomide (LEN) Failed","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Royal Victoria Hospital; Vancouver General Hospital","funders":"","keywords":"Medicine; Pomalidomide; Internal medicine; Neutropenia; Multiple myeloma; Lenalidomide; Bortezomib; Clinical endpoint; Cohort; Adverse effect; Surgery; Population; Gastroenterology; Randomized controlled trial; Chemotherapy","score_opus":0.01574568132597968,"score_gpt":0.2580557407215349,"score_spread":0.24231005939555525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782099884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925933,0.000621853,0.000006215718,0.00017306971,0.000010370771,0.006432471,0.00004691701,0.00006684155,0.00004898152],"genre_scores_gemma":[0.9960622,0.000522528,0.0023837558,0.000046805486,0.00005154673,0.00045839231,0.00007166248,0.000113931485,0.00028913043],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966683,0.0002909257,0.00054293324,0.0010399596,0.000634214,0.00082371506],"domain_scores_gemma":[0.99759215,0.00040116892,0.00038616726,0.0008609069,0.00018694926,0.0005726748],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042894468,0.00063421007,0.001111457,0.00035335092,0.00038713805,0.00022570908,0.00017415459,0.00021549426,0.000014694935],"category_scores_gemma":[0.00060326664,0.0003676426,0.000043231197,0.00027018585,0.0006287656,0.00053011754,0.000126633,0.00054005755,0.0000037730126],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.122246936,0.004873148,0.8425927,0.00023321474,0.0004478589,0.0010890283,0.00094395,0.0000016415879,0.0022048121,8.056427e-7,0.0000020223401,0.025363855],"study_design_scores_gemma":[0.22128887,0.008004996,0.76245284,0.0019173509,0.00014039401,0.0000996447,0.00010736783,0.00006671541,0.0054846327,0.0000010141733,0.00006726567,0.00036887944],"about_ca_topic_score_codex":0.00095715455,"about_ca_topic_score_gemma":0.004758258,"teacher_disagreement_score":0.099041946,"about_ca_system_score_codex":0.00014131796,"about_ca_system_score_gemma":0.0003803318,"threshold_uncertainty_score":0.9998776},"labels":[],"label_agreement":null},{"id":"W2782210410","doi":"10.1182/blood.v128.22.4755.4755","title":"Risk of Venous Thromboembolism in Hospitalized Patients with Sickle Cell Disease","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Incidence (geometry); Venous thromboembolism; Retrospective cohort study; Population; Poisson regression; Multivariate analysis; Internal medicine; Complication; Disease; Pediatrics; Intensive care medicine; Thrombosis","score_opus":0.0022454570388288774,"score_gpt":0.18121176946532522,"score_spread":0.17896631242649633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782210410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973324,0.00043552523,0.00000861805,0.000111995236,0.000042458883,0.00033284162,0.000040013325,0.000022454311,0.001673681],"genre_scores_gemma":[0.9994216,0.0002782605,0.000089018366,0.000040173403,0.000014143604,0.000008002539,0.000008625492,0.000018462462,0.0001217166],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993023,0.000024808414,0.00016391769,0.00015454295,0.00017497796,0.00017943143],"domain_scores_gemma":[0.9994891,0.000021593489,0.000082634695,0.00022623944,0.000053434964,0.00012698548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000044882137,0.00009796713,0.00025162668,0.000054888398,0.000019612238,0.0000020147816,0.000048304846,0.0000581327,0.00005949278],"category_scores_gemma":[0.000052067837,0.000052310872,0.000050469152,0.00011725819,0.00007077441,0.000035513396,0.000018149603,0.00007269214,0.000022988941],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024745724,0.0047377073,0.9925491,0.00007250643,0.00007157696,0.000036665828,0.00026608733,0.0000015785324,0.0003642737,0.00001783376,0.000070498325,0.0015646758],"study_design_scores_gemma":[0.017018344,0.0006949445,0.9799722,0.00023807609,0.0003882565,6.4905674e-7,0.00003924028,0.0000018582612,0.0012397222,0.00013203574,0.00017303503,0.000101649144],"about_ca_topic_score_codex":0.000062374995,"about_ca_topic_score_gemma":0.0000034835527,"teacher_disagreement_score":0.016770886,"about_ca_system_score_codex":0.000011118647,"about_ca_system_score_gemma":0.00006935534,"threshold_uncertainty_score":0.21331754},"labels":[],"label_agreement":null},{"id":"W2782297997","doi":"10.1182/blood.v130.suppl_1.lba-2.lba-2","title":"Venetoclax Plus Rituximab Is Superior to Bendamustine Plus Rituximab in Patients with Relapsed/ Refractory Chronic Lymphocytic Leukemia - Results from Pre-Planned Interim Analysis of the Randomized Phase 3 Murano Study","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Jewish General Hospital","funders":"","keywords":"Rituximab; Bendamustine; Medicine; Chemoimmunotherapy; Tumor lysis syndrome; Internal medicine; Interim analysis; Venetoclax; Neutropenia; Gastroenterology; Refractory (planetary science); Obinutuzumab; Chronic lymphocytic leukemia; Oncology; Randomized controlled trial; Leukemia; Chemotherapy; Lymphoma","score_opus":0.0174912156410489,"score_gpt":0.30971087613635917,"score_spread":0.2922196604953103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782297997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99284226,0.0003312825,0.00001529882,0.00009503268,0.00019344616,0.0053501553,0.00081857375,0.000057437403,0.0002965396],"genre_scores_gemma":[0.99828213,0.000037876245,0.00016765646,0.000109765766,0.00015229062,0.00030669986,0.00031892222,0.00009004241,0.00053458795],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9941047,0.0005159149,0.001595754,0.0012436063,0.0016781727,0.00086185563],"domain_scores_gemma":[0.99386364,0.0007450938,0.000792964,0.003815613,0.000400663,0.0003820202],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012642991,0.0005956055,0.0029572062,0.000675168,0.00032403108,0.00012841007,0.0013389583,0.00026107611,0.00019894537],"category_scores_gemma":[0.002598526,0.0003956452,0.0005101319,0.00096557784,0.00059408613,0.00024844045,0.00071341114,0.0005907123,0.000041238734],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.94754356,0.009267274,0.0079248855,0.00032342173,0.012110321,0.0006638994,0.016807,0.0025131362,0.0008976817,0.0000028235645,0.00035002877,0.0015959379],"study_design_scores_gemma":[0.90946335,0.00341513,0.03920979,0.0007974527,0.0069614756,0.000009469044,0.00029987734,0.03715303,0.0021920858,0.000003549179,0.00009873497,0.0003960717],"about_ca_topic_score_codex":0.044907235,"about_ca_topic_score_gemma":0.0051057963,"teacher_disagreement_score":0.039801437,"about_ca_system_score_codex":0.067214645,"about_ca_system_score_gemma":0.032058727,"threshold_uncertainty_score":0.99984956},"labels":[],"label_agreement":null},{"id":"W2782311208","doi":"10.1182/blood.v130.suppl_1.3398.3398","title":"Protective Environment for Hematopoietic Cell Transplant (HSCT) Recipients: The Infectious Diseases Working Party EBMT Analysis of Global Recommendations on Health-Care Facilities","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Infection Control and Ventilation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Health care; Isolation (microbiology); Transplantation; Family medicine; Hematopoietic stem cell transplantation; Intensive care medicine; Internal medicine","score_opus":0.019569221028894475,"score_gpt":0.28011433235608796,"score_spread":0.2605451113271935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782311208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9460455,0.0008068561,0.03991297,0.004760267,0.00044730425,0.0039081126,0.0018021857,0.00009252985,0.0022242765],"genre_scores_gemma":[0.9992429,0.00005274517,0.00003887748,0.00009306161,0.0000634373,0.00030989476,0.00013677693,0.0000059714503,0.000056322693],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991897,0.000060560516,0.00025427205,0.00019016219,0.00015418492,0.0001511306],"domain_scores_gemma":[0.9992104,0.000079331905,0.00027151097,0.00033261967,0.000048768026,0.00005738025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012655341,0.00010820509,0.0002774129,0.00005469317,0.00057671004,0.000028436667,0.00006308287,0.00004228964,0.00004538764],"category_scores_gemma":[0.000045872082,0.000077239325,0.00025800487,0.000079359685,0.000056259676,0.000045369045,0.000012363816,0.00007222052,0.0000037003317],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008660872,0.003072072,0.951973,0.00054382585,0.0032112692,0.000002740926,0.007550266,0.00095048134,0.00010992181,0.0013947494,0.00022993184,0.030095628],"study_design_scores_gemma":[0.008200394,0.0017136236,0.9701795,0.00036527778,0.0069640675,0.0000072104617,0.0017665745,0.000604953,0.0012291818,0.00057675934,0.008136788,0.0002556873],"about_ca_topic_score_codex":0.0001448977,"about_ca_topic_score_gemma":0.00027638118,"teacher_disagreement_score":0.053197414,"about_ca_system_score_codex":0.000110690904,"about_ca_system_score_gemma":0.000046519606,"threshold_uncertainty_score":0.44356456},"labels":[],"label_agreement":null},{"id":"W2782431592","doi":"10.1182/blood.v130.suppl_1.lba-6.lba-6","title":"A Randomized, Open-Label, Blinded Outcome Assessment Trial Evaluating the Efficacy and Safety of LMWH/Edoxaban Versus Dalteparin for Venous Thromboembolism Associated with Cancer: Hokusai VTE-Cancer Study","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; University Health Network; University of Toronto; McMaster University; London Health Sciences Centre; Victoria Hospital; Ottawa Hospital","funders":"","keywords":"Medicine; Edoxaban; Low molecular weight heparin; Hazard ratio; Cancer; Randomized controlled trial; Venous thromboembolism; Surgery; Confidence interval; Internal medicine; Heparin; Thrombosis; Warfarin; Rivaroxaban","score_opus":0.20021113132985935,"score_gpt":0.4766885718574798,"score_spread":0.27647744052762047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782431592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9754874,0.00044639135,0.000026829346,0.0015101152,0.0009029321,0.020331314,0.00007382641,0.000040624796,0.0011805441],"genre_scores_gemma":[0.9942217,0.00039447195,0.0004448438,0.0001605812,0.00035314026,0.004170631,0.000019558414,0.00006558799,0.00016952313],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99671125,0.000411054,0.0009099964,0.00062754826,0.0008428839,0.0004972426],"domain_scores_gemma":[0.99579436,0.0013441845,0.0012754949,0.0010759493,0.0003680915,0.00014193181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044326433,0.0003809781,0.0025189356,0.000080837846,0.0010939031,0.00027860785,0.0006925191,0.000119591365,0.000052889438],"category_scores_gemma":[0.0016668866,0.00023793787,0.00013809733,0.00012419737,0.0003001267,0.00017194966,0.000513904,0.00031134606,8.990856e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90263283,0.043614298,0.017895073,0.00024604972,0.01788123,0.000022094968,0.003080762,0.00006797858,0.00020363813,0.0010829156,0.00035985847,0.012913293],"study_design_scores_gemma":[0.8233584,0.012892064,0.15009722,0.0003348035,0.012136272,9.0396884e-7,0.00040678022,0.00034711053,0.000055810615,0.000044673787,0.00007260719,0.000253337],"about_ca_topic_score_codex":0.0026552337,"about_ca_topic_score_gemma":0.0013978103,"teacher_disagreement_score":0.13220215,"about_ca_system_score_codex":0.00013584395,"about_ca_system_score_gemma":0.0005158907,"threshold_uncertainty_score":0.9702825},"labels":[],"label_agreement":null},{"id":"W2782477194","doi":"10.1182/blood.v128.22.878.878","title":"A Pilot Study in Cancer Patients with Central Venous Catheter Associated Deep Vein Thrombosis in Upper Extremity Treated with Rivaroxaban (Catheter 2)","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Central Venous Catheters and Hemodialysis","field":"Health Professions","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Jewish General Hospital; University of Ottawa; Western University; University of Calgary","funders":"","keywords":"Medicine; Rivaroxaban; Thrombosis; Surgery; Warfarin; Pulmonary embolism; Cancer; Low molecular weight heparin; Deep vein; Internal medicine","score_opus":0.032974844019983594,"score_gpt":0.30294183619153153,"score_spread":0.26996699217154796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782477194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99706304,0.00003427414,0.0000050356734,0.00013087536,0.0000920081,0.0021802993,0.00014586715,0.000079759186,0.00026882128],"genre_scores_gemma":[0.9989466,0.000034466917,0.000029339073,0.0001607999,0.0000622627,0.00046660108,0.00004698332,0.00008551613,0.0001674467],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963334,0.0005918064,0.00061416294,0.0006697249,0.00044517027,0.0013456907],"domain_scores_gemma":[0.99863416,0.00020731748,0.00029772698,0.00046058462,0.00018184737,0.00021838838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000283621,0.00040291235,0.00073916797,0.00023981399,0.0002743072,0.00001817329,0.00025898925,0.00013617131,0.0003949855],"category_scores_gemma":[0.000058876263,0.0002333318,0.00008609847,0.0005298223,0.000073154966,0.00019420023,0.00008287358,0.00046186216,0.00004198742],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005128757,0.05958987,0.930316,0.000019721718,0.00027210568,0.000013809673,0.008847454,0.0000025283694,0.0000911649,0.0000019672395,0.000026418682,0.00030611063],"study_design_scores_gemma":[0.021529155,0.0063812765,0.9705203,0.0004489818,0.0003219193,1.508698e-7,0.00032615356,0.0000057622483,0.00004116233,0.000010742661,0.000022453138,0.00039192554],"about_ca_topic_score_codex":0.010011608,"about_ca_topic_score_gemma":0.08251109,"teacher_disagreement_score":0.07249948,"about_ca_system_score_codex":0.00082720525,"about_ca_system_score_gemma":0.00021163723,"threshold_uncertainty_score":0.99658084},"labels":[],"label_agreement":null},{"id":"W2782500168","doi":"10.1182/blood.v130.suppl_1.651.651","title":"Nivolumab for Newly Diagnosed Advanced-Stage Classical Hodgkin Lymphoma (cHL): Results from the Phase 2 Checkmate 205 Study","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Stage (stratigraphy); Medicine; Classical Hodgkin lymphoma; Internal medicine; Lymphoma; Phases of clinical research; Nivolumab; Oncology; Hodgkin lymphoma; Chemotherapy; Cancer; Biology; Immunotherapy","score_opus":0.03561818650001681,"score_gpt":0.33332527162124137,"score_spread":0.29770708512122457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782500168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99105865,0.00054413493,0.000023785351,0.00287843,0.00033597407,0.0025652873,0.0012297924,0.00009969339,0.0012642696],"genre_scores_gemma":[0.9957206,0.00012423638,0.0007614722,0.00038484458,0.0005405782,0.0007631034,0.00024353119,0.0000516843,0.0014099221],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979421,0.00006342994,0.00047064185,0.00068225246,0.00038555375,0.00045602093],"domain_scores_gemma":[0.9967341,0.000780179,0.00034654242,0.0018044369,0.000102902115,0.00023188272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026671306,0.00033187502,0.0005525906,0.000033155487,0.00069997186,0.00019329092,0.00042953083,0.00011467921,0.00006164931],"category_scores_gemma":[0.0011119017,0.00021189913,0.00025565538,0.000054522614,0.00013576403,0.00015429963,0.00015118085,0.00008267599,0.00006885933],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019547481,0.15689671,0.19200313,0.000096756376,0.005023778,0.005525508,0.0057463204,0.000011157423,0.003212292,0.0010464757,0.046119623,0.56477076],"study_design_scores_gemma":[0.39199454,0.0051240544,0.5449117,0.00019029558,0.001960015,0.000020992946,0.0008263473,0.00022434471,0.009966436,0.00023320776,0.04415547,0.00039264793],"about_ca_topic_score_codex":0.0013173916,"about_ca_topic_score_gemma":0.00072270114,"teacher_disagreement_score":0.56437814,"about_ca_system_score_codex":0.00011196097,"about_ca_system_score_gemma":0.0001762401,"threshold_uncertainty_score":0.86409956},"labels":[],"label_agreement":null},{"id":"W2782542268","doi":"10.1182/blood.v130.suppl_1.739.739","title":"Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in Relapsed or Refractory Multiple Myeloma (RRMM): Updated Efficacy and Safety Analysis of Pollux","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Lenalidomide; Daratumumab; Medicine; Dexamethasone; Internal medicine; Interim analysis; Pomalidomide; Oncology; Multiple myeloma; Bortezomib; Clinical endpoint; Neutropenia; Ixazomib; Progression-free survival; Carfilzomib; Gastroenterology; Clinical trial; Chemotherapy","score_opus":0.04574990434246723,"score_gpt":0.3348571041925786,"score_spread":0.28910719985011135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782542268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99488384,0.0028112223,0.000019324953,0.00038495712,0.00006509456,0.00095721526,0.0002141153,0.00004387014,0.000620353],"genre_scores_gemma":[0.99389607,0.0018857077,0.0035017626,0.000035847213,0.000058960537,0.00003557751,0.00016887856,0.000051773834,0.00036543194],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99681085,0.0003111624,0.0007576445,0.00088972884,0.0005640466,0.0006665883],"domain_scores_gemma":[0.9960205,0.0016104447,0.00044649956,0.00115117,0.00017423737,0.0005971559],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009076099,0.00045712563,0.0014757172,0.0008245854,0.0003950361,0.00010836682,0.0002346387,0.0002946234,0.00015459044],"category_scores_gemma":[0.0041484185,0.0003597508,0.00015074463,0.0006089257,0.0006987426,0.0002517919,0.00033031128,0.00047966986,0.000005382288],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07353045,0.0027008865,0.8269658,0.00028518884,0.00985682,0.001410376,0.0008051136,0.000008346322,0.033167373,0.000045616187,0.000091720794,0.05113231],"study_design_scores_gemma":[0.1194409,0.0013121831,0.8650502,0.0002229346,0.003410397,0.00006414633,0.00022925156,0.0011272022,0.008396016,0.000010672327,0.0004106154,0.000325488],"about_ca_topic_score_codex":0.0020500808,"about_ca_topic_score_gemma":0.003470706,"teacher_disagreement_score":0.05080682,"about_ca_system_score_codex":0.00008819549,"about_ca_system_score_gemma":0.00018835216,"threshold_uncertainty_score":0.99988544},"labels":[],"label_agreement":null},{"id":"W2782888072","doi":"10.1182/blood.v130.suppl_1.484.484","title":"Assessment of Maintenance Rituximab after First-Line Bendamustine-Rituximab in Patients with Follicular Lymphoma: An Analysis from the BRIGHT Trial","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Ottawa Hospital","funders":"","keywords":"Rituximab; Vincristine; Bendamustine; Medicine; Maintenance therapy; Internal medicine; Prednisone; Follicular lymphoma; Cyclophosphamide; Surgery; Oncology; Lymphoma; Gastroenterology; Chemotherapy","score_opus":0.008873379052378016,"score_gpt":0.258439779029947,"score_spread":0.24956639997756902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782888072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977698,0.00018830477,0.000045534347,0.0005218559,0.00007820476,0.00093354867,0.0002370194,0.000015657723,0.00021008075],"genre_scores_gemma":[0.9978304,0.000040166127,0.0013297448,0.00012937532,0.0001394422,0.00022946637,0.0002491431,0.00002216107,0.000030110132],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820435,0.00006107946,0.00043854667,0.00047784307,0.000523857,0.00029433577],"domain_scores_gemma":[0.9978991,0.000092253205,0.0003429943,0.0013849731,0.00015968186,0.00012096379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018111034,0.00025741654,0.00080298405,0.00009623672,0.00016649342,0.00007094828,0.00027006448,0.00009106848,0.00010438892],"category_scores_gemma":[0.000069183436,0.00014130598,0.00025484312,0.00018368886,0.00012144874,0.00014850167,0.00008676399,0.00006978372,0.0000058791593],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004825324,0.03127221,0.96072775,0.000013979696,0.0013630926,0.00019821755,0.0000859661,0.00000668049,0.0000013313169,0.000043197433,0.000018276241,0.001443959],"study_design_scores_gemma":[0.28543544,0.00094688934,0.70928246,0.00011865819,0.003648011,0.0000014820229,0.000014671397,0.00014138265,0.00013094622,0.000021352223,0.00013926731,0.00011946944],"about_ca_topic_score_codex":0.0028406885,"about_ca_topic_score_gemma":0.0033535156,"teacher_disagreement_score":0.2806101,"about_ca_system_score_codex":0.00012041684,"about_ca_system_score_gemma":0.00013034319,"threshold_uncertainty_score":0.57622904},"labels":[],"label_agreement":null},{"id":"W2783239571","doi":"10.1182/blood.v130.suppl_1.4916.4916","title":"Protein C Infusion Therapy in an Adult Case of Severe Congenital Protein C Deficiency","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; St. Joseph's Hospital; McMaster University","funders":"","keywords":"Medicine; Bolus (digestion); Purpura fulminans; Dosing; Adverse effect; Pharmacokinetics; Protein C; Clinical trial; Transplantation; Surgery; Internal medicine","score_opus":0.030461349903111785,"score_gpt":0.29319632995609085,"score_spread":0.2627349800529791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783239571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967769,0.000054484986,0.000008570067,0.00016626081,0.000031317126,0.0013108928,0.000007637222,0.000033363838,0.0016105712],"genre_scores_gemma":[0.9984569,0.000005095645,0.0012043159,0.00005468082,0.000041203726,0.000077909106,0.0000064133815,0.000017787514,0.00013571294],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991271,0.000045613015,0.00025256863,0.00021992407,0.00018558772,0.0001692194],"domain_scores_gemma":[0.9989739,0.0000056917415,0.00016903107,0.00058924785,0.00016761008,0.00009453053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001621734,0.00012376303,0.00023688248,0.00008765441,0.00013126063,0.00002885577,0.00012716815,0.00011458561,0.00010251835],"category_scores_gemma":[0.000103913604,0.00010368843,0.000052239753,0.00007094806,0.000061982675,0.00017177772,0.000043008244,0.00012968626,0.000009872777],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019717753,0.0033457961,0.019965647,0.00009158588,0.000035600387,0.0007580929,0.0011155417,5.670796e-7,0.9577691,0.0056418558,0.0000022537606,0.011076763],"study_design_scores_gemma":[0.019850958,0.0036974975,0.08415481,0.00038588382,0.000087641914,0.0010550545,0.00072126515,0.00020427292,0.88786846,0.0016267343,0.000017473087,0.00032994422],"about_ca_topic_score_codex":0.00043965742,"about_ca_topic_score_gemma":0.00065866805,"teacher_disagreement_score":0.069900654,"about_ca_system_score_codex":0.000009589785,"about_ca_system_score_gemma":0.00009499699,"threshold_uncertainty_score":0.42282912},"labels":[],"label_agreement":null},{"id":"W2783313741","doi":"10.1182/blood-2017-09-803809","title":"A phase 1 study of azacitidine combined with chemotherapy in childhood leukemia: a report from the TACL consortium","year":2018,"lang":"en","type":"letter","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"National Cancer Institute","keywords":"Childhood leukemia; Azacitidine; Leukemia; Medicine; Chemotherapy; Chemotherapy regimen; Oncology; Pediatrics; Internal medicine; Lymphoblastic Leukemia; Biology","score_opus":0.01774558876828727,"score_gpt":0.28934808157544445,"score_spread":0.2716024928071572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783313741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8788814,0.0001787803,0.000005546535,0.11574057,0.00007978181,0.0037111267,0.00012321176,0.00007448483,0.001205112],"genre_scores_gemma":[0.84603673,0.00008648268,0.0002872347,0.14514013,0.0044916975,0.0005054736,0.0015732978,0.0002882894,0.0015906434],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9956624,0.00027913763,0.0010491421,0.0009879542,0.0013449432,0.00067640457],"domain_scores_gemma":[0.99616903,0.00047653675,0.0006465435,0.002210031,0.00037759202,0.00012024492],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0006235218,0.0006048881,0.0015376061,0.0002917712,0.00008024517,0.000035721067,0.0006329054,0.000711118,0.00031810973],"category_scores_gemma":[0.0003060048,0.0003717237,0.00016771613,0.0006864764,0.00045379868,0.00006859824,0.00015427376,0.0033616372,0.000023140217],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003703007,0.017859535,0.03025304,0.00019546052,0.004342687,0.04563453,0.0041940217,3.2775094e-7,0.0012998161,0.0000018806975,0.8922138,0.00030188652],"study_design_scores_gemma":[0.6329358,0.06583076,0.07411927,0.0028151518,0.0066520846,0.008050848,0.0034389393,0.00007878179,0.01643218,0.00015667218,0.18721433,0.002275194],"about_ca_topic_score_codex":0.0016800716,"about_ca_topic_score_gemma":0.00019728203,"teacher_disagreement_score":0.7049995,"about_ca_system_score_codex":0.00032611066,"about_ca_system_score_gemma":0.0020548222,"threshold_uncertainty_score":0.99987346},"labels":[],"label_agreement":null},{"id":"W2783856957","doi":"10.1182/blood.v130.suppl_1.2735.2735","title":"The Mutational Landscape and Immune Microenvironment of Primary Intestinal Follicular Lymphoma (PIFL)","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"Follicular lymphoma; Lymph node; Pathology; Lymphoma; Follicular hyperplasia; Medicine; Biology; Cancer research","score_opus":0.00840595834896702,"score_gpt":0.2197076728861736,"score_spread":0.2113017145372066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783856957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99099886,0.0051819496,0.0000026954754,0.0009370154,0.000031285734,0.00017259426,0.0000069885036,0.000006204465,0.002662412],"genre_scores_gemma":[0.9986067,0.0004216315,0.00063323247,0.000056745317,0.0000432006,0.00003081243,0.000018721368,0.0000072439707,0.00018175537],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994627,0.000011277547,0.0001477086,0.00012231691,0.00014938692,0.00010659768],"domain_scores_gemma":[0.9994144,0.00007442984,0.0001186215,0.00032341972,0.000019868428,0.000049296432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008560807,0.00008292698,0.0001563589,0.000013799874,0.00023334705,0.000029490673,0.00007606206,0.000024920111,0.000014637716],"category_scores_gemma":[0.0000463874,0.000050390463,0.00005987584,0.000010289601,0.0001314706,0.000029530895,0.00007493508,0.00001913956,0.000008513578],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013378811,0.001985358,0.9486128,0.000060987262,0.00046324354,0.0002546764,0.000114683884,4.4602467e-7,0.010298232,0.00063035346,0.00017734827,0.0372681],"study_design_scores_gemma":[0.0065484587,0.00021718025,0.9645328,0.00007337099,0.0002745967,0.00037530327,0.000030659063,0.000008315349,0.026686395,0.0000925987,0.0011129853,0.000047372534],"about_ca_topic_score_codex":0.000037262656,"about_ca_topic_score_gemma":0.0000028383793,"teacher_disagreement_score":0.037220728,"about_ca_system_score_codex":0.000023662735,"about_ca_system_score_gemma":0.000047246926,"threshold_uncertainty_score":0.20548634},"labels":[],"label_agreement":null},{"id":"W2784273498","doi":"10.1182/blood.v130.suppl_1.457.457","title":"Exome Sequencing Studies Identify Mutations in STAB2 As a Genetic Risk for Venous Thromboembolic Disease","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Public Health and Social Inequalities","field":"Social Sciences","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Hospital; McGill University; Queen's University","funders":"","keywords":"Odds ratio; Genetics; Exome sequencing; Genome-wide association study; Exome; Biology; Missense mutation; Nonsense mutation; Internal medicine; Medicine; Single-nucleotide polymorphism; Mutation; Gene; Genotype","score_opus":0.1453785992861189,"score_gpt":0.45858472904375613,"score_spread":0.31320612975763723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2784273498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935483,0.0015657817,0.000025395302,0.0013664621,0.00034576334,0.00053282094,0.000091467344,0.0000495254,0.0024745276],"genre_scores_gemma":[0.99754614,0.001026244,0.0001884812,0.00017073873,0.0004824724,0.00023557383,0.0000050200706,0.000011036255,0.00033430068],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.99857575,0.00023455931,0.000258346,0.00019844859,0.0002572439,0.00047563127],"domain_scores_gemma":[0.9988382,0.00031638585,0.00020063056,0.00024046791,0.0001592259,0.00024511604],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0010484332,0.00008879639,0.00023087104,0.00007158766,0.0026788188,0.00024429514,0.00030590076,0.000064612825,0.000015240854],"category_scores_gemma":[0.0065482515,0.00009320658,0.00007028877,0.00009001346,0.00035000825,0.00032030424,0.000048451297,0.000097703705,0.000018157472],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029643446,0.0009765169,0.27390987,0.00046890363,0.00031644735,0.00012343432,0.6031491,0.000033286557,0.000055222314,0.11194556,0.0003707595,0.008621253],"study_design_scores_gemma":[0.0015126289,0.00010497082,0.66958827,0.00009374795,0.0001827984,5.7473716e-7,0.10372397,0.000021825746,0.000025464346,0.220096,0.00433728,0.00031248105],"about_ca_topic_score_codex":0.020306312,"about_ca_topic_score_gemma":0.018851206,"teacher_disagreement_score":0.4994251,"about_ca_system_score_codex":0.00014624809,"about_ca_system_score_gemma":0.0013515064,"threshold_uncertainty_score":0.9990522},"labels":[],"label_agreement":null},{"id":"W2784467022","doi":"10.1182/blood.v130.suppl_1.464.464","title":"Two Cycles of Consolidation Chemotherapy Are Associated with Similar Clinical Outcomes to Three Cycles in AML Patients with Favorable Risk Cytogenetics","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Leukemia & Lymphoma Society of Canada; University of Alberta","funders":"","keywords":"Cytarabine; Medicine; Induction chemotherapy; Myeloid leukemia; Internal medicine; Chemotherapy; Oncology; Chemotherapy regimen; Leukemia; Anthracycline; Surgery; Cancer","score_opus":0.037201712826959395,"score_gpt":0.34722138044299133,"score_spread":0.31001966761603195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2784467022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99781936,0.00002068238,0.000063911335,0.0006334274,0.000023052567,0.0009044681,0.000103745886,0.00003009916,0.00040122756],"genre_scores_gemma":[0.9963958,0.00006955911,0.0030929472,0.00023291551,0.000039801616,0.00002304281,0.000042681608,0.00004890631,0.000054327702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981897,0.00010569022,0.00044009788,0.00035399233,0.0005616506,0.00034889256],"domain_scores_gemma":[0.9978638,0.0002650801,0.0005266685,0.00080203114,0.00036561675,0.00017676427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053360144,0.00020230803,0.0006482638,0.0001274947,0.0001293051,0.00003927207,0.0002958741,0.00013814964,0.000021141279],"category_scores_gemma":[0.0013149895,0.00014114067,0.00006953493,0.00014481373,0.00024035039,0.00008586498,0.000088575405,0.00034465638,0.000009860798],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063399354,0.001417982,0.9956707,0.00002016872,0.0004342793,0.000025808813,0.00012235648,0.000033350003,0.00009074326,0.0000059517492,0.00006664423,0.0014780542],"study_design_scores_gemma":[0.023937607,0.0009845736,0.9706688,0.00025822257,0.00020000442,0.0000012770957,0.00008032965,0.00007074467,0.0035534312,0.000059349924,0.000023521425,0.00016211782],"about_ca_topic_score_codex":0.00036354834,"about_ca_topic_score_gemma":0.0022142793,"teacher_disagreement_score":0.025001846,"about_ca_system_score_codex":0.0000876716,"about_ca_system_score_gemma":0.00024814307,"threshold_uncertainty_score":0.57555497},"labels":[],"label_agreement":null},{"id":"W2784569481","doi":"10.1182/blood.v114.22.3125.3125","title":"A Systematic Review and Meta-Analysis of Proportions of Thrombosis and Bleeding in Patients Receiving Venous Thromboembolism (VTE) Prophylaxis After Orthopedic Surgery (OS). An Update.","year":2009,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; London Health Sciences Centre","funders":"","keywords":"Medicine; Pulmonary embolism; Thrombosis; Randomized controlled trial; Surgery; Orthopedic surgery; Venography; Venous thrombosis; Apixaban; Pulmonary angiography; Hemostasis; Internal medicine; Rivaroxaban; Warfarin","score_opus":0.05337601304723699,"score_gpt":0.32420952250589286,"score_spread":0.27083350945865586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2784569481","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0059806393,0.9876562,0.0000011821326,0.000043140386,0.000026932752,0.0059071886,0.00029337357,0.000027374734,0.00006402046],"genre_scores_gemma":[0.0126097165,0.9853813,0.00018489847,0.00016107845,0.00001956758,0.001138481,0.00041944772,0.00006941337,0.000016061658],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9944997,0.00052652,0.0030518402,0.00084125606,0.0006672127,0.00041348027],"domain_scores_gemma":[0.9961289,0.00026986815,0.0020926718,0.0010194444,0.0002853578,0.00020375046],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0016674293,0.0006861019,0.020037705,0.0015032301,0.000057827518,0.000033926517,0.0001783326,0.0002886925,0.00033597814],"category_scores_gemma":[0.00044064896,0.00047438897,0.0018419515,0.0019573907,0.00012407538,0.00018833652,0.00015660736,0.0003256416,0.0000027098965],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000023369162,0.0041845003,0.0006677857,0.86275977,0.12621431,0.000016049782,0.0001898266,1.2733693e-7,9.022939e-8,0.000016616588,0.00008689079,0.005861701],"study_design_scores_gemma":[0.00023886331,0.00044785676,0.012154819,0.111225404,0.87498343,0.00000854744,0.000024285157,5.7008936e-7,4.3231216e-7,0.000006539773,0.00055116945,0.00035810212],"about_ca_topic_score_codex":0.0000841353,"about_ca_topic_score_gemma":0.000067160276,"teacher_disagreement_score":0.75153434,"about_ca_system_score_codex":0.00005210914,"about_ca_system_score_gemma":0.00017455411,"threshold_uncertainty_score":0.99977076},"labels":[],"label_agreement":null},{"id":"W2784746802","doi":"10.1182/blood.v130.suppl_1.4076.4076","title":"A Single Direct Intratumoral Injection of TTI-621 (SIRPαFc) Induces Antitumor Activity in Patients with Relapsed/Refractory Mycosis Fungoides and Sézary Syndrome: Preliminary Findings Employing an Immune Checkpoint Inhibitor Blocking the CD47 Do Not Eat Signal","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Therapeutics (Canada)","funders":"","keywords":"Medicine; Mycosis fungoides; Immune checkpoint; Tumor microenvironment; Internal medicine; Melanoma; Immune system; Cancer research; Cancer; Immunology; Oncology; Lymphoma; Immunotherapy","score_opus":0.014620042806377286,"score_gpt":0.2204256022449864,"score_spread":0.2058055594386091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2784746802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980204,0.001129486,0.0000021710105,0.00004111505,0.00023512896,0.00044907263,0.000022224518,0.000037336096,0.000063060164],"genre_scores_gemma":[0.9997686,0.00003636288,0.000031488034,0.00000792887,0.000026797463,0.00003145271,0.000035341167,0.00003132978,0.000030660114],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984116,0.0002746916,0.00042955496,0.0004315971,0.00010563385,0.0003469474],"domain_scores_gemma":[0.9986863,0.00012529777,0.00056251977,0.0005118652,0.00008703002,0.000026977807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049256015,0.00028215884,0.00048780997,0.00019200829,0.0007119114,0.000113666305,0.00027927954,0.0002385989,0.000015372678],"category_scores_gemma":[0.0001130992,0.0002103758,0.00008027237,0.00012770179,0.00038453756,0.00095993734,0.0002210096,0.00045784653,0.0000022347822],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093765167,0.001435262,0.25812042,0.000047356978,0.00013533678,0.0000061408823,0.0008156713,0.0000045476545,0.73436576,0.0000043465875,0.000003819075,0.0041237217],"study_design_scores_gemma":[0.0021364493,0.0019046536,0.55181634,0.00030225242,0.00008581058,0.00005129843,0.000100850004,0.0000032703228,0.4434345,0.0000059346744,0.0000068375093,0.00015180328],"about_ca_topic_score_codex":0.0003470705,"about_ca_topic_score_gemma":0.00003851065,"teacher_disagreement_score":0.29369593,"about_ca_system_score_codex":0.000056196324,"about_ca_system_score_gemma":0.000057871133,"threshold_uncertainty_score":0.8578876},"labels":[],"label_agreement":null},{"id":"W2784752532","doi":"10.1182/blood.v130.suppl_1.824.824","title":"Baseline PET-Derived Metabolic Tumor Volume Metrics Predict Progression-Free and Overall Survival in DLBCL after First-Line Treatment: Results from the Phase 3 GOYA Study","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; International Prognostic Index; Standardized uptake value; Positron emission tomography; Internal medicine; Progression-free survival; Nuclear medicine; Aggressive lymphoma; Oncology; Rituximab; Vincristine; Lymphoma; Cyclophosphamide; Chemotherapy","score_opus":0.033313893593163085,"score_gpt":0.3349638890363999,"score_spread":0.3016499954432368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2784752532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984443,0.00090081984,0.00016654875,0.0116868345,0.00006079522,0.0017538494,0.0007348864,0.00011587705,0.00013736982],"genre_scores_gemma":[0.99280447,0.0005159037,0.005061482,0.00025247026,0.00041882158,0.00053151057,0.00015229217,0.000030023562,0.00023302504],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982673,0.00010609923,0.00046238524,0.00049109966,0.00040153586,0.00027157372],"domain_scores_gemma":[0.9974836,0.0003221645,0.000212585,0.0016704252,0.000080217666,0.00023100294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007237279,0.00023578307,0.0004638988,0.000077971585,0.00024548493,0.000094368064,0.00037133705,0.000046424248,0.000060556693],"category_scores_gemma":[0.0023175378,0.0001396233,0.000075729855,0.00013808058,0.00016923712,0.000089902234,0.00027239075,0.00024024022,0.0000070814444],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021322253,0.03680291,0.9256571,0.000042879165,0.0004722985,0.0016059541,0.001311705,4.147292e-7,0.0009986719,0.000036768688,0.00533658,0.025602477],"study_design_scores_gemma":[0.092065096,0.001988377,0.86296,0.0003050602,0.0017761681,0.000055285855,0.0001340933,0.005716625,0.0018592377,0.00030206397,0.032495826,0.00034217926],"about_ca_topic_score_codex":0.0012755438,"about_ca_topic_score_gemma":0.00044648128,"teacher_disagreement_score":0.08993287,"about_ca_system_score_codex":0.000020974736,"about_ca_system_score_gemma":0.00006836259,"threshold_uncertainty_score":0.5693673},"labels":[],"label_agreement":null},{"id":"W2784767733","doi":"10.1182/blood.v130.suppl_1.3151.3151","title":"Bortezomib-Maintenance for Patients with AL Amyloidosis: A Single Center Experience","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Bortezomib; Amyloidosis; Download; Medicine; Internal medicine; Multiple myeloma; Computer science","score_opus":0.01037841510213772,"score_gpt":0.25348895721285375,"score_spread":0.24311054211071603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2784767733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979966,0.00013754796,0.00020395203,0.00033862307,0.00014354599,0.00051203533,0.00012669362,0.000019878942,0.00052111474],"genre_scores_gemma":[0.9959599,0.000064074855,0.0022232898,0.00068712095,0.00009911321,0.00047047404,0.00011927021,0.000041231455,0.00033556685],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877656,0.000014778947,0.00017218923,0.00050537096,0.00014107373,0.00039002116],"domain_scores_gemma":[0.99871475,0.000013066916,0.00021123493,0.00082505454,0.00013075458,0.00010515329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004030148,0.00023055881,0.00019363973,0.000020924099,0.00029634451,0.00009426666,0.00040392575,0.00009175475,0.000009663675],"category_scores_gemma":[0.00016695619,0.00018118802,0.00011504277,0.000020050269,0.00015503561,0.000015918991,0.00014073399,0.000041650394,0.000008568942],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018837376,0.0021953771,0.9797145,0.0000125352235,0.00020270365,0.000004507251,0.00009547432,8.286511e-7,0.013499414,0.000016750439,0.0026973854,0.0013721335],"study_design_scores_gemma":[0.020112269,0.002488816,0.56355137,0.00012727846,0.00021201374,0.000014251073,0.00015917975,0.0000047834974,0.33120283,0.000022388036,0.081309736,0.00079505664],"about_ca_topic_score_codex":0.000019261077,"about_ca_topic_score_gemma":0.000051998726,"teacher_disagreement_score":0.41616312,"about_ca_system_score_codex":0.000016609172,"about_ca_system_score_gemma":0.00003011423,"threshold_uncertainty_score":0.7388633},"labels":[],"label_agreement":null},{"id":"W2785021126","doi":"10.1182/blood.v130.suppl_1.650.650","title":"Nivolumab Treatment Beyond Investigator-Assessed Progression: Outcomes in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma from the Phase 2 Checkmate 205 Study","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Nivolumab; Brentuximab vedotin; Oncology; Refractory (planetary science); Phases of clinical research; Clinical trial; Lymphoma; Cancer; Hodgkin lymphoma; Immunotherapy","score_opus":0.020506625118198552,"score_gpt":0.3048106614559048,"score_spread":0.28430403633770623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2785021126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950704,0.0003255821,2.1649481e-7,0.0015833095,0.0001630181,0.0022274053,0.000093083305,0.0000647951,0.00047219088],"genre_scores_gemma":[0.9983882,0.000035642042,0.00025040115,0.0002563324,0.000119083925,0.00061923196,0.00012584012,0.000048446884,0.0001568546],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997803,0.00013562951,0.0004155444,0.0006190379,0.000628812,0.00039798484],"domain_scores_gemma":[0.99755126,0.00017991569,0.0003464316,0.0014858075,0.00008037656,0.00035617975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012370649,0.00043739256,0.00072829676,0.00006113299,0.00042460664,0.00016314762,0.00029027252,0.00012850543,0.000049237446],"category_scores_gemma":[0.00018010804,0.00021734594,0.00013193631,0.00008296436,0.00021377657,0.00020174072,0.000115021205,0.00010666154,0.000038072583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007393209,0.085980035,0.88237685,0.0000067765354,0.0008660933,0.00058073865,0.0006725216,9.327866e-8,0.000022625569,0.000012010294,0.00024762284,0.028495286],"study_design_scores_gemma":[0.14602906,0.008517765,0.84140515,0.00014967128,0.0009945655,0.0000031061759,0.00018614573,0.000005268253,0.0012241651,0.000023131,0.0012528304,0.00020913947],"about_ca_topic_score_codex":0.0008808314,"about_ca_topic_score_gemma":0.00046818846,"teacher_disagreement_score":0.14528973,"about_ca_system_score_codex":0.0003316845,"about_ca_system_score_gemma":0.00041729116,"threshold_uncertainty_score":0.886311},"labels":[],"label_agreement":null},{"id":"W2785116040","doi":"10.1182/blood.v130.suppl_1.1116.1116","title":"Pharmacokinetics and Pharmacodynamics of Ionis-FXIRx, an Antisense Inhibitor of Factor XI, in Patients with End-Stage Renal Disease on Hemodialysis","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; Impact; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; End stage renal disease; Pharmacodynamics; Hemodialysis; Internal medicine; Population; Pharmacokinetics; Gastroenterology; Cmax; Placebo; Surrogate endpoint; Surgery; Pathology","score_opus":0.01420449869662118,"score_gpt":0.27248990787487676,"score_spread":0.2582854091782556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2785116040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99894404,0.00012503983,0.000008056158,0.00006500177,0.00006723231,0.00033175724,0.0003707998,0.000014476201,0.00007358849],"genre_scores_gemma":[0.9993646,0.000081907776,0.00019247507,0.000044343476,0.00008941637,0.000004170048,0.00011337072,0.000024650826,0.00008505743],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99887156,0.000032811717,0.00031966905,0.00025784574,0.00034012648,0.00017801077],"domain_scores_gemma":[0.9989242,0.00003816401,0.00030741518,0.00039055437,0.00011745047,0.00022221147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007662148,0.00017223338,0.00035527523,0.0001365763,0.00008056426,0.000020003043,0.00009324117,0.00004110858,0.00006198685],"category_scores_gemma":[0.000058129546,0.00014391528,0.00006515993,0.00007677967,0.00017141624,0.00013664358,0.000041294737,0.00009144768,6.979288e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013159299,0.0020724735,0.98173505,0.00014806383,0.00011361658,0.000040547206,0.00025883838,0.00003004067,0.010799749,0.00003400732,0.000008928229,0.003442756],"study_design_scores_gemma":[0.012661618,0.0005440959,0.9158447,0.0001835849,0.00041933605,9.636904e-7,0.000015408032,0.0011451959,0.06897927,0.000009680937,0.000050532246,0.0001456258],"about_ca_topic_score_codex":0.00007414912,"about_ca_topic_score_gemma":0.00002362818,"teacher_disagreement_score":0.065890364,"about_ca_system_score_codex":0.000012695411,"about_ca_system_score_gemma":0.00007919345,"threshold_uncertainty_score":0.58686954},"labels":[],"label_agreement":null},{"id":"W2785134906","doi":"10.1182/blood.v130.suppl_1.5215.5215","title":"Patient-Reported Quality of Life (QoL) Following CTL019 Infusion in Adult Patients (pts) with Relapsed/Refractory (r/r) Diffuse Large B-Cell Lymphoma (DLBCL)","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont; McMaster University; Juravinski Hospital","funders":"","keywords":"Diffuse large B-cell lymphoma; Medicine; Quality of life (healthcare); Refractory (planetary science); Lymphoma; Chemotherapy regimen; Internal medicine; Oncology; Chemotherapy; Biology; Nursing","score_opus":0.02112061102851404,"score_gpt":0.29239476268406583,"score_spread":0.2712741516555518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2785134906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935728,0.00013251569,0.000004424822,0.000063515574,0.00018294793,0.0010214254,0.000027327023,0.00005159568,0.0049434747],"genre_scores_gemma":[0.9985322,0.00008674393,0.00013750514,0.00015540633,0.000060684633,0.000044938013,0.000078584606,0.00007140582,0.00083253434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964497,0.00020086393,0.0009239186,0.0005457804,0.0012915942,0.0005881545],"domain_scores_gemma":[0.9966897,0.0001596267,0.00076069764,0.0016416227,0.00040699603,0.00034139492],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006401984,0.0002991845,0.0007554194,0.00023592226,0.00020470643,0.000043161417,0.00029928537,0.00023812738,0.00013854163],"category_scores_gemma":[0.0015649326,0.00024584914,0.00024054165,0.00020659633,0.00009525384,0.00024608336,0.00025650644,0.00033525628,0.000020553638],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00209519,0.03459217,0.924667,0.0002265854,0.00022081203,0.0001786964,0.0011740254,1.8442782e-7,0.03161117,0.000012811289,0.00007304356,0.0051482855],"study_design_scores_gemma":[0.16130899,0.0017496259,0.81979316,0.00042122265,0.00015276388,0.0000050208546,0.0002889522,0.000022554319,0.015265648,0.000015396736,0.00066127523,0.00031537403],"about_ca_topic_score_codex":0.0015493401,"about_ca_topic_score_gemma":0.0004611597,"teacher_disagreement_score":0.1592138,"about_ca_system_score_codex":0.00013022381,"about_ca_system_score_gemma":0.00037415154,"threshold_uncertainty_score":0.9999994},"labels":[],"label_agreement":null},{"id":"W2785190631","doi":"10.1182/blood.v130.suppl_1.2545.2545","title":"Importance of Mitochondrial Metabolism As a Selective Therapeutic Approach in Chronic Lymphocytic Leukemia Patients","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Biochemical and Molecular Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"","keywords":"Chronic lymphocytic leukemia; Bioenergetics; Mitochondrion; Cancer research; Oligomycin; NAD+ kinase; Biology; Reactive oxygen species; Cancer cell; Inner mitochondrial membrane; Viability assay; Leukemia; Biochemistry; Apoptosis; Chemistry; Cancer; Immunology; Enzyme; ATPase","score_opus":0.010347857401133191,"score_gpt":0.26567148395538126,"score_spread":0.25532362655424806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2785190631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99492186,0.0016150374,0.00005755408,0.00000878939,0.000051195835,0.00030968976,0.000011653162,0.000004575208,0.0030196225],"genre_scores_gemma":[0.99906564,0.00012151238,0.00028670914,0.00005473195,0.00016386782,0.00005807066,0.000059143265,0.000020632655,0.00016970396],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988659,0.000047932863,0.00019638486,0.00038899216,0.00020097675,0.0002998382],"domain_scores_gemma":[0.9990978,0.0000051112456,0.00013209823,0.00059602456,0.00009724493,0.00007167446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008199675,0.00014581761,0.00019884077,0.000036574253,0.000075150674,0.000025068624,0.00045465984,0.00016850024,0.000005275861],"category_scores_gemma":[0.00012292116,0.0001299746,0.00010510756,0.000060029313,0.00015718462,0.000005145015,0.00019682063,0.00012296607,0.0000047794483],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016459286,0.00017513632,0.007154407,0.000038818074,0.000119339944,0.0000035612554,0.000025867655,0.000010685409,0.99135584,0.00009166856,0.000066358676,0.0007937078],"study_design_scores_gemma":[0.005232692,0.00026319746,0.02736977,0.000013919601,0.000042792006,0.000005962508,0.0000058048126,0.000064558175,0.96594346,0.00019796628,0.0006852338,0.00017465335],"about_ca_topic_score_codex":0.00017502572,"about_ca_topic_score_gemma":0.00003939711,"teacher_disagreement_score":0.025412407,"about_ca_system_score_codex":0.0001543284,"about_ca_system_score_gemma":0.000941825,"threshold_uncertainty_score":0.5300211},"labels":[],"label_agreement":null},{"id":"W2785287594","doi":"10.1182/blood.v130.suppl_1.299.299","title":"Mitochondrial Carrier Homolog 2 (MTCH2) Regulates the Differentiation of AML Cells By Controlling Pyruvate Entry into the Mitochondria, Nuclear Localization of Pyruvate Dehydrogenase Complex and H3 and H4 Histone Acetylation","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Biology; Haematopoiesis; Cell biology; Stem cell; Mitochondrion; Gene knockdown; Molecular biology; Cancer research; Cell culture; Genetics","score_opus":0.010357158832103147,"score_gpt":0.2577830226473378,"score_spread":0.24742586381523468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2785287594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99577236,0.0010641352,0.00062933966,0.001311697,0.00014424634,0.00091951643,0.000042527117,0.000020147892,0.000096017946],"genre_scores_gemma":[0.99851507,0.00049410795,0.00039510767,0.00009278204,0.00016586439,0.000018328232,0.000080711514,0.00003484597,0.0002031586],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984894,0.00016229255,0.0004398937,0.00030169365,0.00037350436,0.00023324952],"domain_scores_gemma":[0.9983346,0.00019224752,0.00050223625,0.00065751164,0.00021381315,0.00009957927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027214014,0.00018898453,0.00041400135,0.00007313624,0.0005256475,0.00006933933,0.00023387461,0.0001610311,0.00003969284],"category_scores_gemma":[0.00029386446,0.000122007266,0.000076297394,0.000087265274,0.0007963497,0.0001378932,0.00016387182,0.00022082492,0.000001732673],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050195603,0.00013575985,0.003377135,0.00013093813,0.00024215863,0.000003590547,0.0022449936,0.00003665313,0.99068445,0.00011098703,0.001449018,0.0010823748],"study_design_scores_gemma":[0.015495141,0.00041908794,0.0134327235,0.00017999538,0.0010222931,0.000021051348,0.00057222194,0.04646253,0.9192023,0.0005239357,0.0024238112,0.00024485972],"about_ca_topic_score_codex":0.00055506965,"about_ca_topic_score_gemma":0.000052872816,"teacher_disagreement_score":0.071482085,"about_ca_system_score_codex":0.000055530312,"about_ca_system_score_gemma":0.00006239884,"threshold_uncertainty_score":0.4975312},"labels":[],"label_agreement":null},{"id":"W2785430226","doi":"10.1182/blood.v128.22.4645.4645","title":"Preliminary Results of FDG-PET Scanning after GDP Chemotherapy Prior to Autologous Stem Cell Transplant (ASCT) for Relapsed/Refractory (RR) Lymphoma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Autologous stem-cell transplantation; Chemotherapy regimen; Gemcitabine; Internal medicine; Progression-free survival; Salvage therapy; Diffuse large B-cell lymphoma; Chemotherapy; Transplantation; Lymphoma; Oncology; Nuclear medicine","score_opus":0.010632128441959598,"score_gpt":0.23622632263690035,"score_spread":0.22559419419494076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2785430226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99473226,0.0011793046,0.0000994438,0.0013829342,0.00014305346,0.0012374264,0.0004821095,0.00007920444,0.0006642516],"genre_scores_gemma":[0.9940349,0.00025159869,0.0023693023,0.0004435026,0.00012477345,0.00046054195,0.000023428354,0.00005750762,0.002234456],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99827415,0.000036850313,0.00051659095,0.0005005411,0.00026192205,0.00040994716],"domain_scores_gemma":[0.9986578,0.0003104743,0.00016797554,0.0005332081,0.0000988939,0.00023164676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017584342,0.00028068625,0.00051648583,0.0001254283,0.0000541536,0.000009319471,0.00012575835,0.00012751431,0.0000320284],"category_scores_gemma":[0.00002004235,0.00017942075,0.00023198502,0.00009984639,0.000052869065,0.00006781879,0.00002337537,0.000033561515,0.000038464706],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09169813,0.031939697,0.08824122,0.001693856,0.0020736142,0.0034490346,0.013371795,0.000005281387,0.11887246,0.000064358595,0.014534341,0.6340562],"study_design_scores_gemma":[0.08114245,0.011305448,0.32100442,0.0017172166,0.0009964069,0.0003614009,0.00012221154,0.000008813985,0.5622991,0.000015710291,0.02061476,0.0004120665],"about_ca_topic_score_codex":0.000044982244,"about_ca_topic_score_gemma":0.000008968615,"teacher_disagreement_score":0.63364416,"about_ca_system_score_codex":0.0001366026,"about_ca_system_score_gemma":0.00019654595,"threshold_uncertainty_score":0.73165655},"labels":[],"label_agreement":null},{"id":"W2785461701","doi":"10.1182/blood.v130.suppl_1.2141.2141","title":"Sexual Health in Patients with Hemophilia; The Insights from the Patient Reported Outcomes, Burdens and Experiences (PROBE) Study","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; Canadian Hemophilia Society; McMaster University","funders":"","keywords":"Medicine; Logistic regression; Reproductive health; Health care; Pediatrics; Joint pain; Quality of life (healthcare); Physical therapy; Population; Internal medicine","score_opus":0.034731845609815765,"score_gpt":0.31136195884448087,"score_spread":0.27663011323466513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2785461701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99297726,0.00029126147,1.7922622e-7,0.0046930984,0.0000611412,0.0018143409,0.0000049846562,0.000015312402,0.0001424332],"genre_scores_gemma":[0.9993539,0.000011924803,0.00002858725,0.00024066088,0.0000487612,0.00011026316,0.00001500798,0.000012092534,0.00017879656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985506,0.00010868441,0.0002722962,0.00032809444,0.0005046422,0.00023566655],"domain_scores_gemma":[0.9986566,0.0000998921,0.00016672374,0.0008976349,0.0000654185,0.00011376084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016845675,0.00015138854,0.00029675657,0.00003285403,0.00060704804,0.00007782316,0.00018318636,0.000036556623,0.000013015014],"category_scores_gemma":[0.00015126578,0.00005716253,0.000020850905,0.00006788503,0.00020657394,0.000065896646,0.00013482722,0.00019900866,0.0000029568164],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011194471,0.002074192,0.96479434,0.000004697551,0.0001606767,0.00008599087,0.030325461,5.1765102e-8,0.000004090293,0.0000028038303,0.00005624869,0.0023795185],"study_design_scores_gemma":[0.0067318813,0.0022883026,0.97545004,0.000039466373,0.00006036473,0.000003827608,0.015174434,0.0000024865546,0.00004157709,0.000020612282,0.00011601646,0.0000710217],"about_ca_topic_score_codex":0.0021381786,"about_ca_topic_score_gemma":0.0010271497,"teacher_disagreement_score":0.015151027,"about_ca_system_score_codex":0.000024955538,"about_ca_system_score_gemma":0.00011996272,"threshold_uncertainty_score":0.4668984},"labels":[],"label_agreement":null},{"id":"W2785579624","doi":"10.1182/blood.v116.21.113.113","title":"Gemcitabine, Dexamethasone, and Cisplatin (GDP) Is An Effective and Well-Tolerated out-Patient Salvage Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) and Hodgkin Lymphoma (HL)","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency","funders":"","keywords":"Gemcitabine; Salvage therapy; Medicine; Internal medicine; Regimen; Oncology; Dexamethasone; Refractory (planetary science); Chemotherapy regimen; Diffuse large B-cell lymphoma; Transplantation; Surgery; Chemotherapy; Gastroenterology","score_opus":0.008520843326517624,"score_gpt":0.24411519858818992,"score_spread":0.2355943552616723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2785579624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926878,0.0037339935,0.000021828955,0.00020004007,0.00023193221,0.0023513932,0.00020368776,0.00010433278,0.000464954],"genre_scores_gemma":[0.9950858,0.0010597415,0.0018281195,0.0010185845,0.00015555914,0.0004884619,0.00009806605,0.00009892672,0.00016678237],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99772745,0.00012009265,0.000404845,0.0009009126,0.0002865104,0.0005601919],"domain_scores_gemma":[0.9979997,0.0005771919,0.00020851925,0.000551102,0.00014972586,0.00051375583],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028795598,0.00054046087,0.0007127589,0.00017346996,0.00029397363,0.00012254641,0.00008399638,0.00035750965,0.00003500063],"category_scores_gemma":[0.00009910147,0.00042413603,0.0001170178,0.000137846,0.00016827129,0.00022159632,0.00008536542,0.00013051824,0.000011350869],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030300003,0.07726368,0.5311371,0.00039509533,0.0012117646,0.0004063935,0.010875218,8.345735e-8,0.056549966,0.000317905,0.0014348358,0.31737792],"study_design_scores_gemma":[0.19203216,0.006529164,0.68561774,0.00011216573,0.00076195813,0.00023417911,0.0003894224,0.00032286978,0.10409636,0.00011502337,0.009171887,0.00061708834],"about_ca_topic_score_codex":0.00017489771,"about_ca_topic_score_gemma":0.00015711716,"teacher_disagreement_score":0.31676084,"about_ca_system_score_codex":0.000059036032,"about_ca_system_score_gemma":0.00009226735,"threshold_uncertainty_score":0.99982107},"labels":[],"label_agreement":null},{"id":"W2785907460","doi":"10.1182/blood.v130.suppl_1.5211.5211","title":"Clinical Pharmacology of CTL019 in Patients with Relapsed/Refractory (r/r) Diffuse Large B-Cell Lymphoma (DLBCL)","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Hospital","funders":"","keywords":"Oncology; Biology; Internal medicine; Proportional hazards model; Diffuse large B-cell lymphoma; Medicine; Pharmacology; Lymphoma","score_opus":0.024839222204071004,"score_gpt":0.34428355097916125,"score_spread":0.3194443287750902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2785907460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915831,0.00013502546,0.00000144843,0.00011018463,0.00030911167,0.0005910455,0.000022078375,0.000020832806,0.0072271787],"genre_scores_gemma":[0.9963604,0.00017653253,0.0001139026,0.00019117875,0.0002490918,0.000018897104,0.000020549705,0.00004265386,0.0028267961],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982254,0.00014574634,0.00043598257,0.0003494213,0.00042384933,0.00041958925],"domain_scores_gemma":[0.99840254,0.00017585517,0.00025430857,0.0008155301,0.00015095422,0.00020083073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005419591,0.00015827011,0.0005081967,0.00013110621,0.00007694232,0.000012785615,0.00032590824,0.0001902263,0.0007684747],"category_scores_gemma":[0.00014967383,0.00012577181,0.000116783965,0.000078571094,0.00023943055,0.00008796062,0.00016140053,0.00034383775,0.000055916964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024935408,0.057529278,0.9271463,0.00008064919,0.00014979465,0.00013006097,0.00010686,3.9933724e-8,0.0065651042,0.000004476145,0.0006037563,0.005190126],"study_design_scores_gemma":[0.18412736,0.0020104984,0.79990774,0.000055752804,0.00013162353,0.000003708934,0.000014470931,0.000007195452,0.007471121,0.000004531102,0.006153928,0.0001120814],"about_ca_topic_score_codex":0.00005286726,"about_ca_topic_score_gemma":0.000033581506,"teacher_disagreement_score":0.18163382,"about_ca_system_score_codex":0.00004500808,"about_ca_system_score_gemma":0.00021437967,"threshold_uncertainty_score":0.84142596},"labels":[],"label_agreement":null},{"id":"W2786335525","doi":"10.1182/blood.v130.suppl_1.2722.2722","title":"The Fanconi Pathway in Pediatric T-Cell Acute Lymphoblastic Leukemia","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Fanconi anemia; Biology; Cancer research; Genetics; Germline mutation; Mutation; FANCD2; DNA repair; Molecular biology; Gene","score_opus":0.01210409649618236,"score_gpt":0.2645586992804755,"score_spread":0.2524546027842931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2786335525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9658401,0.00062227616,0.00005234105,0.0006569534,0.00029833286,0.00050716667,0.000013235364,0.000062520536,0.03194705],"genre_scores_gemma":[0.99207836,0.00085219863,0.00023764386,0.00014294907,0.00064807275,0.00007783256,0.00000710017,0.000052029172,0.005903797],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977415,0.000059078775,0.00037787572,0.00042849933,0.0006203012,0.00077271566],"domain_scores_gemma":[0.9975485,0.00045170487,0.00019119515,0.0014252119,0.00011565785,0.0002677375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047891555,0.00024148308,0.0003540375,0.00013731392,0.00059489167,0.0001928801,0.0007868497,0.0001847084,0.000037330123],"category_scores_gemma":[0.0007729436,0.00016142333,0.0001243765,0.00018181559,0.00023444521,0.00013831141,0.00035701998,0.00040097593,0.0005259813],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029021257,0.0047495617,0.83409,0.0013583918,0.0012267773,0.021674149,0.0020509164,0.000054513577,0.052752607,0.002579001,0.032832712,0.043729242],"study_design_scores_gemma":[0.10281831,0.0018824626,0.7744982,0.00030478672,0.0015660538,0.0016784613,0.0003251378,0.004033235,0.08972101,0.0011342901,0.020690454,0.0013476083],"about_ca_topic_score_codex":0.00017322123,"about_ca_topic_score_gemma":0.0000924444,"teacher_disagreement_score":0.09991618,"about_ca_system_score_codex":0.00062463805,"about_ca_system_score_gemma":0.0025265734,"threshold_uncertainty_score":0.6760601},"labels":[],"label_agreement":null},{"id":"W2786634922","doi":"10.1182/blood.v128.22.873.873","title":"Novel Insights into the Clinical Phenotype and Pathophysiology Underlying Low VWF Levels: The Low Von Willebrand Factor in Ireland Cohort (LoVIC) Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Von Willebrand factor; Von Willebrand disease; Medicine; Cohort; Internal medicine; Prospective cohort study; Gastroenterology; Cohort study; Immunology; Platelet","score_opus":0.043675429767485674,"score_gpt":0.31398307324735664,"score_spread":0.27030764347987096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2786634922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99737126,0.000681985,0.000033461,0.00062266295,0.00012027199,0.0009072561,0.0000062149047,0.000019267352,0.00023763135],"genre_scores_gemma":[0.999046,0.0003420802,0.000029107223,0.0003511227,0.000065537424,0.000037958012,0.0000037593184,0.000018893432,0.000105502666],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988108,0.00012986524,0.00032399438,0.00035426766,0.00016429306,0.0002167461],"domain_scores_gemma":[0.998953,0.0005112154,0.00008317811,0.0003433012,0.00003441793,0.000074874115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019897669,0.00017843138,0.00040993703,0.00004240985,0.00013912558,0.00001704255,0.00010979607,0.00011512592,0.000018122033],"category_scores_gemma":[0.00014262594,0.00007156494,0.000058615144,0.00010775562,0.00016632491,0.00006070227,0.000073704075,0.00018566125,0.000020659769],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025677762,0.0034410816,0.96740013,0.000018356117,0.00053853,0.00015135838,0.0023259656,3.0372905e-7,0.006034121,0.00006584693,0.000017559176,0.019749941],"study_design_scores_gemma":[0.014493724,0.0008091966,0.98280585,0.00008494891,0.00021187821,0.000016650723,0.00042747037,0.000011487415,0.000099246,0.0007788926,0.00014999452,0.000110653775],"about_ca_topic_score_codex":0.00014613022,"about_ca_topic_score_gemma":0.00091673865,"teacher_disagreement_score":0.019639289,"about_ca_system_score_codex":0.000015402222,"about_ca_system_score_gemma":0.00008055541,"threshold_uncertainty_score":0.29183334},"labels":[],"label_agreement":null},{"id":"W2787624638","doi":"10.1182/blood-2017-06-792267","title":"Dual PD1/LAG3 immune checkpoint blockade limits tumor development in a murine model of chronic lymphocytic leukemia","year":2018,"lang":"en","type":"letter","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":139,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Chronic lymphocytic leukemia; Tumor microenvironment; Stromal cell; Cancer research; Immune checkpoint; Immune system; Blockade; Ibrutinib; Leukemia; Medicine; Immunology; Biology; Immunotherapy; Receptor; Internal medicine","score_opus":0.028136847163922007,"score_gpt":0.2685611499825817,"score_spread":0.24042430281865967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2787624638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97861934,0.004365695,0.000037146154,0.010914476,0.00034505315,0.0024679126,0.0000672729,0.0002112432,0.0029718538],"genre_scores_gemma":[0.856039,0.0012119764,0.010590303,0.0602504,0.0176881,0.001764862,0.0020979492,0.001461023,0.0488964],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9921099,0.00013966674,0.002246385,0.001401804,0.0021592362,0.0019429867],"domain_scores_gemma":[0.99639297,0.00024864578,0.0006609708,0.0019317495,0.0004532604,0.0003124294],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0009036305,0.0010456437,0.0022485629,0.001017449,0.00009783131,0.000042524483,0.00083638466,0.0012991732,0.00037007986],"category_scores_gemma":[0.00043992538,0.0009718954,0.0004703063,0.0007541831,0.00055945636,0.00009955544,0.0006850201,0.0023892294,0.00044378778],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.004684912,0.007991155,0.00027062092,0.07916726,0.011781606,0.09905479,0.00886328,0.00664479,0.27339312,0.00004535645,0.5013321,0.0067710215],"study_design_scores_gemma":[0.15599683,0.0015010583,0.00022159785,0.008384299,0.00135672,0.0061051883,0.00004673432,0.12029076,0.62690014,0.00008942336,0.076993085,0.0021141574],"about_ca_topic_score_codex":0.0013780752,"about_ca_topic_score_gemma":0.0001674121,"teacher_disagreement_score":0.424339,"about_ca_system_score_codex":0.13155814,"about_ca_system_score_gemma":0.17502716,"threshold_uncertainty_score":0.9999974},"labels":[],"label_agreement":null},{"id":"W2787698700","doi":"10.1182/blood.v128.22.5782.5782","title":"Low-Dose Anti-Thymocyte Globulin for Graft-Versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplant","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Thymoglobulin; Medicine; Hematopoietic stem cell transplantation; Graft-versus-host disease; Internal medicine; Anti-thymocyte globulin; Cumulative incidence; Transplantation; Incidence (geometry); Single Center; Gastroenterology; Retrospective cohort study; Immunology; Surgery; Tacrolimus","score_opus":0.017022274227241552,"score_gpt":0.24579756625537977,"score_spread":0.2287752920281382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2787698700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936745,0.00097364775,0.001402504,0.0005416417,0.00028682046,0.0024446063,0.0002267501,0.00019846675,0.0002510586],"genre_scores_gemma":[0.9978114,0.00048076888,0.00057399157,0.0000900935,0.00007950164,0.00029521217,0.00009669664,0.000101712925,0.00047064607],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99717176,0.00011141155,0.0008040177,0.00073012296,0.0004787364,0.00070393],"domain_scores_gemma":[0.99827904,0.00037515818,0.0001545145,0.0005937243,0.000117122945,0.0004804719],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034848892,0.00043352228,0.00068984256,0.00024520053,0.000069706606,0.000021548982,0.00021480679,0.00029453574,0.000111434645],"category_scores_gemma":[0.00002416409,0.0003226911,0.00027277338,0.00038045496,0.000097015574,0.00011527088,0.0000180408,0.00017985221,0.00021019306],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0083530415,0.005148951,0.050698448,0.0076841824,0.00046113785,0.0027151443,0.0038852068,0.000018905957,0.9192149,0.0002660497,0.00006231712,0.0014917064],"study_design_scores_gemma":[0.07371715,0.0014970286,0.041773688,0.0031242734,0.001664945,0.0001730159,0.00038306785,0.000072376395,0.87639385,0.00010836589,0.00020815509,0.0008840649],"about_ca_topic_score_codex":0.000017143813,"about_ca_topic_score_gemma":0.000019994979,"teacher_disagreement_score":0.06536411,"about_ca_system_score_codex":0.00009402752,"about_ca_system_score_gemma":0.00030788366,"threshold_uncertainty_score":0.9999225},"labels":[],"label_agreement":null},{"id":"W2788028374","doi":"10.1182/blood.v130.suppl_1.3713.3713","title":"Comparing Medication Adherence Tools for the Direct Oral Anticoagulants Rivaroxaban and Apixaban","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Apixaban; Rivaroxaban; Medicine; Dosing; Pill; Medical prescription; Anticoagulant; Randomized controlled trial; Pharmacy; Internal medicine; Emergency medicine; Warfarin; Atrial fibrillation; Pharmacology","score_opus":0.6902669640918389,"score_gpt":0.5786185704270361,"score_spread":0.11164839366480273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2788028374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862747,0.0012721263,0.000087617795,0.005517633,0.0010235368,0.0007880784,0.00009442834,0.00007427537,0.0048676115],"genre_scores_gemma":[0.99744725,0.0005308439,0.00010514352,0.0010819301,0.00043424926,0.00010804541,0.000017429657,0.000012963259,0.00026215962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987773,0.00018274465,0.0002373222,0.00027615382,0.00011443065,0.00041209682],"domain_scores_gemma":[0.9981118,0.001018319,0.0001754994,0.0003498647,0.000065268294,0.00027923993],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0010302153,0.0001565326,0.00026732418,0.000022328766,0.0017005403,0.00015223195,0.0005049045,0.00028846698,0.0001472181],"category_scores_gemma":[0.00064679136,0.00011661589,0.000052395815,0.000031495696,0.00041911128,0.0002478591,0.00014097318,0.0007287528,0.000024355135],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048152593,0.0008882556,0.8312861,0.0003253728,0.0008115884,0.000036242436,0.00094147224,0.00001743288,0.015551941,0.006457069,0.0052029197,0.13800013],"study_design_scores_gemma":[0.010065793,0.00033609004,0.718086,0.00012014559,0.0016279139,0.0000895271,0.0002952157,0.015690343,0.08947455,0.0015323836,0.16206329,0.000618759],"about_ca_topic_score_codex":0.00007326948,"about_ca_topic_score_gemma":0.00006802476,"teacher_disagreement_score":0.15686037,"about_ca_system_score_codex":0.000012171626,"about_ca_system_score_gemma":0.000059006456,"threshold_uncertainty_score":0.9995991},"labels":[],"label_agreement":null},{"id":"W2788380546","doi":"10.1182/blood-2017-12-820605","title":"High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":244,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"BCL6; Lymphoma; Diffuse large B-cell lymphoma; Biology; Cancer research; Medicine; Pathology; B cell; Antibody; Immunology; Germinal center","score_opus":0.00948183249674868,"score_gpt":0.2246054535518878,"score_spread":0.2151236210551391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2788380546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952805,0.0011789772,0.00001492617,0.00044670835,0.00007445639,0.00068748684,0.00005782607,0.0001036585,0.0021554711],"genre_scores_gemma":[0.9931768,0.00060431147,0.0029144776,0.0010256374,0.00020792626,0.00013484985,0.000055347235,0.00007381236,0.001806804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804705,0.000054682547,0.0002611922,0.0006999048,0.00033734716,0.0005998113],"domain_scores_gemma":[0.9987546,0.00007867818,0.00014220671,0.000554928,0.000096448435,0.00037309097],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000102527025,0.00041783613,0.0005712037,0.00013194402,0.00020769048,0.00005401135,0.000099789,0.00015674929,0.000091936425],"category_scores_gemma":[0.00001209976,0.00025094167,0.00004594808,0.00021045253,0.0002987203,0.00010066458,0.00010752132,0.000047588568,0.000078516256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057765506,0.13925532,0.81735307,0.0005789223,0.0017470149,0.00789747,0.0021253277,9.97135e-8,0.009035294,0.00046624016,0.004957138,0.010807548],"study_design_scores_gemma":[0.39142632,0.013956837,0.48104128,0.00031916707,0.0026164148,0.002883656,0.00046447385,0.000018795328,0.094106734,0.000032993143,0.01244552,0.00068780343],"about_ca_topic_score_codex":0.00039061563,"about_ca_topic_score_gemma":0.0002031052,"teacher_disagreement_score":0.38564977,"about_ca_system_score_codex":0.00007116282,"about_ca_system_score_gemma":0.00014339302,"threshold_uncertainty_score":0.9999943},"labels":[],"label_agreement":null},{"id":"W2788782730","doi":"10.1182/blood-2018-01-827725","title":"A Ser725Arg mutation in Band 3 abolishes transport function and leads to anemia and renal tubular acidosis","year":2018,"lang":"en","type":"letter","venue":"Blood","topic":"Metabolism and Genetic Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Alberta","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Canadian Institutes of Health Research","keywords":"Renal tubular acidosis; Anemia; Medicine; Mutation; Distal renal tubular acidosis; Renal function; Acidosis; Internal medicine; Chemistry; Biochemistry","score_opus":0.004740537911903842,"score_gpt":0.20214251524685717,"score_spread":0.19740197733495332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2788782730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986409,0.004164269,0.0001479152,0.008357785,0.00015290768,0.00029526977,0.00006032595,0.000008029406,0.00040447462],"genre_scores_gemma":[0.8553387,0.0023115666,0.0010081507,0.13216896,0.0042898725,0.0001597871,0.0025760576,0.00011918396,0.0020277344],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987413,0.000049717146,0.00022648109,0.00057839724,0.00014662658,0.00025747702],"domain_scores_gemma":[0.99956816,0.000006193428,0.00006009858,0.0002491885,0.000048377235,0.00006796679],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001331351,0.00025177945,0.00024810387,0.000109654444,0.000045144847,0.00003321277,0.0000945052,0.0005862685,0.000030184388],"category_scores_gemma":[0.000021683036,0.00025276936,0.000044274213,0.000091481495,0.00007992239,0.00000483624,0.000027395994,0.00020421446,0.0000049479536],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046736372,0.00027621168,0.07619417,0.0008483724,0.00033149007,0.00018574052,0.0007585441,0.000016589704,0.5029497,0.000007476066,0.4085368,0.009427547],"study_design_scores_gemma":[0.0034104679,0.00068521756,0.12280153,0.0000928992,0.00051428244,0.00007561918,0.000045732173,0.0000017086523,0.078483485,0.0001921093,0.7929383,0.00075865205],"about_ca_topic_score_codex":0.000048356433,"about_ca_topic_score_gemma":0.00015132711,"teacher_disagreement_score":0.42446622,"about_ca_system_score_codex":0.0000014026914,"about_ca_system_score_gemma":0.000044246935,"threshold_uncertainty_score":0.99999243},"labels":[],"label_agreement":null},{"id":"W2788918661","doi":"10.1182/blood-2017-09-808907","title":"Somatic IL4R mutations in primary mediastinal large B-cell lymphoma lead to constitutive JAK-STAT signaling activation","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Deutsche Krebshilfe; Michael Smith Health Research BC; Canadian Institutes of Health Research; Canada's Michael Smith Genome Sciences Centre; European Hematology Association","keywords":"stat; Biology; JAK-STAT signaling pathway; Gene; Cancer research; Somatic cell; Signal transduction; Immunology; Genetics; Receptor tyrosine kinase","score_opus":0.0192351612244417,"score_gpt":0.29143483890282246,"score_spread":0.27219967767838077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2788918661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98274416,0.00006332524,0.0022288659,0.00026979123,0.00008842371,0.00081142434,0.000018073666,0.00007272661,0.013703238],"genre_scores_gemma":[0.994417,0.000005162222,0.004080495,0.0005294349,0.0003250963,0.00008769118,0.00008181669,0.00002976032,0.00044350725],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99805355,0.000077309196,0.0003766729,0.00036758877,0.00057779637,0.0005470928],"domain_scores_gemma":[0.9987514,0.00039922073,0.000081060636,0.00030353456,0.00024229966,0.0002224529],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003872369,0.00017817908,0.00030522834,0.00033584825,0.00013100995,0.000029785642,0.0001381145,0.000106935084,0.00013949454],"category_scores_gemma":[0.0006745688,0.00016997218,0.000056313056,0.00064093794,0.00021173764,0.00015345715,0.00010383151,0.00014206533,0.0005062233],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00211666,0.023336835,0.013171315,0.002464271,0.00053916295,0.0022662592,0.03307971,0.00011906277,0.901677,0.0012753553,0.0019432707,0.018011061],"study_design_scores_gemma":[0.16815732,0.0011673032,0.015796013,0.0015194785,0.00031251783,0.00051410607,0.0028744482,0.006301019,0.80118483,0.00036854434,0.0012286794,0.00057574006],"about_ca_topic_score_codex":0.00018179014,"about_ca_topic_score_gemma":0.00007676187,"teacher_disagreement_score":0.16604067,"about_ca_system_score_codex":0.003989544,"about_ca_system_score_gemma":0.006778886,"threshold_uncertainty_score":0.99983394},"labels":[],"label_agreement":null},{"id":"W2789089139","doi":"10.1182/blood-2017-07-795278","title":"Fine-tuning of FOXO3A in cHL as a survival mechanism and a hallmark of abortive plasma cell differentiation","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"FOXO transcription factor regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Cell biology; Cellular differentiation; Biology; Mechanism (biology); Chemistry; Cancer research; Genetics; Physics; Gene","score_opus":0.007061226995222686,"score_gpt":0.21554754993762398,"score_spread":0.2084863229424013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789089139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99828917,0.00006299971,0.00097417965,0.000011551544,0.000052364667,0.0000994066,0.000014150171,0.0000032718308,0.00049288815],"genre_scores_gemma":[0.999532,0.000017986009,0.00030220457,0.0000037764464,0.000030659507,0.0000038511685,0.00004469193,0.000007979008,0.00005686639],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994967,0.000035477184,0.00016236075,0.00014416168,0.00008236438,0.00007894644],"domain_scores_gemma":[0.999703,0.000007062365,0.000093278206,0.00010536754,0.00006986031,0.000021421049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007486378,0.000069255635,0.00010278497,0.000047123565,0.000013996954,0.0000034530376,0.000045642406,0.000083584935,0.000012903179],"category_scores_gemma":[0.00002342386,0.00007111673,0.000027530312,0.000054653876,0.000046940353,0.000003667691,0.00002139001,0.000027185399,8.274513e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006615898,0.00012901492,0.010990481,0.000028140523,0.000021618214,2.7014696e-7,0.00022695243,0.0000023560435,0.98803216,0.00038162648,0.0000026291914,0.00011857377],"study_design_scores_gemma":[0.0013922078,0.00035055788,0.07142939,0.000017993125,0.000023604885,0.0000012923947,0.000052281364,0.00013389037,0.9262218,0.0002793512,0.000034991743,0.000062683226],"about_ca_topic_score_codex":0.00004970093,"about_ca_topic_score_gemma":0.00030287015,"teacher_disagreement_score":0.06181042,"about_ca_system_score_codex":0.0000029601424,"about_ca_system_score_gemma":0.00002250214,"threshold_uncertainty_score":0.2900056},"labels":[],"label_agreement":null},{"id":"W2790683955","doi":"10.1182/blood-2017-10-811455","title":"Cell-extrinsic hematopoietic impact of Ezh2 inactivation in fetal liver endothelial cells","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Heart and Stroke Foundation; Hospital for Sick Children","funders":"Medical Research Council; University of Oxford","keywords":"Haematopoiesis; Fetus; Endothelium; Biology; EZH2; Immunology; Cell biology; Endothelial stem cell; Cell; Cancer research; Stem cell; Histone; Pregnancy; Genetics; Gene; In vitro","score_opus":0.007722143124875004,"score_gpt":0.23909725780475702,"score_spread":0.231375114679882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790683955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99084294,0.00032335575,0.000028046608,0.000036558777,0.00008438884,0.00025076556,0.000007538826,0.000021538039,0.008404843],"genre_scores_gemma":[0.99926853,0.00013771054,0.00015841112,0.000035276724,0.0000984083,0.0000035190171,0.0000054718403,0.000016823904,0.00027581764],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999241,0.000025514737,0.00022806856,0.00015266043,0.00015287711,0.00019985599],"domain_scores_gemma":[0.9995553,0.000026943793,0.00010337384,0.00018038711,0.000062789455,0.000071188435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008309194,0.00011276956,0.0002254804,0.0001356599,0.00002521256,0.000004651146,0.00005094821,0.00013046853,0.00025992168],"category_scores_gemma":[0.00003369035,0.0000868366,0.00011635601,0.0002495598,0.000090655645,0.000048017748,0.000022979557,0.00015301087,0.00009618741],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031356825,0.0028741742,0.029561827,0.00022561237,0.0001152544,0.00010844197,0.0023609125,0.000009959095,0.9607002,0.00006161714,0.00058554095,0.0030828952],"study_design_scores_gemma":[0.009530346,0.0018678734,0.03575216,0.00019957383,0.0001844631,0.00009801617,0.00042842052,0.00017710503,0.9512045,0.0000749442,0.0003005512,0.00018208557],"about_ca_topic_score_codex":0.0003613152,"about_ca_topic_score_gemma":0.000008605216,"teacher_disagreement_score":0.009495736,"about_ca_system_score_codex":0.00003878488,"about_ca_system_score_gemma":0.00012080322,"threshold_uncertainty_score":0.35410935},"labels":[],"label_agreement":null},{"id":"W2791038224","doi":"10.1182/blood-2018-01-824888","title":"Statins for high cholesterol … and for low platelets?","year":2018,"lang":"en","type":"letter","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Atorvastatin; Platelet; Bone marrow; Medicine; Immune thrombocytopenia; Progenitor cell; Internal medicine; Cholesterol; Immune system; Immunology; Endocrinology; Stem cell; Biology","score_opus":0.017283744299420555,"score_gpt":0.2676550320114971,"score_spread":0.25037128771207656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791038224","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8230578,0.0005523094,0.00025432254,0.16889042,0.0003906834,0.0039044572,0.002491189,0.00009713332,0.00036170435],"genre_scores_gemma":[0.054168176,0.000372972,0.014309244,0.88553214,0.009121009,0.0022510064,0.014497029,0.0004621992,0.019286241],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988595,0.000008121823,0.00021000499,0.000411953,0.00013633024,0.0003740808],"domain_scores_gemma":[0.99935204,0.00013023446,0.00011555844,0.00024930265,0.00008617191,0.00006671174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000046278532,0.00028462682,0.0005667762,0.000082616,0.00008011936,0.00003444281,0.00006398963,0.00047360949,0.000027926078],"category_scores_gemma":[0.0000369999,0.00023087546,0.000108784465,0.000030202249,0.000057173747,0.000035723962,0.000019430348,0.00023079716,0.000018471283],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015291685,0.00047411447,0.00036900028,0.0014908756,0.0011078526,0.0006059575,0.00007625164,2.0560396e-8,0.00007961572,0.000009859513,0.9914892,0.0041443887],"study_design_scores_gemma":[0.030422255,0.0028429732,0.0009086969,0.00040829208,0.0021684293,0.00038310606,0.000009714124,0.000011991487,0.0023341938,0.001290691,0.9588078,0.00041182866],"about_ca_topic_score_codex":0.000023453213,"about_ca_topic_score_gemma":0.000010752071,"teacher_disagreement_score":0.7688896,"about_ca_system_score_codex":0.0000152052935,"about_ca_system_score_gemma":0.000053902975,"threshold_uncertainty_score":0.94148284},"labels":[],"label_agreement":null},{"id":"W2791144604","doi":"10.1182/blood-2017-10-810796","title":"Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":163,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; McMaster University; University of Toronto; University Health Network","funders":"Agios Pharmaceuticals","keywords":"Pyruvate kinase deficiency; Pyruvate kinase; Medicine; Splenectomy; Internal medicine; Glycolysis; Metabolism; Spleen","score_opus":0.07229826173143698,"score_gpt":0.32497772803934666,"score_spread":0.25267946630790966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791144604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98961467,0.0042372644,0.000029891835,0.0004773752,0.0026445605,0.0005257217,0.000083225794,0.00009495822,0.0022923471],"genre_scores_gemma":[0.9961473,0.00015225726,0.0002991716,0.0014432691,0.0012222397,0.0000085368465,0.00014977103,0.000030043499,0.00054746575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997391,0.00031353434,0.00072205707,0.00078733545,0.00039669315,0.00038941248],"domain_scores_gemma":[0.9968961,0.00038576144,0.0002922216,0.0021311978,0.00015213942,0.00014259832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087529264,0.0002482721,0.00054304214,0.000079482335,0.00016088453,0.000009298579,0.0007147738,0.00013779312,0.0007562265],"category_scores_gemma":[0.0007013824,0.00016416797,0.0001474932,0.0002717573,0.0007624594,0.000101099555,0.00043571534,0.00054246467,0.0003451835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035666109,0.03028944,0.70325464,0.00018391461,0.000702358,0.00073135947,0.005415796,0.0000023251098,0.18021812,0.0009614167,0.06795981,0.006714222],"study_design_scores_gemma":[0.013868792,0.007897647,0.93332255,0.00016022216,0.0018154329,0.00003453458,0.001550003,0.0005044599,0.004821382,0.00045260458,0.035007592,0.0005647815],"about_ca_topic_score_codex":0.00053958903,"about_ca_topic_score_gemma":0.00041083407,"teacher_disagreement_score":0.23006791,"about_ca_system_score_codex":0.00004966111,"about_ca_system_score_gemma":0.00035378218,"threshold_uncertainty_score":0.82801497},"labels":[],"label_agreement":null},{"id":"W2791396067","doi":"10.1182/blood-2017-05-743187","title":"Cancer and platelet crosstalk: opportunities and challenges for aspirin and other antiplatelet agents","year":2018,"lang":"en","type":"review","venue":"Blood","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":320,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"Canadian Institutes of Health Research","keywords":"Platelet; Medicine; Metastasis; Cancer research; Aspirin; Cancer cell; Cancer; Immunology; Thrombopoiesis; Platelet activation; Angiogenesis; Biology; Internal medicine; Cell biology; Stem cell; Haematopoiesis","score_opus":0.21395628484155454,"score_gpt":0.3723771008491055,"score_spread":0.15842081600755098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791396067","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014470216,0.98227113,4.0213467e-7,0.00012472548,0.0001267441,0.0016182035,0.0007123709,0.000055675897,0.00062054466],"genre_scores_gemma":[0.00008720154,0.99810463,0.00023962742,0.0001579116,0.000388815,0.0005021347,0.00005947909,0.00010881874,0.0003513859],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99848497,0.0000483281,0.0004070124,0.00056123413,0.00015995294,0.00033851294],"domain_scores_gemma":[0.9990279,0.00011505175,0.0002398242,0.00028279904,0.0000730175,0.0002613714],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028655116,0.00045614675,0.0012294393,0.00016529643,0.00013020173,0.000069620684,0.000081942635,0.0003805526,0.000052281255],"category_scores_gemma":[0.000045818375,0.0003655332,0.00013916129,0.000042670737,0.0004309122,0.00006206227,0.00013751606,0.00012441458,0.0000027894523],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000075348704,0.00012096403,0.00062954123,0.08874314,0.0016844362,0.0001689857,0.00015882139,4.7427784e-10,5.955145e-7,0.000070179674,0.00084078935,0.9075072],"study_design_scores_gemma":[0.0022995998,0.00018840308,0.00023552326,0.014442581,0.0030392057,0.0003998999,0.00006348767,0.0000015743085,0.000017241575,0.00002606903,0.97891873,0.00036768717],"about_ca_topic_score_codex":0.000007612093,"about_ca_topic_score_gemma":0.000010343843,"teacher_disagreement_score":0.97807795,"about_ca_system_score_codex":0.000018346946,"about_ca_system_score_gemma":0.00017365653,"threshold_uncertainty_score":0.99987966},"labels":[],"label_agreement":null},{"id":"W2791545369","doi":"10.1182/blood.v130.suppl_1.418.418","title":"BCL2 Expression Identifies a Population with Unmet Medical Need in Previously Untreated (1L) Patients with DLBCL","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Venetoclax; Chemoimmunotherapy; Rituximab; Obinutuzumab; Medicine; Population; Internal medicine; Oncology; Vincristine; Diffuse large B-cell lymphoma; Immunohistochemistry; CHOP; Lymphoma; Cyclophosphamide; Chemotherapy; Leukemia; Chronic lymphocytic leukemia","score_opus":0.006761546769676733,"score_gpt":0.2442388575797485,"score_spread":0.23747731081007176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791545369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983456,0.000101367055,0.0000024880312,0.00030813372,0.000038652295,0.0005997924,0.0000061533183,0.000040225623,0.0005575992],"genre_scores_gemma":[0.9992324,0.000032048156,0.0002156166,0.00006297003,0.00004150212,0.00008561844,0.00017706314,0.000020668522,0.00013211323],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871904,0.000032569635,0.00020299236,0.00027672175,0.00055323815,0.00021545442],"domain_scores_gemma":[0.999102,0.000030664778,0.00015728611,0.00047724985,0.00006896382,0.0001638611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008420745,0.00016400074,0.00029723113,0.0000815122,0.00014019002,0.00006095697,0.00010154671,0.00009699931,0.000068161564],"category_scores_gemma":[0.00012753769,0.0000943436,0.000032825355,0.000070949645,0.00005705742,0.00016371188,0.000046843652,0.00007254881,0.000015487693],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036368406,0.003519346,0.99332064,0.000041290685,0.000100765326,0.00037101578,0.0001840708,5.922635e-7,0.000040527557,0.000011097043,0.00009002387,0.001956952],"study_design_scores_gemma":[0.02965525,0.0006744673,0.9644091,0.0012224437,0.000279985,0.00003096627,0.00002976631,0.0000106261605,0.003520149,0.000013965737,0.000037128644,0.000116138595],"about_ca_topic_score_codex":0.0012746649,"about_ca_topic_score_gemma":0.00074229843,"teacher_disagreement_score":0.029291565,"about_ca_system_score_codex":0.000059207367,"about_ca_system_score_gemma":0.00007329697,"threshold_uncertainty_score":0.38472205},"labels":[],"label_agreement":null},{"id":"W2791573308","doi":"10.1182/blood-2017-09-772632","title":"Biology of classical Hodgkin lymphoma: implications for prognosis and novel therapies","year":2018,"lang":"en","type":"review","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Classical Hodgkin lymphoma; Lymphoma; Medicine; Hodgkin lymphoma; Immunology; Biology; Internal medicine; Oncology; Cancer research","score_opus":0.0847715086468631,"score_gpt":0.3691724369392336,"score_spread":0.28440092829237046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791573308","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006179929,0.99649006,0.000047314228,0.0003741702,0.000046878515,0.0016856374,0.000501533,0.000025424391,0.00021099263],"genre_scores_gemma":[0.0012475128,0.99306864,0.0030733151,0.000036094487,0.00022464778,0.0020064048,0.00026125758,0.000033484142,0.00004865867],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990056,0.000024243054,0.00038684817,0.00035619372,0.000045787867,0.00018129245],"domain_scores_gemma":[0.99894017,0.00034481884,0.00023237795,0.00030419367,0.00009753491,0.00008088012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007803917,0.00024616224,0.0012302016,0.00009779181,0.000049343067,0.000009015001,0.00008010574,0.00026873293,0.0000064437404],"category_scores_gemma":[0.00006182322,0.00015435302,0.0003576116,0.00011267532,0.00018070936,0.0000125201095,0.000044345958,0.000028372691,0.0000048039524],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008226862,0.0036866083,0.0028530653,0.004873993,0.001604988,7.090009e-7,0.000022964738,1.4989382e-10,0.0000106939415,0.006345976,0.00046173474,0.98013103],"study_design_scores_gemma":[0.004002702,0.00093677285,0.003901038,0.0026151014,0.006391593,0.00014822374,0.00000376897,1.6246288e-7,0.000066652334,0.00019557578,0.98159534,0.00014304832],"about_ca_topic_score_codex":0.0000087411,"about_ca_topic_score_gemma":0.0000029317632,"teacher_disagreement_score":0.98113364,"about_ca_system_score_codex":0.00003648372,"about_ca_system_score_gemma":0.0002556102,"threshold_uncertainty_score":0.62943333},"labels":[],"label_agreement":null},{"id":"W2793071797","doi":"10.1182/blood-2018-01-785956","title":"How I treat the postthrombotic syndrome","year":2018,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Deep vein; Compression stockings; Thrombosis; Post-thrombotic syndrome; Surgery; Thrombolysis; Intensive care medicine; Internal medicine; Myocardial infarction","score_opus":0.04752568472436072,"score_gpt":0.3078362793459418,"score_spread":0.2603105946215811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793071797","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010162636,0.9899594,0.0000025675135,0.00073711167,0.00033771465,0.0019974348,0.000021579495,0.00010348711,0.006739066],"genre_scores_gemma":[0.000110196845,0.9919452,0.00007620494,0.0002883024,0.0006503485,0.00026399284,0.00009569024,0.00010613529,0.0064639295],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99825263,0.000104238905,0.0003505068,0.0005063895,0.00035500992,0.00043121388],"domain_scores_gemma":[0.9982957,0.00011071582,0.0002313827,0.0011618907,0.000056083878,0.00014423161],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021656285,0.00048754198,0.0023947288,0.00014317172,0.00014959411,0.00013146951,0.00037347467,0.00025067144,0.00019469872],"category_scores_gemma":[0.000074900294,0.00025783773,0.000771986,0.00030615367,0.00014533571,0.000044655335,0.00018068177,0.00031198445,0.0007566962],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000003935808,0.004685634,0.000014396653,0.07138582,0.006747709,0.0018564976,0.00017387157,1.8295633e-8,5.1213993e-7,0.0016356749,0.09060857,0.82288736],"study_design_scores_gemma":[0.0005232621,0.0005624241,0.00017580485,0.010992765,0.021940596,0.0015865732,0.000024059364,1.12431906e-7,0.0000012672278,0.000025746973,0.9639087,0.00025868826],"about_ca_topic_score_codex":0.000021292384,"about_ca_topic_score_gemma":0.000005943673,"teacher_disagreement_score":0.87330014,"about_ca_system_score_codex":0.000057847516,"about_ca_system_score_gemma":0.00015689376,"threshold_uncertainty_score":0.99998736},"labels":[],"label_agreement":null},{"id":"W2793259357","doi":"10.1182/blood-2017-09-805689","title":"Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Venous thromboembolism; Thrombosis; Antiphospholipid syndrome; Venous thrombosis; D-dimer; Antibody; Thrombophilia; Internal medicine; Immunology","score_opus":0.013688788566165259,"score_gpt":0.26132493342247093,"score_spread":0.24763614485630567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793259357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98762226,0.0027792149,0.000015486276,0.0012800071,0.00059265044,0.0007905907,0.000022101902,0.00017399284,0.0067236656],"genre_scores_gemma":[0.99297786,0.0037822162,0.000888552,0.0012283906,0.00080200343,0.000112761685,0.000015467494,0.00005905604,0.00013366631],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99809694,0.00002938658,0.00035576016,0.00060549873,0.00034616853,0.0005662255],"domain_scores_gemma":[0.9989019,0.00003956299,0.0001058556,0.0005672562,0.0001519347,0.00023347096],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019280388,0.00033797658,0.0008699523,0.00014750335,0.00027370354,0.000080116435,0.00013018082,0.00013155234,0.00042504555],"category_scores_gemma":[0.000060762977,0.00028824533,0.00013555797,0.00023926541,0.00038560652,0.00013131092,0.00023512178,0.00017388351,0.000229812],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010086797,0.051692665,0.75927156,0.0047482103,0.0066917883,0.0008575976,0.033913456,9.967309e-7,0.013282926,0.008055266,0.07904776,0.041429117],"study_design_scores_gemma":[0.0029382138,0.002047859,0.9585359,0.0005163427,0.001418163,0.00006444233,0.0002277681,0.000019339626,0.007007281,0.00027489854,0.026550429,0.0003993823],"about_ca_topic_score_codex":0.00013894388,"about_ca_topic_score_gemma":0.00017439031,"teacher_disagreement_score":0.19926435,"about_ca_system_score_codex":0.00003147041,"about_ca_system_score_gemma":0.000049872106,"threshold_uncertainty_score":0.99995697},"labels":[],"label_agreement":null},{"id":"W2794609724","doi":"10.1182/blood-2017-12-822908","title":"Tolerogenic properties of the Fc portion of IgG and its relevance to the treatment and management of hemophilia","year":2018,"lang":"en","type":"review","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Canadian Institutes of Health Research; National Heart, Lung, and Blood Institute; Uniformed Services University of the Health Sciences; Institute of Genetics; National Institutes of Health; Université Pierre et Marie Curie; Centre National de la Recherche Scientifique; Institut National de la Santé et de la Recherche Médicale; Deutsche Forschungsgemeinschaft; Agence Nationale de la Recherche; National Institute of Diabetes and Digestive and Kidney Diseases; Brigham and Women's Hospital","keywords":"Immunogenicity; Immunology; Immune tolerance; Factor IX; Immune system; Recombinant DNA; Medicine; Antibody; Coagulation; Neonatal Fc receptor; Immunoglobulin G; Biology; Genetics; Internal medicine; Gene","score_opus":0.07937724051414034,"score_gpt":0.33164137950959555,"score_spread":0.2522641389954552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794609724","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16406325,0.8332332,7.2249755e-8,0.00020923796,0.000030351468,0.0022380576,0.000022502834,0.0000038404814,0.00019952866],"genre_scores_gemma":[0.026030336,0.971387,0.000033333657,0.000005833274,0.000050490544,0.000126774,0.000005836112,0.00001704723,0.002343312],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988983,0.00006852046,0.0004091013,0.00022641156,0.00025711244,0.00014052723],"domain_scores_gemma":[0.9991799,0.00002861925,0.00020264137,0.0004466557,0.00008796544,0.000054214215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018008039,0.00018900888,0.0007614083,0.00006306104,0.000042825388,0.0000036363015,0.00011673934,0.000080201535,0.000007574671],"category_scores_gemma":[0.000024910045,0.00007408638,0.00018140436,0.00020062673,0.00013153905,0.000013539564,0.00010715665,0.000062505555,0.000004667402],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020161348,0.0023864042,0.0005408947,0.10893882,0.0048013777,0.000024751014,0.0008462549,1.8168785e-7,0.00047722762,0.00018054467,0.00019478718,0.88140714],"study_design_scores_gemma":[0.005093947,0.006601005,0.0017744208,0.09859197,0.019371664,0.00023101068,0.00019423195,0.0000062112326,0.042754438,0.000027773465,0.8249588,0.0003945173],"about_ca_topic_score_codex":0.000008846497,"about_ca_topic_score_gemma":0.0000067453802,"teacher_disagreement_score":0.8810126,"about_ca_system_score_codex":0.000027388101,"about_ca_system_score_gemma":0.00008067403,"threshold_uncertainty_score":0.3021155},"labels":[],"label_agreement":null},{"id":"W2795058342","doi":"10.1182/blood.v130.suppl_1.2010.2010","title":"Real World Outcomes of Newly Diagnosed High-Risk Multiple Myeloma Patients Treated at Princess Margaret Cancer Centre: A Retrospective Chart Review","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Multiple myeloma; Internal medicine; Oncology; Retrospective cohort study; Surgery; Proportional hazards model; Cancer; Progression-free survival; Overall survival","score_opus":0.02020551344361357,"score_gpt":0.3067184191123035,"score_spread":0.2865129056686899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795058342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99364024,0.0012207988,2.6711814e-7,0.00070577505,0.0001273321,0.0020327053,0.0008406577,0.00006537866,0.0013668354],"genre_scores_gemma":[0.9793228,0.016414443,0.00020207367,0.00007899794,0.00008613766,0.0002252209,0.000294714,0.00004962521,0.003325977],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99754405,0.00011872424,0.00047946148,0.00056188647,0.00073363364,0.0005622144],"domain_scores_gemma":[0.9973042,0.00015409046,0.0006146411,0.0011530888,0.00038909726,0.00038487848],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015485211,0.00033183437,0.0010126414,0.00012024747,0.00033468768,0.00002838643,0.00030968362,0.00008832209,0.0004764078],"category_scores_gemma":[0.0011994761,0.00024809252,0.00023861855,0.00017047595,0.00016099362,0.00014020015,0.00023802498,0.00021524461,0.000068448484],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040678424,0.0018815806,0.9863798,0.00045615452,0.0010447763,0.00019661877,0.00007933867,7.250883e-8,0.00009505942,0.000010801798,0.0009603189,0.00848872],"study_design_scores_gemma":[0.024036976,0.00032875562,0.9674086,0.0014714756,0.00081824634,0.000001523528,0.000004759887,0.00000960974,0.005266801,0.000007614811,0.00044865193,0.00019697448],"about_ca_topic_score_codex":0.017559716,"about_ca_topic_score_gemma":0.014134292,"teacher_disagreement_score":0.02363019,"about_ca_system_score_codex":0.00031358877,"about_ca_system_score_gemma":0.000106569154,"threshold_uncertainty_score":0.99999714},"labels":[],"label_agreement":null},{"id":"W2795810770","doi":"10.1182/blood-2017-10-810630","title":"The tumor suppressive TGF-β/SMAD1/S1PR2 signaling axis is recurrently inactivated in diffuse large B-cell lymphoma","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Universität Zürich","keywords":"Diffuse large B-cell lymphoma; Cancer research; Lymphoma; Transforming growth factor; In vivo; Biology; Signal transduction; In vitro; Immunology; Cell biology; Genetics","score_opus":0.010369576097939912,"score_gpt":0.25087357832482116,"score_spread":0.24050400222688123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795810770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941628,0.0016849845,0.0000032174637,0.0008125599,0.00022230498,0.0005431239,0.000054125572,0.000061453815,0.0024554185],"genre_scores_gemma":[0.998295,0.00014277223,0.00010410089,0.0006296532,0.00024751778,0.00013806323,0.00003086912,0.00003641148,0.00037557606],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982689,0.0000865218,0.00035292958,0.0004168929,0.00031732375,0.00055740745],"domain_scores_gemma":[0.9988327,0.00020205982,0.00014444467,0.0005095845,0.0001384035,0.00017281061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017388818,0.00026184754,0.0003422719,0.00009659234,0.00025198955,0.00006071084,0.00017067423,0.00009067514,0.0001330426],"category_scores_gemma":[0.00010659526,0.00016914234,0.00013407516,0.00031222097,0.00010376045,0.0000979687,0.00009817562,0.00009770932,0.0001930403],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024713334,0.20757589,0.6758273,0.00032064284,0.0014696544,0.0036164562,0.012484332,3.6567585e-7,0.040057432,0.0008837377,0.027204785,0.028088044],"study_design_scores_gemma":[0.09191171,0.0012331198,0.056657527,0.00043050546,0.0005197521,0.0001629043,0.0007373168,0.000093953415,0.81790394,0.00019040491,0.02978977,0.00036907638],"about_ca_topic_score_codex":0.0001773145,"about_ca_topic_score_gemma":0.000055034674,"teacher_disagreement_score":0.7778465,"about_ca_system_score_codex":0.00016433558,"about_ca_system_score_gemma":0.00015809444,"threshold_uncertainty_score":0.68974245},"labels":[],"label_agreement":null},{"id":"W2796115040","doi":"10.1182/blood.v130.suppl_1.741.741","title":"Deep and Durable Responses in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (MM) Treated with Monotherapy GSK2857916, an Antibody Drug Conjugate Against B-Cell Maturation Antigen (BCMA): Preliminary Results from Part 2 of Study BMA117159","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency; University of Toronto","funders":"","keywords":"Medicine; Multiple myeloma; Antibody; Internal medicine; Plasma cell leukemia; Pharmacokinetics; Immunology; Pharmacology; Oncology; Gastroenterology; Cancer research","score_opus":0.01649827824944232,"score_gpt":0.2736216586074257,"score_spread":0.2571233803579834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2796115040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964296,0.00023588352,0.0000035203027,0.000054809305,0.00002697724,0.0025506578,0.00032283465,0.00005395994,0.00032173737],"genre_scores_gemma":[0.99735534,0.00035315656,0.0007615571,0.000021215872,0.00004302072,0.00008261262,0.0009933108,0.00006907529,0.00032069007],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99728775,0.00034837652,0.0005516925,0.00077219476,0.00059053604,0.0004494527],"domain_scores_gemma":[0.9974797,0.00026196594,0.0005027494,0.0012095127,0.0002573916,0.00028868444],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031443333,0.0003912101,0.0006391752,0.00023609943,0.00033657387,0.00010345771,0.00021854394,0.0001230729,0.0000116550145],"category_scores_gemma":[0.00022572189,0.00027410372,0.000043516306,0.00013724713,0.00022454932,0.0005482519,0.000065113,0.0002636156,0.0000065302315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10528787,0.012202395,0.8671985,0.00004299941,0.00041586478,0.0006326941,0.0018629525,0.00000982385,0.00924512,1.8475147e-7,0.000015790658,0.0030857718],"study_design_scores_gemma":[0.099866055,0.013200252,0.85841185,0.00034539495,0.00016943103,0.0000054494117,0.0007098217,0.0006074074,0.02639139,0.0000017195736,0.000038094917,0.00025313025],"about_ca_topic_score_codex":0.003121612,"about_ca_topic_score_gemma":0.0015910019,"teacher_disagreement_score":0.01714627,"about_ca_system_score_codex":0.000051059276,"about_ca_system_score_gemma":0.00013414699,"threshold_uncertainty_score":0.9999711},"labels":[],"label_agreement":null},{"id":"W2797135930","doi":"10.1182/blood.v122.21.2191.2191","title":"Eculizumab (ECU) Inhibits Thrombotic Microangiopathy (TMA) and Improves Renal Function In Pediatric Patients (Pts) With Atypical Hemolytic Uremic Syndrome (aHUS)","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Eculizumab; Atypical hemolytic uremic syndrome; Medicine; Thrombotic microangiopathy; Internal medicine; Gastroenterology; Renal function; Complement system; Immunology; Disease; Antibody","score_opus":0.004828384445695569,"score_gpt":0.17986345059908138,"score_spread":0.17503506615338582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2797135930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964244,0.0022256149,0.000009325307,0.00004242019,0.000204601,0.000902798,0.00002214467,0.0000728158,0.00009589764],"genre_scores_gemma":[0.9994691,0.000020487421,0.00003490289,0.00006430978,0.00003330363,0.00012293113,0.00013163424,0.000027145772,0.00009620456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984593,0.0001436668,0.00039637665,0.00047617804,0.00007476013,0.00044974778],"domain_scores_gemma":[0.999354,0.00008400577,0.00015083521,0.0002806703,0.000074423384,0.000056045643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008599487,0.00026251483,0.00034825542,0.0002092215,0.00010611765,0.00003430198,0.00014990295,0.00017019635,0.00023675193],"category_scores_gemma":[0.00004719761,0.00021767836,0.00005829632,0.00023157842,0.000107202846,0.000184887,0.00012693432,0.00021437375,0.00041601664],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034018196,0.0019213692,0.9396394,0.00021466622,0.00022163158,0.000025291816,0.00023002544,0.0000021492508,0.05521665,0.00005236201,0.0013858706,0.0007503993],"study_design_scores_gemma":[0.007971866,0.0011569678,0.9874252,0.0001149453,0.00031696883,0.00018814066,0.00008252772,0.0000028256047,0.0022817382,0.00010063418,0.00005735834,0.00030081783],"about_ca_topic_score_codex":0.00007405823,"about_ca_topic_score_gemma":0.000047656275,"teacher_disagreement_score":0.052934915,"about_ca_system_score_codex":0.00004423275,"about_ca_system_score_gemma":0.000059765083,"threshold_uncertainty_score":0.8876666},"labels":[],"label_agreement":null},{"id":"W2797388535","doi":"10.1182/blood-2017-10-812735","title":"Donor telomere length and causes of death after unrelated hematopoietic cell transplantation in patients with marrow failure","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Transplantation; Hematopoietic cell; Telomere; Hematopoietic stem cell transplantation; Bone marrow transplantation; Medicine; Immunology; Haematopoiesis; Internal medicine; Biology; Stem cell; Genetics; DNA","score_opus":0.004985240521441396,"score_gpt":0.19892802289902328,"score_spread":0.1939427823775819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2797388535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99898773,0.00027013756,0.000013382255,0.00005177192,0.00002404296,0.00032249145,0.000026761416,0.000026999125,0.00027665077],"genre_scores_gemma":[0.9988918,0.00007246648,0.00082016323,0.00006563333,0.00002449966,0.000010175187,0.000030737225,0.000022360467,0.00006217341],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911886,0.000026997097,0.00022982393,0.00023413092,0.0001957223,0.00019448425],"domain_scores_gemma":[0.99953526,0.000028769051,0.00007001472,0.00017781298,0.00009894645,0.000089185225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004957569,0.000151303,0.00025727562,0.0001336882,0.000028898281,0.0000080196005,0.000043667635,0.00009522654,0.00007549805],"category_scores_gemma":[0.000009729118,0.000115240844,0.000023830191,0.00019775289,0.0001053221,0.000088024564,0.00000916953,0.000113189664,0.000008795756],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006451221,0.0006261342,0.99372965,0.00042791822,0.000038669583,0.000049002974,0.0019715284,1.8842155e-7,0.0022514635,0.000012074573,0.000011677537,0.00023655874],"study_design_scores_gemma":[0.0067904787,0.0008069127,0.9533677,0.00038373077,0.0002521132,0.00003493517,0.00015506594,0.0000021545125,0.03799153,0.000012461575,0.000056973364,0.00014590834],"about_ca_topic_score_codex":0.00007931756,"about_ca_topic_score_gemma":0.00021929853,"teacher_disagreement_score":0.040361926,"about_ca_system_score_codex":0.000009982157,"about_ca_system_score_gemma":0.000038707632,"threshold_uncertainty_score":0.46993852},"labels":[],"label_agreement":null},{"id":"W2799276341","doi":"10.1182/blood-2017-11-814608","title":"Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Simon Fraser University; CancerCare Manitoba; BC Cancer Agency","funders":"National Cancer Institute; National Center for Advancing Translational Sciences; National Center for Chronic Disease Prevention and Health Promotion; World Health Organization","keywords":"Lymphocytosis; Chronic lymphocytic leukemia; Medicine; Internal medicine; Leukemia; Oncology; Immunology","score_opus":0.007869645992896872,"score_gpt":0.23130352391642708,"score_spread":0.2234338779235302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2799276341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951112,0.0028369073,0.000052055948,0.000057137135,0.00004638307,0.00055120944,0.00006412856,0.00003499592,0.0012459664],"genre_scores_gemma":[0.99636394,0.001776891,0.00034277808,0.000038913084,0.00033320725,0.000028437837,0.000009344097,0.00004565631,0.0010608406],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976012,0.00019397105,0.000430338,0.00038871894,0.0008973452,0.00048842916],"domain_scores_gemma":[0.9975323,0.0005725232,0.0006497285,0.00068726484,0.00039805155,0.00016014918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008448203,0.000238967,0.00050905166,0.00014050132,0.00016377434,0.00001828447,0.00024024153,0.00019720236,0.00009534245],"category_scores_gemma":[0.0003258313,0.00015278789,0.00014246606,0.00050907297,0.0005555164,0.00007508716,0.00014488873,0.0002399193,0.000031341442],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0071632946,0.002411546,0.87238663,0.0034582363,0.011196943,0.0001508169,0.006758706,0.00064648624,0.06863973,0.00016290725,0.0078123743,0.01921233],"study_design_scores_gemma":[0.20881228,0.0066268505,0.15205657,0.0007121942,0.008498831,0.0005704295,0.000551291,0.045412853,0.575002,0.00014334843,0.0009916137,0.0006216837],"about_ca_topic_score_codex":0.0055271112,"about_ca_topic_score_gemma":0.0006156096,"teacher_disagreement_score":0.72033006,"about_ca_system_score_codex":0.025557797,"about_ca_system_score_gemma":0.023710571,"threshold_uncertainty_score":0.9818241},"labels":[],"label_agreement":null},{"id":"W2801024840","doi":"10.1182/blood-2018-03-836700","title":"Plerixafor effectively mobilizes CD56bright NK cells in blood, providing an allograft predicted to protect against GVHD","year":2018,"lang":"en","type":"letter","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Health Sciences Centre; Dalhousie University; BC Children's Hospital; Hamilton Health Sciences; Memorial University of Newfoundland; University of British Columbia; BC Cancer Agency","funders":"Dalhousie University; Amgen","keywords":"Plerixafor; Haematopoiesis; Progenitor cell; Hematopoietic stem cell; Stem cell; Blood cell; Immunology; Cancer research; Medicine; CXCR4; Biology; Cell biology; Inflammation","score_opus":0.01025147534360324,"score_gpt":0.22154058564961024,"score_spread":0.211289110306007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801024840","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9620534,0.00085018907,0.000099712015,0.00977081,0.012603306,0.008094859,0.000227026,0.00087547215,0.0054252096],"genre_scores_gemma":[0.39298207,0.0005803871,0.0013909207,0.44348726,0.010980366,0.010512532,0.016904963,0.001209031,0.12195247],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99611783,0.0008975514,0.00074831414,0.0011791919,0.00011192793,0.0009451752],"domain_scores_gemma":[0.9984038,0.00020743227,0.00035476597,0.00077203545,0.00021252704,0.000049458748],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0004157772,0.00072004314,0.00081868377,0.00072687725,0.00026897903,0.00008987033,0.00057692,0.0020061324,0.0012274125],"category_scores_gemma":[0.00017754057,0.0006508759,0.00026458417,0.00037144378,0.00019193122,0.00026897746,0.0001739612,0.0025366803,0.0010741049],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002754001,0.0008125711,0.00028680637,0.00021573245,0.00067709724,0.00010394877,0.00044090848,0.000002862664,0.66816515,0.0000011816962,0.32854155,0.00047680325],"study_design_scores_gemma":[0.0029579145,0.0019311847,0.000623184,0.00025183256,0.00026796875,0.0000781078,0.00004246695,0.0000021955568,0.47995314,0.000005370435,0.5133332,0.0005534303],"about_ca_topic_score_codex":0.00033151638,"about_ca_topic_score_gemma":0.000073338895,"teacher_disagreement_score":0.56907135,"about_ca_system_score_codex":0.00010907196,"about_ca_system_score_gemma":0.00014572502,"threshold_uncertainty_score":0.9997645},"labels":[],"label_agreement":null},{"id":"W2801146643","doi":"10.1182/blood-2017-09-804658","title":"Health-related quality of life in adults with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Blinatumomab; Medicine; Refractory (planetary science); Lymphoblastic Leukemia; Quality of life (healthcare); Acute lymphocytic leukemia; Leukemia; Internal medicine; Pediatrics; Nursing","score_opus":0.015363566067399095,"score_gpt":0.2808820992361169,"score_spread":0.2655185331687178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801146643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954766,0.00037407968,0.000085418615,0.00042258642,0.00004124034,0.0009830284,0.000045650293,0.00015062523,0.0024207607],"genre_scores_gemma":[0.99763334,0.00008038387,0.001046494,0.00026639272,0.00010450545,0.000053371878,0.00008797706,0.00009589861,0.00063165574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959271,0.0002931635,0.0011622941,0.00072448154,0.0010492075,0.0008437341],"domain_scores_gemma":[0.99699765,0.00039863324,0.0005646039,0.00087063585,0.000568822,0.00059965736],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006401695,0.00040784135,0.001259238,0.0004766484,0.00009872726,0.000014690623,0.00027230117,0.00030011326,0.00012011773],"category_scores_gemma":[0.00050873426,0.00028394285,0.000086378015,0.0014979591,0.00074366573,0.00015852791,0.00009021738,0.00052705826,0.00008809569],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.115887955,0.010530503,0.8381168,0.0036912556,0.00461557,0.0032201991,0.0066562654,0.000048759135,0.010215914,0.0005472038,0.0029440625,0.0035254785],"study_design_scores_gemma":[0.19415292,0.027401006,0.75888014,0.0049598604,0.0006654187,0.0013402574,0.0006863002,0.0016085494,0.009309613,0.00004189797,0.00011560677,0.0008384572],"about_ca_topic_score_codex":0.004954572,"about_ca_topic_score_gemma":0.0011375366,"teacher_disagreement_score":0.079236716,"about_ca_system_score_codex":0.001318817,"about_ca_system_score_gemma":0.006270447,"threshold_uncertainty_score":0.99996126},"labels":[],"label_agreement":null},{"id":"W2801448223","doi":"10.1182/blood-2017-10-809822","title":"B-cell differentiation and IL-21 response in IL2RG/JAK3 SCID patients after hematopoietic stem cell transplantation","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Transplantation; Immunology; Hematopoietic stem cell transplantation; Haematopoiesis; Immune system; Severe combined immunodeficiency; Stem cell; Biology; Immunity; Medicine; Internal medicine; Cell biology; In vivo; Biotechnology","score_opus":0.004026436065545117,"score_gpt":0.18513393485440935,"score_spread":0.18110749878886423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801448223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947971,0.0042106076,0.000053739615,0.00003108137,0.00026630936,0.00022324707,0.00002989237,0.00002878695,0.000359228],"genre_scores_gemma":[0.9991407,0.000096508986,0.0000073136853,0.00006273282,0.0000024553601,0.000026483684,0.000072377545,0.000013487726,0.00057796616],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998928,0.00023980386,0.00026671487,0.0002567526,0.00003945113,0.0002692388],"domain_scores_gemma":[0.99963045,0.00006702003,0.00008070655,0.0001738566,0.000041747135,0.00000624679],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001894677,0.00015034137,0.00016221215,0.00013475213,0.00013480806,0.000018390001,0.000100810845,0.0001645812,0.00011049797],"category_scores_gemma":[0.0000065545914,0.00014053425,0.000039672028,0.00012224598,0.00015188963,0.00011088244,0.000027135335,0.00014071084,0.00020861778],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006433245,0.005091904,0.11141741,0.00031325006,0.00006682938,0.000015885555,0.030068247,0.0000021202181,0.84224933,0.000056325072,0.000057398174,0.004228025],"study_design_scores_gemma":[0.0076773735,0.000530588,0.6726579,0.00006590494,0.000080059726,0.000007733172,0.00053747225,0.0000034294187,0.3175969,0.00004735267,0.0005549054,0.00024034329],"about_ca_topic_score_codex":0.0000218436,"about_ca_topic_score_gemma":0.0000052766413,"teacher_disagreement_score":0.5612405,"about_ca_system_score_codex":0.000010321198,"about_ca_system_score_gemma":0.000023391976,"threshold_uncertainty_score":0.57308203},"labels":[],"label_agreement":null},{"id":"W2801611492","doi":"10.1182/blood-2018-02-832147","title":"Improving on R-ICE in relapsed DLBCL","year":2018,"lang":"en","type":"letter","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Ibrutinib; Ifosfamide; Rituximab; Medicine; Carboplatin; Internal medicine; Oncology; Diffuse large B-cell lymphoma; Etoposide; Lymphoma; Chemotherapy; Leukemia; Cisplatin; Chronic lymphocytic leukemia","score_opus":0.013951492984184986,"score_gpt":0.2403761922440867,"score_spread":0.22642469925990172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801611492","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4984909,0.000741835,6.0009944e-7,0.4626637,0.0007907802,0.0011286826,0.000053242387,0.0001482206,0.035982043],"genre_scores_gemma":[0.06296848,0.00006890172,0.0004660877,0.91747326,0.008137281,0.00024291592,0.00039946486,0.000122031364,0.010121598],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99863917,0.00003498916,0.00024398773,0.00044560022,0.00030141088,0.0003348506],"domain_scores_gemma":[0.9991637,0.000114705144,0.00010752635,0.0005213486,0.00003707793,0.000055639946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000077481636,0.00026788484,0.00042956276,0.00017740781,0.000031096402,0.000019760559,0.00009220659,0.00055902696,0.00012826957],"category_scores_gemma":[0.00007648436,0.00020650243,0.00013751765,0.00010254901,0.000033068576,0.000014245924,0.00003586442,0.0005320523,0.0006577513],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047671532,0.0023155804,0.014272478,0.00025506032,0.0002471214,0.00849905,0.00007873862,3.2778694e-8,0.00008306709,0.000012360753,0.9710598,0.0031290327],"study_design_scores_gemma":[0.026102358,0.0019598058,0.031021677,0.0014246827,0.0011349579,0.00023952241,0.000008631855,0.0000055873757,0.0057023647,0.000033229026,0.9319192,0.00044794276],"about_ca_topic_score_codex":0.00027002493,"about_ca_topic_score_gemma":0.000019301606,"teacher_disagreement_score":0.45480955,"about_ca_system_score_codex":0.00015991782,"about_ca_system_score_gemma":0.00013328005,"threshold_uncertainty_score":0.8454281},"labels":[],"label_agreement":null},{"id":"W2801814129","doi":"10.1182/blood-2017-10-811216","title":"Can thrombophilia predict recurrent catheter-related deep vein thrombosis in children?","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Canadian Institutes of Health Research","keywords":"Thrombophilia; Medicine; Thrombosis; Deep vein; Catheter; Surgery","score_opus":0.010673797741478176,"score_gpt":0.25314541015003583,"score_spread":0.24247161240855766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801814129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907079,0.000514967,0.000006837922,0.0018507431,0.00037464884,0.0011131294,0.000020529002,0.00016302922,0.005248265],"genre_scores_gemma":[0.998004,0.0005830894,0.00021111227,0.000518181,0.00034993922,0.00009470448,0.000084767715,0.00005444131,0.00009977262],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979354,0.00006778183,0.0004889422,0.0005652912,0.00037318913,0.00056935265],"domain_scores_gemma":[0.9989286,0.00002340706,0.00011826629,0.00064135477,0.000082899685,0.00020549227],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026914745,0.0002932058,0.00063628674,0.00024400467,0.00013041018,0.000030939886,0.000220526,0.00016008448,0.00057095016],"category_scores_gemma":[0.00006398099,0.0002608323,0.00015492659,0.00045455532,0.00017404376,0.000072735624,0.00014464729,0.00027446108,0.00021159573],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057859434,0.027602863,0.94137645,0.00017080673,0.0022750741,0.000070147,0.0072879824,0.0000066878083,0.0023962236,0.001933347,0.0072320444,0.009590503],"study_design_scores_gemma":[0.005043924,0.002345417,0.98724854,0.0002942246,0.0008178747,0.000041964402,0.00010707344,0.00007312995,0.0024129683,0.00072337966,0.00058374257,0.00030777237],"about_ca_topic_score_codex":0.00053821324,"about_ca_topic_score_gemma":0.0006268559,"teacher_disagreement_score":0.045872066,"about_ca_system_score_codex":0.00011728524,"about_ca_system_score_gemma":0.00007195532,"threshold_uncertainty_score":0.9999844},"labels":[],"label_agreement":null},{"id":"W2802582740","doi":"10.1182/blood-2018-03-839753","title":"Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease","year":2018,"lang":"en","type":"review","venue":"Blood","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":624,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; National Institutes of Health; Memorial Sloan-Kettering Cancer Center; Hospital for Sick Children; American Society of Hematology","keywords":"Histiocyte; Medicine; Histiocytosis; Neuroblastoma RAS viral oncogene homolog; Rosai–Dorfman disease; Disease; Langerhans cell histiocytosis; Dermatology; Consensus conference; Pathology; KRAS; Intensive care medicine; Internal medicine; Cancer","score_opus":0.16214808708255693,"score_gpt":0.4446205446533409,"score_spread":0.282472457570784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802582740","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009097074,0.99590683,0.00001373235,0.00054336304,0.00019317417,0.0022718436,0.00041582377,0.000015799016,0.00054844934],"genre_scores_gemma":[0.00007852839,0.9963906,0.0014238294,0.000053376734,0.000099108336,0.00075900677,0.0002245027,0.000028888735,0.00094215374],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989056,0.000052560532,0.0005287348,0.0002807853,0.00010030472,0.00013203062],"domain_scores_gemma":[0.9983908,0.0007968413,0.00022390495,0.00040715456,0.0000543773,0.00012692047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020195227,0.00019012888,0.0007644164,0.00004542138,0.00009537598,0.000010948402,0.00008246696,0.0000795442,0.000050412193],"category_scores_gemma":[0.00012298174,0.000112596885,0.00039400355,0.00008398071,0.0001951765,0.0000068398977,0.000056200104,0.00007648709,0.000018482435],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026304526,0.002093253,0.0012065151,0.012195517,0.0036452876,0.000034120712,0.0000108297345,4.840105e-9,2.9449482e-10,0.0005890956,0.0149663715,0.9652327],"study_design_scores_gemma":[0.002317234,0.00025460226,0.00050334603,0.008339317,0.032993834,0.000009838662,0.000022172646,0.0000019668826,4.8842256e-8,0.000100382975,0.9553618,0.000095493255],"about_ca_topic_score_codex":0.0000092202135,"about_ca_topic_score_gemma":0.000005132167,"teacher_disagreement_score":0.9651372,"about_ca_system_score_codex":0.0000160555,"about_ca_system_score_gemma":0.00011235472,"threshold_uncertainty_score":0.45915678},"labels":[],"label_agreement":null},{"id":"W2803478601","doi":"10.1182/blood-2018-01-829937","title":"Lineage restriction analyses in CHIP indicate myeloid bias for TET2 and multipotent stem cell origin for DNMT3A","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Canadian Institutes of Health Research","keywords":"Myeloid; Biology; Haematopoiesis; Lineage (genetic); clone (Java method); Stem cell; Mutation; Genetics; Multipotent Stem Cell; Immunology; Progenitor cell; Molecular biology; Gene","score_opus":0.1255946732299508,"score_gpt":0.37441067995669913,"score_spread":0.24881600672674833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803478601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99526906,0.00045946284,0.0013731001,0.0004042156,0.00007888144,0.0019276348,0.000058216545,0.000057659294,0.0003717686],"genre_scores_gemma":[0.990082,0.0002533511,0.0073210937,0.00013179066,0.0006699112,0.00029790783,0.000068828485,0.000044562243,0.0011305406],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985177,0.000053461823,0.00035257192,0.0004191396,0.00023056242,0.00042658456],"domain_scores_gemma":[0.99889773,0.00033923704,0.000117235344,0.0002996297,0.00016590246,0.00018027668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000510787,0.00017398405,0.00033816887,0.00043632448,0.00011388286,0.000031096428,0.00011446231,0.0001633516,0.0000101741325],"category_scores_gemma":[0.00024141891,0.00014186128,0.00009103366,0.0004185479,0.000106004925,0.0000745458,0.000058206053,0.0002114806,0.00001794332],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004180737,0.0031141506,0.15681607,0.0019199897,0.0006812457,0.00013027845,0.002328043,0.000018362089,0.7940182,0.0002099341,0.006223967,0.030359007],"study_design_scores_gemma":[0.029767081,0.0032624495,0.07770401,0.00018709485,0.00061478605,0.000048213806,0.00066561456,0.0071799294,0.860013,0.00010092086,0.02007991,0.00037696393],"about_ca_topic_score_codex":0.0001511088,"about_ca_topic_score_gemma":0.00005476754,"teacher_disagreement_score":0.07911205,"about_ca_system_score_codex":0.00011744884,"about_ca_system_score_gemma":0.00022299551,"threshold_uncertainty_score":0.57849354},"labels":[],"label_agreement":null},{"id":"W2804219602","doi":"10.1182/blood-2018-03-838136","title":"A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; BC Cancer Agency","funders":"European Regional Development Fund; Instituto de Salud Carlos III; National Cancer Institute; Agència de Gestió d'Ajuts Universitaris i de Recerca; National Institutes of Health; Ministerio de Economía y Competitividad; Generalitat de Catalunya; Centres de Recerca de Catalunya","keywords":"Mantle cell lymphoma; Lymphoma; Outcome (game theory); Gene signature; Signature (topology); Biology; Computational biology; Cancer research; Bioinformatics; Oncology; Gene; Medicine; Genetics; Immunology; Gene expression; Mathematics","score_opus":0.016956971499266515,"score_gpt":0.24578776240413516,"score_spread":0.22883079090486866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804219602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99070966,0.0018920964,0.000011134283,0.00022235102,0.00021702141,0.00028142598,0.000080825565,0.00007149127,0.006513971],"genre_scores_gemma":[0.99647385,0.0000665395,0.00094946305,0.00030685228,0.0005972591,0.00003780659,0.000097025106,0.000023338682,0.001447892],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989552,0.00001947767,0.00019249605,0.00032577707,0.00025881274,0.0002482726],"domain_scores_gemma":[0.99940425,0.0000594388,0.000078596524,0.00022422077,0.00007098965,0.00016252189],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000782794,0.00018710435,0.0002639654,0.000051123327,0.00011871732,0.00003194703,0.00006438938,0.00011433181,0.00017387707],"category_scores_gemma":[0.000035731366,0.00014238375,0.00009976433,0.0000674283,0.00012993006,0.000042956202,0.00006649492,0.00004986075,0.00008327138],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000093030314,0.0021483887,0.99007595,0.000110063476,0.00021626425,0.00036906655,0.00012341536,5.905112e-8,0.0034539124,0.00011813759,0.0018195572,0.0014721348],"study_design_scores_gemma":[0.018152928,0.00067543506,0.8767763,0.0001064171,0.0006304642,0.0005608259,0.000075720585,0.000039137543,0.099501796,0.00008757261,0.0032086729,0.00018472079],"about_ca_topic_score_codex":0.00005593597,"about_ca_topic_score_gemma":0.000009954644,"teacher_disagreement_score":0.11329966,"about_ca_system_score_codex":0.00006977555,"about_ca_system_score_gemma":0.00009335527,"threshold_uncertainty_score":0.5806241},"labels":[],"label_agreement":null},{"id":"W2804273416","doi":"10.1182/blood-2017-12-820779","title":"GPIbα is required for platelet-mediated hepatic thrombopoietin generation","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"Canadian Institutes of Health Research","keywords":"Thrombopoietin; Thrombopoiesis; Platelet; Internal medicine; Endocrinology; Haematopoiesis; Chemistry; Hepatocyte; Biology; Immunology; Cell biology; In vitro; Megakaryocyte; Medicine; Stem cell; Biochemistry","score_opus":0.02945828740673566,"score_gpt":0.2825324321591479,"score_spread":0.25307414475241224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804273416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99642366,0.00022992778,0.00018654774,0.0008139566,0.00015268961,0.00062120944,0.000048382622,0.00007526876,0.0014483721],"genre_scores_gemma":[0.9950666,0.00006256931,0.0022695262,0.0010604582,0.0003928632,0.00006933893,0.0003937512,0.000027864766,0.0006570578],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99917597,0.000011899632,0.0001918852,0.00024149801,0.00014236353,0.00023637115],"domain_scores_gemma":[0.99949956,0.000032850054,0.000060850958,0.00021266751,0.0001064205,0.0000876522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007314014,0.00013177173,0.00025216612,0.000051081734,0.00011002804,0.000016068885,0.00004355045,0.00010090486,0.00023033029],"category_scores_gemma":[0.000079161364,0.000108684835,0.00007381492,0.00010987293,0.000050172348,0.000057233636,0.000012487463,0.000042271116,0.0002928233],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011299005,0.010830838,0.045190673,0.00045451932,0.0038006948,0.0008103271,0.0053865886,8.0557305e-7,0.7666072,0.00047633538,0.13958614,0.025725976],"study_design_scores_gemma":[0.043026116,0.005320966,0.01268092,0.00015215065,0.0013306249,0.0003021224,0.0001139121,0.004455857,0.90390426,0.0012229296,0.02689916,0.0005910115],"about_ca_topic_score_codex":0.00003110466,"about_ca_topic_score_gemma":0.000034610774,"teacher_disagreement_score":0.13729703,"about_ca_system_score_codex":0.000017876426,"about_ca_system_score_gemma":0.000054191594,"threshold_uncertainty_score":0.4432039},"labels":[],"label_agreement":null},{"id":"W2804545068","doi":"10.1182/blood-2018-02-831289","title":"Hemostatic efficacy of pathogen-inactivated vs untreated platelets: a randomized controlled trial","year":2018,"lang":"en","type":"review","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Hospital; London Health Sciences Centre; Health Sciences Centre; Kingston General Hospital; Ottawa Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Randomized controlled trial; Platelet; Confidence interval; Internal medicine; Platelet transfusion; Intention-to-treat analysis; Surgery; Clinical endpoint; Blood transfusion","score_opus":0.025932506720484343,"score_gpt":0.3122567828313291,"score_spread":0.28632427611084477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804545068","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015848749,0.9583066,0.000036650097,0.000078100464,0.00051557773,0.03579373,0.000054884767,0.00018518743,0.0034443839],"genre_scores_gemma":[0.00018227189,0.99572515,0.00027682108,0.00011950285,0.00027343584,0.001584505,0.0004370326,0.00011564328,0.0012856572],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.995028,0.0009835389,0.0023806782,0.0006279659,0.0005633753,0.0004164127],"domain_scores_gemma":[0.99601716,0.0015939437,0.0011705909,0.0007826048,0.00021065534,0.00022505967],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013166912,0.0007504751,0.012954929,0.0005053392,0.000062191575,0.000023227674,0.00023083673,0.0004799068,0.0006612364],"category_scores_gemma":[0.001037572,0.0004542572,0.0030064406,0.0005914775,0.0002079883,0.000028715554,0.000060458548,0.00040037857,0.000121665886],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9244134,0.004853502,9.373631e-8,0.011663155,0.012045503,0.00025772888,0.00007504597,1.9670846e-8,0.000010366778,0.00008250105,0.00051353255,0.04608519],"study_design_scores_gemma":[0.71791846,0.0010130539,1.6337522e-7,0.01072903,0.048014026,0.00006618719,0.000006466897,0.000002722258,0.000034901226,0.0000066699017,0.22194692,0.0002614106],"about_ca_topic_score_codex":0.000023806739,"about_ca_topic_score_gemma":0.0000015376786,"teacher_disagreement_score":0.22143339,"about_ca_system_score_codex":0.00004094654,"about_ca_system_score_gemma":0.00046818552,"threshold_uncertainty_score":0.9997909},"labels":[],"label_agreement":null},{"id":"W2804858543","doi":"10.1182/blood-2017-12-820571","title":"Blood-induced bone loss in murine hemophilic arthropathy is prevented by blocking the iRhom2/ADAM17/TNF-α pathway","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute; National Institute of General Medical Sciences; Bayer HealthCare","keywords":"Proinflammatory cytokine; Medicine; Tumor necrosis factor alpha; Cytokine; Immunology; Bone resorption; Internal medicine; Endocrinology; Inflammation","score_opus":0.021009932261980186,"score_gpt":0.28326035820575063,"score_spread":0.26225042594377046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804858543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98774,0.0017668712,0.0000019097454,0.0064256424,0.00012931402,0.0010560097,0.000026716416,0.00010569439,0.002747871],"genre_scores_gemma":[0.9941319,0.00026197292,0.00007890268,0.0006288706,0.0007315525,0.00009253119,0.00004205716,0.000063691514,0.003968486],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972532,0.0001498535,0.0004982959,0.00059673865,0.00070225477,0.00079967314],"domain_scores_gemma":[0.9984911,0.00012342361,0.000105934385,0.00085400057,0.00016366981,0.00026183916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005543217,0.00034706184,0.00050627976,0.00020181043,0.00025551327,0.000041480514,0.0002547579,0.00020758853,0.0005791722],"category_scores_gemma":[0.00016976222,0.0002260066,0.0001754817,0.00071815634,0.00027144363,0.00008571785,0.00017595629,0.00051939423,0.00028158055],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058838236,0.01633883,0.30347562,0.00036927714,0.0012518078,0.0032479546,0.004735093,2.9370509e-7,0.6393941,0.00012881124,0.0053707124,0.025099108],"study_design_scores_gemma":[0.017437855,0.0025551098,0.024354579,0.0005423449,0.00043942523,0.0007917213,0.0002326932,0.000085455686,0.9434211,0.00024543703,0.009437034,0.00045724594],"about_ca_topic_score_codex":0.00014269799,"about_ca_topic_score_gemma":0.00008589974,"teacher_disagreement_score":0.304027,"about_ca_system_score_codex":0.00005192051,"about_ca_system_score_gemma":0.00019240483,"threshold_uncertainty_score":0.9216282},"labels":[],"label_agreement":null},{"id":"W2805579785","doi":"10.1182/blood-2017-12-768994","title":"Exploring traditional and nontraditional roles for thrombomodulin","year":2018,"lang":"en","type":"review","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":248,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Thrombomodulin; Thrombin; Cell biology; Hemostasis; Protein C; Endothelium; Inflammation; Fibrinolysis; Coagulation; Biology; Immunology; Chemistry; Platelet; Medicine; Biochemistry; Internal medicine; Endocrinology","score_opus":0.3470861673345894,"score_gpt":0.3410400549020656,"score_spread":0.006046112432523787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805579785","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001866051,0.9965991,0.00038369992,0.000086752785,0.0003531596,0.0011622335,0.00043442217,0.000094040915,0.0007000143],"genre_scores_gemma":[0.00016847541,0.9899894,0.0053386884,0.00010343163,0.0022957446,0.0007986392,0.0011455357,0.00007420579,0.000085870655],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985734,0.000036676316,0.00043367533,0.00046214115,0.00026108697,0.00023301583],"domain_scores_gemma":[0.9991636,0.00018457306,0.00016334667,0.00022438527,0.000086589374,0.00017748169],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018850822,0.00032569803,0.0011875624,0.00017085418,0.00013764101,0.000033829318,0.00008045612,0.00020662391,0.00016313052],"category_scores_gemma":[0.00005003962,0.00027749964,0.00041458363,0.000113804126,0.0000792144,0.000119795455,0.00001607296,0.00018242252,0.000044519005],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044063785,0.0040596128,0.000009658964,0.043872707,0.004226174,0.00003956073,0.00019871703,8.704809e-8,0.00007278404,0.114801735,0.0030649654,0.82960993],"study_design_scores_gemma":[0.0032784368,0.0007730982,0.00017486264,0.0130769,0.0059260908,0.0007466367,0.000017452352,0.000011243736,0.00015004043,0.0043095117,0.9710314,0.000504325],"about_ca_topic_score_codex":7.298567e-7,"about_ca_topic_score_gemma":0.000001347892,"teacher_disagreement_score":0.96796644,"about_ca_system_score_codex":0.000024692787,"about_ca_system_score_gemma":0.00020356085,"threshold_uncertainty_score":0.9999677},"labels":[],"label_agreement":null},{"id":"W2808201717","doi":"10.1182/blood-2017-03-773028","title":"Normalizing hepcidin predicts TMPRSS6 mutation status in patients with chronic iron deficiency","year":2018,"lang":"en","type":"letter","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute","keywords":"TMPRSS6; Hepcidin; Iron-deficiency anemia; Iron status; Iron deficiency; Mutation; Anemia; Medicine; Internal medicine; Biology; Genetics; Gene; Biochemistry","score_opus":0.006293343253273753,"score_gpt":0.21293352249172207,"score_spread":0.20664017923844832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808201717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98536575,0.0028303668,0.000040397386,0.005897816,0.00042837745,0.0011914328,0.00008485723,0.00009541063,0.0040655863],"genre_scores_gemma":[0.8587234,0.00037449144,0.0011872622,0.12679693,0.0049488707,0.0001711796,0.00637662,0.0002875546,0.0011337092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99754536,0.00006713099,0.00038300751,0.0005191465,0.00072189886,0.0007634463],"domain_scores_gemma":[0.9990915,0.00002839244,0.00021580815,0.00044406598,0.00012697907,0.00009327003],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011128829,0.00036104125,0.00045090754,0.00033357934,0.00006840466,0.000027966931,0.00012678595,0.0004682812,0.00014490442],"category_scores_gemma":[0.000066022185,0.00029611605,0.00006453084,0.00029200863,0.00011721079,0.00014745568,0.000041358224,0.000782336,0.00009283974],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040278962,0.0018974615,0.7168548,0.0045646382,0.000058900743,0.0007074285,0.0014423426,0.000021781252,0.000053959917,0.000014780617,0.27033836,0.0036427733],"study_design_scores_gemma":[0.03512251,0.0033264824,0.8361303,0.00095813663,0.0013731774,0.00003182127,0.000071914066,0.000013234726,0.00029951718,0.00002791967,0.12172732,0.0009176646],"about_ca_topic_score_codex":0.00028569755,"about_ca_topic_score_gemma":0.00010283207,"teacher_disagreement_score":0.14861102,"about_ca_system_score_codex":0.000120892044,"about_ca_system_score_gemma":0.0004121208,"threshold_uncertainty_score":0.9999491},"labels":[],"label_agreement":null},{"id":"W2813119750","doi":"10.1182/blood-2018-01-828277","title":"Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Hematopoietic cell; Immunology; Immune system; Hemophagocytic lymphohistiocytosis; Haematopoiesis; Medicine; Conditioning; Hematopoietic stem cell transplantation; Hematologic Neoplasms; Transplantation; Biology; Stem cell; Internal medicine; Disease; Genetics","score_opus":0.018676457464207024,"score_gpt":0.26499110084168254,"score_spread":0.24631464337747552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2813119750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923934,0.0016786716,0.0016984384,0.00036479704,0.000060798422,0.00086420827,0.000030144689,0.0000530134,0.0028565286],"genre_scores_gemma":[0.99750155,0.00008076409,0.0011626141,0.0002137095,0.00008108764,0.000100229685,0.00007758492,0.000020473544,0.00076201116],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991178,0.000009871975,0.00023807777,0.00020993447,0.00013266562,0.0002916881],"domain_scores_gemma":[0.99940807,0.000081950915,0.000054304117,0.00018194749,0.00021049795,0.000063248044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026448417,0.00010821413,0.00030909418,0.00006571872,0.00028159827,0.000021690254,0.00006439339,0.0000715123,0.000029503935],"category_scores_gemma":[0.000054876116,0.00009396281,0.00009157189,0.000065338245,0.00022756039,0.000065031156,0.000022453321,0.00008386721,0.00001022407],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007935282,0.0007339986,0.003061967,0.0019672774,0.000122069236,0.000015242931,0.0036509198,2.7176097e-7,0.9860577,0.0008584762,0.0019470833,0.0007914699],"study_design_scores_gemma":[0.010952608,0.0023068108,0.028497566,0.00031501317,0.00043964392,0.00031734406,0.0017527504,0.00023131692,0.94760334,0.000770591,0.0065062414,0.00030677032],"about_ca_topic_score_codex":0.000007209426,"about_ca_topic_score_gemma":0.0000011973792,"teacher_disagreement_score":0.03845435,"about_ca_system_score_codex":0.000012297575,"about_ca_system_score_gemma":0.00012864724,"threshold_uncertainty_score":0.3831692},"labels":[],"label_agreement":null},{"id":"W2876645126","doi":"10.1182/blood-2018-03-842161","title":"Concurrent JAK2 mutation and isolated del(5q) associated with marrow fibrosis and small hypo/monolobated megakaryocytes","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Mean corpuscular volume; Hemoglobin; Platelet; Medicine; Megakaryocyte; Internal medicine; Anemia; Mean corpuscular hemoglobin; Gastroenterology; Immunology; Pathology; Biology; Haematopoiesis; Genetics","score_opus":0.014407507337810316,"score_gpt":0.23238097441988328,"score_spread":0.21797346708207296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2876645126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997123,0.0010975682,0.000040906085,0.0005828679,0.000043249674,0.0005580698,0.000039812665,0.00009255463,0.00042194885],"genre_scores_gemma":[0.99865955,0.00020724937,0.00051757664,0.00019159535,0.000056207933,0.000057523317,0.0001422689,0.000025162473,0.00014287463],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989573,0.00006326503,0.0002150271,0.000365362,0.00015248271,0.00024660781],"domain_scores_gemma":[0.9991822,0.00015782082,0.00011820635,0.00013193677,0.00023914262,0.00017068649],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000092510185,0.00023008948,0.00034672697,0.00007626888,0.00016191154,0.00004825707,0.000029629282,0.00011701831,0.00005616296],"category_scores_gemma":[0.0001244664,0.00016646965,0.00002938975,0.00018382732,0.00015544411,0.00006697668,0.000030113557,0.00010342889,0.000012221958],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042188776,0.0019522829,0.97597736,0.00008761283,0.0018850547,0.00025660335,0.0013444987,7.9706876e-7,0.0071764668,0.00020506432,0.0004621875,0.010230195],"study_design_scores_gemma":[0.017909873,0.0074436422,0.8815509,0.0005622234,0.0016726413,0.00034770154,0.00014203081,0.0012090509,0.08843777,0.00007818476,0.00027866245,0.00036732468],"about_ca_topic_score_codex":0.000083353516,"about_ca_topic_score_gemma":0.00028431037,"teacher_disagreement_score":0.09442645,"about_ca_system_score_codex":0.00003979242,"about_ca_system_score_gemma":0.000060247243,"threshold_uncertainty_score":0.6788435},"labels":[],"label_agreement":null},{"id":"W2883895192","doi":"10.1182/blood.v122.21.2965.2965","title":"Intensity Of Smoking Increases The Odds Of Acute Myeloid Leukemia In Adult Smokers","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Odds ratio; Internal medicine; Myeloid leukemia; Oncology; Population; Leukemia; Cohort study; Confidence interval; Cohort; Environmental health","score_opus":0.011316580223706211,"score_gpt":0.2543324738295793,"score_spread":0.24301589360587308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883895192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99666697,0.00008327652,0.000021522614,0.0004094555,0.000035355013,0.00045404764,0.0000136589515,0.000020910154,0.002294801],"genre_scores_gemma":[0.9989452,0.00011607708,0.0003279887,0.0003552602,0.00006090493,0.000031286727,0.000011463115,0.00002078816,0.0001310835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984876,0.00006572237,0.00041955218,0.00020624639,0.00050382107,0.00031706181],"domain_scores_gemma":[0.9984692,0.0003028865,0.00014182451,0.0004933641,0.00048474374,0.00010803638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002845963,0.00014136182,0.00042459217,0.00016265245,0.000030222356,0.00000815946,0.00025656103,0.00012004944,0.00012529486],"category_scores_gemma":[0.00069491356,0.00009187824,0.000104819606,0.00040899744,0.00031034474,0.00008308696,0.00019608301,0.00029827218,0.000017981181],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094614964,0.001201938,0.8120445,0.00062777044,0.00199577,0.00030352725,0.0021944467,0.000021843092,0.16939336,0.0007765054,0.006279669,0.0042145383],"study_design_scores_gemma":[0.011963195,0.00057265535,0.7934153,0.0006432016,0.00074004935,0.0003418544,0.0013432509,0.0017923929,0.18864758,0.00029522902,0.00005292863,0.00019237553],"about_ca_topic_score_codex":0.013715536,"about_ca_topic_score_gemma":0.0000651326,"teacher_disagreement_score":0.01925422,"about_ca_system_score_codex":0.0003355978,"about_ca_system_score_gemma":0.0007792833,"threshold_uncertainty_score":0.9928522},"labels":[],"label_agreement":null},{"id":"W2884038698","doi":"10.1182/blood-2018-02-831503","title":"AMPK-ACC signaling modulates platelet phospholipids and potentiates thrombus formation","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Fonds pour la Formation à la Recherche dans l’Industrie et dans l’Agriculture; Interreg; State Government of Victoria; National Health and Medical Research Council; Medical Research Council; Fonds De La Recherche Scientifique - FNRS; Fondation Louvain","keywords":"Platelet; AMPK; Hemostasis; Thrombus; Platelet activation; Signal transduction; Chemistry; Cell biology; Dense granule; Lysophosphatidic acid; Pharmacology; Internal medicine; Medicine; Biochemistry; Phosphorylation; Biology; Receptor; Protein kinase A","score_opus":0.007384637499569921,"score_gpt":0.21838211000902052,"score_spread":0.2109974725094506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884038698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93882453,0.060285106,0.00029848467,0.000008828465,0.00015420072,0.0000833503,0.000014215203,0.000016290098,0.000314992],"genre_scores_gemma":[0.9906162,0.007821106,0.0005762885,0.00023780197,0.00060191733,0.00000824283,0.00007277728,0.00001672513,0.00004896793],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99934083,0.000019936631,0.00014247204,0.00021008642,0.00008095127,0.00020574665],"domain_scores_gemma":[0.99963605,0.0000039635365,0.0000604506,0.00017014693,0.00007217978,0.000057210473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009875932,0.000115790084,0.00011962633,0.000022365828,0.00010085608,0.000043113563,0.0000857732,0.00010330153,0.000060733706],"category_scores_gemma":[0.000020243966,0.000108305256,0.00004092301,0.00005029246,0.00007446145,0.000010674764,0.000055252523,0.000040554383,0.000019195908],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028266593,0.00008324434,0.0011451434,0.00003621812,0.000104812,0.0000010579939,0.00020074056,0.0000099288645,0.96932846,0.00006278745,0.00097401853,0.028025327],"study_design_scores_gemma":[0.0008500572,0.000108302185,0.00089028187,0.00001240632,0.000044658533,0.000010203237,0.00005007421,0.00008150101,0.9685362,0.0002877964,0.028974125,0.00015437494],"about_ca_topic_score_codex":0.000013553984,"about_ca_topic_score_gemma":0.000009392029,"teacher_disagreement_score":0.052464,"about_ca_system_score_codex":0.0000024169299,"about_ca_system_score_gemma":0.000016048314,"threshold_uncertainty_score":0.44165602},"labels":[],"label_agreement":null},{"id":"W2884117406","doi":"10.1182/blood-2018-02-831347","title":"DNA methylation age is associated with an altered hemostatic profile in a multiethnic meta-analysis","year":2018,"lang":"en","type":"review","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; Public Health Ontario; University of Toronto","funders":"Hjärt-Lungfonden; National Institute on Aging; National Institute of Diabetes and Digestive and Kidney Diseases; Biotechnology and Biological Sciences Research Council; Medical Research Council; National Institutes of Health; National Heart, Lung, and Blood Institute; Vetenskapsrådet; National Center for Advancing Translational Sciences; Agence Nationale de la Recherche; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Fondation Leducq","keywords":"Epigenetics; Meta-analysis; DNA methylation; Confidence interval; Fibrinogen; Bioinformatics; Medicine; Hemostasis; Genetics; Biology; Oncology; Internal medicine; Gene","score_opus":0.10293196713476589,"score_gpt":0.3575857942245884,"score_spread":0.25465382708982254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884117406","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0078023626,0.99044967,0.00039686618,0.0000069682524,0.000031858373,0.0008699036,0.00024770058,0.000015050164,0.00017962727],"genre_scores_gemma":[0.005391087,0.98161197,0.0025461256,0.00005335521,0.00013685755,0.0003821925,0.008871322,0.00011087491,0.0008962257],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99723023,0.0006833584,0.00068771635,0.0008203772,0.0002663839,0.000311904],"domain_scores_gemma":[0.9982747,0.000059983024,0.00063545,0.0007778618,0.0001503737,0.000101640406],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007331709,0.00045739522,0.0018911803,0.00028469638,0.00005586261,0.000052606694,0.00026234376,0.0005188558,0.00008916756],"category_scores_gemma":[0.00015256894,0.00034300724,0.0010353242,0.0008320227,0.00005876596,0.000006200201,0.00006799298,0.00017912786,0.000011290434],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012287685,0.00548833,0.00041927816,0.0058237053,0.78736454,0.0001369617,0.0012495102,0.00009759413,0.007986241,0.000011588603,0.00030733342,0.19099201],"study_design_scores_gemma":[0.0023111945,0.0020568145,0.00025878442,0.0004393573,0.78064364,0.000005750099,0.00002570532,0.00012177385,0.017788244,0.0001639351,0.19424833,0.0019364357],"about_ca_topic_score_codex":0.00003749342,"about_ca_topic_score_gemma":0.00088869984,"teacher_disagreement_score":0.193941,"about_ca_system_score_codex":0.000025171696,"about_ca_system_score_gemma":0.00015710972,"threshold_uncertainty_score":0.9999022},"labels":[],"label_agreement":null},{"id":"W2885521384","doi":"10.1182/blood.v114.22.4056.4056","title":"Chelation Choices and Iron Burden Among Patients with Thalassemia in the 21st Century: a Report From the Thalassemia Clinical Research Network (TCRN) Longitudinal Cohort.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Deferasirox; Deferiprone; Medicine; Thalassemia; Beta thalassemia; Deferoxamine; Chelation therapy; Clinical trial; Internal medicine; Pediatrics; Retrospective cohort study","score_opus":0.020504348689555647,"score_gpt":0.3099345007893592,"score_spread":0.28943015209980355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885521384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98737377,0.001984411,0.000001359191,0.00213631,0.00009796728,0.0010728145,0.000004204949,0.00002874338,0.0073004263],"genre_scores_gemma":[0.9974968,0.0014330931,0.00006273235,0.0001828228,0.00056912523,0.000023131166,0.00013693972,0.000017357226,0.00007800212],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973816,0.00036107295,0.0005021344,0.0004888757,0.00077828916,0.00048801303],"domain_scores_gemma":[0.99837375,0.00061170454,0.00018649534,0.0005726274,0.00013695414,0.00011848415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021452906,0.00018355514,0.00031199207,0.000046194124,0.00028353478,0.00008119841,0.00019240363,0.00028310638,0.00002119835],"category_scores_gemma":[0.00039847178,0.00009081927,0.00006634759,0.0004803565,0.00027248941,0.00012092939,0.000059787424,0.0011673587,0.000006759734],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015383356,0.00047261282,0.995303,0.00000810035,0.00009136359,0.00018062505,0.0004582522,0.000012799463,0.000005761175,0.00004790533,0.0009902114,0.0022755696],"study_design_scores_gemma":[0.0033386447,0.0004913918,0.9922476,0.00030442528,0.0002774922,0.000045123947,0.00097193767,0.000049493225,0.0000033550257,0.00012135075,0.002034869,0.0001143493],"about_ca_topic_score_codex":0.00065916835,"about_ca_topic_score_gemma":0.00023394832,"teacher_disagreement_score":0.010123032,"about_ca_system_score_codex":0.000030903127,"about_ca_system_score_gemma":0.000098749326,"threshold_uncertainty_score":0.50716573},"labels":[],"label_agreement":null},{"id":"W2886500852","doi":"10.1182/blood.v130.suppl_1.3411.3411","title":"Burden of Comorbid Diseases in Patients with Hemophilia: The Cross-Sectional Analysis of the Patient Reported Outcomes, Burden and Experiences (PROBE) Study","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Hemophilia Society; McMaster University","funders":"","keywords":"Medicine; Cross-sectional study; Comorbidity; Internal medicine; Odds ratio; Haemophilia; Diabetes mellitus; Physical therapy; Pediatrics; Pathology","score_opus":0.024508114359319502,"score_gpt":0.32025895542122945,"score_spread":0.29575084106190996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886500852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99868727,0.00008552265,1.0857385e-7,0.00021915864,0.000034206827,0.0008463826,0.000023952434,0.0000046198525,0.0000987798],"genre_scores_gemma":[0.9997116,0.0000046875466,0.0000081604085,0.0000052545156,0.000022467813,0.00006299307,0.000011915835,0.0000061749174,0.00016679334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985353,0.000059117407,0.00034448542,0.00022557662,0.0006992494,0.00013631664],"domain_scores_gemma":[0.99867684,0.00006964865,0.0002818825,0.0007275408,0.00018648301,0.0000575879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001587908,0.00010826613,0.00036055423,0.00010630661,0.00022675328,0.000032012795,0.00019477136,0.000033981534,0.000037147573],"category_scores_gemma":[0.00023856908,0.000045447334,0.00010297022,0.00024441074,0.00042605758,0.000053416472,0.00015033493,0.000091275455,2.1010354e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001843894,0.0014875258,0.99251044,0.000016128539,0.0014070853,0.0000191053,0.00414763,0.00000994632,0.00001845119,0.0000020897949,0.0000017109512,0.00019550433],"study_design_scores_gemma":[0.004016785,0.0006486157,0.9919745,0.000025072313,0.0009601412,0.0000015227389,0.0020953494,0.000023557175,0.00019551282,0.000006244858,0.0000038174417,0.000048924136],"about_ca_topic_score_codex":0.00091732916,"about_ca_topic_score_gemma":0.00009272938,"teacher_disagreement_score":0.0038323954,"about_ca_system_score_codex":0.00001513382,"about_ca_system_score_gemma":0.00006762214,"threshold_uncertainty_score":0.18532884},"labels":[],"label_agreement":null},{"id":"W2886628870","doi":"10.1182/blood-2018-05-852798","title":"Crbn I391V is sufficient to confer in vivo sensitivity to thalidomide and its derivatives in mice","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":127,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Heart, Lung, and Blood Institute; National Cancer Institute; National Institutes of Health; National Institute of General Medical Sciences; Henry and Marilyn Taub Foundation; Edward P. Evans Foundation; Howard Hughes Medical Institute","keywords":"Thalidomide; Lenalidomide; In vivo; Cereblon; Pharmacology; Multiple myeloma; Medicine; Cancer research; Chemistry; Immunology; Biology; Genetics; Biochemistry","score_opus":0.03244490506308645,"score_gpt":0.3242023924631409,"score_spread":0.29175748740005447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886628870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996379,0.000064067695,0.000015159661,0.001538605,0.000022218677,0.00074427284,0.00003272911,0.000013428009,0.0011905043],"genre_scores_gemma":[0.998047,0.00001079954,0.0005493558,0.00091186597,0.00005565068,0.00003302705,0.0000024494836,0.000011397311,0.00037843682],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989461,0.00007995135,0.00014223353,0.00030167506,0.00019957608,0.0003304688],"domain_scores_gemma":[0.9993668,0.00011253456,0.000015724716,0.00014161576,0.00009412736,0.00026917618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023376547,0.00011668751,0.00022794631,0.000204953,0.000032342046,0.000016628268,0.000034037075,0.000044686836,0.000103156126],"category_scores_gemma":[0.00040735785,0.0000978452,0.00001975076,0.0002729566,0.000036855712,0.000040092767,0.00009058997,0.00008371605,0.00011744058],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013195522,0.0021806913,0.42341754,0.00009586626,0.000128398,0.0014010399,0.0118861245,0.0000037703085,0.5571458,0.00008183793,0.00061540946,0.0017240057],"study_design_scores_gemma":[0.0056972895,0.0005958106,0.49011064,0.00015225008,0.000016470787,0.00004265625,0.00037274096,0.00023962987,0.5021426,0.0000046961723,0.00051833515,0.00010687175],"about_ca_topic_score_codex":0.00046156105,"about_ca_topic_score_gemma":0.0011593156,"teacher_disagreement_score":0.0666931,"about_ca_system_score_codex":0.000041585696,"about_ca_system_score_gemma":0.00006633045,"threshold_uncertainty_score":0.39900115},"labels":[],"label_agreement":null},{"id":"W2887390738","doi":"","title":"The Thrombosis Interest Group of Canada website A practical, no charge resource","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Thrombosis; Medicine; Group (periodic table); Internal medicine; Chemistry","score_opus":0.023617231835497465,"score_gpt":0.26446166303138746,"score_spread":0.24084443119589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887390738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7809081,0.0006252126,0.000014083863,0.006009685,0.00033218766,0.00069953286,0.000011792205,0.000039117058,0.21136028],"genre_scores_gemma":[0.9958505,0.00031287674,0.00032358928,0.0014047985,0.000090948386,0.000037698355,0.000005450662,0.000023148978,0.0019509571],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989226,0.00007059933,0.00025240696,0.00018436468,0.00027001026,0.00030001518],"domain_scores_gemma":[0.99908906,0.00017883597,0.00011355577,0.00042661035,0.0000733164,0.00011860491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000335015,0.000118778065,0.00029622615,0.000026350812,0.00014510276,0.00001953203,0.0000949178,0.00003907169,0.00040139735],"category_scores_gemma":[0.00047104096,0.00007977455,0.000067899295,0.00012482965,0.000060706887,0.000033179134,0.00004936323,0.00014019737,0.00004908559],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006571169,0.00547829,0.01092765,0.00034346597,0.0015038842,0.00012592383,0.00040848137,4.152315e-7,0.0074495953,0.09578531,0.87751406,0.00039722692],"study_design_scores_gemma":[0.0015275626,0.00040411943,0.022321979,0.00012743451,0.00049950037,0.000025701165,0.00034700157,0.0000059197437,0.0066135875,0.000044713677,0.96795416,0.00012830218],"about_ca_topic_score_codex":0.013153259,"about_ca_topic_score_gemma":0.04637759,"teacher_disagreement_score":0.21494243,"about_ca_system_score_codex":0.000038791855,"about_ca_system_score_gemma":0.00020864452,"threshold_uncertainty_score":0.9934182},"labels":[],"label_agreement":null},{"id":"W2888444682","doi":"10.1182/blood-2018-03-837252","title":"Duodenal-type and nodal follicular lymphomas differ by their immune microenvironment rather than their mutation profiles","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"NODAL; Biology; Immune system; Mutation; Cancer research; Immune escape; Immunology; Genetics; Gene","score_opus":0.006708021906625637,"score_gpt":0.20607972822612577,"score_spread":0.19937170631950013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888444682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928232,0.0054141013,0.00001121899,0.00059699133,0.0000775442,0.00051917887,0.000048232163,0.00004233272,0.00046722262],"genre_scores_gemma":[0.9980388,0.00047734883,0.00021878787,0.0002558073,0.00015895057,0.000075447875,0.0001472311,0.000035274174,0.0005923064],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99905705,0.000040278825,0.00019419708,0.00031701114,0.0001504644,0.0002409979],"domain_scores_gemma":[0.99943817,0.000035387893,0.000072010575,0.0003060153,0.00004198163,0.000106445215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000070565635,0.00023311055,0.00027958385,0.000036222187,0.00011799459,0.000030297175,0.000055821754,0.00008468698,0.0001507651],"category_scores_gemma":[0.000012563749,0.00014509949,0.00007979123,0.0000798184,0.00012973549,0.000048233174,0.0000519094,0.000037939597,0.000070039605],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037041848,0.006854226,0.37263376,0.000081166254,0.0016588907,0.00019000136,0.002893032,1.9613493e-7,0.60085356,0.0001290695,0.002377935,0.011957767],"study_design_scores_gemma":[0.0063843043,0.00082873856,0.3261658,0.00007235286,0.00028699677,0.00020468024,0.00018608848,0.000021863338,0.661299,0.000060994495,0.0043378947,0.00015129347],"about_ca_topic_score_codex":0.000059053986,"about_ca_topic_score_gemma":0.0000049838513,"teacher_disagreement_score":0.060445443,"about_ca_system_score_codex":0.000058281166,"about_ca_system_score_gemma":0.000033872548,"threshold_uncertainty_score":0.5916985},"labels":[],"label_agreement":null},{"id":"W2889412507","doi":"10.1182/blood-2018-03-840702","title":"SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":175,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; BC Children's Hospital; Université de Montréal; University of Manitoba; Centre Hospitalier Universitaire Sainte-Justine","funders":"National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Severe combined immunodeficiency; Medicine; Immune system; Transplantation; Internal medicine; Immunosuppression; Hematopoietic stem cell transplantation; Genotype; Survival analysis; Immunology; Regimen; Oncology; Biology","score_opus":0.006313346357264111,"score_gpt":0.19734969336138855,"score_spread":0.19103634700412445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889412507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9237572,0.070895895,0.00004120934,0.00010123012,0.0007829724,0.00017523723,0.000074507916,0.00007162193,0.0041001155],"genre_scores_gemma":[0.9978475,0.0013478872,0.000030380792,0.00007668917,0.000014269161,0.000007680007,0.000095599855,0.00001797883,0.00056200987],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988877,0.00009813835,0.00026052954,0.0003256006,0.000041136478,0.00038688089],"domain_scores_gemma":[0.999515,0.00007396353,0.00007450476,0.00026699316,0.000059199294,0.000010339734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032557483,0.0001959211,0.00027280793,0.00007214732,0.00041357407,0.000030231164,0.00015944756,0.00020252734,0.00020981561],"category_scores_gemma":[0.00003618172,0.00017281115,0.000047320464,0.00009397551,0.0006263687,0.00011253082,0.00008018934,0.00020559863,0.00012299661],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005518904,0.0005044022,0.0063831382,0.00005442201,0.00042472925,0.000011853068,0.001226746,4.0991762e-7,0.978201,0.0011616362,0.00006642756,0.011413374],"study_design_scores_gemma":[0.014876804,0.003618439,0.55858153,0.00026031747,0.00071413047,0.00080728065,0.0014775936,0.000014556662,0.3702034,0.0010047071,0.047250506,0.0011907152],"about_ca_topic_score_codex":0.0002991715,"about_ca_topic_score_gemma":0.000015929221,"teacher_disagreement_score":0.60799754,"about_ca_system_score_codex":0.0000065027198,"about_ca_system_score_gemma":0.000054010183,"threshold_uncertainty_score":0.7047034},"labels":[],"label_agreement":null},{"id":"W2889728303","doi":"10.1182/blood-2018-07-859967","title":"Pathogen-induced coagulation: a new angle?","year":2018,"lang":"en","type":"letter","venue":"Blood","topic":"Vibrio bacteria research studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Disseminated intravascular coagulation; Coagulation; Peptidoglycan; Tissue factor; Microbiology; Pathogen; Immunology; Biology; Medicine; Pathology; Bacteria; Internal medicine","score_opus":0.026335975708854722,"score_gpt":0.271334510234259,"score_spread":0.24499853452540427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889728303","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4609097,0.004521014,0.0002496712,0.5158427,0.001969502,0.00185369,0.0006488368,0.00017868457,0.01382623],"genre_scores_gemma":[0.058474697,0.00094580854,0.0043969774,0.667269,0.18540464,0.00031509902,0.013747537,0.000585547,0.06886067],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99839276,0.00008822238,0.00020587827,0.000573969,0.0002868378,0.00045235816],"domain_scores_gemma":[0.9989481,0.000012332908,0.00010895927,0.0006938641,0.0001523254,0.000084428146],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008982534,0.00030081053,0.00026854695,0.000059953825,0.000097562035,0.00006111225,0.0003497842,0.0007749132,0.000118066724],"category_scores_gemma":[0.00014685828,0.00028302002,0.00015628718,0.0000829447,0.000075493976,0.000002197897,0.0003294489,0.00036879905,0.0001448845],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009564196,0.00002478772,0.00011484922,0.000028751983,0.00020666457,0.000065521825,0.000013088737,2.0583474e-8,0.31540486,6.6108703e-7,0.68392104,0.0002101679],"study_design_scores_gemma":[0.00087803794,0.00039865487,0.0005976997,0.000028267445,0.00008668707,0.00003952238,0.0000032201103,3.2310433e-7,0.08421389,0.00004459157,0.9133837,0.00032537692],"about_ca_topic_score_codex":0.000026414638,"about_ca_topic_score_gemma":0.000024855928,"teacher_disagreement_score":0.402435,"about_ca_system_score_codex":0.000011620731,"about_ca_system_score_gemma":0.00027072255,"threshold_uncertainty_score":0.9999622},"labels":[],"label_agreement":null},{"id":"W2889851685","doi":"10.1182/blood-2018-03-841197","title":"Hepcidin-mediated hypoferremic response to acute inflammation requires a threshold of Bmp6/Hjv/Smad signaling","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research; Institut national de la recherche scientifique","keywords":"Hepcidin; Ferroportin; Hemochromatosis; Endocrinology; Internal medicine; SMAD; Bone morphogenetic protein 6; Inflammation; Bone morphogenetic protein; Medicine; Biology; Immunology; Bone morphogenetic protein 7; Transforming growth factor; Biochemistry","score_opus":0.015843884422773093,"score_gpt":0.2747012011540373,"score_spread":0.2588573167312642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889851685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962473,0.0003534731,0.00014330185,0.0009042907,0.00017009815,0.00043676878,0.000018494286,0.00009298472,0.0016332947],"genre_scores_gemma":[0.997232,0.00003610708,0.0014602654,0.00043294774,0.00038519868,0.000020619846,0.000031373234,0.000029566883,0.0003718819],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986187,0.00007332103,0.0004060151,0.00025667777,0.00035384623,0.00029142448],"domain_scores_gemma":[0.99898833,0.00011471184,0.000121489844,0.0004030695,0.00020327237,0.00016910968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053286715,0.00016260814,0.00032520268,0.00026190482,0.0000662922,0.0000128686515,0.00012993542,0.00011777123,0.00015263386],"category_scores_gemma":[0.0006999192,0.00014352043,0.00008264795,0.00040762842,0.000105875115,0.00010426272,0.00005713336,0.00010874591,0.00018923894],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038298036,0.00017043662,0.005026036,0.000056775087,0.000066253495,0.000028048264,0.0016340141,0.000003686976,0.9877224,0.00011835057,0.0006336652,0.00071055384],"study_design_scores_gemma":[0.0075947163,0.0015159675,0.033077877,0.00021573277,0.0007235242,0.00004584773,0.00044820327,0.000058962665,0.9526748,0.0002728477,0.003091184,0.00028030705],"about_ca_topic_score_codex":0.000030094825,"about_ca_topic_score_gemma":0.000012069461,"teacher_disagreement_score":0.035047546,"about_ca_system_score_codex":0.000014336536,"about_ca_system_score_gemma":0.00015334976,"threshold_uncertainty_score":0.5852594},"labels":[],"label_agreement":null},{"id":"W2890680400","doi":"10.1182/blood-2018-07-862334","title":"International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":414,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"National Institute of Allergy and Infectious Diseases; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Heart, Lung, and Blood Institute","keywords":"Medicine; Castleman disease; Tocilizumab; Disease; Internal medicine; Expert opinion; Lymph node; Consensus conference; Oncology; Intensive care medicine","score_opus":0.11221155930132938,"score_gpt":0.37427377049068256,"score_spread":0.2620622111893532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890680400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9516602,0.009736973,0.000409295,0.03492396,0.00081699,0.0013684046,0.0001336663,0.00014596278,0.00080452464],"genre_scores_gemma":[0.9948425,0.0004030022,0.001286641,0.0019173224,0.00080218166,0.00011017991,0.000033237797,0.000020943913,0.00058395055],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990589,0.000022253285,0.0002580121,0.0002462449,0.00020342448,0.0002111683],"domain_scores_gemma":[0.9987772,0.00007438702,0.00010242145,0.0001934956,0.00067249907,0.0001799596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001319721,0.00013494746,0.0001924454,0.00008311338,0.00008841889,0.000020587058,0.00006597707,0.000050014958,0.000095360796],"category_scores_gemma":[0.001541354,0.000106404426,0.00014863291,0.00010518047,0.00006805446,0.000030506699,0.000010505611,0.000032672328,0.0000385043],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023809996,0.019857805,0.5993138,0.0014532213,0.0047104335,0.0014642199,0.0019586915,0.00038661395,0.029626109,0.0007810524,0.1726076,0.14403047],"study_design_scores_gemma":[0.3025794,0.023298245,0.092865326,0.008884784,0.018228926,0.0001220744,0.0023995852,0.09933934,0.06717344,0.0010719835,0.38123247,0.0028044328],"about_ca_topic_score_codex":0.00013738626,"about_ca_topic_score_gemma":0.000042124528,"teacher_disagreement_score":0.50644845,"about_ca_system_score_codex":0.00013174348,"about_ca_system_score_gemma":0.0003884228,"threshold_uncertainty_score":0.43390465},"labels":[],"label_agreement":null},{"id":"W2890990726","doi":"10.1182/blood-2018-08-867069","title":"CRISPRing the CRL4CRBN RING in multiple myeloma","year":2018,"lang":"en","type":"letter","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Lenalidomide; Multiple myeloma; Cereblon; Cancer research; Blood cancer; Ubiquitin; Biology; Medicine; Cancer; Immunology; Genetics; Ubiquitin ligase; Gene","score_opus":0.013772261844404079,"score_gpt":0.22929771012697517,"score_spread":0.21552544828257109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890990726","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73284405,0.003724048,0.00043760397,0.24488832,0.0015076804,0.001412946,0.00007098703,0.00009141109,0.015022922],"genre_scores_gemma":[0.47560245,0.00026880397,0.0017016897,0.48596543,0.026850196,0.000276283,0.0008066926,0.00019239675,0.008336054],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989485,0.00007581934,0.00020354071,0.00035618662,0.00014388002,0.00027206924],"domain_scores_gemma":[0.9993318,0.000016977627,0.00009216273,0.0004902483,0.000046526882,0.000022328803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014805776,0.00018855368,0.0001320487,0.000052782216,0.000083509774,0.00004667454,0.0003516841,0.00048963894,0.000027884345],"category_scores_gemma":[0.0001344385,0.00014591424,0.00009448495,0.00006850428,0.000085413725,0.0000024968738,0.00017679956,0.00048370467,0.00004757512],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011559765,0.00006663686,0.0027657438,0.000057539743,0.000085801854,0.000056080753,0.00004702319,0.0000014529094,0.08863229,0.0000057597053,0.90701526,0.0012548466],"study_design_scores_gemma":[0.0004789682,0.000042487874,0.0005289667,0.000035875968,0.000014982706,0.000011678443,0.000007841286,0.000008964311,0.23892072,0.000014211073,0.7597648,0.00017050598],"about_ca_topic_score_codex":0.00003712477,"about_ca_topic_score_gemma":0.000059455997,"teacher_disagreement_score":0.2572416,"about_ca_system_score_codex":0.000008579704,"about_ca_system_score_gemma":0.000044186872,"threshold_uncertainty_score":0.595021},"labels":[],"label_agreement":null},{"id":"W2891211505","doi":"10.1182/blood-2018-06-855296","title":"Genome-wide association study implicates immune dysfunction in the development of Hodgkin lymphoma","year":2018,"lang":"en","type":"review","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University and Génome Québec Innovation Centre; McGill Genome Centre","funders":"Medical Research Council; National Heart, Lung, and Blood Institute; Blood Cancer UK; European Commission; National Institute for Health and Care Research; National Cancer Institute; Cancer Research UK; Wellcome Trust","keywords":"Genome-wide association study; Genetic predisposition; Biology; Germinal center; Lymphoma; Genetics; Genetic association; Immune system; Immunology; Gene; Cancer research; B cell; Single-nucleotide polymorphism; Genotype","score_opus":0.0356225186678527,"score_gpt":0.3046171304650697,"score_spread":0.268994611797217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891211505","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.120255105,0.8766062,0.0000010906678,0.00003944038,0.000087262604,0.0024404468,0.00001022986,0.000020217009,0.00053998694],"genre_scores_gemma":[0.036941875,0.9608315,0.00018114556,0.00003703155,0.00016081975,0.0013796668,0.00028559426,0.000039909286,0.00014245976],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978034,0.00021569779,0.0009726848,0.0003457498,0.0004217118,0.00024076289],"domain_scores_gemma":[0.99823695,0.00047824267,0.0006625939,0.00048827732,0.00009571701,0.000038191105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093563594,0.00031146492,0.0012752443,0.0001823698,0.00007488704,0.000021992204,0.00018570613,0.00019570447,0.000025804102],"category_scores_gemma":[0.00018411518,0.00018172844,0.00027618228,0.0003911564,0.000015783278,0.000026397945,0.00006758837,0.00007970897,0.00011612672],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025614167,0.021795098,0.23074228,0.0042589214,0.0038944483,0.00005386145,0.0026197617,2.2188077e-8,0.0000030120152,0.0000054125276,0.00018797696,0.7364136],"study_design_scores_gemma":[0.0045214766,0.00054549734,0.62094635,0.002160342,0.0040850607,0.000017407785,0.00021879806,2.9066861e-8,0.00004495073,0.000004670084,0.36728424,0.00017119628],"about_ca_topic_score_codex":0.00005233579,"about_ca_topic_score_gemma":0.00005689858,"teacher_disagreement_score":0.7362424,"about_ca_system_score_codex":0.00073278265,"about_ca_system_score_gemma":0.00052037573,"threshold_uncertainty_score":0.74106705},"labels":[],"label_agreement":null},{"id":"W2891756647","doi":"10.1182/blood.v120.21.21.21","title":"Benefit of Extended Maintenance Therapy for Venous Thromboembolism with Dabigatran Etexilate Is Maintained Over 1 Year of Post-Treatment Follow-up","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Hospital; McMaster University","funders":"","keywords":"Medicine; Pulmonary embolism; Clinical endpoint; Population; Dabigatran; Surgery; Discontinuation; Intention-to-treat analysis; Vitamin K antagonist; Placebo; Apixaban; Warfarin; Randomization; Deep vein; Randomized controlled trial; Internal medicine; Thrombosis; Rivaroxaban; Atrial fibrillation","score_opus":0.2008345460548317,"score_gpt":0.466002715671639,"score_spread":0.2651681696168073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891756647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945439,0.0015478197,0.000014340842,0.00074843,0.0005323018,0.0010673443,0.00068154436,0.000040608258,0.0008237022],"genre_scores_gemma":[0.99625397,0.00080787286,0.00032644675,0.0016691061,0.0002664669,0.00008710415,0.000048207425,0.000042794272,0.0004980392],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99827445,0.00012869242,0.00041386136,0.00027216563,0.0001629771,0.0007478298],"domain_scores_gemma":[0.9986054,0.00023418489,0.00023029212,0.00028180334,0.00027470806,0.00037361318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038205396,0.0002857696,0.0005825458,0.000066212444,0.00014210684,0.000005017354,0.00021100426,0.000436047,0.0008111176],"category_scores_gemma":[0.00002534851,0.00021729713,0.0001787084,0.00017850901,0.0002280737,0.00011740172,0.000028682744,0.00041913873,0.0000119941615],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028272318,0.029488757,0.2140989,0.0011966601,0.008381267,0.00006735565,0.020317825,0.00008567727,0.613111,0.03622875,0.0016141264,0.047137316],"study_design_scores_gemma":[0.025899418,0.0055732564,0.061787672,0.00008830831,0.0011379633,0.00005145067,0.0005730735,0.00007475842,0.86896306,0.0010857702,0.03429592,0.00046936425],"about_ca_topic_score_codex":0.00006678407,"about_ca_topic_score_gemma":0.00001850154,"teacher_disagreement_score":0.255852,"about_ca_system_score_codex":0.000048743463,"about_ca_system_score_gemma":0.00015481855,"threshold_uncertainty_score":0.88811684},"labels":[],"label_agreement":null},{"id":"W2892392661","doi":"10.1182/blood-2018-05-851154","title":"Molecular classification of primary mediastinal large B-cell lymphoma using routinely available tissue specimens","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Concordance; Lymphoma; Molecular diagnostics; Medicine; Pathology; Diffuse large B-cell lymphoma; Biopsy; Mediastinum; Computational biology; Oncology; Radiology; Bioinformatics; Internal medicine; Biology","score_opus":0.028917160059069837,"score_gpt":0.2649211411833282,"score_spread":0.23600398112425838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892392661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96481067,0.0008798975,0.0001523296,0.00009026229,0.00008900347,0.0002819002,0.000022904962,0.000035103785,0.033637952],"genre_scores_gemma":[0.99489594,0.000033686305,0.0041232724,0.00016888646,0.0002486035,0.0000133731455,0.000058730984,0.000025184345,0.0004322993],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99884045,0.00002563242,0.0002933428,0.00027857185,0.00029716807,0.00026483618],"domain_scores_gemma":[0.99916464,0.000031077303,0.0001550729,0.0003664954,0.00016222987,0.00012049376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012618315,0.00015057948,0.00029821662,0.00007828118,0.00006046924,0.000010617168,0.00007046379,0.000081142134,0.00033436055],"category_scores_gemma":[0.000030539522,0.00013040577,0.00007224216,0.00017332924,0.00007563743,0.000047505302,0.000046739355,0.00002917323,0.0003008904],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010343884,0.01185374,0.061556812,0.0001393567,0.00017785045,0.00022990356,0.00019349117,3.0959944e-7,0.9224821,0.00039151267,0.0010838318,0.0017876532],"study_design_scores_gemma":[0.013851105,0.0006334634,0.15974748,0.000109833956,0.00065350276,0.0001253693,0.00003919452,0.00014783048,0.8193994,0.000014186883,0.005150711,0.0001278939],"about_ca_topic_score_codex":0.00005555421,"about_ca_topic_score_gemma":0.0000038360367,"teacher_disagreement_score":0.10308268,"about_ca_system_score_codex":0.00011666793,"about_ca_system_score_gemma":0.00022635816,"threshold_uncertainty_score":0.5317793},"labels":[],"label_agreement":null},{"id":"W2892827065","doi":"10.1182/blood-2018-08-867036","title":"Higher-risk APS: do we dare to DOAC?","year":2018,"lang":"en","type":"letter","venue":"Blood","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Rivaroxaban; Medicine; Antiphospholipid syndrome; Warfarin; Randomized controlled trial; Internal medicine; Atrial fibrillation; Thrombosis","score_opus":0.029553706344212224,"score_gpt":0.30210559470298165,"score_spread":0.2725518883587694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892827065","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.032382976,0.008757288,0.000024832476,0.90681565,0.0026870049,0.0032230448,0.00044855903,0.0004900692,0.04517056],"genre_scores_gemma":[0.0047236597,0.0015539024,0.0025668428,0.5299179,0.0951878,0.0008422286,0.00062455854,0.00083378237,0.36374936],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955627,0.00023070937,0.0005805504,0.001001071,0.0016365256,0.0009884823],"domain_scores_gemma":[0.9966743,0.00027106574,0.00021169498,0.0020766575,0.00041327937,0.0003530161],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00047592787,0.0005374843,0.0010509371,0.0005159219,0.00011144553,0.000097669,0.00066951034,0.0012821739,0.0026279767],"category_scores_gemma":[0.00033110887,0.0004213724,0.0003013954,0.00046762088,0.00012279564,0.000040968305,0.00032997364,0.0022248859,0.008364817],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004204491,0.00012993994,0.0074984604,0.0022120099,0.0005405062,0.0019532118,0.0004951589,2.1152761e-8,0.00019936427,0.00000452474,0.98640865,0.0005160861],"study_design_scores_gemma":[0.0029381614,0.0004923417,0.00012867626,0.0037726688,0.0005983237,0.0049632816,0.00007915492,4.0473515e-7,0.00052913715,0.00010844425,0.98597366,0.0004157408],"about_ca_topic_score_codex":0.00010039031,"about_ca_topic_score_gemma":0.0000059098998,"teacher_disagreement_score":0.37689778,"about_ca_system_score_codex":0.00017755303,"about_ca_system_score_gemma":0.00036373638,"threshold_uncertainty_score":0.9998238},"labels":[],"label_agreement":null},{"id":"W2893535784","doi":"10.1182/blood-2018-07-863431","title":"T-cell defects in patients with ARPC1B germline mutations account for combined immunodeficiency","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Biology; T-cell receptor; CD8; T cell; Severe combined immunodeficiency; Immunodeficiency; Wiskott–Aldrich syndrome; Immunology; Wiskott–Aldrich syndrome protein; Molecular biology; Cell biology; Actin cytoskeleton; Antigen; Cell; Cytoskeleton; Immune system; In vivo; Genetics; Gene","score_opus":0.004452480612805064,"score_gpt":0.1997276932744777,"score_spread":0.19527521266167264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2893535784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927759,0.0040664584,0.00022487961,0.000029403376,0.0003693374,0.00071328314,0.000050567727,0.00006877061,0.00170141],"genre_scores_gemma":[0.99869215,0.000010204137,0.00008877274,0.00011151404,0.0000040349105,0.00009988254,0.00042060218,0.000027082031,0.0005457307],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986995,0.000058681424,0.00034166322,0.0003334341,0.000050302056,0.0005164428],"domain_scores_gemma":[0.99919766,0.00010184602,0.00014158928,0.00035437007,0.00019867833,0.000005833394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018517472,0.00021540374,0.00026144442,0.00016698528,0.00035701043,0.000023632763,0.00028566565,0.0001585445,0.00013882606],"category_scores_gemma":[0.00006328113,0.00018185313,0.000078723344,0.00032210263,0.00031994286,0.00014446263,0.00004919154,0.00017954991,0.0002364741],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060976474,0.05656587,0.41355222,0.00034905944,0.0008154441,0.000010179583,0.010299062,0.00013921341,0.49452856,0.0060898177,0.0011346724,0.010418242],"study_design_scores_gemma":[0.06980787,0.0060612354,0.7940831,0.00014755195,0.00034382226,0.000009260788,0.0008308838,0.00003001963,0.11430072,0.00075881963,0.01248686,0.0011398153],"about_ca_topic_score_codex":0.000057899237,"about_ca_topic_score_gemma":0.000011076483,"teacher_disagreement_score":0.38053092,"about_ca_system_score_codex":0.0000202933,"about_ca_system_score_gemma":0.00009081402,"threshold_uncertainty_score":0.74157554},"labels":[],"label_agreement":null},{"id":"W2896822607","doi":"10.1182/blood-2018-04-848028","title":"Next-generation sequencing–based posttransplant monitoring of acute myeloid leukemia identifies patients at high risk of relapse","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Chonnam National University Hwasun Hospital; National Research Foundation of Korea; Chonnam National University; National Natural Science Foundation of China; Ministry of Science, ICT and Future Planning; National Research Foundation; Natural Sciences and Engineering Research Council of Canada; Princess Margaret Cancer Foundation","keywords":"Myeloid leukemia; Medicine; Oncology; Internal medicine; Leukemia; Intensive care medicine","score_opus":0.035319199620235504,"score_gpt":0.2730305429663111,"score_spread":0.23771134334607558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896822607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985015,0.000100158024,0.00008854017,0.00004079052,0.00033240314,0.0004440144,0.000262448,0.000047176993,0.00018300123],"genre_scores_gemma":[0.99552464,0.00026169038,0.003035252,0.000026550002,0.0004515456,0.000019099822,0.00028719322,0.00004278677,0.00035121205],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978871,0.00011472758,0.00056087517,0.0003511907,0.00073300616,0.0003531497],"domain_scores_gemma":[0.9982024,0.000095541385,0.00030676977,0.0005675696,0.0006744908,0.00015323142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003679767,0.00020403259,0.0004131288,0.00023757227,0.00014048324,0.000015475822,0.00019409838,0.00018214801,0.00007531367],"category_scores_gemma":[0.00018072418,0.00017907351,0.00013367446,0.000312203,0.00023274812,0.0001671175,0.00007564071,0.0002657411,0.000044707696],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042637702,0.00016469571,0.21859401,0.00016121045,0.00041374253,0.000033548324,0.0004663978,0.000012250095,0.7791099,0.000008794991,0.00029608968,0.0003129877],"study_design_scores_gemma":[0.0055910307,0.00096225744,0.09893128,0.00022432346,0.0009706335,0.000016087057,0.000044641027,0.00047554914,0.8926067,0.000012915658,0.00003223627,0.00013234498],"about_ca_topic_score_codex":0.0011334135,"about_ca_topic_score_gemma":0.00003531278,"teacher_disagreement_score":0.119662724,"about_ca_system_score_codex":0.00057941326,"about_ca_system_score_gemma":0.0005944736,"threshold_uncertainty_score":0.7302406},"labels":[],"label_agreement":null},{"id":"W2897241170","doi":"10.1182/blood-2018-06-858852","title":"Selinexor plus low-dose bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Alberta; Vancouver General Hospital; CancerCare Manitoba; Royal Victoria Hospital; Dalhousie University","funders":"Karyopharm Therapeutics","keywords":"Bortezomib; Dexamethasone; Multiple myeloma; Carfilzomib; Medicine; Refractory (planetary science); Oncology; Internal medicine; Pomalidomide; Lenalidomide; Biology","score_opus":0.02251411635390486,"score_gpt":0.28837410980690453,"score_spread":0.26585999345299965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897241170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99721414,0.00016566887,0.0001420361,0.00010280443,0.000066262524,0.0018736995,0.00012212258,0.00008214138,0.00023111806],"genre_scores_gemma":[0.980551,0.000043213007,0.017271819,0.00014531893,0.00027533542,0.00020334736,0.00019034166,0.000060283997,0.0012593577],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983959,0.00004237957,0.00024661756,0.00046111053,0.00036809448,0.00048586784],"domain_scores_gemma":[0.99830365,0.00035865922,0.00009542257,0.0004267102,0.00040546575,0.00041008394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014522014,0.0002385237,0.0003753876,0.00011887391,0.00017039702,0.000027750377,0.00008489291,0.000117477786,0.000089375484],"category_scores_gemma":[0.0009292944,0.00014989701,0.00005590643,0.00017090954,0.00018804707,0.00011519136,0.000053652537,0.00014259896,0.00004163263],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038160328,0.0074775983,0.8909952,0.00047256553,0.001337833,0.00028081553,0.000656144,2.2751682e-7,0.0037923928,0.000010510301,0.001446119,0.055370264],"study_design_scores_gemma":[0.13485333,0.013591834,0.83561105,0.00029959096,0.0005089711,0.00005532403,0.000097290496,0.00077733205,0.0084999995,0.00001371801,0.005351833,0.0003396925],"about_ca_topic_score_codex":0.00006303009,"about_ca_topic_score_gemma":0.00015765481,"teacher_disagreement_score":0.09669301,"about_ca_system_score_codex":0.000060424034,"about_ca_system_score_gemma":0.00024484945,"threshold_uncertainty_score":0.61126226},"labels":[],"label_agreement":null},{"id":"W2898630421","doi":"10.1182/blood-2018-99-116653","title":"Ibrutinib Alone or in Combination with Rituximab Produces Superior Progression Free Survival (PFS) Compared with Bendamustine Plus Rituximab in Untreated Older Patients with Chronic Lymphocytic Leukemia (CLL): Results of Alliance North American Intergroup Study A041202","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Bendamustine; Ibrutinib; Rituximab; Chronic lymphocytic leukemia; Medicine; Alemtuzumab; Internal medicine; Progression-free survival; Ofatumumab; Oncology; Leukemia; Chemotherapy; Lymphoma; Transplantation","score_opus":0.015088365161569457,"score_gpt":0.28321230479839604,"score_spread":0.26812393963682657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898630421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941559,0.00012142425,0.0000097424945,0.00008242469,0.000055662375,0.005262557,0.0000881128,0.00012358812,0.00010060708],"genre_scores_gemma":[0.997843,0.000026003534,0.0010121382,0.0000226396,0.00011184749,0.00035358555,0.00039008763,0.00012206893,0.00011862419],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99421686,0.0003398221,0.0011809333,0.0013463766,0.0018895583,0.0010264532],"domain_scores_gemma":[0.99652445,0.00025554237,0.000626656,0.0013984322,0.00092935486,0.0002655399],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005935934,0.00064985885,0.0016697085,0.0004765805,0.000119943565,0.000057412704,0.0005855362,0.00010676646,0.000026682852],"category_scores_gemma":[0.00038938902,0.00041295405,0.00004720693,0.00307277,0.0011836968,0.00031447338,0.00028086343,0.0004654059,0.000013846219],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.11677639,0.031022672,0.83754015,0.0010981411,0.0007426205,0.0014925553,0.006924835,0.00028087257,0.00015103687,0.0000022893278,0.00008687483,0.0038815464],"study_design_scores_gemma":[0.46542075,0.022792073,0.5010086,0.002364865,0.00027321395,0.00007660372,0.00089506083,0.0042370316,0.0024929193,4.4641357e-7,0.000016010106,0.0004223955],"about_ca_topic_score_codex":0.015444949,"about_ca_topic_score_gemma":0.1463584,"teacher_disagreement_score":0.34864435,"about_ca_system_score_codex":0.020005558,"about_ca_system_score_gemma":0.016458005,"threshold_uncertainty_score":0.9998322},"labels":[],"label_agreement":null},{"id":"W2898644963","doi":"10.1182/blood-2018-99-114960","title":"Atezolizumab in Combination with Daratumumab with or without Lenalidomide or Pomalidomide: A Phase Ib Study in Patients with Multiple Myeloma","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Pomalidomide; Lenalidomide; Atezolizumab; Daratumumab; Medicine; Internal medicine; Oncology; Multiple myeloma; Cohort; Tolerability; Cancer; Adverse effect; Immunotherapy; Nivolumab","score_opus":0.02632864527307843,"score_gpt":0.3215447505745981,"score_spread":0.29521610530151965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898644963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99423975,0.00001864244,0.00003438482,0.000065668326,0.00002391155,0.0051015527,0.00003222355,0.000078614416,0.00040523394],"genre_scores_gemma":[0.9969122,0.0000035695273,0.0017624845,0.000050218423,0.000054472806,0.0005150595,0.00012945132,0.0000894662,0.00048309524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968012,0.0002077587,0.00047705707,0.0007434341,0.0010195412,0.0007509892],"domain_scores_gemma":[0.9983097,0.00013725276,0.00018352542,0.0006344818,0.00041343388,0.00032165018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002546355,0.00045689236,0.00078988314,0.00053010933,0.00015323905,0.00006749343,0.00018229292,0.00009615445,0.0001258982],"category_scores_gemma":[0.00020722304,0.00023764934,0.00003218873,0.0011058142,0.00024203022,0.0003211817,0.00006705585,0.00032428183,0.000039584873],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14493456,0.030423373,0.818175,0.00006428981,0.00042187708,0.0020850839,0.0013130889,0.0000011879644,0.00006441744,0.000002883202,0.000012938881,0.0025012896],"study_design_scores_gemma":[0.31983948,0.04543193,0.63122815,0.00042448542,0.00019082549,0.00009408779,0.0005886782,0.00021292838,0.0017022229,0.0000017613293,0.00002926427,0.00025621685],"about_ca_topic_score_codex":0.001045477,"about_ca_topic_score_gemma":0.026602902,"teacher_disagreement_score":0.18694688,"about_ca_system_score_codex":0.00022322882,"about_ca_system_score_gemma":0.0005025868,"threshold_uncertainty_score":0.9911591},"labels":[],"label_agreement":null},{"id":"W2898813536","doi":"10.1182/blood-2018-99-113585","title":"Immunoglobulin Lambda Translocations Identify Poor Outcome and IMiD Resistance in Multiple Myeloma and Co-Occur with Hyperdiploidy","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Multiple myeloma; Chromosomal translocation; Lenalidomide; Internal medicine; Biology; Hazard ratio; Oncology; Immunology; Cancer research; Medicine; Genetics; Confidence interval; Gene","score_opus":0.031954615612353764,"score_gpt":0.3240272048402091,"score_spread":0.29207258922785534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898813536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995902,0.0014772022,0.000032474356,0.0006234663,0.000017347844,0.0006275141,0.00006874148,0.00004351112,0.0012077626],"genre_scores_gemma":[0.99546957,0.000105129075,0.0034706555,0.000091256516,0.000058006153,0.00007185879,0.000043926022,0.000024736812,0.0006648564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987786,0.000048934642,0.0002498484,0.00034725893,0.0002561624,0.00031918968],"domain_scores_gemma":[0.9992784,0.00010444843,0.000043262742,0.0002825484,0.00008930427,0.00020199238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015372357,0.00017046582,0.00028962418,0.0001383033,0.00015314638,0.00004186401,0.000069105234,0.00007013978,0.000035649846],"category_scores_gemma":[0.000119345765,0.00013169524,0.000028789062,0.00020736505,0.0002775485,0.00011236823,0.000026036389,0.00015277477,0.00003110524],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079029135,0.0005591112,0.9871705,0.00011793628,0.00016168981,0.00020355085,0.0003742192,4.5814435e-8,0.009537307,0.00004428527,0.000039332834,0.0010017046],"study_design_scores_gemma":[0.014923904,0.0004038091,0.97839385,0.00013344591,0.0001110676,0.000101389414,0.00016620012,0.00003399844,0.0050713723,0.000034264558,0.00049196684,0.00013471363],"about_ca_topic_score_codex":0.0002107799,"about_ca_topic_score_gemma":0.0027101112,"teacher_disagreement_score":0.014133613,"about_ca_system_score_codex":0.000027562906,"about_ca_system_score_gemma":0.00007130388,"threshold_uncertainty_score":0.5370376},"labels":[],"label_agreement":null},{"id":"W2898993254","doi":"10.1182/blood.v130.suppl_1.921.921","title":"GWAS of Complete Blood Count (CBC) Measures in 13,403 Blood Donors in the Multi-Racial RBC-Omics Study Reveal Novel Genetic Loci in Minority Populations Which Provide Insights into the Pathways That May Connect Them to Disease","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; University of British Columbia","funders":"","keywords":"Genome-wide association study; Single-nucleotide polymorphism; Medicine; Omics; Biology; Immunology; Genetics; Internal medicine; Genotype; Gene","score_opus":0.07773308751866716,"score_gpt":0.2889771567022781,"score_spread":0.21124406918361094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898993254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931506,0.0011804078,0.000019289582,0.0016189147,0.00013679484,0.0036050999,0.00005915442,0.00002408557,0.00020564356],"genre_scores_gemma":[0.9987093,0.00020153324,0.0004044094,0.00028059437,0.00009311162,0.0002275566,0.000030825133,0.000036010435,0.000016616723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99707276,0.00036206094,0.0008202049,0.0005792907,0.0006750069,0.0004907008],"domain_scores_gemma":[0.9978328,0.00017683143,0.0003261449,0.0012922501,0.00017766857,0.00019430627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082749047,0.00038160637,0.0006422454,0.000220982,0.0004121978,0.00009590411,0.00076850154,0.00020089328,0.0000065623367],"category_scores_gemma":[0.0010954606,0.00023900822,0.00013254957,0.00047813565,0.0002070878,0.00011776754,0.00022260903,0.00067591434,0.00000654024],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028831055,0.00996561,0.95754254,0.00012390228,0.00015951334,0.00019228876,0.02884711,0.00039305398,0.001767455,0.00021647528,0.000011278596,0.0004924857],"study_design_scores_gemma":[0.0153615745,0.00043780654,0.97335947,0.00023994899,0.00087435107,0.000022378219,0.008167312,0.0004298739,0.00032503108,0.00036388755,0.00009772414,0.0003206488],"about_ca_topic_score_codex":0.014639509,"about_ca_topic_score_gemma":0.15517616,"teacher_disagreement_score":0.14053667,"about_ca_system_score_codex":0.000060197017,"about_ca_system_score_gemma":0.00036873977,"threshold_uncertainty_score":0.9919221},"labels":[],"label_agreement":null},{"id":"W2899175992","doi":"10.1182/blood-2018-99-118828","title":"Brentuximab Vedotin Plus Chemotherapy in Patients with Advanced-Stage Classical Hodgkin Lymphoma (cHL): Evaluation of Modified Progression-Free Survival (mPFS) and Traditional PFS in the Phase 3 ECHELON-1 Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Brentuximab vedotin; Internal medicine; Medicine; Classical Hodgkin lymphoma; Oncology; Chemotherapy; Progression-free survival; Chemotherapy regimen; Hodgkin lymphoma; Overall survival; Lymphoma; Stage (stratigraphy); Biology","score_opus":0.04121726497175998,"score_gpt":0.326195023048547,"score_spread":0.284977758076787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899175992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968297,0.00013774438,0.0000043432465,0.00028247837,0.000048411595,0.0022957295,0.00006039379,0.000013360252,0.00032785928],"genre_scores_gemma":[0.9992234,0.000011122124,0.00023757656,0.00006802747,0.00006953973,0.00027249404,0.00009413027,0.000018122013,0.0000055736236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977832,0.00023371169,0.00033113096,0.00034457783,0.0011022392,0.00020512944],"domain_scores_gemma":[0.9991228,0.00013713905,0.0001375471,0.00037234958,0.00016597193,0.00006420777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000681307,0.00019160224,0.00035010476,0.00011362738,0.00005281759,0.00001717153,0.00012109329,0.000065236636,0.000034350218],"category_scores_gemma":[0.00008774168,0.000116502444,0.000037441707,0.00025490898,0.00013901279,0.000087948276,0.000027098897,0.000066978755,0.0000013993949],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004634326,0.093068086,0.7921699,0.0000383177,0.00021665827,0.00004440861,0.0035325265,0.000009769578,0.00008751446,0.00017049671,0.000048179547,0.10597977],"study_design_scores_gemma":[0.1986582,0.006106857,0.7926127,0.00012964032,0.00020147281,0.0000047262242,0.00046384044,0.0006406048,0.00097629725,0.00008979008,0.0000144921205,0.00010140065],"about_ca_topic_score_codex":0.00004862411,"about_ca_topic_score_gemma":0.00017752995,"teacher_disagreement_score":0.19402388,"about_ca_system_score_codex":0.00016618562,"about_ca_system_score_gemma":0.00025941862,"threshold_uncertainty_score":0.4750832},"labels":[],"label_agreement":null},{"id":"W2899267864","doi":"10.1182/blood-2018-99-118617","title":"Analysis of Sequential Patient Samples from the Mmrf Commpass Study Identifies a High Risk Progression Phenotype","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neuroblastoma RAS viral oncogene homolog; KRAS; Multiple myeloma; Oncology; Internal medicine; Exome; Medicine; Malignancy; Exome sequencing; Mutation; Cancer; Biology; Genetics; Gene; Colorectal cancer","score_opus":0.035692975071496,"score_gpt":0.33525018888877617,"score_spread":0.2995572138172802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899267864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984118,0.00025246225,0.00003501267,0.00008362831,0.00007069666,0.0007415303,0.000292759,0.000027397224,0.00008475405],"genre_scores_gemma":[0.99910814,0.000023461766,0.0004157942,0.000019064351,0.00013497332,0.000053974014,0.0002100379,0.000011383686,0.000023182594],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844164,0.0002516133,0.0002672771,0.00025076282,0.00058569654,0.00020302973],"domain_scores_gemma":[0.9987405,0.00021372529,0.00016414151,0.0005705802,0.00021536244,0.00009569109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018870503,0.00012184886,0.00033815324,0.00011744669,0.0001836071,0.00003101954,0.0001371996,0.000038658665,0.00039086293],"category_scores_gemma":[0.00022870845,0.000067457666,0.0001347162,0.0004575774,0.00015654576,0.000037803144,0.0001330765,0.000108826476,0.000030649186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004705628,0.0038121762,0.9731297,0.000006956038,0.008527682,0.00003778563,0.0024271014,0.000001069442,0.0012798264,0.000005320717,0.00012753891,0.01017429],"study_design_scores_gemma":[0.0042619277,0.001621608,0.972933,0.000035871122,0.007170234,7.351762e-7,0.0009860873,0.00013203251,0.012677142,0.00005284918,0.00006713357,0.00006138827],"about_ca_topic_score_codex":0.011536756,"about_ca_topic_score_gemma":0.003530732,"teacher_disagreement_score":0.011397316,"about_ca_system_score_codex":0.00001900061,"about_ca_system_score_gemma":0.000048611757,"threshold_uncertainty_score":0.9950455},"labels":[],"label_agreement":null},{"id":"W2899283766","doi":"10.1182/blood-2018-99-111893","title":"Resolution of Peripheral Neuropathy (PN) in Patients Who Received A+AVD or ABVD in the Phase 3 ECHELON-1 Trial","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Spinal Cord Injury BC","funders":"","keywords":"ABVD; Dacarbazine; Brentuximab vedotin; Medicine; Vinblastine; Internal medicine; Hazard ratio; Gastroenterology; Oncology; Confidence interval; Surgery; Chemotherapy; Vincristine; Lymphoma; Hodgkin lymphoma","score_opus":0.0260380212226272,"score_gpt":0.3034584903612505,"score_spread":0.2774204691386233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899283766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99788207,0.000058856545,9.2407294e-7,0.00020567446,0.00014329044,0.00084854075,0.000012888489,0.0000087943245,0.00083897234],"genre_scores_gemma":[0.99927115,0.000043923887,0.00007546714,0.00023276292,0.00018689244,0.000070610346,0.000023545896,0.000009787696,0.00008583147],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989817,0.00014537665,0.00029789802,0.0001863232,0.00021767162,0.00017100084],"domain_scores_gemma":[0.9995081,0.00006545324,0.00008313738,0.0002491423,0.000058334703,0.000035833033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020189262,0.00010434604,0.00023490674,0.000074263306,0.000028337687,0.000010399104,0.00007635992,0.000058690937,0.000044393746],"category_scores_gemma":[0.00020836909,0.00006115736,0.00005419184,0.00022284202,0.000054692835,0.000060069586,0.000019138773,0.000064891654,0.000009293018],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10949965,0.06707447,0.786431,0.000074401796,0.00012931372,0.00041989327,0.008491974,0.0000013004442,0.0010671117,0.000060418617,0.0016725814,0.025077855],"study_design_scores_gemma":[0.28724185,0.010255762,0.6977873,0.00012425934,0.000102458056,0.000007358705,0.00008711512,0.000042542015,0.0036450934,0.000013571059,0.000622271,0.00007043694],"about_ca_topic_score_codex":0.00019920668,"about_ca_topic_score_gemma":0.00015843805,"teacher_disagreement_score":0.1777422,"about_ca_system_score_codex":0.000060509636,"about_ca_system_score_gemma":0.000081345854,"threshold_uncertainty_score":0.24939248},"labels":[],"label_agreement":null},{"id":"W2899297281","doi":"10.1182/blood-2018-99-112178","title":"Older Patients (pts) with Previously Untreated Classical Hodgkin Lymphoma (cHL): A Detailed Analysis from the Phase 3 ECHELON-1 Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Medicine; Dacarbazine; ABVD; Brentuximab vedotin; Internal medicine; Chemotherapy regimen; Tolerability; Regimen; Population; Bleomycin; Vinblastine; Oncology; Gastroenterology; Surgery; Adverse effect; Vincristine; Chemotherapy; Lymphoma; Hodgkin lymphoma; Cyclophosphamide","score_opus":0.011473343163321065,"score_gpt":0.2686328478128635,"score_spread":0.25715950464954246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899297281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99730366,0.00018773248,0.000022480084,0.00030470875,0.000041141746,0.001554656,0.000073590076,0.000097695214,0.00041433802],"genre_scores_gemma":[0.99848014,0.000012702243,0.00021733608,0.00038239927,0.0002072614,0.0002596421,0.0002560166,0.000034872726,0.00014963429],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979641,0.00016741682,0.00035397225,0.0006041735,0.00053392287,0.00037642883],"domain_scores_gemma":[0.9983171,0.00019073102,0.00015493824,0.0008680305,0.00024125236,0.0002279498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011887175,0.00032986188,0.0006234415,0.0001096938,0.00019790958,0.00006914542,0.00017295741,0.00009464986,0.0003888008],"category_scores_gemma":[0.00006511463,0.00016838964,0.00021215314,0.000853543,0.00015149075,0.00006019649,0.00006878134,0.0000641553,0.00017096901],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008577244,0.042777095,0.93403596,0.0000039880215,0.008868744,0.00021204565,0.0016453658,1.9568614e-7,0.00001961169,0.0000033640595,0.00048117217,0.0110947285],"study_design_scores_gemma":[0.07738283,0.0075709065,0.8898754,0.00006113703,0.022224043,0.000008506569,0.00030693057,0.000084773914,0.001983672,0.0000040482146,0.00030604607,0.00019170628],"about_ca_topic_score_codex":0.00075647444,"about_ca_topic_score_gemma":0.0021444855,"teacher_disagreement_score":0.076525114,"about_ca_system_score_codex":0.00013079669,"about_ca_system_score_gemma":0.00014163472,"threshold_uncertainty_score":0.686673},"labels":[],"label_agreement":null},{"id":"W2899428983","doi":"10.1182/blood-2018-99-110563","title":"The ECHELON-2 Trial: Results of a Randomized, Double-Blind, Active-Controlled Phase 3 Study of Brentuximab Vedotin and CHP (A+CHP) Versus CHOP in the Frontline Treatment of Patients with CD30+ Peripheral T-Cell Lymphomas","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Brentuximab vedotin; Medicine; Internal medicine; Vincristine; CHOP; Oncology; Anaplastic large-cell lymphoma; Chemotherapy regimen; Prednisone; Phases of clinical research; Lymphoma; Cyclophosphamide; Chemotherapy; CD30","score_opus":0.024992037168233224,"score_gpt":0.3012498438549492,"score_spread":0.27625780668671596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899428983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98865575,0.000770971,4.5970776e-7,0.00014861427,0.0001207488,0.009481777,0.000070313596,0.000008794446,0.0007425457],"genre_scores_gemma":[0.9985623,0.00023602533,0.00006121929,0.000008214739,0.00009724968,0.00091027876,0.0000414152,0.000020197725,0.00006314969],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99765795,0.0003799914,0.00087720755,0.0003404955,0.0005049415,0.00023939842],"domain_scores_gemma":[0.99731904,0.0010836619,0.00071129436,0.0005620471,0.00025400575,0.00006992896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005902228,0.00030002734,0.0015357626,0.000101108555,0.00008902461,0.000016794667,0.00013193022,0.00007164567,0.000009412559],"category_scores_gemma":[0.00014147158,0.00012863538,0.0002356437,0.0002088328,0.00027794656,0.000049252467,0.000028665834,0.000047342284,7.7073804e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.88534445,0.095642865,0.0077912635,0.000017232698,0.002086207,0.000015698048,0.005768759,8.3738337e-7,0.000057100297,0.000008236665,0.00001072492,0.003256658],"study_design_scores_gemma":[0.92788756,0.04554833,0.015328216,0.00005805036,0.003495755,0.0000020824948,0.0016863537,0.00003284203,0.0057972567,0.000002482201,0.00006140676,0.00009964124],"about_ca_topic_score_codex":0.0010349127,"about_ca_topic_score_gemma":0.0005705773,"teacher_disagreement_score":0.05009453,"about_ca_system_score_codex":0.0001007972,"about_ca_system_score_gemma":0.0001714974,"threshold_uncertainty_score":0.52455986},"labels":[],"label_agreement":null},{"id":"W2899509505","doi":"10.1182/blood-2018-99-111178","title":"Ibrutinib Treatment in Waldenström's Macroglobulinemia: Follow-up Efficacy and Safety from the iNNOVATETM Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Royal Victoria Regional Health Centre; Ottawa Hospital; Royal Victoria Hospital; University of Ottawa","funders":"","keywords":"Ibrutinib; Waldenstrom macroglobulinemia; Macroglobulinemia; Lymphoplasmacytic Lymphoma; Medicine; Internal medicine; Oncology; Chronic lymphocytic leukemia; Leukemia; Lymphoma; Multiple myeloma","score_opus":0.026874480907454215,"score_gpt":0.31492963179554817,"score_spread":0.28805515088809397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899509505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99522847,0.00049852795,0.0000020566079,0.00091310975,0.00015257744,0.0015992128,0.000025448342,0.00005341321,0.0015272131],"genre_scores_gemma":[0.99792695,0.000101353486,0.0001592895,0.00020896891,0.0005927397,0.00005422003,0.00003022912,0.000030560226,0.00089568953],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998146,0.00011726117,0.00039815297,0.0004883039,0.0004031354,0.00044717285],"domain_scores_gemma":[0.99853027,0.00044476148,0.000058343026,0.00073057495,0.000102174796,0.0001338627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035202582,0.0002286227,0.00039888328,0.000071352355,0.00013168693,0.000041111933,0.00018223074,0.0001154793,0.00018543302],"category_scores_gemma":[0.00028730012,0.00013864775,0.000049734816,0.0004642784,0.00024556302,0.000037345442,0.0001956274,0.00022591537,0.00013019628],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0150307,0.028667048,0.6975386,0.000120073804,0.0038918196,0.007257536,0.037429113,0.0000026298876,0.010464706,0.00025949767,0.004575768,0.19476251],"study_design_scores_gemma":[0.54212385,0.0059255627,0.41816458,0.0002715816,0.00088336,0.00050869293,0.0029839454,0.00037148793,0.015352087,0.00009494453,0.012885643,0.00043425054],"about_ca_topic_score_codex":0.004626158,"about_ca_topic_score_gemma":0.0019194622,"teacher_disagreement_score":0.5270932,"about_ca_system_score_codex":0.0017409953,"about_ca_system_score_gemma":0.0017889597,"threshold_uncertainty_score":0.6993398},"labels":[],"label_agreement":null},{"id":"W2899610534","doi":"10.1182/blood-2018-99-111324","title":"Prognostic Value of Clone Size in Paroxysmal Nocturnal Hemoglobinuria (PNH) for Thrombotic Events in Untreated Patients in the International PNH Registry","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Medicine; Cohort; Eculizumab; clone (Java method); Internal medicine; Immunology; Biology; Complement system","score_opus":0.011874894491424443,"score_gpt":0.2562762055720637,"score_spread":0.24440131108063926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899610534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99806523,0.00013419818,0.0000043415903,0.00012390468,0.00043310988,0.0009270643,0.00012326398,0.0000099258295,0.0001789324],"genre_scores_gemma":[0.9994987,0.000003173445,0.000054744036,0.00006026943,0.00004191449,0.000108506894,0.0001626915,0.000009763633,0.000060236147],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986857,0.00023798006,0.00050204224,0.00023205545,0.00007514187,0.00026706734],"domain_scores_gemma":[0.9990575,0.0004324468,0.00019309073,0.00022552416,0.000080523896,0.00001092653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031221387,0.00013447861,0.0002392345,0.00009932379,0.000034133867,0.0000060495295,0.00044321836,0.00010189079,0.00017627263],"category_scores_gemma":[0.0006274632,0.00010555015,0.000058304406,0.00016933675,0.000101197555,0.000050889783,0.000080645244,0.00012068291,0.00002423045],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024365737,0.0020340607,0.9915161,0.000039532108,0.00009153164,0.000003980144,0.00047123618,0.0000054057673,0.005035467,0.000149069,0.00035257018,0.000057398433],"study_design_scores_gemma":[0.009367613,0.0003293249,0.9854028,0.00024455079,0.000051725867,0.000012438597,0.00018912408,0.000013930125,0.003643691,0.0005476288,0.00009478611,0.00010237681],"about_ca_topic_score_codex":0.00038359407,"about_ca_topic_score_gemma":0.0006871097,"teacher_disagreement_score":0.009123956,"about_ca_system_score_codex":0.000054311648,"about_ca_system_score_gemma":0.00007027577,"threshold_uncertainty_score":0.43042102},"labels":[],"label_agreement":null},{"id":"W2899663130","doi":"10.1182/blood-2018-99-111306","title":"Efficacy of Eculizumab in Pediatric Patients with Paroxysmal Nocturnal Hemoglobinuria in the International PNH Registry","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Eculizumab; Paroxysmal nocturnal hemoglobinuria; Medicine; Disease registry; Pediatrics; Cohort; Demographics; Hemoglobinuria; Internal medicine; Disease; Anemia; Immunology; Demography","score_opus":0.007753470290376171,"score_gpt":0.2268289054195395,"score_spread":0.21907543512916333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899663130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99773145,0.00023765433,0.0000021403794,0.00007181033,0.0002558638,0.00025057164,0.00003729018,0.000008614843,0.0014046197],"genre_scores_gemma":[0.9997018,0.000003411038,0.000026030659,0.00004111753,0.000088521665,0.000016235366,0.00007136519,0.000005613699,0.00004592813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99919903,0.0001178536,0.00027653037,0.00016556474,0.000073573385,0.00016747181],"domain_scores_gemma":[0.9994479,0.000103694576,0.00014792827,0.00023183823,0.000060250877,0.000008399095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014037683,0.0000939234,0.00013149563,0.000097921846,0.00003104657,0.000008567327,0.00042643936,0.000056297667,0.00029434732],"category_scores_gemma":[0.000084521846,0.00006301993,0.000033975113,0.00015400929,0.00009374085,0.000039795916,0.00006597656,0.00011377348,0.0000502531],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036759875,0.0012489817,0.9962189,0.000015716201,0.0000461406,0.0000060139923,0.0003730006,0.0000014477446,0.00033786547,0.000082896346,0.0011883639,0.00011307004],"study_design_scores_gemma":[0.009632537,0.0002260032,0.98785347,0.000035109144,0.000043459102,0.000012625542,0.00010122727,4.7487566e-7,0.0011365156,0.000027017599,0.000853414,0.0000781483],"about_ca_topic_score_codex":0.000056536588,"about_ca_topic_score_gemma":0.0001539732,"teacher_disagreement_score":0.0092649385,"about_ca_system_score_codex":0.000020523104,"about_ca_system_score_gemma":0.000060597915,"threshold_uncertainty_score":0.32228968},"labels":[],"label_agreement":null},{"id":"W2900081406","doi":"10.1182/blood-2018-99-110623","title":"A Phase 3 Study of Ravulizumab (ALXN1210) Versus Eculizumab in Adults with Paroxysmal Nocturnal Hemoglobinuria Naive to Complement Inhibitors: Results of a Subgroup Analysis with Patients Stratified By Baseline Hemolysis Level, Transfusion History, and Demographics","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Eculizumab; Paroxysmal nocturnal hemoglobinuria; Medicine; Clinical endpoint; Internal medicine; Surrogate endpoint; Hemoglobinuria; Pediatrics; Hemolysis; Immunology; Clinical trial; Antibody; Complement system","score_opus":0.017172275138689526,"score_gpt":0.25097813515086737,"score_spread":0.23380586001217785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900081406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961096,0.00039119564,0.00016456346,0.00002983516,0.00010190626,0.0016591686,0.0014876972,0.000020889634,0.000035147066],"genre_scores_gemma":[0.9988547,0.0000095000705,0.00023862558,0.000012622273,0.00001799564,0.00008393993,0.00075092766,0.000020338013,0.000011337355],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9971171,0.000484189,0.0010792582,0.00068890915,0.0002630373,0.0003675136],"domain_scores_gemma":[0.99826306,0.00017676094,0.0005376208,0.00050458865,0.0004286555,0.00008928665],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035558952,0.00036153456,0.000834741,0.0006064327,0.00010666696,0.000009152898,0.00024717496,0.00010256553,0.00013772535],"category_scores_gemma":[0.000057568537,0.00029066452,0.00010557825,0.0009668509,0.00027492095,0.00008685684,0.00007492308,0.00014895815,0.0000016144327],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20481302,0.057560306,0.6691095,0.00038721084,0.010121319,0.00004621319,0.025643243,0.000037934507,0.027565539,0.000013271079,0.0027144311,0.0019879702],"study_design_scores_gemma":[0.61680424,0.12351095,0.17263496,0.0011409001,0.009798598,0.000019598792,0.019315446,0.00009681132,0.05456135,0.0000023247196,0.0007701638,0.0013446813],"about_ca_topic_score_codex":0.0025090026,"about_ca_topic_score_gemma":0.02186761,"teacher_disagreement_score":0.4964746,"about_ca_system_score_codex":0.00010084841,"about_ca_system_score_gemma":0.00011446507,"threshold_uncertainty_score":0.9999545},"labels":[],"label_agreement":null},{"id":"W2900093343","doi":"10.1182/blood-2018-99-110805","title":"The Medalist Trial: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Luspatercept to Treat Anemia in Patients with Very Low-, Low-, or Intermediate-Risk Myelodysplastic Syndromes (MDS) with Ring Sideroblasts (RS) Who Require Red Blood Cell (RBC) Transfusions","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Myelodysplastic syndromes; Anemia; Clinical endpoint; Internal medicine; Erythropoiesis; International Prognostic Scoring System; Placebo; Ineffective erythropoiesis; Randomized controlled trial; Gastroenterology; Surgery; Bone marrow; Pathology","score_opus":0.010065386404065764,"score_gpt":0.2538856776182557,"score_spread":0.24382029121418994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900093343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98605,0.00007701449,0.000021695536,0.00009782217,0.0001786685,0.0128965145,0.000077812314,0.00006071845,0.000539761],"genre_scores_gemma":[0.9985824,0.00020280945,0.000058388112,0.000022100656,0.00007137315,0.0005920394,0.000032003434,0.00009176778,0.00034708125],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99532354,0.0005678399,0.0018860807,0.00072577666,0.00085422327,0.0006425419],"domain_scores_gemma":[0.99637496,0.0012403929,0.00080811616,0.0008518841,0.0003993917,0.00032524284],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011376714,0.000584582,0.0023136851,0.00049372035,0.00023768068,0.00004224183,0.00032551136,0.00026247563,0.000041981075],"category_scores_gemma":[0.00073228875,0.000292512,0.00023266544,0.0008759529,0.00050790946,0.00015340258,0.000081228434,0.0004724391,0.000005586466],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9683352,0.017054465,0.0018826232,0.00033096195,0.0011144424,0.00019112992,0.010067496,0.00016884643,0.00057818566,0.0000011235827,0.000025142723,0.0002503909],"study_design_scores_gemma":[0.95082015,0.033889674,0.0005813561,0.0021191072,0.004849162,0.00002126506,0.0035263882,0.00012112113,0.0037271709,0.0000023455382,0.0000033838605,0.00033885954],"about_ca_topic_score_codex":0.0006993026,"about_ca_topic_score_gemma":0.0028402267,"teacher_disagreement_score":0.017515024,"about_ca_system_score_codex":0.000049345163,"about_ca_system_score_gemma":0.00032396775,"threshold_uncertainty_score":0.9999527},"labels":[],"label_agreement":null},{"id":"W2900103202","doi":"10.1182/blood.v130.suppl_1.3683.3683","title":"Results from a Prospective, Dose Escalating, Prophylaxis Study in Young Boys with Severe Hemophilia a in China: The China Hemophilia Individualized Prophylaxis Study (CHIPS) (NCT02999308)","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Haemophilia; Haemophilia A; Arthropathy; Hemarthrosis; Prospective cohort study; Surgery; Pediatrics; Osteoarthritis","score_opus":0.02020664609443931,"score_gpt":0.29551954189944607,"score_spread":0.2753128958050068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900103202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97813874,0.00014479106,4.839809e-7,0.0008842355,0.0001277633,0.014870896,0.00012469353,0.0001270841,0.0055813016],"genre_scores_gemma":[0.9958912,0.000021389236,0.00038504845,0.000014503147,0.0003457741,0.0011762691,0.000061141254,0.000121508114,0.0019831818],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9934625,0.0007259607,0.0011309562,0.0017574432,0.0018447029,0.0010784118],"domain_scores_gemma":[0.99589694,0.00019239764,0.00051274634,0.0028979536,0.00017738827,0.00032257385],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020450612,0.0008141732,0.0013322408,0.00049028936,0.0009472658,0.0003940668,0.001094169,0.00029628194,0.000056359353],"category_scores_gemma":[0.0015691506,0.0004683184,0.00018005559,0.0009781898,0.00039233363,0.00037763678,0.0006724922,0.0019403568,0.000049576523],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00584261,0.02601823,0.93075895,0.0000795883,0.00070043694,0.0027233849,0.030653846,0.0000072125595,0.0002826981,0.000005969296,0.000015631187,0.002911423],"study_design_scores_gemma":[0.073019706,0.0132833375,0.9079157,0.00038343878,0.00031559812,0.00009227479,0.0035751255,0.00006823071,0.0005464992,0.0002847462,0.0000064666833,0.0005088407],"about_ca_topic_score_codex":0.010941247,"about_ca_topic_score_gemma":0.014752496,"teacher_disagreement_score":0.067177095,"about_ca_system_score_codex":0.0002575737,"about_ca_system_score_gemma":0.0005029724,"threshold_uncertainty_score":0.99977684},"labels":[],"label_agreement":null},{"id":"W2900183696","doi":"10.1182/blood-2018-99-119086","title":"Efficacy and Safety of a Single Dose of Donor Lymphocytes Depleted of Alloreactive T-Cells (ATIR101) Following T-Cell-Depleted Haploidentical HSCT: A Pooled Analysis of Two Phase II Studies","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Juravinski Hospital; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Hematopoietic stem cell transplantation; Graft-versus-host disease; Stem cell; Internal medicine; Immune system; Transplantation; Immunology; T cell; Leukemia; Gastroenterology; Biology","score_opus":0.03347189124600687,"score_gpt":0.3430399669022948,"score_spread":0.30956807565628797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900183696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99674195,0.0015793119,0.00006787298,0.000038869868,0.000042926607,0.000792866,0.00007943997,0.00002467815,0.00063207914],"genre_scores_gemma":[0.99849474,0.00015639904,0.0010466381,0.000020131974,0.000051522362,0.000014601018,0.00002984304,0.00004099094,0.00014511724],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997155,0.00018457853,0.0010750564,0.00044907333,0.0007718847,0.00036440435],"domain_scores_gemma":[0.99685335,0.0009886223,0.0005114571,0.0006153226,0.0008631749,0.00016805253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006969405,0.0002764758,0.0017379944,0.0007579739,0.000076447424,0.0000070120855,0.00019013797,0.000113898335,0.0001518738],"category_scores_gemma":[0.0007327868,0.00023679032,0.00053795555,0.0016019979,0.0007817216,0.000077630975,0.00022561957,0.00013244242,0.0000011373362],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062383544,0.008200185,0.0043026283,0.00028874233,0.01808113,0.00002734229,0.0045040934,0.0000040838568,0.9563367,0.00002194952,0.000012385295,0.0019824381],"study_design_scores_gemma":[0.051735643,0.0055968906,0.0036596765,0.00031053036,0.014331642,0.0000062950407,0.0008711207,0.00057458825,0.9226973,0.00003052425,0.000019617879,0.00016618113],"about_ca_topic_score_codex":0.00032769566,"about_ca_topic_score_gemma":0.00009714665,"teacher_disagreement_score":0.045497287,"about_ca_system_score_codex":0.00007972276,"about_ca_system_score_gemma":0.00019083437,"threshold_uncertainty_score":0.96560293},"labels":[],"label_agreement":null},{"id":"W2900213158","doi":"10.1182/blood-2018-99-119147","title":"Results from a Phase 3, Multicenter, Non-Inferiority Study of Ravulizumab (ALXN1210) Versus Eculizumab in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria Currently Treated with Eculizumab","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Eculizumab; Paroxysmal nocturnal hemoglobinuria; Medicine; Hemoglobinuria; Internal medicine; Dosing; Gastroenterology; Anemia; Immunology; Antibody; Complement system","score_opus":0.012626238582977225,"score_gpt":0.2637900671497698,"score_spread":0.2511638285667926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900213158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948175,0.0001222892,0.000013571616,0.000012856895,0.0005164061,0.0021041783,0.0020249092,0.00008358821,0.00030470686],"genre_scores_gemma":[0.9983722,0.000004117062,0.00010656343,0.00001248793,0.000075018615,0.00010927011,0.0012518173,0.000042974018,0.000025569485],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99671805,0.00043339076,0.0010335194,0.0009116075,0.00024545437,0.0006579694],"domain_scores_gemma":[0.99756163,0.00020006344,0.0006536128,0.000907424,0.0005787399,0.00009852519],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000123315,0.00055155077,0.0008281437,0.00022477658,0.00019271985,0.000035743175,0.00052306475,0.00017428343,0.000286994],"category_scores_gemma":[0.00014695208,0.00042187163,0.000097247954,0.0004172559,0.00031649403,0.00020410067,0.00017467873,0.00031423246,0.000098309676],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17629246,0.056095444,0.75246674,0.000081003964,0.0026216272,0.00015536786,0.006191084,0.000008849677,0.003781728,0.0000062015188,0.00051445555,0.0017850599],"study_design_scores_gemma":[0.57090414,0.024013478,0.37966344,0.00055404106,0.0011570075,0.000012228178,0.0025336256,0.000035880163,0.020087315,0.000002356203,0.00031216006,0.0007243526],"about_ca_topic_score_codex":0.00429857,"about_ca_topic_score_gemma":0.0042308006,"teacher_disagreement_score":0.39461166,"about_ca_system_score_codex":0.00012873627,"about_ca_system_score_gemma":0.00018007215,"threshold_uncertainty_score":0.99982333},"labels":[],"label_agreement":null},{"id":"W2900220084","doi":"10.1182/blood-2018-99-111349","title":"Hepcidin Suppression By Momelotinib Is Associated with Increased Iron Availability and Erythropoiesis in Transfusion-Dependent Myelofibrosis Patients","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Myelofibrosis; Hepcidin; Medicine; Anemia; Ruxolitinib; Erythropoiesis; Internal medicine; Gastroenterology; Blood transfusion; Bone marrow","score_opus":0.007465237073062167,"score_gpt":0.22755221059686007,"score_spread":0.2200869735237979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900220084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975085,0.00016580542,0.0000028609873,0.0005032785,0.000040645755,0.00096119015,0.00023573764,0.000048552254,0.0005333987],"genre_scores_gemma":[0.9987816,0.0002424852,0.00018063962,0.00029659917,0.00003228403,0.0001260759,0.00018878486,0.000032801385,0.00011868584],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981071,0.00014675663,0.00035702993,0.00058763585,0.00046709384,0.0003344219],"domain_scores_gemma":[0.9990277,0.00017353822,0.00010581545,0.00028983023,0.00018307133,0.00022002964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020730284,0.00028646062,0.0004923192,0.00009387548,0.00015824892,0.000028495842,0.000057913585,0.0001626734,0.0006758677],"category_scores_gemma":[0.00016333887,0.00020365581,0.00005294089,0.00022581636,0.00017418088,0.00010516609,0.00004216402,0.0001442198,0.00002152695],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004921886,0.005948754,0.98435205,0.000049187092,0.0001356474,0.000016243313,0.0010272698,4.320976e-8,0.0059205815,0.0000020082166,0.0013112918,0.0007447269],"study_design_scores_gemma":[0.0147578325,0.0026397402,0.8121029,0.0003230666,0.000283588,0.0000059126687,0.00009306135,0.000013339878,0.16946702,0.000011452963,0.00010778884,0.00019429806],"about_ca_topic_score_codex":0.00086628104,"about_ca_topic_score_gemma":0.0006613699,"teacher_disagreement_score":0.17224915,"about_ca_system_score_codex":0.00011510714,"about_ca_system_score_gemma":0.00006746425,"threshold_uncertainty_score":0.83048433},"labels":[],"label_agreement":null},{"id":"W2900334754","doi":"10.1182/blood-2018-08-868406","title":"Managing antithrombotic therapy in immune thrombocytopenia: development of the TH2 risk assessment score","year":2018,"lang":"en","type":"letter","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; McMaster University","funders":"","keywords":"Immune thrombocytopenia; Antithrombotic; Medicine; Heparin-induced thrombocytopenia; Intensive care medicine; Pediatrics; Internal medicine; Immunology; Platelet","score_opus":0.02384950397803071,"score_gpt":0.2781651550260172,"score_spread":0.2543156510479865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900334754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95903796,0.0014209135,0.00001531659,0.034566693,0.00031009022,0.0012379274,0.000020457179,0.000028407674,0.003362226],"genre_scores_gemma":[0.93509555,0.0029514213,0.005082682,0.05444587,0.0006115846,0.00014585345,0.0003558226,0.00017716849,0.0011340536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980016,0.00010007925,0.0005547103,0.0004250536,0.00051719765,0.00040135894],"domain_scores_gemma":[0.99874634,0.00004594608,0.00038536708,0.0007176834,0.00007501921,0.000029640109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022290887,0.00037404773,0.0010189638,0.00015769052,0.00013102715,0.000024912004,0.00032467121,0.00034311757,0.00013770515],"category_scores_gemma":[0.00001337373,0.00023121275,0.00019695643,0.0002597941,0.00012701182,0.00004936854,0.00013928131,0.0009776653,0.00002844096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015521402,0.007702798,0.86024225,0.0016358776,0.010557464,0.0056875753,0.0030707049,0.000004247954,0.003365994,0.000019631816,0.084594786,0.022963427],"study_design_scores_gemma":[0.0136926435,0.00053403963,0.9417222,0.002261577,0.0010231349,0.00016307674,0.00009123873,0.000013009129,0.010586154,0.0005097816,0.028878897,0.0005242226],"about_ca_topic_score_codex":0.00014300452,"about_ca_topic_score_gemma":0.000060195467,"teacher_disagreement_score":0.081479944,"about_ca_system_score_codex":0.0001021072,"about_ca_system_score_gemma":0.00041904193,"threshold_uncertainty_score":0.9428582},"labels":[],"label_agreement":null},{"id":"W2900337270","doi":"10.1182/blood-2018-99-118857","title":"Depletion of Alloreactive T Cells after Haploidentical HSCT: Comparison of Outcomes for Ex Vivo Versus In Vivo Treatment Strategies","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Ex vivo; In vivo; Hematopoietic stem cell transplantation; T cell; Graft-versus-host disease; Cyclophosphamide; Stem cell; Immune system; Transplantation; Clinical trial; Immunology; Internal medicine; Biology; Chemotherapy","score_opus":0.03587811967963969,"score_gpt":0.3350981371938174,"score_spread":0.2992200175141777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900337270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99650407,0.000037196925,0.0008208079,0.000041209223,0.0001421665,0.0006359674,0.000047670543,0.000014265213,0.0017566503],"genre_scores_gemma":[0.99769217,0.000012846976,0.0020869696,0.000007189705,0.00004311497,0.000059209473,0.000011391274,0.000015205715,0.00007190356],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990509,0.000024979996,0.00039598305,0.00017341523,0.00019709808,0.0001576211],"domain_scores_gemma":[0.999329,0.0002476377,0.00010629103,0.0001644132,0.00010466882,0.000048017813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008181469,0.0001275599,0.00043684914,0.00009927795,0.000011639047,0.000005793237,0.000039135055,0.000089366586,0.00010255294],"category_scores_gemma":[0.000019531135,0.00010412255,0.00010484131,0.00007416046,0.000100024394,0.000059234277,0.000005693597,0.000037380272,0.0000073163724],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005267866,0.0049218726,0.40343678,0.0007999611,0.0005698246,0.000023764922,0.0106305275,0.0000059246136,0.5732118,0.0008717875,0.000032699598,0.0002271804],"study_design_scores_gemma":[0.011162071,0.0022431945,0.07298764,0.00015101179,0.00055373483,0.0000035561693,0.0019576938,0.00009421986,0.91064364,0.000058165308,0.00006117484,0.000083880775],"about_ca_topic_score_codex":0.00014815193,"about_ca_topic_score_gemma":0.00040168545,"teacher_disagreement_score":0.33743185,"about_ca_system_score_codex":0.00003989449,"about_ca_system_score_gemma":0.00006962612,"threshold_uncertainty_score":0.4245994},"labels":[],"label_agreement":null},{"id":"W2900369580","doi":"10.1182/blood-2018-99-110858","title":"Ravulizumab (ALXN1210) Versus Eculizumab in Adults with Paroxysmal Nocturnal Hemoglobinuria: Pharmacokinetics and Pharmacodynamics Observed in Two Phase 3 Randomized, Multicenter Studies","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Eculizumab; Paroxysmal nocturnal hemoglobinuria; Medicine; Pharmacodynamics; Surrogate endpoint; Clinical endpoint; Internal medicine; Pharmacokinetics; Dosing; Gastroenterology; Phases of clinical research; Clinical trial; Pharmacology; Immunology; Antibody; Complement system","score_opus":0.027220159485534474,"score_gpt":0.33126125908906984,"score_spread":0.30404109960353537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900369580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870789,0.009915684,0.000021101318,0.00012016508,0.0010082015,0.0014666251,0.00010732786,0.00006160216,0.00022036064],"genre_scores_gemma":[0.9986333,0.0005176341,0.00024435561,0.00008763961,0.00013441073,0.00019865119,0.000089364905,0.00003271835,0.00006192805],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99734443,0.00064753654,0.00074831536,0.00055947795,0.00009572364,0.0006044884],"domain_scores_gemma":[0.9987108,0.0005385645,0.00025303444,0.0002725934,0.00016372539,0.00006125575],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042325375,0.00040993706,0.0008900978,0.00020995845,0.00012181649,0.000026621527,0.00027024047,0.000083690495,0.00026417666],"category_scores_gemma":[0.00017792758,0.00032863682,0.00009916855,0.00023242646,0.00070058537,0.00014776347,0.00020062478,0.00031330407,0.000047145302],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9005599,0.0063968184,0.039969657,0.0006539394,0.0043672672,0.00060818275,0.007940791,0.00006601358,0.035307337,0.00016571229,0.0007340317,0.0032303361],"study_design_scores_gemma":[0.97838074,0.0007272122,0.0014270807,0.0005102265,0.0007488641,0.000099237994,0.0013927915,0.00077474554,0.014959334,0.000025308187,0.00050027843,0.00045416068],"about_ca_topic_score_codex":0.00018136522,"about_ca_topic_score_gemma":0.0012366128,"teacher_disagreement_score":0.077820845,"about_ca_system_score_codex":0.00009347778,"about_ca_system_score_gemma":0.00007330547,"threshold_uncertainty_score":0.99991655},"labels":[],"label_agreement":null},{"id":"W2900503714","doi":"10.1182/blood-2018-99-116974","title":"Reasons for Switching from Warfarin to a Direct Oral Anticoagulant: A Retrospective Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Warfarin; Medicine; Atrial fibrillation; Retrospective cohort study; Surgery; Internal medicine","score_opus":0.06899553597237426,"score_gpt":0.3595092053540329,"score_spread":0.2905136693816587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900503714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931945,0.000020753192,0.00083999004,0.0009879495,0.00021864533,0.0014773462,0.000014530686,0.00012179523,0.0031244878],"genre_scores_gemma":[0.99356174,0.0000013165348,0.0035290727,0.00017764358,0.0015437197,0.000011151541,0.0000109877965,0.000021207521,0.0011431456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991526,0.000025646548,0.00016917037,0.00028817,0.00018208804,0.00018234747],"domain_scores_gemma":[0.9994583,0.00006495848,0.000049327202,0.00025578067,0.00008502194,0.00008658446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020991506,0.000112798196,0.00033363918,0.00008618526,0.00011943939,0.000032057844,0.00006256727,0.000033693697,0.000061891],"category_scores_gemma":[0.00038754815,0.00009248232,0.00009193099,0.0001896187,0.000011230153,0.000048476613,0.00006735388,0.000045357974,0.000072346746],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030906106,0.00012027592,0.99329317,0.000006695254,0.0003835902,0.000010644867,0.0014232593,2.3655389e-7,0.0022715682,0.00016129317,0.0006427184,0.0013775078],"study_design_scores_gemma":[0.0056934427,0.0013694352,0.9850295,0.000037957147,0.0008187194,0.0000015369978,0.0004496387,0.00008208025,0.0014698927,0.0002122304,0.00469774,0.00013777836],"about_ca_topic_score_codex":0.0003063198,"about_ca_topic_score_gemma":0.00024330945,"teacher_disagreement_score":0.008263601,"about_ca_system_score_codex":0.000023775008,"about_ca_system_score_gemma":0.000017948227,"threshold_uncertainty_score":0.37713194},"labels":[],"label_agreement":null},{"id":"W2900579722","doi":"10.1182/blood-2018-99-114231","title":"Risk Factors of Clostridium Difficile Infection in Hematopoietic Stem Cell Transplant Recipients: A Systemic Review and Meta-Analysis","year":2018,"lang":"en","type":"review","venue":"Blood","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Odds ratio; Hematopoietic stem cell transplantation; Confidence interval; Meta-analysis; Clostridium difficile; Graft-versus-host disease; Transplantation; Risk factor; Antibiotics","score_opus":0.0701155510009092,"score_gpt":0.32904480155609245,"score_spread":0.25892925055518323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900579722","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.055877663,0.9397674,0.000005684588,0.000014779485,0.000055315988,0.0029235303,0.001126825,0.000046799483,0.00018199955],"genre_scores_gemma":[0.028055547,0.9707134,0.000009932513,0.000009713534,0.00006199809,0.00030035377,0.00035422243,0.00008998717,0.00040487348],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9943321,0.00081073854,0.002317863,0.0010920146,0.0008369477,0.0006103704],"domain_scores_gemma":[0.9965565,0.0004726608,0.0011756226,0.0012231816,0.0002503382,0.0003216623],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010993881,0.0009007889,0.009683755,0.0012974939,0.00008003776,0.00003067267,0.00027923306,0.0006094095,0.00037543385],"category_scores_gemma":[0.00008695064,0.00061437953,0.0038658425,0.0028959464,0.00015039218,0.00005743865,0.0001212874,0.0010128327,0.00004583247],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007463437,0.005590733,0.002994661,0.7042975,0.280268,0.00023918936,0.0006740866,0.000002198615,0.000059369217,0.000007924107,0.0005162407,0.005275453],"study_design_scores_gemma":[0.00094418763,0.0004930713,0.000032641114,0.0110318465,0.97225076,0.00023909818,0.000027163076,0.0000020681157,0.0017313065,7.266324e-7,0.012726117,0.00052098796],"about_ca_topic_score_codex":0.00060628646,"about_ca_topic_score_gemma":0.00006996278,"teacher_disagreement_score":0.6932657,"about_ca_system_score_codex":0.00018222979,"about_ca_system_score_gemma":0.00037444616,"threshold_uncertainty_score":0.99963075},"labels":[],"label_agreement":null},{"id":"W2900662379","doi":"10.1182/blood-2018-99-112572","title":"Checkpoint Inhibitors Augment CD19-Directed Chimeric Antigen Receptor (CAR) T Cell Therapy in Relapsed B-Cell Acute Lymphoblastic Leukemia","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":155,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Cytokine release syndrome; Medicine; Chimeric antigen receptor; CD19; T cell; Internal medicine; Immunology; B cell; Blinatumomab; Pembrolizumab; Oncology; Immunotherapy; Antigen; Immune system; Cancer; Antibody","score_opus":0.013840445879683815,"score_gpt":0.26218224226146203,"score_spread":0.24834179638177822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900662379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98342204,0.00093408243,0.000008052916,0.00019841989,0.0005128229,0.0013431429,0.000016041498,0.00028974106,0.013275656],"genre_scores_gemma":[0.9824382,0.0016667378,0.001130305,0.00032673808,0.0009934189,0.00012072875,0.00007389964,0.00015990758,0.013090074],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99660677,0.0002074631,0.00068780687,0.00078147027,0.000801508,0.00091501285],"domain_scores_gemma":[0.9982536,0.00011737595,0.00018339693,0.00084302085,0.00022175242,0.0003808749],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00053730723,0.0004459744,0.00067764515,0.00045375485,0.00012662442,0.000047918693,0.00031595572,0.00029028766,0.004308338],"category_scores_gemma":[0.00006238907,0.00039174972,0.00025549278,0.0011720402,0.0002534586,0.00007037296,0.00012225585,0.00050194055,0.0008400789],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012255606,0.0018466482,0.0075185946,0.000054359974,0.00023154332,0.00011142543,0.0010772876,0.0000017993167,0.9815207,0.000001178422,0.0027458076,0.0036651006],"study_design_scores_gemma":[0.02253923,0.0029318272,0.010045999,0.00014740956,0.00010233221,0.00004476732,0.0001204737,0.00019266029,0.9531388,0.000015529005,0.010319346,0.00040161159],"about_ca_topic_score_codex":0.00053586886,"about_ca_topic_score_gemma":0.000046370817,"teacher_disagreement_score":0.02838188,"about_ca_system_score_codex":0.000606096,"about_ca_system_score_gemma":0.00076707057,"threshold_uncertainty_score":0.9999379},"labels":[],"label_agreement":null},{"id":"W2900694112","doi":"10.1182/blood-2018-99-111370","title":"Ibrutinib + Obinutuzumab Versus Chlorambucil + Obinutuzumab As First-Line Treatment in Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (CLL/SLL): Results from Phase 3 iLLUMINATE","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Obinutuzumab; Ibrutinib; Chlorambucil; Chronic lymphocytic leukemia; Medicine; Leukemia; Lymphoma; Internal medicine; Immunology; Oncology; Chemotherapy; Cyclophosphamide","score_opus":0.03171698714767747,"score_gpt":0.29276020909419587,"score_spread":0.2610432219465184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900694112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99100083,0.0006458098,0.000012298533,0.000093268354,0.00074602145,0.0034723233,0.0006863021,0.0004402138,0.0029029492],"genre_scores_gemma":[0.9908353,0.0005935496,0.00061071827,0.00019160527,0.0014362676,0.0004358528,0.0017423909,0.00031878636,0.0038354986],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9913085,0.00022510189,0.0016572088,0.0025048757,0.0018181056,0.0024862122],"domain_scores_gemma":[0.99340546,0.0011470674,0.0006073911,0.0029827524,0.00070611556,0.0011511964],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00048775505,0.0014467918,0.0018579848,0.00069833343,0.000454756,0.00019373377,0.0009058167,0.0007159953,0.0007287654],"category_scores_gemma":[0.0011759166,0.0010863263,0.0003704342,0.0017608728,0.0011222757,0.00036093718,0.0004337639,0.00033414437,0.0017145623],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.82278454,0.014051195,0.0012870185,0.0014695206,0.007981084,0.0231413,0.011515362,0.0032265629,0.0008119124,0.00011969569,0.0019773718,0.11163443],"study_design_scores_gemma":[0.8753395,0.043254722,0.002097547,0.0015275715,0.0015997251,0.00042262167,0.00025662416,0.038245484,0.02067786,0.000028435525,0.015115863,0.0014340341],"about_ca_topic_score_codex":0.049968578,"about_ca_topic_score_gemma":0.015612342,"teacher_disagreement_score":0.30989143,"about_ca_system_score_codex":0.5086357,"about_ca_system_score_gemma":0.19874425,"threshold_uncertainty_score":0.99982816},"labels":[],"label_agreement":null},{"id":"W2900733038","doi":"10.1182/blood-2018-99-118344","title":"Mosunetuzumab, a Full-Length Bispecific CD20/CD3 Antibody, Displays Clinical Activity in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (NHL): Interim Safety and Efficacy Results from a Phase 1 Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Tolerability; Mantle cell lymphoma; Internal medicine; Follicular lymphoma; CD20; Lymphoma; Gastroenterology; Rituximab; Refractory (planetary science); Adverse effect; Biology","score_opus":0.04516121939774342,"score_gpt":0.3896615740049443,"score_spread":0.34450035460720085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900733038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922761,0.0002534038,0.00006508209,0.00019554682,0.00044725885,0.0021568697,0.00027664364,0.0001124051,0.004216691],"genre_scores_gemma":[0.9962737,0.00063384307,0.0003036033,0.00007840587,0.0011518796,0.000032748354,0.0001493735,0.00011303908,0.0012634154],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99466276,0.00081062835,0.0013400373,0.0015495789,0.00081435085,0.00082266564],"domain_scores_gemma":[0.99558336,0.0016597278,0.00033867283,0.001658267,0.00018312187,0.0005768627],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023148265,0.00053373695,0.0012514025,0.0003839487,0.00018354531,0.00009246671,0.00042899884,0.00040756154,0.00069998816],"category_scores_gemma":[0.0007282702,0.00047419002,0.0002488129,0.00064918987,0.00063097634,0.00016563045,0.00045616683,0.0009881973,0.00017501182],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1382599,0.106252044,0.04595418,0.00008220778,0.0008151402,0.0019667118,0.0068077235,6.6473234e-7,0.5339423,0.0000026714722,0.0007901817,0.16512628],"study_design_scores_gemma":[0.3506332,0.03810691,0.57257086,0.00049007405,0.00053266995,0.0001112714,0.0012491171,0.0014337564,0.018804766,0.000014876898,0.015173379,0.0008790983],"about_ca_topic_score_codex":0.0011669255,"about_ca_topic_score_gemma":0.000639182,"teacher_disagreement_score":0.5266167,"about_ca_system_score_codex":0.00021420841,"about_ca_system_score_gemma":0.00041030513,"threshold_uncertainty_score":0.999771},"labels":[],"label_agreement":null},{"id":"W2900883426","doi":"10.1182/blood-2018-99-113918","title":"High Expression of SPAG1 Is Associated with a Worse Clinical Outcome in Intermediate Risk Acute Myeloid Leukemia That Can be Partially Overcome By Hematopoietic Stem Cell Transplantation","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"NPM1; CEBPA; Oncology; Internal medicine; Hematopoietic stem cell transplantation; Hazard ratio; Medicine; Transplantation; Myeloid leukemia; Univariate analysis; Proportional hazards model; Immunology; Multivariate analysis; Biology; Karyotype; Gene; Confidence interval","score_opus":0.02693370500462444,"score_gpt":0.3033483830629298,"score_spread":0.2764146780583054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900883426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978612,0.00006539204,0.00013538872,0.00042955665,0.00011942862,0.0007295838,0.00044171122,0.00007414145,0.00014360994],"genre_scores_gemma":[0.99740267,0.00053403684,0.00040735418,0.00044307797,0.00011562524,0.00004974684,0.00020097331,0.00007026972,0.0007762212],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99655414,0.00040392773,0.0010030499,0.00059359166,0.00083446794,0.0006108464],"domain_scores_gemma":[0.9979611,0.00042864718,0.000532266,0.0005734079,0.00018205163,0.00032251418],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010059938,0.0003357844,0.00095162936,0.00021521983,0.00007275176,0.000024413936,0.00030520375,0.0003905534,0.0001250551],"category_scores_gemma":[0.00008625778,0.00025532235,0.00016470512,0.0004269575,0.00036092405,0.00014180038,0.00008738534,0.0008702068,0.000027386575],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026463296,0.0013012326,0.9499419,0.000291499,0.00041408584,0.000663302,0.0049467096,0.0000030231004,0.037118398,0.0000044236385,0.0020336586,0.0006354911],"study_design_scores_gemma":[0.029814404,0.002600361,0.35735703,0.0009823045,0.0013096643,0.00007418756,0.00047087524,0.00015955152,0.6066721,0.000026127633,0.000106816165,0.00042658218],"about_ca_topic_score_codex":0.0005550901,"about_ca_topic_score_gemma":0.00056167436,"teacher_disagreement_score":0.59258485,"about_ca_system_score_codex":0.00032224433,"about_ca_system_score_gemma":0.000556687,"threshold_uncertainty_score":0.9999899},"labels":[],"label_agreement":null},{"id":"W2900918500","doi":"10.1182/blood-2018-09-873125","title":"Plateletpheresis-associated lymphopenia in frequent platelet donors","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Center for Research Resources; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Dana-Farber/Harvard Cancer Center; National Cancer Institute; National Institutes of Health; University of Melbourne; Harvard University; National Heart, Lung, and Blood Institute; Brigham and Women's Hospital","keywords":"Plateletpheresis; Leukoreduction; Medicine; Immunology; Apheresis; CD8; Leukapheresis; Lymphocyte; Internal medicine; Platelet; Immune system; Biology; Stem cell","score_opus":0.012017510753464364,"score_gpt":0.24947804410249827,"score_spread":0.23746053334903391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900918500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815242,0.00032053763,0.0000014756296,0.00022445459,0.00010605982,0.00034896508,0.000016990885,0.000085562744,0.017371746],"genre_scores_gemma":[0.99820346,0.000114556,0.0002316335,0.0004456164,0.00007047473,0.00002513217,0.00007294889,0.00003170036,0.0008044674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99874866,0.000032911343,0.00028073456,0.00030804338,0.00020722389,0.00042245063],"domain_scores_gemma":[0.9994351,0.000034943147,0.00007394564,0.00026131075,0.00005700245,0.00013764913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000112913884,0.00019604171,0.00040781323,0.00012296568,0.000071285656,0.000020208221,0.00009661581,0.00016457534,0.0004930329],"category_scores_gemma":[0.00006838565,0.00016777398,0.00007866662,0.00031201416,0.00007136956,0.000072311304,0.000036235375,0.000119436736,0.00050960184],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009466033,0.013170674,0.93198115,0.00008506689,0.0018430173,0.016388504,0.00155184,0.0000026767639,0.012038936,0.00028337335,0.0057946104,0.015913557],"study_design_scores_gemma":[0.0977236,0.003081398,0.77875715,0.0006860199,0.00069873454,0.0014151182,0.0003526168,0.00016793863,0.1024972,0.0017526714,0.011794086,0.001073449],"about_ca_topic_score_codex":0.0007850724,"about_ca_topic_score_gemma":0.0014293329,"teacher_disagreement_score":0.15322398,"about_ca_system_score_codex":0.00009745189,"about_ca_system_score_gemma":0.00010363252,"threshold_uncertainty_score":0.68416244},"labels":[],"label_agreement":null},{"id":"W2900973449","doi":"10.1182/blood-2018-99-117738","title":"Engaging Patients in Clinical Trial Planning: Exploring the Concept of a Minimal Clinically Important Difference Among Patients with Obstetrical Antiphospholipid Syndrome","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; McMaster University; Western University; University of Calgary","funders":"","keywords":"Medicine; Minimal clinically important difference; Antiphospholipid syndrome; Pregnancy; Specialty; Clinical trial; Randomized controlled trial; Physical therapy; Aspirin; Thrombosis; Surgery; Internal medicine; Family medicine","score_opus":0.08315063295835738,"score_gpt":0.33076931827388134,"score_spread":0.24761868531552395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900973449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976221,0.000030597505,0.000004374548,0.000028115724,0.0008009492,0.0012015522,0.000015154281,0.000039862567,0.00025731034],"genre_scores_gemma":[0.9992331,0.000015852043,0.0002932132,0.00009061145,0.00022969164,0.000057734364,0.000025419393,0.000041224437,0.000013143067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995921,0.00026662296,0.002044648,0.0006035124,0.00063722406,0.0005269703],"domain_scores_gemma":[0.99716544,0.0010429666,0.0006291771,0.00062806084,0.00025993877,0.00027443006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068486173,0.0002961653,0.0011019085,0.00013583974,0.000119500575,0.000027484768,0.00034157166,0.00018817412,0.000035233275],"category_scores_gemma":[0.0024014385,0.00018794826,0.00020281707,0.0005274734,0.0006584143,0.00014503057,0.0001918319,0.0007689125,0.000009476876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059305136,0.004199329,0.9872867,0.000017586199,0.00019811466,0.00005713936,0.0012885695,1.3314181e-7,0.000027277729,0.000016522783,0.000009002726,0.00096914015],"study_design_scores_gemma":[0.07717226,0.009680119,0.9111866,0.00041394995,0.00029435905,0.000005824922,0.00025366753,0.00001404822,0.00073218154,0.0000075196813,0.000026475855,0.00021300233],"about_ca_topic_score_codex":0.00008709818,"about_ca_topic_score_gemma":0.000011216593,"teacher_disagreement_score":0.076100074,"about_ca_system_score_codex":0.00003552742,"about_ca_system_score_gemma":0.00020000456,"threshold_uncertainty_score":0.76643074},"labels":[],"label_agreement":null},{"id":"W2901026782","doi":"10.1182/blood-2018-99-111061","title":"Comparison of Efficacy and Toxicity of CD19-Specific Chimeric Antigen Receptor T-Cells Alone or in Combination with Ibrutinib for Relapsed and/or Refractory CLL","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ibrutinib; Medicine; Fludarabine; Internal medicine; Leukapheresis; Neutropenia; Chronic lymphocytic leukemia; Cyclophosphamide; Immunology; Leukemia; Gastroenterology; Toxicity; Chemotherapy; Stem cell; Biology","score_opus":0.05115529306873292,"score_gpt":0.34419640482197367,"score_spread":0.29304111175324077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901026782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99776083,0.00039401455,0.00006245708,0.00012258612,0.000045379642,0.0011977375,0.00001586835,0.00001644407,0.00038469455],"genre_scores_gemma":[0.99568534,0.00048463914,0.00297792,0.000021153804,0.00007063548,0.000017324212,0.000021920516,0.000027769902,0.0006932695],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987566,0.00008219176,0.0003953551,0.00026834046,0.00029171084,0.00020581801],"domain_scores_gemma":[0.9988802,0.00039620916,0.00019288935,0.00026240593,0.00017966972,0.000088628505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045045943,0.00012968354,0.000543562,0.00017668938,0.000039794446,0.0000068509207,0.00007909621,0.00010061207,0.00030917762],"category_scores_gemma":[0.00011423314,0.00009228001,0.00002813564,0.00033047478,0.0002819174,0.00004993808,0.00003454831,0.00014668536,0.000002296868],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01245091,0.0033097495,0.039523486,0.00022642789,0.000094623974,0.0000025383865,0.0012296999,1.7666575e-7,0.93533474,0.000017651446,0.00043324498,0.0073767463],"study_design_scores_gemma":[0.026727235,0.013905569,0.083087765,0.00027576138,0.00006076856,0.000011047416,0.0002424609,0.0000797761,0.8725393,0.000011981917,0.0029281615,0.00013020805],"about_ca_topic_score_codex":0.000029797446,"about_ca_topic_score_gemma":0.00004486473,"teacher_disagreement_score":0.06279548,"about_ca_system_score_codex":0.000021571863,"about_ca_system_score_gemma":0.000094894465,"threshold_uncertainty_score":0.37630695},"labels":[],"label_agreement":null},{"id":"W2901041030","doi":"10.1182/blood-2018-99-110260","title":"Reduced Intensity Conditioned Sibling Transplantation Versus No Transplant in Intermediate or High Risk Acute Myeloid Leukemia: A Prospective Multi-Center Study in Patients 50-70 Years in First Complete Remission and with at Least One Potential Sibling Donor (ClinTrialGov 00342316)","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; Hôpital de l'Enfant-Jésus; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Fludarabine; Transplantation; Medicine; Busulfan; Sibling; Internal medicine; Pediatrics; Surgery; Hematopoietic stem cell transplantation; Cyclophosphamide; Chemotherapy; Psychology","score_opus":0.024479457781221677,"score_gpt":0.27489440295125855,"score_spread":0.2504149451700369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901041030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961981,0.000011276816,0.00009416142,0.00007812444,0.00024424738,0.002995858,0.0003048929,0.000050833794,0.000022497574],"genre_scores_gemma":[0.99753463,0.00039273952,0.001159824,0.000038360642,0.00019167697,0.00011034991,0.00047492998,0.000058738686,0.000038760063],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99694854,0.00024756815,0.00077045104,0.0008539628,0.0005773684,0.0006021232],"domain_scores_gemma":[0.99876523,0.00018028158,0.000237738,0.00029559038,0.00030273164,0.00021840072],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005786467,0.00035713648,0.0007718872,0.0008847735,0.00016157479,0.00004708721,0.00016617768,0.00022441229,0.000044809392],"category_scores_gemma":[0.0002089552,0.00030130692,0.00005775218,0.0007586734,0.00024108886,0.00026219775,0.000099422345,0.000918385,0.000026927826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17185833,0.0044122916,0.80215096,0.00018138949,0.00045260033,0.001456882,0.009211225,0.000031492815,0.009952161,5.2603036e-7,0.000016575135,0.0002755473],"study_design_scores_gemma":[0.19060859,0.005042446,0.7973253,0.0011284457,0.0004420032,0.00005885912,0.00054976455,0.00158077,0.0029642473,0.0000026666523,0.000003416525,0.00029348404],"about_ca_topic_score_codex":0.0023444588,"about_ca_topic_score_gemma":0.0119458,"teacher_disagreement_score":0.018750278,"about_ca_system_score_codex":0.0010949686,"about_ca_system_score_gemma":0.00026715454,"threshold_uncertainty_score":0.9999439},"labels":[],"label_agreement":null},{"id":"W2901076366","doi":"10.1182/blood-2018-99-109906","title":"Fetal-Neonatal Alloimmune Thrombocytopenia (FNAIT): Guidance to Reduce the Risk of Intracranial Bleeding","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McMaster University; Centre Hospitalier Universitaire Sainte-Justine; Hospital for Sick Children; St. Michael's Hospital; Mount Sinai Hospital; Canadian Blood Services; University of Toronto","funders":"","keywords":"Medicine; Neonatal alloimmune thrombocytopenia; Obstetrics; Neonatology; Systematic review; MEDLINE; Pediatrics; Pregnancy; Intensive care medicine; Fetus","score_opus":0.012344994576728639,"score_gpt":0.2678629872025804,"score_spread":0.25551799262585173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901076366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99275714,0.00070576963,0.00012128491,0.0006992223,0.00019026156,0.00042830562,0.000029764888,0.000033639717,0.00503459],"genre_scores_gemma":[0.99655825,0.000101640435,0.002470893,0.00017433922,0.0002589023,0.000017121585,0.000008319545,0.00002121919,0.00038934324],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989927,0.000027709671,0.0002563936,0.00023293226,0.00023585313,0.00025441163],"domain_scores_gemma":[0.9992793,0.000047772715,0.000107262975,0.00037546296,0.00010726924,0.00008293201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019707148,0.00014936211,0.00034696524,0.000044151264,0.00013977558,0.000015194139,0.00018147753,0.000063301195,0.00014084832],"category_scores_gemma":[0.00013833758,0.000096683856,0.00009298634,0.00021638314,0.00013468045,0.00007741225,0.00008496301,0.0001298171,0.0001795865],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031727797,0.0057486915,0.08773619,0.00020981191,0.005855591,0.0016100879,0.008414786,0.0000088506395,0.72117555,0.0011862227,0.008153931,0.15672751],"study_design_scores_gemma":[0.0205579,0.0036677427,0.4939112,0.00050569203,0.0025451402,0.0013314058,0.00070324994,0.00016851828,0.46177578,0.0006715771,0.0136545105,0.0005072859],"about_ca_topic_score_codex":0.0002562562,"about_ca_topic_score_gemma":0.00005724865,"teacher_disagreement_score":0.40617502,"about_ca_system_score_codex":0.000016266167,"about_ca_system_score_gemma":0.00005492329,"threshold_uncertainty_score":0.39426532},"labels":[],"label_agreement":null},{"id":"W2901163551","doi":"10.1182/blood.v126.23.2209.2209","title":"Bisphosphonate Therapy in Langerhans Cell Histiocytosis: An International Retrospective Descriptive Study","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Université de Montréal; SickKids Foundation; Centre Hospitalier Universitaire Sainte-Justine; University of Toronto","funders":"","keywords":"Langerhans cell histiocytosis; Medicine; Denosumab; Bone pain; Histiocytosis; Bisphosphonate; Curettage; Internal medicine; Surgery; Pathology; Dermatology; Disease; Osteoporosis","score_opus":0.03894942794614252,"score_gpt":0.28757194675471276,"score_spread":0.24862251880857023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901163551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797975,0.00027324352,0.000008649299,0.00005646029,0.00020629904,0.00050205935,0.000016760727,0.000047365287,0.019091658],"genre_scores_gemma":[0.9980443,0.000057413636,0.00028696298,0.00009229755,0.00003173488,0.00007884177,0.00003637649,0.000019823594,0.0013522324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911433,0.000033647528,0.00015212136,0.00026999155,0.00027919104,0.00015070272],"domain_scores_gemma":[0.9994873,0.0000065962718,0.00004611376,0.000203404,0.00012874084,0.00012784582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012411324,0.00012645517,0.00019954541,0.000105988656,0.000024700608,0.000017794273,0.0000910169,0.0000443033,0.00007448175],"category_scores_gemma":[0.00003359908,0.0001058379,0.000035109104,0.00015262478,0.000026837613,0.00010999568,0.00001844603,0.00010325794,0.000054924592],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003877706,0.014257945,0.97097677,0.000002345472,0.00018130538,0.0003815586,0.011792011,0.0000017433634,0.00019367105,0.000046555117,0.0001781687,0.0016001364],"study_design_scores_gemma":[0.04478852,0.0061519006,0.9327331,0.000036797548,0.00018996566,0.000025879384,0.01007021,0.000074608266,0.0032755828,0.00044939033,0.0019663074,0.00023770957],"about_ca_topic_score_codex":0.0019621626,"about_ca_topic_score_gemma":0.0005989445,"teacher_disagreement_score":0.044400748,"about_ca_system_score_codex":0.00028411893,"about_ca_system_score_gemma":0.00013066675,"threshold_uncertainty_score":0.4315944},"labels":[],"label_agreement":null},{"id":"W2901204098","doi":"10.1182/blood-2018-04-843540","title":"Definitive radiotherapy for localized follicular lymphoma staged by 18F-FDG PET-CT: a collaborative study by ILROG","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Follicular lymphoma; Radiation therapy; Medicine; Nuclear medicine; Positron emission tomography; Lymphoma; Radiology; Pathology","score_opus":0.010438094308450493,"score_gpt":0.2782999149906337,"score_spread":0.2678618206821832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901204098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891332,0.004688506,0.0001630458,0.00044066084,0.00011880265,0.0037843466,0.00071765506,0.00010906818,0.0008447587],"genre_scores_gemma":[0.9940238,0.000286191,0.001815638,0.0010718042,0.0001664917,0.0015116431,0.00024861228,0.00007245418,0.0008033443],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99804074,0.00014385374,0.00035924392,0.0005923065,0.00037838795,0.00048544852],"domain_scores_gemma":[0.9985856,0.00024940984,0.00015348097,0.00042645243,0.0003486805,0.00023638668],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022997764,0.00036477132,0.00069526874,0.00007050016,0.00027819956,0.00006168499,0.00011560567,0.00003236634,0.00013657256],"category_scores_gemma":[0.00010646731,0.00028580398,0.0001720962,0.00035138015,0.00015612388,0.00007248905,0.00002863676,0.000041882082,0.000045504326],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013109415,0.19784808,0.28987718,0.00025461015,0.030816164,0.0070395316,0.014745873,7.2512574e-7,0.023651935,0.0014922234,0.39632663,0.024837606],"study_design_scores_gemma":[0.33700296,0.03517773,0.01182095,0.00021155957,0.0045342175,0.00056352536,0.008320565,0.00008137066,0.3865348,0.00013572085,0.21446346,0.0011531389],"about_ca_topic_score_codex":0.00020148251,"about_ca_topic_score_gemma":0.000049556744,"teacher_disagreement_score":0.36288288,"about_ca_system_score_codex":0.00023890768,"about_ca_system_score_gemma":0.00028937502,"threshold_uncertainty_score":0.9999594},"labels":[],"label_agreement":null},{"id":"W2901204777","doi":"10.1182/blood-2018-99-116868","title":"Single Agent Oral Selinexor Demonstrates Deep and Durable Responses in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) in Both GCB and Non-GCB Subtypes: The Phase 2b Sadal Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Diffuse large B-cell lymphoma; Medicine; Refractory (planetary science); Lymphoma; Ibrutinib; Internal medicine; Leukemia; Chronic lymphocytic leukemia; Biology","score_opus":0.016858601160989892,"score_gpt":0.27331609459260914,"score_spread":0.2564574934316192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901204777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99516976,0.003183449,0.0000019589318,0.00024434127,0.00007417478,0.0009685069,0.000024108958,0.000030996638,0.0003027024],"genre_scores_gemma":[0.9987829,0.00032453885,0.00017171641,0.0002714731,0.00009088872,0.00009876776,0.000011201071,0.000031855874,0.00021670849],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982959,0.00019445946,0.00039434832,0.00046257098,0.00022781178,0.00042492765],"domain_scores_gemma":[0.9989702,0.0003303291,0.000100884485,0.00037903458,0.000049754093,0.00016981462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048232352,0.0002761607,0.0004156294,0.00016346599,0.00015553215,0.000066399196,0.000090216294,0.000106384985,0.000023818862],"category_scores_gemma":[0.00013491999,0.00018277699,0.000046055702,0.00024624114,0.00015388856,0.00009207547,0.000083982995,0.00010140749,0.000016803788],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001451821,0.12407673,0.86044216,0.000042563486,0.00013507817,0.0011074956,0.0037192518,1.1330502e-7,0.0043021613,0.0000069215685,0.00014492277,0.0045707896],"study_design_scores_gemma":[0.17657565,0.006025886,0.79876727,0.00014913281,0.0004728218,0.00015498132,0.004375001,0.00021863813,0.011753097,0.000022758722,0.0012082786,0.00027650184],"about_ca_topic_score_codex":0.000584415,"about_ca_topic_score_gemma":0.0034219972,"teacher_disagreement_score":0.17512383,"about_ca_system_score_codex":0.000107045395,"about_ca_system_score_gemma":0.00015958349,"threshold_uncertainty_score":0.7453429},"labels":[],"label_agreement":null},{"id":"W2901228410","doi":"10.1182/blood-2018-99-110561","title":"Multivariable Modeling of Disease and Treatment Characteristics of Adults with B-ALL in MRD-Negative CR after CD19 CAR-T Cells Identifies Factors Impacting Disease-Free Survival","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Minimal residual disease; Bone marrow; Internal medicine; Fludarabine; Chimeric antigen receptor; Leukemia; Immunotherapy; Oncology; Immunology; Chemotherapy; Cancer; Cyclophosphamide","score_opus":0.030691553626037777,"score_gpt":0.2904626950089509,"score_spread":0.25977114138291313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901228410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99861354,0.000102769525,0.00003585965,0.00003107408,0.000050640123,0.0006873174,0.00037964422,0.000015635382,0.00008353981],"genre_scores_gemma":[0.99916184,0.00010693294,0.00027883588,0.000008014379,0.00010375797,0.000032952386,0.000033836575,0.000039175764,0.0002346299],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853265,0.00008054073,0.00034526305,0.0003259783,0.0003993014,0.00031625543],"domain_scores_gemma":[0.9986183,0.00020605598,0.0001279517,0.0004730378,0.0002472949,0.00032736428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015588947,0.00022028429,0.00046889187,0.00015666641,0.000032998993,0.00001953622,0.00009124637,0.00005072601,0.00015863024],"category_scores_gemma":[0.00023327624,0.0001615172,0.00007748858,0.00015406148,0.00018281485,0.00010338817,0.00008278904,0.000109601126,0.0000011354498],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017254753,0.0024027966,0.8012493,0.0007551608,0.0007571062,0.00017010662,0.012694889,0.00003750719,0.16428442,0.000004517392,0.0000033912634,0.0003860161],"study_design_scores_gemma":[0.021688925,0.0024095357,0.7585842,0.0017446169,0.0012467119,0.0000033633494,0.00300182,0.010721781,0.2000631,0.00009697385,0.000008051268,0.0004309358],"about_ca_topic_score_codex":0.002055971,"about_ca_topic_score_gemma":0.00039424349,"teacher_disagreement_score":0.04266514,"about_ca_system_score_codex":0.00007372645,"about_ca_system_score_gemma":0.00018513932,"threshold_uncertainty_score":0.658648},"labels":[],"label_agreement":null},{"id":"W2901260218","doi":"10.1182/blood-2018-120737","title":"Phase 3 Randomized Study of Daratumumab Plus Lenalidomide and Dexamethasone (D-Rd) Versus Lenalidomide and Dexamethasone (Rd) in Patients with Newly Diagnosed Multiple Myeloma (NDMM) Ineligible for Transplant (MAIA)","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Alberta; University of Calgary","funders":"","keywords":"Lenalidomide; Medicine; Internal medicine; Daratumumab; Transplantation; Multiple myeloma; Melphalan; Surgery; Gastroenterology; Oncology","score_opus":0.029646445552999362,"score_gpt":0.3113519878671562,"score_spread":0.2817055423141568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901260218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99074894,0.0007838225,0.00037492823,0.000086385546,0.00009040345,0.0075603174,0.00021419904,0.000048162532,0.00009283662],"genre_scores_gemma":[0.9927059,0.00020671515,0.0058932025,0.00003347248,0.00010694713,0.00076936244,0.00017079704,0.00007586021,0.00003776463],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9964647,0.00041178975,0.0008372958,0.0008270947,0.00070995366,0.00074915297],"domain_scores_gemma":[0.9954098,0.0029127812,0.0002886581,0.0005453211,0.00036948756,0.00047399383],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009382963,0.00051754894,0.0018137271,0.0004873473,0.00018687248,0.00005138558,0.00016197118,0.00016288107,0.00002600033],"category_scores_gemma":[0.0015430708,0.0003784984,0.0001393945,0.00044044116,0.00051423477,0.00020858538,0.00007947701,0.00026807643,0.0000033494791],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7484752,0.014172799,0.22415125,0.0002935965,0.0021353518,0.00024494127,0.003283503,0.000004534077,0.0014674012,0.0000068864156,0.000036197456,0.0057283384],"study_design_scores_gemma":[0.91492623,0.0155476425,0.05192847,0.00036298277,0.0016112102,0.00001932964,0.0007165691,0.0009556134,0.013531159,0.000016357902,0.000032374268,0.00035203435],"about_ca_topic_score_codex":0.001410491,"about_ca_topic_score_gemma":0.0021068165,"teacher_disagreement_score":0.17222278,"about_ca_system_score_codex":0.00008155557,"about_ca_system_score_gemma":0.00018876357,"threshold_uncertainty_score":0.9998667},"labels":[],"label_agreement":null},{"id":"W2901391190","doi":"10.1182/blood-2018-99-111698","title":"Thrombotic and Bleeding Outcomes Following Perioperative Interruption of Direct Oral Anticoagulants and Vitamin K Antagonists in Patients with Non-Valvular Atrial Fibrillation - a Comparative Analysis","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Perioperative; Warfarin; Atrial fibrillation; Rivaroxaban; Apixaban; Thrombosis; Stroke (engine); Anticoagulant; Dabigatran; Surgery; Anesthesia; Internal medicine","score_opus":0.04206725940426517,"score_gpt":0.34176192844633324,"score_spread":0.2996946690420681,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901391190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989359,0.000047452068,0.00011641707,0.00006106445,0.000065397326,0.0005245904,0.000005729828,0.000015435106,0.00022803577],"genre_scores_gemma":[0.99873525,0.000009336384,0.0010680439,0.00000859354,0.00009262022,5.5879184e-7,0.00004196915,0.000008294376,0.000035320485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899495,0.000056760393,0.00031637435,0.00025755857,0.00023239442,0.00014196559],"domain_scores_gemma":[0.9995475,0.00007665187,0.000142805,0.00010824899,0.000076193246,0.0000486488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019053734,0.00015972675,0.0007941228,0.00033334765,0.000083832754,0.00003684707,0.000024989737,0.000050576047,0.000009171526],"category_scores_gemma":[0.00005447357,0.00011864955,0.00012444623,0.00046461282,0.00010335526,0.00021318995,0.00004594721,0.000045914683,0.0000010548414],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028102158,0.000018624374,0.9951265,0.000029167253,0.0017397602,0.0000023270218,0.001987508,0.0000327147,0.0005766655,0.000023414499,5.711115e-7,0.00018172905],"study_design_scores_gemma":[0.008022885,0.00070232665,0.98543215,0.00009461321,0.0027732207,5.02284e-7,0.00037840393,0.0018303365,0.0006276767,0.0000030844453,0.0000068741506,0.00012791762],"about_ca_topic_score_codex":0.00007835295,"about_ca_topic_score_gemma":0.0000910621,"teacher_disagreement_score":0.009694338,"about_ca_system_score_codex":0.000020386786,"about_ca_system_score_gemma":0.000015565409,"threshold_uncertainty_score":0.48383883},"labels":[],"label_agreement":null},{"id":"W2901474034","doi":"10.1182/blood-2018-05-848697","title":"Anticoagulating patients with high-risk acquired thrombophilias","year":2018,"lang":"en","type":"review","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Calgary","funders":"","keywords":"Medicine; Internal medicine; Thrombophilia; Thrombosis","score_opus":0.038239147024490855,"score_gpt":0.295642347242661,"score_spread":0.2574032002181701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901474034","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015681462,0.98001766,0.00005558274,0.000013880176,0.0004959034,0.0022959777,0.000116931325,0.00031536497,0.0010072377],"genre_scores_gemma":[0.006212209,0.98769146,0.0039124815,0.00009322561,0.0007917158,0.00007703152,0.0007560815,0.00023369511,0.00023210021],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971272,0.0001696155,0.00078351976,0.0007793871,0.0006661853,0.00047411534],"domain_scores_gemma":[0.99757063,0.00010135607,0.00081450684,0.0009900947,0.00027055613,0.00025283193],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022646297,0.0006703167,0.0025168534,0.00024783204,0.00020311805,0.000055960034,0.00022644975,0.00049748964,0.0004126618],"category_scores_gemma":[0.00011767308,0.000458846,0.00042595892,0.00053373224,0.000117869415,0.00009602221,0.00012174191,0.00030836032,0.0005056389],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008715808,0.008984025,0.011304763,0.037740014,0.010455525,0.00010866156,0.00029335314,3.4243453e-7,0.000009064884,0.0018053167,0.0009906079,0.92822117],"study_design_scores_gemma":[0.029628176,0.0073947934,0.02832351,0.10470373,0.101684555,0.00025492397,0.000038873266,0.0000108478835,0.00028793007,0.00068417797,0.7233943,0.0035941876],"about_ca_topic_score_codex":0.000022651688,"about_ca_topic_score_gemma":0.0000048480556,"teacher_disagreement_score":0.924627,"about_ca_system_score_codex":0.000045048884,"about_ca_system_score_gemma":0.00025475008,"threshold_uncertainty_score":0.9997863},"labels":[],"label_agreement":null},{"id":"W2901483559","doi":"10.1182/blood-2018-99-111219","title":"Characterization of Novel Subtypes in B Progenitor Acute Lymphoblastic Leukemia","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Biology; ETV6; BCL6; Immunophenotyping; Genetics; Minimal residual disease; Missense mutation; Gene expression profiling; Cancer research; Gene; Leukemia; Mutation; B cell; Chromosomal translocation; Gene expression","score_opus":0.01496194736933237,"score_gpt":0.27096173048851946,"score_spread":0.2559997831191871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901483559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99753714,0.000016128804,0.00092607556,0.00008850601,0.000112645954,0.00043934307,0.000032204036,0.00004360239,0.00080437626],"genre_scores_gemma":[0.99746865,0.000019961853,0.0014130851,0.00009090862,0.00042658887,0.000034664277,0.00005750693,0.000033982113,0.00045465335],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986484,0.000022302269,0.00034415882,0.00027238147,0.00038650414,0.00032624797],"domain_scores_gemma":[0.9991597,0.000060062095,0.00010213869,0.00030836655,0.00025026657,0.00011950068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001522978,0.0001416357,0.00031279228,0.00023353155,0.000030746614,0.000010641936,0.000140456,0.00013522264,0.00008959168],"category_scores_gemma":[0.00019555326,0.00012298622,0.000053531836,0.0005072998,0.00019104859,0.00009261582,0.000077363526,0.0001038379,0.00008689146],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036439014,0.0006586798,0.024061874,0.00009379559,0.0001059826,0.000054355936,0.00024998237,2.9145744e-7,0.97388947,0.000065325505,0.000034824076,0.0004210545],"study_design_scores_gemma":[0.012485475,0.00079382677,0.122349136,0.0002235358,0.00024487523,0.00029101514,0.00002430023,0.002321129,0.8608143,0.000009854408,0.00029618552,0.0001464173],"about_ca_topic_score_codex":0.000056924302,"about_ca_topic_score_gemma":0.0000130960125,"teacher_disagreement_score":0.1130752,"about_ca_system_score_codex":0.00034433775,"about_ca_system_score_gemma":0.0011410129,"threshold_uncertainty_score":0.50152326},"labels":[],"label_agreement":null},{"id":"W2901537792","doi":"10.1182/blood-2018-99-117677","title":"\"Part of the Ritual\": a Qualitative Study of Patient and Physician Perspectives on the Use of Anticoagulation for Improving Pregnancy Outcomes in Obstetrical Antiphospholipid Syndrome","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; McMaster University; Ottawa Hospital; University of Calgary","funders":"","keywords":"Medicine; Antiphospholipid syndrome; Pregnancy; Specialty; Low molecular weight heparin; Thrombophilia; Population; Family medicine; Qualitative research; Thrombosis; Grounded theory; Intensive care medicine; Pediatrics; Obstetrics; Surgery","score_opus":0.07645171933766214,"score_gpt":0.3305188760018067,"score_spread":0.25406715666414453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901537792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99814576,0.00009579558,0.0000026705684,0.00008475694,0.00006134008,0.0015470166,0.000020941874,0.0000050943413,0.000036629073],"genre_scores_gemma":[0.99979556,0.0000043298646,0.00012440853,0.00001964831,0.00000926118,0.000024640149,7.8582804e-7,0.000012205318,0.000009153185],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.9988994,0.00015919337,0.00037979032,0.00020503317,0.00022854138,0.00012805712],"domain_scores_gemma":[0.9985231,0.0006761181,0.00026599417,0.00032912905,0.00018160936,0.000024004714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000098556695,0.00011559469,0.00049046555,0.00008275162,0.000054029268,0.000006064941,0.000076003314,0.000043781576,0.0000026401067],"category_scores_gemma":[0.00076717645,0.0000648751,0.000081324164,0.0002943469,0.0001957009,0.00007152314,0.000062526924,0.00008623772,2.8883815e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021788149,0.015690193,0.3414484,0.00030448154,0.0007125217,0.000002828798,0.60170764,0.0000022817203,0.035703406,0.002818102,0.0000042066563,0.0013880605],"study_design_scores_gemma":[0.0038834228,0.005021856,0.78006285,0.0005484694,0.00033719026,0.0000018129028,0.15052372,0.000050636347,0.059385177,0.000092094626,0.0000020401053,0.000090728965],"about_ca_topic_score_codex":0.00022388408,"about_ca_topic_score_gemma":0.000034558198,"teacher_disagreement_score":0.45118392,"about_ca_system_score_codex":0.000018601582,"about_ca_system_score_gemma":0.00003909729,"threshold_uncertainty_score":0.26455298},"labels":[],"label_agreement":null},{"id":"W2901646507","doi":"10.1182/blood-2018-99-111725","title":"Are There Inequities in Access to Care Amongst Women with Inherited Bleeding Disorders? a Systematic Review","year":2018,"lang":"en","type":"review","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Medicine; Referral; Systematic review; MEDLINE; Family medicine; Health care; Pediatrics","score_opus":0.07397855349827902,"score_gpt":0.3695611572511172,"score_spread":0.2955826037528382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901646507","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029627797,0.98612237,1.8567516e-7,0.00014884418,0.00003691483,0.009395931,0.000033563563,0.000066643755,0.0012327413],"genre_scores_gemma":[0.0007691742,0.99353087,0.000018880011,0.00013615025,0.00016999175,0.004460871,0.00007183544,0.000108748194,0.0007335088],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99728376,0.0002331378,0.00079042895,0.00053173845,0.0005544513,0.0006064776],"domain_scores_gemma":[0.99829936,0.00011859075,0.00041683897,0.0007081769,0.0001871438,0.00026991562],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039846072,0.0005252408,0.004013702,0.00044635503,0.00007760686,0.00010288674,0.00046713365,0.00023252906,0.000110627785],"category_scores_gemma":[0.00033004905,0.0002977458,0.00020778616,0.0012707649,0.000074004034,0.00010112837,0.00023110145,0.0004128378,0.0001178368],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013609427,0.00022615168,0.0010140578,0.9907861,0.0006526774,0.00030786032,0.00057831843,6.7109496e-9,4.9529675e-8,8.29058e-7,0.00016374422,0.006256591],"study_design_scores_gemma":[0.00094477896,0.0004944496,0.0001328549,0.9646405,0.0036968528,0.0000734866,0.0015231752,7.2905365e-8,5.482755e-7,0.0000013059715,0.028165461,0.00032648505],"about_ca_topic_score_codex":0.000038353686,"about_ca_topic_score_gemma":0.00024172857,"teacher_disagreement_score":0.028001718,"about_ca_system_score_codex":0.0003274498,"about_ca_system_score_gemma":0.00033682003,"threshold_uncertainty_score":0.9999475},"labels":[],"label_agreement":null},{"id":"W2901686792","doi":"10.1182/blood-2018-99-117559","title":"Tobacco Use in the Myeloproliferative Neoplasms: Patient Behavior, Opinions, and Care","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Myeloproliferative neoplasm; Snuff; Smokeless tobacco; Population; Family medicine; Chewing tobacco; Demographics; Tobacco use; Internal medicine; Myelofibrosis; Environmental health; Demography; Pathology; Cancer","score_opus":0.02337470025487498,"score_gpt":0.27581004930028713,"score_spread":0.25243534904541215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901686792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959123,0.00093652285,0.0000014431157,0.0007122944,0.0001020492,0.0012405738,0.00006176646,0.000027469208,0.0010055463],"genre_scores_gemma":[0.99686736,0.0002117375,0.0010111098,0.001009998,0.00016794083,0.00058060884,0.00009723003,0.000018312297,0.000035684025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987982,0.00010302188,0.00025506565,0.0003526258,0.00023099578,0.00026007544],"domain_scores_gemma":[0.99917656,0.00015560442,0.000058799338,0.00033457702,0.00016796,0.00010649512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007635755,0.0002144632,0.00026929006,0.0000876382,0.00017310398,0.00007372394,0.00006591801,0.00008676581,0.000057063873],"category_scores_gemma":[0.00009617364,0.00013265848,0.00005506561,0.00018072625,0.00013031617,0.000109637745,0.000052209016,0.00016718314,0.000036041514],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000073589224,0.0013262047,0.9786841,0.000015543721,0.00006956236,0.00018565086,0.012802396,1.5974683e-7,0.000066671055,0.001095476,0.0005608618,0.0051197344],"study_design_scores_gemma":[0.004683416,0.0026337118,0.97062,0.00015153158,0.00029727622,0.00026475848,0.0049232775,0.0000038617936,0.010153739,0.000028157292,0.0060427827,0.00019752444],"about_ca_topic_score_codex":0.00017366248,"about_ca_topic_score_gemma":0.0008942175,"teacher_disagreement_score":0.010087067,"about_ca_system_score_codex":0.000039901992,"about_ca_system_score_gemma":0.00008617521,"threshold_uncertainty_score":0.54096556},"labels":[],"label_agreement":null},{"id":"W2901763385","doi":"10.1182/blood-2018-99-110871","title":"Treatment Patterns and Healthcare Resource Utilization (HRU) in Patients with Relapsed/Refractory (R/R) FLT3-Mutated (FLT3mut) and FLT3-Wild Type (FLT3wt) Acute Myeloid Leukemia (AML): A Multi-Country Medical Chart Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; CEBPA; Internal medicine; Clofarabine; Chemotherapy regimen; Hematopoietic stem cell transplantation; Transplantation; Oncology; NPM1; Myeloid leukemia; Pediatrics; Cytarabine; Chemotherapy; Mutation; Biology","score_opus":0.022135249482547033,"score_gpt":0.30290709179672626,"score_spread":0.28077184231417923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901763385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99620473,0.00046556114,0.000014523361,0.00053499604,0.000084100444,0.0023905486,0.00007977554,0.00012846029,0.00009732196],"genre_scores_gemma":[0.9973768,0.00070797413,0.00016697231,0.00047140082,0.00021966921,0.00010791192,0.0004886483,0.00010840314,0.00035224744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962138,0.0003194591,0.0005996665,0.00097633945,0.0011397334,0.000751029],"domain_scores_gemma":[0.9979485,0.00013144608,0.00017457551,0.0006638379,0.00038209418,0.0006995403],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043003954,0.0004909726,0.00072572107,0.00039146683,0.00023340364,0.00005569163,0.00018750611,0.0003899109,0.000087399065],"category_scores_gemma":[0.00024862296,0.0003705131,0.000036895173,0.00064000505,0.00031247258,0.00019240177,0.00020545653,0.0006810776,0.000029982673],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028506932,0.003109184,0.97973704,0.00013459135,0.00049671147,0.00063040794,0.004005747,3.8947564e-7,0.000095713636,0.0000033743963,0.00018085726,0.008755299],"study_design_scores_gemma":[0.052666858,0.013890124,0.92824554,0.0004755624,0.00044218957,0.00015634045,0.0012262741,0.00063213054,0.00041300736,0.0000016123396,0.0014680921,0.0003822818],"about_ca_topic_score_codex":0.0019105286,"about_ca_topic_score_gemma":0.0026717572,"teacher_disagreement_score":0.051491503,"about_ca_system_score_codex":0.00090278784,"about_ca_system_score_gemma":0.001088717,"threshold_uncertainty_score":0.9998747},"labels":[],"label_agreement":null},{"id":"W2901941522","doi":"10.1182/blood-2018-10-877076","title":"Postthrombotic syndrome: simple prevention","year":2018,"lang":"en","type":"letter","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Post-thrombotic syndrome; Venous thromboembolism; Incidence (geometry); Surgery; Internal medicine; Cardiology; Thrombosis; Deep vein","score_opus":0.020733305689945428,"score_gpt":0.27544857819201024,"score_spread":0.2547152725020648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901941522","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22616501,0.001322931,0.000097451106,0.72907,0.0019081476,0.004167779,0.00009468728,0.000681665,0.036492307],"genre_scores_gemma":[0.05065672,0.00039193517,0.0009875492,0.9160485,0.009140617,0.00025014204,0.0026963002,0.00027363916,0.019554557],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978902,0.00006096773,0.00039079835,0.00058246637,0.0005401159,0.000535484],"domain_scores_gemma":[0.99873304,0.00003689838,0.00019496317,0.0008314676,0.00011051217,0.00009311913],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0001564788,0.00036869143,0.0009183326,0.00021728863,0.00009821764,0.000052514515,0.00020751501,0.00061884656,0.0023411463],"category_scores_gemma":[0.000046526362,0.00033797056,0.00031946614,0.00017010124,0.00008503144,0.000058227688,0.00013834272,0.0007387287,0.0014857221],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000029498074,0.0009927824,0.00024725994,0.0007666877,0.00090344634,0.002094957,0.000035181612,8.426669e-8,0.000033678843,0.000020350437,0.99465543,0.00024716958],"study_design_scores_gemma":[0.00200218,0.001858377,0.018022165,0.0006724016,0.004633596,0.00073800044,0.000013501392,0.0000020397172,0.0002162994,0.0007675046,0.97065485,0.00041906728],"about_ca_topic_score_codex":0.000054815122,"about_ca_topic_score_gemma":0.0000070016995,"teacher_disagreement_score":0.18697852,"about_ca_system_score_codex":0.000059046855,"about_ca_system_score_gemma":0.00011258909,"threshold_uncertainty_score":0.99990726},"labels":[],"label_agreement":null},{"id":"W2902267135","doi":"10.1182/blood-2018-99-119926","title":"Early Prediction of Moderate-Severe Chronic GvHD By Immunity Related Transcriptome","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; Calgary Laboratory Services; University of Calgary","funders":"","keywords":"Medicine; Graft-versus-host disease; Internal medicine; Cohort; Peripheral blood mononuclear cell; Immunology; Hematopoietic stem cell transplantation; Transcriptome; Transplantation; Oncology; Gastroenterology; Gene expression; Gene; Biology","score_opus":0.012926315844425093,"score_gpt":0.23289907129431187,"score_spread":0.21997275544988676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902267135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99068,0.0006407397,0.0006345208,0.00007854849,0.000150752,0.0003561972,0.000074233336,0.00010199731,0.0072830315],"genre_scores_gemma":[0.9987962,0.0001226951,0.00020956124,0.000021044509,0.000064020285,0.000012112254,0.0000932152,0.000024071043,0.00065707404],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99899524,0.00005968602,0.0003474905,0.00017494743,0.00024329925,0.00017933574],"domain_scores_gemma":[0.99939954,0.000039977374,0.00007130245,0.00027734865,0.00013063,0.00008120966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017698585,0.00011637678,0.00023043333,0.00006696486,0.00005962666,0.0000068091667,0.00006765354,0.00015982153,0.00058127736],"category_scores_gemma":[0.000019336943,0.00010901325,0.00006732974,0.00019282839,0.000102793834,0.00010549447,0.000005028989,0.00017023004,0.0000675199],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026152734,0.0006396243,0.010754235,0.00052857056,0.0002853581,0.000012024782,0.0036080282,0.0000020460707,0.9828136,0.00007646525,0.00032652353,0.000692019],"study_design_scores_gemma":[0.010123426,0.0023604238,0.12849966,0.00056498457,0.0009053054,0.00022274343,0.000111122514,0.0003881841,0.8563437,0.000105091305,0.00021005838,0.0001652858],"about_ca_topic_score_codex":0.00009901551,"about_ca_topic_score_gemma":0.000004038672,"teacher_disagreement_score":0.12646987,"about_ca_system_score_codex":0.00003700195,"about_ca_system_score_gemma":0.00010123132,"threshold_uncertainty_score":0.6364579},"labels":[],"label_agreement":null},{"id":"W2902348661","doi":"10.1182/blood-2018-06-860015","title":"Carfilzomib vs bortezomib in patients with multiple myeloma and renal failure: a subgroup analysis of ENDEAVOR","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Carfilzomib; Hazard ratio; Renal function; Multiple myeloma; Internal medicine; Confidence interval; Urology; Creatinine; Population; Dexamethasone; Gastroenterology; Subgroup analysis; Bortezomib","score_opus":0.008370298583563177,"score_gpt":0.24236132120059722,"score_spread":0.23399102261703406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902348661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989569,0.000060125,0.000017734217,0.000055484954,0.000008225162,0.00047144148,0.0000907924,0.00001807623,0.00032119718],"genre_scores_gemma":[0.9978192,0.000008373968,0.0018274223,0.000029418734,0.000036825357,0.00003102773,0.00016395652,0.00001734285,0.000066474444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986016,0.000049084676,0.0002611193,0.00033845287,0.00041603556,0.0003336903],"domain_scores_gemma":[0.99907947,0.00007499651,0.00008681538,0.00034574652,0.00019915921,0.00021384483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011543563,0.00016486367,0.0004931612,0.00049901294,0.000045863657,0.000012516006,0.00007036442,0.0000733366,0.00008107945],"category_scores_gemma":[0.00012898461,0.00011775173,0.000077414275,0.000864842,0.00017269875,0.00007257055,0.000052516334,0.00011069573,0.0000067040264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018999026,0.001383641,0.990764,0.00003527812,0.002064226,0.00006097365,0.00026592173,5.081246e-7,0.0011496583,0.0000076262936,0.000023943463,0.0023443135],"study_design_scores_gemma":[0.020771267,0.0018098069,0.9694571,0.000056775203,0.0012575234,0.000003922933,0.00003912927,0.0002940823,0.006140767,0.0000033989072,0.00006117653,0.000105087616],"about_ca_topic_score_codex":0.00055229664,"about_ca_topic_score_gemma":0.0032482774,"teacher_disagreement_score":0.021306945,"about_ca_system_score_codex":0.00003165294,"about_ca_system_score_gemma":0.000065854365,"threshold_uncertainty_score":0.48017764},"labels":[],"label_agreement":null},{"id":"W2902375054","doi":"10.1182/blood-2018-08-835595","title":"How I treat cancer-associated venous thromboembolism","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Venous thromboembolism; Medicine; Cancer; Venous thrombosis; Internal medicine; Intensive care medicine; Surgery; Thrombosis","score_opus":0.01886063355089625,"score_gpt":0.27017651673945725,"score_spread":0.251315883188561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902375054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9664,0.00094969885,0.000012297882,0.003841747,0.00042234294,0.0005040436,0.00002190492,0.00023631097,0.0276116],"genre_scores_gemma":[0.99274266,0.00062761403,0.00014660465,0.0014374488,0.0010738189,0.00009323683,0.000026881951,0.000049522074,0.0038021926],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9986556,0.00003069571,0.00016923324,0.00035865765,0.0003109896,0.00047481537],"domain_scores_gemma":[0.9991333,0.000023036437,0.00009739859,0.00040627408,0.00016229623,0.0001777269],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011170801,0.00021301035,0.0006357567,0.00009866392,0.00018167011,0.00007044271,0.0001329457,0.000120914316,0.00036868508],"category_scores_gemma":[0.0000773876,0.00018235347,0.00012961027,0.00025937654,0.00012442033,0.00008774449,0.00007171263,0.00012308883,0.00013506824],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002837457,0.10284433,0.11992355,0.0012253303,0.013401968,0.0016444941,0.013912416,0.0000044392277,0.11077421,0.01621031,0.4510632,0.16871203],"study_design_scores_gemma":[0.013203535,0.005299476,0.7746589,0.0005691544,0.005892255,0.00007048855,0.0006056088,0.000046728725,0.095460914,0.00089187105,0.10243906,0.0008619789],"about_ca_topic_score_codex":0.00052740384,"about_ca_topic_score_gemma":0.00029114494,"teacher_disagreement_score":0.6547354,"about_ca_system_score_codex":0.00007805354,"about_ca_system_score_gemma":0.00008794389,"threshold_uncertainty_score":0.74361587},"labels":[],"label_agreement":null},{"id":"W2902552969","doi":"10.1182/blood-2018-09-876805","title":"Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor–experienced adult patients with PNH: the 302 study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":378,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Alexion Pharmaceuticals","keywords":"Eculizumab; Medicine; Paroxysmal nocturnal hemoglobinuria; Adverse effect; Hemoglobinuria; Internal medicine; Lactate dehydrogenase; Clinical endpoint; Hemolysis; Gastroenterology; Clinical trial; Immunology; Complement system; Antibody","score_opus":0.006469923226486906,"score_gpt":0.22626029373919967,"score_spread":0.21979037051271277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902552969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99662024,0.00017962868,0.0000053002864,0.0000774172,0.00056063343,0.0014303663,0.000039309863,0.000084816966,0.0010023029],"genre_scores_gemma":[0.9991548,0.0000011595574,0.00001509354,0.0001266942,0.00008888129,0.0002680972,0.000050781724,0.000024390336,0.00027007857],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99813354,0.0003801456,0.00041051515,0.0004773538,0.00012544535,0.0004730113],"domain_scores_gemma":[0.99878174,0.00010310378,0.00015520815,0.0007089368,0.00021969991,0.00003133753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014348482,0.0002597453,0.00030730065,0.0000974774,0.00032116193,0.000033376728,0.00051668636,0.00008909195,0.0007564037],"category_scores_gemma":[0.000115975294,0.00016420812,0.00005892178,0.000278277,0.00031145668,0.000104467865,0.00019814174,0.00017544845,0.0005573812],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011867987,0.005958363,0.9757356,0.000016830398,0.0003296253,0.000019022576,0.010693417,7.170012e-7,0.0022324896,0.00015857478,0.0030634312,0.00060512073],"study_design_scores_gemma":[0.03360634,0.0051995,0.9320049,0.0001439008,0.0002183718,0.000023062523,0.010472531,0.0000014845009,0.013073927,0.000035031346,0.00468733,0.0005335657],"about_ca_topic_score_codex":0.00023837727,"about_ca_topic_score_gemma":0.0007203225,"teacher_disagreement_score":0.043730654,"about_ca_system_score_codex":0.00004134934,"about_ca_system_score_gemma":0.00007552665,"threshold_uncertainty_score":0.82820904},"labels":[],"label_agreement":null},{"id":"W2902600349","doi":"10.1182/blood-2019-127280","title":"Three-Year Follow-up of Keynote-087: Pembrolizumab Monotherapy in Relapsed/Refractory Classic Hodgkin Lymphoma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Pembrolizumab; Refractory (planetary science); Lymphoma; Oncology; Internal medicine; Surgery; Cancer; Immunotherapy","score_opus":0.012815881808589792,"score_gpt":0.24030197541749965,"score_spread":0.22748609360890987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902600349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991816,0.0015893596,0.000004955703,0.00025540576,0.0002760099,0.00071625796,0.000016876958,0.00005539163,0.005269743],"genre_scores_gemma":[0.9982018,0.00029036216,0.00030750813,0.00021078368,0.00009827964,0.000075181626,0.00002349556,0.000054427896,0.0007381868],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836093,0.00004191348,0.000428954,0.00042585237,0.0003819718,0.00036037262],"domain_scores_gemma":[0.9988333,0.00012303404,0.000167215,0.0006830688,0.00006335856,0.00013003836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001297457,0.00026721501,0.0006292282,0.00020622852,0.00002650811,0.000013077847,0.00014201002,0.00020499737,0.00035598184],"category_scores_gemma":[0.000032120355,0.0002185882,0.00024380784,0.00025598193,0.00005282044,0.00006838466,0.00003995267,0.0000974436,0.00031141593],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002024388,0.0056681065,0.9678888,0.00010491238,0.0004257158,0.00015800685,0.00040417767,0.0000029601472,0.0057704607,0.0007591001,0.00067353627,0.016119836],"study_design_scores_gemma":[0.11896384,0.002062392,0.8538804,0.0003081994,0.00025631452,0.00004825422,0.000080956925,0.000050484286,0.020682951,0.00026935415,0.0031472442,0.00024962964],"about_ca_topic_score_codex":0.0004556386,"about_ca_topic_score_gemma":0.00019527636,"teacher_disagreement_score":0.11693945,"about_ca_system_score_codex":0.00018735608,"about_ca_system_score_gemma":0.00027433658,"threshold_uncertainty_score":0.89137685},"labels":[],"label_agreement":null},{"id":"W2902652237","doi":"10.1182/blood-2018-99-113675","title":"Frontline Therapy with Bendamustine and Rituximab (BR) in Follicular Lymphoma: Prognosis Among Patients with Progression of Disease By 24 Months (POD24) Is Poor with Majority Having Transformed Lymphoma","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Bendamustine; Medicine; Follicular lymphoma; Rituximab; Internal medicine; Population; Regimen; Oncology; Lymphoma; Surgery","score_opus":0.00557072672014043,"score_gpt":0.2196003428673482,"score_spread":0.21402961614720778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902652237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947368,0.002060966,0.000015011035,0.00036328664,0.000021697186,0.0024744098,0.00018527677,0.000059595004,0.000082955914],"genre_scores_gemma":[0.99684674,0.00020049115,0.0019516291,0.00013525815,0.000048414488,0.0005281426,0.00019468964,0.00006768775,0.000026953863],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99777466,0.000046834826,0.00039114096,0.00065067835,0.00067842286,0.00045828754],"domain_scores_gemma":[0.9987593,0.000036257443,0.00021391579,0.00035934773,0.0002592629,0.00037186625],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009371929,0.0004507049,0.00069331675,0.00013650706,0.0001291202,0.000035928122,0.00009667085,0.00010811488,0.000023515853],"category_scores_gemma":[0.000013107237,0.0002552664,0.00007102598,0.00035427776,0.0003634749,0.00022417653,0.000026635857,0.000052291703,0.00000132592],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006934587,0.030976037,0.9354989,0.000174676,0.0005010981,0.00014338866,0.0005764753,1.9094252e-7,0.00008854174,0.0000030198246,0.00009734134,0.025005726],"study_design_scores_gemma":[0.12417448,0.007915835,0.8426962,0.0013849358,0.00091040594,0.000015033307,0.00008703334,0.00006676851,0.022242785,0.0000036051574,0.00019732075,0.0003055864],"about_ca_topic_score_codex":0.0006749849,"about_ca_topic_score_gemma":0.00037076348,"teacher_disagreement_score":0.1172399,"about_ca_system_score_codex":0.000104410195,"about_ca_system_score_gemma":0.00022204556,"threshold_uncertainty_score":0.9999899},"labels":[],"label_agreement":null},{"id":"W2902667315","doi":"10.1182/blood-2018-99-113911","title":"Recurrent Genetic HLA Loss in Acute Myeloid Leukemia Relapsed after Matched Unrelated Allogeneic Hematopoietic Cell Transplant","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Transplantation; Medicine; Myeloid leukemia; Hematopoietic stem cell transplantation; Human leukocyte antigen; Immunology; Myeloid; Internal medicine; Leukemia; Oncology; Antigen","score_opus":0.010402470694813539,"score_gpt":0.2548453137556772,"score_spread":0.24444284306086367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902667315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994488,0.0017654097,0.00012244117,0.0005783285,0.00021740762,0.0010510583,0.000043362874,0.00015017712,0.0015837899],"genre_scores_gemma":[0.99390846,0.001190537,0.0021574073,0.00045281497,0.00026350116,0.00019329201,0.000083030856,0.00012153992,0.0016293955],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964578,0.00018441916,0.00077013235,0.0008339378,0.00068083504,0.0010728699],"domain_scores_gemma":[0.99824506,0.000096527634,0.00011637015,0.0009161739,0.00017007487,0.00045577934],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038958335,0.00046665414,0.00071352866,0.00040095806,0.00008308653,0.0000336284,0.00038991,0.0004812917,0.00070269336],"category_scores_gemma":[0.00003571038,0.0004099848,0.00020678471,0.00079652393,0.00033447993,0.00008040586,0.00012353907,0.0009428966,0.0012273175],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009907567,0.004801754,0.36578378,0.0019123731,0.0018756755,0.03214298,0.017800372,0.000021558475,0.55831337,0.00006091184,0.003725836,0.003653824],"study_design_scores_gemma":[0.055239048,0.0041991696,0.40683275,0.0017756243,0.0029078017,0.0055956882,0.0003530461,0.00081337517,0.516378,0.00045235603,0.0036141244,0.0018390148],"about_ca_topic_score_codex":0.000100474106,"about_ca_topic_score_gemma":0.000092135095,"teacher_disagreement_score":0.045331478,"about_ca_system_score_codex":0.0005575964,"about_ca_system_score_gemma":0.0008299305,"threshold_uncertainty_score":0.9998352},"labels":[],"label_agreement":null},{"id":"W2902790828","doi":"10.1182/blood-2018-99-117448","title":"Checkpoint Blockade Therapy May Sensitize Aggressive and Indolent Non-Hodgkin Lymphoma to Subsequent Therapy","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Blockade; Medicine; Lymphoma; Oncology; Internal medicine; Immunology","score_opus":0.019498867215680917,"score_gpt":0.27856004572648846,"score_spread":0.25906117851080757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902790828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916275,0.0027232997,0.000005454735,0.0029776918,0.00017130109,0.001023661,0.000016656424,0.0000751026,0.001379337],"genre_scores_gemma":[0.99277806,0.0025699812,0.0008212378,0.0027287486,0.00064701383,0.00016385083,0.000012381433,0.000045622382,0.00023312135],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983956,0.000049860217,0.0002917549,0.0005106744,0.00032958746,0.0004225104],"domain_scores_gemma":[0.9987911,0.000058668295,0.00013974853,0.00048824452,0.00015457402,0.0003676625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014616875,0.00032297778,0.0004391619,0.00011782834,0.00013062726,0.000048746286,0.00008178736,0.00012228462,0.000101934536],"category_scores_gemma":[0.000030457717,0.00022663029,0.0001296673,0.00017809636,0.00012791295,0.000039260318,0.00006192043,0.000052961324,0.00015731064],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032042162,0.014286935,0.2747428,0.000066748325,0.0029493212,0.0039950893,0.010806599,0.0000010325948,0.24471886,0.00019666975,0.003002121,0.4420296],"study_design_scores_gemma":[0.020460073,0.0028275303,0.39464223,0.00019967768,0.000102807404,0.00057239935,0.000109700435,0.000008093318,0.57425195,0.000037403046,0.006557588,0.00023053218],"about_ca_topic_score_codex":0.00027447718,"about_ca_topic_score_gemma":0.000026057523,"teacher_disagreement_score":0.44179907,"about_ca_system_score_codex":0.000103075305,"about_ca_system_score_gemma":0.00013931667,"threshold_uncertainty_score":0.9241715},"labels":[],"label_agreement":null},{"id":"W2902802838","doi":"10.1182/blood-2018-99-116827","title":"The Double-Hit Gene Expression Signature Defines a Clinically and Biologically Distinct Subgroup within GCB-DLBCL","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Simon Fraser University; Princess Margaret Cancer Centre; University of Toronto; University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"BCL6; Lymphoma; Diffuse large B-cell lymphoma; Population; Oncology; Biology; Gene signature; Gene; Internal medicine; Cancer research; Gene expression; Medicine; Genetics; B cell; Germinal center; Antibody","score_opus":0.022561162751613236,"score_gpt":0.2816231978053977,"score_spread":0.25906203505378445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902802838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938699,0.002434108,0.000016447724,0.0012266577,0.00015716667,0.00038461023,0.000011625795,0.00007239985,0.0018270988],"genre_scores_gemma":[0.9958746,0.00033902403,0.002467555,0.00050913705,0.00046583408,0.00007292173,0.000027068925,0.000015180621,0.0002286813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882174,0.000051713658,0.0003353093,0.00036471637,0.0001824064,0.00024412388],"domain_scores_gemma":[0.99893904,0.00030733994,0.00013050037,0.00035790098,0.00010545729,0.00015975053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028198241,0.00018598045,0.00026828155,0.00002046855,0.00028128288,0.000053333,0.000111391564,0.00018027816,0.000033895827],"category_scores_gemma":[0.00019911834,0.00008569535,0.000088802,0.00009122041,0.0002643231,0.00002954885,0.00011439269,0.000117855896,0.00003894694],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019786623,0.003826767,0.9504859,0.000030147949,0.00031825397,0.00023925494,0.00029267377,9.329626e-8,0.031901002,0.0013024816,0.0018840822,0.0077406806],"study_design_scores_gemma":[0.028717019,0.004477819,0.8746257,0.00027736128,0.00070683897,0.00032889034,0.000080037404,0.000018292083,0.08211072,0.0011772048,0.007147216,0.00033291886],"about_ca_topic_score_codex":0.000028854487,"about_ca_topic_score_gemma":0.000040246694,"teacher_disagreement_score":0.07586022,"about_ca_system_score_codex":0.0000143834495,"about_ca_system_score_gemma":0.00005585514,"threshold_uncertainty_score":0.3494555},"labels":[],"label_agreement":null},{"id":"W2902954276","doi":"10.1182/blood-2018-99-119740","title":"Modeling Targeted Lymphodepletion with Radiolabeled CD45 Antibody As a Promising Preparative Regimen Prior to Adoptive Cell Therapy or CAR-T","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Immune system; Medicine; Adoptive cell transfer; Immunology; Cytokine release syndrome; T cell; Bone marrow; Cancer research; Myeloid; Haematopoiesis; Cell therapy; Tumor microenvironment; Transplantation; Stem cell; Chimeric antigen receptor; Internal medicine; Biology","score_opus":0.029191515712546977,"score_gpt":0.3330513123574293,"score_spread":0.30385979664488233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902954276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879253,0.00037322752,0.0024735027,0.00022915317,0.000050052142,0.0031980115,0.000007742217,0.00017069317,0.0055723162],"genre_scores_gemma":[0.98204255,0.00016331514,0.008771597,0.00036787393,0.00048430514,0.00013119206,0.00004809843,0.00011294954,0.007878146],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99750835,0.00017836857,0.00032471164,0.00071484025,0.0006667142,0.00060699956],"domain_scores_gemma":[0.9982085,0.000065489214,0.000096712036,0.0006254925,0.0006827931,0.00032101694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043672652,0.00033002978,0.0005322722,0.00022803829,0.0002217202,0.00007037791,0.00018799704,0.00014726982,0.00082050863],"category_scores_gemma":[0.00008385455,0.00022989535,0.000087881024,0.0006880798,0.00011674648,0.000143562,0.000058289614,0.00023169706,0.00010372685],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021093931,0.0008888435,0.00072359137,0.00004042161,0.00043840506,0.00011802477,0.010007528,0.00011131646,0.9645647,0.000008979686,0.0000842447,0.0019200204],"study_design_scores_gemma":[0.026870722,0.015411591,0.00039344613,0.00037558342,0.0002408516,0.0003509694,0.0011801233,0.01825072,0.9344029,0.000028651357,0.0019408826,0.00055354956],"about_ca_topic_score_codex":0.00032197125,"about_ca_topic_score_gemma":0.000047844787,"teacher_disagreement_score":0.030161785,"about_ca_system_score_codex":0.00019695549,"about_ca_system_score_gemma":0.00083253987,"threshold_uncertainty_score":0.937486},"labels":[],"label_agreement":null},{"id":"W2902987035","doi":"10.1182/blood-2018-99-116677","title":"Prediction and Characterization of Diffuse Large B-Cell Lymphoma (DLBCL) Cell of Origin (COO) Subtypes Using Genomic Features from Targeted Next-Generation Sequencing","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Diffuse large B-cell lymphoma; Cancer research; Medicine; Biology; Oncology; Lymphoma; Internal medicine","score_opus":0.036568247213582844,"score_gpt":0.232895199376039,"score_spread":0.19632695216245616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902987035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99837434,0.0007549237,0.000097738906,0.000013336122,0.00014414795,0.0002840753,0.00023642482,0.000025269768,0.00006972718],"genre_scores_gemma":[0.99766356,0.0002377896,0.001042541,0.000042456777,0.0003669629,0.0000077846835,0.0005805867,0.0000204693,0.00003787546],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99917454,0.000037510305,0.00027167724,0.00023239914,0.00014486673,0.00013902613],"domain_scores_gemma":[0.9994027,0.000019987,0.00021527353,0.00018607758,0.00011282509,0.00006315675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006535228,0.00013614233,0.00025169112,0.00008860676,0.00007007973,0.000017699387,0.000032603275,0.00010490089,0.000023553499],"category_scores_gemma":[0.000011124233,0.00011773901,0.000047724956,0.000100818295,0.00004125196,0.00012129442,0.0000235596,0.000024881694,0.0000027359815],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057184312,0.0024744202,0.13491733,0.000055674947,0.000071886636,0.0000054891802,0.0005680699,5.981108e-7,0.8614951,0.000010209273,0.000010660131,0.0003333728],"study_design_scores_gemma":[0.010547962,0.00024634262,0.2961334,0.000056107085,0.00040839694,0.000008568041,0.000042359923,0.0015666883,0.69087654,0.0000046023224,0.00004631993,0.00006272444],"about_ca_topic_score_codex":0.000501744,"about_ca_topic_score_gemma":0.000033993656,"teacher_disagreement_score":0.17061856,"about_ca_system_score_codex":0.00009306154,"about_ca_system_score_gemma":0.00012025399,"threshold_uncertainty_score":0.48012576},"labels":[],"label_agreement":null},{"id":"W2902998154","doi":"10.1182/blood-2018-99-112697","title":"Three-Year Follow up of the Phase 3 Pollux Study of Daratumumab Plus Lenalidomide and Dexamethasone (D-Rd) Versus Lenalidomide and Dexamethasone (Rd) Alone in Relapsed or Refractory Multiple Myeloma (RRMM)","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University; University of Calgary","funders":"","keywords":"Lenalidomide; Daratumumab; Medicine; Internal medicine; Dexamethasone; Oncology; Gastroenterology","score_opus":0.06057921579186873,"score_gpt":0.3349619899212702,"score_spread":0.2743827741294015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902998154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953627,0.0014273104,0.000023145096,0.00017813932,0.00022539575,0.0023829087,0.000102862854,0.000036554913,0.0002610057],"genre_scores_gemma":[0.99722487,0.00016178725,0.0019782912,0.00002946276,0.00014785492,0.00009594381,0.00001742383,0.00006986333,0.0002745092],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99643064,0.00040223103,0.00084002834,0.0007488481,0.0009157458,0.00066253514],"domain_scores_gemma":[0.99655265,0.0013028367,0.0003994724,0.0010840757,0.0002887786,0.00037218918],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008907406,0.00044980628,0.0012049429,0.0003810626,0.0002009265,0.000028540357,0.0002972568,0.00022126258,0.000114096],"category_scores_gemma":[0.0029154217,0.00030061387,0.00014991258,0.0007493103,0.0006964325,0.00014818902,0.00033775522,0.00049374707,0.000008857995],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22588456,0.020342326,0.57539463,0.0005924239,0.0044562826,0.0009649606,0.008284309,0.0000031531902,0.13403858,0.000029499892,0.00045469246,0.029554578],"study_design_scores_gemma":[0.5735987,0.017877283,0.31046635,0.0005836079,0.0013135076,0.00012473272,0.0038477632,0.0005795008,0.09090707,0.000051120867,0.00020490083,0.00044546108],"about_ca_topic_score_codex":0.0031032523,"about_ca_topic_score_gemma":0.013590184,"teacher_disagreement_score":0.34771416,"about_ca_system_score_codex":0.0001264746,"about_ca_system_score_gemma":0.00038549086,"threshold_uncertainty_score":0.9999446},"labels":[],"label_agreement":null},{"id":"W2903010260","doi":"10.1182/blood-2018-120738","title":"Rivaroxaban Thromboprophylaxis in High-Risk Ambulatory Cancer Patients Receiving Systemic Therapy: Results of a Randomized Clinical Trial (CASSINI)","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Clinical endpoint; Pulmonary embolism; Ambulatory; Rivaroxaban; Randomized controlled trial; Population; Surgery; Regimen; Placebo; Internal medicine; Intention-to-treat analysis; Asymptomatic; Warfarin; Atrial fibrillation","score_opus":0.02814067883854346,"score_gpt":0.3215850616743574,"score_spread":0.293444382835814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903010260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931482,0.0006948393,0.000008551498,0.0001398109,0.0015301526,0.0034255437,0.00003703898,0.00005272805,0.00096310955],"genre_scores_gemma":[0.99432784,0.0038072777,0.00023888185,0.00024755538,0.0010046605,0.00025524726,0.000019687674,0.000041909367,0.000056945348],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9959212,0.00087685935,0.0018245527,0.00053906813,0.0004941088,0.00034423475],"domain_scores_gemma":[0.9974231,0.0005983126,0.0008945201,0.0006070352,0.0003512065,0.00012583034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033694522,0.00024456467,0.002084624,0.00021131276,0.00006979832,0.00001841561,0.00017992222,0.0002030634,0.00006710823],"category_scores_gemma":[0.0021983986,0.00018120765,0.00038070034,0.00030230108,0.00031491756,0.00006883982,0.00008920231,0.00027139357,0.000021649968],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.67909104,0.024001082,0.24838658,0.0003263173,0.0034226268,0.000030703344,0.0030704497,0.0000045653733,0.00050365395,0.00016753106,0.0035315535,0.037463922],"study_design_scores_gemma":[0.7038048,0.0031335587,0.29055166,0.0006243593,0.0006110767,8.993934e-7,0.000046583315,0.000023757355,0.0008002377,0.000073299656,0.00017375615,0.00015602876],"about_ca_topic_score_codex":0.0030731747,"about_ca_topic_score_gemma":0.00024171486,"teacher_disagreement_score":0.0421651,"about_ca_system_score_codex":0.00006331289,"about_ca_system_score_gemma":0.00016483988,"threshold_uncertainty_score":0.73894334},"labels":[],"label_agreement":null},{"id":"W2903132660","doi":"10.1182/blood-2018-99-113504","title":"Preclinical Activity of Novel MCL1 Inhibitor AZD5991 in Multiple Myeloma","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"MCL1; Cell culture; Apoptosis; Venetoclax; Stromal cell; Annexin A5; IC50; Programmed cell death; Molecular biology; Annexin; Chemistry; Cancer research; Medicine; Biology; Leukemia; Immunology; Biochemistry; Downregulation and upregulation; Genetics","score_opus":0.07668441025883248,"score_gpt":0.3614075094630266,"score_spread":0.2847230992041941,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903132660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969731,0.000056442113,0.00004620168,0.00019590362,0.00007747601,0.0004970654,0.000036408397,0.000030593543,0.0020868203],"genre_scores_gemma":[0.99643636,0.000011541761,0.0028804543,0.00003419208,0.00030579005,0.00003310615,0.00001212714,0.000018274073,0.00026817553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987266,0.000046807723,0.00027145995,0.00029183875,0.00033175322,0.0003315237],"domain_scores_gemma":[0.9989921,0.00025359023,0.00006869608,0.00036176454,0.00012097466,0.00020286595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022540831,0.00012811356,0.00032736693,0.00012697892,0.000036662204,0.0000061424507,0.00008817118,0.000121667916,0.000115178904],"category_scores_gemma":[0.0009888258,0.00010374772,0.000095693336,0.00021137296,0.00020261665,0.00007015856,0.0000863771,0.00019389665,0.00006947427],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012959964,0.010099517,0.797701,0.00008853287,0.00016490689,0.00007706181,0.00014636676,1.5632261e-7,0.17667654,0.000018058481,0.00010063884,0.013631208],"study_design_scores_gemma":[0.017404892,0.001063362,0.68371737,0.000107485306,0.000043548847,0.000021355962,0.000012955886,0.00040814432,0.29689053,0.00000930556,0.00024941727,0.000071619404],"about_ca_topic_score_codex":0.00026406956,"about_ca_topic_score_gemma":0.00033072638,"teacher_disagreement_score":0.12021398,"about_ca_system_score_codex":0.000031458054,"about_ca_system_score_gemma":0.0001395254,"threshold_uncertainty_score":0.4230709},"labels":[],"label_agreement":null},{"id":"W2903157580","doi":"10.1182/blood-2018-99-115024","title":"Primary Mediastinal B-Cell Lymphoma: Evaluation of Clinicopathologic Diagnosis Compared to Gene Expression Based Diagnosis in a Clinical Trial with CD30+ B-Cell Lymphomas","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC","funders":"","keywords":"Medicine; Lymphoma; CD30; Clinical trial; Biopsy; Pathology; Follicular lymphoma; Diffuse large B-cell lymphoma; Large-cell lymphoma; Oncology; Internal medicine","score_opus":0.07992429991209805,"score_gpt":0.3515623862252238,"score_spread":0.27163808631312575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903157580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99323183,0.0009422987,0.000032641998,0.00028182927,0.0003882738,0.003382786,0.00005591049,0.00006902211,0.0016153858],"genre_scores_gemma":[0.98287255,0.0002156832,0.012160663,0.00075121335,0.0006171421,0.003168091,0.00014454842,0.000053474236,0.000016629889],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99466056,0.00082612457,0.0015827604,0.001007526,0.0013920346,0.0005309913],"domain_scores_gemma":[0.9959744,0.0014669994,0.00061027537,0.0008965617,0.000605208,0.00044651495],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002695156,0.00044943573,0.0012584528,0.0003444465,0.00009492212,0.000026674605,0.00025906978,0.00030589054,0.00024238785],"category_scores_gemma":[0.0008501951,0.00033187942,0.00033282075,0.0006206289,0.00025777306,0.00009494801,0.0001347288,0.00011376933,0.0000944383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022797834,0.07344049,0.8871001,0.00011449195,0.00007200572,0.00025891248,0.00023817441,0.000019795561,0.0012076535,0.0000014934279,0.0009772024,0.013771855],"study_design_scores_gemma":[0.34068465,0.010899712,0.4734789,0.0005224811,0.0015094539,0.000022525357,0.000055743603,0.00018713892,0.17216977,0.000011525518,0.00018090804,0.00027718462],"about_ca_topic_score_codex":0.00009924391,"about_ca_topic_score_gemma":0.00006969742,"teacher_disagreement_score":0.4136212,"about_ca_system_score_codex":0.00034809342,"about_ca_system_score_gemma":0.0013249663,"threshold_uncertainty_score":0.99991333},"labels":[],"label_agreement":null},{"id":"W2903245161","doi":"10.1182/blood-2018-163","title":"The Believe Trial: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Luspatercept in Adult Beta-Thalassemia Patients Who Require Regular Red Blood Cell (RBC) Transfusions","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Thalassemia; Ineffective erythropoiesis; Beta thalassemia; Erythropoiesis; Placebo; Clinical endpoint; Internal medicine; Randomization; Anemia; Blood transfusion; Randomized controlled trial; Surgery; Gastroenterology; Pediatrics; Pathology","score_opus":0.013931081137482754,"score_gpt":0.2760082175400377,"score_spread":0.2620771364025549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903245161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98086566,0.00035167887,0.0000053176273,0.00052321894,0.00027643773,0.013827148,0.00004657806,0.00004021097,0.0040637776],"genre_scores_gemma":[0.9975431,0.0007457847,0.000052854644,0.00004136561,0.00011291126,0.00050127436,0.000042408385,0.000055422235,0.00090486853],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9949759,0.00077798567,0.0023689393,0.0005705869,0.0007959933,0.00051058864],"domain_scores_gemma":[0.99674356,0.0005902729,0.0008200641,0.0009561523,0.00069987366,0.00019007646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020302539,0.0004001062,0.002066791,0.00029654853,0.00020768525,0.00001991556,0.00032104217,0.00038838858,0.000033890185],"category_scores_gemma":[0.0007491057,0.00024187188,0.00053261593,0.00065060996,0.0004063505,0.000096109565,0.000069040296,0.00044287572,0.00000523188],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9584843,0.027422933,0.00040613208,0.00009253901,0.0012365013,0.00003078342,0.008592695,0.0000052697633,0.0030640303,0.000015914291,0.00022180645,0.00042709915],"study_design_scores_gemma":[0.967428,0.010928241,0.00007405857,0.0004177927,0.004232784,0.0000051168236,0.0031796452,0.000099381505,0.013311775,0.000023903707,0.00007865637,0.00022060149],"about_ca_topic_score_codex":0.0005663967,"about_ca_topic_score_gemma":0.0005134769,"teacher_disagreement_score":0.016677478,"about_ca_system_score_codex":0.00002312362,"about_ca_system_score_gemma":0.00019352196,"threshold_uncertainty_score":0.9863249},"labels":[],"label_agreement":null},{"id":"W2903424253","doi":"10.1182/blood-2018-99-114842","title":"Long-Term Efficacy and Safety from the Copanlisib CHRONOS-1 Study in Patients with Relapsed or Refractory Indolent B-Cell Lymphoma","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Internal medicine; Adverse effect; Bendamustine; Common Terminology Criteria for Adverse Events; Regimen; Chemotherapy regimen; Gastroenterology; Clinical endpoint; Follicular lymphoma; Rituximab; Oncology; Surgery; Lymphoma; Cancer; Clinical trial","score_opus":0.014822651330837785,"score_gpt":0.27289593111506094,"score_spread":0.2580732797842232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903424253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969472,0.0003257861,0.000002769797,0.00005534346,0.0000827723,0.0020744605,0.000018947865,0.00004011635,0.00045259634],"genre_scores_gemma":[0.9990465,0.00005271452,0.00005828018,0.00016833191,0.00027381745,0.00003907203,0.000047777175,0.00004874022,0.0002647661],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977742,0.00017829628,0.0003758328,0.00053825986,0.0007000571,0.0004333759],"domain_scores_gemma":[0.9982033,0.0004893762,0.00011080068,0.0008697524,0.00013677556,0.00019003321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003157763,0.00024325607,0.00038310513,0.000082544866,0.00013126503,0.00004024893,0.00025344794,0.00011115185,0.00017063208],"category_scores_gemma":[0.00019504216,0.00013447386,0.000029792654,0.0002954521,0.00031137306,0.00008572076,0.00022771196,0.0002313102,0.00008025232],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012728877,0.017965209,0.9543579,0.00006323636,0.0002590268,0.00040061455,0.003932341,2.8976322e-7,0.00007973956,8.464964e-7,0.00021513239,0.009996744],"study_design_scores_gemma":[0.25531772,0.0047230264,0.73855925,0.00022976242,0.00017837071,0.000013137453,0.00018917043,0.000015211439,0.0005007468,6.2099093e-7,0.00013905959,0.00013390701],"about_ca_topic_score_codex":0.000859659,"about_ca_topic_score_gemma":0.0009501614,"teacher_disagreement_score":0.24258883,"about_ca_system_score_codex":0.0021258306,"about_ca_system_score_gemma":0.002689121,"threshold_uncertainty_score":0.55589736},"labels":[],"label_agreement":null},{"id":"W2903617726","doi":"10.1182/blood.v130.suppl_1.1836.1836","title":"Minimal Residual Disease (MRD) Assessed By Flow Cytometry in Patients with AL Amyloidosis Treated with Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD)","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Medicine; Bortezomib; Minimal residual disease; Cyclophosphamide; AL amyloidosis; Internal medicine; Dexamethasone; Multiple myeloma; Surgery; Gastroenterology; Progressive disease; Chemotherapy; Leukemia; Immunology","score_opus":0.004875786268968509,"score_gpt":0.22903060452203297,"score_spread":0.22415481825306446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903617726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977949,0.00079122384,0.000023059145,0.000228938,0.000026804464,0.00053865986,0.00042420832,0.000028903329,0.00014330601],"genre_scores_gemma":[0.996903,0.00025025674,0.0015149392,0.00026207094,0.00004106572,0.00017646971,0.00061499927,0.00007912148,0.00015810116],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998014,0.00011094914,0.00027948708,0.00077688927,0.00031724467,0.00050144625],"domain_scores_gemma":[0.99831605,0.000055720608,0.00026719572,0.00093400327,0.00010357901,0.00032345633],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013452956,0.0004530363,0.00042068795,0.000098786244,0.00030390377,0.00014713815,0.00033254485,0.00017482133,0.000014484421],"category_scores_gemma":[0.0002281902,0.00035621494,0.00006284924,0.00013610833,0.00027203053,0.000033916476,0.00017619434,0.0001702524,0.000003893998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014070446,0.0023045233,0.9894384,0.00002540502,0.0004267973,0.000058736645,0.000021095078,0.0000034159505,0.004645431,0.0000011330537,0.00067958626,0.0009884018],"study_design_scores_gemma":[0.014195921,0.0014313586,0.93193245,0.000062401494,0.0003717197,0.0000031291936,0.000035329635,0.0000044869184,0.051246453,0.000002188981,0.00026189873,0.00045267394],"about_ca_topic_score_codex":0.00029282828,"about_ca_topic_score_gemma":0.00020440966,"teacher_disagreement_score":0.05750599,"about_ca_system_score_codex":0.000030375448,"about_ca_system_score_gemma":0.00010868673,"threshold_uncertainty_score":0.99988896},"labels":[],"label_agreement":null},{"id":"W2903769801","doi":"10.1182/blood-2018-99-113818","title":"Realizing Effectiveness across Continents with Hydroxyurea (REACH): A Prospective Multi-National Trial of Hydroxyurea for Sickle Cell Anemia in Sub-Saharan Africa","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Medicine; Anemia; Malaria; Clinical trial; Sickle cell anemia; Pediatrics; Prospective cohort study; Disease; Internal medicine; Immunology","score_opus":0.015334502319671137,"score_gpt":0.280819502946299,"score_spread":0.26548500062662783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903769801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918103,0.00042460999,0.00029148726,0.000057240937,0.00010466508,0.0031823353,0.000094579606,0.00005252382,0.003982208],"genre_scores_gemma":[0.9986507,0.000055456527,0.0005623808,0.000024659184,0.0001735464,0.00028682617,0.00006740264,0.00004511598,0.00013386995],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99829113,0.000073866046,0.00039508284,0.0004172996,0.00038440173,0.00043818724],"domain_scores_gemma":[0.9989162,0.00017444936,0.00019906282,0.00021269881,0.00038858212,0.000108997316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006298608,0.00023970296,0.0005331859,0.000117028554,0.00010756949,0.000014110107,0.00010682533,0.00023302747,0.0000065001987],"category_scores_gemma":[0.0002243724,0.00018602987,0.00012663293,0.00037934326,0.00023207103,0.00008528264,0.00003478637,0.00022303016,0.0000075728635],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26475754,0.03912057,0.17520338,0.0034829655,0.0015390167,0.00023825283,0.01312279,0.00020683704,0.49846268,0.0003025341,0.0016501849,0.0019132238],"study_design_scores_gemma":[0.5973712,0.009489005,0.06207744,0.0011718718,0.0005717999,0.000051859195,0.00056996656,0.0009381895,0.32552296,0.00020655566,0.0014258401,0.0006032585],"about_ca_topic_score_codex":0.00017407912,"about_ca_topic_score_gemma":0.00010507887,"teacher_disagreement_score":0.33261368,"about_ca_system_score_codex":0.00008034757,"about_ca_system_score_gemma":0.00020379659,"threshold_uncertainty_score":0.75860775},"labels":[],"label_agreement":null},{"id":"W2903856391","doi":"10.1182/blood-2018-07-862151","title":"CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1− mantle cell lymphoma","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"European Regional Development Fund; Barcelona Supercomputing Center; Instituto de Salud Carlos III; Ministerio de Economía y Competitividad; Generalitat de Catalunya; Centres de Recerca de Catalunya","keywords":"Cyclin D1; Mantle cell lymphoma; Cyclin D2; Cancer research; Fluorescence in situ hybridization; Biology; Cyclin D; Molecular biology; Genetics; Cell cycle; Lymphoma; Gene; Immunology","score_opus":0.0064014389525026616,"score_gpt":0.2319694801515984,"score_spread":0.22556804119909574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903856391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9762054,0.0039385324,0.0000038081455,0.0006414686,0.00020496383,0.0003687904,0.000009192678,0.000050231785,0.018577587],"genre_scores_gemma":[0.99662304,0.00075938803,0.000614513,0.00042716248,0.00025593495,0.000058796057,0.00001500397,0.000028094033,0.0012180392],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987288,0.00003582726,0.00029853254,0.00039357232,0.00018925448,0.0003540065],"domain_scores_gemma":[0.99931014,0.000055816723,0.00007463797,0.00036420056,0.000044528373,0.00015069555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013257707,0.00021667672,0.0003466243,0.0001091615,0.00006931858,0.000026803253,0.00007945698,0.0001284321,0.00015847907],"category_scores_gemma":[0.000026738866,0.00017768137,0.000075569085,0.00017603117,0.00008619208,0.00005309376,0.00006805985,0.000051619285,0.00040328444],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00129767,0.03239903,0.74548674,0.00057231257,0.0008692318,0.0029588495,0.005269499,7.38187e-7,0.115680456,0.00053951325,0.011780624,0.083145365],"study_design_scores_gemma":[0.03279179,0.0013660385,0.4132707,0.00027929601,0.00031403484,0.00016444399,0.00027291474,0.000035297115,0.53586215,0.00014819563,0.015174675,0.00032045678],"about_ca_topic_score_codex":0.00040206307,"about_ca_topic_score_gemma":0.00008991082,"teacher_disagreement_score":0.4201817,"about_ca_system_score_codex":0.000119248965,"about_ca_system_score_gemma":0.00010367599,"threshold_uncertainty_score":0.7245636},"labels":[],"label_agreement":null},{"id":"W2903962322","doi":"10.1182/blood-2018-99-112988","title":"A Global, Randomized, Placebo-Controlled, Phase 3 Study of Ibrutinib Plus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (RCHOP) in Patients with Previously Untreated Non-Germinal Center B-Cell-like (GCB) Diffuse Large B-Cell Lymphoma (DLBCL)","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Ibrutinib; Vincristine; Rituximab; Medicine; Prednisone; Cyclophosphamide; Internal medicine; Phases of clinical research; Nuclear medicine; Oncology; Surgery; Chemotherapy; Lymphoma; Leukemia; Chronic lymphocytic leukemia","score_opus":0.004923132404732803,"score_gpt":0.2569880009048837,"score_spread":0.2520648685001509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903962322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854748,0.00092164986,0.00005115434,0.000021341206,0.0001235762,0.0113565745,0.00017368302,0.00008944139,0.0017877842],"genre_scores_gemma":[0.9979074,0.0001404834,0.00033982203,0.00012249761,0.00014038784,0.0005226126,0.00012520133,0.00010274706,0.0005988542],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9939597,0.0005287137,0.0015587532,0.0011835308,0.0014136318,0.0013556525],"domain_scores_gemma":[0.9964643,0.00053519075,0.00061646185,0.0011309742,0.00065463496,0.0005984116],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012034767,0.0007866178,0.0029386734,0.00036059535,0.00017862034,0.0000754266,0.00040068963,0.00027435969,0.0000820483],"category_scores_gemma":[0.0004465661,0.0005722133,0.0002360823,0.00088227243,0.0006135305,0.00018459387,0.0003856712,0.0002658332,0.000041020423],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.70444685,0.22661592,0.06333394,0.00063276885,0.000854434,0.00078084006,0.0022762255,0.000001689948,0.000060238148,0.000002962209,0.00044528008,0.0005488518],"study_design_scores_gemma":[0.9786305,0.008097155,0.0053878417,0.0005257337,0.0018516115,0.00013289592,0.00048388357,0.003582907,0.0007198177,0.000004623471,0.00009045474,0.0004925839],"about_ca_topic_score_codex":0.0029798967,"about_ca_topic_score_gemma":0.00062044035,"teacher_disagreement_score":0.27418366,"about_ca_system_score_codex":0.0024409438,"about_ca_system_score_gemma":0.0028836213,"threshold_uncertainty_score":0.99967295},"labels":[],"label_agreement":null},{"id":"W2904063612","doi":"10.1182/blood-2018-99-117464","title":"Glycemic Control in Patients Treated with Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: A Systematic Review","year":2018,"lang":"en","type":"review","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster Children's Hospital; Juravinski Cancer Centre; Impact; McMaster University; Hamilton Health Sciences","funders":"","keywords":"Medicine; Nilotinib; Dasatinib; Bosutinib; Ponatinib; Population; Internal medicine; Randomized controlled trial; Glycemic; Oncology; Myeloid leukemia; Imatinib; Insulin","score_opus":0.014493104895645306,"score_gpt":0.2698555046363557,"score_spread":0.2553623997407104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904063612","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00056166045,0.97054285,0.0000045388297,0.000016546155,0.00011475424,0.028217198,0.00030604517,0.00013661268,0.0000998234],"genre_scores_gemma":[0.0005262519,0.98878527,0.00008975818,0.00018753752,0.0004254138,0.007406792,0.0018393134,0.00029947227,0.00044022003],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9946714,0.0002946651,0.0022759766,0.0011838668,0.00064797106,0.00092610816],"domain_scores_gemma":[0.99596006,0.00035965236,0.0014555685,0.0015570433,0.0003424177,0.00032526988],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043306482,0.0012703302,0.007818745,0.00044494416,0.00008425526,0.000032398828,0.0003619867,0.00065535214,0.000045530596],"category_scores_gemma":[0.0005254537,0.0008452781,0.000938944,0.0009198461,0.00013686522,0.00009765778,0.00006610247,0.0005951909,0.000220421],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024591776,0.0009293159,0.00013279144,0.98807627,0.0019419477,0.00014295502,0.000011397126,6.143106e-8,5.0672395e-7,0.0000024291,0.0006823563,0.007834057],"study_design_scores_gemma":[0.04308783,0.004606506,0.0000130955605,0.86626375,0.050721027,0.00026994277,0.0000016877945,0.0000057531806,0.0000079199135,6.640679e-7,0.034353543,0.0006682719],"about_ca_topic_score_codex":0.00007168125,"about_ca_topic_score_gemma":0.000046937803,"teacher_disagreement_score":0.12181251,"about_ca_system_score_codex":0.007982725,"about_ca_system_score_gemma":0.0039635273,"threshold_uncertainty_score":0.9993998},"labels":[],"label_agreement":null},{"id":"W2904119070","doi":"10.1182/blood-2018-99-112125","title":"Integrated Efficacy Results from the Phase II and Phase III Studies with Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Internal medicine; Gastroenterology; Population; Platelet; Immunosuppression; Clinical endpoint; Thrombotic thrombocytopenic purpura; Thrombotic microangiopathy; Von Willebrand factor; Exacerbation; Surgery; Immunology; Clinical trial; Disease","score_opus":0.027377338701024448,"score_gpt":0.28909595435009267,"score_spread":0.26171861564906823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904119070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958886,0.0017862092,0.000004804977,0.00016465274,0.00017552619,0.0012280997,0.00058313174,0.000073817646,0.00009518794],"genre_scores_gemma":[0.99895185,0.000023073557,0.000047861246,0.00008318269,0.00004000002,0.00005679163,0.000681017,0.000023784713,0.000092425376],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998223,0.0002809743,0.0004702324,0.0005470983,0.000087631895,0.00039103546],"domain_scores_gemma":[0.99852496,0.0004089469,0.00023498443,0.0006029418,0.00019546266,0.000032695418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017745481,0.0003167873,0.000550387,0.000070417365,0.00045142564,0.000032028423,0.00031556483,0.00008353999,0.00017206014],"category_scores_gemma":[0.00017653553,0.00017195444,0.00003342131,0.00026161407,0.0008104196,0.00013882872,0.00021231998,0.00013725997,0.000049302158],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23115247,0.14718293,0.26032043,0.00021310245,0.040054876,0.00031517778,0.12959015,0.000010994828,0.10647983,0.00068194,0.045538954,0.03845913],"study_design_scores_gemma":[0.6561386,0.020731324,0.28542662,0.001200029,0.0019589495,0.00003611466,0.0076326705,0.0000065546456,0.023337523,0.00008358869,0.00248104,0.0009669916],"about_ca_topic_score_codex":0.0003451409,"about_ca_topic_score_gemma":0.00097552635,"teacher_disagreement_score":0.42498612,"about_ca_system_score_codex":0.00004123331,"about_ca_system_score_gemma":0.000091202826,"threshold_uncertainty_score":0.7012099},"labels":[],"label_agreement":null},{"id":"W2904192212","doi":"10.1182/blood-2018-99-115252","title":"Sustained Disease Control for Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: An Updated Analysis of Juliet, a Global Pivotal Phase 2 Trial of Tisagenlecleucel","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Hospital; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Diffuse large B-cell lymphoma; Medicine; Refractory (planetary science); Lymphoma; Oncology; Phases of clinical research; Clinical trial; Internal medicine; Disease; Biology","score_opus":0.010535377818389088,"score_gpt":0.30110402064912417,"score_spread":0.2905686428307351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904192212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937567,0.00003626727,0.00040914153,0.000041160052,0.00006289211,0.0026279078,0.0027286084,0.00004761117,0.00028971935],"genre_scores_gemma":[0.9970337,0.000007038049,0.00021161046,0.00014951389,0.00018362244,0.00009411026,0.0014198341,0.00004744846,0.00085309404],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9974159,0.00017807743,0.00061811565,0.00048675155,0.0007817946,0.00051937706],"domain_scores_gemma":[0.99643606,0.00011909005,0.0003628263,0.0008318983,0.0017414874,0.0005086348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030793052,0.0002666963,0.00089650106,0.0002836883,0.00008173487,0.000016432652,0.00021450827,0.00013278911,0.00062007573],"category_scores_gemma":[0.00043570367,0.0001936304,0.0003455377,0.0011292784,0.00022835616,0.000115140516,0.000050054427,0.00008158444,0.0000030850492],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8097761,0.15327662,0.018254446,0.00016606222,0.004489796,0.000077118515,0.0002690115,5.3643527e-7,0.010938403,0.000030716375,0.0005371974,0.0021839358],"study_design_scores_gemma":[0.94112563,0.030092595,0.011542578,0.000032331245,0.01054061,0.0000011957133,0.00015687298,0.001925835,0.0038729492,0.000012584134,0.00045483056,0.00024195806],"about_ca_topic_score_codex":0.000074142095,"about_ca_topic_score_gemma":0.0001548632,"teacher_disagreement_score":0.1313495,"about_ca_system_score_codex":0.000114993665,"about_ca_system_score_gemma":0.00064505375,"threshold_uncertainty_score":0.78960186},"labels":[],"label_agreement":null},{"id":"W2904280057","doi":"10.1182/blood-2018-99-116563","title":"Updated 18-Month Results from Dasfree: A Study Evaluating Dasatinib Discontinuation in Patients (Pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) and Deep Molecular Response (DMR)","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Dasatinib; Discontinuation; Medicine; Internal medicine; Clinical endpoint; Imatinib; Imatinib mesylate; Myeloid leukemia; Oncology; Randomized controlled trial","score_opus":0.019105447816516262,"score_gpt":0.3126539785206752,"score_spread":0.293548530704159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904280057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99505913,0.0006705516,0.00002545031,0.000071715986,0.0000686622,0.0036435442,0.000107632135,0.000090601665,0.0002627196],"genre_scores_gemma":[0.99741274,0.000022531014,0.00088316563,0.000057473913,0.00018855852,0.00024213389,0.000998808,0.000096111675,0.00009845053],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952744,0.0007372284,0.0010888889,0.0012646711,0.0009024789,0.0007322824],"domain_scores_gemma":[0.9977157,0.00027893897,0.00043970335,0.0011206628,0.00021517914,0.00022979788],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013035594,0.0005403096,0.00076525984,0.0004162339,0.00012500476,0.000064871805,0.0002246192,0.00020228155,0.00013314236],"category_scores_gemma":[0.000941999,0.00046999,0.000057638114,0.0008153724,0.00020034703,0.0002876258,0.00017883768,0.00048663074,0.00003808488],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.123478025,0.024390059,0.5606612,0.00017957854,0.0023408504,0.002921414,0.02803684,0.00083509437,0.14905371,0.0000092259625,0.00019548326,0.10789855],"study_design_scores_gemma":[0.31014183,0.029905697,0.63697803,0.0008503837,0.0007600821,0.000016233269,0.0005196823,0.011102704,0.00912572,0.000017581247,0.000055536315,0.000526488],"about_ca_topic_score_codex":0.0033281466,"about_ca_topic_score_gemma":0.011621829,"teacher_disagreement_score":0.18666382,"about_ca_system_score_codex":0.00649577,"about_ca_system_score_gemma":0.0027135527,"threshold_uncertainty_score":0.9997752},"labels":[],"label_agreement":null},{"id":"W2904401218","doi":"10.1182/blood-2018-99-110976","title":"Multicenter, Open-Label, 3-Arm Study of Gilteritinib, Gilteritinib Plus Azacitidine, or Azacitidine Alone in Newly Diagnosed FLT3 Mutated (FLT3mut+) Acute Myeloid Leukemia (AML) Patients Ineligible for Intensive Induction Chemotherapy: Findings from the Safety Cohort","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Tolerability; Medicine; Internal medicine; Surgery; Gastroenterology; Adverse effect","score_opus":0.028286793621804054,"score_gpt":0.2888090432221396,"score_spread":0.2605222496003356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904401218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937155,0.00020916351,0.00006007814,0.00021709876,0.000778409,0.004239512,0.0006664121,0.00006168511,0.000052092215],"genre_scores_gemma":[0.99610144,0.00029122614,0.0002447994,0.00047444765,0.00011589821,0.00047065952,0.0020274569,0.00006953127,0.0002045489],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970732,0.00032494246,0.0011711011,0.0007394385,0.00012240355,0.0005689241],"domain_scores_gemma":[0.99773043,0.00035631828,0.00051622384,0.0005981706,0.0007565395,0.000042285872],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041674403,0.00045016172,0.00097254815,0.00018183196,0.00037016865,0.000071798735,0.0007254541,0.0003351139,0.00022277606],"category_scores_gemma":[0.0003764178,0.0003424422,0.00009022093,0.0004813554,0.00032536892,0.0004441293,0.0003496836,0.00033321354,0.000029342027],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017107077,0.008420218,0.08518273,0.000039536673,0.0025285792,0.00001666197,0.008090446,0.0000068683134,0.8707572,0.000016271513,0.0023135068,0.0055208863],"study_design_scores_gemma":[0.12810478,0.00534062,0.37166837,0.00033572587,0.00056886906,0.000027392987,0.0034780998,0.000089164845,0.48818782,0.000031325755,0.0016300908,0.0005377492],"about_ca_topic_score_codex":0.0025554455,"about_ca_topic_score_gemma":0.00084952416,"teacher_disagreement_score":0.3825694,"about_ca_system_score_codex":0.0002022185,"about_ca_system_score_gemma":0.00016281883,"threshold_uncertainty_score":0.9999028},"labels":[],"label_agreement":null},{"id":"W2904662447","doi":"10.1182/blood-2018-05-850404","title":"Transferrin receptor 1 controls systemic iron homeostasis by fine-tuning hepcidin expression to hepatocellular iron load","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"HAMP; Hepcidin; Transferrin receptor; Transferrin; Biology; Endocrinology; Hepatocyte; Hereditary hemochromatosis; Internal medicine; Anemia; Hemochromatosis; Medicine; Biochemistry; In vitro","score_opus":0.01121295555342397,"score_gpt":0.23652568301865914,"score_spread":0.22531272746523517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904662447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870417,0.0076294052,0.0013267825,0.00057067105,0.00031334255,0.001024588,0.00008139507,0.00015685955,0.0018552225],"genre_scores_gemma":[0.9964158,0.00019598145,0.0008509442,0.0005383918,0.000457552,0.00009328292,0.00008039147,0.00006380146,0.0013038409],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979169,0.000114216775,0.00042408652,0.00051007693,0.00051514927,0.000519577],"domain_scores_gemma":[0.9988639,0.000045772344,0.00007230172,0.00052115927,0.00012144592,0.00037547355],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032674355,0.00030371084,0.0005456699,0.000116584946,0.00014861791,0.000032393003,0.00018279246,0.00019447342,0.0006031223],"category_scores_gemma":[0.00014373625,0.00026232807,0.00013167433,0.00022198918,0.000075057455,0.00010102745,0.00004071265,0.00018497699,0.00051528006],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045780992,0.00043369367,0.0052730152,0.00028355312,0.000018081946,0.000017431343,0.0010716027,0.0000010773638,0.9765702,0.000033681743,0.012232093,0.0036077914],"study_design_scores_gemma":[0.015432666,0.0012207148,0.0007251912,0.0007794645,0.0005443064,0.000059960355,0.0008802943,0.00003626691,0.94349456,0.0000126482655,0.036230367,0.00058357976],"about_ca_topic_score_codex":0.00015082254,"about_ca_topic_score_gemma":0.000015249359,"teacher_disagreement_score":0.033075627,"about_ca_system_score_codex":0.000050073882,"about_ca_system_score_gemma":0.000099034056,"threshold_uncertainty_score":0.9999829},"labels":[],"label_agreement":null},{"id":"W2904677338","doi":"10.1182/blood-2018-99-115362","title":"PRM-151 in Myelofibrosis: Efficacy and Safety in an Open Label Extension Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Myelofibrosis; Ruxolitinib; Internal medicine; Essential thrombocythemia; Bone marrow; Fibrosis; Surgery; Gastroenterology; Polycythemia vera","score_opus":0.05360718723972167,"score_gpt":0.35552935264706864,"score_spread":0.30192216540734695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904677338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99619466,0.00029743378,8.189846e-7,0.00040586345,0.00003650258,0.0021339874,0.0000051910515,0.000020455813,0.00090506946],"genre_scores_gemma":[0.9984838,0.00008341643,0.000815254,0.00026039884,0.00008193656,0.00016245767,0.000014142245,0.000019813842,0.00007878326],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873513,0.0001212251,0.00029370488,0.0004664454,0.00016395062,0.00021954067],"domain_scores_gemma":[0.99933416,0.00007756477,0.000046621048,0.00034242653,0.00007030904,0.00012891329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032888143,0.00016515118,0.00038872092,0.00011644649,0.00007246208,0.000045885663,0.0000990924,0.00006262036,0.000058157082],"category_scores_gemma":[0.000084651576,0.00012563216,0.000009842526,0.00022951876,0.00004944212,0.0001416726,0.00015276838,0.000110253684,0.000028413904],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093210477,0.021210432,0.9652229,0.000017751603,0.000058305308,0.00019652763,0.0023795585,2.7396567e-7,0.002159822,0.00007920169,0.0000613812,0.0076817665],"study_design_scores_gemma":[0.035924356,0.007873405,0.9526094,0.00030384,0.00010059826,0.000021928332,0.00032943016,0.000026718284,0.0025159551,0.000032777985,0.00013874518,0.00012283784],"about_ca_topic_score_codex":0.00029357235,"about_ca_topic_score_gemma":0.0022409726,"teacher_disagreement_score":0.03499225,"about_ca_system_score_codex":0.000036520472,"about_ca_system_score_gemma":0.00005999239,"threshold_uncertainty_score":0.51231307},"labels":[],"label_agreement":null},{"id":"W2904680572","doi":"10.1182/blood-2018-06-820746","title":"Treatment of bleeding complications in patients on anticoagulant therapy","year":2018,"lang":"en","type":"review","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Medicine; Fondaparinux; Anticoagulant; Hemostasis; Prothrombin complex concentrate; Rivaroxaban; Intensive care medicine; Warfarin; Anticoagulant therapy; Antifibrinolytic; Discovery and development of direct thrombin inhibitors; Vitamin k; Surgery; Heparin; Thrombin; Thrombosis; Tranexamic acid; Venous thromboembolism; Internal medicine; Atrial fibrillation; Blood loss","score_opus":0.209444874975656,"score_gpt":0.410710122256477,"score_spread":0.201265247280821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904680572","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0065599247,0.9885138,0.0000014007127,0.000061802115,0.00012069083,0.0019197677,0.000019460385,0.000024508161,0.002778638],"genre_scores_gemma":[0.0015109613,0.9976403,0.000092542716,0.000010096755,0.00026645907,0.0000113374945,0.00018789773,0.00002005356,0.00026034238],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99915594,0.00002921891,0.00039680646,0.00017914767,0.00013797639,0.00010088367],"domain_scores_gemma":[0.9993816,0.00007687967,0.00021391816,0.00026233328,0.000035249275,0.000030010833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003849567,0.00016886207,0.0009153928,0.0002285819,0.00002039627,0.0000049763585,0.000049952345,0.000078379264,0.000024576955],"category_scores_gemma":[0.000015549676,0.00010954917,0.00026874445,0.00018865873,0.000020415087,0.000012414917,0.000011413822,0.000031646538,0.00005437621],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004271884,0.000933196,0.15003979,0.0024054965,0.00076410855,0.0000034919487,0.00007622597,1.1857637e-7,6.8206714e-7,0.0004513058,0.000093599185,0.8451893],"study_design_scores_gemma":[0.0044452758,0.0012886894,0.041524656,0.00321765,0.00097053376,0.0000012609179,0.0000028697473,9.879684e-7,0.000009011836,0.000007386146,0.94841653,0.0001151568],"about_ca_topic_score_codex":0.000008952275,"about_ca_topic_score_gemma":6.1473514e-7,"teacher_disagreement_score":0.9483229,"about_ca_system_score_codex":0.000044126835,"about_ca_system_score_gemma":0.000033570108,"threshold_uncertainty_score":0.44672853},"labels":[],"label_agreement":null},{"id":"W2904696422","doi":"10.1182/blood-2018-99-111390","title":"Comprehensive Single-Cell RNA-Sequencing Mapping of Primary Acute Myeloid Leukemias and Profiling of NPM1-Mutated Cells","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"NPM1; Biology; Myeloid leukemia; Computational biology; RNA; Transcriptome; Massive parallel sequencing; Single-cell analysis; Leukemia; Stem cell; Haematopoiesis; Deep sequencing; Myeloid; DNA sequencing; Genetics; Cancer research; Gene; Cell; Karyotype; Genome; Gene expression; Chromosome","score_opus":0.037113768101205404,"score_gpt":0.26270053718529013,"score_spread":0.22558676908408473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904696422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98824394,0.00067086326,0.00030225396,0.00006839859,0.00007710168,0.0007405732,0.000032366082,0.000065809676,0.009798671],"genre_scores_gemma":[0.9683185,0.00018300329,0.030590342,0.00020303507,0.00018734613,0.00001076959,0.000041194195,0.000059078793,0.00040669343],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978297,0.00009080652,0.00063890766,0.00044094888,0.00050993136,0.0004897021],"domain_scores_gemma":[0.99804753,0.00022576435,0.00031900604,0.00047399531,0.0007333335,0.00020036312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029123758,0.00025736025,0.0007432015,0.00032785526,0.00008417013,0.000014970025,0.00019533804,0.00019030215,0.0000357544],"category_scores_gemma":[0.000077875,0.00023665621,0.00010542384,0.0005205358,0.0005727264,0.00011507614,0.00026109905,0.0003964683,0.000019033498],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021559028,0.00023360517,0.0014890025,0.0012039123,0.0003182017,0.00014672289,0.0012918641,0.0000031676198,0.9938942,0.000011525782,0.00013911694,0.0010530654],"study_design_scores_gemma":[0.0059563764,0.0009748522,0.0014071501,0.00042257895,0.000339509,0.00020802571,0.0008656859,0.00039765128,0.98899615,0.000028507528,0.00020935599,0.00019416782],"about_ca_topic_score_codex":0.00011809132,"about_ca_topic_score_gemma":0.0000016641168,"teacher_disagreement_score":0.030288087,"about_ca_system_score_codex":0.00032047968,"about_ca_system_score_gemma":0.000866064,"threshold_uncertainty_score":0.96505606},"labels":[],"label_agreement":null},{"id":"W2904699949","doi":"10.1182/blood-2018-99-113368","title":"Prognostic Significance of MYC Single, Double, Triple Hit and MYC-Translocation Partner Status in Diffuse Large B-Cell Lymphoma - a Study By the Lunenburg Lymphoma Biomarker Consortium (LLBC)","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"BCL6; Diffuse large B-cell lymphoma; Lymphoma; Tissue microarray; Cancer research; Medicine; Chromosomal translocation; Oncology; Context (archaeology); Internal medicine; Biology; B cell; Cancer; Immunology; Antibody; Gene; Germinal center; Genetics","score_opus":0.02082289218833942,"score_gpt":0.2655952379511926,"score_spread":0.2447723457628532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904699949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922998,0.0034007395,0.000014691528,0.00030833186,0.00010214542,0.002768374,0.000087941604,0.00004971963,0.0009682545],"genre_scores_gemma":[0.99842554,0.00020455659,0.00007088006,0.00015148205,0.000067841196,0.00058963406,0.00006193591,0.000040124512,0.00038799067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997724,0.00015180979,0.0006142264,0.00054522656,0.00041303,0.0005517124],"domain_scores_gemma":[0.99862105,0.00025434454,0.000230448,0.0005410279,0.00016199239,0.0001911532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003444737,0.00031753248,0.0005214333,0.00012982782,0.000130387,0.000048034333,0.00012312854,0.000114094,0.000036703488],"category_scores_gemma":[0.00006527743,0.0002175756,0.000086148306,0.0004898231,0.00026613692,0.00009802811,0.00005236817,0.000041900443,0.000015414795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001266163,0.14447668,0.82482874,0.00013530596,0.00047177126,0.00012289721,0.0032850564,8.4261146e-8,0.014231493,0.00004602011,0.0016083891,0.009527376],"study_design_scores_gemma":[0.16739036,0.0023869516,0.7528014,0.00015922106,0.0010270519,0.00004441261,0.001179989,0.00007319191,0.07115429,0.000020381987,0.0034698837,0.0002928571],"about_ca_topic_score_codex":0.00086495024,"about_ca_topic_score_gemma":0.00041170977,"teacher_disagreement_score":0.1661242,"about_ca_system_score_codex":0.00011718355,"about_ca_system_score_gemma":0.00023630612,"threshold_uncertainty_score":0.8872475},"labels":[],"label_agreement":null},{"id":"W2904768589","doi":"10.1182/blood-2018-99-113467","title":"Updated Results from the Phase 2 Centaurus Study of Daratumumab (DARA) Monotherapy in Patients with Intermediate-Risk or High-Risk Smoldering Multiple Myeloma (SMM)","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Daratumumab; Internal medicine; Multiple myeloma; Lenalidomide; Oncology; AL amyloidosis; Phases of clinical research; Monoclonal gammopathy of undetermined significance; Clinical trial; Gastroenterology; Monoclonal; Immunology; Antibody; Monoclonal antibody","score_opus":0.01780307888727778,"score_gpt":0.2831513490794173,"score_spread":0.2653482701921395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904768589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962958,0.000052112366,0.000011669098,0.000032469223,0.000110826346,0.0022756981,0.0011258493,0.000054773955,0.000040820596],"genre_scores_gemma":[0.99858767,0.000057999463,0.0004498667,0.00003540674,0.00014390434,0.000077366094,0.0005564654,0.000054266908,0.00003703098],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973911,0.0002965512,0.00059574115,0.0005787787,0.00065900123,0.00047884532],"domain_scores_gemma":[0.9979774,0.0003352814,0.00034590345,0.0009288731,0.00021567565,0.00019688431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024074194,0.0003131482,0.00051389704,0.00016175296,0.00018579315,0.00003298047,0.00028597124,0.00008840749,0.00010214355],"category_scores_gemma":[0.00042373204,0.00017185506,0.000056447785,0.00045729816,0.00018237215,0.00011476057,0.000107345426,0.00037065765,0.000028132818],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045193344,0.01605729,0.91123194,0.0000067890546,0.0010717566,0.00016950793,0.003710566,0.0000033452145,0.00019084978,1.8112256e-7,0.000118461074,0.022245977],"study_design_scores_gemma":[0.20285504,0.012107841,0.77706665,0.00011155877,0.0002578645,0.0000014699852,0.0008103461,0.00023371393,0.006335578,0.0000033682718,0.00007321367,0.00014339105],"about_ca_topic_score_codex":0.011630367,"about_ca_topic_score_gemma":0.009716601,"teacher_disagreement_score":0.15766169,"about_ca_system_score_codex":0.00006678653,"about_ca_system_score_gemma":0.00010553138,"threshold_uncertainty_score":0.99495125},"labels":[],"label_agreement":null},{"id":"W2904896757","doi":"10.1182/blood-2018-99-109791","title":"Predictors of Remission in Adults with Immune Thrombocytopenia Treated with Romiplostim","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Romiplostim; Medicine; Thrombopoietin; Eltrombopag; Internal medicine; Immune thrombocytopenia; Platelet","score_opus":0.0063495838372909915,"score_gpt":0.22310787938443455,"score_spread":0.21675829554714357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904896757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99474853,0.00020662625,0.000002260355,0.00005049334,0.000009947532,0.00039369968,0.000008182941,0.000032426997,0.004547828],"genre_scores_gemma":[0.9991191,0.00004747025,0.00046684314,0.000013934654,0.000021735963,0.000011289127,0.000047063404,0.000020598825,0.0002519649],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99928516,0.000013429834,0.00017032269,0.00019650339,0.00016685005,0.00016773975],"domain_scores_gemma":[0.99953324,0.000016990809,0.00007467644,0.00023238754,0.00007259516,0.00007014249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000034734,0.0001326706,0.00038080683,0.00007433043,0.000025825508,0.0000032079863,0.000047527563,0.000061938874,0.00006942387],"category_scores_gemma":[0.00001787278,0.00007672036,0.000022636881,0.00024083017,0.000095194344,0.00005149582,0.000014292592,0.00006875104,0.000010893487],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004003721,0.0024586155,0.9817769,0.00007891215,0.00036462047,0.0006952342,0.0005439125,7.5705833e-7,0.00944289,0.0000046801024,0.000035923666,0.00059386704],"study_design_scores_gemma":[0.035258774,0.008013943,0.779675,0.0019715023,0.0004611099,0.00020987239,0.0001399641,0.00003281372,0.17401035,0.000008068747,0.00007398241,0.00014459853],"about_ca_topic_score_codex":0.0002911322,"about_ca_topic_score_gemma":0.00013111683,"teacher_disagreement_score":0.20210184,"about_ca_system_score_codex":0.000015758818,"about_ca_system_score_gemma":0.00006468905,"threshold_uncertainty_score":0.31285655},"labels":[],"label_agreement":null},{"id":"W2904943167","doi":"10.1182/blood-2018-99-117309","title":"Inhibiting the Core Autophagy Enzyme ATG4B with Novel Drugs Sensitizes Resistant Leukemic Stem/Progenitor Cells to Standard Targeted Therapy","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia; Simon Fraser University; Leukemia & Lymphoma Society of Canada; Terry Fox Research Institute; University of British Columbia","funders":"","keywords":"Stem cell; Progenitor cell; Cancer research; Myeloid leukemia; CD34; Imatinib mesylate; Haematopoiesis; Autophagy; Leukemia; K562 cells; Myeloid; Bone marrow; Medicine; Imatinib; Biology; Immunology; Cell biology; Biochemistry","score_opus":0.019366957654133217,"score_gpt":0.2521375220791523,"score_spread":0.2327705644250191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904943167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99553084,0.0010831477,0.00008301528,0.00048664492,0.00018254979,0.0014400494,0.00017780224,0.00022652242,0.000789414],"genre_scores_gemma":[0.9935758,0.000057097524,0.0024383205,0.0010416468,0.0009004268,0.00007507174,0.000029927813,0.0001046377,0.0017770354],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975807,0.00005677481,0.00041156184,0.00059257733,0.000722065,0.00063629996],"domain_scores_gemma":[0.9982734,0.0001608448,0.0001795487,0.0007612731,0.00035439234,0.00027055474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033167592,0.00039730727,0.0005019039,0.000101837395,0.0003178246,0.000055255165,0.00018658876,0.00012926184,0.000109736284],"category_scores_gemma":[0.000035474397,0.00024156102,0.000114495786,0.00042688783,0.00021261157,0.00006243563,0.00008800396,0.000270872,0.0001030361],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026827676,0.00035524124,0.0007119798,0.000053791584,0.00065334147,0.00023349034,0.0038316161,0.0000034814334,0.98728377,0.00006490472,0.0025353003,0.0015902928],"study_design_scores_gemma":[0.01785477,0.0024770068,0.001620818,0.00033865203,0.00031735064,0.00023325584,0.0011088867,0.000051472718,0.96907085,0.00000956819,0.006612855,0.00030450607],"about_ca_topic_score_codex":0.0002284821,"about_ca_topic_score_gemma":0.00006551726,"teacher_disagreement_score":0.018212935,"about_ca_system_score_codex":0.000684439,"about_ca_system_score_gemma":0.0010584333,"threshold_uncertainty_score":0.98505723},"labels":[],"label_agreement":null},{"id":"W2905016588","doi":"10.1182/blood-2018-99-118299","title":"Pregnancy Outcomes in Patients with Myeloproliferative Neoplasms: A Systematic Review and Meta-Analysis","year":2018,"lang":"en","type":"review","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Mount Sinai Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Pregnancy; Essential thrombocythemia; Systematic review; Pediatrics; Myelofibrosis; Meta-analysis; Polycythemia vera; Obstetrics; MEDLINE; Internal medicine; Bone marrow","score_opus":0.04454477695995088,"score_gpt":0.31853800400413357,"score_spread":0.2739932270441827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905016588","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000085443906,0.98581016,0.0000018869298,0.00009195281,0.000013937743,0.013495776,0.0002991286,0.00003786497,0.00016386565],"genre_scores_gemma":[0.000092042705,0.9922924,0.0005123397,0.00034945112,0.000011761838,0.0054615582,0.00036702023,0.00008238554,0.0008310127],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9955686,0.00058796984,0.0016928443,0.0010785592,0.00064479146,0.00042724362],"domain_scores_gemma":[0.9968476,0.00044301397,0.001031005,0.0010857319,0.00034565123,0.0002469631],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00031272706,0.0011378828,0.018349357,0.0005816677,0.000083288425,0.000060606635,0.00017536413,0.00026081252,0.0002434387],"category_scores_gemma":[0.00030994497,0.00054148305,0.002062677,0.0011967093,0.00009586682,0.00010143578,0.000092715076,0.00034117486,0.00007760311],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004215473,0.0016067487,0.009769011,0.61538655,0.37289715,0.000062270425,0.00007561156,1.4444312e-8,1.83501e-10,0.000031948177,0.000016794504,0.0001496645],"study_design_scores_gemma":[0.0017072555,0.0006911379,0.00092666526,0.16457637,0.8310483,0.000022811118,0.0000043954137,1.3334711e-7,2.662179e-7,0.0000026677517,0.00061146123,0.00040853507],"about_ca_topic_score_codex":0.000013838218,"about_ca_topic_score_gemma":0.00009934816,"teacher_disagreement_score":0.45815116,"about_ca_system_score_codex":0.00009911217,"about_ca_system_score_gemma":0.00023931275,"threshold_uncertainty_score":0.99970365},"labels":[],"label_agreement":null},{"id":"W2905066255","doi":"10.1182/blood-2018-99-117349","title":"Selinexor Plus Pomalidomide and Low Dose Dexamethasone (SPd) in Patients with Relapsed or Refractory Multiple Myeloma","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Hôpital Maisonneuve-Rosemont; Queen Elizabeth II Health Sciences Centre; CancerCare Manitoba; Vancouver General Hospital; Dalhousie University; Royal Victoria Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Pomalidomide; Lenalidomide; Tolerability; Medicine; Multiple myeloma; Internal medicine; Refractory (planetary science); Dexamethasone; Oncology; Carfilzomib; Ixazomib; Dosing; Neutropenia; Pharmacology; Adverse effect; Gastroenterology; Toxicity; Biology","score_opus":0.005060556858729406,"score_gpt":0.20308393228926244,"score_spread":0.19802337543053303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905066255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993866,0.00008805851,0.000055566194,0.00001634144,0.00009503464,0.00017399459,0.000010317633,0.000011825621,0.00016222546],"genre_scores_gemma":[0.9968116,0.000018532817,0.0024380996,0.00018549469,0.00023827945,0.000006455761,0.00005590334,0.000024151492,0.00022145793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993097,0.000035986668,0.0001260061,0.00028175054,0.00008408727,0.000162431],"domain_scores_gemma":[0.9995711,0.000012855824,0.00005744056,0.00023043434,0.000070045244,0.000058120455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006539428,0.00012095607,0.00011731362,0.000036377165,0.00004833533,0.00001411332,0.00006326986,0.00013517348,0.000024030152],"category_scores_gemma":[0.00010378933,0.0000879749,0.000018233306,0.00007727322,0.000078318466,0.000005911081,0.000047876725,0.000076284756,0.0000073762067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012877436,0.0009494902,0.51909375,0.000068956346,0.00023642859,0.000030840834,0.00041225957,0.000008129252,0.44535723,0.000010995804,0.0013129081,0.01964159],"study_design_scores_gemma":[0.023836263,0.0041945074,0.87774867,0.000049584363,0.0000744158,0.000022166183,0.000075898024,0.00006832563,0.08312202,0.00001380502,0.01040104,0.00039331405],"about_ca_topic_score_codex":0.000025168141,"about_ca_topic_score_gemma":0.0002538687,"teacher_disagreement_score":0.3622352,"about_ca_system_score_codex":0.000007831127,"about_ca_system_score_gemma":0.000040936095,"threshold_uncertainty_score":0.3587512},"labels":[],"label_agreement":null},{"id":"W2905066790","doi":"10.1182/blood-2018-99-116013","title":"Safety, Efficacy, Pharmacokinetic (PK) and Biomarker Analyses of BCL2 Inhibitor Venetoclax (Ven) Plus MDM2 Inhibitor Idasanutlin (idasa) in Patients (pts) with Relapsed or Refractory (R/R) AML: A Phase Ib, Non-Randomized, Open-Label Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Venetoclax; Medicine; Refractory (planetary science); Internal medicine; Pharmacokinetics; Ven; Oncology; Pharmacology; Leukemia; Chronic lymphocytic leukemia; Biology","score_opus":0.056373079134783344,"score_gpt":0.39210336875744756,"score_spread":0.3357302896226642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905066790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99059623,0.00036017364,0.000033312623,0.000108016,0.00020802737,0.008006632,0.000069496695,0.000059516722,0.00055858877],"genre_scores_gemma":[0.99726033,0.00013633199,0.0010167784,0.00016528842,0.0003832512,0.00034880853,0.00008631321,0.00013738046,0.00046548923],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9947296,0.0007574074,0.0014768653,0.0010703545,0.0011863023,0.00077949825],"domain_scores_gemma":[0.996388,0.00081365637,0.0005658115,0.00094625406,0.00078047236,0.00050576497],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017485558,0.00061700644,0.002017378,0.000840547,0.00025049556,0.00007099002,0.0005669343,0.00024553307,0.00019587665],"category_scores_gemma":[0.0013060633,0.00042842314,0.000112062255,0.0015139845,0.0010754134,0.00033930785,0.00090080965,0.0006900035,0.00003628446],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.83815163,0.050150305,0.016797801,0.0004706478,0.0029969632,0.00084372435,0.0045820116,0.0000051712555,0.07250698,0.000001841299,0.0025077634,0.010985148],"study_design_scores_gemma":[0.92799467,0.018174153,0.020133272,0.000897291,0.0019166977,0.000034646913,0.00050665985,0.001476763,0.02803838,0.0000033085664,0.0002963587,0.0005277874],"about_ca_topic_score_codex":0.00092030055,"about_ca_topic_score_gemma":0.00016947075,"teacher_disagreement_score":0.08984304,"about_ca_system_score_codex":0.0005402222,"about_ca_system_score_gemma":0.0012617159,"threshold_uncertainty_score":0.9998168},"labels":[],"label_agreement":null},{"id":"W2905162633","doi":"10.1182/blood-2018-09-875914","title":"Systemic mastocytosis with an associated hematological neoplasm masquerading as overt primary myelofibrosis","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Jubilee Hospital; University of British Columbia","funders":"","keywords":"Myelofibrosis; Myeloproliferative neoplasm; Systemic mastocytosis; Medicine; Neoplasm; Polycythemia vera; Complete blood count; Hemoglobin; Platelet; Myeloproliferative Disorders; Pathology; Internal medicine; Gastroenterology; Bone marrow","score_opus":0.00831577732525043,"score_gpt":0.2016148828845669,"score_spread":0.19329910555931645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905162633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98050714,0.000552045,0.00005723383,0.000060788643,0.00021769608,0.00023087248,0.00002622872,0.00015834605,0.018189643],"genre_scores_gemma":[0.9941072,0.000021672295,0.0002855699,0.00029724595,0.00005995252,0.000030514922,0.00012879827,0.00002894239,0.005040141],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986283,0.00014731688,0.00027712152,0.0004287071,0.00006250545,0.00045602678],"domain_scores_gemma":[0.9992927,0.000077668315,0.00015605414,0.00032652495,0.000094335875,0.000052749114],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00016230054,0.0002382637,0.00044240188,0.00008128421,0.0003044476,0.000031252825,0.00022416012,0.00034888767,0.0013676601],"category_scores_gemma":[0.00003274675,0.00018251695,0.0000675563,0.00016441951,0.00025693976,0.000101338694,0.0000750667,0.00021745315,0.0011291797],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062637863,0.0018254033,0.06016492,0.0001286198,0.00083670643,0.0001018263,0.0011007973,7.4823953e-7,0.9304969,0.002674151,0.0013239887,0.0007196163],"study_design_scores_gemma":[0.028549382,0.016552547,0.12291773,0.0012631825,0.001794116,0.01169682,0.0010252648,0.000023639675,0.75459045,0.00027769463,0.058549162,0.002760015],"about_ca_topic_score_codex":0.00013658429,"about_ca_topic_score_gemma":0.000087339984,"teacher_disagreement_score":0.17590639,"about_ca_system_score_codex":0.00005138753,"about_ca_system_score_gemma":0.00006917911,"threshold_uncertainty_score":0.9996486},"labels":[],"label_agreement":null},{"id":"W2905241205","doi":"10.1182/blood-2018-99-112599","title":"Updated Analysis of the Efficacy and Safety of Tisagenlecleucel in Pediatric and Young Adult Patients with Relapsed/Refractory (r/r) Acute Lymphoblastic Leukemia","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Sunnybrook Health Science Centre; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Clinical endpoint; Internal medicine; Blinatumomab; Peripheral blood mononuclear cell; Oncology; Phases of clinical research; Cytokine release syndrome; Chimeric antigen receptor; Gastroenterology; Clinical trial; Leukemia; Immunotherapy; Lymphoblastic Leukemia; Biology; Cancer","score_opus":0.006299406194958854,"score_gpt":0.23970613893982043,"score_spread":0.23340673274486157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905241205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988079,0.00014187905,0.000004921285,0.00001630252,0.000026143674,0.0003733425,0.000032308624,0.000008242428,0.0005889798],"genre_scores_gemma":[0.99923664,0.00032713835,0.00006683567,0.000024883358,0.00003432651,0.00000405099,0.000024818426,0.000018006122,0.00026331117],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988055,0.00007581659,0.00030377373,0.00024176865,0.0003839302,0.00018918332],"domain_scores_gemma":[0.9990482,0.00011085369,0.00014541061,0.00036006217,0.00025297722,0.00008250547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015574676,0.00012247145,0.00038714925,0.00033590003,0.00003972479,0.0000058381274,0.000097208234,0.00008195384,0.00013550081],"category_scores_gemma":[0.00010706677,0.00007951811,0.000049943847,0.0013402757,0.00023561499,0.000041870306,0.000081272156,0.00013899298,0.0000012624913],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001690709,0.0005011445,0.9865667,0.000051307885,0.0009788601,0.000005931772,0.00062608,0.0000030792776,0.008513245,0.0000040787904,0.000027494156,0.0010313434],"study_design_scores_gemma":[0.014086542,0.00083225715,0.97860396,0.0000461816,0.0032298497,0.000005159485,0.00002622258,0.00017612608,0.0029001168,0.0000024827746,0.000013620668,0.000077493605],"about_ca_topic_score_codex":0.00018899544,"about_ca_topic_score_gemma":0.00025342937,"teacher_disagreement_score":0.012395833,"about_ca_system_score_codex":0.000059218437,"about_ca_system_score_gemma":0.00015390992,"threshold_uncertainty_score":0.32426545},"labels":[],"label_agreement":null},{"id":"W2905274124","doi":"10.1182/blood-2018-99-120258","title":"Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT) Activity Selectively Targets Human Acute Myeloid Leukemia Stem Cells","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"CD34; Myeloid leukemia; CD38; Stem cell; Leukemia; Cancer research; Haematopoiesis; Biology; Population; CD33; Bone marrow; Myeloid; Immunology; Medicine; Cell biology","score_opus":0.015579652367410882,"score_gpt":0.2736847430810969,"score_spread":0.25810509071368604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905274124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99362254,0.00015380094,0.0012483539,0.000114793795,0.00021645078,0.00063524116,0.00013756935,0.00016506949,0.0037061882],"genre_scores_gemma":[0.9979055,0.000116288844,0.00052266463,0.00026003804,0.0004653373,0.000059462553,0.000028756423,0.00005994498,0.0005819918],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981341,0.0000957405,0.00041704962,0.0004933153,0.00044518439,0.0004146055],"domain_scores_gemma":[0.9987434,0.000053919357,0.00020422033,0.00043021046,0.0003797782,0.00018845679],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025909656,0.00029001653,0.0005123201,0.00015561438,0.00018993574,0.000016123278,0.00010360405,0.00019528663,0.0003258065],"category_scores_gemma":[0.000007740847,0.0002909334,0.00018597292,0.0004091545,0.00028809818,0.00018401901,0.000028487912,0.00033224508,0.000070792],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005681723,0.0007937275,0.0016433952,0.0000980196,0.00033545066,0.000033835255,0.00083032757,0.000001475226,0.993657,0.00012084379,0.0008448303,0.0010729479],"study_design_scores_gemma":[0.0075134193,0.0017553673,0.0056921584,0.0002212257,0.0003676017,0.000066651475,0.000057701036,0.000017695811,0.983114,0.00021748857,0.00071583694,0.00026086124],"about_ca_topic_score_codex":0.00013145483,"about_ca_topic_score_gemma":0.00004066278,"teacher_disagreement_score":0.010542982,"about_ca_system_score_codex":0.00035143606,"about_ca_system_score_gemma":0.00034288972,"threshold_uncertainty_score":0.9999543},"labels":[],"label_agreement":null},{"id":"W2905418023","doi":"10.1182/blood-2018-99-111294","title":"The Predictive Value of Intracellular Imatinib Levels in Chronic Myeloid Leukemia","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Princess Margaret Cancer Centre; University Health Network; Dalhousie University; University of Alberta; Université de Montréal; University of Ottawa; University of Calgary; Windsor Regional Hospital; Juravinski Cancer Centre; McMaster University","funders":"","keywords":"Imatinib; Medicine; Intracellular; Myeloid leukemia; Imatinib mesylate; Internal medicine; Gastroenterology; Pharmacology; Oncology; Immunology; Biology; Genetics","score_opus":0.014179183226821108,"score_gpt":0.2640143196536612,"score_spread":0.24983513642684008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905418023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99034303,0.002116609,0.00009611989,0.00016956736,0.00014089358,0.0007000124,0.00002242108,0.000048208633,0.0063631097],"genre_scores_gemma":[0.99781895,0.00015722305,0.0006975991,0.00004501894,0.00046037527,0.000057452242,0.000012798111,0.00003350036,0.00071708654],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983638,0.00008011384,0.00046744614,0.00030827982,0.0003621018,0.00041829227],"domain_scores_gemma":[0.9987869,0.00019931493,0.00016850937,0.0006287754,0.00011764764,0.00009885204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037659833,0.00019886861,0.0003625303,0.000082974504,0.00009673371,0.000011225183,0.00020499504,0.00013335438,0.00015132311],"category_scores_gemma":[0.00022888176,0.00013856069,0.000094175775,0.0002914897,0.0003784672,0.000066632056,0.000090885536,0.00026646763,0.00010597441],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018743939,0.003711791,0.11958862,0.0013172047,0.0043031136,0.00083248684,0.012019026,0.00031273867,0.7680401,0.009578231,0.0031170782,0.07530519],"study_design_scores_gemma":[0.024259668,0.0030892221,0.22361003,0.00074309343,0.00062221906,0.00020960963,0.0003235202,0.005663967,0.7364379,0.00083317264,0.0039185174,0.00028908096],"about_ca_topic_score_codex":0.00022281108,"about_ca_topic_score_gemma":0.00010675132,"teacher_disagreement_score":0.1040214,"about_ca_system_score_codex":0.0016756393,"about_ca_system_score_gemma":0.0019502341,"threshold_uncertainty_score":0.5650341},"labels":[],"label_agreement":null},{"id":"W2905442284","doi":"10.1182/blood-2018-99-117201","title":"Deep and Durable Responses with Selinexor, Daratumumab, and Dexamethasome (SDd) in Patients with Multiple Myeloma (MM) Previously Exposed to Proteasome Inhibitors and Immunomodulatory Drugs: Results of Phase 1b Study of SDd","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Hôpital Maisonneuve-Rosemont; Queen Elizabeth II Health Sciences Centre; Royal Victoria Hospital; Dalhousie University; CancerCare Manitoba; Vancouver General Hospital; University of Calgary","funders":"","keywords":"Tolerability; Medicine; Daratumumab; Internal medicine; Carfilzomib; Neutropenia; Lenalidomide; Adverse effect; Refractory (planetary science); Gastroenterology; Phases of clinical research; Multiple myeloma; Oncology; Toxicity","score_opus":0.012893574554797959,"score_gpt":0.27032631820654307,"score_spread":0.2574327436517451,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905442284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949212,0.00049403677,0.000004288909,0.000025734831,0.000012609712,0.0044292496,0.000056684246,0.000022031678,0.000034130524],"genre_scores_gemma":[0.9976908,0.000025345196,0.0019713768,0.000012174878,0.000026330496,0.00015562556,0.000023313198,0.00003926295,0.000055749195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99769956,0.0002265109,0.0005486857,0.00058184034,0.00054925494,0.00039417768],"domain_scores_gemma":[0.99836713,0.0002302242,0.00021763954,0.0004972029,0.00036318006,0.0003245974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046780994,0.0002940382,0.00063557876,0.0004011496,0.00010249898,0.000023543835,0.00008192297,0.00007719502,0.0000030183987],"category_scores_gemma":[0.0005628612,0.00020267662,0.000020164893,0.00041836288,0.00030525684,0.00017423286,0.00011617481,0.00016107986,9.3492804e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05492197,0.013512902,0.904572,0.00025257122,0.00044212147,0.000089330875,0.008933638,8.7144804e-7,0.008708919,5.054184e-7,0.0000061414003,0.008559014],"study_design_scores_gemma":[0.15554626,0.03735727,0.7750462,0.00058401853,0.00017871041,0.000019224079,0.001607696,0.000078211546,0.02937511,0.0000020082853,0.00001262136,0.00019261814],"about_ca_topic_score_codex":0.00044853508,"about_ca_topic_score_gemma":0.00063305005,"teacher_disagreement_score":0.12952577,"about_ca_system_score_codex":0.00003379451,"about_ca_system_score_gemma":0.00012246695,"threshold_uncertainty_score":0.82649124},"labels":[],"label_agreement":null},{"id":"W2905465042","doi":"10.1182/blood-2018-99-114656","title":"Second Attempt of TKI Discontinuation with Dasatinib for Treatment-Free Remission after Failing First Attempt with Imatinib: Treatment-Free Remission Accomplished By Dasatinib (TRAD) Trial","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hamilton Health Sciences; McGill University Health Centre; Alberta Hospital Edmonton; London Health Sciences Centre; Juravinski Cancer Centre; Hôpital de l'Enfant-Jésus; Princess Margaret Cancer Centre; University of Calgary; Université de Montréal; Leukemia & Lymphoma Society of Canada; Université Laval; Queen Elizabeth II Health Sciences Centre; Hôpital Maisonneuve-Rosemont; Health Sciences Centre; CancerCare Manitoba; University of Alberta Hospital; Ottawa Hospital; University Health Network","funders":"","keywords":"Discontinuation; Medicine; Dasatinib; Internal medicine; Imatinib; Imatinib mesylate; Oncology","score_opus":0.01882563202833285,"score_gpt":0.27185925639656455,"score_spread":0.2530336243682317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905465042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896239,0.0003584655,0.00022195496,0.00073919713,0.00015936935,0.0056600235,0.0007118026,0.00018967023,0.002335591],"genre_scores_gemma":[0.9716677,0.000052804673,0.019633198,0.000077534794,0.0009118431,0.0013308164,0.0013152087,0.00021426391,0.0047966223],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99594355,0.00009605992,0.0011411262,0.0012820328,0.00075220043,0.0007850104],"domain_scores_gemma":[0.9952801,0.0005264887,0.00088519626,0.0025565985,0.00032643453,0.00042519756],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029425448,0.00090526306,0.0014175356,0.00020358255,0.00034394494,0.00007939493,0.00043098006,0.00033546783,0.0007825187],"category_scores_gemma":[0.00036551786,0.00057428615,0.00031344112,0.00035527823,0.0002978754,0.00039537955,0.00012114642,0.00015135233,0.000017067714],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4912011,0.038929492,0.23770718,0.002550853,0.011388104,0.00044236126,0.019766636,0.000013891844,0.11834792,0.000078337296,0.030744176,0.04882993],"study_design_scores_gemma":[0.6383502,0.050610363,0.008328629,0.002616112,0.004383578,0.00021140906,0.00075848587,0.0003048273,0.28261504,0.0001428046,0.010605067,0.0010735028],"about_ca_topic_score_codex":0.00032005468,"about_ca_topic_score_gemma":0.001062317,"teacher_disagreement_score":0.22937855,"about_ca_system_score_codex":0.00088834716,"about_ca_system_score_gemma":0.0007525459,"threshold_uncertainty_score":0.99967086},"labels":[],"label_agreement":null},{"id":"W2905506084","doi":"10.1182/blood-2018-99-113177","title":"Evaluation of Sustained Minimal Residual Disease (MRD) Negativity in Relapsed/Refractory Multiple Myeloma (RRMM) Patients (Pts) Treated with Daratumumab in Combination with Lenalidomide Plus Dexamethasone (D-Rd) or Bortezomib Plus Dexamethasone (D-Vd): Analysis of Pollux and Castor","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Daratumumab; Lenalidomide; Medicine; Internal medicine; Oncology; Minimal residual disease; Multiple myeloma; Dexamethasone; Bone marrow","score_opus":0.03312665798193124,"score_gpt":0.30586820979717566,"score_spread":0.2727415518152444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905506084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968373,0.0002770079,0.000039242677,0.00007234095,0.000013869293,0.002387072,0.0002350879,0.000024709223,0.00011337906],"genre_scores_gemma":[0.9978346,0.000023108601,0.001330713,0.000010947578,0.000025739822,0.00017550647,0.00045444389,0.000047239264,0.00009769613],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99529785,0.0009415987,0.0007573429,0.000716573,0.0017512398,0.0005354094],"domain_scores_gemma":[0.99632007,0.0006808635,0.00052397244,0.0005966035,0.0015021152,0.00037635613],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013980021,0.00039726327,0.0011564874,0.0014930626,0.00009357358,0.000021552558,0.00012639146,0.00016124386,0.00007834966],"category_scores_gemma":[0.002859875,0.00028641627,0.00009190271,0.0023757364,0.00050585996,0.00026271743,0.0000747162,0.0002615345,0.0000014005284],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.054401983,0.006160926,0.92711085,0.00018787663,0.0022789293,0.0002745855,0.0013029242,0.0001335659,0.0014936049,0.0000047387634,0.000009709467,0.006640284],"study_design_scores_gemma":[0.12319801,0.005994881,0.8369842,0.00032206264,0.0050081485,0.0000070467713,0.000625124,0.021059044,0.006555841,0.0000075887,0.000002226471,0.0002358355],"about_ca_topic_score_codex":0.0035021,"about_ca_topic_score_gemma":0.021275777,"teacher_disagreement_score":0.09012668,"about_ca_system_score_codex":0.0007586195,"about_ca_system_score_gemma":0.0015004918,"threshold_uncertainty_score":0.9999588},"labels":[],"label_agreement":null},{"id":"W2905558559","doi":"10.1182/blood-2018-07-862953","title":"Bruton tyrosine kinase degradation as a therapeutic strategy for cancer","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":169,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada; National Institutes of Health; Harvard University; National Cancer Institute; Damon Runyon Cancer Research Foundation","keywords":"Bruton's tyrosine kinase; Ibrutinib; Mantle cell lymphoma; Cancer research; Tyrosine kinase; B cell; Lymphoma; Medicine; Biology; Immunology; Chronic lymphocytic leukemia; Signal transduction; Leukemia; Cell biology; Antibody","score_opus":0.05432628899998896,"score_gpt":0.3694761640136313,"score_spread":0.31514987501364233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905558559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932115,0.0017337677,0.00026417937,0.0006910074,0.00011431316,0.00076981797,0.000014285111,0.00006878568,0.0031323119],"genre_scores_gemma":[0.99252367,0.000110291185,0.00030425374,0.00048695365,0.00073369953,0.00015592818,0.000035129226,0.000032448475,0.005617622],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989964,0.000019744106,0.00015503008,0.0002452751,0.00026313518,0.00032044126],"domain_scores_gemma":[0.99924463,0.00006819481,0.00004173398,0.0002904265,0.00023604823,0.00011896136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001509012,0.00011122821,0.00016493228,0.0000655411,0.000080620426,0.000024704672,0.0000869345,0.00008513338,0.00042311594],"category_scores_gemma":[0.00008338767,0.00008976023,0.0000599089,0.00017927948,0.000108364795,0.00005678911,0.000022042643,0.00007797242,0.00011520422],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048920014,0.0059890538,0.005919431,0.001667781,0.0018159027,0.00031233564,0.0015346869,0.000015621603,0.5893193,0.01370595,0.010086451,0.36474147],"study_design_scores_gemma":[0.08739858,0.0033866868,0.004693479,0.00028664045,0.00078022643,0.00033573073,0.00015038288,0.008750405,0.8516236,0.0016367957,0.04060238,0.00035510733],"about_ca_topic_score_codex":0.0012407502,"about_ca_topic_score_gemma":0.00022519274,"teacher_disagreement_score":0.36438638,"about_ca_system_score_codex":0.0012400821,"about_ca_system_score_gemma":0.0041023744,"threshold_uncertainty_score":0.7277436},"labels":[],"label_agreement":null},{"id":"W2905649019","doi":"10.1182/blood-2018-99-114409","title":"Avadomide (CC-122), a Novel Cereblon Modulating Agent, Plus Rituximab in Patients with Relapsed or Refractory Follicular Lymphoma","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Rituximab; Medicine; Follicular lymphoma; Internal medicine; Obinutuzumab; Diffuse large B-cell lymphoma; Oncology; Refractory (planetary science); Gastroenterology; Lenalidomide; Tolerability; Lymphoma; Adverse effect; Multiple myeloma","score_opus":0.015568378575487164,"score_gpt":0.23924584669105659,"score_spread":0.22367746811556943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905649019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971157,0.0001539234,0.000031142023,0.00008904118,0.00011907697,0.00085197116,0.000022850201,0.00008107961,0.0015352173],"genre_scores_gemma":[0.99551743,0.000015902531,0.0033832367,0.0003562641,0.00017903815,0.000108027714,0.000074440366,0.000059704365,0.00030594005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998123,0.000038170114,0.00040446152,0.0005277861,0.00045821228,0.00044838522],"domain_scores_gemma":[0.9988574,0.00007388999,0.0001799104,0.00055124186,0.00014680506,0.00019079962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000113861555,0.00030778119,0.0005328649,0.0001559431,0.00011624371,0.000030538657,0.00010306796,0.00014479696,0.000045400746],"category_scores_gemma":[0.00012420565,0.00020739132,0.000101910315,0.00030800467,0.00008244351,0.00012590944,0.000065806336,0.00007914683,0.00011368521],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003886386,0.24196562,0.73862255,0.00013808151,0.00084481115,0.00072539505,0.0010803291,0.0000021220865,0.00030178868,0.00007145039,0.00040670953,0.011954782],"study_design_scores_gemma":[0.44788212,0.0025133723,0.54442745,0.00048456492,0.00044769084,0.000050501294,0.000053673382,0.0001866959,0.002463124,0.0000075911903,0.0012215474,0.00026163438],"about_ca_topic_score_codex":0.0005410339,"about_ca_topic_score_gemma":0.00025040683,"teacher_disagreement_score":0.44399574,"about_ca_system_score_codex":0.0004082999,"about_ca_system_score_gemma":0.0002458942,"threshold_uncertainty_score":0.84571725},"labels":[],"label_agreement":null},{"id":"W2905757675","doi":"10.1182/blood-2018-99-118551","title":"Polatuzumab Vedotin (Pola) Plus Bendamustine (B) with Rituximab (R) or Obinutuzumab (G) in Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): Updated Results of a Phase (Ph) Ib/II Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); McGill University; BC Cancer Agency","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Rituximab; Internal medicine; Bendamustine; Gastroenterology; Oncology; Nuclear medicine; Lymphoma","score_opus":0.01508975381121335,"score_gpt":0.2740723254785748,"score_spread":0.25898257166736144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905757675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99385345,0.0007337342,0.00000519494,0.00013624092,0.00017714199,0.0020570485,0.00047119553,0.00017301487,0.0023929789],"genre_scores_gemma":[0.99698377,0.00007452674,0.00076177466,0.00020961167,0.00026459247,0.00016363418,0.0003609263,0.000116056595,0.0010650986],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99585265,0.0001835168,0.0012072305,0.001053376,0.00081214233,0.0008910985],"domain_scores_gemma":[0.99720967,0.00018240702,0.00055574183,0.001339743,0.00035112206,0.00036133904],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034925865,0.0006683271,0.0013322223,0.0004212874,0.0002513307,0.00003192797,0.00031103814,0.00026589943,0.00015565881],"category_scores_gemma":[0.0002166111,0.00046882866,0.00017299016,0.0010299189,0.00021329903,0.0001752499,0.00023994572,0.0002469287,0.000090357236],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.064413324,0.8732381,0.025509402,0.00028554458,0.0017323372,0.007543464,0.014950351,0.0000021185886,0.0051251766,0.00008055179,0.003937363,0.0031822848],"study_design_scores_gemma":[0.88287336,0.04862126,0.027173022,0.00055400416,0.0019490166,0.00030694337,0.0023871108,0.00026476357,0.028321749,0.000008957925,0.006909326,0.0006305054],"about_ca_topic_score_codex":0.0016532119,"about_ca_topic_score_gemma":0.0016751627,"teacher_disagreement_score":0.82461685,"about_ca_system_score_codex":0.0009014492,"about_ca_system_score_gemma":0.001571025,"threshold_uncertainty_score":0.99977636},"labels":[],"label_agreement":null},{"id":"W2905823399","doi":"10.1182/blood-2018-99-113858","title":"Observational Study of Real-World Factor Utilization and Health Outcomes in Patients with Hemophilia in Canada","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; BC Children's Hospital; Dalhousie University; University of British Columbia; Hospital for Sick Children; Canadian Hemophilia Society; St. Michael's Hospital; Children's Hospital of Eastern Ontario; University of Calgary; University of Alberta","funders":"","keywords":"Medicine; Observational study; Quality of life (healthcare); Regimen; Haemophilia; Medical prescription; Family medicine; Pediatrics; Internal medicine; Pharmacology","score_opus":0.1281732191399086,"score_gpt":0.36113945183748936,"score_spread":0.23296623269758077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905823399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99868065,0.000013909798,8.075639e-8,0.00047185406,0.00001597222,0.00068477716,0.000012356325,0.0000034036434,0.00011696656],"genre_scores_gemma":[0.99965954,0.000009284715,0.00005003791,0.000061602106,0.000011338596,0.000009550043,0.000032358104,0.000006576141,0.00015974068],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991774,0.000029679886,0.00020243367,0.00013364111,0.0003195823,0.0001372859],"domain_scores_gemma":[0.9996709,0.00002852906,0.00004505189,0.000108806365,0.00008153412,0.00006515932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007161098,0.000068125664,0.00021633423,0.000125939,0.000022125054,0.0000023038651,0.000027069387,0.0000134539205,0.000023363113],"category_scores_gemma":[0.000020257405,0.000046123656,0.000005402643,0.0002750059,0.000021677499,0.000032958178,0.00001589824,0.0000547172,3.6750566e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007566349,0.0017540003,0.9969685,0.000032651667,0.000030325233,0.000006074481,0.0003729773,2.2846962e-7,0.0000023986302,0.000008671089,0.000016459267,0.0007320315],"study_design_scores_gemma":[0.008023468,0.0011511266,0.99048007,0.000048814403,0.000008748897,1.6557954e-7,0.00015272612,0.000013031696,0.000070835915,0.0000045421853,0.00001008255,0.00003641296],"about_ca_topic_score_codex":0.60021234,"about_ca_topic_score_gemma":0.965628,"teacher_disagreement_score":0.36541566,"about_ca_system_score_codex":0.0001546289,"about_ca_system_score_gemma":0.0007154381,"threshold_uncertainty_score":0.40244988},"labels":[],"label_agreement":null},{"id":"W2905841490","doi":"10.1182/blood-2018-99-111920","title":"Pomalidomide + Low-Dose Dexamethasone + Daratumumab in Relapsed and/or Refractory Multiple Myeloma after Lenalidomide-Based Treatment Failure","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Vancouver General Hospital; University of Calgary; McGill University Health Centre","funders":"","keywords":"Pomalidomide; Lenalidomide; Medicine; Daratumumab; Population; Multiple myeloma; Internal medicine; Regimen; Clinical endpoint; Cohort; Dexamethasone; Progressive disease; Surgery; Oncology; Clinical trial; Chemotherapy","score_opus":0.02318288688704756,"score_gpt":0.2923809173059088,"score_spread":0.26919803041886126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905841490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99657065,0.0007614171,0.000029244931,0.00056122104,0.00007567563,0.0014055391,0.000072201394,0.00010621865,0.0004178584],"genre_scores_gemma":[0.98951966,0.00008321483,0.008197632,0.00024592492,0.0002813014,0.0004880633,0.00008365138,0.0000755603,0.0010249742],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99726427,0.00022894975,0.00048738482,0.00075539976,0.00047308693,0.00079088507],"domain_scores_gemma":[0.9979898,0.00045326535,0.000111488036,0.0007517591,0.00014845286,0.000545289],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026204914,0.00045953522,0.0006920472,0.00040301218,0.00014265467,0.00005465127,0.000118738106,0.00024640106,0.00048627213],"category_scores_gemma":[0.00058823475,0.000321923,0.00016356583,0.00039348193,0.0003113818,0.00012241407,0.00006928562,0.00027876362,0.00020954864],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055481132,0.014410154,0.82622975,0.00035429344,0.0011226526,0.009995099,0.001210518,0.0000027644587,0.057096433,0.0000139015065,0.00028096733,0.033802364],"study_design_scores_gemma":[0.18167719,0.010315624,0.67328995,0.00084280217,0.00053018704,0.00036068785,0.00023872926,0.0008526544,0.12533735,0.00002923247,0.0058617466,0.0006638211],"about_ca_topic_score_codex":0.00051632244,"about_ca_topic_score_gemma":0.0039696624,"teacher_disagreement_score":0.15293975,"about_ca_system_score_codex":0.00028182633,"about_ca_system_score_gemma":0.0003912836,"threshold_uncertainty_score":0.9999233},"labels":[],"label_agreement":null},{"id":"W2905955227","doi":"10.1182/blood.v130.suppl_1.lba-1.lba-1","title":"Results of the Randomized, Double-Blind, Placebo-Controlled, Phase 3 Hercules Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Thrombotic microangiopathy; Von Willebrand factor; ADAMTS13; Gastroenterology; Internal medicine; Immunosuppression; Thrombotic thrombocytopenic purpura; Platelet; Schistocyte; Clinical endpoint; Immunology; Randomized controlled trial; Disease","score_opus":0.027832608310268465,"score_gpt":0.29134801022010687,"score_spread":0.2635154019098384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905955227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99030566,0.0003654834,0.0000010992851,0.00004702406,0.0002930081,0.007956428,0.0001236058,0.00001540783,0.0008922546],"genre_scores_gemma":[0.9993831,0.0000051412912,0.0000069000034,0.0000060321972,0.000011366287,0.00035252294,0.000043632102,0.000018988772,0.00017232832],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972378,0.000826531,0.0010835045,0.00038158245,0.00016077772,0.00030977628],"domain_scores_gemma":[0.99653155,0.00042152504,0.0013597218,0.0014918563,0.0001769239,0.000018417117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007853426,0.00027285767,0.0015318061,0.000113188005,0.0002725933,0.00002995643,0.000987297,0.000110053224,0.00012094948],"category_scores_gemma":[0.00039340765,0.00015754605,0.0002147934,0.0000943687,0.0005009565,0.00014930556,0.00029766824,0.000121939476,0.000017358034],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9148674,0.012944378,0.06650182,0.000052642234,0.002235056,0.000003658696,0.0013768307,0.000019646113,0.001765484,0.0000729436,0.000095744515,0.00006441342],"study_design_scores_gemma":[0.9352827,0.0010474785,0.05630553,0.00018340876,0.001107426,0.0000029502824,0.00068852707,0.0000017125068,0.005189456,0.000020633468,0.000007117189,0.0001630377],"about_ca_topic_score_codex":0.0008265651,"about_ca_topic_score_gemma":0.0010735175,"teacher_disagreement_score":0.020415336,"about_ca_system_score_codex":0.000026176951,"about_ca_system_score_gemma":0.0001084289,"threshold_uncertainty_score":0.64245415},"labels":[],"label_agreement":null},{"id":"W2906113898","doi":"10.1182/blood-2018-05-850370","title":"Fibronectin modulates formation of PF4/heparin complexes and is a potential factor for reducing risk of developing HIT","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Deutsche Forschungsgemeinschaft","keywords":"Platelet factor 4; Heparin; Heparin-induced thrombocytopenia; Platelet; Fibronectin; Platelet activation; Chemistry; Antibody; Pharmacology; Immunology; Medicine; Biochemistry","score_opus":0.03635175979675429,"score_gpt":0.29284148253589354,"score_spread":0.2564897227391392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906113898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99644786,0.000057143665,0.0025714042,0.00014888248,0.000061342726,0.0004374003,0.00007983114,0.000024044082,0.000172074],"genre_scores_gemma":[0.9850805,0.00004479559,0.014687837,0.000024606208,0.00009790734,0.000009144909,0.00001541301,0.000017062834,0.000022733147],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990942,0.00002596289,0.00037844587,0.00018746349,0.00012881256,0.00018515516],"domain_scores_gemma":[0.999264,0.00006380012,0.00023861692,0.00018025994,0.00019469792,0.000058613037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013111686,0.000121978286,0.00041634653,0.000105801526,0.000100206984,0.000010877063,0.00005745978,0.00008828583,0.00004350259],"category_scores_gemma":[0.00012796119,0.00010938178,0.00007680892,0.00011516017,0.00008596882,0.00012916944,0.00005499583,0.00006529894,0.0000029378018],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012922435,0.00019690733,0.022453172,0.0006425772,0.0003526579,5.9352016e-7,0.0035088172,0.0000014358985,0.96706885,0.00018742974,0.00005717907,0.0054011797],"study_design_scores_gemma":[0.0022011765,0.00047542126,0.19569077,0.0002358624,0.00032835483,0.000021441614,0.00014906508,0.0009107386,0.7994575,0.00036200645,0.00006518576,0.0001024638],"about_ca_topic_score_codex":0.00030882927,"about_ca_topic_score_gemma":0.000029972609,"teacher_disagreement_score":0.17323759,"about_ca_system_score_codex":0.000019037516,"about_ca_system_score_gemma":0.0000631624,"threshold_uncertainty_score":0.44604596},"labels":[],"label_agreement":null},{"id":"W2906129219","doi":"10.1182/blood-2018-99-118519","title":"Venetoclax Plus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisolone (R-CHOP) Improves Outcomes in BCL2-Positive First-Line Diffuse Large B-Cell Lymphoma (DLBCL): First Safety, Efficacy and Biomarker Analyses from the Phase II CAVALLI Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Hôpital de l'Enfant-Jésus; Jewish General Hospital","funders":"","keywords":"Medicine; Venetoclax; Rituximab; Internal medicine; CHOP; International Prognostic Index; Oncology; Population; Vincristine; Diffuse large B-cell lymphoma; Lymphoma; Cyclophosphamide; Gastroenterology; Chemotherapy; Leukemia; Chronic lymphocytic leukemia","score_opus":0.02116876407871913,"score_gpt":0.3110601321079146,"score_spread":0.28989136802919546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906129219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98706293,0.008459422,0.000014434211,0.0011410203,0.00015279329,0.0023391624,0.0005684595,0.000085752676,0.00017600543],"genre_scores_gemma":[0.99686927,0.0016317344,0.00022262648,0.00046639366,0.00020625381,0.00020144277,0.00015861157,0.0000642008,0.00017944402],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970796,0.00013561896,0.00077448983,0.0009623872,0.0004236671,0.00062422716],"domain_scores_gemma":[0.99743533,0.0010627775,0.0002598331,0.00079357735,0.00013994877,0.00030855907],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002962831,0.0006245297,0.001171668,0.00015334325,0.0007925237,0.000093970215,0.00020760692,0.0001710322,0.000041846182],"category_scores_gemma":[0.00027290807,0.0004019276,0.00014659086,0.00036162342,0.0003708342,0.00013136455,0.0004862424,0.00013005981,0.000018375522],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068712025,0.2075983,0.7562961,0.00011512311,0.0036208187,0.0013996077,0.007422175,0.0000021675344,0.0034105899,0.000014592782,0.0004593246,0.012789982],"study_design_scores_gemma":[0.2681646,0.004988217,0.7177274,0.00020829965,0.0021831586,0.00004357303,0.0003916204,0.00046807012,0.004925771,0.00001785327,0.0005498297,0.00033158823],"about_ca_topic_score_codex":0.009821859,"about_ca_topic_score_gemma":0.005263792,"teacher_disagreement_score":0.2612934,"about_ca_system_score_codex":0.00033730373,"about_ca_system_score_gemma":0.00017223704,"threshold_uncertainty_score":0.99984324},"labels":[],"label_agreement":null},{"id":"W2906135263","doi":"10.1182/blood-2018-99-116845","title":"No Added Benefit of Eight Versus Six Cycles of CHOP When Combined with Rituximab in Previously Untreated Diffuse Large B-Cell Lymphoma Patients: Results from the International Phase III GOYA Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Rituximab; Diffuse large B-cell lymphoma; Medicine; Lymphoma; CHOP; Internal medicine; Phases of clinical research; Oncology; Chemotherapy","score_opus":0.011417399477641605,"score_gpt":0.24798358695039535,"score_spread":0.23656618747275374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906135263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958355,0.00013398964,3.044555e-7,0.00010268858,0.00013632936,0.0012007797,0.0009072268,0.000021409956,0.0016618073],"genre_scores_gemma":[0.99878734,0.00004635816,0.00012416736,0.000060715454,0.00008524946,0.00008015491,0.0006786388,0.000022891572,0.00011450495],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99833435,0.00005633716,0.000564318,0.00035848503,0.0004645602,0.00022197478],"domain_scores_gemma":[0.99838495,0.0003063082,0.00032298043,0.0005400085,0.00036523913,0.00008051719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012469648,0.00022379923,0.00048813038,0.000082388186,0.000049086648,0.000015736514,0.00023300077,0.00006386622,0.00009135239],"category_scores_gemma":[0.00012569127,0.00013436752,0.00007697697,0.00015430983,0.000088116576,0.00007068054,0.00010209766,0.000045201763,0.000023148996],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044121165,0.3988747,0.54755265,0.000020763164,0.0015701046,0.00008325433,0.0053917863,2.1417854e-7,0.0001842805,0.00002849463,0.0006460503,0.001526531],"study_design_scores_gemma":[0.6674765,0.010254139,0.31139383,0.00021002068,0.00081546203,9.806583e-7,0.00038067042,0.00004406185,0.008980198,0.00000868225,0.00031884908,0.00011664157],"about_ca_topic_score_codex":0.002655843,"about_ca_topic_score_gemma":0.0019744644,"teacher_disagreement_score":0.6233553,"about_ca_system_score_codex":0.000097113254,"about_ca_system_score_gemma":0.00008504592,"threshold_uncertainty_score":0.54793483},"labels":[],"label_agreement":null},{"id":"W2906220152","doi":"10.1182/blood-2018-99-117824","title":"MCRN¯003/MYX·1: A Single Arm Phase II Study of High-Dose Weekly Carfilzomib Plus Cyclophosphamide and Dexamethasone in the Treatment of Relapsed Multiple Myeloma after 1-3 Prior Therapies","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; London Health Sciences Centre; Western University; Saint John Regional Hospital; Hôtel-Dieu de Québec; University of Ottawa; University Health Network; Ottawa Hospital; Princess Margaret Cancer Centre; University of Alberta; University of New Brunswick; Université de Montréal; Queen Elizabeth II Health Sciences Centre; Dalhousie University; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Carfilzomib; Medicine; Dexamethasone; Cyclophosphamide; Internal medicine; Multiple myeloma; Oncology; Refractory (planetary science); Phases of clinical research; Progressive disease; Lenalidomide; Clinical trial; Gastroenterology; Pharmacology; Urology; Chemotherapy","score_opus":0.028921294288764245,"score_gpt":0.30297931295058567,"score_spread":0.27405801866182145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906220152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941535,0.0027432141,0.00000382287,0.00019064895,0.000052213232,0.002647701,0.00006869183,0.0000248875,0.00011532097],"genre_scores_gemma":[0.9975755,0.00029923732,0.0013270682,0.000033868702,0.000092329254,0.0004018772,0.000019905436,0.00003491511,0.00021528716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979632,0.00021708691,0.0004885593,0.00043144802,0.00049202034,0.0004077054],"domain_scores_gemma":[0.99850976,0.0003696971,0.00016333172,0.00066958816,0.00013650864,0.00015113411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023505083,0.00030346125,0.0007017722,0.00020253833,0.00012133734,0.00001596211,0.00013522129,0.00009326848,0.000067356064],"category_scores_gemma":[0.00016102003,0.00018501785,0.000101192825,0.00036260375,0.0003022481,0.000071497176,0.000062063256,0.000114137416,0.000005099402],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025820848,0.226303,0.49037376,0.0001702484,0.00262994,0.0013836051,0.08831641,0.000001421126,0.034565188,0.000010331476,0.000029143932,0.1303961],"study_design_scores_gemma":[0.17140235,0.10544623,0.65130556,0.00014480435,0.0006956229,0.000056928628,0.0055175805,0.00007251913,0.06479404,0.000036615023,0.0003199618,0.00020782427],"about_ca_topic_score_codex":0.0022215839,"about_ca_topic_score_gemma":0.0018499345,"teacher_disagreement_score":0.16093175,"about_ca_system_score_codex":0.00009227672,"about_ca_system_score_gemma":0.0001077649,"threshold_uncertainty_score":0.7544809},"labels":[],"label_agreement":null},{"id":"W2906294268","doi":"10.1182/blood-2018-120770","title":"Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study: A Perioperative Management Plan for Patients with Atrial Fibrillation Who Are Receiving a Direct Oral Anticoagulant","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of Calgary; Jewish General Hospital; Université de Montréal; University of Ottawa; McGill University; University of Toronto; Hamilton Health Sciences; Dalhousie University; Hamilton Regional Laboratory Medicine Program; Centre Hospitalier Universitaire de Sherbrooke; University of British Columbia; Institut du Savoir Montfort; Montfort Hospital; Ottawa Hospital; McMaster University; University of Manitoba; Montreal General Hospital","funders":"","keywords":"Medicine; Dabigatran; Perioperative; Apixaban; Rivaroxaban; Atrial fibrillation; Bleed; Anticoagulant; Anesthesia; Warfarin; Surgery; Direct thrombin inhibitor; Thrombosis; Internal medicine","score_opus":0.10255255521904377,"score_gpt":0.3419859358118036,"score_spread":0.23943338059275981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906294268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98697513,0.000049833157,0.000801205,0.0002478185,0.00040357746,0.011169353,0.00009387378,0.00009944133,0.00015974589],"genre_scores_gemma":[0.99437064,0.000030613264,0.0026829925,0.000051928575,0.0016162382,0.00007853212,0.00045231235,0.000063629974,0.00065308716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99750966,0.00020244709,0.0005652393,0.00063956593,0.00068839476,0.0003947039],"domain_scores_gemma":[0.99773705,0.00047801586,0.00033847505,0.00034681536,0.000996228,0.000103413666],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009067071,0.00034947344,0.0008745415,0.00029539573,0.00047939946,0.00020917914,0.00006830514,0.00008304706,0.00003782716],"category_scores_gemma":[0.0007459081,0.00026406054,0.00026200968,0.0003165458,0.00007196939,0.00041355618,0.00005910368,0.00005567511,0.000007901288],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036524364,0.00014150336,0.98916143,0.00014113485,0.0014324612,0.00000583389,0.0017039712,0.00009234248,0.000058306356,0.00007183464,0.0001919698,0.0033467838],"study_design_scores_gemma":[0.022562923,0.0028942411,0.9614955,0.00039188092,0.003418977,0.000002502997,0.0011230476,0.0037238689,0.00026751295,0.0000066060484,0.0036947331,0.00041816165],"about_ca_topic_score_codex":0.00003999526,"about_ca_topic_score_gemma":0.00017099203,"teacher_disagreement_score":0.027665876,"about_ca_system_score_codex":0.00010252743,"about_ca_system_score_gemma":0.00009684516,"threshold_uncertainty_score":0.99998116},"labels":[],"label_agreement":null},{"id":"W2906428280","doi":"10.1182/blood-2018-99-118691","title":"A Single-Cell Transcriptional Analysis of Tumour Cells and the Immune Microenvironment during Disease Evolution in a Transgenic Mouse Model of Myeloma","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; McGill University; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Immune system; Biology; Multiple myeloma; Tumor microenvironment; Plasma cell; Pathogenesis; Monoclonal gammopathy of undetermined significance; Bone marrow; Cancer research; Transcriptome; Gene expression profiling; Immunology; Gene expression; Gene; Monoclonal; Monoclonal antibody; Antibody; Genetics","score_opus":0.014724086288724575,"score_gpt":0.2251622792467876,"score_spread":0.21043819295806304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906428280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980152,0.0010289608,0.0002921229,0.00008312057,0.0000041099465,0.0003836766,0.00014232236,0.000004827757,0.000045618657],"genre_scores_gemma":[0.9992089,0.00013607855,0.00039145956,0.000004959091,0.000010617724,0.000025314917,0.000021519732,0.000009562003,0.00019153532],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990378,0.00006057649,0.00028601778,0.0001780879,0.00026283023,0.00017469317],"domain_scores_gemma":[0.9995726,0.000027892132,0.00006359611,0.00020260645,0.000030322119,0.0001029832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012555071,0.00010007437,0.00030115747,0.00022667834,0.000037063353,0.0000035191838,0.000058768175,0.000028247201,0.0000331279],"category_scores_gemma":[0.000010704543,0.00007100914,0.0001843083,0.00021838426,0.00026596963,0.000034253047,0.00001626325,0.000063626954,0.0000015415634],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023176132,0.002237604,0.025633048,0.00012538116,0.00063372334,0.000004696686,0.0005800063,0.00022387487,0.96817905,0.000026405833,1.7645768e-7,0.000038398975],"study_design_scores_gemma":[0.013290628,0.00013614265,0.45097426,0.00003141878,0.0016670848,8.276792e-7,0.000053115913,0.01164993,0.5221307,0.000020466405,3.548398e-7,0.000045079913],"about_ca_topic_score_codex":0.00011191056,"about_ca_topic_score_gemma":0.000057953843,"teacher_disagreement_score":0.44604838,"about_ca_system_score_codex":0.000042819585,"about_ca_system_score_gemma":0.00004316577,"threshold_uncertainty_score":0.28956687},"labels":[],"label_agreement":null},{"id":"W2906488389","doi":"10.1182/blood-2018-99-110650","title":"Prospective Diagnosis of VWD in a Large Cohort of Patients with Bleeding Symptoms through the Zimmerman Program","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Von Willebrand disease; Medicine; Prospective cohort study; Population; Internal medicine; Cohort; Bleeding diathesis; Von Willebrand factor; Pediatrics; Gastroenterology; Platelet","score_opus":0.006269166769258372,"score_gpt":0.2551807815896957,"score_spread":0.24891161482043733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906488389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954952,0.000112825066,0.0000017500471,0.00004132999,0.00001815512,0.0014181869,0.00002577513,0.000015085965,0.002871718],"genre_scores_gemma":[0.9994182,0.000024232475,0.00019930437,0.00003344407,0.000017553351,0.0002537082,0.000021657832,0.000012723824,0.000019201976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99929017,0.000011959446,0.00016925718,0.00015037923,0.00020141283,0.00017684104],"domain_scores_gemma":[0.9995682,0.000024425588,0.00010029755,0.00016212695,0.00012171444,0.000023194014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005271609,0.00009685307,0.000262252,0.000034534874,0.000032515283,0.000003375212,0.00005352363,0.000038282957,0.000025799316],"category_scores_gemma":[0.00002071798,0.000054405926,0.000036818372,0.0002471338,0.00011511167,0.000053942225,0.000025780537,0.000062211664,0.0000030786357],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012381683,0.006754334,0.99064195,0.00003489758,0.00042316483,0.0000140017155,0.0011607239,5.4071666e-8,0.000010187902,0.000087504,0.000021234007,0.00072811113],"study_design_scores_gemma":[0.008251941,0.0023300215,0.9833739,0.00017603918,0.0003623787,0.0000033336607,0.00012664302,0.0000042593097,0.0051428033,0.00006830574,0.0001053151,0.0000551073],"about_ca_topic_score_codex":0.00012872876,"about_ca_topic_score_gemma":0.00009362215,"teacher_disagreement_score":0.008128124,"about_ca_system_score_codex":0.000014308373,"about_ca_system_score_gemma":0.000025274363,"threshold_uncertainty_score":0.22186093},"labels":[],"label_agreement":null},{"id":"W2906562397","doi":"10.1182/blood-2018-99-115930","title":"Minimal Residual Disease Response at End of Induction and during Maintenance Correlates with Updated Outcome in the Phase III GALLIUM Study of Obinutuzumab- or Rituximab-Based Immunochemotherapy in Previously Untreated Follicular Lymphoma Patients","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Obinutuzumab; Follicular lymphoma; Minimal residual disease; Internal medicine; Bendamustine; Rituximab; Oncology; Alemtuzumab; Maintenance therapy; Induction chemotherapy; Hazard ratio; Chemotherapy regimen; Chemotherapy; Surgery; Immunology; Lymphoma; Bone marrow; Confidence interval; Transplantation","score_opus":0.011792630741376752,"score_gpt":0.26488086493538404,"score_spread":0.2530882341940073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906562397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99788654,0.00019553285,2.5475703e-7,0.000072410636,0.00001988209,0.0017702421,0.000034472334,0.000014759298,0.0000059177587],"genre_scores_gemma":[0.9996011,0.000024126857,0.000055425433,0.000044953245,0.000012669259,0.00013585128,0.000065705004,0.000022488952,0.00003763123],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983198,0.00024367077,0.00053935027,0.00033445354,0.00032028498,0.00024246388],"domain_scores_gemma":[0.9990209,0.00012406618,0.00024614204,0.00040531336,0.00012862735,0.000074986296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026459518,0.00022393953,0.00048121417,0.00018639865,0.00006259097,0.000010011188,0.00008908825,0.00006252296,0.000023930781],"category_scores_gemma":[0.00009567241,0.00012803008,0.00004237368,0.0003887468,0.00017747073,0.00006232903,0.000030776806,0.000050714236,0.0000013281036],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09748954,0.0243054,0.8721743,0.00005947895,0.00021324132,0.00047224373,0.0028548064,0.0000037392704,0.0022420215,9.261159e-7,0.00000905909,0.00017519105],"study_design_scores_gemma":[0.18756531,0.0077748024,0.7844918,0.00030046617,0.00037209256,0.000025535812,0.00061133556,0.000035399113,0.018713392,9.274386e-7,0.0000051355237,0.00010383572],"about_ca_topic_score_codex":0.0005340956,"about_ca_topic_score_gemma":0.00036394494,"teacher_disagreement_score":0.090075776,"about_ca_system_score_codex":0.00026076884,"about_ca_system_score_gemma":0.00021199477,"threshold_uncertainty_score":0.5220915},"labels":[],"label_agreement":null},{"id":"W2906744624","doi":"10.1182/blood-2018-99-118235","title":"Integrated Proteomic and Phosphoproteomic Analysis Reveal Novel Targets and Suggest Rationale for Ibrutinib Efficacy in UM-CLL","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Ibrutinib; Bruton's tyrosine kinase; Phosphorylation; Cancer research; Chronic lymphocytic leukemia; Proteome; Serine; Chemistry; Biology; Leukemia; Tyrosine kinase; Biochemistry; Signal transduction; Immunology","score_opus":0.021671160244736063,"score_gpt":0.29613637393494185,"score_spread":0.27446521369020577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906744624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963256,0.0003643694,0.00033768642,0.00042377197,0.000026672684,0.002255895,0.000053930464,0.00003352776,0.00017851849],"genre_scores_gemma":[0.98812765,0.00003726675,0.010391635,0.000113437476,0.00017648666,0.00022996902,0.00012482975,0.000027227401,0.00077152275],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99850905,0.00003096798,0.00034188826,0.0004893544,0.00025287305,0.0003758479],"domain_scores_gemma":[0.99907523,0.00019134543,0.000077832825,0.00029010515,0.00019551929,0.00016993943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005334749,0.00017935496,0.00043300432,0.0003066428,0.000089401176,0.000044715667,0.00009823606,0.00013713978,0.00007384838],"category_scores_gemma":[0.0006798264,0.00015181782,0.00007391032,0.0006231323,0.00025581336,0.00007076319,0.00008225987,0.00017460628,0.000012172904],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009881012,0.010297174,0.08993253,0.0019041771,0.0056016142,0.00024352802,0.0064094607,0.000044340857,0.8585237,0.0009560182,0.0034667403,0.0127397],"study_design_scores_gemma":[0.26198003,0.0023655081,0.23515703,0.0005095946,0.0025493836,0.0005290132,0.0003264986,0.065830275,0.42687246,0.00024976523,0.0027900734,0.0008403851],"about_ca_topic_score_codex":0.0008600803,"about_ca_topic_score_gemma":0.00032337615,"teacher_disagreement_score":0.43165126,"about_ca_system_score_codex":0.0007620848,"about_ca_system_score_gemma":0.0017389266,"threshold_uncertainty_score":0.6190951},"labels":[],"label_agreement":null},{"id":"W2906757730","doi":"10.1182/blood-2018-99-110470","title":"Unsuccessful Cytogenetics and Outcomes in Acute Leukemia","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Leukemia & Lymphoma Society of Canada","funders":"","keywords":"Cytogenetics; Medicine; Leukemia; Internal medicine; Acute leukemia; Oncology; Bone marrow; Myeloid leukemia; Karyotype; Chromosome abnormality; Biology; Chromosome","score_opus":0.016634628328675446,"score_gpt":0.308878373676749,"score_spread":0.2922437453480735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906757730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934431,0.00018390664,0.000022380787,0.00086734805,0.000045005552,0.00025942535,0.000008325646,0.000041209827,0.005129354],"genre_scores_gemma":[0.9947493,0.0002111653,0.0023832913,0.00055462966,0.00015960053,0.000014385779,0.000006891097,0.000025696223,0.0018950327],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989455,0.000028263847,0.00019160032,0.00026002902,0.00023931923,0.00033528995],"domain_scores_gemma":[0.9993485,0.000060184248,0.000029220093,0.00032311984,0.00008006282,0.00015888114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016192491,0.00012909195,0.00028762862,0.00016198508,0.00004507069,0.000020798036,0.00011840936,0.0001140331,0.000089085814],"category_scores_gemma":[0.00010972771,0.00010406106,0.00003380289,0.00023767557,0.0002038131,0.000046320336,0.00013759827,0.00022908385,0.00011060035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000075250784,0.00014243944,0.98255926,0.00003188115,0.00016219036,0.00030168658,0.00026267307,1.2696292e-7,0.01351591,0.00010358419,0.0005288332,0.002316188],"study_design_scores_gemma":[0.0095510995,0.00067975634,0.9087293,0.000054394117,0.00023433861,0.000313817,0.000091582195,0.00014724441,0.07617362,0.00018811817,0.003641781,0.00019491035],"about_ca_topic_score_codex":0.00010753049,"about_ca_topic_score_gemma":0.00008988158,"teacher_disagreement_score":0.0738299,"about_ca_system_score_codex":0.000119148644,"about_ca_system_score_gemma":0.00028055577,"threshold_uncertainty_score":0.42434865},"labels":[],"label_agreement":null},{"id":"W2906785804","doi":"10.1182/blood-2018-99-112631","title":"Inpatient Mortality and Length of Stay Among Direct-Acting Oral Anticoagulant (DOAC) and Warfarin Users Presenting with Major Hemorrhage","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; University of British Columbia","funders":"","keywords":"Medicine; Warfarin; Apixaban; Rivaroxaban; Dabigatran; Atrial fibrillation; Propensity score matching; Aspirin; Internal medicine; Cohort; Emergency medicine; Intensive care medicine","score_opus":0.0680582056749667,"score_gpt":0.320936023273744,"score_spread":0.25287781759877725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906785804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99596405,0.000054125645,0.000051648985,0.00007401644,0.000046412802,0.00035453407,0.0000029227922,0.000040186507,0.0034120858],"genre_scores_gemma":[0.9979838,0.000009636074,0.0015053313,0.000022149314,0.00015444645,0.0000010337139,0.000006001932,0.000014173782,0.00030341733],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991809,0.000031359523,0.0002212865,0.00020548582,0.00019894727,0.00016203492],"domain_scores_gemma":[0.99951035,0.000053050422,0.00015003973,0.00016036649,0.000053381093,0.00007281381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019944862,0.00011276879,0.0002808887,0.00006701231,0.000078638564,0.00002333321,0.000027835036,0.000035012647,0.000020323167],"category_scores_gemma":[0.000091318296,0.0000842259,0.000028463062,0.000113682254,0.00014403452,0.000117870964,0.000086133434,0.000054095482,7.569898e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006448353,0.000023803372,0.99757034,0.00017245048,0.00017573747,0.000017724897,0.00046103372,7.8106615e-7,0.0006480974,0.000022442584,0.000008021613,0.0008350912],"study_design_scores_gemma":[0.002517848,0.00022543373,0.986445,0.000041066913,0.00054676016,0.000005416761,0.00032986994,0.00063741556,0.008979176,0.0000070462725,0.00016086992,0.00010411366],"about_ca_topic_score_codex":0.0002794565,"about_ca_topic_score_gemma":0.00010498293,"teacher_disagreement_score":0.01112535,"about_ca_system_score_codex":0.0000056336835,"about_ca_system_score_gemma":0.000011861241,"threshold_uncertainty_score":0.34346327},"labels":[],"label_agreement":null},{"id":"W2906797443","doi":"10.1182/blood-2018-99-119079","title":"Hepatitis B Virus (HBV) Screening and Associated Outcomes in Malignant Hematology Patients Receiving Rituximab Therapy within the Rossy Cancer Network","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Rituximab; Internal medicine; HBsAg; Hepatitis B virus; Hepatitis B; Oncology; Cancer; Lymphoma; Immunology; Virus","score_opus":0.022862772058371037,"score_gpt":0.28334179350124045,"score_spread":0.2604790214428694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906797443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995446,0.002611348,0.000015077451,0.00071023294,0.00030965757,0.00053380703,0.000023209097,0.0000659617,0.00028467714],"genre_scores_gemma":[0.99544,0.0020581386,0.0005122952,0.0015519864,0.00016504878,0.00011348277,0.000009220306,0.00003806716,0.00011175203],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833035,0.00017731402,0.0004337195,0.00032492512,0.00026876703,0.00046489164],"domain_scores_gemma":[0.99907243,0.00023535825,0.0002096049,0.00024299479,0.00016966043,0.00006994897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004243193,0.00022376058,0.0006184678,0.000062655825,0.0003034702,0.00002966544,0.000106597734,0.00012584988,0.00004687636],"category_scores_gemma":[0.0004977761,0.00014900304,0.000057044257,0.00027657865,0.0002318349,0.0000741308,0.00011394555,0.000238295,0.000011920642],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005326443,0.00045466144,0.99487853,0.000009477465,0.00032668532,0.000027544409,0.0014405343,0.0000013088578,0.000090993024,0.000042448497,0.00043039303,0.0022441493],"study_design_scores_gemma":[0.0066519165,0.000352902,0.9908293,0.000359743,0.0000921519,0.000009165029,0.000025743073,0.00010740084,0.0010585014,0.0001066515,0.00023765166,0.00016891304],"about_ca_topic_score_codex":0.024611043,"about_ca_topic_score_gemma":0.19182478,"teacher_disagreement_score":0.16721374,"about_ca_system_score_codex":0.000050007853,"about_ca_system_score_gemma":0.00005572481,"threshold_uncertainty_score":0.9818842},"labels":[],"label_agreement":null},{"id":"W2906819145","doi":"10.1182/blood-2018-99-112982","title":"Imatinib Suspension and Validation (ISAV) Study: Final Results at 79 Months","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Discontinuation; Imatinib; Medicine; Internal medicine; Imatinib mesylate; Oncology; Surgery; Myeloid leukemia; Minimal residual disease; Gastroenterology; Leukemia","score_opus":0.034307350655045366,"score_gpt":0.2990021715276285,"score_spread":0.2646948208725831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906819145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99216765,0.00011275258,0.0000018394537,0.00025527674,0.00008982381,0.00068918767,0.000012371,0.0000669597,0.006604128],"genre_scores_gemma":[0.99683684,0.000022788914,0.0007617431,0.00006062586,0.00026984696,0.000017591537,0.00007450981,0.000018760004,0.0019373201],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891096,0.00004627654,0.0002489593,0.00033625806,0.0002640426,0.00019352729],"domain_scores_gemma":[0.99926656,0.000070039,0.000089001216,0.0003815681,0.00008711123,0.00010570162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019697762,0.00013762011,0.00020772839,0.000055351007,0.00012606209,0.000015475343,0.00004288859,0.00006295549,0.00013498047],"category_scores_gemma":[0.00019514385,0.00011263125,0.000029628809,0.00009688197,0.0000638864,0.00004852065,0.00009546195,0.00007521539,0.00023140381],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061190818,0.008326925,0.8706944,0.00021551552,0.001133319,0.0012201746,0.013808097,0.0000024293777,0.06018673,0.000119794975,0.015999286,0.022174276],"study_design_scores_gemma":[0.07952241,0.0062453565,0.7752038,0.00023527107,0.0012034146,0.0004987805,0.0004966824,0.00024447712,0.13375333,0.000121908655,0.0021640114,0.00031054948],"about_ca_topic_score_codex":0.00015741517,"about_ca_topic_score_gemma":0.0001326217,"teacher_disagreement_score":0.09549056,"about_ca_system_score_codex":0.00016896124,"about_ca_system_score_gemma":0.00008570644,"threshold_uncertainty_score":0.4592969},"labels":[],"label_agreement":null},{"id":"W2906849431","doi":"10.1182/blood-2018-99-110271","title":"Case Fatality Rate of Recurrent Venous Thromboembolism and Major Bleeding Events Among Patients Treated for Cancer-Associated Venous Thromboembolism: A Systematic Review","year":2018,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Columbian Hospital; University of Victoria; University of British Columbia","funders":"","keywords":"Medicine; Case fatality rate; Population; Cancer; Vitamin K antagonist; Low molecular weight heparin; Incidence (geometry); Randomized controlled trial; Internal medicine; Intensive care medicine; Pediatrics; Surgery; Warfarin; Heparin; Epidemiology; Atrial fibrillation","score_opus":0.0423992451104517,"score_gpt":0.3281736356932113,"score_spread":0.2857743905827596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906849431","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.038764086,0.93769467,0.0000024576682,0.000022223841,0.0007015339,0.020868829,0.0017051479,0.00014024826,0.00010077582],"genre_scores_gemma":[0.0052553834,0.9884113,0.000052943164,0.00016356687,0.0002687588,0.0043001724,0.0012171833,0.00026037125,0.00007028457],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9931901,0.0007141334,0.0030503948,0.0013583628,0.00063616363,0.0010508627],"domain_scores_gemma":[0.99357533,0.00041994374,0.0034467813,0.0012416478,0.0008613051,0.00045496968],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0017687783,0.0012883636,0.014124284,0.00041405254,0.00036746476,0.000060943104,0.0004587511,0.00063443644,0.000049114104],"category_scores_gemma":[0.0010782718,0.0010501721,0.0013215016,0.0008127243,0.00022292098,0.0001749941,0.00034674996,0.0004784912,0.000018189834],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001491967,0.009625827,0.00014188432,0.96863276,0.009745782,0.0002416495,0.00034334906,3.6290846e-8,5.9245934e-7,0.000034370085,0.0010779005,0.010140918],"study_design_scores_gemma":[0.003917269,0.0025048396,0.0011945508,0.8288217,0.15797289,0.00030926423,0.000044721834,0.0000050123585,0.000011905817,0.0000458935,0.0041502593,0.0010216885],"about_ca_topic_score_codex":0.0009897902,"about_ca_topic_score_gemma":0.00018914093,"teacher_disagreement_score":0.14822711,"about_ca_system_score_codex":0.00043915276,"about_ca_system_score_gemma":0.00037329466,"threshold_uncertainty_score":0.9999868},"labels":[],"label_agreement":null},{"id":"W2906981998","doi":"10.1182/blood-2018-99-111869","title":"Pomalidomide + Bortezomib + Low-Dose Dexamethasone Vs Bortezomib + Low-Dose Dexamethasone As Second-Line Treatment in Patients with Lenalidomide-Pretreated Multiple Myeloma: A Subgroup Analysis of the Phase 3 Optimismm Trial","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Fleurimont; Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Pomalidomide; Bortezomib; Dexamethasone; Lenalidomide; Medicine; Multiple myeloma; Internal medicine; Oncology; Subgroup analysis; Thalidomide; Confidence interval","score_opus":0.019588685657509066,"score_gpt":0.299463498173763,"score_spread":0.27987481251625396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906981998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991994,0.00027867517,0.00005503429,0.00014358197,0.0001701926,0.006131695,0.00081010256,0.00011131101,0.00030538664],"genre_scores_gemma":[0.99430835,0.000067643945,0.0026324845,0.00015267855,0.0002544929,0.00059271784,0.0010650788,0.00014594653,0.00078059995],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9931832,0.00076935475,0.0016282116,0.0014648559,0.0015328686,0.0014215164],"domain_scores_gemma":[0.9944614,0.0008834086,0.00082404417,0.002189385,0.00078073674,0.0008610349],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00079238875,0.0010419535,0.00255235,0.0013093096,0.0002846924,0.00008685724,0.00055716763,0.00040473568,0.0011277478],"category_scores_gemma":[0.0013636986,0.0006669636,0.00095293927,0.003667753,0.0007030246,0.00029874037,0.00021886303,0.00050675357,0.00006563313],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.33210835,0.049875792,0.58529973,0.00014717583,0.016670391,0.0007067243,0.000998213,0.00010187181,0.007499657,0.000007991297,0.000053033862,0.0065310565],"study_design_scores_gemma":[0.5110155,0.017144272,0.37662825,0.00028057233,0.0074493005,0.000025283263,0.00012163251,0.0026464465,0.08407742,0.000008521809,0.00006175802,0.0005410839],"about_ca_topic_score_codex":0.0030270573,"about_ca_topic_score_gemma":0.00415123,"teacher_disagreement_score":0.2086715,"about_ca_system_score_codex":0.00057793903,"about_ca_system_score_gemma":0.0008125878,"threshold_uncertainty_score":0.99978536},"labels":[],"label_agreement":null},{"id":"W2906996236","doi":"10.1182/blood-2018-99-116745","title":"Efficacy and Toxicity of JCAR014 in Combination with Durvalumab for the Treatment of Patients with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Durvalumab; Medicine; Fludarabine; Cyclophosphamide; Internal medicine; Tolerability; Combination therapy; Refractory (planetary science); Immunotherapy; Oncology; Gastroenterology; Immunology; Pharmacology; Chemotherapy; Adverse effect; Cancer; Nivolumab; Biology","score_opus":0.01234072366315731,"score_gpt":0.26925204596260044,"score_spread":0.25691132229944313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906996236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974875,0.00023950962,0.000032861604,0.00003896357,0.000020255498,0.0017485095,0.000018861132,0.000006140679,0.00040742],"genre_scores_gemma":[0.9991757,0.00013108851,0.00028061777,0.000012888433,0.000033217573,0.00007242233,0.000019964498,0.000022785733,0.00025129205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991082,0.000045451747,0.00018684875,0.00019111365,0.00030548108,0.00016288132],"domain_scores_gemma":[0.9988657,0.0003076008,0.00020568885,0.00029324956,0.00027741102,0.00005030158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001274621,0.00012200889,0.00027994314,0.000094434305,0.00004274291,0.000005220557,0.000062884465,0.000056752535,0.0000374944],"category_scores_gemma":[0.000038442435,0.00006772049,0.00003440973,0.00016663212,0.00025271837,0.000033713844,0.0000133624835,0.000039478324,7.579654e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043167666,0.058967322,0.6630809,0.0004451727,0.0009987527,0.000030060948,0.009940213,0.0000054408924,0.0853777,0.000028635044,0.000076112105,0.13788205],"study_design_scores_gemma":[0.107334696,0.03961367,0.5694038,0.000200284,0.00025308543,0.000004477629,0.00012755145,0.00009511239,0.2826183,0.000011131813,0.00024667816,0.000091209215],"about_ca_topic_score_codex":0.00008644802,"about_ca_topic_score_gemma":0.00007130193,"teacher_disagreement_score":0.1972406,"about_ca_system_score_codex":0.00006585694,"about_ca_system_score_gemma":0.00010858938,"threshold_uncertainty_score":0.27615613},"labels":[],"label_agreement":null},{"id":"W2907047034","doi":"10.1182/blood-2018-99-119189","title":"Impact of Perioperative Tranexamic Acid on Risk of Bleeding in Total Hip and Knee Arthroplasty: An Analysis of the Epcat II Data","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Tranexamic acid; Medicine; Rivaroxaban; Randomized controlled trial; Perioperative; Aspirin; Orthopedic surgery; Surgery; Arthroplasty; Population; Internal medicine; Warfarin; Blood loss","score_opus":0.02250795931234263,"score_gpt":0.29833865500200524,"score_spread":0.2758306956896626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907047034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987702,0.00015572285,0.000006819208,0.000040348386,0.000030234498,0.00030071646,0.00015564637,0.0000043119394,0.0005360271],"genre_scores_gemma":[0.9996566,0.00015734168,0.00008533624,0.000017595909,0.000033315373,0.000004201594,0.000024842242,0.00000885572,0.000011881276],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991103,0.00006336088,0.00027420706,0.00023171466,0.00018944376,0.00013099854],"domain_scores_gemma":[0.99908966,0.000037748756,0.00016231868,0.0006029565,0.00006161003,0.000045706834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028713662,0.00011015796,0.0005426778,0.00021201647,0.00005489548,0.0000049820565,0.00010572954,0.000041864903,0.00009712396],"category_scores_gemma":[0.000087800065,0.000069213704,0.00009862948,0.00041872048,0.0001944554,0.00007962045,0.00013152834,0.0000841684,4.8943735e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020382312,0.005654165,0.8966853,0.00011016757,0.006499986,0.000004863165,0.015475754,0.00026076107,0.06948021,0.0002395728,0.000039725997,0.0053456626],"study_design_scores_gemma":[0.0019978164,0.0030455478,0.9765137,0.00012242884,0.0038946394,0.0000025688958,0.0009674576,0.0015772615,0.011807095,0.0000037011855,0.000005938807,0.00006183429],"about_ca_topic_score_codex":0.0010454128,"about_ca_topic_score_gemma":0.000788551,"teacher_disagreement_score":0.079828404,"about_ca_system_score_codex":0.000014727356,"about_ca_system_score_gemma":0.0000471299,"threshold_uncertainty_score":0.28224528},"labels":[],"label_agreement":null},{"id":"W2907052423","doi":"10.1182/blood-2018-99-111528","title":"Immunotherapy with T-Cells Engineered with a Chimeric Antigen Receptor Bearing a Human CD19-Binding Single Chain Variable Fragment for Relapsed or Refractory Acute Lymphoblastic Leukemia and B-Cell Non-Hodgkin Lymphoma","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Fludarabine; Medicine; Cyclophosphamide; Bone marrow; Immunology; CD8; Leukemia; Antigen; Chimeric antigen receptor; Immunotherapy; Lymphoma; Cancer research; Internal medicine; Immune system; Chemotherapy","score_opus":0.012418857225724647,"score_gpt":0.24743296599175882,"score_spread":0.23501410876603418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907052423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928588,0.00021247166,0.0031162868,0.000029318611,0.000117137686,0.0019412244,0.000030440764,0.00014337832,0.0015509265],"genre_scores_gemma":[0.9496792,0.00016189183,0.03347859,0.00012958057,0.0005304532,0.00030031145,0.00007672526,0.0002999143,0.01534335],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99737716,0.000059382208,0.0004093565,0.00074996636,0.0005421262,0.0008619824],"domain_scores_gemma":[0.9984244,0.00020645976,0.00020278805,0.0006764738,0.00020096946,0.00028888698],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046308595,0.0004744596,0.00069158146,0.00033384893,0.0003691507,0.000114996066,0.0002302208,0.00020788371,0.00060782616],"category_scores_gemma":[0.000023572866,0.00035084196,0.00008332429,0.00059806503,0.0002382924,0.00014174641,0.00006926716,0.0002104494,0.000021924989],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006232619,0.0012315346,0.0005996522,0.00022358725,0.0009562001,0.00005452689,0.0012294976,0.000007977297,0.9872093,0.0000065268405,0.00015022716,0.0020983485],"study_design_scores_gemma":[0.050856978,0.0220791,0.0007823139,0.00075264124,0.00047102224,0.0002593478,0.0002878608,0.0007290192,0.9169617,0.000006175043,0.006153681,0.0006601518],"about_ca_topic_score_codex":0.0001474904,"about_ca_topic_score_gemma":0.00002230113,"teacher_disagreement_score":0.0702476,"about_ca_system_score_codex":0.00050744053,"about_ca_system_score_gemma":0.00064729946,"threshold_uncertainty_score":0.9998944},"labels":[],"label_agreement":null},{"id":"W2907079093","doi":"10.1182/blood-2018-99-110429","title":"Final Analysis of the Front-Line Phase III Randomized ACT-1 Trial in Younger Patients with Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated By Autologous Hematopoietic Stem Cell Transplant","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC; University Health Network","funders":"","keywords":"CHOP; Medicine; Alemtuzumab; Internal medicine; Clinical endpoint; Interim analysis; Peripheral T-cell lymphoma; Lymphoma; Randomized controlled trial; Surgery; Oncology; Transplantation; Immunology; Immune system; T cell","score_opus":0.011782559397960343,"score_gpt":0.2600723246321082,"score_spread":0.24828976523414786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907079093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942707,0.00030948702,0.00010703082,0.000037000606,0.000023387724,0.004775634,0.00013124858,0.00005164424,0.0002939006],"genre_scores_gemma":[0.996654,0.00009876806,0.00009075546,0.00007144484,0.00003934748,0.00022713881,0.00012812376,0.00007837837,0.0026120648],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99685115,0.00046324145,0.00076778873,0.0006251952,0.0007715803,0.00052104215],"domain_scores_gemma":[0.9982238,0.0001874609,0.00044317712,0.0006558515,0.00029670203,0.00019303845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044679188,0.00048993714,0.0022979567,0.0003093322,0.00010015319,0.000041147003,0.00022058956,0.00018627144,0.0005184474],"category_scores_gemma":[0.0000066995544,0.00023258747,0.00018148376,0.0009682578,0.0007730526,0.000085678184,0.00001852674,0.00022115592,0.0000014059927],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9338173,0.0057292692,0.03230419,0.00020566629,0.0035182121,0.000076831086,0.004066386,0.0000053125664,0.019837381,3.1058187e-7,0.000014040513,0.00042509308],"study_design_scores_gemma":[0.92360973,0.00883324,0.0009551554,0.00041409963,0.0062868507,0.00017854777,0.00035232512,0.0016344779,0.057402764,2.0775256e-7,0.000014758259,0.00031786368],"about_ca_topic_score_codex":0.0004761184,"about_ca_topic_score_gemma":0.00031434651,"teacher_disagreement_score":0.03756538,"about_ca_system_score_codex":0.00012604207,"about_ca_system_score_gemma":0.00046464454,"threshold_uncertainty_score":0.94846416},"labels":[],"label_agreement":null},{"id":"W2907087254","doi":"10.1182/blood-2018-99-116618","title":"Quantification of Fusion Transcripts Reveals Slower Treatment Kinetics As Compared with Multiparameter Flow Cytometry during Induction Treatment of Acute Myeloid Leukemia in Children","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; University Health Network","funders":"","keywords":"Minimal residual disease; Myeloid leukemia; Medicine; Bone marrow; Leukemia; Oncology; Flow cytometry; Internal medicine; Fusion transcript; Immunology; Fusion gene; Cancer research; Biology; Genetics","score_opus":0.02540567221413169,"score_gpt":0.293604899073447,"score_spread":0.2681992268593153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907087254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978559,0.00015438473,0.000111192436,0.000074800024,0.000048207457,0.001492029,0.00006707561,0.000036355155,0.00016007313],"genre_scores_gemma":[0.9934218,0.00041170703,0.005360859,0.000009652244,0.00012920027,0.00008129397,0.00020140415,0.000044264212,0.00033985157],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99809563,0.00009445893,0.00057351997,0.0004521424,0.00044563503,0.00033859783],"domain_scores_gemma":[0.9987483,0.0000430089,0.00021035639,0.00062316126,0.00024178771,0.00013341052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011504892,0.00028112868,0.00065498427,0.0005481715,0.000051871757,0.000010110038,0.00010860736,0.00017594817,0.000055823617],"category_scores_gemma":[0.00002654274,0.00020482943,0.000120973906,0.00068693224,0.0002198524,0.000088748275,0.000018441036,0.000118113516,0.000018396377],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023501734,0.0026063174,0.1260189,0.000059271893,0.00085518573,0.00002762349,0.0015483332,0.000043534506,0.86365485,0.0000025112495,0.000007991073,0.0028252853],"study_design_scores_gemma":[0.013677919,0.0046504065,0.42017072,0.00012978808,0.0005279312,0.00015769944,0.000074212476,0.00022179859,0.56026393,0.0000025786028,0.0000161201,0.000106877706],"about_ca_topic_score_codex":0.0008270665,"about_ca_topic_score_gemma":0.000066816065,"teacher_disagreement_score":0.30339095,"about_ca_system_score_codex":0.0010726943,"about_ca_system_score_gemma":0.0002624446,"threshold_uncertainty_score":0.83527017},"labels":[],"label_agreement":null},{"id":"W2907100365","doi":"10.1182/blood-2018-99-112067","title":"Nivolumab for Relapsed or Refractory Classical Hodgkin Lymphoma (cHL) after Autologous Hematopoietic Cell Transplantation (auto-HCT): Extended Follow-up of the Phase 2 Single-Arm CheckMate 205 Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Cohort; Internal medicine; Nivolumab; Oncology; Clinical endpoint; Transplantation; Refractory (planetary science); Brentuximab vedotin; Phases of clinical research; Surgery; Lymphoma; Toxicity; Clinical trial; Cancer; Immunotherapy; Hodgkin lymphoma","score_opus":0.02067717367996881,"score_gpt":0.281082601874021,"score_spread":0.2604054281940522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907100365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961198,0.00030410642,0.000079511,0.00024653756,0.00044441546,0.0021614956,0.000102556645,0.00009631943,0.000445261],"genre_scores_gemma":[0.9973638,0.00003223893,0.000597099,0.00017749211,0.00016504187,0.0005547091,0.000037368747,0.000057936242,0.0010142903],"study_design_codex":"nonrandomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979786,0.00012053075,0.00058752426,0.0005040346,0.00041549033,0.0003937937],"domain_scores_gemma":[0.9985914,0.00018789199,0.00025941225,0.00064839807,0.00016868256,0.00014420989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018679335,0.00032280985,0.0005925111,0.00009082663,0.00015059712,0.000025638055,0.00016821698,0.00018060119,0.00016935272],"category_scores_gemma":[0.00007200194,0.0001982548,0.00030656974,0.00021088467,0.0001866727,0.000078193254,0.000035666526,0.000072413524,0.000025703368],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07839602,0.5569861,0.053759284,0.0029401171,0.004221178,0.0032313915,0.03199382,0.0000010975205,0.1626495,0.00022336986,0.0039504897,0.10164766],"study_design_scores_gemma":[0.2402114,0.043464243,0.18172677,0.00053081027,0.0074248016,0.0005623927,0.0010062616,0.00013535186,0.52163726,0.00013456048,0.0026151326,0.00055103435],"about_ca_topic_score_codex":0.000048637707,"about_ca_topic_score_gemma":0.00012897822,"teacher_disagreement_score":0.51352185,"about_ca_system_score_codex":0.0001455804,"about_ca_system_score_gemma":0.00025459178,"threshold_uncertainty_score":0.8084596},"labels":[],"label_agreement":null},{"id":"W2907119357","doi":"10.1182/blood-2018-99-117636","title":"New Genomic Model Integrating Clinical Factors and Gene Mutations to Predict Overall Survival in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Diffuse large B-cell lymphoma; BCL6; Oncology; International Prognostic Index; Internal medicine; Medicine; CHOP; Lymphoma; Concordance; Biology; Cancer research; Immunology; B cell; Germinal center","score_opus":0.014994731413112701,"score_gpt":0.2550936897779762,"score_spread":0.2400989583648635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907119357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985994,0.00003228884,0.00019784797,0.00003856279,0.000027722223,0.00065472984,0.00008726058,0.000044338936,0.0003178584],"genre_scores_gemma":[0.99509126,0.000012318592,0.0043909424,0.00012964035,0.00007109313,0.000027645467,0.0001299963,0.00003599871,0.00011109756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875236,0.000038797236,0.00031244435,0.00039932,0.00021049392,0.00028655992],"domain_scores_gemma":[0.9991619,0.00008350218,0.00008372697,0.00025124566,0.00008920208,0.00033040225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000070974456,0.00023527694,0.00038036084,0.00009706255,0.0000713817,0.000030187224,0.0000546692,0.00008148891,0.0000113098695],"category_scores_gemma":[0.000036567584,0.00014232774,0.000044134013,0.0001382285,0.00004313857,0.00007007279,0.000041136736,0.00005708883,0.000009243406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051342696,0.009565975,0.98808,0.00000777582,0.00016325474,0.000025562993,0.0006125466,0.0000053229373,0.00006015735,0.000012519835,0.00003681022,0.0009166073],"study_design_scores_gemma":[0.07866862,0.0030749647,0.9161244,0.000082009625,0.00036752358,0.0000038940007,0.0000642727,0.00054377393,0.00089496665,0.000007100195,0.000017240682,0.00015121688],"about_ca_topic_score_codex":0.00054948864,"about_ca_topic_score_gemma":0.0006757496,"teacher_disagreement_score":0.07815519,"about_ca_system_score_codex":0.00009397253,"about_ca_system_score_gemma":0.00021045333,"threshold_uncertainty_score":0.5803957},"labels":[],"label_agreement":null},{"id":"W2907227169","doi":"10.1182/blood-2018-99-116915","title":"Intralesional Administration of the CD47 Antagonist TTI-621 (SIRPαFc) Induces Responses in Both Injected and Non-Injected Lesions in Patients with Relapsed/Refractory Mycosis Fungoides and Sézary Syndrome: Interim Results of a Multicenter Phase I Trial","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Therapeutics (Canada)","funders":"","keywords":"Medicine; CD47; Pharmacology; Tolerability; Neutropenia; Immune system; Immunology; Internal medicine; Chemotherapy; Adverse effect","score_opus":0.014648857214511632,"score_gpt":0.26201059051469283,"score_spread":0.24736173330018119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907227169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99870926,0.00026316693,0.0000014394699,0.000049332695,0.00014328882,0.0006240573,0.00018204481,0.000008514438,0.00001888247],"genre_scores_gemma":[0.9996792,0.00004451451,0.00006051182,0.000013673207,0.0000105240415,0.000018756036,0.00012759365,0.000011132789,0.000034058263],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99846137,0.00040647562,0.0006163451,0.00027250237,0.00006787121,0.0001754353],"domain_scores_gemma":[0.99902886,0.0002488119,0.00037636637,0.00023027735,0.00009725777,0.000018443601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027725744,0.00016310904,0.00033333036,0.00022501436,0.00009749248,0.000012048697,0.000117047304,0.00019949689,0.000012003114],"category_scores_gemma":[0.00030335784,0.000114362054,0.00003510515,0.00022023669,0.00049282855,0.00017974996,0.00008930734,0.0002048729,6.949665e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16953781,0.005456443,0.095387466,0.000046185938,0.00015204918,0.00000399313,0.0016010548,1.4506854e-7,0.72538275,0.000007263773,0.000046237186,0.0023786142],"study_design_scores_gemma":[0.070101984,0.005835057,0.75614315,0.00034515263,0.00005655409,0.000014385049,0.00015338446,0.0000029089542,0.16721861,0.000004157154,0.00002543948,0.000099198725],"about_ca_topic_score_codex":0.00014153897,"about_ca_topic_score_gemma":0.00029509005,"teacher_disagreement_score":0.6607557,"about_ca_system_score_codex":0.000020909483,"about_ca_system_score_gemma":0.00014240545,"threshold_uncertainty_score":0.4663549},"labels":[],"label_agreement":null},{"id":"W2907302590","doi":"10.1182/blood-2018-99-112858","title":"Results from the ITP World IMPACT Survey (I-WISh): Patients with Immune Thrombocytopenia (ITP) Experience Impaired Quality of Life (QoL) Regarding Daily Activities, Social Interactions, Emotional Well-Being and Working Lives","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Immune thrombocytopenia; Quality of life (healthcare); Family medicine; Gerontology; Internal medicine; Nursing","score_opus":0.03546193573118094,"score_gpt":0.30325094326290475,"score_spread":0.2677890075317238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907302590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979075,0.00017805959,0.000011780294,0.00012551928,0.00012190348,0.00033597607,0.00017496417,0.00003163448,0.0011126441],"genre_scores_gemma":[0.99906945,0.00002270079,0.00020169737,0.00006681793,0.00016796381,0.00001157756,0.00034055882,0.000023543509,0.00009565865],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982553,0.0002589919,0.00047129227,0.00036043485,0.00038193853,0.00027200094],"domain_scores_gemma":[0.9983607,0.0007321169,0.00039543025,0.00029139913,0.0001250869,0.000095248586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038433436,0.0002271526,0.0005767022,0.00006915259,0.00040836315,0.00007081091,0.00012222969,0.000051026866,0.000070245944],"category_scores_gemma":[0.00032567387,0.00014783874,0.00009972692,0.0002681816,0.0002695686,0.00027855055,0.000096418895,0.00019787195,0.0000034720204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002621688,0.00085229566,0.9831197,0.000010031737,0.00072104816,0.000008077673,0.010981888,4.2079353e-7,0.00062734773,0.0000067515584,0.0001340607,0.0009166449],"study_design_scores_gemma":[0.008881543,0.00028168948,0.9873959,0.00028671027,0.00012542319,0.000005363854,0.0017672065,0.000013634516,0.0010202173,0.00003535195,0.00003240649,0.00015454687],"about_ca_topic_score_codex":0.004604177,"about_ca_topic_score_gemma":0.0025783863,"teacher_disagreement_score":0.009214682,"about_ca_system_score_codex":0.00006172899,"about_ca_system_score_gemma":0.00012431902,"threshold_uncertainty_score":0.6960169},"labels":[],"label_agreement":null},{"id":"W2907303596","doi":"10.1182/blood-2018-99-119002","title":"Survival Advantage to Allogeneic Transplant in Patients with Myelofibrosis with Intermediate-1 or Higher DIPSS Score","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Transplantation; Myelofibrosis; International Prognostic Scoring System; Internal medicine; Adverse effect; Proportional hazards model; Surgery; Bone marrow; Myelodysplastic syndromes","score_opus":0.013722650090068289,"score_gpt":0.2441999052133536,"score_spread":0.23047725512328532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907303596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978081,0.000025326068,0.000020704594,0.00025328773,0.00010877773,0.0009696929,0.00009011716,0.000043023876,0.00068097987],"genre_scores_gemma":[0.99768555,0.000021725751,0.0009701492,0.0005230575,0.00013878172,0.00020027086,0.00010568307,0.000047771642,0.0003070149],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852234,0.00003992383,0.00023433585,0.00045051432,0.00037336696,0.00037950661],"domain_scores_gemma":[0.99922234,0.000056244637,0.000054426222,0.00029478586,0.00012209176,0.00025009993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005772387,0.00028753481,0.0004386845,0.00013282616,0.000054745342,0.000020001107,0.00008965281,0.000067986184,0.00035064633],"category_scores_gemma":[0.000009965354,0.00015514801,0.00003790336,0.0002826823,0.000088358385,0.00006994133,0.000025579402,0.00010310589,0.000074529504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048784483,0.0025232045,0.99042004,0.000050029208,0.0002470164,0.00024358965,0.0005610003,5.967028e-7,0.00020487823,0.000027303104,0.00005917536,0.0007847259],"study_design_scores_gemma":[0.01508511,0.010421266,0.9592313,0.00062189973,0.00029914465,0.000011960991,0.000043986995,5.074322e-7,0.013600689,0.0000014865008,0.00045697147,0.00022562937],"about_ca_topic_score_codex":0.000037227397,"about_ca_topic_score_gemma":0.0012266554,"teacher_disagreement_score":0.031188685,"about_ca_system_score_codex":0.000050122664,"about_ca_system_score_gemma":0.00008196142,"threshold_uncertainty_score":0.63267523},"labels":[],"label_agreement":null},{"id":"W2907316332","doi":"10.1182/blood-2018-99-110483","title":"Fostamatinib, a Spleen Tyrosine Kinase Inhibitor, for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia: Initial Results of the Multicenter, Open-Label Extension Period of the Soar Phase 2 Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Autoimmune hemolytic anemia; Syk; Medicine; Anemia; Antibody; Internal medicine; Immunology; Gastroenterology; Pharmacology; Tyrosine kinase; Receptor","score_opus":0.04474451519208964,"score_gpt":0.35827260273701017,"score_spread":0.3135280875449205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907316332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921351,0.0008465076,0.000022067396,0.0010321138,0.000378634,0.005206492,0.000285989,0.0000131203105,0.00007997813],"genre_scores_gemma":[0.9991236,0.000081672806,0.00032786065,0.00006713651,0.00017281184,0.00006639887,0.000028095183,0.000031873227,0.000100560734],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981352,0.000121187266,0.00079398067,0.00032219407,0.0003932923,0.00023415964],"domain_scores_gemma":[0.99781436,0.00019245256,0.0004175162,0.0011459294,0.00037972367,0.00005002247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042028032,0.00023762882,0.00057550747,0.000046193018,0.0002706033,0.000016193986,0.00038858788,0.0000923305,0.000012221216],"category_scores_gemma":[0.00017424332,0.00010623265,0.00018364972,0.00029458743,0.00036174056,0.000058626865,0.00017418466,0.0001224346,9.143741e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011327339,0.10194597,0.0038398628,0.00030832374,0.0006164239,0.000023363425,0.013421493,0.0000011215284,0.8562699,0.000029086297,0.00012158091,0.012095528],"study_design_scores_gemma":[0.19362594,0.023431811,0.027419602,0.0007545173,0.0032704084,0.000037912898,0.0017930656,0.0005845121,0.74846596,0.000012732876,0.00046467903,0.00013887827],"about_ca_topic_score_codex":0.0005721753,"about_ca_topic_score_gemma":0.00009699013,"teacher_disagreement_score":0.1822986,"about_ca_system_score_codex":0.000020935042,"about_ca_system_score_gemma":0.00014253324,"threshold_uncertainty_score":0.43320417},"labels":[],"label_agreement":null},{"id":"W2907355714","doi":"10.1182/blood-2018-99-119201","title":"Results from Ongoing Phase 1/2 Clinical Trial of Tagraxofusp (SL-401) in Patients with Intermediate or High Risk Relapsed/Refractory Myelofibrosis","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Refractory (planetary science); Regimen; Myelofibrosis; Internal medicine; Interleukin-3 receptor; Clinical trial; Oncology; Cohort; Malignancy; Stage (stratigraphy); Gastroenterology; Myeloid; Bone marrow; Biology","score_opus":0.02825834787298184,"score_gpt":0.31896612430573273,"score_spread":0.2907077764327509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907355714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99708056,0.000027613722,0.000008366075,0.00008827323,0.00046756177,0.0012491206,0.0007491968,0.000031213956,0.00029808265],"genre_scores_gemma":[0.99658453,0.00021231943,0.0017803601,0.00013385754,0.00072275073,0.0000828259,0.0003470712,0.000039268944,0.00009699606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970607,0.0002726172,0.0012146605,0.0006474597,0.00048285472,0.0003217183],"domain_scores_gemma":[0.9971899,0.0010861796,0.00064506126,0.00060794066,0.00023652613,0.00023443463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045060666,0.0002998909,0.0008791742,0.00015723874,0.000066504595,0.000018371333,0.00012401615,0.00020938608,0.00023591207],"category_scores_gemma":[0.0012900258,0.000188687,0.00014582984,0.00025232838,0.00024278546,0.00011033721,0.00006951574,0.00034879553,0.0000743938],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23888496,0.023882808,0.7204845,0.000016746517,0.0005846418,0.00006612139,0.0004968208,2.1417905e-7,0.00003803945,0.000005922623,0.0004863183,0.015052914],"study_design_scores_gemma":[0.39751467,0.035627443,0.5611274,0.0003893792,0.00059079647,7.1091216e-7,0.000027556385,0.00000670458,0.0041743116,0.000015690202,0.00037733576,0.0001479479],"about_ca_topic_score_codex":0.00068540435,"about_ca_topic_score_gemma":0.0009491706,"teacher_disagreement_score":0.15935704,"about_ca_system_score_codex":0.00005760342,"about_ca_system_score_gemma":0.00021998567,"threshold_uncertainty_score":0.7694433},"labels":[],"label_agreement":null},{"id":"W2907443362","doi":"10.1182/blood-2018-99-119302","title":"Results from Ongoing Phase 1/2 Clinical Trial of Tagraxofusp (SL-401) in Patients with Relapsed/Refractory Chronic Myelomonocytic Leukemia (CMML)","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Chronic myelomonocytic leukemia; Internal medicine; Refractory (planetary science); Interleukin-3 receptor; Regimen; Oncology; Decitabine; Azacitidine; Gastroenterology; Leukemia; Myelodysplastic syndromes; Bone marrow; Biology","score_opus":0.0379540287808474,"score_gpt":0.34927666036952626,"score_spread":0.31132263158867884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907443362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99501854,0.00019444746,0.000015880134,0.000046983714,0.00041231266,0.0016211793,0.00010794199,0.00006926106,0.0025134804],"genre_scores_gemma":[0.99692285,0.00010155711,0.0005800708,0.0000675149,0.0016422997,0.00003791624,0.00024690846,0.000077751865,0.00032313],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99522007,0.0002957762,0.0016674727,0.0009305848,0.0011377707,0.0007483407],"domain_scores_gemma":[0.9962392,0.0010868902,0.00052399316,0.001428882,0.00033483858,0.00038620978],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012561447,0.00035006218,0.0009936279,0.0002848066,0.00007363474,0.000025633644,0.000387449,0.0004112324,0.00014959581],"category_scores_gemma":[0.002273299,0.00027992768,0.00020290248,0.0005765472,0.0006713803,0.00017561056,0.00019600091,0.0007941538,0.000160119],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.8180576,0.03628063,0.024648108,0.00042049654,0.0017026773,0.0009602985,0.0019503247,0.000015963074,0.0017363994,0.00004859312,0.0027695321,0.11140938],"study_design_scores_gemma":[0.9507207,0.0237608,0.01573885,0.0008095573,0.00039982132,0.000010073353,0.00005085378,0.0010796712,0.0051580747,0.000030444373,0.0019175075,0.0003236175],"about_ca_topic_score_codex":0.0017535938,"about_ca_topic_score_gemma":0.0005510647,"teacher_disagreement_score":0.13266313,"about_ca_system_score_codex":0.008117394,"about_ca_system_score_gemma":0.01622927,"threshold_uncertainty_score":0.9999653},"labels":[],"label_agreement":null},{"id":"W2907519508","doi":"10.1182/blood-2018-99-117363","title":"Real-World Outcomes with Bortezomib-Containing Regimens and Lenalidomide Plus Dexamethasone for the Treatment of Transplant Ineligible MM Patients: A Multi-Institutional Report from the National Myeloma Canada Research Network (MCRN) Database","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; University Health Network; Ottawa Hospital; CancerCare Manitoba; Saint John Regional Hospital; Leukemia & Lymphoma Society of Canada; University of New Brunswick; Hôpital Maisonneuve-Rosemont; University of Calgary; Princess Margaret Cancer Centre; University of Ottawa; McGill University Health Centre","funders":"","keywords":"Lenalidomide; Multiple myeloma; Medicine; Bortezomib; Dexamethasone; Exact test; Internal medicine; Log-rank test; Regimen; Oncology; Survival analysis","score_opus":0.08947436621363755,"score_gpt":0.36217797116085987,"score_spread":0.27270360494722234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907519508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99427384,0.0005211549,0.0002820028,0.0012661755,0.00007552009,0.0020234191,0.0012045441,0.000016324351,0.00033699567],"genre_scores_gemma":[0.9920958,0.00028940226,0.0052313474,0.00012891866,0.00037423012,0.00045025628,0.0009707302,0.000023336233,0.00043593772],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974957,0.000110763525,0.00039353708,0.00041810333,0.0010578405,0.000524022],"domain_scores_gemma":[0.9961687,0.0023492028,0.00014169466,0.00042282138,0.00072481815,0.00019281352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007359448,0.00022287092,0.00040194477,0.00007939496,0.00066804804,0.00002949183,0.00013852218,0.000041193456,0.000023485947],"category_scores_gemma":[0.00039314633,0.00010264608,0.00007199541,0.00028544426,0.00043607206,0.00007366073,0.00003953273,0.00014376805,0.0000011786157],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00459827,0.0011214342,0.98824507,0.000029664834,0.0022729093,0.00030434784,0.00050470425,0.000035992558,0.00013144652,0.00024184356,0.0014516829,0.001062641],"study_design_scores_gemma":[0.03481646,0.0014897417,0.9527583,0.00026373236,0.00057774264,0.000084561325,0.00020566466,0.0012649418,0.0023143457,0.000037545782,0.006032318,0.00015463213],"about_ca_topic_score_codex":0.42872465,"about_ca_topic_score_gemma":0.68456256,"teacher_disagreement_score":0.25583792,"about_ca_system_score_codex":0.00037738946,"about_ca_system_score_gemma":0.0021882022,"threshold_uncertainty_score":0.5750795},"labels":[],"label_agreement":null},{"id":"W2907543221","doi":"10.1182/blood-2018-99-112378","title":"Patients with Immune Thrombocytopenia (ITP) Frequently Experience Severe Fatigue but Is It Under-Recognized By Physicians: Results from the ITP World Impact Survey (I-WISh)","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Immune thrombocytopenia; Quality of life (healthcare); Anxiety; Demographics; Internal medicine; Pediatrics; Physical therapy; Platelet; Demography; Psychiatry","score_opus":0.037519464801031396,"score_gpt":0.29564613090906494,"score_spread":0.25812666610803353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907543221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99191904,0.0003871975,0.000018680497,0.0007756875,0.00013422414,0.0008667763,0.0034466574,0.000055996756,0.0023957165],"genre_scores_gemma":[0.9943855,0.00005784018,0.00018542694,0.0015931453,0.00009012045,0.000040317518,0.0024113792,0.000055573015,0.0011806901],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99769616,0.00014450468,0.00045168208,0.00064086093,0.0005401374,0.0005266452],"domain_scores_gemma":[0.9981209,0.00031561207,0.0002881595,0.00085580465,0.00027075937,0.00014876375],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015869796,0.00041826713,0.00070216454,0.000046565576,0.0002821646,0.00009388898,0.00032448367,0.00010278302,0.0005083087],"category_scores_gemma":[0.00013035584,0.00024943083,0.00013734128,0.00046465074,0.00025369675,0.0002577756,0.00007603072,0.00022871608,0.00018737263],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053027426,0.007196637,0.905031,0.000016279897,0.0035796748,0.00011707017,0.010217575,0.000001496541,0.0041304743,0.0000026907405,0.059488337,0.004915974],"study_design_scores_gemma":[0.033973835,0.001223218,0.9458697,0.0003732999,0.00046894827,0.0000096675885,0.00086621125,0.000013088028,0.016031265,0.00008677353,0.0006268737,0.0004571045],"about_ca_topic_score_codex":0.0137918275,"about_ca_topic_score_gemma":0.0037384334,"teacher_disagreement_score":0.058861464,"about_ca_system_score_codex":0.00007514784,"about_ca_system_score_gemma":0.000118433345,"threshold_uncertainty_score":0.99999577},"labels":[],"label_agreement":null},{"id":"W2907573039","doi":"10.1182/blood-2018-99-115527","title":"Outcome of Patients with Aggressive B Cell Lymphomas Who Receive Second-Line Salvage Immunochemotherapy Following Treatment Failure of Intensive First-Line Immunochemotherapy","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Salvage therapy; Internal medicine; Oncology; Bendamustine; Diffuse large B-cell lymphoma; Transplantation; Rituximab; Venetoclax; Chemotherapy regimen; Lymphoma; Surgery; Chemotherapy; Leukemia; Chronic lymphocytic leukemia","score_opus":0.013170153013662008,"score_gpt":0.2739594107118696,"score_spread":0.26078925769820754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907573039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99581355,0.0013859719,0.000044817127,0.00020949033,0.00013232567,0.0013994694,0.000114000446,0.00004945035,0.00085092837],"genre_scores_gemma":[0.9956801,0.00028158378,0.0017583126,0.00035475497,0.00018495326,0.000051154188,0.00014400117,0.00012646684,0.0014186675],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99709255,0.00007486169,0.00089484785,0.0005839284,0.0007557116,0.0005980845],"domain_scores_gemma":[0.9959069,0.00025087953,0.00076039764,0.0011578286,0.0017428825,0.00018112668],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018395239,0.0005072645,0.0012757871,0.00026047076,0.00010594454,0.00001637175,0.0003234241,0.00024681076,0.0005620585],"category_scores_gemma":[0.00021521703,0.00036185022,0.00041115886,0.00048792665,0.00044800207,0.00011601068,0.00008800779,0.00018655896,0.000025584335],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048085887,0.04244241,0.5400156,0.004464797,0.028409429,0.001856823,0.05126604,0.000040203242,0.24280655,0.00007078127,0.0031648949,0.037376594],"study_design_scores_gemma":[0.17048566,0.010174237,0.012968754,0.0009386426,0.0005810066,0.000058868034,0.00069070904,0.000116428135,0.8025927,0.000029515784,0.0009697787,0.00039373426],"about_ca_topic_score_codex":0.0005254088,"about_ca_topic_score_gemma":0.00018965127,"teacher_disagreement_score":0.5597861,"about_ca_system_score_codex":0.002244186,"about_ca_system_score_gemma":0.0014805462,"threshold_uncertainty_score":0.99988335},"labels":[],"label_agreement":null},{"id":"W2907581136","doi":"10.1182/blood.v130.suppl_1.5272.5272","title":"The Real-World Treatment of Polycythemia Vera: Adherence to Treatment Guidelines and Outcomes","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Juravinski Cancer Centre; McMaster University","funders":"","keywords":"Medicine; Polycythemia vera; Phlebotomy; Internal medicine; Aspirin; Hazard ratio; Thrombocytosis; Guideline; Thrombosis; Cohort; Retrospective cohort study; Surgery; Pediatrics; Confidence interval","score_opus":0.08085762637258775,"score_gpt":0.38188358250009796,"score_spread":0.3010259561275102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907581136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861931,0.0009258482,0.000001256322,0.007177556,0.00010506353,0.0008294706,0.00003658311,0.000021750506,0.004709323],"genre_scores_gemma":[0.98495436,0.004783032,0.0012211339,0.000106895495,0.00013033459,0.00033785604,0.000007155475,0.000017599756,0.008441644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989666,0.000020438523,0.0003262967,0.0002866392,0.0001776248,0.00022241328],"domain_scores_gemma":[0.9985892,0.0001851348,0.00015917886,0.00077371916,0.00011681831,0.00017591263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006534685,0.00024267359,0.0004881963,0.000046655776,0.00039221783,0.00005880523,0.00009275997,0.000036986818,0.000027998087],"category_scores_gemma":[0.00011538497,0.00011811879,0.00012619587,0.00003795044,0.00009291907,0.00003555885,0.000040393894,0.000023618619,0.000021224418],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015093565,0.001370652,0.9246663,0.000009419153,0.0006916913,0.00005406656,0.0003437965,3.633946e-7,0.00045582588,0.0007074952,0.00023576347,0.0713137],"study_design_scores_gemma":[0.007817389,0.005351943,0.8926958,0.00009350547,0.0006979616,0.000016872124,0.00006923126,0.000006180415,0.07609764,0.00007588815,0.016948642,0.00012899007],"about_ca_topic_score_codex":0.002655723,"about_ca_topic_score_gemma":0.0035426628,"teacher_disagreement_score":0.07564181,"about_ca_system_score_codex":0.00008802817,"about_ca_system_score_gemma":0.00009509614,"threshold_uncertainty_score":0.48167446},"labels":[],"label_agreement":null},{"id":"W2907595676","doi":"10.1182/blood-2018-08-870089","title":"Identification and targeting of novel CDK9 complexes in acute myeloid leukemia","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"National Cancer Institute; National Institutes of Health; Northwestern University; National Institute of General Medical Sciences; Robert H. Lurie Comprehensive Cancer Center; U.S. Department of Veterans Affairs","keywords":"PI3K/AKT/mTOR pathway; Myeloid leukemia; Biology; EIF4E; Cancer research; Cell biology; Phosphorylation; Signal transduction; Messenger RNA; Translation (biology); Gene; Genetics","score_opus":0.0119273523527831,"score_gpt":0.2629353472591664,"score_spread":0.2510079949063833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907595676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980573,0.00055225467,0.0010008964,0.000024512987,0.00007386736,0.00006978739,0.00002337664,0.0000052771325,0.00019273063],"genre_scores_gemma":[0.99787056,0.00006239181,0.0017087203,0.000044981804,0.00017265501,0.000007326581,0.0000353302,0.000010527833,0.00008752434],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99943084,0.00001424659,0.00017663733,0.00019916146,0.00006644465,0.0001126939],"domain_scores_gemma":[0.9996607,0.0000071031177,0.000086310705,0.0001565198,0.00006616585,0.000023252991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014815362,0.00006896512,0.000090113535,0.000029021776,0.00002890524,0.000009947419,0.00010066504,0.00007194993,0.0000071782038],"category_scores_gemma":[0.00004567353,0.00007190091,0.00002077017,0.00006176013,0.00010476814,0.0000029873022,0.00006022951,0.0000378346,0.0000018693039],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017781831,0.00004897848,0.006436881,0.0000134314505,0.0000336953,4.1506192e-7,0.000064767635,0.0000052925616,0.9929236,0.000033276512,0.00021241177,0.0002094443],"study_design_scores_gemma":[0.00084606995,0.000102243466,0.009958911,0.000017239234,0.000024505234,0.0000060278244,0.000024178144,0.000092007926,0.98773,0.00003207639,0.001082665,0.00008407088],"about_ca_topic_score_codex":0.000035111323,"about_ca_topic_score_gemma":0.000032379146,"teacher_disagreement_score":0.0051936186,"about_ca_system_score_codex":0.00000891808,"about_ca_system_score_gemma":0.000045171368,"threshold_uncertainty_score":0.2932034},"labels":[],"label_agreement":null},{"id":"W2907712464","doi":"10.1182/blood-2018-99-117672","title":"Checkpoint Blockade Therapy May Sensitize Hodgkin Lymphoma to Subsequent Therapy","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Blockade; Lymphoma; Hodgkin lymphoma; Oncology; Internal medicine; Immunology","score_opus":0.02823176709554303,"score_gpt":0.28415972426768377,"score_spread":0.25592795717214073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907712464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98688215,0.0013168496,0.000006954566,0.005119051,0.00022657705,0.00083764654,0.0000139099,0.00015989813,0.0054369923],"genre_scores_gemma":[0.9915667,0.0008336659,0.0013684203,0.0042381925,0.0009623967,0.00013862463,0.000015374271,0.000052317006,0.0008242812],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983536,0.000054119126,0.00029443362,0.0004735821,0.00036307113,0.00046119222],"domain_scores_gemma":[0.9987415,0.00005148938,0.00006856353,0.00064207346,0.00015538416,0.00034099704],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001703234,0.0003011568,0.0004023501,0.00010926134,0.00011858613,0.000041758733,0.00010727854,0.00011580509,0.00035658354],"category_scores_gemma":[0.000026125712,0.00021370182,0.00020238331,0.00024297857,0.00008915291,0.000035894143,0.000040037383,0.00004412601,0.000790287],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00264943,0.022453513,0.2092517,0.000040072246,0.0030636396,0.0024223416,0.0045320517,0.0000012679291,0.4297258,0.00084217533,0.0085772965,0.31644073],"study_design_scores_gemma":[0.016903007,0.002439973,0.26410428,0.0000644069,0.00009452297,0.00037400317,0.000055977383,0.000004607082,0.6662885,0.00006091398,0.04938181,0.00022797109],"about_ca_topic_score_codex":0.00032560597,"about_ca_topic_score_gemma":0.000028322613,"teacher_disagreement_score":0.31621274,"about_ca_system_score_codex":0.00013084404,"about_ca_system_score_gemma":0.00016011835,"threshold_uncertainty_score":0.9999877},"labels":[],"label_agreement":null},{"id":"W2907714971","doi":"10.1182/blood-2018-99-116241","title":"Identification of High Risk Group for Leukemic Transformation in Higher Risk MDS Patients Using Targeted RNA-Sequencing: Hematopoietic Stem Cell Signature As a High Risk Profile for Leukemic Transformation","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Occupational Cancer Research Centre; University of Toronto","funders":"","keywords":"Decitabine; Oncology; Azacitidine; Internal medicine; Myelodysplastic syndromes; Leukemia; Myeloid; Myeloid leukemia; Bone marrow; International Prognostic Scoring System; Medicine; Biology; Bioinformatics; Computational biology; Gene; Genetics; DNA methylation; Gene expression","score_opus":0.018564046637274016,"score_gpt":0.26255205115011615,"score_spread":0.24398800451284214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907714971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9670208,0.00015678794,0.02473207,0.000050981507,0.00031583253,0.0062485654,0.0012520704,0.000115885894,0.00010700859],"genre_scores_gemma":[0.99372745,0.000180408,0.0036755959,0.00003829925,0.00024746536,0.0006246527,0.0012169704,0.00011373818,0.00017543879],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99603796,0.00028839477,0.0015495357,0.0006181464,0.00078025943,0.0007256752],"domain_scores_gemma":[0.9969214,0.00033489597,0.0011245969,0.00056113617,0.00087169226,0.00018627799],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001405831,0.0004333453,0.00071851315,0.00064185925,0.00033290815,0.0000532326,0.00031511008,0.00059669284,0.00004762494],"category_scores_gemma":[0.00021194218,0.00037680162,0.00027842773,0.000813694,0.0001576793,0.0007501471,0.000026109015,0.00071863295,0.000029174966],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00490466,0.0026004112,0.009796126,0.0068801045,0.00082168076,0.000006811657,0.026345093,0.0011225134,0.9265928,0.0014243135,0.0007465447,0.018758902],"study_design_scores_gemma":[0.0346764,0.0035595282,0.013895864,0.00041579164,0.0016962532,0.00001396247,0.0012616221,0.03865603,0.9027392,0.0024528636,0.00015992658,0.0004725438],"about_ca_topic_score_codex":0.0017552365,"about_ca_topic_score_gemma":0.00006416777,"teacher_disagreement_score":0.037533518,"about_ca_system_score_codex":0.0014312108,"about_ca_system_score_gemma":0.00063628994,"threshold_uncertainty_score":0.9998684},"labels":[],"label_agreement":null},{"id":"W2907779296","doi":"10.1182/blood-2018-99-119824","title":"Structural Variation within the Beta-Globin Gene Cluster Among HbS Haplotype Groups","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Haplotype; Restriction fragment length polymorphism; Genetics; Globin; Biology; Gene cluster; Locus (genetics); Gene; Allele; Genotype","score_opus":0.008510431590912713,"score_gpt":0.22120877462988167,"score_spread":0.21269834303896895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907779296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99322975,0.00020760339,0.0002731867,0.0017135023,0.00051294395,0.00038752792,0.000004624098,0.0000892307,0.0035816128],"genre_scores_gemma":[0.9964651,0.000012148167,0.00097155414,0.0011758149,0.00062203326,0.000009115404,0.000023660106,0.000027076747,0.0006934867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898255,0.000058360893,0.00025626374,0.00022687862,0.0002427965,0.00023313517],"domain_scores_gemma":[0.99932796,0.000028661843,0.00010830035,0.00033941245,0.00010141934,0.00009423087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023797926,0.00014615241,0.00017492837,0.000043281376,0.00021325791,0.00003237508,0.000111833295,0.00016952379,0.00016948639],"category_scores_gemma":[0.00006103521,0.000084565516,0.000077744655,0.00020152124,0.00015537687,0.000077808436,0.000053267548,0.00023975105,0.00013784479],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023946806,0.002658545,0.736205,0.00055414427,0.006318625,0.00041987625,0.061158713,0.00081677845,0.12037081,0.023401015,0.028753588,0.016948225],"study_design_scores_gemma":[0.01358056,0.0015921956,0.93895906,0.00016246174,0.0021977306,0.00067905703,0.000991821,0.015957825,0.020811697,0.002130396,0.0023058841,0.000631326],"about_ca_topic_score_codex":0.00020521504,"about_ca_topic_score_gemma":0.000080925056,"teacher_disagreement_score":0.20275405,"about_ca_system_score_codex":0.000021009148,"about_ca_system_score_gemma":0.000057757105,"threshold_uncertainty_score":0.34484816},"labels":[],"label_agreement":null},{"id":"W2907826353","doi":"10.1182/blood-2018-99-115341","title":"Biosimilar G-CSF Versus Originator G-CSF for Autologous Peripheral Blood Stem Cell Mobilization: A Comparative Analysis of Mobilization and Engraftment","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Saskatchewan; Saskatchewan Cancer Agency","funders":"","keywords":"Biosimilar; Plerixafor; Medicine; Mobilization; Apheresis; Internal medicine","score_opus":0.034531517415535846,"score_gpt":0.3129585065225609,"score_spread":0.27842698910702507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907826353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909206,0.0033023034,0.0032729264,0.00012558336,0.00043401445,0.0007371846,0.00028095956,0.00006843799,0.0008579594],"genre_scores_gemma":[0.99534047,0.00010791126,0.0037796067,0.00010151518,0.00004150503,0.0000631573,0.000096721706,0.000012026911,0.00045711815],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99848706,0.00023567116,0.00042889448,0.0004785251,0.00005722286,0.00031263148],"domain_scores_gemma":[0.99875754,0.00031209906,0.00021673195,0.00030147788,0.000363816,0.000048310125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029232042,0.00024069696,0.00065640523,0.00020563186,0.00019627853,0.000023675706,0.00016019319,0.0003163758,0.00029382642],"category_scores_gemma":[0.000035366553,0.00019759146,0.00019552186,0.0006471222,0.0005203152,0.00007197209,0.00006422065,0.000104224244,0.0000045961187],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006589573,0.013034147,0.039457213,0.0006175834,0.042128637,0.000014582906,0.008140321,0.00013488205,0.85864645,0.020695377,0.0031527216,0.0073885173],"study_design_scores_gemma":[0.00943958,0.0038304296,0.0031586795,0.000022287648,0.011274857,0.000008162902,0.00082567765,0.0013301795,0.9593132,0.00011137705,0.010286856,0.0003987081],"about_ca_topic_score_codex":0.00001314692,"about_ca_topic_score_gemma":0.00005372495,"teacher_disagreement_score":0.10066676,"about_ca_system_score_codex":0.000021278633,"about_ca_system_score_gemma":0.0000537291,"threshold_uncertainty_score":0.80575466},"labels":[],"label_agreement":null},{"id":"W2907883664","doi":"10.1182/blood-2018-99-117333","title":"Obinutuzumab Plus Gemcitabine, Dexamethasone and Cisplatin (O-GDP) As Salvage Chemotherapy Prior to Autologous Stem Cell Transplant in Aggressive B Cell Lymphoma","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University Health Network; University of Toronto; BC Cancer Agency; Simon Fraser University; Princess Margaret Cancer Centre","funders":"","keywords":"Obinutuzumab; Medicine; Rituximab; Internal medicine; Oncology; Salvage therapy; Follicular lymphoma; Gemcitabine; Chemotherapy regimen; Autologous stem-cell transplantation; Regimen; Aggressive lymphoma; Lymphoma; Chemotherapy; Surgery","score_opus":0.01397642299068248,"score_gpt":0.27317063032083616,"score_spread":0.2591942073301537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907883664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98482174,0.0015758708,0.00009064739,0.00040847136,0.00011663041,0.0015980562,0.000036865033,0.00010957692,0.011242128],"genre_scores_gemma":[0.9862913,0.0005238869,0.0021022866,0.00083926873,0.00027274757,0.00010178166,0.00001576133,0.00011190299,0.009741055],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99716014,0.00015160782,0.00048604066,0.00078449765,0.00058422575,0.000833467],"domain_scores_gemma":[0.9983144,0.0002735478,0.00016020522,0.0006618062,0.00013319762,0.00045686506],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00045345887,0.00040558062,0.0007463313,0.00038583975,0.00011163518,0.000055819386,0.00027612527,0.00029481578,0.0009782028],"category_scores_gemma":[0.000034692912,0.00036606746,0.00011601174,0.00057698693,0.00021955499,0.00007503258,0.00007761782,0.00031002486,0.0002278498],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006154206,0.0017896907,0.006553131,0.0005187105,0.0002018527,0.0029860034,0.017137896,0.0000057420707,0.8269645,0.00003396581,0.00064970925,0.13700461],"study_design_scores_gemma":[0.05326263,0.0048516397,0.030376062,0.00049498543,0.00020895322,0.0011366749,0.0005956533,0.00041736962,0.9021754,0.000058166363,0.005728878,0.00069356646],"about_ca_topic_score_codex":0.00048324172,"about_ca_topic_score_gemma":0.00021305917,"teacher_disagreement_score":0.13631105,"about_ca_system_score_codex":0.0003534723,"about_ca_system_score_gemma":0.0006239462,"threshold_uncertainty_score":0.99993503},"labels":[],"label_agreement":null},{"id":"W2907901533","doi":"10.1182/blood-2018-99-112037","title":"RNA Sequencing-Based Measurement of Fusion-Transcript for Minimal Residual Disease (MRD) Monitoring in Core-Binding Factor Acute Myeloid Leukemia (CBF-AML)","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Minimal residual disease; Fusion gene; Biology; Myeloid leukemia; Gene; Leukemia; Cancer research; Computational biology; Genetics","score_opus":0.07279583285388672,"score_gpt":0.31779115377525297,"score_spread":0.24499532092136625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907901533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99656594,0.00033990605,0.0002689449,0.0004107211,0.00031234184,0.0015234089,0.00023464584,0.00008894818,0.00025513128],"genre_scores_gemma":[0.9940413,0.000039318867,0.0043865624,0.00008250745,0.0008986693,0.00016950298,0.000052906762,0.0000894407,0.00023974164],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99623436,0.000083007384,0.00073026255,0.00065254146,0.0014117418,0.0008880621],"domain_scores_gemma":[0.9977397,0.00017767402,0.00019076449,0.00064782996,0.0007035212,0.00054056535],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00086656836,0.00037065052,0.00062419474,0.0004961387,0.00017118131,0.00003165017,0.00036806968,0.0002036163,0.000094475996],"category_scores_gemma":[0.00074075203,0.00034065213,0.00022828918,0.0004905825,0.00024719254,0.00014164332,0.00008841605,0.00044139035,0.000024647305],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002958577,0.00034384406,0.042597957,0.00053509837,0.00027920952,0.00023196673,0.00066179817,0.000011863505,0.9510999,0.00001627385,0.0004684167,0.0007951296],"study_design_scores_gemma":[0.016242867,0.0013267467,0.0501835,0.0011577706,0.00063721644,0.000014284818,0.00035502278,0.0009323681,0.92832077,0.000029280669,0.00041276912,0.00038741808],"about_ca_topic_score_codex":0.00019758879,"about_ca_topic_score_gemma":0.0000681675,"teacher_disagreement_score":0.022779113,"about_ca_system_score_codex":0.0020243488,"about_ca_system_score_gemma":0.004046073,"threshold_uncertainty_score":0.9999046},"labels":[],"label_agreement":null},{"id":"W2907933864","doi":"10.1182/blood-2018-99-112906","title":"Residual Allelic Burden Measured By Next-Generation Sequencing (NGS) at Remission Provides Limited Prognostic Value to Predict Relapse and Long-Term Outcome in Core Binding Factor Acute Myeloid Leukemia (CBF-AML)","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Neuroblastoma RAS viral oncogene homolog; Minimal residual disease; KRAS; Oncology; Internal medicine; Medicine; Myeloid leukemia; Core binding factor; Leukemia; Cancer; Gene; Biology; Genetics","score_opus":0.08726598268565837,"score_gpt":0.31505686867048516,"score_spread":0.22779088598482677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907933864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951583,0.00047005963,0.000058380963,0.0010941692,0.00013937346,0.00267031,0.00007064557,0.0002240457,0.00011468902],"genre_scores_gemma":[0.99330634,0.00018329303,0.0017059197,0.00029915274,0.0008964884,0.00016216532,0.00043997497,0.0001244013,0.0028822564],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99581486,0.00022810095,0.00085984706,0.0010680058,0.0011116304,0.0009175656],"domain_scores_gemma":[0.9978317,0.00023110001,0.00021696613,0.0006803914,0.0003431612,0.0006966533],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008666167,0.0004912478,0.00067341677,0.0005569024,0.0003490019,0.00014995204,0.00031682296,0.00046754206,0.00006841219],"category_scores_gemma":[0.0024913922,0.00042321516,0.00008548591,0.00070494594,0.00018878058,0.00037595077,0.00041090287,0.00072404003,0.00007492099],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041524722,0.000066752,0.3118995,0.00016220254,0.00015087881,0.00029298212,0.0014462755,0.0000053241697,0.68279195,0.0000021187207,0.0016534616,0.0011132803],"study_design_scores_gemma":[0.021250973,0.0050045117,0.39722642,0.0027018618,0.0013020374,0.0013404997,0.0004678112,0.008977125,0.55939174,0.000017820996,0.00080234144,0.001516838],"about_ca_topic_score_codex":0.00031009445,"about_ca_topic_score_gemma":0.0002162036,"teacher_disagreement_score":0.12340022,"about_ca_system_score_codex":0.0025416813,"about_ca_system_score_gemma":0.0009744144,"threshold_uncertainty_score":0.99982196},"labels":[],"label_agreement":null},{"id":"W2907997089","doi":"10.1182/blood-2018-99-110439","title":"Efficacy and Safety of Single-Agent Quizartinib (Q), a Potent and Selective FLT3 Inhibitor (FLT3i), in Patients (pts) with FLT3-Internal Tandem Duplication (FLT3-ITD)-Mutated Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) Enrolled in the Global, Phase 3, Randomized Controlled Quantum-R Trial","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Refractory (planetary science); Medicine; Pharmacology; Cancer research; Biology","score_opus":0.01136844868066464,"score_gpt":0.28137589329560836,"score_spread":0.2700074446149437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907997089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865729,0.00041257223,0.00019992716,0.0004675707,0.00013011124,0.011660755,0.00004943603,0.000056984594,0.0004497205],"genre_scores_gemma":[0.9983215,0.0002694901,0.00021974699,0.00016969461,0.00026203916,0.000553552,0.00009854072,0.000055552715,0.00004990292],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99403036,0.0014881125,0.0018100255,0.00086808443,0.001092373,0.00071106805],"domain_scores_gemma":[0.9962461,0.0013925498,0.00087329815,0.00056540687,0.000625,0.00029765296],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0029135647,0.000565961,0.0024289468,0.00041451876,0.00016993693,0.00007795497,0.00029597172,0.0003285856,0.000030225217],"category_scores_gemma":[0.0023221658,0.00035295353,0.0002398091,0.0009020561,0.0007618822,0.00021040678,0.00014661194,0.000747864,0.000010960407],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97080314,0.006041834,0.007963897,0.000050123537,0.00139595,0.00010809268,0.002194195,0.0000046837245,0.0094894795,0.000059600225,0.00013079403,0.0017582327],"study_design_scores_gemma":[0.9662567,0.010467345,0.014709306,0.00042383256,0.0013571217,0.00009605301,0.00027983746,0.0015735363,0.0043692742,0.000064528926,0.00006796745,0.00033449157],"about_ca_topic_score_codex":0.0003460826,"about_ca_topic_score_gemma":0.00013088969,"teacher_disagreement_score":0.011748558,"about_ca_system_score_codex":0.0010710527,"about_ca_system_score_gemma":0.00091902533,"threshold_uncertainty_score":0.99989223},"labels":[],"label_agreement":null},{"id":"W2908000108","doi":"10.1182/blood-2018-99-110467","title":"Real-World Data of Immune Tolerance Induction Using rFVIIIFc in Subjects With Severe Hemophilia A With Inhibitors at High Risk for ITI Failure","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Children's Hospital; University of Alberta Hospital; Alberta Hospital Edmonton; Hospital for Sick Children","funders":"","keywords":"Medicine; Internal medicine; Immune tolerance; Immunology; Immune system","score_opus":0.0387190631254739,"score_gpt":0.30461644205501237,"score_spread":0.26589737892953846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908000108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981057,0.000080470556,0.000010811451,0.00040987553,0.000049554008,0.0009851628,0.0000892895,0.000029286815,0.00023986588],"genre_scores_gemma":[0.99123806,0.000049760034,0.007389802,0.000010221807,0.00041794078,0.000026239366,0.0001749022,0.000040821447,0.00065226236],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99852806,0.000047726888,0.00028052728,0.00044337913,0.00035361524,0.00034667124],"domain_scores_gemma":[0.9987367,0.000064527616,0.00017307188,0.0007329699,0.00019767444,0.000095061616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028205768,0.00018830124,0.0004135268,0.00022835132,0.00012475785,0.000011741734,0.00014284592,0.000080566984,0.000023073986],"category_scores_gemma":[0.00005045092,0.0001250346,0.000035073368,0.0006974976,0.0002676678,0.0001757992,0.00010162615,0.0001944687,0.0000044657604],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004447466,0.0011895412,0.94261354,0.00042193782,0.00040146164,0.00010110538,0.0006110271,0.000016700109,0.048609268,0.000033278488,0.00023146109,0.0013232265],"study_design_scores_gemma":[0.03292585,0.005938388,0.46549755,0.0023812868,0.0010192054,0.00040570524,0.00047966675,0.000519481,0.48956358,0.000082312064,0.00066852226,0.00051843934],"about_ca_topic_score_codex":0.0023685899,"about_ca_topic_score_gemma":0.010436525,"teacher_disagreement_score":0.477116,"about_ca_system_score_codex":0.000098067656,"about_ca_system_score_gemma":0.0002228502,"threshold_uncertainty_score":0.58238256},"labels":[],"label_agreement":null},{"id":"W2908013812","doi":"10.1182/blood-2018-99-111533","title":"Characteristics of Patients (pts) Who Relapse and Die of Multiple Myeloma (MM) within One Year Post Frontline Autologous Stem Cell Transplant (ASCT) in the Novel Agent Era: An Ultra-High Risk Population","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; Vancouver General Hospital; Leukemia & Lymphoma Society of Canada","funders":"","keywords":"Medicine; Lenalidomide; Autologous stem-cell transplantation; Internal medicine; Oncology; Multiple myeloma; Population; Bortezomib; Surgery","score_opus":0.017135795948242282,"score_gpt":0.24143210044389063,"score_spread":0.22429630449564836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908013812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977307,0.000060017366,0.00003580299,0.000030343343,0.00005565064,0.0007771124,0.0012535055,0.000014154292,0.00004271212],"genre_scores_gemma":[0.9980333,0.00013158134,0.001018615,0.000022791362,0.000058817808,0.000017208866,0.00066691986,0.00002233598,0.000028461338],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849087,0.00013250054,0.00048341707,0.0002623489,0.0003956426,0.00023522813],"domain_scores_gemma":[0.99899286,0.000113973234,0.0002606089,0.00034211483,0.00016904753,0.00012138509],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002641253,0.00016501526,0.00040200268,0.00011616984,0.00006595669,0.000009464199,0.00010719013,0.00010588749,0.000012868408],"category_scores_gemma":[0.00009031292,0.00011545199,0.000048260295,0.00010318368,0.00010762203,0.00007212089,0.00001451622,0.00019267797,0.000003936701],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015201579,0.005316774,0.97243345,0.00018345162,0.00013695509,0.00003626671,0.0039476156,0.0000010270253,0.012056464,0.000011785232,0.0000023626071,0.0043536997],"study_design_scores_gemma":[0.012175999,0.0025608384,0.9625862,0.00014780277,0.0002732803,0.000006761443,0.00017059491,0.0003791234,0.021590905,0.0000067328506,0.0000058669207,0.00009588437],"about_ca_topic_score_codex":0.002914934,"about_ca_topic_score_gemma":0.0013129044,"teacher_disagreement_score":0.010655841,"about_ca_system_score_codex":0.00002678073,"about_ca_system_score_gemma":0.000039966286,"threshold_uncertainty_score":0.47079957},"labels":[],"label_agreement":null},{"id":"W2908094279","doi":"10.1182/blood-2018-184","title":"MURANO Trial Establishes Feasibility of Time-Limited Venetoclax-Rituximab (VenR) Combination Therapy in Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Jewish General Hospital","funders":"","keywords":"Venetoclax; Medicine; Bendamustine; Rituximab; Internal medicine; Ven; Gastroenterology; Neutropenia; Minimal residual disease; Refractory (planetary science); Chronic lymphocytic leukemia; Oncology; Leukemia; Chemotherapy; Lymphoma","score_opus":0.03220331108193749,"score_gpt":0.306262982912542,"score_spread":0.27405967183060453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908094279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928098,0.0014450016,0.000007749216,0.00004807192,0.0003017076,0.002645517,0.000015533282,0.00013791854,0.0025887182],"genre_scores_gemma":[0.99772143,0.00038135838,0.00014043106,0.0000812048,0.0005927529,0.00011400967,0.00008383257,0.00007976254,0.0008051953],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9959424,0.0003698267,0.0010037585,0.0007724822,0.0011427318,0.00076879247],"domain_scores_gemma":[0.9971533,0.0005363858,0.0003141277,0.0012888466,0.00046681144,0.00024052939],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014063127,0.0003775631,0.0009508514,0.0004747178,0.00010301143,0.000045057288,0.00047245383,0.00044233282,0.00060789793],"category_scores_gemma":[0.0010101194,0.00034535397,0.00024346006,0.0010539461,0.00066023215,0.00022239395,0.00014411623,0.00044366688,0.0002493935],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.44125333,0.040671732,0.015695143,0.004543801,0.0029647797,0.0017015714,0.009120254,0.00068944454,0.40684083,0.0008724038,0.007725136,0.06792154],"study_design_scores_gemma":[0.89237434,0.010870125,0.0055261706,0.0005178445,0.00018298735,0.00013735729,0.000070539376,0.023597041,0.06512886,0.00033267224,0.0008393713,0.0004226866],"about_ca_topic_score_codex":0.0026263723,"about_ca_topic_score_gemma":0.00018005155,"teacher_disagreement_score":0.451121,"about_ca_system_score_codex":0.07624866,"about_ca_system_score_gemma":0.04728512,"threshold_uncertainty_score":0.99989986},"labels":[],"label_agreement":null},{"id":"W2908188218","doi":"10.1182/blood-2018-99-113589","title":"Meta-Analysis of Long-Term Risk of Recurrent Venous Thromboembolism after Stopping Anticoagulation in Men and Women with First Unprovoked Venous Thromboembolism","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Venous thromboembolism; Meta-analysis; Observational study; Cumulative incidence; Randomized controlled trial; Incidence (geometry); MEDLINE; Anticoagulant therapy; Relative risk; Pediatrics; Surgery; Internal medicine; Confidence interval; Thrombosis; Cohort","score_opus":0.027939936338854998,"score_gpt":0.26954500014719707,"score_spread":0.24160506380834207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908188218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954316,0.002480473,0.00010002547,0.000114620845,0.000060700113,0.0011072807,0.000060444825,0.00003554522,0.00060932926],"genre_scores_gemma":[0.9979099,0.0011318495,0.0005017986,0.000082273444,0.00008728679,0.00018862207,0.000029650311,0.000047118567,0.000021496095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973076,0.0001364543,0.00083041645,0.0006271085,0.0005752924,0.0005231233],"domain_scores_gemma":[0.99808884,0.00012543377,0.0005960614,0.0007698414,0.00025339422,0.00016644177],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006663294,0.00037574852,0.0033182877,0.0007594776,0.00010203078,0.000028166578,0.00016847257,0.00013929568,0.0003193254],"category_scores_gemma":[0.00005447517,0.00029166698,0.00033193914,0.0010512404,0.00033004984,0.00015429221,0.00014716918,0.00018927956,0.0000047770172],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010731972,0.024972355,0.50529236,0.002245968,0.40550804,0.00021091635,0.053694233,0.0002370064,0.0018819041,0.00029906342,0.00006216651,0.004522813],"study_design_scores_gemma":[0.0022054159,0.0021800308,0.8121064,0.00013253524,0.18116373,0.000008547771,0.0003492516,0.000108690845,0.0014232334,0.00007206404,0.000013612597,0.00023653248],"about_ca_topic_score_codex":0.00060993654,"about_ca_topic_score_gemma":0.0011170767,"teacher_disagreement_score":0.30681401,"about_ca_system_score_codex":0.00007521858,"about_ca_system_score_gemma":0.0000846826,"threshold_uncertainty_score":0.99995357},"labels":[],"label_agreement":null},{"id":"W2908201785","doi":"10.1182/blood-2018-99-115123","title":"Age Subgroup Analysis of Health-Related Quality of Life of Blinatumomab Versus Standard-of-Care Chemotherapy in Patients with Relapsed or Refractory Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia in a Randomized, Open-Label, Phase 3 Study (TOWER)","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Blinatumomab; Medicine; Internal medicine; Minimal residual disease; Chemotherapy; Gastroenterology; Oncology; Leukemia; Immunology; Surgery; Lymphoblastic Leukemia","score_opus":0.04176677496032077,"score_gpt":0.36662445671732125,"score_spread":0.32485768175700047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908201785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99285185,0.0005624799,0.000010594595,0.0000397546,0.00006081984,0.0058671115,0.00035398264,0.000016001995,0.00023743101],"genre_scores_gemma":[0.9990737,0.00017083572,0.00032703456,0.000019885878,0.000013611289,0.00011472676,0.00014229323,0.00006207222,0.00007587812],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.993246,0.0016176542,0.0026708667,0.00065246044,0.0013623754,0.0004505986],"domain_scores_gemma":[0.99421346,0.0014966342,0.002024231,0.00096056564,0.0011093903,0.00019570506],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0029659353,0.00038768092,0.0045246715,0.0012642738,0.000041645853,0.0000112842245,0.00049630884,0.00020955043,0.00058917736],"category_scores_gemma":[0.0011595932,0.0002933005,0.00023477525,0.0038271223,0.00075611845,0.00015725032,0.00014066676,0.0004007079,8.350173e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91686237,0.026980082,0.020830674,0.0006127625,0.008341796,0.00003440769,0.017464953,0.000012290575,0.008104029,0.0000039502715,0.000011700619,0.00074098987],"study_design_scores_gemma":[0.890752,0.06238331,0.024199205,0.0005903901,0.002147817,4.4177693e-7,0.0020033326,0.00013464419,0.01753373,0.000007927434,0.0000030454578,0.00024411206],"about_ca_topic_score_codex":0.0020527728,"about_ca_topic_score_gemma":0.0017452844,"teacher_disagreement_score":0.03540323,"about_ca_system_score_codex":0.0007582626,"about_ca_system_score_gemma":0.0026205361,"threshold_uncertainty_score":0.9999519},"labels":[],"label_agreement":null},{"id":"W2908301161","doi":"10.1182/blood-2018-99-110560","title":"Forty Percent of MDS Patients Wish They Received Red Blood Cell Transfusions at Higher Hemoglobin Thresholds Than They Currently Are: A Multinational Transfusion Audit","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Blood transfusion; Anemia; Quality of life (healthcare); Pediatrics; Family medicine; Internal medicine","score_opus":0.01710499241444917,"score_gpt":0.26593320425830125,"score_spread":0.24882821184385207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908301161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904649,0.00019432121,0.000010974386,0.00047444267,0.00042509218,0.0015394244,0.00022392356,0.00009945268,0.0065674195],"genre_scores_gemma":[0.9963846,0.000536287,0.00040145798,0.000097296856,0.0003891738,0.00009153835,0.00020957303,0.00007904173,0.0018110205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99621665,0.00015021738,0.00069827324,0.0007432217,0.0014865036,0.00070511],"domain_scores_gemma":[0.9977431,0.00016294079,0.0002225544,0.00079497835,0.0007028572,0.00037351926],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038090712,0.00038725117,0.00058532535,0.00020188944,0.00028278548,0.000019988254,0.00037924293,0.00031037416,0.001345092],"category_scores_gemma":[0.00011886369,0.0003111206,0.00034653963,0.000293087,0.00026910054,0.00012589252,0.00015914043,0.0003552057,0.00007378932],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060811066,0.051494144,0.568408,0.0018351017,0.001397093,0.00024295715,0.014771088,0.000022990638,0.3415095,0.0001142896,0.00958221,0.004541525],"study_design_scores_gemma":[0.1930135,0.0032848625,0.62414426,0.0010976479,0.0016149046,0.00014983257,0.00026487862,0.00068010355,0.1708342,0.00026606172,0.0038466963,0.0008030684],"about_ca_topic_score_codex":0.0008596686,"about_ca_topic_score_gemma":0.0013812248,"teacher_disagreement_score":0.1869324,"about_ca_system_score_codex":0.0016959303,"about_ca_system_score_gemma":0.0014663389,"threshold_uncertainty_score":0.9999341},"labels":[],"label_agreement":null},{"id":"W2908312420","doi":"10.1182/blood-2018-99-117198","title":"Postnatally Acquired Mutations Underlie the Progression of Transient Leukemia to Myeloid Leukemia of Down Syndrome","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; SickKids Foundation; Hospital for Sick Children; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"GATA1; Biology; Haploinsufficiency; Leukemia; Myeloid leukemia; Genetics; Mutation; Cancer research; Haematopoiesis; Gene; Phenotype; Stem cell","score_opus":0.018335980615901273,"score_gpt":0.30228421754157364,"score_spread":0.2839482369256724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908312420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99131376,0.00019796685,0.0002958069,0.001713372,0.00008428547,0.0013320831,0.00005840597,0.00006140503,0.004942894],"genre_scores_gemma":[0.99546844,0.000025981846,0.0033460115,0.00026692546,0.00011656562,0.00007416283,0.00005281166,0.000045423876,0.0006037053],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99760705,0.00009943802,0.000584507,0.00037622196,0.00087247236,0.00046030988],"domain_scores_gemma":[0.99802554,0.00018358862,0.00016994707,0.00081476674,0.00054975075,0.00025643146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048370313,0.00021913656,0.00045706754,0.0002620009,0.00014599545,0.00001592681,0.0004451208,0.00016421462,0.00024451644],"category_scores_gemma":[0.00027066772,0.00014681394,0.00016172198,0.00084004435,0.00061776966,0.00009286915,0.00014688102,0.00022164313,0.00010237517],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014820716,0.0010396615,0.0025260116,0.00067604834,0.00084219046,0.00038465654,0.007347276,0.00006057517,0.96695316,0.0010997788,0.004075838,0.013512735],"study_design_scores_gemma":[0.0118626235,0.007965949,0.23277992,0.0012126329,0.0009101389,0.0018982937,0.0017008528,0.00051788444,0.7364432,0.00020381421,0.0040505505,0.00045412895],"about_ca_topic_score_codex":0.0001518998,"about_ca_topic_score_gemma":0.00004037185,"teacher_disagreement_score":0.23050995,"about_ca_system_score_codex":0.0003326152,"about_ca_system_score_gemma":0.0019228637,"threshold_uncertainty_score":0.59868985},"labels":[],"label_agreement":null},{"id":"W2908326359","doi":"10.1182/blood-2018-99-113689","title":"Muscle Depletion Is an Important and Clinically Relevant Predictor of Outcomes after Autologous Hematopoietic Cell Transplantation","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Transplantation; Diffuse large B-cell lymphoma; Population; Hematopoietic stem cell transplantation; Internal medicine; Skeletal muscle; Sarcopenia; Lymphoma; Surgery; Oncology; Gastroenterology","score_opus":0.012582643657045811,"score_gpt":0.2699589181107026,"score_spread":0.2573762744536568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908326359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986602,0.00027543175,0.00009847834,0.0002520877,0.00015324412,0.00019567393,0.000059673806,0.00004352709,0.00026170016],"genre_scores_gemma":[0.9987178,0.0002212872,0.0004347624,0.0004001584,0.000096094685,0.000017062024,0.000021083042,0.000015614021,0.00007612802],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905807,0.000029934723,0.00038393927,0.00021865289,0.00018009375,0.00012928201],"domain_scores_gemma":[0.99943745,0.000040071296,0.00010219072,0.00023061526,0.00008550846,0.00010414368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016372687,0.000098724406,0.00024326012,0.00004192702,0.000023301045,0.0000064121514,0.00003831994,0.00010100755,0.00013189123],"category_scores_gemma":[0.00001896995,0.00007893526,0.00006674526,0.000057760284,0.000094494186,0.000047525657,0.000009157356,0.00007502969,0.0000051855227],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003778727,0.00044236082,0.98642755,0.00041511186,0.000040076873,0.000058898666,0.006559835,1.5755615e-8,0.004787371,0.000015549094,0.000035173874,0.0008401931],"study_design_scores_gemma":[0.0024421082,0.0012733055,0.98363626,0.000090333284,0.000505293,0.00006474302,0.00027624684,0.000016027921,0.011265812,0.00012002513,0.00020926745,0.00010057206],"about_ca_topic_score_codex":0.000113932525,"about_ca_topic_score_gemma":0.0003370552,"teacher_disagreement_score":0.006478442,"about_ca_system_score_codex":0.000005838773,"about_ca_system_score_gemma":0.000048460515,"threshold_uncertainty_score":0.3218887},"labels":[],"label_agreement":null},{"id":"W2908337540","doi":"10.1182/blood-2018-99-119974","title":"Comparison of the Transcriptomic Signature of Pediatric Vs. Adult CML and Normal Bone Marrow Stem Cells","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Bone marrow; Stem cell; CD34; Imatinib; Imatinib mesylate; Pediatric cancer; Myeloid leukemia; Hematopoietic stem cell transplantation; Myeloid; Transplantation; Immunology; Internal medicine; Oncology; Cancer; Biology","score_opus":0.01135950920785769,"score_gpt":0.2461413045899703,"score_spread":0.2347817953821126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908337540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955225,0.0031630804,0.0000040588156,0.00014193117,0.00016034665,0.00036644554,0.000037232767,0.000016563794,0.00058785005],"genre_scores_gemma":[0.99888545,0.00011348431,0.00023318597,0.00008466666,0.00022716439,0.000005053861,0.000003812005,0.000017750554,0.00042940883],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990163,0.000037584814,0.00032034144,0.00018322608,0.00026188316,0.00018065596],"domain_scores_gemma":[0.9992613,0.000051834068,0.0001716228,0.00033047664,0.00011361539,0.00007111819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007348731,0.00013770201,0.00038720036,0.000057164194,0.000038294133,0.0000032247278,0.00010206794,0.00012877659,0.00006483772],"category_scores_gemma":[0.000013078822,0.00009291104,0.00009290608,0.0001810964,0.00012997001,0.000031033633,0.00003317579,0.00017930727,0.0000075110706],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073117705,0.0025859678,0.71516865,0.0013375299,0.0004867155,0.00002022408,0.0059046387,0.0000028170846,0.26442835,0.00008758457,0.006689736,0.0025566171],"study_design_scores_gemma":[0.0121594425,0.0010139527,0.08465852,0.00011356163,0.001593947,0.00003660264,0.00020675799,0.00011738754,0.8996135,0.0000064935366,0.00036353464,0.000116301766],"about_ca_topic_score_codex":0.000058267633,"about_ca_topic_score_gemma":0.00003799048,"teacher_disagreement_score":0.6351852,"about_ca_system_score_codex":0.000041653664,"about_ca_system_score_gemma":0.00015739801,"threshold_uncertainty_score":0.3788802},"labels":[],"label_agreement":null},{"id":"W2908342487","doi":"10.1182/blood-2018-99-118569","title":"T Cells Engineered with a Novel Chimeric Receptor Demonstrate Durable In Vivo Efficacy Against Disseminated Multiple Myeloma","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Chimeric antigen receptor; Multiple myeloma; Cancer research; Immunotherapy; In vivo; T cell; Medicine; Cytokine; Immunology; Biology; Immune system","score_opus":0.013051482795145466,"score_gpt":0.2546756408468227,"score_spread":0.24162415805167725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908342487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922513,0.000081832484,0.00005387198,0.00012703807,0.00008139811,0.0008675959,0.000036593916,0.000126654,0.0063737407],"genre_scores_gemma":[0.99145246,0.00008153047,0.0026575103,0.000052322142,0.00021212662,0.000075483804,0.00003120842,0.00007819413,0.0053591845],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99828494,0.00003867399,0.0002894264,0.00042685826,0.00036384523,0.000596238],"domain_scores_gemma":[0.9989196,0.00015779545,0.00006267121,0.00046721418,0.00014167499,0.00025100991],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022258711,0.00025296822,0.00038484955,0.00023795279,0.00006866242,0.000031508724,0.00017021272,0.0001265809,0.001524358],"category_scores_gemma":[0.000116086834,0.00020628245,0.000069810616,0.0009414737,0.00018160597,0.000069541034,0.00003979219,0.0003353936,0.000110446024],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080472615,0.001695167,0.008843188,0.000052332212,0.00014244353,0.00004930212,0.00041328548,0.00000937935,0.9841236,0.000002091311,0.00028506268,0.0035794566],"study_design_scores_gemma":[0.012765415,0.0009177863,0.01375037,0.00029867757,0.000050207585,0.000044045773,0.00013234532,0.00073376426,0.967846,6.706239e-7,0.0032086899,0.00025205777],"about_ca_topic_score_codex":0.00007174608,"about_ca_topic_score_gemma":0.000099541976,"teacher_disagreement_score":0.016277594,"about_ca_system_score_codex":0.00006021027,"about_ca_system_score_gemma":0.0001507285,"threshold_uncertainty_score":0.9993884},"labels":[],"label_agreement":null},{"id":"W2908347173","doi":"10.1182/blood-2018-99-113837","title":"Enhancing Appropriate Coagulation Testing at a Large Academic Hospital","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Clinical Laboratory Practices and Quality Control","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Psychological intervention; Coagulation testing; Test (biology); Stakeholder; Patient safety; Medical laboratory; Medical emergency; Medical education; Health care; Nursing","score_opus":0.049814270428039306,"score_gpt":0.35733193143952396,"score_spread":0.30751766101148464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908347173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99620616,0.0001626192,0.0004012309,0.0010717312,0.00018888485,0.00028819364,0.000008801665,0.000103460916,0.0015689364],"genre_scores_gemma":[0.99492455,0.00000687396,0.0021321347,0.0010644796,0.0014634557,0.000009434864,0.000010994448,0.0000175556,0.00037054226],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886316,0.00006518257,0.00036752457,0.00024668174,0.00020794275,0.00024949742],"domain_scores_gemma":[0.9987988,0.00042430253,0.00020889274,0.00021723859,0.00021946909,0.00013128329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008264046,0.00009809796,0.00021698802,0.000027755588,0.00014426243,0.0000141536675,0.000053690073,0.00014733635,0.0001463982],"category_scores_gemma":[0.003851257,0.00008405498,0.000049519655,0.00018358215,0.00004284696,0.0001246855,0.000065705746,0.00028334165,0.0003236741],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039506308,0.0015200858,0.66345954,0.0001697036,0.00024893464,0.000044891072,0.0013960165,5.235846e-7,0.325828,0.0012210922,0.00030707032,0.0054091057],"study_design_scores_gemma":[0.04010997,0.0061162263,0.7362257,0.000991455,0.002753549,0.00011108836,0.0006711859,0.0063838176,0.13031523,0.0011948121,0.07398424,0.0011427265],"about_ca_topic_score_codex":0.000013597619,"about_ca_topic_score_gemma":0.000026121452,"teacher_disagreement_score":0.19551277,"about_ca_system_score_codex":0.000023611292,"about_ca_system_score_gemma":0.00006835902,"threshold_uncertainty_score":0.46105924},"labels":[],"label_agreement":null},{"id":"W2908403203","doi":"10.1182/blood-2018-99-115593","title":"High Vs. Low-Intensity Bridging Chemotherapy in Children with Acute Lymphoblastic Leukemia Awaiting Chimeric Antigen Receptor T-Cell Therapy: A Population-Based Study from Ontario, Canada","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario; London Health Sciences Centre; McMaster University; McMaster Children's Hospital; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Chimeric antigen receptor; Population; Chemotherapy regimen; Neutropenia; Regimen; Contraindication; Internal medicine; Pediatrics; Cytokine release syndrome; Chemotherapy; Immunotherapy; Cancer; Pathology","score_opus":0.007779938623790587,"score_gpt":0.22598578685935888,"score_spread":0.2182058482355683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908403203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978842,0.000049757302,0.000027987846,0.00014883859,0.00011730822,0.0015562965,0.000030666062,0.000080830425,0.000104130086],"genre_scores_gemma":[0.99717593,0.0000145770455,0.000599062,0.0009411119,0.0004884416,0.000039984436,0.00024645397,0.000102585676,0.00039184818],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973874,0.000101843296,0.00041215634,0.0007030615,0.0007761922,0.00061935413],"domain_scores_gemma":[0.9986916,0.00008701913,0.00017095546,0.00063533586,0.00019680106,0.00021828886],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002309,0.00037715732,0.0006762126,0.000185905,0.00018379028,0.000056812925,0.00024336945,0.00009439986,0.002120573],"category_scores_gemma":[0.0000214921,0.00032363355,0.0000754968,0.0005300355,0.00006671064,0.000069654896,0.000039114842,0.00039145566,0.000014496487],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022238637,0.0009769298,0.9628885,0.0000059329323,0.00074159226,0.00008415282,0.00064439647,0.000029512428,0.03089357,1.5685849e-7,0.00011445743,0.001396976],"study_design_scores_gemma":[0.02090288,0.0012766068,0.9238458,0.00011584145,0.00011867403,0.000024132061,0.0000799785,0.00028944266,0.052971292,0.000002298951,0.000043271226,0.0003297529],"about_ca_topic_score_codex":0.98266923,"about_ca_topic_score_gemma":0.89998835,"teacher_disagreement_score":0.08268088,"about_ca_system_score_codex":0.0014723411,"about_ca_system_score_gemma":0.003215038,"threshold_uncertainty_score":0.99992156},"labels":[],"label_agreement":null},{"id":"W2908417681","doi":"10.1182/blood-2018-99-115126","title":"Factors Impacting Progression-Free Survival after CD19-Specific CAR-T Cell Therapy for Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Fludarabine; Internal medicine; Cyclophosphamide; Oncology; Non-Hodgkin's lymphoma; Lymphoma; Aggressive lymphoma; Immunology; Chemotherapy; Gastroenterology; Rituximab","score_opus":0.03312583949626026,"score_gpt":0.3160237853105035,"score_spread":0.28289794581424327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908417681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853195,0.00367266,0.00007533956,0.00015367517,0.00091720367,0.0023704823,0.00010634037,0.00017241726,0.0072123725],"genre_scores_gemma":[0.9888477,0.0008027164,0.0011831996,0.00014308645,0.002401545,0.000349222,0.00007697476,0.00026027326,0.005935337],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9959425,0.00018538175,0.00058451167,0.0009304124,0.001135574,0.0012216701],"domain_scores_gemma":[0.9961245,0.0007204759,0.00044468217,0.001573337,0.0005776972,0.00055930804],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007236074,0.0006156293,0.00077141944,0.00032307373,0.0003278207,0.00010014016,0.000584863,0.00042900763,0.002465098],"category_scores_gemma":[0.0002152019,0.0004593686,0.00050610123,0.0004277744,0.00030570728,0.00020289874,0.00020742405,0.00044922638,0.00010310499],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0087577095,0.006651881,0.09624094,0.00031360865,0.00049811456,0.00030930561,0.0053964606,2.443236e-7,0.8163115,0.0000048313354,0.0051548807,0.06036056],"study_design_scores_gemma":[0.04051676,0.006978761,0.053967297,0.00037752677,0.00016758198,0.000043833188,0.0009994276,0.00002111741,0.84489733,0.00010409449,0.051146038,0.0007802172],"about_ca_topic_score_codex":0.0000601589,"about_ca_topic_score_gemma":0.000022390252,"teacher_disagreement_score":0.05958034,"about_ca_system_score_codex":0.00021380544,"about_ca_system_score_gemma":0.0004532954,"threshold_uncertainty_score":0.9997858},"labels":[],"label_agreement":null},{"id":"W2908473823","doi":"10.1182/blood-2018-99-111554","title":"Immune Profiling of Relapsed or Refractory Multiple Myeloma Patients Treated with Pomalidomide and Low-Dose Dexamethasone in Combination with Daratumumab","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Vancouver General Hospital; McGill University Health Centre; University of Calgary","funders":"","keywords":"Pomalidomide; Daratumumab; Lenalidomide; Medicine; Multiple myeloma; Immunology; Immune system; Dexamethasone; Oncology; Internal medicine; Cancer research","score_opus":0.01639173408916918,"score_gpt":0.26744380952402597,"score_spread":0.2510520754348568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908473823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981476,0.00012833477,0.000013868625,0.000021857777,0.0000127782005,0.0012904516,0.000020151752,0.000035787776,0.00032915664],"genre_scores_gemma":[0.9946282,0.000027013979,0.004883568,0.00000992871,0.000018422206,0.000074622614,0.00015755468,0.000037154347,0.00016355369],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985479,0.0001004479,0.00031408868,0.00033412094,0.00038847295,0.0003149652],"domain_scores_gemma":[0.9988753,0.0001621687,0.0001635059,0.0003193113,0.00033196574,0.00014769916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016016158,0.000203453,0.00041504484,0.00023938673,0.00007718604,0.000013571912,0.000062860054,0.00009074487,0.000022084678],"category_scores_gemma":[0.00033238836,0.00012566165,0.00002515796,0.00041720082,0.00022945688,0.0001447897,0.000036551617,0.00016908896,0.0000056385743],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018074995,0.0047749346,0.9458362,0.0001593905,0.00026501878,0.00023036073,0.00028937598,3.1001056e-7,0.026062591,0.000006102752,0.0000024012452,0.0042983154],"study_design_scores_gemma":[0.07568302,0.009292391,0.73849016,0.0004989652,0.000118730975,0.000034889403,0.00009595782,0.00026025614,0.17539884,0.0000025560278,0.0000056485633,0.00011858311],"about_ca_topic_score_codex":0.00035775738,"about_ca_topic_score_gemma":0.00032687085,"teacher_disagreement_score":0.20734604,"about_ca_system_score_codex":0.00006242504,"about_ca_system_score_gemma":0.00013436154,"threshold_uncertainty_score":0.51243335},"labels":[],"label_agreement":null},{"id":"W2908534685","doi":"10.1182/blood-2018-99-111532","title":"Older Adults with Acute Myeloid Leukemia in Rural Areas Are Less Likely to Receive Azacitidine with Worsened Overall Survival","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Leukemia & Lymphoma Society of Canada; University of British Columbia","funders":"","keywords":"Medicine; Azacitidine; Population; Cancer registry; Myelodysplastic syndromes; Cohort; Pediatrics; Internal medicine; Cancer; Bone marrow","score_opus":0.012052438910200776,"score_gpt":0.25732891481309916,"score_spread":0.2452764759028984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908534685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99237406,0.000069821705,0.00012373562,0.001803517,0.00009391309,0.001510341,0.000055290766,0.00015881305,0.0038104898],"genre_scores_gemma":[0.99222237,0.000056895817,0.0031753706,0.0009553261,0.00072426436,0.0001778346,0.00010614215,0.00013444078,0.0024473497],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965941,0.00012214886,0.0004078143,0.0007919198,0.0009995427,0.0010845198],"domain_scores_gemma":[0.9976174,0.00011173624,0.00014948822,0.00084782153,0.0006389815,0.00063456735],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031528025,0.0005026234,0.00080633006,0.00042147943,0.0001273346,0.00006457537,0.00036557592,0.00022953232,0.00018009459],"category_scores_gemma":[0.000111032925,0.0003610197,0.00007926416,0.0010749532,0.00030876414,0.00022161625,0.00017829766,0.0007145849,0.00020595385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08662967,0.0030606615,0.8194066,0.0008458726,0.0037742846,0.019041976,0.01702268,0.000055462864,0.022388102,0.00043614575,0.011856758,0.015481764],"study_design_scores_gemma":[0.06313683,0.0064462963,0.8709489,0.0050331233,0.0006245146,0.0018211582,0.0056908713,0.00022348344,0.043805014,0.000029675559,0.0009804849,0.0012596585],"about_ca_topic_score_codex":0.0014858944,"about_ca_topic_score_gemma":0.004667955,"teacher_disagreement_score":0.05154226,"about_ca_system_score_codex":0.00084827887,"about_ca_system_score_gemma":0.0012134408,"threshold_uncertainty_score":0.9998842},"labels":[],"label_agreement":null},{"id":"W2908539961","doi":"10.1182/blood-2018-99-110473","title":"Recurrent IL4R Somatic Mutations in Diffuse Large B-Cell Lymphoma Lead to an Altered Gene Expression Profile and Changes in Tumor Microenvironment Composition","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; BC Cancer Agency; Spinal Cord Injury BC","funders":"","keywords":"Biology; Cancer research; Diffuse large B-cell lymphoma; Janus kinase; JAK-STAT signaling pathway; Lymphoma; Tumor microenvironment; STAT protein; Signal transduction; STAT3; Immunology; Cell biology; Tyrosine kinase","score_opus":0.013576140935969242,"score_gpt":0.2542137003401468,"score_spread":0.24063755940417755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908539961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981513,0.0003911088,0.0000107856695,0.00034926774,0.000051730833,0.0009095238,0.000055979082,0.000020271702,0.0000600575],"genre_scores_gemma":[0.9958255,0.00006617437,0.0031637722,0.00025444868,0.000087563574,0.00038346282,0.00017907872,0.000016879656,0.000023116949],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990679,0.000058889207,0.00019984116,0.00030202596,0.00013452375,0.00023680643],"domain_scores_gemma":[0.99956614,0.000022117007,0.00005507164,0.0002119828,0.000012115355,0.00013258413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000696528,0.0001434584,0.00021255173,0.00014569552,0.000059118236,0.000017383352,0.000040145005,0.00003699125,0.000031224557],"category_scores_gemma":[0.000006212458,0.000121241166,0.00002038736,0.00008406294,0.000028752298,0.0000535249,0.000051045794,0.000028148186,0.00005402438],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021299359,0.06966421,0.16163054,0.00016200803,0.000025712083,0.00019844138,0.00512099,4.7265576e-7,0.7573069,0.000006620999,0.00011779578,0.0055533685],"study_design_scores_gemma":[0.023612112,0.001083353,0.36360595,0.0003254369,0.0000646495,0.00004040007,0.00022817381,0.00014682888,0.61069703,0.000009698098,0.00007795973,0.00010840327],"about_ca_topic_score_codex":0.00004269996,"about_ca_topic_score_gemma":0.00025413412,"teacher_disagreement_score":0.2019754,"about_ca_system_score_codex":0.00012906721,"about_ca_system_score_gemma":0.00002076416,"threshold_uncertainty_score":0.49440712},"labels":[],"label_agreement":null},{"id":"W2908541188","doi":"10.1182/blood-2018-99-116149","title":"Prognostic Impact of Insertion Site in Acute Myeloid Leukemia (AML) with FLT3 Internal Tandem Duplication: Results from the Ratify Study (Alliance 10603)","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Princess Margaret Cancer Centre","funders":"","keywords":"Gene duplication; Tandem exon duplication; Internal medicine; Medicine; Biology; Gene; Genetics","score_opus":0.02006874160011539,"score_gpt":0.3099494255746088,"score_spread":0.2898806839744934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908541188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99658245,0.00012662233,0.00010820777,0.0006849754,0.000035794055,0.0017401475,0.00007960163,0.000048366976,0.0005938455],"genre_scores_gemma":[0.9982837,0.00006853401,0.000566881,0.00010248792,0.00038788517,0.00011105906,0.000110275316,0.000036126414,0.00033306898],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99777216,0.00017486469,0.00056383206,0.0005124587,0.00060899556,0.00036771427],"domain_scores_gemma":[0.9979707,0.00034612298,0.00025796966,0.00088007544,0.00040833856,0.00013680098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060871936,0.00023832568,0.0003989842,0.00009425747,0.00009132659,0.00004142066,0.000377689,0.00011364438,0.000059534592],"category_scores_gemma":[0.0005370449,0.00014064678,0.000081137914,0.0007325189,0.00024801557,0.00016394941,0.0001310022,0.0005395783,0.00009060222],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003978487,0.000873675,0.9511299,0.000012018198,0.00064846664,0.00013978605,0.0037910934,0.000011747017,0.03742455,0.0000044764747,0.0008065026,0.0011792737],"study_design_scores_gemma":[0.014395593,0.003922076,0.96877384,0.000325345,0.00033003895,0.00006830414,0.0003418445,0.0007730063,0.010831197,0.000020641062,0.00007324054,0.00014488024],"about_ca_topic_score_codex":0.0033114518,"about_ca_topic_score_gemma":0.0017358627,"teacher_disagreement_score":0.026593352,"about_ca_system_score_codex":0.0005039915,"about_ca_system_score_gemma":0.00095837103,"threshold_uncertainty_score":0.5735409},"labels":[],"label_agreement":null},{"id":"W2908606174","doi":"10.1182/blood-2018-99-110223","title":"High Healthcare Utilization and Costs in Patients with Higher-Risk MDS/Low Blast Count AML Treated with Azacitidine in Ontario, Canada","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; Sunnybrook Hospital; University of Toronto","funders":"","keywords":"Medicine; Azacitidine; Population; Emergency medicine; Health care; Emergency department; Internal medicine; Demography; Pediatrics; Environmental health","score_opus":0.010308871555503763,"score_gpt":0.2266011312865167,"score_spread":0.21629225973101296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908606174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99838144,0.000051320963,0.0000020395664,0.0003803941,0.00002854848,0.0008181951,0.00006651038,0.00002188876,0.000249639],"genre_scores_gemma":[0.9987881,0.000025681851,0.00017528019,0.00027373453,0.000045316756,0.000035495024,0.0003209746,0.0000347973,0.0003005876],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99838716,0.00007522582,0.00023836429,0.0003716797,0.00051262096,0.00041496102],"domain_scores_gemma":[0.9990681,0.00004205584,0.00008491339,0.0002667539,0.00032309425,0.00021509612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000114481314,0.00019620695,0.0003293108,0.00016494413,0.00006574809,0.000016253649,0.00006765783,0.000094004,0.000104893916],"category_scores_gemma":[0.000030487266,0.00014391453,0.000007549966,0.00047418373,0.00011355543,0.00008226741,0.00003161516,0.0003767102,0.0000027415858],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013942552,0.00033808115,0.9965725,0.00004605712,0.000050505063,0.00014966857,0.00020150821,0.000002025836,0.000020435751,0.000015150229,0.0003511839,0.0008586302],"study_design_scores_gemma":[0.018338483,0.002284831,0.9771362,0.0004202991,0.000053778484,0.0000115179555,0.00006431221,0.0000428683,0.00095117814,0.0000018381705,0.00054296036,0.00015174646],"about_ca_topic_score_codex":0.98629177,"about_ca_topic_score_gemma":0.99859715,"teacher_disagreement_score":0.019436311,"about_ca_system_score_codex":0.0019558577,"about_ca_system_score_gemma":0.002004343,"threshold_uncertainty_score":0.58686644},"labels":[],"label_agreement":null},{"id":"W2908656034","doi":"10.1182/blood-2018-99-113247","title":"The Prognostic Impact of Baseline Positron Emission Tomography (PET) Imaging in Untreated High Risk (HR) Follicular Lymphoma (FL): Analysis from E2408, the Bortezomib Induction or Novel Imid® Continuation (BIONIC) Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Medicine; Rituximab; Internal medicine; Positron emission tomography; Follicular lymphoma; Bendamustine; Context (archaeology); Progression-free survival; Nuclear medicine; Log-rank test; Surgery; Survival analysis; Lymphoma; Overall survival","score_opus":0.009055247994627667,"score_gpt":0.2662754435938216,"score_spread":0.25722019559919396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908656034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99395925,0.0041942867,0.000054881577,0.00013643522,0.000055832155,0.0014776897,0.00006542719,0.00004457124,0.000011598738],"genre_scores_gemma":[0.9981702,0.0011269639,0.00017318604,0.000015758294,0.00012841598,0.00013945813,0.00021422557,0.00002390528,0.000007860197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979227,0.00031708454,0.0006305866,0.0004430174,0.00038958748,0.00029703375],"domain_scores_gemma":[0.9980169,0.00053786486,0.00043985614,0.0006447127,0.0002580066,0.00010269197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062968524,0.0002912591,0.0005637296,0.00033480933,0.00027783314,0.000072681316,0.00015183468,0.000060731756,0.000043371674],"category_scores_gemma":[0.0003306219,0.00013336739,0.00040628656,0.0017840909,0.00011144455,0.00010750724,0.000055116772,0.000081817794,0.0000053241456],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006092435,0.006635722,0.95629233,0.000005774501,0.0039696964,0.0000541526,0.00047807122,0.000013713072,0.0018192512,0.0000029000446,0.0000192333,0.03009994],"study_design_scores_gemma":[0.012953742,0.0012493773,0.9645933,0.00015852858,0.013952848,0.000027687092,0.00049079675,0.0014736318,0.0049200524,0.000017221002,0.000024531297,0.00013831878],"about_ca_topic_score_codex":0.020124018,"about_ca_topic_score_gemma":0.0013632075,"teacher_disagreement_score":0.029961621,"about_ca_system_score_codex":0.00018599207,"about_ca_system_score_gemma":0.00017577618,"threshold_uncertainty_score":0.9864011},"labels":[],"label_agreement":null},{"id":"W2908673988","doi":"10.1182/blood-2018-99-118745","title":"Small-Molecule Targeting of Musashi RNA-Binding Activity in Acute Myeloid Leukemia","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University","funders":"","keywords":"RNA-binding protein; RNA; Biology; RNA splicing; Microscale thermophoresis; RNA recognition motif; Molecular biology; Cancer research; Cell biology; Gene; Genetics","score_opus":0.013753448566403,"score_gpt":0.2615378820363267,"score_spread":0.2477844334699237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908673988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974987,0.00011936115,0.00021718378,0.00002802927,0.00003920539,0.0001096693,0.000008333632,0.0000072909206,0.001972223],"genre_scores_gemma":[0.9983306,0.00007540105,0.0008030099,0.000029347908,0.00016161647,0.000008789361,0.000018684457,0.000017287342,0.0005552741],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99905336,0.000058331072,0.00015738886,0.00026744636,0.000120189834,0.00034327013],"domain_scores_gemma":[0.99954265,0.000012241353,0.00007126024,0.00023254626,0.0000647699,0.00007651655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002878635,0.000108872475,0.0001465959,0.000066912005,0.000059930462,0.000014819929,0.00020168032,0.00011429542,0.0000142584695],"category_scores_gemma":[0.00013104743,0.00010681612,0.000062534746,0.00014239477,0.00008332706,0.000004406791,0.00016254146,0.00012161663,0.000009924249],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006469524,0.000075624106,0.0058533526,0.000016467886,0.000056492612,0.000013438713,0.00003856238,0.0000020101554,0.9928468,0.000007605193,0.00009725683,0.0009277064],"study_design_scores_gemma":[0.000914179,0.00030230018,0.0031869372,0.000022590968,0.000014081614,0.000005844482,0.000039720402,0.000098504184,0.99509346,0.0000056908243,0.0002022671,0.000114416755],"about_ca_topic_score_codex":0.00013597625,"about_ca_topic_score_gemma":0.00012992433,"teacher_disagreement_score":0.0026664154,"about_ca_system_score_codex":0.000018952607,"about_ca_system_score_gemma":0.0001239496,"threshold_uncertainty_score":0.4355835},"labels":[],"label_agreement":null},{"id":"W2908676058","doi":"10.1182/blood-2018-99-112069","title":"Nivolumab Combined with Brentuximab Vedotin for Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma: Preliminary Results from the Phase 2 CheckMate 436 Trial","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Brentuximab vedotin; Nivolumab; Medicine; CD30; Oncology; Internal medicine; Lymphoma; Population; Cancer research; Immunology; Immunotherapy; Cancer","score_opus":0.015925346957359265,"score_gpt":0.25692168728656334,"score_spread":0.24099634032920408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908676058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99074936,0.00097436615,0.000039766383,0.000995479,0.00056172884,0.0026796097,0.0010944324,0.00014443,0.0027608054],"genre_scores_gemma":[0.99308497,0.00008052282,0.0014169936,0.0006951758,0.001771848,0.00050885236,0.0017060254,0.00007683679,0.0006587985],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99745727,0.00010884583,0.0006113254,0.00069491036,0.00053383864,0.00059384305],"domain_scores_gemma":[0.9974223,0.0008764258,0.00037434266,0.00086234993,0.00021709944,0.00024748003],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040924986,0.00040554858,0.0006252686,0.00006163748,0.00034255622,0.00005260413,0.0002512862,0.00017634958,0.000060792197],"category_scores_gemma":[0.00024248874,0.00024817762,0.0002269125,0.00017097352,0.00020865405,0.000115199015,0.00010656578,0.00012213805,0.00009995451],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.81224984,0.13588212,0.0016430333,0.00012609761,0.001129249,0.0005244172,0.002006916,1.4859577e-7,0.001378695,0.000059756374,0.032983366,0.0120163355],"study_design_scores_gemma":[0.88986623,0.056137387,0.016171945,0.0002883948,0.0023533127,0.00007308325,0.00018295055,0.000084793406,0.017736485,0.000036370708,0.016753342,0.000315685],"about_ca_topic_score_codex":0.00014655312,"about_ca_topic_score_gemma":0.000045161996,"teacher_disagreement_score":0.07974474,"about_ca_system_score_codex":0.00016312678,"about_ca_system_score_gemma":0.0006197988,"threshold_uncertainty_score":0.999997},"labels":[],"label_agreement":null},{"id":"W2908908514","doi":"10.1182/blood-2018-99-113090","title":"Molecular Residual Disease Monitoring Provides Insufficient Lead-Time to Prevent Morphologic Relapse in the Majority of Patients with Core-Binding Factor AML","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Minimal residual disease; Medicine; Internal medicine; Bone marrow; Oncology; Myeloid leukemia; Pathology","score_opus":0.021612390333653423,"score_gpt":0.28232590341301245,"score_spread":0.260713513079359,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908908514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977339,0.00006701964,0.000013249652,0.00030847648,0.000035300956,0.0015774382,0.00006184064,0.000029964714,0.00017284162],"genre_scores_gemma":[0.99877626,0.0000032412615,0.0007352162,0.00007806439,0.000115866766,0.00008289192,0.000025431355,0.000026332185,0.00015667883],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979451,0.00014568713,0.0002917812,0.00037522474,0.0008304434,0.00041179243],"domain_scores_gemma":[0.99880964,0.000100798025,0.00009800219,0.0005766067,0.00021480834,0.00020014709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038038843,0.00018164191,0.0002665421,0.00019381866,0.00007605794,0.000020031286,0.0003096671,0.00007123563,0.00004601066],"category_scores_gemma":[0.000646685,0.00011309087,0.000051289357,0.00051063206,0.00016288219,0.00006165343,0.00017354164,0.0003174783,0.00008670123],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016392698,0.0053225677,0.9310537,0.00018274825,0.00012380528,0.0004968536,0.0021723488,0.00002028086,0.058067914,0.000020572925,0.00028802795,0.0006119069],"study_design_scores_gemma":[0.004110787,0.0029827363,0.90424496,0.00034708765,0.00017517316,0.000007806028,0.0002407071,0.000038826216,0.08755133,0.000015929088,0.000090138594,0.00019454214],"about_ca_topic_score_codex":0.00005520932,"about_ca_topic_score_gemma":0.0000029690425,"teacher_disagreement_score":0.029483417,"about_ca_system_score_codex":0.0001785084,"about_ca_system_score_gemma":0.00024694813,"threshold_uncertainty_score":0.46117118},"labels":[],"label_agreement":null},{"id":"W2908999604","doi":"10.1182/blood-2018-99-113403","title":"Developing Applicable and Cost-Efficient Screens for Early Detection of AML","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Myeloid leukemia; Leukemia; Myeloid; Computational biology; Biology; Medicine; Bioinformatics; Oncology; Internal medicine","score_opus":0.03616010690561902,"score_gpt":0.31531506695959677,"score_spread":0.2791549600539778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908999604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95060885,0.000075066535,0.04714664,0.00017942734,0.000021803577,0.0009908836,0.0000075884536,0.000028600947,0.0009411572],"genre_scores_gemma":[0.98863333,0.000011465842,0.010735874,0.00007356667,0.00017333818,0.00009648837,0.0000035805929,0.00001582,0.000256546],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99933165,0.000010114684,0.00013303367,0.00017150116,0.00014484624,0.00020886364],"domain_scores_gemma":[0.99944913,0.00006025259,0.000038911774,0.00015457501,0.00022128005,0.00007582615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021481415,0.00006577857,0.00014779743,0.000083240775,0.00007609287,0.000008274875,0.000046812173,0.00006245895,0.0000082719625],"category_scores_gemma":[0.000111744164,0.000057448146,0.00002650381,0.00016428661,0.000110806344,0.000018108874,0.0000468984,0.0000751526,0.000012858538],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008594073,0.00043246493,0.013786303,0.00049106876,0.00026394252,0.000009809451,0.0006622921,0.0000023522405,0.90853953,0.0014670996,0.00037233034,0.073113374],"study_design_scores_gemma":[0.0056833136,0.0010205553,0.033949446,0.00007807929,0.000112713285,0.000058491805,0.0001119612,0.0016127334,0.9476232,0.0000812755,0.009563844,0.000104368555],"about_ca_topic_score_codex":0.00009329637,"about_ca_topic_score_gemma":0.000018761253,"teacher_disagreement_score":0.07300901,"about_ca_system_score_codex":0.000051081315,"about_ca_system_score_gemma":0.000112998954,"threshold_uncertainty_score":0.23426674},"labels":[],"label_agreement":null},{"id":"W2909071270","doi":"10.1182/blood-2018-99-110140","title":"Economics of Multiple Myeloma","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Medicine; Multiple myeloma; Cohort; Retrospective cohort study; Health care; Cancer; Pharmacy; Emergency medicine; Family medicine; Internal medicine","score_opus":0.027497074112993864,"score_gpt":0.2880651789637725,"score_spread":0.26056810485077864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909071270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876481,0.000076591394,0.000013746958,0.0000904097,0.000037689842,0.00018263138,0.000017340517,0.000021277707,0.011912172],"genre_scores_gemma":[0.9965883,0.00003387621,0.0025491267,0.000042285348,0.00017162853,0.000008837632,0.000015375013,0.000011314117,0.0005792558],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99948716,0.000010348882,0.00012795697,0.00012675369,0.00007748585,0.0001702727],"domain_scores_gemma":[0.9994841,0.0000410424,0.000034443157,0.00023924746,0.00007852681,0.0001226157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005292061,0.000064868014,0.00015167437,0.000058132664,0.000029768922,0.00000396809,0.00005154504,0.000038045433,0.0002056604],"category_scores_gemma":[0.000110429944,0.000052880667,0.000055190623,0.000057359754,0.000097353244,0.00002831623,0.00003170046,0.000041402665,0.00019893551],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040215935,0.0015919729,0.95111686,0.000065138636,0.0004527714,0.00005522153,0.00016663199,1.7572073e-7,0.02187773,0.00024415375,0.00031699633,0.02371018],"study_design_scores_gemma":[0.010288192,0.0010589706,0.5686606,0.000034726225,0.000093858194,0.000059958777,0.00003422872,0.00027551476,0.41564214,0.000096442585,0.0036809323,0.00007440464],"about_ca_topic_score_codex":0.000054992248,"about_ca_topic_score_gemma":0.000043381595,"teacher_disagreement_score":0.3937644,"about_ca_system_score_codex":0.00001198427,"about_ca_system_score_gemma":0.000062629326,"threshold_uncertainty_score":0.25569797},"labels":[],"label_agreement":null},{"id":"W2909116479","doi":"10.1182/blood-2018-99-118362","title":"Safety and Efficacy of Venetoclax (VEN) in Combination with Bendamustine (B) Plus Rituximab (R) or Obinutuzumab (G) in Patients (pts) with Previously Untreated Chronic Lymphocytic Leukemia (CLL): Results from a Phase Ib Study (GO28440)","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Venetoclax; Obinutuzumab; Bendamustine; Chronic lymphocytic leukemia; Rituximab; Medicine; Ofatumumab; Ven; Internal medicine; Leukemia; Ibrutinib; Fludarabine; Oncology; Immunology; Lymphoma; Cyclophosphamide; Chemotherapy","score_opus":0.014411513921813463,"score_gpt":0.2837384014800938,"score_spread":0.2693268875582804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909116479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99511683,0.00023131228,0.0000094328325,0.00001365522,0.000042192998,0.0041762735,0.000120234035,0.00006731472,0.00022273631],"genre_scores_gemma":[0.99875176,0.00006871785,0.00024570638,0.000020891443,0.00011143979,0.000089227455,0.00044622546,0.00007864005,0.00018738408],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99606645,0.00023114833,0.0010705661,0.000949528,0.000968314,0.0007140133],"domain_scores_gemma":[0.9975379,0.00045449173,0.000370268,0.0008985189,0.00048918533,0.00024962527],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00053410215,0.0004453359,0.0010808292,0.00043650306,0.000087857225,0.000032082604,0.00025373843,0.00018952994,0.00005956386],"category_scores_gemma":[0.00067445583,0.00031783603,0.000041380248,0.0012703302,0.00041616947,0.00018226379,0.00016308553,0.00033832353,0.000016372853],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.82949775,0.041726246,0.043988675,0.0020002846,0.002876204,0.0056699286,0.03633274,0.003984068,0.00091109076,0.000038385195,0.00021110228,0.032763537],"study_design_scores_gemma":[0.8609108,0.034229785,0.0680041,0.002108128,0.0005910666,0.000087867076,0.00036174408,0.0311466,0.0021074985,0.000004162602,0.00007476452,0.00037350622],"about_ca_topic_score_codex":0.022821372,"about_ca_topic_score_gemma":0.012318243,"teacher_disagreement_score":0.044689346,"about_ca_system_score_codex":0.08740255,"about_ca_system_score_gemma":0.04271321,"threshold_uncertainty_score":0.99992734},"labels":[],"label_agreement":null},{"id":"W2909129451","doi":"10.1182/blood-2018-99-113062","title":"Genetic Characterization of ABT-199 Sensitivity in Human AML","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal","funders":"","keywords":"NPM1; Myeloid leukemia; Gene mutation; Leukemia; Oncology; Mutation; Internal medicine; Concomitant; Cancer research; Cytarabine; Biology; Medicine; Gene; Genetics; Karyotype","score_opus":0.016490683470503722,"score_gpt":0.2881090579277114,"score_spread":0.2716183744572077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909129451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99810934,0.000008584115,0.000092961556,0.00015517263,0.00002457144,0.00023365261,0.000006692284,0.000020691932,0.0013483554],"genre_scores_gemma":[0.9988955,0.000011341236,0.0003692959,0.00010937345,0.00028056325,0.000005525676,0.000028388691,0.000015060224,0.0002848987],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9992565,0.00005342239,0.00017427038,0.00015620684,0.00018352421,0.00017606733],"domain_scores_gemma":[0.9995245,0.000018532277,0.000048315716,0.00024279483,0.0001071961,0.000058685815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002073655,0.000067972964,0.00017550787,0.00013466967,0.000026304766,0.00000461012,0.000041068866,0.000069135676,0.00009432517],"category_scores_gemma":[0.00006124453,0.000064214095,0.00002730223,0.00021900324,0.00010921338,0.000034684712,0.000044982397,0.00011929743,0.000044446795],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027994856,0.00023669476,0.13603489,0.000042265343,0.000017672355,0.00007408602,0.00020084022,6.885089e-8,0.8623802,0.00003365743,0.000023770453,0.0009278575],"study_design_scores_gemma":[0.0015789886,0.00020170533,0.676837,0.000041417366,0.000023866703,0.00004150641,0.000009264611,0.000109098604,0.32095683,0.000013127202,0.0001456803,0.00004150291],"about_ca_topic_score_codex":0.0001319118,"about_ca_topic_score_gemma":0.0000777815,"teacher_disagreement_score":0.5414234,"about_ca_system_score_codex":0.000042026804,"about_ca_system_score_gemma":0.00009093761,"threshold_uncertainty_score":0.26185748},"labels":[],"label_agreement":null},{"id":"W2909182124","doi":"10.1182/blood-2018-99-111514","title":"Efficacy and Safety of CPX-351 Versus 7+3 in a Subgroup of Older Patients with Newly Diagnosed Acute Myeloid Leukemia with Myelodysplasia-Related Changes (AML-MRC) Enrolled in a Phase 3 Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada","funders":"","keywords":"Medicine; Internal medicine; Cytarabine; Chemotherapy regimen; Oncology; Myelodysplastic syndromes; Decitabine; Regimen; Gastroenterology; Leukemia; Chemotherapy; Bone marrow","score_opus":0.010559426140119,"score_gpt":0.27632452406411334,"score_spread":0.26576509792399433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909182124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952799,0.00011352941,0.000005500729,0.000117200434,0.00004283335,0.00394323,0.00004163631,0.000047956917,0.00040818058],"genre_scores_gemma":[0.9989298,0.0001054851,0.0005111584,0.000032159725,0.000047920275,0.00014711147,0.00006724802,0.00007430598,0.000084824846],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969665,0.00021578239,0.00070877577,0.0006633574,0.0008261342,0.0006194838],"domain_scores_gemma":[0.9979856,0.00046023092,0.0003192147,0.0006427278,0.0003526731,0.00023953656],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00050562527,0.00040724542,0.0011267888,0.00072931417,0.000057481062,0.000013102017,0.00024571098,0.00020790259,0.00007381665],"category_scores_gemma":[0.000261054,0.00029669487,0.000044756875,0.0015170559,0.00047382055,0.00013652218,0.00015824143,0.0005335229,0.0000061446212],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13394083,0.017785959,0.812708,0.00026602735,0.0023482826,0.001132109,0.019534865,0.000010717064,0.005541163,0.000012160835,0.00006159982,0.0066582714],"study_design_scores_gemma":[0.36060256,0.021667052,0.6112856,0.00052946,0.0005795114,0.000017722601,0.001021016,0.000114802235,0.0039284676,0.0000011219229,0.000017519567,0.00023510249],"about_ca_topic_score_codex":0.00075347506,"about_ca_topic_score_gemma":0.00220031,"teacher_disagreement_score":0.22666173,"about_ca_system_score_codex":0.00028991717,"about_ca_system_score_gemma":0.0005986254,"threshold_uncertainty_score":0.9999485},"labels":[],"label_agreement":null},{"id":"W2909348260","doi":"10.1182/blood-2018-11-882167","title":"Resolved HBV and anti-CD20 therapy","year":2019,"lang":"en","type":"letter","venue":"Blood","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Obinutuzumab; Medicine; HBsAg; Rituximab; Hepatitis B; Hepatitis B virus; Immunology; Virology; CD20; Antibody; Lamivudine; Internal medicine; Gastroenterology; Virus","score_opus":0.03056170355547452,"score_gpt":0.2656063242309663,"score_spread":0.23504462067549178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909348260","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21652399,0.016381389,0.0000037921895,0.7485608,0.00061900745,0.0012419224,0.00010615702,0.00019269793,0.01637023],"genre_scores_gemma":[0.016569406,0.010240946,0.0003335248,0.95349026,0.005575601,0.00004559347,0.00018091136,0.00013022138,0.0134335235],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986847,0.00004821337,0.00021782599,0.00040163353,0.00031313483,0.000334459],"domain_scores_gemma":[0.99918085,0.00012476774,0.00008678986,0.00049446046,0.000075713775,0.00003742672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009017848,0.0002823721,0.000681244,0.00010708506,0.0000571895,0.000021805747,0.00008967342,0.0004994388,0.0001221083],"category_scores_gemma":[0.00007662265,0.00022248807,0.000099879995,0.00007104008,0.000092318805,0.000025576179,0.0000699114,0.0009126268,0.0002506334],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010980715,0.000075440796,0.08044551,0.00021419056,0.00044950162,0.00068483036,0.00014091564,3.8104204e-9,0.00073002407,0.0000017988739,0.9165457,0.00070112065],"study_design_scores_gemma":[0.0029929816,0.0002293418,0.032235477,0.00023566034,0.00025374562,0.00008066801,0.0000032654284,4.6170513e-7,0.0008198712,0.000012923761,0.96290684,0.00022877604],"about_ca_topic_score_codex":0.00028421683,"about_ca_topic_score_gemma":0.00002762726,"teacher_disagreement_score":0.20492947,"about_ca_system_score_codex":0.000014104677,"about_ca_system_score_gemma":0.000073919866,"threshold_uncertainty_score":0.9072801},"labels":[],"label_agreement":null},{"id":"W2909444021","doi":"10.1182/blood-2018-99-114518","title":"99.3% of Inhibitors in Severe Hemophilia a Develop before Exposure Day 75. Time to Change Definition of Previously Treated Patients; Data from 1038 Patients with Severe Hemophilia a of the Pednet Registry","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Hospital for Sick Children","funders":"","keywords":"Medicine; Titer; Incidence (geometry); Internal medicine; Factor IX; Antibody; Pediatrics; Gastroenterology; Immunology","score_opus":0.030250887499567527,"score_gpt":0.25370222510149965,"score_spread":0.22345133760193212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909444021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948854,0.00010100326,2.8393902e-7,0.0002546521,0.00004515413,0.002053072,0.0016490663,0.000020605898,0.0009907507],"genre_scores_gemma":[0.99633557,0.000014113641,0.00059003406,0.000063183565,0.00012366119,0.000053086635,0.0023102062,0.000045521978,0.00046464737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99743295,0.00014878805,0.000655653,0.00054132944,0.0008435784,0.00037772002],"domain_scores_gemma":[0.997347,0.00008121631,0.00035604107,0.0013498039,0.0006995597,0.0001663686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024495512,0.00030066416,0.00064151414,0.0001919487,0.000058696958,0.000007563067,0.0004826435,0.00021897905,0.00019805372],"category_scores_gemma":[0.0004046677,0.00018906736,0.00007486964,0.000965493,0.0002407253,0.00016400137,0.0003995537,0.00020068762,0.000038021804],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007806534,0.0028829481,0.98916936,0.00028372998,0.00023579707,0.000011827928,0.0025859473,1.0229501e-7,0.00052898476,0.000002395859,0.0010086602,0.0025095942],"study_design_scores_gemma":[0.011373802,0.00355434,0.97224754,0.002081559,0.00038773785,0.0000074909995,0.00009507896,0.000007918714,0.009780762,0.00006078271,0.00018547093,0.00021753447],"about_ca_topic_score_codex":0.0003878872,"about_ca_topic_score_gemma":0.00034066313,"teacher_disagreement_score":0.016921835,"about_ca_system_score_codex":0.00007256203,"about_ca_system_score_gemma":0.00025884356,"threshold_uncertainty_score":0.7709943},"labels":[],"label_agreement":null},{"id":"W2909553215","doi":"10.1182/blood-2018-10-878025","title":"A topological view of human CD34+ cell state trajectories from integrated single-cell output and proteomic data","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency; National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research","keywords":"Biology; Transcription factor; Haematopoiesis; Cell biology; Single-cell analysis; Cell; Cord blood; CD34; Stromal cell; Computational biology; Genetics; Stem cell; Gene; Cancer research","score_opus":0.029483356174941792,"score_gpt":0.23223082421768135,"score_spread":0.20274746804273955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909553215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99703956,0.0013155675,0.0001758924,0.000014349264,0.00009897072,0.0002978657,0.00031454,0.0000147803585,0.0007284815],"genre_scores_gemma":[0.99739975,0.0001472449,0.0010858234,0.00004753895,0.00006621085,0.000005125147,0.00067641755,0.00002070719,0.00055119686],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989723,0.00006293483,0.00024958403,0.00044472952,0.000087367276,0.0001830707],"domain_scores_gemma":[0.99925715,0.000013733342,0.00009216239,0.00053248514,0.000045803346,0.00005867642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000095064,0.00017223781,0.00025096606,0.00002094789,0.00003664739,0.000026395146,0.0003193943,0.00014576498,0.000035454956],"category_scores_gemma":[0.000015355694,0.00014335707,0.000046574773,0.000047228525,0.00010444809,0.000006216741,0.00014192642,0.00011101354,0.0000058183373],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006288165,0.00055719406,0.015179213,0.00006652896,0.00003747496,0.0000023750383,0.000095575415,9.561302e-7,0.98352885,0.000004170821,0.00004726708,0.00041751793],"study_design_scores_gemma":[0.0019562442,0.00088826986,0.0022933304,0.000028032948,0.000064495725,0.0000023839236,0.00007210473,0.000022001681,0.9921326,0.000088741814,0.0022475254,0.00020427388],"about_ca_topic_score_codex":0.0003171775,"about_ca_topic_score_gemma":0.00009160205,"teacher_disagreement_score":0.0128858825,"about_ca_system_score_codex":0.000003717051,"about_ca_system_score_gemma":0.000049313086,"threshold_uncertainty_score":0.5845932},"labels":[],"label_agreement":null},{"id":"W2909590336","doi":"10.1182/blood-2018-99-118238","title":"Tocilizumab to Prevent Infusion-Related Events in Patients with Chronic Lymphocytic Leukemia and Co-Morbidities Treated with Obinutuzumab and Chlorambucil: Results from the Randomized Phase Ib GALACTA Trial","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Medicine; Obinutuzumab; Internal medicine; Tolerability; Chlorambucil; Neutropenia; Chronic lymphocytic leukemia; Population; Gastroenterology; Placebo; Rituximab; Pharmacology; Adverse effect; Leukemia; Cyclophosphamide; Toxicity; Chemotherapy; Lymphoma","score_opus":0.011956630688166204,"score_gpt":0.2743807633454712,"score_spread":0.26242413265730496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909590336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919224,0.0003725185,0.0000030238223,0.00010013229,0.00006673129,0.006891385,0.00013438509,0.00008072591,0.0004287108],"genre_scores_gemma":[0.99816954,0.00014665248,0.00007011337,0.00009816017,0.00023490866,0.00034546727,0.00033125357,0.000066732944,0.0005371645],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99633664,0.0003914794,0.00082353735,0.00083013874,0.00096369715,0.0006545207],"domain_scores_gemma":[0.9973144,0.0010133013,0.00025528274,0.00081612094,0.00023963217,0.00036124713],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008399466,0.00046101643,0.0010774066,0.00019941755,0.0002059476,0.0000638504,0.00022272626,0.00021441486,0.00009277271],"category_scores_gemma":[0.00085335266,0.0002598836,0.000078272504,0.00051639474,0.0007208394,0.00015845499,0.00017068256,0.0003128303,0.000028819008],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.9928483,0.0007768451,0.0009590941,0.000064791435,0.00081864116,0.00010844724,0.0026313702,0.000023154023,0.00010378617,0.0000077068225,0.00029817666,0.0013597278],"study_design_scores_gemma":[0.97838706,0.008568873,0.0053857774,0.0010406933,0.00072264764,0.00006723856,0.0001166552,0.0032036316,0.0020152468,0.000030428426,0.00012806317,0.00033369908],"about_ca_topic_score_codex":0.011490595,"about_ca_topic_score_gemma":0.0012454198,"teacher_disagreement_score":0.014461214,"about_ca_system_score_codex":0.021441769,"about_ca_system_score_gemma":0.015858253,"threshold_uncertainty_score":0.99998534},"labels":[],"label_agreement":null},{"id":"W2909637775","doi":"10.1182/blood-2018-99-114371","title":"Bendamustine Adversely Affects Stem Cell Mobilization Among Patients with Mantle Cell Lymphoma (MCL): A Comparison of the BR Vs RCHOP Eras in British Columbia (BC), Canada","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Vancouver General Hospital; BC Cancer Agency; Leukemia & Lymphoma Society of Canada","funders":"","keywords":"Medicine; Plerixafor; Bendamustine; Mantle cell lymphoma; Internal medicine; Rituximab; Univariate analysis; Apheresis; Surgery; Population; Oncology; Lymphoma; CXCR4; Multivariate analysis","score_opus":0.004469381499133683,"score_gpt":0.18556027031006475,"score_spread":0.18109088881093108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909637775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99737054,0.00017322859,9.768382e-7,0.000016851858,0.00013664128,0.0009593014,0.00007591811,0.000016665714,0.0012498497],"genre_scores_gemma":[0.9991292,0.000010267551,0.00005316031,0.000079445825,0.000031449366,0.000052691383,0.00006154821,0.000026597274,0.0005556466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869835,0.000058880458,0.00027060296,0.00028836148,0.0004225073,0.00026129445],"domain_scores_gemma":[0.99918026,0.00005860631,0.0002051398,0.00031112158,0.00014988368,0.00009499615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000051531253,0.00013529976,0.00034983712,0.0000289779,0.000100768826,0.000034099998,0.00010486602,0.000069821224,0.000066052155],"category_scores_gemma":[0.000010556383,0.00013263564,0.00004713189,0.00029164765,0.000093597366,0.00005305221,0.00005046534,0.000049907754,0.0000032279377],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005160493,0.0048543434,0.9898205,0.00013960412,0.000044787226,0.00003414485,0.00021178863,0.000012800798,0.00005634855,3.7090157e-7,0.0031944888,0.0015792525],"study_design_scores_gemma":[0.018120749,0.00087270106,0.96189797,0.0004007392,0.00026423324,0.0000060625694,0.0002333202,0.00010363616,0.01745324,5.265899e-7,0.0005163191,0.00013052158],"about_ca_topic_score_codex":0.7141932,"about_ca_topic_score_gemma":0.96279705,"teacher_disagreement_score":0.24860382,"about_ca_system_score_codex":0.00023817527,"about_ca_system_score_gemma":0.00043898745,"threshold_uncertainty_score":0.54087245},"labels":[],"label_agreement":null},{"id":"W2909672303","doi":"10.1182/blood-2018-99-114218","title":"Molecular Features of Primary Central Nervous System Lymphoma in a Large Tissue Microarray","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"","keywords":"BCL6; Primary central nervous system lymphoma; Medicine; Tissue microarray; Immunohistochemistry; Lymphoma; In situ hybridization; Rituximab; Diffuse large B-cell lymphoma; Pathology; Oncology; Biopsy; Fluorescence in situ hybridization; Cancer; Internal medicine; Biology; B cell; Antibody; Immunology; Gene expression","score_opus":0.005291384543819037,"score_gpt":0.22590844002281216,"score_spread":0.22061705547899313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909672303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897297,0.0032825954,0.000011352567,0.00012244155,0.00010418643,0.00039956285,0.000031791315,0.00004113213,0.006277252],"genre_scores_gemma":[0.99888474,0.000028073646,0.0005811485,0.00019167745,0.00012647537,0.000032127435,0.000036997335,0.000024019933,0.0000947205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896723,0.00003422717,0.00023580805,0.00023798157,0.00019048523,0.00033424218],"domain_scores_gemma":[0.99942505,0.000019340263,0.00006888874,0.00032272394,0.0000556039,0.00010836639],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007248882,0.00014818338,0.0003749832,0.000097802484,0.000026732776,0.000008896501,0.00007321657,0.00009257234,0.000023597479],"category_scores_gemma":[0.00001610886,0.00012197439,0.00008876809,0.00016960794,0.000047583,0.000022422404,0.000040233357,0.000033323548,0.000025632027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056062563,0.017496511,0.4340569,0.0016028964,0.0009808814,0.0067310836,0.0021361515,0.0000013891515,0.42623028,0.0027806445,0.0020422768,0.10538035],"study_design_scores_gemma":[0.0057935994,0.00034553502,0.6538598,0.00027219238,0.00018797949,0.00033734302,0.000072926,0.0000018085542,0.33802024,0.0000031658776,0.0010297766,0.00007564606],"about_ca_topic_score_codex":0.00030923347,"about_ca_topic_score_gemma":0.00007653168,"teacher_disagreement_score":0.21980287,"about_ca_system_score_codex":0.00015035241,"about_ca_system_score_gemma":0.00012235685,"threshold_uncertainty_score":0.49739712},"labels":[],"label_agreement":null},{"id":"W2909752273","doi":"10.1182/blood-2018-99-111200","title":"Serial Biomarker Monitoring Early after HCT Identifies Different Risks for Relapse and Graft-Vs-Host Disease","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Graft-versus-host disease; Internal medicine; Biomarker; Disease; Malignancy; Oncology; Biology","score_opus":0.030779955939677913,"score_gpt":0.29575332893346534,"score_spread":0.2649733729937874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909752273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99759483,0.0002894496,0.00028452565,0.0001322649,0.0009145544,0.00061040744,0.000055268178,0.00006106552,0.000057611644],"genre_scores_gemma":[0.99816805,0.000057316705,0.00036591035,0.000023229166,0.0008506112,0.00015839704,0.00001836045,0.000032486456,0.00032563572],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99907,0.000027937804,0.00021748563,0.00027415055,0.00019021898,0.00022021968],"domain_scores_gemma":[0.9993323,0.00007919867,0.00004538396,0.00022446219,0.0001032583,0.00021541234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009903101,0.00015211811,0.0001994938,0.00007020248,0.00008214813,0.00005247587,0.0000424523,0.00007310117,0.000043874792],"category_scores_gemma":[0.000069165864,0.0001254529,0.00007238255,0.000055052376,0.0000883093,0.00008084917,0.000020422958,0.00005652373,0.00002169036],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002385539,0.00028942054,0.91270703,0.0006104037,0.00015421995,0.00006481579,0.0011840769,9.224155e-9,0.082281575,0.0000097640295,0.000066126544,0.00024703736],"study_design_scores_gemma":[0.004260041,0.00023051642,0.9463241,0.00038244456,0.0008019079,0.000013789433,0.00005436452,0.000008989643,0.047572378,0.00008977597,0.0001278085,0.00013385508],"about_ca_topic_score_codex":0.000023649707,"about_ca_topic_score_gemma":0.0000074560485,"teacher_disagreement_score":0.034709197,"about_ca_system_score_codex":0.000011318464,"about_ca_system_score_gemma":0.00002061854,"threshold_uncertainty_score":0.51158214},"labels":[],"label_agreement":null},{"id":"W2910069319","doi":"10.1182/blood.v130.suppl_1.734.734","title":"A Pilot Study of Brentuximab Vedotin and AVD Chemotherapy Followed By 20 Gy Involved-Site Radiotherapy in Early Stage, Unfavorable Risk Hodgkin Lymphoma","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Brentuximab vedotin; Medicine; Radiation therapy; Stage (stratigraphy); Oncology; Chemotherapy; Lymphoma; Internal medicine; Hodgkin lymphoma; Dacarbazine; Chemotherapy regimen; Biology","score_opus":0.01568668766621641,"score_gpt":0.2655099403892108,"score_spread":0.24982325272299435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910069319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948212,0.0031685454,0.000003999573,0.00019138459,0.00008073057,0.0012471974,0.0000827547,0.000037038644,0.0003671738],"genre_scores_gemma":[0.9966942,0.002019529,0.00029679787,0.00012813145,0.00006015129,0.00011783692,0.000016796643,0.000053056945,0.00061351137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998269,0.0001100653,0.00041437973,0.0005141901,0.0003368565,0.0003555071],"domain_scores_gemma":[0.9984105,0.00009470076,0.00037788437,0.00089631253,0.00005466581,0.00016590254],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003015411,0.0003085914,0.00073897024,0.00013460853,0.0001821145,0.00009579593,0.0001933918,0.00006599332,0.000045696564],"category_scores_gemma":[0.00005174826,0.00025809451,0.00008062193,0.000117937954,0.00010079112,0.00014452665,0.00005583237,0.00008916564,0.0000069374814],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095158775,0.028988281,0.95491385,0.000040881867,0.00064630865,0.00013420808,0.0015979395,6.999342e-7,0.006067521,0.000008169205,0.00062796584,0.006022604],"study_design_scores_gemma":[0.104805216,0.010261352,0.87348765,0.000119773686,0.00028656132,0.000009021929,0.00019302273,0.00003332691,0.009649503,0.000014896102,0.0009276614,0.00021202634],"about_ca_topic_score_codex":0.016441254,"about_ca_topic_score_gemma":0.002417846,"teacher_disagreement_score":0.10385363,"about_ca_system_score_codex":0.000100744524,"about_ca_system_score_gemma":0.00010664734,"threshold_uncertainty_score":0.9999871},"labels":[],"label_agreement":null},{"id":"W2910106990","doi":"10.1182/blood-2018-99-119631","title":"Examining Convergent Construct Validity and Inter-Rater Reliability Between ESMO-MCBS and ASCO-VF When Evaluating Hematologic Malignancies","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Cancer Care Ontario; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Clinical Oncology; Oncology; Clinical trial; Construct validity; Cancer; Surgery","score_opus":0.44237836745620407,"score_gpt":0.41268956492985104,"score_spread":0.02968880252635303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910106990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99317396,0.00074130355,0.0010413111,0.0026273702,0.0004229086,0.0005928196,0.00017098477,0.00007448867,0.0011548692],"genre_scores_gemma":[0.9887788,0.000051182946,0.009201037,0.0013585306,0.00037657106,0.000058127363,0.000018582165,0.000027089944,0.00013002446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952237,0.0005753519,0.0027480666,0.0008765244,0.000105335814,0.00047099733],"domain_scores_gemma":[0.9963423,0.0013768438,0.0013561933,0.00056230725,0.00013520606,0.00022714028],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.01598418,0.00027140827,0.0011078767,0.00017097084,0.00033855852,0.00014737104,0.00020456535,0.00021044532,0.00049902475],"category_scores_gemma":[0.004198483,0.00030912823,0.00006150865,0.000092630995,0.00049829367,0.00040692178,0.00022114553,0.00018865675,0.0003334608],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006072981,0.000045368204,0.99349105,0.0003002095,0.00006128723,9.691043e-7,0.0023235728,4.377987e-7,0.00002666861,0.0028889603,0.00072763953,0.00012778213],"study_design_scores_gemma":[0.0036690678,0.00095655565,0.92287827,0.0003454817,0.00012410623,0.000084106505,0.002767211,0.0014762259,0.0009805922,0.061269414,0.004458684,0.000990313],"about_ca_topic_score_codex":0.00044018685,"about_ca_topic_score_gemma":0.000048991114,"teacher_disagreement_score":0.07061279,"about_ca_system_score_codex":0.000116405885,"about_ca_system_score_gemma":0.00009667984,"threshold_uncertainty_score":0.9999361},"labels":[],"label_agreement":null},{"id":"W2910138223","doi":"10.1182/blood-2018-99-120393","title":"Clinical Outcomes and Molecular Responses in Children with Langerhans Cell Histiocytosis Treated with MAPK Pathway Inhibitors","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Langerhans cell histiocytosis; Medicine; Macrophage activation syndrome; Hemophagocytic lymphohistiocytosis; Histiocytosis; Salvage therapy; Progressive disease; MAPK/ERK pathway; Immunology; Oncology; Internal medicine; Disease; Biology; Chemotherapy; Signal transduction; Genetics","score_opus":0.010306626443513225,"score_gpt":0.2585120021039315,"score_spread":0.24820537566041828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910138223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969336,0.00021216356,0.00001104282,0.00010702921,0.000011732081,0.0003761069,0.0000207647,0.000044916153,0.0022826623],"genre_scores_gemma":[0.9978001,0.000024007843,0.0009929244,0.00019957991,0.000031216325,0.000024483077,0.00003020876,0.000027765835,0.00086973043],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908763,0.000052449283,0.00020221206,0.00030574377,0.00016093538,0.0001910418],"domain_scores_gemma":[0.99949944,0.00004221794,0.000058752546,0.0002325324,0.00004344161,0.00012361034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008919341,0.00016938795,0.0003266749,0.00010224745,0.00004371658,0.000011982437,0.00003653987,0.00008017546,0.000022342074],"category_scores_gemma":[0.000034250494,0.000105680934,0.000039911447,0.00015549817,0.00018647996,0.000028485383,0.000016477561,0.0000944347,0.000019598174],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046291194,0.0013627738,0.996367,0.000009152227,0.00024244176,0.00030743025,0.00009192156,5.9187325e-8,0.00019078834,0.00000789616,0.00003923112,0.0009184402],"study_design_scores_gemma":[0.015912475,0.0029739083,0.97032285,0.00009121551,0.00050155114,0.000105858664,0.000048351776,0.0000018457172,0.009600079,0.000006039476,0.00028335408,0.00015244925],"about_ca_topic_score_codex":0.00030519336,"about_ca_topic_score_gemma":0.00016342501,"teacher_disagreement_score":0.02604408,"about_ca_system_score_codex":0.000022411645,"about_ca_system_score_gemma":0.00009724616,"threshold_uncertainty_score":0.43095434},"labels":[],"label_agreement":null},{"id":"W2910162643","doi":"10.1182/blood.v130.suppl_1.1750.1750","title":"Single-Agent Ibrutinib Vs Chemoimmunotherapy Regimens for Treatment-Naïve Patients with Chronic Lymphocytic Leukemia (CLL): A Cross-Trial Comparison","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Ibrutinib; Chemoimmunotherapy; Chronic lymphocytic leukemia; Medicine; Venetoclax; Oncology; Internal medicine; Idelalisib; Leukemia; Immunology","score_opus":0.0438073010882187,"score_gpt":0.34324263776981506,"score_spread":0.2994353366815964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910162643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99239707,0.0006731377,0.0000520264,0.00010381343,0.00036394942,0.004451073,0.00007410658,0.00015118612,0.00173364],"genre_scores_gemma":[0.9941306,0.0000673838,0.00084567734,0.00009535242,0.0007379909,0.00056883984,0.0002244134,0.00015138034,0.0031783222],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99658114,0.000045810622,0.0006304245,0.0008467334,0.0008024745,0.0010934492],"domain_scores_gemma":[0.996422,0.000220059,0.00053291034,0.002133158,0.00034706978,0.00034480263],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023906464,0.000532336,0.001008719,0.0001274287,0.0006860476,0.00037332135,0.000552127,0.00028725585,0.00012106145],"category_scores_gemma":[0.0002557739,0.00040340968,0.00032788012,0.00011270871,0.0005451036,0.00021605696,0.00012771063,0.00015317589,0.000100009565],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.74358326,0.028649122,0.09915236,0.0026399787,0.012820649,0.0010583439,0.004119158,0.0005718352,0.023587393,0.0004427604,0.005321765,0.0780534],"study_design_scores_gemma":[0.88733566,0.017453803,0.0077561936,0.00035522348,0.0007529403,0.00007553644,0.000021952903,0.002821233,0.06939943,0.000024163082,0.013479034,0.00052483304],"about_ca_topic_score_codex":0.0015264241,"about_ca_topic_score_gemma":0.000163546,"teacher_disagreement_score":0.14375241,"about_ca_system_score_codex":0.07296437,"about_ca_system_score_gemma":0.022921149,"threshold_uncertainty_score":0.99984175},"labels":[],"label_agreement":null},{"id":"W2910240398","doi":"10.1182/blood-2018-99-117251","title":"Prolonged Overall Survival (OS) in a Subset of Responders to the Combination of Brentuximab Vedotin (Bv) and Bendamustine (B) in Heavily Treated Patients with Relapsed or Refractory Hodgkin Lymphoma (HL): Results of an International Multi- Center Phase I/II Experience","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Spinal Cord Injury BC; Princess Margaret Cancer Centre; BC Cancer Agency; University of Toronto","funders":"","keywords":"Medicine; Brentuximab vedotin; Internal medicine; Bendamustine; Refractory (planetary science); Population; Gastroenterology; Chemotherapy; Oncology; Lymphoma; Surgery; Hodgkin lymphoma; Rituximab","score_opus":0.021566203594226972,"score_gpt":0.2996807255284848,"score_spread":0.27811452193425784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910240398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99853253,0.000016591903,0.0000013027227,0.00019046458,0.00005623021,0.0008569491,0.00029164934,0.000008174801,0.00004608517],"genre_scores_gemma":[0.9991967,0.000012913537,0.00035903262,0.000042906173,0.000013273035,0.00005800717,0.00028107796,0.000013760568,0.00002230461],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850476,0.00013875008,0.00052750757,0.00030524892,0.00036300858,0.00016070686],"domain_scores_gemma":[0.9990009,0.00009813973,0.0002731408,0.00029172108,0.00026551346,0.0000706018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002521611,0.00015264389,0.0003383038,0.0002394081,0.000027332097,0.000005859682,0.00011474236,0.00006195587,0.0000116515275],"category_scores_gemma":[0.00027478658,0.00009644472,0.000028330625,0.00027810605,0.00013572324,0.00013034279,0.000053251864,0.00004412902,3.7886178e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0468021,0.057179164,0.8777481,0.000036944468,0.0001190362,0.00004449354,0.009812623,0.0000020602824,0.0030481177,0.000011893651,0.000024023424,0.0051714666],"study_design_scores_gemma":[0.15055686,0.010890341,0.81498855,0.0003080044,0.00004782973,0.000005665746,0.00028254825,0.00015952585,0.022638325,0.000001076466,0.00004496077,0.000076286124],"about_ca_topic_score_codex":0.000985069,"about_ca_topic_score_gemma":0.0019232255,"teacher_disagreement_score":0.10375477,"about_ca_system_score_codex":0.000090581176,"about_ca_system_score_gemma":0.00008922281,"threshold_uncertainty_score":0.39329016},"labels":[],"label_agreement":null},{"id":"W2910307207","doi":"10.1182/blood-2018-99-115743","title":"FOXM1 and the NPM-ALK/STAT3 Axis Form a Novel Positive Feedback Loop in Promoting the Oncogenesis of ALK-Positive Anaplastic Large Cell Lymphoma","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"FOXO transcription factor regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"FOXM1; Anaplastic large-cell lymphoma; Cancer research; Anaplastic lymphoma kinase; Carcinogenesis; Lymphoma; Biology; Medicine; Cancer; Cell cycle; Oncology; Pathology; Internal medicine","score_opus":0.005488466961725385,"score_gpt":0.20896264684999355,"score_spread":0.20347417988826816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910307207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99673593,0.00039171355,0.0012116822,0.00018572998,0.00005135428,0.0004522836,0.0001256856,0.000005869651,0.000839767],"genre_scores_gemma":[0.9993915,0.000031893363,0.00018365803,0.00012039153,0.000083483275,0.000021664588,0.000058605932,0.000018478708,0.000090302965],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990516,0.00008316728,0.00023294905,0.0002686667,0.00013359844,0.00023002567],"domain_scores_gemma":[0.99941266,0.000060195358,0.00012875177,0.00022234875,0.00013742542,0.000038640457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027031638,0.0001500366,0.00015669318,0.000036576494,0.00012390263,0.000023233204,0.00014378525,0.000103493054,0.0000052496716],"category_scores_gemma":[0.000058900132,0.00009960601,0.00007422825,0.00014105157,0.00027943085,0.000009363899,0.000076007316,0.0000456543,0.0000028504396],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006047197,0.00081353297,0.003659437,0.00004102741,0.00014086261,0.0000018795179,0.003055159,0.0000033788288,0.98934084,0.00024256216,0.000025293464,0.0020713063],"study_design_scores_gemma":[0.0112307,0.000717146,0.07169045,0.000052006184,0.00012795914,0.000028873603,0.0005296003,0.00057529064,0.9145413,0.000057816495,0.00027546578,0.0001733663],"about_ca_topic_score_codex":0.00010560755,"about_ca_topic_score_gemma":0.00052667584,"teacher_disagreement_score":0.07479951,"about_ca_system_score_codex":0.000014466623,"about_ca_system_score_gemma":0.000054836582,"threshold_uncertainty_score":0.4061815},"labels":[],"label_agreement":null},{"id":"W2910326971","doi":"10.1182/blood-2018-99-118577","title":"PD-L1 Blockade with Atezolizumab in Higher-Risk Myelodysplastic Syndrome: An Initial Safety and Efficacy Analysis","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Atezolizumab; Medicine; Tolerability; Azacitidine; Internal medicine; Oncology; Cohort; Adverse effect; Cancer; Pembrolizumab; Immunotherapy","score_opus":0.017595141718359266,"score_gpt":0.29007160154806483,"score_spread":0.2724764598297056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910326971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99643743,0.00012764292,0.00012798124,0.000363364,0.00004095112,0.0004296341,0.000039268332,0.000092248105,0.0023414844],"genre_scores_gemma":[0.9976344,0.00010193736,0.0011912625,0.00009129912,0.0003068137,0.000017624661,0.000074223266,0.000049645376,0.00053278],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99766546,0.00018148027,0.00038845968,0.0006373087,0.0005257398,0.00060155574],"domain_scores_gemma":[0.99845535,0.00023478066,0.0001043466,0.0006381498,0.0001512889,0.0004160908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036242072,0.00027778104,0.00067091966,0.0006818292,0.00015573,0.000046326906,0.00019262529,0.0001902983,0.0005443762],"category_scores_gemma":[0.00017992151,0.0002168526,0.000075059026,0.0017518646,0.00042683948,0.00011162893,0.00012235269,0.0005651705,0.00008585432],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025684573,0.006417482,0.9071001,0.00041294273,0.0123350965,0.014958952,0.004004069,0.00020519133,0.005001255,0.00045452063,0.00028794646,0.023137903],"study_design_scores_gemma":[0.020134045,0.003415565,0.9685127,0.00011439199,0.0034298466,0.00086126366,0.00009195704,0.0011841094,0.001411905,0.000026192516,0.00050443655,0.00031359028],"about_ca_topic_score_codex":0.00040472418,"about_ca_topic_score_gemma":0.0003859009,"teacher_disagreement_score":0.061412625,"about_ca_system_score_codex":0.0001387619,"about_ca_system_score_gemma":0.00029144657,"threshold_uncertainty_score":0.8842992},"labels":[],"label_agreement":null},{"id":"W2910406726","doi":"10.1182/blood-2018-99-113516","title":"Somatic PRAME Deletions Are Associated with Decreased Immunogenicity, Apoptosis Resistance and Poor Outcomes in Diffuse Large B-Cell Lymphoma","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC","funders":"","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Oncology; Population; Internal medicine; Biology; Immunology; Cancer research; Medicine","score_opus":0.013721261010528483,"score_gpt":0.26497802880941534,"score_spread":0.25125676779888684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910406726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996366,0.0004050432,0.000015440224,0.00068707066,0.000019740519,0.0006448495,0.000048876187,0.00008058059,0.0017323954],"genre_scores_gemma":[0.99410313,0.00006474696,0.00039642092,0.00031110182,0.000037515605,0.0000786286,0.00003146765,0.00004886627,0.0049281204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983284,0.00013937471,0.0002798291,0.0003237712,0.00044123366,0.00048737862],"domain_scores_gemma":[0.99881566,0.00026421726,0.000125649,0.00043228577,0.00018042803,0.00018178114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033798546,0.0002008985,0.0004544968,0.00018148492,0.00013930004,0.000047746034,0.00013275011,0.00012667393,0.00016491197],"category_scores_gemma":[0.0004622083,0.00016163234,0.0000738559,0.00044037783,0.00015703509,0.00006527662,0.00007199464,0.00014782543,0.000024429883],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008566976,0.02665782,0.8813909,0.00017868938,0.00064965704,0.00010536197,0.0007426161,3.3587135e-8,0.088935964,0.0000344857,0.00022562132,0.00022212337],"study_design_scores_gemma":[0.09879981,0.00072696724,0.81433904,0.0006366775,0.0004542323,0.000029172505,0.00044553392,0.00007385941,0.08346109,0.00012311476,0.00053991,0.0003705719],"about_ca_topic_score_codex":0.00013208283,"about_ca_topic_score_gemma":0.0022227813,"teacher_disagreement_score":0.09794311,"about_ca_system_score_codex":0.00012321508,"about_ca_system_score_gemma":0.00015067187,"threshold_uncertainty_score":0.6591176},"labels":[],"label_agreement":null},{"id":"W2910473883","doi":"10.1182/blood-2018-99-111955","title":"Combination of ATG and Post-Transplant Cyclophosphamide for Gvhd Prophylaxis in Matched Unrelated Donor Peripheral Blood Stem Cell Transplants for High-Risk Hematological Malignancies- a Single Centre Experience","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Fludarabine; Thymoglobulin; Internal medicine; Gastroenterology; Cyclophosphamide; Transplantation; Busulfan; Graft-versus-host disease; Surgery; Hematopoietic stem cell transplantation; Regimen; Chemotherapy; Tacrolimus","score_opus":0.009877455664426958,"score_gpt":0.2228697114282961,"score_spread":0.21299225576386913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910473883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957495,0.0017586066,0.00014974088,0.00007230232,0.0001091237,0.0015153025,0.00054335024,0.000055889366,0.000046224166],"genre_scores_gemma":[0.9985106,0.00017085702,0.0008906182,0.00004332845,0.000026294041,0.00010878774,0.00010078492,0.000027754942,0.0001209999],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99855566,0.000043938115,0.00046650993,0.00038358406,0.0001708583,0.0003794709],"domain_scores_gemma":[0.9992258,0.00012841578,0.00016572258,0.0001699088,0.00015476425,0.0001554058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010390051,0.00022604482,0.00047943724,0.0000818234,0.000100403624,0.000014144302,0.000090337264,0.00026489823,0.0000322479],"category_scores_gemma":[0.000027650325,0.00017330635,0.00011161497,0.00016154711,0.00018848067,0.00007248501,0.000012105232,0.000113200294,0.000001295391],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065500718,0.014599345,0.52442247,0.0028172783,0.00047663655,0.0002983031,0.016060192,0.000005597298,0.4319648,0.0006197011,0.00002065322,0.0021649625],"study_design_scores_gemma":[0.03209986,0.006570542,0.20329261,0.00067714276,0.0013111003,0.000126103,0.0012582692,0.00012263806,0.7538987,0.00021510397,0.000025907342,0.00040202955],"about_ca_topic_score_codex":0.00015504123,"about_ca_topic_score_gemma":0.000045301986,"teacher_disagreement_score":0.3219339,"about_ca_system_score_codex":0.000019043138,"about_ca_system_score_gemma":0.00007044202,"threshold_uncertainty_score":0.70672286},"labels":[],"label_agreement":null},{"id":"W2910474565","doi":"10.1182/blood-2018-99-114097","title":"Outcomes of Stage I and II Follicular Lymphoma in the Era of 18F-FDG PET-CT Staging: An International Collaborative Study from the Australian Lymphoma Alliance","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; BC Cancer Agency; CancerCare Manitoba; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Follicular lymphoma; Stage (stratigraphy); Positron emission tomography; Radiation therapy; Lymphoma; Rituximab; Watchful waiting; Radiology; Nuclear medicine; Oncology; Internal medicine; Cancer; Prostate cancer","score_opus":0.021450753864987127,"score_gpt":0.3060370750388127,"score_spread":0.2845863211738256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910474565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996742,0.00026843807,5.028501e-7,0.0016297144,0.00008364411,0.00078860985,0.00021465591,0.000010233563,0.00026221073],"genre_scores_gemma":[0.9991569,0.00008334061,0.00023595712,0.00025554808,0.00006836273,0.00007003996,0.000024978344,0.000012400083,0.000092467584],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855924,0.00014417247,0.00034428164,0.00028172732,0.00051307725,0.00015753148],"domain_scores_gemma":[0.9989052,0.0001632388,0.00018444854,0.00048767673,0.00020521926,0.000054256467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003118683,0.00017773635,0.00036029302,0.00003264875,0.00009337378,0.000029378927,0.00026195383,0.000014874873,0.000048913193],"category_scores_gemma":[0.00009258447,0.00009604531,0.000059605656,0.00021362948,0.00018517648,0.00011094425,0.00007834204,0.000037618945,0.0000024339827],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010835228,0.0076921275,0.9820148,0.000007560113,0.0007627358,0.0003513067,0.0066729095,5.7602574e-7,0.00018432591,0.0002787753,0.00009536821,0.0018311663],"study_design_scores_gemma":[0.013459269,0.0013346813,0.96783435,0.000077879056,0.0003041057,0.00002412257,0.009304547,0.000013684335,0.00639476,0.000040411982,0.0011245133,0.00008765594],"about_ca_topic_score_codex":0.0023363167,"about_ca_topic_score_gemma":0.0009093721,"teacher_disagreement_score":0.0141804265,"about_ca_system_score_codex":0.0000649511,"about_ca_system_score_gemma":0.00015985561,"threshold_uncertainty_score":0.3916614},"labels":[],"label_agreement":null},{"id":"W2910526560","doi":"10.1182/blood-2018-99-113559","title":"Global Transcriptome Profiling Identifies a Key Mir-185-PAK6 Axis That Promotes Survival of Leukemic Stem Cells and Drug-Insensitive Blasts in BCR-ABL+ Human Leukemia","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; Terry Fox Research Institute; BC Cancer Agency","funders":"","keywords":"CD34; Stem cell; Cancer research; Progenitor cell; Nilotinib; Transcriptome; Biology; microRNA; Myeloid leukemia; Gene expression profiling; Leukemia; Haematopoiesis; Immunology; Gene expression; Cell biology; Imatinib; Gene","score_opus":0.012247200633980897,"score_gpt":0.24202490450953476,"score_spread":0.22977770387555385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910526560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983603,0.0006949989,0.00006087304,0.000012308931,0.000116471696,0.00041580026,0.00013046236,0.000017828308,0.00019097424],"genre_scores_gemma":[0.9994345,0.000027571514,0.0001738774,0.000011891959,0.0001230391,0.000013412065,0.00006637345,0.00002273694,0.00012664846],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986466,0.00012902587,0.00030064743,0.00046578408,0.00018014606,0.00027779068],"domain_scores_gemma":[0.9993555,0.000012127581,0.00013922661,0.00028589272,0.00013025606,0.000077010365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023445342,0.00021149313,0.000253919,0.00006088704,0.00007024619,0.00003276663,0.0001390065,0.00015924338,0.000005175512],"category_scores_gemma":[0.000013770587,0.00022087083,0.000082637416,0.00013635513,0.00026093776,0.00001274023,0.00008723486,0.00006137131,0.000003167443],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007400942,0.00011827113,0.021016369,0.00013999679,0.00008871833,0.00000723095,0.0003886336,0.0000063491416,0.977988,0.000023891289,0.00004590758,0.000102593796],"study_design_scores_gemma":[0.001549252,0.0001449371,0.047102287,0.0001022176,0.00007273625,0.000014541189,0.00033094184,0.000039404793,0.95031536,0.00007441436,0.000042808824,0.00021112859],"about_ca_topic_score_codex":0.00015055694,"about_ca_topic_score_gemma":0.00071759935,"teacher_disagreement_score":0.027672699,"about_ca_system_score_codex":0.00005661234,"about_ca_system_score_gemma":0.00014057089,"threshold_uncertainty_score":0.90068513},"labels":[],"label_agreement":null},{"id":"W2910542347","doi":"10.1182/blood-2018-99-110543","title":"Efficacy and Safety Following Dose Reduction of Bosutinib or Imatinib in Patients with Newly Diagnosed Chronic Myeloid Leukemia: Analysis of the Phase 3 BFORE Trial","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Bosutinib; Medicine; Imatinib; Adverse effect; Internal medicine; Tyrosine-kinase inhibitor; Population; Tolerability; Oncology; Myeloid leukemia; Pharmacology; Nilotinib; Cancer","score_opus":0.012736563623910518,"score_gpt":0.2805123147050226,"score_spread":0.26777575108111207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910542347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99773455,0.00012085393,0.000006286004,0.000037272137,0.00015891464,0.0017262524,0.000039797254,0.000018967896,0.00015708563],"genre_scores_gemma":[0.9991326,0.000030577296,0.00041896926,0.000013109867,0.00018258553,0.000035944184,0.00009277354,0.000024693434,0.00006874435],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99817926,0.00009379958,0.0006591331,0.000359373,0.000439939,0.00026848723],"domain_scores_gemma":[0.9986645,0.00015624902,0.00040159703,0.00058993715,0.000101316466,0.00008641283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024894124,0.00021799724,0.0007404549,0.00025281252,0.00007710057,0.000007471353,0.000121220306,0.00012214882,0.0000907411],"category_scores_gemma":[0.0003180596,0.00012961698,0.0001944665,0.0012844272,0.0002128153,0.00009173885,0.00006519674,0.00016876188,0.0000013978071],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.35218617,0.022880351,0.5120849,0.0006295759,0.020414503,0.000085546686,0.008450009,0.00027894584,0.013167986,0.000039745253,0.00019521512,0.06958703],"study_design_scores_gemma":[0.5652855,0.0064410353,0.4131348,0.00043071475,0.007284446,0.0000055482337,0.00011186492,0.0001955385,0.0069183386,0.0000025880986,0.000050826122,0.0001387931],"about_ca_topic_score_codex":0.000275756,"about_ca_topic_score_gemma":0.00025052085,"teacher_disagreement_score":0.21309932,"about_ca_system_score_codex":0.00058418995,"about_ca_system_score_gemma":0.0009243766,"threshold_uncertainty_score":0.52856266},"labels":[],"label_agreement":null},{"id":"W2910571611","doi":"10.1182/blood-2018-99-112152","title":"Quality of Life in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Children's Hospital of Eastern Ontario","funders":"","keywords":"Medicine; Internal medicine; Common Terminology Criteria for Adverse Events; Quality of life (healthcare); Chemotherapy regimen; Adverse effect; Hazard ratio; Oncology; Pediatrics; Cancer; Confidence interval","score_opus":0.026157437349547195,"score_gpt":0.3216000273087694,"score_spread":0.29544258995922223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910571611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99150485,0.001073872,0.00005717645,0.0037330799,0.00036582362,0.0005337091,0.000063449064,0.000070674236,0.0025973797],"genre_scores_gemma":[0.99220186,0.0002841005,0.0010092567,0.003003421,0.0032721865,0.000027976716,0.00010513798,0.000030491954,0.00006557241],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99689066,0.00041677832,0.0012476912,0.000511674,0.00059304544,0.000340174],"domain_scores_gemma":[0.9973138,0.0006751596,0.0006617187,0.0010217844,0.00013764473,0.00018990414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019146233,0.00021297445,0.00084279315,0.00009831924,0.000068064735,0.000009868018,0.0003153657,0.00025624048,0.00012859108],"category_scores_gemma":[0.001553311,0.0001634098,0.00019124085,0.0004764678,0.00025540387,0.000070689326,0.00017157517,0.00048608644,0.0000455931],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031343088,0.000896408,0.9913583,0.000040872565,0.00035691285,0.00008383123,0.0021783176,1.5842718e-7,0.00048651797,0.00009500838,0.003655263,0.0005350168],"study_design_scores_gemma":[0.006447093,0.0005388587,0.99017745,0.000034277033,0.0004638461,0.00012983335,0.00022942579,0.0000012434308,0.00053441746,0.0003395806,0.0009341325,0.00016986037],"about_ca_topic_score_codex":0.013304961,"about_ca_topic_score_gemma":0.0059558935,"teacher_disagreement_score":0.007349068,"about_ca_system_score_codex":0.00012534545,"about_ca_system_score_gemma":0.0010455898,"threshold_uncertainty_score":0.9932655},"labels":[],"label_agreement":null},{"id":"W2910614206","doi":"10.1182/blood-2018-99-110465","title":"Long Term Results of a Randomized Phase 2 Dose-Response Study of Guadecitabine, a Novel Subcutaneous (SC) Hypomethylating Agent (HMA), in 102 Patients with Intermediate or High Risk Myelodysplastic Syndromes (MDS) or Chronic Myelomonocytic Leukemia (CMML)","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Decitabine; Internal medicine; Myelodysplastic syndromes; Adverse effect; Neutropenia; International Prognostic Scoring System; Phases of clinical research; Gastroenterology; Febrile neutropenia; Hypomethylating agent; Clinical trial; Bone marrow; Chemotherapy; Biology","score_opus":0.021611702975837824,"score_gpt":0.3030744257456999,"score_spread":0.2814627227698621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910614206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934078,0.00012610317,0.00014730879,0.000024047704,0.00015721601,0.0057478347,0.00027478317,0.00007800182,0.000036922633],"genre_scores_gemma":[0.9977318,0.00010041451,0.0010219206,0.000016664415,0.00016823107,0.00030944817,0.00007723115,0.00014068473,0.00043362676],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99285275,0.0011185982,0.0024948474,0.0010435177,0.0014680922,0.001022176],"domain_scores_gemma":[0.99083626,0.005377999,0.001428379,0.0012303236,0.00073335203,0.00039371083],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0027698737,0.0006913592,0.002682885,0.0013821428,0.00012745881,0.00004040024,0.0006057514,0.00025554284,0.00018406831],"category_scores_gemma":[0.012337253,0.00043625632,0.00022716752,0.0018238055,0.0008381727,0.00019431023,0.00040072892,0.0008348016,0.000028355065],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94559216,0.010936023,0.013946058,0.00055461295,0.0022277634,0.0032550732,0.007005267,0.00008274212,0.009087753,8.0464804e-7,0.000019955374,0.0072918036],"study_design_scores_gemma":[0.77043885,0.047136378,0.16858803,0.0016537394,0.002022084,0.00040154933,0.0006099518,0.0021563487,0.0065133106,0.0000030227422,0.0000033761596,0.00047335683],"about_ca_topic_score_codex":0.0012164621,"about_ca_topic_score_gemma":0.0016364453,"teacher_disagreement_score":0.17515329,"about_ca_system_score_codex":0.0014491272,"about_ca_system_score_gemma":0.0027689787,"threshold_uncertainty_score":0.9998089},"labels":[],"label_agreement":null},{"id":"W2910718731","doi":"10.1182/blood-2018-99-111911","title":"Medically Ill Patients with Moderate Renal Insufficiency Have More Thrombotic and Bleeding Events Than Those with Normal Renal Function: Insights from the Magellan and Mariner Trials of Extended Thrombprophylaxis","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Medicine; Rivaroxaban; Renal function; Placebo; Kidney disease; Randomization; Surgery; Internal medicine; Clinical trial; Warfarin","score_opus":0.016396577451269816,"score_gpt":0.24520336611534346,"score_spread":0.22880678866407364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910718731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960739,0.00035277227,0.00026052582,0.00046311182,0.000095720985,0.0009903776,0.000027533044,0.000031722724,0.0017043368],"genre_scores_gemma":[0.99776864,0.0001718434,0.001075014,0.00048216357,0.00031538194,0.000033155746,0.00005084533,0.00003388095,0.00006906613],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978081,0.00013160489,0.00053404906,0.0004964516,0.00073287624,0.00029691003],"domain_scores_gemma":[0.998548,0.00014500406,0.00033747085,0.00039312537,0.00039405702,0.00018235069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040065346,0.00029789776,0.0008345529,0.00009483955,0.00025575323,0.000045470086,0.00013077618,0.00009591202,0.00012893655],"category_scores_gemma":[0.00013754786,0.00014989058,0.000059245354,0.00016314693,0.00047870938,0.00014401948,0.00017384648,0.00019261151,0.0000028013608],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017152216,0.034007672,0.85034347,0.0010101763,0.0139322365,0.0003225072,0.030617608,0.0000630689,0.014121082,0.0032918316,0.0028694274,0.032268688],"study_design_scores_gemma":[0.010915764,0.007851255,0.9755998,0.00058351253,0.0018455661,0.000013566989,0.0007172249,0.00014988186,0.0016285639,0.0002856741,0.000170125,0.00023905326],"about_ca_topic_score_codex":0.00033598067,"about_ca_topic_score_gemma":0.00025269637,"teacher_disagreement_score":0.12525633,"about_ca_system_score_codex":0.000015040263,"about_ca_system_score_gemma":0.00008536059,"threshold_uncertainty_score":0.61123604},"labels":[],"label_agreement":null},{"id":"W2910748507","doi":"10.1182/blood-2018-99-117050","title":"First Prospective Data on Impact of Minimal Residual Disease on Long-Term Clinical Outcomes after Venetoclax Plus Rituximab Versus Bendamustine Plus Rituximab: Phase III MURANO Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Rituximab; Bendamustine; Medicine; Venetoclax; Minimal residual disease; Internal medicine; Phases of clinical research; Oncology; Clinical trial; Lymphoma; Leukemia; Chronic lymphocytic leukemia","score_opus":0.09003169841071502,"score_gpt":0.448789138950056,"score_spread":0.358757440539341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910748507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99413073,0.00022386559,0.0000057991174,0.00014349076,0.00044847676,0.003404595,0.0011174718,0.00011135009,0.00041420027],"genre_scores_gemma":[0.99717075,0.000032809898,0.00012600211,0.00008483745,0.0016139944,0.00017360719,0.00032993394,0.000113794675,0.0003542568],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99433047,0.0002480865,0.0011994567,0.0015723219,0.0016710634,0.0009785952],"domain_scores_gemma":[0.9937893,0.0012191226,0.00031829384,0.0033958545,0.00036761892,0.00090978347],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009579143,0.00063134334,0.0015682483,0.0003012936,0.00019218242,0.00006277338,0.00094057334,0.00020330561,0.0006681301],"category_scores_gemma":[0.0024073916,0.00047730788,0.0004295732,0.00040330098,0.00085865863,0.00021142235,0.00089963403,0.0007139474,0.00034736344],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.4606552,0.07302903,0.4426864,0.0005245538,0.005444478,0.012039499,0.0013785566,0.000028112398,0.00002296768,0.000020319507,0.0030699698,0.001100915],"study_design_scores_gemma":[0.45400682,0.019688018,0.52232164,0.0003365103,0.0015581261,0.000041276413,0.00008874214,0.0014689337,0.00012213904,0.000003424839,0.000030890864,0.00033348164],"about_ca_topic_score_codex":0.0011378293,"about_ca_topic_score_gemma":0.00078677095,"teacher_disagreement_score":0.07963525,"about_ca_system_score_codex":0.00908872,"about_ca_system_score_gemma":0.01447923,"threshold_uncertainty_score":0.99976784},"labels":[],"label_agreement":null},{"id":"W2910763590","doi":"10.1182/blood-2018-99-112313","title":"Minimal Residual Disease Evaluation Using 8-Color Flow Cytometry Predicts Risk of Relapse in High-Risk and/or Young Myeloma Patients Who Receive Bortezomib Consolidation after Frontline Tandem Transplantation","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Research in Immunology and Cancer; Centre Hospitalier de l’Université de Montréal; McGill University Health Centre; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Fludarabine; Minimal residual disease; Bortezomib; Transplantation; Internal medicine; Autologous stem-cell transplantation; Oncology; Multiple myeloma; Bone marrow; Surgery; Cyclophosphamide; Chemotherapy","score_opus":0.018830946460843448,"score_gpt":0.29474875021054175,"score_spread":0.2759178037496983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910763590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99677014,0.0002361154,0.00021436343,0.000025320958,0.00009290726,0.0015536807,0.0010477368,0.000021834245,0.000037912072],"genre_scores_gemma":[0.9939914,0.0004210608,0.0044628447,0.00001419913,0.00017415386,0.00011507153,0.00076654705,0.000026855034,0.000027863185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976375,0.00040298013,0.00049185404,0.0004057121,0.0007665908,0.0002953248],"domain_scores_gemma":[0.99866325,0.000137743,0.00024915955,0.00023784443,0.0004621525,0.00024986634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059072615,0.00019751856,0.00033705786,0.00036562566,0.00010192471,0.00001993641,0.000050491188,0.0001314031,0.00010665778],"category_scores_gemma":[0.0011966446,0.00015995427,0.00004932674,0.00032223813,0.00014460187,0.00024573802,0.000025127001,0.00016846071,0.0000067712213],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013694877,0.0011168666,0.97522026,0.00012216758,0.00023919674,0.000098868164,0.00092973834,0.00001338392,0.00029410177,7.231638e-7,0.00001913272,0.008250697],"study_design_scores_gemma":[0.029605875,0.0016366079,0.94444877,0.00039034119,0.0018440814,0.0000104570245,0.000066366796,0.01751557,0.0043081106,0.000042204425,0.0000021345493,0.00012947813],"about_ca_topic_score_codex":0.0004178028,"about_ca_topic_score_gemma":0.0006688906,"teacher_disagreement_score":0.030771473,"about_ca_system_score_codex":0.00012539742,"about_ca_system_score_gemma":0.00024657737,"threshold_uncertainty_score":0.6522746},"labels":[],"label_agreement":null},{"id":"W2910822872","doi":"10.1182/blood-2018-99-119568","title":"Prospective Study of the Immunological Mechanisms of Immune Tolerance Induction in Severe Haemophilia a Patients with Inhibitors: Preliminary Analysis of a Multi-Center Longitudinal Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Immune system; Immunology; Immune tolerance; Antibody; Adverse effect; Internal medicine","score_opus":0.026740177638446452,"score_gpt":0.29041676575134195,"score_spread":0.2636765881128955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910822872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99722046,0.000052962303,0.0000043109353,0.000021873919,0.00003797712,0.0026217496,0.00001257087,0.000007527319,0.000020585807],"genre_scores_gemma":[0.9997268,0.000002332935,0.00011539935,0.000001365317,0.000016573409,0.00008156721,0.0000063912416,0.000009928143,0.00003967522],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983579,0.00015914784,0.00047521936,0.0003042067,0.0005348469,0.00016868641],"domain_scores_gemma":[0.9988165,0.000028927745,0.00023449093,0.0004450121,0.0004469945,0.000028071652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002238162,0.00014876253,0.0005846556,0.0002998519,0.00005081854,0.0000030672522,0.00013709263,0.000071148665,0.000020035826],"category_scores_gemma":[0.00006466213,0.000079780955,0.00011244662,0.0013616285,0.00018570999,0.000059216592,0.00014219143,0.00018752535,6.838683e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024338218,0.08069303,0.9069436,0.000031304182,0.0024420125,0.000013598067,0.005050985,0.000005464024,0.002221579,0.000002065932,4.1496898e-7,0.00016212657],"study_design_scores_gemma":[0.022361789,0.019291617,0.93529457,0.00015952991,0.0015188896,0.0000033403721,0.003382563,0.000034880828,0.01787914,0.0000072807206,5.2930776e-8,0.00006636431],"about_ca_topic_score_codex":0.00025409498,"about_ca_topic_score_gemma":0.0002411827,"teacher_disagreement_score":0.061401412,"about_ca_system_score_codex":0.00004321266,"about_ca_system_score_gemma":0.00004624646,"threshold_uncertainty_score":0.3253373},"labels":[],"label_agreement":null},{"id":"W2910854333","doi":"10.1182/blood-2018-99-114191","title":"Risk of Death, Relapse or Progression, and Loss of Life Expectancy at Different Progression-Free Survival Milestones in Primary Central Nervous System Lymphoma","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC","funders":"","keywords":"Primary central nervous system lymphoma; Medicine; Oncology; Internal medicine; Diffuse large B-cell lymphoma; Population; Progression-free survival; Lymphoma; Chemotherapy","score_opus":0.011934131618514782,"score_gpt":0.25461236214669736,"score_spread":0.24267823052818258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910854333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99206924,0.006312579,0.0000021537835,0.000080922,0.00019649432,0.0009374432,0.00007559998,0.00005124941,0.00027432598],"genre_scores_gemma":[0.9983641,0.0005511922,0.0006500994,0.000011472091,0.00015958019,0.00015205755,0.000027116026,0.000037625836,0.00004676554],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978975,0.00013582844,0.0006577296,0.0004111804,0.0005203785,0.00037737287],"domain_scores_gemma":[0.998403,0.00018177065,0.00038937095,0.00062141754,0.000125775,0.000278661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013235929,0.00028532126,0.0008263762,0.00012781439,0.00008311032,0.000008677619,0.0001370006,0.00014746077,0.000025645453],"category_scores_gemma":[0.00019251175,0.00017317409,0.00012307787,0.0001805926,0.00022085609,0.00004456143,0.00023758323,0.00005379278,0.0000028703005],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018503036,0.005705382,0.97357184,0.0008896013,0.00028611286,0.00037240205,0.0007340816,1.0540022e-7,0.00070368516,0.00008530203,0.000087071065,0.015714113],"study_design_scores_gemma":[0.015671274,0.0016303502,0.9556887,0.0023118583,0.0005121885,0.00022879361,0.00021726823,0.000014268292,0.023528459,0.000012997395,0.000027259859,0.00015659623],"about_ca_topic_score_codex":0.00013786452,"about_ca_topic_score_gemma":0.00016026996,"teacher_disagreement_score":0.022824774,"about_ca_system_score_codex":0.00019294846,"about_ca_system_score_gemma":0.00016917042,"threshold_uncertainty_score":0.70618343},"labels":[],"label_agreement":null},{"id":"W2910882807","doi":"10.1182/blood-2018-99-112010","title":"Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 As a Therapeutic Target for Restoring MHC Expression in Diffuse Large B-Cell Lymphoma","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Simon Fraser University; Princess Margaret Cancer Centre; University of Toronto; University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Biology; Major histocompatibility complex; Diffuse large B-cell lymphoma; Cancer research; MHC class I; Immune system; Lymphoma; Immunology","score_opus":0.007902801343226767,"score_gpt":0.22367128789391796,"score_spread":0.2157684865506912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910882807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949935,0.0016632226,0.0020351396,0.000015162597,0.00082964654,0.00023193791,0.000004064898,0.000020991109,0.00020631515],"genre_scores_gemma":[0.9986688,0.00010746321,0.000056718905,0.000059808925,0.000021792697,0.000033350323,0.000057629313,0.000014082928,0.0009803553],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99927837,0.00008148659,0.00023291032,0.00019799119,0.000027242428,0.00018199357],"domain_scores_gemma":[0.99961084,0.000029408042,0.00012408625,0.00015942883,0.000067034656,0.000009211467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000922817,0.00010132148,0.00013717312,0.00012115642,0.00010235641,0.000013166353,0.00007307392,0.00012326142,0.00007129907],"category_scores_gemma":[0.000034777728,0.00009508047,0.000040021805,0.00007827949,0.000055819735,0.00009606234,0.000038771246,0.00005105,0.00003249558],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014139057,0.0013702901,0.0014148679,0.000035578654,0.000017323404,0.0000011055239,0.0006031209,1.5133801e-7,0.9959271,0.00005350161,0.00001785064,0.00041772344],"study_design_scores_gemma":[0.006136555,0.0003791406,0.013032789,0.000047976824,0.000037212198,0.000018915181,0.0001356375,0.000014987597,0.9764986,0.00006634381,0.0035350726,0.00009677088],"about_ca_topic_score_codex":0.000014470232,"about_ca_topic_score_gemma":0.000002655821,"teacher_disagreement_score":0.019428497,"about_ca_system_score_codex":0.000011553078,"about_ca_system_score_gemma":0.000019608555,"threshold_uncertainty_score":0.3877269},"labels":[],"label_agreement":null},{"id":"W2910984157","doi":"10.1182/blood-2018-99-119491","title":"A Standardized Kit for a Chromogenic Modified Nijmegen-Bethesda Assay: Repeatability, Reproducibility, and Analytical Sensitivity","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision BioLogic (Canada)","funders":"","keywords":"Serial dilution; Chromogenic; Antibody; Titer; Chemistry; Nijmegen breakage syndrome; Reproducibility; Repeatability; Chromatography; Medicine; Immunology; Molecular biology; Biology; Biochemistry; Pathology","score_opus":0.056557354550955244,"score_gpt":0.3533298403637271,"score_spread":0.2967724858127719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910984157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921302,0.00020902547,0.0004455137,0.003237127,0.000059044214,0.0014935978,0.000097647666,0.00010717197,0.002220624],"genre_scores_gemma":[0.99591213,0.000026662496,0.0019873746,0.00008973467,0.00058788684,0.000052630843,0.000037305537,0.000030382967,0.0012759144],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99716604,0.0002562852,0.00033469903,0.0013216932,0.00044390047,0.00047737634],"domain_scores_gemma":[0.9970594,0.00048882084,0.000048282145,0.0016437051,0.00043742862,0.0003223662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053173513,0.00020778069,0.00056391244,0.00010169547,0.00018944884,0.00003874822,0.000061044935,0.00016297403,0.000071976305],"category_scores_gemma":[0.0040913313,0.00015517024,0.00020408207,0.0002355862,0.0005254909,0.000060283975,0.00015734487,0.00018646079,0.000018316188],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012989831,0.013897674,0.6794851,0.0022548004,0.0050394554,0.0012020881,0.0024119902,0.0000010813184,0.22302935,0.0026440711,0.0035128419,0.053531755],"study_design_scores_gemma":[0.0548912,0.009721558,0.21705918,0.00038870474,0.004529472,0.001790421,0.00024607714,0.0096698385,0.68491316,0.009625026,0.0059701973,0.0011951732],"about_ca_topic_score_codex":0.000056812343,"about_ca_topic_score_gemma":0.000060208025,"teacher_disagreement_score":0.4624259,"about_ca_system_score_codex":0.00007936501,"about_ca_system_score_gemma":0.00028759762,"threshold_uncertainty_score":0.6327659},"labels":[],"label_agreement":null},{"id":"W2910996719","doi":"10.1182/blood-2018-09-871418","title":"Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":281,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Simon Fraser University","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Somatic hypermutation; Biology; Cancer research; Cytidine deaminase; Genetics; Epstein–Barr virus; Genome; Gene; Virology; B cell; Virus; Antibody","score_opus":0.008075936175682058,"score_gpt":0.2272281990305858,"score_spread":0.21915226285490375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910996719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949457,0.003255398,0.00001530275,0.00010245188,0.00003862845,0.0002467469,0.0000067893748,0.000014309694,0.0013746519],"genre_scores_gemma":[0.9982498,0.0014050169,0.00008692535,0.00007247751,0.00003264308,0.0000068661857,0.000012134301,0.000013237245,0.00012086655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99931467,0.000015879472,0.00022496383,0.00016482154,0.00011800559,0.00016164048],"domain_scores_gemma":[0.9996317,0.00009634139,0.00010755632,0.00009861949,0.00001542111,0.000050343715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012148515,0.00009119253,0.00026003367,0.00017216761,0.0000274973,0.000014225817,0.00003065381,0.00006120788,0.000009662268],"category_scores_gemma":[0.00007184737,0.00008711913,0.000031557945,0.00021769639,0.000030566986,0.00012731578,0.000023430668,0.00006248354,0.0000029031767],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018992028,0.00011724376,0.99466664,0.00029909008,0.00002964438,0.000012392655,0.0007761293,0.0000069371954,0.003749391,0.00005439988,0.0000043205646,0.00026479363],"study_design_scores_gemma":[0.007857878,0.00013876008,0.9895283,0.00010407343,0.00026315404,0.000018553046,0.0011768695,0.00013695481,0.0003211211,0.00033620902,0.000010520274,0.000107635846],"about_ca_topic_score_codex":0.00007560716,"about_ca_topic_score_gemma":0.000026434482,"teacher_disagreement_score":0.007838885,"about_ca_system_score_codex":0.000040637242,"about_ca_system_score_gemma":0.00010486842,"threshold_uncertainty_score":0.3552615},"labels":[],"label_agreement":null},{"id":"W2911035440","doi":"10.1182/blood-2018-99-112997","title":"Urgent Management of Bleeding in Immune Thrombocytopenia: Towards a Standardized Protocol in the Emergency Department","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; Canadian Blood Services; University of Toronto; McMaster University","funders":"","keywords":"Medicine; Interquartile range; Emergency department; Retrospective cohort study; Pediatrics; Cohort; Gastrointestinal bleeding; Immune thrombocytopenia; Surgery; Internal medicine; Platelet","score_opus":0.023914560082328867,"score_gpt":0.32555509023607543,"score_spread":0.3016405301537466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911035440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9462462,0.00012951634,0.000010263252,0.00027940332,0.00004741453,0.037060764,0.000008183925,0.000011604358,0.016206615],"genre_scores_gemma":[0.9749765,0.00008217227,0.00052102085,0.0000339209,0.000021403996,0.024266426,0.000008614924,0.000011050268,0.000078888625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882865,0.00003781724,0.00039832166,0.00018721624,0.00031087286,0.00023712788],"domain_scores_gemma":[0.99958014,0.0000059220815,0.000080117796,0.00025596714,0.000037800408,0.000040030056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033986254,0.00012938425,0.00036464748,0.000084473955,0.000034546327,0.0000057544958,0.00011271444,0.00003865308,0.00034923814],"category_scores_gemma":[0.000010771085,0.00008243737,0.00007549901,0.00030739603,0.000033520362,0.000038446717,0.0000588738,0.00007390637,0.000011445101],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010952892,0.08529121,0.7334751,0.005270763,0.008053636,0.015876805,0.02059935,0.0000112695525,0.022208003,0.005785257,0.003868931,0.08860683],"study_design_scores_gemma":[0.0698911,0.0032556057,0.86034834,0.0010662152,0.00079582015,0.00012416192,0.0020411727,0.000035245335,0.049943153,0.0013227197,0.01080486,0.00037157632],"about_ca_topic_score_codex":0.000101759804,"about_ca_topic_score_gemma":0.00008014108,"teacher_disagreement_score":0.12687331,"about_ca_system_score_codex":0.00004625147,"about_ca_system_score_gemma":0.000049832266,"threshold_uncertainty_score":0.38239124},"labels":[],"label_agreement":null},{"id":"W2911052699","doi":"10.1182/blood-2018-99-113844","title":"Venous Thromboembolism in Children 0-18 Years — a Regional Population-Based Study from Sweden","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Medicine; Pulmonary embolism; Population; Pediatrics; Thrombosis; Incidence (geometry); Protein C deficiency; Protein S deficiency; Internal medicine; Venous thrombosis; Surgery","score_opus":0.022022998405976008,"score_gpt":0.2860887650780161,"score_spread":0.2640657666720401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911052699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972637,0.0001472292,0.000007995581,0.00024463836,0.00013511519,0.0011585566,0.000015034019,0.0000910823,0.0009366412],"genre_scores_gemma":[0.99748075,0.000011014011,0.00041043962,0.0010753676,0.00072053034,0.0000756232,0.0001472573,0.000038758302,0.000040286697],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848926,0.00006033661,0.0003103049,0.0004383204,0.00039927132,0.00030251787],"domain_scores_gemma":[0.9992182,0.000040117582,0.000087640154,0.00049267826,0.00005163989,0.00010971235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016552523,0.00017874182,0.00053978874,0.00019163861,0.00007680814,0.000030817253,0.00016031746,0.00008416379,0.00059042714],"category_scores_gemma":[0.000037604877,0.00017530413,0.0000828783,0.00025928562,0.000039247498,0.00005613428,0.000063344545,0.0001397935,0.00017962493],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031196843,0.011032872,0.9850968,0.0000068792883,0.000353549,0.000053571584,0.0008191671,0.00000896041,0.000095326206,0.00007057585,0.0014391916,0.0009918915],"study_design_scores_gemma":[0.005510109,0.0009591908,0.9920396,0.00008219608,0.0004784376,0.0000047103863,0.00015528488,0.000022026943,0.00008962919,0.00025553053,0.00022435798,0.00017891156],"about_ca_topic_score_codex":0.0075170663,"about_ca_topic_score_gemma":0.0008484529,"teacher_disagreement_score":0.010073681,"about_ca_system_score_codex":0.000056995057,"about_ca_system_score_gemma":0.00007521298,"threshold_uncertainty_score":0.999092},"labels":[],"label_agreement":null},{"id":"W2911065823","doi":"10.1182/blood-2018-99-112177","title":"Safety of Caplacizumab for the Treatment of Patients with Acquired Thrombotic Thrombocytopenic Purpura - Results Normalized to Time of Exposure in a Double-Blind, Placebo-Controlled, Phase 3 Hercules Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Thrombotic microangiopathy; Medicine; ADAMTS13; Von Willebrand factor; Placebo; Internal medicine; Gastroenterology; Thrombotic thrombocytopenic purpura; Platelet; Pathology; Disease","score_opus":0.027896159732658916,"score_gpt":0.29806074834402907,"score_spread":0.27016458861137016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911065823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98774326,0.0004989382,0.000014482235,0.000030357858,0.00010618678,0.010541153,0.0009468246,0.000014142413,0.000104653926],"genre_scores_gemma":[0.9987923,0.000008636592,0.000058596073,0.000006332328,0.000017212657,0.0007282216,0.00019094814,0.000019242512,0.00017850127],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99792,0.00029245883,0.0010480682,0.00033362623,0.000108394226,0.00029746554],"domain_scores_gemma":[0.99788404,0.0005716011,0.00054593186,0.00067529076,0.00030071702,0.000022397942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003573308,0.00025606962,0.001070094,0.00014283479,0.000101776626,0.000006257852,0.0003419196,0.00008228545,0.00024483632],"category_scores_gemma":[0.00006656506,0.00015197165,0.00015957245,0.00021844631,0.00020129448,0.00006147651,0.00006148895,0.00002968247,0.00002043501],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.88248837,0.037510835,0.03743707,0.00008781953,0.004988428,0.000002438338,0.011337696,0.000052567233,0.025445692,0.000040377632,0.00017084724,0.00043786597],"study_design_scores_gemma":[0.8638285,0.03296269,0.04863129,0.00013630661,0.0016747997,0.00000249562,0.0016866896,0.000005184583,0.050666165,0.0000047683575,0.00019329155,0.00020782185],"about_ca_topic_score_codex":0.0002679976,"about_ca_topic_score_gemma":0.0007259002,"teacher_disagreement_score":0.025220472,"about_ca_system_score_codex":0.000048779046,"about_ca_system_score_gemma":0.0001116284,"threshold_uncertainty_score":0.61972237},"labels":[],"label_agreement":null},{"id":"W2911094905","doi":"10.1182/blood-2018-99-113582","title":"Radius: A Phase 2 Randomized Trial Investigating Standard of Care ± Midostaurin after Allogeneic Stem Cell Transplant in FLT3-ITD-Mutated AML","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Midostaurin; Internal medicine; Clinical endpoint; Maintenance therapy; Surgery; Transplantation; Oncology; Chemotherapy regimen; Randomized controlled trial; Myeloid leukemia; Chemotherapy","score_opus":0.01583776255456517,"score_gpt":0.29424815104342794,"score_spread":0.2784103884888628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911094905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99379474,0.0017806455,0.00006448391,0.00017030296,0.00010987495,0.0030742246,0.00022339981,0.000058622856,0.00072371354],"genre_scores_gemma":[0.9975207,0.00010642266,0.0013826666,0.00011567274,0.00030569194,0.0002615865,0.00009763283,0.00005773279,0.00015190513],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9969055,0.0005499102,0.0009121998,0.0004490456,0.00063753733,0.00054579147],"domain_scores_gemma":[0.9984783,0.00033543564,0.00018457364,0.000435687,0.00027611534,0.00028987366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010799406,0.00028677707,0.0012969995,0.00034552434,0.000048798098,0.000020077834,0.00019422668,0.00020756437,0.00017990594],"category_scores_gemma":[0.00017089673,0.00022932263,0.00025602806,0.00046284418,0.0004988797,0.000069537295,0.000049275564,0.00041801817,0.00001848545],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8970485,0.0007224667,0.0010085413,0.0006213054,0.00029474363,0.00063812913,0.012845871,0.0000017380885,0.08560318,0.0000059021327,0.000071061506,0.0011385806],"study_design_scores_gemma":[0.64475715,0.0024572518,0.000031956726,0.000348553,0.00046753514,0.00003081444,0.0005727208,0.000109463355,0.35094807,0.000011174653,0.0001188333,0.00014645993],"about_ca_topic_score_codex":0.00015424412,"about_ca_topic_score_gemma":0.00013103477,"teacher_disagreement_score":0.2653449,"about_ca_system_score_codex":0.00018418419,"about_ca_system_score_gemma":0.0009562741,"threshold_uncertainty_score":0.93515056},"labels":[],"label_agreement":null},{"id":"W2911134236","doi":"10.1182/blood-2018-99-117229","title":"Targeting Oncogenic Polyamines in Refractory Pediatric Leukemias Using the Anti-Protozoan Drug Α-Difluoromethylornithine (DFMO) in Combination with GC7 and Aurothioglucose","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Polyamine Metabolism and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Ornithine decarboxylase; Spermidine; Polyamine; Biology; Cancer research; Pharmacology; Cell growth; Population; Biochemistry; Medicine; Enzyme","score_opus":0.008607913285311455,"score_gpt":0.245262864678889,"score_spread":0.23665495139357753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911134236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99637115,0.0027982173,0.0001470547,0.00008729717,0.00003746541,0.00046816224,0.00001293673,0.00001022715,0.000067485336],"genre_scores_gemma":[0.99807864,0.00035050232,0.0009965755,0.00008312071,0.00031385507,0.00006555319,0.000045833356,0.000018966019,0.000046959784],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99902576,0.000093372015,0.00023218917,0.00031076185,0.0001098818,0.00022805265],"domain_scores_gemma":[0.9994942,0.00002510892,0.000117263924,0.00026160636,0.0000588158,0.000043038828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035169825,0.00014941627,0.00014841357,0.00011923784,0.00010948639,0.000025553541,0.00016079152,0.00008216114,0.00000363739],"category_scores_gemma":[0.00008385273,0.00011100773,0.00002285387,0.00037309414,0.000114699455,0.000011381056,0.000097769895,0.00013675481,0.0000021664923],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030158146,0.00035434304,0.10763062,0.000022361406,0.000015836871,0.0000038881763,0.00028615983,0.000011427522,0.8908896,0.000031102743,0.00003991841,0.0006846176],"study_design_scores_gemma":[0.008308341,0.0004891447,0.25153673,0.000040564268,0.0002092189,0.00007189995,0.0006531287,0.0005357778,0.7336093,0.00017469715,0.0036476715,0.00072350225],"about_ca_topic_score_codex":0.00018367582,"about_ca_topic_score_gemma":0.000110422756,"teacher_disagreement_score":0.15728025,"about_ca_system_score_codex":0.000011141136,"about_ca_system_score_gemma":0.000092040944,"threshold_uncertainty_score":0.4526764},"labels":[],"label_agreement":null},{"id":"W2911244264","doi":"10.1182/blood-2018-99-118938","title":"Impact of Genetic Profile on Clinical Outcomes in Adults ≥60 with AML: The Princess Margaret Cancer Centre Experience","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Myeloid leukemia; Internal medicine; Oncology; Acute promyelocytic leukemia; Leukemia; Cancer; Bone marrow; Myeloid; Gene; Genetics; Biology","score_opus":0.029802715637877737,"score_gpt":0.38533895859087514,"score_spread":0.3555362429529974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911244264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976434,0.00006035963,0.0000026246823,0.0005596334,0.000043404365,0.0007166713,0.000020666235,0.000017301636,0.0009359199],"genre_scores_gemma":[0.9987247,0.00008066115,0.00036610643,0.00015923787,0.00017467093,0.00006824379,0.0000033976644,0.000021452599,0.0004015323],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985517,0.00009684866,0.0003167576,0.0002951099,0.00040168245,0.0003378577],"domain_scores_gemma":[0.9989415,0.00016043278,0.000102230886,0.0005128446,0.00015783265,0.00012517156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018492203,0.00013639245,0.00031399305,0.000058706348,0.00003462921,0.000008079149,0.00025166015,0.00007859502,0.0004145217],"category_scores_gemma":[0.00023184522,0.00006587126,0.000082400205,0.00025323997,0.00039938246,0.00003188709,0.00007715875,0.0002923683,0.000028048766],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009593018,0.0006229185,0.9941992,0.000030793228,0.000113419825,0.00006723795,0.0015463326,0.0000020155617,0.000099392855,0.000004646131,0.00032369,0.0020310415],"study_design_scores_gemma":[0.005328174,0.0019753748,0.9897413,0.00026646644,0.000036328744,0.00001307426,0.00028565296,0.000110925845,0.002068156,0.0000022151899,0.000092419,0.00007991334],"about_ca_topic_score_codex":0.0013953934,"about_ca_topic_score_gemma":0.0006817146,"teacher_disagreement_score":0.0044579105,"about_ca_system_score_codex":0.00009756632,"about_ca_system_score_gemma":0.0005478566,"threshold_uncertainty_score":0.4538722},"labels":[],"label_agreement":null},{"id":"W2911268218","doi":"10.1182/blood-2018-99-110021","title":"The Metabolic Enzyme Hexokinase 2 Localizes to the Nucleus in AML and Normal Hematopoietic Stem/Progenitor Cells to Maintain Stemness","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Stem cell; Biology; Haematopoiesis; CD34; Progenitor cell; Cell biology; Population; Myeloid leukemia; Mitochondrion; Cancer research","score_opus":0.012341740049882253,"score_gpt":0.267667596272133,"score_spread":0.25532585622225074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911268218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98995745,0.0016153088,0.000119862394,0.006025857,0.00016747479,0.0015821644,0.00002479552,0.000045866433,0.00046121064],"genre_scores_gemma":[0.99548405,0.0001276762,0.00045012616,0.0016389636,0.0006766492,0.0002209365,0.0000019699364,0.000052704043,0.0013469404],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99776345,0.00022782902,0.00035346646,0.00040041536,0.00052262755,0.00073222944],"domain_scores_gemma":[0.998317,0.0002515072,0.000047543297,0.0008035986,0.00016517888,0.00041514297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010841364,0.00022940744,0.00035757603,0.00014704057,0.00029513735,0.00011699791,0.00046935066,0.00009679158,0.00006724883],"category_scores_gemma":[0.0001344524,0.00012965214,0.00006417433,0.000633098,0.00020545104,0.00005893158,0.00044067507,0.00032420087,0.0005994016],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013611501,0.007499745,0.06407182,0.0020440475,0.0036935913,0.006194666,0.066366866,0.000116071154,0.4180654,0.047596604,0.11898783,0.25175187],"study_design_scores_gemma":[0.0072249565,0.0013764842,0.00911989,0.00020152464,0.00032907826,0.0006066096,0.0047991606,0.00037226497,0.6097689,0.000111497175,0.365605,0.00048463352],"about_ca_topic_score_codex":0.00031368318,"about_ca_topic_score_gemma":0.00036316607,"teacher_disagreement_score":0.25126722,"about_ca_system_score_codex":0.000082953506,"about_ca_system_score_gemma":0.00021899256,"threshold_uncertainty_score":0.7704295},"labels":[],"label_agreement":null},{"id":"W2911270078","doi":"10.1182/blood-2018-99-115317","title":"Clinical Characteristics and Outcome of Patients with Wild-Type Transthyretin and AL Cardiac Amyloidosis Confirmed By Mass Spectrometry","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Transthyretin; Amyloidosis; Cardiac amyloidosis; Internal medicine; Amyloid (mycology); Gastroenterology; Biopsy; AL amyloidosis; Heart failure; Pathology","score_opus":0.008444735356402992,"score_gpt":0.2644205465205267,"score_spread":0.2559758111641237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911270078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983929,0.00056962634,0.00005955276,0.00013991822,0.00012477871,0.00026722936,0.00033635026,0.000011658145,0.00009803074],"genre_scores_gemma":[0.997024,0.0009082093,0.0013104092,0.00031957196,0.00010121703,0.000012894035,0.00022846954,0.0000330466,0.0000622009],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986696,0.00008449788,0.00039602013,0.00044430606,0.00015855873,0.00024702123],"domain_scores_gemma":[0.99919003,0.000056780038,0.0001835924,0.00030694896,0.00011882995,0.00014381371],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001524103,0.00023077213,0.00045892276,0.000039143666,0.000055709326,0.000018728058,0.00010491926,0.00017567594,0.00002078472],"category_scores_gemma":[0.00009752868,0.00019007587,0.00008152242,0.00008711976,0.00041392224,0.000005303393,0.000053247208,0.000089336296,0.0000033725246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001857969,0.0004407355,0.97259146,0.000019246723,0.00043271805,0.0000014133258,0.000022340007,4.4303414e-9,0.025224471,0.0000060091156,0.00042319944,0.0006525808],"study_design_scores_gemma":[0.003271986,0.0022042338,0.9326679,0.000013578738,0.00038672367,0.0000015523497,0.000022347609,4.9354225e-7,0.057525415,0.0000026663788,0.003673573,0.00022951746],"about_ca_topic_score_codex":0.000013679345,"about_ca_topic_score_gemma":0.0000049077084,"teacher_disagreement_score":0.03992357,"about_ca_system_score_codex":0.000005589971,"about_ca_system_score_gemma":0.000025237581,"threshold_uncertainty_score":0.7751069},"labels":[],"label_agreement":null},{"id":"W2911353246","doi":"10.1182/blood-2018-99-117027","title":"The Impact of Marital Status on Hematopoietic Stem Cell Transplant (HCT) Recipient Outcomes: A Surrogate for Consistent Caregiver. a CIBMTR Registry Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Family Support in Illness","field":"Social Sciences","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Marital status; Medicine; Transplantation; Univariate analysis; Population; Multivariate analysis; Internal medicine; Hematopoietic stem cell transplantation; Demography; Gerontology","score_opus":0.030219574774231973,"score_gpt":0.31359908351331095,"score_spread":0.28337950873907897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911353246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902658,0.00013214398,0.0000071482013,0.00013861127,0.0005518271,0.0015226023,0.0003300239,0.000050076083,0.007001784],"genre_scores_gemma":[0.99855036,0.000041560663,0.000022673345,0.0000260507,0.000081105994,0.00011407321,0.00000586802,0.00002436936,0.0011339406],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9976159,0.00026937475,0.0004423981,0.00037118274,0.0006342602,0.00066689716],"domain_scores_gemma":[0.9977985,0.00088553934,0.000272651,0.0005960914,0.00024495125,0.00020229227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000982133,0.0002240701,0.00038529886,0.000052700827,0.00069782295,0.00008719438,0.00046664075,0.00010293741,0.00002937802],"category_scores_gemma":[0.000083747545,0.00014727013,0.0003322575,0.00020900878,0.00058233255,0.000068080386,0.000044575874,0.00012892771,0.000015132655],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072138367,0.0058637564,0.698358,0.0001342458,0.0008723186,0.000102552505,0.28831762,0.00001054549,0.00020587405,0.0015262727,0.0027377324,0.0011497313],"study_design_scores_gemma":[0.020625357,0.011816657,0.26003516,0.00045593927,0.001311946,0.0000243265,0.69160694,0.000032163683,0.0043275617,0.000899603,0.007355468,0.0015088873],"about_ca_topic_score_codex":0.004279572,"about_ca_topic_score_gemma":0.0036445225,"teacher_disagreement_score":0.43832284,"about_ca_system_score_codex":0.00015691876,"about_ca_system_score_gemma":0.0005329559,"threshold_uncertainty_score":0.6469461},"labels":[],"label_agreement":null},{"id":"W2911441731","doi":"10.1182/blood-2018-99-115842","title":"Comprehensive Molecular Profiling of FLT3-Mutated Acute Myeloid Leukemia (AML) Patients Treated within the Ratify Trial (Alliance C10603)","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Myeloid leukemia; Medicine; Oncology; Leukemia; Internal medicine; Cancer research; Immunology","score_opus":0.021026784088619226,"score_gpt":0.2961449774553005,"score_spread":0.27511819336668125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911441731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994861,0.0002032708,0.00007026534,0.00028898718,0.00022365242,0.0028520187,0.00006120265,0.00011253055,0.001327083],"genre_scores_gemma":[0.995869,0.000052287225,0.002472502,0.00039701798,0.00031912042,0.00012744978,0.00022262597,0.00008005405,0.0004599364],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970112,0.00028017382,0.00073757046,0.00055245205,0.0008673084,0.000551308],"domain_scores_gemma":[0.9971519,0.000161345,0.0003582416,0.0008781834,0.0012389875,0.00021135622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003114414,0.00035345674,0.00066012295,0.00012444129,0.00018547551,0.00003590582,0.00044115802,0.0002415082,0.00006523118],"category_scores_gemma":[0.00038492773,0.00024005318,0.00018773506,0.0008264636,0.000779779,0.000107600725,0.00018226505,0.0006126885,0.00011986655],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038356163,0.0013144662,0.014537617,0.00024059763,0.0026463594,0.00042330733,0.0015543614,0.000028338556,0.9383611,0.0003147048,0.0012187564,0.0010042449],"study_design_scores_gemma":[0.09519526,0.003375746,0.0049635815,0.00016374316,0.00077637524,0.00004666779,0.00016795768,0.0009977812,0.893699,0.000051703388,0.00029967132,0.00026250022],"about_ca_topic_score_codex":0.00019647696,"about_ca_topic_score_gemma":0.000009556564,"teacher_disagreement_score":0.0568391,"about_ca_system_score_codex":0.0002706227,"about_ca_system_score_gemma":0.00090745656,"threshold_uncertainty_score":0.9789085},"labels":[],"label_agreement":null},{"id":"W2911504656","doi":"10.1182/blood-2018-11-883710","title":"Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":401,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Juno Therapeutics; National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; Celgene","keywords":"Medicine; CAR T-cell therapy; CD19; Internal medicine; Oncology; Immunology; T cell; Chimeric antigen receptor; Antibody; Immune system","score_opus":0.019104211371907664,"score_gpt":0.2534960935338183,"score_spread":0.23439188216191065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911504656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906471,0.00014000987,5.7320165e-7,0.00008227414,0.00007805332,0.00150884,0.000041861233,0.00006189974,0.0074394112],"genre_scores_gemma":[0.98889863,0.000101168735,0.000036866226,0.0003618391,0.000040936262,0.00006700472,0.000087557164,0.0000976159,0.010308348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975819,0.00019167448,0.000320771,0.00050578144,0.0007262894,0.0006735965],"domain_scores_gemma":[0.99859905,0.0002791431,0.00013920404,0.00047444287,0.00030601496,0.00020215426],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023251583,0.0003357751,0.0005268477,0.000215439,0.000040622323,0.000040253744,0.0001868838,0.00020224915,0.0015080712],"category_scores_gemma":[0.000099804274,0.0002443121,0.00013031582,0.0004160965,0.00005756458,0.00014126301,0.000053099793,0.00058544055,0.00010520268],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007567676,0.002938472,0.9012592,0.00005928744,0.00021800377,0.0000341282,0.0029234546,0.0000037733523,0.0915934,7.397785e-7,0.000069907175,0.00014287527],"study_design_scores_gemma":[0.036937933,0.0026103177,0.75714254,0.0003034808,0.00009678229,0.000001131355,0.00053016597,0.000028666946,0.20142162,0.000008724396,0.00049108686,0.00042754316],"about_ca_topic_score_codex":0.00035545925,"about_ca_topic_score_gemma":0.00028364567,"teacher_disagreement_score":0.14411664,"about_ca_system_score_codex":0.00019700419,"about_ca_system_score_gemma":0.00013920169,"threshold_uncertainty_score":0.99940467},"labels":[],"label_agreement":null},{"id":"W2911507042","doi":"10.1182/blood-2018-99-118501","title":"Cell Type-Specific Deregulation of Polypyrimidine Tract- Binding Proteins (PTBPs) Drive Aberrant Splicing in Multiple Myeloma (MM) and Acute Myeloid Leukemia (AML)","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Downregulation and upregulation; Myeloid leukemia; Cancer research; Myeloid; Biology; RNA splicing; Cell culture; Molecular biology; Stromal cell; Intron; Bone marrow; Polypyrimidine tract-binding protein; Transcriptome; Immunology; Gene expression; RNA; Gene; Genetics","score_opus":0.014748968561705439,"score_gpt":0.24306404928530237,"score_spread":0.22831508072359694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911507042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983003,0.000557115,0.00027468565,0.000031130297,0.00003905873,0.00035673796,0.000012160735,0.000009073699,0.00041969793],"genre_scores_gemma":[0.9972026,0.00030151455,0.0017652435,0.000015638252,0.0001740993,0.000013307119,0.000048883197,0.000024957806,0.00045376958],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99888057,0.00004510142,0.00025547761,0.0003431398,0.00015126065,0.00032443958],"domain_scores_gemma":[0.9994336,0.000019119989,0.00010173616,0.00026162204,0.00009263885,0.00009128252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019850889,0.00014965159,0.00018243064,0.000119504424,0.00009474126,0.000023728568,0.00013023823,0.0001460304,0.000013658975],"category_scores_gemma":[0.000044763452,0.00014161044,0.0000433708,0.00018113854,0.00011030541,0.000011379782,0.00009266366,0.00011523691,0.0000069892194],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014876384,0.00011360021,0.013498833,0.000030497364,0.000030594452,0.000009160546,0.00015424374,0.0000115385465,0.9841017,0.000009990934,0.000065920256,0.0018251367],"study_design_scores_gemma":[0.0019161003,0.00054038625,0.023949008,0.00004991102,0.000018623616,0.000021133075,0.000098885714,0.0005096509,0.97237897,0.000009868896,0.00035272414,0.00015475985],"about_ca_topic_score_codex":0.00013114222,"about_ca_topic_score_gemma":0.000109854496,"teacher_disagreement_score":0.011722773,"about_ca_system_score_codex":0.000025076612,"about_ca_system_score_gemma":0.00008343689,"threshold_uncertainty_score":0.5774706},"labels":[],"label_agreement":null},{"id":"W2911523759","doi":"10.1182/blood-2018-99-114133","title":"Impact of Prolonged Anticoagulation with Rivaroxaban on Provoked Venous Thromboembolism Recurrence: The Improve-VTE Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Rivaroxaban; Medicine; Pulmonary embolism; Aspirin; Thrombosis; Deep vein; Clinical endpoint; Propensity score matching; Warfarin; Surgery; Randomized controlled trial; Venous thrombosis; Internal medicine; Atrial fibrillation","score_opus":0.017876943592707757,"score_gpt":0.30722309050190433,"score_spread":0.2893461469091966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911523759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99386173,0.000036953123,0.0000090177,0.00017673943,0.00014351969,0.0036147495,0.000010634924,0.000063268366,0.0020833653],"genre_scores_gemma":[0.99923235,0.000015013565,0.00009288709,0.00009178874,0.00034975685,0.00012520558,0.00001424581,0.000036843845,0.000041912812],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983725,0.000087481014,0.00031507638,0.00038457438,0.00050099357,0.00033935712],"domain_scores_gemma":[0.9985739,0.000047137015,0.00023662539,0.0007429775,0.00031022105,0.00008912614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035278292,0.00024449627,0.00062602054,0.00011307848,0.0001831866,0.000032320015,0.0001899792,0.00006330806,0.00005476339],"category_scores_gemma":[0.00008571627,0.00013170548,0.00011512148,0.0003257003,0.00019274079,0.00007837373,0.000064057735,0.00018634838,0.000029542975],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012519183,0.08909458,0.86654425,0.000235725,0.0040417993,0.000041825897,0.01281884,0.000017213975,0.0069011273,0.0006116997,0.0014800881,0.016960934],"study_design_scores_gemma":[0.0054053366,0.031222826,0.958426,0.00012478032,0.0011838082,0.0000059190425,0.00019231881,0.000031362386,0.0031492817,0.000060050814,0.000046198944,0.0001521485],"about_ca_topic_score_codex":0.00025887278,"about_ca_topic_score_gemma":0.00004990217,"teacher_disagreement_score":0.09188172,"about_ca_system_score_codex":0.000041496492,"about_ca_system_score_gemma":0.00013646859,"threshold_uncertainty_score":0.53707933},"labels":[],"label_agreement":null},{"id":"W2911576962","doi":"10.1182/blood-2018-99-114314","title":"Identification of Gene Regulatory Networks Governing Stemness Properties of Human HSC and LSC","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of British Columbia; University Health Network; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Stem cell; Biology; Hematopoietic stem cell; Haematopoiesis; Chromatin; Gene; Progenitor cell; Transcription factor; Computational biology; Cell biology; Genetics","score_opus":0.024989102033489103,"score_gpt":0.27207084111767754,"score_spread":0.24708173908418843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911576962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99777454,0.0013112167,0.00016100905,0.000036538484,0.0000367881,0.0002295568,0.0000028874463,0.000016841941,0.00043064484],"genre_scores_gemma":[0.9986917,0.000031743188,0.00012180355,0.000013292587,0.00022714793,0.000008963712,0.000005577551,0.000016431613,0.00088334334],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99913263,0.000040920066,0.0002842699,0.0001545369,0.0002568286,0.00013081185],"domain_scores_gemma":[0.9992409,0.000013506905,0.00014787985,0.00031091226,0.00023656822,0.00005026945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036837248,0.00006840047,0.00019738077,0.000058971367,0.000057445166,0.000007175754,0.000081709666,0.000071312184,0.000018212324],"category_scores_gemma":[0.00006537556,0.000056260273,0.000026543074,0.000116079835,0.00030222905,0.000054892214,0.00005608235,0.00009575054,0.000003965037],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006190047,0.000113095644,0.010746709,0.00022069659,0.000075810305,0.0000025933277,0.00048717242,0.0000016504251,0.98692137,0.000070162714,0.00013096433,0.0011678768],"study_design_scores_gemma":[0.0014901118,0.00024406418,0.088819146,0.00020239479,0.00011518855,0.000018437717,0.0002100186,0.0009099021,0.90788364,0.000006927046,0.000043401553,0.000056780482],"about_ca_topic_score_codex":0.000043676984,"about_ca_topic_score_gemma":0.0000061356977,"teacher_disagreement_score":0.07903774,"about_ca_system_score_codex":0.000028045004,"about_ca_system_score_gemma":0.000066167384,"threshold_uncertainty_score":0.22942273},"labels":[],"label_agreement":null},{"id":"W2911608346","doi":"10.1182/blood-2018-99-118063","title":"PARP14 Is a Novel Therapeutic Target in STAT6 mutant Follicular Lymphoma","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"STAT6; Biology; Mutant; Follicular lymphoma; Gene; Molecular biology; Cancer research; Lymphoma; Cell biology; Genetics; Transcription factor; Immunology","score_opus":0.018019898871330316,"score_gpt":0.2642321548697092,"score_spread":0.24621225599837887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911608346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949425,0.00120934,0.00004288683,0.0008906737,0.00009062082,0.00048250292,0.0000229762,0.000045864672,0.0022726539],"genre_scores_gemma":[0.996227,0.00008889627,0.0012090654,0.001996172,0.00015800433,0.00011355343,0.000013982887,0.000024583725,0.00016873634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989193,0.000016885642,0.00021810085,0.00029930656,0.00023122324,0.00031516232],"domain_scores_gemma":[0.9993966,0.00003203865,0.000048467544,0.00034868674,0.000055728626,0.00011846373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000085551466,0.00017099932,0.00028052487,0.00007658161,0.00004736677,0.00001708781,0.00006817807,0.00007848727,0.00033093538],"category_scores_gemma":[0.000014498761,0.00012647256,0.00010173007,0.00018150586,0.000060683575,0.000040047988,0.00002912831,0.00003098467,0.00024858382],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007465346,0.033238485,0.90566075,0.00010042606,0.0017133815,0.0013624568,0.0037894475,8.250355e-7,0.033156067,0.0018911144,0.0012385221,0.017101998],"study_design_scores_gemma":[0.07415288,0.0016653552,0.63698775,0.00018802872,0.0006011144,0.000324639,0.00015875489,0.00019772166,0.24741633,0.00051576574,0.037459075,0.00033257777],"about_ca_topic_score_codex":0.00020527471,"about_ca_topic_score_gemma":0.000021952597,"teacher_disagreement_score":0.26867297,"about_ca_system_score_codex":0.00008728431,"about_ca_system_score_gemma":0.00013878242,"threshold_uncertainty_score":0.51574016},"labels":[],"label_agreement":null},{"id":"W2911631051","doi":"10.1182/blood-2018-99-115132","title":"Updated Report on Identification of Molecular Predictors of Tazemetostat Response in an Ongoing NHL Phase 2 Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Internal medicine; Identification (biology); Oncology; Pharmacology; Biology","score_opus":0.012379843531050885,"score_gpt":0.31457846685337837,"score_spread":0.3021986233223275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911631051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991242,0.000084541854,0.00034003687,0.000009624813,0.00006566024,0.00028401965,0.000018386561,0.0000049961786,0.000068523186],"genre_scores_gemma":[0.999596,0.000007834804,0.00014544839,0.0000054326833,0.000043155338,0.00000985516,0.00014695503,0.0000140362135,0.00003126606],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987773,0.00021247729,0.00046756968,0.00027747182,0.00016630051,0.000098891884],"domain_scores_gemma":[0.9989923,0.000010839498,0.00026021877,0.0005069171,0.000192236,0.0000374452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087069673,0.000085619795,0.00012334346,0.00011296759,0.000020365665,0.000006845564,0.000108157,0.00007512482,0.000004952838],"category_scores_gemma":[0.00028769957,0.00008818556,0.0000335537,0.00016074827,0.000053522814,0.000003892257,0.000033181426,0.00003665037,8.602619e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006928249,0.001927991,0.045952547,0.0000049349546,0.000039285354,0.000015461777,0.00021062374,0.00005136132,0.9508888,0.0000029187524,0.0000031203192,0.00021012398],"study_design_scores_gemma":[0.0017941232,0.0045704413,0.083410345,0.000007719524,0.000038358186,0.0000015288294,0.00011971976,0.00003230424,0.9098565,0.000017083928,0.00007953139,0.00007233013],"about_ca_topic_score_codex":0.00001804471,"about_ca_topic_score_gemma":0.000022631508,"teacher_disagreement_score":0.041032292,"about_ca_system_score_codex":0.0000048134602,"about_ca_system_score_gemma":0.00005299265,"threshold_uncertainty_score":0.35961026},"labels":[],"label_agreement":null},{"id":"W2911644503","doi":"10.1182/blood-2018-99-112557","title":"The Impact of Hematopoietic Cell Transplantation on Survival: An Exploratory Analysis of a Phase 3 Study of CPX-351 Versus 7+3 in Older Patients with Newly Diagnosed, High-Risk/Secondary AML","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada","funders":"","keywords":"Medicine; Internal medicine; Cytarabine; Clinical endpoint; Transplantation; Regimen; Chemotherapy regimen; Phases of clinical research; Gastroenterology; Daunorubicin; Hematopoietic stem cell transplantation; Chemotherapy; Surgery; Oncology; Randomized controlled trial","score_opus":0.017697652083110034,"score_gpt":0.3120321033799052,"score_spread":0.2943344512967952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911644503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987179,0.00004026527,0.000018183742,0.0000058745013,0.000033080447,0.00089202414,0.00017445277,0.000010492121,0.000107705855],"genre_scores_gemma":[0.9996708,0.00006768568,0.000045375247,0.0000039409324,0.000024377754,0.000037347578,0.000117594645,0.000027984484,0.0000048985107],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979973,0.00034849934,0.0004921912,0.00027928187,0.0006395056,0.00024322137],"domain_scores_gemma":[0.99807936,0.0004967427,0.0003223143,0.00063449447,0.0003515198,0.000115560535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048966234,0.00017789793,0.0005882623,0.00049456104,0.000049965027,0.0000069268335,0.0001939059,0.00006770266,0.000074245305],"category_scores_gemma":[0.00007601601,0.0001111164,0.000117066826,0.001160782,0.0001736186,0.00010869068,0.000020473391,0.00023048003,0.0000023375294],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016811654,0.02894374,0.9235568,0.00016400548,0.0031615621,0.00006337643,0.02315495,0.00019266634,0.002125661,0.0000041702206,0.000033704506,0.0017876977],"study_design_scores_gemma":[0.08627923,0.026340215,0.86290693,0.00006629352,0.0027930497,4.1022275e-7,0.005278862,0.00013018507,0.016093938,0.0000024741364,5.099029e-7,0.00010787279],"about_ca_topic_score_codex":0.0025944023,"about_ca_topic_score_gemma":0.0024719918,"teacher_disagreement_score":0.069467574,"about_ca_system_score_codex":0.000075197706,"about_ca_system_score_gemma":0.00028480386,"threshold_uncertainty_score":0.45311952},"labels":[],"label_agreement":null},{"id":"W2911720118","doi":"10.1182/blood-2018-99-120229","title":"Comprehensive Integrated Genomic Perturbations Reveal Molecular Mechanisms of Red Blood Cell Trait Associations","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Biology; Genetics; Genome-wide association study; Single-nucleotide polymorphism; Chromatin; Gene; Computational biology; Genotype","score_opus":0.007157463926986183,"score_gpt":0.24437593890513581,"score_spread":0.23721847497814963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911720118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9706633,0.00040297245,0.027102703,0.000055656037,0.00009251095,0.00016621116,0.00013837276,0.000019282214,0.0013589666],"genre_scores_gemma":[0.9899976,0.000023508883,0.009184024,0.00009189528,0.00009743501,0.00001256794,0.00024564238,0.000024794548,0.00032252326],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992449,0.000034418797,0.0002181601,0.00022955476,0.00009316125,0.0001797967],"domain_scores_gemma":[0.99937356,0.000010333735,0.00008006426,0.00026588596,0.00021180545,0.00005836092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005517594,0.00013172292,0.00014729277,0.00004673922,0.000059582268,0.000010153206,0.00014808649,0.00013327957,0.000027243363],"category_scores_gemma":[0.00004069332,0.00013952282,0.00010000974,0.000112895614,0.000043601554,0.0000017034577,0.00005263062,0.00006828791,0.000004848788],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000049833257,0.00020914132,0.00008959711,0.000011646146,0.00013152423,0.0000017053477,0.00006637211,0.00007224023,0.99896663,0.00013589393,0.00026118144,0.000049094644],"study_design_scores_gemma":[0.0010061467,0.0003525025,0.0041831816,0.000007606392,0.000171758,0.000009166811,0.000078570825,0.0000578598,0.99245256,0.00022080963,0.0013063622,0.00015347793],"about_ca_topic_score_codex":0.000018631688,"about_ca_topic_score_gemma":0.000010892609,"teacher_disagreement_score":0.019334285,"about_ca_system_score_codex":0.000005724363,"about_ca_system_score_gemma":0.00005629566,"threshold_uncertainty_score":0.5689575},"labels":[],"label_agreement":null},{"id":"W2911739477","doi":"10.1182/blood-2018-99-117321","title":"Treatment Patterns and Intensity Differ between Pediatric and Adult Centers in AYA with Hodgkin's Lymphoma but Result in Equivalent Outcomes: A Population-Based Study Using the IMPACT Cohort","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Occupational Cancer Research Centre; University of Toronto; Pediatric Oncology Group; St. Michael's Hospital; Institute for Clinical Evaluative Sciences; Hospital for Sick Children","funders":"","keywords":"Medicine; Population; Cohort; Young adult; Pediatrics; Oncology; Internal medicine; Pediatric cancer; Cancer","score_opus":0.026701133965860845,"score_gpt":0.3196857512666651,"score_spread":0.2929846173008043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911739477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99807066,0.000018465287,0.000045738536,0.00020825377,0.0000179989,0.0015548635,0.000058443886,0.000018968529,0.0000066345447],"genre_scores_gemma":[0.9995962,0.0000139982485,0.00008144752,0.00007191963,0.00012763125,0.00003763967,0.000032373107,0.000027857232,0.000010946699],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832207,0.00013834563,0.00032715034,0.0004129479,0.0004077291,0.00039174102],"domain_scores_gemma":[0.99900883,0.00026009863,0.000089913345,0.00036000813,0.000117977856,0.00016316657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002248171,0.00025513314,0.00050312973,0.00027078646,0.00008211344,0.000037724658,0.00007878062,0.00007154282,0.0000050223885],"category_scores_gemma":[0.00014034795,0.00013507382,0.00004179771,0.0002748979,0.000076223725,0.000053972406,0.00008406733,0.00010644296,0.0000010092582],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006672244,0.0011669571,0.99640787,0.00002978139,0.0002086001,0.0002279939,0.0009948558,0.0000037087482,0.00002418254,1.731986e-7,0.0000020709447,0.00026656187],"study_design_scores_gemma":[0.027911946,0.0023833807,0.96688515,0.00007095003,0.00049611053,0.00004844319,0.00070183835,0.0012741494,0.00009440034,0.000001858364,1.5439196e-7,0.00013162418],"about_ca_topic_score_codex":0.032311752,"about_ca_topic_score_gemma":0.0021266623,"teacher_disagreement_score":0.03018509,"about_ca_system_score_codex":0.0009193862,"about_ca_system_score_gemma":0.00024244048,"threshold_uncertainty_score":0.9741322},"labels":[],"label_agreement":null},{"id":"W2911837214","doi":"10.1182/blood-2018-99-112689","title":"Prognostic Biomarkers Converge on a Germinal Centre Dark Zone Phenotype As a Determinant of Adverse Outcome in Follicular Lymphoma Patients Treated with Rituximab and Chemotherapy","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; BC Cancer Agency; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Rituximab; Oncology; Follicular lymphoma; Internal medicine; Medicine; Log-rank test; Chemotherapy regimen; Progression-free survival; International Prognostic Index; Prednisone; Framingham Risk Score; Lymphoma; Proportional hazards model; Chemotherapy; Disease","score_opus":0.005317571305958473,"score_gpt":0.22532732062255795,"score_spread":0.22000974931659947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911837214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99931747,0.00010514895,0.000015522446,0.000022354816,0.000017921831,0.00029345605,0.00002261509,0.0000049380255,0.0002005664],"genre_scores_gemma":[0.9994872,0.000047554182,0.0001895053,0.00008425437,0.000022231055,0.000022088627,0.000042470903,0.00001695698,0.0000876934],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992667,0.000027474187,0.00017315982,0.00027277856,0.00009670905,0.0001632011],"domain_scores_gemma":[0.99953604,0.000005845122,0.00009428448,0.00022761548,0.000084489235,0.000051738065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000045845678,0.00013326606,0.00015347745,0.000046220655,0.00003401483,0.000004538038,0.00007445275,0.00007676001,0.000012697919],"category_scores_gemma":[0.000018157743,0.00010515262,0.000034113804,0.000104539184,0.00012228024,0.000003543738,0.000018796685,0.000019905992,0.000004610888],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001149587,0.0017590225,0.9573367,0.0000305566,0.00013008088,0.0000145863405,0.00009466895,2.6341576e-7,0.033621244,0.000010832046,0.000027909837,0.005824553],"study_design_scores_gemma":[0.015604627,0.0024682048,0.8489867,0.00007966252,0.00010717407,0.00001294511,0.0000695161,0.00003399015,0.13145776,0.0000043802543,0.0009337912,0.0002412893],"about_ca_topic_score_codex":0.00009210551,"about_ca_topic_score_gemma":0.000054950982,"teacher_disagreement_score":0.10835003,"about_ca_system_score_codex":0.0000107158585,"about_ca_system_score_gemma":0.00004703853,"threshold_uncertainty_score":0.42879993},"labels":[],"label_agreement":null},{"id":"W2911881511","doi":"10.1182/blood-2018-99-117650","title":"Fcγ Receptors I and III on Splenic Macrophages Mediate GPIIb/IIIa Autoantibody-Dependent Phagocytosis of Platelets in Human Immune Thrombocytopenia","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; University Health Network; Health Sciences Centre; Canadian Blood Services; St. Michael's Hospital","funders":"","keywords":"Phagocytosis; Platelet; Autoantibody; Immunology; Antibody; Fc receptor; Opsonin; Macrophage; Immune system; Spleen; Immunoglobulin G; Medicine; Chemistry; In vitro; Biochemistry","score_opus":0.01244185220658029,"score_gpt":0.2791279451768954,"score_spread":0.2666860929703151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911881511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952282,0.0013539579,0.0000010030129,0.000116444346,0.00016502247,0.00051779865,0.000025570424,0.00004963365,0.0025424263],"genre_scores_gemma":[0.99838865,0.0007592612,0.00012588153,0.000074858406,0.00007642213,0.0000195731,0.000057425314,0.00004025206,0.00045766676],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99834925,0.000047822745,0.0004762156,0.0004224655,0.00031929888,0.0003849555],"domain_scores_gemma":[0.99923533,0.000049948496,0.00017036106,0.00036401363,0.000054615117,0.00012574666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018884338,0.0002782145,0.0008055311,0.00022065984,0.00010793004,0.00001695917,0.00011805808,0.00015542326,0.00045523274],"category_scores_gemma":[0.000031608506,0.0002304207,0.00009241407,0.00020947847,0.00018809993,0.000085801716,0.00008991268,0.0001947725,0.0000678174],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018695288,0.010577088,0.20768194,0.00043858195,0.0023677538,0.0035664083,0.0041854107,0.0000019191402,0.7554159,0.00042319414,0.00053875236,0.012933527],"study_design_scores_gemma":[0.026734458,0.0029222723,0.26818147,0.0004271135,0.0004793051,0.00019972525,0.00015106122,0.000013312079,0.7001622,0.00022168794,0.00019047358,0.00031690567],"about_ca_topic_score_codex":0.00040809796,"about_ca_topic_score_gemma":0.00017378414,"teacher_disagreement_score":0.060499545,"about_ca_system_score_codex":0.000038130154,"about_ca_system_score_gemma":0.00004958253,"threshold_uncertainty_score":0.93962836},"labels":[],"label_agreement":null},{"id":"W2911905058","doi":"10.1182/blood-2018-99-114182","title":"Single-Cell Profiling Reveals Distinct Tumor Subtypes and Their Associated T-Cell Environments in Follicular Lymphoma","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Biology; Mass cytometry; Germinal center; Follicular lymphoma; Tumor microenvironment; Lymphoma; Malignancy; Phenotype; Cancer research; B cell; Immune system; Computational biology; Pathology; Immunology; Medicine; Genetics; Antibody; Gene","score_opus":0.011840313258328905,"score_gpt":0.21159649058641491,"score_spread":0.199756177328086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911905058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99489534,0.0012754995,0.0000024326962,0.00006916366,0.00004430095,0.0004600796,0.000022119382,0.00003123998,0.0031997978],"genre_scores_gemma":[0.99887645,0.000044028566,0.00026150627,0.00016260527,0.00008157649,0.00005055939,0.00004907318,0.000028490163,0.0004457368],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99888587,0.000057109784,0.00024881036,0.00035234998,0.00015426075,0.00030158256],"domain_scores_gemma":[0.999429,0.00008179982,0.00011097521,0.00023859015,0.000017934055,0.00012172599],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015758983,0.0002058368,0.00033074003,0.000060189137,0.000072211245,0.000022365455,0.000055177876,0.000077264944,0.000027700282],"category_scores_gemma":[0.00006503817,0.000151805,0.00006700252,0.000112946625,0.0000613028,0.0000420971,0.000055200264,0.00003859619,0.00005395048],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004441667,0.0072617442,0.90504247,0.0000422629,0.00009191972,0.0002226441,0.00023366722,6.3713195e-8,0.08605606,0.000008280954,0.000058938458,0.00093752815],"study_design_scores_gemma":[0.011161107,0.000718861,0.47558087,0.00013029709,0.00019792705,0.00003452892,0.000078192956,0.00002240814,0.51131415,0.00005192152,0.0005552298,0.0001544872],"about_ca_topic_score_codex":0.00005961173,"about_ca_topic_score_gemma":0.000022389704,"teacher_disagreement_score":0.4294616,"about_ca_system_score_codex":0.00013729365,"about_ca_system_score_gemma":0.0000372471,"threshold_uncertainty_score":0.6190428},"labels":[],"label_agreement":null},{"id":"W2911906784","doi":"10.1182/blood-2018-99-114913","title":"Bone Marrow Biopsy Impacts Response Assessment in a Minority of Patients with Follicular Lymphoma and Diffuse Large B-Cell Lymphoma Treated with Immunochemotherapy: Results from the Randomized Phase III GALLIUM and GOYA Trials","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Follicular lymphoma; Diffuse large B-cell lymphoma; Rituximab; Internal medicine; Bendamustine; Obinutuzumab; CHOP; Lymphoma; Surgery; Oncology","score_opus":0.010191179172773545,"score_gpt":0.2654772174291932,"score_spread":0.25528603825641966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911906784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99429005,0.0018108716,0.000009266801,0.00033638402,0.000022596776,0.002766808,0.00063983374,0.000028198792,0.00009599093],"genre_scores_gemma":[0.99810237,0.00040824266,0.00080030516,0.00014650765,0.00005280455,0.00017170435,0.00023076686,0.000034883094,0.00005243533],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99677557,0.0009900003,0.00087429077,0.00054363743,0.00043926248,0.00037721824],"domain_scores_gemma":[0.9966294,0.0017199592,0.0006130386,0.0006511654,0.00018754558,0.00019886522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019920198,0.0004184171,0.001656368,0.00013230885,0.0001173757,0.00005736093,0.00008651761,0.00013967926,0.000016144822],"category_scores_gemma":[0.00037427072,0.00020693445,0.00014400312,0.00028098686,0.0003366859,0.000087655106,0.000049369166,0.00005124923,0.0000010839788],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7326199,0.0427272,0.21284744,0.000034335786,0.0016478831,0.00024887314,0.0014926484,2.5228807e-8,0.0071022906,0.0000071982677,0.000048936137,0.0012233194],"study_design_scores_gemma":[0.5697763,0.0022928196,0.40810347,0.00022011592,0.0013446643,0.000021897775,0.00010582661,0.0000248721,0.01791063,0.0000052163477,0.000048968624,0.00014519643],"about_ca_topic_score_codex":0.0023531038,"about_ca_topic_score_gemma":0.00017633257,"teacher_disagreement_score":0.19525604,"about_ca_system_score_codex":0.00011512525,"about_ca_system_score_gemma":0.00028133485,"threshold_uncertainty_score":0.8438542},"labels":[],"label_agreement":null},{"id":"W2911926938","doi":"10.1182/blood-2018-99-119472","title":"Comprehensive Analysis of Systemic Immunosuppression (SIS) Duration after Allogeneic Hematopoietic Stem Cell Transplant: Risk Score Model Provides Stratification of Patients According to Probability of SIS Discontinuation","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Discontinuation; Cumulative incidence; Internal medicine; Hazard ratio; Immunosuppression; Transplantation; Hematopoietic stem cell transplantation; Univariate analysis; Retrospective cohort study; Proportional hazards model; Multivariate analysis; Graft-versus-host disease; Confidence interval; Oncology","score_opus":0.01917492965388984,"score_gpt":0.24872862304122623,"score_spread":0.2295536933873364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911926938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97710437,0.00012651885,0.020440454,0.000012022428,0.0000394831,0.0018618609,0.0003443331,0.000023553424,0.000047426995],"genre_scores_gemma":[0.9970283,0.00004360324,0.0024045617,0.000006025679,0.0000135650025,0.000114479626,0.0003590619,0.000022306369,0.000008106327],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971365,0.0001983118,0.0014964065,0.0004237124,0.00056218856,0.00018291936],"domain_scores_gemma":[0.9973684,0.00013332778,0.00093712675,0.00057022186,0.00090966537,0.00008125878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003343316,0.00022324605,0.00076971913,0.00039833412,0.000051810326,0.00001012288,0.00011156266,0.00014746848,0.000016828655],"category_scores_gemma":[0.000023282675,0.00019223744,0.00023235066,0.00072220614,0.00010110552,0.00016370714,0.00001800264,0.00008255718,0.000002357865],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000703646,0.0010639062,0.44764334,0.002614823,0.00047458158,7.424821e-7,0.011221164,0.001192775,0.5347167,0.000016962282,9.0333174e-7,0.00035041638],"study_design_scores_gemma":[0.0017468649,0.00051043363,0.24682502,0.0012135791,0.0059443824,0.000002999506,0.0011907629,0.006215383,0.7361609,0.000033276818,1.5492706e-7,0.00015625663],"about_ca_topic_score_codex":0.000061140876,"about_ca_topic_score_gemma":0.000035613288,"teacher_disagreement_score":0.20144416,"about_ca_system_score_codex":0.000041585354,"about_ca_system_score_gemma":0.00009615703,"threshold_uncertainty_score":0.78392154},"labels":[],"label_agreement":null},{"id":"W2911938277","doi":"10.1182/blood-2018-99-110132","title":"How Do ASH Guidelines Panels Make Decisions? Association between Decision Making Factors and the Strength of Recommendations","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University; Impact","funders":"","keywords":"Logistic regression; Certainty; Grading (engineering); Psychology; Normative; Actuarial science; Medicine; Family medicine; Business; Political science; Internal medicine","score_opus":0.2542843075986898,"score_gpt":0.4815703838389741,"score_spread":0.2272860762402843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911938277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9725093,0.00010365736,0.006002771,0.02033621,0.00027102706,0.00046594787,0.00008427407,0.00003187766,0.00019489577],"genre_scores_gemma":[0.97066754,0.00026837309,0.027708443,0.00047848557,0.0006496387,0.000008053931,0.00007743159,0.000018089588,0.00012394851],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977783,0.00019495812,0.0010763087,0.00025245422,0.0005196658,0.00017830112],"domain_scores_gemma":[0.98510325,0.012673114,0.00080528535,0.000361429,0.0009843472,0.00007258294],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0024476813,0.00014051906,0.00037244303,0.00011051785,0.00017425508,0.00008818722,0.000114199254,0.000120765246,0.00011597976],"category_scores_gemma":[0.059913825,0.00008893774,0.00010826819,0.0002717503,0.00009051162,0.00017426428,0.00012525423,0.00018810443,0.000007370578],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017992171,0.00018294956,0.6001635,0.000010234687,0.00036224115,9.768349e-7,0.00043315146,2.736097e-7,0.0003581358,0.00020422674,0.006043228,0.39206117],"study_design_scores_gemma":[0.021469722,0.00080761843,0.9034548,0.00083518523,0.0038276184,0.000023522873,0.0045328783,0.0002736758,0.005753445,0.009107377,0.049562182,0.00035201755],"about_ca_topic_score_codex":0.000057535686,"about_ca_topic_score_gemma":0.00012228599,"teacher_disagreement_score":0.39170915,"about_ca_system_score_codex":0.000043009713,"about_ca_system_score_gemma":0.000074228235,"threshold_uncertainty_score":0.9480049},"labels":[],"label_agreement":null},{"id":"W2911986426","doi":"10.1182/blood-2018-99-118889","title":"AML-Fated Clones Arise in Stem and Progenitor Cells in Myelofibrosis Patients Several Years Prior to AML Diagnosis","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Princess Margaret Cancer Centre; Health Sciences Centre; University Health Network","funders":"","keywords":"Myelofibrosis; Myeloid; Myeloid leukemia; Biology; clone (Java method); Cancer research; CD34; Stem cell; Bone marrow; Immunology; Gene; Genetics","score_opus":0.011462270574794155,"score_gpt":0.24440863269196084,"score_spread":0.23294636211716668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911986426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977163,0.00013659478,7.9885234e-7,0.000283993,0.00013052353,0.001551465,0.000052507694,0.00003228663,0.00009553286],"genre_scores_gemma":[0.99762243,0.00013353424,0.0011462172,0.00029372133,0.00012213862,0.00051413866,0.000019829959,0.000031545314,0.00011646948],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852526,0.00006950864,0.00035192506,0.00045076924,0.0002477044,0.00035483253],"domain_scores_gemma":[0.999304,0.000087398555,0.000065232474,0.00021809981,0.000101702055,0.00022355243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009880553,0.00022366442,0.00040714355,0.00023063445,0.000043061336,0.000034748085,0.00006374801,0.00011338832,0.00005719087],"category_scores_gemma":[0.000046144072,0.00019404734,0.00004855185,0.00037146136,0.00005206395,0.00007823131,0.000076826764,0.000110114546,0.00012054149],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021847808,0.0029203848,0.9871771,0.000047644862,0.00007477414,0.00008209908,0.0017162997,0.000001053125,0.00063811184,0.0000058989935,0.0004341605,0.0066840127],"study_design_scores_gemma":[0.0072575076,0.0015599747,0.90740895,0.00027477404,0.000102097714,0.000004512,0.00007904217,0.00001592553,0.08212483,0.0000056188755,0.0009821622,0.00018458109],"about_ca_topic_score_codex":0.00026042614,"about_ca_topic_score_gemma":0.00042963444,"teacher_disagreement_score":0.08148672,"about_ca_system_score_codex":0.00008529012,"about_ca_system_score_gemma":0.000058065452,"threshold_uncertainty_score":0.7913021},"labels":[],"label_agreement":null},{"id":"W2912061124","doi":"10.1182/blood-2018-99-115350","title":"Ruxolitinib for the Treatment of Inadequately Controlled Polycythemia Vera without Splenomegaly: 156-Week Follow-up from the Phase 3 Response-2 Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Phlebotomy; Ruxolitinib; Medicine; Polycythemia vera; Clinical endpoint; Myelofibrosis; Internal medicine; Surrogate endpoint; Hematocrit; Gastroenterology; Phases of clinical research; Clinical trial; Bone marrow","score_opus":0.05647221275066861,"score_gpt":0.34353198903802135,"score_spread":0.28705977628735274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912061124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876646,0.0014436663,0.00004623885,0.0033275897,0.0002567749,0.0065224622,0.00036115508,0.000040718227,0.0003368033],"genre_scores_gemma":[0.99478084,0.00014228614,0.0002395597,0.0004025857,0.0007284156,0.0023368055,0.000049872415,0.000046560115,0.0012730972],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99799335,0.00027895637,0.00055820105,0.00043826754,0.00035930338,0.00037190272],"domain_scores_gemma":[0.9952028,0.0033542062,0.000258047,0.00081997825,0.00023001252,0.00013496602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000490888,0.0003610828,0.0009439907,0.000058839905,0.00035994282,0.00004478465,0.00018338546,0.00007595257,0.00021578204],"category_scores_gemma":[0.0003793311,0.00016480626,0.0003747447,0.00013557616,0.00019956486,0.00003900377,0.000026784464,0.00008515483,0.00003722244],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3991754,0.1361587,0.3455282,0.000039595256,0.027540293,0.00021237308,0.047544215,0.0000015824867,0.012343153,0.0007752856,0.0028613391,0.027819874],"study_design_scores_gemma":[0.60200673,0.107283905,0.1145456,0.00014839185,0.013241939,0.000033587585,0.005674491,0.00018947895,0.11794575,0.000228347,0.038281742,0.0004200139],"about_ca_topic_score_codex":0.0005227923,"about_ca_topic_score_gemma":0.00034384665,"teacher_disagreement_score":0.23098257,"about_ca_system_score_codex":0.00009124887,"about_ca_system_score_gemma":0.0002686267,"threshold_uncertainty_score":0.67206043},"labels":[],"label_agreement":null},{"id":"W2912062763","doi":"10.1182/blood-2018-99-109740","title":"3,023 Mayo Clinic Patients with Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont; Jewish General Hospital","funders":"","keywords":"Medicine; Myelofibrosis; Polycythemia vera; Essential thrombocythemia; Internal medicine; Population; International Prognostic Scoring System; Myelodysplastic syndromes; Bone marrow","score_opus":0.033849180491706904,"score_gpt":0.31555831732710066,"score_spread":0.2817091368353938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912062763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99659085,0.00021664026,0.0000356336,0.00018599784,0.00013864228,0.0012050462,0.0008396739,0.00005133889,0.000736163],"genre_scores_gemma":[0.9971805,0.0000956942,0.0013747864,0.00006710776,0.00012827093,0.00007050712,0.00087700743,0.000041142932,0.00016494888],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99752057,0.00017160363,0.00064327073,0.0007459844,0.00057588395,0.0003426748],"domain_scores_gemma":[0.9973415,0.00044070318,0.0004440625,0.0009964557,0.00036513346,0.00041211382],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026173572,0.0003857241,0.00095166115,0.00010064792,0.00020364061,0.00004563389,0.00019620251,0.00010171743,0.00015122523],"category_scores_gemma":[0.00034431063,0.00025638795,0.00007248754,0.00019131848,0.0005016741,0.00021812724,0.00017848163,0.00022861632,0.000037323578],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009477389,0.004396874,0.9919233,0.000091930626,0.0009621263,0.000021438698,0.00062672567,4.1558468e-7,0.000005797839,0.00012873113,0.00022666427,0.0006683036],"study_design_scores_gemma":[0.011857008,0.002346902,0.982037,0.00018647399,0.0015971579,0.000001576701,0.00028954278,0.00016163045,0.00113834,0.000040610892,0.00008840758,0.00025535782],"about_ca_topic_score_codex":0.0001129631,"about_ca_topic_score_gemma":0.00082613406,"teacher_disagreement_score":0.010909269,"about_ca_system_score_codex":0.00002001007,"about_ca_system_score_gemma":0.00015699967,"threshold_uncertainty_score":0.99998885},"labels":[],"label_agreement":null},{"id":"W2912185676","doi":"10.1182/blood-2018-99-118090","title":"Anti-Glycoprotein V Autoantibodies in Patients with Immune Thrombocytopenia: Regularly Detectable and Functionally Relevant","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Autoantibody; Immunology; Platelet; Antigen; Antibody; Avidity; Immune system; Immune thrombocytopenia; Rituximab; Internal medicine","score_opus":0.004793463016132493,"score_gpt":0.2011474816387452,"score_spread":0.19635401862261273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912185676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99746174,0.00055745663,0.000010817717,0.00014531407,0.00003738824,0.00048650746,0.00000879919,0.00003867604,0.0012532873],"genre_scores_gemma":[0.9982176,0.000040478513,0.0011897006,0.000057258723,0.000026504533,0.000017537994,0.00003228603,0.000020988404,0.0003976751],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991022,0.000015860458,0.00017273118,0.00026911098,0.0002044376,0.00023566694],"domain_scores_gemma":[0.99956363,0.000013587764,0.000056285266,0.00021004044,0.00009896055,0.00005750886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000069634,0.000149347,0.00038115765,0.00008774263,0.00009532237,0.000023344419,0.00003911035,0.00006566432,0.000065890104],"category_scores_gemma":[0.000027459553,0.00010584234,0.00002469366,0.00015065844,0.00010754876,0.00013177995,0.000036662135,0.00009532854,0.00003392741],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054300064,0.0014215889,0.9919457,0.000045040186,0.00026520024,0.00019112686,0.00012735961,1.9787575e-7,0.0039802943,0.000039115723,0.000037412028,0.0014040045],"study_design_scores_gemma":[0.013305865,0.0019094206,0.9758067,0.00016884785,0.00015925863,0.000061871775,0.000023038858,0.00000768642,0.008129798,0.00010465099,0.00019772927,0.00012509701],"about_ca_topic_score_codex":0.00015791417,"about_ca_topic_score_gemma":0.0001246172,"teacher_disagreement_score":0.016138924,"about_ca_system_score_codex":0.000017956962,"about_ca_system_score_gemma":0.000054213855,"threshold_uncertainty_score":0.43161255},"labels":[],"label_agreement":null},{"id":"W2912196844","doi":"10.1182/blood-2018-99-118069","title":"Final Results from a Non-Interventional Safety and Efficacy Study of a VWF/FVIII Concentrate (wilate®) in Patients with Von Willebrand Disease","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Tolerability; Von Willebrand disease; Population; Internal medicine; Clinical trial; Haemophilia; Adverse effect; Von Willebrand factor; Pediatrics; Surgery","score_opus":0.009648436342013188,"score_gpt":0.24213770141892768,"score_spread":0.2324892650769145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912196844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986026,0.00006513061,0.0000035344592,0.000047658574,0.000025705898,0.0007183832,0.00030470482,0.000008710341,0.00022352654],"genre_scores_gemma":[0.9995872,0.000007963436,0.000053992553,0.000021076303,0.00002078647,0.0000069255498,0.00024212344,0.00001026511,0.000049718186],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990394,0.00002865591,0.00029337424,0.00027841813,0.00021044155,0.00014971851],"domain_scores_gemma":[0.999503,0.000037191832,0.00010226714,0.00017008619,0.000067172754,0.000120288125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000049124596,0.00012688173,0.00029081374,0.00005006338,0.000042615262,0.000008173106,0.000038200447,0.00002993841,0.000029621975],"category_scores_gemma":[0.000035687593,0.00009392263,0.000032882905,0.00009666984,0.00007740971,0.000053405984,0.000028081204,0.00006276588,0.0000050533076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020716924,0.015418088,0.9619071,0.000016702095,0.00034560612,0.00020171731,0.0007799092,0.000002102892,0.00001171352,0.0000030496706,0.000016299291,0.00058080174],"study_design_scores_gemma":[0.116108954,0.003934836,0.8790723,0.00028133963,0.000325113,0.0000015413921,0.00006993292,0.000036175297,0.00005212943,0.00001648472,0.000022689304,0.00007851872],"about_ca_topic_score_codex":0.00019855594,"about_ca_topic_score_gemma":0.00021060169,"teacher_disagreement_score":0.095392026,"about_ca_system_score_codex":0.000010392621,"about_ca_system_score_gemma":0.000049618528,"threshold_uncertainty_score":0.38300535},"labels":[],"label_agreement":null},{"id":"W2912211355","doi":"10.1182/blood-2018-99-116783","title":"S100B Is a Useful Marker for the Diagnosis of Haemophagocytic Lymphohistiocytosis","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Hemophagocytic lymphohistiocytosis; Pathology; Macrophage activation syndrome; Context (archaeology); Immunology; Pathological; Cytopenia; Inflammation; Medicine; Biology; Disease; Bone marrow","score_opus":0.036695933855020534,"score_gpt":0.3111264789076103,"score_spread":0.2744305450525898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912211355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890998,0.00330001,0.00020479929,0.0018922287,0.00012494721,0.00090880593,0.00003346789,0.000035382673,0.0044005667],"genre_scores_gemma":[0.9957498,0.0004419536,0.00024675525,0.0007445843,0.00021596294,0.00029998945,0.0000051557513,0.000026930727,0.0022688874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989947,0.000024120665,0.00027663005,0.00018137805,0.0002669944,0.00025615498],"domain_scores_gemma":[0.9988556,0.00026697083,0.00007964222,0.0004857919,0.0002543681,0.000057646717],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028288158,0.00010923391,0.00026395347,0.00007246797,0.00014890496,0.000012723532,0.00017464385,0.00007578401,0.0010434178],"category_scores_gemma":[0.00034324813,0.000072312985,0.00016966634,0.0001996431,0.00028530194,0.00004733251,0.00006182287,0.000068786445,0.00009888981],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001343243,0.0024031939,0.8080175,0.00097214984,0.0020024802,0.000028144188,0.0028177479,5.36236e-7,0.0056975214,0.0005575027,0.1299312,0.046228785],"study_design_scores_gemma":[0.013126988,0.0017142281,0.3808936,0.00026345105,0.0011828505,0.00005816204,0.0005945217,0.0007853283,0.2603153,0.00030504924,0.3404852,0.00027532765],"about_ca_topic_score_codex":0.000059059304,"about_ca_topic_score_gemma":0.000006196935,"teacher_disagreement_score":0.4271239,"about_ca_system_score_codex":0.000024786024,"about_ca_system_score_gemma":0.00021642112,"threshold_uncertainty_score":0.99986976},"labels":[],"label_agreement":null},{"id":"W2912279633","doi":"10.1182/blood.v128.22.1683.1683","title":"Differential Gene Expression Using RNA Sequencing Between Elderly Acute Myeloid Leukemia (AML) Patients with Long Versus Short-Term Survival","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"","keywords":"Oncology; Myeloid leukemia; Medicine; Internal medicine; Population; Survival analysis; Transcriptome; Bioinformatics; Biology; Gene; Genetics; Gene expression","score_opus":0.036512948176246104,"score_gpt":0.28961118042338724,"score_spread":0.2530982322471411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912279633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928132,0.00003428644,0.005568286,0.000047634836,0.00028013892,0.0006563084,0.00010265194,0.00014192784,0.0003555267],"genre_scores_gemma":[0.9959911,0.00003993161,0.0025416075,0.000012745463,0.00091383286,0.000019526584,0.00014508475,0.00012144628,0.00021473598],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99658984,0.00012852426,0.00045517882,0.0007307871,0.00118957,0.0009060906],"domain_scores_gemma":[0.9980983,0.00020979247,0.00014083003,0.0007515271,0.00030960428,0.0004899248],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016474849,0.00042973857,0.0006288278,0.00022857879,0.00023590737,0.000060820592,0.00034189102,0.00027415532,0.00019858833],"category_scores_gemma":[0.00008905577,0.0002701492,0.00014418885,0.00024523752,0.00017767762,0.00033404774,0.00029499072,0.0004577771,0.000043727967],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011661516,0.00011370714,0.4007492,0.000039885963,0.00059192756,0.00026212254,0.0000896436,0.0000010541016,0.5899732,0.0000021267804,0.000014517131,0.0069964402],"study_design_scores_gemma":[0.024080358,0.0013494221,0.38158396,0.00056808593,0.0012203226,0.000031567437,0.00003105965,0.000017052836,0.59064245,0.0000053888443,0.0000139719,0.00045635668],"about_ca_topic_score_codex":0.00010009674,"about_ca_topic_score_gemma":0.0000143642765,"teacher_disagreement_score":0.022914207,"about_ca_system_score_codex":0.0013444088,"about_ca_system_score_gemma":0.00096581207,"threshold_uncertainty_score":0.9999751},"labels":[],"label_agreement":null},{"id":"W2912322416","doi":"10.1182/blood-2018-99-115065","title":"A Stemness Screen Reveals C3ORF54/INKA1 As a Gate-Keeper of Human Stem Cell Latency","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Stem cell; Haematopoiesis; Biology; Progenitor cell; Transplantation; CD34; Cord blood; CD38; Hematopoietic stem cell; Cancer research; Cell biology; Immunology; Medicine; Internal medicine","score_opus":0.01343063462971991,"score_gpt":0.261594914187077,"score_spread":0.24816427955735706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912322416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842811,0.0014547852,0.00015972728,0.00001721102,0.00006618824,0.0001834283,0.000021042233,0.000010843523,0.013805653],"genre_scores_gemma":[0.99640965,0.00009894934,0.00038357172,0.00004208456,0.00029190574,0.000010321735,0.00005377227,0.00002691265,0.0026828211],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989649,0.00007346181,0.00029122975,0.0003083518,0.00015156876,0.00021048145],"domain_scores_gemma":[0.9991204,0.000007837626,0.00015337738,0.0004398301,0.00019993413,0.00007862869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023345384,0.00014066862,0.00017427988,0.000043550615,0.00008498563,0.000015586242,0.00019480324,0.00017824832,0.00005855245],"category_scores_gemma":[0.000012813118,0.00013328802,0.00008590457,0.00009172935,0.000086776105,0.0000030583117,0.000100348865,0.000053544434,0.00003474121],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018111363,0.00019633507,0.009415264,0.000035672732,0.000038643877,0.0000017138404,0.0000953334,0.0000018517947,0.989487,0.00010930642,0.00005542749,0.000545334],"study_design_scores_gemma":[0.0009429,0.0009484019,0.007380693,0.00002521531,0.0000572783,0.0000020849839,0.000048487294,0.0000032081778,0.98816115,0.00044101724,0.0018179296,0.00017162786],"about_ca_topic_score_codex":0.00007155818,"about_ca_topic_score_gemma":0.000034463832,"teacher_disagreement_score":0.012128539,"about_ca_system_score_codex":0.0000034525542,"about_ca_system_score_gemma":0.00004174649,"threshold_uncertainty_score":0.5435327},"labels":[],"label_agreement":null},{"id":"W2912368033","doi":"10.1182/blood-2018-99-116316","title":"Prognostic Significance of Neutrophil to Lymphocyte Ratio (NLR) in Relapsed/Refractory Aggressive Lymphoma Salvage Chemotherapy — Analysis of Canadian Cancer Trials Group (CCTG) ly.10 Trial","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Queen's University","funders":"","keywords":"Medicine; Internal medicine; Oncology; Salvage therapy; Lymphoma; Gemcitabine; Chemotherapy regimen; Neutrophil to lymphocyte ratio; Transplantation; Chemotherapy; Lymphocyte","score_opus":0.028648757679344994,"score_gpt":0.30250972980489604,"score_spread":0.27386097212555105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912368033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99398637,0.001493365,0.000014628548,0.00028793915,0.00034575324,0.0029699535,0.00033360205,0.000038754384,0.0005296346],"genre_scores_gemma":[0.99726576,0.000232368,0.0006407488,0.00035867354,0.0005813799,0.0006829614,0.00006637869,0.000064327025,0.00010742376],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99611384,0.000505211,0.0015485774,0.0006551631,0.0006026635,0.0005745394],"domain_scores_gemma":[0.99644893,0.0004709771,0.0012323721,0.0007933126,0.0005185978,0.0005358154],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013103224,0.00037516272,0.0016886848,0.0025721733,0.00007933371,0.00002159395,0.000347521,0.00028403054,0.00088537467],"category_scores_gemma":[0.0021316453,0.00034785274,0.0005247363,0.00375797,0.00032723264,0.00008390481,0.000042183292,0.000095009156,0.000014765076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22142312,0.009095072,0.43913043,0.0010575398,0.021982448,0.0010644718,0.005255838,0.000092031936,0.24590212,0.00017570246,0.004345436,0.050475802],"study_design_scores_gemma":[0.19836263,0.004060985,0.56999314,0.0011167985,0.014640914,0.000009323973,0.00025590282,0.00040884013,0.20680767,0.000040093866,0.0033972694,0.00090642564],"about_ca_topic_score_codex":0.021565335,"about_ca_topic_score_gemma":0.035246,"teacher_disagreement_score":0.13086271,"about_ca_system_score_codex":0.00048982206,"about_ca_system_score_gemma":0.0023447042,"threshold_uncertainty_score":0.99989736},"labels":[],"label_agreement":null},{"id":"W2912389126","doi":"10.1182/blood.v130.suppl_1.4654.4654","title":"Bleeding Risk Using INR/aPTT Pre-Surgery: Systemtic Review (BRUISR) (BRUISR)","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Cardiac, Anesthesia and Surgical Outcomes","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Medicine; Partial thromboplastin time; Coagulation testing; Prothrombin time; MEDLINE; Surgery; Coagulation; Internal medicine","score_opus":0.04154684217073049,"score_gpt":0.314811294482736,"score_spread":0.27326445231200547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912389126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92474616,0.0480078,0.00006684395,0.0013407357,0.0007679665,0.0012146158,0.0000138874,0.00019602355,0.02364596],"genre_scores_gemma":[0.9799619,0.014921424,0.00051617605,0.000829197,0.00093495176,0.00003761979,0.000013348617,0.00006621367,0.0027191883],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978489,0.00016817573,0.000600682,0.00040867567,0.0005139837,0.00045954093],"domain_scores_gemma":[0.997378,0.00057914946,0.00046890354,0.0011370312,0.00013447365,0.0003024518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013172624,0.00028877758,0.0016557396,0.000099283185,0.00043675362,0.00015134436,0.0002141177,0.00015282957,0.00011900133],"category_scores_gemma":[0.0022839776,0.00022411642,0.0007950882,0.00011771074,0.000101418154,0.00023233492,0.00009152236,0.00028677314,0.00008284691],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007227505,0.00033948896,0.9833393,0.0067977477,0.00080350536,0.0011808536,0.00009991925,0.000002226129,0.00047232767,0.0009198319,0.0009664297,0.0050061033],"study_design_scores_gemma":[0.006034774,0.00023608515,0.6310468,0.035754964,0.01472765,0.004717093,0.0001031839,0.00023809323,0.0015181054,0.000058885966,0.30419815,0.0013662468],"about_ca_topic_score_codex":0.00038759617,"about_ca_topic_score_gemma":0.000007720993,"teacher_disagreement_score":0.3522925,"about_ca_system_score_codex":0.000048032365,"about_ca_system_score_gemma":0.00013869978,"threshold_uncertainty_score":0.9139202},"labels":[],"label_agreement":null},{"id":"W2912442487","doi":"10.1182/blood-2018-09-874636","title":"Increased galactose expression and enhanced clearance in patients with low von Willebrand factor","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Heart, Lung, and Blood Institute; Science Foundation Ireland","keywords":"Von Willebrand factor; Glycan; Von Willebrand disease; Population; ABO blood group system; Glycosylation; Immunology; Glycoprotein; Medicine; Internal medicine; Chemistry; Platelet; Biochemistry","score_opus":0.0026583370953200906,"score_gpt":0.1932128973455862,"score_spread":0.1905545602502661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912442487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986819,0.00011227305,0.0000018415027,0.0000114377945,0.000017693721,0.0004774792,0.000009861456,0.000017516926,0.0006699676],"genre_scores_gemma":[0.9996652,0.000024056697,0.00009505618,0.00005087157,0.0000062519357,0.00000896368,0.000029673505,0.000014396206,0.000105556996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994024,0.000013835954,0.00009405661,0.00020130274,0.00014090691,0.00014751223],"domain_scores_gemma":[0.99970675,0.00001697888,0.000038850358,0.0001431996,0.000021307507,0.00007294339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000015934356,0.000110342924,0.00022320799,0.000046610523,0.000017366387,0.000008005812,0.000023016613,0.000053171243,0.00007060919],"category_scores_gemma":[0.0000115185485,0.00007501306,0.000015896207,0.00006583218,0.000015654288,0.000086534215,0.000012596473,0.00007377582,0.000023876473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013553767,0.0012850425,0.9810656,0.000059598417,0.000032355987,0.000028869115,0.00018154224,2.9184594e-7,0.015046636,4.9613584e-7,0.0000056273047,0.0009385753],"study_design_scores_gemma":[0.028325263,0.00056711026,0.93635285,0.00031976617,0.000026972773,0.0000026250998,0.00001807059,0.000004614085,0.034274686,0.000005136361,0.000014364657,0.00008852912],"about_ca_topic_score_codex":0.000028389164,"about_ca_topic_score_gemma":0.0000092058835,"teacher_disagreement_score":0.044712726,"about_ca_system_score_codex":0.000009030134,"about_ca_system_score_gemma":0.000017261696,"threshold_uncertainty_score":0.30589437},"labels":[],"label_agreement":null},{"id":"W2912471182","doi":"10.1182/blood-2018-99-119128","title":"Sphingosine-1-Phosphate Receptor 3 (S1PR3) Promotes Myeloid Commitment of Human Hematopoietic and Leukemic Stem Cells","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Biology; Stem cell; Haematopoiesis; Myeloid; Cell biology; Progenitor cell; Myelopoiesis; CD34; S1PR1; Lymphopoiesis; Myeloid leukemia; Hematopoietic stem cell; Immunology; Cancer research","score_opus":0.010759485794709662,"score_gpt":0.23143746703943643,"score_spread":0.22067798124472676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912471182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99637175,0.0027785634,0.00009184949,0.000025006684,0.00016798377,0.00021368264,0.000016254982,0.000017147142,0.0003177745],"genre_scores_gemma":[0.99812883,0.00018498779,0.00069674297,0.000085890424,0.0004175705,0.0000126966725,0.000019621713,0.00002768088,0.00042595065],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99900466,0.000040620016,0.00027671628,0.00032179718,0.00012307818,0.00023312494],"domain_scores_gemma":[0.9993371,0.0000092589735,0.00013659892,0.0003392912,0.00008904454,0.00008870939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020952885,0.00017232033,0.0002325964,0.00003466055,0.00011422559,0.000023409986,0.00017244794,0.000113625116,0.000035600402],"category_scores_gemma":[0.0000109448065,0.00015849566,0.00006420989,0.00006943778,0.00016559377,0.0000045208344,0.00013467878,0.00006272968,0.000009673228],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020005853,0.00014162081,0.0014037415,0.000072342285,0.00006540934,8.2500185e-7,0.00029352715,4.823104e-7,0.99715805,0.00012548063,0.0003133958,0.00040510588],"study_design_scores_gemma":[0.001339455,0.00040312702,0.00036388737,0.00005112609,0.00007327661,0.0000106729485,0.00011348173,0.000005411585,0.9936679,0.00004712684,0.0037474968,0.0001770603],"about_ca_topic_score_codex":0.00002818033,"about_ca_topic_score_gemma":0.0000055669007,"teacher_disagreement_score":0.0034901858,"about_ca_system_score_codex":0.0000045628426,"about_ca_system_score_gemma":0.00003622299,"threshold_uncertainty_score":0.64632654},"labels":[],"label_agreement":null},{"id":"W2912499188","doi":"10.1182/blood-2018-99-111047","title":"Validation of a Simplified International Prognostic Score (IPS-3) in Patients with Advanced Stage Hodgkin Lymphoma","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"ABVD; Medicine; Stage (stratigraphy); Internal medicine; Oncology; Chemotherapy regimen; Hazard ratio; Progression-free survival; Proportional hazards model; B symptoms; Cancer; Surgery; Lymphoma; Chemotherapy; Confidence interval; Vincristine; Cyclophosphamide","score_opus":0.010763282935626627,"score_gpt":0.24672947740824483,"score_spread":0.2359661944726182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912499188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998297,0.000020114312,0.000009892769,0.000059627087,0.000064806845,0.0005465131,0.000030827625,0.000019297353,0.0009519648],"genre_scores_gemma":[0.99882823,0.0000043162877,0.00079623755,0.00005406501,0.000042418844,0.00006122099,0.0001495773,0.0000124966655,0.000051437157],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992086,0.000014816516,0.00019755597,0.00018676158,0.00026641204,0.0001258086],"domain_scores_gemma":[0.99946284,0.000031821255,0.00010650096,0.00016729945,0.0001825537,0.000048996575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000044468918,0.00010042832,0.0001673532,0.0001005339,0.000017390097,0.000008216922,0.000055028282,0.00003571527,0.000057187615],"category_scores_gemma":[0.0000788721,0.000074147436,0.000028220544,0.00014071612,0.000039923358,0.00007417271,0.000024127961,0.000018330053,0.00001432873],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045024717,0.004160575,0.986562,0.000026200372,0.000110391586,0.000017295237,0.00018765226,0.0000021514634,0.00026732555,0.00008168334,0.000015318334,0.008119127],"study_design_scores_gemma":[0.021333998,0.0016476952,0.9339539,0.0002151381,0.000097985954,0.0000030786719,0.000037919723,0.0000090314325,0.04252696,0.000016256889,0.00008861107,0.000069462665],"about_ca_topic_score_codex":0.000024962854,"about_ca_topic_score_gemma":0.000013007566,"teacher_disagreement_score":0.05260817,"about_ca_system_score_codex":0.00006533626,"about_ca_system_score_gemma":0.00007586233,"threshold_uncertainty_score":0.30236447},"labels":[],"label_agreement":null},{"id":"W2912636441","doi":"10.1182/blood-2018-99-112307","title":"Iron Overload in Patients Aged 60 Years and Older with Acute Myeloid Leukemia May Impact Adversely on Overall Survival","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Myeloid leukemia; Myelodysplastic syndromes; Anemia; Ferritin; Bone marrow; Comorbidity; Univariate analysis; Transplantation; Surgery; Gastroenterology; Multivariate analysis","score_opus":0.006483280316009538,"score_gpt":0.2412641764136554,"score_spread":0.23478089609764588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912636441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99586296,0.00008196267,0.0000014293461,0.000041657422,0.00010769892,0.0003134432,0.000024831059,0.000028593186,0.0035374474],"genre_scores_gemma":[0.9984979,0.000081404796,0.00014895837,0.00037227813,0.0001139363,0.0000049654554,0.000039817227,0.000028486802,0.0007122503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989456,0.0000407001,0.00014219565,0.00027410543,0.00029962647,0.000297779],"domain_scores_gemma":[0.99952275,0.000016943486,0.000053179323,0.00024447215,0.00003162089,0.0001310483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009556912,0.00017677978,0.00026310954,0.000110090856,0.000035612284,0.000015650145,0.000055950026,0.00008957903,0.00013340778],"category_scores_gemma":[0.000023648096,0.00013344054,0.000043232496,0.000117722986,0.00008976172,0.00009542316,0.00002818593,0.0001638209,0.00005191355],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021653567,0.0008775845,0.99020696,0.00004781943,0.000096101365,0.0001987224,0.0012948726,0.0000037696063,0.0010439422,0.000056166362,0.0018587189,0.002149978],"study_design_scores_gemma":[0.020806633,0.0013074701,0.9767112,0.00005871161,0.00017722306,0.000006470924,0.0000623925,0.00000218789,0.00036289508,0.0000113005235,0.00033229653,0.00016119739],"about_ca_topic_score_codex":0.00045081458,"about_ca_topic_score_gemma":0.00008951233,"teacher_disagreement_score":0.018641276,"about_ca_system_score_codex":0.000044920213,"about_ca_system_score_gemma":0.00010200887,"threshold_uncertainty_score":0.5441547},"labels":[],"label_agreement":null},{"id":"W2912665906","doi":"10.1182/blood-2018-99-119088","title":"Myelofibrosis Is Initiated and Sustained By Rare Multipotent Stem Cells","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Myelofibrosis; Myeloid; Biology; Progenitor cell; Haematopoiesis; Stem cell; Cancer research; Myeloproliferative neoplasm; Bone marrow; CD34; Immunology; Genetics","score_opus":0.019564278486328714,"score_gpt":0.2544280399630079,"score_spread":0.23486376147667917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912665906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956067,0.00078137196,0.000019434667,0.001167453,0.00006079131,0.0006687927,0.00011450492,0.000071058974,0.0015098769],"genre_scores_gemma":[0.9962245,0.00026945423,0.00053249917,0.0011905086,0.00012806914,0.00008525444,0.000037782174,0.000028001168,0.0015039144],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99892414,0.000038393384,0.00021493662,0.00035033067,0.00019877555,0.00027343558],"domain_scores_gemma":[0.99923146,0.00006794139,0.00006282245,0.00023265585,0.00019117487,0.00021396807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000063342195,0.00020505834,0.00030474216,0.0000594359,0.00012921791,0.000034960816,0.00004166839,0.00009804524,0.00029193645],"category_scores_gemma":[0.000013763852,0.0001564139,0.000059293747,0.00012892278,0.0000939782,0.000051949733,0.00004795007,0.000077176126,0.000102197206],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008898273,0.008453731,0.6994203,0.00055649877,0.0024876816,0.00060267403,0.006332678,2.1265315e-7,0.14983161,0.0002697681,0.10748533,0.023669707],"study_design_scores_gemma":[0.009847998,0.0018545769,0.02217942,0.00013918347,0.00047392698,0.00003840136,0.0005663945,0.000055675213,0.951908,0.000015370348,0.012703226,0.00021783031],"about_ca_topic_score_codex":0.000043359938,"about_ca_topic_score_gemma":0.0000095390815,"teacher_disagreement_score":0.8020764,"about_ca_system_score_codex":0.000030960357,"about_ca_system_score_gemma":0.000049258266,"threshold_uncertainty_score":0.63783735},"labels":[],"label_agreement":null},{"id":"W2912674942","doi":"10.1182/blood-2018-99-113206","title":"Health Related Quality of Life and Fatigue in Patients with Pyruvate Kinase Deficiency","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; University Health Network","funders":"","keywords":"Medicine; Missense mutation; Quality of life (healthcare); Anemia; Internal medicine; Compound heterozygosity; Pediatrics; Genetics; Mutation","score_opus":0.033177411652893625,"score_gpt":0.28851984515529333,"score_spread":0.2553424335023997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912674942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987108,0.0001524953,0.00001319335,0.00020977754,0.000047153644,0.00018048847,0.0000058242413,0.000016541295,0.0006637146],"genre_scores_gemma":[0.9992475,0.00001571573,0.00025004213,0.00040857913,0.000016544785,0.0000022612153,0.000018983812,0.000005998488,0.000034370136],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992811,0.000074923155,0.00027788608,0.00014740374,0.000097665004,0.00012102825],"domain_scores_gemma":[0.9995356,0.000025965344,0.00012679808,0.0001435617,0.000080761565,0.00008729825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016576193,0.00006289097,0.00025505418,0.000060613067,0.000029105533,0.0000012027754,0.000019482139,0.000046817084,0.000035979796],"category_scores_gemma":[0.000115282055,0.000046284687,0.000013624228,0.00017230448,0.00011795272,0.000022465058,0.00001340767,0.00007974833,0.0000055777246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000493939,0.0008335902,0.99642247,0.00011562889,0.000013192425,0.0000011629111,0.00046116015,3.6907733e-7,0.000879846,0.0001851072,0.000049093072,0.000544423],"study_design_scores_gemma":[0.0068904255,0.0023650082,0.99020296,0.000058825382,0.000010059891,9.736689e-7,0.000053553857,0.000004629354,0.00029991186,0.000041793115,0.000024137016,0.000047692985],"about_ca_topic_score_codex":0.0002513985,"about_ca_topic_score_gemma":0.00008547791,"teacher_disagreement_score":0.0063964864,"about_ca_system_score_codex":0.000007829695,"about_ca_system_score_gemma":0.00008889825,"threshold_uncertainty_score":0.18874349},"labels":[],"label_agreement":null},{"id":"W2912722310","doi":"10.1182/blood-2018-170","title":"Sphingolipid Perturbation Activates Proteostasis Programs to Govern Human Hematopoietic Stem Cell Self-Renewal","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Biology; Proteostasis; Stem cell; Cell biology; Haematopoiesis; Sphingolipid; Hematopoietic stem cell; Immunology","score_opus":0.010150814684841601,"score_gpt":0.23212125905532652,"score_spread":0.2219704443704849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912722310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99689573,0.0002505358,0.00037384834,0.0000631721,0.00015390477,0.00055246765,0.00000812624,0.00008058746,0.0016216354],"genre_scores_gemma":[0.99548745,0.0000144076375,0.0016861385,0.00020361182,0.0016011251,0.00010380866,0.000054866723,0.00004776563,0.00080084254],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986265,0.00005154286,0.00024030289,0.00048434557,0.0002191516,0.00037820236],"domain_scores_gemma":[0.9991622,0.000006388969,0.0001096142,0.00042683442,0.00013014878,0.00016481802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018077566,0.00022736116,0.0001895969,0.000044854893,0.00021390554,0.000087385655,0.00026359202,0.00015695827,0.000029535378],"category_scores_gemma":[0.000018649653,0.0002115947,0.00010009255,0.00015462445,0.000046082077,0.000007750644,0.00014309827,0.00007925377,0.000059455193],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031766955,0.0004885616,0.0014697779,0.000058284753,0.00006367033,0.0000014500366,0.00088757445,0.0000016696633,0.99572945,0.000091225826,0.0001979591,0.0009786377],"study_design_scores_gemma":[0.001002721,0.0005723292,0.00024998485,0.000027106973,0.00008197004,0.000012267778,0.00020284377,0.0000055419223,0.9824424,0.000069408045,0.01504188,0.0002915667],"about_ca_topic_score_codex":0.00003698445,"about_ca_topic_score_gemma":0.00001914681,"teacher_disagreement_score":0.014843921,"about_ca_system_score_codex":0.000011999449,"about_ca_system_score_gemma":0.00005226034,"threshold_uncertainty_score":0.8628581},"labels":[],"label_agreement":null},{"id":"W2912728781","doi":"10.1182/blood-2018-99-118225","title":"Apoptotic Blocks in Primary Non-Hodgkin B-Cell Lymphomas Identified By BH3 Profiling","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Hôpital Maisonneuve-Rosemont; BC Cancer Agency; Jewish General Hospital","funders":"","keywords":"Venetoclax; Mantle cell lymphoma; Cancer research; Apoptosis; MCL1; Lymphoma; Chronic lymphocytic leukemia; B cell; Biology; Gene expression profiling; Germinal center; Peripheral blood mononuclear cell; Immunology; Leukemia; Antibody; Gene expression; Downregulation and upregulation; Gene","score_opus":0.004260882046025065,"score_gpt":0.21000995686986393,"score_spread":0.20574907482383886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912728781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865552,0.00046013453,0.0002791532,0.00004177299,0.00017774697,0.00025949773,0.000010128726,0.000017250766,0.01219912],"genre_scores_gemma":[0.99493563,0.000037813872,0.0011025746,0.0003108152,0.0003181803,0.000033770903,0.00018657022,0.000022388098,0.0030522346],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990122,0.000036942405,0.0002316278,0.0003482231,0.0001264623,0.0002445823],"domain_scores_gemma":[0.9995008,0.0000050051776,0.00007396636,0.00030134755,0.000053266987,0.0000656106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017250484,0.0001379343,0.000120938996,0.000050687264,0.000058639354,0.000030956086,0.00018337365,0.0001552154,0.00003484141],"category_scores_gemma":[0.00003991456,0.00013974978,0.000053645344,0.000118888915,0.00007183881,0.0000055553473,0.000100495396,0.000068241294,0.000046634963],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002487137,0.00031944236,0.0035290166,0.0000194396,0.000013083754,0.0000023295906,0.00002183873,4.1424136e-7,0.99109846,0.00000540104,0.004541975,0.00042374307],"study_design_scores_gemma":[0.001992847,0.00018652387,0.00089228165,0.000017006643,0.000013890039,0.0000061714763,0.000022142542,0.000019782881,0.9908845,0.000022055621,0.005763278,0.0001795193],"about_ca_topic_score_codex":0.000019240095,"about_ca_topic_score_gemma":0.000010231282,"teacher_disagreement_score":0.009146885,"about_ca_system_score_codex":0.000014314294,"about_ca_system_score_gemma":0.00008462829,"threshold_uncertainty_score":0.56988305},"labels":[],"label_agreement":null},{"id":"W2912749718","doi":"10.1182/blood.v130.suppl_1.2022.2022","title":"Impact of Carmustine (BCNU) Substitution for Bendamustine in the Conditioning Regimen Prior to Autologous Hematopoietic Cell Transplantation for the Treatment of Lymphoma","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Carmustine; Medicine; Bendamustine; Regimen; Transplantation; Hematopoietic stem cell transplantation; Internal medicine; Oncology; Surgery; Lymphoma; Chemotherapy; Rituximab; Cyclophosphamide","score_opus":0.03213510006849791,"score_gpt":0.3491480611486845,"score_spread":0.3170129610801866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912749718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952184,0.000313739,0.0010249886,0.000358559,0.00004025795,0.0027508694,0.00015025029,0.000009203435,0.0001337572],"genre_scores_gemma":[0.9982977,0.000094809344,0.0008815446,0.000012425488,0.00008425076,0.0004395104,0.00008205381,0.000014207777,0.00009350669],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990414,0.00002785348,0.0002966796,0.000179183,0.00021051394,0.0002443905],"domain_scores_gemma":[0.99846816,0.0006329412,0.00018889109,0.00051986467,0.00014082475,0.000049342954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003133292,0.0001242338,0.00029677912,0.000077372,0.00019398319,0.000017917242,0.0001983026,0.00006524107,0.000008616615],"category_scores_gemma":[0.00019183182,0.00006798212,0.00017623736,0.000080698,0.0001315109,0.000042051714,0.000008604691,0.000028837323,0.0000011733459],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.058307976,0.06042825,0.08956399,0.025265584,0.0066508306,0.001246084,0.17687425,0.01383654,0.38181502,0.009056459,0.00270941,0.1742456],"study_design_scores_gemma":[0.20892042,0.011225954,0.4082802,0.0006689396,0.0030431075,0.00074123684,0.001028457,0.00843114,0.35668805,0.00019843358,0.00047557746,0.0002985074],"about_ca_topic_score_codex":0.0011904073,"about_ca_topic_score_gemma":0.00012765007,"teacher_disagreement_score":0.3187162,"about_ca_system_score_codex":0.0010182323,"about_ca_system_score_gemma":0.0014893314,"threshold_uncertainty_score":0.27722305},"labels":[],"label_agreement":null},{"id":"W2912833910","doi":"10.1182/blood.v130.suppl_1.3500.3500","title":"Randomized, Double-Blind Trial of Ferumoxytol Compared to Ferric Carboxymaltose for Treatment of Iron Deficiency Anemia: Safety and Efficacy","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Clinical endpoint; Internal medicine; Anemia; Randomized controlled trial; Ferumoxytol; Transferrin saturation; Population; Ferritin; Iron deficiency; Adverse effect; Iron-deficiency anemia; Gastroenterology; Surgery","score_opus":0.05567864183606244,"score_gpt":0.34181751408535116,"score_spread":0.2861388722492887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912833910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896979,0.0008323459,0.00002462802,0.0008402202,0.00013855616,0.00552728,0.00003990136,0.00001874925,0.002880447],"genre_scores_gemma":[0.997299,0.0005028662,0.0013191727,0.000012732442,0.0001367809,0.00018242016,0.000034007917,0.000020389109,0.00049262104],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99863,0.000040183415,0.0005574162,0.00032005526,0.0002111483,0.00024118977],"domain_scores_gemma":[0.99853146,0.00025819647,0.0003283453,0.000610196,0.00009646988,0.00017533415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002529416,0.00022625121,0.0012352539,0.00009090923,0.00016738584,0.000017199714,0.000106038206,0.00010435616,0.000017455059],"category_scores_gemma":[0.0001446486,0.00015654859,0.00026837847,0.000051766263,0.00021865645,0.000028403036,0.000039263225,0.00003720456,0.0000024355118],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9867526,0.006378176,0.0011733527,0.0002865604,0.00013661683,0.000015224447,0.0007514654,0.0000053220706,0.0019870426,0.00023969253,0.00002264663,0.0022512982],"study_design_scores_gemma":[0.9643063,0.0048377425,0.0015331447,0.0001231529,0.001905964,0.000024572535,0.00010010345,0.00001015516,0.026864024,0.0000136820645,0.00015460204,0.00012656995],"about_ca_topic_score_codex":0.0002952807,"about_ca_topic_score_gemma":0.000029428862,"teacher_disagreement_score":0.024876982,"about_ca_system_score_codex":0.00004659532,"about_ca_system_score_gemma":0.00010837533,"threshold_uncertainty_score":0.6383866},"labels":[],"label_agreement":null},{"id":"W2912837387","doi":"10.1182/blood-2018-99-117178","title":"Duffy Antigen Phenotyping Is a Useful and Clinically Available Test for Benign Ethnic Neutropenia","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Neutropenia; Medicine; Immunology; Serology; Absolute neutrophil count; Internal medicine; Antigen; Antibody; Chemotherapy","score_opus":0.02650949967333004,"score_gpt":0.2891193065042793,"score_spread":0.26260980683094926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912837387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99330753,0.0030950755,0.00022365102,0.0001489935,0.00006764393,0.00034011353,0.00006316671,0.000015510232,0.0027383443],"genre_scores_gemma":[0.99404603,0.0006987025,0.0024265007,0.00094742747,0.00030057397,0.000038111473,0.000053991964,0.00003094863,0.0014576969],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99904764,0.000016772927,0.00019558457,0.0004239439,0.000056440753,0.00025961557],"domain_scores_gemma":[0.9994167,0.000030155927,0.000071456714,0.0003072953,0.000090043155,0.000084362626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011538299,0.000144839,0.00015602654,0.000017884666,0.0001359015,0.00003187766,0.00012306377,0.0001479942,0.00005646543],"category_scores_gemma":[0.00009340175,0.00013152862,0.00007290328,0.000054107782,0.000095231975,0.0000042834054,0.00009670079,0.00004405092,0.00006143513],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050912745,0.003651824,0.54088455,0.000103971615,0.0012111833,0.0000115349685,0.0003981272,5.299152e-7,0.4036809,0.00010668622,0.029178848,0.0202627],"study_design_scores_gemma":[0.021672344,0.008026923,0.04517785,0.00007719089,0.0007778761,0.00005226192,0.00012188859,0.00012996618,0.7380541,0.0009147308,0.18393238,0.0010624783],"about_ca_topic_score_codex":0.000021152558,"about_ca_topic_score_gemma":0.000060105478,"teacher_disagreement_score":0.4957067,"about_ca_system_score_codex":0.0000016947597,"about_ca_system_score_gemma":0.00005271183,"threshold_uncertainty_score":0.5363582},"labels":[],"label_agreement":null},{"id":"W2912877565","doi":"10.1182/blood-2018-99-109964","title":"Double Blind Randomized Control Trial of Postoperative Low Molecular Weight Heparin Bridging Therapy for Patients Who Are at High Risk for Arterial Thromboembolism (PERIOP 2)","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Mary's Hospital Centre; Jewish General Hospital; London Health Sciences Centre; McMaster University; Juravinski Hospital; Ottawa Hospital; McGill University; Victoria Hospital","funders":"","keywords":"Medicine; Warfarin; Surgery; Atrial fibrillation; Anesthesia; Randomized controlled trial; Randomization; Anticoagulant; Activated clotting time; Stroke (engine); Cardiology","score_opus":0.021507519582556967,"score_gpt":0.29715617420082724,"score_spread":0.27564865461827026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912877565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841783,0.000079692036,0.0027647025,0.0005866573,0.0010390118,0.011059366,0.00011824579,0.000034830064,0.00013917167],"genre_scores_gemma":[0.9960895,0.00007110051,0.0006211682,0.00023042671,0.0022684012,0.00019634198,0.00014570919,0.000040302522,0.0003370354],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9984546,0.00011647072,0.0005899574,0.0003176824,0.00026270683,0.00025858337],"domain_scores_gemma":[0.99850184,0.00029663122,0.00048439653,0.0002573614,0.0003860125,0.0000737729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004454814,0.00022879212,0.0013191184,0.00010346434,0.00017480424,0.000034151923,0.000086375956,0.00011745511,0.000084394174],"category_scores_gemma":[0.00029605985,0.00017014536,0.0005114922,0.00008783745,0.00012947967,0.00008816566,0.0000307195,0.000048382797,0.000006175267],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9886531,0.00023891593,0.0050044265,0.000037419748,0.0012491122,8.545749e-7,0.00037058836,0.000004211865,0.0030824523,0.000588458,0.00030183044,0.0004686295],"study_design_scores_gemma":[0.9491535,0.0019110026,0.0031010122,0.0000533649,0.0010577624,3.5669467e-7,0.000014287371,0.00038942177,0.042458177,0.00020381692,0.0014814999,0.00017579485],"about_ca_topic_score_codex":0.00003815106,"about_ca_topic_score_gemma":0.000008378343,"teacher_disagreement_score":0.039499596,"about_ca_system_score_codex":0.000024034462,"about_ca_system_score_gemma":0.00004243382,"threshold_uncertainty_score":0.69383264},"labels":[],"label_agreement":null},{"id":"W2912881431","doi":"10.1182/blood-2018-99-117528","title":"The Potential of Plant-Based Compounds As Iron Chelators","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Plant Micronutrient Interactions and Effects","field":"Agricultural and Biological Sciences","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"","keywords":"Lavandula; Chelation; Chemistry; Chlorogenic acid; Botany; Lavender; Horticulture; Biology; Food science; Organic chemistry","score_opus":0.006549577381004401,"score_gpt":0.1933997730330033,"score_spread":0.1868501956519989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912881431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980578,0.00005405598,8.7963895e-7,0.00024708157,0.00018427207,0.00006207395,0.000063731524,0.000017873926,0.0013122191],"genre_scores_gemma":[0.99955064,0.000011425734,0.00001051906,0.000058452355,0.00019590388,0.0000026237044,0.000048058944,2.9302666e-7,0.00012206281],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995953,0.000027030466,0.00008714844,0.00008537597,0.00008363852,0.00012154384],"domain_scores_gemma":[0.9997258,0.00013334485,0.000051215724,0.000033176548,0.000027441058,0.000028981678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008181929,0.000052398136,0.000057871814,0.0000043956647,0.00022626153,0.00002588272,0.00012683909,0.00003496562,0.00009348928],"category_scores_gemma":[0.000012704346,0.000015195657,0.000046850604,0.00007951004,0.000069600006,0.000026218693,0.000018689723,0.00004430104,0.000076261866],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000554199,0.00018328524,0.0016139993,0.0000022011163,0.000011247338,0.0000025059585,0.0000089878395,5.618463e-7,0.994276,0.000121024925,0.0020556883,0.0016691114],"study_design_scores_gemma":[0.00071705325,0.0014349674,0.06152818,0.000050717827,0.00006112022,0.00007635386,0.0001707607,0.00016053104,0.7722787,0.0001731908,0.16315831,0.0001900515],"about_ca_topic_score_codex":0.00012918333,"about_ca_topic_score_gemma":0.000116796095,"teacher_disagreement_score":0.22199722,"about_ca_system_score_codex":0.000003087838,"about_ca_system_score_gemma":0.000004464613,"threshold_uncertainty_score":0.17402436},"labels":[],"label_agreement":null},{"id":"W2912923795","doi":"10.1182/blood-2018-99-119318","title":"Isolation of CD34− and CD34+ Leukemia Stem Cells from Acute Myeloid Leukemia Blasts Using CD200","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"CD34; Myeloid leukemia; CD38; Population; Biology; Stem cell; Haematopoiesis; Molecular biology; clone (Java method); Leukemia; Myeloid; Flow cytometry; Immunology; Cancer research; Medicine; Cell biology; Genetics; Gene","score_opus":0.02190746870018337,"score_gpt":0.2781117039048168,"score_spread":0.2562042352046334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912923795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951237,0.00034435606,0.0021329105,0.00008530601,0.00018524185,0.0005175521,0.000090189875,0.00008517326,0.0014356014],"genre_scores_gemma":[0.9833581,0.00018784548,0.014209613,0.00018846367,0.0008603416,0.0000087807,0.000037689344,0.00007722449,0.0010719718],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99763644,0.00010107982,0.000544384,0.00058623153,0.00059058325,0.0005412643],"domain_scores_gemma":[0.99829847,0.00017222368,0.0002293291,0.00066163554,0.0003353643,0.00030299393],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031209807,0.00030826597,0.00059191056,0.00025487944,0.0001470105,0.00004223703,0.00021710433,0.00032024915,0.0001947686],"category_scores_gemma":[0.000043363703,0.00028411436,0.000111555586,0.00042350646,0.0004656554,0.00022581647,0.00023418553,0.00043056937,0.0001242347],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038725202,0.0000968378,0.009816298,0.00009323278,0.00048497086,0.00009024076,0.00080307387,0.00000871087,0.9835334,0.000029218383,0.001048201,0.0036085593],"study_design_scores_gemma":[0.008574027,0.0008166543,0.014357346,0.0003333483,0.0010334564,0.00017961032,0.0003093004,0.013774353,0.95909655,0.000098517005,0.0010651837,0.00036165144],"about_ca_topic_score_codex":0.00073753146,"about_ca_topic_score_gemma":0.000043486227,"teacher_disagreement_score":0.024436852,"about_ca_system_score_codex":0.0007112226,"about_ca_system_score_gemma":0.001185355,"threshold_uncertainty_score":0.9999611},"labels":[],"label_agreement":null},{"id":"W2912934187","doi":"10.1182/blood-2018-99-114484","title":"Results of the Primary Analysis of Complement A+B: A Phase III Study of Ofatumumab in Combination with Bendamustine Versus Bendamustine Alone in Patients with Indolent Non-Hodgkin's Lymphoma That Is Unresponsive Following Rituximab or Rituximab-Containing Regimen","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Bendamustine; Medicine; Ofatumumab; Rituximab; Regimen; Internal medicine; Phases of clinical research; Gastroenterology; Clinical endpoint; Lymphoma; Surgery; Chemotherapy; Clinical trial","score_opus":0.02245756639100244,"score_gpt":0.2913779166618864,"score_spread":0.26892035027088396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912934187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970068,0.00005332939,0.0000073263163,0.00009870466,0.000054937547,0.0024003596,0.00018390974,0.000010933237,0.00018372518],"genre_scores_gemma":[0.9990376,0.0000061050696,0.00050975126,0.00005077113,0.000012665198,0.00011265493,0.00023004966,0.00002834983,0.000012055538],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968214,0.00018331695,0.0010405226,0.00053991086,0.0010711721,0.00034366234],"domain_scores_gemma":[0.99741846,0.0003484356,0.0009591419,0.00075127865,0.0004387631,0.00008388911],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004899926,0.0003430504,0.0015063698,0.00079700776,0.00007644696,0.000009772951,0.0002058141,0.00007363996,0.000017810426],"category_scores_gemma":[0.00011386331,0.00021103442,0.00016330513,0.0020032402,0.00014943746,0.00011433573,0.0001605804,0.00009375384,4.2934167e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11343155,0.11028772,0.75490487,0.00009210504,0.0062412685,0.00013476818,0.011688967,0.00002381153,0.00014460381,0.000007093731,0.000019822302,0.0030234281],"study_design_scores_gemma":[0.39244178,0.022849083,0.5687622,0.0006410067,0.005062003,0.000001652962,0.0026566458,0.00010930831,0.007343748,6.3534907e-7,0.0000047988888,0.00012714101],"about_ca_topic_score_codex":0.0026107258,"about_ca_topic_score_gemma":0.0035890401,"teacher_disagreement_score":0.27901024,"about_ca_system_score_codex":0.0003414093,"about_ca_system_score_gemma":0.00034613904,"threshold_uncertainty_score":0.8605734},"labels":[],"label_agreement":null},{"id":"W2912934447","doi":"10.1182/blood-2018-99-118594","title":"Loss-of-Function Mutation in tet2 in Zebrafish Leads to Early MDS like Phenotype","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Zebrafish; Biology; GATA1; Myeloid leukemia; Phenotype; Mutant; Myeloid; Cancer research; Haematopoiesis; Leukemia; Genetics; Mutation; Molecular biology; Loss function; Gene; Stem cell","score_opus":0.01829648522703515,"score_gpt":0.2912914208634463,"score_spread":0.27299493563641114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912934447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947733,0.000049383623,0.00014182401,0.00051092025,0.00011751139,0.00042558843,0.0000026533237,0.000030848125,0.0039479407],"genre_scores_gemma":[0.99789363,0.000004665982,0.0008662654,0.00034774703,0.00026469337,0.000026993917,0.000013990332,0.000023829287,0.00055820425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988478,0.000053566964,0.00027023384,0.00024419415,0.00030758395,0.00027664282],"domain_scores_gemma":[0.9993735,0.00005734844,0.000041212457,0.00026393673,0.00016535491,0.00009864918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003520884,0.000098516524,0.00021247468,0.00041700847,0.000019682773,0.000010481159,0.0000971906,0.00011728173,0.00014253047],"category_scores_gemma":[0.00028429276,0.000094910174,0.00003086193,0.00084192026,0.00007795221,0.00010438668,0.000051554867,0.00024035612,0.00033674436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018561856,0.0012631617,0.78501505,0.00016862573,0.000068251895,0.00028893235,0.0040047276,0.000013328322,0.19421943,0.0003368444,0.0015260063,0.011239449],"study_design_scores_gemma":[0.0068717245,0.0024081368,0.938606,0.0001725256,0.00005209823,0.00002618564,0.0001478666,0.00012486216,0.050142482,0.00026943506,0.0010392034,0.00013945908],"about_ca_topic_score_codex":0.0006777358,"about_ca_topic_score_gemma":0.0005308004,"teacher_disagreement_score":0.15359096,"about_ca_system_score_codex":0.00013573279,"about_ca_system_score_gemma":0.00020065448,"threshold_uncertainty_score":0.43282795},"labels":[],"label_agreement":null},{"id":"W2912951041","doi":"10.1182/blood-2018-99-110258","title":"Donor T Cells Require Notch Signals but Not Alloantigen Presentation from Specialized Secondary Lymphoid Organ Fibroblasts to Drive Graft-Versus-Host Disease","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Reticular cell; Stromal cell; Bone marrow; Biology; Haematopoiesis; Immunology; High endothelial venules; T cell; Myeloid; Lymphatic system; Stem cell; Pathology; Cancer research; Cell biology; Immune system; Spleen; Medicine","score_opus":0.012884810804562451,"score_gpt":0.23506561227358663,"score_spread":0.2221808014690242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912951041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923433,0.00072738074,0.00011788927,0.0005241001,0.0028854273,0.0006880468,0.0008735969,0.0001921925,0.001648051],"genre_scores_gemma":[0.98887384,0.000097271324,0.0003407822,0.00069520733,0.0007064722,0.000051601797,0.0007041941,0.000056150206,0.008474462],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99734795,0.00035709754,0.00056339917,0.00087494863,0.00009867491,0.00075790635],"domain_scores_gemma":[0.9983673,0.0003152564,0.00023756904,0.00072215975,0.00020336838,0.0001543161],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00013803794,0.00043475121,0.00053099403,0.00017932407,0.00042210252,0.00006459965,0.00061173516,0.0004119164,0.009010359],"category_scores_gemma":[0.00010541478,0.00041857056,0.00019874788,0.00024433198,0.00047405463,0.00027291707,0.00036285285,0.00026840655,0.009014659],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032426657,0.00063450495,0.0007155838,0.00001768769,0.0006919515,0.000047584857,0.0009750343,0.0000011873434,0.98533225,0.00008396689,0.0077242767,0.0005332904],"study_design_scores_gemma":[0.010050463,0.0006631718,0.0031097443,0.00004612568,0.00030256686,0.000012618883,0.0002568588,0.0000011603346,0.927659,0.00010759522,0.057306837,0.00048387758],"about_ca_topic_score_codex":0.0010018117,"about_ca_topic_score_gemma":0.00039660788,"teacher_disagreement_score":0.057673283,"about_ca_system_score_codex":0.000054092594,"about_ca_system_score_gemma":0.00028108957,"threshold_uncertainty_score":0.9998266},"labels":[],"label_agreement":null},{"id":"W2912988019","doi":"10.1182/blood-2018-99-110997","title":"Inherited Thrombophilia and the Risk of Arterial Ischemic Stroke: A Systematic Review and Meta-Analysis","year":2018,"lang":"en","type":"review","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Thrombophilia; Stroke (engine); Internal medicine; Meta-analysis; Factor V Leiden; Protein S deficiency; Thrombosis; Cochrane Library; Venous thrombosis; Guideline; Pediatrics; Cardiology; Pathology","score_opus":0.06777147726274517,"score_gpt":0.3243762395591432,"score_spread":0.256604762296398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912988019","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000049057813,0.9957565,0.00001754987,0.00007135045,0.000029366813,0.0036771158,0.00019748772,0.000025256408,0.00017632301],"genre_scores_gemma":[0.00025220466,0.99856067,0.0002557324,0.00019211129,0.00005700786,0.00034559667,0.000059194845,0.00003628479,0.0002412006],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9968478,0.0008731346,0.0013389159,0.00044093176,0.00033738787,0.00016183044],"domain_scores_gemma":[0.9970468,0.00029085542,0.00142765,0.0009814552,0.00014795506,0.00010526352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014375768,0.0004504893,0.011540217,0.00017954325,0.000067694884,0.000031110743,0.00016351984,0.00023991328,0.00027210393],"category_scores_gemma":[0.00037798646,0.00021430662,0.0023143298,0.0005871031,0.00023847805,0.00003310067,0.000107080115,0.00025925424,0.000012477711],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000045581523,0.000101679405,7.705168e-7,0.63900775,0.36056373,0.0000014015036,0.00003686816,1.5379837e-9,0.0000031394227,0.00014656073,0.00006766592,0.00006586783],"study_design_scores_gemma":[0.0012857063,0.000074127674,0.000002464007,0.024608029,0.969986,0.00009703648,0.000009276462,0.000002249567,0.000006334896,0.000024597495,0.0037368233,0.00016736123],"about_ca_topic_score_codex":0.000017732702,"about_ca_topic_score_gemma":0.0000069102007,"teacher_disagreement_score":0.61439973,"about_ca_system_score_codex":0.000006658613,"about_ca_system_score_gemma":0.00006589135,"threshold_uncertainty_score":0.87391704},"labels":[],"label_agreement":null},{"id":"W2913001468","doi":"10.1182/blood-2018-99-118455","title":"Enhanced Zebrafish Xenograft Platform Improves Hematopoietic Stem Cell Engraftment and Leukemogenesis","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Zebrafish Biomedical Research Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Zebrafish; Stem cell; Haematopoiesis; Biology; Cancer research; Stem cell factor; Leukemia; Immunology; Cytokine; Bone marrow; Transplantation; Hematopoietic stem cell; Xenotransplantation; Cell biology; Medicine; Internal medicine","score_opus":0.009380486964555448,"score_gpt":0.24806362494300477,"score_spread":0.2386831379784493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913001468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99481404,0.0007315638,0.0013371268,0.0001591267,0.000037164868,0.0003657287,0.000023066325,0.000031711785,0.0025005005],"genre_scores_gemma":[0.99738556,0.0002500555,0.00080184406,0.00025220233,0.00027343296,0.00015183202,0.00004802494,0.000027925918,0.0008091379],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986897,0.000022726961,0.00020538368,0.0004558984,0.00023163027,0.00039464104],"domain_scores_gemma":[0.99908155,0.000022649172,0.000060852006,0.0004553512,0.000101284655,0.00027830043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016143332,0.00016717656,0.00014125115,0.00004992443,0.00015586884,0.00004844672,0.00025049553,0.00015525911,0.00003402915],"category_scores_gemma":[0.000028818367,0.00015107499,0.00006167219,0.00014191178,0.00031269455,0.000005414495,0.00024672874,0.000077850615,0.00006044035],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021023854,0.00024780675,0.00006989831,0.000035975347,0.00005243329,0.0000014699174,0.00007187124,2.6940615e-8,0.99214154,0.00006320424,0.000827048,0.00646771],"study_design_scores_gemma":[0.0011495791,0.000592421,0.00092447404,0.000009170973,0.000033799282,0.000011857379,0.000114264745,0.000008335038,0.98156875,0.000114463735,0.015296348,0.00017654817],"about_ca_topic_score_codex":0.0000114276445,"about_ca_topic_score_gemma":0.00002634596,"teacher_disagreement_score":0.0144693,"about_ca_system_score_codex":0.000011930564,"about_ca_system_score_gemma":0.00010345769,"threshold_uncertainty_score":0.6160659},"labels":[],"label_agreement":null},{"id":"W2913060591","doi":"10.1182/blood-2018-99-110622","title":"White Blood Cell Count Trajectory and Mortality in Septic Shock: A Retrospective Cohort Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Sepsis Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Septic shock; Medicine; Retrospective cohort study; Population; White blood cell; Shock (circulatory); Trajectory; Cohort; Emergency medicine; Cohort study; Intensive care; Sepsis; Internal medicine; Intensive care medicine","score_opus":0.030184666773368663,"score_gpt":0.3030670282976031,"score_spread":0.27288236152423445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913060591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98994595,0.0004688174,5.0133565e-7,0.000044272627,0.00007653341,0.0012706327,0.000011285189,0.00004531851,0.008136662],"genre_scores_gemma":[0.9991774,0.00008388037,0.000073743555,0.0001484097,0.00014954069,0.00016186558,0.000007305081,0.000023314838,0.00017454628],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986346,0.000056210527,0.00025262765,0.00048122424,0.00032749333,0.0002478915],"domain_scores_gemma":[0.9992981,0.00003471734,0.00006152745,0.00038828445,0.000091343674,0.00012600397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029955563,0.00019079665,0.00044243797,0.000090371446,0.000057421283,0.000020815305,0.000048735463,0.000070310685,0.0001917913],"category_scores_gemma":[0.000032452554,0.00015737064,0.000057854762,0.00018757895,0.00008522175,0.00004337723,0.000035502315,0.00013631862,0.000027596023],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026171772,0.012060603,0.985499,0.00002500529,0.0004883722,0.0002584906,0.0013360494,1.1202259e-7,0.00019064777,0.000007064172,0.00008919959,0.00001924728],"study_design_scores_gemma":[0.008720447,0.0026649728,0.98323345,0.000049191487,0.001993848,0.000029397343,0.00044095074,0.0000072116313,0.0026805871,0.000021782862,0.000016942424,0.0001412351],"about_ca_topic_score_codex":0.00035057415,"about_ca_topic_score_gemma":0.0015618249,"teacher_disagreement_score":0.009395631,"about_ca_system_score_codex":0.000078520534,"about_ca_system_score_gemma":0.00006232033,"threshold_uncertainty_score":0.64173883},"labels":[],"label_agreement":null},{"id":"W291306460","doi":"10.1182/blood-2015-03-630855","title":"Fibronectin: extra domain brings extra risk?","year":2015,"lang":"en","type":"letter","venue":"Blood","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services","funders":"","keywords":"Fibronectin; Thrombosis; Platelet; In vivo; In vitro; Cell biology; Medicine; Chemistry; Biology; Computational biology; Immunology; Internal medicine; Extracellular matrix; Genetics; Biochemistry","score_opus":0.030557334573355115,"score_gpt":0.28750276185889234,"score_spread":0.2569454272855372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W291306460","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22028928,0.008892382,0.0002581187,0.6290056,0.0008596246,0.0035024835,0.00027007767,0.0008114481,0.13611098],"genre_scores_gemma":[0.006462877,0.0013747787,0.019162636,0.6183118,0.032688506,0.0004028618,0.0023157771,0.0013441638,0.3179366],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955981,0.00026170202,0.00049389066,0.0009110367,0.0017820727,0.00095322466],"domain_scores_gemma":[0.99751776,0.00024424389,0.00022703786,0.0013227717,0.00028994065,0.00039823528],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00062656513,0.0005127188,0.00080506963,0.00039781615,0.00010004717,0.00008455582,0.0004472668,0.0012127633,0.001654259],"category_scores_gemma":[0.00047806778,0.00046359655,0.00036001956,0.00033280102,0.00016253882,0.00005122541,0.00025930174,0.004561932,0.0020573614],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000591628,0.00025361532,0.00097586494,0.00048290947,0.00025200442,0.007867448,0.00012023273,1.602196e-7,0.0051590996,0.0000024363508,0.9831328,0.0016943039],"study_design_scores_gemma":[0.0040555582,0.0005163253,0.0009266262,0.00029255424,0.0004699986,0.0011186405,0.000028525947,0.000004142382,0.0037998906,0.00028447452,0.9880454,0.00045788242],"about_ca_topic_score_codex":0.00023164484,"about_ca_topic_score_gemma":0.000008173382,"teacher_disagreement_score":0.21382639,"about_ca_system_score_codex":0.00014875752,"about_ca_system_score_gemma":0.0005398137,"threshold_uncertainty_score":0.99978155},"labels":[],"label_agreement":null},{"id":"W2913122734","doi":"10.1182/blood-2018-99-119964","title":"Targeting β3 Integrin Psi Domain Inhibits Both Platelet Aggregation and Blood Coagulation: Two Birds with One Stone","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Axon Guidance and Neuronal Signaling","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Integrin; Platelet; Fibrin; Chemistry; Fibrinogen; Coagulation; Biochemistry; Clot retraction; Platelet activation; Molecular biology; Immunology; Biology; Thrombin; Medicine; Internal medicine; Receptor","score_opus":0.02474047284834801,"score_gpt":0.25578213519221016,"score_spread":0.23104166234386214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913122734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970822,0.00013096341,0.0013779437,0.00018464394,0.00007248091,0.0002745117,0.00000806988,0.00014115548,0.00072807656],"genre_scores_gemma":[0.9961377,0.00004172889,0.0027482193,0.0005011803,0.00043315868,0.000015684782,0.000004217261,0.000037303384,0.00008083014],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983158,0.000114288036,0.00029215467,0.00053600984,0.00040410284,0.0003376415],"domain_scores_gemma":[0.999296,0.00015072337,0.00019278919,0.00018760115,0.000062916966,0.00010993456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027001192,0.00020190985,0.0002062795,0.00009706233,0.00035588437,0.00008895573,0.00014041076,0.000065372325,0.00006073719],"category_scores_gemma":[0.00014346432,0.00017599162,0.000025918851,0.000382526,0.00025265687,0.00039515074,0.00008034883,0.00021566245,0.00003539707],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010370082,0.00027801562,0.0031518089,0.00002047008,0.000016449343,0.00005756889,0.00059255067,0.0000353837,0.9927377,0.0013956504,0.000022213793,0.0015884609],"study_design_scores_gemma":[0.0031101117,0.0005869809,0.0008477287,0.00016070463,0.0000471874,0.00016404843,0.000066472494,0.00029462186,0.9935603,0.00064017903,0.00026911029,0.00025252692],"about_ca_topic_score_codex":0.000036046273,"about_ca_topic_score_gemma":0.000035388533,"teacher_disagreement_score":0.003006411,"about_ca_system_score_codex":0.000011175521,"about_ca_system_score_gemma":0.000054947803,"threshold_uncertainty_score":0.717673},"labels":[],"label_agreement":null},{"id":"W2913164552","doi":"10.1182/blood-2018-99-116589","title":"Splicing Factor Pathway Is Rarely Mutated in Myeloid Blast Phase of PV with Dysmyelopoiesis and Ring Sideroblast","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Dysplasia; Medicine; Somatic evolution in cancer; Ring chromosome; Mutation; Biology; Pathology; Internal medicine; Cancer; Genetics; Karyotype; Gene; Chromosome","score_opus":0.011236996478659837,"score_gpt":0.24485394014829184,"score_spread":0.233616943669632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913164552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962303,0.000337968,0.000063537955,0.00023551453,0.000030022886,0.0002904028,0.000021700109,0.00004881794,0.0027417222],"genre_scores_gemma":[0.9990442,0.0001011256,0.00049199007,0.0001611818,0.000042350595,0.0000059357153,0.0000061752567,0.000032269676,0.000114802635],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988989,0.000021848067,0.00032190245,0.00027806524,0.00018585002,0.00029340462],"domain_scores_gemma":[0.999422,0.000040978917,0.00010650558,0.0002046875,0.00009542265,0.00013037835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000080698126,0.00018524968,0.00036386115,0.00017698423,0.00006504747,0.000013377708,0.00005275428,0.00012709666,0.00016844033],"category_scores_gemma":[0.000052841093,0.0001386122,0.000037714104,0.0003619543,0.00020736692,0.00007424415,0.00004035281,0.00018733839,0.000012205699],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019719477,0.004186004,0.09036911,0.0012905933,0.0009438783,0.0007849049,0.03038734,0.0000129324135,0.83641696,0.00006610426,0.00021552565,0.03335472],"study_design_scores_gemma":[0.037447367,0.0039380062,0.042749148,0.0021471772,0.0002932864,0.00043076754,0.005115373,0.0008330157,0.905892,0.000036392925,0.00061367184,0.0005037862],"about_ca_topic_score_codex":0.00017141388,"about_ca_topic_score_gemma":0.00008312809,"teacher_disagreement_score":0.06947507,"about_ca_system_score_codex":0.000016104976,"about_ca_system_score_gemma":0.00009023791,"threshold_uncertainty_score":0.5652442},"labels":[],"label_agreement":null},{"id":"W2913197449","doi":"10.1182/blood-2018-99-116795","title":"Reduced Intensity Conditioning (RIC) Regimens Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia (AML): A Comparison of Fludarabine/Busulfan (FB) and Fludarabine/Melphalan (FM) Based Regimens from the CIBMTR","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Fludarabine; Internal medicine; Busulfan; Melphalan; Transplantation; Alemtuzumab; Oncology; Gastroenterology; Proportional hazards model; Surgery; Hematopoietic stem cell transplantation; Cyclophosphamide; Chemotherapy","score_opus":0.02312116928575433,"score_gpt":0.30142788708525686,"score_spread":0.27830671779950256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913197449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904327,0.0003935634,0.0032126273,0.0026111468,0.00016432036,0.0017605716,0.00038994756,0.00013453387,0.00090059557],"genre_scores_gemma":[0.99024063,0.00009375913,0.0070284093,0.00066040835,0.00045585618,0.00010450271,0.0010022436,0.000087500004,0.00032670694],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99692607,0.00017883889,0.00081231777,0.00078321976,0.00063672394,0.0006628402],"domain_scores_gemma":[0.996848,0.0007948422,0.00042186273,0.00089656055,0.00073766033,0.0003010998],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006316849,0.0004372679,0.0009888604,0.00020849233,0.00044358103,0.000063785184,0.00034212958,0.00029788786,0.00010418115],"category_scores_gemma":[0.00022753734,0.00034713635,0.00022214801,0.00045714455,0.0007076684,0.00015031123,0.00007920373,0.00057930296,0.000031245392],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037599797,0.00070455496,0.013915769,0.0005597748,0.0009371378,0.000105423154,0.0075213765,0.000014113545,0.9564254,0.00018135733,0.015345848,0.0005292124],"study_design_scores_gemma":[0.017146247,0.0018851853,0.029041657,0.00052861025,0.0028660542,0.00021831726,0.0016317826,0.004274063,0.9411046,0.00029362552,0.00057447806,0.00043540276],"about_ca_topic_score_codex":0.0003969502,"about_ca_topic_score_gemma":0.00006304137,"teacher_disagreement_score":0.015320876,"about_ca_system_score_codex":0.00024961247,"about_ca_system_score_gemma":0.00065656455,"threshold_uncertainty_score":0.9998981},"labels":[],"label_agreement":null},{"id":"W2913199767","doi":"10.1182/blood-2018-99-119045","title":"T Cells Engineered with T Cell Antigen Coupler (TAC) Receptors for Haematological Malignancies","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Therapeutics (Canada); McMaster University","funders":"","keywords":"Chimeric antigen receptor; Cytotoxic T cell; Antigen; Cancer research; T-cell receptor; Immunology; Biology; T cell; Cytokine; CD19; Antigen-presenting cell; Molecular biology; Immune system; In vitro; Biochemistry","score_opus":0.025981840969429938,"score_gpt":0.2740505944299949,"score_spread":0.24806875346056498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913199767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99215114,0.00025954115,0.000512072,0.00024040852,0.00015735728,0.0009640529,0.000015076377,0.000116978146,0.0055833845],"genre_scores_gemma":[0.97786605,0.00010548687,0.007216993,0.00015476684,0.00043059184,0.000088554916,0.000025829271,0.00005676325,0.014054957],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99865395,0.000022713726,0.00019084928,0.00032634477,0.00032991768,0.0004762358],"domain_scores_gemma":[0.9990395,0.00011747579,0.00004429591,0.00036707488,0.00025011683,0.0001815476],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021642755,0.00018118188,0.00035704504,0.0000890373,0.00008331068,0.000025318113,0.00013949079,0.0001369973,0.002698679],"category_scores_gemma":[0.00004097654,0.00012670194,0.000097471086,0.00021238743,0.0002027925,0.000036738693,0.000035126846,0.00014020204,0.00016142725],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005746612,0.00073348125,0.012949446,0.0001807962,0.00015379074,0.00005979863,0.0003220723,0.0000013772773,0.97801673,0.00007106216,0.006529969,0.0004068244],"study_design_scores_gemma":[0.004779085,0.0021742273,0.0017237054,0.00006137382,0.000095902964,0.00009646508,0.00009141072,0.00009143379,0.94266534,0.000021882273,0.048016567,0.00018258799],"about_ca_topic_score_codex":0.000011747583,"about_ca_topic_score_gemma":0.000009236171,"teacher_disagreement_score":0.0414866,"about_ca_system_score_codex":0.00002114667,"about_ca_system_score_gemma":0.00010232071,"threshold_uncertainty_score":0.998213},"labels":[],"label_agreement":null},{"id":"W2913290054","doi":"10.1182/blood-2018-99-110798","title":"Bosutinib or Imatinib in Older Vs Younger Patients with Newly Diagnosed Chronic Myeloid Leukemia in the Phase 3 BFORE Trial","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Bosutinib; Medicine; Imatinib; Internal medicine; Population; Adverse effect; Myeloid leukemia; Imatinib mesylate; Surgery; Oncology; Gastroenterology; Nilotinib","score_opus":0.015334596920880966,"score_gpt":0.28505220632130956,"score_spread":0.2697176094004286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913290054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99399495,0.00015697024,0.0000054938696,0.00024433833,0.0002161693,0.003693642,0.00003800051,0.00006193894,0.0015885148],"genre_scores_gemma":[0.9967349,0.000037437705,0.00042409767,0.0007049151,0.0008971271,0.0005070249,0.00021853475,0.00006830576,0.00040766317],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99721545,0.00015281465,0.00064509927,0.0005840061,0.00067239645,0.00073025626],"domain_scores_gemma":[0.9984279,0.0002705947,0.00021071837,0.0008417944,0.00010306066,0.00014587611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037810652,0.00040482444,0.0006013568,0.00020496812,0.0000976494,0.000043586548,0.0003093074,0.00019896802,0.00081035536],"category_scores_gemma":[0.00030274122,0.00022988756,0.000099200755,0.0006864824,0.00021310557,0.00021025592,0.00006462748,0.0004463079,0.0001548935],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2896604,0.04987022,0.55684257,0.00083956274,0.0014686368,0.005419876,0.025997078,0.000025829011,0.0008654268,0.0001561987,0.013894077,0.054960154],"study_design_scores_gemma":[0.7916632,0.012916327,0.18935838,0.0006023846,0.00042099183,0.00006612856,0.0002570028,0.00014576515,0.0010867782,0.000014317225,0.0031102786,0.0003584264],"about_ca_topic_score_codex":0.00056837866,"about_ca_topic_score_gemma":0.0017729118,"teacher_disagreement_score":0.50200284,"about_ca_system_score_codex":0.0017781766,"about_ca_system_score_gemma":0.0023273549,"threshold_uncertainty_score":0.9374543},"labels":[],"label_agreement":null},{"id":"W2913302924","doi":"10.1182/blood-2018-99-117531","title":"Immunome Single Cell Profiling Reveals T Cell Exhaustion with Upregulation of Checkpoint Inhibitors LAG3 and Tigit on Marrow Infiltrating T Lymphocytes in Daratumumab and IMiDs Resistant Patients","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Daratumumab; TIGIT; Pomalidomide; CD38; Bone marrow; Immunotherapy; Biology; Cancer research; Immunology; Immune system; Antibody; Multiple myeloma; Monoclonal antibody; CD34; Stem cell; Lenalidomide","score_opus":0.012237757286525952,"score_gpt":0.2354026129571714,"score_spread":0.22316485567064545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913302924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969261,0.00026780897,0.0000025039087,0.0000136101435,0.000016998403,0.00062862644,0.000013760227,0.00001581281,0.002114752],"genre_scores_gemma":[0.99770564,0.000020541735,0.0020407564,0.000007173539,0.00004190434,0.000019787762,0.000059987586,0.000019434423,0.00008478855],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988613,0.000048161266,0.00031788912,0.00026900184,0.00028256734,0.000221079],"domain_scores_gemma":[0.99938095,0.000053648422,0.00015568094,0.00017735364,0.0001386545,0.000093730436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017211246,0.00014835614,0.00023062697,0.00015777923,0.00007765233,0.000026082707,0.000029133718,0.00007116487,0.000006436968],"category_scores_gemma":[0.00007662284,0.00011570696,0.000020076217,0.00017079331,0.0000980721,0.00011241864,0.00003343265,0.00008376508,0.0000019757197],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013549567,0.0010095354,0.538782,0.00030946004,0.000025270298,0.00001427855,0.00036109463,0.0000016529572,0.45720345,0.000007489805,0.000003118652,0.0009276531],"study_design_scores_gemma":[0.009360002,0.0029778616,0.36524525,0.00051562506,0.00004109271,0.000004687681,0.000107654334,0.0000992231,0.62154347,0.000017154594,0.000003394706,0.00008456466],"about_ca_topic_score_codex":0.00010354189,"about_ca_topic_score_gemma":0.000027492622,"teacher_disagreement_score":0.17353676,"about_ca_system_score_codex":0.00008223608,"about_ca_system_score_gemma":0.000059074875,"threshold_uncertainty_score":0.47183925},"labels":[],"label_agreement":null},{"id":"W2913322643","doi":"10.1182/blood-2018-99-115370","title":"Slit-Robo Pathway Is Clinically Relevant and May Represent a Potential Target in Acute Promyelocytic Leukemia","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Acute promyelocytic leukemia; Cancer research; Arsenic trioxide; Annexin A5; Promyelocytic leukemia protein; Medicine; Bone marrow; Differentiation therapy; Cell growth; Cell cycle; Progenitor cell; Leukemia; Immunology; Stem cell; Apoptosis; Biology; Cell culture; Annexin; Internal medicine; Cancer; Cell biology; Flow cytometry","score_opus":0.007066961688592632,"score_gpt":0.2533104579737238,"score_spread":0.24624349628513117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913322643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99564695,0.0010310839,0.00051075016,0.00020979693,0.00013849545,0.0002411423,0.000016786931,0.000018637997,0.0021863491],"genre_scores_gemma":[0.9929588,0.0006710011,0.0036341313,0.00036975776,0.00050184637,0.000034930363,0.000048393813,0.00003063004,0.0017505141],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983046,0.000079680736,0.00042441487,0.00066201465,0.0001739386,0.00035532223],"domain_scores_gemma":[0.99914455,0.000013177178,0.00011895587,0.0005018294,0.00010665954,0.00011481341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032747295,0.0002017575,0.00023168452,0.000041807918,0.000078196645,0.00004357411,0.0002498384,0.00028621877,0.000042676787],"category_scores_gemma":[0.00015638652,0.0001796679,0.00008595702,0.000105464685,0.00024350428,0.000006386599,0.0002575519,0.00017717731,0.000024960862],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003030806,0.0002609334,0.017212382,0.00009302495,0.00019765724,0.00018621891,0.00025506222,0.000005643194,0.977943,0.000057354242,0.0015123566,0.0019732781],"study_design_scores_gemma":[0.002906829,0.001077057,0.002552226,0.00005377122,0.00009143588,0.00021222961,0.00006526398,0.00018185693,0.9759498,0.00068975746,0.015844863,0.0003748632],"about_ca_topic_score_codex":0.000021423157,"about_ca_topic_score_gemma":0.0000060437665,"teacher_disagreement_score":0.014660155,"about_ca_system_score_codex":0.00002135474,"about_ca_system_score_gemma":0.00036774084,"threshold_uncertainty_score":0.7326644},"labels":[],"label_agreement":null},{"id":"W2913397271","doi":"10.1182/blood-2018-99-110934","title":"Glasdegib in Addition to Intensive or Non-Intensive Chemotherapy in Patients with Acute Myeloid Leukemia: Safety Analysis of Glasdegib 'On Target' Adverse Events","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada); Juravinski Hospital","funders":"","keywords":"Medicine; Cytarabine; Internal medicine; Adverse effect; Myeloid leukemia; Oncology; Intensive care; Dysgeusia; Tolerability; Smoothened; Intensive care medicine; Hedgehog","score_opus":0.006101621967110521,"score_gpt":0.23452339151291868,"score_spread":0.22842176954580815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913397271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985769,0.000013408345,0.0003321346,0.0000911162,0.000076488606,0.0004806402,0.00028496215,0.000008202859,0.00013616585],"genre_scores_gemma":[0.9970732,0.000036660997,0.00079149543,0.0014223037,0.00007585801,0.0000428708,0.00042669007,0.00003119014,0.00009976705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984537,0.000058601086,0.00039173156,0.0005374867,0.00022935569,0.00032915347],"domain_scores_gemma":[0.99830884,0.000027034543,0.00017601237,0.00039314752,0.0010146224,0.00008035953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012868695,0.0002625571,0.000498099,0.00036139137,0.00004381136,0.0000031171874,0.00018919761,0.00016437337,0.000036000256],"category_scores_gemma":[0.00027373905,0.00021068528,0.00011783488,0.0008741152,0.000107264656,0.000007951939,0.00009864576,0.000118204145,0.00001322705],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02705485,0.0022793612,0.72096574,0.000068954025,0.010832147,0.00012354848,0.0060938857,0.0019369674,0.22695892,0.000010557428,0.0019693177,0.0017057664],"study_design_scores_gemma":[0.009759564,0.0044520586,0.65472764,0.000189404,0.00051500293,0.0000021684075,0.00097014534,0.00009209889,0.3280757,0.0000066974694,0.0007642387,0.00044526582],"about_ca_topic_score_codex":0.00007430915,"about_ca_topic_score_gemma":0.0007390707,"teacher_disagreement_score":0.10111678,"about_ca_system_score_codex":0.00008900846,"about_ca_system_score_gemma":0.0001299621,"threshold_uncertainty_score":0.85914963},"labels":[],"label_agreement":null},{"id":"W2913523295","doi":"10.1182/blood-2018-99-112949","title":"A Feasibility Randomized Trial of Red Cell Transfusion Thresholds in Myelodysplasia","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Red Cell; Blood transfusion; Randomization; Hemoglobin; Randomized controlled trial; Surgery; Pediatrics; Internal medicine","score_opus":0.011847124724755702,"score_gpt":0.25734215862396226,"score_spread":0.24549503389920654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913523295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96850634,0.0002524177,0.000025110852,0.0004173244,0.00019944287,0.0019007728,0.0000029017956,0.00002971282,0.028665999],"genre_scores_gemma":[0.99897623,0.0003835607,0.00022923724,0.00005532008,0.00009977277,0.000024365945,0.0000068195145,0.000013156563,0.00021155136],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9987326,0.00013421847,0.0004968749,0.0002295776,0.00021303832,0.00019363944],"domain_scores_gemma":[0.99939746,0.00008220989,0.00008173299,0.00028908756,0.000070737806,0.000078789235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075688976,0.00011965029,0.00062821014,0.00010289438,0.000030616975,0.0000035863188,0.000064159394,0.00021449826,0.00018333166],"category_scores_gemma":[0.00019749174,0.000085785534,0.00021299139,0.0002588474,0.00022979725,0.000027760845,0.000015189477,0.00018176112,0.000011095171],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9518567,0.0037382504,0.0051464345,0.0001312019,0.00006328614,0.000025097748,0.0009797773,6.3371476e-7,0.037415493,0.00004911277,0.00011489852,0.00047912254],"study_design_scores_gemma":[0.9683559,0.0010258146,0.0012153328,0.000108839595,0.00029726367,0.000013179838,0.00011976522,0.000062788684,0.028324123,0.00028347826,0.000107682725,0.00008584587],"about_ca_topic_score_codex":0.000117153526,"about_ca_topic_score_gemma":0.00005005586,"teacher_disagreement_score":0.030469898,"about_ca_system_score_codex":0.000013913415,"about_ca_system_score_gemma":0.000108834625,"threshold_uncertainty_score":0.34982324},"labels":[],"label_agreement":null},{"id":"W2913568177","doi":"10.1182/blood-2018-99-112146","title":"Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) for Children and Young Adults with T-Cell Acute Lymphoblastic Leukemia (T-ALL) Treated at Investigator Discretion: A Report from Children's Oncology Group (COG) AALL0434","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Medicine; Internal medicine; Interim analysis; Transplantation; Oncology; Hematopoietic stem cell transplantation; Regimen; Minimal residual disease; Clinical endpoint; Clinical trial; Leukemia","score_opus":0.007756378313757745,"score_gpt":0.23534886568819055,"score_spread":0.2275924873744328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913568177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925836,0.00038337763,0.0026826544,0.0001835201,0.00010347028,0.0029265017,0.00053589244,0.00021602101,0.0003849902],"genre_scores_gemma":[0.98899466,0.00029340264,0.0047927443,0.00034412957,0.0004745336,0.000407142,0.0035899156,0.00016440196,0.0009390984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961578,0.00014075644,0.00079306547,0.0013420891,0.00070984045,0.0008564343],"domain_scores_gemma":[0.99738806,0.000289503,0.00041857382,0.00073508243,0.00026890385,0.00089987315],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026248253,0.0006225064,0.0008713799,0.00021561632,0.00029074782,0.00006175758,0.00028235605,0.0004969079,0.000078175566],"category_scores_gemma":[0.00004085337,0.0004959322,0.00016200216,0.00033199793,0.0006455343,0.00017856053,0.00009887125,0.0002632544,0.000053248263],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031625897,0.004316232,0.62721294,0.0015986218,0.008032734,0.008716833,0.012409668,0.000019634177,0.29838768,0.000054648815,0.005096946,0.0025281617],"study_design_scores_gemma":[0.1548797,0.017491085,0.3998002,0.0013047023,0.0187393,0.04941993,0.0003938121,0.0014658076,0.35412362,0.00009129646,0.00025100308,0.0020395385],"about_ca_topic_score_codex":0.0010070752,"about_ca_topic_score_gemma":0.0005235238,"teacher_disagreement_score":0.22741273,"about_ca_system_score_codex":0.0010041904,"about_ca_system_score_gemma":0.0013271465,"threshold_uncertainty_score":0.99974924},"labels":[],"label_agreement":null},{"id":"W2913642842","doi":"10.1182/blood-2018-99-119718","title":"Differential Effects of Pathogenic and Non-Pathogenic Early-Life Exposures on Acute Lymphoblastic Leukemia Progression in Eμ-RET Mice","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Leukemia; Immunology; Medicine; Childhood leukemia; Biology; Lymphoblastic Leukemia","score_opus":0.0070190090824454815,"score_gpt":0.26386395286573816,"score_spread":0.2568449437832927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913642842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99793583,0.00027143434,0.00017489614,0.00003852347,0.00019986095,0.0010730694,0.000023917362,0.000056422272,0.00022601611],"genre_scores_gemma":[0.9984553,0.00011992379,0.0005401193,0.00011944245,0.00043099615,0.00010869472,0.000021808986,0.000072059054,0.00013165777],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971916,0.00011978913,0.0005358888,0.0006582354,0.0008169205,0.00067753217],"domain_scores_gemma":[0.9982281,0.00047007424,0.00018010831,0.00054623163,0.00016012743,0.00041541416],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017214588,0.0003732567,0.0006867941,0.00037873842,0.000091195136,0.000028161605,0.00025201132,0.00031493296,0.00004936305],"category_scores_gemma":[0.0005858719,0.000293873,0.00013427244,0.00041880514,0.00037328174,0.0000834373,0.0002600077,0.00030973865,0.00006868615],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022079889,0.0010285134,0.04631054,0.0006950148,0.00036615398,0.000696801,0.0007948642,5.770097e-7,0.9450618,0.000027803026,0.00021305989,0.002596874],"study_design_scores_gemma":[0.028121857,0.007916087,0.4702393,0.001678187,0.0007942532,0.00025423494,0.000034358745,0.0009490365,0.48960817,0.000051356812,0.0000130661565,0.00034007576],"about_ca_topic_score_codex":0.00006213741,"about_ca_topic_score_gemma":0.00001673789,"teacher_disagreement_score":0.45545363,"about_ca_system_score_codex":0.0003078143,"about_ca_system_score_gemma":0.0009112339,"threshold_uncertainty_score":0.99995136},"labels":[],"label_agreement":null},{"id":"W2913648166","doi":"10.1182/blood-2018-99-110051","title":"Padi4 Regulates NET Formation and Inflammatory Cell Death Downstream of Mlkl","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Necroptosis; Cell biology; Programmed cell death; Biology; Neutrophil extracellular traps; Apoptosis; Biochemistry; Inflammation; Immunology","score_opus":0.00834533197737533,"score_gpt":0.1988019909257967,"score_spread":0.19045665894842137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913648166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99658287,0.00061283685,0.00012792525,0.000023223622,0.00010113597,0.00013405817,0.00001848204,0.000033733828,0.00236574],"genre_scores_gemma":[0.9990358,0.00006019223,0.0003403186,0.000049236878,0.000039749204,0.000004433246,0.000041501316,0.000008700028,0.0004200635],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993927,0.0000662472,0.00019832686,0.00014900725,0.000020881047,0.00017286191],"domain_scores_gemma":[0.99959034,0.000030684227,0.00010814758,0.00018439809,0.00006956698,0.000016886923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000100159574,0.000111740876,0.00016027552,0.000067570196,0.00009323577,0.000006564904,0.000086520085,0.00012631115,0.00015902222],"category_scores_gemma":[0.000010023917,0.0000926021,0.000030610554,0.000052461834,0.00014936512,0.00011588768,0.000058342255,0.00007720145,0.00014266167],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003406721,0.00008486695,0.0011664551,0.00002926276,0.000044127275,0.000002030552,0.00031232325,7.530853e-8,0.994868,0.0017264814,0.00017377702,0.0015585251],"study_design_scores_gemma":[0.0015024713,0.00038029734,0.006447457,0.00002639731,0.000060020746,0.000038017668,0.00008924667,0.0000015807137,0.98759085,0.00082133926,0.0029407863,0.00010150816],"about_ca_topic_score_codex":0.000015720478,"about_ca_topic_score_gemma":0.0000115415905,"teacher_disagreement_score":0.0072771306,"about_ca_system_score_codex":0.000004574613,"about_ca_system_score_gemma":0.00001692367,"threshold_uncertainty_score":0.37762043},"labels":[],"label_agreement":null},{"id":"W2913684592","doi":"10.1182/blood-2018-99-117235","title":"Baseline PET-Derived Metabolic Tumor Volume Metrics Did Not Predict Outcomes in Follicular Lymphoma Patients Treated with First-Line Immunochemotherapy and Antibody Maintenance in the Phase III GALLIUM Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Alberta","funders":"","keywords":"Bendamustine; Medicine; Follicular lymphoma; Internal medicine; Rituximab; Lymphoma; Oncology; Nuclear medicine","score_opus":0.010318130048000295,"score_gpt":0.2672494228489772,"score_spread":0.2569312928009769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913684592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962759,0.0006923922,0.000023510136,0.00045363602,0.000041170526,0.0023631535,0.00007596741,0.000042989846,0.000031263335],"genre_scores_gemma":[0.9979595,0.0005294402,0.00025514732,0.0006554148,0.00006302478,0.0002889765,0.00014868355,0.000043596843,0.00005621309],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99781483,0.00015928678,0.0005573003,0.0005370216,0.0004939478,0.00043763782],"domain_scores_gemma":[0.9987398,0.00018479786,0.00018404557,0.0005928445,0.00018584795,0.00011266586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043948862,0.0003979138,0.0008575343,0.00030148262,0.00011053736,0.00004604339,0.00017573754,0.000046473255,0.000024198165],"category_scores_gemma":[0.00020269537,0.00021837793,0.00009578112,0.000849504,0.00012394262,0.000100395686,0.00004795418,0.000081013,0.000008186289],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013406657,0.036984608,0.9576363,0.0000200781,0.0005813774,0.0008491413,0.00085703644,6.787953e-7,0.00033746104,0.0000030072104,0.00003096788,0.0013586917],"study_design_scores_gemma":[0.1363096,0.005551727,0.85233194,0.00010436358,0.0006938705,0.00007211405,0.0002635789,0.00035602722,0.0038152565,0.0000014877337,0.00029707333,0.0002029862],"about_ca_topic_score_codex":0.0012582497,"about_ca_topic_score_gemma":0.0005770517,"teacher_disagreement_score":0.13496894,"about_ca_system_score_codex":0.00007918106,"about_ca_system_score_gemma":0.00008494638,"threshold_uncertainty_score":0.8905194},"labels":[],"label_agreement":null},{"id":"W2913688890","doi":"10.1182/blood-2018-99-117173","title":"Incidence of Post-Hematopoietic Stem Cell Transplantation (HSCT) Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) without Hyperbilirubinemia at Diagnosis and Efficacy of Defibrotide in an Expanded-Access Program","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Defibrotide; Medicine; Hepatic veno-occlusive disease; Hematopoietic stem cell transplantation; Internal medicine; Transplantation; Expanded access; Incidence (geometry); Surgery; Gastroenterology; Pediatrics","score_opus":0.01572255366329239,"score_gpt":0.2855507420370331,"score_spread":0.26982818837374073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913688890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997401,0.00033997023,0.000062911786,0.000028804641,0.00008002193,0.0018304294,0.00006220291,0.000070374204,0.0001242661],"genre_scores_gemma":[0.998153,0.00019038997,0.0012269256,0.000020471763,0.000042674157,0.00018842691,0.000120757424,0.000045546403,0.000011826549],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997893,0.0001306574,0.0007178361,0.00045266352,0.0004828172,0.00032305458],"domain_scores_gemma":[0.99858487,0.00022068918,0.0003064862,0.00037440986,0.0002348489,0.00027867185],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020900366,0.00026925502,0.00057158683,0.0002445964,0.0000671263,0.00002107956,0.00014566132,0.00014682129,0.000027824384],"category_scores_gemma":[0.000037668484,0.0002586008,0.000085893094,0.0003663853,0.00027471234,0.0003895904,0.000037845482,0.00012854821,0.000005640529],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011619768,0.0017721909,0.9244443,0.004460211,0.00003798315,0.00013010799,0.005579512,0.000012790574,0.06148167,0.00001912661,0.0000012736789,0.0008988552],"study_design_scores_gemma":[0.004694206,0.0012329214,0.7151778,0.001602692,0.00057036645,0.00084059744,0.00037398946,0.000051634634,0.27525377,0.000015426707,9.104136e-7,0.00018568618],"about_ca_topic_score_codex":0.00010908182,"about_ca_topic_score_gemma":0.00016421819,"teacher_disagreement_score":0.2137721,"about_ca_system_score_codex":0.000062771076,"about_ca_system_score_gemma":0.00013428916,"threshold_uncertainty_score":0.99998665},"labels":[],"label_agreement":null},{"id":"W2913760846","doi":"10.1182/blood-2018-99-112306","title":"Is There Difference between the Survival Rate and Treatment Related Complications between Peripheral Blood Stem Cell Transplantation and Bone Marrow Transplantation for Pediatric Hematological Malignancy?: Systematic Review and Meta-Analysis","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Transplantation; Hematopoietic stem cell transplantation; Meta-analysis; Internal medicine; Surgery; Oncology","score_opus":0.05930825914353703,"score_gpt":0.28977549031652444,"score_spread":0.2304672311729874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913760846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9612468,0.029721992,0.0029075646,0.001323589,0.000010434146,0.0038358031,0.00079187145,0.00006100416,0.00010095649],"genre_scores_gemma":[0.9811135,0.01709718,0.00054669566,0.00011974741,0.000033372187,0.000522648,0.0003421144,0.000027046206,0.00019769173],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99767345,0.0004217877,0.00087283726,0.00054239476,0.00023717106,0.00025233996],"domain_scores_gemma":[0.9980885,0.00095077185,0.00032876898,0.00034580924,0.00013090987,0.00015527548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005814046,0.00035318788,0.0018052848,0.000112916015,0.00026946721,0.000052132298,0.00008423323,0.00015755492,0.000037474503],"category_scores_gemma":[0.000009311254,0.00021007852,0.00030864388,0.00037409386,0.00013016211,0.0000690928,0.000006959557,0.00010269292,0.0000035949035],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001529533,0.000827818,0.51532096,0.38641164,0.083821885,0.00008380823,0.010889152,7.992181e-7,0.0018452819,0.0005427406,0.000008763726,0.00009421354],"study_design_scores_gemma":[0.0029442506,0.0004721044,0.21147652,0.00058756326,0.78121835,0.00022694378,0.00011845004,0.000026623515,0.0026207354,0.00007698769,8.7298724e-7,0.00023058413],"about_ca_topic_score_codex":0.000023678142,"about_ca_topic_score_gemma":0.000023698569,"teacher_disagreement_score":0.69739646,"about_ca_system_score_codex":0.00001237993,"about_ca_system_score_gemma":0.000030421592,"threshold_uncertainty_score":0.8566753},"labels":[],"label_agreement":null},{"id":"W2913903457","doi":"10.1182/blood-2018-99-119688","title":"Combination of Enasidenib and Venetoclax Shows Superior Anti-Leukemic Activity Against IDH2 Mutated AML in Patient-Derived Xenograft Models","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Venetoclax; IDH2; Medicine; Cancer research; Pharmacology; Isocitrate dehydrogenase; Refractory (planetary science); Internal medicine; Oncology; Mutant; Leukemia; Chemistry; Biology; IDH1; Enzyme; Gene; Biochemistry; Chronic lymphocytic leukemia","score_opus":0.019848479157771968,"score_gpt":0.27125006066385116,"score_spread":0.25140158150607916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913903457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980247,0.00015139727,0.000069927395,0.00012400938,0.0000423127,0.0008356928,0.000025914695,0.000053227614,0.00067281845],"genre_scores_gemma":[0.99914837,0.00014582323,0.00041975113,0.00008960379,0.000046879024,0.000037295915,0.000040074912,0.00003791062,0.000034269066],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984067,0.0001273148,0.00033318833,0.0003642364,0.0003795268,0.00038904443],"domain_scores_gemma":[0.9990499,0.00008484189,0.00010794723,0.00035020313,0.00025209412,0.00015501078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023654518,0.00019150988,0.0004435678,0.00031931317,0.00006487533,0.000019857926,0.00011651029,0.00017421531,0.000027626227],"category_scores_gemma":[0.00015380328,0.00018172986,0.000057167083,0.00041051113,0.0003202452,0.00024298081,0.00013251495,0.0003126685,0.000009106853],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003432501,0.00048228077,0.009355188,0.00011355033,0.00009133896,0.0001447703,0.0017552858,0.000025490226,0.9796745,0.000022234955,0.000045808425,0.007946311],"study_design_scores_gemma":[0.012098913,0.001264709,0.05667636,0.00020924822,0.00009030722,0.000107710264,0.00033059093,0.025167638,0.9036268,0.0001685338,0.000036178757,0.00022303821],"about_ca_topic_score_codex":0.0004323204,"about_ca_topic_score_gemma":0.00010643697,"teacher_disagreement_score":0.07604772,"about_ca_system_score_codex":0.00030497814,"about_ca_system_score_gemma":0.0005564907,"threshold_uncertainty_score":0.7410729},"labels":[],"label_agreement":null},{"id":"W2913936095","doi":"10.1182/blood-2018-99-114327","title":"Health Related Quality of Life Remains Stable over Time in Myelodysplastic Syndrome: An MDS-CAN Prospective Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Princess Margaret Cancer Centre; Centre hospitalier de l'Université Laval; University of British Columbia; Dr. Georges-L.-Dumont University Hospital Centre; St. Paul's Hospital; McMaster University; Queen Elizabeth II Health Sciences Centre; University of Alberta; CancerCare Manitoba; Saskatchewan Cancer Agency; Health Sciences Centre; Ottawa Hospital; University Health Network; Dalhousie University; University of Toronto; Jewish General Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Quality of life (healthcare); International Prognostic Scoring System; Myelodysplastic syndromes; Internal medicine; Azacitidine; Prospective cohort study; Decitabine; Physical therapy; Pediatrics","score_opus":0.02840776455512473,"score_gpt":0.33600840608707794,"score_spread":0.3076006415319532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913936095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959224,0.000089969646,0.0000053708854,0.00043808788,0.00004317576,0.0019555732,0.000042652013,0.00008348833,0.0014193146],"genre_scores_gemma":[0.99813455,0.000008076785,0.00029444476,0.00012704871,0.00007637011,0.000042329935,0.000027748454,0.00004775522,0.001241699],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99671495,0.00057703437,0.00085914496,0.00054729235,0.00071821787,0.00058333453],"domain_scores_gemma":[0.99812424,0.0001899829,0.00025505698,0.0007507542,0.00026978404,0.00041018726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021455677,0.00020422968,0.0008987663,0.00030692483,0.00009378479,0.000014175566,0.000201572,0.00012814254,0.0003905045],"category_scores_gemma":[0.0012318391,0.00018111579,0.00005365955,0.0009907727,0.0002256475,0.00012620608,0.00013053106,0.00052613317,0.000112515576],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010173648,0.007470415,0.980596,0.00022999078,0.0004046463,0.00020388686,0.005485904,0.0000023761736,0.0038732083,0.00018077425,0.0004551824,0.00008022692],"study_design_scores_gemma":[0.013767535,0.0071931886,0.97698987,0.00014326771,0.00006674629,0.00007604561,0.00084586383,0.00017997746,0.00043396433,0.00012947601,0.00001180225,0.0001622899],"about_ca_topic_score_codex":0.0032409043,"about_ca_topic_score_gemma":0.001711269,"teacher_disagreement_score":0.01275017,"about_ca_system_score_codex":0.00048920786,"about_ca_system_score_gemma":0.0016685558,"threshold_uncertainty_score":0.7385687},"labels":[],"label_agreement":null},{"id":"W2913941843","doi":"10.1182/blood-2018-99-115400","title":"Functional Predictors of Chemotherapy Toxicity in Elderly Lymphoma Patients: A Prospective Pilot Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Geriatric oncology; Prospective cohort study; Performance status; Chemotherapy; Internal medicine; Chemotherapy regimen; Dosing; Physical therapy; Cancer","score_opus":0.13660582127144946,"score_gpt":0.34332311278293093,"score_spread":0.20671729151148147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913941843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949482,0.00010337682,0.00015602565,0.0005723644,0.00042776766,0.0012281708,0.00012490773,0.000031898897,0.0024072845],"genre_scores_gemma":[0.9982648,0.0000067937003,0.00022504828,0.0008265529,0.00036491733,0.00013801019,0.000010573361,0.000023117473,0.000140225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99674594,0.0001524302,0.002263775,0.0004664277,0.00011329221,0.00025811687],"domain_scores_gemma":[0.9981533,0.00021109571,0.0010750853,0.00034760238,0.00013310269,0.00007978471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038125357,0.00015007758,0.0006239377,0.0002829303,0.00008399595,0.000021662518,0.00017242179,0.000059948732,0.00037531278],"category_scores_gemma":[0.0009304093,0.0001857641,0.000050344006,0.00027391253,0.00009155496,0.00026537618,0.00003251159,0.00006656404,0.00032198557],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008594614,0.006686153,0.9875539,0.000037239337,0.000110650515,2.1607217e-7,0.0023816824,0.0000026074679,0.0000057089223,0.0019653689,0.0011013836,0.000069128815],"study_design_scores_gemma":[0.007931369,0.0045086564,0.9840083,0.00002540515,0.000007029183,5.94395e-7,0.0005194207,0.00005213112,0.00010081218,0.0023104504,0.00037072643,0.00016507755],"about_ca_topic_score_codex":0.0007667576,"about_ca_topic_score_gemma":0.00060438295,"teacher_disagreement_score":0.007845423,"about_ca_system_score_codex":0.00026826674,"about_ca_system_score_gemma":0.00011275644,"threshold_uncertainty_score":0.757524},"labels":[],"label_agreement":null},{"id":"W2913976092","doi":"10.1182/blood-2018-99-110387","title":"Reassessing the Need for Pre-Operative Transfusions in Sickle Cell Disease Patients with a High Baseline Hemoglobin","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Fetal hemoglobin; Hemoglobin; Thalassemia; Acute chest syndrome; Cohort; Blood transfusion; Hemoglobin C; Population; Retrospective cohort study; Anemia; Hemoglobinopathy; Internal medicine; Hemoglobin F; Surgery; Hemoglobin A; Disease; Sickle cell anemia; Pediatrics; Fetus; Pregnancy","score_opus":0.005160534568096228,"score_gpt":0.2388795590441896,"score_spread":0.23371902447609336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913976092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941852,0.0001951453,0.00063880155,0.0027118162,0.00007277901,0.0014208271,0.00006364391,0.000039196657,0.0006725529],"genre_scores_gemma":[0.99743617,0.000029768049,0.00094105303,0.00091921934,0.000102551945,0.00008961739,0.00008017973,0.0000293679,0.0003720622],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990338,0.00005975585,0.00020614725,0.00025158512,0.0001800464,0.00026863013],"domain_scores_gemma":[0.999292,0.00008509215,0.000044799304,0.00025777126,0.00016449686,0.00015584166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014206007,0.00015456756,0.00019488882,0.00005661187,0.00020686792,0.000020816067,0.00007499495,0.00007058111,0.00006472314],"category_scores_gemma":[0.000080661244,0.000085254724,0.0000595567,0.00027332737,0.000135044,0.00006603554,0.00001658083,0.00016105441,0.000007161664],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0200648,0.044462252,0.86139524,0.0012563975,0.0008176303,0.00024418556,0.023343656,0.00039668777,0.017676353,0.00096241565,0.008490461,0.020889891],"study_design_scores_gemma":[0.14679357,0.008166808,0.79517454,0.0026451114,0.003926471,0.00002323381,0.005608766,0.0064806268,0.018383574,0.0005270117,0.010851339,0.0014189582],"about_ca_topic_score_codex":0.00013903124,"about_ca_topic_score_gemma":0.00009773718,"teacher_disagreement_score":0.12672879,"about_ca_system_score_codex":0.000020803449,"about_ca_system_score_gemma":0.00019562304,"threshold_uncertainty_score":0.34765866},"labels":[],"label_agreement":null},{"id":"W2914020209","doi":"10.1182/blood-2018-99-116715","title":"Outcomes for Patients with High-Risk Relapsed or Refractory Indolent B-Cell Lymphoma Treated with Copanlisib in the CHRONOS-1 Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Internal medicine; Follicular lymphoma; Bendamustine; Regimen; Population; Clinical endpoint; Adverse effect; Rituximab; Phases of clinical research; Oncology; Salvage therapy; Neutropenia; Refractory (planetary science); Lymphoma; Gastroenterology; Surgery; Chemotherapy; Clinical trial","score_opus":0.010597715923788036,"score_gpt":0.24323089587957988,"score_spread":0.23263317995579186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914020209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960361,0.000053123887,0.0000019399063,0.00008904255,0.000047292135,0.0033572216,0.0000610635,0.000046597343,0.0003076318],"genre_scores_gemma":[0.9982371,0.000018038887,0.0003195757,0.0002547906,0.00008031895,0.0007581208,0.00008117158,0.000042850104,0.00020804642],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99846786,0.000102050115,0.00029123004,0.00041335518,0.00040510308,0.0003203723],"domain_scores_gemma":[0.99869645,0.00027829863,0.00018632032,0.00058825646,0.00015805644,0.00009263143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014891595,0.0002935007,0.00045627536,0.00009972209,0.00014192931,0.00003030088,0.00013531494,0.00006948018,0.00002859094],"category_scores_gemma":[0.00005069648,0.00012288848,0.000056999314,0.00024506447,0.000086341395,0.00006902895,0.000024089259,0.00006195964,0.000025347115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031178654,0.050806627,0.94159836,0.000022673907,0.00044832495,0.00012403143,0.0014004341,2.531755e-7,0.000002820613,0.0000038682438,0.00022028812,0.0022544318],"study_design_scores_gemma":[0.13584252,0.03609377,0.82475084,0.00007993065,0.001219381,0.000006959658,0.0006543069,0.000001590904,0.0008478575,0.0000016404723,0.00034781525,0.00015339002],"about_ca_topic_score_codex":0.00087075913,"about_ca_topic_score_gemma":0.00090408284,"teacher_disagreement_score":0.13272464,"about_ca_system_score_codex":0.00014973152,"about_ca_system_score_gemma":0.00017137371,"threshold_uncertainty_score":0.5011247},"labels":[],"label_agreement":null},{"id":"W2914088338","doi":"10.1182/blood-2018-176","title":"Resistance to Lenalidomide in Del(5q) MDS Is Mediated By Inhibition of Drug-Induced Megakaryocytic Differentiation","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"","keywords":"RUNX1; Cancer research; Lenalidomide; Biology; Immunology; Molecular biology; Medicine; Haematopoiesis; Stem cell; Genetics","score_opus":0.015403974334596985,"score_gpt":0.2805320959159446,"score_spread":0.2651281215813476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914088338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968628,0.0002195519,0.000048409693,0.00084230787,0.00006559351,0.000585239,0.000029473247,0.000039840153,0.0013067756],"genre_scores_gemma":[0.9981589,0.000034781864,0.00020555708,0.00040346826,0.00014422271,0.000048320577,0.0000767961,0.00003131766,0.0008966358],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980268,0.0000907081,0.0004865708,0.0003663125,0.0006493998,0.0003802261],"domain_scores_gemma":[0.9988816,0.00015594553,0.00011065626,0.00042736236,0.00023815944,0.00018629729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000371964,0.00015987593,0.00035883833,0.00027105768,0.00004019574,0.000013100336,0.00011332525,0.00012441065,0.00012937207],"category_scores_gemma":[0.00048188548,0.00014830192,0.00006184993,0.00063657603,0.00008224582,0.0000883863,0.00007260289,0.00015839926,0.00012372991],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010694443,0.0011185049,0.0030970662,0.00038797333,0.000120244134,0.00006930909,0.0023693673,4.3795717e-7,0.9776061,0.00008873079,0.013722101,0.00035071644],"study_design_scores_gemma":[0.034952626,0.0002336488,0.007023802,0.00053258456,0.000092909366,0.00001385161,0.00009703439,0.0003443171,0.9560025,0.00011034749,0.00043711922,0.0001593107],"about_ca_topic_score_codex":0.0007604599,"about_ca_topic_score_gemma":0.0009034748,"teacher_disagreement_score":0.033883184,"about_ca_system_score_codex":0.0024020062,"about_ca_system_score_gemma":0.0013521372,"threshold_uncertainty_score":0.62811625},"labels":[],"label_agreement":null},{"id":"W2914336110","doi":"10.1182/blood-2018-99-119716","title":"Is There a Role for Thromboprophylaxis in Sickle Cell Patients with Central Venous Access Devices?","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Queen's University; University Health Network","funders":"","keywords":"Medicine; Venous access; Thrombosis; Venous thrombosis; Pulmonary embolism; Venous thromboembolism; Central venous catheter; Internal medicine; Pediatrics; Intensive care medicine; Surgery; Catheter","score_opus":0.00964972642600055,"score_gpt":0.24562133108621373,"score_spread":0.2359716046602132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914336110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9798901,0.00013599853,0.00007611864,0.00013702516,0.000059887127,0.001049274,0.000030113617,0.0000351131,0.018586336],"genre_scores_gemma":[0.997252,0.0000048211905,0.0013359874,0.00065414165,0.00019029477,0.00006229398,0.000031447704,0.00003483434,0.00043419926],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99894196,0.000008219155,0.0001600662,0.00029203837,0.0002239779,0.000373713],"domain_scores_gemma":[0.9994044,0.000016631422,0.000086755696,0.00031147865,0.0001002195,0.00008052193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000044265355,0.00014727243,0.00022492389,0.00006146392,0.000042837102,0.000024624274,0.00018598259,0.000056845496,0.00018265724],"category_scores_gemma":[0.000012328283,0.00011179643,0.00004503527,0.00016857078,0.000050451446,0.000089437635,0.00008993324,0.000082827406,0.00003795936],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031407113,0.0032399609,0.9886999,0.00025139516,0.00017376042,0.000015501902,0.0011874692,4.7551626e-7,0.0007379373,0.000005721816,0.003450272,0.0019235214],"study_design_scores_gemma":[0.012096362,0.0030479701,0.9056676,0.00014243936,0.00032731652,0.0000023618686,0.00025656944,0.000047571164,0.059962578,0.000024202149,0.018199341,0.00022570537],"about_ca_topic_score_codex":0.00009459873,"about_ca_topic_score_gemma":0.000053539163,"teacher_disagreement_score":0.08303233,"about_ca_system_score_codex":0.000042576827,"about_ca_system_score_gemma":0.000048598104,"threshold_uncertainty_score":0.4558926},"labels":[],"label_agreement":null},{"id":"W2914360051","doi":"10.1182/blood-2018-99-112718","title":"Transfusion Practice Following Intracranial Hemorrhage in Acute Leukemia: An Institutional Review","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Intracerebral and Subarachnoid Hemorrhage Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Queen's University; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Acute leukemia; Platelet transfusion; Intracerebral hemorrhage; Bleed; Leukemia; Complication; Internal medicine; Surgery; Pediatrics; Platelet; Subarachnoid hemorrhage","score_opus":0.016274804639557085,"score_gpt":0.32046583621623365,"score_spread":0.30419103157667654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914360051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824946,0.003463365,0.00044575956,0.0034268594,0.00020421657,0.00071971177,0.0000069403113,0.00007733236,0.009161239],"genre_scores_gemma":[0.9631267,0.0029083663,0.029096324,0.0034468547,0.00093781226,0.000052451833,0.00007042732,0.000030035491,0.00033103267],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981067,0.0001233799,0.0003781039,0.00038386052,0.0005844454,0.00042351466],"domain_scores_gemma":[0.99917346,0.00006046604,0.000046384986,0.00032885524,0.00018176856,0.00020906441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091018254,0.00017012247,0.00037610254,0.00012773744,0.00019346234,0.000025845757,0.0001577811,0.00016488209,0.000386946],"category_scores_gemma":[0.0005062063,0.00014724389,0.00013539099,0.0004890884,0.0001102117,0.0005463363,0.00004087128,0.0006367049,0.0002344874],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022456904,0.0068612495,0.009019099,0.0043473756,0.00048205527,0.060388267,0.0013330183,0.0000016282121,0.12409391,0.0013787494,0.00053458835,0.7893144],"study_design_scores_gemma":[0.19053821,0.03452865,0.09759939,0.035497326,0.02469441,0.19209619,0.003025523,0.14253338,0.2296941,0.002051885,0.039432652,0.008308284],"about_ca_topic_score_codex":0.00015965276,"about_ca_topic_score_gemma":0.00006739532,"teacher_disagreement_score":0.7810061,"about_ca_system_score_codex":0.00014475879,"about_ca_system_score_gemma":0.0005704942,"threshold_uncertainty_score":0.6004431},"labels":[],"label_agreement":null},{"id":"W2914468434","doi":"10.1182/blood-2018-99-111364","title":"Validation of Sickle Cell Disease Severity Score in a Cohort of Hemoglobin SC Disease Patients","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brampton Civic Hospital; University Health Network; Toronto General Hospital; University of Toronto; McMaster University","funders":"","keywords":"Medicine; Acute chest syndrome; Cohort; Internal medicine; Sickle cell anemia; SSS*; Disease; Pediatrics","score_opus":0.0064014727190399865,"score_gpt":0.22097872058625573,"score_spread":0.21457724786721574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914468434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997478,0.00022470477,0.0000073155397,0.0000779043,0.00007654091,0.0005618804,0.00007880412,0.000018254323,0.0014765641],"genre_scores_gemma":[0.99949604,0.00005323671,0.0000774959,0.000072010065,0.000031840522,0.0000105697945,0.00010848399,0.000014657153,0.00013569099],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989648,0.000039511942,0.00032956272,0.00020688592,0.00028578934,0.0001734603],"domain_scores_gemma":[0.9991462,0.0000151750755,0.00012560983,0.0003011587,0.00017825012,0.00023356767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010757538,0.00011348225,0.00024110584,0.00009518293,0.000025810008,0.0000031353577,0.00007057568,0.00006650549,0.000111806105],"category_scores_gemma":[0.00014539916,0.00009891816,0.000085408756,0.00026869972,0.00014832219,0.00005816559,0.000044399665,0.00008843348,0.00001665137],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004171882,0.0034722546,0.99395907,0.0003909021,0.000029058363,0.000016252929,0.00015540027,0.000005194815,0.0011268994,0.000012348909,0.00016792578,0.00024752264],"study_design_scores_gemma":[0.005250396,0.00025168378,0.972113,0.0002850827,0.00033579147,5.384946e-7,0.00004084583,0.00010327231,0.021293674,0.00011039738,0.00010711897,0.00010817908],"about_ca_topic_score_codex":0.00008681108,"about_ca_topic_score_gemma":0.0000036635279,"teacher_disagreement_score":0.021846032,"about_ca_system_score_codex":0.000020319621,"about_ca_system_score_gemma":0.0001735379,"threshold_uncertainty_score":0.40337652},"labels":[],"label_agreement":null},{"id":"W2914468812","doi":"10.1182/blood-2018-99-116866","title":"Microrna-130a Regulates Hematopoietic Stem Cell Self-Renewal By Repressing Chromatin Modifiers and Shaping the Accessible Chromatin Landscape","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Biology; microRNA; Stem cell; Haematopoiesis; Cell biology; Chromatin; Hematopoietic stem cell; Regulation of gene expression; Progenitor cell; Genetics; Gene","score_opus":0.008934110036451365,"score_gpt":0.2260406809644597,"score_spread":0.21710657092800834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914468812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99232924,0.0062159803,0.00011052586,0.00010077716,0.0000662574,0.00024321197,0.00001862833,0.000052296644,0.0008631016],"genre_scores_gemma":[0.9982786,0.00009829189,0.00091890566,0.00008863364,0.00026720169,0.00003167208,0.00006311213,0.000038670078,0.0002148745],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987234,0.00009579681,0.00027748552,0.0004619441,0.00014546906,0.00029590097],"domain_scores_gemma":[0.99910986,0.000020838987,0.00019434775,0.0005196148,0.00006622627,0.00008912386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020192243,0.0002136104,0.00016517696,0.00003396356,0.00028935433,0.00014838831,0.00026283352,0.00014754827,0.000028247938],"category_scores_gemma":[0.000013624839,0.00017154244,0.00006567361,0.000110002555,0.00014708936,0.000015065692,0.00019951432,0.00006944092,0.000010070584],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001548289,0.00010034031,0.0013640245,0.0000963022,0.00007343727,0.0000016012026,0.0003311618,0.0000045801808,0.99494934,0.0000056773056,0.0027313605,0.000326677],"study_design_scores_gemma":[0.0009769915,0.00008308975,0.0018544439,0.00007191411,0.000111863475,0.00004982428,0.00015952795,0.00037119124,0.9952074,0.000057284866,0.0008214757,0.00023493891],"about_ca_topic_score_codex":0.000013974952,"about_ca_topic_score_gemma":0.000005643258,"teacher_disagreement_score":0.0061176885,"about_ca_system_score_codex":0.000009508833,"about_ca_system_score_gemma":0.000057189198,"threshold_uncertainty_score":0.6995298},"labels":[],"label_agreement":null},{"id":"W2914494465","doi":"10.1182/blood-2018-99-110482","title":"Two-Year Safety and Efficacy Outcomes with Fostamatinib in Adult Patients with Immune Thrombocytopenia (ITP): Open-Label Extension to Phase 3 Trial Program","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; McMaster University","funders":"","keywords":"Medicine; Syk; Tolerability; Placebo; Internal medicine; Immune thrombocytopenia; Platelet; Discontinuation; Adverse effect; Gastroenterology","score_opus":0.02239597663668361,"score_gpt":0.33445044232435023,"score_spread":0.3120544656876666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914494465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99280393,0.000029599372,0.00000447766,0.000250977,0.00004744585,0.0055345907,0.000027647375,0.000049031758,0.0012522897],"genre_scores_gemma":[0.99162996,0.000010483806,0.007711975,0.00025173737,0.00002829954,0.00012281477,0.00011216782,0.00003717765,0.000095396565],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9986264,0.000036676967,0.000320348,0.00042256626,0.00027533976,0.0003186559],"domain_scores_gemma":[0.99913347,0.000041932013,0.00010290232,0.00037090288,0.00018072122,0.00017006537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000106874424,0.00024471886,0.0007062028,0.00008507384,0.000107103784,0.000061547886,0.00011493219,0.00005721316,0.00003162322],"category_scores_gemma":[0.00008847295,0.00014747083,0.000020624131,0.00026156483,0.00008445258,0.00014389145,0.00011322773,0.00011089422,0.000030948842],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44894695,0.12358866,0.30905676,0.00008130938,0.0011258635,0.0007512018,0.0017853539,4.9208546e-7,0.0005509349,0.00013575745,0.0001323334,0.11384439],"study_design_scores_gemma":[0.73588884,0.03169477,0.23073947,0.00031454317,0.00031686146,0.000021128337,0.000111616064,0.000008432429,0.0005261575,0.0000078892235,0.00015598463,0.00021432017],"about_ca_topic_score_codex":0.0001896468,"about_ca_topic_score_gemma":0.00024789866,"teacher_disagreement_score":0.2869419,"about_ca_system_score_codex":0.000023164894,"about_ca_system_score_gemma":0.000071134134,"threshold_uncertainty_score":0.60136855},"labels":[],"label_agreement":null},{"id":"W2914576346","doi":"10.1182/blood-2018-99-115518","title":"Delayed Hematologic Recovery in AML Patients after Induction Chemotherapy Is Associated with Inferior Relapse-Free Survival and Persistence of Preleukemic Mutations","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Chemotherapy; Induction chemotherapy; Chemotherapy regimen; Bone marrow; Gastroenterology; Myeloid; Oncology; Surgery","score_opus":0.01633460785572742,"score_gpt":0.2513236050758728,"score_spread":0.23498899722014538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914576346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986035,0.00006209005,0.000012689711,0.00030887238,0.000034868117,0.00045225307,0.000032881526,0.000026964059,0.0004658877],"genre_scores_gemma":[0.9987811,0.000054943663,0.00069577585,0.00014498398,0.00002748746,0.000044743058,0.00003313413,0.000022628697,0.00019523066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886906,0.000072312076,0.00025547933,0.0002631866,0.00031023705,0.00022974903],"domain_scores_gemma":[0.9991221,0.00008402687,0.0001246403,0.00029010605,0.00030622902,0.00007289742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020089942,0.00012841722,0.0002922883,0.00017429508,0.00004074461,0.000010122264,0.000092072354,0.00016192289,0.00007122902],"category_scores_gemma":[0.00048437904,0.000104566425,0.000036009944,0.00042911072,0.00024489482,0.00013064487,0.000050375063,0.00022535757,0.0000058603655],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015441102,0.00077971286,0.99060714,0.00006216371,0.00029031985,0.000028823788,0.0021481304,5.104952e-7,0.0036402096,0.000005360298,0.0002500159,0.00064348563],"study_design_scores_gemma":[0.012223964,0.002255818,0.97422516,0.00022551806,0.00012688617,0.000033684144,0.0003358576,0.00007035963,0.010257639,0.00009636541,0.000016730954,0.00013199143],"about_ca_topic_score_codex":0.0001345517,"about_ca_topic_score_gemma":0.00019675745,"teacher_disagreement_score":0.016381972,"about_ca_system_score_codex":0.00020190881,"about_ca_system_score_gemma":0.00023952797,"threshold_uncertainty_score":0.4264095},"labels":[],"label_agreement":null},{"id":"W2914594525","doi":"10.1182/blood-2018-99-110869","title":"The Mitochondrial Protease, Neurolysin (NLN), Regulates Respiratory Chain Supercomplex Formation and Represents a New Therapeutic Target for AML","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Gene knockdown; Haematopoiesis; Biology; Stem cell; Myeloid; Myeloid leukemia; Respiratory chain; Cancer research; Leukemia; Cell culture; Mitochondrion; Molecular biology; Cell biology; Immunology; Genetics","score_opus":0.021427361657703207,"score_gpt":0.2818912512840969,"score_spread":0.2604638896263937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914594525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951765,0.0015201658,0.0011553766,0.0006063726,0.00015848118,0.0011747496,0.000022228365,0.000019613952,0.0001665467],"genre_scores_gemma":[0.9915299,0.00005748805,0.0020218508,0.0003490286,0.003062208,0.00028765184,0.00009405527,0.000060795508,0.0025370524],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987895,0.00014753135,0.00021845923,0.00034376569,0.0001854216,0.0003153466],"domain_scores_gemma":[0.99917316,0.0000390165,0.00006263825,0.000476375,0.00013936879,0.00010946434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026233803,0.00013690966,0.000109184824,0.00004129145,0.00037374705,0.00007678703,0.00021139377,0.000117575066,0.000007086927],"category_scores_gemma":[0.0002956506,0.00010579782,0.000071020775,0.00008459184,0.00021075235,0.000010824611,0.00010654903,0.000085237516,0.000008949081],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033415676,0.00006472196,0.00009477293,0.0000148415975,0.00004112027,0.000001073036,0.000106279316,8.459417e-7,0.9860707,0.000039586983,0.009713255,0.0035186624],"study_design_scores_gemma":[0.0018551302,0.0008137827,0.00028264604,0.000008463402,0.000018142924,0.000014555567,0.000024584724,0.00013817815,0.7921119,0.00043701328,0.20417593,0.000119690885],"about_ca_topic_score_codex":0.00002352421,"about_ca_topic_score_gemma":0.00006253652,"teacher_disagreement_score":0.19446267,"about_ca_system_score_codex":0.0000085997135,"about_ca_system_score_gemma":0.00011207163,"threshold_uncertainty_score":0.431431},"labels":[],"label_agreement":null},{"id":"W2914595070","doi":"10.1182/blood-2018-99-119934","title":"Accounting for the Unique Molecular Landscape of Pediatric Malignancies Improves Target-Agent Pair Identification for Pediatric Precision Oncology","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Precision medicine; Pediatric oncology; Precision oncology; Pediatric cancer; Oncology; Targeted therapy; Cog; Genomic sequencing; Amplicon; Clinical trial; Cancer; Deep sequencing; Personalized medicine; Internal medicine; Bioinformatics; Biology; Pathology; Genome; Genetics; Gene; Computer science","score_opus":0.01880576311427587,"score_gpt":0.3071335643023618,"score_spread":0.2883278011880859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914595070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99056304,0.0009651199,0.0060227904,0.00030561126,0.00015255652,0.0018444314,0.000039677012,0.000031236486,0.00007552223],"genre_scores_gemma":[0.99384034,0.00017179843,0.0045769378,0.000054470223,0.00067059573,0.0004210344,0.000032554515,0.000024657566,0.00020761443],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989536,0.000039669787,0.00030628935,0.0002136994,0.00021908872,0.00026764584],"domain_scores_gemma":[0.99859977,0.00044080958,0.00020317765,0.00027142867,0.00041888843,0.00006591752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045972908,0.00010951636,0.0001857891,0.00014721253,0.0001300977,0.000018182662,0.00013400905,0.00007563222,0.000014198041],"category_scores_gemma":[0.000526777,0.000072466864,0.00012671981,0.00024279488,0.00003967705,0.000057315872,0.00005017839,0.00006372677,0.000008511683],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016017612,0.0041048513,0.17878567,0.001446003,0.00058833644,0.000035741792,0.0006741191,0.0000055279515,0.79314166,0.00041875977,0.0074194875,0.011778089],"study_design_scores_gemma":[0.010609225,0.0071591055,0.10869158,0.000024941623,0.0020055186,0.000034920435,0.0002164014,0.00083759904,0.86647177,0.0011759466,0.0025655355,0.00020745203],"about_ca_topic_score_codex":0.000007701499,"about_ca_topic_score_gemma":0.000004317948,"teacher_disagreement_score":0.07333011,"about_ca_system_score_codex":0.000020056379,"about_ca_system_score_gemma":0.00019128683,"threshold_uncertainty_score":0.29551128},"labels":[],"label_agreement":null},{"id":"W2914598974","doi":"10.1182/blood-2018-08-864728","title":"Unusual presentation of Burkitt-like lymphoma with 11q aberration in an elderly patient","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Columbian Hospital","funders":"","keywords":"Nucleolus; Burkitt's lymphoma; Bone marrow; Lymphoma; Presentation (obstetrics); Pathology; Medicine; Bone marrow aspirate; Chromatin; Biology; Radiology; Genetics","score_opus":0.008771280507293519,"score_gpt":0.2435758252875199,"score_spread":0.2348045447802264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914598974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997718,0.000060030663,0.0000028965935,0.000091981194,0.00005184287,0.0005331162,0.0000057199545,0.00001629058,0.0015201288],"genre_scores_gemma":[0.9993515,0.0000108118575,0.00029588392,0.000084759304,0.000022142141,0.000048724803,0.00008994987,0.000010805657,0.000085428765],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992721,0.000028602455,0.00018289078,0.00017743796,0.00022587941,0.00011305274],"domain_scores_gemma":[0.9995762,0.000023620232,0.00007983728,0.00020176517,0.00006429055,0.000054246837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000035631765,0.00009029759,0.00017118272,0.00007877281,0.000012026934,0.000008982978,0.000027272672,0.000044672957,0.00003858496],"category_scores_gemma":[0.000005278683,0.000066536515,0.000027032625,0.00012542441,0.00001522925,0.00011290385,0.000008841694,0.000018684314,0.000015418134],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023581262,0.005222122,0.9693978,0.00005391989,0.00008267283,0.000039904033,0.0013865753,0.00002719266,0.003354362,0.00016330092,0.00005407842,0.019982275],"study_design_scores_gemma":[0.013505468,0.0054106736,0.91795784,0.0001128312,0.00013763884,0.000031877058,0.0004727158,0.00009434246,0.06200869,0.000013237253,0.0001711377,0.00008356654],"about_ca_topic_score_codex":0.00024740782,"about_ca_topic_score_gemma":0.00017414184,"teacher_disagreement_score":0.05865433,"about_ca_system_score_codex":0.000044274653,"about_ca_system_score_gemma":0.00008140351,"threshold_uncertainty_score":0.27132803},"labels":[],"label_agreement":null},{"id":"W2914624001","doi":"10.1182/blood-2018-99-117157","title":"Human Erythroblasts with c-Kit Activating Mutations Have Reduced Cell Culture Costs and Remain Capable of Terminal Maturation and Enucleation","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Haematopoiesis; Progenitor cell; Cord blood; Stem cell; Immunology; Erythropoietin; CD34; Umbilical cord; Biology; Induced pluripotent stem cell; Andrology; Cell biology; Medicine; Embryonic stem cell; Genetics","score_opus":0.010353432536496383,"score_gpt":0.2520371304152092,"score_spread":0.24168369787871283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914624001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995831,0.000034580637,0.000053689917,0.00008223701,0.00002443843,0.000202831,0.0000044981116,0.000022406488,0.0037442923],"genre_scores_gemma":[0.99603355,0.000009047437,0.0028881994,0.00007789541,0.00015960238,0.000006871785,0.00004803895,0.000011232635,0.0007655626],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994871,0.00003120011,0.0001356908,0.000170431,0.00008275835,0.000092820796],"domain_scores_gemma":[0.9995765,0.000018998728,0.00011951472,0.00009789749,0.0001364994,0.0000505917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000052225074,0.000086524116,0.00014559022,0.00005543899,0.00014476766,0.000011295818,0.000014275289,0.000078252495,0.000031490097],"category_scores_gemma":[0.000027228712,0.00006820047,0.000012668927,0.00007236536,0.00013887072,0.000089548135,0.000011473973,0.00009334964,0.000002264108],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013945557,0.00013692759,0.0018721492,0.00009777128,0.000022807486,0.0000053331332,0.0023006324,6.956611e-7,0.9946506,0.00006497138,0.00017236974,0.0005362788],"study_design_scores_gemma":[0.006896645,0.0050858203,0.17787315,0.00049896934,0.00031651233,0.0006414936,0.0041932757,0.00026653535,0.8034029,0.00014143257,0.0004464537,0.00023682194],"about_ca_topic_score_codex":0.000029717561,"about_ca_topic_score_gemma":0.000048706945,"teacher_disagreement_score":0.19124772,"about_ca_system_score_codex":0.000013098279,"about_ca_system_score_gemma":0.000025627154,"threshold_uncertainty_score":0.27811345},"labels":[],"label_agreement":null},{"id":"W2914654146","doi":"10.1182/blood-2018-99-119235","title":"Germline GAB2 Mutations in Childhood Acute Lymphoblastic Leukemia","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Neuroblastoma RAS viral oncogene homolog; Sanger sequencing; Multiplex ligation-dependent probe amplification; Germline mutation; Genetics; Biology; Germline; KRAS; Exome sequencing; Exome; Cancer research; Mutation; Gene; Exon","score_opus":0.01052056294931273,"score_gpt":0.27835046597392,"score_spread":0.26782990302460724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914654146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873569,0.000100338824,0.00054852903,0.00053213263,0.00014084925,0.000523003,0.000031708252,0.00014678227,0.010619759],"genre_scores_gemma":[0.9938448,0.00003936378,0.002997421,0.00060920604,0.0007739623,0.00006716669,0.0000807435,0.00006175843,0.001525566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978378,0.000052570747,0.00043795575,0.00047267662,0.00054207986,0.00065691123],"domain_scores_gemma":[0.9986471,0.00020522256,0.00007464851,0.0005474668,0.00021834321,0.0003072183],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021508524,0.00023891321,0.0004005435,0.00039016854,0.00011264167,0.00003210591,0.00022609101,0.0001800926,0.000508889],"category_scores_gemma":[0.0004973247,0.00021153859,0.00010143917,0.0008371818,0.00030698313,0.000115906994,0.00013166027,0.00028189775,0.0012297871],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005222171,0.033733774,0.41560662,0.0013706032,0.00964576,0.0282813,0.028467657,0.00025764728,0.36812204,0.0075278142,0.054678407,0.04708619],"study_design_scores_gemma":[0.08058472,0.003703082,0.817343,0.00084153475,0.0019988494,0.006431635,0.0004483445,0.0095247,0.0725459,0.0014912202,0.0039754272,0.0011116002],"about_ca_topic_score_codex":0.000118648415,"about_ca_topic_score_gemma":0.00006758596,"teacher_disagreement_score":0.40173635,"about_ca_system_score_codex":0.0007402723,"about_ca_system_score_gemma":0.002004787,"threshold_uncertainty_score":0.9995479},"labels":[],"label_agreement":null},{"id":"W2914655788","doi":"10.1182/blood-2018-99-110588","title":"Correlations of Plasma Cytokine Levels and Anti-FVIII Antibodies during Immune Tolerance Induction","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Titer; Medicine; Immunology; Cytokine; Antibody; Immune tolerance; Tumor necrosis factor alpha; Internal medicine; Antibody titer; Gastroenterology","score_opus":0.03221863466643333,"score_gpt":0.2967526556272365,"score_spread":0.2645340209608032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914655788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99744695,0.0003240877,0.000006164953,0.00031414063,0.000079479985,0.00017769645,0.000010860434,0.000025341804,0.0016152973],"genre_scores_gemma":[0.9979703,0.00012123987,0.0003912204,0.0000039473475,0.0002108388,0.000003741441,0.00000775685,0.000009196075,0.0012817587],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999416,0.000014253433,0.00015835262,0.00013177082,0.00014153725,0.00013810216],"domain_scores_gemma":[0.9996352,0.0000236005,0.000042274358,0.00014435501,0.000107128464,0.00004741866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000068691035,0.00007413093,0.0001834092,0.00010189009,0.00012274637,0.0000065577506,0.000027680428,0.00005899959,0.000060462113],"category_scores_gemma":[0.000050514678,0.00005791201,0.000030233272,0.0001465218,0.00018108793,0.000072009134,0.00003139554,0.000089944144,0.000018263036],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052502735,0.00031344368,0.3489832,0.00009038617,0.00010770365,0.000017436425,0.0004387882,7.4529964e-7,0.64916646,0.00005104425,0.000014299523,0.00076401833],"study_design_scores_gemma":[0.0020323137,0.00013045147,0.57083726,0.00010247184,0.000058883154,0.00008323615,0.000047842892,0.000036619665,0.4265767,0.000010810191,0.000047293408,0.00003612124],"about_ca_topic_score_codex":0.000019002306,"about_ca_topic_score_gemma":0.000003526742,"teacher_disagreement_score":0.22258975,"about_ca_system_score_codex":0.000007826254,"about_ca_system_score_gemma":0.00003073856,"threshold_uncertainty_score":0.23615833},"labels":[],"label_agreement":null},{"id":"W2914667081","doi":"10.1182/blood-2018-99-113099","title":"A Pooled Analysis of Survival By Defibrotide Timing of Initiation in Adults with Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) Following Hematopoietic Stem Cell Transplant (HSCT)","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Defibrotide; Medicine; Hepatic veno-occlusive disease; Expanded access; Hematopoietic stem cell transplantation; Surgery; Complication; Internal medicine; Transplantation","score_opus":0.008897714578352416,"score_gpt":0.2273450944127979,"score_spread":0.21844737983444548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914667081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963744,0.00018997071,0.0019525809,0.000024050067,0.00006754608,0.00061631325,0.00013395483,0.000037178048,0.0006039906],"genre_scores_gemma":[0.99896693,0.000019862706,0.00056506775,0.000012374741,0.000019744059,0.000027785827,0.00033408374,0.000037165726,0.00001699098],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978083,0.00012371855,0.0007541918,0.0003953125,0.0006313721,0.0002871479],"domain_scores_gemma":[0.9988788,0.00017033672,0.00033202406,0.00031879637,0.00014725892,0.00015277762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021642404,0.00024085221,0.00082053617,0.00051746,0.000048800193,0.0000091148695,0.000096276955,0.0001162029,0.00003272017],"category_scores_gemma":[0.000013297111,0.0002246705,0.00022905263,0.0011205977,0.00008604585,0.00013665122,0.00001062653,0.0001254018,0.000004433636],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039525474,0.0026955737,0.7976258,0.007771056,0.0044137016,0.0010913985,0.031564437,0.00037773573,0.15015432,0.000115455325,0.000005859471,0.0002321097],"study_design_scores_gemma":[0.020221148,0.0016641413,0.5968627,0.008031064,0.028562881,0.0003307495,0.004281339,0.0028876127,0.33647236,0.000035973368,0.0000015155,0.000648554],"about_ca_topic_score_codex":0.00013053484,"about_ca_topic_score_gemma":0.00015035913,"teacher_disagreement_score":0.20076315,"about_ca_system_score_codex":0.000055005574,"about_ca_system_score_gemma":0.00013818801,"threshold_uncertainty_score":0.9161797},"labels":[],"label_agreement":null},{"id":"W2914737132","doi":"10.1182/blood.v130.suppl_1.4862.4862","title":"ITP Patients in the Asia Pacific: Are They Different?","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Epidemiology; Population; Cohort; Pediatrics; Internal medicine; Environmental health","score_opus":0.015673651818789415,"score_gpt":0.25176063961523565,"score_spread":0.23608698779644624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914737132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.974352,0.000056367564,1.8761578e-7,0.00087053166,0.000056620665,0.00025727134,0.000013702193,0.000010565111,0.024382744],"genre_scores_gemma":[0.9994345,0.000052417745,0.0000079474885,0.00008631412,0.000028658988,0.000020510124,0.000026479738,0.000008509274,0.00033468762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99946797,0.000018082208,0.00008636067,0.00012601147,0.00015066628,0.00015089154],"domain_scores_gemma":[0.99941564,0.000016643735,0.00007081644,0.0004449116,0.000016524531,0.000035478966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000035603432,0.00009309296,0.00016231097,0.000023685392,0.00013201684,0.000039561754,0.00013823362,0.00004311439,0.00001874799],"category_scores_gemma":[0.000053898057,0.00004892483,0.000047510028,0.000014072978,0.00002260159,0.000041295938,0.0000261063,0.00008897414,0.000048236107],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023949322,0.0021218264,0.9952076,0.0000094682955,0.000049957336,0.00024753355,0.00034676082,1.224164e-8,0.000017894188,0.000037919395,0.0003097801,0.0016273088],"study_design_scores_gemma":[0.0053578303,0.00012527195,0.99296176,0.000048597365,0.00008608605,0.000013300312,0.00025806218,0.0000015119149,0.00017241204,0.000374666,0.0005487874,0.000051717867],"about_ca_topic_score_codex":0.00008365058,"about_ca_topic_score_gemma":0.00022250513,"teacher_disagreement_score":0.025082465,"about_ca_system_score_codex":0.000007174433,"about_ca_system_score_gemma":0.000006701612,"threshold_uncertainty_score":0.19950967},"labels":[],"label_agreement":null},{"id":"W2914775586","doi":"10.1182/blood-2018-99-114318","title":"Ratify (Alliance 10603): Prognostic Impact of FLT3 tyrosine Kinase Domain (TKD) and NPM1 Mutation Status in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Treated with Midostaurin or Placebo Plus Standard Chemotherapy","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Midostaurin; NPM1; Internal medicine; Medicine; Oncology; Myeloid leukemia; Chemotherapy regimen; Chemotherapy; Biology; Genetics; Gene","score_opus":0.008338723426162282,"score_gpt":0.2722119528022429,"score_spread":0.26387322937608065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914775586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99573535,0.00016450489,0.00020119014,0.0001024858,0.000015293688,0.003246183,0.00033980008,0.000078364974,0.00011683951],"genre_scores_gemma":[0.9912417,0.00020732629,0.0076036826,0.00007833415,0.0000811177,0.00015651814,0.00036821683,0.000116487754,0.00014663563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99703324,0.00014915367,0.00051376,0.0006569399,0.00082284096,0.00082408293],"domain_scores_gemma":[0.99785054,0.0003092891,0.00028649665,0.0005289106,0.00061336806,0.00041137345],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027523524,0.00048977963,0.00085406436,0.00029438312,0.00010102241,0.000059153168,0.00015641825,0.00019008761,0.00013902564],"category_scores_gemma":[0.000262269,0.00031042477,0.000060936116,0.0010707064,0.00053401425,0.0002692464,0.000050499042,0.0003803781,0.000007785941],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11170605,0.0010721587,0.8691188,0.00024936165,0.0009078595,0.0011644305,0.0028805584,0.000049288352,0.007432499,0.0000066279854,0.00032505253,0.0050872816],"study_design_scores_gemma":[0.14368148,0.018805945,0.8049746,0.0007950201,0.00035316433,0.00007758314,0.0002686966,0.00024586645,0.030326817,0.000010734758,0.00005445593,0.00040563216],"about_ca_topic_score_codex":0.0009477085,"about_ca_topic_score_gemma":0.00081759144,"teacher_disagreement_score":0.064144224,"about_ca_system_score_codex":0.0012961909,"about_ca_system_score_gemma":0.0024652302,"threshold_uncertainty_score":0.9999348},"labels":[],"label_agreement":null},{"id":"W2914847033","doi":"10.1182/blood-2018-99-114481","title":"Avadomide (CC-122) Alters T Cell Repertoire and Enhances Infiltration of Lymphocytes into Tumor Microenvironment in DLBCL Patients","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Immunophenotyping; Cancer research; Aldesleukin; Tumor microenvironment; T cell; Lymphoma; Population; Immunology; Interleukin-7 receptor; Biology; Flow cytometry; Immune system; Medicine; IL-2 receptor","score_opus":0.0025517270540910356,"score_gpt":0.18706907670916115,"score_spread":0.1845173496550701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914847033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988976,0.00046167977,0.000030931402,0.00002264284,0.00005152163,0.00013923083,0.000004514316,0.0000029039732,0.0003889642],"genre_scores_gemma":[0.9987555,0.00016632101,0.0007504182,0.00013161583,0.00006326506,0.0000126851755,0.000043140084,0.0000072835005,0.00006975404],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99942803,0.000029974792,0.00018470328,0.0001937863,0.000069995716,0.000093492235],"domain_scores_gemma":[0.9997103,0.00000390026,0.000091133,0.00013983766,0.00002299231,0.000031786956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000060514838,0.000081324164,0.00008125962,0.000031095606,0.000032303647,0.000007758147,0.000061013794,0.00004601781,0.0000055141663],"category_scores_gemma":[0.000033997312,0.0000766581,0.000021804923,0.000033788576,0.00010679261,0.0000060632183,0.000047393172,0.000021387263,0.0000039828074],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035690868,0.0018298592,0.026048616,0.000022486138,0.00000828024,4.3957084e-7,0.00012589296,1.708331e-7,0.97049576,0.0000023260093,0.00013234731,0.001298158],"study_design_scores_gemma":[0.0073006065,0.0003150513,0.005239873,0.000020182959,0.00000720621,0.0000011686739,0.0000449229,0.000007462315,0.98530054,0.0000126844225,0.0016660241,0.00008429369],"about_ca_topic_score_codex":0.000043610613,"about_ca_topic_score_gemma":0.000040956264,"teacher_disagreement_score":0.020808741,"about_ca_system_score_codex":0.000009873352,"about_ca_system_score_gemma":0.000022543536,"threshold_uncertainty_score":0.31260264},"labels":[],"label_agreement":null},{"id":"W2914856252","doi":"10.1182/blood-2018-99-118967","title":"CD4+ T-Cell Lymphopenia in Frequent Platelet Donors Who Have Ceased Platelet Donation for at Least 1 Year","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Blood donation and transfusion practices","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Plateletpheresis; Leukoreduction; Medicine; Apheresis; Platelet; Donation; Platelet transfusion; Internal medicine; Immunology; Surgery","score_opus":0.016447668959619938,"score_gpt":0.2291518904668239,"score_spread":0.21270422150720397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914856252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9433108,0.000059010792,0.00014379954,0.0012652442,0.00029783364,0.0006135511,0.000021226318,0.000091813214,0.05419671],"genre_scores_gemma":[0.9954374,0.00002944081,0.00045141243,0.0017439473,0.0007559266,0.00006625685,0.00013488207,0.000039990868,0.001340757],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99869096,0.000015951868,0.00033960454,0.00037732176,0.0002739319,0.00030221613],"domain_scores_gemma":[0.9992655,0.00008243951,0.00022882725,0.00020408869,0.00019541458,0.000023763918],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003874274,0.00019414512,0.00020562716,0.00030485314,0.00023123296,0.00024352084,0.00021691149,0.00012271757,0.0010493499],"category_scores_gemma":[0.00008076695,0.00019021526,0.000080729,0.00028937674,0.000052661617,0.0010499359,0.0000743378,0.000093357485,0.00072583364],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068948916,0.016619992,0.59920096,0.0028961753,0.0010640054,0.00040644457,0.0035053259,0.00027392362,0.07108713,0.0972607,0.120764524,0.08002592],"study_design_scores_gemma":[0.033142775,0.000120553035,0.026511455,0.00013164936,0.00026229216,0.0000152348,0.0005465245,0.0038542645,0.05895606,0.0022633423,0.8731981,0.000997755],"about_ca_topic_score_codex":0.0005896112,"about_ca_topic_score_gemma":0.0023960532,"teacher_disagreement_score":0.7524336,"about_ca_system_score_codex":0.000035282166,"about_ca_system_score_gemma":0.000032431257,"threshold_uncertainty_score":0.9998638},"labels":[],"label_agreement":null},{"id":"W2914866404","doi":"10.1182/blood-2018-99-117659","title":"Targeting Oncoprotein Translation with Rocaglates in MYC-Driven Lymphoma","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Phytochemical compounds biological activities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cancer research; Kinome; Lymphoma; Biology; Synthetic lethality; Kinase; Immunology; Gene; DNA repair; Cell biology; Genetics","score_opus":0.010287082363683343,"score_gpt":0.22292885320775238,"score_spread":0.21264177084406904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914866404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99735385,0.00027228106,0.00033248487,0.000066014836,0.000015714457,0.00014140485,0.000004762749,0.000018930908,0.0017945786],"genre_scores_gemma":[0.9965279,0.000010580075,0.0030170311,0.00008061925,0.0002459867,0.000028429347,0.00005191283,0.00001140017,0.000026102201],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999322,0.00003568615,0.00012021067,0.0002569395,0.000070354996,0.00019483366],"domain_scores_gemma":[0.9997508,0.000013689162,0.00004088429,0.00012350822,0.00003453645,0.000036611564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000061556995,0.00011201187,0.00010758413,0.000020839992,0.000040529005,0.000013219489,0.00011324694,0.00011300391,0.000012042612],"category_scores_gemma":[0.00003322104,0.00008674916,0.000027735265,0.00008411365,0.00011208823,0.000004536734,0.000036065645,0.000044578283,0.0000071926174],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012098885,0.00018166123,0.0064129625,0.000006273019,0.000018902081,0.0000029042524,0.000034430403,0.000005933377,0.9913327,0.00000538501,0.000015294829,0.0018625659],"study_design_scores_gemma":[0.0013088752,0.00066035823,0.003180249,0.000019525118,0.0000081056505,0.0000084870635,0.00002428439,0.00007744709,0.9920787,0.00016817628,0.0023080665,0.00015769791],"about_ca_topic_score_codex":0.000019592862,"about_ca_topic_score_gemma":0.00004824666,"teacher_disagreement_score":0.0032327138,"about_ca_system_score_codex":0.000007477834,"about_ca_system_score_gemma":0.000026783488,"threshold_uncertainty_score":0.3537528},"labels":[],"label_agreement":null},{"id":"W2914870447","doi":"10.1182/blood-2018-99-110343","title":"Clinical Characterization of a Novel Mutation in SLC25A38 Resulting in Congenital Sideroblastic Anemia in a Canadian First Nations Population","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Porphyrin Metabolism and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Anemia; Population; Missense mutation; Thalassemia; Sideroblastic anemia; Internal medicine; Mutation; Pediatrics; Immunology; Genetics; Biology","score_opus":0.011853744377721482,"score_gpt":0.27124085185506325,"score_spread":0.2593871074773418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914870447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992592,0.00003023114,0.00012088492,0.000033834185,0.00006313127,0.00016194934,0.000037214973,0.0000024285134,0.00029113583],"genre_scores_gemma":[0.998968,0.000021603011,0.00042716842,0.000034774825,0.00005837597,0.000013465694,0.00046131443,0.000007375998,0.000007931453],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992083,0.000037878108,0.00037061409,0.00017512971,0.000053534954,0.00015459086],"domain_scores_gemma":[0.9996997,0.000023868317,0.00008881352,0.0000969997,0.000046102694,0.000044512017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023549303,0.000063565334,0.00010073178,0.00022992428,0.000029275834,0.0000070882793,0.000056181365,0.00011663478,0.000004905552],"category_scores_gemma":[0.00076105894,0.00007415281,0.000020983478,0.0002644304,0.000034657885,0.000009390434,0.00001529207,0.00005106701,0.0000014365476],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036085192,0.00032174776,0.8570299,0.000020333371,0.0000058520186,0.0000035044536,0.00022430175,0.000116743926,0.1418595,0.00010512182,0.0000019222339,0.00027499037],"study_design_scores_gemma":[0.0022720606,0.00006145903,0.99251807,0.000033399378,0.000007554426,0.000002878255,0.000054370288,0.0010149031,0.0038848133,0.0000163119,0.000051696927,0.000082456536],"about_ca_topic_score_codex":0.0408203,"about_ca_topic_score_gemma":0.82229334,"teacher_disagreement_score":0.78147304,"about_ca_system_score_codex":0.000010436298,"about_ca_system_score_gemma":0.00011554108,"threshold_uncertainty_score":0.96556693},"labels":[],"label_agreement":null},{"id":"W2915022322","doi":"10.1182/blood-2018-99-111728","title":"Genotypic Representation of Myelodysplastic/Myeloproliferative Neoplasms in Nrg, Nrg-3GS and Srg-W41 Mice with Transgenic Expression of Human Cytokines","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Chronic myelomonocytic leukemia; Juvenile myelomonocytic leukemia; Cancer research; Leukemia; Biology; Myelodysplastic syndromes; Bone marrow; Myeloid; CD34; Immunology; Stem cell; Haematopoiesis; Genetics","score_opus":0.01863917191312366,"score_gpt":0.2970871510892594,"score_spread":0.2784479791761358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2915022322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978162,0.00018406348,0.00023676429,0.0001305691,0.000022744165,0.0006522542,0.000016055337,0.00002242491,0.00091889274],"genre_scores_gemma":[0.9965273,0.000078806275,0.0028930996,0.000029074721,0.00013621892,0.00003774085,0.000027753978,0.000032547152,0.0002374678],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983262,0.00011092638,0.0004458259,0.00039134023,0.00044402218,0.00028171125],"domain_scores_gemma":[0.99888587,0.00016899634,0.00016272938,0.00032672417,0.00034005768,0.00011562484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021080526,0.00018837403,0.00048320822,0.00029825402,0.00006831478,0.0000093948665,0.00012342793,0.00013128486,0.00007483348],"category_scores_gemma":[0.00012260138,0.00014484495,0.000043990454,0.00050342584,0.00042133746,0.00013299409,0.000057757723,0.0002370839,0.0000051005227],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015420506,0.00036485482,0.075682975,0.0002704045,0.00009105571,0.000028833443,0.004063701,0.0000037059363,0.91742814,0.00009427567,0.000059115606,0.00037087893],"study_design_scores_gemma":[0.00847963,0.0018245254,0.12719996,0.0004120275,0.00015795181,0.00006841031,0.000597751,0.000120591125,0.86090446,0.000095013536,0.000015954169,0.00012370503],"about_ca_topic_score_codex":0.00023416802,"about_ca_topic_score_gemma":0.00028654505,"teacher_disagreement_score":0.05652367,"about_ca_system_score_codex":0.000041307907,"about_ca_system_score_gemma":0.00021050352,"threshold_uncertainty_score":0.5906606},"labels":[],"label_agreement":null},{"id":"W2915036163","doi":"10.1182/blood-2018-99-115539","title":"Gemcitabine, Dexamethasone, Cisplatin +/- Rituximab (GDP +/- R) Is Highly Effective As a Mobilization Regimen in Relapsed or Refractory Lymphoma (COLLYM STUDY)","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Hôpital Maisonneuve-Rosemont; Centre intégré universitaire de santé et de services sociaux de l'Est-de-l'Île-de-Montréal; Centre hospitalier universitaire de Québec; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Plerixafor; Rituximab; Regimen; Internal medicine; Gemcitabine; Chemotherapy regimen; Autologous stem-cell transplantation; Cyclophosphamide; Surgery; Oncology; Transplantation; Gastroenterology; Urology; Chemotherapy; Lymphoma","score_opus":0.013147775919567123,"score_gpt":0.28851874612038403,"score_spread":0.2753709702008169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2915036163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99040836,0.000461529,0.000008170265,0.00028404227,0.0001873522,0.003370596,0.00001992472,0.00013482863,0.0051251776],"genre_scores_gemma":[0.9955321,0.00007191752,0.0008323891,0.00065166637,0.00025317373,0.001026576,0.000025832129,0.00007055096,0.0015358052],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973732,0.00024682286,0.00055301015,0.0008205259,0.00053784717,0.00046856597],"domain_scores_gemma":[0.99807996,0.0004573907,0.00021738216,0.0007821026,0.0002470517,0.00021613046],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004054943,0.00040207835,0.0007391595,0.00033945203,0.00014426987,0.00004510814,0.00014761808,0.0002320774,0.00037328622],"category_scores_gemma":[0.00054541044,0.0003058243,0.00012879375,0.00089660607,0.00011569163,0.00014522245,0.000092277965,0.00010939513,0.00048040162],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063258447,0.09046573,0.83027226,0.00019177454,0.0016251544,0.002695338,0.009293955,0.000001558236,0.0033029425,0.00019664326,0.004068371,0.051560413],"study_design_scores_gemma":[0.110890776,0.016215745,0.8338889,0.00040673223,0.0011610206,0.00018450728,0.00101201,0.00010924317,0.03333045,0.00011511147,0.0022291634,0.00045635272],"about_ca_topic_score_codex":0.0011906562,"about_ca_topic_score_gemma":0.0005346095,"teacher_disagreement_score":0.104564935,"about_ca_system_score_codex":0.0004923123,"about_ca_system_score_gemma":0.00037907524,"threshold_uncertainty_score":0.9999394},"labels":[],"label_agreement":null},{"id":"W2915039560","doi":"10.1182/blood-2018-99-113057","title":"Targeting CD47 and TNFAIP8 By Mir-155 Overcomes Drug Resistance and Inhibits Tumor Growth through Induction of Phagocytosis and Apoptosis in Multiple Myeloma","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"CD47; Downregulation and upregulation; Phagocytosis; Apoptosis; Cancer research; Cell culture; Drug resistance; Biology; Molecular biology; Chemistry; Cell biology; Biochemistry; Gene","score_opus":0.009552585215572342,"score_gpt":0.21589260721998213,"score_spread":0.2063400220044098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2915039560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98043513,0.018880835,0.000015925296,0.00018008506,0.000105556865,0.0002087608,0.000032120195,0.00002441177,0.00011715408],"genre_scores_gemma":[0.99838823,0.0009042539,0.0003961798,0.000045079876,0.000027842772,0.000016369386,0.00004112805,0.000016377966,0.00016452481],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99885756,0.00014067459,0.0003591455,0.00035573792,0.000041862168,0.00024504642],"domain_scores_gemma":[0.9994742,0.00011857121,0.00019058073,0.00012904988,0.00006904878,0.000018501343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002309798,0.000180689,0.00034447422,0.00009013596,0.00018527839,0.00001860312,0.00006438359,0.00013773043,0.000016131373],"category_scores_gemma":[0.00012787103,0.00017072698,0.000026100515,0.00016910797,0.00040185932,0.00033763572,0.000099428944,0.00014269172,0.0000027551005],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012417289,0.00016856482,0.04350136,0.000075101125,0.00007058433,4.851171e-7,0.0014510626,3.852946e-8,0.9530416,0.000095204065,0.00083590014,0.00063594175],"study_design_scores_gemma":[0.003358291,0.00009600056,0.05982427,0.00012416829,0.00005403394,0.000027518738,0.00041659104,0.0000028388774,0.93459964,0.00021329112,0.0011034756,0.00017985865],"about_ca_topic_score_codex":0.00017211569,"about_ca_topic_score_gemma":0.00007220535,"teacher_disagreement_score":0.018441923,"about_ca_system_score_codex":0.000014779684,"about_ca_system_score_gemma":0.000015351228,"threshold_uncertainty_score":0.6962044},"labels":[],"label_agreement":null},{"id":"W2915117294","doi":"10.1182/blood-2018-99-110363","title":"Modeling the Initiation and Evolution of Down Syndrome Associated Leukemia Using CRISPR/Cas9","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"GATA1; Haematopoiesis; Myeloid leukemia; Biology; Leukemia; Progenitor cell; Cancer research; Myeloid; Acute leukemia; Stem cell; CRISPR; Immunology; Genetics; Gene","score_opus":0.03366271168343069,"score_gpt":0.3024676171566177,"score_spread":0.268804905473187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2915117294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957501,0.00028662686,0.0027982756,0.00016670767,0.000037679263,0.00026203028,0.000007740734,0.000033181615,0.0006576019],"genre_scores_gemma":[0.99909514,0.000024985937,0.0006174273,0.00006453697,0.00011918087,0.000004974834,0.000010379827,0.000017397217,0.00004595557],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99900657,0.0000804057,0.00022093822,0.00016641601,0.00030908984,0.0002165591],"domain_scores_gemma":[0.99926263,0.000064447304,0.00007486471,0.0002173374,0.00032023052,0.000060489554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051320647,0.00008936981,0.00018563266,0.00011243867,0.00014465794,0.000014776468,0.00007445122,0.0001174257,0.00002402507],"category_scores_gemma":[0.00046659794,0.000065847635,0.00003751596,0.0002969163,0.00013102792,0.00010298484,0.000071958435,0.00021020109,0.0000093278795],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007393881,0.0012693929,0.19348153,0.0006390699,0.001954702,0.00030623135,0.0063623753,0.002143387,0.7881776,0.0022121544,0.0008615438,0.0018525877],"study_design_scores_gemma":[0.006966542,0.00079803367,0.088241875,0.0004207936,0.00079218706,0.0008872859,0.00071642216,0.8814073,0.018765505,0.00076603785,0.000021323645,0.00021665453],"about_ca_topic_score_codex":0.000622439,"about_ca_topic_score_gemma":0.000030471556,"teacher_disagreement_score":0.87926394,"about_ca_system_score_codex":0.00045930324,"about_ca_system_score_gemma":0.0004374778,"threshold_uncertainty_score":0.26851887},"labels":[],"label_agreement":null},{"id":"W2915128108","doi":"10.1182/blood-2018-11-833996","title":"Prevention of transfusion-transmitted infections","year":2019,"lang":"en","type":"review","venue":"Blood","topic":"Animal Disease Management and Epidemiology","field":"Agricultural and Biological Sciences","cited_by":299,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; University of British Columbia","funders":"","keywords":"Residual risk; Context (archaeology); Virology; Hepatitis B virus; Window period; Immunology; Medicine; Pandemic; Hepatitis C virus; Zika virus; Virus; Biology; Serology; Infectious disease (medical specialty); Antibody; Disease; Internal medicine; Coronavirus disease 2019 (COVID-19)","score_opus":0.07109606391359351,"score_gpt":0.3059199849785224,"score_spread":0.2348239210649289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2915128108","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028596092,0.993642,0.000005976911,0.000022621736,0.000083882536,0.00060378335,0.00006529638,0.000042670006,0.0026741598],"genre_scores_gemma":[0.00043796742,0.99847203,0.000009422594,0.000012328578,0.00011454147,0.00003950026,0.0003252883,0.0000011398033,0.0005877811],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990032,0.00017158804,0.0003634447,0.00023616309,0.000077051525,0.00014858207],"domain_scores_gemma":[0.9995262,0.00019174477,0.00017094745,0.000052390802,0.000019936551,0.000038783546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014409728,0.00016244732,0.0007484958,0.000020753841,0.00004827604,0.0000066650136,0.00016893876,0.00019015578,0.00070070283],"category_scores_gemma":[0.00002228074,0.00005508387,0.00064576033,0.00028604033,0.000025871339,0.00003437685,0.000028342345,0.00010678906,0.00011642664],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000020152356,0.00043573533,0.00020436004,0.002904847,0.00014995818,8.2360447e-7,0.0000025573786,6.272866e-8,0.00003037451,0.00036309919,0.00023932963,0.99566686],"study_design_scores_gemma":[0.00009898823,0.0002952465,0.0013441555,0.0014469153,0.0017950498,0.0000026018708,0.0000053808535,5.158853e-7,9.773406e-7,0.0001899251,0.99466896,0.0001512904],"about_ca_topic_score_codex":0.000060194805,"about_ca_topic_score_gemma":0.00007567893,"teacher_disagreement_score":0.9955155,"about_ca_system_score_codex":0.000004303809,"about_ca_system_score_gemma":0.000011796058,"threshold_uncertainty_score":0.76722044},"labels":[],"label_agreement":null},{"id":"W29151859","doi":"10.1182/blood.v122.21.2970.2970","title":"Non-Invasive Hemoglobin Measurements In Anemic Patients","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Joseph's Hospital; Centre Hospitalier Universitaire Sainte-Justine; McMaster University; Université de Montréal; St. Joseph’s Healthcare Hamilton; University of British Columbia","funders":"","keywords":"Medicine; Anemia; Hemoglobin; Complete blood count; Cohort; Hematocrit; Population; Outpatient clinic; Internal medicine; Pediatrics; Surgery","score_opus":0.010396564083522382,"score_gpt":0.21574045128311645,"score_spread":0.20534388719959407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W29151859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841878,0.00021402644,0.0000013932643,0.00029994705,0.000120706725,0.00075110246,0.0000019211436,0.000034867247,0.014388235],"genre_scores_gemma":[0.998697,0.000075798554,0.00016295661,0.00061053794,0.000031224903,0.00004752611,0.000026572541,0.00002045865,0.00032794746],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989084,0.00001709941,0.000255721,0.00022515617,0.00027615033,0.00031745786],"domain_scores_gemma":[0.99945354,0.000013053294,0.000051420415,0.00021832406,0.000120441386,0.00014323877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007111808,0.00014198107,0.00021789587,0.00010794622,0.00003520186,0.00001271913,0.00007784597,0.00014294036,0.00023970279],"category_scores_gemma":[0.00009511832,0.000116083786,0.00006266473,0.00022790465,0.00003461434,0.000078499346,0.000033119573,0.00019231097,0.0006384799],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018889023,0.0015749884,0.9803443,0.000078280566,0.00006070601,0.00001918341,0.00028710917,0.0000028354877,0.013177021,0.0000020897314,0.0026951146,0.0017394775],"study_design_scores_gemma":[0.021834232,0.00055567996,0.94735754,0.00046899013,0.00016686367,0.000029076928,0.00040397412,0.000033191736,0.02827984,0.000121087374,0.00042737453,0.00032214896],"about_ca_topic_score_codex":0.00029287575,"about_ca_topic_score_gemma":0.000022723887,"teacher_disagreement_score":0.032986764,"about_ca_system_score_codex":0.000045850415,"about_ca_system_score_gemma":0.00008452012,"threshold_uncertainty_score":0.820658},"labels":[],"label_agreement":null},{"id":"W2915478666","doi":"10.1182/blood-2018-99-113642","title":"CAR-Modified Th1/Tc1-Polarized T-Rapa Cells Dissociate Inflammatory Cytokine Secretion from Anti-Tumor Cytotoxicity","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Immunology; Cytokine release syndrome; Chimeric antigen receptor; Cytokine; Interleukin 21; Interleukin 12; Cancer research; Biology; Medicine; Immunotherapy; Cytotoxic T cell; T cell; Immune system; In vitro","score_opus":0.018173105808239463,"score_gpt":0.2748453735791264,"score_spread":0.256672267770887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2915478666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98903954,0.0001578592,0.00021935056,0.00030087493,0.0002644475,0.0009859293,0.00014203237,0.00025246115,0.008637482],"genre_scores_gemma":[0.99501294,0.00007784964,0.00027194008,0.0005676092,0.001704767,0.00004717287,0.00015227642,0.00009345721,0.0020719978],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971502,0.00024283449,0.00052117754,0.00062349037,0.0007605707,0.0007017179],"domain_scores_gemma":[0.9979526,0.0001726524,0.00020229732,0.0008636645,0.00043501635,0.00037379374],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006584117,0.00034291876,0.0006887329,0.00019787066,0.00022316407,0.00008149798,0.00026713207,0.00025567558,0.0025028812],"category_scores_gemma":[0.000215684,0.00031372614,0.00027264954,0.00037995985,0.00031651565,0.00014905068,0.00015360264,0.0005691675,0.00040410456],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006248773,0.0006054501,0.015080086,0.000059397382,0.00035754702,0.00017200503,0.0005284268,4.0017218e-7,0.9819693,0.000047182897,0.0003962694,0.0001590755],"study_design_scores_gemma":[0.010394503,0.00052388845,0.054239746,0.00011961208,0.00029351225,0.000028318758,0.00009064864,0.00031707413,0.9299818,0.00037716844,0.0032870984,0.0003465843],"about_ca_topic_score_codex":0.0005397885,"about_ca_topic_score_gemma":0.000095267875,"teacher_disagreement_score":0.051987436,"about_ca_system_score_codex":0.00014767265,"about_ca_system_score_gemma":0.00024407572,"threshold_uncertainty_score":0.99993145},"labels":[],"label_agreement":null},{"id":"W2915517176","doi":"10.1182/blood-2018-99-111015","title":"Targeting the Mitochondrial Metallochaperone Cox17 Reduces DNA Methylation and Promotes AML Differentiation through a Copper Dependent Mechanism","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Stem cell; Haematopoiesis; Gene knockdown; Clonogenic assay; Biology; Leukemia; Cancer research; Myeloid leukemia; Small hairpin RNA; Intermembrane space; Molecular biology; Cell biology; Chemistry; Apoptosis; Biochemistry; Immunology; Gene","score_opus":0.021842327363755173,"score_gpt":0.2837363163207829,"score_spread":0.2618939889570277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2915517176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99249077,0.00051317597,0.002860984,0.002272738,0.00024261094,0.0010316581,0.0000075742582,0.000076446544,0.00050402654],"genre_scores_gemma":[0.99075043,0.0001220917,0.007197439,0.00016418712,0.001163647,0.000079286896,0.000051259725,0.000034331897,0.00043730927],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99833375,0.0001702604,0.00027564712,0.00037569777,0.00052421406,0.00032041728],"domain_scores_gemma":[0.9991906,0.00013221076,0.00011845813,0.00026971695,0.0002033412,0.00008563485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037530615,0.00018097373,0.0002605251,0.00006369173,0.00031119183,0.00007721673,0.00013119342,0.00013246901,0.0001505677],"category_scores_gemma":[0.00044422896,0.00011616228,0.000056688103,0.00015621047,0.00016361909,0.0001825722,0.00013900198,0.00026719947,0.00004291098],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012291071,0.00018290263,0.00011997101,0.000030984527,0.00026534923,0.0000073130514,0.0018617806,1.8587376e-7,0.9953619,0.0008654285,0.0002578151,0.00092343334],"study_design_scores_gemma":[0.0040682945,0.0006005974,0.001267214,0.000051711548,0.00054387574,0.00007180563,0.0005240543,0.0007746623,0.9890343,0.002588829,0.00031498593,0.0001597009],"about_ca_topic_score_codex":0.000071163144,"about_ca_topic_score_gemma":0.000017798546,"teacher_disagreement_score":0.0063276566,"about_ca_system_score_codex":0.000058894933,"about_ca_system_score_gemma":0.00010451226,"threshold_uncertainty_score":0.47369605},"labels":[],"label_agreement":null},{"id":"W2915663078","doi":"10.1182/blood-2018-99-119734","title":"Functional and Molecular Consequences of Trisomy 21 on Human Fetal Hematopoiesis","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Prenatal Screening and Diagnostics","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Biology; Haematopoiesis; Trisomy; Bone marrow; Progenitor cell; Immunology; Leukemia; Fetus; Flow cytometry; Transplantation; Stem cell; Andrology; Molecular biology; Cancer research; Genetics; Internal medicine; Medicine; Pregnancy","score_opus":0.028603121713281013,"score_gpt":0.2797724438841057,"score_spread":0.2511693221708247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2915663078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99020743,0.00026045533,0.000109703,0.00028834294,0.000027482267,0.000064571075,0.000008706201,0.00002135676,0.009011937],"genre_scores_gemma":[0.99892306,0.000004826472,0.000680974,0.00018917749,0.00008225413,0.0000032194755,0.0000104632145,0.0000047779463,0.00010124153],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995718,0.000012215951,0.00009765965,0.00010438024,0.00013703843,0.00007688746],"domain_scores_gemma":[0.9996866,0.00007145593,0.000034173536,0.000100356825,0.000048228838,0.000059187085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000054632128,0.000056174027,0.00012005097,0.000037317554,0.000042114814,0.000004597782,0.000023393166,0.000039613755,0.00008227555],"category_scores_gemma":[0.00017974943,0.000045676377,0.000028874221,0.000049703332,0.00023996223,0.000014490138,0.000017932718,0.000046537592,0.000013639984],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005802788,0.002329275,0.19391195,0.00030974767,0.0006767626,0.00045431466,0.00036681257,0.0000017743513,0.7482345,0.04325861,0.0068663126,0.0030096665],"study_design_scores_gemma":[0.003048677,0.0014314719,0.06992733,0.00018291322,0.00021788642,0.00016068143,0.00006809394,0.0000051313764,0.92333174,0.0012284442,0.00030935724,0.00008825787],"about_ca_topic_score_codex":0.000041524832,"about_ca_topic_score_gemma":0.0000024955707,"teacher_disagreement_score":0.17509727,"about_ca_system_score_codex":0.0000025910874,"about_ca_system_score_gemma":0.000024060195,"threshold_uncertainty_score":0.18626286},"labels":[],"label_agreement":null},{"id":"W2915705121","doi":"10.1182/blood-2018-99-115191","title":"Genetic Analysis of B-Cell Acute Lymphoblastic Leukemia Dissemination to the Central Nervous System Identifies Clonal Selection and Therapeutic Vulnerability","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Biology; Disease; Bone marrow; Leukemia; Central nervous system; Immunology; Cancer research; Medicine; Pathology; Neuroscience","score_opus":0.008555314083640965,"score_gpt":0.27267350032508825,"score_spread":0.2641181862414473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2915705121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930826,0.00017049887,0.005705371,0.00012669025,0.00010790631,0.00052707305,0.000031551772,0.00005129103,0.00019700524],"genre_scores_gemma":[0.99883175,0.000017073426,0.00045271695,0.000059554335,0.00024570158,0.000044513967,0.000017636905,0.000022133705,0.0003089147],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980348,0.00016032899,0.00040348183,0.00041155829,0.0005983694,0.00039149544],"domain_scores_gemma":[0.9985968,0.00031207502,0.00012366084,0.00039791578,0.0003827613,0.00018682209],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037356463,0.00018250351,0.00039381027,0.0003096693,0.00019271672,0.000049537077,0.00017050968,0.00010780502,0.00004987658],"category_scores_gemma":[0.00013025249,0.00012592447,0.00013291396,0.0013609617,0.00018987607,0.000042765707,0.00008788299,0.000118230586,0.000019533993],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016686445,0.0013445134,0.2577908,0.0011520281,0.010766295,0.000087415276,0.0062130825,0.001037623,0.70674235,0.00036084803,0.00088382856,0.011952577],"study_design_scores_gemma":[0.0017805751,0.00062837545,0.83866054,0.00007526385,0.0081700785,0.00017814615,0.00032607513,0.068084724,0.08190438,0.0000121386265,0.00003594078,0.00014374894],"about_ca_topic_score_codex":0.0002876803,"about_ca_topic_score_gemma":0.0002012232,"teacher_disagreement_score":0.624838,"about_ca_system_score_codex":0.0006567381,"about_ca_system_score_gemma":0.00039081144,"threshold_uncertainty_score":0.5135051},"labels":[],"label_agreement":null},{"id":"W2915763999","doi":"10.1182/blood-2018-99-118775","title":"Infectious Complications in the Outpatient and Inpatient Autologous Stem Cell Transplantation Setting for Patients with Multiple Myeloma. Princess Margaret Cancer Center Experience","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Sinai Health System; Princess Margaret Cancer Centre; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Multiple myeloma; Febrile neutropenia; Internal medicine; Transplantation; Autologous stem-cell transplantation; Population; Neutropenia; Cohort; Cancer; Retrospective cohort study; Surgery; Chemotherapy","score_opus":0.011671446969694963,"score_gpt":0.2622487145610008,"score_spread":0.25057726759130583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2915763999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971898,0.00002626694,0.00050239597,0.00015912531,0.00009826015,0.0014416138,0.0000794616,0.000031810185,0.00047126503],"genre_scores_gemma":[0.99817693,0.00002501496,0.0002234413,0.0003523811,0.000044023367,0.0011013575,0.000052354128,0.000013032387,0.000011461498],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999239,0.00003590354,0.00018295375,0.0002283757,0.00013682168,0.00017692547],"domain_scores_gemma":[0.9994955,0.000071051836,0.0000898234,0.000159661,0.0001394002,0.000044530694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000047288388,0.00010788529,0.00011941205,0.00005512636,0.00020005343,0.000021444781,0.000059075104,0.000037351852,0.0000056712943],"category_scores_gemma":[0.000004844023,0.00007254985,0.000021620503,0.00014003586,0.00008678233,0.00007651475,0.000011967342,0.00008736677,0.0000014182405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001231996,0.0008198558,0.98703295,0.00008921156,0.000015086582,0.0000011832583,0.008311012,0.000006002599,0.00015128266,0.000021261596,0.000020940526,0.003407996],"study_design_scores_gemma":[0.005297313,0.0010064116,0.98935646,0.00010265261,0.00008963139,0.00001732936,0.00038976173,0.000046851994,0.0025945825,0.0000044903727,0.0009949399,0.00009958119],"about_ca_topic_score_codex":0.00012763987,"about_ca_topic_score_gemma":0.0008594182,"teacher_disagreement_score":0.00792125,"about_ca_system_score_codex":0.00004009258,"about_ca_system_score_gemma":0.000039656195,"threshold_uncertainty_score":0.29584968},"labels":[],"label_agreement":null},{"id":"W2915866752","doi":"10.1182/blood-2018-99-116128","title":"RNA-Seq Analysis of Clonal Hematopoiesis (CHIP) Blood Leukocytes Shows Dysregulation of Neutrophil / Innate Immunity-Related Genes","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; Queen's University","funders":"","keywords":"Biology; Myeloid; Haematopoiesis; Transcriptome; Gene; Immunology; Innate immune system; Gene expression; Cancer research; Genetics; Stem cell; Immune system","score_opus":0.017965576849921915,"score_gpt":0.279425923879767,"score_spread":0.2614603470298451,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2915866752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996062,0.0011446861,0.000042234566,0.0002838523,0.000049330927,0.00033110185,0.000062373954,0.000065732835,0.0019587222],"genre_scores_gemma":[0.997145,0.0001785251,0.0016850696,0.000053672968,0.00013403788,0.00001568462,0.00017443042,0.00004386288,0.0005697457],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99741995,0.00020500128,0.0008763997,0.0003683259,0.00073056563,0.00039977964],"domain_scores_gemma":[0.9975494,0.00022086351,0.00040495986,0.0008968124,0.00076655264,0.00016140997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062516285,0.00025673636,0.00095327804,0.0011211325,0.000121637626,0.000014554502,0.0003335266,0.00025701217,0.0007235073],"category_scores_gemma":[0.00026007486,0.00022702874,0.00039634,0.0025430412,0.0005589032,0.000121472425,0.00020323339,0.0003354847,0.00002218587],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045279,0.0015765603,0.07590772,0.0002707758,0.012153476,0.000048213285,0.00091597013,0.00008624449,0.9059241,0.0010352602,0.000103937266,0.0015249848],"study_design_scores_gemma":[0.0054420508,0.0007815628,0.16289952,0.00010636193,0.00980494,0.00006824003,0.00018323348,0.0026877436,0.81750786,0.0002197919,0.00008145099,0.00021724508],"about_ca_topic_score_codex":0.00056256476,"about_ca_topic_score_gemma":0.00009958039,"teacher_disagreement_score":0.08841621,"about_ca_system_score_codex":0.00006710217,"about_ca_system_score_gemma":0.00033690306,"threshold_uncertainty_score":0.92579633},"labels":[],"label_agreement":null},{"id":"W2916182471","doi":"10.1182/blood-2018-99-111479","title":"Updated Results from an Open-Label, Multicenter, Expanded Treatment Protocol (ETP) Phase (Ph) 3b Study of Ruxolitinib (RUX) in Patients (Pts) with Polycythemia Vera (PV) Who Were Hydroxyurea (HU) Resistant or Intolerant and for Whom No Alternative Treatment (Tx) Was Available","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; University of British Columbia","funders":"","keywords":"Medicine; Discontinuation; Ruxolitinib; Population; Internal medicine; Clinical endpoint; Gastroenterology; Surgery; Clinical trial; Pediatrics; Myelofibrosis; Bone marrow","score_opus":0.05792644211943544,"score_gpt":0.3666678888084303,"score_spread":0.3087414466889949,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2916182471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.898059,0.000021835589,0.0000021853868,0.00009301874,0.0000497734,0.099358894,0.001846272,0.000040436295,0.0005285615],"genre_scores_gemma":[0.92769146,0.000030702508,0.0016265202,0.00007297202,0.00014429056,0.06830928,0.0010600172,0.000086539985,0.0009782158],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9962337,0.00024628537,0.001119245,0.0013189007,0.0004873174,0.000594553],"domain_scores_gemma":[0.99735504,0.00024906264,0.00057572033,0.0009167193,0.0005118162,0.0003916674],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001964975,0.0007474483,0.001401291,0.00019519057,0.00028268568,0.00015138224,0.00023180053,0.00013957101,0.00021827522],"category_scores_gemma":[0.00008919459,0.00044823095,0.000055295935,0.0002042694,0.00017623257,0.00030621994,0.000113110014,0.00011710058,0.000021674738],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36454973,0.37506223,0.21954903,0.00012513067,0.004603017,0.00048938417,0.023541227,0.0000022293186,0.0032584646,0.000016943179,0.0005125416,0.008290086],"study_design_scores_gemma":[0.6024927,0.27258685,0.021716332,0.0009980556,0.0012640146,0.0000063376733,0.0010625308,0.0006838186,0.09518081,0.000009902327,0.0034926743,0.00050597236],"about_ca_topic_score_codex":0.006827194,"about_ca_topic_score_gemma":0.007138721,"teacher_disagreement_score":0.23794296,"about_ca_system_score_codex":0.00047191815,"about_ca_system_score_gemma":0.00038670996,"threshold_uncertainty_score":0.9997969},"labels":[],"label_agreement":null},{"id":"W2916437498","doi":"10.1182/blood-2018-99-113103","title":"Cost-Effectiveness and Cost-Utility Analysis of ABVD Versus Beacopp in the Treatment of Advanced-Stage Hodgkin Lymphoma","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Institute for Clinical Evaluative Sciences; Canadian Centre for Applied Research in Cancer Control; Health Sciences Centre; Cancer Care Ontario; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"ABVD; Medicine; Dacarbazine; Procarbazine; Hodgkin's lymphoma; Quality-adjusted life year; Oncology; Cost effectiveness; Vincristine; Internal medicine; Lymphoma; Chemotherapy; Cyclophosphamide","score_opus":0.049330074411012406,"score_gpt":0.3458001553955375,"score_spread":0.2964700809845251,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2916437498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99656004,0.0012847055,0.000009435749,0.00004504305,0.000050287843,0.0011939728,0.00012460246,0.000008666992,0.00072323607],"genre_scores_gemma":[0.9990313,0.00048681456,0.00011426091,0.00001934818,0.00002390224,0.00026016484,0.000040055136,0.000007326647,0.000016836771],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989883,0.00012934247,0.00024652667,0.0002677791,0.00019835163,0.00016973288],"domain_scores_gemma":[0.9988482,0.00046514507,0.00011232381,0.0004315039,0.000085925174,0.00005687394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020068887,0.00015615851,0.00055880664,0.00015640233,0.000036425175,0.0000072750286,0.000060831557,0.000058236037,0.000025284058],"category_scores_gemma":[0.00004681887,0.00009676002,0.0001624263,0.00053815433,0.00015189966,0.0000453198,0.00001603529,0.000016103859,0.0000017350574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002296312,0.013422148,0.840542,0.00007180093,0.003185939,0.00007644782,0.0016955023,0.00000765196,0.00088501594,0.00013446921,0.0000067143988,0.13767599],"study_design_scores_gemma":[0.026293138,0.0034276457,0.90662533,0.000044200584,0.0038893688,0.0000039083934,0.00043747635,0.0000641675,0.05825646,0.000006391865,0.0008851746,0.00006676735],"about_ca_topic_score_codex":0.0006613536,"about_ca_topic_score_gemma":0.00065941183,"teacher_disagreement_score":0.13760923,"about_ca_system_score_codex":0.0001252588,"about_ca_system_score_gemma":0.00006489789,"threshold_uncertainty_score":0.3945759},"labels":[],"label_agreement":null},{"id":"W2916498352","doi":"10.1182/blood-2018-99-113694","title":"Reducing Unnecessary Coagulation Testing in Outpatients (REDUCTION): A Quality Improvement Project","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; St. Michael's Hospital; University of Toronto","funders":"","keywords":"Medicine; Partial thromboplastin time; Quality management; Emergency medicine; Psychological intervention; PDCA; Coagulation testing; Internal medicine; Operations management; Coagulation; Nursing","score_opus":0.09561803711103928,"score_gpt":0.38028896570682963,"score_spread":0.28467092859579035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2916498352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99451387,0.000040484418,0.0000054231205,0.00024716387,0.00010571731,0.0007236698,0.000002671398,0.000050165778,0.0043108286],"genre_scores_gemma":[0.9973799,0.000004486856,0.0015366721,0.000022013697,0.0003601305,0.00005060009,0.000027473568,0.000012528056,0.0006062193],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988686,0.000053306332,0.00028005822,0.0002591322,0.00029430876,0.000244583],"domain_scores_gemma":[0.999478,0.00004021639,0.00006386386,0.0002010066,0.00015844581,0.000058492238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003818921,0.00009414941,0.00015897109,0.00016701975,0.00008988813,0.0000134404445,0.000041525385,0.000058405414,0.000028390095],"category_scores_gemma":[0.00030033142,0.00007511216,0.000031110416,0.0004245201,0.000059504673,0.00007993214,0.000037710284,0.00011475622,0.00002670065],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020891504,0.002594426,0.7713877,0.0002091507,0.000091970396,0.000022176446,0.0016610799,0.0000020561558,0.17004897,0.000021220381,0.0001349674,0.053617343],"study_design_scores_gemma":[0.0122373905,0.0035209188,0.71360904,0.000591129,0.00014184268,0.000047099365,0.00096840283,0.0006672568,0.26758903,0.0002007488,0.00015105882,0.00027604605],"about_ca_topic_score_codex":0.00086700363,"about_ca_topic_score_gemma":0.000022430035,"teacher_disagreement_score":0.09754007,"about_ca_system_score_codex":0.00008652134,"about_ca_system_score_gemma":0.00016665374,"threshold_uncertainty_score":0.3062985},"labels":[],"label_agreement":null},{"id":"W2916526154","doi":"10.1182/blood-2018-10-860809","title":"Transfusion-associated circulatory overload and transfusion-related acute lung injury","year":2019,"lang":"en","type":"review","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":341,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Vetenskapsrådet; Lunds Universitet; Crafoordska Stiftelsen","keywords":"Transfusion-related acute lung injury; Medicine; Intensive care medicine; Pulmonary edema; Volume overload; Transfusion therapy; Pathophysiology; Biomarker; Acute kidney injury; Lung; Blood transfusion; Immunology; Pathology; Heart failure; Internal medicine; Biology","score_opus":0.01896863535610193,"score_gpt":0.2930851381748244,"score_spread":0.27411650281872246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2916526154","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031441594,0.9854355,0.0000124378585,0.00014512581,0.0007262694,0.0048314603,0.00022604981,0.00036405175,0.0051149856],"genre_scores_gemma":[0.00036202613,0.99532586,0.000038246926,0.0003330824,0.000092849186,0.00016271367,0.000460788,0.00019811864,0.0030263085],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961517,0.00021594949,0.0011795927,0.0011292995,0.00069077936,0.0006326774],"domain_scores_gemma":[0.9982592,0.00011731259,0.00027613968,0.0008458615,0.00009076232,0.0004107346],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043786483,0.000907893,0.003185168,0.00054763147,0.00018325301,0.000050578976,0.00025360883,0.0011652716,0.0007405115],"category_scores_gemma":[0.000028521374,0.00075227086,0.001206858,0.000758001,0.00010598566,0.0001022386,0.00008053673,0.0012290538,0.0001664386],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008165477,0.0032417884,0.00022479799,0.045727678,0.01415091,0.0005275467,0.0005233315,1.0503706e-7,0.00025247378,0.00034977548,0.0023670536,0.9325529],"study_design_scores_gemma":[0.00969342,0.0005316685,0.00049836293,0.024930451,0.07180747,0.000443311,0.000032440155,0.000010300764,0.000017505394,0.000020060806,0.89092165,0.001093364],"about_ca_topic_score_codex":0.00006660309,"about_ca_topic_score_gemma":0.000016378355,"teacher_disagreement_score":0.93145955,"about_ca_system_score_codex":0.0001068558,"about_ca_system_score_gemma":0.00042971087,"threshold_uncertainty_score":0.9994928},"labels":[],"label_agreement":null},{"id":"W2916620152","doi":"10.1182/blood-2018-10-881441","title":"A stemness screen reveals C3orf54/INKA1 as a promoter of human leukemia stem cell latency","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Natural Sciences and Engineering Research Council of Canada; Ontario Genomics; Terry Fox Foundation; Canada First Research Excellence Fund; Hospital for Sick Children; Ontario Genomics Institute; Krembil Foundation; University of Toronto; Princess Margaret Hospital Foundation; Deutsche Forschungsgemeinschaft; Canadian Institutes of Health Research; Genome Canada","keywords":"Stem cell; Haematopoiesis; Biology; Progenitor cell; Cancer research; Gene silencing; CD34; Cell biology; Hematopoietic stem cell; Leukemia; Immunology; Genetics; Gene","score_opus":0.01910847136617008,"score_gpt":0.2824806832355092,"score_spread":0.2633722118693391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2916620152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9475147,0.00029722962,0.000004865157,0.00017553852,0.000048341284,0.0015373419,0.000022814938,0.000086843094,0.05031233],"genre_scores_gemma":[0.94733465,0.000022039461,0.0003675389,0.0001593716,0.00014906724,0.00003964264,0.00003549127,0.00007344084,0.05181877],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974987,0.00012884711,0.0005556615,0.0005128913,0.0007414836,0.0005624389],"domain_scores_gemma":[0.9981514,0.00007730872,0.00020269514,0.0010294967,0.00027903347,0.00026003504],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00058326876,0.00026102294,0.00068807864,0.00023345742,0.000061100756,0.000022962138,0.00038586883,0.0002568482,0.0007634131],"category_scores_gemma":[0.000026681319,0.00021543357,0.00017809017,0.0003812668,0.000091092115,0.000121301026,0.00022385691,0.00051684876,0.0010776955],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026847716,0.00095367554,0.11097876,0.0020438947,0.00031722462,0.00032067482,0.001187636,0.0000013400324,0.8802189,0.0005059511,0.0018410406,0.0013623931],"study_design_scores_gemma":[0.033519126,0.005963716,0.11767007,0.0018584412,0.00086188613,0.0005305229,0.0010244778,0.00012088303,0.8344337,0.0005324123,0.0025798117,0.0009049701],"about_ca_topic_score_codex":0.00039588782,"about_ca_topic_score_gemma":0.000007484397,"teacher_disagreement_score":0.04578525,"about_ca_system_score_codex":0.00022697434,"about_ca_system_score_gemma":0.00066399394,"threshold_uncertainty_score":0.99970007},"labels":[],"label_agreement":null},{"id":"W2916634237","doi":"10.1182/blood-2018-99-116599","title":"Long Term AML Survivors Have Increased Mortality and High Prevalence of Clonal Hematopoiesis","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Myeloid leukemia; Cohort; Disease; Leukemia; Pediatrics","score_opus":0.026404491206395035,"score_gpt":0.3091116873562066,"score_spread":0.28270719614981155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2916634237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99812776,0.00024671233,0.000044927034,0.00012332377,0.00003288183,0.00032493033,0.000053978263,0.00003637344,0.0010091125],"genre_scores_gemma":[0.99858516,0.000093986026,0.00058219914,0.00008069566,0.00022209193,0.000014913409,0.000015784255,0.000019921868,0.00038521647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986065,0.00008354215,0.00026871613,0.0003070879,0.00045555318,0.00027858428],"domain_scores_gemma":[0.9988725,0.00014437927,0.00008781249,0.00047992653,0.00021363454,0.0002017549],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045683346,0.00013771089,0.00031693757,0.00009240134,0.000059823487,0.000011442728,0.00014235845,0.00010298828,0.00039276193],"category_scores_gemma":[0.00030999372,0.00011625909,0.00005497053,0.00013702735,0.00052556826,0.00007147175,0.00014813301,0.00016517707,0.000018953535],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010747143,0.00032622062,0.9828248,0.00093351124,0.00018241811,0.00008546951,0.00017518747,1.3989793e-8,0.014838827,0.00009740984,0.0001339259,0.00029474296],"study_design_scores_gemma":[0.0023039219,0.00028260052,0.87856406,0.00014415734,0.00027605635,0.00011404908,0.000028989818,0.000024161165,0.11808757,0.00006814903,0.0000131994975,0.00009308023],"about_ca_topic_score_codex":0.0022240723,"about_ca_topic_score_gemma":0.0003252698,"teacher_disagreement_score":0.10426073,"about_ca_system_score_codex":0.00003878759,"about_ca_system_score_gemma":0.00020391773,"threshold_uncertainty_score":0.4740908},"labels":[],"label_agreement":null},{"id":"W2916635613","doi":"10.1182/blood-2018-99-112076","title":"Alemtuzumab Added to CHOP for Treatment of Peripheral T-Cell Lymphoma (PTCL) in Previously Untreated Young and Elderly Patients: Pooled Analysis of the International ACT-1/2 Phase III Trials","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; CHOP; Alemtuzumab; Internal medicine; Clinical endpoint; Interim analysis; Progression-free survival; Surgery; Randomized controlled trial; Lymphoma; Chemotherapy; Transplantation","score_opus":0.0197811737049774,"score_gpt":0.3063851743890686,"score_spread":0.2866040006840912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2916635613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99686575,0.00028839445,0.0000069817033,0.00017026077,0.00009744532,0.0018482205,0.0002844106,0.00000974006,0.00042881965],"genre_scores_gemma":[0.99874884,0.000106897605,0.00029666416,0.00006640012,0.00006751333,0.00029909262,0.00016278439,0.0000140318725,0.0002377736],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985367,0.000076033706,0.0006693613,0.00029975898,0.0002304828,0.00018764827],"domain_scores_gemma":[0.9988699,0.00016197405,0.00031451244,0.00031301737,0.00024542093,0.00009515928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017648937,0.00019356616,0.00089118833,0.00024012323,0.000040232146,0.00001609134,0.000098843295,0.0000681655,0.00013051354],"category_scores_gemma":[0.00016070409,0.00011749839,0.0003364261,0.00041100467,0.000054203614,0.000042050633,0.000029530669,0.000009777611,0.0000011752259],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007810905,0.049051635,0.82706046,0.000060975115,0.014533397,0.000014953822,0.0063585127,0.0000053135445,0.010347344,0.000041830113,0.00028668588,0.08442799],"study_design_scores_gemma":[0.32030264,0.01653332,0.4515448,0.00019415522,0.023760946,0.000007315301,0.00024302592,0.00046222482,0.18599139,0.000013618999,0.00071862875,0.00022792951],"about_ca_topic_score_codex":0.000850798,"about_ca_topic_score_gemma":0.00070353877,"teacher_disagreement_score":0.37551567,"about_ca_system_score_codex":0.00026047477,"about_ca_system_score_gemma":0.0001404117,"threshold_uncertainty_score":0.47914454},"labels":[],"label_agreement":null},{"id":"W2916907431","doi":"10.1182/blood-2018-99-109523","title":"Enhancer Deregulation in Myeloma","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Bromodomain; BRD4; Enhancer; Biology; Chromatin; Transcription factor; Enhancer RNAs; BET inhibitor; Promoter; Transcriptional regulation; Regulation of gene expression; Gene; Cancer research; Cell biology; Gene expression; Genetics; Histone","score_opus":0.02346340077979518,"score_gpt":0.3191593964861414,"score_spread":0.2956959957063462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2916907431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857777,0.00010840749,0.00003136011,0.00021230502,0.0000265284,0.00019291765,0.0000013400246,0.000023369143,0.01362609],"genre_scores_gemma":[0.997726,0.000010477089,0.0010094702,0.0000519477,0.00018837619,0.000020198368,0.000012767734,0.000007599395,0.0009731343],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99946713,0.000014904614,0.0000837776,0.00012229549,0.00014293562,0.0001689801],"domain_scores_gemma":[0.99971104,0.000015552061,0.000013053342,0.00014031884,0.00004542422,0.00007461862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000052612933,0.00005165766,0.000084687126,0.00007501643,0.00002512163,0.0000060514685,0.000025534027,0.000035281788,0.00042140836],"category_scores_gemma":[0.00005480616,0.000041367293,0.000021305541,0.00012558045,0.000038221446,0.00003640859,0.000014503415,0.00004505241,0.00034651873],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002934492,0.0012535057,0.8733513,0.000036775724,0.000107276384,0.00019458533,0.0002942614,1.2511647e-7,0.05851276,0.00015260819,0.0003231901,0.065480165],"study_design_scores_gemma":[0.0044058454,0.0002594926,0.8520633,0.000037434886,0.00001854704,0.00002158824,0.000011325143,0.00008924873,0.14226314,0.000104551465,0.0006882668,0.000037229776],"about_ca_topic_score_codex":0.00005614069,"about_ca_topic_score_gemma":0.00014548839,"teacher_disagreement_score":0.08375038,"about_ca_system_score_codex":0.000022428832,"about_ca_system_score_gemma":0.00004105117,"threshold_uncertainty_score":0.4614126},"labels":[],"label_agreement":null},{"id":"W2916964239","doi":"10.1182/blood-2018-99-113849","title":"Provincial Disparities in Access to Allogeneic Transplant in Canada","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; BC Children's Hospital; Juravinski Hospital; Alberta Children's Hospital; University of Calgary; Hospital for Sick Children; University of British Columbia; McMaster University; CancerCare Manitoba; Ottawa Hospital; University of Manitoba; BC Cancer Agency","funders":"","keywords":"Medicine; Residence; Population; Health care; Census; Family medicine; Demography; Environmental health; Economic growth","score_opus":0.017026077866782303,"score_gpt":0.27587592301783237,"score_spread":0.2588498451510501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2916964239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99644727,0.000033959845,0.000014949468,0.0016581591,0.00007750288,0.00043608458,0.00004683634,0.000010481952,0.0012747868],"genre_scores_gemma":[0.9983605,0.000010492967,0.00011503957,0.0011107717,0.0002041584,0.000058842914,0.000012561756,0.000014715474,0.000112887974],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881613,0.000028125258,0.00019783179,0.00021390153,0.00033799667,0.00040600626],"domain_scores_gemma":[0.99955034,0.000058415062,0.000013810879,0.00017197855,0.000040699473,0.0001647611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000111448986,0.0000959916,0.00020097164,0.00014272665,0.000020582227,0.000015345127,0.00020327352,0.000048029528,0.000063717634],"category_scores_gemma":[0.00009343185,0.00008260243,0.000015208408,0.0002944615,0.000042405012,0.000052306295,0.000063027845,0.00013018576,0.000010979626],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036272238,0.00023390213,0.99103296,0.000102539096,0.000024612875,0.0013448736,0.00030229226,0.000004800544,0.0034156784,0.000044054297,0.0023150053,0.00081658456],"study_design_scores_gemma":[0.0057745115,0.00024335661,0.9676282,0.000196132,0.00002982508,0.00009998099,0.00004516015,0.00014919358,0.024552194,0.000021536165,0.0011124694,0.00014745898],"about_ca_topic_score_codex":0.9356393,"about_ca_topic_score_gemma":0.99513805,"teacher_disagreement_score":0.05949873,"about_ca_system_score_codex":0.00086220785,"about_ca_system_score_gemma":0.005301738,"threshold_uncertainty_score":0.94050556},"labels":[],"label_agreement":null},{"id":"W2916991757","doi":"10.1182/blood-2018-99-119984","title":"Anticoagulation Prophylaxis with Weight-Adjusted Enoxaparin Reduces Rates of Venous Thromboembolism in Patients with Acute Lymphoblastic Leukemia Receiving Asparaginase-Based Intensification Therapy","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Asparaginase; Cohort; Thrombosis; Regimen; Chemotherapy; Ambulatory; Venous thrombosis; Induction chemotherapy; Surgery; Internal medicine; Pediatrics; Leukemia; Lymphoblastic Leukemia","score_opus":0.017022952189051706,"score_gpt":0.26157153567789376,"score_spread":0.24454858348884206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2916991757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997561,0.000065079905,0.00063115056,0.00010103676,0.00006379882,0.0013027355,0.0000112170865,0.000071488415,0.00019254046],"genre_scores_gemma":[0.9967121,0.00002450054,0.002778544,0.00006841672,0.00011596295,0.000067095345,0.00012488477,0.000074107134,0.000034419398],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975802,0.00012663541,0.0004759458,0.0005549522,0.0007887925,0.00047350815],"domain_scores_gemma":[0.9977065,0.00017938435,0.00030940637,0.00056569,0.0011001059,0.0001389268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002361796,0.0003167159,0.00065686996,0.00044364895,0.000098480494,0.000031667798,0.00020026541,0.00017479937,0.000035640634],"category_scores_gemma":[0.00016806097,0.00021837775,0.000043761633,0.0010480512,0.00048434985,0.00018910148,0.000034669407,0.00022339134,0.000021008533],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016447136,0.007161193,0.83581847,0.00038121612,0.0013441397,0.00016891693,0.002816423,0.00018480893,0.12149591,0.000075698736,0.000102080296,0.014003994],"study_design_scores_gemma":[0.018379042,0.00763047,0.7455666,0.00061765476,0.00022378951,0.00002981285,0.000062065556,0.0019727529,0.22527254,0.00002050757,0.00000704286,0.00021771419],"about_ca_topic_score_codex":0.00034681437,"about_ca_topic_score_gemma":0.000041571224,"teacher_disagreement_score":0.10377663,"about_ca_system_score_codex":0.0005701664,"about_ca_system_score_gemma":0.0016467645,"threshold_uncertainty_score":0.8905186},"labels":[],"label_agreement":null},{"id":"W2917127842","doi":"10.1182/blood-2018-11-887067","title":"The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":336,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Institutes of Health; Juno Therapeutics; University of British Columbia; Celgene; Fred Hutchinson Cancer Research Center","keywords":"Medicine; Fludarabine; Cyclophosphamide; Cytokine release syndrome; Cytokine; Immunology; Internal medicine; Immunotherapy; Gastroenterology; Chemotherapy; Immune system; Chimeric antigen receptor","score_opus":0.005690642519163778,"score_gpt":0.24280284708367725,"score_spread":0.23711220456451346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917127842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967811,0.000058469373,0.0000032086439,0.00023312759,0.00004230042,0.0020346763,0.000018857352,0.000038060825,0.0007901627],"genre_scores_gemma":[0.9957189,0.00002624792,0.00012093075,0.00018802713,0.00004302089,0.00007432757,0.000026394198,0.000071962226,0.0037301749],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978201,0.00023475986,0.00022752023,0.00040854316,0.00073832815,0.00057079864],"domain_scores_gemma":[0.99830544,0.00029169075,0.00013115963,0.0007491138,0.00025476614,0.00026780556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004886565,0.00024457605,0.000342609,0.00023591229,0.00007879343,0.00005331181,0.00018125234,0.00010362029,0.0001573183],"category_scores_gemma":[0.00010579409,0.0001385636,0.000052284482,0.0006733315,0.0000722301,0.000069103335,0.000053494154,0.00013021305,0.00019007479],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.064367734,0.0010963104,0.6300261,0.00003592719,0.000213895,0.00026290203,0.0010854842,0.00003388877,0.2993216,0.0000010182277,0.0001768568,0.0033782905],"study_design_scores_gemma":[0.034545843,0.0067520654,0.80110174,0.00044269627,0.00007954845,0.000040743216,0.00016708371,0.00002824833,0.15561318,0.0000014169875,0.0010063688,0.00022102616],"about_ca_topic_score_codex":0.00038218385,"about_ca_topic_score_gemma":0.00014396815,"teacher_disagreement_score":0.17107569,"about_ca_system_score_codex":0.00031119672,"about_ca_system_score_gemma":0.00040144788,"threshold_uncertainty_score":0.56504595},"labels":[],"label_agreement":null},{"id":"W2917325471","doi":"10.1182/blood-2018-99-117332","title":"High Pre-HCT Exposure to Thymoglobulin Is Associated with a Low Incidence of Relapse","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Calgary","funders":"","keywords":"Thymoglobulin; Medicine; Fludarabine; Busulfan; Gastroenterology; Cumulative incidence; Graft-versus-host disease; Internal medicine; Transplantation; Hematopoietic stem cell transplantation; Immunology; Chemotherapy; Cyclophosphamide; Kidney transplantation","score_opus":0.008144182177514177,"score_gpt":0.2393999732748907,"score_spread":0.23125579109737654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917325471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99748564,0.000042696007,0.0004707105,0.00029855518,0.000057272275,0.0004461854,0.000028258131,0.00005789142,0.0011127985],"genre_scores_gemma":[0.99550813,0.000008272784,0.0032693138,0.00040583147,0.00007885151,0.000019884383,0.000017668557,0.000021936701,0.0006701147],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99888986,0.000037099115,0.00026982382,0.00022855011,0.00038671328,0.00018797403],"domain_scores_gemma":[0.99912757,0.000089605346,0.00010165917,0.00031266967,0.0002445082,0.00012399048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019626373,0.000120833705,0.00028408796,0.00006669683,0.000031252835,0.000006351321,0.0000875697,0.00010367937,0.00021280024],"category_scores_gemma":[0.00015315409,0.000095644165,0.000037222144,0.00032246276,0.000064027954,0.000044376957,0.000013877341,0.00008975898,0.000088205685],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024340393,0.003961058,0.6786422,0.0012336286,0.0013073481,0.00077666173,0.034722924,0.000019355888,0.27231854,0.000407484,0.003211249,0.0009654838],"study_design_scores_gemma":[0.006477277,0.0039208024,0.33282226,0.0022657677,0.0006133431,0.00017212184,0.00014133769,0.000014980968,0.6532704,0.000056031702,0.000052899366,0.0001927295],"about_ca_topic_score_codex":0.00009055401,"about_ca_topic_score_gemma":0.00007348142,"teacher_disagreement_score":0.3809519,"about_ca_system_score_codex":0.000021042359,"about_ca_system_score_gemma":0.000110495654,"threshold_uncertainty_score":0.3900256},"labels":[],"label_agreement":null},{"id":"W2917399988","doi":"10.1182/blood-2018-99-120057","title":"Young High Risk Patients with MYC/BCL2 Double Hit Lymphoma, BCL2+ and/or Germinal Centre B-Cell like Diffuse Large B-Cell Lymphoma Benefit from Dose-Dense Chemoimmunotherapy Including Early CNS Prophylaxis: Analysis of Data from the Nordic Lymphoma Group CRY-04 and Chic Trials","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Chemoimmunotherapy; Medicine; Internal medicine; Diffuse large B-cell lymphoma; Lymphoma; BCL6; Germinal center; Gastroenterology; Oncology; Clinical trial; Rituximab; Surgery; Pathology; B cell; Immunology; Antibody","score_opus":0.0244855579973748,"score_gpt":0.2585151062525909,"score_spread":0.2340295482552161,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917399988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98776007,0.0053100036,0.000020999358,0.00007475487,0.0001903297,0.0016930373,0.004793992,0.00009354039,0.000063278196],"genre_scores_gemma":[0.99360317,0.0021273468,0.0010400619,0.0001742324,0.0003973109,0.00010292491,0.0022722932,0.00014305823,0.00013961257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950483,0.00031453875,0.0012717324,0.0015590693,0.0010127214,0.0007936593],"domain_scores_gemma":[0.99470836,0.0010250193,0.0012528662,0.00236273,0.00028150165,0.00036953262],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00071293174,0.00085531926,0.0021257745,0.000356536,0.00062836637,0.00026357334,0.0006680368,0.00034971937,0.00023372726],"category_scores_gemma":[0.00009111404,0.00052252685,0.00035382734,0.0010306245,0.0003513462,0.00039213782,0.00064709544,0.000118571785,0.000025812997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008305175,0.030997852,0.91172487,0.000059839636,0.007837384,0.0001270065,0.003338748,2.670083e-7,0.0010262977,0.000009078722,0.00008622515,0.036487285],"study_design_scores_gemma":[0.16838871,0.0018617632,0.808477,0.00026154387,0.016095532,0.000012802912,0.0003931435,0.00019521803,0.0034555334,0.000028235037,0.0003198182,0.0005107263],"about_ca_topic_score_codex":0.029821107,"about_ca_topic_score_gemma":0.0054503162,"teacher_disagreement_score":0.16008353,"about_ca_system_score_codex":0.00021120039,"about_ca_system_score_gemma":0.00023418284,"threshold_uncertainty_score":0.99972266},"labels":[],"label_agreement":null},{"id":"W2917436728","doi":"10.1182/blood.v130.suppl_1.4160.4160","title":"The Efficacy of PET-CT in Detecting Bone Marrow Involvement in Patients with Newly Diagnosed Lymphoma: A Retrospective Study","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Lymphoma; Positron emission tomography; Bone marrow; Biopsy; Retrospective cohort study; Radiology; Stage (stratigraphy); Nuclear medicine; PET-CT; Cancer; Pathology; Internal medicine","score_opus":0.011057630791984924,"score_gpt":0.24529626903765167,"score_spread":0.23423863824566674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917436728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977144,0.0001548418,1.0929114e-7,0.000096209165,0.000053760927,0.0016917718,0.0000044872145,0.000012663417,0.00027176767],"genre_scores_gemma":[0.9996236,0.000023635752,0.00006193348,0.000019405732,0.000025544012,0.00020365346,0.0000039060833,0.00001959168,0.000018723616],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986247,0.000059879527,0.00034060268,0.00031563098,0.00038845226,0.0002707593],"domain_scores_gemma":[0.99872035,0.00016017602,0.00027364228,0.000701584,0.000078054436,0.00006619099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028802414,0.00017739038,0.00039678524,0.00008830774,0.00019506243,0.000043535558,0.00014755025,0.000014075347,0.0000041616076],"category_scores_gemma":[0.00041804937,0.000107729604,0.00005799669,0.00012788802,0.00007226462,0.00006758808,0.00009863928,0.00007037312,0.0000032571065],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042674877,0.019689515,0.97317904,0.000014589542,0.00019623437,0.0010359968,0.0008010949,0.0000013230397,0.000012544996,0.000009337057,0.0000058082446,0.004627743],"study_design_scores_gemma":[0.08786657,0.0023507625,0.90749,0.00022772496,0.00018369243,0.000007949048,0.0008031427,0.0000037453929,0.00095402804,0.000008959389,0.000005894919,0.00009749964],"about_ca_topic_score_codex":0.002393018,"about_ca_topic_score_gemma":0.0052357498,"teacher_disagreement_score":0.08743982,"about_ca_system_score_codex":0.00025945948,"about_ca_system_score_gemma":0.000095477044,"threshold_uncertainty_score":0.43930858},"labels":[],"label_agreement":null},{"id":"W2917467665","doi":"10.1182/blood-2018-99-116145","title":"Donor Cell Leukemia: The Role of Recipient Microenvironment","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Myeloid leukemia; Leukemia; Population; Myeloid; Medicine; Oncology; Internal medicine; RUNX1; Myelodysplastic syndromes; Haematopoiesis; Bone marrow; Biology; Stem cell; Genetics","score_opus":0.008544603280817577,"score_gpt":0.23483125606652341,"score_spread":0.22628665278570584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917467665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95857984,0.000900538,0.000018698927,0.00047209798,0.000045760575,0.00036517731,0.000007750957,0.00001760744,0.039592527],"genre_scores_gemma":[0.995437,0.00017974319,0.0011351513,0.00030098035,0.0003609686,0.000023160796,0.0000061268397,0.000022130422,0.0025347376],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998964,0.00004285497,0.00020035035,0.00020481879,0.0003073076,0.00028067434],"domain_scores_gemma":[0.99917865,0.000055242857,0.00006518585,0.0005450567,0.00005318425,0.00010268242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024404001,0.00010384532,0.0001717063,0.000048521317,0.00007193322,0.000006679409,0.00020565333,0.00007457441,0.00038550398],"category_scores_gemma":[0.000036439666,0.0000654356,0.00007655184,0.00012504078,0.0002881697,0.000021249727,0.00015696792,0.00023173435,0.00036077586],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022395312,0.00080669654,0.023016062,0.000056132758,0.00014951492,0.000028700528,0.0010588584,0.0000011931215,0.9606902,0.00020332467,0.0063059404,0.007459446],"study_design_scores_gemma":[0.0025031664,0.00059777615,0.01367212,0.000028510007,0.00014388368,0.00005362211,0.00034340832,0.000066774155,0.8749271,0.00006061547,0.10753332,0.0000697044],"about_ca_topic_score_codex":0.00011288785,"about_ca_topic_score_gemma":0.000009116536,"teacher_disagreement_score":0.10122738,"about_ca_system_score_codex":0.00018810955,"about_ca_system_score_gemma":0.000198592,"threshold_uncertainty_score":0.46371642},"labels":[],"label_agreement":null},{"id":"W2917469099","doi":"10.1182/blood-2018-99-110264","title":"Appropriateness of B12 Administration in a Real-World Population","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Cohort; Population; Medical prescription; Pediatrics; Vitamin B12; Cohort study; Randomized controlled trial; Internal medicine; Environmental health","score_opus":0.03889647981737655,"score_gpt":0.3540728282661678,"score_spread":0.3151763484487913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917469099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897767,0.000015101136,0.0000071841932,0.00011367336,0.000026730038,0.00017802572,0.000001619273,0.000013235581,0.009867767],"genre_scores_gemma":[0.9987013,0.000013173421,0.00032007368,0.00001378408,0.00013238004,0.0000070820893,0.000034922483,0.0000066889143,0.0007706412],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994253,0.000021866957,0.00016879573,0.00010559857,0.00017157257,0.00010686052],"domain_scores_gemma":[0.99969524,0.000012488534,0.000034579152,0.00014356586,0.00007829476,0.000035833615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016375096,0.000043988923,0.000117828204,0.000156823,0.000014811646,0.0000044936824,0.00003304302,0.00004286612,0.00006408889],"category_scores_gemma":[0.000042702217,0.00003682607,0.000021478405,0.00031832702,0.000031072293,0.000044098662,0.000012406604,0.0000593974,0.000019005096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033359756,0.0011018049,0.9250885,0.00015033832,0.000032379623,0.000032711363,0.00021265981,2.566689e-7,0.06678469,0.00087074,0.000051785086,0.0053405315],"study_design_scores_gemma":[0.0015352301,0.0005503264,0.9140899,0.000064240296,0.000026611613,0.000008345035,0.000025860389,0.000106367166,0.08332689,0.00012405016,0.00010319189,0.00003894776],"about_ca_topic_score_codex":0.000953581,"about_ca_topic_score_gemma":0.0019354703,"teacher_disagreement_score":0.016542206,"about_ca_system_score_codex":0.000014155337,"about_ca_system_score_gemma":0.00006132285,"threshold_uncertainty_score":0.15017235},"labels":[],"label_agreement":null},{"id":"W2918032742","doi":"10.1182/blood-2018-99-111791","title":"The Highly Prevalent Deletions in F8 Intron 13 Found in French Mild Haemophilia a Patients Result of Both Founder Effect and Recurrent De Novo Events","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Haemophilia; Haemophilia A; Intron; Haplotype; Founder effect; Genetics; Biology; Genotype; Gene; Internal medicine; Medicine","score_opus":0.018457972784730037,"score_gpt":0.3074513590434022,"score_spread":0.28899338625867216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2918032742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967672,0.0009660376,0.0000023796244,0.00072644354,0.000103265986,0.0010914078,0.000010161759,0.000009497397,0.00032355552],"genre_scores_gemma":[0.99905986,0.0003237282,0.00010109303,0.000024969871,0.00009581057,0.000094220886,0.000018628496,0.000013807726,0.0002678992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850494,0.00020459977,0.00032245766,0.00025032074,0.00034928988,0.0003683934],"domain_scores_gemma":[0.9991952,0.00024852343,0.000060033522,0.00028113124,0.00010734253,0.00010773856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057206786,0.00014083921,0.000244189,0.00015878139,0.00009033,0.000011835964,0.00010116369,0.00009277835,0.0000124218495],"category_scores_gemma":[0.00035289244,0.000088657216,0.000046944264,0.00029865012,0.00016512076,0.000046007906,0.00007666959,0.00020678148,0.0000112081325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040138868,0.0018217138,0.9914738,0.00018309926,0.000090387686,0.000015748737,0.00068227126,4.593918e-7,0.00043064757,0.00002251491,0.00018441633,0.004693535],"study_design_scores_gemma":[0.011797999,0.0026502386,0.98273116,0.00056073075,0.00010022786,0.00000897293,0.00001735766,0.000067653185,0.0013097771,0.0003094405,0.00036219083,0.00008427311],"about_ca_topic_score_codex":0.00028170546,"about_ca_topic_score_gemma":0.0017442189,"teacher_disagreement_score":0.01139661,"about_ca_system_score_codex":0.000131363,"about_ca_system_score_gemma":0.00011135465,"threshold_uncertainty_score":0.36153364},"labels":[],"label_agreement":null},{"id":"W2918242042","doi":"10.1182/blood-2018-99-110406","title":"A Genome-Wide CRISPR/Cas9 Knockout Screen Identifies BEND3 As a Determinant of Sensitivity to UBA1 Inhibition in Acute Myeloid Leukemia","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Biology; CRISPR; Cancer research; Myeloid leukemia; Haematopoiesis; Leukemia; Stem cell; Cell biology; Genetics; Gene","score_opus":0.007455371732781443,"score_gpt":0.2468446757432538,"score_spread":0.23938930401047237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2918242042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979034,0.00009715196,0.00070999545,0.00011738542,0.00007626037,0.00031156468,0.00004887826,0.000013394484,0.00072198996],"genre_scores_gemma":[0.9982023,0.000044929126,0.0005599104,0.0003379841,0.00020576165,0.000023870456,0.00010228327,0.00001893596,0.0005040109],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988727,0.0000847678,0.00029162984,0.000356319,0.00015329238,0.00024129695],"domain_scores_gemma":[0.9993203,0.000011496858,0.00010641544,0.00033210052,0.00013778369,0.000091887036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025813072,0.0001551023,0.00019244895,0.00012232087,0.000060998926,0.000024571342,0.00007909286,0.00014620139,0.000020890206],"category_scores_gemma":[0.00018852168,0.00015666305,0.00008073255,0.00016701958,0.00009715875,0.000011965504,0.00018116114,0.0000756491,0.000053281077],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008471652,0.0000910162,0.0017673882,0.000013608799,0.000037008507,0.000037481674,0.00013389546,0.0000019407478,0.99677265,0.000010639465,0.0002752253,0.00077443395],"study_design_scores_gemma":[0.00080227485,0.00045705514,0.029673673,0.00004745565,0.00003450167,0.00005428495,0.00006125946,0.000007799558,0.96645695,0.000048381848,0.0021730177,0.00018336896],"about_ca_topic_score_codex":0.00024391628,"about_ca_topic_score_gemma":0.0009044442,"teacher_disagreement_score":0.03031572,"about_ca_system_score_codex":0.00002554167,"about_ca_system_score_gemma":0.00011383988,"threshold_uncertainty_score":0.6388534},"labels":[],"label_agreement":null},{"id":"W2918385393","doi":"10.1182/blood.v130.suppl_1.627.627","title":"The Khorana Score for the Prediction of Venous Thromboembolism in Patients with Solid Cancer: An Individual Patient Data Meta-Analysis","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Joseph’s Healthcare Hamilton; St. Joseph's Hospital; McMaster University; Impact","funders":"","keywords":"Medicine; Internal medicine; Placebo; Cancer; Low molecular weight heparin; Lung cancer; Meta-analysis; Randomized controlled trial; Heparin; Chemoprophylaxis; Surgery; Pathology","score_opus":0.11086320247788478,"score_gpt":0.33085498352359416,"score_spread":0.21999178104570938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2918385393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99348164,0.0017002457,0.000055660945,0.0007966845,0.00014960598,0.002176685,0.0015016377,0.000017091254,0.00012073593],"genre_scores_gemma":[0.9984768,0.00035373593,0.00013770915,0.00016727399,0.00008725858,0.00035745633,0.00038442534,0.00002354262,0.000011792905],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983066,0.000052543845,0.00039314976,0.00039641824,0.0005640102,0.0002873269],"domain_scores_gemma":[0.99677557,0.00009896263,0.00045796492,0.002416842,0.00018088214,0.000069803435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050762255,0.00017954357,0.0009330915,0.00009321381,0.0006035651,0.00010407142,0.0008561914,0.000054934844,0.00002821572],"category_scores_gemma":[0.00009098681,0.00008684775,0.00022040862,0.000159116,0.00016950436,0.00021410637,0.0002815862,0.0001207405,6.612146e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041887484,0.016117476,0.5036359,0.00019288369,0.4357413,0.000008869728,0.0040129586,0.00081235263,0.00001924469,0.00062259525,0.0024083748,0.036009163],"study_design_scores_gemma":[0.001883959,0.0009895475,0.7707048,0.000014960551,0.22508386,2.7444986e-7,0.00019076935,0.00022552116,0.00012212501,0.00003904663,0.0006702433,0.00007486727],"about_ca_topic_score_codex":0.0013535647,"about_ca_topic_score_gemma":0.0029391027,"teacher_disagreement_score":0.26706892,"about_ca_system_score_codex":0.00001699484,"about_ca_system_score_gemma":0.00008416981,"threshold_uncertainty_score":0.46421954},"labels":[],"label_agreement":null},{"id":"W2918542982","doi":"10.1182/blood-2018-09-876292","title":"Ibrutinib therapy downregulates AID enzyme and proliferative fractions in chronic lymphocytic leukemia","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"National Cancer Institute; CLL Global Research Foundation","keywords":"Ibrutinib; Idelalisib; Chronic lymphocytic leukemia; Somatic hypermutation; IGHV@; Cytidine deaminase; Activation-induced (cytidine) deaminase; Cancer research; Bruton's tyrosine kinase; Venetoclax; breakpoint cluster region; Leukemia; Immunology; Medicine; Oncology; Biology; Tyrosine kinase; B cell; Internal medicine; Antibody; Receptor","score_opus":0.0156079771638856,"score_gpt":0.2860090554580569,"score_spread":0.27040107829417126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2918542982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899541,0.0044525024,0.0000044404046,0.00015210507,0.000070252296,0.0012839569,0.0000058305295,0.000090617934,0.003986172],"genre_scores_gemma":[0.9956967,0.0010468689,0.00014624315,0.00020981462,0.00023388033,0.000110319124,0.00002136557,0.0000443117,0.002490466],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9981364,0.00007732108,0.00032714754,0.0005077614,0.00039785774,0.00055349624],"domain_scores_gemma":[0.99889386,0.00024351598,0.00007006784,0.0005193003,0.00008243847,0.00019080864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026110106,0.00024077925,0.00045189052,0.00022695494,0.00007571775,0.00004849381,0.00012486284,0.00019288615,0.00048269218],"category_scores_gemma":[0.00008567597,0.00019778869,0.000076110635,0.00038653877,0.00015035032,0.00017400944,0.00008352285,0.00032902986,0.00033627564],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.008513668,0.0040566544,0.12544644,0.0040320884,0.004089857,0.0030347088,0.0150828995,0.0066802716,0.7782067,0.005831715,0.004764322,0.040260695],"study_design_scores_gemma":[0.4529274,0.0036801095,0.08495424,0.0012886479,0.00027157523,0.003639943,0.00088219857,0.093560904,0.3394501,0.0007307923,0.017369991,0.0012441138],"about_ca_topic_score_codex":0.0009695141,"about_ca_topic_score_gemma":0.00009166274,"teacher_disagreement_score":0.44441372,"about_ca_system_score_codex":0.029656915,"about_ca_system_score_gemma":0.023000699,"threshold_uncertainty_score":0.982538},"labels":[],"label_agreement":null},{"id":"W2919015634","doi":"10.1182/blood-2018-07-862862","title":"Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; BC Cancer Agency","funders":"Genentech; F. Hoffmann-La Roche; Celgene; Gilead Sciences","keywords":"International Prognostic Index; Internal medicine; Medicine; Hazard ratio; Oncology; Vincristine; Diffuse large B-cell lymphoma; Proportional hazards model; Rituximab; Prednisone; Cyclophosphamide; Lymphoma; Confidence interval; Chemotherapy","score_opus":0.01686258356205417,"score_gpt":0.2982068188558396,"score_spread":0.28134423529378544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2919015634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969245,0.00015705696,0.000028921724,0.00030422743,0.00034089872,0.0006131146,0.000012106972,0.000012802898,0.0016063706],"genre_scores_gemma":[0.9989888,0.00017462319,0.0003443096,0.000038586153,0.00008994461,0.00004993116,0.00005472359,0.000010032641,0.00024904232],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895215,0.000046565885,0.0005053191,0.00018001927,0.00022972323,0.00008621757],"domain_scores_gemma":[0.9992239,0.0002251649,0.0001872477,0.00022322677,0.0001046749,0.00003581931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027845823,0.00009061465,0.00022578717,0.000099560595,0.000011015359,0.000006060462,0.00008623193,0.000090536414,0.000054398526],"category_scores_gemma":[0.00018851356,0.00005781633,0.000106892636,0.00013575814,0.00005671966,0.000058496295,0.00003655553,0.00012619629,0.000020299407],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001278283,0.004414263,0.97063047,0.00004263482,0.00010251084,0.000004878957,0.0005420633,0.0000031697623,0.013896585,0.00029942385,0.000108600856,0.009827564],"study_design_scores_gemma":[0.00643494,0.000859941,0.9711205,0.00020530327,0.00018021968,0.0000075268713,0.00025891393,0.00066122046,0.019774862,0.00009758589,0.00035578533,0.00004324813],"about_ca_topic_score_codex":0.00029256145,"about_ca_topic_score_gemma":0.00010565854,"teacher_disagreement_score":0.009784316,"about_ca_system_score_codex":0.00004648672,"about_ca_system_score_gemma":0.00012135616,"threshold_uncertainty_score":0.23576815},"labels":[],"label_agreement":null},{"id":"W2919299825","doi":"10.1182/blood-2018-99-115068","title":"Metformintreatment Overcomes ATRA-Resistance in Acute Promyelocytic Leukemia and Increases FOXO3A Expression","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Acute promyelocytic leukemia; Arsenic trioxide; Medicine; Tretinoin; Idarubicin; Internal medicine; Metformin; Cancer research; Retinoic acid; Apoptosis; Leukemia; Viability assay; Peripheral blood mononuclear cell; Oncology; Immunology; Cell culture; Biology; Cytarabine; In vitro; Biochemistry","score_opus":0.004692256100860804,"score_gpt":0.2266431342068718,"score_spread":0.221950878106011,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2919299825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929774,0.0044701966,0.000083060644,0.000018289593,0.00003435627,0.00018016233,0.000009592543,0.000014384901,0.0022125598],"genre_scores_gemma":[0.99539936,0.00083259575,0.0024933377,0.0000663673,0.00016468477,0.000050553394,0.000039198265,0.000018322873,0.00093557226],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99908096,0.000034325727,0.00017376334,0.0003651917,0.00011132096,0.00023444755],"domain_scores_gemma":[0.9995362,0.00001370112,0.00006160221,0.00027101676,0.000044764336,0.00007272837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008990925,0.00017068244,0.00015641526,0.000037145266,0.000077374825,0.000027078871,0.00013408039,0.00012973123,0.000015664447],"category_scores_gemma":[0.000053716743,0.00014045673,0.000040845407,0.00007783436,0.00013792973,0.000008541248,0.000109001856,0.000058269135,0.000005983103],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001755014,0.00019927838,0.019633481,0.00008389391,0.000102360806,0.000045299257,0.00013199689,5.008404e-7,0.97819453,0.000099851764,0.00046340804,0.00086989964],"study_design_scores_gemma":[0.001776072,0.00029474802,0.0038618282,0.00007307736,0.000075241725,0.00003829936,0.000045422858,0.0000041535995,0.98906636,0.00036968867,0.0042019705,0.00019313484],"about_ca_topic_score_codex":0.00002946091,"about_ca_topic_score_gemma":0.0000952352,"teacher_disagreement_score":0.015771654,"about_ca_system_score_codex":0.000034796118,"about_ca_system_score_gemma":0.00014782521,"threshold_uncertainty_score":0.57276595},"labels":[],"label_agreement":null},{"id":"W2919325005","doi":"10.1182/blood-2018-99-120313","title":"Diagnosis to Treatment Interval in DLBCL Is Predictive of Overall Survival in a Large, Population-Based Registry","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Population; Internal medicine; Hazard ratio; Rituximab; Proportional hazards model; Lymphoma; Oncology; Confidence interval","score_opus":0.01781749140102718,"score_gpt":0.2882148490005848,"score_spread":0.27039735759955763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2919325005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973694,0.00013007152,0.000006773801,0.00083806936,0.00007965075,0.0005801878,0.00015280262,0.000018101504,0.000824936],"genre_scores_gemma":[0.9987508,0.00003254584,0.0003151717,0.00034214064,0.00009363151,0.00030736058,0.00006497998,0.0000152027205,0.00007815616],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989179,0.00004397938,0.00031973812,0.00029273258,0.00019790362,0.00022778746],"domain_scores_gemma":[0.99935174,0.00010793956,0.0000739456,0.00030470025,0.000057015306,0.00010467435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000091987116,0.00015670138,0.0003872554,0.00017412899,0.000018078857,0.0000069783327,0.000054441974,0.000077907964,0.00013195607],"category_scores_gemma":[0.000085729574,0.00012721689,0.00010269806,0.00021420495,0.000021026175,0.000034002598,0.000025736035,0.000037184072,0.000019685504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031077437,0.010951806,0.9862842,0.000027832522,0.00011597056,0.000092435344,0.00077691354,0.0000045135575,0.00003148242,0.000049698523,0.0001252415,0.0012291054],"study_design_scores_gemma":[0.017741065,0.002134464,0.9647659,0.00038606365,0.00014119051,0.0000030705587,0.000065590204,0.00009439218,0.014100701,0.000029386125,0.00044600488,0.00009216099],"about_ca_topic_score_codex":0.0042599672,"about_ca_topic_score_gemma":0.0031486666,"teacher_disagreement_score":0.021518316,"about_ca_system_score_codex":0.0003218548,"about_ca_system_score_gemma":0.00010766151,"threshold_uncertainty_score":0.64398247},"labels":[],"label_agreement":null},{"id":"W2919501631","doi":"10.1182/blood-2018-99-117482","title":"Identification of Specificity Groups in Myeloma Patients T Cell Receptor (TCR) Repertoire through Single Cell TCR Sequencing","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Daratumumab; T-cell receptor; Biology; T cell; Pomalidomide; CD8; Cytotoxic T cell; Antigen; Multiple myeloma; Immunology; Immune system; Molecular biology; Cancer research; Lenalidomide; Genetics","score_opus":0.030470224684984535,"score_gpt":0.27012999997290854,"score_spread":0.239659775287924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2919501631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909727,0.00015247421,0.00005710195,0.000047873196,0.00014550697,0.000639883,0.000041467658,0.00003956521,0.007903458],"genre_scores_gemma":[0.9972582,0.000047172838,0.0014792029,0.000031540618,0.00017718184,0.000025976457,0.000121320336,0.000031317944,0.0008281234],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980602,0.000090326845,0.0005483577,0.00043019303,0.0004921775,0.00037871342],"domain_scores_gemma":[0.9987745,0.00006419989,0.00021572583,0.0005236756,0.00029405009,0.00012781098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019663932,0.00017744067,0.00030650824,0.00013354537,0.00008953278,0.000020793377,0.00013891417,0.00011533727,0.0002165997],"category_scores_gemma":[0.00019136207,0.00015725965,0.000088956076,0.00035533472,0.00013759975,0.00017588874,0.000065618435,0.00015479636,0.00023355297],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002831454,0.0048951386,0.2504885,0.00022958593,0.00004557089,0.000040289717,0.0016657284,4.847068e-7,0.7397727,0.000012633187,0.00032648508,0.0022397833],"study_design_scores_gemma":[0.00563444,0.000890439,0.100293376,0.0001140982,0.000050353603,0.0000039794627,0.00026918374,0.00004014169,0.8922704,0.000058251964,0.00025306444,0.0001223076],"about_ca_topic_score_codex":0.00024954556,"about_ca_topic_score_gemma":0.00007451725,"teacher_disagreement_score":0.1524977,"about_ca_system_score_codex":0.00023602441,"about_ca_system_score_gemma":0.0001088771,"threshold_uncertainty_score":0.64128625},"labels":[],"label_agreement":null},{"id":"W2919509343","doi":"10.1182/blood-2018-99-116750","title":"Prognostic Impact of Germ-Line FCGR2A (H131R), FCGR3A (F158V), and FCGR2B (I232T) Single Nucleotide Polymorphisms in Lymphoma Patients Treated with Obinutuzumab or Rituximab in Combination with Chemotherapy: Results from the Phase III GALLIUM and GOYA Clinical Trials","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Obinutuzumab; Rituximab; Medicine; Internal medicine; Oncology; Lymphoma; Single-nucleotide polymorphism; Ibrutinib; Chemotherapy regimen; Chemotherapy; Cancer research; Biology; Genotype; Leukemia; Genetics; Chronic lymphocytic leukemia","score_opus":0.06400395745196007,"score_gpt":0.3742934563001233,"score_spread":0.3102894988481632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2919509343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969066,0.0003200967,0.000003986332,0.0005958906,0.000029758547,0.0016386014,0.00031883706,0.00002365239,0.00016256903],"genre_scores_gemma":[0.99857163,0.0002866706,0.0002776156,0.00015795558,0.00018994244,0.000028317681,0.00027421545,0.00004121145,0.00017241543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968836,0.00051508675,0.0011557259,0.0005406144,0.00049196783,0.0004130209],"domain_scores_gemma":[0.99687994,0.0018442203,0.00045389243,0.0003421436,0.00025859606,0.00022120643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001363018,0.0003274489,0.0011100647,0.00017670475,0.00008557823,0.000045209297,0.00014166256,0.00015960808,0.000053401676],"category_scores_gemma":[0.0009907002,0.00016274174,0.00009586977,0.00048520564,0.0007131704,0.00012154012,0.00006371742,0.00023120781,0.0000037453638],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.102170266,0.013537889,0.86209744,0.000048296977,0.00048113646,0.0001607818,0.0009659325,3.767163e-7,0.0027294168,0.000007714178,0.00015832594,0.017642422],"study_design_scores_gemma":[0.15869623,0.022111762,0.81332827,0.0007189903,0.00025066425,0.00004732154,0.0000675719,0.00061804097,0.0038379177,0.000036445534,0.00007918847,0.00020757236],"about_ca_topic_score_codex":0.005461791,"about_ca_topic_score_gemma":0.0012770796,"teacher_disagreement_score":0.056525975,"about_ca_system_score_codex":0.00010123717,"about_ca_system_score_gemma":0.00043786695,"threshold_uncertainty_score":0.82566303},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"agree"},{"id":"W2919541373","doi":"10.1182/blood-2018-99-110819","title":"The Integrated Stress Response Activity Marks Stem Cells in Normal Hematopoiesis and Leukemia","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Endoplasmic Reticulum Stress and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Integrated stress response; Biology; Haematopoiesis; Stem cell; Cell biology; Progenitor cell; CD34; Myeloid leukemia; Immunology; Translation (biology); Biochemistry; Messenger RNA","score_opus":0.004298278332668489,"score_gpt":0.21221350392163127,"score_spread":0.20791522558896278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2919541373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99878025,0.00040210632,0.000019890214,0.000061043116,0.000062735446,0.00010832656,0.000052646352,0.0000074084055,0.00050559733],"genre_scores_gemma":[0.99922043,0.00014406462,0.000039434046,0.000039363716,0.000063544736,0.000018147604,0.000006188781,0.000010860627,0.00045794327],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992067,0.00015028639,0.000116953284,0.00023385692,0.000079468424,0.00021273225],"domain_scores_gemma":[0.9994899,0.000057008743,0.000046898153,0.0002807692,0.000043482352,0.00008193894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001961702,0.000118366625,0.000098299075,0.00002170816,0.00011291893,0.000045114502,0.00012943846,0.00009603602,0.00000774292],"category_scores_gemma":[0.00004906247,0.000083823514,0.000036433754,0.00006427909,0.00018272555,0.000003883407,0.00011262675,0.00007848354,0.000004162334],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002121891,0.00018464292,0.017474627,0.000027737804,0.000057174035,0.00003119721,0.00009421526,0.000004628344,0.97700113,0.000029391998,0.0007783118,0.0021950335],"study_design_scores_gemma":[0.0011233948,0.00018344623,0.021041077,0.000023944804,0.000021362106,0.000011452094,0.00023363673,0.00007320651,0.974584,0.0000073510446,0.0025695122,0.00012762645],"about_ca_topic_score_codex":0.000061636565,"about_ca_topic_score_gemma":0.0002663005,"teacher_disagreement_score":0.0035664502,"about_ca_system_score_codex":0.000010838754,"about_ca_system_score_gemma":0.00010707139,"threshold_uncertainty_score":0.34182236},"labels":[],"label_agreement":null},{"id":"W2919654992","doi":"10.1182/blood-2018-99-117640","title":"Management of Diffuse Large B Cell Lymphoma in the Oldest Old—Insight into the Management Decision Process: A Canadian Perspective","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Charles-Le Moyne; Hôpital Fleurimont; Université de Sherbrooke","funders":"","keywords":"Medicine; Rituximab; Diffuse large B-cell lymphoma; Internal medicine; Population; Performance status; Lymphoma; Chemotherapy regimen; CHOP; Chemotherapy; Surgery","score_opus":0.006891637688299459,"score_gpt":0.25017249624536536,"score_spread":0.2432808585570659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2919654992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93576324,0.001116331,0.000006845928,0.0013178925,0.00006554514,0.0011734728,0.000008539999,0.000013603045,0.06053451],"genre_scores_gemma":[0.99753094,0.00050436455,0.0004616658,0.000859751,0.00006963002,0.00025725356,0.000007717953,0.000017584272,0.00029111022],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986591,0.00004319717,0.00023546911,0.0003270481,0.00039835303,0.00033687582],"domain_scores_gemma":[0.99904966,0.000055441826,0.00006687477,0.00061318174,0.000103549304,0.00011127426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025106003,0.00018124793,0.00019960104,0.00016371193,0.00017337808,0.000031952877,0.0002888914,0.00005024641,0.00004834591],"category_scores_gemma":[0.000008866226,0.000094971394,0.000084831445,0.00049996644,0.00008367428,0.000044171087,0.000074594915,0.000044864835,0.000073226125],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008910244,0.13159552,0.35804495,0.0013606107,0.0041194805,0.01116599,0.2907338,0.000002939051,0.00006645725,0.12166609,0.004260259,0.07609285],"study_design_scores_gemma":[0.043789513,0.0008608278,0.8872146,0.00076629064,0.0015323082,0.000054727425,0.04220212,0.00003464539,0.0035519132,0.002152808,0.017575186,0.00026506474],"about_ca_topic_score_codex":0.018876271,"about_ca_topic_score_gemma":0.044019286,"teacher_disagreement_score":0.5291696,"about_ca_system_score_codex":0.0003072562,"about_ca_system_score_gemma":0.00008720889,"threshold_uncertainty_score":0.9876571},"labels":[],"label_agreement":null},{"id":"W2920137816","doi":"10.1182/blood-2018-12-890236","title":"HAP1 loss confers l-asparaginase resistance in ALL by downregulating the calpain-1-Bid-caspase-3/12 pathway","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Apoptosis; Calpain; Endoplasmic reticulum; Programmed cell death; Downregulation and upregulation; Inositol; Caspase 3; Cell biology; Biology; Chemistry; Molecular biology; Receptor; Biochemistry; Enzyme","score_opus":0.01598484364113016,"score_gpt":0.2640081409015547,"score_spread":0.24802329726042455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2920137816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.976612,0.00080538035,0.00006894319,0.0037509932,0.00008485033,0.0009346861,0.000043291315,0.00007175626,0.017628098],"genre_scores_gemma":[0.98811525,0.00003256971,0.00048173274,0.0013015427,0.00011799918,0.000063414045,0.000052930525,0.00005194465,0.009782622],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99759173,0.00015944199,0.0003807588,0.00048703252,0.00066325,0.00071779004],"domain_scores_gemma":[0.9981972,0.00056185474,0.000101329584,0.0008176733,0.00009378566,0.00022813847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007084327,0.00024314784,0.0003865121,0.00010118803,0.000074228315,0.00004570643,0.00032156688,0.00015912761,0.00024370181],"category_scores_gemma":[0.00034405896,0.00017287955,0.000091240596,0.0002888452,0.0002020768,0.000088942244,0.000120293065,0.0004831983,0.00031469984],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003933312,0.005430307,0.44144332,0.0022434182,0.0016850147,0.010240383,0.011133682,0.0001942922,0.37297133,0.0149256615,0.13223061,0.0035686747],"study_design_scores_gemma":[0.15208647,0.0024758885,0.18193749,0.003744943,0.0010972441,0.0017368546,0.004639162,0.01351699,0.20510654,0.0022787256,0.42797834,0.0034013623],"about_ca_topic_score_codex":0.000383475,"about_ca_topic_score_gemma":0.00033159988,"teacher_disagreement_score":0.29574773,"about_ca_system_score_codex":0.000275871,"about_ca_system_score_gemma":0.000583214,"threshold_uncertainty_score":0.70498234},"labels":[],"label_agreement":null},{"id":"W2920231006","doi":"10.1182/blood-2018-99-112124","title":"A Zebrafish JAK1-A634D Gain-of-Function Model Provides New Insights into the Pathogenesis of Familial Hypereosinophilia","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Hypereosinophilia; Biology; Gain of function; Ruxolitinib; Eosinophil; Zebrafish; Haematopoiesis; Eosinophilia; Cancer research; Immunology; Bone marrow; Mutant; Stem cell; Genetics; Gene; Myelofibrosis","score_opus":0.02077045516594838,"score_gpt":0.24901792908593406,"score_spread":0.22824747391998568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2920231006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956907,0.00093864684,0.00042318023,0.0005912956,0.00011825912,0.0006742227,0.000008208674,0.000029480912,0.0015260126],"genre_scores_gemma":[0.9963668,0.0001612798,0.0022347365,0.00038655248,0.00039670133,0.00007113955,0.000014760589,0.000023956727,0.00034409878],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99879825,0.000055005123,0.00036102702,0.00028966542,0.00032557396,0.00017047428],"domain_scores_gemma":[0.9989459,0.0000944516,0.00015209067,0.00041857007,0.00027665382,0.000112349546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009661904,0.00019454228,0.0003782594,0.00008665399,0.00010893269,0.000010066391,0.00009848803,0.000099377714,0.000045391873],"category_scores_gemma":[0.00012006824,0.00011697369,0.00014208231,0.00020773584,0.00016154711,0.00006722958,0.000050590068,0.00008010683,0.000020431824],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022915737,0.00917951,0.1874321,0.0005398985,0.0023012601,0.000048001806,0.023248788,0.00012575918,0.7091465,0.009049945,0.0048829466,0.051753726],"study_design_scores_gemma":[0.0107656345,0.0060237874,0.1769894,0.00042787474,0.0027100737,0.000031749183,0.0005054066,0.0037107999,0.79037726,0.005821655,0.0022748844,0.0003614596],"about_ca_topic_score_codex":0.0003156852,"about_ca_topic_score_gemma":0.00022896817,"teacher_disagreement_score":0.081230775,"about_ca_system_score_codex":0.00002504807,"about_ca_system_score_gemma":0.00030547293,"threshold_uncertainty_score":0.4770049},"labels":[],"label_agreement":null},{"id":"W2920418016","doi":"10.1182/blood-2018-99-118361","title":"Inhibition of Sialylation Impairs Adhesion on Madcam-1 and E-Selectin and Sensitize Multiple Myeloma Cells to Bortezomib in a Xenograft Mouse Model","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Bortezomib; Cancer research; Homing (biology); Cancer cell; Bone marrow; Multiple myeloma; Biology; Immunology; Chemistry; Cancer; Medicine; Internal medicine","score_opus":0.010143012323887505,"score_gpt":0.24910745135456724,"score_spread":0.23896443903067974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2920418016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988649,0.000027623923,0.00045494066,0.00006262089,0.000008882525,0.00033654398,0.000019681418,0.0000073220262,0.00021746758],"genre_scores_gemma":[0.99803066,0.000033271557,0.00160249,0.000075712254,0.000049401093,0.000012983372,0.000029544653,0.000012714585,0.00015323989],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99927884,0.000046096662,0.00015447068,0.00025234759,0.00011623531,0.000151986],"domain_scores_gemma":[0.9996387,0.000012328668,0.000039980096,0.00013997903,0.00009194224,0.00007711011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017082298,0.000092173155,0.000099773606,0.0001196052,0.000045419343,0.000014083632,0.000027225133,0.0001085151,0.0000036948281],"category_scores_gemma":[0.000073764415,0.00009134023,0.000020255136,0.00011018932,0.00004768255,0.0000049551136,0.000056660934,0.00005683102,0.0000039709316],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028647934,0.00012391167,0.0021079492,0.000017119017,0.000006820441,0.0000013154862,0.00017133816,0.00008166549,0.9958105,0.0000076252363,0.000070887196,0.0013143965],"study_design_scores_gemma":[0.001598958,0.00077445485,0.004363838,0.000020359546,0.0000053242175,0.0000034242048,0.000044233086,0.006269801,0.9867123,0.000026474301,0.000083292725,0.00009757773],"about_ca_topic_score_codex":0.00005089676,"about_ca_topic_score_gemma":0.00027175396,"teacher_disagreement_score":0.00909823,"about_ca_system_score_codex":0.0000063213984,"about_ca_system_score_gemma":0.000027820997,"threshold_uncertainty_score":0.37247464},"labels":[],"label_agreement":null},{"id":"W2920688135","doi":"10.1182/blood-2018-99-117715","title":"Periprocedural Interruption of Anticoagulation in Patients with Cancer-Associated VTE: An Analysis of Thrombotic and Bleeding Outcomes","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; McMaster University; University of Ottawa","funders":"","keywords":"Medicine; Perioperative; Warfarin; Thrombosis; Rivaroxaban; Cancer; Population; Interim analysis; Major bleeding; Low molecular weight heparin; Surgery; Malignancy; Pulmonary embolism; Dabigatran; Internal medicine; Randomized controlled trial; Myocardial infarction; Atrial fibrillation","score_opus":0.019332661187738256,"score_gpt":0.3006265625828508,"score_spread":0.28129390139511257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2920688135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995896,0.000021891314,0.000010633976,0.00005058855,0.000027155033,0.00022046008,0.000006809635,0.000009946292,0.000062895764],"genre_scores_gemma":[0.99976,0.00001893941,0.00011706949,0.00003831192,0.000010636724,0.0000061526703,0.000036120055,0.000007698826,0.000005088175],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99933815,0.000015928397,0.00022658701,0.00014185556,0.00017380557,0.00010367719],"domain_scores_gemma":[0.9995454,0.000011089432,0.00015953969,0.000104591214,0.00014786185,0.000031541324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009642696,0.000077273435,0.00046879056,0.00026510257,0.000020314636,0.0000055987957,0.00003067864,0.00003445652,0.000037020032],"category_scores_gemma":[0.000031589534,0.000059500206,0.00003439483,0.00040476932,0.000060383583,0.00009393944,0.000019949783,0.000030384232,1.6491663e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034840905,0.001767179,0.99455863,0.000064363485,0.001035001,3.1744648e-7,0.0012919831,0.000028812254,0.00081267377,0.000052910782,0.0000018961101,0.00035137648],"study_design_scores_gemma":[0.002557939,0.0009818583,0.9903909,0.00016268504,0.003364613,6.9569985e-8,0.00029596657,0.0011791637,0.0010018985,0.0000057683546,3.0873744e-7,0.00005881104],"about_ca_topic_score_codex":0.00074551435,"about_ca_topic_score_gemma":0.0011344312,"teacher_disagreement_score":0.0041677277,"about_ca_system_score_codex":0.000027645596,"about_ca_system_score_gemma":0.000014842407,"threshold_uncertainty_score":0.24263479},"labels":[],"label_agreement":null},{"id":"W2920874835","doi":"10.1182/blood-2018-99-114345","title":"5-Fluorotroxacitabine Displays Potent Anti-Leukemic Effects and Circumvents Resistance to Ara-C","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Cytidine deaminase; Cytarabine; HEK 293 cells; Nucleoside; Cytidine; Wild type; Cell culture; IC50; Molecular biology; Chemistry; Pharmacology; Cancer research; Biology; Biochemistry; Mutant; Enzyme; Myeloid leukemia; Genetics; Gene","score_opus":0.00583787542143912,"score_gpt":0.23433161636638566,"score_spread":0.22849374094494654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2920874835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99272823,0.0006242815,0.00011005561,0.0013886648,0.0001276762,0.000677546,0.000007529936,0.00007245814,0.0042635375],"genre_scores_gemma":[0.98277,0.000055260913,0.0029635886,0.0003248086,0.00020204896,0.0000626109,0.000020911591,0.000026715024,0.013574044],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99883217,0.000023809002,0.00019325025,0.00037078775,0.0002486428,0.00033135634],"domain_scores_gemma":[0.9992954,0.000036403104,0.000041546788,0.000291792,0.00006482524,0.00027000345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000097130884,0.00019843178,0.0003068267,0.000107255626,0.00011474129,0.000019696625,0.00006639518,0.00005994169,0.000028383702],"category_scores_gemma":[0.00006479373,0.00016178052,0.00004858126,0.00019841807,0.00006196432,0.00005015138,0.000054396358,0.00007595339,0.0003144694],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006068678,0.0031035074,0.756122,0.0010359769,0.0013244117,0.001446343,0.0028514504,2.6009587e-7,0.20314267,0.0008641402,0.021016886,0.00848547],"study_design_scores_gemma":[0.011655338,0.0006153219,0.8045029,0.0009506658,0.0006697605,0.00014040762,0.000041108327,0.000008793852,0.16759391,0.00018390283,0.013228221,0.0004096631],"about_ca_topic_score_codex":0.0000047165527,"about_ca_topic_score_gemma":0.000014363078,"teacher_disagreement_score":0.04838089,"about_ca_system_score_codex":0.00006197267,"about_ca_system_score_gemma":0.00005820507,"threshold_uncertainty_score":0.65972185},"labels":[],"label_agreement":null},{"id":"W2920903135","doi":"10.1182/blood-2018-99-117063","title":"Outcomes for Patients with Pre-Existing Diabetes or Hypertension Treated with Copanlisib from the CHRONOS-1 Study in Patients with Relapsed or Refractory Indolent B-Cell Lymphoma","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Internal medicine; Adverse effect; Regimen; Chemotherapy regimen; Common Terminology Criteria for Adverse Events; Tolerability; Neutropenia; Follicular lymphoma; Clinical endpoint; Gastroenterology; Surgery; Lymphoma; Chemotherapy; Clinical trial","score_opus":0.022655990364634494,"score_gpt":0.2685119626622047,"score_spread":0.24585597229757017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2920903135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944771,0.00003857944,0.000003591342,0.000031845037,0.000051228057,0.005147776,0.00007538906,0.000081219165,0.00009328097],"genre_scores_gemma":[0.99796456,0.0000034640595,0.0006243852,0.00021500055,0.00011704193,0.00034247793,0.00021651026,0.0001217708,0.0003948005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968569,0.0001541471,0.0004853016,0.0007553589,0.0010445871,0.0007036583],"domain_scores_gemma":[0.99691033,0.0010433707,0.00027220524,0.0009407123,0.00063766044,0.0001957455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002442255,0.00044229688,0.000729506,0.00013166011,0.00022930524,0.00005253277,0.0002920075,0.00012690845,0.0000441697],"category_scores_gemma":[0.00046772597,0.00018335244,0.00004723767,0.00048430322,0.0002663941,0.00015725609,0.0001261636,0.0001958395,0.000014117418],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021759503,0.016906139,0.9573291,0.00008577098,0.0004650815,0.00007345648,0.0012390567,0.0000014515663,0.000021347778,1.5548079e-7,0.00013307678,0.0019858757],"study_design_scores_gemma":[0.2648295,0.024934813,0.7077073,0.00053018134,0.0005151316,0.000002258535,0.0003778221,0.00016288088,0.000614214,4.6319283e-7,0.000084589425,0.00024085164],"about_ca_topic_score_codex":0.0013319146,"about_ca_topic_score_gemma":0.001391311,"teacher_disagreement_score":0.24962178,"about_ca_system_score_codex":0.0020816526,"about_ca_system_score_gemma":0.00251121,"threshold_uncertainty_score":0.74768955},"labels":[],"label_agreement":null},{"id":"W2921042444","doi":"10.1182/blood-2018-99-117249","title":"A Longitudinal Toxicity over Time (ToxT) Analysis of Bortezomib When Added to Bendamustine-Rituximab (BR) in Previously Untreated High Risk (HR) Follicular Lymphoma (FL) from in E2408","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Bendamustine; Medicine; Rituximab; Bortezomib; Follicular lymphoma; Internal medicine; Toxicity; Oncology; Lymphoma; Pharmacology; Multiple myeloma","score_opus":0.005428912173925897,"score_gpt":0.22163284751802553,"score_spread":0.21620393534409962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921042444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99857366,0.00030891845,0.0001777733,0.00005171364,0.00003687219,0.00037677906,0.00030258409,0.0000169246,0.00015474559],"genre_scores_gemma":[0.9975331,0.00004116842,0.0012825176,0.00012234067,0.00014969963,0.000039785948,0.00066757976,0.000021792806,0.00014204218],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981953,0.00015153592,0.0005130449,0.0006024016,0.00021488225,0.00032283427],"domain_scores_gemma":[0.9989708,0.000020489806,0.00020112957,0.0005670166,0.00011910453,0.00012146919],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023442962,0.00023930229,0.00049478083,0.00032336588,0.0000418009,0.000023415625,0.00025885718,0.00023052872,0.00033943553],"category_scores_gemma":[0.00024173656,0.00023378799,0.00018364844,0.0007865236,0.00007304986,0.00001085591,0.00015367137,0.00007208812,0.000028703598],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005967982,0.0024005892,0.46590027,0.000014726255,0.0016333379,0.000035271467,0.00032649643,0.000078706114,0.52538943,0.000019447487,0.0013294138,0.0022755226],"study_design_scores_gemma":[0.0060065906,0.0005354189,0.37244287,0.00004687136,0.00066837965,0.0000018320691,0.000015033516,0.000437734,0.6187336,0.000058844256,0.0007462267,0.0003066056],"about_ca_topic_score_codex":0.0041897204,"about_ca_topic_score_gemma":0.0064455094,"teacher_disagreement_score":0.09345738,"about_ca_system_score_codex":0.000040110608,"about_ca_system_score_gemma":0.00008961681,"threshold_uncertainty_score":0.9533597},"labels":[],"label_agreement":null},{"id":"W2921133565","doi":"10.1182/blood-2018-99-111297","title":"Neutrophil Extracellular Traps in the Development of Sepsis-Induced Disseminated Intravascular Coagulation","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; University of Saskatchewan; McMaster University","funders":"","keywords":"Neutrophil extracellular traps; Disseminated intravascular coagulation; Sepsis; Medicine; Systemic inflammatory response syndrome; Immunology; Coagulation; Myeloperoxidase; Fibrinolysis; Organ dysfunction; Inflammation; Pathology; Internal medicine","score_opus":0.020790965512700293,"score_gpt":0.2480310514010016,"score_spread":0.2272400858883013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921133565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981567,0.00058802764,0.000351116,0.00009429239,0.00015506068,0.0003203043,0.0000043848236,0.000026273248,0.00030381812],"genre_scores_gemma":[0.9992734,0.000009691445,0.00041613597,0.000048296246,0.0000367286,0.00003160886,0.00007338882,0.00001484256,0.00009589795],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986897,0.00027528786,0.0004192943,0.0002672806,0.000065942964,0.00028245847],"domain_scores_gemma":[0.99939275,0.0000645294,0.00012171816,0.00031961215,0.00008716909,0.000014240834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048521196,0.0001754192,0.0002492363,0.00012659175,0.00015776478,0.000009328261,0.0002969365,0.00017762392,0.00018846706],"category_scores_gemma":[0.000027385098,0.00012555356,0.0000658138,0.0002949451,0.00012758678,0.00006552134,0.00004169234,0.00020183623,0.0001266967],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039689003,0.00048612524,0.00039088723,0.000012175711,0.00011600937,0.000008467514,0.0034811592,3.4411462e-7,0.9900347,0.0011939447,0.000025664911,0.0042108363],"study_design_scores_gemma":[0.0015917451,0.00023940783,0.024943976,0.000044040426,0.00006568851,0.000020211717,0.0006440813,0.0000016839459,0.97015625,0.00018933478,0.0019533013,0.00015029706],"about_ca_topic_score_codex":0.000015846665,"about_ca_topic_score_gemma":0.00005218977,"teacher_disagreement_score":0.024553088,"about_ca_system_score_codex":0.000013792666,"about_ca_system_score_gemma":0.000056196146,"threshold_uncertainty_score":0.5119926},"labels":[],"label_agreement":null},{"id":"W2921140763","doi":"10.1182/blood-2018-99-118148","title":"Efficacy and Safety of Ibrutinib (IBR) after Venetoclax (VEN) Treatment in IBR-Naïve Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): Follow-up of Patients from the MURANO Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Ven; Venetoclax; Medicine; Bendamustine; Rituximab; Ibrutinib; Internal medicine; Bristol-Myers; Neutropenia; Chronic lymphocytic leukemia; Oncology; Leukemia; Chemotherapy; Lymphoma","score_opus":0.010548661146973648,"score_gpt":0.2510935840606621,"score_spread":0.24054492291368848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921140763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951835,0.00082111824,0.0000015354067,0.000008216757,0.00017163003,0.003366915,0.00014507363,0.000026860738,0.00027510672],"genre_scores_gemma":[0.99907607,0.0001020713,0.000063488114,0.000034410128,0.0001807871,0.00015456606,0.000116749376,0.00007227203,0.00019958409],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99670017,0.00024410771,0.0008530315,0.000673814,0.00095530873,0.00057357847],"domain_scores_gemma":[0.9973667,0.00059617317,0.00033185852,0.0011496771,0.0003552534,0.00020031862],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026435318,0.00041558617,0.0008379325,0.00015751818,0.000088018736,0.00001660513,0.00028206178,0.00018199168,0.00015783314],"category_scores_gemma":[0.00025695658,0.00026115513,0.00011909773,0.00043213877,0.00053583295,0.00012513228,0.00021440123,0.0002100159,0.000028134229],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.029758615,0.0051354947,0.9454856,0.00022583334,0.0014847841,0.0000945013,0.007985647,0.000029754936,0.00027799443,0.0000028335874,0.00009276609,0.009426156],"study_design_scores_gemma":[0.26667836,0.010272122,0.71924496,0.00051599013,0.0006213596,0.0000030187152,0.00018180859,0.00019953215,0.0017517438,0.0000042902357,0.00033132778,0.00019548526],"about_ca_topic_score_codex":0.0048252484,"about_ca_topic_score_gemma":0.0014051874,"teacher_disagreement_score":0.23691976,"about_ca_system_score_codex":0.026216915,"about_ca_system_score_gemma":0.014129674,"threshold_uncertainty_score":0.9999841},"labels":[],"label_agreement":null},{"id":"W2921144267","doi":"10.1182/blood-2018-99-111367","title":"The Influence of Activity Roles and Use of a Structured Framework on Developing Hematology Clinical Practice Guidelines","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Summative assessment; Grading (engineering); Thrombophilia; Evidence-based medicine; Hematology; MEDLINE; Family medicine; Medical education; Internal medicine; Alternative medicine; Psychology; Thrombosis; Pathology; Formative assessment","score_opus":0.2655925211820789,"score_gpt":0.5429479428838111,"score_spread":0.2773554217017322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921144267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842762,0.000099926634,0.0012936955,0.013878721,0.00012199589,0.00029010084,0.000007275735,0.000013622428,0.000018494675],"genre_scores_gemma":[0.8631065,0.00032074985,0.1332453,0.0031116777,0.00019501237,0.000004237843,0.0000016451863,0.00001036041,0.0000045064685],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977502,0.00026639894,0.0013194474,0.00023229542,0.0002885886,0.00014306408],"domain_scores_gemma":[0.9801366,0.016672092,0.00096664095,0.00042296297,0.001747595,0.000054147906],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0016923058,0.00010773233,0.00035941912,0.000038541984,0.00007730037,0.000013806786,0.00008876942,0.00015854054,0.000006834408],"category_scores_gemma":[0.23399594,0.00007227778,0.000054780816,0.00015708212,0.0003879707,0.00020901972,0.000101721016,0.00029268046,0.0000027374895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014784699,0.003029485,0.5568799,0.0005119116,0.0025206252,0.00007692348,0.0012655032,0.00006920177,0.023180071,0.038994994,0.004490831,0.35419586],"study_design_scores_gemma":[0.0043222713,0.0028117977,0.9349794,0.0009412164,0.0012622039,0.00038565436,0.00069934217,0.00028663504,0.02998929,0.0050102435,0.019066503,0.00024547515],"about_ca_topic_score_codex":0.00008946951,"about_ca_topic_score_gemma":0.00010755848,"teacher_disagreement_score":0.37809947,"about_ca_system_score_codex":0.0000075895678,"about_ca_system_score_gemma":0.00024147103,"threshold_uncertainty_score":0.7724564},"labels":[],"label_agreement":null},{"id":"W2921247651","doi":"10.1182/blood.v130.suppl_1.4533.4533","title":"High Rate of Sustained Minimal Residual Disease Negativity Predicts Prolonged Survival for the Overall Patient Population in the Phase 2 KRd Plus Autologous Stem Cell Transplantation MMRC Trial","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Transplantation; Minimal residual disease; Medicine; Population; Stem cell; Negativity effect; Oncology; Surgery; Internal medicine; Biology; Bone marrow; Genetics; Psychology","score_opus":0.039029666609865184,"score_gpt":0.3211773204419465,"score_spread":0.28214765383208135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921247651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936088,0.00007112559,0.00005220519,0.0009125206,0.000121931815,0.004744357,0.00044081692,0.00001635396,0.000031930693],"genre_scores_gemma":[0.9987963,0.000028402566,0.00008622592,0.000019820984,0.00015115966,0.00044930182,0.00039513252,0.000013432963,0.000060246395],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99846524,0.00033878066,0.00031603477,0.0002306459,0.00037184544,0.00027745983],"domain_scores_gemma":[0.99857336,0.00054290716,0.00024623878,0.00044375777,0.00009383336,0.000099888246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005773442,0.00014376128,0.00027051652,0.000054996177,0.00027152343,0.000044881057,0.00016746458,0.000061048086,0.000005057503],"category_scores_gemma":[0.00032077628,0.00008090422,0.00009503093,0.00004452058,0.00007870523,0.000114416325,0.00002132784,0.00012455512,6.9363716e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8285,0.014970591,0.1166559,0.0013805773,0.00061941537,0.0012428757,0.0066383365,0.0001615309,0.0016122594,0.00041432388,0.00015240394,0.02765181],"study_design_scores_gemma":[0.22987896,0.0034603633,0.7606404,0.000048634014,0.0005713519,0.0000037356945,0.00019836788,0.0013872805,0.003599176,0.000116285475,0.000013858858,0.000081583494],"about_ca_topic_score_codex":0.00077521533,"about_ca_topic_score_gemma":0.0002978048,"teacher_disagreement_score":0.6439845,"about_ca_system_score_codex":0.000043054028,"about_ca_system_score_gemma":0.00020918867,"threshold_uncertainty_score":0.32991785},"labels":[],"label_agreement":null},{"id":"W2921394315","doi":"10.1182/blood-2018-99-115611","title":"Quantitative Modeling of Ineffective Hematopoiesis in Myelodysplastic Syndrome Patients Yields Distinct Clinical Phenotypes and Can Identify a State of Disease Predictive of Loss of Response to Azacitidine","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; University of Toronto","funders":"","keywords":"Haematopoiesis; Myelodysplastic syndromes; Bone marrow; International Prognostic Scoring System; Myeloid; Disease; Progenitor cell; Immunology; Oncology; Population; Medicine; Internal medicine; Biology; Bioinformatics; Stem cell; Genetics","score_opus":0.024539937133281245,"score_gpt":0.33776402166404657,"score_spread":0.31322408453076533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921394315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972302,0.00007253406,0.0009871483,0.00006098051,0.000033641616,0.0008892223,0.0006961585,0.000008229432,0.000021927877],"genre_scores_gemma":[0.99903834,0.000019336725,0.00083905156,0.000009084325,0.000012595216,0.000029174604,0.000015786176,0.000024657616,0.000011989771],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99754965,0.00040787217,0.0009483383,0.00034595057,0.0005063495,0.00024184294],"domain_scores_gemma":[0.996435,0.001731508,0.00031562688,0.0003172016,0.00095806905,0.00024259044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010386674,0.00017112703,0.00085604604,0.0004327248,0.000021515652,0.000002762482,0.0001339198,0.00007637213,0.00000966266],"category_scores_gemma":[0.007527556,0.00014903146,0.000091972644,0.0005599275,0.00063070393,0.00007221621,0.00021020984,0.00020129031,0.0000013088876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07318939,0.0032204087,0.9057785,0.0019609013,0.0007812154,0.0001151989,0.006273079,0.00032896615,0.00801601,0.000054131964,0.000010800656,0.0002713597],"study_design_scores_gemma":[0.0076037073,0.010558012,0.96170396,0.0017565084,0.00039259176,0.000006865339,0.00042500906,0.008474417,0.008650679,0.0003043021,2.2265786e-7,0.0001237531],"about_ca_topic_score_codex":0.0003490548,"about_ca_topic_score_gemma":0.00011121449,"teacher_disagreement_score":0.06558569,"about_ca_system_score_codex":0.000063572385,"about_ca_system_score_gemma":0.00043006561,"threshold_uncertainty_score":0.9011731},"labels":[],"label_agreement":null},{"id":"W2921597540","doi":"10.1182/blood-2018-99-112133","title":"Should Women with Sickle Cell Disease be Administered Prophylactic Transfusions to Avoid Complications during Pregnancy?","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Mount Sinai Hospital; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Pregnancy; Obstetrics; Gestation; Intrauterine growth restriction; Acute chest syndrome; Preeclampsia; Anemia; Adverse effect; Sickle cell anemia; Disease; Pediatrics; Internal medicine","score_opus":0.01870214386595442,"score_gpt":0.25270037361468056,"score_spread":0.23399822974872614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921597540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830535,0.00021586582,0.00009741116,0.005095184,0.00004100567,0.0010482558,0.000034381235,0.00012870027,0.010285704],"genre_scores_gemma":[0.9962977,0.000034746186,0.00046111748,0.0005899539,0.000064467786,0.00023914536,0.000011058811,0.000038887654,0.0022629083],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99889094,0.000021999569,0.00018308895,0.00032904293,0.00021211152,0.00036281563],"domain_scores_gemma":[0.99876016,0.000016013188,0.00003876628,0.0004809347,0.0000967474,0.00060736586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000027144766,0.00016139915,0.00018476561,0.00008122848,0.000283843,0.000020536318,0.00009941746,0.0000667359,0.00020557195],"category_scores_gemma":[0.000026176325,0.00012061975,0.000044410404,0.00030143032,0.00011259809,0.00004798032,0.000029704726,0.00017358302,0.00010684016],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01186634,0.049811475,0.10430258,0.009993752,0.001494578,0.002510278,0.07939251,0.00007109079,0.7292142,0.0006564879,0.0017768842,0.008909808],"study_design_scores_gemma":[0.05697682,0.01991718,0.742234,0.005907389,0.0043387013,0.00081347517,0.011884406,0.00017108112,0.1261744,0.0002752021,0.028495353,0.0028119627],"about_ca_topic_score_codex":0.000012778455,"about_ca_topic_score_gemma":0.000017678401,"teacher_disagreement_score":0.63793147,"about_ca_system_score_codex":0.0000342118,"about_ca_system_score_gemma":0.00018179903,"threshold_uncertainty_score":0.4918731},"labels":[],"label_agreement":null},{"id":"W2921627467","doi":"10.1182/blood-2018-99-112179","title":"Risk Factors and Manageability of the Mainly Mild Mucocutaneous Bleeding Profile Observed in Attp Patients Treated with Caplacizumab during the Phase III Hercules Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Concomitant; Internal medicine; Adverse effect; Population; Mucocutaneous zone; MedDRA; Placebo; Antithrombotic; Gastroenterology; Surgery; Disease; Pathology","score_opus":0.013551492503692437,"score_gpt":0.23815030774409748,"score_spread":0.22459881524040504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921627467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973686,0.0001105734,2.33911e-7,0.000017651691,0.000025789212,0.0022204034,0.000058941423,0.000043389486,0.00015446315],"genre_scores_gemma":[0.99973124,0.0000075311914,0.000025818932,0.000009431154,0.000021448042,0.000045174616,0.000009135566,0.000028509003,0.00012173847],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985433,0.00017732916,0.00034992842,0.0003360467,0.00032354676,0.0002698516],"domain_scores_gemma":[0.9988944,0.00011662713,0.00021844408,0.00059953926,0.00011486168,0.00005613815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016739215,0.00022506637,0.00036515205,0.000057070894,0.00024137126,0.000017420583,0.00018110318,0.000052446594,0.00005014284],"category_scores_gemma":[0.00021920654,0.00011130519,0.00006290704,0.00029170263,0.00030899607,0.00005269014,0.00013671568,0.00017967663,0.0000016695977],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009799652,0.004988208,0.9899943,0.000086316,0.00025935902,0.000039406892,0.0029299643,0.0000013089359,0.0005971212,5.662949e-7,0.0000051745633,0.00011834434],"study_design_scores_gemma":[0.018993478,0.0012322586,0.9681457,0.00015078965,0.0006968626,0.00001897435,0.0028730212,0.000037550635,0.0077244984,0.0000037053717,0.0000033783356,0.00011972436],"about_ca_topic_score_codex":0.0018393359,"about_ca_topic_score_gemma":0.0005534164,"teacher_disagreement_score":0.021848507,"about_ca_system_score_codex":0.000059463226,"about_ca_system_score_gemma":0.000046638015,"threshold_uncertainty_score":0.45388937},"labels":[],"label_agreement":null},{"id":"W2921843572","doi":"10.1182/blood-2018-99-111925","title":"Transfusion Practices Among Hematology/Oncology Healthcare Professionals","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Transfusion medicine; Hematology; Blood transfusion; Internal medicine; Premedication; Platelet transfusion; Family medicine; Intensive care medicine; Surgery; Platelet","score_opus":0.035104247245254454,"score_gpt":0.39550561316269617,"score_spread":0.3604013659174417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921843572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.965464,0.00042209582,0.000020026237,0.01581381,0.00048648604,0.000456828,0.0000033236893,0.00009554589,0.017237915],"genre_scores_gemma":[0.9960596,0.0001326167,0.00033976338,0.0018103261,0.00056304294,0.00009838947,0.000008125525,0.000014876686,0.000973246],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914235,0.00009933026,0.00019222635,0.00022760587,0.00013192231,0.00020653923],"domain_scores_gemma":[0.9992505,0.00007370704,0.0001724786,0.00020468165,0.00016597215,0.0001326707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015528768,0.000089610876,0.00023202373,0.00006440647,0.00019958902,0.000006157333,0.000054171924,0.00015038057,0.0005731315],"category_scores_gemma":[0.00008081909,0.000069436355,0.000056341396,0.00016487419,0.00013678381,0.00009174569,0.000021302309,0.0002369184,0.00014654903],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045304236,0.0033695758,0.9489992,0.00031255407,0.00021186589,0.00021738284,0.0017970174,4.3268006e-8,0.027135475,0.0030231837,0.009077127,0.005403492],"study_design_scores_gemma":[0.011061014,0.0067826626,0.5264184,0.00066280644,0.0009973752,0.0036772497,0.0019682236,0.0000059461404,0.25296357,0.000608987,0.19446038,0.00039338498],"about_ca_topic_score_codex":0.00020926911,"about_ca_topic_score_gemma":0.00083753583,"teacher_disagreement_score":0.42258084,"about_ca_system_score_codex":0.000026577278,"about_ca_system_score_gemma":0.0003037878,"threshold_uncertainty_score":0.6275388},"labels":[],"label_agreement":null},{"id":"W2922010758","doi":"10.1182/blood-2018-99-120186","title":"Small-Volume Tubes to Reduce Transufusion (STRATUS): A Pilot Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Vacutainer; Blood volume; Intensive care unit; Blood transfusion; Hematocrit; Anemia; Surgery; Emergency medicine; Intensive care medicine; Anesthesia; Internal medicine","score_opus":0.044806218245838914,"score_gpt":0.2805911449434165,"score_spread":0.2357849266975776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922010758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97714347,0.000061289174,0.00023445567,0.0023565535,0.00025471972,0.0017634345,0.0000035891674,0.00019160328,0.017990896],"genre_scores_gemma":[0.99265647,0.000021370432,0.0012443919,0.0013401271,0.00039205412,0.00008163988,0.0000044888616,0.000031493706,0.004227943],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99868643,0.00004308507,0.00025651898,0.00041270035,0.00029470393,0.00030653516],"domain_scores_gemma":[0.9991436,0.000010176477,0.000014535724,0.0004584338,0.00010016518,0.0002730624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022264985,0.00017788907,0.00026152475,0.0001446217,0.00012265767,0.000027949836,0.00014072742,0.0000355156,0.0006547988],"category_scores_gemma":[0.000022322225,0.00015220497,0.00005715521,0.0003364,0.000044583947,0.00003246664,0.000045719305,0.0001342038,0.0004846117],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040886556,0.0895461,0.04823423,0.00036119184,0.0013979047,0.0008046804,0.012240698,0.0000010807871,0.782824,0.00069051865,0.018153047,0.041657884],"study_design_scores_gemma":[0.043202564,0.11095787,0.60913867,0.0004267405,0.0035580012,0.00018725019,0.0043740873,0.000025900144,0.15273994,0.00007164824,0.074374735,0.0009425913],"about_ca_topic_score_codex":0.00022855107,"about_ca_topic_score_gemma":0.00045069956,"teacher_disagreement_score":0.63008404,"about_ca_system_score_codex":0.000010842744,"about_ca_system_score_gemma":0.000046399462,"threshold_uncertainty_score":0.7169588},"labels":[],"label_agreement":null},{"id":"W2922012528","doi":"10.1182/blood.v130.suppl_1.814.814","title":"TAK-243 Is a Selective UBA1 Inhibitor That Displays Preclinical Activity in Acute Myeloid Leukemia (AML)","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Clonogenic assay; Myeloid leukemia; Haematopoiesis; Leukemia; Cell culture; Cytarabine; Cancer research; Stem cell; Biology; Immunology; Molecular biology; Medicine; Chemistry; Cell biology; Genetics","score_opus":0.018958893769351958,"score_gpt":0.2893341320414129,"score_spread":0.27037523827206095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922012528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99507225,0.00014254719,0.000112267146,0.00044625538,0.00021613216,0.00032109756,0.00006790339,0.000017406808,0.003604135],"genre_scores_gemma":[0.9972423,0.00018570952,0.00027555935,0.000255583,0.00039571448,0.000065443484,0.00004637236,0.000024940684,0.0015083924],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99872464,0.000078304336,0.0001957008,0.00052652333,0.00017124935,0.00030357382],"domain_scores_gemma":[0.9989154,0.000016932961,0.00020469967,0.0006951089,0.000054492586,0.00011338524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022120906,0.00020293097,0.00021730446,0.000041215564,0.00021190727,0.00009319793,0.00037267117,0.00031953186,0.000028417764],"category_scores_gemma":[0.00025472787,0.0001910796,0.00013208433,0.000051175444,0.00013395453,0.0000250829,0.00027186258,0.0002529868,0.000028879209],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002688212,0.00044537344,0.057553854,0.000017048102,0.00016399504,0.000018735514,0.000092712326,9.1988886e-7,0.9324011,0.000031510997,0.0052000294,0.0038058572],"study_design_scores_gemma":[0.0022293583,0.0002635515,0.054955855,0.000028357532,0.00004319745,0.000012741307,0.000010651935,0.000022180793,0.933369,0.000072822135,0.008749287,0.00024301355],"about_ca_topic_score_codex":0.00009148976,"about_ca_topic_score_gemma":0.0001697588,"teacher_disagreement_score":0.0035628437,"about_ca_system_score_codex":0.000036326102,"about_ca_system_score_gemma":0.00019844173,"threshold_uncertainty_score":0.7792},"labels":[],"label_agreement":null},{"id":"W2922013703","doi":"10.1182/blood-2018-99-120196","title":"Coenzyme Q10 Attenuates Platelet Integrin αIIbβ3 Outside-in Signaling through Targeting cAMP/PKA Pathway and Inhibits Atherosclerosis","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Coenzyme Q10 studies and effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Canadian Blood Services; University of Toronto","funders":"","keywords":"Platelet; Integrin; Clot retraction; Platelet activation; Phosphorylation; Biology; Endocrinology; Internal medicine; Chemistry; Cell biology; Immunology; Medicine; Biochemistry; Thrombin; Receptor","score_opus":0.01119426414307336,"score_gpt":0.2306244707222984,"score_spread":0.21943020657922505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922013703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967554,0.0022672445,0.00016147825,0.00016183316,0.0001425673,0.00021485076,0.000022464823,0.000025690506,0.00024844354],"genre_scores_gemma":[0.99761087,0.00034864023,0.00088436,0.0003166062,0.00066097657,0.0000309285,0.000036072262,0.000037897425,0.000073637195],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985806,0.000059476373,0.00028114844,0.00051172415,0.000119166936,0.00044788927],"domain_scores_gemma":[0.9994889,0.0000437384,0.00009223118,0.0002222161,0.00008244308,0.00007046707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002782558,0.00025382315,0.00026195642,0.000032186745,0.00017526704,0.000044296725,0.0001289591,0.0001713378,0.000019224392],"category_scores_gemma":[0.00015847021,0.00022768581,0.00007066081,0.00012299542,0.00014257783,0.000008600044,0.00027146123,0.00014868836,0.00002251602],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042641463,0.00013285957,0.013059807,0.00003388575,0.000073954136,0.000008191767,0.00088050513,0.0000045815727,0.97975725,0.000032063712,0.005635596,0.0003386867],"study_design_scores_gemma":[0.001600969,0.0005160121,0.0016132544,0.00010874051,0.000022163234,0.000014262791,0.00047820908,0.000024933544,0.98611367,0.000050797953,0.009143155,0.000313857],"about_ca_topic_score_codex":0.0001797838,"about_ca_topic_score_gemma":0.00033756692,"teacher_disagreement_score":0.011446552,"about_ca_system_score_codex":0.000010513931,"about_ca_system_score_gemma":0.00002830367,"threshold_uncertainty_score":0.9284758},"labels":[],"label_agreement":null},{"id":"W2922069184","doi":"10.1182/blood-2018-99-115567","title":"Analysis of the Frequency of Spontaneous, Functionally-Significant Mutations in Genes Associated with Platelet Disorders in &gt;120,000 Healthy Individuals","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biology; Genetics; Phenotype; Population; Gene; Platelet disorder; Exome; Exome sequencing; Loss function; Context (archaeology); Platelet; Immunology; Medicine","score_opus":0.010451034476869611,"score_gpt":0.24351306738236966,"score_spread":0.23306203290550004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922069184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99813986,0.0001877227,0.000006293589,0.00025754856,0.000023249748,0.00041048345,0.00020630874,0.000009939894,0.0007586147],"genre_scores_gemma":[0.9994468,0.00006847404,0.00013749725,0.00006613398,0.000006981326,0.000027789716,0.00019128194,0.000011780138,0.000043279702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988194,0.00008254082,0.00039599166,0.0002014224,0.00030051084,0.00020012415],"domain_scores_gemma":[0.99930274,0.00013000763,0.00022262319,0.00021298054,0.00008792239,0.000043732678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018199366,0.00012353779,0.00046359716,0.0004133153,0.000043567365,0.0000036221863,0.000084722924,0.00008161651,0.0001157759],"category_scores_gemma":[0.000093753246,0.000083175146,0.00008977905,0.0016630086,0.00014334611,0.000034995093,0.000014228421,0.000095956864,0.0000015904579],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000916381,0.0023055824,0.9939309,0.000015126551,0.0017162292,0.00009275029,0.0005973069,0.00012233734,0.0006183265,0.0000533972,0.0000053507006,0.00045110207],"study_design_scores_gemma":[0.004158976,0.00052435853,0.9929693,0.00007554764,0.0011817252,0.000023217422,0.00020573822,0.000082976265,0.00044888587,0.0002366745,0.000014373964,0.00007823903],"about_ca_topic_score_codex":0.0015017044,"about_ca_topic_score_gemma":0.039531346,"teacher_disagreement_score":0.03802964,"about_ca_system_score_codex":0.000046614423,"about_ca_system_score_gemma":0.00018127238,"threshold_uncertainty_score":0.9779947},"labels":[],"label_agreement":null},{"id":"W2922069978","doi":"10.1182/blood-2018-99-117571","title":"Canadian Retrospective Multicentric Study Comparing the Combination of Bortezomib, Cyclophosphamide and Dexamethasone (Cybord) Versus Bortezomib, Thalidomide and Dexamethasone (VTD) Versus Bortezomib and Dexamethasone (Vd) in Patients with Newly Diagnosed Multiple Myeloma Eligible for Autologous Hematopoietic Stem Cell Transplantation (HCT)","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Bortezomib; Medicine; Multiple myeloma; Thalidomide; Dexamethasone; Internal medicine; Cyclophosphamide; Autologous stem-cell transplantation; Lenalidomide; Oncology; Melphalan; Plasma cell leukemia; Hematopoietic stem cell transplantation; Progression-free survival; Transplantation; Surgery; Chemotherapy","score_opus":0.01675167144090109,"score_gpt":0.26230357450800973,"score_spread":0.24555190306710864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922069978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922956,0.0012230102,0.00012484849,0.00009044908,0.00015908535,0.0057527306,0.0001560197,0.000054278767,0.00014397546],"genre_scores_gemma":[0.99629956,0.0003980099,0.002641783,0.000023326906,0.000044886412,0.0003527049,0.00013851283,0.00008065707,0.00002056813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964218,0.00031635957,0.0007172375,0.00094652077,0.00068962475,0.00090842356],"domain_scores_gemma":[0.9958336,0.0021653452,0.0003778508,0.00054203405,0.00049753755,0.00058367517],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00076236675,0.0005463804,0.0010680095,0.0005313415,0.0004078454,0.000096681484,0.00018932739,0.00021563371,0.000007971034],"category_scores_gemma":[0.0005028509,0.00043473832,0.00007670574,0.0007256392,0.00042219678,0.0002670819,0.000077753,0.00037078044,0.0000022582071],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01916745,0.002482713,0.9684189,0.00027879392,0.0007160237,0.00015438918,0.004226746,0.000009996131,0.00023131652,0.00002640471,0.0000087919425,0.0042785006],"study_design_scores_gemma":[0.15836576,0.006589319,0.82323796,0.0001617096,0.0011537725,0.000020525482,0.002486606,0.0016013817,0.006015169,0.000017872151,0.0000071836807,0.00034278005],"about_ca_topic_score_codex":0.034520745,"about_ca_topic_score_gemma":0.111369275,"teacher_disagreement_score":0.14518094,"about_ca_system_score_codex":0.00037228395,"about_ca_system_score_gemma":0.000331934,"threshold_uncertainty_score":0.99981046},"labels":[],"label_agreement":null},{"id":"W2922145728","doi":"10.1182/blood-2018-99-109468","title":"Metabolic Dysregulation in Normal and Malignant Hematopoiesis","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Biology; Carcinogenesis; Haematopoiesis; Malignant transformation; Myeloid; Cancer research; Genome instability; Isocitrate dehydrogenase; Phenotype; Leukemia; Cell biology; Stem cell; Cancer; Immunology; Genetics; DNA damage; Gene; Biochemistry; Enzyme","score_opus":0.014672360246995432,"score_gpt":0.27611255142411567,"score_spread":0.26144019117712025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922145728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933528,0.00059135904,0.000022485685,0.0006363977,0.00002253796,0.00019225742,0.0000019121262,0.000026338868,0.005153921],"genre_scores_gemma":[0.9973279,0.000057426285,0.0015964806,0.00016204471,0.00021510792,0.000013411143,0.0000054139005,0.000013005959,0.0006092038],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992783,0.000023455013,0.00014040056,0.0001665153,0.00017598669,0.00021535537],"domain_scores_gemma":[0.9996156,0.000026846594,0.000022541277,0.00018867907,0.000059777605,0.00008651735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000225798,0.000073610114,0.00017210106,0.00015512256,0.00003653182,0.000011909315,0.000043927223,0.00006142571,0.00017612321],"category_scores_gemma":[0.00008034366,0.000060454993,0.000026497035,0.00023361518,0.000100585414,0.00007264598,0.00005755028,0.00009261787,0.00007126343],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053805986,0.0011703311,0.60177696,0.0003416002,0.00041277113,0.000508547,0.0032419127,7.491956e-7,0.35915565,0.01342259,0.0020945556,0.017336281],"study_design_scores_gemma":[0.006783495,0.0002770759,0.6793593,0.00008916227,0.00016951757,0.00047228936,0.0001638295,0.0004116921,0.30697072,0.00035304597,0.004797394,0.00015244092],"about_ca_topic_score_codex":0.00009701001,"about_ca_topic_score_gemma":0.000049509945,"teacher_disagreement_score":0.07758238,"about_ca_system_score_codex":0.00001941404,"about_ca_system_score_gemma":0.00007872204,"threshold_uncertainty_score":0.2465283},"labels":[],"label_agreement":null},{"id":"W2922180683","doi":"10.1182/blood-2018-99-115037","title":"Fluid-Phase Immune Complexes Can Assemble and Activate Platelets in Heparin-Induced Thrombocytopenia","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Platelet factor 4; Platelet; Platelet activation; Chemistry; Epitope; Heparin-induced thrombocytopenia; Molecular biology; Heparin; Alanine; Monoclonal antibody; Antibody; Biochemistry; Biology; Immunology; Amino acid","score_opus":0.041138928932442746,"score_gpt":0.3294600619118434,"score_spread":0.28832113297940065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922180683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890432,0.00013080736,0.000006648955,0.0008119242,0.0002124306,0.0008436108,0.000018117928,0.00015044962,0.008782821],"genre_scores_gemma":[0.99831504,0.000098179946,0.00057209685,0.00036186268,0.00028027088,0.000048162052,0.000044690292,0.000080419326,0.00019930793],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99735504,0.0001111302,0.0006507946,0.0007471515,0.00033291793,0.00080295413],"domain_scores_gemma":[0.9984611,0.00010396848,0.00014896023,0.0007567627,0.00013570605,0.00039348853],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003665707,0.00044854067,0.0012174972,0.00029695476,0.00025130904,0.00009310069,0.0002470713,0.00028293658,0.0003110723],"category_scores_gemma":[0.000130596,0.0004145002,0.00011413521,0.0005366038,0.00021809425,0.00025298895,0.00025843218,0.00046146582,0.00015042709],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022155167,0.001590371,0.022650722,0.00006927589,0.0002667914,0.000202186,0.00078555977,7.865476e-8,0.97142106,0.00049227674,0.000070367605,0.0022297534],"study_design_scores_gemma":[0.01383058,0.0013892686,0.26266712,0.00019946121,0.0002307759,0.00033803837,0.00016649946,0.00005470003,0.7195304,0.00018073888,0.0010065476,0.00040586424],"about_ca_topic_score_codex":0.0019643356,"about_ca_topic_score_gemma":0.0010308494,"teacher_disagreement_score":0.25189066,"about_ca_system_score_codex":0.00010500691,"about_ca_system_score_gemma":0.00025835852,"threshold_uncertainty_score":0.99983066},"labels":[],"label_agreement":null},{"id":"W2922237910","doi":"10.1182/blood-2018-11-880526","title":"Venetoclax plus R- or G-CHOP in non-Hodgkin lymphoma: results from the CAVALLI phase 1b trial","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Cilag; Pharmacyclics; National Cancer Institute; H. Lundbeck A/S; Servier; Amgen; TG Therapeutics; Genentech; Celgene; Gilead Sciences; F. Hoffmann-La Roche","keywords":"Venetoclax; CHOP; Medicine; Internal medicine; Lymphoma; Radioimmunotherapy; Oncology; Cancer research; Immunology; Leukemia; Chronic lymphocytic leukemia; Antibody","score_opus":0.0250096202725218,"score_gpt":0.2999874654202687,"score_spread":0.2749778451477469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922237910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929409,0.00049523095,7.203509e-7,0.00071496115,0.00048212067,0.0017307022,0.00016882662,0.000037249516,0.0034293027],"genre_scores_gemma":[0.9972082,0.00015442212,0.00015518928,0.0005245089,0.0006312835,0.00016656838,0.00015932418,0.000027627653,0.00097290945],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9984415,0.000069557886,0.00043029562,0.0004296996,0.00031876026,0.00031017236],"domain_scores_gemma":[0.99845254,0.00057593803,0.00011753255,0.00070024177,0.000033566386,0.000120184304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023015111,0.00021343207,0.0004466314,0.000051374045,0.00004827976,0.00003462734,0.00015922103,0.00013015194,0.00016333892],"category_scores_gemma":[0.00019500409,0.00012000071,0.00013602352,0.00019666122,0.000034556077,0.000047450976,0.00005811645,0.000080809674,0.0004539592],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7112298,0.06925939,0.06290647,0.00014828297,0.0034867504,0.008948167,0.01205765,0.00009971583,0.0046927747,0.0003102325,0.032569773,0.094290964],"study_design_scores_gemma":[0.9370598,0.0030218596,0.04107529,0.0002479225,0.0004821142,0.000039338156,0.00019043607,0.000269927,0.005247995,0.0000403203,0.012124922,0.00020006922],"about_ca_topic_score_codex":0.0038368073,"about_ca_topic_score_gemma":0.00043556915,"teacher_disagreement_score":0.22582997,"about_ca_system_score_codex":0.00043625062,"about_ca_system_score_gemma":0.00075869635,"threshold_uncertainty_score":0.58348787},"labels":[],"label_agreement":null},{"id":"W2922249564","doi":"10.1182/blood-2019-01-896290","title":"Phase 1b study of venetoclax-obinutuzumab in previously untreated and relapsed/refractory chronic lymphocytic leukemia","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"Genentech; Cancer Research UK; F. Hoffmann-La Roche","keywords":"Venetoclax; Obinutuzumab; Chronic lymphocytic leukemia; Medicine; Refractory (planetary science); Fludarabine; Leukemia; Bendamustine; Ibrutinib; Oncology; Internal medicine; Chemotherapy; Cyclophosphamide; Biology","score_opus":0.013317298047628056,"score_gpt":0.29284353042942995,"score_spread":0.2795262323818019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922249564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927392,0.0033597331,5.4338483e-7,0.0000054017573,0.00007667455,0.002532637,0.0000059402446,0.00006914798,0.001210736],"genre_scores_gemma":[0.99802727,0.0003568352,0.00002821494,0.000025439536,0.00008979321,0.000079995414,0.000022857961,0.00006310392,0.0013064763],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9973672,0.00014598075,0.00063288136,0.0006260804,0.0006098542,0.00061800814],"domain_scores_gemma":[0.99833626,0.00022098658,0.0001651814,0.0009333384,0.00010751888,0.00023674897],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041444748,0.00029429168,0.0008061907,0.00033963996,0.000035790337,0.000019052311,0.00021505746,0.00020452669,0.00017589456],"category_scores_gemma":[0.00015223442,0.00026184166,0.00007710847,0.0005502464,0.00012409917,0.00012072398,0.0001708247,0.0003490743,0.000114337214],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.047048338,0.11920931,0.18151884,0.032519553,0.011680437,0.0280707,0.081152126,0.009836788,0.38064757,0.00059844047,0.003102003,0.10461589],"study_design_scores_gemma":[0.91991466,0.025275625,0.0056478744,0.0011967645,0.0007292755,0.0008096516,0.0012734847,0.030098855,0.013901128,0.000027255188,0.00061911653,0.00050633546],"about_ca_topic_score_codex":0.0060196947,"about_ca_topic_score_gemma":0.00045267493,"teacher_disagreement_score":0.8728663,"about_ca_system_score_codex":0.09242295,"about_ca_system_score_gemma":0.046071474,"threshold_uncertainty_score":0.9999834},"labels":[],"label_agreement":null},{"id":"W2922297179","doi":"10.1182/blood-2018-99-113884","title":"Comparison of the Impact of Pre-Transplant Co-Morbidity Scores on Allogeneic Hematopoietic Stem Cell Transplant Outcomes","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Transplantation; Internal medicine; Hematopoietic stem cell transplantation; Univariate analysis; Concordance; Population; Hematopoietic cell; Oncology; Multivariate analysis; Stem cell; Haematopoiesis","score_opus":0.036195934036838316,"score_gpt":0.33661543288369306,"score_spread":0.30041949884685476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922297179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961739,0.0001500725,0.00019692692,0.000053060707,0.00013350583,0.0008037139,0.00027487907,0.000044258246,0.0021696633],"genre_scores_gemma":[0.9995783,0.000046904155,0.00010125725,0.000031910775,0.000049559767,0.00001525671,0.00003440858,0.000035686,0.000106746615],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978061,0.00013599933,0.0007855327,0.00031145476,0.0006308439,0.00033007178],"domain_scores_gemma":[0.9984945,0.00026438947,0.00031898145,0.00067624054,0.0001077876,0.00013808277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025616042,0.00030289323,0.0008510778,0.00011277894,0.000074313066,0.0000072591138,0.0002836689,0.00016570713,0.00013926366],"category_scores_gemma":[0.0000067425103,0.00018015668,0.00045252734,0.00020380117,0.00027757577,0.000034163964,0.000010479271,0.00020304655,0.000028418272],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004188066,0.001959029,0.81907654,0.0009995104,0.0002820365,0.0000144535925,0.0061117774,0.000028953516,0.17094809,0.000048678325,0.00007530545,0.000036833888],"study_design_scores_gemma":[0.0021263426,0.0008768527,0.44626287,0.00056195253,0.0005077119,0.00006820111,0.000079083125,0.00003428191,0.54936796,0.000009795543,0.000003117522,0.00010183224],"about_ca_topic_score_codex":0.00020102688,"about_ca_topic_score_gemma":0.0000418743,"teacher_disagreement_score":0.37841985,"about_ca_system_score_codex":0.000029426974,"about_ca_system_score_gemma":0.00017313406,"threshold_uncertainty_score":0.73465765},"labels":[],"label_agreement":null},{"id":"W2922326480","doi":"10.1182/blood-2018-99-120168","title":"The Clonal Hematopoietic Spectrum of Down Syndrome and ML-DS","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Izaak Walton Killam Health Centre","funders":"","keywords":"GATA1; Myeloid; Haematopoiesis; Biology; Epigenetics; Medicine; Oncology; Cancer research; Immunology; Genetics; Bioinformatics; Gene; Stem cell","score_opus":0.010559153827508867,"score_gpt":0.2672958792687105,"score_spread":0.25673672544120163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922326480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893679,0.0005928301,0.000012079974,0.0031542277,0.000044995948,0.00020456612,0.0000048854863,0.000022067916,0.0065964162],"genre_scores_gemma":[0.997761,0.00010817613,0.00031214126,0.00010202433,0.0001638658,0.000007632344,0.000002315706,0.000014301498,0.001528531],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991086,0.00002777514,0.00016188876,0.00015595538,0.0002909677,0.0002547822],"domain_scores_gemma":[0.9993359,0.00012282388,0.000039007366,0.0003296114,0.00006497038,0.000107679516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028463494,0.00008168436,0.00017812662,0.000046655045,0.00010262576,0.000013684003,0.00011917818,0.00005737279,0.00015431613],"category_scores_gemma":[0.00011885614,0.00005006427,0.000039367183,0.00015246961,0.000459486,0.00002419317,0.00010174084,0.00017064372,0.000089635374],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031533698,0.0054916707,0.43859532,0.0028939426,0.004954302,0.0050264522,0.008412754,5.176394e-7,0.36830696,0.078780085,0.067188844,0.017195787],"study_design_scores_gemma":[0.019640734,0.006788628,0.62121016,0.00049995526,0.0007873251,0.018607259,0.0008737287,0.00025536842,0.29000744,0.007625403,0.03317278,0.0005311963],"about_ca_topic_score_codex":0.00003513483,"about_ca_topic_score_gemma":0.000012610898,"teacher_disagreement_score":0.18261485,"about_ca_system_score_codex":0.000022060862,"about_ca_system_score_gemma":0.0001406035,"threshold_uncertainty_score":0.20415618},"labels":[],"label_agreement":null},{"id":"W2922339619","doi":"10.1182/blood-2018-99-113938","title":"High Post-Transplant Ferritin Level Associates with Adverse Survival and Higher Mortality Rate following Allogeneic Hematopoietic Stem Cell Transplant, whereas Pre-Transplant Ferritin Level Does Not","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Ferritin; Transplantation; Hematopoietic stem cell transplantation; Hazard ratio; Cumulative incidence; Graft-versus-host disease; Proportional hazards model; Gastroenterology; Oncology; Immunology; Confidence interval","score_opus":0.03054152214065489,"score_gpt":0.25824855689357673,"score_spread":0.22770703475292184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922339619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913357,0.00028716482,0.0008561139,0.0005202529,0.0005801401,0.0013857252,0.0034400523,0.00033584284,0.0012589927],"genre_scores_gemma":[0.99513286,0.00033076922,0.0010612126,0.00035574302,0.00031615185,0.00011290088,0.0006953254,0.00018487428,0.0018101363],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99477684,0.00044128703,0.0011562175,0.001285982,0.0011462044,0.0011934568],"domain_scores_gemma":[0.9975592,0.00048944034,0.00036926343,0.0007100272,0.00026104733,0.0006110108],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010728117,0.0009500103,0.0014214198,0.00020618443,0.0003887006,0.00009389169,0.00033427402,0.0005327042,0.00023340009],"category_scores_gemma":[0.00001036152,0.0007213979,0.0003581916,0.00029982647,0.00031541885,0.0002906376,0.000026688442,0.0005335223,0.000056728284],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020658465,0.0018071203,0.65640837,0.0037857972,0.0022103488,0.0037585383,0.0083510345,0.000005057436,0.3209437,0.00053044263,0.000022646376,0.000111097965],"study_design_scores_gemma":[0.013607458,0.00081305765,0.64810973,0.0023543148,0.004785503,0.00059199566,0.00071572245,0.000011181789,0.32792482,0.00005022208,0.000034428165,0.0010015611],"about_ca_topic_score_codex":0.0019766458,"about_ca_topic_score_gemma":0.003711045,"teacher_disagreement_score":0.011541612,"about_ca_system_score_codex":0.000082640756,"about_ca_system_score_gemma":0.00029650994,"threshold_uncertainty_score":0.9995237},"labels":[],"label_agreement":null},{"id":"W2922392474","doi":"10.1182/blood.v130.suppl_1.2821.2821","title":"Addition of Polatuzumab Vedotin to Bendamustine and Rituximab (BR) Improves Outcomes in Transplant-Ineligible Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Versus BR Alone: Results from a Randomized Phase 2 Study","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); University of British Columbia; BC Cancer Agency","funders":"","keywords":"Bendamustine; Rituximab; Medicine; Diffuse large B-cell lymphoma; Refractory (planetary science); Internal medicine; Oncology; Lymphoma","score_opus":0.010540814596921865,"score_gpt":0.2612747554390845,"score_spread":0.25073394084216266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922392474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99415433,0.0003493543,0.000002749754,0.00013243868,0.00015509101,0.002471228,0.0024830604,0.000039743652,0.00021202507],"genre_scores_gemma":[0.99835354,0.00015243213,0.00034213037,0.000049678816,0.00005189587,0.00021109995,0.0007523009,0.000040801144,0.000046091027],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9977347,0.00011357428,0.0007152302,0.0006177057,0.00045045558,0.0003683376],"domain_scores_gemma":[0.9977998,0.0005974387,0.00044977115,0.00079061463,0.00011520154,0.00024717287],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002291214,0.0003876261,0.0013836955,0.00020754979,0.00016687544,0.00005349447,0.00016087505,0.00012024293,0.000012155303],"category_scores_gemma":[0.00045353986,0.00027004533,0.00014243486,0.00008891064,0.0000858621,0.00019444249,0.00007171603,0.00010009456,0.000009431176],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.400765,0.33244553,0.25772482,0.000071541785,0.0012272594,0.00037199684,0.0034304822,1.943911e-7,0.0007720059,0.0000053795893,0.00007178121,0.0031140002],"study_design_scores_gemma":[0.64991784,0.0031916564,0.3426969,0.00022367976,0.001219817,0.0000020871446,0.0001693276,0.000017595265,0.0023413473,0.0000041344506,0.000033581524,0.00018201134],"about_ca_topic_score_codex":0.0028086533,"about_ca_topic_score_gemma":0.0007831927,"teacher_disagreement_score":0.32925385,"about_ca_system_score_codex":0.000088581364,"about_ca_system_score_gemma":0.00011468739,"threshold_uncertainty_score":0.99997514},"labels":[],"label_agreement":null},{"id":"W2922421833","doi":"10.1182/blood-2018-99-117184","title":"Human Plasminogen Replacement Therapy Vs. Best Supportive Care in Patients with Congenital Plasminogen Deficiency: A Comparison of Health Care Resource Use over a 48-Week Period","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Clinical trial; Pediatrics; Randomized controlled trial; Health care; Internal medicine; Surgery","score_opus":0.03314920543835829,"score_gpt":0.2995004654293495,"score_spread":0.2663512599909912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922421833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971823,0.0005716095,0.000007834171,0.00004539738,0.000060305858,0.00138359,0.000117912,0.000042215317,0.00058881193],"genre_scores_gemma":[0.9987849,0.000003572865,0.0004448963,0.00026759368,0.000039551465,0.000042817002,0.00030424423,0.000047505215,0.000064899585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976299,0.0001256474,0.00067493104,0.00049844483,0.0006500142,0.00042108164],"domain_scores_gemma":[0.9985435,0.000020515588,0.0003951488,0.0004931125,0.00037830943,0.0001694387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013009484,0.00028442137,0.0006742662,0.0002139829,0.0001974144,0.000029162475,0.00013192228,0.00012275892,0.0001491492],"category_scores_gemma":[0.000021345511,0.00024033964,0.00008617587,0.0002771824,0.0001670629,0.00009729427,0.000061788465,0.00017704583,0.000014637168],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014504798,0.00426841,0.9402112,0.000108726934,0.00021169036,0.000006664641,0.051961213,0.000001865946,0.0006893919,0.000076190816,0.00015113373,0.00086302496],"study_design_scores_gemma":[0.030318063,0.031618007,0.8793755,0.0002844728,0.000289416,0.0000073529427,0.022268659,0.000011964502,0.03437601,0.00000307407,0.0010662391,0.0003812301],"about_ca_topic_score_codex":0.00030953094,"about_ca_topic_score_gemma":0.00079995644,"teacher_disagreement_score":0.060835693,"about_ca_system_score_codex":0.00013558858,"about_ca_system_score_gemma":0.00030736212,"threshold_uncertainty_score":0.9800766},"labels":[],"label_agreement":null},{"id":"W2922464087","doi":"10.1182/blood-2018-99-116806","title":"Efficacy and Safety of Venetoclax (Ven) + Rituximab (R) or Ven + Bendamustine (B) + R Randomized Versus B + R in Patients (pts) with Relapsed/Refractory (R/R) Follicular Lymphoma (FL): Final Analysis of Phase II CONTRALTO Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Ven; Medicine; Internal medicine; Venetoclax; Bendamustine; Rituximab; Gastroenterology; Clinical endpoint; Regimen; Chronic lymphocytic leukemia; Randomized controlled trial; Lymphoma; Leukemia","score_opus":0.02138922789065322,"score_gpt":0.3128269048354661,"score_spread":0.2914376769448129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922464087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967198,0.0003742502,0.00001575523,0.00001813268,0.00007126778,0.002575485,0.000060406655,0.000021801012,0.00014309556],"genre_scores_gemma":[0.99926794,0.000062134925,0.00026205688,0.00001631147,0.00008016739,0.00007115025,0.000093070514,0.000037020756,0.00011017716],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9967856,0.00032361425,0.0009999825,0.0005378472,0.000898694,0.00045427264],"domain_scores_gemma":[0.99724984,0.00085556955,0.000409857,0.0007192887,0.0005487582,0.00021666825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010112331,0.0003015917,0.0019878715,0.00059004466,0.000091265196,0.0000092651335,0.0002022248,0.00014186397,0.00016680238],"category_scores_gemma":[0.0016229106,0.00021322482,0.00020708279,0.0013026668,0.0005648567,0.00008835749,0.00015480588,0.00016068191,0.000003713726],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9410896,0.036045745,0.0056251134,0.00018843009,0.008987321,0.0002888724,0.0023860692,0.00003584701,0.00035087502,0.000013431608,0.00003600421,0.0049526924],"study_design_scores_gemma":[0.9394593,0.019983793,0.026958868,0.0002526568,0.009129004,0.000010212477,0.0002040396,0.0024592916,0.0012331001,0.0000016211644,0.00010920181,0.00019886535],"about_ca_topic_score_codex":0.0012268227,"about_ca_topic_score_gemma":0.0004935969,"teacher_disagreement_score":0.021333754,"about_ca_system_score_codex":0.0017151025,"about_ca_system_score_gemma":0.003067183,"threshold_uncertainty_score":0.8695056},"labels":[],"label_agreement":null},{"id":"W2922487873","doi":"10.1182/blood.v130.suppl_1.626.626","title":"An Individual Participant Data Meta-Analysis of 13 Randomized Trials to Evaluate the Impact of Prophylactic Use of Heparin in Oncological Patients","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; Impact","funders":"","keywords":"Medicine; Randomized controlled trial; Meta-analysis; Cancer; Low molecular weight heparin; Internal medicine; Sample size determination; Heparin; Surgery; Intensive care medicine; Oncology; Statistics","score_opus":0.5920563654867362,"score_gpt":0.5011193675254986,"score_spread":0.09093699796123766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922487873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99654377,0.00014950239,0.0000104118735,0.00019758647,0.00002407783,0.0027192116,0.00029799854,0.00000406393,0.000053406948],"genre_scores_gemma":[0.99924535,0.00004081923,0.00036481456,0.000055300497,0.000015974203,0.00016881255,0.00009324538,0.000008785785,0.000006907349],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.99587584,0.0016484288,0.0013480269,0.00031226096,0.0006028599,0.00021258913],"domain_scores_gemma":[0.99530596,0.0012438067,0.0010579248,0.002087045,0.0001996445,0.00010562791],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.010224973,0.00016329673,0.004910287,0.00024131217,0.000045816618,0.000037245092,0.00064139004,0.00006008069,0.00024956],"category_scores_gemma":[0.012305223,0.000074097494,0.0011173312,0.00024642548,0.00016091747,0.00015741099,0.0003921203,0.0000851946,0.0000014918938],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030169027,0.039536696,0.1675848,0.00015255902,0.75185657,0.000018153905,0.0033391828,0.0028210282,0.0018324743,0.00018973087,0.00040632172,0.002093469],"study_design_scores_gemma":[0.037116908,0.0010830673,0.5279223,0.000008452085,0.43258014,1.09693175e-7,0.00002878029,0.00049421017,0.0006858921,0.000027070853,0.0000028184847,0.000050236995],"about_ca_topic_score_codex":0.0052469033,"about_ca_topic_score_gemma":0.00048852153,"teacher_disagreement_score":0.3603375,"about_ca_system_score_codex":0.0000104630335,"about_ca_system_score_gemma":0.000109425164,"threshold_uncertainty_score":0.99601454},"labels":[],"label_agreement":null},{"id":"W2922521872","doi":"10.1182/blood-2018-99-116069","title":"PD-1/PD-L Pathway Potentially Involved in ITP Immunopathogenesis","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Immunology; Medicine; Platelet; Monoclonal antibody; Immune system; Antibody; CD28; Immune tolerance; T cell","score_opus":0.011964140878302937,"score_gpt":0.23403839854673275,"score_spread":0.2220742576684298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922521872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933623,0.0010174487,0.000018257002,0.00022924504,0.000123789,0.00026262473,0.000014256656,0.000054269236,0.0049177865],"genre_scores_gemma":[0.9978946,0.0001104839,0.0008508069,0.0002988395,0.000111650996,0.000023213504,0.00004663358,0.000025319197,0.00063847075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990559,0.000027367689,0.00021114424,0.00025056925,0.00016984578,0.00028516195],"domain_scores_gemma":[0.99949586,0.000014040055,0.000047530844,0.00029382991,0.000062201936,0.000086525506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009989214,0.00014809321,0.0002806261,0.000110089844,0.000057868616,0.000014239112,0.00007969499,0.00009693933,0.00016218155],"category_scores_gemma":[0.000037623064,0.00012507415,0.00007916464,0.00020498838,0.000054991753,0.000054108772,0.000039432165,0.00007833619,0.00029535798],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000768423,0.01023751,0.48838612,0.0001251318,0.0007789655,0.008406094,0.00088462856,5.0153585e-7,0.44680846,0.00028997893,0.00048306727,0.042831123],"study_design_scores_gemma":[0.035274506,0.0024799474,0.6704167,0.0003581343,0.00072518113,0.0005208155,0.0003636844,0.000047722828,0.2765651,0.00084054953,0.011776399,0.0006312013],"about_ca_topic_score_codex":0.000120820434,"about_ca_topic_score_gemma":0.00027461027,"teacher_disagreement_score":0.18203062,"about_ca_system_score_codex":0.0000222964,"about_ca_system_score_gemma":0.00009887121,"threshold_uncertainty_score":0.5100376},"labels":[],"label_agreement":null},{"id":"W2922533100","doi":"10.1182/blood-2018-99-118369","title":"Management of Cerebral Vein Thrombosis in a Canadian Tertiary Hospital","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Cerebral Venous Sinus Thrombosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Pediatrics; Pregnancy; Thrombosis; Venous thrombosis; Medical record; Stroke (engine); Deep vein; Retrospective cohort study; Emergency medicine; Surgery","score_opus":0.010085813631843155,"score_gpt":0.247497415217559,"score_spread":0.23741160158571584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922533100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97217155,0.000083927574,0.000001959723,0.0009586974,0.00012997164,0.00044369398,0.000015929927,0.000031822823,0.026162436],"genre_scores_gemma":[0.99790055,0.000017529872,0.0014573275,0.00024160699,0.00011766876,0.00001763572,0.000014166884,0.000028435148,0.0002050949],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987764,0.000019094152,0.00026376607,0.00026071563,0.0002044999,0.00047553462],"domain_scores_gemma":[0.9992553,0.0000086693835,0.0000503351,0.00038019478,0.000057145444,0.0002483456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012694616,0.00013900986,0.00028890834,0.00023775437,0.00004120524,0.000008377898,0.00013414354,0.00008772047,0.00059200294],"category_scores_gemma":[0.000014687302,0.0001354895,0.00007772548,0.00033763508,0.00012554934,0.00006350343,0.000060915776,0.000106653024,0.00013011835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000130920935,0.0015882622,0.992158,0.00018644074,0.00035651986,0.00015412872,0.0012089584,1.1695237e-7,0.0011438115,0.0005943784,0.00096348184,0.0016328236],"study_design_scores_gemma":[0.0023348045,0.00068015297,0.9861094,0.0002868122,0.00023971756,0.000015430307,0.00026433053,0.000013680558,0.009323309,0.0000887637,0.0004963814,0.00014725329],"about_ca_topic_score_codex":0.15024665,"about_ca_topic_score_gemma":0.14379379,"teacher_disagreement_score":0.025957342,"about_ca_system_score_codex":0.00013875637,"about_ca_system_score_gemma":0.00015858682,"threshold_uncertainty_score":0.87182975},"labels":[],"label_agreement":null},{"id":"W2922990580","doi":"10.1182/blood-2018-99-117405","title":"Development of a Clinical Prediction Rule for the Risk of Venous Thromboembolism in Patients with Acute Leukemia","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Interquartile range; Acute leukemia; Internal medicine; Univariate analysis; Retrospective cohort study; Population; Proportional hazards model; Leukemia; Surgery; Multivariate analysis","score_opus":0.01985306589006217,"score_gpt":0.30419629413442284,"score_spread":0.28434322824436065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922990580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986504,0.000017746212,0.000236034,0.000013009084,0.00015236619,0.0005020069,0.0000355238,0.000008853492,0.00038411465],"genre_scores_gemma":[0.9973057,0.000023504248,0.0024343776,0.000025398078,0.000118778444,0.00005289847,0.000009557195,0.000008411591,0.000021363883],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993532,0.000016233651,0.0003174469,0.00010331373,0.00012283823,0.000087024615],"domain_scores_gemma":[0.9994786,0.000050519055,0.00014672952,0.00015577159,0.00014165531,0.00002675706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018811588,0.000052833297,0.0002371209,0.000029544108,0.000052587766,0.0000016054237,0.000044347762,0.000043033426,0.000012940354],"category_scores_gemma":[0.00003167586,0.000031115575,0.00004390265,0.00009718592,0.000085866144,0.000022702547,0.000015184335,0.00008388683,0.000002138547],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006347411,0.0015056293,0.98538125,0.00003205398,0.0006704515,4.4867326e-7,0.0008032489,0.0000020786383,0.0003123464,0.000025176803,0.00011573124,0.010516836],"study_design_scores_gemma":[0.0065929024,0.0014917692,0.98257405,0.00006497434,0.0006920502,0.0000019399934,0.000034981156,0.000008799481,0.0074021094,0.000020823238,0.0010848707,0.00003071557],"about_ca_topic_score_codex":0.000037614227,"about_ca_topic_score_gemma":0.000078372024,"teacher_disagreement_score":0.01048612,"about_ca_system_score_codex":0.000022467528,"about_ca_system_score_gemma":0.00032599398,"threshold_uncertainty_score":0.12688564},"labels":[],"label_agreement":null},{"id":"W2923671895","doi":"10.1182/blood-2018-99-115308","title":"Creating a Population Model for PK-Tailored Dosing Using Real-World Data from the Web-Accessible Population Pharmacokinetic Service-Hemophilia (WAPPS-Hemo) Platform","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; McMaster University; University of Waterloo","funders":"","keywords":"Medicine; NONMEM; Dosing; Population; Pharmacokinetics; Clotting factor; Pediatrics; Internal medicine","score_opus":0.1809529358240557,"score_gpt":0.4084802228270557,"score_spread":0.227527287003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2923671895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958787,0.000107423875,0.00045153772,0.0009529068,0.00013113035,0.0013130428,0.00019747895,0.00012971893,0.0008380697],"genre_scores_gemma":[0.9819553,0.000043736527,0.012244595,0.00026646713,0.001580224,0.00005515589,0.0033155684,0.000073081275,0.00046585852],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99784666,0.000043068147,0.00049351586,0.00060417695,0.0005121992,0.0005003483],"domain_scores_gemma":[0.9982818,0.00018257757,0.00023018055,0.0009273434,0.00022165338,0.00015649454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004216867,0.00027220938,0.0003869511,0.00017329758,0.00062195037,0.00013713283,0.00039293506,0.00010114479,0.00010206296],"category_scores_gemma":[0.00011866893,0.00019175572,0.000083808656,0.0006546053,0.000064609485,0.0005119859,0.00024965135,0.00020182619,0.000022135744],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015454716,0.0010720718,0.8458194,0.00048468667,0.00073766115,0.000017534763,0.0012770102,0.0008286381,0.13675311,0.00016222883,0.00096165016,0.010340487],"study_design_scores_gemma":[0.005128397,0.00009588549,0.091505475,0.00036961568,0.00092312007,0.000007912556,0.00007639974,0.8956788,0.0050397585,0.00090536085,0.000061335006,0.00020794559],"about_ca_topic_score_codex":0.0056128884,"about_ca_topic_score_gemma":0.0031669121,"teacher_disagreement_score":0.89485013,"about_ca_system_score_codex":0.00012646579,"about_ca_system_score_gemma":0.00013961419,"threshold_uncertainty_score":0.84850454},"labels":[],"label_agreement":null},{"id":"W2923717249","doi":"10.1182/blood-2018-99-114949","title":"Successful Management of Pregnancy with Severe Von Willebrand Disease in a Jehovah's Witness with Recombinant Von Willebrand Factor","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University Health Network","funders":"","keywords":"Medicine; Von Willebrand disease; Desmopressin; Pregnancy; Von Willebrand factor; Obstetrics; Fresh frozen plasma; Surgery; Tranexamic acid; Gynecology; Internal medicine; Platelet","score_opus":0.007918908350631105,"score_gpt":0.22818277274253995,"score_spread":0.22026386439190884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2923717249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99495095,0.000919127,0.000030896073,0.00016234058,0.0000513824,0.0011156775,0.000033908655,0.000037522062,0.0026982166],"genre_scores_gemma":[0.99815327,0.00031868892,0.0003851995,0.00003284011,0.000018196277,0.00008625244,0.000049340386,0.00004179418,0.0009144314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858284,0.000027320742,0.0002577756,0.00043219826,0.00034834363,0.0003515188],"domain_scores_gemma":[0.99915904,0.000016910684,0.0001305494,0.00041947266,0.00008452793,0.00018952986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000039601397,0.00028163102,0.0005002258,0.00013081761,0.0000632703,0.000016528951,0.00010699568,0.000060118033,0.00010885281],"category_scores_gemma":[0.00000492314,0.00017919563,0.00005257607,0.0003527767,0.00016004783,0.00016091924,0.000040251012,0.00009662757,0.000010412365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032783113,0.0038814333,0.9828742,0.0008918813,0.0007881657,0.0035446389,0.0004108502,0.0000030109495,0.00004107537,0.000085866064,0.000027118664,0.004173411],"study_design_scores_gemma":[0.061778564,0.003920638,0.9196281,0.009088318,0.0015088208,0.00021791033,0.0003263712,0.000035143283,0.0023408928,0.00034461563,0.00027500262,0.00053562253],"about_ca_topic_score_codex":0.00009860745,"about_ca_topic_score_gemma":0.00022992652,"teacher_disagreement_score":0.06324614,"about_ca_system_score_codex":0.000028334183,"about_ca_system_score_gemma":0.00007913208,"threshold_uncertainty_score":0.7307386},"labels":[],"label_agreement":null},{"id":"W2923957324","doi":"10.1182/blood-2018-99-111130","title":"Adoptive Transfers of Plasmacytoid Dendritic Cells after Hematopoietic Stem Cell Transplantation Decrease the Risk Acute Lymphoblastic Leukemia Relapse without Increasing the Risk of Graft-Versus-Host-Disease","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Immunology; Hematopoietic stem cell transplantation; Medicine; Myeloid leukemia; Immunotherapy; Transplantation; Adoptive cell transfer; Leukemia; Stem cell; Myeloid; Cancer; Immune system; Cancer research; T cell; Biology; Internal medicine","score_opus":0.005742572700983251,"score_gpt":0.20157590087603433,"score_spread":0.19583332817505109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2923957324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959458,0.00097359315,0.0007662249,0.000021191143,0.0012471464,0.0004762109,0.00020004265,0.00003974261,0.0003300581],"genre_scores_gemma":[0.9981728,0.0012078459,0.000042564643,0.000058603382,0.00003731911,0.000050890503,0.00004330663,0.00003174894,0.0003549235],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99777555,0.0009856141,0.0005287312,0.0003059874,0.00010099178,0.00030310662],"domain_scores_gemma":[0.99809504,0.00086255616,0.00035271942,0.0004444848,0.00018674559,0.000058455313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039752855,0.00027140378,0.0003079653,0.0001067419,0.0003470314,0.000017436896,0.00025369774,0.00016942176,0.00035371678],"category_scores_gemma":[0.000066830115,0.00017629986,0.00027434964,0.00018651628,0.0006326447,0.00014885869,0.000026209664,0.00037492678,0.00017320974],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044962384,0.0010153161,0.011175718,0.0002916537,0.0027079817,0.00003081397,0.013595386,0.00010463285,0.92537045,0.00008485923,0.00027543254,0.000385359],"study_design_scores_gemma":[0.008517701,0.0009566583,0.015137008,0.00020532667,0.007083661,0.00011514136,0.0025659495,0.00008428287,0.9648334,0.000021109447,0.00022420014,0.0002555682],"about_ca_topic_score_codex":0.0004187628,"about_ca_topic_score_gemma":0.00007525506,"teacher_disagreement_score":0.03946293,"about_ca_system_score_codex":0.000059123904,"about_ca_system_score_gemma":0.00021156731,"threshold_uncertainty_score":0.71892995},"labels":[],"label_agreement":null},{"id":"W2924655050","doi":"10.1182/blood-2018-99-118331","title":"Identification of Novel Lncrnas That Predict Survival in AML Patients and Modulate Leukemic Cells","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute","funders":"","keywords":"Myelopoiesis; Biology; Myeloid; Myeloid leukemia; Lymphopoiesis; Transcriptome; Haematopoiesis; Computational biology; Cancer research; Genetics; Stem cell; Gene expression; Gene","score_opus":0.011223903241823764,"score_gpt":0.24625677565152973,"score_spread":0.23503287240970597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2924655050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957619,0.00013648467,0.0035028688,0.000009498124,0.00013945771,0.00022024485,0.000047184043,0.0000048801844,0.00017748382],"genre_scores_gemma":[0.9994168,0.00013919556,0.00013595252,0.000015469765,0.00006066711,0.000011542292,0.000052670708,0.000018461518,0.0001492119],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991115,0.000037587197,0.00019164712,0.00028938282,0.00019071599,0.0001791636],"domain_scores_gemma":[0.9994898,0.000005203994,0.00008425139,0.00026122827,0.00011028437,0.00004925448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018923874,0.0000921549,0.000102502665,0.00006858976,0.00002714445,0.000013034619,0.000135691,0.0001323837,0.0000058113496],"category_scores_gemma":[0.00004344761,0.00009763184,0.00003192513,0.00009669128,0.00008987448,0.000004111077,0.0001228777,0.0000712855,0.0000031679135],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046631154,0.00021547284,0.002054272,0.000018249308,0.00003226263,5.748475e-7,0.000037843944,0.000019837247,0.99716425,0.000014703424,0.00003024037,0.00036567252],"study_design_scores_gemma":[0.0023258263,0.00024447244,0.02216232,0.000015447598,0.000017175616,0.0000018060297,0.000012990856,0.0004638686,0.97450316,0.000021781792,0.00014018928,0.000090984584],"about_ca_topic_score_codex":0.000050529,"about_ca_topic_score_gemma":0.00004662138,"teacher_disagreement_score":0.022661103,"about_ca_system_score_codex":0.000013303129,"about_ca_system_score_gemma":0.00005366955,"threshold_uncertainty_score":0.39813107},"labels":[],"label_agreement":null},{"id":"W2925021200","doi":"10.1182/blood-2018-99-118998","title":"Relapse-Initiating Clones Preexisting at Diagnosis in B- Cell Acute Lymphoblastic Leukemia Help Predict Molecular Pathways of Relapse","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Biology; Somatic evolution in cancer; clone (Java method); Epigenetics; Transplantation; CDKN2B; Exome sequencing; Disease; Acute lymphocytic leukemia; CDKN2A; Leukemia; Genetics; Cancer; Phenotype; Immunology; Cancer research; Gene; Medicine; Internal medicine; Lymphoblastic Leukemia","score_opus":0.016627547992174162,"score_gpt":0.2580005084798575,"score_spread":0.24137296048768334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2925021200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98558617,0.00054652826,0.00033562403,0.00008451409,0.000174512,0.00080175843,0.000081366365,0.00015080227,0.012238719],"genre_scores_gemma":[0.9938106,0.00018892161,0.004724833,0.00018347378,0.0003583793,0.0001947698,0.00006452305,0.00012743972,0.0003470763],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.995998,0.00019643901,0.001008479,0.0007770358,0.0010585124,0.000961529],"domain_scores_gemma":[0.99705446,0.0009670167,0.00037738887,0.0008562787,0.00036459405,0.00038029108],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006399086,0.0004219296,0.0007737131,0.0004121136,0.00016597814,0.000025930578,0.0003942097,0.00037241867,0.00016662599],"category_scores_gemma":[0.001955039,0.00039874183,0.00020788517,0.0008547114,0.0004187864,0.0001537326,0.00057326036,0.00041752728,0.00017660396],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016787311,0.0027066001,0.3962949,0.0020571905,0.00090710295,0.007379407,0.0043675853,0.00012045659,0.57945716,0.00041244397,0.002758198,0.0018602613],"study_design_scores_gemma":[0.025722241,0.0034882138,0.021070782,0.0022246013,0.0012102827,0.0008776677,0.00039682604,0.006440202,0.937454,0.0003026528,0.0001868865,0.0006256383],"about_ca_topic_score_codex":0.0002596732,"about_ca_topic_score_gemma":0.00004501069,"teacher_disagreement_score":0.3752241,"about_ca_system_score_codex":0.0013747407,"about_ca_system_score_gemma":0.0013285854,"threshold_uncertainty_score":0.99984646},"labels":[],"label_agreement":null},{"id":"W2925230746","doi":"10.1182/blood-2018-11-844530","title":"Neutrophils and NETs in modulating acute and chronic inflammation","year":2019,"lang":"en","type":"review","venue":"Blood","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":777,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research; Canada Research Chairs; Heart and Stroke Foundation of Canada","keywords":"Inflammation; Neutrophil extracellular traps; Innate immune system; Phagocytosis; Immunology; Limiting; Immune system; Biology","score_opus":0.027076723901499906,"score_gpt":0.27837698648244263,"score_spread":0.25130026258094273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2925230746","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.032359034,0.9664709,0.000006503907,0.000028134982,0.00018876225,0.00076677924,0.000042854364,0.000031286643,0.000105765575],"genre_scores_gemma":[0.0021764175,0.9970365,0.000051332667,0.00002111838,0.00006907644,0.00006413078,0.00027460104,0.00004050956,0.0002662968],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99843675,0.00024617935,0.00045872782,0.0004985582,0.000026183592,0.00033359765],"domain_scores_gemma":[0.99933016,0.000106497406,0.00025232616,0.000269345,0.00002007736,0.000021593893],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001550021,0.0003752924,0.001158536,0.00023627181,0.00007892324,0.000029200592,0.00013481433,0.0005004646,0.00004041956],"category_scores_gemma":[0.000014646066,0.0003096209,0.00009337636,0.00014131871,0.00007388297,0.00011676411,0.00018884362,0.0004946947,0.00013966218],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008175073,0.00005719739,0.000019647085,0.004288201,0.0005988799,0.000049720384,0.00009686406,6.3758733e-7,0.038855143,0.0014127936,0.00001941182,0.9545933],"study_design_scores_gemma":[0.004297525,0.00058825983,0.00013303437,0.010520152,0.0024904825,0.00087893236,0.000017628941,0.000003761984,0.010973952,0.00030229727,0.9687953,0.0009986713],"about_ca_topic_score_codex":0.000011758891,"about_ca_topic_score_gemma":0.000013466533,"teacher_disagreement_score":0.96877587,"about_ca_system_score_codex":0.000037720878,"about_ca_system_score_gemma":0.000096967466,"threshold_uncertainty_score":0.99993557},"labels":[],"label_agreement":null},{"id":"W2926169207","doi":"10.1182/blood.v130.suppl_1.883.883","title":"Efficacy of ALL Therapy for WHO2016-Defined Mixed Phenotype Acute Leukemia: A Report from the Children's Oncology Group","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre","funders":"","keywords":"Medicine; Oncology; Clinical trial; Internal medicine; Leukemia; Pediatrics; Immunology","score_opus":0.028368176376709305,"score_gpt":0.3259910163843031,"score_spread":0.2976228400075938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2926169207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907482,0.0005603848,0.0005008242,0.004076983,0.0002768759,0.0017569521,0.00011610425,0.000060833103,0.0019028337],"genre_scores_gemma":[0.9916533,0.00042407122,0.004950472,0.00068582594,0.0010279182,0.00016286399,0.0003846225,0.00007220091,0.00063871255],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9979515,0.00008076075,0.00050618616,0.00051060255,0.00046840776,0.00048253784],"domain_scores_gemma":[0.99599355,0.0012072797,0.00052738865,0.0018808594,0.00022071689,0.00017022483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058100076,0.00024715316,0.0006566643,0.000052568437,0.00027256523,0.000044730397,0.0007643772,0.00030095733,0.00007787272],"category_scores_gemma":[0.0015565082,0.00015350625,0.00027030613,0.00006750558,0.0003934548,0.00007957937,0.00022957554,0.00032532203,0.000033165194],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038314506,0.0126327425,0.15381995,0.00016996937,0.0321561,0.0044251033,0.0035661121,0.00000560935,0.36064428,0.0028735409,0.21375588,0.17763622],"study_design_scores_gemma":[0.094968945,0.0033129898,0.83017206,0.00012203576,0.0022566682,0.0009460587,0.000050740993,0.00011710172,0.02847836,0.0011185409,0.03809112,0.00036538613],"about_ca_topic_score_codex":0.0011188709,"about_ca_topic_score_gemma":0.00007862011,"teacher_disagreement_score":0.6763521,"about_ca_system_score_codex":0.00027634742,"about_ca_system_score_gemma":0.0014844586,"threshold_uncertainty_score":0.6259803},"labels":[],"label_agreement":null},{"id":"W2926662368","doi":"10.1182/blood-2019-01-846048","title":"How I manage anticoagulant therapy in older individuals with atrial fibrillation or venous thromboembolism","year":2019,"lang":"en","type":"review","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Atrial fibrillation; Warfarin; Polypharmacy; Vitamin K antagonist; Antithrombotic; Anticoagulant; Anticoagulant therapy; Pulmonary embolism; Intensive care medicine; Stroke (engine); Thrombosis; Internal medicine; Venous thrombosis; Cardiology","score_opus":0.11140936643546553,"score_gpt":0.3606816197439007,"score_spread":0.2492722533084352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2926662368","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038642492,0.9899009,0.000018215886,0.00027648147,0.00037827578,0.004951218,0.000026417356,0.00009969101,0.00048454286],"genre_scores_gemma":[0.0007620353,0.99243486,0.00034868706,0.000035621146,0.0030203322,0.0000050469366,0.00036937997,0.00010824616,0.0029157817],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978547,0.00014578184,0.000561233,0.0005416312,0.00052563346,0.00037100635],"domain_scores_gemma":[0.99859285,0.00022684444,0.0004938433,0.0005679341,0.000041534273,0.000076986034],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028268647,0.00051136775,0.002935386,0.0005363997,0.000050082213,0.00014047355,0.00015719939,0.00036671304,0.00009996163],"category_scores_gemma":[0.00006242265,0.00030412004,0.0006009349,0.0006402238,0.000030897398,0.00015045148,0.00007300989,0.00024716355,0.000080979094],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017989842,0.00006712069,0.018062918,0.014635316,0.0029726452,0.00022326692,0.00023328,0.000009459133,7.4736454e-7,0.00023690754,0.00014270224,0.96323574],"study_design_scores_gemma":[0.008208969,0.000655223,0.008116684,0.0065348498,0.0047156005,0.0000958464,0.000028182434,0.0000036907122,0.000001803371,0.000012672523,0.97116756,0.0004588928],"about_ca_topic_score_codex":0.000013459449,"about_ca_topic_score_gemma":0.000007463192,"teacher_disagreement_score":0.9710249,"about_ca_system_score_codex":0.000047960282,"about_ca_system_score_gemma":0.00021829183,"threshold_uncertainty_score":0.9999411},"labels":[],"label_agreement":null},{"id":"W2926995464","doi":"10.1182/blood-2019-02-900480","title":"MAA868 locks factor XIa in a zymogen-like state","year":2019,"lang":"en","type":"letter","venue":"Blood","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Hemostasis; Zymogen; Antithrombotic; Medicine; Thrombosis; Pharmacology; Immunology; Internal medicine; Chemistry; Biochemistry","score_opus":0.017992665834077985,"score_gpt":0.2438799633561526,"score_spread":0.22588729752207462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2926995464","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68098015,0.012703151,0.000047509944,0.28943115,0.0036654025,0.003305974,0.0008308541,0.00053540134,0.008500422],"genre_scores_gemma":[0.12942566,0.00055427855,0.0003226675,0.69824934,0.007424587,0.0000979328,0.0023836463,0.00041103942,0.16113082],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99742955,0.000060641974,0.00058430026,0.00066713453,0.00056518853,0.0006931982],"domain_scores_gemma":[0.9986742,0.0001543104,0.00022835571,0.00074743584,0.00009158644,0.000104105085],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001090126,0.0004977965,0.0008823888,0.00036140543,0.00004200492,0.000048569316,0.00022180247,0.0007498225,0.0009889014],"category_scores_gemma":[0.00005081881,0.00045581986,0.00029711658,0.00024606462,0.00006284825,0.000079758844,0.0000787976,0.0011881337,0.00070872897],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000068987705,0.00035504898,0.074566334,0.0007377901,0.0003846546,0.0018151097,0.000721826,0.0000023779326,0.00036661763,0.0000043606415,0.9186384,0.002338507],"study_design_scores_gemma":[0.005194943,0.0002373123,0.045488812,0.0005644477,0.00032642248,0.00015944528,0.000014207656,0.000023186107,0.0010898522,0.000091750226,0.9462224,0.00058720063],"about_ca_topic_score_codex":0.00033669092,"about_ca_topic_score_gemma":0.00006461765,"teacher_disagreement_score":0.55155444,"about_ca_system_score_codex":0.00007786182,"about_ca_system_score_gemma":0.00034040984,"threshold_uncertainty_score":0.9999243},"labels":[],"label_agreement":null},{"id":"W2927509568","doi":"10.1182/blood.v130.suppl_1.822.822","title":"The Impact of Upfront Autologous Transplant on the Survival of Adult Patients with ALCL and PTCL-NOS According to Their <i>ALK</i>, <i>DUSP22</i> and <i>TP63</i> Gene Rearrangement Status - a Joined Nordic Lymphoma Group and Mayo Clinic Analysis","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Anaplastic large-cell lymphoma; Oncology; Internal medicine; Medicine; Lymphoma; Autologous stem-cell transplantation; CHOP; Fluorescence in situ hybridization; Cancer research; Biology; Genetics; Gene","score_opus":0.012790078093340372,"score_gpt":0.254559342506017,"score_spread":0.2417692644126766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2927509568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971693,0.00070175366,0.000008297336,0.00039692197,0.000037466856,0.00093597337,0.00038380869,0.000013274349,0.00035316503],"genre_scores_gemma":[0.9977576,0.0018470702,0.000101147794,0.00012288801,0.000024874329,0.00007126461,0.000040824605,0.000022960234,0.000011372925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983517,0.000108113076,0.00042730887,0.0004119004,0.00033627666,0.00036468985],"domain_scores_gemma":[0.9980998,0.00041240844,0.00037430125,0.0007691958,0.00012402657,0.000220272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032275068,0.0003062814,0.00074541377,0.00009110729,0.00036558264,0.000071744464,0.00014763829,0.00006961371,0.000006073412],"category_scores_gemma":[0.00007772035,0.00013662697,0.0001844674,0.00013913446,0.00023623636,0.00006223959,0.000088687724,0.00006236302,7.428353e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015571087,0.0014396188,0.9772919,0.000039581697,0.0035678996,0.000023141722,0.0007000321,0.0000019152067,0.0007178968,0.0000334159,0.00003987618,0.014587646],"study_design_scores_gemma":[0.012933082,0.0035807935,0.9774573,0.00018450135,0.0030055526,0.000014483008,0.00027163798,0.000041545984,0.0023172835,0.000014814284,0.000029803577,0.00014923154],"about_ca_topic_score_codex":0.0018836666,"about_ca_topic_score_gemma":0.0006234849,"teacher_disagreement_score":0.014438415,"about_ca_system_score_codex":0.00004362275,"about_ca_system_score_gemma":0.000067179426,"threshold_uncertainty_score":0.55714864},"labels":[],"label_agreement":null},{"id":"W2927827681","doi":"10.1182/blood.v130.suppl_1.3231.3231","title":"Effectiveness of Acyclovir Prophylaxis Against Varicella Zoster Virus Infection after Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis","year":2017,"lang":"en","type":"review","venue":"Blood","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Varicella zoster virus; Discontinuation; Hematopoietic stem cell transplantation; Transplantation; Postherpetic neuralgia; Incidence (geometry); Internal medicine; Chemoprophylaxis; Aciclovir; Antibiotic prophylaxis; Immunology; Virus; Viral disease; Antibiotics; Herpesviridae; Anesthesia","score_opus":0.05283747861843161,"score_gpt":0.33192147067642996,"score_spread":0.27908399205799833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2927827681","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00041947325,0.9923103,0.00007803017,0.0000022930615,0.000039221657,0.006221344,0.00021527515,0.000035500507,0.00067855127],"genre_scores_gemma":[0.0095559275,0.9866249,0.0000331623,0.000022244792,0.000014371169,0.0031546345,0.00011015044,0.000060645478,0.0004239775],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99654835,0.0010892996,0.0012062469,0.0006113895,0.0003261536,0.00021858393],"domain_scores_gemma":[0.99711317,0.0003462591,0.001071206,0.0011513124,0.00017754233,0.00014053837],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008632967,0.0006485332,0.008929794,0.00046035973,0.00011211324,0.000055522254,0.00010888089,0.0003432558,0.00009072443],"category_scores_gemma":[0.000024620296,0.00039912833,0.0031105725,0.00058191887,0.00006861364,0.00009491081,0.000038437745,0.0002907606,0.00006772247],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000954624,0.00070110615,0.00002933089,0.85878575,0.13783965,0.00013981707,0.000031703457,1.3832889e-7,5.0764595e-7,0.0000011204557,4.920491e-7,0.002460812],"study_design_scores_gemma":[0.00061643455,0.00019879728,0.000040864055,0.09504429,0.90093577,0.00026809511,8.640146e-7,1.4065802e-7,0.000053022508,0.0000014285123,0.0025688098,0.00027146362],"about_ca_topic_score_codex":0.00008828289,"about_ca_topic_score_gemma":0.00001978716,"teacher_disagreement_score":0.7637415,"about_ca_system_score_codex":0.00006953566,"about_ca_system_score_gemma":0.00014103235,"threshold_uncertainty_score":0.99984604},"labels":[],"label_agreement":null},{"id":"W2928495578","doi":"10.1182/blood-2018-09-873695","title":"Activation of hedgehog signaling associates with early disease progression in chronic lymphocytic leukemia","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; Comisión Nacional de Investigación Científica y Tecnológica; China Scholarship Council; Ontario Genomics Institute; Ohio State University; Ontario Genomics; National Institutes of Health; Ontario Institute for Cancer Research; Government of Canada; Fondo de Fomento al Desarrollo Científico y Tecnológico; Canadian Institutes of Health Research; Genome Canada","keywords":"Chronic lymphocytic leukemia; Hedgehog; Medicine; Cancer research; Leukemia; Immunology; Signal transduction; Biology; Genetics","score_opus":0.007002044017250252,"score_gpt":0.23366836263992244,"score_spread":0.2266663186226722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2928495578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985351,0.00093932054,0.00004123293,0.0000080376485,0.000023740033,0.0002692092,0.000005905312,0.000013426919,0.00016401314],"genre_scores_gemma":[0.99954575,0.000028664475,0.00014657367,0.00001676467,0.00007719515,0.000028190996,0.00003584706,0.00002167817,0.00009932453],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99915236,0.00004518356,0.00017436944,0.00026678294,0.00015864449,0.0002026621],"domain_scores_gemma":[0.99953014,0.000021500286,0.00012482808,0.00020501629,0.000070895025,0.0000475949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012809956,0.00012835026,0.00016932523,0.000048336547,0.000029676485,0.000010231777,0.000103284714,0.000081795355,0.0000051561465],"category_scores_gemma":[0.00006482139,0.00010768349,0.000044925444,0.00012100333,0.00004098233,0.000005763823,0.000057399233,0.000058032587,0.00000653328],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011919814,0.000049414044,0.14249147,0.00010110807,0.00006807314,0.0000037414638,0.000100256446,0.0018702471,0.85494983,0.000007671785,0.000005461879,0.00023351572],"study_design_scores_gemma":[0.0026415302,0.0005528139,0.053338647,0.0003941038,0.00004048907,8.690315e-7,0.000045736542,0.00017658147,0.9425511,0.000017505368,0.000068186404,0.00017247394],"about_ca_topic_score_codex":0.000037630598,"about_ca_topic_score_gemma":0.000010517529,"teacher_disagreement_score":0.08915283,"about_ca_system_score_codex":0.0002751147,"about_ca_system_score_gemma":0.00088454154,"threshold_uncertainty_score":0.43912053},"labels":[],"label_agreement":null},{"id":"W2930876421","doi":"10.1182/blood-2018-99-114999","title":"Predictors of Post-Thrombotic Syndrome (PTS) in Pediatric Thrombosis: A Systematic Review and Meta-Analysis of the Literature","year":2018,"lang":"en","type":"review","venue":"Blood","topic":"Central Venous Catheters and Hemodialysis","field":"Health Professions","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Post-thrombotic syndrome; MEDLINE; Meta-analysis; Pediatrics; Cochrane Library; Venous thrombosis; Thrombosis; Systematic review; Complication; Psychological intervention; Internal medicine","score_opus":0.06980125892998675,"score_gpt":0.36837596397010713,"score_spread":0.2985747050401204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2930876421","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00073906186,0.9925207,3.0201798e-7,0.000055880995,0.000099626675,0.0054890364,0.0010279635,0.000013214773,0.000054201235],"genre_scores_gemma":[0.00085556175,0.99796945,0.000023568697,0.00015741009,0.00004110501,0.0005957315,0.00010372704,0.000046099674,0.00020731891],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99276215,0.002687559,0.0030819695,0.00054305355,0.00048013663,0.000445125],"domain_scores_gemma":[0.99423736,0.00081634696,0.0030709382,0.0014472415,0.00031649278,0.00011163002],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017975315,0.0005410715,0.013959383,0.000773817,0.00014592751,0.000011130038,0.000675512,0.0005677701,0.00029199437],"category_scores_gemma":[0.0005011164,0.00026971096,0.0044970964,0.0040764604,0.0000916251,0.00006473362,0.0002713008,0.00075485354,0.000016828646],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[4.1496864e-7,0.00027360668,0.00033797493,0.8920741,0.10620603,0.0000024347933,0.001020261,7.283272e-8,3.4031363e-8,0.0000143277175,0.00006554671,0.000005213644],"study_design_scores_gemma":[0.00013942788,0.000065842854,0.0005366872,0.11971889,0.8790202,0.000008464172,0.000040083913,3.1251673e-7,2.563288e-8,0.00000481463,0.00028092906,0.00018430415],"about_ca_topic_score_codex":0.000061423976,"about_ca_topic_score_gemma":0.0001276989,"teacher_disagreement_score":0.7728142,"about_ca_system_score_codex":0.000062455256,"about_ca_system_score_gemma":0.00038525774,"threshold_uncertainty_score":0.9999755},"labels":[],"label_agreement":null},{"id":"W2935624839","doi":"10.1182/blood-2018-99-111396","title":"Cost-Effectiveness of Defibrotide for the Treatment of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) with Multi-Organ Dysfunction (MOD) Post-Hematopoietic Stem Cell Transplantation (HSCT) in Canada","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Hepatic veno-occlusive disease; Defibrotide; Internal medicine; Hematopoietic stem cell transplantation; Transplantation; Surgery; Intensive care medicine; Pediatrics","score_opus":0.01776112312461917,"score_gpt":0.24159789253826133,"score_spread":0.22383676941364217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2935624839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98805696,0.00019106733,0.0075974637,0.000032885015,0.00015746936,0.0036492583,0.00025360464,0.000019259456,0.000042032327],"genre_scores_gemma":[0.9987062,0.00007415764,0.0005670123,0.000010447372,0.000029496923,0.00035458143,0.00019360511,0.000040992585,0.000023506274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852437,0.000120456534,0.00043903908,0.00031782332,0.0003495046,0.00024879602],"domain_scores_gemma":[0.9985626,0.0005191138,0.00022356579,0.00029440984,0.0002884851,0.00011182272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014797361,0.00023694836,0.00045566846,0.00011754626,0.00007990366,0.000006438585,0.00007119898,0.000069737885,0.000012417453],"category_scores_gemma":[0.000008344983,0.00016978761,0.00008936079,0.00025673848,0.000102595855,0.00007911554,0.0000034732957,0.000062085724,0.0000024940714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027785012,0.007248373,0.52468544,0.025728678,0.0012634156,0.00068155554,0.017138477,0.002501458,0.38892043,0.00023929693,0.000006290359,0.0038015589],"study_design_scores_gemma":[0.013569641,0.0023376325,0.52846557,0.0009855005,0.0014268355,0.00042508004,0.0015069951,0.0003334901,0.4507801,0.000008794923,0.0000056882022,0.00015464805],"about_ca_topic_score_codex":0.05033738,"about_ca_topic_score_gemma":0.104466684,"teacher_disagreement_score":0.061859664,"about_ca_system_score_codex":0.0003725199,"about_ca_system_score_gemma":0.00087261887,"threshold_uncertainty_score":0.9559865},"labels":[],"label_agreement":null},{"id":"W2936701964","doi":"10.1182/blood-2018-99-119525","title":"Impact of Omitting Prophylactic Antibiotics, to Preserve Gut Microbiota, on the Incidence of Bacteraemia during the Pre-Engraftment Period of Allogenic Hematopoietic Stem Cell Transplantation","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Hematopoietic stem cell transplantation; Internal medicine; Incidence (geometry); Adverse effect; Transplantation; Regimen; Retrospective cohort study; Surgery","score_opus":0.009889925542620717,"score_gpt":0.2630541162918234,"score_spread":0.2531641907492027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2936701964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985244,0.00007672004,0.000012611705,0.00013557439,0.000049942588,0.0009030166,0.000027530652,0.000009779944,0.00026041246],"genre_scores_gemma":[0.99969006,0.000026341328,0.00006613348,0.000019404102,0.000058871257,0.0000069755383,0.0000019487106,0.000015664182,0.00011460865],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99904704,0.00008201591,0.00035353686,0.0001687764,0.00018634187,0.00016230847],"domain_scores_gemma":[0.99906,0.00008861352,0.00023013823,0.00041077298,0.00016445726,0.000046060923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017299631,0.00012459629,0.00023962885,0.000059603663,0.00008976123,0.000010200892,0.00015631989,0.000044065568,0.000051780924],"category_scores_gemma":[0.00001733089,0.00006914218,0.0001573291,0.00019570817,0.000110804765,0.000040479266,0.000031743995,0.00012899913,0.000005510422],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003447741,0.00044042748,0.0638248,0.00069924357,0.00013774578,0.0000037000284,0.0044556255,0.000031145424,0.92999864,0.00001240618,0.00000681661,0.000044706212],"study_design_scores_gemma":[0.0006908799,0.0010536658,0.3975594,0.000261737,0.0002320487,0.00005454829,0.00015375312,0.0000025523234,0.59994656,0.0000017351459,0.0000017379524,0.000041350453],"about_ca_topic_score_codex":0.00016086004,"about_ca_topic_score_gemma":0.00003531393,"teacher_disagreement_score":0.3337346,"about_ca_system_score_codex":0.000042878277,"about_ca_system_score_gemma":0.00012615325,"threshold_uncertainty_score":0.28195363},"labels":[],"label_agreement":null},{"id":"W2936956800","doi":"10.1182/blood.v130.suppl_1.3125.3125","title":"Comparison of Proteasome Inhibition Activity between Carfilzomib and Bortezomib in the Phase 3 Endeavor Study","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Carfilzomib; Medicine; Dexamethasone; Bortezomib; Population; Multiple myeloma; Internal medicine; Pharmacology; Hazard ratio; Peripheral blood mononuclear cell; Ixazomib; Gastroenterology; Urology; Confidence interval; Chemistry","score_opus":0.11287543437803774,"score_gpt":0.4464530792465211,"score_spread":0.3335776448684834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2936956800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971585,0.000051943236,0.0000034885552,0.00024337145,0.0000078721905,0.0018460817,0.00003616009,0.000007945083,0.00064459443],"genre_scores_gemma":[0.99973255,0.0000049405735,0.000045751985,0.000004338678,0.000059088296,0.00011275764,0.000013591833,0.000006776396,0.00002018999],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991005,0.000110476525,0.0001547086,0.0001747191,0.0002945679,0.00016501445],"domain_scores_gemma":[0.9992629,0.0000728041,0.000115712384,0.00043526312,0.000036351525,0.00007694768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033306328,0.00009280845,0.0003049565,0.000063464766,0.00014384337,0.00003272997,0.00008476956,0.00003943489,0.0000066847156],"category_scores_gemma":[0.00020098411,0.00005934317,0.000031675194,0.000044310258,0.00008613539,0.0000949478,0.000058977083,0.00017579464,0.0000026891528],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029370651,0.008084001,0.96776885,0.000050476745,0.00012409127,0.00009650699,0.0010364658,2.0754273e-8,0.0055057486,0.0000033835142,0.000007834594,0.017028939],"study_design_scores_gemma":[0.024250688,0.0017866772,0.93908364,0.00004439089,0.00015665223,0.0000066022512,0.00041510086,0.000021442927,0.034157485,0.000020067631,0.00001192194,0.000045311874],"about_ca_topic_score_codex":0.00063624856,"about_ca_topic_score_gemma":0.00017783468,"teacher_disagreement_score":0.028685166,"about_ca_system_score_codex":0.000014012244,"about_ca_system_score_gemma":0.000042354,"threshold_uncertainty_score":0.24199443},"labels":[],"label_agreement":null},{"id":"W2936978084","doi":"10.1182/blood.v130.suppl_1.2194.2194","title":"Results Update from the DRIVE PK Study: Effects of AG-348, a Pyruvate Kinase Activator, in Patients with Pyruvate Kinase Deficiency","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pyruvate kinase deficiency; Pyruvate kinase; Medicine; Tolerability; Pharmacokinetics; Pharmacodynamics; Ex vivo; Internal medicine; Anemia; Hemolytic anemia; Pharmacology; Hemoglobin; Adverse effect; Endocrinology; Gastroenterology; Glycolysis; Chemistry; Biochemistry; In vitro; Metabolism","score_opus":0.009270670414417717,"score_gpt":0.2377377369287966,"score_spread":0.22846706651437887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2936978084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975437,0.00009239173,0.000004084485,0.00024682275,0.00032744274,0.0011906396,0.000071302435,0.00003678056,0.00048685228],"genre_scores_gemma":[0.9992328,0.000029936713,0.000089268964,0.000322764,0.00010184033,0.000049647904,0.00007872922,0.000028980427,0.00006597704],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831325,0.00016987367,0.00036449404,0.0004924645,0.0003409127,0.0003190308],"domain_scores_gemma":[0.9977795,0.00025447537,0.0004230774,0.0012792728,0.00015127845,0.000112391404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018309368,0.00025029166,0.00048393468,0.000082748455,0.00023855535,0.00002625167,0.00030212975,0.00010641211,0.000020459336],"category_scores_gemma":[0.00067488546,0.00015345882,0.000074442345,0.00016151718,0.00020852628,0.00012788206,0.00015284753,0.0003228834,0.00003984087],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006080642,0.008934732,0.94437116,0.000106707026,0.00026479334,0.0003479288,0.002849962,0.0000055903147,0.03418067,0.000046292218,0.0004051823,0.0024063403],"study_design_scores_gemma":[0.028250596,0.0029671546,0.94198155,0.0002952021,0.00029177364,6.747199e-7,0.00023601318,0.00000630209,0.025506645,0.00006236992,0.0002327757,0.0001689119],"about_ca_topic_score_codex":0.00080746046,"about_ca_topic_score_gemma":0.00023785628,"teacher_disagreement_score":0.022169953,"about_ca_system_score_codex":0.00002608491,"about_ca_system_score_gemma":0.00009146662,"threshold_uncertainty_score":0.6257869},"labels":[],"label_agreement":null},{"id":"W2937090388","doi":"10.1182/blood.v130.suppl_1.123.123","title":"Single Cell Resolution Profiling Defines the Innate and Adaptive Immune Repertoires Modulated By Daratumumab and IMiDs Treatment in Multiple Myeloma (MM)","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Daratumumab; Antibody-dependent cell-mediated cytotoxicity; Immunology; Biology; CD38; Bone marrow; Immune system; Cytotoxic T cell; Cancer research; Multiple myeloma; Antibody; Monoclonal antibody; CD34; Cell biology; Stem cell","score_opus":0.03623905010016729,"score_gpt":0.27122481486140737,"score_spread":0.23498576476124008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2937090388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99175066,0.0061381496,0.0000052161877,0.0004205023,0.000026759466,0.00092375575,0.000039786348,0.000027313548,0.0006678682],"genre_scores_gemma":[0.997731,0.00062333734,0.0008009061,0.000011740359,0.000034003537,0.000109756686,0.00006577763,0.000022969316,0.0006005424],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988263,0.00007942513,0.0002153934,0.0003659872,0.00018121704,0.00033165608],"domain_scores_gemma":[0.99912786,0.00008586049,0.00010775268,0.0005020678,0.0000604987,0.0001159752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014319779,0.00020221614,0.00027233508,0.0000740679,0.00055190193,0.00008759751,0.00008553303,0.000088764034,0.0000029839332],"category_scores_gemma":[0.00022237113,0.00012741853,0.000041254967,0.00006030983,0.00022655388,0.00010162471,0.00011258837,0.00012099405,0.0000029991738],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019420274,0.0027224766,0.40721694,0.000075872056,0.00033858122,0.0003623762,0.00078352937,0.000005361808,0.5604394,0.000023689965,0.00003810066,0.026051635],"study_design_scores_gemma":[0.019031476,0.0016794299,0.57113236,0.00013719272,0.00014046712,0.00008347466,0.00021349758,0.006460492,0.40072766,0.000047692643,0.00018091283,0.0001653116],"about_ca_topic_score_codex":0.0023336993,"about_ca_topic_score_gemma":0.0004112685,"teacher_disagreement_score":0.16391546,"about_ca_system_score_codex":0.00006871448,"about_ca_system_score_gemma":0.000048921414,"threshold_uncertainty_score":0.5195977},"labels":[],"label_agreement":null},{"id":"W294175278","doi":"10.1182/blood.v122.21.5610.5610","title":"First Year Experience Of Subcutaneous Bortezomib Use In a University Teaching Hospital","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Bortezomib; Medicine; Multiple myeloma; Neutropenia; Adverse effect; Retrospective cohort study; Surgery; Proteasome inhibitor; Internal medicine; Toxicity","score_opus":0.014258937918007645,"score_gpt":0.2442562630735579,"score_spread":0.22999732515555027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W294175278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99855405,0.000022897433,0.0000057868197,0.000077409466,0.000013231355,0.0003005626,0.000006692785,0.0000159946,0.0010033967],"genre_scores_gemma":[0.9977622,0.000022810837,0.0015053186,0.0000055428436,0.000011624525,0.0000037850207,0.0000053898816,0.0000061538403,0.00067719014],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994516,0.000021032594,0.00008072837,0.00013190758,0.00014330952,0.00017144629],"domain_scores_gemma":[0.9996136,0.00005458528,0.000024581526,0.00017084528,0.00003208614,0.00010431736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000029017827,0.000060767376,0.00012530948,0.00007309106,0.00003266791,0.000008272714,0.00006224948,0.000034168756,0.00011816272],"category_scores_gemma":[0.00012537988,0.000053891592,0.000036113583,0.0000732334,0.000044521974,0.00011710459,0.000040931114,0.0001048278,0.000041896845],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000077628094,0.0011280585,0.99471045,0.000022614522,0.00004327911,0.001205084,0.0012403859,5.7837093e-7,0.0010528574,0.00005907266,0.00007448886,0.00038549013],"study_design_scores_gemma":[0.0053413208,0.0006576979,0.9902088,0.000088494955,0.000028963474,0.00006644275,0.0013615778,0.00012484408,0.0016494503,0.000010675762,0.0003776148,0.000084088446],"about_ca_topic_score_codex":0.0037659497,"about_ca_topic_score_gemma":0.00015978565,"teacher_disagreement_score":0.0052636927,"about_ca_system_score_codex":0.000032457687,"about_ca_system_score_gemma":0.000030110925,"threshold_uncertainty_score":0.5693015},"labels":[],"label_agreement":null},{"id":"W2943067820","doi":"10.1182/blood.v130.suppl_1.2780.2780","title":"Bendamustine and Rituximab As Initial Therapy in Indolent Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma in a Canadian Population; Highly Effective with Frequent Infections","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Medicine; Bendamustine; Rituximab; Mantle cell lymphoma; Internal medicine; Follicular lymphoma; Lymphoma; Population; Marginal zone B-cell lymphoma; Macroglobulinemia; Chronic lymphocytic leukemia; Aggressive lymphoma; Oncology; Leukemia; Immunology; Multiple myeloma; B cell; Antibody; Marginal zone","score_opus":0.006971393602849175,"score_gpt":0.2569838505892882,"score_spread":0.25001245698643904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943067820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946498,0.0005102788,5.0571776e-7,0.00045314248,0.00006387247,0.0010638027,0.000031629515,0.000016466074,0.003210459],"genre_scores_gemma":[0.9989285,0.00031330134,0.00010863968,0.00019149696,0.00007245603,0.00029998255,0.000038277034,0.000025883388,0.000021452048],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998873,0.00004307631,0.00020350545,0.0003719156,0.00015176456,0.00035671657],"domain_scores_gemma":[0.9991843,0.0000650643,0.00009883452,0.00031424037,0.00004270233,0.000294866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011752232,0.00023137676,0.0003709277,0.00031083176,0.00024134856,0.00009067352,0.000057683195,0.000116230716,0.00001809402],"category_scores_gemma":[0.00003791609,0.00018489621,0.00003346855,0.00010605479,0.00008563519,0.00014530208,0.00003615427,0.00005892836,0.000008139626],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018381847,0.0041879336,0.95595926,0.00003556446,0.000083040555,0.00096673,0.00055228977,0.0000011833121,0.00004942124,0.00008486846,0.0000069805938,0.037888933],"study_design_scores_gemma":[0.06779835,0.001566276,0.9258045,0.00019489063,0.00010086051,0.0002997826,0.000059315906,0.000029568624,0.0037189869,0.00007771904,0.00016947562,0.00018031048],"about_ca_topic_score_codex":0.58338374,"about_ca_topic_score_gemma":0.4583889,"teacher_disagreement_score":0.124994814,"about_ca_system_score_codex":0.0003541729,"about_ca_system_score_gemma":0.00031660346,"threshold_uncertainty_score":0.75398487},"labels":[],"label_agreement":null},{"id":"W2943086918","doi":"10.1182/blood.v130.suppl_1.5189.5189","title":"Case Report of Aggressive T-Cell Large Granular Lymphocytic Leukemia","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont; Université de Sherbrooke","funders":"","keywords":"Pancytopenia; Lymphocytosis; Medicine; Cytopenia; Leukemia; Pathology; Splenectomy; Bone marrow; Prolymphocytic leukemia; Immunology; Gastroenterology; Chronic lymphocytic leukemia; Spleen","score_opus":0.022470025270042566,"score_gpt":0.3068712634872941,"score_spread":0.28440123821725155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943086918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810305,0.0010004856,0.000031583815,0.00004443691,0.00015342803,0.00048077301,0.000027108934,0.00005656106,0.017175114],"genre_scores_gemma":[0.99450225,0.00010088489,0.0005044816,0.000052789805,0.00024055659,0.000029247045,0.000026205695,0.000049606915,0.0044939816],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9977471,0.000041356645,0.00050718774,0.00046684814,0.0006580499,0.00057942746],"domain_scores_gemma":[0.99598426,0.00009874164,0.0009557668,0.002358975,0.00028699948,0.00031527466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000557027,0.00021876355,0.00055976055,0.0001214216,0.0003209079,0.00004657361,0.00035079135,0.00019651026,0.00015900639],"category_scores_gemma":[0.0017963612,0.00018867488,0.0002162484,0.00009459008,0.00029229542,0.00011617819,0.00031543992,0.00022341708,0.00010854061],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00015852014,0.0005631086,0.0027959663,0.0006576251,0.00017030581,0.9890713,0.00028575718,0.0000043035648,0.0044632955,0.00008197108,0.0012995087,0.00044830123],"study_design_scores_gemma":[0.101098716,0.000310848,0.0009310946,0.00041949665,0.00074577157,0.68470365,0.00015775127,0.0023661023,0.20700684,0.00011403358,0.0018465312,0.00029918496],"about_ca_topic_score_codex":0.002412487,"about_ca_topic_score_gemma":0.00006630995,"teacher_disagreement_score":0.30436772,"about_ca_system_score_codex":0.0068866364,"about_ca_system_score_gemma":0.017700411,"threshold_uncertainty_score":0.9969258},"labels":[],"label_agreement":null},{"id":"W2943171620","doi":"10.1182/blood.2019000216","title":"Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteria","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of Alberta; Centre Hospitalier Universitaire Sainte-Justine; University of British Columbia; Hospital for Sick Children; University of Calgary; Alberta Children's Hospital; University of Toronto; Montreal Children's Hospital; University of Manitoba; SickKids Foundation; CancerCare Manitoba","funders":"National Heart, Lung, and Blood Institute; Canadian Glycomics Network; Canadian Institutes of Health Research; National Cancer Institute; National Institutes of Health; University of Alberta; Pediatric Blood and Marrow Transplant Consortium","keywords":"Medicine; Bronchiolitis obliterans; Graft-versus-host disease; Hematopoietic stem cell transplantation; Incidence (geometry); Internal medicine; Disease; Transplantation; Pediatrics; Immunology; Lung transplantation","score_opus":0.023979478254107123,"score_gpt":0.25749318061902754,"score_spread":0.23351370236492042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943171620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860171,0.012547952,0.0000020448313,0.00064121606,0.000024892674,0.00048005686,0.000007521207,0.000016514165,0.00026266527],"genre_scores_gemma":[0.9946196,0.0048600975,0.00039831232,0.000052077234,0.00003402632,0.0000054588154,0.000005014993,0.000016907317,0.0000085163665],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994174,0.00003066914,0.00011506592,0.0001896369,0.0000954691,0.00015175999],"domain_scores_gemma":[0.99966913,0.000098783275,0.000035152207,0.00013743163,0.000016680291,0.000042819425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011055566,0.00010177439,0.00017804856,0.00004466823,0.000034106553,0.000017375445,0.000024691246,0.000050987932,0.00001618905],"category_scores_gemma":[0.000005090449,0.00006782468,0.000010081356,0.00005249864,0.00005265133,0.000028439023,0.000013305696,0.00008679287,0.0000023284126],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000084764964,0.00012970451,0.9782863,0.0005237206,0.00028585523,0.00008082893,0.0028727544,0.000020958918,0.012006478,0.00014981432,0.0000012783102,0.005557497],"study_design_scores_gemma":[0.005287772,0.00023828475,0.98379326,0.00070150243,0.00040884223,0.0018264963,0.00014183678,0.00017489985,0.0072962153,0.000012844499,0.0000069007115,0.000111164874],"about_ca_topic_score_codex":0.000042995925,"about_ca_topic_score_gemma":0.000042173793,"teacher_disagreement_score":0.008602452,"about_ca_system_score_codex":0.000011146765,"about_ca_system_score_gemma":0.000037798145,"threshold_uncertainty_score":0.27658102},"labels":[],"label_agreement":null},{"id":"W2943967571","doi":"10.1182/blood.2018862383","title":"Hepatic leukemia factor is a novel leukemic stem cell regulator in DNMT3A, NPM1, and FLT3-ITD triple-mutated AML","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Centre hospitalier universitaire de Québec; BC Cancer Agency; Institute for Research in Immunology and Cancer; Université Laval; Université de Montréal","funders":"","keywords":"NPM1; Stem cell; Leukemia; Regulator; Cancer research; Biology; Medicine; Immunology; Karyotype; Genetics; Gene","score_opus":0.015219965049069702,"score_gpt":0.25354746397311984,"score_spread":0.23832749892405014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943967571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995271,0.0007861431,0.00002201708,0.0003263226,0.00013277862,0.0015964784,0.00008714237,0.0001250206,0.0016530682],"genre_scores_gemma":[0.98395455,0.00014667277,0.00059214886,0.0004824151,0.00011565815,0.000051836163,0.000042541506,0.00010564069,0.014508529],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969059,0.00008737839,0.0006374093,0.00082485826,0.00069520605,0.00084920635],"domain_scores_gemma":[0.99818,0.00021575828,0.0001626065,0.0008707636,0.00014756214,0.00042336062],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035843943,0.0004162071,0.00082491164,0.00048011757,0.000063977575,0.000060459282,0.00029072986,0.0003668452,0.0004041219],"category_scores_gemma":[0.000063360945,0.00037093103,0.00013754198,0.0007284682,0.00012337667,0.00019838584,0.00021236793,0.0008216462,0.000519082],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070234924,0.0007424767,0.23059922,0.0011618262,0.00025908556,0.00025157887,0.0022989577,0.000008136886,0.7598827,0.000047506503,0.0021734193,0.0018727592],"study_design_scores_gemma":[0.08599184,0.0017987653,0.4225658,0.000999895,0.00048836763,0.00065368967,0.0015358194,0.014628957,0.465753,0.00005512903,0.0042046444,0.0013241211],"about_ca_topic_score_codex":0.00058461644,"about_ca_topic_score_gemma":0.00004031329,"teacher_disagreement_score":0.2941297,"about_ca_system_score_codex":0.0011386309,"about_ca_system_score_gemma":0.001488884,"threshold_uncertainty_score":0.99987423},"labels":[],"label_agreement":null},{"id":"W2943990582","doi":"10.1182/blood-2019-02-900787","title":"The role of the megakaryocyte in immunity has gone viral","year":2019,"lang":"en","type":"letter","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Megakaryocyte; Immunity; Immunology; Virology; Biology; Medicine; Haematopoiesis; Immune system; Genetics; Stem cell","score_opus":0.010088661528795414,"score_gpt":0.21733092679879346,"score_spread":0.20724226526999803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943990582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81433713,0.006645228,9.338255e-8,0.16370898,0.00023888133,0.0007753456,0.000056616384,0.000015317688,0.014222435],"genre_scores_gemma":[0.8840793,0.00046257794,0.000026276944,0.105584666,0.00046071468,0.000052015068,0.00021138723,0.00006623774,0.0090568615],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990244,0.00008835146,0.0002271521,0.00015649403,0.00025302806,0.00025057615],"domain_scores_gemma":[0.99895906,0.00012660478,0.00013605275,0.000736625,0.000028595776,0.000013058468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010276424,0.00018123847,0.00039762576,0.000042455034,0.00008890991,0.000016471751,0.00027226287,0.00030069548,0.000021565362],"category_scores_gemma":[0.00004097746,0.00008972777,0.00017503198,0.0001020516,0.00011650868,0.000020291425,0.00009875434,0.0010354501,0.000046668476],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007012291,0.005355838,0.16152748,0.00075655314,0.0055631343,0.0032909873,0.0016843883,0.000003330954,0.0062003364,0.00014286804,0.8009596,0.013814231],"study_design_scores_gemma":[0.0067677367,0.0002445111,0.02796004,0.00030417912,0.0007047116,0.00015091205,0.00006676149,0.000009076487,0.006251231,0.00095116417,0.9564059,0.00018382336],"about_ca_topic_score_codex":0.00067753094,"about_ca_topic_score_gemma":0.00008567702,"teacher_disagreement_score":0.15544625,"about_ca_system_score_codex":0.000025464537,"about_ca_system_score_gemma":0.00013553687,"threshold_uncertainty_score":0.44985732},"labels":[],"label_agreement":null},{"id":"W2944125872","doi":"10.1182/blood.2019000972","title":"Osteopontin mediates murine transfusion-related acute lung injury via stimulation of pulmonary neutrophil accumulation","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Bone and Dental Protein Studies","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Vetenskapsrådet; Lunds Universitet; Crafoordska Stiftelsen","keywords":"Osteopontin; Immunology; Inflammation; Medicine; Antibody; Lung; Transfusion-related acute lung injury; Internal medicine; Pulmonary edema","score_opus":0.009371566262815522,"score_gpt":0.26743290651710644,"score_spread":0.2580613402542909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944125872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99600786,0.0007804056,0.000039986608,0.00024075329,0.00016135628,0.0008600128,0.000011974974,0.000074941876,0.0018226797],"genre_scores_gemma":[0.99887204,0.00020229307,0.00018588231,0.00005079517,0.00007647664,0.000015003084,0.0001052681,0.000023577184,0.00046865633],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989239,0.000029789691,0.0003877855,0.00022339277,0.00027606494,0.00015907548],"domain_scores_gemma":[0.9994506,0.00004815919,0.00012207356,0.00022428058,0.00009815371,0.00005671949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010944477,0.0001475195,0.0003448963,0.000120529585,0.000046260313,0.0000047340795,0.000048990052,0.00012159312,0.00021410568],"category_scores_gemma":[0.000016228878,0.0001256525,0.0001096669,0.00024022406,0.00003566397,0.00013638943,0.000045109067,0.00014257964,0.000064478314],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067207456,0.00075145444,0.32717,0.0002421334,0.0004024176,0.000043866818,0.00038340865,0.0000547237,0.6655181,0.000032171512,0.000045604702,0.0046840208],"study_design_scores_gemma":[0.0067901183,0.000761688,0.8521105,0.0002589869,0.001176417,0.000092372604,0.00006967602,0.00560796,0.13241562,0.00040459787,0.00005893211,0.0002531002],"about_ca_topic_score_codex":0.0000838647,"about_ca_topic_score_gemma":0.0000031859458,"teacher_disagreement_score":0.5331025,"about_ca_system_score_codex":0.000016766247,"about_ca_system_score_gemma":0.000019702513,"threshold_uncertainty_score":0.51239604},"labels":[],"label_agreement":null},{"id":"W2944978620","doi":"10.1182/blood.v130.suppl_1.4081.4081","title":"Comparison of Outcomes By Age of Patients with Limited Stage Hodgkin Lymphoma Treated with ABVD Alone; A Secondary Analysis of the Canadian Cancer Trial Group HD.6 Trial","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; McGill University; University of Calgary; Juravinski Cancer Centre; McMaster University; Queen's University","funders":"","keywords":"ABVD; Medicine; Dacarbazine; Internal medicine; Population; Chemotherapy regimen; Oncology; Vinblastine; Survival analysis; Cancer; Surgery; Chemotherapy; Vincristine","score_opus":0.02303102582636087,"score_gpt":0.29204542761465074,"score_spread":0.2690144017882899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944978620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99623793,0.00012504002,6.6078144e-7,0.00010556349,0.00006979249,0.0014801701,0.001570131,0.000007848091,0.00040285167],"genre_scores_gemma":[0.99911094,0.000008751841,0.000048858445,0.000047443482,0.000019661626,0.00011072427,0.00043194636,0.000021350088,0.00020032401],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832153,0.00007871223,0.0005476609,0.00027914875,0.00052735646,0.00024557958],"domain_scores_gemma":[0.9977955,0.00007624418,0.00094729837,0.00085613877,0.00015887275,0.00016592891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010465315,0.00023950823,0.0013508435,0.00022637163,0.0001584678,0.00002965185,0.00022569114,0.0001119952,0.00005907263],"category_scores_gemma":[0.000057976697,0.00012755733,0.00027750846,0.00033040467,0.0001989144,0.00007470595,0.00003240928,0.000057966845,2.7056464e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048274536,0.006217943,0.93525875,0.000034979927,0.008176322,0.000021131335,0.00029624416,0.0000036407366,0.00006176662,0.0000075272387,0.00010926571,0.0015378863],"study_design_scores_gemma":[0.32802492,0.0024768293,0.6581449,0.00006575231,0.0072719175,1.9498817e-7,0.00003747588,0.000010891897,0.0037891483,2.8757987e-7,0.00008950059,0.000088176974],"about_ca_topic_score_codex":0.37912598,"about_ca_topic_score_gemma":0.5502538,"teacher_disagreement_score":0.27975038,"about_ca_system_score_codex":0.00016218591,"about_ca_system_score_gemma":0.00055274053,"threshold_uncertainty_score":0.62500846},"labels":[],"label_agreement":null},{"id":"W2945032248","doi":"10.1182/blood-2018-99-110188","title":"Single UM171 Expanded Cord Blood Permits Transplantation of Better HLA Matched Cords with Excellent Gvhd Relapse Free Survival","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Research in Immunology and Cancer; Université de Montréal; Université Laval; Hôpital de l'Enfant-Jésus; University of Toronto; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Cord blood; Transplantation; Medicine; CD34; Internal medicine; Haematopoiesis; Hematopoietic stem cell transplantation; Stem cell; Surgery; Immunology; Urology; Gastroenterology; Biology","score_opus":0.022090416503270722,"score_gpt":0.2521713922604354,"score_spread":0.23008097575716466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945032248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852046,0.00008349713,0.0019440933,0.00031436162,0.00025971173,0.00061966246,0.00006584724,0.00011365783,0.011394569],"genre_scores_gemma":[0.99315184,0.00007815618,0.005667598,0.00012986564,0.00022928517,0.000032863845,0.0001411631,0.000064842476,0.0005043982],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99792564,0.00009185255,0.00054488395,0.00041551504,0.0006779757,0.00034413757],"domain_scores_gemma":[0.9986523,0.00015433074,0.00019462325,0.000576424,0.00025387268,0.00016848804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024741227,0.000277724,0.00052085565,0.00014140218,0.00007459062,0.000016345655,0.00016490942,0.00017728821,0.0005018479],"category_scores_gemma":[0.000027533142,0.00023330888,0.000101011465,0.00025468442,0.00019809396,0.00009589935,0.000014249233,0.00016895641,0.000044197684],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004337658,0.005797928,0.18362881,0.003090298,0.001065415,0.0010448229,0.011372435,0.0000013446142,0.78616166,0.0002397828,0.00029348873,0.0029663374],"study_design_scores_gemma":[0.024505967,0.00417308,0.07493997,0.0006630186,0.0029834257,0.0011879731,0.000600641,0.000013559759,0.8903439,0.00008521993,0.00013130756,0.00037192614],"about_ca_topic_score_codex":0.00006044583,"about_ca_topic_score_gemma":0.00013466598,"teacher_disagreement_score":0.10868884,"about_ca_system_score_codex":0.000020180973,"about_ca_system_score_gemma":0.00010615889,"threshold_uncertainty_score":0.951406},"labels":[],"label_agreement":null},{"id":"W2946139933","doi":"10.1182/blood.v130.suppl_1.3440.3440","title":"Cognitive Function in Older Adults with Hematological Malignancies","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Montreal Cognitive Assessment; Medicine; Geriatric Depression Scale; Depression (economics); Neuropsychology; Neuropsychological assessment; Cognition; Physical therapy; Pediatrics; Psychiatry; Cognitive impairment","score_opus":0.016135498500760792,"score_gpt":0.2664712714388476,"score_spread":0.2503357729380868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946139933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98793423,0.00045626814,0.000055953762,0.0006123254,0.00007681661,0.0006271976,0.0000074361456,0.000055724206,0.010174064],"genre_scores_gemma":[0.9989715,0.000064345804,0.00004826396,0.0002668668,0.00008267798,0.00013185102,0.000009437775,0.000012971388,0.00041207208],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991918,0.000016036181,0.00013402483,0.00025680682,0.00017813871,0.00022319653],"domain_scores_gemma":[0.9994723,0.000051840456,0.00009897462,0.00016770702,0.00015344722,0.000055734137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000066983026,0.0001344474,0.00025894996,0.000060172853,0.0001666415,0.000020777477,0.000045132412,0.000073645,0.00010075654],"category_scores_gemma":[0.00025050296,0.00009521807,0.000039124723,0.00006010417,0.00019421731,0.00009511694,0.000050026712,0.0001647207,0.000054283744],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026961756,0.0015443915,0.99053437,0.00014510143,0.00033780094,0.0005777563,0.0007807874,9.273513e-8,0.00014352007,0.0000796757,0.00027022426,0.0028900865],"study_design_scores_gemma":[0.017273882,0.0010070602,0.97473645,0.0019719112,0.00046219557,0.00017896669,0.0013381863,0.0000032413952,0.0028124542,0.00003765804,0.00004887401,0.00012909365],"about_ca_topic_score_codex":0.00004101491,"about_ca_topic_score_gemma":0.00011039118,"teacher_disagreement_score":0.015797913,"about_ca_system_score_codex":0.000017462775,"about_ca_system_score_gemma":0.000038925224,"threshold_uncertainty_score":0.38828802},"labels":[],"label_agreement":null},{"id":"W2947331943","doi":"10.1182/blood-2018-99-117281","title":"Targeting the MTF2-MDM2 Axis Sensitizes Refractory Acute Myeloid Leukemia to Chemotherapy","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stem Cell Network; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Cancer research; Myeloid leukemia; Epigenetics; Mdm2; Epigenetic therapy; Azacitidine; Biology; Ubiquitin ligase; Progenitor cell; Leukemia; Myeloid; Decitabine; DNA methylation; Medicine; Stem cell; Immunology; Ubiquitin; Genetics; Apoptosis; Gene; Gene expression","score_opus":0.006126329952928123,"score_gpt":0.23363715021156525,"score_spread":0.22751082025863714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947331943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950672,0.0002725479,0.00050436537,0.0011319404,0.00021523316,0.00021840453,0.000011786336,0.00003227712,0.0025462864],"genre_scores_gemma":[0.99093705,0.0001506859,0.001540826,0.003706524,0.0016004847,0.00001907606,0.000048545033,0.000027803086,0.0019690073],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991702,0.00004982862,0.00015418908,0.00027966005,0.00012320318,0.00022293981],"domain_scores_gemma":[0.9993886,0.000008360959,0.000060327846,0.00036588195,0.00010062622,0.00007622433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018020264,0.00013477461,0.00009471587,0.000023979133,0.00016817177,0.00003433136,0.00019346825,0.0001100423,0.00006557041],"category_scores_gemma":[0.00008058811,0.000099483055,0.00006361549,0.000094476614,0.00008862284,0.0000040171435,0.00008615973,0.00008254517,0.00009917868],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004046741,0.00003262126,0.00013239443,0.0000021828128,0.00006964191,0.0000017529113,0.000118703894,7.297915e-7,0.9728167,0.000016001475,0.024068674,0.0027001193],"study_design_scores_gemma":[0.00045009598,0.00023294087,0.000424728,0.000005707167,0.000014640472,0.000009931138,0.000046188306,0.000006989209,0.7600182,0.000014707098,0.23865412,0.00012171417],"about_ca_topic_score_codex":0.00001837181,"about_ca_topic_score_gemma":0.0000097246275,"teacher_disagreement_score":0.21458545,"about_ca_system_score_codex":0.000014087484,"about_ca_system_score_gemma":0.00007275502,"threshold_uncertainty_score":0.40568012},"labels":[],"label_agreement":null},{"id":"W2947443070","doi":"10.1182/blood.2019000012","title":"Follicular lymphoma with composite in situ mantle cell neoplasia","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Jubilee Hospital","funders":"","keywords":"Axillary Lymphadenopathy; Follicular lymphoma; Mantle cell lymphoma; Pathology; Lymphoma; Population; Lymph node; CD5; Mediastinum; Biology; Medicine; Internal medicine; Anatomy; Breast cancer; Cancer","score_opus":0.004247111547884484,"score_gpt":0.19873589739316863,"score_spread":0.19448878584528415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947443070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9681297,0.0006035935,0.0000014041872,0.00017199972,0.000036109832,0.00040498038,0.0000029565756,0.00003172669,0.030617505],"genre_scores_gemma":[0.998135,0.000039291263,0.0006202185,0.00025574912,0.000029287405,0.000031204483,0.000027168753,0.00001885593,0.0008432298],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992553,0.000014133107,0.00012292199,0.0002290088,0.00017377376,0.00020488081],"domain_scores_gemma":[0.999551,0.000026988053,0.00003597718,0.00027900597,0.00001999641,0.00008702737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000033129756,0.00013268134,0.0002491559,0.00006310244,0.000018147724,0.000014114665,0.000046540994,0.000053256033,0.000064091335],"category_scores_gemma":[0.0000014059549,0.000092956405,0.00005692454,0.0001276615,0.0000133827325,0.000037098263,0.00002176146,0.000030202838,0.0005340788],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000114738905,0.0037113603,0.97676367,0.00006766329,0.00010856576,0.0011378364,0.00014656832,0.000005031949,0.016971083,0.00007572882,0.00012131926,0.00077643245],"study_design_scores_gemma":[0.025121635,0.00068403315,0.76793915,0.00014792137,0.00023525923,0.00026659048,0.000056913697,0.000013452688,0.20311113,0.0000083514915,0.002285606,0.00012998187],"about_ca_topic_score_codex":0.000111306654,"about_ca_topic_score_gemma":0.00004847249,"teacher_disagreement_score":0.20882455,"about_ca_system_score_codex":0.00005520019,"about_ca_system_score_gemma":0.00006260367,"threshold_uncertainty_score":0.68646806},"labels":[],"label_agreement":null},{"id":"W2948851811","doi":"10.1182/blood.v130.suppl_1.1228.1228","title":"Functional Investigation of the Gene NFKBIZ and the Impact of 3'UTR Mutations in Diffuse Large B-Cell Lymphoma","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Simon Fraser University","funders":"","keywords":"Diffuse large B-cell lymphoma; Biology; Untranslated region; Genetics; Gene; Germinal center; Three prime untranslated region; Mutation; Locus (genetics); Five prime untranslated region; Somatic hypermutation; Cancer research; B cell; Messenger RNA","score_opus":0.016111810455539808,"score_gpt":0.2539010740458301,"score_spread":0.23778926359029032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948851811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982489,0.00035848116,0.00000158218,0.00055037055,0.000028256147,0.00025579816,0.000035563935,0.0000029287846,0.00051815744],"genre_scores_gemma":[0.9997187,0.000056769473,0.00004217071,0.000038795235,0.000027400896,0.000028808648,0.000013701508,0.000004903063,0.00006874972],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99954283,0.00003428901,0.00014662233,0.00008274652,0.00011844106,0.00007506331],"domain_scores_gemma":[0.99937063,0.000088347326,0.00015681572,0.0003076214,0.000043638764,0.000032924716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011608738,0.000064203676,0.00014380434,0.000027765836,0.0001053594,0.000010662289,0.000057081295,0.000031579013,0.000010359719],"category_scores_gemma":[0.00009516696,0.000030240675,0.00008903439,0.00004532495,0.00018390207,0.000039629787,0.000039806553,0.000021744934,0.0000016364845],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006612626,0.0034352974,0.9915869,0.000017516859,0.00010889528,0.0000035181536,0.0005066304,0.000002540691,0.0034638683,0.0004860538,0.0000811674,0.00024146498],"study_design_scores_gemma":[0.04675635,0.00007633396,0.9091922,0.000036443787,0.00018927487,0.000016419563,0.000037866615,0.000080496786,0.043157462,0.00042715375,0.0000050679405,0.000024901852],"about_ca_topic_score_codex":0.00065192237,"about_ca_topic_score_gemma":0.000055798657,"teacher_disagreement_score":0.08239469,"about_ca_system_score_codex":0.000025544916,"about_ca_system_score_gemma":0.0001194849,"threshold_uncertainty_score":0.1233179},"labels":[],"label_agreement":null},{"id":"W2948910641","doi":"10.1182/blood.v130.suppl_1.704.704","title":"Hemostatic Efficacy of Pathogen-Inactivated Buffy Coat-Derived Platelet Concentrates in Hemato-Oncological Patients: Outcomes of the Prepares Trial","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Buffy coat; Platelet; Randomized controlled trial; Randomization; Platelet transfusion; Surgery; Clinical trial; Internal medicine","score_opus":0.022381483056035528,"score_gpt":0.29179494930763406,"score_spread":0.2694134662515985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948910641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99612486,0.00003740397,0.0000033552642,0.00060253753,0.00018704985,0.0020305302,0.000027985938,0.000021279451,0.0009649665],"genre_scores_gemma":[0.9995547,0.000040271203,0.00012403462,0.00017232126,0.000013872694,0.00003706055,0.000014148736,0.000011460348,0.000032156873],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868083,0.00009087824,0.00051310315,0.00021132115,0.0003049369,0.00019892066],"domain_scores_gemma":[0.9987495,0.00018377464,0.00035667833,0.0005510174,0.0000952439,0.00006377665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001732776,0.00014996895,0.00058500655,0.000040423816,0.00007980544,0.000013356646,0.00025496102,0.000093249546,0.000075837284],"category_scores_gemma":[0.0007032244,0.0000893006,0.00015015058,0.00007540999,0.0002107736,0.000053178133,0.00011038565,0.00013014366,0.000002113312],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017481016,0.022267366,0.8849627,0.00041579362,0.0007596962,0.00008560326,0.001861973,0.000004038463,0.06865643,0.00069806783,0.000286773,0.002520589],"study_design_scores_gemma":[0.14804614,0.0010115809,0.71077734,0.00017422327,0.00025383077,0.0000024007043,0.00023360789,0.0000074309414,0.1391748,0.00005225607,0.0001712837,0.000095104595],"about_ca_topic_score_codex":0.000074937736,"about_ca_topic_score_gemma":0.000026569765,"teacher_disagreement_score":0.1741853,"about_ca_system_score_codex":0.000016770435,"about_ca_system_score_gemma":0.00006991513,"threshold_uncertainty_score":0.36415726},"labels":[],"label_agreement":null},{"id":"W2949367253","doi":"10.1182/blood-2018-99-120129","title":"Safe Start of Ibrutinib in Patients with Chronic Lymphocytic Leukemia and Uncontrolled Autoimmune Hemolytic Anemia","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Ibrutinib; Medicine; Autoimmune hemolytic anemia; Chronic lymphocytic leukemia; Internal medicine; Anemia; Gastroenterology; Rituximab; Hemolysis; Context (archaeology); Immunology; Leukemia; Lymphoma","score_opus":0.00670622587491227,"score_gpt":0.23393850485983597,"score_spread":0.2272322789849237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949367253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955662,0.00082935253,0.0000071857703,0.0000344223,0.000055956865,0.0010533194,0.000009919013,0.000046980174,0.0023967007],"genre_scores_gemma":[0.99862427,0.000046549776,0.00040450436,0.000079984195,0.00012369444,0.000030872176,0.000026527678,0.000049929677,0.0006136467],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9975845,0.000067057474,0.0005617412,0.00047047742,0.0006758252,0.0006403483],"domain_scores_gemma":[0.9985144,0.0001748524,0.00015906744,0.0006951084,0.00025589167,0.00020069412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003493353,0.00027351992,0.00073361536,0.00025640853,0.00006401569,0.000018327124,0.00017730542,0.0001651898,0.00020061676],"category_scores_gemma":[0.0002196269,0.00021180575,0.000062041574,0.0005072973,0.00055909227,0.00010060643,0.00013760652,0.00021520127,0.00005113967],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.05581204,0.0068015996,0.84591347,0.009479646,0.003406279,0.0019787601,0.0057661957,0.00043662454,0.032318845,0.000695089,0.0020331205,0.03535834],"study_design_scores_gemma":[0.5661417,0.0069852793,0.39690673,0.001313472,0.00053956197,0.0002218077,0.000073170755,0.01054663,0.016205315,0.00006379658,0.00050313974,0.0004994029],"about_ca_topic_score_codex":0.0014703295,"about_ca_topic_score_gemma":0.00024947512,"teacher_disagreement_score":0.51032966,"about_ca_system_score_codex":0.021577379,"about_ca_system_score_gemma":0.024496302,"threshold_uncertainty_score":0.9821786},"labels":[],"label_agreement":null},{"id":"W2949446669","doi":"10.1182/blood-2019-126867","title":"Outcomes of Patients with t(11;14) Multiple Myeloma: An International Myeloma Working Group Multicenter Study","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Multiple myeloma; Medicine; Internal medicine; Regimen; Chromosome abnormality; Cohort; Lenalidomide; Bortezomib; Stage (stratigraphy); Median follow-up; Oncology; Gastroenterology; Surgery; Karyotype; Chemotherapy; Chromosome; Biology","score_opus":0.01910243048310636,"score_gpt":0.2842938596114688,"score_spread":0.26519142912836247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949446669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971448,0.00001254821,0.000009913715,0.000031424934,0.0001916321,0.0018028466,0.000042050706,0.000055167904,0.00070961675],"genre_scores_gemma":[0.99756676,0.0000024410026,0.0016391195,0.000045451783,0.000059126258,0.00006525908,0.00023520076,0.000043424287,0.0003432343],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978896,0.00007337479,0.0003429449,0.00044196093,0.00089081883,0.00036134967],"domain_scores_gemma":[0.9987227,0.0001190839,0.00014498783,0.0005579261,0.0002365271,0.000218794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013703208,0.00023935505,0.00042935894,0.0002007282,0.00005240967,0.000030092026,0.00023431882,0.000062600506,0.00023327158],"category_scores_gemma":[0.0001140776,0.00016454638,0.00009183998,0.00014802448,0.000047204292,0.00022546954,0.000120367265,0.00015476924,0.00006983845],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011867873,0.015513261,0.9782361,0.000031487194,0.0010306214,0.00009065196,0.00047683003,0.0000015817401,0.0002222234,0.000008746032,0.0000042633565,0.0031974574],"study_design_scores_gemma":[0.045182727,0.001915837,0.9513742,0.00006780423,0.00017923047,0.0000024141693,0.00031812896,0.00013970002,0.0005361691,0.0000012670655,0.00013480175,0.00014774936],"about_ca_topic_score_codex":0.00012204566,"about_ca_topic_score_gemma":0.0002365781,"teacher_disagreement_score":0.04399594,"about_ca_system_score_codex":0.000049231083,"about_ca_system_score_gemma":0.00003336086,"threshold_uncertainty_score":0.67100066},"labels":[],"label_agreement":null},{"id":"W2950618735","doi":"10.1182/blood-2019-122902","title":"A Phase 1b/2 Study of Selinexor, Carfilzomib, and Dexamethasone (SKd) in Relapsed/ Refractory Multiple Myeloma (RRMM)","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Vancouver General Hospital; CancerCare Manitoba; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; Royal Victoria Hospital; Dalhousie University","funders":"","keywords":"Carfilzomib; Medicine; Refractory (planetary science); Dexamethasone; Internal medicine; Bortezomib; Regimen; Oncology; Gastroenterology; Pharmacology; Multiple myeloma; Materials science","score_opus":0.028058839664640654,"score_gpt":0.3223427778076554,"score_spread":0.29428393814301473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950618735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964688,0.000942902,0.0000017057423,0.00004605163,0.000046846857,0.0017624381,0.000030969077,0.000035506873,0.00066481705],"genre_scores_gemma":[0.99838597,0.000089335284,0.0007865555,0.000028647966,0.000047514903,0.000071652474,0.00002869771,0.000034776396,0.00052683015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981468,0.00015209924,0.0004143469,0.00045125443,0.00045464543,0.00038088099],"domain_scores_gemma":[0.9986731,0.00031986157,0.00011183718,0.0005358459,0.00010967694,0.0002496797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003373239,0.00021238584,0.00057074736,0.00028999752,0.000033341283,0.000010430647,0.000099491386,0.000106731495,0.000099256285],"category_scores_gemma":[0.00045820823,0.00017344984,0.00006224623,0.0003091373,0.000056014404,0.00007030548,0.00009840865,0.00030595018,0.000047684796],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022048368,0.04499726,0.8950919,0.00017832543,0.00038620122,0.00056914944,0.0015257801,0.0000011519394,0.04036758,0.0000037056388,0.000031154224,0.014642982],"study_design_scores_gemma":[0.32588533,0.015691461,0.6373712,0.00024303654,0.0003032194,0.00009334015,0.0025256805,0.00080620445,0.016401792,0.0000142768995,0.00039332386,0.00027113216],"about_ca_topic_score_codex":0.0008283861,"about_ca_topic_score_gemma":0.00044837245,"teacher_disagreement_score":0.3236805,"about_ca_system_score_codex":0.000044686643,"about_ca_system_score_gemma":0.000115954594,"threshold_uncertainty_score":0.7073079},"labels":[],"label_agreement":null},{"id":"W2950921432","doi":"10.1182/blood-2018-99-114275","title":"A Novel Predictor of Response to Gemtuzumab Ozogamicin Therapy in AML Provides Strategies for Sensitization of Leukemia Stem Cells in Individual Patients","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Gemtuzumab ozogamicin; Stem cell; Leukemia; Medicine; Calicheamicin; Oncology; Immunology; Sensitization; Internal medicine; Myeloid leukemia; Cancer research; CD33; Biology; CD34; Genetics","score_opus":0.03047327767904125,"score_gpt":0.2925056112534201,"score_spread":0.2620323335743789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950921432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970763,0.000022788527,0.00024809802,0.00011542111,0.000039957496,0.0021723881,0.00024049488,0.000015211364,0.00006934387],"genre_scores_gemma":[0.99734217,0.000010529727,0.0022623213,0.00008404998,0.00006657466,0.000068061876,0.000034154396,0.00003245356,0.000099681005],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983442,0.00012224812,0.00052313175,0.00028503334,0.00041862257,0.000306786],"domain_scores_gemma":[0.99872124,0.0003445319,0.00014976034,0.0002902761,0.0004153498,0.00007885961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007066178,0.0001508497,0.0003862171,0.0005526595,0.000019134352,0.000012703091,0.00015271653,0.00014315252,0.000008344616],"category_scores_gemma":[0.00022322607,0.00013368696,0.000047901634,0.0005466872,0.00011980672,0.000120406236,0.000066545916,0.0001384361,0.0000029327432],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013225466,0.0012934993,0.070704505,0.00030821902,0.000098778175,0.0000072442135,0.007996679,0.00006798928,0.9037275,0.00006519425,0.00024129271,0.0022636708],"study_design_scores_gemma":[0.029440874,0.0072676074,0.3245521,0.00045139864,0.00004510784,0.0000045115253,0.0014888038,0.0006759877,0.63577366,0.00005494923,0.0000913639,0.00015365443],"about_ca_topic_score_codex":0.00030236552,"about_ca_topic_score_gemma":0.00019464742,"teacher_disagreement_score":0.2679538,"about_ca_system_score_codex":0.00029230182,"about_ca_system_score_gemma":0.0014441741,"threshold_uncertainty_score":0.54515964},"labels":[],"label_agreement":null},{"id":"W2950951334","doi":"10.1182/blood.v130.suppl_1.823.823","title":"Long-Term Results of PET-Guided Radiation Therapy in Patients with Advanced-Stage Diffuse Large B-Cell Lymphoma Treated with R-CHOP in British Columbia","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Hôpital Charles-Le Moyne; BC Cancer Agency","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Stage (stratigraphy); Nuclear medicine; Radiation therapy; Lymphoma; Positron emission tomography; Cancer; Radiology; Internal medicine","score_opus":0.008040677581259705,"score_gpt":0.23356799256188834,"score_spread":0.22552731498062864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950951334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978655,0.00023619513,2.3652314e-7,0.00002304692,0.000019981842,0.001095387,0.00020057266,0.000022829952,0.000536262],"genre_scores_gemma":[0.998471,0.0005345687,0.00008008505,0.000042123917,0.000015514799,0.00010150685,0.00026821543,0.000032742755,0.0004542503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986732,0.00003728689,0.00034958814,0.00036923867,0.00028333548,0.00028732498],"domain_scores_gemma":[0.99885577,0.000034909746,0.000329604,0.0005838082,0.00010116984,0.00009473454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008364654,0.0001554653,0.0004142819,0.00006827327,0.00008591317,0.000091810514,0.00011074634,0.000061261206,0.000017550396],"category_scores_gemma":[0.000040764455,0.00015564334,0.000044184955,0.000117123906,0.000055419212,0.00017400848,0.000022964152,0.000045724835,0.000002592846],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001126692,0.032686263,0.95122147,0.000042967844,0.00008725066,0.0008976016,0.00012924877,7.586189e-7,0.000038104125,4.3456328e-7,0.000035209883,0.013734019],"study_design_scores_gemma":[0.2713173,0.0017832828,0.72473127,0.0003808727,0.00006266127,0.0000127967105,0.000012784616,0.0000036587594,0.0015398442,5.163736e-7,0.0000316511,0.00012336382],"about_ca_topic_score_codex":0.011414126,"about_ca_topic_score_gemma":0.047780655,"teacher_disagreement_score":0.2701906,"about_ca_system_score_codex":0.00012992069,"about_ca_system_score_gemma":0.00010114576,"threshold_uncertainty_score":0.9951689},"labels":[],"label_agreement":null},{"id":"W2951802836","doi":"10.1182/blood.v128.22.5561.5561","title":"Revelance of Gammaglobulin Levels at Diagnosis and during Disease Course in Chronic Lymphocytic Leukemia","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Research Institute in Oncology and Hematology; University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Hypogammaglobulinemia; Chemoimmunotherapy; Chronic lymphocytic leukemia; Lymphocytosis; Rituximab; Internal medicine; Alemtuzumab; IGHV@; Bendamustine; Immunology; Pediatrics; Oncology; Leukemia; Transplantation; Antibody; Lymphoma","score_opus":0.02020083842510304,"score_gpt":0.2881160953476421,"score_spread":0.26791525692253904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951802836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911618,0.0077778,0.000004373593,0.00024308318,0.00003419987,0.0004974134,0.000053800057,0.000040128838,0.00018736342],"genre_scores_gemma":[0.9951356,0.002620442,0.000082757295,0.000037235623,0.00014893925,0.00011580801,0.0000035214348,0.000037757527,0.0018179299],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99809843,0.000056815235,0.00040326195,0.00045675092,0.00045191232,0.00053282344],"domain_scores_gemma":[0.9985748,0.00029403405,0.000100473044,0.0005850299,0.000070844835,0.00037479977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023500332,0.00019829063,0.0004399496,0.00012573137,0.00004471715,0.0000075974112,0.00014996041,0.00010076853,0.00023962324],"category_scores_gemma":[0.00044864567,0.0001447447,0.000077020486,0.00023545435,0.00028343435,0.000097504824,0.00022816542,0.00009422444,0.000070967],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0029214055,0.0010844632,0.76448053,0.007578205,0.00059699983,0.0076552005,0.0006111881,0.00014202742,0.19707559,0.0002546631,0.0010930015,0.016506735],"study_design_scores_gemma":[0.11032352,0.00022053185,0.72591966,0.003396398,0.0002866092,0.0004070588,0.000014544428,0.0007903603,0.15781881,0.00009310852,0.00040595638,0.00032347522],"about_ca_topic_score_codex":0.00032527372,"about_ca_topic_score_gemma":0.00015909193,"teacher_disagreement_score":0.10740211,"about_ca_system_score_codex":0.04966306,"about_ca_system_score_gemma":0.018457217,"threshold_uncertainty_score":0.9871072},"labels":[],"label_agreement":null},{"id":"W2952842269","doi":"10.1182/blood.2019000905","title":"High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":174,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Follicular lymphoma; Complete remission; Medicine; Immunotherapy; CD19; Lymphoma; Oncology; Internal medicine; Cancer research; Immunology; Chemotherapy; Cancer; Peripheral blood","score_opus":0.01127728596737254,"score_gpt":0.24931235077624367,"score_spread":0.23803506480887113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952842269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940518,0.0014143756,0.0000046815953,0.00021580161,0.00009671013,0.00072517124,0.000011571585,0.000026337564,0.0034535136],"genre_scores_gemma":[0.98368114,0.0004125186,0.000382668,0.00022839326,0.00006077121,0.000033856704,0.000022460888,0.000052900406,0.01512531],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99850094,0.00012687968,0.0003529866,0.00031501646,0.00033472155,0.00036943096],"domain_scores_gemma":[0.9989481,0.00008292069,0.00008213439,0.00068992923,0.00009594143,0.00010097807],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041759587,0.00017490829,0.00048357502,0.00017678576,0.000019434481,0.000013104713,0.00015389989,0.00012857145,0.0046031387],"category_scores_gemma":[0.000014910052,0.00014762957,0.00015159216,0.00031574184,0.000044512624,0.000054226224,0.00005056973,0.00015389023,0.00015859],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013208939,0.00069606723,0.03133833,0.00016626315,0.00007551197,0.000121398734,0.0002246712,0.0000054027337,0.9647944,0.000013884248,0.00008897614,0.0011542097],"study_design_scores_gemma":[0.022402681,0.0006206496,0.08538118,0.00025554595,0.000042902302,0.000036504825,0.00006288351,0.000070965354,0.87592626,0.00010795105,0.014896304,0.00019614953],"about_ca_topic_score_codex":0.00072526623,"about_ca_topic_score_gemma":0.000011533805,"teacher_disagreement_score":0.08886811,"about_ca_system_score_codex":0.000073248135,"about_ca_system_score_gemma":0.00012768203,"threshold_uncertainty_score":0.9963068},"labels":[],"label_agreement":null},{"id":"W2952975510","doi":"10.1182/blood-2019-122765","title":"Randomized, Open-Label, Non-Inferiority, Phase 3 Study of Subcutaneous (SC) Versus Intravenous (IV) Daratumumab (DARA) Administration in Patients with Relapsed or Refractory Multiple Myeloma: Columba Update","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Daratumumab; Medicine; Clinical endpoint; Internal medicine; Adverse effect; Refractory (planetary science); Population; Phases of clinical research; Multiple myeloma; Gastroenterology; Randomized controlled trial; Lenalidomide; Clinical trial","score_opus":0.028028583787347874,"score_gpt":0.3247151012838969,"score_spread":0.29668651749654906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952975510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98858386,0.0000456354,0.000004427898,0.000025407937,0.00019179784,0.010180728,0.000100925776,0.000037237067,0.0008299544],"genre_scores_gemma":[0.9982844,0.000030751995,0.00055155606,0.00001669017,0.00003564234,0.00029245974,0.00043539578,0.00005825882,0.0002948313],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99686795,0.00031853165,0.00077475543,0.0006427736,0.000870845,0.0005251257],"domain_scores_gemma":[0.997799,0.00042722686,0.00035740167,0.00080226356,0.00032774924,0.00028640186],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044331866,0.00036209208,0.0013140952,0.00023761876,0.00011182954,0.000081075355,0.00032875236,0.0001543502,0.00016886937],"category_scores_gemma":[0.000437986,0.00026958738,0.00005910575,0.00043729428,0.00012204823,0.00027038483,0.0001722175,0.00040880134,0.000074587064],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7876751,0.070144035,0.13516335,0.000116100986,0.0010046487,0.0019385034,0.0005932797,0.0000015861381,0.000488526,0.000003809521,0.000020236752,0.002850868],"study_design_scores_gemma":[0.8804671,0.06626969,0.050839502,0.00016283705,0.00051386055,0.000043682132,0.00030252998,0.00024783626,0.0008466926,0.0000021672413,0.000040205876,0.0002638774],"about_ca_topic_score_codex":0.00076930807,"about_ca_topic_score_gemma":0.0024927112,"teacher_disagreement_score":0.09279206,"about_ca_system_score_codex":0.00015326984,"about_ca_system_score_gemma":0.0006266383,"threshold_uncertainty_score":0.9999756},"labels":[],"label_agreement":null},{"id":"W2953143769","doi":"10.1182/blood.v130.suppl_1.4534.4534","title":"Phase I/II Study of Infusional Gemcitabine and High-Dose Melphalan Conditioning Prior to Autologous Stem Cell Transplantation for Patients with Relapsed/Refractory Lymphoma: Interim Safety Analysis","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Melphalan; Medicine; Gemcitabine; Oncology; Transplantation; Internal medicine; Autologous stem-cell transplantation; Bendamustine; Chemotherapy; Tolerability; Lymphoma; Salvage therapy; Surgery; Hematopoietic stem cell transplantation; Rituximab; Adverse effect","score_opus":0.011351165151622144,"score_gpt":0.2694832333893683,"score_spread":0.25813206823774615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953143769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979614,0.000044415297,0.00008769705,0.00006279173,0.000048807502,0.0012900482,0.0004319399,0.000020385613,0.000052492967],"genre_scores_gemma":[0.99851704,0.000019322897,0.00073823583,0.00003096906,0.000021834912,0.00015558294,0.00045007773,0.0000156687,0.000051250474],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989478,0.000028491175,0.00032431554,0.0003133591,0.00023410785,0.0001519297],"domain_scores_gemma":[0.9990143,0.000093848284,0.00027459904,0.0003293099,0.00015829655,0.00012961814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008659142,0.00016993504,0.00046126425,0.00016884854,0.00036012402,0.000024396564,0.00007534067,0.00005309462,0.000019425546],"category_scores_gemma":[0.000015495123,0.00012538671,0.00007049004,0.00008669545,0.00004191454,0.000110681634,0.000037376263,0.000027898357,0.0000010990669],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007061494,0.07556897,0.85917836,0.00019506554,0.002955633,0.00012697186,0.0051309112,0.000012867646,0.000943007,0.000030857012,0.00002339268,0.048772443],"study_design_scores_gemma":[0.10413318,0.019370569,0.86754286,0.00008107016,0.005801637,0.0000069221487,0.00026627863,0.000018356477,0.0026227194,0.000002116132,0.000037696536,0.00011659497],"about_ca_topic_score_codex":0.0001889263,"about_ca_topic_score_gemma":0.00014963717,"teacher_disagreement_score":0.097071685,"about_ca_system_score_codex":0.000053335265,"about_ca_system_score_gemma":0.000057867153,"threshold_uncertainty_score":0.5113121},"labels":[],"label_agreement":null},{"id":"W2953435662","doi":"10.1182/blood.2019001014","title":"Yet do much less...so much less!","year":2019,"lang":"en","type":"letter","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Discontinuation; Myeloid leukemia; Medicine; Tyrosine kinase; Polymerase chain reaction; Oncology; Internal medicine; Immunology; Intensive care medicine; Cancer research; Biology; Genetics; Receptor; Gene","score_opus":0.02532328184483203,"score_gpt":0.2614187806101923,"score_spread":0.23609549876536026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953435662","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40101534,0.009847767,0.000011292674,0.4953594,0.0035414319,0.0035662672,0.00061212626,0.0006930644,0.08535332],"genre_scores_gemma":[0.05116451,0.00087877805,0.0011537662,0.7385037,0.017355446,0.00032512288,0.0058886046,0.00071961567,0.18401048],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961685,0.00010600115,0.00058685645,0.0011391095,0.0010231443,0.0009763952],"domain_scores_gemma":[0.99712443,0.00027281523,0.0003112122,0.0019940345,0.00014571974,0.00015180284],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0001600955,0.0008056448,0.0013220174,0.0002912336,0.00010635328,0.00009552732,0.00046908003,0.0017101566,0.0011926091],"category_scores_gemma":[0.0001144251,0.0006956071,0.0004454138,0.0002358431,0.00014257505,0.00007441529,0.00020440071,0.0026381994,0.003622294],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030728963,0.000465123,0.0037345388,0.0009862148,0.001217271,0.004663532,0.00018769316,2.3516402e-7,0.00021828403,0.000018898285,0.98591745,0.002560011],"study_design_scores_gemma":[0.01425222,0.00036125793,0.0008407516,0.0010265482,0.0024016295,0.0009997013,0.00008030581,0.000004714046,0.0017319114,0.00008623095,0.977539,0.0006757244],"about_ca_topic_score_codex":0.00044435728,"about_ca_topic_score_gemma":0.000023739369,"teacher_disagreement_score":0.34985083,"about_ca_system_score_codex":0.00082822173,"about_ca_system_score_gemma":0.0016316294,"threshold_uncertainty_score":0.99972045},"labels":[],"label_agreement":null},{"id":"W2953944003","doi":"10.1182/blood.v130.suppl_1.5479.5479","title":"Efficacy of Cidofovir in Treatment of BK Virus Induced Hemorrhagic Cystitis in Post Allogeneic Hematopoietic Cell Transplant Recipients","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Cidofovir; BK virus; Hemorrhagic cystitis; Medicine; Polyomavirus Infections; Transplantation; Internal medicine; Gastroenterology; Hematopoietic stem cell transplantation; Immunology; Graft-versus-host disease; Immunosuppression; Kidney transplantation; Virus","score_opus":0.019329072909167126,"score_gpt":0.27244698767639275,"score_spread":0.2531179147672256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953944003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957518,0.0021185735,3.1327752e-7,0.00006333417,0.00009211126,0.00043247218,0.000092325114,0.00001063836,0.0014384224],"genre_scores_gemma":[0.99899304,0.00076350715,0.000042973435,0.000018734154,0.000024151206,0.000017501763,0.000032662923,0.000018814637,0.00008860724],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99887395,0.000035351717,0.00042817974,0.0002349998,0.0001836481,0.00024386914],"domain_scores_gemma":[0.99910486,0.00004560394,0.00018932848,0.0005025697,0.000028489232,0.00012915497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006028225,0.00017120477,0.0004970795,0.00018696632,0.000037046582,0.0000058398487,0.0001407143,0.00014905228,0.000055830722],"category_scores_gemma":[0.000035454406,0.00013422,0.0001410209,0.00009096338,0.00007570642,0.000038264876,0.000018969415,0.00008604005,0.000014664189],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088796305,0.013846555,0.42198926,0.00018618935,0.00014617814,0.0013665924,0.0012420119,0.0000065458585,0.5577112,0.000011045684,0.000003082687,0.00260338],"study_design_scores_gemma":[0.015030979,0.0008254307,0.58527905,0.00040107334,0.00033702367,0.00004837667,0.000027118378,0.0000055676687,0.3979329,0.00000872942,0.000007984854,0.000095807576],"about_ca_topic_score_codex":0.0020530398,"about_ca_topic_score_gemma":0.00027896406,"teacher_disagreement_score":0.16328977,"about_ca_system_score_codex":0.000038567236,"about_ca_system_score_gemma":0.00013950911,"threshold_uncertainty_score":0.5473333},"labels":[],"label_agreement":null},{"id":"W2954109926","doi":"10.1182/blood.v130.suppl_1.3291.3291","title":"Comparative Effectiveness of High-Dose Bendamustine-EAM Versus BEAM in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplantation","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Carmustine; Bendamustine; Internal medicine; Melphalan; Transplantation; Etoposide; Surgery; Autologous stem-cell transplantation; Salvage therapy; Oncology; Chemotherapy; Leukemia; Chronic lymphocytic leukemia","score_opus":0.016771659613164853,"score_gpt":0.25747848850571314,"score_spread":0.2407068288925483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954109926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99793935,0.00009624419,0.000013216329,0.000024597797,0.00017950336,0.00070899085,0.000049944018,0.000029561603,0.0009586156],"genre_scores_gemma":[0.999511,0.0000337248,0.00020017197,0.0000065215254,0.000025053421,0.000064858774,0.000118976255,0.000020541025,0.000019171566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987377,0.00012163551,0.00026372078,0.00034692697,0.00029656032,0.00023349043],"domain_scores_gemma":[0.9985353,0.0006163641,0.00026973226,0.00038777723,0.0000907553,0.000100076424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011128235,0.00022741518,0.00058948743,0.00009927814,0.00012624598,0.000021580936,0.00010937959,0.00012311719,0.0000055776736],"category_scores_gemma":[0.000018100925,0.00017381778,0.000070967464,0.00007177527,0.00012660472,0.00014212208,0.000024679026,0.00008386731,0.000010039547],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013759508,0.013314677,0.96603394,0.00061240187,0.0004542944,0.00034043475,0.0006624147,0.00006835982,0.0006133948,0.00015448147,0.000011804864,0.0039743036],"study_design_scores_gemma":[0.09095477,0.0042972313,0.8545881,0.00059127127,0.00064018654,0.0000076724245,0.000064760316,0.000008471971,0.048687384,0.000007494387,0.0000069977373,0.00014568216],"about_ca_topic_score_codex":0.0001983588,"about_ca_topic_score_gemma":0.00017136933,"teacher_disagreement_score":0.11144585,"about_ca_system_score_codex":0.00019317101,"about_ca_system_score_gemma":0.00021929042,"threshold_uncertainty_score":0.7088083},"labels":[],"label_agreement":null},{"id":"W2954226397","doi":"10.1182/blood.2019003127","title":"Brentuximab vedotin with chemotherapy for stage III/IV classical Hodgkin lymphoma: 3-year update of the ECHELON-1 study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"Takeda Oncology","keywords":"ABVD; Dacarbazine; Brentuximab vedotin; Medicine; Vinblastine; Bleomycin; Internal medicine; Chemotherapy regimen; Population; Progression-free survival; Nuclear medicine; Oncology; Surgery; Chemotherapy; Lymphoma; Vincristine; Hodgkin lymphoma; Cyclophosphamide","score_opus":0.016476718114087244,"score_gpt":0.2523826619715569,"score_spread":0.23590594385746966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954226397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99188936,0.00012863716,0.000043344207,0.0057758223,0.000039591345,0.0016265524,0.000052406107,0.000045595058,0.00039870176],"genre_scores_gemma":[0.9975954,0.00002561766,0.00075874606,0.0011018118,0.00012970732,0.00014810394,0.000014184501,0.000036785386,0.0001895903],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99883664,0.000038003105,0.00024590312,0.00032542876,0.00031239758,0.00024160242],"domain_scores_gemma":[0.99923825,0.00006470653,0.00012467938,0.00037427156,0.000071323906,0.0001267817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000093790244,0.00019156243,0.00041780117,0.000022066031,0.00006945847,0.000016447311,0.00014852118,0.000055228324,0.000058479814],"category_scores_gemma":[0.000029715426,0.00010707887,0.00014952758,0.00018656958,0.00006682028,0.00002945364,0.000055030472,0.000051089686,0.000011380027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00493798,0.048498176,0.9151331,0.00028806194,0.0031935615,0.00017514487,0.0038309125,0.0000054503457,0.0033517855,0.0012193196,0.0048612207,0.014505278],"study_design_scores_gemma":[0.22852193,0.00984441,0.58535576,0.0001545825,0.002144725,0.0000357722,0.0019892827,0.00015329356,0.15581225,0.000031959295,0.015574524,0.00038152587],"about_ca_topic_score_codex":0.000032265394,"about_ca_topic_score_gemma":0.00001701975,"teacher_disagreement_score":0.32977736,"about_ca_system_score_codex":0.00004201706,"about_ca_system_score_gemma":0.00018402733,"threshold_uncertainty_score":0.43665496},"labels":[],"label_agreement":null},{"id":"W2954346506","doi":"10.1182/blood.v128.22.1366.1366","title":"Diagnosis and Outcomes of Patients Presenting with Microangiopathic Hemolytic Anemia and Thrombocytopenia to a University Hospital Apheresis Unit","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Microangiopathic hemolytic anemia; ADAMTS13; Etiology; Apheresis; Thrombotic thrombocytopenic purpura; Pediatrics; Internal medicine; Thrombotic microangiopathy; Eculizumab; Complement system; Disease; Immune system; Immunology; Platelet","score_opus":0.00871546931162517,"score_gpt":0.20699621402666998,"score_spread":0.1982807447150448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954346506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99893206,0.00032509692,0.0000040301484,0.00013356416,0.000035760542,0.00036018342,0.00013444854,0.000020547875,0.000054279433],"genre_scores_gemma":[0.9996155,0.00002224028,0.00006232745,0.000013077942,0.0000031023787,0.000006105353,0.0000066495445,0.00000811995,0.0002629025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99939674,0.00006632673,0.00012077355,0.00021577961,0.000031068987,0.00016932521],"domain_scores_gemma":[0.9994943,0.00016333342,0.00008375808,0.00016952901,0.000056628112,0.00003242329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004762061,0.000111100526,0.00024065912,0.00006220883,0.00008060836,0.0000063324937,0.000112022244,0.000047110807,0.000098749515],"category_scores_gemma":[0.000054284264,0.00007583457,0.000026283034,0.00007060425,0.000118535434,0.0000680867,0.00019912174,0.00002897372,0.000013221489],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050074086,0.00028818508,0.9940079,0.00004742234,0.00017192651,0.0000050732606,0.00021730663,2.1479146e-8,0.0046809153,0.000025207966,0.00018089535,0.0003250767],"study_design_scores_gemma":[0.0031730684,0.00024149155,0.9795069,0.00008763905,0.00019787223,0.0000034459874,0.0002025347,1.4800873e-8,0.016105289,0.000008973723,0.00035139074,0.00012135226],"about_ca_topic_score_codex":0.000088699846,"about_ca_topic_score_gemma":0.000045714518,"teacher_disagreement_score":0.014500968,"about_ca_system_score_codex":0.000008323504,"about_ca_system_score_gemma":0.00001674957,"threshold_uncertainty_score":0.3092444},"labels":[],"label_agreement":null},{"id":"W2955312833","doi":"10.1182/blood.v130.suppl_1.3107.3107","title":"Safety and Efficacy of Daratumumab Monotherapy in Patients with Heavily Pretreated Relapsed and Refractory Multiple Myeloma: Final Results from GEN501 and Sirius","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Daratumumab; Medicine; Internal medicine; Refractory (planetary science); Phases of clinical research; Proteasome inhibitor; Gastroenterology; Multiple myeloma; Lenalidomide; Oncology; Surgery; Clinical trial","score_opus":0.01985083109453835,"score_gpt":0.26899780093365966,"score_spread":0.24914696983912132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955312833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997799,0.0007014278,0.0000018294535,0.000096561394,0.000014273495,0.0007662221,0.00032085442,0.000016292717,0.00028355233],"genre_scores_gemma":[0.9983608,0.0004208283,0.0008803842,0.000011685525,0.000021354133,0.000009638205,0.00018549757,0.00002313598,0.000086667926],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998702,0.00006150309,0.00029537702,0.00043486894,0.0002598291,0.00024645776],"domain_scores_gemma":[0.99875605,0.00024001556,0.00018144789,0.00053309824,0.00008256357,0.00020681472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010225168,0.00019602175,0.00040865355,0.00009666916,0.0001679757,0.000036201767,0.000072401584,0.000108894106,0.000005669924],"category_scores_gemma":[0.00043748773,0.00014328113,0.000021853593,0.000051492712,0.00023705025,0.00013365885,0.00006488272,0.0001821392,0.000001112797],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03193473,0.0014949214,0.94620997,0.00003209628,0.00025845785,0.000114847106,0.00040825515,2.733571e-7,0.000910409,0.0000012588539,0.000008820925,0.018625952],"study_design_scores_gemma":[0.14280231,0.0018021117,0.8531592,0.00022920128,0.00008817294,0.000005685622,0.000021914051,0.000078315665,0.001632358,0.000005680252,0.00006499279,0.000110077155],"about_ca_topic_score_codex":0.0014043631,"about_ca_topic_score_gemma":0.0003995749,"teacher_disagreement_score":0.11086758,"about_ca_system_score_codex":0.00002461804,"about_ca_system_score_gemma":0.000053124662,"threshold_uncertainty_score":0.5842835},"labels":[],"label_agreement":null},{"id":"W2955754108","doi":"10.1182/blood.v130.suppl_1.3136.3136","title":"Selinexor in Combination with Pomalidomide and Low Dose Dexamethasone in a Relapsed / Refractory Multiple Myeloma Patient Population with Prior Proteasome Inhibitor and Lenalidomide Exposure","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; CancerCare Manitoba; Vancouver General Hospital; Dalhousie University; University of Toronto; Royal Victoria Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Pomalidomide; Lenalidomide; Tolerability; Medicine; Multiple myeloma; Internal medicine; Dexamethasone; Carfilzomib; Refractory (planetary science); Population; Oncology; Ixazomib; Febrile neutropenia; Neutropenia; Pharmacology; Gastroenterology; Adverse effect; Toxicity; Biology","score_opus":0.004781769013664378,"score_gpt":0.19938319499115054,"score_spread":0.19460142597748617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955754108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990769,0.00020535331,0.000018929888,0.00007371501,0.000031903986,0.00055999495,0.000004946212,0.0000076256247,0.000020652476],"genre_scores_gemma":[0.99789137,0.000025274205,0.0018597128,0.00003480997,0.000057105328,0.000044226006,0.000041107065,0.000021418971,0.000024971856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992237,0.00005841054,0.00016720963,0.0003122448,0.000103043596,0.00013539393],"domain_scores_gemma":[0.9994748,0.000011577793,0.00016705952,0.00025333898,0.000045852717,0.000047362744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011930747,0.00013618574,0.0001498407,0.00006190861,0.00009782119,0.0000498146,0.000048974845,0.00013411876,0.0000010727526],"category_scores_gemma":[0.00012716881,0.0001068146,0.000012397403,0.00003980335,0.000058098125,0.000021479374,0.000044561337,0.00011202757,2.769125e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024948518,0.00032951284,0.6873518,0.00005737588,0.000030718635,0.000025004683,0.0002523889,0.000019030747,0.2967743,0.0000102139,0.000005537943,0.012649243],"study_design_scores_gemma":[0.014469581,0.0016653779,0.9387047,0.00013179131,0.000024980965,0.000046724937,0.00008940088,0.00008742523,0.04444848,0.000028637764,0.00010880232,0.00019404477],"about_ca_topic_score_codex":0.00018666849,"about_ca_topic_score_gemma":0.0012529879,"teacher_disagreement_score":0.2523258,"about_ca_system_score_codex":0.000012542037,"about_ca_system_score_gemma":0.000024730633,"threshold_uncertainty_score":0.4355773},"labels":[],"label_agreement":null},{"id":"W2956168677","doi":"10.1182/blood.2019000239","title":"Combining gene mutation with gene expression analysis improves outcome prediction in acute promyelocytic leukemia","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Fundação de Amparo à Pesquisa do Estado de São Paulo; Conselho Nacional de Desenvolvimento Científico e Tecnológico; American Society of Hematology","keywords":"Acute promyelocytic leukemia; Myeloid leukemia; Anthracycline; Oncology; Medicine; Retinoic acid; Internal medicine; Mutation; Tretinoin; Daunorubicin; Gene; Leukemia; Malignancy; Cancer research; Bioinformatics; Genetics; Biology; Cancer","score_opus":0.004782189312045509,"score_gpt":0.22027469336649574,"score_spread":0.21549250405445022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956168677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964452,0.00028883648,0.0025066494,0.000007240638,0.000059025944,0.00027147768,0.000010832896,0.000023193299,0.0003875483],"genre_scores_gemma":[0.9957818,0.000045664212,0.0028280267,0.00003437167,0.00007441565,0.00005522675,0.00044829526,0.000023502338,0.0007087056],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988355,0.000044573444,0.00027828623,0.00044382058,0.00017904498,0.00021878532],"domain_scores_gemma":[0.99939996,0.000008060665,0.00012929109,0.00034527693,0.00006660038,0.00005081998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014548532,0.00016847774,0.00022618246,0.00011763637,0.00004668518,0.00003149087,0.00014900594,0.00016743192,0.000013346563],"category_scores_gemma":[0.000018774554,0.00013972809,0.00007797747,0.00031555793,0.00003212696,0.000012598557,0.000060706494,0.000115146286,0.000009562305],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000069200505,0.00005992304,0.19850542,0.000033932072,0.00025070534,0.000014356654,0.000064284526,0.00097300403,0.7998982,0.000002109504,0.0000049147434,0.00012393332],"study_design_scores_gemma":[0.0022848097,0.00041532054,0.024088588,0.000019311248,0.00047127242,0.000032758817,0.00006784354,0.0007858581,0.97159415,0.000013324422,0.000041320713,0.00018544176],"about_ca_topic_score_codex":0.00001671719,"about_ca_topic_score_gemma":0.00000844097,"teacher_disagreement_score":0.17441683,"about_ca_system_score_codex":0.00004279463,"about_ca_system_score_gemma":0.00013388935,"threshold_uncertainty_score":0.5697946},"labels":[],"label_agreement":null},{"id":"W2956178192","doi":"10.1182/blood.2019000258","title":"Early progression after bendamustine-rituximab is associated with high risk of transformation in advanced stage follicular lymphoma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Rituximab; Follicular lymphoma; Medicine; Bendamustine; Internal medicine; Oncology; Prednisone; Vincristine; Population; Hazard ratio; Lymphoma; Immunology; Cyclophosphamide; Confidence interval; Chemotherapy","score_opus":0.004026528704495895,"score_gpt":0.2221321651778771,"score_spread":0.2181056364733812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956178192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998136,0.00035607,0.0000042096417,0.00009466489,0.000025882171,0.00092782686,0.000103629485,0.000032533233,0.0003191873],"genre_scores_gemma":[0.99907845,0.00007323631,0.00045513085,0.00004863384,0.000009215526,0.00014022659,0.00007626893,0.000019585783,0.000099240795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99894774,0.000037401744,0.00027250394,0.00021018853,0.00033001462,0.00020212303],"domain_scores_gemma":[0.9994416,0.000035694822,0.00015944961,0.00022055232,0.00008072687,0.000061937906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009874634,0.00015599647,0.00036758513,0.00009476082,0.00001929755,0.000009283708,0.000038763523,0.00009385648,0.00009142324],"category_scores_gemma":[0.000017712495,0.00010638492,0.00007994582,0.00021535065,0.000019708375,0.00014140873,0.000009805769,0.00004895501,0.000023387147],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007274052,0.0052972767,0.9828992,0.00010731307,0.000295635,0.00012722096,0.0010925267,0.0000068219597,0.00057545456,0.00002762072,0.0000034530876,0.00884011],"study_design_scores_gemma":[0.048879378,0.0015318345,0.89759827,0.00072149094,0.00040545635,0.0000072577577,0.00007315712,0.00004091725,0.05054441,0.000010131899,0.0000744686,0.00011321682],"about_ca_topic_score_codex":0.00022647057,"about_ca_topic_score_gemma":0.000048673992,"teacher_disagreement_score":0.085300885,"about_ca_system_score_codex":0.00008341883,"about_ca_system_score_gemma":0.00006667303,"threshold_uncertainty_score":0.4338251},"labels":[],"label_agreement":null},{"id":"W2957088376","doi":"10.1182/blood-2018-99-120297","title":"Germline TIM-3 Mutations Characterize Sub-Cutaneous Panniculitis T-Cell Lymphomas with Hemophagocytic Lymphohistiocytic Syndrome","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Galectins and Cancer Biology","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital; Sinai Health System; McGill University Health Centre; Ontario Genomics; University of Toronto; McGill University","funders":"","keywords":"Hemophagocytic lymphohistiocytosis; Missense mutation; Biology; Germline; Lymphoma; T cell; Immune system; Mutation; Cancer research; Immunology; Genetics; Gene; Medicine; Pathology; Disease","score_opus":0.0058402188589746695,"score_gpt":0.193542319907535,"score_spread":0.18770210104856033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2957088376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99463665,0.0014420757,0.000053052136,0.00010204951,0.00058546726,0.00027348945,0.00014919588,0.00018049733,0.0025775062],"genre_scores_gemma":[0.99502915,0.000076756834,0.00012671635,0.0003204254,0.000120297664,0.000068963476,0.00037854095,0.00004188241,0.0038372716],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99837565,0.000114639945,0.00033558745,0.0005236082,0.00004848482,0.000602024],"domain_scores_gemma":[0.9990885,0.00008926527,0.00017496196,0.00043169185,0.00015593373,0.000059609934],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00007949264,0.00029823027,0.00040937262,0.00010944564,0.00034105987,0.000025297475,0.0002550898,0.0002885761,0.0011337305],"category_scores_gemma":[0.000028213555,0.0002499559,0.00009355181,0.00024222638,0.0005748183,0.00006381883,0.0000634189,0.0001590666,0.001919065],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047182167,0.0013339656,0.005565131,0.000074404496,0.0006494803,0.0010976776,0.0005286935,0.0000018588631,0.9873626,0.00024272266,0.00062509964,0.0020465064],"study_design_scores_gemma":[0.020825764,0.0071057966,0.076591216,0.00014174519,0.0011480155,0.09783975,0.00021407746,0.000014795562,0.76772636,0.0002447559,0.026763387,0.0013843499],"about_ca_topic_score_codex":0.00015759516,"about_ca_topic_score_gemma":0.00009025586,"teacher_disagreement_score":0.21963629,"about_ca_system_score_codex":0.00010950119,"about_ca_system_score_gemma":0.00031544632,"threshold_uncertainty_score":0.9999953},"labels":[],"label_agreement":null},{"id":"W2957390366","doi":"10.1182/blood.2019896175","title":"Shared roles for Scl and Lyl1 in murine platelet production and function","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"FLI1; GATA1; Biology; Conditional gene knockout; Thrombopoietin; Platelet; Phenotype; RUNX1; Megakaryocyte; Haematopoiesis; Transcription factor; Platelet disorder; Thrombopoiesis; Cancer research; Cell biology; Genetics; Immunology; Gene; Stem cell","score_opus":0.00933833139347251,"score_gpt":0.2253165397241582,"score_spread":0.21597820833068568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2957390366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99792063,0.00084829854,0.0000028831578,0.00032827945,0.00005426673,0.00056222116,0.0000072006046,0.000017483337,0.00025875028],"genre_scores_gemma":[0.99907297,0.000095528754,0.00017605747,0.00004365941,0.000037158334,0.000029366047,0.00004899802,0.000008394453,0.00048788422],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99962133,0.000003758305,0.00007205112,0.00017268905,0.00004448865,0.0000856689],"domain_scores_gemma":[0.9998587,0.000009263982,0.000019785259,0.00006937546,0.0000152558705,0.00002762459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000043919685,0.000062381696,0.00013056834,0.000053139585,0.00001878465,0.000008150485,0.000007498955,0.000037889247,0.000014249517],"category_scores_gemma":[0.000022976847,0.000051448093,0.000011722887,0.000042290292,0.000008985373,0.000065498236,0.000008322694,0.00003308,0.0000059618687],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013984044,0.0016192164,0.9358186,0.00050948974,0.00027923004,0.00007216516,0.00036123514,0.0000039707506,0.025668943,0.00012808258,0.00046321796,0.033677448],"study_design_scores_gemma":[0.025211161,0.0016588451,0.9503096,0.00026166684,0.00028318554,0.00039161113,0.00021518712,0.00021872942,0.01740832,0.0009902532,0.0028559738,0.0001955037],"about_ca_topic_score_codex":0.000016394508,"about_ca_topic_score_gemma":0.000049786537,"teacher_disagreement_score":0.03348194,"about_ca_system_score_codex":0.0000053402696,"about_ca_system_score_gemma":0.000008548031,"threshold_uncertainty_score":0.20979923},"labels":[],"label_agreement":null},{"id":"W2959230337","doi":"10.1182/blood-2018-99-112199","title":"Examining the Role of Sickle Cell Disease Patients As Teachers in the Emergency Department: Patient Directed Physician Education","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cancer Care Ontario; Toronto General Hospital; University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Emergency department; Psychological intervention; Qualitative research; Context (archaeology); Population; Disease; Family medicine; Health care; Nursing; Internal medicine","score_opus":0.005166451472554091,"score_gpt":0.22042402683615195,"score_spread":0.21525757536359785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2959230337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97139686,0.0012277781,2.522805e-7,0.00013890884,0.00013839967,0.0005163846,0.00000607195,0.00001858937,0.026556779],"genre_scores_gemma":[0.99930084,0.000071940856,0.000014551681,0.00032379225,0.00007073795,0.000049197803,0.000045497793,0.000012492147,0.000110978406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991845,0.00009020868,0.00020616758,0.00014283245,0.00021623581,0.00016007418],"domain_scores_gemma":[0.99947345,0.000019744151,0.00010111426,0.00026893747,0.00007635721,0.000060413106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007679895,0.000096917305,0.00009948946,0.00003740764,0.000085505926,0.0000046895957,0.00009509773,0.000038092756,0.000051373197],"category_scores_gemma":[0.00006310126,0.00005446896,0.000047437694,0.00024630592,0.000058734855,0.00003234397,0.000022520637,0.00011048516,0.000028864632],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014478626,0.013752977,0.85124654,0.00006594386,0.00009761427,0.0000038302155,0.034337837,0.0000037442542,0.0024714668,0.000098072705,0.0019431923,0.09583401],"study_design_scores_gemma":[0.0033828365,0.0016146258,0.9326148,0.0002005892,0.0006411683,0.0000015985516,0.026753884,0.000083211526,0.010232555,0.00069478416,0.02352358,0.00025633693],"about_ca_topic_score_codex":0.00011574454,"about_ca_topic_score_gemma":0.0000118436465,"teacher_disagreement_score":0.09557767,"about_ca_system_score_codex":0.0000139605,"about_ca_system_score_gemma":0.000102201215,"threshold_uncertainty_score":0.22211798},"labels":[],"label_agreement":null},{"id":"W2959261838","doi":"10.1182/blood.2019001126","title":"Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Simon Fraser University; Spinal Cord Injury BC; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Biology; Cancer research; Lymphoma; CDKN2A; BCL10; Gene expression profiling; Gene; Genetics; Gene expression; Immunology","score_opus":0.005698343079260077,"score_gpt":0.21639656889591574,"score_spread":0.21069822581665568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2959261838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929872,0.0013482785,0.00008888822,0.00007952438,0.00012202677,0.0004853684,0.00006443866,0.000042172527,0.0047820993],"genre_scores_gemma":[0.99687135,0.00018385981,0.0010695206,0.00028452542,0.000045804984,0.00009033669,0.00023460471,0.000023388302,0.0011965953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984414,0.000068277455,0.00035671293,0.00045941735,0.00031282761,0.0003613924],"domain_scores_gemma":[0.9991797,0.00009923218,0.00012072573,0.0004084531,0.000062535706,0.00012935337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022463512,0.00024540545,0.0006255338,0.00037931954,0.00003927178,0.000030202522,0.0001198715,0.000105743835,0.00036916684],"category_scores_gemma":[0.000023485869,0.00018665272,0.00033671464,0.00054756313,0.000021948275,0.000077647936,0.00009224489,0.00007307073,0.00049699604],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025074967,0.01856075,0.85375094,0.0001708612,0.0029593005,0.0012221232,0.0025948356,0.0000058937944,0.11743096,0.0010176093,0.00014875669,0.0018871907],"study_design_scores_gemma":[0.022488771,0.00040937672,0.92789865,0.0000804998,0.003243323,0.000053111024,0.00067347515,0.00009912558,0.044493824,0.00020174256,0.00013190377,0.00022622959],"about_ca_topic_score_codex":0.00011033249,"about_ca_topic_score_gemma":0.0002002952,"teacher_disagreement_score":0.07414766,"about_ca_system_score_codex":0.0002526496,"about_ca_system_score_gemma":0.00019648323,"threshold_uncertainty_score":0.7611477},"labels":[],"label_agreement":null},{"id":"W2960892248","doi":"10.1182/blood.v130.suppl_1.4936.4936","title":"Anti-CD20 Monoclonal Antibody Therapy for Immune Modulation Across a Range of Autoimmune Diseases","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Blood Services; McMaster University","funders":"","keywords":"Medicine; Rituximab; Multifocal motor neuropathy; Randomized controlled trial; Adverse effect; Internal medicine; Immunology; Cochrane Library; Meta-analysis; Antibody; Mismatch negativity","score_opus":0.021934274752570947,"score_gpt":0.3235464094112895,"score_spread":0.30161213465871856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2960892248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99539834,0.0030907348,0.00014739597,0.00037509963,0.00016312124,0.00050357933,0.00011086312,0.00003944449,0.00017143297],"genre_scores_gemma":[0.99869317,0.00058595795,0.00023945398,0.00008962983,0.000100093,0.000027549431,0.000059375976,0.000024052799,0.00018071964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99923295,0.000013548305,0.00022168722,0.00018302312,0.00014352932,0.00020523736],"domain_scores_gemma":[0.99914986,0.00002444168,0.00018349297,0.00049981556,0.00009029377,0.00005212079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007884991,0.00012228392,0.00033175584,0.000022090082,0.00026384066,0.00003444184,0.00014278632,0.000052614734,0.000024995612],"category_scores_gemma":[0.000113835864,0.0001003618,0.00019454543,0.00003264672,0.00011630055,0.00011972104,0.000041395775,0.000053379135,0.0000017235767],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010776862,0.0019705992,0.58951974,0.00018179268,0.00018850029,0.00002100164,0.00032313517,0.000015859176,0.3915204,0.00008369729,0.0000892348,0.015008304],"study_design_scores_gemma":[0.011366394,0.00043218152,0.98104906,0.00005988986,0.00007548409,0.000006820427,0.000050921542,0.0007752165,0.00517797,0.00010271907,0.0007983411,0.00010500838],"about_ca_topic_score_codex":0.00012204179,"about_ca_topic_score_gemma":0.0000046680784,"teacher_disagreement_score":0.3915293,"about_ca_system_score_codex":0.000003814249,"about_ca_system_score_gemma":0.000036717047,"threshold_uncertainty_score":0.40926355},"labels":[],"label_agreement":null},{"id":"W2960897154","doi":"10.1182/blood-2018-99-115592","title":"Outcomes of T-Cell Depleted Haploidentical Peripheral Blood Stem Cell Transplantation for Adult Acute Leukemia: A Meta-Analysis","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Myeloid leukemia; Transplantation; Hematopoietic stem cell transplantation; Internal medicine; Acute leukemia; Leukemia; Meta-analysis; Stem cell; CD34; Oncology; Gastroenterology; Immunology; Biology","score_opus":0.04250206580678483,"score_gpt":0.31770761034001443,"score_spread":0.2752055445332296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2960897154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99385923,0.00026728032,0.0024630744,0.00027188487,0.00004675013,0.0009614938,0.00021077643,0.00006342301,0.001856104],"genre_scores_gemma":[0.9829239,0.00008566768,0.0038909393,0.00030529627,0.00011060333,0.00014751022,0.00011180865,0.000056359033,0.012367898],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99766856,0.000111810805,0.0006028188,0.00047404345,0.0006999685,0.0004428081],"domain_scores_gemma":[0.9980936,0.00023033877,0.00015497245,0.0005709705,0.0007495967,0.00020051064],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035123577,0.00026904972,0.0013090435,0.00030783552,0.000084395324,0.00003317388,0.00021696927,0.00018921975,0.0015926735],"category_scores_gemma":[0.000025476631,0.00020692399,0.001719462,0.00058628933,0.00015377664,0.000080705635,0.00002583797,0.0002058433,0.000020704092],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011645857,0.0018644581,0.017647725,0.00048604803,0.17089374,0.000102741724,0.0013386012,0.0000037075251,0.8061466,0.00006905128,0.00012963155,0.00015308395],"study_design_scores_gemma":[0.009082213,0.001091645,0.0047360943,0.000004090861,0.38684514,0.00003336838,0.0001156544,0.00030737097,0.5975351,0.000025448107,0.0000560483,0.00016787056],"about_ca_topic_score_codex":0.00012044431,"about_ca_topic_score_gemma":0.00017627892,"teacher_disagreement_score":0.21595141,"about_ca_system_score_codex":0.00004431905,"about_ca_system_score_gemma":0.00016304507,"threshold_uncertainty_score":0.99932003},"labels":[],"label_agreement":null},{"id":"W2961134298","doi":"10.1182/blood-2018-99-109470","title":"Mitochondrial Dysfunction in Normal and Malignant Hematopoiesis","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Biology; Stem cell; Oxidative stress; Myeloid leukemia; Mitochondrion; Haematopoiesis; Cancer research; Respiratory chain; Oxidative phosphorylation; Preleukemia; Mitochondrial DNA; Leukemia; Cell biology; Immunology; Genetics; Biochemistry; Gene","score_opus":0.013304267480336177,"score_gpt":0.26345548648232125,"score_spread":0.25015121900198506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2961134298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920192,0.00011071028,0.000054821667,0.00064280437,0.00013437787,0.00024119805,0.0000023275104,0.000032346357,0.0067622336],"genre_scores_gemma":[0.9960361,0.000029900286,0.0017218938,0.00019863139,0.00081449613,0.00002136714,0.0000062288727,0.00001546798,0.001155932],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99919105,0.000027172182,0.00014693312,0.00020396261,0.00018990124,0.00024095709],"domain_scores_gemma":[0.9995895,0.000034044588,0.000021904372,0.00019160674,0.0000615052,0.000101413374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012813734,0.000081845465,0.00015862673,0.00013471952,0.00004535204,0.000014350502,0.00004475961,0.00008588572,0.00026358775],"category_scores_gemma":[0.00012337958,0.00006769565,0.000024749577,0.00018583974,0.00011026976,0.00006770201,0.00006164289,0.00014285558,0.00012737475],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022203126,0.001398111,0.18509287,0.0003775363,0.000249701,0.0009620545,0.0020249744,2.8375675e-7,0.7841406,0.0013687584,0.015309289,0.0068555074],"study_design_scores_gemma":[0.045360673,0.0031757075,0.20338939,0.0004168332,0.00035339873,0.0023885556,0.0007612692,0.0005079522,0.72256005,0.00052789785,0.020033417,0.00052482414],"about_ca_topic_score_codex":0.00013018397,"about_ca_topic_score_gemma":0.000077512035,"teacher_disagreement_score":0.061580528,"about_ca_system_score_codex":0.000044220633,"about_ca_system_score_gemma":0.00010462941,"threshold_uncertainty_score":0.2886101},"labels":[],"label_agreement":null},{"id":"W2961458743","doi":"10.1182/blood-2018-99-120112","title":"A Retrospective Case Series Describing the Efficacy of Ketotifen in Systemic Mastocytosis","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Ketotifen; Medicine; Systemic mastocytosis; Anaphylaxis; Mast cell; Cromolyn Sodium; Cutaneous Mastocytosis; Retrospective cohort study; Internal medicine; Asthma; Allergy; Gastroenterology; Immunology","score_opus":0.020180629658555098,"score_gpt":0.21349042302587976,"score_spread":0.19330979336732465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2961458743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99585533,0.0011494233,0.000015648979,0.000048514026,0.0001997037,0.00020394342,0.00001878618,0.000019845302,0.0024887975],"genre_scores_gemma":[0.99890286,0.000017002536,0.000037838803,0.000014086897,0.000043886223,0.00001199946,0.000004455939,0.000008890194,0.00095898635],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99931836,0.00010293314,0.00021252932,0.0001629612,0.000019119538,0.00018410767],"domain_scores_gemma":[0.99954426,0.00005566165,0.000088876484,0.00024309897,0.000060141105,0.000007940577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001917135,0.00009190691,0.00019930453,0.00005831728,0.00012390086,0.000006260448,0.00011813324,0.00009184016,0.00023569659],"category_scores_gemma":[0.00007018176,0.00006456705,0.00004536275,0.00014582748,0.00030009358,0.00003486443,0.00006192542,0.00013120058,0.000074386546],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042199492,0.00076591584,0.07287613,0.000094202966,0.00034297167,0.0003983437,0.011549088,0.0000018736714,0.90790594,0.0040596467,0.0004462286,0.0011376572],"study_design_scores_gemma":[0.013849171,0.0021934558,0.06157554,0.00064764166,0.00049662654,0.03681165,0.0076413276,0.0000058925407,0.87174416,0.00016751986,0.0042614727,0.0006055726],"about_ca_topic_score_codex":0.0003859371,"about_ca_topic_score_gemma":0.0006446238,"teacher_disagreement_score":0.036413305,"about_ca_system_score_codex":0.000020974268,"about_ca_system_score_gemma":0.000025513351,"threshold_uncertainty_score":0.26329678},"labels":[],"label_agreement":null},{"id":"W2961670806","doi":"10.1182/blood-2018-99-118017","title":"Development of a Data Portal for Aggregation and Analysis of Genomics Data in Familial Platelet Disorder with Predisposition to Myeloid Malignancy - the RUNX1.DB","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; University of Calgary","funders":"","keywords":"Germline mutation; Platelet disorder; Germline; Malignancy; Genetics; Penetrance; Genetic testing; Medicine; Biology; Bioinformatics; Mutation; Internal medicine; Gene","score_opus":0.03561656374646475,"score_gpt":0.3111472051199699,"score_spread":0.27553064137350514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2961670806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99398863,0.00011211841,0.0039097276,0.00017627013,0.000009356983,0.0008456667,0.00089328474,0.0000055275664,0.00005944055],"genre_scores_gemma":[0.9524046,0.000042230153,0.04371508,0.00004054897,0.000054830318,0.000032138152,0.003673085,0.00001386155,0.000023613115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988906,0.000020308897,0.00033337696,0.0003392459,0.0002525914,0.00016388475],"domain_scores_gemma":[0.9987345,0.000059388298,0.00011400717,0.000918054,0.00012193835,0.000052159612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005354336,0.0000920688,0.00026726746,0.00021812513,0.00004828943,0.00000842786,0.00036133113,0.000049382168,0.000010406138],"category_scores_gemma":[0.00009708765,0.000062588435,0.000014947467,0.0005623479,0.000096943375,0.00013607372,0.00037427235,0.00006435835,7.1226225e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009161937,0.00333424,0.5076443,0.0011879331,0.01122064,0.00007065059,0.022385482,0.000065506385,0.14463346,0.00045143403,0.0010010477,0.29884338],"study_design_scores_gemma":[0.012155462,0.0012764749,0.9102794,0.00035263156,0.003435293,0.000045261357,0.0018230582,0.018545063,0.048242457,0.000021253541,0.0035212918,0.00030233292],"about_ca_topic_score_codex":0.00013939007,"about_ca_topic_score_gemma":0.0024529821,"teacher_disagreement_score":0.40263513,"about_ca_system_score_codex":0.000030099776,"about_ca_system_score_gemma":0.0003731643,"threshold_uncertainty_score":0.25522822},"labels":[],"label_agreement":null},{"id":"W2961690031","doi":"10.1182/blood.v128.22.1687.1687","title":"Down Syndrome AML Is Unique in Phenotype Both at Diagnosis and in Post Chemotherapy Regeneration","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Hospital for Sick Children","funders":"","keywords":"Medicine; Internal medicine; Down syndrome; Chemotherapy; Oncology; Myeloid leukemia; Immunophenotyping; Minimal residual disease; Bone marrow; Leukemia; Immunology; Gastroenterology; Pathology; Flow cytometry","score_opus":0.013075281456186041,"score_gpt":0.26551842900611544,"score_spread":0.2524431475499294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2961690031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985139,0.000498802,0.000008716015,0.0134902075,0.00001604951,0.00042500504,0.000013337407,0.000022928025,0.00038591886],"genre_scores_gemma":[0.99464995,0.0021892625,0.0003851769,0.0011608221,0.00005151729,0.00008251848,0.000011684633,0.00002674631,0.0014423233],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990641,0.000056651854,0.00018150831,0.00027279562,0.00017560742,0.00024936022],"domain_scores_gemma":[0.9994773,0.00010261967,0.000031523436,0.00025276036,0.000040774677,0.00009497084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022669473,0.00011292729,0.000212173,0.00018730995,0.000025469553,0.000010276069,0.000066853856,0.00012385356,0.0004236174],"category_scores_gemma":[0.00010316195,0.00007912779,0.000023457847,0.00022088383,0.000057351885,0.00008454492,0.00005049417,0.00012651487,0.000050454775],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036606484,0.00053190417,0.7266959,0.00006579365,0.000061636245,0.00034070486,0.0007119697,2.2328723e-7,0.25730154,0.00008222322,0.0024326383,0.011409419],"study_design_scores_gemma":[0.010930223,0.00044524728,0.78829306,0.00024597943,0.000023387518,0.00019632665,0.000023381208,0.00002607927,0.19747882,0.00011198828,0.0020636793,0.00016183053],"about_ca_topic_score_codex":0.00033333283,"about_ca_topic_score_gemma":0.00059356773,"teacher_disagreement_score":0.06159718,"about_ca_system_score_codex":0.0002578275,"about_ca_system_score_gemma":0.00013183168,"threshold_uncertainty_score":0.46383134},"labels":[],"label_agreement":null},{"id":"W2961723827","doi":"10.1182/blood-2018-99-111024","title":"A Practical, One Clinic Visit, Population Pharmacokinetic (PK) Protocol for Generation of PK Profiles in Subjects with Severe Hemophilia a","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; Institute for Clinical Evaluative Sciences; University of Toronto; SickKids Foundation; University of British Columbia; Hospital for Sick Children","funders":"","keywords":"Medicine; Pharmacokinetics; Population; Dosing; Internal medicine","score_opus":0.11489881817860266,"score_gpt":0.425064166012238,"score_spread":0.31016534783363536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2961723827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89847547,0.000005958408,0.00005218821,0.0009840413,0.00001682349,0.09952161,0.000007879474,0.000027855856,0.0009081564],"genre_scores_gemma":[0.9223524,0.0000029323758,0.00936439,0.00005272764,0.0005239205,0.06689759,0.00007133813,0.000026560943,0.00070815353],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998786,0.00006842478,0.0003189484,0.00027069222,0.00032062244,0.00023533414],"domain_scores_gemma":[0.99927557,0.000080296166,0.00011677859,0.00019789691,0.00024240895,0.00008708148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028336098,0.00012587696,0.00026327444,0.00014293913,0.00005416592,0.000012837132,0.00004070774,0.00009230216,0.00020287881],"category_scores_gemma":[0.00016789178,0.00008961031,0.00004645034,0.00026830105,0.00006806181,0.00010151843,0.00001812844,0.000118258846,0.000020220128],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01437238,0.021403776,0.6593543,0.004052996,0.0007395608,0.00015138325,0.00082835427,0.000004602904,0.28708765,0.00024540914,0.003558063,0.008201481],"study_design_scores_gemma":[0.073368065,0.018871883,0.16108774,0.0013056254,0.0007494928,0.00022034651,0.00007779742,0.0037587099,0.73875666,0.00025036486,0.0011103064,0.00044302683],"about_ca_topic_score_codex":0.000033658856,"about_ca_topic_score_gemma":0.00005375988,"teacher_disagreement_score":0.4982666,"about_ca_system_score_codex":0.000034884157,"about_ca_system_score_gemma":0.00021185057,"threshold_uncertainty_score":0.36542025},"labels":[],"label_agreement":null},{"id":"W2962628474","doi":"10.1182/blood.v130.suppl_1.4537.4537","title":"Toxicity and Outcomes of Autologous Stem Cell Transplant in Multiple Myeloma Patients with Renal Insufficiency: An Institutional Comparison between Two Eras","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Lenalidomide; Multiple myeloma; Dialysis; Internal medicine; Bortezomib; Melphalan; Surgery; Retrospective cohort study; Autologous stem-cell transplantation","score_opus":0.03488918285128841,"score_gpt":0.3012494014383221,"score_spread":0.2663602185870337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2962628474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99881816,0.000046087767,0.00004783129,0.000038059577,0.00001715066,0.0005005935,0.00020440496,0.00001873638,0.00030899583],"genre_scores_gemma":[0.9989545,0.000005176778,0.0008639792,0.000008272296,0.000016498152,0.000015235575,0.00010897286,0.000009650371,0.000017727965],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987269,0.00005058224,0.00027993458,0.0002760297,0.00039281856,0.00027373046],"domain_scores_gemma":[0.9991765,0.00007716374,0.00013721095,0.00033779046,0.000067916444,0.00020342514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000118374555,0.0001590872,0.0004538858,0.00011562289,0.00021417449,0.000023542108,0.0001482819,0.00006545177,0.000005594681],"category_scores_gemma":[0.000029265904,0.00011025475,0.00003522465,0.00005030492,0.00025402138,0.00014640359,0.000042273656,0.00016596186,0.000002582048],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039635532,0.0057262927,0.98666364,0.000060680326,0.000105529994,0.00009007721,0.00042485955,0.000006556945,0.00039568858,0.00001723749,7.509163e-7,0.006112344],"study_design_scores_gemma":[0.025075028,0.0015509301,0.96300274,0.00008357117,0.0001014872,0.0000064761284,0.000024637373,0.0002982384,0.009740162,0.000004506982,0.000007223921,0.000104967694],"about_ca_topic_score_codex":0.00056417787,"about_ca_topic_score_gemma":0.0007422033,"teacher_disagreement_score":0.024678674,"about_ca_system_score_codex":0.00002952943,"about_ca_system_score_gemma":0.00012709772,"threshold_uncertainty_score":0.44960582},"labels":[],"label_agreement":null},{"id":"W2963514687","doi":"10.1182/blood.v130.suppl_1.1460.1460","title":"Genomic Characteristics Clinical Phenotype and Disease Course of TP53 Mutated Diffuse Large B Cell Lymphoma at Diagnosis and Relapse","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Phenotype; Clinical phenotype; Disease; Medicine; Biology; Cancer research; Genetics; Pathology; Gene","score_opus":0.02013525932036717,"score_gpt":0.2905528530478353,"score_spread":0.2704175937274681,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963514687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953442,0.0030633027,5.625157e-7,0.00051330356,0.00012769611,0.00036730253,0.00040892742,0.000023429282,0.00015125984],"genre_scores_gemma":[0.992894,0.0063474122,0.00008676614,0.00021283151,0.00011999205,0.00004668421,0.000083602994,0.000028811217,0.00017991551],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988769,0.000041303112,0.00036677142,0.00035357932,0.0001281031,0.0002333374],"domain_scores_gemma":[0.9982684,0.00017855625,0.00029230092,0.00063928444,0.00005948729,0.00056196324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014101238,0.00019603787,0.0004883975,0.00002926084,0.00021764336,0.000038858485,0.00008624103,0.000100404475,0.00003181763],"category_scores_gemma":[0.00027630248,0.00015388406,0.00010102494,0.000019432713,0.00021726257,0.00005285529,0.00021516113,0.00004709673,0.000022651333],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033159988,0.017935574,0.9746497,0.00013262365,0.00022288245,0.00050576776,0.00011738844,4.928608e-9,0.00017435406,0.000039394217,0.00034851613,0.0055421786],"study_design_scores_gemma":[0.035340626,0.00039383527,0.9595277,0.00011113992,0.0018824433,0.000022060705,0.000016417664,0.000033440563,0.0012804813,0.000028914807,0.0012197361,0.00014321192],"about_ca_topic_score_codex":0.000038391718,"about_ca_topic_score_gemma":0.000013422261,"teacher_disagreement_score":0.035009027,"about_ca_system_score_codex":0.000031584208,"about_ca_system_score_gemma":0.000116078554,"threshold_uncertainty_score":0.627521},"labels":[],"label_agreement":null},{"id":"W2963547298","doi":"10.1182/blood.v130.suppl_1.3123.3123","title":"Treatment Patterns and Associated Outcomes in Patients with Relapsed or Refractory Multiple Myeloma in the US and Non-US Countries: Findings from Preamble","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Daratumumab; Internal medicine; Observational study; Ixazomib; Multiple myeloma; Family medicine; Bortezomib; Oncology; Carfilzomib","score_opus":0.016773592280238402,"score_gpt":0.2749713511974358,"score_spread":0.25819775891719743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963547298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981771,0.000046858124,3.2677298e-7,0.00019737254,0.000021291935,0.0011572009,0.00028352637,0.000013017997,0.0001033126],"genre_scores_gemma":[0.99917305,0.00014382588,0.000066978784,0.00006934128,0.000013232815,0.000120795696,0.00015421327,0.000020488083,0.00023807808],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987425,0.00006274265,0.00020106258,0.00032593342,0.00033652864,0.0003311849],"domain_scores_gemma":[0.99892473,0.00035649122,0.00010913138,0.0004491164,0.00004288051,0.00011763594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011071313,0.00021365676,0.00040139485,0.00008630215,0.00018846878,0.00009974931,0.00011076714,0.00010244992,0.000022245884],"category_scores_gemma":[0.0003727993,0.0001094151,0.000027251255,0.00004460308,0.00008565006,0.00015006035,0.00005360778,0.00014881605,0.00000524859],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001348644,0.0025009608,0.9934118,0.000019771538,0.0003052543,0.0004189493,0.0011436634,7.492251e-8,0.000017575341,2.7998536e-7,0.0000073122446,0.0008257417],"study_design_scores_gemma":[0.058498483,0.0022299595,0.93845123,0.00017664173,0.00012984258,0.0000033036624,0.00010287792,0.000036713904,0.00019896596,0.00000281968,0.000058335234,0.00011083377],"about_ca_topic_score_codex":0.010945268,"about_ca_topic_score_gemma":0.014444655,"teacher_disagreement_score":0.05714984,"about_ca_system_score_codex":0.00011844845,"about_ca_system_score_gemma":0.00007253105,"threshold_uncertainty_score":0.99564093},"labels":[],"label_agreement":null},{"id":"W2963593007","doi":"10.1182/blood.v130.suppl_1.5634.5634","title":"Incidence of Venous Thromboembolism in Acute Leukemia: A Systematic Review and Meta-Analysis","year":2017,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Internal medicine; Acute promyelocytic leukemia; Incidence (geometry); Hazard ratio; Acute leukemia; Leukemia; Myeloid leukemia; Observational study; Randomized controlled trial; Confidence interval; Gastroenterology; Meta-analysis; Cancer","score_opus":0.09808677125668032,"score_gpt":0.3817355586337651,"score_spread":0.2836487873770848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963593007","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012932952,0.9934187,0.0000029307673,0.00008032548,0.000027146316,0.005668736,0.0000805665,0.00002357289,0.0006851056],"genre_scores_gemma":[0.00014718233,0.9975774,0.00015672017,0.00031793496,0.00002273764,0.0013025969,0.000060108658,0.000054478598,0.00036082193],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.996263,0.000312329,0.0018807466,0.0006908897,0.000496862,0.00035613595],"domain_scores_gemma":[0.9955776,0.00017766777,0.0019247588,0.0020535209,0.00011836529,0.00014810014],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0012896565,0.0006281305,0.029674435,0.0006352441,0.00006949851,0.000042787273,0.000546606,0.00029677147,0.00011607037],"category_scores_gemma":[0.0003409622,0.00040924014,0.003138974,0.00066005293,0.000111772904,0.00008945451,0.00032310942,0.00041100028,0.00003087665],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[3.321833e-7,0.00046903008,0.0000012959555,0.7059077,0.29247308,0.00018409615,0.0000449862,6.936356e-8,3.995951e-8,0.00008696006,0.00008066282,0.0007517297],"study_design_scores_gemma":[0.00024460908,0.00011701509,0.00005183537,0.13598035,0.8575035,0.00013568328,0.000005514501,3.58869e-7,4.1845448e-7,0.000015299425,0.0056870235,0.00025841303],"about_ca_topic_score_codex":0.00025692803,"about_ca_topic_score_gemma":0.00008194431,"teacher_disagreement_score":0.56992733,"about_ca_system_score_codex":0.00010217669,"about_ca_system_score_gemma":0.00034558907,"threshold_uncertainty_score":0.99983597},"labels":[],"label_agreement":null},{"id":"W2963628757","doi":"10.1182/blood-2018-99-118162","title":"Ubiquitin-Activating Enzyme E1 Inhibition Caused Acute Leukemia Cell Apoptosis By Affecting CHOP Pathway","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Endoplasmic Reticulum Stress and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"CHOP; K562 cells; Endoplasmic reticulum; Apoptosis; Small hairpin RNA; Myeloid leukemia; Leukemia; Cancer research; Biology; Molecular biology; Transfection; U937 cell; Chemistry; Cell culture; Immunology; Cell biology; Biochemistry; Gene knockdown","score_opus":0.005288154207226064,"score_gpt":0.21873898027873415,"score_spread":0.2134508260715081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963628757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99285495,0.0001938282,0.00045602772,0.00003566751,0.00011560703,0.00016910274,0.000095802585,0.000042129715,0.0060368627],"genre_scores_gemma":[0.9981391,0.00005657899,0.000298034,0.00026262863,0.00055067154,0.000036185884,0.000256664,0.0000382255,0.00036190826],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99879545,0.000059454287,0.0002066239,0.0004373922,0.00014546548,0.00035564214],"domain_scores_gemma":[0.9993103,0.000020032749,0.00014032463,0.0002991535,0.00008083386,0.00014935307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000978117,0.00020859404,0.00014934101,0.00002804761,0.00019799436,0.00005374806,0.00010370532,0.00016354499,0.000046105786],"category_scores_gemma":[0.000075929514,0.00020466089,0.000102919745,0.000087991866,0.000078038036,0.0000085755055,0.00011041336,0.00010461088,0.000023742909],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029231485,0.00014389,0.0010868203,0.00002583303,0.000055459677,0.000005432908,0.00007080851,0.0000021791873,0.9953697,0.000008916339,0.0027764747,0.00042528627],"study_design_scores_gemma":[0.0017582335,0.00032197667,0.00022252151,0.00003569664,0.00006675965,0.00000874248,0.00012735583,0.000024848301,0.9954346,0.000011947902,0.0017276256,0.00025968332],"about_ca_topic_score_codex":0.00003893347,"about_ca_topic_score_gemma":0.000008888277,"teacher_disagreement_score":0.0056749545,"about_ca_system_score_codex":0.000022839615,"about_ca_system_score_gemma":0.000089623296,"threshold_uncertainty_score":0.83458287},"labels":[],"label_agreement":null},{"id":"W2964426877","doi":"10.1182/blood-2018-99-116600","title":"Efficacy and Adverse Reactions of Gemcitabine Combined with Cyclophosphamide, Vinblastine and Prednisone Hydrogenation Regiments in Relapse and/or Refractory Non-Hodgkin's Lymphoma","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Mitoxantrone; Gastroenterology; Internal medicine; Vinblastine; Prednisolone; Cyclophosphamide; Surgery; Chemotherapy; Gemcitabine; CHOP","score_opus":0.008263935582247806,"score_gpt":0.23970893129106874,"score_spread":0.23144499570882093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964426877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982495,0.0003760848,0.0000041690646,0.00016004086,0.000033881064,0.0006247867,0.0000104470255,0.000028048851,0.0005130727],"genre_scores_gemma":[0.9980688,0.0005493883,0.000905195,0.000051187737,0.00003884729,0.00005681194,0.000023212797,0.00002240074,0.000284138],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990318,0.00003617812,0.00028945366,0.0002970526,0.00017581637,0.00016971021],"domain_scores_gemma":[0.99923724,0.00014484477,0.00015832578,0.00023703171,0.00008233613,0.00014022151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013220409,0.00018011377,0.00033110575,0.00014160012,0.000086558575,0.000008029913,0.000028242048,0.000084337036,0.000013832441],"category_scores_gemma":[0.00010684324,0.00012925413,0.000018538816,0.00020959758,0.00019390504,0.00011917565,0.000046567926,0.000056969915,0.000002240595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014400983,0.017658954,0.9234294,0.00047170438,0.00093249045,0.00044362617,0.0022855697,0.0000021313938,0.024303606,0.00012971647,0.00019112969,0.015750632],"study_design_scores_gemma":[0.0555306,0.007067223,0.91648173,0.0005582301,0.00040558135,0.00023888734,0.00013336519,0.00007251375,0.018993303,0.00001755132,0.00036919452,0.00013182557],"about_ca_topic_score_codex":0.00027389603,"about_ca_topic_score_gemma":0.000108508306,"teacher_disagreement_score":0.04112962,"about_ca_system_score_codex":0.00005520864,"about_ca_system_score_gemma":0.00007262976,"threshold_uncertainty_score":0.52708304},"labels":[],"label_agreement":null},{"id":"W2964488893","doi":"10.1182/blood.2019001279","title":"Lysine acetyltransferase Tip60 is required for hematopoietic stem cell maintenance","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; Medical Research Council; Cancer Research UK; Wellcome Trust","keywords":"Biology; Histone acetyltransferase; Chromatin; Stem cell; Haematopoiesis; Cell biology; Epigenetics; Acetyltransferase; Progenitor cell; Acetylation; Molecular biology; Cancer research; Genetics; Gene","score_opus":0.017648706258888442,"score_gpt":0.23565348795089924,"score_spread":0.2180047816920108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964488893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95866716,0.0026814116,0.035701226,0.0016217234,0.00006264361,0.00034324746,0.00008805193,0.000020431788,0.0008141095],"genre_scores_gemma":[0.9964008,0.00034371004,0.0014317397,0.0007984678,0.00023225012,0.000033098742,0.00008344099,0.000030100397,0.00064644526],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991511,0.00002122299,0.00019294658,0.00033795612,0.00008823245,0.00020851725],"domain_scores_gemma":[0.9995182,0.000011390963,0.000049990915,0.00023079834,0.0000753586,0.0001142315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008148925,0.00013166523,0.00014012569,0.0000119921415,0.000053794796,0.000019249286,0.00013454807,0.000109053115,0.000015504165],"category_scores_gemma":[0.0000168456,0.00012761845,0.00011665785,0.00007086193,0.000025989295,0.0000023162474,0.00003241717,0.000041416377,0.000014860185],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052937285,0.00009716346,0.00026024508,0.00008317333,0.000030727613,0.0000018964251,0.00021619798,0.0000157908,0.9974299,0.000034109413,0.00091342384,0.00086444116],"study_design_scores_gemma":[0.0017221671,0.00040090558,0.000043433978,0.000007551683,0.000057698533,0.0000013445449,0.000056248547,0.00008597684,0.9655374,0.000090793634,0.031832527,0.00016393587],"about_ca_topic_score_codex":0.0000016476658,"about_ca_topic_score_gemma":0.0000016275412,"teacher_disagreement_score":0.037733592,"about_ca_system_score_codex":0.0000028136265,"about_ca_system_score_gemma":0.000036522084,"threshold_uncertainty_score":0.520413},"labels":[],"label_agreement":null},{"id":"W2964527614","doi":"10.1182/blood-2018-99-113026","title":"Marcks Inhibition By a Peptide Inhibitor, MPS, Cooperates with Bortezomib to Effectively Eliminate Drug Resistance in Multiple Myeloma","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"MARCKS; Bortezomib; Cancer research; Proteasome inhibitor; Cytotoxic T cell; Pharmacology; Drug resistance; Carfilzomib; Medicine; Chemistry; Multiple myeloma; Biology; Molecular biology; Phosphorylation; Myristoylation; Immunology; Biochemistry; In vitro","score_opus":0.009708367469993708,"score_gpt":0.25451907581628086,"score_spread":0.24481070834628715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964527614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945471,0.00036709858,0.000046233115,0.00083995634,0.00003241991,0.0015602472,0.000077229284,0.00008692059,0.0024427688],"genre_scores_gemma":[0.993329,0.000028985572,0.0028590544,0.00025034262,0.00014658365,0.00035085337,0.00012652714,0.000052960113,0.0028557156],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979585,0.00012396008,0.00027564616,0.0005779157,0.0004555928,0.00060839404],"domain_scores_gemma":[0.99876416,0.00015677276,0.00005999289,0.000347911,0.00028892825,0.00038221275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026262895,0.0002823445,0.00037715957,0.00022988337,0.00015313408,0.00004790422,0.00008363452,0.00007020233,0.000051644663],"category_scores_gemma":[0.00033581458,0.00022008206,0.000048569826,0.0005727383,0.00016467374,0.00014311387,0.00006874519,0.00023181445,0.00021694513],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01457979,0.0056046695,0.62278235,0.00044371834,0.00047744205,0.0027808477,0.0022826437,0.0000011064468,0.32381165,0.00005164783,0.022477506,0.0047066235],"study_design_scores_gemma":[0.023712095,0.0019979114,0.37997898,0.0010612581,0.000092133705,0.00006247357,0.00014729913,0.000043318745,0.5889803,0.000025327849,0.0035626863,0.00033618108],"about_ca_topic_score_codex":0.00037627833,"about_ca_topic_score_gemma":0.0042265565,"teacher_disagreement_score":0.2651687,"about_ca_system_score_codex":0.00014330707,"about_ca_system_score_gemma":0.00013122275,"threshold_uncertainty_score":0.89746857},"labels":[],"label_agreement":null},{"id":"W2964541799","doi":"10.1182/blood.v128.22.4506.4506","title":"IKZF1/3 Protein Expressions Are Associated with a Better Survival in Relapsed/Refractory Multiple Myeloma Patients Treated with Lenalidomide","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Lenalidomide; Multiple myeloma; Bortezomib; Thalidomide; Medicine; Bone marrow; Internal medicine; Oncology; Cancer research; Immunology","score_opus":0.018945569644428065,"score_gpt":0.2451466673186635,"score_spread":0.22620109767423544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964541799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99721974,0.000036592028,0.000008713187,0.00030172334,0.00001400819,0.0016124188,0.00015856043,0.00011271806,0.00053553696],"genre_scores_gemma":[0.99744356,0.000005711823,0.00028885296,0.000048718714,0.00004376415,0.00046926056,0.00012976967,0.00007315297,0.0014971998],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975269,0.00023968727,0.00031220703,0.0005243819,0.00072460226,0.0006722488],"domain_scores_gemma":[0.99844265,0.0002877213,0.00019397006,0.00046834841,0.00024883254,0.000358467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014666007,0.00033321374,0.0005091413,0.00022575339,0.00010454262,0.00002044445,0.00012288243,0.00016066525,0.00012234075],"category_scores_gemma":[0.0007087753,0.00016713123,0.000072075236,0.0003369367,0.00012546792,0.00013984862,0.000054206463,0.0002616532,0.000058094825],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003099226,0.0048567336,0.97036505,0.000026799913,0.00045429997,0.0009168135,0.000082185055,2.283532e-7,0.018403042,0.000001005967,0.00005949206,0.0017351375],"study_design_scores_gemma":[0.07342839,0.0017358992,0.89607567,0.0021570795,0.00011981098,0.0000079617585,0.000041340267,0.000005875585,0.026087021,0.0000042471206,0.00010131836,0.00023541684],"about_ca_topic_score_codex":0.00022006551,"about_ca_topic_score_gemma":0.0009514391,"teacher_disagreement_score":0.0742894,"about_ca_system_score_codex":0.00019130204,"about_ca_system_score_gemma":0.00013704173,"threshold_uncertainty_score":0.6815414},"labels":[],"label_agreement":null},{"id":"W2964704906","doi":"10.1182/blood.v130.suppl_1.607.607","title":"Survival By Race/Ethnicity in Children and Adolescents with Hodgkin Lymphoma Treated on Cooperative Group Trials in the U.S. and Canada: A Pooled Analysis of Children's Oncology Group Trials","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cog; Internal medicine; Ethnic group; Population; Clinical trial; Hazard ratio; Demography; Incidence (geometry); Cancer; Proportional hazards model; Oncology; Confidence interval","score_opus":0.021316472089275548,"score_gpt":0.29346448360750743,"score_spread":0.27214801151823187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964704906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996351,0.0008356703,9.704253e-7,0.0005590713,0.000021312218,0.0017671017,0.00039022975,0.0000065424333,0.00006809522],"genre_scores_gemma":[0.9987055,0.000663429,0.000016488408,0.00021178658,0.000042702843,0.00010679065,0.00023335346,0.000014348019,0.0000055879445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962763,0.0018291873,0.0008037255,0.00047645852,0.00034277624,0.00027155588],"domain_scores_gemma":[0.99800575,0.000818993,0.00054044666,0.0004668099,0.000048514044,0.000119499105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027518473,0.0002981513,0.0024501954,0.00022749398,0.00013272116,0.000048220118,0.00015545427,0.00014575117,0.000008735825],"category_scores_gemma":[0.0010453803,0.00016373249,0.00013089471,0.00027806737,0.00016595935,0.00005839779,0.000048275673,0.000102859485,2.29733e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020919612,0.004531515,0.98375195,0.000009282689,0.0042144004,0.00009514963,0.00022477747,0.0000019620015,0.00025342059,0.00002648014,0.00007947544,0.004719598],"study_design_scores_gemma":[0.05567198,0.0016990645,0.9329671,0.00018189735,0.0075231907,0.000030337036,0.00008667552,0.000010106511,0.00167593,0.0000016274915,0.0000057661846,0.00014628367],"about_ca_topic_score_codex":0.5650853,"about_ca_topic_score_gemma":0.6497204,"teacher_disagreement_score":0.084635094,"about_ca_system_score_codex":0.0001907332,"about_ca_system_score_gemma":0.0002535313,"threshold_uncertainty_score":0.66768175},"labels":[],"label_agreement":null},{"id":"W2964823446","doi":"10.1182/blood.v130.suppl_1.3100.3100","title":"A Phase 1b Study to Assess the Combination of Selinexor and Daratumumab in Patients with Relapsed / Refractory Multiple Myeloma Previously Exposed to Proteasome Inhibitors (PI) and Immunomodulatory Drugs (IMiDs)","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hôpital Maisonneuve-Rosemont; Vancouver General Hospital; CancerCare Manitoba; University of Toronto; Royal Victoria Hospital; Dalhousie University","funders":"","keywords":"Daratumumab; Medicine; Internal medicine; Regimen; Phases of clinical research; Pomalidomide; Lenalidomide; Clinical endpoint; Carfilzomib; Multiple myeloma; Adverse effect; Oncology; Nausea; Neutropenia; Gastroenterology; Clinical trial; Toxicity","score_opus":0.02393189601697607,"score_gpt":0.3035758967366704,"score_spread":0.2796440007196943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964823446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99298507,0.0001435614,0.0000034684467,0.0001282409,0.000035607594,0.0066091493,0.000023502613,0.000020395846,0.000051019462],"genre_scores_gemma":[0.999167,0.000010116265,0.00029134468,0.000026936823,0.00002511106,0.00036981562,0.000023428724,0.00003108724,0.00005515419],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982568,0.00016290156,0.0003437353,0.00040654535,0.000535994,0.00029403972],"domain_scores_gemma":[0.9984341,0.00010697826,0.00019259444,0.0007641135,0.00024559733,0.00025659538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047522146,0.00021623849,0.00039253425,0.00019337125,0.0002595272,0.000071928705,0.00017195306,0.00005239975,0.0000027404103],"category_scores_gemma":[0.00063960603,0.00014058458,0.000027685703,0.00013238365,0.00010207554,0.00021065037,0.0001784036,0.00020445714,0.0000030743054],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004560238,0.028079242,0.9405446,0.00010890964,0.00024735028,0.00004902448,0.005160492,4.0607085e-7,0.00476759,0.0000024023898,0.000024323657,0.016455391],"study_design_scores_gemma":[0.094672956,0.011272377,0.88730496,0.0002899559,0.00010523006,0.0000031133668,0.0006021345,0.000041861407,0.0055369707,0.0000030313224,0.000031761494,0.00013565205],"about_ca_topic_score_codex":0.0002060102,"about_ca_topic_score_gemma":0.00014705067,"teacher_disagreement_score":0.090112716,"about_ca_system_score_codex":0.000063064384,"about_ca_system_score_gemma":0.00010130914,"threshold_uncertainty_score":0.5732873},"labels":[],"label_agreement":null},{"id":"W2964967733","doi":"10.1182/blood.v130.suppl_1.1622.1622","title":"Interim Results of the Canadian Tyrosine Kinase Inhibitor Discontinuation Trial for 2nd Attempt of Treatment Free Remission: Treatment Free Remission Accomplished By Dasatinib (TRAD)","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; London Health Sciences Centre; CancerCare Manitoba; University Health Network; Ottawa Hospital; University of Alberta Hospital; Alberta Hospital Edmonton; McGill University Health Centre; Hôpital de l'Enfant-Jésus; Juravinski Hospital; Hôpital Maisonneuve-Rosemont; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; University of Calgary; BC Cancer Agency","funders":"","keywords":"Discontinuation; Medicine; Dasatinib; Internal medicine; Interim analysis; Imatinib mesylate; Tyrosine-kinase inhibitor; Imatinib; Oncology; Gastroenterology; Clinical trial; Cancer; Myeloid leukemia","score_opus":0.04639728352886525,"score_gpt":0.3133246904818379,"score_spread":0.2669274069529727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964967733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98722637,0.00033640058,0.0000035355558,0.0042251986,0.0005109322,0.0036125574,0.0016839406,0.000025753661,0.002375286],"genre_scores_gemma":[0.9939672,0.000057173096,0.0007794541,0.000029286115,0.00050812424,0.00022906398,0.0005586104,0.000048652862,0.0038224338],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99770296,0.00008432375,0.0008794814,0.0005676456,0.000379252,0.00038633475],"domain_scores_gemma":[0.9954976,0.00016592687,0.0009020731,0.0029097674,0.00017033872,0.00035429126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025870552,0.0003890105,0.0007596296,0.00009560054,0.00043418654,0.00005291736,0.00052736513,0.00023535741,0.000056663805],"category_scores_gemma":[0.0015506836,0.00023795666,0.0003588684,0.0000852709,0.0001787529,0.00012531197,0.00013002873,0.00010529974,0.000001738039],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12849677,0.025395073,0.038628824,0.0006736688,0.004147796,0.00015696637,0.006608758,0.000009248214,0.53799266,0.00014530146,0.15093721,0.10680774],"study_design_scores_gemma":[0.38115984,0.007913667,0.01387022,0.0010540962,0.0012894945,0.000018314357,0.000100861536,0.00006130723,0.5790332,0.00008409634,0.015173394,0.00024149822],"about_ca_topic_score_codex":0.09853432,"about_ca_topic_score_gemma":0.07523204,"teacher_disagreement_score":0.25266308,"about_ca_system_score_codex":0.002007772,"about_ca_system_score_gemma":0.0016301351,"threshold_uncertainty_score":0.9703591},"labels":[],"label_agreement":null},{"id":"W2966084920","doi":"10.1182/blood.v130.suppl_1.2880.2880","title":"Dasatinib Induced Reversible Nephrotic Range Proteinuria Occurs More Frequently Compared to Other Tyrosine Kinase Inhibitors in the Treatment of Chronic Myeloid Leukemia","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Dasatinib; Medicine; Proteinuria; Ponatinib; Bosutinib; Nilotinib; Nephrotic syndrome; Internal medicine; Discontinuation; Gastroenterology; Myeloid leukemia; Imatinib; Kidney","score_opus":0.03632181369499163,"score_gpt":0.3000526370663322,"score_spread":0.2637308233713406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966084920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918812,0.001103047,0.0000020577381,0.0011677335,0.00015902388,0.0042324304,0.00005832027,0.000047501988,0.0013486954],"genre_scores_gemma":[0.99775445,0.00006356233,0.00048771477,0.00024215833,0.0004253386,0.0005241055,0.000040573992,0.00005915192,0.00040292484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99777925,0.00010689941,0.00054269284,0.00052957167,0.00050755235,0.00053400616],"domain_scores_gemma":[0.99747795,0.00007518866,0.00035392764,0.0018178764,0.00008150492,0.00019356233],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023396587,0.00041537292,0.00074364274,0.00018555121,0.00020505782,0.000055465785,0.0004546154,0.00017485603,0.00014370376],"category_scores_gemma":[0.000129544,0.0002898549,0.00019643441,0.00025742344,0.00016361164,0.00013214267,0.0000627947,0.0002052062,0.00008304235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022835974,0.018029267,0.540565,0.0010643458,0.001899578,0.0021399227,0.025436278,0.00010741208,0.37780973,0.00017122501,0.0034638199,0.0270298],"study_design_scores_gemma":[0.092756934,0.0076101953,0.4470388,0.0021555934,0.0015084733,0.00015324731,0.0010041624,0.00015771484,0.4364606,0.000053774842,0.010320542,0.0007799432],"about_ca_topic_score_codex":0.005631565,"about_ca_topic_score_gemma":0.0011704095,"teacher_disagreement_score":0.09352622,"about_ca_system_score_codex":0.002438295,"about_ca_system_score_gemma":0.0010080506,"threshold_uncertainty_score":0.99995536},"labels":[],"label_agreement":null},{"id":"W2966217223","doi":"10.1182/blood.v130.suppl_1.4922.4922","title":"Catheter-Directed Thrombolysis for Acute Deep Vein Thrombosis: Experience from a Canadian Thrombosis Referral Centre","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Thrombolysis; Thrombosis; Post-thrombotic syndrome; Thrombus; Surgery; Deep vein; Retrospective cohort study; Venous thrombosis; Medical record; Internal medicine; Myocardial infarction","score_opus":0.032746438030498426,"score_gpt":0.312616119727419,"score_spread":0.27986968169692056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966217223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98674524,0.00030322804,0.00005522138,0.0035699373,0.0005988567,0.0013628744,0.00029655723,0.0002503408,0.006817716],"genre_scores_gemma":[0.99295306,0.000533344,0.0036744257,0.0013111577,0.00044368647,0.00040439967,0.00026349918,0.000097029515,0.00031936684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971804,0.000044675227,0.00045830227,0.00090315833,0.00040905082,0.0010044121],"domain_scores_gemma":[0.99689066,0.000064225125,0.00028553707,0.0018695521,0.00020620436,0.00068378955],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015023645,0.00045595027,0.0011221806,0.0001883899,0.0011114135,0.00031234647,0.00073356106,0.00024788216,0.00077251974],"category_scores_gemma":[0.00015720013,0.0004186293,0.0004108546,0.00013426437,0.00019581919,0.00033260515,0.00018641744,0.00020394035,0.00012124584],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039035603,0.035016064,0.6351546,0.00076513836,0.049659234,0.00085176615,0.078901835,0.000015842403,0.07958073,0.006456745,0.09770516,0.015502541],"study_design_scores_gemma":[0.006205161,0.00061940984,0.95042807,0.00037183418,0.0076999473,0.000009152454,0.0022859594,0.00028666432,0.017522678,0.00044283675,0.013270098,0.00085816195],"about_ca_topic_score_codex":0.13435803,"about_ca_topic_score_gemma":0.15717329,"teacher_disagreement_score":0.31527352,"about_ca_system_score_codex":0.00018404053,"about_ca_system_score_gemma":0.0002227304,"threshold_uncertainty_score":0.99982655},"labels":[],"label_agreement":null},{"id":"W2966411388","doi":"10.1182/blood.2018890764","title":"Inherited genetic susceptibility to acute lymphoblastic leukemia in Down syndrome","year":2019,"lang":"en","type":"review","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"National Center for Chronic Disease Prevention and Health Promotion; National Institute of General Medical Sciences; University of California, San Diego; University of California, Davis; Centers for Disease Control and Prevention; National Institutes of Health; National Institute of Environmental Health Sciences; University of California, Los Angeles; American Lebanese Syrian Associated Charities; University of Washington; California Department of Public Health; Pediatric Cancer Research Foundation; Washington State University; Pride Foundation; Children's Hospital Los Angeles; National Cancer Institute; Kaiser Permanente; Cancer Prevention and Research Institute of Texas; University of Southern California; Cedars-Sinai Medical Center; Alex's Lemonade Stand Foundation for Childhood Cancer; University of California, San Francisco; Children's Hospital of Philadelphia","keywords":"Allele; Penetrance; Biology; CDKN2A; Genetics; Genome-wide association study; Locus (genetics); Immunology; Single-nucleotide polymorphism; Gene; Genotype; Phenotype","score_opus":0.034443591233482514,"score_gpt":0.3287497320057195,"score_spread":0.294306140772237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966411388","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03325905,0.9589703,0.000058196056,0.000036715723,0.00035606965,0.005943167,0.00022294275,0.00018656674,0.00096696016],"genre_scores_gemma":[0.0015260959,0.992434,0.0016024698,0.00021153109,0.00026218235,0.0005688774,0.00030870448,0.00030290577,0.0027831816],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9936899,0.0003707883,0.0016285131,0.0017334883,0.0011613057,0.0014160251],"domain_scores_gemma":[0.99574757,0.0006820525,0.00029180196,0.002268165,0.00019305987,0.0008173598],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005457611,0.0010526851,0.0044312403,0.0012027954,0.000056730783,0.00007642585,0.00090656086,0.0011135121,0.00050798914],"category_scores_gemma":[0.0007320958,0.0008642821,0.0007517593,0.0023209837,0.00016199717,0.0000752906,0.00071192195,0.001139963,0.005351877],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0006280787,0.0029755486,0.0018548502,0.19057085,0.00630069,0.037878968,0.0004324427,0.000041509116,0.00020461397,0.000030777923,0.0054857163,0.75359595],"study_design_scores_gemma":[0.020135447,0.0037206553,0.0077445097,0.073914655,0.017744029,0.030776564,0.00003647204,0.0002295011,0.000021192945,0.000029422765,0.8428939,0.0027536724],"about_ca_topic_score_codex":0.0003587281,"about_ca_topic_score_gemma":0.000067530345,"teacher_disagreement_score":0.8374082,"about_ca_system_score_codex":0.0077923825,"about_ca_system_score_gemma":0.011487176,"threshold_uncertainty_score":0.99938077},"labels":[],"label_agreement":null},{"id":"W2966593132","doi":"10.1182/blood.2019000773","title":"Effect of donor, component, and recipient characteristics on hemoglobin increments following red blood cell transfusion","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Hemoglobin; Yield (engineering); Medicine; Blood transfusion; Blood component; Red Blood Cell Transfusion; Transfusion reaction; Red blood cell; Immunology; Internal medicine; Intensive care medicine; Physics","score_opus":0.004101859236137473,"score_gpt":0.21500246623436822,"score_spread":0.21090060699823074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966593132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940843,0.00035652836,0.00000248514,0.00012314951,0.0003099209,0.0008939802,0.000012105042,0.00003813323,0.0041794176],"genre_scores_gemma":[0.998908,0.0005372014,0.000081584374,0.00010876402,0.000029585086,0.00000847189,0.000050106486,0.00002798627,0.00024834642],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987355,0.00009191107,0.00033887834,0.0002991311,0.0002906287,0.00024397136],"domain_scores_gemma":[0.9993654,0.0000882796,0.00010437313,0.00028677736,0.000025491741,0.00012969463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032111065,0.00020453661,0.0004951837,0.000100773024,0.00005460211,0.000009367552,0.00006566163,0.00016808072,0.000055369062],"category_scores_gemma":[0.000033868324,0.00015853449,0.00015313913,0.00013093802,0.000027218239,0.00003139425,0.000036396916,0.0002299403,0.000030264106],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009546868,0.0017978565,0.2842089,0.0008503283,0.00029723148,0.00008745354,0.00027655825,0.0000014104227,0.7087707,0.000008066347,0.000055330336,0.0026915022],"study_design_scores_gemma":[0.058065195,0.012076357,0.09359565,0.0019660483,0.0028842536,0.000084536805,0.0001148405,0.00013136622,0.8290708,0.00000710091,0.0015455027,0.00045836356],"about_ca_topic_score_codex":0.00003190096,"about_ca_topic_score_gemma":5.0987796e-7,"teacher_disagreement_score":0.19061325,"about_ca_system_score_codex":0.000014847066,"about_ca_system_score_gemma":0.000022278673,"threshold_uncertainty_score":0.6464849},"labels":[],"label_agreement":null},{"id":"W2966611796","doi":"10.1182/blood-2018-99-111377","title":"Predictors of Hydroxyurea Use in Children with Sickle Cell Disease","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"","keywords":"Medicine; Hydroxycarbamide; Sickle cell anemia; Acute chest syndrome; Anemia; Pediatrics; Hemoglobinopathy; Fetal hemoglobin; Thalassemia; Medical prescription; Disease; Internal medicine; Pharmacology; Pregnancy","score_opus":0.004401614427260784,"score_gpt":0.1919033112348214,"score_spread":0.18750169680756062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966611796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99722874,0.00029084735,0.000003727097,0.0000646097,0.00003303771,0.00029221553,0.000012601381,0.000031425756,0.0020428041],"genre_scores_gemma":[0.9993107,0.000042755924,0.00010455664,0.000089207075,0.00006063049,0.0000048352717,0.000022819397,0.000017276472,0.00034726723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993677,0.000013982149,0.0001423054,0.00015296631,0.00015673415,0.0001662747],"domain_scores_gemma":[0.99953336,0.0000100254665,0.000043870747,0.00023280997,0.000029421204,0.00015050113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000042439853,0.00009328065,0.00015668453,0.00007129234,0.000020293892,0.0000044007656,0.00004866851,0.00006189073,0.000040377272],"category_scores_gemma":[0.000028936258,0.00006464398,0.00004662133,0.0001885731,0.00011297759,0.000048281494,0.000018488743,0.0001012332,0.000017985381],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000103206745,0.0010073327,0.9977832,0.000021999072,0.00009261044,0.000027489552,0.0001687763,0.000003902708,0.00054444984,0.000008371558,0.00019388323,0.00004479026],"study_design_scores_gemma":[0.005971162,0.00064015196,0.987338,0.00012536671,0.00044964976,0.000012146988,0.000049320843,0.000027732573,0.0050238315,0.0000101863125,0.0002529109,0.00009953577],"about_ca_topic_score_codex":0.00013765096,"about_ca_topic_score_gemma":0.000021121408,"teacher_disagreement_score":0.010445183,"about_ca_system_score_codex":0.0000061527494,"about_ca_system_score_gemma":0.000085535496,"threshold_uncertainty_score":0.2636105},"labels":[],"label_agreement":null},{"id":"W2966646582","doi":"10.1182/blood.2019000190","title":"Genetic determinants of VWF clearance and FVIII binding modify FVIII pharmacokinetics in pediatric hemophilia A patients","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto; Queen's University","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research","keywords":"Von Willebrand factor; ABO blood group system; Internal medicine; Medicine; Population; Pharmacokinetics; Coagulation; Immunology; Von Willebrand disease; Endocrinology; Platelet","score_opus":0.008522998697468875,"score_gpt":0.2458837718655428,"score_spread":0.23736077316807394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966646582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982676,0.00070256524,3.6309626e-7,0.000010563768,0.00007335782,0.00045381775,0.000017323722,0.00001080788,0.00046363816],"genre_scores_gemma":[0.9987632,0.0008303386,0.00022445647,0.00003562103,0.000023507182,0.000008341878,0.0000063065354,0.000019708981,0.00008850799],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991104,0.000014780708,0.00025224424,0.0002289237,0.00017197503,0.00022170023],"domain_scores_gemma":[0.99962705,0.000021593738,0.00009397038,0.00015074613,0.000032125383,0.00007452262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000036400947,0.00013087658,0.0003240582,0.00014629528,0.000018081017,0.0000052336295,0.000054193442,0.00006690185,0.000017675302],"category_scores_gemma":[0.000016377395,0.00011995593,0.00003772552,0.00019134498,0.000021124131,0.000039755017,0.00003971339,0.0000895285,0.000031029434],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008998542,0.0010061123,0.99377537,0.00022136062,0.000024302508,0.000116751784,0.000115889234,0.0000035634903,0.0007140765,0.0000012162631,0.000006833294,0.003924519],"study_design_scores_gemma":[0.013860855,0.00045085436,0.9823171,0.00007619103,0.00021236246,0.00003044971,0.0000105452455,0.0002847378,0.002598782,0.000023117955,0.000022900496,0.00011212823],"about_ca_topic_score_codex":0.000030512323,"about_ca_topic_score_gemma":0.000010473443,"teacher_disagreement_score":0.01377087,"about_ca_system_score_codex":0.000010984232,"about_ca_system_score_gemma":0.000033258784,"threshold_uncertainty_score":0.48916605},"labels":[],"label_agreement":null},{"id":"W2966652102","doi":"10.1182/blood-2018-99-118474","title":"An Exploratory Study of Cytokine Markers of Cancer-Related Cognitive Impairment in Hematological Malignancy","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Context (archaeology); Cancer; Internal medicine; Cytokine; Multiple myeloma; Malignancy; Oncology; Immunology; Biology","score_opus":0.021105305703385514,"score_gpt":0.3125161405777257,"score_spread":0.29141083487434016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966652102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962725,0.00060336216,0.000003767332,0.00007495146,0.00012789152,0.0018942055,0.000050093473,0.00007589819,0.0008973173],"genre_scores_gemma":[0.99934506,0.00014506538,0.000052697545,0.00006389832,0.000059872404,0.0002691046,0.000010237815,0.000028584334,0.000025470055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979013,0.00018655726,0.00074280164,0.00042795064,0.00040416632,0.0003372263],"domain_scores_gemma":[0.99869496,0.0001078243,0.00031234135,0.00025917523,0.00050611974,0.00011956866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032671666,0.00025027402,0.00075866224,0.00027925093,0.000049932845,0.0000032190987,0.00010301813,0.00012337086,0.00028845805],"category_scores_gemma":[0.00010796391,0.00021357035,0.000085555504,0.000653964,0.00030806303,0.00009128764,0.00008784036,0.0002067809,0.0000097765305],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002900757,0.027878275,0.9472593,0.00022622694,0.0016452,0.00023467596,0.013279221,0.0000012913232,0.005689998,0.000015155182,0.00008852107,0.0007813474],"study_design_scores_gemma":[0.030908024,0.02666503,0.8585102,0.0014935257,0.0014898701,0.000037255108,0.028248245,0.00003079147,0.052299146,0.000043777563,0.000007826577,0.00026630808],"about_ca_topic_score_codex":0.0001974966,"about_ca_topic_score_gemma":0.0005614209,"teacher_disagreement_score":0.088749126,"about_ca_system_score_codex":0.000082278486,"about_ca_system_score_gemma":0.00015764506,"threshold_uncertainty_score":0.8709146},"labels":[],"label_agreement":null},{"id":"W2966760111","doi":"10.1182/blood.v130.suppl_1.2524.2524","title":"The Thymidine Dideoxynucleoside Analogue, Alovudine, Inhibits the Mitochondrial DNA Polyermase, POLG, Impairs Oxidative Phosphorylation and Promotes Monocytic Differentiation in AML","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Biology; Mitochondrial DNA; Molecular biology; Mitochondrion; Respiratory chain; Oxidative phosphorylation; Phosphorylation; Nuclear DNA; DNA polymerase; DNA replication; DNA; Cell biology; Biochemistry; Gene","score_opus":0.016856302334789113,"score_gpt":0.27751911610081714,"score_spread":0.260662813766028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966760111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99003786,0.0006471922,0.000031086103,0.0071899467,0.00012799242,0.0012943982,0.000025674062,0.00003954041,0.00060634076],"genre_scores_gemma":[0.99842644,0.00035044653,0.0001670484,0.000106321866,0.00036022742,0.0000925088,0.00006502689,0.000034947647,0.000397064],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981905,0.00015619115,0.00037657292,0.0003829793,0.0004393298,0.00045440724],"domain_scores_gemma":[0.99825954,0.00038228516,0.00027233886,0.0008124163,0.00013468254,0.00013876206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045518085,0.00023717283,0.000303106,0.00012151452,0.0008421876,0.00026855234,0.00034036735,0.0001344699,0.000018537385],"category_scores_gemma":[0.0014610065,0.00013512187,0.000082535444,0.00018523974,0.00035842563,0.00028846733,0.0002683908,0.00048929435,0.00002362201],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022710492,0.0010093446,0.28709835,0.00014882772,0.0007972793,0.00013316025,0.003440669,0.0000057804477,0.68508744,0.0013790085,0.0023322075,0.01629687],"study_design_scores_gemma":[0.0073386137,0.00038745892,0.82048315,0.00013319663,0.00022245396,0.00004750673,0.00030970614,0.0018276898,0.1679264,0.00089415093,0.00024557958,0.00018412917],"about_ca_topic_score_codex":0.0008802504,"about_ca_topic_score_gemma":0.0010065073,"teacher_disagreement_score":0.5333848,"about_ca_system_score_codex":0.00014955892,"about_ca_system_score_gemma":0.00019153766,"threshold_uncertainty_score":0.64775115},"labels":[],"label_agreement":null},{"id":"W2966938034","doi":"10.1182/blood-2018-99-111748","title":"Normalization of Survival and No Relapses after One Year in Adult Burkitt Lymphoma Patients Treated with Intensive Immunochemotherapy: An International Study of 159 Real-World Patients","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Burkitt's lymphoma; Internal medicine; Lymphoma; Population; Rituximab; International Prognostic Index; Oncology; Pediatrics","score_opus":0.008242619169865946,"score_gpt":0.24103867549234473,"score_spread":0.2327960563224788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966938034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99830234,0.000009278701,3.6236858e-7,0.000007757623,0.000056052293,0.0005350664,0.000032082007,0.0000104406445,0.0010466019],"genre_scores_gemma":[0.99947536,0.00007979331,0.00012636888,0.000040624956,0.000032112574,0.000038634767,0.00014175836,0.000018971132,0.000046404795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905515,0.00003569144,0.0003017748,0.0002128776,0.000289796,0.0001047333],"domain_scores_gemma":[0.9982427,0.000022070819,0.00016225669,0.00020583087,0.0013210142,0.000046145386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000039672148,0.00012841474,0.00028540308,0.00016685243,0.000015590122,0.0000064903347,0.000050088718,0.00003854782,0.00003192661],"category_scores_gemma":[0.00004569812,0.00009791626,0.000021457736,0.00017728143,0.00006839811,0.000103504026,0.000029485347,0.000020436844,0.000003111255],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002506365,0.017160546,0.976743,0.000019896577,0.00035754367,0.000005542035,0.0019553844,1.18614885e-7,0.000097786746,0.000018483594,0.0000074022787,0.0011279673],"study_design_scores_gemma":[0.03434267,0.0070911814,0.9530046,0.00022813758,0.00019088226,7.792112e-7,0.0003898135,0.000008659984,0.0046509216,0.0000021517687,0.000007788929,0.00008243722],"about_ca_topic_score_codex":0.0025040368,"about_ca_topic_score_gemma":0.001126311,"teacher_disagreement_score":0.031836305,"about_ca_system_score_codex":0.00005566618,"about_ca_system_score_gemma":0.000027583592,"threshold_uncertainty_score":0.3992909},"labels":[],"label_agreement":null},{"id":"W2967055487","doi":"10.1182/blood.v130.suppl_1.813.813","title":"Preliminary Results from a Phase Ib Study Evaluating BCL-2 Inhibitor Venetoclax in Combination with MEK Inhibitor Cobimetinib or MDM2 Inhibitor Idasanutlin in Patients with Relapsed or Refractory (R/R) AML","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Venetoclax; Refractory (planetary science); Medicine; MEK inhibitor; Lenalidomide; Internal medicine; Oncology; Leukemia; Chemistry; Multiple myeloma; Biology; Kinase; Chronic lymphocytic leukemia; MAPK/ERK pathway","score_opus":0.04089107456193912,"score_gpt":0.3463352910666302,"score_spread":0.30544421650469106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967055487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99156666,0.00007942025,0.0000047194358,0.00030607378,0.00021859414,0.007224575,0.00024903278,0.00012152573,0.00022942715],"genre_scores_gemma":[0.995,0.000016725315,0.0023549176,0.000075381446,0.00048557812,0.0006465797,0.00063115254,0.00017876364,0.0006109187],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99319,0.00077545486,0.0014997995,0.0014820617,0.0021259002,0.0009268077],"domain_scores_gemma":[0.99502915,0.000940339,0.0010464888,0.0018919455,0.00068072486,0.00041135828],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021922737,0.0006756877,0.0011664452,0.00071834953,0.00040063178,0.00019415242,0.0005965806,0.00038706503,0.00008012126],"category_scores_gemma":[0.004844394,0.0004610744,0.00007654058,0.0007405195,0.00030718674,0.00073798635,0.0004095255,0.001541061,0.000046616704],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48698086,0.05478023,0.41254455,0.00034460897,0.00066387805,0.0046884543,0.0130337225,0.00003715013,0.008389395,0.0000021898545,0.0016242412,0.016910715],"study_design_scores_gemma":[0.40847132,0.11766249,0.45654494,0.0033137249,0.00053334085,0.000023177521,0.002507272,0.0008895654,0.009085984,0.000009388124,0.00018532701,0.0007735069],"about_ca_topic_score_codex":0.0015764912,"about_ca_topic_score_gemma":0.0017764736,"teacher_disagreement_score":0.07850957,"about_ca_system_score_codex":0.0012712847,"about_ca_system_score_gemma":0.0025594837,"threshold_uncertainty_score":0.9997841},"labels":[],"label_agreement":null},{"id":"W2967118336","doi":"10.1182/blood-2018-99-111963","title":"Integrin-α3 Is a New Marker of Long-Term Hematopoietic Stem Cells in Ex Vivo Expanded Cells","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Stem cell; Haematopoiesis; Ex vivo; Biology; Transplantation; Cord blood; Immunology; Population; CD90; Hematopoietic stem cell; CD34; Cell biology; In vivo; Genetics; Medicine; Internal medicine","score_opus":0.019273663179879292,"score_gpt":0.263805889073493,"score_spread":0.2445322258936137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967118336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99117464,0.00021774827,0.0008284426,0.00012317415,0.00024964675,0.0006784464,0.000020954614,0.000053385287,0.0066535412],"genre_scores_gemma":[0.99357456,0.000116922274,0.0010309828,0.00020546274,0.00016179796,0.000012991658,0.0000066478456,0.00004810041,0.004842529],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981068,0.00006302184,0.0006520181,0.0003994776,0.00041099128,0.00036771697],"domain_scores_gemma":[0.9988544,0.000121284305,0.00015547003,0.00054289197,0.000103481405,0.00022248045],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023563711,0.00025233324,0.00055124017,0.00020740915,0.000021733264,0.00001553762,0.0001698868,0.0001970212,0.0017815718],"category_scores_gemma":[0.000007024342,0.00022565524,0.00013356541,0.00032315083,0.00010734833,0.00006816414,0.00003457491,0.00018856932,0.00035612087],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004039276,0.001661468,0.1513757,0.0027406828,0.00021760345,0.00046284823,0.01549392,4.3214135e-7,0.82446355,0.000051865278,0.0013247714,0.0018032477],"study_design_scores_gemma":[0.0056599206,0.00032271133,0.015623386,0.0015471157,0.00028713295,0.00020600624,0.00037628406,0.000015761003,0.9756304,0.00003127419,0.00009790124,0.00020212363],"about_ca_topic_score_codex":0.00008127192,"about_ca_topic_score_gemma":0.00006371015,"teacher_disagreement_score":0.15116684,"about_ca_system_score_codex":0.00003422856,"about_ca_system_score_gemma":0.00018086068,"threshold_uncertainty_score":0.99913096},"labels":[],"label_agreement":null},{"id":"W2967137243","doi":"10.1182/blood.v130.suppl_1.727.727","title":"Low Peripheral Blood NK Cell Count Is Associated with Worse Clinical Outcome in Patients with Follicular Lymphoma (FL) and Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Immunochemotherapy: Results from the Frontline Phase 3 GALLIUM and GOYA Trials","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Rituximab; Follicular lymphoma; CD20; Lymphoma; CHOP; Internal medicine; Diffuse large B-cell lymphoma; Antibody-dependent cell-mediated cytotoxicity; Immunology; Obinutuzumab; Oncology; Cancer research; Antibody; Monoclonal antibody","score_opus":0.01647211128988471,"score_gpt":0.2615446754962655,"score_spread":0.24507256420638077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967137243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967369,0.0012364708,0.000015428857,0.00014632105,0.00034752363,0.0009040827,0.00038881,0.000059294383,0.00016515871],"genre_scores_gemma":[0.995153,0.0003736148,0.000044741184,0.0005412838,0.0000539834,0.000039478433,0.0009341532,0.000063104424,0.0027966131],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9968904,0.0007250463,0.0010191912,0.00072946894,0.00013200981,0.00050383614],"domain_scores_gemma":[0.9971811,0.00051101384,0.0011560356,0.00089163444,0.0001966389,0.00006355785],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009737158,0.00050288724,0.0010592238,0.00006895767,0.0005923446,0.00019115463,0.0003015685,0.00044632363,0.00012234248],"category_scores_gemma":[0.0002853593,0.00028822885,0.00013345716,0.00009167743,0.00034963526,0.00026074683,0.00008327164,0.00031491584,0.000019555024],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045344386,0.057536278,0.875875,0.000019750389,0.0032239973,0.00007576832,0.0015403843,4.798245e-7,0.01376476,0.0000021231733,0.0010654824,0.001551591],"study_design_scores_gemma":[0.49336532,0.003975084,0.46613076,0.00021506267,0.0012341149,0.000017678854,0.0002960143,0.000023075843,0.030891476,0.0000017787264,0.0033348475,0.0005147687],"about_ca_topic_score_codex":0.0010565108,"about_ca_topic_score_gemma":0.00040709155,"teacher_disagreement_score":0.44802094,"about_ca_system_score_codex":0.000058190588,"about_ca_system_score_gemma":0.000091755,"threshold_uncertainty_score":0.99995697},"labels":[],"label_agreement":null},{"id":"W2967232987","doi":"10.1182/blood.v130.suppl_1.87.87","title":"Phase 1/2 Trial of Subcutaneously Administered Factor IX Variant CB2679d/ISU304: Pharmacokinetics and Activity","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacokinetics; Potency; Factor IX; Pharmacology; In vivo; Medicine; Antigen; Bioavailability; Clotting factor; Antibody; Chemistry; In vitro; Immunology; Internal medicine; Biology; Biochemistry; Biotechnology","score_opus":0.08010780582738142,"score_gpt":0.396971835392356,"score_spread":0.31686402956497456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967232987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960178,0.000097938144,0.0000072044395,0.0007284813,0.00015603601,0.000736812,0.00008508933,0.000021899516,0.0021487128],"genre_scores_gemma":[0.99763674,0.00024232216,0.00015608052,0.000013002638,0.0003077583,0.000013433776,0.000009045643,0.000018212904,0.0016034339],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998994,0.000044892855,0.00018331505,0.00023680112,0.0003020259,0.00023894856],"domain_scores_gemma":[0.99897337,0.00009450554,0.00013300491,0.0005023729,0.00006890875,0.00022781276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012513413,0.00014493354,0.00036217255,0.00006242647,0.00014811382,0.000042502234,0.00012633913,0.00009723857,0.00015285859],"category_scores_gemma":[0.0001830829,0.000107432425,0.000088143686,0.00003236196,0.0001682645,0.00006159878,0.000083682215,0.00015985986,0.000010701635],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.102246076,0.032703057,0.009510113,0.0005598033,0.001432199,0.0063812616,0.00065097795,4.6258926e-8,0.7091064,0.000046796245,0.00030687582,0.13705638],"study_design_scores_gemma":[0.41921645,0.011668782,0.0044733873,0.00009418928,0.0008381316,0.00069364905,0.000019299696,0.00011189279,0.5610146,0.000034844827,0.0016285012,0.00020627564],"about_ca_topic_score_codex":0.000033853292,"about_ca_topic_score_gemma":0.000004270346,"teacher_disagreement_score":0.31697038,"about_ca_system_score_codex":0.000011542455,"about_ca_system_score_gemma":0.00013491508,"threshold_uncertainty_score":0.4380967},"labels":[],"label_agreement":null},{"id":"W2967665015","doi":"10.1182/blood.v128.22.5329.5329","title":"Risks and Benefits of Rituximab Maintenance in Elderly Patients with Advanced Follicular Lymphoma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Rituximab; Internal medicine; Follicular lymphoma; Adverse effect; Gastroenterology; Chemotherapy; Chemotherapy regimen; Maintenance therapy; Log-rank test; Surgery; Lymphoma; Survival analysis","score_opus":0.01026836671055691,"score_gpt":0.2224505972521075,"score_spread":0.21218223054155058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967665015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980602,0.0010997669,0.000004369398,0.00016663641,0.000015308618,0.00033173175,0.000028432456,0.000012258938,0.0002812406],"genre_scores_gemma":[0.99882966,0.00033583646,0.00067909656,0.000045844838,0.000009313694,0.000049723327,0.000005219216,0.000012356158,0.000032967677],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992903,0.000010691912,0.00015913998,0.0002091273,0.00015719756,0.00017353709],"domain_scores_gemma":[0.9995502,0.00004214055,0.000069922455,0.00019465413,0.000071991795,0.000071060276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000032922915,0.00011417196,0.0002655953,0.0000518248,0.000015357347,0.0000032208768,0.000031892367,0.000041679647,0.000008245459],"category_scores_gemma":[0.00003205515,0.000060521714,0.000030971936,0.00008408211,0.000043472934,0.000058915044,0.000018554561,0.000012939305,0.0000051710413],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020030099,0.0033432383,0.8535379,0.000024594157,0.000072798095,0.000034299963,0.000041955765,3.970744e-7,0.0001019828,0.00014372778,0.00000907711,0.1424897],"study_design_scores_gemma":[0.06640016,0.0013632821,0.92011595,0.00063639286,0.00012049867,0.000013903842,0.000011520828,5.3400333e-7,0.011043966,0.000036818736,0.0001765437,0.00008041341],"about_ca_topic_score_codex":0.00007185277,"about_ca_topic_score_gemma":0.000043569227,"teacher_disagreement_score":0.1424093,"about_ca_system_score_codex":0.000036560898,"about_ca_system_score_gemma":0.00003208563,"threshold_uncertainty_score":0.24680038},"labels":[],"label_agreement":null},{"id":"W2967767513","doi":"10.1182/blood.v130.suppl_1.4064.4064","title":"Rituximab Maintenance for Two Years in Previously Untreated Follicular Lymphoma: No Difference in Outcome between Patients Receiving Treatment at Two Month Versus Three Month Interval","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; Hôpital du Sacré-Cœur de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Rituximab; Follicular lymphoma; Medicine; Regimen; Internal medicine; Lymphoma; Maintenance therapy; Follicular phase; Surgery; Gastroenterology; Chemotherapy","score_opus":0.0357693816582513,"score_gpt":0.3041681683564822,"score_spread":0.2683987866982309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967767513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99639356,0.00035823334,0.000004772907,0.00015057248,0.00023288233,0.0020558606,0.00010527165,0.000041492796,0.0006573232],"genre_scores_gemma":[0.99802464,0.000096811425,0.00049507816,0.000029967963,0.00010304524,0.00067500514,0.00016008728,0.000048116726,0.00036724246],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977962,0.000047605678,0.0005730719,0.0006526908,0.000273746,0.00065669324],"domain_scores_gemma":[0.99834853,0.00019679275,0.00028232776,0.00089022226,0.000090255584,0.00019188614],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014366451,0.00040340988,0.0009811581,0.000126597,0.00015191904,0.00006755992,0.00026682223,0.00011152746,0.0000142109075],"category_scores_gemma":[0.00029293043,0.00031445228,0.00026195965,0.00008301024,0.00007247675,0.00011756853,0.00016832787,0.000062431776,0.000060644605],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010708097,0.0055522993,0.9527243,0.000037285656,0.00033487708,0.0002853833,0.0002665605,0.0000021094543,0.00001663166,0.000016188218,0.000023902681,0.039669655],"study_design_scores_gemma":[0.17498608,0.0020105205,0.8208885,0.0004525435,0.000531862,0.000003480218,0.000012103806,0.00013791105,0.00057346997,0.000031951407,0.00013757878,0.00023396553],"about_ca_topic_score_codex":0.006639999,"about_ca_topic_score_gemma":0.015449004,"teacher_disagreement_score":0.17391527,"about_ca_system_score_codex":0.0014770725,"about_ca_system_score_gemma":0.000084402345,"threshold_uncertainty_score":0.99997485},"labels":[],"label_agreement":null},{"id":"W2967774833","doi":"10.1182/blood.v130.suppl_1.1261.1261","title":"FOXM1 Is Associated with Development of Therapeutic Resistance in Multiple Myeloma","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Corporation; Business; Political science; Management; Finance; Economics","score_opus":0.04853608577264014,"score_gpt":0.30529568128767887,"score_spread":0.25675959551503874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967774833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99514246,0.00033037295,0.000012737401,0.00020745189,0.000010557403,0.00036557514,0.000011258855,0.000015807043,0.0039037676],"genre_scores_gemma":[0.9953477,0.000014508075,0.0031627773,0.00003651484,0.000010277302,0.00004375489,0.000015872203,0.000016167809,0.0013524633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897707,0.000024727802,0.00019345827,0.00019644543,0.00033960067,0.00026870673],"domain_scores_gemma":[0.9991832,0.000065928536,0.00013315157,0.00042936782,0.000094531715,0.000093847775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015461301,0.00011262833,0.0002624865,0.00007162589,0.0001505643,0.000017343827,0.00013762372,0.00005622643,0.00003875733],"category_scores_gemma":[0.00023270506,0.000081574566,0.0000335991,0.00007096585,0.00008396412,0.00005517454,0.000038407852,0.00009872137,0.000013768345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049635995,0.0013345472,0.9869813,0.000055613044,0.0004825149,0.00022184731,0.00078879285,4.4493596e-8,0.0037635902,0.000016410895,0.000022009504,0.0058370177],"study_design_scores_gemma":[0.012527622,0.00013013455,0.92738557,0.00033178294,0.00004816309,0.000003241932,0.00003410146,0.000014271425,0.059117775,0.000034334837,0.00029540673,0.00007760594],"about_ca_topic_score_codex":0.000052483058,"about_ca_topic_score_gemma":0.00228245,"teacher_disagreement_score":0.059595693,"about_ca_system_score_codex":0.00005463174,"about_ca_system_score_gemma":0.00021339665,"threshold_uncertainty_score":0.3326514},"labels":[],"label_agreement":null},{"id":"W2968109725","doi":"10.1182/blood-2018-99-111726","title":"Literature Review of All Cases of Aggressive T-Cell Large Granular Lymphocytic Leukemia Cases and Report of an Additional Case","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont; Hôpital Fleurimont; Université de Sherbrooke","funders":"","keywords":"Leukemia; Medicine; Immunology; Immunophenotyping; Lymphoproliferative disorders; Cytopenia; Chronic lymphocytic leukemia; Pathology; Lymphoma; Bone marrow; Antigen","score_opus":0.018976846275266804,"score_gpt":0.31106945743667974,"score_spread":0.29209261116141294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968109725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92319745,0.07368755,0.0000012871094,0.000018665667,0.000036602498,0.0004988789,0.0020451974,0.000016887436,0.0004974682],"genre_scores_gemma":[0.98666996,0.010467923,0.0009054565,0.00020135714,0.00021194652,0.00003032692,0.0012177707,0.000031821644,0.0002634548],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99784046,0.000113830036,0.0007473878,0.00038399626,0.0006073435,0.00030700705],"domain_scores_gemma":[0.99667996,0.0005381616,0.000829127,0.0007590508,0.0009573926,0.00023629169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046974517,0.00020842641,0.0007080257,0.00015992847,0.000047536676,0.0000072563553,0.00011304985,0.00015282759,0.00069622364],"category_scores_gemma":[0.0030173766,0.0001696753,0.00014764158,0.00035034178,0.0004460248,0.00011195001,0.00011025592,0.00013924052,0.0000040956484],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077498954,0.0022484877,0.0004387426,0.06576952,0.0005539211,0.89706105,0.0010186594,6.8420246e-7,0.0074661877,0.000108345426,0.023389436,0.0011699559],"study_design_scores_gemma":[0.02534011,0.0020322036,0.00016953028,0.031895004,0.0011340973,0.83714116,0.00013811723,0.00025018945,0.0973877,0.00003207047,0.0042513427,0.00022846276],"about_ca_topic_score_codex":0.0006527367,"about_ca_topic_score_gemma":0.000076979566,"teacher_disagreement_score":0.08992151,"about_ca_system_score_codex":0.001307928,"about_ca_system_score_gemma":0.007591255,"threshold_uncertainty_score":0.9980348},"labels":[],"label_agreement":null},{"id":"W2968552050","doi":"","title":"Performance Characteristics of a Novel Platelet Viability Assay for Heparin-Induced Thrombocytopenia","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; McMaster University","funders":"","keywords":"Platelet; Heparin; Platelet factor 4; Heparin-induced thrombocytopenia; Platelet activation; Serotonin; Chemistry; Anticoagulant; Medicine; Antibody; Immunology; Pharmacology; Internal medicine","score_opus":0.06279415574380673,"score_gpt":0.31558967308230695,"score_spread":0.25279551733850025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968552050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99104,0.000007476706,0.00012077798,0.000366485,0.00038569683,0.0013994841,0.00012494982,0.00007076282,0.006484353],"genre_scores_gemma":[0.99592394,0.000031810963,0.0032358512,0.000095469084,0.00028969737,0.0001121315,0.0000574034,0.00006094876,0.00019273261],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99781835,0.00003082294,0.00070468994,0.00056709105,0.00033120968,0.0005478533],"domain_scores_gemma":[0.9969443,0.00015781097,0.0005599841,0.0017226764,0.00035951342,0.00025568667],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007929061,0.00034572068,0.0012917593,0.000087845765,0.0004730024,0.00007929368,0.00054241426,0.0002920409,0.00008652347],"category_scores_gemma":[0.00090132887,0.00031014244,0.00027433608,0.00008462747,0.00020599952,0.00030663025,0.00023452908,0.00030690053,0.000034374538],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032481243,0.0029693174,0.33333635,0.00074635935,0.00050101784,0.000009896254,0.00023658948,1.904998e-7,0.65375704,0.00047380448,0.000039428007,0.007605163],"study_design_scores_gemma":[0.0070310584,0.000729239,0.6794569,0.00016362355,0.00043253374,0.00005646558,0.000017379372,0.00041062522,0.31071967,0.00002605426,0.0006912853,0.00026519448],"about_ca_topic_score_codex":0.00013499687,"about_ca_topic_score_gemma":0.000026931957,"teacher_disagreement_score":0.3461205,"about_ca_system_score_codex":0.00006180473,"about_ca_system_score_gemma":0.0003139563,"threshold_uncertainty_score":0.9999351},"labels":[],"label_agreement":null},{"id":"W2968629904","doi":"10.1182/blood-2018-99-119797","title":"Complications and Toxicities Associated with Autologous Stem Cell Transplantation for Severe Autoimmune Diseases: Single Center Experience","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Autologous stem-cell transplantation; Chronic inflammatory demyelinating polyneuropathy; Hematopoietic stem cell transplantation; Transplantation; Single Center; Internal medicine; Surgery; Immunology; Antibody","score_opus":0.010614661717637681,"score_gpt":0.21429197352469412,"score_spread":0.20367731180705645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968629904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99173146,0.0045250715,0.0008630027,0.000073465126,0.00016220156,0.00036599746,0.00029742208,0.00013315381,0.0018482214],"genre_scores_gemma":[0.99855065,0.00003553737,0.000038852402,0.00013010667,0.0000022731758,0.00010542043,0.00040733107,0.000015374424,0.0007144352],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991696,0.00006235017,0.00019758602,0.00025112758,0.000027954537,0.00029139928],"domain_scores_gemma":[0.9995038,0.000111968715,0.0001073565,0.00018381125,0.00008598275,0.0000071135214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000047583497,0.00015118433,0.00017833192,0.000047901696,0.00051500066,0.000025971813,0.0001457353,0.00011001698,0.000025323981],"category_scores_gemma":[0.000009652993,0.00013044903,0.00004325769,0.00008802295,0.00047634594,0.00011510671,0.000019423265,0.000075665484,0.00001868897],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000812354,0.00700892,0.017244427,0.00021429411,0.0006489816,0.0000075324547,0.04777454,0.0000133363765,0.8967236,0.0017430133,0.00020289789,0.027606057],"study_design_scores_gemma":[0.021485036,0.0032129937,0.73386985,0.00040175853,0.00074886315,0.0004012885,0.013948355,0.0000564626,0.21195532,0.0002919107,0.012384198,0.0012439778],"about_ca_topic_score_codex":0.000016883496,"about_ca_topic_score_gemma":0.000008012921,"teacher_disagreement_score":0.7166254,"about_ca_system_score_codex":0.00001248437,"about_ca_system_score_gemma":0.000031707004,"threshold_uncertainty_score":0.5319557},"labels":[],"label_agreement":null},{"id":"W2968763813","doi":"10.1182/blood.v130.suppl_1.4276.4276","title":"Spliceosome Mutations Are Associated with Frailty in Older Patients with Myeloid Malignancies","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Context (archaeology); Medicine; Myeloid leukemia; Grip strength; Weight loss; Internal medicine; Gerontology; Oncology; Obesity; Physical therapy; Biology","score_opus":0.01945734949908235,"score_gpt":0.271853245221163,"score_spread":0.25239589572208065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968763813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99559104,0.000030943866,0.000010376428,0.00076480437,0.000019353547,0.0006774755,0.00005753035,0.000054587243,0.002793872],"genre_scores_gemma":[0.99730337,0.0000049807,0.0003943738,0.00016889884,0.000045904115,0.000085601336,0.00012012288,0.00004223987,0.001834526],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853706,0.00003479915,0.00017644209,0.0003120716,0.0005277191,0.00041192252],"domain_scores_gemma":[0.9986132,0.00006848762,0.00020478074,0.0006359256,0.0003284135,0.0001492115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001358495,0.00017420892,0.00030921167,0.00013852214,0.00025392027,0.00007203095,0.00022507246,0.00011106426,0.00007406567],"category_scores_gemma":[0.00050554227,0.00012225113,0.000032642387,0.00019206875,0.00020319753,0.00020817484,0.00007799978,0.00033681752,0.000045421093],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011762209,0.0010048768,0.99752295,0.000036253612,0.00012812148,0.0002407467,0.00032554692,0.000003201546,0.00024294318,0.000024521567,0.00018640973,0.00016679874],"study_design_scores_gemma":[0.015492328,0.00035999538,0.981932,0.0004284908,0.00013337954,0.000010721881,0.0001660134,0.0000199441,0.0011630094,0.000016462767,0.00011295146,0.00016469331],"about_ca_topic_score_codex":0.0001706576,"about_ca_topic_score_gemma":0.00072952465,"teacher_disagreement_score":0.015590948,"about_ca_system_score_codex":0.00014773446,"about_ca_system_score_gemma":0.00028703033,"threshold_uncertainty_score":0.49852565},"labels":[],"label_agreement":null},{"id":"W2968772284","doi":"10.1182/blood.2019001988","title":"Oxidative hemolysis due to Wilson disease","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Jubilee Hospital","funders":"","keywords":"Hemolysis; Jaundice; Medicine; Hemolytic anemia; Anemia; Gastroenterology; Creatinine; Internal medicine; Heinz body; Pediatrics; Hemoglobin","score_opus":0.006256400356282426,"score_gpt":0.23725136172379735,"score_spread":0.23099496136751493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968772284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98713994,0.00051213277,0.000090300964,0.0011285983,0.00009547686,0.00033087152,0.000011114684,0.000042959495,0.010648626],"genre_scores_gemma":[0.99266016,0.000013474055,0.00066769985,0.0018683221,0.00009835285,0.000014670578,0.000022744027,0.000014674463,0.004639882],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993634,0.000015542704,0.00008945194,0.00019678763,0.00017004022,0.00016477829],"domain_scores_gemma":[0.99937403,0.000015474598,0.000019598318,0.00030459109,0.00003280861,0.00025351718],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000050671486,0.000087686996,0.00018486928,0.000065990556,0.0000205915,0.000008535146,0.000054287608,0.000026428283,0.00063929835],"category_scores_gemma":[0.00008221782,0.000072636874,0.00006829048,0.0001590129,0.000012415689,0.0000438875,0.000029271412,0.0000542917,0.0015862642],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018811353,0.0068873595,0.7657539,0.0009780522,0.0003562875,0.0008184083,0.003593843,0.000031451393,0.16823168,0.0062539186,0.018257469,0.026956484],"study_design_scores_gemma":[0.009619449,0.00032121185,0.930739,0.000089759465,0.0011520885,0.00002052191,0.0006819945,0.000017544602,0.028806139,0.00033148786,0.027836587,0.00038421736],"about_ca_topic_score_codex":0.00002071262,"about_ca_topic_score_gemma":0.000001942717,"teacher_disagreement_score":0.16498508,"about_ca_system_score_codex":0.0000048729266,"about_ca_system_score_gemma":0.00004944056,"threshold_uncertainty_score":0.9991911},"labels":[],"label_agreement":null},{"id":"W2968942240","doi":"10.1182/blood.2019000324","title":"Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":329,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"National Cancer Institute","keywords":"Pembrolizumab; Medicine; Refractory (planetary science); Lymphoma; Internal medicine; Oncology; Hodgkin lymphoma; Cancer; Immunotherapy; Biology","score_opus":0.013537593036623564,"score_gpt":0.24921475331283308,"score_spread":0.23567716027620952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968942240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895297,0.0006280101,5.3067987e-7,0.00016656554,0.00024487296,0.00057231163,0.000017439796,0.000044851608,0.008795692],"genre_scores_gemma":[0.9958994,0.00015603815,0.00029449473,0.00014432802,0.00006912749,0.000052252322,0.000027579952,0.000036556597,0.0033202604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852157,0.000051088104,0.00039338594,0.0003538167,0.00033960334,0.0003405291],"domain_scores_gemma":[0.99895597,0.00014366438,0.00013587785,0.00057824753,0.00006509071,0.0001211664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014454598,0.00020710977,0.0005563865,0.00016838331,0.000022636368,0.000008837976,0.00011004047,0.00016692324,0.00051542063],"category_scores_gemma":[0.0001141731,0.00015174811,0.00016672233,0.00025859693,0.0000369551,0.00005455761,0.000058020694,0.00007442479,0.00034736362],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00513801,0.009648028,0.96615845,0.0003023146,0.00048505695,0.00071554584,0.0007392837,0.000002139317,0.006107178,0.00057724485,0.0014267495,0.008700015],"study_design_scores_gemma":[0.15308313,0.0029612111,0.8077798,0.0004894765,0.00045435253,0.00012982902,0.0002143923,0.000014880502,0.029991299,0.00005877736,0.0045635663,0.00025932296],"about_ca_topic_score_codex":0.0003185599,"about_ca_topic_score_gemma":0.00008305148,"teacher_disagreement_score":0.15837868,"about_ca_system_score_codex":0.00015702636,"about_ca_system_score_gemma":0.00032819458,"threshold_uncertainty_score":0.6188109},"labels":[],"label_agreement":null},{"id":"W2969113056","doi":"10.1182/blood.v130.suppl_1.315.315","title":"Persistence with Generic Imatinib for Chronic Myeloid Leukemia: A Matched Cohort Study","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Université de Montréal; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Hôpital Maisonneuve-Rosemont; Jewish General Hospital","funders":"","keywords":"Medicine; Internal medicine; Discontinuation; Hazard ratio; Imatinib; Imatinib mesylate; Myeloid leukemia; Cohort; Proportional hazards model; Confidence interval; Oncology; Surgery","score_opus":0.02978029303048314,"score_gpt":0.2783285087066372,"score_spread":0.2485482156761541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969113056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992416,0.00040107805,0.00008520696,0.00020559649,0.00009680036,0.0034643572,0.000019216151,0.00011137454,0.0032003266],"genre_scores_gemma":[0.99171996,0.00004972035,0.00399767,0.00006890314,0.00035075826,0.00095321017,0.000037458456,0.00006873745,0.0027535742],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981819,0.000023092342,0.00028145855,0.0006167346,0.00040813244,0.0004887323],"domain_scores_gemma":[0.9977863,0.00005329755,0.0002713333,0.0015609275,0.00013707517,0.00019109955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023272817,0.00030840107,0.00059563975,0.000058370948,0.00047133886,0.0000852843,0.00034416877,0.000101838945,0.000095628006],"category_scores_gemma":[0.00011871932,0.00023320857,0.00013611752,0.000070567934,0.00014460104,0.00013508511,0.000102822196,0.00018207703,0.000068980895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004226351,0.0021579727,0.9846674,0.00036901963,0.0022594903,0.00044552895,0.0009029393,0.000014216576,0.0054803346,0.000016470829,0.00040974846,0.0028541978],"study_design_scores_gemma":[0.04766252,0.0048956973,0.9337609,0.00022896608,0.003631355,0.0004964256,0.00063509797,0.00046917857,0.0071647107,0.000013786596,0.00062970084,0.00041169787],"about_ca_topic_score_codex":0.0002538516,"about_ca_topic_score_gemma":0.0002227067,"teacher_disagreement_score":0.05090658,"about_ca_system_score_codex":0.0012438069,"about_ca_system_score_gemma":0.0014011443,"threshold_uncertainty_score":0.95099694},"labels":[],"label_agreement":null},{"id":"W2969441126","doi":"10.1182/blood.v128.22.3811.3811","title":"Infections Are Associated with Higher Risk of Venous Thromboembolism in Hospitalized Children with Nephrotic Syndrome","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Renal Diseases and Glomerulopathies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Nephrotic syndrome; Pediatrics; Logistic regression; Internal medicine; Medical record; Retrospective cohort study; Cohort","score_opus":0.004962827873443907,"score_gpt":0.20555567083543674,"score_spread":0.20059284296199284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969441126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985381,0.00038725833,0.00000441802,0.00012056667,0.000022823551,0.000398497,0.00009611387,0.000057195066,0.00037506231],"genre_scores_gemma":[0.9995447,0.00015311343,0.00003512626,0.000031629326,0.000025921707,0.00003339422,0.0000121871935,0.000027011562,0.00013694049],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991568,0.000038654267,0.0001761709,0.00019371556,0.00022224656,0.00021245469],"domain_scores_gemma":[0.9993818,0.00003863331,0.00018495963,0.00020391021,0.000093209324,0.000097514516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006190067,0.00014602796,0.0004622954,0.00011400117,0.000040076942,0.0000075977455,0.000047156787,0.000068948495,0.00007540236],"category_scores_gemma":[0.00007501904,0.00007722939,0.0000666502,0.0003381222,0.00011423897,0.000074988755,0.000016557218,0.00009819323,0.000011010856],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007712342,0.0025362035,0.996126,0.000030477022,0.0007891482,0.00010085253,0.000055225515,0.000002321463,0.00012465473,0.000047021564,0.000028743674,0.00008224784],"study_design_scores_gemma":[0.007840527,0.0020272825,0.98730224,0.0011688875,0.0011124111,0.000120497505,0.000014095489,3.8323253e-7,0.00015429944,0.00011794536,0.00000833196,0.00013307565],"about_ca_topic_score_codex":0.00022805929,"about_ca_topic_score_gemma":0.000084128726,"teacher_disagreement_score":0.008823717,"about_ca_system_score_codex":0.000027382737,"about_ca_system_score_gemma":0.00006494449,"threshold_uncertainty_score":0.31493235},"labels":[],"label_agreement":null},{"id":"W2969949156","doi":"10.1182/blood-2018-99-116676","title":"Real World Experience with Sublingual Fentanyl for the Treatment of Sickle Cell Vaso-Occlusive Episodes in Adults in a Tertiary Canadian Emergency Department","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University Health Network; University of British Columbia","funders":"","keywords":"Medicine; Acute chest syndrome; Emergency department; Sickle cell anemia; Fentanyl; Pediatrics; Opioid; Vaso-occlusive crisis; Internal medicine; Anesthesia; Disease","score_opus":0.007751244034381613,"score_gpt":0.253284161686046,"score_spread":0.2455329176516644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969949156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956559,0.0009288847,0.0000031865259,0.00045470524,0.00009635748,0.0011179913,0.00002681132,0.000009014,0.001707159],"genre_scores_gemma":[0.9981753,0.00092067616,0.00019376968,0.000066284825,0.00007802833,0.00019414876,0.0000182603,0.000015835487,0.00033766023],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99904364,0.000018839011,0.0002643369,0.00021868237,0.00011671755,0.00033780411],"domain_scores_gemma":[0.99950236,0.000035872847,0.000059046175,0.00021611757,0.00005952351,0.00012708092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005886551,0.00013801678,0.00019423998,0.00015408541,0.00007004542,0.0000035206972,0.000074304786,0.00005549758,0.00008163415],"category_scores_gemma":[0.000011346428,0.000082504615,0.000053113832,0.00029992865,0.000094779476,0.000028540502,0.000008914732,0.000055795324,0.0000029892033],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071320345,0.0026627935,0.9635764,0.00007641553,0.00008701922,0.00015802143,0.02972025,0.000012105617,0.00049504166,0.00003314393,0.00014992761,0.00231572],"study_design_scores_gemma":[0.042011563,0.011094615,0.8213318,0.0008482374,0.00056571007,0.000052167405,0.032152478,0.0010415365,0.08127466,0.000084167,0.008893027,0.0006500265],"about_ca_topic_score_codex":0.12220292,"about_ca_topic_score_gemma":0.6856944,"teacher_disagreement_score":0.5634915,"about_ca_system_score_codex":0.00012422891,"about_ca_system_score_gemma":0.0002629667,"threshold_uncertainty_score":0.88364244},"labels":[],"label_agreement":null},{"id":"W2970632109","doi":"10.1182/blood.v130.suppl_1.3886.3886","title":"Investigating the Efficacy of Anti-CD200 Immunotherapy in MRD Low and Risk B Cell Precursor ALL","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Therapeutics (Canada)","funders":"","keywords":"Minimal residual disease; Antigen; Immunology; Population; CD19; Medicine; Immunotherapy; Cancer research; Immune system; Chimeric antigen receptor; Oncology; Internal medicine; Leukemia","score_opus":0.017926323014650334,"score_gpt":0.29011163584072774,"score_spread":0.2721853128260774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970632109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99670535,0.00064231,0.000010549315,0.0005367126,0.000033516284,0.0004437241,0.000008426001,0.00001335681,0.0016060484],"genre_scores_gemma":[0.9978401,0.0007779577,0.00092196546,0.000117502284,0.00008573515,0.000011923762,0.000002776765,0.000023659677,0.00021838404],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895555,0.00008259096,0.00023495319,0.0002035713,0.00026470647,0.00025865025],"domain_scores_gemma":[0.9985837,0.0003990504,0.00020287756,0.0006794289,0.000049609713,0.000085351625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048673933,0.00011620848,0.00025339678,0.000057584293,0.0001275905,0.000040241423,0.00028723667,0.00008339903,0.00001861416],"category_scores_gemma":[0.0008776478,0.000076158656,0.000044789947,0.000064615604,0.00036984342,0.00006178525,0.00011613309,0.00028071384,0.00001162107],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019206961,0.0012458373,0.80171305,0.00033699803,0.00031032827,0.00007118112,0.004258118,0.000013780839,0.182472,0.000047522662,0.0006060177,0.008733094],"study_design_scores_gemma":[0.024595415,0.0003525121,0.81924254,0.00040214445,0.00015632801,0.000045081364,0.00011789752,0.0013026164,0.15299362,0.00012252505,0.0005294025,0.00013991451],"about_ca_topic_score_codex":0.00081443845,"about_ca_topic_score_gemma":0.000030250356,"teacher_disagreement_score":0.029478386,"about_ca_system_score_codex":0.00003422969,"about_ca_system_score_gemma":0.00023273494,"threshold_uncertainty_score":0.31056598},"labels":[],"label_agreement":null},{"id":"W2970658501","doi":"10.1182/blood-2018-99-117819","title":"Monoclonal Gammopathy of Clinical Significance - a Single Center Experience","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Medicine; Multiple myeloma; Monoclonal gammopathy of undetermined significance; Hematology; Internal medicine; Retrospective cohort study; Nomogram; Pediatrics; Oncology; Monoclonal; Immunology","score_opus":0.1009190964356573,"score_gpt":0.4012438631901661,"score_spread":0.3003247667545088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970658501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99336845,0.00008876339,0.00005372528,0.00007973975,0.000087422064,0.00021806845,0.000016749482,0.000021634285,0.0060654595],"genre_scores_gemma":[0.9960184,0.00001855769,0.0030753373,0.000082989005,0.00034917967,0.00002252173,0.0000094125235,0.000010032574,0.0004135533],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891114,0.00004486687,0.00030839923,0.00022951174,0.000276093,0.00022997324],"domain_scores_gemma":[0.99924123,0.00007166077,0.000070442875,0.00027790703,0.00013293518,0.00020580046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013007963,0.00008146045,0.00023938357,0.000036815687,0.000031681466,0.0000059094136,0.00008396155,0.000050734066,0.00028633396],"category_scores_gemma":[0.0002877414,0.000062142906,0.000097294454,0.00009578446,0.00028927985,0.000039655286,0.000041676267,0.00008455385,0.00010451852],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005862001,0.0048663174,0.958503,0.000026864782,0.00010997561,0.00015028667,0.00034763297,1.3761411e-8,0.024638703,0.000022394059,0.00020924152,0.010539358],"study_design_scores_gemma":[0.014483906,0.0043260427,0.6861175,0.00013774421,0.00007866388,0.00012632318,0.00014748989,0.00009718257,0.28908145,0.00003790699,0.0052329344,0.0001328774],"about_ca_topic_score_codex":0.000038606395,"about_ca_topic_score_gemma":0.000009255727,"teacher_disagreement_score":0.27238554,"about_ca_system_score_codex":0.0000091290385,"about_ca_system_score_gemma":0.000082555955,"threshold_uncertainty_score":0.31351563},"labels":[],"label_agreement":null},{"id":"W2971024070","doi":"10.1182/blood.v130.suppl_1.3111.3111","title":"Initial Phase 2 Results of Ibrutinib Combined with Carfilzomib/Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Carfilzomib; Ibrutinib; Multiple myeloma; Medicine; Lenalidomide; Pomalidomide; Dexamethasone; Refractory (planetary science); Oncology; Internal medicine; Leukemia; Chronic lymphocytic leukemia; Biology","score_opus":0.02258653904098449,"score_gpt":0.30556453754721075,"score_spread":0.28297799850622624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971024070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99515826,0.00004099033,0.0000064049336,0.00008756597,0.00006289022,0.001042131,0.00012586391,0.00003779395,0.0034380779],"genre_scores_gemma":[0.99827623,0.000009031376,0.0009568739,0.00003217298,0.000089585694,0.000038804446,0.00014942473,0.000056017077,0.00039185944],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99755484,0.00008611906,0.0005026859,0.0004887301,0.00086376246,0.0005038832],"domain_scores_gemma":[0.99726284,0.00031566035,0.00040754976,0.0014334655,0.00033626895,0.0002442262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003941791,0.00025617328,0.0006229692,0.00019181472,0.0001268847,0.000042815343,0.00034379773,0.00016470026,0.000027736214],"category_scores_gemma":[0.0014189468,0.00018377119,0.000058709917,0.00018150231,0.0004985464,0.00027877663,0.00014638025,0.00040000095,0.000014002228],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2877094,0.044206366,0.6389816,0.0009270182,0.001284011,0.003167669,0.0029139437,0.000018354178,0.0038913572,0.00006579273,0.0007149301,0.016119575],"study_design_scores_gemma":[0.6670317,0.010481813,0.2952613,0.0006581148,0.00019147909,0.0000342874,0.000082527215,0.00022348277,0.025476333,0.000005724536,0.00030124545,0.00025198673],"about_ca_topic_score_codex":0.0013452121,"about_ca_topic_score_gemma":0.00043497342,"teacher_disagreement_score":0.37932232,"about_ca_system_score_codex":0.00089445605,"about_ca_system_score_gemma":0.0029906065,"threshold_uncertainty_score":0.74939716},"labels":[],"label_agreement":null},{"id":"W2971053411","doi":"10.1182/blood-2018-99-119438","title":"In Vitro Activity and Target Modulation of PV-10 Against Relapsed and Refractory Pediatric Leukemia","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Medicine; Leukemia; Oncology; Internal medicine; Transplantation; Pediatric cancer; Myeloid leukemia; Cancer; Refractory (planetary science); Acute leukemia; Cancer research; Immunology; Biology","score_opus":0.007119541544815468,"score_gpt":0.2298396906626565,"score_spread":0.22272014911784102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971053411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99871475,0.00058827025,0.00026984414,0.000021186988,0.000055236058,0.00007239774,0.00001292768,0.000002707652,0.00026271312],"genre_scores_gemma":[0.9986054,0.00051441754,0.00046178472,0.00007700338,0.00019985103,0.000004152768,0.000013590784,0.000009116287,0.00011470208],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995864,0.000019876336,0.00008378206,0.00017102092,0.000047586334,0.00009131062],"domain_scores_gemma":[0.99975383,0.0000063667453,0.000056942332,0.000121752004,0.000030180832,0.000030929838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000086268796,0.00006758141,0.00008867298,0.000035732854,0.000022450417,0.0000050728167,0.00003261441,0.00009625237,0.0000048768825],"category_scores_gemma":[0.000015153119,0.00006905837,0.000016181782,0.000045203993,0.000034965615,0.0000041964167,0.00003952287,0.00004063578,4.804602e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012238293,0.000055823006,0.0005244811,0.0000143464795,0.000011656587,6.3816645e-7,0.000037558362,0.000001625883,0.9973851,0.000010098341,0.000026157122,0.0018101488],"study_design_scores_gemma":[0.0013161927,0.00027044438,0.007416225,0.0000026934786,0.000019496774,0.0000021243275,0.000007340854,0.00017250377,0.9881305,0.00017764192,0.002396852,0.00008795759],"about_ca_topic_score_codex":0.000019330822,"about_ca_topic_score_gemma":0.000013577501,"teacher_disagreement_score":0.009254556,"about_ca_system_score_codex":0.0000078846915,"about_ca_system_score_gemma":0.000046160178,"threshold_uncertainty_score":0.28161186},"labels":[],"label_agreement":null},{"id":"W2971426133","doi":"10.1182/blood.v130.suppl_1.2082.2082","title":"Evidence-Based Diagnosis of Venous Thromboembolism: A Systematic Review","year":2017,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Systematic review; MEDLINE; Randomized controlled trial; Inclusion and exclusion criteria; Intensive care medicine; Pulmonary embolism; Meta-analysis; Evidence-based medicine; Quality of evidence; Deep vein; Medical physics; Thrombosis; Alternative medicine; Surgery; Pathology","score_opus":0.17858258860436063,"score_gpt":0.38984460234281887,"score_spread":0.21126201373845824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971426133","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000041820895,0.98723733,0.0000035683074,0.00020327304,0.00027276823,0.011048041,0.00005893906,0.00009212032,0.0010797894],"genre_scores_gemma":[0.00003722595,0.9935066,0.00017099595,0.00065013213,0.00023202668,0.00503826,0.00008564395,0.00014352972,0.00013559138],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99527454,0.0004185157,0.0021317343,0.0007599804,0.00088862114,0.0005265928],"domain_scores_gemma":[0.9927771,0.0007411427,0.002711773,0.003242907,0.00026931913,0.0002577481],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0013465567,0.0007831184,0.015641568,0.000355996,0.00015061843,0.00006196395,0.0009839466,0.00037370436,0.00024499494],"category_scores_gemma":[0.0026280445,0.0005817746,0.0022811037,0.00033561763,0.00015261096,0.00012614913,0.00022856917,0.0004232197,0.00030685225],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000013426663,0.0031814503,0.0000062856952,0.9172102,0.0024508017,0.00017125433,0.000017117389,3.5391047e-8,5.8229574e-8,0.000085097265,0.0025982033,0.07427813],"study_design_scores_gemma":[0.00040672388,0.0004668535,0.000025473691,0.74198943,0.11722088,0.00007107688,0.0000029494984,2.1232377e-7,0.000004563514,0.0000065355075,0.13945536,0.0003499258],"about_ca_topic_score_codex":0.00007231698,"about_ca_topic_score_gemma":0.0000049352275,"teacher_disagreement_score":0.17522079,"about_ca_system_score_codex":0.00011051307,"about_ca_system_score_gemma":0.0008967622,"threshold_uncertainty_score":0.99966335},"labels":[],"label_agreement":null},{"id":"W2971467278","doi":"10.1182/blood-2018-99-118078","title":"Fibrinogen Concentrate Vs. Cryoprecipitate for Acquired Hypofibrinogenemia in Cardiac Surgery — the FIBRES Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Trauma, Hemostasis, Coagulopathy, Resuscitation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto General Hospital","funders":"","keywords":"Cryoprecipitate; Hypofibrinogenemia; Medicine; Fibrinogen; Coagulopathy; Surgery; Hemostasis; Blood transfusion; Cardiopulmonary bypass; Adverse effect; Thromboelastography; Blood product; Cardiac surgery; Randomized controlled trial; Clinical endpoint; Internal medicine; Coagulation","score_opus":0.03445432264280485,"score_gpt":0.29102555274302727,"score_spread":0.2565712301002224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971467278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99449414,0.0008844639,0.000023223562,0.000581759,0.000634581,0.0026226914,0.000089410736,0.00010895108,0.0005607779],"genre_scores_gemma":[0.9979099,0.00006879878,0.00036072326,0.00022221175,0.0008508078,0.00028444038,0.00006220646,0.000059233196,0.00018165952],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976959,0.00024277705,0.0005620169,0.00051337114,0.00039168826,0.0005942221],"domain_scores_gemma":[0.99801743,0.00078284595,0.00015811635,0.0006452923,0.00024879843,0.00014750012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093635323,0.00026669583,0.0006208024,0.0001439261,0.0001649718,0.00005973374,0.00017997062,0.00010460686,0.000031715634],"category_scores_gemma":[0.00042635403,0.00020775672,0.00024259833,0.0004237554,0.00018644168,0.00013394795,0.00007160141,0.000088516514,0.000059737537],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013778805,0.000899619,0.93125445,0.00015401685,0.0005054116,0.000063208805,0.004366272,0.00000510007,0.04081658,0.00003377197,0.004186177,0.016337542],"study_design_scores_gemma":[0.0036497568,0.0008995819,0.81442857,0.00011873316,0.00043942465,0.00001749704,0.0014415095,0.00003606411,0.17602463,0.00008583217,0.0025917192,0.00026668244],"about_ca_topic_score_codex":0.00009746217,"about_ca_topic_score_gemma":0.000116086,"teacher_disagreement_score":0.13520804,"about_ca_system_score_codex":0.0000655163,"about_ca_system_score_gemma":0.00024970906,"threshold_uncertainty_score":0.8472073},"labels":[],"label_agreement":null},{"id":"W2971754743","doi":"10.1182/blood.v130.suppl_1.700.700","title":"Comparative Risk of Acute Kidney Injury with Oral Anticoagulant Use Among Patients with Nonvalvular Atrial Fibrillation","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Apixaban; Medicine; Rivaroxaban; Dabigatran; Atrial fibrillation; Internal medicine; Warfarin; Hazard ratio; Kidney disease; Acute kidney injury; Cohort; Proportional hazards model; Confidence interval","score_opus":0.039153053055466895,"score_gpt":0.3125923208140877,"score_spread":0.2734392677586208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971754743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983951,0.0000055933847,0.00014949862,0.00008075324,0.00010447058,0.00082570163,0.00012985418,0.00003439448,0.00027465672],"genre_scores_gemma":[0.9973089,0.000022519405,0.0018285598,0.000014241768,0.00036041977,5.7130785e-7,0.00017023236,0.00001848258,0.00027604483],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891824,0.00004967942,0.00025677585,0.00022177307,0.00039019657,0.00016335765],"domain_scores_gemma":[0.99857295,0.00003695883,0.00057620276,0.00048083774,0.00020847672,0.0001245873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011159154,0.0001713506,0.0005034396,0.00009130146,0.00020038174,0.00007082711,0.00008394929,0.000060312872,0.00002523631],"category_scores_gemma":[0.00011991752,0.00011179566,0.00013013983,0.000085691056,0.00015372681,0.00041953864,0.000059189355,0.00007986158,0.000008824095],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020626967,0.000021335061,0.9956846,0.000024020144,0.0016340114,0.0000075695043,0.00012189586,0.000026674003,0.0000842962,0.000040177623,0.00015361368,0.00013909175],"study_design_scores_gemma":[0.012004388,0.000987653,0.9810085,0.000109804314,0.0034221483,0.0000011603264,0.000010516349,0.00019359589,0.001463558,0.00000904705,0.0006371805,0.00015242434],"about_ca_topic_score_codex":0.00020581864,"about_ca_topic_score_gemma":0.00001370767,"teacher_disagreement_score":0.014676094,"about_ca_system_score_codex":0.000011329158,"about_ca_system_score_gemma":0.000055182667,"threshold_uncertainty_score":0.4558895},"labels":[],"label_agreement":null},{"id":"W2971830193","doi":"10.1182/blood-2018-99-117930","title":"Monoclonal Gammopathy of Undetermined Significance - Patient Characteristics and Referral Patterns","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Monoclonal gammopathy of undetermined significance; Medicine; Multiple myeloma; Population; Internal medicine; Paraproteinemia; Hematology; Referral; Incidence (geometry); Cohort; Pediatrics; Monoclonal; Immunology; Family medicine; Monoclonal antibody","score_opus":0.031993882816636995,"score_gpt":0.2924877797108114,"score_spread":0.2604938968941744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971830193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99898255,0.000048030706,0.000026371063,0.00006121317,0.0000394205,0.00023977466,0.000112023314,0.000015166384,0.00047544652],"genre_scores_gemma":[0.9989627,0.000038200982,0.00062504224,0.000049858096,0.00012714659,0.000017914504,0.00004404271,0.000011425056,0.00012366122],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992478,0.000022684591,0.00017659216,0.00016955858,0.00019585874,0.0001875313],"domain_scores_gemma":[0.99947035,0.00003030647,0.00006451666,0.0001867481,0.00009648685,0.00015156833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004186664,0.00009226344,0.00018933904,0.00004869304,0.000033542514,0.000007482479,0.00003649056,0.000038099195,0.000089246016],"category_scores_gemma":[0.000059596914,0.00007265886,0.000031483996,0.00004622211,0.00009776749,0.000027208396,0.000038825983,0.000061160674,0.00001374533],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046090363,0.00094166596,0.94223994,0.0001232872,0.0001372165,0.00020509263,0.0003237792,4.8972875e-9,0.03031,0.000020971696,0.00003603397,0.025201105],"study_design_scores_gemma":[0.0031831916,0.0022009052,0.92044115,0.00008728578,0.00008200975,0.000063785,0.000036916485,0.000083776424,0.07352065,0.000015413312,0.00021147588,0.00007346244],"about_ca_topic_score_codex":0.00006569471,"about_ca_topic_score_gemma":0.0000124746975,"teacher_disagreement_score":0.04321065,"about_ca_system_score_codex":0.000012590251,"about_ca_system_score_gemma":0.00004721384,"threshold_uncertainty_score":0.29629424},"labels":[],"label_agreement":null},{"id":"W2972201755","doi":"10.1182/blood.v130.suppl_1.5645.5645","title":"Psychometric Properties of the Patient Reported Outcomes Burdens and Experiences (PROBE) Questionnaire","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; Canadian Hemophilia Society; McMaster University","funders":"","keywords":"Interquartile range; Ceiling effect; Medicine; Convergent validity; Population; Clinical psychology; Exploratory factor analysis; Psychometrics; Physical therapy; Psychology; Internal consistency; Surgery","score_opus":0.05164459029773763,"score_gpt":0.3170757817673131,"score_spread":0.2654311914695755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972201755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955223,0.0013469,3.4826314e-7,0.0019101014,0.0000936918,0.00032224355,4.2853316e-7,0.00001253324,0.0007914129],"genre_scores_gemma":[0.9985861,0.000066448985,0.0000418523,0.000018744277,0.000025348161,0.00004143402,2.4434553e-7,0.000005079785,0.0012147179],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993311,0.000015858937,0.00015369775,0.00012978773,0.0002631429,0.00010642456],"domain_scores_gemma":[0.99930125,0.0000068430354,0.000105746876,0.00045232943,0.000081378384,0.00005247237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008311364,0.00006714446,0.00014945028,0.000060804352,0.00022663939,0.000024653016,0.00008888831,0.00003679727,0.000011401722],"category_scores_gemma":[0.00060638774,0.000029615047,0.00004882736,0.000076524855,0.0002472062,0.000041563853,0.00006433581,0.000060140886,0.0000015208714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017644532,0.00033937753,0.9900259,0.000052647472,0.00008123611,0.000010650157,0.0026149321,1.1340014e-8,0.0035848916,0.000009427985,0.000027666603,0.0032356353],"study_design_scores_gemma":[0.0011885114,0.00022969279,0.92568624,0.0002173009,0.0000796103,0.000047648424,0.0009503449,0.0000023229861,0.07145869,0.000020800482,0.00007493302,0.000043932996],"about_ca_topic_score_codex":0.00009396679,"about_ca_topic_score_gemma":0.000006342653,"teacher_disagreement_score":0.0678738,"about_ca_system_score_codex":0.0000060216557,"about_ca_system_score_gemma":0.00004747996,"threshold_uncertainty_score":0.17431498},"labels":[],"label_agreement":null},{"id":"W2972473004","doi":"10.1182/blood.v128.22.4245.4245","title":"Results from Ongoing Phase 2 Trial of SL-401 in Patients with Advanced, High-Risk Myeloproliferative Neoplasms Including Chronic Myelomonocytic Leukemia","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Interleukin-3 receptor; Chronic myelomonocytic leukemia; Myelofibrosis; Internal medicine; Myeloid; Myeloid leukemia; Oncology; Plasmacytoid dendritic cell; Immunology; Myeloproliferative neoplasm; Leukemia; Hematology; Bone marrow; Cancer research; Myelodysplastic syndromes; Immune system; Dendritic cell","score_opus":0.008983238579847404,"score_gpt":0.23006918769690227,"score_spread":0.22108594911705487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972473004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997179,0.00023748071,0.00013371943,0.000029115265,0.0014736496,0.00050468673,0.00009389055,0.000041217638,0.00030724186],"genre_scores_gemma":[0.9986944,0.00016192724,0.00009516429,0.000018255685,0.00007222314,0.000034949193,0.00023841728,0.000020047308,0.0006646098],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99850255,0.00021470943,0.0005653839,0.00037451638,0.000059779017,0.00028308207],"domain_scores_gemma":[0.99875236,0.00037394153,0.00045507483,0.00029898813,0.00010088102,0.000018775403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016815621,0.00020188255,0.00036720987,0.00015239265,0.00011423409,0.000008498879,0.00012726524,0.00018225313,0.00020944778],"category_scores_gemma":[0.00031477583,0.00013697146,0.000059716684,0.00014095355,0.00009453509,0.0002792106,0.00006107484,0.00027727938,0.00014812735],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37140194,0.003763802,0.00938079,0.000022796812,0.0012955109,0.000009453931,0.0020362928,0.00011277086,0.5177679,0.00013828815,0.0005596134,0.093510844],"study_design_scores_gemma":[0.49909613,0.006306439,0.010437413,0.00033722038,0.00015085188,0.000002519548,0.000114782604,0.00000718152,0.48150852,0.00004433643,0.001729336,0.00026526285],"about_ca_topic_score_codex":0.00042233206,"about_ca_topic_score_gemma":0.00016041771,"teacher_disagreement_score":0.12769419,"about_ca_system_score_codex":0.00031264086,"about_ca_system_score_gemma":0.00018610805,"threshold_uncertainty_score":0.5585534},"labels":[],"label_agreement":null},{"id":"W2972591852","doi":"10.1182/blood.v130.suppl_1.105.105","title":"Podoplanin Expression in the Bleeding Complications of Acute Promyelocytic Leukemias","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Podoplanin; Acute promyelocytic leukemia; Medicine; Hyperfibrinolysis; Disseminated intravascular coagulation; Platelet; Internal medicine; Cancer research; Immunology; Coagulation; Biology; Lymphatic system; Gene","score_opus":0.03612194752782044,"score_gpt":0.3094667177751043,"score_spread":0.2733447702472839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972591852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98136145,0.00016646569,0.000020753452,0.00048052674,0.00002914173,0.00032937917,0.000010217396,0.000012463024,0.017589575],"genre_scores_gemma":[0.9994251,0.000010222404,0.00025352402,0.000074502655,0.00006145932,0.00003952041,0.00000953268,0.0000051175175,0.00012101002],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99950033,0.000020000834,0.00015168895,0.00009323961,0.00014763481,0.000087122804],"domain_scores_gemma":[0.9992649,0.00005590849,0.0001132526,0.00049671665,0.00003077643,0.00003845497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011455513,0.000053508662,0.00013201479,0.000032223637,0.00010683853,0.000020576337,0.00018626437,0.000027993252,0.000011495546],"category_scores_gemma":[0.000099872384,0.000031941094,0.00003735854,0.000033129007,0.000046517616,0.000049954797,0.00003343899,0.000014248746,0.000011960427],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007926494,0.0014472045,0.8166828,0.00046598946,0.00017047746,0.00013691539,0.002807301,7.9302424e-7,0.17304091,0.0011470297,0.0033000056,0.0007212922],"study_design_scores_gemma":[0.0043049008,0.00007983306,0.95564973,0.0007426259,0.00041510718,0.00017135129,0.0005677266,0.000046572844,0.037659142,0.00014316865,0.00015601967,0.00006379677],"about_ca_topic_score_codex":0.000036217574,"about_ca_topic_score_gemma":0.0000021736328,"teacher_disagreement_score":0.13896693,"about_ca_system_score_codex":0.000014710476,"about_ca_system_score_gemma":0.00009645331,"threshold_uncertainty_score":0.130252},"labels":[],"label_agreement":null},{"id":"W2972713843","doi":"10.1182/blood.2019002516","title":"Skin colonization by circulating neoplastic clones in cutaneous T-cell lymphoma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Mycosis fungoides; T-cell receptor; Biology; Lymphoma; Cutaneous T-cell lymphoma; Neoplastic cell; T cell; Peripheral T-cell lymphoma; Cell; Immunology; Pathology; Cancer research; Medicine; Genetics; Immune system","score_opus":0.0061209031104297994,"score_gpt":0.2412390462832716,"score_spread":0.23511814317284183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972713843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921589,0.00047426487,0.00005517743,0.00013299742,0.00006836969,0.0007985175,0.000010126338,0.000056942386,0.0062447],"genre_scores_gemma":[0.99726033,0.00004514834,0.00015521645,0.0001674568,0.00004646857,0.000026612566,0.00008772895,0.000046389312,0.0021646232],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984827,0.000069018024,0.0002826942,0.00036698463,0.00040551517,0.0003930877],"domain_scores_gemma":[0.9992619,0.00019061891,0.00006482022,0.00025861416,0.00011583415,0.00010820463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009859105,0.00016812813,0.0003015802,0.00016707397,0.000051463703,0.00003380114,0.00009557928,0.00012691507,0.00029229044],"category_scores_gemma":[0.00021685213,0.00016905762,0.000055384895,0.00043856143,0.000039947547,0.000051669973,0.000048276328,0.0001149375,0.00039125682],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026169437,0.0028988793,0.8207953,0.00033777894,0.00005886006,0.0009698732,0.0009213808,0.00019869689,0.17087378,0.00004099164,0.00038049804,0.0022622612],"study_design_scores_gemma":[0.1664541,0.009702237,0.16698858,0.0018046754,0.00088936044,0.060462672,0.0059644077,0.11486159,0.45964697,0.0007348857,0.008619148,0.0038713722],"about_ca_topic_score_codex":0.00017556745,"about_ca_topic_score_gemma":0.00006740981,"teacher_disagreement_score":0.65380675,"about_ca_system_score_codex":0.0001309529,"about_ca_system_score_gemma":0.00023222808,"threshold_uncertainty_score":0.689397},"labels":[],"label_agreement":null},{"id":"W2972816620","doi":"10.1182/blood.v130.suppl_1.3859.3859","title":"Outcomes Based on CNS Disease Status in Pediatric Acute Myeloid Leukemia and the Role of Peripheral Blood Contamination in Diagnostic Lumbar Punctures; A Report from the Children's Oncology Group Studies AAML0531 and AAML1031","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Medicine; Cytarabine; Internal medicine; Oncology; Myeloid leukemia; Leukemia; Cog","score_opus":0.00980078755354569,"score_gpt":0.2887167770377611,"score_spread":0.2789159894842154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972816620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881457,0.0065973685,0.0000029184964,0.003272084,0.000068921785,0.0015861361,0.000094252915,0.000018214885,0.00021437925],"genre_scores_gemma":[0.99302596,0.0057662837,0.00011518139,0.0004801367,0.0001903101,0.0002548557,0.000084057974,0.000030441914,0.00005276042],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976081,0.00037645455,0.00056595495,0.00051879743,0.00049491716,0.00043574924],"domain_scores_gemma":[0.99555176,0.0029014626,0.00038537922,0.00087641214,0.00010733476,0.00017762888],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0010220223,0.00029408882,0.0007767287,0.00016586654,0.00024566933,0.000058214842,0.00028246507,0.00014456392,0.00000937639],"category_scores_gemma":[0.008906112,0.00016239275,0.00009782974,0.00014319325,0.0006931733,0.00011684347,0.00028216347,0.00061018387,0.0000011001528],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007276194,0.00051287614,0.9932778,0.000041298157,0.00036732518,0.0009985513,0.0012891092,0.000007657903,0.00012277969,0.00008284642,0.00006166166,0.0025105067],"study_design_scores_gemma":[0.027415693,0.00039525304,0.96912086,0.00008241995,0.001469035,0.000051417315,0.0004282688,0.00035374513,0.00010101231,0.000365282,0.0000657342,0.00015128149],"about_ca_topic_score_codex":0.0023933083,"about_ca_topic_score_gemma":0.0018682621,"teacher_disagreement_score":0.026688073,"about_ca_system_score_codex":0.00026260744,"about_ca_system_score_gemma":0.00065231684,"threshold_uncertainty_score":0.9994423},"labels":[],"label_agreement":null},{"id":"W2972879138","doi":"10.1182/blood.v130.suppl_1.714.714","title":"Single Cell-Resolution Analysis of HSC Dysfunction in <i>Mir-146a</i> knockout Mice","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency; Terry Fox Research Institute","funders":"","keywords":"Stem cell; Biology; Haematopoiesis; Hematopoietic stem cell; Progenitor cell; Population; Cancer research; Transplantation; Immunology; Myeloid; Cell biology; Internal medicine; Medicine","score_opus":0.009448443980333602,"score_gpt":0.2290195666808444,"score_spread":0.2195711227005108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972879138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969543,0.0005655146,0.00045357348,0.00002544037,0.00005874786,0.000090314636,0.000023489947,0.000005159918,0.0018234386],"genre_scores_gemma":[0.9992278,0.000026779155,0.00026353597,0.000016637621,0.000067812754,0.0000067658198,0.00018667588,0.000009290809,0.00019468843],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993466,0.000034897443,0.00017957563,0.00022671772,0.00008881276,0.00012335465],"domain_scores_gemma":[0.99921376,0.000004619881,0.0002024429,0.00048389158,0.000060732425,0.00003458639],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001088011,0.00008453398,0.00013100532,0.00009790868,0.00006634567,0.000018883151,0.00014758049,0.00011388096,0.000015652433],"category_scores_gemma":[0.000060371047,0.00009151202,0.00011354981,0.00010415255,0.000057805082,0.0000060855477,0.00006740919,0.000033686505,0.0000041521607],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003827966,0.0003528428,0.018141778,0.000016457721,0.00015229495,0.0000010107707,0.000018029517,0.00033401354,0.98050463,0.000005803482,0.00013387676,0.00030095884],"study_design_scores_gemma":[0.0009076445,0.00006698829,0.15700725,0.000009403128,0.0005207198,9.370979e-7,0.000014974362,0.00034033094,0.8399519,0.000010837727,0.0010703129,0.00009873991],"about_ca_topic_score_codex":0.000104818355,"about_ca_topic_score_gemma":0.0002753393,"teacher_disagreement_score":0.14055279,"about_ca_system_score_codex":0.000012394199,"about_ca_system_score_gemma":0.000027135577,"threshold_uncertainty_score":0.37317517},"labels":[],"label_agreement":null},{"id":"W2972977533","doi":"10.1182/blood.v130.suppl_1.4053.4053","title":"Efficacy of Copanlisib Monotherapy in Patients with Relapsed or Refractory Marginal Zone Lymphoma: Subset Analysis from the CHRONOS-1 Trial","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Internal medicine; Gastroenterology; Lymphoma; Marginal zone B-cell lymphoma; Marginal zone; B cell; Immunology","score_opus":0.016015841514752494,"score_gpt":0.26419870347118507,"score_spread":0.24818286195643258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972977533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982879,0.00029563747,0.0000038500984,0.0002364822,0.000071225935,0.0008255315,0.000105573556,0.000013438857,0.00016035794],"genre_scores_gemma":[0.9990744,0.000107638,0.00023971559,0.00008570493,0.00013292134,0.00006479281,0.00019256987,0.00001985206,0.00008239159],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998684,0.00007088411,0.00033691037,0.00031468717,0.0003952543,0.00019825462],"domain_scores_gemma":[0.9981553,0.00027305097,0.00036167048,0.0010600475,0.00006868189,0.00008126785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001406448,0.000189674,0.00059282803,0.00009317263,0.0001221622,0.00004095364,0.00023923116,0.00008708555,0.00017468816],"category_scores_gemma":[0.00010323068,0.00009754685,0.00016972014,0.00018664662,0.000121969606,0.000078550416,0.000034919834,0.00005930756,0.000010453179],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07707075,0.011368342,0.90208393,0.0000055361656,0.002441039,0.000068788715,0.00024076246,0.000002056164,0.000017435093,0.0000056018403,0.00013580776,0.006559916],"study_design_scores_gemma":[0.31350687,0.001999363,0.68145764,0.0000614204,0.0020539698,5.9042964e-7,0.000020260344,0.0000060365014,0.0005184176,0.0000015797144,0.0002947344,0.00007912325],"about_ca_topic_score_codex":0.002238034,"about_ca_topic_score_gemma":0.0006628392,"teacher_disagreement_score":0.23643613,"about_ca_system_score_codex":0.000098453995,"about_ca_system_score_gemma":0.00019664771,"threshold_uncertainty_score":0.3977845},"labels":[],"label_agreement":null},{"id":"W2973474652","doi":"10.1182/blood-2018-99-116576","title":"Validation and Clinical Impact of the Oncomine Myeloid Targeted DNA and RNA Ion Semiconductor Sequencing Assay","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"","keywords":"Ion semiconductor sequencing; DNA sequencing; Computational biology; Biology; Medicine; Bioinformatics; Gene; Genetics","score_opus":0.04038048989938673,"score_gpt":0.352317190312023,"score_spread":0.31193670041263627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973474652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983635,0.00014686395,0.00001145866,0.00036710795,0.00009381982,0.00033665908,0.000015361407,0.000021683973,0.00064355246],"genre_scores_gemma":[0.99852985,0.000096957476,0.0004860112,0.00008542098,0.00053703145,0.0000029472546,0.000012737859,0.000018738643,0.0002303019],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998786,0.00020232316,0.00032646226,0.00023770555,0.00024301626,0.00020452424],"domain_scores_gemma":[0.99895686,0.00024692185,0.00013214811,0.00032628464,0.00018853451,0.00014924457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010375485,0.000116904106,0.00027873667,0.00006857474,0.00007362322,0.000015616157,0.00009045151,0.00013984491,0.000069621645],"category_scores_gemma":[0.0011626518,0.000071035276,0.00008834236,0.00018972415,0.00033746898,0.00008659199,0.00012252959,0.00029602688,0.0000065007366],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009746018,0.00011640107,0.11316153,0.000032484193,0.00016376104,0.000004413297,0.00023799257,9.424403e-8,0.88394237,0.000008658901,0.0005918285,0.0016430048],"study_design_scores_gemma":[0.0054780566,0.0013660627,0.24621344,0.00011539649,0.00024861225,0.00015728499,0.00008282332,0.00042400186,0.745661,0.00007157153,0.000083422296,0.000098287936],"about_ca_topic_score_codex":0.00018821527,"about_ca_topic_score_gemma":0.000010116871,"teacher_disagreement_score":0.13828133,"about_ca_system_score_codex":0.00012861087,"about_ca_system_score_gemma":0.00045286855,"threshold_uncertainty_score":0.28967345},"labels":[],"label_agreement":null},{"id":"W2973571486","doi":"10.1182/blood-2018-99-116322","title":"Pediatric Reference Intervals for the DxH 520* Hematology Analyzer","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Clinical Laboratory Practices and Quality Control","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; Hospital for Sick Children","funders":"","keywords":"Mean corpuscular volume; Medicine; Red blood cell distribution width; Hematocrit; Mean corpuscular hemoglobin concentration; Mean corpuscular hemoglobin; Hematology analyzer; Complete blood count; Hematology; White blood cell; Internal medicine; Gastroenterology; Pediatrics","score_opus":0.10081887536575934,"score_gpt":0.41006955964537367,"score_spread":0.30925068427961433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973571486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9735315,0.0023369605,0.0014550944,0.0170399,0.00045067267,0.0007954287,0.000042385032,0.0000812262,0.004266848],"genre_scores_gemma":[0.9932972,0.00011461592,0.0006022544,0.004059284,0.0013290783,0.000039429822,0.000005520414,0.000011137591,0.0005414849],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99909973,0.0000776314,0.00032513283,0.00020185517,0.000111244604,0.000184395],"domain_scores_gemma":[0.9973912,0.0017109063,0.00015072156,0.00038593495,0.00027787092,0.00008336172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007267345,0.00008482924,0.0002647424,0.00003047522,0.00009157858,0.00001933702,0.00012769172,0.00009497482,0.00039903077],"category_scores_gemma":[0.00224295,0.000049781596,0.000096176474,0.00015266704,0.00007759974,0.00004970778,0.000038004942,0.00016167165,0.00017650613],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005637823,0.009914534,0.65810895,0.0013865196,0.004067392,0.00015676182,0.001849354,0.0000012271428,0.0046510394,0.16168563,0.11604449,0.03649626],"study_design_scores_gemma":[0.022641975,0.005376699,0.1000201,0.000090814814,0.009241362,0.00017492802,0.00043984005,0.0009803281,0.003972031,0.00312045,0.85338867,0.0005528124],"about_ca_topic_score_codex":0.000017230446,"about_ca_topic_score_gemma":0.00005188112,"teacher_disagreement_score":0.73734415,"about_ca_system_score_codex":0.0000043839923,"about_ca_system_score_gemma":0.00008017352,"threshold_uncertainty_score":0.4369107},"labels":[],"label_agreement":null},{"id":"W2973607898","doi":"10.1182/blood.2019002600","title":"The double-hit signature identifies double-hit diffuse large B-cell lymphoma with genetic events cryptic to FISH","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; Simon Fraser University","funders":"Canadian Institutes of Health Research; BC Cancer Foundation; Mitacs; Terry Fox Research Institute; Michael Smith Health Research BC","keywords":"BCL6; Biology; Diffuse large B-cell lymphoma; Germinal center; Fluorescence in situ hybridization; Cancer research; Lymphoma; Chromosomal translocation; Gene expression profiling; Copy-number variation; Genetics; Gene; B cell; Gene expression; Genome; Chromosome; Immunology","score_opus":0.00696804429419057,"score_gpt":0.22408201506769435,"score_spread":0.21711397077350378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973607898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99186355,0.0014158156,0.000006457773,0.0013553008,0.00030746267,0.0016846444,0.000028133141,0.00009264074,0.003246006],"genre_scores_gemma":[0.98732674,0.00018118747,0.00017101673,0.00092785043,0.00017520339,0.00029750884,0.000042286854,0.000064251566,0.010813935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99783003,0.000034954694,0.00031500158,0.0005500917,0.00062754826,0.00064237],"domain_scores_gemma":[0.99843645,0.000109142726,0.0001227266,0.00090256584,0.00013083561,0.00029825824],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012279302,0.00035782356,0.00041511425,0.00008891703,0.00023725627,0.00013083522,0.0002832686,0.00015432465,0.00015102926],"category_scores_gemma":[0.00000971797,0.00021189336,0.00016882818,0.00029063682,0.000034887922,0.00008166484,0.00013645474,0.00010767324,0.0009776338],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058762194,0.05911493,0.8982134,0.00058769656,0.0029440506,0.0015558089,0.0025761088,0.000035139947,0.005354634,0.0009432956,0.017790277,0.005008456],"study_design_scores_gemma":[0.25700316,0.0021532043,0.6584786,0.00055100414,0.0019352532,0.00023623383,0.00049939356,0.000025184816,0.047659453,0.00009252772,0.03063159,0.00073438144],"about_ca_topic_score_codex":0.00009370221,"about_ca_topic_score_gemma":0.00017042541,"teacher_disagreement_score":0.25112692,"about_ca_system_score_codex":0.000116781215,"about_ca_system_score_gemma":0.00016209055,"threshold_uncertainty_score":0.9998002},"labels":[],"label_agreement":null},{"id":"W2973711526","doi":"10.1182/blood.v130.suppl_1.759.759","title":"Novel Use of Hydroxyurea in an African Region with Malaria (NOHARM): A Randomized Controlled Trial","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Malaria; Medicine; Sickle cell anemia; Placebo; Anemia; Adverse effect; Internal medicine; Clinical trial; Pediatrics; Neutropenia; Immunology; Chemotherapy","score_opus":0.022014911643915887,"score_gpt":0.2560790293740613,"score_spread":0.2340641177301454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973711526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99094176,0.00010224806,0.000120911456,0.0012012108,0.00010382803,0.003763355,0.0000024804046,0.000025280908,0.0037389423],"genre_scores_gemma":[0.99869037,0.000085006686,0.0005235169,0.00007999506,0.000073172836,0.00014060402,0.0000073056394,0.000021260697,0.00037876584],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998786,0.0001079656,0.00046523684,0.00021635053,0.00021700478,0.00020744589],"domain_scores_gemma":[0.9986693,0.00015417044,0.00041080144,0.0005657976,0.00008400159,0.00011587377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047800332,0.00015850527,0.0013720246,0.00011869386,0.000075039745,0.000040470808,0.000117694435,0.00016443912,0.000013906422],"category_scores_gemma":[0.00086561084,0.000093972965,0.00020933845,0.000069966634,0.00023007412,0.00014182442,0.000023794946,0.00020483272,0.0000015991875],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9918091,0.0023748223,0.0021341161,0.000025265117,0.00038989153,0.000121387384,0.0003779851,0.0000089043315,0.0022166658,0.00038085796,0.000019421186,0.00014156857],"study_design_scores_gemma":[0.99491835,0.0009974268,0.0015799296,0.00018487194,0.0010938589,0.000051968418,0.00011026399,0.00057340716,0.0002728602,0.000035859666,0.00006401198,0.00011718184],"about_ca_topic_score_codex":0.00043593874,"about_ca_topic_score_gemma":0.000103927414,"teacher_disagreement_score":0.0077486294,"about_ca_system_score_codex":0.000009975968,"about_ca_system_score_gemma":0.0001375518,"threshold_uncertainty_score":0.38321063},"labels":[],"label_agreement":null},{"id":"W2973857198","doi":"10.1182/blood.v128.22.272.272","title":"Do Genetic Contributors to Warfarin Responsiveness or Common Thrombophilias Influence the Risk of Major Bleeding in Patients on Extended Duration Vitamin K Antagonist (VKA) for Venous Thromboembolic Disease?","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; McGill University; University of Ottawa; Jewish General Hospital; McMaster University; London Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Vitamin K antagonist; Warfarin; Internal medicine; Factor V Leiden; Thrombophilia; Population; Prospective cohort study; Risk factor; Cohort; Venous thrombosis; Thrombosis; Atrial fibrillation","score_opus":0.012523330993623264,"score_gpt":0.2736332815450592,"score_spread":0.261109950551436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973857198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949264,0.00010180849,0.0000810135,0.0010680802,0.0001746709,0.003321868,0.00024892663,0.000036337788,0.000040901723],"genre_scores_gemma":[0.9984982,0.00028716002,0.00014379682,0.00043026285,0.000091628106,0.00045919704,0.000021340606,0.0000443694,0.000024072633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99779224,0.00016876117,0.00064835843,0.00047711981,0.00045728163,0.000456234],"domain_scores_gemma":[0.9980407,0.0005544522,0.00031273684,0.00067082036,0.00023851354,0.00018277131],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005225973,0.0002711959,0.00073771266,0.00021731405,0.000202763,0.00003611143,0.00027023972,0.0000853416,0.000019943926],"category_scores_gemma":[0.0011149395,0.00015546787,0.00013058117,0.00033288467,0.0001110551,0.000092360526,0.000120605095,0.00010515748,0.00001678131],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005814823,0.014156609,0.9369924,0.00048800517,0.0008032604,0.00006731735,0.0015616446,0.00020372623,0.023410784,0.0024720647,0.00046709273,0.013562254],"study_design_scores_gemma":[0.0076885195,0.00304421,0.9732082,0.00078025,0.00066449586,0.0000017522764,0.00011741662,0.000011503293,0.013479079,0.0004889354,0.00030234005,0.00021331682],"about_ca_topic_score_codex":0.00016076319,"about_ca_topic_score_gemma":0.0001281253,"teacher_disagreement_score":0.03621576,"about_ca_system_score_codex":0.0001336577,"about_ca_system_score_gemma":0.00013050878,"threshold_uncertainty_score":0.63397956},"labels":[],"label_agreement":null},{"id":"W2973862136","doi":"10.1182/blood.v130.suppl_1.sci-46.sci-46","title":"Enforcing Post-Transcriptional Circuitries to Achieve Human Hematopoietic Stem Cell Expansion","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Biology; Stem cell; RNA-binding protein; Cell biology; Computational biology; Transcription factor; Regulation of gene expression; Cell fate determination; Genetics; RNA; Gene","score_opus":0.016878693958642832,"score_gpt":0.27159777140352775,"score_spread":0.2547190774448849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973862136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99630034,0.000253123,0.00039003405,0.00022885442,0.000058024198,0.00017004405,0.000016775542,0.000011925202,0.002570893],"genre_scores_gemma":[0.99536014,0.000023481025,0.000117427015,0.00017047615,0.00017595176,0.000019720579,0.00003915405,0.00001897484,0.004074653],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990679,0.000024411995,0.00014073744,0.00027871618,0.00019157829,0.00029664827],"domain_scores_gemma":[0.99915856,0.0000053234285,0.00005251907,0.0005407926,0.000085065534,0.0001577469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015430812,0.000119418204,0.00011326745,0.000038014987,0.00054651307,0.00012489215,0.00035978726,0.00009004653,0.000018890654],"category_scores_gemma":[0.000021306138,0.00011354192,0.00008310234,0.000019987481,0.000052377858,0.000008430381,0.00013456616,0.00008953316,0.000033340315],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003231315,0.000086894965,0.0017837001,0.00003354764,0.000019054212,0.000009850308,0.00012731428,0.000005096565,0.9969838,0.00023358222,0.00012675497,0.0005580632],"study_design_scores_gemma":[0.00093533157,0.0005662462,0.007907692,0.0000322298,0.000016437132,0.000019458079,0.00023152752,0.0000035127598,0.9885216,0.000055681958,0.0015291219,0.00018115992],"about_ca_topic_score_codex":0.00006995943,"about_ca_topic_score_gemma":0.000049222428,"teacher_disagreement_score":0.008462228,"about_ca_system_score_codex":0.0000061393507,"about_ca_system_score_gemma":0.000059115086,"threshold_uncertainty_score":0.46301052},"labels":[],"label_agreement":null},{"id":"W2974090375","doi":"10.1182/blood.v128.22.908.908","title":"RANK-RANKL Mediated Bone Destruction in B-Cell Acute Lymphoblastic Leukemia","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; University Health Network; University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; RANKL; Osteoclast; Denosumab; Osteopenia; Population; Bone pain; Internal medicine; Osteoporosis; Leukemia; Oncology; Cancer research; Bone mineral; Receptor; Activator (genetics)","score_opus":0.009303716871800162,"score_gpt":0.24396471638801975,"score_spread":0.2346609995162196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2974090375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99411625,0.00022653089,0.0008507572,0.00066925853,0.00018255238,0.00051807053,0.000030627954,0.00017102082,0.003234936],"genre_scores_gemma":[0.9957989,0.0003602145,0.0011524928,0.00020703659,0.0002622143,0.00007002391,0.00003170969,0.00007060916,0.002046811],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99740684,0.00009376729,0.00051900005,0.0005356838,0.00070593046,0.00073875714],"domain_scores_gemma":[0.99834883,0.00050865184,0.000109529654,0.00053066347,0.00014423678,0.00035806003],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003248431,0.00028394486,0.0005141497,0.00042239585,0.000059053244,0.000020177877,0.00019355207,0.00028301709,0.00030547997],"category_scores_gemma":[0.00056824606,0.00019363486,0.00011580455,0.0006340844,0.00019598757,0.00013766112,0.00011127346,0.00022503953,0.0008757035],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015957492,0.0010449477,0.027074415,0.00019557627,0.00031614522,0.0031147378,0.00023209241,0.000004004812,0.95722646,0.00010903183,0.0017024574,0.007384378],"study_design_scores_gemma":[0.27918777,0.0024060472,0.102894425,0.0016375228,0.0019243116,0.007003848,0.00018689071,0.0019906135,0.5964405,0.00086346956,0.004019692,0.0014449144],"about_ca_topic_score_codex":0.00013675382,"about_ca_topic_score_gemma":0.00003570411,"teacher_disagreement_score":0.36078596,"about_ca_system_score_codex":0.0014235514,"about_ca_system_score_gemma":0.0014493738,"threshold_uncertainty_score":0.99990225},"labels":[],"label_agreement":null},{"id":"W2974693007","doi":"10.1182/blood.v130.suppl_1.3135.3135","title":"Selinexor in Combination with Weekly Low Dose Bortezomib and Dexamethasone (SVd) Induces a High Response Rate with Durable Responses in Patients with Refractory Multiple Myeloma (MM)","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hôpital Maisonneuve-Rosemont; Vancouver General Hospital; CancerCare Manitoba; University of Toronto; Royal Victoria Hospital; Dalhousie University","funders":"","keywords":"Medicine; Tolerability; Bortezomib; Dexamethasone; Combination therapy; Internal medicine; Lenalidomide; Ixazomib; Oncology; Pharmacology; Refractory (planetary science); Multiple myeloma; Carfilzomib; Adverse effect","score_opus":0.017489383093827988,"score_gpt":0.27008165047396276,"score_spread":0.2525922673801348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2974693007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99744487,0.00009828065,0.0000049492355,0.00071294454,0.00001752153,0.0015759632,0.000047701313,0.000039625138,0.00005814726],"genre_scores_gemma":[0.99696976,0.00004420012,0.0020446768,0.000051491515,0.000019746913,0.00018896224,0.00007277835,0.00005627445,0.0005520813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974857,0.00054122746,0.00031051328,0.000588107,0.00054769224,0.0005267415],"domain_scores_gemma":[0.99767935,0.00075512007,0.00026215115,0.00075919833,0.00026557167,0.00027860794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009598973,0.00032692644,0.0005188734,0.00045516834,0.00023431762,0.00011924239,0.00016560152,0.00013336694,0.000014542751],"category_scores_gemma":[0.0017135727,0.0002129798,0.000021603493,0.00026854902,0.0002733929,0.00048662184,0.00007073049,0.00039022556,0.000008044596],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13804586,0.004141578,0.8493919,0.00007655814,0.00017640213,0.0011536604,0.00033523922,0.0000022401282,0.0037715374,0.0000025701713,0.00000952385,0.0028929578],"study_design_scores_gemma":[0.09359646,0.0068832384,0.8913304,0.00074452773,0.00008772708,0.000030959476,0.00014567729,0.00006543714,0.0068321563,0.000007452785,0.000033562723,0.00024240842],"about_ca_topic_score_codex":0.0013788227,"about_ca_topic_score_gemma":0.002179763,"teacher_disagreement_score":0.044449408,"about_ca_system_score_codex":0.00011877094,"about_ca_system_score_gemma":0.00042546753,"threshold_uncertainty_score":0.8685064},"labels":[],"label_agreement":null},{"id":"W2974872597","doi":"10.1182/blood-2018-99-113515","title":"Evaluation of Unexplained Lymphadenopathy and Suspected Lymphoma in a Lymphoma Rapid Diagnostic Clinic","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphadenopathy Diagnosis and Analysis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Medical diagnosis; Lymphoma; Lymph node; Retrospective cohort study; Biopsy; Exact test; Follicular lymphoma; Radiology; Surgery; Internal medicine","score_opus":0.023506545067820142,"score_gpt":0.29270094374590483,"score_spread":0.2691943986780847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2974872597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913022,0.0052965223,0.0000063907046,0.0002189313,0.000094542294,0.0005344302,0.000011975913,0.00004596297,0.0024890697],"genre_scores_gemma":[0.99827266,0.0008620227,0.00017017288,0.00018881375,0.00029616445,0.00009285725,0.000031365205,0.00003358261,0.00005237228],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972527,0.00032545492,0.0007111536,0.0004945753,0.0008802969,0.0003357878],"domain_scores_gemma":[0.9978697,0.0005649713,0.0002538592,0.0004592995,0.0006795837,0.00017261492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001821651,0.00023570737,0.0006372181,0.0004249278,0.00006896446,0.00002254184,0.000117935895,0.00016074858,0.00045386178],"category_scores_gemma":[0.003744505,0.00020990297,0.00012600342,0.0008635863,0.00022424772,0.000109138884,0.0000673329,0.0000290792,0.000060298782],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029632932,0.00892342,0.6577241,0.00017359764,0.00076223584,0.00023253406,0.0021104892,0.0000014680514,0.013212273,0.00010400916,0.00027862654,0.31618094],"study_design_scores_gemma":[0.032451037,0.0013198336,0.9332587,0.00043312158,0.003591594,0.00015622411,0.0004929976,0.001304588,0.026272263,0.00033106972,0.00013269494,0.0002558858],"about_ca_topic_score_codex":0.00019312705,"about_ca_topic_score_gemma":0.000121041936,"teacher_disagreement_score":0.31592506,"about_ca_system_score_codex":0.00015896105,"about_ca_system_score_gemma":0.0005022382,"threshold_uncertainty_score":0.8559594},"labels":[],"label_agreement":null},{"id":"W2975001300","doi":"10.1182/blood.2019000779","title":"Reproducing the molecular subclassification of peripheral T-cell lymphoma–NOS by immunohistochemistry","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":168,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Medical Research Council; Medical Research Council; Singapore General Hospital; Tanoto Foundation; National Cancer Institute; National Institutes of Health; University of Nebraska Medical Center","keywords":"Immunohistochemistry; Pathology; Lymphoma; Medicine","score_opus":0.00494663866105653,"score_gpt":0.22244532650186885,"score_spread":0.21749868784081233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2975001300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98462254,0.0045062904,0.000005363432,0.00041519842,0.000049815804,0.0003273557,0.0000061889896,0.000020810527,0.0100464355],"genre_scores_gemma":[0.99801826,0.00006428618,0.00014510685,0.00010783553,0.000027998769,0.000045227956,0.000046330948,0.000015065446,0.0015298717],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992158,0.000015553147,0.00019183506,0.00027070526,0.00018172614,0.00012437813],"domain_scores_gemma":[0.99901766,0.000026076492,0.00010721678,0.0007561358,0.00005562099,0.000037304297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000095953954,0.00010312881,0.00017183807,0.00001269302,0.000031947184,0.0000089876885,0.00008568779,0.000053745815,0.00007766811],"category_scores_gemma":[0.000025463742,0.00007034334,0.00010056448,0.00007704168,0.000036550162,0.000021340029,0.00002210062,0.000033406166,0.00003387563],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003155256,0.0018275486,0.037117124,0.00007266642,0.000093635805,0.000009089807,0.000169963,0.0000010836259,0.95906055,0.00006791469,0.00049324124,0.0010556442],"study_design_scores_gemma":[0.0051580854,0.00014231847,0.027189804,0.000045994893,0.00021866593,0.000037990427,0.000092087525,0.00001620483,0.96560746,0.000007987579,0.0014097017,0.00007370718],"about_ca_topic_score_codex":0.00009812189,"about_ca_topic_score_gemma":1.3510834e-7,"teacher_disagreement_score":0.013395735,"about_ca_system_score_codex":0.000072729985,"about_ca_system_score_gemma":0.00009012188,"threshold_uncertainty_score":0.28685182},"labels":[],"label_agreement":null},{"id":"W2975037999","doi":"10.1182/blood.v130.suppl_1.4592.4592","title":"Alemtuzumab/Low Dose TBI Conditioning Facilitates Stable Long-Term Donor Hematopoietic Cell Engraftment from Sibling Donors in Children with Sickle Cell Disease","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Stollery Children's Hospital; Alberta Children's Hospital; University of Alberta; University of Calgary","funders":"","keywords":"Medicine; Alemtuzumab; Total body irradiation; Regimen; Hematopoietic stem cell transplantation; Sickle cell anemia; Anemia; Internal medicine; Population; Transplantation; Pediatrics; Surgery; Disease; Chemotherapy; Cyclophosphamide","score_opus":0.006659728399557555,"score_gpt":0.22060662094125177,"score_spread":0.21394689254169422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2975037999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99445957,0.00282782,0.000036176974,0.00023286586,0.00006756033,0.0009440497,0.00015648488,0.00008533603,0.001190116],"genre_scores_gemma":[0.9977109,0.0005060758,0.00036835714,0.00011081664,0.0000701888,0.000070883136,0.00042346877,0.00004850418,0.0006908506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981773,0.000042730404,0.0003754507,0.0005508496,0.00030991505,0.000543785],"domain_scores_gemma":[0.99848104,0.000058876765,0.00021652001,0.00078345893,0.000058158243,0.00040193784],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012833814,0.0003305866,0.0004331822,0.00014085659,0.00042525725,0.00016582686,0.00023431976,0.00013450575,0.00025249933],"category_scores_gemma":[0.000044469638,0.00026414613,0.00012101537,0.000111694746,0.0001741089,0.0002290947,0.00010063348,0.00036640916,0.00010135458],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018167285,0.0019041456,0.9934822,0.00024957108,0.00016483912,0.00031482885,0.00088959,0.00024406247,0.0023344734,0.0000062437175,0.000051344614,0.0001770478],"study_design_scores_gemma":[0.020544631,0.0003860711,0.9450811,0.0009763322,0.00087138155,0.000026430542,0.00079425354,0.00011498292,0.030505551,0.00010676177,0.000037380127,0.00055513263],"about_ca_topic_score_codex":0.0009820828,"about_ca_topic_score_gemma":0.000111395726,"teacher_disagreement_score":0.048401088,"about_ca_system_score_codex":0.00006384268,"about_ca_system_score_gemma":0.00020849753,"threshold_uncertainty_score":0.99998105},"labels":[],"label_agreement":null},{"id":"W2975492890","doi":"10.1182/blood.v128.22.326.326","title":"Differential Glycosylation Between Recombinant Factor VIII Produced in Baby Hamster Kidney and Chinese Hamster Ovary Cells Confers Differences in Immunogenicity in a Humanized Hemophilia Α Mouse Model","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Queen's University","funders":"","keywords":"Chinese hamster ovary cell; Immunogenicity; Baby hamster kidney cell; Molecular biology; Biotinylation; Recombinant DNA; Glycan; Biology; Antibody; Antigen; Chemistry; Immunology; Biochemistry; Receptor; Glycoprotein","score_opus":0.031622794664015956,"score_gpt":0.27489038431422,"score_spread":0.24326758965020406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2975492890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99731207,0.000057478064,0.000018087907,0.0011157938,0.00007223192,0.0012673003,0.000061574145,0.000033008993,0.00006246421],"genre_scores_gemma":[0.99831545,0.00015705317,0.0000728879,0.000036896818,0.00006994796,0.00007633935,0.000053613174,0.00003451549,0.0011832644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977894,0.00016609898,0.00057470053,0.00059976534,0.00035363523,0.00051643146],"domain_scores_gemma":[0.99915665,0.00012225538,0.00008482676,0.0003665635,0.00005253983,0.0002171486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020729667,0.00033168631,0.0007259616,0.00045099435,0.000049985563,0.00003686739,0.0001412007,0.00022422719,0.000120785306],"category_scores_gemma":[0.00013790956,0.0001957412,0.00008742933,0.00022596079,0.00010658057,0.00020274147,0.00013004383,0.00030398517,0.000014261427],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049364247,0.00091279217,0.6482458,0.00007999778,0.000056532957,0.000029815874,0.00063857314,1.1627433e-7,0.34845823,0.0000035826026,0.000004459604,0.0010764212],"study_design_scores_gemma":[0.0257577,0.00035507313,0.83193344,0.00039666586,0.000055321598,0.0000043253012,0.000017038907,0.0006030281,0.14031845,0.0002746377,0.00000386589,0.00028045574],"about_ca_topic_score_codex":0.0002477106,"about_ca_topic_score_gemma":0.00017204846,"teacher_disagreement_score":0.20813978,"about_ca_system_score_codex":0.00012368083,"about_ca_system_score_gemma":0.00016075875,"threshold_uncertainty_score":0.7982094},"labels":[],"label_agreement":null},{"id":"W2975900312","doi":"10.1182/blood.v130.suppl_1.1861.1861","title":"A Phase Ib/II Trial of Selinexor Combined with Lenalidomide and Low Dose Dexamethasone in Patients with Relapsed / Refractory Multiple Myeloma","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Princess Margaret Cancer Centre; Dalhousie University; Royal Victoria Hospital; University of Toronto; CancerCare Manitoba; Vancouver General Hospital","funders":"","keywords":"Lenalidomide; Tolerability; Neutropenia; Medicine; Regimen; Dexamethasone; Internal medicine; Multiple myeloma; Febrile neutropenia; Oncology; Phases of clinical research; Pomalidomide; Refractory (planetary science); Gastroenterology; Pharmacology; Adverse effect; Clinical trial; Toxicity; Biology","score_opus":0.006399400487065476,"score_gpt":0.22313358608058748,"score_spread":0.216734185593522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2975900312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994007,0.000038245053,0.000021279204,0.000020431145,0.00006317034,0.00035291462,0.00001796596,0.00000499987,0.000080346465],"genre_scores_gemma":[0.9988254,0.0000142488,0.00090116286,0.000026609143,0.0000803807,0.0000105453255,0.00006222823,0.000018814175,0.000060650007],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993587,0.000033508695,0.00015057279,0.00023380332,0.00010280496,0.000120621124],"domain_scores_gemma":[0.9992843,0.000010782071,0.0001900244,0.0003968625,0.0000699811,0.00004799563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000089714595,0.00011896781,0.00017791345,0.000030971583,0.000094951145,0.000015862166,0.00009466519,0.00010492905,0.0000037964771],"category_scores_gemma":[0.00012294407,0.00008626853,0.00002470252,0.000026973621,0.00009801298,0.000009120828,0.000055001,0.000080354206,3.7295138e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4132519,0.0081264945,0.13262397,0.00007545276,0.00037077666,0.000017907134,0.00021705667,0.0000065790887,0.43272352,0.000011430505,0.0001484478,0.012426423],"study_design_scores_gemma":[0.69768035,0.031960934,0.15007438,0.00007793283,0.0001497887,0.00000535497,0.000032909105,0.00002809361,0.11870055,0.000013285892,0.00097327575,0.0003031244],"about_ca_topic_score_codex":0.000031656782,"about_ca_topic_score_gemma":0.00010967507,"teacher_disagreement_score":0.314023,"about_ca_system_score_codex":0.0000034073646,"about_ca_system_score_gemma":0.000035470097,"threshold_uncertainty_score":0.35179284},"labels":[],"label_agreement":null},{"id":"W2976980698","doi":"10.1182/blood.v128.22.936.936","title":"The Focal Adhesion Complex Ilk-Pinch-Parvin Is Key to Niche Interactions and Survival of Quiescent Stem Cells in Chronic Myeloid Leukemia In Vitro and In Vivo","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"CD34; Integrin-linked kinase; CD38; Myeloid leukemia; Stem cell; Cancer research; Progenitor cell; Focal adhesion; Biology; Population; Leukemia; Immunology; Cell biology; Medicine; Signal transduction; Kinase; Protein kinase A; Cyclin-dependent kinase 2","score_opus":0.02830810594428384,"score_gpt":0.29748307811117924,"score_spread":0.2691749721668954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2976980698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972105,0.00043148137,0.0000141945175,0.0014320973,0.0000515629,0.00055680296,0.000015552707,0.000008198593,0.0002795952],"genre_scores_gemma":[0.998138,0.00076508813,0.00008654485,0.00008150617,0.000036371,0.000031087275,0.0000013231727,0.000019265795,0.0008407773],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99839616,0.00018903989,0.00041619243,0.0003250034,0.00032077104,0.0003528356],"domain_scores_gemma":[0.99894303,0.00048780115,0.000057028345,0.00031334785,0.000048713253,0.00015008304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045958295,0.00014310236,0.00032353587,0.00026847044,0.00003777462,0.00001739886,0.00012944381,0.00007356344,0.00007597085],"category_scores_gemma":[0.00008132654,0.0000929945,0.000036785696,0.00030710807,0.00012301958,0.000049559767,0.00026142405,0.00025659453,0.000015918304],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006066765,0.00016850629,0.0141938655,0.00009100363,0.000013264642,0.000034249377,0.0003683491,0.0000021011672,0.97594017,0.000009472559,0.0003987842,0.008173541],"study_design_scores_gemma":[0.0058999825,0.0003721522,0.09197341,0.00045839496,0.000016223428,0.000015897127,0.00047316746,0.0004693493,0.8938573,0.000013934462,0.0063236104,0.00012655542],"about_ca_topic_score_codex":0.0006595176,"about_ca_topic_score_gemma":0.004446689,"teacher_disagreement_score":0.08208286,"about_ca_system_score_codex":0.0005535291,"about_ca_system_score_gemma":0.00028488657,"threshold_uncertainty_score":0.37922058},"labels":[],"label_agreement":null},{"id":"W2977190700","doi":"10.1182/blood.2019001880","title":"The whole-genome landscape of Burkitt lymphoma subtypes","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":200,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Biology; Genetics; Gene; Genome; Cancer research; Virology","score_opus":0.006947996934359438,"score_gpt":0.2183594275006246,"score_spread":0.21141143056626516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2977190700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830815,0.0022593264,2.1534215e-7,0.00082595786,0.000082549726,0.00023140383,0.000018551744,0.000020471145,0.013479998],"genre_scores_gemma":[0.9975256,0.0002133079,0.000036831134,0.00015087458,0.00007263314,0.00001751786,0.000027189351,0.0000108622435,0.0019452331],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994069,0.000013093053,0.0001409348,0.00012905015,0.0001606549,0.00014940547],"domain_scores_gemma":[0.9994221,0.0000858289,0.000054895623,0.00033880176,0.00004446435,0.000053941847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007384826,0.00008431031,0.00017992717,0.000026032469,0.000038965572,0.000011299414,0.000072489354,0.000040014995,0.00008822055],"category_scores_gemma":[0.000016215627,0.000046895573,0.00008666659,0.00008198427,0.00002686662,0.000019164008,0.000028190647,0.000018452552,0.0002920528],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000118067226,0.0019368563,0.97752887,0.000065310516,0.0005049256,0.000053644042,0.00020038326,0.0000012087136,0.01090596,0.0011512452,0.00081200997,0.006721509],"study_design_scores_gemma":[0.008118763,0.0004808021,0.9043836,0.000043838798,0.000268641,0.00006491902,0.00011700097,0.0000059625436,0.017786086,0.000048769743,0.06860804,0.00007354988],"about_ca_topic_score_codex":0.000027273136,"about_ca_topic_score_gemma":0.000007423688,"teacher_disagreement_score":0.073145255,"about_ca_system_score_codex":0.000014798224,"about_ca_system_score_gemma":0.000066992674,"threshold_uncertainty_score":0.37538454},"labels":[],"label_agreement":null},{"id":"W2977283561","doi":"10.1182/blood.v114.22.1845.1845","title":"Inhibition of the Proteasome in Bone Marrow-Derived CD138+ Tumor Cells Following Carfilzomib Administration in Relapsed or Refractory Myeloma Patients.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Carfilzomib; Bortezomib; Multiple myeloma; Bone marrow; Proteasome; Proteasome inhibitor; Medicine; Peripheral blood mononuclear cell; Pharmacology; Cancer research; Internal medicine; Chemistry; In vitro; Biochemistry","score_opus":0.01535904812107852,"score_gpt":0.26540346366588624,"score_spread":0.2500444155448077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2977283561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974488,0.00007739248,6.0446473e-7,0.00024922733,0.000047526,0.0016752147,0.000020288437,0.000018389326,0.0004625468],"genre_scores_gemma":[0.99923515,0.000008078765,0.00032090297,0.00008871585,0.000028206234,0.000084711595,0.00005994031,0.000014435385,0.00015984595],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99847454,0.00013182471,0.0004249672,0.0002488272,0.00043500724,0.0002848211],"domain_scores_gemma":[0.99937844,0.000047362602,0.00013698218,0.00028338374,0.000057281308,0.000096519834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018720831,0.00014994627,0.00029783606,0.0001698775,0.000040899005,0.0000101262385,0.00006354419,0.00008324613,0.000030830895],"category_scores_gemma":[0.00031893447,0.00010108404,0.00010379154,0.0003739366,0.000032510445,0.00009463863,0.000024215251,0.00023378669,0.000007535707],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002407332,0.006824077,0.2591094,0.00013338546,0.000054729462,0.0010540809,0.00059214776,0.000001818415,0.724758,0.000008900328,0.00003740609,0.0050186943],"study_design_scores_gemma":[0.014513181,0.0013384784,0.63005584,0.00037176983,0.000036851474,0.000008796498,0.00007386656,0.000018010198,0.3534499,0.000033902696,0.000020292167,0.00007907684],"about_ca_topic_score_codex":0.000066925684,"about_ca_topic_score_gemma":0.00021050108,"teacher_disagreement_score":0.37130812,"about_ca_system_score_codex":0.00011875741,"about_ca_system_score_gemma":0.00024603924,"threshold_uncertainty_score":0.41220877},"labels":[],"label_agreement":null},{"id":"W2977472578","doi":"10.1182/blood.v106.11.1976.1976","title":"Immunodeficient Mice Are Poor Mobilizers -Novel Evidence That Demonstrates a Pivotal Role of Complement in Triggering Mobilization of HSPC.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Complement system; Alternative complement pathway; Haematopoiesis; Antibody; Bone marrow; Classical complement pathway; Mobilization; Progenitor cell; Immunoglobulin D; Cell biology; Immunology; Chemistry; Biology; Molecular biology; B cell; Stem cell","score_opus":0.02741472315072356,"score_gpt":0.2828255884800747,"score_spread":0.25541086532935114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2977472578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99567544,0.003294614,0.00040641002,0.000055813824,0.000010522201,0.00035952107,0.000022369644,0.000004248606,0.00017105821],"genre_scores_gemma":[0.9986965,0.00019356745,0.0009846869,0.00001335929,0.00001465516,0.000031583342,0.000024755826,0.00000921371,0.00003167685],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990741,0.000039187096,0.00028971813,0.00021299873,0.0002092798,0.00017469305],"domain_scores_gemma":[0.99946773,0.000020204272,0.00017236355,0.00019877485,0.0001079769,0.00003297134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024652755,0.00009536322,0.00014459489,0.00008493835,0.000025797834,0.000008844577,0.00015302045,0.00006644248,0.000030351111],"category_scores_gemma":[0.00010685466,0.00009365722,0.000060585164,0.00015267839,0.0000613307,0.00000844931,0.00008492984,0.0000576332,0.0000016689569],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008092588,0.00056036597,0.019881424,0.000049398943,0.000020508332,3.740122e-7,0.00007557685,0.0021214858,0.97585225,0.00004175615,0.000004506375,0.0013113995],"study_design_scores_gemma":[0.0012812311,0.00019109764,0.013596816,0.00011631757,0.000011016138,0.000005591664,0.0006075425,0.0021148622,0.9816155,0.0000065903214,0.00036140875,0.00009201956],"about_ca_topic_score_codex":0.00010544256,"about_ca_topic_score_gemma":0.00017181931,"teacher_disagreement_score":0.0062846085,"about_ca_system_score_codex":0.000014447817,"about_ca_system_score_gemma":0.00006572119,"threshold_uncertainty_score":0.38192305},"labels":[],"label_agreement":null},{"id":"W2977473977","doi":"10.1182/blood.v128.22.1186.1186","title":"Bendamustine and Rituximab Versus Conventional Chemoimmunotherapy As a Frontline Treatment for Patients with Indolent B-Cell Lymphoma: A Cost-Effectiveness Analysis","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Chemoimmunotherapy; Medicine; Rituximab; Oncology; Regimen; Internal medicine; Bendamustine; Progression-free survival; Lymphoma; Chemotherapy","score_opus":0.015589283134948293,"score_gpt":0.2726982390252723,"score_spread":0.257108955890324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2977473977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964355,0.00078430603,0.00018925275,0.00018140151,0.00005798225,0.001906857,0.0002734539,0.00003553519,0.00013571532],"genre_scores_gemma":[0.99714863,0.00022503785,0.00073078583,0.000044351516,0.000051928168,0.0012524102,0.00032797997,0.000027523145,0.00019136938],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988642,0.00003388029,0.00020493372,0.00041868573,0.00022711704,0.0002512137],"domain_scores_gemma":[0.999012,0.0003093245,0.00011394149,0.00025584074,0.00016884354,0.00014003606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006961902,0.0002637119,0.0005446796,0.0001325798,0.00008759124,0.00001846166,0.000038382772,0.000069665395,0.00007661456],"category_scores_gemma":[0.00002175641,0.00014488595,0.00022231099,0.0001595892,0.00006451935,0.00005509981,0.00001657209,0.000013512576,0.000014211303],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022309387,0.08939641,0.81070334,0.000082440405,0.011651098,0.000049594884,0.000112560934,9.3659025e-7,0.0004182125,0.00012380468,0.000025531886,0.065126695],"study_design_scores_gemma":[0.42520684,0.0070949593,0.5468087,0.00009770145,0.0059158877,0.000007311198,0.0000133257845,0.000010654649,0.012819318,0.000010289298,0.0018485244,0.00016647039],"about_ca_topic_score_codex":0.00012479053,"about_ca_topic_score_gemma":0.000028287084,"teacher_disagreement_score":0.40289745,"about_ca_system_score_codex":0.00032265656,"about_ca_system_score_gemma":0.00012957906,"threshold_uncertainty_score":0.59082776},"labels":[],"label_agreement":null},{"id":"W2977485976","doi":"10.1182/blood-2018-99-116891","title":"Trends in Vital Signs in Relation to Patient Outcomes during Induction Phase in Treatment of Acute Leukemia","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Regional Hospital; University of Windsor; Western University","funders":"","keywords":"Medicine; Induction chemotherapy; Intensive care unit; Acute leukemia; Ambulatory; Chemotherapy; Leukemia; Emergency medicine; Internal medicine; Pediatrics","score_opus":0.02218146775016618,"score_gpt":0.32023983524914557,"score_spread":0.2980583674989794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2977485976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986138,0.000012483432,0.000003412883,0.00018339144,0.00009768833,0.00021729695,0.000006935874,0.000011407954,0.00085360004],"genre_scores_gemma":[0.9996153,0.000008741384,0.000057800968,0.0000215492,0.00004318601,0.0000668533,0.0000129330265,0.000007662821,0.000165983],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994153,0.000018166724,0.00023105544,0.00014102957,0.00008053045,0.00011395296],"domain_scores_gemma":[0.9997839,0.000007215671,0.000040271523,0.000113917835,0.000016957945,0.000037743648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000026233462,0.000075269345,0.0001842005,0.00047055967,0.00001499011,0.0000027557796,0.000014913808,0.000044999364,0.000048445258],"category_scores_gemma":[0.0000058386763,0.00006473932,0.00003713579,0.00045206895,0.000013905813,0.000068348694,0.000008166009,0.000054384174,0.0000070014958],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003491855,0.0024743516,0.7276618,0.000006809012,0.00005681605,0.000053873577,0.0035460626,0.000036818765,0.25231484,0.000015284602,0.00000970268,0.01347446],"study_design_scores_gemma":[0.011321463,0.003473357,0.8027467,0.000052374297,0.00007323499,0.000017596047,0.00011182256,0.0000039377583,0.18203564,0.000007664203,0.00009335594,0.000062825544],"about_ca_topic_score_codex":0.00052074855,"about_ca_topic_score_gemma":0.0010737055,"teacher_disagreement_score":0.07508492,"about_ca_system_score_codex":0.00040884447,"about_ca_system_score_gemma":0.00003978241,"threshold_uncertainty_score":0.26399928},"labels":[],"label_agreement":null},{"id":"W2977598599","doi":"10.1182/blood-2018-99-116264","title":"A Next-Generation Fc-Bearing CD3-Engaging Bispecific DART® Platform with Extended Pharmacokinetic and Expanded Pharmacologic Window: Characterization As CD123 x CD3 and CD19 x CD3 DART Molecules","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Interleukin-3 receptor; CD3; CD19; Cmax; Cytokine release syndrome; Cytokine; Chemistry; Immunology; Pharmacology; Antigen; Medicine; Cancer research; T cell; Biology; Pharmacokinetics; Immune system; CD8","score_opus":0.059474206092329174,"score_gpt":0.31518270128561837,"score_spread":0.2557084951932892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2977598599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950783,0.0005069716,0.0002548988,0.00032732665,0.00013753101,0.001218583,0.000012263188,0.00015120319,0.0023128684],"genre_scores_gemma":[0.9952323,0.0009818968,0.0006139852,0.00047937533,0.0010033627,0.00010026699,0.00018045906,0.000075642856,0.0013327084],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977681,0.000113063055,0.00035062918,0.00068204146,0.0005474618,0.00053872337],"domain_scores_gemma":[0.99897313,0.00007033249,0.0001345899,0.00030841658,0.00021049532,0.00030303004],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00047619175,0.00034199774,0.0004055126,0.00031255776,0.00040439048,0.00024252357,0.0001173878,0.00012221944,0.00092230435],"category_scores_gemma":[0.00004801422,0.00028960264,0.000048030666,0.00037099034,0.00028453305,0.00042499157,0.000109640416,0.00042222842,0.000036888665],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089741824,0.00037803894,0.0041655055,0.000093738745,0.00022962962,0.00012219498,0.0010926044,0.0000011041884,0.96892464,0.000029006793,0.000039031394,0.024027087],"study_design_scores_gemma":[0.01391221,0.0021088587,0.025821026,0.00017749371,0.0005074735,0.00075411436,0.00035347315,0.0042705685,0.9494145,0.00004076773,0.0021919936,0.0004475088],"about_ca_topic_score_codex":0.000025793754,"about_ca_topic_score_gemma":0.00001788137,"teacher_disagreement_score":0.023579579,"about_ca_system_score_codex":0.00005723987,"about_ca_system_score_gemma":0.0001267418,"threshold_uncertainty_score":0.999991},"labels":[],"label_agreement":null},{"id":"W2977813434","doi":"10.1182/blood.v118.21.1289.1289","title":"Genome-Wide shRNA Screen for DNA Damage Response Regulators in Human Hematopoietic Stem and Progenitor Cells","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Molecular Biology Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"DNA damage; Haematopoiesis; Gene knockdown; Biology; Progenitor cell; Stem cell; Bone marrow; Genome instability; Small hairpin RNA; DNA repair; Cancer research; Molecular biology; Apoptosis; Cell biology; Gene; DNA; Genetics; Immunology","score_opus":0.01410620163764434,"score_gpt":0.24174832685893535,"score_spread":0.22764212522129101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2977813434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99769086,0.00023125173,0.0010504245,0.0000381633,0.0000101865735,0.0006858203,0.000054632525,0.000023604027,0.00021504535],"genre_scores_gemma":[0.9948459,0.000020309233,0.004358632,0.0000912537,0.000038279013,0.00026086965,0.00008072055,0.00002766499,0.00027633487],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99910986,0.00006676286,0.0002028475,0.0003617617,0.000043690277,0.00021506277],"domain_scores_gemma":[0.999414,0.000011551937,0.00006872443,0.00039889087,0.000033384847,0.0000734155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027285586,0.00013913456,0.00013561487,0.000052871164,0.00008136702,0.000010596012,0.00018416555,0.00018569174,0.0000061523665],"category_scores_gemma":[0.000013321593,0.0001375235,0.000062249186,0.000061322244,0.00009570661,0.000002138141,0.00011026478,0.000055997618,0.0000014045447],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000994011,0.00016649261,0.0072406977,0.000016424332,0.000028470291,0.0000041284507,0.00006700505,1.078724e-7,0.9919621,0.00028941248,0.00008443941,0.000041331168],"study_design_scores_gemma":[0.0007422346,0.00037047104,0.027159324,0.000008974946,0.000032157375,0.000011314686,0.000041678453,0.000001582109,0.9666354,0.00026294703,0.004557583,0.00017629888],"about_ca_topic_score_codex":0.000008161616,"about_ca_topic_score_gemma":0.000015692189,"teacher_disagreement_score":0.025326656,"about_ca_system_score_codex":0.000004985994,"about_ca_system_score_gemma":0.000027336193,"threshold_uncertainty_score":0.56080455},"labels":[],"label_agreement":null},{"id":"W2977871361","doi":"10.1182/blood.v108.11.2865.2865","title":"Adult Recipients of Matched Related Donor Blood Cell Transplants Given Pretransplant Antithymocyte Globulin Have Less Graft-Versus-Host Disease and Transplant-Related Mortality: Follow-Up of a Matched Pair Analysis.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre","funders":"","keywords":"Thymoglobulin; Medicine; Fludarabine; Internal medicine; Gastroenterology; Busulfan; Graft-versus-host disease; Cyclophosphamide; Transplantation; Surgery; Hematopoietic stem cell transplantation; Chemotherapy; Tacrolimus","score_opus":0.014052232737893234,"score_gpt":0.23844591239829924,"score_spread":0.224393679660406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2977871361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932701,0.0009383011,0.00037200333,0.00013033142,0.00021631896,0.0014571554,0.0026321097,0.0001654976,0.00081816345],"genre_scores_gemma":[0.9953938,0.0011684399,0.0006633708,0.00002038745,0.000030794305,0.000049113867,0.0022058557,0.00009354267,0.000374703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99491185,0.00026971768,0.0020668898,0.0009892121,0.0010639612,0.0006983511],"domain_scores_gemma":[0.99746853,0.00026668026,0.0006602217,0.0008101085,0.00030283662,0.0004916443],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00049909815,0.00068466633,0.0018370916,0.00058779493,0.00010307055,0.000025141331,0.00029316198,0.0005289725,0.00012395975],"category_scores_gemma":[0.000022663598,0.00064879673,0.0007237243,0.0011243166,0.000302171,0.0001809233,0.000017182567,0.0004040487,0.00000956061],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005689002,0.0035127054,0.87395376,0.00466508,0.007814834,0.0012282344,0.003552684,0.000102737344,0.09933835,0.00010868445,0.000011204788,0.00002272498],"study_design_scores_gemma":[0.05281708,0.00060516445,0.6284635,0.002065671,0.064727135,0.00014113785,0.00036137522,0.0006734874,0.24935739,0.000092546885,0.0000029716332,0.00069255877],"about_ca_topic_score_codex":0.0015690452,"about_ca_topic_score_gemma":0.0007526472,"teacher_disagreement_score":0.24549027,"about_ca_system_score_codex":0.000032399934,"about_ca_system_score_gemma":0.00018768093,"threshold_uncertainty_score":0.99959636},"labels":[],"label_agreement":null},{"id":"W2977970933","doi":"10.1182/blood.v116.21.5177.5177","title":"A Novel Dendritic Cell Population Generated by Fusing Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-21 Induces Tumor-Antigen Specific Immunity","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University; Institute for Research in Immunology and Cancer; Jewish General Hospital","funders":"","keywords":"Immunology; Immune system; Dendritic cell; Antigen; CD8; Cancer immunotherapy; Cancer; Cancer research; Population; Antigen presentation; Acquired immune system; Biology; Medicine; Immunotherapy; T cell; Internal medicine","score_opus":0.013419122042838879,"score_gpt":0.232771422626979,"score_spread":0.21935230058414013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2977970933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989818,0.0084019145,0.00009939659,0.000019643223,0.0010122737,0.00032910507,0.000085838794,0.00010518188,0.00012867062],"genre_scores_gemma":[0.99852383,0.00015990557,0.0004208693,0.00007546053,0.000058673588,0.000014266682,0.0002722381,0.00004635216,0.00042841368],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99834645,0.0002681531,0.00047360105,0.0003820033,0.00005615463,0.0004736645],"domain_scores_gemma":[0.9990439,0.00024730692,0.00022023114,0.00036852606,0.0000863374,0.000033693712],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002674671,0.0003228864,0.00039408964,0.00015717451,0.00065468776,0.00010756796,0.00025150747,0.00033653996,0.00036552563],"category_scores_gemma":[0.00009119705,0.00031196495,0.00008929787,0.00018659403,0.00023161617,0.00021080251,0.000107258355,0.0008242782,0.000062522646],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028112164,0.00047432,0.0070592766,0.000014949962,0.00011007441,0.000007746134,0.0006944906,0.0000014196279,0.9897275,0.000016028402,0.000051490333,0.0015615829],"study_design_scores_gemma":[0.0038894585,0.00020265067,0.092617065,0.00003881784,0.00003679624,0.00024432712,0.00017036151,0.00001015138,0.89984107,0.000012624938,0.00258247,0.00035417872],"about_ca_topic_score_codex":0.00065431884,"about_ca_topic_score_gemma":0.000049787774,"teacher_disagreement_score":0.089886405,"about_ca_system_score_codex":0.00002322894,"about_ca_system_score_gemma":0.000045706165,"threshold_uncertainty_score":0.99993324},"labels":[],"label_agreement":null},{"id":"W2978422592","doi":"10.1182/blood-2018-99-114274","title":"An Increased Number of Cybord Induction Cycles Does Not Increase Peri-Transplant Morbidity in Multiple Myeloma Patients","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital; McGill University Health Centre","funders":"","keywords":"Medicine; Multiple myeloma; Melphalan; Bortezomib; Autologous stem-cell transplantation; Busulfan; Internal medicine; Transplantation; Surgery; Hematopoietic stem cell transplantation; Oncology","score_opus":0.02380352254892753,"score_gpt":0.3019297641042701,"score_spread":0.27812624155534255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978422592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984618,0.000011482801,0.0000051488405,0.000028481398,0.00007438969,0.00056750333,0.0002762409,0.00004926671,0.00052571663],"genre_scores_gemma":[0.9982127,0.000032652693,0.0010579868,0.00004319594,0.0001933335,0.000052399042,0.0003556279,0.000027301934,0.000024788022],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983028,0.00016211566,0.00034612787,0.0003618715,0.00046589674,0.000361177],"domain_scores_gemma":[0.9988605,0.00007902542,0.000092474605,0.00042267193,0.0002166061,0.000328733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019933206,0.00019652031,0.00033819865,0.00016140469,0.000085031985,0.000013833369,0.00011787712,0.00012901697,0.00026939248],"category_scores_gemma":[0.00024895804,0.00014192841,0.00007327799,0.00023113457,0.00019072008,0.00019242261,0.000032672833,0.00016860219,0.000058769743],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001919794,0.005057425,0.9370939,0.00008122859,0.000108880864,0.00009591036,0.0003334439,1.2925342e-7,0.052044727,0.000009031703,0.000008184799,0.0032473388],"study_design_scores_gemma":[0.01103729,0.00053982856,0.78707516,0.00009878444,0.00008792374,0.0000220121,0.000058825208,0.00012597187,0.20079894,0.000018658333,0.00002308,0.00011351742],"about_ca_topic_score_codex":0.010742577,"about_ca_topic_score_gemma":0.0015559439,"teacher_disagreement_score":0.15001874,"about_ca_system_score_codex":0.00005145187,"about_ca_system_score_gemma":0.0001068596,"threshold_uncertainty_score":0.99584496},"labels":[],"label_agreement":null},{"id":"W2978647547","doi":"10.1182/blood.v126.23.5384.5384","title":"Pomalidomide-Containing Regimens (PCR) for the Treatment of Relapsed and Refractory Multiple Myeloma","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Calgary Laboratory Services; University of Alberta; University of Calgary","funders":"","keywords":"Pomalidomide; Lenalidomide; Bortezomib; Medicine; Multiple myeloma; Internal medicine; Dexamethasone; Oncology; Thalidomide; Surgery; Gastroenterology","score_opus":0.06323097932850842,"score_gpt":0.31696981247590034,"score_spread":0.25373883314739193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978647547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931521,0.0041274223,0.000047259622,0.00048276954,0.000059578066,0.0012644911,0.000036965743,0.000033255175,0.00079618185],"genre_scores_gemma":[0.9958736,0.00034724458,0.0022121095,0.000035902816,0.00013008135,0.00021232497,0.00003502949,0.000024812613,0.0011289096],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990181,0.00004402109,0.00021172497,0.00022408663,0.0002264899,0.0002756103],"domain_scores_gemma":[0.9985259,0.0006345366,0.00008672441,0.00036208285,0.00014054877,0.00025019769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019573969,0.0001492361,0.00030814685,0.00006542545,0.000087956716,0.000012519197,0.00005628569,0.000066712724,0.000009273795],"category_scores_gemma":[0.00042831592,0.000087210574,0.0001008989,0.00007250306,0.00009529539,0.000045308523,0.000020072748,0.000054496842,0.0000068529116],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017029226,0.009654269,0.8194701,0.00020956658,0.0043910425,0.00048615775,0.00783833,0.0000049237565,0.022544997,0.00038866207,0.0014113949,0.11657133],"study_design_scores_gemma":[0.28699306,0.0460391,0.43506187,0.0002993944,0.002938295,0.00043520372,0.004611053,0.002323216,0.13284343,0.000381811,0.08751949,0.00055408484],"about_ca_topic_score_codex":0.00022311306,"about_ca_topic_score_gemma":0.000058682577,"teacher_disagreement_score":0.38440824,"about_ca_system_score_codex":0.000068373294,"about_ca_system_score_gemma":0.00013312203,"threshold_uncertainty_score":0.3556344},"labels":[],"label_agreement":null},{"id":"W2979098064","doi":"10.1182/blood.v118.21.1144.1144","title":"Characterization of the Binding Between the Polymeric Platelet Adhesive Proteins, Multimerin 1 and Von Willebrand Factor","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Regional Laboratory Medicine Program; McMaster University","funders":"","keywords":"Von Willebrand factor; Platelet; Chemistry; Glycoprotein; Molecular biology; Glycoprotein Ib; Disintegrin; Plasma protein binding; Von Willebrand disease; Integrin; Binding site; Platelet membrane glycoprotein; Platelet activation; Biochemistry; Biology; Immunology; Metalloproteinase; Cell; Enzyme","score_opus":0.019771444286428744,"score_gpt":0.22090959256503814,"score_spread":0.2011381482786094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979098064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998799,0.00012557,0.0000061505198,0.00010820314,0.00002680878,0.00065602706,0.00006537206,0.000013237219,0.00019958336],"genre_scores_gemma":[0.9996645,0.000054775388,0.000054314158,0.000032199307,0.000024950752,0.000020406356,0.000028016575,0.000012419996,0.00010844798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995025,0.00002775231,0.00013197551,0.00011704896,0.000103928345,0.0001167931],"domain_scores_gemma":[0.9996606,0.000019748599,0.000111535956,0.00015537317,0.000016424314,0.000036301928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000030965395,0.000098093005,0.00018425252,0.00003064063,0.00008051364,0.0000056593494,0.000057851685,0.000048338465,0.00004057688],"category_scores_gemma":[0.000018225031,0.000049836533,0.000041085415,0.00010395365,0.00006247869,0.00004956285,0.000029356579,0.00006962677,0.000005192103],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006548833,0.00030458585,0.62516963,0.000045173056,0.00034748984,0.00002059263,0.0019054421,5.683738e-9,0.36259618,0.0000067972296,0.0000021047788,0.009536512],"study_design_scores_gemma":[0.0015833061,0.00012162498,0.5719453,0.000043533928,0.0001272541,0.000020788668,0.00004039808,0.0000016756214,0.42601553,0.000005732228,0.00005325752,0.00004159699],"about_ca_topic_score_codex":0.00007428863,"about_ca_topic_score_gemma":0.0000025265556,"teacher_disagreement_score":0.06341934,"about_ca_system_score_codex":0.0000041674925,"about_ca_system_score_gemma":0.000019326728,"threshold_uncertainty_score":0.20322748},"labels":[],"label_agreement":null},{"id":"W2979180314","doi":"10.1182/blood-2018-99-115728","title":"Bleeding Patterns in Type I VWD in Effect of VWF Levels: An Individual Participant Data Meta-Analysis of Three Cohorts","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Kingston General Hospital; Queen's University","funders":"","keywords":"Von Willebrand disease; Medicine; Pediatrics; Cohort; Von Willebrand factor; Internal medicine; Platelet","score_opus":0.2758816473749033,"score_gpt":0.38398524464690986,"score_spread":0.10810359727200658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979180314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99849206,0.0008096956,0.000004944125,0.000027195812,0.000020308236,0.000261136,0.000260917,0.0000068674667,0.00011685686],"genre_scores_gemma":[0.99954945,0.000013694053,0.00010646649,0.00002371824,0.00001349788,0.000011406023,0.0002667269,0.000010464306,0.0000045892193],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987945,0.00007555563,0.00038350193,0.0002860409,0.00025653798,0.00020383808],"domain_scores_gemma":[0.9990828,0.00009948219,0.00012454821,0.0005952532,0.000039740396,0.000058182184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066054886,0.00012730234,0.0012010316,0.00032017851,0.000011771967,0.000005520234,0.00017353237,0.00006395168,0.00020986794],"category_scores_gemma":[0.00010904114,0.00009033232,0.00012582206,0.0006340566,0.000046789246,0.000094815696,0.00010283838,0.00007471789,0.000003338187],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008944181,0.0010824924,0.92831796,0.000045866193,0.06889515,0.00014930508,0.0003825494,0.000004986985,0.0005640893,0.00000791163,0.0000047640297,0.00045545105],"study_design_scores_gemma":[0.0026884875,0.0010647889,0.71249324,0.000024541925,0.27667627,0.000005397714,0.00004735057,0.00034842678,0.0065558515,0.000018937917,0.0000037625446,0.00007291984],"about_ca_topic_score_codex":0.001168428,"about_ca_topic_score_gemma":0.009867876,"teacher_disagreement_score":0.21582474,"about_ca_system_score_codex":0.000004165552,"about_ca_system_score_gemma":0.00003907214,"threshold_uncertainty_score":0.5506506},"labels":[],"label_agreement":null},{"id":"W2979242992","doi":"10.1182/blood.v128.22.2301.2301","title":"Impact of Genomic Alterations on Outcomes in Myelofibrosis Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Myelofibrosis; Ruxolitinib; Hematopoietic stem cell transplantation; Oncology; Internal medicine; Transplantation; Cohort; Cancer; Bone marrow","score_opus":0.01415079610792921,"score_gpt":0.26121368671327877,"score_spread":0.24706289060534956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979242992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998814,0.00005064504,0.000039100352,0.00015063623,0.0000304233,0.0004797074,0.00008998229,0.000014536949,0.0003310031],"genre_scores_gemma":[0.99933416,0.0002267235,0.00016944259,0.000040372317,0.000012517447,0.000067169385,0.000033910612,0.000018181709,0.00009752888],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990892,0.000046001267,0.00031691615,0.00021151637,0.00016517163,0.00017122895],"domain_scores_gemma":[0.9993675,0.00024075543,0.000096230586,0.0001762885,0.0000453585,0.00007391399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000044129338,0.00015885566,0.00030682073,0.00014151656,0.000033528573,0.000007414843,0.00003823922,0.000052306234,0.000070973234],"category_scores_gemma":[0.00000793665,0.00009316438,0.00014056335,0.00006965481,0.000017452523,0.000052450232,0.000007023346,0.000037529164,0.000044476757],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009086794,0.002635304,0.97602767,0.00007726221,0.00014741952,0.000011372118,0.0004895847,0.000022154094,0.01979334,0.00006970989,0.000009577188,0.0006257338],"study_design_scores_gemma":[0.008500865,0.0015685178,0.9010974,0.00022215142,0.00016702405,0.0000046284154,0.000014839043,0.0000015818831,0.08831263,0.000022947645,0.0000013708764,0.00008604585],"about_ca_topic_score_codex":0.00002493398,"about_ca_topic_score_gemma":0.00006309898,"teacher_disagreement_score":0.07493028,"about_ca_system_score_codex":0.00011024496,"about_ca_system_score_gemma":0.00009250345,"threshold_uncertainty_score":0.37991333},"labels":[],"label_agreement":null},{"id":"W2979293481","doi":"10.1182/blood.v122.21.1.1","title":"EZH2 and BCL6 Cooperate To Create The Germinal Center B-Cell Phenotype and Induce Lymphomas Through Formation and Repression Of Bivalent Chromatin Domains","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"PRC2; Bivalent chromatin; EZH2; Biology; Germinal center; Histone methyltransferase; Chromatin; H3K4me3; Cancer research; Histone H3; Molecular biology; Somatic hypermutation; Cell biology; B cell; Chromatin remodeling; Promoter; Genetics; Gene expression; Gene; Antibody","score_opus":0.008531605639970961,"score_gpt":0.22990761349479205,"score_spread":0.2213760078548211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979293481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963683,0.00216535,0.0003108008,0.00013183092,0.000020518606,0.00025444455,0.0000085764095,0.0000030453227,0.000737135],"genre_scores_gemma":[0.99739015,0.0012117445,0.0011613196,0.0000789121,0.00004048521,0.000015910306,0.000019472887,0.00000816034,0.00007387139],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999471,0.00004716959,0.00015046555,0.00016854095,0.000064175554,0.0000986588],"domain_scores_gemma":[0.9996542,0.000011966021,0.00007131121,0.00016042078,0.000057391793,0.00004475308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000099392906,0.00008672603,0.00008451327,0.000014650443,0.00007572053,0.000032283686,0.000043359014,0.000065772176,0.0000057912534],"category_scores_gemma":[0.000022948485,0.000060094713,0.000012966972,0.00003523541,0.00004619936,0.00001030632,0.00010471363,0.000027047889,0.0000015739103],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016199274,0.00007114064,0.0037985162,0.000037848262,0.000011015925,2.951825e-7,0.00042373734,0.000004363614,0.9924988,0.000021236812,0.00003765975,0.0030791862],"study_design_scores_gemma":[0.0011513719,0.00027099016,0.045722134,0.000027934579,0.000027996808,0.000007589898,0.00009468114,0.00008451822,0.9512629,0.0001554026,0.0011025484,0.00009192457],"about_ca_topic_score_codex":0.0000474735,"about_ca_topic_score_gemma":0.0000071555073,"teacher_disagreement_score":0.04192362,"about_ca_system_score_codex":0.0000020726625,"about_ca_system_score_gemma":0.00001005141,"threshold_uncertainty_score":0.24505913},"labels":[],"label_agreement":null},{"id":"W2979296208","doi":"10.1182/blood.v124.21.3016.3016","title":"Accurate Diagnosis of Aggressive B Cell Non-Hodgkin Lymphomas Using Gene Expression Profiling of Formalin-Fixed, Paraffin-Embedded Tissues","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Gene expression profiling; Lymphoma; Pathology; Gene expression; Biology; Medicine; Gene; Cancer research; Genetics","score_opus":0.01801471228970975,"score_gpt":0.2771314768097298,"score_spread":0.2591167645200201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979296208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960903,0.002167786,0.00032066755,0.00003242814,0.00011499046,0.0006241566,0.00003538524,0.000035052828,0.00057923666],"genre_scores_gemma":[0.969631,0.0004614738,0.029490532,0.000043651104,0.00013809909,0.00012023825,0.000050005863,0.00003864308,0.000026335103],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99825865,0.00007391693,0.00060974236,0.00035020403,0.00037354694,0.00033392082],"domain_scores_gemma":[0.997929,0.00021736427,0.0010035943,0.0004987675,0.00019527909,0.00015601508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001804752,0.0002769492,0.00069936714,0.00013837867,0.00007540405,0.000013474232,0.0001357857,0.00015300562,0.00005507844],"category_scores_gemma":[0.00015320249,0.00021359322,0.0002026759,0.00018606066,0.000073314295,0.00011766669,0.00010807955,0.00005898747,0.000013136039],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028627005,0.0056854794,0.3796573,0.0007949143,0.00029685983,0.00014907417,0.0009866504,0.0002693081,0.6083767,0.000091054586,0.00012358447,0.0032828434],"study_design_scores_gemma":[0.009539922,0.00069964863,0.009763494,0.0010654874,0.0007065991,0.00004719881,0.000119490105,0.000898016,0.9768846,0.000037666414,0.00004702464,0.0001908259],"about_ca_topic_score_codex":0.000110608526,"about_ca_topic_score_gemma":0.0000026212851,"teacher_disagreement_score":0.36989382,"about_ca_system_score_codex":0.000046082514,"about_ca_system_score_gemma":0.00012683634,"threshold_uncertainty_score":0.87100786},"labels":[],"label_agreement":null},{"id":"W2979300664","doi":"10.1182/blood.v110.11.1271.1271","title":"Deletion of HoxA Genes Inhibits Proliferation and Differentiation of Myeloid Progenitors.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Biology; Haematopoiesis; Progenitor cell; Myeloid; Hox gene; Stem cell; Cre recombinase; Gene; Cell biology; Molecular biology; Genetics; Transgene; Cancer research; Gene expression; Genetically modified mouse","score_opus":0.004972849728697486,"score_gpt":0.2165610691958886,"score_spread":0.2115882194671911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979300664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99600464,0.0012180118,0.0024502643,0.000014014573,0.000052197214,0.00020343075,0.000005036224,0.0000050403955,0.000047381847],"genre_scores_gemma":[0.99905366,0.00013999718,0.0004820142,0.0000033882768,0.00016632545,0.0000059557237,0.00011624105,0.000008460098,0.00002396438],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99947965,0.000017201177,0.00020336261,0.00013019667,0.000094066265,0.000075549804],"domain_scores_gemma":[0.99962133,0.0000036522226,0.00013845241,0.00009800653,0.0001160749,0.00002250012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011707336,0.00006342314,0.000076396565,0.000046436013,0.000020701245,0.000003680678,0.000025189584,0.00011375903,0.0000017603227],"category_scores_gemma":[0.000019733528,0.00006442791,0.000028316292,0.000065031956,0.000030013156,0.0000037992488,0.000019550786,0.000021463444,2.3120855e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051136485,0.00008770819,0.02972466,0.000038498,0.00003392067,5.4865982e-8,0.00003716187,0.000021943302,0.9623218,0.000038678383,0.000007437071,0.007636972],"study_design_scores_gemma":[0.00062864885,0.0001693884,0.07992078,0.000013028917,0.000043100685,0.0000057824477,0.000010514099,0.00004424052,0.91897964,0.00003098027,0.00009721382,0.00005669618],"about_ca_topic_score_codex":0.0000052335813,"about_ca_topic_score_gemma":0.00003320831,"teacher_disagreement_score":0.050196122,"about_ca_system_score_codex":0.0000046565547,"about_ca_system_score_gemma":0.000024892912,"threshold_uncertainty_score":0.2627294},"labels":[],"label_agreement":null},{"id":"W2979301166","doi":"10.1182/blood.v118.21.4111.4111","title":"Very Good Partial Response and Complete Response Predict Superior Overall Survival and Progression Free Survival After Single Autologous Stem Cell Transplant in Patients with Multiple Myeloma,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Multiple myeloma; Melphalan; Internal medicine; Progression-free survival; Hazard ratio; Cyclophosphamide; Autologous stem-cell transplantation; Proportional hazards model; Creatinine; Urology; Surgery; Gastroenterology; Oncology; Overall survival; Chemotherapy; Confidence interval","score_opus":0.02356297165650279,"score_gpt":0.23620530064740333,"score_spread":0.21264232899090055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979301166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976444,0.00031565028,0.000007581934,0.000058092526,0.00006924757,0.001269272,0.00048406748,0.00007153852,0.00008010312],"genre_scores_gemma":[0.9988947,0.000019524148,0.00072654855,0.000016389788,0.000027562,0.00012697012,0.000057108202,0.00005048459,0.000080698366],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970471,0.00077523506,0.0003550027,0.00058285444,0.0006115336,0.0006282432],"domain_scores_gemma":[0.9984748,0.00048089353,0.00007353788,0.00046488165,0.00007770048,0.00042820696],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00058990286,0.00033944455,0.00051920477,0.00019683153,0.00010321981,0.000037196405,0.00011439526,0.00015909997,0.000034916913],"category_scores_gemma":[0.00009934633,0.00024788085,0.000053989505,0.00012254296,0.0002292328,0.00015962879,0.000115033174,0.00025237154,0.000006293703],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1973287,0.0029300458,0.7906842,0.00010530978,0.00012026471,0.0014691899,0.0014177542,1.157144e-7,0.0049244617,0.0000010541775,0.0000022558595,0.0010166334],"study_design_scores_gemma":[0.04502124,0.007372159,0.9410436,0.0002793584,0.00015643629,0.000049080205,0.00009955478,0.00006340665,0.0056103547,0.0000024911367,0.000061724895,0.00024056724],"about_ca_topic_score_codex":0.00015151109,"about_ca_topic_score_gemma":0.00023526374,"teacher_disagreement_score":0.15230747,"about_ca_system_score_codex":0.00005227277,"about_ca_system_score_gemma":0.00013271533,"threshold_uncertainty_score":0.9999973},"labels":[],"label_agreement":null},{"id":"W2979301202","doi":"10.1182/blood.v114.22.1919.1919","title":"TNFRSF14 Is Mutated in a Subset of Follicular Lymphoma and Correlated with Inferior Prognosis.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Biology; Loss of heterozygosity; Genetics; Comparative genomic hybridization; Gene; Follicular lymphoma; Cancer research; Mutation; Allele; Chromosome; Lymphoma; Immunology","score_opus":0.006622444621639754,"score_gpt":0.22405857994122275,"score_spread":0.217436135319583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979301202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971762,0.0011817988,9.49109e-7,0.00059444614,0.000008490948,0.0005237776,0.000010589716,0.000032501983,0.00047128458],"genre_scores_gemma":[0.9990082,0.00014322114,0.00035506737,0.00037148583,0.000008832038,0.00004121239,0.00002788611,0.000011016847,0.000033082517],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99919116,0.000018080984,0.00022524399,0.00022130081,0.00016209729,0.00018213323],"domain_scores_gemma":[0.9995806,0.000024161993,0.00007282884,0.00016775413,0.00005746415,0.00009713968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000052517807,0.00014773125,0.0003516978,0.00010437087,0.000019120302,0.000009780506,0.000030802537,0.00008098602,0.000022246686],"category_scores_gemma":[0.000018455969,0.00010304534,0.00004372444,0.00030375662,0.000042829044,0.000041670377,0.000010342836,0.000032925724,0.000005297024],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021916756,0.0042397007,0.9858769,0.000036365822,0.00020928445,0.000731628,0.0005050944,7.4153e-7,0.00095547055,0.00005101456,0.00008684172,0.0070877713],"study_design_scores_gemma":[0.021708172,0.0017688744,0.9274187,0.0003099087,0.00044368513,0.00028510825,0.000045222387,0.00004843423,0.047709152,0.000024386147,0.00013301591,0.00010535806],"about_ca_topic_score_codex":0.00016316662,"about_ca_topic_score_gemma":0.00003195195,"teacher_disagreement_score":0.058458235,"about_ca_system_score_codex":0.00002913192,"about_ca_system_score_gemma":0.00008857308,"threshold_uncertainty_score":0.42020673},"labels":[],"label_agreement":null},{"id":"W2979301583","doi":"10.1182/blood.v126.23.2254.2254","title":"Natural Killer Cells Contribute to Pathophysiology of Placenta Leading to Miscarriage in Fetal and Neonatal Alloimmune Thrombocytopenia","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Placenta; Biology; Trophoblast; Neonatal alloimmune thrombocytopenia; Fetus; Andrology; Immunology; Medicine; Pregnancy","score_opus":0.012208299366492991,"score_gpt":0.2585668883188362,"score_spread":0.2463585889523432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979301583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997723,0.00096912164,0.000009470034,0.00034200324,0.00023996377,0.00045992885,0.000021073993,0.000011485762,0.00022398875],"genre_scores_gemma":[0.9983877,0.000026760084,0.0006129999,0.00033346965,0.000022552924,0.000011221996,0.000041137722,0.000012325454,0.00055185554],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992166,0.00002514958,0.00018494116,0.00021628464,0.00011856273,0.00023845889],"domain_scores_gemma":[0.9995679,0.00003165771,0.000044190572,0.00014527737,0.000040953248,0.00016999256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008157611,0.00012905261,0.00048792156,0.000082139995,0.00001642389,0.000006249316,0.000060387058,0.000062391264,0.000012808242],"category_scores_gemma":[0.00006559918,0.00010556363,0.00003747885,0.000115600575,0.000025833919,0.000041813742,0.00009038592,0.00009480442,0.00003962349],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024370865,0.001600396,0.03435627,0.000093582246,0.0005074224,0.0028149006,0.004168408,0.000028256869,0.93945986,0.00006550977,0.0030825997,0.011385705],"study_design_scores_gemma":[0.13947836,0.008331309,0.291721,0.00091169623,0.00096073025,0.00094226195,0.003073141,0.00016944761,0.5368923,0.0004599734,0.01569502,0.0013647691],"about_ca_topic_score_codex":0.00014021488,"about_ca_topic_score_gemma":0.000080415186,"teacher_disagreement_score":0.40256757,"about_ca_system_score_codex":0.00002647141,"about_ca_system_score_gemma":0.000037170255,"threshold_uncertainty_score":0.43047598},"labels":[],"label_agreement":null},{"id":"W2979304829","doi":"10.1182/blood.v114.22.40.40","title":"GNF-2, An Allosteric BCR-ABL Inhibitor, Identifies a Novel Myristoylation-Mediated Mechanism Regulating the Ability of BCR-ABL to Activate HCK and IGF-1 Signaling.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Allosteric regulation; Kinase; Myristoylation; Dasatinib; Biology; Autophosphorylation; Cell biology; ABL; Imatinib mesylate; Proto-oncogene tyrosine-protein kinase Src; Protein kinase domain; Nilotinib; Signal transduction; Cancer research; Phosphorylation; Tyrosine kinase; Chemistry; Protein kinase A; Imatinib; Biochemistry; Mutant; Receptor","score_opus":0.01710268104111163,"score_gpt":0.26105384173302265,"score_spread":0.24395116069191103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979304829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974316,0.00019043394,0.00021453625,0.0007093895,0.000101293386,0.0009397661,0.000029829216,0.000098548844,0.00028465065],"genre_scores_gemma":[0.9960273,0.000013076612,0.0032108813,0.00030553437,0.00017889364,0.000029240722,0.000054833323,0.000032205044,0.00014806166],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99798363,0.000091905364,0.0005676269,0.00052314915,0.00048046082,0.00035323884],"domain_scores_gemma":[0.9984091,0.00026114014,0.0002672156,0.00067453284,0.00017382787,0.00021418097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000491288,0.0002849172,0.00046660626,0.0001245862,0.00016869116,0.00004557094,0.00015324319,0.00015105665,0.000062575265],"category_scores_gemma":[0.00048036358,0.00021798295,0.00009193517,0.00037699036,0.00008550759,0.00020442353,0.00008569373,0.00021844472,0.000011421249],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023878287,0.0009254428,0.0014962462,0.00008890074,0.00014942941,0.000012827277,0.002216314,0.000023928256,0.9922875,0.000091582995,0.00003562812,0.0024333815],"study_design_scores_gemma":[0.012722327,0.0019488579,0.20175299,0.0005611922,0.0008050548,0.00013756231,0.00087357947,0.0011798737,0.7775646,0.0018389532,0.00014003272,0.000475017],"about_ca_topic_score_codex":0.00025036721,"about_ca_topic_score_gemma":0.00003968601,"teacher_disagreement_score":0.21472298,"about_ca_system_score_codex":0.00021377408,"about_ca_system_score_gemma":0.00021469442,"threshold_uncertainty_score":0.8889087},"labels":[],"label_agreement":null},{"id":"W2979306928","doi":"10.1182/blood.v118.21.4630.4630","title":"Notch Signaling Represses Mir-223 in T-Cell Acute Lymphoblastic Leukemia","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Notch signaling pathway; Jurkat cells; Biology; microRNA; HES1; Signal transduction; Cancer research; Leukemia; Gene expression profiling; Cell biology; T cell; Molecular biology; Gene expression; Immunology; Genetics; Gene","score_opus":0.04162700988124669,"score_gpt":0.2792706520277158,"score_spread":0.2376436421464691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979306928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.928426,0.0005388844,0.000066820816,0.000032016113,0.0000667184,0.00037536398,0.0000033641684,0.000061474275,0.070429325],"genre_scores_gemma":[0.9940828,0.000081220016,0.0015566084,0.00008516768,0.00011009013,0.00003944211,0.000008073933,0.00003858103,0.003998013],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981798,0.000070290065,0.00034260005,0.00042212126,0.00046660216,0.00051858556],"domain_scores_gemma":[0.9989413,0.00017007111,0.00006514243,0.00048581805,0.00009242246,0.00024522975],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035647216,0.00017330174,0.0003415163,0.00018266207,0.00004575092,0.000017352182,0.00020980972,0.00013958772,0.0010412788],"category_scores_gemma":[0.00021415105,0.00015035541,0.00008125237,0.00036041084,0.00006343335,0.00006877758,0.00011897557,0.00027047796,0.0005013905],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042893924,0.0018479984,0.08217883,0.00044797204,0.00016526204,0.003352082,0.0013723504,0.000007008304,0.9086828,0.00007054817,0.00068924326,0.0007569432],"study_design_scores_gemma":[0.007853835,0.0004753157,0.021658566,0.0002959737,0.0002476416,0.00018379538,0.00015151229,0.00017179959,0.9680108,0.00016646214,0.0005446151,0.00023968848],"about_ca_topic_score_codex":0.0006329041,"about_ca_topic_score_gemma":0.00003223882,"teacher_disagreement_score":0.066431314,"about_ca_system_score_codex":0.00011623057,"about_ca_system_score_gemma":0.00034092693,"threshold_uncertainty_score":0.9998719},"labels":[],"label_agreement":null},{"id":"W2979307590","doi":"10.1182/blood.v128.22.2263.2263","title":"Immunoglobulin Recovery after ASCT for Patients with Multiple Myeloma: Impact on Overall Survival and Progression-Free Survival","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Medicine; Multiple myeloma; Bortezomib; Internal medicine; Progression-free survival; Lenalidomide; Oncology; Urology; Gastroenterology; Surgery; Chemotherapy","score_opus":0.012076879897014323,"score_gpt":0.2806665186982146,"score_spread":0.26858963880120024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979307590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99667084,0.0002129514,0.00004669714,0.0002439762,0.00011069798,0.0016026264,0.0007060744,0.000056881483,0.00034925085],"genre_scores_gemma":[0.9973681,0.000062090614,0.0014823524,0.000027871245,0.00014390815,0.0002877371,0.0001221379,0.000056906938,0.00044892324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980458,0.00007461294,0.00022466,0.00046143238,0.00061973254,0.0005737797],"domain_scores_gemma":[0.9982141,0.00058162626,0.00008435942,0.00058663933,0.0001893833,0.00034389127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019381488,0.00030898003,0.00041000667,0.00010485593,0.00009535209,0.000038727212,0.000118552234,0.00010715494,0.000099819365],"category_scores_gemma":[0.00059084326,0.00014849752,0.0001453828,0.00007772017,0.000087763154,0.00015322155,0.00009951346,0.00010540151,0.000032261778],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026135048,0.0026338976,0.9412578,0.000064073734,0.0006582443,0.0000843261,0.000020272648,1.5425059e-7,0.00040194317,0.0000068846807,0.00017940013,0.028557956],"study_design_scores_gemma":[0.056946453,0.007991614,0.9327136,0.00038953644,0.00013098672,0.000009066756,0.0000059418003,0.000007395182,0.0012628324,0.00007287722,0.00026821002,0.00020145056],"about_ca_topic_score_codex":0.00006128437,"about_ca_topic_score_gemma":0.000043147167,"teacher_disagreement_score":0.030811403,"about_ca_system_score_codex":0.00008952425,"about_ca_system_score_gemma":0.000116668234,"threshold_uncertainty_score":0.6055553},"labels":[],"label_agreement":null},{"id":"W2979308051","doi":"10.1182/blood.v118.21.1645.1645","title":"Lymphopenia and EBER-Negativity Predict Poor Survival in Patients with Post-Transplant Lymphoproliferative Disorder (PTLD) Treated in the Rituximab Era","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of Calgary","funders":"","keywords":"Rituximab; Medicine; Internal medicine; Post-transplant lymphoproliferative disorder; Lymphoproliferative disorders; Immunosuppression; Gastroenterology; Lymphoma; Oncology","score_opus":0.007162625648947385,"score_gpt":0.19933020805740406,"score_spread":0.1921675824084567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979308051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952678,0.00022442499,0.0000035588257,0.00033682794,0.000029386218,0.00092605257,0.00012972088,0.000029705781,0.003052509],"genre_scores_gemma":[0.9990942,0.00007699487,0.000045066885,0.0005192939,0.000015340622,0.000083069885,0.00010270564,0.000025350591,0.0000379996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99856055,0.00016729359,0.00025734314,0.00033811264,0.00032432092,0.00035236712],"domain_scores_gemma":[0.9994979,0.000056284072,0.00008115481,0.00020101374,0.00008209392,0.000081545295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021650718,0.00024156053,0.00041366834,0.00011059519,0.00007548959,0.000021666714,0.00010296815,0.0001182482,0.00004865578],"category_scores_gemma":[0.00004389606,0.00014918766,0.000043912118,0.00034477128,0.0001122931,0.00014814235,0.000018965782,0.00019069265,0.000004733895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022519222,0.004103732,0.9873194,0.00003103691,0.000114340706,0.000063409025,0.0053107427,6.5958426e-7,0.000021079284,0.000029938574,0.00002053681,0.000733201],"study_design_scores_gemma":[0.051052917,0.001391311,0.9460369,0.0001210319,0.00020336431,0.000011150674,0.0007606365,0.000020534246,0.00015534305,0.00004200317,0.000018197756,0.00018660726],"about_ca_topic_score_codex":0.005774624,"about_ca_topic_score_gemma":0.0101009905,"teacher_disagreement_score":0.048800994,"about_ca_system_score_codex":0.000059475944,"about_ca_system_score_gemma":0.00014081408,"threshold_uncertainty_score":0.87295425},"labels":[],"label_agreement":null},{"id":"W2979308942","doi":"10.1182/blood.v128.22.882.882","title":"Safety of Weight-Adjusted Dosing of LMWH in Clinically Obese Cancer Patients with Venous Thromboembolism","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Medicine; Cancer; Body mass index; Thrombosis; Low molecular weight heparin; Internal medicine; Surgery; Venous thrombosis; Malignancy","score_opus":0.012412228633588212,"score_gpt":0.26187134036200654,"score_spread":0.24945911172841834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979308942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99666107,0.0003438912,0.0000312858,0.0003763968,0.00013325571,0.00065413077,0.000037427562,0.000022460128,0.0017401086],"genre_scores_gemma":[0.9982781,0.0009225389,0.00044456648,0.00016295278,0.00007180591,0.000030581847,0.0000066092703,0.00003157739,0.000051259227],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982859,0.000049322858,0.000707297,0.00028597168,0.0003831007,0.0002883914],"domain_scores_gemma":[0.9988725,0.00011338488,0.00032400468,0.0003874575,0.00020490905,0.00009774571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022798739,0.00016772156,0.0009219331,0.00013869678,0.000024156425,0.0000030607332,0.00013090766,0.00009610063,0.00016832989],"category_scores_gemma":[0.000087924716,0.00010160735,0.000089827874,0.00024939489,0.00012269685,0.000073945106,0.00007460833,0.00009458857,0.0000061721926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051019207,0.015173767,0.963994,0.00045189654,0.0006176152,0.000022459268,0.0006916372,0.000005173235,0.0037045467,0.00047899448,0.00022369662,0.01412601],"study_design_scores_gemma":[0.012215281,0.0015294952,0.97690254,0.002158639,0.0006240067,9.144728e-7,0.000035915855,0.0000015209163,0.005953975,0.000048583846,0.0003912992,0.00013783255],"about_ca_topic_score_codex":0.00039343027,"about_ca_topic_score_gemma":0.00016541358,"teacher_disagreement_score":0.013988177,"about_ca_system_score_codex":0.00004702672,"about_ca_system_score_gemma":0.00013426447,"threshold_uncertainty_score":0.41434276},"labels":[],"label_agreement":null},{"id":"W2979311448","doi":"10.1182/blood.v124.21.475.475","title":"Thymocyte Selection-Associated High-Mobility Group Box Protein (TOX) Induces Genomic Instability in T-Cell Acute Lymphoblastic Leukemia","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Ku70; Biology; Thymocyte; Ku80; Genome instability; Molecular biology; DNA repair; Cancer research; T cell; DNA repair protein XRCC4; Zebrafish; Progenitor cell; Cell biology; DNA damage; Genetics; Gene; Stem cell; DNA; DNA-binding protein; Transcription factor; Nucleotide excision repair","score_opus":0.008678231806457685,"score_gpt":0.23610248001190562,"score_spread":0.22742424820544793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979311448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99542147,0.00006990491,0.0003183205,0.00016216726,0.00013227705,0.0019302223,0.00003628286,0.00028231237,0.0016470259],"genre_scores_gemma":[0.9973305,0.000020560366,0.0011887492,0.00020234956,0.0002401849,0.0003677601,0.00009584502,0.00009322919,0.00046080936],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9953884,0.00057432585,0.0009069733,0.0011171018,0.00089183165,0.0011214038],"domain_scores_gemma":[0.9976682,0.00052929507,0.00025854117,0.0008328791,0.0002780224,0.0004330505],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016688533,0.00050239736,0.00093901594,0.00036386237,0.00020270215,0.000071095084,0.00043761698,0.0005706873,0.00018117092],"category_scores_gemma":[0.0014932432,0.0004591374,0.0001867818,0.0011410685,0.00028222872,0.0002276641,0.0002786305,0.0009040455,0.00021411692],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013712988,0.006631849,0.08281756,0.00057598745,0.00055063295,0.00015948906,0.0006063874,0.00007696762,0.90537184,0.00028263772,0.00022774926,0.0013275861],"study_design_scores_gemma":[0.052733358,0.0032115274,0.6617757,0.00040572567,0.0007800963,0.00018362887,0.00015972213,0.005269667,0.2726932,0.0013951989,0.00033388156,0.0010582979],"about_ca_topic_score_codex":0.0023476505,"about_ca_topic_score_gemma":0.0008271534,"teacher_disagreement_score":0.6326787,"about_ca_system_score_codex":0.005297906,"about_ca_system_score_gemma":0.0024209204,"threshold_uncertainty_score":0.999786},"labels":[],"label_agreement":null},{"id":"W2979313480","doi":"10.1182/blood.v116.21.2078.2078","title":"A Pilot Study of Epigenetic-Differentiation Therapy with Decitabine to Treat β-Thalassemia Intermedia","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Decitabine; Medicine; Thalassemia; Internal medicine; Pharmacology; Pediatrics; Gastroenterology; Immunology; DNA methylation; Biology; Gene expression; Genetics; Gene","score_opus":0.010985585976010665,"score_gpt":0.2450575429689131,"score_spread":0.23407195699290245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979313480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978403,0.00010003198,0.00004496541,0.0002152223,0.000121990866,0.0007978878,0.0000024034707,0.000037311813,0.0008398903],"genre_scores_gemma":[0.99930006,0.000066639885,0.00026545709,0.000074092386,0.00006164536,0.00004091815,0.000008648229,0.000024780938,0.00015777997],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991866,0.000022267053,0.0002093239,0.00020249056,0.00021318794,0.00016612896],"domain_scores_gemma":[0.99936146,0.00003372542,0.000060351394,0.0003141577,0.000095157215,0.0001351487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006585163,0.00013597356,0.00024595918,0.00011234319,0.00003246718,0.000008514116,0.00007713607,0.000044322667,0.000110396395],"category_scores_gemma":[0.000039187325,0.00008677338,0.00002847318,0.0002067203,0.00003265071,0.00002118331,0.000020056192,0.00019146469,0.000012472651],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010264943,0.01522424,0.4022263,0.00003366503,0.00023501937,0.000033928187,0.0029188562,0.0000028694126,0.571705,0.000012754233,0.0001298198,0.0064510605],"study_design_scores_gemma":[0.024352165,0.03389794,0.8303594,0.00010642454,0.0004527879,0.000054623673,0.0015493733,0.000015907548,0.10885533,0.00001778832,0.00013764188,0.00020059492],"about_ca_topic_score_codex":0.000115373834,"about_ca_topic_score_gemma":0.00023619157,"teacher_disagreement_score":0.46284968,"about_ca_system_score_codex":0.00000590021,"about_ca_system_score_gemma":0.000043160228,"threshold_uncertainty_score":0.3538516},"labels":[],"label_agreement":null},{"id":"W2979315058","doi":"10.1182/blood.v126.23.692.692","title":"Genomic Landscape of Relapsed Acute Lymphoblastic Leukemia","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Myeloid leukemia; Internal medicine; SNP array; Oncology; Exome sequencing; Leukemia; Single-nucleotide polymorphism; Biology; Genetics; Gene; Genotype; Mutation","score_opus":0.01838601881461223,"score_gpt":0.26532256232789814,"score_spread":0.24693654351328592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979315058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98168063,0.0004119429,0.00027474065,0.0001585074,0.0001354107,0.00030926123,0.000023336512,0.000089806286,0.01691634],"genre_scores_gemma":[0.9948861,0.000050365452,0.0022366364,0.00015512409,0.00024208729,0.000019727133,0.000039311773,0.00005151953,0.0023191134],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982207,0.00004709893,0.0003769748,0.00031150755,0.00062100333,0.0004227228],"domain_scores_gemma":[0.9984802,0.00014112929,0.000110788715,0.00055817084,0.00025624176,0.00045347767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029298858,0.00018772099,0.0004717567,0.00020042901,0.000030990293,0.0000128942365,0.00022930645,0.00016654021,0.000128547],"category_scores_gemma":[0.0003858858,0.00015519446,0.00011359433,0.00034457198,0.0001309662,0.00006184952,0.0001517809,0.00018079419,0.00042024473],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074187317,0.0039081327,0.271101,0.0010287118,0.005593897,0.0055049756,0.0039838557,0.00034055946,0.5767805,0.001750815,0.118533716,0.0040551154],"study_design_scores_gemma":[0.33812454,0.013560784,0.19872674,0.0012807804,0.010535749,0.014617772,0.0021066924,0.025251389,0.36929992,0.0019371727,0.022154767,0.0024037017],"about_ca_topic_score_codex":0.000065105705,"about_ca_topic_score_gemma":0.0000032980215,"teacher_disagreement_score":0.3307058,"about_ca_system_score_codex":0.00052469096,"about_ca_system_score_gemma":0.0030026478,"threshold_uncertainty_score":0.63286465},"labels":[],"label_agreement":null},{"id":"W2979315362","doi":"10.1182/blood.v116.21.1433.1433","title":"Steroids Are Less Effective In Treating Thrombocytopenia Caused by Immune Responses Against Platelet GPIbα: A Comparative Study Using Passive and Active ITP Models.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Immune thrombocytopenia; Platelet; Antibody; Autoantibody; Immune system; Immunology; Monoclonal antibody; Dexamethasone; Splenocyte; Medicine; Pharmacology; Internal medicine; Chemistry","score_opus":0.034119712864042556,"score_gpt":0.30874010541216657,"score_spread":0.274620392548124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979315362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968017,0.0003252977,0.0000128976335,0.000044219694,0.000047330734,0.002240879,0.00011632213,0.000040696443,0.00037067052],"genre_scores_gemma":[0.99946594,0.000025872763,0.00015889763,0.00004390069,0.000020766875,0.00015497184,0.000046133435,0.00003596627,0.00004757199],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984004,0.0002077838,0.00031249784,0.00051063567,0.00021963139,0.00034904873],"domain_scores_gemma":[0.9990201,0.00029291786,0.00020903713,0.00026740073,0.00009143242,0.00011909691],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012657212,0.00035251863,0.0010001444,0.00017054305,0.00018816155,0.000048904385,0.00007806656,0.00014150844,0.0000056170334],"category_scores_gemma":[0.000053571053,0.0002929764,0.000059180053,0.0002402432,0.00011385292,0.0002519241,0.00008138792,0.00046177246,0.0000026895914],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006520439,0.022026625,0.36694828,0.00014022771,0.004297897,0.008262345,0.06842878,0.00012569467,0.5092772,0.0000211386,0.000040962634,0.013910375],"study_design_scores_gemma":[0.08254635,0.0034834233,0.66411716,0.0005898952,0.0011898476,0.0002893488,0.04864664,0.0030420376,0.19502667,0.00014266455,0.000016523112,0.00090943725],"about_ca_topic_score_codex":0.0005881302,"about_ca_topic_score_gemma":0.0012378354,"teacher_disagreement_score":0.31425056,"about_ca_system_score_codex":0.00007681647,"about_ca_system_score_gemma":0.00007319368,"threshold_uncertainty_score":0.99995226},"labels":[],"label_agreement":null},{"id":"W2979315802","doi":"10.1182/blood.v108.11.1515.1515","title":"Fibronectin Is Not the Only Important Molecule Required for Fibrinogen/VWF-Independent Platelet Aggregation: Study of Thrombosis in a New Strain of Triple Deficient Mice.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Platelet; Fibrinogen; Von Willebrand factor; Chemistry; Knockout mouse; Thrombin; Fibronectin; Thrombus; Platelet activation; Integrin; Platelet adhesiveness; Internal medicine; Endocrinology; Immunology; Molecular biology; Receptor; Biology; Biochemistry; Medicine; Extracellular matrix; Platelet aggregation","score_opus":0.0242563220907328,"score_gpt":0.2747962976715009,"score_spread":0.25053997558076807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979315802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968191,0.00043494653,0.00002295632,0.00036674555,0.000040940537,0.0018680014,0.00016977267,0.000014025298,0.0002635142],"genre_scores_gemma":[0.9992202,0.000018898325,0.00032389694,0.00006138593,0.000024352667,0.00003722279,0.00007206758,0.000021446445,0.00022055133],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99841624,0.0000315456,0.0006495961,0.00029427215,0.00035855596,0.0002497956],"domain_scores_gemma":[0.99919975,0.000064493775,0.00030525046,0.00032240956,0.00006359097,0.00004451099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017830536,0.00017356468,0.00048608053,0.000107913846,0.000048083268,0.000009556593,0.000109484914,0.00007788416,0.000034576857],"category_scores_gemma":[0.000029819665,0.00012950785,0.00014142849,0.00024306693,0.000028323968,0.000038789065,0.000031052154,0.00007448101,0.0000018076419],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039563626,0.06973401,0.50250864,0.0009042275,0.003742945,0.00090481865,0.018010924,0.00027346445,0.38492242,0.0018749414,0.0033455025,0.009821744],"study_design_scores_gemma":[0.061490133,0.0067776116,0.2723555,0.0002693086,0.0012260138,0.00018886461,0.004771697,0.00024031509,0.6513924,0.0006540608,0.00026307607,0.0003709973],"about_ca_topic_score_codex":0.0025081178,"about_ca_topic_score_gemma":0.0026411465,"teacher_disagreement_score":0.26647002,"about_ca_system_score_codex":0.000029307932,"about_ca_system_score_gemma":0.00027591645,"threshold_uncertainty_score":0.52811766},"labels":[],"label_agreement":null},{"id":"W2979316304","doi":"10.1182/blood.v126.23.2720.2720","title":"Safety and Efficacy of Mini-CHOP-R Chemotherapy for Treatment of Diffuse Large B Cell Lymphoma in Very Elderly Patients: A Quality Assurance Study","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; CHOP; Diffuse large B-cell lymphoma; Internal medicine; Chemotherapy regimen; Adverse effect; Lymphoma; Chemotherapy; Surgery; Oncology","score_opus":0.022182109144243553,"score_gpt":0.2953172491095272,"score_spread":0.27313513996528366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979316304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99693644,0.00091014226,0.0000041797744,0.000065424596,0.000039160248,0.0017348976,0.00012930913,0.000010880849,0.00016957163],"genre_scores_gemma":[0.99922526,0.00023726588,0.00027016734,0.000031200176,0.00002246727,0.00011539254,0.000031363586,0.000016552438,0.000050347277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881625,0.000065381035,0.000465571,0.0002602493,0.00020958201,0.00018293547],"domain_scores_gemma":[0.9990065,0.00028015312,0.00018186549,0.00031105,0.0001119039,0.00010852196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017346155,0.0001719589,0.0006301168,0.00006290594,0.000018274686,0.0000045169263,0.00004166712,0.000058166854,0.000003129029],"category_scores_gemma":[0.00007485078,0.00012682524,0.0001000293,0.00010198148,0.000028505516,0.00003581657,0.00001289355,0.000009646186,9.173474e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023320918,0.20838833,0.7740819,0.000083736566,0.00024472096,0.000008772397,0.0033802458,1.9114857e-7,0.00008913925,0.000008809484,0.000026566799,0.011355524],"study_design_scores_gemma":[0.2857716,0.008531311,0.69730663,0.00004620324,0.00022673854,9.721197e-7,0.0004355229,0.00000277138,0.007194055,0.0000056479466,0.00040380782,0.00007472635],"about_ca_topic_score_codex":0.00032670045,"about_ca_topic_score_gemma":0.00011369818,"teacher_disagreement_score":0.28343952,"about_ca_system_score_codex":0.000113233335,"about_ca_system_score_gemma":0.000112694994,"threshold_uncertainty_score":0.51717836},"labels":[],"label_agreement":null},{"id":"W2979320847","doi":"10.1182/blood.v116.21.2522.2522","title":"Clinical Features, Treatment, and Outcome of Severe HIV-Associated Immune Thrombocytopenic Purpura In the HAART Era","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Thrombocytopenic purpura; Internal medicine; Pediatrics; Splenectomy; Immunology; Platelet","score_opus":0.02332023383837091,"score_gpt":0.3140072338265726,"score_spread":0.2906869999882017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979320847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99490464,0.00056879246,3.6630675e-7,0.0019058462,0.00012099913,0.0004798971,0.000023096041,0.000020476085,0.0019759007],"genre_scores_gemma":[0.99874043,0.00030505823,0.00017459602,0.00022529351,0.000080274694,0.000013558781,0.00004211004,0.000014650771,0.00040403468],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989459,0.00008427046,0.0004273057,0.0002126395,0.00014572356,0.00018414207],"domain_scores_gemma":[0.9992674,0.00018594418,0.00009105695,0.0003620361,0.00003368164,0.00005988014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046286898,0.00014213912,0.000502283,0.000043735672,0.00005336542,0.000014072405,0.000102657,0.00020962239,0.00005890406],"category_scores_gemma":[0.00009412083,0.00008175835,0.00014827086,0.00014310023,0.0000951349,0.000044658962,0.000023366008,0.00052651926,0.0000072540197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000089453235,0.0028781171,0.98509693,0.000023043509,0.0001890365,0.00005697628,0.00039531008,3.4085474e-8,0.00807094,0.00027697548,0.00008314956,0.0028400195],"study_design_scores_gemma":[0.012502935,0.0007010184,0.9839077,0.000043763263,0.000520186,0.00018487035,0.00008794323,0.000001674525,0.0011204052,0.00007504161,0.0007686663,0.00008581341],"about_ca_topic_score_codex":0.00033299206,"about_ca_topic_score_gemma":0.001092475,"teacher_disagreement_score":0.012413481,"about_ca_system_score_codex":0.00000671601,"about_ca_system_score_gemma":0.00004408599,"threshold_uncertainty_score":0.33340088},"labels":[],"label_agreement":null},{"id":"W2979321393","doi":"10.1182/blood.v116.21.3331.3331","title":"Rivaroxaban Compared with Enoxaparin for the Prevention of Venous Thromboembolism In Acutely Ill Medical Patients: MAGELLAN Study Methodology","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre","funders":"","keywords":"Medicine; Rivaroxaban; Venous thromboembolism; Placebo; Clinical trial; Randomized controlled trial; Internal medicine; Surgery; Warfarin; Thrombosis","score_opus":0.03932376503744761,"score_gpt":0.32683394998727,"score_spread":0.2875101849498224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979321393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947155,0.000064179956,0.0005360316,0.0006082492,0.00027929785,0.0030940794,0.000010255453,0.000031307085,0.00066110236],"genre_scores_gemma":[0.99497056,0.00003709795,0.0040909275,0.00034903825,0.00013273899,0.00031163072,0.000033793975,0.000031193547,0.000042989544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982647,0.0001688322,0.00046123168,0.0003281876,0.00046744128,0.00030962733],"domain_scores_gemma":[0.9985421,0.00042384455,0.00019073252,0.000507354,0.00023153725,0.000104469975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010960641,0.00018302977,0.0008558385,0.00012520683,0.00007715292,0.000011341525,0.00027915437,0.00011718416,0.00015321776],"category_scores_gemma":[0.00049636874,0.00011540767,0.00009524342,0.00019089328,0.00013960685,0.00003990825,0.00010868955,0.00031049023,0.0000047770473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020042688,0.22597742,0.64501804,0.0010327585,0.0068707974,0.00020908807,0.023395345,0.00005173807,0.005707194,0.007534472,0.003563957,0.07863489],"study_design_scores_gemma":[0.014204677,0.0048810607,0.9744863,0.0000938615,0.0015212776,0.000017689583,0.0014089178,0.00006173586,0.0016123462,0.00036850778,0.0011836644,0.00015996692],"about_ca_topic_score_codex":0.00047742,"about_ca_topic_score_gemma":0.0022890724,"teacher_disagreement_score":0.32946822,"about_ca_system_score_codex":0.000013493396,"about_ca_system_score_gemma":0.00010293644,"threshold_uncertainty_score":0.47061878},"labels":[],"label_agreement":null},{"id":"W2979335764","doi":"10.1182/blood.v114.22.439.439","title":"Base-Pair Resolution of Somatic and Germline-Derived Genome Rearrangement Breakpoints in Follicular Lymphoma.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Breakpoint; Biology; Genome; Genetics; Gene rearrangement; Reference genome; Contig; Follicular lymphoma; Human genome; Computational biology; Chromosomal rearrangement; Chromosomal translocation; Gene; Chromosome; Karyotype; Lymphoma","score_opus":0.01063980709240351,"score_gpt":0.23102950305049613,"score_spread":0.22038969595809263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979335764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956385,0.0023078385,0.000008503537,0.00095605064,0.00001612678,0.00044098718,0.0000072771586,0.000030304922,0.0005944038],"genre_scores_gemma":[0.99794483,0.00024300376,0.0014622337,0.00020387997,0.000035765093,0.000028521661,0.000028198612,0.00000945691,0.000044088454],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990875,0.000035990248,0.00029050486,0.00021514816,0.00018758555,0.00018324109],"domain_scores_gemma":[0.99951863,0.000026511118,0.000076988035,0.0002551611,0.000034028144,0.00008870308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013746337,0.00012801531,0.00030660885,0.000114410475,0.000026265025,0.0000069965677,0.0000355461,0.000059618316,0.000024583613],"category_scores_gemma":[0.000032246895,0.000105783234,0.00006974786,0.00012850558,0.000027319027,0.000039204253,0.000017645685,0.00002264059,0.000010456841],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005034025,0.022658035,0.43485424,0.0006033939,0.00073727086,0.0015794021,0.001998301,0.000023988508,0.5011343,0.0005128871,0.0002924812,0.035102304],"study_design_scores_gemma":[0.013068603,0.000577972,0.9541023,0.00023501029,0.00027177614,0.00009140765,0.000049884035,0.00010648188,0.03109333,0.00015919717,0.00014925629,0.00009480364],"about_ca_topic_score_codex":0.00010996147,"about_ca_topic_score_gemma":0.000015268579,"teacher_disagreement_score":0.51924807,"about_ca_system_score_codex":0.00007735576,"about_ca_system_score_gemma":0.000046752237,"threshold_uncertainty_score":0.4313715},"labels":[],"label_agreement":null},{"id":"W2979335783","doi":"10.1182/blood.v120.21.155.155","title":"Differences in Quality of Life Between Bendamustine Plus Rituximab Compared with Standard First-Line Treatments in Patients with Previously Untreated Advanced Indolent Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Capital District Health Authority; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Bendamustine; Rituximab; Medicine; Vincristine; Mantle cell lymphoma; CHOP; Internal medicine; Prednisone; Cyclophosphamide; Gastroenterology; Lymphoma; Surgery; Oncology; Chemotherapy","score_opus":0.02467016764433753,"score_gpt":0.26533158984352495,"score_spread":0.24066142219918743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979335783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99661607,0.0005752473,0.000012809573,0.00004980633,0.000037303555,0.0020754253,0.00038639453,0.000045502482,0.0002014474],"genre_scores_gemma":[0.9978832,0.00013094462,0.0010655177,0.000037290174,0.000047017846,0.00026453089,0.00046234138,0.00005307316,0.000056077737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99692726,0.00012715902,0.00092754356,0.0005389586,0.0007440341,0.0007350215],"domain_scores_gemma":[0.9981446,0.00024805302,0.00049560715,0.0005352382,0.00017135452,0.00040509348],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001846965,0.0005515871,0.0017496629,0.00025481734,0.000070093265,0.000018456401,0.00015532618,0.00014222934,0.000053869615],"category_scores_gemma":[0.000053601645,0.00033135238,0.00009163711,0.00056422607,0.00011525614,0.00019006364,0.00007454798,0.00006737645,0.0000095295345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012344652,0.030951641,0.94948024,0.00036566597,0.000540993,0.000057926372,0.0014501974,0.000011601274,0.0000063772045,0.0000021836859,0.000007544932,0.0047809803],"study_design_scores_gemma":[0.2199804,0.005061398,0.7694009,0.00085217645,0.0006186166,0.0000034377672,0.0002099876,0.000009582911,0.00355171,0.0000011686053,0.000018696139,0.0002919133],"about_ca_topic_score_codex":0.0019039273,"about_ca_topic_score_gemma":0.0013006342,"teacher_disagreement_score":0.20763576,"about_ca_system_score_codex":0.0007717438,"about_ca_system_score_gemma":0.0004565456,"threshold_uncertainty_score":0.9999139},"labels":[],"label_agreement":null},{"id":"W2979343298","doi":"10.1182/blood.v116.21.2884.2884","title":"The Role of Human Nucleoside Transporters In Uptake of 5-Azacitidine, 5-Aza-2′-Deoxycytidine and Gemcitabine","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cytidine; Uridine; Azacitidine; Nucleoside; Gemcitabine; Deoxycytidine; Biochemistry; Nucleoside transporter; Chemistry; Biology; Transporter; Enzyme; RNA; Cancer","score_opus":0.0034312660563473605,"score_gpt":0.2071422519008717,"score_spread":0.20371098584452435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979343298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99705964,0.0019695258,0.0000075612384,0.00004238382,0.000027142096,0.000081620965,0.0000127755775,0.0000032403589,0.0007961278],"genre_scores_gemma":[0.9994906,0.00013974227,0.00016807558,0.000014577942,0.000100566926,0.0000055236465,0.000020766414,0.000012673749,0.00004742634],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993574,0.00001236565,0.00026707066,0.00015059946,0.00007488432,0.00013768366],"domain_scores_gemma":[0.999616,0.000013145595,0.00008483838,0.0002121438,0.00003759349,0.00003626702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015872986,0.00009230392,0.00013354709,0.0000307662,0.000040933523,0.0000047239946,0.00012941574,0.000085837004,0.000010032714],"category_scores_gemma":[0.000022878556,0.0000728098,0.00005039373,0.000063265026,0.000113043854,0.000002643003,0.000027624561,0.00009369884,1.9096747e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025495367,0.00009526307,0.020484963,0.000012505278,0.000030384583,0.0000019736397,0.000061008624,0.0000036358526,0.97813624,0.0005555544,0.000041713374,0.0005512695],"study_design_scores_gemma":[0.0010622423,0.00017703428,0.023079332,0.00001334066,0.00003359044,0.0000104416595,0.00016947745,0.00000971714,0.9732088,0.000264072,0.0018841944,0.00008776166],"about_ca_topic_score_codex":0.00006751217,"about_ca_topic_score_gemma":0.00014992102,"teacher_disagreement_score":0.0049274373,"about_ca_system_score_codex":6.5699584e-7,"about_ca_system_score_gemma":0.000019826713,"threshold_uncertainty_score":0.29690975},"labels":[],"label_agreement":null},{"id":"W2979344457","doi":"10.1182/blood.v114.22.2008.2008","title":"Renal Dysfunction in Thalassemia.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Toronto General Hospital","funders":"","keywords":"Deferasirox; Medicine; Renal function; Thalassemia; Creatinine; Internal medicine; Chelation therapy; Gastroenterology; Nephropathy; Urology; Endocrinology","score_opus":0.006648182069684418,"score_gpt":0.2267582880850192,"score_spread":0.22011010601533476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979344457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95451444,0.0004999489,0.000019273955,0.0017490176,0.00005538665,0.00010550686,3.5283364e-7,0.000046126155,0.04300992],"genre_scores_gemma":[0.998344,0.00013369235,0.00012872615,0.0005800929,0.000060931652,0.0000018999522,0.0000070182537,0.0000045967986,0.0007390138],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99955434,0.000009074655,0.00010757469,0.00010510743,0.000090944755,0.000132977],"domain_scores_gemma":[0.99981207,0.0000062169315,0.000016478047,0.000101671365,0.000013507085,0.00005005501],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000060271075,0.000056145964,0.00009715536,0.00006305816,0.00001805191,0.000004286398,0.000020553745,0.00009445225,0.00005755448],"category_scores_gemma":[0.00002912448,0.000044258817,0.000034471344,0.00015913688,0.000009963658,0.000026280166,0.0000038195485,0.00015529252,0.000050281415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087114243,0.012069377,0.36641467,0.00016182821,0.00026970147,0.0027192123,0.0018507743,0.00014426492,0.35784394,0.0031601484,0.022501513,0.23199342],"study_design_scores_gemma":[0.027949167,0.0021631564,0.9059176,0.000520732,0.0003606803,0.00078191166,0.00048697295,0.00030359463,0.033002395,0.0016460541,0.026472837,0.00039491607],"about_ca_topic_score_codex":0.0000120939385,"about_ca_topic_score_gemma":0.0000039705183,"teacher_disagreement_score":0.5395029,"about_ca_system_score_codex":0.00001219618,"about_ca_system_score_gemma":0.000029423965,"threshold_uncertainty_score":0.18048221},"labels":[],"label_agreement":null},{"id":"W2979345699","doi":"10.1182/blood.v124.21.2872.2872","title":"Low Dose Oral Vitamin K Does Not Increase Time in Therapeutic Range: Results of a Multicentre Clinical Trial","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; Western University; St. Joseph’s Healthcare Hamilton; University of Toronto; McMaster University; St. Joseph's Hospital","funders":"","keywords":"Warfarin; Medicine; Placebo; Clinical trial; Internal medicine; Anticoagulant; Oral anticoagulant; Randomized controlled trial; Therapeutic index; Acenocoumarol; Atrial fibrillation; Pharmacology; Drug","score_opus":0.05762883617261518,"score_gpt":0.36200808208935537,"score_spread":0.3043792459167402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979345699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965298,0.0000201955,0.000018773564,0.0013944125,0.00022727155,0.00085087935,0.000010919767,0.00003969132,0.0009080335],"genre_scores_gemma":[0.99594736,0.000013005407,0.00042251867,0.0002402612,0.0009073213,0.000002501597,0.000023679775,0.0000144543865,0.0024288741],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982982,0.00030047414,0.00074566616,0.00023648408,0.0002444897,0.00017465262],"domain_scores_gemma":[0.9986036,0.00075070426,0.00019850873,0.00031048642,0.000046348854,0.00009039321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013265061,0.0001235675,0.0005072605,0.0001174033,0.000018509378,0.0000103574885,0.00008290403,0.00011316509,0.00008053049],"category_scores_gemma":[0.0015157163,0.00008236308,0.00019378844,0.00015613575,0.00005688608,0.00005372616,0.000047388796,0.00011571411,0.00008856707],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34695685,0.0022300691,0.59677416,0.00026975732,0.000612238,0.00007407206,0.0005596819,0.000010341898,0.008226907,0.000499307,0.00047357092,0.043313038],"study_design_scores_gemma":[0.6122922,0.0013583909,0.37761754,0.00012675505,0.00081104296,0.0000017396595,0.00006616338,0.0013436698,0.0027594804,0.00010144362,0.0033052338,0.00021637323],"about_ca_topic_score_codex":0.00007118288,"about_ca_topic_score_gemma":0.00004906115,"teacher_disagreement_score":0.26533532,"about_ca_system_score_codex":0.000011537409,"about_ca_system_score_gemma":0.000040152754,"threshold_uncertainty_score":0.3358669},"labels":[],"label_agreement":null},{"id":"W2979350016","doi":"10.1182/blood.v114.22.4323.4323","title":"Short Progression Free Survival Post Non-Myeloablative Sibling Allogeneic Stem Cell Transplantion for Multiple Myeloma.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada; University of British Columbia","funders":"","keywords":"Medicine; Fludarabine; Stem cell; Transplantation; Multiple myeloma; Autologous stem-cell transplantation; Internal medicine; Cyclophosphamide; Melphalan; Median follow-up; Oncology; Surgery; Gastroenterology; Chemotherapy; Biology","score_opus":0.029549942311992778,"score_gpt":0.3096492217573308,"score_spread":0.280099279445338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979350016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938294,0.00042659108,0.0013665825,0.00038181627,0.00009161447,0.002213434,0.00021900212,0.0001146637,0.0013568952],"genre_scores_gemma":[0.99320847,0.00009160809,0.0053736945,0.0000690847,0.00021909874,0.0001230717,0.0005488743,0.000037171027,0.00032892873],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980368,0.00005588147,0.00031983264,0.00046840712,0.0005360312,0.00058305485],"domain_scores_gemma":[0.9987846,0.00019281881,0.0000638993,0.0004079894,0.0002360326,0.00031466817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026773804,0.0002702757,0.00038907648,0.00019878802,0.00019863521,0.000035202513,0.00016832855,0.00016276381,0.000015906238],"category_scores_gemma":[0.00005944315,0.0002133313,0.00021200787,0.00022115461,0.00003821212,0.00012631166,0.000025615494,0.00018086041,0.000021134845],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040202956,0.005557165,0.37085405,0.00054577994,0.0005058213,0.0005187637,0.0006049328,0.000013107741,0.47702652,0.000030222425,0.0001578213,0.14016551],"study_design_scores_gemma":[0.020396331,0.0032177437,0.5531265,0.00031636367,0.0005138464,0.0000374238,0.00019780967,0.000989217,0.4206856,0.00004867768,0.00017148799,0.00029899302],"about_ca_topic_score_codex":0.00001977312,"about_ca_topic_score_gemma":0.00005051816,"teacher_disagreement_score":0.18227246,"about_ca_system_score_codex":0.000046379646,"about_ca_system_score_gemma":0.00010616076,"threshold_uncertainty_score":0.8699398},"labels":[],"label_agreement":null},{"id":"W2979352584","doi":"10.1182/blood.v122.21.3798.3798","title":"Targeting Folate Metabolism In Acute Myelogenous Leukemia","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Gene knockdown; Chronic myelogenous leukemia; Biology; Cancer research; Leukemia; Mitochondrion; Cell culture; Molecular biology; Gene; Biochemistry; Genetics","score_opus":0.004735059697007746,"score_gpt":0.20500878486655272,"score_spread":0.20027372516954497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979352584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968064,0.0014042419,0.00012981353,0.00007741071,0.000097590724,0.00020163148,0.0000039140346,0.000014725031,0.001264294],"genre_scores_gemma":[0.9970163,0.00020004682,0.0015244068,0.00028580564,0.00018716989,0.00005421659,0.00006696633,0.000015370233,0.0006497042],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993288,0.00003310321,0.00016189556,0.00020254667,0.00006782562,0.00020582498],"domain_scores_gemma":[0.9996903,0.0000026670562,0.000045823508,0.00017168085,0.00003735933,0.00005216895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008475556,0.00009848059,0.00010083445,0.000035980192,0.00003883459,0.000023925102,0.0001228301,0.00010520038,0.00006327496],"category_scores_gemma":[0.000041969153,0.00009099682,0.000044666445,0.0000726217,0.000020554082,0.0000058238334,0.000068130284,0.00007425311,0.000082771236],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004232054,0.000043887932,0.0011031819,0.0000029459443,0.000038165643,0.0000036789738,0.000027555567,0.0000061352976,0.9960088,0.00004937262,0.0013384845,0.0013735208],"study_design_scores_gemma":[0.0011445765,0.000072899675,0.0051380633,0.0000054437596,0.000024765714,0.000013002345,0.000028420935,0.00004342716,0.9760359,0.00019968659,0.017105421,0.00018842396],"about_ca_topic_score_codex":0.00009477961,"about_ca_topic_score_gemma":0.000007961709,"teacher_disagreement_score":0.01997297,"about_ca_system_score_codex":0.0000072673183,"about_ca_system_score_gemma":0.000048858707,"threshold_uncertainty_score":0.3710743},"labels":[],"label_agreement":null},{"id":"W2979353546","doi":"10.1182/blood.v128.22.4537.4537","title":"Enhanced and Accelerated Repopulation of Mutant C-Kit Immunodeficient Mice By Transplants of Primary Chronic and Acute Myeloid Leukemic Human Cells","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Haematopoiesis; Biology; Myeloid; Immunology; Bone marrow; Myeloid leukemia; Cancer research; Severe combined immunodeficiency; Leukemia; Stem cell; In vivo; Genetics","score_opus":0.007159402830932342,"score_gpt":0.20765322737522146,"score_spread":0.20049382454428913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979353546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9678164,0.031309143,0.00012605652,0.000016380105,0.00010981036,0.00022977802,0.00016167588,0.000027188089,0.0002035678],"genre_scores_gemma":[0.9972112,0.0022067218,0.000007815677,0.000011204526,0.0000012606704,0.0000087313665,0.00014229256,0.000014972914,0.00039576294],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998762,0.00008565868,0.0005273776,0.00030286677,0.000046084817,0.00027602885],"domain_scores_gemma":[0.9993585,0.00005572883,0.00029921456,0.0002267149,0.00005348724,0.000006364091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016198416,0.00018562171,0.00038888335,0.000084314306,0.00013901536,0.000005939117,0.00014153887,0.0001915098,0.00005969857],"category_scores_gemma":[0.000007148897,0.00014185831,0.000055691526,0.00010521372,0.00034887905,0.000105515865,0.000049404964,0.00011319936,0.00000774722],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012237283,0.0003119329,0.0001870568,0.00009528449,0.00017843598,0.0000010427981,0.0006618733,0.0000010462887,0.9935903,0.00004129073,0.0000069807347,0.0048023625],"study_design_scores_gemma":[0.0048627625,0.00034974786,0.009940388,0.00019287023,0.00017118847,0.00003818266,0.00006689806,0.0000010941473,0.98400307,0.000023725206,0.00017121766,0.00017884522],"about_ca_topic_score_codex":0.00014515323,"about_ca_topic_score_gemma":0.0000034892303,"teacher_disagreement_score":0.029394837,"about_ca_system_score_codex":0.00002775955,"about_ca_system_score_gemma":0.000060654824,"threshold_uncertainty_score":0.57848144},"labels":[],"label_agreement":null},{"id":"W2979356821","doi":"10.1182/blood.v120.21.3080.3080","title":"Final Report of Safety and Efficacy From a Novel Conditioning Regimen, Individualized Once-Daily Intravenous Busulfan with Bortezomib, in Relapsed Multiple Myeloma Patients Undergoing a Second Autologous Hematopoietic Stem Cell Transplantation.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Multiple myeloma; Busulfan; Bortezomib; Regimen; Autologous stem-cell transplantation; Transplantation; Surgery; Internal medicine; Hematopoietic stem cell transplantation; Oncology","score_opus":0.01865443310180049,"score_gpt":0.25196456350417323,"score_spread":0.23331013040237275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979356821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973905,0.00033714765,0.00028777448,0.00003579293,0.000034078028,0.0009979943,0.0002977937,0.00004222807,0.00057666143],"genre_scores_gemma":[0.99271226,0.000035724977,0.0061737895,0.000026216383,0.0000278497,0.000048495003,0.0008216336,0.000036805923,0.0001171973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979417,0.0000961674,0.00063997286,0.0003900377,0.000452463,0.00047968928],"domain_scores_gemma":[0.9984162,0.0005665355,0.00033950212,0.00030414583,0.00009749581,0.00027612926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023233205,0.00025181146,0.00057880447,0.00019323143,0.000113316775,0.00001916819,0.00007448482,0.00013688406,0.000058448433],"category_scores_gemma":[0.00008294332,0.00021358396,0.00005810415,0.00022113808,0.00012740909,0.00013689806,0.000029450079,0.0002491287,0.0000050178287],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035020113,0.005330567,0.9746275,0.0005184289,0.00052757683,0.0012350101,0.008264544,0.000013782694,0.0042457287,0.000021539474,0.000008849552,0.0017044434],"study_design_scores_gemma":[0.07145162,0.0009466096,0.9106643,0.00056561455,0.00039135403,0.0006541724,0.0005065621,0.000056816727,0.01453242,0.0000074568625,0.000024400477,0.00019864037],"about_ca_topic_score_codex":0.00022108438,"about_ca_topic_score_gemma":0.00025721107,"teacher_disagreement_score":0.06794961,"about_ca_system_score_codex":0.000073157695,"about_ca_system_score_gemma":0.00023992149,"threshold_uncertainty_score":0.87097013},"labels":[],"label_agreement":null},{"id":"W2979356970","doi":"10.1182/blood.v108.11.293.293","title":"Survival Analysis of Anaplastic Large Cell Lymphoma, Systemic and Cutaneous-Types: Report from the International T-Cell Lymphoma Project.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Anaplastic large-cell lymphoma; Anaplastic lymphoma kinase; Medicine; CHOP; Lymphoma; Immunophenotyping; Large cell; Internal medicine; Vincristine; T-cell lymphoma; Oncology; Large-cell lymphoma; Pathology; Chemotherapy; Immunology; Cancer; Cyclophosphamide; Adenocarcinoma","score_opus":0.007833225404596656,"score_gpt":0.22691961161227495,"score_spread":0.21908638620767829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979356970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901079,0.0020870182,0.00002579664,0.000084486506,0.0001926342,0.0003269294,0.00030655976,0.000038982373,0.0068296986],"genre_scores_gemma":[0.998062,0.00016520248,0.00016193127,0.00006111806,0.0001810005,0.00003518617,0.000561032,0.000020673051,0.000751861],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983609,0.000049568243,0.00050159823,0.00040258173,0.00046667678,0.00021867454],"domain_scores_gemma":[0.9987036,0.00036705285,0.00029168476,0.00045128143,0.0001261842,0.000060168964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015533075,0.00020404924,0.00050576794,0.00016560686,0.00006979148,0.000038250426,0.00013770924,0.00009145965,0.000051740342],"category_scores_gemma":[0.000049915325,0.00013545928,0.00021494972,0.00037509884,0.0000490883,0.00003568742,0.00007249947,0.000027876491,0.000013398444],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014810351,0.007914997,0.98342085,0.0000635677,0.002664764,0.0021147481,0.00021706383,0.000014862025,0.0018934764,0.00008339772,0.0011031027,0.00036108628],"study_design_scores_gemma":[0.037969608,0.0004952451,0.90188223,0.0002590075,0.024466427,0.0022758853,0.00095083064,0.0020960434,0.0239661,0.000047791014,0.0051387004,0.0004521168],"about_ca_topic_score_codex":0.004152489,"about_ca_topic_score_gemma":0.00070840435,"teacher_disagreement_score":0.08153859,"about_ca_system_score_codex":0.00010833267,"about_ca_system_score_gemma":0.00021000521,"threshold_uncertainty_score":0.6277349},"labels":[],"label_agreement":null},{"id":"W2979359606","doi":"10.1182/blood.v118.21.2358.2358","title":"Growth Factor Independence 1b (Gfi1b) Is An Essential Regulator of Late Stage Megakaryocyte Maturation and Platelet Production","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Megakaryocyte; Thrombopoiesis; Platelet; Haematopoiesis; Megakaryocytopoiesis; Bone marrow; Thrombopoietin; Biology; Mean platelet volume; Cell biology; Molecular biology; Immunology; Andrology; Chemistry; Stem cell; Medicine","score_opus":0.01236484413700299,"score_gpt":0.2200932207567967,"score_spread":0.2077283766197937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979359606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990807,0.0003991909,0.000036932866,0.000017629862,0.00007258307,0.00016523867,0.000052223833,0.000009885327,0.00016561143],"genre_scores_gemma":[0.998933,0.00016243765,0.00046443407,0.00002289832,0.000057433277,0.0000078256035,0.00008067212,0.000013508464,0.00025775668],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993276,0.000024528004,0.00013323996,0.00029468955,0.00010291309,0.00011705457],"domain_scores_gemma":[0.99957275,0.0000010641116,0.00009368614,0.00021392036,0.000068556365,0.000050006198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000041429765,0.00011343389,0.00010210815,0.000027273918,0.000046658282,0.000011452324,0.0000665442,0.00012526565,0.000027059628],"category_scores_gemma":[0.000011564927,0.00010237412,0.000029747815,0.000042377225,0.000047959365,0.000018394463,0.000039645645,0.00004345773,0.0000017151161],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037980644,0.0014371631,0.031946354,0.000078264085,0.00036344092,0.000009833028,0.00087462284,0.0000013184938,0.9628733,0.00013489262,0.000064583226,0.0018364505],"study_design_scores_gemma":[0.0011835765,0.00033996103,0.03415941,0.0000063620355,0.000062434876,0.000009686691,0.000041143758,0.0000060814396,0.96388125,0.0001404273,0.0000588081,0.00011084176],"about_ca_topic_score_codex":0.00011442681,"about_ca_topic_score_gemma":0.00005339622,"teacher_disagreement_score":0.0022130548,"about_ca_system_score_codex":0.0000015926174,"about_ca_system_score_gemma":0.000026047308,"threshold_uncertainty_score":0.41746956},"labels":[],"label_agreement":null},{"id":"W2979362461","doi":"10.1182/blood.v118.21.2105.2105","title":"Associations Between Single Nucleotide Polymorphisms in Iron-Related Genes and Iron Status in Multiethnic Populations","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Transferrin saturation; Single-nucleotide polymorphism; Serum iron; Total iron-binding capacity; Transferrin; Genetics; Ferritin; Biology; Iron deficiency; Transferrin receptor; Genotype; Hemochromatosis; Genome-wide association study; Hereditary hemochromatosis; Population; Soluble transferrin receptor; Medicine; Internal medicine; Gene; Anemia; Endocrinology; Iron status","score_opus":0.04335857051943064,"score_gpt":0.2703354173938261,"score_spread":0.22697684687439545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979362461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937152,0.0025990664,0.000004265575,0.00015620202,0.000091207454,0.00026456153,0.000044592845,0.00003602147,0.003088847],"genre_scores_gemma":[0.99810356,0.00015538587,0.0012504939,0.000044402354,0.000040731473,0.000007832165,0.00012761466,0.000021577556,0.00024837942],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99902385,0.000051695428,0.00031287016,0.00020111038,0.00011975291,0.00029068795],"domain_scores_gemma":[0.9995373,0.000031003012,0.000104934064,0.0002056436,0.000018356464,0.00010278185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013579223,0.00011580653,0.00026160033,0.00020387564,0.00007188175,0.0000106235075,0.000051851373,0.00012415992,0.000053045023],"category_scores_gemma":[0.00013093578,0.00011817148,0.00003726755,0.00016265268,0.000058853082,0.00011733212,0.000032776476,0.00015076378,0.000016189728],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008515936,0.0005762574,0.9923902,0.000009607126,0.000007946341,0.000011147914,0.0017486692,0.0000021186306,0.0018395823,0.00012380007,0.000013859346,0.003268264],"study_design_scores_gemma":[0.0042275707,0.00005917225,0.99437666,0.000026145555,0.00016333262,0.0000015550248,0.00017049178,0.000008160194,0.0003920995,0.0004006215,0.00005411668,0.00012007062],"about_ca_topic_score_codex":0.0040459144,"about_ca_topic_score_gemma":0.0021714387,"teacher_disagreement_score":0.004388347,"about_ca_system_score_codex":0.000029452533,"about_ca_system_score_gemma":0.00004166462,"threshold_uncertainty_score":0.61162394},"labels":[],"label_agreement":null},{"id":"W2979363781","doi":"10.1182/blood.v124.21.3870.3870","title":"Propensity Score Matching Analysis Comparing Reduced Intensity Versus Myeloablative Conditioning in AML/MDS Patients Transplanted with Fludarabine-Busulfan-Low Dose Total Body Irradiation Based Regimen","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Busulfan; Fludarabine; Medicine; Total body irradiation; Internal medicine; Propensity score matching; Regimen; Transplantation; Hematopoietic stem cell transplantation; Oncology; Surgery; Chemotherapy; Cyclophosphamide","score_opus":0.024134020601869876,"score_gpt":0.2589182373673408,"score_spread":0.23478421676547095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979363781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99689925,0.0000069939183,0.00093869824,0.00017191702,0.00005849985,0.00090820476,0.000024566636,0.00010422874,0.0008876291],"genre_scores_gemma":[0.9974611,0.0000028393079,0.000898966,0.00008390901,0.000074287214,0.00004198952,0.0013691961,0.000037632544,0.000030121424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975691,0.00025133917,0.0004442851,0.00060234225,0.0006374446,0.000495497],"domain_scores_gemma":[0.99843585,0.00023439764,0.00021658912,0.00045085678,0.0004373822,0.0002249464],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00055575726,0.00029616736,0.00080840656,0.000630904,0.00022443103,0.00005846709,0.00014342132,0.00013892881,0.000030733896],"category_scores_gemma":[0.0003067311,0.0002570074,0.00012450237,0.0012939827,0.00012437023,0.00026795152,0.00004816808,0.00065125444,0.000013773817],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014227643,0.0012186444,0.9525563,0.00022192347,0.0016989113,0.00016848008,0.0020488235,0.004336791,0.023068959,0.000029769082,0.000031840482,0.00039188482],"study_design_scores_gemma":[0.024166266,0.0007581367,0.9246591,0.0005487833,0.0012873958,0.00001416173,0.00013903537,0.036811236,0.011333134,0.000006135153,0.0000015201757,0.00027511144],"about_ca_topic_score_codex":0.0007570231,"about_ca_topic_score_gemma":0.00030446032,"teacher_disagreement_score":0.032474443,"about_ca_system_score_codex":0.00041280972,"about_ca_system_score_gemma":0.00025240978,"threshold_uncertainty_score":0.9999882},"labels":[],"label_agreement":null},{"id":"W2979365039","doi":"10.1182/blood.v106.11.2977.2977","title":"A National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) Phase II Study of Oral Fludarabine in Untreated B-Cell Chronic Lymphocytic Leukemia.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Fludarabine; Medicine; Chronic lymphocytic leukemia; Internal medicine; Gastroenterology; Cancer; CD5; Leukemia; Oncology; Immunology; Chemotherapy; Lymphoma; Cyclophosphamide","score_opus":0.08770439753966136,"score_gpt":0.42592015847087195,"score_spread":0.3382157609312106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979365039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953946,0.0017481039,0.0000035197336,0.00011553852,0.00024877,0.0016738081,0.00008384344,0.000026479338,0.0007053479],"genre_scores_gemma":[0.99790263,0.00022824315,0.000122098,0.000111407106,0.0004872667,0.00013487252,0.000065215136,0.00003671807,0.0009115518],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9946941,0.0004570427,0.002271273,0.0005440237,0.0014620457,0.00057150284],"domain_scores_gemma":[0.9977071,0.00054003875,0.00053114275,0.00050875184,0.00041761767,0.0002953352],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003334835,0.00029285694,0.0015955964,0.00031659254,0.00006956509,0.000007629947,0.00030616307,0.00019604835,0.00035036818],"category_scores_gemma":[0.0017220244,0.00024808422,0.00018321534,0.0008464696,0.00021484663,0.00012931938,0.00015933876,0.00035310627,0.000005762696],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.07306472,0.31349772,0.055661585,0.010088258,0.019465309,0.009449896,0.010014699,0.11138675,0.1175419,0.0008428299,0.06814759,0.21083872],"study_design_scores_gemma":[0.88954705,0.008287836,0.003324012,0.00060923013,0.0012863302,0.0001360791,0.00025854597,0.06707606,0.022986492,0.000016986913,0.0059933737,0.0004779873],"about_ca_topic_score_codex":0.56631756,"about_ca_topic_score_gemma":0.7376335,"teacher_disagreement_score":0.81648237,"about_ca_system_score_codex":0.06887754,"about_ca_system_score_gemma":0.2099892,"threshold_uncertainty_score":0.99999714},"labels":[],"label_agreement":null},{"id":"W2979367976","doi":"10.1182/blood.v124.21.3450.3450","title":"Long-Term Outcome of a Phase 1 Study of the Investigational Oral Proteasome Inhibitor (PI) Ixazomib at the Recommended Phase 3 Dose (RP3D) in Patients (Pts) with Relapsed or Refractory Systemic Light-Chain (AL) Amyloidosis (RRAL)","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ixazomib; Medicine; Tolerability; Internal medicine; AL amyloidosis; Adverse effect; Population; Progression-free survival; Oncology; Proteasome inhibitor; Gastroenterology; Surgery; Multiple myeloma; Carfilzomib; Overall survival; Immunology","score_opus":0.018375764002588824,"score_gpt":0.28126438728025493,"score_spread":0.2628886232776661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979367976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962704,0.00013327743,0.0000044560275,0.00047859107,0.00013910394,0.002821228,0.00011231895,0.000017021743,0.000023567032],"genre_scores_gemma":[0.9983646,0.00002026661,0.00008551262,0.00034619326,0.000060658378,0.00071957195,0.00012734496,0.000058169873,0.00021764528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969402,0.00066782197,0.0009352741,0.000601509,0.00050619966,0.00034899096],"domain_scores_gemma":[0.9976135,0.0001224662,0.0008852504,0.0010818464,0.00017284318,0.00012408463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004991695,0.0004162306,0.00059113,0.00010924455,0.00014973585,0.000019704363,0.0005185622,0.00018389629,0.000029737294],"category_scores_gemma":[0.0004265303,0.00022854515,0.00017142638,0.0003106813,0.00016971213,0.000019752744,0.00030938818,0.00021055232,0.000004189809],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016704719,0.01448275,0.9083752,0.00010112193,0.00043858588,0.0000052200317,0.0005755816,0.000008929261,0.073330484,0.000004294263,0.0002718916,0.00073549914],"study_design_scores_gemma":[0.12870887,0.016465008,0.4478125,0.00050504884,0.0008626751,0.000027085223,0.0005679049,0.000016194736,0.40396187,0.00001085862,0.00032501968,0.00073698896],"about_ca_topic_score_codex":0.00007875652,"about_ca_topic_score_gemma":0.0006650492,"teacher_disagreement_score":0.46056268,"about_ca_system_score_codex":0.0001080862,"about_ca_system_score_gemma":0.00012461649,"threshold_uncertainty_score":0.9319801},"labels":[],"label_agreement":null},{"id":"W2979368108","doi":"10.1182/blood.v104.11.170.170","title":"Genes Encoding Telomere-Binding Proteins TERF1, TERF2 and TIN2 Are mutated in Patients with Acquired Aplastic Anemia.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Telomere; Biology; Exon; Telomerase; Molecular biology; Dyskeratosis congenita; Haplotype; Mutation; Aplastic anemia; Missense mutation; Single-nucleotide polymorphism; Genetics; Gene; Immunology; Bone marrow; Genotype","score_opus":0.008764602297176597,"score_gpt":0.20808148005283217,"score_spread":0.19931687775565557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979368108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99835944,0.00026720835,0.000024904612,0.000115680996,0.00006113064,0.0008555933,0.000018085999,0.00011053652,0.00018741898],"genre_scores_gemma":[0.9983929,0.000035143352,0.0012148098,0.00008250436,0.00007633276,0.000042817588,0.000039203773,0.00004451401,0.00007180137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983331,0.000030678773,0.00033804172,0.00047657176,0.0003465707,0.00047503147],"domain_scores_gemma":[0.9992598,0.00004376187,0.00014886082,0.00025701648,0.00008401924,0.00020651975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010010625,0.0002841309,0.00041695914,0.00029792133,0.000119621065,0.000041695872,0.00009816196,0.000120863275,0.000025630075],"category_scores_gemma":[0.0001112868,0.00022728115,0.000032741096,0.0004428242,0.00011621946,0.0001631701,0.000051078856,0.00016791669,0.000019407138],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033302567,0.0009776362,0.9669265,0.00030437217,0.000055003467,0.00036076075,0.0008891133,0.000013126122,0.027599698,0.000012644672,0.0000042590236,0.0025238479],"study_design_scores_gemma":[0.016114382,0.00090344663,0.90717626,0.001384032,0.00016443593,0.00011652422,0.00040798157,0.00000930264,0.07327342,0.000022099164,0.000033361455,0.00039478298],"about_ca_topic_score_codex":0.00012054999,"about_ca_topic_score_gemma":0.000106743515,"teacher_disagreement_score":0.05975028,"about_ca_system_score_codex":0.00007483929,"about_ca_system_score_gemma":0.00010551187,"threshold_uncertainty_score":0.92682564},"labels":[],"label_agreement":null},{"id":"W2979370887","doi":"10.1182/blood.v110.11.2965.2965","title":"HyperCKemia in CML Patients on Imatinib Mesylate.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; myalgia; Imatinib mesylate; Muscle cramp; Internal medicine; Gastroenterology; Creatine kinase; Adverse effect; Rhabdomyolysis; Imatinib; Chronic myelogenous leukemia; Surgery; Leukemia; Myeloid leukemia","score_opus":0.011314892418957528,"score_gpt":0.2648738234964562,"score_spread":0.2535589310774987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979370887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9648599,0.000087602464,0.0000022335887,0.000070651215,0.00010550834,0.00037326606,0.0000053076515,0.00005517012,0.034440387],"genre_scores_gemma":[0.99807674,0.00001672821,0.0007294777,0.0003765714,0.00009308396,0.000011435052,0.000052146923,0.000027000026,0.0006167901],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882704,0.0000150928445,0.00027853122,0.00024769662,0.00028948692,0.00034215083],"domain_scores_gemma":[0.9993933,0.000078131234,0.00005145642,0.00031483083,0.00003497243,0.00012730478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016919403,0.00015071139,0.00023108743,0.00014015917,0.00002510356,0.000005348153,0.0000651144,0.00010412992,0.00017904311],"category_scores_gemma":[0.00012717556,0.00012654657,0.00005685594,0.00018572314,0.000023216635,0.00003565196,0.00002642123,0.0001951687,0.00042582912],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028598096,0.003685655,0.97407484,0.00005660115,0.00009621463,0.00047149375,0.0004118596,0.0000016751317,0.0013580694,0.000107276035,0.0005909686,0.018859383],"study_design_scores_gemma":[0.02379648,0.0006853927,0.9507772,0.00018541176,0.00010156185,0.000030449293,0.000038382885,0.000011476164,0.022305006,0.000052776384,0.0018677711,0.00014812761],"about_ca_topic_score_codex":0.00009541544,"about_ca_topic_score_gemma":0.000048869857,"teacher_disagreement_score":0.0338236,"about_ca_system_score_codex":0.00042100626,"about_ca_system_score_gemma":0.00010222682,"threshold_uncertainty_score":0.5473314},"labels":[],"label_agreement":null},{"id":"W2979372680","doi":"10.1182/blood.v124.21.1701.1701","title":"Phase 2A Study of Copanlisib, a Novel PI3K Inhibitor, in Patients with Indolent Lymphoma","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Internal medicine; Follicular lymphoma; Tolerability; Chronic lymphocytic leukemia; Bendamustine; Phases of clinical research; Lymphoma; Gastroenterology; Clinical endpoint; Progressive disease; Oncology; Adverse effect; Chemotherapy; Clinical trial; Leukemia","score_opus":0.013141868499546829,"score_gpt":0.27885855896993317,"score_spread":0.2657166904703863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979372680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99806106,0.00003157594,0.000019205121,0.00001595043,0.000045568868,0.0011797576,0.000008667043,0.000025643814,0.00061258883],"genre_scores_gemma":[0.99955714,0.0000018147991,0.0001426409,0.00005492408,0.000083806226,0.000051257208,0.000017916906,0.000033954948,0.000056544897],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9979736,0.00006136525,0.0003976808,0.00034291472,0.0008733715,0.00035105852],"domain_scores_gemma":[0.99888694,0.0000973173,0.000109970366,0.0005563474,0.00018657763,0.00016285985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029720456,0.00017274304,0.0004331213,0.00022316196,0.000026911877,0.000010637642,0.00014911345,0.00007465057,0.000021076414],"category_scores_gemma":[0.000200777,0.00013096567,0.000037322166,0.00040297795,0.00007923376,0.000061138155,0.00011126435,0.00012142945,0.000015605452],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008230306,0.41221008,0.5428438,0.0006324782,0.00058685924,0.00021963974,0.0067766835,0.000027510228,0.0031782687,0.000056302586,0.0002522972,0.02498572],"study_design_scores_gemma":[0.7924814,0.01957599,0.17758538,0.00036522132,0.00019234096,0.000027305854,0.0004497829,0.0005370755,0.008414499,0.0000037075265,0.00017030399,0.00019697538],"about_ca_topic_score_codex":0.00079255406,"about_ca_topic_score_gemma":0.00015580471,"teacher_disagreement_score":0.7842511,"about_ca_system_score_codex":0.0012979087,"about_ca_system_score_gemma":0.0017752359,"threshold_uncertainty_score":0.5340625},"labels":[],"label_agreement":null},{"id":"W2979373204","doi":"10.1182/blood.v104.11.3842.3842","title":"Identifying Mechanisms of Enhanced NK Cell Cytotoxicity Using Permanent NK Cell Lines.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital; Canadian Blood Services; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Cytotoxicity; NKG2D; CD16; Natural killer cell; Lymphokine-activated killer cell; Biology; Cell culture; Flow cytometry; Cytotoxic T cell; Antibody-dependent cell-mediated cytotoxicity; Perforin; Receptor; Cell biology; Interleukin 21; Molecular biology; Immunology; CD8; CD3; Antigen; In vitro; Biochemistry; Genetics","score_opus":0.017008791894934178,"score_gpt":0.23971924050511295,"score_spread":0.22271044861017877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979373204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9722919,0.0008726185,0.021726951,0.000012793612,0.0020039936,0.00018723149,0.0000041874796,0.000061435785,0.0028389054],"genre_scores_gemma":[0.99596995,0.000103010796,0.00066840736,0.00009534117,0.000037167658,0.000006647635,0.00004917285,0.000019741849,0.0030505834],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99902683,0.00006800112,0.00035821987,0.00024765026,0.0000448993,0.00025438226],"domain_scores_gemma":[0.99940586,0.000023085033,0.00022446964,0.00023664277,0.000092581846,0.000017346376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000119251075,0.00016433033,0.00023149015,0.00011423634,0.00015458623,0.000013227103,0.0001374674,0.00020765302,0.0007217258],"category_scores_gemma":[0.000014669825,0.00016218337,0.00014119479,0.00010706104,0.00004907613,0.0001285483,0.00006617965,0.00025920334,0.00046302722],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054378233,0.00068821746,0.000010441903,0.000074618074,0.000056731733,0.000002704105,0.0003970633,0.00009348954,0.99839705,0.00014371942,0.000058705235,0.000022866972],"study_design_scores_gemma":[0.0027508917,0.0001701789,0.000076215096,0.00006819174,0.00012320143,0.000041281943,0.0004104057,0.000004280113,0.99578,0.00020969566,0.00020443801,0.00016123978],"about_ca_topic_score_codex":0.00015686222,"about_ca_topic_score_gemma":0.000007019161,"teacher_disagreement_score":0.023678044,"about_ca_system_score_codex":0.00004725742,"about_ca_system_score_gemma":0.00005349267,"threshold_uncertainty_score":0.79023916},"labels":[],"label_agreement":null},{"id":"W2979374358","doi":"10.1182/blood.v106.11.1890.1890","title":"Red Blood Cell Allo and Autoantibody Production in Patients in the Thalassemia Clinical Research Network.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Splenectomy; Thalassemia; Leukoreduction; Autoantibody; Blood transfusion; Immunology; Internal medicine; Pediatrics; Antibody","score_opus":0.036699088704487834,"score_gpt":0.34628171288092996,"score_spread":0.3095826241764421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979374358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99363375,0.00046897138,5.5259176e-7,0.0027638748,0.00010600849,0.0008344094,0.0000010219053,0.00001988753,0.0021715397],"genre_scores_gemma":[0.99766994,0.0008118268,0.00043682184,0.0001596128,0.00070758763,0.000022673254,0.000019536501,0.000017230414,0.00015477362],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979562,0.00036481096,0.0004252599,0.0004030005,0.0004279993,0.0004227338],"domain_scores_gemma":[0.9993086,0.00014794743,0.000042849937,0.00034916014,0.00007621503,0.000075253985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027508095,0.00011314639,0.00023816798,0.00011360958,0.000086826985,0.000020759768,0.00010672403,0.0001641086,0.000013536526],"category_scores_gemma":[0.00013815232,0.0000786064,0.00004640947,0.00046919394,0.00008078363,0.0000811588,0.000048267913,0.0008190657,0.0000103801085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015071423,0.005725484,0.9888916,0.000044069566,0.000021113601,0.00002995068,0.0003963376,0.0000060536754,0.00057836587,0.000026246042,0.0008659382,0.0032641196],"study_design_scores_gemma":[0.00898266,0.0008065323,0.9870022,0.00014703658,0.00011385467,0.000020625637,0.00007513966,0.000047561203,0.001163887,0.000066229804,0.0014906371,0.00008366397],"about_ca_topic_score_codex":0.00008054962,"about_ca_topic_score_gemma":0.00037459587,"teacher_disagreement_score":0.008831945,"about_ca_system_score_codex":0.000010515104,"about_ca_system_score_gemma":0.000050059876,"threshold_uncertainty_score":0.35584784},"labels":[],"label_agreement":null},{"id":"W2979375622","doi":"10.1182/blood.v128.22.533.533","title":"External Validation of a Clinical and Claims-Based Approach for Predicting 90-Day Post-Pulmonary Embolism Outcomes Among US Veterans","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Pulmonary embolism; Atrial fibrillation; Internal medicine; Myocardial infarction; Heart failure; Stroke (engine); Coagulopathy; Cardiology","score_opus":0.029834658242721912,"score_gpt":0.3122285840713642,"score_spread":0.2823939258286423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979375622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98684716,0.000093419585,0.01095598,0.00040440267,0.00016088536,0.0009571442,0.000051857132,0.000052124902,0.00047702968],"genre_scores_gemma":[0.99410063,0.000055080163,0.00498513,0.0003036929,0.0002621907,0.00012761314,0.000027487284,0.000029802826,0.000108353524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849486,0.000083200364,0.00059887615,0.00034703416,0.00024386859,0.00023215049],"domain_scores_gemma":[0.9988854,0.00035532465,0.00021683409,0.0002831215,0.00012588309,0.0001334514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007575279,0.00015888968,0.00061971054,0.00009888988,0.0000621167,0.000014565387,0.00008930007,0.00011778213,0.000022394514],"category_scores_gemma":[0.0002826034,0.000104870356,0.00021427068,0.000050748375,0.00012254294,0.000097806624,0.000048626258,0.000079819605,0.0000016849657],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010675858,0.0021985394,0.9808104,0.00028286705,0.00023282104,0.000011602924,0.00014391096,0.0000066273583,0.0024838236,0.0001234962,0.00004848341,0.013550661],"study_design_scores_gemma":[0.0070302407,0.000648357,0.98599494,0.00028353953,0.00081805285,0.0000073570404,0.000068309535,0.0005987142,0.004217544,0.0000675843,0.00013864743,0.00012672629],"about_ca_topic_score_codex":0.0000651426,"about_ca_topic_score_gemma":0.0000032372131,"teacher_disagreement_score":0.013423935,"about_ca_system_score_codex":0.000007865671,"about_ca_system_score_gemma":0.000044996737,"threshold_uncertainty_score":0.4276489},"labels":[],"label_agreement":null},{"id":"W2979378086","doi":"10.1182/blood.v116.21.4621.4621","title":"Left Atrium Enlargement Is An Independent Predictor of Overall Mortality In Patients with Cardiac AL Amyloidosis.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Ejection fraction; Internal medicine; Cardiology; Cardiac amyloidosis; Amyloidosis; Left atrial enlargement; Cohort; Refractory (planetary science); Heart failure; Atrial fibrillation","score_opus":0.006184666668517804,"score_gpt":0.2354524797918107,"score_spread":0.2292678131232929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979378086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986053,0.000111644564,0.000004972605,0.000058370428,0.00018711654,0.00050315284,0.00034759135,0.0000135819855,0.00016827873],"genre_scores_gemma":[0.99870926,0.00007258869,0.00031720748,0.00031116308,0.00008226802,0.000057258752,0.000367828,0.000032944532,0.000049492854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984013,0.00006277578,0.00032402278,0.00051796454,0.0003758496,0.000318105],"domain_scores_gemma":[0.99886596,0.000012027031,0.00016838551,0.00070771,0.00010740127,0.00013849979],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016178668,0.0002510672,0.0003090864,0.00006012321,0.00003490198,0.00001699541,0.00023679978,0.00019008692,0.00007930708],"category_scores_gemma":[0.000040453233,0.00021482703,0.00012926495,0.00005655317,0.000071285074,0.000013218582,0.00013855,0.00014832529,0.0000046937007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007032046,0.0021963804,0.96281284,0.000015252736,0.00040144642,0.0000023480086,0.000113761154,0.0000035865892,0.03397897,0.000013163047,0.00031049066,0.0000814364],"study_design_scores_gemma":[0.003590891,0.0006475285,0.8297464,0.000008006498,0.00016076725,4.815067e-7,0.000025331805,0.0000010896028,0.16455273,0.0000066938937,0.0010673869,0.00019268433],"about_ca_topic_score_codex":0.00018561583,"about_ca_topic_score_gemma":0.00036275113,"teacher_disagreement_score":0.13306643,"about_ca_system_score_codex":0.000017245475,"about_ca_system_score_gemma":0.00007979369,"threshold_uncertainty_score":0.8760392},"labels":[],"label_agreement":null},{"id":"W2979380409","doi":"10.1182/blood.v126.23.807.807","title":"Genetic and Response-Based Risk Classification Identifies a Subgroup of NCI High Risk Childhood B-Lymphoblastic Leukemia (HR B-ALL) with Outstanding Outcomes: A Report from the Children's Oncology Group (COG)","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Minimal residual disease; Internal medicine; Oncology; Bone marrow; Pediatrics","score_opus":0.020638752276132325,"score_gpt":0.2720690911721481,"score_spread":0.2514303388960158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979380409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922787,0.00058228296,0.0046393503,0.00051909155,0.00012654638,0.001417188,0.00023433517,0.000121301186,0.00008121498],"genre_scores_gemma":[0.9939617,0.000116440875,0.0050710547,0.00017866494,0.00020888075,0.00015338081,0.00015486333,0.00009178464,0.00006322503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954954,0.0008863062,0.0009368979,0.00086923596,0.0012283765,0.0005837829],"domain_scores_gemma":[0.9940125,0.0029125777,0.00096873374,0.0013073268,0.0003580243,0.00044086576],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018807059,0.00043947154,0.00087589567,0.00027148632,0.00021646247,0.000079310805,0.00038253635,0.0003215799,0.000023947605],"category_scores_gemma":[0.0047415136,0.0002787156,0.00015211767,0.00049750286,0.0006514733,0.000118949145,0.00017296117,0.000597001,0.00002131507],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004431995,0.00087216747,0.98697746,0.000033502547,0.0015340982,0.0006168617,0.0020095836,0.00007983164,0.0020084756,0.000024103005,0.00044491945,0.0009670201],"study_design_scores_gemma":[0.025790129,0.002099065,0.9637152,0.00018976502,0.003378446,0.0009793846,0.0011013817,0.0010855589,0.0010070859,0.0002792739,0.0000831532,0.00029154037],"about_ca_topic_score_codex":0.0066135605,"about_ca_topic_score_gemma":0.00072725245,"teacher_disagreement_score":0.023262225,"about_ca_system_score_codex":0.0012546984,"about_ca_system_score_gemma":0.0033914906,"threshold_uncertainty_score":0.9999665},"labels":[],"label_agreement":null},{"id":"W2979382944","doi":"10.1182/blood.v128.22.4562.4562","title":"Incidence, Risk Factors and Outcome of Late Onset Noninfectious Pulmonary Complications after Allogeneic Hematopoietic Stem Cell Transplantation: A Prospective Cohort Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Bronchiolitis obliterans; Transplantation; Incidence (geometry); Hematopoietic stem cell transplantation; Prospective cohort study; Internal medicine; Cumulative incidence; Retrospective cohort study; Surgery; Cohort; Epidemiology; Pediatrics; Cohort study; Lung transplantation","score_opus":0.007870772268638802,"score_gpt":0.23931832764023053,"score_spread":0.23144755537159173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979382944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972565,0.00030703383,0.0001269081,0.000041077892,0.00004797424,0.0012577691,0.00038455235,0.0000491404,0.00052901],"genre_scores_gemma":[0.99930483,0.00016723356,0.0000321062,0.000023920478,0.000025991927,0.0002058208,0.000014066384,0.0000216522,0.00020438591],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988312,0.00007411292,0.000363273,0.0003403593,0.00022123143,0.00016982238],"domain_scores_gemma":[0.99924016,0.000096312506,0.00014270132,0.00028791546,0.00009848564,0.00013440373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000119019,0.00018460477,0.00035699515,0.0000938001,0.000087362794,0.000009616802,0.00006447523,0.00006403724,0.00004368833],"category_scores_gemma":[0.000007773074,0.00012116334,0.000116684314,0.000120494515,0.00011074408,0.00008451626,0.000029842227,0.00009496511,0.000013595861],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055622414,0.0016564456,0.9952116,0.00022546641,0.00016857649,0.00013594195,0.00062400504,5.155573e-7,0.0013669507,0.000008053804,0.0000025642432,0.00004363381],"study_design_scores_gemma":[0.001457388,0.0016367523,0.99302435,0.00019768627,0.0014411453,0.00019250142,0.00019359514,0.0000041720928,0.0016492638,0.00005284107,0.0000039463675,0.0001463312],"about_ca_topic_score_codex":0.000179024,"about_ca_topic_score_gemma":0.0000318634,"teacher_disagreement_score":0.0021872453,"about_ca_system_score_codex":0.000032395117,"about_ca_system_score_gemma":0.000043043707,"threshold_uncertainty_score":0.49408975},"labels":[],"label_agreement":null},{"id":"W2979384469","doi":"10.1182/blood.v116.21.1504.1504","title":"Combined Modality Therapy Versus Chemotherapy Alone as An Induction Regimen for Primary CNS Lymphoma: a Decision Analysis.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Life expectancy; Oncology; Internal medicine; Regimen; Chemotherapy; Cytarabine; Chemotherapy regimen; Induction chemotherapy; Surgery; Population","score_opus":0.01969887883909359,"score_gpt":0.29928227969963733,"score_spread":0.27958340086054373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979384469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99656093,0.00017650041,0.00009207103,0.0012673168,0.00029224445,0.0009793376,0.000018875264,0.00010489869,0.0005078041],"genre_scores_gemma":[0.9936408,0.00026043435,0.004607016,0.0004947573,0.00026947472,0.0002486934,0.000342088,0.000038737016,0.000097991986],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99861586,0.0000298183,0.0002864808,0.0004897523,0.00031820638,0.00025987398],"domain_scores_gemma":[0.99858177,0.00016728786,0.0001268173,0.0007678386,0.00014645698,0.00020983395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002610772,0.0002306862,0.00052158366,0.00018952672,0.0001366623,0.00004192997,0.00011139416,0.00019467335,0.00012098265],"category_scores_gemma":[0.00005255957,0.00018355098,0.00032332315,0.00041651455,0.000055994893,0.000120872384,0.000018224666,0.000075893186,0.000015106862],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023141403,0.04102095,0.112344,0.000036630463,0.009216618,0.00007007068,0.00073524436,0.0000046639557,0.060507983,0.0011110397,0.0006867036,0.7511247],"study_design_scores_gemma":[0.08604094,0.0031690067,0.850003,0.000013435492,0.0020660348,0.0000293795,0.000047773337,0.000084259256,0.05455754,0.0011432384,0.0026072417,0.00023812041],"about_ca_topic_score_codex":0.00034079055,"about_ca_topic_score_gemma":0.00011145057,"teacher_disagreement_score":0.75088656,"about_ca_system_score_codex":0.000097288976,"about_ca_system_score_gemma":0.00016868714,"threshold_uncertainty_score":0.74849916},"labels":[],"label_agreement":null},{"id":"W2979388195","doi":"10.1182/blood.v108.11.1932.1932","title":"BCR-ABL Activates IGF-1 Expression and Signaling in Chronic Myelogenous Leukemia Blast Crisis Cell Lines.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Autocrine signalling; Cancer research; Biology; Philadelphia chromosome; Chronic myelogenous leukemia; Imatinib mesylate; breakpoint cluster region; ABL; Signal transduction; Imatinib; Myeloid leukemia; Cell biology; Cell culture; Leukemia; Immunology; Receptor; Genetics; Chromosomal translocation; Tyrosine kinase","score_opus":0.008307562850966019,"score_gpt":0.22633433926904356,"score_spread":0.21802677641807755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979388195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99220294,0.005624114,0.000024756026,0.0000880852,0.000052548712,0.00043958693,0.000010295626,0.000100129095,0.0014575431],"genre_scores_gemma":[0.99714077,0.00028192328,0.0012680894,0.00007688918,0.00047678367,0.000049833616,0.000063164225,0.00005873762,0.0005838301],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982734,0.000046747966,0.00039091645,0.0005171004,0.0002683514,0.00050349574],"domain_scores_gemma":[0.9992047,0.00011812043,0.00012253388,0.00037558543,0.00004504648,0.00013398887],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000122043435,0.0003059415,0.00043515651,0.00018094096,0.00009678373,0.000029654935,0.000099012555,0.0002120621,0.00013882863],"category_scores_gemma":[0.000028909883,0.0002652861,0.00008073496,0.00023415354,0.000054958877,0.00010663558,0.0000901751,0.00030640065,0.000045127206],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009043457,0.0006150756,0.017868267,0.0002635581,0.000046656485,0.00036365038,0.00026507667,0.00023579045,0.9786531,0.0000039814777,0.0006601529,0.00093429524],"study_design_scores_gemma":[0.014437509,0.0003697267,0.011431054,0.00040478038,0.00024412324,0.00013210907,0.00018397292,0.0002430443,0.97143406,0.00007402389,0.00076652004,0.00027910652],"about_ca_topic_score_codex":0.0014537226,"about_ca_topic_score_gemma":0.0001575005,"teacher_disagreement_score":0.014347075,"about_ca_system_score_codex":0.0014916128,"about_ca_system_score_gemma":0.00077605114,"threshold_uncertainty_score":0.9999799},"labels":[],"label_agreement":null},{"id":"W2979393303","doi":"10.1182/blood.v108.11.2942.2942","title":"Determination of a Limited Sampling Strategy for IV Busulfan Dose Individualization in Children.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Busulfan; Area under the curve; Medicine; Intraclass correlation; Coefficient of variation; Pharmacokinetics; Urology; Internal medicine; Gastroenterology; Hematopoietic stem cell transplantation; Chemistry; Transplantation; Chromatography","score_opus":0.2648427197199653,"score_gpt":0.400707476426206,"score_spread":0.1358647567062407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979393303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9758732,0.0007034213,0.020746607,0.0006223538,0.00007882625,0.0009639215,0.00036475595,0.000028526667,0.00061842275],"genre_scores_gemma":[0.98944676,0.000025818787,0.009507953,0.00027725103,0.0001954237,0.00011899602,0.0003503751,0.000023993836,0.000053451848],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996775,0.000087066925,0.002523916,0.00032185405,0.00005592496,0.0002362903],"domain_scores_gemma":[0.99788845,0.00035467852,0.0014371355,0.00021971225,0.000060830367,0.00003920391],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004261502,0.00011768147,0.0004808479,0.000459209,0.00006526435,0.000040990475,0.0001362097,0.00013352516,0.000031756004],"category_scores_gemma":[0.0008995635,0.00016555586,0.000069325906,0.00024873728,0.000024673274,0.00028276868,0.000016420421,0.00006137059,0.000030408994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014148334,0.00079243997,0.89991045,0.00030887363,0.000039268034,1.8401214e-7,0.0006072095,0.0016039653,0.00005670391,0.09535258,0.00023581689,0.0010783585],"study_design_scores_gemma":[0.0037577865,0.00011472492,0.95759803,0.00007320427,0.000017129127,0.0000037571892,0.00013535033,0.007096221,0.00014792873,0.030255362,0.0005412201,0.00025930637],"about_ca_topic_score_codex":0.0008730525,"about_ca_topic_score_gemma":0.00030532503,"teacher_disagreement_score":0.06509723,"about_ca_system_score_codex":0.00009207544,"about_ca_system_score_gemma":0.00006513369,"threshold_uncertainty_score":0.6751172},"labels":[],"label_agreement":null},{"id":"W2979393346","doi":"10.1182/blood.v124.21.471.471","title":"Characterization of Type 2N Von Willebrand Disease Mutations Using Ιn Vitro and Ιn Vivo Mouse Models","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Von Willebrand disease; Von Willebrand factor; Molecular biology; In vivo; Chemistry; In vitro; Wild type; Coagulation; Point mutation; Mutation; Biology; Immunology; Gene; Mutant; Platelet; Internal medicine; Genetics; Medicine; Biochemistry","score_opus":0.014106833265824414,"score_gpt":0.23732792487417095,"score_spread":0.22322109160834655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979393346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986577,0.00007899723,0.00075848907,0.00006711804,0.00002188383,0.0001711841,0.00004604803,0.000018050965,0.00018055039],"genre_scores_gemma":[0.9991575,0.000051926403,0.00039374988,0.000062869236,0.000022523798,0.0000035543098,0.00015912054,0.00001302053,0.00013575151],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996066,0.000013449678,0.000103731196,0.00011130856,0.000082139086,0.0000827505],"domain_scores_gemma":[0.99970496,0.000011147161,0.00004864265,0.00010453485,0.000045686058,0.00008503469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000024668681,0.00007119228,0.00014941207,0.000048968897,0.00004250411,0.000007855298,0.0000153673,0.000029029472,0.000011820328],"category_scores_gemma":[0.000021948279,0.00006157955,0.000022612458,0.00006739324,0.000024136078,0.00009211608,0.000009471753,0.000025536017,0.000001884967],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027776428,0.000990957,0.015839756,0.00012075557,0.00015296323,0.00003215269,0.0003089917,0.000085804364,0.9811106,0.00012412181,0.0000042963056,0.00095186493],"study_design_scores_gemma":[0.033808097,0.00093088264,0.06957477,0.00042477093,0.004554123,0.00014495198,0.00011279782,0.22143203,0.6648121,0.0031015,0.0004174284,0.0006865537],"about_ca_topic_score_codex":0.000013013327,"about_ca_topic_score_gemma":0.0000015685351,"teacher_disagreement_score":0.31629848,"about_ca_system_score_codex":0.0000049328028,"about_ca_system_score_gemma":0.000025731071,"threshold_uncertainty_score":0.25111413},"labels":[],"label_agreement":null},{"id":"W2979393711","doi":"10.1182/blood.v118.21.2366.2366","title":"A MiR-142-3p/EGR2 Feedback Circuitry In Human CSF-1 Driven Differentiation of Monocytes Into Macrophages","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Transcription factor; Biology; microRNA; Cancer research; Cell biology; Monocyte; Gene expression; Gene; Molecular biology; Immunology; Genetics","score_opus":0.013820974538332422,"score_gpt":0.2345544686316619,"score_spread":0.22073349409332949,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979393711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99850583,0.0005978166,0.00012597146,0.0000066631255,0.000031751802,0.0001665286,0.000012762012,0.000010040393,0.00054261775],"genre_scores_gemma":[0.99923545,0.000032152657,0.00043753043,0.000013549319,0.00006467452,0.000019003985,0.00012399995,0.000019054633,0.000054588036],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99923915,0.000053936285,0.00023817664,0.00024372304,0.000083038016,0.00014199624],"domain_scores_gemma":[0.9995237,0.000004044941,0.00012536421,0.0002471119,0.000054818298,0.00004498543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000053083782,0.00011887095,0.00013240722,0.00006563039,0.000031153915,0.000008316729,0.00015182038,0.00013242623,0.000059165064],"category_scores_gemma":[0.000024800112,0.00012456664,0.000074061565,0.00007259449,0.000054811906,0.0000055500136,0.0000760203,0.000047061483,0.0000055968326],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020037036,0.00039640855,0.056428988,0.0000559504,0.00005694895,0.0000022961433,0.00027673112,0.0000029202645,0.94241565,0.000061275685,0.000046435063,0.00023637667],"study_design_scores_gemma":[0.0007972553,0.00007294128,0.33994922,0.000020994401,0.000034188164,0.0000016795151,0.000030150904,0.000009149265,0.65864265,0.00032333244,0.00002593659,0.0000925266],"about_ca_topic_score_codex":0.000069405614,"about_ca_topic_score_gemma":0.000071563816,"teacher_disagreement_score":0.283773,"about_ca_system_score_codex":0.000010165828,"about_ca_system_score_gemma":0.000025815843,"threshold_uncertainty_score":0.507968},"labels":[],"label_agreement":null},{"id":"W2979396655","doi":"10.1182/blood.v126.23.1051.1051","title":"Thrombosis in Immune Thrombocytopenia Patients with Antiphospholipid Antibodies: A Meta-Analysis","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Meta-analysis; Lupus anticoagulant; Thrombosis; Odds ratio; Publication bias; Antiphospholipid syndrome; Rheumatology","score_opus":0.05174881354250401,"score_gpt":0.2882510199733835,"score_spread":0.23650220643087946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979396655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946935,0.001601993,0.000008573852,0.00016763392,0.000022710145,0.00042991227,0.000038926784,0.000035951765,0.0030007719],"genre_scores_gemma":[0.9983788,0.000054996286,0.001016559,0.00015094386,0.000007889095,0.00003118961,0.00016932646,0.000023046465,0.00016725423],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986393,0.000036536952,0.00029794703,0.00034396822,0.00038872653,0.00029354665],"domain_scores_gemma":[0.99915147,0.000023161436,0.0001055695,0.00044337852,0.00013332083,0.0001431276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013257662,0.00023170379,0.001607127,0.00021610159,0.00003659935,0.00002389917,0.000094786876,0.000071564566,0.0001949938],"category_scores_gemma":[0.000031273445,0.0001452084,0.00039595895,0.00084883155,0.000051951505,0.00012793635,0.000043192267,0.000108043445,0.00006758202],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015069504,0.004017776,0.88243234,0.000014093106,0.11258978,0.00018090334,0.0004363455,0.0000096405765,0.000036482536,0.0000140679995,0.000082749255,0.00003511233],"study_design_scores_gemma":[0.012946216,0.00059573504,0.75997627,0.000009696596,0.22437708,0.0000093290955,0.00014375655,0.000010386017,0.0015337446,0.00003898449,0.00015527141,0.00020354195],"about_ca_topic_score_codex":0.0006822744,"about_ca_topic_score_gemma":0.00023679936,"teacher_disagreement_score":0.122456096,"about_ca_system_score_codex":0.000030530347,"about_ca_system_score_gemma":0.00007156313,"threshold_uncertainty_score":0.59214264},"labels":[],"label_agreement":null},{"id":"W2979396924","doi":"10.1182/blood.v114.22.268.268","title":"Gene Expression Profiling of Microdissected Hodgkin Reed Sternberg Cells: Molecular Subtypes and Treatment Outcome Correlations.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Laser capture microdissection; Germinal center; Reed–Sternberg cell; Gene expression profiling; Cancer research; Biology; Gene expression; Microdissection; Lymphoma; Molecular biology; Pathology; Gene; Medicine; B cell; Immunology; Hodgkin lymphoma; Genetics; Antibody","score_opus":0.015680890463886533,"score_gpt":0.2602055001670626,"score_spread":0.24452460970317608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979396924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971492,0.0018456749,0.00003203765,0.00013892514,0.000033122746,0.00043974924,0.000014511757,0.000034267385,0.0003124633],"genre_scores_gemma":[0.9912651,0.00014289356,0.008302515,0.00005270226,0.000024996694,0.000020507432,0.000055486813,0.000010486992,0.00012527927],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992641,0.000025400563,0.00024507777,0.00021889464,0.00011750665,0.00012902461],"domain_scores_gemma":[0.9995221,0.00003192637,0.000087477725,0.00023140093,0.000045100365,0.00008199876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000035602192,0.00014054336,0.0002694781,0.00006579883,0.00003641746,0.000008907481,0.000026889256,0.00006564562,0.000014408056],"category_scores_gemma":[0.000015092203,0.00010080323,0.00007184021,0.00007767689,0.000018999352,0.000026687765,0.0000115224775,0.000028554698,0.00000613997],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007498926,0.0017454658,0.2884225,0.000014924517,0.00008438125,0.00010852296,0.00011999395,0.000003442004,0.70734376,0.000024080224,0.0000090866215,0.0020488761],"study_design_scores_gemma":[0.0051383656,0.00075344427,0.21076028,0.00006380558,0.00037366862,0.00003408757,0.000023400282,0.000013366183,0.78273606,0.000013712902,0.00002207267,0.00006774445],"about_ca_topic_score_codex":0.000027890328,"about_ca_topic_score_gemma":0.000002086095,"teacher_disagreement_score":0.07766221,"about_ca_system_score_codex":0.00003770243,"about_ca_system_score_gemma":0.000031637992,"threshold_uncertainty_score":0.41106364},"labels":[],"label_agreement":null},{"id":"W2979397416","doi":"10.1182/blood.v116.21.4733.4733","title":"Multilevel Modeling to Predict Factors Influencing the Length of Stay for An Inpatient Malignant Hematology Service","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Disease Management Strategies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Juravinski Hospital","funders":"","keywords":"Medicine; Referral; Residence; Hematology; Emergency medicine; Family medicine; Internal medicine; Demography","score_opus":0.05269696074086667,"score_gpt":0.3107264118091267,"score_spread":0.25802945106826003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979397416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99673784,0.00002458832,0.001365934,0.00023402054,0.0001565155,0.0010538389,0.000050460105,0.000057732806,0.00031907682],"genre_scores_gemma":[0.9979292,0.0000020105952,0.0015481773,0.00029741484,0.000065422595,0.00008117482,0.00003442461,0.000022654447,0.000019476596],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99901813,0.000016509463,0.00028740228,0.00023208445,0.00020248405,0.00024340632],"domain_scores_gemma":[0.9991125,0.00006493713,0.00008054364,0.0004587997,0.00016092834,0.00012232098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015546016,0.00013618407,0.00022831204,0.00007806888,0.00006419199,0.000013810754,0.00018308692,0.00005788955,0.0000347706],"category_scores_gemma":[0.00010218029,0.00009085601,0.000056699835,0.00009698576,0.000026892561,0.00008600402,0.00009080825,0.00011454748,0.0000029871728],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024244287,0.01602936,0.38329,0.012776852,0.004777979,0.000083393075,0.11230106,0.03753661,0.36246547,0.05690765,0.0014175707,0.009989621],"study_design_scores_gemma":[0.032316998,0.005440991,0.12012497,0.0014568036,0.0053879754,0.00007696243,0.06361871,0.6053892,0.15926166,0.0030384515,0.0022760667,0.0016112542],"about_ca_topic_score_codex":0.00026510027,"about_ca_topic_score_gemma":0.0003713928,"teacher_disagreement_score":0.56785256,"about_ca_system_score_codex":0.000013758882,"about_ca_system_score_gemma":0.00012554885,"threshold_uncertainty_score":0.37050006},"labels":[],"label_agreement":null},{"id":"W2979397972","doi":"10.1182/blood.v114.22.4002.4002","title":"Subsegmental Pulmonary Embolism Diagnosed by Computed Tomography: Incidence and Clinical Implications. A Systematic Review and Meta-Analysis of the Management Outcome Studies.","year":2009,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Dalhousie University; University of Ottawa","funders":"","keywords":"Medicine; Pulmonary embolism; Radiology; Incidence (geometry); Thrombus; Meta-analysis; Prospective cohort study; Nuclear medicine; Surgery; Internal medicine","score_opus":0.10103535055444723,"score_gpt":0.4033397286227164,"score_spread":0.30230437806826915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979397972","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000041061245,0.9901345,0.0000068317736,0.0008485673,0.000037248814,0.008666965,0.00015033937,0.000033827226,0.00008069165],"genre_scores_gemma":[0.000557465,0.99520975,0.00021986,0.002531865,0.000016747363,0.0012181482,0.000110138986,0.000032046024,0.00010400162],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99521923,0.000577019,0.0026591304,0.00080312684,0.00046501166,0.00027648662],"domain_scores_gemma":[0.9962887,0.0004976525,0.0014994554,0.0014278603,0.00012335891,0.00016297789],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014143671,0.00059498294,0.013483028,0.00035821428,0.00012295376,0.000030152594,0.00043884842,0.0001558924,0.000017184293],"category_scores_gemma":[0.00011176154,0.0003287358,0.00328544,0.0014867925,0.00021620907,0.000047041303,0.00053380115,0.0002821601,0.000002822841],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[5.9512433e-7,0.0013563454,0.00029723236,0.5970499,0.39509878,0.000028053475,0.000015467866,4.1215714e-8,1.802215e-8,0.00022612387,0.00074069895,0.0051867315],"study_design_scores_gemma":[0.0003183398,0.00007901948,0.006865986,0.03634882,0.95089895,0.000042763106,0.0000261862,9.1625617e-7,6.441461e-8,0.000016251164,0.0051450618,0.000257619],"about_ca_topic_score_codex":0.000022002101,"about_ca_topic_score_gemma":0.000009295113,"teacher_disagreement_score":0.5607011,"about_ca_system_score_codex":0.0000400737,"about_ca_system_score_gemma":0.000027302141,"threshold_uncertainty_score":0.9999165},"labels":[],"label_agreement":null},{"id":"W2979403628","doi":"10.1182/blood.v128.22.2486.2486","title":"Blood Group Genotyping to Prevent Alloimmunization in Children with Sickle Cell Disease","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Héma-Québec; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Genotyping; ABO blood group system; Blood transfusion; Hemolysis; Antigen; Internal medicine; Immunology; Vacutainer; Disease; Isoantibodies; Gastroenterology; Genotype; Gene; Genetics; Biology","score_opus":0.004079417250325326,"score_gpt":0.19308057926791397,"score_spread":0.18900116201758865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979403628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969361,0.0004808028,0.00075434055,0.0005861724,0.000020235415,0.0008230422,0.000010758236,0.000061185725,0.00032738256],"genre_scores_gemma":[0.99817634,0.00012645486,0.0009807464,0.00024006088,0.00009409487,0.000044672015,0.000032558426,0.000036335532,0.0002687254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990463,0.000029706966,0.00018247424,0.00029530452,0.00019994384,0.0002462597],"domain_scores_gemma":[0.99936604,0.000015488358,0.000035416044,0.00033035377,0.000034538218,0.0002181525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000973177,0.00014578358,0.00017844226,0.00010557263,0.000047209298,0.000010731409,0.000085287116,0.00004888597,0.000065192806],"category_scores_gemma":[0.000013741386,0.00009292106,0.000043454424,0.00022544911,0.000019617828,0.00008014308,0.00003567735,0.00008159823,0.00003633613],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023736549,0.005839042,0.8952717,0.00006377923,0.00014148673,0.00004990565,0.00023869496,0.0000068695163,0.094022036,0.00019004747,0.000016192878,0.0039228457],"study_design_scores_gemma":[0.009578401,0.0006508065,0.9508681,0.00045129616,0.000689043,0.000033299904,0.000012231675,0.0000032718806,0.037321936,0.00004888031,0.00014159032,0.00020112544],"about_ca_topic_score_codex":0.00007148482,"about_ca_topic_score_gemma":0.000055874505,"teacher_disagreement_score":0.056700103,"about_ca_system_score_codex":0.000014094919,"about_ca_system_score_gemma":0.00004697302,"threshold_uncertainty_score":0.3789211},"labels":[],"label_agreement":null},{"id":"W2979405160","doi":"10.1182/blood.v128.22.314.314","title":"Pilot Study of Online Learning Modules for Hemoglobinopathy Education in Canadian Hematology Training Programs","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; University Health Network; University of Toronto; McMaster University; Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Curriculum; Hemoglobinopathy; Medicine; Medical education; Hematology; Family medicine; Internal medicine; Psychology; Disease; Pedagogy","score_opus":0.02348238370296339,"score_gpt":0.27819310417926313,"score_spread":0.2547107204762997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979405160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99723154,0.00049229176,0.00001969377,0.00060758775,0.00011358445,0.0010790708,0.000005484318,0.00003159745,0.0004191712],"genre_scores_gemma":[0.99863964,0.000034649896,0.00080904627,0.00005400605,0.000047128622,0.00008548734,0.000030740688,0.000023233002,0.00027606328],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896675,0.00004277759,0.00031358746,0.00022119585,0.00009456402,0.00036114966],"domain_scores_gemma":[0.9994495,0.000047099456,0.000083617975,0.00014950644,0.00009258857,0.00017766787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018262226,0.000115316216,0.00030491728,0.00022701715,0.000049131602,0.000004078723,0.000065841006,0.000063217725,0.000010717668],"category_scores_gemma":[0.00023899121,0.000082176404,0.000036444737,0.00018131467,0.000041648025,0.000034613997,0.0000112311145,0.00012244105,0.0000025375934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017538184,0.013294762,0.68448097,0.00016083197,0.00011339478,0.000030174644,0.003807417,0.000008172655,0.004108103,0.0005949133,0.00003818943,0.29318768],"study_design_scores_gemma":[0.08853107,0.07012812,0.679951,0.0045990064,0.00132357,0.00093119283,0.13854359,0.0004626214,0.0033689353,0.001475993,0.009389518,0.0012953614],"about_ca_topic_score_codex":0.035430364,"about_ca_topic_score_gemma":0.16810577,"teacher_disagreement_score":0.29189232,"about_ca_system_score_codex":0.00005092259,"about_ca_system_score_gemma":0.0007070313,"threshold_uncertainty_score":0.9709928},"labels":[],"label_agreement":null},{"id":"W2979406515","doi":"10.1182/blood.v110.11.954.954","title":"Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM) Patients with Dialysis-Dependent Renal Failure Is Effective but Carries High Rates of Toxicity.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Melphalan; Multiple myeloma; Neutropenia; Transplantation; Internal medicine; Dialysis; Hemodialysis; Surgery; Gastroenterology; Toxicity; Autologous stem-cell transplantation; Urology","score_opus":0.008605388553050658,"score_gpt":0.24092020208927659,"score_spread":0.23231481353622593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979406515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979402,0.00011396161,0.0001863906,0.000032940643,0.000023821722,0.0013002682,0.00022837771,0.000032869255,0.00014117188],"genre_scores_gemma":[0.99881655,0.000023349166,0.0006718716,0.00002070601,0.000030879604,0.000073889925,0.00021514438,0.000025582289,0.00012200392],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816465,0.00010789531,0.00035692452,0.00036437862,0.00058383524,0.00042231215],"domain_scores_gemma":[0.99892795,0.00032276564,0.00013801374,0.00024136489,0.00018941595,0.00018048364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020248839,0.0002337322,0.00046743348,0.00027998528,0.0000697169,0.000013242879,0.000087917695,0.0001326475,0.00003350135],"category_scores_gemma":[0.000033314427,0.00017225291,0.000085782034,0.00028981385,0.00009331596,0.00010215989,0.000020442836,0.00019714993,0.000011914614],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033220933,0.0020112803,0.9573684,0.00029535618,0.00040793294,0.0005575628,0.0018050174,0.000013625462,0.027657842,0.0000036731162,0.0000060361003,0.006551216],"study_design_scores_gemma":[0.013148507,0.00093890494,0.53920156,0.00008743374,0.00019947028,0.000010081712,0.00018053524,0.000013563107,0.44612637,0.0000034107518,0.0000033612594,0.00008682773],"about_ca_topic_score_codex":0.0010008812,"about_ca_topic_score_gemma":0.0023602773,"teacher_disagreement_score":0.41846853,"about_ca_system_score_codex":0.00008661325,"about_ca_system_score_gemma":0.00007789755,"threshold_uncertainty_score":0.70242697},"labels":[],"label_agreement":null},{"id":"W2979407471","doi":"10.1182/blood.v126.23.1138.1138","title":"North American Cooperative Group Members' Patterns of Blood Products Transfusion for Patients with Acute Leukemia","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Acute leukemia; Internal medicine; Population; Leukemia; Blood transfusion; Clinical trial; Cancer","score_opus":0.011196587329853895,"score_gpt":0.24262667292120374,"score_spread":0.23143008559134984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979407471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99798983,0.000018769744,0.0001535693,0.00011139848,0.00008608749,0.0011446711,0.00015176184,0.000037829665,0.00030608982],"genre_scores_gemma":[0.9985329,0.000036984577,0.0006651637,0.000111889356,0.000116257455,0.00015185383,0.00017072281,0.00002798407,0.00018624318],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991522,0.000022212165,0.00018247729,0.00026061866,0.00019836672,0.00018414661],"domain_scores_gemma":[0.9990426,0.00001667968,0.00009785696,0.00023211795,0.00047178013,0.00013900218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000043376953,0.00014300253,0.0003160419,0.000056452544,0.000053304626,0.000007633912,0.000058388556,0.00002344202,0.000013099386],"category_scores_gemma":[0.000019808629,0.000103003906,0.00004719593,0.00029011478,0.00006723706,0.00008548364,0.000013163176,0.000099007106,0.0000025976674],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094934227,0.002222287,0.9913792,0.00010585905,0.0007567275,0.000014496542,0.0010199771,0.000010993336,0.0023490184,0.00002850399,0.0002532013,0.0009104181],"study_design_scores_gemma":[0.0459412,0.025677184,0.81370145,0.00018914272,0.0068944874,0.00009290472,0.00044236478,0.0000069763314,0.102714874,0.000004066125,0.0038598129,0.00047556413],"about_ca_topic_score_codex":0.00040604977,"about_ca_topic_score_gemma":0.0013116607,"teacher_disagreement_score":0.17767775,"about_ca_system_score_codex":0.000034059503,"about_ca_system_score_gemma":0.00024080861,"threshold_uncertainty_score":0.42003772},"labels":[],"label_agreement":null},{"id":"W2979412921","doi":"10.1182/blood.v114.22.223.223","title":"Administration of Anti-Platelet Antibodies Prevents the Anti-Platelet Immune Response and Bleeding Complications of Neonatal Immune Thrombocytopenia in a Murine Model.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; St. Michael's Hospital","funders":"","keywords":"Medicine; Antibody; Immunology; Immune system; Antigen; Immunogen; Platelet; Fetus; Immunization; Isoantibodies; Pregnancy; Platelet transfusion; Monoclonal antibody; Biology","score_opus":0.018555836064988625,"score_gpt":0.2878935900870413,"score_spread":0.2693377540220527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979412921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99627274,0.0017078015,0.00004114925,0.00093917956,0.000016085782,0.0006513138,0.00006692617,0.000019309136,0.0002854718],"genre_scores_gemma":[0.998168,0.0007047185,0.0009230019,0.00003162472,0.0000073427477,0.000010748245,0.00009375731,0.000013338978,0.00004748546],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987279,0.00005571801,0.0005668764,0.00023475965,0.00020141089,0.00021330397],"domain_scores_gemma":[0.99921376,0.000086550994,0.00023910042,0.0003451378,0.00006971955,0.000045748464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029392447,0.00018473012,0.0006374778,0.0001459092,0.000087246866,0.0000134295915,0.00012446872,0.000086177664,0.000010650862],"category_scores_gemma":[0.000057499965,0.00014049793,0.00007948986,0.00024281918,0.0001237539,0.00013516415,0.000045643745,0.00014332555,0.0000017291068],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023428232,0.0045344206,0.027215794,0.0001986289,0.0005132452,0.00041607214,0.0017560206,0.00013410061,0.9575633,0.00053417095,0.000024302994,0.004767111],"study_design_scores_gemma":[0.0071861316,0.0007724458,0.7522992,0.0003108225,0.00017437962,0.00056986674,0.00021262438,0.0011088626,0.23680471,0.00040552177,0.000021619133,0.00013383303],"about_ca_topic_score_codex":0.00006132029,"about_ca_topic_score_gemma":0.000009206874,"teacher_disagreement_score":0.7250834,"about_ca_system_score_codex":0.000011355955,"about_ca_system_score_gemma":0.00009118218,"threshold_uncertainty_score":0.5729339},"labels":[],"label_agreement":null},{"id":"W2979413716","doi":"10.1182/blood.v108.11.1478.1478","title":"Role of Gender in the Clinical Presentation of a First Deep Venous Thrombosis (DVT) in Outpatients.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Deep vein; Thrombosis; Venous thrombosis; Retrospective cohort study; Internal medicine; Surgery; Physical therapy","score_opus":0.03292295886151303,"score_gpt":0.31413244163141746,"score_spread":0.28120948276990443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979413716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929918,0.00041522607,0.000008539012,0.00015706153,0.000038353992,0.00058499497,0.0000033345302,0.000006048951,0.0057946173],"genre_scores_gemma":[0.9994155,0.00015314553,0.00020312058,0.00009447561,0.000055072014,0.000046334215,0.000017220167,0.000009358509,0.000005739749],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885255,0.000075163385,0.0005296663,0.0001496479,0.00024871645,0.00014427346],"domain_scores_gemma":[0.9994492,0.00010704704,0.00014217032,0.0002452921,0.00003825515,0.000018035425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035232396,0.00007642065,0.0003637347,0.000100867146,0.000015021168,0.0000037709717,0.000103620856,0.000058711455,0.000028723405],"category_scores_gemma":[0.00005808464,0.000057286095,0.00008493786,0.00020749086,0.000049142163,0.000033594497,0.000035320987,0.00009129043,0.00000390425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027367987,0.017627645,0.97670424,0.00015084333,0.00007432867,0.00000758896,0.0030903514,0.00009197399,0.00021280228,0.00083622074,0.00028241272,0.00089424336],"study_design_scores_gemma":[0.002840428,0.00047003952,0.99359053,0.00006805914,0.00019973924,0.0000011971617,0.0008816546,0.000087859524,0.00077311264,0.0007748439,0.00026309412,0.00004942251],"about_ca_topic_score_codex":0.0015940677,"about_ca_topic_score_gemma":0.0016074649,"teacher_disagreement_score":0.017157605,"about_ca_system_score_codex":0.00001310638,"about_ca_system_score_gemma":0.000020275062,"threshold_uncertainty_score":0.24097641},"labels":[],"label_agreement":null},{"id":"W2979415664","doi":"10.1182/blood.v110.11.6.6","title":"Oral Rivaroxaban Compared with Subcutaneous Enoxaparin for Extended Thromboprophylaxis after Total Hip Arthroplasty: The RECORD1 Trial.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Rivaroxaban; Clinical endpoint; Surgery; Population; Pulmonary embolism; Venography; Deep vein; Thrombosis; Randomized controlled trial; Anesthesia; Internal medicine; Warfarin","score_opus":0.01679545102973993,"score_gpt":0.26068199610882503,"score_spread":0.2438865450790851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979415664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99139714,0.00028262468,0.00052514335,0.00058275554,0.0006416068,0.0037230921,0.000021424537,0.00013543956,0.0026907835],"genre_scores_gemma":[0.9948513,0.000043124557,0.0023969891,0.00056907535,0.0007483172,0.00043838267,0.000036148096,0.0000712487,0.0008453971],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9978765,0.00004507379,0.00046311304,0.00050538743,0.00043628304,0.0006735961],"domain_scores_gemma":[0.9986489,0.00019583224,0.00015551344,0.00066949526,0.00013447272,0.00019582492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051933434,0.00032788282,0.0007467844,0.00010905184,0.00020433006,0.00006765425,0.00014476207,0.00010592458,0.00022487066],"category_scores_gemma":[0.00006358946,0.00020547763,0.00020840262,0.00023964535,0.00017058256,0.00006609577,0.0000773166,0.0002154642,0.000060386967],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5347283,0.09736121,0.030538822,0.0023808244,0.01688998,0.0106443325,0.012379648,0.00009150974,0.011031788,0.00838036,0.051384714,0.22418855],"study_design_scores_gemma":[0.3262193,0.06055477,0.49975672,0.00061774027,0.007622549,0.0025999097,0.0033047816,0.000121133606,0.014237646,0.0014512634,0.08127879,0.0022354177],"about_ca_topic_score_codex":0.00015062542,"about_ca_topic_score_gemma":0.00054014707,"teacher_disagreement_score":0.4692179,"about_ca_system_score_codex":0.000052820702,"about_ca_system_score_gemma":0.00008533728,"threshold_uncertainty_score":0.83791345},"labels":[],"label_agreement":null},{"id":"W2979416306","doi":"10.1182/blood.v128.22.2372.2372","title":"Burden of Relapse Following Allogeneic Hematopoietic Stem Cell Transplantation on Health Care Resource Utilization in the Management of Acute Leukemia and Myelodysplastic Syndrome","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Hematopoietic stem cell transplantation; Transplantation; Medical record; Internal medicine; Disease; Myelodysplastic syndromes; Health care; Oncology; Intensive care medicine; Bone marrow","score_opus":0.016759242856853266,"score_gpt":0.27389275208317326,"score_spread":0.25713350922632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979416306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970225,0.0007947808,0.00019794775,0.00044350387,0.000021953174,0.00075557805,0.000024210727,0.000014495872,0.00072503317],"genre_scores_gemma":[0.9983768,0.001066152,0.00024183826,0.00005747494,0.000012481782,0.00002948141,0.000029774963,0.00002157631,0.00016445383],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.9985634,0.00014174225,0.00036740364,0.00024609437,0.00045359772,0.00022776103],"domain_scores_gemma":[0.9993072,0.00016155746,0.00011813321,0.00030977026,0.00003976716,0.00006353443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036276592,0.00012816556,0.00029421935,0.00017844977,0.00004183713,0.000004943817,0.00013590282,0.00007161621,0.0000043627633],"category_scores_gemma":[0.000006243292,0.00007971262,0.000060924383,0.00026812422,0.00004972975,0.000039543575,0.000028346016,0.00011451099,0.000003725957],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01327895,0.004441934,0.08467905,0.110058054,0.00924321,0.020597817,0.38331234,0.0010918226,0.21732944,0.008091556,0.0017557921,0.14612003],"study_design_scores_gemma":[0.13349406,0.017569596,0.46707997,0.03830958,0.010600624,0.0030872654,0.07892001,0.0003289751,0.24687575,0.0003034588,0.0017556428,0.0016750762],"about_ca_topic_score_codex":0.000037774953,"about_ca_topic_score_gemma":0.0000057618777,"teacher_disagreement_score":0.3824009,"about_ca_system_score_codex":0.00017906401,"about_ca_system_score_gemma":0.00013531814,"threshold_uncertainty_score":0.3250586},"labels":[],"label_agreement":null},{"id":"W2979417036","doi":"10.1182/blood.v110.11.783.783","title":"A Phase II Open-Label Study Evaluating Hemostatic Activity, Pharmacokinetics and Safety of Recombinant Porcine Factor VIII (OBI-1) in Hemophilia A Patients with Alloantibody Inhibitors Directed Against Human FVIII.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; University of Alberta","funders":"","keywords":"Medicine; Pharmacokinetics; Bleed; Dosing; Titer; Adverse effect; Antibody; Concomitant; Gastroenterology; Anesthesia; Surgery; Internal medicine; Pharmacology; Immunology","score_opus":0.05498507333231037,"score_gpt":0.3995429855266346,"score_spread":0.3445579121943242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979417036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99482554,0.00009377819,0.000001621704,0.00015426415,0.00006875598,0.0043856823,0.000028602906,0.00004736186,0.00039441098],"genre_scores_gemma":[0.99893767,0.000050245813,0.0004433799,0.0000351413,0.000033700824,0.000037586153,0.00010868256,0.00005532706,0.00029826994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972706,0.00016911534,0.0006788542,0.0005406418,0.00080013514,0.00054069434],"domain_scores_gemma":[0.9986463,0.00016622637,0.00025135506,0.00035413925,0.0003002952,0.0002816441],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009043341,0.00034577918,0.0007612983,0.00036697238,0.0002314446,0.000028017303,0.00017576729,0.00008811603,0.00003873381],"category_scores_gemma":[0.00017401477,0.0002514297,0.000036031048,0.0007112004,0.00012160712,0.00016647158,0.00034168834,0.00036538264,0.0000020168334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004519421,0.12567051,0.63601774,0.0001906973,0.00049746555,0.00037094238,0.002097492,4.354534e-7,0.1991043,0.000001724756,0.000036754514,0.031492498],"study_design_scores_gemma":[0.35297528,0.043488916,0.5193155,0.0009342753,0.000563682,0.000015109245,0.000439757,0.00031684473,0.08142576,0.000010520566,0.000037352533,0.00047700695],"about_ca_topic_score_codex":0.0001430257,"about_ca_topic_score_gemma":0.000117004114,"teacher_disagreement_score":0.34845585,"about_ca_system_score_codex":0.00009941252,"about_ca_system_score_gemma":0.00014772301,"threshold_uncertainty_score":0.9999938},"labels":[],"label_agreement":null},{"id":"W2979418457","doi":"10.1182/blood.v126.23.2621.2621","title":"Evidence for Heterogeneous Genetic Associations with Acute Lymphoblastic Leukemia (ALL) By Cytogenetics and Sex in High-Risk Patients Treated with Matched Unrelated Donor Allogeneic Blood or Marrow Transplant (URD-BMT)","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"","keywords":"Genome-wide association study; Single-nucleotide polymorphism; Internal medicine; Oncology; Cohort; Cytogenetics; Biology; Population; Medicine; Immunology; Genetics; Genotype; Chromosome; Gene","score_opus":0.024803534609225075,"score_gpt":0.26308871881271967,"score_spread":0.2382851842034946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979418457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947608,0.00076516345,0.00091823173,0.00009135415,0.000027456445,0.0024027247,0.0008967998,0.00012282025,0.000014616691],"genre_scores_gemma":[0.99066776,0.0011291348,0.0064617265,0.00015694498,0.000057015444,0.00043657955,0.00056221994,0.00016525034,0.0003633679],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99621814,0.00021866958,0.0007069136,0.00093431165,0.00092405104,0.0009978923],"domain_scores_gemma":[0.99722886,0.0007461857,0.00032092785,0.0005644056,0.0004180236,0.0007215977],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030082514,0.0006023495,0.00089212874,0.00026741548,0.00013496331,0.00007926033,0.00029183648,0.00040892296,0.000014904537],"category_scores_gemma":[0.00028649383,0.00042321105,0.00007782532,0.0006491704,0.00021011563,0.00012244462,0.00006923575,0.00030378217,0.0000104383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005888669,0.0014762217,0.97890997,0.0001822444,0.0032646046,0.0013424297,0.0007049072,0.0007663518,0.006843046,0.0000017221902,0.00019372815,0.00042608703],"study_design_scores_gemma":[0.31333485,0.044478115,0.45316893,0.0025551966,0.03322155,0.00578623,0.00027038917,0.011677837,0.13248506,0.00007213305,0.00011377334,0.0028359331],"about_ca_topic_score_codex":0.0013398665,"about_ca_topic_score_gemma":0.0011066478,"teacher_disagreement_score":0.5257411,"about_ca_system_score_codex":0.0011408015,"about_ca_system_score_gemma":0.0020689117,"threshold_uncertainty_score":0.99982196},"labels":[],"label_agreement":null},{"id":"W2979421492","doi":"10.1182/blood.v116.21.3686.3686","title":"Allogeneic Platelet MHC Class I Antigens Prevent CD61 Specific Cytotoxic T Cell (CTL)-Mediated Immune Thrombocytopenia (ITP).","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; St. Michael's Hospital","funders":"","keywords":"Medicine; Immunology; Immune system; Platelet; Antigen; CD8; Bone marrow; CTL*; Platelet transfusion","score_opus":0.010866950095045822,"score_gpt":0.23405287585061874,"score_spread":0.22318592575557292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979421492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886891,0.0017703548,0.0000068336603,0.00031661373,0.00048082956,0.0010699516,0.00009166551,0.00017212308,0.007402511],"genre_scores_gemma":[0.99546665,0.001148952,0.0006473291,0.00020909506,0.00020404265,0.000053739215,0.00047192766,0.00008813612,0.001710142],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977082,0.00004503831,0.0005193718,0.0006170294,0.00040803917,0.0007023447],"domain_scores_gemma":[0.998508,0.00006986771,0.00018067057,0.00083338306,0.000083191226,0.0003249026],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00017747126,0.00043253857,0.0008444372,0.0001522995,0.00017185003,0.000050486804,0.00026148965,0.00034183418,0.0012244082],"category_scores_gemma":[0.00003219562,0.00036303818,0.00025195544,0.00028880595,0.00012374143,0.000104092614,0.00010151648,0.0005761088,0.0015171687],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012639229,0.0053168647,0.012301804,0.000066986686,0.00044956733,0.002634074,0.00019506512,0.0000015747488,0.9767598,0.0000389043,0.0012637104,0.00084525364],"study_design_scores_gemma":[0.018280169,0.0009534162,0.091558754,0.000085822416,0.000517997,0.0011068392,0.00009278356,0.00003722213,0.8460462,0.00014876608,0.040510885,0.00066113984],"about_ca_topic_score_codex":0.00005108127,"about_ca_topic_score_gemma":0.00007525062,"teacher_disagreement_score":0.1307136,"about_ca_system_score_codex":0.000035498007,"about_ca_system_score_gemma":0.0001585192,"threshold_uncertainty_score":0.99988216},"labels":[],"label_agreement":null},{"id":"W2979422056","doi":"10.1182/blood.v114.22.555.555","title":"Symptoms of Anxiety and Depression Among Teens and Adults in the Thalassemia Longitudinal Cohort Study.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Anxiety; Psychosocial; Depression (economics); Medicine; Cohort; Quality of life (healthcare); Psychological intervention; Psychiatry; Thalassemia; Clinical psychology; Internal medicine","score_opus":0.004251992437317327,"score_gpt":0.22690597773789586,"score_spread":0.22265398530057853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979422056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99647456,0.0013082294,8.397336e-7,0.00010708775,0.000015897635,0.0005761408,0.0000011783133,0.000012101124,0.0015039734],"genre_scores_gemma":[0.99936265,0.0005221496,0.0000163078,0.000048746413,0.000020111895,0.000006770618,0.0000025297984,0.0000048072075,0.000015932574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993201,0.000035760684,0.00016056038,0.00019126882,0.0001652575,0.00012708205],"domain_scores_gemma":[0.99968255,0.000028035962,0.00004371565,0.00017048891,0.000026506037,0.00004870382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020873177,0.00009047284,0.00018746126,0.000042888583,0.000040351035,0.000007781675,0.000041601816,0.0000850626,0.0000035721616],"category_scores_gemma":[0.00004466325,0.000052561725,0.000022819524,0.00012587995,0.000059156322,0.000034748107,0.000020120302,0.00017223408,3.4213116e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000526574,0.0008562999,0.99236196,0.000024164163,0.000036787787,0.000045694655,0.0012523438,5.6019803e-7,0.00024967172,0.00000586226,0.00003283775,0.005081155],"study_design_scores_gemma":[0.0037016287,0.0004935689,0.9933103,0.00018246777,0.00020780157,0.000103703314,0.001651922,0.000039236253,0.00022652863,0.000015110845,0.000010541588,0.000057203553],"about_ca_topic_score_codex":0.000112687725,"about_ca_topic_score_gemma":0.000040627478,"teacher_disagreement_score":0.005023951,"about_ca_system_score_codex":0.00000349972,"about_ca_system_score_gemma":0.000011446926,"threshold_uncertainty_score":0.2143405},"labels":[],"label_agreement":null},{"id":"W2979422744","doi":"10.1182/blood.v126.23.1863.1863","title":"Tracking Normal and Chronic Myeloid Leukemia Progenitor Cell Cycle Kinetics in a Defined Niche Using Live Time Lapse Confocal Imaging with Fucci2BL a Novel Lentiviral Bicistronic Reporter","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Biology; Progenitor cell; Stem cell; Cell biology; Cell cycle; Flow cytometry; Reporter gene; Cancer research; Cell; Immunology; Gene expression; Genetics; Gene","score_opus":0.015671071358286274,"score_gpt":0.2556956920971982,"score_spread":0.24002462073891195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979422744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969619,0.002193292,0.00018819996,0.000026453514,0.000028028478,0.00036005714,0.000019402718,0.000016914193,0.00020575887],"genre_scores_gemma":[0.99831367,0.00002221744,0.0011289348,0.000041313375,0.0002315767,0.000026353466,0.00006360544,0.000056384975,0.000115955525],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99835336,0.00007168051,0.00029230927,0.0004885384,0.00024948464,0.000544615],"domain_scores_gemma":[0.9992365,0.000011286408,0.00012562276,0.000346835,0.0001250533,0.00015465227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003249994,0.0002404047,0.00021681825,0.00008208853,0.0000557373,0.00007037251,0.00016610022,0.000119608885,0.000008992133],"category_scores_gemma":[0.000031878517,0.00022747449,0.000053693617,0.00013113978,0.00015383716,0.00001582104,0.00014920665,0.0001998,0.0000073954848],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007893691,0.00028396645,0.009822252,0.000030268971,0.00005734982,0.00007625719,0.00012826694,0.00035100442,0.9878387,5.8033453e-7,0.000020676258,0.00060135225],"study_design_scores_gemma":[0.007936825,0.002715771,0.0008906202,0.000047222566,0.00008242397,0.00037352572,0.00011834442,0.0042235195,0.98300534,0.000005497426,0.00022160614,0.00037932015],"about_ca_topic_score_codex":0.000073887764,"about_ca_topic_score_gemma":0.0003645404,"teacher_disagreement_score":0.008931631,"about_ca_system_score_codex":0.000130038,"about_ca_system_score_gemma":0.0008694881,"threshold_uncertainty_score":0.92761403},"labels":[],"label_agreement":null},{"id":"W2979429646","doi":"10.1182/blood.v114.22.4759.4759","title":"Darinaparsin a Novel Organic Arsenic Molecule Active in Lymphoma: Development of An Oral Form.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Dosing; Pharmacology; Medicine; Mucositis; Arsenic trioxide; Toxicity; Oral administration; Apoptosis; Internal medicine; Chemistry; Biochemistry","score_opus":0.008162077240873034,"score_gpt":0.23388065952318224,"score_spread":0.2257185822823092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979429646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997547,0.00022176151,0.000931473,0.000011625599,0.000021524982,0.00010690817,0.000003410943,0.000008135963,0.0011482151],"genre_scores_gemma":[0.99295425,0.0000196328,0.0067525734,0.00007279825,0.00003072053,0.000007626147,0.00007152885,0.000013110399,0.0000777576],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99914867,0.000018773204,0.00022853413,0.00027527523,0.00011243996,0.00021629626],"domain_scores_gemma":[0.99957824,0.000002912853,0.000077370256,0.0002332512,0.000054169202,0.000054044416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010126269,0.00013401418,0.00014995299,0.000043598106,0.000035914803,0.000009371299,0.0002012319,0.0001339236,0.00000820693],"category_scores_gemma":[0.00003477071,0.00013236997,0.000037679914,0.00013872267,0.000033966782,0.000006799561,0.00005092999,0.00004827414,0.0000025253232],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062673156,0.0010569001,0.00029823737,0.000014513199,0.000026106532,0.000006591867,0.00022639663,0.000002803314,0.9891468,0.000032848195,0.0000054315074,0.009120639],"study_design_scores_gemma":[0.0022976324,0.00033986726,0.008965186,0.00001559617,0.000017579214,0.000036378486,0.00011051974,0.000013360631,0.9874037,0.000091378606,0.00054206763,0.00016676664],"about_ca_topic_score_codex":0.0000052532223,"about_ca_topic_score_gemma":0.000042010066,"teacher_disagreement_score":0.008953873,"about_ca_system_score_codex":0.00002209185,"about_ca_system_score_gemma":0.00036244918,"threshold_uncertainty_score":0.5397891},"labels":[],"label_agreement":null},{"id":"W2979429674","doi":"10.1182/blood.v120.21.4143.4143","title":"Association Between Busulfan First-Dose Pharmacokinetics and Outcome in Children Receiving Myeloablative Busulfan-Based Conditioning Before Unrelated Umbilical Cord Blood Transplantation for Malignancies","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Busulfan; Medicine; Transplantation; Internal medicine; Gastroenterology; Acute leukemia; Pharmacokinetics; Cyclophosphamide; Surgery; Hepatic veno-occlusive disease; Leukemia; Mucositis; Graft-versus-host disease; Dosing; Toxicity; Oncology; Hematopoietic stem cell transplantation; Chemotherapy","score_opus":0.021829648741822527,"score_gpt":0.30771313624655705,"score_spread":0.2858834875047345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979429674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960771,0.0001936604,0.00048735444,0.0010395739,0.00005542545,0.0015909415,0.0003552188,0.00010044274,0.000100279016],"genre_scores_gemma":[0.99567896,0.00008360631,0.002087312,0.00016758611,0.00034117626,0.0001552822,0.0012606819,0.000057263205,0.00016811342],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977995,0.00013296257,0.0005865851,0.0003564546,0.00043803846,0.0006864366],"domain_scores_gemma":[0.998288,0.0008533255,0.00023668849,0.00016820156,0.00020692513,0.00024689405],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009536202,0.00026136645,0.0004871026,0.00028733438,0.00019860739,0.00003952746,0.00010200054,0.0003102706,0.000047767207],"category_scores_gemma":[0.0007420677,0.00025960457,0.00009769756,0.00044524108,0.0000820881,0.0002450386,0.000026508147,0.00052072137,0.000008129611],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021460852,0.00035546086,0.99346936,0.00021136811,0.0005001935,0.000009060981,0.00095659227,0.000020390133,0.0029390017,0.00003152048,0.000052941872,0.0012394986],"study_design_scores_gemma":[0.015737072,0.00048826763,0.96380717,0.00021832349,0.0018948208,0.000053537435,0.00006487982,0.0003995727,0.017001126,0.000047998623,0.000050114853,0.00023712433],"about_ca_topic_score_codex":0.00011512877,"about_ca_topic_score_gemma":0.000043130483,"teacher_disagreement_score":0.0296622,"about_ca_system_score_codex":0.00028054893,"about_ca_system_score_gemma":0.00012169294,"threshold_uncertainty_score":0.99998564},"labels":[],"label_agreement":null},{"id":"W2979430133","doi":"10.1182/blood.v106.11.447.447","title":"Results of Phase II Study of Lenalidomide (L) {Revlimid®} in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL).","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Lenalidomide; Medicine; Thalidomide; Internal medicine; Rituximab; Neutropenia; Gastroenterology; Bendamustine; Chronic lymphocytic leukemia; Pomalidomide; Refractory (planetary science); Multiple myeloma; Progressive disease; Phases of clinical research; Oncology; Immunology; Toxicity; Leukemia; Lymphoma; Disease","score_opus":0.018964499863187115,"score_gpt":0.2976178362957274,"score_spread":0.2786533364325403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979430133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968428,0.0003902187,0.0000016292493,0.00002678379,0.000041066523,0.0017930302,0.000038114555,0.000045353663,0.00082102534],"genre_scores_gemma":[0.99829304,0.00006842381,0.00026105443,0.000036142024,0.00014019295,0.000057769677,0.000049615486,0.000065565066,0.001028203],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.996055,0.00016349912,0.0012565415,0.00059983716,0.0013236629,0.0006014749],"domain_scores_gemma":[0.9974939,0.00030043448,0.00046814262,0.0011804556,0.0003287832,0.00022828697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006637552,0.00032312836,0.0009264946,0.0004447267,0.00006260338,0.0000084306175,0.00035287303,0.00017799211,0.00011159599],"category_scores_gemma":[0.0006367497,0.00022980153,0.00009293839,0.00080117135,0.00021073979,0.00017602128,0.00019953353,0.00034859296,0.000017660212],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.4935891,0.2655083,0.031244861,0.0064550703,0.006095399,0.0036247314,0.03401255,0.007525475,0.028995914,0.000051538347,0.005471905,0.11742516],"study_design_scores_gemma":[0.9153573,0.046636242,0.010771427,0.0011344507,0.00061730697,0.00005530563,0.000496842,0.0027150402,0.0210231,0.000002540685,0.0008451876,0.00034527498],"about_ca_topic_score_codex":0.0019117619,"about_ca_topic_score_gemma":0.0012295282,"teacher_disagreement_score":0.42176816,"about_ca_system_score_codex":0.03340332,"about_ca_system_score_gemma":0.028020756,"threshold_uncertainty_score":0.9774895},"labels":[],"label_agreement":null},{"id":"W2979430192","doi":"10.1182/blood.v120.21.1965.1965","title":"Intermittent Zolendronic Acid (ZA) for the Prevention of Osteoporosis After Allogeneic Hematopoietic Cell Transplantation (HCT)","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Bone health and treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Osteopenia; Osteoporosis; Transplantation; Surgery; Internal medicine; Bone mineral","score_opus":0.016972268908022083,"score_gpt":0.27642808721248235,"score_spread":0.2594558183044603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979430192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99292624,0.0052527017,0.0004087822,0.00021797631,0.0001294812,0.00088232895,0.000022915003,0.000014659515,0.0001449081],"genre_scores_gemma":[0.9981324,0.0003430915,0.0005947832,0.00012531946,0.00004668563,0.0003421115,0.000048844944,0.000014942986,0.00035179686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99931663,0.000022544791,0.00022043403,0.0001000831,0.00011729791,0.00022301986],"domain_scores_gemma":[0.9995884,0.000037949107,0.000084532396,0.00017109177,0.000030459269,0.000087619075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000122035235,0.000091633075,0.00015194948,0.000032249638,0.000038128805,0.000002827075,0.000034900735,0.000055842193,0.000055211494],"category_scores_gemma":[0.000004743207,0.000060571045,0.00012585788,0.00004555404,0.000021170086,0.00005027084,0.0000064415062,0.000049095877,0.000019282084],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023484703,0.01112784,0.88967824,0.00726826,0.0008824387,0.000025499729,0.009020944,0.0000017166178,0.04136757,0.00011142728,0.0002546095,0.037912983],"study_design_scores_gemma":[0.009746846,0.001080115,0.5853019,0.00025700062,0.0032279287,0.00018486692,0.0002475172,0.0000063078523,0.39930132,0.00006663237,0.00045962312,0.00011992847],"about_ca_topic_score_codex":0.000016634702,"about_ca_topic_score_gemma":0.000021004207,"teacher_disagreement_score":0.35793376,"about_ca_system_score_codex":0.000017793756,"about_ca_system_score_gemma":0.000043298205,"threshold_uncertainty_score":0.24700156},"labels":[],"label_agreement":null},{"id":"W2979430300","doi":"10.1182/blood.v122.21.3749.3749","title":"Aberrant Splicing In Patients With AML Is Associated With Over- Expression Of Specific Splicing Factors","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"RNA splicing; Splicing factor; Alternative splicing; Gene; Biology; HEK 293 cells; Minigene; Gene expression; Molecular biology; Transfection; Messenger RNA; Genetics; RNA; Cancer research","score_opus":0.007432664033738929,"score_gpt":0.21163081445690562,"score_spread":0.2041981504231667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979430300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993258,0.000059969614,0.00004409012,0.000009268133,0.000011182882,0.0003086248,0.000011583206,0.0000067443902,0.00022269835],"genre_scores_gemma":[0.999482,0.000017261455,0.00015430519,0.000026079126,0.000020120242,0.000011862188,0.0000670339,0.00002492706,0.00019645588],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888897,0.000037347785,0.00019617325,0.00028514964,0.00027109063,0.0003212972],"domain_scores_gemma":[0.9993998,0.000017308503,0.000118239084,0.00027366195,0.00010539586,0.0000856151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008165826,0.00015173745,0.00019487547,0.00006942994,0.000046585406,0.000021632986,0.0001345432,0.00009521627,0.0000442687],"category_scores_gemma":[0.000031773423,0.00010341954,0.000035627076,0.00014472939,0.000044112086,0.000010936574,0.00006249364,0.00011345935,0.0000024269157],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047141297,0.00020555459,0.50097746,0.000008070068,0.000025316782,0.000001270553,0.00006606975,0.00001061558,0.4984842,7.7058485e-7,0.000089621026,0.0000839475],"study_design_scores_gemma":[0.0021718577,0.00045075768,0.52358246,0.00013524301,0.0000067545,3.3772733e-7,0.00006615987,0.000012587697,0.4734438,0.0000021313178,0.000018621546,0.00010929685],"about_ca_topic_score_codex":0.00033055674,"about_ca_topic_score_gemma":0.000071311246,"teacher_disagreement_score":0.025040383,"about_ca_system_score_codex":0.000014618688,"about_ca_system_score_gemma":0.0000298798,"threshold_uncertainty_score":0.42173263},"labels":[],"label_agreement":null},{"id":"W2979430900","doi":"10.1182/blood.v110.11.787.787","title":"Limited-Stage Diffuse Large B-Cell Lymphoma (DLBCL) Patients with a Negative Pet Scan Following Three Cycles of R-CHOP Can Be Effectively Treated with Abbreviated Chemoimmunotherapy Alone.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Chemoimmunotherapy; Medicine; CHOP; Stage (stratigraphy); Diffuse large B-cell lymphoma; Internal medicine; Chemotherapy; Gastroenterology; Lymphoma; Nuclear medicine; Oncology; Surgery; Rituximab; Biology","score_opus":0.007477208399966654,"score_gpt":0.223628791387473,"score_spread":0.21615158298750634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979430900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964085,0.00042207885,0.000023018907,0.000054979464,0.000025769397,0.001700953,0.00021563245,0.00012386567,0.0010251665],"genre_scores_gemma":[0.9984927,0.000052451654,0.0006164406,0.00022346673,0.000025232077,0.000109580105,0.000239418,0.00010413192,0.00013654282],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99777764,0.000059130973,0.0004168514,0.00054121384,0.00057991483,0.0006252697],"domain_scores_gemma":[0.99838585,0.00027062363,0.00033236304,0.00053269847,0.00023091599,0.0002475411],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018349197,0.0005220005,0.0008723503,0.00022246379,0.00015534853,0.000028780942,0.00012966085,0.00010700846,0.000021358637],"category_scores_gemma":[0.000037700913,0.0003414534,0.00022542095,0.00060352945,0.00010488556,0.000107508626,0.000034333745,0.000094556155,0.0000047418876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025550276,0.044313964,0.9447301,0.00009996979,0.0022127733,0.0008023624,0.0008542172,5.47322e-7,0.002143632,0.000013372002,0.000014407546,0.0022596293],"study_design_scores_gemma":[0.16910534,0.0028393064,0.7213667,0.00047180132,0.0010812174,0.000023379982,0.00016847921,0.0000069578164,0.10458718,0.00000233675,0.00005961546,0.00028770632],"about_ca_topic_score_codex":0.002131457,"about_ca_topic_score_gemma":0.0016006505,"teacher_disagreement_score":0.2233634,"about_ca_system_score_codex":0.00027627527,"about_ca_system_score_gemma":0.0001700358,"threshold_uncertainty_score":0.99990374},"labels":[],"label_agreement":null},{"id":"W2979433440","doi":"10.1182/blood.v120.21.1152.1152","title":"The Economic Burden of Acute Venous Thromboembolism During One Year Following Diagnosis: A Population-Based Cohort Study","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Healthcare Systems and Practices","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Pulmonary embolism; Cohort; Population; Deep vein; Diagnosis code; Emergency medicine; Health care; Venous thrombosis; Medical prescription; Acute care; Thrombosis; Pediatrics; Intensive care medicine; Internal medicine; Environmental health","score_opus":0.05077571009494329,"score_gpt":0.4037989879289904,"score_spread":0.3530232778340471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979433440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951004,0.0004912088,0.000001009351,0.00046557948,0.0011498661,0.0017824573,0.000024251822,0.000051149626,0.0009340761],"genre_scores_gemma":[0.99815553,0.000054727014,0.000056041692,0.000038319737,0.0009447834,0.00059467764,0.000008177437,0.000031047402,0.0001167176],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975244,0.0009862616,0.00062040106,0.00017138758,0.00021874071,0.00047880292],"domain_scores_gemma":[0.99786466,0.0011162262,0.00041880278,0.00043103058,0.0000401477,0.00012913543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021157807,0.000117513744,0.00041990337,0.000050991333,0.00097235874,0.000013809906,0.00016611352,0.0001162278,0.000101013386],"category_scores_gemma":[0.00016135251,0.000091262504,0.000085925,0.00007559915,0.000010503655,0.00019597485,0.00005675739,0.00031289118,0.00016781955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001448119,0.00030778765,0.99377215,0.00009528556,0.00054195867,0.0000017522942,0.004962452,0.0000068759255,0.00003508268,0.00012885271,0.00003687358,0.000096421914],"study_design_scores_gemma":[0.0011758289,0.00009167848,0.9934874,0.00014526586,0.0004544765,4.911181e-7,0.0034164516,0.000005804233,0.000037739057,0.000017372211,0.0010681556,0.000099301295],"about_ca_topic_score_codex":0.013215272,"about_ca_topic_score_gemma":0.0006505219,"teacher_disagreement_score":0.012564749,"about_ca_system_score_codex":0.0001242169,"about_ca_system_score_gemma":0.0002493528,"threshold_uncertainty_score":0.9933558},"labels":[],"label_agreement":null},{"id":"W2979433645","doi":"10.1182/blood.v116.21.122.122","title":"Iron Overload Accelerates Development of Leukaemia: Evidence From a Mouse Model","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Bone marrow; Haematopoiesis; Context (archaeology); Ferritin; DNA damage; Biology; Cancer research; Chemistry; Internal medicine; Medicine; Stem cell; Immunology; Biochemistry; Genetics; DNA","score_opus":0.02055707004373822,"score_gpt":0.25515125021504714,"score_spread":0.23459418017130892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979433645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977768,0.0007116566,0.00013077447,0.00019564628,0.000068461806,0.0001726014,0.0000075067655,0.00004708514,0.0008894636],"genre_scores_gemma":[0.9830158,0.00020653218,0.016021539,0.00010462256,0.000036396486,0.000010793191,0.000012521588,0.000016484428,0.00057533255],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991348,0.000007594353,0.0002666589,0.0002024164,0.00020903852,0.00017949681],"domain_scores_gemma":[0.99944675,0.0000387579,0.00007157908,0.00026545746,0.00006873508,0.000108696215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009234687,0.00012103112,0.00021454731,0.000044214907,0.00005184161,0.000009239806,0.000101567384,0.0001976823,0.00011778374],"category_scores_gemma":[0.000109583256,0.00009486305,0.0000539502,0.00008169695,0.000051487717,0.000074925054,0.000051715044,0.0003268774,0.000038959686],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000615769,0.0005214915,0.012769146,0.00007239972,0.00007276677,0.000008771412,0.001593669,0.000055849905,0.98177207,0.000024604602,0.00019987821,0.002847776],"study_design_scores_gemma":[0.0029614707,0.0000922409,0.006694724,0.0002819233,0.0002254559,0.000010592633,0.00023739043,0.0022138907,0.98669505,0.00008719143,0.0003030865,0.00019695995],"about_ca_topic_score_codex":0.00010407452,"about_ca_topic_score_gemma":0.000058990678,"teacher_disagreement_score":0.015890764,"about_ca_system_score_codex":0.000011867799,"about_ca_system_score_gemma":0.0003057695,"threshold_uncertainty_score":0.38684028},"labels":[],"label_agreement":null},{"id":"W2979433675","doi":"10.1182/blood.v110.11.2708.2708","title":"Human von Willebrand Disease Mutations in Mouse von Willebrand Factor Alter Its Cleavage by ADAMTS13.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"ADAMTS13; Von Willebrand factor; Von Willebrand disease; Chemistry; Molecular biology; Recombinant DNA; Platelet; Glycoprotein; Gene; Biology; Immunology; Biochemistry","score_opus":0.011582482128993245,"score_gpt":0.2681984342410805,"score_spread":0.2566159521120872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979433675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99554485,0.0010544343,0.0000150958895,0.00023167946,0.000045132372,0.00057479244,0.00021470306,0.0000672442,0.0022520688],"genre_scores_gemma":[0.9957818,0.00006351018,0.000045480403,0.000317314,0.000052556454,0.000023255061,0.00034855178,0.000040248917,0.003327287],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987081,0.000024101439,0.00030140573,0.00032550236,0.00025117013,0.0003897129],"domain_scores_gemma":[0.9992971,0.000038232156,0.00006545141,0.0002364759,0.000032784934,0.0003299901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000078405574,0.00021817537,0.00031151823,0.00015858994,0.000114418035,0.000024415316,0.0000687876,0.000093347386,0.00017464631],"category_scores_gemma":[0.000045273686,0.00018902321,0.000089586414,0.00016669768,0.000043768345,0.000147862,0.000021284432,0.00015922509,0.00007537113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009833821,0.013851163,0.8561323,0.0003190496,0.00074872514,0.0060908594,0.0019811667,0.0000067805195,0.10888321,0.00013720627,0.006812515,0.004053605],"study_design_scores_gemma":[0.057850584,0.0009734151,0.78704435,0.00029637542,0.0009158307,0.00009171668,0.00033850071,0.00005144786,0.14554623,0.00030350045,0.0056828116,0.00090522127],"about_ca_topic_score_codex":0.000056588775,"about_ca_topic_score_gemma":0.00018233866,"teacher_disagreement_score":0.069087975,"about_ca_system_score_codex":0.000037088394,"about_ca_system_score_gemma":0.000037930768,"threshold_uncertainty_score":0.7708143},"labels":[],"label_agreement":null},{"id":"W2979436156","doi":"10.1182/blood.v116.21.2730.2730","title":"A Prognostic Score of Overall Survival In Adults with Acute Myeloid Leukemia","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; McMaster University","funders":"","keywords":"Medicine; Internal medicine; Proportional hazards model; Hazard ratio; Concordance; Oncology; Myeloid leukemia; Performance status; Cytogenetics; Malignancy; Chemotherapy; Gastroenterology; Confidence interval; Biology","score_opus":0.01123630471411018,"score_gpt":0.25703478816529385,"score_spread":0.24579848345118366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979436156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938737,0.000052174335,0.000011703509,0.00027204293,0.00006762636,0.0008560333,0.000020316276,0.000052674313,0.004793685],"genre_scores_gemma":[0.9966164,0.00004901563,0.002450181,0.00007330933,0.00015981932,0.000063828724,0.000042605483,0.000046625923,0.00049819687],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982864,0.000038421425,0.00030311354,0.00035953315,0.0005524242,0.00046008933],"domain_scores_gemma":[0.99885756,0.00013483205,0.00008938847,0.0005179952,0.00019662596,0.00020359294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027313206,0.00019629179,0.000446517,0.00021857559,0.000026952343,0.000011818124,0.0002182317,0.00017130238,0.00011207299],"category_scores_gemma":[0.00028335472,0.00014711912,0.000063894906,0.00040437173,0.00018550725,0.00009170474,0.00009598368,0.0008767848,0.000035603614],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002440982,0.00091855245,0.8824635,0.00048636703,0.00033807772,0.0018966577,0.0007636697,0.000002717022,0.1083658,0.00057579996,0.0002355188,0.0015123737],"study_design_scores_gemma":[0.028323237,0.0018067227,0.9247769,0.00087604974,0.00035988176,0.00085844775,0.00013126734,0.00029037855,0.041834414,0.000095038464,0.0003308049,0.00031683792],"about_ca_topic_score_codex":0.00050762546,"about_ca_topic_score_gemma":0.00078241416,"teacher_disagreement_score":0.06653138,"about_ca_system_score_codex":0.0000915949,"about_ca_system_score_gemma":0.0012426552,"threshold_uncertainty_score":0.59993434},"labels":[],"label_agreement":null},{"id":"W2979442364","doi":"10.1182/blood.v110.11.99.99","title":"A New Murine Model of Immune Thrombocytopenia: Evidence of Both Antibody- and CD8+ T Cell-Mediated Platelet Destruction.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; St. Michael's Hospital","funders":"","keywords":"Immune system; Immunology; Antibody; Platelet; CD8; Autoantibody; T cell; Medicine; Biology","score_opus":0.019544075790625108,"score_gpt":0.279583894421252,"score_spread":0.26003981863062686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979442364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931863,0.0046182065,0.0012042713,0.000053902044,0.000028898137,0.0002727609,0.000010842179,0.000021842065,0.0006029907],"genre_scores_gemma":[0.99069655,0.0013353798,0.0077020684,0.000019985342,0.000018319064,0.0000013702255,0.000021329104,0.00001638246,0.00018858812],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99903053,0.0000085331085,0.00037389406,0.00018995006,0.00019882042,0.00019827455],"domain_scores_gemma":[0.99936527,0.00007239155,0.00016262858,0.00022280685,0.000058656668,0.0001182211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013778594,0.00013956761,0.00050618895,0.000098117824,0.000028284207,0.0000041067487,0.0000618797,0.00008959975,0.00003912185],"category_scores_gemma":[0.00004456608,0.00011665942,0.00006489886,0.00017685404,0.00006485053,0.000103151186,0.000039947765,0.0000945804,0.0000039066767],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005589333,0.0010948444,0.058994442,0.00038604185,0.00029848886,0.00029199352,0.0003550949,0.000035665766,0.9359209,0.00006241632,0.000051673727,0.0019495332],"study_design_scores_gemma":[0.018465133,0.0013919384,0.13377215,0.00071399234,0.00078289886,0.0005548073,0.00012168844,0.0011712622,0.8423131,0.0004435223,0.000021475586,0.00024805358],"about_ca_topic_score_codex":0.00042110827,"about_ca_topic_score_gemma":0.000019315334,"teacher_disagreement_score":0.09360779,"about_ca_system_score_codex":0.0000101202195,"about_ca_system_score_gemma":0.00011229026,"threshold_uncertainty_score":0.47572333},"labels":[],"label_agreement":null},{"id":"W2979442961","doi":"10.1182/blood.v114.22.4169.4169","title":"The Kids-DOTT Trial: Novel Aspects of the ‘Parallel Cohort RCT‘ Design and Its Application to the Investigation of Duration of Anticoagulant Therapy for Pediatric Venous Thromboembolism.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; St. Joseph's Hospital","funders":"","keywords":"Randomized controlled trial; Medicine; Population; Cohort; Randomization; Pediatrics; Internal medicine; Physical therapy","score_opus":0.03568914444068024,"score_gpt":0.2783152749803055,"score_spread":0.24262613053962526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979442961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97496414,0.0005565664,0.016167691,0.0024859093,0.000110443856,0.0056292377,0.000009158849,0.000018030198,0.000058820642],"genre_scores_gemma":[0.99769646,0.0003063917,0.0013798608,0.0002950458,0.00015931374,0.0001300034,0.000008872046,0.000013593417,0.000010460779],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99876815,0.00009321489,0.0004918085,0.00018256623,0.00033433948,0.00012993591],"domain_scores_gemma":[0.9986437,0.00021464714,0.00044918855,0.00037589172,0.00026751496,0.000049034043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008131557,0.00012179084,0.00034060376,0.00005822857,0.00014692619,0.000011074916,0.0001643715,0.00007933111,0.0000012836744],"category_scores_gemma":[0.00017386285,0.00006496129,0.000084543404,0.00034637406,0.000047853733,0.000044899887,0.000016907745,0.00007068956,6.00625e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019624692,0.0015431639,0.0020295936,0.0000991173,0.00022874089,1.09838865e-7,0.001333424,0.00030728205,0.9223238,0.06789692,0.00010065273,0.002174675],"study_design_scores_gemma":[0.019447153,0.0025235992,0.37088746,0.0000507583,0.0008078553,0.000009097784,0.000081244696,0.0023598943,0.59641564,0.007237238,0.00005766622,0.00012239409],"about_ca_topic_score_codex":0.000010705766,"about_ca_topic_score_gemma":0.000003930054,"teacher_disagreement_score":0.36885786,"about_ca_system_score_codex":0.000008535659,"about_ca_system_score_gemma":0.00014029273,"threshold_uncertainty_score":0.26490444},"labels":[],"label_agreement":null},{"id":"W2979445655","doi":"10.1182/blood.v110.11.686.686","title":"CD20 Mutations at the Rituximab Binding Site Are Rare and Are Not a Significant Cause of R-CHOP Resistance in Patients with De Novo Diffuse Large B-Cell Lymphoma.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia; BC Cancer Agency","funders":"","keywords":"Rituximab; CHOP; Diffuse large B-cell lymphoma; CD20; Lymphoma; Medicine; Chemotherapy regimen; Cancer research; Internal medicine; Immunology; Oncology; Chemotherapy","score_opus":0.008062252860932654,"score_gpt":0.22027380265435584,"score_spread":0.2122115497934232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979445655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99804777,0.000595085,0.0000053817284,0.00021803132,0.000015175716,0.0005273469,0.00040048567,0.000017859491,0.00017286743],"genre_scores_gemma":[0.999136,0.000052953077,0.00025157613,0.0001969068,0.00001644201,0.000043168573,0.00007533174,0.000022781,0.00020484676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99887747,0.000033110737,0.00025178358,0.00025948745,0.00026701187,0.00031111715],"domain_scores_gemma":[0.9991212,0.00018854179,0.00019652823,0.0002924499,0.00008570824,0.00011559797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014423286,0.00016279706,0.00028425525,0.0001035402,0.00012302707,0.00001527962,0.000051535422,0.00006211692,0.000009236895],"category_scores_gemma":[0.00006075598,0.00010478668,0.000043932832,0.00023726461,0.0000690755,0.000045989116,0.000041909712,0.00005078674,0.000009342153],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005280386,0.016135944,0.9809211,0.000106232044,0.00009154997,0.0005370345,0.0011066783,3.8861404e-7,0.0004216524,0.000012648616,0.00007743557,0.00006132845],"study_design_scores_gemma":[0.0687532,0.00015751744,0.9173317,0.00035446466,0.00033978716,0.000014475589,0.0004122876,0.0000018081254,0.0123397065,0.0000027957637,0.00018134732,0.00011090246],"about_ca_topic_score_codex":0.00005556816,"about_ca_topic_score_gemma":0.0024796897,"teacher_disagreement_score":0.06822516,"about_ca_system_score_codex":0.00017926721,"about_ca_system_score_gemma":0.00005908869,"threshold_uncertainty_score":0.4273077},"labels":[],"label_agreement":null},{"id":"W2979448310","doi":"10.1182/blood.v114.22.1412.1412","title":"A Multifaceted Strategy to Reduce Inappropriate Use of Fresh Frozen Plasma Transfusions in the Intensive Care Unit.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Blood donation and transfusion practices","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; Université de Sherbrooke; St. Joseph's Hospital; McMaster University; Canadian Blood Services","funders":"","keywords":"Medicine; Fresh frozen plasma; Context (archaeology); Intensive care unit; Intensive care medicine; Plasmapheresis; Emergency medicine; Internal medicine","score_opus":0.05040846027056621,"score_gpt":0.2754200766069196,"score_spread":0.22501161633635336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979448310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907885,0.000049972172,0.00003254817,0.0037808714,0.000084656844,0.00059260236,0.000013563922,0.00005350821,0.0046037636],"genre_scores_gemma":[0.99575704,0.000023887376,0.00029908994,0.0037299495,0.00009127048,0.000019837255,0.000027888558,0.000012504498,0.000038556795],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99891496,0.000045222187,0.00031618305,0.00024806883,0.00027367688,0.00020191034],"domain_scores_gemma":[0.99887735,0.000114777315,0.00012460203,0.0002626557,0.0006040002,0.000016609594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019388375,0.00015802962,0.00019460969,0.00030482677,0.00011992424,0.0001935599,0.00028630882,0.00008242667,0.000115761715],"category_scores_gemma":[0.00034442474,0.00011851537,0.00006736418,0.00091351406,0.00002863842,0.0008211078,0.000027659631,0.00023662261,0.00004355708],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038827553,0.013441508,0.09592163,0.0010378078,0.0008422567,0.00073745317,0.09967339,0.0074850065,0.29959175,0.100757726,0.008508316,0.3681204],"study_design_scores_gemma":[0.025513183,0.0007146011,0.6491781,0.000650928,0.0014344389,0.00003951265,0.21295892,0.0023642075,0.028187403,0.002304616,0.0750516,0.0016025392],"about_ca_topic_score_codex":0.0014626981,"about_ca_topic_score_gemma":0.0019452155,"teacher_disagreement_score":0.55325645,"about_ca_system_score_codex":0.000004217793,"about_ca_system_score_gemma":0.0000301588,"threshold_uncertainty_score":0.48329163},"labels":[],"label_agreement":null},{"id":"W2979450983","doi":"10.1182/blood.v120.21.1048.1048","title":"A GM-CSF and IL-4 Fusion Cytokine Triggers Conversion of B-Cells to Tumoricidal Effectors","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Biology; CD80; Cytokine; Interleukin 10; Cytotoxic T cell; Immune system; Interleukin 4; Interleukin 15; CD40; Cell biology; Interleukin 21; Antigen-presenting cell; CD86; Immunology; Interleukin 12; T cell; Interleukin; In vitro","score_opus":0.0063859547755613245,"score_gpt":0.2123819621213062,"score_spread":0.20599600734574486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979450983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99179065,0.0068440977,0.000020824828,0.000048456397,0.0006388599,0.00026486197,0.000024682266,0.000028541443,0.0003390167],"genre_scores_gemma":[0.99867904,0.00027486886,0.000059263337,0.00012402963,0.000027937931,0.000009372555,0.00002150574,0.000014435896,0.0007895286],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99905187,0.00021915793,0.00021567746,0.00014973304,0.000034106386,0.0003294266],"domain_scores_gemma":[0.9994272,0.00022019335,0.00008605008,0.00020079876,0.0000338299,0.000031901815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000316099,0.0001538464,0.00028566032,0.00014417287,0.000104982304,0.0000051700827,0.000111548674,0.00015101804,0.00038122607],"category_scores_gemma":[0.00005752591,0.00012669845,0.000076162214,0.00014561598,0.00011030816,0.000091993184,0.000078262354,0.00013011562,0.00018108814],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094863906,0.00048040217,0.0035419883,0.000036663678,0.00013226195,0.0000014814945,0.00073836127,2.0869767e-7,0.9921563,0.000038534698,0.0005495081,0.0013756475],"study_design_scores_gemma":[0.00377184,0.0006978815,0.016952936,0.000039945033,0.00008066572,0.000055525972,0.00012386154,1.7869738e-7,0.93997926,0.0000016522745,0.03815394,0.00014229803],"about_ca_topic_score_codex":0.00008644427,"about_ca_topic_score_gemma":5.430177e-7,"teacher_disagreement_score":0.052177023,"about_ca_system_score_codex":0.000011234142,"about_ca_system_score_gemma":0.000021004029,"threshold_uncertainty_score":0.5166613},"labels":[],"label_agreement":null},{"id":"W2979451218","doi":"10.1182/blood.v128.22.120.120","title":"Cereblon Splicing of Exon 10 Mediates IMiDs Resistance in Multiple Myeloma: Clinical Validation in the CoMMpass Trial","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Cereblon; Exon; Pomalidomide; Ubiquitin ligase; Alternative splicing; Molecular biology; HEK 293 cells; RNA splicing; Biology; Lenalidomide; Chemistry; Cell biology; Cell culture; Genetics; Ubiquitin; Multiple myeloma; Gene; Immunology; RNA","score_opus":0.029415549728761765,"score_gpt":0.2918812347304499,"score_spread":0.26246568500168815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979451218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998407,0.0001395321,0.000083864434,0.0005342077,0.000093945404,0.00028075883,0.0000073849487,0.000003824274,0.0004494967],"genre_scores_gemma":[0.999187,0.00009945566,0.0002455694,0.00004997812,0.00022577593,0.000033100052,0.000029749217,0.0000066118455,0.00012273854],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989719,0.0002416683,0.00038507153,0.00017774224,0.000111239155,0.00011237541],"domain_scores_gemma":[0.99943936,0.00012718745,0.00012875503,0.00025199258,0.00003266502,0.00002002561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077456527,0.00007153759,0.00012336968,0.00003478432,0.000019327827,0.000008038446,0.00016078702,0.000119204014,0.0000114895265],"category_scores_gemma":[0.0007481277,0.000044702374,0.00005397093,0.00008354332,0.000060532893,0.000006418743,0.00003634935,0.00005880311,0.0000035360754],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005607798,0.0013003532,0.10520708,0.00003210747,0.000032113054,0.000004399172,0.00018069372,0.0000019369459,0.8817889,0.00022155307,0.00215382,0.0034692509],"study_design_scores_gemma":[0.032147337,0.00034209003,0.022510085,0.00006599017,0.000011949278,8.512097e-7,0.000068643756,0.0000049051414,0.94007504,0.00012165394,0.004537841,0.000113591326],"about_ca_topic_score_codex":0.000022282871,"about_ca_topic_score_gemma":0.0004746241,"teacher_disagreement_score":0.082697,"about_ca_system_score_codex":0.0000054720404,"about_ca_system_score_gemma":0.0000341968,"threshold_uncertainty_score":0.18229099},"labels":[],"label_agreement":null},{"id":"W2979452863","doi":"10.1182/blood.v118.21.3761.3761","title":"Subcutaneous Omacetaxine in Chronic or Accelerated Chronic Myeloid Leukemia Resistant to Two or More Tyrosine-Kinase Inhibitors Including Imatinib,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Imatinib; Myeloid leukemia; Internal medicine; Dasatinib; Leukemia; Chronic myelogenous leukemia; Imatinib mesylate; Tyrosine-kinase inhibitor; Tyrosine kinase; Pharmacology; Gastroenterology; Cancer","score_opus":0.058431577757724666,"score_gpt":0.3155030366773857,"score_spread":0.25707145891966104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979452863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926847,0.002227789,0.000010895987,0.00024935594,0.00024716638,0.0021391534,0.000055748562,0.00036067306,0.0020245085],"genre_scores_gemma":[0.9922728,0.00029951637,0.0026932496,0.00029193764,0.000701541,0.0003199495,0.00011699347,0.00019746044,0.0031065545],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99553645,0.00012041254,0.0011745556,0.0011179788,0.0006914115,0.0013591688],"domain_scores_gemma":[0.9975767,0.00015782427,0.0002952903,0.0011728628,0.0001787243,0.00061855675],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037225557,0.00076940784,0.0010924862,0.0005923157,0.00020925599,0.00005729315,0.00043150468,0.00029865906,0.0021095688],"category_scores_gemma":[0.00041106963,0.0005768671,0.00017829236,0.0016833711,0.00015192488,0.0002174944,0.0003818036,0.00067583274,0.00035320153],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0189874,0.0038268678,0.010758078,0.002109217,0.0012988439,0.05975584,0.0070347185,0.0002682705,0.86711085,0.000109632725,0.0029058484,0.025834443],"study_design_scores_gemma":[0.08598137,0.01432224,0.022595547,0.004928795,0.0014354978,0.0051887697,0.00072363426,0.0015860734,0.8564631,0.000037812613,0.004693341,0.0020438428],"about_ca_topic_score_codex":0.002471061,"about_ca_topic_score_gemma":0.006865784,"teacher_disagreement_score":0.06699397,"about_ca_system_score_codex":0.011969164,"about_ca_system_score_gemma":0.0065132715,"threshold_uncertainty_score":0.9996683},"labels":[],"label_agreement":null},{"id":"W2979457035","doi":"10.1182/blood.v128.22.1408.1408","title":"Perioperative Management of Von Willebrand Disease, a Systematic Review and Meta-Analysis","year":2016,"lang":"en","type":"review","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Von Willebrand disease; Meta-analysis; Von Willebrand factor; Hemostasis; Perioperative; Desmopressin; Internal medicine; Adverse effect; Confidence interval; Surgery; Observational study; Incidence (geometry); Platelet","score_opus":0.04407242495771056,"score_gpt":0.3303918837660111,"score_spread":0.2863194588083005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979457035","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000020975135,0.9945032,0.00000461406,0.00007073413,0.0000049154455,0.0042481115,0.0003103004,0.000011300745,0.0008447024],"genre_scores_gemma":[0.000019247773,0.99424,0.00007664809,0.00007289135,0.000003945147,0.00096201256,0.00012959179,0.00002504381,0.004470643],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9983343,0.00015793467,0.0007364621,0.0003823914,0.0002456015,0.00014330179],"domain_scores_gemma":[0.99874336,0.000054458244,0.00041935395,0.00058662303,0.000054462806,0.00014174164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016811528,0.00039125182,0.009473796,0.00016240969,0.000031155858,0.000011356016,0.000086176726,0.00006324315,0.00031834867],"category_scores_gemma":[0.000022597562,0.00017720643,0.0022504656,0.0003618766,0.00003943083,0.00003066117,0.000051918658,0.00005963426,0.00003147741],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000001332705,0.00017648618,0.0000012596138,0.6064231,0.39241952,0.00022916323,0.0000043457567,1.4384279e-9,2.2927764e-9,0.00003807312,0.000010677861,0.00069604925],"study_design_scores_gemma":[0.00053292164,0.000036568166,0.0000020008486,0.16565749,0.8233701,0.0000385123,0.0000035367157,4.9574286e-8,5.401181e-8,0.0000030947251,0.010232397,0.00012324972],"about_ca_topic_score_codex":0.0000015631987,"about_ca_topic_score_gemma":7.965465e-7,"teacher_disagreement_score":0.4407656,"about_ca_system_score_codex":0.000015495702,"about_ca_system_score_gemma":0.00004205951,"threshold_uncertainty_score":0.72262686},"labels":[],"label_agreement":null},{"id":"W2979466979","doi":"10.1182/blood.v114.22.487.487","title":"Clinical Outcomes with the LMWH, Tinzaparin (Innohep®) in Pregnancy. An International Retrospective Audit..","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Cardiovascular Issues in Pregnancy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Pregnancy; Miscarriage; Obstetrics; Low molecular weight heparin; Population; Retrospective cohort study; Gynecology; Heparin; Surgery","score_opus":0.01947072030591892,"score_gpt":0.3274460106992377,"score_spread":0.3079752903933188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979466979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9607254,0.0008680574,0.00011551132,0.0026380147,0.00034503077,0.000667396,0.0000057791594,0.000109905326,0.034524858],"genre_scores_gemma":[0.9960456,0.000112164234,0.0015655524,0.0005455787,0.00034878426,0.00003057695,0.000015370719,0.000021966336,0.0013144054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998327,0.00011248525,0.00035265432,0.00043253996,0.0005346947,0.00024059424],"domain_scores_gemma":[0.9987565,0.000065473534,0.0000934083,0.0008725459,0.00012353262,0.00008851457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004551852,0.00017454731,0.0004528838,0.000081892744,0.000040376453,0.000029032402,0.0002992276,0.00011373072,0.0000702044],"category_scores_gemma":[0.00029260502,0.00010848478,0.00023678293,0.00021864877,0.00011518149,0.00014728305,0.000045255965,0.0004790579,0.000032116994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008430262,0.0011300226,0.98511577,0.0000059348304,0.00042786673,0.0006343883,0.00043877008,0.000004302859,0.000020400896,0.00084957975,0.00015070633,0.0111379875],"study_design_scores_gemma":[0.005694424,0.00063373504,0.9903402,0.00038952683,0.00026205584,0.00032999724,0.00008470538,0.000015695588,0.00014352135,0.00025891647,0.0017054583,0.00014179025],"about_ca_topic_score_codex":0.00002025119,"about_ca_topic_score_gemma":0.00010560931,"teacher_disagreement_score":0.035320155,"about_ca_system_score_codex":0.000060185735,"about_ca_system_score_gemma":0.00007398358,"threshold_uncertainty_score":0.44238812},"labels":[],"label_agreement":null},{"id":"W2979467998","doi":"10.1182/blood.v120.21.2003.2003","title":"Prolonged Survival in Secondary CNS Lymphoma Following High Dose Thiotepa/Busulfan-Based Chemotherapy (HDTB) and Autologous Stem Cell Transplantation (ASCT): Single Institution Results From Calgary, Canada","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; ThioTEPA; Busulfan; Lymphoma; Autologous stem-cell transplantation; Transplantation; Internal medicine; Diffuse large B-cell lymphoma; Meninges; Vincristine; Chemotherapy; Surgery; Oncology; Gastroenterology; Pathology; Hematopoietic stem cell transplantation; Cyclophosphamide","score_opus":0.010621090147979179,"score_gpt":0.2094789424291085,"score_spread":0.19885785228112932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979467998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99605685,0.0013455806,0.000018005338,0.00047429706,0.0003919187,0.00063246663,0.00020143106,0.00006110117,0.00081832195],"genre_scores_gemma":[0.99833244,0.00008244514,0.0004926728,0.0003135064,0.00010537137,0.00004738964,0.0005709923,0.000028939838,0.000026235717],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984816,0.00009362711,0.00038394544,0.0003664556,0.0002969545,0.00037747418],"domain_scores_gemma":[0.9992164,0.00020402815,0.00011058636,0.0002508111,0.000025928128,0.00019225609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019460253,0.00025096833,0.00040589686,0.00009198907,0.00010168453,0.000023060213,0.000056341112,0.00016339503,0.000012842081],"category_scores_gemma":[0.000013982665,0.00022490436,0.000074478245,0.00015143571,0.000034945984,0.00012313915,0.00000929834,0.00009577364,0.0000027926108],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038988388,0.009615033,0.5080498,0.0002984813,0.0006232813,0.002659917,0.0049840705,0.000030768257,0.021126503,0.000052224495,0.00018272258,0.4484784],"study_design_scores_gemma":[0.030598518,0.00023477817,0.8761297,0.00014007496,0.00034908397,0.00003436538,0.00010665411,0.000051099345,0.09188323,0.000004460924,0.00026913488,0.00019892382],"about_ca_topic_score_codex":0.31057876,"about_ca_topic_score_gemma":0.22757667,"teacher_disagreement_score":0.44827947,"about_ca_system_score_codex":0.00035537593,"about_ca_system_score_gemma":0.0007145207,"threshold_uncertainty_score":0.91713333},"labels":[],"label_agreement":null},{"id":"W2979468281","doi":"10.1182/blood.v126.23.1163.1163","title":"Therapeutic Targeting of CD163 on Hematopoietic Progenitor Cells By Novel Monoclonal Antibody TBI 304H Demonstrates an Increase in Erythropoiesis in Humanized Mice","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Therapure Biopharma (Canada)","funders":"","keywords":"Haematopoiesis; Erythropoiesis; Severe combined immunodeficiency; Progenitor cell; CD34; Stem cell; Bone marrow; Immunology; CD163; Monoclonal antibody; Biology; Cancer research; Antibody; Medicine; In vivo; Macrophage; Internal medicine; Anemia; Cell biology; In vitro","score_opus":0.027575026824888948,"score_gpt":0.2904524776822054,"score_spread":0.26287745085731645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979468281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99815696,0.0007118485,0.000029742636,0.00011520898,0.00012964476,0.00042785515,0.000022094373,0.000042299125,0.00036434422],"genre_scores_gemma":[0.9975953,0.000041720257,0.0016911334,0.0003148021,0.00012246717,0.000024620023,0.000116253446,0.000032808555,0.000060874303],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99845064,0.00016035842,0.0004960341,0.00035605003,0.0002283932,0.00030852802],"domain_scores_gemma":[0.99920803,0.00012635259,0.00015768706,0.00022980878,0.000106398475,0.00017174253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037437578,0.00021782678,0.0005064276,0.00018224772,0.000033654072,0.000009394207,0.00010573879,0.00016877569,0.00006523789],"category_scores_gemma":[0.000099715515,0.00019251464,0.000070594964,0.00030342973,0.00012021805,0.00007919976,0.000028392209,0.00026577877,0.000025236382],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006721739,0.0041422965,0.042407226,0.00011444687,0.000049642647,0.000040299707,0.00066317146,0.000010526103,0.9516118,0.00006506497,0.00012333077,0.00010002155],"study_design_scores_gemma":[0.024747737,0.003542869,0.027574686,0.00038972957,0.00026186195,0.00014134556,0.0039394074,0.0010227863,0.93724406,0.00026082783,0.0003252068,0.0005494619],"about_ca_topic_score_codex":0.0003695282,"about_ca_topic_score_gemma":0.000045983892,"teacher_disagreement_score":0.024075562,"about_ca_system_score_codex":0.000040122344,"about_ca_system_score_gemma":0.00019404037,"threshold_uncertainty_score":0.7850519},"labels":[],"label_agreement":null},{"id":"W2979470196","doi":"10.1182/blood.v108.11.3335.3335","title":"Younger Patients with CLL/SLL Are Less Frequent and Have Favorable Survival in a Canadian Population Based Study: The Manitoba Cohort.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Research Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Cancer registry; Population; Incidence (geometry); Chronic lymphocytic leukemia; Internal medicine; Cancer; Cohort; Referral; Leukemia; Database; Pediatrics; Family medicine","score_opus":0.01485561576767083,"score_gpt":0.24086195886480347,"score_spread":0.22600634309713263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979470196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974409,0.00007956676,0.0000015465647,0.00022590964,0.000038537677,0.0014919814,0.000029341121,0.0000158454,0.0006763979],"genre_scores_gemma":[0.99945456,0.0000016736036,0.000025807973,0.00009648735,0.0000696004,0.00007208846,0.00012005631,0.000026781434,0.0001329489],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843824,0.0001038145,0.0002012408,0.0002879956,0.00054200133,0.00042670383],"domain_scores_gemma":[0.99925387,0.00006320145,0.00005775167,0.0003460113,0.0001162487,0.00016291886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035207145,0.00014057706,0.00022725952,0.00014301063,0.00010912455,0.000046075602,0.00008608885,0.000065132255,0.000016827638],"category_scores_gemma":[0.00005085925,0.000093860304,0.000019798892,0.00018950988,0.000038887374,0.0000644161,0.000023158353,0.00016783603,0.000004674183],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007909953,0.00073661015,0.99862105,0.000030116513,0.000049073038,0.00018525703,0.00007684054,0.000045749322,0.00000268543,0.000016180296,0.000046172834,0.00011118953],"study_design_scores_gemma":[0.025525507,0.00017160532,0.97262144,0.00006890855,0.00012343853,0.000007581442,0.00060611544,0.00063930306,0.0000261186,0.000011680086,0.00008924758,0.000109061075],"about_ca_topic_score_codex":0.9539595,"about_ca_topic_score_gemma":0.9833749,"teacher_disagreement_score":0.029415358,"about_ca_system_score_codex":0.0044395775,"about_ca_system_score_gemma":0.002148111,"threshold_uncertainty_score":0.9993822},"labels":[],"label_agreement":null},{"id":"W2979470572","doi":"10.1182/blood.v120.21.2203.2203","title":"Deficient ADAMTS13 Activity in Ticlopidine-Associated Thrombotic Thrombocytopenic Purpura (TTP) in Populations From Japan in 2012: Validation of Findings Initially Reported in the United States in 1998 and 2000.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; London Health Sciences Centre","funders":"","keywords":"Thrombotic thrombocytopenic purpura; ADAMTS13; Medicine; Thrombotic microangiopathy; Cohort; Internal medicine; Pediatrics; Platelet","score_opus":0.05785631871128367,"score_gpt":0.29540455127376136,"score_spread":0.2375482325624777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979470572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983073,0.0005321654,0.0000016039414,0.00012098709,0.00009399223,0.00077124505,0.00010633008,0.00001416445,0.000052219308],"genre_scores_gemma":[0.9988828,0.000032525677,0.000014445037,0.00002889291,0.000004895947,0.00006696284,0.0009516635,0.000011146592,0.00000667495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997617,0.0009109818,0.0007577588,0.0002473851,0.000079202735,0.00038764987],"domain_scores_gemma":[0.9989758,0.0004905246,0.0002632396,0.00022806099,0.000026013526,0.000016363274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010093137,0.00016449059,0.00041055985,0.00056672754,0.000040203497,0.000014799282,0.00016499928,0.000155215,0.000079577876],"category_scores_gemma":[0.00037181075,0.00014753203,0.000031513748,0.0009636874,0.0000702966,0.00025692597,0.00008768063,0.00026512274,0.00000975205],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005247697,0.0020698279,0.9600768,0.000017198467,0.00003565599,0.000008561873,0.0049125818,0.00015918452,0.032528155,0.00008478116,0.000024574778,0.000030214627],"study_design_scores_gemma":[0.0037410755,0.000060123715,0.9889286,0.00021196777,0.000049391005,0.0000072847392,0.0014868528,0.00005732507,0.005043792,0.00025754608,0.000012753535,0.000143277],"about_ca_topic_score_codex":0.01772383,"about_ca_topic_score_gemma":0.025313042,"teacher_disagreement_score":0.028851822,"about_ca_system_score_codex":0.00015592552,"about_ca_system_score_gemma":0.000068400266,"threshold_uncertainty_score":0.99247247},"labels":[],"label_agreement":null},{"id":"W2979475210","doi":"10.1182/blood.v124.21.1703.1703","title":"Gray Zone Lymphoma (GZL) with Features Intermediate Between Classical Hodgkin Lymphoma (cHL) and Diffuse Large B-Cell Lymphoma (DLBCL): Analysis of Tumor Immunophenotype (IP) and Critical Examination of Therapy with Associated Impact on Outcome","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; B symptoms; CD30; Diffuse large B-cell lymphoma; Univariate analysis; Internal medicine; International Prognostic Index; Immunophenotyping; Rituximab; Lymphoma; Vincristine; Anaplastic large-cell lymphoma; Oncology; CD20; Gastroenterology; Chemotherapy; Multivariate analysis; Immunology; Cyclophosphamide","score_opus":0.009504412341319787,"score_gpt":0.26205442569274834,"score_spread":0.25255001335142857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979475210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99818444,0.0007468205,0.000041408468,0.00011099019,0.000024596991,0.0004335773,0.00022426654,0.000049232167,0.00018465558],"genre_scores_gemma":[0.9991381,0.00010629356,0.00021885226,0.00013502632,0.000053929187,0.000044019023,0.00020533627,0.000057127003,0.000041318646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99747443,0.000269191,0.00058045395,0.00056329905,0.0006454079,0.00046723863],"domain_scores_gemma":[0.997571,0.0009977657,0.00038787603,0.000506335,0.00023958375,0.000297431],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043480974,0.0004928081,0.0015019935,0.00048210396,0.000103576276,0.000050204904,0.00012526254,0.00019557666,0.000013127982],"category_scores_gemma":[0.0001977871,0.00029454756,0.00022852505,0.0006590549,0.00035459572,0.000106685315,0.000060423994,0.000072015326,0.0000017495937],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00156839,0.026059365,0.94063866,0.00010365594,0.0044736164,0.00009451198,0.00054988515,7.808551e-7,0.0007111556,0.00020398325,0.000010576152,0.0255854],"study_design_scores_gemma":[0.072925545,0.008619223,0.9023216,0.00019784698,0.005578823,0.00003645048,0.00010426291,0.00015455093,0.009753017,0.0000137248535,0.000013435647,0.0002815457],"about_ca_topic_score_codex":0.00025652815,"about_ca_topic_score_gemma":0.00009264518,"teacher_disagreement_score":0.07135715,"about_ca_system_score_codex":0.00017428494,"about_ca_system_score_gemma":0.000111876165,"threshold_uncertainty_score":0.99995065},"labels":[],"label_agreement":null},{"id":"W2979482090","doi":"10.1182/blood.v128.22.2821.2821","title":"A Phase I/II Study of Vaccination By Autologous Leukemic Apoptotic Corpse Pulsed Dendritic Cells for Elderly Acute Myeloid Leukemia Patients in First or Second Complete Remission (LAM DC trial)","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Leukapheresis; Apheresis; Regimen; Bone marrow; Chemotherapy; Internal medicine; Vaccination; Immunology; Chemotherapy regimen; Leukemia; Surgery; Platelet; Stem cell; CD34","score_opus":0.01463228801087329,"score_gpt":0.2623334377374483,"score_spread":0.24770114972657503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979482090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978595,0.000072165756,0.00016586116,0.000019878964,0.00019345184,0.0013939098,0.0002575658,0.000011088404,0.000026603111],"genre_scores_gemma":[0.99819094,0.00011459616,0.00007004483,0.00003804668,0.00005550128,0.0001492843,0.00020972939,0.000025596919,0.0011462463],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99847883,0.000077437624,0.0005355237,0.00047099323,0.00014046606,0.0002967658],"domain_scores_gemma":[0.9991151,0.00006277437,0.0002416405,0.00034641425,0.000157806,0.00007626349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014047077,0.00021949023,0.00032997242,0.000089377354,0.000094134484,0.000014088152,0.0002663454,0.00019058502,0.000062154264],"category_scores_gemma":[0.00010798337,0.00016271482,0.00009285411,0.000091966875,0.000024473642,0.000013741796,0.00009016566,0.00006758117,0.0000041775497],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009202326,0.0039723013,0.00035311503,0.000047361802,0.00013696274,0.0000058560117,0.0001625585,0.000002296967,0.9772825,3.6204693e-7,0.0018720326,0.006962319],"study_design_scores_gemma":[0.14982413,0.038102325,0.0005736823,0.00007728692,0.00015949516,0.0000059173576,0.000096916374,0.000056863875,0.8099545,0.00001704725,0.0008615315,0.00027028227],"about_ca_topic_score_codex":0.000038396985,"about_ca_topic_score_gemma":0.00037273738,"teacher_disagreement_score":0.16732799,"about_ca_system_score_codex":0.0000660422,"about_ca_system_score_gemma":0.00013820625,"threshold_uncertainty_score":0.6635318},"labels":[],"label_agreement":null},{"id":"W2979483347","doi":"10.1182/blood.v106.11.1992.1992","title":"ReSETting PP2A Tumor Suppressor Activity Overcomes BCR/ABL Leukemogenic Potential in Blast Crisis CML.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Protein phosphatase 2; Cancer research; Progenitor cell; Chronic myelogenous leukemia; Biology; Imatinib mesylate; Myeloid leukemia; Cell biology; Stem cell; Phosphatase; Leukemia; Immunology; Imatinib; Phosphorylation","score_opus":0.01090257695061078,"score_gpt":0.2600076689796081,"score_spread":0.2491050920289973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979483347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99529314,0.0005217833,0.000013574358,0.0016602702,0.00012697054,0.00056127616,0.000036353056,0.0001352388,0.0016513809],"genre_scores_gemma":[0.9964937,0.000046735764,0.0013494226,0.00035335266,0.00062827585,0.00006200561,0.000027381579,0.000063833344,0.00097531255],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976368,0.000112066155,0.00040379836,0.0006068301,0.0005256961,0.000714799],"domain_scores_gemma":[0.9987992,0.00010859262,0.00013960988,0.00067326025,0.00005525121,0.00022408302],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025815118,0.00032321352,0.00054302986,0.00023029139,0.00010242001,0.00003968778,0.00019246653,0.00014548715,0.0006182312],"category_scores_gemma":[0.00019375022,0.00030545495,0.00021328707,0.00030977966,0.00005787602,0.00026714194,0.00016546309,0.00046985655,0.0002573052],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025123225,0.017617323,0.24869448,0.0008400171,0.0026180746,0.007298623,0.0029808774,0.0005428948,0.670363,0.000071060924,0.021153824,0.025307473],"study_design_scores_gemma":[0.052559726,0.00070725795,0.4370411,0.00041688533,0.0013367134,0.0012797528,0.0005066226,0.0019420377,0.49707812,0.00005447116,0.006236881,0.0008404263],"about_ca_topic_score_codex":0.0008254119,"about_ca_topic_score_gemma":0.00037231334,"teacher_disagreement_score":0.18834662,"about_ca_system_score_codex":0.0009594324,"about_ca_system_score_gemma":0.00046055592,"threshold_uncertainty_score":0.99993974},"labels":[],"label_agreement":null},{"id":"W2979488028","doi":"10.1182/blood.v118.21.223.223","title":"The Growth Factor Independence 1 variant form GFI136N Predisposes to Acute Myeloid Leukemia by Inducing Epigenetic Changes in Oncogenes Such As Hoxa9","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Biology; Myeloid leukemia; Haematopoiesis; Syngenic; Myeloid; Epigenetics; Cancer research; Progenitor cell; Leukemia; Gene; Myelopoiesis; Phenotype; Ectopic expression; Stem cell; Genetics; In vitro","score_opus":0.011083938797047835,"score_gpt":0.22803094010049418,"score_spread":0.21694700130344635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979488028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99596125,0.0024055317,0.000064057516,0.000111629095,0.00011309997,0.00041018106,0.00008755299,0.0000148043655,0.0008319193],"genre_scores_gemma":[0.997125,0.0017460479,0.00022180869,0.00023206807,0.00007220758,0.00014860027,0.000053762597,0.00003192094,0.00036857039],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986605,0.000045713256,0.00019901567,0.00046474257,0.00018486258,0.00044513922],"domain_scores_gemma":[0.99932104,0.000017423245,0.00007945396,0.00038530666,0.00006236588,0.00013439622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000107267886,0.00024388147,0.00017431144,0.000048226644,0.00015271765,0.000041367333,0.00038078867,0.000214552,0.000019790916],"category_scores_gemma":[0.000056652745,0.00018162775,0.00005928115,0.00014156607,0.00004858919,0.000007890248,0.0001933159,0.00010743074,0.00002025439],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045245068,0.0017984998,0.18929815,0.00004877864,0.0013665792,0.00015862267,0.003351885,0.000002507048,0.7726632,0.00020652325,0.0007658008,0.029887049],"study_design_scores_gemma":[0.0015604218,0.0009896463,0.036374096,0.0000231094,0.00011194464,0.00003769996,0.00021081557,0.0000014996339,0.9590198,0.00034923124,0.0010283131,0.00029344423],"about_ca_topic_score_codex":0.00095024396,"about_ca_topic_score_gemma":0.0027110702,"teacher_disagreement_score":0.18635663,"about_ca_system_score_codex":0.000023465254,"about_ca_system_score_gemma":0.00015198569,"threshold_uncertainty_score":0.7406565},"labels":[],"label_agreement":null},{"id":"W2979488430","doi":"10.1182/blood.v120.21.2650.2650","title":"Evaluation of Quality of Biomarker Data Capture by Peripheral Sites in an International, Cooperative Study: Analysis of 104 Cases From the T-Cell Project.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Biomarker; Pathology; Data quality; Sample (material); Data collection; Medical physics; Data mining; Computer science; Statistics","score_opus":0.19438578130786338,"score_gpt":0.4312805722622565,"score_spread":0.23689479095439314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979488430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99594265,0.0018017044,0.0000014531457,0.0000693369,0.000020209814,0.00055563415,0.0014621781,0.0000025994436,0.00014424695],"genre_scores_gemma":[0.99780107,0.000030386343,0.000086134896,0.000025045514,0.000018350405,0.000035635487,0.0019918294,0.000004325655,0.00000720427],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847275,0.0004428336,0.0003283468,0.00016681824,0.0005216318,0.0000676208],"domain_scores_gemma":[0.99870586,0.0002297511,0.00019538618,0.0005003375,0.00034582953,0.000022802209],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00105541,0.00008086249,0.0003113707,0.00007036922,0.000012987284,0.0000055508194,0.00013580287,0.000031985976,0.00015307318],"category_scores_gemma":[0.00030633152,0.00004854908,0.000048493264,0.0003039993,0.00004171857,0.00013884366,0.00005654582,0.000025412704,2.8114334e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008826034,0.014111956,0.9662031,0.0000072785456,0.0027730998,0.0000013554125,0.005096059,0.0000076156007,0.011086153,0.000004590365,0.00015976561,0.0004607757],"study_design_scores_gemma":[0.004708587,0.0002054147,0.97118556,0.000016268987,0.006604449,4.3826378e-7,0.005126125,0.0008672348,0.011228021,9.2232784e-7,0.0000131149645,0.000043838194],"about_ca_topic_score_codex":0.014298653,"about_ca_topic_score_gemma":0.0053550424,"teacher_disagreement_score":0.013906541,"about_ca_system_score_codex":0.00004303677,"about_ca_system_score_gemma":0.000108319975,"threshold_uncertainty_score":0.9922652},"labels":[],"label_agreement":null},{"id":"W2979491005","doi":"10.1182/blood.v120.21.3677.3677","title":"MEDI-551, a Humanized Monoclonal Anti-CD19, in Adults with Relapsed or Refractory Advanced B-Cell Malignancies: Results From a Phase 1/2 Study","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Neutropenia; Refractory (planetary science); Internal medicine; Toxicity; Adverse effect; Tumor lysis syndrome; Phases of clinical research; Gastroenterology; Oncology; Chemotherapy; Biology","score_opus":0.025345979115550258,"score_gpt":0.3122596468222849,"score_spread":0.28691366770673465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979491005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99518764,0.0010215193,0.0000074201876,0.00007708426,0.00014222541,0.0022738196,0.00014021648,0.00013702457,0.0010130581],"genre_scores_gemma":[0.9955272,0.00014717662,0.0019837725,0.00012226103,0.00041011063,0.00022761642,0.00021299049,0.00009655855,0.0012722966],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9959161,0.00021357772,0.00083656376,0.00080392725,0.0011965247,0.0010332668],"domain_scores_gemma":[0.9972244,0.00066901307,0.00025925032,0.0011233251,0.00019952498,0.0005244912],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00080343895,0.00041637506,0.0008326665,0.00027313278,0.000098960634,0.000025672909,0.00032167247,0.00020118193,0.0002697679],"category_scores_gemma":[0.0008950765,0.00029290497,0.000087521126,0.00064978545,0.00014924274,0.00032614009,0.00015479325,0.0005923262,0.0001297963],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.35324028,0.28432417,0.038523193,0.0015416902,0.0021413045,0.027260894,0.12041016,0.000026003818,0.1604418,0.000025966647,0.0038022087,0.008262312],"study_design_scores_gemma":[0.94118583,0.0077490155,0.01258556,0.0014717885,0.00048987387,0.00023141294,0.008136164,0.00045549808,0.025155528,0.0000056423646,0.0019104443,0.0006232528],"about_ca_topic_score_codex":0.0020378632,"about_ca_topic_score_gemma":0.0006589607,"teacher_disagreement_score":0.5879455,"about_ca_system_score_codex":0.0022469226,"about_ca_system_score_gemma":0.004021654,"threshold_uncertainty_score":0.9999523},"labels":[],"label_agreement":null},{"id":"W2979493147","doi":"10.1182/blood.v114.22.3092.3092","title":"Role of Spleen Tyrosine Kinase Signaling in Early B Cell Acute Lymphoblastic Leukemia.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Centre for Phenogenomics; Hospital for Sick Children","funders":"","keywords":"Syk; Cancer research; Leukemia; B cell; breakpoint cluster region; Progenitor cell; Acute lymphocytic leukemia; Stem cell; Biology; Bone marrow; Immunology; Tyrosine kinase; Medicine; Signal transduction; Receptor; Internal medicine; Cell biology; Antibody; Lymphoblastic Leukemia","score_opus":0.008018424830920063,"score_gpt":0.24375173213051138,"score_spread":0.23573330729959133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979493147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99429756,0.000601818,0.00010237483,0.00013370038,0.00002834037,0.00040852735,0.00002075611,0.00006141722,0.0043455274],"genre_scores_gemma":[0.99696255,0.000049393584,0.0020933247,0.00019625043,0.00015802422,0.000012766202,0.000024052497,0.00003833817,0.00046528084],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977892,0.00005429142,0.0005250919,0.00040025293,0.00062802574,0.0006031312],"domain_scores_gemma":[0.9988146,0.00017062476,0.00012503077,0.0004779974,0.00014729882,0.00026443746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002469921,0.0002471717,0.00055535533,0.00035717248,0.0000389911,0.000020509267,0.00025413046,0.00019007674,0.000079742975],"category_scores_gemma":[0.00014576316,0.0002247624,0.00012636473,0.0006572262,0.00008880391,0.00010947662,0.00007603079,0.00028074774,0.00009215281],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005002888,0.0011161107,0.009742748,0.0000914653,0.000088630644,0.00071559835,0.00051493593,0.000085544,0.98568463,0.000110047025,0.00015684715,0.0011931793],"study_design_scores_gemma":[0.021202836,0.0019386228,0.06512288,0.00039112003,0.00048687545,0.00019262101,0.0001232724,0.0018924163,0.90783054,0.0003791099,0.00013679807,0.0003029287],"about_ca_topic_score_codex":0.0002822291,"about_ca_topic_score_gemma":0.000006758294,"teacher_disagreement_score":0.07785409,"about_ca_system_score_codex":0.00050845434,"about_ca_system_score_gemma":0.0009959757,"threshold_uncertainty_score":0.9165545},"labels":[],"label_agreement":null},{"id":"W2979494049","doi":"10.1182/blood.v106.11.906.906","title":"Anti-Xa Levels and Renal Function: Analysis of the First 32 Patients in the Tinzaparin in Renal Insufficiency for Venous Thromboembolism Study.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph's Hospital","funders":"","keywords":"Medicine; Renal function; Warfarin; Low molecular weight heparin; Urology; Nomogram; Hemodialysis; Internal medicine; Anticoagulant; Creatinine; Heparin; Gastroenterology","score_opus":0.018744813173592285,"score_gpt":0.2613348665058658,"score_spread":0.24259005333227351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979494049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968335,0.00019383861,0.000015549755,0.00065650087,0.00006649579,0.0014803015,0.000018406057,0.0000097245975,0.00072565494],"genre_scores_gemma":[0.999084,0.000038753653,0.000059360114,0.000575999,0.00008413827,0.00011862225,0.000009930467,0.000011864539,0.00001734777],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853456,0.00006913456,0.00045909785,0.0003061358,0.00036975436,0.00026133304],"domain_scores_gemma":[0.99923456,0.0000941648,0.00015366572,0.00042318544,0.00006119679,0.000033236865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005714158,0.00015315194,0.0006359113,0.00029041545,0.00012930803,0.000021741105,0.00020642547,0.000057753958,0.000024836312],"category_scores_gemma":[0.00007214014,0.00009345382,0.00013031991,0.0010308916,0.00006698686,0.00006253784,0.00010117406,0.00014668782,0.000001395041],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057794598,0.03766539,0.947091,0.000074794916,0.0011041579,0.000006556197,0.008646331,0.0006984712,0.00009045649,0.00044052023,0.0005087928,0.0036157703],"study_design_scores_gemma":[0.0042355144,0.0011871489,0.98909295,0.00006309799,0.0026277706,0.0000012662971,0.0006405938,0.00019292823,0.00011184024,0.000027122765,0.0017221698,0.000097598786],"about_ca_topic_score_codex":0.0003149298,"about_ca_topic_score_gemma":0.0033315495,"teacher_disagreement_score":0.04200198,"about_ca_system_score_codex":0.00003115953,"about_ca_system_score_gemma":0.00003739998,"threshold_uncertainty_score":0.38109362},"labels":[],"label_agreement":null},{"id":"W2979495503","doi":"10.1182/blood.v104.11.3672.3672","title":"Hemoglobin Oxygen Saturation Discrepancy Using Various Methods in Patients with Sickle Cell Disease.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dartmouth General Hospital; Dalhousie University; University of Saskatchewan","funders":"","keywords":"Pulse oximetry; Medicine; Hypoxemia; Oxygen–haemoglobin dissociation curve; Hemoglobin; Vaso-occlusive crisis; Internal medicine; Oxygen saturation; Gastroenterology; Anesthesia; Arterial blood; Cardiology; Sickle cell anemia; Disease; Oxygen","score_opus":0.00707799519985697,"score_gpt":0.2562751258668826,"score_spread":0.24919713066702565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979495503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951409,0.0006581378,0.0021194038,0.00021813106,0.00007655214,0.0005726042,0.0000077442755,0.00005607562,0.0011504496],"genre_scores_gemma":[0.9584906,0.000026444839,0.041078385,0.00018230645,0.000034602363,0.000008787129,0.00006597588,0.00003195816,0.00008093454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989252,0.00005134077,0.00023889818,0.0002828233,0.00022097415,0.00028075834],"domain_scores_gemma":[0.99941224,0.000013970925,0.00007701427,0.00026146308,0.00005699887,0.00017830968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009854104,0.00016981176,0.00023075101,0.00009674607,0.00007084546,0.000017865837,0.00005565148,0.00010290803,0.000021830523],"category_scores_gemma":[0.000039045364,0.00012542425,0.000060547423,0.0003295012,0.000041509957,0.00009958429,0.000028344502,0.0002012446,0.000010571478],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017355125,0.014172968,0.9564224,0.00059623166,0.00030507598,0.00046924496,0.0025147707,0.0037264668,0.011861812,0.00054597564,0.000046876958,0.0076026637],"study_design_scores_gemma":[0.04108718,0.0009821182,0.94622403,0.000661034,0.0011244068,0.00002554401,0.00034563412,0.0004497798,0.0068380604,0.0011399329,0.00047430082,0.0006479691],"about_ca_topic_score_codex":0.0001841072,"about_ca_topic_score_gemma":0.000014684335,"teacher_disagreement_score":0.03935167,"about_ca_system_score_codex":0.00008626342,"about_ca_system_score_gemma":0.00020317321,"threshold_uncertainty_score":0.51146525},"labels":[],"label_agreement":null},{"id":"W2979495882","doi":"10.1182/blood.v114.22.1576.1576","title":"CD34, CD56 and CD2 Are Predictive of NPM1 Mutation, FLT3-ITD and Their Favorable Prognosis Combination in Cytogenetically Normal Acute Myeloid Leukemia.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital","funders":"","keywords":"NPM1; CD33; Myeloid leukemia; Biology; Fms-Like Tyrosine Kinase 3; CD117; Cancer research; Myeloid; Mutation; Internal medicine; CD34; Immunology; Molecular biology; Medicine; Genetics; Stem cell; Gene; Karyotype","score_opus":0.009980209771996745,"score_gpt":0.25058723007311895,"score_spread":0.24060702030112222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979495882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953543,0.00075266,0.00029877786,0.0012496078,0.00001618492,0.0009827975,0.00004923097,0.00004519936,0.0012512596],"genre_scores_gemma":[0.9976524,0.0003936844,0.001444707,0.0001877006,0.000049401853,0.000056639597,0.000058028698,0.000022408956,0.00013499033],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842995,0.000091629816,0.00039262546,0.00038267602,0.00034495426,0.00035814164],"domain_scores_gemma":[0.9990161,0.00012422091,0.00013235607,0.00022146135,0.00032141333,0.00018445808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036554073,0.0002092629,0.00044128692,0.00027964334,0.0000743837,0.000029934085,0.00010810767,0.00018226882,0.000014245184],"category_scores_gemma":[0.0002089361,0.00017722546,0.00004507031,0.00042900257,0.0001887744,0.00018133075,0.00007580287,0.0003307741,0.0000027054396],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016789217,0.002869911,0.8404185,0.0006157674,0.0008686081,0.0004989755,0.0068293735,0.00007938981,0.11601389,0.0010252276,0.0006600153,0.028441405],"study_design_scores_gemma":[0.011632258,0.0024733152,0.87241876,0.00028652445,0.00029062887,0.00030776116,0.00085165456,0.0049526966,0.10552992,0.0009850875,0.000054709144,0.00021665578],"about_ca_topic_score_codex":0.000054407854,"about_ca_topic_score_gemma":0.000025063262,"teacher_disagreement_score":0.032000277,"about_ca_system_score_codex":0.00015152428,"about_ca_system_score_gemma":0.00036465886,"threshold_uncertainty_score":0.72270447},"labels":[],"label_agreement":null},{"id":"W2979496671","doi":"10.1182/blood.v116.21.2403.2403","title":"High-Dose Melphalan for AL Amyloidosis: The Importance of Case Selection to Improve Clinical Outcomes","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Melphalan; AL amyloidosis; Medicine; Internal medicine; Multiple myeloma; Autologous stem-cell transplantation; Regimen; Amyloidosis; Hematopoietic stem cell transplantation; Surgery; Oncology; Transplantation; Gastroenterology; Immunology; Immunoglobulin light chain; Antibody","score_opus":0.014004056504294522,"score_gpt":0.3186089048867387,"score_spread":0.30460484838244417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979496671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99650276,0.00012008052,0.00012686005,0.001689148,0.00054653373,0.0008353606,0.00012310925,0.000023846653,0.000032315584],"genre_scores_gemma":[0.9924333,0.000050468185,0.004640832,0.001788807,0.00033692093,0.00046350283,0.00004395688,0.00003937706,0.00020283944],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99851906,0.00005568057,0.0005040637,0.000491772,0.0001257734,0.00030364245],"domain_scores_gemma":[0.99874437,0.00016368306,0.00024091049,0.00060643745,0.0001100829,0.00013452115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040723025,0.00023007941,0.0003265718,0.000036076854,0.00011892448,0.000021391554,0.00024867035,0.00021350013,0.000015521202],"category_scores_gemma":[0.0006014881,0.0001606374,0.00031892592,0.00009571313,0.000091588154,0.0000056155927,0.00010627676,0.00015465225,0.000007769325],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010707197,0.0008852903,0.80988634,0.000011769065,0.00058239757,0.000016881648,0.000032374643,0.0000021768542,0.18336312,0.0001548835,0.0031000916,0.0018575733],"study_design_scores_gemma":[0.006121953,0.0017238235,0.2821169,0.000007619136,0.0007028207,0.00021666741,0.00012093067,0.0000097271795,0.69794995,0.00010537055,0.0105143115,0.00040995155],"about_ca_topic_score_codex":0.00012389095,"about_ca_topic_score_gemma":0.0016330666,"teacher_disagreement_score":0.52776945,"about_ca_system_score_codex":0.000007247532,"about_ca_system_score_gemma":0.00007774628,"threshold_uncertainty_score":0.65506035},"labels":[],"label_agreement":null},{"id":"W2979498219","doi":"10.1182/blood.v116.21.428.428","title":"A Phase 2, Double-Blind, Placebo-Controlled Trial of Rituximab + Galiximab Vs Rituximab + Placebo In Advanced Follicular Non-Hodgkin's Lymphoma (NHL)","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Rituximab; Medicine; Follicular lymphoma; Internal medicine; Lymphoma; Clinical endpoint; Phases of clinical research; Oncology; Chemotherapy regimen; CD20; Immunology; Gastroenterology; Chemotherapy; Clinical trial","score_opus":0.013479268799512315,"score_gpt":0.29742260063127457,"score_spread":0.28394333183176224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979498219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849258,0.00051481556,0.0000200537,0.0005085572,0.0007483716,0.009197188,0.000043509717,0.00011411498,0.003927576],"genre_scores_gemma":[0.99296016,0.000106941814,0.0020756812,0.00018119742,0.000444648,0.003716166,0.00009732913,0.000091449816,0.0003264465],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9959877,0.00011655793,0.0013211374,0.0009027003,0.00084830896,0.00082356855],"domain_scores_gemma":[0.99728924,0.00038687786,0.00051425723,0.0011792581,0.00022514309,0.00040522453],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007022258,0.00066705636,0.0023876338,0.00050719135,0.00011687285,0.00005727209,0.0003239138,0.00045435695,0.00021428848],"category_scores_gemma":[0.00024817418,0.00054542214,0.0007608041,0.000533702,0.00016123705,0.00022563993,0.00010619039,0.00031433415,0.00012496377],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8523382,0.12670837,0.0013291235,0.000115429626,0.000920962,0.00089573767,0.00026700553,0.000003742921,0.011062202,0.00031260715,0.00010909309,0.00593756],"study_design_scores_gemma":[0.91797954,0.0060630543,0.0005198134,0.00021051691,0.0016498062,0.00019901653,0.00007634167,0.0002365128,0.07129095,0.00006231019,0.0012583168,0.0004538322],"about_ca_topic_score_codex":0.0002825409,"about_ca_topic_score_gemma":0.00022690483,"teacher_disagreement_score":0.120645314,"about_ca_system_score_codex":0.00015159299,"about_ca_system_score_gemma":0.00067026226,"threshold_uncertainty_score":0.9996997},"labels":[],"label_agreement":null},{"id":"W2979499925","doi":"10.1182/blood.v122.21.4090.4090","title":"Myeloproliferative Neoplasm Quality Of Life (MPN-QOL) Study Group: Observational Study Of Quality Of Life and Symptomatic Response In Myelofibrosis Patients Receiving Undergoing Treatment With Conventional Therapy, The Measures Trial and Allogeneic Stem Cell Transplant, The Symptoms Trial","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Myeloproliferative neoplasm; Myelofibrosis; Quality of life (healthcare); Internal medicine; Clinical trial; Prospective cohort study; Randomized controlled trial; Observational study; Physical therapy; Surgery; Bone marrow","score_opus":0.08535212569603451,"score_gpt":0.30497268848416986,"score_spread":0.21962056278813535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979499925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882308,0.0005126186,0.000007860324,0.0002702269,0.00006041815,0.0108135315,0.00007473942,0.000013614778,0.000016163114],"genre_scores_gemma":[0.99786353,0.00020520264,0.00006478911,0.00006247934,0.00004716503,0.0016900168,0.000025585538,0.000026613066,0.000014618208],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99298954,0.0034515185,0.00172863,0.00051727344,0.001061558,0.00025145238],"domain_scores_gemma":[0.9928708,0.0051941993,0.0009827014,0.00044690247,0.00036013112,0.0001452608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020406977,0.00041318272,0.001348857,0.0001388187,0.00020211478,0.0000408272,0.00014226162,0.00009882076,0.000018215418],"category_scores_gemma":[0.00026910752,0.00021380404,0.00014736176,0.0002788863,0.00023031664,0.00013560835,0.00004501203,0.00014952813,4.5310867e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17992811,0.023828007,0.779699,0.00012435066,0.0019690623,0.000001238622,0.013282825,0.00001609671,0.00062458415,0.000044189903,0.000001478162,0.00048100812],"study_design_scores_gemma":[0.29236516,0.027907416,0.67289984,0.00011652817,0.00035275234,0.0000011179621,0.0056399433,0.000012680725,0.00055823463,0.0000148496165,6.9006086e-7,0.0001307677],"about_ca_topic_score_codex":0.0012160421,"about_ca_topic_score_gemma":0.0016559138,"teacher_disagreement_score":0.11243705,"about_ca_system_score_codex":0.00006947497,"about_ca_system_score_gemma":0.00047378658,"threshold_uncertainty_score":0.8718676},"labels":[],"label_agreement":null},{"id":"W2979505219","doi":"10.1182/blood.v130.suppl_1.2393.2393","title":"Effectiveness and Safety of Rivaroxaban Vs. Warfarin in Patients with Nonvalvular Atrial Fibrillation and Moderate-to-Severe Chronic Kidney Disease","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Rivaroxaban; Medicine; Warfarin; Atrial fibrillation; Discontinuation; Internal medicine; Stroke (engine); Interquartile range; Kidney disease; Propensity score matching; Hazard ratio; Confidence interval","score_opus":0.06203749859195346,"score_gpt":0.3278182720626058,"score_spread":0.2657807734706523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979505219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99649495,0.00046264,0.00023793183,0.0011175968,0.00010615008,0.0010608849,0.0003934684,0.000009351562,0.00011705364],"genre_scores_gemma":[0.9993456,0.000059907852,0.00026785472,0.00012341434,0.00012425084,0.000012480675,0.000033258606,0.000019754203,0.00001345136],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99808615,0.000153538,0.0010501399,0.00043460476,0.00006829556,0.00020728358],"domain_scores_gemma":[0.99819815,0.00021626259,0.00083573,0.00045070934,0.000043861604,0.00025529246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027053996,0.00014285072,0.0006332762,0.00015142282,0.0002040009,0.00007550465,0.000118890974,0.00007584977,0.000018204253],"category_scores_gemma":[0.0016276836,0.00016426876,0.00004303043,0.000049417176,0.00006628081,0.00040599605,0.000085882406,0.000068908965,0.000021472268],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000569597,0.00004342631,0.99556655,0.0005295661,0.000055994158,4.6271109e-7,0.0001823349,0.000784028,8.378871e-7,0.0020870417,0.000019171235,0.00016099906],"study_design_scores_gemma":[0.008783835,0.0001974758,0.98720497,0.00025406622,0.000019361474,4.1526874e-7,0.000006703494,0.0018013222,0.0000071863697,0.0012288167,0.00029965173,0.00019619652],"about_ca_topic_score_codex":0.0005799352,"about_ca_topic_score_gemma":0.00007122227,"teacher_disagreement_score":0.0083615715,"about_ca_system_score_codex":0.00014083614,"about_ca_system_score_gemma":0.00015358401,"threshold_uncertainty_score":0.6698685},"labels":[],"label_agreement":null},{"id":"W2979506023","doi":"10.1182/blood.v128.22.2770.2770","title":"Whole-Exome Sequencing Revealed No Recurrent Mutations within the PI3K Pathway in Relapsed Chronic Lymphocytic Leukemia Patients Progressing Under Idelalisib Treatment","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Idelalisib; Ofatumumab; Medicine; Rituximab; Chronic lymphocytic leukemia; Internal medicine; Immunology; Oncology; IGHV@; Gastroenterology; Leukemia; Ibrutinib; Lymphoma","score_opus":0.02836843321877025,"score_gpt":0.2900238229310968,"score_spread":0.26165538971232655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979506023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951841,0.0011555881,0.000033186647,0.00039247173,0.00028022437,0.0018843933,0.000035359462,0.00013445919,0.00090018037],"genre_scores_gemma":[0.9965228,0.00008066342,0.00034535246,0.0001242107,0.0002927634,0.00044784098,0.000075235854,0.00008502364,0.002026115],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99638397,0.00029593855,0.00085878384,0.00071202323,0.0008977606,0.00085151667],"domain_scores_gemma":[0.9977033,0.0004767952,0.0002941643,0.000959307,0.00028935424,0.00027708628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062399276,0.00040679623,0.0005206602,0.0002505819,0.00024281256,0.000070741684,0.0002858846,0.00020651771,0.00007240345],"category_scores_gemma":[0.000609464,0.00022175477,0.00017782116,0.00060220493,0.00032421763,0.00017603156,0.00012392405,0.00027131735,0.0003950734],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.01122371,0.018245656,0.08917248,0.00683373,0.008660716,0.012742146,0.05077017,0.011463999,0.34844008,0.0064213783,0.0038463639,0.43217957],"study_design_scores_gemma":[0.7819743,0.012716864,0.03300567,0.019259471,0.0017620284,0.0018527565,0.0018460931,0.0491874,0.088932626,0.0023604624,0.004394329,0.0027079557],"about_ca_topic_score_codex":0.00075034285,"about_ca_topic_score_gemma":0.00044332515,"teacher_disagreement_score":0.77075064,"about_ca_system_score_codex":0.18298629,"about_ca_system_score_gemma":0.047792807,"threshold_uncertainty_score":0.9576053},"labels":[],"label_agreement":null},{"id":"W2979506821","doi":"10.1182/blood.v104.11.151.151","title":"A Potential New Application of Mobilization/Leukapheresis for Enrichment of Peripheral Blood in Circulating Non-Hematopoietic CXCR4+CD45− Tissue-Committed Stem Cells (TCSC) for Organ/Tissue Regeneration.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Leukapheresis; Haematopoiesis; Stem cell; CXCR4; Biology; Transplantation; Cell biology; Bone marrow; Regeneration (biology); Immunology; Neurosphere; Medicine; CD34; Internal medicine; In vitro; Adult stem cell; Endothelial stem cell; Inflammation; Chemokine","score_opus":0.015782839550637626,"score_gpt":0.2869967207024175,"score_spread":0.27121388115177986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979506821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86313057,0.0007397655,0.13098152,0.00022573395,0.000068952286,0.004670573,0.000020771296,0.000030734067,0.00013138483],"genre_scores_gemma":[0.976068,0.000033886503,0.022357905,0.000030484061,0.00019546077,0.00036373598,0.00009967032,0.000060837658,0.00078997965],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976456,0.000049133007,0.0009113103,0.0004700824,0.00054082193,0.00038306345],"domain_scores_gemma":[0.9983356,0.00012221084,0.0003300812,0.00051029754,0.0005254887,0.00017630098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040253694,0.00022557931,0.00058127125,0.00019293318,0.00008286114,0.000020755686,0.00019396837,0.00019354538,0.00006850829],"category_scores_gemma":[0.000094008734,0.00022666098,0.000112957205,0.00067327055,0.000052529507,0.000077667246,0.000051969677,0.00011046599,0.000004590614],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015372832,0.0014447488,0.0021137116,0.0015749815,0.00012783946,0.000006838076,0.00082592556,0.003958546,0.98695976,0.00037251826,0.00008175791,0.0023796638],"study_design_scores_gemma":[0.012190111,0.0010906078,0.00085898157,0.00023326259,0.00035620344,0.000025694517,0.00037045742,0.0027090507,0.9815076,0.0003040343,0.00016386798,0.00019010864],"about_ca_topic_score_codex":0.00030845153,"about_ca_topic_score_gemma":0.0000685352,"teacher_disagreement_score":0.11293747,"about_ca_system_score_codex":0.00010545084,"about_ca_system_score_gemma":0.00045284364,"threshold_uncertainty_score":0.9242966},"labels":[],"label_agreement":null},{"id":"W2979509136","doi":"10.1182/blood.v118.21.955.955","title":"Frontline Therapy with Brentuximab Vedotin Combined with ABVD or AVD in Patients with Newly Diagnosed Advanced Stage Hodgkin Lymphoma","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Brentuximab vedotin; ABVD; Medicine; Internal medicine; Oncology; Dacarbazine; Regimen; Chemotherapy regimen; Hodgkin's lymphoma; Chemotherapy; Surgery; Lymphoma; CD30; Vincristine; Cyclophosphamide","score_opus":0.013137553990264885,"score_gpt":0.21696171838328743,"score_spread":0.20382416439302253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979509136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99690783,0.0002670063,0.00003634474,0.00007748729,0.000042273397,0.0018721499,0.00004601252,0.00010747254,0.00064341334],"genre_scores_gemma":[0.9928211,0.00011089294,0.005618634,0.00037477174,0.000025118454,0.00040670237,0.00014668576,0.00009165379,0.0004044424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99800396,0.000057401518,0.0003394362,0.00058573636,0.000501856,0.0005115932],"domain_scores_gemma":[0.9987127,0.00008873131,0.00020924714,0.0006080707,0.00015558998,0.00022566579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000069936395,0.00046299183,0.0006880465,0.00014791125,0.00006914641,0.00003159979,0.00014333021,0.000091078036,0.00017265258],"category_scores_gemma":[0.000021762267,0.00024258193,0.00005436896,0.00036387055,0.00009020806,0.00022273361,0.000028709683,0.00008797438,0.00002062905],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034160055,0.03162044,0.91817296,0.000040226885,0.00056555524,0.0014244217,0.00094805146,0.00000551769,0.000020265144,0.000055043656,0.00005389217,0.012933546],"study_design_scores_gemma":[0.23118205,0.02207169,0.74171644,0.00036777277,0.00021794261,0.000018851935,0.00016187617,0.0000057440534,0.003809934,0.00000766618,0.0001384287,0.00030161868],"about_ca_topic_score_codex":0.00057953736,"about_ca_topic_score_gemma":0.0010315622,"teacher_disagreement_score":0.19702199,"about_ca_system_score_codex":0.00013077304,"about_ca_system_score_gemma":0.00030120029,"threshold_uncertainty_score":0.9892204},"labels":[],"label_agreement":null},{"id":"W2979509462","doi":"10.1182/blood.v108.11.3068.3068","title":"Inferior Progression-Free Survival after Autotransplant for Relapsed or Refractory Aggressive Non-Hodgkin’s Lymphoma in Patients &gt; 60 Versus ≤ 60 Years of Age.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Salvage therapy; Internal medicine; Melphalan; Surgery; Chemotherapy regimen; Regimen; Transplantation; Progression-free survival; Chemotherapy; Oncology","score_opus":0.011398951170519813,"score_gpt":0.26229187269958676,"score_spread":0.25089292152906695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979509462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971474,0.00045433952,0.0000026474222,0.00005779951,0.00041493,0.0012154189,0.0002581182,0.000038736307,0.0004106459],"genre_scores_gemma":[0.99758965,0.000081823964,0.0011943862,0.000036838035,0.00012208143,0.0005520206,0.00023656242,0.00004595024,0.00014066687],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982581,0.000043005624,0.000492176,0.0003717463,0.00046275312,0.0003721806],"domain_scores_gemma":[0.9987378,0.000271518,0.00027574072,0.00049207587,0.000110888475,0.00011196967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000113462935,0.0002466307,0.00052732066,0.0001564677,0.000034436278,0.00001534156,0.0001389702,0.00018868528,0.000050748808],"category_scores_gemma":[0.00016738575,0.00018800744,0.00017360986,0.0001677065,0.0000771911,0.00007811541,0.00005285486,0.000060562637,0.000012040031],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025187524,0.0234789,0.8989631,0.0005164283,0.00061505835,0.009356122,0.0007644616,0.0000055462383,0.0005734577,0.00003917869,0.0010295932,0.039470665],"study_design_scores_gemma":[0.08153313,0.0031690917,0.9096596,0.00089865306,0.00045485265,0.000007714127,0.000016529617,0.000008155241,0.002903435,0.000022594028,0.0011318922,0.00019432262],"about_ca_topic_score_codex":0.00022645257,"about_ca_topic_score_gemma":0.00034769415,"teacher_disagreement_score":0.056345604,"about_ca_system_score_codex":0.0001568941,"about_ca_system_score_gemma":0.00025346424,"threshold_uncertainty_score":0.76667213},"labels":[],"label_agreement":null},{"id":"W2979510277","doi":"10.1182/blood.v128.22.1226.1226","title":"Donor Lymphocytes Depleted of Alloreactive T-Cells (ATIR101) Improve Event-Free Survival (GRFS) and Overall Survival in a T-Cell Depleted Haploidentical HSCT: Phase 2 Trial in Patients with AML and ALL","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Hospital; Université de Montréal; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"ThioTEPA; Fludarabine; Medicine; Hematopoietic stem cell transplantation; CD34; Graft-versus-host disease; Internal medicine; Melphalan; Total body irradiation; Gastroenterology; Stem cell; Donor lymphocyte infusion; Transplantation; Phases of clinical research; Immunology; Surgery; Clinical trial; Cyclophosphamide; Chemotherapy; Biology","score_opus":0.01072469247725687,"score_gpt":0.2426826855259805,"score_spread":0.2319579930487236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979510277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974083,0.000057411857,0.00015992457,0.00007737057,0.0001367747,0.0017155275,0.00016284296,0.000026392727,0.0002554753],"genre_scores_gemma":[0.9991713,0.000060635703,0.00048941793,0.00003501403,0.000047326113,0.000056454443,0.000059160975,0.000048464273,0.000032231095],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9975912,0.00018728462,0.00071131514,0.0005449512,0.0005507511,0.00041447117],"domain_scores_gemma":[0.9984368,0.0006265462,0.00021980474,0.0003759679,0.00012651223,0.00021434028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042679525,0.00031307666,0.000728809,0.00023391446,0.000020967735,0.000019180468,0.00012244482,0.00018406965,0.000020191123],"category_scores_gemma":[0.00019968425,0.00022426924,0.000061335326,0.00017117875,0.00015261456,0.00017457933,0.00005835872,0.00014518136,0.0000029835664],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.095724136,0.009869632,0.48703983,0.0006393096,0.000441674,0.00020139413,0.0015925618,4.516646e-7,0.40312758,0.00014437802,0.000012850227,0.001206217],"study_design_scores_gemma":[0.6629555,0.0043452447,0.18392767,0.00054523675,0.0006091697,0.000013861636,0.00013309825,0.00008086377,0.14685538,0.00014223918,0.000010315471,0.00038138384],"about_ca_topic_score_codex":0.0003297283,"about_ca_topic_score_gemma":0.00037742592,"teacher_disagreement_score":0.5672314,"about_ca_system_score_codex":0.00008582566,"about_ca_system_score_gemma":0.00016923141,"threshold_uncertainty_score":0.91454345},"labels":[],"label_agreement":null},{"id":"W2979511540","doi":"10.1182/blood.v128.22.1573.1573","title":"Leveraging Increased Nucleoside Kinase Activity to Selectively Deplete Mitochondrial DNA (mtDNA), Impair Oxidative Phosphorylation, and Target AML Cells","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Deoxycytidine kinase; Biology; TFAM; Molecular biology; Mitochondrial biogenesis; Gene knockdown; Mitochondrial DNA; Mitochondrion; Kinase; Biochemistry; Gene; Genetics","score_opus":0.007825503350334276,"score_gpt":0.21489598401986376,"score_spread":0.2070704806695295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979511540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9767599,0.00007011745,0.021622522,0.00023802879,0.0004096879,0.00038976208,0.000106416155,0.00003948443,0.00036406334],"genre_scores_gemma":[0.9911281,0.000030142752,0.006963712,0.00051487854,0.00059964287,0.00005283225,0.000033958167,0.000035884525,0.00064087065],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99854976,0.0001937202,0.00018299487,0.00061984395,0.00012338629,0.00033032257],"domain_scores_gemma":[0.99919176,0.000059802995,0.00009995783,0.00030037222,0.00011895429,0.00022914825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001348202,0.00023425827,0.00021303051,0.000072875766,0.00014766055,0.00002982103,0.0001224657,0.00018937032,0.00011738915],"category_scores_gemma":[0.0002728816,0.00019337964,0.00007942071,0.00012199281,0.00006918219,0.00001298951,0.0001174213,0.000087662556,0.00006088931],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005233914,0.00014060283,0.0035711578,0.0000058970377,0.00006941378,0.000008532692,0.0001240354,0.0000019052072,0.9919022,0.000012622707,0.0027292585,0.00091101695],"study_design_scores_gemma":[0.002777892,0.0004912092,0.008768543,0.000014312966,0.000042835745,0.00002374694,0.000020035115,0.000006599125,0.9697775,0.00007369246,0.017718256,0.00028534542],"about_ca_topic_score_codex":0.00007935504,"about_ca_topic_score_gemma":0.000046995818,"teacher_disagreement_score":0.022124633,"about_ca_system_score_codex":0.00002046544,"about_ca_system_score_gemma":0.00008845105,"threshold_uncertainty_score":0.7885793},"labels":[],"label_agreement":null},{"id":"W2979513542","doi":"10.1182/blood.v118.21.1693.1693","title":"Combination Targeted Therapy to Impair Self-Renewal Capacity of Human Blast Crisis Leukemia Stem Cells","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Dasatinib; Progenitor cell; Bone marrow; Medicine; CD34; Population; Stem cell; Haematopoiesis; Immunology; Cancer research; Internal medicine; Myeloid leukemia; Biology; Imatinib","score_opus":0.030206154551618406,"score_gpt":0.24691443842859162,"score_spread":0.21670828387697322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979513542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966153,0.00009971049,0.000011732681,0.00003403186,0.000104574945,0.0007057905,0.00002506581,0.00016369826,0.00224012],"genre_scores_gemma":[0.99797875,0.000028780316,0.0014132494,0.00014176121,0.00006449727,0.000043735086,0.000021182648,0.000040090526,0.0002679521],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99860275,0.00006572838,0.0003711212,0.0003276598,0.00033100703,0.0003017236],"domain_scores_gemma":[0.9989404,0.000026014686,0.00015269678,0.0005109814,0.0001613249,0.00020859162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015553593,0.00022913754,0.00040294472,0.0001517519,0.00006916303,0.0000069720536,0.0001471587,0.00013875781,0.00029074817],"category_scores_gemma":[0.000006541299,0.00020054769,0.00013347872,0.00024052008,0.00003558428,0.00006208303,0.000041080526,0.00013794602,0.00007399576],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038853803,0.009117086,0.08434871,0.00027513102,0.0019098483,0.00009949247,0.021258729,0.000003670953,0.8773706,0.0003728022,0.0036022451,0.0012531424],"study_design_scores_gemma":[0.0127731515,0.0021451162,0.042142056,0.000055249886,0.00029184076,0.000019413357,0.0002957083,0.000011952005,0.94186413,0.000096034666,0.00012848628,0.00017684793],"about_ca_topic_score_codex":0.0014307122,"about_ca_topic_score_gemma":0.000062646344,"teacher_disagreement_score":0.06449354,"about_ca_system_score_codex":0.00059067213,"about_ca_system_score_gemma":0.00026471002,"threshold_uncertainty_score":0.8178097},"labels":[],"label_agreement":null},{"id":"W2979513932","doi":"10.1182/blood.v114.22.1299.1299","title":"Immune-Modulatory Effects of Mesenchymal Stromal Cell Infusions for the Treatment of Factor VIII Inhibitor in Hemophilia A.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University; Queen's University","funders":"","keywords":"Mesenchymal stem cell; Antibody; Medicine; In vivo; Immunology; Chemokine; Bone marrow; Immune system; Stromal cell; Ex vivo; Internal medicine; Pathology; Biology","score_opus":0.014872110843081831,"score_gpt":0.28489985707312576,"score_spread":0.27002774623004394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979513932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99457425,0.0030460155,0.0000030839008,0.0003719063,0.00007697055,0.001622585,0.000026162923,0.000013595518,0.00026540723],"genre_scores_gemma":[0.99850136,0.00036886157,0.00022280679,0.000012062608,0.00012338627,0.00006347958,0.000014930544,0.00001318639,0.000679939],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99892217,0.00003695077,0.00032023355,0.00018119843,0.00026338812,0.00027604887],"domain_scores_gemma":[0.9990422,0.00037198883,0.00007657018,0.00035104252,0.00006964478,0.000088541485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007643124,0.00016234042,0.0004104767,0.0001396343,0.000053708987,0.0000037714722,0.00008864071,0.0001045909,0.00002479839],"category_scores_gemma":[0.000058246253,0.00009297721,0.00023648348,0.00018000412,0.000077763645,0.00002970669,0.000015928335,0.00008331637,0.000004461492],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032369856,0.012185674,0.04289331,0.00030980335,0.00021598318,0.00006710572,0.0013574586,0.000004194472,0.9294703,0.00006374851,0.000049688042,0.013059059],"study_design_scores_gemma":[0.010457164,0.005323596,0.22170097,0.000098672215,0.00020230065,0.00000437926,0.00006326698,0.000049808725,0.76179963,0.00003403771,0.00019888487,0.0000673034],"about_ca_topic_score_codex":0.000041654817,"about_ca_topic_score_gemma":0.000006639406,"teacher_disagreement_score":0.17880765,"about_ca_system_score_codex":0.00005044517,"about_ca_system_score_gemma":0.0001501775,"threshold_uncertainty_score":0.37915003},"labels":[],"label_agreement":null},{"id":"W2979518836","doi":"10.1182/blood.v114.22.2000.2000","title":"Development of a Sandwich ELISA to Detect Hepcidin in Human Serum.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada)","funders":"","keywords":"Hepcidin; Polyclonal antibodies; Epitope; Antibody; Monoclonal antibody; Immunogenicity; Molecular biology; Chemistry; Biology; Immunology; Inflammation","score_opus":0.014016970468092122,"score_gpt":0.27480779898417024,"score_spread":0.2607908285160781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979518836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99364084,0.00039724156,0.000049304625,0.00016208587,0.000020369462,0.00022365482,0.0000011472193,0.000020360276,0.005484978],"genre_scores_gemma":[0.9857928,0.000007769791,0.01341902,0.0005338815,0.000030643176,0.0000070609317,0.0000036200327,0.0000068420736,0.00019832593],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99927163,0.0000123421105,0.0002389977,0.0001396498,0.0001587528,0.0001786094],"domain_scores_gemma":[0.9997073,0.000005547103,0.000028254572,0.00015524794,0.000022358246,0.00008133813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014353123,0.000085857966,0.00020985083,0.00013686571,0.000025641135,0.000003452735,0.000060437123,0.000043818978,0.00007714515],"category_scores_gemma":[0.0000369818,0.00007661838,0.000029916207,0.00019893292,0.000008313355,0.000020163849,0.000015732405,0.00006183097,0.000019152138],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017035654,0.0017598573,0.0562336,0.00017395243,0.000031722404,0.000056358436,0.0066928207,0.0000054686834,0.7968217,0.00043117753,0.0005632975,0.13705966],"study_design_scores_gemma":[0.0043340432,0.00015493503,0.66861576,0.00006779727,0.000045718858,0.000005795799,0.00017976022,4.2436884e-7,0.32405996,0.00010662719,0.0023186589,0.000110514346],"about_ca_topic_score_codex":0.000017635844,"about_ca_topic_score_gemma":0.00009737752,"teacher_disagreement_score":0.6123822,"about_ca_system_score_codex":0.000009770927,"about_ca_system_score_gemma":0.000071418785,"threshold_uncertainty_score":0.3124407},"labels":[],"label_agreement":null},{"id":"W2979519729","doi":"10.1182/blood.v128.22.1562.1562","title":"The Mitochondrial Carrier Homolog 2 (MTCH2) Regulates the Differentiation of AML Cells By Influencing the Localization of Pyruvate Dehydrogenase Complex and H3 and H4 Histone Acetylation","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Gene knockdown; Biology; Haematopoiesis; Cell biology; Molecular biology; Stem cell; Cancer research; Apoptosis; Genetics","score_opus":0.009723854391474926,"score_gpt":0.24919708682128813,"score_spread":0.23947323242981322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979519729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961962,0.0009801527,0.0007014802,0.0014703406,0.000049495768,0.0005271167,0.00003011193,0.000011539275,0.00003353671],"genre_scores_gemma":[0.99915594,0.00039389377,0.000063362124,0.00006191925,0.00006994239,0.000016462187,0.000019995477,0.000014962819,0.0002035016],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989377,0.00016033735,0.0002932322,0.00016307624,0.00028149385,0.0001641355],"domain_scores_gemma":[0.9988532,0.00041237488,0.00020363764,0.0003239959,0.00015751632,0.00004925449],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002915944,0.000106259184,0.00017932555,0.000039142156,0.00021246506,0.000016232108,0.000109216904,0.00007829776,0.000016404863],"category_scores_gemma":[0.00020057897,0.00004459986,0.000035476656,0.00013509755,0.0005493369,0.00006381493,0.000082101615,0.00009457138,8.238498e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014374696,0.000041366136,0.0046569607,0.00004166718,0.00009816297,6.9528613e-7,0.000854434,0.000007028017,0.99062616,0.000090320136,0.0011112813,0.0023281826],"study_design_scores_gemma":[0.003951682,0.00018115721,0.020740762,0.00007876234,0.00027205513,0.000016264485,0.00025579784,0.001801892,0.9709513,0.0003757633,0.0012940193,0.00008049985],"about_ca_topic_score_codex":0.00013472435,"about_ca_topic_score_gemma":0.000038100992,"teacher_disagreement_score":0.01967481,"about_ca_system_score_codex":0.000049646802,"about_ca_system_score_gemma":0.0000646467,"threshold_uncertainty_score":0.20240547},"labels":[],"label_agreement":null},{"id":"W2979521435","doi":"10.1182/blood.v128.22.1854.1854","title":"Dose-Dense Chemoimmunotherapy Including Early CNS Prophylaxis for High-Risk DLBCL. -Final Analysis from a Nordic Phase II Study (the CHIC trial)","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Chemoimmunotherapy; Medicine; Internal medicine; Clinical endpoint; Discontinuation; Antimetabolite; Cytarabine; Oncology; Primary central nervous system lymphoma; Methotrexate; Lymphoma; Surgery; Gastroenterology; Chemotherapy; Clinical trial; Rituximab","score_opus":0.04028724231131238,"score_gpt":0.31359562974784305,"score_spread":0.2733083874365307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979521435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942953,0.00076461997,0.00013226418,0.00090979744,0.00014695934,0.0034435051,0.00020373455,0.00008852518,0.000015276091],"genre_scores_gemma":[0.9970468,0.00018043979,0.00031045967,0.000083921324,0.00051464105,0.001462529,0.000040375082,0.000054550583,0.00030622972],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9979251,0.00013465414,0.00053198746,0.0006032154,0.000432377,0.0003726777],"domain_scores_gemma":[0.9980156,0.0005079311,0.00029403114,0.0009307873,0.00012108816,0.00013060271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044461864,0.00032847945,0.00080161827,0.00023793336,0.000503331,0.000054633212,0.00020385068,0.000102938306,0.0001917844],"category_scores_gemma":[0.0001856023,0.00017065604,0.0005627846,0.0006231118,0.000074498355,0.0000711532,0.000084838204,0.00011020169,0.000039158964],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.052046515,0.11206824,0.3356633,0.000018113484,0.03964841,0.00021341551,0.004894345,7.909657e-7,0.016202785,0.000047411526,0.00015733695,0.43903935],"study_design_scores_gemma":[0.5444909,0.031504527,0.3938862,0.00006614885,0.01819137,0.0000064712845,0.00019295141,0.000011515689,0.010636664,0.00019582549,0.0005138971,0.00030357114],"about_ca_topic_score_codex":0.0022162532,"about_ca_topic_score_gemma":0.00033171527,"teacher_disagreement_score":0.49244434,"about_ca_system_score_codex":0.00012602571,"about_ca_system_score_gemma":0.00011600452,"threshold_uncertainty_score":0.69591516},"labels":[],"label_agreement":null},{"id":"W2979521610","doi":"10.1182/blood.v120.21.1143.1143","title":"Contemporary Estimates of the Incidence of Venous Thromboembolism: A Population-Based Cohort Study","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Pulmonary embolism; Incidence (geometry); Population; Deep vein; Cohort; Diagnosis code; Retrospective cohort study; Reimbursement; Cohort study; Venous thrombosis; Pediatrics; Thrombosis; Emergency medicine; Health care; Internal medicine; Environmental health","score_opus":0.01968671326916279,"score_gpt":0.27901752235025484,"score_spread":0.2593308090810921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979521610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99564886,0.0006452159,0.00001757268,0.00011063408,0.00016377661,0.001559716,0.000008036008,0.000028693908,0.001817484],"genre_scores_gemma":[0.99935836,0.000007351685,0.00030256034,0.00015923879,0.00006321466,0.000068131,0.000010749926,0.00001896172,0.000011462216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987979,0.000057776295,0.00039201317,0.00014779485,0.00041678493,0.00018775511],"domain_scores_gemma":[0.9989492,0.000102586964,0.00025810298,0.0005265372,0.00009376734,0.000069756104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041107796,0.00012894903,0.00064788543,0.00006781743,0.000058836962,0.000004697127,0.00015311236,0.0000439553,0.00005397689],"category_scores_gemma":[0.00015953805,0.00008844616,0.00010884411,0.00020914599,0.00006155945,0.00007273162,0.000079679136,0.000080156315,0.000004798012],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001289393,0.011303536,0.9862959,0.00015927243,0.0003253445,0.000002905183,0.000600561,0.000016995413,0.00071142847,0.000166833,0.00032291308,0.00008146363],"study_design_scores_gemma":[0.0013819903,0.00043144615,0.98940146,0.00016283765,0.00096175115,0.0000035093362,0.00024480908,0.000024182264,0.0072389008,0.000045844274,0.000023880722,0.00007938674],"about_ca_topic_score_codex":0.0017442027,"about_ca_topic_score_gemma":0.000020507543,"teacher_disagreement_score":0.01087209,"about_ca_system_score_codex":0.00001828863,"about_ca_system_score_gemma":0.00009163183,"threshold_uncertainty_score":0.36067298},"labels":[],"label_agreement":null},{"id":"W2979525324","doi":"10.1182/blood.v116.21.3887.3887","title":"Incorporation of ABVD Increases Cure Rates of Patients with Limited Stage Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL)","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"ABVD; Medicine; Stage (stratigraphy); Radiation therapy; Lymphoma; Diffuse large B-cell lymphoma; Chemotherapy; Cancer; Vinblastine; Internal medicine; Oncology; Vincristine; Cyclophosphamide","score_opus":0.007020985185413978,"score_gpt":0.22547519973223126,"score_spread":0.2184542145468173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979525324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99857146,0.00022085957,0.000010592192,0.00003514182,0.00005639945,0.00068542844,0.00019516298,0.000027893799,0.00019705106],"genre_scores_gemma":[0.99766713,0.00007378517,0.001650839,0.00004211963,0.000045165194,0.00005947372,0.00034551354,0.00002882372,0.00008715002],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986643,0.000045581375,0.0004270204,0.00027824918,0.00039740404,0.00018742759],"domain_scores_gemma":[0.9984821,0.00010599548,0.0004451265,0.00047585505,0.00037031207,0.00012062605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011591845,0.00021969316,0.00050615566,0.00013740214,0.00004334565,0.000014287115,0.0000890566,0.00012071763,0.00005802286],"category_scores_gemma":[0.00011838424,0.00015036925,0.000095532974,0.00023752282,0.000121126504,0.00013876392,0.000043533495,0.000041992993,0.0000065713693],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092353864,0.010712659,0.9718417,0.00017999088,0.000343708,0.000055984754,0.00012694724,0.000002336695,0.012448784,0.00030190896,0.000048819165,0.0030136385],"study_design_scores_gemma":[0.020046975,0.0012428777,0.6694511,0.0001612373,0.00047087832,0.0000117639975,0.000028866345,0.000026101474,0.3082117,0.000016760221,0.00022393098,0.000107776206],"about_ca_topic_score_codex":0.0006099052,"about_ca_topic_score_gemma":0.00013003369,"teacher_disagreement_score":0.30239058,"about_ca_system_score_codex":0.000046468784,"about_ca_system_score_gemma":0.0003123648,"threshold_uncertainty_score":0.613188},"labels":[],"label_agreement":null},{"id":"W2979527276","doi":"10.1182/blood.v116.21.1271.1271","title":"High IL-15 Serum Levels on Day 7 After Hematopoietic Cell Transplantation Are Associated with a Low Likelihood of Graft-Vs-Host Disease and a High Likelihood of Infections","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Cytokine; Immunology; Graft-versus-host disease; Transplantation; Internal medicine; Hematopoietic stem cell transplantation; Filgrastim; Gastroenterology; Granulocyte colony-stimulating factor; Chemotherapy","score_opus":0.00534326421881899,"score_gpt":0.20840072897516893,"score_spread":0.20305746475634995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979527276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99661523,0.000058096208,0.00038157083,0.00024259184,0.00014269448,0.0008671316,0.0014835668,0.000084678315,0.00012446164],"genre_scores_gemma":[0.99894863,0.0000677963,0.00044092888,0.00011017924,0.000057881258,0.00010526785,0.00014861963,0.000065064756,0.000055607383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980095,0.000100932884,0.0005639469,0.00042738393,0.0005399691,0.00035828783],"domain_scores_gemma":[0.9983632,0.00028234674,0.00034171523,0.0004161015,0.00025952494,0.0003370933],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002044072,0.00032946552,0.0006074283,0.00024823443,0.00006673398,0.000018501396,0.00008401407,0.00021946033,0.00015482682],"category_scores_gemma":[0.000068994224,0.00028063258,0.00011713124,0.00037870798,0.00014416287,0.00011681251,0.000011610423,0.00035156126,0.000012557048],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019944878,0.0104637565,0.7565471,0.008188059,0.00081784796,0.0006287286,0.004163476,0.000016076738,0.21666649,0.0002449566,0.00003327239,0.00023573467],"study_design_scores_gemma":[0.0082411915,0.0009140819,0.77865607,0.0019258047,0.0021159654,0.00007756355,0.00009821795,0.000011356516,0.20753634,0.0001711249,0.000002747571,0.00024953028],"about_ca_topic_score_codex":0.00006393223,"about_ca_topic_score_gemma":0.00037727435,"teacher_disagreement_score":0.022108966,"about_ca_system_score_codex":0.000017883438,"about_ca_system_score_gemma":0.00018070305,"threshold_uncertainty_score":0.9999646},"labels":[],"label_agreement":null},{"id":"W2979527793","doi":"10.1182/blood.v124.21.689.689","title":"Modeling Minimally-Effective FVIII Trough Levels in Hemophilia a Patients on PK-Guided Prophylaxis","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Dosing; Trough level; Bleed; Regimen; Internal medicine; Surgery; Transplantation","score_opus":0.03407082076466017,"score_gpt":0.3023262789418344,"score_spread":0.2682554581771742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979527793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912753,0.000044912897,0.000025127812,0.000341618,0.000065724504,0.0014253618,0.000008493664,0.00005325916,0.0067602037],"genre_scores_gemma":[0.9981709,0.000007913467,0.00051062385,0.00014361176,0.0001830493,0.00015957303,0.000025845913,0.000037551206,0.00076093554],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99813396,0.00014754447,0.0003059103,0.00044771587,0.00051075954,0.00045411085],"domain_scores_gemma":[0.99916416,0.00012255578,0.000036259516,0.00035108454,0.00014985446,0.00017606227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032958644,0.00022732362,0.0003977107,0.00024227031,0.00007429636,0.0000176889,0.00011062325,0.00015890197,0.000043103348],"category_scores_gemma":[0.000514565,0.0001678887,0.00011677841,0.00029441313,0.000044935427,0.00006446253,0.000055807417,0.0003269048,0.00022173802],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018813711,0.0161544,0.88571185,0.00078187033,0.00059481,0.00041923707,0.0029124578,0.0003960875,0.020200038,0.00046336954,0.00039363213,0.0700909],"study_design_scores_gemma":[0.10130042,0.022917215,0.7006704,0.0018692901,0.000487997,0.000060564256,0.00018256015,0.034885954,0.13354252,0.0020391454,0.00066880416,0.0013751246],"about_ca_topic_score_codex":0.000072520044,"about_ca_topic_score_gemma":0.000014494663,"teacher_disagreement_score":0.18504143,"about_ca_system_score_codex":0.000107615444,"about_ca_system_score_gemma":0.00007413758,"threshold_uncertainty_score":0.6846303},"labels":[],"label_agreement":null},{"id":"W2979530151","doi":"10.1182/blood.v128.22.2873.2873","title":"Discovery and Validation of Cell-Surface Protein Mesothelin (MSLN) As a Novel Therapeutic Target in AML: Results from the COG/NCI Target AML Initiative","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Mesothelin; Cancer research; Biology; Haematopoiesis; Cancer; Stem cell; Genetics","score_opus":0.017059214864655687,"score_gpt":0.24061048421269915,"score_spread":0.22355126934804345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979530151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955024,0.0005739619,0.00023455005,0.001209706,0.000019196363,0.00052766805,0.001320305,0.000011744006,0.000600454],"genre_scores_gemma":[0.99784666,0.000055998982,0.0012709206,0.000230258,0.00005260517,0.000024706627,0.00017535835,0.000015293701,0.00032819383],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990839,0.000067704976,0.00025378275,0.00022599226,0.00024508065,0.0001235694],"domain_scores_gemma":[0.99936134,0.00026406493,0.00012751875,0.00018110476,0.000018746212,0.000047211623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014012173,0.00012247488,0.00016900916,0.000021708092,0.00003341955,0.00001048883,0.00006478459,0.00005073788,0.00007499341],"category_scores_gemma":[0.00010935774,0.000067497866,0.000043110445,0.000069644855,0.00011634754,0.00015867579,0.0000414934,0.00006563453,0.00002191459],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016448225,0.0015989046,0.16084953,0.00003394427,0.00012080139,0.00000743407,0.0007200174,0.000014529606,0.83467615,0.00014761364,0.00004789336,0.00013836293],"study_design_scores_gemma":[0.007274025,0.00026380585,0.37901765,0.00025203198,0.00013301548,0.000001982776,0.0002671824,0.000036340793,0.6105764,0.0019129288,0.0001485938,0.00011603428],"about_ca_topic_score_codex":0.00018473202,"about_ca_topic_score_gemma":0.0000075826615,"teacher_disagreement_score":0.22409976,"about_ca_system_score_codex":0.000021929145,"about_ca_system_score_gemma":0.00006485668,"threshold_uncertainty_score":0.27524832},"labels":[],"label_agreement":null},{"id":"W2979532361","doi":"10.1182/blood.v112.11.822.822","title":"Immunosuppression Modulates Immune Responses to AAV Capsid in Human Subjects Undergoing Intramuscular Gene Transfer for Lipoprotein Lipase Deficiency","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Chicoutimi; Université de Montréal","funders":"","keywords":"Genetic enhancement; Immunology; Immunosuppression; Immune system; ELISPOT; Lipoprotein lipase; Biology; Medicine; CD8; Internal medicine; Gene; Adipose tissue","score_opus":0.0193407967844535,"score_gpt":0.2809671073335194,"score_spread":0.2616263105490659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979532361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933408,0.0046264064,0.0007692639,0.00011243088,0.000044782282,0.0010070289,0.000030092648,0.000024499945,0.00004467996],"genre_scores_gemma":[0.99791926,0.00038470447,0.00079295854,0.000085888336,0.00011968979,0.00027518623,0.00010698725,0.00006328075,0.0002520566],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980926,0.0001904074,0.00035477252,0.00055176415,0.00023715665,0.00057330827],"domain_scores_gemma":[0.99907017,0.00004084337,0.00003047572,0.00063120166,0.00010413871,0.00012317339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046389128,0.00024313762,0.00024173956,0.00019529315,0.00027995586,0.000028271153,0.00037279204,0.00019883882,0.00001984614],"category_scores_gemma":[0.0001954657,0.00024154579,0.00015777559,0.00023554864,0.000084792264,0.000008518594,0.00009463623,0.00014427712,0.000007002376],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002485005,0.0005037857,0.0005210851,0.00004258463,0.000046346155,0.00003443456,0.00023779528,0.00034246923,0.99518764,0.00000915744,0.000022640581,0.0005670276],"study_design_scores_gemma":[0.0035093883,0.0044134143,0.003451228,0.000049091606,0.000016607932,0.000037639627,0.000042552518,0.000016723254,0.9879359,0.000060159033,0.00016012642,0.00030715397],"about_ca_topic_score_codex":0.00014797125,"about_ca_topic_score_gemma":0.00041680937,"teacher_disagreement_score":0.0072517535,"about_ca_system_score_codex":0.000025722362,"about_ca_system_score_gemma":0.00021769527,"threshold_uncertainty_score":0.9849951},"labels":[],"label_agreement":null},{"id":"W2979532487","doi":"10.1182/blood.v126.23.2899.2899","title":"Targeting Cell-Bound MUC1 on Myelomonocytic and Monocytic Leukemias and Leukemic Stem Cells: Therapeutic Implications","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Biomod (Canada)","funders":"","keywords":"Chronic myelomonocytic leukemia; Monocytic leukemia; Juvenile myelomonocytic leukemia; Biology; Leukemia; Stem cell; Cancer research; Haematopoiesis; Molecular biology; Immunology; Cell biology; Myelodysplastic syndromes","score_opus":0.04963958323945775,"score_gpt":0.294967298003222,"score_spread":0.24532771476376428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979532487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98821527,0.0052579683,0.00014094065,0.0007682169,0.00006460297,0.00079222996,0.000012013298,0.00013961055,0.004609165],"genre_scores_gemma":[0.99547714,0.001023152,0.0006325794,0.0006854814,0.00019575603,0.000080577156,0.000015911508,0.000077556026,0.001811818],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979804,0.00011261279,0.00036523127,0.0006142366,0.00035333075,0.000574154],"domain_scores_gemma":[0.9982789,0.0003035012,0.00010997407,0.0005721473,0.00015463436,0.0005808518],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005080191,0.00030789603,0.00041254045,0.00022041041,0.00019591366,0.00010353091,0.00017981174,0.0001899634,0.00001421252],"category_scores_gemma":[0.00005803848,0.0002681278,0.000055741944,0.0002920291,0.00021406727,0.000124608,0.0001648487,0.00055069965,0.000118705946],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015305018,0.00251434,0.06478359,0.0023303244,0.0014400419,0.0007006886,0.010942104,0.00033653804,0.83978623,0.0027090823,0.012530901,0.060395673],"study_design_scores_gemma":[0.11146426,0.009601549,0.04467431,0.0009834842,0.0047412342,0.0039034635,0.018709257,0.034211732,0.724953,0.006508004,0.0361673,0.004082389],"about_ca_topic_score_codex":0.0001090495,"about_ca_topic_score_gemma":0.0000028090603,"teacher_disagreement_score":0.1148332,"about_ca_system_score_codex":0.00074197876,"about_ca_system_score_gemma":0.0009704487,"threshold_uncertainty_score":0.9999771},"labels":[],"label_agreement":null},{"id":"W2979532806","doi":"10.1182/blood.v128.22.2235.2235","title":"Refined Hepatic Grading System Improves Risk Stratification of Long-Term Outcomes in the Patients Developing Chronic Gvhd","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Grading (engineering); Gastroenterology; Overlap syndrome; Common Terminology Criteria for Adverse Events; Bilirubin; Retrospective cohort study; Oncology; Adverse effect; Disease; Biology","score_opus":0.015234422591757476,"score_gpt":0.2711114562617843,"score_spread":0.2558770336700268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979532806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985502,0.000114851966,0.0006865675,0.00008649072,0.000036580153,0.00035990297,0.0000129017435,0.0000062165855,0.00014629857],"genre_scores_gemma":[0.9995758,0.00005947125,0.00015837007,0.000009616533,0.000028431901,0.00005528336,0.000033966448,0.000008494303,0.000070553586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99912024,0.00012410917,0.00024773512,0.00018268204,0.00016909627,0.00015615704],"domain_scores_gemma":[0.99944186,0.00003223254,0.00013102803,0.00029211107,0.000081313454,0.000021431746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026323853,0.00008613095,0.00010464947,0.00005134117,0.00005249215,0.000015154454,0.000190163,0.00006644935,0.000004779741],"category_scores_gemma":[0.0001724875,0.000048922117,0.00004281753,0.00009056244,0.000033422657,0.000005519067,0.000037636717,0.000046020214,0.0000055637965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015609154,0.00013175303,0.721764,0.00011355972,0.000040900926,0.0000013509764,0.000044586443,6.299807e-7,0.26064768,0.0002479691,0.0000054117654,0.016986525],"study_design_scores_gemma":[0.0012456964,0.00016351571,0.7723387,0.000045084595,0.000011756662,0.0000012505978,0.000019926518,0.000008267171,0.22605908,0.00001272881,0.0000222509,0.000071767245],"about_ca_topic_score_codex":0.000029799701,"about_ca_topic_score_gemma":0.00016794619,"teacher_disagreement_score":0.05057464,"about_ca_system_score_codex":0.000030743377,"about_ca_system_score_gemma":0.00007924126,"threshold_uncertainty_score":0.19949861},"labels":[],"label_agreement":null},{"id":"W2979535436","doi":"10.1182/blood.v104.11.1598.1598","title":"Regulation of SCL Expression by the Homeodomain Protein Otx-1 and the Erythroid Transcription Factor GATA-1.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Homeobox; Transcription factor; Chromatin immunoprecipitation; Biology; Haematopoiesis; Cell biology; Chromatin; Transcription (linguistics); Myeloid; GATA2; Molecular biology; Promoter; Stem cell; Cancer research; Gene; Genetics; Gene expression","score_opus":0.007008008872776574,"score_gpt":0.21041403381643436,"score_spread":0.20340602494365778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979535436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99002177,0.0046507493,0.004412993,0.0003482183,0.000025648373,0.00038436888,0.00002295096,0.000004606932,0.00012870677],"genre_scores_gemma":[0.99897736,0.00030304136,0.00044329625,0.000020932643,0.00006469998,0.00002627349,0.000057403737,0.000010011863,0.000096970245],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99939066,0.00008961573,0.00015619717,0.0001541078,0.00011958962,0.00008981436],"domain_scores_gemma":[0.99961674,0.000010951536,0.0000910172,0.00022161391,0.00003707493,0.000022628745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002112634,0.00008290019,0.000082279876,0.00001203879,0.0000953328,0.000016792534,0.00008503124,0.00008685005,0.000005378289],"category_scores_gemma":[0.0000388393,0.00004775786,0.000046811834,0.00004405601,0.00013688915,0.0000041169214,0.000024151093,0.00004904918,6.043797e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006204782,0.0000578446,0.00013468633,0.000010775426,0.000014080968,5.4434114e-8,0.00015299025,0.00002801507,0.99853367,0.00018772091,0.000015658357,0.0008024556],"study_design_scores_gemma":[0.0024855018,0.00011469498,0.004248096,0.000018818444,0.000022611452,0.0000013928197,0.0000423481,0.000006705684,0.98990744,0.001954622,0.0011330409,0.00006473065],"about_ca_topic_score_codex":0.000025191921,"about_ca_topic_score_gemma":0.000011143465,"teacher_disagreement_score":0.008955613,"about_ca_system_score_codex":0.0000031710422,"about_ca_system_score_gemma":0.000018039513,"threshold_uncertainty_score":0.19475092},"labels":[],"label_agreement":null},{"id":"W2979538470","doi":"10.1182/blood.v128.22.902.902","title":"Analysis of Efficacy By Age for Patients Aged 60-75 with Untreated Secondary Acute Myeloid Leukemia (AML) Treated with CPX-351 Liposome Injection Versus Conventional Cytarabine and Daunorubicin in a Phase III Trial","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cytarabine; Daunorubicin; Medicine; Internal medicine; Gastroenterology; Surgery; Leukemia","score_opus":0.012806519909864866,"score_gpt":0.2791860526841156,"score_spread":0.26637953277425075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979538470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99634606,0.00006171849,0.00015067436,0.00008721956,0.0000350115,0.0023910822,0.00074563257,0.00005919364,0.00012338832],"genre_scores_gemma":[0.99581444,0.000068129564,0.00028107275,0.000030258083,0.000068063295,0.00021174073,0.0024715716,0.00005399589,0.0010007367],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99754786,0.0001431802,0.00063416787,0.00065753434,0.00054373726,0.00047354196],"domain_scores_gemma":[0.9983167,0.00046102263,0.00030889647,0.00039882064,0.00027441132,0.0002401331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030959555,0.0003517239,0.0010331628,0.00091073004,0.00009187353,0.000024962977,0.00012862036,0.00020463187,0.00014382426],"category_scores_gemma":[0.00015564756,0.00022204654,0.00016182943,0.0014947674,0.000274714,0.0002160977,0.00004589058,0.00027699705,0.000002455103],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8059962,0.006522489,0.054165576,0.00012385921,0.01605111,0.00034712895,0.00041600614,0.000014973945,0.10788241,0.000010739679,0.00059860613,0.007870935],"study_design_scores_gemma":[0.87235373,0.02720472,0.06324855,0.00021863321,0.008844833,0.000023554909,0.00006640313,0.00025538087,0.027333552,0.0000027822346,0.00011434241,0.00033351238],"about_ca_topic_score_codex":0.0005777013,"about_ca_topic_score_gemma":0.0002612446,"teacher_disagreement_score":0.08054886,"about_ca_system_score_codex":0.0005140138,"about_ca_system_score_gemma":0.0004929714,"threshold_uncertainty_score":0.90547955},"labels":[],"label_agreement":null},{"id":"W2979544688","doi":"10.1182/blood.v124.21.3180.3180","title":"Comparison of the Impact of Two Different Definitions of Red-Cell Transfusion Dependence on the Natural History of Myeloproliferative Neoplasm (MPN)-Associated Myelofibrosis (MF)","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Leukemia & Lymphoma Society of Canada; Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Myelofibrosis; Natural history; Myeloproliferative neoplasm; Internal medicine; Essential thrombocythemia; Cohort; Red Cell; Gastroenterology; Polycythemia vera; Bone marrow","score_opus":0.03439543966203235,"score_gpt":0.2862136202716494,"score_spread":0.2518181806096171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979544688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943953,0.00048460352,0.000014978654,0.00030089988,0.0001283042,0.0007928373,0.00011771138,0.00001295714,0.0037523739],"genre_scores_gemma":[0.99943674,0.00019413292,0.00009777138,0.000041714615,0.000023921119,0.00006184342,0.000031106178,0.000021817295,0.000090985755],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997806,0.00037777878,0.00073437387,0.000261556,0.00059802807,0.00022227403],"domain_scores_gemma":[0.997261,0.001054951,0.0007337312,0.0005026576,0.00037154258,0.0000761155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023354944,0.00028804792,0.0009076804,0.0001035847,0.00008597497,0.0000034917066,0.00020097286,0.00011359881,0.00010748756],"category_scores_gemma":[0.00029218633,0.00014547756,0.00051997055,0.00021483829,0.00026963386,0.00003643011,0.000045834087,0.00031807477,0.0000018846562],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047294248,0.010599369,0.72753894,0.00016854335,0.000840577,0.0000012654609,0.00437685,0.00012168705,0.25225177,0.0026248319,0.0006394918,0.0003637229],"study_design_scores_gemma":[0.0041144397,0.0019926904,0.4723712,0.00047747922,0.0005648846,0.0000037046832,0.00013103311,0.00036659784,0.51968706,0.00018816836,0.0000071180716,0.00009563665],"about_ca_topic_score_codex":0.0004519926,"about_ca_topic_score_gemma":0.00028323202,"teacher_disagreement_score":0.26743525,"about_ca_system_score_codex":0.00021453461,"about_ca_system_score_gemma":0.0002707782,"threshold_uncertainty_score":0.5932403},"labels":[],"label_agreement":null},{"id":"W2979544794","doi":"10.1182/blood.v108.11.3662.3662","title":"Prior Rituximab Reduces Relapse and Improves Survival Following High Dose Chemotherapy and Stem Cell Transplantation for Relapsed Composite Low and Intermediate Grade (Including Transformed) Lymphoma.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Vancouver General Hospital","funders":"","keywords":"Medicine; Rituximab; Internal medicine; Transplantation; Autologous stem-cell transplantation; Chemotherapy; Lymphoma; Gastroenterology; Surgery","score_opus":0.00981939846412819,"score_gpt":0.23821807369363573,"score_spread":0.22839867522950755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979544794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994916,0.0031981796,0.00004835597,0.0004536527,0.00017138792,0.0010166453,0.0000555281,0.00006557606,0.00007466352],"genre_scores_gemma":[0.9959743,0.0021733271,0.0013294073,0.00007710325,0.000111882975,0.00011180429,0.00010041285,0.000042371812,0.00007937533],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987432,0.00003147231,0.00033779768,0.0004263748,0.00017210544,0.00028909819],"domain_scores_gemma":[0.99943274,0.00020205264,0.000093686795,0.000115205774,0.000024547127,0.0001317758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015513021,0.00027261482,0.0004806546,0.000094343886,0.0002054268,0.00007755449,0.00003980828,0.00012180019,9.637316e-7],"category_scores_gemma":[0.00000285336,0.00022532175,0.00010501806,0.00007304743,0.000078279416,0.00017189038,0.000010492384,0.00004990015,4.4771838e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037274358,0.008671103,0.10331385,0.0032794094,0.0011334295,0.0005070488,0.0075438884,0.000001119114,0.698672,0.00027931403,0.000052711537,0.1728187],"study_design_scores_gemma":[0.10396101,0.0010528775,0.4657935,0.0005647187,0.0015608931,0.00013284295,0.00027304742,0.000088614084,0.42593783,0.0001963425,0.00009268183,0.00034564472],"about_ca_topic_score_codex":0.00014630226,"about_ca_topic_score_gemma":0.000036235142,"teacher_disagreement_score":0.36247963,"about_ca_system_score_codex":0.00004541856,"about_ca_system_score_gemma":0.00004216108,"threshold_uncertainty_score":0.91883546},"labels":[],"label_agreement":null},{"id":"W2979546056","doi":"10.1182/blood.v114.22.394.394","title":"An RNA Interference Screen Identifies the Cell Fate Determinants Msi2 and Prox1 as Novel Regulators of Hematopoietic Stem Cell Self-Renewal.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Small hairpin RNA; Biology; RNA interference; Haematopoiesis; Stem cell; Hematopoietic stem cell; Cell biology; Genetics; RNA; Cancer research; Gene","score_opus":0.0086596314107407,"score_gpt":0.23675233834965198,"score_spread":0.2280927069389113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979546056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99746495,0.0011094717,0.00021313416,0.000034647423,0.000029838395,0.00017361612,0.00001717146,0.000010138229,0.00094703666],"genre_scores_gemma":[0.998834,0.00023377281,0.00021912616,0.00005783923,0.0000411958,0.000011716982,0.000006970139,0.00001068932,0.0005847013],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99927145,0.000028606748,0.00019503283,0.00026725847,0.00009218887,0.00014547104],"domain_scores_gemma":[0.9992767,0.000005061248,0.00012470117,0.00047164355,0.0000667937,0.000055128257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010559147,0.00012185566,0.00011780243,0.000023347042,0.00007579925,0.000039632527,0.00025497406,0.00008175189,0.0000043956607],"category_scores_gemma":[0.0000027292576,0.00009078619,0.000042451287,0.00005856401,0.00006387916,0.0000073119472,0.00004682425,0.000047641817,0.0000020636787],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001515338,0.00030697693,0.0007422663,0.00003103008,0.000014836104,8.387152e-7,0.0002738643,0.0000031624024,0.9965924,0.00004505634,0.00003361671,0.0019408069],"study_design_scores_gemma":[0.0005140384,0.0003467831,0.0035430167,0.000021588985,0.000059678787,0.000014551328,0.00026216469,0.00002882274,0.9948206,0.000099178425,0.00016709349,0.00012250264],"about_ca_topic_score_codex":0.000024405455,"about_ca_topic_score_gemma":0.00001649271,"teacher_disagreement_score":0.0028007505,"about_ca_system_score_codex":0.0000029768714,"about_ca_system_score_gemma":0.000045325916,"threshold_uncertainty_score":0.37021533},"labels":[],"label_agreement":null},{"id":"W2979547422","doi":"10.1182/blood.v114.22.1217.1217","title":"Second Autologous Stem Cell Transplant (ASCT) as Salvage Therapy in Patients with Relapsed Multiple Myeloma.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Melphalan; Salvage therapy; Multiple myeloma; Surgery; Regimen; Internal medicine; Etoposide; Transplantation; Cyclophosphamide; Median follow-up; Autologous stem-cell transplantation; Oncology; Chemotherapy","score_opus":0.01067422038702937,"score_gpt":0.23469763147845232,"score_spread":0.22402341109142296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979547422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940919,0.00035104202,0.0000043375435,0.00010956943,0.000027010212,0.00118771,0.000052482053,0.000087985594,0.004087923],"genre_scores_gemma":[0.9982116,0.000070951384,0.00033564074,0.00026261416,0.000026976544,0.000039051974,0.0001505816,0.000030347106,0.00087221],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830335,0.00007746709,0.00026309924,0.0003964088,0.0004331878,0.00052649266],"domain_scores_gemma":[0.9991551,0.00007864762,0.00006310428,0.00037957434,0.00006139187,0.00026218136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000092437,0.00025171012,0.00038141117,0.000169736,0.00006700326,0.000019521745,0.00011763665,0.0001263046,0.00019329178],"category_scores_gemma":[0.000009148572,0.00017544186,0.00007756828,0.0002133879,0.000040766816,0.00008591288,0.0000084616195,0.00027654707,0.00010287662],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042034835,0.007310264,0.95145845,0.00005045964,0.00018627677,0.0014592855,0.0009240061,0.0000016731427,0.003723427,0.000008091692,0.00007016218,0.030604439],"study_design_scores_gemma":[0.05442214,0.005345298,0.90876687,0.00008381626,0.000049491773,0.000030635892,0.000035365887,0.00002477765,0.030775245,0.000011608837,0.00027896406,0.00017579492],"about_ca_topic_score_codex":0.00004927539,"about_ca_topic_score_gemma":0.00008117196,"teacher_disagreement_score":0.050218657,"about_ca_system_score_codex":0.000051050727,"about_ca_system_score_gemma":0.00011410563,"threshold_uncertainty_score":0.71543115},"labels":[],"label_agreement":null},{"id":"W2979549320","doi":"10.1182/blood.v128.22.3032.3032","title":"Results of a Phase Ib Study of Venetoclax Plus R- or G-CHOP in Patients with B-Cell Non-Hodgkin Lymphoma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; CHOP; Internal medicine; Ven; Rituximab; Gastroenterology; Venetoclax; Lymphoma; Oncology; Leukemia; Chronic lymphocytic leukemia","score_opus":0.016160185981264712,"score_gpt":0.29477173776963367,"score_spread":0.27861155178836894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979549320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99756545,0.00003206049,0.000005176984,0.000014160012,0.000028709579,0.0014844544,0.000050657614,0.00001406824,0.0008052552],"genre_scores_gemma":[0.9988496,0.000011035359,0.00014725521,0.000011820011,0.000037190177,0.000048245343,0.000008619673,0.000033983222,0.0008522682],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9978425,0.00007323211,0.00058485445,0.00036540924,0.00078046473,0.00035357603],"domain_scores_gemma":[0.9984358,0.0002478453,0.00021106258,0.00073308026,0.00022827109,0.0001439678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030331034,0.0001715225,0.0005218667,0.00022600364,0.000016052456,0.0000038189264,0.00020146044,0.00008562627,0.000039761486],"category_scores_gemma":[0.00028634307,0.00009461709,0.000043720218,0.00044875752,0.00011057575,0.000060144994,0.00010674852,0.000066624045,0.000014862077],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4057294,0.24730515,0.17778899,0.0030533925,0.0021730938,0.0042024,0.026369661,0.000104454484,0.047128092,0.000012285169,0.0022775156,0.08385554],"study_design_scores_gemma":[0.89893544,0.019081462,0.041049626,0.00070679985,0.00019088162,0.000016814629,0.00039163168,0.00021837837,0.039149817,0.0000023384064,0.000097305594,0.00015948997],"about_ca_topic_score_codex":0.0017516855,"about_ca_topic_score_gemma":0.00031841313,"teacher_disagreement_score":0.49320602,"about_ca_system_score_codex":0.0037431966,"about_ca_system_score_gemma":0.0077329082,"threshold_uncertainty_score":0.9978923},"labels":[],"label_agreement":null},{"id":"W2979549500","doi":"10.1182/blood.v118.21.4224.4224","title":"Venous Thromboembolism: A United States Cost Model for a Preventable and Costly Adverse Event,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Pulmonary embolism; Emergency medicine; Deep vein; Total cost; Incidence (geometry); Venous thromboembolism; Intensive care medicine; Medical emergency; Thrombosis; Surgery","score_opus":0.042102717095900126,"score_gpt":0.27841605647037343,"score_spread":0.2363133393744733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979549500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988816,0.00053016434,0.004045363,0.00021551902,0.000101298356,0.0029191184,0.00012868499,0.00013762356,0.0031061855],"genre_scores_gemma":[0.9899307,0.0011682451,0.0053542377,0.0016495892,0.00007340494,0.00054686633,0.00021891714,0.000062875675,0.0009951795],"study_design_codex":"nonrandomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9987527,0.000022626195,0.00028388144,0.00034637944,0.00016841272,0.0004259891],"domain_scores_gemma":[0.99920684,0.000037486854,0.00010371116,0.00032483105,0.00010827547,0.00021884262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021393335,0.00021121721,0.0005418761,0.00015639908,0.0001308415,0.000014530209,0.00009937899,0.00008060515,0.000085714055],"category_scores_gemma":[0.000039715203,0.00019230822,0.000106338324,0.00016056573,0.000066045446,0.000103670216,0.00008794943,0.00009907705,0.000017913237],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054880744,0.27977723,0.07807237,0.015179958,0.025860785,0.0012650086,0.19063875,0.0068351803,0.012665955,0.09971456,0.23290789,0.05159424],"study_design_scores_gemma":[0.11186322,0.018426979,0.32822084,0.0030902599,0.03206269,0.0005890221,0.012203707,0.2981663,0.029731458,0.04142004,0.119766966,0.0044585],"about_ca_topic_score_codex":0.00032091906,"about_ca_topic_score_gemma":0.000059154485,"teacher_disagreement_score":0.29133114,"about_ca_system_score_codex":0.000030163494,"about_ca_system_score_gemma":0.00006913537,"threshold_uncertainty_score":0.78421015},"labels":[],"label_agreement":null},{"id":"W2979550461","doi":"10.1182/blood.v128.22.735.735","title":"Crebbp Mutations Disrupt Dynamic Enhancer Acetylation in B-Cells, Enabling HDAC3 to Drive Lymphomagenesis","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Enhancer; Biology; Diffuse large B-cell lymphoma; Cancer research; Lymphoma; Histone acetyltransferase; Molecular biology; Gene knockdown; Histone; Gene; Gene expression; Genetics; Immunology","score_opus":0.008501052353975032,"score_gpt":0.2647485629452033,"score_spread":0.2562475105912283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979550461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959332,0.00042976617,0.000464477,0.0018589201,0.000103814775,0.0004659698,0.0000248674,0.00005521708,0.0006637804],"genre_scores_gemma":[0.99687916,0.00024943473,0.0013548152,0.0003151534,0.000071510185,0.00021174343,0.0000239189,0.000023561093,0.00087071455],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989906,0.000026945534,0.00023510608,0.0003147929,0.00018248863,0.00025004934],"domain_scores_gemma":[0.9993306,0.000119149154,0.00005175258,0.00025666234,0.00010346301,0.00013838928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007165945,0.00014559938,0.00020935605,0.00017410578,0.000055678498,0.00001687798,0.000052868923,0.00006723139,0.00013033453],"category_scores_gemma":[0.00010576958,0.00009962675,0.00007629572,0.00026313856,0.000022278493,0.000092860355,0.00003213349,0.000017296417,0.00034825283],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013847991,0.005613854,0.16672263,0.00007572808,0.00033565334,0.0003337777,0.0018050416,0.00005411142,0.7184926,0.00016826112,0.0004545574,0.10580531],"study_design_scores_gemma":[0.012409606,0.00030166088,0.43366098,0.0004100032,0.00034561355,0.000031971198,0.00022023563,0.000071329334,0.551152,0.00009294749,0.0010710999,0.00023257901],"about_ca_topic_score_codex":0.000112564005,"about_ca_topic_score_gemma":0.00019517528,"teacher_disagreement_score":0.26693836,"about_ca_system_score_codex":0.0002909943,"about_ca_system_score_gemma":0.00010512945,"threshold_uncertainty_score":0.44762018},"labels":[],"label_agreement":null},{"id":"W2979554836","doi":"10.1182/blood.v108.11.3005.3005","title":"Favourable Overall Survival with Myeloablative Allogeneic Stem Cell Transplantation for Follicular Lymphoma.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Follicular lymphoma; Busulfan; Transplantation; Internal medicine; Cyclophosphamide; Rituximab; Surgery; Gastroenterology; Fludarabine; Alemtuzumab; Chemotherapy; Lymphoma","score_opus":0.009975011514347366,"score_gpt":0.21564022909604896,"score_spread":0.2056652175817016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979554836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919569,0.0007469585,0.0005880823,0.00014867474,0.00004553308,0.00081155315,0.0000763703,0.00005794511,0.005567979],"genre_scores_gemma":[0.9960225,0.000103073966,0.0017216033,0.00008769745,0.00010857508,0.00021249299,0.00026976774,0.000030174244,0.0014441041],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990437,0.00002364135,0.00017912337,0.00027934604,0.00021664197,0.00025754157],"domain_scores_gemma":[0.999523,0.000083161845,0.00007247136,0.0001690031,0.000077809214,0.00007454426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006534049,0.00018370201,0.00028175602,0.000046980662,0.00008633753,0.000021940497,0.000040909516,0.00007010182,0.000014367239],"category_scores_gemma":[0.0000010531131,0.00013158898,0.0001157596,0.0000805918,0.000020854071,0.00006247281,0.00000413116,0.000019568968,0.0000147224555],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030419966,0.018191155,0.91951823,0.0011545665,0.0021880881,0.001827976,0.0010651896,0.0006662582,0.034743387,0.006359544,0.001427097,0.009816517],"study_design_scores_gemma":[0.051437628,0.0015586622,0.53748727,0.00013514775,0.0023781904,0.00016974269,0.000106557745,0.000057874582,0.4028439,0.00019465016,0.0032989534,0.00033140497],"about_ca_topic_score_codex":0.0002996785,"about_ca_topic_score_gemma":0.00009221118,"teacher_disagreement_score":0.38203093,"about_ca_system_score_codex":0.00007081564,"about_ca_system_score_gemma":0.00010256613,"threshold_uncertainty_score":0.5366043},"labels":[],"label_agreement":null},{"id":"W2979559101","doi":"10.1182/blood.v118.21.3359.3359","title":"A Novel Polymer Based Antidote for Reversing the Anticoagulation Effect of Clinically Used Heparins,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Heparin; Pharmacology; Medicine; Antidote; Fondaparinux; Partial thromboplastin time; Platelet; Chemistry; Surgery; Immunology; Thrombosis; Internal medicine; Toxicity; Venous thromboembolism","score_opus":0.05991873752565248,"score_gpt":0.3479533794754216,"score_spread":0.28803464194976913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979559101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997204,0.00016049261,0.00061823055,0.0002675704,0.00013622467,0.0006365803,0.000014467012,0.000018805822,0.0009436085],"genre_scores_gemma":[0.9982464,0.000006773943,0.0012836297,0.00021461265,0.000100518664,0.000020318033,0.000018938837,0.000008756545,0.00010005229],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99947536,0.000034343273,0.00019671577,0.00011281262,0.00007261761,0.00010817811],"domain_scores_gemma":[0.9993605,0.00033175002,0.000100150675,0.0001422168,0.00003199051,0.00003340544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026360445,0.00007315505,0.00021131568,0.00003227294,0.000043875683,0.00000204668,0.000041359544,0.00005071464,0.000060633545],"category_scores_gemma":[0.00005077632,0.000046151938,0.00012313506,0.00006740057,0.00004806231,0.000019270954,0.000006598629,0.00004976452,0.000002487946],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038314646,0.0017254769,0.6074383,0.00019514479,0.00044491113,0.000005916969,0.00028010798,7.5843303e-7,0.38328716,0.00004355384,0.0002843512,0.002462844],"study_design_scores_gemma":[0.026401537,0.0035725292,0.17967102,0.00008457477,0.00257433,0.000015716196,0.000006018814,0.00042163001,0.7868286,0.0000068210375,0.00033990954,0.00007733135],"about_ca_topic_score_codex":0.000108691645,"about_ca_topic_score_gemma":0.0000094226725,"teacher_disagreement_score":0.4277673,"about_ca_system_score_codex":0.0000073215583,"about_ca_system_score_gemma":0.00004480644,"threshold_uncertainty_score":0.18820213},"labels":[],"label_agreement":null},{"id":"W2979559846","doi":"10.1182/blood.v108.11.4237.4237","title":"Expression of MTPG-24, a Peptide Derived from a Protein Regulating Dynamic Changes in Cortical Actin, Induces Endomitotic Replication in Megakaryocytic Cells.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Héma-Québec","funders":"","keywords":"Biology; Cytokinesis; Cell biology; Transfection; Cell cycle; Mitosis; Actin; Cell division; Molecular biology; Cell; Cell culture; Biochemistry; Genetics","score_opus":0.012250066642929037,"score_gpt":0.24524132667481705,"score_spread":0.232991260031888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979559846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984151,0.0003017953,0.000010375042,0.00016329488,0.000018667848,0.00083091226,0.000008011863,0.00002692472,0.00022491263],"genre_scores_gemma":[0.9975494,0.000017309787,0.0020803374,0.000015757061,0.000023419529,0.0001359753,0.000082654515,0.00001922773,0.00007590319],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988464,0.000069451184,0.00034659135,0.00034601433,0.00018057266,0.00021097202],"domain_scores_gemma":[0.99934965,0.000100583326,0.00016145696,0.0003213193,0.00002502736,0.00004197486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010450583,0.00014007292,0.00036938975,0.00014771994,0.000024543162,0.0000074378336,0.00005791938,0.00011184245,0.000014472248],"category_scores_gemma":[0.00013974907,0.00012189235,0.000039570084,0.00019366143,0.000033804932,0.00005676549,0.000031648564,0.00016625595,0.0000036966524],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020715062,0.0012653259,0.021510286,0.00005751237,0.00001811717,0.00015506524,0.00025028887,0.000009283652,0.97576505,0.000003984063,0.000003094953,0.00075482565],"study_design_scores_gemma":[0.007866092,0.00014113632,0.19658889,0.00064705225,0.00007116503,0.000014529938,0.00016033089,0.00054165703,0.7935579,0.0003181356,0.0000020370699,0.00009109961],"about_ca_topic_score_codex":0.001380792,"about_ca_topic_score_gemma":0.0014607274,"teacher_disagreement_score":0.1822072,"about_ca_system_score_codex":0.00006392427,"about_ca_system_score_gemma":0.000049498765,"threshold_uncertainty_score":0.4970626},"labels":[],"label_agreement":null},{"id":"W2979561552","doi":"10.1182/blood.v120.21.2190.2190","title":"Thrombocytopenia and Platelet Ultra-Structural Abnormalities Associated with RUNX1 Haploinsufficiency in Monosomy 21 Mosaicism.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"RUNX1; Haploinsufficiency; Platelet disorder; Monosomy; Chromosome 7 (human); Biology; Internal medicine; Medicine; Genetics; Platelet; Endocrinology; Cancer research; Karyotype; Phenotype; Gene; Transcription factor; Chromosome","score_opus":0.01706266976980778,"score_gpt":0.26184296200053875,"score_spread":0.24478029223073097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979561552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99288446,0.0008202813,0.0000039762717,0.00029180877,0.000048859794,0.00048857176,0.000026746882,0.00007879742,0.005356477],"genre_scores_gemma":[0.9985717,0.0000743978,0.00033210826,0.00020678737,0.00012815933,0.000030473357,0.00005585154,0.00003847985,0.0005620544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981488,0.00008302149,0.00028174472,0.00026635287,0.0004286851,0.0007913909],"domain_scores_gemma":[0.9991541,0.00015836842,0.000078233425,0.00026311414,0.00007814719,0.0002680213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036632412,0.00023231629,0.00046981897,0.00016547402,0.00010651526,0.000039696035,0.00013277624,0.0001594609,0.000100255376],"category_scores_gemma":[0.00021498972,0.00017205297,0.000037554422,0.00037207096,0.00021479408,0.0003365532,0.0000576765,0.0004962142,0.000021256466],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028918195,0.00073669065,0.97580695,0.000110511166,0.0002745857,0.00033690574,0.0059784343,0.000006193369,0.014681374,0.00070702896,0.00037217318,0.0006999967],"study_design_scores_gemma":[0.011714215,0.0006509747,0.9447357,0.00018160531,0.0001509418,0.00089123554,0.0012550943,0.00015357272,0.039397426,0.00007158528,0.00042500446,0.00037265205],"about_ca_topic_score_codex":0.00031015844,"about_ca_topic_score_gemma":0.00006474295,"teacher_disagreement_score":0.031071234,"about_ca_system_score_codex":0.00015758976,"about_ca_system_score_gemma":0.00019429663,"threshold_uncertainty_score":0.70161164},"labels":[],"label_agreement":null},{"id":"W2979564813","doi":"10.1182/blood.v128.22.1533.1533","title":"Hoxa9 and Meis1 Cooperatively Induce Addiction to Syk Signaling By Suppression of Mir-146a in Acute Myeloid Leukemia","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Syk; Myeloid leukemia; Hox gene; Biology; Cancer research; Leukemia; Cell biology; Downregulation and upregulation; Signal transduction; Transcriptome; Transcription factor; Context (archaeology); Tyrosine kinase; Gene expression; Immunology; Gene; Genetics","score_opus":0.007866881087451918,"score_gpt":0.25561431554759084,"score_spread":0.24774743446013892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979564813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988929,0.00048812045,0.00010489365,0.00012145984,0.000027985468,0.00018804934,0.00007365371,0.0000041981903,0.000098709475],"genre_scores_gemma":[0.999123,0.00015570148,0.00020000574,0.000029812807,0.000038450453,0.000031325482,0.000030946536,0.000014689057,0.00037609416],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99908483,0.00008756236,0.00019794877,0.00029715788,0.00013286424,0.00019961467],"domain_scores_gemma":[0.99964714,0.00002258081,0.000037896534,0.00015446426,0.00005936918,0.00007852966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001810295,0.0001024217,0.00014234104,0.00009136359,0.000026840904,0.0000074523373,0.00009703118,0.00014523578,0.0000149523075],"category_scores_gemma":[0.000114708484,0.00008090743,0.000021282776,0.00013118789,0.000054376884,0.0000071074546,0.00009766522,0.00008313912,0.0000053107156],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011110356,0.00008837276,0.0017429217,0.0000074125937,0.000020029396,0.0000048813085,0.00010502579,0.000004356477,0.99509937,0.0000021081898,0.0017548639,0.0010595702],"study_design_scores_gemma":[0.0016428769,0.0002686546,0.0021494871,0.00011241475,0.000007982909,0.0000058239434,0.000023982268,0.000004039712,0.9932323,0.0000019915824,0.0024433685,0.00010706595],"about_ca_topic_score_codex":0.000075661024,"about_ca_topic_score_gemma":0.00007302167,"teacher_disagreement_score":0.0018670424,"about_ca_system_score_codex":0.0000383038,"about_ca_system_score_gemma":0.000097488046,"threshold_uncertainty_score":0.32993093},"labels":[],"label_agreement":null},{"id":"W2979567485","doi":"10.1182/blood.v118.21.1246.1246","title":"Exploring the Impact of Clinical Anticoagulants on Venous Thrombosis Stability Using a Novel Intravital Murine Model","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Thrombus; Medicine; Thrombosis; Heparin; Femoral vein; Platelet; Embolization; Fondaparinux; Anticoagulant; Pulmonary embolism; Jugular vein; Pathology; Anesthesia; Surgery; Internal medicine; Venous thromboembolism","score_opus":0.5301225822800292,"score_gpt":0.41192857156392415,"score_spread":0.11819401071610502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979567485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974293,0.00002073802,0.00027931482,0.000030137317,0.0001311696,0.00051962247,0.000025603029,0.000035096473,0.0015290097],"genre_scores_gemma":[0.99748015,0.00012875686,0.0021374305,0.00006313447,0.0001352647,0.000020536087,0.000003482884,0.000028624467,0.0000026122223],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852085,0.00004485583,0.00055222283,0.00030374568,0.00027253883,0.0003057757],"domain_scores_gemma":[0.9989106,0.00008427582,0.0001709898,0.0006257175,0.000082105274,0.00012633526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000603346,0.00018316986,0.0007466633,0.00006529328,0.00007324293,0.000009028798,0.00015744248,0.000053296644,0.000072939685],"category_scores_gemma":[0.0001534307,0.00011421092,0.00033410246,0.00013702924,0.00012462436,0.000100332705,0.00011541794,0.00021181899,0.000006833958],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001201722,0.21935625,0.6640065,0.0007738941,0.007960858,0.00009560615,0.0182583,0.0023452525,0.0736411,0.0035432694,0.0001531452,0.00866414],"study_design_scores_gemma":[0.0024364607,0.0021647776,0.97840893,0.00017385934,0.00085532357,0.0000123589,0.0002395182,0.0036586258,0.011771338,0.00013462563,0.0000017434263,0.00014244461],"about_ca_topic_score_codex":0.00091882277,"about_ca_topic_score_gemma":0.000008039224,"teacher_disagreement_score":0.31440246,"about_ca_system_score_codex":0.000034058845,"about_ca_system_score_gemma":0.00011596278,"threshold_uncertainty_score":0.4657386},"labels":[],"label_agreement":null},{"id":"W2979567890","doi":"10.1182/blood.v104.11.1474.1474","title":"Activation of VEGFR-2 in Hematopoietic Progenitor Cells Leads to Accumulation of Myeloid Cells through Up-Regulation of GM-CSF.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Autocrine signalling; Paracrine signalling; Haematopoiesis; Bone marrow; Myeloid; Biology; Cancer research; Cell biology; Interleukin 3; Progenitor cell; Receptor; Immunology; Stem cell; T cell; Immune system; Antigen-presenting cell; Biochemistry","score_opus":0.02435765323606774,"score_gpt":0.2904237978669919,"score_spread":0.26606614463092415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979567890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972549,0.00018875481,0.002039257,0.000030502742,0.00007641025,0.00027889974,0.000014142795,0.0000033126653,0.00011383677],"genre_scores_gemma":[0.99750066,0.0000362412,0.0022491447,0.000024568553,0.00007801323,0.000016953863,0.000035584446,0.0000151307595,0.000043724653],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991827,0.000023174465,0.00034532137,0.00018872705,0.0001458926,0.0001141867],"domain_scores_gemma":[0.9994122,0.000008391842,0.00020446841,0.00022171575,0.00013050032,0.000022751772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000089777845,0.00010019142,0.0001764595,0.000053055926,0.000013598486,0.0000028797385,0.00009412727,0.00012990575,0.000011060668],"category_scores_gemma":[0.000016960745,0.00010114621,0.00008681817,0.00017772318,0.000035950816,0.00000932396,0.00003649421,0.000025415746,0.0000017845455],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006978203,0.00025307096,0.0045040264,0.00010232434,0.000024365392,8.995977e-8,0.0002271867,0.004320182,0.990131,0.000084469226,0.000024162813,0.0002593426],"study_design_scores_gemma":[0.0010020428,0.00022539732,0.012661631,0.00007322324,0.000027541522,6.9736086e-7,0.000048754802,0.00000945183,0.9856359,0.00009883918,0.000121904384,0.00009461103],"about_ca_topic_score_codex":0.00007078617,"about_ca_topic_score_gemma":0.00001783762,"teacher_disagreement_score":0.008157605,"about_ca_system_score_codex":0.000014457265,"about_ca_system_score_gemma":0.00007734906,"threshold_uncertainty_score":0.41246226},"labels":[],"label_agreement":null},{"id":"W2979575332","doi":"10.1182/blood.v122.21.424.424","title":"Shifting Paradigm In Physician Practice Patterns In The Application Of Thromboprophylaxis Guidelines: An Updated Analysis Of Venous Thromboembolism Prevention At a University-Affiliated Tertiary Care Center","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Venous thromboembolism; Antithrombotic; Tertiary care; Retrospective cohort study; Intensive care medicine; Emergency medicine; Cohort; Internal medicine; Thrombosis","score_opus":0.014760505362776295,"score_gpt":0.2898844425545792,"score_spread":0.2751239371918029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979575332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99738514,0.000117719086,0.0001250908,0.00044533203,0.000020196487,0.0013370645,0.00003772782,0.000022029319,0.0005096713],"genre_scores_gemma":[0.9982577,0.00010143013,0.00031827146,0.00039588782,0.000030073728,0.000034016124,0.00084026804,0.000016919106,0.000005423805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983301,0.00023502464,0.00054864964,0.00034291332,0.00031611256,0.00022715682],"domain_scores_gemma":[0.99873173,0.000048782294,0.00040005267,0.0005448037,0.00023038723,0.000044239525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028564685,0.0001636575,0.0006479894,0.00042855163,0.000048960803,0.000012128566,0.00023135179,0.000086874104,0.000043320848],"category_scores_gemma":[0.000030613577,0.00013663502,0.00014933833,0.0011827886,0.00004245189,0.0002733562,0.000082726445,0.00012882422,0.000007605596],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013847239,0.038898535,0.8742473,0.000787967,0.004526093,0.00007913383,0.0407745,0.0012052348,0.020157149,0.0007737181,0.00027503943,0.018136866],"study_design_scores_gemma":[0.0019168775,0.00037910245,0.9816202,0.00013495068,0.0025078643,0.0000022160355,0.010777034,0.0013150377,0.0009898116,0.000032309657,0.00019528775,0.00012929406],"about_ca_topic_score_codex":0.0062158927,"about_ca_topic_score_gemma":0.0024265032,"teacher_disagreement_score":0.107372925,"about_ca_system_score_codex":0.000092462884,"about_ca_system_score_gemma":0.000038110167,"threshold_uncertainty_score":0.9396612},"labels":[],"label_agreement":null},{"id":"W2979578945","doi":"10.1182/blood.v114.22.1310.1310","title":"Efficacy and Safety of Rituximab in Common Variable Immunodeficiency-Associated Immune Cytopenias: a Retrospective Analysis of 10 Cases.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Rituximab; Medicine; Hypogammaglobulinemia; Common variable immunodeficiency; Internal medicine; Splenectomy; Autoimmune hemolytic anemia; Retrospective cohort study; Anemia; Cytopenia; Immunology; Pediatrics; Antibody; Lymphoma","score_opus":0.005691778840497558,"score_gpt":0.2243311009463363,"score_spread":0.21863932210583872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979578945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9663063,0.030354215,0.000016882974,0.000030783172,0.00006045264,0.0002885069,0.000114108465,0.000032681877,0.0027960204],"genre_scores_gemma":[0.9991626,0.00032109878,0.000025181307,0.000022475851,5.555593e-7,0.0000058510486,0.00020924522,0.000010240684,0.00024273359],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99791247,0.00025526527,0.00096425373,0.00036110086,0.00007827731,0.00042865388],"domain_scores_gemma":[0.9986359,0.00025579904,0.00047094421,0.0004976933,0.00013313387,0.000006545699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073661766,0.00024262129,0.0012643883,0.0005181631,0.0001583261,0.000009866951,0.0003411237,0.000286586,0.00033625928],"category_scores_gemma":[0.00031777436,0.00023664183,0.00019957972,0.001988874,0.00031564318,0.00011194581,0.00009282442,0.00033260186,0.000010190364],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017594632,0.019720625,0.024269467,0.000035915054,0.0035004797,0.000021336684,0.0035341564,0.00026281667,0.93790007,0.004639573,0.000009686559,0.0043463875],"study_design_scores_gemma":[0.01999841,0.001005479,0.93716776,0.00014063329,0.0017801835,0.000024826426,0.000596898,0.00005601203,0.038445357,0.00030420112,0.00013272942,0.00034749287],"about_ca_topic_score_codex":0.0011083215,"about_ca_topic_score_gemma":0.00003351561,"teacher_disagreement_score":0.9128983,"about_ca_system_score_codex":0.000044312852,"about_ca_system_score_gemma":0.000078072284,"threshold_uncertainty_score":0.96499735},"labels":[],"label_agreement":null},{"id":"W2979588198","doi":"10.1182/blood.v104.11.915.915","title":"A Prospective Phase II Comparison of Stem Cell Source Using Rituximab, Ifosfamide, Carboplatin, Etoposide (RICE) RE—Induction, Then High Dose Fludarabine, Busulfan (FLUBU) and Autologous (ASCT) or Allogeneic (AlloSCT) Hematopoietic Blood Stem Cell Transplantation for Mantle Cell (MCL) and Relapsed Low-Grade B-Cell Non-Hodgkin’s Lymphoma (NHL).","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; University of Calgary","funders":"","keywords":"Medicine; Carboplatin; Internal medicine; Ifosfamide; Etoposide; Fludarabine; Busulfan; Surgery; Follicular lymphoma; Hematopoietic stem cell transplantation; Gastroenterology; Rituximab; Urology; Chemotherapy; Transplantation; Oncology; Lymphoma; Cyclophosphamide; Cisplatin","score_opus":0.015807966027398954,"score_gpt":0.26104568378791243,"score_spread":0.24523771776051348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979588198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99122596,0.0040575266,0.00045880693,0.00012406902,0.00015172148,0.0034043714,0.00022147018,0.00013300878,0.00022308399],"genre_scores_gemma":[0.9917077,0.0005764639,0.006653697,0.000070454,0.00010686061,0.00027493117,0.00012445217,0.00013365674,0.0003517747],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964055,0.00012119919,0.0011464497,0.0011217647,0.0005168952,0.0006881977],"domain_scores_gemma":[0.99782526,0.00026280616,0.00072214473,0.0005924012,0.00023223896,0.00036512653],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025474103,0.00074333814,0.001424377,0.00029689434,0.00047874294,0.00006855312,0.00017354391,0.00041499262,0.000009798209],"category_scores_gemma":[0.0000066922235,0.00062138395,0.0002406674,0.0003809089,0.00020395471,0.00019180539,0.00007418435,0.00019868987,0.0000043891205],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005930335,0.09432545,0.04053413,0.009960461,0.0013928612,0.0010467108,0.03905063,0.0010030668,0.80292207,0.00012698985,0.00009876985,0.0036085201],"study_design_scores_gemma":[0.12313147,0.006160713,0.012685451,0.0005232081,0.0057896385,0.00065730105,0.0029268176,0.0004996376,0.84690446,0.00008416823,0.000023790537,0.00061333325],"about_ca_topic_score_codex":0.00085043046,"about_ca_topic_score_gemma":0.00014427268,"teacher_disagreement_score":0.117201135,"about_ca_system_score_codex":0.00026979425,"about_ca_system_score_gemma":0.00044699156,"threshold_uncertainty_score":0.9996238},"labels":[],"label_agreement":null},{"id":"W2979589483","doi":"10.1182/blood.v114.22.451.451","title":"Extended Follow-up of the Multi-Center Multi-National Prospective Cohort Study That Derived the “Men Continue and HERDOO2” Clinical Decision Rule Which Identifies Low Risk Patients Who May Be Able to Discontinue Oral Anticoagulants (Oac) 5-7 Months After Treatment for Unprovoked Venous Thromboembolism (VTE).","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; Hôpital du Sacré-Cœur de Montréal; St. Joseph's Hospital; McGill University; University of Ottawa; Jewish General Hospital; McMaster University; London Health Sciences Centre; Capital District Health Authority; Ottawa Hospital","funders":"","keywords":"Medicine; Prospective cohort study; Cohort; Pediatrics; Cohort study; Internal medicine; Surgery","score_opus":0.02847783743795971,"score_gpt":0.3270855588920035,"score_spread":0.2986077214540438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979589483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98690045,0.00019182387,0.00014944134,0.00038145177,0.00046166705,0.011515147,0.00028599947,0.000035861267,0.00007818591],"genre_scores_gemma":[0.99674475,0.0002444371,0.0010702355,0.00033830033,0.00010188792,0.0010113142,0.000042666787,0.000046989986,0.00039940872],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99692243,0.00024671023,0.00077815866,0.00081147894,0.0007538136,0.00048737566],"domain_scores_gemma":[0.9979935,0.00023164818,0.00038954825,0.0006804639,0.00054075004,0.0001640383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084962585,0.00042125554,0.0013296837,0.0000932773,0.00035643126,0.00010292108,0.0002701862,0.0001297871,0.000013291512],"category_scores_gemma":[0.0004964543,0.00024386938,0.0003054651,0.00019232817,0.00013581339,0.00015893878,0.00021563805,0.0001799997,0.000005010777],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082783186,0.03821347,0.9510688,0.00003062637,0.0016187514,0.000008269179,0.0040789405,0.0000060511006,0.00010927272,0.000010353139,0.0007354961,0.003292116],"study_design_scores_gemma":[0.037127342,0.002394447,0.95469743,0.000249443,0.0019976078,0.0000025841764,0.0010211959,0.00018735006,0.0018690585,0.00011011532,0.000094532705,0.00024887218],"about_ca_topic_score_codex":0.00038369442,"about_ca_topic_score_gemma":0.0017159277,"teacher_disagreement_score":0.036299508,"about_ca_system_score_codex":0.00010515172,"about_ca_system_score_gemma":0.00009040039,"threshold_uncertainty_score":0.9944704},"labels":[],"label_agreement":null},{"id":"W2979591734","doi":"10.1182/blood.v124.21.737.737","title":"Granulocyte-Colony Stimulating Factor (G-CSF) in Secondary Prophylaxis for Advanced-Stage Hodgkin Lymphoma Treated with ABVD Chemotherapy: A Cost-Effectiveness Analysis","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Mount Sinai Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; ABVD; Febrile neutropenia; Granulocyte colony-stimulating factor; Chemotherapy regimen; Neutropenia; Internal medicine; Oncology; Intensive care medicine; Surgery; Chemotherapy","score_opus":0.015604238936121404,"score_gpt":0.2907261100996851,"score_spread":0.2751218711635637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979591734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928771,0.00007079874,0.0035028593,0.000041196443,0.000036976875,0.002547276,0.00008217639,0.000110399786,0.000731174],"genre_scores_gemma":[0.9973958,0.0000099155695,0.0007267533,0.00013966634,0.00007230646,0.0011603289,0.000069810914,0.00005535671,0.00037006472],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985741,0.000107876745,0.00027098253,0.0005041595,0.00018566656,0.00035726148],"domain_scores_gemma":[0.9990037,0.0002285349,0.00012969242,0.00036703367,0.00015441768,0.0001165905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019194932,0.0002658335,0.000687853,0.00033251176,0.000119164775,0.000041916115,0.00008020486,0.00011269245,0.00007521306],"category_scores_gemma":[0.00005929448,0.00021130039,0.00019750281,0.001035167,0.00004980216,0.00016833104,0.000014656987,0.00014123305,0.0000036790373],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024318376,0.001158252,0.8798344,0.00035268182,0.0011226615,0.00002837265,0.00020855406,0.0006721896,0.040371314,0.000030381421,0.0000029844616,0.07378638],"study_design_scores_gemma":[0.029491834,0.003033663,0.88062745,0.00012934506,0.0008883617,0.000017122464,0.000040634786,0.00046013368,0.08398179,0.000013632843,0.0010216526,0.0002943799],"about_ca_topic_score_codex":0.00029294365,"about_ca_topic_score_gemma":0.0006111321,"teacher_disagreement_score":0.073492,"about_ca_system_score_codex":0.00016798406,"about_ca_system_score_gemma":0.00014530576,"threshold_uncertainty_score":0.861658},"labels":[],"label_agreement":null},{"id":"W2979591768","doi":"10.1182/blood.v120.21.1545.1545","title":"Diagnostic Accuracy of a Defined Immunophenotypic and Molecular Genetic Approach for Peripheral T/NK-Cell Lymphomas: A North American PTCL Study Group Project","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Medical diagnosis; Peripheral T-cell lymphoma; CD30; Lymphoma; Not Otherwise Specified; CD5; Immunophenotyping; Diffuse large B-cell lymphoma; Pathology; Oncology; Internal medicine; T cell; Antigen; Immunology","score_opus":0.01284821034073624,"score_gpt":0.2514833486208536,"score_spread":0.23863513828011734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979591768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98986167,0.006378072,0.00018931838,0.000015303754,0.0000327502,0.0032583238,0.000029826579,0.000037948106,0.00019679412],"genre_scores_gemma":[0.9839388,0.00019799608,0.01401159,0.00009182536,0.000076938304,0.0015566426,0.00006577134,0.000047923004,0.000012499487],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985803,0.000074498006,0.0003427284,0.00034863717,0.00022875411,0.0004251346],"domain_scores_gemma":[0.9988505,0.00032211508,0.00019254517,0.0004172949,0.00006525346,0.00015224163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000996957,0.00027691392,0.0005491722,0.0000925509,0.00007329123,0.000020495065,0.00009304656,0.000037893067,0.0000047818216],"category_scores_gemma":[0.00021632205,0.00021713141,0.00013451597,0.0002656549,0.00009581132,0.00006152379,0.000070143826,0.00004705378,0.0000018610027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020334382,0.021881562,0.9680534,0.00028172298,0.00054845866,0.000034786673,0.00162256,0.0000024759536,0.0012701396,0.00002921859,0.00002430384,0.006048032],"study_design_scores_gemma":[0.017343909,0.0039356267,0.9728753,0.000029915154,0.0020163006,0.0000832856,0.0009076582,0.00005626062,0.0024508466,0.000004283183,0.00007241304,0.00022418264],"about_ca_topic_score_codex":0.00059205526,"about_ca_topic_score_gemma":0.000024211802,"teacher_disagreement_score":0.017945934,"about_ca_system_score_codex":0.00006088535,"about_ca_system_score_gemma":0.00010423401,"threshold_uncertainty_score":0.8854362},"labels":[],"label_agreement":null},{"id":"W2979592087","doi":"10.1182/blood.v116.21.1705.1705","title":"The Incidence and Prognostic Significance of 9p21 Abnormalities In Pediatric Acute Lymphoblastic Leukemia Patients – the IWK Experience","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cancer Care Nova Scotia; Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"CDKN2A; Multiplex ligation-dependent probe amplification; CDKN2B; Fluorescence in situ hybridization; Medicine; Oncology; Childhood leukemia; Leukemia; Internal medicine; Pathology; Biology; Lymphoblastic Leukemia; Chromosome; Cancer; Genetics","score_opus":0.007508996602252126,"score_gpt":0.25153867146168973,"score_spread":0.2440296748594376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979592087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981205,0.00029135315,0.000026245774,0.00015030164,0.00015552201,0.0007941716,0.000011539196,0.000023067605,0.00042731082],"genre_scores_gemma":[0.99871826,0.00040376783,0.00022573209,0.00009515796,0.00013870263,0.00021278438,0.0000036589925,0.000021580661,0.00018037038],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99798363,0.00008872128,0.00043885302,0.00031230567,0.0006979857,0.00047847859],"domain_scores_gemma":[0.9971198,0.001828789,0.00016088584,0.00052077003,0.0002296921,0.00014007054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046130666,0.00018698146,0.00025294078,0.000096244774,0.0001929745,0.000049857987,0.00043869377,0.00010648259,0.000014623604],"category_scores_gemma":[0.0021611983,0.00010458979,0.000045771783,0.00048218126,0.0007282932,0.00014219194,0.0002329333,0.00040646433,0.000011012752],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018982314,0.0002446351,0.99101347,0.00013745979,0.000044159246,0.00007289126,0.003140531,0.0000037536834,0.003879438,0.0002703519,0.00013539342,0.0008681114],"study_design_scores_gemma":[0.0045423503,0.0004147206,0.98537743,0.000074393516,0.00022407123,0.00015360636,0.0006491607,0.000672069,0.0074142665,0.00017437004,0.00013020127,0.00017337623],"about_ca_topic_score_codex":0.0002725151,"about_ca_topic_score_gemma":0.00014224096,"teacher_disagreement_score":0.005636038,"about_ca_system_score_codex":0.00012387255,"about_ca_system_score_gemma":0.0010632029,"threshold_uncertainty_score":0.42650476},"labels":[],"label_agreement":null},{"id":"W2979593281","doi":"10.1182/blood.v128.22.393.393","title":"Significantly Inferior Overall and Event Free Survival in Pediatric Oncology Patients with Symptomatic Venous Thrombotic Events As Compared to Those without Symptomatic Venous Thrombotic Events: A Population Based Study from Maritimes, Canada","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Central Venous Catheters and Hemodialysis","field":"Health Professions","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Izaak Walton Killam Health Centre","funders":"","keywords":"Medicine; Population; Pediatric oncology; Cohort; Incidence (geometry); Retrospective cohort study; Pediatrics; Internal medicine; Cancer; Emergency medicine","score_opus":0.017283875752643243,"score_gpt":0.29739423242430196,"score_spread":0.28011035667165873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979593281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940397,0.000067421504,0.00007434386,0.00030175957,0.0004823601,0.004600253,0.00030143867,0.00008458378,0.00004809776],"genre_scores_gemma":[0.99841684,0.000018354627,0.000378537,0.00039538599,0.00013535596,0.0003691304,0.0001606331,0.00009097541,0.00003477085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945867,0.001336756,0.0012472516,0.0008039118,0.00097144546,0.0010539409],"domain_scores_gemma":[0.99684966,0.0010418305,0.00060597155,0.00083655026,0.00018107248,0.00048494365],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005569649,0.00051894365,0.0014157243,0.00028981362,0.00047050373,0.000020112902,0.0004366524,0.00021153488,0.00019506837],"category_scores_gemma":[0.00032016027,0.0003898362,0.000086927044,0.00041243547,0.00002266546,0.0001729567,0.00022108876,0.00035948798,0.000049698276],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027063812,0.008892776,0.98683435,0.00020531863,0.00027088117,0.000039771174,0.0030048615,0.00009093109,0.000028102284,0.000007526444,0.000041353156,0.00031351377],"study_design_scores_gemma":[0.016214807,0.0024521064,0.97801244,0.0007282512,0.0010043875,0.0000011953767,0.0006259837,0.00011735183,0.000002749793,0.00032480166,0.000007137955,0.00050880725],"about_ca_topic_score_codex":0.27882978,"about_ca_topic_score_gemma":0.53188914,"teacher_disagreement_score":0.2530594,"about_ca_system_score_codex":0.0014214483,"about_ca_system_score_gemma":0.0017697962,"threshold_uncertainty_score":0.99985534},"labels":[],"label_agreement":null},{"id":"W2979595928","doi":"10.1182/blood.v122.21.2673.2673","title":"In Vitro Growth Inhibition, Target Modulation and Drug Synergy In Pediatric Leukemia By The Novel Proteasome Inhibitor Carfilzomib","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"","keywords":"Carfilzomib; Bortezomib; Proteasome inhibitor; Leukemia; Cancer research; Multiple myeloma; Pharmacology; Biology; Immunology; Medicine","score_opus":0.004526548124036907,"score_gpt":0.18740362476012687,"score_spread":0.18287707663608996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979595928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99759454,0.0008490026,0.00011437397,0.00043997852,0.00004683041,0.0006412854,0.000039045924,0.000009881618,0.00026503744],"genre_scores_gemma":[0.998077,0.00010467926,0.0004999404,0.0002679088,0.00033039838,0.00036185805,0.00013455201,0.000021035754,0.00020268108],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99899447,0.000075959324,0.00023937412,0.00032308596,0.00011703124,0.00025009827],"domain_scores_gemma":[0.99961597,0.000015540567,0.00007652425,0.0001736867,0.000057177844,0.000061094666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021217132,0.00015722321,0.00012713263,0.000069343034,0.000055658238,0.00003908958,0.0000952944,0.00013897436,0.000012115617],"category_scores_gemma":[0.00008222862,0.00012870382,0.00003297299,0.00017400071,0.00004379736,0.00001947501,0.000092587776,0.00014878434,0.000007853386],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021178785,0.0001394666,0.0054721013,0.000033768763,0.000006300769,0.0000015870833,0.00011275193,0.000011410815,0.9928423,0.000046005196,0.0012170465,0.00009604713],"study_design_scores_gemma":[0.0020276317,0.00005513309,0.008566759,0.000010085905,0.000009015581,0.0000145882,0.000040920542,0.00015565472,0.98774606,0.0006556811,0.00051476224,0.00020369909],"about_ca_topic_score_codex":0.00043903416,"about_ca_topic_score_gemma":0.00003835564,"teacher_disagreement_score":0.0050962656,"about_ca_system_score_codex":0.000022062348,"about_ca_system_score_gemma":0.000069078116,"threshold_uncertainty_score":0.5248389},"labels":[],"label_agreement":null},{"id":"W2979597473","doi":"10.1182/blood.v108.11.566.566","title":"Preliminary Results from the North American Acute Promyelocytic Leukemia (APL) Study C9710.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Cytarabine; Internal medicine; Acute promyelocytic leukemia; Adverse effect; Gastroenterology; Daunorubicin; Arsenic trioxide; Randomized controlled trial; Leukemia; Surgery; Retinoic acid; Chemistry","score_opus":0.005428539224334964,"score_gpt":0.21599046255655902,"score_spread":0.21056192333222404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979597473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971897,0.0004936608,0.000052675823,0.00009513555,0.00007477315,0.00043835308,0.000104728264,0.000035958805,0.0015150398],"genre_scores_gemma":[0.99696153,0.00008956243,0.00033330804,0.00013324,0.00073862314,0.00007445517,0.0006001502,0.000034669814,0.0010344682],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984443,0.00011078019,0.00033127016,0.00057447684,0.00022996825,0.0003091917],"domain_scores_gemma":[0.9988634,0.000047241563,0.00018389607,0.00077262317,0.00007761195,0.000055226326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013878378,0.00023438071,0.00019117125,0.000017527998,0.00017422315,0.00005429079,0.00051169505,0.00007185203,0.0000038559174],"category_scores_gemma":[0.00007985433,0.00016783395,0.00008949717,0.00020138282,0.00018431207,0.000004411685,0.00019773518,0.00016821513,0.000022328166],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041146176,0.004589596,0.68789047,0.000055612636,0.0022421612,0.00065114436,0.0017441146,0.00045433588,0.2608663,0.0000335941,0.027984058,0.009374016],"study_design_scores_gemma":[0.008864738,0.0057021137,0.57713366,0.000027520975,0.0011233997,0.0000848537,0.0010464888,0.00006710134,0.38752404,0.000120807796,0.017367044,0.0009382584],"about_ca_topic_score_codex":0.0008320184,"about_ca_topic_score_gemma":0.00047451173,"teacher_disagreement_score":0.12665772,"about_ca_system_score_codex":0.000026201875,"about_ca_system_score_gemma":0.00022984702,"threshold_uncertainty_score":0.68440694},"labels":[],"label_agreement":null},{"id":"W2979597750","doi":"10.1182/blood.v128.22.3394.3394","title":"Impact of ABO Incompatibility on Engraftment in Allogeneic Hematopoietic Stem Cell Transplantation","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Calgary Laboratory Services; University of Calgary; University of Saskatchewan; Saskatchewan Health Authority","funders":"","keywords":"Medicine; ABO blood group system; Fludarabine; Transplantation; Hematopoietic stem cell transplantation; Busulfan; Total body irradiation; Internal medicine; Cord blood; Population; Stem cell; Immunology; Surgery; Gastroenterology; Chemotherapy; Cyclophosphamide; Biology","score_opus":0.01698902325376063,"score_gpt":0.2753216153429757,"score_spread":0.2583325920892151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979597750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975674,0.00007307076,0.00038393514,0.00007490544,0.0000353098,0.0006143226,0.00005375595,0.00003437005,0.0011629387],"genre_scores_gemma":[0.9994912,0.00012344442,0.00023028825,0.00001824976,0.000017689257,0.000030897976,0.000017623292,0.000020476056,0.000050126848],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99856496,0.0000979444,0.00050338503,0.00029156645,0.00031425705,0.00022788208],"domain_scores_gemma":[0.99916464,0.00022710855,0.00011253797,0.00033514493,0.00005098755,0.0001095776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002575977,0.00017801454,0.00036791668,0.0001328119,0.000015353788,0.0000034328102,0.00007203413,0.000100480116,0.000113759656],"category_scores_gemma":[0.0000062184567,0.00011377705,0.00015042277,0.00017373344,0.00004110956,0.000046315283,0.000004499141,0.000077533216,0.00004668459],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045532433,0.0022786546,0.7007624,0.0008202998,0.000069991096,0.00009355153,0.0016302819,0.000016335423,0.29262522,0.00008350926,0.000005488495,0.0011589779],"study_design_scores_gemma":[0.006186828,0.0007100256,0.58426535,0.00051672343,0.00013412122,0.000058924732,0.000037695663,0.0000034697307,0.40794367,0.000049444614,0.0000013338575,0.00009240352],"about_ca_topic_score_codex":0.000060365506,"about_ca_topic_score_gemma":0.000029209335,"teacher_disagreement_score":0.116497025,"about_ca_system_score_codex":0.00010858615,"about_ca_system_score_gemma":0.00012295938,"threshold_uncertainty_score":0.46396935},"labels":[],"label_agreement":null},{"id":"W2979610811","doi":"10.1182/blood.v110.11.894.894","title":"Phase I Study Demonstrates Activity and Tolerability of Diphtheria Toxin Interleukin-3 Fusion Protein in Patients with AML and MDS.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute","funders":"","keywords":"Medicine; Diphtheria toxin; Internal medicine; Tolerability; Myeloid leukemia; Gastroenterology; Phases of clinical research; Oncology; Immunology; Toxicity; Adverse effect; Biology; Toxin","score_opus":0.006377029916629597,"score_gpt":0.22896477632954196,"score_spread":0.22258774641291237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979610811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987138,0.00015039978,0.00003946868,0.000007916397,0.000040481886,0.00096679584,0.000018792847,0.000015471094,0.000046892197],"genre_scores_gemma":[0.9997771,0.0000029973407,0.00015207822,0.0000062709064,0.000003209082,0.000016464617,0.0000060759257,0.000009182072,0.000026631255],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991237,0.00012386247,0.0002451349,0.0002671071,0.000034120672,0.00020610566],"domain_scores_gemma":[0.9995993,0.000045217785,0.00011241236,0.00018822581,0.000035619836,0.000019259176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039715433,0.00014603301,0.000282638,0.00007207492,0.000063425534,0.0000089910145,0.00007233583,0.000114823946,0.000041230334],"category_scores_gemma":[0.00003269478,0.00011148992,0.000016782293,0.00008931965,0.00014444349,0.00009505155,0.00008165141,0.00018081239,0.0000014186949],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012859156,0.009044378,0.23273143,0.000017422333,0.00006159532,0.000003085943,0.00070758123,2.2492802e-8,0.74153423,0.00002028601,5.089988e-7,0.014593564],"study_design_scores_gemma":[0.012980028,0.004512517,0.53372043,0.000037768452,0.000026429572,0.0000031603668,0.00040328252,3.229757e-7,0.4481711,0.00003313968,0.000011141956,0.00010070426],"about_ca_topic_score_codex":0.00018333772,"about_ca_topic_score_gemma":0.00030299128,"teacher_disagreement_score":0.30098897,"about_ca_system_score_codex":0.000010648818,"about_ca_system_score_gemma":0.000018252958,"threshold_uncertainty_score":0.45464268},"labels":[],"label_agreement":null},{"id":"W2979616184","doi":"10.1182/blood.v116.21.4223.4223","title":"Pediatric Infective Endocarditis Over the Last 30 Years: Thromboembolic Complications and Associations of Valve Vegetation and Heart Failure with Increased Mortality","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Infective Endocarditis Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Pediatric Oncology Group","funders":"","keywords":"Medicine; Infective endocarditis; Endocarditis; Heart failure; Etiology; Internal medicine; Stroke (engine); Surgery; Pediatrics; Cardiology","score_opus":0.010542691810585121,"score_gpt":0.26706832659056656,"score_spread":0.2565256347799814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979616184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99763006,0.00009242138,0.0000416659,0.00001418808,0.00003344233,0.00056766084,0.000056073815,0.000024510466,0.0015399919],"genre_scores_gemma":[0.9992036,0.00007084439,0.00024314407,0.00019778544,0.00012389418,0.000115187526,0.00003428019,0.000011205859,3.2503433e-8],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99935687,0.00005795144,0.00013060076,0.00017014593,0.00017449638,0.00010993489],"domain_scores_gemma":[0.99929464,0.00021443139,0.00010237437,0.00020355318,0.00013085404,0.000054161752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014622475,0.00009071686,0.00021025712,0.000065687454,0.00009589479,0.000023994226,0.000027275073,0.00004257979,0.000015253403],"category_scores_gemma":[0.00013540352,0.00006832312,0.00006117103,0.00015538117,0.00010589379,0.00007685666,0.000035966634,0.00016309578,0.0000042626493],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[1.2570655e-7,0.00027087663,0.9961077,0.000027962697,0.00030751617,0.0000013280938,0.00020697614,0.0000014911953,0.00066995557,0.0019828826,0.0003185528,0.00010462344],"study_design_scores_gemma":[0.0015865746,0.00011613405,0.9962107,0.000016161928,0.00095675024,0.000019326208,0.00005522552,0.0000054041034,0.00030066524,0.00023690607,0.00042600508,0.00007017915],"about_ca_topic_score_codex":0.0003553437,"about_ca_topic_score_gemma":0.0004322737,"teacher_disagreement_score":0.0017459766,"about_ca_system_score_codex":0.000011250166,"about_ca_system_score_gemma":0.00004204727,"threshold_uncertainty_score":0.2786136},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"agree"},{"id":"W2979619193","doi":"10.1182/blood.v122.21.4009.4009","title":"ENESTxtnd: Impact Of Nilotinib Dose Re-Escalation In Patients (pts) With Newly Diagnosed Chronic Myeloid Leukemia In Chronic Phase (CML-CP)","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Nilotinib; Medicine; Tolerability; Adverse effect; Internal medicine; Clinical endpoint; Clinical trial; Interim analysis; Imatinib; Oncology; Myeloid leukemia","score_opus":0.011478519877969141,"score_gpt":0.275172306118641,"score_spread":0.26369378624067186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979619193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958804,0.0007055686,0.0000067001574,0.000053603486,0.000055479883,0.0025529116,0.000028102826,0.00006735625,0.00064987334],"genre_scores_gemma":[0.9984326,0.00019085378,0.00029341012,0.000036816746,0.00016620621,0.00029715121,0.00035520483,0.00008779828,0.00014000542],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99703795,0.00011592196,0.0008647477,0.0006375342,0.00057012925,0.0007737042],"domain_scores_gemma":[0.9982535,0.00015904204,0.0003719092,0.00079404074,0.00014731975,0.00027415194],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019416187,0.00048589078,0.0008239873,0.0004653691,0.000039747785,0.00002482238,0.00019999394,0.0002498755,0.0008125711],"category_scores_gemma":[0.00013361381,0.0003846901,0.00017403142,0.000771578,0.00014972576,0.00038873585,0.000070922375,0.00042164157,0.00014246098],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010232744,0.006002946,0.94193816,0.0003719393,0.00042968366,0.00021227989,0.0008402486,0.0021290656,0.015037075,0.000009805639,0.00034979082,0.03165574],"study_design_scores_gemma":[0.1434639,0.00826276,0.8385464,0.0008634747,0.00022319228,0.000018274266,0.000044033393,0.0016281423,0.0065554813,0.000017483373,0.000044204524,0.00033268315],"about_ca_topic_score_codex":0.012536617,"about_ca_topic_score_gemma":0.0030257225,"teacher_disagreement_score":0.14244062,"about_ca_system_score_codex":0.013023279,"about_ca_system_score_gemma":0.004257669,"threshold_uncertainty_score":0.9998605},"labels":[],"label_agreement":null},{"id":"W2979622327","doi":"10.1182/blood.v106.11.3995.3995","title":"Rapid Assessment of Platelet Function Using Thromboelastography and Small Volumes of Citrated Whole Blood.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Thromboelastography; Platelet; Whole blood; Fibrin; Chemistry; Thrombelastography; Thrombin; Adenosine diphosphate; Epinephrine; Pharmacology; Thromboxane; Platelet activation; Internal medicine; Medicine; Immunology; Platelet aggregation","score_opus":0.01922880361818931,"score_gpt":0.2582089832609265,"score_spread":0.23898017964273718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979622327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964222,0.0020434135,0.00012148507,0.000038609327,0.000030396848,0.00023147964,0.000023277862,0.000022823893,0.0010663522],"genre_scores_gemma":[0.9950958,0.0002225712,0.004522591,0.00003890266,0.00002799961,0.000004135599,0.000038812515,0.000014670992,0.00003453596],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99925715,0.000020169118,0.00025419993,0.0001756716,0.00014202799,0.0001507992],"domain_scores_gemma":[0.9995645,0.000020317828,0.0001343957,0.00014794407,0.00007039275,0.00006240342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000076608514,0.00012713717,0.00036943692,0.00013743361,0.000036571233,0.000006168771,0.000028602395,0.000080582155,0.000053016174],"category_scores_gemma":[0.0000062239587,0.00011004013,0.00008065051,0.00019800215,0.000068626716,0.000059267557,0.00001645513,0.00007886691,9.921717e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022091025,0.009007038,0.46985728,0.0003896312,0.0042245495,0.00010674372,0.0003046117,0.000059612696,0.48916635,0.0001468414,0.00008140408,0.02643503],"study_design_scores_gemma":[0.036289956,0.004760843,0.76692814,0.00051458547,0.007094393,0.00050897483,0.00042103388,0.0024387103,0.17875391,0.0002379843,0.0016185334,0.0004329253],"about_ca_topic_score_codex":0.000065267384,"about_ca_topic_score_gemma":0.000023870665,"teacher_disagreement_score":0.31041244,"about_ca_system_score_codex":0.0000053381345,"about_ca_system_score_gemma":0.0000518087,"threshold_uncertainty_score":0.44873062},"labels":[],"label_agreement":null},{"id":"W2979622356","doi":"10.1182/blood.v118.21.1854.1854","title":"Efficacy of NK-92 Against Human Multiple Myeloma in a NOD/SCID Gamma Null Mouse Model","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Synthesis and Biological Evaluation","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Bioluminescence imaging; Bone marrow; Nod; In vivo; Pathology; Spleen; Immunohistochemistry; Cell culture; Medicine; Biology; Luciferase; Immunology; Cancer research; Transfection","score_opus":0.07184368393147553,"score_gpt":0.2628611447298157,"score_spread":0.19101746079834017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979622356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841554,0.000046710375,0.000016652137,0.000009565226,0.0000074036907,0.00008481543,0.000018555818,0.00004731197,0.015613551],"genre_scores_gemma":[0.99863136,0.000015810105,0.00096585456,0.000031213887,0.00004382926,0.000022040054,0.000024890636,0.000013422169,0.00025156018],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990658,0.000026394106,0.00031687485,0.0002451671,0.00015430813,0.00019143407],"domain_scores_gemma":[0.9994271,0.00007699158,0.00011913866,0.0002839904,0.00004197201,0.00005085167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018240714,0.00012591333,0.00020517479,0.00003787197,0.000034434303,0.000006575209,0.00020505667,0.00015934982,0.00034016123],"category_scores_gemma":[0.0002609547,0.000100377816,0.00009079363,0.00006222851,0.00005194131,0.00003683854,0.000057055782,0.000100250145,0.000022635435],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005682454,0.001501638,0.023212371,0.000033761127,0.000022023805,0.0000030600918,0.00036353164,0.00004267285,0.9724046,0.000057838293,0.000014154249,0.0022875275],"study_design_scores_gemma":[0.0024725806,0.000038204336,0.018287014,0.0000492024,0.0000234719,6.6527537e-7,0.000063758336,0.003818346,0.9748631,0.00020880927,0.00002091083,0.00015392913],"about_ca_topic_score_codex":0.000054464927,"about_ca_topic_score_gemma":0.000047409772,"teacher_disagreement_score":0.015361991,"about_ca_system_score_codex":0.000015399091,"about_ca_system_score_gemma":0.000019954805,"threshold_uncertainty_score":0.40932885},"labels":[],"label_agreement":null},{"id":"W2979624149","doi":"10.1182/blood.v128.22.249.249","title":"Clinical Characteristics and Quality of Life of Children with ITP Starting Second Line Treatments: Data from the ITP Consortium of North America ICON1 Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Taxation and Legal Issues","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; McMaster University; Children's Hospital of Eastern Ontario","funders":"","keywords":"Medicine; Quality of life (healthcare); Cohort; Prednisone; Pediatrics; Clinical trial; Observational study; Romiplostim; Internal medicine; Thrombopoietin","score_opus":0.07415975621224351,"score_gpt":0.31320394143384994,"score_spread":0.23904418522160642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979624149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99874586,0.000067286186,0.00003460271,0.00012296074,0.00003130195,0.00028342023,0.0005541106,0.00001455052,0.00014589602],"genre_scores_gemma":[0.99918664,0.00002064879,0.0001015575,0.0002285987,0.00025376637,0.000002927054,0.0001554413,0.000009901377,0.000040501705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987259,0.000059577236,0.00071481214,0.0002316532,0.00017446022,0.000093609684],"domain_scores_gemma":[0.9977198,0.0002860608,0.0013239804,0.000517316,0.0001382102,0.000014581694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035028378,0.00010975754,0.00040996648,0.000028814668,0.00003966683,0.000025658583,0.00024782802,0.00002227862,0.00016297822],"category_scores_gemma":[0.00064622774,0.000057706806,0.000029397428,0.000111535424,0.00017775346,0.00029603497,0.00020864721,0.00005452052,0.000005851718],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011141903,0.0011622747,0.99449545,0.000024234572,0.00042380072,4.132372e-7,0.00011964241,1.0657304e-7,0.00011116777,0.000023191926,0.00006635421,0.0034619623],"study_design_scores_gemma":[0.0028928602,0.00010503284,0.9954673,0.000035887966,0.00033079475,4.538844e-8,0.0003182028,0.000012230398,0.00006168214,0.0000053138815,0.00069164793,0.000078975165],"about_ca_topic_score_codex":0.0023594068,"about_ca_topic_score_gemma":0.0016846487,"teacher_disagreement_score":0.003382987,"about_ca_system_score_codex":0.0000013242635,"about_ca_system_score_gemma":0.000023756502,"threshold_uncertainty_score":0.3566733},"labels":[],"label_agreement":null},{"id":"W2979625562","doi":"10.1182/blood.v120.21.3925.3925","title":"Updated Interim Results of the Safety and Efficacy of Different Lenalidomide Starting Dose Regimens in Patients with Relapsed or Refractory (rel/ref) Chronic Lymphocytic Leukemia (CLL) (CC-5013-CLL-009 Study)","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"","keywords":"Bendamustine; Medicine; Tolerability; Lenalidomide; Regimen; Internal medicine; Chronic lymphocytic leukemia; Tumor lysis syndrome; Rituximab; Neutropenia; Phases of clinical research; Febrile neutropenia; Interim analysis; Clinical trial; Oncology; Pharmacology; Adverse effect; Leukemia; Chemotherapy; Lymphoma; Multiple myeloma","score_opus":0.018436055264159572,"score_gpt":0.2763225775722773,"score_spread":0.2578865223081177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979625562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99702096,0.00045114596,0.0000015205177,0.000039120336,0.000103237355,0.0020425315,0.000030426465,0.000050890434,0.00026018725],"genre_scores_gemma":[0.999263,0.000090388705,0.00005518298,0.000037957227,0.00008931262,0.00002660247,0.00004043622,0.00008138116,0.00031572836],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960523,0.00041844902,0.0012666106,0.0005191729,0.0009841751,0.000759288],"domain_scores_gemma":[0.99708307,0.0005634955,0.00065100106,0.0012240582,0.00021725017,0.0002611227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009052505,0.0003826175,0.00089844054,0.00023177853,0.00008722933,0.000014139882,0.00033187217,0.00017350818,0.00002272131],"category_scores_gemma":[0.0009891781,0.00021802107,0.0001010737,0.0005923275,0.00028522732,0.00016765304,0.00040834112,0.00046510942,0.000006011582],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.2994817,0.07826731,0.53955334,0.004025686,0.0053065736,0.00038389358,0.035308592,0.00039003964,0.021327818,0.00014941668,0.0012329774,0.014572677],"study_design_scores_gemma":[0.4815946,0.0042023426,0.49471617,0.0014477608,0.00057838863,0.000027059301,0.00056424766,0.00046527322,0.015953181,0.0000029041869,0.00015600634,0.00029208805],"about_ca_topic_score_codex":0.0011699947,"about_ca_topic_score_gemma":0.00043214552,"teacher_disagreement_score":0.1821129,"about_ca_system_score_codex":0.019498723,"about_ca_system_score_gemma":0.007227304,"threshold_uncertainty_score":0.9984008},"labels":[],"label_agreement":null},{"id":"W2979628842","doi":"10.1182/blood.v114.22.3392.3392","title":"Optimizing Patient Selection for Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Transplantation; Internal medicine; Stem cell; Hematopoietic stem cell transplantation; Busulfan; Imatinib mesylate; Myeloid leukemia; Imatinib; Oncology; Univariate analysis; Bone marrow; Cyclophosphamide; Surgery; Gastroenterology; Chemotherapy; Multivariate analysis","score_opus":0.012599521397272951,"score_gpt":0.24140445001694935,"score_spread":0.2288049286196764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979628842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956769,0.0013157565,0.00075463566,0.00007808608,0.00006103759,0.0011065956,0.000010680492,0.00008625123,0.000910085],"genre_scores_gemma":[0.99485534,0.00042373897,0.0039460273,0.00014960955,0.00013058595,0.000111792295,0.00011886229,0.000026078265,0.00023797298],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987762,0.000027821981,0.0003194719,0.0003379147,0.00018338776,0.00035522957],"domain_scores_gemma":[0.9995786,0.000040880048,0.000089168214,0.000159944,0.000044191554,0.00008724967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008733074,0.0001868869,0.00026326376,0.0001459301,0.00006073266,0.000012440919,0.000051319716,0.00013031124,0.00002080067],"category_scores_gemma":[0.0000041341546,0.00018110483,0.00009649298,0.00020243207,0.000010770631,0.00008271291,0.0000044783715,0.00014098537,0.000014273874],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012190093,0.0022412306,0.010378236,0.0010489946,0.00024337979,0.00021643532,0.0044263727,0.012037443,0.81324196,0.00008803199,0.0002391447,0.15461978],"study_design_scores_gemma":[0.033475157,0.004608311,0.02023995,0.0003668735,0.00074375386,0.00028256417,0.00014044005,0.0046167215,0.93414944,0.000044572265,0.00095063436,0.00038157112],"about_ca_topic_score_codex":0.000055770477,"about_ca_topic_score_gemma":0.00009556936,"teacher_disagreement_score":0.15423821,"about_ca_system_score_codex":0.0024651515,"about_ca_system_score_gemma":0.0007333068,"threshold_uncertainty_score":0.7385241},"labels":[],"label_agreement":null},{"id":"W2979629189","doi":"10.1182/blood.v116.21.2742.2742","title":"Results of An International Study of Quantitative BCR/ABL Assays Using Defined RNA Samples","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Advanced biosensing and bioanalysis techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Horizon Health Network; Centre hospitalier universitaire de Québec; BC Cancer Agency","funders":"","keywords":"Serial dilution; Housekeeping gene; RNA; Real-time polymerase chain reaction; Reverse transcriptase; Biology; Multiplex; RNA extraction; Reverse transcription polymerase chain reaction; Molecular biology; Medicine; Messenger RNA; Gene expression; Bioinformatics; Gene; Genetics; Pathology","score_opus":0.030112208365396395,"score_gpt":0.33192367592457506,"score_spread":0.30181146755917865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979629189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99896175,0.000013393884,0.00044736845,0.000009903248,0.000049416754,0.00008600794,0.000080155274,0.000010772866,0.00034124457],"genre_scores_gemma":[0.9369165,0.000011492414,0.06290435,0.0000075667454,0.000053124844,0.0000012531311,0.000083014274,0.0000081204025,0.000014595314],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99924237,0.000047567126,0.0002711462,0.00022517522,0.00012995116,0.000083821586],"domain_scores_gemma":[0.9992041,0.00001932372,0.00022283131,0.00030274127,0.00022373477,0.000027294733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002219452,0.00008903986,0.00014791565,0.00006217342,0.00002860291,0.0000066825396,0.00016040575,0.00008187928,9.410185e-7],"category_scores_gemma":[0.00029715258,0.00007667976,0.000054781478,0.000082119775,0.00007383687,0.000005420054,0.00006467003,0.00006736682,1.1234421e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012664586,0.0010226386,0.0026989335,0.0000030496337,0.00013811533,0.0000015295727,0.00006888765,0.000008935456,0.99524313,0.000068449524,0.0000061172473,0.000613562],"study_design_scores_gemma":[0.0010573228,0.00085781777,0.0034153035,0.000007879155,0.00008506682,0.0000056453014,0.00033228507,0.00009547577,0.99384856,0.00008197593,0.00012074081,0.000091909154],"about_ca_topic_score_codex":0.00014869103,"about_ca_topic_score_gemma":0.00039111325,"teacher_disagreement_score":0.06245698,"about_ca_system_score_codex":0.0000019043428,"about_ca_system_score_gemma":0.00002522315,"threshold_uncertainty_score":0.31269097},"labels":[],"label_agreement":null},{"id":"W2979635197","doi":"10.1182/blood.v116.21.484.484","title":"Plasma Fibronectin In Thrombosis and Hemostasis: Exploring the Fibrin Dependent and Independent Mechanisms","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Blood properties and coagulation","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; McMaster University Medical Centre; Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Von Willebrand factor; Platelet; Hemostasis; Thromboelastography; Knockout mouse; Fibrin; Thrombus; Intravital microscopy; Umbilical vein; Chemistry; Fibronectin; Internal medicine; Thrombosis; Von Willebrand disease; Bleeding time; Fibrinogen; Endocrinology; Andrology; Immunology; Medicine; Microcirculation; Receptor; Biochemistry; In vitro","score_opus":0.04150227589770018,"score_gpt":0.24885513045650043,"score_spread":0.20735285455880026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979635197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99786794,0.00019548244,0.000017474218,0.0012018502,0.00011444328,0.00028769244,0.0000017938632,0.000029450292,0.0002839],"genre_scores_gemma":[0.99883646,0.00014776921,0.00071660726,0.00010790487,0.000065045875,0.000052394094,0.0000019349993,0.00001602136,0.000055862853],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9992424,0.000023790535,0.00015941627,0.000219086,0.00018284094,0.00017245341],"domain_scores_gemma":[0.999637,0.00004268957,0.000034947436,0.00019469748,0.000019221066,0.0000714148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021516236,0.00011100627,0.00016094549,0.0000511975,0.000089097986,0.00004223323,0.00004774761,0.00006903283,0.000032788994],"category_scores_gemma":[0.000034556266,0.00007490847,0.000021170306,0.00007386569,0.000031242267,0.000105834224,0.000095224284,0.0002757553,0.0000040798523],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032772598,0.0009500198,0.26823664,0.00033487906,0.0003564215,0.00006034156,0.0062234667,0.000011709801,0.6264092,0.0050617876,0.00005666495,0.091971196],"study_design_scores_gemma":[0.0044055316,0.00036518177,0.67796385,0.0001285991,0.00024148036,0.00030323613,0.0017417193,0.0003098747,0.31317967,0.0009199261,0.00023848252,0.00020245044],"about_ca_topic_score_codex":0.00021774134,"about_ca_topic_score_gemma":0.00052117056,"teacher_disagreement_score":0.40972722,"about_ca_system_score_codex":0.0000063104712,"about_ca_system_score_gemma":0.000020357225,"threshold_uncertainty_score":0.3054679},"labels":[],"label_agreement":null},{"id":"W2979637103","doi":"10.1182/blood.v114.22.1110.1110","title":"Comprehensive Evaluation of Time-to-Response Parameter as a Predictor of Long-Term Outcomes Following Imatinib Therapy in Chronic Phase Chronic Myeloid Leukemia.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Imatinib; Oncology; Internal medicine; Hazard ratio; Surrogate endpoint; Guideline; Nilotinib; Myeloid leukemia; Dasatinib; Proportional hazards model; Imatinib mesylate; Confidence interval; Pathology","score_opus":0.037978300145872015,"score_gpt":0.35547855773314907,"score_spread":0.31750025758727707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979637103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99326617,0.0034123417,0.000015517462,0.00016396154,0.00006940308,0.0027986765,0.000032906057,0.00006013655,0.0001808891],"genre_scores_gemma":[0.99878865,0.00008754285,0.00036292482,0.0001789712,0.00007083235,0.00013899727,0.000093796625,0.00004521161,0.0002330679],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9966674,0.00037281634,0.0008937018,0.000501733,0.0010874339,0.0004769207],"domain_scores_gemma":[0.99793214,0.0004996138,0.00033271738,0.00080661924,0.00024880588,0.00018010555],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00075717,0.00039041459,0.0010578784,0.00040673386,0.000036158013,0.000011896628,0.00021505146,0.00018232435,0.0007254524],"category_scores_gemma":[0.00048659302,0.00033575614,0.00036563163,0.00043950952,0.00007257085,0.00013331637,0.00004428727,0.00022432618,0.00012466416],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004768404,0.004738786,0.06696575,0.00028256158,0.0019436595,0.00029104573,0.0017863468,0.0007602204,0.8072497,0.0000028967993,0.00007183993,0.11113875],"study_design_scores_gemma":[0.11816403,0.011212702,0.6812946,0.0010432651,0.0011766091,0.000058084774,0.000027686512,0.0025181624,0.1841048,0.000041417607,0.00003590216,0.00032269204],"about_ca_topic_score_codex":0.00006773777,"about_ca_topic_score_gemma":0.000012441376,"teacher_disagreement_score":0.6231449,"about_ca_system_score_codex":0.0034566522,"about_ca_system_score_gemma":0.0039722878,"threshold_uncertainty_score":0.99990946},"labels":[],"label_agreement":null},{"id":"W2979640471","doi":"10.1182/blood.v120.21.985.985","title":"Eculizumab (ECU) Safety and Efficacy in Atypical Hemolytic Uremic Syndrome (aHUS) Patients with Long Disease Duration and Chronic Kidney Disease (CKD): 2-Year Results","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Eculizumab; Atypical hemolytic uremic syndrome; Medicine; Thrombotic microangiopathy; Dialysis; Kidney disease; Internal medicine; Population; Renal function; Gastroenterology; End stage renal disease; Hemodialysis; Surgery; Complement system; Disease; Immunology; Antibody","score_opus":0.006024240597087886,"score_gpt":0.2125440736484064,"score_spread":0.20651983305131852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979640471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99452376,0.003573983,0.000008454049,0.00016818687,0.00014865116,0.0008935086,0.00058220996,0.000056485664,0.000044745437],"genre_scores_gemma":[0.99833614,0.000051438088,0.0000134612,0.000058727008,0.000037274214,0.000039357783,0.0013640283,0.00002341114,0.00007618862],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835396,0.00021579818,0.00045744207,0.00041924522,0.00008506013,0.00046848305],"domain_scores_gemma":[0.99898726,0.0001268777,0.00014451929,0.00037065908,0.000036261965,0.00033440988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015587425,0.00024142115,0.00027771076,0.00010570502,0.00014703837,0.000024124865,0.0001159996,0.00008667874,0.000115499446],"category_scores_gemma":[0.0003701397,0.00020566961,0.000041322623,0.00012037351,0.00017337725,0.00021443408,0.00013379198,0.00015517169,0.00007104225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061906404,0.002023108,0.99028933,0.0002076793,0.00014812748,0.000044953373,0.00014918066,0.0000032566732,0.00028302555,0.00015624597,0.00028086867,0.00022360857],"study_design_scores_gemma":[0.020636763,0.00022391317,0.97750944,0.00035508283,0.0002969517,0.000029687275,0.000018399614,0.0000049123914,0.00010309886,0.000010812869,0.0005492491,0.0002617092],"about_ca_topic_score_codex":0.000014806078,"about_ca_topic_score_gemma":0.00001795783,"teacher_disagreement_score":0.0144461235,"about_ca_system_score_codex":0.00008709533,"about_ca_system_score_gemma":0.00014512482,"threshold_uncertainty_score":0.8386963},"labels":[],"label_agreement":null},{"id":"W2979641343","doi":"10.1182/blood.v118.21.1.1","title":"Increased Incidence of Chronic Graft-Versus-Host Disease (GVHD) and No Survival Advantage with Filgrastim-Mobilized Peripheral Blood Stem Cells (PBSC) Compared to Bone Marrow (BM) Transplants From Unrelated Donors: Results of Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Protocol 0201, a Phase III, Prospective, Randomized Trial","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Internal medicine; Filgrastim; Transplantation; Graft-versus-host disease; Surgery; Interquartile range; Randomized controlled trial; Randomization; Gastroenterology; Granulocyte colony-stimulating factor; Chemotherapy","score_opus":0.044368342362323676,"score_gpt":0.32926961348592804,"score_spread":0.28490127112360436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979641343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89751065,0.00033992136,0.000584115,0.000019581903,0.00030650673,0.09838103,0.0024542285,0.0001231865,0.0002807722],"genre_scores_gemma":[0.9813933,0.00035533676,0.0032104722,0.000020659209,0.0003183629,0.014165756,0.0003747877,0.000107399064,0.00005394146],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9891835,0.0030711424,0.004495682,0.0014409632,0.001035389,0.0007733632],"domain_scores_gemma":[0.99086344,0.0050562383,0.0016804662,0.00084270415,0.00040021652,0.0011569238],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0058441856,0.0009089801,0.0050488194,0.00023160242,0.00013634408,0.000042322685,0.00030401908,0.00044097533,0.00027785217],"category_scores_gemma":[0.0005325093,0.00069603533,0.0005800485,0.0005026904,0.00078763877,0.00022594881,0.00004438714,0.0005754893,0.0000040847476],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92950064,0.0090093175,0.009720786,0.0015774075,0.003509347,0.00068813347,0.001974302,0.000010377327,0.04388007,0.000013584215,0.000019685898,0.00009634027],"study_design_scores_gemma":[0.90860826,0.010083051,0.003359901,0.0032073252,0.017874073,0.00008105869,0.00012671406,0.00044502385,0.055515073,0.00001785418,0.000007924685,0.00067375763],"about_ca_topic_score_codex":0.000858132,"about_ca_topic_score_gemma":0.0004669086,"teacher_disagreement_score":0.084215276,"about_ca_system_score_codex":0.00003727737,"about_ca_system_score_gemma":0.00076975854,"threshold_uncertainty_score":0.9995491},"labels":[],"label_agreement":null},{"id":"W2979642205","doi":"10.1182/blood.v124.21.899.899","title":"Targeting TKI-Insensitive CML Stem/Progenitor Cells By Effective Inhibition of a Novel PP2A-AHI-1-BCR-ABL-JAK2 Complex","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Beetle Biology and Toxicology Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Stem cell; Progenitor cell; Imatinib mesylate; Cancer research; Tyrosine kinase; Medicine; Biology; Imatinib; Cell biology; Signal transduction; Myeloid leukemia","score_opus":0.009288060313120095,"score_gpt":0.22404584832463803,"score_spread":0.21475778801151793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979642205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99676883,0.0006248055,0.00095488585,0.000066912675,0.00018616549,0.0003834664,0.00014891877,0.000020922676,0.00084506604],"genre_scores_gemma":[0.99820244,0.00004300731,0.0007551333,0.00030484863,0.00030006826,0.00005558214,0.00019667816,0.000021055266,0.00012118149],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99875736,0.00019026383,0.00025920232,0.00041882702,0.00008439509,0.00028995366],"domain_scores_gemma":[0.9993183,0.000088395675,0.00019007632,0.00020232888,0.00014281836,0.00005810757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002801739,0.00021637505,0.00031291437,0.00003289187,0.00015118787,0.0000058081087,0.00009264874,0.0003258127,0.000005677931],"category_scores_gemma":[0.00009007442,0.0002019641,0.00011204177,0.00006902565,0.0002999732,0.0000036229756,0.0001388341,0.00012501766,0.0000094196575],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009866479,0.00054528815,0.0025697674,0.0000323734,0.0003189087,0.0000020445932,0.00006423105,0.000003993769,0.99363565,0.00009134994,0.0023258775,0.0003118591],"study_design_scores_gemma":[0.0023446546,0.0008552938,0.0019617393,0.000016426064,0.00011457134,0.000012881229,0.00011888821,0.000036874866,0.99020267,0.000021842921,0.0040917248,0.00022243192],"about_ca_topic_score_codex":0.000013392468,"about_ca_topic_score_gemma":0.00001042053,"teacher_disagreement_score":0.0034329705,"about_ca_system_score_codex":0.000008257242,"about_ca_system_score_gemma":0.000022423596,"threshold_uncertainty_score":0.8235857},"labels":[],"label_agreement":null},{"id":"W2979642431","doi":"10.1182/blood.v128.22.2337.2337","title":"Reduced Costs and Length-of-Stay Associated with Rivaroxaban As Compared to Parenteral Bridging and Warfarin in Pulmonary Embolism Patients Managed in Observation Status","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Rivaroxaban; Warfarin; Pulmonary embolism; Dosing; Propensity score matching; Bridging (networking); Emergency medicine; Surgery; Internal medicine; Atrial fibrillation","score_opus":0.014829599366727628,"score_gpt":0.2440743012948218,"score_spread":0.22924470192809418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979642431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979513,0.00005329556,0.0000033006274,0.00046257535,0.000049062648,0.0009095739,0.000023941044,0.000024439945,0.0005224823],"genre_scores_gemma":[0.9993443,0.00012270112,0.00010710907,0.00020506696,0.000017335991,0.000050355993,0.00007369536,0.000022100083,0.000057367495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875474,0.000067568835,0.00031818476,0.00031607648,0.00022904052,0.00031438863],"domain_scores_gemma":[0.99945205,0.00006457845,0.00011358736,0.00016300674,0.00007858389,0.00012821733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016541043,0.00015809007,0.00043498896,0.00023112554,0.000034693676,0.00001877843,0.00005276815,0.000045236553,0.000007290791],"category_scores_gemma":[0.00016027935,0.00012178981,0.000017677505,0.00019126672,0.00004332326,0.00013476783,0.00008941612,0.00007854093,0.0000015689332],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015393268,0.0021734007,0.9849032,0.000051894123,0.00009152933,0.000031145177,0.0012335305,0.0000016975022,0.00074664096,0.000114968236,0.00007508228,0.010422957],"study_design_scores_gemma":[0.00864105,0.0003694928,0.98896796,0.00094163866,0.00010119876,0.0000010128956,0.000167006,0.00003370686,0.00048793468,0.000025242658,0.00011289136,0.00015089432],"about_ca_topic_score_codex":0.0010583518,"about_ca_topic_score_gemma":0.0006713987,"teacher_disagreement_score":0.010272062,"about_ca_system_score_codex":0.00010555909,"about_ca_system_score_gemma":0.000022705644,"threshold_uncertainty_score":0.49664444},"labels":[],"label_agreement":null},{"id":"W2979642774","doi":"10.1182/blood.v108.11.1618.1618","title":"Characterization of an Ideal Amphipathic Peptide as a Potential Hemostatic Agent.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Enzyme Production and Characterization","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Defence Research and Development Canada; McGill University","funders":"","keywords":"Factor X; Thrombin; Peptide; Factor IXa; Chemistry; Tissue factor; Coagulation; Factor IX; Phospholipid; Amphiphile; Biochemistry; Prothrombinase; Thromboplastin; Biophysics; Membrane; Platelet; Biology; Immunology; Internal medicine","score_opus":0.004813067674729908,"score_gpt":0.21568710191543006,"score_spread":0.21087403424070014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979642774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99777925,0.000034693312,0.0015980488,0.00011005378,0.00011095343,0.000110367386,0.000022081449,0.00001722432,0.0002173194],"genre_scores_gemma":[0.9964209,0.000028932067,0.00032945976,0.00014384212,0.0003593107,0.000009515392,0.0020417755,0.000017018734,0.00064919854],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993283,0.00004799319,0.00019458383,0.00021188709,0.000107233456,0.00010996167],"domain_scores_gemma":[0.9995684,9.006091e-7,0.00012110758,0.00019263173,0.00008220026,0.000034754587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000077690995,0.00008784536,0.00008199441,0.000035455356,0.000042379677,0.00001679507,0.000072129296,0.00007845016,0.00003666414],"category_scores_gemma":[0.000017992053,0.00009354523,0.000040342104,0.00006962025,0.000029633406,0.000008948624,0.000022927954,0.00003556269,0.000011164316],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029539577,0.00022202427,0.0006441012,0.000016621701,0.000013680015,0.0000026906432,0.000023771896,0.000015635065,0.99852836,0.00009145558,0.000026720554,0.00038541673],"study_design_scores_gemma":[0.0006164623,0.00018478127,0.021522904,0.000006245515,0.00003065643,0.000031369225,0.00001674767,0.000039676004,0.97551745,0.000075583346,0.0018518681,0.000106228355],"about_ca_topic_score_codex":0.000024412046,"about_ca_topic_score_gemma":0.000006775875,"teacher_disagreement_score":0.023010865,"about_ca_system_score_codex":0.0000026924592,"about_ca_system_score_gemma":0.000033409815,"threshold_uncertainty_score":0.3814664},"labels":[],"label_agreement":null},{"id":"W2979643211","doi":"10.1182/blood.v118.21.480.480","title":"Vantage 095: Vorinostat in Combination with Bortezomib in Salvage Multiple Myeloma Patients: Final Study Results of a Global Phase 2b Trial","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bortezomib; Multiple myeloma; Regimen; Vorinostat; Clinical endpoint; Internal medicine; Phases of clinical research; Dexamethasone; Oncology; Salvage therapy; Refractory (planetary science); Gastroenterology; Progressive disease; Clinical trial; Combination therapy; Pharmacology; Chemotherapy; Histone deacetylase","score_opus":0.04700091844040593,"score_gpt":0.3249367596965943,"score_spread":0.27793584125618837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979643211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952698,0.000021908616,0.0000055855076,0.000017834587,0.00005609995,0.003321963,0.00025140212,0.000023761777,0.0010316572],"genre_scores_gemma":[0.99904317,0.000006370274,0.00053237006,0.0000095642,0.000023649896,0.00013881558,0.00019638998,0.000015703527,0.000033953536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979316,0.0001751433,0.00057725166,0.00038379326,0.0005570137,0.00037517722],"domain_scores_gemma":[0.99909663,0.00009435432,0.00016381206,0.00035166988,0.00013739099,0.00015612665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031146285,0.00019810534,0.0004365274,0.00018558338,0.000029023806,0.000008618829,0.00011557139,0.000069031725,0.000020109734],"category_scores_gemma":[0.00047763548,0.00015463888,0.00005326604,0.00047180342,0.00005958033,0.0001357117,0.00005543583,0.00016974569,0.000007645923],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15676878,0.069078095,0.7672181,0.000030867253,0.00012841327,0.0009538707,0.0010439308,2.344739e-7,0.00004485064,0.00001115602,0.000011320944,0.0047103674],"study_design_scores_gemma":[0.42705017,0.015650423,0.5560226,0.00006559171,0.00006508053,0.000003981868,0.00026335995,0.000049425777,0.0007396867,0.000009183074,0.00000597984,0.00007454725],"about_ca_topic_score_codex":0.0024066549,"about_ca_topic_score_gemma":0.0036387397,"teacher_disagreement_score":0.27028137,"about_ca_system_score_codex":0.00010585367,"about_ca_system_score_gemma":0.00014979983,"threshold_uncertainty_score":0.6305991},"labels":[],"label_agreement":null},{"id":"W2979644514","doi":"10.1182/blood.v128.22.4207.4207","title":"Outcome of Bone Marrow Biopsy in Patients with Diffuse Large B-Cell Lymphoma Patients Staged by Combined 18 FGD-PET/CT Scan","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Medicine; Lymphoma; Biopsy; Concordance; Bone marrow; Stage (stratigraphy); Malignancy; Nuclear medicine; Radiology; PET-CT; Infiltration (HVAC); Positron emission tomography; Internal medicine","score_opus":0.0060974759857379485,"score_gpt":0.21043702477858464,"score_spread":0.2043395487928467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979644514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979272,0.00008925768,0.000001153359,0.00009306844,0.000073435454,0.00078092905,0.00051852525,0.00003889093,0.0004775339],"genre_scores_gemma":[0.9987758,0.000019262929,0.00012324209,0.00012985028,0.000010051309,0.0000698947,0.00021017694,0.000046181285,0.00061554153],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980936,0.000058363905,0.00053112203,0.0003835404,0.000499129,0.00043422365],"domain_scores_gemma":[0.9988485,0.0000782952,0.00024003413,0.0005022825,0.00012172778,0.00020913864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000099105615,0.00029030305,0.0006048803,0.00014912529,0.00004411797,0.00001050643,0.00009792449,0.00002766375,0.00011446149],"category_scores_gemma":[0.0000550953,0.00017063244,0.000103809754,0.00020383934,0.000064489504,0.000088818335,0.000065444794,0.000039491184,0.0000433449],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005468623,0.081556864,0.9159122,0.00007290408,0.00013005687,0.00021464506,0.000033903358,1.0264385e-8,0.00031138537,0.00001275623,0.00055761886,0.0006507724],"study_design_scores_gemma":[0.2166694,0.0016214488,0.76905304,0.00019104828,0.00020405265,0.0000070651804,0.000014094607,5.204775e-7,0.011884984,0.0000039186925,0.00017373532,0.00017672665],"about_ca_topic_score_codex":0.00017160726,"about_ca_topic_score_gemma":0.000029102148,"teacher_disagreement_score":0.21612254,"about_ca_system_score_codex":0.00017315595,"about_ca_system_score_gemma":0.000058756203,"threshold_uncertainty_score":0.6958189},"labels":[],"label_agreement":null},{"id":"W2979646671","doi":"10.1182/blood.v104.11.3829.3829","title":"The Effect of IVIG on Fcγ Receptor-Dependent Monocyte Phagocytosis and FcγR Gene Expression.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; McMaster University","funders":"","keywords":"Monocyte; Phagocytosis; CD14; Molecular biology; Peripheral blood mononuclear cell; Antibody; Receptor; CD163; Immunology; Chemistry; Whole blood; In vitro; Macrophage; Biology; Flow cytometry; Biochemistry","score_opus":0.013427729518557861,"score_gpt":0.28479421060518345,"score_spread":0.2713664810866256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979646671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935929,0.0028856832,0.000008016016,0.0009695516,0.00007647064,0.00035422674,0.000018469733,0.000020806317,0.002073882],"genre_scores_gemma":[0.9960961,0.0017844504,0.00028823887,0.00007726297,0.0001922046,0.000034478555,0.000008917083,0.000017314516,0.0015010791],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99878496,0.00007954019,0.00019454367,0.0002235882,0.00045503525,0.00026234853],"domain_scores_gemma":[0.999161,0.00031594187,0.000055520395,0.00026961733,0.000040649982,0.00015726882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030203434,0.00014844713,0.0002624384,0.000052103205,0.00016906811,0.00001678529,0.000119076605,0.00006807884,0.000050397924],"category_scores_gemma":[0.00010407105,0.00007844847,0.000095451636,0.00008514093,0.00013142554,0.000026316799,0.00009776315,0.00020829261,0.0000556088],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037698827,0.0005578718,0.037103385,0.0002922411,0.00035629774,0.00010689953,0.00024501566,0.000016342477,0.9338119,0.0003001322,0.0006999958,0.022740057],"study_design_scores_gemma":[0.004367574,0.0022201783,0.0077004083,0.00016864114,0.00007325665,0.00005909035,0.000019496709,0.0000029109733,0.98256034,0.000066117194,0.0026803834,0.00008160264],"about_ca_topic_score_codex":0.000089244495,"about_ca_topic_score_gemma":0.000005188653,"teacher_disagreement_score":0.04874846,"about_ca_system_score_codex":0.000020257829,"about_ca_system_score_gemma":0.000040484225,"threshold_uncertainty_score":0.31990358},"labels":[],"label_agreement":null},{"id":"W2979654752","doi":"10.1182/blood.v104.11.4047.4047","title":"Is Thrombophilia a Risk Factor for Peripheral Vein Infusion Thrombophlebitis?.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal General Hospital; Jewish General Hospital","funders":"","keywords":"Medicine; Thrombophilia; Surgery; Catheter; Thrombosis; Thrombophlebitis; Risk factor; Thrombus; Cohort; Vein; Internal medicine","score_opus":0.019548744273879048,"score_gpt":0.2786158818225016,"score_spread":0.25906713754862254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979654752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926679,0.0004933373,0.0005520938,0.001651198,0.00030071943,0.0014361539,0.00020709536,0.00016202265,0.0025294884],"genre_scores_gemma":[0.992285,0.00076179794,0.0039877268,0.0020091252,0.00043761166,0.00015188189,0.000029936558,0.000058427326,0.0002784533],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984697,0.000018031462,0.00031083924,0.00044357017,0.0003123575,0.00044551818],"domain_scores_gemma":[0.9991062,0.000031908836,0.00011906939,0.00045900745,0.00009991621,0.00018384003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011601805,0.0002545299,0.00056416,0.00008994204,0.00021536447,0.000046673722,0.00013223574,0.00013605093,0.000862996],"category_scores_gemma":[0.00007973185,0.00022062262,0.0002756376,0.00015526717,0.00006430418,0.000110606095,0.00008261797,0.00016911754,0.000098575045],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012773426,0.09841625,0.213574,0.0061481455,0.014368856,0.0009585629,0.07407778,0.00042751982,0.28697112,0.045925364,0.08028547,0.17756958],"study_design_scores_gemma":[0.021937367,0.0037774704,0.9030602,0.00041153713,0.0016954743,0.00004657229,0.0004057843,0.00003601953,0.03560837,0.006434704,0.025948916,0.00063760875],"about_ca_topic_score_codex":0.00024010704,"about_ca_topic_score_gemma":0.00005742545,"teacher_disagreement_score":0.68948615,"about_ca_system_score_codex":0.000085363434,"about_ca_system_score_gemma":0.00010567127,"threshold_uncertainty_score":0.94492006},"labels":[],"label_agreement":null},{"id":"W2979656437","doi":"10.1182/blood.v108.11.1377.1377","title":"ENMD-981693 Is an Orally-Active Kinase Inhibitor with Activity towards Human Hematologic Cancers In Vitro and In Vivo.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Kinase; Aurora inhibitor; Tyrosine kinase; Cancer research; Ponatinib; Chronic myelogenous leukemia; Pharmacology; Dasatinib; Biology; Imatinib; Leukemia; Apoptosis; Cell cycle; Cell biology; Immunology; Biochemistry; Myeloid leukemia; Signal transduction","score_opus":0.015070919677906807,"score_gpt":0.2672596203174913,"score_spread":0.2521887006395845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979656437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99700284,0.00018239036,0.0000016126085,0.00017611907,0.00002077923,0.00056683965,0.000037512964,0.000047427406,0.0019644995],"genre_scores_gemma":[0.99900496,0.000021451127,0.0004922545,0.000103795486,0.00007533472,0.00009377038,0.000022661849,0.000027798269,0.00015795777],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99870884,0.000053223604,0.00019369963,0.00046941088,0.00022036191,0.00035445997],"domain_scores_gemma":[0.9994575,0.000022971499,0.000085201114,0.0002884671,0.000030858675,0.00011502076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000080111,0.00024441752,0.00046434946,0.00016107644,0.000046349,0.000015892887,0.00006061723,0.00012967088,0.00007768887],"category_scores_gemma":[0.000013852898,0.00019897924,0.00003197301,0.00025176912,0.00010522318,0.00016845929,0.000039105395,0.00024223859,0.0000025560119],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00369085,0.006250698,0.2693642,0.0003076903,0.00022272747,0.004649604,0.0020868499,0.00001749447,0.70716196,0.00004184632,0.00020125472,0.0060048467],"study_design_scores_gemma":[0.018959649,0.0007304828,0.1640555,0.00017279455,0.00009607748,0.00016737556,0.00020789,0.00004894134,0.81513333,0.00007725613,0.000111349116,0.00023935536],"about_ca_topic_score_codex":0.017394478,"about_ca_topic_score_gemma":0.008874507,"teacher_disagreement_score":0.10797139,"about_ca_system_score_codex":0.0010505085,"about_ca_system_score_gemma":0.00045590225,"threshold_uncertainty_score":0.9891488},"labels":[],"label_agreement":null},{"id":"W2979656709","doi":"10.1182/blood.v120.21.2770.2770","title":"Longterm Serial Transplantability of BCR-ABL+ Chronic Phase CML Cells Is Predicted by a 6-Week LTC-IC Assay.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"CD34; Haematopoiesis; CD38; Molecular biology; Biology; Flow cytometry; Stem cell; Imatinib mesylate; Bone marrow; Stromal cell; Immunology; Cancer research; Imatinib; Myeloid leukemia; Cell biology","score_opus":0.01377356161243415,"score_gpt":0.26515686154616774,"score_spread":0.2513832999337336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979656709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936457,0.001866351,0.00008468681,0.000091629496,0.0003934861,0.0009833265,0.0017352392,0.00012126925,0.0010782777],"genre_scores_gemma":[0.9975678,0.00022276485,0.00027841338,0.000088472625,0.0006103293,0.000063711544,0.0005691174,0.00005439115,0.00054500275],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99766284,0.000117361444,0.0005855719,0.00043350653,0.00049388956,0.00070680986],"domain_scores_gemma":[0.9984978,0.00011977481,0.00018577519,0.00074407633,0.000069457325,0.000383134],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033668656,0.00034670264,0.00065190584,0.000077518474,0.000057389087,0.000010281407,0.0001737796,0.00025814513,0.0020663736],"category_scores_gemma":[0.000039195613,0.00030672978,0.00021885552,0.00019922043,0.00015439153,0.00017458503,0.000037858634,0.0002747048,0.00007697878],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015707497,0.03278675,0.04323414,0.0018089818,0.0016058211,0.00010115155,0.0031027207,7.080433e-7,0.90269387,0.000007968655,0.008936925,0.0041502034],"study_design_scores_gemma":[0.05205797,0.0024246247,0.0067814155,0.00027659148,0.002069782,0.00016978326,0.000043400138,0.00007008614,0.93244123,0.0000060778307,0.0033702827,0.00028877385],"about_ca_topic_score_codex":0.00025837292,"about_ca_topic_score_gemma":0.000022656675,"teacher_disagreement_score":0.05048722,"about_ca_system_score_codex":0.0005269377,"about_ca_system_score_gemma":0.0006002026,"threshold_uncertainty_score":0.9999385},"labels":[],"label_agreement":null},{"id":"W2979666356","doi":"10.1182/blood.v108.11.3360.3360","title":"Ferritin Levels, Compliance and Adverse Events Related to Infused Iron Chelation Therapy in a Cohort of Patients from Usual Care Setting in the United States.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Association of Radiation Oncology","funders":"","keywords":"Medicine; Adverse effect; Ferritin; Thalassemia; Cohort; Deferoxamine; Cohort study; Internal medicine; Pediatrics","score_opus":0.011617921011820435,"score_gpt":0.2500524594467379,"score_spread":0.23843453843491744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979666356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99837136,0.0003054744,0.00000261711,0.00021358025,0.000023123775,0.0007749866,0.000069769405,0.000014476786,0.00022459189],"genre_scores_gemma":[0.99866766,0.00008066038,0.00010922714,0.0002281164,0.0000066142543,0.000014486708,0.0008682625,0.000013012147,0.000011963598],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901974,0.00009451347,0.00034746487,0.00017715943,0.00019856945,0.00016254929],"domain_scores_gemma":[0.99962854,0.00005237279,0.00008521219,0.00013317553,0.00006811466,0.00003256984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013725272,0.00011140094,0.00018102831,0.00013563647,0.000033703745,0.0000030101166,0.000054253753,0.00011687179,0.000011186063],"category_scores_gemma":[0.000039518523,0.00008544448,0.000023859378,0.00042596803,0.000027466323,0.000038002905,0.00001732792,0.00020045998,0.0000022458053],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009895203,0.000482923,0.9926539,0.000029857583,0.000018933324,0.000010662323,0.004901758,0.00048026483,0.00039597906,0.0000051159177,0.00001540509,0.00090624974],"study_design_scores_gemma":[0.010492908,0.00019041666,0.985566,0.0003077432,0.000033519507,0.0000011703399,0.0025208574,0.0004053145,0.00023951201,0.00006165492,0.000091159716,0.0000897339],"about_ca_topic_score_codex":0.0036357385,"about_ca_topic_score_gemma":0.00026262554,"teacher_disagreement_score":0.010393957,"about_ca_system_score_codex":0.000035263998,"about_ca_system_score_gemma":0.000026566775,"threshold_uncertainty_score":0.5496173},"labels":[],"label_agreement":null},{"id":"W2979669101","doi":"10.1182/blood.v126.23.1045.1045","title":"Successful Treatment of Thrombocytopenia with Staphylococcal Protein A (PRTX-100) in a Murine Model of Immune Thrombocytopenia (ITP)","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Platelet; Immunology; Thrombocytopenic purpura; Immune system; Spleen; Autoantibody; Bone marrow; Internal medicine; Rituximab; Splenocyte; Platelet transfusion; Antibody; Gastroenterology","score_opus":0.03508722334931214,"score_gpt":0.27488850383603186,"score_spread":0.23980128048671973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979669101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948139,0.0009103259,0.000034080043,0.00013773849,0.0000116807205,0.0017434844,0.000058100257,0.000026801255,0.0022638945],"genre_scores_gemma":[0.99630356,0.000070336,0.0030377656,0.0000113333845,0.00001373607,0.00016880482,0.000049487866,0.00003812503,0.00030684457],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983739,0.00003876616,0.00053941086,0.0003417482,0.0003741567,0.00033198946],"domain_scores_gemma":[0.99894285,0.000017637658,0.00022057437,0.00049956475,0.00015556072,0.00016380807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011130214,0.00030041471,0.0012986866,0.00017219775,0.000021524922,0.000008361206,0.00012491673,0.000105842824,0.000037709986],"category_scores_gemma":[0.000018046198,0.00020476914,0.000119698976,0.0003329713,0.00012698038,0.00011878645,0.000046776313,0.000090652014,0.000008612854],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011645028,0.086912945,0.51684636,0.0010146522,0.0038522393,0.0036445402,0.00866528,0.001187524,0.3610596,0.00091847277,0.000049838283,0.0042035077],"study_design_scores_gemma":[0.14163707,0.024069076,0.07530437,0.0010393895,0.0015070823,0.0003059807,0.001261906,0.0027151913,0.75030345,0.001072792,0.00009471261,0.0006889989],"about_ca_topic_score_codex":0.001716429,"about_ca_topic_score_gemma":0.00052179093,"teacher_disagreement_score":0.441542,"about_ca_system_score_codex":0.000093681665,"about_ca_system_score_gemma":0.0004302091,"threshold_uncertainty_score":0.8350243},"labels":[],"label_agreement":null},{"id":"W2979669873","doi":"10.1182/blood.v124.21.1626.1626","title":"Characterization of the Microrna Expression Profiles of Paired Primary and Relapsed Diffuse Large B-Cell Lymphoma (DLBCL) By Next-Generation Sequencing","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"microRNA; Diffuse large B-cell lymphoma; Biology; Gene expression profiling; Deep sequencing; Lymphoma; Cancer research; Computational biology; Gene expression; Oncology; Gene; Genetics; Medicine; Immunology; Genome","score_opus":0.01168022921751322,"score_gpt":0.20404985547662838,"score_spread":0.19236962625911516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979669873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926151,0.00039377098,0.0064959717,0.000031338222,0.000050810057,0.0002770414,0.000054614888,0.0000058090604,0.00007554911],"genre_scores_gemma":[0.99880636,0.00018513367,0.00029492626,0.00007369461,0.000061554325,0.000020063233,0.00037386705,0.000021935728,0.00016246711],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991019,0.00015046909,0.0002027219,0.00023351141,0.00016561034,0.00014581415],"domain_scores_gemma":[0.99939287,0.000006633732,0.00017286348,0.00030770327,0.00008148398,0.000038445225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018654093,0.00010300963,0.0001215713,0.000027741846,0.0000666563,0.000013471681,0.00012987257,0.000155844,0.000002587186],"category_scores_gemma":[0.000056423803,0.00008388071,0.0000518669,0.00007331468,0.000044087563,0.00000697121,0.00013653065,0.00004883083,3.4961047e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003132562,0.000489074,0.000088551744,0.00007843297,0.000015880563,2.2168184e-7,0.000057044737,7.5127446e-7,0.9985454,0.000011066165,0.000074578915,0.00060763716],"study_design_scores_gemma":[0.004224994,0.00013898531,0.0003710536,0.000044452707,0.000025951995,0.000004040956,0.000014009511,0.00029347753,0.9940835,0.000004497967,0.00070724206,0.000087775035],"about_ca_topic_score_codex":0.0000086543005,"about_ca_topic_score_gemma":0.0000030767314,"teacher_disagreement_score":0.0062010456,"about_ca_system_score_codex":0.000013870275,"about_ca_system_score_gemma":0.000083898085,"threshold_uncertainty_score":0.34205562},"labels":[],"label_agreement":null},{"id":"W2979670769","doi":"10.1182/blood.v128.22.371.371","title":"Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells Via Transcription Factor Conversion of Hemogenic Endothelium","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Biology; Stem cell; Cell biology; Haematopoiesis; RUNX1; Immunology; Progenitor cell; Cellular differentiation","score_opus":0.01331571882822824,"score_gpt":0.22089977230346727,"score_spread":0.20758405347523903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979670769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99676716,0.0013189806,0.0008245042,0.000042314918,0.00015599292,0.0005252203,0.00030698517,0.000020187497,0.000038633847],"genre_scores_gemma":[0.9980839,0.000361452,0.000122054655,0.000016579525,0.00012285783,0.000023508082,0.000021965776,0.000040821236,0.0012068701],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982716,0.00013224567,0.00036784253,0.00054400205,0.0003325613,0.00035174427],"domain_scores_gemma":[0.99910617,0.000026908137,0.00013805517,0.00045232696,0.0000979178,0.00017862981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001238833,0.00023878807,0.00027183772,0.00006502103,0.00007747643,0.000018845021,0.00025905535,0.0002155455,0.000067221736],"category_scores_gemma":[0.000001942509,0.0001825734,0.00015685201,0.00005479157,0.00013717225,0.000010011976,0.00012318935,0.00007712764,0.000040855455],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000808656,0.00027487875,0.0014133645,0.00015582702,0.00014576668,0.000008862817,0.00008917843,3.7853934e-7,0.99698126,0.000002752711,0.000056525038,0.00079030875],"study_design_scores_gemma":[0.0028926034,0.0004184856,0.0004447856,0.000061287974,0.00007966537,0.000012581194,0.00006335752,0.000005114642,0.99445355,0.000011495346,0.0013300022,0.00022708862],"about_ca_topic_score_codex":0.00003075532,"about_ca_topic_score_gemma":0.0000066482357,"teacher_disagreement_score":0.0028117378,"about_ca_system_score_codex":0.000019684388,"about_ca_system_score_gemma":0.00004594942,"threshold_uncertainty_score":0.7445128},"labels":[],"label_agreement":null},{"id":"W2979671217","doi":"10.1182/blood.v114.22.2812.2812","title":"Correlation of Cytomorphology, Immunophenotyping, and Interphase Fluorescence in Situ Hybridization (FISH) in 381 Patients with MGUS and 310 Patients with Multiple Myeloma.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunophenotyping; Fluorescence in situ hybridization; Monoclonal gammopathy of undetermined significance; Multiple myeloma; Pathology; Medicine; Bone marrow; Flow cytometry; Internal medicine; Biology; Monoclonal; Immunology; Monoclonal antibody; Antibody","score_opus":0.005562170629835833,"score_gpt":0.22689641794004728,"score_spread":0.22133424731021145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979671217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988127,0.0000897871,0.00006349851,0.000034108492,0.000012059693,0.00087397057,0.000026889304,0.000013325294,0.00007366116],"genre_scores_gemma":[0.99855834,0.000027214432,0.0010152002,0.000039442493,0.0000055090045,0.000012718162,0.0003202169,0.000012886236,0.000008482963],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895793,0.00005292391,0.00025069717,0.00027800357,0.00023408944,0.0002263546],"domain_scores_gemma":[0.99943095,0.00005691773,0.00011117696,0.00016572989,0.00013793824,0.000097285825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007559471,0.0001523285,0.00026598742,0.00023045175,0.000033331366,0.000011558315,0.000042133743,0.00006145803,0.000005378003],"category_scores_gemma":[0.00015734,0.0001151479,0.0000112884345,0.00023835954,0.00010380075,0.00016089025,0.000027193011,0.00014342995,0.0000011811926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027293013,0.0024679487,0.9826588,0.000038508537,0.000036870948,0.000055571985,0.00037979873,0.0000053231024,0.0012714993,0.0000038544417,0.0000039656766,0.010348545],"study_design_scores_gemma":[0.035487577,0.002438836,0.9589352,0.00034333076,0.00004577957,0.000009221879,0.00003727467,0.00035972972,0.002230982,0.000007187923,0.000001957742,0.000102942766],"about_ca_topic_score_codex":0.00016073472,"about_ca_topic_score_gemma":0.00029290302,"teacher_disagreement_score":0.032758273,"about_ca_system_score_codex":0.00004299403,"about_ca_system_score_gemma":0.000041199724,"threshold_uncertainty_score":0.46955952},"labels":[],"label_agreement":null},{"id":"W2979673767","doi":"10.1182/blood.v116.21.783.783","title":"Cancer-Specific Nuclear Positioning of Translocation Prone Gene Loci In Non-Malignant B-Cells From Patients with Multiple Myeloma","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of Alberta","funders":"","keywords":"Chromosomal translocation; CD19; Biology; Molecular biology; CD34; Multiple myeloma; Cancer research; Immunoglobulin heavy chain; Antibody; Stem cell; Gene; Immunology; Genetics; Flow cytometry","score_opus":0.008865589308113335,"score_gpt":0.2335077814258115,"score_spread":0.22464219211769815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979673767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985458,0.00013159975,0.00004365508,0.00007775247,0.000044266188,0.00088285375,0.00014703938,0.000020286394,0.0001067441],"genre_scores_gemma":[0.9942225,0.00007184513,0.00521494,0.000020282672,0.00006490218,0.0000686902,0.00028709185,0.000033059005,0.000016655842],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988497,0.000023308896,0.00024354314,0.00027940102,0.00034857512,0.00025549828],"domain_scores_gemma":[0.99928707,0.00003930255,0.000083163446,0.0002697419,0.00018167587,0.00013903934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005980677,0.00013900855,0.00025430194,0.00010852748,0.000053494976,0.000012625586,0.0000791939,0.00008217181,0.00014556773],"category_scores_gemma":[0.000017387058,0.00010920965,0.00004129049,0.00018021064,0.00006634753,0.00008134917,0.000015103912,0.00019354488,0.00001923598],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006753954,0.0027184978,0.3995337,0.00003804244,0.00013508933,0.00004541425,0.0005713978,0.0000066351918,0.5833818,0.0000032902901,0.000014891298,0.012875873],"study_design_scores_gemma":[0.013893994,0.0003332278,0.62491953,0.00015348381,0.00004741111,0.0000019047013,0.000036845744,0.00022856757,0.36025903,0.0000036918698,0.00004063691,0.00008167233],"about_ca_topic_score_codex":0.0015599942,"about_ca_topic_score_gemma":0.0010022902,"teacher_disagreement_score":0.22538583,"about_ca_system_score_codex":0.00003589953,"about_ca_system_score_gemma":0.0000694333,"threshold_uncertainty_score":0.44534403},"labels":[],"label_agreement":null},{"id":"W2979674793","doi":"10.1182/blood.v124.21.511.511","title":"Malignant Reprogramming of Progenitors into Leukemia Stem Cells Is Enhanced By Upregulation of CD44 Transcript Variant 3 in Malignant Microenvironments","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; CD44; Cancer research; Myeloid leukemia; Progenitor cell; Reprogramming; Molecular biology; Haematopoiesis; Stem cell; Cancer stem cell; Cell biology; Genetics; Gene; Cell","score_opus":0.005831550880350832,"score_gpt":0.2150537243177319,"score_spread":0.20922217343738106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979674793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99765754,0.00024785864,0.0015772817,0.000010784844,0.000040432835,0.00039831427,0.000023576184,0.0000051196835,0.00003909169],"genre_scores_gemma":[0.9983288,0.00004637262,0.0013349043,0.000010003028,0.000027368633,0.000033411285,0.00004220322,0.000029570481,0.00014735208],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984247,0.00012468353,0.00045603633,0.00044506224,0.00025114973,0.00029837165],"domain_scores_gemma":[0.99926716,0.000011499777,0.00016771212,0.0004436318,0.00003949298,0.00007051123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029869395,0.0001659332,0.0002350871,0.00006374111,0.000024300647,0.000009119133,0.00022897933,0.00017477569,0.000011837153],"category_scores_gemma":[0.0000113583055,0.0001604786,0.00009620683,0.0001070956,0.000097906006,0.0000065658733,0.00007987131,0.00007647767,0.0000031631762],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000085492306,0.00023303223,0.0041400823,0.00016210174,0.00006253181,0.0000016000604,0.00028671324,0.000024699992,0.99261785,0.00000598673,0.00004181537,0.002338087],"study_design_scores_gemma":[0.0013449765,0.000486418,0.0009830853,0.00008731538,0.000026520667,0.0000034364157,0.000064648724,0.00003669849,0.99609387,0.000015837919,0.00070834096,0.00014882759],"about_ca_topic_score_codex":0.0001543904,"about_ca_topic_score_gemma":0.000016888182,"teacher_disagreement_score":0.0034760372,"about_ca_system_score_codex":0.000037292182,"about_ca_system_score_gemma":0.000062856605,"threshold_uncertainty_score":0.6544127},"labels":[],"label_agreement":null},{"id":"W2979675032","doi":"10.1182/blood.v116.21.2005.2005","title":"Concurrent BCL2 and MYC Protein Expression by Immunohistochemistry Determines Clinical Outcome In DLBCL Patients Treated with R-CHOP","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Immunohistochemistry; Diffuse large B-cell lymphoma; Germinal center; Fluorescence in situ hybridization; Vincristine; clone (Java method); Lymphoma; CHOP; Immunophenotyping; Pathology; Biology; Medicine; Cancer research; Internal medicine; Molecular biology; Antibody; Cyclophosphamide; Immunology; B cell; Flow cytometry; Gene; Chemotherapy","score_opus":0.01285526685516439,"score_gpt":0.30258160713388976,"score_spread":0.28972634027872535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979675032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998719,0.00024869578,3.3380834e-7,0.00006937978,0.00005068372,0.000614756,0.000022559789,0.000028854052,0.00024573843],"genre_scores_gemma":[0.9992537,0.000018175308,0.00014909204,0.000046328907,0.00004789897,0.00018846491,0.000075381,0.000016679554,0.00020430869],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897414,0.000022138773,0.00036256152,0.0003065677,0.00015946572,0.00017509334],"domain_scores_gemma":[0.99939257,0.00004966037,0.00010856993,0.00025346628,0.000049256334,0.00014650171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000069561545,0.00017514994,0.00033032757,0.0000282041,0.000035356148,0.000014528389,0.000049428792,0.00013150866,0.000026270833],"category_scores_gemma":[0.00007399056,0.00011266408,0.000049196547,0.000051248506,0.000086540196,0.00003975067,0.000036600057,0.00016593123,0.000006265364],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008740628,0.0052244593,0.9306162,0.000042696716,0.00003388076,0.000054441007,0.000025977171,2.7441531e-9,0.057399936,6.873504e-7,0.00014109336,0.0063732457],"study_design_scores_gemma":[0.02852502,0.00068296184,0.8209773,0.00023784583,0.00013629034,0.000023701192,0.000008571933,0.0000025656198,0.14867775,0.0000010001777,0.0005853345,0.00014168267],"about_ca_topic_score_codex":0.00005433037,"about_ca_topic_score_gemma":0.000005285074,"teacher_disagreement_score":0.10963891,"about_ca_system_score_codex":0.000022874754,"about_ca_system_score_gemma":0.000034705638,"threshold_uncertainty_score":0.45943078},"labels":[],"label_agreement":null},{"id":"W2979675472","doi":"10.1182/blood.v104.11.2810.2810","title":"Proteasome Inhibiters Up-Regulate TRAIL/Apo2L and Its Receptors Significantly Contributing to Proteasome Inhibitor-Induced Apoptosis in Primary Chronic Lymphocytic Leukemia (CLL) Cells.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Proteasome; Apoptosis; Proteasome inhibitor; Chronic lymphocytic leukemia; Bortezomib; Cancer research; Annexin; Annexin A5; Receptor; Caspase 8; Biology; Leukemia; Caspase; Immunology; Programmed cell death; Multiple myeloma; Cell biology; Biochemistry","score_opus":0.010308004772972935,"score_gpt":0.2147806984326608,"score_spread":0.20447269365968784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979675472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99510396,0.0010548548,0.00004393971,0.0001309791,0.0002545587,0.0030236784,0.00006522099,0.00008059658,0.00024223124],"genre_scores_gemma":[0.99763244,0.000104939885,0.00044012262,0.0003209462,0.00044331292,0.00063192466,0.00010841376,0.000091411464,0.00022649573],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966844,0.00016038795,0.00063058885,0.001047369,0.00033843823,0.001138832],"domain_scores_gemma":[0.99880403,0.000022092414,0.0002145784,0.0004430898,0.000116695075,0.00039949222],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006755156,0.0005243785,0.00050944445,0.00020790938,0.00021367095,0.00009704645,0.00032467386,0.00045853842,0.000015373722],"category_scores_gemma":[0.00016369927,0.00054302946,0.00014408171,0.00043294654,0.000078051846,0.000028129109,0.00033264968,0.00031684706,0.000042374224],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019266878,0.00010332946,0.0002056325,0.00023360702,0.00006764863,0.000012333997,0.0003628479,0.00021372888,0.9965194,0.000034494155,0.000025110425,0.0020291822],"study_design_scores_gemma":[0.008153081,0.001069567,0.0006907482,0.00037249931,0.000051736468,0.000037576985,0.0000833145,0.00002122211,0.98812544,0.00005875568,0.00063167897,0.0007043767],"about_ca_topic_score_codex":0.00010888718,"about_ca_topic_score_gemma":0.00004167921,"teacher_disagreement_score":0.008393973,"about_ca_system_score_codex":0.0012387775,"about_ca_system_score_gemma":0.0017821556,"threshold_uncertainty_score":0.9997021},"labels":[],"label_agreement":null},{"id":"W2979676761","doi":"10.1182/blood.v116.21.661.661","title":"Transfusion of Fresh but Not Stored Blood Reduces Infarct Size and Improves Cardiac Function Following Acute Myocardial Infarction In Anemic Rats","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Myocardial infarction; Phlebotomy; Blood transfusion; Anemia; Cardiac function curve; Infarction; Cardiology; Internal medicine; Surgery; Heart failure","score_opus":0.005602441382614542,"score_gpt":0.23089079540659327,"score_spread":0.22528835402397873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979676761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99715036,0.0005141614,0.0000011575902,0.00048271273,0.00081627833,0.0005491532,0.000023824505,0.000057847716,0.00040449176],"genre_scores_gemma":[0.99787295,0.00083901064,0.0006606366,0.000079645986,0.0003216827,0.000042424974,0.00003754339,0.000027560827,0.00011856574],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99871266,0.000052651034,0.0003400738,0.00035665795,0.00029347435,0.00024449034],"domain_scores_gemma":[0.99938697,0.000106496766,0.000090029345,0.00024576788,0.000051880346,0.000118878146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002431184,0.00021422599,0.00046765705,0.00012753805,0.00008098705,0.000016866421,0.000046357833,0.0002275146,0.000026868196],"category_scores_gemma":[0.00009006476,0.00018645929,0.00025894455,0.0001762274,0.00009227173,0.00012246473,0.000027268143,0.0003565535,0.000002272182],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034717112,0.00051359204,0.038623594,0.000056702647,0.0006701118,0.000030699222,0.00060205074,2.3809537e-7,0.95609605,0.000007812353,0.000033913402,0.0030180903],"study_design_scores_gemma":[0.008265361,0.0010312924,0.2569085,0.00011896676,0.0025144713,0.00006299477,0.0004766201,0.0000028682753,0.73026234,0.000026390751,0.00015450327,0.00017566919],"about_ca_topic_score_codex":0.00051532773,"about_ca_topic_score_gemma":0.00008124608,"teacher_disagreement_score":0.22583365,"about_ca_system_score_codex":0.000017836319,"about_ca_system_score_gemma":0.00009776685,"threshold_uncertainty_score":0.7603589},"labels":[],"label_agreement":null},{"id":"W2979678735","doi":"10.1182/blood.v116.21.3108.3108","title":"The Risk of Lymphoproliferative Disorders In Patients with Diabetes Mellitus: A Meta-Analysis","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Multiple myeloma; Chronic lymphocytic leukemia; Relative risk; Meta-analysis; Funnel plot; Incidence (geometry); Diabetes mellitus; Cohort study; Publication bias; Leukemia; Confidence interval; Endocrinology","score_opus":0.004055787328190479,"score_gpt":0.20403228375626128,"score_spread":0.1999764964280708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979678735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99663615,0.0026406369,0.000023032351,0.000035518206,0.00023893155,0.00017382001,0.000073542535,0.0000024759877,0.00017586158],"genre_scores_gemma":[0.9989612,0.0003665119,0.00017311495,0.000029138362,0.00029553112,0.000058164784,0.00003543968,0.000009361276,0.00007152916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992696,0.00007234372,0.00016624226,0.00020779183,0.0001234195,0.0001606029],"domain_scores_gemma":[0.9993729,0.000026317768,0.00012147349,0.0003668667,0.00007691232,0.00003551539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019242975,0.00011259261,0.00029356297,0.000041998013,0.000055252414,0.000012406773,0.00014088984,0.000063861065,0.000013366674],"category_scores_gemma":[0.00007158781,0.00006312226,0.00029189367,0.00018716778,0.00011038144,0.000002617208,0.000034554647,0.00007428248,6.482031e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000087372435,0.00050223613,0.94806516,0.00000589873,0.043551885,6.3389156e-9,0.00014695452,0.00005316928,0.0063979295,0.00007089813,0.00013523798,0.0009832412],"study_design_scores_gemma":[0.0047758757,0.00040447846,0.79616964,0.000001364228,0.091145925,1.03444876e-7,0.00010684828,0.000021219614,0.05520681,0.00022984497,0.051566582,0.00037133627],"about_ca_topic_score_codex":0.00007923089,"about_ca_topic_score_gemma":0.004694721,"teacher_disagreement_score":0.15189557,"about_ca_system_score_codex":0.0000013228075,"about_ca_system_score_gemma":0.000039056507,"threshold_uncertainty_score":0.26197645},"labels":[],"label_agreement":null},{"id":"W2979679621","doi":"10.1182/blood.v106.11.2417.2417","title":"Treatment with Intermediate Subviral Particles Overcomes Resistance to Reovirus Induced Oncolysis in Mantle Cell Lymphoma Cell Lines.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Cell culture; Mantle cell lymphoma; Biology; Molecular biology; Virology; Lymphoma; Chemistry; Immunology","score_opus":0.013012500235777377,"score_gpt":0.2668776132857788,"score_spread":0.2538651130500014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979679621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99750483,0.001064433,0.000005344368,0.00027380357,0.000019007288,0.0003090124,0.000021467862,0.000015218239,0.0007868611],"genre_scores_gemma":[0.9966511,0.00033829652,0.00058638223,0.0002563492,0.00017906116,0.000118223885,0.000025073388,0.00003824387,0.0018072856],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986512,0.00008965237,0.00021866914,0.00043440412,0.00018806288,0.0004180048],"domain_scores_gemma":[0.99925286,0.000016186581,0.000055856915,0.00048122057,0.00004393005,0.00014992169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011373465,0.00020739262,0.00020191488,0.0000939265,0.000047467922,0.000031213076,0.00022115318,0.0000995594,0.000018371578],"category_scores_gemma":[0.000010199963,0.00017237406,0.000067687506,0.0002154516,0.000038460334,0.0000068654476,0.00007031441,0.00005195992,0.000067532055],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025636978,0.0015772434,0.0072041727,0.000013280008,0.000046687346,0.000045696976,0.0002076407,0.00004802606,0.9798012,6.750287e-7,0.00011101771,0.008380667],"study_design_scores_gemma":[0.0064807725,0.0038635333,0.0031109771,0.000012241436,0.00002827408,0.0000026844173,0.00006689138,0.000014130333,0.9812026,0.0000034121779,0.0049924045,0.00022209718],"about_ca_topic_score_codex":0.00006467366,"about_ca_topic_score_gemma":0.0076348516,"teacher_disagreement_score":0.00815857,"about_ca_system_score_codex":0.00008461082,"about_ca_system_score_gemma":0.00016920618,"threshold_uncertainty_score":0.70292103},"labels":[],"label_agreement":null},{"id":"W2979679841","doi":"10.1182/blood.v110.11.3491.3491","title":"Allogeneic Stem Cell Transplant in First Complete Remission Overcomes the Poor Prognosis Associated with the FLT-3 Internal Tandem Duplication in Acute Myeloid Leukemia.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"NPM1; Internal medicine; Cytarabine; Induction chemotherapy; Medicine; Oncology; Transplantation; Chemotherapy; Chemotherapy regimen; Myeloid leukemia; Gastroenterology; Biology; Genetics; Karyotype; Gene","score_opus":0.018670967193013942,"score_gpt":0.2551994610937699,"score_spread":0.23652849390075595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979679841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918507,0.00037567198,0.00014568651,0.0051876474,0.000025858526,0.0012977644,0.000024672583,0.000055087774,0.0010369556],"genre_scores_gemma":[0.99795806,0.00034285444,0.00009087419,0.0005611467,0.00007216724,0.00010629922,0.000071230905,0.000044272827,0.000753071],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977149,0.00016084824,0.00046101803,0.00040403826,0.0006511428,0.0006081042],"domain_scores_gemma":[0.9986395,0.0005769529,0.000168343,0.00038442115,0.00009602813,0.0001347153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015532052,0.00025037385,0.00037648302,0.0001874141,0.00016048893,0.000038252678,0.00046605256,0.00019007799,0.000026556161],"category_scores_gemma":[0.000037384554,0.00013213875,0.00008904568,0.0007542498,0.00013839912,0.000077000535,0.000078285084,0.0008707932,0.000015332063],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001376383,0.0010123261,0.86649835,0.000105767744,0.00045119962,0.00084610377,0.00440863,0.000049359984,0.12081996,0.00003771402,0.0013084039,0.0030857911],"study_design_scores_gemma":[0.011277507,0.00051701174,0.91182774,0.0007090624,0.00035784722,0.00024244387,0.00080240465,0.0012676625,0.07003306,0.0000112528505,0.0026790006,0.0002749933],"about_ca_topic_score_codex":0.00042669178,"about_ca_topic_score_gemma":0.0026816989,"teacher_disagreement_score":0.050786905,"about_ca_system_score_codex":0.00088322465,"about_ca_system_score_gemma":0.00033128908,"threshold_uncertainty_score":0.5388462},"labels":[],"label_agreement":null},{"id":"W2979681014","doi":"10.1182/blood.v128.22.1418.1418","title":"Surgery in Patients with Factor VIII Inhibitors: A Retrospective Case Series at the Largest Canadian Hemophilia Care Centre","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Perioperative; Surgery; Retrospective cohort study; Factor IX; Population; Recombinant factor VIIa; Single Center; Prothrombin complex concentrate; Risk factor; Clotting factor; Internal medicine; Warfarin","score_opus":0.0091094554662451,"score_gpt":0.21965575688292194,"score_spread":0.21054630141667685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979681014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994796,0.00018327554,1.7931919e-8,0.0034259888,0.00007049064,0.0006118102,0.00033507193,0.000022292996,0.00055505685],"genre_scores_gemma":[0.99731445,0.000023908522,0.0000058632086,0.000050111496,0.00011754876,0.000021070522,0.000057280093,0.000027251785,0.0023825355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870515,0.000055939694,0.00015275118,0.00028248332,0.00031552376,0.00048818206],"domain_scores_gemma":[0.9990536,0.00008536275,0.00003482995,0.00032260173,0.00018761802,0.00031599242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006789045,0.00017010274,0.00024609827,0.00015278239,0.00018049801,0.000015675667,0.000047808207,0.000094499774,0.00029271288],"category_scores_gemma":[0.0001271801,0.000076663266,0.00006531087,0.00024404196,0.0001221807,0.00009245557,0.000037791044,0.00012982295,0.00006716887],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015318856,0.00025762353,0.993155,0.00002918642,0.00007524716,0.004054737,0.00095888454,1.0828058e-8,0.00005562851,0.0000045670786,0.0005719048,0.0006840353],"study_design_scores_gemma":[0.0054674796,0.00032185388,0.9853231,0.00028487423,0.00006421743,0.00032762243,0.0005845302,5.411998e-8,0.0058294907,0.000004513467,0.0016309387,0.00016134411],"about_ca_topic_score_codex":0.012126919,"about_ca_topic_score_gemma":0.3068985,"teacher_disagreement_score":0.29477158,"about_ca_system_score_codex":0.0005702227,"about_ca_system_score_gemma":0.00039521343,"threshold_uncertainty_score":0.9944514},"labels":[],"label_agreement":null},{"id":"W2979683054","doi":"10.1182/blood.v120.21.207.207","title":"Thymocyte Reprogramming by the Scl, Lmo1 and Notch1 Oncogenes","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Biology; Thymocyte; Progenitor cell; Reprogramming; CD8; Stem cell; Transplantation; Haematopoiesis; Cell biology; Cellular differentiation; T cell; Leukemia; Immunology; Cancer research; Cell; Genetics; Gene; Immune system; Medicine","score_opus":0.019072302748956157,"score_gpt":0.286489785365258,"score_spread":0.2674174826163018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979683054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856851,0.007990996,0.00010814296,0.0012843368,0.00007807168,0.000335948,0.000005254688,0.000064124855,0.004448004],"genre_scores_gemma":[0.9959297,0.00020464534,0.0010629791,0.00045579326,0.0005350164,0.00003793232,0.000009656996,0.000027016617,0.0017372661],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988426,0.000043601063,0.00014223681,0.00019113056,0.00033507362,0.00044534303],"domain_scores_gemma":[0.99911785,0.00019236474,0.000035944326,0.000381616,0.00004818388,0.00022406189],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044845458,0.00011333336,0.00016712712,0.00003280448,0.00012413485,0.000030770752,0.00010378341,0.00007802723,0.000050237206],"category_scores_gemma":[0.00024539215,0.000068061214,0.00004277971,0.00014740144,0.00015403308,0.00007883251,0.00012391579,0.00016423118,0.00007688176],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049192196,0.0029522742,0.4012723,0.00041469905,0.001115873,0.00025058223,0.0046511604,3.8171797e-7,0.19576392,0.0007913673,0.049211986,0.34308353],"study_design_scores_gemma":[0.02189145,0.001019975,0.053569883,0.00026238745,0.0014865877,0.0054416507,0.0018701821,0.00027386576,0.35185367,0.00010440388,0.5615569,0.00066907867],"about_ca_topic_score_codex":0.00011828848,"about_ca_topic_score_gemma":0.0000035642859,"teacher_disagreement_score":0.5123449,"about_ca_system_score_codex":0.0000640846,"about_ca_system_score_gemma":0.000119056735,"threshold_uncertainty_score":0.27754557},"labels":[],"label_agreement":null},{"id":"W2979684740","doi":"10.1182/blood.v104.11.911.911","title":"High Dose Thiotepa, Busulfan, Cyclophosphamide (TBC) and Autologous Hematopoietic Stem Cell Transplantation (ASCT) without Whole Brain Radiotherapy (WBRT) for Primary Central Nervous System Lymphoma (PCNSL).","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; ThioTEPA; Procarbazine; Busulfan; Autologous stem-cell transplantation; Cyclophosphamide; Hematopoietic stem cell transplantation; Internal medicine; Vincristine; Surgery; Primary central nervous system lymphoma; Gastroenterology; Transplantation; Urology; Oncology; Chemotherapy","score_opus":0.005546771723343391,"score_gpt":0.2127555546371017,"score_spread":0.2072087829137583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979684740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884931,0.006450964,0.00082705595,0.001620238,0.00022834534,0.0018828523,0.0001088703,0.0002481461,0.00014044877],"genre_scores_gemma":[0.9931012,0.000414348,0.0051582744,0.0005343983,0.00016284929,0.00023816265,0.00016754578,0.00008188154,0.00014137522],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99804723,0.00005414335,0.0004680087,0.00055408943,0.00030702507,0.0005694767],"domain_scores_gemma":[0.9989678,0.00013631549,0.00017944009,0.00036378033,0.00006373247,0.0002888887],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014559687,0.00038728234,0.0007056157,0.000117204785,0.00017767404,0.000061274935,0.00010185631,0.00021246394,0.0000047103927],"category_scores_gemma":[0.000004815631,0.00032166523,0.00018096664,0.00017104177,0.00006847724,0.00010032433,0.000012450848,0.000085329615,0.000011802536],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010198083,0.036375117,0.19537123,0.03401171,0.006531943,0.021013007,0.039578427,0.0029182665,0.34096935,0.011277818,0.0026956706,0.2990594],"study_design_scores_gemma":[0.071571715,0.0021831228,0.75820965,0.001047126,0.0021077602,0.004721538,0.0006337293,0.000082091465,0.15782961,0.00013419602,0.0008030752,0.0006763608],"about_ca_topic_score_codex":0.0002584722,"about_ca_topic_score_gemma":0.000025964699,"teacher_disagreement_score":0.56283844,"about_ca_system_score_codex":0.00030131097,"about_ca_system_score_gemma":0.00020052136,"threshold_uncertainty_score":0.9999235},"labels":[],"label_agreement":null},{"id":"W2979686089","doi":"10.1182/blood.v128.22.4984.4984","title":"Rationale for Investigator-Assigned Prophylaxis Dosing Frequency in the Leopold I Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bayer (Canada)","funders":"","keywords":"Regimen; Medicine; Tolerability; Dosing; Referral; Clinical trial; Internal medicine; Adverse effect; Family medicine; Surgery; Pediatrics","score_opus":0.05501542133558061,"score_gpt":0.31930597746246553,"score_spread":0.2642905561268849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979686089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99047875,0.00014665796,0.000019124906,0.005962886,0.000027745597,0.002216909,0.000005197467,0.000018238312,0.0011244719],"genre_scores_gemma":[0.99763864,0.0000060390353,0.00043070575,0.0001488924,0.0001666419,0.00040718462,0.0000047708822,0.00001016639,0.0011869441],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914813,0.00008206604,0.00014660218,0.00017056894,0.00026679086,0.00018584555],"domain_scores_gemma":[0.9993796,0.00024707188,0.000022251372,0.0002152706,0.000057533645,0.0000782739],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004003726,0.00007890366,0.00012101849,0.000078186305,0.00008425337,0.000015863108,0.00008784438,0.000042496253,0.000048900783],"category_scores_gemma":[0.0005029818,0.000033965793,0.000042017415,0.00016554615,0.0000618959,0.000055280005,0.000012644465,0.00006407901,0.000022611623],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007288984,0.003627395,0.903692,0.00005323609,0.00010086126,0.000094809264,0.0019803282,4.2766192e-8,0.085549146,0.0006303261,0.00065022986,0.0035487474],"study_design_scores_gemma":[0.0756773,0.01790558,0.6909548,0.00059230905,0.0005254504,0.0001016344,0.005022472,0.000015583746,0.19500278,0.011630999,0.0020064618,0.00056461286],"about_ca_topic_score_codex":0.00002743731,"about_ca_topic_score_gemma":0.000038605507,"teacher_disagreement_score":0.21273716,"about_ca_system_score_codex":0.000028659022,"about_ca_system_score_gemma":0.00022267662,"threshold_uncertainty_score":0.13850848},"labels":[],"label_agreement":null},{"id":"W2979687275","doi":"10.1182/blood.v106.11.1884.1884","title":"Novel Single Agents with Combined Anti-Coagulant and Anti-Platelet Activities: Potential Treatment Option for the Management of HIT.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Medicure (Canada)","funders":"","keywords":"Fondaparinux; Argatroban; Antithrombotic; Medicine; Platelet; Platelet activation; Thrombin; Thrombosis; Pharmacology; Direct thrombin inhibitor; Discovery and development of direct thrombin inhibitors; Heparin-induced thrombocytopenia; Immunology; Internal medicine; Warfarin; Dabigatran","score_opus":0.03614651840060222,"score_gpt":0.27142297338556387,"score_spread":0.23527645498496164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979687275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964535,0.00007429747,0.0010015063,0.000555317,0.00006151649,0.0011431633,0.0000333828,0.000031004172,0.0006462925],"genre_scores_gemma":[0.9951591,0.00026078481,0.0040975395,0.00005600807,0.000080345664,0.00006142087,0.00003517382,0.000025795074,0.00022385239],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991424,0.0000109622915,0.00020151342,0.00024160657,0.00017417854,0.00022934757],"domain_scores_gemma":[0.99949944,0.00003224235,0.000098907585,0.00026624347,0.00003314304,0.0000700491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007766873,0.00017759309,0.0003829876,0.000054828153,0.00011252883,0.000023828452,0.00006380944,0.000057819438,0.000024390742],"category_scores_gemma":[0.0000019458814,0.00011021247,0.000073939096,0.000082376784,0.000070709066,0.00008082839,0.00003476947,0.000048315345,0.0000025973134],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009179275,0.015114868,0.0056836857,0.0006289264,0.00762911,0.00008980979,0.0012304138,0.00014286427,0.93642193,0.0019085329,0.00008237847,0.030149568],"study_design_scores_gemma":[0.045315117,0.0043566558,0.20933849,0.000443363,0.005068022,0.0003332022,0.0014096067,0.001448677,0.7287354,0.000020602261,0.0031358995,0.00039498584],"about_ca_topic_score_codex":0.000049513845,"about_ca_topic_score_gemma":0.000014414795,"teacher_disagreement_score":0.20768653,"about_ca_system_score_codex":0.000045085162,"about_ca_system_score_gemma":0.000026277221,"threshold_uncertainty_score":0.44943345},"labels":[],"label_agreement":null},{"id":"W2979691426","doi":"10.1182/blood.v108.11.3556.3556","title":"Expanded Access Program (EAP) for Lenalidomide (Revlimid®) Plus Dexamethasone in over 1400 Subjects with Relapsed or Refractory Multiple Myeloma.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Lenalidomide; Medicine; Multiple myeloma; Dexamethasone; Internal medicine; Thalidomide; Interim analysis; Data monitoring committee; Expanded access; Neutropenia; Refractory (planetary science); Oncology; Surgery; Clinical trial; Toxicity","score_opus":0.043862974235070865,"score_gpt":0.342573809831714,"score_spread":0.29871083559664313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979691426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931567,0.0006383267,0.00011214454,0.00014227729,0.00005419993,0.0045680767,0.000050795632,0.00021806548,0.0010594198],"genre_scores_gemma":[0.98347723,0.00007974116,0.01194851,0.00008835868,0.00024193722,0.0019013901,0.00029917556,0.00009712057,0.0018665198],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972328,0.00010683175,0.00046595442,0.0006732879,0.00060459826,0.0009165573],"domain_scores_gemma":[0.9981521,0.00062723475,0.0001633398,0.0005760324,0.0001755204,0.00030580882],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003078091,0.00038311415,0.0006840048,0.00032378026,0.00011772202,0.00008781078,0.00023032648,0.00020783074,0.00011038716],"category_scores_gemma":[0.0005373315,0.0002583994,0.00014538455,0.00055321807,0.00012682837,0.00029435797,0.00008049301,0.00032920192,0.000018788087],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.046248384,0.015977224,0.8775164,0.0009910407,0.00096539466,0.0033655604,0.00030324538,0.000037444093,0.014652317,0.000038901904,0.0015220174,0.03838207],"study_design_scores_gemma":[0.15030865,0.004472398,0.78512895,0.0005804707,0.00041107502,0.00018720806,0.00010168502,0.0009405566,0.05426515,0.00006736895,0.0030140814,0.0005224038],"about_ca_topic_score_codex":0.0015460758,"about_ca_topic_score_gemma":0.0052418984,"teacher_disagreement_score":0.10406027,"about_ca_system_score_codex":0.0002252028,"about_ca_system_score_gemma":0.00053219235,"threshold_uncertainty_score":0.9999868},"labels":[],"label_agreement":null},{"id":"W2979692070","doi":"10.1182/blood.v124.21.628.628","title":"A Phase 2/3 Multicenter, Randomized Study Comparing the Efficacy and Safety of Lenalidomide Versus Investigator’s Choice in Relapsed/Refractory DLBCL","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Lenalidomide; Medicine; Internal medicine; Diffuse large B-cell lymphoma; Clinical endpoint; Rituximab; Oncology; Phases of clinical research; Transplantation; Lymphoma; Clinical trial; Multiple myeloma","score_opus":0.030729300273096775,"score_gpt":0.30688280287865816,"score_spread":0.2761535026055614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979692070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99650127,0.00086208846,0.0000023384114,0.00027998775,0.000113255555,0.001650031,0.0000023992054,0.000021806452,0.0005668299],"genre_scores_gemma":[0.9994916,0.000070452465,0.00009188395,0.00014083378,0.0000686368,0.00010332652,0.0000061782407,0.000014570384,0.0000125448305],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9985169,0.00038557022,0.00046839332,0.00024225481,0.00021078595,0.00017605103],"domain_scores_gemma":[0.99670947,0.0025864549,0.00016695351,0.00034434177,0.000037437076,0.00015536837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076319487,0.00016907573,0.00075123395,0.00007369534,0.000059353046,0.00001365288,0.000082149796,0.000043730706,0.000007986036],"category_scores_gemma":[0.001996208,0.000102539656,0.000092377406,0.000104530896,0.00016641182,0.00003414407,0.00006107112,0.00012094707,0.0000049261976],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19525012,0.06814678,0.72627527,0.00011585165,0.0016594635,0.000063992964,0.0037283439,0.00001193284,0.0010420934,0.00021225316,0.000105158724,0.0033887317],"study_design_scores_gemma":[0.8488634,0.001105963,0.14622718,0.00017424744,0.0011747049,0.000003880791,0.00019186903,0.0003210228,0.001496263,0.000004128957,0.00035528617,0.0000820412],"about_ca_topic_score_codex":0.0007657399,"about_ca_topic_score_gemma":0.00016466287,"teacher_disagreement_score":0.6536133,"about_ca_system_score_codex":0.000041712596,"about_ca_system_score_gemma":0.000057741192,"threshold_uncertainty_score":0.41814458},"labels":[],"label_agreement":null},{"id":"W2979695032","doi":"10.1182/blood.v120.21.2787.2787","title":"Long-Term Follow-up of Ongoing Patients in 2 Studies of Omacetaxine Mepesuccinate for Chronic Myeloid Leukemia.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Tolerability; Internal medicine; Myeloid leukemia; Adverse effect; Phases of clinical research; Oncology; Gastroenterology; Clinical trial","score_opus":0.02828955524897615,"score_gpt":0.30231408564641565,"score_spread":0.2740245303974395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979695032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893735,0.008747651,0.000010630483,0.000029390438,0.00029602204,0.0011729227,0.00003717875,0.000026392281,0.0003062959],"genre_scores_gemma":[0.9978955,0.0006665836,0.00051396096,0.00002183336,0.00016844089,0.00011761955,0.000076992575,0.000044400305,0.0004946859],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981374,0.000040945546,0.00067010376,0.00027277175,0.00033373295,0.0005450306],"domain_scores_gemma":[0.99870217,0.00019666948,0.00033411596,0.0004268971,0.00022012145,0.00012004395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031600602,0.00026050807,0.00086140045,0.00021107847,0.0000365069,0.0000025480078,0.00012449047,0.0001185382,0.00003985007],"category_scores_gemma":[0.00035555777,0.00022038056,0.00020102269,0.00024709036,0.00008842062,0.00014181346,0.00009858613,0.00013433248,0.000008842504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030158594,0.0016489034,0.9775381,0.0021438617,0.0010302999,0.000010130851,0.0014691553,0.000004498933,0.008594689,0.000039979048,0.000101554986,0.0071172486],"study_design_scores_gemma":[0.05412709,0.0013452717,0.7645836,0.0010832297,0.0009701553,0.000015058649,0.000107621294,0.000017002907,0.17745127,0.000016717884,0.00008414431,0.00019886876],"about_ca_topic_score_codex":0.00009407729,"about_ca_topic_score_gemma":0.00021067305,"teacher_disagreement_score":0.21295452,"about_ca_system_score_codex":0.001257852,"about_ca_system_score_gemma":0.00040704914,"threshold_uncertainty_score":0.8986858},"labels":[],"label_agreement":null},{"id":"W2979699646","doi":"10.1182/blood.v116.21.515.515","title":"BCR-ABL1 Kinase Activity but Not Its Expression Is Dispensable for Ph+ Quiescent Stem Cell Survival Which Depends on the PP2A-Controlled Jak2 Activation and Is Sensitive to FTY720 Treatment","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"CD38; Progenitor cell; Stem cell; Chronic myelogenous leukemia; CD34; Haematopoiesis; Tyrosine kinase; Cancer research; Biology; Imatinib mesylate; Cell biology; Chemistry; Leukemia; Immunology; Imatinib; Myeloid leukemia; Signal transduction","score_opus":0.024861234722222018,"score_gpt":0.2680445943309308,"score_spread":0.2431833596087088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979699646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99086374,0.000018491288,0.000067830726,0.0034939626,0.000253406,0.0037620906,0.00018252281,0.000058934125,0.0012990208],"genre_scores_gemma":[0.9932319,0.000040377563,0.00019119063,0.0006255979,0.00028107167,0.0005014453,0.000034158424,0.000058643873,0.0050356467],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979559,0.00012146683,0.0002780461,0.0007011807,0.0004618965,0.00048149808],"domain_scores_gemma":[0.99784774,0.00079677324,0.00019256507,0.0006661497,0.00021426548,0.00028252596],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002854029,0.00043665429,0.0006744285,0.00009129788,0.0003010989,0.00006150596,0.000093087096,0.00020659354,0.000113339345],"category_scores_gemma":[0.00014176713,0.00027329166,0.00016869047,0.0001551625,0.000029768908,0.00012850905,0.00007258732,0.00026919087,0.000055079046],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006709545,0.0026121363,0.0007161777,0.00007368037,0.00036580957,0.000023848328,0.0015735034,0.0000033574472,0.9825145,0.0000370033,0.0004635462,0.0049069133],"study_design_scores_gemma":[0.03873297,0.0015201229,0.005322426,0.00014657786,0.00059083133,0.000013452211,0.00035246872,0.0005332271,0.95174336,0.0000035647706,0.0008032029,0.00023777985],"about_ca_topic_score_codex":0.00028806448,"about_ca_topic_score_gemma":0.00021290418,"teacher_disagreement_score":0.032023422,"about_ca_system_score_codex":0.0004648951,"about_ca_system_score_gemma":0.00028299793,"threshold_uncertainty_score":0.9999719},"labels":[],"label_agreement":null},{"id":"W2979701566","doi":"10.1182/blood.v128.22.3774.3774","title":"Risk Factors for the Development of High-Titer Inhibitors in 260 Children with Severe Hemophilia a Born Between 1990 and 2009: The Remain Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Institute for Clinical Evaluative Sciences; SickKids Foundation; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Titer; Medicine; Internal medicine; Univariate analysis; Immunology; Logistic regression; Concomitant; Antibody; Multivariate analysis","score_opus":0.018352246699898916,"score_gpt":0.2670467438372086,"score_spread":0.2486944971373097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979701566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965404,0.00014649062,0.000018819403,0.0010254779,0.00001494882,0.002151758,0.00005813493,0.000012446839,0.000031491385],"genre_scores_gemma":[0.9990145,0.000031601092,0.0003668497,0.000009561767,0.000109243934,0.00006258964,0.000010763918,0.000019888466,0.00037501607],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998848,0.00007231141,0.00026046173,0.00024067255,0.00031853083,0.00025999048],"domain_scores_gemma":[0.99901605,0.00048442624,0.00007628018,0.00029741818,0.000049450482,0.00007637732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005229289,0.0001589779,0.00027096283,0.00008429627,0.00014724836,0.000011082356,0.00011620685,0.0000586067,0.000012677508],"category_scores_gemma":[0.00010020277,0.00005327584,0.00003868596,0.00017194983,0.0001125812,0.00003697318,0.000068957685,0.00012779886,0.0000028865556],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011027719,0.00043497197,0.9856629,0.000014048501,0.0005825573,0.0000030668486,0.0023088588,1.2055224e-7,0.000115190254,0.0000023813782,0.000073549876,0.010692115],"study_design_scores_gemma":[0.00774095,0.00071724254,0.984379,0.000111993315,0.00032356003,0.000005964405,0.00057180173,4.692171e-7,0.0058707083,0.000045399094,0.00014383503,0.00008911069],"about_ca_topic_score_codex":0.00021213372,"about_ca_topic_score_gemma":0.0003922757,"teacher_disagreement_score":0.010603004,"about_ca_system_score_codex":0.000029258616,"about_ca_system_score_gemma":0.0001212122,"threshold_uncertainty_score":0.21725255},"labels":[],"label_agreement":null},{"id":"W2979704099","doi":"10.1182/blood.v118.21.2936.2936","title":"Lenalidomide (Revlimid), Bortezomib (Velcade) and Dexamethasone (RVD) for Heavily Pretreated Relapsed or Refractory Multiple Myeloma","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Lenalidomide; Medicine; Internal medicine; Bortezomib; Regimen; Multiple myeloma; Dexamethasone; Refractory (planetary science); Neutropenia; Oncology; Progression-free survival; Thalidomide; Toxicity; Gastroenterology; Surgery; Chemotherapy","score_opus":0.07568505293985034,"score_gpt":0.30700020220972785,"score_spread":0.2313151492698775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979704099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936352,0.0016763149,0.00014460605,0.00014543734,0.000078142984,0.002152418,0.00013029613,0.00019537419,0.0018422286],"genre_scores_gemma":[0.97464216,0.0005446118,0.021260945,0.00016093315,0.00014805689,0.0003878406,0.0001343486,0.000091199225,0.0026299094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977381,0.00010570851,0.00044366284,0.000636081,0.0003598115,0.0007166385],"domain_scores_gemma":[0.99793595,0.00054756977,0.0001397423,0.0005685335,0.0001990863,0.0006091371],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003319598,0.00035792618,0.0006165928,0.0002136825,0.00017591166,0.000025186258,0.00013874912,0.0002470624,0.0003116361],"category_scores_gemma":[0.0013825357,0.00025902072,0.00016329088,0.00023558726,0.00016188924,0.00016560883,0.00007749619,0.00028457353,0.000048076483],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0417428,0.010246747,0.7711442,0.001118944,0.003974803,0.0023328639,0.002285547,2.4075302e-7,0.08099984,0.00013846201,0.0029743952,0.083041124],"study_design_scores_gemma":[0.08613577,0.0066400953,0.68463016,0.00043162,0.0013452667,0.000547197,0.000291191,0.00033811637,0.21461812,0.00015341102,0.0042765583,0.0005925252],"about_ca_topic_score_codex":0.00035206228,"about_ca_topic_score_gemma":0.00015462923,"teacher_disagreement_score":0.13361828,"about_ca_system_score_codex":0.000068069,"about_ca_system_score_gemma":0.00021298105,"threshold_uncertainty_score":0.9999862},"labels":[],"label_agreement":null},{"id":"W2979704659","doi":"10.1182/blood.v122.21.3440.3440","title":"GDF15 Is Not The Sole Negative Regulator Of Hepcidin In Hereditary Xerocytosis","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Hepcidin; Endocrinology; Internal medicine; Erythropoiesis; Biology; Ineffective erythropoiesis; Anemia; Medicine","score_opus":0.017725558277071774,"score_gpt":0.2382065886524031,"score_spread":0.22048103037533132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979704659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993374,0.00016421723,0.00000535392,0.0030690893,0.00015629442,0.00031266888,0.000008506754,0.000020886731,0.0028889922],"genre_scores_gemma":[0.99510044,0.000041608597,0.00033563163,0.0027558987,0.00022687417,0.00004220717,0.0000061647224,0.000012064378,0.0014791121],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99927974,0.000054781427,0.00021676424,0.00016367946,0.00012986638,0.00015515859],"domain_scores_gemma":[0.99939674,0.00011624696,0.0000696438,0.0002820579,0.00008012822,0.00005520758],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000077035904,0.00009649691,0.00024397684,0.000054410215,0.000031522428,0.0000032831858,0.000071803064,0.00009112475,0.0009506026],"category_scores_gemma":[0.00007303374,0.00006266284,0.00007700765,0.00016249475,0.00009753724,0.00005037956,0.000036064313,0.00015423339,0.00016611388],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074690185,0.0023946536,0.053826857,0.00030102642,0.00047655342,0.000060204722,0.0072010397,0.000010442217,0.80175436,0.00054386107,0.126488,0.0061961184],"study_design_scores_gemma":[0.005701485,0.000840237,0.39521596,0.00013194249,0.00014755128,0.00007799848,0.0015037692,0.00016003131,0.59247404,0.000904258,0.0026768602,0.00016586849],"about_ca_topic_score_codex":0.00043707623,"about_ca_topic_score_gemma":0.0000377303,"teacher_disagreement_score":0.3413891,"about_ca_system_score_codex":0.00001253166,"about_ca_system_score_gemma":0.000047565507,"threshold_uncertainty_score":0.9999627},"labels":[],"label_agreement":null},{"id":"W2979707063","doi":"10.1182/blood.v114.22.3479.3479","title":"Assay of Factor VIII Antibodies by ELISA Using Plasma Specimens Dried On Filter Paper and Stored at Room Temperature.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Queen's University; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Antibody; Haemophilia; Fresh frozen plasma; Haemophilia A; Whole blood; Medicine; Chemistry; Chromatography; Molecular biology; Immunology; Andrology; Surgery; Biology; Platelet","score_opus":0.025134552242243067,"score_gpt":0.2886475492380184,"score_spread":0.2635129969957753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979707063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961133,0.0005349951,4.4257936e-7,0.00080699363,0.000039037077,0.00026745547,0.00006922188,0.000022472092,0.0021460738],"genre_scores_gemma":[0.99509054,0.00015100864,0.00039968186,0.00014500903,0.000117055504,0.0000015829814,0.00005157182,0.000014941286,0.004028579],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989941,0.000041767686,0.00016353284,0.00023583157,0.00031903398,0.0002457246],"domain_scores_gemma":[0.9995035,0.000074047464,0.000038978447,0.00020582501,0.000050161234,0.00012749662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007397552,0.0001591099,0.00030055462,0.00007855557,0.000092987124,0.000016730357,0.000041814452,0.00012228773,0.000273008],"category_scores_gemma":[0.000038623017,0.00010856912,0.000062381194,0.00007730794,0.000057705696,0.000053480042,0.00002620836,0.00014225641,0.000013284451],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022660798,0.0007663814,0.039931577,0.00003127196,0.00016494599,0.00007508133,0.00030167014,8.9668464e-7,0.9553569,0.000017651877,0.0028167272,0.00031031153],"study_design_scores_gemma":[0.0061793034,0.0009987818,0.09478941,0.00017142789,0.00016831703,0.000042276544,0.000060883867,0.00004458767,0.894248,0.000012824801,0.0031173099,0.00016688392],"about_ca_topic_score_codex":0.000009190796,"about_ca_topic_score_gemma":0.000004293528,"teacher_disagreement_score":0.061108883,"about_ca_system_score_codex":0.000039819708,"about_ca_system_score_gemma":0.00003206855,"threshold_uncertainty_score":0.442732},"labels":[],"label_agreement":null},{"id":"W2979713829","doi":"10.1182/blood.v106.11.2186.2186","title":"Inhibition of IL-1β and TNFα Gene Expression by IVIg or Anti-Red Blood Cell Antibodies in a Mouse Model of ITP.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Héma-Québec","funders":"","keywords":"Antibody; Spleen; Immunology; Cytokine; Medicine; Autoantibody; Platelet; Monoclonal antibody; Tumor necrosis factor alpha; Gene expression; Biology; Gene","score_opus":0.013330306925711348,"score_gpt":0.2377112035544335,"score_spread":0.22438089662872215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979713829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99794096,0.0011730578,0.00002537774,0.00007156604,0.000005260361,0.00025165838,0.00018070417,0.000015551255,0.00033584042],"genre_scores_gemma":[0.9947621,0.00148713,0.0031833644,0.000034691915,0.000010654164,0.000008256665,0.000066831504,0.000016003823,0.00043095433],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992259,0.000015627329,0.00026857934,0.00018920902,0.00014813624,0.00015253757],"domain_scores_gemma":[0.9996364,0.0000170283,0.00010638636,0.00014997699,0.000035314686,0.00005486132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000051174255,0.00012794776,0.00036266234,0.00009886409,0.000020412795,0.0000035354324,0.000027401433,0.00008787145,0.000013694369],"category_scores_gemma":[0.000014968274,0.000097575685,0.00003882899,0.00007616294,0.000042079606,0.000082917766,0.00003144221,0.00006212313,0.0000012907922],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013704394,0.0043360074,0.019913811,0.00015362566,0.000050199786,0.00004353114,0.00037847366,0.00004209596,0.9745741,0.0000013353908,0.00013036218,0.0002394185],"study_design_scores_gemma":[0.011739112,0.0002844313,0.0011204126,0.00016196641,0.00018430589,0.000020586986,0.00006833208,0.00064225076,0.9856562,0.00002545945,0.000010076704,0.00008688095],"about_ca_topic_score_codex":0.000039932827,"about_ca_topic_score_gemma":0.000021607482,"teacher_disagreement_score":0.018793399,"about_ca_system_score_codex":0.0000055127343,"about_ca_system_score_gemma":0.000030714196,"threshold_uncertainty_score":0.3979021},"labels":[],"label_agreement":null},{"id":"W2979720787","doi":"10.1182/blood.v128.22.1907.1907","title":"Failure to Achieve Early Molecular Milestone within 3 Months Is Associated with Higher Risk of Relapse and Worse Survival after Allogeneic Hematopoietic Stem Cell Transplant for Chronic Myeloid Leukemia Patients, Especially after Tyrosine Kinase Inhibitor Failure","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Juravinski Hospital; McMaster University; Université Laval; Princess Margaret Cancer Centre; Ottawa Hospital; University of Calgary; University of Ottawa; University of Toronto","funders":"","keywords":"Medicine; Transplantation; Internal medicine; Myeloid leukemia; Milestone; Hematopoietic stem cell transplantation; Oncology; Refractory (planetary science); Disease","score_opus":0.004515056254231405,"score_gpt":0.19101327670544416,"score_spread":0.18649822045121275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979720787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99420637,0.0013165185,0.00013359835,0.0004451715,0.00012754537,0.0022866267,0.0013846462,0.00007581272,0.000023728262],"genre_scores_gemma":[0.9962602,0.00007635605,0.0014361986,0.00014622063,0.00016036344,0.00056791905,0.00008833861,0.00017110551,0.0010932581],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968025,0.00015020487,0.0007243097,0.00091283204,0.00070445996,0.0007056853],"domain_scores_gemma":[0.99797964,0.00015930031,0.00037949716,0.0007182613,0.00029808117,0.00046523788],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022835012,0.0006588506,0.00096262567,0.00018624823,0.000075351236,0.000030828396,0.00016876735,0.00040705712,0.00011790017],"category_scores_gemma":[0.000030136494,0.0004467506,0.00023286614,0.0003080905,0.00016941754,0.00014507805,0.000077023105,0.00027838463,0.00002211047],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024399979,0.0056176144,0.69062835,0.0017485656,0.0049225893,0.0020067182,0.011091298,0.000034513807,0.25693527,0.00005398339,0.00085945876,0.001701644],"study_design_scores_gemma":[0.11525088,0.0150220385,0.45048788,0.005851437,0.00852174,0.00006724018,0.00016242305,0.00000720499,0.40142563,0.000062047984,0.0012800884,0.00186141],"about_ca_topic_score_codex":0.0000989472,"about_ca_topic_score_gemma":0.0008537309,"teacher_disagreement_score":0.2401405,"about_ca_system_score_codex":0.00096009485,"about_ca_system_score_gemma":0.0006384951,"threshold_uncertainty_score":0.9997984},"labels":[],"label_agreement":null},{"id":"W2979725095","doi":"10.1182/blood.v120.21.2973.2973","title":"Phase 1b/2a Open-Label, Multiple-Dose, Dose-Escalation Study to Evaluate the Safety and Tolerability of SNS01-T Administered by Intravenous Infusion in Patients with Relapsed or Refractory Multiple Myeloma.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Polyamine Metabolism and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Medicine; Tolerability; Multiple myeloma; In vivo; Apoptosis; Pharmacokinetics; Internal medicine; Pharmacology; Cancer research; Adverse effect; Biology","score_opus":0.02299840380290632,"score_gpt":0.3060890977822555,"score_spread":0.2830906939793492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979725095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99723256,0.00017631965,0.000087797765,0.000044956694,0.000038517697,0.0021236385,0.00024629876,0.0000063352604,0.0000435556],"genre_scores_gemma":[0.99891007,0.000024845407,0.00042962408,0.00007350593,0.000035876194,0.00013097774,0.0003309968,0.000016274058,0.000047852915],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986605,0.00020750657,0.0003973597,0.00033262276,0.00017321587,0.00022878754],"domain_scores_gemma":[0.9990355,0.00006166681,0.00013950076,0.00054540526,0.00009895524,0.00011902119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005053525,0.00017145117,0.00024410056,0.000032420332,0.00011340199,0.000020623213,0.00024385855,0.000071822535,0.0000064951846],"category_scores_gemma":[0.00027557585,0.00011177859,0.000015123311,0.00016811168,0.00006370047,0.000019532557,0.00025781238,0.00009239023,0.0000020983907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076499684,0.061164595,0.5531877,0.00002670996,0.00010981916,4.4934697e-7,0.0016247318,0.0000038419053,0.3413104,0.000004307934,0.000121228186,0.0347962],"study_design_scores_gemma":[0.051149026,0.005057877,0.90454555,0.000017902154,0.000118701995,0.0000013684228,0.00023382883,0.0000431567,0.03583364,0.000002134867,0.0027602029,0.00023663694],"about_ca_topic_score_codex":0.00008785104,"about_ca_topic_score_gemma":0.00023751358,"teacher_disagreement_score":0.3513578,"about_ca_system_score_codex":0.000010136304,"about_ca_system_score_gemma":0.00005478384,"threshold_uncertainty_score":0.45581988},"labels":[],"label_agreement":null},{"id":"W2979726845","doi":"10.1182/blood.v128.22.994.994","title":"Patients (pts) with Renal Insufficiency (RI) and Multiple Myeloma (MM) Have Similar Outcomes after Autologous Hematopoietic Cell Transplantation (AHCT) As Those without","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Multiple myeloma; Transplantation; Hazard ratio; Melphalan; Internal medicine; Urology; Proportional hazards model; Renal function; Surgery; Creatinine; Lenalidomide; Confidence interval","score_opus":0.011511772549474096,"score_gpt":0.2590326137767893,"score_spread":0.2475208412273152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979726845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972182,0.00020551044,0.00017436966,0.00025751806,0.000027428616,0.00090743444,0.00009469128,0.00008106638,0.0010337647],"genre_scores_gemma":[0.9972569,0.00014081325,0.0014763144,0.0001389798,0.00002445837,0.00010305212,0.000046018296,0.000041271855,0.00077219657],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99807346,0.00007402344,0.00027860835,0.00049210835,0.00055072946,0.0005310638],"domain_scores_gemma":[0.99891263,0.0001635664,0.000088288274,0.00034659807,0.00012434184,0.00036454733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000101515696,0.00029812742,0.0003901351,0.00014753982,0.00011011057,0.000026656564,0.00008610611,0.000114568196,0.00008634461],"category_scores_gemma":[0.00010417784,0.00016195048,0.000075401476,0.00009397031,0.00016085009,0.00014110959,0.00003401071,0.00012717053,0.00008822969],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014728927,0.0027511716,0.9871492,0.0001597858,0.00015071403,0.0007334344,0.0008291655,3.4806482e-7,0.0016804686,0.000005869134,0.000012374614,0.0050546015],"study_design_scores_gemma":[0.029495928,0.0022719002,0.94341505,0.00030209258,0.00036271987,0.00018654758,0.00006807723,0.00002948164,0.023481667,0.000023846249,0.00012186124,0.00024084511],"about_ca_topic_score_codex":0.00006699614,"about_ca_topic_score_gemma":0.00009228675,"teacher_disagreement_score":0.04373414,"about_ca_system_score_codex":0.000044519715,"about_ca_system_score_gemma":0.00010703581,"threshold_uncertainty_score":0.6604149},"labels":[],"label_agreement":null},{"id":"W2979727212","doi":"10.1182/blood.v128.22.1535.1535","title":"Modeling of Pediatric Acute Megakaryoblastic Leukemia Using Cord Blood Stem/Progenitor Cells","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Institute for Research in Immunology and Cancer; Université de Montréal","funders":"","keywords":"Fusion gene; Cancer research; Biology; Chimeric gene; Progenitor cell; Molecular biology; Stem cell; Acute megakaryoblastic leukemia; CTL*; Myeloid; Myeloid leukemia; Gene; In vitro; Cytotoxic T cell; Gene expression; Cell biology; Genetics","score_opus":0.03346565617792274,"score_gpt":0.2857944216548569,"score_spread":0.25232876547693417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979727212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99480724,0.0006348865,0.003222079,0.0000665278,0.00019301417,0.00058257,0.000066570516,0.00010397844,0.00032310188],"genre_scores_gemma":[0.9918443,0.000452311,0.005669068,0.000041551815,0.0010325956,0.000021167085,0.0000051071315,0.00009521689,0.0008386784],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99732596,0.00007727776,0.0006336826,0.0005222501,0.00074930297,0.0006915449],"domain_scores_gemma":[0.9982175,0.0002040374,0.00016145907,0.00068638934,0.00037318302,0.00035739038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032189116,0.00030531394,0.00059767446,0.00037349996,0.000091193426,0.000017988597,0.00032801027,0.00023240484,0.000100250814],"category_scores_gemma":[0.00010146043,0.0002150373,0.00021558173,0.00053622166,0.00009145845,0.00015527176,0.00022453709,0.00031169195,0.000105442465],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052244216,0.0005740773,0.009209296,0.00035682565,0.00097131776,0.0004914419,0.00010052261,0.00021863809,0.98638666,0.000034716173,0.00019173382,0.0009423607],"study_design_scores_gemma":[0.024623115,0.001816128,0.000413908,0.0004231069,0.009390406,0.0009117795,0.000116075455,0.039382838,0.9220602,0.000080895916,0.00007460241,0.0007069378],"about_ca_topic_score_codex":0.0000836405,"about_ca_topic_score_gemma":0.0000024181472,"teacher_disagreement_score":0.06432642,"about_ca_system_score_codex":0.00026779663,"about_ca_system_score_gemma":0.0013367948,"threshold_uncertainty_score":0.8768967},"labels":[],"label_agreement":null},{"id":"W2979728937","doi":"10.1182/blood.v116.21.3465.3465","title":"Allogeneic Hematopoietic Stem Cell Transplantation for CLL: Eradication of Specific FISH Abnormalities with Relation to Gvhd and Transplant Outcomes.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada; Vancouver Hospital and Health Sciences Centre; Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Fludarabine; Medicine; Internal medicine; Hematopoietic stem cell transplantation; Transplantation; Refractory (planetary science); Gastroenterology; Oncology; Leukemia; Surgery; Immunology; Chemotherapy; Cyclophosphamide; Biology","score_opus":0.014760483570183803,"score_gpt":0.2518967631824073,"score_spread":0.23713627961222347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979728937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99599165,0.00010899994,0.0018909317,0.00036195535,0.00005056248,0.0009890645,0.00007046949,0.00003085165,0.0005055335],"genre_scores_gemma":[0.99635285,0.00015383773,0.0028455644,0.00006957803,0.000041900115,0.000091225425,0.00010348767,0.000025728084,0.00031580115],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989604,0.000019882467,0.00028460557,0.00023197097,0.00030070933,0.00020243012],"domain_scores_gemma":[0.99928665,0.00017327219,0.00007212734,0.00024571925,0.00009305642,0.00012918077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022878674,0.00012406548,0.00024431857,0.0001208977,0.000049751845,0.000013662679,0.00006748722,0.00010089499,0.000030517182],"category_scores_gemma":[0.000005925286,0.00009815415,0.000047371028,0.00011254726,0.00007031736,0.00007214672,0.0000050561,0.00011877827,0.0000037211469],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008426161,0.004877587,0.27944735,0.02221966,0.0011979734,0.00044848004,0.07083963,0.00022158127,0.5748584,0.010928171,0.0008892134,0.025645746],"study_design_scores_gemma":[0.056995124,0.0011991333,0.4331936,0.00025471958,0.0008439136,0.0011456077,0.0005585786,0.00026165025,0.5038017,0.00011452502,0.0012427379,0.00038869298],"about_ca_topic_score_codex":0.000048153666,"about_ca_topic_score_gemma":0.00008748507,"teacher_disagreement_score":0.15374625,"about_ca_system_score_codex":0.00014923429,"about_ca_system_score_gemma":0.00047288113,"threshold_uncertainty_score":0.400261},"labels":[],"label_agreement":null},{"id":"W2979732157","doi":"10.1182/blood.v122.21.282.282","title":"Novel Targeting Of Phospho-Marcks Overcomes Drug Resistance and Induces Anti-Tumor Activity In Preclinical Models Of Multiple Myeloma","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Bortezomib; MARCKS; Multiple myeloma; Cancer research; Cell culture; Viability assay; Dexamethasone; MTT assay; Western blot; Drug resistance; Pharmacology; Lenalidomide; Molecular biology; Biology; Medicine; Kinase; Immunology; Internal medicine; Protein kinase C; Cell biology; Biochemistry","score_opus":0.039176749387891605,"score_gpt":0.3084121908889006,"score_spread":0.269235441501009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979732157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976469,0.0009083251,0.000037915433,0.00017105868,0.000019356414,0.00068051676,0.000038483748,0.000015238735,0.00048215038],"genre_scores_gemma":[0.99360114,0.00012646876,0.0060047708,0.0000146581815,0.000020685005,0.000048309255,0.000008480923,0.000017443172,0.00015802191],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985896,0.00006198058,0.00039789575,0.0003073325,0.00034512303,0.00029806953],"domain_scores_gemma":[0.99874675,0.00053697167,0.00017501184,0.00026065158,0.00012725474,0.00015336818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030140686,0.00015047047,0.00053013075,0.0001096706,0.000031957636,0.000009781457,0.00009539935,0.0000700785,0.000030359779],"category_scores_gemma":[0.000695309,0.00012183977,0.00007340755,0.00017418343,0.00014759167,0.0002160686,0.000104891245,0.00021395087,0.0000023782611],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044068106,0.003290846,0.64689606,0.00044715218,0.00017722542,0.000029427354,0.0003779276,0.000006030269,0.34584358,0.000032270622,0.00005543111,0.0024033694],"study_design_scores_gemma":[0.008269887,0.00010537454,0.71524894,0.00026834966,0.000038352162,0.0000046612204,0.00009698696,0.0015701308,0.2741766,0.000121513076,0.000009128733,0.00009010835],"about_ca_topic_score_codex":0.0015260048,"about_ca_topic_score_gemma":0.00018344386,"teacher_disagreement_score":0.07166698,"about_ca_system_score_codex":0.00001945516,"about_ca_system_score_gemma":0.00009769978,"threshold_uncertainty_score":0.49684817},"labels":[],"label_agreement":null},{"id":"W2979733933","doi":"10.1182/blood.v112.11.1280.1280","title":"A Cost-Benefit Analysis of D-Dimer Measurement by a High Sensitivity Asay, as the First Step to Rule out a Venous Thromboembolism Suspected Episode, Independently of Pretest Clinical Probability.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; D-dimer; Pulmonary embolism; Deep vein; Pre- and post-test probability; Venous thrombosis; Thrombosis; Venous thromboembolism; Radiology; Surgery","score_opus":0.05153910538746791,"score_gpt":0.299280934759839,"score_spread":0.2477418293723711,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979733933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933271,0.00040854784,0.00015730076,0.0016125268,0.00015991798,0.002958033,0.00013797195,0.000070759415,0.0011678467],"genre_scores_gemma":[0.99784267,0.00019293178,0.0005897638,0.0009035916,0.00009557513,0.0002052273,0.000048963444,0.0000432482,0.000078030724],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957059,0.00026031415,0.0012481437,0.00074485666,0.0015163183,0.0005244376],"domain_scores_gemma":[0.99668425,0.00034080425,0.0005163618,0.0013148447,0.0008559347,0.00028777792],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019646226,0.0003658757,0.0021614747,0.00027367263,0.00018447996,0.000018233262,0.00029309158,0.00020778907,0.00015535844],"category_scores_gemma":[0.0007909829,0.00027831516,0.0006143522,0.001017265,0.00029840317,0.00006747968,0.0002740872,0.0003391535,0.000040722563],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010995298,0.10539127,0.77853906,0.0009874228,0.06447998,0.0004041534,0.01173608,0.0009665255,0.009704431,0.0016667243,0.01893998,0.0060848533],"study_design_scores_gemma":[0.0037604838,0.0019039819,0.9692336,0.00018712196,0.013469221,0.000026057518,0.0001495151,0.00011797653,0.008856012,0.00015006302,0.0018215136,0.00032448716],"about_ca_topic_score_codex":0.0049754274,"about_ca_topic_score_gemma":0.0060112453,"teacher_disagreement_score":0.19069451,"about_ca_system_score_codex":0.0001287452,"about_ca_system_score_gemma":0.00020232805,"threshold_uncertainty_score":0.9999669},"labels":[],"label_agreement":null},{"id":"W2979734755","doi":"10.1182/blood.v128.22.2616.2616","title":"Persistence with Dabigatran Therapy for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation: The Gloria-AF Registry","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Medicine; Discontinuation; Atrial fibrillation; Dabigatran; Stroke (engine); Interim analysis; Internal medicine; Rivaroxaban; Hazard ratio; Pediatrics; Warfarin; Vitamin K antagonist; Clinical trial; Confidence interval","score_opus":0.03296743715889104,"score_gpt":0.27607784383999456,"score_spread":0.2431104066811035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979734755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99412,0.00009679907,0.00092695997,0.0026812071,0.000114803595,0.0017108014,0.000011173386,0.000028587174,0.0003096913],"genre_scores_gemma":[0.9957299,0.00004046695,0.0010695433,0.0000367867,0.0011669111,0.0000066138005,0.000027368022,0.000019481611,0.0019028945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990583,0.000029721348,0.0002055618,0.00022961997,0.00030685862,0.0001699558],"domain_scores_gemma":[0.9993286,0.000098057106,0.00014223983,0.0002938449,0.000095908355,0.00004134692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001784772,0.0001306893,0.00020382668,0.000051032122,0.00008349901,0.00002229596,0.00007466351,0.00005420262,0.000028101029],"category_scores_gemma":[0.00004389169,0.000059783786,0.0001508249,0.00014280566,0.00005444856,0.00013742365,0.0000121514095,0.000040100644,0.000004123675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00341316,0.000019673676,0.9889079,0.000025407151,0.00023231546,0.0000014780711,0.000099399615,0.00002115364,0.00018862332,0.00010494893,0.00006421413,0.0069217654],"study_design_scores_gemma":[0.046174426,0.0022238626,0.93978465,0.00019891736,0.0003936703,0.000002947689,0.000106502535,0.000017367505,0.0006984409,0.00007718448,0.010150032,0.0001719958],"about_ca_topic_score_codex":0.0000059445892,"about_ca_topic_score_gemma":0.000010845007,"teacher_disagreement_score":0.04912321,"about_ca_system_score_codex":0.000025084722,"about_ca_system_score_gemma":0.000062115134,"threshold_uncertainty_score":0.24379121},"labels":[],"label_agreement":null},{"id":"W2979737440","doi":"10.1182/blood.v126.23.2775.2775","title":"Imatinib Suspension and Validation (ISAV) Study: Results at 24 Months","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Imatinib; Discontinuation; Medicine; Imatinib mesylate; Internal medicine; Oncology; Minimal residual disease; Myeloid leukemia; Digital polymerase chain reaction; Surgery; Gastroenterology; Leukemia; Polymerase chain reaction; Biology","score_opus":0.0445280892108227,"score_gpt":0.2954789681220792,"score_spread":0.2509508789112565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979737440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914208,0.00030451623,0.0000010129464,0.00033677914,0.00011951448,0.0007581139,0.000010486496,0.00007636987,0.0069724033],"genre_scores_gemma":[0.9962021,0.000024100671,0.0006578744,0.000047440204,0.00011644813,0.000020781448,0.00010315493,0.000019757137,0.0028083283],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989204,0.000053756976,0.00024047411,0.00029507032,0.00032314882,0.00016715578],"domain_scores_gemma":[0.9992154,0.000060104638,0.000081975035,0.000369202,0.00008266128,0.00019063876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026967836,0.00013012603,0.00021780473,0.00005210706,0.000053265587,0.000014991839,0.000037916016,0.00006046428,0.000025787678],"category_scores_gemma":[0.00031103578,0.00010515926,0.000025547415,0.00008997407,0.0000258945,0.00006649823,0.000095176794,0.00007971015,0.00014564309],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003813276,0.008941598,0.9068672,0.0001571698,0.0009051949,0.0015761758,0.017561048,0.000020234796,0.014818782,0.000065395034,0.036290623,0.008983292],"study_design_scores_gemma":[0.29905978,0.009419537,0.5361055,0.0004448391,0.0032940297,0.0012793265,0.00430412,0.0006706365,0.13475223,0.00036405347,0.009497347,0.0008086265],"about_ca_topic_score_codex":0.00019479515,"about_ca_topic_score_gemma":0.00007682788,"teacher_disagreement_score":0.37076172,"about_ca_system_score_codex":0.00026056473,"about_ca_system_score_gemma":0.00013177609,"threshold_uncertainty_score":0.42882705},"labels":[],"label_agreement":null},{"id":"W2979737867","doi":"10.1182/blood.v128.22.2593.2593","title":"Interim Canadian Data from a Prospective, Observational Study of Routine Clinical Use of a Von Willebrand Factor Concentrate (Wilate®)","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; St. Michael's Hospital; Queen's University","funders":"","keywords":"Medicine; Von Willebrand disease; Von Willebrand factor; Interim analysis; Tolerability; Desmopressin; Pediatrics; Observational study; Clinical trial; Adverse effect; Internal medicine; Surgery","score_opus":0.24786771501430263,"score_gpt":0.373868396459862,"score_spread":0.12600068144555934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979737867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972009,0.00007056971,0.00000677394,0.00016534526,0.000063982116,0.0005843267,0.0018420175,0.000009315983,0.000056779376],"genre_scores_gemma":[0.9993592,0.00003930864,0.00016732879,0.00005482129,0.00002988978,0.000006331565,0.00022483154,0.000011350627,0.000106959946],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99894893,0.00004360101,0.00041162164,0.0002865831,0.00016102145,0.00014825386],"domain_scores_gemma":[0.99900955,0.00014487536,0.0001410571,0.00045175303,0.00010303747,0.00014971774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006883116,0.00010772009,0.00041130107,0.00003901251,0.00001962332,0.000006384952,0.00011909493,0.000060084334,0.00019902774],"category_scores_gemma":[0.0002379565,0.000067929286,0.000039866198,0.00007410866,0.00006112172,0.00014731831,0.00005549759,0.000059001028,0.000007759344],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029269748,0.0029566113,0.99387944,0.000006320676,0.0007888316,0.00010167698,0.00018541768,6.406484e-8,0.0010118723,0.00000732221,0.00016073821,0.0006090185],"study_design_scores_gemma":[0.016227039,0.00088479556,0.98123085,0.00011102087,0.0002918211,0.0000046839436,0.00006640121,0.00002112957,0.0008053147,0.000028220767,0.00026214911,0.00006657503],"about_ca_topic_score_codex":0.03601491,"about_ca_topic_score_gemma":0.050430767,"teacher_disagreement_score":0.01593434,"about_ca_system_score_codex":0.000022124537,"about_ca_system_score_gemma":0.0002649632,"threshold_uncertainty_score":0.9704043},"labels":[],"label_agreement":null},{"id":"W2979745798","doi":"10.1182/blood.v124.21.1389.1389","title":"Divergence from Hardy Weinberg Equilibrium in Newborn Screening Cohorts for Sickle Hemoglobin","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Confidence interval; Medicine; Newborn screening; Relative risk; Sickle cell anemia; Hemoglobin; Pediatrics; Internal medicine; Gastroenterology; Demography; Disease","score_opus":0.011190698475664439,"score_gpt":0.236995575383437,"score_spread":0.22580487690777254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979745798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887632,0.00089403836,0.0042161173,0.0009901188,0.00030894228,0.0006154883,0.000029285802,0.00011097952,0.0040717926],"genre_scores_gemma":[0.987855,0.000064333886,0.010247424,0.0005848305,0.00029393277,0.00004200298,0.00011246245,0.000041208983,0.0007588091],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985977,0.000037660247,0.00032632763,0.00039424168,0.00021575594,0.00042834837],"domain_scores_gemma":[0.9992288,0.00011250866,0.00007456874,0.00034442983,0.000057452256,0.00018227694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022470835,0.0001889033,0.00038970576,0.00008235047,0.000061108854,0.000019752051,0.00012990423,0.00019334958,0.00014259983],"category_scores_gemma":[0.000221319,0.00016860905,0.00013032835,0.00020561225,0.000057774956,0.00007810871,0.00007932038,0.00020783923,0.000050398474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007902264,0.0022398357,0.82160413,0.00029714569,0.00053765,0.00019333547,0.0012882467,0.00039704473,0.09980894,0.00045223613,0.010795379,0.061595853],"study_design_scores_gemma":[0.0705347,0.0027509471,0.3949647,0.0022992096,0.0023165978,0.00014912566,0.0017209459,0.026494635,0.12362021,0.0044916067,0.36842155,0.002235755],"about_ca_topic_score_codex":0.0004899582,"about_ca_topic_score_gemma":0.000050254283,"teacher_disagreement_score":0.4266394,"about_ca_system_score_codex":0.000017790004,"about_ca_system_score_gemma":0.000056708777,"threshold_uncertainty_score":0.6875678},"labels":[],"label_agreement":null},{"id":"W2979748361","doi":"10.1182/blood.v126.23.825.825","title":"Phase 1b/2 Study of the Efficacy and Safety of Sonidegib (LDE225) in Combination with Ruxolitinib (INC424) in Patients with Myelofibrosis","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Ruxolitinib; Medicine; Myelofibrosis; Internal medicine; Phases of clinical research; Janus kinase inhibitor; Oncology; Gastroenterology; Surgery; Bone marrow; Toxicity; Janus kinase","score_opus":0.015993639499208036,"score_gpt":0.26365822068121864,"score_spread":0.2476645811820106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979748361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99784017,0.000040713097,0.0000011686935,0.00010615954,0.000012956371,0.0016893725,0.000013283234,0.0000043939244,0.00029180877],"genre_scores_gemma":[0.9997254,0.000006258189,0.00013497252,0.000019796105,0.00000602506,0.00006620063,0.000013399963,0.0000119400775,0.000015997193],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989459,0.00009392488,0.0002960598,0.00019152496,0.00034538252,0.00012719042],"domain_scores_gemma":[0.9993119,0.00009078386,0.00015143043,0.00021680769,0.00016127029,0.00006776229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015571162,0.00013023076,0.00035713345,0.000092489325,0.000022007274,0.000004999331,0.000045932047,0.0000336702,0.0000050992626],"category_scores_gemma":[0.00006862856,0.00007176452,0.000014797199,0.00027522532,0.00006475811,0.00005063017,0.000031467185,0.00008297189,5.536817e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022707405,0.060815,0.9328652,0.00003608256,0.00009818403,0.000006832717,0.0027404695,0.0000060777134,0.0000184069,0.00008146521,0.00000575892,0.0010557822],"study_design_scores_gemma":[0.16279908,0.013644072,0.81996286,0.00031155444,0.00017342578,0.0000019366644,0.00052259094,0.0000070410388,0.0025012852,0.00000890549,0.0000073459933,0.00005989453],"about_ca_topic_score_codex":0.00023789583,"about_ca_topic_score_gemma":0.00058372144,"teacher_disagreement_score":0.16052833,"about_ca_system_score_codex":0.0000368287,"about_ca_system_score_gemma":0.00008667582,"threshold_uncertainty_score":0.29264724},"labels":[],"label_agreement":null},{"id":"W2979749366","doi":"10.1182/blood.v114.22.2280.2280","title":"The Presence of HLA DR15 Antigen in Patients with Severe Aplastic Anemia Does Not Impact Engraftment and Survival After HLA-Identical Sibling Transplantation.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia; Princess Margaret Cancer Centre","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Aplastic anemia; Medicine; Human leukocyte antigen; Immunology; Internal medicine; Transplantation; Sibling; Hematopoietic stem cell transplantation; Bone marrow; Gastroenterology; Antigen","score_opus":0.0056706947561891855,"score_gpt":0.2388943562316772,"score_spread":0.233223661475488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979749366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998779,0.00008342159,0.00028938896,0.00010696858,0.000042629243,0.0005012827,0.0000409185,0.000014750659,0.00014162174],"genre_scores_gemma":[0.9992913,0.00016195787,0.0004269754,0.000024626544,0.000022385799,0.0000109944585,0.00002692289,0.000010950086,0.00002385989],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987445,0.000063831256,0.00033270128,0.00020627245,0.0004263098,0.00022640002],"domain_scores_gemma":[0.9992558,0.00035142258,0.000067479785,0.00015882328,0.00007241385,0.00009407305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020846755,0.00014524354,0.00022887834,0.00008430099,0.000043833967,0.00002397631,0.000058361256,0.00006194941,0.00001849322],"category_scores_gemma":[0.00004175771,0.00007950592,0.000036851714,0.00015236944,0.00006567356,0.000086650594,0.000004584904,0.0001177035,0.0000020207565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015213948,0.00044649627,0.9935947,0.0002709314,0.000052575226,0.00008815425,0.0015122169,0.000022131853,0.0020886858,0.000027650782,0.0000013164965,0.00037375465],"study_design_scores_gemma":[0.005895665,0.0005383245,0.9794194,0.000425186,0.00024567745,0.00004516059,0.00008541827,0.00004505483,0.013160475,0.000031563388,0.0000024338872,0.00010565966],"about_ca_topic_score_codex":0.00003346345,"about_ca_topic_score_gemma":0.000069543144,"teacher_disagreement_score":0.01417531,"about_ca_system_score_codex":0.000015220782,"about_ca_system_score_gemma":0.000055007054,"threshold_uncertainty_score":0.32421574},"labels":[],"label_agreement":null},{"id":"W2979752482","doi":"10.1182/blood.v120.21.5134.5134","title":"Incidental Venous Thromboembolism in Kidney Cancer Patients: A Retrospective Case-Control Study","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Cancer; Hazard ratio; Pulmonary embolism; Retrospective cohort study; Kidney cancer; Asymptomatic; Stage (stratigraphy); Deep vein; Internal medicine; Surgery; Radiology; Thrombosis; Confidence interval","score_opus":0.01011932112070702,"score_gpt":0.27030148933209003,"score_spread":0.260182168211383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979752482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938883,0.00057462533,0.0000026915372,0.00013999014,0.000588212,0.002310022,0.00008197378,0.000072673676,0.0023415205],"genre_scores_gemma":[0.99744505,0.000060983235,0.000035273642,0.0013873442,0.0005131118,0.00045078507,0.000010835568,0.000048442897,0.000048194892],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998158,0.00009359194,0.0003731345,0.0003530159,0.0004055486,0.00061674125],"domain_scores_gemma":[0.9990551,0.000029581372,0.000118249234,0.00034726303,0.00009650858,0.0003533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003432835,0.00024940993,0.0007983762,0.00019479629,0.00010854312,0.000024442854,0.00009862628,0.00008678312,0.0004292363],"category_scores_gemma":[0.00015657737,0.00022358992,0.000100593985,0.0002949998,0.00003940659,0.00021847076,0.00009592335,0.00025815106,0.00006843591],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003782743,0.04027848,0.95015496,0.000052013016,0.00061074126,0.00074009644,0.006328104,0.0000010828549,0.00007613299,0.00010838294,0.0009398911,0.0006723079],"study_design_scores_gemma":[0.0133667635,0.0013558656,0.98170686,0.00011483806,0.0013469955,0.00011827888,0.0014196723,0.000004427283,0.00013352968,0.00002400563,0.00018294292,0.00022580907],"about_ca_topic_score_codex":0.0029555378,"about_ca_topic_score_gemma":0.0006691757,"teacher_disagreement_score":0.03892261,"about_ca_system_score_codex":0.00028396945,"about_ca_system_score_gemma":0.00007766124,"threshold_uncertainty_score":0.9117732},"labels":[],"label_agreement":null},{"id":"W2979752621","doi":"10.1182/blood.v114.22.2363.2363","title":"Fludarabine (F) and Rituximab (R) (FR) as Initial Therapy for Symptomatic Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL): Population-Based Experience Matches Clinical Trials.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; St. Paul's Hospital; Leukemia & Lymphoma Society of Canada; University of British Columbia","funders":"","keywords":"Medicine; Fludarabine; Internal medicine; Rituximab; Chronic lymphocytic leukemia; Population; Cyclophosphamide; Gastroenterology; Oncology; Surgery; Lymphoma; Leukemia; Chemotherapy","score_opus":0.11322839515593047,"score_gpt":0.429709454932312,"score_spread":0.3164810597763815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979752621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99010634,0.0038846922,0.00041970235,0.0003193091,0.00038826535,0.004143043,0.00004335924,0.00044313667,0.00025212223],"genre_scores_gemma":[0.99079335,0.0010234528,0.0029647176,0.0022484078,0.0015259178,0.0006421901,0.00020516333,0.00015050327,0.00044628442],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99262935,0.00072254136,0.0026974997,0.0014543332,0.00109628,0.0014000102],"domain_scores_gemma":[0.99208254,0.004603954,0.0006718339,0.0014047396,0.00034941777,0.00088750327],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0033129659,0.00085310586,0.0025187307,0.00043400517,0.0003997452,0.0002434177,0.00059076067,0.0007177526,0.00027321692],"category_scores_gemma":[0.0059838346,0.0006586464,0.0007184847,0.00069019134,0.0004705174,0.0002594853,0.00010491204,0.00027676887,0.00011306598],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.09008933,0.017013801,0.0057417443,0.0068975,0.004318877,0.0048706387,0.0048651537,0.0009954722,0.01160656,0.0021479814,0.0019925877,0.84946036],"study_design_scores_gemma":[0.74625385,0.011522471,0.010886687,0.0017570609,0.0015014483,0.0031249542,0.0003470369,0.18933749,0.030792342,0.0014335309,0.0014323633,0.0016107821],"about_ca_topic_score_codex":0.0016801017,"about_ca_topic_score_gemma":0.00009351831,"teacher_disagreement_score":0.84784955,"about_ca_system_score_codex":0.042999454,"about_ca_system_score_gemma":0.07673521,"threshold_uncertainty_score":0.99958646},"labels":[],"label_agreement":null},{"id":"W2979755727","doi":"10.1182/blood.v118.21.2520.2520","title":"Prognostic Significance of FLT3 and NPM1 Mutations in Adults of Age 18–60 with De Novo Acute Myeloid Leukemia (AML) on SWOG S0106 Study: A Study by FHCRC and SWOG","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"NPM1; Internal medicine; Medicine; Oncology; Univariate analysis; Gemtuzumab ozogamicin; Myeloid leukemia; Proportional hazards model; Minimal residual disease; Bone marrow; Biology; Multivariate analysis; Genetics; Gene; CD33; Stem cell","score_opus":0.020723960275824103,"score_gpt":0.277662064979687,"score_spread":0.25693810470386286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979755727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953636,0.00017980376,0.00002216359,0.000041233103,0.000010730498,0.0034283719,0.00005938659,0.000031934967,0.00086275657],"genre_scores_gemma":[0.99812967,0.000061118975,0.0011864178,0.000033471286,0.000022714787,0.00031037672,0.000017261329,0.000046028938,0.00019293971],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979492,0.00016875585,0.00046267823,0.0005148916,0.0005071914,0.0003973297],"domain_scores_gemma":[0.9987445,0.0002659881,0.0001705492,0.00043674477,0.00017916993,0.00020304942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047177722,0.00025371398,0.00058937573,0.00028600593,0.000057318455,0.000012786016,0.00017450936,0.0000955566,0.000024299434],"category_scores_gemma":[0.00026953916,0.0002051693,0.000029699619,0.0005326828,0.00030355537,0.00009062245,0.00010098726,0.00041592712,0.0000028991128],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027724192,0.0077734767,0.93238646,0.00037132512,0.00070072466,0.0019519201,0.024459654,0.0000033280492,0.028306654,0.000013637408,0.000089241374,0.0011711842],"study_design_scores_gemma":[0.02849076,0.014842826,0.9208281,0.00051038055,0.0009091711,0.0001378405,0.010411506,0.00005918761,0.02351283,0.000030417326,0.000009566159,0.00025741555],"about_ca_topic_score_codex":0.0015597708,"about_ca_topic_score_gemma":0.0008043723,"teacher_disagreement_score":0.02571834,"about_ca_system_score_codex":0.00013637936,"about_ca_system_score_gemma":0.00053196965,"threshold_uncertainty_score":0.83665615},"labels":[],"label_agreement":null},{"id":"W2979756100","doi":"10.1182/blood.v116.21.1102.1102","title":"Outcome of Saddle Pulmonary Embolism: A Nested Case-Control Study.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Pulmonary embolism; Saddle; Cohort; Cardiology; Internal medicine; Retrospective cohort study; Thrombus; Surgery; Radiology","score_opus":0.01620043645668403,"score_gpt":0.2788192607137143,"score_spread":0.2626188242570303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979756100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925953,0.00010354203,0.00001393707,0.0003399296,0.0003108961,0.0012958051,0.000020814165,0.00007954002,0.0052402182],"genre_scores_gemma":[0.99861956,0.000008021345,0.00025947057,0.00039248232,0.00023755721,0.0000930157,0.0000036967917,0.00003156011,0.00035466225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987413,0.00004015806,0.00042594227,0.00027016125,0.00026084617,0.00026153718],"domain_scores_gemma":[0.9989858,0.00007257489,0.00011413252,0.0005877633,0.000095400406,0.00014431591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032894232,0.00017020009,0.0006490775,0.00013393458,0.00006662658,0.000013110651,0.00011545174,0.00008457814,0.0004177079],"category_scores_gemma":[0.00010826449,0.00014086008,0.00013568823,0.00017430217,0.000048126374,0.00005434268,0.00006523533,0.00023372244,0.000046021458],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067393274,0.021759259,0.9459592,0.00021892069,0.00083545246,0.009506997,0.0009097513,0.0000028894522,0.013059124,0.0009144501,0.00038818535,0.0063783964],"study_design_scores_gemma":[0.006441113,0.000664469,0.98606116,0.000025320269,0.002117082,0.0016492333,0.000902876,0.000047604375,0.00087387883,0.00004299499,0.0010012708,0.00017297137],"about_ca_topic_score_codex":0.00042322127,"about_ca_topic_score_gemma":0.00024768425,"teacher_disagreement_score":0.040102005,"about_ca_system_score_codex":0.000006306711,"about_ca_system_score_gemma":0.000030019426,"threshold_uncertainty_score":0.57441074},"labels":[],"label_agreement":null},{"id":"W2979760837","doi":"10.1182/blood.v114.22.649.649","title":"Reducing the Risk for Transplant Related Mortality After Allogeneic Hematopoietic Cell Transplantation: How Much Progress Has Been Made?.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Proportional hazards model; Transplantation; Incidence (geometry); Graft-versus-host disease; Surgery; Oncology; Confidence interval","score_opus":0.020369246147848647,"score_gpt":0.25743112578517585,"score_spread":0.2370618796373272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979760837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98831826,0.001600825,0.0021688994,0.0044885473,0.00014576518,0.002332008,0.00021338166,0.0001859817,0.00054634886],"genre_scores_gemma":[0.9956604,0.00044844672,0.0025664286,0.00021781161,0.00014834612,0.00032553336,0.00028629886,0.000053446172,0.00029325602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99763685,0.00015307117,0.0005889336,0.00058102293,0.0005022819,0.00053785986],"domain_scores_gemma":[0.9987176,0.00018774976,0.00020394142,0.00058188516,0.00011109332,0.00019775164],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00057811476,0.00036472594,0.0004798581,0.00009769173,0.0002734909,0.00008749785,0.00019888206,0.00026743513,0.000070325485],"category_scores_gemma":[0.000014804209,0.00026509695,0.0003169509,0.0002667886,0.00016118778,0.000115827264,0.00000409496,0.00034458833,0.00001949614],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00592001,0.009901133,0.648337,0.0152834,0.0036547484,0.0046219886,0.10694449,0.000113500915,0.1966047,0.0013412187,0.00095686986,0.0063209618],"study_design_scores_gemma":[0.0140209915,0.0009014663,0.5606414,0.0010803834,0.009542283,0.0024071636,0.0006275182,0.00019646989,0.4085943,0.0010001728,0.0002600495,0.0007277893],"about_ca_topic_score_codex":0.000016611886,"about_ca_topic_score_gemma":0.000012731146,"teacher_disagreement_score":0.21198961,"about_ca_system_score_codex":0.000026647742,"about_ca_system_score_gemma":0.00013211767,"threshold_uncertainty_score":0.99998015},"labels":[],"label_agreement":null},{"id":"W2979762052","doi":"10.1182/blood.v118.21.3715.3715","title":"An Open-Label, Phase I Study of R-CVP in Combination with Inotuzumab Ozogamicin in Patients with Relapsed/Refractory CD22-Positive B-Cell Non-Hodgkin Lymphoma,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Rituximab; Tolerability; Calicheamicin; Internal medicine; Refractory (planetary science); Regimen; Febrile neutropenia; Gastroenterology; Chemotherapy regimen; Vincristine; Cyclophosphamide; Phases of clinical research; Lymphoma; Chemotherapy; Oncology; Neutropenia; Adverse effect","score_opus":0.01756875012756951,"score_gpt":0.2685898187690278,"score_spread":0.2510210686414583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979762052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99545586,0.000039319373,0.0000027678188,0.0000072607436,0.00002774833,0.002727492,0.000022437724,0.000016902928,0.0017001943],"genre_scores_gemma":[0.9990753,0.000008368652,0.00047537155,0.000056831464,0.00000739196,0.00019120424,0.000119515214,0.00004087103,0.000025160785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836284,0.00012659754,0.0004149325,0.00046411963,0.00036977063,0.0002617345],"domain_scores_gemma":[0.9989352,0.000047814578,0.00024721885,0.00048057854,0.00016757206,0.000121587145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015657862,0.00026679374,0.0005433486,0.0002922307,0.000041411164,0.000017374829,0.0001911344,0.000087731336,0.000021186765],"category_scores_gemma":[0.000009967931,0.0001935053,0.000014402666,0.00041232948,0.000054525593,0.00033198923,0.00006148451,0.00009290611,0.000006970455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004240247,0.3285941,0.65818805,0.000023438653,0.00012538517,0.0002775768,0.0050612767,7.614734e-7,0.00024526907,0.000013458912,0.0000061411047,0.0032243298],"study_design_scores_gemma":[0.27114776,0.06702406,0.6515898,0.0002285111,0.00027028244,0.000003878108,0.00086071756,0.00001729486,0.00869793,0.0000051079646,0.0000017161475,0.00015294053],"about_ca_topic_score_codex":0.0035564248,"about_ca_topic_score_gemma":0.00092950417,"teacher_disagreement_score":0.2669075,"about_ca_system_score_codex":0.00025322914,"about_ca_system_score_gemma":0.00020311662,"threshold_uncertainty_score":0.7890917},"labels":[],"label_agreement":null},{"id":"W2979762908","doi":"10.1182/blood.v114.22.816.816","title":"Identification of Single Human Hematopoietic Stem Cells Capable of Long-Term Multilineage Engraftment and Self-Renewal.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto General Hospital","funders":"","keywords":"Stem cell; Haematopoiesis; Cord blood; Biology; CD90; Transplantation; Cell biology; CD34; Immunology; CD38; Cancer research; Medicine; Internal medicine","score_opus":0.02600238333074685,"score_gpt":0.2954222083115235,"score_spread":0.26941982498077666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979762908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99757236,0.0007017834,0.000033291944,0.00003832496,0.000022101949,0.0005809624,0.000004721674,0.000029094397,0.0010173286],"genre_scores_gemma":[0.998172,0.00007234202,0.0002447673,0.000008795982,0.000030605897,0.000007844958,0.000007225789,0.000012490921,0.0014439635],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99861646,0.00005048385,0.00048432357,0.00023865455,0.00041093503,0.00019912915],"domain_scores_gemma":[0.9991124,0.000051804633,0.0001772851,0.00038471734,0.00014941544,0.00012437123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034123668,0.000113870905,0.00031462096,0.00011404845,0.0000406204,0.0000125154775,0.000093056056,0.00007370007,0.000053045627],"category_scores_gemma":[0.000014761289,0.00010160501,0.00005968609,0.00014334136,0.00005583249,0.000038717768,0.00003266684,0.00007981259,0.0000078175735],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001759189,0.00301234,0.009018857,0.00074487366,0.000058896618,0.00002980528,0.00053321925,0.0000010483672,0.98579425,0.00004746148,0.000015067699,0.0007266011],"study_design_scores_gemma":[0.0020031107,0.00069637294,0.020933084,0.0001618361,0.00016850399,0.000024849922,0.000072551535,0.000033325043,0.9758018,0.000024550287,0.00000824333,0.00007171787],"about_ca_topic_score_codex":0.000019406016,"about_ca_topic_score_gemma":0.0000060965353,"teacher_disagreement_score":0.011914228,"about_ca_system_score_codex":0.00002643613,"about_ca_system_score_gemma":0.00003523105,"threshold_uncertainty_score":0.4143332},"labels":[],"label_agreement":null},{"id":"W2979763386","doi":"10.1182/blood.v124.21.2730.2730","title":"Understanding Neutropenia: The 20 Year Experience of the Severe Chronic Neutropenia International Registry (SCNIR)","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome Canada; Hospital for Sick Children","funders":"","keywords":"Medicine; Neutropenia; Internal medicine; Absolute neutrophil count; Transplantation; Granulocyte colony-stimulating factor; Rheumatoid arthritis; Congenital Neutropenia; Febrile neutropenia; Clinical trial; Pediatrics; Chemotherapy","score_opus":0.01733110994533771,"score_gpt":0.23011134351429224,"score_spread":0.21278023356895454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979763386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858993,0.00040301456,0.00026640113,0.00070758996,0.00023783004,0.00016263874,0.000018076857,0.000006194137,0.012298951],"genre_scores_gemma":[0.9986166,0.00007404965,0.00004560347,0.00013648412,0.00015081295,0.000013833997,0.000015900114,0.000011801571,0.0009349245],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993918,0.000043237458,0.00011577978,0.00019125808,0.00012500124,0.0001329147],"domain_scores_gemma":[0.9994061,0.000008876749,0.000090611284,0.00044340026,0.00002574815,0.000025263615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000054700125,0.000096183736,0.00007936617,0.000008433801,0.00010966782,0.00002625527,0.00046164467,0.00006126164,0.00003040908],"category_scores_gemma":[0.000024249475,0.000056686782,0.0000802952,0.000053285232,0.00012303544,0.000004250617,0.00018379359,0.00006726382,0.0000053206536],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003229112,0.0018507913,0.35047805,0.000086683416,0.001662073,0.000012296865,0.0011896605,0.0008312132,0.6069749,0.01657242,0.017946552,0.002072472],"study_design_scores_gemma":[0.017943172,0.001228598,0.047186468,0.00016616096,0.00054102717,0.00022039292,0.0024947205,0.00024681177,0.7630766,0.0020883821,0.1638591,0.00094855536],"about_ca_topic_score_codex":0.000022240687,"about_ca_topic_score_gemma":0.000107341824,"teacher_disagreement_score":0.3032916,"about_ca_system_score_codex":0.000013641716,"about_ca_system_score_gemma":0.000048039296,"threshold_uncertainty_score":0.231162},"labels":[],"label_agreement":null},{"id":"W2979764516","doi":"10.1182/blood.v114.22.1535.1535","title":"The Utilization of a Computerized Pain Assessment Tool-PAINReportIt® in Adolescents with Sickle Cell Disease.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; McGill Pain Questionnaire; Pain assessment; Disease; Physical therapy; Chronic pain; Sickle cell anemia; Visual analogue scale; Internal medicine; Pain management","score_opus":0.008051263229431541,"score_gpt":0.24487473787898628,"score_spread":0.23682347464955475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979764516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953643,0.0006401472,0.0018778647,0.00074691576,0.00002980729,0.00048344504,0.000001264272,0.000029192135,0.00082704995],"genre_scores_gemma":[0.9990445,0.00014780145,0.0003232664,0.00038239217,0.000015285432,0.000005809737,0.000011505513,0.000007729996,0.00006172026],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991546,0.00007967899,0.0002619094,0.00013325328,0.00021290957,0.0001576307],"domain_scores_gemma":[0.99955434,0.000015220311,0.000106608466,0.00020899356,0.000048214937,0.00006660083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003280343,0.00008770246,0.00015625608,0.000036525485,0.000043588436,0.000010334045,0.000050793027,0.0000411712,0.000004277656],"category_scores_gemma":[0.000034537967,0.000052508887,0.00004177585,0.00017968487,0.00003563317,0.00002378625,0.000010693302,0.00010409342,9.889726e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080513547,0.0079267,0.94923395,0.0005115716,0.00007070824,0.0004052458,0.00035291867,0.00023438131,0.0055928235,0.0002895748,0.00034205796,0.03423493],"study_design_scores_gemma":[0.008833339,0.00082849985,0.98237973,0.0010280263,0.00017298546,0.00001003934,0.00026234394,0.004664269,0.0008361661,0.00012976902,0.0007161394,0.00013871127],"about_ca_topic_score_codex":0.00001249507,"about_ca_topic_score_gemma":0.000004611211,"teacher_disagreement_score":0.03409622,"about_ca_system_score_codex":0.000015781789,"about_ca_system_score_gemma":0.00014162206,"threshold_uncertainty_score":0.21412502},"labels":[],"label_agreement":null},{"id":"W2979764529","doi":"10.1182/blood.v124.21.1450.1450","title":"PETIT and PETIT 2: Treatment with Eltrombopag in 171 Children with Chronic Immune Thrombocytopenia (ITP)","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; Hospital for Sick Children","funders":"","keywords":"Medicine; Eltrombopag; Internal medicine; Adverse effect; Tolerability; Randomized controlled trial; Population; Cohort; Romiplostim; Gastroenterology; Pediatrics; Surgery; Thrombopoietin; Immune thrombocytopenia; Platelet; Biology","score_opus":0.005151098133502272,"score_gpt":0.21159002745721672,"score_spread":0.20643892932371444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979764529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99430525,0.0016961335,0.000006957824,0.00035066876,0.000010201821,0.00064076594,0.00000874291,0.00004175239,0.0029395134],"genre_scores_gemma":[0.9982,0.0005165883,0.00046420726,0.00004619524,0.000049338356,0.000061672494,0.00007254098,0.00003575907,0.000553677],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989899,0.000024554678,0.00015512857,0.00035267507,0.00016387978,0.0003138827],"domain_scores_gemma":[0.9994686,0.000021261852,0.000058705584,0.0003212915,0.000020055633,0.00011007532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000050616174,0.0002530266,0.0005595117,0.00007880144,0.00006381564,0.000024518773,0.000053767882,0.00005763872,0.00008870879],"category_scores_gemma":[0.000004458481,0.00015444143,0.000035512563,0.00012628107,0.00008171276,0.000068121844,0.00002099124,0.00009826408,0.000039317943],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031145624,0.0024977739,0.9869741,0.000040180323,0.00089855463,0.00045198144,0.0002195039,0.0000031306047,0.0016405687,0.000101528196,0.000011008726,0.006850171],"study_design_scores_gemma":[0.0341184,0.008655702,0.9486889,0.00023624212,0.0007216342,0.0013054325,0.000024639232,0.000018602484,0.005484362,0.000028609014,0.0004883991,0.00022902904],"about_ca_topic_score_codex":0.0006534556,"about_ca_topic_score_gemma":0.0014677788,"teacher_disagreement_score":0.038285192,"about_ca_system_score_codex":0.00007794103,"about_ca_system_score_gemma":0.00010057099,"threshold_uncertainty_score":0.6297939},"labels":[],"label_agreement":null},{"id":"W2979765136","doi":"10.1182/blood.v120.21.2745.2745","title":"Long-Term Remissions Observed in an Ongoing Phase 2 Study of Brentuximab Vedotin in Patients with Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Brentuximab vedotin; Medicine; Anaplastic large-cell lymphoma; Internal medicine; CD30; Oncology; Population; Phases of clinical research; Clinical endpoint; Lymphoma; Surgery; Chemotherapy; Gastroenterology; Clinical trial","score_opus":0.024482869844130693,"score_gpt":0.2785730313743936,"score_spread":0.2540901615302629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979765136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980922,0.0004180887,8.2948594e-7,0.0000036758288,0.0000856356,0.0012967201,0.000026285785,0.000030413608,0.000046194236],"genre_scores_gemma":[0.99958384,0.000015900781,0.00005477778,0.000016179145,0.000036295478,0.00010541491,0.000114671515,0.0000381362,0.00003480673],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981508,0.00016024047,0.00054980995,0.00033462857,0.00036355513,0.00044096963],"domain_scores_gemma":[0.99883574,0.00013317991,0.00023087123,0.00047010623,0.000071301925,0.0002588115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019766141,0.00024280169,0.0005546016,0.00022155818,0.00004663521,0.0000105847785,0.00009974872,0.000095164236,0.000034578774],"category_scores_gemma":[0.00007317185,0.00016509584,0.000043344033,0.0003389513,0.000016813903,0.00019313175,0.000047311216,0.000090144444,0.000007674529],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001636284,0.20893069,0.78628457,0.00018981924,0.00007402177,0.0002331994,0.0017094582,0.0000013521474,0.00032812392,6.5451235e-7,0.0000048985858,0.00060693483],"study_design_scores_gemma":[0.17741114,0.007529359,0.8119435,0.0009957493,0.00037705657,0.000013563444,0.0006562565,0.000012151758,0.0009146271,9.0926214e-8,0.000002645552,0.0001438787],"about_ca_topic_score_codex":0.000107706306,"about_ca_topic_score_gemma":0.00043022993,"teacher_disagreement_score":0.20140132,"about_ca_system_score_codex":0.0002444104,"about_ca_system_score_gemma":0.00016804399,"threshold_uncertainty_score":0.6732413},"labels":[],"label_agreement":null},{"id":"W2979766391","doi":"10.1182/blood.v124.21.165.165","title":"Patient Related Factors Have an Indepedent Impact on Overall Survival in Myelodysplastic Syndrome Patients: A Report of the MDS-Can Registry","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Vancouver General Hospital; Princess Margaret Cancer Centre; University of Calgary; University Health Network; Health Sciences Centre; CancerCare Manitoba; McMaster University Medical Centre; Ottawa Hospital; St. Paul's Hospital; University of Alberta; University of British Columbia; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; International Prognostic Scoring System; Comorbidity; Hazard ratio; Proportional hazards model; Physical therapy; Grip strength; Myelodysplastic syndromes; Univariate analysis; Internal medicine; Gerontology; Multivariate analysis; Confidence interval","score_opus":0.01628195494846258,"score_gpt":0.2832352493381658,"score_spread":0.2669532943897032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979766391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99791527,0.000008737217,0.0000015294388,0.00023937131,0.00030103445,0.0004313865,0.000022232312,0.000028509534,0.0010519299],"genre_scores_gemma":[0.9995837,0.000004410003,0.000027604136,0.00017970742,0.000023444663,0.000009131703,0.000071724644,0.000021865693,0.000078382254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998281,0.00014211876,0.0005910026,0.00025616566,0.0004733624,0.00025634738],"domain_scores_gemma":[0.9987803,0.00009030543,0.0003406436,0.0005139119,0.000091646114,0.00018316363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025414096,0.00015918774,0.00034827902,0.00012834718,0.000054158034,0.000008722792,0.00008386991,0.00012308506,0.00004870118],"category_scores_gemma":[0.00039803513,0.000103021215,0.00010107476,0.00014081533,0.000046887293,0.000038408652,0.00003413591,0.00037157073,0.000002634203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009511331,0.0017255917,0.99705786,0.000105782776,0.000034076515,0.000108931046,0.00054925936,0.000023263505,0.00011177452,0.000055156695,0.00004499021,0.000088214],"study_design_scores_gemma":[0.004263403,0.0015329059,0.99250126,0.0005961422,0.00005250907,0.00016838337,0.00013458305,0.00006690644,0.00037929838,0.00011854229,0.00008195266,0.00010411184],"about_ca_topic_score_codex":0.0003468368,"about_ca_topic_score_gemma":0.000059224094,"teacher_disagreement_score":0.004556584,"about_ca_system_score_codex":0.00012299772,"about_ca_system_score_gemma":0.00010924683,"threshold_uncertainty_score":0.42010832},"labels":[],"label_agreement":null},{"id":"W2979766680","doi":"10.1182/blood.v116.21.4202.4202","title":"Patients with Cancer Who Develop a First Venous Thromboembolic Event After Surgery Are at High Risk of Venous Thromboembolism Recurrence During the Anticoagulation Period","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Victoria Hospital; Ottawa Hospital; University of Ottawa; CancerCare Manitoba; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Pulmonary embolism; Thrombosis; Cancer; Surgery; Venous thrombosis; Venous thromboembolism; Retrospective cohort study; Malignancy; Internal medicine","score_opus":0.0065402105735762614,"score_gpt":0.21827259477037256,"score_spread":0.2117323841967963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979766680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99690247,0.0005981938,0.000006880764,0.00036327014,0.00061480515,0.0012359523,0.00013921631,0.00006601384,0.00007318664],"genre_scores_gemma":[0.9979059,0.0010374011,0.00013524685,0.00013042173,0.00028385108,0.00034656838,0.00004420099,0.0000756433,0.00004073199],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974742,0.00007762814,0.0005802481,0.0005567389,0.00072808604,0.000583108],"domain_scores_gemma":[0.99782604,0.00012558947,0.00062458235,0.0008330864,0.00042708995,0.00016360183],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029695858,0.00039044555,0.001196465,0.0001653321,0.00047509177,0.000042505402,0.00021780827,0.00015727335,0.0003485318],"category_scores_gemma":[0.00016353051,0.00026653506,0.00017191409,0.00048208283,0.00022693342,0.00014579212,0.00020641835,0.0004035148,0.000026334079],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016182216,0.0050438843,0.9887225,0.00056460645,0.0008341768,0.00004449185,0.0026209925,0.000053881235,0.00022503026,0.00003426185,0.00025531198,0.0014390292],"study_design_scores_gemma":[0.0021896635,0.00029224274,0.991642,0.00081522105,0.0014011927,0.000021946513,0.00008265568,0.000011071503,0.0025180327,0.000028426319,0.0006606716,0.00033689683],"about_ca_topic_score_codex":0.0010483362,"about_ca_topic_score_gemma":0.002780918,"teacher_disagreement_score":0.0047516413,"about_ca_system_score_codex":0.00010254658,"about_ca_system_score_gemma":0.0001893219,"threshold_uncertainty_score":0.99997866},"labels":[],"label_agreement":null},{"id":"W2979766708","doi":"10.1182/blood.v126.23.2695.2695","title":"ABVD Chemotherapy Results in Excellent Outcomes with Reduced Radiation Therapy Rates in Children, Adolescents and Young Adults with Hodgkin Lymphoma","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; BC Children's Hospital; University of British Columbia","funders":"","keywords":"ABVD; Medicine; Dacarbazine; Vinblastine; Cohort; Pediatrics; Population; Radiation therapy; Chemotherapy regimen; Regimen; Internal medicine; Surgery; Chemotherapy; Vincristine","score_opus":0.010607261620675315,"score_gpt":0.24328512799549887,"score_spread":0.23267786637482354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979766708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963592,0.0016002645,5.7561704e-7,0.0006809293,0.000030163697,0.001127888,0.000009765806,0.000033032975,0.00015812629],"genre_scores_gemma":[0.99782753,0.0014203247,0.00020330692,0.00024904206,0.000045303223,0.00010848672,0.000060864622,0.00003154533,0.000053601165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870235,0.00005217208,0.00028044716,0.00041260236,0.0002901271,0.00026227752],"domain_scores_gemma":[0.9993992,0.000021036121,0.00011438933,0.00026680203,0.00005389593,0.00014467281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015130336,0.00025107426,0.00037980723,0.00016003137,0.000024727573,0.00003537012,0.000054776578,0.00007987696,0.0000015633761],"category_scores_gemma":[0.000020671736,0.00015636279,0.000027751666,0.00022993065,0.00004170506,0.00011572634,0.0000110134415,0.000054206237,0.0000033056563],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043509924,0.0038444826,0.97094774,0.000013415818,0.0001453789,0.00009092981,0.0019157643,0.0000022750894,0.0000677389,0.0000031080904,0.000041730895,0.018576445],"study_design_scores_gemma":[0.13878028,0.0013529082,0.8495986,0.0004514419,0.000042102303,0.00011279029,0.00016408486,0.000012715029,0.009294259,0.0000051149764,0.00002164945,0.00016409083],"about_ca_topic_score_codex":0.0012020007,"about_ca_topic_score_gemma":0.0003335718,"teacher_disagreement_score":0.13442929,"about_ca_system_score_codex":0.00013452489,"about_ca_system_score_gemma":0.00014351308,"threshold_uncertainty_score":0.637629},"labels":[],"label_agreement":null},{"id":"W2979767770","doi":"10.1182/blood.v124.21.3996.3996","title":"Autologous Stem Cell Transplant for Myasthenia Gravis: A Single-Centre Experience","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Myasthenia gravis; Internal medicine; Hematopoietic stem cell transplantation; Busulfan; Cyclophosphamide; Autologous stem-cell transplantation; Surgery; Transplantation; Chemotherapy","score_opus":0.015736741834691724,"score_gpt":0.22511757388232032,"score_spread":0.20938083204762858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979767770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947696,0.00023557163,0.0016581304,0.00035773765,0.00013872402,0.00057269,0.000026704021,0.00013303907,0.0021078459],"genre_scores_gemma":[0.9960586,0.0000054543316,0.0017220074,0.00029478056,0.0001668707,0.000063536456,0.00002157145,0.000036385023,0.0016308024],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987694,0.000035363864,0.00026574475,0.00034409168,0.00019226121,0.00039315107],"domain_scores_gemma":[0.999252,0.00007566401,0.000075708005,0.00034271675,0.000060149458,0.00019374501],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000116323645,0.00019309676,0.00034559245,0.00005673087,0.00008943963,0.000023470146,0.00013153804,0.00010484394,0.000056838373],"category_scores_gemma":[0.000010342783,0.00015455381,0.00015362544,0.000089701476,0.00005358779,0.00003444438,0.000014007473,0.00009700313,0.000045252575],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002479203,0.010341731,0.120058976,0.0024885356,0.0004999609,0.000669513,0.0586692,0.0000065739814,0.67761916,0.013757085,0.0026368583,0.11077319],"study_design_scores_gemma":[0.047409408,0.007832724,0.024745174,0.0011632434,0.002251164,0.0016428214,0.0033898049,0.0017731546,0.72093195,0.0011854563,0.18587117,0.0018039147],"about_ca_topic_score_codex":0.000007316397,"about_ca_topic_score_gemma":0.000008111319,"teacher_disagreement_score":0.1832343,"about_ca_system_score_codex":0.000012827514,"about_ca_system_score_gemma":0.00003253436,"threshold_uncertainty_score":0.6302522},"labels":[],"label_agreement":null},{"id":"W2979769168","doi":"10.1182/blood.v122.21.1091.1091","title":"The Endothelial Lectin Receptor CLEC4M Internalizes Factor VIII and Von Willebrand Factor Via a Clathrin-Coated Pit-Dependent Mechanism","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Endocytosis; Endocytic cycle; Cell biology; Von Willebrand factor; Clathrin; Chemistry; GPVI; Receptor; Mannose receptor; Dynamin; Ectodomain; Molecular biology; Biology; Platelet membrane glycoprotein; Biochemistry; Platelet; Immunology; Macrophage","score_opus":0.010686215664345994,"score_gpt":0.22308481932891336,"score_spread":0.21239860366456736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979769168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945987,0.0022608156,0.00015182432,0.000212369,0.0013237565,0.00093895575,0.00019618204,0.00014689661,0.00017052874],"genre_scores_gemma":[0.9967,0.00015713788,0.000020076437,0.00007671882,0.00008850468,0.00015905565,0.000031510757,0.00003396998,0.0027330434],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99830246,0.00031215287,0.0004223286,0.00039863115,0.00008295624,0.00048149444],"domain_scores_gemma":[0.99898636,0.00030805578,0.00019507861,0.00036827708,0.00008031934,0.00006188421],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00011181161,0.00028671755,0.00031217223,0.00007279873,0.00039981923,0.00011322045,0.00035972282,0.00016664354,0.00444797],"category_scores_gemma":[0.000094402465,0.00019685006,0.00011308863,0.000059855083,0.00012527256,0.0001231825,0.00022874454,0.00023554444,0.0009552242],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001253037,0.00021540473,0.007156855,0.000019910683,0.00049833726,0.0000024029648,0.00051971595,3.440555e-8,0.98705256,0.00028373633,0.0015126244,0.0026131016],"study_design_scores_gemma":[0.00710236,0.0005685581,0.013331622,0.00008241084,0.00013703437,0.00015220602,0.0004371817,0.0000048914562,0.96051,0.0009787353,0.016223261,0.00047169765],"about_ca_topic_score_codex":0.00049383944,"about_ca_topic_score_gemma":0.00017436112,"teacher_disagreement_score":0.02654253,"about_ca_system_score_codex":0.000032831755,"about_ca_system_score_gemma":0.00003657812,"threshold_uncertainty_score":0.9998227},"labels":[],"label_agreement":null},{"id":"W2979769416","doi":"10.1182/blood.v114.22.1156.1156","title":"Collagen and Elastin Degradation Products as Potential Biomarkers for Chronic Graft-Versus-Host Disease (cGVHD).","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Bone and Joint Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Transplantation; Internal medicine; Gastroenterology; Graft-versus-host disease; Proteinuria; Urinary system; Immunology; Surgery; Kidney","score_opus":0.013119749633959845,"score_gpt":0.2584498168367536,"score_spread":0.24533006720279377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979769416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885886,0.004840587,0.00007390263,0.0048166965,0.00016375931,0.0010453197,0.000058987156,0.000092136324,0.0003200169],"genre_scores_gemma":[0.9977095,0.00012561883,0.0005148332,0.00024880972,0.00044497082,0.000033994726,0.00020325003,0.000017452076,0.00070157147],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991146,0.000018011982,0.00015861425,0.00030930096,0.00017070687,0.00022877613],"domain_scores_gemma":[0.99935627,0.000027191312,0.000056009787,0.00020424117,0.00009159717,0.0002646877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007124186,0.00013724688,0.00016557705,0.00007618065,0.00010498701,0.00002942225,0.00003667366,0.000045946734,0.000039961044],"category_scores_gemma":[0.00029361638,0.00012362961,0.00007179452,0.00014272414,0.000048041427,0.00009619885,0.000013733481,0.0000319153,0.00001846606],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043952152,0.012848232,0.021798044,0.0032129423,0.0028780543,0.0016185573,0.00035119598,0.000014264561,0.67953205,0.0023954082,0.15487601,0.07652307],"study_design_scores_gemma":[0.072573796,0.0086719515,0.80548626,0.0005669894,0.009588227,0.00017340724,0.0002412516,0.00066836446,0.07238964,0.0011031996,0.027412536,0.0011243775],"about_ca_topic_score_codex":0.000011196802,"about_ca_topic_score_gemma":0.000005439312,"teacher_disagreement_score":0.7836882,"about_ca_system_score_codex":0.000027746933,"about_ca_system_score_gemma":0.00031648562,"threshold_uncertainty_score":0.50414693},"labels":[],"label_agreement":null},{"id":"W2979772193","doi":"10.1182/blood.v104.11.1769.1769","title":"A Prospective Registry on Venous Thromboembolic Events: Findings from PROVE.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Prospective cohort study; Deep vein; Venous thrombosis; Observational study; Thrombosis; Internal medicine; Medical history; Pediatrics; Emergency medicine","score_opus":0.010703253599064141,"score_gpt":0.2498953532445465,"score_spread":0.23919209964548238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979772193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98239136,0.00027722344,0.000028944543,0.0012377251,0.00021095699,0.0012456161,0.00002903822,0.00019163778,0.014387496],"genre_scores_gemma":[0.99668396,0.00014584718,0.00069834053,0.0015146205,0.00037935225,0.0001946726,0.000045437213,0.000053312004,0.00028448505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99838924,0.000016323815,0.00025658341,0.00053571636,0.00040578458,0.0003963721],"domain_scores_gemma":[0.9990682,0.000021239746,0.000091595815,0.00059834716,0.000059000133,0.00016160244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009547269,0.0002526416,0.00057118066,0.00009726555,0.0001310261,0.000028948903,0.0001640824,0.00012088406,0.00014333734],"category_scores_gemma":[0.00009582241,0.00022209846,0.00014857492,0.00019820579,0.00005320943,0.00007742875,0.0000749003,0.0002596625,0.00044182228],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014408887,0.31013456,0.38784325,0.0017714768,0.011845334,0.0050705387,0.033593524,0.0003038009,0.078604914,0.13509354,0.024143001,0.010155178],"study_design_scores_gemma":[0.009893059,0.0025716156,0.94258136,0.0007269382,0.0009363285,0.000038148944,0.00032453932,0.0000010780844,0.029675791,0.010590729,0.0023158414,0.0003445629],"about_ca_topic_score_codex":0.0005168477,"about_ca_topic_score_gemma":0.000035267913,"teacher_disagreement_score":0.5547381,"about_ca_system_score_codex":0.00017321951,"about_ca_system_score_gemma":0.00013017804,"threshold_uncertainty_score":0.90569127},"labels":[],"label_agreement":null},{"id":"W2979774829","doi":"10.1182/blood.v116.21.4532.4532","title":"CMV Specific T Cells Prevent Progression From Low to High Level Viremia In D+R+ but Not D-R+ Patients.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Calgary","funders":"","keywords":"Viremia; Peripheral blood mononuclear cell; Immunology; CD8; T cell; Medicine; Flow cytometry; Virology; Biology; Immune system; Virus; In vitro","score_opus":0.025164195973351424,"score_gpt":0.29570780545482345,"score_spread":0.27054360948147205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979774829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99710894,0.00006265523,0.000008920102,0.0004081642,0.00034183986,0.0010171413,0.00018633046,0.000040923933,0.00082511106],"genre_scores_gemma":[0.99530077,0.00004337979,0.0026150364,0.0002612972,0.0004567055,0.000072167575,0.00007937968,0.000042593587,0.0011286763],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998024,0.00003971699,0.00035117572,0.00047422815,0.0006554106,0.0004554691],"domain_scores_gemma":[0.9988679,0.000067683424,0.00005807435,0.0005360948,0.00011257665,0.00035763858],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00021978977,0.00019456918,0.00033437557,0.00019927128,0.00006150581,0.000041825748,0.00020732955,0.0001934911,0.0011888038],"category_scores_gemma":[0.00006912328,0.00015883309,0.0000792567,0.0002607438,0.000060104863,0.00006999521,0.0001615265,0.0006474685,0.0009310126],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005313085,0.0045092152,0.04717931,0.000054249333,0.000036504924,0.00012563703,0.0004279271,8.910665e-7,0.89045155,0.000039584498,0.0027535236,0.0538903],"study_design_scores_gemma":[0.004254317,0.00031041718,0.33037564,0.0001745739,0.000022407694,0.0000017927875,0.000020480467,0.000008903999,0.64038813,0.000035663146,0.024234485,0.00017316693],"about_ca_topic_score_codex":0.00085228134,"about_ca_topic_score_gemma":0.0004973176,"teacher_disagreement_score":0.28319633,"about_ca_system_score_codex":0.000057907404,"about_ca_system_score_gemma":0.00012396665,"threshold_uncertainty_score":0.9998469},"labels":[],"label_agreement":null},{"id":"W2979776691","doi":"10.1182/blood.v122.21.854.854","title":"BP5-087, a Novel STAT3 Inhibitor, Combines With BCR-ABL1 Inhibition To Overcome Kinase-Independent Resistance In Chronic Myeloid Leukemia","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Imatinib; Myeloid leukemia; Cancer research; Tyrosine-kinase inhibitor; Imatinib mesylate; Tyrosine kinase; Leukemia; breakpoint cluster region; Chemistry; Biology; Signal transduction; Immunology; Cell biology; Biochemistry; Genetics; Receptor; Cancer","score_opus":0.010732773050989158,"score_gpt":0.2340605270182843,"score_spread":0.22332775396729515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979776691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99292713,0.0009775186,0.00009561092,0.00084276305,0.00012302656,0.0022901066,0.00004745403,0.00017611025,0.0025202741],"genre_scores_gemma":[0.9923052,0.00008305101,0.0028774291,0.0005450513,0.00030432062,0.0006194703,0.0001317649,0.00010602167,0.0030276896],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99672604,0.000052742344,0.00064249703,0.00086505135,0.00083948305,0.000874185],"domain_scores_gemma":[0.99823046,0.00009102517,0.0001860833,0.00085238396,0.00020273699,0.0004373015],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020125923,0.00051586557,0.0007082606,0.00036971885,0.00011172172,0.000076738004,0.00016795893,0.00022411389,0.00033312227],"category_scores_gemma":[0.00008557143,0.00044278076,0.00010398168,0.00074377743,0.000104068386,0.00035549141,0.00013915985,0.0004963603,0.0004950661],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028839738,0.008990999,0.12847073,0.0025046798,0.0011514967,0.00305233,0.0040172366,0.00038393695,0.8307233,0.0019146223,0.012360988,0.0035457362],"study_design_scores_gemma":[0.12346637,0.0046441564,0.6490157,0.005835432,0.0006870195,0.00055356923,0.0004957265,0.00021574955,0.20541829,0.00065248704,0.007228705,0.0017867888],"about_ca_topic_score_codex":0.0022794248,"about_ca_topic_score_gemma":0.0046703503,"teacher_disagreement_score":0.625305,"about_ca_system_score_codex":0.006062513,"about_ca_system_score_gemma":0.0018154052,"threshold_uncertainty_score":0.9998024},"labels":[],"label_agreement":null},{"id":"W2979780878","doi":"10.1182/blood.v128.22.2925.2925","title":"Characterization of Genomic Rearrangements Involving CIITA and SOCS1 Using Targeted Capture Sequencing of Archival Tissue Specimens","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; BC Cancer Agency","funders":"","keywords":"CIITA; Biology; Cosmid; Fluorescence in situ hybridization; Comparative genomic hybridization; Cancer research; Lymphoma; Gene; Genetics; Genome; Chromosome; Major histocompatibility complex; Immunology; MHC class II","score_opus":0.03499561241405926,"score_gpt":0.2825740323504561,"score_spread":0.24757841993639682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979780878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99868983,0.0003014646,0.000100729645,0.00018202658,0.000031609256,0.00019891375,0.000076091404,0.000007848879,0.0004114653],"genre_scores_gemma":[0.99784046,0.00028089303,0.0012072136,0.00002678233,0.00012239531,0.0000014913725,0.000028202869,0.000013893135,0.00047869352],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99920917,0.0000310796,0.00022988257,0.00015013455,0.00020894376,0.0001708075],"domain_scores_gemma":[0.9995692,0.000047555888,0.000107279266,0.00012361111,0.00007678798,0.00007559085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011740335,0.00008842501,0.00022619545,0.00009876905,0.000036081696,0.0000040489203,0.000051999414,0.000037936177,0.000105996325],"category_scores_gemma":[0.000047206162,0.00006070079,0.00003316498,0.00006314944,0.00010098836,0.000053661774,0.00007049485,0.00006392434,0.0000037406148],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008365228,0.000062179795,0.027363103,0.00020862925,0.00009024326,0.000017302704,0.00045370508,1.577309e-7,0.9705628,0.000089838635,0.0000041556814,0.001064193],"study_design_scores_gemma":[0.0011345537,0.00013669497,0.19209878,0.00031957804,0.00007768815,0.00004386134,0.000051826046,0.000043356245,0.8057727,0.00006771691,0.00018154949,0.00007169172],"about_ca_topic_score_codex":0.00017484152,"about_ca_topic_score_gemma":0.0000058634796,"teacher_disagreement_score":0.16479014,"about_ca_system_score_codex":0.000022947666,"about_ca_system_score_gemma":0.00007870735,"threshold_uncertainty_score":0.24753064},"labels":[],"label_agreement":null},{"id":"W2979782779","doi":"10.1182/blood.v120.21.1186.1186","title":"Ten-Year Canadian National Prospective Data On Utilization of Anti-Hemophilic Concentrates: Indications and Trends","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; St. Michael's Hospital; Université de Montréal; University of Alberta; McMaster University","funders":"","keywords":"Medicine; Factor IX; Blood transfusion; Blood product; Pediatrics; Emergency medicine; Surgery; Internal medicine","score_opus":0.07211172277711134,"score_gpt":0.3467693064912354,"score_spread":0.2746575837141241,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979782779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.975855,0.00039012512,0.0000013857025,0.0012576622,0.000027312883,0.00024913537,0.00028872467,0.000014074482,0.021916607],"genre_scores_gemma":[0.9985186,0.00010154926,0.00010975101,0.00005121477,0.000115868475,0.000009185949,0.0006597548,0.0000082390325,0.00042583735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99930495,0.000018269946,0.00010264235,0.00014687952,0.00024139733,0.00018584967],"domain_scores_gemma":[0.9994185,0.000034275705,0.00003061631,0.0002022622,0.00009790276,0.00021646106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014318353,0.00006458974,0.00010849686,0.00021708656,0.00007078707,0.0000070802057,0.00006559661,0.000054770575,0.00014069396],"category_scores_gemma":[0.00012657928,0.000050749793,0.000013202848,0.000279258,0.00008459126,0.00009839617,0.000022095752,0.00007319791,0.000018656685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011954691,0.00068924663,0.9920846,0.000022211883,0.00010762225,0.0000026164662,0.0002656778,1.0743245e-7,0.0006308696,0.0044627152,0.00062228675,0.001100087],"study_design_scores_gemma":[0.0017859224,0.00013060299,0.99035776,0.000035334302,0.00008776777,0.000016131316,0.00009909986,0.00004389674,0.006509526,0.000059637463,0.0008212384,0.000053103562],"about_ca_topic_score_codex":0.00064333633,"about_ca_topic_score_gemma":0.00045460975,"teacher_disagreement_score":0.022663627,"about_ca_system_score_codex":0.00004660154,"about_ca_system_score_gemma":0.00026096063,"threshold_uncertainty_score":0.20695165},"labels":[],"label_agreement":null},{"id":"W2979783168","doi":"10.1182/blood.v128.22.1440.1440","title":"Incidence and Risk Factors for Venous Thromboembolism in Patients with Spinal Cord Injury: A Retrospective Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; McMaster University","funders":"","keywords":"Medicine; Pulmonary embolism; Incidence (geometry); Deep vein; Retrospective cohort study; Thrombosis; Venous thrombosis; Spinal cord injury; Surgery; Spinal cord","score_opus":0.011359597223364737,"score_gpt":0.2707276215485595,"score_spread":0.2593680243251948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979783168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971576,0.00004496883,0.000041425625,0.000062119834,0.00007371704,0.0024429145,0.00004912481,0.000038789276,0.00008936105],"genre_scores_gemma":[0.99943036,0.00008757841,0.00017370269,0.000046022862,0.000053611486,0.00015514375,0.0000038553226,0.000029645775,0.000020108986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875003,0.000035411835,0.00021373518,0.00042041426,0.00028128971,0.000299116],"domain_scores_gemma":[0.9993282,0.000042647956,0.00013015639,0.0002827764,0.00011233401,0.000103863655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017621666,0.00019309936,0.0005887819,0.00013047317,0.00009078145,0.000018458095,0.00008070885,0.0000499646,0.000013509264],"category_scores_gemma":[0.00016457908,0.00011543641,0.000036854173,0.00015004097,0.00006888936,0.00011150767,0.000074693235,0.0000956662,0.000003739374],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008911744,0.007431492,0.98653954,0.000029106941,0.00029891965,0.000009194917,0.00060511054,5.9037298e-8,0.00002860178,0.00010877116,0.00006458389,0.003993439],"study_design_scores_gemma":[0.009355453,0.034612138,0.95420897,0.00019498501,0.00066023006,8.537041e-7,0.00041131125,3.878928e-7,0.00016086927,0.0001821622,0.000047374368,0.00016523863],"about_ca_topic_score_codex":0.0004001053,"about_ca_topic_score_gemma":0.00022433612,"teacher_disagreement_score":0.03233055,"about_ca_system_score_codex":0.00007600864,"about_ca_system_score_gemma":0.000038128626,"threshold_uncertainty_score":0.470736},"labels":[],"label_agreement":null},{"id":"W2979784225","doi":"10.1182/blood.v116.21.3278.3278","title":"Differential Dependence On Wnt Signaling Allows Chemical Mediated Eradication of Human Acute Leukemia without Affecting Normal Blood Stem Cells","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; Western University; McMaster University; Ontario Institute for Cancer Research","funders":"","keywords":"Wnt signaling pathway; Haematopoiesis; Stem cell; Ex vivo; Progenitor cell; Biology; Cancer research; Myeloid leukemia; Myeloid; In vivo; Leukemia; Clonogenic assay; Immunology; Cell biology; Signal transduction; Genetics","score_opus":0.007513582362043482,"score_gpt":0.23213640286227216,"score_spread":0.2246228205002287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979784225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99931,0.000025696325,0.000103287486,0.0000073391475,0.00015834831,0.00015190523,0.00001883963,0.000019211124,0.00020536722],"genre_scores_gemma":[0.99919695,0.00001704113,0.00020851148,0.000037127138,0.0002998339,0.000014508986,0.00011081929,0.000022709004,0.0000924828],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99885195,0.000039322367,0.00028453427,0.00037694888,0.00020116403,0.00024609175],"domain_scores_gemma":[0.99930733,0.000019279767,0.0001810642,0.0003150287,0.000085204934,0.00009208272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010835629,0.0001898553,0.00019716253,0.000045980643,0.000072565555,0.000023168574,0.00030088113,0.00025933448,0.00004265461],"category_scores_gemma":[0.000018206496,0.0001780366,0.00011341463,0.00005289125,0.00006733087,0.0000065145796,0.0000938562,0.00026935188,0.000011414487],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060583738,0.00025156245,0.0022323346,0.000017803264,0.0002015567,0.000005871875,0.00009188185,0.000008039603,0.99690443,0.0000111392965,0.000018247476,0.00019656745],"study_design_scores_gemma":[0.001307396,0.0004853981,0.00047781097,0.00003309921,0.00020575643,0.00002083273,0.000033431552,0.000050614457,0.9971711,0.000006405458,0.000010843212,0.00019729715],"about_ca_topic_score_codex":0.000022609796,"about_ca_topic_score_gemma":0.000030152854,"teacher_disagreement_score":0.0017545237,"about_ca_system_score_codex":0.000006266823,"about_ca_system_score_gemma":0.000067335895,"threshold_uncertainty_score":0.72601223},"labels":[],"label_agreement":null},{"id":"W2979787365","doi":"10.1182/blood.v128.22.4227.4227","title":"A Single-Center Retrospective Study of 140 Patients with Post-Transplant Lymphoproliferative Disorder Following Solid Organ Transplantation","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Transplantation; Organ transplantation; Internal medicine; Rituximab; Post-transplant lymphoproliferative disorder; Diffuse large B-cell lymphoma; Population; Interquartile range; Immunosuppression; Lymphoproliferative disorders; Retrospective cohort study; Gastroenterology; Lymphoma","score_opus":0.005474891554571558,"score_gpt":0.21968676404035517,"score_spread":0.2142118724857836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979787365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99800545,0.000036016547,0.00015309872,0.00015640886,0.00006650748,0.0009364704,0.00014312286,0.000043484048,0.00045943787],"genre_scores_gemma":[0.9996169,0.000022629374,0.000037526584,0.00010524168,0.00002296385,0.000040954536,0.000060659124,0.000034327142,0.000058792884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870604,0.000046846944,0.00026211108,0.00029756615,0.0004178399,0.00026961032],"domain_scores_gemma":[0.9993975,0.000020952046,0.00012840636,0.00016036798,0.00021579496,0.000076943186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006314424,0.00018708844,0.00035866062,0.00008788881,0.00008446841,0.000009473376,0.000057560457,0.00006902821,0.000036532674],"category_scores_gemma":[0.000024233845,0.00011376284,0.00008561185,0.00018853795,0.00003477533,0.00013809926,0.0000072662087,0.000065733315,0.0000038455414],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014941626,0.007952653,0.97527736,0.000032767464,0.0006841804,0.000037169113,0.00775303,6.1496183e-7,0.006375094,0.0000050022286,0.000006899867,0.00038106117],"study_design_scores_gemma":[0.07799431,0.009049862,0.90470153,0.00043748718,0.001139572,0.000009040132,0.0018763908,8.7098067e-7,0.004546958,0.000015313719,0.0000066007233,0.00022205008],"about_ca_topic_score_codex":0.00011246172,"about_ca_topic_score_gemma":0.00062815,"teacher_disagreement_score":0.07650014,"about_ca_system_score_codex":0.00009448365,"about_ca_system_score_gemma":0.000078870034,"threshold_uncertainty_score":0.46391138},"labels":[],"label_agreement":null},{"id":"W2979788559","doi":"10.1182/blood.v128.22.2338.2338","title":"Does Cell Size Matter?: Utilizing Mean Cell Volume in Hospitalized Patients As a Screen to Determine Common Causes of Anemia Including Iron Deficiency Anemia, Vitamin B12 and Folate Deficiency","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Hospital; London Health Sciences Centre; Western University","funders":"","keywords":"Vitamin B12; Medicine; Anemia; Macrocytic anemia; Iron deficiency; Megaloblastic anemia; Iron-deficiency anemia; Gastroenterology; Ferritin; Hemoglobin; Internal medicine; Microcytic anemia; Mean corpuscular volume","score_opus":0.008929446857574392,"score_gpt":0.23676346164218806,"score_spread":0.22783401478461368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979788559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99514115,0.000683545,0.000013993042,0.00012762958,0.000121977384,0.0007153808,0.000051704606,0.000038804792,0.0031058379],"genre_scores_gemma":[0.9980407,0.00015266327,0.00091577653,0.0002527536,0.000024451645,0.000019423176,0.0000098399305,0.00004712977,0.00053727214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997799,0.000082976556,0.00061253604,0.00053933007,0.00040041495,0.000565748],"domain_scores_gemma":[0.99886996,0.00015137403,0.00021633078,0.00044953867,0.00008663015,0.00022619919],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002636562,0.00031765498,0.0005661362,0.0002588496,0.0000931118,0.000023882125,0.00020527496,0.00014020967,0.00010401237],"category_scores_gemma":[0.00018608135,0.00020217843,0.0000767166,0.00031368714,0.0001280012,0.00020001973,0.00023461819,0.00012271613,0.000045731245],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014262588,0.0010460196,0.8968681,0.00063204166,0.0000014954534,0.000026588921,0.0014510681,5.1769894e-7,0.09737131,0.0000063776324,0.0000629564,0.0023909104],"study_design_scores_gemma":[0.013682666,0.0011499507,0.9059036,0.00037723195,0.00031185933,0.000009531552,0.0008112626,0.0000033441063,0.077118084,0.00010740945,0.00005384787,0.0004712306],"about_ca_topic_score_codex":0.0009728489,"about_ca_topic_score_gemma":0.00015284753,"teacher_disagreement_score":0.020253226,"about_ca_system_score_codex":0.00003592787,"about_ca_system_score_gemma":0.000057201672,"threshold_uncertainty_score":0.82445973},"labels":[],"label_agreement":null},{"id":"W2979791957","doi":"10.1182/blood.v108.11.3329.3329","title":"Discrimination of Health States in Follicular Lymphoma with Utilities Derived from the EuroQOL EQ5D Instrument.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Context (archaeology); Population; Follicular lymphoma; Cohort; Quality of life (healthcare); Internal medicine; Physical therapy; Lymphoma","score_opus":0.15644264785259876,"score_gpt":0.3344620449751012,"score_spread":0.17801939712250242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979791957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98017323,0.0037160937,0.0009725736,0.01349364,0.000083969855,0.00051997154,0.00036784227,0.000020871375,0.0006517912],"genre_scores_gemma":[0.9965178,0.00013508488,0.0012943906,0.001663418,0.00007536101,0.00006412023,0.00016301278,0.00002006412,0.00006676293],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967289,0.0003187123,0.0022761957,0.00031500318,0.000090398,0.00027079548],"domain_scores_gemma":[0.99767816,0.000493907,0.0014029754,0.0003518268,0.0000326015,0.000040522646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038901693,0.00013545052,0.0005895188,0.000127774,0.00011073116,0.000041542946,0.0001898158,0.000051024508,0.00005838831],"category_scores_gemma":[0.00025542136,0.00012514561,0.000052983676,0.00015799199,0.000082835184,0.0002341223,0.00002999878,0.000055855675,0.00005119927],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023840868,0.0007473014,0.9385756,0.0002968722,0.00009851716,0.0000014934109,0.0072163334,0.00032547262,0.000017129738,0.050632283,0.0012755737,0.00078957836],"study_design_scores_gemma":[0.0028871284,0.00012246694,0.96915036,0.0001632324,0.000010168262,0.0000027295941,0.0045483047,0.0009299226,0.0001636475,0.01920725,0.0026246083,0.00019019008],"about_ca_topic_score_codex":0.034015704,"about_ca_topic_score_gemma":0.0048440103,"teacher_disagreement_score":0.031425033,"about_ca_system_score_codex":0.00016753006,"about_ca_system_score_gemma":0.00014670698,"threshold_uncertainty_score":0.9724169},"labels":[],"label_agreement":null},{"id":"W2979796411","doi":"10.1182/blood.v118.21.4305.4305","title":"Outcome of Patients with Refractory Acute Leukemia Treated with a Third Induction Chemotherapy Regimen","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Leukemia & Lymphoma Society of Canada; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Induction chemotherapy; Regimen; Refractory (planetary science); Log-rank test; Internal medicine; Chemotherapy regimen; Surgery; Chemotherapy; Acute leukemia; Leukemia; Survival analysis","score_opus":0.023017816656497516,"score_gpt":0.26166293091531617,"score_spread":0.23864511425881865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979796411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99226505,0.000020349462,0.000021783459,0.000067671615,0.000014359537,0.00063296285,0.000012282364,0.00008333722,0.0068822345],"genre_scores_gemma":[0.9945572,0.000025728596,0.002851559,0.00014497053,0.0000498746,0.00003513409,0.00005074259,0.000059045044,0.0022257464],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986373,0.00003795612,0.00026241218,0.0003044044,0.00046850782,0.00028939467],"domain_scores_gemma":[0.99883413,0.000016049149,0.00017410082,0.00053856004,0.00029161014,0.00014552551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011832409,0.00020125182,0.00039270904,0.00017412852,0.00004051017,0.0000055439477,0.0001327489,0.0001461978,0.00012808932],"category_scores_gemma":[0.000019809298,0.00012518218,0.000049006405,0.0003549699,0.00015428604,0.00014124994,0.000026450422,0.00034727625,0.000021016427],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050228504,0.0012421716,0.9845693,0.000067995745,0.0011002434,0.00008916211,0.0009845047,1.3587939e-7,0.005088262,0.000018417148,0.0005519353,0.0012649826],"study_design_scores_gemma":[0.021629263,0.0047519375,0.89451194,0.00009911199,0.00059164834,0.000055191715,0.00011609721,0.0000038405624,0.07745319,0.000008018484,0.0005799338,0.00019985516],"about_ca_topic_score_codex":0.00032393218,"about_ca_topic_score_gemma":0.0000105625,"teacher_disagreement_score":0.090057425,"about_ca_system_score_codex":0.00024180459,"about_ca_system_score_gemma":0.00028074143,"threshold_uncertainty_score":0.5104781},"labels":[],"label_agreement":null},{"id":"W2979798341","doi":"10.1182/blood.v126.23.2320.2320","title":"Evaluating the Need for Anticoagulation Beyond 6 Months for Patients with Cancer-Associated Venous Thromboembolism (VTE): A Retrospect of Real Life (EXTEND study - updated results)","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Warfarin; Low molecular weight heparin; Cancer; Thrombosis; Retrospective cohort study; Venous thromboembolism; Surgery; Malignancy; Cohort; Pediatrics; Internal medicine","score_opus":0.04965312857379707,"score_gpt":0.3440549730942864,"score_spread":0.29440184452048934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979798341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908505,0.000122067235,0.000028950708,0.00047427023,0.00023670627,0.0074366117,0.00032340284,0.00007176526,0.00045570463],"genre_scores_gemma":[0.9977487,0.00002579051,0.0005933999,0.00016130677,0.00019162973,0.00065112306,0.0005002823,0.00006069194,0.00006711718],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977292,0.00010331436,0.00063102506,0.0004255353,0.0007171406,0.0003938131],"domain_scores_gemma":[0.9975398,0.0001785313,0.00059038075,0.00048557794,0.0010584733,0.00014720923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012050798,0.00024001265,0.000883669,0.00009890018,0.00020840981,0.000035702476,0.0001649211,0.000088985056,0.0000066147604],"category_scores_gemma":[0.000949425,0.00016238258,0.00010775004,0.0003407919,0.00005943208,0.00009465311,0.00006012697,0.00010487045,0.0000010467706],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016766628,0.13038455,0.7538126,0.00070066156,0.015163641,0.00001610891,0.03991789,0.0027007624,0.0021126897,0.0015711942,0.029687464,0.00716582],"study_design_scores_gemma":[0.04532855,0.021780048,0.92292905,0.00014941435,0.005072248,4.7598445e-7,0.0017889328,0.0020075138,0.00037122643,0.0002647186,0.00007192741,0.00023589593],"about_ca_topic_score_codex":0.0018397309,"about_ca_topic_score_gemma":0.00045862855,"teacher_disagreement_score":0.16911645,"about_ca_system_score_codex":0.00011392901,"about_ca_system_score_gemma":0.00029399837,"threshold_uncertainty_score":0.66217697},"labels":[],"label_agreement":null},{"id":"W2979802032","doi":"10.1182/blood.v114.22.1813.1813","title":"Molecular Biclonality: Analysis of Clonotypic IgH VDJ Reveals the Frequent Occurrence of a Second Clone in Multiple Myeloma.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"clone (Java method); Biology; Isotype; Molecular biology; Immunoglobulin heavy chain; Monoclonal; Antibody; Gene; Monoclonal antibody; Genetics","score_opus":0.028354871174469408,"score_gpt":0.3050883526976066,"score_spread":0.2767334815231372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979802032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968539,0.0015544273,0.000026104492,0.0003403272,0.000012752965,0.0005316416,0.00022986153,0.000011936455,0.00043906612],"genre_scores_gemma":[0.9990367,0.00006488477,0.0005486557,0.00014462075,0.000013016076,0.000025255229,0.0001207737,0.0000061188216,0.000039974966],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982593,0.0001462858,0.0005190199,0.00028858805,0.00047287162,0.00031393883],"domain_scores_gemma":[0.9987272,0.00019920935,0.00017655507,0.0006165978,0.00014602454,0.0001344013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000386883,0.00015771715,0.00061644125,0.00038475025,0.000031061372,0.000007037487,0.00018511523,0.000074976866,0.00015616682],"category_scores_gemma":[0.00035247105,0.00010813075,0.00026538078,0.0012933742,0.00011224726,0.00004004263,0.00003902573,0.00017754556,0.0000056619847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032978773,0.0025948165,0.8311128,0.0001098216,0.002146043,0.00023925562,0.00029624187,0.000036365935,0.15821515,0.00025569156,0.000035636454,0.004628401],"study_design_scores_gemma":[0.0042185998,0.0003913666,0.89902335,0.00007535408,0.0010306777,0.000008969724,0.000040457024,0.0003207123,0.09456888,0.0002006842,0.000038266367,0.00008270181],"about_ca_topic_score_codex":0.0002634576,"about_ca_topic_score_gemma":0.00024426417,"teacher_disagreement_score":0.067910545,"about_ca_system_score_codex":0.00003356692,"about_ca_system_score_gemma":0.000101014164,"threshold_uncertainty_score":0.4409444},"labels":[],"label_agreement":null},{"id":"W2979805398","doi":"10.1182/blood.v124.21.1513.1513","title":"Safety, Efficacy and Pharmacokinetics of Nonacog Beta Pegol (N9-GP) in Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Pediatric Hemophilia B Patients","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Haemophilia; Factor IX; Hemarthrosis; Quality of life (healthcare); Pediatrics; Pharmacokinetics; Incidence (geometry); Clinical trial; Haemophilia B; Haemophilia A; Internal medicine; Surgery","score_opus":0.01627483039638213,"score_gpt":0.27869246874111236,"score_spread":0.26241763834473025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979805398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966466,0.0014611778,4.741844e-7,0.000123439,0.000017325694,0.001295482,0.000014341807,0.000011673574,0.0004295036],"genre_scores_gemma":[0.994747,0.0048230593,0.00017035042,0.00000346633,0.00006621001,0.000028883782,0.000029470335,0.00002189127,0.00010970778],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985476,0.000088838,0.00047835356,0.00031782326,0.00026886835,0.0002985217],"domain_scores_gemma":[0.9992784,0.00020467593,0.000105896936,0.00018092408,0.00008618462,0.00014387674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015587936,0.00020856729,0.00057727867,0.000405981,0.000025548949,0.000006026205,0.00005489796,0.00010437192,0.0000131998095],"category_scores_gemma":[0.00008763369,0.00015253758,0.00004897639,0.00040733136,0.00009878384,0.00004225631,0.000048924012,0.000099953395,0.0000015235922],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041148224,0.0046345196,0.96090007,0.00046682186,0.00008205541,0.00003143139,0.0006862591,0.0000018669189,0.003647633,0.000005450511,0.000002836642,0.029129546],"study_design_scores_gemma":[0.0329159,0.0065230276,0.9320894,0.00017557331,0.0004122075,0.000010151844,0.000024790197,0.00014546598,0.027526038,0.000016584832,0.000028587834,0.00013228293],"about_ca_topic_score_codex":0.00013568031,"about_ca_topic_score_gemma":0.000030549927,"teacher_disagreement_score":0.03250442,"about_ca_system_score_codex":0.000051136183,"about_ca_system_score_gemma":0.000046844518,"threshold_uncertainty_score":0.6220302},"labels":[],"label_agreement":null},{"id":"W2979809231","doi":"10.1182/blood.v124.21.519.519","title":"Epic: A Phase 3 Trial of Ponatinib Compared with Imatinib in Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CP-CML)","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Ponatinib; Medicine; Imatinib; Internal medicine; Imatinib mesylate; Myeloid leukemia; Clinical endpoint; Nilotinib; Oncology; Randomized controlled trial","score_opus":0.012773701566025007,"score_gpt":0.2755707507136372,"score_spread":0.26279704914761215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979809231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946512,0.00027362024,0.00005670717,0.000058738224,0.00008654508,0.0036792895,0.00007659066,0.00007945392,0.0010378853],"genre_scores_gemma":[0.9972504,0.00003620174,0.0012725818,0.0000647716,0.00026839433,0.00040297332,0.0005164294,0.00010093868,0.00008732965],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99625117,0.0002094237,0.0010923492,0.00077393226,0.00085619034,0.00081691967],"domain_scores_gemma":[0.99771124,0.00034270994,0.0005578778,0.00095082266,0.00015371686,0.00028361648],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039152656,0.00057193474,0.0013747598,0.00045281646,0.00005442689,0.000021785198,0.0002841825,0.00019788425,0.0002673196],"category_scores_gemma":[0.000230476,0.00044062166,0.00012470942,0.0007798557,0.00022372922,0.00020091291,0.00007001464,0.0005142928,0.000030185516],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.45892137,0.10451161,0.28762537,0.0032842949,0.0028954253,0.0018502071,0.0048971167,0.0031925007,0.010154321,0.00030662402,0.00057298836,0.12178817],"study_design_scores_gemma":[0.92559373,0.031367354,0.031718384,0.0014399404,0.0005004991,0.0000240501,0.000050695748,0.0026939476,0.00571754,0.000016368382,0.00040735296,0.0004701055],"about_ca_topic_score_codex":0.000807854,"about_ca_topic_score_gemma":0.0017939102,"teacher_disagreement_score":0.4666724,"about_ca_system_score_codex":0.0045844344,"about_ca_system_score_gemma":0.004158864,"threshold_uncertainty_score":0.99980456},"labels":[],"label_agreement":null},{"id":"W2979810607","doi":"10.1182/blood.v128.22.2919.2919","title":"Targeted Sequencing Reveals Novel Gene Mutations Associated with Transformation and Early Progression in Follicular Lymphoma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Canada's Michael Smith Genome Sciences Centre; Jewish General Hospital; BC Cancer Agency","funders":"","keywords":"Follicular lymphoma; CDKN2A; Medicine; Internal medicine; Progression-free survival; Oncology; Lymphoma; Cancer; Cohort; Pathology; Chemotherapy","score_opus":0.01432218670861094,"score_gpt":0.24345127967833197,"score_spread":0.22912909296972103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979810607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983271,0.00033401788,0.00013557698,0.00044107105,0.00001024785,0.00053139264,0.000019965497,0.000043944165,0.00015670985],"genre_scores_gemma":[0.9985264,0.00004043661,0.0011712284,0.000041771655,0.000013677576,0.00012561685,0.000036431342,0.000012680351,0.00003177464],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992826,0.000022873026,0.00019264224,0.00015982837,0.00017728622,0.00016477451],"domain_scores_gemma":[0.999644,0.000052491494,0.00007075296,0.00009538291,0.00006061185,0.000076803175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011075526,0.00010573108,0.00018221674,0.00008574529,0.00005152966,0.000013797886,0.000019377834,0.000066840155,0.0000050706935],"category_scores_gemma":[0.000053591382,0.00005935992,0.000029426716,0.00016391693,0.000027206264,0.00013776372,0.0000052384466,0.000017734665,0.0000030852495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000083913,0.0017783885,0.7833204,0.00003288617,0.00027164904,0.00018281183,0.0014400369,0.0000015205972,0.19948965,0.00015959932,0.000005154386,0.013233941],"study_design_scores_gemma":[0.01957707,0.00043002344,0.8638264,0.0007581164,0.00022477203,0.00008004753,0.000044093325,0.00001818524,0.11489383,0.000042935048,0.000013226128,0.00009130716],"about_ca_topic_score_codex":0.00006198957,"about_ca_topic_score_gemma":0.000030309713,"teacher_disagreement_score":0.084595814,"about_ca_system_score_codex":0.0001661744,"about_ca_system_score_gemma":0.000088642,"threshold_uncertainty_score":0.24206273},"labels":[],"label_agreement":null},{"id":"W2979812322","doi":"10.1182/blood.v114.22.1083.1083","title":"Correlation of Telomere Length in Blood, Buccal Cells, and Fibroblasts From Patients with Inherited Bone Marrow Failure Syndromes.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute","funders":"","keywords":"Dyskeratosis congenita; Buccal swab; Biology; Telomere; Fluorescence in situ hybridization; Buccal administration; DNA extraction; Molecular biology; Pathology; Bone marrow; Polymerase chain reaction; DNA; Immunology; Medicine; Genetics; Gene; Bioinformatics","score_opus":0.005664594554175058,"score_gpt":0.1936471216419801,"score_spread":0.18798252708780505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979812322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984598,0.00064285455,0.00001465382,0.00017820495,0.00004010017,0.0004242771,0.000063239335,0.000050898267,0.00012593028],"genre_scores_gemma":[0.9975729,0.00008784686,0.001949212,0.00009256235,0.00003999201,0.0000048143816,0.00014550635,0.00002450099,0.000082695144],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985262,0.000045357177,0.00040159817,0.00038632512,0.00035973504,0.00028079367],"domain_scores_gemma":[0.9992197,0.00006391335,0.0001579001,0.00029498865,0.00010127355,0.00016222752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006795925,0.00023756835,0.0004915009,0.00020396333,0.000038866416,0.000014774947,0.000071808194,0.00018450653,0.00006227367],"category_scores_gemma":[0.000048493373,0.00020129539,0.000043389853,0.00040781312,0.000089203735,0.00014505464,0.000024079929,0.00027445622,0.0000075261364],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045793297,0.0026201904,0.9551056,0.00012949253,0.00010705057,0.00019466899,0.00084619405,0.000011720911,0.0363539,0.000022752874,0.00015386904,0.003996635],"study_design_scores_gemma":[0.011176305,0.0012565837,0.9721682,0.00060530513,0.00025033051,0.0000497767,0.00013876022,0.00007485763,0.013894889,0.000039546165,0.00010271297,0.00024270974],"about_ca_topic_score_codex":0.00017854574,"about_ca_topic_score_gemma":0.0001296708,"teacher_disagreement_score":0.022459013,"about_ca_system_score_codex":0.000016650863,"about_ca_system_score_gemma":0.000058449918,"threshold_uncertainty_score":0.82085884},"labels":[],"label_agreement":null},{"id":"W2979814079","doi":"10.1182/blood.v110.11.3005.3005","title":"C-Reactive Protein on Admission Predicts Transplant-Related Mortality in Recipients of Allogeneic Stem Cell Transplant.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Hematological disorders and diagnostics","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Internal medicine; Univariate analysis; C-reactive protein; Gastroenterology; Transplantation; Multivariate analysis; Immunology; Surgery; Inflammation","score_opus":0.021216475834145807,"score_gpt":0.2653237060823047,"score_spread":0.2441072302481589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979814079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919658,0.00021463791,0.000072618306,0.00006192446,0.00004505404,0.0008628545,0.000060178063,0.00003994267,0.0066770148],"genre_scores_gemma":[0.9996029,0.000042600637,0.00007253125,0.00007944227,0.000009962695,0.000016411732,0.00005935102,0.000015086588,0.00010169223],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99854016,0.00005459628,0.0004959475,0.000279113,0.0003280644,0.00030209805],"domain_scores_gemma":[0.99928325,0.0001584305,0.00010095076,0.00020250816,0.000039004775,0.00021583753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003084371,0.00016807471,0.0003881828,0.00010642311,0.000022639651,0.00000233412,0.00007981177,0.0002676354,0.000075671946],"category_scores_gemma":[0.00004915063,0.00012787308,0.00009186995,0.00019949277,0.000046453504,0.000027429287,0.000006625491,0.0002601651,0.00001670415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014876595,0.009700587,0.89644814,0.0004038427,0.00010741659,0.0012715523,0.0014341085,0.000010180461,0.088150494,0.00020456094,0.000020794598,0.0007606739],"study_design_scores_gemma":[0.007249264,0.0013126618,0.52912766,0.0011871632,0.00021294992,0.00003241852,0.000107865184,0.000017673461,0.46044162,0.00012717847,0.0000342251,0.00014932292],"about_ca_topic_score_codex":0.000044012908,"about_ca_topic_score_gemma":0.0000314184,"teacher_disagreement_score":0.37229115,"about_ca_system_score_codex":0.000017531562,"about_ca_system_score_gemma":0.000062954496,"threshold_uncertainty_score":0.5214513},"labels":[],"label_agreement":null},{"id":"W2979816540","doi":"10.1182/blood.v118.21.167.167","title":"B-Cell Depletion, Remissions of Malignancy, and Cytokine-Associated Toxicity in a Clinical Trial of T Cells Genetically-Engineered to Express An Anti-CD19 Chimeric Antigen Receptor","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Chimeric antigen receptor; Adoptive cell transfer; CD19; Immunology; Fludarabine; Chronic lymphocytic leukemia; Lymphoma; Antigen; Leukemia; Cyclophosphamide; T cell; Cancer research; Internal medicine; Chemotherapy; Immune system","score_opus":0.05633769417147613,"score_gpt":0.326840488072401,"score_spread":0.2705027939009249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979816540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978818,0.00014560281,0.00007866452,0.000037138103,0.00010623313,0.0011317444,0.00004556373,0.000028313056,0.0005449282],"genre_scores_gemma":[0.99487567,0.0006502207,0.004008188,0.0000371703,0.00009539443,0.000022259108,0.000019282686,0.000038229005,0.0002535646],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997621,0.0003381556,0.0009143408,0.0004028565,0.0003862769,0.0003373639],"domain_scores_gemma":[0.9985728,0.00018004276,0.00017026825,0.0005075713,0.00019769403,0.00037162303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00107172,0.00017225507,0.00072292605,0.00020876854,0.00002371343,0.0000051667403,0.00019448227,0.0002419024,0.00062815],"category_scores_gemma":[0.0005093101,0.00015804626,0.00013501261,0.0004645276,0.00011583529,0.00003607213,0.00009710539,0.00027174136,0.0000053467843],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053077843,0.006778856,0.03818666,0.000059684055,0.00008078049,0.000014936422,0.00049543055,0.0000012350624,0.9481756,0.0000038477133,0.00015045183,0.00074470346],"study_design_scores_gemma":[0.04296332,0.003834961,0.14615212,0.00016061799,0.00008796552,0.000003975454,0.000046138546,0.000035649107,0.806405,0.000015382577,0.00014044184,0.00015441776],"about_ca_topic_score_codex":0.00016841128,"about_ca_topic_score_gemma":0.000014650764,"teacher_disagreement_score":0.14177063,"about_ca_system_score_codex":0.000017064565,"about_ca_system_score_gemma":0.00015706642,"threshold_uncertainty_score":0.6877802},"labels":[],"label_agreement":null},{"id":"W2979819506","doi":"10.1182/blood.v128.22.1884.1884","title":"Impact of Long-Term Tyrosine Kinase Inhibitor Exposure on Spermatogenesis in Juvenile Rats","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Shriners Hospitals for Children - Canada","funders":"","keywords":"Spermatogenesis; Dasatinib; Internal medicine; Endocrinology; Tyrosine-kinase inhibitor; Imatinib; Biology; Tyrosine kinase; Medicine; Andrology; Receptor; Cancer; Myeloid leukemia","score_opus":0.015866259245845768,"score_gpt":0.2786456389294777,"score_spread":0.2627793796836319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979819506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983257,0.0006362684,0.0000017823229,0.00011802779,0.000069969414,0.00036891238,0.000058910315,0.000034558678,0.00038587718],"genre_scores_gemma":[0.99906677,0.00009960981,0.000062008825,0.000031753436,0.00016352949,0.000024189316,0.000022528031,0.000034736553,0.00049486797],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988233,0.000037081616,0.0003380838,0.00027020086,0.00024412265,0.00028721255],"domain_scores_gemma":[0.99914396,0.00007001736,0.0001028019,0.00048893935,0.000048326,0.00014597068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007678963,0.00020366226,0.00040611497,0.00016131953,0.00001609995,0.000004559324,0.00007876238,0.00011016036,0.0004858858],"category_scores_gemma":[0.000079287565,0.00012375027,0.00017212617,0.00017968079,0.000049039387,0.000060921015,0.000035534635,0.000073328796,0.00012668215],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027377473,0.0018354598,0.731457,0.00006159163,0.0001217626,0.0005615567,0.00006717057,6.577197e-7,0.25988507,0.0000036485796,0.0002060542,0.0055262526],"study_design_scores_gemma":[0.012058099,0.0009676731,0.59711736,0.0005227822,0.00009890745,0.00008032894,0.0000025926136,4.824884e-7,0.38905522,0.0000023390828,0.000009374133,0.000084845604],"about_ca_topic_score_codex":0.000073699564,"about_ca_topic_score_gemma":0.000033504788,"teacher_disagreement_score":0.13433965,"about_ca_system_score_codex":0.00045155842,"about_ca_system_score_gemma":0.00033351438,"threshold_uncertainty_score":0.53201085},"labels":[],"label_agreement":null},{"id":"W2979822567","doi":"10.1182/blood.v116.21.1165.1165","title":"TINF2 Mutations In Patients with Aplastic Anemia Result In Low TIN2 Expression In Hematopoietic Cells and Very Short Telomeres.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute","funders":"","keywords":"Dyskeratosis congenita; Telomere; Aplastic anemia; Biology; Shelterin; Telomerase; Exon; Cancer research; Genetics; Molecular biology; Gene; Immunology; Bone marrow","score_opus":0.004868574062163351,"score_gpt":0.21213682783106222,"score_spread":0.20726825376889887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979822567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99893975,0.00006170767,0.0000039999322,0.000045309094,0.000088911554,0.00048375156,0.000015220983,0.0000288918,0.00033245436],"genre_scores_gemma":[0.9989477,0.000021667563,0.00076598785,0.00005628067,0.000033558612,0.000031292962,0.00005394288,0.000025674404,0.000063941596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985607,0.000036562476,0.00039831595,0.00037848618,0.00029109532,0.00033483625],"domain_scores_gemma":[0.9993017,0.0001527876,0.00005782507,0.00029104113,0.00005240807,0.0001442916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014712599,0.00019094787,0.00032298657,0.000367611,0.00003526477,0.00001878008,0.00008528223,0.00015039026,0.000038746177],"category_scores_gemma":[0.00016911578,0.00015810801,0.000020215482,0.00044392576,0.000109830886,0.000120340555,0.00004139418,0.00050274574,0.000013483914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002522451,0.0012832187,0.95793694,0.00019691286,0.000004826413,0.00018546397,0.0010548634,0.000014589228,0.038198877,0.000004899439,0.00003727658,0.0008299042],"study_design_scores_gemma":[0.0066173985,0.00020235746,0.9581642,0.0007678467,0.000028919865,0.000021096996,0.00019723039,0.000053638476,0.03368336,0.000017582826,0.000043606517,0.00020273832],"about_ca_topic_score_codex":0.0000859102,"about_ca_topic_score_gemma":0.0007235615,"teacher_disagreement_score":0.0063651535,"about_ca_system_score_codex":0.00002343994,"about_ca_system_score_gemma":0.00009583016,"threshold_uncertainty_score":0.64474577},"labels":[],"label_agreement":null},{"id":"W2979825973","doi":"10.1182/blood.v124.21.3672.3672","title":"Adolescents and Young Adults (AYA) with Acute Myeloid Leukemia (AML) Have Increased Treatment-Related Mortality with Similar Outcomes -- a Report from the Children's Oncology Group Trials AAML03P1 and AAML0531","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Internal medicine; Population; Induction chemotherapy; Chemotherapy; Adverse effect; Chemotherapy regimen; Oncology; Pediatrics","score_opus":0.01624827527453899,"score_gpt":0.29058954246376884,"score_spread":0.27434126718922985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979825973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947343,0.0003887135,0.00006058774,0.0010414171,0.00005969518,0.0027509395,0.00019828872,0.00016496562,0.0006010844],"genre_scores_gemma":[0.9963878,0.00047610278,0.0011193942,0.00055520755,0.00024942352,0.00017765969,0.0006574769,0.00009845931,0.0002784693],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99561393,0.00086319563,0.0009210297,0.0011345375,0.00077054685,0.0006967807],"domain_scores_gemma":[0.99668384,0.0007644361,0.00061307626,0.0012072066,0.00018581004,0.00054561824],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016157596,0.0006533579,0.0017990539,0.00013766889,0.0003008487,0.0000912276,0.00023670333,0.00040358191,0.000033149998],"category_scores_gemma":[0.0007856755,0.00033928186,0.00016606129,0.0002456902,0.0006256033,0.0001689447,0.00016574924,0.00066580315,0.000008350887],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038962937,0.0007203962,0.9825403,0.000035846246,0.0052717635,0.0021559293,0.00072081387,6.6169525e-7,0.0010456752,0.000012734347,0.00016262385,0.0034369708],"study_design_scores_gemma":[0.05781927,0.0030401943,0.9267291,0.00033077277,0.0059202937,0.0037356135,0.00026867248,0.0001403496,0.0013230006,0.000043108004,0.0002658241,0.00038383433],"about_ca_topic_score_codex":0.0131163355,"about_ca_topic_score_gemma":0.0028784533,"teacher_disagreement_score":0.055811226,"about_ca_system_score_codex":0.00045723715,"about_ca_system_score_gemma":0.0008504574,"threshold_uncertainty_score":0.99990594},"labels":[],"label_agreement":null},{"id":"W2979826979","doi":"10.1182/blood.v116.21.3691.3691","title":"The Utility of Bone Marrow Examinations for the Diagnosis of Immune Thrombocytopenia.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Hospital; McMaster University","funders":"","keywords":"Medicine; Bone marrow; Biopsy; Bone marrow failure; Pathology; Myelofibrosis; Aplastic anemia; Haematopoiesis; Internal medicine","score_opus":0.021300568634350963,"score_gpt":0.28021147530234786,"score_spread":0.2589109066679969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979826979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951331,0.0014332915,0.0000121960675,0.0011857657,0.000083029205,0.00057459937,0.000051136274,0.0000066681782,0.0015202229],"genre_scores_gemma":[0.999081,0.00030066576,0.00022261436,0.000017680106,0.000016149414,0.00013952964,0.000011880026,0.0000067337464,0.00020374816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995111,0.000011262719,0.0001953532,0.000078168356,0.0001045288,0.00009956081],"domain_scores_gemma":[0.99890625,0.00054676697,0.00009489601,0.0003420702,0.00008990331,0.000020090476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022303665,0.000059399707,0.00020821733,0.000014671365,0.000115222254,0.0000045766965,0.000081764105,0.00003895907,0.000086411266],"category_scores_gemma":[0.00026588608,0.000029644922,0.000103411476,0.00007321621,0.00013457135,0.000020745589,0.000023449387,0.000071957795,0.000001980437],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000501201,0.016177889,0.6765572,0.00045039674,0.0032995802,0.000045176763,0.0016986362,3.504547e-7,0.13890943,0.007133485,0.005590619,0.14963603],"study_design_scores_gemma":[0.003912425,0.00023314774,0.83010244,0.00002342904,0.0006852369,0.000022082815,0.00017816658,0.00006487476,0.15986612,0.00077726674,0.004089756,0.000045055],"about_ca_topic_score_codex":0.00011612318,"about_ca_topic_score_gemma":0.0002160308,"teacher_disagreement_score":0.15354522,"about_ca_system_score_codex":0.0000016470962,"about_ca_system_score_gemma":0.000033785873,"threshold_uncertainty_score":0.12088849},"labels":[],"label_agreement":null},{"id":"W2979828569","doi":"10.1182/blood.v118.21.3622.3622","title":"NUP98-HOXA9 drives High-Risk Myeloid Disease in Zebrafish – An In Vivo platform to Study Interacting Genes and Perform Drug Discovery,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Zebrafish Biomedical Research Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Atlantic Cancer Research Institute; Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Zebrafish; Leukemia; Biology; Myeloid leukemia; Cancer research; Apoptosis; Carcinogenesis; Myeloid; Cancer; Immunology; Genetics; Gene","score_opus":0.013181587101965273,"score_gpt":0.2708922980680524,"score_spread":0.2577107109660871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979828569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988616,0.00013443672,0.000044327408,0.00008273573,0.000031610543,0.00065671187,0.00005964901,0.000012735207,0.00011619232],"genre_scores_gemma":[0.9987411,0.00013214638,0.0005887478,0.000070321796,0.000104696635,0.00024380919,0.00004073251,0.000025198575,0.000053252308],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857277,0.000067172754,0.00026792826,0.00054001826,0.00019525524,0.00035687874],"domain_scores_gemma":[0.9990681,0.00003663291,0.000058558886,0.0004348085,0.00003382099,0.00036810737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003412741,0.00016120991,0.00015885606,0.00014184855,0.000081688595,0.000062322986,0.00032692516,0.00006229624,0.00004055741],"category_scores_gemma":[0.00030345246,0.00015235874,0.000031808155,0.00020173709,0.00007901754,0.00004021689,0.0003922101,0.00017525238,0.0000059868516],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029088208,0.0033956298,0.8383235,0.000022395958,0.000063441614,0.000033489643,0.0021148908,0.0000028069503,0.14523584,0.00003943911,0.000059935108,0.010417792],"study_design_scores_gemma":[0.0021821728,0.0006359796,0.85705703,0.00003067686,0.000032154952,0.0000026069501,0.0019435321,0.000061055965,0.1371375,0.00027219573,0.00036394832,0.0002811162],"about_ca_topic_score_codex":0.0011262129,"about_ca_topic_score_gemma":0.0045157196,"teacher_disagreement_score":0.018733595,"about_ca_system_score_codex":0.000015775731,"about_ca_system_score_gemma":0.00007403213,"threshold_uncertainty_score":0.62130094},"labels":[],"label_agreement":null},{"id":"W2979830663","doi":"10.1182/blood.v116.21.862.862","title":"Carfilzomib, Lenalidomide, and Dexamethasone In Newly Diagnosed Multiple Myeloma: Initial Results of Phase I/II MMRC Trial","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Carfilzomib; Lenalidomide; Neutropenia; Medicine; Dexamethasone; Multiple myeloma; Toxicity; Refractory (planetary science); Internal medicine; Phases of clinical research; Pharmacology; Urology; Gastroenterology; Materials science","score_opus":0.0364600752379513,"score_gpt":0.3428658753765564,"score_spread":0.3064058001386051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979830663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968926,0.0001855886,0.0000051969996,0.0002063897,0.00017405592,0.0014173812,0.00023140504,0.000035244953,0.00085215963],"genre_scores_gemma":[0.9958764,0.00006978097,0.003235618,0.00003443285,0.00036926146,0.00011984173,0.00013229107,0.000028443166,0.00013395338],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980308,0.00010909706,0.0005815288,0.00042202845,0.000417871,0.0004386731],"domain_scores_gemma":[0.9982195,0.0007206079,0.0001427379,0.00043844615,0.00012275131,0.00035597984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005263129,0.00022272796,0.00058686547,0.00027597917,0.00007896509,0.000017630286,0.00011117961,0.00018947262,0.000065926324],"category_scores_gemma":[0.003956844,0.0001843473,0.000108220345,0.00027340668,0.00019150625,0.0001054886,0.000110157365,0.0004482243,0.000009477003],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.46839187,0.03444765,0.090220764,0.00022946537,0.00076604425,0.00391537,0.0022578088,0.0000011637871,0.2752206,0.00005582508,0.00047926855,0.12401416],"study_design_scores_gemma":[0.814298,0.0050763343,0.04177518,0.00008410473,0.00017794913,0.0000739666,0.00009511397,0.00012963181,0.13745512,0.000030291812,0.00063387543,0.00017048056],"about_ca_topic_score_codex":0.0016296125,"about_ca_topic_score_gemma":0.0019193216,"teacher_disagreement_score":0.34590608,"about_ca_system_score_codex":0.000018818902,"about_ca_system_score_gemma":0.0002186712,"threshold_uncertainty_score":0.7517465},"labels":[],"label_agreement":null},{"id":"W2979830967","doi":"10.1182/blood.v122.21.3918.3918","title":"Heterodimer-Specific Stimulation Of Toll-Like Receptor 2 Induces Divergent Downstream Effects In Primary Samples Of Precursor B Cell Acute Lymphoblastic Leukemia","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; BC Children's Hospital; University of British Columbia","funders":"","keywords":"TLR2; Immune system; Biology; Receptor; Toll-like receptor; In vivo; Stimulation; Cell biology; Cancer research; Immunology; Chemistry; Innate immune system; Biochemistry; Endocrinology","score_opus":0.006949633259134538,"score_gpt":0.19396529618064276,"score_spread":0.18701566292150823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979830967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99651664,0.0021584034,0.000052385396,0.000010208581,0.0003883258,0.00055368146,0.00001842693,0.000021836702,0.00028010318],"genre_scores_gemma":[0.99881434,0.0002912264,0.00025933265,0.0000096282865,0.000014060922,0.000051318075,0.00023555706,0.000012369057,0.00031213736],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99877834,0.0002498726,0.00048281153,0.00020903807,0.00005618604,0.00022374827],"domain_scores_gemma":[0.99908113,0.00030227753,0.00027703427,0.0002458984,0.00007897055,0.000014659751],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001333738,0.0001645793,0.00036254004,0.00019282587,0.000042674856,0.000006873211,0.00015966495,0.0002299532,0.00034930534],"category_scores_gemma":[0.000032452128,0.00014485627,0.00008455896,0.0001431348,0.00009852525,0.00017667908,0.00007116983,0.000113659815,0.00025323706],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027310548,0.0003893018,0.005465923,0.0001230011,0.0001429927,8.681778e-7,0.00051739934,0.00005539791,0.9883339,0.000017517506,0.0005729321,0.0041076527],"study_design_scores_gemma":[0.0031991631,0.00036862827,0.16844843,0.00010376473,0.0000717997,0.000004619312,0.00003354217,0.0000034923632,0.82727844,0.000019539431,0.0003502038,0.000118379176],"about_ca_topic_score_codex":0.00014370821,"about_ca_topic_score_gemma":0.000002999304,"teacher_disagreement_score":0.16298251,"about_ca_system_score_codex":0.00006883133,"about_ca_system_score_gemma":0.00009080527,"threshold_uncertainty_score":0.59070677},"labels":[],"label_agreement":null},{"id":"W2979831829","doi":"10.1182/blood.v126.23.950.950","title":"Iron Level and Monocyte Morphology Predict TLR4 Expression and Reactive Oxygen Species Production Which Influences Chronic Inflammation in β-Thalassemia","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"","keywords":"Inflammation; TLR4; Innate immune system; Pattern recognition receptor; Monocyte; Immunology; Thalassemia; Toll-like receptor; Heme; Biology; Immune system; Medicine; Internal medicine; Biochemistry","score_opus":0.02469772620196418,"score_gpt":0.25124048545741023,"score_spread":0.22654275925544606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979831829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99504346,0.0024517968,0.000008286792,0.0010469982,0.00010567645,0.00042414453,0.0000031253355,0.000038853945,0.0008776335],"genre_scores_gemma":[0.99805427,0.0012250101,0.00020887153,0.000014852167,0.00017299614,0.00002547784,0.000031911954,0.000011885707,0.0002547478],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990932,0.000056502526,0.00021902617,0.0002920839,0.0001595283,0.00017968698],"domain_scores_gemma":[0.9995492,0.00002035529,0.00008928612,0.00014703572,0.00009088372,0.0001032427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002300067,0.00012763092,0.00019872251,0.00013096488,0.000051598752,0.000015066362,0.000033072378,0.00019376732,0.0000043788027],"category_scores_gemma":[0.00028191984,0.000101813755,0.000012233761,0.00017779598,0.000096941534,0.00021920969,0.000050673556,0.00022549424,0.0000045849165],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027036117,0.0002132084,0.20549026,0.00018361004,0.000043540193,0.000038522696,0.003520701,0.0001410432,0.78699315,0.000027154922,0.0003524253,0.002726034],"study_design_scores_gemma":[0.0071724546,0.0008809358,0.81240654,0.00053005747,0.00017472204,0.0004254718,0.0029251236,0.00031280043,0.17347395,0.00025727873,0.00120819,0.00023247545],"about_ca_topic_score_codex":0.00008352223,"about_ca_topic_score_gemma":0.00008242384,"teacher_disagreement_score":0.6135192,"about_ca_system_score_codex":0.00006917817,"about_ca_system_score_gemma":0.00013159553,"threshold_uncertainty_score":0.41518444},"labels":[],"label_agreement":null},{"id":"W2979832275","doi":"10.1182/blood.v122.21.37.37","title":"Passenger Lymphocyte Syndrome Following Solid Organ Transplantation: Graft Source, Incidence, Specificity, Duration, and Severity Of Hemolysis","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University Health Network; McGill University","funders":"","keywords":"Medicine; Hemolysis; Serology; Transplantation; Incidence (geometry); Internal medicine; Immunology; Gastroenterology; Antibody","score_opus":0.005687917698169277,"score_gpt":0.21466338636632107,"score_spread":0.20897546866815178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979832275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978124,0.00032974326,0.00062062585,0.00035143484,0.00006468883,0.00036215907,0.000006842279,0.0000550112,0.0003970869],"genre_scores_gemma":[0.9981494,0.00029532277,0.0011451464,0.000106901265,0.00006155853,0.000017374592,0.000032463042,0.000022831724,0.00016901582],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987626,0.000033839056,0.00041785548,0.0002644884,0.00031156407,0.0002096487],"domain_scores_gemma":[0.99940854,0.000049482773,0.00008752504,0.00021815667,0.00010165875,0.00013465015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015930722,0.00015919702,0.00038030132,0.00011134165,0.000119069686,0.000029664352,0.00006102791,0.00011264521,0.00020770519],"category_scores_gemma":[0.000017225264,0.00013956007,0.00011875352,0.00028093776,0.000054601132,0.00020611219,0.000019307,0.0001053736,0.000023455703],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000111450696,0.0014369703,0.7145599,0.0008440731,0.0008228269,0.00066608057,0.0026200204,0.0000042181564,0.2754309,0.00010336893,0.000093862145,0.0033063374],"study_design_scores_gemma":[0.0064483536,0.00033379003,0.87692577,0.00026696164,0.0013816088,0.0022202737,0.00023124524,0.000112136695,0.11155836,0.00018916259,0.00008399203,0.00024833556],"about_ca_topic_score_codex":0.00035123448,"about_ca_topic_score_gemma":0.00004272959,"teacher_disagreement_score":0.16387253,"about_ca_system_score_codex":0.0000122159345,"about_ca_system_score_gemma":0.000050537263,"threshold_uncertainty_score":0.56910944},"labels":[],"label_agreement":null},{"id":"W2979832351","doi":"10.1182/blood.v124.21.2168.2168","title":"Hemoglobinopathy Education in Canadian Hematology Training Programs: How Much Are Residents Learning?","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; University of Toronto; McMaster University","funders":"","keywords":"Hemoglobinopathy; Medicine; Thalassemia; Public health; Family medicine; Disease; Pediatrics; Internal medicine; Nursing","score_opus":0.009703124173965728,"score_gpt":0.23922285440052155,"score_spread":0.2295197302265558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979832351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98234546,0.001016392,0.000005102098,0.0044939583,0.00019991642,0.00040089924,8.243011e-7,0.000077559474,0.011459892],"genre_scores_gemma":[0.9975313,0.000060511833,0.0002854535,0.0005994939,0.00010150832,0.000042788884,0.000051288258,0.00003116714,0.001296501],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986227,0.000102682985,0.00021307889,0.0003095326,0.0001623614,0.0005896217],"domain_scores_gemma":[0.9991754,0.000023396758,0.00009499942,0.0002191044,0.000078944475,0.00040814315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002832107,0.00016270168,0.00032525687,0.00029800608,0.00010724881,0.00003349791,0.000094446936,0.00026646338,0.000028933277],"category_scores_gemma":[0.00046652238,0.00015345663,0.00006274775,0.0003222277,0.00005933523,0.000057792244,0.000016572483,0.0004387207,0.000045397832],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018398734,0.0005669917,0.95809674,0.00014994339,0.000038393653,0.00011709595,0.0019829043,0.0000024864914,0.00017502964,0.0009505663,0.00057107746,0.037330374],"study_design_scores_gemma":[0.016992414,0.0017879733,0.78571165,0.0032886893,0.00055518537,0.0031567207,0.06756699,0.0006674262,0.001780324,0.0016677753,0.1155438,0.0012810628],"about_ca_topic_score_codex":0.037028138,"about_ca_topic_score_gemma":0.08860578,"teacher_disagreement_score":0.1723851,"about_ca_system_score_codex":0.00008808621,"about_ca_system_score_gemma":0.0011130917,"threshold_uncertainty_score":0.9693844},"labels":[],"label_agreement":null},{"id":"W2979832938","doi":"10.1182/blood.v116.21.3197.3197","title":"Anthocyanins Inhibit Platelet Activation and Attenuate Thrombus Growth In Both Human and Murine Thrombosis Models","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Natural product bioactivities and synthesis","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto; Canadian Blood Services","funders":"","keywords":"Platelet; Platelet activation; Thrombus; Ex vivo; Chemistry; Pharmacology; Thrombosis; Bleeding time; Thrombin; In vivo; Whole blood; Biochemistry; Medicine; Immunology; In vitro; Internal medicine; Biology; Platelet aggregation; Biotechnology","score_opus":0.011929472702918806,"score_gpt":0.23321894505189025,"score_spread":0.22128947234897145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979832938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991834,0.00015059994,0.000015188265,0.00016367048,0.000022909546,0.00010526057,0.00001304541,0.0000054253296,0.00034049735],"genre_scores_gemma":[0.99913824,0.00027686913,0.0004179497,0.00003258717,0.00007118547,0.000003352246,0.000019224834,0.000012342359,0.000028246508],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994178,0.00001966081,0.00012866425,0.00024826778,0.00006055253,0.0001251011],"domain_scores_gemma":[0.9997333,0.000011359313,0.000060614366,0.00013690813,0.000025628493,0.00003215548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010721883,0.00010545927,0.0001443041,0.000042651973,0.000050448445,0.000013857188,0.000052804724,0.0001223151,0.0000047080716],"category_scores_gemma":[0.000029451705,0.00009360263,0.000021627373,0.000049269434,0.00009963372,0.000013713781,0.0000747363,0.00011285403,1.310437e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014848604,0.00009765954,0.0055607986,0.000026699861,0.000027317968,6.7169225e-7,0.000065297725,7.793665e-7,0.9932426,0.0003648313,0.000018459952,0.0005799874],"study_design_scores_gemma":[0.00066911813,0.00013018826,0.037815657,0.000014227732,0.0000143194475,0.000009384505,0.000038902836,0.000016956505,0.960283,0.00084080885,0.000047221874,0.00012025219],"about_ca_topic_score_codex":0.00014393494,"about_ca_topic_score_gemma":0.00009822087,"teacher_disagreement_score":0.032959685,"about_ca_system_score_codex":0.0000016790709,"about_ca_system_score_gemma":0.000010705657,"threshold_uncertainty_score":0.38170046},"labels":[],"label_agreement":null},{"id":"W2979834153","doi":"10.1182/blood.v128.22.2859.2859","title":"Impact of Gene Mutations on Overall Survival in Older Patients with Acute Myeloid Leukemia (AML) Treated with Azacitidine (AZA) or Conventional Care Regimens (CCR)","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"CEBPA; NPM1; Medicine; Internal medicine; Oncology; Azacitidine; Myeloid leukemia; Gastroenterology; Mutation; Gene; Biology; Genetics","score_opus":0.01328118774093202,"score_gpt":0.2785716039095239,"score_spread":0.2652904161685919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979834153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99712604,0.000024391085,0.000053696236,0.0001324782,0.00001850829,0.0009902394,0.00063840795,0.000049492395,0.00096675125],"genre_scores_gemma":[0.99677414,0.000029458473,0.00072635827,0.000036012887,0.00006401407,0.00007861797,0.0007190168,0.00007022677,0.0015021478],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978074,0.00009421318,0.0003561489,0.00046056235,0.00078905287,0.00049266365],"domain_scores_gemma":[0.99833745,0.0001763394,0.0001682924,0.00046843078,0.0006087533,0.00024075691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010113104,0.0003123927,0.0005176471,0.00034899687,0.000059995644,0.000012649884,0.00014321634,0.00013457486,0.0004067082],"category_scores_gemma":[0.00007337274,0.00015902428,0.000119387696,0.00046725362,0.00019850417,0.00014768033,0.000035277306,0.00023688545,0.000029097366],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01044949,0.0016188645,0.9637206,0.000084500396,0.0016197298,0.0006901648,0.0004214898,0.000037676764,0.020386491,0.00006490203,0.00033783214,0.00056823256],"study_design_scores_gemma":[0.057657734,0.006226936,0.9053716,0.0005394163,0.00040109304,0.0000925908,0.00008849561,0.000012263417,0.029325692,0.000005949252,0.000026392216,0.0002518086],"about_ca_topic_score_codex":0.0004343095,"about_ca_topic_score_gemma":0.0001623982,"teacher_disagreement_score":0.058348995,"about_ca_system_score_codex":0.0010612916,"about_ca_system_score_gemma":0.001573762,"threshold_uncertainty_score":0.6484822},"labels":[],"label_agreement":null},{"id":"W2979843743","doi":"10.1182/blood.v118.21.1393.1393","title":"Ectopic Expression of the Leukemogenic Protein E2A-PBX1 in Early Hematopoietic Progenitors Blocks B-Lymphoid Commitment","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Biology; Myeloid; Lymphopoiesis; Progenitor cell; Transplantation; Haematopoiesis; Cancer research; Molecular biology; Stem cell; BMI1; Immunology; Cell biology; Internal medicine; Medicine","score_opus":0.02063810369503652,"score_gpt":0.2445773443388402,"score_spread":0.2239392406438037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979843743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99533063,0.00027104857,0.000021215465,0.00009623736,0.00008496198,0.0019458941,0.0000047679873,0.000041381903,0.0022038515],"genre_scores_gemma":[0.99773216,0.0000065121376,0.0010132449,0.000044775927,0.00009011266,0.00027975804,0.0000023427092,0.00003739501,0.0007937048],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99791527,0.00013751899,0.00048538778,0.0003366621,0.0006734622,0.00045168438],"domain_scores_gemma":[0.998717,0.00005455404,0.00014685809,0.0008246813,0.00010200633,0.00015487628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026504148,0.0002153767,0.00037675884,0.00014630536,0.0000663902,0.000008926326,0.00041119527,0.00017178837,0.00016327828],"category_scores_gemma":[0.00014553555,0.00013900094,0.00016381251,0.00041618725,0.00018448303,0.00005953157,0.0002814996,0.00028370923,0.00003332149],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047751644,0.0038185844,0.4637473,0.00051218935,0.00018745397,0.0002709781,0.005033419,0.000001146323,0.52480793,0.00018010942,0.00026838272,0.00069498474],"study_design_scores_gemma":[0.008307496,0.00045790218,0.039024655,0.0005394021,0.00011492078,0.00022746278,0.00017205933,0.000028372799,0.9506845,0.00021577558,0.000087436936,0.00014000827],"about_ca_topic_score_codex":0.00042399374,"about_ca_topic_score_gemma":0.000021749447,"teacher_disagreement_score":0.4258766,"about_ca_system_score_codex":0.0003051453,"about_ca_system_score_gemma":0.00064565433,"threshold_uncertainty_score":0.5668294},"labels":[],"label_agreement":null},{"id":"W2979850125","doi":"10.1182/blood.v120.21.3729.3729","title":"Chronic Myeloid Leukemia Patients Undergoing Interferon Alpha Therapy Exhibit Normal Peripheral Blood Gamma Delta T Cells That May Be Expanded in Vitro to Generate Predominantly CD45RA-Positive Effector Memory Cells for Immunotherapy","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Immunology; Immunotherapy; NKG2D; K562 cells; Peripheral blood mononuclear cell; Medicine; Immunophenotyping; Cytotoxic T cell; Interferon gamma; Leukemia; Myeloid leukemia; Immune system; Biology; In vitro; Antigen","score_opus":0.018237107019923933,"score_gpt":0.27089205772571906,"score_spread":0.25265495070579513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979850125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897909,0.0029644205,0.00026326478,0.00015613185,0.0007068044,0.0054525784,0.00018143652,0.0001009779,0.00038346136],"genre_scores_gemma":[0.9909161,0.0010349576,0.001365911,0.00080840115,0.0012391058,0.000944642,0.00026646457,0.00027695374,0.0031474733],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9953289,0.00042238002,0.0007262259,0.00088282564,0.0007921461,0.0018475265],"domain_scores_gemma":[0.9977061,0.00045425157,0.00022469692,0.00085172645,0.00022359457,0.00053961395],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009117302,0.00076518493,0.0010159943,0.00042505047,0.00021625475,0.00012709599,0.0004693684,0.0003632455,0.00082992826],"category_scores_gemma":[0.000033623397,0.000689668,0.00044317287,0.0003922059,0.00013996042,0.00050714484,0.00016642494,0.0005959275,0.00004642137],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0112783015,0.0019892799,0.006460584,0.00021206954,0.0007029355,0.000032979624,0.0032387755,0.00003658876,0.9529891,0.0000022875463,0.00023442078,0.022822667],"study_design_scores_gemma":[0.046308026,0.0066369297,0.0061973054,0.00028010932,0.00016962667,0.00003490032,0.00016812881,0.000085430074,0.9383326,0.000002715364,0.0011145092,0.00066969986],"about_ca_topic_score_codex":0.00024870835,"about_ca_topic_score_gemma":0.00009983241,"teacher_disagreement_score":0.035029724,"about_ca_system_score_codex":0.0011766072,"about_ca_system_score_gemma":0.0006099224,"threshold_uncertainty_score":0.99955547},"labels":[],"label_agreement":null},{"id":"W2979851941","doi":"10.1182/blood.v108.11.3818.3818","title":"Beta-Thalassemia Intermedia Complicated by Autoimmune Hemolytic Anemia.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Autoimmune hemolytic anemia; Medicine; Hemolysis; Immunology; Hemolytic anemia; Thalassemia; Internal medicine; Anemia; Gastroenterology; Hemoglobin electrophoresis","score_opus":0.006532053446557234,"score_gpt":0.21964725139972802,"score_spread":0.21311519795317077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979851941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984014,0.0015522805,0.00011893837,0.0012702704,0.00009974546,0.00033203236,0.000024776455,0.00023011111,0.01235788],"genre_scores_gemma":[0.99704754,0.00003840953,0.0003586044,0.0003076478,0.00014854746,0.000020734205,0.0003725207,0.00003866082,0.0016673116],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99879766,0.000019076617,0.00032245182,0.0003101462,0.00023184097,0.00031882594],"domain_scores_gemma":[0.99935555,0.00004015817,0.000060166778,0.0003792128,0.000055544668,0.000109343564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000820499,0.00019468488,0.00034937132,0.0000653358,0.00007113266,0.000020748359,0.00011601989,0.00012278851,0.00019717141],"category_scores_gemma":[0.000008286583,0.00016633271,0.00011680142,0.0002108727,0.00008276769,0.000047229914,0.000031979507,0.00026680474,0.00014379877],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000094372655,0.004359593,0.081333205,0.00021445802,0.00016569023,0.0003096376,0.00007600308,8.1586376e-7,0.88285226,0.0004283403,0.027181972,0.0029836523],"study_design_scores_gemma":[0.01926662,0.00075878575,0.5645526,0.0003439268,0.0015184694,0.0012335308,0.00004250499,0.00014925191,0.38390476,0.0003055248,0.027359203,0.0005648093],"about_ca_topic_score_codex":0.00024892023,"about_ca_topic_score_gemma":0.000014544082,"teacher_disagreement_score":0.4989475,"about_ca_system_score_codex":0.000020510908,"about_ca_system_score_gemma":0.000036677837,"threshold_uncertainty_score":0.6782851},"labels":[],"label_agreement":null},{"id":"W2979853677","doi":"10.1182/blood.v124.21.467.467","title":"Platelet Desialylation: A Novel Mechanism of Fc-Independent Platelet Clearance and a Potential Diagnostic Biomarker and Therapeutic Target in immune Thrombocytopenia","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Platelet; Antibody; Flow cytometry; Monoclonal antibody; Chemistry; Autoantibody; Immunology; Platelet activation; Spleen; Immune system; Platelet Glycoprotein GPIb-IX Complex; Platelet membrane glycoprotein; Western blot; Neuraminidase; Isoantibodies; Immunofluorescence; Biology; Biochemistry; Virus","score_opus":0.011885023200591345,"score_gpt":0.23494243198047382,"score_spread":0.22305740877988248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979853677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99620414,0.0018249954,0.00094608584,0.00018749663,0.000052642066,0.0005273707,0.000018427689,0.000020254225,0.00021857959],"genre_scores_gemma":[0.9984208,0.00035775307,0.0010165644,0.00008920454,0.000019840805,0.000022278306,0.000026826961,0.000024446168,0.000022335027],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998906,0.00003940031,0.00031220468,0.00030226083,0.0002024854,0.0002376096],"domain_scores_gemma":[0.99947435,0.000117004696,0.000107823405,0.00018713875,0.00003258084,0.00008111052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019915294,0.00019168468,0.0005426643,0.00011470536,0.0000544796,0.000019614452,0.000055395893,0.00013189821,0.000042855023],"category_scores_gemma":[0.00005592731,0.00016341681,0.00004773933,0.00012471057,0.000069006936,0.00006770136,0.000047328682,0.00011828449,0.000006663903],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055462555,0.01388411,0.11441341,0.0012013542,0.0037860742,0.00365648,0.0029683209,0.000094122544,0.7701359,0.009764799,0.000030835985,0.074518345],"study_design_scores_gemma":[0.04452896,0.0014787597,0.88415104,0.00036062996,0.00048001198,0.0017189351,0.000105091895,0.0039006015,0.05785603,0.004855447,0.00014483991,0.0004196308],"about_ca_topic_score_codex":0.00009486753,"about_ca_topic_score_gemma":0.000025050218,"teacher_disagreement_score":0.76973766,"about_ca_system_score_codex":0.000011774497,"about_ca_system_score_gemma":0.000030756586,"threshold_uncertainty_score":0.6663944},"labels":[],"label_agreement":null},{"id":"W2979856584","doi":"10.1182/blood.v120.21.1968.1968","title":"Effect of Physical Activity (PA) Interventions On Health-Related Quality of Life (HRQoL) Post Hematopoietic Stem Cell Transplantation (HSCT): A Systematic Review and Meta-Analysis","year":2012,"lang":"en","type":"review","venue":"Blood","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Meta-analysis; Psychological intervention; Quality of life (healthcare); Placebo; Internal medicine; Hematopoietic stem cell transplantation; Randomized controlled trial; Body mass index; Transplantation; Physical therapy; MEDLINE; Gerontology; Alternative medicine; Pathology; Psychiatry","score_opus":0.10976049790689946,"score_gpt":0.39737161183629477,"score_spread":0.2876111139293953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979856584","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0036874178,0.99126065,0.00002096114,0.00006275147,0.000030284034,0.0041750674,0.00068204454,0.000023735449,0.00005707977],"genre_scores_gemma":[0.16521882,0.83396065,0.0000022648019,0.000032594304,0.000013076905,0.00044012725,0.00021102627,0.000033517485,0.000087950866],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99331015,0.0038356641,0.0017695475,0.0003832842,0.00049983495,0.00020150506],"domain_scores_gemma":[0.995244,0.0012529019,0.0024256657,0.00074361614,0.00012333773,0.000210436],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025116613,0.00046108058,0.0140788,0.0002672034,0.00003382632,0.000007095061,0.00012666616,0.00017972209,0.00004963285],"category_scores_gemma":[0.00007237391,0.00028819553,0.0068479637,0.00076834427,0.000053199892,0.000045891382,0.000022658289,0.00035781332,0.000008600716],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032061427,0.00090645795,0.000003479901,0.93196744,0.06471321,0.0000017307499,0.00032633537,6.257579e-8,0.0000011995115,0.00002853328,0.0000015353348,0.0020179788],"study_design_scores_gemma":[0.00051993225,0.000832864,0.0000161238,0.124979176,0.873374,0.000020720514,0.000021125446,3.1961787e-7,0.000045664343,4.748367e-7,0.000024996103,0.00016460166],"about_ca_topic_score_codex":0.00047639786,"about_ca_topic_score_gemma":0.00017572103,"teacher_disagreement_score":0.8086608,"about_ca_system_score_codex":0.000046521054,"about_ca_system_score_gemma":0.00013095204,"threshold_uncertainty_score":0.999957},"labels":[],"label_agreement":null},{"id":"W2979857657","doi":"10.1182/blood.v122.21.2921.2921","title":"Feasibility Study Of a Randomized Control Trial To Evaluate An Internet-Based Self-Management Program For Adolescents With Hemophilia","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children; McMaster University","funders":"","keywords":"Randomized controlled trial; Attrition; Medicine; Coaching; Physical therapy; Intervention (counseling); Family medicine; Psychology; Nursing; Surgery","score_opus":0.054882310780384795,"score_gpt":0.4171699785926362,"score_spread":0.3622876678122514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979857657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9059382,0.000018600478,0.0005453682,0.0003197003,0.00028514507,0.09259361,0.000016496879,0.00019518522,0.00008767478],"genre_scores_gemma":[0.9811794,0.0000013459455,0.0019057924,0.00049826154,0.00037759647,0.0158825,0.000017174674,0.000038886214,0.00009901911],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99501365,0.002188287,0.0011375544,0.00052972086,0.0005187806,0.0006120092],"domain_scores_gemma":[0.99758357,0.0002995656,0.00046093107,0.00059803267,0.0006774743,0.0003804348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027857858,0.0002617923,0.0010295168,0.00014423211,0.0002008451,0.000016438458,0.00028811404,0.00013804401,0.00006176867],"category_scores_gemma":[0.00024529282,0.00018111579,0.00015262874,0.00023298088,0.000031633215,0.00008195079,0.000057189714,0.00028879716,0.000043132037],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.72368675,0.027690401,0.23883821,0.0026248184,0.00029860897,0.0000033015835,0.0042261607,0.000007917537,0.0000019024943,0.000020617053,0.00042396202,0.002177349],"study_design_scores_gemma":[0.96299183,0.0067675584,0.025911592,0.00033980297,0.0009969126,9.573236e-8,0.0015375603,0.0011393168,0.000004388908,0.00004196488,0.00007001238,0.00019897181],"about_ca_topic_score_codex":0.00047181608,"about_ca_topic_score_gemma":0.00031360035,"teacher_disagreement_score":0.23930508,"about_ca_system_score_codex":0.000081141625,"about_ca_system_score_gemma":0.00028349578,"threshold_uncertainty_score":0.7385687},"labels":[],"label_agreement":null},{"id":"W2979857835","doi":"10.1182/blood.v118.21.4509.4509","title":"Pharmacokinetics and Safety of a Novel Conditioning Regimen, Individualized Once-Daily Intravenous Busulfan with Bortezomib, in Relapsed Multiple Myeloma Patients Undergoing a Second Autologous Hematopoietic Stem Cell Transplantation","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Busulfan; Melphalan; Multiple myeloma; Bortezomib; Mucositis; Hematopoietic stem cell transplantation; Regimen; Internal medicine; Transplantation; Oncology; Surgery; Chemotherapy","score_opus":0.02110035861322016,"score_gpt":0.24831750718497356,"score_spread":0.2272171485717534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979857835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968667,0.00015514782,0.0002824624,0.000015258773,0.000022764605,0.0011106447,0.00018296951,0.00003998536,0.0013240651],"genre_scores_gemma":[0.99293876,0.0000946465,0.006556214,0.00003287311,0.000009798899,0.00006105061,0.00020434869,0.00003640489,0.0000658853],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983799,0.000083170016,0.0004741876,0.0003538944,0.00034177513,0.00036706065],"domain_scores_gemma":[0.9990681,0.00020424221,0.00022792726,0.00019864495,0.00011144286,0.0001896566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014603176,0.00022907698,0.00044103048,0.0002286173,0.00008290824,0.0000124656135,0.00007793558,0.00010883543,0.000059249374],"category_scores_gemma":[0.000022582815,0.00019714145,0.000043426884,0.00023044687,0.00013320889,0.00008592758,0.000024608455,0.00021391425,0.0000027129286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00768942,0.008210867,0.9348454,0.0021109753,0.00075271167,0.00086883205,0.023193603,0.00001971671,0.017963385,0.00006117801,0.000009897363,0.004274044],"study_design_scores_gemma":[0.10715859,0.0023741827,0.8021564,0.0006603492,0.000495459,0.00021308266,0.00077830424,0.00035341748,0.08555276,0.000015791931,0.000007925043,0.00023372158],"about_ca_topic_score_codex":0.00009582564,"about_ca_topic_score_gemma":0.00023348705,"teacher_disagreement_score":0.13268895,"about_ca_system_score_codex":0.000049173817,"about_ca_system_score_gemma":0.00016660435,"threshold_uncertainty_score":0.8039195},"labels":[],"label_agreement":null},{"id":"W2979857875","doi":"10.1182/blood.v106.11.3343.3343","title":"International Primary Central Nervous System Lymphoma Collaborative Group (IPCG) Study on Low-Grade Primary Central Nervous System Lymphoma in Immunocompetent Patients.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Primary central nervous system lymphoma; Medicine; Radiation therapy; Lymphoma; Chemotherapy; Internal medicine; Central nervous system; Performance status; Oncology; Surgery","score_opus":0.006117688135648124,"score_gpt":0.21402634180118962,"score_spread":0.2079086536655415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979857875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98752904,0.00097440556,0.000004691503,0.00025921452,0.001239762,0.0039189057,0.00026202493,0.00031121273,0.005500749],"genre_scores_gemma":[0.99676174,0.00008931062,0.00032921604,0.0003725092,0.00069797615,0.00074458483,0.00079811196,0.00011531333,0.000091246446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99481314,0.00032342828,0.0012951897,0.0010569352,0.001374161,0.0011371585],"domain_scores_gemma":[0.99787307,0.00015324997,0.00045336416,0.00080840697,0.00025267748,0.00045926138],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024317736,0.000763919,0.001191941,0.00042358693,0.00020248673,0.00014882124,0.000438209,0.00022256841,0.000024315394],"category_scores_gemma":[0.000028910144,0.00066277373,0.0003450324,0.0005880703,0.000083101164,0.00025990728,0.00022409597,0.00015548458,0.000113947215],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019888617,0.08611652,0.7700346,0.0006672715,0.002379263,0.0033960145,0.004023498,0.00015149775,0.0004783687,0.0007105496,0.00051487866,0.12953867],"study_design_scores_gemma":[0.042886782,0.0020918443,0.94659984,0.0012283726,0.0006197589,0.00027787988,0.003430882,0.00015853316,0.0007681949,7.0890053e-7,0.0014120458,0.00052513456],"about_ca_topic_score_codex":0.00048568443,"about_ca_topic_score_gemma":0.00008796266,"teacher_disagreement_score":0.17656526,"about_ca_system_score_codex":0.0073335273,"about_ca_system_score_gemma":0.00050331024,"threshold_uncertainty_score":0.99958235},"labels":[],"label_agreement":null},{"id":"W2979859691","doi":"10.1182/blood.v128.22.2253.2253","title":"Comprehensive Analysis of Pre-Transplant Pulmonary Function Test Parameters Including FEV1, FVC, DLco, FEF50%/75%, Frc, RV and TLC As Prognostic Factors for Long-Term Outcomes after Allogeneic Transplantation","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Transplantation: Methods and Outcomes","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"DLCO; Medicine; Pulmonary function testing; Internal medicine; Cumulative incidence; Transplantation; Surgery; Lung; Lung function; Diffusing capacity","score_opus":0.04324361034970032,"score_gpt":0.32132211449261155,"score_spread":0.27807850414291124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979859691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817156,0.00044557126,0.015771843,0.00019655109,0.00013712056,0.0010434152,0.0005977508,0.00007596017,0.00001618138],"genre_scores_gemma":[0.99553317,0.0007080289,0.0028342323,0.0001732988,0.00003597251,0.00013995382,0.00044421921,0.00003850225,0.000092643866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981598,0.00009193572,0.0005926531,0.0004965246,0.00032273005,0.00033635757],"domain_scores_gemma":[0.9968866,0.0023508833,0.00020271487,0.00024768207,0.00013934627,0.0001727413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016369275,0.00034629166,0.0008089386,0.00045762,0.00010464782,0.000021676857,0.0000834741,0.00017616685,0.00004527516],"category_scores_gemma":[0.00008970325,0.00022483834,0.00038463788,0.00032244873,0.00011393623,0.00017943159,0.000010676367,0.00009589641,0.0000020960426],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011959336,0.00039508683,0.9520733,0.0009642456,0.002339911,0.00008930624,0.00084232184,0.000008388397,0.04008632,0.00001158063,6.8941273e-7,0.0019929418],"study_design_scores_gemma":[0.0035690062,0.00056152575,0.95588773,0.00041578623,0.0183708,0.00007935552,0.000077901095,0.000030443467,0.020680605,0.000047840633,0.000005730611,0.00027326876],"about_ca_topic_score_codex":0.00005947905,"about_ca_topic_score_gemma":0.000080722995,"teacher_disagreement_score":0.019405715,"about_ca_system_score_codex":0.000023775525,"about_ca_system_score_gemma":0.00003802492,"threshold_uncertainty_score":0.91686416},"labels":[],"label_agreement":null},{"id":"W2979861224","doi":"10.1182/blood.v104.11.3364.3364","title":"Depletion of the Intracellular Akt Kinase, and Its Downstream Signaling, Mediates Synergy between the Proteasome Inhibitor MG-132 and the Heat Shock Protein 90 Inhibitor 17-AAG in the Multiple Myeloma Cell Line U266.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Protein kinase B; Geldanamycin; Proteasome inhibitor; Heat shock protein; Hsp90 inhibitor; Apoptosis; Proteasome; Kinase; Annexin A5; Annexin; Chemistry; Inhibitor of apoptosis; Molecular biology; Bortezomib; Hsp90; Biology; Programmed cell death; Biochemistry; Immunology; Multiple myeloma","score_opus":0.0076545622993870206,"score_gpt":0.19781897968080778,"score_spread":0.19016441738142076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979861224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98972625,0.005770335,0.000028426504,0.0017241223,0.00004653566,0.002528002,0.00007080308,0.000012533418,0.000093019815],"genre_scores_gemma":[0.99832064,0.00014841181,0.00010777549,0.0001760051,0.0006474102,0.00045424636,0.00005834109,0.000029234652,0.000057922534],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99807614,0.00045285662,0.00041992194,0.0004062749,0.00031394084,0.00033086335],"domain_scores_gemma":[0.99904734,0.00012811735,0.00018414577,0.0004885501,0.000083364095,0.000068511705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009606313,0.00028722358,0.00027234253,0.000036817088,0.0002612914,0.00006320858,0.00042470038,0.00024278475,0.000005174398],"category_scores_gemma":[0.00031828065,0.00013606192,0.00011245848,0.000197554,0.00036267363,0.000011360846,0.00025762743,0.00033780787,0.0000018466959],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012499855,0.00023777824,0.0050606113,0.0000996109,0.000045514797,0.0000040562013,0.0006866292,0.000045993573,0.99323225,0.00010620485,0.000021156999,0.00033520168],"study_design_scores_gemma":[0.0041576847,0.00036445583,0.0026934932,0.00013171865,0.00007268731,0.000018452078,0.0002502225,0.00003749389,0.99078435,0.00032251657,0.000973559,0.00019334347],"about_ca_topic_score_codex":0.00015088287,"about_ca_topic_score_gemma":0.00015172428,"teacher_disagreement_score":0.008594431,"about_ca_system_score_codex":0.0000102462045,"about_ca_system_score_gemma":0.000089400135,"threshold_uncertainty_score":0.55484444},"labels":[],"label_agreement":null},{"id":"W2979861852","doi":"10.1182/blood.v120.21.1753.1753","title":"Niche Requirements of Transient Leukemia Cells in Down Syndrome","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Haematopoiesis; GATA1; Bone marrow; Biology; Leukemia; Context (archaeology); Fetus; Trisomy; Stem cell; Immunology; Pathology; Cancer research; Medicine; Cell biology; Genetics; Pregnancy","score_opus":0.028323981704892327,"score_gpt":0.2941409615994923,"score_spread":0.2658169798946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979861852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99132174,0.0004700111,0.000013859709,0.00014382905,0.00008892098,0.00042697598,0.00001060039,0.000022708204,0.0075013605],"genre_scores_gemma":[0.9981212,0.0000806355,0.0006946759,0.00011978286,0.000064759144,0.000023796096,0.000011599395,0.000024481249,0.0008590395],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99845314,0.00005778728,0.00034321417,0.0001805601,0.00045005354,0.0005152272],"domain_scores_gemma":[0.9992521,0.000051084906,0.000054946067,0.0003794023,0.00004849373,0.00021397357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000503079,0.00012581485,0.0003233203,0.0001887794,0.00001727132,0.000003773333,0.00014114872,0.00011641035,0.00026887786],"category_scores_gemma":[0.0000539041,0.00010828208,0.00007933078,0.00033339515,0.000070151116,0.00010453254,0.000052757998,0.0002894823,0.00013742053],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002645132,0.002569677,0.15124266,0.0005803678,0.000258793,0.000428969,0.0019156361,0.000006778525,0.83833784,0.00013961572,0.0028161367,0.0014390014],"study_design_scores_gemma":[0.012967127,0.0006200654,0.48068383,0.00029498746,0.00025201525,0.00041629694,0.00023532638,0.000046462163,0.5001618,0.000022400658,0.0040681465,0.00023149682],"about_ca_topic_score_codex":0.000111074536,"about_ca_topic_score_gemma":0.000006857578,"teacher_disagreement_score":0.338176,"about_ca_system_score_codex":0.00029119666,"about_ca_system_score_gemma":0.00027385785,"threshold_uncertainty_score":0.4415615},"labels":[],"label_agreement":null},{"id":"W2979863015","doi":"10.1182/blood.v116.21.22.22","title":"Mouse Models of the Common, Recurring Type 1 von Willebrand Disease Mutations Y1584C and R1205H","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Von Willebrand disease; ADAMTS13; Von Willebrand factor; Platelet; Knockout mouse; Wild type; Chemistry; Missense mutation; Molecular biology; Bleeding time; Internal medicine; Endocrinology; Mutant; Mutation; Medicine; Biology; Gene; Biochemistry; Receptor","score_opus":0.011534803129255415,"score_gpt":0.24439700197185968,"score_spread":0.23286219884260426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979863015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979602,0.00030554418,0.0000029704192,0.00028076762,0.00004638924,0.00018330643,0.000023429096,0.000013863807,0.0011834964],"genre_scores_gemma":[0.9994305,0.000046913796,0.00014740306,0.00007808018,0.000012786319,0.000005522448,0.000014497787,0.000009007878,0.00025529444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99966323,0.000008324835,0.00008471154,0.000087259425,0.00008041243,0.00007603437],"domain_scores_gemma":[0.99966127,0.000019818803,0.000032177588,0.00018413841,0.000032588392,0.00007003451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000025739248,0.000060162205,0.000112596215,0.00002108858,0.000057365178,0.0000060611933,0.00003501365,0.000028568713,0.0000114464165],"category_scores_gemma":[0.000027693359,0.00003882507,0.000029890782,0.00006554708,0.00005229713,0.00004308228,0.000022319819,0.00008516587,0.000002249999],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031674144,0.0033486388,0.9545699,0.0001958628,0.00054037967,0.000163913,0.0012708268,0.00006274814,0.032540236,0.0022510595,0.00029192204,0.0044477694],"study_design_scores_gemma":[0.0394628,0.0007805151,0.83753747,0.0005270765,0.0059280097,0.00042694405,0.0004184132,0.0075470908,0.07086516,0.033177283,0.002561927,0.00076728436],"about_ca_topic_score_codex":0.000034766348,"about_ca_topic_score_gemma":0.000057278194,"teacher_disagreement_score":0.11703241,"about_ca_system_score_codex":0.0000018968136,"about_ca_system_score_gemma":0.000029128574,"threshold_uncertainty_score":0.15832403},"labels":[],"label_agreement":null},{"id":"W2979863150","doi":"10.1182/blood.v116.21.5002.5002","title":"A Review of Multiple Myeloma Patients on Dialysis Treated with High Cutoff Hemodialysis","year":2010,"lang":"en","type":"review","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Dialysis; Hemodialysis; Bortezomib; Multiple myeloma; Urology; Surgery; Nephropathy; Internal medicine; Gastroenterology; Endocrinology","score_opus":0.02807284779152683,"score_gpt":0.30759914028755475,"score_spread":0.2795262924960279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979863150","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0042542773,0.99071676,8.015381e-7,0.00002089477,0.000037958158,0.0034308415,0.0005636301,0.00006626776,0.00090855267],"genre_scores_gemma":[0.0007998756,0.99273545,0.00055071677,0.000082892046,0.00013451451,0.0006722598,0.0045212964,0.00013115638,0.00037186831],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963827,0.00028957633,0.0009998375,0.00081149716,0.0009702508,0.00054613734],"domain_scores_gemma":[0.99643004,0.00042840332,0.00073877315,0.0014755868,0.00046617535,0.0004610002],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021952482,0.00077993097,0.0044316025,0.00055559457,0.00007913113,0.000017679988,0.00030018942,0.00040880337,0.00030275487],"category_scores_gemma":[0.0008652632,0.00045844325,0.0011817184,0.0011396818,0.00012271335,0.000047705475,0.00008475077,0.00067036547,0.00022879355],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015295387,0.0045455783,0.008711661,0.105909534,0.004173242,0.00018368466,0.0000072020307,1.6762375e-8,0.0000015640189,0.0000022220902,0.00021756686,0.87609476],"study_design_scores_gemma":[0.01346285,0.0024007352,0.0032206434,0.26706904,0.038101092,0.00005998247,0.0000013201511,0.0000013842904,0.0002250323,0.0000011096905,0.6748238,0.00063299475],"about_ca_topic_score_codex":0.00023721142,"about_ca_topic_score_gemma":0.000040848547,"teacher_disagreement_score":0.87546176,"about_ca_system_score_codex":0.00010308667,"about_ca_system_score_gemma":0.00040235516,"threshold_uncertainty_score":0.99978673},"labels":[],"label_agreement":null},{"id":"W2979864420","doi":"10.1182/blood.v116.21.111.111","title":"Randomised Intergroup Trial of First line Treatment for young Low-Risk Patients (&lt;61 years) with Diffuse Large B-Cell Non-Hodgkin's Lymphoma (DLBCL) with a CHOP-like Regimen with or without the Anti-CD20 Antibody Rituximab – 6-Year Follow-up of the Mint Study of the Mabthera International Trial (MInT) Group","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Rituximab; Medicine; Regimen; Internal medicine; CHOP; Clinical endpoint; Chemotherapy regimen; Diffuse large B-cell lymphoma; Surgery; Oncology; Randomized controlled trial; Lymphoma; Chemotherapy","score_opus":0.006993248135219416,"score_gpt":0.24344037576304184,"score_spread":0.2364471276278224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979864420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860692,0.000022143606,0.000031836367,0.000090414294,0.00075678533,0.012670157,0.00025627823,0.000018760335,0.00008439477],"genre_scores_gemma":[0.997891,0.000043174754,0.00024507038,0.000029353158,0.0002570768,0.0011719732,0.00005886463,0.00008091648,0.00022256601],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99713695,0.00017777104,0.0008298906,0.0005429569,0.0009569194,0.00035552573],"domain_scores_gemma":[0.9967738,0.0004000603,0.0011934512,0.0012043667,0.00032856522,0.00009975244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004460409,0.0004830739,0.0011622715,0.000104342835,0.00021094226,0.00004783982,0.00052902586,0.00012558862,0.00001970499],"category_scores_gemma":[0.00010787796,0.00018137143,0.00042577554,0.0002843671,0.00029062238,0.000082794664,0.00013522015,0.00014541899,0.0000011551059],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5117803,0.11980143,0.36107248,0.000051372328,0.0027280815,0.000014278771,0.0037087935,0.0000013134488,0.00029524477,0.000008183333,0.0000334271,0.00050508045],"study_design_scores_gemma":[0.86563987,0.033196867,0.09095231,0.0003609892,0.0038763678,0.000019137542,0.0007437144,0.00007303943,0.0047062645,0.0000026551547,0.00022853227,0.00020026338],"about_ca_topic_score_codex":0.00096388056,"about_ca_topic_score_gemma":0.005678896,"teacher_disagreement_score":0.35385954,"about_ca_system_score_codex":0.00010647992,"about_ca_system_score_gemma":0.00032673546,"threshold_uncertainty_score":0.7396112},"labels":[],"label_agreement":null},{"id":"W2979865431","doi":"10.1182/blood-2018-99-117705","title":"Lenalidomide Maintenance Does Not Negatively Impact Overall and Progression Free Survival Using Lenalidomide-Based Regimens for Multiple Myeloma in First Relapse","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Lenalidomide; Medicine; Multiple myeloma; Maintenance therapy; Internal medicine; Oncology; Bortezomib; Clinical endpoint; Autologous stem-cell transplantation; Progression-free survival; Surgery; Clinical trial; Chemotherapy","score_opus":0.04025280004998385,"score_gpt":0.3362893295632122,"score_spread":0.2960365295132284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979865431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960713,0.00016718364,0.00035174814,0.0010232031,0.00009564677,0.0018240705,0.00029023073,0.00005784307,0.000118774806],"genre_scores_gemma":[0.9838776,0.00003272051,0.015238135,0.0001116356,0.00026852434,0.00014045637,0.000054347383,0.000058150967,0.0002184164],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99766856,0.00012186966,0.0004026855,0.00058195856,0.00045874435,0.0007661891],"domain_scores_gemma":[0.9980123,0.0006747067,0.00017855491,0.0005171807,0.00026322837,0.0003540166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000547294,0.0003348298,0.0005516261,0.00022343567,0.00024586354,0.00005972898,0.0001540004,0.00014794816,0.000037978232],"category_scores_gemma":[0.0020086318,0.0002117133,0.00017019924,0.00018888182,0.00029877122,0.0001836438,0.000111617366,0.00020673829,0.000006626787],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022995867,0.0021813565,0.8784621,0.00046466652,0.000529191,0.00055320887,0.0005492566,0.000017043672,0.09110434,0.000085493004,0.00046173553,0.0025957495],"study_design_scores_gemma":[0.13569474,0.0033433635,0.554493,0.0021087292,0.00029015486,0.00010624855,0.00012598927,0.017006233,0.2852112,0.0005234226,0.00053612306,0.0005607906],"about_ca_topic_score_codex":0.0012182277,"about_ca_topic_score_gemma":0.0016382191,"teacher_disagreement_score":0.3239691,"about_ca_system_score_codex":0.00019561741,"about_ca_system_score_gemma":0.00026010312,"threshold_uncertainty_score":0.8633418},"labels":[],"label_agreement":null},{"id":"W2979865757","doi":"10.1182/blood.v104.11.2073.2073","title":"Can IVIg Preparations with Specificity for Soluble Antigens Mimic the Therapeutic Effects of IVIg in the Treatment of Immune Thrombocytopenia?.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services","funders":"","keywords":"Antigen; Ovalbumin; Antibody; Immunology; Immune system; Platelet; Transferrin receptor; Thrombocytopenic purpura; Immunoglobulin G; Medicine; Receptor; Chemistry; Internal medicine","score_opus":0.018729479558307723,"score_gpt":0.27069089746300895,"score_spread":0.2519614179047012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979865757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951288,0.0015405895,0.000049562623,0.00070509233,0.000031104522,0.0021210238,0.000017570279,0.00000815428,0.0003980791],"genre_scores_gemma":[0.999037,0.00039908692,0.00020881135,0.000045761437,0.00001518437,0.0001739178,0.000026842117,0.000012440668,0.00008092686],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993211,0.000031566964,0.00019950078,0.0001429903,0.00013304454,0.00017179643],"domain_scores_gemma":[0.99934745,0.00014267441,0.0000965406,0.00035731177,0.000036676072,0.000019361252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006845127,0.00013035534,0.00036871256,0.00002906261,0.000078492085,0.0000072605726,0.00008694702,0.000036472713,0.000004079206],"category_scores_gemma":[0.000006666973,0.000059923404,0.000105519954,0.00015319836,0.00008748009,0.00002242054,0.0000050165963,0.00003923671,0.0000013006588],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004831018,0.17249514,0.2874632,0.0017573233,0.0138680665,0.0009846705,0.12027341,0.0010337115,0.37346914,0.01258278,0.00014382352,0.01109774],"study_design_scores_gemma":[0.03850803,0.012151134,0.36386508,0.00028160057,0.002260593,0.00015504497,0.0012495843,0.000027574519,0.5784662,0.0025406752,0.00029815684,0.00019635228],"about_ca_topic_score_codex":0.0006397243,"about_ca_topic_score_gemma":0.001465312,"teacher_disagreement_score":0.20499703,"about_ca_system_score_codex":0.000031565025,"about_ca_system_score_gemma":0.0001152839,"threshold_uncertainty_score":0.24436055},"labels":[],"label_agreement":null},{"id":"W2979867208","doi":"10.1182/blood.v110.11.3143.3143","title":"Recombinant Activated Factor VII (rFVIIa) in the Treatment of Non-Hemophilia Patients: Physician Underreporting of Thromboembolic Adverse Events.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Hospital; Canadian Blood Services; London Health Sciences Centre","funders":"","keywords":"Medicine; Adverse effect; Recombinant factor VIIa; Intensive care medicine; Pediatrics; Emergency medicine; Surgery; Internal medicine","score_opus":0.03224057607225673,"score_gpt":0.3256429307884312,"score_spread":0.2934023547161745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979867208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99658275,0.000054471126,0.0000026398377,0.00011740516,0.00007840377,0.0009923668,0.000009322812,0.000012886842,0.0021497773],"genre_scores_gemma":[0.99952215,0.000107703985,0.00007731901,0.00003319607,0.000048535796,0.000017761935,0.0000489145,0.000020230013,0.00012419325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829626,0.000051834675,0.0005768117,0.000235748,0.0004691324,0.0003701979],"domain_scores_gemma":[0.99898005,0.00013622375,0.00027815698,0.00040409362,0.00012015591,0.000081335456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022777767,0.00018837432,0.00050386693,0.00018517899,0.000049438746,0.0000016159607,0.00010641697,0.00009390566,0.000026639527],"category_scores_gemma":[0.000057860903,0.00011132704,0.00019259928,0.00046691415,0.0000736984,0.00006602377,0.000019580542,0.00011652118,0.000007774186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022275696,0.02526149,0.8820106,0.0001284293,0.0004359796,0.00010668803,0.0036251654,0.0000010420672,0.07209356,0.000018347195,0.000009651298,0.01608631],"study_design_scores_gemma":[0.0066017653,0.0020231705,0.7394755,0.00014964442,0.00014146163,0.0000042407187,0.0006574092,0.000005275541,0.25073773,0.000052420375,0.00007376461,0.00007763618],"about_ca_topic_score_codex":0.00018234864,"about_ca_topic_score_gemma":0.000036437785,"teacher_disagreement_score":0.17864415,"about_ca_system_score_codex":0.00011352862,"about_ca_system_score_gemma":0.00010188945,"threshold_uncertainty_score":0.45397848},"labels":[],"label_agreement":null},{"id":"W2979867872","doi":"10.1182/blood.v110.11.2768.2768","title":"Continuous Improvement of Bone Mineral Density Two Years Post Zoledronic Acid Discontinuation in Patients with Thalassemia-Induced Osteoporosis: Long-Term Follow-Up of a Randomized, Placebo-Controlled Trial.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Bone health and treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Zoledronic acid; Medicine; Osteoporosis; Femoral neck; Discontinuation; Placebo; Surgery; Bisphosphonate; Randomized controlled trial; Bone mineral; Internal medicine","score_opus":0.006538071667344206,"score_gpt":0.25159098486921094,"score_spread":0.24505291320186673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979867872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990424,0.000201164,0.00001110062,0.000037511167,0.00019838095,0.009000077,0.000012339495,0.000020648722,0.00009481528],"genre_scores_gemma":[0.9992012,0.000009577274,0.00014067524,0.000051724935,0.00003688939,0.00025453552,0.00011810604,0.000029120363,0.0001581969],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9973411,0.00011761288,0.0012669228,0.0003138048,0.0005347312,0.0004258309],"domain_scores_gemma":[0.99816227,0.00018218493,0.00086645223,0.00033646947,0.00028328455,0.00016934078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011706717,0.0002556256,0.0018847072,0.00024940167,0.000026915444,0.000007816664,0.00005886527,0.00012313543,0.000013533055],"category_scores_gemma":[0.00029838408,0.000185876,0.00029486694,0.00018211869,0.000062666055,0.00009429955,0.000029223656,0.00016512223,0.000002746578],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7023632,0.0043178764,0.2820677,0.000061726016,0.00052982394,0.000048897044,0.0003763085,1.3622606e-7,0.0077995653,0.0000030463254,0.0000017090564,0.0024300406],"study_design_scores_gemma":[0.66951346,0.0035542129,0.30960754,0.00021404962,0.0011574193,0.000004407671,0.0000414471,0.000002062999,0.015806224,0.0000022548538,7.433333e-8,0.00009687997],"about_ca_topic_score_codex":0.000624655,"about_ca_topic_score_gemma":0.0017523314,"teacher_disagreement_score":0.032849737,"about_ca_system_score_codex":0.00009489493,"about_ca_system_score_gemma":0.00023557585,"threshold_uncertainty_score":0.7579803},"labels":[],"label_agreement":null},{"id":"W2979870112","doi":"10.1182/blood.v128.22.317.317","title":"Comprehensive Structured Transition Program with Dedicated Transition Navigator Reduced Lost to Follow-up and Improved Medication Adherence in Sickle Cell Disease and Thalassemia Adolescents and Young Adults","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Medicine; Adult care; Psychosocial; Attendance; Young adult; Pediatrics; Hemoglobinopathy; Family medicine; Disease; Gerontology; Psychiatry","score_opus":0.01627006898931737,"score_gpt":0.31560628893708575,"score_spread":0.2993362199477684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979870112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940845,0.00043254084,0.00014069662,0.0018802349,0.00014224867,0.0030774374,0.00015285067,0.000081709186,0.000007823036],"genre_scores_gemma":[0.9984979,0.00037519014,0.00028535927,0.00033547575,0.0001567703,0.00019792694,0.00010409172,0.00002884457,0.000018445702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99815875,0.00027555058,0.00039381455,0.00051078445,0.00023141675,0.00042968083],"domain_scores_gemma":[0.9987662,0.00007039478,0.00015356249,0.00017672883,0.00017470612,0.00065840024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013674294,0.00022625923,0.0002673387,0.000101802776,0.00022638113,0.000011924167,0.000065854336,0.00022219523,0.0000120397535],"category_scores_gemma":[0.000036947276,0.00016258261,0.000018855206,0.00021240744,0.00008879813,0.00016890802,0.000025186608,0.00031968954,0.0000052955515],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008093079,0.0009813497,0.8281075,0.0091314595,0.0000596096,0.000064641055,0.041222367,3.6591942e-7,0.056417704,0.000011623943,0.00031892594,0.055591367],"study_design_scores_gemma":[0.018140636,0.00068196334,0.9731389,0.0039913664,0.00018069072,0.000007012243,0.0026258333,0.00018287328,0.0006141758,0.00004795067,0.00005195486,0.0003366016],"about_ca_topic_score_codex":0.00026566634,"about_ca_topic_score_gemma":0.00055115786,"teacher_disagreement_score":0.14503144,"about_ca_system_score_codex":0.00004541248,"about_ca_system_score_gemma":0.0002445161,"threshold_uncertainty_score":0.66299266},"labels":[],"label_agreement":null},{"id":"W2979871905","doi":"10.1182/blood.v114.22.2793.2793","title":"“Longterm Survival (≥10 years) in Multiple Myeloma (MM) Is Associated with Longer Duration of Therapy and Improved Quality of Response to Novel agents”.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Multiple myeloma; Internal medicine; Surgery; Bortezomib; Median follow-up; Pediatrics; Overall survival","score_opus":0.06679748478643414,"score_gpt":0.33681122747382264,"score_spread":0.2700137426873885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979871905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988174,0.00006544689,0.000014255451,0.00025269671,0.000008890619,0.0006814047,0.000091188915,0.000012952264,0.000055806984],"genre_scores_gemma":[0.99894285,0.000020710015,0.0006250233,0.000078808516,0.000011748834,0.000014342777,0.000037417696,0.000011814413,0.00025731119],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987446,0.00014223381,0.000335371,0.00022379085,0.0003453733,0.00020864863],"domain_scores_gemma":[0.9991172,0.00022805537,0.0001337383,0.00024489796,0.00015170935,0.00012442473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059680577,0.00011938503,0.00037041382,0.00014870364,0.000019434858,0.0000081932585,0.00005640878,0.00007731883,0.00005615533],"category_scores_gemma":[0.0007213575,0.00009433661,0.000044563567,0.0002547391,0.00004453973,0.000054995293,0.000017623432,0.00008034311,0.000002755565],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017186228,0.0036889983,0.40304625,0.000021576241,0.00024356891,0.00004711628,0.0013985276,4.3277836e-7,0.5676409,0.0000031852235,0.00001395653,0.006709282],"study_design_scores_gemma":[0.025174625,0.0018625042,0.9054151,0.00007122788,0.000023064817,0.0000032585301,0.0000786648,0.0000953242,0.0671841,0.0000030089736,0.000012363864,0.000076725926],"about_ca_topic_score_codex":0.00028116157,"about_ca_topic_score_gemma":0.00022451964,"teacher_disagreement_score":0.5023689,"about_ca_system_score_codex":0.000033991953,"about_ca_system_score_gemma":0.000085533204,"threshold_uncertainty_score":0.38469353},"labels":[],"label_agreement":null},{"id":"W2979872579","doi":"10.1182/blood.v126.23.1921.1921","title":"Incidence and Risk Factors for Vzv Infection after Allogeneic Hematopoietic Cell Transplantation in 1,045 Patients: Younger Age Less Than or Equal to 45, Occurrence of Cgvhd By NIH Consensus Criteria, and No T-Cell Depletion","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Cumulative incidence; Incidence (geometry); Transplantation; Hematopoietic stem cell transplantation; Varicella zoster virus; Retrospective cohort study; Postherpetic neuralgia; Univariate analysis; Risk factor; Internal medicine; Complication; Immunosuppression; Pediatrics; Surgery; Immunology; Multivariate analysis; Virus; Pathology","score_opus":0.024762225378060724,"score_gpt":0.2806525730816329,"score_spread":0.25589034770357216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979872579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979681,0.0001490916,0.0005596848,0.0000065998174,0.00011773201,0.0007406985,0.0003909271,0.000016695494,0.00005051063],"genre_scores_gemma":[0.9991056,0.0002108916,0.00037355314,0.00002647917,0.000014293614,0.00009803425,0.00012816607,0.000012309456,0.000030678577],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991239,0.00007089163,0.00026441235,0.0002500614,0.00013191572,0.00015884811],"domain_scores_gemma":[0.99943155,0.000103596656,0.000093664756,0.000109162975,0.00012435958,0.00013763754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001408186,0.0001510687,0.00022827093,0.00011437259,0.00003901376,0.000016871352,0.000019575233,0.00009959335,0.0000082759],"category_scores_gemma":[0.00008947601,0.0001224972,0.000029269115,0.000116839634,0.00004594598,0.00008329315,0.000012679709,0.00007171535,0.000003881092],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060751225,0.001112904,0.99280185,0.00033043895,0.000029890003,0.000013750128,0.0020755508,0.0000019820232,0.0024010579,8.0178637e-7,0.000116606585,0.00050766167],"study_design_scores_gemma":[0.020589141,0.004442429,0.9031301,0.0004220086,0.0011649992,0.00005502057,0.0003746161,0.000044507124,0.06850478,0.000054214295,0.00076167745,0.00045652266],"about_ca_topic_score_codex":0.0018225638,"about_ca_topic_score_gemma":0.0006860423,"teacher_disagreement_score":0.08967176,"about_ca_system_score_codex":0.00003432041,"about_ca_system_score_gemma":0.000042294505,"threshold_uncertainty_score":0.49952903},"labels":[],"label_agreement":null},{"id":"W2979874966","doi":"10.1182/blood.v116.21.854.854","title":"FDG-PET Scan Guided Consolidative Radiation Therapy Optimizes Outcome In Patients with Advanced-Stage Diffuse Large B-Cell Lymphoma (DLBCL) with Residual Abnormalities on CT Scan Following R-CHOP","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Stage (stratigraphy); Lymphoma; Radiation therapy; Radiology; Nuclear medicine; Internal medicine","score_opus":0.009785499901045713,"score_gpt":0.2544558754198473,"score_spread":0.2446703755188016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979874966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99578875,0.00016171687,0.0000016738568,0.0001489527,0.00014294202,0.0012670167,0.00016097423,0.00008392316,0.0022440192],"genre_scores_gemma":[0.9971944,0.00008127797,0.0012116935,0.00050578883,0.00006416069,0.00023143327,0.00025924988,0.000065661494,0.00038633798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99791634,0.00008266097,0.000427634,0.00049708615,0.00055809674,0.0005181829],"domain_scores_gemma":[0.99875975,0.000182453,0.0002332998,0.00052973995,0.00009903199,0.00019573294],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018579245,0.0004108553,0.0005850416,0.00021752826,0.00015607158,0.000064676664,0.00012274747,0.000060188824,0.000047233534],"category_scores_gemma":[0.0000601203,0.0002727057,0.00010009795,0.00021803794,0.00007907863,0.00026167894,0.000030189995,0.00014653594,0.000013238866],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013375027,0.019337,0.9751644,0.000027357291,0.00033392687,0.0004673097,0.00082307606,0.000017020404,0.00007132766,0.00015282197,0.00007004548,0.002198182],"study_design_scores_gemma":[0.21990058,0.0023209285,0.758621,0.00015935874,0.00021531858,0.000021355489,0.0004972583,0.000010697642,0.01733896,0.00000488657,0.0005581632,0.00035154368],"about_ca_topic_score_codex":0.00034361944,"about_ca_topic_score_gemma":0.00024624675,"teacher_disagreement_score":0.21856308,"about_ca_system_score_codex":0.00017824069,"about_ca_system_score_gemma":0.00021900376,"threshold_uncertainty_score":0.9999725},"labels":[],"label_agreement":null},{"id":"W2979877733","doi":"10.1182/blood.v120.21.2772.2772","title":"The RNA Editase ADAR1 Promotes Malignant Progenitor Reprogramming in Chronic Myeloid Leukemia.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"RNA regulation and disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Biology; Reprogramming; Progenitor cell; Stem cell; Cancer research; Myeloid leukemia; RNA editing; Haematopoiesis; Myeloid; Cell biology; Genetics; Cell; Gene expression; Gene","score_opus":0.008743237416531022,"score_gpt":0.2411016576963182,"score_spread":0.23235842027978718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979877733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899731,0.009041649,0.000024098455,0.00010116039,0.00016509449,0.00030116175,0.0000060792167,0.000016792676,0.00037085282],"genre_scores_gemma":[0.9978974,0.00009290912,0.00022339552,0.000041055733,0.0011788342,0.000094706804,0.000049960472,0.000016502976,0.00040521988],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999124,0.000049955415,0.00016913746,0.0001964539,0.00011484362,0.00034562527],"domain_scores_gemma":[0.99942935,0.000009272544,0.000059991096,0.00034011554,0.000031461397,0.0001297849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024735034,0.00010842214,0.00007307975,0.000018771112,0.00010421036,0.000034649132,0.00013163974,0.00008259906,0.000009245939],"category_scores_gemma":[0.00010457656,0.00007796021,0.000066273424,0.0000764857,0.000058589438,0.0000060574307,0.00006903251,0.00005673982,0.000016983437],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007950714,0.00043945268,0.041711837,0.00004383742,0.000075485,0.00001274767,0.000080892845,0.000010554824,0.9296898,0.0002390506,0.001337636,0.026279159],"study_design_scores_gemma":[0.0020251523,0.00020536497,0.023178792,0.000028147344,0.000058547143,0.000033989698,0.00011727658,0.000052510404,0.8654528,0.00004575918,0.10851059,0.00029103187],"about_ca_topic_score_codex":0.000013394894,"about_ca_topic_score_gemma":0.000027305285,"teacher_disagreement_score":0.10717296,"about_ca_system_score_codex":0.00003623165,"about_ca_system_score_gemma":0.00022314304,"threshold_uncertainty_score":0.31791252},"labels":[],"label_agreement":null},{"id":"W2979878225","doi":"10.1182/blood.v124.21.3624.3624","title":"Development of a Clinically Relevant in Vitro Drug Screening Platform for Chemo-Refractory AML Patients","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Pharmacology; Bortezomib; Homoharringtonine; Oncology; Myeloid leukemia; Cytarabine; Proteasome inhibitor; Internal medicine; Panobinostat; Idarubicin; Cancer research; Multiple myeloma; Biology; Histone deacetylase","score_opus":0.027766607716471707,"score_gpt":0.3055776461738024,"score_spread":0.2778110384573307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979878225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972928,0.000024081468,0.0009190453,0.0001118633,0.000040366587,0.00068496284,0.0000091249285,0.000026609563,0.0008911427],"genre_scores_gemma":[0.8583854,0.000007466052,0.14100704,0.00016636262,0.00008443314,0.00006441166,0.00009072458,0.000030935058,0.00016322572],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99811417,0.000022995906,0.00079240534,0.00027910378,0.00041648682,0.00037483554],"domain_scores_gemma":[0.99878585,0.00039726592,0.00018824822,0.00029105204,0.000184302,0.00015326557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011134642,0.00013818279,0.00041168559,0.00015869601,0.00004371194,0.000006232961,0.00016726264,0.00011275457,0.000015021839],"category_scores_gemma":[0.0013452466,0.0001173198,0.00008882605,0.00014137257,0.000050913826,0.000062332016,0.000114834715,0.00030556397,0.000015684474],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008299476,0.006910525,0.18702362,0.0013162113,0.0005242429,0.000024039953,0.005170026,0.0000025631664,0.27825728,0.00007236852,0.0014195926,0.51098007],"study_design_scores_gemma":[0.075414255,0.0012591644,0.26307508,0.0009084914,0.00022387627,0.000013323523,0.0004931267,0.0019515379,0.60696,0.00012656489,0.048945356,0.00062919484],"about_ca_topic_score_codex":0.00001748547,"about_ca_topic_score_gemma":0.000012987259,"teacher_disagreement_score":0.5103509,"about_ca_system_score_codex":0.00011704211,"about_ca_system_score_gemma":0.00039405018,"threshold_uncertainty_score":0.4784163},"labels":[],"label_agreement":null},{"id":"W2979884687","doi":"10.1182/blood.v128.22.4742.4742","title":"Attitudes Toward Prenatal Diagnosis and Pregnancy Management in Carriers of Hemophilia: A Qualitative Analysis Exploring the Views of Carriers in Southern Alberta","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Prenatal diagnosis; Pregnancy; Genetic counseling; Family medicine; Genetic testing; Carrier testing; Obstetrics; Pediatrics; Fetus; Internal medicine","score_opus":0.08265157941701429,"score_gpt":0.35603592045518156,"score_spread":0.2733843410381673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979884687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955996,0.0025301804,0.000004315335,0.00065497454,0.000011884601,0.00064559374,0.00003138629,0.000004106907,0.0005179199],"genre_scores_gemma":[0.9969365,0.0019714355,0.00013778145,0.0000051957463,0.0000075756434,0.000376455,0.0000036583986,0.000010961892,0.0005504219],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870735,0.00016501907,0.00035607832,0.00025663545,0.00028994613,0.00022495804],"domain_scores_gemma":[0.9991448,0.0003711551,0.00007907664,0.0002873903,0.000040081457,0.00007747738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003584411,0.00013103026,0.00044406828,0.00035147436,0.000020384005,0.000004066217,0.00010884032,0.000041935018,0.000041613126],"category_scores_gemma":[0.00015054032,0.00006826773,0.00012618318,0.00063073845,0.00019538683,0.00006692633,0.0000871744,0.00007782171,0.0000017960507],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009434585,0.00048991555,0.903241,0.0005023594,0.0019141395,0.00005466455,0.079975635,0.0000023139064,0.00030629756,0.000078225195,0.0000022437132,0.013338912],"study_design_scores_gemma":[0.021519467,0.0012231601,0.74171346,0.010754579,0.005077134,0.0000059074036,0.15278907,0.000026875921,0.065811194,0.00048636264,0.00007016993,0.0005225985],"about_ca_topic_score_codex":0.0014691575,"about_ca_topic_score_gemma":0.0020700872,"teacher_disagreement_score":0.16152747,"about_ca_system_score_codex":0.000033909157,"about_ca_system_score_gemma":0.000031218293,"threshold_uncertainty_score":0.2783877},"labels":[],"label_agreement":null},{"id":"W2979884819","doi":"10.1182/blood.v114.22.4538.4538","title":"Erythropoietin Stimulating Agents (ESAs): Reassessment of Use in Cancer and Chronic Kidney Disease (CKD) Settings in the United States, Canada, and Europe.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Reimbursement; Kidney disease; Cancer; Anemia; Internal medicine; Dialysis; Intensive care medicine; Darbepoetin alfa; Erythropoietin; Health care","score_opus":0.018238014004271497,"score_gpt":0.28273850084218943,"score_spread":0.26450048683791794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979884819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98992866,0.0010016409,6.90777e-7,0.008497609,0.000018607509,0.0003962114,0.0000712967,0.00000999999,0.000075273805],"genre_scores_gemma":[0.9955647,0.0014433644,0.00017919911,0.002486161,0.000032263688,0.000012716892,0.00013630335,0.000013504611,0.00013177058],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988923,0.00008588321,0.00028117604,0.0002450218,0.00024839083,0.00024721122],"domain_scores_gemma":[0.9993777,0.00008940369,0.000086926135,0.00019870096,0.000045778877,0.00020144899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015766144,0.00015956615,0.0002270156,0.00008512414,0.000046991758,0.000019582287,0.000051613177,0.000029970839,0.000027968184],"category_scores_gemma":[0.00011547362,0.00011350791,0.000017075827,0.00030158626,0.00006478184,0.000043169035,0.000030289379,0.00016206513,2.3151989e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001228343,0.0011313898,0.98981774,0.0003382514,0.000048422255,0.0008800847,0.0010027001,0.00014388433,0.000602542,0.000044419827,0.003634389,0.00223336],"study_design_scores_gemma":[0.0067074406,0.0003687509,0.9870508,0.0010115082,0.00018677236,0.000021647098,0.00038462065,0.00076672767,0.00022424909,0.00001579373,0.0031259265,0.00013579283],"about_ca_topic_score_codex":0.28713328,"about_ca_topic_score_gemma":0.11045146,"teacher_disagreement_score":0.17668182,"about_ca_system_score_codex":0.00012753262,"about_ca_system_score_gemma":0.000561612,"threshold_uncertainty_score":0.9057805},"labels":[],"label_agreement":null},{"id":"W2979885356","doi":"10.1182/blood.v110.11.790.790","title":"Addition of Rituximab to CHOP Chemotherapy Significantly Improves Survival of Patients with Transformed Lymphoma.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Rituximab; Follicular lymphoma; Lymphoma; Internal medicine; Diffuse large B-cell lymphoma; CHOP; Oncology; Aggressive lymphoma; Chemotherapy; Lymphoplasmacytic Lymphoma; Chemotherapy regimen; Gastroenterology; Waldenstrom macroglobulinemia","score_opus":0.006081263969989547,"score_gpt":0.22558463689789424,"score_spread":0.2195033729279047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979885356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975852,0.000048501657,0.000082348786,0.000079990714,0.000037762013,0.00065511465,0.0001241664,0.000019128003,0.0013678317],"genre_scores_gemma":[0.9985057,0.000024156116,0.0011710183,0.00010297898,0.000037922055,0.000026682279,0.00008864676,0.000019328836,0.000023557875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901044,0.000009079904,0.00028397367,0.00017788702,0.0003256587,0.00019296634],"domain_scores_gemma":[0.9993787,0.000060363538,0.00009644768,0.00019192783,0.0001540421,0.000118550175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009958104,0.00013366887,0.00035326445,0.00009315778,0.000019477904,0.0000030891322,0.000047846323,0.000055253233,0.00006189613],"category_scores_gemma":[0.000014700981,0.00009419393,0.00008016381,0.00018506046,0.000042894342,0.000039941202,0.0000045433735,0.000018456622,0.0000047953267],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007233514,0.058411337,0.67626303,0.00040547826,0.0013803382,0.00004590415,0.0017542384,4.3257026e-7,0.04668285,0.0002840795,0.00021004058,0.20732878],"study_design_scores_gemma":[0.030721229,0.0019287003,0.70348567,0.00007901513,0.00019299584,0.0000018192667,0.000076134944,3.2862152e-7,0.26319492,0.00000910863,0.00023626992,0.00007381244],"about_ca_topic_score_codex":0.0000791798,"about_ca_topic_score_gemma":0.000042030486,"teacher_disagreement_score":0.21651205,"about_ca_system_score_codex":0.000043314372,"about_ca_system_score_gemma":0.00007919216,"threshold_uncertainty_score":0.3841117},"labels":[],"label_agreement":null},{"id":"W2979886571","doi":"10.1182/blood.v128.22.3523.3523","title":"The Novel Sulfonamidebenzamide ML291 Activates Apoptotic UPR Signaling in Pediatric Leukemia","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Endoplasmic Reticulum Stress and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Izaak Walton Killam Health Centre","funders":"","keywords":"Unfolded protein response; Cancer research; Apoptosis; Leukemia; CHOP; In vivo; Biology; Cell growth; K562 cells; Cancer; Medicine; Immunology; Internal medicine; Biochemistry","score_opus":0.006252210145509473,"score_gpt":0.2137153434266371,"score_spread":0.20746313328112762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979886571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977134,0.0011131826,0.00015557915,0.00015541464,0.0000845564,0.000115404364,0.000016959451,0.000012403668,0.0006331321],"genre_scores_gemma":[0.99817336,0.00092120894,0.000105387415,0.00006573384,0.00028955942,0.000030978885,0.000010964516,0.000020231026,0.00038255067],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990209,0.00003281812,0.00020622622,0.00029554908,0.00012508931,0.00031941952],"domain_scores_gemma":[0.99939215,0.000103077466,0.00007330915,0.0003064223,0.000035889065,0.000089168236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001237177,0.00014547665,0.000107265885,0.00003239687,0.000089588066,0.000030164912,0.00022106123,0.000091462505,0.0000083989435],"category_scores_gemma":[0.00028786904,0.00008358769,0.00008132343,0.000086158994,0.00005857605,0.0000049780065,0.000093053095,0.000061827464,0.000013140888],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005974832,0.00013518927,0.04053227,0.000016309394,0.000027803177,0.000006750765,0.000010746827,0.000056756275,0.9580235,0.00023174737,0.00017097249,0.0007281959],"study_design_scores_gemma":[0.0034392222,0.00011110259,0.028167289,0.00003675547,0.000071270355,0.000012881539,0.00005020137,0.000022991293,0.96603525,0.0002636148,0.0014938087,0.00029562326],"about_ca_topic_score_codex":0.00002141515,"about_ca_topic_score_gemma":0.00003265442,"teacher_disagreement_score":0.012364979,"about_ca_system_score_codex":0.000018356855,"about_ca_system_score_gemma":0.00013264152,"threshold_uncertainty_score":0.34086072},"labels":[],"label_agreement":null},{"id":"W2979889594","doi":"10.1182/blood.v120.21.303.303","title":"The Outcome of Primary Mediastinal Large B-Cell Lymphoma (PMBCL) in the R-CHOP Treatment Era","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"CHOP; Medicine; Lymphoma; Mediastinum; Oncology; Internal medicine; Chemotherapy; Radiology","score_opus":0.022981081287490567,"score_gpt":0.26769107464787917,"score_spread":0.2447099933603886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979889594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98042005,0.0063359095,0.0000013995475,0.0010122844,0.00013201663,0.0005181367,0.000021582382,0.000015720188,0.011542884],"genre_scores_gemma":[0.99816734,0.00047370262,0.00014749475,0.000477421,0.00020801226,0.00018009973,0.000021796897,0.0000147735445,0.00030936772],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870306,0.000087995744,0.00033146658,0.00014361128,0.0003246334,0.00040921816],"domain_scores_gemma":[0.9988747,0.00045111807,0.00010273398,0.00044451855,0.000027391561,0.0000995082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038160442,0.00017652339,0.00030838564,0.000043307966,0.000097085474,0.00001302566,0.000125368,0.000057295052,0.00002697933],"category_scores_gemma":[0.000043060914,0.00007787763,0.00015868458,0.00013583887,0.000053267293,0.000047073172,0.00003635131,0.000048211794,0.000057331436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008626284,0.024020031,0.9613766,0.000036767502,0.00013984792,0.000085763575,0.0014218412,1.0061075e-7,0.0001554779,0.00054102583,0.00029785177,0.01183845],"study_design_scores_gemma":[0.022841044,0.0005442503,0.9563253,0.000029329203,0.0004914551,0.00012125816,0.00038399492,0.000002248502,0.0043184245,0.000015152811,0.014846863,0.00008067594],"about_ca_topic_score_codex":0.00014029598,"about_ca_topic_score_gemma":0.000054273863,"teacher_disagreement_score":0.023475781,"about_ca_system_score_codex":0.00015810874,"about_ca_system_score_gemma":0.00009798829,"threshold_uncertainty_score":0.31757575},"labels":[],"label_agreement":null},{"id":"W2979890501","doi":"10.1182/blood.v128.22.3608.3608","title":"Health Utility during the First Two Years of Treatment of Hematological Malignancies","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Dalhousie University; University of Calgary; Canadian Centre for Applied Research in Cancer Control; Simon Fraser University; BC Cancer Agency","funders":"","keywords":"Medicine; Quality of life (healthcare); Population; Psychological intervention; Disease; Incidence (geometry); Family medicine; Pediatrics; Gerontology; Environmental health; Internal medicine; Psychiatry","score_opus":0.2512518226391557,"score_gpt":0.38925101582844807,"score_spread":0.13799919318929238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979890501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819786,0.0024571458,0.00011441951,0.014338512,0.00009784731,0.00037876304,0.00021149001,0.000017414535,0.00040583793],"genre_scores_gemma":[0.998728,0.0003524296,0.0003228478,0.0003495852,0.000060854,0.0000413215,0.0000015948701,0.000008996639,0.00013440056],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972273,0.00012223813,0.002106506,0.0002567131,0.000049302173,0.00023795129],"domain_scores_gemma":[0.9973832,0.00064287306,0.0014144479,0.00046756072,0.000025903766,0.00006602735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002890394,0.00009627738,0.0007702279,0.00007343075,0.0000840207,0.000006617556,0.00016711562,0.000048283146,0.00017255067],"category_scores_gemma":[0.0005594133,0.00007116852,0.0001259247,0.00008200216,0.00012660566,0.000079130325,0.00003056234,0.000025211966,0.00014413302],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018923321,0.0006946427,0.953866,0.0003381823,0.0001284163,0.0000010314709,0.002026648,0.0000057285993,0.000027466018,0.041824438,0.00053267897,0.00053582015],"study_design_scores_gemma":[0.0032697355,0.00035352254,0.97653884,0.00014438106,0.000009692907,0.0000149177,0.0002827581,0.0000314516,0.00063403224,0.0047125644,0.013852024,0.00015606359],"about_ca_topic_score_codex":0.00089237065,"about_ca_topic_score_gemma":0.00029712307,"teacher_disagreement_score":0.037111875,"about_ca_system_score_codex":0.00016567594,"about_ca_system_score_gemma":0.00009544012,"threshold_uncertainty_score":0.2902168},"labels":[],"label_agreement":null},{"id":"W2979896943","doi":"10.1182/blood.v116.21.4130.4130","title":"The Autoantibody Response to ALK In Pediatric Anaplastic Large Cell Lymphoma: A Children's Oncology Group Report","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Anaplastic lymphoma kinase; Anaplastic large-cell lymphoma; Internal medicine; Lymphoma; Pathology; Gastroenterology; Oncology; Lung cancer","score_opus":0.004334842240175358,"score_gpt":0.2560303503450307,"score_spread":0.2516955081048553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979896943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994845,0.0003652299,0.0000042748766,0.0015885232,0.00041003036,0.000683639,0.000015459023,0.000061816034,0.0020260317],"genre_scores_gemma":[0.9980412,0.00012314126,0.00053016556,0.00031854236,0.00034731516,0.00015472135,0.000034005,0.000026937374,0.000423979],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832875,0.00010858112,0.00039781892,0.0004123554,0.00026271722,0.00048979407],"domain_scores_gemma":[0.9983548,0.0006224185,0.00012208853,0.0006020098,0.00005024137,0.00024844665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080515613,0.00019477146,0.00031789942,0.00018681906,0.00014805773,0.000028568642,0.00014096862,0.00016028022,0.000028959805],"category_scores_gemma":[0.0006158571,0.00012891993,0.00010794411,0.00039561174,0.000032970973,0.000033875574,0.00009890855,0.00014921611,0.0001690514],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011607468,0.014369776,0.97108865,0.000014209387,0.000074975454,0.0069412272,0.00021743211,3.475631e-7,0.0024691238,0.00014548158,0.001622534,0.0018955128],"study_design_scores_gemma":[0.018851615,0.0014569894,0.9534804,0.0000105235695,0.00034228273,0.0018295773,0.000031659954,0.0000047687254,0.0015433807,0.000014365406,0.022298785,0.00013563313],"about_ca_topic_score_codex":0.00011639006,"about_ca_topic_score_gemma":0.0006813242,"teacher_disagreement_score":0.020676252,"about_ca_system_score_codex":0.00010490524,"about_ca_system_score_gemma":0.00044687916,"threshold_uncertainty_score":0.52572024},"labels":[],"label_agreement":null},{"id":"W2979901787","doi":"10.1182/blood.v114.22.2589.2589","title":"White Matter Integrity and Core Cognitive Function in Children Diagnosed with Sickle Cell Disease.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"White matter; Neuropsychology; Effective diffusion coefficient; Medicine; Neuropsychological test; Wechsler Adult Intelligence Scale; Magnetic resonance imaging; Psychology; Cognition; Nuclear medicine; Audiology; Radiology; Psychiatry","score_opus":0.0051246448279017275,"score_gpt":0.20545983557467587,"score_spread":0.20033519074677414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979901787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949803,0.0008831425,0.000018364615,0.0006627702,0.000015011945,0.00040187855,0.000011970319,0.00003065452,0.0029959292],"genre_scores_gemma":[0.998002,0.000118503376,0.000032654643,0.0014819837,0.000033426157,0.000008737557,0.000068874455,0.000010253984,0.00024358295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994325,0.000015394276,0.000101225785,0.00019535373,0.00009955723,0.0001559618],"domain_scores_gemma":[0.999709,0.000015592192,0.000029478964,0.00008914421,0.000031473694,0.00012528812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000040370607,0.000110799694,0.00014437416,0.00005914532,0.000033564997,0.000010573492,0.000019210453,0.00007553593,0.000094527764],"category_scores_gemma":[0.000012874071,0.000078425874,0.000024718773,0.00012618456,0.000047082583,0.000046248806,0.00000869777,0.0002931693,0.0000331013],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034053603,0.0008884978,0.9972715,0.000020951671,0.000032306158,0.00006611874,0.00020516517,8.859155e-7,0.000042057018,0.000005557512,0.00029892023,0.0008275078],"study_design_scores_gemma":[0.0070867264,0.0005284966,0.99112993,0.00020472256,0.00042263223,0.000031364743,0.0003144958,0.000012270414,0.00007084526,0.00007067417,0.000019634723,0.0001081946],"about_ca_topic_score_codex":0.00003575635,"about_ca_topic_score_gemma":0.000011369444,"teacher_disagreement_score":0.00674619,"about_ca_system_score_codex":0.000006389576,"about_ca_system_score_gemma":0.000037255668,"threshold_uncertainty_score":0.31981143},"labels":[],"label_agreement":null},{"id":"W2979902190","doi":"10.1182/blood.v114.22.3578.3578","title":"Genetically-Engineered Endothelial Cells Implanted Into the Omentum of Hemophilia A Dogs Provides Long-Term Circulating FVIII Resulting From Sustained FVIII Expression and Persistent Cell Viability.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Genetic enhancement; Cryoprecipitate; Immunology; Andrology; Viral vector; Transgene; Ex vivo; In vivo; Recombinant DNA; Biology; Gene; Platelet","score_opus":0.011970327408741219,"score_gpt":0.25205507191589777,"score_spread":0.24008474450715656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979902190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965248,0.0009494586,0.00002809415,0.0008305731,0.0000449276,0.0012252769,0.000034411016,0.00005493806,0.0003075282],"genre_scores_gemma":[0.99799085,0.00008178932,0.0013225783,0.000053396077,0.00019412131,0.00002305528,0.000063607804,0.000024894338,0.0002457307],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99792963,0.00013957404,0.00049876445,0.00047580863,0.0005005971,0.00045563976],"domain_scores_gemma":[0.9986693,0.0003385633,0.00012112233,0.00049070426,0.0001541613,0.00022611441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003687284,0.00026082539,0.0004210784,0.000111203124,0.00020732873,0.000043175776,0.00016466397,0.00014195126,0.000043491516],"category_scores_gemma":[0.00020254758,0.00016524208,0.00018158002,0.00017349026,0.00014439464,0.000056695026,0.00011217687,0.0002833239,0.000004460595],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036239094,0.0009134899,0.031513534,0.00029094607,0.00011488157,0.00013330647,0.003045218,0.0000071763193,0.9613858,0.000004058722,0.000014428459,0.0022147608],"study_design_scores_gemma":[0.009638068,0.0011984942,0.04951276,0.0004308408,0.00046814862,0.00004556889,0.0010751287,0.00092227,0.93633777,0.00011868848,0.000018381448,0.0002338681],"about_ca_topic_score_codex":0.00008906867,"about_ca_topic_score_gemma":0.0000037499656,"teacher_disagreement_score":0.025048025,"about_ca_system_score_codex":0.000062664636,"about_ca_system_score_gemma":0.00011072207,"threshold_uncertainty_score":0.67383766},"labels":[],"label_agreement":null},{"id":"W2979902603","doi":"10.1182/blood.v128.22.4576.4576","title":"Differential Expression of Immunity Related Genes and Early Prediction of Severe Graft Versus Host Disease after Allogeneic Hematopoietic Cell Transplantation","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Graft-versus-host disease; Immunology; Transplantation; Haematopoiesis; Hematopoietic stem cell transplantation; Peripheral blood mononuclear cell; Medicine; Immune system; Gene expression profiling; Gene; Gene expression; Biology; Stem cell; Internal medicine","score_opus":0.010029617970066063,"score_gpt":0.21662333828896968,"score_spread":0.2065937203189036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979902603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979299,0.0005970983,0.0005762918,0.000036564365,0.0001172954,0.00039338748,0.00020568036,0.0000366627,0.00010717406],"genre_scores_gemma":[0.99869883,0.00088378147,0.00021134503,0.0000023308744,0.00002222649,0.000029206141,0.000056900513,0.0000226951,0.000072709685],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998835,0.00008698967,0.0004294512,0.00021628592,0.0002867564,0.00014548993],"domain_scores_gemma":[0.99925095,0.0001285536,0.0001480158,0.00025288292,0.000081231476,0.00013837268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007257727,0.00015338502,0.000269093,0.000105679734,0.000032221094,0.000004124244,0.00005147377,0.0001240851,0.00013038571],"category_scores_gemma":[0.000014242673,0.00011039828,0.00008976896,0.000086463544,0.00009853224,0.00009627532,0.000012675721,0.000067719615,0.0000038412054],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002158548,0.00039493752,0.2511888,0.0013199225,0.0000555117,0.000028666711,0.0008843897,3.3912383e-7,0.7438191,0.000009365974,0.0000013302478,0.0001390609],"study_design_scores_gemma":[0.0074210516,0.00024116009,0.4972538,0.0007224079,0.00079308765,0.000030320087,0.000036587084,0.0000014694112,0.493409,0.000021450052,0.000001725659,0.00006794154],"about_ca_topic_score_codex":0.000016547934,"about_ca_topic_score_gemma":0.0000018663663,"teacher_disagreement_score":0.2504101,"about_ca_system_score_codex":0.000009826391,"about_ca_system_score_gemma":0.00004256065,"threshold_uncertainty_score":0.4501911},"labels":[],"label_agreement":null},{"id":"W2979904816","doi":"10.1182/blood.v128.22.5197.5197","title":"Phloridzin Docosahexaenoate (PZ-DHA) : A Novel Naturally Derived Drug Active in T-Cell Acute Lymphoblastic Leukemia (T-ALL)","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Pomegranate: compositions and health benefits","field":"Nursing","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Jurkat cells; Docosahexaenoic acid; Apoptosis; Biology; Pharmacology; Cell growth; Cell culture; Biochemistry; T cell; Fatty acid; Immunology; Polyunsaturated fatty acid; Immune system","score_opus":0.011027755151204577,"score_gpt":0.2465098573452232,"score_spread":0.23548210219401863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979904816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933258,0.00034150097,0.00012265141,0.002747571,0.0007461572,0.00055151066,0.00017155487,0.00017628843,0.0018169503],"genre_scores_gemma":[0.9970241,0.00011287804,0.0012587694,0.0008816983,0.00018239548,0.00008279826,0.000023352297,0.00006599609,0.0003679808],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975993,0.00008110898,0.0005026246,0.000600189,0.00032298086,0.0008937987],"domain_scores_gemma":[0.99868053,0.00030666642,0.00020296889,0.00042598098,0.00011862252,0.0002652448],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017709563,0.00036453616,0.00043164365,0.00034290506,0.00022279256,0.00005769429,0.00038868986,0.00018738804,0.000056228364],"category_scores_gemma":[0.000040594397,0.00028280128,0.00013009264,0.0003981815,0.0000796557,0.00036326924,0.000100131205,0.00031265293,0.00019550795],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010042212,0.0010975823,0.00048107846,0.000086842134,0.00013232167,0.00009897398,0.0015090505,0.000024767762,0.9845268,0.00036406872,0.00046869423,0.010205578],"study_design_scores_gemma":[0.03889423,0.0006954732,0.07203028,0.0011448103,0.00058972224,0.00019613821,0.00020562804,0.00053208147,0.8774036,0.001294799,0.0055922996,0.0014209179],"about_ca_topic_score_codex":0.0004754,"about_ca_topic_score_gemma":0.0005917991,"teacher_disagreement_score":0.107123196,"about_ca_system_score_codex":0.0006987834,"about_ca_system_score_gemma":0.00024031253,"threshold_uncertainty_score":0.9999624},"labels":[],"label_agreement":null},{"id":"W2979907661","doi":"10.1182/blood.v122.21.179.179","title":"Exome Sequencing Identifies Genes and Variant Alleles Associated With Severity Of Iron Overload In Hemochromatosis HFE C282Y Homozygotes","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Hemochromatosis; Exome sequencing; Phlebotomy; Hereditary hemochromatosis; Genetics; Biology; Serum iron; Exome; Hepcidin; Allele; Confounding; Internal medicine; Medicine; Gene; Mutation; Anemia","score_opus":0.009141826527007154,"score_gpt":0.20955343833590012,"score_spread":0.20041161180889297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979907661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99610305,0.0029282016,0.000010724704,0.00014530205,0.00002942802,0.00029320637,0.000011613987,0.000036258418,0.00044221902],"genre_scores_gemma":[0.9986352,0.00040261424,0.0006443236,0.00008113868,0.000021334457,0.00002106115,0.000018624658,0.000017321823,0.00015840445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990341,0.00005036431,0.000247229,0.00021871523,0.0002230015,0.00022656766],"domain_scores_gemma":[0.9994934,0.00006450406,0.00010767294,0.00018822595,0.00007217981,0.00007399249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015410296,0.00014782179,0.00037898682,0.000109961584,0.000042339878,0.000025907131,0.00005759266,0.00009291284,0.00009029731],"category_scores_gemma":[0.00013164325,0.000117349475,0.00003630562,0.00017914598,0.00010846229,0.00017283742,0.00004030082,0.00009175128,0.0000055484816],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008774524,0.0013565065,0.6782695,0.0009523669,0.00021930187,0.00016575136,0.0035959785,0.000014100678,0.31315872,0.00024703323,0.0002305247,0.001702446],"study_design_scores_gemma":[0.004638949,0.0001391051,0.95850533,0.00024236762,0.00029573793,0.00007888298,0.0016978555,0.000054111246,0.03386678,0.0002654514,0.000013509839,0.00020190718],"about_ca_topic_score_codex":0.0023678748,"about_ca_topic_score_gemma":0.00046905293,"teacher_disagreement_score":0.28023583,"about_ca_system_score_codex":0.00001640052,"about_ca_system_score_gemma":0.00007404065,"threshold_uncertainty_score":0.47853726},"labels":[],"label_agreement":null},{"id":"W2979907850","doi":"10.1182/blood.v122.21.3111.3111","title":"A Meta-Analysis Of Genome-Wide Association Studies Of Multiple Myeloma In Cases and Controls Of European Origin Identifies a Risk Locus In 12q23.1","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Genome-wide association study; Biology; Single-nucleotide polymorphism; Population stratification; Genetics; Genetic association; Linkage disequilibrium; Imputation (statistics); Meta-analysis; SNP; Case-control study; Population; Genotype; Medicine; Gene; Internal medicine; Missing data","score_opus":0.08138664452300585,"score_gpt":0.32777504303364174,"score_spread":0.24638839851063588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979907850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918541,0.0072419327,0.0000028030793,0.000094980765,0.000005934163,0.00058762345,0.000111915644,0.000005182061,0.00009558351],"genre_scores_gemma":[0.9988081,0.0007112466,0.00020233289,0.000011964402,0.000006621925,0.00005701415,0.000019762048,0.000009476355,0.00017348296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982722,0.00037587207,0.00062331307,0.00020025944,0.00033706837,0.00019129591],"domain_scores_gemma":[0.9965147,0.0024884418,0.00041761357,0.0002254612,0.00029481426,0.000059013506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000756336,0.00012382689,0.0012824745,0.0005805715,0.000016732518,0.0000074141076,0.0000582542,0.000035785535,0.00005338775],"category_scores_gemma":[0.0052800598,0.00008947381,0.00027614107,0.00053604384,0.00007588339,0.00007715888,0.00005510788,0.000086758264,0.000004143899],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009423755,0.0007213452,0.91053486,0.00010767853,0.081067845,0.00007632784,0.00087213825,0.000023528328,0.0063233613,0.0000018325376,0.0000095100495,0.00016731647],"study_design_scores_gemma":[0.0058365855,0.00021627238,0.9430575,0.000020224492,0.04337419,0.0000013184591,0.0005815531,0.00014394698,0.0066820094,0.000025241929,0.0000058267206,0.000055374974],"about_ca_topic_score_codex":0.0053421766,"about_ca_topic_score_gemma":0.0039211623,"teacher_disagreement_score":0.037693657,"about_ca_system_score_codex":0.000044059114,"about_ca_system_score_gemma":0.00002725733,"threshold_uncertainty_score":0.8075809},"labels":[],"label_agreement":null},{"id":"W2979912181","doi":"10.1182/blood.v116.21.4388.4388","title":"Comparison of Incidence and Investigation of In-Hospital Pulmonary Embolism In Patients Receiving Dalteparin Prophylaxis Following Elective Knee Replacement at Two Hospitals","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph's Hospital; McMaster University","funders":"","keywords":"Medicine; Pulmonary embolism; Incidence (geometry); Medical record; Surgery; Anesthesia","score_opus":0.006865612819096658,"score_gpt":0.26854218635259036,"score_spread":0.2616765735334937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979912181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978819,0.00017113984,0.0000017158143,0.00006602919,0.00017942043,0.0011868386,0.000002124491,0.00001217101,0.0004986485],"genre_scores_gemma":[0.99921435,0.000026008172,0.00059127447,0.00002196853,0.000023484954,0.00007697469,0.000016359341,0.000017079494,0.000012521732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99846596,0.00005053984,0.0005878299,0.00033319052,0.00034181256,0.00022068311],"domain_scores_gemma":[0.99922645,0.00006708634,0.00028462423,0.00026492844,0.00008142873,0.00007546905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039536328,0.0001502919,0.0005993173,0.0002323783,0.00003768909,0.0000072859543,0.00007702708,0.00007978205,0.000007994232],"category_scores_gemma":[0.0002689231,0.00014859324,0.000054499225,0.00029318826,0.000074182884,0.000117697935,0.00017843638,0.00021421803,0.0000012123235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053165066,0.0018648424,0.97849214,0.0001757004,0.000058877304,0.000008084292,0.0032259938,0.0000059378026,0.014131033,0.000100268044,0.000017355369,0.001866605],"study_design_scores_gemma":[0.002956336,0.0019727447,0.96136934,0.00040347644,0.00009451628,8.6259354e-7,0.00024509197,0.00007473297,0.03257186,0.00017757122,0.0000044493236,0.00012904356],"about_ca_topic_score_codex":0.0005666707,"about_ca_topic_score_gemma":0.00044238416,"teacher_disagreement_score":0.018440828,"about_ca_system_score_codex":0.0000637327,"about_ca_system_score_gemma":0.00004607985,"threshold_uncertainty_score":0.60594565},"labels":[],"label_agreement":null},{"id":"W2979914039","doi":"10.1182/blood.v128.22.774.774","title":"Alteration of Chromatin Modifiers and Misregulation of Transcription Factors Define the Genomic Profile of Infant AML","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Biology; Cancer research; Exome; Transcriptome; Haematopoiesis; Genome; Genetics; Computational biology; Stem cell; Exome sequencing; Mutation; Gene","score_opus":0.019327343196059714,"score_gpt":0.2527766367166423,"score_spread":0.23344929352058258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979914039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983778,0.00015413733,0.0005589697,0.00027674015,0.000013954166,0.0004311589,0.000038963,0.000006786457,0.00014151722],"genre_scores_gemma":[0.9992466,0.000057521123,0.00054561184,0.000005919875,0.000022031787,0.000009074781,0.000022108334,0.000008695768,0.000082434075],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993089,0.000045310175,0.000272859,0.00009772107,0.00018790428,0.00008732339],"domain_scores_gemma":[0.99949324,0.000071217284,0.0001333137,0.00017636351,0.00009559502,0.00003025252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019152183,0.00006426701,0.000180711,0.000079875186,0.000018536286,0.0000019963863,0.00004593356,0.000051157742,0.000045475997],"category_scores_gemma":[0.0000751773,0.00003418913,0.000040735045,0.000084494175,0.00012728052,0.000057746845,0.000011885671,0.000043359287,8.822461e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000098823024,0.00008080635,0.01857525,0.00016683793,0.000056031906,2.5993546e-7,0.0008635916,0.0000036473646,0.97801787,0.0001967601,0.000034373064,0.0019057444],"study_design_scores_gemma":[0.0021799114,0.00024248248,0.3202587,0.00008857801,0.0000808146,0.000004940171,0.000085573134,0.00036949545,0.6765932,0.000052810177,0.000015361727,0.000028114753],"about_ca_topic_score_codex":0.000111659654,"about_ca_topic_score_gemma":0.000008124589,"teacher_disagreement_score":0.30168346,"about_ca_system_score_codex":0.000027663507,"about_ca_system_score_gemma":0.00008416171,"threshold_uncertainty_score":0.13941921},"labels":[],"label_agreement":null},{"id":"W2979919762","doi":"10.1182/blood.v118.21.4353.4353","title":"Pseudoallergy Induced by Factor VIII Injection in Three Subjects with Hemophilia A","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Von Willebrand factor; Medicine; Immunology; Internal medicine; Platelet","score_opus":0.0438851623266636,"score_gpt":0.27155267783631837,"score_spread":0.22766751550965478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979919762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932186,0.00010797361,0.000008080508,0.00015302989,0.000038728034,0.00045176543,0.0000042250617,0.0000649767,0.0059526446],"genre_scores_gemma":[0.99869245,0.000024908284,0.00020752824,0.000047563077,0.00006507226,0.000049148974,0.000014468827,0.000028072012,0.00087080605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989192,0.000027639928,0.00015834585,0.00027762115,0.0002882858,0.00032890833],"domain_scores_gemma":[0.99950415,0.000020949918,0.00003313001,0.00025851603,0.000054499,0.00012878276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007894297,0.00015770651,0.00022952665,0.00017320324,0.000045280758,0.00000905167,0.00007149105,0.00013568593,0.00026539812],"category_scores_gemma":[0.00003108365,0.00010744991,0.000043180084,0.0003371291,0.00003965096,0.000077283315,0.0000272017,0.00024104722,0.00006775506],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010211039,0.0040851487,0.8780855,0.00008795446,0.00032024054,0.000505498,0.0015570567,9.720245e-8,0.109243855,0.00010576738,0.00012723461,0.004860538],"study_design_scores_gemma":[0.013832994,0.004426937,0.7548844,0.0001633496,0.000098607336,0.00021069853,0.00013698879,0.000018685569,0.22555728,0.0002546476,0.00012803107,0.00028737524],"about_ca_topic_score_codex":0.00048605277,"about_ca_topic_score_gemma":0.0005003406,"teacher_disagreement_score":0.1232011,"about_ca_system_score_codex":0.00004616455,"about_ca_system_score_gemma":0.0001223139,"threshold_uncertainty_score":0.43816802},"labels":[],"label_agreement":null},{"id":"W2979922329","doi":"10.1182/blood.v124.21.1288.1288","title":"Obinutuzumab and Chlorambucil Versus Chlorambucil Monotherapy for Treatment of Previously Untreated Chronic Lymphocytic Leukemia Where Fludarabine-Based Chemotherapy Is Considered Inappropriate: A Canadian Cost-Utility Analysis","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Chlorambucil; Obinutuzumab; Fludarabine; Medicine; Chronic lymphocytic leukemia; Internal medicine; Chemotherapy; Oncology; Leukemia; Cyclophosphamide","score_opus":0.02775496467073465,"score_gpt":0.2916717141451928,"score_spread":0.26391674947445815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979922329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99038607,0.004153437,0.0002960949,0.00041697925,0.00008015343,0.0039245435,0.00023285254,0.00012626167,0.00038358042],"genre_scores_gemma":[0.9960331,0.0012943196,0.00079161505,0.000276982,0.00017220945,0.00055576675,0.00027445238,0.00011023418,0.000491331],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9962024,0.00014800832,0.0008026371,0.0010969546,0.00058471784,0.0011652639],"domain_scores_gemma":[0.9962643,0.0005491519,0.00029422375,0.001489968,0.0005264232,0.0008759329],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005217456,0.00064644957,0.0016685559,0.0006027333,0.00021411551,0.00008555191,0.00024717595,0.00045226314,0.00041420342],"category_scores_gemma":[0.00021809318,0.00055676774,0.0005549359,0.001130849,0.00045950877,0.0000889396,0.000025338766,0.00012443587,0.00001563316],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.16820104,0.009013973,0.05062842,0.016433997,0.123698935,0.0011682637,0.021643996,0.012185749,0.024869306,0.0008094767,0.007222255,0.5641246],"study_design_scores_gemma":[0.4195699,0.0075934697,0.002294444,0.00024617676,0.006291345,0.00006870182,0.00013945275,0.46924463,0.07963588,0.00006896061,0.014086732,0.0007602965],"about_ca_topic_score_codex":0.21788724,"about_ca_topic_score_gemma":0.105019175,"teacher_disagreement_score":0.56336427,"about_ca_system_score_codex":0.09325779,"about_ca_system_score_gemma":0.080146454,"threshold_uncertainty_score":0.9996884},"labels":[],"label_agreement":null},{"id":"W2979923058","doi":"10.1182/blood.v108.11.3530.3530","title":"Preliminary Safety and Efficacy Results from an International Phase 3b Study for Expanded Access to Bortezomib in 624 Patients with Relapsed and/or Refractory Multiple Myeloma.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Bortezomib; Medicine; Multiple myeloma; Progressive disease; Adverse effect; Internal medicine; Proteasome inhibitor; Dexamethasone; Refractory (planetary science); Gastroenterology; Phases of clinical research; Surgery; Urology; Toxicity; Chemotherapy","score_opus":0.03056316464014592,"score_gpt":0.3498052333605649,"score_spread":0.319242068720419,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979923058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99536574,0.00003719944,0.00002841966,0.00015626726,0.000043454595,0.0034399608,0.0007847112,0.000040167375,0.000104089435],"genre_scores_gemma":[0.996339,0.00001560126,0.0014805757,0.000052034597,0.00010562937,0.0001953054,0.0016434113,0.000031270793,0.00013713255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982973,0.00006830946,0.00039192932,0.00058891857,0.00037199672,0.00028157988],"domain_scores_gemma":[0.99876,0.0004199893,0.00009428269,0.00033388764,0.00013274347,0.00025912005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016197258,0.00020346566,0.00031602776,0.00020002484,0.0000890129,0.00006376892,0.00013739275,0.00006726336,0.00001332853],"category_scores_gemma":[0.0005009648,0.00014473201,0.000024166742,0.00013088809,0.00003939352,0.00031294246,0.000106710075,0.00012703014,0.0000017111304],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12346504,0.023454675,0.82971525,0.000015860585,0.00022349684,0.00021864695,0.00074700423,0.0000041063613,0.00026878857,7.4711767e-7,0.000060770035,0.021825625],"study_design_scores_gemma":[0.18848754,0.009257726,0.800853,0.00010070303,0.000109059794,0.000003832711,0.00013352832,0.00027582608,0.00042051836,0.0000039408374,0.00022340594,0.00013087559],"about_ca_topic_score_codex":0.0009671222,"about_ca_topic_score_gemma":0.0012588138,"teacher_disagreement_score":0.06502251,"about_ca_system_score_codex":0.000057276728,"about_ca_system_score_gemma":0.00006919486,"threshold_uncertainty_score":0.5902},"labels":[],"label_agreement":null},{"id":"W2979925754","doi":"10.1182/blood.v104.11.1778.1778","title":"Safety and Efficacy of Low Molecular Weight Heparins for Hemodialysis in Patients with End-Stage Renal Disease: A Meta-Analysis of Randomized Trials.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Hemodialysis; End stage renal disease; Randomized controlled trial; Dialysis; Population; Thrombosis; Low molecular weight heparin; Internal medicine; Extracorporeal; Clinical trial; Anticoagulant; Intensive care medicine; Surgery","score_opus":0.020495029303666677,"score_gpt":0.2751658677859647,"score_spread":0.254670838482298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979925754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921908,0.0013318373,0.0030628433,0.00025854204,0.000010426917,0.0027797318,0.00026150135,0.000009849815,0.000094473486],"genre_scores_gemma":[0.9972695,0.00018588617,0.001980024,0.00008775732,0.000010339336,0.00018583638,0.00023757709,0.000017516928,0.0000255595],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99788713,0.00021848679,0.000987996,0.00032072308,0.00040546554,0.00018019992],"domain_scores_gemma":[0.99836564,0.0004793868,0.0004979579,0.00039809325,0.00013591882,0.00012297848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014262861,0.00019123929,0.004782445,0.00045624544,0.000023320477,0.000007726263,0.00007459442,0.000044157925,0.00012649575],"category_scores_gemma":[0.00070457,0.00012219646,0.0017150245,0.0005384833,0.00009872971,0.000035690173,0.0000394867,0.000048363298,2.3807816e-7],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14113025,0.024322823,0.016155321,0.00083232205,0.8008702,0.00004809853,0.0007449602,0.008644716,0.0004244947,0.006192922,0.000016469954,0.000617459],"study_design_scores_gemma":[0.32028762,0.00027519307,0.08179129,0.00003957233,0.5945173,6.7740274e-8,0.00000848455,0.00007632243,0.0027840084,0.00006706352,0.000035130823,0.00011796944],"about_ca_topic_score_codex":0.00015193263,"about_ca_topic_score_gemma":0.000057605008,"teacher_disagreement_score":0.20635287,"about_ca_system_score_codex":0.000020629794,"about_ca_system_score_gemma":0.0000685627,"threshold_uncertainty_score":0.49830276},"labels":[],"label_agreement":null},{"id":"W2979926896","doi":"10.1182/blood.v106.11.3988.3988","title":"Equivalence of Liquid and Freeze-Dried Formulations of WinRho® SDF.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bioequivalence; Cmax; Pharmacokinetics; Tolerability; Medicine; Adverse effect; Pharmacology","score_opus":0.009075865966792837,"score_gpt":0.22495377624994256,"score_spread":0.21587791028314973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979926896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9778793,0.019225398,0.00010633972,0.00008128214,0.0000626514,0.000095601186,0.000027188671,0.000019976169,0.0025022784],"genre_scores_gemma":[0.9992862,0.00015177224,0.00014932932,0.000027337226,0.0000021433973,0.000004292676,0.00002150091,0.0000059441923,0.0003515316],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993751,0.00003461648,0.0002830267,0.00011781218,0.000023539335,0.00016589688],"domain_scores_gemma":[0.9995611,0.00006300599,0.000121063844,0.00020367779,0.000047895057,0.0000032737503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011321379,0.00008273874,0.00018794683,0.00006275878,0.00007866355,0.0000017430569,0.00013537622,0.000103152015,0.0001759248],"category_scores_gemma":[0.00005056794,0.0000784166,0.000055203625,0.00009430471,0.00025055744,0.000085726235,0.000056804845,0.00008692557,0.000022143831],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056967085,0.00041294284,0.001041991,0.00002615912,0.00007211811,1.6274481e-7,0.00075451756,0.000012769145,0.98918235,0.0058931243,0.000015479081,0.0025314034],"study_design_scores_gemma":[0.002110308,0.00032468024,0.016821934,0.00004596242,0.00008756943,0.000016806605,0.00022452373,0.0000042536726,0.97541815,0.00020744723,0.0046225367,0.000115829636],"about_ca_topic_score_codex":0.00006261904,"about_ca_topic_score_gemma":0.00000509468,"teacher_disagreement_score":0.021406863,"about_ca_system_score_codex":0.0000024146839,"about_ca_system_score_gemma":0.000028896593,"threshold_uncertainty_score":0.3197736},"labels":[],"label_agreement":null},{"id":"W2979928084","doi":"10.1182/blood.v106.11.3545.3545","title":"Hemin Prophylaxis for Patients with Frequently Recurring Acute Porphyric Attacks: Experience with Five Cases.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Porphyrin Metabolism and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Hemin; Acute intermittent porphyria; Medicine; Porphyria; Heme; Porphobilinogen; Internal medicine; Gastroenterology; Ferrochelatase; Surgery; Enzyme; Biochemistry; Chemistry","score_opus":0.004459565934132055,"score_gpt":0.22357208508544732,"score_spread":0.21911251915131527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979928084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977194,0.00070242415,0.00046040624,0.000020621124,0.000036184083,0.0004946667,0.000088004854,0.000017964996,0.00046032105],"genre_scores_gemma":[0.9916083,0.00005923954,0.007258792,0.00018430813,0.00014557452,0.00021165253,0.00018598823,0.000031533615,0.00031456063],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99893665,0.000013675818,0.00015049998,0.00042566887,0.00015625163,0.00031725434],"domain_scores_gemma":[0.99934065,0.000008790093,0.00009608139,0.00033396072,0.00012095488,0.00009956691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000041477764,0.0002003623,0.00015376761,0.00003315453,0.00009620352,0.00002463637,0.00017970723,0.00008476898,0.000010716389],"category_scores_gemma":[0.00003874961,0.00015009961,0.000053723146,0.0001042348,0.000084055995,0.000013714056,0.000046296565,0.000057145808,0.000004527305],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004903249,0.008780055,0.7489512,0.0002601052,0.0017491223,0.00014456581,0.0029782532,0.00028650693,0.18000573,0.00022869576,0.005355007,0.0463575],"study_design_scores_gemma":[0.031110212,0.012325552,0.061997026,0.00014339187,0.0007430623,0.0001984915,0.0008910137,0.00002769584,0.80366915,0.00004915771,0.08639388,0.0024513826],"about_ca_topic_score_codex":0.000018787747,"about_ca_topic_score_gemma":0.00003829698,"teacher_disagreement_score":0.6869542,"about_ca_system_score_codex":0.000006311447,"about_ca_system_score_gemma":0.000059298894,"threshold_uncertainty_score":0.6120885},"labels":[],"label_agreement":null},{"id":"W2979929150","doi":"10.1182/blood.v104.11.215.215","title":"Loss of Ubr1 Cooperatively Synergizes with HOX11 in B Cell Lymphomagenesis.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Biology; Provirus; Insertional mutagenesis; Murine leukemia virus; B cell; Molecular biology; Southern blot; Retrovirus; Breakpoint; Gene rearrangement; Genetics; Cancer research; Gene; Chromosomal translocation; Genome; Antibody","score_opus":0.006909539543208942,"score_gpt":0.2037756091160657,"score_spread":0.19686606957285677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979929150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951975,0.0010991684,0.00015479799,0.00003233824,0.000015069816,0.00013562651,0.000020506557,0.0000065847057,0.0033384478],"genre_scores_gemma":[0.9979796,0.00013727558,0.0014912862,0.000073231626,0.000044486038,0.000022803011,0.000023515946,0.000015908236,0.00021191394],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99938995,0.000030214847,0.00013354374,0.00020746772,0.00007952806,0.00015928308],"domain_scores_gemma":[0.99966615,0.0000043636305,0.000051280513,0.00018426863,0.000051600884,0.000042323056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000075493954,0.000112147136,0.00013086796,0.000030478517,0.000023532632,0.0000069569223,0.00011786289,0.00008251459,0.000011730613],"category_scores_gemma":[0.0000138645055,0.00009282808,0.000033484856,0.00009820535,0.00007442771,0.0000023920652,0.000041192463,0.000035251072,0.0000063199823],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000873311,0.0005125244,0.008688052,0.000041555442,0.000026503285,0.000031591033,0.000113664995,0.00018522676,0.9900113,0.00015747808,0.000015952113,0.00012887196],"study_design_scores_gemma":[0.0033579834,0.0005177224,0.004252372,0.000027661466,0.000015338122,0.000023728677,0.000046385932,6.04902e-7,0.99101025,0.000029561606,0.00058375695,0.00013465158],"about_ca_topic_score_codex":0.00005370309,"about_ca_topic_score_gemma":0.00007856549,"teacher_disagreement_score":0.00443568,"about_ca_system_score_codex":0.0000051998354,"about_ca_system_score_gemma":0.00014578966,"threshold_uncertainty_score":0.37854192},"labels":[],"label_agreement":null},{"id":"W2979930021","doi":"10.1182/blood.v116.21.3681.3681","title":"Response to Steroids Predicts Response to Rituximab In Pediatric Chronic Immune Thrombocytopenia.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; Hospital for Sick Children","funders":"","keywords":"Medicine; Rituximab; Prednisone; Internal medicine; Univariate analysis; Logistic regression; Immune thrombocytopenia; Evans syndrome; Incidence (geometry); Platelet; Multivariate analysis; Gastroenterology; Lymphoma; Anemia","score_opus":0.008674766537305856,"score_gpt":0.2637154780169517,"score_spread":0.25504071147964585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979930021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99396306,0.00052893243,0.000005762727,0.003541148,0.00023792687,0.001130184,0.000034496727,0.00011485848,0.00044363624],"genre_scores_gemma":[0.99713093,0.000046610494,0.0008192682,0.00047425838,0.00014082635,0.00012731118,0.000015460173,0.000046795445,0.0011985637],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99815464,0.00015171368,0.00037022727,0.0004614389,0.00032792002,0.0005340557],"domain_scores_gemma":[0.9986384,0.00020185675,0.000051374976,0.00068673503,0.000059863,0.0003617725],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007863247,0.00024920722,0.00057371386,0.0004736558,0.00007112634,0.00003273047,0.00020470697,0.00016815438,0.00011949474],"category_scores_gemma":[0.00065401377,0.00022282702,0.000085700674,0.0006607754,0.000026461925,0.00009164771,0.0001362541,0.00035554692,0.00090288237],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.052032877,0.012901294,0.10444924,0.00011967688,0.0002211151,0.0072066747,0.002448031,0.000007574434,0.814724,0.000016971933,0.002310829,0.003561689],"study_design_scores_gemma":[0.038797714,0.0041075777,0.9291938,0.000079517304,0.00024583167,0.00033514734,0.000049108407,0.000010195463,0.019423362,0.000022518641,0.0074317786,0.0003034703],"about_ca_topic_score_codex":0.000072885974,"about_ca_topic_score_gemma":0.0003112653,"teacher_disagreement_score":0.8247445,"about_ca_system_score_codex":0.0000989765,"about_ca_system_score_gemma":0.00044216396,"threshold_uncertainty_score":0.999875},"labels":[],"label_agreement":null},{"id":"W2979930904","doi":"10.1182/blood.v118.21.4012.4012","title":"Plasma Levels of Soluble Interleukin-7 Receptor Alpha (sIL-7Ra) and IL-7Ra Polymorphism After Allogeneic Stemcell Transplantation,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada","funders":"","keywords":"Single-nucleotide polymorphism; Transplantation; Biology; Immune system; Immunology; Cytokine; Genotype; Haplotype; Receptor; Internal medicine; Exon; Medicine; Genetics; Gene","score_opus":0.02588114631764317,"score_gpt":0.2250993458063265,"score_spread":0.19921819948868336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979930904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960017,0.0012940607,0.000019415918,0.00015181027,0.00017212504,0.0003458192,0.00014495151,0.000035169003,0.0018349114],"genre_scores_gemma":[0.99659234,0.00044807143,0.0017754153,0.00016744042,0.000064963184,0.00008569724,0.000030312563,0.000027937838,0.0008078011],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99891603,0.000033085948,0.0003310712,0.00029833612,0.00018558391,0.00023592054],"domain_scores_gemma":[0.99938107,0.000045454934,0.0000976582,0.0002513621,0.000066689056,0.0001577938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000084107,0.00020020982,0.00034253937,0.0000977984,0.00003521227,0.0000096390195,0.00006930576,0.000108455344,0.00059780566],"category_scores_gemma":[0.000007242028,0.00016052397,0.000100465695,0.00008062428,0.00008229105,0.00007686617,0.000023592911,0.00005464353,0.00006196679],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019387273,0.007227939,0.9005295,0.0008308132,0.0018665406,0.0009139257,0.011438899,3.0179615e-7,0.05992814,0.00047153496,0.001166521,0.01368714],"study_design_scores_gemma":[0.011240049,0.0011239137,0.4296656,0.0002670327,0.0010477598,0.00026705992,0.00013324046,0.000003815345,0.5549747,0.00003984491,0.0010383083,0.0001986902],"about_ca_topic_score_codex":0.00019025739,"about_ca_topic_score_gemma":0.000075453056,"teacher_disagreement_score":0.49504656,"about_ca_system_score_codex":0.000026146496,"about_ca_system_score_gemma":0.0000713115,"threshold_uncertainty_score":0.65459776},"labels":[],"label_agreement":null},{"id":"W2979931387","doi":"10.1182/blood.v124.21.1659.1659","title":"No Increased Risk of Secondary Neoplasms in Patients Treated with Rituximab for Non-Hodgkin’s Lymphoma : A Meta-Analysis of 9 Trials","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Rituximab; Medicine; Internal medicine; Lymphoma; CD20; Clinical trial; Oncology; Hazard ratio; Clinical endpoint; Immunology; Confidence interval","score_opus":0.02316821813579454,"score_gpt":0.2641002941934727,"score_spread":0.24093207605767816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979931387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996983,0.0001761424,0.000020851629,0.000017958195,0.000013953973,0.0011716979,0.00082483364,0.000012974967,0.0007786042],"genre_scores_gemma":[0.99727565,0.000020591106,0.0018336184,0.00006273712,0.00001777752,0.00034625403,0.00036314124,0.000022999679,0.00005723449],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99795246,0.00026929303,0.0009071093,0.000346067,0.00031274656,0.00021231436],"domain_scores_gemma":[0.99726975,0.001058025,0.00074270554,0.000501747,0.0003161335,0.00011161372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085831265,0.00024976014,0.0031564399,0.00044375457,0.000026879732,0.00000745569,0.000082674,0.000104469626,0.00018688901],"category_scores_gemma":[0.00059979287,0.00015036561,0.0012100294,0.0005468998,0.000048058966,0.000046394503,0.000019762965,0.000033003693,0.000005347895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024433827,0.013925124,0.8159348,0.00010199111,0.165051,0.000006490409,0.0000936318,0.000006489726,0.00011046303,0.000013504095,0.00006645172,0.002246723],"study_design_scores_gemma":[0.06936331,0.0026748853,0.563906,0.000020808877,0.34874362,0.0000010408114,0.000008092029,0.00018018967,0.014913631,0.0000075046814,0.00008103997,0.00009988835],"about_ca_topic_score_codex":0.0032157078,"about_ca_topic_score_gemma":0.00045144485,"teacher_disagreement_score":0.25202876,"about_ca_system_score_codex":0.00004627677,"about_ca_system_score_gemma":0.00013801653,"threshold_uncertainty_score":0.6131731},"labels":[],"label_agreement":null},{"id":"W2979936924","doi":"10.1182/blood.v126.23.2098.2098","title":"Time to Diagnosis and Treatment of Lymphoma: A Canadian Population Based Study","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Medicine; Cancer registry; Population; Cancer; Lymphoma; Not Otherwise Specified; Pediatrics; Internal medicine","score_opus":0.07470759294753797,"score_gpt":0.31525762881835745,"score_spread":0.24055003587081947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979936924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984169,0.00017643657,6.037349e-7,0.00036490502,0.000011116789,0.00036248268,0.000009638521,0.000008598737,0.0006493001],"genre_scores_gemma":[0.99940425,0.0000013000354,0.00024084636,0.00017394632,0.00003432148,0.00004018302,0.00000970427,0.000004370236,0.00009106232],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99959636,0.0000131157185,0.000082718485,0.00009699067,0.0001184339,0.00009236096],"domain_scores_gemma":[0.999539,0.000011036647,0.000016540793,0.000102245904,0.00004612805,0.00028500843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005610093,0.00005185694,0.00013030533,0.000068256864,0.000017407518,0.0000045715947,0.000016598071,0.000019091282,0.000036606714],"category_scores_gemma":[0.000044044355,0.000043115248,0.000015398775,0.00009524563,0.0000041619755,0.000020037704,0.0000038904327,0.000005829141,0.00001984611],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042086318,0.00044661813,0.99016416,0.000002298123,0.000028224327,0.000047234804,0.00040619666,0.0000088670295,0.000012035554,8.77857e-7,0.00020759516,0.008633787],"study_design_scores_gemma":[0.004438534,0.0029228227,0.99057984,0.000030641306,0.00020230569,0.0000069956427,0.00028952982,0.000044607466,0.00034903127,0.0000027512751,0.0010848131,0.00004813817],"about_ca_topic_score_codex":0.27074367,"about_ca_topic_score_gemma":0.095671244,"teacher_disagreement_score":0.17507242,"about_ca_system_score_codex":0.00013683004,"about_ca_system_score_gemma":0.00017078882,"threshold_uncertainty_score":0.9208304},"labels":[],"label_agreement":null},{"id":"W2979937661","doi":"10.1182/blood.v114.22.3173.3173","title":"Herpes Simplex Virus Initiates the Intrinsic Pathway of Coagulation.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of British Columbia","funders":"","keywords":"Factor XII; Coagulation; Kallikrein; Prekallikrein; Chemistry; Tissue factor; Alternative complement pathway; Herpes simplex virus; Clotting time; Plasmin; Cell biology; Immunology; Molecular biology; Virus; Antibody; Biochemistry; Complement system; Enzyme; Biology; Internal medicine; Medicine","score_opus":0.016411461210967426,"score_gpt":0.2539685041843436,"score_spread":0.23755704297337615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979937661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877116,0.0005265386,0.00003690656,0.0021930176,0.00004239885,0.0001735106,0.000012756992,0.000047261055,0.009256029],"genre_scores_gemma":[0.99907523,0.0000510104,0.00010151821,0.0005195117,0.00009390022,0.0000038797943,0.00002261347,0.000005219063,0.00012713765],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9995331,0.000020825519,0.00016113652,0.000076326214,0.00010890584,0.00009970718],"domain_scores_gemma":[0.99961215,0.00006570014,0.000044849236,0.00017682966,0.000060244638,0.000040239556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004540195,0.00005965761,0.00011619159,0.000041089865,0.000062609455,0.0000061276455,0.000046175057,0.00006248062,0.00015049241],"category_scores_gemma":[0.000050164348,0.000036211008,0.000057360037,0.0001522921,0.000057995578,0.000029175062,0.000008152698,0.00008645178,0.000030122404],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003567074,0.012747621,0.015755955,0.00008597637,0.005149841,0.0004460973,0.006907693,0.00010032339,0.4092089,0.1966027,0.0065149153,0.34612328],"study_design_scores_gemma":[0.006855642,0.0010209465,0.59021944,0.00013814367,0.0031554005,0.00019615356,0.00037490804,0.00011626919,0.3621392,0.019936156,0.015612236,0.00023552301],"about_ca_topic_score_codex":0.000013378033,"about_ca_topic_score_gemma":0.0000032047299,"teacher_disagreement_score":0.5744635,"about_ca_system_score_codex":0.0000039928846,"about_ca_system_score_gemma":0.00004839953,"threshold_uncertainty_score":0.16477863},"labels":[],"label_agreement":null},{"id":"W2979939976","doi":"10.1182/blood.v122.21.507.507","title":"Specific KIR and HLA Genotypes Affect Outcomes Of Single-Agent Anti-CD20 Immunotherapy Of Follicular Lymphoma","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Rituximab; Antibody-dependent cell-mediated cytotoxicity; Follicular lymphoma; Medicine; Immunology; CD20; Immunotherapy; Oncology; Lymphoma; Internal medicine; Human leukocyte antigen; Aggressive lymphoma; Antigen; Antibody; Monoclonal antibody; Immune system","score_opus":0.010931387878656922,"score_gpt":0.20861426981382103,"score_spread":0.19768288193516412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979939976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889185,0.008789092,0.0000680012,0.000055096378,0.0009181514,0.0002324272,0.000003058475,0.000027289612,0.0009883863],"genre_scores_gemma":[0.99732965,0.000587387,0.000082713595,0.000060319526,0.00001265165,0.000010430485,0.000023220313,0.000015016036,0.001878588],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992441,0.00009776922,0.00030261156,0.0001650626,0.000031814794,0.00015862002],"domain_scores_gemma":[0.9994144,0.000078791265,0.00017611723,0.00024298804,0.00007720559,0.0000105006275],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008587376,0.00013903657,0.00032989404,0.0001002482,0.000056397108,0.000010147101,0.0000929667,0.00013466668,0.0012303648],"category_scores_gemma":[0.000017750437,0.00011173171,0.00012680668,0.00006943253,0.00011703246,0.000089847796,0.000031690175,0.00006077765,0.00019307339],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045669745,0.0006590774,0.01522967,0.000018170464,0.0005105194,6.7293195e-7,0.00020748445,5.653682e-7,0.9781746,0.00008784806,0.0009227407,0.004142937],"study_design_scores_gemma":[0.0024333333,0.00031331475,0.20229092,0.000019723833,0.000049717375,0.00003184175,0.000111753616,5.4263506e-7,0.7808807,0.000018682378,0.01375002,0.00009945622],"about_ca_topic_score_codex":0.000155339,"about_ca_topic_score_gemma":0.0000014732473,"teacher_disagreement_score":0.19729395,"about_ca_system_score_codex":0.000010358616,"about_ca_system_score_gemma":0.000011280161,"threshold_uncertainty_score":0.99968266},"labels":[],"label_agreement":null},{"id":"W2979940110","doi":"10.1182/blood.v128.22.613.613","title":"Minimal Residual Disease in Patients with Follicular Lymphoma Treated with Obinutuzumab or Rituximab As First-Line Induction Immunochemotherapy and Maintenance in the Phase 3 GALLIUM Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Obinutuzumab; Follicular lymphoma; Medicine; Minimal residual disease; Bendamustine; Internal medicine; Rituximab; Oncology; Surrogate endpoint; Hazard ratio; Gastroenterology; Immunology; Lymphoma; Leukemia; Confidence interval","score_opus":0.009680727142649836,"score_gpt":0.2451488242248452,"score_spread":0.23546809708219538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979940110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99719286,0.00021870634,0.0000011826437,0.0007037691,0.000011370713,0.0017971531,0.000029117198,0.000022906506,0.000022931406],"genre_scores_gemma":[0.99910265,0.00012043864,0.000065469365,0.00013584034,0.000037322152,0.00038499935,0.000038068403,0.00002792025,0.00008729818],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99864084,0.00008136942,0.00024897087,0.00040945903,0.00034355398,0.00027579692],"domain_scores_gemma":[0.99927795,0.00007408462,0.00008861065,0.00038620544,0.00007188513,0.00010128418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011379974,0.00025221144,0.00033552508,0.00010628713,0.000066212284,0.00002647124,0.00007821836,0.000047514495,0.000020868358],"category_scores_gemma":[0.00004111751,0.00010095481,0.000028952947,0.00027733133,0.000084079926,0.000113367736,0.000017283877,0.00004344059,0.0000062704567],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02233059,0.037402596,0.9341261,0.000019103782,0.00024856147,0.0013513061,0.0007347633,6.296006e-7,0.000035807065,0.0000057125917,0.000023132334,0.0037217329],"study_design_scores_gemma":[0.216388,0.010697748,0.77105725,0.00034877076,0.00031202586,0.00004183655,0.0002550513,0.0000026077919,0.0006762521,0.0000058691894,0.00007658328,0.00013798995],"about_ca_topic_score_codex":0.00055680383,"about_ca_topic_score_gemma":0.00042755576,"teacher_disagreement_score":0.1940574,"about_ca_system_score_codex":0.00023572656,"about_ca_system_score_gemma":0.00020474121,"threshold_uncertainty_score":0.41168177},"labels":[],"label_agreement":null},{"id":"W2979940690","doi":"10.1182/blood.v116.21.1942.1942","title":"Responses and Survival Are Not Affected by Cytogenetics In Patients with Relapsed and Refractory Multiple Myeloma (R/R MM) Treated with Single-Agent Carfilzomib","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Carfilzomib; Pomalidomide; Lenalidomide; Multiple myeloma; Bortezomib; Cytogenetics; Proteasome inhibitor; Internal medicine; Fluorescence in situ hybridization; Oncology; Medicine; Biology; Chromosome; Genetics","score_opus":0.01629366573959535,"score_gpt":0.2407367586772273,"score_spread":0.22444309293763196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979940690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984862,0.00015179791,0.0000019058454,0.000067059766,0.00002268934,0.00093319063,0.00020282103,0.000054355107,0.000079971935],"genre_scores_gemma":[0.99846107,0.000038973274,0.0008953209,0.00002934652,0.000023756687,0.00004957087,0.00019270579,0.00005268722,0.00025658376],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983437,0.00013985595,0.00019989259,0.0004698105,0.0004397399,0.00040698095],"domain_scores_gemma":[0.9987864,0.00023534111,0.00010060085,0.00035574049,0.00015730984,0.00036461884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000116377116,0.00028331415,0.00039923127,0.0001719198,0.000094084164,0.000037011814,0.000057615114,0.00014597736,0.000014061046],"category_scores_gemma":[0.00033112333,0.00019312378,0.000022273916,0.00021273193,0.00019305068,0.000067303816,0.00004779627,0.0003232248,0.0000031239656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007843378,0.0036905166,0.914206,0.00005504597,0.00020825195,0.00029414974,0.00012981561,1.0293992e-7,0.07179814,4.4233002e-7,0.000020970292,0.0017531393],"study_design_scores_gemma":[0.046322066,0.0034856165,0.9007972,0.0001237422,0.00015673033,0.000028367002,0.000056731882,0.000015293277,0.048681796,4.3004886e-7,0.00013335698,0.00019865483],"about_ca_topic_score_codex":0.00024703256,"about_ca_topic_score_gemma":0.0014415431,"teacher_disagreement_score":0.038478687,"about_ca_system_score_codex":0.000039242488,"about_ca_system_score_gemma":0.00006839172,"threshold_uncertainty_score":0.7875359},"labels":[],"label_agreement":null},{"id":"W2979943258","doi":"10.1182/blood.v120.21.31.31","title":"STAT3 Inhibition Synergizes with BCR-ABL1 Inhibition to Overcome Kinase-Independent TKI Resistance in Chronic Myeloid Leukemia (CML)","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Imatinib mesylate; Imatinib; Cancer research; Dasatinib; K562 cells; Myeloid leukemia; Progenitor cell; Medicine; Leukemia; Biology; Immunology; Stem cell; Cell biology","score_opus":0.011499081624645462,"score_gpt":0.245605280269978,"score_spread":0.23410619864533252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979943258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98985684,0.0026556156,0.000078826306,0.00038922214,0.00012611871,0.0012608544,0.000050253926,0.00017301989,0.0054092244],"genre_scores_gemma":[0.9945974,0.00019858535,0.0018735126,0.00035276826,0.00052767125,0.00030095156,0.0002152097,0.000096439224,0.0018375092],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99688184,0.0001006005,0.0005563157,0.0006402734,0.00081328064,0.0010076994],"domain_scores_gemma":[0.99845254,0.00008497498,0.00018146877,0.0006928212,0.00010220048,0.00048600053],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038222846,0.00045275228,0.0005676825,0.0003724416,0.00011339401,0.00003848432,0.000090140995,0.00022503735,0.00025184447],"category_scores_gemma":[0.00007604871,0.0004007012,0.00010129605,0.0006711725,0.00008030679,0.00046954496,0.00009726833,0.00045501272,0.0003236339],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008081956,0.012023219,0.30522618,0.004374092,0.0017023394,0.0068213907,0.011104284,0.00072454946,0.6223992,0.009714748,0.010441028,0.007387038],"study_design_scores_gemma":[0.060433336,0.0027711992,0.4928855,0.0053469017,0.0009928633,0.00065285363,0.00067812746,0.000033667948,0.4233882,0.0004703029,0.010797653,0.0015493921],"about_ca_topic_score_codex":0.0005834904,"about_ca_topic_score_gemma":0.0027755725,"teacher_disagreement_score":0.19901098,"about_ca_system_score_codex":0.008451445,"about_ca_system_score_gemma":0.0012340196,"threshold_uncertainty_score":0.9998445},"labels":[],"label_agreement":null},{"id":"W2979946059","doi":"10.1182/blood.v118.21.2174.2174","title":"Notch Signaling Requires Gfi1 for T Cell Development","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Biology; T cell; Notch signaling pathway; Transcription factor; Phenotype; Repressor; T-cell receptor; Negative selection; Cell biology; Thymocyte; Genetics; Cre recombinase; Cancer research; Transgene; Molecular biology; Signal transduction; Gene; Genetically modified mouse","score_opus":0.04272021161839167,"score_gpt":0.22196538693454795,"score_spread":0.17924517531615627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979946059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926814,0.0007427013,0.0027918369,0.000021710335,0.0003311112,0.00032078192,0.0000143794605,0.00008289303,0.0030131943],"genre_scores_gemma":[0.9873669,0.000009410863,0.010250719,0.00018914275,0.00004073639,0.00009430715,0.000053798434,0.00002358238,0.0019714083],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990653,0.00004808303,0.00023580056,0.00027958103,0.000022696999,0.00034855594],"domain_scores_gemma":[0.99959856,0.000054656382,0.000079842684,0.00017884611,0.00006512003,0.00002297716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016541668,0.00016161919,0.00019223602,0.00006587838,0.00020439689,0.000007369989,0.00019925504,0.00014053614,0.000600679],"category_scores_gemma":[0.000015557898,0.00013896567,0.00006900416,0.0000587431,0.000047722653,0.00006185216,0.00006372383,0.0001070095,0.00058127585],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006827818,0.0004286172,0.00023410904,0.000023220162,0.00010895044,0.000006946531,0.0010932545,8.158611e-8,0.9951973,0.0014423274,0.00024828184,0.0011486264],"study_design_scores_gemma":[0.0020638646,0.00021114865,0.00030082747,0.000020488544,0.00006472641,0.000011430524,0.00016077133,7.273107e-8,0.9783584,0.00053869124,0.01807244,0.00019717023],"about_ca_topic_score_codex":0.000010369009,"about_ca_topic_score_gemma":0.000004784193,"teacher_disagreement_score":0.017824156,"about_ca_system_score_codex":0.0000099462495,"about_ca_system_score_gemma":0.00006174917,"threshold_uncertainty_score":0.7471319},"labels":[],"label_agreement":null},{"id":"W2979946483","doi":"10.1182/blood.v118.21.3842.3842","title":"Associations Between Improvements in Myelofibrosis (MF) Symptoms and Quality of Life Measures with Splenomegaly Reduction in COMFORT-I: A Randomized, Double-Blind, Phase III Trial of the JAK1 and JAK2 Inhibitor Ruxolitinib Versus Placebo in Patients with MF,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Ruxolitinib; Medicine; Myelofibrosis; Placebo; Quality of life (healthcare); Internal medicine; Clinical trial; Bone pain; Phases of clinical research; Randomized controlled trial; Anemia; Adverse effect; Surgery; Gastroenterology; Physical therapy; Bone marrow; Pathology","score_opus":0.05957677631218394,"score_gpt":0.2992773968094112,"score_spread":0.23970062049722723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979946483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947931,0.000066836124,0.00000176765,0.000057832334,0.00005348384,0.004693986,0.00013374344,0.000006390474,0.0001928179],"genre_scores_gemma":[0.9992601,0.000032061434,0.00013091647,0.0000091051315,0.00004302898,0.00043064688,0.00007109361,0.00001541609,0.000007584171],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9978796,0.0002810146,0.0008951205,0.00030238804,0.00043497948,0.00020685601],"domain_scores_gemma":[0.99868315,0.00029761525,0.00058353395,0.00020572243,0.00013398519,0.00009597077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008867004,0.00020883094,0.0010635926,0.0002100936,0.000045398207,0.000009368427,0.00005188047,0.000107033484,0.0000056998106],"category_scores_gemma":[0.0002011548,0.00012982069,0.00006399635,0.00030480215,0.00018375345,0.0001188302,0.00003868226,0.00016407884,1.2034718e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.47431988,0.0030653104,0.5205025,0.000034086206,0.00037525978,4.1570127e-7,0.001359996,6.182031e-7,0.00003296889,0.00006225686,6.654855e-7,0.00024607437],"study_design_scores_gemma":[0.62432796,0.0021944817,0.36963582,0.00017264298,0.00036587406,1.7216601e-7,0.00014856648,0.0000013530946,0.003061371,0.000010043789,5.222996e-7,0.00008118638],"about_ca_topic_score_codex":0.0027690595,"about_ca_topic_score_gemma":0.0014663719,"teacher_disagreement_score":0.15086667,"about_ca_system_score_codex":0.00008789648,"about_ca_system_score_gemma":0.00017768661,"threshold_uncertainty_score":0.5293934},"labels":[],"label_agreement":null},{"id":"W2979952702","doi":"10.1182/blood.v118.21.2653.2653","title":"An Index of SNPs in Immune Genes May Enhance the Prognostic Value of IPI in Patients with Aggressive Non-Hodgkin's Lymphoma","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Oncology; Medicine; International Prognostic Index; Cohort; Internal medicine; Single-nucleotide polymorphism; Genotyping; Cancer; Immune system; Lymphoma; Blood sampling; Immunology; Genotype; Diffuse large B-cell lymphoma; Biology; Gene; Genetics","score_opus":0.006683805290195919,"score_gpt":0.2280399197516781,"score_spread":0.22135611446148218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979952702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980795,0.0007741312,0.0000023312516,0.000019117271,0.000030677355,0.0007613388,0.00001053716,0.000006279183,0.00031613756],"genre_scores_gemma":[0.99940234,0.00007089485,0.00032586275,0.000023261146,0.000013257235,0.00012580439,0.000014811527,0.00001674926,0.0000069944663],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898916,0.00005723194,0.0003301321,0.00020258,0.00023446795,0.00018642697],"domain_scores_gemma":[0.99911606,0.00006360911,0.00029283683,0.00038527898,0.00009636679,0.00004583701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000100642435,0.00014504939,0.00034407066,0.00010169855,0.000016446545,0.0000030580777,0.00012659194,0.00006220309,0.000018552933],"category_scores_gemma":[0.0000399525,0.00008394538,0.0000434878,0.00022991281,0.00009807862,0.000058077854,0.000033095697,0.000038335133,0.0000025815298],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034030314,0.010289363,0.97785485,0.00005998078,0.00012191268,0.0000780713,0.0015008528,0.000004111357,0.0002727304,0.000037679347,0.000001453256,0.0094387205],"study_design_scores_gemma":[0.010870109,0.0015893696,0.88388854,0.00062063907,0.00014702354,0.000006207217,0.00012546018,0.000015899777,0.10263443,0.000023582106,0.0000021167764,0.000076595235],"about_ca_topic_score_codex":0.0011846469,"about_ca_topic_score_gemma":0.00010319648,"teacher_disagreement_score":0.1023617,"about_ca_system_score_codex":0.000033514712,"about_ca_system_score_gemma":0.00011846566,"threshold_uncertainty_score":0.34231934},"labels":[],"label_agreement":null},{"id":"W2979954166","doi":"10.1182/blood.v114.22.37.37","title":"The Bcr-Abl SH2-Kinase Domain Interface Is Critical for Leukemogenesis and An Additional Therapeutic Target in CML.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"SH2 domain; Tyrosine kinase; Cancer research; ABL; Protein kinase domain; Autophosphorylation; Philadelphia chromosome; Biology; Cell biology; Proto-oncogene tyrosine-protein kinase Src; Kinase; Signal transduction; Chemistry; Protein kinase A; Biochemistry; Mutant","score_opus":0.017092326915973316,"score_gpt":0.3116450184784985,"score_spread":0.29455269156252517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979954166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873317,0.004174758,0.00028200756,0.0062728566,0.000060185852,0.00068251864,0.0005382091,0.00005105262,0.00060670945],"genre_scores_gemma":[0.99260145,0.00007649555,0.0053175115,0.0013373143,0.00020987226,0.00010885431,0.00013661964,0.00002185655,0.00019002208],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988861,0.000055948927,0.0002197803,0.00031352774,0.00018797233,0.0003366443],"domain_scores_gemma":[0.99895006,0.0005399917,0.000029437644,0.00028870365,0.000052856525,0.00013893911],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001779089,0.00016931964,0.00021709465,0.00005404345,0.000137816,0.000033906614,0.000093802235,0.00009135175,0.0005445287],"category_scores_gemma":[0.00015367623,0.00012172093,0.00006416674,0.00009441522,0.00011268707,0.00007946978,0.000019184357,0.00012130681,0.000014449665],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014706099,0.047181815,0.0655114,0.0012009257,0.0039820494,0.0026005222,0.017076567,0.000044451026,0.16556437,0.08558356,0.14317693,0.45337132],"study_design_scores_gemma":[0.104331605,0.011603152,0.4649957,0.0010842651,0.0020840124,0.0017472329,0.0041757775,0.0035762386,0.13317701,0.12625813,0.14505401,0.001912846],"about_ca_topic_score_codex":0.00001686795,"about_ca_topic_score_gemma":0.00003068986,"teacher_disagreement_score":0.45145845,"about_ca_system_score_codex":0.00018639059,"about_ca_system_score_gemma":0.00021135603,"threshold_uncertainty_score":0.5962208},"labels":[],"label_agreement":null},{"id":"W2979962503","doi":"10.1182/blood.v128.22.1027.1027","title":"Erythromer (EM), a Nanoscale Bio-Synthetic Artificial Red Cell: Proof of Concept and In Vivo Efficacy Results","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobin structure and function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Dynamic light scattering; Zeta potential; In vivo; Biophysics; Dispersity; Chemistry; Ex vivo; Biocompatibility; Hemoglobin; Nanotechnology; Chromatography; Materials science; Nanoparticle; Biochemistry; In vitro; Organic chemistry; Biology","score_opus":0.00771926138671003,"score_gpt":0.2134479287978573,"score_spread":0.20572866741114726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979962503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984366,0.00025288918,0.00009357137,0.00013270341,0.00008404737,0.00015497277,0.00005677931,0.000005537158,0.0007828789],"genre_scores_gemma":[0.9993319,0.00002751759,0.0001240642,0.000023922808,0.00010405767,0.000006843644,0.0000107938895,0.000010316885,0.0003606018],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992518,0.000038171027,0.00022066999,0.00027018687,0.00007163131,0.00014757],"domain_scores_gemma":[0.99961925,0.000018035647,0.000071505754,0.00021776058,0.000031859843,0.000041618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000084185194,0.00009613047,0.00012775951,0.000033188022,0.000020523257,0.0000054153234,0.000059119247,0.00013650705,0.000020815642],"category_scores_gemma":[0.00008961212,0.00006860878,0.000037430207,0.00006509963,0.00009401503,0.0000025872757,0.000039633043,0.000032215932,0.0000012227375],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019834103,0.00016255898,0.00044140025,0.000009386274,0.000013748333,0.000001812896,0.00009331801,0.0000011667536,0.9934519,0.000005456322,0.00046533093,0.005155596],"study_design_scores_gemma":[0.0021844937,0.00028591964,0.0020235921,0.000028530982,0.000022061295,0.000008589722,0.000028094604,0.0000010150352,0.9902195,0.000057137768,0.0050397995,0.00010126348],"about_ca_topic_score_codex":0.0000058349788,"about_ca_topic_score_gemma":0.000025266127,"teacher_disagreement_score":0.0050543323,"about_ca_system_score_codex":0.0000032694354,"about_ca_system_score_gemma":0.000028907543,"threshold_uncertainty_score":0.27977848},"labels":[],"label_agreement":null},{"id":"W2979962742","doi":"10.1182/blood.v120.21.501.501","title":"Thromboembolic and Bleeding Events Following Elective Hip and Knee Arthroplasty Using Oral Factor Xa Inhibitor","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Rivaroxaban; Pulmonary embolism; Surgery; Institutional review board; Venous thrombosis; Thrombosis; Internal medicine; Warfarin; Atrial fibrillation","score_opus":0.026669109831787188,"score_gpt":0.28244613379331907,"score_spread":0.2557770239615319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979962742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961653,0.002239511,0.00005331367,0.00007087128,0.00040442354,0.0005577979,0.000005031143,0.00006846939,0.00043529493],"genre_scores_gemma":[0.9979772,0.00016145912,0.0010857092,0.00020179604,0.00047241856,0.000020556432,0.0000044796184,0.00004309383,0.000033271375],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986266,0.000038142585,0.00022615006,0.0003047795,0.00025807292,0.0005462793],"domain_scores_gemma":[0.9993947,0.000047533624,0.000081242,0.00016001302,0.000032897726,0.0002835718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019821904,0.00023968797,0.00054637116,0.00013394003,0.00022685996,0.000037564918,0.000028771778,0.00010157906,0.000039538252],"category_scores_gemma":[0.000065302855,0.00021359987,0.000086859436,0.00015491928,0.000049190938,0.00032622047,0.0001364687,0.00016456223,0.000009798101],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002256291,0.0017360826,0.9566328,0.0001975606,0.0011305694,0.000026870184,0.0030320378,8.9571745e-7,0.031767003,0.00038447249,0.00016267736,0.0049064783],"study_design_scores_gemma":[0.004256199,0.00040065072,0.98360115,0.0002995388,0.0013728153,0.00008314009,0.000722776,0.00005161395,0.00794915,0.00009445908,0.00084217434,0.00032633683],"about_ca_topic_score_codex":0.00009062819,"about_ca_topic_score_gemma":0.000009572225,"teacher_disagreement_score":0.026968354,"about_ca_system_score_codex":0.00004822539,"about_ca_system_score_gemma":0.000033525546,"threshold_uncertainty_score":0.8710349},"labels":[],"label_agreement":null},{"id":"W2979964452","doi":"10.1182/blood.v106.11.2033.2033","title":"A Phase 3, Randomized, Placebo-Controlled Trial of Filgrastim in Patients (Pts) with Hematologic Malignancies (HM) Treated with a Myeloablative Conditioning Regimen and Allogenic Bone Marrow Transplantation (allo BMT).","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Berger (Canada)","funders":"","keywords":"Medicine; Filgrastim; Internal medicine; Neutropenia; Absolute neutrophil count; Transplantation; Randomization; Granulocyte colony-stimulating factor; Febrile neutropenia; Surgery; Regimen; Chemotherapy regimen; Gastroenterology; Clinical endpoint; Surrogate endpoint; Randomized controlled trial; Chemotherapy","score_opus":0.00736748950761514,"score_gpt":0.24121495412776542,"score_spread":0.23384746462015027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979964452","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99449265,0.00013762606,0.00011734857,0.000111106136,0.000013284742,0.0041783997,0.000030085148,0.00003686612,0.00088264956],"genre_scores_gemma":[0.99807596,0.00007682459,0.00050851674,0.000047348232,0.0000308456,0.0009804814,0.0001028639,0.000017729475,0.00015943493],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9987331,0.0001643625,0.00044107425,0.00025509344,0.00021201279,0.00019437101],"domain_scores_gemma":[0.9991962,0.00022643952,0.0002729026,0.00011868713,0.0001138667,0.00007195891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021619229,0.00019976436,0.0009829536,0.00018319328,0.00006561868,0.0000128830225,0.000029549,0.000073703326,0.00006580684],"category_scores_gemma":[0.000045376746,0.00013023734,0.00008669641,0.00021102812,0.0001690247,0.0001255311,0.000004708023,0.0001197914,0.0000018049316],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.985683,0.0028542485,0.0071232123,0.00007715747,0.00059263175,0.00006594009,0.0006878775,0.00005415551,0.0026628762,0.00007434858,0.000011761931,0.00011276336],"study_design_scores_gemma":[0.98042786,0.0050219097,0.0011702917,0.0003360168,0.0021005315,0.00014156342,0.00009660566,0.00006594367,0.010470164,0.000015164013,0.000005646773,0.00014827806],"about_ca_topic_score_codex":0.000056954017,"about_ca_topic_score_gemma":0.0001625276,"teacher_disagreement_score":0.0078072883,"about_ca_system_score_codex":0.00003344278,"about_ca_system_score_gemma":0.000094779294,"threshold_uncertainty_score":0.53109246},"labels":[],"label_agreement":null},{"id":"W2979965207","doi":"10.1182/blood.v114.22.2922.2922","title":"Chromosomal Alterations in Gene Expression-Defined Pediatric Aggressive B-Cell Non-Hodgkin Lymphoma (B-NHL).","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lymphoma; Comparative genomic hybridization; Diffuse large B-cell lymphoma; Lymphoblastic lymphoma; Gene expression profiling; Cancer research; Pathology; Germinal center; B cell; Biology; Hematology; Oncology; Medicine; Gene; Immunology; Gene expression; Genetics; T cell; Chromosome; Antibody","score_opus":0.007971965767967668,"score_gpt":0.23806919359847328,"score_spread":0.23009722783050562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979965207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920384,0.0023596429,0.0000131489205,0.00049192295,0.000108937755,0.00052153127,0.000024859746,0.000064391,0.0043771164],"genre_scores_gemma":[0.99465805,0.00051015854,0.0032895545,0.00047855388,0.00052273856,0.00012991767,0.00010697139,0.00002215042,0.00028187636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850965,0.000038074053,0.00037426926,0.00041736613,0.00028603402,0.00037463827],"domain_scores_gemma":[0.99906343,0.00007817258,0.00017462729,0.00041253187,0.000062940904,0.00020828778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000061639854,0.00025293446,0.00036903023,0.00021228268,0.00010316975,0.000035561206,0.0001018883,0.00013299989,0.00011468305],"category_scores_gemma":[0.00005726596,0.0002054346,0.00013427355,0.000333667,0.000018825263,0.00009666858,0.000034841472,0.000070036294,0.00015655397],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046287014,0.054754116,0.7611501,0.00014827398,0.0001608291,0.010470127,0.0017309582,0.000052457264,0.14892499,0.00018063503,0.008502136,0.013462498],"study_design_scores_gemma":[0.02663311,0.0011265953,0.5709821,0.00015039963,0.00037769263,0.0002674679,0.000033239663,0.00005118459,0.3998386,0.00009184967,0.00017003575,0.00027775866],"about_ca_topic_score_codex":0.000045719262,"about_ca_topic_score_gemma":0.000006731298,"teacher_disagreement_score":0.2509136,"about_ca_system_score_codex":0.0001018181,"about_ca_system_score_gemma":0.0002370583,"threshold_uncertainty_score":0.837738},"labels":[],"label_agreement":null},{"id":"W2979965816","doi":"10.1182/blood.v106.11.3449.3449","title":"CHIR-258 Efficacy in a Newly Developed Preclinical Bone Marrow Model of t(4;14) Multiple Myeloma.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Cancer research; Bone marrow; In vivo; Multiple myeloma; Medicine; Tyrosine-kinase inhibitor; Pathology; Biology; Immunology; Cancer; Internal medicine","score_opus":0.06207645131023944,"score_gpt":0.34061328693648424,"score_spread":0.2785368356262448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979965816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99486566,0.00050970254,0.00009868068,0.0007743186,0.0000235886,0.0008523795,0.000033727367,0.00005864972,0.0027833213],"genre_scores_gemma":[0.9641165,0.000110935376,0.033863135,0.00012099992,0.000112712216,0.00006577551,0.00006163903,0.000036542868,0.0015117364],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99786913,0.00007215029,0.0006370703,0.00041147933,0.00048642608,0.000523715],"domain_scores_gemma":[0.9987037,0.0002724598,0.00010358906,0.0004668333,0.00011237009,0.00034104174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031962048,0.0002184078,0.00056447723,0.00021016077,0.000040695923,0.00001057085,0.00014800068,0.00016319685,0.00010173539],"category_scores_gemma":[0.0011360851,0.00018327759,0.00015225743,0.00028350097,0.00009027808,0.000092407965,0.000104359126,0.00031569204,0.00012293742],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004678224,0.029520728,0.76181954,0.0003356353,0.00082634203,0.0005242821,0.0011776441,0.0010045992,0.058823828,0.00010419131,0.00088417163,0.1403008],"study_design_scores_gemma":[0.09038207,0.0008156417,0.7943551,0.00036922333,0.0002501138,0.00009927825,0.000039450242,0.055265706,0.05679184,0.000061519066,0.0011693428,0.00040072543],"about_ca_topic_score_codex":0.000084626874,"about_ca_topic_score_gemma":0.00035099708,"teacher_disagreement_score":0.13990007,"about_ca_system_score_codex":0.000059251495,"about_ca_system_score_gemma":0.00036510365,"threshold_uncertainty_score":0.7473843},"labels":[],"label_agreement":null},{"id":"W2979965900","doi":"10.1182/blood.v126.23.2778.2778","title":"Comparative Effectiveness of Generic Imatinib and Brand-Name Imatinib for the Treatment of Chronic Myeloid Leukemia","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Notre-Dame; McGill University Health Centre; Hôpital du Sacré-Cœur de Montréal; Hôpital Maisonneuve-Rosemont; Hôpital de l'Enfant-Jésus; Jewish General Hospital","funders":"","keywords":"Imatinib; Hazard ratio; Medicine; Internal medicine; Oncology; Cumulative incidence; Proportional hazards model; Confidence interval; Odds ratio; Poisson regression; Myeloid leukemia; Imatinib mesylate; Cohort; Population","score_opus":0.04255657440685568,"score_gpt":0.3102607268209065,"score_spread":0.2677041524140508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979965900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98367584,0.013038157,0.00032304358,0.00003485956,0.00008543537,0.0022003807,0.00008200176,0.000024447392,0.00053582597],"genre_scores_gemma":[0.9971911,0.0004877918,0.0016081666,0.00000872161,0.00011645596,0.00038440147,0.00005981714,0.000025486423,0.000118116885],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988033,0.00010572495,0.0003588538,0.00026850775,0.0002274872,0.00023609982],"domain_scores_gemma":[0.99820733,0.00086391537,0.00022850647,0.0004083351,0.00017051592,0.00012138074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002659224,0.00024145187,0.0008453653,0.00005695554,0.00005223653,0.000007090003,0.000087052926,0.00007731726,0.000017349648],"category_scores_gemma":[0.000056720382,0.00014783259,0.00014763886,0.00013743121,0.00021440123,0.000047098303,0.000026534417,0.000055239336,0.000005491719],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029617105,0.038338725,0.14658312,0.017888347,0.03458203,0.00018503878,0.060543302,0.0041517946,0.48456022,0.0029091372,0.0017637209,0.17887744],"study_design_scores_gemma":[0.119982615,0.01777364,0.08210279,0.00068424543,0.0041087843,0.00022988456,0.00074599264,0.007711342,0.76382923,0.00028893555,0.0021820797,0.00036048456],"about_ca_topic_score_codex":0.00020195633,"about_ca_topic_score_gemma":0.0000219247,"teacher_disagreement_score":0.27926898,"about_ca_system_score_codex":0.0008244363,"about_ca_system_score_gemma":0.0009834096,"threshold_uncertainty_score":0.60284376},"labels":[],"label_agreement":null},{"id":"W2979970416","doi":"10.1182/blood.v104.11.711.711","title":"Leukemic Stem Cells of Chronic Phase CML Patients Consistently Display Very High BCR-ABL Transcript Levels and Reduced Responsiveness to Imatinib Mesylate in Addition to Generating a Rare Subset That Produce Imatinib Mesylate-Resistant Differentiated Progeny.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"CD38; Imatinib mesylate; CD34; Haematopoiesis; Cancer research; Stem cell; Imatinib; Myeloid leukemia; Biology; Immunology; Medicine; Cell biology","score_opus":0.022833019468571577,"score_gpt":0.26156553584485576,"score_spread":0.23873251637628418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979970416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99254286,0.0006129765,0.000053906293,0.00017480784,0.00023152062,0.0045209257,0.0017484342,0.000096375436,0.00001818445],"genre_scores_gemma":[0.99672014,0.00003093079,0.0015656777,0.00010108352,0.000072433,0.0005296956,0.0007553729,0.0001092347,0.000115431896],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99599326,0.00027499523,0.0011668896,0.0010739437,0.000707667,0.0007832363],"domain_scores_gemma":[0.9979814,0.0001274259,0.00041277372,0.00075664785,0.00029928284,0.00042241532],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034707141,0.00063076324,0.0011331345,0.00043060334,0.00015269018,0.00005923677,0.00020703899,0.00021076437,0.00007216336],"category_scores_gemma":[0.00014308178,0.00057084655,0.00016135917,0.0006512804,0.000095181254,0.00022355426,0.00010113143,0.00029432826,0.000017985247],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003064028,0.0031786375,0.0015173575,0.0010296978,0.00044318056,0.0002279163,0.0026775713,0.00025432542,0.9847227,0.00002080363,0.00004979809,0.002814001],"study_design_scores_gemma":[0.049070325,0.0029254497,0.040400416,0.0029003373,0.00067993114,0.000053968815,0.00019352554,0.00016055722,0.9030368,0.000019811352,0.00003067061,0.00052823016],"about_ca_topic_score_codex":0.00025512482,"about_ca_topic_score_gemma":0.00018802762,"teacher_disagreement_score":0.08168591,"about_ca_system_score_codex":0.0017072314,"about_ca_system_score_gemma":0.0012493798,"threshold_uncertainty_score":0.9996743},"labels":[],"label_agreement":null},{"id":"W2979970673","doi":"10.1182/blood.v112.11.3847.3847","title":"The Role of Heme Oxygenase 1 in Erythroid Differentiation.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Heme Oxygenase-1 and Carbon Monoxide","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Heme; Heme oxygenase; Biochemistry; Chemistry; Red blood cell; Catabolism; Oxidative phosphorylation; Cell biology; Biology; Metabolism; Enzyme","score_opus":0.0051252264995709515,"score_gpt":0.19465275223509074,"score_spread":0.1895275257355198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979970673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99475086,0.0030011267,0.000015252809,0.00003761929,0.000029616587,0.00007718212,0.000007176979,0.000004689336,0.0020764982],"genre_scores_gemma":[0.99873304,0.0006294109,0.00007308463,0.00004053545,0.00008091691,0.000016496151,0.000019655768,0.000010187593,0.00039666862],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994048,0.000033958713,0.0001696438,0.00014487584,0.00009032298,0.0001563865],"domain_scores_gemma":[0.999608,0.000009508055,0.00004969902,0.00026367727,0.000031199408,0.000037953156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007346684,0.00007805349,0.00008318387,0.000018766177,0.000058342837,0.0000045587813,0.000132479,0.000065763554,0.000011751285],"category_scores_gemma":[0.00004125202,0.00005963414,0.000062518986,0.000062815634,0.00005692125,0.000001491804,0.00004807296,0.000046948484,0.0000063733005],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018975843,0.00018043291,0.023078028,0.000003286734,0.000029312785,0.0000037878813,0.00004923416,0.0000037851787,0.975854,0.0000982462,0.00021682556,0.0004641023],"study_design_scores_gemma":[0.0007096461,0.00007148335,0.03662652,0.0000036443291,0.00000850291,0.00001417172,0.00008050903,0.00001614122,0.95139945,0.00010089881,0.010884558,0.00008448037],"about_ca_topic_score_codex":0.000023788722,"about_ca_topic_score_gemma":0.00008480588,"teacher_disagreement_score":0.024454542,"about_ca_system_score_codex":0.000002904868,"about_ca_system_score_gemma":0.000045545734,"threshold_uncertainty_score":0.24318096},"labels":[],"label_agreement":null},{"id":"W2979971137","doi":"10.1182/blood.v122.21.3678.3678","title":"Phosphatidylinositol-3-Kinase p110d Uniquely Promotes Gain-Of-Function PTPN11-Induced GM-CSF Hypersensitivity In a Model Of Juvenile Myelomonocytic Leukemia","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Discovery Centre; University Health Network; Ontario Institute for Cancer Research","funders":"","keywords":"Juvenile myelomonocytic leukemia; PTPN11; KRAS; Cancer research; Neuroblastoma RAS viral oncogene homolog; PI3K/AKT/mTOR pathway; MAPK/ERK pathway; Leukemia; Trametinib; Idelalisib; Biology; Immunology; PTEN; Medicine; Internal medicine; Kinase; Mutation; Haematopoiesis; Signal transduction; Cell biology; Genetics; Stem cell; Chronic lymphocytic leukemia","score_opus":0.01504031316133734,"score_gpt":0.2269688193111373,"score_spread":0.21192850614979997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979971137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964357,0.0015968085,0.0007582253,0.000044048604,0.00004972647,0.00070309796,0.000057330788,0.000019863226,0.00033520718],"genre_scores_gemma":[0.9970964,0.000050923856,0.0024367091,0.00006999534,0.000036268822,0.00010421196,0.0001089783,0.00003294739,0.00006355852],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985878,0.00009622476,0.00043815255,0.00040894994,0.0001709046,0.0002979809],"domain_scores_gemma":[0.99890953,0.00002829061,0.00024911278,0.00052369887,0.00020417038,0.000085171494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022415353,0.00023241325,0.0003604203,0.0000822998,0.000037096714,0.0000140560205,0.00018268786,0.00022019965,0.000010759535],"category_scores_gemma":[0.00024218555,0.00023712579,0.00011211723,0.00017997561,0.0000905125,0.000021586926,0.00014500116,0.00013287296,0.000007167775],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000097238284,0.00041615398,0.0014142643,0.00010265721,0.000057120025,0.0000051555458,0.000057750913,0.0005122871,0.99417824,0.00032834627,0.00009037503,0.0027403953],"study_design_scores_gemma":[0.0016045804,0.0005111023,0.0033795645,0.000076802666,0.000059591566,0.000007853456,0.000039339287,0.0046921135,0.9885721,0.00080338103,0.000016408925,0.00023713234],"about_ca_topic_score_codex":0.0010346323,"about_ca_topic_score_gemma":0.00010174857,"teacher_disagreement_score":0.0056061265,"about_ca_system_score_codex":0.000037640726,"about_ca_system_score_gemma":0.0003531721,"threshold_uncertainty_score":0.9669709},"labels":[],"label_agreement":null},{"id":"W2979971328","doi":"10.1182/blood.v108.11.3302.3302","title":"Thromboprophylaxis of Adult Medical Inpatients in St. John’s Newfoundland.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Deep vein; Pulmonary embolism; Population; Demographics; Thrombosis; Emergency medicine; Randomized controlled trial; Psychological intervention; Internal medicine; Intensive care medicine; Pediatrics","score_opus":0.0064818224822376855,"score_gpt":0.24048872481968114,"score_spread":0.23400690233744345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979971328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801061,0.00016668245,0.000016579217,0.0005050263,0.00012970794,0.00035778654,0.000007520008,0.000029671697,0.018680917],"genre_scores_gemma":[0.9987771,0.00015603543,0.00028714066,0.00039393458,0.00015520172,0.000030239195,0.000039569008,0.000017723229,0.00014309092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985102,0.000025507055,0.0004025343,0.00021940623,0.0005996466,0.00024270595],"domain_scores_gemma":[0.9994479,0.00002779698,0.00008480903,0.00026262243,0.00008499089,0.00009192391],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012823708,0.00012261557,0.00044394084,0.00015261919,0.000021835069,0.000006733592,0.00011124023,0.00010275945,0.00045303002],"category_scores_gemma":[0.00010420223,0.00010214943,0.00007593283,0.00024033774,0.00006366637,0.000041546195,0.00006898495,0.000131008,0.000030412522],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047830443,0.013601101,0.96896416,0.00037264707,0.00015301596,0.00022898498,0.0002614779,0.000005574353,0.0007884332,0.00621677,0.0049634557,0.0043965513],"study_design_scores_gemma":[0.0060892846,0.00065643934,0.98873466,0.00029274786,0.00012871019,0.000011768537,0.00005104896,0.000029390585,0.0016792523,0.00056402344,0.001640255,0.00012240409],"about_ca_topic_score_codex":0.004699157,"about_ca_topic_score_gemma":0.0030368443,"teacher_disagreement_score":0.019770518,"about_ca_system_score_codex":0.000036072604,"about_ca_system_score_gemma":0.000077780925,"threshold_uncertainty_score":0.71037513},"labels":[],"label_agreement":null},{"id":"W2979973001","doi":"10.1182/blood.v108.11.3012.3012","title":"Influence of Killer Immunoglobulin-Like Receptor (KIR) Matching on Achieving T Cell (CD3+) Complete Donor Chimerism (CDC) in Related Donor Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation (NMHSCT).","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Fludarabine; Hematopoietic stem cell transplantation; Human leukocyte antigen; Immunology; Transplantation; CD3; Genotype; Biology; T cell; Medicine; Internal medicine; Immune system; Antigen; Genetics; Chemotherapy; CD8; Cyclophosphamide; Gene","score_opus":0.006430092639632512,"score_gpt":0.19617548353547315,"score_spread":0.18974539089584064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979973001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941275,0.001312739,0.000089681664,0.00005307108,0.001162892,0.00048511292,0.000029282843,0.00008274831,0.002656938],"genre_scores_gemma":[0.9944125,0.00031939574,0.000107304055,0.000101578386,0.000021496828,0.000035063018,0.00047430268,0.000042801712,0.004485561],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99766546,0.00038249505,0.00096591125,0.00047638975,0.00008415499,0.00042557126],"domain_scores_gemma":[0.9988033,0.00021913325,0.0005262936,0.0003419277,0.00008684479,0.000022499755],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026462198,0.0003556979,0.0004897129,0.0002925118,0.00020279174,0.000021572241,0.00024172592,0.00036797253,0.00043054018],"category_scores_gemma":[0.000005722236,0.00034963893,0.0001706031,0.00028764064,0.00011035057,0.000239035,0.000041641822,0.0006437153,0.00079677923],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051317486,0.0008876076,0.0042247633,0.00012675661,0.000113137336,0.0000075091775,0.0022034931,0.0033548735,0.9882041,0.00006385735,0.00018788654,0.00011279522],"study_design_scores_gemma":[0.008084339,0.00067613175,0.096965976,0.00048942416,0.0002450367,0.000110819085,0.0009423554,0.000013158814,0.88811195,0.000051361454,0.0036672575,0.00064220245],"about_ca_topic_score_codex":0.00088586635,"about_ca_topic_score_gemma":0.0000498864,"teacher_disagreement_score":0.1000922,"about_ca_system_score_codex":0.00007046685,"about_ca_system_score_gemma":0.000046279685,"threshold_uncertainty_score":0.9999812},"labels":[],"label_agreement":null},{"id":"W2979974108","doi":"10.1182/blood.v116.21.3180.3180","title":"Outcomes of Pulmonary Embolism In Surgical Patients: A Retrospective Cohort Study","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Pulmonary embolism; Retrospective cohort study; Deep vein; Surgery; Thrombosis; Orthopedic surgery; Venous thrombosis","score_opus":0.005827862402055207,"score_gpt":0.25470406501639237,"score_spread":0.24887620261433716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979974108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835813,0.000020609943,2.8118117e-7,0.00011109802,0.00021595121,0.0013649848,0.000007137574,0.000029270364,0.014669386],"genre_scores_gemma":[0.9995166,0.000027008668,0.00004802726,0.000064747604,0.00006243321,0.00010878286,0.00001170574,0.000017769296,0.00014292014],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998765,0.00003128853,0.000333611,0.00028108194,0.00038628542,0.0002027296],"domain_scores_gemma":[0.99932945,0.000036708105,0.00008477371,0.0003719939,0.000100747435,0.00007634712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002808599,0.00013345214,0.0006901002,0.00014280758,0.00002500591,0.0000061356322,0.00009577563,0.00006792648,0.00018166746],"category_scores_gemma":[0.000102393584,0.00010637562,0.000087883345,0.00018850858,0.000045738798,0.00004721933,0.000091989474,0.00023095639,0.000014771331],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021876056,0.025465464,0.9726419,0.000020009247,0.00022713623,0.00016990642,0.00031648396,1.5300509e-7,0.00006585795,0.00049154914,0.000055916116,0.0005237704],"study_design_scores_gemma":[0.004443039,0.0004155059,0.9940587,0.000018113346,0.00031996766,0.0000053980857,0.00016465658,0.0000030587314,0.00012171925,0.00006792932,0.0002831956,0.0000986986],"about_ca_topic_score_codex":0.00037551075,"about_ca_topic_score_gemma":0.00014217192,"teacher_disagreement_score":0.025049958,"about_ca_system_score_codex":0.000019881014,"about_ca_system_score_gemma":0.000022029004,"threshold_uncertainty_score":0.4337872},"labels":[],"label_agreement":null},{"id":"W2979979447","doi":"10.1182/blood.v116.21.1876.1876","title":"Characteristics of Patients Presenting with Secondary Myelodysplastic Syndrome During Treatment with Lenalidomide for Relapsed/Refractory Multiple Myeloma: 5q Deletions Can Be Observed","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"","keywords":"Lenalidomide; Medicine; Multiple myeloma; Thalidomide; Internal medicine; Melphalan; Autologous stem-cell transplantation; Cyclophosphamide; Transplantation; Bortezomib; Surgery; Prednisone; Oncology; Gastroenterology; Chemotherapy","score_opus":0.020990196200028812,"score_gpt":0.24221128164855416,"score_spread":0.22122108544852534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979979447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968423,0.000029084607,0.0000251282,0.000077536024,0.00007567215,0.0018465052,0.00094067265,0.000065753244,0.00009735041],"genre_scores_gemma":[0.9939888,0.000021951331,0.0038210044,0.000013512848,0.000081311664,0.0004808769,0.0009706455,0.00008363083,0.0005382676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99803525,0.00003978637,0.00042910632,0.00046156932,0.00044188075,0.000592426],"domain_scores_gemma":[0.9981298,0.00032263936,0.00027567914,0.00051447295,0.00038038366,0.0003770142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000079115416,0.0003487921,0.0005961524,0.0001804687,0.00024904206,0.000029697067,0.00011931136,0.000121590696,0.00006934194],"category_scores_gemma":[0.00025705583,0.00024189615,0.00012724886,0.00016523423,0.00015518453,0.00012473259,0.00004687156,0.00030088835,0.0000037206098],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026364652,0.0043761665,0.97005063,0.0005218791,0.0012276574,0.00044204204,0.00026062832,0.0000016106402,0.01967698,0.0000059809095,0.00000528943,0.0007946698],"study_design_scores_gemma":[0.04063808,0.0041526235,0.9287265,0.00014027358,0.0007727333,0.00019675911,0.00004503115,0.00008225769,0.024725761,0.000002371601,0.00028682832,0.00023077863],"about_ca_topic_score_codex":0.00019843814,"about_ca_topic_score_gemma":0.000763132,"teacher_disagreement_score":0.041324127,"about_ca_system_score_codex":0.000090528956,"about_ca_system_score_gemma":0.00034936165,"threshold_uncertainty_score":0.9864239},"labels":[],"label_agreement":null},{"id":"W2979979714","doi":"10.1182/blood.v120.21.2087.2087","title":"Glycine Supplementation – A Novel Therapeutic Strategy for Congenital Sideroblastic Anemia.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Porphyrin Metabolism and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Sideroblastic anemia; Heme; Mutant; Biochemistry; Microcytic anemia; Biology; Molecular biology; Glycine; Enzyme; Gene; Amino acid; Hemoglobin","score_opus":0.021132292533197036,"score_gpt":0.27724881816021224,"score_spread":0.2561165256270152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979979714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821157,0.002726499,0.013822466,0.000039428975,0.00013310212,0.00029758058,0.0001171361,0.000012342608,0.00073574245],"genre_scores_gemma":[0.99749357,0.00004503802,0.001186871,0.0002061031,0.0003270671,0.000065969376,0.0004408411,0.000017586251,0.00021698487],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99939466,0.0000117424115,0.00012407453,0.00014439209,0.00006392374,0.00026122475],"domain_scores_gemma":[0.99970746,0.000012504787,0.00004400446,0.00013395534,0.000034552537,0.00006751502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000080129874,0.000107296364,0.000082825005,0.000019625735,0.000048425474,0.000014689235,0.00007143207,0.00006491934,0.000040483803],"category_scores_gemma":[0.000023710352,0.00009943353,0.00005478884,0.000034556408,0.000026861431,0.0000066190423,0.000020858839,0.000025629326,0.0000073585093],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000075229415,0.0005107311,0.0049670343,0.000025037376,0.00008702825,1.8212256e-7,0.000043543558,0.000016761878,0.9919413,0.00091011706,0.0005257544,0.00089728186],"study_design_scores_gemma":[0.01519714,0.000917009,0.032144483,0.000005760839,0.00050245016,0.000055501325,0.0006972229,0.000044027678,0.92129725,0.0004826191,0.028045056,0.0006114716],"about_ca_topic_score_codex":0.000008479641,"about_ca_topic_score_gemma":0.000016481074,"teacher_disagreement_score":0.07064404,"about_ca_system_score_codex":0.0000017247705,"about_ca_system_score_gemma":0.000030381507,"threshold_uncertainty_score":0.40547815},"labels":[],"label_agreement":null},{"id":"W2979981237","doi":"10.1182/blood.v120.21.1528.1528","title":"Prognostic Factors in Patients with HIV-Associated Hodgkin Lymphoma: An Analysis of 199 Cases","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"ABVD; Medicine; Internal medicine; Dacarbazine; Vinblastine; Univariate analysis; Lymphoma; Hodgkin's lymphoma; Hodgkin lymphoma; Incidence (geometry); Multivariate analysis; Gastroenterology; Oncology; Chemotherapy; Vincristine; Cyclophosphamide","score_opus":0.010409257861823482,"score_gpt":0.23649277233391383,"score_spread":0.22608351447209035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979981237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99914443,0.00017164106,0.000001673868,0.00001276522,0.00002690574,0.0002526566,0.00009462086,0.000032824933,0.00026245494],"genre_scores_gemma":[0.9993051,0.000006689029,0.000026305554,0.00004777099,0.00001228614,0.0000122126185,0.00054088695,0.00001899056,0.000029730838],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890447,0.000056473607,0.00023410021,0.00016495372,0.00030612256,0.00033385452],"domain_scores_gemma":[0.99935824,0.00006141796,0.00017109214,0.0001785291,0.000089341775,0.00014138888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000107950815,0.00014350061,0.00044970535,0.000292574,0.00003082164,0.0000063748817,0.000053788255,0.000097488395,0.00005750704],"category_scores_gemma":[0.00022561068,0.00010922429,0.00009511626,0.0010346819,0.000036953894,0.00012368191,0.000012844792,0.00005811016,0.000002132017],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000114722694,0.005715863,0.9920841,0.000013727229,0.0010696509,0.0000063714288,0.00074298837,0.000013027237,0.00002000016,0.0000049887462,0.00002648112,0.00018806377],"study_design_scores_gemma":[0.009021985,0.0007452953,0.98528534,0.000041644547,0.0039970893,3.7532382e-7,0.00054282567,0.00002722492,0.00019695413,0.0000016159983,0.000010015156,0.00012960559],"about_ca_topic_score_codex":0.0011032104,"about_ca_topic_score_gemma":0.0008891463,"teacher_disagreement_score":0.008907263,"about_ca_system_score_codex":0.000104063816,"about_ca_system_score_gemma":0.000073542666,"threshold_uncertainty_score":0.44540372},"labels":[],"label_agreement":null},{"id":"W2979981332","doi":"10.1182/blood.v104.11.2208.2208","title":"The VEINES-QOL/Sym Questionnaire Is a Valid and Reliable Measure of Quality of Life in Patients with Deep Venous Thrombosis.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; McGill University Health Centre; Hôpital Maisonneuve-Rosemont; Hôpital Notre-Dame; Jewish General Hospital","funders":"","keywords":"Medicine; Quality of life (healthcare); Deep vein; Venous thrombosis; Thrombosis; Construct validity; Discriminant validity; Cohort; Prospective cohort study; Physical therapy; Surgery; Internal consistency; Internal medicine; Patient satisfaction","score_opus":0.015017604256472718,"score_gpt":0.256816912675149,"score_spread":0.24179930841867628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979981332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963771,0.001851248,0.000021926951,0.00076207606,0.00003894157,0.0005403447,0.000005499096,0.0000148368745,0.00038802036],"genre_scores_gemma":[0.9989861,0.00040762412,0.00023344488,0.000299506,0.000020863352,0.000025675596,0.0000043436426,0.000015777103,0.000006663292],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988265,0.000042432643,0.00038345568,0.0001888019,0.0003801469,0.00017863383],"domain_scores_gemma":[0.99918824,0.000030380725,0.00019281858,0.00033644892,0.00018062336,0.00007146161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000382374,0.00012087471,0.0005079617,0.00005335601,0.000063142135,0.000008226562,0.00008061077,0.000056090656,0.0000058592736],"category_scores_gemma":[0.00014729431,0.000078738005,0.000046794863,0.00019258117,0.0001073488,0.000047599395,0.0000417017,0.0000888704,0.0000013611739],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019114009,0.0087101,0.9849311,0.00063678867,0.00040686267,0.0000026732073,0.002146934,0.000064802894,0.0001901856,0.001657419,0.00012714576,0.0009348406],"study_design_scores_gemma":[0.0066007567,0.0012193605,0.98980784,0.00057415414,0.00025534953,5.909018e-7,0.00016206712,0.0000015648666,0.0008505199,0.00037388277,0.00006591745,0.00008799091],"about_ca_topic_score_codex":0.001291352,"about_ca_topic_score_gemma":0.00036711045,"teacher_disagreement_score":0.0074907397,"about_ca_system_score_codex":0.00002737544,"about_ca_system_score_gemma":0.00009806757,"threshold_uncertainty_score":0.32108426},"labels":[],"label_agreement":null},{"id":"W2979983686","doi":"10.1182/blood.v114.22.3265.3265","title":"Multi-Tissue, Long-Term Engraftment and Expansion of BCR-ABL-transduced Human Lin-CD34+ Cord Blood Cells in a Large Animal Model.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Haematopoiesis; CD34; Stem cell; Transplantation; Biology; Cord blood; Bone marrow; Cancer research; Immunology; Andrology; Medicine; Internal medicine; Cell biology","score_opus":0.038454808886290416,"score_gpt":0.3408520330716057,"score_spread":0.3023972241853153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979983686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964012,0.0014463266,0.00012702566,0.000119796874,0.00002266178,0.0012626448,0.000024333272,0.00004407467,0.00055196136],"genre_scores_gemma":[0.99599326,0.00039013746,0.002705302,0.00007298435,0.00006173977,0.000028557986,0.00003150492,0.00003430467,0.0006821912],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99754345,0.00009800207,0.0005747568,0.0005429783,0.0006175664,0.0006232292],"domain_scores_gemma":[0.99895793,0.00005306114,0.00010127106,0.00046193696,0.00010618746,0.00031963782],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048516938,0.00027786058,0.0006116514,0.000270798,0.00007830025,0.000021806818,0.00016657708,0.00020226157,0.00014742037],"category_scores_gemma":[0.000040259598,0.00025064108,0.00009207754,0.00027274035,0.00006610609,0.000082214494,0.00007413173,0.00038167648,0.000013210768],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031039008,0.004784335,0.023224574,0.00033959537,0.000058089317,0.00051547633,0.00067046785,0.0000053190897,0.968569,0.000042467716,0.000010634548,0.0014696439],"study_design_scores_gemma":[0.014556481,0.0034021295,0.17185567,0.0003663312,0.00021999833,0.000049038612,0.000054376123,0.0008855016,0.80835795,0.000013366004,0.000018854302,0.00022031328],"about_ca_topic_score_codex":0.00006535929,"about_ca_topic_score_gemma":0.000093260685,"teacher_disagreement_score":0.16021107,"about_ca_system_score_codex":0.000027839495,"about_ca_system_score_gemma":0.00009246131,"threshold_uncertainty_score":0.9999946},"labels":[],"label_agreement":null},{"id":"W2979994330","doi":"10.1182/blood.v128.22.1093.1093","title":"A Novel Prognostic Model Based on Tumor Microenvironment Biology in Relapse Biopsies Predicts Post-Autologous Stem Cell Transplantation Outcomes in Classical Hodgkin Lymphoma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Autologous stem-cell transplantation; Oncology; Internal medicine; Transplantation; ABVD; Concordance; Chemotherapy regimen; Chemotherapy; Vincristine","score_opus":0.011777306645267549,"score_gpt":0.22417088622470108,"score_spread":0.21239357957943353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979994330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955792,0.00011812185,0.00029631495,0.0026311222,0.00005994323,0.0008524225,0.00023860595,0.000047916044,0.0001763458],"genre_scores_gemma":[0.99745286,0.00008150877,0.0010366541,0.0009006145,0.000015121479,0.00034576957,0.000056236302,0.000026463274,0.000084797386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849457,0.00007377495,0.00040305426,0.00046934816,0.00018353217,0.00037574803],"domain_scores_gemma":[0.99914247,0.0003743091,0.00009090809,0.00026275753,0.000015654354,0.00011393107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011039742,0.00026379336,0.00045301623,0.00024201062,0.000025730127,0.0000073388665,0.00008111645,0.00014478771,0.000007738506],"category_scores_gemma":[0.000031031548,0.00016272276,0.00009845304,0.00009692494,0.00008983469,0.000042053845,0.000017771486,0.000059497797,0.000037610178],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074794475,0.015491865,0.9176808,0.00010421584,0.000055942903,0.00085849484,0.00019615091,0.00017860465,0.059477016,0.00009705382,0.000012782178,0.0050991443],"study_design_scores_gemma":[0.03662371,0.0017626372,0.92074406,0.00040572503,0.00021958626,0.000058992842,0.000033032826,0.0021568155,0.037761044,0.000025436604,0.00001801134,0.00019097084],"about_ca_topic_score_codex":0.000037705016,"about_ca_topic_score_gemma":0.00005482748,"teacher_disagreement_score":0.035875767,"about_ca_system_score_codex":0.00025809248,"about_ca_system_score_gemma":0.00015314689,"threshold_uncertainty_score":0.66356415},"labels":[],"label_agreement":null},{"id":"W2979998128","doi":"10.1182/blood.v118.21.1243.1243","title":"The VKORC1 and CYP2C9 Genotypes Significantly Affect Vitamin K Antagonist Dosing Only in Patients Aged 20 Years or Older","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Dosing; VKORC1; CYP2C9; Genotyping; Vitamin K epoxide reductase; Genotype; Medicine; Vitamin K antagonist; Internal medicine; Pharmacology; Warfarin; Biology; Genetics; Cytochrome P450","score_opus":0.0583335750379268,"score_gpt":0.3491726163983779,"score_spread":0.2908390413604511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979998128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99485403,0.0016723551,0.0000041886715,0.00004905768,0.0007281236,0.0005132051,0.000066986635,0.000037042846,0.0020750102],"genre_scores_gemma":[0.9972125,0.0013938172,0.00016655689,0.0006220361,0.00014225488,0.000030175725,0.000013069983,0.000033154938,0.00038640492],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824196,0.00046373808,0.00031298495,0.0003289006,0.00014820544,0.00050418987],"domain_scores_gemma":[0.99917525,0.0002863714,0.00011320159,0.00019260419,0.000039713104,0.00019286796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066644256,0.00022286901,0.00023779548,0.000088914734,0.00031448138,0.000042724052,0.000278453,0.00018545438,0.0002742435],"category_scores_gemma":[0.000057019093,0.0001648086,0.00005693917,0.00019442313,0.00022624072,0.00007043157,0.0001177204,0.00049985235,0.00004379438],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021099984,0.004151751,0.75164616,0.00007600133,0.0007179418,0.00034939632,0.009084206,0.000009508913,0.10977071,0.0003850036,0.0024300027,0.119269304],"study_design_scores_gemma":[0.009655974,0.00021694585,0.87389034,0.000016216918,0.00035974768,0.00001594104,0.00015241453,0.0000634251,0.09408017,0.00016419249,0.020992814,0.00039178823],"about_ca_topic_score_codex":0.00003918852,"about_ca_topic_score_gemma":0.00012504596,"teacher_disagreement_score":0.122244194,"about_ca_system_score_codex":0.000014249593,"about_ca_system_score_gemma":0.000091015776,"threshold_uncertainty_score":0.67206997},"labels":[],"label_agreement":null},{"id":"W2980000661","doi":"10.1182/blood.v114.22.3361.3361","title":"Bone Marrow Transplantation From HLA-Identical Sibling for Thalassemia.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Thalassemia; Busulfan; Transplantation; Population; Internal medicine; Beta thalassemia; Bone marrow; Pediatrics; Surgery; Hematopoietic stem cell transplantation","score_opus":0.01817467558793938,"score_gpt":0.2775974562907937,"score_spread":0.2594227807028543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980000661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9677176,0.00023349008,0.027342381,0.0010104445,0.00011628177,0.00058088754,0.00006087675,0.00012011236,0.0028179549],"genre_scores_gemma":[0.9828417,0.00010652529,0.01576808,0.0003704058,0.00025319715,0.00002455416,0.0004227683,0.000020009384,0.00019280665],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988809,0.000021171145,0.0003521844,0.00025879708,0.00025827932,0.00022862056],"domain_scores_gemma":[0.9993818,0.000209242,0.000056516652,0.0001713621,0.000059494974,0.000121590216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016554997,0.0001328843,0.0002512953,0.00009525401,0.00005201914,0.000024443003,0.000050427072,0.00012871546,0.000085434694],"category_scores_gemma":[0.000045550045,0.00012687099,0.00011094836,0.000121217316,0.000016376245,0.00008046046,0.0000014891867,0.00010280525,0.000044142995],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065094285,0.0012130627,0.022730306,0.00065438147,0.00016976759,0.000482005,0.001577789,0.0000067934616,0.96759,0.0014966974,0.0004988598,0.002929394],"study_design_scores_gemma":[0.019165255,0.00069993985,0.12947977,0.0008587589,0.002798968,0.0006984253,0.0001868553,0.0006552403,0.8413388,0.0032181116,0.0005106665,0.00038917564],"about_ca_topic_score_codex":0.000013846801,"about_ca_topic_score_gemma":0.000008444113,"teacher_disagreement_score":0.12625116,"about_ca_system_score_codex":0.000014327567,"about_ca_system_score_gemma":0.00004357084,"threshold_uncertainty_score":0.51736486},"labels":[],"label_agreement":null},{"id":"W2980000801","doi":"10.1182/blood.v116.21.12.12","title":"Notch-Mediated Suppression of PKCθ Reduces Reactive Oxygen Species and Promotes Leukemic Stem Cell Activity In T-Cell Acute Lymphoblastic Leukemia (T-ALL)","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Stem cell; Cancer research; Progenitor cell; Biology; Leukemia; Cancer stem cell; Haematopoiesis; Immunology; Radioresistance; Cell biology; Cell culture; Genetics","score_opus":0.012489038414686857,"score_gpt":0.24880922944171488,"score_spread":0.23632019102702803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980000801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949463,0.00013724649,0.000015012218,0.00019490349,0.00017298425,0.0009652054,0.00010350948,0.00008627786,0.0033785321],"genre_scores_gemma":[0.99722636,0.00021582538,0.00061915675,0.000040502346,0.0001605231,0.000057565994,0.00006289653,0.00007842821,0.0015387217],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99701625,0.00014338226,0.0005456829,0.00076276663,0.00080077763,0.0007311631],"domain_scores_gemma":[0.99748546,0.00094290386,0.00032290493,0.0006384855,0.00021994933,0.0003902876],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044175918,0.00043268365,0.00080800033,0.00042839383,0.00008485331,0.00004023036,0.00033366797,0.000488396,0.00006268369],"category_scores_gemma":[0.00026696635,0.00035835506,0.00011395863,0.00050366856,0.00045510626,0.00028188742,0.00033550558,0.0009351148,0.000035216737],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009186492,0.001121377,0.003220882,0.00037988697,0.00014436801,0.00027928458,0.0012712355,0.0000016655886,0.9915239,0.00000589079,0.00032045215,0.00081239844],"study_design_scores_gemma":[0.012867279,0.00066341285,0.04033887,0.00024250956,0.0003614639,0.00020366305,0.0003616797,0.0010852221,0.94337136,0.000027622229,0.0001658468,0.0003110961],"about_ca_topic_score_codex":0.00032969908,"about_ca_topic_score_gemma":0.000049328424,"teacher_disagreement_score":0.048152577,"about_ca_system_score_codex":0.000635102,"about_ca_system_score_gemma":0.0020091853,"threshold_uncertainty_score":0.9998869},"labels":[],"label_agreement":null},{"id":"W2980002850","doi":"10.1182/blood.v114.22.3167.3167","title":"Covalent Antithrombin-Heparin Complex Catalysis of Activated Protein C Inhibition by Protein C Inhibitor.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Protein C; Antithrombin; Chemistry; Thrombin; Conventional PCI; Heparin; Thrombomodulin; Anticoagulant; Covalent bond; Low molecular weight heparin; Molecular biology; Pharmacology; Biochemistry; Internal medicine; Medicine; Platelet; Biology; Organic chemistry","score_opus":0.022109227767795156,"score_gpt":0.262195999524214,"score_spread":0.24008677175641885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980002850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99589723,0.00008616176,0.00021792538,0.00093743193,0.000020415904,0.0014282997,0.000024610441,0.00014850583,0.0012394045],"genre_scores_gemma":[0.997289,0.000005711911,0.0016991514,0.00020593034,0.00005988665,0.000048527043,0.00032729073,0.000024687712,0.00033982203],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984227,0.00006850003,0.00048281197,0.00035023407,0.0004139822,0.0002618024],"domain_scores_gemma":[0.99903035,0.000008236088,0.0002462114,0.00039204155,0.00017475108,0.00014839534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017574006,0.00022043636,0.0005114676,0.00016051687,0.000078958125,0.00001900331,0.000072901676,0.00015671932,0.00022573672],"category_scores_gemma":[0.000047986352,0.00020826915,0.00014070238,0.00047981483,0.00006175073,0.00012255662,0.00003062459,0.00017685066,0.000035250025],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007925488,0.0035322898,0.00021166656,0.00009199012,0.00012930129,0.000009643168,0.00008914588,6.785897e-7,0.9931935,0.0013822152,0.00044620395,0.00083410484],"study_design_scores_gemma":[0.0051967017,0.0011644746,0.006842587,0.0003381366,0.00026217446,0.000017491975,0.000037643626,0.000030181973,0.98492587,0.0006661809,0.00031931457,0.00019923096],"about_ca_topic_score_codex":0.00006659807,"about_ca_topic_score_gemma":0.0000058385144,"teacher_disagreement_score":0.008267624,"about_ca_system_score_codex":0.000034413275,"about_ca_system_score_gemma":0.00006959848,"threshold_uncertainty_score":0.8492969},"labels":[],"label_agreement":null},{"id":"W2980002967","doi":"10.1182/blood.v128.22.2113.2113","title":"Ex Vivo Modeling of Multiple Myeloma Provides Basis for Studying Treatment Combinations and Immunotherapy","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Immunotherapy; Medicine; Ipilimumab; Pembrolizumab; Ex vivo; Cancer research; Tumor microenvironment; Nivolumab; Multiple myeloma; Immunology; In vivo; Immune system; Biology","score_opus":0.05339702392790718,"score_gpt":0.3135478860589719,"score_spread":0.2601508621310647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980002967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99554306,0.00069831405,0.0017590572,0.00036734733,0.000015649422,0.0013302398,0.000085529544,0.000031486587,0.0001693135],"genre_scores_gemma":[0.9943718,0.00038589517,0.004489198,0.000011465201,0.000026162303,0.0002926502,0.000008116863,0.000021980033,0.00039275145],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99921817,0.000024428662,0.00019315767,0.00020159001,0.00015148077,0.00021120334],"domain_scores_gemma":[0.9992166,0.00031211754,0.000046971738,0.00020704398,0.00012312092,0.000094133335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000088354805,0.00012230325,0.00024626293,0.000101647325,0.000092575305,0.000010040443,0.000039776107,0.000038121245,0.000021673468],"category_scores_gemma":[0.00014152868,0.0000720574,0.00008369922,0.00005761326,0.000042563046,0.00006707495,0.000017314382,0.000019949386,0.000002323502],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013503148,0.009001482,0.48093152,0.00021175589,0.0022468,0.000026091951,0.0013297844,0.000007654747,0.2951253,0.0002691737,0.000019605704,0.2094805],"study_design_scores_gemma":[0.23529659,0.0134373475,0.12731099,0.0011741499,0.0011596202,0.00008552132,0.0012538141,0.03408221,0.583409,0.0013112263,0.0008779924,0.0006015425],"about_ca_topic_score_codex":0.00011865483,"about_ca_topic_score_gemma":0.000032142212,"teacher_disagreement_score":0.35362053,"about_ca_system_score_codex":0.000053339456,"about_ca_system_score_gemma":0.00006926863,"threshold_uncertainty_score":0.29384154},"labels":[],"label_agreement":null},{"id":"W2980003339","doi":"10.1182/blood.v126.23.651.651","title":"Anatomical Predictors of Venous Thromboembolism Recurrence after Isolated Superficial Vein Thrombosis","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Pulmonary embolism; Thrombosis; Varicose veins; Deep vein; Surgery; Venous thrombosis; Cumulative incidence; Prospective cohort study; Proportional hazards model; Trunk; Radiology; Internal medicine","score_opus":0.021843287178219293,"score_gpt":0.267693407825849,"score_spread":0.2458501206476297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980003339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99327105,0.0013553608,0.00004114268,0.00030166056,0.0006800192,0.00062463165,0.000039924114,0.00012317458,0.0035630339],"genre_scores_gemma":[0.99844074,0.00027554703,0.00037122195,0.00030854228,0.00041046095,0.00006684725,0.000037447426,0.000046292153,0.000042911946],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979501,0.000073134164,0.0005186224,0.0004332572,0.00056812254,0.00045676754],"domain_scores_gemma":[0.9986973,0.00003930608,0.00012378527,0.0005378581,0.0002407695,0.00036097807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030185867,0.00026931375,0.0009784369,0.00018373613,0.000045943834,0.000022885359,0.00020677454,0.00019693412,0.00020564979],"category_scores_gemma":[0.00013135333,0.00024009385,0.000176556,0.0003880318,0.00017211445,0.00012743202,0.00015241803,0.00024411576,0.00009325426],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020890073,0.10357323,0.73680145,0.00197961,0.008910659,0.0013813911,0.029966617,0.00006392406,0.020933788,0.006168281,0.0736204,0.014511624],"study_design_scores_gemma":[0.008291466,0.005044321,0.95880365,0.00057622587,0.0032722997,0.00008771429,0.0007594661,0.00018903456,0.015470005,0.00061810965,0.0062334873,0.00065422663],"about_ca_topic_score_codex":0.00018989095,"about_ca_topic_score_gemma":0.000025551102,"teacher_disagreement_score":0.22200218,"about_ca_system_score_codex":0.000059940558,"about_ca_system_score_gemma":0.00023402844,"threshold_uncertainty_score":0.9790743},"labels":[],"label_agreement":null},{"id":"W2980004091","doi":"10.1182/blood.v122.21.155.155","title":"A Randomized Trial Of Rituximab Vs Observation Following Autologous Stem Cell Transplantation (ASCT) For Relapsed Or Refractory CD20-Positive B Cell Lymphoma: Final Results Of NCIC CTG LY.12","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; Saskatoon Medical Imaging; Université de Montréal; Dalhousie University; CancerCare Manitoba; Health Sciences Centre; University of Manitoba; Juravinski Cancer Centre; Sunnybrook Health Science Centre; London Health Sciences Centre; Juravinski Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Autologous stem-cell transplantation; Internal medicine; Rituximab; Hazard ratio; Clinical endpoint; Salvage therapy; Surgery; Transplantation; Oncology; Regimen; Randomized controlled trial; Lymphoma; Chemotherapy; Confidence interval","score_opus":0.027161036740339522,"score_gpt":0.25792133454448146,"score_spread":0.23076029780414195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980004091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99308664,0.0003935635,0.00018055612,0.00017420798,0.00026585485,0.004880995,0.00017593271,0.00004621794,0.00079600746],"genre_scores_gemma":[0.9945003,0.00021264506,0.0030685074,0.0000633262,0.00009108219,0.0008705678,0.0004124001,0.00003190071,0.00074928586],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99763566,0.0002364788,0.0010917813,0.00038031262,0.00038281968,0.0002729279],"domain_scores_gemma":[0.99695724,0.0017277515,0.0006824353,0.00030710318,0.00022885234,0.00009662748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005578193,0.00026542268,0.0012388078,0.00013853413,0.00007438477,0.000014993235,0.00009098219,0.00022232116,0.0000131973675],"category_scores_gemma":[0.00015765769,0.00019241637,0.0005824994,0.00015054867,0.00006095916,0.00017251309,0.000011345411,0.000056458444,0.000010276541],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96791303,0.014381494,0.0004296156,0.00066684216,0.0006056195,0.00009549491,0.002057826,0.0000045428906,0.008905687,0.000023123686,0.0002657588,0.004650934],"study_design_scores_gemma":[0.8113674,0.0040751905,0.00775732,0.0003143779,0.00320892,0.000016729242,0.0001331471,0.00017487432,0.17273222,0.000030439001,0.000041583517,0.00014778828],"about_ca_topic_score_codex":0.00050736766,"about_ca_topic_score_gemma":0.000021992395,"teacher_disagreement_score":0.16382654,"about_ca_system_score_codex":0.0001142594,"about_ca_system_score_gemma":0.0003614189,"threshold_uncertainty_score":0.78465116},"labels":[],"label_agreement":null},{"id":"W2980006228","doi":"10.1182/blood.v110.11.2773.2773","title":"Leukocyte Apoptosis and Mitochondrial Dysfunction in β-Thalassemia Patients Treated with Deferasirox or Deferoxamine.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Deferasirox; Deferoxamine; Apoptosis; Thalassemia; Medicine; Internal medicine; Mitochondrion; Beta thalassemia; Gastroenterology; Immunology; Pharmacology; Biology; Biochemistry","score_opus":0.007601064522144643,"score_gpt":0.21676889437705582,"score_spread":0.20916782985491117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980006228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970698,0.0001521227,0.00004137122,0.00004356421,0.00009253604,0.0004860717,0.000002620897,0.00006108116,0.0020508585],"genre_scores_gemma":[0.9987766,0.00012376274,0.0003962663,0.00010470007,0.000066322384,0.000013558811,0.00004933484,0.000028845818,0.00044060504],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989055,0.000021341944,0.0002608185,0.00028813933,0.00020662736,0.00031762224],"domain_scores_gemma":[0.99950814,0.000052748965,0.000059271773,0.00015871912,0.00006710703,0.00015399745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007860041,0.00018246887,0.00025714698,0.00017992454,0.000057555633,0.000014821233,0.000032584227,0.00021176624,0.000030224142],"category_scores_gemma":[0.00007411852,0.00011877925,0.000033811826,0.00036951844,0.00005273486,0.000064987384,0.000017270047,0.0002156625,0.000010113619],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029052189,0.001288548,0.9821996,0.00006599666,0.000121825455,0.00008738788,0.00021995539,0.0000019999395,0.008381009,0.0000072073167,0.00013355364,0.0045876787],"study_design_scores_gemma":[0.047267873,0.0034098017,0.8914058,0.00034750922,0.00065969187,0.00013593663,0.0005106803,0.000021980099,0.055027466,0.000005907021,0.0008563389,0.0003509781],"about_ca_topic_score_codex":0.00013643797,"about_ca_topic_score_gemma":0.00016127009,"teacher_disagreement_score":0.09079378,"about_ca_system_score_codex":0.00004925685,"about_ca_system_score_gemma":0.000048336504,"threshold_uncertainty_score":0.48436773},"labels":[],"label_agreement":null},{"id":"W2980007401","doi":"10.1182/blood.v120.21.1470.1470","title":"TYK2-STAT1 Pathway Positively Regulates BCL2 Gene Expression in T-Cell Acute Lymphoblastic Leukemia","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Tyrosine kinase 2; Gene knockdown; Gene silencing; Biology; STAT1; RNA interference; Small hairpin RNA; Effector; Signal transduction; Cancer research; Molecular biology; Cell biology; Cell culture; Gene; Genetics; Receptor; RNA","score_opus":0.011544749198120038,"score_gpt":0.2512168430760463,"score_spread":0.23967209387792626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980007401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922156,0.0011600092,0.00048047453,0.00010450548,0.00016754323,0.0005971901,0.000052025658,0.00012830299,0.0050943936],"genre_scores_gemma":[0.9895415,0.00012206944,0.006338163,0.00026909582,0.00046215483,0.00008107366,0.000104368344,0.00009923084,0.0029823466],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99687606,0.00014207886,0.00050437375,0.0005181337,0.0007653864,0.001193953],"domain_scores_gemma":[0.9981732,0.00033409736,0.0001318665,0.000610161,0.00013616333,0.00061455084],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042203904,0.00037784263,0.00055557,0.0003384302,0.00010569662,0.00003444055,0.00026318047,0.00031053802,0.00019407374],"category_scores_gemma":[0.00020003649,0.00031457422,0.00013893416,0.0004963934,0.0001462074,0.00029474287,0.0002672616,0.0003690755,0.000496782],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047987257,0.0013057468,0.023876598,0.0001296292,0.00011866865,0.00073634076,0.0011690672,0.0000121764015,0.9705481,0.000034786055,0.0010012123,0.00058781204],"study_design_scores_gemma":[0.014294508,0.00038495113,0.048596535,0.00030932768,0.00024712732,0.00076643785,0.00015063716,0.000334977,0.93390733,0.000038477698,0.0006194722,0.00035021213],"about_ca_topic_score_codex":0.00007343715,"about_ca_topic_score_gemma":0.0000035564549,"teacher_disagreement_score":0.036640756,"about_ca_system_score_codex":0.0015790465,"about_ca_system_score_gemma":0.001658204,"threshold_uncertainty_score":0.9999306},"labels":[],"label_agreement":null},{"id":"W2980007647","doi":"10.1182/blood.v128.22.2378.2378","title":"Wait Times and Bed Capacity for Hematopoietic Cell Transplantation in Ontario: A System Dynamics Model","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Healthcare Operations and Scheduling Optimization","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hamilton Health Sciences; Juravinski Hospital; Cancer Care Ontario","funders":"","keywords":"Hematopoietic cell; Transplantation; Benchmark (surveying); Medicine; Operations management; Hematopoietic stem cell transplantation; Waiting list; Emergency medicine; Operations research; Surgery; Engineering; Haematopoiesis; Geography","score_opus":0.04113474087259816,"score_gpt":0.3086235273791422,"score_spread":0.26748878650654406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980007647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88142335,0.000014915679,0.11617847,0.00047961387,0.000068398745,0.0008352577,0.00008367456,0.000040601095,0.00087570294],"genre_scores_gemma":[0.97396916,0.00002434966,0.024582598,0.00006601638,0.000017960414,0.00024678416,0.000044574554,0.000014991768,0.001033545],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9990739,0.00010416339,0.0003445772,0.00018141637,0.00007325736,0.00022265926],"domain_scores_gemma":[0.99947554,0.00017266329,0.00007155686,0.000113818875,0.00009679979,0.000069596645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035427164,0.000085867876,0.00015819218,0.00006179988,0.00026404913,0.000007347947,0.00004020973,0.00015806401,0.000014348184],"category_scores_gemma":[0.000020537283,0.0000638075,0.000020275702,0.000049413517,0.000013376553,0.0000998272,0.000006921883,0.00012789901,0.000007911873],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063394406,0.001646234,0.509244,0.016924204,0.00010469871,0.000024021596,0.11649527,0.012019549,0.007880678,0.3324863,0.0003496631,0.0021914223],"study_design_scores_gemma":[0.022495473,0.00036938494,0.019915972,0.0038088097,0.0002941,0.000027648332,0.0045879344,0.9428196,0.0016645346,0.0030132579,0.00014693804,0.00085633615],"about_ca_topic_score_codex":0.006623234,"about_ca_topic_score_gemma":0.14769422,"teacher_disagreement_score":0.9308001,"about_ca_system_score_codex":0.00020870555,"about_ca_system_score_gemma":0.00034664426,"threshold_uncertainty_score":0.9999918},"labels":[],"label_agreement":null},{"id":"W2980007653","doi":"10.1182/blood.v114.22.915.915","title":"The Orphan Nuclear Receptor NR2F6 Is a Novel Negative Regulator of T-Cell Development.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Biology; Lymphopoiesis; Progenitor cell; Haematopoiesis; Stem cell; Myeloid; Cell biology; Bone marrow; Cell fate determination; Cancer research; Cellular differentiation; Immunology; Genetics; Transcription factor; Gene","score_opus":0.007884356291241247,"score_gpt":0.1996915394066065,"score_spread":0.19180718311536527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980007653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859509,0.0005968552,0.000043351898,0.0005672563,0.0013072898,0.00018462824,0.0000035975065,0.000057690264,0.011288455],"genre_scores_gemma":[0.966409,0.000052177173,0.00052701577,0.00052277645,0.000026908083,0.0000040151353,0.000017831784,0.000011384479,0.032428835],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99935776,0.000043465534,0.0002472438,0.0001469431,0.00002995287,0.00017461443],"domain_scores_gemma":[0.9995016,0.000057839334,0.00015022537,0.00019190578,0.000087141816,0.000011318514],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00010958496,0.00010492626,0.00012640901,0.000039781433,0.0002527784,0.0000120407485,0.00014413019,0.00011903861,0.0013785056],"category_scores_gemma":[0.000042579937,0.0000762666,0.000064443346,0.00009120541,0.00007243691,0.00006671928,0.000024664838,0.00016397367,0.0009582484],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014821024,0.00041445266,0.000034420773,0.0000028210425,0.000107990585,9.6847536e-8,0.0010842847,8.710162e-8,0.96529305,0.000330363,0.030678788,0.00190543],"study_design_scores_gemma":[0.0011786086,0.00012896661,0.0012094908,0.000011876107,0.000020484482,0.000007564906,0.00031550103,4.4547312e-7,0.6530428,0.000012871744,0.34400648,0.00006493914],"about_ca_topic_score_codex":0.000010546751,"about_ca_topic_score_gemma":0.0000018101288,"teacher_disagreement_score":0.3133277,"about_ca_system_score_codex":0.000016597796,"about_ca_system_score_gemma":0.0000431669,"threshold_uncertainty_score":0.99981964},"labels":[],"label_agreement":null},{"id":"W2980009311","doi":"10.1182/blood.v128.22.3072.3072","title":"Timely Molecular Monitoring and Achievement of Major Molecular Response in Chronic Myeloid Leukemia","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Notre-Dame; McGill University Health Centre; Hôpital du Sacré-Cœur de Montréal; Hôpital Maisonneuve-Rosemont; Hôpital de l'Enfant-Jésus; Jewish General Hospital","funders":"","keywords":"Medicine; Internal medicine; Odds ratio; Confidence interval; Nilotinib; Myeloid leukemia; Cohort; Generalized estimating equation; Oncology; Pediatrics; Imatinib","score_opus":0.009334774563588175,"score_gpt":0.2540622047700731,"score_spread":0.2447274302064849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980009311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951815,0.0034973319,0.00008483091,0.0004227798,0.00004120909,0.0004723445,0.0000091625825,0.000037466692,0.00025338662],"genre_scores_gemma":[0.9980151,0.00020769557,0.0012416436,0.000029958532,0.00005005513,0.000053968226,0.0000031781228,0.000042682554,0.0003557025],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99843866,0.00010177109,0.00036726266,0.00038638295,0.00033603175,0.00036989542],"domain_scores_gemma":[0.9990922,0.00010711338,0.000102020145,0.000502941,0.00004480119,0.00015092226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031307872,0.00022234183,0.00038527645,0.00019444933,0.0000218534,0.000006561498,0.00010516684,0.00011859256,0.000043743337],"category_scores_gemma":[0.00014149847,0.00016848702,0.0000798082,0.0001816178,0.000086734406,0.0000602793,0.000108334905,0.00012561906,0.000028046314],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007554809,0.00021522655,0.022006191,0.00009936262,0.00020628341,0.0007334504,0.00009061076,0.0000060391158,0.9724345,0.00006203266,0.0000056395825,0.0033851708],"study_design_scores_gemma":[0.01825001,0.00095961895,0.10557645,0.00073057227,0.00023045744,0.00008028581,0.000021032205,0.000010186683,0.87372845,0.000060054157,0.00019388781,0.00015899695],"about_ca_topic_score_codex":0.000086901535,"about_ca_topic_score_gemma":0.0000033692108,"teacher_disagreement_score":0.09870606,"about_ca_system_score_codex":0.0016668625,"about_ca_system_score_gemma":0.0008280675,"threshold_uncertainty_score":0.68707013},"labels":[],"label_agreement":null},{"id":"W2980009485","doi":"10.1182/blood.v104.11.3190.3190","title":"Consequences of DMT1 Mutation on Proliferation and Hemoglobinization of Erythroid Progenitors In Vitro.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Hemin; DMT1; Heme; Molecular biology; Transferrin receptor; Transferrin; Erythropoietin; Chemistry; Biology; Biochemistry; Endocrinology; Transporter; Enzyme","score_opus":0.012762860244231108,"score_gpt":0.2500557050734049,"score_spread":0.2372928448291738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980009485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991072,0.00006838273,0.00006319344,0.0002053254,0.000045090743,0.0002895258,0.000004024657,0.000011710356,0.00020553738],"genre_scores_gemma":[0.9988674,0.000031688185,0.00091825944,0.00008333219,0.00003894453,0.00001111656,0.000035685876,0.000004582155,0.0000090163],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999533,0.000025229083,0.00019513658,0.00010389,0.00008751056,0.000055262848],"domain_scores_gemma":[0.99973714,0.000019708086,0.00009141716,0.000052769683,0.0000772915,0.000021698628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005368936,0.00005315148,0.00014709205,0.0000964237,0.000012899173,0.0000015699794,0.000011664487,0.00005817703,0.000005061336],"category_scores_gemma":[0.000081136954,0.00004625305,0.00001757504,0.00014207982,0.00008534269,0.00003717592,0.0000037969273,0.00004557188,0.0000017350277],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003373817,0.0004375521,0.011055105,0.00011401216,0.000014906508,0.0000067332244,0.00043114193,0.000082770835,0.9864995,0.0004748695,0.0000017369841,0.0005442787],"study_design_scores_gemma":[0.003226803,0.0008746446,0.024918463,0.00007650929,0.000033769084,0.00005863363,0.00013485312,0.000015214627,0.97007567,0.0005437856,0.0000048455663,0.0000367885],"about_ca_topic_score_codex":0.00002023807,"about_ca_topic_score_gemma":0.000005155321,"teacher_disagreement_score":0.01642382,"about_ca_system_score_codex":0.000012298405,"about_ca_system_score_gemma":0.0000898823,"threshold_uncertainty_score":0.18861446},"labels":[],"label_agreement":null},{"id":"W2980010147","doi":"10.1182/blood.v122.21.2114.2114","title":"Allogeneic Hematopoietic Stem Cell Transplant Reverses The Phenotype Of DOCK8 Deficiency","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Hematopoietic stem cell transplantation; Fludarabine; Immunology; Graft-versus-host disease; Mucositis; Internal medicine; Transplantation; Alemtuzumab; Immunodeficiency; Gastroenterology; Primary immunodeficiency; Toxicity; Disease; Chemotherapy; Immune system; Cyclophosphamide","score_opus":0.0069642579171080255,"score_gpt":0.1832557138028735,"score_spread":0.17629145588576547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980010147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9383048,0.05584223,0.00003808539,0.00011360872,0.00027994553,0.00029119127,0.000013137771,0.00004175474,0.0050752405],"genre_scores_gemma":[0.9981174,0.00027899034,0.000007848228,0.000098763005,0.0000018758196,0.000032187098,0.000016268703,0.0000130150875,0.0014336522],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989233,0.00012638763,0.0003389167,0.00020793642,0.00004740548,0.00035607684],"domain_scores_gemma":[0.9992923,0.00010559938,0.00013084753,0.00041344707,0.000052651,0.000005169826],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015680368,0.00016702493,0.00023400554,0.000047326874,0.00022493249,0.000011257361,0.00045629207,0.00013514429,0.0006939659],"category_scores_gemma":[0.000005533063,0.000109067485,0.00013228545,0.00016373282,0.0002800593,0.000065423876,0.000044318676,0.00019005436,0.0008440916],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016225944,0.0008154521,0.0006908625,0.000075979304,0.00006969284,0.000001550304,0.0038889383,0.000014876981,0.9906178,0.00082176324,0.00018873755,0.002798131],"study_design_scores_gemma":[0.0033660515,0.00037583205,0.013528941,0.00009301976,0.00040760505,0.00012171669,0.007173552,0.0000032519306,0.96779346,0.0005810831,0.0060597123,0.0004957922],"about_ca_topic_score_codex":0.00017644274,"about_ca_topic_score_gemma":0.000001965346,"teacher_disagreement_score":0.05981259,"about_ca_system_score_codex":0.000004206541,"about_ca_system_score_gemma":0.00004838448,"threshold_uncertainty_score":0.99993384},"labels":[],"label_agreement":null},{"id":"W2980012151","doi":"10.1182/blood-2018-99-114589","title":"Patients' Perspectives on the Definition of Cure in Chronic Myeloid Leukemia: A US Based Survey","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Respondent; Family medicine; Myeloid leukemia; Disease; Internal medicine","score_opus":0.023972809184352604,"score_gpt":0.2560843325740426,"score_spread":0.23211152338969002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980012151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99354917,0.00024126067,0.000005828971,0.0001418355,0.00005361699,0.00053449906,0.000058221092,0.000027269023,0.0053883176],"genre_scores_gemma":[0.9992706,0.00006385937,0.00016536028,0.00016071502,0.0001300749,0.000044909226,0.000096856704,0.000025605303,0.00004199208],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870336,0.00017073145,0.0002521789,0.00030151967,0.0003181443,0.00025407103],"domain_scores_gemma":[0.9988518,0.00030543402,0.0001198381,0.00047238695,0.00019516419,0.00005540334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030333226,0.00017234278,0.00026279772,0.0001222964,0.000056543722,0.000006851366,0.00010900057,0.00011226365,0.00032155847],"category_scores_gemma":[0.00041976833,0.00011843076,0.000079126025,0.00034222967,0.00018670125,0.000036687125,0.000027840671,0.00023076477,0.0000966891],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000977806,0.004386345,0.98472065,0.00016153834,0.00033643012,0.000039402756,0.0023877933,0.00001253803,0.0034376364,0.0014274928,0.001089727,0.0010226225],"study_design_scores_gemma":[0.014642245,0.0024893172,0.96541995,0.0003129994,0.00012694461,0.000004801407,0.00018763014,0.00012471875,0.016342413,0.000075947595,0.00014596769,0.00012707172],"about_ca_topic_score_codex":0.0009052046,"about_ca_topic_score_gemma":0.00083727145,"teacher_disagreement_score":0.019300723,"about_ca_system_score_codex":0.0017287943,"about_ca_system_score_gemma":0.001107838,"threshold_uncertainty_score":0.48294663},"labels":[],"label_agreement":null},{"id":"W2980012658","doi":"10.1182/blood.v122.21.554.554","title":"Survival Improvements Following Myeloablative Allogeneic Hematopoietic Cell Transplantation For Acute Lymphoblastic Leukemia In Adolescents and Young Adults Have Been Comparable To Younger Children: A Study From The Cibmtr","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Young adult; Hazard ratio; Transplantation; Hematopoietic stem cell transplantation; Acute lymphocytic leukemia; Pediatrics; Umbilical cord; Leukemia; Internal medicine; Lymphoblastic Leukemia; Confidence interval; Immunology","score_opus":0.010108857867292473,"score_gpt":0.26212538989587747,"score_spread":0.252016532028585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980012658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920103,0.00015593568,0.0006840853,0.00009812544,0.0001469862,0.006666849,0.00012585158,0.00004133523,0.00007054834],"genre_scores_gemma":[0.9979608,0.000028238657,0.0004980379,0.00024788082,0.00012591618,0.0007936825,0.00013675948,0.00006852753,0.00014015031],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971872,0.00014171533,0.00054964394,0.00074126595,0.00068692234,0.00069323264],"domain_scores_gemma":[0.99878734,0.00025820814,0.00011275548,0.00042552402,0.00013752638,0.0002786289],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003238404,0.0003760348,0.0006057684,0.00014925604,0.00018581285,0.0000987037,0.00029908906,0.00013071689,0.000017564922],"category_scores_gemma":[0.00007436888,0.00028533966,0.0001213178,0.00026857748,0.000056594017,0.00022185527,0.0001234875,0.00023005651,0.000045936344],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011497913,0.0011004591,0.9687855,0.00013016451,0.00092765613,0.00009645655,0.009206008,0.000030077405,0.018049138,0.0000015226395,0.00010855283,0.00041464964],"study_design_scores_gemma":[0.037988316,0.0010697148,0.9480947,0.0005904091,0.0013682297,0.000035686124,0.002732765,0.0014043638,0.006360683,0.000034970224,0.0000013859072,0.0003187253],"about_ca_topic_score_codex":0.008100036,"about_ca_topic_score_gemma":0.0009811139,"teacher_disagreement_score":0.036838524,"about_ca_system_score_codex":0.00056270335,"about_ca_system_score_gemma":0.00037397695,"threshold_uncertainty_score":0.9999599},"labels":[],"label_agreement":null},{"id":"W2980014795","doi":"10.1182/blood.v126.23.2502.2502","title":"Treatment-Related Mortality (TRM) in Children with Down Syndrome (DS) and B-Lymphoblastic Leukemia (B-ALL): An Interim Report from the Children's Oncology Group Trials AALL0932 and AALL1131","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Induction chemotherapy; Interim analysis; Internal medicine; Induction therapy; Interim; Adverse effect; Neutropenia; Oncology; Clinical trial; Overall survival; Chemotherapy","score_opus":0.04515832847485156,"score_gpt":0.3296787221108517,"score_spread":0.2845203936360001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980014795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99589044,0.00093792327,0.00003459612,0.00039553843,0.00007924818,0.0020505774,0.00011934966,0.000113980605,0.00037833958],"genre_scores_gemma":[0.99773526,0.0002522716,0.00060219166,0.00019181699,0.00019668558,0.00014434465,0.0006926606,0.000072973395,0.000111769165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99588454,0.0007468348,0.0010558198,0.0010304849,0.0006349931,0.0006473586],"domain_scores_gemma":[0.997063,0.00075285276,0.00040704844,0.0009730902,0.0001064988,0.0006975318],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016252396,0.00051161123,0.001422932,0.00018546138,0.000100300735,0.00010204195,0.0002687756,0.00041267817,0.00005685767],"category_scores_gemma":[0.001021353,0.00030128928,0.00009791242,0.00034339976,0.00059631653,0.0002330723,0.00023071382,0.0004353133,0.000017773835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013771974,0.0017395291,0.9825785,0.000013855669,0.0036074782,0.0049585514,0.0014046655,0.000008836221,0.001059476,0.00004777231,0.00015348374,0.0030506216],"study_design_scores_gemma":[0.048976664,0.005486379,0.90856403,0.00013686561,0.0020959415,0.03342573,0.00024409295,0.00024307778,0.0001958992,0.00020810134,0.00009395239,0.000329283],"about_ca_topic_score_codex":0.013784374,"about_ca_topic_score_gemma":0.0011629752,"teacher_disagreement_score":0.074014515,"about_ca_system_score_codex":0.0013682701,"about_ca_system_score_gemma":0.0019447836,"threshold_uncertainty_score":0.9999439},"labels":[],"label_agreement":null},{"id":"W2980015356","doi":"10.1182/blood.v126.23.42.42","title":"Content, Utilization and Impact of a Hematology e-Consultation Service","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Healthcare Systems and Technology","field":"Business, Management and Accounting","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; Champlain Regional College; Bruyère; University of Ottawa","funders":"","keywords":"Medicine; Specialty; Referral; Family medicine; Service (business); Hematology; Internal medicine","score_opus":0.11434947694248616,"score_gpt":0.30584237308206685,"score_spread":0.1914928961395807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980015356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99705744,0.0003302826,0.000102296035,0.00047219,0.00005798606,0.00015599572,0.0000016495154,0.000060142098,0.0017620357],"genre_scores_gemma":[0.99967283,0.000004354866,0.000052294556,0.00017103658,0.00006157379,0.0000069997513,0.000012361447,0.0000063093453,0.000012248844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99958223,0.0000070726987,0.00016527082,0.00009332065,0.000056185014,0.00009590765],"domain_scores_gemma":[0.99941415,0.000013903882,0.00014273683,0.00008470891,0.00033489824,0.000009595688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014378621,0.000056294353,0.00013698718,0.00011451657,0.000022794708,0.000015779366,0.00004445545,0.00007249263,0.0000073191463],"category_scores_gemma":[0.00019599147,0.00004659243,0.0000153809,0.00025020933,0.000018976107,0.00019080154,0.00003349215,0.00003274931,0.00002028409],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053313244,0.00027907355,0.8581299,0.0007988023,0.00010345839,0.0000119331135,0.00038869114,0.0000034100572,0.0019637116,0.122515544,0.00069217314,0.015059972],"study_design_scores_gemma":[0.028299516,0.0004951609,0.8789408,0.0005122371,0.00046728505,0.00039791426,0.00797208,0.009614756,0.0031334527,0.031549014,0.03760672,0.0010110394],"about_ca_topic_score_codex":0.006991212,"about_ca_topic_score_gemma":0.00062542094,"teacher_disagreement_score":0.09096653,"about_ca_system_score_codex":0.0000053063422,"about_ca_system_score_gemma":0.000027810802,"threshold_uncertainty_score":0.99962133},"labels":[],"label_agreement":null},{"id":"W2980015714","doi":"10.1182/blood.v118.21.3579.3579","title":"Acute Lymphoblastic Leukemia in Children with Down Syndrome: A Report From the Ponte Di Legno Study Group,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Cumulative incidence; Internal medicine; White blood cell; Incidence (geometry); Lymphoblastic Leukemia; Pediatrics; Down syndrome; Leukemia; Gastroenterology; Cohort","score_opus":0.013719805269731412,"score_gpt":0.2429525834796345,"score_spread":0.2292327782099031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980015714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952745,0.00014664061,0.00013052615,0.000082084734,0.00007181747,0.002044542,0.00004189234,0.00013358482,0.0020744246],"genre_scores_gemma":[0.9981679,0.000021369018,0.00054250495,0.00019334364,0.0001539169,0.00025653123,0.000089564724,0.00008958458,0.00048528676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966627,0.00015306269,0.00060555735,0.00084346836,0.0010135998,0.0007216177],"domain_scores_gemma":[0.99773425,0.00024438428,0.0001885826,0.0014403892,0.000109700595,0.00028267817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005029259,0.00040234916,0.00064422353,0.00017304401,0.00013290063,0.00004820382,0.0005691323,0.00015935153,0.00020476643],"category_scores_gemma":[0.00024077749,0.00023811214,0.00010694442,0.00067763455,0.00024355025,0.00016267439,0.00031112536,0.00053119624,0.00014269081],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083912513,0.0020010278,0.96677804,0.0000094329625,0.0022228614,0.025363006,0.0017758665,0.0000021991289,0.00035322027,0.000015760477,0.00041734846,0.00022213948],"study_design_scores_gemma":[0.021466337,0.0019907765,0.9506464,0.00017706158,0.0015083483,0.022889188,0.00051876117,0.00009253129,0.00035719472,0.000037722555,0.00003104739,0.00028463863],"about_ca_topic_score_codex":0.010584351,"about_ca_topic_score_gemma":0.0008251311,"teacher_disagreement_score":0.020627212,"about_ca_system_score_codex":0.00084839656,"about_ca_system_score_gemma":0.0014262814,"threshold_uncertainty_score":0.9960042},"labels":[],"label_agreement":null},{"id":"W2980015749","doi":"10.1182/blood.v122.21.2052.2052","title":"Influence Of GST Gene Polymorphisms On Busulfan Pharmacokinetics and Outcome Of Hematopoietic Stem Cell Transplantation In Thalassemia Pediatric Patients","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Busulfan; Medicine; Hematopoietic stem cell transplantation; Thalassemia; Transplantation; Internal medicine; Pharmacokinetics; Gastroenterology; Oncology; Pharmacology","score_opus":0.006212790474031365,"score_gpt":0.2184738423844073,"score_spread":0.21226105191037595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980015749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99881303,0.00046007187,0.0000024297829,0.000050030096,0.000027536771,0.000383472,0.000014522746,0.000009423543,0.00023948716],"genre_scores_gemma":[0.9990312,0.0007784176,0.00006204253,0.00005954478,0.0000098207265,0.000008391964,0.000010624807,0.000012824318,0.000027150156],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911165,0.000022063045,0.00039604737,0.00013759278,0.00019375271,0.00013888319],"domain_scores_gemma":[0.9995789,0.00003827488,0.00013390681,0.000112700705,0.000064588065,0.00007166369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000050312752,0.00010920078,0.00023415856,0.00014310825,0.000012297029,0.0000031641,0.000048237183,0.00009410697,0.000012874593],"category_scores_gemma":[0.0000064368583,0.000089310925,0.000034069846,0.00019871535,0.000034784527,0.000040941628,0.00001020584,0.000121329365,0.000006760273],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003558204,0.00079277944,0.9643874,0.0006071239,0.0000131650695,0.000009597538,0.0007314721,0.00016610984,0.03293514,0.000005497023,0.000007590216,0.000308505],"study_design_scores_gemma":[0.0054157684,0.0003493276,0.88784796,0.00008467019,0.0002496626,0.00000812865,0.000071166454,0.000030803192,0.10584559,0.000008776689,0.0000015651148,0.000086553846],"about_ca_topic_score_codex":0.00006836981,"about_ca_topic_score_gemma":8.0334627e-7,"teacher_disagreement_score":0.07653946,"about_ca_system_score_codex":0.000006865408,"about_ca_system_score_gemma":0.000018890216,"threshold_uncertainty_score":0.3641994},"labels":[],"label_agreement":null},{"id":"W2980016168","doi":"10.1182/blood.v124.21.3076.3076","title":"Primary Cutaneous Anaplastic Large Cell Lymphoma: The British Columbia Cancer Agency Experience","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; CHOP; Anaplastic large-cell lymphoma; Radiation therapy; Chemotherapy; Stage (stratigraphy); Cancer; Internal medicine; Lymphoma; CD30; Oncology; Surgery","score_opus":0.009167287820153273,"score_gpt":0.2557470896235527,"score_spread":0.24657980180339942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980016168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97886676,0.0019777438,0.000086881446,0.00015056012,0.00014458905,0.00065027707,0.00004579399,0.00009016553,0.017987236],"genre_scores_gemma":[0.98199886,0.0005115798,0.00009412676,0.0011486069,0.0002337345,0.00021627946,0.0000246203,0.000049840743,0.01572236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978885,0.00011676512,0.00026472032,0.00046171274,0.000625283,0.000642993],"domain_scores_gemma":[0.9988373,0.00019638077,0.00006865554,0.0004945134,0.00019091806,0.00021224996],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015480023,0.00015517925,0.0003198845,0.000028103468,0.0006958691,0.00039885775,0.00029054395,0.00010048021,0.0011760128],"category_scores_gemma":[0.00029115134,0.00016920392,0.000110381,0.00030351276,0.00020619482,0.000054337794,0.00013488471,0.00015956181,0.00010265128],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043707213,0.014212157,0.8306631,0.0009778135,0.00038838712,0.005841662,0.0061447173,0.000011107212,0.02825626,0.00003358003,0.04423149,0.06880266],"study_design_scores_gemma":[0.08071673,0.006199626,0.5541718,0.0012684856,0.0016036815,0.06903343,0.0035607626,0.005157938,0.014434073,0.00080053846,0.26001966,0.0030332815],"about_ca_topic_score_codex":0.00888229,"about_ca_topic_score_gemma":0.027527696,"teacher_disagreement_score":0.2764913,"about_ca_system_score_codex":0.00011291914,"about_ca_system_score_gemma":0.0004165533,"threshold_uncertainty_score":0.999737},"labels":[],"label_agreement":null},{"id":"W2980020394","doi":"10.1182/blood.v104.11.1850.1850","title":"Significant Differences in Neutralization of Heparin and Its Low Molecular Fragments by Protamine Sulfate: An In Vivo Study.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Heparin; Low molecular weight heparin; Protamine sulfate; In vivo; Protamine; Chemistry; Neutralization; Saline; Anticoagulant; Pharmacology; Pharmacokinetics; Anesthesia; Medicine; Internal medicine; Immunology; Biochemistry; Antibody; Biology","score_opus":0.011689504033427599,"score_gpt":0.25189174600569386,"score_spread":0.24020224197226625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980020394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99803317,0.00016746532,0.000016465467,0.00009923544,0.000016074095,0.0015401617,0.0000049803807,0.000011811716,0.000110647205],"genre_scores_gemma":[0.9995658,0.00016672131,0.00004266922,0.000052286152,0.000007442761,0.00012745234,0.00001001007,0.000011216369,0.00001643299],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913,0.000042062158,0.00025904764,0.00023126676,0.00018258525,0.00015505296],"domain_scores_gemma":[0.9997212,0.0000062604404,0.000059241163,0.00013092357,0.000023948036,0.000058371534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012946258,0.000108116525,0.00032679565,0.00011906729,0.000013038974,0.0000099855615,0.000058980622,0.000039108585,0.000015265272],"category_scores_gemma":[0.00001699376,0.000095072784,0.000014225666,0.00019091135,0.0000174723,0.000059351045,0.000032434677,0.00005777992,6.7559864e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056387486,0.032303084,0.70638335,0.00036859047,0.00010746478,0.00018763731,0.0023743662,0.000111790345,0.25695702,0.00081115204,0.000015188103,0.00032397598],"study_design_scores_gemma":[0.0074306014,0.0015370834,0.80785215,0.00022530807,0.00010457935,0.000001363491,0.00044727637,0.000057551042,0.18214805,0.00007461181,0.0000060208545,0.00011538096],"about_ca_topic_score_codex":0.00066120934,"about_ca_topic_score_gemma":0.00023772268,"teacher_disagreement_score":0.10146883,"about_ca_system_score_codex":0.000018295623,"about_ca_system_score_gemma":0.000020763424,"threshold_uncertainty_score":0.38769555},"labels":[],"label_agreement":null},{"id":"W2980025644","doi":"10.1182/blood.v120.21.295.295","title":"Large-Scale High Resolution Integration of Copy Number and Gene Expression in DLBCL Reveals Focal and Frequent Deletions in Chromatin Modifying Genes with Outcome Correlation","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Jewish General Hospital; BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Oncology; SNP array; Population; Lymphoma; Biology; Vincristine; CHOP; CDKN2A; Internal medicine; Cancer research; Cancer; Medicine; Cyclophosphamide; Immunology; Genetics; Single-nucleotide polymorphism; Gene; Chemotherapy","score_opus":0.019773345774014885,"score_gpt":0.2749280046682969,"score_spread":0.255154658894282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980025644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996613,0.0010925314,0.0017038364,0.00011543871,0.000026126056,0.00035728936,0.0000124519765,0.000011067531,0.000068246634],"genre_scores_gemma":[0.98567593,0.00011365894,0.013988677,0.000024236131,0.000030782376,0.00007295293,0.0000683971,0.00000888012,0.000016484708],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992585,0.00005318254,0.00027314035,0.00014047565,0.00012716392,0.00014749958],"domain_scores_gemma":[0.99966764,0.000046502497,0.000090286834,0.000104024366,0.000029775938,0.00006178833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018641641,0.00009607811,0.00021413638,0.00007824163,0.000035914603,0.000006361035,0.0000128517395,0.00007976763,0.000009816076],"category_scores_gemma":[0.00002516525,0.00007029601,0.000016003281,0.000099396224,0.00002548265,0.00013111994,0.000018045632,0.00005490921,0.0000018067934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056558623,0.0012313611,0.9759448,0.000045146873,0.0000118753815,0.0000052985188,0.00091507984,0.000013646331,0.021060988,0.00017657755,0.000010279828,0.0005283405],"study_design_scores_gemma":[0.0067462963,0.00012243143,0.9473122,0.00036645462,0.00008845482,0.000050533865,0.0002456064,0.00056212815,0.044386536,0.00004429338,0.000007336608,0.00006776442],"about_ca_topic_score_codex":0.00028089917,"about_ca_topic_score_gemma":0.0002160467,"teacher_disagreement_score":0.028632682,"about_ca_system_score_codex":0.00007090963,"about_ca_system_score_gemma":0.0000146596,"threshold_uncertainty_score":0.2866588},"labels":[],"label_agreement":null},{"id":"W2980025971","doi":"10.1182/blood.v114.22.3588.3588","title":"Notch Signaling Is Required for Mast Cell Development in the Zebrafish.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Animal Genetics and Reproduction","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Izaak Walton Killam Health Centre","funders":"","keywords":"Zebrafish; Notch signaling pathway; Biology; GATA1; Cell biology; Cell fate determination; Mast cell; Haematopoiesis; Transcription factor; Signal transduction; Notch proteins; GATA2; Stem cell; Genetics; Immunology; Gene","score_opus":0.014624823198462339,"score_gpt":0.23358639468778997,"score_spread":0.21896157148932763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980025971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970589,0.0005522141,0.00082660204,0.0004958547,0.000041258056,0.00021523921,0.0000024553515,0.0000038947924,0.00080358],"genre_scores_gemma":[0.99558055,0.00002736029,0.0030193003,0.00062222325,0.000254783,0.000017209431,0.000028499879,0.0000071172,0.00044292348],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99940765,0.00001382487,0.00013019545,0.00023286631,0.000069598966,0.00014584656],"domain_scores_gemma":[0.9997415,0.0000032596556,0.00003597974,0.00016672979,0.00003443777,0.000018082237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018143895,0.000076022705,0.000057862784,0.000015902939,0.00006342905,0.00001669847,0.00011704825,0.00006727423,0.0000034006366],"category_scores_gemma":[0.0000115311095,0.000056760928,0.00003916784,0.000049509184,0.0000113690585,0.000001103587,0.000015763124,0.000034276363,0.0000033091862],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023074661,0.00019060807,0.00019369149,0.0000070391156,0.0000075388793,7.9777766e-7,0.00024752118,0.000012795839,0.99731594,0.000017092783,0.0006138031,0.0013701002],"study_design_scores_gemma":[0.00056939054,0.00025279456,0.0021283189,0.0000045871548,0.000011903687,0.000005028416,0.00009138183,0.0000052598666,0.9535005,0.00007700516,0.043260265,0.00009355212],"about_ca_topic_score_codex":0.0000014383272,"about_ca_topic_score_gemma":0.000003242607,"teacher_disagreement_score":0.043815427,"about_ca_system_score_codex":0.0000027584074,"about_ca_system_score_gemma":0.000034584737,"threshold_uncertainty_score":0.23146436},"labels":[],"label_agreement":null},{"id":"W2980027724","doi":"10.1182/blood.v110.11.1388.1388","title":"Synthetic 15-mer Peptide (PCK3145) Derived from Prostate Secretory Protein with In Vitro and In Vivo Activity Against Non-Hodgkin’s Lymphoma and Other Hematologic Malignancies.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"In vivo; Peptide; In vitro; Lymphoma; Prostate; Amino acid; Prostate cancer; Cancer research; Cytotoxic T cell; Biology; Chemistry; Cancer; Medicine; Internal medicine; Immunology; Biochemistry","score_opus":0.011777020004754299,"score_gpt":0.24793274727593909,"score_spread":0.23615572727118478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980027724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99593663,0.0015301787,0.000017716033,0.00018405227,0.000012105328,0.0014548557,0.000037744936,0.000033330904,0.0007934048],"genre_scores_gemma":[0.998452,0.00011249608,0.00073287415,0.00014071047,0.000024626452,0.00017909231,0.0000073745337,0.000036924932,0.00031387853],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985322,0.00005870063,0.00020611307,0.00047258113,0.00023544043,0.0004950176],"domain_scores_gemma":[0.99940604,0.00008466396,0.00007411473,0.00023229675,0.00003579984,0.00016705964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002996305,0.0002391071,0.0004291464,0.00018454215,0.00006287943,0.000024964844,0.000055721666,0.000121195284,0.00002429875],"category_scores_gemma":[0.000033220447,0.00016850806,0.000027482549,0.0002034311,0.0002655279,0.00009294933,0.00005936601,0.00016638986,0.0000036362599],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00347459,0.0007154099,0.21242788,0.00019470796,0.00008209555,0.0014570348,0.0012377736,3.1196123e-7,0.77764356,0.0000013399416,0.0000054950333,0.0027598133],"study_design_scores_gemma":[0.011968414,0.00033750598,0.19474985,0.0006633066,0.000047992366,0.000072212824,0.00046210038,0.00005016683,0.79132444,0.000029835512,0.000089652916,0.00020453648],"about_ca_topic_score_codex":0.0007215686,"about_ca_topic_score_gemma":0.0009777492,"teacher_disagreement_score":0.017678032,"about_ca_system_score_codex":0.00011019818,"about_ca_system_score_gemma":0.00016872189,"threshold_uncertainty_score":0.68715596},"labels":[],"label_agreement":null},{"id":"W2980027737","doi":"10.1182/blood.v108.11.1580.1580","title":"A New Generation of γGlobin Gene Inducers Act on Novel Molecular and Cellular Targets.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Butyrate; Globin; Biology; Fetal hemoglobin; Molecular biology; Biochemistry; Fetus; Gene; Genetics","score_opus":0.010185376520467939,"score_gpt":0.21162558167590675,"score_spread":0.2014402051554388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980027737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919973,0.002407907,0.0018776838,0.00040721678,0.00006231518,0.00020711977,0.0000047918397,0.00002217411,0.0030134975],"genre_scores_gemma":[0.99621606,0.000046065263,0.003096371,0.00019695381,0.00011116338,0.0000025108197,0.000052954452,0.000017606812,0.00026029305],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99932367,0.000010941091,0.00018104383,0.00017870993,0.00016196507,0.00014368228],"domain_scores_gemma":[0.99966985,0.000005847017,0.000056379584,0.00015472951,0.00003079626,0.00008237941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000057471316,0.00010966784,0.00017143326,0.00007105081,0.00002938503,0.000007150135,0.000030857536,0.00013702607,0.000027354115],"category_scores_gemma":[0.000017394754,0.00009303315,0.000053816533,0.00012148323,0.000025850897,0.0000216713,0.0000137477155,0.00010958098,0.000005681519],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021603948,0.00038261266,0.00082798844,0.000023133756,0.000059808266,0.000037494796,0.00005898201,0.00011059201,0.9963283,0.0004840902,0.000601232,0.0010641756],"study_design_scores_gemma":[0.0042460007,0.00030828352,0.0014001275,0.000035799774,0.00019793506,0.00003058416,0.000025328487,0.00017826837,0.99232316,0.000061514584,0.001087804,0.0001051832],"about_ca_topic_score_codex":0.00033655675,"about_ca_topic_score_gemma":0.0000039793213,"teacher_disagreement_score":0.004224397,"about_ca_system_score_codex":0.000013114908,"about_ca_system_score_gemma":0.00008322889,"threshold_uncertainty_score":0.37937817},"labels":[],"label_agreement":null},{"id":"W2980030656","doi":"10.1182/blood.v126.23.2404.2404","title":"Bone Marrow Failure and Developmental Delay Caused By Mutations in Poly(A)-Specific Ribonuclease","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; SickKids Foundation; University of Toronto; Dalhousie University; Izaak Walton Killam Health Centre; Hospital for Sick Children","funders":"","keywords":"Diamond–Blackfan anemia; Zebrafish; Biology; Dyskeratosis congenita; Bone marrow; Cancer research; Mutation; Haematopoiesis; Gene knockdown; Genetics; Bone marrow failure; Cell biology; Stem cell; Gene; Immunology; RNA; Telomerase","score_opus":0.012420535879026676,"score_gpt":0.22478500600026957,"score_spread":0.2123644701212429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980030656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99436015,0.004378683,0.00017405402,0.00026478784,0.000023922436,0.000093673945,0.00004590811,0.0000066566536,0.00065215694],"genre_scores_gemma":[0.9975078,0.0001153882,0.0013989402,0.00008947668,0.00003849575,0.000032653905,0.00020389786,0.000012306492,0.0006010498],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99948007,0.000019415023,0.000116047915,0.00019641021,0.00006557264,0.00012249277],"domain_scores_gemma":[0.99972785,0.0000029314485,0.000026714051,0.000115194314,0.00003353426,0.00009378718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000650887,0.00007880793,0.00006443083,0.000029380075,0.000039771636,0.000022332353,0.000054844513,0.00006843272,0.00001639804],"category_scores_gemma":[0.000015803002,0.00008052862,0.000015069855,0.00007194175,0.000043327243,0.000004150522,0.0000307834,0.000043585394,0.000012506923],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032005282,0.00039978718,0.014473894,0.0000070469046,0.00004570432,0.00002966662,0.00036919996,0.0000057346215,0.94878125,0.00014631335,0.03258166,0.0031277582],"study_design_scores_gemma":[0.008301384,0.00023455945,0.018351847,0.000021873435,0.000050450257,0.0002229389,0.0023394742,0.000034397493,0.32485098,0.00016300999,0.6447441,0.00068496686],"about_ca_topic_score_codex":0.000028420802,"about_ca_topic_score_gemma":0.00014502117,"teacher_disagreement_score":0.6239302,"about_ca_system_score_codex":0.000013169118,"about_ca_system_score_gemma":0.00007372128,"threshold_uncertainty_score":0.32838616},"labels":[],"label_agreement":null},{"id":"W2980033596","doi":"10.1182/blood.v108.11.4118.4118","title":"Retrospective Analysis of the Effect of Argatroban and Coumadin on INR Values in Heparin Induced Thrombocytopenia.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Toronto General Hospital","funders":"","keywords":"Argatroban; Medicine; Concomitant; Direct thrombin inhibitor; Warfarin; Heparin; Heparin-induced thrombocytopenia; Anticoagulant; Clinical endpoint; Combination therapy; Discovery and development of direct thrombin inhibitors; Retrospective cohort study; Surgery; Anesthesia; Internal medicine; Clinical trial; Atrial fibrillation; Thrombin; Dabigatran","score_opus":0.010844219455533306,"score_gpt":0.2658028349004934,"score_spread":0.25495861544496007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980033596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99269336,0.000065141234,0.0000010610199,0.00010590637,0.000055451026,0.0006519579,0.000020913014,0.000020780482,0.0063854307],"genre_scores_gemma":[0.9997529,0.000017762603,0.000047753085,0.00003223639,0.000039798706,0.000020891684,0.000013133934,0.000023075381,0.00005245489],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816567,0.00022791266,0.00053858064,0.00040505626,0.0003896381,0.00027314227],"domain_scores_gemma":[0.9988118,0.00018230011,0.00025187834,0.000612413,0.00007373773,0.00006789617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050696294,0.00025144726,0.0014389316,0.00043867948,0.000058361027,0.000012145626,0.00017670504,0.00017896426,0.00004304358],"category_scores_gemma":[0.00019020455,0.00016943373,0.0002784709,0.0016308181,0.00017256929,0.00006253381,0.00010664121,0.00031661527,0.0000032470425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009914333,0.0004412116,0.8317382,0.000058927253,0.0009180441,0.000006467923,0.00018551822,0.000011908242,0.16564429,0.0007871651,0.000011897095,0.00009724083],"study_design_scores_gemma":[0.0028681152,0.0009356387,0.65870225,0.00011367387,0.0023133056,0.000004554367,0.000023446457,0.00004243878,0.33472914,0.00016781251,0.0000029608693,0.00009666627],"about_ca_topic_score_codex":0.001965631,"about_ca_topic_score_gemma":0.0008838283,"teacher_disagreement_score":0.17303593,"about_ca_system_score_codex":0.00009413191,"about_ca_system_score_gemma":0.000065211374,"threshold_uncertainty_score":0.69093066},"labels":[],"label_agreement":null},{"id":"W2980034179","doi":"10.1182/blood.v120.21.2098.2098","title":"Ferumoxytol Treatment Results in Robust Hemoglobin Increases in Iron Deficiency Anemia Patients with a History of Unsatisfactory Oral Iron Therapy in a Phase III, Randomized, Placebo-Controlled Trial.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Ferumoxytol; Placebo; Transferrin saturation; Anemia; Internal medicine; Iron deficiency; Randomized controlled trial; Iron-deficiency anemia; Ferritin; Gastroenterology; Surgery; Pathology","score_opus":0.015409833719186083,"score_gpt":0.24713779499172794,"score_spread":0.23172796127254186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980034179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827585,0.008315468,0.000002718075,0.00001866479,0.00011243353,0.006967914,0.00002447754,0.000022079645,0.0017777317],"genre_scores_gemma":[0.99827033,0.0004633994,0.00017799468,0.0000631908,0.000040786887,0.00063293474,0.00008858457,0.0000263821,0.00023641594],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99715495,0.00058496435,0.0010397546,0.0003483189,0.00037984506,0.00049214525],"domain_scores_gemma":[0.9987469,0.0003435019,0.00036547522,0.00035599965,0.000041017658,0.00014713433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009843259,0.00034803257,0.0016819042,0.0005207672,0.00001699239,0.0000045216348,0.00008695638,0.00014825362,0.00007523451],"category_scores_gemma":[0.00037471668,0.00023521757,0.00015223642,0.000270793,0.000165343,0.00016294132,0.000014914779,0.00016708126,0.0000026545108],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8620532,0.023593526,0.10962175,0.000060445338,0.00001592229,0.000022106758,0.0021318668,0.000036767124,0.0001587524,0.000012305774,0.000047604844,0.0022457168],"study_design_scores_gemma":[0.94712096,0.002192696,0.04971404,0.00008556278,0.00029835931,0.0000025413124,0.00019803921,0.000016672255,0.000116071846,0.0000025544011,0.00003619504,0.00021630294],"about_ca_topic_score_codex":0.006666611,"about_ca_topic_score_gemma":0.001179666,"teacher_disagreement_score":0.08506773,"about_ca_system_score_codex":0.00045818952,"about_ca_system_score_gemma":0.00045069336,"threshold_uncertainty_score":0.9999481},"labels":[],"label_agreement":null},{"id":"W2980034992","doi":"10.1182/blood.v106.11.4261.4261","title":"Pharmacokinetics and Pharmacodynamics of CNTO 528, a Novel Erythropoietin Receptor Agonist in Normal and Anemic Rats.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"","keywords":"Erythropoietin; Erythropoiesis; Pharmacokinetics; Agonist; Reticulocytosis; In vivo; Pharmacodynamics; Anemia; Pharmacology; Medicine; Internal medicine; Endocrinology; Erythropoietin receptor; Receptor; Biology","score_opus":0.010850092468918672,"score_gpt":0.2684461842971885,"score_spread":0.2575960918282698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980034992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924125,0.0026798504,0.000014821544,0.0027701461,0.00006432746,0.0003295127,0.000045921413,0.00003350664,0.001649407],"genre_scores_gemma":[0.98502874,0.0037611667,0.010043056,0.0003376023,0.00019130723,0.000014380418,0.0000406013,0.000029868303,0.0005532617],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988863,0.000021673482,0.00035408436,0.00028858293,0.00017871686,0.00027065532],"domain_scores_gemma":[0.9994904,0.000048551196,0.00009510857,0.00014945384,0.000049187685,0.0001673144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013679739,0.00020858992,0.0003441665,0.00010270684,0.000046173795,0.0000129848495,0.00005257409,0.00009077529,0.00015434751],"category_scores_gemma":[0.00001874032,0.00018909501,0.000046996676,0.00014852388,0.00023466049,0.000060186314,0.000065076485,0.00021115987,0.000007652027],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036213812,0.0039736787,0.073788755,0.00048390005,0.00018459446,0.000089907575,0.0012248629,0.0000111528125,0.90803194,0.0001120114,0.0012014154,0.010535638],"study_design_scores_gemma":[0.06964737,0.0018173261,0.03191525,0.00075215974,0.0015982199,0.0017807771,0.0012600655,0.0027650113,0.8541817,0.0000203146,0.033338062,0.00092374894],"about_ca_topic_score_codex":0.00005839114,"about_ca_topic_score_gemma":0.000045132638,"teacher_disagreement_score":0.06928524,"about_ca_system_score_codex":0.000037667945,"about_ca_system_score_gemma":0.00006157955,"threshold_uncertainty_score":0.7711071},"labels":[],"label_agreement":null},{"id":"W2980035451","doi":"10.1182/blood.v114.22.619.619","title":"ABC and GCB DLBCLs Display Unique Biologically Distinct and Clinically Relevant Epigenetic Signatures.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Epigenetics; DNA methylation; Diffuse large B-cell lymphoma; Gene expression profiling; Germinal center; Biology; Cancer research; DNA microarray; Gene; Lymphoma; Gene expression; Oncology; Genetics; B cell; Medicine; Immunology","score_opus":0.011648649584348697,"score_gpt":0.2732922411509418,"score_spread":0.2616435915665931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980035451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909066,0.004723589,0.000018476769,0.0022382082,0.000029590612,0.00036878965,0.000016096881,0.000052335326,0.0016463023],"genre_scores_gemma":[0.9943761,0.0025205559,0.0016481738,0.0011970486,0.00008907651,0.000018758945,0.000026740177,0.000009085725,0.00011444288],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989531,0.000049811744,0.00029858522,0.0003721948,0.00010158426,0.00022470641],"domain_scores_gemma":[0.9991666,0.00026034206,0.00007139155,0.00022691545,0.000037209345,0.00023753778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001594424,0.00017988718,0.00034349188,0.00003233197,0.00007385456,0.000025651343,0.000049340677,0.00016481579,0.000022417811],"category_scores_gemma":[0.00022797444,0.00011117054,0.000065302294,0.00006305421,0.00010803898,0.00002003466,0.0000374826,0.00011597958,0.000008803411],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003159366,0.004871311,0.9082961,0.000055192955,0.0002549513,0.00091478013,0.000120729965,4.185479e-7,0.008564105,0.0022363153,0.00039523965,0.073974885],"study_design_scores_gemma":[0.004931996,0.0028095143,0.9870451,0.00010739864,0.0003396242,0.00013458959,0.0000069885577,0.000011395155,0.001530321,0.001149457,0.0017910255,0.00014258598],"about_ca_topic_score_codex":0.000012253054,"about_ca_topic_score_gemma":0.00000718011,"teacher_disagreement_score":0.07874897,"about_ca_system_score_codex":0.000014144609,"about_ca_system_score_gemma":0.0000423168,"threshold_uncertainty_score":0.45334032},"labels":[],"label_agreement":null},{"id":"W2980036644","doi":"10.1182/blood.v124.21.995.995","title":"Selective Inhibitor of Nuclear Export (SINE), Selinexor (KPT-330), Shows Remarkable Activity Against AML Leukemia-Initiating Cells","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Nuclear export signal; Myeloid leukemia; Cancer research; Leukemia; Nuclear transport; Nuclear protein; Biology; Protein phosphatase 2; Suppressor; Cancer; Cell nucleus; Cell biology; Cytoplasm; Phosphorylation; Genetics; Gene; Phosphatase; Transcription factor","score_opus":0.0051613485602556835,"score_gpt":0.19532017431425425,"score_spread":0.19015882575399856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980036644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989106,0.000043783246,0.00024430008,0.000022227434,0.00024146956,0.00015037387,0.000019260668,0.000031246505,0.010141332],"genre_scores_gemma":[0.99707925,0.00003426359,0.0015007169,0.0002764217,0.0007903118,0.0000051125767,0.000040160485,0.00004729299,0.00022644707],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989206,0.000078624376,0.00022823889,0.00037722476,0.00014860036,0.00024668867],"domain_scores_gemma":[0.9992255,0.000018438177,0.00019345939,0.0003494402,0.00013531889,0.000077848286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002045242,0.00018455189,0.0002221167,0.00004220718,0.0001029401,0.000019666213,0.00012691841,0.00022482028,0.000027625407],"category_scores_gemma":[0.00011963776,0.00017979524,0.00011555484,0.0001063395,0.000054778488,0.000010394039,0.0000905821,0.00016151195,0.0000124647995],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009578339,0.0001086657,0.00054113095,0.000040531017,0.00007386769,0.0000013588664,0.00006116801,0.00003618343,0.9939234,0.000016849717,0.0028193297,0.0022816777],"study_design_scores_gemma":[0.0010327236,0.00046626086,0.0018097241,0.000022691267,0.000059049307,0.000009106301,0.000058147692,0.0002684013,0.97754097,0.000024901146,0.018485527,0.00022247912],"about_ca_topic_score_codex":0.000022419412,"about_ca_topic_score_gemma":0.00001855509,"teacher_disagreement_score":0.016382467,"about_ca_system_score_codex":0.000020227735,"about_ca_system_score_gemma":0.00008078629,"threshold_uncertainty_score":0.73318374},"labels":[],"label_agreement":null},{"id":"W2980044878","doi":"10.1182/blood.v110.11.972.972","title":"The Direct Medical Costs Associated with Suspected and Confirmed Cases of Heparin-Induced Thrombocytopenia.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Heparin-induced thrombocytopenia; Pharmacy; Emergency medicine; Argatroban; Indirect costs; Adverse effect; Internal medicine; Thrombosis; Family medicine","score_opus":0.024300766368508225,"score_gpt":0.2900184280590211,"score_spread":0.2657176616905129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980044878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9742966,0.00024811993,0.0000041594053,0.0006051435,0.000113241855,0.0007040398,0.000011312231,0.00012875375,0.023888584],"genre_scores_gemma":[0.99913454,0.00017843835,0.00006218399,0.00018704133,0.000098764154,0.000018286119,0.000027701866,0.000051498057,0.00024156457],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972793,0.0001440925,0.00061338977,0.00044416435,0.0008595256,0.00065953727],"domain_scores_gemma":[0.99654496,0.0018254877,0.00025381154,0.000531621,0.0003271085,0.00051701016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013043667,0.00031969367,0.0009648997,0.000111525944,0.00029939137,0.000042767624,0.00023186067,0.00030622023,0.00013368971],"category_scores_gemma":[0.0023544761,0.00020017171,0.00009985019,0.00055323174,0.00046548978,0.00008258198,0.00012573806,0.00045905358,0.000011208483],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017457646,0.004759163,0.73108774,0.00015538398,0.005218662,0.0035901233,0.0011091587,9.5494485e-8,0.23520763,0.005396423,0.00039624443,0.01133358],"study_design_scores_gemma":[0.008689672,0.0015087599,0.7925085,0.00041284025,0.0008552016,0.00084738823,0.000357199,0.000010646537,0.19398816,0.000024161078,0.0004974067,0.0003001143],"about_ca_topic_score_codex":0.0007775607,"about_ca_topic_score_gemma":0.0056806384,"teacher_disagreement_score":0.06142068,"about_ca_system_score_codex":0.00009816335,"about_ca_system_score_gemma":0.00048490206,"threshold_uncertainty_score":0.8162765},"labels":[],"label_agreement":null},{"id":"W2980046939","doi":"10.1182/blood.v124.21.3670.3670","title":"Pediatric Acute Megakaryoblastic Leukemia without Down Syndrome: A Retrospective Study by the International Berlin-Frankfurt-Munster Study Group (I-BFMSG)","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Hematopoietic stem cell transplantation; Acute megakaryoblastic leukemia; Internal medicine; Transplantation; Retrospective cohort study; Down syndrome; Leukemia; Myeloid leukemia; Acute leukemia; Pediatrics; Surgery","score_opus":0.008341565081181385,"score_gpt":0.26505632564225534,"score_spread":0.25671476056107395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980046939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99272305,0.00013011902,0.00019931473,0.00057565846,0.0004283746,0.0031842995,0.000045345427,0.00018644628,0.002527377],"genre_scores_gemma":[0.99488264,0.000035957535,0.00018148724,0.00041744736,0.0008751828,0.0004048215,0.000054737997,0.000105130646,0.0030425715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953552,0.00038482444,0.000657137,0.0009785563,0.001922507,0.00070180686],"domain_scores_gemma":[0.9976187,0.0003197196,0.00022358472,0.0011987141,0.00034024304,0.00029906025],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001526333,0.00048087558,0.00075122115,0.00033171746,0.0003141018,0.00017578063,0.0010576547,0.00015966692,0.00028432196],"category_scores_gemma":[0.0004924919,0.00032315726,0.00018613106,0.0007510538,0.00015455998,0.00021996211,0.0005839449,0.0012530976,0.00036548555],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048646893,0.005472679,0.9790702,0.000028000233,0.0025092538,0.0006253519,0.002449892,0.0000027755925,0.0008719738,0.000040688632,0.008137926,0.00030481917],"study_design_scores_gemma":[0.031504713,0.008583241,0.9505434,0.000034567503,0.0038854321,0.0012283687,0.0020573132,0.00061642117,0.0001426136,0.000093149334,0.0008031274,0.0005076317],"about_ca_topic_score_codex":0.00033052004,"about_ca_topic_score_gemma":0.0001270041,"teacher_disagreement_score":0.031018242,"about_ca_system_score_codex":0.0007758757,"about_ca_system_score_gemma":0.00032070413,"threshold_uncertainty_score":0.99992204},"labels":[],"label_agreement":null},{"id":"W2980047654","doi":"10.1182/blood.v106.11.3686.3686","title":"GAS-6 Rescues Endothelial Cells from Apoptosis through FOXO1 Inactivation.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"FOXO transcription factor regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"FOXO1; Phosphorylation; Cytoplasm; Biology; Cell biology; Protein kinase B; Apoptosis; GAS6; Wortmannin; Molecular biology; Receptor tyrosine kinase; Biochemistry","score_opus":0.010807188164472377,"score_gpt":0.22366992532274957,"score_spread":0.2128627371582772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980047654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99537885,0.00026123016,0.0018137969,0.00030263932,0.00014927732,0.00012914314,0.00011946534,0.00003513628,0.0018104549],"genre_scores_gemma":[0.9925222,0.00013717038,0.0056557935,0.00023966025,0.0007460627,0.000015364278,0.00028655777,0.000022618819,0.0003745917],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99922353,0.000038221766,0.00016748965,0.000280058,0.000133357,0.00015736719],"domain_scores_gemma":[0.9995689,0.000008973778,0.000055922912,0.0002801014,0.000047054244,0.000039095925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000040287272,0.000125315,0.000094798015,0.000021158146,0.00006248969,0.00002545883,0.000119112294,0.00013174665,0.000110346824],"category_scores_gemma":[0.000017608929,0.00012695769,0.0000790872,0.00005767472,0.00003833846,0.0000138040605,0.00002339469,0.000057815152,0.0000678561],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037132573,0.00016940491,0.0004735397,0.000003087122,0.00005393322,1.6565158e-7,0.000097369004,0.000043409786,0.99633867,0.000081049904,0.0013664986,0.001335724],"study_design_scores_gemma":[0.0010661373,0.0000697618,0.0012084992,0.000005771834,0.000032671403,9.898624e-7,0.00002657002,0.000009630721,0.8838399,0.00013229692,0.11347571,0.0001320523],"about_ca_topic_score_codex":0.00008691303,"about_ca_topic_score_gemma":0.000047419104,"teacher_disagreement_score":0.112498775,"about_ca_system_score_codex":0.000012213957,"about_ca_system_score_gemma":0.000024165973,"threshold_uncertainty_score":0.51771843},"labels":[],"label_agreement":null},{"id":"W2980052436","doi":"10.1182/blood.v128.22.4018.4018","title":"Hyper-CVAD Plus Epratuzumab As Salvage Regimen for Younger Relapsed/Refractory CD22+ B Acute Lymphoblastic Leukemia (ALL) Patients: Results of the Phase 2 Prospective Cheprall Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Regimen; Minimal residual disease; Internal medicine; Salvage therapy; Refractory (planetary science); Gastroenterology; Vincristine; Cyclophosphamide; Surgery; Immunology; Leukemia; Chemotherapy; Biology","score_opus":0.014215464166263396,"score_gpt":0.29077324172684654,"score_spread":0.27655777756058314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980052436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98863137,0.00011281569,0.000114835,0.0006325827,0.0003886139,0.0056857346,0.00055625156,0.00012821553,0.0037495669],"genre_scores_gemma":[0.98840857,0.00005071608,0.00032690697,0.00031208008,0.00033234403,0.00059122,0.000059772185,0.00014089583,0.00977748],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9953224,0.00023361093,0.001010761,0.0010867778,0.0014394063,0.00090706686],"domain_scores_gemma":[0.9952248,0.0011015676,0.00058575947,0.0017492437,0.0009778783,0.00036079687],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006984306,0.00052903965,0.00087314245,0.00022099726,0.0002044277,0.000036634272,0.0007263423,0.00031936218,0.000057336318],"category_scores_gemma":[0.003987,0.00029683486,0.00033466073,0.0004991047,0.0004203689,0.0003800157,0.00042787482,0.00037779487,0.00013042834],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20511515,0.08626018,0.064076364,0.0012071034,0.023291262,0.0015524146,0.027677435,0.000021007449,0.46238375,0.0014120977,0.102878384,0.024124859],"study_design_scores_gemma":[0.7539463,0.039966136,0.06670494,0.0013542523,0.0073026773,0.0003515366,0.0014602464,0.00024211375,0.111594126,0.00056827924,0.015156025,0.0013533895],"about_ca_topic_score_codex":0.00025384047,"about_ca_topic_score_gemma":0.00002625799,"teacher_disagreement_score":0.5488311,"about_ca_system_score_codex":0.0038297877,"about_ca_system_score_gemma":0.003552961,"threshold_uncertainty_score":0.99999434},"labels":[],"label_agreement":null},{"id":"W2980053490","doi":"10.1182/blood.v116.21.4045.4045","title":"Chromosomal Abnormalities in Bone Marrow Lymphocytes of MM Patients","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Alberta Health Services","funders":"","keywords":"Chromosomal translocation; Bone marrow; Trisomy; Biology; Pathology; Chromosomal Deletion; Molecular biology; G banding; Trisomy 8; Karyotype; Multiple myeloma; Chromosome; Immunology; Medicine; Genetics; Gene","score_opus":0.010587794535055546,"score_gpt":0.25593362982723117,"score_spread":0.24534583529217563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980053490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950824,0.000164321,1.8814936e-7,0.000041591484,0.00005941937,0.00025693025,0.00003433159,0.000017408116,0.0043434477],"genre_scores_gemma":[0.99886227,0.000025421687,0.0005448901,0.000022367583,0.000055066354,0.000027179836,0.000058991387,0.000012224248,0.0003915788],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991111,0.000020177784,0.00020236037,0.00013583971,0.000279266,0.00025122677],"domain_scores_gemma":[0.99948776,0.00004828145,0.00004416711,0.00021856326,0.000077820754,0.00012340666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008020278,0.00009399736,0.00021455355,0.00012014385,0.000021370553,0.0000060570073,0.000057808997,0.00006595088,0.00028213486],"category_scores_gemma":[0.0001704896,0.000075702534,0.000052777028,0.000108576045,0.00007562551,0.00006043917,0.00003913209,0.000118484975,0.000037596896],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001550453,0.0019317953,0.97896075,0.00009380217,0.00005817027,0.00013839989,0.00013726299,6.5955035e-8,0.015600947,0.0000631047,0.000040392126,0.0028202513],"study_design_scores_gemma":[0.013606785,0.00036729683,0.8727943,0.000052761177,0.000032808497,0.000033097258,0.000032246633,0.000015495707,0.11275562,0.000032925745,0.00021454408,0.0000621183],"about_ca_topic_score_codex":0.00037431638,"about_ca_topic_score_gemma":0.00018899712,"teacher_disagreement_score":0.10616647,"about_ca_system_score_codex":0.000019326415,"about_ca_system_score_gemma":0.00010560129,"threshold_uncertainty_score":0.3089179},"labels":[],"label_agreement":null},{"id":"W2980054153","doi":"10.1182/blood.v120.21.1633.1633","title":"An Open-Label, Phase 1 Study of R-CVP in Combination with Inotuzumab Ozogamicin in Patients with CD22-Positive B-Cell Non-Hodgkin's Lymphoma: Preliminary Safety and Efficacy Data","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Queen Elizabeth II Health Sciences Centre; University of Toronto","funders":"","keywords":"Medicine; Calicheamicin; Internal medicine; Adverse effect; Rituximab; Gastroenterology; Refractory (planetary science); Lymphoma; Neutropenia; Regimen; Vincristine; Febrile neutropenia; Cyclophosphamide; Toxicity; Chemotherapy","score_opus":0.019772973559272888,"score_gpt":0.298823900790615,"score_spread":0.2790509272313421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980054153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99642235,0.00014438297,0.000004367721,0.000024811861,0.0000194971,0.0030347486,0.000091616654,0.000010978474,0.00024723142],"genre_scores_gemma":[0.9986663,0.00002072493,0.00044348618,0.00003630789,0.000012868821,0.00006217403,0.0007208026,0.000029558892,0.00000780687],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985257,0.0001196497,0.00034362005,0.00043901065,0.0003032303,0.0002687897],"domain_scores_gemma":[0.9988082,0.00010621164,0.00017510394,0.00068746746,0.00008212287,0.00014086453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023678715,0.00022856277,0.00048611045,0.00016688908,0.000050272247,0.000021787826,0.00021875864,0.00006144102,0.000004521057],"category_scores_gemma":[0.000016556733,0.00016365938,0.0000059758518,0.0003035454,0.00005337902,0.00056441856,0.0002247508,0.000066339875,0.000001765531],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007969226,0.29822522,0.68322736,0.00003459571,0.00012003358,0.00007208306,0.0023938736,0.0000016744307,0.00006292779,0.0000069593,0.0000069215416,0.007879156],"study_design_scores_gemma":[0.27769783,0.03894245,0.6809347,0.00021895669,0.00042106153,0.000009185393,0.0005376716,0.00008168335,0.0010233112,5.0540905e-7,0.0000037735715,0.00012884276],"about_ca_topic_score_codex":0.00091840985,"about_ca_topic_score_gemma":0.00016452282,"teacher_disagreement_score":0.2697286,"about_ca_system_score_codex":0.00012937492,"about_ca_system_score_gemma":0.000108748754,"threshold_uncertainty_score":0.66738355},"labels":[],"label_agreement":null},{"id":"W2980054885","doi":"10.1182/blood.v126.23.2342.2342","title":"CD4+CD25+Foxp3+ T Regulatory Cells Protect Against Murine Antibody-Mediated Transfusion-Related Acute Lung Injury (TRALI)","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Transfusion-related acute lung injury; Immunology; Antibody; Medicine; FOXP3; IL-2 receptor; Adoptive cell transfer; Human leukocyte antigen; Antigen; Sepsis; T cell; Immune system; Pulmonary edema; Lung; Internal medicine","score_opus":0.010338680657738443,"score_gpt":0.2574316593755892,"score_spread":0.24709297871785077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980054885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.978937,0.0005910526,0.00019676836,0.002111169,0.00067987206,0.0028965476,0.000065476925,0.0006994709,0.013822643],"genre_scores_gemma":[0.9908623,0.0012028408,0.00094992213,0.0017306024,0.00021951173,0.00012780497,0.0003807266,0.00012748224,0.0043988135],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970483,0.00012481646,0.00070140633,0.000679878,0.000806146,0.0006394492],"domain_scores_gemma":[0.998152,0.00002964913,0.00013243678,0.00079154136,0.00019608076,0.00069827423],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00057172845,0.00045276593,0.00066564576,0.00035550958,0.00013229341,0.00003553186,0.00024938947,0.00033288865,0.00030862988],"category_scores_gemma":[0.00004121816,0.00039265797,0.00027281584,0.0007288693,0.0001361574,0.00015662174,0.000082651626,0.00057988195,0.00033133896],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011694948,0.0062447493,0.0047637094,0.0007208523,0.002981552,0.0018590264,0.0019272758,0.0000332747,0.9498192,0.0003104584,0.023725232,0.0064451685],"study_design_scores_gemma":[0.08442194,0.0039660847,0.034286197,0.0015881687,0.008354816,0.00039353647,0.0007314805,0.0013702468,0.756483,0.00019600648,0.10569536,0.0025131195],"about_ca_topic_score_codex":0.00008481015,"about_ca_topic_score_gemma":0.000016075184,"teacher_disagreement_score":0.19333616,"about_ca_system_score_codex":0.00006194195,"about_ca_system_score_gemma":0.00022818783,"threshold_uncertainty_score":0.99985254},"labels":[],"label_agreement":null},{"id":"W2980055023","doi":"10.1182/blood.v126.23.6.6","title":"The Multi-Kinase Inhibitor Midostaurin (M) Prolongs Survival Compared with Placebo (P) in Combination with Daunorubicin (D)/Cytarabine (C) Induction (ind), High-Dose C Consolidation (consol), and As Maintenance (maint) Therapy in Newly Diagnosed Acute Myeloid Leukemia (AML) Patients (pts) Age 18-60 with FLT3 Mutations (muts): An International Prospective Randomized (rand) P-Controlled Double-Blind Trial (CALGB 10603/RATIFY [Alliance])","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":158,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cytarabine; Midostaurin; Medicine; Internal medicine; Gastroenterology; Chemotherapy; Oncology; Surgery; Leukemia","score_opus":0.03245016808503368,"score_gpt":0.3022962509159641,"score_spread":0.2698460828309304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980055023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9743197,0.00008367674,0.0003663801,0.0011501606,0.00025540363,0.023473376,0.00004735957,0.000102778096,0.0002011591],"genre_scores_gemma":[0.990379,0.0002449375,0.0019600845,0.00008949921,0.00019984685,0.0056739743,0.0010490716,0.000103349856,0.00030025587],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9944286,0.0011661197,0.001202969,0.0010950869,0.0013575057,0.0007497726],"domain_scores_gemma":[0.9959947,0.00090764277,0.0007793553,0.00058217096,0.001342711,0.00039340896],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024997452,0.00068601617,0.0015884623,0.0005719476,0.00029593534,0.00033409017,0.00035824708,0.0002927981,0.000019881662],"category_scores_gemma":[0.0007930881,0.0004232615,0.00009891904,0.0009877648,0.0009873037,0.0009908543,0.00007833255,0.0011141879,0.000007745122],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9609457,0.004024558,0.027046913,0.000025663889,0.00096197316,0.0005572562,0.0038279442,0.00050284894,0.00092346716,0.0002726961,0.000025823634,0.0008851558],"study_design_scores_gemma":[0.9444584,0.0076557193,0.03815255,0.00033597776,0.00037484692,0.00007795972,0.0015455383,0.0038399587,0.0028525034,0.00016836301,0.00002918297,0.0005089606],"about_ca_topic_score_codex":0.0028082032,"about_ca_topic_score_gemma":0.008760114,"teacher_disagreement_score":0.017799402,"about_ca_system_score_codex":0.0014790244,"about_ca_system_score_gemma":0.0019942974,"threshold_uncertainty_score":0.9998219},"labels":[],"label_agreement":null},{"id":"W2980056665","doi":"10.1182/blood.v128.22.1424.1424","title":"Natural Killer Cells Induce the Formation of Neutrophil Extracellular Traps (NETs) in Venous Thrombosis","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Neutrophil extracellular traps; Innate immune system; Thrombosis; Venous thrombosis; Platelet; Immunology; Coagulation; Extracellular; Immune system; Biology; Chemistry; Inflammation; Medicine; Cell biology; Internal medicine","score_opus":0.014418781622006552,"score_gpt":0.2146642427273204,"score_spread":0.20024546110531385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980056665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953353,0.0027372811,0.00011028385,0.0006700192,0.00068930926,0.00027489188,0.000015067519,0.00002477533,0.00014309876],"genre_scores_gemma":[0.9988696,0.000318535,0.000045385026,0.00013128805,0.000023794493,0.000023345992,0.000017159648,0.000015240891,0.00055564375],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99890476,0.00021821099,0.0003223788,0.00020744791,0.000046981328,0.00030022056],"domain_scores_gemma":[0.9993693,0.00012222462,0.00014301015,0.00030147753,0.00005071376,0.000013240101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020929787,0.00016350036,0.00025751768,0.00010011655,0.000092702816,0.0000065222207,0.00027070922,0.00016127924,0.00018182895],"category_scores_gemma":[0.000015248323,0.000089355235,0.00008943174,0.00015696796,0.00014063789,0.00016641738,0.000058574526,0.00021710091,0.00019784772],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035294488,0.00040528137,0.000056818582,0.000008962938,0.000058779377,0.000005377886,0.0005291864,7.710387e-7,0.99414396,0.0012098085,0.00028669203,0.0032590467],"study_design_scores_gemma":[0.0021674507,0.00024937897,0.0025974591,0.000059680915,0.000047352856,0.00002551348,0.00014557393,5.677248e-7,0.9872978,0.0003461065,0.0069291117,0.00013401754],"about_ca_topic_score_codex":0.00003599636,"about_ca_topic_score_gemma":0.000023881155,"teacher_disagreement_score":0.006846194,"about_ca_system_score_codex":0.000019481824,"about_ca_system_score_gemma":0.000027072287,"threshold_uncertainty_score":0.3643801},"labels":[],"label_agreement":null},{"id":"W2980063723","doi":"10.1182/blood.v122.21.394.394","title":"Phase 3 Study Of Pomalidomide In Myeloproliferative Neoplasm (MPN)-Associated Myelofibrosis With RBC-Transfusion-Dependence","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pomalidomide; Myelofibrosis; Medicine; Internal medicine; Randomization; Placebo; Anemia; Gastroenterology; Clinical endpoint; Surgery; Randomized controlled trial; Bone marrow; Thalidomide; Pathology; Multiple myeloma","score_opus":0.013092591579987867,"score_gpt":0.26569894429509877,"score_spread":0.2526063527151109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980063723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99416375,0.00012304887,0.000012831495,0.00042255703,0.00004448343,0.0036199219,0.00002986558,0.00006619193,0.001517365],"genre_scores_gemma":[0.99762684,0.000105930536,0.00060980173,0.0001480665,0.00004089202,0.001127275,0.000033614033,0.000048036083,0.00025954715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973575,0.0001948791,0.0006839827,0.0006235763,0.00066858943,0.00047149512],"domain_scores_gemma":[0.9984127,0.00027258616,0.00023030097,0.00043245978,0.0004074864,0.0002444622],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021456151,0.000415994,0.0009402619,0.000268662,0.00011623338,0.000040705036,0.00013541512,0.00014574028,0.00036813648],"category_scores_gemma":[0.00014226497,0.0002968146,0.00010107122,0.0006617135,0.00008810037,0.00022631498,0.000046722085,0.0002934906,0.000058360496],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007533629,0.05650052,0.92170817,0.00005384875,0.00095303264,0.00035845255,0.006062254,0.000016287404,0.011837852,0.000058391677,0.000075796306,0.0016220611],"study_design_scores_gemma":[0.09481891,0.018954374,0.78230435,0.0005540472,0.0008216533,0.00009739581,0.0037771608,0.00010791726,0.09804198,0.00006838465,0.000019008352,0.00043480808],"about_ca_topic_score_codex":0.002280661,"about_ca_topic_score_gemma":0.002444409,"teacher_disagreement_score":0.13940379,"about_ca_system_score_codex":0.00009605852,"about_ca_system_score_gemma":0.00021988826,"threshold_uncertainty_score":0.9999484},"labels":[],"label_agreement":null},{"id":"W2980064088","doi":"10.1182/blood.v114.22.169.169","title":"Quantitative Benefit–Risk Assessment of Rivaroxaban for the Prevention of Venous Thromboembolism.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Rivaroxaban; Medicine; Pulmonary embolism; Deep vein; Population; Thrombosis; Knee replacement; Placebo; Internal medicine; Surgery; Absolute risk reduction; Warfarin; Confidence interval; Arthroplasty; Atrial fibrillation","score_opus":0.025324607625251908,"score_gpt":0.3391275280490621,"score_spread":0.3138029204238102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980064088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98789054,0.0010858094,0.005152256,0.0007839028,0.00012292922,0.001717219,0.00004962622,0.000027059214,0.003170658],"genre_scores_gemma":[0.9889159,0.00091190805,0.009814946,0.00012363536,0.00007082355,0.00006388922,0.000021247697,0.000014628497,0.00006300971],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9989143,0.00003240339,0.00039150115,0.00019406491,0.00027560384,0.00019213151],"domain_scores_gemma":[0.998861,0.00017816875,0.00034537603,0.00037753495,0.00019398934,0.00004389245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040752906,0.00013036921,0.00059696625,0.00007843967,0.000087889275,0.000008183838,0.00013562848,0.00005403076,0.000035447476],"category_scores_gemma":[0.00008251748,0.0000915937,0.00023745748,0.00015482101,0.00005963795,0.000055127788,0.000026514914,0.000090424444,0.000001420738],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005293866,0.079703294,0.0205193,0.0018529554,0.008521577,0.000016386059,0.0067444663,0.0012330078,0.070648685,0.6817197,0.004585086,0.12392611],"study_design_scores_gemma":[0.0039006216,0.009113405,0.95069784,0.0002783737,0.0037766683,0.0000042820525,0.000652706,0.00053226406,0.018669713,0.011679191,0.0005579881,0.00013693365],"about_ca_topic_score_codex":0.000072368064,"about_ca_topic_score_gemma":0.000016568092,"teacher_disagreement_score":0.9301785,"about_ca_system_score_codex":0.000016981556,"about_ca_system_score_gemma":0.000066217835,"threshold_uncertainty_score":0.37350824},"labels":[],"label_agreement":null},{"id":"W2980067870","doi":"10.1182/blood.v104.11.3821.3821","title":"Atorvastatin Inhibits Leukocyte Firm Adhesion to Arterial Thrombi as Observed in the Mouse Cremaster Muscle.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Atorvastatin; Cremaster muscle; CD18; Thrombus; Internal medicine; Lovastatin; Medicine; Endocrinology; Pharmacology; In vivo; Immunology; Biology; Cholesterol; Integrin; Microcirculation; Receptor","score_opus":0.03082825072001421,"score_gpt":0.2605507162328461,"score_spread":0.22972246551283187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980067870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960716,0.00025206077,0.000030406554,0.0018039733,0.00010637981,0.0011245434,0.000004860993,0.000048078866,0.0005581077],"genre_scores_gemma":[0.99536103,0.000032253316,0.0007519433,0.0031464645,0.00046467155,0.00008764655,0.000017365068,0.000031262472,0.00010735092],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99836737,0.00011310039,0.00030706445,0.00031483034,0.00054946216,0.00034818563],"domain_scores_gemma":[0.9990898,0.000020217141,0.000047546466,0.0006253415,0.00005206375,0.0001650396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060055975,0.00017060214,0.0003374454,0.00006902198,0.00007651205,0.0000361665,0.00012622774,0.000099640776,0.00006020882],"category_scores_gemma":[0.000108169,0.00011646705,0.00017726366,0.00025489295,0.000023569515,0.000056280773,0.00005091251,0.00021018284,0.00021393855],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019264426,0.009363089,0.008631718,0.0013712316,0.0007428816,0.0027371896,0.037910122,0.00015782344,0.8959712,0.0014737298,0.0020172708,0.03769735],"study_design_scores_gemma":[0.045178127,0.0036234527,0.42054498,0.0009442453,0.00048492855,0.00057517155,0.002569972,0.0000057611906,0.50624436,0.0006072913,0.018499315,0.00072238495],"about_ca_topic_score_codex":0.0009953422,"about_ca_topic_score_gemma":0.00037052916,"teacher_disagreement_score":0.41191328,"about_ca_system_score_codex":0.00006354558,"about_ca_system_score_gemma":0.0002086247,"threshold_uncertainty_score":0.47493884},"labels":[],"label_agreement":null},{"id":"W2980074380","doi":"10.1182/blood.v128.22.2273.2273","title":"Bortezomib-High Dose Melphalan Conditioning for the Treatment of MM Patients Undergoing ASCT","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; Institute of Cancer Research; University of Calgary","funders":"","keywords":"Medicine; Melphalan; Bortezomib; Internal medicine; Regimen; Autologous stem-cell transplantation; Urology; Surgery; Oncology; Chemotherapy; Multiple myeloma","score_opus":0.02671847572376897,"score_gpt":0.30074199320638323,"score_spread":0.2740235174826143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980074380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975091,0.0002886417,0.00017931107,0.00041219112,0.00006216319,0.0010195782,0.00015958468,0.000023203413,0.00034618395],"genre_scores_gemma":[0.9980203,0.0003368773,0.00058145804,0.000023319702,0.00009547855,0.00019733593,0.00008673706,0.000017855138,0.00064065994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991687,0.000024182358,0.00017497812,0.00017016508,0.00021702464,0.0002449576],"domain_scores_gemma":[0.99881136,0.00064578874,0.00007281573,0.0002588817,0.00010575184,0.00010536851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005610957,0.00011412761,0.00019946332,0.000050940682,0.000112121255,0.0000088130555,0.000053477637,0.000037261354,0.00010214844],"category_scores_gemma":[0.00014019181,0.00005185639,0.00011788319,0.000055867422,0.000056730078,0.000044053286,0.000011359476,0.000019908297,0.000023144701],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010485125,0.0076618153,0.8854295,0.00010253916,0.0026428998,0.000047067595,0.00032975888,0.000001227783,0.005317936,0.000697919,0.00032246028,0.09639836],"study_design_scores_gemma":[0.08124511,0.007118506,0.8253986,0.0002191499,0.0008176474,0.0000113560955,0.00007815609,0.000024997069,0.0825453,0.0003500586,0.0020647245,0.00012639028],"about_ca_topic_score_codex":0.00007752964,"about_ca_topic_score_gemma":0.00004600709,"teacher_disagreement_score":0.09627197,"about_ca_system_score_codex":0.00006858807,"about_ca_system_score_gemma":0.00008603739,"threshold_uncertainty_score":0.21146423},"labels":[],"label_agreement":null},{"id":"W2980079533","doi":"10.1182/blood.v120.21.3822.3822","title":"Eltrombopag Treatment of Thrombocytopenia in Advanced Myelodysplastic Syndromes and Acute Myeloid Leukemia: Results of the 8-Week Open-Label Part of an Ongoing Study","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Eltrombopag; Medicine; Myelodysplastic syndromes; Internal medicine; Platelet; Gastroenterology; Myeloid leukemia; Thrombopoietin; Surgery; Bone marrow; Immune thrombocytopenia; Haematopoiesis; Stem cell","score_opus":0.03955608528551621,"score_gpt":0.3101716799405464,"score_spread":0.27061559465503016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980079533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971964,0.00071050215,2.785136e-7,0.00003093668,0.000060237282,0.001328868,0.0000907055,0.0000072584994,0.00057484285],"genre_scores_gemma":[0.99916047,0.00023480873,0.00037002997,0.00000814,0.000010718708,0.000049322232,0.000021605732,0.000018517536,0.00012636243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987192,0.00007843611,0.0004936104,0.00024225167,0.00021309365,0.00025340062],"domain_scores_gemma":[0.99905473,0.00010711562,0.00026242618,0.00043992858,0.000043672113,0.00009211752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001561293,0.00019308508,0.0008408841,0.00007592298,0.00004175648,0.00000639271,0.00014584741,0.000060183324,0.0000056130584],"category_scores_gemma":[0.000050921055,0.00012239955,0.000038349746,0.00021886137,0.00008454898,0.00020030398,0.00010096481,0.0000668006,0.0000011818623],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004406389,0.11281893,0.7743344,0.00027325697,0.0038785222,0.0004986108,0.011439007,0.000015609214,0.079069786,0.00009057863,0.000024561254,0.013150409],"study_design_scores_gemma":[0.074861415,0.0124054495,0.8613298,0.00030940445,0.0016797038,0.00017986912,0.0012490499,0.00001586701,0.047751658,0.000044097436,0.000031385982,0.00014228623],"about_ca_topic_score_codex":0.0003271551,"about_ca_topic_score_gemma":0.00026581853,"teacher_disagreement_score":0.10041348,"about_ca_system_score_codex":0.000059042562,"about_ca_system_score_gemma":0.000118632866,"threshold_uncertainty_score":0.49913087},"labels":[],"label_agreement":null},{"id":"W2980082982","doi":"10.1182/blood.v112.11.243.243","title":"Induction of Immune Tolerance to Canine FVIII in Hemophilia a Dogs with Inhibitors Using AAV-Mediated Expression of Canine FVIII","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Genetic enhancement; Immune tolerance; Immunology; Population; Antibody; Immune system; Gene; Biology","score_opus":0.025385272815559384,"score_gpt":0.27289870543716716,"score_spread":0.24751343262160777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980082982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99826205,0.00044715742,0.000005370113,0.00031577586,0.000062896135,0.0006356013,0.000013306233,0.000023338389,0.00023449678],"genre_scores_gemma":[0.9981776,0.00008311206,0.0011802308,0.000019345784,0.00012864379,0.000021976493,0.00003408099,0.000029827552,0.00032520207],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983545,0.00004964417,0.00049393246,0.00027833472,0.0005134556,0.0003101611],"domain_scores_gemma":[0.99913514,0.0000381622,0.00014214077,0.00031287025,0.00020803412,0.00016364595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016881418,0.00018495882,0.00052679196,0.0003736974,0.000059078553,0.0000025427664,0.0000831639,0.00012608465,0.000055527355],"category_scores_gemma":[0.000100050114,0.00013400998,0.000060734987,0.0009378587,0.00013122996,0.000085966894,0.00005414621,0.0002205753,0.0000052663945],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006125898,0.0009024103,0.18633236,0.0001381764,0.00004317419,0.00019754712,0.0012095285,0.00013744547,0.8102103,0.0000016144004,0.000055812114,0.00015902083],"study_design_scores_gemma":[0.008421022,0.0009580965,0.10857213,0.0011865916,0.00006874865,0.00019421913,0.00016902965,0.00010523881,0.8801443,0.000002179411,0.000033445587,0.00014501698],"about_ca_topic_score_codex":0.002589205,"about_ca_topic_score_gemma":0.00015475876,"teacher_disagreement_score":0.077760234,"about_ca_system_score_codex":0.00008058016,"about_ca_system_score_gemma":0.00030663933,"threshold_uncertainty_score":0.54647684},"labels":[],"label_agreement":null},{"id":"W2980084028","doi":"10.1182/blood.v116.21.1390.1390","title":"Assessment of Minimal Residual Disease (MRD) In Relapsed CLL Patients Treated with Fludarabine and Cyclophosphamide with or without Rituximab (REACH)","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Fludarabine; Minimal residual disease; Rituximab; Chronic lymphocytic leukemia; Cyclophosphamide; Medicine; IGHV@; Immunoglobulin heavy chain; Internal medicine; Bendamustine; Immunology; Oncology; Leukemia; Antibody; Chemotherapy","score_opus":0.008512637684117213,"score_gpt":0.2769209660103856,"score_spread":0.26840832832626843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980084028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976263,0.00009624138,0.000002166657,0.000091682465,0.00001903544,0.0010730608,0.000045484052,0.000043612374,0.0010023975],"genre_scores_gemma":[0.9959521,0.000029731904,0.0031727771,0.000042777396,0.00005185341,0.00008476517,0.00009049319,0.00005972705,0.00051573437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977943,0.00006210051,0.00039068714,0.00051533437,0.0007881304,0.00044946783],"domain_scores_gemma":[0.9985168,0.00013428401,0.00013581531,0.00058078935,0.00021485657,0.00041748473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024261515,0.00027395407,0.00059778616,0.00018869482,0.000052550524,0.000018907056,0.00012817791,0.00011635464,0.00007844866],"category_scores_gemma":[0.00018904702,0.00016824274,0.000031968317,0.0003877386,0.00035687396,0.00008350717,0.00008170355,0.0004341306,0.0000035080895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00929706,0.0056171846,0.98124546,0.00034287898,0.00016279198,0.0009245539,0.00016423901,0.0000020248501,0.0016991785,0.00003217905,0.00005620163,0.00045626954],"study_design_scores_gemma":[0.18404575,0.0029019737,0.8075935,0.0004010029,0.00040243095,0.00012755998,0.00007017436,0.0006220804,0.0035594706,0.0000052234027,0.000058525504,0.0002122751],"about_ca_topic_score_codex":0.0009070081,"about_ca_topic_score_gemma":0.0010345944,"teacher_disagreement_score":0.17474867,"about_ca_system_score_codex":0.0005658578,"about_ca_system_score_gemma":0.004630426,"threshold_uncertainty_score":0.8214176},"labels":[],"label_agreement":null},{"id":"W2980088049","doi":"10.1182/blood.v110.11.908.908","title":"A Phase I Trial of Two Sequence-Specific Schedules of Decitabine and Vorinostat in Patients with Acute Myeloid Leukemia (AML).","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Decitabine; Medicine; Tolerability; Mucositis; Vorinostat; Regimen; Internal medicine; Hypomethylating agent; Leukopenia; Neutropenia; Phases of clinical research; Oncology; Gastroenterology; Adverse effect; Pharmacology; Surgery; Toxicity; Histone deacetylase; Biology","score_opus":0.013084975064968155,"score_gpt":0.2923354127578263,"score_spread":0.2792504376928582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980088049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989792,0.0002613828,0.00013254769,0.0000047281364,0.00004780321,0.00036769232,0.000080134814,0.0000031581335,0.00012335302],"genre_scores_gemma":[0.9976062,0.00010403691,0.0020501385,0.0000044087533,0.000076130375,0.000008688915,0.00010147743,0.00001633843,0.000032569056],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99888986,0.000039282106,0.000317692,0.00026450938,0.00025376154,0.00023491366],"domain_scores_gemma":[0.9993715,0.00002217622,0.000109028486,0.0002721999,0.00014440854,0.00008068005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027859252,0.00012112821,0.00020623165,0.00011727992,0.00002154035,0.0000053068356,0.00011682727,0.00008821386,0.0000047739636],"category_scores_gemma":[0.00005201919,0.00010630463,0.000037585796,0.00017088297,0.00020638277,0.0000055187083,0.000068156485,0.00009860387,7.681427e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024143219,0.0020049228,0.015199634,0.000030607054,0.00010050976,0.000031448293,0.00009204856,0.0000035228,0.9541063,0.000059526817,0.000032221862,0.004196095],"study_design_scores_gemma":[0.119469784,0.0035501644,0.0022019413,0.00003109697,0.000022676864,0.0000046803802,0.000022157326,0.0000019333847,0.87423414,0.000009475828,0.0003367206,0.00011523951],"about_ca_topic_score_codex":0.000036850706,"about_ca_topic_score_gemma":0.00006804824,"teacher_disagreement_score":0.095326565,"about_ca_system_score_codex":0.00002134667,"about_ca_system_score_gemma":0.00014473428,"threshold_uncertainty_score":0.4334977},"labels":[],"label_agreement":null},{"id":"W2980088373","doi":"10.1182/blood.v128.22.2666.2666","title":"CSF1R Is Associated with Poor Overall Survival in AML and Mediates Supportive Interactions Between AML and Stromal Cells in the AML Microenvironment","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Stromal cell; Haematopoiesis; Cytokine; Bone marrow; Myeloid; Myeloid leukemia; Biology; Cancer research; Cell biology; Immunophenotyping; Stem cell; Immunology; Flow cytometry","score_opus":0.014955770887005912,"score_gpt":0.2600988974472439,"score_spread":0.24514312656023798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980088373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937667,0.00007823024,0.0000051278143,0.005131134,0.000021117858,0.00050476106,0.00020378196,0.00001343518,0.00027567576],"genre_scores_gemma":[0.9986281,0.00023135678,0.00009544217,0.0002711112,0.00008465474,0.000036451176,0.000040387604,0.000025077914,0.0005874609],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998417,0.00019531361,0.00027382665,0.00034506185,0.00035123312,0.0004175615],"domain_scores_gemma":[0.998821,0.00071467116,0.00009543727,0.00020604748,0.000027562577,0.00013528862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046810365,0.00018482782,0.00034637866,0.00014811412,0.000048090675,0.000027677022,0.00011466343,0.00009140391,0.00012083866],"category_scores_gemma":[0.00012724155,0.000104192426,0.0000307589,0.00013908459,0.00020914145,0.00012869656,0.00010930104,0.00038172258,0.000016720125],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016407047,0.00047076662,0.94082606,0.000019386007,0.00022699214,0.000240817,0.001924984,1.2161873e-7,0.054623947,0.000007465298,0.000809515,0.0006858928],"study_design_scores_gemma":[0.008906213,0.0006040653,0.96534675,0.00017052688,0.00015383627,0.00002933374,0.0007967309,0.000007831114,0.023339082,0.000032915523,0.00047080003,0.00014188331],"about_ca_topic_score_codex":0.0003871113,"about_ca_topic_score_gemma":0.0005966626,"teacher_disagreement_score":0.031284865,"about_ca_system_score_codex":0.00020028866,"about_ca_system_score_gemma":0.00009884825,"threshold_uncertainty_score":0.4248844},"labels":[],"label_agreement":null},{"id":"W2980092244","doi":"10.1182/blood.v116.21.2245.2245","title":"Safety and Efficacy of Hematopoietic Stem Cell Remobilization with Plerixafor (Mozobil®) + G-CSF In Pediatric Patients with Malignant Disorders","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Plerixafor; Medicine; Apheresis; Granulocyte colony-stimulating factor; CXCR4 antagonist; CD34; Hematopoietic stem cell transplantation; Chemotherapy; CXCR4; Transplantation; Surgery; Oncology; Internal medicine; Stem cell; Biology","score_opus":0.0038854145764979746,"score_gpt":0.20854717887389726,"score_spread":0.2046617642973993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980092244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986375,0.000043658627,0.0000157127,0.000034926223,0.0000143039115,0.00088542135,0.00000985083,0.000016992954,0.00034165249],"genre_scores_gemma":[0.99947894,0.00007183755,0.0002884141,0.000008587247,0.0000116571955,0.000017073493,0.000020901236,0.000024771549,0.00007780163],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999048,0.000025105412,0.00018706174,0.00024512195,0.00028036776,0.00021433293],"domain_scores_gemma":[0.9994254,0.00006624367,0.000081601596,0.00022942419,0.000067050576,0.00013028254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000583385,0.00012949904,0.00021463248,0.00013153789,0.000031693384,0.000007750701,0.000045846427,0.000044238994,0.000016322047],"category_scores_gemma":[0.00001558263,0.00008249895,0.000019812476,0.0002894552,0.00006243333,0.000059916667,0.000026432353,0.00013603386,0.0000030741662],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011754964,0.0035796068,0.9925868,0.000296709,0.000026622842,0.00003339402,0.0001894365,0.000003463074,0.0012568091,0.000012934601,0.0000031478846,0.00083561667],"study_design_scores_gemma":[0.026673524,0.0030227818,0.959895,0.00007997405,0.00017717396,0.000016302085,0.00004718686,0.000015610942,0.009933082,0.000006777006,0.000021769285,0.0001108225],"about_ca_topic_score_codex":0.000018314557,"about_ca_topic_score_gemma":0.0001707654,"teacher_disagreement_score":0.03269177,"about_ca_system_score_codex":0.000008422294,"about_ca_system_score_gemma":0.00007750443,"threshold_uncertainty_score":0.33642095},"labels":[],"label_agreement":null},{"id":"W2980094467","doi":"10.1182/blood.v122.21.1946.1946","title":"Bone Marrow Fibrosis In Patients With Multiple Myeloma: A New Prognostic Factor For Survival?","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Bone marrow; Multiple myeloma; Fibrosis; Proportional hazards model; Incidence (geometry); Internal medicine; Gastroenterology; Survival analysis; Pathology; Stage (stratigraphy); Surgery; Biology","score_opus":0.019363241565154635,"score_gpt":0.2520494521895545,"score_spread":0.23268621062439987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980094467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99576426,0.00008133158,0.000052882835,0.00022452605,0.000033693603,0.0035367922,0.00009673659,0.00005195172,0.00015785366],"genre_scores_gemma":[0.992808,0.000003953384,0.00554538,0.000032124117,0.0000663058,0.00046698813,0.00017962247,0.00004198045,0.0008556901],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985587,0.000028489263,0.00021438148,0.00032206345,0.00036753743,0.00050882215],"domain_scores_gemma":[0.9989128,0.00022543369,0.000054816326,0.00027519485,0.0001597855,0.0003719589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000042940137,0.00019644528,0.00033063386,0.00013162833,0.000048971306,0.000034939298,0.00007296451,0.00007542019,0.00023980248],"category_scores_gemma":[0.0004504338,0.00013612099,0.000069400405,0.000190728,0.00003074068,0.0001273248,0.00003474777,0.00010824737,0.00011574729],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055073464,0.0019482808,0.98703325,0.00011450299,0.0001524337,0.000017247154,0.00009465099,2.8188177e-7,0.00075342634,0.000002398383,0.00021560192,0.009117188],"study_design_scores_gemma":[0.036069345,0.0016133507,0.9594429,0.0001261835,0.00007580602,0.0000024642682,0.000019990004,0.0000711204,0.002214561,0.000016364009,0.00020716783,0.00014073067],"about_ca_topic_score_codex":0.0006182483,"about_ca_topic_score_gemma":0.00025161618,"teacher_disagreement_score":0.03551861,"about_ca_system_score_codex":0.000045231063,"about_ca_system_score_gemma":0.00012934244,"threshold_uncertainty_score":0.5550853},"labels":[],"label_agreement":null},{"id":"W2980096036","doi":"10.1182/blood.v128.22.1422.1422","title":"Predictors of Venous Thmromboembolism in Colorectal Cancer: Results from a Global Prospective Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Colorectal cancer; Prospective cohort study; Odds ratio; Cancer; Cohort; Body mass index; Incidence (geometry); Confidence interval; Surgery","score_opus":0.00991499772320333,"score_gpt":0.26280504585873293,"score_spread":0.2528900481355296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980096036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933469,0.00030865317,0.000003306025,0.00031676816,0.00029980516,0.0016700382,0.0005090681,0.000064106505,0.0034813525],"genre_scores_gemma":[0.99917316,0.00020023134,0.000057587386,0.000043569486,0.00024200638,0.00022106079,0.000009951105,0.0000185957,0.00003384022],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983483,0.000058284124,0.00046082446,0.00045854255,0.0003718178,0.00030225219],"domain_scores_gemma":[0.9992641,0.000079881414,0.00016152991,0.00029890717,0.00008821514,0.000107359854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019237363,0.00018318891,0.00069573376,0.00007971191,0.000030721858,0.000007772482,0.00014246037,0.00007850695,0.000056171295],"category_scores_gemma":[0.0001573913,0.0001255166,0.00007989311,0.00028537153,0.00007502973,0.0000633898,0.0001110268,0.0000804997,0.000015124733],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006204206,0.018175941,0.97107,0.000022042039,0.0009669467,0.00015980711,0.0030138989,0.0000027244434,0.0029147116,0.00021599604,0.00045285866,0.002384659],"study_design_scores_gemma":[0.018106638,0.0023229,0.9707183,0.00029334155,0.0006387611,0.0000032491162,0.00051475916,0.0000015943997,0.0068433722,0.00033548722,0.00008888614,0.00013266144],"about_ca_topic_score_codex":0.005343612,"about_ca_topic_score_gemma":0.0023490658,"teacher_disagreement_score":0.017486217,"about_ca_system_score_codex":0.00017360413,"about_ca_system_score_gemma":0.00014858313,"threshold_uncertainty_score":0.80779785},"labels":[],"label_agreement":null},{"id":"W2980096240","doi":"10.1182/blood.v128.22.sci-45.sci-45","title":"Platelet Toll-Like Receptors: Bridging Inflammation and Immunity","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Platelet; Inflammation; Immune system; Receptor; Cell biology; Biology; Platelet activation; Innate immune system; Immunology; Neutrophil extracellular traps; Immunity; Biochemistry","score_opus":0.010185742316667523,"score_gpt":0.2086412204394956,"score_spread":0.19845547812282807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980096240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976239,0.00052375684,0.00037392313,0.00036942633,0.00042954538,0.00013696238,0.000009154012,0.0000877639,0.0004455265],"genre_scores_gemma":[0.9974379,0.00020475738,0.00012278241,0.000072030074,0.000069595015,0.000014990071,0.000027965589,0.000014052795,0.0020359075],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999208,0.00014494061,0.00017811121,0.00020809438,0.000023580638,0.0002373247],"domain_scores_gemma":[0.9995733,0.000087087,0.00007249173,0.00020710037,0.000038732698,0.000021321543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017769096,0.0001365042,0.00016932852,0.00007307855,0.00017389767,0.0000134030315,0.000109569715,0.00013478672,0.00041587724],"category_scores_gemma":[0.000043565564,0.000093528615,0.000034288583,0.000059288104,0.00009958379,0.0001683966,0.000093622635,0.00012169818,0.0004981134],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003460228,0.000046954465,0.0004920913,0.000005493555,0.00008706555,0.000006697846,0.00015740313,3.272103e-8,0.9643312,0.0010644882,0.00036874454,0.033405244],"study_design_scores_gemma":[0.0026523564,0.00012369092,0.0014461108,0.000057243433,0.000030102048,0.00009977788,0.00006032858,1.1440233e-7,0.9708105,0.00039390638,0.024172183,0.00015369349],"about_ca_topic_score_codex":0.000017496077,"about_ca_topic_score_gemma":0.000008920451,"teacher_disagreement_score":0.03325155,"about_ca_system_score_codex":0.000011705245,"about_ca_system_score_gemma":0.000017752569,"threshold_uncertainty_score":0.6402406},"labels":[],"label_agreement":null},{"id":"W2980097577","doi":"10.1182/blood.v126.23.430.430","title":"Switching to Warfarin after 6-Month Completion of Anticoagulant Treatment for Cancer-Associated Thrombosis","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; St. Joseph's Hospital; McMaster University","funders":"","keywords":"Medicine; Warfarin; Hazard ratio; Cumulative incidence; Low molecular weight heparin; Confidence interval; Anticoagulant; Internal medicine; Thrombosis; Surgery; Proportional hazards model; Incidence (geometry); Cohort","score_opus":0.07985627931886718,"score_gpt":0.3406775094373579,"score_spread":0.26082123011849073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980097577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963364,0.00034281999,0.00030511964,0.0010287309,0.00014838789,0.0012185742,0.00004978049,0.000045906272,0.00052430935],"genre_scores_gemma":[0.9976022,0.00013607365,0.001195536,0.00038581307,0.0000978212,0.00043958743,0.0000348726,0.000023813753,0.000084268584],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990771,0.00001988881,0.00024126316,0.0002146686,0.00020862801,0.00023844502],"domain_scores_gemma":[0.9993837,0.000027780652,0.00008734194,0.00020926932,0.00013500154,0.00015693036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015941933,0.00013873081,0.0005471535,0.000082256774,0.00003509274,0.000011698194,0.000052259275,0.00004711554,0.000025171903],"category_scores_gemma":[0.000043699813,0.000110889334,0.00010915896,0.000110685105,0.000010456854,0.000030624335,0.000036440557,0.000029397777,0.000008406637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013651332,0.060031805,0.74293953,0.0010679872,0.008514152,0.00009115065,0.021280777,0.00050765503,0.10504778,0.0022923788,0.016021192,0.04084047],"study_design_scores_gemma":[0.012128099,0.005152291,0.93319654,0.0005255428,0.002883324,0.0000027347442,0.00047675805,0.00029376856,0.038299013,0.00015755389,0.0066037765,0.00028056576],"about_ca_topic_score_codex":0.0023992183,"about_ca_topic_score_gemma":0.0008636163,"teacher_disagreement_score":0.19025706,"about_ca_system_score_codex":0.00015449154,"about_ca_system_score_gemma":0.000069071844,"threshold_uncertainty_score":0.4521936},"labels":[],"label_agreement":null},{"id":"W2980097874","doi":"10.1182/blood.v106.11.1956.1956","title":"Zinc2+ Promotes Heparin Binding to Fibrin and Subsequent Formation of Ternary Heparin-Thrombin-Fibrin Complexes.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Blood properties and coagulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Fibrin; Heparin; Thrombin; Antithrombin; Fibrinogen; Chemistry; Ternary complex; Biochemistry; Immunology; Platelet; Medicine; Enzyme","score_opus":0.02635796532933296,"score_gpt":0.25678651505647626,"score_spread":0.2304285497271433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980097874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99637294,0.00046319462,0.00013721567,0.001090831,0.000031147407,0.0005688851,0.000008405639,0.000058917427,0.0012684551],"genre_scores_gemma":[0.9950194,0.000044077355,0.0042655272,0.00012772389,0.00013110298,0.000017917582,0.00003841138,0.000019895471,0.00033594968],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989689,0.000026468657,0.00036094582,0.00020270483,0.00022394936,0.00021702208],"domain_scores_gemma":[0.99947435,0.000017940381,0.000100882455,0.00022010654,0.00006042584,0.00012632186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015157186,0.00013916293,0.00028610107,0.00011240452,0.00006459507,0.000025295214,0.00006173732,0.00006434572,0.000045237506],"category_scores_gemma":[0.000023890982,0.00012185604,0.000051593415,0.00013410975,0.000036675672,0.00020538807,0.00009469833,0.000081607985,0.000033314296],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023236655,0.0008186658,0.11093711,0.00055905065,0.00013274008,0.000013538001,0.0015001851,0.00004414661,0.8574158,0.00054565456,0.00047361336,0.027327148],"study_design_scores_gemma":[0.002921724,0.00088005495,0.11155237,0.0003645888,0.00020883988,0.0003489355,0.000105537365,0.0021206688,0.87883437,0.00007726494,0.0023699417,0.00021572468],"about_ca_topic_score_codex":0.000191418,"about_ca_topic_score_gemma":0.0000696172,"teacher_disagreement_score":0.027111424,"about_ca_system_score_codex":0.000033367145,"about_ca_system_score_gemma":0.000028743187,"threshold_uncertainty_score":0.49691454},"labels":[],"label_agreement":null},{"id":"W2980105847","doi":"10.1182/blood.v104.11.914.914","title":"High Dose Therapy / ASCT with Rituximab for In-Vivo Purging and Post-ASCT Consolidation in Relapsed Follicular Lymphoma Achieves Prolonged Clinical and Molecular Remissions.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Rituximab; Follicular lymphoma; Autologous stem-cell transplantation; Surgery; Internal medicine; Regimen; Cyclophosphamide; Salvage therapy; Median follow-up; Minimal residual disease; Transplantation; Oncology; Lymphoma; Gastroenterology; Chemotherapy; Bone marrow","score_opus":0.012657508223058085,"score_gpt":0.2777905432569917,"score_spread":0.2651330350339336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980105847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929133,0.0030216377,0.00001201609,0.0025205833,0.000024527182,0.0014318844,0.000010111163,0.00002892979,0.00003702737],"genre_scores_gemma":[0.9948979,0.0008447457,0.0034289772,0.00048956554,0.000029799457,0.00024357784,0.000028087847,0.000025900606,0.000011428402],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987811,0.000069873626,0.00035086938,0.0004143766,0.00015493292,0.0002288861],"domain_scores_gemma":[0.99936205,0.00013594922,0.000088641376,0.00022424448,0.00005510902,0.00013397491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002915048,0.00019212397,0.00044778344,0.000101286896,0.000059831003,0.000029215864,0.000038688504,0.00013971094,0.000004034238],"category_scores_gemma":[0.00013234552,0.00013601578,0.00006280959,0.0001379224,0.000091684735,0.0000641563,0.000021644813,0.00007121416,8.4318435e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038976853,0.013351625,0.9384566,0.00012046587,0.0005260071,0.0017006571,0.00060995115,0.000011699826,0.01783569,0.0010555558,0.000018330502,0.022415763],"study_design_scores_gemma":[0.1889767,0.0025578768,0.753778,0.0005266567,0.00027944124,0.0002913113,0.00010489119,0.000026404063,0.0526158,0.00041918637,0.00020249675,0.00022125187],"about_ca_topic_score_codex":0.00012519593,"about_ca_topic_score_gemma":0.000042805492,"teacher_disagreement_score":0.18507902,"about_ca_system_score_codex":0.0000477328,"about_ca_system_score_gemma":0.00019041992,"threshold_uncertainty_score":0.55465627},"labels":[],"label_agreement":null},{"id":"W2980106908","doi":"10.1182/blood.v126.23.427.427","title":"Dalteparin Thromboprophylaxis in Cancer Patients at High Risk for Venous Thromboembolism: A Randomized Trial","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Randomized controlled trial; Clinical endpoint; Hazard ratio; Surgery; Internal medicine; Ambulatory; Relative risk; Regimen; Absolute risk reduction; Cancer; Confidence interval","score_opus":0.023985153060849213,"score_gpt":0.28932903399924537,"score_spread":0.26534388093839617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980106908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98821,0.00078912167,0.00002711789,0.00026526535,0.0012899784,0.0077779647,0.000094848474,0.00008542133,0.001460256],"genre_scores_gemma":[0.9944298,0.000778755,0.0005313151,0.00037084692,0.00062784966,0.0028162026,0.00013272741,0.00007037251,0.00024210765],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99743944,0.00018320652,0.0007055354,0.0005672132,0.0005292966,0.0005753279],"domain_scores_gemma":[0.9985047,0.00020680061,0.0003181911,0.00046754227,0.00022340908,0.00027938507],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00092533376,0.00032296634,0.0021341068,0.000200279,0.000124773,0.00003217076,0.0001770472,0.00016596516,0.00009916673],"category_scores_gemma":[0.0007097187,0.00026004572,0.00031564658,0.0002577722,0.00011468831,0.00009164999,0.0001622986,0.00018887225,0.000049566297],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8593999,0.057588626,0.045885857,0.0005513322,0.0033633034,0.000049733742,0.0049129096,0.00013109435,0.00013844638,0.0018332831,0.019325264,0.006820261],"study_design_scores_gemma":[0.9493745,0.0037307858,0.040160663,0.00010393711,0.001950238,0.0000017317951,0.00006234332,0.000060235096,0.0008113455,0.0015410425,0.0018966441,0.00030650976],"about_ca_topic_score_codex":0.0048707286,"about_ca_topic_score_gemma":0.0007113658,"teacher_disagreement_score":0.08997464,"about_ca_system_score_codex":0.0002705454,"about_ca_system_score_gemma":0.0001990855,"threshold_uncertainty_score":0.99998516},"labels":[],"label_agreement":null},{"id":"W2980110131","doi":"10.1182/blood.v126.23.434.434","title":"A Chromatin Reader That Acts As a Key to Lock in and Coordinate Recruitment of Transcription Factors and a Novel Polycomb Complex to Bivalent Chromatin Thus Driving Formation of Germinal Centers and B-Cell Lymphomas","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"EZH2; Chromatin; Histone methyltransferase; Conditional gene knockout; Biology; Bivalent chromatin; PRC2; Chromodomain; Promoter; Repressor; BCL6; Germinal center; Transcription factor; Cell biology; Genetics; Cancer research; Chromatin remodeling; Gene; B cell; Gene expression; Phenotype","score_opus":0.06482930963498788,"score_gpt":0.28209744957430893,"score_spread":0.21726813993932104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980110131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99744594,0.00052021886,0.0012743953,0.00008788019,0.000022023338,0.000495798,0.000021731606,0.0000033005379,0.00012868893],"genre_scores_gemma":[0.99798584,0.00010327932,0.0017993485,0.000024389255,0.000009660032,0.00001684733,0.000036687943,0.000010137866,0.000013823447],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99926966,0.000041207786,0.00024070247,0.0001910882,0.00012329798,0.00013403482],"domain_scores_gemma":[0.999592,0.000011871848,0.000112975715,0.000111897636,0.000043832508,0.00012741405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017305098,0.00012410717,0.00017736093,0.00009864796,0.000020965474,0.000015676496,0.000045104258,0.00007138943,0.0000010651836],"category_scores_gemma":[0.00003429335,0.00011541231,0.000021695978,0.0000699026,0.000029707577,0.000010631376,0.00005576032,0.000024439447,1.8728474e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005792813,0.00019057967,0.023115404,0.00010353681,0.000012689223,5.223726e-7,0.0029110329,0.00001542129,0.97293854,0.0000119423885,0.000005314753,0.0006371188],"study_design_scores_gemma":[0.002245454,0.00078331295,0.13367139,0.000096925265,0.00002446718,0.000007056575,0.00087652844,0.00015745511,0.8618411,0.000023742772,0.00016018035,0.00011239965],"about_ca_topic_score_codex":0.00014720044,"about_ca_topic_score_gemma":0.00012145353,"teacher_disagreement_score":0.11109742,"about_ca_system_score_codex":0.000013079173,"about_ca_system_score_gemma":0.000025322042,"threshold_uncertainty_score":0.47063774},"labels":[],"label_agreement":null},{"id":"W2980110969","doi":"10.1182/blood.v118.21.4518.4518","title":"Very Late Relapse of a Philadelphia Positive Acute Megakaryocytic Leukemia Post Allogenic Bone Marrow Transplant","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Cytarabine; Bone marrow; Leukemia; Internal medicine; Acute leukemia; Minimal residual disease; Cyclophosphamide; Induction chemotherapy; Chemotherapy; Acute megakaryoblastic leukemia; Oncology","score_opus":0.014640710586387969,"score_gpt":0.2255738572674379,"score_spread":0.21093314668104993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980110969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933905,0.0012149083,0.000007687344,0.00022940568,0.000120788616,0.0006081188,0.00025117156,0.00010134986,0.0040760734],"genre_scores_gemma":[0.996685,0.00048235,0.0011185507,0.00030857004,0.00007463798,0.000035352798,0.00022933389,0.000067075845,0.0009990947],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981111,0.00005793882,0.00052215526,0.00045863233,0.0003671643,0.00048300286],"domain_scores_gemma":[0.9987625,0.00006689069,0.00018676417,0.0006062944,0.00012258752,0.00025494958],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013699075,0.0003436308,0.0006543681,0.00017801813,0.00005759472,0.000005490775,0.00016862278,0.00023007377,0.0003042926],"category_scores_gemma":[0.000027835993,0.00029885457,0.0003093137,0.0002265151,0.0001457639,0.00011944082,0.000051875275,0.00031762826,0.00014343549],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055545564,0.0033236765,0.018657062,0.00045832852,0.008714172,0.013666716,0.009419965,0.000003491567,0.9389235,0.0002987975,0.00052958773,0.00045018166],"study_design_scores_gemma":[0.055220254,0.0049881237,0.22390364,0.0013558544,0.01666448,0.008182532,0.00018025827,0.00013110047,0.6880987,0.00023116429,0.00015457133,0.0008892641],"about_ca_topic_score_codex":0.0005578703,"about_ca_topic_score_gemma":0.000046209963,"teacher_disagreement_score":0.25082472,"about_ca_system_score_codex":0.00052381615,"about_ca_system_score_gemma":0.0008522378,"threshold_uncertainty_score":0.99994636},"labels":[],"label_agreement":null},{"id":"W2980113071","doi":"10.1182/blood.v108.11.2134.2134","title":"RIZ1 Is Downregulated during CML Progression and Displays Tumor Suppressor Properties in CML Cell Lines.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Bone marrow; Cancer research; Myeloid; Biology; Loss of heterozygosity; CD34; Tumor suppressor gene; Myeloid leukemia; Pathology; Immunology; Medicine; Stem cell; Genetics; Cancer; Gene; Carcinogenesis","score_opus":0.00940533670119168,"score_gpt":0.24437811980038857,"score_spread":0.2349727830991969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980113071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949115,0.001720978,9.2193596e-7,0.00072748575,0.000025075227,0.00082004943,0.000013188901,0.000090123955,0.0016907114],"genre_scores_gemma":[0.9957524,0.000046920897,0.00044268405,0.00006051615,0.00020949305,0.000086907,0.00002823971,0.000047373305,0.0033254453],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983201,0.00005112511,0.00033228408,0.00041442027,0.00038324884,0.00049881736],"domain_scores_gemma":[0.99935496,0.00002607544,0.000067210654,0.00032859776,0.00008633935,0.00013680916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015845217,0.000216502,0.0003289925,0.00020147613,0.00009501862,0.000045532004,0.00011880679,0.00012344793,0.000065809174],"category_scores_gemma":[0.000054193537,0.0001548669,0.000048014605,0.00028087798,0.00013575637,0.00012242919,0.00016654292,0.00036222863,0.00003140024],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004362294,0.0012412537,0.08748628,0.00082395703,0.000027153585,0.0007370659,0.00038298863,0.0000059101544,0.90785843,0.0000059688464,0.00076983497,0.00022493917],"study_design_scores_gemma":[0.008678689,0.00016893882,0.20942585,0.00043776445,0.000067178466,0.00021648717,0.000058086327,0.0006981915,0.77968806,0.000014180625,0.00036513925,0.00018143238],"about_ca_topic_score_codex":0.00024264576,"about_ca_topic_score_gemma":0.000026625557,"teacher_disagreement_score":0.12817036,"about_ca_system_score_codex":0.00007413337,"about_ca_system_score_gemma":0.00012289993,"threshold_uncertainty_score":0.63152885},"labels":[],"label_agreement":null},{"id":"W2980115092","doi":"10.1182/blood.v106.11.2175.2175","title":"A Novel Inherited Platelet Function Disorder Involving the Thromboxane A2 Pathway of Platelet Activation.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hospital for Sick Children","funders":"","keywords":"Platelet; Thromboxane A2; Platelet activation; Thromboxane receptor; Internal medicine; Thromboxane; Endocrinology; Platelet disorder; Chemistry; GPVI; Medicine","score_opus":0.014263375915548049,"score_gpt":0.2228538831262656,"score_spread":0.20859050721071756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980115092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926384,0.003615495,0.0021172164,0.00046532834,0.0000624175,0.00041617983,0.000017352973,0.0000886102,0.0005789639],"genre_scores_gemma":[0.9980756,0.0003694394,0.00032877433,0.0006068506,0.00033792996,0.000028260167,0.000075311975,0.000033366825,0.00014448831],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988612,0.000045555284,0.00028639197,0.00022948504,0.000360173,0.00021720922],"domain_scores_gemma":[0.9992259,0.000071187314,0.000116913834,0.00040610763,0.000108674896,0.000071179944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021558293,0.00017531912,0.00032884363,0.00007118057,0.00012911158,0.000017277407,0.0001008346,0.000118563876,0.00023293808],"category_scores_gemma":[0.00006768546,0.000121719335,0.00027099677,0.00029847957,0.00009338077,0.00016031973,0.000032623957,0.0001962476,0.000021115758],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016719572,0.0063903914,0.014816512,0.0003695464,0.0062166043,0.00004465182,0.002021795,0.0007185248,0.7827278,0.0017139394,0.0009447615,0.18236354],"study_design_scores_gemma":[0.03553633,0.0011700602,0.28281233,0.0006237652,0.0015799986,0.000633598,0.0021782003,0.0007304551,0.51341456,0.0002643275,0.16021357,0.0008427676],"about_ca_topic_score_codex":0.000041096795,"about_ca_topic_score_gemma":0.000012956148,"teacher_disagreement_score":0.26931322,"about_ca_system_score_codex":0.00001696772,"about_ca_system_score_gemma":0.00008044685,"threshold_uncertainty_score":0.49635702},"labels":[],"label_agreement":null},{"id":"W2980116131","doi":"10.1182/blood.v114.22.526.526","title":"Comparable Disease-Free and Overall Survival After “Well-Matched” Unrelated Donor and Matched Sibling Donor Transplantation in Acute Myeloid Leukemia with Adverse Risk Karyotype in First Complete Remission: A Report From the Acute Leukemia Working Committee of the Centre for International Blood and Marrow Transplant Research.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Internal medicine; Myeloid leukemia; Medicine; Oncology; Transplantation; Hematopoietic stem cell transplantation; Gastroenterology","score_opus":0.0211312943778187,"score_gpt":0.26708225049304873,"score_spread":0.24595095611523005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980116131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99253595,0.00069888466,0.000044031312,0.0043727458,0.000070619004,0.0015758777,0.0005010651,0.000028225024,0.00017261517],"genre_scores_gemma":[0.994452,0.0032112428,0.0014960347,0.0001454565,0.000106022504,0.000059683764,0.00031142877,0.000040014274,0.00017812294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970891,0.0003007128,0.0006869927,0.00065568887,0.0007279919,0.0005395093],"domain_scores_gemma":[0.99762076,0.0010500283,0.00023416859,0.0006195663,0.00023287063,0.00024262628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011547838,0.00032452084,0.00059038267,0.0002349577,0.00023370651,0.000069408095,0.00037966314,0.0001839826,0.000022528415],"category_scores_gemma":[0.00020097598,0.00021182079,0.00008600589,0.00047691623,0.00031856092,0.0001915663,0.00012163178,0.0010008583,6.934911e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015355406,0.000249374,0.97241485,0.00019553442,0.0007236388,0.0017623841,0.0041976003,0.0001558877,0.0044798832,0.000029550702,0.00026560272,0.00017030464],"study_design_scores_gemma":[0.027086455,0.00022096962,0.9618329,0.0023287479,0.0013526545,0.00032546418,0.00049487577,0.003846232,0.0012842477,0.0005522021,0.0003959117,0.00027933388],"about_ca_topic_score_codex":0.0018258974,"about_ca_topic_score_gemma":0.0033194178,"teacher_disagreement_score":0.011731049,"about_ca_system_score_codex":0.00025808936,"about_ca_system_score_gemma":0.00045371335,"threshold_uncertainty_score":0.86378014},"labels":[],"label_agreement":null},{"id":"W2980118121","doi":"10.1182/blood.v128.22.5025.5025","title":"Rationale and Design of a Phase IIb/III Open-Label, Multicenter Study of Dabigatran Etexilate for Venous Thromboembolism in Children: The Diversity Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Toronto; SickKids Foundation; University of Ottawa; Hospital for Sick Children; University of Alberta","funders":"","keywords":"Medicine; Direct thrombin inhibitor; Dabigatran; Heparin; Dosing; Off-label use; Low molecular weight heparin; Internal medicine; Intensive care medicine; Surgery; Warfarin","score_opus":0.05798566934412044,"score_gpt":0.3214446270882047,"score_spread":0.2634589577440843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980118121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98852307,0.00012351335,0.0001672554,0.00018707359,0.000040073763,0.0108782975,0.000036814505,0.000009529383,0.00003437567],"genre_scores_gemma":[0.99930066,0.00007724319,0.00021471824,0.00008841075,0.00003037605,0.00024305312,0.000003965363,0.000015036878,0.000026529393],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988195,0.0001207621,0.00035101685,0.0002908181,0.00023683805,0.00018109163],"domain_scores_gemma":[0.9991902,0.00016122224,0.00016299465,0.0003441682,0.000089059315,0.000052373573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006025877,0.00014085788,0.00060247956,0.00008456837,0.00014834107,0.000013592767,0.00026011412,0.000033599266,0.000017644366],"category_scores_gemma":[0.00005203468,0.00008415956,0.000029475583,0.00011110715,0.00007559398,0.000107768334,0.00041214967,0.00005619555,8.9697676e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021239095,0.42710167,0.4959154,0.00015271328,0.00404272,0.00003507301,0.045432623,0.000019077721,0.016916508,0.0002953603,0.00047681085,0.0074881245],"study_design_scores_gemma":[0.14384302,0.013829996,0.8340187,0.00013439426,0.001994717,0.0000039928605,0.0036444573,0.000039836617,0.0022377453,0.00009175941,0.000015529295,0.00014583368],"about_ca_topic_score_codex":0.0004445269,"about_ca_topic_score_gemma":0.00013470958,"teacher_disagreement_score":0.41327167,"about_ca_system_score_codex":0.000014387301,"about_ca_system_score_gemma":0.00003432672,"threshold_uncertainty_score":0.34319273},"labels":[],"label_agreement":null},{"id":"W2980118535","doi":"10.1182/blood.v106.11.2135.2135","title":"Insights into Disturbed Hemostasis in the Quebec Platelet Disorder Using Thromboelastography, Blood Clots Formed at Low Shear, and Perfusion Studies of Fibrinolysis.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Blood properties and coagulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; McMaster University","funders":"","keywords":"Fibrinolysis; Fibrin; Plasmin; Thromboelastography; Platelet; Plasminogen activator; Whole blood; Hemostasis; Medicine; Immunology; Chemistry; Andrology; Internal medicine; Biochemistry; Enzyme","score_opus":0.021771772093459957,"score_gpt":0.26814216793566226,"score_spread":0.2463703958422023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980118535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98100513,0.017818108,0.000009951081,0.0005960374,0.000028749197,0.00045716233,0.0000019917793,0.000020919722,0.00006195853],"genre_scores_gemma":[0.99781877,0.001231917,0.0005970262,0.00018209197,0.00008192795,0.00001793675,0.000013694507,0.000019218753,0.000037404265],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987754,0.00006995326,0.0003772011,0.00026836808,0.000297641,0.0002114273],"domain_scores_gemma":[0.9994013,0.000080569465,0.00010858198,0.0002826601,0.00007836478,0.000048542828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011612666,0.00019600775,0.00044336088,0.0001353768,0.00018619382,0.000016922319,0.000079238846,0.00009628541,0.000013186472],"category_scores_gemma":[0.000040267558,0.00011987964,0.00010086771,0.00034388303,0.00017421014,0.00014030792,0.00012358963,0.00013176336,0.0000015069259],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010912293,0.0067399535,0.48595852,0.0017341343,0.0020221532,0.00006773541,0.090858065,0.0003560663,0.3213934,0.00029346024,0.00018766832,0.089297615],"study_design_scores_gemma":[0.022438029,0.0017422438,0.70035714,0.0014936905,0.0033208786,0.00024929707,0.014312709,0.0019283595,0.2510771,0.00030832176,0.001961063,0.00081117864],"about_ca_topic_score_codex":0.0017980859,"about_ca_topic_score_gemma":0.007954388,"teacher_disagreement_score":0.21439864,"about_ca_system_score_codex":0.000026835694,"about_ca_system_score_gemma":0.000034702018,"threshold_uncertainty_score":0.48885497},"labels":[],"label_agreement":null},{"id":"W2980121220","doi":"10.1182/blood.v122.21.4237.4237","title":"Impact of Time from Diagnosis to Initiation of Curative-Intent Chemotherapy on Clinical Outcomes in Patients with Hodgkin Lymphoma","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"ABVD; Medicine; Vinblastine; Dacarbazine; Chemotherapy regimen; Chemotherapy; Internal medicine; Hodgkin's lymphoma; Bleomycin; Cancer; Lymphoma; Surgery; Performance status; Oncology; Vincristine; Cyclophosphamide","score_opus":0.018888842947638068,"score_gpt":0.3124675849527905,"score_spread":0.29357874200515244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980121220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99851835,0.00001649332,0.0000014574784,0.00029889992,0.000021522133,0.0008629362,0.000074826676,0.000009862606,0.00019567831],"genre_scores_gemma":[0.99905896,0.000032860495,0.00036067842,0.00030340388,0.000017403165,0.00013900326,0.000060016646,0.000015652777,0.000012004899],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989304,0.000050802308,0.00043443282,0.00020608492,0.00024602946,0.0001322347],"domain_scores_gemma":[0.9990001,0.0003180625,0.00017639123,0.00025181388,0.00014781531,0.00010584915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005591071,0.00015084018,0.00053523644,0.00009920381,0.000008511896,0.000005758936,0.000053805496,0.00006494256,0.00032542818],"category_scores_gemma":[0.00012230837,0.00008973152,0.00015965424,0.00012273678,0.000029586787,0.00005861704,0.000015362994,0.000029356135,0.00007645988],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041349677,0.01789164,0.9657734,0.0000044463736,0.00057600136,0.0000037236255,0.00022663559,0.000002034193,0.000038655802,0.0000033045717,0.00016632587,0.01490036],"study_design_scores_gemma":[0.02256425,0.00800364,0.96407837,0.0001900739,0.000113588765,2.3257753e-7,0.000011766868,0.000004991281,0.004930453,0.000014434825,0.000006951762,0.000081233586],"about_ca_topic_score_codex":0.0013930226,"about_ca_topic_score_gemma":0.000018453746,"teacher_disagreement_score":0.022150751,"about_ca_system_score_codex":0.000092249735,"about_ca_system_score_gemma":0.000064588894,"threshold_uncertainty_score":0.3659145},"labels":[],"label_agreement":null},{"id":"W2980122607","doi":"10.1182/blood.v110.11.770.770","title":"Ex Vivo Graft Purging and Expansion of Autologous Mobilized Peripheral Blood Progenitor Cell (PBPC) Products from Patients with Multiple Myeloma (MM).","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ex vivo; Progenitor cell; Stem cell; Medicine; CD34; Transplantation; Bortezomib; Population; Bone marrow; Autologous stem-cell transplantation; Rituximab; Haematopoiesis; Cancer research; Immunology; Multiple myeloma; In vivo; Biology; Antibody; Internal medicine; Cell biology","score_opus":0.009498205135958917,"score_gpt":0.23854233297526226,"score_spread":0.22904412783930334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980122607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99669,0.0008912299,0.000022529211,0.00003285236,0.00006584831,0.0019142342,0.00007913854,0.00009120207,0.00021297246],"genre_scores_gemma":[0.9882604,0.000030553034,0.011106938,0.000017089804,0.00012420968,0.0000589008,0.00014596782,0.000053600274,0.00020237113],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977119,0.00006370407,0.00039413836,0.0006068192,0.00063230685,0.00059112016],"domain_scores_gemma":[0.99855614,0.0001363193,0.00016244511,0.00047750288,0.00031445813,0.0003531614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016991468,0.00030538073,0.0005078622,0.00015033239,0.00011353999,0.00002226841,0.00010525147,0.00012815667,0.00006609759],"category_scores_gemma":[0.00019626248,0.0002233377,0.000069997826,0.0002456306,0.00015783493,0.000117381074,0.00008567777,0.0001946002,0.000006793161],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002083198,0.0042429892,0.81106067,0.00022898267,0.00038073014,0.00037740087,0.0006044985,5.26423e-7,0.17529574,8.082055e-7,0.000015637466,0.0057088095],"study_design_scores_gemma":[0.02778686,0.0014847998,0.48956606,0.00012262416,0.0003543691,0.000031318883,0.00013700679,0.00004546567,0.48022112,0.0000035534113,0.00008171435,0.00016511022],"about_ca_topic_score_codex":0.0003414081,"about_ca_topic_score_gemma":0.00007351458,"teacher_disagreement_score":0.32149464,"about_ca_system_score_codex":0.000033885688,"about_ca_system_score_gemma":0.00014657924,"threshold_uncertainty_score":0.9107447},"labels":[],"label_agreement":null},{"id":"W2980124547","doi":"10.1182/blood.v116.21.2266.2266","title":"Allogeneic Stem Cell Transplantation for Blast Crisis (BC) Chronic Myelogenous Leukemia (CML) In the Tyrosine Kinase Inhibitors (TKIs) Era. Analysis of Pre-Transplant Variables on Transplant Outcome. On Behalf of the Societe Francaise De Greffe De Moelle Et De Therapie Cellulaire and the French Group of CML","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Dasatinib; Medicine; Imatinib; Transplantation; Internal medicine; Imatinib mesylate; Chronic myelogenous leukemia; Chemotherapy; Surgery; Chemotherapy regimen; Hematopoietic stem cell transplantation; Oncology; Gastroenterology; Myeloid leukemia; Leukemia","score_opus":0.008025564271183915,"score_gpt":0.23945587822861347,"score_spread":0.23143031395742955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980124547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99540323,0.0012084732,0.00059459085,0.00040139232,0.00006436505,0.001495718,0.00075173867,0.000016870648,0.00006360162],"genre_scores_gemma":[0.9976548,0.0011279322,0.00046924036,0.00028211178,0.000058071462,0.00019395814,0.0001485058,0.0000433285,0.000022066732],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975476,0.000401235,0.0007546168,0.000391363,0.0004544276,0.00045076004],"domain_scores_gemma":[0.99779564,0.0010215949,0.00037670488,0.00066294905,0.00005923141,0.0000838903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013212466,0.00036314945,0.0007779823,0.0001884028,0.0001446555,0.00001374697,0.00037242184,0.00028869652,0.000018703871],"category_scores_gemma":[0.0000147906185,0.00019993208,0.0005202802,0.00049047376,0.00027190105,0.00004126745,0.000013697155,0.0005078576,3.1564883e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033320258,0.0032950048,0.19250627,0.0027731047,0.0037977647,0.00007688584,0.056376062,0.0077720527,0.72802,0.0006232413,0.000048525457,0.001379064],"study_design_scores_gemma":[0.025162,0.0014629705,0.32459798,0.0005491524,0.014050105,0.00007430286,0.00048307335,0.003630415,0.62959105,0.00009927183,0.00002512043,0.00027455774],"about_ca_topic_score_codex":0.004621349,"about_ca_topic_score_gemma":0.005169372,"teacher_disagreement_score":0.13209172,"about_ca_system_score_codex":0.00032256966,"about_ca_system_score_gemma":0.0007550126,"threshold_uncertainty_score":0.8152994},"labels":[],"label_agreement":null},{"id":"W2980125828","doi":"10.1182/blood.v128.22.615.615","title":"Obinutuzumab plus Bendamustine Followed by Obinutuzumab Maintenance Prolongs Overall Survival Compared with Bendamustine Alone in Patients with Rituximab-Refractory Indolent Non-Hodgkin Lymphoma: Updated Results of the GADOLIN Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Obinutuzumab; Bendamustine; Rituximab; Internal medicine; Neutropenia; Refractory (planetary science); Clinical endpoint; Adverse effect; Surgery; Gastroenterology; Oncology; Clinical trial; Lymphoma; Chemotherapy","score_opus":0.006972763046238773,"score_gpt":0.21212413540489797,"score_spread":0.20515137235865918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980125828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944512,0.00010658807,0.000009946201,0.00028351624,0.00016441765,0.003910811,0.00071975973,0.0000766627,0.000277057],"genre_scores_gemma":[0.9984561,0.000020013109,0.00025497022,0.00010365462,0.000060593884,0.0002961709,0.00034392404,0.00009096052,0.00037360968],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995653,0.00022330286,0.001080596,0.0010040948,0.0012279098,0.00081110524],"domain_scores_gemma":[0.9970916,0.00018802559,0.00075133104,0.0012306849,0.00047937265,0.00025901623],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036354392,0.0006894533,0.0014079708,0.00018200731,0.0001238807,0.000027576887,0.00040515722,0.00016231663,0.000031828513],"category_scores_gemma":[0.00013074832,0.0003367304,0.00015285402,0.0006013186,0.00026001807,0.0001799255,0.0002055718,0.00019359271,0.000014384986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036603566,0.03506719,0.9205802,0.00009783667,0.0012423041,0.0003778435,0.0013779356,0.00003619223,0.00066003075,0.000008737378,0.002789407,0.0011587578],"study_design_scores_gemma":[0.31012514,0.006036755,0.6780007,0.0009293768,0.0006633073,0.000022082526,0.00016242814,0.000026385476,0.0033219429,0.0000022166776,0.00035464563,0.00035503588],"about_ca_topic_score_codex":0.0027916457,"about_ca_topic_score_gemma":0.0014631688,"teacher_disagreement_score":0.27352157,"about_ca_system_score_codex":0.001775711,"about_ca_system_score_gemma":0.0011548619,"threshold_uncertainty_score":0.99990845},"labels":[],"label_agreement":null},{"id":"W2980129206","doi":"10.1182/blood.v122.21.1105.1105","title":"Plasmin Cleaves Complement iC3b, Preventing CR3/4 Mediated Phagocytosis By Macrophages","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Plasmin; iC3b; Complement system; Anaphylatoxin; Complement receptor; Cell biology; Chemistry; Alternative complement pathway; Complement factor I; Complement receptor 1; Opsonin; Factor H; Complement membrane attack complex; Phagocytosis; Immune system; Biology; Immunology; Biochemistry; Enzyme","score_opus":0.020154048760205937,"score_gpt":0.26414083833643953,"score_spread":0.2439867895762336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980129206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939212,0.00054265634,0.00020266579,0.0011894356,0.00013347762,0.0007637032,0.00003063037,0.00021034836,0.0030058634],"genre_scores_gemma":[0.99462354,0.00006812333,0.0025874875,0.000951375,0.000111451096,0.00010290474,0.00014144968,0.000040473184,0.0013731961],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984913,0.00006173823,0.00039077134,0.0003161778,0.00037226168,0.00036777617],"domain_scores_gemma":[0.999189,0.00007687534,0.00013454678,0.0002856568,0.00009505141,0.00021887977],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015289854,0.00020457205,0.00034559728,0.000083536295,0.00012137042,0.000053972828,0.000118311786,0.000093909934,0.0037437547],"category_scores_gemma":[0.000060136957,0.00018211489,0.00010470657,0.00017881264,0.000038833856,0.00011261926,0.000075052194,0.0001463012,0.00071706786],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001977577,0.0023990923,0.011962639,0.00014333632,0.0005685848,0.00001591999,0.0003322721,6.8530863e-7,0.95587564,0.00043303816,0.024406753,0.003842251],"study_design_scores_gemma":[0.008134899,0.00046574802,0.029686114,0.00014443636,0.0005137382,0.000037479225,0.00034381548,0.00032502107,0.95423365,0.00029395294,0.0055025457,0.00031857635],"about_ca_topic_score_codex":0.00006701391,"about_ca_topic_score_gemma":0.0000076529805,"teacher_disagreement_score":0.018904207,"about_ca_system_score_codex":0.000019067154,"about_ca_system_score_gemma":0.000030756757,"threshold_uncertainty_score":0.99716693},"labels":[],"label_agreement":null},{"id":"W2980129669","doi":"10.1182/blood.v124.21.2858.2858","title":"Trajectories of Inflammation Markers after Acute DVT and Their Association with the Postthrombotic Syndrome","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Body mass index; Post-thrombotic syndrome; Internal medicine; Biomarker; Confounding; Confidence interval; Poisson regression; C-reactive protein; Venous thrombosis; Surgery; Thrombosis; Inflammation; Population","score_opus":0.0033366194030520937,"score_gpt":0.19101131924469333,"score_spread":0.18767469984164123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980129669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99584424,0.0001026119,0.00007891818,0.0023485376,0.000037634967,0.00040361792,0.0000034081952,0.000021202268,0.0011598119],"genre_scores_gemma":[0.999386,0.00008721281,0.00010872147,0.00018372496,0.000045189117,0.000051104547,0.000006600796,0.000011494078,0.000119943434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994211,0.00005891623,0.00013221925,0.000108410335,0.00016342918,0.00011588773],"domain_scores_gemma":[0.99951726,0.00011824971,0.00011882306,0.00015584513,0.000059908132,0.000029941488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036017946,0.000092101065,0.00030832842,0.00003868438,0.0000394943,0.000017372146,0.000036099515,0.000041984385,0.000022419932],"category_scores_gemma":[0.000044946566,0.000049084705,0.00004106683,0.00008151904,0.00006450145,0.000059322643,0.000021642774,0.000059110436,0.000003191352],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050291126,0.0039167907,0.8635728,0.0028112726,0.024785513,0.00012412945,0.035483476,0.000048683953,0.022169555,0.022946576,0.003975606,0.015136529],"study_design_scores_gemma":[0.004786162,0.0006039201,0.98861474,0.00011429718,0.0014710757,0.000030225432,0.0002987244,0.000047959747,0.003431626,0.00018161595,0.00033687628,0.00008275169],"about_ca_topic_score_codex":0.000033715824,"about_ca_topic_score_gemma":0.000029925486,"teacher_disagreement_score":0.125042,"about_ca_system_score_codex":0.000017271917,"about_ca_system_score_gemma":0.000013446135,"threshold_uncertainty_score":0.20016162},"labels":[],"label_agreement":null},{"id":"W2980132597","doi":"10.1182/blood.v120.21.4938.4938","title":"The Effects of Azacitidine On Quality of Life: A Prospective Longitudinal Assessment","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Pneumocystis jirovecii pneumonia detection and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Quality of life (healthcare); Repeated measures design; Prospective cohort study; Physical therapy; Randomized controlled trial; Azacitidine; Analysis of variance; Randomization; Longitudinal study; Covariate; Internal medicine; Statistics","score_opus":0.01960338666675403,"score_gpt":0.31856462166291727,"score_spread":0.2989612349961632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980132597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951044,0.00059568224,0.000033848264,0.0001724447,0.00019642316,0.00057592307,0.0000075079647,0.000025894778,0.0032879112],"genre_scores_gemma":[0.9994354,0.000063990614,0.000117228345,0.000033822194,0.00009362414,0.00007891339,0.000002160111,0.000010948005,0.00016388977],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989484,0.00008891949,0.00029027046,0.00013426808,0.00034161404,0.00019655509],"domain_scores_gemma":[0.998842,0.00045269838,0.00018734738,0.00029835038,0.00008504807,0.00013457607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027847395,0.00012052681,0.00032121068,0.00004318072,0.000066900066,0.0000042040992,0.000046584864,0.000043159893,0.000011332923],"category_scores_gemma":[0.00037925123,0.0000729784,0.00012419237,0.00012802743,0.00007985594,0.0000319328,0.000024858515,0.00012008874,0.000008602258],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003271754,0.00486883,0.9034814,0.0003036118,0.0006355174,0.0000073966003,0.00012809131,3.1825854e-7,0.08444582,0.0046638544,0.000024695495,0.0011132474],"study_design_scores_gemma":[0.0039894916,0.0014786217,0.8412146,0.000093114,0.00022104959,0.000017112996,0.000031605407,0.0000015918424,0.15278837,0.000051107407,0.0000613297,0.000052025243],"about_ca_topic_score_codex":0.0000328703,"about_ca_topic_score_gemma":0.0000064443566,"teacher_disagreement_score":0.06834255,"about_ca_system_score_codex":0.000053114592,"about_ca_system_score_gemma":0.0000640447,"threshold_uncertainty_score":0.2975973},"labels":[],"label_agreement":null},{"id":"W2980133902","doi":"10.1182/blood.v118.21.1717.1717","title":"Immunosuppressive Treatment for Patients with Myelodysplastic Syndromes: A Review of 358 Patients","year":2011,"lang":"en","type":"review","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Alemtuzumab; Clinical trial; Myelodysplastic syndromes; Daclizumab; Eltrombopag; Internal medicine; Transplantation; Oncology; Tacrolimus","score_opus":0.042072958654804544,"score_gpt":0.32577499875524807,"score_spread":0.28370204010044353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980133902","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030045497,0.98760027,0.0000052837336,0.0000052198466,0.000093474766,0.010283534,0.0010256284,0.00003342873,0.00065271056],"genre_scores_gemma":[0.000020856567,0.9928059,0.0008083625,0.00003410678,0.00006626154,0.002249456,0.0032396468,0.00017138229,0.00060401874],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969954,0.00014725712,0.0010787223,0.00066478306,0.00054802746,0.0005658307],"domain_scores_gemma":[0.9965205,0.00041869842,0.0009181707,0.0010716241,0.0008232303,0.00024774266],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013954708,0.0007392151,0.003799441,0.0002944778,0.000060269107,0.000009018735,0.0003669723,0.00030713322,0.00020005573],"category_scores_gemma":[0.00051366276,0.00043013913,0.00078722724,0.00039644397,0.000129175,0.00006421305,0.00011982929,0.00031148616,0.000091674636],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026864442,0.0057518515,0.00048105785,0.47775188,0.004374922,0.000042292584,0.00006015371,3.974103e-9,6.1527146e-8,0.0000139197955,0.001265255,0.50999],"study_design_scores_gemma":[0.009918312,0.007895393,0.0002561919,0.323189,0.016643392,0.000054439282,0.0000023737,1.12683566e-7,0.0000037033728,0.0000019056722,0.6416895,0.0003457235],"about_ca_topic_score_codex":0.000021405946,"about_ca_topic_score_gemma":7.8822546e-7,"teacher_disagreement_score":0.6404242,"about_ca_system_score_codex":0.00044058255,"about_ca_system_score_gemma":0.0014315387,"threshold_uncertainty_score":0.99981505},"labels":[],"label_agreement":null},{"id":"W2980136873","doi":"10.1182/blood.v120.21.2229.2229","title":"Prospective Comparison of the Pediatric Bleeding Questionnaire (PBQ) and the International Society On Thrombosis and Haemostasis Bleeding Assessment Tool (ISTH-BAT) in Children Referred to a Tertiary-Care Pediatric Centre.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Hospital for Sick Children","funders":"","keywords":"Medicine; Von Willebrand disease; Mucocutaneous zone; Prospective cohort study; Platelet disorder; Pediatrics; Surgery; Internal medicine; Platelet; Disease; Von Willebrand factor","score_opus":0.014935276367984366,"score_gpt":0.29671541850752975,"score_spread":0.2817801421395454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980136873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957915,0.0014534469,0.0000046365803,0.0013293395,0.00010283884,0.0010283648,0.000023971297,0.000017878125,0.00024801615],"genre_scores_gemma":[0.9987237,0.000543149,0.00031502996,0.00013898853,0.00019018399,0.000050038405,0.00001349741,0.000013909955,0.0000115360035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989345,0.000033937064,0.00025960337,0.0002325084,0.00031840857,0.00022100918],"domain_scores_gemma":[0.9995247,0.0000668026,0.0001322967,0.00014144472,0.000065823304,0.000068906906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018985597,0.00016446131,0.00029349804,0.00007756763,0.00013889158,0.000032552143,0.00009555846,0.00006954522,0.000005255194],"category_scores_gemma":[0.000055628974,0.000098616765,0.0000838999,0.00024466196,0.000045030767,0.000101035665,0.00012562331,0.00020027565,0.0000011923255],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005182645,0.0007513224,0.99321496,0.000046214398,0.000227993,6.5587164e-7,0.0048345774,0.0000030149297,0.000034107976,0.00014024964,0.00020438276,0.0004907044],"study_design_scores_gemma":[0.007547653,0.000075876276,0.9896805,0.000083538296,0.0007645645,0.0000145917365,0.0012905032,0.00006167749,0.00034532283,0.000034345267,0.00000398373,0.0000974307],"about_ca_topic_score_codex":0.00010375766,"about_ca_topic_score_gemma":0.00001789636,"teacher_disagreement_score":0.007495826,"about_ca_system_score_codex":0.00011774194,"about_ca_system_score_gemma":0.000049257895,"threshold_uncertainty_score":0.4021475},"labels":[],"label_agreement":null},{"id":"W2980137220","doi":"10.1182/blood.v110.11.3601.3601","title":"A Phase II Trial of Myeloma Induction Therapy with Cyclophosphamide, Bortezomib, and Dexamethasone (Cybor-D): Improved Response over Historical Lenalidomide-Dexamethasone Controls.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Lenalidomide; Dexamethasone; Medicine; Multiple myeloma; Bortezomib; Internal medicine; Prednisone; Cyclophosphamide; Gastroenterology; Phases of clinical research; Surgery; Toxicity; Oncology; Chemotherapy","score_opus":0.025775856841918833,"score_gpt":0.3137336558421229,"score_spread":0.2879577990002041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980137220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939059,0.002764007,0.00041142324,0.00031098197,0.00013416304,0.0022156034,0.000024349321,0.00007813274,0.0001554377],"genre_scores_gemma":[0.9949189,0.00036128375,0.0035511453,0.00009403114,0.00027038966,0.000116492076,0.000019441353,0.00006122466,0.0006071245],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9971905,0.00035964596,0.00064683723,0.00051398703,0.0006839473,0.0006050905],"domain_scores_gemma":[0.9974633,0.00091190304,0.00031144812,0.0005493155,0.00025131166,0.0005127086],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022423216,0.00035714475,0.0008759131,0.00034382922,0.00020463378,0.0000206779,0.00010352716,0.00024248425,0.000056603127],"category_scores_gemma":[0.0011666007,0.0002585661,0.00016159948,0.0004752243,0.00021867832,0.00015525309,0.000051524927,0.00051215827,0.0000021823068],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.55373657,0.013372275,0.0040869974,0.000030818195,0.0007990666,0.0002831973,0.000297096,6.1814696e-8,0.327988,0.000008018415,0.00003586096,0.099362],"study_design_scores_gemma":[0.7086519,0.064849466,0.08022101,0.000096881566,0.00043723543,0.00022646763,0.000100634505,0.000029455696,0.14347541,0.000030430332,0.0015993642,0.0002817471],"about_ca_topic_score_codex":0.00087595586,"about_ca_topic_score_gemma":0.000048278256,"teacher_disagreement_score":0.1845126,"about_ca_system_score_codex":0.00027653878,"about_ca_system_score_gemma":0.00032673115,"threshold_uncertainty_score":0.99998665},"labels":[],"label_agreement":null},{"id":"W2980142174","doi":"10.1182/blood.v104.11.3611.3611","title":"Safety and Efficacy of Alternate Desferrioxamine and Deferiprone Compared to Desferrioxamine Alone in the Treatment of Iron Overload in Transfusion-Dependent Thalassemia Patients.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Apotex (Canada)","funders":"","keywords":"Deferiprone; Medicine; Thalassemia; Adverse effect; Deferoxamine; Chelation therapy; Gastroenterology; Internal medicine; Deferasirox; Anemia; Surgery","score_opus":0.008911556644396029,"score_gpt":0.2352864650200229,"score_spread":0.22637490837562688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980142174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965557,0.0016959261,0.000011881735,0.00029369057,0.000026795917,0.0011776867,0.000026762305,0.000008299151,0.00020329592],"genre_scores_gemma":[0.9953426,0.0043020677,0.00022031846,0.000050399027,0.00000893354,0.000017789587,0.000030114326,0.000014948734,0.000012833848],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987488,0.00004750194,0.00048021582,0.0002610551,0.00024038897,0.00022205261],"domain_scores_gemma":[0.9995089,0.00006989631,0.000066453205,0.00022628292,0.000032465843,0.00009598854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013056274,0.00018936045,0.0004948711,0.0001526569,0.00002765888,0.0000050703065,0.000065861284,0.00009775373,0.000007807243],"category_scores_gemma":[0.00002935397,0.0001249173,0.000046666737,0.00024990345,0.000080253616,0.00003130369,0.000020462594,0.00010756313,8.609954e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042824033,0.02698049,0.8624868,0.00036944184,0.00022384818,0.00021104528,0.025916,0.0008874293,0.057645895,0.000098785385,0.0000029264709,0.02089498],"study_design_scores_gemma":[0.05744265,0.0033689346,0.92381847,0.00036089125,0.00021369649,0.00004928834,0.0006313015,0.000022923447,0.013882904,0.000025654173,0.000048566097,0.00013474177],"about_ca_topic_score_codex":0.0022371984,"about_ca_topic_score_gemma":0.001214866,"teacher_disagreement_score":0.06133169,"about_ca_system_score_codex":0.00007317721,"about_ca_system_score_gemma":0.000042796033,"threshold_uncertainty_score":0.5093979},"labels":[],"label_agreement":null},{"id":"W2980143174","doi":"10.1182/blood.v126.23.80.80","title":"A Multicenter Phase II Study Using a Dose Intensified Pegylated-Asparaginase Pediatric Regimen in Adults with Untreated Acute Lymphoblastic Leukemia: A DFCI ALL Consortium Trial","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal General Hospital; Queen Elizabeth II Health Sciences Centre; Université de Montréal; Hôpital Maisonneuve-Rosemont; CancerCare Manitoba; Vancouver General Hospital","funders":"","keywords":"Medicine; Vincristine; Regimen; Asparaginase; Etoposide; Cytarabine; Internal medicine; Surgery; Acute lymphocytic leukemia; Chemotherapy; Gastroenterology; Leukemia; Cyclophosphamide; Lymphoblastic Leukemia","score_opus":0.03645715616874136,"score_gpt":0.3200959354394813,"score_spread":0.28363877927073994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980143174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935382,0.00016697329,0.000057853948,0.00014972515,0.00019676053,0.005391269,0.00003913106,0.00022097108,0.00023912411],"genre_scores_gemma":[0.9977082,0.00002837912,0.00075925735,0.00022425143,0.00042904145,0.0002757928,0.00009001219,0.0001322572,0.00035280283],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9951209,0.00033965037,0.00099424,0.0011253254,0.0012249489,0.0011949493],"domain_scores_gemma":[0.9966647,0.00027042982,0.00034437352,0.00095255,0.00078760064,0.0009803667],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00064758444,0.0006543104,0.0011493794,0.0008699999,0.000118467884,0.00007154686,0.00034008705,0.00030983487,0.000035323355],"category_scores_gemma":[0.0009100498,0.0005046823,0.00012614968,0.0013982059,0.00020406448,0.0002524791,0.00035390756,0.0006779776,0.00007122406],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8670681,0.04004647,0.022823934,0.0002649604,0.0026443244,0.04748592,0.015715785,0.00015749976,0.0021735937,0.00000435586,0.0012746415,0.00034038167],"study_design_scores_gemma":[0.9224451,0.04122369,0.0011579649,0.00040556653,0.0051293774,0.0016996365,0.0033263678,0.023036597,0.00089123775,0.0000045521856,0.000039056093,0.00064081326],"about_ca_topic_score_codex":0.0020087468,"about_ca_topic_score_gemma":0.00019344855,"teacher_disagreement_score":0.05537701,"about_ca_system_score_codex":0.0021617396,"about_ca_system_score_gemma":0.0044191135,"threshold_uncertainty_score":0.9997405},"labels":[],"label_agreement":null},{"id":"W2980145352","doi":"10.1182/blood.v114.22.325.325","title":"Classification of Acute Myeloid Leukemia (AML) Based On Apoptosis and Myeloid Signaling Networks.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Myeloid leukemia; Cancer research; Myeloid; Biology; Signal transduction; Immunology; Leukemia; Medicine; Cell biology","score_opus":0.018189904617942815,"score_gpt":0.27384785418803925,"score_spread":0.25565794957009647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980145352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910153,0.00022086246,0.0018581166,0.0018117148,0.0000466407,0.00055896566,0.000011699281,0.0001091079,0.004367597],"genre_scores_gemma":[0.9940162,0.00024029794,0.0040653776,0.0010139374,0.0002581501,0.000022813201,0.00008812704,0.000036083315,0.00025905488],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980781,0.00008561373,0.000418083,0.00045661017,0.00052524,0.00043632102],"domain_scores_gemma":[0.9986651,0.00018866264,0.00016081844,0.00055416225,0.00017788932,0.00025339334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004416784,0.00024235762,0.00044622517,0.00027848667,0.000105346946,0.00002970928,0.00017455823,0.00023087242,0.000057771158],"category_scores_gemma":[0.00011521462,0.00021499717,0.00011979704,0.0005014256,0.00012039401,0.00008757745,0.000032928325,0.0004725552,0.000016856804],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011381629,0.00079585984,0.009768233,0.00011362732,0.00036098657,0.00005251794,0.00016647056,0.0005532784,0.9542575,0.000510226,0.0017295392,0.030553585],"study_design_scores_gemma":[0.017035313,0.0038021496,0.17452641,0.00066459214,0.0016434771,0.00009476671,0.00016565078,0.1012731,0.69896144,0.00019508487,0.0009850848,0.0006529654],"about_ca_topic_score_codex":0.000021377535,"about_ca_topic_score_gemma":8.2807566e-7,"teacher_disagreement_score":0.2552961,"about_ca_system_score_codex":0.00022787627,"about_ca_system_score_gemma":0.00036830385,"threshold_uncertainty_score":0.876733},"labels":[],"label_agreement":null},{"id":"W2980151503","doi":"10.1182/blood.v128.22.2624.2624","title":"Incidence and Risk Factors of Venous Thromboembolism in Patients with Multiple Myeloma Receiving Immunomodulatory Agents","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Toronto","funders":"","keywords":"Medicine; Lenalidomide; Multiple myeloma; Internal medicine; Thalidomide; Pomalidomide; Incidence (geometry); Risk factor; Odds ratio; Concomitant; Surgery","score_opus":0.011960707307669004,"score_gpt":0.24445870463224875,"score_spread":0.23249799732457974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980151503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991683,0.00016451564,0.0000071935337,0.000008186859,0.000025431502,0.00048209613,0.000052487318,0.000018909272,0.00007288137],"genre_scores_gemma":[0.9994351,0.00015584372,0.00031790265,0.000004451934,0.000012281544,0.000013733544,0.000011898767,0.00002191788,0.000026856838],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988247,0.00006377508,0.00021505583,0.0002600331,0.00034391487,0.0002925197],"domain_scores_gemma":[0.9991941,0.0001620602,0.00011458546,0.00029548156,0.000087895096,0.00014588387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010736874,0.00015070832,0.00035193822,0.00013833202,0.000051391435,0.0000063768066,0.000074923475,0.000062335865,0.000031518215],"category_scores_gemma":[0.0003540203,0.00008709057,0.000033891607,0.00012305545,0.00010941216,0.00012807653,0.0000662625,0.00010168752,0.0000075143175],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002653747,0.0014843016,0.9841109,0.00003763877,0.00024042695,0.000029445619,0.00040131368,3.2378878e-7,0.0015409945,0.000001187766,0.0000025896009,0.011885495],"study_design_scores_gemma":[0.013418174,0.0009833183,0.97855675,0.0003455427,0.000086693064,0.0000034609243,0.000034717945,0.000008062538,0.00644759,0.000012645236,0.0000069798043,0.000096037744],"about_ca_topic_score_codex":0.0007155963,"about_ca_topic_score_gemma":0.000116332776,"teacher_disagreement_score":0.0131528,"about_ca_system_score_codex":0.00005072799,"about_ca_system_score_gemma":0.00006148533,"threshold_uncertainty_score":0.35514504},"labels":[],"label_agreement":null},{"id":"W2980153846","doi":"10.1182/blood.v128.22.3775.3775","title":"Let's Talk Period: Preliminary Results of an Online Bleeding Awareness Knowledge Translation Project and Bleeding Assessment Tool Promoted on Social Media","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Von Willebrand disease; Social media; Vaginal bleeding; Family medicine; Pediatrics; Pregnancy; Von Willebrand factor; Internal medicine","score_opus":0.126042283310599,"score_gpt":0.3838246994763345,"score_spread":0.2577824161657355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980153846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99667346,0.000162613,0.000009531775,0.0012419303,0.000067924375,0.0007897222,0.00011179077,0.00006282367,0.0008802057],"genre_scores_gemma":[0.9977104,0.00011822309,0.001251149,0.0000039697734,0.0004633979,0.00003961604,0.0001688534,0.0000285152,0.00021587935],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985191,0.00008919026,0.00034263163,0.00036493593,0.00040383294,0.00028027134],"domain_scores_gemma":[0.99925447,0.00024215828,0.0000875166,0.00016251244,0.00015968256,0.000093692965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044318385,0.00018043781,0.00033131582,0.00022774923,0.00014342634,0.00001887949,0.000072723415,0.00015442239,0.000014232314],"category_scores_gemma":[0.00016737399,0.00011251174,0.000066124594,0.00021529729,0.00011202237,0.00015638385,0.000032860153,0.00014834452,0.0000017311304],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004296981,0.008843708,0.010632088,0.00071223645,0.0004194017,0.00024056093,0.013606905,3.5222305e-7,0.46456873,0.000098456876,0.000079195204,0.4965014],"study_design_scores_gemma":[0.10619122,0.023033744,0.53900516,0.0050996365,0.002090528,0.00051646144,0.0053256284,0.0027689491,0.31354007,0.00014349468,0.0011628035,0.0011222957],"about_ca_topic_score_codex":0.000013191849,"about_ca_topic_score_gemma":0.000020135349,"teacher_disagreement_score":0.5283731,"about_ca_system_score_codex":0.000055785946,"about_ca_system_score_gemma":0.0003385867,"threshold_uncertainty_score":0.45880955},"labels":[],"label_agreement":null},{"id":"W2980154814","doi":"10.1182/blood.v112.11.735.735","title":"An Automated and Quantitative Protein Expression-Based Classification System to Identify High Risk Multiple Myeloma Patients","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Multiple myeloma; Medicine; Oncology; Autologous stem-cell transplantation; Internal medicine; Lenalidomide; Gene expression profiling; Transplantation; Tissue microarray; Immunohistochemistry; Bioinformatics; Cancer research; Gene expression; Biology","score_opus":0.034102122960087175,"score_gpt":0.33283503642319123,"score_spread":0.29873291346310404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980154814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99690145,0.000040590043,0.00025593053,0.000046588088,0.00003454212,0.0020557619,0.00015722374,0.0004400953,0.000067789544],"genre_scores_gemma":[0.9863073,0.000003963811,0.012844555,0.000018387054,0.00003013668,0.00041864955,0.000309178,0.00003296424,0.000034823843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998242,0.00023007033,0.00028181126,0.00044797306,0.0004928782,0.00030522142],"domain_scores_gemma":[0.9986092,0.00011115772,0.00012908438,0.00041652308,0.0002759994,0.000458027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013542523,0.00018874035,0.00027218164,0.00019855934,0.00029345948,0.000029848634,0.000090497495,0.00009611477,0.000012735636],"category_scores_gemma":[0.0004568909,0.000149715,0.000043787637,0.00023309173,0.000065955064,0.0001282535,0.00002895594,0.00012453747,0.00010610106],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083910255,0.002546587,0.84664094,0.00018268131,0.000118535194,0.0001303073,0.00038774786,0.000009869133,0.14800876,0.000030296573,0.000103867205,0.0010012952],"study_design_scores_gemma":[0.010539361,0.0012702039,0.88914007,0.0002670179,0.000065781285,0.0000092016135,0.0002002105,0.014073681,0.08428699,0.0000018784334,0.000013956301,0.00013162168],"about_ca_topic_score_codex":0.0004963966,"about_ca_topic_score_gemma":0.000023634624,"teacher_disagreement_score":0.063721776,"about_ca_system_score_codex":0.00007570333,"about_ca_system_score_gemma":0.00009498498,"threshold_uncertainty_score":0.61052},"labels":[],"label_agreement":null},{"id":"W2980161915","doi":"10.1182/blood.v118.21.2743.2743","title":"Targeting the CML Stem/Progenitor Cell with JAK2 (BMS-911543)/ABL Inhibitor Combination Therapy","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Progenitor cell; Stem cell; Cancer research; Imatinib mesylate; Haematopoiesis; Biology; Tyrosine kinase; Imatinib; Medicine; Immunology; Myeloid leukemia; Cell biology; Signal transduction","score_opus":0.021412703126364174,"score_gpt":0.2213805887140572,"score_spread":0.19996788558769302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980161915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990608,0.0014887002,0.000021975971,0.00016638392,0.0001717375,0.0010108075,0.0000057910884,0.000118453965,0.006408154],"genre_scores_gemma":[0.9960267,0.00012239197,0.0012031131,0.00019900348,0.00031713172,0.00012026646,0.000028097775,0.000056938854,0.0019263745],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986901,0.00006957606,0.0002454268,0.00030819274,0.00036201792,0.00032466959],"domain_scores_gemma":[0.99911255,0.000059940896,0.00014781383,0.0004477698,0.00012206241,0.00010985692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019338199,0.0002286062,0.00023875778,0.000053668296,0.0001547088,0.00002061718,0.00014675457,0.00009691994,0.00021717712],"category_scores_gemma":[0.000013782907,0.00013224593,0.000074406315,0.00018818282,0.00007268434,0.00008909167,0.000036430753,0.00021789136,0.00014476976],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033130394,0.025866425,0.6723466,0.00066493906,0.0033817843,0.0011460384,0.025086394,0.000006373825,0.22832368,0.001054098,0.008835777,0.029974837],"study_design_scores_gemma":[0.03918314,0.0030167073,0.026282988,0.00018070861,0.00067813316,0.00018774193,0.0011033076,0.00008474308,0.92279047,0.00007300793,0.005989494,0.0004295312],"about_ca_topic_score_codex":0.000117974465,"about_ca_topic_score_gemma":0.000006045968,"teacher_disagreement_score":0.6944668,"about_ca_system_score_codex":0.00014524828,"about_ca_system_score_gemma":0.00023800302,"threshold_uncertainty_score":0.5392833},"labels":[],"label_agreement":null},{"id":"W2980163531","doi":"10.1182/blood.v116.21.1114.1114","title":"Transfusion Requirements In Cariovascular Surgery (TRICI).","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University of Ottawa; St. Michael's Hospital","funders":"","keywords":"Medicine; Randomization; Confidence interval; Cardiopulmonary bypass; Blood transfusion; Sample size determination; Anemia; Cardiac surgery; Randomized controlled trial; Surgery; Anesthesia; Internal medicine","score_opus":0.018463739592190498,"score_gpt":0.2488055272057724,"score_spread":0.2303417876135819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980163531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889864,0.00019980596,0.00007522645,0.00088197686,0.00038947264,0.00048916816,0.0000012357774,0.00007464065,0.008902076],"genre_scores_gemma":[0.9979376,0.0005158291,0.00043799815,0.00056173804,0.00009533877,0.000033373457,0.000014785692,0.000020541484,0.00038280518],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99887526,0.00002446709,0.0002694169,0.00026092157,0.0003233384,0.00024660377],"domain_scores_gemma":[0.9994383,0.000029768384,0.000023171897,0.00035949377,0.000032576987,0.000116696516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042478606,0.00012126651,0.00027224762,0.0002518229,0.00003857194,0.000010529904,0.00006387433,0.00010198898,0.00044057626],"category_scores_gemma":[0.000042359123,0.000107591346,0.00017160301,0.00032264667,0.000026289455,0.00005415357,0.000018496537,0.00028126792,0.00005076204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021350569,0.008856036,0.624113,0.00050618214,0.00051105383,0.0015432764,0.0007763685,0.0000016484139,0.27831358,0.0010560649,0.0019575718,0.08215169],"study_design_scores_gemma":[0.018118296,0.0002093855,0.7956168,0.00025427065,0.0010451637,0.0001759022,0.00014967701,0.00003055723,0.0885198,0.00015734496,0.09524661,0.00047620662],"about_ca_topic_score_codex":0.0003556425,"about_ca_topic_score_gemma":0.0006470362,"teacher_disagreement_score":0.18979378,"about_ca_system_score_codex":0.000007982969,"about_ca_system_score_gemma":0.00005256725,"threshold_uncertainty_score":0.48240012},"labels":[],"label_agreement":null},{"id":"W2980164909","doi":"10.1182/blood.v114.22.26.26","title":"In Vitro and In Vivo Mouse Models of the Type 1 Von Willebrand Disease Mutations Y1584C and R1205H.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Von Willebrand disease; Recombinant DNA; Von Willebrand factor; Molecular biology; ADAMTS13; In vivo; Wild type; Missense mutation; Mutant; Transfection; In vitro; Chemistry; Phenotype; Mutation; Immunology; Biology; Gene; Genetics; Biochemistry; Platelet","score_opus":0.00874531473201642,"score_gpt":0.23551788485987016,"score_spread":0.22677257012785373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980164909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978837,0.00091087545,0.0000011200975,0.0005863519,0.0000071326117,0.00018937835,0.000017761015,0.000003875041,0.00039983648],"genre_scores_gemma":[0.99941134,0.00015989544,0.0000666216,0.00016542219,0.0000039727374,0.00000328792,0.000004542248,0.000003764004,0.00018113354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999689,0.00001050248,0.00008367608,0.00008771806,0.000056811536,0.00007232812],"domain_scores_gemma":[0.9998309,0.000013408722,0.000017961258,0.00008295281,0.000010174139,0.00004462127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000021923915,0.00005308979,0.00011796075,0.000044836648,0.00001532323,0.0000036470628,0.000016367896,0.000022076933,0.000004237201],"category_scores_gemma":[0.00001843839,0.000036073125,0.00001294692,0.000096387645,0.000025341049,0.000053171203,0.000008027329,0.000039324663,2.8336396e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049691084,0.014724801,0.6609997,0.0003613127,0.00034325774,0.0017436944,0.006233147,0.00057869515,0.30173406,0.0011317636,0.00042819584,0.0067522423],"study_design_scores_gemma":[0.047398303,0.0005986668,0.8192522,0.00032864488,0.00079116947,0.0001296439,0.00033595567,0.006351949,0.10043852,0.023846343,0.0001556674,0.00037292304],"about_ca_topic_score_codex":0.000037519058,"about_ca_topic_score_gemma":0.000032780517,"teacher_disagreement_score":0.20129554,"about_ca_system_score_codex":0.000004483308,"about_ca_system_score_gemma":0.000022010005,"threshold_uncertainty_score":0.14710192},"labels":[],"label_agreement":null},{"id":"W2980165771","doi":"10.1182/blood.v128.22.470.470","title":"Obinutuzumab or Rituximab Plus CHOP in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma: Final Results from an Open-Label, Randomized Phase 3 Study (GOYA)","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Alberta Health Services","funders":"","keywords":"Medicine; Obinutuzumab; Rituximab; Internal medicine; Diffuse large B-cell lymphoma; CHOP; International Prognostic Index; Febrile neutropenia; Neutropenia; Gastroenterology; Oncology; Lymphoma; Surgery; Chemotherapy","score_opus":0.02549305422727246,"score_gpt":0.29496860662074637,"score_spread":0.2694755523934739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980165771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913935,0.00022765808,0.000004458297,0.00012782446,0.00007447195,0.006850368,0.0008164085,0.000105560415,0.00039973375],"genre_scores_gemma":[0.9967791,0.00010955004,0.0003700774,0.00017560521,0.00007331568,0.0008846337,0.0005802666,0.00007243757,0.00095501606],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99642956,0.0004408374,0.00087204564,0.0010218818,0.00059167494,0.0006440001],"domain_scores_gemma":[0.9974674,0.0005606242,0.000343669,0.0010691537,0.0001799609,0.0003791969],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044829224,0.000528893,0.001700463,0.00016021304,0.00013261446,0.000109220804,0.00036331607,0.00013968197,0.00012224048],"category_scores_gemma":[0.00033789742,0.00026196946,0.000072203584,0.00031457984,0.00008511246,0.00033830875,0.00019330303,0.00007642758,0.00010115583],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.49437663,0.43510938,0.06299225,0.000017591174,0.00077310426,0.00139793,0.0013353574,1.1436643e-7,0.00003559826,0.000004798715,0.00020915103,0.0037481014],"study_design_scores_gemma":[0.9168309,0.013931449,0.065336436,0.00044534562,0.0020502592,0.00001012125,0.00011873985,0.000036925867,0.0006942724,0.0000074538207,0.00016885284,0.00036925275],"about_ca_topic_score_codex":0.0022540884,"about_ca_topic_score_gemma":0.0009377571,"teacher_disagreement_score":0.42245427,"about_ca_system_score_codex":0.0006894304,"about_ca_system_score_gemma":0.00073225115,"threshold_uncertainty_score":0.99998325},"labels":[],"label_agreement":null},{"id":"W2980169763","doi":"10.1182/blood.v104.11.1375.1375","title":"Extranodal Follicular Lymphoma - a Retrospective Review and Comparison with Localized Nodal Follicular Lymphoma.","year":2004,"lang":"en","type":"review","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Follicular lymphoma; Medicine; Lymphoma; Follicular phase; Radiation therapy; Gastroenterology; Retrospective cohort study; Stage (stratigraphy); Internal medicine; Surgery","score_opus":0.020217842109453644,"score_gpt":0.2966447442041029,"score_spread":0.27642690209464926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980169763","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042101517,0.9930986,0.000031982592,0.00015232965,0.00008343361,0.004908932,0.00013565623,0.00018610022,0.0009819295],"genre_scores_gemma":[0.0006812544,0.9950756,0.0014950061,0.000362454,0.00018993202,0.0012531775,0.0005284022,0.00020802426,0.0002061399],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99536425,0.00021613852,0.0012642109,0.0014891488,0.00088765495,0.0007786161],"domain_scores_gemma":[0.99715364,0.00010702007,0.0007178602,0.0012254626,0.00019817565,0.00059784006],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00028342573,0.0014056421,0.0069257496,0.00023091323,0.0002005449,0.000094288196,0.00026023024,0.00058770075,0.000109450375],"category_scores_gemma":[0.00007581605,0.00091482664,0.0012425976,0.0007948913,0.00024331262,0.00010027931,0.00012516479,0.00020331799,0.00012909019],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016542558,0.014513883,0.005084121,0.20727195,0.015086435,0.008204408,0.00012613075,2.9668826e-7,6.928864e-7,0.0008731719,0.0010874075,0.7475861],"study_design_scores_gemma":[0.024808196,0.0013688287,0.0012665237,0.15028867,0.067526676,0.0066367425,0.000011025843,9.925852e-7,0.000022232385,0.000022874672,0.74708945,0.0009577556],"about_ca_topic_score_codex":0.00022334387,"about_ca_topic_score_gemma":0.000022765349,"teacher_disagreement_score":0.74662834,"about_ca_system_score_codex":0.001073872,"about_ca_system_score_gemma":0.0014900713,"threshold_uncertainty_score":0.9998694},"labels":[],"label_agreement":null},{"id":"W2980171540","doi":"10.1182/blood.v122.21.6.6","title":"Head-To-Head Comparison Of Obinutuzumab (GA101) Plus Chlorambucil (Clb) Versus Rituximab Plus Clb In Patients With Chronic Lymphocytic Leukemia (CLL) and Co-Existing Medical Conditions (Comorbidities): Final Stage 2 Results Of The CLL11 Trial","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Internal medicine; Clinical endpoint; Interim analysis; Obinutuzumab; Rituximab; Chlorambucil; Chronic lymphocytic leukemia; Surgery; Oncology; Gastroenterology; Randomized controlled trial; Chemotherapy; Leukemia; Cyclophosphamide; Lymphoma","score_opus":0.07089950402949753,"score_gpt":0.3653070094932137,"score_spread":0.2944075054637162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980171540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944425,0.00023030775,0.000010924302,0.00011084811,0.00028770918,0.0029655192,0.00029358902,0.000051005987,0.0016075933],"genre_scores_gemma":[0.998684,0.000025378717,0.00016182623,0.00006602353,0.00023544069,0.00018100931,0.0002133627,0.00006005772,0.00037292056],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9946154,0.00025084056,0.0014289604,0.00068008614,0.0021709914,0.0008537249],"domain_scores_gemma":[0.9964143,0.0011961062,0.00050187967,0.0010094602,0.0003936641,0.00048459298],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006563898,0.00041349957,0.001331231,0.0002912679,0.00018303581,0.00004484191,0.0005286162,0.00034035053,0.0002714993],"category_scores_gemma":[0.0019584293,0.00030569494,0.00015243099,0.0007177295,0.0009706127,0.00016434556,0.0003400011,0.00072367716,0.000042019627],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.8751612,0.013882755,0.035639193,0.010010328,0.0034408811,0.0010828521,0.018847238,0.012957442,0.001238943,0.0014888044,0.013957803,0.0122925965],"study_design_scores_gemma":[0.93093336,0.006786196,0.022309577,0.0016011173,0.00031688903,0.000056806955,0.0006132732,0.03445088,0.0020820743,0.000014778016,0.0004554852,0.00037958432],"about_ca_topic_score_codex":0.019352729,"about_ca_topic_score_gemma":0.004502008,"teacher_disagreement_score":0.055772178,"about_ca_system_score_codex":0.044149388,"about_ca_system_score_gemma":0.057335485,"threshold_uncertainty_score":0.9999395},"labels":[],"label_agreement":null},{"id":"W2980174578","doi":"10.1182/blood.v120.21.3603.3603","title":"Targeting the Mammalian Mitochondrial Clpp (mClpP) As a Novel Therapeutic Strategy for Acute Myeloid Leukemia","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Myeloid leukemia; Gene knockdown; Biology; Molecular biology; Leukemia; Chaperone (clinical); Haematopoiesis; Viability assay; Stem cell; Cancer research; Cell culture; Cell biology; Cell; Immunology; Medicine; Biochemistry","score_opus":0.022088818266692546,"score_gpt":0.30949366674955686,"score_spread":0.2874048484828643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980174578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890338,0.006463794,0.0014557437,0.0002452837,0.00041410414,0.0009784722,0.00019284587,0.000020150112,0.0011957794],"genre_scores_gemma":[0.9956616,0.00018697542,0.0005915951,0.00022320508,0.0016652801,0.00025349308,0.00027109103,0.000031236195,0.0011154911],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989772,0.000029762927,0.00012790725,0.0002250611,0.00013690238,0.00050317333],"domain_scores_gemma":[0.9994948,0.00001815024,0.000051576197,0.00026398432,0.000048293692,0.00012320034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010678341,0.0001492618,0.00010926763,0.000016862625,0.00016753726,0.000048476875,0.00020453059,0.00010250321,0.00003262632],"category_scores_gemma":[0.000029287447,0.00010332612,0.00011960486,0.00005285123,0.000054306674,0.0000063728894,0.0000668576,0.000084935964,0.000036643],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032811458,0.0002956804,0.0010072351,0.0000110670235,0.0008505685,0.0000023971115,0.00006717325,0.000009681392,0.9933883,0.00026283818,0.0016868053,0.002090135],"study_design_scores_gemma":[0.0074107493,0.0011316804,0.001091228,0.000008594107,0.00048403526,0.000059697817,0.00014670411,0.000023336428,0.8463846,0.00023117171,0.14269777,0.00033043514],"about_ca_topic_score_codex":0.0001250441,"about_ca_topic_score_gemma":0.00004083871,"teacher_disagreement_score":0.14700371,"about_ca_system_score_codex":0.000024563007,"about_ca_system_score_gemma":0.0001804827,"threshold_uncertainty_score":0.4213517},"labels":[],"label_agreement":null},{"id":"W2980176026","doi":"10.1182/blood.v120.21.2937.2937","title":"Small Molecule MIRA-1 Induces p53-Independent Apoptosis in Multiple Myeloma Cells Through Activation of the p38 MAPK Signaling Pathway.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Apoptosis; Biology; Mutant; Multiple myeloma; Bone marrow; Cytotoxic T cell; Cancer research; Molecular biology; p38 mitogen-activated protein kinases; MAPK/ERK pathway; In vitro; Immunology; Signal transduction; Cell biology; Gene; Genetics","score_opus":0.037549377600666706,"score_gpt":0.242807133533202,"score_spread":0.20525775593253529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980176026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981071,0.0002641082,0.00032406516,0.00014030463,0.00021099723,0.00042123967,0.00000767845,0.000018934366,0.00050557306],"genre_scores_gemma":[0.99834245,0.000022133108,0.0010159828,0.0003069548,0.00017132211,0.000035737503,0.0000052100763,0.00002373421,0.00007647002],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99906445,0.000047440324,0.00023914044,0.00015898065,0.0002442022,0.00024579387],"domain_scores_gemma":[0.999464,0.00004863069,0.00013683969,0.0002551455,0.00004449617,0.00005089166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001794437,0.00012681783,0.00021106307,0.000050594143,0.000045955763,0.000008108469,0.00010413192,0.000106922846,0.00007869192],"category_scores_gemma":[0.000024156212,0.00009293132,0.000097765296,0.00019769206,0.000020829162,0.00009022924,0.000041468516,0.00017191161,0.0000055006044],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060914852,0.00070409157,0.003819238,0.000045410277,0.000054009633,9.119692e-7,0.00198691,0.000007910504,0.9919925,0.00028517036,0.0000072223693,0.0010357186],"study_design_scores_gemma":[0.0026627986,0.00011022398,0.006208197,0.00015097811,0.00004861521,0.000003236684,0.0005287273,0.000010593739,0.98978245,0.00014927072,0.00024560717,0.00009930566],"about_ca_topic_score_codex":0.00037300476,"about_ca_topic_score_gemma":0.00003681561,"teacher_disagreement_score":0.0026018838,"about_ca_system_score_codex":0.000039585306,"about_ca_system_score_gemma":0.000059624905,"threshold_uncertainty_score":0.37896293},"labels":[],"label_agreement":null},{"id":"W2980176712","doi":"10.1182/blood.v124.21.3841.3841","title":"TGF-Beta Signaling Favors Central Memory Phenotype Expression By Ex-Vivo Stimulated Human T Cells","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"CD28; Ex vivo; T cell; Biology; Cell biology; Cytotoxic T cell; CD8; Homing (biology); Adoptive cell transfer; Transforming growth factor beta; IL-2 receptor; Cytokine; Immunology; Cancer research; Transforming growth factor; In vivo; Immune system; In vitro","score_opus":0.01853857482162006,"score_gpt":0.2808982350244735,"score_spread":0.2623596602028534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980176712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848438,0.00035061163,0.00016665176,0.00009965012,0.00016540784,0.0005124556,0.000011927084,0.0001663783,0.013683138],"genre_scores_gemma":[0.9849213,0.000023816103,0.00031070865,0.00020141437,0.00049298035,0.00000903902,0.00006693139,0.00007945533,0.013894391],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977281,0.00017585269,0.0003300238,0.0004511659,0.0006352762,0.00067954516],"domain_scores_gemma":[0.99871886,0.00013580245,0.00008566337,0.00057689846,0.000100649064,0.00038215562],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00039100964,0.00024358052,0.00039271583,0.000113522976,0.00015457574,0.00004484857,0.00022911078,0.0001814051,0.0070696124],"category_scores_gemma":[0.000042323583,0.00021344308,0.00013896184,0.00019126576,0.00008881672,0.00006766111,0.00008815179,0.0004193253,0.00013484458],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001519956,0.00063684,0.001191094,0.00008327542,0.0000907472,0.000026304388,0.00041514338,0.0000732928,0.99173003,0.000011354186,0.004210202,0.0013797204],"study_design_scores_gemma":[0.005726709,0.00043735327,0.0004032924,0.00014768427,0.0001366814,0.0000071008008,0.0000639613,0.00032962253,0.9848789,0.000047599882,0.0075927526,0.00022834641],"about_ca_topic_score_codex":0.00011457161,"about_ca_topic_score_gemma":0.000004620199,"teacher_disagreement_score":0.006934768,"about_ca_system_score_codex":0.000051501745,"about_ca_system_score_gemma":0.00005818459,"threshold_uncertainty_score":0.9938381},"labels":[],"label_agreement":null},{"id":"W2980178991","doi":"10.1182/blood.v118.21.4567.4567","title":"Reduced Incidence of Early Invasive Fungal Infection in Allogeneic Transplant Patients Following Micafungin Prophylaxis","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Vancouver Hospital and Health Sciences Centre; Leukemia & Lymphoma Society of Canada; Vancouver Coastal Health; University of British Columbia","funders":"","keywords":"Medicine; Incidence (geometry); Micafungin; Internal medicine; Cumulative incidence; Transplantation; Population; Hematopoietic stem cell transplantation; Alemtuzumab; Cohort; Neutropenia; Retrospective cohort study; Surgery; Pediatrics; Chemotherapy; Amphotericin B; Antifungal","score_opus":0.020599358465035834,"score_gpt":0.24103973005809232,"score_spread":0.2204403715930565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980178991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987652,0.00011325574,0.000015419479,0.0000038735293,0.0000842941,0.00045001417,0.000007833197,0.00002161496,0.0005385022],"genre_scores_gemma":[0.9995576,0.000052962896,0.00027680304,0.00001910125,0.000018457004,0.00001820106,0.00001007378,0.000012577532,0.000034209585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99887884,0.00005971103,0.00034432186,0.00026209315,0.00024558228,0.00020946765],"domain_scores_gemma":[0.99948406,0.00003946934,0.00008364502,0.00023057833,0.000085789645,0.00007646741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019300189,0.00012230381,0.00028306845,0.00012028439,0.000027139882,0.0000032020516,0.00006838824,0.00011432767,0.000028266797],"category_scores_gemma":[0.00019159957,0.00010743629,0.00013759044,0.0002507393,0.00004686109,0.00011057781,0.00001624207,0.00016658094,0.0000107665455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032833236,0.00095306645,0.8734265,0.00012302324,0.00004981605,0.00006600432,0.0014767731,1.3367462e-7,0.12325363,0.000007670263,0.0000015465847,0.00031349168],"study_design_scores_gemma":[0.001567099,0.0010209113,0.8139608,0.0002550637,0.00009334062,0.000003641975,0.000023869183,4.293598e-7,0.18295395,0.00003794728,6.523197e-7,0.000082308004],"about_ca_topic_score_codex":0.00087916764,"about_ca_topic_score_gemma":0.00072589604,"teacher_disagreement_score":0.05970032,"about_ca_system_score_codex":0.00003382399,"about_ca_system_score_gemma":0.00013033401,"threshold_uncertainty_score":0.43811247},"labels":[],"label_agreement":null},{"id":"W2980185927","doi":"10.1182/blood.v120.21.1531.1531","title":"The Outcome of Advanced Stage Nodular Lymphocyte Predominant Hodgkin's Lymphoma (NLPHL) Compared to Classical Hodgkin's Lymphoma (CHL): A Matched Pair Analysis","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Stage (stratigraphy); Lymphoma; Medicine; Internal medicine; Classical Hodgkin lymphoma; Oncology; Hodgkin lymphoma; Follicular lymphoma; Biology","score_opus":0.0195261788529377,"score_gpt":0.28718714716581983,"score_spread":0.2676609683128821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980185927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99354076,0.0023890764,0.0001824887,0.00112477,0.00031662956,0.0014232566,0.00017326375,0.00016620615,0.0006835671],"genre_scores_gemma":[0.99369025,0.00016169965,0.0034415564,0.0005223423,0.00023612153,0.00048663115,0.00010000093,0.000085705644,0.0012757154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953176,0.0002665249,0.0013257221,0.0007552184,0.0010816467,0.0012532937],"domain_scores_gemma":[0.9958697,0.00064484414,0.000546019,0.0017893619,0.00026241242,0.0008876516],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000784877,0.00067110057,0.0019232479,0.000371952,0.00031612947,0.00007592205,0.00047972173,0.00023746294,0.00013546033],"category_scores_gemma":[0.00030900692,0.00044287555,0.0010672475,0.001377965,0.00023693386,0.00018073084,0.00029608945,0.00007581545,0.00018976767],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018869012,0.011276593,0.94352615,0.00016422794,0.006655854,0.00025691613,0.0012591385,0.000098456345,0.004067018,0.0007404552,0.00053430063,0.029533988],"study_design_scores_gemma":[0.029799147,0.0007553415,0.8765064,0.00012341003,0.0073253997,0.00010843962,0.0009948526,0.00036127173,0.057776153,0.000016113509,0.025663255,0.0005702346],"about_ca_topic_score_codex":0.00034534401,"about_ca_topic_score_gemma":0.00013057374,"teacher_disagreement_score":0.06701977,"about_ca_system_score_codex":0.00068921794,"about_ca_system_score_gemma":0.00029066842,"threshold_uncertainty_score":0.9998023},"labels":[],"label_agreement":null},{"id":"W2980188076","doi":"10.1182/blood.v116.21.3685.3685","title":"Potential Identification of High Risk Populations for Acute Hemolytic Reactions Following Rh0 (D) Immune Globulin.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Haptoglobin; Hemolysis; Hemoglobinuria; Internal medicine; Hemolytic anemia; Hemoglobin; Adverse effect; Paroxysmal nocturnal hemoglobinuria; Immune system; Gastroenterology; Immunology","score_opus":0.008763299901742586,"score_gpt":0.27205618206226195,"score_spread":0.2632928821605194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980188076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98878384,0.00006693694,0.00884056,0.00049653853,0.0009946583,0.00057697896,0.00009389256,0.000062385196,0.00008421534],"genre_scores_gemma":[0.9910485,0.000032795517,0.008090669,0.000013532238,0.0002139262,0.000041824343,0.00023032287,0.000024158273,0.00030422662],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99898285,0.00001348837,0.0004543559,0.00021115992,0.0001822638,0.00015588802],"domain_scores_gemma":[0.9992239,0.000030254643,0.00017800435,0.000380521,0.00011665023,0.00007068914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020895425,0.00010488721,0.00023802635,0.000097123324,0.0002008908,0.000016068761,0.00007115343,0.00012571123,0.000029710625],"category_scores_gemma":[0.00009012558,0.00009854988,0.00028191027,0.00017855049,0.000028691842,0.000101901926,0.000013333991,0.00020655357,0.000009780447],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007895798,0.0010560729,0.0076088496,0.0000500444,0.00051236985,0.0000083462555,0.0000638661,0.000011346639,0.9865817,0.0020936215,0.000027036056,0.0019078238],"study_design_scores_gemma":[0.010870794,0.000347386,0.60260636,0.000079307596,0.011569223,0.0001709252,0.00006983915,0.0008313263,0.36809793,0.0048310673,0.00029655264,0.00022930314],"about_ca_topic_score_codex":0.0004776693,"about_ca_topic_score_gemma":0.0000702906,"teacher_disagreement_score":0.6184837,"about_ca_system_score_codex":0.0000064855553,"about_ca_system_score_gemma":0.000039354345,"threshold_uncertainty_score":0.40187475},"labels":[],"label_agreement":null},{"id":"W2980188423","doi":"10.1182/blood.v120.21.291.291","title":"ITIM-Containing Inhibitory Receptors Are Required to Balance Oncogenic Signaling Strength in Ph+ ALL","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"LYN; Receptor; Signal transduction; Biology; Immune system; Immunology; Cell biology; Cancer research; Molecular biology; Tyrosine kinase; Biochemistry","score_opus":0.04128835398626353,"score_gpt":0.31732266275408166,"score_spread":0.27603430876781815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980188423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99315995,0.0020356604,0.000005315524,0.001150095,0.00023257452,0.00029668416,0.000012981105,0.000048404276,0.0030583641],"genre_scores_gemma":[0.9951555,0.000101250815,0.0010605707,0.00089959684,0.001122449,0.000036745416,0.000033583205,0.000030331883,0.0015599803],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99816984,0.000083037856,0.00032979142,0.00027276456,0.00042370707,0.0007208882],"domain_scores_gemma":[0.99905694,0.00015118613,0.00006809681,0.00020720618,0.000064525666,0.0004520726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004620421,0.0001826912,0.00035439225,0.00018051705,0.000060375667,0.000015527554,0.00012573617,0.00010440737,0.00027828474],"category_scores_gemma":[0.00017386318,0.0001611592,0.00010088686,0.00026636018,0.000042221214,0.00012429612,0.00010252179,0.00034160144,0.00024706832],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070386456,0.0012355798,0.78716314,0.00020677848,0.00018931193,0.00022839631,0.0024552734,0.0000066396046,0.19766024,0.00013624273,0.002417373,0.0075971656],"study_design_scores_gemma":[0.013139852,0.0023257008,0.23489267,0.0031258815,0.0003433057,0.000358227,0.003783693,0.00020639178,0.56835425,0.00012684564,0.1719024,0.0014407891],"about_ca_topic_score_codex":0.0001501435,"about_ca_topic_score_gemma":0.000033006887,"teacher_disagreement_score":0.5522705,"about_ca_system_score_codex":0.00007797949,"about_ca_system_score_gemma":0.00008361028,"threshold_uncertainty_score":0.6571881},"labels":[],"label_agreement":null},{"id":"W2980189821","doi":"10.1182/blood.v120.21.2777.2777","title":"BCR/ABL Transcript At 3 Months Predicts Long-Term Outcomes Following Second Generation Tyrosine Kinase Inhibitor Therapy in the Patients with CML in Chronic Phase Who Failed Imatinib.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Imatinib; Medicine; Dasatinib; Internal medicine; Tyrosine-kinase inhibitor; Myeloid leukemia; Imatinib mesylate; Tyrosine kinase; Gastroenterology; Oncology; Cancer; Receptor","score_opus":0.02163640729661542,"score_gpt":0.2752854487210246,"score_spread":0.2536490414244092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980189821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99393743,0.0031051962,0.000008748266,0.00013169949,0.00021558563,0.0023456488,0.000050839713,0.000045469187,0.00015935922],"genre_scores_gemma":[0.99809057,0.00005619443,0.00012075924,0.00029085306,0.00027986636,0.00035754216,0.0004951701,0.00006050774,0.0002485549],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978042,0.0001460563,0.0005147626,0.00038169057,0.0005397415,0.0006134949],"domain_scores_gemma":[0.9990686,0.000073742776,0.00013510117,0.00053265865,0.000038726426,0.0001511449],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029658093,0.00037779263,0.0005329475,0.00016526217,0.00010139595,0.000035960722,0.00014112529,0.00014099659,0.00022290982],"category_scores_gemma":[0.00003761935,0.00023687277,0.00013888955,0.00028510558,0.000046553454,0.0004209154,0.000024726509,0.00026139154,0.00001772083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027973513,0.004193106,0.9738986,0.000083422055,0.0002352015,0.000109217995,0.0037380632,0.00000514688,0.0146204885,0.0000027792582,0.000102111095,0.0027321535],"study_design_scores_gemma":[0.09370101,0.0014250637,0.87751025,0.0002754311,0.00023959951,0.000008910538,0.000047004643,0.00008849096,0.026366398,8.891539e-7,0.000105185914,0.00023174567],"about_ca_topic_score_codex":0.000075334116,"about_ca_topic_score_gemma":0.0013175498,"teacher_disagreement_score":0.0963883,"about_ca_system_score_codex":0.0010752117,"about_ca_system_score_gemma":0.00023938024,"threshold_uncertainty_score":0.9659391},"labels":[],"label_agreement":null},{"id":"W2980189994","doi":"10.1182/blood.v108.11.5215.5215","title":"Screening for the Megakaryocytopoietic Potential of Cord Blood Units.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Buffy coat; Cord blood; Megakaryocyte; Transplantation; Haematopoiesis; Platelet; Medicine; Andrology; Immunology; Internal medicine; Stem cell; Biology","score_opus":0.018989901146294424,"score_gpt":0.25038438383848943,"score_spread":0.231394482692195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980189994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947637,0.0016721667,0.0011856785,0.00032501866,0.000055104465,0.0004740004,0.00004132768,0.000029306426,0.0014537036],"genre_scores_gemma":[0.99726874,0.000037463567,0.001649989,0.00007528207,0.00010134379,0.000027181524,0.00006814767,0.00001730171,0.0007545294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993648,0.000009163759,0.00017231453,0.00012759394,0.00014688414,0.00017925701],"domain_scores_gemma":[0.99956566,0.000068241585,0.000066433604,0.00019022274,0.00007664288,0.000032785658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000062374726,0.00009969163,0.0002079403,0.00003855871,0.00008773163,0.000008154564,0.00006920673,0.00004944949,0.00002933465],"category_scores_gemma":[0.000025114665,0.00006523592,0.000091353184,0.00014380756,0.00005034727,0.000023759132,0.000018944145,0.000058149162,0.0000028682975],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010531134,0.05428749,0.4211496,0.0023034683,0.024003524,0.007996053,0.0010092595,0.00093295146,0.28367615,0.020161811,0.024563557,0.14938499],"study_design_scores_gemma":[0.16734691,0.009755046,0.40360782,0.00063861086,0.034428965,0.004069398,0.0011917311,0.0023844314,0.35356706,0.006243924,0.015620791,0.0011452927],"about_ca_topic_score_codex":0.00021364902,"about_ca_topic_score_gemma":0.000022253142,"teacher_disagreement_score":0.15681577,"about_ca_system_score_codex":0.0000026255927,"about_ca_system_score_gemma":0.00003862582,"threshold_uncertainty_score":0.26602435},"labels":[],"label_agreement":null},{"id":"W2980200289","doi":"10.1182/blood.v116.21.1803.1803","title":"Front-Line Therapy with Rituximab, Cyclophosphamide, Vincristine, and Prednisone (R-CVP) Followed by 2 Years of Rituximab Maintenance for Follicular Lymphoma (FL) Is Associated with Excellent Outcomes and Improved Progression-Free Survival (PFS) In Comparison to No Maintenance","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Rituximab; Maintenance therapy; Population; Follicular lymphoma; Vincristine; Internal medicine; Hazard ratio; Surgery; Interim analysis; Chemotherapy regimen; Prednisone; Cyclophosphamide; Oncology; Cancer; Chemotherapy; Randomized controlled trial; Confidence interval; Lymphoma","score_opus":0.007413235680799319,"score_gpt":0.2505795066936167,"score_spread":0.2431662710128174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980200289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934885,0.0020989035,0.00009647508,0.0010488927,0.00010294038,0.002689704,0.00034290476,0.00005556119,0.000076104785],"genre_scores_gemma":[0.9880311,0.00034964588,0.010091428,0.00031182825,0.00003271906,0.0006406861,0.00008427392,0.00007268174,0.00038565966],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976416,0.000042647152,0.0005693254,0.00071129284,0.00046197258,0.0005731298],"domain_scores_gemma":[0.9982072,0.0002742833,0.00033946903,0.0005978452,0.00030306383,0.0002781217],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034754715,0.0004415485,0.0013181469,0.00009593835,0.00008417953,0.00004131675,0.00018208177,0.0001802979,0.000015619584],"category_scores_gemma":[0.0003354509,0.00029391897,0.00010663132,0.00019375682,0.00017590118,0.000080595644,0.0000934248,0.00013064008,0.0000025575812],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005248997,0.016211152,0.9595558,0.00012424875,0.00093354454,0.00013981965,0.00054259633,4.766303e-7,0.0059815957,0.000030841973,0.0022920978,0.008938844],"study_design_scores_gemma":[0.20085032,0.0057509546,0.773732,0.00083096867,0.00050313753,0.000039014547,0.00016454325,0.0005070318,0.014999446,0.000035606667,0.0020699697,0.00051702035],"about_ca_topic_score_codex":0.0006935954,"about_ca_topic_score_gemma":0.0010230672,"teacher_disagreement_score":0.19560133,"about_ca_system_score_codex":0.00008489702,"about_ca_system_score_gemma":0.00014053257,"threshold_uncertainty_score":0.9999513},"labels":[],"label_agreement":null},{"id":"W2980202758","doi":"10.1182/blood.v108.11.3232.3232","title":"Inflammatory Markers and Autoantibodies That Correlate with Early and Late Onset of New Onset Pediatric Chronic Graft-Versus-Host Disease (GVHD).","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Autoantibody; Medicine; Antibody; Internal medicine; Immunology; Gastroenterology; Graft-versus-host disease; Disease","score_opus":0.008010759790945668,"score_gpt":0.21400217220364903,"score_spread":0.20599141241270336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980202758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957514,0.0030147792,0.00003074051,0.00011686145,0.00007495842,0.00041890863,0.000056887387,0.00006263446,0.00047285546],"genre_scores_gemma":[0.9979822,0.000974145,0.0002907987,0.000014952454,0.00006648553,0.000007755075,0.000053245178,0.000030555228,0.0005798533],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99894243,0.000036434056,0.00024612306,0.00026581294,0.00027248764,0.00023668214],"domain_scores_gemma":[0.9992546,0.00014763013,0.00012750729,0.00020868065,0.000034586585,0.00022701526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011234433,0.00019780181,0.00028119583,0.00013761608,0.000056782756,0.000020716938,0.00004362472,0.0000796467,0.000046070993],"category_scores_gemma":[0.00001579551,0.0001657493,0.000040991265,0.0001239875,0.00013790955,0.000102028614,0.000018946008,0.00012776555,0.000009337885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009789382,0.00010056986,0.99676067,0.0009671273,0.000115234005,0.00029469645,0.00030463916,0.0000042406955,0.00020745509,0.000029355597,0.00013281607,0.0001042546],"study_design_scores_gemma":[0.009570644,0.00038649057,0.9872202,0.00020864148,0.0016174853,0.00011064997,0.000039470582,0.000037050486,0.0005502165,0.00003377418,0.00004981728,0.0001755275],"about_ca_topic_score_codex":0.0001760944,"about_ca_topic_score_gemma":0.00008365723,"teacher_disagreement_score":0.009540441,"about_ca_system_score_codex":0.000018364335,"about_ca_system_score_gemma":0.00027727828,"threshold_uncertainty_score":0.675906},"labels":[],"label_agreement":null},{"id":"W2980204031","doi":"10.1182/blood.v122.21.3547.3547","title":"Characterization Of The Immature Platelet Fraction (IPF) Parameters In Children With Immune Thrombocytopenia","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; Hospital for Sick Children","funders":"","keywords":"Medicine; Internal medicine; Platelet; Gastroenterology; Hematology; Population; Immunology","score_opus":0.005262520120632624,"score_gpt":0.20161145192198487,"score_spread":0.19634893180135224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980204031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99867034,0.000054439948,0.000004732558,0.00028470423,0.00002293946,0.0007642986,0.00000803209,0.000013357229,0.00017716641],"genre_scores_gemma":[0.9994847,0.000045534314,0.00014276392,0.0001011591,0.00000918172,0.000033796554,0.00010693472,0.000012638587,0.0000632536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994731,0.00001872085,0.00014715121,0.00012089624,0.00012303976,0.00011708808],"domain_scores_gemma":[0.9996347,0.0000073498645,0.00010686497,0.00019957578,0.000027817141,0.000023695418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000026592803,0.00009636419,0.00024123756,0.000040917883,0.000028493227,0.000010815957,0.000054322834,0.00007043676,0.000045526667],"category_scores_gemma":[0.000007735045,0.00005487224,0.000038389662,0.00016340612,0.000029296583,0.00012359743,0.000014839866,0.00012177173,0.00001806358],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011450072,0.00106836,0.75517213,0.000019126397,0.0003689919,0.0000130308445,0.00017130854,0.0000033354206,0.24121359,0.000008654055,0.00001273162,0.0018342232],"study_design_scores_gemma":[0.0033343916,0.00012429006,0.86275905,0.00005940173,0.000087764194,0.00012239125,0.000019265519,0.000008986357,0.13339677,0.000026056332,0.0000106137,0.00005101573],"about_ca_topic_score_codex":0.0003147148,"about_ca_topic_score_gemma":0.000012245971,"teacher_disagreement_score":0.107816815,"about_ca_system_score_codex":0.000013514113,"about_ca_system_score_gemma":0.000023906168,"threshold_uncertainty_score":0.2237625},"labels":[],"label_agreement":null},{"id":"W2980207913","doi":"10.1182/blood.v110.11.3056.3056","title":"Matching for 12 HLA Alleles Is Associated with a Significantly Superior Survival Due to a Lower Mortality in Recipients of Unrelated Donor Haematopoietic Cell Transplants for Early but Not Late Stage Leukaemia.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Allele; Locus (genetics); Human leukocyte antigen; Transplantation; Biology; Immunology; Genetics; Internal medicine; Medicine; Antigen; Gene","score_opus":0.02892344005609101,"score_gpt":0.27480953122519136,"score_spread":0.24588609116910035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980207913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857866,0.000018873596,0.009384499,0.00004986243,0.00012907646,0.003172986,0.0011117511,0.000070536946,0.00027578432],"genre_scores_gemma":[0.9951557,0.000010643615,0.0035181744,0.00011488011,0.000026531583,0.00014688169,0.00020070378,0.00009136052,0.00073510717],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99714285,0.000076667464,0.0009776752,0.0005587355,0.0005512648,0.00069278735],"domain_scores_gemma":[0.99823153,0.0007221801,0.00023432632,0.00033471893,0.00021769709,0.00025955983],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011436244,0.00035033267,0.0009491603,0.0002417899,0.00006914611,0.000023451392,0.00016488152,0.00030171534,0.00003540064],"category_scores_gemma":[0.00006666469,0.0003166043,0.00018539035,0.00032302452,0.000057836074,0.00010025364,0.000010826006,0.00021402517,0.0000058211454],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01147182,0.004340099,0.37086773,0.004097628,0.0011940664,0.0013219103,0.024772037,0.0001298727,0.58157676,0.000095555035,0.000015778258,0.00011677646],"study_design_scores_gemma":[0.025615014,0.0017327514,0.40154728,0.001964623,0.0012614566,0.000039278922,0.0009773398,0.00008298294,0.56617063,0.00006119805,0.00001364966,0.00053379673],"about_ca_topic_score_codex":0.00078275346,"about_ca_topic_score_gemma":0.0024353506,"teacher_disagreement_score":0.030679554,"about_ca_system_score_codex":0.00008039463,"about_ca_system_score_gemma":0.00020365519,"threshold_uncertainty_score":0.9999286},"labels":[],"label_agreement":null},{"id":"W2980209785","doi":"10.1182/blood.v124.21.1543.1543","title":"Time in Therapeutic Range (TTR) and Relative Efficacy and Safety of Treatment with Apixaban or Enoxaparin/Warfarin for Acute Symptomatic Venous Thromboembolism: An Analysis of the Amplify Trial Data","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Apixaban; Warfarin; Medicine; Quartile; Anesthesia; Rivaroxaban; Randomized controlled trial; Internal medicine; Surgery; Atrial fibrillation; Confidence interval","score_opus":0.23713626074430155,"score_gpt":0.4074972759894043,"score_spread":0.17036101524510272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980209785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995324,0.00043694055,0.00075798837,0.00061922136,0.000036639605,0.0018024173,0.0008850352,0.000009585203,0.00012812902],"genre_scores_gemma":[0.9986071,0.00009177114,0.000842533,0.00016769423,0.000044896067,0.00007803262,0.0000907936,0.000019983114,0.000057210455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99728817,0.00033805228,0.0016701728,0.00045538926,0.000056276298,0.00019197036],"domain_scores_gemma":[0.9960277,0.0017130313,0.0013040022,0.0008630875,0.000025940075,0.00006623785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041793487,0.00016118506,0.0014910154,0.00024462526,0.00009184133,0.00002358595,0.00026538,0.00009833239,0.00002719764],"category_scores_gemma":[0.00038739943,0.00012133778,0.000059923357,0.0002763558,0.00013865085,0.0002257854,0.00006085318,0.000063179825,0.0000040961954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026613265,0.01764384,0.63077277,0.0021064316,0.057798978,0.0000024212811,0.08693936,0.002053981,0.0001633129,0.16725637,0.00010815142,0.00854114],"study_design_scores_gemma":[0.10737008,0.007868437,0.77812266,0.00018944035,0.0057849344,0.000008649506,0.00094712083,0.09398083,0.000022433334,0.0044217072,0.00069305795,0.0005906692],"about_ca_topic_score_codex":0.000678687,"about_ca_topic_score_gemma":0.00080501055,"teacher_disagreement_score":0.16283466,"about_ca_system_score_codex":0.00010134125,"about_ca_system_score_gemma":0.00010849001,"threshold_uncertainty_score":0.4948011},"labels":[],"label_agreement":null},{"id":"W2980210272","doi":"10.1182/blood.v128.22.3382.3382","title":"Intergraft Variability in Nonhematopoietic Immunoregulatory Cell Number and Expression of Immune Checkpoint Inhibitor Receptors and Ligands in Both Allo- and Autografts: Potential Target for Intervention","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; CancerCare Manitoba; Research Manitoba","funders":"","keywords":"Medicine; Immunology; Stem cell; Myeloid; CD34; Cancer research; Filgrastim; CD14; Immune system; Biology; Internal medicine; Chemotherapy; Granulocyte colony-stimulating factor; Cell biology","score_opus":0.0032660250278101054,"score_gpt":0.20938362882930167,"score_spread":0.20611760380149158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980210272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924093,0.0061187786,0.00038329198,0.00006575999,0.0005004719,0.000433951,0.000019993075,0.000018859211,0.000049631362],"genre_scores_gemma":[0.9986433,0.00036201492,0.0005790357,0.0000066566977,0.000015504951,0.00007601132,0.000017044269,0.00002273396,0.00027773526],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99840224,0.00019105712,0.0006976624,0.00039608622,0.000036672922,0.0002763004],"domain_scores_gemma":[0.9992903,0.00017049155,0.00022505708,0.00025262695,0.00004171219,0.000019852914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010788318,0.00020365755,0.00041481803,0.00011822473,0.000043893575,0.000011129698,0.00011648826,0.00031294485,0.00013302344],"category_scores_gemma":[0.00010026832,0.0001601444,0.00008952408,0.00007387216,0.00037383536,0.00014078962,0.0003237706,0.0001735098,0.0000027104718],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031792835,0.00057267275,0.043013733,0.0003008389,0.000037197522,0.0000010404552,0.00061812485,2.4762693e-7,0.9530257,0.000020548128,0.000048065853,0.0020439192],"study_design_scores_gemma":[0.009529676,0.00024880114,0.038109772,0.0007486255,0.000039314207,0.000026253432,0.00017900439,0.0000031281083,0.9496429,0.00090566766,0.0003728986,0.00019397974],"about_ca_topic_score_codex":0.00008457119,"about_ca_topic_score_gemma":0.000016542066,"teacher_disagreement_score":0.009211748,"about_ca_system_score_codex":0.000035798825,"about_ca_system_score_gemma":0.000027812812,"threshold_uncertainty_score":0.6530499},"labels":[],"label_agreement":null},{"id":"W2980212795","doi":"10.1182/blood.v118.21.3426.3426","title":"Screening Patients with Myelodysplastic Syndrome and Aplastic Anemia for Paroxysmal Nocturnal Hemoglobinuria Clones: A Retrospective Study,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Victoria Hospital; Health Sciences Centre; University of Toronto; London Health Sciences Centre; Sunnybrook Health Science Centre; Western University","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Bone marrow failure; Aplastic anemia; Medicine; Hemoglobinuria; Myelodysplastic syndromes; clone (Java method); Bone marrow; Internal medicine; Immunology; Anemia; Gastroenterology; Stem cell; Haematopoiesis; Biology","score_opus":0.011707157938888548,"score_gpt":0.20504458773617515,"score_spread":0.1933374297972866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980212795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967441,0.00006178758,0.001418269,0.000012340711,0.00007861439,0.0014215149,0.000035339825,0.00006114306,0.00016687927],"genre_scores_gemma":[0.9951571,0.0000030156052,0.0045578876,0.00003439954,0.00007030197,0.00007275268,0.000023382825,0.000042786145,0.000038344522],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986934,0.000021935273,0.00024116787,0.00042541756,0.00029273378,0.00032536825],"domain_scores_gemma":[0.9993318,0.000049326765,0.00008586798,0.00019402587,0.00013634539,0.00020263807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010484204,0.0002403655,0.00040449874,0.000094726536,0.00016078344,0.000020839503,0.00006450948,0.000090520196,0.000048640304],"category_scores_gemma":[0.00004463422,0.00017446592,0.000053696695,0.00016227612,0.00007530148,0.000100297766,0.00002987762,0.00021216723,0.0000032387331],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017868554,0.002500666,0.9935467,0.00012126463,0.00032902995,0.0002065725,0.0010326653,3.894568e-7,0.00010486871,0.000046271183,0.000008648866,0.00031602188],"study_design_scores_gemma":[0.024911793,0.011170641,0.9608294,0.00018380507,0.0017106332,0.00044112955,0.00025895893,0.000023237391,0.00019465141,0.000058115507,0.000006928528,0.00021071744],"about_ca_topic_score_codex":0.000061494786,"about_ca_topic_score_gemma":0.000050608538,"teacher_disagreement_score":0.03271736,"about_ca_system_score_codex":0.000016291768,"about_ca_system_score_gemma":0.000036866393,"threshold_uncertainty_score":0.71145135},"labels":[],"label_agreement":null},{"id":"W2980213505","doi":"10.1182/blood.v104.11.428.428","title":"Differential Effects of Three Small Molecules Blocking Phosphatidylinositol-3 Kinase or AKT in Hodgkin Disease Cell Lines: Induction of Apoptosis and Cell Cycle Arrest.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Protein kinase B; PI3K/AKT/mTOR pathway; LY294002; Cancer research; Cell cycle; Propidium iodide; Biology; Phosphatidylinositol; Kinase; Apoptosis; Phosphorylation; Molecular biology; Chemistry; Cell biology; Signal transduction; Programmed cell death; Biochemistry","score_opus":0.011803989024415281,"score_gpt":0.24411431225805522,"score_spread":0.23231032323363993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980213505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976089,0.0010937911,0.00023584151,0.000056352423,0.00012897179,0.000785112,0.000009444288,0.000026277565,0.000055282944],"genre_scores_gemma":[0.99844676,0.00021611589,0.001065306,0.000015858492,0.0001336081,0.00004310087,0.000015793583,0.000037509457,0.00002597174],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998407,0.00005154398,0.0004210815,0.00037628447,0.00040238083,0.00034169536],"domain_scores_gemma":[0.99892634,0.00018949357,0.00015971987,0.00039461878,0.000086750515,0.00024309338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000082165294,0.00021996001,0.00044924844,0.00021947581,0.00003587599,0.000013406559,0.00013492446,0.00013815144,0.000017586424],"category_scores_gemma":[0.00020692161,0.00018177436,0.00009669347,0.0003393384,0.0001491651,0.000053980802,0.00012847375,0.00020604866,0.0000025120478],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025059038,0.010095106,0.015822353,0.012647972,0.00016341514,0.0005943086,0.0011460069,0.0006799313,0.9533819,0.00005984305,0.000009674462,0.0028936039],"study_design_scores_gemma":[0.0463941,0.00047930548,0.014094489,0.0010092694,0.00039042137,0.000009666911,0.0000674123,0.0009844865,0.93626565,0.00014598611,0.0000015682002,0.00015765242],"about_ca_topic_score_codex":0.0016161035,"about_ca_topic_score_gemma":0.000151394,"teacher_disagreement_score":0.043888193,"about_ca_system_score_codex":0.0005002704,"about_ca_system_score_gemma":0.0015381143,"threshold_uncertainty_score":0.7412543},"labels":[],"label_agreement":null},{"id":"W2980215397","doi":"10.1182/blood.v128.22.2089.2089","title":"Small RNA Next Generation Sequencing (NGS) of CD138+ Plasma Cells from Multiple Myeloma Patients and Comparison to the 70-Gene mRNA-Based Prognostic Risk Score","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"RNA; Biology; Gene; microRNA; Bone marrow; RNA extraction; Molecular biology; Multiple myeloma; Primer (cosmetics); Gene expression; Small RNA; Genetics; Immunology; Chemistry","score_opus":0.030182336476645942,"score_gpt":0.21499707258367112,"score_spread":0.18481473610702517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980215397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99569935,0.00029599987,0.0031053307,0.0000404155,0.00008972831,0.00048144866,0.00027191517,0.000009357928,0.0000064669484],"genre_scores_gemma":[0.9965941,0.000022121521,0.002852549,0.00004685698,0.00017139372,0.00003098628,0.00025187133,0.000020640393,0.000009527634],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990576,0.00009580495,0.00025128495,0.00031537694,0.0001226824,0.0001572543],"domain_scores_gemma":[0.9992475,0.000052100208,0.00019299536,0.00030096824,0.00012245186,0.00008396388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009268238,0.00014037009,0.00012921463,0.000029871015,0.0000799097,0.000024252557,0.00013108696,0.000097977456,0.00000650133],"category_scores_gemma":[0.00019568241,0.00009620823,0.000049450675,0.000054302756,0.00004601174,0.0000051667207,0.00007087034,0.00003631258,0.0000071718177],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005012611,0.000117868636,0.13973263,0.000009806558,0.000044608154,4.3710045e-7,0.000046568035,0.00042188063,0.855788,4.7601807e-7,0.00011468414,0.0036729109],"study_design_scores_gemma":[0.0016732179,0.0001822839,0.07508096,0.000038191905,0.00010060963,3.9527595e-7,0.000011371953,0.0023458295,0.9203082,0.000004146115,0.00012670112,0.0001281156],"about_ca_topic_score_codex":0.00007593689,"about_ca_topic_score_gemma":0.0002678033,"teacher_disagreement_score":0.06465167,"about_ca_system_score_codex":0.000016640748,"about_ca_system_score_gemma":0.00006427773,"threshold_uncertainty_score":0.39232576},"labels":[],"label_agreement":null},{"id":"W2980217808","doi":"10.1182/blood.v120.21.500.500","title":"Rivaroxaban for Thromboprophylaxis After Total Hip or Knee Replacement Surgery: Comparison of Outcomes of the XAMOS and RECORD Studies","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Rivaroxaban; Knee replacement; Orthopedic surgery; Hip replacement; Surgery; Adverse effect; Incidence (geometry); Cohort; Hip fracture; Internal medicine; Osteoporosis; Warfarin","score_opus":0.057860127865593566,"score_gpt":0.334338636821808,"score_spread":0.2764785089562144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980217808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957668,0.0018763007,0.0000074330374,0.000546829,0.00051540724,0.0011320728,0.000017950899,0.0000137532115,0.0001234172],"genre_scores_gemma":[0.9984053,0.00014179645,0.0006297407,0.00017840856,0.00011133153,0.00020939895,0.0000026444338,0.000018201916,0.00030321314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988831,0.00003815442,0.00044604094,0.00016468877,0.00022586064,0.00024211509],"domain_scores_gemma":[0.9989262,0.00030811486,0.00022631933,0.00036782556,0.00011101369,0.000060515897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036805114,0.00014883495,0.00089969777,0.000059054546,0.000051480638,0.000004609004,0.0000489984,0.000043801214,0.00004327975],"category_scores_gemma":[0.00031225532,0.00008251123,0.00016738584,0.000097170305,0.000109411674,0.00005010161,0.00013859585,0.000054378943,0.0000014649423],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020823764,0.0025834015,0.98584867,0.00083952077,0.0012764736,6.5479645e-7,0.002021258,1.8093253e-7,0.00029445544,0.00010017702,0.0045208056,0.0023061973],"study_design_scores_gemma":[0.0016022332,0.000904219,0.9817792,0.00017743531,0.0010795248,0.0000032796013,0.0015654223,0.000002132637,0.011298016,0.000039053477,0.0014445097,0.00010494341],"about_ca_topic_score_codex":0.000049220973,"about_ca_topic_score_gemma":0.000030226423,"teacher_disagreement_score":0.011003559,"about_ca_system_score_codex":0.00001795707,"about_ca_system_score_gemma":0.000024911975,"threshold_uncertainty_score":0.33647102},"labels":[],"label_agreement":null},{"id":"W2980219326","doi":"10.1182/blood.v122.21.932.932","title":"A Review Of Computed Tomography Pulmonary Angiograms In Three Teaching Hospitals: The Rise Of Sub-Segmental Pulmonary Emboli and Their Management","year":2013,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; St. Joseph's Hospital; McMaster University; University of British Columbia","funders":"","keywords":"Medicine; Pulmonary embolism; Pulmonary angiography; Thrombosis; Radiology; Thrombus; Population; Retrospective cohort study; Surgery","score_opus":0.01858762601708734,"score_gpt":0.2728000286786918,"score_spread":0.25421240266160444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980219326","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018176306,0.988455,0.000009054389,0.00010146398,0.00010127045,0.0065665753,0.000053218944,0.000039012986,0.0028567885],"genre_scores_gemma":[0.0025587918,0.99589455,0.0003309485,0.00016642125,0.00008379925,0.00073528016,0.00014013863,0.000075696444,0.000014357115],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.997005,0.0002845304,0.0013288797,0.00060749456,0.00035883312,0.0004152976],"domain_scores_gemma":[0.99791443,0.00014796738,0.00077136134,0.0009886081,0.000057592315,0.00012006572],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009917533,0.000627408,0.003371951,0.00053415674,0.00007242094,0.00002135979,0.0004854082,0.00017091996,0.000029395542],"category_scores_gemma":[0.000018655239,0.00037586977,0.0010626521,0.00072495796,0.0002133374,0.00007831249,0.000605018,0.00046604185,0.0000058518826],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000032947855,0.0028283354,0.00079530774,0.21789166,0.0016912728,0.00008453731,0.000057260364,7.282731e-8,0.0000025844174,0.0002529973,0.0007600154,0.7756327],"study_design_scores_gemma":[0.0012186719,0.0005750258,0.013213756,0.6022364,0.013661544,0.00027865882,0.00033718842,0.00003361419,0.000011496626,0.0002426701,0.3674124,0.00077859766],"about_ca_topic_score_codex":0.00020947639,"about_ca_topic_score_gemma":0.000009040997,"teacher_disagreement_score":0.77485406,"about_ca_system_score_codex":0.00003349885,"about_ca_system_score_gemma":0.000037966438,"threshold_uncertainty_score":0.99986935},"labels":[],"label_agreement":null},{"id":"W2980222462","doi":"10.1182/blood.v114.22.3841.3841","title":"Molecular Mechanisms Mediating Antimyeloma Activity of An MDM2 Antagonist Nutlin.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Mdm2; Apoptosis; Cell culture; Cancer research; Cell growth; Cell cycle; Viability assay; Biology; Molecular biology; Cell biology; Genetics","score_opus":0.007998113150191069,"score_gpt":0.25030426732901606,"score_spread":0.242306154178825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980222462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99125314,0.0002795385,0.004715072,0.00030192835,0.00011446812,0.0003801243,0.000025843867,0.00013666473,0.0027932324],"genre_scores_gemma":[0.9926412,0.000032807246,0.0068397815,0.00029278325,0.000093592884,0.0000052936675,0.000042763062,0.000035889927,0.000015852102],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985594,0.000062714535,0.00028461445,0.0003529357,0.00043333042,0.0003069912],"domain_scores_gemma":[0.99896854,0.000019593832,0.00016910175,0.000546423,0.0000987078,0.00019762547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021374655,0.00019447689,0.00040065992,0.00011675712,0.00006477678,0.000014217186,0.0001284279,0.00017382347,0.00002878562],"category_scores_gemma":[0.00012170091,0.00019720588,0.00014149961,0.00028232305,0.00004583726,0.00008257933,0.00003007656,0.00026267636,0.000009663394],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011159976,0.0012730579,0.000051973493,0.00003767535,0.000085016545,0.00045854496,0.00011579339,0.00001691004,0.9862424,0.0007974474,0.000007921193,0.010801659],"study_design_scores_gemma":[0.003771944,0.0013359034,0.0044138147,0.00009146808,0.00032325016,0.00022118125,0.000033579887,0.00056457816,0.9884311,0.00056927325,0.000061491686,0.00018243241],"about_ca_topic_score_codex":0.00003179554,"about_ca_topic_score_gemma":0.0000040803598,"teacher_disagreement_score":0.010619226,"about_ca_system_score_codex":0.000038036356,"about_ca_system_score_gemma":0.00016241602,"threshold_uncertainty_score":0.80418223},"labels":[],"label_agreement":null},{"id":"W2980223642","doi":"10.1182/blood.v126.23.817.817","title":"Diffuse Large B-Cell Lymphoma Patient-Derived Xenograft Models Capture Molecular and Biologic Heterogeneity and Inform Therapy","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"breakpoint cluster region; Biology; Cancer research; Germinal center; Diffuse large B-cell lymphoma; B-cell receptor; B cell; Lymphoma; Somatic cell; Immunology; Genetics; Gene; Antibody","score_opus":0.022665537814345185,"score_gpt":0.23796284176925872,"score_spread":0.21529730395491353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980223642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837323,0.014812837,0.000015057236,0.00013644186,0.000029317893,0.00043133763,0.000036563248,0.000052125266,0.00075403595],"genre_scores_gemma":[0.99743515,0.0011289723,0.00034124454,0.0009405535,0.000017517426,0.000057115787,0.00004970274,0.000016267557,0.000013445854],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99915665,0.000021905124,0.00015940919,0.0002548233,0.00015457522,0.00025264866],"domain_scores_gemma":[0.9993386,0.000017134354,0.000060339764,0.00023940485,0.00006115085,0.00028332046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000054006498,0.00020394879,0.00026904483,0.000047771624,0.000053023665,0.000029118391,0.00003951232,0.00012327508,0.0000020746334],"category_scores_gemma":[0.000009719965,0.00013566302,0.000060482907,0.000060562197,0.000052711413,0.00007495431,0.000069954694,0.000034285917,0.0000044428284],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011261788,0.06885013,0.81406707,0.00020097094,0.001819021,0.0018793956,0.008877631,0.000010246094,0.0645238,0.00116573,0.0004278831,0.037051927],"study_design_scores_gemma":[0.2589666,0.006084095,0.08051478,0.00010151448,0.00079321815,0.0007344335,0.0012834249,0.0006449674,0.6431057,0.001352206,0.005526608,0.0008924877],"about_ca_topic_score_codex":0.00008933937,"about_ca_topic_score_gemma":0.000012551264,"teacher_disagreement_score":0.7335523,"about_ca_system_score_codex":0.000027350781,"about_ca_system_score_gemma":0.000043653996,"threshold_uncertainty_score":0.5532177},"labels":[],"label_agreement":null},{"id":"W2980226374","doi":"10.1182/blood.v126.23.802.802","title":"Mutational and Transcriptomic Landscape of AML with Core-Binding Factor Rearrangements","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Core binding factor; Biology; RUNX1; NPM1; Neuroblastoma RAS viral oncogene homolog; Gene; Genetics; Sanger sequencing; Mutation; Transcriptome; Cancer research; Gene expression; Transcription factor; Chromosome; KRAS","score_opus":0.049539934073913806,"score_gpt":0.2983059213550274,"score_spread":0.24876598728111363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980226374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967339,0.00015815545,0.000037190384,0.00016652497,0.000017885857,0.00021519535,0.000035285942,0.000021017759,0.0026148404],"genre_scores_gemma":[0.99792814,0.000012518586,0.0013706287,0.000038892777,0.000046019988,0.000007970672,0.000041510026,0.000014119655,0.0005401769],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992884,0.0000129378695,0.00010866377,0.00012947184,0.00032175146,0.00013876824],"domain_scores_gemma":[0.99959046,0.00002657873,0.000033364606,0.00010347897,0.00010108119,0.00014504256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010414392,0.00007125263,0.00015541584,0.00009203894,0.000018293402,0.0000068407376,0.00004423546,0.000038816306,0.00007625869],"category_scores_gemma":[0.000040260213,0.00005235238,0.000017115279,0.00010898094,0.000059436312,0.0000496514,0.00001310407,0.0001006318,0.00001230869],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013086399,0.0005023198,0.85115415,0.00024305952,0.0005355819,0.00022421163,0.0034231371,0.0000021341086,0.13864055,0.00014466696,0.0023589958,0.0014625444],"study_design_scores_gemma":[0.08799007,0.004102577,0.78007627,0.00044740326,0.00085033884,0.0011694768,0.0032928025,0.0006204827,0.1181515,0.00016685322,0.002650311,0.00048191648],"about_ca_topic_score_codex":0.000028811057,"about_ca_topic_score_gemma":0.00000914953,"teacher_disagreement_score":0.086681426,"about_ca_system_score_codex":0.00002625837,"about_ca_system_score_gemma":0.00019023944,"threshold_uncertainty_score":0.21348682},"labels":[],"label_agreement":null},{"id":"W2980227759","doi":"10.1182/blood.v122.21.3651.3651","title":"Exposure To ABO Compatible But Non-Group Identical Blood and In-Hospital Mortality","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Blood donation and transfusion practices","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hamilton General Hospital; McMaster University; University of Waterloo","funders":"","keywords":"ABO blood group system; Medicine; Blood transfusion; Retrospective cohort study; Internal medicine; Surgery","score_opus":0.011326442165801243,"score_gpt":0.23245573375830897,"score_spread":0.22112929159250772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980227759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98922557,0.000062788204,0.00006832406,0.0014776468,0.00021715745,0.00048826163,0.0000022880936,0.000076581404,0.008381409],"genre_scores_gemma":[0.997692,0.000013570261,0.00039829357,0.0014243104,0.00029104727,0.00006951257,0.000011361357,0.000018674144,0.0000812574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877775,0.000011913934,0.00033486134,0.00033156376,0.00028524664,0.00025864958],"domain_scores_gemma":[0.99949783,0.00004856568,0.000098101315,0.00020479878,0.0001089942,0.000041730873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025184135,0.0001650112,0.00020691019,0.00019404721,0.00010925693,0.00051811454,0.00017066757,0.00007515591,0.0006368916],"category_scores_gemma":[0.00008922084,0.00015548569,0.000043746888,0.00037511808,0.000037488673,0.0016589584,0.00012620118,0.00015864075,0.00054718467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001223074,0.003107435,0.9848579,0.00015196885,0.00010651064,0.000044134773,0.00014636066,0.000004619711,0.0038462542,0.0056579183,0.00065111683,0.001413519],"study_design_scores_gemma":[0.0027760004,0.00005692097,0.99319655,0.000036452613,0.00020157082,0.0000036012527,0.0003053791,0.00014335108,0.00042125286,0.00092881906,0.001664077,0.00026604888],"about_ca_topic_score_codex":0.0016553788,"about_ca_topic_score_gemma":0.00057512935,"teacher_disagreement_score":0.008466429,"about_ca_system_score_codex":0.0000028135191,"about_ca_system_score_gemma":0.000008642941,"threshold_uncertainty_score":0.70331347},"labels":[],"label_agreement":null},{"id":"W2980229027","doi":"10.1182/blood.v104.11.704.704","title":"The Safety of Co-Administered Low-Molecular-Weight Heparin and Continuous Epidural Analgesia after Major Orthopedic Surgery: Assessment of a Standardized Management Protocol.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Medicine; Anesthesia; Surgery; Low molecular weight heparin; Orthopedic surgery; Bupivacaine; Anticoagulant; Fentanyl; Regimen; Thrombosis","score_opus":0.007350070681241115,"score_gpt":0.2887895339583878,"score_spread":0.2814394632771467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980229027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94885814,0.00030213082,0.00062225567,0.0010540485,0.00007898239,0.041276034,0.000058301404,0.000042629483,0.0077074487],"genre_scores_gemma":[0.98145056,0.00026731176,0.0016014418,0.0002144005,0.00003542289,0.016256277,0.00002000378,0.000032750537,0.00012180575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997802,0.0001091088,0.00079524354,0.00033804614,0.00060082314,0.00035477366],"domain_scores_gemma":[0.9987618,0.00008393719,0.00034407416,0.0005437074,0.0001244008,0.00014210411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085190433,0.00024057754,0.0008964805,0.00012993201,0.0000907796,0.00003089653,0.00011703507,0.00006506634,0.00007086504],"category_scores_gemma":[0.000031409578,0.0001665279,0.00023018257,0.00019615957,0.00020207031,0.000044889457,0.00014047939,0.00011116044,0.0000017564694],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011392723,0.028237714,0.8061293,0.016946372,0.016928291,0.0054881447,0.0012057541,0.000025626841,0.005687642,0.045034368,0.0048614875,0.058062594],"study_design_scores_gemma":[0.020713871,0.0011077662,0.94680023,0.0012506237,0.0019102553,0.000041517258,0.00022463387,0.0000058288297,0.010569174,0.0002750762,0.016781768,0.00031927717],"about_ca_topic_score_codex":0.00004358089,"about_ca_topic_score_gemma":0.000032145635,"teacher_disagreement_score":0.14067093,"about_ca_system_score_codex":0.000055400084,"about_ca_system_score_gemma":0.00016679904,"threshold_uncertainty_score":0.6790811},"labels":[],"label_agreement":null},{"id":"W2980237789","doi":"10.1182/blood.v126.23.1638.1638","title":"Fishing with a Transgenic Line: Using Zebrafish to Elucidate Mechanisms and Therapeutics in NUP98-NSD1 AML","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Zebrafish; Biology; Cancer research; Myeloproliferative neoplasm; Myeloid leukemia; Myeloid; Genetics; Gene; Immunology; Myelofibrosis; Bone marrow","score_opus":0.054046360722011764,"score_gpt":0.3128327379445687,"score_spread":0.25878637722255693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980237789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912508,0.00020825678,0.0047846246,0.00264109,0.000027692407,0.000587543,0.0000073795095,0.00005420243,0.00043838084],"genre_scores_gemma":[0.97228664,0.000032609,0.025744738,0.0015993908,0.00010380428,0.00001895351,0.000007826755,0.000053923497,0.00015211939],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985895,0.000061540355,0.0002064437,0.00032527337,0.00039984845,0.00041738115],"domain_scores_gemma":[0.9991855,0.000043705484,0.00003313076,0.0002977807,0.00010735521,0.0003325014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046462874,0.00017102208,0.0003007807,0.00019602227,0.0000403208,0.00005166127,0.00012796801,0.00011263455,0.000014093701],"category_scores_gemma":[0.000054834756,0.00013641198,0.00002873145,0.00044433158,0.000042074756,0.0001204798,0.00006135827,0.00036834495,0.000012051343],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038871688,0.002079596,0.030570477,0.00050463044,0.0011032848,0.0021693152,0.02089184,0.0004635932,0.9236242,0.0005966402,0.00060397695,0.013505278],"study_design_scores_gemma":[0.10844447,0.011206098,0.021360684,0.0021617236,0.0024999275,0.0036266884,0.007489864,0.025797207,0.80217457,0.0032689262,0.009649594,0.0023202316],"about_ca_topic_score_codex":0.00021351571,"about_ca_topic_score_gemma":0.00025446084,"teacher_disagreement_score":0.12144961,"about_ca_system_score_codex":0.000120907556,"about_ca_system_score_gemma":0.0003926821,"threshold_uncertainty_score":0.5562719},"labels":[],"label_agreement":null},{"id":"W2980237990","doi":"10.1182/blood.v118.21.2211.2211","title":"Involvement of Lipid Rafts and Caveolae in gas6-Axl Signaling in Endothelial Cells","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Caveolae; Lipid raft; Cell biology; Proto-oncogene tyrosine-protein kinase Src; GAS6; Receptor tyrosine kinase; Biology; Tyrosine kinase; Biochemistry; Chemistry; Signal transduction","score_opus":0.0206227549956888,"score_gpt":0.20703971766368348,"score_spread":0.18641696266799468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980237990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973781,0.0017136515,0.000006392299,0.0000070792757,0.00012334567,0.00013727983,0.000008290516,0.0000068975532,0.0006189711],"genre_scores_gemma":[0.9996372,0.00010873763,0.00009448625,0.000019324096,0.000011433766,0.000009594316,0.000009352843,0.0000063079483,0.00010357467],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993235,0.000088492256,0.00026825894,0.00013845415,0.000017243698,0.00016406964],"domain_scores_gemma":[0.99976283,0.00003083721,0.00007797095,0.000105711646,0.000014746462,0.000007880743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021096686,0.000081451195,0.00018668502,0.000117829855,0.000018347453,0.0000023040236,0.000069135574,0.00010248354,0.0001380977],"category_scores_gemma":[0.000010816257,0.000076159755,0.000027045018,0.00007028182,0.000058514648,0.00005420138,0.0000439655,0.000095190575,0.000012825931],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005614106,0.0004028501,0.0510067,0.000017146407,0.000027626716,0.0000017674487,0.001743684,0.0000017040073,0.9460281,0.00012918965,0.000010017486,0.00057506067],"study_design_scores_gemma":[0.0031010087,0.000117937765,0.06595273,0.00005382717,0.000014876677,0.000004055058,0.0001455753,0.0000026262376,0.93015283,0.00009624107,0.00028515857,0.00007315536],"about_ca_topic_score_codex":0.00041196824,"about_ca_topic_score_gemma":0.000095616684,"teacher_disagreement_score":0.015875308,"about_ca_system_score_codex":0.000009557522,"about_ca_system_score_gemma":0.000020047268,"threshold_uncertainty_score":0.31057045},"labels":[],"label_agreement":null},{"id":"W2980241767","doi":"10.1182/blood.v116.21.687.687","title":"Autologous Stem Cell Transplantation Is a Curative Treatment Modality for Relapsed or Refractory Follicular Lymphoma, and Both Recent Rituximab Exposure and Follicular Lymphoma International Prognostic Index (FLIPI) 0–1 Scores Predict Improved Outcome","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Follicular lymphoma; Rituximab; Autologous stem-cell transplantation; Internal medicine; International Prognostic Index; Transplantation; Oncology; Surgery; Lymphoma; Chemotherapy; Chemotherapy regimen; Gastroenterology","score_opus":0.01665442135254028,"score_gpt":0.26566532709463186,"score_spread":0.2490109057420916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980241767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937343,0.0013161299,0.00017925145,0.00083188474,0.0003256356,0.0028930707,0.00051931833,0.000114093215,0.00008629458],"genre_scores_gemma":[0.9947249,0.0013744698,0.0017218122,0.00027165355,0.00013094359,0.0012376679,0.0002668697,0.00004984968,0.00022182288],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978176,0.000072737625,0.0006025624,0.00077379635,0.00035250638,0.00038081795],"domain_scores_gemma":[0.9985719,0.0002940695,0.0002808155,0.00038206895,0.00018446056,0.0002867221],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017605622,0.00047074468,0.0006796773,0.00013809581,0.00019497306,0.000090747,0.00010253865,0.0003085655,0.000029040697],"category_scores_gemma":[0.00006207812,0.00032471368,0.00018788362,0.000111746,0.00012366039,0.00019801919,0.000033977,0.00007860723,0.0000030210772],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038491688,0.013815847,0.86686116,0.00046051445,0.0017735661,0.0005941546,0.0027114314,9.432252e-7,0.0053938436,0.00011297965,0.000065126194,0.10436129],"study_design_scores_gemma":[0.10854929,0.005871203,0.84634435,0.00017454106,0.0029087923,0.0007313183,0.000278878,0.0012671603,0.03018844,0.000103520535,0.003110802,0.00047170874],"about_ca_topic_score_codex":0.00022275573,"about_ca_topic_score_gemma":0.00021336885,"teacher_disagreement_score":0.10470012,"about_ca_system_score_codex":0.00023105872,"about_ca_system_score_gemma":0.0003308928,"threshold_uncertainty_score":0.9999205},"labels":[],"label_agreement":null},{"id":"W2980248458","doi":"10.1182/blood.v108.11.3548.3548","title":"Use of Lenalidomide (Revlimid® +/− Corticosteroids in Relapsed/Refractory Multiple Myeloma Patients with Elevated Baseline Serum Creatinine Levels.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Lenalidomide; Medicine; Thalidomide; Internal medicine; Prednisone; Gastroenterology; Multiple myeloma; Creatinine; Dexamethasone; Refractory (planetary science); Cyclophosphamide; Urology; Surgery; Chemotherapy","score_opus":0.028874828547414425,"score_gpt":0.2551794900175741,"score_spread":0.2263046614701597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980248458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980731,0.00016526543,0.000029216275,0.00007882356,0.00002921369,0.0010166139,0.0003398023,0.0000612986,0.00020666038],"genre_scores_gemma":[0.99544126,0.000020999114,0.0029085,0.00007054123,0.00005696073,0.000055634006,0.0005779909,0.00006180701,0.00080630503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974994,0.00015425724,0.0006920077,0.00043641584,0.0006605404,0.00055737724],"domain_scores_gemma":[0.99822485,0.00040625044,0.00022843386,0.00053594087,0.00037810596,0.00022643046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019040612,0.00031106293,0.0005944502,0.0003142171,0.000051238963,0.000018610219,0.00010160204,0.00013190456,0.0001963214],"category_scores_gemma":[0.00066747714,0.00023313679,0.000092776405,0.00045301951,0.00011501394,0.00016730142,0.00005995707,0.0002750196,0.000026280464],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027278697,0.007169463,0.9725288,0.000109149325,0.00022012496,0.00031990843,0.000040775678,0.00003248655,0.013479271,0.000004877786,0.00012400435,0.00324324],"study_design_scores_gemma":[0.04340961,0.0015710834,0.91550946,0.00034668922,0.00018575035,0.000016849051,0.0000141621495,0.00046840485,0.038038608,0.0000044350877,0.00024149523,0.00019347528],"about_ca_topic_score_codex":0.0011757048,"about_ca_topic_score_gemma":0.00074976037,"teacher_disagreement_score":0.05701939,"about_ca_system_score_codex":0.00008655639,"about_ca_system_score_gemma":0.00015241765,"threshold_uncertainty_score":0.9507042},"labels":[],"label_agreement":null},{"id":"W2980249817","doi":"10.1182/blood.v114.22.1314.1314","title":"Diagnostic Utility of Platelet Secretion Testing by ATP Release Assays: Results From a Prospective Study of Individuals Referred for Bleeding Disorder Assessments.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Platelet; Platelet disorder; Medicine; Prospective cohort study; Internal medicine; Thromboxane A2; Blood Platelet Disorders; Epinephrine; Gastroenterology; Endocrinology; Platelet aggregation","score_opus":0.03521092850615897,"score_gpt":0.3112882625263943,"score_spread":0.2760773340202353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980249817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99499154,0.00028800737,0.00009109534,0.00007182757,0.000029825967,0.0024202245,0.0013065229,0.000050834857,0.000750118],"genre_scores_gemma":[0.9975742,0.000021726199,0.0014673275,0.000023890709,0.00002743189,0.000095530704,0.0007449542,0.000019906736,0.000025037605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982125,0.000055428398,0.0006425458,0.00046229397,0.00037587213,0.0002513192],"domain_scores_gemma":[0.9979492,0.0009987566,0.00043376573,0.000304967,0.000221591,0.000091712565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002958941,0.00021649315,0.0006136124,0.000085558,0.000079579964,0.000012576076,0.00008703334,0.0001116843,0.000010174594],"category_scores_gemma":[0.0024888488,0.00018899997,0.000074559546,0.0002856531,0.00003165468,0.000105024206,0.000029129731,0.00014141169,0.0000011802164],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013177796,0.026989263,0.95297223,0.00008297223,0.0011252826,0.00008487216,0.0022798062,0.000007014256,0.00451539,0.0000062669374,0.0003143267,0.010304796],"study_design_scores_gemma":[0.04777093,0.0077847242,0.9298976,0.00041315253,0.0015119892,0.000010156882,0.0019700287,0.00048201816,0.0088470625,0.0010506897,0.000042609387,0.00021905282],"about_ca_topic_score_codex":0.0006051285,"about_ca_topic_score_gemma":0.000027007465,"teacher_disagreement_score":0.046453148,"about_ca_system_score_codex":0.000027864251,"about_ca_system_score_gemma":0.000066294764,"threshold_uncertainty_score":0.77071947},"labels":[],"label_agreement":null},{"id":"W2980250177","doi":"10.1182/blood.v104.11.526.526","title":"Detection of T-Cells Specific for Leukemia-Associated Antigens in Pediatric Patients with Acute Lymphoblastic Leukemia in First Complete Remission.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Immunology; ELISPOT; Human leukocyte antigen; Leukemia; Immune system; Antigen; Hematopoietic stem cell transplantation; Medicine; Epitope; Transplantation; T cell; Biology; Internal medicine","score_opus":0.011890019892372095,"score_gpt":0.2303672077744983,"score_spread":0.2184771878821262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980250177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970543,0.00008784392,0.00095921924,0.000036166144,0.00010575937,0.0014581273,0.00009662532,0.000050149167,0.00015185337],"genre_scores_gemma":[0.99783695,0.00021370342,0.0014865645,0.000034776065,0.00010328946,0.00007508939,0.00010626785,0.000073797324,0.000069570924],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972455,0.000049551887,0.00072872126,0.0005593536,0.0007123458,0.0007045249],"domain_scores_gemma":[0.99844515,0.0003523156,0.00027768954,0.0004003999,0.0003087455,0.0002156763],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029023192,0.00031231958,0.00066266477,0.000657486,0.000087319844,0.000016867587,0.00021122237,0.00027611208,0.0000151877275],"category_scores_gemma":[0.00029712328,0.00026742922,0.000116171024,0.0013391013,0.00010212014,0.000111439724,0.00007260225,0.00030796806,0.00002093686],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010955744,0.008009763,0.74925834,0.0019827099,0.0008661108,0.0013405802,0.0021383704,0.00953043,0.21374938,0.000055429824,0.0008517231,0.0012614196],"study_design_scores_gemma":[0.13590138,0.0034307651,0.7779526,0.0009522774,0.00061814184,0.000057136163,0.00009041837,0.0017841711,0.07823817,0.0001306284,0.0002275187,0.000616772],"about_ca_topic_score_codex":0.00032741373,"about_ca_topic_score_gemma":0.00049381336,"teacher_disagreement_score":0.1355112,"about_ca_system_score_codex":0.0059717256,"about_ca_system_score_gemma":0.0022886517,"threshold_uncertainty_score":0.99997777},"labels":[],"label_agreement":null},{"id":"W2980250364","doi":"10.1182/blood.v114.22.2178.2178","title":"IFN-γ (interferon-gamma) Genotype Predict Cytogenetic and Molecular Response to Imatinib Therapy in Chronic Myeloid Leukemia.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"","keywords":"Imatinib; Cancer research; Myeloid leukemia; Imatinib mesylate; Medicine; Interferon; Pharmacology; Immunology; Biology","score_opus":0.012863517730166836,"score_gpt":0.2668555399682042,"score_spread":0.25399202223803735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980250364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901241,0.006759659,0.000051327243,0.0009786191,0.00004592961,0.0012024393,0.000011806591,0.00010256267,0.0007235686],"genre_scores_gemma":[0.9959564,0.00072115747,0.0016081842,0.0010570914,0.00012573293,0.00007215281,0.000019955176,0.00005148243,0.00038782874],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99796253,0.0001399541,0.00041035516,0.0005853269,0.00034535388,0.0005564588],"domain_scores_gemma":[0.9988151,0.000082413804,0.00007100119,0.0006720193,0.000050927025,0.0003085488],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032132634,0.00033795822,0.00047907443,0.00021326929,0.000047938087,0.000029781722,0.00016803524,0.00016560078,0.0001186554],"category_scores_gemma":[0.00012399128,0.00030688502,0.00008671016,0.00032904977,0.000054676657,0.00005455007,0.000059593258,0.00025662518,0.00009629503],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047648665,0.00055582396,0.0049718064,0.000054991742,0.00020801031,0.0010252845,0.0009715797,0.00010638563,0.94828665,0.000018109506,0.00024179643,0.03879469],"study_design_scores_gemma":[0.046668753,0.018096954,0.44716167,0.00064308726,0.00028870718,0.00071524846,0.00007059551,0.00046471806,0.4815157,0.00016958445,0.0035580741,0.00064688467],"about_ca_topic_score_codex":0.00007253175,"about_ca_topic_score_gemma":0.000035155917,"teacher_disagreement_score":0.46677095,"about_ca_system_score_codex":0.0015838968,"about_ca_system_score_gemma":0.0011861012,"threshold_uncertainty_score":0.9999383},"labels":[],"label_agreement":null},{"id":"W2980250637","doi":"10.1182/blood.v120.21.682.682","title":"Tumor-Associated Macrophages Predict Outcome in Follicular Lymphoma","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Rituximab; Medicine; Follicular lymphoma; Internal medicine; Lymphoma; Oncology; CD163; Cancer; Vincristine; Cyclophosphamide; CD68; Prednisone; Pathology; Immunology; Gastroenterology; Chemotherapy; Immunohistochemistry; Phenotype; Biology","score_opus":0.0157364697953283,"score_gpt":0.26271878795040415,"score_spread":0.24698231815507585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980250637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993755,0.0028623168,6.1767696e-7,0.00020648535,0.00013930805,0.00033192773,0.000017990935,0.00008467999,0.0026016769],"genre_scores_gemma":[0.9987608,0.000046868307,0.00014056222,0.0004385961,0.0001312669,0.00009602741,0.00003561701,0.000023873152,0.00032639506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988188,0.00004107293,0.00027831158,0.0001796768,0.00024600388,0.00043611226],"domain_scores_gemma":[0.9994078,0.00005428228,0.00006786676,0.00024603622,0.00002623768,0.00019777463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017869359,0.0001663042,0.00034555217,0.00008692901,0.000037765436,0.000012387176,0.00005775538,0.000077243145,0.00009955194],"category_scores_gemma":[0.00011777859,0.00012848512,0.00013095792,0.00019294886,0.000023145942,0.00007619646,0.000037742404,0.000043816985,0.00017233177],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018189674,0.0067808935,0.9906101,0.000022996477,0.00020052305,0.0005635077,0.0001245083,2.3789997e-7,0.00025869918,0.00008568667,0.00026780408,0.0010668115],"study_design_scores_gemma":[0.013869875,0.00017675868,0.9740409,0.00007150726,0.00037900044,0.000135812,0.000037931608,0.000005954733,0.010079074,0.00001317127,0.0010736029,0.000116382165],"about_ca_topic_score_codex":0.00016914024,"about_ca_topic_score_gemma":0.0000131259985,"teacher_disagreement_score":0.016569212,"about_ca_system_score_codex":0.00017575895,"about_ca_system_score_gemma":0.000046842182,"threshold_uncertainty_score":0.5239471},"labels":[],"label_agreement":null},{"id":"W2980252815","doi":"10.1182/blood.v128.22.2060.2060","title":"Restoration of Mir-138 Expression By Epigenetic Modulation Overcomes Drug Resistance in Multiple Myeloma Cells","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto General Hospital; University of Toronto","funders":"","keywords":"EZH2; PRC2; Gene silencing; Epigenetics; Histone methyltransferase; Cancer research; Downregulation and upregulation; Histone; Chromatin; Biology; Multiple myeloma; Chemistry; Molecular biology; Immunology; Genetics; Gene","score_opus":0.006052078812827921,"score_gpt":0.20761488213811824,"score_spread":0.2015628033252903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980252815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99646544,0.0017389187,0.0012470743,0.000091542744,0.000083623665,0.00013955697,0.00007849673,0.0000039505544,0.00015139264],"genre_scores_gemma":[0.9973759,0.0006058604,0.001303577,0.000024921601,0.00006354734,0.000016202825,0.000052839565,0.00001369965,0.00054346625],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99932706,0.00003543536,0.00020701243,0.00022044631,0.00008867251,0.00012138321],"domain_scores_gemma":[0.99951684,0.00004368336,0.00010333161,0.0002573696,0.000044011398,0.00003473776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008119297,0.000087242435,0.00009820698,0.00003104615,0.000023924606,0.000006548037,0.0000895758,0.00007921656,0.000006497319],"category_scores_gemma":[0.00008983875,0.00007420083,0.00003457831,0.000048232512,0.0000329695,0.0000042424613,0.000042461725,0.000022362714,0.0000027244141],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062547144,0.000118033066,0.011140641,0.000013631897,0.0000053609974,6.2663423e-7,0.000044780958,0.000033350887,0.9853015,0.000015792077,0.0027879465,0.00047578648],"study_design_scores_gemma":[0.0013940895,0.000040844123,0.016696882,0.000052067066,0.000006605562,2.0967222e-7,0.00000881226,0.000012830343,0.97308916,0.00015918569,0.008432502,0.00010682396],"about_ca_topic_score_codex":0.00002882175,"about_ca_topic_score_gemma":0.00043916507,"teacher_disagreement_score":0.012212354,"about_ca_system_score_codex":0.000014412121,"about_ca_system_score_gemma":0.000035752142,"threshold_uncertainty_score":0.3025822},"labels":[],"label_agreement":null},{"id":"W2980253233","doi":"10.1182/blood.v114.22.3136.3136","title":"Tinzaparin Versus Dalteparin for Peri-Procedure Thromboembolic Prophylaxis in Patients with Dialysis Dependent Renal Disease.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saint John Regional Hospital; University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Warfarin; Hemodialysis; Dialysis; Low molecular weight heparin; Dialysis catheter; Perioperative; Anticoagulant; Randomized controlled trial; Surgery; Heparin; Internal medicine; Atrial fibrillation","score_opus":0.011249991376593311,"score_gpt":0.24616768880899664,"score_spread":0.23491769743240334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980253233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99591875,0.00017966585,0.00003954107,0.00034867006,0.00009137354,0.0019116923,0.00002454815,0.000071397866,0.001414372],"genre_scores_gemma":[0.9983429,0.000051876275,0.00054693583,0.00033568504,0.00017144847,0.0002746286,0.00015210634,0.00003524627,0.00008918692],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980964,0.00002626835,0.0003240186,0.0005487226,0.0005206016,0.00048399981],"domain_scores_gemma":[0.99901694,0.000031591546,0.00010928886,0.00046804582,0.0001181817,0.00025596164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013892357,0.0002723508,0.00060757314,0.00019083788,0.00011062402,0.00004187736,0.00015721223,0.0000875122,0.000058076588],"category_scores_gemma":[0.000105760955,0.0002156581,0.00013252765,0.00030121647,0.00003814453,0.00010199517,0.000049198225,0.00016508368,0.000017335029],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075769187,0.039436087,0.9213913,0.00066666905,0.0015545243,0.00013642195,0.0012118411,0.00026826555,0.0003998721,0.0025003776,0.0019672818,0.02289043],"study_design_scores_gemma":[0.018194506,0.0040995767,0.9750564,0.00013259047,0.0009379885,7.1590017e-7,0.000053396063,0.000032094023,0.0004001871,0.00012226969,0.0006913258,0.00027893917],"about_ca_topic_score_codex":0.00004838826,"about_ca_topic_score_gemma":0.00012682177,"teacher_disagreement_score":0.0536651,"about_ca_system_score_codex":0.000083446415,"about_ca_system_score_gemma":0.00012836601,"threshold_uncertainty_score":0.87942827},"labels":[],"label_agreement":null},{"id":"W2980254204","doi":"10.1182/blood.v120.21.2467.2467","title":"The Conserved Kxgffkr Motif of α-Integrin Cytoplasmic Tail Mediates Chemoresistance to Doxorubicin in T-Cell Leukemia.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; University of British Columbia","funders":"","keywords":"Jurkat cells; Integrin; Cell biology; Biology; Cell adhesion; Extracellular; Cytoskeleton; Cytoplasm; Intracellular; Molecular biology; Cell; Immunology; T cell; Biochemistry","score_opus":0.015892512228072503,"score_gpt":0.26671634039818953,"score_spread":0.25082382817011706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980254204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895059,0.0022288298,0.000008693322,0.0008602693,0.00007351501,0.00052620017,0.000009599534,0.00002577066,0.006761211],"genre_scores_gemma":[0.9958839,0.00023983151,0.0007101625,0.00021351775,0.000090314286,0.00005176757,0.000009288752,0.000032700875,0.0027685303],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981051,0.00010506142,0.00042036566,0.00023733785,0.0005304794,0.0006016478],"domain_scores_gemma":[0.99841595,0.00050632615,0.00008590065,0.0005587054,0.00012916538,0.00030394457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074706535,0.00017067832,0.000362256,0.00014723645,0.00005179715,0.000014146762,0.0002842387,0.00010558772,0.0001154463],"category_scores_gemma":[0.0006999544,0.00011892603,0.000090588605,0.00045331425,0.00013569242,0.000042174706,0.00014024992,0.00037010817,0.00021552067],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003179557,0.00066285516,0.14939173,0.00017826336,0.000041064388,0.00004763565,0.0004546166,0.00000402764,0.84594584,0.00010206876,0.0022566745,0.0005972764],"study_design_scores_gemma":[0.0031153965,0.00015646232,0.076832816,0.00011281906,0.00004486344,0.000018612589,0.00044135592,0.000042315187,0.9159943,0.000024479963,0.0030987915,0.000117809126],"about_ca_topic_score_codex":0.00018418588,"about_ca_topic_score_gemma":0.00030831576,"teacher_disagreement_score":0.07255891,"about_ca_system_score_codex":0.00013269827,"about_ca_system_score_gemma":0.00026536448,"threshold_uncertainty_score":0.48496628},"labels":[],"label_agreement":null},{"id":"W2980254768","doi":"10.1182/blood.v116.21.4600.4600","title":"Light Chain Deposition Disease: Impact of Stem Cell Tranplant on Hematological Response Achievement.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Melphalan; Multiple myeloma; Prednisone; Lenalidomide; Internal medicine; Gastroenterology; Autologous stem-cell transplantation; Pathology","score_opus":0.007172475477560616,"score_gpt":0.25128543904614864,"score_spread":0.24411296356858803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980254768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985813,0.00043364943,0.000030563737,0.00032095055,0.000056290522,0.00026527332,0.000121766345,0.000019434861,0.00017080188],"genre_scores_gemma":[0.9993204,0.00009434334,0.00015688977,0.00009817583,0.000051925326,0.00006185296,0.000090106856,0.00002032366,0.00010601722],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989847,0.00012236531,0.00020961574,0.00031556893,0.0001418518,0.00022588705],"domain_scores_gemma":[0.99923986,0.00005068336,0.00011047923,0.00041040275,0.000027598695,0.00016099279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013884268,0.00019765587,0.00019641004,0.0000471009,0.000052083877,0.000012110016,0.00015358321,0.00015712122,0.000029140609],"category_scores_gemma":[0.000025465983,0.00014682247,0.0002394807,0.000052818083,0.00003378621,0.000002832349,0.00004230479,0.00009871164,0.000015874279],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012976895,0.0021765446,0.08426236,0.000019959278,0.00012912315,0.000044704633,0.000023226792,0.000005652689,0.9115549,0.000046584722,0.0002532242,0.00018603187],"study_design_scores_gemma":[0.001687182,0.0011270137,0.15213564,0.000017137476,0.00010752059,0.000015927893,0.0000124154785,0.0000029521657,0.8445161,0.0000063774037,0.00022601464,0.0001457213],"about_ca_topic_score_codex":0.000007207308,"about_ca_topic_score_gemma":0.000008512978,"teacher_disagreement_score":0.067873284,"about_ca_system_score_codex":0.000010368527,"about_ca_system_score_gemma":0.000061033123,"threshold_uncertainty_score":0.5987246},"labels":[],"label_agreement":null},{"id":"W2980258435","doi":"10.1182/blood.v128.22.415.415","title":"Real-Life Incidence of Cancer Following a First Unprovoked Venous Thrombosis: Results from the Epigetbo Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Incidence (geometry); Cancer; Cumulative incidence; Pulmonary embolism; Malignancy; Hazard ratio; Deep vein; Venous thrombosis; Pediatrics; Internal medicine; Thrombosis; Surgery; Cohort; Confidence interval","score_opus":0.0263472700708369,"score_gpt":0.29939249860186445,"score_spread":0.27304522853102753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980258435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920788,0.00080640847,0.000011398405,0.004439118,0.00029187682,0.0012524542,0.000077747354,0.00007032938,0.0009718756],"genre_scores_gemma":[0.99718976,0.0016641949,0.00008706734,0.00041200354,0.0002882217,0.00022214095,0.0000059475537,0.00003241801,0.00009824781],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812293,0.000080982805,0.000532639,0.00043991822,0.00050912553,0.00031441555],"domain_scores_gemma":[0.99823236,0.00046082813,0.00024056871,0.0008597052,0.00008440739,0.00012213788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049419486,0.00019663866,0.0006375175,0.00004688973,0.00016075412,0.00001638426,0.00030482913,0.00006245176,0.00007309835],"category_scores_gemma":[0.0005322235,0.00010590985,0.00016791049,0.00020714836,0.00008477863,0.00008306459,0.00017774497,0.00009573797,0.00003262845],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045436912,0.02157143,0.9138111,0.00013289921,0.006774729,0.00024472122,0.029385837,0.0000151971035,0.014233893,0.00031100085,0.008429154,0.0046357117],"study_design_scores_gemma":[0.008793461,0.00095540186,0.9810223,0.0009891435,0.002216579,6.1462225e-7,0.0021738026,0.0000032912858,0.0028639894,0.00007417189,0.00074386934,0.00016340295],"about_ca_topic_score_codex":0.023498213,"about_ca_topic_score_gemma":0.0052715847,"teacher_disagreement_score":0.06721121,"about_ca_system_score_codex":0.00005609624,"about_ca_system_score_gemma":0.00015724658,"threshold_uncertainty_score":0.9830044},"labels":[],"label_agreement":null},{"id":"W2980263526","doi":"10.1182/blood.v108.11.2349.2349","title":"Molecular Characterization of Distinct Hot Spot Regions on Chromosome 7q in Myeloid Leukemias.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Biology; Chromosomal translocation; Breakpoint; Genetics; Myeloid leukemia; Fluorescence in situ hybridization; Chromosome; Myeloid; Chromosome regions; Chromosome 7 (human); Comparative genomic hybridization; Candidate gene; Molecular biology; Gene; Cancer research","score_opus":0.012320525303801955,"score_gpt":0.2523666776143828,"score_spread":0.24004615231058085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980263526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907716,0.00005497957,0.00011069971,0.0006835321,0.00003492425,0.00046704017,0.000032924345,0.00005172939,0.007792596],"genre_scores_gemma":[0.9981405,0.000035583198,0.00014890872,0.00016278014,0.0001822857,0.00004019643,0.00038366817,0.000041998235,0.00086404104],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99849683,0.00006423062,0.00036949848,0.00031430987,0.00041992613,0.00033521003],"domain_scores_gemma":[0.9991944,0.000052143263,0.00010663182,0.0004622036,0.00009194507,0.00009266537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017537891,0.00016937623,0.00034299833,0.0002973933,0.000033120272,0.000010688965,0.00014282108,0.00013810639,0.000068811314],"category_scores_gemma":[0.00012718106,0.00015723314,0.00008768036,0.0005483451,0.00009801134,0.00006110292,0.00005263562,0.00031277814,0.000061077204],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018438809,0.00092283933,0.012404501,0.000112766866,0.00003476862,0.00056001375,0.000056705823,0.0000067590254,0.98366964,0.0013389571,0.0003018572,0.00040681916],"study_design_scores_gemma":[0.0054968107,0.00040769044,0.41358072,0.00026120254,0.00008080117,0.00010257634,0.000014470319,0.00015289504,0.5777017,0.00008783222,0.0019362938,0.00017702102],"about_ca_topic_score_codex":0.00024596773,"about_ca_topic_score_gemma":0.00002251284,"teacher_disagreement_score":0.40596792,"about_ca_system_score_codex":0.00023172746,"about_ca_system_score_gemma":0.00027999445,"threshold_uncertainty_score":0.64117813},"labels":[],"label_agreement":null},{"id":"W2980266028","doi":"10.1182/blood.v128.22.2909.2909","title":"Potential Targeting Ph+ Acute Lymphoblastic Leukemia Stem and Progenitor Cells By Modulating the CIP2A-SET-SETBP1 -Mediated Suppression of PP2A Activity","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Progenitor cell; Cancer research; Protein phosphatase 2; Haematopoiesis; Stem cell; Leukemia; Myeloid leukemia; Biology; Immunology; Medicine; Cell biology; Phosphatase","score_opus":0.007683294762602238,"score_gpt":0.2254734273308391,"score_spread":0.21779013256823687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980266028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99805725,0.0004050926,0.00019434757,0.00014396902,0.00020128443,0.00066676957,0.00019798585,0.000076950004,0.000056333472],"genre_scores_gemma":[0.9987664,0.000105737636,0.00032532672,0.00002202598,0.00020085783,0.0000427413,0.00003663348,0.000048431528,0.00045183947],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982089,0.00012024687,0.0003659023,0.00043026468,0.00044611946,0.00042861424],"domain_scores_gemma":[0.9987185,0.00033269936,0.00029842235,0.0003899379,0.000084377825,0.00017608554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020530973,0.00027641203,0.00040904302,0.00005322318,0.00014732395,0.000018529598,0.00013745484,0.00016844847,0.0000577951],"category_scores_gemma":[0.000104620354,0.00015175862,0.000102163474,0.00013279848,0.000142267,0.0001321767,0.00016188227,0.00014874896,0.00002011781],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022884499,0.00023731144,0.008355051,0.00010512643,0.00040642457,0.00005501843,0.00017843406,0.000004398945,0.9847988,9.1542256e-7,0.0007368442,0.0048928633],"study_design_scores_gemma":[0.012722731,0.00033189944,0.006585114,0.00035857773,0.00090245454,0.00010354845,0.000081760314,0.001751169,0.97680795,0.000006077776,0.0001566146,0.00019208489],"about_ca_topic_score_codex":0.00007584045,"about_ca_topic_score_gemma":0.0000015564902,"teacher_disagreement_score":0.012493885,"about_ca_system_score_codex":0.00039287377,"about_ca_system_score_gemma":0.0003491071,"threshold_uncertainty_score":0.6188537},"labels":[],"label_agreement":null},{"id":"W2980266043","doi":"10.1182/blood.v112.11.975.975","title":"Salvage Therapy with Allogeneic Stem Cell Transplantation Results in Better Outcome for Patients with Relapsed/Refractory Follicular Lymphoma Compared to Those with Transformed Non-Hodgkin Lymphoma: A Population-Based Comparative Study.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Leukemia & Lymphoma Society of Canada; BC Cancer Agency; St. Paul's Hospital","funders":"","keywords":"Follicular lymphoma; Medicine; Internal medicine; Transplantation; Lymphoma; Rituximab; Cumulative incidence; Population; International Prognostic Index; Oncology; Autologous stem-cell transplantation; Gastroenterology","score_opus":0.02767573097854681,"score_gpt":0.2692484739617451,"score_spread":0.2415727429831983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980266043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99215144,0.000080264195,0.0002664653,0.00012877019,0.000029322538,0.0069621126,0.00023244922,0.00006694413,0.000082233586],"genre_scores_gemma":[0.9941752,0.000016493608,0.0027537332,0.00041869018,0.000028433426,0.0015394256,0.0009661151,0.00007283195,0.000029103474],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99737847,0.00011449888,0.00066679175,0.0007178443,0.000666359,0.00045605886],"domain_scores_gemma":[0.9986572,0.00023758179,0.00023193391,0.00044996926,0.00019697714,0.00022630116],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013252955,0.0005251826,0.000905168,0.00027542724,0.00019067821,0.000025712548,0.00012209649,0.00010453339,0.0000035197659],"category_scores_gemma":[0.0000024683425,0.0003261644,0.000116989904,0.0004444995,0.00004924071,0.00014604678,0.0000044665803,0.00005900862,0.000005435999],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027184479,0.024688754,0.93775284,0.000081143255,0.0004756042,0.0004510839,0.007757763,0.0004001003,0.000088608016,7.116885e-7,0.000019811376,0.0010990916],"study_design_scores_gemma":[0.19742914,0.011889875,0.784603,0.00022132648,0.00051254424,0.000019684778,0.00037767124,0.000042100473,0.0044812234,4.2082956e-7,0.000056121193,0.0003669325],"about_ca_topic_score_codex":0.00057163753,"about_ca_topic_score_gemma":0.0013311658,"teacher_disagreement_score":0.17024465,"about_ca_system_score_codex":0.00028863613,"about_ca_system_score_gemma":0.0002682876,"threshold_uncertainty_score":0.99991906},"labels":[],"label_agreement":null},{"id":"W2980267019","doi":"10.1182/blood.v128.22.1730.1730","title":"Engraftment and Long-Term Survival at Low Burden of Leukemic Blasts from Primary MRD+ Human Bone Marrow in a Xenotransplant Setting","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Minimal residual disease; Bone marrow; Medicine; Leukemia; clone (Java method); Induction chemotherapy; Immunology; Chemotherapy; Oncology; Immunophenotyping; Internal medicine; Cancer research; Flow cytometry; Biology","score_opus":0.01081259564522719,"score_gpt":0.236223089362375,"score_spread":0.2254104937171478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980267019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99829316,0.0004969794,0.00008281543,0.0001612958,0.000052457013,0.00043646694,0.00009704582,0.000035491834,0.00034430745],"genre_scores_gemma":[0.9988728,0.00028871,0.00032974465,0.000028832497,0.00009271191,0.000019528487,0.00012861857,0.000029636316,0.00020941303],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985652,0.00006931573,0.00045730043,0.00032968778,0.0003177651,0.00026072888],"domain_scores_gemma":[0.99927527,0.00022727046,0.0001108867,0.00024479875,0.000028432823,0.000113319606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022815357,0.00018064452,0.0004213142,0.00010209007,0.00003381874,0.000005860954,0.0000638832,0.00011210449,0.000117613105],"category_scores_gemma":[0.000011827576,0.00013779754,0.000056965386,0.000065211025,0.00007362206,0.00004997892,0.000027319957,0.000092017974,0.000015480624],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001425004,0.00017834127,0.29526907,0.0007001437,0.00008011998,0.00036188352,0.0014049201,3.9867865e-7,0.7009027,0.000006515335,0.0000027965182,0.0009506136],"study_design_scores_gemma":[0.01180021,0.00016358709,0.6705344,0.0031631007,0.00031581742,0.00017572643,0.000043350406,0.0000047068766,0.3136071,0.000021449245,0.0000045059705,0.00016608079],"about_ca_topic_score_codex":0.0001559567,"about_ca_topic_score_gemma":0.00015132102,"teacher_disagreement_score":0.3872956,"about_ca_system_score_codex":0.00009862982,"about_ca_system_score_gemma":0.000061230676,"threshold_uncertainty_score":0.5619221},"labels":[],"label_agreement":null},{"id":"W2980269600","doi":"10.1182/blood.v116.21.4675.4675","title":"Pregnancy-associated Thrombotic Thrombocytopenic Purpura: A Single Institution's Experience","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Medicine; Microangiopathic hemolytic anemia; Thrombotic thrombocytopenic purpura; Pregnancy; Pediatrics; Population; Surgery; ADAMTS13; Thrombotic microangiopathy; Schistocyte; Internal medicine; Platelet; Disease","score_opus":0.015079821244949297,"score_gpt":0.25053931969008775,"score_spread":0.23545949844513844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980269600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9749198,0.0007076119,0.00002632127,0.00046962145,0.0005624184,0.00043950748,0.000003998869,0.00020533461,0.022665404],"genre_scores_gemma":[0.99847996,0.0001262657,0.00037873234,0.00020983294,0.000061737606,0.00003591746,0.00001685244,0.00002377154,0.0006669304],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987866,0.000021151553,0.00025051078,0.0003087565,0.00025978126,0.00037314443],"domain_scores_gemma":[0.9992361,0.000023482837,0.000083289255,0.0003886152,0.00009477159,0.00017371777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006856844,0.00017770827,0.0003102281,0.00006186704,0.00018958846,0.000034499437,0.00014167254,0.0002716204,0.00035927747],"category_scores_gemma":[0.00032860215,0.00014350012,0.000113561764,0.00033458706,0.00024718256,0.00014779443,0.000057300396,0.00047050457,0.00014612537],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005259199,0.010445026,0.07956108,0.00016296693,0.00053929584,0.00063956605,0.0049246433,0.0000069477837,0.8928488,0.003957795,0.0006530783,0.0062082307],"study_design_scores_gemma":[0.060567115,0.0048297686,0.48992273,0.0049898326,0.0036427479,0.0034428893,0.0054240027,0.0004834754,0.39387065,0.002173226,0.027527317,0.0031262294],"about_ca_topic_score_codex":0.000051817646,"about_ca_topic_score_gemma":0.00007576586,"teacher_disagreement_score":0.4989781,"about_ca_system_score_codex":0.000030315052,"about_ca_system_score_gemma":0.0001672525,"threshold_uncertainty_score":0.58517647},"labels":[],"label_agreement":null},{"id":"W2980273922","doi":"10.1182/blood.v126.23.1203.1203","title":"Disrupted Expression of the Splicing Regulators Tra2-Beta and SRSF1 and Subsequent Aberrant Splicing of FLVCR1 Transcript As an Underlying Mechanism for the Erythropoietic Failure Observed in Diamond-Blackfan Anemia","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre; Hospital for Sick Children","funders":"","keywords":"Diamond–Blackfan anemia; Biology; RNA splicing; Exon; Alternative splicing; GATA1; Erythropoiesis; Splicing factor; Intron; RNA-binding protein; Sideroblastic anemia; Mutation; Genetics; Cell biology; Gene; Gene expression; Anemia; RNA; Ribosome; Internal medicine; Medicine","score_opus":0.0400989452091332,"score_gpt":0.27313649935703127,"score_spread":0.23303755414789806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980273922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99720573,0.0011248742,0.00078737026,0.00035568333,0.000044079447,0.0004446355,0.000015209183,0.000003919976,0.00001850608],"genre_scores_gemma":[0.99928737,0.00018554926,0.00037050512,0.00003275449,0.000026249258,0.000040575982,0.000012731335,0.000018234789,0.000026032749],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99917114,0.0000616803,0.00024548543,0.0002548228,0.000115910465,0.00015097894],"domain_scores_gemma":[0.99934214,0.000019628076,0.00012009927,0.00038674942,0.00007122275,0.000060161983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024567946,0.00012427171,0.00016144564,0.000023983312,0.00008867132,0.000017407476,0.00015737388,0.000110016364,0.0000013088128],"category_scores_gemma":[0.000024208024,0.00007973545,0.00005421993,0.00008482736,0.000119816345,0.000010372376,0.00003882219,0.00006848636,3.008136e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005551828,0.000071049195,0.0020522124,0.000060349517,0.000019722402,2.666239e-7,0.0011683833,0.00005751964,0.99534357,0.0008242359,0.00000921111,0.00033796794],"study_design_scores_gemma":[0.0018350326,0.0002316385,0.014011057,0.000106857515,0.000108838736,0.000011388711,0.0031407285,0.00033701592,0.9791348,0.0009149245,0.000045408015,0.00012229824],"about_ca_topic_score_codex":0.00025598807,"about_ca_topic_score_gemma":0.0004920355,"teacher_disagreement_score":0.016208753,"about_ca_system_score_codex":0.000008551043,"about_ca_system_score_gemma":0.00006018848,"threshold_uncertainty_score":0.32515174},"labels":[],"label_agreement":null},{"id":"W2980279355","doi":"10.1182/blood.v114.22.1941.1941","title":"A Comparison of Gene Expression Pattern in Major Histocompatibility Class II-Low Diffuse Large B-Cell Lymphoma with Plasmablastic Lymphoma.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Plasmablastic lymphoma; Diffuse large B-cell lymphoma; Lymphoma; Biology; Major histocompatibility complex; Cancer research; Immunology; Antigen","score_opus":0.011953641619551451,"score_gpt":0.257491452968735,"score_spread":0.24553781134918354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980279355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974978,0.00057979464,0.00010344656,0.00012364275,0.000046316367,0.0008788798,0.00004964741,0.00006193132,0.0006585489],"genre_scores_gemma":[0.99845576,0.000014643628,0.0010260514,0.00017984258,0.000045185152,0.00009548941,0.000076731114,0.000027065375,0.0000792293],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978843,0.00007264786,0.000606573,0.0005307847,0.00045482273,0.00045092136],"domain_scores_gemma":[0.9987057,0.00010197315,0.0002605473,0.00064112444,0.00007734239,0.00021334329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011271844,0.00033442694,0.00083022757,0.00015680993,0.00009358117,0.000013195958,0.00013918184,0.00014063616,0.00003544253],"category_scores_gemma":[0.000025922855,0.00024387475,0.00012820483,0.00022387238,0.00005562028,0.00007466946,0.00005208515,0.000061964274,0.000017576353],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007610408,0.15767144,0.8111195,0.00018513527,0.0000743571,0.00028655192,0.00113284,0.000008897426,0.022952836,0.000009438275,0.00022188714,0.005576091],"study_design_scores_gemma":[0.087988265,0.0021133306,0.5637767,0.00044617764,0.00027282388,0.000038087925,0.000096506315,0.00052083255,0.3444175,0.000008564713,0.00012574636,0.00019549968],"about_ca_topic_score_codex":0.00013207947,"about_ca_topic_score_gemma":0.00015558023,"teacher_disagreement_score":0.3214647,"about_ca_system_score_codex":0.0002831804,"about_ca_system_score_gemma":0.00016971388,"threshold_uncertainty_score":0.99449235},"labels":[],"label_agreement":null},{"id":"W2980279408","doi":"10.1182/blood.v116.21.257.257","title":"Changes In Health Status and Quality of Life In Parental Reports of Children with Thalassemia: Year 1 Report of the Thalassemia Longitudinal Cohort Study","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Thalassemia; Psychosocial; Quality of life (healthcare); Life expectancy; Cohort; Pediatrics; Longitudinal study; Gerontology; Psychiatry; Population; Internal medicine; Environmental health; Pathology","score_opus":0.01218648912196175,"score_gpt":0.2784950206714253,"score_spread":0.26630853154946355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980279408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99812484,0.00036117627,1.412354e-7,0.00017374461,0.000055830296,0.0010209143,0.0000106141715,0.0000068171244,0.0002459216],"genre_scores_gemma":[0.99971163,0.00016163164,0.00004629988,0.000011938422,0.000013509163,0.000013174791,0.0000115614275,0.000011982741,0.00001828243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99828184,0.00008691402,0.00078019407,0.00026864017,0.00038107048,0.00020136511],"domain_scores_gemma":[0.99864256,0.00003488859,0.0006979638,0.00046666255,0.00006418116,0.00009374308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010948793,0.00011729114,0.0005946622,0.000091489565,0.0000190479,0.0000022757222,0.0000507916,0.00010569313,0.000010330887],"category_scores_gemma":[0.00028947476,0.00007344007,0.00003811575,0.00028531477,0.00015228908,0.000025410227,0.000060826103,0.00036998602,5.6401912e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007787128,0.0019178326,0.9957326,0.00016557629,0.00014406697,0.0000534256,0.00079853076,0.0000014906612,0.0010473854,0.00000971905,0.000011530787,0.000039947725],"study_design_scores_gemma":[0.002865037,0.00050270424,0.9930421,0.00020221582,0.00008027326,0.00022803036,0.0015162745,5.503099e-7,0.0014906343,0.00000547799,0.000002682101,0.00006399968],"about_ca_topic_score_codex":0.0077237845,"about_ca_topic_score_gemma":0.014129726,"teacher_disagreement_score":0.006405942,"about_ca_system_score_codex":0.000014980101,"about_ca_system_score_gemma":0.00035897444,"threshold_uncertainty_score":0.99888384},"labels":[],"label_agreement":null},{"id":"W2980279621","doi":"10.1182/blood.v120.21.3705.3705","title":"Differences in Outcomes in Males and Females with Diffuse Large B-Cell Lymphoma with Induction Rituximab and Follicular Lymphoma Treated with Maintenance Rituximab","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Rituximab; Medicine; Follicular lymphoma; Vincristine; CHOP; Prednisone; Internal medicine; Diffuse large B-cell lymphoma; Proportional hazards model; Lymphoma; Cyclophosphamide; Randomization; Oncology; Randomized controlled trial; Chemotherapy","score_opus":0.013546955892940799,"score_gpt":0.22138933082237197,"score_spread":0.20784237492943117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980279621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957522,0.0029549426,0.000005903274,0.00027110113,0.000014912426,0.0006837355,0.000021547865,0.000050255887,0.00024540655],"genre_scores_gemma":[0.9980827,0.0004988419,0.0008316132,0.000102470774,0.00003042807,0.00023064126,0.000025513247,0.000040847517,0.00015693581],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983069,0.00006446689,0.00026462425,0.00047791118,0.00029045244,0.0005956547],"domain_scores_gemma":[0.9992463,0.00008271952,0.00012156243,0.00028465778,0.00004579756,0.00021898975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011713857,0.00041683123,0.00080638414,0.00022299743,0.00008524111,0.00005029705,0.000056532444,0.00012493371,0.000005344441],"category_scores_gemma":[0.00001426403,0.0002284213,0.000034799516,0.00029793452,0.00017842864,0.00027205437,0.00003989865,0.00006383723,0.0000044646627],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068799715,0.039560974,0.95677054,0.00011727083,0.00021176874,0.00060185225,0.0005468927,5.805526e-8,0.00006545211,0.00013697316,0.0000026260916,0.0012975931],"study_design_scores_gemma":[0.147444,0.0011761694,0.8461769,0.00046492548,0.00040186683,0.0007675717,0.0007450449,0.000011235334,0.002471922,0.0000058512455,0.00004910038,0.0002854001],"about_ca_topic_score_codex":0.00060262444,"about_ca_topic_score_gemma":0.0012129522,"teacher_disagreement_score":0.146756,"about_ca_system_score_codex":0.00011164588,"about_ca_system_score_gemma":0.000074238,"threshold_uncertainty_score":0.931475},"labels":[],"label_agreement":null},{"id":"W2980280330","doi":"10.1182/blood.v124.21.319.319","title":"Superiority of Pediatric Chemotherapy over Allogeneic Hematopoietic Cell Transplantation for Philadelphia Chromosome Negative Adult ALL in First Complete Remission: A Combined Analysis of Dana-Farber ALL Consortium and CIBMTR Cohorts","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Dalhousie University; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Cohort; Transplantation; Internal medicine; Chemotherapy; Chemotherapy regimen; Hematopoietic stem cell transplantation; Regimen; Hematopoietic cell; Cumulative incidence; Oncology; Busulfan; Surgery; Pediatrics; Haematopoiesis; Stem cell; Biology","score_opus":0.01833025270181832,"score_gpt":0.2790356225244107,"score_spread":0.2607053698225924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980280330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976499,0.00017065206,0.00040802342,0.00052452245,0.000022179624,0.00095371064,0.00016452275,0.00001765636,0.000088836015],"genre_scores_gemma":[0.9974618,0.000781727,0.0011256279,0.00024636847,0.000058812886,0.000055196786,0.00021829194,0.000031943775,0.000020207426],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99800086,0.00009205563,0.0006874397,0.0004360632,0.0004525275,0.0003310599],"domain_scores_gemma":[0.99824536,0.00070212915,0.0002512049,0.00035626575,0.00025681863,0.0001882501],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033855753,0.00023484185,0.0009785244,0.00041744713,0.000035912308,0.000008468463,0.00013073428,0.00018078339,0.00009060442],"category_scores_gemma":[0.0001491915,0.00020795615,0.00018737852,0.0006757643,0.00016531887,0.000059241367,0.000028488777,0.00013991223,7.79517e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023118842,0.0021823426,0.84187335,0.0036161528,0.0023510582,0.000058044956,0.0045385393,0.000094164956,0.14257303,0.00012871815,0.00023987085,0.00003288124],"study_design_scores_gemma":[0.04576662,0.0015984091,0.85633755,0.0001876468,0.009285457,0.000055208893,0.00015220152,0.016133536,0.06979128,0.0001530217,0.000119747194,0.0004193235],"about_ca_topic_score_codex":0.00030546237,"about_ca_topic_score_gemma":0.00022217976,"teacher_disagreement_score":0.07278174,"about_ca_system_score_codex":0.00007970034,"about_ca_system_score_gemma":0.00018141976,"threshold_uncertainty_score":0.84802055},"labels":[],"label_agreement":null},{"id":"W2980282716","doi":"10.1182/blood.v128.22.2462.2462","title":"Heme Oxygenase 1 Inhibition Reverses Anemia in β-Thalassemia Mice","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Heme; Thalassemia; Heme oxygenase; Globin; Biology; Biochemistry; Chemistry; Immunology; Hemoglobin; Enzyme; Genetics","score_opus":0.00792842867080928,"score_gpt":0.2263833850551131,"score_spread":0.21845495638430382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980282716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99009925,0.0005402341,0.000011651372,0.0022355064,0.00007345132,0.00019491394,0.000007259993,0.00006084716,0.00677691],"genre_scores_gemma":[0.9974308,0.00051108736,0.00021400195,0.00041699418,0.0000723801,0.000010669867,0.000010633868,0.000016553358,0.0013168621],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99921453,0.000023229273,0.0001970696,0.00020510318,0.00013259331,0.00022745486],"domain_scores_gemma":[0.9996217,0.00003463179,0.00004071167,0.00017241122,0.000030449371,0.00010011099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010089417,0.000105213745,0.00015716488,0.000094333875,0.000027075437,0.000005015814,0.00003175567,0.0001561691,0.00021132693],"category_scores_gemma":[0.00012225253,0.00006826747,0.000053524673,0.00018433182,0.000043311862,0.00006919067,0.00002100673,0.00012403954,0.00020363045],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012832953,0.0010387433,0.06189853,0.00015406791,0.000041806594,0.0008920862,0.00026297363,6.295424e-7,0.92309314,0.00017576717,0.008060366,0.0042535816],"study_design_scores_gemma":[0.04664829,0.0010080822,0.115356915,0.0037698243,0.00051874673,0.001349288,0.0013177656,0.000014106584,0.79307663,0.0008039467,0.035262696,0.0008737122],"about_ca_topic_score_codex":0.000047486883,"about_ca_topic_score_gemma":0.000021167329,"teacher_disagreement_score":0.13001649,"about_ca_system_score_codex":0.00003776961,"about_ca_system_score_gemma":0.000054788507,"threshold_uncertainty_score":0.27838668},"labels":[],"label_agreement":null},{"id":"W2980282927","doi":"10.1182/blood.v114.22.234.234","title":"TRAIL/ DR5 Interactions Are Important for Thymic Damage After Allogeneic Bone Marrow Transplantation.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"T cell; Fas ligand; Immunology; Bone marrow; Transplantation; Major histocompatibility complex; Graft-versus-host disease; Medicine; Apoptosis; Cancer research; Biology; Antigen; Immune system; Internal medicine; Programmed cell death","score_opus":0.014104155983544217,"score_gpt":0.2666104455609402,"score_spread":0.252506289577396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980282927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918646,0.00034006653,0.003119684,0.0017329424,0.00016533288,0.00091504346,0.00020366721,0.00012318736,0.0015354278],"genre_scores_gemma":[0.9927146,0.00025137133,0.00482207,0.000815289,0.00016642384,0.00014994215,0.00028735376,0.000030705916,0.0007622628],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987327,0.00002480184,0.00045895926,0.00030336183,0.00020160101,0.00027859965],"domain_scores_gemma":[0.999327,0.00008618785,0.000114416514,0.00025184965,0.000076008284,0.00014455836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013819094,0.0001907477,0.00030109115,0.00013513638,0.00006765723,0.000022127204,0.000060890565,0.00009440542,0.00022927218],"category_scores_gemma":[0.000018107738,0.00017400911,0.00017475647,0.00013049558,0.000026050157,0.00010915471,0.0000018842159,0.00013389673,0.000033397733],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025233242,0.0036308668,0.08093089,0.0020634565,0.0005512934,0.0028862674,0.005488897,0.000012392675,0.89731264,0.0006090716,0.0012613748,0.0027295288],"study_design_scores_gemma":[0.018394548,0.0010641587,0.69025683,0.0012411952,0.0038847297,0.004091876,0.0006217356,0.00019453376,0.27493793,0.0008260075,0.0037470742,0.00073939963],"about_ca_topic_score_codex":0.00000558324,"about_ca_topic_score_gemma":0.00007836042,"teacher_disagreement_score":0.6223747,"about_ca_system_score_codex":0.000023200268,"about_ca_system_score_gemma":0.00005956392,"threshold_uncertainty_score":0.7095886},"labels":[],"label_agreement":null},{"id":"W2980283429","doi":"10.1182/blood.v126.23.61.61","title":"Combined Donor and Recipient Non-HLA Genotypes Show Evidence of Genome Wide Association with Transplant Related Mortality (TRM) after HLA-Matched Unrelated Donor Blood and Marrow Transplantation (URD-BMT) (DISCOVeRY-BMT study)","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; Single-nucleotide polymorphism; Cohort; Genotype; Transplantation; Human leukocyte antigen; Internal medicine; Genotyping; Oncology; Genome-wide association study; SNP; Immunology; Genetics; Biology; Gene; Antigen","score_opus":0.019930295613293774,"score_gpt":0.2622134005433011,"score_spread":0.24228310493000735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980283429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99669766,0.00085682573,0.00019044873,0.00026440146,0.000075600234,0.0016015593,0.00015806241,0.000057356774,0.00009807705],"genre_scores_gemma":[0.9972308,0.001528548,0.00046473916,0.00007745604,0.000019360485,0.00009915535,0.00022801853,0.000041047573,0.00031083613],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997601,0.0001747159,0.0007074982,0.0005443736,0.00064855814,0.00032385567],"domain_scores_gemma":[0.9985693,0.00030106312,0.00034429273,0.00029676783,0.00021827391,0.00027027048],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005562937,0.00037000116,0.0007271237,0.00016263944,0.00007939901,0.00006085731,0.00008117292,0.00020526272,0.00001882517],"category_scores_gemma":[0.00004599828,0.00028154935,0.00009125735,0.00031366007,0.00007578063,0.0004282628,0.000012102941,0.0002371777,0.000004954477],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040162047,0.0017096368,0.978156,0.0006748519,0.0025186923,0.00057559606,0.0070308195,0.00005060446,0.0052346857,0.000006492907,0.000001279682,0.000025158024],"study_design_scores_gemma":[0.026044484,0.0030295257,0.9548258,0.0011632786,0.008419282,0.00013444472,0.0003001405,0.000047613463,0.005699212,0.00003819576,0.0000015874306,0.00029638736],"about_ca_topic_score_codex":0.0005625271,"about_ca_topic_score_gemma":0.00043537546,"teacher_disagreement_score":0.02333013,"about_ca_system_score_codex":0.000077327,"about_ca_system_score_gemma":0.00013981672,"threshold_uncertainty_score":0.99996364},"labels":[],"label_agreement":null},{"id":"W2980283917","doi":"10.1182/blood.v114.22.38.38","title":"A Novel AHI-1-BCR-ABL-JAK2 Interaction Complex Mediates Cellular Resistance to Tyrosine Kinase Inhibitors in CML .","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia Hospital","funders":"","keywords":"Cancer research; Tyrosine kinase; Imatinib mesylate; Biology; Stem cell; Myeloid leukemia; Protein kinase B; Imatinib; Signal transduction; Cell biology","score_opus":0.020534149640663465,"score_gpt":0.27000577000732534,"score_spread":0.24947162036666187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980283917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926366,0.0009127154,0.00008087378,0.0025211421,0.0001898491,0.0006851573,0.000019153802,0.00010974538,0.0028447425],"genre_scores_gemma":[0.9929412,0.000039603587,0.004463382,0.0008746608,0.0003657833,0.00003753782,0.00013131439,0.00003168466,0.0011148597],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99831563,0.000030169049,0.00044382573,0.00045380293,0.00034940493,0.00040716553],"domain_scores_gemma":[0.9990735,0.00006889389,0.00010677898,0.00044572027,0.000066962646,0.00023811468],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014713116,0.00025896693,0.00040471606,0.00025061332,0.000052321666,0.000024834013,0.00011197914,0.00011384422,0.00014240724],"category_scores_gemma":[0.00019580137,0.0002455056,0.00008582526,0.0005004514,0.00003415533,0.00011843239,0.000039664705,0.00024737132,0.00011983783],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005254279,0.0037628128,0.008888537,0.0000987521,0.000083102634,0.000569385,0.00076627627,0.000018330265,0.9761735,0.00009418895,0.0053003374,0.0037193072],"study_design_scores_gemma":[0.030967284,0.0013396677,0.12845819,0.0015009727,0.0004016744,0.00014307928,0.0003038954,0.00029737357,0.8029773,0.00013940614,0.03281054,0.0006606294],"about_ca_topic_score_codex":0.0001870841,"about_ca_topic_score_gemma":0.0004060689,"teacher_disagreement_score":0.17319624,"about_ca_system_score_codex":0.00066184276,"about_ca_system_score_gemma":0.00015534947,"threshold_uncertainty_score":0.9999997},"labels":[],"label_agreement":null},{"id":"W2980288837","doi":"10.1182/blood.v128.22.144.144","title":"Risk of Venous Thromboembolism Recurrence Among Rivaroxaban Treated Patients Who Continued Versus Discontinued Therapy: Analyses Among VTE Patients","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Rivaroxaban; Cohort; Venous thromboembolism; Retrospective cohort study; Surgery; Cohort study; Internal medicine; Warfarin; Thrombosis; Atrial fibrillation","score_opus":0.022966673394815715,"score_gpt":0.2790338963131248,"score_spread":0.2560672229183091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980288837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951441,0.00024258698,0.000014217406,0.000035349767,0.00041781415,0.0014417637,0.00020989546,0.000101834084,0.0023924254],"genre_scores_gemma":[0.9978852,0.0013886103,0.000066549575,0.00003538131,0.00012592245,0.000102853206,0.000114537106,0.00006764907,0.00021324084],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971386,0.00020477806,0.00074788294,0.00065386615,0.00065117946,0.00060366275],"domain_scores_gemma":[0.99751955,0.000202518,0.00076472416,0.000830014,0.00042893318,0.00025425365],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002179213,0.00044376557,0.0013778681,0.00025147345,0.00014951859,0.000035445963,0.0003113305,0.00016824131,0.00018232141],"category_scores_gemma":[0.00043715912,0.00029254335,0.00035529086,0.00040032715,0.00034594606,0.00028016116,0.00013198814,0.00017302047,0.000030143388],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034633925,0.008188265,0.9660376,0.00004262697,0.0018821316,0.000010412849,0.0007102413,7.168252e-7,0.00064978126,0.000027135215,0.00094912975,0.02115566],"study_design_scores_gemma":[0.023602867,0.0024760207,0.9551525,0.0005561862,0.001871436,1.9350426e-7,0.000060213344,0.000004397842,0.015573716,0.00003978544,0.00032015267,0.00034252202],"about_ca_topic_score_codex":0.0011316602,"about_ca_topic_score_gemma":0.000157824,"teacher_disagreement_score":0.023256527,"about_ca_system_score_codex":0.000060877857,"about_ca_system_score_gemma":0.000040452738,"threshold_uncertainty_score":0.9999527},"labels":[],"label_agreement":null},{"id":"W2980289955","doi":"10.1182/blood.v128.22.2886.2886","title":"Utility of Next Generation Sequencing in Prognostication and Therapeutic Decision Making in Cytogenetically Normal AML with DNMT3A Mutations","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"CEBPA; NPM1; DNA sequencing; Sanger sequencing; Myeloid leukemia; Biology; Oncology; Genetics; Bioinformatics; Computational biology; Internal medicine; Medicine; Gene; Karyotype; Mutation; Chromosome","score_opus":0.06727627985738448,"score_gpt":0.3194251479342947,"score_spread":0.2521488680769102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980289955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99027544,0.00016237776,0.008585545,0.00024241331,0.0000062725526,0.00048860686,0.0000030129922,0.00001045651,0.00022588961],"genre_scores_gemma":[0.9879041,0.00004290662,0.011926836,0.000040359875,0.000027938688,0.00003305775,0.0000053890017,0.000011088055,0.000008336806],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905795,0.00006716565,0.0002628885,0.00020948134,0.00022958902,0.0001729416],"domain_scores_gemma":[0.9993538,0.000258544,0.000049892507,0.00017545445,0.00011733238,0.00004493666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032034022,0.000077353616,0.00014395932,0.00018002579,0.000024316876,0.000011078121,0.000047328293,0.0000641844,0.000028899303],"category_scores_gemma":[0.00031051858,0.000050901905,0.000012793597,0.00027063992,0.00009975694,0.00008892688,0.00002752079,0.00009879202,0.0000027668425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020450153,0.00014087978,0.5346378,0.00003840432,0.000017262748,0.00002681025,0.0004416306,0.000013390286,0.3822515,0.00016277602,0.0000011029564,0.08206393],"study_design_scores_gemma":[0.004286384,0.00033036128,0.9060948,0.00043997882,0.000057406953,0.00008423031,0.00013529554,0.011873554,0.076304965,0.00030346971,0.0000052226565,0.00008437394],"about_ca_topic_score_codex":0.000044530974,"about_ca_topic_score_gemma":0.0003911462,"teacher_disagreement_score":0.37145695,"about_ca_system_score_codex":0.00009545951,"about_ca_system_score_gemma":0.00039306516,"threshold_uncertainty_score":0.20757194},"labels":[],"label_agreement":null},{"id":"W2980297967","doi":"10.1182/blood.v114.22.1136.1136","title":"High Incidence of Invasive Fungal Infections in Adult Patients Undergoing Hematopoietic Stem Cell Transplantation.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Leukemia & Lymphoma Society of Canada; Vancouver Coastal Health; Providence Health Care","funders":"","keywords":"Medicine; Hematopoietic stem cell transplantation; Internal medicine; Incidence (geometry); Transplantation; Cumulative incidence; Chronic lymphocytic leukemia; Surgery; Fluconazole; Leukemia; Multiple myeloma; Population; Antifungal","score_opus":0.007760450464512809,"score_gpt":0.22874060336092725,"score_spread":0.22098015289641443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980297967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984251,0.00007846247,0.000111858804,0.000072470655,0.00003480698,0.00025829565,0.000011154884,0.000021351929,0.0009864988],"genre_scores_gemma":[0.9993346,0.00021561969,0.00020165642,0.00012867239,0.000015750631,0.0000052187024,0.000014709055,0.00000607814,0.00007770196],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990962,0.000036643152,0.00031591882,0.00018330818,0.00021692629,0.00015100051],"domain_scores_gemma":[0.99938935,0.00014565319,0.00008436441,0.0001726251,0.00014783775,0.00006014691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000074581265,0.00009568627,0.0002198874,0.00008693033,0.000037410577,0.0000051163497,0.000049018014,0.00006768137,0.0000206798],"category_scores_gemma":[0.00006728552,0.00008903247,0.000060450202,0.00023252435,0.000033525695,0.000098713186,0.000005673267,0.0001286461,0.000011361669],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009428974,0.0016462646,0.99055636,0.00044592243,0.000010982846,0.00004101787,0.0009715377,0.000014439974,0.0056499895,0.0003320058,0.000015751692,0.00022146145],"study_design_scores_gemma":[0.0039258613,0.0007213447,0.9267691,0.0004687889,0.000107985295,0.0000134315305,0.00032867174,0.0000024794076,0.06731354,0.00026090845,6.0670556e-7,0.00008729714],"about_ca_topic_score_codex":0.000061681196,"about_ca_topic_score_gemma":0.00076095865,"teacher_disagreement_score":0.063787244,"about_ca_system_score_codex":0.000032180913,"about_ca_system_score_gemma":0.00014981435,"threshold_uncertainty_score":0.3630639},"labels":[],"label_agreement":null},{"id":"W2980298754","doi":"10.1182/blood.v110.11.3618.3618","title":"Bortezomib [VELCADE™], Pegylated Liposomal Doxorubicin [DOXIL/CAELYX®] and Dexamethasone in the Treatment of Previously Untreated Multiple Myeloma Patients: Impact on Quality-of-Life.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Nova Scotia Cancer Centre; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bortezomib; Internal medicine; Quality of life (healthcare); Multiple myeloma; Cancer; Oncology; Gastroenterology; Surgery","score_opus":0.03760358170003624,"score_gpt":0.3455037861999114,"score_spread":0.30790020449987515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980298754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99601716,0.0012294839,0.0000066655543,0.00008501742,0.000024596444,0.002033223,0.00013019529,0.000032536977,0.00044114172],"genre_scores_gemma":[0.99873835,0.00043819827,0.00036992732,0.000046318797,0.000049327497,0.000048920683,0.00022070334,0.00003500173,0.000053230313],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970486,0.0003233589,0.0008621891,0.00042739857,0.0006872073,0.0006512308],"domain_scores_gemma":[0.99732393,0.0012587275,0.00029591584,0.00058257027,0.00018622473,0.00035265728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006428186,0.00038376465,0.00087251945,0.0003726872,0.00006904272,0.000015089078,0.00013945102,0.0001815061,0.00004594014],"category_scores_gemma":[0.00070678955,0.00021952421,0.00022424462,0.000589767,0.00017120667,0.00007179844,0.000027347915,0.00019307171,0.000009780178],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006072672,0.013798836,0.9519076,0.00011964301,0.0008233719,0.00014006771,0.0020380204,0.0000043237196,0.0064936373,0.000019542915,0.000010869206,0.018571429],"study_design_scores_gemma":[0.03970975,0.010041247,0.91558915,0.00015500987,0.0002542832,0.00001818455,0.00029898246,0.0000618783,0.033665724,0.00001057839,0.00003746216,0.00015777232],"about_ca_topic_score_codex":0.003358722,"about_ca_topic_score_gemma":0.0005696676,"teacher_disagreement_score":0.03631846,"about_ca_system_score_codex":0.00015010401,"about_ca_system_score_gemma":0.00014841704,"threshold_uncertainty_score":0.89519376},"labels":[],"label_agreement":null},{"id":"W2980301706","doi":"10.1182/blood.v120.21.800.800","title":"Long-Term Outcome of Ruxolitinib Treatment in Patients with Myelofibrosis: Durable Reductions in Spleen Volume, Improvements in Quality of Life, and Overall Survival Advantage in COMFORT-I","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Ruxolitinib; Medicine; Myelofibrosis; Clinical endpoint; Internal medicine; Placebo; Randomized controlled trial; Quality of life (healthcare); Intention-to-treat analysis; Anemia; Surgery; Gastroenterology; Bone marrow; Pathology","score_opus":0.027013929775404608,"score_gpt":0.3025728459730689,"score_spread":0.27555891619766426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980301706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979569,0.00023302561,5.768699e-7,0.00006634736,0.000049817845,0.0013364935,0.0001232172,0.00000635798,0.00022728133],"genre_scores_gemma":[0.99915695,0.00011758656,0.000249721,0.000023383504,0.000018001156,0.00021488359,0.00011644664,0.00001893682,0.000084116655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980261,0.000127306,0.00091505033,0.00028433377,0.0002698783,0.0003773734],"domain_scores_gemma":[0.9992254,0.00008450841,0.00024184534,0.00026255695,0.000047408415,0.0001382757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029419726,0.00023276554,0.00083641073,0.000286574,0.000016432263,0.0000055283576,0.000045648994,0.00008244159,0.00003585256],"category_scores_gemma":[0.000062811974,0.00018180399,0.000051844563,0.00024162067,0.000061006715,0.00018754587,0.00003904055,0.000114940405,0.0000011470191],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069694413,0.014995264,0.9824652,0.00023373627,0.00011077192,0.00000842651,0.0007403437,0.0000042243105,0.0002252633,0.000094379,0.0000011085885,0.0004243589],"study_design_scores_gemma":[0.030257829,0.0012320774,0.96588236,0.00027583673,0.0000704957,0.0000011192755,0.00021890562,0.0000026153718,0.0019083184,0.0000074634895,0.0000035162852,0.00013948213],"about_ca_topic_score_codex":0.0035572539,"about_ca_topic_score_gemma":0.00523507,"teacher_disagreement_score":0.029560883,"about_ca_system_score_codex":0.00018145621,"about_ca_system_score_gemma":0.000074037765,"threshold_uncertainty_score":0.7413752},"labels":[],"label_agreement":null},{"id":"W2980301843","doi":"10.1182/blood.v120.21.1862.1862","title":"Phase I Study of the PARP1-2 Inhibitor Veliparib in Combination with Bortezomib in Patients with Relapsed or Refractory Multiple Myeloma","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Veliparib; Bortezomib; PARP inhibitor; Medicine; Proteasome inhibitor; Multiple myeloma; Internal medicine; Ixazomib; Pharmacology; Carfilzomib; Plasma cell leukemia; Oncology; Tolerability; Cancer research; Adverse effect; Poly ADP ribose polymerase; Biology","score_opus":0.019029572776951803,"score_gpt":0.281547447479599,"score_spread":0.2625178747026472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980301843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99789435,0.00006619433,0.0000051776315,0.000059421254,0.000109984525,0.0017033789,0.000012541152,0.000021788683,0.00012718781],"genre_scores_gemma":[0.9994462,0.000003537259,0.00013211387,0.00009401137,0.00005654765,0.00017234261,0.000020820182,0.000030047968,0.00004433656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985906,0.000132804,0.0003724182,0.00019726752,0.0004667486,0.00024019387],"domain_scores_gemma":[0.99911153,0.00008451002,0.00022589075,0.00038774233,0.00011701255,0.00007331302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023775685,0.00015430583,0.00029704254,0.0001445137,0.00003696768,0.0000049917535,0.00008350301,0.00006998406,0.000028801243],"category_scores_gemma":[0.00007743142,0.00008902045,0.0000219215,0.00050507986,0.00006685867,0.00017958075,0.00002250443,0.00025029838,0.0000025608733],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00560877,0.045128785,0.94396496,0.00003111351,0.000062536354,0.000007697381,0.0032766722,0.0000031892803,0.00093638676,0.0000039757138,0.000055076198,0.0009208563],"study_design_scores_gemma":[0.15251374,0.0070715416,0.8307131,0.00030885453,0.00008154753,0.0000034919642,0.0007050091,0.00001035572,0.008313476,0.0000019940949,0.00016136453,0.000115526156],"about_ca_topic_score_codex":0.00008944528,"about_ca_topic_score_gemma":0.00033089088,"teacher_disagreement_score":0.14690498,"about_ca_system_score_codex":0.00011016453,"about_ca_system_score_gemma":0.000112210255,"threshold_uncertainty_score":0.36301485},"labels":[],"label_agreement":null},{"id":"W2980302906","doi":"10.1182/blood.v114.22.2606.2606","title":"Secondary Chromosomal Abnormalities Appear to Be Less Prognostic for Children with Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) Treated with Intensified Imatinib and Chemotherapy: Results of the Children's Oncology Group (COG) Study AALL0031.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Etoposide; Chemotherapy; Imatinib; Chemotherapy regimen; Philadelphia chromosome; Acute lymphocytic leukemia; Ifosfamide; Imatinib mesylate; Cohort; Oncology; Gastroenterology; Leukemia; Chromosomal translocation; Lymphoblastic Leukemia; Biology; Myeloid leukemia","score_opus":0.012310091314362148,"score_gpt":0.24852121687732937,"score_spread":0.23621112556296722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980302906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98867273,0.00017748383,0.00001525908,0.0017646959,0.000027640563,0.008209755,0.0007691097,0.00012874803,0.0002345943],"genre_scores_gemma":[0.9964199,0.000027510836,0.0009767984,0.0013507674,0.0001582233,0.00033775778,0.00052905193,0.00009882618,0.0001011282],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970619,0.00013825229,0.0006962322,0.000908345,0.0004992846,0.00069597905],"domain_scores_gemma":[0.9980171,0.00022835255,0.00044201192,0.00074112776,0.00028771948,0.00028374066],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019835298,0.00066300604,0.0011341699,0.0001807757,0.00020538659,0.000043112606,0.00030335883,0.00020967766,0.000014399378],"category_scores_gemma":[0.000087798515,0.0004133979,0.00013071732,0.00043826725,0.000345167,0.00015702622,0.00009876573,0.00034171165,0.0000020520263],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12433292,0.04291607,0.6269185,0.0008057548,0.07665499,0.0018576352,0.061314695,0.00019049793,0.039540894,0.00036140817,0.0016461763,0.023460489],"study_design_scores_gemma":[0.083462924,0.0361457,0.8573056,0.0005700265,0.0057002963,0.00309798,0.0010134614,0.000040221203,0.012167996,0.000009531409,0.000016812852,0.0004694694],"about_ca_topic_score_codex":0.00045072194,"about_ca_topic_score_gemma":0.00026704327,"teacher_disagreement_score":0.2303871,"about_ca_system_score_codex":0.0005758113,"about_ca_system_score_gemma":0.000982053,"threshold_uncertainty_score":0.9998318},"labels":[],"label_agreement":null},{"id":"W2980310592","doi":"10.1182/blood.v114.22.4738.4738","title":"Effect of Ivig On Human T Cells: Interference with Activation Rather Than Suppression of Activated Cell Functions.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Héma-Québec","funders":"","keywords":"CD28; Jurkat cells; Secretion; T cell; Peripheral blood mononuclear cell; Molecular biology; Antigen; Cell culture; Cytokine; Chemistry; Immunology; Biology; In vitro; Immune system; Biochemistry","score_opus":0.006503020498882675,"score_gpt":0.22503090368779316,"score_spread":0.21852788318891048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980310592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943896,0.0004324654,0.000073995194,0.000014355516,0.00008831347,0.00020718836,0.0000064925403,0.000033913024,0.004753677],"genre_scores_gemma":[0.99929625,0.000008716117,0.0000035001672,0.000018038942,0.0000015556353,0.0000067760625,0.000056693494,0.000009046732,0.00059941114],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992071,0.00019329449,0.00020883266,0.00018626824,0.00003845054,0.00016607581],"domain_scores_gemma":[0.99937505,0.00009554948,0.00020362175,0.0002784204,0.000043859578,0.0000034745972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013892878,0.00015410104,0.00024285437,0.000104939674,0.00010719241,0.0000037824782,0.00015822565,0.00013972391,0.00013137433],"category_scores_gemma":[0.000014985577,0.00010683309,0.00006534908,0.00015478852,0.00010526227,0.00007359189,0.000017297933,0.00020495048,0.000024622159],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082717533,0.0011449865,0.00021611348,0.00003395622,0.000049620943,3.041114e-7,0.00031287354,0.000019723966,0.99288607,0.000025594674,0.000035618472,0.0044479906],"study_design_scores_gemma":[0.003136593,0.0051621753,0.004419728,0.00019524814,0.00006667789,0.0000017942153,0.00010252282,5.948301e-7,0.986592,0.000012419369,0.00020086937,0.000109365224],"about_ca_topic_score_codex":0.00003231042,"about_ca_topic_score_gemma":3.824415e-7,"teacher_disagreement_score":0.00629403,"about_ca_system_score_codex":0.0000057847883,"about_ca_system_score_gemma":0.000017785014,"threshold_uncertainty_score":0.4356527},"labels":[],"label_agreement":null},{"id":"W2980310908","doi":"10.1182/blood.v118.21.205.205","title":"A Randomized Trial of Dabigatran Versus Warfarin in the Treatment of Acute Venous Thromboembolism (RE-COVER II)","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Hospital; McMaster University","funders":"","keywords":"Medicine; Dabigatran; Hazard ratio; Warfarin; Confidence interval; Randomized controlled trial; Internal medicine; Venous thromboembolism; Surgery; Anesthesia; Atrial fibrillation; Thrombosis","score_opus":0.049935560514862185,"score_gpt":0.2944005454672142,"score_spread":0.24446498495235203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980310908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.973498,0.00047245124,0.000004227685,0.00016039342,0.00035033692,0.002946146,0.000015748685,0.00001948452,0.022533206],"genre_scores_gemma":[0.9966399,0.0024421066,0.00027739408,0.00008515623,0.00013482601,0.00030141865,0.00001733921,0.000021718819,0.0000801153],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983798,0.00016127627,0.00060248206,0.00024247731,0.00034379386,0.00027013494],"domain_scores_gemma":[0.9989187,0.00018496328,0.00022496325,0.0005720082,0.000044273656,0.000055060736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047495135,0.00021374866,0.0016314344,0.00013225242,0.000044896708,0.0000047333656,0.00019070206,0.00009453936,0.00022079835],"category_scores_gemma":[0.000040387913,0.00012939947,0.00043822973,0.00019560663,0.0001652515,0.000042140204,0.000035479392,0.00008147285,0.000009917195],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.84752643,0.08748452,0.00018550718,0.00013335381,0.0068509984,0.00016480855,0.049239203,0.0000032555427,0.0009895386,0.0044168606,0.00032801394,0.0026774935],"study_design_scores_gemma":[0.96196556,0.012354378,0.005200494,0.00006383642,0.007076851,0.000006469534,0.00037726495,0.0000068041777,0.011931248,0.00031176678,0.0005822149,0.00012313765],"about_ca_topic_score_codex":0.0011572767,"about_ca_topic_score_gemma":0.0000603162,"teacher_disagreement_score":0.11443909,"about_ca_system_score_codex":0.000028680697,"about_ca_system_score_gemma":0.00007266736,"threshold_uncertainty_score":0.5276757},"labels":[],"label_agreement":null},{"id":"W2980314982","doi":"10.1182/blood.v110.11.3326.3326","title":"Multiple Myeloma in Manitoba: A Population Based Study.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Medicine; Transplantation; Multiple myeloma; Surgery; Cohort; Population; Incidence (geometry); Retrospective cohort study; Cohort study; Internal medicine","score_opus":0.03315161237594816,"score_gpt":0.312131879283865,"score_spread":0.27898026690791683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980314982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99798423,0.000053858985,0.000047365345,0.000054221247,0.000032216718,0.0009829884,0.000003919716,0.000051968254,0.0007892074],"genre_scores_gemma":[0.9984811,0.000001043365,0.0011916996,0.000051125808,0.00007772451,0.0000374174,0.00006360443,0.000016759479,0.00007951443],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998883,0.000038210284,0.00021344743,0.00021563424,0.0003306582,0.00031904152],"domain_scores_gemma":[0.9994316,0.000111625784,0.000030571548,0.00023467767,0.000040326322,0.00015119849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029979536,0.000106207735,0.00017529532,0.00023936472,0.000043461605,0.000010519898,0.000048065267,0.00005063365,0.000048028254],"category_scores_gemma":[0.0002137276,0.000089632726,0.00004488373,0.00025050386,0.000007972339,0.000043254662,0.00002003325,0.00012119356,0.0000625934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038415537,0.004286595,0.9852402,0.000021039956,0.000051294217,0.001205479,0.00006647659,0.0000015472017,0.00095055776,0.0000033601084,0.0000060708044,0.0077831848],"study_design_scores_gemma":[0.018431846,0.0004992531,0.9777654,0.00003322944,0.000045903354,0.000012897088,0.00024240608,0.00020585161,0.0026473477,0.000008154376,0.000035794867,0.00007195848],"about_ca_topic_score_codex":0.0020476098,"about_ca_topic_score_gemma":0.0124995075,"teacher_disagreement_score":0.018047692,"about_ca_system_score_codex":0.00008965976,"about_ca_system_score_gemma":0.000036998783,"threshold_uncertainty_score":0.6975019},"labels":[],"label_agreement":null},{"id":"W2980316438","doi":"10.1182/blood.v120.21.56.56","title":"A Phase I Study of the Anti-CD79b Antibody-Drug Conjugate (ADC) DCDS4501A Targeting CD79b in Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; BC Cancer Agency","funders":"","keywords":"Medicine; Tolerability; Internal medicine; Rituximab; Lymphoma; Oncology; Follicular lymphoma; Diffuse large B-cell lymphoma; Radioimmunotherapy; Antibody-drug conjugate; Gastroenterology; Adverse effect; Antibody; Immunology; Monoclonal antibody","score_opus":0.023125627101480035,"score_gpt":0.33318811948875654,"score_spread":0.3100624923872765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980316438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929159,0.0015730569,0.0000018591987,0.00034555024,0.00032755252,0.0012899071,0.000037880433,0.000039422386,0.00346882],"genre_scores_gemma":[0.995116,0.0002149993,0.00019075528,0.00027108402,0.0004413086,0.000037689184,0.000030385812,0.000060346938,0.003637411],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99657977,0.00037437034,0.0008031412,0.00044188712,0.0009076921,0.00089315575],"domain_scores_gemma":[0.99821097,0.00034549623,0.00029765395,0.00065912044,0.00016875149,0.00031801834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011947075,0.00036255087,0.00077203696,0.00023025555,0.0002036564,0.00002294065,0.00042861913,0.00014061465,0.00019523321],"category_scores_gemma":[0.00026194743,0.00022125829,0.00021033871,0.0006650361,0.00019831864,0.00014988787,0.00031950744,0.00050687935,0.000075180506],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002800702,0.06762341,0.5967631,0.0006791844,0.00037197952,0.0005513959,0.0081648305,0.000003681287,0.31804016,0.00002741546,0.0024411508,0.0025330377],"study_design_scores_gemma":[0.13346845,0.008989057,0.52179265,0.0010927167,0.0009638169,0.00032880928,0.0083574625,0.0003942989,0.29387617,0.000028918734,0.029543024,0.0011646255],"about_ca_topic_score_codex":0.0010821815,"about_ca_topic_score_gemma":0.00006389465,"teacher_disagreement_score":0.13066776,"about_ca_system_score_codex":0.00005042493,"about_ca_system_score_gemma":0.00028448825,"threshold_uncertainty_score":0.90226513},"labels":[],"label_agreement":null},{"id":"W2980324440","doi":"10.1182/blood.v122.21.3093.3093","title":"Microrna-Dependent Modulation Of Osteogenesis In a 3D In Vitro Bone Marrow Model System Of Multiple Myeloma","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Mesenchymal stem cell; Bone marrow; Stromal cell; Cancer research; Chemistry; Pathology; Cell biology; Biology; Medicine","score_opus":0.018325820125034416,"score_gpt":0.25072213554782347,"score_spread":0.23239631542278905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980324440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998107,0.0003272837,0.000089733214,0.000046014044,0.000014402876,0.0010927002,0.000054831293,0.000015214071,0.00025277823],"genre_scores_gemma":[0.9944766,0.000015850186,0.005145577,0.0000055837427,0.000013707379,0.00014862392,0.00005194691,0.000021050088,0.00012104076],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998576,0.00006562722,0.00049509754,0.0002298729,0.00035541187,0.00027802412],"domain_scores_gemma":[0.9992681,0.00006104977,0.00012640622,0.00031103397,0.00012545954,0.000107951826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017369588,0.00013395632,0.00043795435,0.00034863444,0.000012702945,0.0000049614328,0.00007392351,0.00009496771,0.000022885808],"category_scores_gemma":[0.000088456414,0.00011673199,0.00007376235,0.00021708249,0.000030378864,0.0000802188,0.000049769227,0.000086562744,0.000019059424],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003950898,0.00104294,0.23366848,0.00043874595,0.00006382739,0.00006180233,0.00016164781,0.0003645064,0.7598147,0.000003657241,0.0000025845595,0.0039820503],"study_design_scores_gemma":[0.011640988,0.000121221834,0.37346044,0.00023432149,0.000042294207,0.000028147833,0.00014436044,0.13907534,0.4751676,0.000008935233,4.920339e-7,0.000075878714],"about_ca_topic_score_codex":0.002700787,"about_ca_topic_score_gemma":0.00024640706,"teacher_disagreement_score":0.28464708,"about_ca_system_score_codex":0.0000976905,"about_ca_system_score_gemma":0.00008270262,"threshold_uncertainty_score":0.47601926},"labels":[],"label_agreement":null},{"id":"W2980326533","doi":"10.1182/blood.v120.21.3392.3392","title":"Recurrence Rate and Hazard Modeling for Recurrence in Children with a First Episode of Venous Thromboembolism","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Cohort; Hazard ratio; Pediatrics; Retrospective cohort study; Epidemiology; Cohort study; Disease; Surgery; Internal medicine; Confidence interval","score_opus":0.02015313347811929,"score_gpt":0.26011994052231086,"score_spread":0.23996680704419157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980326533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942053,0.0031552152,0.0008832691,0.00021949474,0.00007120879,0.0011907099,0.000021788817,0.000023348983,0.00022965185],"genre_scores_gemma":[0.99482983,0.0014554677,0.0032559931,0.00010621676,0.00011557328,0.0001846437,0.000019959867,0.000025176114,0.0000071394074],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988644,0.000025266667,0.00027968964,0.00027268892,0.00014854928,0.0004093897],"domain_scores_gemma":[0.9993712,0.0000653282,0.000105026826,0.0002646119,0.00006640097,0.00012748351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003824926,0.00017550448,0.0005922521,0.00011624209,0.000066247914,0.00001191412,0.00009199679,0.00006440195,0.000008090189],"category_scores_gemma":[0.00009769279,0.00014552541,0.000047574016,0.00016932168,0.00006319383,0.00013724997,0.000059238046,0.00011677011,0.0000027098251],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011217512,0.0075315996,0.97562575,0.000944181,0.00050541473,0.0000045931356,0.0029233238,0.00034676454,0.00020198648,0.0023504996,0.0003557138,0.009098023],"study_design_scores_gemma":[0.006178578,0.0013556025,0.9847827,0.0014191143,0.00097253895,0.00006967193,0.00019368395,0.0019687943,0.0019889737,0.00039197897,0.00030783922,0.00037053978],"about_ca_topic_score_codex":0.00027365875,"about_ca_topic_score_gemma":0.00021053545,"teacher_disagreement_score":0.00915696,"about_ca_system_score_codex":0.000017551773,"about_ca_system_score_gemma":0.000040739353,"threshold_uncertainty_score":0.5934354},"labels":[],"label_agreement":null},{"id":"W2980326575","doi":"10.1182/blood.v118.21.5283.5283","title":"Awareness of and Identifying Iron Overload in Transfusion-Dependent Patients Can Be Improved: A Retrospective Review At a Single Tertiary Care Centre","year":2011,"lang":"en","type":"review","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Victoria Hospital; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Tertiary care; Thalassemia; Hematology; Transfusion medicine; Incidence (geometry); Blood transfusion; Pediatrics; Retrospective cohort study; Internal medicine; Intensive care medicine","score_opus":0.018230535806462424,"score_gpt":0.26897128398796194,"score_spread":0.2507407481814995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980326575","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02729236,0.96941614,2.1964127e-7,0.00002628989,0.00014827124,0.0024949668,0.00025306616,0.000023808198,0.00034488252],"genre_scores_gemma":[0.0040714615,0.9952381,0.000019004181,0.00007543901,0.000023865823,0.00005623245,0.00034190738,0.00006919925,0.00010479463],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9976908,0.00013396832,0.00088292774,0.000638108,0.00029854025,0.00035563917],"domain_scores_gemma":[0.9988196,0.00002738033,0.00040826807,0.0004363876,0.00014437403,0.00016398278],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001282081,0.00046451407,0.0019801988,0.00019013774,0.000068398265,0.000008315929,0.0001311545,0.00046555317,0.00007266175],"category_scores_gemma":[0.0000846087,0.00035539072,0.00039306996,0.00027300732,0.00007138238,0.000044968907,0.00013887526,0.00048381984,0.0000027147219],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040585604,0.002180729,0.067709416,0.44730073,0.00047754106,0.00016506544,0.004048792,1.8874806e-8,0.00006596949,0.000004002308,0.00008000067,0.47792715],"study_design_scores_gemma":[0.014833311,0.0012062797,0.0090966625,0.8317903,0.02308292,0.00032918362,0.0012508071,0.0000010407855,0.00023570056,0.0000119040005,0.11641021,0.0017516792],"about_ca_topic_score_codex":0.0011861965,"about_ca_topic_score_gemma":0.0012041111,"teacher_disagreement_score":0.47617546,"about_ca_system_score_codex":0.00031426462,"about_ca_system_score_gemma":0.00024362239,"threshold_uncertainty_score":0.9998898},"labels":[],"label_agreement":null},{"id":"W2980338073","doi":"10.1182/blood-2018-99-116879","title":"Building Capacity for Relapsed/Refractory ALL Patients Needing CAR-T Cells: How Do We Prepare?","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency; Leukemia & Lymphoma Society of Canada; Ottawa Hospital","funders":"","keywords":"Medicine; Refractory (planetary science); Internal medicine; Cohort; Retrospective cohort study; Chimeric antigen receptor; Surgery; Pediatrics; Cancer; Immunotherapy","score_opus":0.04342856139981292,"score_gpt":0.30487345148900186,"score_spread":0.2614448900891889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980338073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99418396,0.00029539666,0.00020330478,0.00041487764,0.0005732588,0.0011623472,0.00004323191,0.00011961087,0.0030039945],"genre_scores_gemma":[0.9871675,0.00015265943,0.007492192,0.00016960253,0.001440491,0.00009661016,0.000017376191,0.00008913376,0.0033744464],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980357,0.000056184017,0.00023805856,0.00048904965,0.00055515766,0.0006257962],"domain_scores_gemma":[0.99843895,0.00020065524,0.00011112211,0.00053764624,0.00042564442,0.00028598102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004363212,0.00022589011,0.0003415154,0.00017931058,0.00014728475,0.00007153691,0.0002139949,0.00019223282,0.00043898768],"category_scores_gemma":[0.00030818034,0.00020643442,0.00018382758,0.00019757918,0.00015005132,0.00014863895,0.000098358396,0.00027148618,0.000028973063],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005233245,0.0011503986,0.01060419,0.00027668884,0.00037233028,0.000011021247,0.002076509,3.5771865e-7,0.9535256,0.00008359864,0.0134496605,0.017926292],"study_design_scores_gemma":[0.009997417,0.0025282626,0.0010663518,0.00025553763,0.00029515236,0.000016321443,0.00016849973,0.00007471518,0.5114179,0.00026865632,0.47359005,0.00032109607],"about_ca_topic_score_codex":0.000042433832,"about_ca_topic_score_gemma":0.00001769247,"teacher_disagreement_score":0.46014038,"about_ca_system_score_codex":0.00015052035,"about_ca_system_score_gemma":0.000089028246,"threshold_uncertainty_score":0.8418151},"labels":[],"label_agreement":null},{"id":"W2980353767","doi":"10.1182/blood-2018-99-118415","title":"A Retrospective Case Series Describing the Efficacy of Omalizumab in Systemic Mastocytosis","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Omalizumab; Medicine; Systemic mastocytosis; Anaphylaxis; Retrospective cohort study; Tryptase; Cutaneous Mastocytosis; Immunoglobulin E; Internal medicine; Mast cell; Monoclonal; Gastroenterology; Immunology; Disease; Allergy; Antibody; Monoclonal antibody","score_opus":0.019457415500690224,"score_gpt":0.21552452493432708,"score_spread":0.19606710943363687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980353767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956656,0.001360068,0.000015540418,0.000040237446,0.00019348731,0.00020431823,0.00001981527,0.000021220532,0.0024797088],"genre_scores_gemma":[0.9990972,0.00001640758,0.00004002344,0.000012580147,0.000039055936,0.000013756721,0.0000046024575,0.000009347945,0.00076699],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992926,0.0001058441,0.00022170815,0.00016849974,0.000020060195,0.00019129043],"domain_scores_gemma":[0.9995353,0.000050502218,0.00009292154,0.00025205952,0.00006133437,0.000007889353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016396785,0.00009634911,0.00020459034,0.000061636805,0.00013226936,0.0000063711905,0.00011895491,0.00009588993,0.00025155072],"category_scores_gemma":[0.00006376185,0.00006811986,0.0000482591,0.00015130002,0.00031324927,0.000036177724,0.000061378276,0.00012694654,0.00006624872],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061037124,0.0009112391,0.047240652,0.00010988063,0.00037474907,0.00063114637,0.013169427,0.0000015082047,0.9275225,0.007687818,0.0003919011,0.0013488219],"study_design_scores_gemma":[0.018200522,0.0026950743,0.04564209,0.0006666837,0.0005239791,0.058155242,0.008304244,0.0000064963046,0.8598718,0.00017548584,0.0051215733,0.00063679245],"about_ca_topic_score_codex":0.00047898563,"about_ca_topic_score_gemma":0.0008035353,"teacher_disagreement_score":0.06765067,"about_ca_system_score_codex":0.00002422549,"about_ca_system_score_gemma":0.00002678755,"threshold_uncertainty_score":0.2777847},"labels":[],"label_agreement":null},{"id":"W2980367116","doi":"10.1182/blood-2018-99-119431","title":"Feasibility of Educating Stem Cell Transplant Patients on Advance Care Planning: A Pilot Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Intervention (counseling); Quality of life (healthcare); Transplantation; Population; Advance care planning; Randomized controlled trial; Health care; Hematopoietic stem cell transplantation; Proxy (statistics); Hematologic Neoplasms; Family medicine; Nursing; Internal medicine; Palliative care","score_opus":0.14674698589675003,"score_gpt":0.4111522383203864,"score_spread":0.2644052524236363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980367116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933773,0.00075086136,0.000006596884,0.000006694771,0.00012385249,0.00049744296,0.000045003915,0.000018542101,0.0051736813],"genre_scores_gemma":[0.99945676,0.00001176775,0.00031343396,0.000032517837,0.00009277616,0.000010851086,0.0000154384,0.000012224316,0.000054217166],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990977,0.00004760774,0.00025864918,0.0002176973,0.00023878782,0.00013957398],"domain_scores_gemma":[0.99919754,0.00008727083,0.00012420474,0.00027534613,0.0002498045,0.00006580858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007563576,0.0001136874,0.00028655713,0.00004628221,0.00003322213,0.0000019203887,0.00007780877,0.000022110917,0.000010625743],"category_scores_gemma":[0.00003728217,0.0000929612,0.00003887086,0.00009991146,0.0000488045,0.00002466093,0.000012815301,0.00008429185,0.0000055642504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044803537,0.0054884464,0.9536374,0.00032239076,0.000040080187,0.000005726991,0.038131215,8.187007e-7,0.001462751,0.0000020110433,0.00002363233,0.0004374711],"study_design_scores_gemma":[0.009912076,0.028200215,0.76415277,0.0020728207,0.0003602322,0.0000012019892,0.027875112,0.0000018681654,0.16699581,0.000005669934,0.00024903382,0.00017319937],"about_ca_topic_score_codex":0.00005809156,"about_ca_topic_score_gemma":0.00001829906,"teacher_disagreement_score":0.18948466,"about_ca_system_score_codex":0.00002382771,"about_ca_system_score_gemma":0.00006074195,"threshold_uncertainty_score":0.37908477},"labels":[],"label_agreement":null},{"id":"W2980369460","doi":"10.1182/blood.v122.21.1997.1997","title":"BMT Doubles The Lifespan Of A Mouse Model Of Farber Disease and Corrects Hematopoietic Defects","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Hepatosplenomegaly; Leukocytosis; Monocytosis; Bone marrow; Medicine; Lysosomal storage disease; Pathology; Haematopoiesis; Histiocyte; Immunology; Disease; Biology; Stem cell","score_opus":0.009253565480578093,"score_gpt":0.21838286757553269,"score_spread":0.2091293020949546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980369460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985444,0.0006755587,0.00023421668,0.00003355533,0.00001782227,0.00017878853,0.000010350477,0.0000026771977,0.0003026374],"genre_scores_gemma":[0.99917966,0.000104702296,0.0002075257,0.00005638687,0.000019398449,0.00002458102,0.00001488438,0.000006894992,0.00038596004],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996301,0.00002270434,0.00010376445,0.0001035016,0.000067515735,0.00007244163],"domain_scores_gemma":[0.9996687,0.000010450791,0.00005840045,0.00017472869,0.000039794984,0.000047932277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000042353422,0.0000604336,0.00007257284,0.000011435211,0.000020967871,0.000006682065,0.00006378344,0.00003500466,0.000006598792],"category_scores_gemma":[0.000028640043,0.000042261723,0.000033173168,0.000020490774,0.000052710682,0.0000022048878,0.000041866322,0.000019888244,0.0000016030821],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023074086,0.00013293825,0.0095706945,0.00006839008,0.00003774342,2.0694321e-7,0.00013282594,0.00009760154,0.9891028,0.00026846587,0.000506849,0.00005840073],"study_design_scores_gemma":[0.0008107423,0.00008174628,0.0026567944,0.000014841704,0.00007513311,0.00000240247,0.000081478116,0.0008131957,0.9950481,0.0003179198,0.000025784404,0.00007182701],"about_ca_topic_score_codex":0.000018900042,"about_ca_topic_score_gemma":0.0000052794076,"teacher_disagreement_score":0.0069139,"about_ca_system_score_codex":7.1662015e-7,"about_ca_system_score_gemma":0.000023732804,"threshold_uncertainty_score":0.1723383},"labels":[],"label_agreement":null},{"id":"W2980372057","doi":"10.1182/blood-2018-99-116792","title":"Prevalence of Iron Deficiency in Pregnancy: A Single Centre Canadian Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Pregnancy; Iron deficiency; Ferritin; Obstetrics; Pediatrics; Anemia; Psychiatry; Internal medicine","score_opus":0.012651407916651715,"score_gpt":0.2399354796259419,"score_spread":0.2272840717092902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980372057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817904,0.0020580806,0.0000012138124,0.00007358154,0.000063575564,0.00043799364,0.000007696165,0.00001033029,0.015557123],"genre_scores_gemma":[0.9990324,0.000017677843,0.00012423578,0.000047011577,0.000030342591,0.0000045375273,0.0000012878013,0.000008064459,0.00073447963],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992883,0.000027599537,0.00015168209,0.00016562511,0.00013886555,0.00022791124],"domain_scores_gemma":[0.99957776,0.00000804829,0.00003295394,0.00023131203,0.000046317866,0.00010361261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000072520874,0.00007112463,0.00012730963,0.00011914428,0.000025445976,0.0000032464366,0.00007628374,0.000034715114,0.0001877488],"category_scores_gemma":[0.000077000615,0.00006351659,0.00002046865,0.00019086657,0.00006070488,0.000033217017,0.000014799375,0.000049334085,0.000025785292],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014471183,0.0024736668,0.99103796,0.00026957018,0.0000021631456,0.000025835978,0.003717939,2.6354473e-7,0.00096372206,0.000059982674,0.000056550798,0.0013778951],"study_design_scores_gemma":[0.003902337,0.0007235905,0.99078107,0.00022710569,0.00017200243,0.0000043525697,0.0015317206,0.0000021141425,0.0024265337,0.000025991862,0.00011111533,0.00009203955],"about_ca_topic_score_codex":0.015474532,"about_ca_topic_score_gemma":0.11328239,"teacher_disagreement_score":0.097807854,"about_ca_system_score_codex":0.000014345101,"about_ca_system_score_gemma":0.00015431602,"threshold_uncertainty_score":0.99108154},"labels":[],"label_agreement":null},{"id":"W2980377461","doi":"10.1182/blood-2018-99-118330","title":"Canadian Hematology Mentorship and Career Counseling Resident Survey (2015-2017)","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Mentorship; Subspecialty; Medical education; Career development; Medicine; Curriculum; Graduate medical education; Family medicine; Graduation (instrument); Psychology; Accreditation; Pedagogy","score_opus":0.02723308851150681,"score_gpt":0.3442634611740579,"score_spread":0.31703037266255113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980377461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847188,0.00825953,0.00014390591,0.0018349538,0.00072382047,0.00021856959,0.000014937461,0.000036014953,0.004049451],"genre_scores_gemma":[0.9952276,0.0004928406,0.0006614796,0.0016555459,0.0004917075,0.000007225608,0.000014883788,0.000015549516,0.0014331948],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992142,0.00008218355,0.00013433314,0.00020098488,0.000088078734,0.00028027353],"domain_scores_gemma":[0.99926513,0.00013839158,0.000038625312,0.00020867186,0.000112223526,0.00023698063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044218294,0.000093248345,0.00021688994,0.00008077518,0.00013860308,0.00000675464,0.00006290644,0.00015205253,0.00017579849],"category_scores_gemma":[0.00015845483,0.000078865676,0.000017608327,0.00007053556,0.000210162,0.000032091986,0.0000091850125,0.000121624056,0.00003672329],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019592264,0.000116890216,0.96882814,0.000038999082,0.0002664676,0.0003868191,0.0023868585,3.1833116e-7,0.00028146734,0.00065036176,0.026341245,0.0005065161],"study_design_scores_gemma":[0.010299001,0.0022284507,0.76784307,0.00018650392,0.00040152346,0.004387031,0.0005820066,0.00004943185,0.005732526,0.0017176156,0.20597671,0.00059615995],"about_ca_topic_score_codex":0.02450196,"about_ca_topic_score_gemma":0.36279607,"teacher_disagreement_score":0.3382941,"about_ca_system_score_codex":0.0000719665,"about_ca_system_score_gemma":0.00030798276,"threshold_uncertainty_score":0.981994},"labels":[],"label_agreement":null},{"id":"W2980380302","doi":"10.1182/blood.v122.21.3500.3500","title":"Making “Sense” Of Persistent Polyclonal B Cell Lymphocytosis","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Lymphocytosis; Pathology; Population; Immunology; Biology; Extramedullary hematopoiesis; Medicine; Haematopoiesis; Stem cell","score_opus":0.06195625264244477,"score_gpt":0.29919913559330974,"score_spread":0.237242882950865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980380302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9767638,0.001147278,0.0000050177537,0.00053979165,0.00003822617,0.00034793033,0.000007966976,0.000030172921,0.021119853],"genre_scores_gemma":[0.99690413,0.00017945854,0.0017954011,0.00015615823,0.00010267576,0.000039267048,0.000003436445,0.000016178667,0.0008033134],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99885833,0.000029243236,0.00020675191,0.00018595895,0.00042748637,0.0002922547],"domain_scores_gemma":[0.9993262,0.000085461965,0.000060128637,0.00025143896,0.00016958918,0.00010717514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000090225505,0.00011379256,0.00026591984,0.00009507932,0.000058816626,0.00001151239,0.00006825384,0.0000471153,0.0005384638],"category_scores_gemma":[0.0001330186,0.00008743567,0.0002537387,0.00012564533,0.000104171384,0.00003968852,0.0001125091,0.000086796084,0.00014865317],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012466835,0.0025813284,0.15038592,0.0008237581,0.001125613,0.0000444462,0.0014455904,0.000010353029,0.82985723,0.000039147588,0.006251419,0.007310542],"study_design_scores_gemma":[0.012084946,0.0009965262,0.6832452,0.00047313623,0.0006317381,0.000108423905,0.002096351,0.0008865135,0.29705855,0.000014040698,0.0020745976,0.00032998752],"about_ca_topic_score_codex":0.00018834205,"about_ca_topic_score_gemma":0.0000032455096,"teacher_disagreement_score":0.53285927,"about_ca_system_score_codex":0.00004327512,"about_ca_system_score_gemma":0.00006842043,"threshold_uncertainty_score":0.5895801},"labels":[],"label_agreement":null},{"id":"W2980380805","doi":"10.1182/blood.v120.21.323.323","title":"Role of Mir-30e in Multiple Myeloma Cells Resistance to Lenalidomide and Bortezomib","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Lenalidomide; Bortezomib; Multiple myeloma; Biology; microRNA; Cancer research; Downregulation and upregulation; Molecular biology; Immunology; Gene; Genetics","score_opus":0.01852438703072472,"score_gpt":0.2730364971323385,"score_spread":0.2545121101016138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980380805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952117,0.002321008,0.000005323156,0.0001466677,0.000020469637,0.00050678704,0.000032301254,0.000015013573,0.0017407228],"genre_scores_gemma":[0.99479437,0.00006258838,0.0043435674,0.00006244079,0.0000638302,0.000046705183,0.000010008407,0.000017070892,0.00059944764],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893093,0.000043025837,0.00021607369,0.00018062403,0.0002315026,0.0003978621],"domain_scores_gemma":[0.9992092,0.00011269428,0.000040697178,0.00025131356,0.000041243544,0.0003448261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016812429,0.00011614459,0.00027128612,0.00013531533,0.000027747617,0.000006337647,0.00005745092,0.000055308625,0.000039970673],"category_scores_gemma":[0.00016157953,0.00009813166,0.000041357354,0.00015518635,0.00004191174,0.00007093834,0.000052353415,0.00009113255,0.000042581712],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073512597,0.001179041,0.6632969,0.000102119324,0.00008653454,0.00004213694,0.00050611637,5.29803e-7,0.33118573,0.0000354435,0.0002598927,0.0025704678],"study_design_scores_gemma":[0.007359209,0.00011692644,0.6069155,0.00010367699,0.000042491778,0.000010316842,0.00011286869,0.000015314428,0.3808399,0.000016839866,0.0043885605,0.00007839078],"about_ca_topic_score_codex":0.0001778833,"about_ca_topic_score_gemma":0.00034032774,"teacher_disagreement_score":0.056381375,"about_ca_system_score_codex":0.00002622361,"about_ca_system_score_gemma":0.000036816476,"threshold_uncertainty_score":0.4001693},"labels":[],"label_agreement":null},{"id":"W2980383141","doi":"10.1182/blood.v118.21.834.834","title":"Influence of Cytogenetic, Molecular Abnormalities and Other Risk Factors on the Outcomes of Children with Acute Myelogenous Leukemia Given An Unrelated Cord Blood Transplantation. A Survey on Behalf of Eurocord, ALWP and PDWP of EBMT","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Internal medicine; Transplantation; Leukemia; Cord blood; Busulfan; Gastroenterology; Oncology; Surgery; Hematopoietic stem cell transplantation","score_opus":0.023335814333689333,"score_gpt":0.25571999136478746,"score_spread":0.23238417703109812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980383141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978905,0.00013159584,0.0000118095395,0.000008659613,0.0000037516966,0.0007142379,0.0010575273,0.000012253566,0.00016971101],"genre_scores_gemma":[0.9991126,0.00045725045,0.00027937794,0.000040531802,0.000003190004,0.000009885951,0.000042100368,0.00003878312,0.000016295287],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983089,0.000325074,0.00044425062,0.00026996437,0.0004316662,0.00022013602],"domain_scores_gemma":[0.998544,0.00031606772,0.00035972957,0.0004552781,0.00022157311,0.0001033533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038022074,0.00023659904,0.0005605821,0.00017721506,0.000044266642,0.0000040778787,0.0002052966,0.000119867495,0.000016749178],"category_scores_gemma":[0.00009567169,0.0001471538,0.000058512716,0.00021629356,0.0005576684,0.00004738725,0.00003536076,0.00024362274,4.2724844e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015506658,0.00051580375,0.96393526,0.000088345856,0.0022863057,0.000033703825,0.004036332,0.00006484292,0.027325083,0.00008666081,9.984418e-7,0.00007603074],"study_design_scores_gemma":[0.0032083574,0.0037787508,0.6750856,0.000080261045,0.0011072301,0.000060538376,0.00013076687,0.0000040672535,0.3164397,0.000014813555,2.1297043e-7,0.000089675064],"about_ca_topic_score_codex":0.0107039,"about_ca_topic_score_gemma":0.00022472712,"teacher_disagreement_score":0.28911462,"about_ca_system_score_codex":0.000013593739,"about_ca_system_score_gemma":0.00018768864,"threshold_uncertainty_score":0.9958839},"labels":[],"label_agreement":null},{"id":"W2980391958","doi":"10.1182/blood.v122.21.2743.2743","title":"Final Analysis Of The Efficacy and Tolerability Of Subcutaneous Omacetaxine Mepesuccinate, ≥24 Months After First Dose, In Patients With Chronic Phase (CP) Or Accelerated Phase (AP) Chronic Myeloid Leukemia (CML)","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Tolerability; Discontinuation; Internal medicine; Adverse effect; Cohort; Nilotinib; Dasatinib; Neutropenia; Oncology; Imatinib; Surgery; Myeloid leukemia; Chemotherapy","score_opus":0.013854395526400921,"score_gpt":0.2597159242319458,"score_spread":0.24586152870554487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980391958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99575204,0.0011340735,0.000003866137,0.00010373126,0.00004927662,0.0026626165,0.00017553703,0.00003730093,0.00008158219],"genre_scores_gemma":[0.9990639,0.00010424624,0.00011637621,0.00003319247,0.000046077537,0.00020685438,0.00015334619,0.000048372698,0.00022759846],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969337,0.00012636544,0.0010058647,0.00073255925,0.0006100873,0.0005914309],"domain_scores_gemma":[0.9976019,0.00022235392,0.0004735024,0.0011628029,0.00032030573,0.0002191276],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001693764,0.0005001148,0.0013243542,0.00036644773,0.000085451655,0.000026479676,0.0002773592,0.00020445995,0.0016471593],"category_scores_gemma":[0.00014744476,0.00030237617,0.00021374453,0.0018095883,0.00031550846,0.0001882481,0.00014356949,0.00038418698,0.000008223256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02153714,0.026563462,0.9082229,0.001498274,0.0068044676,0.00045193496,0.001292183,0.0010883993,0.0095892465,0.0000027846877,0.00011294998,0.022836268],"study_design_scores_gemma":[0.12731154,0.007987753,0.84260195,0.00039923567,0.0049063913,0.00004597224,0.000021734382,0.003354539,0.012979603,0.00000240509,0.00006359318,0.00032525812],"about_ca_topic_score_codex":0.0017164329,"about_ca_topic_score_gemma":0.0050933743,"teacher_disagreement_score":0.105774395,"about_ca_system_score_codex":0.0018049759,"about_ca_system_score_gemma":0.001227811,"threshold_uncertainty_score":0.99994284},"labels":[],"label_agreement":null},{"id":"W2980405084","doi":"10.1182/blood-2018-99-114907","title":"New Blood Based M-Protein Quantification Method 3,000 Times More Sensitive Than Standard SPEP","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Polyclonal antibodies; Protein sequencing; Peptide sequence; Biology; Antibody; Molecular biology; Immunology; Biochemistry; Gene","score_opus":0.03101908213188804,"score_gpt":0.34597890965560985,"score_spread":0.3149598275237218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980405084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94832516,0.0001978432,0.04012568,0.00200101,0.000072196104,0.0016102181,0.00021015512,0.0002178542,0.007239892],"genre_scores_gemma":[0.8793144,0.000006178346,0.116490945,0.00009936006,0.00039064846,0.000027989614,0.0001466386,0.000037969818,0.0034858182],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982023,0.00015557327,0.00022390098,0.00044343734,0.0005706609,0.00040410654],"domain_scores_gemma":[0.99856746,0.000106641215,0.000082831844,0.0005470689,0.00030339413,0.0003925981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032990126,0.00021043773,0.00032541447,0.0001579286,0.00013893754,0.00004199779,0.000092639304,0.00011743989,0.00074155256],"category_scores_gemma":[0.0002987357,0.0001687204,0.0001148156,0.00027109555,0.000113118615,0.00007081491,0.000026359323,0.00017488908,0.00031232578],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053712456,0.003830882,0.04857727,0.0002766418,0.0029589396,0.0017466939,0.0014333187,0.0000023780867,0.8563876,0.0016303285,0.0030869953,0.074697666],"study_design_scores_gemma":[0.011037663,0.0013916406,0.03354861,0.00014787469,0.0004765393,0.00006443101,0.00009498017,0.00044068595,0.9514554,0.00014984036,0.001027859,0.00016447454],"about_ca_topic_score_codex":0.00050587225,"about_ca_topic_score_gemma":0.000060202725,"teacher_disagreement_score":0.09506776,"about_ca_system_score_codex":0.000040167324,"about_ca_system_score_gemma":0.0003426131,"threshold_uncertainty_score":0.81194806},"labels":[],"label_agreement":null},{"id":"W2980412254","doi":"10.1182/blood.v118.21.590.590","title":"Final Analysis of a Randomized Comparison of ABVD Chemotherapy with a Strategy That Includes Radiation Therapy (RT) in Patients with Limited-Stage Hodgkin Lymphoma (HL): NCIC CTG/ECOG HD.6","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; McGill University Health Centre; Queen's University; London Health Sciences Centre; BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"ABVD; Medicine; Nodular sclerosis; Radiation therapy; Internal medicine; Surgery; Randomized controlled trial; Randomization; Stage (stratigraphy); Cumulative incidence; Oncology; Chemotherapy; Lymphoma; Transplantation; Vincristine; Hodgkin lymphoma; Cyclophosphamide","score_opus":0.0363731819641558,"score_gpt":0.27078300285530243,"score_spread":0.23440982089114665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980412254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973488,0.0009055986,0.000039178103,0.000022484572,0.00001033991,0.0012248143,0.000035357156,0.000021066595,0.00039237028],"genre_scores_gemma":[0.99855536,0.00035015307,0.0006764668,0.000062628926,0.000010039973,0.0001381281,0.000152823,0.000026304837,0.00002806838],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982252,0.00015145798,0.00058694754,0.00031762733,0.00049016415,0.00022860899],"domain_scores_gemma":[0.9986131,0.00015446231,0.00061751297,0.00037632056,0.00015831094,0.00008026581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025624176,0.00027571194,0.001635781,0.0005163934,0.000030386922,0.000013753434,0.00010031431,0.0001005397,0.000090929694],"category_scores_gemma":[0.000019156367,0.00016892179,0.0002446099,0.0007873758,0.00011550379,0.00011902152,0.000012327993,0.000049638526,0.0000010474263],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07048532,0.0140562365,0.898048,0.000041928604,0.005772819,0.000015017282,0.0025890758,0.000032435757,0.00007071916,0.000036093155,0.000005472452,0.008846911],"study_design_scores_gemma":[0.2990221,0.0021619976,0.67054003,0.00009662134,0.0020362143,0.0000010521075,0.00014885848,0.00020002127,0.02566407,0.000006887779,0.0000042130337,0.00011795871],"about_ca_topic_score_codex":0.0013085448,"about_ca_topic_score_gemma":0.00040603834,"teacher_disagreement_score":0.22853677,"about_ca_system_score_codex":0.000078017256,"about_ca_system_score_gemma":0.00015799822,"threshold_uncertainty_score":0.6888431},"labels":[],"label_agreement":null},{"id":"W2980420821","doi":"10.1182/blood.v122.21.2928.2928","title":"Adjusting For Drug Wastage In Economic Evaluations Of New Therapies For Hematologic Malignancies: A Systematic Review Of The Literature and Implications","year":2013,"lang":"en","type":"review","venue":"Blood","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Drug; Population; Intensive care medicine; Cancer; Pharmacology; Internal medicine; Environmental health","score_opus":0.308142283419466,"score_gpt":0.454845324250083,"score_spread":0.14670304083061703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980420821","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017770928,0.98042333,0.00024637644,0.0022271487,0.00014259899,0.014478396,0.002232469,0.000011926232,0.000060036105],"genre_scores_gemma":[0.000080536374,0.98936325,0.0032268823,0.0004983557,0.000089584435,0.00621603,0.00011929719,0.000048957518,0.00035710374],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9915051,0.00042456528,0.0072113173,0.00052299374,0.00005307505,0.0002829624],"domain_scores_gemma":[0.98689336,0.0037333667,0.008230355,0.00093212025,0.00013822029,0.00007260997],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.010184457,0.0003365537,0.0047427784,0.00031725873,0.00010998726,0.000050296134,0.00056066917,0.00022269024,0.000031443],"category_scores_gemma":[0.006259528,0.0002758503,0.0006535911,0.00026553078,0.000062715924,0.00018983208,0.00007413618,0.00014360642,0.000020548263],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[4.251274e-7,0.000052331576,0.00007235148,0.9610374,0.0002015538,1.4435215e-8,0.0010380595,0.0000013395686,1.0346242e-7,0.0351116,0.0020631822,0.00042163747],"study_design_scores_gemma":[0.0009803647,0.000050923165,0.00005962805,0.9394817,0.0012784224,0.000024525674,0.00041780705,0.000087324945,0.0000012820087,0.018541746,0.038614273,0.00046201036],"about_ca_topic_score_codex":0.000084924206,"about_ca_topic_score_gemma":0.000053694934,"teacher_disagreement_score":0.03655109,"about_ca_system_score_codex":0.0001919865,"about_ca_system_score_gemma":0.0006235214,"threshold_uncertainty_score":0.99996936},"labels":[],"label_agreement":null},{"id":"W2980431299","doi":"10.1182/blood-2018-99-114176","title":"Saskatoon Urban Hospital Frozen Plasma Utilization and Appropriateness Audit","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Trauma, Hemostasis, Coagulopathy, Resuscitation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Royal University Hospital; Saskatchewan Health Authority; University of Saskatchewan","funders":"","keywords":"Fresh frozen plasma; Medicine; Coagulopathy; Prothrombin complex concentrate; Audit; Warfarin; Emergency medicine; Dosing; Blood transfusion; Intensive care medicine; Surgery; Internal medicine; Platelet","score_opus":0.022700182209728755,"score_gpt":0.26055149649189163,"score_spread":0.23785131428216288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980431299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99481875,0.00031188203,0.0003127381,0.00047010684,0.00037063993,0.00047942973,0.000014397959,0.00015346457,0.0030686138],"genre_scores_gemma":[0.996949,0.00003518259,0.0017866449,0.00010019976,0.0005830561,0.000023494085,0.00007833852,0.000036618374,0.00040747426],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988862,0.000034432305,0.0002218224,0.00035180358,0.00027293473,0.00023276567],"domain_scores_gemma":[0.9992713,0.000032998392,0.000094469615,0.0002760232,0.0001901825,0.00013507468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014285385,0.00015763773,0.00021166366,0.00010194094,0.00010736179,0.00004028635,0.000066851964,0.0001308089,0.000051849445],"category_scores_gemma":[0.00015006545,0.00014497287,0.000037676495,0.00021685941,0.00014105812,0.00015235672,0.000041608826,0.00010099653,0.00010101824],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008816764,0.0039828615,0.7191803,0.00079970644,0.0005469806,0.0001639995,0.013638305,0.0000014076627,0.032280423,0.0017706378,0.010506346,0.21624738],"study_design_scores_gemma":[0.010113903,0.0021379478,0.89449084,0.000223526,0.00050877675,0.00008897649,0.00083143864,0.00061651604,0.08035506,0.00037677854,0.00983927,0.00041696077],"about_ca_topic_score_codex":0.000019676792,"about_ca_topic_score_gemma":0.000045022316,"teacher_disagreement_score":0.21583043,"about_ca_system_score_codex":0.000027154,"about_ca_system_score_gemma":0.00007769789,"threshold_uncertainty_score":0.59118223},"labels":[],"label_agreement":null},{"id":"W2980438022","doi":"10.1182/blood.v118.21.847.847","title":"A Randomized, Double-Blind, Adaptive Phase 2 Multi-Center Study of Prasugrel Compared to Placebo in Adults with Sickle Cell Disease","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Prasugrel; Medicine; Thienopyridine; Internal medicine; Placebo; Clinical endpoint; P2Y12; Data monitoring committee; Randomized controlled trial; Acute coronary syndrome; Clopidogrel; Myocardial infarction; Pathology","score_opus":0.03750654459984658,"score_gpt":0.2802895920574635,"score_spread":0.24278304745761692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980438022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911328,0.00024216609,0.000110259716,0.000044169694,0.00004852055,0.0063667833,0.00001893143,0.00003760133,0.0019987882],"genre_scores_gemma":[0.99862885,0.00002310016,0.0006941399,0.000075270524,0.000017338642,0.00033772347,0.00001808869,0.000031712458,0.00017378612],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99851555,0.00011783427,0.0004531772,0.00035633857,0.00027029947,0.00028678295],"domain_scores_gemma":[0.9989971,0.000046377285,0.00014274834,0.00033824577,0.00012720979,0.00034832992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021416246,0.00022935549,0.00070028356,0.00019773052,0.00003220849,0.000005118305,0.00010832836,0.00006889916,0.00005776625],"category_scores_gemma":[0.00003542695,0.00015555214,0.00009367721,0.00029213878,0.000087327564,0.00005211795,0.000049359933,0.00021379367,0.000028914743],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.88488144,0.07573696,0.016788017,0.00011913351,0.00028443718,0.00036303193,0.021638162,0.000030518164,0.000042864114,0.0000055859764,0.00004085966,0.00006901263],"study_design_scores_gemma":[0.9831937,0.0024758,0.0010763941,0.00047713888,0.0007726399,0.000007775414,0.010668615,0.00050941965,0.0006130861,0.000001592678,0.000012741022,0.00019108018],"about_ca_topic_score_codex":0.00070178433,"about_ca_topic_score_gemma":0.0003425216,"teacher_disagreement_score":0.0983123,"about_ca_system_score_codex":0.000016599784,"about_ca_system_score_gemma":0.000104487684,"threshold_uncertainty_score":0.63432324},"labels":[],"label_agreement":null},{"id":"W2980440810","doi":"10.1182/blood.v104.11.4194.4194","title":"Transgenic Blimp-1 Promoter Directs Hematopoietic Specific Gene Expression in Mice.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Biology; Molecular biology; Promoter; Transfection; Transgene; clone (Java method); Gene; Repressor; Gene expression; Genetics","score_opus":0.02726622442150989,"score_gpt":0.28361040690557887,"score_spread":0.256344182484069,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980440810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936473,0.0010617928,0.00008267489,0.00058332883,0.00007134038,0.0007543117,0.000003245444,0.000071564704,0.0037244365],"genre_scores_gemma":[0.9954782,0.00043891178,0.0019547788,0.00008287132,0.00021038977,0.000056809633,0.000015012641,0.000051722185,0.001711271],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99847585,0.000048693906,0.00026397308,0.00036727055,0.0004201231,0.00042408338],"domain_scores_gemma":[0.9993279,0.000029709781,0.00002958039,0.00039846372,0.000039589824,0.00017478105],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022369043,0.0001666462,0.00029480987,0.00020662487,0.0000360768,0.00002160826,0.0001344138,0.00012449344,0.0015787483],"category_scores_gemma":[0.000016488255,0.00014188455,0.000119221346,0.000351803,0.000053674998,0.000056779973,0.000030942603,0.00030768584,0.00022566039],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017807659,0.0013497116,0.0010695955,0.00009986676,0.000027767454,0.00030213522,0.0011995018,0.0000029075427,0.99433315,0.0000122598,0.000051535528,0.00137349],"study_design_scores_gemma":[0.009210146,0.00028943404,0.004408,0.0002715229,0.0000302442,0.00022194283,0.000040864685,0.0000012438184,0.98290664,0.00028499286,0.002190238,0.00014470186],"about_ca_topic_score_codex":0.000020233356,"about_ca_topic_score_gemma":0.00002118687,"teacher_disagreement_score":0.011426484,"about_ca_system_score_codex":0.00009421247,"about_ca_system_score_gemma":0.00010784612,"threshold_uncertainty_score":0.9993339},"labels":[],"label_agreement":null},{"id":"W2980443893","doi":"10.1182/blood.v112.11.1981.1981","title":"The Unmet Need for Extended Thromboprophylaxis in Acutely Ill Medical Patients: The Findings of IMPROVE, ENDORSE and EXCLAIM.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Foothills Medical Centre; University of Calgary","funders":"","keywords":"Medicine; Population; Venous thromboembolism; Intensive care medicine; Internal medicine; Thrombosis","score_opus":0.01040761004897068,"score_gpt":0.24714055799445628,"score_spread":0.2367329479454856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980443893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953846,0.0005213907,0.000018491535,0.0019243131,0.00015114264,0.0012757021,0.00001650278,0.000016452645,0.0006914387],"genre_scores_gemma":[0.99670064,0.0016491289,0.00025258263,0.0010161952,0.00007673794,0.0001422119,0.000010148479,0.000020162051,0.00013216292],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866533,0.000038606315,0.00035714114,0.00022602003,0.0004238144,0.00028905764],"domain_scores_gemma":[0.99907243,0.00030928632,0.00009228047,0.00031984207,0.00011363969,0.00009254838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040984535,0.0001404498,0.00037594858,0.000064494234,0.00017675658,0.000011182804,0.00018669157,0.00009198567,0.00003479355],"category_scores_gemma":[0.00064594107,0.000074433236,0.000091459406,0.00016951228,0.0002771892,0.00004723464,0.0001190394,0.0001621736,0.0000028081818],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025476916,0.05840472,0.5246839,0.002733093,0.006017059,0.00052696327,0.029990993,0.000003868257,0.019896308,0.046519738,0.080915116,0.22776057],"study_design_scores_gemma":[0.013105834,0.002439808,0.96016574,0.00013300839,0.00039362884,0.000030124176,0.00077990786,0.00006473804,0.008722742,0.00077951996,0.013180188,0.00020476924],"about_ca_topic_score_codex":0.00012613795,"about_ca_topic_score_gemma":0.000053455966,"teacher_disagreement_score":0.43548185,"about_ca_system_score_codex":0.000016767293,"about_ca_system_score_gemma":0.00006897893,"threshold_uncertainty_score":0.30352992},"labels":[],"label_agreement":null},{"id":"W2980451885","doi":"10.1182/blood.v122.21.2723.2723","title":"Bosutinib As Therapy For Chronic Phase Chronic Myeloid Leukemia Following Resistance Or Intolerance To Imatinib: 48-Month Update","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Bosutinib; Medicine; Nilotinib; Internal medicine; Imatinib; Dasatinib; Gastroenterology; Imatinib mesylate; Myeloid leukemia; Tyrosine-kinase inhibitor; Cancer","score_opus":0.01628572101885572,"score_gpt":0.30704614556833904,"score_spread":0.2907604245494833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980451885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788104,0.0095962705,0.00043392018,0.0020266098,0.00047824153,0.0056545855,0.000060693073,0.0003702695,0.0025689634],"genre_scores_gemma":[0.97051257,0.0008416316,0.010050264,0.0019053142,0.0012496546,0.002997859,0.0002006383,0.00021952628,0.012022558],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99631876,0.00006485386,0.00081332546,0.0010229534,0.0005755311,0.0012045657],"domain_scores_gemma":[0.9975806,0.00019082698,0.00025871865,0.0012742829,0.00016133337,0.0005342528],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00030796,0.0006327583,0.0009466191,0.0001713797,0.0002946207,0.00011137052,0.00044270686,0.00023243275,0.0013224384],"category_scores_gemma":[0.00026368498,0.0005061285,0.00041835537,0.00050419895,0.000081857455,0.0003364827,0.000091330745,0.0003364483,0.0013918156],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012009377,0.008436296,0.002362467,0.0029217089,0.0068776584,0.0014807484,0.0044430736,0.00012835494,0.4195716,0.0009471205,0.13390955,0.40691203],"study_design_scores_gemma":[0.251319,0.01097061,0.0036769162,0.0027866901,0.0012835036,0.00025563766,0.00024698733,0.0013700837,0.29680985,0.0006891982,0.42856982,0.0020217034],"about_ca_topic_score_codex":0.00024308193,"about_ca_topic_score_gemma":0.0003642703,"teacher_disagreement_score":0.40489033,"about_ca_system_score_codex":0.0034922077,"about_ca_system_score_gemma":0.003621812,"threshold_uncertainty_score":0.99973905},"labels":[],"label_agreement":null},{"id":"W2980452156","doi":"10.1182/blood.v118.21.676.676","title":"Evaluation of Interventions for Implementation of Thromboprophylaxis in Hospitalized Medical and Surgical Patients At Risk for Venous Thromboembolism: A Systematic Review and Metaanalysis","year":2011,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Jewish General Hospital; Centre Hospitalier de l’Université de Montréal; Health Sciences Centre; McGill University","funders":"","keywords":"Medicine; Psychological intervention; MEDLINE; Randomized controlled trial; Meta-analysis; Intensive care medicine; Venous thromboembolism; Audit; Emergency medicine; Incidence (geometry); Internal medicine; Thrombosis","score_opus":0.06447625227461554,"score_gpt":0.40410169273505075,"score_spread":0.3396254404604352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980452156","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015104041,0.9673429,0.000022919394,0.000012312436,0.000048906022,0.01698895,0.0004498262,0.000007858969,0.000022244747],"genre_scores_gemma":[0.0057772757,0.9887379,0.00024275984,0.000011131505,0.000019439747,0.004641879,0.0005232195,0.000041564836,0.0000048751713],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99585277,0.00058135664,0.0021649338,0.0004545767,0.00072792417,0.00021843101],"domain_scores_gemma":[0.99680275,0.00030314497,0.0017775942,0.00039873683,0.00060645235,0.00011130139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044578733,0.0003287239,0.0063909367,0.00036337395,0.000052616928,0.000007645148,0.00013121421,0.00019565354,0.00015044233],"category_scores_gemma":[0.001073598,0.00024136617,0.0010336338,0.0002937461,0.00008357147,0.000052752726,0.00013213992,0.0001010608,9.200461e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000062065687,0.002118527,0.00027241046,0.9340522,0.006089971,0.0000010166971,0.00016003253,1.5428682e-8,4.661729e-8,0.00010903881,0.00003399005,0.057156537],"study_design_scores_gemma":[0.009054095,0.0024369871,0.005503077,0.46480477,0.5165041,0.000018558329,0.00007457834,0.000012008033,0.000003917161,0.00019046254,0.0010851198,0.00031233917],"about_ca_topic_score_codex":0.00018295336,"about_ca_topic_score_gemma":0.00017989054,"teacher_disagreement_score":0.5104141,"about_ca_system_score_codex":0.0000984819,"about_ca_system_score_gemma":0.00018363027,"threshold_uncertainty_score":0.98426265},"labels":[],"label_agreement":null},{"id":"W2980460186","doi":"10.1182/blood.v118.21.4265.4265","title":"Retrospective Review of Invasive Fungal Disease in a Cohort of Patients with Acute Leukemia","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Internal medicine; Posaconazole; Neutropenia; Acute leukemia; Leukemia; Retrospective cohort study; Fluconazole; Induction chemotherapy; Chemotherapy regimen; Febrile neutropenia; Regimen; Hematopoietic stem cell transplantation; Oncology; Intensive care medicine; Transplantation; Chemotherapy; Amphotericin B; Antifungal","score_opus":0.010733384846135832,"score_gpt":0.23504055355113046,"score_spread":0.22430716870499462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980460186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948218,0.0018197383,0.0000037378377,0.000009332931,0.000010626723,0.00066394213,0.00007032311,0.0000066213483,0.0025938866],"genre_scores_gemma":[0.9977044,0.0018843944,0.00019681542,0.00009304398,0.00000736232,0.000016107926,0.000025068412,0.000008764761,0.00006408299],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990888,0.000030358555,0.00028308036,0.0001968959,0.0002815639,0.000119284785],"domain_scores_gemma":[0.99913865,0.000015591633,0.0001443828,0.00032789973,0.00028124414,0.00009221883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013436312,0.00009349134,0.0004375923,0.00004008748,0.000008941595,5.9483347e-7,0.000060949646,0.000031740907,0.00012874717],"category_scores_gemma":[0.0002782738,0.00006690758,0.00007351956,0.00019719944,0.0001098413,0.000050945207,0.000022743765,0.000100331374,0.0000030666736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008911057,0.00085356133,0.9952477,0.0023827136,0.00015254888,0.00007360011,0.00013689754,9.1837595e-9,0.00012312207,0.0000621687,0.000044047138,0.000032476128],"study_design_scores_gemma":[0.0019946655,0.00049230934,0.98990285,0.0044041057,0.0006912435,7.645754e-7,0.000015710933,1.949535e-7,0.002380507,0.00005135276,0.0000030862993,0.0000631792],"about_ca_topic_score_codex":0.00007796014,"about_ca_topic_score_gemma":0.000068875364,"teacher_disagreement_score":0.0053448696,"about_ca_system_score_codex":0.00006089996,"about_ca_system_score_gemma":0.00036076264,"threshold_uncertainty_score":0.2728412},"labels":[],"label_agreement":null},{"id":"W2980464608","doi":"10.1182/blood-2018-99-116431","title":"Deficiency of Adenosine Deaminase 2 (DADA2) Presenting As Familial Hodgkin Lymphoma","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Hepatosplenomegaly; Medicine; Immunology; Adenosine deaminase deficiency; Immunodeficiency; Lymphoma; Primary immunodeficiency; Adenosine deaminase; Internal medicine; Immune system; Disease; Adenosine","score_opus":0.023937174355385,"score_gpt":0.31204598826292357,"score_spread":0.28810881390753856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980464608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.960906,0.00077372015,0.000021206979,0.000144339,0.00008277787,0.00029693212,0.000014046413,0.000046503057,0.037714444],"genre_scores_gemma":[0.99634445,0.000064865686,0.0005909734,0.00010956287,0.00056708464,0.000011571896,0.0000084378435,0.000028461427,0.002274602],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983409,0.000034871013,0.00031898968,0.0003000222,0.0005741887,0.0004310415],"domain_scores_gemma":[0.9989736,0.000070079775,0.00008234287,0.00041440508,0.00027695968,0.00018257769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027722612,0.00014098643,0.0002958074,0.00019449415,0.0001215871,0.00002189784,0.00017700485,0.00010478121,0.0006298043],"category_scores_gemma":[0.0003544195,0.000121459096,0.0001392771,0.00043058768,0.00026841936,0.00007062605,0.00014481695,0.000108140914,0.00036686042],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015434397,0.009999039,0.24108228,0.0008886546,0.00047455783,0.0011249268,0.0027844866,7.4978226e-7,0.6482328,0.003003948,0.006766965,0.084098116],"study_design_scores_gemma":[0.011500586,0.0026111286,0.21942912,0.00022659688,0.0004233754,0.0005016793,0.00038434193,0.00019869593,0.73643506,0.00030758287,0.027630016,0.00035179642],"about_ca_topic_score_codex":0.0008561035,"about_ca_topic_score_gemma":0.00006899124,"teacher_disagreement_score":0.08820223,"about_ca_system_score_codex":0.000027386213,"about_ca_system_score_gemma":0.0002863045,"threshold_uncertainty_score":0.6895915},"labels":[],"label_agreement":null},{"id":"W2980472943","doi":"10.1182/blood.v112.11.3777.3777","title":"Follicular Non-Hodgkin Lymphoma Grade 3a and 3b Subtypes Exhibit Similar Clinical Behaviour and Treatment Outcome","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Follicular lymphoma; Internal medicine; Biopsy; Cohort; Lymphoma; International Prognostic Index; Cancer; Retrospective cohort study; Diffuse large B-cell lymphoma; Gastroenterology","score_opus":0.052228481596553154,"score_gpt":0.32071763955802535,"score_spread":0.2684891579614722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980472943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952521,0.0028859172,0.0000022012036,0.00083602994,0.000087382134,0.0005668597,0.00002398471,0.000060143484,0.00028538742],"genre_scores_gemma":[0.99435383,0.0035646665,0.00094964635,0.0003880192,0.00017863773,0.00008936703,0.000033291915,0.00003277824,0.00040974043],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845225,0.00005894343,0.00045387744,0.00050823885,0.00022158756,0.0003051066],"domain_scores_gemma":[0.99898833,0.00015292838,0.000090868176,0.0003725378,0.000035071716,0.00036027574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014407103,0.0003008836,0.0006567895,0.00007046085,0.00015545056,0.000021476975,0.000044970893,0.0001698387,0.00002634958],"category_scores_gemma":[0.00004384998,0.00021225524,0.00021103617,0.000081340375,0.00014945329,0.000054096257,0.000051249575,0.00005015934,0.000029076125],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006200266,0.005389774,0.9824979,0.000015706104,0.00038289654,0.0025455595,0.00017777257,7.4196436e-8,0.000058887555,0.00002770729,0.00024059633,0.00860118],"study_design_scores_gemma":[0.02316421,0.0018820749,0.9653773,0.000041706124,0.0014342209,0.0012628075,0.000041693795,0.00001520879,0.0044732033,0.000013468755,0.0020941384,0.0001999961],"about_ca_topic_score_codex":0.00027401972,"about_ca_topic_score_gemma":0.00004113359,"teacher_disagreement_score":0.023102207,"about_ca_system_score_codex":0.000070122944,"about_ca_system_score_gemma":0.000087731576,"threshold_uncertainty_score":0.86555177},"labels":[],"label_agreement":null},{"id":"W2980498207","doi":"10.1182/blood-2018-99-115075","title":"Donor-Specific Isoagglutinin Clearance in ABO Mismatched Stem Cell Transplant Recipients: How Long Should It Normally Take?","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"ABO blood group system; Medicine; Transplantation; Isoantibodies; Immunology; Internal medicine; Antibody; Gastroenterology","score_opus":0.035638868582138244,"score_gpt":0.2570877574890343,"score_spread":0.22144888890689604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980498207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849661,0.00050069654,0.0016957794,0.0016557187,0.0003772665,0.00075906987,0.000039183156,0.00012529737,0.009880864],"genre_scores_gemma":[0.99517673,0.00046107173,0.0012930696,0.00044024154,0.00030912666,0.000044022127,0.00006254489,0.00006905421,0.0021441625],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99753314,0.00010664089,0.0005954929,0.0005960061,0.00054682844,0.0006218609],"domain_scores_gemma":[0.9988363,0.00011384639,0.00014700797,0.000542406,0.00012625777,0.00023420838],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046816422,0.0003306945,0.0005316413,0.00019908059,0.000083379135,0.00004959421,0.00023892797,0.000275406,0.00025451265],"category_scores_gemma":[0.0000062694367,0.00031328294,0.00012663152,0.0004433942,0.00012436317,0.0001639133,0.000014068665,0.00038655917,0.00039363865],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00561763,0.00672817,0.6346581,0.0033528085,0.00042588648,0.0039829332,0.0719541,0.000023069098,0.25923896,0.00029610968,0.005265724,0.008456522],"study_design_scores_gemma":[0.024024814,0.0011727159,0.37416664,0.0030650885,0.00049632613,0.0008625833,0.0019405625,0.00018364898,0.5838711,0.000017645008,0.009270437,0.00092841114],"about_ca_topic_score_codex":0.000030957504,"about_ca_topic_score_gemma":0.00019273814,"teacher_disagreement_score":0.32463217,"about_ca_system_score_codex":0.000056000314,"about_ca_system_score_gemma":0.00009540681,"threshold_uncertainty_score":0.99993193},"labels":[],"label_agreement":null},{"id":"W2980508820","doi":"10.1182/blood-2018-99-111030","title":"Chemogenomic Approach Unveils the Increased Susceptibility of RUNX1-Mutated AML to Glucocorticoids","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"RUNX1; Biology; Transcriptome; Myeloid; Core binding factor; Glucocorticoid receptor; Leukemia; Allele; Myeloid leukemia; Cancer research; Gene; Genetics; Transcription factor; Gene expression","score_opus":0.019347517583490445,"score_gpt":0.2836708683690674,"score_spread":0.26432335078557695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980508820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989483,0.000057050507,0.00013661348,0.00083429215,0.00003550491,0.0013023341,0.000021180409,0.00007391982,0.008056083],"genre_scores_gemma":[0.9956065,0.0000074480804,0.0028246697,0.0005336751,0.00036461046,0.000062076266,0.00003591671,0.000038412112,0.0005266907],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998082,0.00013305199,0.00041534906,0.000430872,0.00045006516,0.0004886814],"domain_scores_gemma":[0.9979737,0.00012516491,0.00009021537,0.0011268483,0.00037541467,0.0003086615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089265214,0.00018840004,0.0003999051,0.0001226778,0.000104367515,0.000017407698,0.00039684697,0.000121604215,0.00028404355],"category_scores_gemma":[0.00068967894,0.00012553057,0.00012112145,0.0006800831,0.00049057644,0.00003875164,0.00022157172,0.0002311972,0.00022885797],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000755891,0.001337643,0.0488785,0.00014918047,0.00030665693,0.00002104014,0.0011044999,0.0000014734114,0.94318944,0.00008823644,0.0024581729,0.0017092375],"study_design_scores_gemma":[0.006600176,0.001150617,0.20098574,0.00003751888,0.00032651026,0.00013300324,0.0005098613,0.00042317505,0.78800184,0.00007826134,0.0015528551,0.00020042088],"about_ca_topic_score_codex":0.0006513218,"about_ca_topic_score_gemma":0.000043746426,"teacher_disagreement_score":0.15518762,"about_ca_system_score_codex":0.00016383153,"about_ca_system_score_gemma":0.0005864392,"threshold_uncertainty_score":0.51189876},"labels":[],"label_agreement":null},{"id":"W2980512717","doi":"10.1182/blood.v108.11.878.878","title":"A Pilot Study of Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombois of the Upper Extremity (UEDVT).","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Central Venous Catheters and Hemodialysis","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; Queen Elizabeth II Health Sciences Centre; Ottawa Hospital; Victoria Hospital","funders":"","keywords":"Medicine; Warfarin; Catheter; Surgery; Central venous catheter; Heparin; Internal medicine","score_opus":0.03684966998997421,"score_gpt":0.3207270907456933,"score_spread":0.2838774207557191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980512717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99627984,0.00052703713,0.00005356699,0.00002885903,0.00036144778,0.0025404592,0.00013293157,0.0000065767235,0.00006928558],"genre_scores_gemma":[0.99952626,0.000077657496,0.00006289797,0.000016834963,0.00008153858,0.00017085331,0.000010926978,0.000029275132,0.000023742756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99784577,0.00032805343,0.00072529167,0.00026022608,0.00032945428,0.0005111825],"domain_scores_gemma":[0.9986252,0.00022683368,0.00046000213,0.00048828934,0.00015586322,0.000043785425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020206242,0.0001991036,0.0005840923,0.000063133004,0.00024901817,0.0000036034326,0.0002459881,0.00006866198,0.000038635822],"category_scores_gemma":[0.00001908278,0.00011793758,0.0002367048,0.0002314779,0.00007286699,0.000032290478,0.000067396424,0.00013580253,4.496008e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023080807,0.043741226,0.94197047,0.00011349102,0.00026547498,0.0000010346056,0.008911485,0.00051437237,0.0037648187,0.000032485055,0.0000048086813,0.00044950985],"study_design_scores_gemma":[0.009345897,0.0028759798,0.9759951,0.00012805371,0.0009906315,2.0361415e-7,0.00090688333,0.00077918946,0.008668921,0.00009253503,0.000047273286,0.00016929989],"about_ca_topic_score_codex":0.046405908,"about_ca_topic_score_gemma":0.032522656,"teacher_disagreement_score":0.040865246,"about_ca_system_score_codex":0.00022692986,"about_ca_system_score_gemma":0.00017401608,"threshold_uncertainty_score":0.98513126},"labels":[],"label_agreement":null},{"id":"W2980523720","doi":"10.1182/blood.v108.11.4223.4223","title":"PBI-1402: A New Candidate for the Treatment of Anemia.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Bone marrow; Medicine; Anemia; Pharmacology; Haematopoiesis; Progenitor cell; Myeloid; Hemoglobin; Ex vivo; Reticulocyte; Internal medicine; Cancer research; In vivo; Stem cell; Chemistry; Biology; Biochemistry","score_opus":0.0170912429959987,"score_gpt":0.2592804998093927,"score_spread":0.242189256813394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980523720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923092,0.0021575266,0.0003888963,0.0012494418,0.00021469155,0.0005310015,0.000023259832,0.0000328151,0.003093141],"genre_scores_gemma":[0.9757772,0.0005452036,0.0011318487,0.0004557316,0.0012349867,0.000055875575,0.000084720465,0.000016428605,0.02069802],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.999666,0.0000065343756,0.00010171362,0.000087414315,0.000043187647,0.000095197465],"domain_scores_gemma":[0.9996779,0.00007073137,0.00003647703,0.00015925574,0.000024565603,0.00003108653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00001806651,0.000060399754,0.00013661232,0.000018945455,0.000031675434,0.0000017781899,0.000021696185,0.000037372494,0.00010566216],"category_scores_gemma":[0.0000072315993,0.000033652006,0.000078418925,0.00004713015,0.00002458545,0.0000067601877,0.0000026137138,0.000018969677,0.000012399064],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006027462,0.013256673,0.051546548,0.00040581703,0.0014560759,0.00010852824,0.002178016,0.000115227405,0.6442938,0.0055097835,0.19089185,0.08421024],"study_design_scores_gemma":[0.027036754,0.0075421426,0.08959099,0.00003884913,0.0018166617,0.0001304166,0.00012627232,0.0000940567,0.19610205,0.0007721296,0.676583,0.00016666632],"about_ca_topic_score_codex":0.0006119812,"about_ca_topic_score_gemma":0.00012233897,"teacher_disagreement_score":0.48569116,"about_ca_system_score_codex":0.000010130171,"about_ca_system_score_gemma":0.000064370535,"threshold_uncertainty_score":0.13722889},"labels":[],"label_agreement":null},{"id":"W2980543393","doi":"10.1182/blood.v122.21.2609.2609","title":"Disease Characteristics and Prognostic Implications Of Cell Surface FLT3 Receptor (CD135) Expression In Pediatric Acute Myeloid Leukemia – A Report From Children’s Oncology Group","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Oncology; Myeloid leukemia; Medicine; Population; Internal medicine; Leukemia; Cancer research; Immunology","score_opus":0.00988660560107224,"score_gpt":0.2616738076224849,"score_spread":0.25178720202141264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980543393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962933,0.00060338835,0.00007415517,0.00070147373,0.000060942446,0.0017096469,0.00022642889,0.000056549983,0.0002740963],"genre_scores_gemma":[0.98973805,0.0015574174,0.0068625477,0.00007886305,0.00028035554,0.00018389364,0.0010042301,0.000048551006,0.00024611907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99790525,0.00012130057,0.00067216175,0.0005803081,0.0003022215,0.00041873424],"domain_scores_gemma":[0.9979707,0.00033718397,0.00033691677,0.0006664643,0.000201469,0.00048724507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021804507,0.00023341249,0.00052345276,0.00017373126,0.0000638288,0.000023298968,0.00019913532,0.000217067,0.00017198907],"category_scores_gemma":[0.00050446676,0.00020550913,0.00007357197,0.00032669373,0.00011283461,0.00014330707,0.00023493919,0.00046389707,0.0000663794],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011409014,0.00076452084,0.7660224,0.00008863004,0.00004438024,0.0001394157,0.00016186183,3.816744e-7,0.23062117,0.0000038739295,0.0015319302,0.000507364],"study_design_scores_gemma":[0.0036570013,0.00026438772,0.98636246,0.00006115184,0.00047878,0.00009746431,0.000036053498,0.000050011397,0.008613384,0.000071944705,0.00012349257,0.0001838551],"about_ca_topic_score_codex":0.00042886502,"about_ca_topic_score_gemma":0.000010933441,"teacher_disagreement_score":0.2220078,"about_ca_system_score_codex":0.000292336,"about_ca_system_score_gemma":0.00089288095,"threshold_uncertainty_score":0.8380419},"labels":[],"label_agreement":null},{"id":"W2980553245","doi":"10.1182/blood.v118.21.544.544","title":"Predicting Disease Recurrence in Patients with Previous Unprovoked Venous Thromboembolism: The DASH Prediction Score","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Vitamin K antagonist; Pulmonary embolism; Prospective cohort study; Clinical prediction rule; Proportional hazards model; Disease; Internal medicine; Anticoagulant therapy; Surgery; Warfarin","score_opus":0.018821357334766853,"score_gpt":0.2161189998362004,"score_spread":0.19729764250143353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980553245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99394125,0.00038102843,0.000016996695,0.0000966202,0.00021950276,0.0020824368,0.00003167905,0.00012371258,0.0031067524],"genre_scores_gemma":[0.998897,0.00015823453,0.00015700524,0.00026906436,0.00013756237,0.00024510798,0.000062935374,0.000038473194,0.000034610166],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831396,0.00006685146,0.0003375911,0.00043178783,0.00044989242,0.00039991335],"domain_scores_gemma":[0.99892265,0.000028669021,0.00014893294,0.0006027099,0.000109596316,0.00018743424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002293313,0.00022673765,0.00041846122,0.000101922524,0.00015083817,0.000025667763,0.000205217,0.000058732934,0.00006700695],"category_scores_gemma":[0.00009659272,0.0001467965,0.000064736,0.00031469742,0.0001099595,0.00015951917,0.00010458351,0.0002537021,0.00002010004],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017826159,0.007464266,0.9870625,0.0001668145,0.00017636741,0.000041559153,0.0020915482,0.00000618388,0.000004225908,0.00019340341,0.00021030808,0.0024045622],"study_design_scores_gemma":[0.0037596382,0.001251086,0.99272805,0.0006531624,0.00092578074,0.000003561436,0.00014829071,0.00003978095,0.000083233565,0.00012898345,0.00012837532,0.00015003145],"about_ca_topic_score_codex":0.00016529488,"about_ca_topic_score_gemma":0.000053788932,"teacher_disagreement_score":0.0062131803,"about_ca_system_score_codex":0.000046489302,"about_ca_system_score_gemma":0.00010210309,"threshold_uncertainty_score":0.5986188},"labels":[],"label_agreement":null},{"id":"W2980554880","doi":"10.1182/blood-2018-99-112210","title":"Venetoclax in Combination with NAMPT Inhibitors Decreases Mitochondrial Bioenergetics through the Impaired AMPK/SIRT/PGC1α Signaling Pathway in CLL","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Calcium signaling and nucleotide metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Boniface Hospital; University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"","keywords":"AMPK; NAD+ kinase; Cancer research; SIRT3; Biology; Cell biology; Signal transduction; Mitochondrion; Bioenergetics; Venetoclax; PPARGC1A; Sirtuin 1; Chronic lymphocytic leukemia; Coactivator; Protein kinase A; Sirtuin; Biochemistry; Kinase; Downregulation and upregulation; Transcription factor; Leukemia; Immunology; Enzyme","score_opus":0.009702996695646863,"score_gpt":0.228413405950567,"score_spread":0.21871040925492014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980554880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997942,0.0008849666,0.0002732817,0.00011296004,0.00032622184,0.00028439914,0.00001079271,0.000019742562,0.00014565855],"genre_scores_gemma":[0.9977401,0.000043402968,0.0009458115,0.00019487478,0.0008702515,0.000039982195,0.00007586171,0.0000360684,0.000053644908],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985762,0.00016930464,0.0003239348,0.00038092368,0.0002152285,0.00033437475],"domain_scores_gemma":[0.9993413,0.000041074007,0.000116907504,0.00034155804,0.00010032751,0.00005879898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023827124,0.00021030763,0.00020370146,0.00007181662,0.000104969724,0.000049954084,0.00023184996,0.0001700925,0.000011469414],"category_scores_gemma":[0.00014101857,0.00015681304,0.00007901776,0.00030203682,0.00019910609,0.000009222457,0.00008288031,0.00014610332,0.000005788589],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034043525,0.00046927272,0.0058417064,0.000013184027,0.000047310597,0.000016369871,0.0006361181,0.00033421215,0.99138284,0.0002193315,0.00027227646,0.0004269541],"study_design_scores_gemma":[0.0041836067,0.0007342532,0.001657215,0.00008137508,0.000037110694,0.000020205376,0.00026265424,0.00008866457,0.98598844,0.00036721225,0.0062990496,0.0002802271],"about_ca_topic_score_codex":0.00056533434,"about_ca_topic_score_gemma":0.00097137317,"teacher_disagreement_score":0.006026773,"about_ca_system_score_codex":0.00002309004,"about_ca_system_score_gemma":0.00016792084,"threshold_uncertainty_score":0.63946503},"labels":[],"label_agreement":null},{"id":"W2980570857","doi":"10.1182/blood.v112.11.3362.3362","title":"Hoxa9 and Meis1 Bind Highly Conserved Elements Near Targets Regulated in Leukemia Cells.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"","keywords":"Chromatin immunoprecipitation; Biology; Chromatin; Transcription factor; Genetics; Sequence motif; Gene; Computational biology; Molecular biology; Promoter; Gene expression","score_opus":0.007852165198117822,"score_gpt":0.20050237427109874,"score_spread":0.19265020907298092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980570857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99845827,0.00085675914,0.000008889787,0.000081650694,0.000062177176,0.00016548682,0.000011028473,0.000012498173,0.000343215],"genre_scores_gemma":[0.9975299,0.0003011478,0.00095798465,0.0001947297,0.000051622115,0.000011721113,0.00010230957,0.000013693773,0.00083686324],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992489,0.000043207423,0.00019476908,0.00024864456,0.0000867156,0.00017774453],"domain_scores_gemma":[0.9996531,0.0000037023785,0.000057715155,0.00018474965,0.000031994365,0.00006874414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000085299806,0.000111930036,0.000106495245,0.000033392826,0.00007592427,0.0000144079695,0.000081801234,0.00012511306,0.000020181189],"category_scores_gemma":[0.000029328963,0.000110646615,0.000029378347,0.0000798386,0.00008868396,0.0000041473554,0.000062536696,0.00006525001,0.000010904748],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032630636,0.000104121405,0.020869408,0.000008784683,0.000029819079,0.000014866276,0.000046550642,0.0000039451,0.9754222,0.0000096144595,0.0033120147,0.00014603979],"study_design_scores_gemma":[0.0024404814,0.00012557543,0.016426219,0.000009517955,0.000009002385,0.000015740827,0.000010165272,0.000048496677,0.9557993,0.000013073719,0.024954824,0.00014759599],"about_ca_topic_score_codex":0.0000504043,"about_ca_topic_score_gemma":0.000036854777,"teacher_disagreement_score":0.02164281,"about_ca_system_score_codex":0.000009950837,"about_ca_system_score_gemma":0.00009518068,"threshold_uncertainty_score":0.4512038},"labels":[],"label_agreement":null},{"id":"W2980576503","doi":"10.1182/blood.v120.21.3237.3237","title":"Vitamin D and Zinc Deficiency Associated with Increased Pain Episodes in Children with Sickle Cell Disease","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"","keywords":"Medicine; Anemia; Pediatrics; Emergency department; Disease; Vitamin B12; Internal medicine; Vitamin D and neurology; Malnutrition","score_opus":0.0034749913158290523,"score_gpt":0.1836931031818787,"score_spread":0.18021811186604966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980576503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99567693,0.0024729832,0.000021781092,0.000121906145,0.000006983063,0.0004129318,0.000013267538,0.000054299722,0.0012189235],"genre_scores_gemma":[0.9993097,0.000076954544,0.00015334752,0.00024595496,0.000021869368,0.000018836206,0.000061909006,0.000026976424,0.00008443644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989796,0.000104435516,0.00013953284,0.00019576208,0.00019214457,0.00038852228],"domain_scores_gemma":[0.99935603,0.00006536746,0.0000588834,0.00016675188,0.000027382282,0.0003255935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037663194,0.00016204378,0.0002141464,0.00008253608,0.00006655566,0.000011707434,0.00004284975,0.00008580406,0.000020348687],"category_scores_gemma":[0.00013350879,0.00010614558,0.000024608493,0.00027682242,0.00010488263,0.00007970646,0.000019919906,0.00017929455,0.000006163646],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000088363944,0.0023295914,0.99655557,0.00003648511,0.000053903357,0.000029454975,0.00023865564,0.0000031733657,0.0002567045,0.000022349695,0.000037493814,0.00034827375],"study_design_scores_gemma":[0.0075318567,0.00043177343,0.99051356,0.00018685812,0.00041887764,0.000029082736,0.0002506325,0.000045836794,0.00037343564,0.000009793691,0.000021432112,0.00018682919],"about_ca_topic_score_codex":0.00019979729,"about_ca_topic_score_gemma":0.000040341078,"teacher_disagreement_score":0.0074434928,"about_ca_system_score_codex":0.000021659338,"about_ca_system_score_gemma":0.0000877018,"threshold_uncertainty_score":0.4328491},"labels":[],"label_agreement":null},{"id":"W2980576711","doi":"10.1182/blood.v110.11.799.799","title":"Design and Development of Small Molecules for Specific Targeted Therapy of Diffuse Large B-Cell Lymphoma.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Corepressor; BCL6; Biology; Repressor; Small molecule; Transcription factor; Transactivation; Binding site; Cell biology; Chemistry; Genetics; Cancer research; Molecular biology; Gene; B cell; Germinal center","score_opus":0.030211249422522648,"score_gpt":0.24566981219154818,"score_spread":0.21545856276902553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980576711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97373635,0.00626435,0.0190996,0.00001862822,0.000023696184,0.0006781823,0.0000100115585,0.000014377594,0.00015479313],"genre_scores_gemma":[0.86094815,0.0005689528,0.13831702,0.000043530297,0.000018180368,0.000035506222,0.000022736875,0.000016563457,0.000029351397],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992107,0.000013121104,0.0002924769,0.00016803086,0.000117752075,0.00019791596],"domain_scores_gemma":[0.99945545,0.0001322842,0.000104257466,0.00015186337,0.00007611676,0.00008004851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022194926,0.00012451799,0.00026755457,0.00007370127,0.00003442778,0.0000036463566,0.00004153955,0.00005750423,0.000009125499],"category_scores_gemma":[0.000008732697,0.00009384442,0.000053148065,0.00006354071,0.000027425898,0.000011536834,0.000015188906,0.000012167721,0.0000016430131],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003570497,0.16120145,0.12352217,0.0006438547,0.0017922043,0.00019394896,0.007841725,0.0000024194244,0.5211676,0.00090231496,0.00046574537,0.17869613],"study_design_scores_gemma":[0.04829396,0.0005068638,0.08691761,0.000042910546,0.000058829493,0.000008126031,0.00010961513,0.000011598558,0.86056733,0.00002041197,0.0033793116,0.00008345237],"about_ca_topic_score_codex":0.000004464779,"about_ca_topic_score_gemma":0.0000027266042,"teacher_disagreement_score":0.33939976,"about_ca_system_score_codex":0.000023195393,"about_ca_system_score_gemma":0.000094432726,"threshold_uncertainty_score":0.38268644},"labels":[],"label_agreement":null},{"id":"W2980591051","doi":"10.1182/blood.v118.21.5099.5099","title":"Discrepancies in Serum Free Light Chain Assays and Immunofixation for Response Evaluation and Prognostication in Plasma Cell Proliferative Disorders","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"B.C. Women's Hospital & Health Centre","funders":"","keywords":"Immunofixation; Multiple myeloma; Monoclonal gammopathy of undetermined significance; Medicine; Serum protein electrophoresis; Context (archaeology); Internal medicine; Monoclonal; Plasma cell; Macroglobulinemia; Population; Plasma cell dyscrasia; Immunoglobulin light chain; Gastroenterology; Immunology; Antibody; Monoclonal antibody; Biology","score_opus":0.029206837937792895,"score_gpt":0.2917082573160104,"score_spread":0.2625014193782175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980591051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995187,0.00036558686,0.000038424943,0.0010431042,0.000010958206,0.0028839235,0.00002076658,0.000012253323,0.00043798832],"genre_scores_gemma":[0.99697894,0.00007430026,0.0018690362,0.0000073026476,0.000010532311,0.0009310969,0.000045687357,0.000010512281,0.00007258947],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991003,0.0001760569,0.00016468433,0.00021278925,0.0001740731,0.000172058],"domain_scores_gemma":[0.9994979,0.00018247226,0.000050251187,0.0001397424,0.000074407995,0.000055241955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076502725,0.000092459,0.0001284133,0.00017355093,0.000045640452,0.000013282885,0.000029987094,0.0000565846,0.000006942431],"category_scores_gemma":[0.0012904278,0.00007557179,0.000014007171,0.000115420546,0.00003734051,0.00011838338,0.000027122453,0.00006488987,0.0000012227872],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058534094,0.0017318364,0.9518541,0.00015386158,0.00005627339,0.000008642401,0.009137355,6.1924686e-7,0.02015049,0.00018163786,0.0000073683796,0.010864414],"study_design_scores_gemma":[0.016404483,0.0009202196,0.93526435,0.00007737775,0.00006698856,0.0000047953217,0.00057122245,0.0044201086,0.04121252,0.0009592708,0.000024503395,0.000074134674],"about_ca_topic_score_codex":0.00014545736,"about_ca_topic_score_gemma":0.0011771945,"teacher_disagreement_score":0.021062031,"about_ca_system_score_codex":0.00004689121,"about_ca_system_score_gemma":0.00010554778,"threshold_uncertainty_score":0.30817282},"labels":[],"label_agreement":null},{"id":"W2980607362","doi":"10.1182/blood.v118.21.1260.1260","title":"The Influence of Bleeding on Trigger Changes for Platelet Transfusion in Chemotherapy-Induced Thrombocytopenic Patients","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Platelet transfusion; Platelet; Internal medicine; Transfusion medicine; Hematology; Chemotherapy; Population; Blood transfusion; Surgery","score_opus":0.035938626489297174,"score_gpt":0.27078325994329205,"score_spread":0.23484463345399487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980607362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99769694,0.000071119095,5.8583333e-7,0.00034412585,0.00003952907,0.0012679154,0.000007992464,0.0000103945285,0.0005613737],"genre_scores_gemma":[0.9986229,0.00076223584,0.000092559996,0.00020364815,0.000026426154,0.00024941063,0.0000056844997,0.000015590138,0.000021566919],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99927646,0.000018966226,0.00019564814,0.00017911186,0.00015264913,0.00017717511],"domain_scores_gemma":[0.9995076,0.00014406085,0.00007398417,0.00015550437,0.00007785294,0.00004099792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013360266,0.00012255834,0.00025780877,0.00005991772,0.00006529478,0.0000051018706,0.00006540344,0.00006394387,0.000024889008],"category_scores_gemma":[0.000044843287,0.0000725705,0.00005738535,0.000102198544,0.000023743161,0.000031439635,0.000007742553,0.0000732655,0.0000033923998],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047333688,0.013841467,0.8072362,0.0002774766,0.00080950605,0.000024895458,0.016283054,0.0000036347756,0.08944622,0.0015970126,0.000102299746,0.06564487],"study_design_scores_gemma":[0.009931811,0.0025052675,0.49167392,0.00017894902,0.000059562368,0.0000015261644,0.00005857566,0.0000029701666,0.49524972,0.000051068087,0.00022261335,0.00006403422],"about_ca_topic_score_codex":0.00005988433,"about_ca_topic_score_gemma":0.0001157386,"teacher_disagreement_score":0.4058035,"about_ca_system_score_codex":0.00002332525,"about_ca_system_score_gemma":0.000028522098,"threshold_uncertainty_score":0.29593393},"labels":[],"label_agreement":null},{"id":"W2980612146","doi":"10.1182/blood.v118.21.903.903","title":"Ferritin-H and a Phytotherapeutic, Alone or Combined, Reprogram RBC Precursor Cells From SCD Patients to Produce Levels of Fetal Hemoglobin That Constitute a Phenotypic Cure for Sickle Cell As Well As Providing Resistance to Malaria and a Probable Treatment for Beta-Thalassemia","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; Cure Foundation","funders":"","keywords":"Biology; Fetal hemoglobin; Globin; Phenotype; Transgene; Fetus; Hemoglobinopathy; Ferritin; Immunology; In vivo; Gene; Molecular biology; Hemolytic anemia; Genetics; Biochemistry","score_opus":0.030821208722685203,"score_gpt":0.25713862125436193,"score_spread":0.22631741253167673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980612146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98376703,0.0014913791,0.0001592195,0.00089228404,0.00013025998,0.0116500035,0.00039271425,0.00007076523,0.0014463534],"genre_scores_gemma":[0.9615791,0.000097142154,0.03255614,0.00034107856,0.000051519484,0.0008830602,0.000055162403,0.00007152516,0.004365269],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978904,0.000042456544,0.0004569152,0.0008598868,0.00023515978,0.00051516894],"domain_scores_gemma":[0.9986959,0.00011125182,0.00021879276,0.00044023915,0.00020482429,0.00032900463],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019402105,0.00038816573,0.00073356845,0.00009301212,0.00015365676,0.0000457814,0.00011773089,0.0002033956,0.000040683055],"category_scores_gemma":[0.000081019796,0.00029842518,0.00011655186,0.00019137569,0.00011217034,0.0001046685,0.0000658946,0.000106577776,0.00001555745],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.107606746,0.0594979,0.14498675,0.013750294,0.0069271373,0.0002730233,0.038044006,0.000017880559,0.5765478,0.0023748036,0.009405822,0.04056786],"study_design_scores_gemma":[0.032050073,0.011513674,0.0024711776,0.0011049771,0.0017927755,0.000019955003,0.00075488054,0.000024359955,0.9330854,0.00068779144,0.015939493,0.0005554448],"about_ca_topic_score_codex":0.00015783713,"about_ca_topic_score_gemma":0.00015954842,"teacher_disagreement_score":0.3565376,"about_ca_system_score_codex":0.00005533315,"about_ca_system_score_gemma":0.00024853292,"threshold_uncertainty_score":0.9999468},"labels":[],"label_agreement":null},{"id":"W2980616290","doi":"10.1182/blood.v104.11.4.4","title":"Gain-of-Function NOTCH1 Mutations Occur Frequently in Human T Cell Acute Lymphoblastic Leukemia.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Frameshift mutation; Biology; Transmembrane domain; Protein subunit; Mutation; Transmembrane protein; Extracellular; Molecular biology; Missense mutation; Genetics; Cell biology; Gene; Receptor","score_opus":0.00847657444441641,"score_gpt":0.23907959427245323,"score_spread":0.23060301982803683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980616290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933908,0.0003236839,0.0040119616,0.00002419236,0.00005979961,0.00011143204,0.00002682075,0.00000793385,0.0020433567],"genre_scores_gemma":[0.9989208,0.00006112948,0.0004080817,0.00006795868,0.00006890936,0.000039998053,0.00016431243,0.000012476,0.00025631877],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993928,0.000015238537,0.00018519271,0.00020180397,0.000073403266,0.00013158153],"domain_scores_gemma":[0.9995988,0.0000037863756,0.00007313896,0.00023841464,0.000050740677,0.000035144847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004899002,0.000087307206,0.0000862167,0.00005260129,0.000054407876,0.000009598891,0.00010093046,0.000088673536,0.000015350515],"category_scores_gemma":[0.000009939293,0.00009087525,0.00005372874,0.00011440614,0.000043491586,0.0000039344445,0.000021002652,0.000046788908,0.000010575356],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011695028,0.00023643304,0.0009865228,0.000011282132,0.000033203924,0.0000027267315,0.000052072857,0.0025156424,0.99553347,0.000424473,0.000059242408,0.00013321155],"study_design_scores_gemma":[0.0030991172,0.00028354995,0.008152927,0.000018681889,0.00010557984,0.000007569391,0.00007285258,0.00001586778,0.98649365,0.0007791023,0.0008107799,0.00016031228],"about_ca_topic_score_codex":0.00011555662,"about_ca_topic_score_gemma":0.0000815897,"teacher_disagreement_score":0.009039834,"about_ca_system_score_codex":0.000039463826,"about_ca_system_score_gemma":0.00018144926,"threshold_uncertainty_score":0.37057853},"labels":[],"label_agreement":null},{"id":"W2980630697","doi":"10.1182/blood-2018-99-110247","title":"Thrombin Generation Impairments in Platelet Function Disorders","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University Medical Centre; Hamilton Regional Laboratory Medicine Program; Centre Hospitalier Universitaire Sainte-Justine; McMaster University","funders":"","keywords":"Platelet; Medicine; Platelet disorder; Thrombin; Immunology; Population; Internal medicine; Bioinformatics; Biology","score_opus":0.012503804111447142,"score_gpt":0.2506227894704366,"score_spread":0.23811898535898945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980630697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99517393,0.00013071511,0.000054886117,0.0001813836,0.00016804604,0.00029090713,0.0000030782871,0.000040301373,0.0039567417],"genre_scores_gemma":[0.99903774,0.000070206595,0.00015718488,0.00021407154,0.00012931941,0.000022940498,0.000099241246,0.000013640249,0.0002556487],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993641,0.00001515647,0.00013349818,0.00018857673,0.00011981445,0.00017886503],"domain_scores_gemma":[0.9997603,0.000005180383,0.000030352587,0.00013406423,0.00002074874,0.000049306836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000055167027,0.00009797431,0.0001459439,0.0000818182,0.000053508524,0.000009970111,0.00002463615,0.00006698292,0.00017013741],"category_scores_gemma":[0.000011190572,0.00008446009,0.00003585752,0.0001456273,0.00003096719,0.000079372585,0.000011553442,0.000059264883,0.00017641606],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006524273,0.013664147,0.84644926,0.00006716793,0.0007704008,0.0009739942,0.001205355,0.0000074066897,0.07874584,0.00023383224,0.006744791,0.050485373],"study_design_scores_gemma":[0.05059345,0.0069568036,0.885276,0.00011529,0.00048410767,0.00067760586,0.00022857373,0.0013320249,0.045833744,0.0027478451,0.0052338047,0.00052075187],"about_ca_topic_score_codex":0.0001228084,"about_ca_topic_score_gemma":0.0004503844,"teacher_disagreement_score":0.049964618,"about_ca_system_score_codex":0.000024186764,"about_ca_system_score_gemma":0.000027245524,"threshold_uncertainty_score":0.34441826},"labels":[],"label_agreement":null},{"id":"W2980644984","doi":"10.1182/blood.v122.21.460.460","title":"Predictors Of The Post-Thrombotic Syndrome In a Large Cohort Of Patients With Proximal DVT: Secondary Analysis Of The Sox Trial","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St Mary's Hospital Centre; University of Toronto; Hamilton General Hospital; Centre hospitalier universitaire de Québec; St. Boniface Hospital; Université de Montréal; Hôpital Notre-Dame; McMaster University; Thrombosis and Atherosclerosis Research Institute; Hôpital Maisonneuve-Rosemont; Health Sciences Centre; Hôpital du Sacré-Cœur de Montréal; St. Joseph's Hospital; Ottawa Hospital; Victoria Heart Institute Foundation; University Health Network; University of Ottawa; Dalhousie University; University of Manitoba; Jewish General Hospital; Montreal General Hospital; Sunnybrook Health Science Centre; McGill University; London Health Sciences Centre","funders":"","keywords":"Medicine; Post-thrombotic syndrome; Cumulative incidence; Hazard ratio; Cohort; Internal medicine; Body mass index; Placebo; Surgery; Proportional hazards model; Clinical endpoint; Thrombosis; Confidence interval; Deep vein; Incidence (geometry); Pulmonary embolism; Randomized controlled trial","score_opus":0.003988035565847252,"score_gpt":0.19985598723703496,"score_spread":0.1958679516711877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980644984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963318,0.0000400719,0.0000010543629,0.00013664179,0.00010014545,0.002762308,0.0000911347,0.0000064488345,0.000530376],"genre_scores_gemma":[0.9996833,0.000007131184,0.000027803937,0.00009059517,0.000013049958,0.00009448091,0.000026327987,0.000013773394,0.000043490465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853534,0.00008156573,0.00049554306,0.0001863538,0.0005033404,0.00019785584],"domain_scores_gemma":[0.99884117,0.000041885956,0.00034514596,0.0005572983,0.00017324611,0.000041240706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023242059,0.0001261338,0.00076197233,0.00017423232,0.000029154582,0.0000043777827,0.00021421422,0.000059231592,0.00029649705],"category_scores_gemma":[0.000078924866,0.00006407601,0.00023376569,0.0007677997,0.00012014037,0.000056454937,0.00013482128,0.0001275776,0.0000012591789],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025033447,0.0059330026,0.98963815,0.00016240348,0.0032282653,0.0000013546396,0.00048239282,0.000013952476,0.00011811271,0.00006447663,0.00007394404,0.000033605284],"study_design_scores_gemma":[0.019572929,0.0011516579,0.9722777,0.00013453966,0.0060087866,7.2437854e-7,0.00012069129,0.0000235471,0.000628459,0.000008471392,0.000011274391,0.000061193095],"about_ca_topic_score_codex":0.00041732832,"about_ca_topic_score_gemma":0.00021129931,"teacher_disagreement_score":0.019322595,"about_ca_system_score_codex":0.000018077793,"about_ca_system_score_gemma":0.00011068899,"threshold_uncertainty_score":0.32464346},"labels":[],"label_agreement":null},{"id":"W2980658977","doi":"10.1182/blood.v118.21.437.437","title":"Inactivating Gene Alterations of MHC Class II Transactivator CIITA Are Recurrent in Primary Mediastinal B Cell Lymphoma and Hodgkin Lymphoma","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"CIITA; Biology; Cancer research; Gene; Genetics; Major histocompatibility complex; MHC class II","score_opus":0.021998688649079792,"score_gpt":0.22247436524657035,"score_spread":0.20047567659749055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980658977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99536306,0.0011891861,0.000025563842,0.00013888412,0.00008839104,0.00043575824,0.00004810887,0.000029643577,0.0026814006],"genre_scores_gemma":[0.99629205,0.00021914438,0.0030774206,0.00011912899,0.0000798664,0.00011820364,0.000036809564,0.000026778338,0.00003058365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859947,0.00005892906,0.00044487423,0.00036264115,0.0002568461,0.00027725013],"domain_scores_gemma":[0.9991732,0.00010825598,0.0002081627,0.0002680716,0.00007418285,0.00016809555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001233473,0.00023317557,0.00046466143,0.00017072575,0.00009297667,0.00000952381,0.00007526519,0.00010675043,0.000045354052],"category_scores_gemma":[0.0000418932,0.00020144435,0.00008870799,0.00021484465,0.000073595555,0.00011962204,0.000046586232,0.0000548135,0.0000030277477],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009292433,0.041636456,0.777426,0.000711607,0.0004375212,0.0006377916,0.008433613,0.0000011405721,0.06376986,0.00017161074,0.00017583696,0.10566932],"study_design_scores_gemma":[0.015082177,0.00089977926,0.6781262,0.00031894736,0.00024059358,0.00012319496,0.00025907677,0.000025623638,0.30464253,0.000027484484,0.00009869403,0.00015566935],"about_ca_topic_score_codex":0.00018425693,"about_ca_topic_score_gemma":0.000048223337,"teacher_disagreement_score":0.24087267,"about_ca_system_score_codex":0.00017552923,"about_ca_system_score_gemma":0.00023331323,"threshold_uncertainty_score":0.8214662},"labels":[],"label_agreement":null},{"id":"W2980665363","doi":"10.1182/blood-2018-99-116796","title":"Mechanical Loading Shows Anti-Myeloma Effects While Rescuing Bone Loss with Net Bone Formation in a Myeloma Bone Disease Murine Model","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Children's Hospital","funders":"","keywords":"Bone resorption; Medicine; Bone remodeling; Bone marrow; Multiple myeloma; Osteolysis; Bone disease; Resorption; In vivo; Pathology; Bone healing; Internal medicine; Osteoporosis; Anatomy; Surgery; Biology","score_opus":0.01951311393566581,"score_gpt":0.27192125542878354,"score_spread":0.25240814149311774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980665363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99510133,0.00053307717,0.0016454359,0.0004287684,0.000042494645,0.0014306764,0.000039530678,0.00015387774,0.0006247881],"genre_scores_gemma":[0.99436295,0.000063520674,0.0044316724,0.00015918158,0.0002710404,0.00020064366,0.00016015761,0.00007013721,0.00028069582],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99715054,0.000108129636,0.0004805913,0.00058239844,0.00079191977,0.0008864282],"domain_scores_gemma":[0.9982313,0.00010660869,0.00012924122,0.0006257146,0.00017053793,0.00073661463],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003412994,0.000364756,0.00063053146,0.00038676563,0.00018634196,0.00006455803,0.00012217724,0.00013086844,0.000059630474],"category_scores_gemma":[0.00029637388,0.00028798336,0.0001147768,0.00048465037,0.00013043518,0.0004227079,0.0001556172,0.00032952894,0.0000918452],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028284578,0.02188223,0.1924426,0.006418942,0.0017066095,0.08692883,0.0031777832,0.00038675673,0.6106631,0.0024127646,0.0015427261,0.044153087],"study_design_scores_gemma":[0.08921818,0.0059231413,0.25743422,0.00479475,0.0012691203,0.0033064787,0.00016743195,0.2831267,0.352312,0.00082648883,0.00023446228,0.001386999],"about_ca_topic_score_codex":0.000070500726,"about_ca_topic_score_gemma":0.0002288781,"teacher_disagreement_score":0.28273997,"about_ca_system_score_codex":0.00014316168,"about_ca_system_score_gemma":0.00015143241,"threshold_uncertainty_score":0.9999572},"labels":[],"label_agreement":null},{"id":"W2980673278","doi":"10.1182/blood.v122.21.3165.3165","title":"XPO1 Inhibition Disrupts Ribosomal Subunits Assembly and Induces Multiple Myeloma (MM) Cell Death","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Nuclear export signal; Biology; Nucleolus; Cell biology; Molecular biology; Nucleophosmin; Cytoplasm; Ribosomal protein; Cell nucleus; Cancer research; RNA; Ribosome; Genetics; Gene","score_opus":0.007433914992321865,"score_gpt":0.19900038431856992,"score_spread":0.19156646932624805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980673278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975765,0.00022728468,0.00005497596,0.000058922535,0.00009434729,0.00014637515,0.000008904918,0.000017852286,0.0018148501],"genre_scores_gemma":[0.9985538,0.000040340878,0.00060379395,0.00016569185,0.0002622519,0.00001436589,0.000103054736,0.00001853179,0.00023815555],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99939495,0.000027340477,0.00010446426,0.00023714828,0.00007276148,0.0001633216],"domain_scores_gemma":[0.9996674,0.0000071914264,0.00004688375,0.00015223445,0.00005302755,0.000073268384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000034180215,0.00011781411,0.00008111327,0.000026577656,0.000085945474,0.000045926015,0.000046003683,0.00015249496,0.000024035182],"category_scores_gemma":[0.0000231156,0.000105949766,0.00003276946,0.00004316153,0.000025629237,0.000010960568,0.00006428085,0.000072194845,0.000029523148],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000121258645,0.00007263821,0.020765131,0.000013373611,0.000017841712,0.0000025775705,0.00003593158,5.5248637e-7,0.97692,0.000022016548,0.0004639352,0.0016738554],"study_design_scores_gemma":[0.0010413398,0.00026682718,0.19090413,0.000006934816,0.000031876716,0.00003398491,0.00006328848,0.000016894393,0.80515325,0.00008997646,0.0022329153,0.0001585964],"about_ca_topic_score_codex":0.000054243566,"about_ca_topic_score_gemma":0.00002554692,"teacher_disagreement_score":0.17176677,"about_ca_system_score_codex":0.0000028811373,"about_ca_system_score_gemma":0.000013429332,"threshold_uncertainty_score":0.43205062},"labels":[],"label_agreement":null},{"id":"W2980674320","doi":"10.1182/blood.v122.21.3432.3432","title":"A Systematic Review Of The Role Of Erythropoietin In The Pathophysiology Of Anemia In Elderly Patients","year":2013,"lang":"en","type":"review","venue":"Blood","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Anemia; Medicine; Erythropoietin; Etiology; Observational study; Cohort study; Population; Internal medicine; Intensive care medicine; Pediatrics","score_opus":0.011204196869179249,"score_gpt":0.2735282063319662,"score_spread":0.26232400946278694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980674320","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0044372436,0.9899327,2.3939156e-8,0.000055808763,0.000038246944,0.0049657593,0.000031591804,0.0000032987393,0.0005353309],"genre_scores_gemma":[0.0020988018,0.99722797,0.00005980855,0.000070031856,0.000017671655,0.00042106566,0.000046682402,0.000024326388,0.000033643144],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99654514,0.00087652967,0.0017846324,0.00023719229,0.0003636893,0.00019279287],"domain_scores_gemma":[0.99714667,0.0003432171,0.001409998,0.00095280935,0.00011995106,0.000027337828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048556074,0.0003082048,0.0034826817,0.000105110594,0.000011951112,0.0000016903267,0.00039193305,0.00022025767,0.00005291661],"category_scores_gemma":[0.00041972921,0.00013291472,0.000626927,0.00049307896,0.00015529158,0.00001342209,0.00008174145,0.00032973266,0.000010657884],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000024368876,0.001663274,0.00035395584,0.98232335,0.00011628108,0.000005388562,0.00021232892,8.990324e-9,0.000009423563,0.000032991025,0.000070779206,0.015209801],"study_design_scores_gemma":[0.001145481,0.00058931287,0.00018613017,0.9916473,0.0038418206,0.000029344985,0.0001927158,9.70775e-8,0.000043519056,0.00005664802,0.0021562942,0.000111348134],"about_ca_topic_score_codex":0.00012019442,"about_ca_topic_score_gemma":0.00000797639,"teacher_disagreement_score":0.015098453,"about_ca_system_score_codex":0.00003789512,"about_ca_system_score_gemma":0.00020545279,"threshold_uncertainty_score":0.5420105},"labels":[],"label_agreement":null},{"id":"W2980682826","doi":"10.1182/blood-2018-99-119638","title":"Mediastinal Mass, Triglycerides Level Above 1000mg/Dl and Intensive Dexamethasone and Asparaginase Treatment Are Risk Factors for Cerebral Sinus Venous Thrombosis in Children Treated for Acute Lymphoblastic Leukemia at the Children's Cancer Center of Lebanon","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Asparaginase; Dexamethasone; Gastroenterology; Internal medicine; Acute lymphocytic leukemia; Odds ratio; Venous thrombosis; Risk factor; Cumulative incidence; Incidence (geometry); Pediatrics; Cohort; Surgery; Thrombosis; Leukemia; Lymphoblastic Leukemia","score_opus":0.02485435861920574,"score_gpt":0.29422670855902994,"score_spread":0.2693723499398242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980682826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99071205,0.00064405083,0.00022436399,0.00024587155,0.00007027597,0.0029535315,0.0051029474,0.00003383939,0.000013081248],"genre_scores_gemma":[0.9970611,0.0006791424,0.00091123715,0.00009835282,0.00027746873,0.00038992488,0.00031484256,0.00008814149,0.00017980496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99760306,0.000098303404,0.00048590355,0.0007373433,0.00034424686,0.0007311539],"domain_scores_gemma":[0.99747634,0.0010249001,0.00036350155,0.0004098448,0.00046031686,0.00026506998],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017863927,0.0005063229,0.000990499,0.00023055804,0.0002495151,0.000036031703,0.0001630989,0.00021823794,0.000041451953],"category_scores_gemma":[0.00065367087,0.0003240776,0.00017251949,0.0002630217,0.0008031896,0.00009964796,0.00012078935,0.0001584416,0.0000025258096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003719828,0.0006927319,0.9840066,0.00007792809,0.0033290423,0.00002286316,0.001581676,0.000009519812,0.0037908724,0.000004760575,0.0004609868,0.0023031794],"study_design_scores_gemma":[0.03962726,0.005290396,0.85876626,0.00029136482,0.0035322288,0.00043922532,0.00037522553,0.0008278811,0.09047798,0.000038991227,0.00001949501,0.0003137127],"about_ca_topic_score_codex":0.00565059,"about_ca_topic_score_gemma":0.0013943283,"teacher_disagreement_score":0.12524037,"about_ca_system_score_codex":0.0014571245,"about_ca_system_score_gemma":0.00066738395,"threshold_uncertainty_score":0.99992114},"labels":[],"label_agreement":null},{"id":"W2980688151","doi":"10.1182/blood.v122.21.2433.2433","title":"Growth Factor Independence 1b (Gfi1b) Regulates The Commitment, Differentiation and Expansion Of Hematopoietic Stem Cells","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Haematopoiesis; Stem cell; Bone marrow; Biology; Cancer research; Cell biology; Hematopoietic stem cell; Ex vivo; Immunology; In vivo; Genetics","score_opus":0.007243006224921911,"score_gpt":0.19946261112044025,"score_spread":0.19221960489551834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980688151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980879,0.0013946637,0.000038873477,0.00007679256,0.000032356955,0.00025822682,0.000013183608,0.0000053060317,0.00009272369],"genre_scores_gemma":[0.9994685,0.00024698596,0.00006010154,0.000036446392,0.000014920636,0.000027691118,0.000019090974,0.000009407333,0.000116826785],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99945474,0.00003589518,0.00012516504,0.0001723993,0.00010119951,0.000110577],"domain_scores_gemma":[0.9995415,0.000011811231,0.00008027551,0.0002807542,0.00005063263,0.000034983193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00002697633,0.00010436178,0.000099281315,0.000013773322,0.00005898868,0.000021039867,0.00012022293,0.00008302942,0.000017685463],"category_scores_gemma":[0.0000047327276,0.00006811607,0.000038351252,0.000031589705,0.00004800617,0.0000051789484,0.0001052087,0.000036536072,0.0000050843237],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012974866,0.00073648605,0.07296842,0.000066795576,0.00025039725,8.5685656e-7,0.00029379834,8.754272e-7,0.92275625,0.00012835633,0.00030064565,0.002484151],"study_design_scores_gemma":[0.0011860055,0.00016748982,0.033679277,0.000013026005,0.00007274473,0.0000045552433,0.0001409649,0.000008765235,0.96415645,0.00046750624,0.000023127286,0.0000800798],"about_ca_topic_score_codex":0.00006990834,"about_ca_topic_score_gemma":0.000011755598,"teacher_disagreement_score":0.041400217,"about_ca_system_score_codex":0.0000013874045,"about_ca_system_score_gemma":0.000010995694,"threshold_uncertainty_score":0.27776927},"labels":[],"label_agreement":null},{"id":"W2980696697","doi":"10.1182/blood-2018-99-113023","title":"Long-Term Risk Factors for Occult Cancer Detection in Patients with Unprovoked Venous Thromboembolism: A Post-Hoc Analysis of the Reverse Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Hospital; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Cancer; Internal medicine; Prostate cancer; Colorectal cancer; Retrospective cohort study; Pulmonary embolism; Incidence (geometry); Univariate analysis; Surgery; Multivariate analysis","score_opus":0.010366661235719266,"score_gpt":0.26302938640430557,"score_spread":0.2526627251685863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980696697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99682397,0.000037401267,0.000021140504,0.000028318364,0.0001683916,0.0027592918,0.00010513085,0.000023697254,0.000032687734],"genre_scores_gemma":[0.99952435,0.000029636736,0.00003232997,0.00010323953,0.0000629939,0.00017359653,0.000026095828,0.000025483578,0.00002226424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986653,0.0000693186,0.0003153726,0.00034615662,0.00034458644,0.0002593179],"domain_scores_gemma":[0.99877995,0.00004332851,0.0002821388,0.00049712666,0.00033771142,0.000059736856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016800157,0.000187075,0.0007174913,0.00026492495,0.0001377347,0.000013438492,0.00014281544,0.00006219932,0.0000514759],"category_scores_gemma":[0.00007309368,0.00011444612,0.00017628116,0.00090649456,0.000082611296,0.00006369225,0.000062681844,0.000107642285,0.0000016211726],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039483028,0.009938863,0.97938126,0.00005939402,0.0041024056,0.0000016861717,0.0042264517,0.000023358625,0.00013233982,0.000001986283,0.000020208483,0.0017172231],"study_design_scores_gemma":[0.006508119,0.0060907872,0.9697717,0.00007512352,0.014863651,1.419198e-7,0.0007895388,0.000019542067,0.0017321022,0.0000022184786,0.000016205433,0.00013088442],"about_ca_topic_score_codex":0.0031289826,"about_ca_topic_score_gemma":0.01663653,"teacher_disagreement_score":0.013507548,"about_ca_system_score_codex":0.00007835043,"about_ca_system_score_gemma":0.000055833378,"threshold_uncertainty_score":0.9283574},"labels":[],"label_agreement":null},{"id":"W2980717214","doi":"10.1182/blood-2018-99-119738","title":"Finding the Gaps: Perceived and Unperceived Needs in Malignant Hematology Training in Canadian Hematology Residents","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Hematology; Medicine; Internal medicine; Curriculum; Certification; Family medicine; Medical education; Oncology; Psychology; Pedagogy","score_opus":0.02576872977373942,"score_gpt":0.27793394034915364,"score_spread":0.25216521057541424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980717214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930105,0.00088444754,1.4252544e-7,0.0027766903,0.00007469376,0.00033920695,0.0000032004239,0.0000131169145,0.0028979771],"genre_scores_gemma":[0.9988586,0.00012081635,0.00008053525,0.0007319156,0.0000515397,0.000062050356,0.000007831498,0.00001510445,0.00007163749],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878407,0.000085356995,0.0002691076,0.00024375536,0.000093234994,0.00052447926],"domain_scores_gemma":[0.99939686,0.00013249998,0.000042265285,0.00021155388,0.00002552671,0.00019128091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021736306,0.00014848099,0.00037767197,0.00038203102,0.00009950387,0.0000165523,0.00008214007,0.00013138287,0.00008237184],"category_scores_gemma":[0.00012370184,0.00010327005,0.000034783865,0.00025557182,0.00015113747,0.000036187554,0.000030235182,0.00010275823,0.000029545517],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027684411,0.00015730991,0.9798894,0.000020851108,0.000055686836,0.001114685,0.01608494,1.6061558e-7,0.00036640928,0.0017779948,0.00007371386,0.0004311451],"study_design_scores_gemma":[0.005358966,0.00020743003,0.98511344,0.00036533628,0.00008421412,0.0015808184,0.0050653145,0.000031184416,0.0016648412,0.00020828717,0.00021215471,0.000108025255],"about_ca_topic_score_codex":0.1338275,"about_ca_topic_score_gemma":0.52481484,"teacher_disagreement_score":0.39098734,"about_ca_system_score_codex":0.00012965819,"about_ca_system_score_gemma":0.00037397983,"threshold_uncertainty_score":0.87194043},"labels":[],"label_agreement":null},{"id":"W2980733620","doi":"10.1182/blood.v122.21.3450.3450","title":"Association Of Cardiac Iron By T2* With Innate Immune Markers In Transfusion-Dependent Thalassemia Patients Undergoing Combined Chelation Therapy","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"","keywords":"Innate immune system; Medicine; Thalassemia; Deferasirox; Immunology; Transfusion therapy; Chelation therapy; Immune system; Internal medicine; Blood transfusion","score_opus":0.002594071542495621,"score_gpt":0.18395847377341865,"score_spread":0.18136440223092304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980733620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959055,0.0006285338,0.000005252369,0.0005690738,0.00008118717,0.00084991753,0.000006990562,0.000025251144,0.0019282799],"genre_scores_gemma":[0.99685895,0.0024722416,0.00004159867,0.000045647346,0.000007865759,0.00003196137,0.00010587868,0.000022538088,0.0004133119],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988962,0.00007855765,0.0003115188,0.00016671135,0.0003460307,0.00020099316],"domain_scores_gemma":[0.9994647,0.00006979506,0.0001668251,0.00013719861,0.00011082832,0.000050676957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001899285,0.00012979085,0.0002718189,0.00008278429,0.00003880289,0.000009986916,0.000043406373,0.0001916252,0.000070290145],"category_scores_gemma":[0.000038702565,0.00009986588,0.00006442268,0.00021013721,0.000018199362,0.00010679916,0.000008744678,0.00020398766,0.0000089010155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023451344,0.0010810578,0.95780885,0.000063066895,0.0002459689,9.949914e-7,0.0005725932,0.000015027137,0.03593602,0.0000039020324,0.00028061142,0.0037574042],"study_design_scores_gemma":[0.0178583,0.0010532422,0.96351075,0.00023745983,0.00015269831,7.307616e-7,0.000536075,0.00006889273,0.016323563,0.00002920852,0.000069430906,0.00015967459],"about_ca_topic_score_codex":0.00056541053,"about_ca_topic_score_gemma":0.000025364363,"teacher_disagreement_score":0.019612458,"about_ca_system_score_codex":0.00009827568,"about_ca_system_score_gemma":0.00005845889,"threshold_uncertainty_score":0.40724123},"labels":[],"label_agreement":null},{"id":"W2980736865","doi":"10.1182/blood-2018-99-117987","title":"Characterization of hTERT Mutations in Bone Marrow Failure Syndromes","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Dyskeratosis congenita; Telomerase; Telomere; Bone marrow failure; Biology; Cancer research; Telomerase reverse transcriptase; Telomere-binding protein; Leukemia; Genetics; Immunology; Haematopoiesis; Stem cell; Gene","score_opus":0.013389393160807677,"score_gpt":0.2466970421052188,"score_spread":0.23330764894441114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980736865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99849594,0.000059420454,0.00005999596,0.00069368427,0.00006932086,0.00017876293,0.000015561176,0.000034232467,0.00039309298],"genre_scores_gemma":[0.9984876,0.000024546163,0.0006625537,0.00013458567,0.000106062114,0.000010155792,0.00008860676,0.000012423308,0.0004735043],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9993257,0.000020208365,0.00022764252,0.00014726695,0.00014050285,0.0001386939],"domain_scores_gemma":[0.9995831,0.000017166014,0.000069412905,0.000186241,0.00008939256,0.000054645185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000068834015,0.00008008081,0.00019874197,0.00016054178,0.000026749887,0.0000061836563,0.00004673,0.00006154402,0.0001953945],"category_scores_gemma":[0.00006182135,0.000073907446,0.00003383564,0.00029621043,0.00008607505,0.0000819851,0.000013768462,0.0000664867,0.000043635777],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029538092,0.00048071914,0.13050874,0.00009707979,0.000027255648,0.00005999582,0.0010847767,5.3222063e-8,0.8658776,0.00010301956,0.00004813801,0.0016830519],"study_design_scores_gemma":[0.0020927826,0.00028402795,0.7364963,0.00022250065,0.00008480919,0.00019173237,0.00016143189,0.000031157055,0.25888625,0.000046344834,0.0013886809,0.00011396186],"about_ca_topic_score_codex":0.000030553507,"about_ca_topic_score_gemma":0.000079345016,"teacher_disagreement_score":0.6069914,"about_ca_system_score_codex":0.000009166216,"about_ca_system_score_gemma":0.000052226947,"threshold_uncertainty_score":0.30138582},"labels":[],"label_agreement":null},{"id":"W2980737301","doi":"10.1182/blood-2018-99-120018","title":"The Yield of Echocardiography in the Diagnosis of Infective Endocarditis in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Myeloid leukemia; Induction chemotherapy; Internal medicine; Infective endocarditis; Cytarabine; Bacteremia; Neutropenia; Chemotherapy; Febrile neutropenia; Surgery; Gastroenterology; Antibiotics","score_opus":0.0113021819092842,"score_gpt":0.2687676942314103,"score_spread":0.25746551232212606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980737301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99640936,0.00011752011,0.00003625348,0.00012543554,0.00011285553,0.00079042185,0.000023190405,0.0000071537565,0.0023777843],"genre_scores_gemma":[0.9982461,0.0010324969,0.000043490752,0.0002256104,0.000099130986,0.0003343627,0.0000034929303,0.000011782337,0.000003555202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993061,0.000044297936,0.00022216013,0.00012601682,0.00014594346,0.0001555029],"domain_scores_gemma":[0.9989943,0.0005459957,0.0000933193,0.00024160495,0.00010664399,0.000018149722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016147977,0.000085041596,0.00023592172,0.00011351892,0.00006230382,0.000007043288,0.0000991887,0.000046571105,0.000006601965],"category_scores_gemma":[0.00008668812,0.00005291979,0.00017521101,0.00045178007,0.00012420682,0.000042264546,0.000015529286,0.00010461333,7.417004e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010865197,0.0002881511,0.99354357,0.000022956896,0.000365053,0.0000010387931,0.0006298998,0.0000018567692,0.00041280387,0.00014215214,0.00043346232,0.0040503982],"study_design_scores_gemma":[0.005112989,0.0014127023,0.93937683,0.00013234257,0.0002302995,0.0000029103649,0.00017538633,8.850974e-7,0.052348983,0.0003656454,0.0007869879,0.00005403418],"about_ca_topic_score_codex":0.0002061952,"about_ca_topic_score_gemma":0.00036402594,"teacher_disagreement_score":0.05416674,"about_ca_system_score_codex":0.00003927691,"about_ca_system_score_gemma":0.00009177094,"threshold_uncertainty_score":0.21580064},"labels":[],"label_agreement":null},{"id":"W2980748787","doi":"10.1182/blood.v110.11.5.5","title":"Mutational Loss of PTEN Induces Resistance to NOTCH1 Inhibition in T-ALL.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital","funders":"","keywords":"PTEN; Protein kinase B; PI3K/AKT/mTOR pathway; Downregulation and upregulation; Cancer research; Gene knockdown; Biology; Small hairpin RNA; Signal transduction; Notch signaling pathway; Tensin; Cell biology; Cell culture; Genetics; Gene","score_opus":0.014551608887158635,"score_gpt":0.2809496300653295,"score_spread":0.2663980211781709,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980748787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997204,0.00039892105,0.00064402365,0.00013142455,0.000062389605,0.00009223074,0.000022223234,0.000004929247,0.0014398424],"genre_scores_gemma":[0.99780554,0.000008856322,0.0015453352,0.00027148903,0.00015855825,0.000010360081,0.000049415623,0.000010376566,0.00014006562],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993066,0.000016305443,0.00019667059,0.00019433354,0.000135578,0.00015050784],"domain_scores_gemma":[0.99966985,0.000015896001,0.000061481085,0.00013564185,0.00007448703,0.00004265711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024143506,0.00007227101,0.00008061709,0.000057979756,0.000013639436,0.000004827097,0.00006784348,0.000095470816,0.000011744997],"category_scores_gemma":[0.000075810356,0.000078766956,0.000029824518,0.00012088245,0.00003394734,0.0000026884231,0.000032436903,0.000050905834,0.00000472521],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000081819904,0.00012325804,0.003838855,0.000016875538,0.000019899024,0.000019613186,0.00009590336,0.0000593288,0.99513316,0.000111366266,0.0002842024,0.00021569127],"study_design_scores_gemma":[0.0006971234,0.00007967238,0.016391655,0.00003929199,0.000008552295,0.000006094964,0.00002721919,4.7305213e-7,0.9802619,0.0001845684,0.0022062096,0.00009721542],"about_ca_topic_score_codex":0.00001496974,"about_ca_topic_score_gemma":0.00026487568,"teacher_disagreement_score":0.014871263,"about_ca_system_score_codex":0.000013293357,"about_ca_system_score_gemma":0.000053393418,"threshold_uncertainty_score":0.32120234},"labels":[],"label_agreement":null},{"id":"W2980762329","doi":"10.1182/blood-2018-99-116577","title":"Practical Utilisation of Octapharma FVIII Concentrates in Previously Untreated and Minimally Treated Haemophilia a Patients Entering Routine Clinical Treatment with Nuwiq®, Octanate® or Wilate® — the Protect-NOW Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Immunogenicity; Haemophilia A; Haemophilia; Cumulative incidence; Titer; Interim analysis; Clinical trial; Von Willebrand factor; Internal medicine; Immunology; Surgery; Cohort; Antibody","score_opus":0.07312230138839558,"score_gpt":0.3859557139712627,"score_spread":0.3128334125828671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980762329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993789,0.00009264909,8.925113e-7,0.00077747717,0.000027378303,0.005039924,0.000013812763,0.000046710713,0.00021211094],"genre_scores_gemma":[0.99891084,0.00023747794,0.0001726885,0.000028645289,0.00009107272,0.00019919407,0.00003563535,0.000033046428,0.00029140408],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974902,0.00042961564,0.00069287006,0.0005227852,0.00042039275,0.0004440821],"domain_scores_gemma":[0.99863786,0.00029003448,0.00020335411,0.00036456404,0.0002963374,0.00020782535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049797224,0.00031373382,0.0006333404,0.00012251313,0.00011658628,0.000033692562,0.00008920302,0.00012198505,0.000085982305],"category_scores_gemma":[0.00023418316,0.00015071244,0.00006871968,0.00044183453,0.00044976585,0.000118436445,0.00006011948,0.00021450307,0.000011291668],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00893976,0.012615592,0.9699126,0.000057619563,0.00081492536,0.00043270335,0.0019247716,1.0274617e-7,0.0005057067,0.0000026447397,0.000019336823,0.0047742636],"study_design_scores_gemma":[0.058177244,0.05944141,0.86082256,0.0003926636,0.0013582777,0.00012903588,0.0011165076,0.0004901979,0.017736763,0.0000031760826,0.00011144531,0.00022070503],"about_ca_topic_score_codex":0.00020914729,"about_ca_topic_score_gemma":0.00049887213,"teacher_disagreement_score":0.10909,"about_ca_system_score_codex":0.0000922625,"about_ca_system_score_gemma":0.00028394678,"threshold_uncertainty_score":0.6145875},"labels":[],"label_agreement":null},{"id":"W2980769243","doi":"10.1182/blood.v130.suppl_1.2153.2153","title":"Venous Thrombotic Events Are Independently Associated with Inferior Survival Outcome in Pediatric Cancer Patients: A Multicenter Study","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Janeway Children's Health and Rehabilitation Centre; Dalhousie University; Izaak Walton Killam Health Centre","funders":"","keywords":"Medicine; Pediatric oncology; Population; Cohort; Cancer; Cancer registry; Pediatrics; Family medicine; Internal medicine","score_opus":0.03916054324148509,"score_gpt":0.3335206959131787,"score_spread":0.2943601526716936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980769243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969449,0.00010253545,0.0000012853825,0.00036132615,0.0006301142,0.0016341239,0.0000655698,0.000073751246,0.00018639394],"genre_scores_gemma":[0.9990666,0.000025087624,0.000017966704,0.0002761582,0.000272449,0.00011709436,0.000022458167,0.00006810592,0.00013408215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996955,0.00022334068,0.00067191117,0.00055005524,0.0010787367,0.0005209935],"domain_scores_gemma":[0.9978314,0.00011438614,0.0007649339,0.00082959124,0.00025017557,0.00020949142],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006146974,0.00033290655,0.0009045262,0.00017280849,0.00022568068,0.00007047652,0.00039261972,0.00014058327,0.000060080136],"category_scores_gemma":[0.0011969294,0.00028646222,0.000102968435,0.00018383178,0.00004942241,0.00023583969,0.00019778831,0.0004963736,0.000029834317],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019159607,0.019183028,0.97723377,0.00012638162,0.00040158632,0.00012984668,0.0026669896,0.0000035579221,0.000001817706,4.871342e-7,0.000013044001,0.000047868398],"study_design_scores_gemma":[0.031317417,0.0012097742,0.96520466,0.00032802447,0.00090143963,0.000001234532,0.0007057207,0.0000042224815,0.000010722067,0.0000038493226,0.00000438846,0.00030857208],"about_ca_topic_score_codex":0.0034800426,"about_ca_topic_score_gemma":0.031480543,"teacher_disagreement_score":0.03112582,"about_ca_system_score_codex":0.00021668874,"about_ca_system_score_gemma":0.00020858775,"threshold_uncertainty_score":0.99995875},"labels":[],"label_agreement":null},{"id":"W2980782974","doi":"10.1182/blood-2018-99-114146","title":"The Safety and Efficacy of Ferumoxytol in the Treatment of Iron Deficiency: A Systematic Review and Meta-Analysis","year":2018,"lang":"en","type":"review","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Ferumoxytol; Medicine; Adverse effect; Placebo; Systematic review; Meta-analysis; Randomized controlled trial; Cochrane Library; MedDRA; Clinical trial; Internal medicine; Iron deficiency; MEDLINE; Anemia; Alternative medicine; Pathology; Pharmacovigilance","score_opus":0.05344742094450236,"score_gpt":0.3366371054473192,"score_spread":0.2831896845028168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980782974","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007944503,0.9956642,0.000001548097,0.00008975654,0.0000074119407,0.0038232473,0.00004782037,0.0000032675287,0.00028329578],"genre_scores_gemma":[0.00017838553,0.99934655,0.00002516832,0.000039067185,0.00001024865,0.00018997487,0.00001883247,0.000012405871,0.0001793662],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99759716,0.0006431173,0.0011045826,0.00026189475,0.00024197545,0.00015128173],"domain_scores_gemma":[0.9976956,0.0007111649,0.0006422737,0.0008694157,0.000042964726,0.000038542934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009749372,0.0003047479,0.006206314,0.0001324506,0.000054363696,0.000010236203,0.00015365287,0.000083925064,0.00001818616],"category_scores_gemma":[0.00021135734,0.000104605584,0.0012978031,0.00059265015,0.00017143638,0.000011876947,0.000018584335,0.000059160455,0.0000024913402],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009219806,0.0009363612,0.000008642038,0.9736875,0.01857559,0.0000036469762,0.00048750857,3.8048498e-8,4.6062297e-8,0.0001840098,0.000007601265,0.00609978],"study_design_scores_gemma":[0.00077342795,0.0003170366,0.000037388454,0.0077631567,0.9671023,0.000031633095,0.00007581797,1.6882463e-7,2.9419257e-7,0.000002829165,0.023810524,0.00008541553],"about_ca_topic_score_codex":0.00004827002,"about_ca_topic_score_gemma":0.00004103666,"teacher_disagreement_score":0.9659244,"about_ca_system_score_codex":0.000011491142,"about_ca_system_score_gemma":0.000087820605,"threshold_uncertainty_score":0.4265692},"labels":[],"label_agreement":null},{"id":"W2980812216","doi":"10.1182/blood-2018-99-119550","title":"Integrin Activity Reduces Immunogenic Cell Death By Inhibiting Cell Surface Presentation of ERp57 and Calreticulin","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Calreticulin; Integrin; Cell biology; Cytosol; Immunogenic cell death; Biology; Endoplasmic reticulum; Cell; Molecular biology; Chemistry; Programmed cell death; Biochemistry; Apoptosis","score_opus":0.01044852280063684,"score_gpt":0.23573945168831964,"score_spread":0.2252909288876828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980812216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99359,0.0048486036,0.00007964236,0.00003318356,0.000117350355,0.00016044304,0.000023503875,0.000024713994,0.0011225442],"genre_scores_gemma":[0.9988437,0.00015168833,0.00017749755,0.0000064936353,0.000019731113,0.000003680565,0.00005105864,0.0000118354355,0.0007342834],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991799,0.00015989025,0.00022338753,0.00021478547,0.00003275901,0.00018929396],"domain_scores_gemma":[0.99950534,0.00007776517,0.00019652223,0.00013270423,0.00007413386,0.000013535689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017912214,0.00012432587,0.0001945993,0.00003361255,0.000118080505,0.0000124157605,0.00008688743,0.00015654022,0.00007383305],"category_scores_gemma":[0.000024486366,0.00011292608,0.000047861533,0.00008014114,0.00017613644,0.00012718904,0.00007558508,0.00013743239,0.000030795873],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006187749,0.0003363666,0.0022901876,0.000021993876,0.00004347414,1.8606208e-7,0.00046329186,9.573553e-7,0.9956397,0.000011802866,0.00022104003,0.0009091326],"study_design_scores_gemma":[0.0016105161,0.00025803215,0.009821258,0.000028213166,0.00007667864,0.000009747994,0.00017940612,0.000018249535,0.98764396,0.000018722223,0.00022099946,0.000114203736],"about_ca_topic_score_codex":0.0002636106,"about_ca_topic_score_gemma":0.0000054280467,"teacher_disagreement_score":0.007995716,"about_ca_system_score_codex":0.000011875698,"about_ca_system_score_gemma":0.0000301762,"threshold_uncertainty_score":0.4604992},"labels":[],"label_agreement":null},{"id":"W2980820239","doi":"10.1182/blood-2018-99-119399","title":"Adamts-13 Inhibitor Testing Is Often Negative on Initial Testing","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"ADAMTS13; ADAMTS; Thrombotic thrombocytopenic purpura; Microangiopathic hemolytic anemia; Von Willebrand factor; Medicine; Autoantibody; Internal medicine; Antibody; Platelet; Coagulation; Immunology; Rituximab; Gastroenterology; Metalloproteinase; Thrombospondin","score_opus":0.05648078421334334,"score_gpt":0.2918556318452744,"score_spread":0.23537484763193106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980820239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9789793,0.00016906373,0.000007537311,0.00016621948,0.0006323199,0.0003061307,0.00011646447,0.00020132399,0.019421628],"genre_scores_gemma":[0.99759555,2.6844828e-7,0.00049253315,0.00088803045,0.00059709634,0.00003724994,0.000021643269,0.000022793454,0.00034484625],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99876356,0.00014827069,0.000311468,0.0003496078,0.000055660552,0.00037141415],"domain_scores_gemma":[0.99841505,0.00086823915,0.00016439601,0.00029504724,0.0002263293,0.000030915893],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014745878,0.00017988641,0.00021240971,0.00008542649,0.00032571732,0.000023171846,0.00020954409,0.00010215473,0.00070328685],"category_scores_gemma":[0.0016897583,0.00017286795,0.000051862447,0.00022381906,0.00019974553,0.00006683987,0.00015297372,0.00015809115,0.0019252627],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033104458,0.0023709603,0.15241617,0.00012932517,0.0008938698,0.000075881784,0.0030630196,0.0000020324087,0.74240613,0.0003793396,0.07137308,0.026559152],"study_design_scores_gemma":[0.007921977,0.0031314942,0.08777053,0.00086128124,0.00032701468,0.00017012324,0.0007110902,0.0000196575,0.88736093,0.00088960724,0.010101228,0.00073505606],"about_ca_topic_score_codex":0.00017956321,"about_ca_topic_score_gemma":0.000019719013,"teacher_disagreement_score":0.14495482,"about_ca_system_score_codex":0.000021944716,"about_ca_system_score_gemma":0.0000870523,"threshold_uncertainty_score":0.99885184},"labels":[],"label_agreement":null},{"id":"W2980853278","doi":"10.1182/blood.v118.21.1274.1274","title":"Enhanced Human Hematopoietic Stem Cell Self-Renewal Enabled by Controlling Feedback Signaling From Lineage Committed Cells","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Viral Infectious Diseases and Gene Expression in Insects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heart and Stroke Foundation; University Health Network; University of Toronto","funders":"","keywords":"Stem cell; Cell biology; Haematopoiesis; Biology; Paracrine signalling; Population; Progenitor cell; Hematopoietic stem cell; Transplantation; Immunology; Receptor; Medicine; Biochemistry; Internal medicine","score_opus":0.008658037150456273,"score_gpt":0.2079047436335778,"score_spread":0.19924670648312154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980853278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99309367,0.0015691776,0.0013977371,0.0000033987517,0.00020778502,0.00026499774,0.00009077564,0.000085555075,0.0032869307],"genre_scores_gemma":[0.99798393,0.000081283746,0.0004925985,0.00021893483,0.0002751639,0.00004934794,0.00018393308,0.00005284422,0.0006619907],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984536,0.000117506635,0.00038033692,0.0005193499,0.00015307438,0.00037609402],"domain_scores_gemma":[0.9990199,0.000023400407,0.000202862,0.00046939362,0.000088632434,0.000195782],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000095458534,0.00029002732,0.0002898471,0.0000309584,0.00023081906,0.000052281088,0.00028360653,0.00024443038,0.00022867978],"category_scores_gemma":[0.0000047216386,0.0002790066,0.00019617351,0.00007213796,0.000041381216,0.0000061718733,0.00011778491,0.00013558812,0.000046183846],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000643493,0.0009409018,0.00041559665,0.00003369154,0.00016714905,0.0000071470827,0.00032813213,0.000022295713,0.9964204,0.000005052024,0.0015777199,0.000017556587],"study_design_scores_gemma":[0.003534735,0.00037677994,0.000024651306,0.000035477788,0.0001766726,0.0000015923947,0.00015701551,0.00001754129,0.9945758,0.00007409376,0.0006646987,0.00036094373],"about_ca_topic_score_codex":0.00015414918,"about_ca_topic_score_gemma":0.000012612108,"teacher_disagreement_score":0.0048902608,"about_ca_system_score_codex":0.0000083501145,"about_ca_system_score_gemma":0.000039272436,"threshold_uncertainty_score":0.9999662},"labels":[],"label_agreement":null},{"id":"W2980861407","doi":"10.1182/blood.v122.21.2893.2893","title":"ALDH Genes and Reactive Aldehydes Play Important Roles in HSCs and Leukemia and May Be Exploited to Treat AML","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Leukemia; Acute leukemia; Biology; Cancer research; Haematopoiesis; Reactive oxygen species; Cell biology; DNA damage; Signal transduction; Chemistry; Stem cell; Biochemistry; Immunology; DNA","score_opus":0.017682094776624285,"score_gpt":0.2742593570421745,"score_spread":0.2565772622655502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980861407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936267,0.002584233,0.0000022945846,0.0022077777,0.000010433944,0.00080323406,0.000020050304,0.000041681862,0.0007035754],"genre_scores_gemma":[0.9952195,0.0020919219,0.0011553838,0.0005100406,0.00009041008,0.00014437403,0.000022098528,0.00003912821,0.0007271088],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985778,0.000052823983,0.0002729683,0.0004644683,0.00023414243,0.00039784054],"domain_scores_gemma":[0.99905753,0.00017362635,0.000050616625,0.0002622868,0.0000722443,0.0003836796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020372805,0.00022534674,0.00039626512,0.00026776502,0.00006243155,0.000061221705,0.000067341905,0.00014497418,0.000043976725],"category_scores_gemma":[0.00016245073,0.00017738079,0.000022862088,0.00020713684,0.00014653824,0.00019123613,0.00015875121,0.00024049116,0.000009840025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028528602,0.00022056577,0.5358993,0.00013860645,0.00014725284,0.00046680684,0.003417813,5.8958125e-7,0.44234195,0.000072304996,0.0022020137,0.014807508],"study_design_scores_gemma":[0.013532483,0.0012070802,0.72369486,0.00028035472,0.0002832799,0.0009919527,0.005776862,0.00031407326,0.25044426,0.00020289994,0.00274315,0.00052874186],"about_ca_topic_score_codex":0.002375745,"about_ca_topic_score_gemma":0.00037768844,"teacher_disagreement_score":0.19189769,"about_ca_system_score_codex":0.00012434824,"about_ca_system_score_gemma":0.00014677027,"threshold_uncertainty_score":0.7233379},"labels":[],"label_agreement":null},{"id":"W2980863065","doi":"10.1182/blood.v122.21.2262.2262","title":"Assessment Of Non-Transfusional Iron Accumulation In Asian Patients With Hemoglobin E β Thalassemia","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Thalassemia; Medicine; Deferasirox; Beta thalassemia; Blood transfusion; Hemoglobin E; Ferritin; Gastroenterology; Internal medicine; Hemoglobin; Hemosiderosis; Anemia; Alanine transaminase; Pediatrics","score_opus":0.005464871401089139,"score_gpt":0.25017142058550257,"score_spread":0.24470654918441342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980863065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891367,0.000022556327,0.00007689484,0.00027791262,0.000039733677,0.00068912836,0.000004355203,0.000015558591,0.009737137],"genre_scores_gemma":[0.99820125,0.00001807892,0.0015194239,0.0000683053,0.000015105196,0.00002426597,0.00007028158,0.000015664968,0.00006762088],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990678,0.000019343592,0.00024827608,0.00017676526,0.00030654907,0.0001812836],"domain_scores_gemma":[0.9995763,0.000017085049,0.00006839731,0.000165689,0.00009268806,0.00007987928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006130212,0.00011641668,0.00021015058,0.00010170619,0.000025435242,0.0000071209547,0.00004824395,0.00012297805,0.00021689749],"category_scores_gemma":[0.000010569837,0.0000831358,0.000042810185,0.00021039917,0.000034945082,0.00009389476,0.000014930914,0.00017764213,0.000012191076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027872256,0.0016384175,0.99006236,0.00008721963,0.00003380232,0.0000060236503,0.00014704093,0.00007033031,0.005589908,0.000028717544,0.000059347727,0.0022489734],"study_design_scores_gemma":[0.0078402655,0.00043193222,0.9897896,0.00020967888,0.00007221926,0.0000045213174,0.00014824836,0.00049711927,0.00086565857,0.000021417774,0.000026038148,0.00009329163],"about_ca_topic_score_codex":0.0001865026,"about_ca_topic_score_gemma":0.000023083236,"teacher_disagreement_score":0.009669516,"about_ca_system_score_codex":0.000032363863,"about_ca_system_score_gemma":0.00009943141,"threshold_uncertainty_score":0.33901796},"labels":[],"label_agreement":null},{"id":"W2980912885","doi":"10.1182/blood-2018-99-118524","title":"UBR5 Mutations in Mantle Cell Lymphoma Lead to Increased Proliferation through a Cyclin D1-Dependent Mechanism","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Genome British Columbia; BC Cancer Agency; Simon Fraser University; University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Mantle cell lymphoma; Cyclin D1; Cancer research; Biology; Cell growth; Cell cycle; Genetics; Lymphoma; Gene; Immunology","score_opus":0.016389354055423445,"score_gpt":0.27068841144320493,"score_spread":0.25429905738778147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980912885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916627,0.000089613204,0.0002394667,0.0008095994,0.00013555841,0.0009454397,0.000021665337,0.00006683634,0.006029148],"genre_scores_gemma":[0.9934672,0.000021556316,0.004233234,0.0010953094,0.00023022026,0.00034873714,0.00006859973,0.000024353276,0.0005107539],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988333,0.000044940454,0.00027576342,0.00033278862,0.0002581479,0.0002550563],"domain_scores_gemma":[0.99940544,0.00004426793,0.00005648751,0.00028920267,0.00008630763,0.00011826964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010819872,0.00016079415,0.00023223876,0.000109191984,0.00008816925,0.00003050436,0.00006375579,0.00008847814,0.00011370736],"category_scores_gemma":[0.0000525077,0.00013803998,0.000059742062,0.00020649319,0.000023999772,0.00008631941,0.000036790847,0.000035295034,0.0007308427],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002004126,0.11999412,0.5221311,0.0005659922,0.0011651879,0.0041042096,0.027115667,0.00002963169,0.27734563,0.017397027,0.0061841663,0.021963168],"study_design_scores_gemma":[0.022144876,0.001440346,0.09507029,0.00013283863,0.00036012515,0.00011580247,0.00032824534,0.00012870056,0.8778701,0.0014621427,0.0007141202,0.00023241682],"about_ca_topic_score_codex":0.0007292329,"about_ca_topic_score_gemma":0.00053928443,"teacher_disagreement_score":0.6005245,"about_ca_system_score_codex":0.00014798394,"about_ca_system_score_gemma":0.00016243185,"threshold_uncertainty_score":0.93937486},"labels":[],"label_agreement":null},{"id":"W2980915548","doi":"10.1182/blood-2018-99-110186","title":"Transfusion Reaction Serology: Results of Applied Practices","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Serology; ABO blood group system; Intensive care medicine; Pediatrics; Internal medicine; Immunology; Antibody","score_opus":0.02459537513158275,"score_gpt":0.2864156488623791,"score_spread":0.2618202737307963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980915548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82793885,0.000026992117,0.00006783665,0.0018050532,0.00012996605,0.00040005366,0.0000035828186,0.000072605406,0.16955508],"genre_scores_gemma":[0.99737746,0.00028003423,0.001122803,0.0005172181,0.0001942743,0.000013005659,0.000015872636,0.000011288565,0.00046804736],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99921244,0.000017966227,0.00023920485,0.00022081687,0.00018431083,0.0001252798],"domain_scores_gemma":[0.99938613,0.000031434087,0.0001761037,0.0002685916,0.000078731115,0.00005898129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002700099,0.00008278738,0.00017341076,0.000089542504,0.000047020185,0.0000035399214,0.00004997082,0.00008600577,0.000069072485],"category_scores_gemma":[0.00004799665,0.00006895851,0.000046319925,0.00015972566,0.0000707274,0.000044520322,0.000013473901,0.00010489839,0.00005288414],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004673041,0.0027601442,0.001085992,0.00017928479,0.00028720245,0.000019427744,0.001366323,1.849224e-7,0.9685189,0.0013498922,0.0019097143,0.017849892],"study_design_scores_gemma":[0.026772827,0.0022666422,0.07462158,0.000097993725,0.0016767516,0.000071240545,0.0006378775,0.000020960804,0.76876354,0.00022611361,0.12466168,0.0001828204],"about_ca_topic_score_codex":0.00011512523,"about_ca_topic_score_gemma":0.00012260865,"teacher_disagreement_score":0.19975539,"about_ca_system_score_codex":0.0000044924145,"about_ca_system_score_gemma":0.000026328662,"threshold_uncertainty_score":0.28120464},"labels":[],"label_agreement":null},{"id":"W2980922311","doi":"10.1182/blood.v118.21.9.9","title":"Pre-Operative Transfusion Reduces Serious Adverse Events in Patients with Sickle Cell Disease (SCD): Results From the Transfusion Alternatives Preoperatively in Sickle Cell Disease (TAPS) Randomised Controlled Multicentre Clinical Trial","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Blood transfusion; Randomized controlled trial; Acute chest syndrome; Adverse effect; Surgery; Clinical trial; Sickle cell anemia; Pediatrics; Disease; Internal medicine","score_opus":0.01196259903391279,"score_gpt":0.25357804649153914,"score_spread":0.24161544745762636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980922311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848784,0.0004546997,0.000016701237,0.00030654232,0.0002902995,0.013072055,0.0002985225,0.000049465063,0.00063330226],"genre_scores_gemma":[0.9974419,0.001156199,0.00013055041,0.00017377624,0.000112401,0.00034409013,0.00027186007,0.000053362943,0.0003158837],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99527943,0.0013430469,0.001378693,0.00090826023,0.0006005724,0.0004900049],"domain_scores_gemma":[0.9978766,0.0006270862,0.00031816994,0.0004784191,0.00015675597,0.000542976],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00062431453,0.0004972796,0.0010093206,0.00011293315,0.00018171057,0.000014185133,0.0002637656,0.00020140946,0.0001307769],"category_scores_gemma":[0.0005222773,0.0002835969,0.000375858,0.00026575022,0.00020715728,0.00025530625,0.000042687403,0.00067518424,0.000016288643],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.82175654,0.02102799,0.13492025,0.000037660244,0.0002061567,0.00017264909,0.020904433,0.00018772525,0.00031119736,8.53935e-7,0.000015752654,0.00045880437],"study_design_scores_gemma":[0.67525196,0.001756359,0.3181644,0.00039557676,0.0008942324,1.8375631e-7,0.0015439518,0.0006762759,0.001015008,0.0000095953765,0.000011997333,0.00028045304],"about_ca_topic_score_codex":0.00087148015,"about_ca_topic_score_gemma":0.0004386099,"teacher_disagreement_score":0.18324415,"about_ca_system_score_codex":0.00005190732,"about_ca_system_score_gemma":0.00043716864,"threshold_uncertainty_score":0.9999616},"labels":[],"label_agreement":null},{"id":"W2980941435","doi":"10.1182/blood-2018-99-110468","title":"Increasing Incidence and Prevalence of Pathologic Hemoglobinopathies Among Children in Ontario, Canada from 1991-2013","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Kingston General Hospital; London Health Sciences Centre; McMaster University; McMaster Children's Hospital; SickKids Foundation; Newborn Screening Ontario; University of Toronto; Hospital for Sick Children; University of Ottawa; Institute for Clinical Evaluative Sciences; Children's Hospital of Eastern Ontario","funders":"","keywords":"Hemoglobinopathy; Medicine; Cohort; Population; Pediatrics; Incidence (geometry); Thalassemia; Cohort study; Disease; Demography; Environmental health; Internal medicine","score_opus":0.005139304044597833,"score_gpt":0.19405417830937574,"score_spread":0.1889148742647779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980941435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99657226,0.0019975558,9.691598e-7,0.00012064659,0.00007182382,0.00030859548,0.000022121467,0.000021264956,0.0008847483],"genre_scores_gemma":[0.99874526,0.00034268553,0.00054273003,0.00019159183,0.000040152685,0.0000063018333,0.000020695792,0.0000119305105,0.00009866837],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879014,0.00006060179,0.00032932736,0.00032102678,0.00023599087,0.00026293335],"domain_scores_gemma":[0.99935925,0.000066430795,0.00012072925,0.0002654534,0.00006720472,0.00012090232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021072886,0.0001636705,0.0003186547,0.000073586816,0.00006417766,0.00000918554,0.00010953841,0.00015052162,0.00011779422],"category_scores_gemma":[0.00017125667,0.00013600606,0.000030417375,0.00016182769,0.00032364632,0.000081193124,0.00009894228,0.00029031388,0.0000023630455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057015935,0.00013950588,0.99510574,0.000051978568,0.00003154314,0.00013026602,0.00071087107,9.426958e-7,0.0033190723,0.000004821117,0.00010078304,0.0003474601],"study_design_scores_gemma":[0.0017185415,0.00023189351,0.99376786,0.00053149636,0.00014912439,0.00024786912,0.00018440658,0.0000152155435,0.0028942907,0.000080611666,0.000034204746,0.00014445897],"about_ca_topic_score_codex":0.9913955,"about_ca_topic_score_gemma":0.97866845,"teacher_disagreement_score":0.012727044,"about_ca_system_score_codex":0.000076388096,"about_ca_system_score_gemma":0.0003859948,"threshold_uncertainty_score":0.55461663},"labels":[],"label_agreement":null},{"id":"W2980948123","doi":"10.1182/blood.v104.11.3642.3642","title":"Use of Intravenous Immunoglobulin for Treatment of Neurological Conditions: A Systematic Review.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Ottawa","funders":"","keywords":"Medicine; Clinical trial; Randomized controlled trial; Placebo; Meta-analysis; Exacerbation; MEDLINE; Systematic review; Intensive care medicine; Pediatrics; Internal medicine; Alternative medicine; Pathology","score_opus":0.029916954113242532,"score_gpt":0.278754082307923,"score_spread":0.24883712819468046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980948123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98188186,0.015707517,0.000053236672,0.00034942973,0.00003044593,0.0018675326,0.00005583104,0.000018680685,0.000035477788],"genre_scores_gemma":[0.9923688,0.006031835,0.0007007021,0.0006565258,0.00001267217,0.00016215675,0.000023822318,0.000009404892,0.000034055123],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99935955,0.000027289716,0.0003434698,0.000099354234,0.00007945773,0.00009090769],"domain_scores_gemma":[0.9995053,0.00006787915,0.000124361,0.0002064039,0.00006205043,0.000034024848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003613651,0.00007829083,0.00053440256,0.000021816819,0.000016739534,0.0000020625976,0.00003143161,0.000030947882,0.000012387213],"category_scores_gemma":[0.0002482841,0.000053886313,0.0001566785,0.00006579338,0.000044799992,0.000018563227,0.0000055410605,0.000016659247,0.000001801515],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017534867,0.046996064,0.0032529735,0.85670614,0.0018095978,0.0005851438,0.0012245364,0.0001715251,0.08156701,0.0046114773,0.00048476076,0.0008372514],"study_design_scores_gemma":[0.15491007,0.27413785,0.05250576,0.34066927,0.05017769,0.004855426,0.00093112694,0.00024221014,0.11087277,0.006083504,0.0026832533,0.0019310622],"about_ca_topic_score_codex":0.000026324371,"about_ca_topic_score_gemma":0.0000035677858,"teacher_disagreement_score":0.5160369,"about_ca_system_score_codex":0.00000745222,"about_ca_system_score_gemma":0.000035181463,"threshold_uncertainty_score":0.219742},"labels":[],"label_agreement":null},{"id":"W2980959578","doi":"10.1182/blood.v122.21.2591.2591","title":"PML-RARa Regulated Vesiculation Of Acute Promyelocytic Leukemia Cells","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal Children's Hospital","funders":"","keywords":"Acute promyelocytic leukemia; Tissue factor; Cancer research; Myeloid leukemia; Leukemia; Microvesicles; Disseminated intravascular coagulation; Flow cytometry; Biology; Immunology; Retinoic acid; Medicine; Coagulation; Cell culture; Pathology; microRNA; Internal medicine","score_opus":0.003889439952693784,"score_gpt":0.19863710226632883,"score_spread":0.19474766231363505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980959578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99673307,0.00035651753,0.00033251586,0.000022084483,0.00006786428,0.00025830255,0.000005388084,0.000018400682,0.0022058426],"genre_scores_gemma":[0.99653506,0.00009986816,0.0012836057,0.000040256957,0.000118385426,0.000035055404,0.00010864403,0.000022528453,0.0017565835],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991259,0.000034933757,0.00024281687,0.00026831828,0.0001343821,0.00019367735],"domain_scores_gemma":[0.999312,0.0000063415764,0.00012905421,0.0003497206,0.00014451491,0.00005839873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000070499904,0.0001405025,0.00014718123,0.000031246553,0.000040455518,0.000020517178,0.00018275765,0.00018598643,0.00006228454],"category_scores_gemma":[0.000018958532,0.00012655619,0.000080214864,0.00008766632,0.000075872,0.0000071482855,0.00006351586,0.000067157926,0.000042681328],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011790861,0.00006226441,0.00079506624,0.000054346587,0.00012797189,0.0000026953278,0.00004008434,0.000047358015,0.99768907,0.00002335891,0.0006596119,0.00048638092],"study_design_scores_gemma":[0.0008453947,0.00017747375,0.0031297808,0.00002024916,0.0001157544,0.000020215219,0.000015904174,0.00011011026,0.9944653,0.00017649961,0.00076596567,0.00015738347],"about_ca_topic_score_codex":0.000021927339,"about_ca_topic_score_gemma":7.906509e-7,"teacher_disagreement_score":0.0032238017,"about_ca_system_score_codex":0.000014958615,"about_ca_system_score_gemma":0.00015207658,"threshold_uncertainty_score":0.51608115},"labels":[],"label_agreement":null},{"id":"W2980962270","doi":"10.1182/blood-2018-99-111917","title":"Coordination of Pro- and Anti-Inflammatory Signals Determine Human Hematopoietic Stem and Progenitor Cell Expansion","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Progenitor cell; Haematopoiesis; Cell biology; Stem cell; Biology; Glucocorticoid receptor; Inflammation; CD86; Immunology; CD34; T cell; Glucocorticoid; Immune system","score_opus":0.012086355739949975,"score_gpt":0.23329839135068728,"score_spread":0.2212120356107373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980962270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908434,0.008588953,0.000011549922,0.000021545877,0.00009293231,0.00031794477,0.0000048890347,0.00003273794,0.00008600646],"genre_scores_gemma":[0.99884963,0.000080688376,0.000030360414,0.000015526512,0.000023617278,0.000017981127,0.000006723384,0.000015063736,0.00096038135],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991919,0.00015491644,0.0002685072,0.00018604645,0.000028259412,0.00017037916],"domain_scores_gemma":[0.99951494,0.0000666011,0.00014864122,0.00017460976,0.00008316518,0.0000120271025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020503972,0.00013148552,0.00023104853,0.00009010901,0.00018807642,0.000011624089,0.00007908518,0.00015060419,0.000054353695],"category_scores_gemma":[0.000010397545,0.00011344551,0.00003273642,0.000054488683,0.00035742283,0.00008473434,0.00005291721,0.00007853034,0.000017122544],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009998363,0.00021438667,0.006346125,0.00010318063,0.00006559034,0.0000022136783,0.0009997668,1.2637674e-8,0.9902841,0.000040900264,0.00004042566,0.0018033227],"study_design_scores_gemma":[0.0025754415,0.000674022,0.009991218,0.000078493504,0.00006204362,0.000106364256,0.0002454853,9.010655e-7,0.9853029,0.000024336941,0.0008117524,0.0001269946],"about_ca_topic_score_codex":0.0000077419545,"about_ca_topic_score_gemma":0.000001487329,"teacher_disagreement_score":0.008508265,"about_ca_system_score_codex":0.0000037140912,"about_ca_system_score_gemma":0.000026893666,"threshold_uncertainty_score":0.46261737},"labels":[],"label_agreement":null},{"id":"W2980964338","doi":"10.1182/blood-2018-99-110135","title":"Early Prediction of Stable MR4.5 By Achievement of 2.8 Log Reduction in BCR-ABL1 qPCR Levels at 6 Months in Patients with Chronic Myeloid Leukemia Treated with Frontline Imatinib","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Discontinuation; Imatinib; Medicine; Imatinib mesylate; Internal medicine; Oncology; Population; Univariate analysis; Tyrosine-kinase inhibitor; Myeloid leukemia; Multivariate analysis; Cancer; Environmental health","score_opus":0.009069011810929513,"score_gpt":0.21465828633521317,"score_spread":0.20558927452428366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980964338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972984,0.00027592617,0.000028098406,0.000032296433,0.00004605179,0.0015843968,0.0002817807,0.00004481277,0.00040823343],"genre_scores_gemma":[0.99769557,0.00003515643,0.0008408224,0.00000800205,0.000071426744,0.000100925354,0.00047552132,0.000056899713,0.0007156971],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99766016,0.000074092815,0.0007352087,0.00050608075,0.0005821034,0.00044237578],"domain_scores_gemma":[0.99867177,0.000025581887,0.00043044702,0.0005352644,0.00022647694,0.000110447916],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019387227,0.00032242035,0.00064718345,0.00026163078,0.000044817272,0.000006042121,0.000106528016,0.00016772689,0.00013039571],"category_scores_gemma":[0.000025303803,0.0002494648,0.00004594529,0.0005179145,0.00020644107,0.00021044524,0.000052947344,0.00020609982,0.000009761873],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035287498,0.004222858,0.9497953,0.00022656075,0.00040157716,0.000011087832,0.0008241783,0.00009157336,0.039376527,0.000002445077,0.00026048912,0.0012586755],"study_design_scores_gemma":[0.05579645,0.01149589,0.76454335,0.00082999223,0.00033654468,0.00000977566,0.000061812316,0.00023229001,0.16646092,0.0000035311812,0.00006310672,0.0001663145],"about_ca_topic_score_codex":0.0050968276,"about_ca_topic_score_gemma":0.0012304893,"teacher_disagreement_score":0.1852519,"about_ca_system_score_codex":0.003280193,"about_ca_system_score_gemma":0.0006170871,"threshold_uncertainty_score":0.99999577},"labels":[],"label_agreement":null},{"id":"W2980975062","doi":"10.1182/blood-2018-99-112337","title":"Excellence in PNH in Canada (EPIC): A Single Centre Pilot Project Evaluating Disease Trajectory for PNH Patients Receiving Eculizumab","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Eculizumab; Paroxysmal nocturnal hemoglobinuria; Medicine; Pediatrics; Internal medicine; Hemoglobinuria; Anemia; Immunology; Complement system","score_opus":0.04036043752115628,"score_gpt":0.27223555578971126,"score_spread":0.23187511826855497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980975062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966129,0.0007142213,0.000003794566,0.0000587935,0.0005752579,0.0015062682,0.00019019075,0.000030275578,0.0003083105],"genre_scores_gemma":[0.99929684,0.0000028741536,0.00008661644,0.00005772152,0.00004990903,0.00019615593,0.00014019407,0.000022478478,0.00014718427],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99808365,0.00035335132,0.00047279356,0.00044964207,0.00008965083,0.00055093545],"domain_scores_gemma":[0.9990944,0.0003000523,0.00015724458,0.00029970665,0.000107393076,0.00004114994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023539543,0.00019725955,0.00026122405,0.00013292131,0.00012328905,0.000012706239,0.00025703118,0.000042165106,0.00024405762],"category_scores_gemma":[0.0006628497,0.00020187967,0.000048576672,0.00018603403,0.000078106656,0.000075316806,0.00009352478,0.000102459344,0.000020438554],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006916799,0.0022353074,0.978365,0.00024384659,0.0000727694,0.000014320392,0.00086171576,0.000010206791,0.011590815,0.0000155552,0.0027361028,0.0031626972],"study_design_scores_gemma":[0.025284668,0.0019391461,0.95184255,0.0015959342,0.0002182991,0.0000048436546,0.0025814732,0.0001640278,0.012864351,0.00011531441,0.0024895286,0.00089984963],"about_ca_topic_score_codex":0.2263647,"about_ca_topic_score_gemma":0.8350896,"teacher_disagreement_score":0.60872495,"about_ca_system_score_codex":0.00041464003,"about_ca_system_score_gemma":0.001240545,"threshold_uncertainty_score":0.8232414},"labels":[],"label_agreement":null},{"id":"W2980976705","doi":"10.1182/blood-2018-99-114289","title":"Blood Loss Due to Laboratory Testing in Critical Care Patients: A Retrospective Cohort Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Phlebotomy; Anemia; Intensive care unit; Retrospective cohort study; Blood transfusion; Population; Cohort study; Cohort; Hemoglobin; Odds ratio; Confidence interval; Hematocrit; Internal medicine","score_opus":0.014152341475314335,"score_gpt":0.29298369444419226,"score_spread":0.2788313529688779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980976705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898262,0.00004788755,0.000015940155,0.00024607548,0.00018852098,0.0018265175,0.000021734142,0.00010794972,0.0077191996],"genre_scores_gemma":[0.997645,0.0000014733853,0.0009896641,0.000921069,0.00021700827,0.00014821612,0.0000060793627,0.000030065361,0.000041380932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983857,0.00006835831,0.00028510168,0.00049649767,0.00043844728,0.000325882],"domain_scores_gemma":[0.99857485,0.00005067248,0.000025042722,0.00038872272,0.0007585185,0.00020219688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002387851,0.00017036217,0.00035467933,0.00017448037,0.00009278857,0.000022593924,0.000100476085,0.00006399689,0.000097919874],"category_scores_gemma":[0.0008613782,0.00015953918,0.000033705808,0.00073198194,0.00007456485,0.000056022967,0.00009256776,0.00020609712,0.000082217484],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004978434,0.0064556426,0.9894916,0.000072491945,0.000104687555,0.0006896703,0.0024339128,7.064971e-8,0.00022524677,0.000114786584,0.000103094266,0.00025902322],"study_design_scores_gemma":[0.007412088,0.0038357824,0.9842605,0.00012990729,0.00068067526,0.000011526506,0.00182092,0.0000011965762,0.0014644044,0.000015650237,0.0001981158,0.00016924096],"about_ca_topic_score_codex":0.00017910181,"about_ca_topic_score_gemma":0.00045569753,"teacher_disagreement_score":0.007818868,"about_ca_system_score_codex":0.000055332963,"about_ca_system_score_gemma":0.000068211506,"threshold_uncertainty_score":0.6505819},"labels":[],"label_agreement":null},{"id":"W2980978150","doi":"10.1182/blood-2018-99-115323","title":"Identification of Compounds That Target Acute Myeloid Leukemia Stem Cells Using a Scalable Next-Generation Screening Platform","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Myeloid leukemia; Stem cell; Gene signature; Haematopoiesis; Minimal residual disease; Progenitor cell; Cancer research; Transplantation; Population; Medicine; Leukemia; Druggability; Immunology; Biology; Internal medicine; Gene expression; Gene; Genetics","score_opus":0.0802634306510698,"score_gpt":0.30208179351234576,"score_spread":0.22181836286127596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980978150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98584044,0.0001835631,0.012448643,0.00007777866,0.00018704095,0.00056782836,0.000033689194,0.00007902571,0.0005820058],"genre_scores_gemma":[0.98185784,0.000058265967,0.016104665,0.000091565824,0.00067570375,0.000016037504,0.00009632148,0.000055009474,0.0010445914],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978339,0.000054724136,0.0005468185,0.00042353023,0.00069124566,0.00044976315],"domain_scores_gemma":[0.99846315,0.000053018513,0.00029813187,0.00058375177,0.00042366737,0.00017826205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006771587,0.00021503733,0.00040060133,0.00028080924,0.0002554184,0.000103693295,0.00023400797,0.0001978287,0.000088502704],"category_scores_gemma":[0.000024199706,0.00020314683,0.00011285245,0.0004904431,0.00021856242,0.00052514876,0.00012877546,0.0002816408,0.00007553142],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012616151,0.00012518387,0.0037333404,0.000082775936,0.0002572717,0.000019684918,0.000331687,0.000045283996,0.99319243,0.000046250247,0.0008759923,0.0011639126],"study_design_scores_gemma":[0.0027574827,0.00020057327,0.0010809781,0.00009820837,0.00033262616,0.00012188083,0.00024569323,0.07898029,0.91563535,0.000021332813,0.00035819717,0.00016738885],"about_ca_topic_score_codex":0.00015344375,"about_ca_topic_score_gemma":0.000011132327,"teacher_disagreement_score":0.078935005,"about_ca_system_score_codex":0.00038347952,"about_ca_system_score_gemma":0.0005162375,"threshold_uncertainty_score":0.8284088},"labels":[],"label_agreement":null},{"id":"W2980978866","doi":"10.1182/blood-2018-99-110649","title":"Cost of Care at NCI-Designated Comprehensive Cancer Centers Vs. Other Treatment Sites for Young Adults with Newly-Diagnosed Acute Lymphoblastic Leukemia (ALL)","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Cancer; Confidence interval; Censoring (clinical trials); Cohort; Comorbidity; Internal medicine; Demography","score_opus":0.023588114158481055,"score_gpt":0.2959930337211731,"score_spread":0.272404919562692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980978866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99414986,0.00066956144,0.00045308348,0.00014959232,0.00012608236,0.0031108386,0.0008522521,0.00010616069,0.00038255003],"genre_scores_gemma":[0.9948263,0.00028972636,0.0021408626,0.0004742892,0.00031833284,0.0007084927,0.0003490095,0.00013611185,0.0007568705],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99758905,0.00005700244,0.00039875394,0.00064193306,0.00056341704,0.00074985996],"domain_scores_gemma":[0.9973846,0.00041521745,0.00021870325,0.00054518745,0.0010845499,0.00035172395],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000042397467,0.00044760382,0.0007487384,0.00018168517,0.00014583649,0.00002096411,0.00021051792,0.00018891688,0.00021283758],"category_scores_gemma":[0.00006354399,0.00032123062,0.00017301104,0.00030614674,0.0004167012,0.00007540865,0.00008472565,0.000087821725,0.000047805825],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13755098,0.0049370867,0.23455396,0.0042610946,0.023379233,0.0026202532,0.04659272,0.00063682173,0.5071548,0.00007342872,0.027883258,0.01035636],"study_design_scores_gemma":[0.23792623,0.025914354,0.023122216,0.0027551854,0.0069097457,0.000558702,0.0033881685,0.007345671,0.68286335,0.000004967547,0.008175224,0.0010361806],"about_ca_topic_score_codex":0.0031877987,"about_ca_topic_score_gemma":0.0030291486,"teacher_disagreement_score":0.21143174,"about_ca_system_score_codex":0.0039413683,"about_ca_system_score_gemma":0.0015298098,"threshold_uncertainty_score":0.999924},"labels":[],"label_agreement":null},{"id":"W2981034078","doi":"10.1182/blood-2018-99-115371","title":"Iron Deficiency Project in Pregnancy: Maternal Iron Optimization (IRON MOM)","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Medicine; Pregnancy; Anemia; Low birth weight; Apgar score; Obstetrics; Pediatrics; Prenatal care; Birth weight; Population; Internal medicine","score_opus":0.012837063448043681,"score_gpt":0.2596591613145928,"score_spread":0.24682209786654913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981034078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97821814,0.0016802083,0.0005964869,0.00011655541,0.00020087574,0.0005709717,0.0000054841894,0.000074536925,0.018536761],"genre_scores_gemma":[0.9931391,0.00030908713,0.005013035,0.00013380783,0.0001940814,0.000034461475,0.000028511058,0.000030694282,0.0011172412],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988605,0.00003884401,0.00024251043,0.00029311562,0.00024474374,0.00032029167],"domain_scores_gemma":[0.9995522,0.000007933241,0.000069955175,0.0002692782,0.000043436798,0.00005719013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000105328836,0.00015065771,0.00018900027,0.00016927376,0.000057266385,0.000020694042,0.00009763559,0.0001011503,0.0002060629],"category_scores_gemma":[0.000051137136,0.00012941431,0.000040688705,0.00024143998,0.000082122395,0.00011901004,0.00003766217,0.000104587605,0.000080543774],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085761887,0.007483703,0.9313531,0.002719743,0.000017027749,0.0002365674,0.0073587107,0.0017428738,0.022080127,0.001768149,0.001585164,0.022797203],"study_design_scores_gemma":[0.05596107,0.004590291,0.8677074,0.0023039423,0.0014030442,0.00037733236,0.0016398631,0.0067033772,0.05455547,0.0003969233,0.002459108,0.0019022377],"about_ca_topic_score_codex":0.00021507037,"about_ca_topic_score_gemma":0.00003598578,"teacher_disagreement_score":0.063645765,"about_ca_system_score_codex":0.000019055178,"about_ca_system_score_gemma":0.00009486779,"threshold_uncertainty_score":0.52773625},"labels":[],"label_agreement":null},{"id":"W2981046189","doi":"10.1182/blood.v122.21.2527.2527","title":"Mutations In UBA3 Confer Resistance To The NEDD8-Activating Enzyme Inhibitor MLN4924 In Human Leukemic Cells","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Neddylation; NEDD8; K562 cells; Cullin; Biology; Efflux; Population; Cell biology; Chemistry; In vitro; Biochemistry; Medicine; Ubiquitin","score_opus":0.012033436406957932,"score_gpt":0.23646808851935916,"score_spread":0.22443465211240124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981046189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946204,0.00020876378,0.00005656497,0.0004046738,0.000046991456,0.00046568064,0.000011544813,0.000008847925,0.0041765473],"genre_scores_gemma":[0.9975133,0.000007469061,0.0004545079,0.00039220255,0.00016858379,0.00022020844,0.000027407179,0.000016780066,0.0011995214],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991612,0.000075936085,0.00020713206,0.0002441282,0.0000802634,0.0002313399],"domain_scores_gemma":[0.9995905,0.000020538046,0.000048722766,0.00025055098,0.000040418396,0.00004922437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000154479,0.000108988235,0.000096877986,0.00004625081,0.000081137914,0.000038221733,0.00016828507,0.00008962129,0.00004869933],"category_scores_gemma":[0.00006713374,0.00009294671,0.000031990254,0.00013373597,0.000031808187,0.000005509241,0.00007367132,0.00012851806,0.00004422425],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006337659,0.00007211646,0.0011830914,0.000011166823,0.000006097943,0.0000022428055,0.00033969517,0.00003360557,0.9972425,0.00012467252,0.00080110895,0.000177383],"study_design_scores_gemma":[0.0006870064,0.00006202098,0.0044949087,0.00004107427,0.0000032415226,0.0000016055434,0.00021939697,0.000008291337,0.98743576,0.00020202805,0.006710202,0.00013443752],"about_ca_topic_score_codex":0.00016771775,"about_ca_topic_score_gemma":0.0007837055,"teacher_disagreement_score":0.009806695,"about_ca_system_score_codex":0.00001584613,"about_ca_system_score_gemma":0.00006442657,"threshold_uncertainty_score":0.3790257},"labels":[],"label_agreement":null},{"id":"W2981047876","doi":"10.1182/blood.v104.11.2600.2600","title":"High Incidence of Pelvic Deep Vein Thrombosis Detected by Magnetic Resonance Venograpy Post-Caesarean Section.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Caesarean section; Radiology; Magnetic resonance imaging; Thrombosis; Deep vein; Incidence (geometry); Venography; Venous thrombosis; Pregnancy; Surgery; Obstetrics","score_opus":0.006591946632104254,"score_gpt":0.22589121810536672,"score_spread":0.21929927147326247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981047876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920694,0.005773833,0.00009873224,0.00060961006,0.0001999639,0.0005666902,0.000024856114,0.000116408635,0.00054049754],"genre_scores_gemma":[0.99544203,0.0019317227,0.0017907708,0.00051000295,0.00012784277,0.00006585925,0.000036781345,0.000038734303,0.000056249974],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984915,0.00003570707,0.0003692975,0.00036619476,0.00039677054,0.00034052855],"domain_scores_gemma":[0.9990347,0.000036134228,0.00012848176,0.00048058396,0.00018852315,0.0001315791],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013072269,0.00020849565,0.00048423497,0.00017274676,0.000097587006,0.000018449671,0.00017092213,0.00011051973,0.00021344572],"category_scores_gemma":[0.00008997182,0.00019966331,0.00012263971,0.00052572787,0.00010798694,0.00008951336,0.00006692494,0.00016944854,0.000036079633],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005719408,0.042339586,0.11236452,0.0020220059,0.0016062481,0.0004907182,0.008050369,0.00030945044,0.74173343,0.0043840795,0.010929252,0.075198375],"study_design_scores_gemma":[0.006072103,0.0036031203,0.90101385,0.00037700875,0.0007127296,0.000040132687,0.00022773346,0.0000071651148,0.084979996,0.0003174783,0.0023606399,0.00028805283],"about_ca_topic_score_codex":0.002197124,"about_ca_topic_score_gemma":0.00036186678,"teacher_disagreement_score":0.7886493,"about_ca_system_score_codex":0.000060013837,"about_ca_system_score_gemma":0.0000725978,"threshold_uncertainty_score":0.8142033},"labels":[],"label_agreement":null},{"id":"W2981054177","doi":"10.1182/blood.v124.21.3040.3040","title":"Genetic Alterations of the MHC Class II Transactivator CIITA Are Frequent in Primary Mediastinal Large B-Cell Lymphoma and Associated with Diminished MHC Class II Expression","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"CIITA; Biology; Genetics; MHC class I; MHC class II; Major histocompatibility complex; Cancer research; Computational biology; Gene","score_opus":0.0065563403538149885,"score_gpt":0.19593731571910683,"score_spread":0.18938097536529183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981054177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972943,0.0003948304,0.00003041135,0.00074978994,0.00005922855,0.0005469559,0.000075175645,0.000024785923,0.0008245064],"genre_scores_gemma":[0.9989811,0.0000502113,0.00026299508,0.0003538762,0.00005405602,0.00012663825,0.000041582396,0.00002667156,0.00010284437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985661,0.00011893697,0.0003348471,0.00032289012,0.00037748783,0.00027973764],"domain_scores_gemma":[0.9990692,0.00016663737,0.00021429225,0.0003439851,0.00007302854,0.00013281684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013982675,0.0002171411,0.00040937387,0.00006616958,0.00021036754,0.000014314923,0.00009827901,0.0001247838,0.00002400605],"category_scores_gemma":[0.000070717084,0.00013323937,0.00008055171,0.00016603502,0.00007868225,0.000059302743,0.000060804945,0.000088737455,0.000001002978],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025807784,0.027540829,0.91003597,0.00019392518,0.00028682544,0.000088659304,0.0023543427,0.000012502437,0.057338733,0.000051040228,0.00047933892,0.0013597502],"study_design_scores_gemma":[0.028690038,0.0009675306,0.88522184,0.00068583305,0.00043326893,0.000028734152,0.00011067338,0.0001277595,0.08324778,0.00001751122,0.00032398145,0.00014502743],"about_ca_topic_score_codex":0.000031269818,"about_ca_topic_score_gemma":0.00017452642,"teacher_disagreement_score":0.028431961,"about_ca_system_score_codex":0.00011678169,"about_ca_system_score_gemma":0.00017174102,"threshold_uncertainty_score":0.5433344},"labels":[],"label_agreement":null},{"id":"W2981054791","doi":"10.1182/blood.v120.21.3390.3390","title":"Non-Cirrhotic Splanchnic Vein Thrombosis: When Is Anticoagulation Enough?","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Splenic vein; Superior mesenteric vein; Thrombosis; Portal vein thrombosis; Splanchnic; Inferior mesenteric vein; Surgery; Portal hypertension; Mesenteric Vein; Splanchnic Circulation; Vein; Radiology; Internal medicine; Cirrhosis; Portal vein; Hemodynamics","score_opus":0.02362631364608325,"score_gpt":0.27065144422241,"score_spread":0.24702513057632675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981054791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99498904,0.0006103122,0.00014225094,0.00026470047,0.0001476983,0.00026891296,0.000014040195,0.000059192662,0.0035038355],"genre_scores_gemma":[0.9984191,0.00008193452,0.00033620463,0.0004690836,0.0004028342,0.000012797342,0.00009557919,0.000019770776,0.00016266518],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992996,0.0000133323,0.00014027234,0.00013334065,0.00019046343,0.00022298802],"domain_scores_gemma":[0.99958426,0.000013436837,0.00004038236,0.0001903246,0.00003283779,0.00013876073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007608903,0.0000999865,0.00015357677,0.000057637746,0.00003828161,0.00001119412,0.00003750936,0.00006522497,0.00031880362],"category_scores_gemma":[0.0000025333713,0.000089647765,0.00006298264,0.00007505496,0.000017327291,0.00021490584,0.000006857036,0.00006967969,0.00055525283],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007419188,0.0016839142,0.966794,0.00055798393,0.00071058073,0.000021269701,0.0080263335,4.3198457e-7,0.020494645,0.00024611814,0.0011821879,0.00020835316],"study_design_scores_gemma":[0.0026697638,0.00010573473,0.9583943,0.00014715637,0.0027118197,0.000038020393,0.000072678966,0.000026297159,0.035245933,0.00029860513,0.0001650218,0.0001246706],"about_ca_topic_score_codex":0.000032190717,"about_ca_topic_score_gemma":0.0000013364186,"teacher_disagreement_score":0.014751287,"about_ca_system_score_codex":0.000011491073,"about_ca_system_score_gemma":0.000027866135,"threshold_uncertainty_score":0.7136837},"labels":[],"label_agreement":null},{"id":"W2981061287","doi":"10.1182/blood-2018-99-116981","title":"Inactivation of Stage-Specific B-Cell Commitment Genes Generates Distinct Molecular Subtypes of BCR-ABL1 Lymphoblastic Leukemia","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Princess Margaret Cancer Centre; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Biology; Imatinib mesylate; Cancer research; Myeloid leukemia; Dasatinib; Leukemia; Immunology; Imatinib","score_opus":0.014884738564380445,"score_gpt":0.24219055843686338,"score_spread":0.22730581987248294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981061287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99430394,0.00233141,0.0004310407,0.000020260772,0.00009906444,0.00041136917,0.00003935108,0.000036413487,0.002327155],"genre_scores_gemma":[0.9966634,0.00016977527,0.002347564,0.000025755333,0.00014739473,0.000024823124,0.000093272334,0.000038428785,0.00048958557],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99860334,0.000054403175,0.00043771986,0.00030826102,0.00035336515,0.00024288803],"domain_scores_gemma":[0.99875,0.00008701818,0.00027896455,0.00054007955,0.00024834715,0.0000955954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011038382,0.00022019564,0.0004341784,0.00012039479,0.000050408853,0.000007685019,0.00012074368,0.000100255376,0.00023614414],"category_scores_gemma":[0.000047784688,0.00018997584,0.000102130594,0.00024130274,0.00019265887,0.0000483672,0.00006401046,0.00007023419,0.000038303642],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002505637,0.0014515226,0.036556467,0.0003202872,0.000303422,0.000050077877,0.00022534296,0.000038491857,0.9584558,0.00023070305,0.00021255932,0.0019047777],"study_design_scores_gemma":[0.0077430317,0.0010700002,0.020095194,0.00012752994,0.00032928342,0.000017249447,0.00007058124,0.0002347276,0.96877426,0.00003129821,0.0013683189,0.00013851139],"about_ca_topic_score_codex":0.0002037818,"about_ca_topic_score_gemma":0.0000135121345,"teacher_disagreement_score":0.016461274,"about_ca_system_score_codex":0.00056234584,"about_ca_system_score_gemma":0.0004698222,"threshold_uncertainty_score":0.774699},"labels":[],"label_agreement":null},{"id":"W2981067009","doi":"10.1182/blood-2018-99-119859","title":"Frozen Plasma Transfusion Practices in Ontario-an Electronic Audit at Five Tertiary Care Hospitals to Inform a Knowledge Translation Strategy to Reduce Inappropriate Plasma Transfusions","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Fresh frozen plasma; Partial thromboplastin time; Prothrombin time; Adverse effect; Intensive care medicine; Population; Audit; Emergency medicine; Coagulation testing; Coagulation; Surgery; Internal medicine; Platelet","score_opus":0.02773891276685643,"score_gpt":0.299272623979093,"score_spread":0.2715337112122366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981067009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9785207,0.00014964944,0.00011683717,0.002936135,0.00024892084,0.0040159696,0.000025937863,0.00023083706,0.013755025],"genre_scores_gemma":[0.99575794,0.0001662667,0.0012643512,0.0004840126,0.00017823373,0.00039675963,0.00011175373,0.00008297109,0.001557719],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.99699664,0.00010681655,0.0006918135,0.0008884897,0.0004932007,0.0008230647],"domain_scores_gemma":[0.9984245,0.00007134796,0.00013468058,0.0005934971,0.00022498002,0.0005509945],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036902045,0.0004521658,0.0005329466,0.0005590703,0.00033031343,0.0000630915,0.00029827593,0.00029152568,0.00065046694],"category_scores_gemma":[0.000049491668,0.00042182827,0.00016851601,0.0007708705,0.000058144466,0.00045505626,0.000055648983,0.00057731755,0.0003002915],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010185638,0.009263335,0.024523683,0.0008810447,0.0010710491,0.00027024312,0.44487554,0.0002197283,0.23371011,0.0008545299,0.0013726922,0.2727724],"study_design_scores_gemma":[0.05817297,0.03515075,0.47069174,0.0017145996,0.0037817275,0.00029844674,0.027806014,0.00069779693,0.26304287,0.00018894796,0.1356667,0.0027874329],"about_ca_topic_score_codex":0.015923575,"about_ca_topic_score_gemma":0.74055475,"teacher_disagreement_score":0.72463113,"about_ca_system_score_codex":0.00039323885,"about_ca_system_score_gemma":0.00071320555,"threshold_uncertainty_score":0.99982333},"labels":[],"label_agreement":null},{"id":"W2981067981","doi":"10.1182/blood.v122.21.3392.3392","title":"Early Recovery Of Absolute Lymphocyte Counts ≥ 0.2x109/L At Day 21 Can Predict Reduced Risk Of Relapse In Acute Lymphoblastic Leukemia Following Allogeneic Stem Cell Transplantation","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Transplantation; Internal medicine; Hematopoietic stem cell transplantation; Lymphocyte; Stem cell; Donor lymphocyte infusion; Acute lymphocytic leukemia; Leukemia; Gastroenterology; Surgery; Immunology; Lymphoblastic Leukemia; Biology","score_opus":0.00780403072152632,"score_gpt":0.22199506324704435,"score_spread":0.21419103252551802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981067981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959469,0.0004056641,0.00009966332,0.000021057836,0.0002345691,0.00076276937,0.00020542934,0.0000432469,0.0022807154],"genre_scores_gemma":[0.99537814,0.0011776348,0.0004431262,0.000030369882,0.000060587394,0.0000690905,0.000087043634,0.000067249304,0.0026867387],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9973897,0.00016839291,0.00075852394,0.00043648045,0.00074256165,0.00050439534],"domain_scores_gemma":[0.99844027,0.0003787469,0.00031633233,0.0005127611,0.00013966764,0.00021220821],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040775313,0.00027019015,0.0006078841,0.00032470256,0.00005232998,0.000013834775,0.00024414636,0.00027381416,0.000112337446],"category_scores_gemma":[0.00007052573,0.0002474282,0.00022455827,0.00043156111,0.00010273353,0.00014652101,0.000069093316,0.00019522855,0.00013027433],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023079126,0.0009401428,0.11136463,0.0015850528,0.002464382,0.0011861924,0.0041495087,0.0006118696,0.8677295,0.0000119317565,0.0020376425,0.0056112404],"study_design_scores_gemma":[0.040919237,0.0016712397,0.55277324,0.0015102726,0.0035676118,0.00039822413,0.00019359156,0.0029440573,0.39522377,0.00006684022,0.00009658194,0.0006353428],"about_ca_topic_score_codex":0.0016661199,"about_ca_topic_score_gemma":0.000057513622,"teacher_disagreement_score":0.47250572,"about_ca_system_score_codex":0.0015296974,"about_ca_system_score_gemma":0.0016231437,"threshold_uncertainty_score":0.9999978},"labels":[],"label_agreement":null},{"id":"W2981072465","doi":"10.1182/blood-2018-99-114440","title":"Protides of 5-Fluorotroxacitabine Display Potent Anti-Proliferative Properties and Circumvent Deoxycytidine Kinase-Mediated Resistance Associated with Cytotoxic Cytidine Analogues; A Novel Approach for Acute Myeloid Leukemia","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Deoxycytidine kinase; Cytarabine; Cytidine deaminase; Deoxycytidine; Cytidine; Cancer research; Myeloid leukemia; Leukemia; Azacitidine; Nucleoside analogue; Gemcitabine; Pharmacology; Biology; Chemistry; Medicine; Chemotherapy; Nucleoside; Immunology; Internal medicine; Biochemistry; Enzyme; Antibody","score_opus":0.030740436558158703,"score_gpt":0.263421444057845,"score_spread":0.23268100749968632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981072465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905282,0.00075392623,0.0026389172,0.00017795326,0.000029229124,0.005042714,0.00040325487,0.00012111745,0.00030467007],"genre_scores_gemma":[0.99037075,0.00010964031,0.006857501,0.00008391228,0.00023496777,0.0010412183,0.0004912455,0.00010639973,0.0007043759],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965392,0.00009540744,0.00072782364,0.0008776482,0.00088439684,0.0008755449],"domain_scores_gemma":[0.9973523,0.00018236609,0.0003810685,0.00062439794,0.0011146014,0.00034525662],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00068182155,0.00050846627,0.0011643193,0.00026782675,0.00024953828,0.00005066508,0.00025563675,0.00023664082,0.000007629632],"category_scores_gemma":[0.0009800122,0.00035348372,0.00014368726,0.0007554507,0.0010331975,0.00019912205,0.00014809432,0.00030799257,0.0000030891647],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061204988,0.0037212095,0.0050142384,0.0017913637,0.004119734,0.0001341562,0.00140437,0.000032168078,0.9769992,0.0002805026,0.00026180976,0.00012070725],"study_design_scores_gemma":[0.10556017,0.005681521,0.021615652,0.0020741785,0.002275396,0.00046950218,0.000396949,0.021893136,0.83908874,0.000036668276,0.00010665397,0.00080141297],"about_ca_topic_score_codex":0.00014537186,"about_ca_topic_score_gemma":0.00014999413,"teacher_disagreement_score":0.13791047,"about_ca_system_score_codex":0.0029560693,"about_ca_system_score_gemma":0.00436104,"threshold_uncertainty_score":0.9998917},"labels":[],"label_agreement":null},{"id":"W2981080019","doi":"10.1182/blood.v118.21.874.874","title":"Randomized Comparison of IV PEG and IM E. Coli Asparaginase in Children and Adolescents with Acute Lymphoblastic Leukemia: Results of the DFCI ALL Consortium Protocol 05-01","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Centre Hospitalier Universitaire Sainte-Justine; McMaster University","funders":"","keywords":"Medicine; Asparaginase; Gastroenterology; Internal medicine; Randomized controlled trial; PEG ratio; Surgery; Pediatrics; Lymphoblastic Leukemia; Leukemia","score_opus":0.018123592860179748,"score_gpt":0.28427164982912656,"score_spread":0.26614805696894683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981080019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95933014,0.000056753455,0.000030330422,0.00006230493,0.000015571602,0.0399804,0.000048908292,0.000019310684,0.00045629297],"genre_scores_gemma":[0.994709,0.000018662244,0.00042799543,0.000062558414,0.000022970815,0.0046547316,0.00000877334,0.000032673892,0.000062641484],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9975254,0.00028504315,0.00081801176,0.00042256046,0.0005558907,0.00039312686],"domain_scores_gemma":[0.99844694,0.00021590486,0.00045776565,0.00051568606,0.00016395516,0.00019976325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005941195,0.00027528201,0.001116235,0.00016698234,0.00004664981,0.00001153147,0.00022087908,0.00016412232,0.000008637188],"category_scores_gemma":[0.00044189632,0.00016481729,0.0000776656,0.0002891547,0.001143371,0.00006875838,0.0002197217,0.00030309017,0.0000018367417],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4226202,0.003056285,0.5631874,0.00095152674,0.0013216151,0.0001747331,0.003172785,0.0000078858375,0.004640996,0.00006702542,0.0005929987,0.00020653664],"study_design_scores_gemma":[0.6169402,0.0009425037,0.34476462,0.0012491042,0.0010030178,0.00049943896,0.00009597756,0.00086882507,0.033427246,0.000030456398,0.000008687062,0.00016994178],"about_ca_topic_score_codex":0.00094200956,"about_ca_topic_score_gemma":0.000073142604,"teacher_disagreement_score":0.21842279,"about_ca_system_score_codex":0.00013684768,"about_ca_system_score_gemma":0.0009249689,"threshold_uncertainty_score":0.6721054},"labels":[],"label_agreement":null},{"id":"W2981104031","doi":"10.1182/blood.v128.22.1032.1032","title":"Transfusion of Red Cells in Hematopoietic Stem Cell Transplantation (TRIST Study): A Randomized Controlled Trial Evaluating 2 Red Cell Transfusion Thresholds","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; McMaster University; Juravinski Hospital; University of Ottawa; Ottawa Hospital; University of Saskatchewan; University of Calgary","funders":"","keywords":"Medicine; Transplantation; Clinical endpoint; Hematopoietic stem cell transplantation; Randomized controlled trial; Incidence (geometry); Randomization; Blood transfusion; Adverse effect; Anemia; Internal medicine; Pediatrics; Surgery","score_opus":0.01880521458679265,"score_gpt":0.2760343270201305,"score_spread":0.25722911243333785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981104031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9723015,0.0002579368,0.0026287467,0.00021381528,0.00036249668,0.020640647,0.000031276777,0.00010338955,0.003460222],"genre_scores_gemma":[0.9960542,0.001609499,0.00053890445,0.000019189503,0.000087968765,0.001130145,0.00002748456,0.00008136974,0.00045124258],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9929679,0.0015956165,0.0028161348,0.00077964086,0.0013312009,0.0005094863],"domain_scores_gemma":[0.99631596,0.0021031834,0.000604086,0.0005603225,0.00021928875,0.00019713672],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004297996,0.000518999,0.002983957,0.00052402046,0.000094498086,0.000020307887,0.00020264857,0.0003468943,0.00026542888],"category_scores_gemma":[0.00005495093,0.0003459159,0.0007808032,0.00050579035,0.000116670075,0.00014595695,0.000009050975,0.00027566476,0.00001592637],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5190868,0.003858272,0.00087163807,0.0008742243,0.000111666865,0.00009931852,0.00549779,0.000008268114,0.46931678,0.0000058331925,0.0000036818894,0.00026576512],"study_design_scores_gemma":[0.62956876,0.0021861354,0.0002442215,0.00085056195,0.0027075454,0.000037176073,0.00067664066,0.00010158928,0.36335838,0.000035202866,0.000001068433,0.00023274911],"about_ca_topic_score_codex":0.00008879435,"about_ca_topic_score_gemma":0.000065097105,"teacher_disagreement_score":0.11048198,"about_ca_system_score_codex":0.000066988585,"about_ca_system_score_gemma":0.00026516104,"threshold_uncertainty_score":0.99989927},"labels":[],"label_agreement":null},{"id":"W2981117365","doi":"10.1182/blood-2018-99-120120","title":"Synthetic De Novo Modeling of Human T-Cell Acute Lymphoblastic Leukemia Reveals HOXB Genes Drive Expansion of Leukemia Cells-of-Origin and Established Tumor Clones","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Biology; Leukemia; Cancer research; Progenitor cell; Haematopoiesis; Context (archaeology); Transcriptome; Stem cell; Immunology; Molecular biology; Gene; Genetics; Gene expression","score_opus":0.021214119919132746,"score_gpt":0.2869788202060972,"score_spread":0.2657647002869645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981117365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973656,0.0006881996,0.00032766454,0.000010779294,0.00006776422,0.00046675306,0.000026936328,0.000030174084,0.0010161485],"genre_scores_gemma":[0.99619395,0.0003874833,0.0025309175,0.000020412017,0.00016623535,0.000016638347,0.000009783913,0.000061647355,0.0006129353],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99789333,0.000106509404,0.0006421627,0.00041638827,0.000514944,0.00042668325],"domain_scores_gemma":[0.998297,0.0001945235,0.00025268222,0.0006236759,0.00043741133,0.00019474352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005117815,0.00024409937,0.0007342909,0.00030531365,0.000075426,0.000013806023,0.0002232463,0.00014335147,0.00019590568],"category_scores_gemma":[0.00008334961,0.00021881364,0.00013533513,0.00030902668,0.00039725093,0.000080644146,0.00013090484,0.00016749353,0.0000049308774],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039913578,0.00023358996,0.004036376,0.0006956212,0.00015283997,0.000052740994,0.0008361593,0.00015641341,0.99288905,0.000022980768,0.000032188498,0.00049288786],"study_design_scores_gemma":[0.0051246197,0.0013000963,0.0005577148,0.0006216818,0.0005701984,0.00012599368,0.00025094888,0.008893522,0.9821751,0.00018016936,0.00001873111,0.00018121407],"about_ca_topic_score_codex":0.0005073249,"about_ca_topic_score_gemma":0.000020596508,"teacher_disagreement_score":0.010713957,"about_ca_system_score_codex":0.00020148704,"about_ca_system_score_gemma":0.00074808445,"threshold_uncertainty_score":0.89229614},"labels":[],"label_agreement":null},{"id":"W2981118230","doi":"10.1182/blood-2018-99-118914","title":"Recurrent Stroke: The Role of Thrombophilia in a Large International Pediatric Stroke Population","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Medicine; Stroke (engine); Hazard ratio; Pediatrics; Thrombophilia; Cohort; Internal medicine; Population; Risk factor; Confidence interval; Surgery; Thrombosis","score_opus":0.01407016364998926,"score_gpt":0.2764092195742243,"score_spread":0.26233905592423507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981118230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950353,0.00024839013,0.00005318428,0.00028983553,0.00037370648,0.00025626802,0.000039304206,0.000026779144,0.0036772368],"genre_scores_gemma":[0.9987961,0.00005057683,0.00034062896,0.00008911619,0.00054363627,0.0000117512045,0.000040597202,0.000011552677,0.00011602828],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901986,0.000040300256,0.0002882482,0.00016493611,0.00033268693,0.00015398067],"domain_scores_gemma":[0.9994782,0.000024898558,0.00012321964,0.00021892341,0.00011117873,0.0000435304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024483053,0.000091008726,0.00017605834,0.00015249965,0.000042113905,0.000009631888,0.00011700518,0.00006971203,0.00031950342],"category_scores_gemma":[0.00006761757,0.000068402995,0.00007099147,0.0001885526,0.000022301412,0.00006122511,0.00005314893,0.00012815159,0.00002992318],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000672403,0.0015677365,0.96694714,0.000019593746,0.00009528748,0.0000017569413,0.0004955683,8.251048e-7,0.015586072,0.012548326,0.00005134607,0.0026190812],"study_design_scores_gemma":[0.0034141266,0.0003730733,0.9760268,0.00003345838,0.00020798157,0.000009333806,0.00023290633,0.00064360106,0.016510028,0.0017347793,0.00072521885,0.000088711284],"about_ca_topic_score_codex":0.00003960483,"about_ca_topic_score_gemma":0.000102828046,"teacher_disagreement_score":0.010813546,"about_ca_system_score_codex":0.000018940078,"about_ca_system_score_gemma":0.000034112334,"threshold_uncertainty_score":0.34983385},"labels":[],"label_agreement":null},{"id":"W2981120128","doi":"10.1182/blood-2018-99-116256","title":"MiR-193a Is a Negative Regulator of Hematopoietic Stem Cells and Promotes Anti-Leukemic Effects in Acute Myeloid Leukemia","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Haematopoiesis; Myeloid; Stem cell; Myeloid leukemia; Biology; Cancer research; Progenitor cell; Hematopoietic stem cell; microRNA; Leukemia; Hematopoietic growth factor; Granulocyte colony-stimulating factor; Immunology; Cell biology; Genetics; Gene; Chemotherapy","score_opus":0.004907692437086848,"score_gpt":0.21814791106522977,"score_spread":0.2132402186281429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981120128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986411,0.00072128966,0.000051269642,0.000021493797,0.00004529295,0.0004141945,0.000030045041,0.000010056871,0.00006525943],"genre_scores_gemma":[0.99895126,0.000046330333,0.00070969074,0.000049637332,0.00007426222,0.00001926619,0.000012243577,0.000024148312,0.00011316742],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990359,0.000062379935,0.00022829112,0.00036253943,0.00010770377,0.0002031744],"domain_scores_gemma":[0.99936545,0.000019525765,0.00013445815,0.00033035388,0.00007804111,0.00007219992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009487439,0.00016697522,0.00022701183,0.000058844435,0.000033519078,0.000012960376,0.00011983458,0.0001642889,0.000007738373],"category_scores_gemma":[0.00001719462,0.00016237647,0.00005696295,0.00012614504,0.00018015449,0.0000061253545,0.00010811508,0.000052185922,0.000006765778],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041699528,0.00008973308,0.00270093,0.00018516398,0.00011142911,0.000005302948,0.00033634185,8.6468617e-7,0.99607915,0.000016174885,0.00020386033,0.00022934885],"study_design_scores_gemma":[0.0016827065,0.0002777287,0.021494105,0.00011704995,0.00011007268,0.00002393891,0.000028955079,0.00006291849,0.97581893,0.00014334383,0.00007457548,0.00016568253],"about_ca_topic_score_codex":0.000015061755,"about_ca_topic_score_gemma":0.000007656805,"teacher_disagreement_score":0.020260228,"about_ca_system_score_codex":0.00002433869,"about_ca_system_score_gemma":0.0001211518,"threshold_uncertainty_score":0.66215205},"labels":[],"label_agreement":null},{"id":"W2981123135","doi":"10.1182/blood.v110.11.2220.2220","title":"Complement Cascade (CC) Cleavage Fragments - C3a and C5a Anaphylatoxins - As New Unexpected Hypoxia-Related Stimulators of Erythropoiesis.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Anaphylatoxin; Erythropoiesis; Erythropoietin; Haematopoiesis; Complement system; Cell biology; Immunology; Bone marrow; Hypoxia (environmental); Biology; Progenitor cell; Chemistry; Andrology; Internal medicine; Endocrinology; Stem cell; Medicine; Anemia; Antibody","score_opus":0.016112858548563116,"score_gpt":0.2776056505216976,"score_spread":0.2614927919731345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981123135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943346,0.0006870746,0.0001259882,0.0002459295,0.00025595768,0.0004156956,0.00001635736,0.000105660125,0.0038127839],"genre_scores_gemma":[0.9970691,0.00013367692,0.0009793148,0.0007435042,0.00012957945,0.0000027037797,0.00007424199,0.000033794324,0.000834056],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983803,0.000049840928,0.0005611896,0.00035597073,0.00028246734,0.00037020442],"domain_scores_gemma":[0.9988914,0.00008989033,0.00018835788,0.00033245364,0.000071067574,0.00042680607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017034632,0.00023397311,0.0005011886,0.00022571339,0.0000942,0.000006745567,0.00007158468,0.00020483599,0.00053605245],"category_scores_gemma":[0.000105830244,0.000211299,0.00011332987,0.00037774432,0.00015892928,0.000052514148,0.00006793364,0.00024594768,0.00006513592],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018604752,0.00955927,0.08018596,0.00042030064,0.0024514843,0.0006608001,0.0041032964,0.000018289391,0.8684926,0.0025231976,0.021822471,0.00790187],"study_design_scores_gemma":[0.045877475,0.0037163757,0.6058338,0.0002455956,0.00084721716,0.00040411094,0.0016071376,0.000069815,0.32497147,0.0006486998,0.015198676,0.00057958363],"about_ca_topic_score_codex":0.00041030088,"about_ca_topic_score_gemma":0.000052030304,"teacher_disagreement_score":0.5435211,"about_ca_system_score_codex":0.000033682478,"about_ca_system_score_gemma":0.00012255655,"threshold_uncertainty_score":0.8616523},"labels":[],"label_agreement":null},{"id":"W2981123209","doi":"10.1182/blood.v122.21.2491.2491","title":"A Single Nucleotide Polymorphism Of Growth Factor Independence 1 (GFI136N) is a Novel Prognostic Marker For The Progression Of Myelodysplastic Syndrome To Acute Myeloid Leukemia","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Myeloid leukemia; Single-nucleotide polymorphism; Internal medicine; Myeloid; Myelodysplastic syndromes; Biology; SNP; Immunology; Oncology; Odds ratio; Hematology; Medicine; Cancer research; Genotype; Bone marrow; Genetics; Gene","score_opus":0.01940704259718913,"score_gpt":0.2715511009333244,"score_spread":0.2521440583361353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981123209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99137574,0.00025834414,0.0014867135,0.0016658587,0.00012213114,0.0045852675,0.00023630798,0.00006240608,0.00020723486],"genre_scores_gemma":[0.9893119,0.00003282498,0.008747417,0.00032574785,0.000104088154,0.000678956,0.00001913483,0.0000917141,0.0006882575],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99688405,0.000048209844,0.000692086,0.0005552438,0.0010910251,0.0007293598],"domain_scores_gemma":[0.9968417,0.0009566373,0.00031444692,0.0007231921,0.0008015985,0.00036242435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003306251,0.0003558764,0.0006989665,0.0003087317,0.00011897312,0.000041002455,0.00059521524,0.00024072785,0.00031979365],"category_scores_gemma":[0.001154557,0.00023607755,0.00022560856,0.0006838815,0.0002775792,0.00020880337,0.00033957168,0.00043558492,0.0000896444],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078343146,0.001500025,0.039396808,0.00093286036,0.0011794656,0.00007353853,0.0010197015,0.0000016466765,0.9483964,0.00009993337,0.0017686686,0.004847533],"study_design_scores_gemma":[0.011631513,0.0061157173,0.61536723,0.0019385879,0.0016780898,0.0012396079,0.00031556285,0.0015029383,0.35886613,0.00012802318,0.00061939744,0.0005972223],"about_ca_topic_score_codex":0.00029079692,"about_ca_topic_score_gemma":0.0000063183606,"teacher_disagreement_score":0.5895303,"about_ca_system_score_codex":0.00018053669,"about_ca_system_score_gemma":0.00081393565,"threshold_uncertainty_score":0.9626963},"labels":[],"label_agreement":null},{"id":"W2981127371","doi":"10.1182/blood-2018-99-113493","title":"Bay 94-9027 Can be Accurately Measured across Regions with Appropriate One-Stage Assay Reagent Use","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bay; Chromogenic; Reagent; Stage (stratigraphy); Immunology; Chromatography; Chemistry; Medicine; Biology; Geography","score_opus":0.16294454241357179,"score_gpt":0.358004836938906,"score_spread":0.19506029452533422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981127371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894918,0.00008911951,0.00006240952,0.005054149,0.00008293659,0.0008602076,0.00008694491,0.00014701832,0.0041253986],"genre_scores_gemma":[0.96523136,0.000082558814,0.0012346158,0.00029521412,0.00040747755,0.00006708743,0.000089162706,0.0000569457,0.032535564],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997715,0.0001301898,0.0002438727,0.0004774569,0.0007484062,0.0006850493],"domain_scores_gemma":[0.9982177,0.0000917995,0.00008240923,0.0007882503,0.00039587967,0.00042394362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052041846,0.00024490873,0.00036651644,0.00008501291,0.00032023017,0.00009743101,0.00016388537,0.00016458619,0.00015712621],"category_scores_gemma":[0.00030190859,0.00016008747,0.0000988108,0.00037401533,0.00032662228,0.000121261866,0.00008319237,0.0003030655,0.00011503143],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074931793,0.02053467,0.70540786,0.00085936784,0.0086334525,0.0071455785,0.021865703,0.0000054302586,0.2025359,0.0015536285,0.013834934,0.010130287],"study_design_scores_gemma":[0.04578689,0.010563445,0.23523562,0.0011057248,0.002222432,0.0006022808,0.002579588,0.00014458128,0.59726363,0.0001462404,0.102826394,0.0015231606],"about_ca_topic_score_codex":0.0003803348,"about_ca_topic_score_gemma":0.0018969764,"teacher_disagreement_score":0.47017226,"about_ca_system_score_codex":0.00007555456,"about_ca_system_score_gemma":0.00033094213,"threshold_uncertainty_score":0.6528178},"labels":[],"label_agreement":null},{"id":"W2981130431","doi":"10.1182/blood-2018-99-111207","title":"Evaluation of Definitions for Oral Anticoagulant–Associated Major Bleeding: A Population-Based Cohort Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; Ottawa Hospital; St. Michael's Hospital; University of Toronto","funders":"","keywords":"Medicine; TIMI; Population; Warfarin; Myocardial infarction; Major bleeding; Thrombolysis; Cohort; Emergency medicine; Internal medicine; Atrial fibrillation","score_opus":0.18466864479362444,"score_gpt":0.3924594724404343,"score_spread":0.20779082764680984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981130431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959059,0.000013545133,0.00026912533,0.00023412058,0.00013442179,0.0024010611,0.00001672774,0.000055965098,0.0009691473],"genre_scores_gemma":[0.99849975,6.4464587e-7,0.00083037687,0.000039128663,0.00026392893,0.000029859646,0.00023176378,0.00001402294,0.00009051589],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876237,0.000074793286,0.00030080322,0.00015820006,0.0005834639,0.000120343095],"domain_scores_gemma":[0.99876463,0.000118052776,0.0001616943,0.00015440435,0.0007657129,0.000035489185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014336416,0.00008409222,0.00025630172,0.00014392653,0.000105403094,0.000011978574,0.000035457877,0.000046508507,0.00014767397],"category_scores_gemma":[0.0010617106,0.00007628955,0.00009714911,0.00024330769,0.00002134816,0.00004496975,0.000011085847,0.000025170715,0.00000973733],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053923937,0.00025511553,0.99826974,0.000016635668,0.00043911245,2.9861167e-7,0.000054119308,0.000013958257,0.00038180692,0.00025282407,0.000096148,0.0001662988],"study_design_scores_gemma":[0.010955217,0.00060790597,0.9757373,0.000029624613,0.006262312,3.736089e-7,0.00008945287,0.0050298776,0.0006929533,0.00049328164,0.000024640809,0.00007710383],"about_ca_topic_score_codex":0.000099890516,"about_ca_topic_score_gemma":0.00011026043,"teacher_disagreement_score":0.022532502,"about_ca_system_score_codex":0.000038946266,"about_ca_system_score_gemma":0.0000797302,"threshold_uncertainty_score":0.31109977},"labels":[],"label_agreement":null},{"id":"W2981131939","doi":"10.1182/blood.v118.21.1189.1189","title":"Exon Skipping and Alternative Splicing of CPB2 mRNA in Multiple Cell Types Results in Variants of TAFI That Are Inactive and Not Secretable","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor; Queen's University","funders":"","keywords":"Exon; Alternative splicing; Molecular biology; Biology; RNA splicing; Biochemistry; RNA; Gene","score_opus":0.02195080606159573,"score_gpt":0.2162760905106491,"score_spread":0.1943252844490534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981131939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99852407,0.0005955008,0.000041905012,0.000008309842,0.000022979935,0.00013362154,0.00002640544,0.0000014388621,0.0006457472],"genre_scores_gemma":[0.9992164,0.00032460925,0.00038388313,0.0000042221045,0.000016981023,0.0000038002663,0.000011246129,0.000007683604,0.000031181655],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994712,0.000033127104,0.0001581063,0.00019457816,0.0000506598,0.00009232031],"domain_scores_gemma":[0.9996555,0.000016824823,0.00016600695,0.00010891495,0.000033735712,0.000019058856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010257036,0.00007224021,0.000133027,0.000063836575,0.000010572128,0.0000024153426,0.000039753504,0.000088259345,0.0000013042777],"category_scores_gemma":[0.00004329267,0.000074914766,0.0000131828565,0.00006497392,0.000036804555,0.0000070931137,0.00005737807,0.000050568153,1.0517672e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032011227,0.00009448377,0.09070106,0.000048163747,0.000028733879,0.000003013273,0.0012332535,0.00011452508,0.907023,0.0000045968527,0.000001526547,0.00042753242],"study_design_scores_gemma":[0.001989799,0.00009554868,0.23699757,0.00008876157,0.000013510315,0.0000030754236,0.00020668098,0.0003158761,0.76019794,0.000026752303,0.0000052627656,0.000059228532],"about_ca_topic_score_codex":0.0009540656,"about_ca_topic_score_gemma":0.0007259367,"teacher_disagreement_score":0.14682506,"about_ca_system_score_codex":0.000008331706,"about_ca_system_score_gemma":0.000019139796,"threshold_uncertainty_score":0.30549356},"labels":[],"label_agreement":null},{"id":"W2981148165","doi":"10.1182/blood.v118.21.1180.1180","title":"Factor Xa-Antithrombin Complex Enhances Tissue Plasminogen Activator-Mediated Clot Lysis","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of British Columbia","funders":"","keywords":"Plasmin; Fibrinolysis; Chemistry; Fibrin; Tissue plasminogen activator; Antithrombin; Plasminogen activator; Molecular biology; Zymogen; T-plasminogen activator; Fibrinolytic agent; Biochemistry; Fibrinogen; Biology; Heparin; Immunology; Enzyme; Internal medicine; Medicine; Endocrinology","score_opus":0.030557291432577023,"score_gpt":0.245755083185893,"score_spread":0.215197791753316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981148165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956499,0.0003106233,0.00033188934,0.000014660838,0.00014217939,0.00020910271,0.00009722813,0.00003894996,0.00320548],"genre_scores_gemma":[0.9979119,0.00008411979,0.0010794292,0.00014536206,0.00024266884,0.00003473784,0.0001836065,0.000028892682,0.00028929173],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989454,0.000050145823,0.00019504863,0.00037588106,0.00014391117,0.00028960995],"domain_scores_gemma":[0.99936646,0.0000069674484,0.000096757765,0.00035478492,0.000053583528,0.00012145856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000587388,0.00019319885,0.00019358016,0.0000384235,0.000082876184,0.000016926837,0.00024116473,0.0001813933,0.00059033144],"category_scores_gemma":[0.000036868234,0.0001778205,0.000087186156,0.000083120045,0.00005461138,0.000007683102,0.0001066485,0.0000747187,0.00016806579],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000333359,0.00031766607,0.0005808278,0.000010203149,0.00015241104,0.000008351773,0.00007675066,3.0868268e-8,0.99782854,0.00006220971,0.0006598871,0.00026979027],"study_design_scores_gemma":[0.0007741631,0.0004722956,0.0013803786,0.000008089617,0.000054237637,0.000010291788,0.000034250534,0.0000013684933,0.9857136,0.00006694831,0.011240637,0.00024372553],"about_ca_topic_score_codex":0.00006135486,"about_ca_topic_score_gemma":0.00002028585,"teacher_disagreement_score":0.0121149225,"about_ca_system_score_codex":0.000005028107,"about_ca_system_score_gemma":0.00005014097,"threshold_uncertainty_score":0.725131},"labels":[],"label_agreement":null},{"id":"W2981157701","doi":"10.1182/blood-2018-99-110335","title":"The Experience of Postpartum Bleeding in Women with Inherited Bleeding Disorders","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Maternal and fetal healthcare","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Medicine; postpartum bleeding; Childbirth; Qualitative research; Obstetrics; Population; Postpartum period; Pregnancy; Pediatrics","score_opus":0.013552694367892672,"score_gpt":0.2716840849519394,"score_spread":0.2581313905840467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981157701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996237,0.00017513755,0.0000036505096,0.00058272714,0.000057316873,0.00015074438,0.0000010882045,0.000017092183,0.0027752828],"genre_scores_gemma":[0.9993774,0.00009822958,0.000089129,0.000120391465,0.00008150037,0.000025883006,4.3155293e-7,0.00000903673,0.00019798506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993217,0.000011351194,0.00015921134,0.00011342955,0.00015441832,0.0002399142],"domain_scores_gemma":[0.9996779,0.000025158452,0.000051203846,0.00011758459,0.00005519069,0.00007297383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001192627,0.00006813838,0.0001270745,0.00003972545,0.00006795835,0.0000080013715,0.00007325753,0.000029387154,0.000029166775],"category_scores_gemma":[0.000023856526,0.000039439867,0.000011283714,0.0002075395,0.00014326039,0.000044546214,0.000028355142,0.00008410574,0.000003670912],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001984869,0.0003948893,0.9306285,0.00043411469,0.0000626983,0.000032561802,0.03568206,2.9642388e-7,0.021482976,0.00036438566,0.000019144176,0.008913552],"study_design_scores_gemma":[0.004615319,0.0034400295,0.9356728,0.0012674647,0.000033153865,0.000092988616,0.027664231,0.0001290113,0.024478026,0.00030905183,0.0020903987,0.00020749672],"about_ca_topic_score_codex":0.00027971232,"about_ca_topic_score_gemma":0.00013494244,"teacher_disagreement_score":0.0087060565,"about_ca_system_score_codex":0.000016715208,"about_ca_system_score_gemma":0.00002972073,"threshold_uncertainty_score":0.16083111},"labels":[],"label_agreement":null},{"id":"W2981158858","doi":"10.1182/blood-2018-99-111304","title":"Chemogenomic Profiling of Complex Karyotype AML Reveals a Novel Susceptibility to G2/M Checkpoint Inhibition Mediated By HMGA2 Overexpression","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Hôpital Maisonneuve-Rosemont; Université de Montréal","funders":"","keywords":"Transcriptome; Biology; Gene expression profiling; Cancer research; NPM1; Myeloid leukemia; HMGA2; Karyotype; Gene signature; CEBPA; Leukemia; Gene; Oncology; Internal medicine; Genetics; Medicine; Gene expression; microRNA; Mutation; Chromosome","score_opus":0.034635431480898156,"score_gpt":0.3069147900190483,"score_spread":0.27227935853815016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981158858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99525726,0.00005010312,0.00041399224,0.000662481,0.000038347418,0.001343565,0.0002225737,0.00008948357,0.0019221724],"genre_scores_gemma":[0.9879576,0.000010023991,0.010481697,0.00044045525,0.00031629097,0.000039304545,0.000439653,0.000047882957,0.00026711117],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977541,0.00007206705,0.00060769235,0.0005471824,0.00054720376,0.00047175935],"domain_scores_gemma":[0.99821806,0.000110314,0.00018210983,0.0006652456,0.00048943085,0.00033486963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007652198,0.0002229819,0.0004950241,0.00015841538,0.00008583849,0.000013362367,0.00016721607,0.00019443082,0.0005030791],"category_scores_gemma":[0.0009769954,0.00019509894,0.00010397574,0.00045510352,0.00021596115,0.000081170445,0.00025223196,0.00030052365,0.00020585168],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006022926,0.0008941895,0.009750461,0.00020378617,0.00006455402,0.000005691419,0.00028964336,2.832922e-7,0.9824868,0.000017949524,0.005527275,0.00015708766],"study_design_scores_gemma":[0.00567597,0.0009500812,0.02894014,0.000326281,0.00006990532,0.000033451062,0.00009576863,0.00019645724,0.96310085,0.000044026845,0.00038716898,0.0001799215],"about_ca_topic_score_codex":0.00017368344,"about_ca_topic_score_gemma":0.000013651936,"teacher_disagreement_score":0.019385956,"about_ca_system_score_codex":0.0002635878,"about_ca_system_score_gemma":0.0002890117,"threshold_uncertainty_score":0.7955904},"labels":[],"label_agreement":null},{"id":"W2981164630","doi":"10.1182/blood.v118.21.289.289","title":"Impact of Age on Outcomes Following Initial Therapy with Various Chemotherapy and Chemoimmunotherapy Regimens in Patients with Chronic Lymphocytic Leukemia (CLL): Results of CALGB Studies","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Alemtuzumab; Chemoimmunotherapy; Fludarabine; Chlorambucil; Internal medicine; Chemotherapy regimen; Chronic lymphocytic leukemia; Rituximab; Leukemia; Regimen; Surgery; Chemotherapy; Oncology; Cyclophosphamide; Transplantation; Lymphoma","score_opus":0.03287535462621271,"score_gpt":0.31727444230787766,"score_spread":0.28439908768166494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981164630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971307,0.0011602861,0.0000021066355,0.000011177705,0.000027558237,0.0011178317,0.000016748978,0.000034683624,0.0004989287],"genre_scores_gemma":[0.99878526,0.0005384751,0.00036747108,0.000066055654,0.000022677652,0.000039745522,0.000016127242,0.000079033794,0.00008516424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99767715,0.00007509699,0.0005837952,0.00047031793,0.00068509014,0.00050852733],"domain_scores_gemma":[0.99846375,0.00022677374,0.00028944862,0.00073484564,0.0001723766,0.00011278913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032054182,0.00039825475,0.0010904026,0.000289709,0.000044890126,0.000009058195,0.00018220824,0.00014314412,0.000015876964],"category_scores_gemma":[0.0000794542,0.00023910774,0.00016733426,0.00040555978,0.0003916946,0.00009609491,0.00004163279,0.00021862084,0.0000014645823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.07727199,0.0060478733,0.8571531,0.00065708545,0.014391191,0.0012052333,0.02906372,0.00010766288,0.003756503,0.00003415826,0.000059713053,0.010251733],"study_design_scores_gemma":[0.3095404,0.014795351,0.6575655,0.0007664403,0.00014507333,0.000026289761,0.00010688618,0.00004421245,0.016725374,0.00001949705,0.0000053510726,0.00025967238],"about_ca_topic_score_codex":0.004849416,"about_ca_topic_score_gemma":0.00017722206,"teacher_disagreement_score":0.23226841,"about_ca_system_score_codex":0.011477505,"about_ca_system_score_gemma":0.00790592,"threshold_uncertainty_score":0.99771833},"labels":[],"label_agreement":null},{"id":"W2981166661","doi":"10.1182/blood.v130.suppl_1.4633.4633","title":"Treatment of Cancer Associated Venous Thrombosis; The Cleveland Clinic Experience","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Rivaroxaban; Vitamin K antagonist; Low molecular weight heparin; Fondaparinux; Cancer; Thrombosis; Exact test; Internal medicine; Warfarin; Venous thromboembolism","score_opus":0.06410158497925991,"score_gpt":0.3740753025686949,"score_spread":0.30997371758943504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981166661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990532,0.0009501929,0.0000012246015,0.0012917083,0.00022964607,0.00045579916,0.000015497444,0.000022250388,0.006501701],"genre_scores_gemma":[0.9951797,0.0035492948,0.000032945474,0.00015411533,0.0001264238,0.0001564619,0.0000042677525,0.000014373782,0.0007823941],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991878,0.000022725864,0.00021096446,0.00018563353,0.00019021868,0.00020265472],"domain_scores_gemma":[0.99891883,0.00004594233,0.00024730235,0.0006752768,0.000056279423,0.000056388533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000849614,0.00011672009,0.00042052838,0.000019991972,0.0003029478,0.000030651958,0.0001865927,0.00005390156,0.00026209],"category_scores_gemma":[0.0000782841,0.00006967949,0.00012084866,0.000034774286,0.00014021272,0.00004085774,0.000052020278,0.000045193534,0.00002519099],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047506048,0.019638564,0.9496533,0.000065459935,0.002503004,0.00006140544,0.008786885,0.0000015777215,0.002321196,0.00029108938,0.001646558,0.014983429],"study_design_scores_gemma":[0.0031013663,0.0011370429,0.98360556,0.00008483317,0.00095610874,0.0000022045847,0.00026692575,0.000005242735,0.0068247933,0.00004000661,0.0038975948,0.0000783391],"about_ca_topic_score_codex":0.00172174,"about_ca_topic_score_gemma":0.00033549167,"teacher_disagreement_score":0.033952218,"about_ca_system_score_codex":0.000042960466,"about_ca_system_score_gemma":0.00006229625,"threshold_uncertainty_score":0.28697017},"labels":[],"label_agreement":null},{"id":"W2981172339","doi":"10.1182/blood-2018-99-111592","title":"Outcomes of Patients with Low Variant Allele Fraction JAK2V617F: A 5-Year Retrospective Analysis","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; St. Paul's Hospital; Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency; Leukemia & Lymphoma Society of Canada","funders":"","keywords":"Medicine; Internal medicine; Cumulative incidence; Population; Gastroenterology; Incidence (geometry); Retrospective cohort study; Cohort","score_opus":0.005193319382316779,"score_gpt":0.2368822388728625,"score_spread":0.2316889194905457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981172339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99688756,0.000012746601,0.00021928253,0.0001409015,0.0000271848,0.0003536282,0.000047645073,0.000023019425,0.0022880298],"genre_scores_gemma":[0.99757206,0.000011564667,0.0019624291,0.000100296544,0.00006457989,0.000037509908,0.00008331492,0.000013874419,0.00015438325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901545,0.00002713934,0.00019928775,0.00026692462,0.00034113627,0.00015006795],"domain_scores_gemma":[0.999043,0.00003980847,0.00014498299,0.00028456526,0.00040572204,0.00008193662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006338809,0.00014145674,0.00047796222,0.00014830139,0.000060225662,0.0000092616565,0.000036316207,0.000056348956,0.00057462306],"category_scores_gemma":[0.00006688111,0.000090499736,0.00012334572,0.00040573152,0.000060168535,0.0000568179,0.000016899474,0.00007179274,0.000039418916],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001835504,0.0034030385,0.9911266,0.000011174934,0.0046595205,0.000014360118,0.0001776466,9.0461975e-7,0.000028750215,0.00018703518,0.000102745005,0.00010466777],"study_design_scores_gemma":[0.0056203525,0.0019164172,0.9837092,0.000020516876,0.0032929666,0.0000016010351,0.000038108734,0.000017881679,0.005173472,0.00003183023,0.00008961212,0.000087996385],"about_ca_topic_score_codex":0.000094894465,"about_ca_topic_score_gemma":0.00014184859,"teacher_disagreement_score":0.0074173617,"about_ca_system_score_codex":0.000052261108,"about_ca_system_score_gemma":0.00004151406,"threshold_uncertainty_score":0.6291719},"labels":[],"label_agreement":null},{"id":"W2981197296","doi":"10.1182/blood.v118.21.5255.5255","title":"The Risk of Malignancy Following Idiopathic Venous Thromboembolism: A Population-Based Cohort Study","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Pulmonary embolism; Cancer; Deep vein; Malignancy; Population; Cohort; Internal medicine; Thrombosis; Venous thrombosis; Medical record; Lung cancer; Pediatrics; Cancer registry; Surgery","score_opus":0.01555871495395211,"score_gpt":0.2469038603368165,"score_spread":0.23134514538286438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981197296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99381083,0.0011541729,0.000040602754,0.000040732106,0.00030054318,0.0018219658,0.00000484014,0.00007825677,0.0027480433],"genre_scores_gemma":[0.9991894,0.00013684022,0.0002425798,0.00007932504,0.000082615115,0.00019329814,0.000006972463,0.000038365008,0.000030636234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982464,0.00015251109,0.000494869,0.00031274348,0.00047932906,0.00031419078],"domain_scores_gemma":[0.9987504,0.00007442839,0.00026234915,0.00074051495,0.00008150521,0.00009082695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009739586,0.00019212888,0.00073405047,0.00008793798,0.00029163528,0.000017783821,0.00019828546,0.000064825916,0.00004095503],"category_scores_gemma":[0.0001719555,0.0001332934,0.00025779768,0.00023080438,0.000036828693,0.00004765371,0.00005974701,0.00015772332,0.00002167798],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025252692,0.008051765,0.988502,0.00005828156,0.0012065427,0.00009076614,0.0009731695,0.000005829371,0.000058759233,0.00040759193,0.00003906169,0.00058093085],"study_design_scores_gemma":[0.0023754747,0.0012597574,0.9903579,0.00016447787,0.0040603476,0.00000336476,0.00050439464,0.000021055444,0.0007482131,0.00033586717,0.000032145337,0.00013704048],"about_ca_topic_score_codex":0.0028022716,"about_ca_topic_score_gemma":0.00022012553,"teacher_disagreement_score":0.006792008,"about_ca_system_score_codex":0.000025582001,"about_ca_system_score_gemma":0.000078123005,"threshold_uncertainty_score":0.5435547},"labels":[],"label_agreement":null},{"id":"W2981216796","doi":"10.1182/blood-2018-99-115594","title":"A Retrospective Assessment of Prevention and Treatment of Iron Deficiency Amongst Patients Requiring Peripartum Transfusion","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Pregnancy; Obstetrics; Iron deficiency; Anemia; Blood transfusion; Pediatrics; Gestational age; Low birth weight; Retrospective cohort study; Iron-deficiency anemia; Fetus; Surgery; Internal medicine","score_opus":0.008947748582146108,"score_gpt":0.26596934873036093,"score_spread":0.25702160014821485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981216796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99427634,0.00023286685,0.000060472332,0.00003150448,0.00005683282,0.00041114865,0.000006686757,0.000011269066,0.0049128504],"genre_scores_gemma":[0.9988917,0.0006291707,0.0003530108,0.0000037243253,0.000019067364,0.000007750137,0.0000075229736,0.000007916105,0.00008013661],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993466,0.000019858611,0.00020721626,0.00015793966,0.00016034883,0.00010801935],"domain_scores_gemma":[0.9996466,0.000004757188,0.00008908567,0.00011865866,0.00009685164,0.000044014356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000055522232,0.0000821809,0.00020020061,0.000053814267,0.000047860318,0.000002464016,0.00001790157,0.00006515002,0.00003209908],"category_scores_gemma":[0.000011422906,0.00006147423,0.000058382288,0.00010131895,0.00011944015,0.00003552052,0.000009263319,0.00003576431,5.444742e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009110722,0.004820857,0.95808357,0.00013855276,0.00005237751,0.000002491098,0.002079137,4.5401765e-7,0.024388872,0.00014650985,0.0000041484163,0.010191917],"study_design_scores_gemma":[0.0067860032,0.010846273,0.9667465,0.0001994332,0.0003630411,0.0000049878477,0.00036602814,0.000064096865,0.014487162,0.000044067718,0.000026839753,0.000065550725],"about_ca_topic_score_codex":0.000055181536,"about_ca_topic_score_gemma":0.000016994054,"teacher_disagreement_score":0.010126366,"about_ca_system_score_codex":0.00004030074,"about_ca_system_score_gemma":0.000040314673,"threshold_uncertainty_score":0.25068465},"labels":[],"label_agreement":null},{"id":"W2981221994","doi":"10.1182/blood-2018-99-113422","title":"A Descriptive Analysis of Obinutuzumab Usage in a Single Canadian Centre","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"","keywords":"Obinutuzumab; Chlorambucil; Medicine; Internal medicine; Population; Chronic lymphocytic leukemia; Regimen; Asymptomatic; Oncology; Surgery; Leukemia; Chemotherapy; Cyclophosphamide","score_opus":0.025284436526268123,"score_gpt":0.2722073062144316,"score_spread":0.2469228696881635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981221994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98612994,0.00011899339,0.0000061964115,0.00009384165,0.000026762167,0.00020715724,0.000025833902,0.000011437002,0.013379813],"genre_scores_gemma":[0.99862397,0.0000063357616,0.00037322854,0.000075203316,0.00006122659,0.0000046490613,0.000019902738,0.000012471029,0.0008230158],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882287,0.00004344986,0.00021947079,0.00022955034,0.00027056754,0.00041406436],"domain_scores_gemma":[0.9991173,0.00004964904,0.000040208408,0.000358576,0.00016135673,0.00027287484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001797156,0.00009185331,0.00033458613,0.00080608204,0.000027044787,0.000009231436,0.00011106035,0.00008308307,0.0005999099],"category_scores_gemma":[0.00023988569,0.00008414114,0.00010173123,0.0017223075,0.00015784998,0.00003667135,0.00003522695,0.00009754387,0.000048097067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0025168203,0.01157058,0.6290511,0.0010618067,0.02787197,0.012942248,0.12343784,0.00015897152,0.16195615,0.0020052525,0.008452631,0.01897463],"study_design_scores_gemma":[0.20878084,0.00385738,0.36564642,0.0014207345,0.017018259,0.00051472534,0.0121983765,0.06810464,0.30660594,0.00028277596,0.014117124,0.001452785],"about_ca_topic_score_codex":0.4086812,"about_ca_topic_score_gemma":0.7109138,"teacher_disagreement_score":0.30223256,"about_ca_system_score_codex":0.011827969,"about_ca_system_score_gemma":0.0097581055,"threshold_uncertainty_score":0.9958556},"labels":[],"label_agreement":null},{"id":"W2981242160","doi":"10.1182/blood.v104.11.3886.3886","title":"Continuous Versus Subsampling Analysis of Thrombin Generation.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; Hospital for Sick Children","funders":"","keywords":"Thrombin generation; Thrombin; Substrate (aquarium); Tris; Chemistry; Analytical Chemistry (journal); Chromatography; Platelet; Biochemistry; Biology; Medicine; Internal medicine","score_opus":0.05555476453773048,"score_gpt":0.30034918913961134,"score_spread":0.24479442460188086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981242160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99401873,0.000170253,0.0039772233,0.00016420637,0.00015466819,0.00012872975,0.0000062669246,0.000051576666,0.0013283505],"genre_scores_gemma":[0.9945916,0.000019627143,0.0050612725,0.00010659722,0.0000849239,0.0000055099063,0.00007656536,0.000011149366,0.000042752345],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99925095,0.000013391955,0.00023824713,0.00016913623,0.00020767779,0.00012060978],"domain_scores_gemma":[0.99947256,0.00002142588,0.000087106084,0.00024920533,0.00010058636,0.000069092224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010492244,0.0000858344,0.00035407685,0.00020128887,0.000040909134,0.000009619171,0.000045993493,0.00006731588,0.00018285128],"category_scores_gemma":[0.000046589434,0.00008069613,0.00016786919,0.00060992455,0.00002501509,0.000036520574,0.000014201808,0.000059161663,0.0000143913385],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000084978135,0.0020931927,0.009069449,0.000027615906,0.006566627,0.000017814176,0.00066415605,0.0014588153,0.93458515,0.04491074,0.00002714655,0.00049430854],"study_design_scores_gemma":[0.016565539,0.0006518628,0.040879983,0.00003356955,0.012256494,0.000012056911,0.00021514618,0.0006818222,0.92800933,0.0004404899,0.00006510895,0.00018857211],"about_ca_topic_score_codex":0.000054017324,"about_ca_topic_score_gemma":0.000056515793,"teacher_disagreement_score":0.04447025,"about_ca_system_score_codex":0.00001540898,"about_ca_system_score_gemma":0.00005586893,"threshold_uncertainty_score":0.3290693},"labels":[],"label_agreement":null},{"id":"W2981257299","doi":"10.1182/blood-2018-99-119162","title":"High Incidence but Very Low Mortality of Epstein Barr Virus Related Post-Transplantation Lymphoproliferative Disorder after T-Cell Replete Haploidentical Peripheral Blood Stem Cell Transplantation","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Fludarabine; Transplantation; Internal medicine; Busulfan; Immunosuppression; Gastroenterology; Total body irradiation; Hematopoietic stem cell transplantation; Cumulative incidence; Incidence (geometry); Lymphoproliferative disorders; Regimen; Post-transplant lymphoproliferative disorder; Immunology; Graft-versus-host disease; Surgery; Rituximab; Cyclophosphamide; Lymphoma; Chemotherapy","score_opus":0.005961662577987114,"score_gpt":0.22670540517342563,"score_spread":0.22074374259543852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981257299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968949,0.0007304488,0.00024103247,0.00011966676,0.00023336805,0.0006641987,0.00034997726,0.00009665919,0.0006697443],"genre_scores_gemma":[0.9975747,0.0008608444,0.00021385601,0.00036319796,0.00010322571,0.00007517647,0.00026569492,0.000054070846,0.0004892284],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974339,0.00017568436,0.00075865275,0.00057494984,0.0006227586,0.00043403264],"domain_scores_gemma":[0.99873364,0.00005877063,0.00027931322,0.00037832628,0.00036731988,0.00018265132],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002606475,0.00033734454,0.00052456284,0.00012060359,0.00013546598,0.00003726394,0.00013330522,0.00032061653,0.00023839233],"category_scores_gemma":[0.000022262304,0.0003204913,0.00021760185,0.0003164815,0.00024808408,0.0003184815,0.000017550372,0.00025234264,0.000036209887],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060826847,0.004151008,0.34717223,0.0020243095,0.0008444694,0.0008972885,0.01351417,0.00007270703,0.624714,0.00009139686,0.00005603826,0.00037971567],"study_design_scores_gemma":[0.026434962,0.0026544703,0.32769233,0.00048356588,0.0039714454,0.00013491059,0.0010852906,0.0001867369,0.63660234,0.000144154,0.000009132226,0.00060065737],"about_ca_topic_score_codex":0.0021360056,"about_ca_topic_score_gemma":0.0012295436,"teacher_disagreement_score":0.020352278,"about_ca_system_score_codex":0.000075915596,"about_ca_system_score_gemma":0.00029009714,"threshold_uncertainty_score":0.9999247},"labels":[],"label_agreement":null},{"id":"W2981261776","doi":"10.1182/blood.v106.11.18.18","title":"Revised Response Criteria for Malignant Lymphomas From the Members of the International Harmonization Project (IHP) of the Competence Network Malignant Lymphoma, Represented by:.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Clinical trial; Context (archaeology); Lymphoma; Internal medicine; Hodgkin lymphoma; Medical physics; Hematopathology; Oncology; Family medicine","score_opus":0.022418844617858345,"score_gpt":0.27795314620817707,"score_spread":0.2555343015903187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981261776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98692286,0.0014314877,0.00004929341,0.0088007,0.00034973148,0.001743052,0.00036940392,0.000021982283,0.000311481],"genre_scores_gemma":[0.9967586,0.0001741333,0.0012759668,0.00091867126,0.00024207983,0.00017769662,0.000071964074,0.00002445556,0.00035647416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981281,0.00033189924,0.0005295627,0.00031669775,0.00047486724,0.00021886193],"domain_scores_gemma":[0.9977965,0.00070152164,0.00042317476,0.0008016115,0.00023715358,0.00004004616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005805729,0.00018562502,0.00031134475,0.000026077683,0.00016985157,0.00002824817,0.00048683878,0.00007216396,0.000069782436],"category_scores_gemma":[0.0005367404,0.000086439744,0.00027590705,0.0002872282,0.00016465086,0.00005736922,0.0001677487,0.000038909948,0.0000019089134],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007665689,0.0066155484,0.689899,0.00015050276,0.002659037,0.000023557348,0.0026655176,0.0002029265,0.17419076,0.0023875437,0.106804945,0.0067349616],"study_design_scores_gemma":[0.0168435,0.00027516182,0.51528984,0.0014283586,0.0012587043,0.00007552429,0.0003507358,0.002467654,0.42889026,0.0001679328,0.032746904,0.00020541796],"about_ca_topic_score_codex":0.0005095381,"about_ca_topic_score_gemma":0.000044726097,"teacher_disagreement_score":0.2546995,"about_ca_system_score_codex":0.00012501376,"about_ca_system_score_gemma":0.00031939577,"threshold_uncertainty_score":0.35249105},"labels":[],"label_agreement":null},{"id":"W2981283097","doi":"10.1182/blood-2018-99-109473","title":"Endothelium-Derived Microparticles: Functions and Clinical Relevance","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Microvesicles; microRNA; Biomarker; Disease; Extracellular vesicle; Bioinformatics; Cell; Medicine; Immunology; Exosome; Biology; Gene; Internal medicine; Genetics","score_opus":0.012077830050592616,"score_gpt":0.275344694911275,"score_spread":0.2632668648606824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981283097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99634695,0.001448936,0.0007696878,0.000081271515,0.00012988057,0.0000878443,0.000014625931,0.000020576366,0.0011002517],"genre_scores_gemma":[0.99617964,0.00019208984,0.0017466547,0.0002392987,0.0006188362,0.0000072950043,0.0000127114745,0.000017766948,0.0009857264],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992573,0.00005922707,0.00017182535,0.00029768053,0.000051424,0.00016251615],"domain_scores_gemma":[0.99942577,0.000019469742,0.000044128286,0.00033923725,0.00005630973,0.00011509464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012956819,0.00008580426,0.00007672742,0.000011055225,0.00008289339,0.00001698,0.000097189666,0.00008039781,0.000026254867],"category_scores_gemma":[0.00022802336,0.00008451419,0.00005627867,0.000037329843,0.00032376387,0.0000025194222,0.00009466132,0.000056124154,0.00009353353],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044612287,0.0002574224,0.020607514,0.0000048085685,0.000052262785,0.0000048146862,0.000012900172,1.04387986e-7,0.975833,0.000021109889,0.0009906251,0.0021708002],"study_design_scores_gemma":[0.0015306673,0.00045286873,0.012943709,0.000007504045,0.00009681869,0.00003614063,0.00005518274,0.000016944226,0.95895386,0.00008943577,0.025659582,0.00015726099],"about_ca_topic_score_codex":0.0000022185827,"about_ca_topic_score_gemma":0.000013162029,"teacher_disagreement_score":0.024668956,"about_ca_system_score_codex":0.0000015472895,"about_ca_system_score_gemma":0.00003709429,"threshold_uncertainty_score":0.34463885},"labels":[],"label_agreement":null},{"id":"W2981287577","doi":"10.1182/blood.v104.11.2981.2981","title":"Evaluation of the Profile of Thrombin Generation during the Process of Whole Blood Clotting as Assessed by Thromboelastography.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Whole blood; Thromboelastography; Thrombelastography; Thrombin; Chemistry; Thrombin generation; Coagulation; Hemostasis; Benzamidine; Fibrinogen; Clotting time; Chromatography; Biochemistry; Surgery; Medicine; Platelet; Internal medicine; Enzyme","score_opus":0.024356206506634004,"score_gpt":0.2941166884091078,"score_spread":0.2697604819024738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981287577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971718,0.0003584918,0.00008796002,0.00025832045,0.00009647168,0.0010979971,0.000017515993,0.000024314537,0.0008871111],"genre_scores_gemma":[0.99941075,0.000012368352,0.000346434,0.000038420898,0.00006072711,0.0000628485,0.000022332702,0.00002300457,0.000023141783],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99775267,0.00017142881,0.0005123557,0.00021749991,0.001190524,0.00015552448],"domain_scores_gemma":[0.9981898,0.000029221757,0.0005429661,0.0004369668,0.00076516514,0.00003589914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010148297,0.00014360543,0.0003244152,0.00007509929,0.00012632216,0.000009757029,0.00017136976,0.00010307602,0.00007489735],"category_scores_gemma":[0.00021851188,0.00009225637,0.00014997456,0.00056426233,0.000116676034,0.000101603895,0.000038525686,0.0001389356,0.000001929087],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009150965,0.0016669466,0.0036999306,0.00018582203,0.0003082666,1.6097037e-7,0.00086215767,0.00025431704,0.9920513,0.0008065136,0.000008832274,0.00014661961],"study_design_scores_gemma":[0.0059080557,0.0003040722,0.047554146,0.0002568329,0.0017186458,0.00001580873,0.0005431107,0.0002553583,0.94213486,0.0012265272,0.0000019024444,0.0000807059],"about_ca_topic_score_codex":0.00005554893,"about_ca_topic_score_gemma":0.000019228335,"teacher_disagreement_score":0.04991645,"about_ca_system_score_codex":0.000016556414,"about_ca_system_score_gemma":0.00034157783,"threshold_uncertainty_score":0.37621054},"labels":[],"label_agreement":null},{"id":"W2981288534","doi":"10.1182/blood-2018-99-119417","title":"Safety and Efficacy of Haploidentical Peripheral Blood Stem Cell Transplantation for Myeloid Malignancies Using Post-Transplantation Cyclophosphamide and Anti-Thymocyte Globulin As Graft Versus Host Disease Prophylaxis","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Busulfan; Anti-thymocyte globulin; Fludarabine; Transplantation; Cyclophosphamide; Cumulative incidence; Internal medicine; Hematopoietic stem cell transplantation; Graft-versus-host disease; Myelofibrosis; Myeloid; Total body irradiation; Gastroenterology; Surgery; Immunology; Chemotherapy; Bone marrow","score_opus":0.0136670454168724,"score_gpt":0.27249140455245946,"score_spread":0.25882435913558705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981288534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954157,0.0014985524,0.0008249686,0.00014857017,0.00011778339,0.0014860461,0.00037723788,0.000056253735,0.000074888376],"genre_scores_gemma":[0.9942351,0.0023006673,0.0028739627,0.000057441266,0.00019434936,0.000023965129,0.00016080703,0.000055123684,0.00009859339],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99797213,0.00008459161,0.000488864,0.00053660764,0.0004655171,0.000452268],"domain_scores_gemma":[0.99860245,0.0002730251,0.00012899347,0.00025684692,0.00037430326,0.00036435766],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026797192,0.00028867243,0.00044580558,0.00015036049,0.00023889857,0.000055001536,0.000109772314,0.00016060002,0.00002046825],"category_scores_gemma":[0.000092865834,0.0002669843,0.00011214178,0.00023498353,0.000465161,0.000212745,0.000034901354,0.00018277307,0.0000045227303],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04499527,0.0012841489,0.048426878,0.0049777087,0.0005062526,0.00067872,0.0036898595,0.000015302352,0.8928938,0.00024680924,0.0000045165075,0.0022807585],"study_design_scores_gemma":[0.04626578,0.004348855,0.5471506,0.00053694425,0.003450482,0.0003821768,0.0004771913,0.00046172715,0.39641014,0.000013525331,0.000059622333,0.00044290844],"about_ca_topic_score_codex":0.00020095726,"about_ca_topic_score_gemma":0.000030896394,"teacher_disagreement_score":0.49872378,"about_ca_system_score_codex":0.0000617831,"about_ca_system_score_gemma":0.00040294172,"threshold_uncertainty_score":0.99997824},"labels":[],"label_agreement":null},{"id":"W2981294154","doi":"10.1182/blood.v118.21.712.712","title":"Relationship Between Subtherapeutic Warfarin Anticoagulation and the Development of Post Thrombotic Syndrome After a First Unprovoked Deep Vein Thrombosis: Results From the REVERSE Cohort Study","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia; Providence Health Care; Victoria Hospital; St. Joseph’s Healthcare Hamilton; McGill University; University of Ottawa; McGill University Health Centre; Hôpital du Sacré-Cœur de Montréal; Ottawa Hospital; St. Joseph's Hospital; Capital District Health Authority; Jewish General Hospital; McMaster University; London Health Sciences Centre","funders":"","keywords":"Medicine; Post-thrombotic syndrome; Warfarin; Thrombosis; Internal medicine; Deep vein; Prospective cohort study; Cohort; Population; Venous thrombosis; Cohort study; Surgery; Pediatrics; Atrial fibrillation","score_opus":0.0534661677620823,"score_gpt":0.26544937132868973,"score_spread":0.21198320356660744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981294154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99546444,0.00027066265,0.00005740293,0.0008958531,0.00006935584,0.0028753865,0.000016849568,0.00004130238,0.00030876292],"genre_scores_gemma":[0.9985173,0.00003087442,0.0008843454,0.00020387114,0.00004240383,0.000212141,0.000051342136,0.000030161586,0.000027573624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797195,0.00021793386,0.0007413686,0.0004074871,0.0004203449,0.00024089978],"domain_scores_gemma":[0.9981878,0.00065878266,0.00026207895,0.000716164,0.00010507089,0.00007010375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012120793,0.00022842106,0.0006339229,0.00007266394,0.00029279597,0.00003057394,0.00019556473,0.00008728141,0.000054951768],"category_scores_gemma":[0.00022603622,0.00013414872,0.00008519527,0.00023811319,0.00021202347,0.00009885972,0.00015231315,0.00019548643,0.000026137159],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021107802,0.0015240147,0.96613795,0.000049357477,0.0009771107,0.000009978255,0.030825222,0.0000011093539,0.000012641949,0.00012039775,0.000016088059,0.00011503902],"study_design_scores_gemma":[0.007432151,0.00033444352,0.9853184,0.0001758781,0.0037002193,0.000004724393,0.0024749958,0.000012826592,0.00009393264,0.00027016382,0.000026608754,0.00015565277],"about_ca_topic_score_codex":0.0010894729,"about_ca_topic_score_gemma":0.0013815789,"teacher_disagreement_score":0.028350227,"about_ca_system_score_codex":0.000034671302,"about_ca_system_score_gemma":0.0000625943,"threshold_uncertainty_score":0.5470426},"labels":[],"label_agreement":null},{"id":"W2981305723","doi":"10.1182/blood-2018-99-114525","title":"Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of Mitochondrial Vulnerability in Acute Myeloid Leukemia","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Myeloid leukemia; Leukemia; Stem cell; Biology; Cancer research; Ex vivo; Immunology; Medicine; In vivo; Genetics","score_opus":0.017556859661834325,"score_gpt":0.2884165497073718,"score_spread":0.27085969004553745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981305723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924784,0.00042422107,0.00002893359,0.0031059205,0.000060604358,0.0011323807,0.000046671426,0.000029866616,0.0026930547],"genre_scores_gemma":[0.99768,0.00018465047,0.0005584416,0.00045523082,0.00061227096,0.000068794485,0.00004608724,0.000027633456,0.00036687675],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9979409,0.00025714363,0.00046614258,0.0003840881,0.00043995734,0.0005117954],"domain_scores_gemma":[0.99869037,0.00030534432,0.00010127919,0.00063338963,0.0001580471,0.00011156921],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011133496,0.00019518888,0.0004742539,0.00008892079,0.0001577885,0.000013629196,0.0003156296,0.00013863055,0.00018853854],"category_scores_gemma":[0.00022249192,0.00011211655,0.00009781284,0.0003956667,0.0006195571,0.000054757686,0.00006983581,0.0006208822,0.000009940072],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003245749,0.0007903336,0.20249489,0.00029196206,0.00068931986,0.00016352757,0.0054215463,0.0000025612078,0.7732957,0.0006582818,0.009805786,0.0031403254],"study_design_scores_gemma":[0.01565616,0.0019869627,0.86908674,0.00012871873,0.0004834888,0.00041825252,0.00045834793,0.00045968886,0.104967326,0.0006348183,0.0054173972,0.00030207343],"about_ca_topic_score_codex":0.000269735,"about_ca_topic_score_gemma":0.0003366977,"teacher_disagreement_score":0.6683284,"about_ca_system_score_codex":0.00009632219,"about_ca_system_score_gemma":0.00039353693,"threshold_uncertainty_score":0.45719802},"labels":[],"label_agreement":null},{"id":"W2981313668","doi":"10.1182/blood-2018-99-111278","title":"Incremental Survival with Nivolumab Relative to Standard of Care in Classical Hodgkin Lymphoma: A Canadian Analysis","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Nivolumab; Medicine; Brentuximab vedotin; Internal medicine; Oncology; Clinical trial; Lymphoma; Relative survival; Immunotherapy; Cancer; Hodgkin lymphoma; Cancer registry","score_opus":0.008280108275120043,"score_gpt":0.2505535477007116,"score_spread":0.24227343942559154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981313668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906243,0.0001378775,0.0000104615765,0.00044676004,0.000026006484,0.00033887947,0.0001566093,0.000011333507,0.008247779],"genre_scores_gemma":[0.9985474,0.00000509983,0.0011484938,0.0000972292,0.000053000625,0.00003459197,0.000046483125,0.000013150423,0.000054581214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988949,0.000046740337,0.00020392209,0.00027398186,0.00031549457,0.00026500953],"domain_scores_gemma":[0.99918956,0.00003588114,0.000047355243,0.00025259797,0.00016866357,0.00030596717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007141838,0.00013761365,0.00047112672,0.00039255168,0.00004948255,0.0000095288315,0.000058676564,0.00006617664,0.00010263605],"category_scores_gemma":[0.00003317008,0.00010532943,0.00009360997,0.00087608956,0.000086218395,0.000038573282,0.000025462641,0.000034837616,0.000017087035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088941486,0.0006735946,0.9910873,0.000015695729,0.0014591727,0.00031370227,0.0022363442,0.0000015981554,0.00006609954,0.0003502055,0.000103377155,0.0028034977],"study_design_scores_gemma":[0.013486848,0.005577733,0.9669455,0.000111539135,0.0021167106,0.000013612789,0.0013662891,0.000008664775,0.00911243,0.000006857874,0.0011162502,0.00013753088],"about_ca_topic_score_codex":0.08842092,"about_ca_topic_score_gemma":0.7928148,"teacher_disagreement_score":0.7043939,"about_ca_system_score_codex":0.0007186703,"about_ca_system_score_gemma":0.00070795,"threshold_uncertainty_score":0.9176494},"labels":[],"label_agreement":null},{"id":"W2981315734","doi":"10.1182/blood.v122.21.3045.3045","title":"Improved Risk Stratification With Addition Of Male Sex (S) To The Elderly International Prognostic Index (S-EIPI) For DLBCL Patients &gt; 60 Years Treated With R-CHOP: An International Collaboration Of The US Intergroup, German High-Grade Non-Hodgkin Lymphoma Study Group and Groupe d’Etude De Lymphome d’Adultes","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"International Prognostic Index; Medicine; Internal medicine; Multivariate analysis; Rituximab; Risk factor; Oncology; Gerontology; Demography; Lymphoma","score_opus":0.004172184406075418,"score_gpt":0.2272438005034719,"score_spread":0.22307161609739648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981315734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955254,0.000010206054,0.00020568239,0.00015711546,0.00008745009,0.0036257186,0.0003350654,0.000021385307,0.000031970616],"genre_scores_gemma":[0.99691397,0.000013489684,0.0009637092,0.00004726013,0.00007865015,0.0014476833,0.00047476028,0.000030150693,0.000030310553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857014,0.0000899109,0.0003886555,0.0003594565,0.00041759844,0.00017421134],"domain_scores_gemma":[0.9985644,0.00011335999,0.00040410538,0.0003452856,0.00048117107,0.00009167065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014103514,0.00021132099,0.00025029038,0.00012841368,0.00009019289,0.00009051494,0.00021958795,0.00007002078,0.000021513624],"category_scores_gemma":[0.00006751629,0.00012349554,0.00004563814,0.00025141553,0.00007988832,0.000298927,0.00004467594,0.000046844074,0.0000012000642],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006387599,0.009867075,0.97047836,0.000023450511,0.0007357875,0.0000052409146,0.0021871298,0.000027029879,0.0019654531,0.00004724942,0.00005122293,0.013973246],"study_design_scores_gemma":[0.018726498,0.0071034757,0.966754,0.00013495439,0.00050011143,0.000020823327,0.0009037447,0.0016400259,0.004039637,0.000022005057,0.000022510663,0.00013221188],"about_ca_topic_score_codex":0.001387146,"about_ca_topic_score_gemma":0.001306346,"teacher_disagreement_score":0.018087737,"about_ca_system_score_codex":0.00015777597,"about_ca_system_score_gemma":0.00009920654,"threshold_uncertainty_score":0.5036002},"labels":[],"label_agreement":null},{"id":"W2981316671","doi":"10.1182/blood-2018-99-119462","title":"The Impact from Frontline CLL Chemo Immunotherapy Regimen Outcomes Based on Patient Tolerability","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"","keywords":"Tolerability; Medicine; Regimen; Obinutuzumab; Fludarabine; Internal medicine; Rituximab; Oncology; Chlorambucil; Cyclophosphamide; Adverse effect; Chemotherapy; Lymphoma","score_opus":0.014930298083944445,"score_gpt":0.3159438096415602,"score_spread":0.30101351155761574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981316671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931022,0.00037086496,0.000033125852,0.0017409598,0.00014552161,0.00067677116,0.000037011367,0.00007994733,0.0038136076],"genre_scores_gemma":[0.9977677,0.000021631135,0.000429447,0.0008897682,0.00029780186,0.00004578665,0.000035271503,0.000040458966,0.00047212208],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99803495,0.000113624235,0.00035034676,0.00038582095,0.0006392411,0.00047601413],"domain_scores_gemma":[0.99742067,0.000655742,0.00009689159,0.0014743925,0.00017488746,0.00017740873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004046621,0.0002272314,0.0003792362,0.000044707376,0.00018679933,0.000046686306,0.000256804,0.00011476943,0.00066764414],"category_scores_gemma":[0.00041380798,0.000121450335,0.00022988765,0.00014168835,0.00027292158,0.00003590697,0.0000597028,0.000242874,0.00023434186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037285417,0.04092086,0.4589468,0.0002231389,0.008095919,0.0007102247,0.009489324,0.00015564269,0.05656717,0.00017693776,0.076025814,0.31140277],"study_design_scores_gemma":[0.21967718,0.009993062,0.47467372,0.00032190827,0.000321555,0.00004106758,0.00033967133,0.039980926,0.2266674,0.0010675634,0.026049351,0.0008665846],"about_ca_topic_score_codex":0.003083712,"about_ca_topic_score_gemma":0.0000670767,"teacher_disagreement_score":0.31053618,"about_ca_system_score_codex":0.0032424654,"about_ca_system_score_gemma":0.0023857912,"threshold_uncertainty_score":0.8478934},"labels":[],"label_agreement":null},{"id":"W2981456572","doi":"10.1182/blood.v110.11.2475.2475","title":"Chromosome 1p21 Deletion Defines a Subgroup of Multiple Myeloma with Poor Clinical Outcomes Independent of del (13q), del(p53), t(4;14) or 1q21 Amplification.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Chromosome 13; Biology; Fluorescence in situ hybridization; Multiple myeloma; Pathogenesis; Internal medicine; Pathology; Molecular biology; Gene; Gastroenterology; Chromosome; Medicine; Immunology; Genetics","score_opus":0.05152371000253943,"score_gpt":0.34424255585638364,"score_spread":0.2927188458538442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981456572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99631345,0.0003228428,0.0016903823,0.00018190235,0.00006652788,0.0010322351,0.00007717029,0.000057537032,0.00025796614],"genre_scores_gemma":[0.9874417,0.00014044745,0.011576904,0.000093579976,0.0001021107,0.00006172374,0.00016109904,0.000045874138,0.00037651256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969407,0.00009360022,0.0010573594,0.00047706396,0.00092140347,0.00050991564],"domain_scores_gemma":[0.997225,0.00079086504,0.00040540774,0.00062588946,0.0005646522,0.00038822842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007818891,0.0002834948,0.0007879044,0.00027630627,0.000079487865,0.000012014977,0.00020029515,0.00021652506,0.00012388555],"category_scores_gemma":[0.0011682546,0.00018454042,0.00023795114,0.0004171412,0.00024279012,0.00010457177,0.00007748217,0.0002600695,0.000040173825],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030808966,0.004804004,0.9763492,0.00020785129,0.0008764061,0.00024244146,0.000090491274,0.0000018656261,0.0071886047,0.000106086176,0.00004814828,0.0070040417],"study_design_scores_gemma":[0.018827055,0.0019303899,0.947251,0.00017501095,0.00038301822,0.00015802939,0.00012089745,0.000073286086,0.030767696,0.000021547996,0.00012114412,0.00017092045],"about_ca_topic_score_codex":0.0006589771,"about_ca_topic_score_gemma":0.0010968718,"teacher_disagreement_score":0.029098159,"about_ca_system_score_codex":0.000056797257,"about_ca_system_score_gemma":0.00029487588,"threshold_uncertainty_score":0.75253403},"labels":[],"label_agreement":null},{"id":"W2981550333","doi":"10.1182/blood.v122.21.3189.3189","title":"Randomized Placebo-Controlled Phase III Study Of Perifosine Combined With Bortezomib and Dexamethasone In Relapsed, Refractory Multiple Myeloma Patients Previously Treated With Bortezomib","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Bortezomib; Internal medicine; Placebo; Dexamethasone; Refractory (planetary science); Phases of clinical research; Gastroenterology; Multiple myeloma; Randomization; Urology; Maintenance therapy; Pharmacology; Surgery; Randomized controlled trial; Clinical trial; Chemotherapy; Pathology","score_opus":0.011842555344181405,"score_gpt":0.2628375749493714,"score_spread":0.25099501960519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981550333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9798555,0.00038571097,0.000008793647,0.000040994037,0.000013635064,0.019333595,0.000018310535,0.000073284325,0.00027021038],"genre_scores_gemma":[0.9957136,0.000079865014,0.00072345196,0.000026349877,0.000020696283,0.002846673,0.00013692112,0.00007701479,0.00037542],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99636513,0.0006284942,0.000954721,0.0006722654,0.0007512917,0.00062810344],"domain_scores_gemma":[0.9970717,0.0008973619,0.00045624407,0.00064518326,0.00046609796,0.00046344264],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005341392,0.0005263771,0.0025172324,0.00042284772,0.00010357314,0.000041678642,0.0001300446,0.00013855714,0.000118268224],"category_scores_gemma":[0.00072929065,0.0003103416,0.00012167426,0.00043469633,0.00027042103,0.0001860839,0.00005976758,0.00034816161,0.000007850807],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.589898,0.027118335,0.37723875,0.00007684653,0.0020562958,0.00024130772,0.0009514307,0.0000024588967,0.000530885,9.975104e-7,0.000017242113,0.0018674437],"study_design_scores_gemma":[0.8269449,0.020952063,0.14733842,0.0002693415,0.001438185,0.00002609714,0.0004899607,0.0013888117,0.0008944193,0.0000015456001,0.000004662178,0.00025161152],"about_ca_topic_score_codex":0.0025678105,"about_ca_topic_score_gemma":0.0007313453,"teacher_disagreement_score":0.23704688,"about_ca_system_score_codex":0.00007657633,"about_ca_system_score_gemma":0.00016170774,"threshold_uncertainty_score":0.99993485},"labels":[],"label_agreement":null},{"id":"W2981751437","doi":"10.1182/blood.v130.suppl_1.2398.2398","title":"Incidence and Risk Factors for IVIG-Mediated Hemolysis","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; Sunnybrook Health Science Centre; University Health Network; University of Toronto; Toronto General Hospital; Health Sciences Centre; Canadian Blood Services","funders":"","keywords":"Hemolysis; Medicine; Reticulocytosis; Incidence (geometry); Internal medicine; Hemoglobin; Gastroenterology; Anemia; ABO blood group system; Relative risk; Confidence interval","score_opus":0.01541311324659766,"score_gpt":0.2707199722701713,"score_spread":0.25530685902357364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981751437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987574,0.00028666688,0.000019536412,0.0001268875,0.00003308155,0.00022350186,0.000060028506,0.000022117192,0.00047073638],"genre_scores_gemma":[0.99887687,0.00038666447,0.00037018227,0.000026705906,0.00002237368,0.000015589794,0.000034297525,0.000009349599,0.00025798136],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995755,0.000004684492,0.00007289071,0.00014664752,0.00007253388,0.00012774645],"domain_scores_gemma":[0.9994987,0.00007581488,0.00007678715,0.00023915114,0.000025879572,0.00008363303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000043124335,0.00008103344,0.00018587963,0.000025082643,0.00021817075,0.00002838286,0.00005076513,0.00004811366,0.000013652558],"category_scores_gemma":[0.00042778096,0.000059547518,0.0000458074,0.000015968802,0.000042513744,0.00006355918,0.00002536569,0.000043779182,0.00000953481],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027006143,0.00025741817,0.9968022,0.000016948323,0.00025121338,0.000074115465,0.000113197166,4.1255472e-8,0.0004487189,0.0000053358617,0.0000835704,0.0019202117],"study_design_scores_gemma":[0.006579956,0.00025479638,0.98507285,0.000028782903,0.0008492473,0.00003261314,0.000060794333,0.00006329696,0.006207965,0.00024686407,0.0005093618,0.00009349424],"about_ca_topic_score_codex":0.0003290695,"about_ca_topic_score_gemma":0.0000764424,"teacher_disagreement_score":0.011729395,"about_ca_system_score_codex":0.0000047599615,"about_ca_system_score_gemma":0.000017642587,"threshold_uncertainty_score":0.24282774},"labels":[],"label_agreement":null},{"id":"W2982057342","doi":"10.1182/blood.v112.11.511.511","title":"Site-Specific PEGylation of Factor VIII (PEG-FVIII) Preserves Full Clotting Activity and Extends Therapeutic Efficacy in HemophiliaA Dogs","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"PEGylation; Medicine; Clotting factor; PEG ratio; Pharmacology; Hematology; Pharmacokinetics; Dosing; Platelet; Internal medicine; Immunology; Chemistry; Polyethylene glycol; Biochemistry","score_opus":0.05446898702010485,"score_gpt":0.30523092915977384,"score_spread":0.250761942139669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982057342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960328,0.001986522,0.0000049592218,0.0004382852,0.000029170935,0.0005068457,0.000010095954,0.00004167232,0.0009496955],"genre_scores_gemma":[0.99832517,0.0008037226,0.00016350215,0.000010626286,0.00011524253,0.000014349417,0.000015765956,0.000024119838,0.00052752334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986356,0.000096148266,0.00025700717,0.0003258204,0.00037906854,0.00030638778],"domain_scores_gemma":[0.9991715,0.00024796659,0.000077492536,0.00030602893,0.00007333123,0.00012368732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017348357,0.00017330138,0.00035879406,0.00020579342,0.0000985904,0.000011514935,0.000072781695,0.00012691972,0.00010465663],"category_scores_gemma":[0.00007440121,0.00013364798,0.00008665498,0.00027970073,0.00014403806,0.000111560556,0.00005838949,0.00024765087,0.000012988002],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051077065,0.0027586904,0.5355163,0.00015574254,0.00009334505,0.00013880992,0.001618323,0.0000030620308,0.44423655,0.00002110522,0.000016770335,0.014930511],"study_design_scores_gemma":[0.0058922684,0.00057165633,0.9115218,0.00008915621,0.000044299162,0.00007653926,0.000036468642,0.00011288434,0.08132899,0.000026397876,0.00018132474,0.000118244694],"about_ca_topic_score_codex":0.00007392779,"about_ca_topic_score_gemma":0.000024387702,"teacher_disagreement_score":0.37600547,"about_ca_system_score_codex":0.00003444685,"about_ca_system_score_gemma":0.0000651121,"threshold_uncertainty_score":0.5450006},"labels":[],"label_agreement":null},{"id":"W2982074944","doi":"10.1182/blood.v112.11.1095.1095","title":"Dasatinib-Associated Major Molecular Responses Are Rapidly Achieved in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Following Resistance, Suboptimal Response, or Intolerance on Imatinib.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Dasatinib; Nilotinib; Imatinib; Medicine; Internal medicine; Imatinib mesylate; Myeloid leukemia; Oncology; Pharmacology; Immunology","score_opus":0.012918723189271996,"score_gpt":0.26444529648828324,"score_spread":0.25152657329901124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982074944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954056,0.0013335941,0.00000941371,0.00019540059,0.00009868548,0.0022984517,0.000115078976,0.00019923829,0.00034453862],"genre_scores_gemma":[0.99606884,0.000089559784,0.0010479013,0.0002643828,0.00008038775,0.00038686703,0.000248612,0.00018611115,0.001627341],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99440324,0.00076689693,0.0011703356,0.0012378627,0.0011391116,0.0012825541],"domain_scores_gemma":[0.99714696,0.0006612351,0.0005686311,0.0011722599,0.00014705266,0.0003038287],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007798459,0.00081199064,0.0013611364,0.0007169962,0.00023369453,0.00003565419,0.0003744427,0.00039108357,0.00011006027],"category_scores_gemma":[0.0014226381,0.0006892739,0.00024902806,0.001674413,0.00021043081,0.00027378942,0.000095003066,0.0009677013,0.000054669494],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.280107,0.013023488,0.6193823,0.0007033153,0.002093143,0.030625248,0.0027192237,0.0015364354,0.047796864,0.000026763073,0.0006590695,0.001327139],"study_design_scores_gemma":[0.19604427,0.007352641,0.7760158,0.0037864463,0.00032061647,0.00004747297,0.000064008425,0.00023432336,0.015083104,0.0000066869575,0.0002635051,0.00078108907],"about_ca_topic_score_codex":0.00016665347,"about_ca_topic_score_gemma":0.002042275,"teacher_disagreement_score":0.15663353,"about_ca_system_score_codex":0.013766481,"about_ca_system_score_gemma":0.0068937005,"threshold_uncertainty_score":0.9995558},"labels":[],"label_agreement":null},{"id":"W2982178284","doi":"10.1182/blood.v112.11.4565.4565","title":"Treatment Patterns and Splenectomy Failure Rates in Patients with Chronic Immune Thrombocytopenic Purpura in Canada: A Retrospective Chart Review","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Burnaby Hospital; Amgen (Canada)","funders":"","keywords":"Medicine; Splenectomy; Thrombocytopenic purpura; Danazol; Retrospective cohort study; Surgery; Adverse effect; Pediatrics; Internal medicine; Platelet; Spleen","score_opus":0.00701235848452799,"score_gpt":0.2101795732542602,"score_spread":0.2031672147697322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982178284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855901,0.0125991255,1.01475656e-7,0.0004152761,0.000013061327,0.0012471013,0.00004039526,0.000009037643,0.00008580777],"genre_scores_gemma":[0.9857236,0.013846814,0.000019600637,0.00009257453,0.000009904403,0.00012677196,0.00012554374,0.000018900533,0.000036298738],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989742,0.000025540086,0.00023307756,0.00030134773,0.00018254419,0.0002832918],"domain_scores_gemma":[0.9995964,0.000012928572,0.00007097147,0.00021222582,0.000033927106,0.00007354658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000023060158,0.00020831588,0.0006749541,0.000060110615,0.00003982176,0.0000042009283,0.00004025287,0.00003521578,0.00006574539],"category_scores_gemma":[0.000008822401,0.0001474422,0.000031428226,0.00019686845,0.000024386427,0.00006985395,0.000018768304,0.00010665509,0.0000043708446],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053027834,0.0008403159,0.9967413,0.00014512245,0.00015512413,0.0013593725,0.0000773989,1.4897574e-7,0.000009972282,0.0000015645254,0.00002156723,0.0005950669],"study_design_scores_gemma":[0.019170383,0.0011554586,0.97759074,0.0011800568,0.0001487527,0.00015819234,0.000021254367,0.0000018976625,0.00033643944,0.000002160314,0.00009687341,0.00013781681],"about_ca_topic_score_codex":0.43556678,"about_ca_topic_score_gemma":0.8318618,"teacher_disagreement_score":0.39629498,"about_ca_system_score_codex":0.0007381534,"about_ca_system_score_gemma":0.00070211897,"threshold_uncertainty_score":0.60125184},"labels":[],"label_agreement":null},{"id":"W2982284915","doi":"10.1182/blood.v130.suppl_1.3493.3493","title":"The KAP 2 Study: Preliminary Results from a Pragmatic Cluster Randomized Trial of a Community Education Intervention to Support Childhood Anemia Control in India","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Anemia; Cluster randomised controlled trial; Randomized controlled trial; Pediatrics; Cluster (spacecraft); Intervention (counseling); Environmental health; Population; Family medicine; Surgery; Internal medicine; Nursing","score_opus":0.010256617067420747,"score_gpt":0.30199723232153386,"score_spread":0.2917406152541131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982284915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990115,0.00011345914,0.000021902002,0.00090628775,0.00035459592,0.0062238704,0.000043333792,0.000012220642,0.0022093577],"genre_scores_gemma":[0.99881786,0.000014238366,0.00008883302,0.00024043598,0.0001303748,0.0004279646,0.00011208519,0.000012322739,0.00015589705],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9974885,0.0012574019,0.0007405706,0.00013272394,0.00023313334,0.00014769145],"domain_scores_gemma":[0.9975631,0.0007987604,0.00049726083,0.0009971554,0.0000749147,0.00006877572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033525936,0.00012532146,0.0005818335,0.00009784125,0.00022045821,0.000048041293,0.0003001739,0.00007104715,0.000014161502],"category_scores_gemma":[0.0061072935,0.00008468786,0.00015009368,0.00005422841,0.00009069791,0.00009057511,0.000098448494,0.0002749653,0.000009620429],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95336866,0.016100293,0.0024882602,0.00006124497,0.000116418116,0.0000031489592,0.015944103,7.617545e-7,0.000042263397,0.000023438677,0.0007688843,0.011082543],"study_design_scores_gemma":[0.7038137,0.0018779496,0.28981188,0.000111165245,0.00066025427,0.0000020193309,0.0033436457,0.0000042382608,0.00004222574,0.00024960848,0.000025690757,0.00005765341],"about_ca_topic_score_codex":0.0029771852,"about_ca_topic_score_gemma":0.00046478832,"teacher_disagreement_score":0.28732362,"about_ca_system_score_codex":0.000011801599,"about_ca_system_score_gemma":0.00018441242,"threshold_uncertainty_score":0.7311442},"labels":[],"label_agreement":null},{"id":"W2982311108","doi":"10.1182/blood.v110.11.1631.1631","title":"Incidence of Post-Thrombotic Syndrome Following Asymptomatic Thrombosis in Survivors of Childhood Acute Lymphoblastic Leukemia.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Children's Hospital; Children's Hospital of Eastern Ontario; Stollery Children's Hospital","funders":"","keywords":"Medicine; Asymptomatic; Pediatrics; Cohort; Post-thrombotic syndrome; Cumulative incidence; Incidence (geometry); Thrombosis; Internal medicine; Surgery; Venous thrombosis","score_opus":0.007539721743369945,"score_gpt":0.2508993939403413,"score_spread":0.24335967219697133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982311108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99720496,0.00033426387,0.00013967605,0.000071492505,0.00020473138,0.0007483641,0.000008985669,0.00005349962,0.0012340123],"genre_scores_gemma":[0.99822307,0.00011828574,0.0013361354,0.00019943713,0.000024186673,0.000019030957,0.000015633426,0.000045711255,0.000018517198],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974538,0.000049661143,0.00097562745,0.00036871026,0.0006329636,0.0005192281],"domain_scores_gemma":[0.99860424,0.00029002957,0.00031150776,0.00054928503,0.00009539981,0.00014955111],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00079454284,0.00027367024,0.0012864647,0.00050277676,0.00004298849,0.0000093220515,0.00025702748,0.00013823355,0.000069512025],"category_scores_gemma":[0.00024928697,0.0002566198,0.0002899661,0.00075699895,0.00009748639,0.00014658151,0.00014939101,0.00014900963,0.000022782027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000119345204,0.021717468,0.8309224,0.0032592951,0.008086894,0.0024347578,0.011713253,0.00026120376,0.117564924,0.0018713691,0.00013766848,0.0019114135],"study_design_scores_gemma":[0.0035361077,0.0012554951,0.978253,0.0013495857,0.0018859454,0.000120282864,0.0006057345,0.000031087464,0.01264187,0.000097507305,0.0000030524359,0.0002203314],"about_ca_topic_score_codex":0.001113571,"about_ca_topic_score_gemma":0.00039764287,"teacher_disagreement_score":0.1473306,"about_ca_system_score_codex":0.00015936683,"about_ca_system_score_gemma":0.00023897692,"threshold_uncertainty_score":0.9999886},"labels":[],"label_agreement":null},{"id":"W2982479910","doi":"10.1182/blood.2019002739","title":"From Montreal to von Willebrand…","year":2019,"lang":"de","type":"article","venue":"Blood","topic":"Social Policies and Family","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.009324770214655989,"score_gpt":0.25126129736104963,"score_spread":0.24193652714639363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982479910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91517043,0.0029290244,0.0000022678073,0.0039118966,0.0030962096,0.00041660666,0.00013429591,0.00006609176,0.07427316],"genre_scores_gemma":[0.98250145,0.000710492,0.0000666821,0.0033406462,0.0067826607,0.000009395487,0.000015419171,0.000026011017,0.006547225],"study_design_codex":"qualitative","study_design_gemma":"not_applicable","domain_scores_codex":[0.99834824,0.0001126001,0.0002133957,0.00034979006,0.00043731742,0.00053865474],"domain_scores_gemma":[0.99914235,0.00014983454,0.00007629416,0.0002864463,0.00005109278,0.0002939982],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017592056,0.0001708573,0.0003056811,0.000039332404,0.000268134,0.00014057582,0.00038703778,0.00022930578,0.0008949358],"category_scores_gemma":[0.00007167378,0.00017260884,0.00016004447,0.00035158856,0.000091302696,0.000091307695,0.000106229105,0.0001411499,0.010161016],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019150121,0.0019757834,0.14980125,0.000041696345,0.0012576666,0.000047942853,0.531695,0.000023206201,0.0037959383,0.007339233,0.26153335,0.04229739],"study_design_scores_gemma":[0.0037360901,0.00038373307,0.2867144,0.00011062639,0.00053499924,1.828485e-7,0.028559646,0.000019123503,0.00033971708,0.009041219,0.66974205,0.00081822666],"about_ca_topic_score_codex":0.1415366,"about_ca_topic_score_gemma":0.0036338172,"teacher_disagreement_score":0.5031354,"about_ca_system_score_codex":0.00003825311,"about_ca_system_score_gemma":0.000113301074,"threshold_uncertainty_score":0.9906097},"labels":[],"label_agreement":null},{"id":"W2982748530","doi":"10.1182/blood-2019-129259","title":"Understanding Pre-Leukemia in Trisomy 21 Human HSC and Modeling Progression Towards Down Syndrome Associated Leukemia Using CRISPR/Cas9 at Single Cell Resolution","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"GATA1; Leukemia; Biology; Acute megakaryoblastic leukemia; Cancer research; Haematopoiesis; Trisomy; Childhood leukemia; Down syndrome; Genetics; Stem cell","score_opus":0.03761265964558379,"score_gpt":0.2685718646018132,"score_spread":0.2309592049562294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982748530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962819,0.001574564,0.00042339845,0.000012488793,0.00009271234,0.00029864858,0.0000064643964,0.000021342856,0.0012884464],"genre_scores_gemma":[0.99908334,0.00017863885,0.00019019163,0.000020447233,0.00004085859,0.0000073916085,0.00008254306,0.000029755533,0.00036683152],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99869055,0.00007553044,0.00027367714,0.0004310131,0.00018234302,0.00034691312],"domain_scores_gemma":[0.9995587,0.000006107781,0.000135859,0.00018567858,0.000033928052,0.00007975355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020742042,0.00018878237,0.00021289084,0.000083657185,0.00016087826,0.000038097987,0.00009932672,0.0004089943,0.000008084627],"category_scores_gemma":[0.000016710963,0.00017136277,0.00007115413,0.00014207586,0.000043570228,0.000012712244,0.0001421596,0.00020145606,0.000002197945],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009978714,0.00008955133,0.0057999543,0.00008034838,0.0000658778,0.000024756186,0.00014543289,0.022584533,0.97100973,0.0000069560674,0.00003996124,0.000053135536],"study_design_scores_gemma":[0.016082942,0.002151446,0.0033878384,0.0015541341,0.00039332354,0.00030883096,0.0005709052,0.13989128,0.83359724,0.00041342908,0.00024218345,0.0014064473],"about_ca_topic_score_codex":0.0001791023,"about_ca_topic_score_gemma":0.000047282207,"teacher_disagreement_score":0.13741247,"about_ca_system_score_codex":0.0010427593,"about_ca_system_score_gemma":0.00018855564,"threshold_uncertainty_score":0.6987971},"labels":[],"label_agreement":null},{"id":"W2982755933","doi":"10.1182/blood-2019-127253","title":"Results from a Global Randomized Phase 3 Study of Guadecitabine (G) Vs Treatment Choice (TC) in 815 Patients with Treatment Naïve (TN) AML Unfit for Intensive Chemotherapy (IC) ASTRAL-1 Study: Analysis By Number of Cycles","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Alberta","funders":"","keywords":"Decitabine; Medicine; Internal medicine; Discontinuation; Clinical endpoint; Randomization; Cytarabine; Azacitidine; Surrogate endpoint; Gastroenterology; Chemotherapy regimen; Oncology; Phases of clinical research; Chemotherapy; Randomized controlled trial; Biology","score_opus":0.015904654197551417,"score_gpt":0.33272079441835567,"score_spread":0.31681614022080423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982755933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98605067,0.000094516574,0.000021237276,0.00014692714,0.000025829817,0.01128978,0.0022452192,0.000023236802,0.00010260629],"genre_scores_gemma":[0.99746704,0.000046088004,0.0006201278,0.000042018582,0.000038352027,0.000570348,0.000931643,0.000042353284,0.00024205176],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99658996,0.00030939147,0.0011146744,0.00080375496,0.00074939453,0.00043283158],"domain_scores_gemma":[0.9967468,0.000905335,0.00054178055,0.000885582,0.0007417641,0.00017875916],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034380596,0.0004661966,0.0026419212,0.00023981191,0.000031713254,0.000015556901,0.00019527558,0.000113465016,0.00008618819],"category_scores_gemma":[0.0003310439,0.00029819435,0.00038751884,0.0009706305,0.0001080792,0.000079126265,0.00004315302,0.00011052115,0.000007433742],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3020063,0.05655353,0.6146324,0.000017503102,0.018819265,0.000027805989,0.0054876343,0.000019098628,0.0003220091,6.6458136e-7,0.00005593014,0.002057849],"study_design_scores_gemma":[0.7823918,0.02301758,0.17840582,0.00006238089,0.0073291995,9.891517e-7,0.0052920277,0.00017642848,0.0030930042,0.0000067172846,0.000029326102,0.0001947482],"about_ca_topic_score_codex":0.013125822,"about_ca_topic_score_gemma":0.0021729374,"teacher_disagreement_score":0.48038548,"about_ca_system_score_codex":0.0006871169,"about_ca_system_score_gemma":0.00023104477,"threshold_uncertainty_score":0.999947},"labels":[],"label_agreement":null},{"id":"W2982767139","doi":"10.1182/blood-2019-125592","title":"Head-to-Head Comparison of Haploidentical HSCT Strategies for Hematologic Malignancies: Phase III Hatcy Study of T-Cell-Depleted HSCT with Adjunctive ATIR101 Versus T-Cell-Replete HSCT with Post‐Transplant Cyclophosphamide","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Hematopoietic stem cell transplantation; Stem cell; T cell; Immunology; Graft-versus-host disease; Transplantation; Cyclophosphamide; Cancer research; Immune system; Oncology; Chemotherapy; Internal medicine; Biology","score_opus":0.028122825967910894,"score_gpt":0.314043462636984,"score_spread":0.28592063666907314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982767139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881788,0.0002540328,0.003844702,0.000069775495,0.00016635536,0.0059196264,0.0002318129,0.00012899806,0.00120591],"genre_scores_gemma":[0.99567837,0.000019698133,0.0035256585,0.000057462094,0.000029995763,0.00027281692,0.00022210239,0.00010554628,0.000088332854],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9959054,0.00012199139,0.0012944738,0.0009152916,0.001063388,0.00069945963],"domain_scores_gemma":[0.99684197,0.0007579714,0.0005798946,0.00084460166,0.00066706847,0.0003084869],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034395166,0.00063592975,0.0019061127,0.00028283047,0.000104393046,0.000036474717,0.0003040152,0.00021058109,0.000055231445],"category_scores_gemma":[0.00003738498,0.00047180473,0.0002057556,0.00059088535,0.00019223969,0.0001849445,0.00002728464,0.00031188555,0.000023380824],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.086083286,0.03301394,0.2872563,0.008235221,0.002312439,0.00062375097,0.025939697,0.00055215356,0.55504614,0.00079436286,0.000053047104,0.00008967608],"study_design_scores_gemma":[0.25069502,0.09545688,0.03562448,0.003280378,0.0074943476,0.0003955345,0.05290606,0.00057586055,0.55228233,0.00003714663,0.000032632943,0.0012193167],"about_ca_topic_score_codex":0.00045069715,"about_ca_topic_score_gemma":0.00052630604,"teacher_disagreement_score":0.25163183,"about_ca_system_score_codex":0.000056557856,"about_ca_system_score_gemma":0.00048722906,"threshold_uncertainty_score":0.9997734},"labels":[],"label_agreement":null},{"id":"W2982819153","doi":"10.1182/blood-2019-126158","title":"Feasibility and Impact of Embedded Geriatric Consultation for Frail Older Adults with Blood Cancer: A Randomized Controlled Trial","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Geriatrics; Randomized controlled trial; Geriatric oncology; Physical therapy; Advance care planning; Cancer; Palliative care; Emergency medicine; Gerontology; Internal medicine; Nursing","score_opus":0.031027357412184636,"score_gpt":0.3709175731406487,"score_spread":0.33989021572846406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982819153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833465,0.0059442455,0.000056266315,0.00003271949,0.00007824922,0.010225433,0.00008122062,0.000018170758,0.0002171435],"genre_scores_gemma":[0.99750364,0.00070688635,0.000997228,0.000017419476,0.00010821992,0.0005005096,0.000029496307,0.000014904252,0.00012167133],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9987646,0.00012349965,0.00051658356,0.00023869882,0.00019919503,0.00015746086],"domain_scores_gemma":[0.99728817,0.0015071695,0.00043895375,0.0001863184,0.0004995078,0.000079899706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004913683,0.00016754123,0.0017723733,0.000092101596,0.000017182867,0.000006113742,0.00003827341,0.000091507805,0.00007879356],"category_scores_gemma":[0.0014922753,0.0000989511,0.00035468658,0.00014161305,0.00009025622,0.000047782407,0.000008201362,0.0000654958,6.460317e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94574577,0.0008681685,0.04701691,0.00042433065,0.0017965762,0.0000015529547,0.0025222437,0.000003108311,0.0013956167,0.000011997794,0.000022768094,0.0001909329],"study_design_scores_gemma":[0.9845105,0.002162629,0.0045268447,0.0006157834,0.00342019,0.0000034046973,0.00035224858,0.00015005298,0.004122527,0.000025861633,0.0000042385414,0.000105760264],"about_ca_topic_score_codex":0.000272559,"about_ca_topic_score_gemma":0.000022609627,"teacher_disagreement_score":0.042490065,"about_ca_system_score_codex":0.000017504304,"about_ca_system_score_gemma":0.00030894118,"threshold_uncertainty_score":0.40351087},"labels":[],"label_agreement":null},{"id":"W2982903806","doi":"10.1182/blood-2019-122781","title":"An Exploratory Analysis of Brentuximab Vedotin Plus CHP (A+CHP) in the Frontline Treatment of Patients with CD30+ Peripheral T-Cell Lymphomas (ECHELON-2): Impact of Consolidative Stem Cell Transplant","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Brentuximab vedotin; Medicine; Internal medicine; Univariate analysis; Transplantation; Oncology; Surgery; Multivariate analysis; Lymphoma; CD30","score_opus":0.015816124630601492,"score_gpt":0.27362272216319433,"score_spread":0.25780659753259283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982903806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970958,0.00046439932,0.000009006033,0.000009848569,0.000016676733,0.0011546687,0.0005908953,0.0000095548385,0.00064910087],"genre_scores_gemma":[0.99916494,0.00013977729,0.00006904961,0.000008844473,0.000016178277,0.000035480243,0.00033874754,0.00003216444,0.0001947951],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979044,0.00031330032,0.0004970925,0.00033907514,0.00063752534,0.00030857394],"domain_scores_gemma":[0.99848473,0.00015441107,0.00029382156,0.00073159114,0.00022060057,0.00011486547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026737477,0.0002704625,0.0010693815,0.00036919647,0.000018139552,0.000007519481,0.00021341561,0.00009545088,0.0005683698],"category_scores_gemma":[0.0000022428799,0.00015931923,0.00035121673,0.0007525139,0.00013674003,0.000081959035,0.000012774228,0.00010984612,0.0000025684642],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056805913,0.016005868,0.83197486,0.00017784553,0.0023939558,0.000029958645,0.028920824,0.00043192462,0.11346277,0.0000016902521,0.0000040983355,0.0009156042],"study_design_scores_gemma":[0.06505076,0.021546395,0.620285,0.0001351006,0.0036941487,0.000004478154,0.0059679397,0.0017365464,0.28126857,0.0000014476892,0.000026226415,0.00028343755],"about_ca_topic_score_codex":0.00063553907,"about_ca_topic_score_gemma":0.00021194853,"teacher_disagreement_score":0.21168993,"about_ca_system_score_codex":0.00023114916,"about_ca_system_score_gemma":0.00047617086,"threshold_uncertainty_score":0.64968497},"labels":[],"label_agreement":null},{"id":"W2982913861","doi":"10.1182/blood-2019-129990","title":"A 9-Gene Expression Signature Identifies Patients with Core-Binding Factor Acute Myeloid Leukemia at High Risk of Relapse after Achieving Complete Remission","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Oncology; Internal medicine; Cytarabine; Proportional hazards model; Hazard ratio; Myeloid leukemia; Medicine; Univariate analysis; Gene signature; Hematology; Chemotherapy regimen; Chemotherapy; Biology; Gene expression; Gene; Multivariate analysis; Confidence interval; Genetics","score_opus":0.010505659448691486,"score_gpt":0.23932540916040174,"score_spread":0.22881974971171026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982913861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99765515,0.00023529108,0.000028823335,0.00004099876,0.00016695456,0.0011460204,0.00045164945,0.00008500576,0.00019007738],"genre_scores_gemma":[0.9936305,0.00014173466,0.0028011624,0.00005389622,0.00010052231,0.00003504555,0.00042355666,0.00009602515,0.0027175145],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.996973,0.00012697322,0.0004946506,0.00068322435,0.0011575853,0.0005646006],"domain_scores_gemma":[0.9978357,0.000207491,0.00042354007,0.0009165163,0.00031581652,0.00030095386],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022999333,0.00038214566,0.00068107084,0.00026959582,0.00017036327,0.000031308846,0.00029671707,0.0003411773,0.0005784563],"category_scores_gemma":[0.00017339418,0.00026359592,0.00016210126,0.00035294238,0.00011633978,0.0002478212,0.00049122155,0.0008891059,0.00015579646],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021903636,0.00015156453,0.4432802,0.00017969366,0.00026162935,0.000071614246,0.0003599774,0.000005387061,0.5529483,9.830873e-7,0.00039228637,0.00015797645],"study_design_scores_gemma":[0.011430813,0.0007910125,0.5135545,0.0012012193,0.00047073563,0.00003292361,0.000058148256,0.000031135653,0.471858,0.000008207621,0.00025619566,0.00030707638],"about_ca_topic_score_codex":0.000073706644,"about_ca_topic_score_gemma":0.000007469766,"teacher_disagreement_score":0.08109032,"about_ca_system_score_codex":0.0005489764,"about_ca_system_score_gemma":0.00022240554,"threshold_uncertainty_score":0.99998164},"labels":[],"label_agreement":null},{"id":"W2982955127","doi":"10.1182/blood-2019-124476","title":"Natural History of Tumor Thrombus: A Single-Centre Retrospective Study","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Thrombus; Thrombosis; Pulmonary embolism; Radiology; Retrospective cohort study; Malignancy; Hazard ratio; Proportional hazards model; Deep vein; Log-rank test; Surgery; Venous thrombosis; Internal medicine","score_opus":0.011961307168101004,"score_gpt":0.22415973791468044,"score_spread":0.21219843074657943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982955127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.974605,0.0010293534,4.4241673e-7,0.00011109908,0.0006121456,0.0011760253,0.0000023661894,0.000053556378,0.022409968],"genre_scores_gemma":[0.99522996,0.000008236789,0.00011219374,0.00027342106,0.000083926956,0.000009225605,0.0000041884655,0.000022253787,0.004256578],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989678,0.000029401057,0.00021587349,0.00027577986,0.00031654813,0.0001945946],"domain_scores_gemma":[0.9993344,0.000016289725,0.00011944849,0.000371215,0.000103021346,0.000055647128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000114995164,0.00012956093,0.00050653657,0.00008260594,0.000013876972,0.0000044747635,0.00008978608,0.000027114782,0.00053396524],"category_scores_gemma":[0.00004410996,0.00011058554,0.00010021247,0.00009784659,0.00003669331,0.00005143914,0.00006979916,0.00013123141,0.000099755256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010547526,0.037644926,0.8939227,0.00035207393,0.0013709067,0.00018949932,0.009370325,0.0000011770802,0.034890287,0.0010462458,0.020840105,0.00026629248],"study_design_scores_gemma":[0.006819677,0.0023928809,0.9797999,0.00016278082,0.00090219686,0.000010243218,0.0027287144,0.00000828411,0.0020532287,0.000031703632,0.0049155527,0.00017478273],"about_ca_topic_score_codex":0.00007829321,"about_ca_topic_score_gemma":0.000038956165,"teacher_disagreement_score":0.08587726,"about_ca_system_score_codex":0.0002720673,"about_ca_system_score_gemma":0.000075620344,"threshold_uncertainty_score":0.5846545},"labels":[],"label_agreement":null},{"id":"W2982996777","doi":"10.1182/blood-2019-123757","title":"An Individualized Risk Mitigation Approach for Safety: Experience from the Mosunetuzumab (CD20/CD3 Bispecific Antibody) Development Program in Relation to Neurotoxicity Risk","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Jewish General Hospital","funders":"","keywords":"Medicine; Adverse effect; Cytokine release syndrome; Internal medicine; Clinical trial; Rituximab; CD20; Oncology; Antibody; Immunology; Chimeric antigen receptor; Immunotherapy; Cancer","score_opus":0.021490878812608593,"score_gpt":0.3128144969756654,"score_spread":0.2913236181630568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982996777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97987455,0.00007437963,0.015181949,0.0005072582,0.00011725336,0.003961545,0.000046690657,0.00007877959,0.00015759862],"genre_scores_gemma":[0.9396791,0.000050517832,0.058598004,0.00016553172,0.00012717494,0.0003534558,0.00097543036,0.000022600056,0.00002822634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981505,0.00018676197,0.00045701428,0.0004714813,0.0004908134,0.00024338436],"domain_scores_gemma":[0.999019,0.00015707315,0.00020272002,0.00038780706,0.000091322996,0.00014202323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000780085,0.00015739122,0.00024115728,0.00009582355,0.00018708888,0.00004898287,0.0001560727,0.000250481,0.000027412443],"category_scores_gemma":[0.00016531193,0.00010810349,0.000057325557,0.00044087655,0.0001221484,0.00010857883,0.00003900257,0.00036145805,0.00001047909],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000926671,0.0036342964,0.73929006,0.00011324345,0.00015508874,0.0000031751142,0.028047884,0.00046885273,0.02791854,0.0007145378,0.00004281971,0.19868483],"study_design_scores_gemma":[0.004718365,0.00043629072,0.9714645,0.00008804114,0.000077986086,0.0000020269376,0.00058473053,0.012458938,0.0051451484,0.00040259364,0.0044527166,0.0001686255],"about_ca_topic_score_codex":0.00019117836,"about_ca_topic_score_gemma":0.000045184996,"teacher_disagreement_score":0.23217447,"about_ca_system_score_codex":0.00005458189,"about_ca_system_score_gemma":0.0001384763,"threshold_uncertainty_score":0.44083327},"labels":[],"label_agreement":null},{"id":"W2982997998","doi":"10.1182/blood-2019-124660","title":"Treatment Decision Making in AML: Factors of Importance to Clinicians, AML Patients and Their Family","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Pfizer (Canada)","funders":"","keywords":"Medicine; Quality of life (healthcare); Myeloid leukemia; Family medicine; Affect (linguistics); Internal medicine; Pediatrics; Psychology; Nursing","score_opus":0.023917873102624648,"score_gpt":0.31672658603077164,"score_spread":0.292808712928147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982997998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981526,0.00021404831,0.000012879472,0.000062806226,0.00005142932,0.0007139581,0.000031091065,0.000012209192,0.0007489915],"genre_scores_gemma":[0.9988059,0.00010133614,0.00081734697,0.00015114638,0.00002027594,0.000010803804,0.00001572647,0.000019935667,0.000057556146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989561,0.000026816753,0.0003172071,0.00026821424,0.00020613473,0.00022551684],"domain_scores_gemma":[0.99925786,0.00021998797,0.000070821596,0.00030183952,0.00005668565,0.000092815775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011779222,0.00013152348,0.0003474666,0.00015881906,0.000013120621,0.0000062364943,0.000079533325,0.000077812525,0.000021725302],"category_scores_gemma":[0.00013137175,0.00008745318,0.000052405132,0.00019732674,0.00002144197,0.000040618917,0.0000664342,0.000106046406,0.00001946467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021630866,0.0004788349,0.9674059,0.000023372815,0.000038132548,0.000012455814,0.0009888225,0.0000010318503,0.0024754226,0.0000048797046,0.00004385339,0.028310964],"study_design_scores_gemma":[0.005752237,0.0014880827,0.98724324,0.00018859374,0.000022585153,0.0000022395982,0.000614479,0.000028248176,0.003990676,0.000028233018,0.0005610555,0.000080336606],"about_ca_topic_score_codex":0.000116024654,"about_ca_topic_score_gemma":0.00007427876,"teacher_disagreement_score":0.028230628,"about_ca_system_score_codex":0.00012885699,"about_ca_system_score_gemma":0.00009667963,"threshold_uncertainty_score":0.3566237},"labels":[],"label_agreement":null},{"id":"W2983008416","doi":"10.1182/blood-2019-125454","title":"Cost Effectiveness of Novel Agents in the Treatment of Multiple Myeloma: A Systematic Review","year":2019,"lang":"en","type":"review","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Checklist; Medicine; Multiple myeloma; MEDLINE; Systematic review; Cochrane Library; Cost effectiveness; Intensive care medicine; Family medicine; Meta-analysis; Internal medicine; Psychology; Risk analysis (engineering)","score_opus":0.19418998858158557,"score_gpt":0.424643867079468,"score_spread":0.23045387849788243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983008416","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042471485,0.9742174,0.0000038483604,0.0000037156688,0.0000401893,0.024865199,0.00026146608,0.000007986698,0.00017549016],"genre_scores_gemma":[0.0015847966,0.99439865,0.000065845015,0.00000816219,0.000020293797,0.0034301772,0.00037582297,0.000043713706,0.000072548486],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99663824,0.0009895214,0.0010926492,0.00037049464,0.00059704325,0.0003120536],"domain_scores_gemma":[0.9959177,0.002129005,0.0006135906,0.0011353606,0.00011418209,0.00009019467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008544913,0.0004335473,0.005325931,0.000228043,0.000019215253,0.0000062779122,0.00029161165,0.00016290467,0.00001311399],"category_scores_gemma":[0.00059909903,0.00021734716,0.00096251484,0.00051978236,0.00005625811,0.000023836485,0.000035168887,0.00015262778,0.00005162683],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004043496,0.008865719,0.00042662956,0.9629126,0.0020397804,0.00011425969,0.00005480206,6.3920815e-8,0.0000023402476,0.0000057321136,0.000003826718,0.025533782],"study_design_scores_gemma":[0.01102962,0.0012717089,0.00093505875,0.9622516,0.017505357,0.00020623443,0.000013203841,0.0000054972534,0.000030502297,3.5654423e-7,0.006597131,0.00015374948],"about_ca_topic_score_codex":0.00011462098,"about_ca_topic_score_gemma":0.000011271648,"teacher_disagreement_score":0.025380034,"about_ca_system_score_codex":0.0001957602,"about_ca_system_score_gemma":0.00032902998,"threshold_uncertainty_score":0.88631594},"labels":[],"label_agreement":null},{"id":"W2983013601","doi":"10.1182/blood-2019-125144","title":"Is There a Role for Titre Monitoring in Kell Alloimmunized Pregnancies?","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Fetus; Population; Pregnancy; Anemia; Obstetrics; Rh blood group system; Immunology; Antigen; Placenta; Antibody; Internal medicine; Biology","score_opus":0.01263490019218291,"score_gpt":0.2466908218316501,"score_spread":0.23405592163946717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983013601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894826,0.0037206383,0.000007993242,0.00022800213,0.000103176026,0.00068379706,0.0000057480056,0.00003499001,0.0057330914],"genre_scores_gemma":[0.99652886,0.00021560794,0.0008007516,0.00006561307,0.00009405933,0.00004375703,0.0000062948825,0.000023961647,0.0022211035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993833,0.000008726943,0.00013499665,0.0001730937,0.00010839309,0.00019153363],"domain_scores_gemma":[0.99961674,0.00003186165,0.000025403951,0.00025167817,0.000032524655,0.000041781608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007982211,0.000094823656,0.0002041852,0.000045325283,0.000023584354,0.000009230113,0.00006709706,0.00008654364,0.000118029486],"category_scores_gemma":[0.000008092632,0.000078249956,0.000086447966,0.00009322599,0.00000794016,0.00004627821,0.000017380708,0.00011952942,0.000056641573],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022727653,0.0011144625,0.8216529,0.00035804228,0.00011870037,0.000016020549,0.0014544335,0.0000011918942,0.17097276,0.00011933254,0.00004103317,0.003923879],"study_design_scores_gemma":[0.040287968,0.001102614,0.6051945,0.0021555277,0.0004297295,0.00003671214,0.0010502621,0.00017853646,0.3303231,0.0004612088,0.018424619,0.00035518807],"about_ca_topic_score_codex":0.00008725765,"about_ca_topic_score_gemma":0.000010930951,"teacher_disagreement_score":0.21645835,"about_ca_system_score_codex":0.000009039561,"about_ca_system_score_gemma":0.000030216968,"threshold_uncertainty_score":0.31909403},"labels":[],"label_agreement":null},{"id":"W2983033302","doi":"10.1182/blood-2019-129428","title":"Improving End of Life Care for Hematology-Oncology Patients within the Rossy Cancer Network","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; McGill University Health Centre; McGill University","funders":"","keywords":"Medicine; Palliative care; Internal medicine; Hematology; Cancer; Advance care planning; Hematologic Neoplasms; Emergency medicine; Intensive care medicine","score_opus":0.04122285127867121,"score_gpt":0.36045962243930735,"score_spread":0.31923677116063615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983033302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98728025,0.010471416,0.000030554496,0.00015197674,0.00045517104,0.0005871223,0.000039983013,0.000012025534,0.00097152346],"genre_scores_gemma":[0.99780256,0.0000878939,0.0013661362,0.0003586277,0.00020589022,0.00005627163,0.0000257468,0.000014150038,0.00008273095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992966,0.00002907984,0.00025720877,0.00013963469,0.00011009658,0.00016736449],"domain_scores_gemma":[0.99903995,0.0002301656,0.00023843706,0.00019227473,0.0002525132,0.000046663718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000097890705,0.00008794179,0.00039458956,0.0000207195,0.000031235875,0.0000018067248,0.0000878071,0.000098679426,0.000031691467],"category_scores_gemma":[0.00022961872,0.00005730854,0.00008162982,0.00007539909,0.000072030634,0.000020426622,0.000037289883,0.0000889626,0.0000031532254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019716316,0.00014467299,0.99048185,0.0006011186,0.00019969349,0.0000011701015,0.0041220216,0.00003866765,0.001035725,0.00032891572,0.00058082957,0.0022681402],"study_design_scores_gemma":[0.084073,0.014116361,0.40795168,0.0064931135,0.0050212624,0.00002556333,0.03168465,0.0010341657,0.2806779,0.0007923068,0.16682553,0.0013044648],"about_ca_topic_score_codex":0.0002440904,"about_ca_topic_score_gemma":0.00021647337,"teacher_disagreement_score":0.5825302,"about_ca_system_score_codex":0.000022256194,"about_ca_system_score_gemma":0.00024749257,"threshold_uncertainty_score":0.23369744},"labels":[],"label_agreement":null},{"id":"W2983035886","doi":"10.1182/blood-2019-125780","title":"Prognostic Impact of a Composite Genetic Profile Defined By Cytogenetics and Next Generation Sequencing at Diagnosis on Treatment Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Oncology; Internal medicine; NPM1; Transplantation; Hematopoietic stem cell transplantation; Myeloid; Fludarabine; Myeloid leukemia; Hazard ratio; Proportional hazards model; Chemotherapy; Cyclophosphamide; Biology; Karyotype; Genetics","score_opus":0.03108196507504248,"score_gpt":0.280488176020727,"score_spread":0.24940621094568452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983035886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962575,0.0012633237,0.000031809166,0.00006180812,0.000038085193,0.0021409187,0.00010618586,0.000034359393,0.000066039735],"genre_scores_gemma":[0.9960005,0.001167508,0.0018491915,0.000054227756,0.000019356336,0.00029724813,0.0003178086,0.00006223126,0.00023190657],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99798405,0.00012078215,0.0005222424,0.0005103378,0.00041663813,0.00044592159],"domain_scores_gemma":[0.99898624,0.00027600955,0.00014963126,0.0003588582,0.00005175462,0.00017750642],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013157974,0.00036728126,0.000687876,0.00024409046,0.00006697574,0.00003337478,0.00009889871,0.0001726102,0.000030096015],"category_scores_gemma":[0.000011203864,0.0002843316,0.00022594274,0.00025750816,0.000037035865,0.0000764103,0.000037539685,0.00014936943,0.00003094502],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000084343796,0.00025857298,0.5430312,0.000173976,0.00026999114,0.00012050087,0.00087238173,0.0002470709,0.45448086,6.6910206e-7,0.000009035691,0.00045138522],"study_design_scores_gemma":[0.008441517,0.0026422513,0.42078498,0.00020189589,0.0009876122,0.00012464722,0.00006068107,0.0015054876,0.5650066,0.0000020850491,0.0000025025822,0.00023972664],"about_ca_topic_score_codex":0.0003411013,"about_ca_topic_score_gemma":0.000050390572,"teacher_disagreement_score":0.12224622,"about_ca_system_score_codex":0.00168987,"about_ca_system_score_gemma":0.0004405718,"threshold_uncertainty_score":0.9999609},"labels":[],"label_agreement":null},{"id":"W2983038788","doi":"10.1182/blood-2019-130129","title":"Predictors of Disease Progression and Survival in Patients with Myelodysplastic Syndrome Secondary to Inherited Bone Marrow Failure Syndromes","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Janeway Children's Health and Rehabilitation Centre; Hospital for Sick Children; University of Saskatchewan; Queen's University; London Health Sciences Centre; McMaster Children's Hospital; Stollery Children's Hospital; Izaak Walton Killam Health Centre; Alberta Children's Hospital; Centre hospitalier de l'Université Laval; Centre Hospitalier Universitaire de Sherbrooke; Kingston General Hospital; Princess Margaret Cancer Centre; University of Toronto; Royal University Hospital; Montreal Children's Hospital; University of Manitoba; Children's Hospital of Eastern Ontario; BC Children's Hospital; University Health Network; SickKids Foundation","funders":"","keywords":"Cytopenia; Medicine; Internal medicine; Myelodysplastic syndromes; International Prognostic Scoring System; Oncology; Bone marrow failure; Bone marrow; Stem cell; Haematopoiesis; Biology","score_opus":0.005455734290218736,"score_gpt":0.228996443804602,"score_spread":0.22354070951438326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983038788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99789196,0.00013369611,0.000001914035,0.00023924708,0.000054162847,0.0014367679,0.000077381446,0.000037574962,0.0001272778],"genre_scores_gemma":[0.99909616,0.0000057584452,0.0004197432,0.000032210362,0.00001587217,0.000043896816,0.00010175513,0.000042638658,0.00024197645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983158,0.00006929336,0.00027526473,0.0003831731,0.0006128785,0.00034359566],"domain_scores_gemma":[0.99896026,0.000079841004,0.0000723852,0.0003504174,0.000119291115,0.00041783828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001636927,0.00019273347,0.00045641785,0.0003245968,0.000022913784,0.000013672187,0.000098223114,0.00009164958,0.00013154105],"category_scores_gemma":[0.00013654405,0.00014382393,0.000031045704,0.00046357905,0.00008673728,0.00011949369,0.00014710751,0.00030040357,0.000024085744],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015446827,0.0007289388,0.9953571,0.0007329465,0.00011108221,0.00031258908,0.00014128097,0.0000029722726,0.00071833655,0.0000047429867,0.00008289894,0.000262454],"study_design_scores_gemma":[0.011722118,0.0025226504,0.98415494,0.0009514598,0.00011314219,0.000049028127,0.000063940926,0.000021856067,0.00014819713,0.0000031231934,0.00009752184,0.00015201622],"about_ca_topic_score_codex":0.0000133638805,"about_ca_topic_score_gemma":0.000012977895,"teacher_disagreement_score":0.011202129,"about_ca_system_score_codex":0.00006197461,"about_ca_system_score_gemma":0.00029802442,"threshold_uncertainty_score":0.58649695},"labels":[],"label_agreement":null},{"id":"W2983059016","doi":"10.1182/blood-2019-129078","title":"Allogeneic Stem Cell Transplantation Has Limited Benefit in Older Patients with Mixed Phenotype Acute Leukemia","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Transplantation; Hematopoietic stem cell transplantation; Oncology; Cohort; Log-rank test; Chemotherapy; Chemotherapy regimen; Survival analysis","score_opus":0.010819720058870193,"score_gpt":0.2221658558371315,"score_spread":0.2113461357782613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983059016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966803,0.000106411106,0.00003083279,0.00012888468,0.00006803647,0.0011835987,0.000042256295,0.000061113446,0.0016985751],"genre_scores_gemma":[0.99687034,0.000077952995,0.00065462926,0.00021019022,0.00004157278,0.00004105842,0.0004260233,0.00006141533,0.0016168036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99828464,0.000045668912,0.0002804079,0.00042735177,0.0005119853,0.00044995663],"domain_scores_gemma":[0.9991316,0.00006799827,0.00007911971,0.0004107419,0.00015501924,0.00015550623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012059543,0.0002234011,0.00035650903,0.00023895557,0.00004361473,0.000028209455,0.00016167297,0.00017523531,0.00013454267],"category_scores_gemma":[0.0000037027687,0.00017794485,0.000056569752,0.00043131967,0.000042845695,0.00012184914,0.00002954433,0.00035171252,0.0002889256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019634427,0.0011738538,0.961191,0.0004443072,0.0003182614,0.00027961246,0.0013720937,0.00011509024,0.02991793,0.000027858738,0.00022952331,0.0029670205],"study_design_scores_gemma":[0.03065006,0.00093993056,0.9240776,0.00018676919,0.00044223876,0.000024765348,0.00008702243,0.0001613863,0.042947467,0.0000063695948,0.00021627956,0.00026016383],"about_ca_topic_score_codex":0.000111767964,"about_ca_topic_score_gemma":0.000098681914,"teacher_disagreement_score":0.03711346,"about_ca_system_score_codex":0.0002777686,"about_ca_system_score_gemma":0.0004092768,"threshold_uncertainty_score":0.72563803},"labels":[],"label_agreement":null},{"id":"W2983081583","doi":"10.1182/blood-2019-126661","title":"Low-Dose Tamoxifen (LDTam) As a Breast Cancer (BC) Risk-Reduction Strategy in Lymphoma Survivors Exposed to Chest Radiation Therapy (RT) during Adolescence/Young Adulthood - a Randomized, Placebo-Controlled Double Blinded Phase IIb Trial","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Tamoxifen; Breast cancer; Cumulative incidence; Internal medicine; Population; Oncology; Randomized controlled trial; Placebo; Clinical endpoint; Cancer; Pathology; Cohort","score_opus":0.0150369800890378,"score_gpt":0.28945518817576565,"score_spread":0.27441820808672784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983081583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986465,0.00054191257,0.000011928413,0.00021296731,0.0011074615,0.011262952,0.00006955464,0.000124723,0.00020350977],"genre_scores_gemma":[0.99508816,0.0015250461,0.000018125414,0.000058385736,0.0012521626,0.0015475348,0.000051822404,0.00008244745,0.00037630566],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99656546,0.0003550416,0.0010281857,0.0007906879,0.00061765715,0.000642939],"domain_scores_gemma":[0.99826425,0.000116915515,0.0005693364,0.0005155751,0.00017370468,0.00036024433],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00095452677,0.00050501275,0.0016424216,0.0004937318,0.0001314521,0.000120564524,0.00018065426,0.000286327,0.00043219325],"category_scores_gemma":[0.00010282239,0.00041674817,0.0004741585,0.00063596386,0.00006211589,0.000319109,0.000029090903,0.00034297653,0.00006108391],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9479441,0.00382282,0.010435613,0.000091666516,0.00049746974,0.000029753071,0.0027907828,0.0002765869,0.021803163,0.0000066998487,0.000014175898,0.012287153],"study_design_scores_gemma":[0.93568444,0.0010340194,0.030992653,0.00033038273,0.00043941374,0.000073993855,0.00074186176,0.00043228435,0.029809607,0.00001068219,0.000013210376,0.00043747708],"about_ca_topic_score_codex":0.020124065,"about_ca_topic_score_gemma":0.0020971086,"teacher_disagreement_score":0.02055704,"about_ca_system_score_codex":0.00041363863,"about_ca_system_score_gemma":0.00083763996,"threshold_uncertainty_score":0.99982846},"labels":[],"label_agreement":null},{"id":"W2983086552","doi":"10.1182/blood-2019-121109","title":"Understanding Erythropoiesis Using Quantitative Proteomics and Single Cell Mass Cytometry","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Biology; Haematopoiesis; Erythropoiesis; Progenitor cell; Cell biology; GATA1; Reprogramming; Stem cell; Ectopic expression; Transcription factor; Cellular differentiation; Cell; Genetics; Gene","score_opus":0.10321875848748188,"score_gpt":0.2855098117254163,"score_spread":0.1822910532379344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983086552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9778352,0.000212415,0.016428044,0.000092318354,0.00020318439,0.00033125776,0.000005368875,0.000046316276,0.004845896],"genre_scores_gemma":[0.9713495,0.000043339576,0.027884169,0.00020511093,0.000066209235,0.0000025550041,0.0000071343843,0.000022521497,0.0004194785],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99930847,0.000036678906,0.00013902776,0.00022954888,0.00010633583,0.00017996338],"domain_scores_gemma":[0.9995811,0.00008144113,0.00007321632,0.00015048118,0.000039435672,0.00007431435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008475712,0.00011344197,0.00024101062,0.00013613675,0.00006952846,0.000015549516,0.000025776208,0.00009970187,0.00014528749],"category_scores_gemma":[0.00003499928,0.00010237092,0.00004672938,0.00019757228,0.00007655237,0.00006748052,0.000026308144,0.00013332292,0.000055026918],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012675714,0.00021068257,0.024329439,0.00018469071,0.000053002637,0.000015566007,0.0002341375,0.0000070248143,0.97433364,0.00046028526,0.000036570564,0.000008199642],"study_design_scores_gemma":[0.0259997,0.008650023,0.016733343,0.0006956595,0.0012755176,0.00064345036,0.02063193,0.004866449,0.9147487,0.0036242579,0.0009449819,0.0011859817],"about_ca_topic_score_codex":0.000008983767,"about_ca_topic_score_gemma":0.0000012811867,"teacher_disagreement_score":0.059584938,"about_ca_system_score_codex":0.000068861096,"about_ca_system_score_gemma":0.00004625875,"threshold_uncertainty_score":0.4174565},"labels":[],"label_agreement":null},{"id":"W2983137419","doi":"10.1182/blood-2019-129825","title":"Interim Analysis of a Prospective Multicentre Study Using Next Generation Sequencing for Kinase Domain Mutational Analysis in CML Patients on First or Subsequent TKI Therapy","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Ponatinib; Prospective cohort study; Internal medicine; Interim analysis; Oncology; Dasatinib; Clinical trial; Myeloid leukemia; Imatinib","score_opus":0.06965957962405488,"score_gpt":0.3214276455862354,"score_spread":0.2517680659621805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983137419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99695116,0.000046161447,0.00013527951,0.00001266571,0.000046408673,0.002710697,0.000064489206,0.000013931838,0.000019194651],"genre_scores_gemma":[0.99742615,0.000006948744,0.001850404,0.000034537556,0.000039414983,0.00013709557,0.00046033945,0.000021484055,0.000023636445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833083,0.00008371801,0.0005014693,0.00047406377,0.00039355172,0.00021639082],"domain_scores_gemma":[0.9989424,0.00016503422,0.00026260843,0.00033872834,0.00022958781,0.00006164564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018991414,0.00020670748,0.000641896,0.00084618997,0.000060001228,0.000020546484,0.00006949938,0.000064585576,0.00017227794],"category_scores_gemma":[0.00010139819,0.0001614352,0.00026397165,0.0015771898,0.000019558744,0.00010262028,0.00002063904,0.000083204555,0.0000030669871],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011955448,0.0054976717,0.9567241,0.00003279506,0.009815436,0.000036017733,0.008754991,0.011651945,0.006009212,0.000008903994,7.167813e-7,0.00027265458],"study_design_scores_gemma":[0.03678799,0.002026015,0.8364057,0.00008609551,0.0097668385,0.0000014818629,0.0029445922,0.10245362,0.009318038,0.000007285552,0.0000018443328,0.00020052219],"about_ca_topic_score_codex":0.0011825033,"about_ca_topic_score_gemma":0.006011472,"teacher_disagreement_score":0.120318435,"about_ca_system_score_codex":0.0017701105,"about_ca_system_score_gemma":0.00022839064,"threshold_uncertainty_score":0.6583136},"labels":[],"label_agreement":null},{"id":"W2983139950","doi":"10.1182/blood-2019-123817","title":"Sporadic Late Onset Nemaline Myopathy with a Monoclonal Gammopathy: Comparative Effectiveness of Immuno- and Chemotherapy","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Biochemical and Molecular Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Regional Health Centre; Western University","funders":"","keywords":"Nemaline myopathy; Medicine; Monoclonal gammopathy of undetermined significance; Internal medicine; Plasmapheresis; Chemotherapy; Rituximab; Autologous stem-cell transplantation; Gammopathy; Gastroenterology; Oncology; Monoclonal; Myopathy; Lymphoma; Immunology; Monoclonal antibody; Antibody","score_opus":0.006077282773513147,"score_gpt":0.24388820265306915,"score_spread":0.237810919879556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983139950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99782085,0.0013467451,0.00009784847,0.00002785928,0.000012401295,0.00033348048,0.00002422817,0.000005798196,0.00033075895],"genre_scores_gemma":[0.99917156,0.000118836026,0.00036425272,0.00005751268,0.00002159744,0.000018127916,0.000109257286,0.000016658078,0.00012222877],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991882,0.000086294305,0.00011746946,0.0002975329,0.00013030066,0.00018021384],"domain_scores_gemma":[0.9995303,0.000020696587,0.000055356893,0.00024457334,0.00008209768,0.00006696712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018440752,0.00014046024,0.0002338742,0.00002859589,0.000022078264,0.000010066581,0.00011520639,0.00009495099,0.000013032174],"category_scores_gemma":[0.000008133341,0.000109348824,0.000050348168,0.00008471852,0.00013609254,0.000002636437,0.000068814,0.00009381387,0.0000047932717],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011122631,0.00026297188,0.052180815,0.00010060137,0.0001454127,0.000006339339,0.000037170455,0.0000044841418,0.9459682,0.00002360149,0.0000107911765,0.00014735053],"study_design_scores_gemma":[0.003443359,0.0011166162,0.060391508,0.000060234615,0.000024293218,0.000038357724,0.000025144558,0.00001926881,0.93430895,0.000036628517,0.00038557808,0.00015004868],"about_ca_topic_score_codex":0.000022591003,"about_ca_topic_score_gemma":0.0000019127224,"teacher_disagreement_score":0.011659237,"about_ca_system_score_codex":0.0000031313652,"about_ca_system_score_gemma":0.000060698065,"threshold_uncertainty_score":0.4459116},"labels":[],"label_agreement":null},{"id":"W2983167487","doi":"10.1182/blood-2019-128830","title":"A Reproducible and Simple Method to Generate Red Blood Cells from Human Pluripotent Stem Cells","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Stemcell Technologies","funders":"","keywords":"Induced pluripotent stem cell; Haematopoiesis; Stem cell; Cell biology; Biology; Embryonic stem cell; Progenitor cell; Matrigel; Cell culture; Cellular differentiation; Embryoid body; Immunology; Genetics","score_opus":0.023627567857687094,"score_gpt":0.26976597792729784,"score_spread":0.24613841006961074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983167487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99681515,0.00030950696,0.00018817857,0.00037392345,0.00036012742,0.0006502402,0.000038460585,0.000101293655,0.0011631312],"genre_scores_gemma":[0.95065427,0.00008818165,0.027988281,0.0032485356,0.0009832307,0.00004560726,0.00008703673,0.00007557817,0.01682926],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99818546,0.00014499438,0.00032489476,0.00087226264,0.00017083774,0.00030155721],"domain_scores_gemma":[0.99864393,0.00006429724,0.00009736083,0.0008638568,0.0000844482,0.00024607658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031255867,0.0002080464,0.00048189473,0.00010152148,0.0000818058,0.00002227148,0.0000833237,0.00013762442,0.0005985028],"category_scores_gemma":[0.00001083163,0.00018179452,0.000089302426,0.00016720765,0.000020242502,0.000037432965,0.000105093386,0.00018911094,0.00037916095],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011035856,0.0004020139,0.0015296553,0.000060482824,0.00016533866,0.00004856429,0.00033242782,0.00003464571,0.99408185,0.000022965865,0.0025666982,0.000645016],"study_design_scores_gemma":[0.00461608,0.0011184986,0.0039534895,0.000041325056,0.00042113612,0.000036436668,0.00011976994,0.000046365054,0.9652323,0.00010936936,0.024087762,0.00021745049],"about_ca_topic_score_codex":0.00019455008,"about_ca_topic_score_gemma":0.000013959747,"teacher_disagreement_score":0.04616085,"about_ca_system_score_codex":0.000012320237,"about_ca_system_score_gemma":0.000043410346,"threshold_uncertainty_score":0.7413365},"labels":[],"label_agreement":null},{"id":"W2983205654","doi":"10.1182/blood-2019-123684","title":"Persistent Red Blood Cell (RBC) Transfusion Is Associated with Increased Mortality Risk in Transfusion-Dependent (TD) Patients with Myelodysplastic Syndromes (MDS) with Ring Sideroblasts (RS+)","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Alberta Hospital Edmonton; University of British Columbia; University of Ottawa; Dr. Georges-L.-Dumont University Hospital Centre; St. Paul's Hospital; McMaster University; Queen Elizabeth II Health Sciences Centre; CancerCare Manitoba; University of Alberta Hospital; Health Sciences Centre; University of Toronto; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; International Prognostic Scoring System; Internal medicine; Myelodysplastic syndromes; Comorbidity; Blood transfusion; Anemia; Population; Bone marrow","score_opus":0.008899973437385215,"score_gpt":0.21488875231073912,"score_spread":0.2059887788733539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983205654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947477,0.00009329297,0.000040306753,0.00008910748,0.00003871749,0.003005589,0.00015869015,0.00015936547,0.0016672526],"genre_scores_gemma":[0.9985328,0.00017735631,0.00037133167,0.000093958355,0.000028775201,0.00011827379,0.00018099157,0.00016048804,0.00033602607],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99468416,0.0003364703,0.000650966,0.0011926345,0.002096841,0.0010389559],"domain_scores_gemma":[0.9975722,0.0003281392,0.00029513685,0.00088650436,0.00039815536,0.00051988155],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005943209,0.0006626856,0.0010788313,0.00044962962,0.00020007348,0.00006115783,0.00030743654,0.00032539616,0.00042451522],"category_scores_gemma":[0.00011014723,0.00046299776,0.00018589696,0.000936733,0.00015647401,0.00025118803,0.00006791623,0.0011795092,0.000046445686],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028621554,0.005598604,0.97970444,0.00040463987,0.0016033648,0.000880375,0.0016016617,0.0002632316,0.0069851675,0.0000012472773,0.000012820369,0.00008228683],"study_design_scores_gemma":[0.07659882,0.0071628685,0.8949916,0.0018793743,0.0031753532,0.0001836661,0.0006908596,0.00063688715,0.013977472,0.0000034460124,0.000006444454,0.00069320033],"about_ca_topic_score_codex":0.003100356,"about_ca_topic_score_gemma":0.002801526,"teacher_disagreement_score":0.08471284,"about_ca_system_score_codex":0.0004073331,"about_ca_system_score_gemma":0.000668664,"threshold_uncertainty_score":0.99978215},"labels":[],"label_agreement":null},{"id":"W2983208837","doi":"10.1182/blood-2019-122715","title":"A Case Report of the Benefit of Cannabidiol (Cannabidiol (CBD)-Predominant Medical Cannabis Preparation) in the Management of Refractory Skin Graft Vs Host Disease (GVHD)","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cannabidiol; Graft-versus-host disease; Rash; Surgery; Gastroenterology; Internal medicine; Transplantation; Cannabis","score_opus":0.009324763840441444,"score_gpt":0.28224181232898765,"score_spread":0.2729170484885462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983208837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864578,0.00073464174,0.0000034138218,0.0071252747,0.0001732611,0.0023958317,0.000100407975,0.000011397621,0.002997935],"genre_scores_gemma":[0.9898356,0.00011328381,0.000033462733,0.00015470193,0.00007876842,0.00030033267,0.000024895808,0.000034041215,0.009424873],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99581075,0.0001980707,0.0011624687,0.00050100137,0.0018771334,0.00045055157],"domain_scores_gemma":[0.99693173,0.000028419425,0.00051377184,0.0018186424,0.00042725317,0.000280188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016172982,0.00026474733,0.0006705722,0.00020431151,0.00006530753,0.000012037639,0.00057239557,0.0001602501,0.00061925314],"category_scores_gemma":[0.00034165673,0.00015937736,0.00039377817,0.0007514954,0.00037467878,0.000077035074,0.00029498988,0.0004139012,0.0000054078437],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010547616,0.029520689,0.5601783,0.023952736,0.0041233725,0.19394179,0.01631092,0.00031356196,0.008558699,0.008686758,0.12801154,0.015854029],"study_design_scores_gemma":[0.010005117,0.0015507358,0.9295601,0.0013007537,0.0012003126,0.01231554,0.0028370467,0.00020689903,0.013514311,0.0001408695,0.026913218,0.0004550869],"about_ca_topic_score_codex":0.0029924891,"about_ca_topic_score_gemma":0.00096435077,"teacher_disagreement_score":0.36938182,"about_ca_system_score_codex":0.00009218611,"about_ca_system_score_gemma":0.0010489076,"threshold_uncertainty_score":0.6780388},"labels":[],"label_agreement":null},{"id":"W2983220476","doi":"10.1182/blood-2019-122637","title":"Overall and Progression Free Survival from the Mcrn-003/Myx.1 Trial: A Single Arm Phase II Study of High-Dose Weekly Carfilzomib Plus Cyclophosphamide and Dexamethasone in the Treatment of Relapsed Multiple Myeloma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; Ottawa Hospital; University of Ottawa; London Health Sciences Centre; Hôtel-Dieu de Québec; Saint John Regional Hospital; Princess Margaret Cancer Centre; University of New Brunswick; Université de Montréal; University of Alberta; Queen Elizabeth II Health Sciences Centre; Dalhousie University; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Carfilzomib; Medicine; Clinical endpoint; Lenalidomide; Internal medicine; Dexamethasone; Oncology; Multiple myeloma; Cyclophosphamide; Progression-free survival; Phases of clinical research; Clinical trial; Chemotherapy","score_opus":0.036434562548736296,"score_gpt":0.31399656386001135,"score_spread":0.27756200131127506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983220476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99112827,0.0025662747,7.903034e-7,0.00030100704,0.000102417165,0.00563998,0.00016647067,0.000019484289,0.000075291864],"genre_scores_gemma":[0.9987155,0.0003279754,0.00043771838,0.000018104034,0.00007499452,0.00022258269,0.00007105668,0.000029309389,0.000102717735],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9976338,0.0004241044,0.00049257075,0.00045947498,0.00066101935,0.00032902003],"domain_scores_gemma":[0.99733365,0.0013671599,0.00022546422,0.00087138545,0.00006815195,0.00013417548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041648067,0.0002841321,0.0007772544,0.000089422356,0.00011031579,0.00002326896,0.00019152368,0.0001013294,0.000026805908],"category_scores_gemma":[0.00037738058,0.00014674001,0.00008770579,0.00021535809,0.00013857326,0.00006903696,0.0001304157,0.00016258997,0.0000015520709],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10940019,0.13794374,0.6681316,0.000100490666,0.0017122655,0.00044653853,0.020320477,0.0000041214803,0.02200944,0.000021385711,0.000045690656,0.039864086],"study_design_scores_gemma":[0.5106487,0.059525244,0.41558483,0.00014777418,0.0005056321,0.00001068471,0.0023866626,0.00011479312,0.01079857,0.00007400326,0.00007620633,0.00012689554],"about_ca_topic_score_codex":0.00759399,"about_ca_topic_score_gemma":0.0015998834,"teacher_disagreement_score":0.4012485,"about_ca_system_score_codex":0.0000662082,"about_ca_system_score_gemma":0.00010059324,"threshold_uncertainty_score":0.99901456},"labels":[],"label_agreement":null},{"id":"W2983230949","doi":"10.1182/blood-2019-124552","title":"Efficacy and Safety of CPX-351 Versus 7+3 in a Phase 3 Exploratory Analysis in Patients with High-Risk/Secondary Acute Myeloid Leukemia (AML) with Prior Hypomethylating Agent Exposure Who Achieved Remission","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada","funders":"","keywords":"Hypomethylating agent; Medicine; Azacitidine; Myeloid leukemia; Oncology; Internal medicine; Decitabine; Leukemia; Phases of clinical research; Clinical trial; Biology; DNA methylation","score_opus":0.010027837225480169,"score_gpt":0.2565633593527956,"score_spread":0.24653552212731544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983230949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977569,0.00027344178,0.00003141946,0.000050495255,0.0000294083,0.0015075376,0.00007140545,0.000031715816,0.000247677],"genre_scores_gemma":[0.99686694,0.0001817364,0.0024835295,0.00003053103,0.00003147355,0.000038510316,0.00018289911,0.00006248933,0.00012191065],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968978,0.00027780185,0.00072358525,0.00074184,0.00081657525,0.00054240786],"domain_scores_gemma":[0.9979741,0.000360142,0.00039866124,0.0007724757,0.00019613841,0.00029849837],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007153431,0.000370792,0.0011111007,0.00091240526,0.000074518925,0.000021990261,0.0002032342,0.00021337967,0.00010546764],"category_scores_gemma":[0.00023226131,0.0002738438,0.00008617518,0.0020224575,0.00012855098,0.00026835673,0.00017118306,0.0009480981,0.000008149395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04735283,0.0017141716,0.9154251,0.00023481839,0.0023976346,0.00019581706,0.0025040149,0.00021361907,0.01205884,0.0000032922774,0.000015419673,0.017884417],"study_design_scores_gemma":[0.16810776,0.006145192,0.8133118,0.0005015171,0.0015982729,0.0000040398345,0.0005259482,0.00021871655,0.009227045,0.0000014786986,0.000046375168,0.00031184763],"about_ca_topic_score_codex":0.00022803417,"about_ca_topic_score_gemma":0.00014614286,"teacher_disagreement_score":0.120754935,"about_ca_system_score_codex":0.0005293776,"about_ca_system_score_gemma":0.0008234854,"threshold_uncertainty_score":0.9999714},"labels":[],"label_agreement":null},{"id":"W2983234492","doi":"10.1182/blood-2019-130978","title":"Area-Based Socioeconomic Disparities in Survival of Children with Newly Diagnosed Acute Myeloid Leukemia: A Report from the Children's Oncology Group","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Socioeconomic status; Medicaid; Poverty; Internal medicine; Demography; Pediatrics; Oncology; Health care; Population; Environmental health","score_opus":0.008565296256992105,"score_gpt":0.24560835266165265,"score_spread":0.23704305640466056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983234492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960202,0.00018194933,0.00009838687,0.0012484703,0.000103640465,0.0013335991,0.00016880424,0.00005342585,0.00079154136],"genre_scores_gemma":[0.99736696,0.00008326736,0.000774926,0.0005375072,0.00022997659,0.00010220606,0.0006790361,0.000061652296,0.0001644934],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99763364,0.00016177974,0.0005955279,0.000592959,0.00047397468,0.00054213614],"domain_scores_gemma":[0.99737394,0.001159575,0.00031393307,0.0009176206,0.00008235235,0.00015260928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049304264,0.0002996705,0.00086467905,0.00012844316,0.00005791271,0.000024472598,0.00040446964,0.0002846511,0.00022279714],"category_scores_gemma":[0.00015385737,0.00020036333,0.00015350289,0.00018845237,0.0003872014,0.00009750488,0.00014806124,0.00061535876,0.00006328862],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007236827,0.00062159146,0.99468225,0.000018494307,0.0010408044,0.0005236468,0.00018461725,0.000067865934,0.0009823836,0.000051569416,0.00070682814,0.00039629126],"study_design_scores_gemma":[0.03004011,0.00096509786,0.9654013,0.0001117357,0.0005467073,0.00048134616,0.00012744963,0.00021337226,0.0017768907,0.000052398118,0.00006173115,0.00022189057],"about_ca_topic_score_codex":0.010081849,"about_ca_topic_score_gemma":0.0015949148,"teacher_disagreement_score":0.029316425,"about_ca_system_score_codex":0.0008260009,"about_ca_system_score_gemma":0.0026581914,"threshold_uncertainty_score":0.9965101},"labels":[],"label_agreement":null},{"id":"W2983237355","doi":"10.1182/blood-2019-121765","title":"Efficacy and Safety of Direct Oral Anticoagulants in Obese Patients with Venous Thromboembolism","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Medicine; Apixaban; Edoxaban; Rivaroxaban; Dabigatran; Internal medicine; Warfarin; Population; Direct thrombin inhibitor; Retrospective cohort study; Atrial fibrillation","score_opus":0.006799627731254897,"score_gpt":0.2282180836084004,"score_spread":0.2214184558771455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983237355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932352,0.0002822836,7.824004e-7,0.000048381702,0.00006668107,0.0009859642,0.000010781495,0.000024205037,0.0053457576],"genre_scores_gemma":[0.9993237,0.00025046506,0.00019943329,0.00010986265,0.00001986632,0.0000086714135,0.00002261819,0.000023501761,0.000041850813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989634,0.000030435669,0.00024028892,0.0002657885,0.00025293778,0.0002471044],"domain_scores_gemma":[0.9994493,0.000044535504,0.00008265815,0.00029556887,0.000050064285,0.00007783564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012674242,0.00014740533,0.0008219105,0.00011668782,0.00002218022,0.000008448434,0.0000666775,0.00005550107,0.00006223284],"category_scores_gemma":[0.000026794974,0.00011119405,0.000031823663,0.00016963515,0.000049754206,0.000058279948,0.00006700407,0.00009106182,0.000019863224],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002939317,0.010266649,0.98396033,0.0003339821,0.00033533337,0.000028337088,0.0006291111,0.000010159889,0.00042352255,0.00017644162,0.000059942176,0.0034822775],"study_design_scores_gemma":[0.013756501,0.0014457412,0.98273474,0.0004908518,0.0003437431,0.0000034745603,0.00004484295,0.000006735688,0.000796817,0.00001904111,0.00022962301,0.00012791707],"about_ca_topic_score_codex":0.00017036746,"about_ca_topic_score_gemma":0.000042706364,"teacher_disagreement_score":0.013462569,"about_ca_system_score_codex":0.000014682462,"about_ca_system_score_gemma":0.000031737363,"threshold_uncertainty_score":0.4534362},"labels":[],"label_agreement":null},{"id":"W2983257358","doi":"10.1182/blood-2019-123191","title":"Epigenomic Determinants of Transcriptional Activity in ASXL1-Mutant Chronic Myelomonocytic Leukemia","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"","keywords":"Epigenomics; Biology; H3K4me3; DNA methylation; Chromatin immunoprecipitation; Histone; Epigenetics; Wild type; Mutant; Enhancer; Genetics; Transcriptome; Cancer research; Molecular biology; Promoter; Transcription factor; Gene; Gene expression","score_opus":0.018691820575642004,"score_gpt":0.28477313549072136,"score_spread":0.26608131491507936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983257358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99691087,0.0004265626,0.000016127971,0.00007792701,0.00008236687,0.00071501103,0.000021715716,0.000025258672,0.0017241611],"genre_scores_gemma":[0.998772,0.00014773112,0.00017912175,0.000032739154,0.0000998095,0.000027603213,0.000008055239,0.000034831446,0.0006980723],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983889,0.00006989254,0.00034655377,0.00036064646,0.00037029697,0.00046374172],"domain_scores_gemma":[0.9991797,0.00009558643,0.000090658374,0.00044918514,0.000056990135,0.00012786935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035059344,0.00017657642,0.00053293025,0.00025235614,0.000023228959,0.000007529095,0.00019432203,0.00016110664,0.00037850678],"category_scores_gemma":[0.000048432907,0.00016297986,0.00013102911,0.0002781758,0.00009201754,0.00011485606,0.000055412147,0.00043378657,0.00026362058],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034691198,0.0003443302,0.13242428,0.0003908294,0.00006688529,0.00015179804,0.0001766142,0.000024255965,0.85984826,0.000053529562,0.000009664543,0.0061626574],"study_design_scores_gemma":[0.011209448,0.00071344397,0.5443532,0.0002438968,0.00009267853,0.00017955729,0.000042041076,0.0028209505,0.43979177,0.00005558945,0.00031507105,0.0001823806],"about_ca_topic_score_codex":0.0003029922,"about_ca_topic_score_gemma":0.0001581684,"teacher_disagreement_score":0.42005646,"about_ca_system_score_codex":0.001462854,"about_ca_system_score_gemma":0.0023183967,"threshold_uncertainty_score":0.6646126},"labels":[],"label_agreement":null},{"id":"W2983300368","doi":"10.1182/blood-2019-129136","title":"Mutations Affecting RNA Binding Proteins Are a Novel Feature of Mantle Cell Lymphoma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; McGill University; Spinal Cord Injury BC; Simon Fraser University","funders":"","keywords":"Biology; Exome; Mantle cell lymphoma; Exome sequencing; Genetics; Intron; Exon; Gene; RNA splicing; Lymphoma; Mutation; Cancer research; RNA; Immunology","score_opus":0.0077727324910689035,"score_gpt":0.2369462443048231,"score_spread":0.2291735118137542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983300368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99733305,0.00020535922,0.0001832976,0.00003788825,0.000030908614,0.00027103216,0.00002476846,0.0000071453874,0.0019065628],"genre_scores_gemma":[0.9946927,0.000010628588,0.0013694132,0.000015107857,0.00006284026,0.000011839908,0.00003547581,0.000015242229,0.003786766],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994169,0.000017175544,0.00008110681,0.00018290128,0.000110619636,0.00019132698],"domain_scores_gemma":[0.999613,0.0000113996975,0.00007673675,0.00019939069,0.000050518094,0.00004894004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009429382,0.00007781254,0.00009486896,0.000043161217,0.000050972165,0.000015008832,0.000111465364,0.0000865768,0.000009092646],"category_scores_gemma":[0.000052540174,0.00007147702,0.000062107596,0.000091992,0.000017393213,0.0000030145243,0.00006620902,0.000054479122,0.000016625963],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013045173,0.00022359037,0.0081834765,0.00008670526,0.000028890818,0.0000028396223,0.000029467055,0.00001459571,0.9911289,0.000007102927,0.00005795684,0.00022343753],"study_design_scores_gemma":[0.0017350807,0.00017589478,0.004495668,0.000048281767,0.000011741411,0.000012507203,0.0002480354,0.00005623233,0.99285746,0.0000024251508,0.00026885027,0.00008780612],"about_ca_topic_score_codex":0.000022303659,"about_ca_topic_score_gemma":0.000013733995,"teacher_disagreement_score":0.0036878088,"about_ca_system_score_codex":0.000005409138,"about_ca_system_score_gemma":0.000050669645,"threshold_uncertainty_score":0.29147485},"labels":[],"label_agreement":null},{"id":"W2983303687","doi":"10.1182/blood-2019-125792","title":"A Comparison of Two-Year Outcomes in ZUMA-1 (Axicabtagene Ciloleucel) and SCHOLAR-1 in Patients with Refractory Large B Cell Lymphoma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Refractory (planetary science); Salvage therapy; Internal medicine; Fludarabine; Oncology; Surgery; Chemotherapy; Cyclophosphamide","score_opus":0.015596657079155847,"score_gpt":0.3028233139120027,"score_spread":0.2872266568328468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983303687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99463326,0.0002888354,4.4721386e-7,0.000027697903,0.000029099852,0.00063933193,0.000014360312,0.000013433419,0.00435353],"genre_scores_gemma":[0.9985986,0.000023017992,0.00020012762,0.00005454064,0.000012744956,0.000010946234,0.000019801895,0.000030548086,0.0010496911],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985234,0.000090338166,0.00031544376,0.00028409087,0.0004671075,0.00031960412],"domain_scores_gemma":[0.9992637,0.000076751305,0.00008777808,0.00039495574,0.000074777694,0.00010204917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035471044,0.00014695579,0.0005402068,0.00026318053,0.000017576845,0.000012452009,0.00010213512,0.000089118876,0.00040850477],"category_scores_gemma":[0.000040347426,0.00011825794,0.000040788847,0.00025163143,0.000039724615,0.00009100468,0.00007769277,0.0002921558,0.00003476863],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006484646,0.0070647174,0.9726284,0.000121966346,0.00004436377,0.000013807273,0.0005288811,7.2177625e-7,0.018070253,0.000011911395,0.000011375653,0.0008551395],"study_design_scores_gemma":[0.055761706,0.001236609,0.9247727,0.00010632785,0.00002823065,9.3625084e-7,0.0002635194,0.000015669608,0.017268114,0.0000054398197,0.00042290674,0.000117831456],"about_ca_topic_score_codex":0.0001129231,"about_ca_topic_score_gemma":0.0001003641,"teacher_disagreement_score":0.05511324,"about_ca_system_score_codex":0.00006587822,"about_ca_system_score_gemma":0.000093094124,"threshold_uncertainty_score":0.4822419},"labels":[],"label_agreement":null},{"id":"W2983305723","doi":"10.1182/blood-2019-125810","title":"Treatment of Myeloma Patients Progressing on Lenalidomide-Based Maintenance after ASCT Performed As Part of 1st, 2nd or 3rd Line Therapy: Real-World Results from the National Myeloma Canada Research Network (MCRN) Database","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Saint John Regional Hospital; University of Alberta; Queen Elizabeth II Health Sciences Centre; Dalhousie University; University of Ottawa; McGill University Health Centre; Hôpital Maisonneuve-Rosemont; University of New Brunswick; Leukemia & Lymphoma Society of Canada; University of British Columbia; University of Calgary; Princess Margaret Cancer Centre; CancerCare Manitoba; Ottawa Hospital","funders":"","keywords":"Lenalidomide; Multiple myeloma; Medicine; Maintenance therapy; Oncology; Thalidomide; Pomalidomide; Internal medicine; Chemotherapy","score_opus":0.07187631093639534,"score_gpt":0.34969379855697524,"score_spread":0.2778174876205799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983305723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915573,0.00033460004,4.808702e-7,0.001142332,0.00011990521,0.0023367326,0.0020033482,0.000017802822,0.0024874883],"genre_scores_gemma":[0.99449605,0.00029828242,0.00054334715,0.000208172,0.00040924505,0.00030570253,0.0016219118,0.000048482765,0.0020688009],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951453,0.00042510938,0.0007310009,0.00062559184,0.0022448958,0.0008280897],"domain_scores_gemma":[0.9957061,0.0019577446,0.0003078641,0.00084990205,0.0008996773,0.0002787221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007390641,0.0003309831,0.00058725185,0.00016127634,0.00018852728,0.000031074847,0.00025565646,0.00008207851,0.000425659],"category_scores_gemma":[0.0006652897,0.00017827172,0.00014119408,0.0006099942,0.00021815076,0.00008674814,0.000077332166,0.00027635708,0.000026913707],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10570049,0.00810488,0.8407078,0.00014778262,0.0017054586,0.00051855505,0.00032825285,0.000078356774,0.00069253496,0.000050316085,0.006046921,0.035918698],"study_design_scores_gemma":[0.062747024,0.007829287,0.87305325,0.0018203439,0.0001452017,0.000006949915,0.000083777486,0.00075288804,0.036296148,0.000030400337,0.01696814,0.0002666078],"about_ca_topic_score_codex":0.108745374,"about_ca_topic_score_gemma":0.116323695,"teacher_disagreement_score":0.04295347,"about_ca_system_score_codex":0.00048997515,"about_ca_system_score_gemma":0.0028438026,"threshold_uncertainty_score":0.8998011},"labels":[],"label_agreement":null},{"id":"W2983319734","doi":"10.1182/blood.v110.11.946.946","title":"Second Autologous Stem Cell Transplant (ASCT) as Salvage Therapy in Patients with Relapsed Multiple Myeloma: Improved Outcomes in Patients with Longer Disease Free Interval after First ASCT.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Melphalan; Salvage therapy; Surgery; Multiple myeloma; Internal medicine; Busulfan; Regimen; Transplantation; Median follow-up; Autologous stem-cell transplantation; Etoposide; Hematopoietic stem cell transplantation; Chemotherapy","score_opus":0.005948708127525622,"score_gpt":0.21454852766541835,"score_spread":0.20859981953789272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983319734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963339,0.0001588276,0.000011032346,0.000062347186,0.00006519946,0.0027760991,0.00036115735,0.000067302644,0.00016411775],"genre_scores_gemma":[0.9985308,0.000010662397,0.00030455814,0.0001728108,0.000020837926,0.00022182908,0.00030297844,0.00008786343,0.0003476526],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970636,0.00009044909,0.00054657116,0.00068595994,0.0007122016,0.0009012576],"domain_scores_gemma":[0.9982294,0.00019382965,0.00013475122,0.0007578438,0.00012828482,0.00055591855],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018658473,0.0004934066,0.0006658775,0.00036690125,0.00006742552,0.0000334502,0.0002381631,0.00015973215,0.0001824141],"category_scores_gemma":[0.00003823034,0.0003178147,0.00012777271,0.00028152988,0.00010987219,0.00020426775,0.000059993334,0.000437255,0.000034298406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032997664,0.012044924,0.94946223,0.00016457756,0.00030157124,0.0016701028,0.0011327495,0.0000010085693,0.000026125354,4.1287979e-7,0.000010829857,0.002187784],"study_design_scores_gemma":[0.11457743,0.004260099,0.879508,0.00023212633,0.000107361506,0.0000024866551,0.00005148709,0.000022919803,0.00088460924,0.0000023603784,0.000028970957,0.00032210775],"about_ca_topic_score_codex":0.00021484705,"about_ca_topic_score_gemma":0.0040118564,"teacher_disagreement_score":0.08157977,"about_ca_system_score_codex":0.0001660518,"about_ca_system_score_gemma":0.00013058409,"threshold_uncertainty_score":0.9999274},"labels":[],"label_agreement":null},{"id":"W2983330076","doi":"10.1182/blood-2019-121870","title":"Immune Landscapes Predict Chemotherapy Resistance and Anti-Leukemic Activity of Flotetuzumab, an Investigational CD123×CD3 Bispecific Dart® Molecule, in Patients with Relapsed/Refractory Acute Myeloid Leukemia","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Immune system; Medicine; Interleukin-3 receptor; Immunotherapy; Chemotherapy regimen; Myeloid leukemia; Oncology; Leukemia; Immunology; Myeloid; Internal medicine; Chemotherapy; Cancer research","score_opus":0.006480575443973489,"score_gpt":0.22549820950477284,"score_spread":0.21901763406079935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983330076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99731535,0.00036517,0.000011344521,0.00015171581,0.00005310309,0.0010402377,0.000097623255,0.00006511902,0.0009003418],"genre_scores_gemma":[0.9973032,0.00032120096,0.0012346472,0.00009381377,0.00006430388,0.00003018694,0.00023084693,0.00008173584,0.0006400491],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99739957,0.00013875835,0.00046014725,0.00067947345,0.0008423418,0.00047969227],"domain_scores_gemma":[0.9983572,0.00010853738,0.00026226952,0.0007868804,0.00023911158,0.000245995],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034616538,0.0003413972,0.00071341393,0.00035858777,0.00006845344,0.000029107718,0.00025722687,0.00024265598,0.0000831812],"category_scores_gemma":[0.000069968824,0.00028783942,0.00006703605,0.00054915017,0.00026020227,0.0004318305,0.00008607176,0.00068778306,0.000014704907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003975815,0.0010676464,0.71213907,0.00029047776,0.00039486444,0.000050677714,0.0005168033,0.000017228876,0.28051028,0.000050944724,0.00026261795,0.0007235754],"study_design_scores_gemma":[0.024660064,0.001238121,0.91433084,0.00035465852,0.0001056895,0.000017636514,0.00004477602,0.00023806943,0.05842689,0.000027538952,0.00027214404,0.000283559],"about_ca_topic_score_codex":0.00010830579,"about_ca_topic_score_gemma":0.00005269973,"teacher_disagreement_score":0.22208337,"about_ca_system_score_codex":0.0004687786,"about_ca_system_score_gemma":0.0011604127,"threshold_uncertainty_score":0.9999574},"labels":[],"label_agreement":null},{"id":"W2983333809","doi":"10.1182/blood-2019-126670","title":"A Phase 2 Study of REGN1979, an Anti-CD20 x Anti-CD3 Bispecific Antibody (Ab), in Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-NHL)","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; CD20; Mantle cell lymphoma; Rituximab; Lymphoma; Tolerability; B cell; Internal medicine; Oncology; Immunology; Gastroenterology; Antibody; Adverse effect","score_opus":0.015190308065964065,"score_gpt":0.30043175066022454,"score_spread":0.2852414425942605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983333809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99347097,0.00017967024,0.000003204715,0.000017160772,0.00017927762,0.0033279492,0.00003606609,0.00007231983,0.0027133774],"genre_scores_gemma":[0.9980278,0.00010748898,0.00012320463,0.000042994165,0.00010961246,0.00003316479,0.00017301171,0.00014728749,0.0012354549],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99590343,0.00026640212,0.000768383,0.00095986144,0.0013541463,0.0007477982],"domain_scores_gemma":[0.99717104,0.00011489494,0.00031369552,0.0017178352,0.0003558741,0.00032664093],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006042803,0.00045421295,0.0011011647,0.00077685073,0.00006890209,0.000042399053,0.00044020682,0.00022044205,0.0008063283],"category_scores_gemma":[0.00003698662,0.00037894756,0.00013003539,0.0011047543,0.00013593427,0.00030087092,0.00013100223,0.00046026174,0.00011851847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027134116,0.10043159,0.6990097,0.00017883797,0.0001952595,0.000249332,0.0014203697,0.0000044843423,0.19258079,0.0000018335626,0.0000618361,0.0031525155],"study_design_scores_gemma":[0.19409312,0.036657996,0.73454595,0.00031159783,0.00021276025,0.000018308574,0.0013080841,0.000066017405,0.03146498,0.0000022800161,0.00084697333,0.00047193744],"about_ca_topic_score_codex":0.0003911098,"about_ca_topic_score_gemma":0.000051883537,"teacher_disagreement_score":0.19137971,"about_ca_system_score_codex":0.000111999856,"about_ca_system_score_gemma":0.00031436083,"threshold_uncertainty_score":0.99986625},"labels":[],"label_agreement":null},{"id":"W2983379402","doi":"10.1182/blood-2019-121388","title":"The Presence and Persistence of Pregnancy-Associated Red Blood Cell Alloantibodies in Blood Donors","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; University of British Columbia","funders":"","keywords":"Medicine; Isoantibodies; Pregnancy; Antibody; Red blood cell; Immunology; Blood transfusion; Antigen; Obstetrics; Biology; Genetics","score_opus":0.00933720772852417,"score_gpt":0.20715570694153357,"score_spread":0.1978184992130094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983379402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986916,0.007701217,4.778854e-7,0.00031792064,0.0000748867,0.00063567923,0.000009832851,0.000029755649,0.0043142345],"genre_scores_gemma":[0.99183375,0.006822137,0.00014761295,0.00002444603,0.000016598979,0.000015084246,0.00000655883,0.000019232166,0.0011145603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865067,0.00006612461,0.0003370824,0.000334471,0.00028907126,0.00032255208],"domain_scores_gemma":[0.9991134,0.00020172955,0.00012737553,0.00038659995,0.00009115784,0.00007973057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023987736,0.00017156868,0.0003605978,0.00006868687,0.00008395167,0.000019218034,0.00015995155,0.00012775061,0.000020639867],"category_scores_gemma":[0.0000936052,0.00012041225,0.00009625502,0.00023992134,0.00013073071,0.00008020698,0.00006932163,0.00023514348,0.0000041899034],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079455654,0.0021487866,0.8726061,0.00032874307,0.00024243623,0.00005543281,0.0011267463,0.0000013846812,0.12303034,0.00009846991,0.000012286147,0.00026984178],"study_design_scores_gemma":[0.02319099,0.0019742742,0.73723274,0.002677348,0.002087752,0.00010045928,0.0011685855,0.00007475662,0.23084487,0.00017749933,0.00011973031,0.00035102363],"about_ca_topic_score_codex":0.0002445121,"about_ca_topic_score_gemma":0.000331735,"teacher_disagreement_score":0.13537335,"about_ca_system_score_codex":0.0000045407164,"about_ca_system_score_gemma":0.00005650385,"threshold_uncertainty_score":0.4910269},"labels":[],"label_agreement":null},{"id":"W2983387522","doi":"10.1182/blood-2019-121336","title":"Outcomes in Older Adults with Acute Lymphoblastic Leukemia (ALL) Receiving Linker Protocol at a Single Center Institution","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Pediatrics; Population; Regimen; Clinical trial; Cohort; Asparaginase; Acute lymphocytic leukemia; Internal medicine; Leukemia; Lymphoblastic Leukemia","score_opus":0.013224176698529171,"score_gpt":0.27640472419046674,"score_spread":0.2631805474919376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983387522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.963261,0.000010683446,0.000028494398,0.0005505741,0.00013964552,0.0336057,0.000011605628,0.00011950965,0.002272766],"genre_scores_gemma":[0.9873545,0.0000021805906,0.0007067735,0.0013918602,0.00012236867,0.009387587,0.0000327184,0.00004916085,0.00095284136],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805534,0.00006802225,0.00046370624,0.0005029395,0.0005023084,0.00040771],"domain_scores_gemma":[0.99901706,0.000079700534,0.0001734398,0.00050070323,0.00007541866,0.00015366882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000199583,0.0002724046,0.0005091214,0.00014616191,0.000043321135,0.000026497208,0.00012379177,0.00014858168,0.00017329775],"category_scores_gemma":[0.00008634351,0.00021212111,0.00009323459,0.00021259094,0.000057689962,0.00019273393,0.00010093371,0.00022610395,0.00021675434],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015098924,0.0019915598,0.99009514,0.0006992709,0.0002850183,0.00014623597,0.0034150456,0.000012598422,0.0013295695,0.000016429076,0.00013798935,0.00036126084],"study_design_scores_gemma":[0.06498928,0.0013356553,0.91944116,0.0047629788,0.000245153,0.0004893147,0.00025587928,0.00008354828,0.0052475706,0.000008699427,0.0026372452,0.0005035136],"about_ca_topic_score_codex":0.0002925144,"about_ca_topic_score_gemma":0.0012168975,"teacher_disagreement_score":0.070653975,"about_ca_system_score_codex":0.000580601,"about_ca_system_score_gemma":0.00031631472,"threshold_uncertainty_score":0.8650048},"labels":[],"label_agreement":null},{"id":"W2983410311","doi":"10.1182/blood-2019-124492","title":"Correlation of Bridging and Lymphodepleting Chemotherapy with Clinical Outcomes in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated with Tisagenlecleucel","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont; Hamilton Health Sciences","funders":"","keywords":"Diffuse large B-cell lymphoma; Medicine; Blinatumomab; Refractory (planetary science); Chemotherapy regimen; Lymphoma; Chemotherapy; Internal medicine; Oncology; Rituximab; Leukemia; Biology","score_opus":0.011000794699848876,"score_gpt":0.2645559058655236,"score_spread":0.2535551111656747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983410311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976589,0.000066984976,0.00004977087,0.000031466352,0.000018312303,0.0009626107,0.000009408031,0.00004272868,0.0011598227],"genre_scores_gemma":[0.99753165,0.000052440955,0.00043909045,0.0001343914,0.0000228553,0.0000125040515,0.000040906165,0.00008130548,0.0016848381],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981851,0.00011023926,0.0004015986,0.00042759004,0.0005213361,0.00035412514],"domain_scores_gemma":[0.9988398,0.00024276871,0.00022861389,0.0004224674,0.00013465255,0.00013169843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036863986,0.0002326958,0.0006073992,0.00017321714,0.000036602534,0.00001681832,0.00007846959,0.00013290184,0.00010964701],"category_scores_gemma":[0.000032624073,0.00015317749,0.00005335577,0.00028166728,0.000100424615,0.00010631888,0.000029304865,0.00019678615,0.0000087099315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050540636,0.009347885,0.9790943,0.00008790895,0.00022166286,0.000030238056,0.00030621712,0.0000030236126,0.0011779169,0.0000015047361,0.0000055431246,0.004669733],"study_design_scores_gemma":[0.15050317,0.003192894,0.8439433,0.0002347131,0.00011144577,0.000012994289,0.00007084864,0.00028910907,0.0014062817,4.945445e-7,0.00006459402,0.00017016298],"about_ca_topic_score_codex":0.00013220482,"about_ca_topic_score_gemma":0.000046715297,"teacher_disagreement_score":0.14544912,"about_ca_system_score_codex":0.000071439485,"about_ca_system_score_gemma":0.00014418545,"threshold_uncertainty_score":0.6246397},"labels":[],"label_agreement":null},{"id":"W2983432301","doi":"10.1182/blood-2019-126473","title":"Enhanced Responses to Fostamatinib As Second-Line Therapy and in Persistent Immune Thrombocytopenia (ITP) Patients","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Immune thrombocytopenia; Second-line therapy; Romiplostim; Medicine; Splenectomy; Immunology; Eltrombopag; Platelet; Internal medicine; Thrombopoietin; Spleen; Chemotherapy","score_opus":0.017825466518763804,"score_gpt":0.2684026603855875,"score_spread":0.2505771938668237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983432301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953425,0.0008541187,3.2118308e-7,0.00024514904,0.00005834433,0.0009740051,0.000018105335,0.000019287772,0.0024881628],"genre_scores_gemma":[0.99721277,0.00016654455,0.00016584396,0.00057576963,0.000009303277,0.000032694858,0.000037536807,0.000018507906,0.0017810117],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991582,0.000031007916,0.00020366865,0.00025269098,0.00014826542,0.00020616008],"domain_scores_gemma":[0.9995493,0.00004662657,0.00004561594,0.00022774716,0.000042301373,0.00008837837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006476598,0.00014360862,0.00038589217,0.00009486466,0.000028639217,0.000015544216,0.000052657077,0.000058518337,0.00046297576],"category_scores_gemma":[0.000037081365,0.00011335462,0.000061612765,0.00011435167,0.000015143642,0.000057614277,0.00003883109,0.00008012277,0.00019857333],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009071649,0.008042544,0.7624999,0.00014770121,0.0008036742,0.0002724044,0.0061148177,0.0000018841441,0.19516453,0.000031267216,0.00010136713,0.01774822],"study_design_scores_gemma":[0.028149102,0.005181346,0.8953641,0.00015433422,0.000065913046,0.000033879667,0.0005351069,0.0000052414425,0.06971451,0.000043567317,0.00055678794,0.00019613176],"about_ca_topic_score_codex":0.00004376707,"about_ca_topic_score_gemma":0.000030221665,"teacher_disagreement_score":0.13286413,"about_ca_system_score_codex":0.00002120202,"about_ca_system_score_gemma":0.000041549352,"threshold_uncertainty_score":0.506926},"labels":[],"label_agreement":null},{"id":"W2983437497","doi":"10.1182/blood-2019-127552","title":"\"Everything Was Blood When It Comes to Me\": Understanding the Lived Experiences of Women with Inherited Bleeding Disorders","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"North York General Hospital; Centre Hospitalier Universitaire Sainte-Justine; St. Michael's Hospital; Canadian Hemophilia Society; University of Toronto","funders":"","keywords":"Medicine; Thematic analysis; Qualitative research; Family medicine; Health care; Inclusion (mineral); MEDLINE; Psychology; Social psychology","score_opus":0.04073677294641698,"score_gpt":0.28533971959731724,"score_spread":0.24460294665090027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983437497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929725,0.00017725016,0.00003280204,0.0026070443,0.000052141324,0.00070105115,9.190176e-7,0.00003823628,0.0034180852],"genre_scores_gemma":[0.9980879,0.00006134047,0.00038252128,0.00015630703,0.000046643985,0.00007618011,0.000002774228,0.000022726299,0.001163629],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.99856573,0.000046176516,0.00019384999,0.00024703224,0.0004951245,0.00045210918],"domain_scores_gemma":[0.9992579,0.00019355786,0.000058880527,0.00027225137,0.000048454964,0.00016895715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033957843,0.00015211725,0.00031407512,0.00013913114,0.00013581096,0.000038572874,0.00017132511,0.000058696485,0.000330767],"category_scores_gemma":[0.00006675734,0.00008391039,0.000047732323,0.00033331141,0.00012504654,0.00009304464,0.000081737344,0.00015806625,0.000017687273],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056646514,0.001072363,0.31776258,0.00026913034,0.0013347256,0.000045747285,0.64772916,0.0000127647,0.030497596,0.00018366985,0.00013369914,0.00039212604],"study_design_scores_gemma":[0.008564203,0.0033843205,0.006353785,0.0007273216,0.00032700997,0.000046220102,0.9614999,0.000098084565,0.018124212,0.00029208793,0.0002983013,0.00028452097],"about_ca_topic_score_codex":0.000053984426,"about_ca_topic_score_gemma":0.00001244718,"teacher_disagreement_score":0.3137708,"about_ca_system_score_codex":0.00009236469,"about_ca_system_score_gemma":0.00009793125,"threshold_uncertainty_score":0.36216667},"labels":[],"label_agreement":null},{"id":"W2983461972","doi":"10.1182/blood-2019-125449","title":"Patient Characteristics and Outcomes in Adolescents and Young Adults (AYA) with Acute Myeloid Leukemia (AML): Princess Margaret Cancer Centre Experience","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Myeloid leukemia; Acute promyelocytic leukemia; Internal medicine; Young adult; Retrospective cohort study; Cancer; Leukemia; Log-rank test; Survival analysis; Oncology; Pediatrics","score_opus":0.006551456879921741,"score_gpt":0.25218412341082663,"score_spread":0.2456326665309049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983461972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981534,0.00024271899,0.0000028851825,0.0002528625,0.00010194332,0.0009927106,0.000054147782,0.00003529878,0.00016401577],"genre_scores_gemma":[0.9981665,0.00071871566,0.00022908223,0.00026772343,0.000041481122,0.000063468186,0.00002222418,0.000038919126,0.00045191305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819195,0.00003950477,0.00028568492,0.00053002185,0.0004607428,0.00049212115],"domain_scores_gemma":[0.9991613,0.000022717319,0.00011079535,0.00034479663,0.00010890669,0.00025148483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007155865,0.00025985364,0.00047076066,0.00011845083,0.000049951104,0.00004309898,0.0001169929,0.00011597654,0.0000421745],"category_scores_gemma":[0.000038468745,0.00019334724,0.000025376057,0.0001787591,0.00013087834,0.00015693519,0.0001973608,0.00037093036,0.0000109263165],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007153103,0.00019360546,0.98885167,0.00031171876,0.000092170456,0.0003619871,0.0035656765,2.449373e-7,0.0017555907,0.0000062506133,0.000016864386,0.004128933],"study_design_scores_gemma":[0.008619194,0.00031411162,0.98512137,0.001151114,0.00008605834,0.00015213169,0.0010332945,0.0001575941,0.0029447307,0.00000117504,0.00017594727,0.00024329772],"about_ca_topic_score_codex":0.00071309233,"about_ca_topic_score_gemma":0.00031256943,"teacher_disagreement_score":0.007903884,"about_ca_system_score_codex":0.00026261347,"about_ca_system_score_gemma":0.00029253578,"threshold_uncertainty_score":0.78844714},"labels":[],"label_agreement":null},{"id":"W2983465809","doi":"10.1182/blood-2019-124601","title":"Apixaban Versus Dalteparin for Thromboprophylaxis in Patients with Acute Spinal Cord Injury: A Pilot Study","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Apixaban; Randomized controlled trial; Population; Low molecular weight heparin; Surgery; Anesthesia; Rivaroxaban; Warfarin; Heparin; Internal medicine","score_opus":0.022373290749466177,"score_gpt":0.2983419820220767,"score_spread":0.2759686912726105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983465809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935626,0.000020757881,0.0000079224,0.00006383338,0.00030286808,0.0047546765,0.000020052286,0.000047515747,0.001219803],"genre_scores_gemma":[0.9988068,0.00000872057,0.00049724197,0.00013059468,0.000067561356,0.0002979914,0.00003880099,0.00004194123,0.00011037123],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99856013,0.000022273807,0.00024849048,0.00043270935,0.00038145907,0.0003549127],"domain_scores_gemma":[0.99923253,0.00002115093,0.00009029824,0.00046499842,0.0000973387,0.00009366573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014519226,0.00020699287,0.00054405583,0.00014729505,0.000051660587,0.000025175263,0.00013412036,0.000033501696,0.00006376178],"category_scores_gemma":[0.000018708803,0.00016302649,0.00004558894,0.00022874825,0.000025360532,0.0000809549,0.000090443784,0.00013488412,0.000067524175],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050211374,0.054097317,0.88721687,0.00022592754,0.0018314172,0.000043720414,0.00022966551,0.0000015231709,0.0002496938,0.00045754854,0.00055887137,0.0048761046],"study_design_scores_gemma":[0.030556075,0.24243493,0.7255154,0.00006862137,0.0006224757,5.522851e-7,0.00014596886,0.0000024109786,0.00014318878,0.000015366715,0.000331758,0.00016320546],"about_ca_topic_score_codex":0.00021811441,"about_ca_topic_score_gemma":0.00015335293,"teacher_disagreement_score":0.18833762,"about_ca_system_score_codex":0.00005594748,"about_ca_system_score_gemma":0.000060914506,"threshold_uncertainty_score":0.66480273},"labels":[],"label_agreement":null},{"id":"W2983477569","doi":"10.1182/blood-2019-127664","title":"Systematic Literature Review of the Clinical Evidence in Relapsed/Refractory (R/R) Large B-Cell Lymphoma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Internal medicine; Oncology; Brentuximab vedotin; Cochrane Library; Follicular lymphoma; Systematic review; Lymphoma; Salvage therapy; Diffuse large B-cell lymphoma; MEDLINE; Randomized controlled trial; Chemotherapy; Hodgkin lymphoma","score_opus":0.03832518770159279,"score_gpt":0.35417166811200146,"score_spread":0.3158464804104087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983477569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.61088854,0.38239825,3.5703064e-7,0.0003998617,0.0001979435,0.0020701191,0.0000050234758,0.000014464712,0.0040254346],"genre_scores_gemma":[0.8273189,0.15375517,0.000059880047,0.0018499132,0.00014467667,0.00006267902,0.0000047997714,0.000038566846,0.016765378],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9972754,0.0007255806,0.00083974923,0.00028058566,0.00062233186,0.00025635384],"domain_scores_gemma":[0.99745506,0.0008372616,0.00024048032,0.0012029555,0.0001764909,0.00008774092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030958783,0.0001361484,0.0007680789,0.000073407464,0.000016503773,0.000011128808,0.00033800481,0.00016267555,0.0005857397],"category_scores_gemma":[0.0016220805,0.000079991914,0.00033256208,0.0005753071,0.00004611969,0.000056233224,0.00012064182,0.00042877908,0.00017380879],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022639219,0.0062015182,0.11709426,0.85481805,0.00017270485,0.00015796674,0.00044681467,6.588448e-8,0.018522628,0.00008665421,0.0016676988,0.00060527446],"study_design_scores_gemma":[0.012895492,0.0006638246,0.024121843,0.95522887,0.00035815802,0.00016609328,0.000051953433,0.000018895313,0.0032641622,0.000016794384,0.0030541678,0.00015975109],"about_ca_topic_score_codex":0.0000040553437,"about_ca_topic_score_gemma":0.0000036130857,"teacher_disagreement_score":0.22864306,"about_ca_system_score_codex":0.000047850135,"about_ca_system_score_gemma":0.00026242575,"threshold_uncertainty_score":0.6413439},"labels":[],"label_agreement":null},{"id":"W2983489157","doi":"10.1182/blood-2019-130510","title":"Reducing Repetitive and Reflexive Diagnostic Phlebotomy in an Intensive Care Unit: A Quality Improvement Project","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Clinical Laboratory Practices and Quality Control","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Phlebotomy; Medicine; Intensive care unit; Emergency medicine; Intensive care; Intensive care medicine; Anemia; Surgery; Internal medicine","score_opus":0.07743352496311429,"score_gpt":0.43340586358235483,"score_spread":0.35597233861924055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983489157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99569774,0.00045015238,0.0000018320582,0.00082580233,0.00009746562,0.0015960723,0.000045465276,0.000037208116,0.0012482434],"genre_scores_gemma":[0.99689233,0.00008049759,0.00019622689,0.002464198,0.00012797778,0.00007460905,0.00004110767,0.000018224455,0.00010485156],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998239,0.00031311813,0.0005003454,0.000505932,0.00020432276,0.00023730421],"domain_scores_gemma":[0.9969726,0.0014296913,0.00022254976,0.00045009886,0.0007940683,0.00013094625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000752712,0.00015681659,0.00045959424,0.000080731625,0.000037479887,0.000034083474,0.00005969967,0.000111299814,0.000041927575],"category_scores_gemma":[0.0058956277,0.00013283629,0.00005245057,0.00018911214,0.000058917183,0.0001915474,0.000069943555,0.0003917811,0.000014833275],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016771624,0.00128829,0.9365012,0.0008840097,0.00024411376,0.00029503205,0.018514661,0.000001867238,0.024898848,0.0014187191,0.000022122069,0.014253946],"study_design_scores_gemma":[0.03355079,0.009900245,0.7838205,0.0016852556,0.00091118325,0.000039868504,0.15611072,0.000092161834,0.008523129,0.00019652308,0.0044344137,0.00073519564],"about_ca_topic_score_codex":0.0009950844,"about_ca_topic_score_gemma":0.00046809748,"teacher_disagreement_score":0.15268072,"about_ca_system_score_codex":0.0000435418,"about_ca_system_score_gemma":0.00023426401,"threshold_uncertainty_score":0.7058043},"labels":[],"label_agreement":null},{"id":"W2983492726","doi":"10.1182/blood-2019-128402","title":"Impact of Mutations in Epigenetic Modifiers in Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis","year":2019,"lang":"en","type":"review","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Oncology; Meta-analysis; Isocitrate dehydrogenase; IDH1; Epigenetics; Hazard ratio; Internal medicine; Confidence interval; EZH2; Medicine; Myeloid leukemia; CEBPA; DNA methylation; Bioinformatics; Biology; Genetics; Mutation; Gene","score_opus":0.08935773024498643,"score_gpt":0.39900896486348214,"score_spread":0.3096512346184957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983492726","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029438784,0.9916659,0.000009768709,0.000041169387,0.000006169978,0.007535053,0.00026409727,0.000013096648,0.00017033165],"genre_scores_gemma":[0.00048475878,0.9969033,0.00023556242,0.00004658417,0.000008281274,0.0011872079,0.00027594078,0.00007026502,0.000788116],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9950836,0.0009156612,0.0022465724,0.000700445,0.0005571801,0.00049658894],"domain_scores_gemma":[0.996745,0.00065813685,0.0008545679,0.0013704643,0.00016089952,0.00021092083],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00146875,0.0006279074,0.016215201,0.002139923,0.000018870849,0.000020546355,0.00038269695,0.00042503822,0.00017487799],"category_scores_gemma":[0.00065904774,0.00039395905,0.0039153267,0.003878097,0.00010203674,0.00006656132,0.00014293604,0.00094733667,0.000057340458],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000032642222,0.0001392372,0.00004340927,0.77091455,0.22827211,0.00014318331,0.000059172362,0.000010324122,7.586711e-7,0.000004165387,0.000018535213,0.0003913119],"study_design_scores_gemma":[0.0009205001,0.0001580402,0.00008852997,0.053215686,0.94496536,0.00022646875,0.00001258686,0.000035798963,6.3998925e-7,0.00000504781,0.000103242135,0.00026807905],"about_ca_topic_score_codex":0.00052652776,"about_ca_topic_score_gemma":0.00006764581,"teacher_disagreement_score":0.7176989,"about_ca_system_score_codex":0.0010037835,"about_ca_system_score_gemma":0.0025390782,"threshold_uncertainty_score":0.9998512},"labels":[],"label_agreement":null},{"id":"W2983523128","doi":"10.1182/blood-2019-130255","title":"Whole Exome and Transcriptome Sequencing in 1042 Cases Reveals Distinct Clinically Relevant Genetic Subgroups of Follicular Lymphoma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Follicular lymphoma; Chemoimmunotherapy; Biology; Germinal center; Oncology; Lymphoma; Exome sequencing; Rituximab; Internal medicine; Medicine; Genetics; Mutation; Gene; Immunology; B cell","score_opus":0.018396098843780892,"score_gpt":0.2609930547105817,"score_spread":0.2425969558668008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983523128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953304,0.00347755,0.0000029076696,0.0001474829,0.000057551315,0.0005866509,0.000031583597,0.000023444163,0.00034243191],"genre_scores_gemma":[0.9983276,0.00036098648,0.00090767373,0.00013401256,0.000041470907,0.00004090915,0.000019025856,0.000024108229,0.00014419126],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848235,0.00006108617,0.0005972118,0.00036589723,0.00023387415,0.0002595824],"domain_scores_gemma":[0.99911475,0.00023285259,0.0001211971,0.00034569704,0.000047089048,0.00013843414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021876815,0.00018052102,0.0005773766,0.00009462984,0.000022127546,0.000012204029,0.00006465977,0.00010330564,0.00003483166],"category_scores_gemma":[0.000115616844,0.00014196288,0.00013308757,0.0001562065,0.00005740046,0.000046584955,0.000027756041,0.000048762144,0.000027993834],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000113017064,0.0010701129,0.9429308,0.0002457966,0.00016851867,0.0014966973,0.0002989597,0.0000021803548,0.05154267,0.00004612031,0.00001455381,0.0020705427],"study_design_scores_gemma":[0.012417773,0.0013282562,0.97752273,0.00054789474,0.0005098174,0.0006942193,0.000121160105,0.000033568278,0.0064075836,0.000095691525,0.00016718128,0.00015412022],"about_ca_topic_score_codex":0.00034927088,"about_ca_topic_score_gemma":0.00004873869,"teacher_disagreement_score":0.045135085,"about_ca_system_score_codex":0.00010981161,"about_ca_system_score_gemma":0.00014291717,"threshold_uncertainty_score":0.57890785},"labels":[],"label_agreement":null},{"id":"W2983529065","doi":"10.1182/blood-2019-123720","title":"Efficacy of Caplacizumab in Patients with aTTP in the HERCULES Study According to Baseline Disease Severity","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Internal medicine; Placebo; Gastroenterology; Stroke (engine); Pathology","score_opus":0.009233346062144815,"score_gpt":0.2380704726177657,"score_spread":0.22883712655562088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983529065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99789727,0.00013433081,0.0000014323224,0.000040830797,0.00007021911,0.001707919,0.000087425695,0.000011085022,0.0000495126],"genre_scores_gemma":[0.9997624,4.6632275e-7,0.000008081865,0.000056731988,0.000005965592,0.000055063796,0.00007931553,0.000008050045,0.000023919825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988153,0.0004279148,0.00026551506,0.00023229461,0.00006647095,0.00019248259],"domain_scores_gemma":[0.9992507,0.0002223821,0.000067654815,0.00040884898,0.000034819463,0.00001558043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002943255,0.00011627948,0.00022406626,0.000100069825,0.000028270291,0.000006434808,0.00026731958,0.000025748304,0.00014736691],"category_scores_gemma":[0.00011239165,0.00007811351,0.000032028685,0.00020036144,0.000020710224,0.000043819924,0.000094616385,0.000090741385,0.0000974156],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009366082,0.0055104485,0.99216247,0.000030557654,0.000059055023,0.000005428579,0.00075698545,0.000027668968,0.00018153197,0.0000072208154,0.00007867151,0.00024334168],"study_design_scores_gemma":[0.010654765,0.00035594884,0.9867051,0.000089698864,0.000059806564,5.415369e-7,0.001812426,8.781318e-7,0.000117518786,0.00000240487,0.00010128301,0.0000996214],"about_ca_topic_score_codex":0.00022345287,"about_ca_topic_score_gemma":0.0002634697,"teacher_disagreement_score":0.009718156,"about_ca_system_score_codex":0.000018920467,"about_ca_system_score_gemma":0.00003728115,"threshold_uncertainty_score":0.31853765},"labels":[],"label_agreement":null},{"id":"W2983568470","doi":"10.1182/blood-2019-122262","title":"Inhibiting Very Long Chain Acyl-CoA Dehydrogenase (VLCAD) Induces Selective Leukemia Cell Death","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Western University; University Health Network; Princess Margaret Cancer Centre; University of Waterloo; University of Guelph","funders":"","keywords":"Biology; Leukemia; Clonogenic assay; Haematopoiesis; Myeloid leukemia; Myeloid; Citric acid cycle; Cancer research; Population; Bone marrow; Oxidative phosphorylation; Biochemistry; Stem cell; Cell; Immunology; Metabolism; Medicine; Cell biology","score_opus":0.015478640206971666,"score_gpt":0.2636724442333163,"score_spread":0.24819380402634464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983568470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9740885,0.0005223938,0.000021346736,0.00021882614,0.000088065084,0.0009449579,0.000011758273,0.00017778382,0.02392637],"genre_scores_gemma":[0.99537385,0.00006796801,0.0006849586,0.0005191935,0.0004830204,0.00005173737,0.000046161702,0.00009688061,0.0026762427],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972943,0.00012385944,0.0003778971,0.00066707865,0.00065580616,0.0008810762],"domain_scores_gemma":[0.9985254,0.0002461832,0.0001404108,0.00052111375,0.00020620636,0.00036070836],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00055950176,0.00033328737,0.00050561735,0.00030319294,0.00013970064,0.00005372268,0.00025592447,0.00029884686,0.00017959834],"category_scores_gemma":[0.00024860507,0.00030417484,0.00016652771,0.0005934691,0.000067443776,0.00021501645,0.00024148202,0.0010640956,0.0010331009],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027784955,0.0006087855,0.099878654,0.00042247435,0.00033537118,0.0011296392,0.001173738,0.000029295716,0.8933284,0.00010405661,0.000926351,0.0017853418],"study_design_scores_gemma":[0.0078098346,0.0005156168,0.013820717,0.00021225937,0.00019699222,0.00034379645,0.00043655824,0.000431304,0.97552997,0.00004679975,0.00030811413,0.00034802884],"about_ca_topic_score_codex":0.000242087,"about_ca_topic_score_gemma":0.000018044835,"teacher_disagreement_score":0.08605793,"about_ca_system_score_codex":0.0007169688,"about_ca_system_score_gemma":0.0014620568,"threshold_uncertainty_score":0.99994105},"labels":[],"label_agreement":null},{"id":"W2983575857","doi":"10.1182/blood-2019-131454","title":"BCR-ABL1 qPCR-Based Doubling Time within the First 6 Months after Imatinib Discontinuation Is a Predictive of Successful TKI Treatment-Free Remission","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; McGill University Health Centre; London Health Sciences Centre; Juravinski Cancer Centre; Hôpital de l'Enfant-Jésus; Dalhousie University; Princess Margaret Cancer Centre; Vancouver General Hospital; University of Calgary; BC Cancer Agency; Alberta Health Services; Alberta Hospital Edmonton; University of British Columbia; Université de Montréal; Hôpital Maisonneuve-Rosemont; CancerCare Manitoba; University of Alberta Hospital; University Health Network; Ottawa Hospital; Western University; University of Toronto","funders":"","keywords":"Discontinuation; Medicine; Internal medicine; Imatinib; Imatinib mesylate; Oncology","score_opus":0.008339008115263034,"score_gpt":0.23771599707618798,"score_spread":0.22937698896092495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983575857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925255,0.00048894103,0.000023420975,0.001366149,0.00009199671,0.0017481815,0.00012604921,0.00007811656,0.003551604],"genre_scores_gemma":[0.9959716,0.000016209571,0.00086249376,0.00017191768,0.00011881816,0.00020411536,0.000108574444,0.000047315396,0.0024989345],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99826634,0.000055319582,0.0004761348,0.00043666246,0.0004893172,0.00027624948],"domain_scores_gemma":[0.99806494,0.0002038894,0.00034799613,0.0011507589,0.00012487124,0.000107545944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020351188,0.00029740582,0.00046845266,0.000103399085,0.00008073732,0.000028882247,0.0002123323,0.00014246214,0.00074507657],"category_scores_gemma":[0.00013329356,0.00017938997,0.00019282979,0.00022967969,0.00007770658,0.00016118471,0.00007488001,0.00014659179,0.00013729848],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056649544,0.0064613824,0.95551115,0.0005240152,0.0020884627,0.00012847404,0.010934242,0.0003711478,0.013653952,0.000038465478,0.0017438601,0.002879868],"study_design_scores_gemma":[0.1613338,0.010060493,0.20428862,0.005141561,0.006740257,0.00011002311,0.0013532193,0.066430256,0.54069537,0.00038376206,0.00239988,0.001062744],"about_ca_topic_score_codex":0.00053868233,"about_ca_topic_score_gemma":0.00008532415,"teacher_disagreement_score":0.75122255,"about_ca_system_score_codex":0.00038817618,"about_ca_system_score_gemma":0.00042615482,"threshold_uncertainty_score":0.81580657},"labels":[],"label_agreement":null},{"id":"W2983593617","doi":"10.1182/blood-2019-126997","title":"The Use of CEP (Lomustine, Etoposide and Prednisone), an All-Oral Palliative Chemotherapy Regimen, in Aggressive Lymphomas","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Lomustine; Medicine; Internal medicine; Prednisone; Etoposide; Regimen; Chemotherapy regimen; Vincristine; Oncology; Aggressive lymphoma; Gastroenterology; Tolerability; Chemotherapy; Surgery; Adverse effect; Lymphoma; Rituximab; Cyclophosphamide","score_opus":0.034150980214548245,"score_gpt":0.2847645866593148,"score_spread":0.25061360644476655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983593617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962499,0.0017623187,7.473906e-7,0.0008463136,0.000041825337,0.0006625648,0.000013220577,0.000018002092,0.00040507864],"genre_scores_gemma":[0.99641556,0.0017454823,0.00091672404,0.00043189497,0.000030871124,0.00005228268,0.000018836085,0.000020644182,0.00036769125],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99903417,0.000059793078,0.00023340737,0.00026266923,0.00019188035,0.00021807099],"domain_scores_gemma":[0.9990545,0.00022192192,0.00020015331,0.00036662482,0.00006275313,0.00009402712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009085016,0.00016059136,0.000306645,0.00005090035,0.000035180714,0.000028614979,0.00006775165,0.000078195495,0.000024723047],"category_scores_gemma":[0.000061720944,0.00009989118,0.00005448982,0.000109049186,0.00008050121,0.000100225836,0.00003196782,0.000052867847,0.000007241254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004973412,0.0021766464,0.9833296,0.00004651608,0.00040766867,0.000113948525,0.0016921702,0.000005404995,0.002094395,0.00067135226,0.00032584436,0.008639093],"study_design_scores_gemma":[0.01976895,0.0011611896,0.93918896,0.0002956352,0.00022436511,0.00005068871,0.00026272578,0.0001760289,0.035363857,0.00012494127,0.003239709,0.00014294212],"about_ca_topic_score_codex":0.00040653365,"about_ca_topic_score_gemma":0.00012457861,"teacher_disagreement_score":0.04414065,"about_ca_system_score_codex":0.000050772604,"about_ca_system_score_gemma":0.000086528744,"threshold_uncertainty_score":0.40734443},"labels":[],"label_agreement":null},{"id":"W2983600820","doi":"10.1182/blood-2019-126222","title":"Reduced Antigen Presentation May Contribute to Immunomodulatory Drug Resistance in Multiple Myeloma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Lenalidomide; Multiple myeloma; Minimal residual disease; Immunology; Bone marrow; Medicine; Peripheral blood mononuclear cell; Cancer; Cancer research; Immune system; Biology; Oncology; Internal medicine; In vitro","score_opus":0.0164877812982664,"score_gpt":0.28995978043999104,"score_spread":0.27347199914172465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983600820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937837,0.0007392564,0.000008100763,0.00081740855,0.00009563769,0.0016578971,0.000031871212,0.000050493385,0.0028156014],"genre_scores_gemma":[0.9909664,0.000039742947,0.0014810893,0.00009198042,0.000057784484,0.000097279844,0.00010756128,0.00002622802,0.007131935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984794,0.00008110573,0.00026475612,0.00036981894,0.00037701277,0.00042787642],"domain_scores_gemma":[0.99904436,0.000107846194,0.000052683332,0.00047646186,0.00010562947,0.00021300615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021048677,0.00014950642,0.0002939668,0.00018859231,0.000048192487,0.000023316643,0.000114641094,0.000058553916,0.000107575914],"category_scores_gemma":[0.00023874905,0.00013544339,0.00006884149,0.00027909316,0.000023759334,0.00010340088,0.000055665987,0.00014454791,0.0005779752],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012065601,0.00078342634,0.81867766,0.00008769002,0.00016943531,0.00023406046,0.00054237625,0.000003928407,0.17651325,0.000046586454,0.00070033316,0.0010347042],"study_design_scores_gemma":[0.012906597,0.00010995952,0.88330024,0.00015951804,0.000022764743,0.000007705198,0.00008960273,0.000050373652,0.10078342,0.000023814515,0.0024233311,0.00012266875],"about_ca_topic_score_codex":0.0002039906,"about_ca_topic_score_gemma":0.00029345744,"teacher_disagreement_score":0.075729825,"about_ca_system_score_codex":0.0000947351,"about_ca_system_score_gemma":0.00011680574,"threshold_uncertainty_score":0.7428894},"labels":[],"label_agreement":null},{"id":"W2983625716","doi":"10.1182/blood-2019-122122","title":"Acute Myeloid Leukemia (AML) Treated with Azacitidine: Survival Outcomes for Patients Who Complete More Than Six Cycles Are Similar to High-Risk Myelodysplastic Syndrome/Low Blast Count AML","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Ottawa Hospital; Princess Margaret Cancer Centre; University of Ottawa","funders":"","keywords":"Azacitidine; Medicine; Internal medicine; Myelodysplastic syndromes; Hypomethylating agent; International Prognostic Scoring System; Myeloid leukemia; Leukemia; Oncology; Bone marrow; Surgery","score_opus":0.01061704548477833,"score_gpt":0.24843113423198265,"score_spread":0.23781408874720433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983625716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99028474,0.000028478064,0.00021568943,0.00076596794,0.00024602035,0.0041972175,0.0037769913,0.0002879197,0.00019695866],"genre_scores_gemma":[0.9934747,0.00006871021,0.0016655858,0.0005059145,0.00017493611,0.000401322,0.0012310351,0.00028922816,0.0021885529],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99462897,0.00017221851,0.000777421,0.0013143582,0.0015994641,0.001507578],"domain_scores_gemma":[0.99565494,0.00094718806,0.0004037749,0.0013118847,0.0008479758,0.00083426305],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039109777,0.0009369208,0.001906359,0.00052079535,0.00031655602,0.0001263674,0.00065186655,0.0003509296,0.00014059684],"category_scores_gemma":[0.00047979678,0.00070725445,0.00032131808,0.0007912843,0.00022781517,0.00026143825,0.00029851493,0.0007352338,0.00045538746],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026255418,0.0008820126,0.98799884,0.00055333134,0.0024393664,0.0005079335,0.0002886722,0.0002719963,0.0024999264,0.000039205668,0.0016364561,0.0002566923],"study_design_scores_gemma":[0.03110095,0.004881529,0.9542836,0.00080281316,0.0017921075,0.00015491826,0.00040250906,0.0010712823,0.003568602,0.0000136423405,0.0009960313,0.0009320363],"about_ca_topic_score_codex":0.0005923152,"about_ca_topic_score_gemma":0.00029839238,"teacher_disagreement_score":0.033715285,"about_ca_system_score_codex":0.0009340557,"about_ca_system_score_gemma":0.0005669995,"threshold_uncertainty_score":0.9995379},"labels":[],"label_agreement":null},{"id":"W2983656320","doi":"10.1182/blood-2019-131431","title":"Efficacy of Fecal Microbiota Transplant in Hematological Cancers Patients with Recurrent Clostridioides Difficile Infection: A Systemic Review and Meta-Analysis","year":2019,"lang":"en","type":"review","venue":"Blood","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Meta-analysis; Hematopoietic stem cell transplantation; Immunosuppression; Surgery; Transplantation","score_opus":0.07336749454061456,"score_gpt":0.34035838346284414,"score_spread":0.26699088892222955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983656320","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.046520792,0.9483687,0.0000010713895,0.00003722821,0.000030201229,0.0042310115,0.0007214961,0.000026442396,0.00006304842],"genre_scores_gemma":[0.0180005,0.9808218,0.00001871866,0.000022339898,0.000028613567,0.00028417114,0.00070421904,0.000051689913,0.00006794442],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.995963,0.00039748786,0.0015414397,0.00096388836,0.00062169065,0.0005125098],"domain_scores_gemma":[0.9977498,0.00039993206,0.00061209686,0.00080029736,0.00021462124,0.00022321993],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039551625,0.0007399796,0.009401215,0.00067355327,0.00004264016,0.000022076425,0.0002122266,0.00041914577,0.00023096228],"category_scores_gemma":[0.000113483526,0.0004399588,0.002233761,0.0020070432,0.00014921556,0.000033758814,0.00009089583,0.0008728536,0.00001957861],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051256554,0.0062829955,0.005208775,0.67038786,0.2895143,0.000262626,0.00007996912,0.0000059028025,0.000019009754,0.00001422748,0.00027509045,0.027436659],"study_design_scores_gemma":[0.0035614932,0.0009332657,0.0004051245,0.021347106,0.95642453,0.00038083486,0.000003631813,8.3828877e-7,0.00007923094,9.944854e-8,0.01633641,0.00052741857],"about_ca_topic_score_codex":0.00021678371,"about_ca_topic_score_gemma":0.000070078015,"teacher_disagreement_score":0.66691023,"about_ca_system_score_codex":0.0002591986,"about_ca_system_score_gemma":0.00065596716,"threshold_uncertainty_score":0.9998052},"labels":[],"label_agreement":null},{"id":"W2983666463","doi":"10.1182/blood-2019-128445","title":"Predictors of Outcomes in Adult Patients with Therapy Related Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation - Twenty Year Experience from a Tertiary Care Centre","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Hematopoietic stem cell transplantation; Myeloid leukemia; Transplantation; Proportional hazards model; Cumulative incidence; Oncology","score_opus":0.004830761862482665,"score_gpt":0.21834557420871867,"score_spread":0.213514812346236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983666463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99817604,0.00018999007,0.000006561263,0.00004247773,0.000076107615,0.0011219798,0.000109403554,0.000052555548,0.00022486325],"genre_scores_gemma":[0.99868125,0.00039548267,0.00023704475,0.00007373538,0.00001221466,0.00002729936,0.00032306046,0.000050115235,0.00019981746],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981095,0.00009222411,0.00042378367,0.00043262055,0.0005923002,0.00034954693],"domain_scores_gemma":[0.99903464,0.00011948479,0.00015079013,0.00042469896,0.00014824647,0.00012216334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000049997434,0.00023959955,0.0004249302,0.00015362876,0.00002998216,0.000011072634,0.00019323286,0.00017212323,0.00008659227],"category_scores_gemma":[0.0000069285393,0.0001788001,0.00008654958,0.00024446784,0.00007464039,0.0001435195,0.00003264288,0.00028255561,0.00002898404],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046856064,0.00032330977,0.96266663,0.00022321218,0.00026635718,0.000069692105,0.026425904,0.00002447584,0.009402044,0.0000024808933,0.0000066476628,0.00012071374],"study_design_scores_gemma":[0.02355082,0.00039784744,0.8893264,0.00045609372,0.00019378542,0.0000063192033,0.0069040884,0.000022826998,0.07893651,0.000002683532,0.000004700186,0.00019793927],"about_ca_topic_score_codex":0.0002404753,"about_ca_topic_score_gemma":0.00006803501,"teacher_disagreement_score":0.073340215,"about_ca_system_score_codex":0.00026488816,"about_ca_system_score_gemma":0.00036792856,"threshold_uncertainty_score":0.7291256},"labels":[],"label_agreement":null},{"id":"W2983677619","doi":"10.1182/blood-2019-122768","title":"Growth Factor-Dependent Activation of a MYC-Induced Latent AML Program in Human Hematopoietic Cells","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Canada's Michael Smith Genome Sciences Centre; University of British Columbia; Terry Fox Research Institute; BC Cancer Agency","funders":"","keywords":"Biology; CD34; Haematopoiesis; Population; Bone marrow; Myeloid; Stem cell; Cancer research; Progenitor cell; Immunology; Transplantation; Molecular biology; CD38; Cell biology; Internal medicine; Medicine","score_opus":0.02562509468783011,"score_gpt":0.30067909875880444,"score_spread":0.27505400407097436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983677619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961571,0.000016121248,0.000004507732,0.00017082857,0.00003659608,0.0015666577,0.000003312563,0.00006195437,0.001982924],"genre_scores_gemma":[0.9990121,0.000009305234,0.0002482436,0.000038597205,0.00004420464,0.00006445067,0.000018315512,0.000031659445,0.00053309795],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985023,0.000054184828,0.00032507282,0.00028616327,0.0005084314,0.00032386012],"domain_scores_gemma":[0.99925387,0.000048056267,0.000103583225,0.00036517432,0.00012359727,0.000105740764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017167204,0.00014406707,0.0003426719,0.0002302348,0.000019886551,0.000013550183,0.00014194606,0.00014307548,0.00019650118],"category_scores_gemma":[0.000043134158,0.00012358514,0.000077730605,0.00028481617,0.000026693178,0.000075263284,0.00008167957,0.00035594616,0.00009226195],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059250455,0.0015121846,0.07480988,0.0003791209,0.00006788801,0.000032368087,0.00057273585,0.000001032242,0.92181945,0.00015272186,0.000028209353,0.0005651851],"study_design_scores_gemma":[0.0056402064,0.00083655,0.090204544,0.00018411495,0.000034825724,0.00001377227,0.00012895424,0.000041269726,0.9027091,0.00006957237,0.000023600405,0.00011345107],"about_ca_topic_score_codex":0.00027074802,"about_ca_topic_score_gemma":0.000009308295,"teacher_disagreement_score":0.019110283,"about_ca_system_score_codex":0.00015717243,"about_ca_system_score_gemma":0.00015633853,"threshold_uncertainty_score":0.5039656},"labels":[],"label_agreement":null},{"id":"W2983690215","doi":"10.1182/blood-2019-126236","title":"Reduced Intensity Conditioning and Dual T-Cell Modulation Improves Gvhd Free, Relapse Free Survival in AML Patients Compared with Myeloablative Conditioning","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Busulfan; Internal medicine; Total body irradiation; Regimen; Fludarabine; Hematopoietic stem cell transplantation; Cyclophosphamide; Gastroenterology; Graft-versus-host disease; Clofarabine; Transplantation; Leukemia; Oncology; Surgery; Chemotherapy; Cytarabine","score_opus":0.010750118959461668,"score_gpt":0.22258601848383613,"score_spread":0.21183589952437445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983690215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941798,0.000019571811,0.00015767921,0.00006358228,0.00015738941,0.0008613022,0.00007317752,0.00006071962,0.004426775],"genre_scores_gemma":[0.9974617,0.0000046492614,0.0015866744,0.000055426593,0.000034409804,0.000021841592,0.0006865395,0.000028761877,0.00012000978],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986073,0.00007473094,0.0003606574,0.00037584087,0.00035026693,0.0002312163],"domain_scores_gemma":[0.9989982,0.00017145976,0.00017847029,0.0003283544,0.0002207466,0.00010274471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018295903,0.00019073396,0.00039487795,0.00015251111,0.00007711485,0.000029253233,0.00006127761,0.00010990728,0.00007515532],"category_scores_gemma":[0.00009146524,0.00017910592,0.000031079613,0.00019049899,0.00008174486,0.00022681535,0.000036527537,0.00023435398,0.00001637647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005708701,0.00067413447,0.9012841,0.00036958398,0.00012357059,0.000057303547,0.0039244983,0.00009651149,0.092533685,0.0002364403,0.00005355427,0.00007576112],"study_design_scores_gemma":[0.020400614,0.00047561497,0.9400813,0.00033069417,0.00016868085,0.00003953829,0.00094145845,0.00078375457,0.03631297,0.0002560299,0.0000022300717,0.0002071161],"about_ca_topic_score_codex":0.00012808494,"about_ca_topic_score_gemma":0.00005533701,"teacher_disagreement_score":0.05622071,"about_ca_system_score_codex":0.000050495124,"about_ca_system_score_gemma":0.00006315935,"threshold_uncertainty_score":0.7303728},"labels":[],"label_agreement":null},{"id":"W2983701330","doi":"10.1182/blood-2019-122187","title":"Peripheral Blood Cell Sorting Strategies for Transcriptomic Analysis in Chronic Myelomonocytic Leukemia","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"","keywords":"Chronic myelomonocytic leukemia; Biology; CD34; Transcriptome; Haematopoiesis; Myeloid; Immunology; Stem cell; Cancer research; Molecular biology; Computational biology; Bone marrow; Genetics; Gene; Myelodysplastic syndromes; Gene expression","score_opus":0.015686559201974287,"score_gpt":0.2829441115322259,"score_spread":0.2672575523302516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983701330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911005,0.0012367343,0.00048118824,0.00011866779,0.000055139746,0.0012434435,0.000016150827,0.00009171613,0.005656497],"genre_scores_gemma":[0.99544233,0.000098166645,0.0015145637,0.000115237606,0.00021670338,0.00013258921,0.000079636586,0.00006526606,0.0023355135],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99756277,0.0000637823,0.0005611032,0.000616458,0.00035407432,0.00084179617],"domain_scores_gemma":[0.9989164,0.0001223489,0.00011572184,0.00057433464,0.00009780564,0.00017342888],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044261824,0.00029028245,0.00079069927,0.00053797336,0.00006680427,0.000081880265,0.0002735928,0.00021475542,0.0003824071],"category_scores_gemma":[0.000034182143,0.0002715221,0.00042814176,0.0009943029,0.000068383626,0.00021340782,0.000043069012,0.00051676587,0.00006493086],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060163706,0.00084503385,0.110554665,0.0020258476,0.003131743,0.0002502594,0.0026213063,0.0057198796,0.87216276,0.0005994883,0.00015626654,0.0013311389],"study_design_scores_gemma":[0.16981304,0.0073994254,0.15047045,0.0007037671,0.0252208,0.00028461815,0.0122912135,0.24439189,0.38299805,0.0012443551,0.0023489473,0.002833456],"about_ca_topic_score_codex":0.0004134396,"about_ca_topic_score_gemma":0.00050886953,"teacher_disagreement_score":0.48916468,"about_ca_system_score_codex":0.0012419814,"about_ca_system_score_gemma":0.0031371263,"threshold_uncertainty_score":0.9999737},"labels":[],"label_agreement":null},{"id":"W2983726993","doi":"10.1182/blood-2019-125852","title":"Overall Survival of Glasdegib in Combination with Low-Dose Cytarabine and Azacitidine By Bone Marrow Blasts Among Adult Patients with Previously Untreated Acute Myeloid Leukemia: Comparative Effectiveness Using Indirect Treatment Comparisons","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Medicine; Cytarabine; Internal medicine; Myeloid leukemia; Decitabine; Oncology; Azacitidine; Population; Randomized controlled trial; Induction chemotherapy; Chemotherapy","score_opus":0.01036229489564015,"score_gpt":0.25289791523269217,"score_spread":0.24253562033705203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983726993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99576324,0.0001285815,0.00004469883,0.000024210776,0.000026793998,0.0036514783,0.00012555232,0.00005042188,0.0001849964],"genre_scores_gemma":[0.9985698,0.000067347966,0.0004185441,0.000012554551,0.000013636654,0.00009843113,0.00064409827,0.00006249464,0.000113077265],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99736065,0.00038220405,0.00044886686,0.0006359368,0.0006363738,0.00053596264],"domain_scores_gemma":[0.9982886,0.0003026256,0.00031903395,0.00038222288,0.00048450637,0.0002230548],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024159947,0.00048393043,0.0014089433,0.00033230282,0.00007028447,0.000029398723,0.000102294915,0.00017079189,0.000016232698],"category_scores_gemma":[0.000027801712,0.00034801548,0.000060538074,0.0006249796,0.00028417664,0.0002635801,0.00006946574,0.00036413484,0.000005150426],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008405255,0.0032236006,0.9640546,0.0003585064,0.0011587853,0.00009825586,0.0007744991,0.00020867249,0.021557821,0.000011407127,0.000021650085,0.00012696943],"study_design_scores_gemma":[0.08841429,0.00815166,0.8305919,0.0012823759,0.0007237055,0.000042093317,0.00013119775,0.0031364781,0.06717769,0.0000024237834,0.000004784518,0.00034141008],"about_ca_topic_score_codex":0.0018415775,"about_ca_topic_score_gemma":0.0006292909,"teacher_disagreement_score":0.13346268,"about_ca_system_score_codex":0.0011207674,"about_ca_system_score_gemma":0.00044697322,"threshold_uncertainty_score":0.9998972},"labels":[],"label_agreement":null},{"id":"W2983728775","doi":"10.1182/blood-2019-128819","title":"Are We Choosing Mobilization Regimens for Autologous Stem Cell Transplantation in Multiple Myeloma Wisely?: A Single Centre Comparison of GCSF+/-Plerixafor Vs Cyclophosphamide/GCSF+/- Plerixafor","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Kingston Health Sciences Centre; Western University; Queen's University","funders":"","keywords":"Plerixafor; Medicine; Multiple myeloma; Autologous stem-cell transplantation; Regimen; Febrile neutropenia; Cyclophosphamide; Surgery; Oncology; Neutropenia; Transplantation; Internal medicine; Chemotherapy; CXCR4","score_opus":0.04005273014943504,"score_gpt":0.29195642878391476,"score_spread":0.2519036986344797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983728775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938846,0.0009091946,0.00044902725,0.00046030962,0.00014552787,0.0035179334,0.00029926037,0.00009758203,0.0002365585],"genre_scores_gemma":[0.9957294,0.00013499292,0.0026233424,0.000050535466,0.000048832597,0.00015832516,0.00055235106,0.00006987656,0.00063234917],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975258,0.000092021124,0.0007272854,0.00056730525,0.00045029056,0.0006372814],"domain_scores_gemma":[0.9982716,0.0003406094,0.00047699377,0.00041571085,0.00028142272,0.00021370673],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016377571,0.0003309047,0.00081234524,0.00027644297,0.00009474953,0.000028013796,0.00014363506,0.00022407799,0.000062799176],"category_scores_gemma":[0.000084954954,0.00030648158,0.00018898539,0.0003655413,0.00006250286,0.00016762334,0.00002717813,0.00018700672,0.0000319003],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004299287,0.005580021,0.8874806,0.003281879,0.00022712332,0.000098973294,0.0032271645,0.000602119,0.088516824,0.000026002288,0.00030098695,0.0063589867],"study_design_scores_gemma":[0.04185391,0.002275584,0.36845168,0.0016245592,0.00046281365,0.000043234148,0.0031585274,0.016557181,0.5637149,0.000039403716,0.001328171,0.00049000233],"about_ca_topic_score_codex":0.00015777619,"about_ca_topic_score_gemma":0.0005634003,"teacher_disagreement_score":0.51902896,"about_ca_system_score_codex":0.00018911228,"about_ca_system_score_gemma":0.0001598259,"threshold_uncertainty_score":0.9999387},"labels":[],"label_agreement":null},{"id":"W2983745227","doi":"10.1182/blood-2019-126828","title":"Genetic and Transcript Changesin Cereblon in IMiD-Treated Myeloma Patients","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Cereblon; Pomalidomide; Lenalidomide; Multiple myeloma; Medicine; Oncology; Drug resistance; Cancer research; Internal medicine; Immunology; Biology; Genetics; Gene; Ubiquitin ligase; Ubiquitin","score_opus":0.014272729494892281,"score_gpt":0.24782498572619427,"score_spread":0.233552256231302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983745227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99675786,0.00056170905,5.031212e-7,0.00010615129,0.000029491712,0.0008124212,0.000017692031,0.00002741424,0.0016867326],"genre_scores_gemma":[0.99896556,0.000121344834,0.00021761947,0.00006201039,0.00002569149,0.000033833454,0.000047915866,0.000021114161,0.00050492707],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99902284,0.00003773371,0.00014365416,0.0002651218,0.0002199173,0.00031071826],"domain_scores_gemma":[0.99954426,0.000021774342,0.000022454338,0.00020247734,0.0000385978,0.00017040718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000040074403,0.00013127958,0.00022398055,0.00015304961,0.000021448077,0.0000121993635,0.000043256478,0.000072023424,0.00017406174],"category_scores_gemma":[0.000020430276,0.00010605458,0.000036026315,0.00015356141,0.0000248911,0.000040049,0.000019717596,0.00009826506,0.000116501746],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001865039,0.0010048288,0.9806347,0.00008855754,0.00007683567,0.00012588772,0.00017524723,1.10593476e-7,0.007424796,0.0000025578936,0.000016480879,0.010263518],"study_design_scores_gemma":[0.017150097,0.0007105194,0.9732358,0.00008241969,0.000067574925,0.00002147599,0.000021694628,0.00006006256,0.008395327,0.000008560349,0.00015666102,0.00008979557],"about_ca_topic_score_codex":0.00024731384,"about_ca_topic_score_gemma":0.00010189856,"teacher_disagreement_score":0.016963592,"about_ca_system_score_codex":0.000027427417,"about_ca_system_score_gemma":0.000024361358,"threshold_uncertainty_score":0.432478},"labels":[],"label_agreement":null},{"id":"W2983767987","doi":"10.1182/blood-2019-122685","title":"Evaluating Luspatercept Responders in the Phase 3, Randomized, Double-Blind, Placebo-Controlled BELIEVE Trial of Luspatercept in Adult Beta-Thalassemia Patients (Pts) Who Require Regular Red Blood Cell (RBC) Transfusions","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Thalassemia; Beta thalassemia; Discontinuation; Randomization; Anemia; Ineffective erythropoiesis; Placebo; Population; Internal medicine; Erythropoiesis; Gastroenterology; Surgery; Randomized controlled trial; Pathology","score_opus":0.021623281680541354,"score_gpt":0.305271933119544,"score_spread":0.28364865143900264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983767987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97690356,0.0003302129,0.000010177034,0.0011508262,0.0003308896,0.016006945,0.000025752834,0.000047318874,0.0051943045],"genre_scores_gemma":[0.9970152,0.0005249038,0.00017531164,0.0002502165,0.000093625364,0.00073352386,0.00011970407,0.000081377504,0.0010061428],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99318576,0.0017899949,0.0021764436,0.0008049415,0.0012662174,0.0007766196],"domain_scores_gemma":[0.99707824,0.0008233019,0.0006211653,0.000978521,0.0003163498,0.00018241994],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0042258054,0.0005632893,0.002336706,0.00064027414,0.00012580256,0.000041695803,0.00043674617,0.00067228364,0.00033200774],"category_scores_gemma":[0.0006236344,0.00037270552,0.0007948089,0.00087969453,0.00019747122,0.00021366762,0.00006946138,0.00096398726,0.000029173985],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9636716,0.009059348,0.0014560422,0.00026784083,0.0004538561,0.00006652754,0.010356498,0.00018215073,0.013672618,0.000031503594,0.00006721011,0.0007147571],"study_design_scores_gemma":[0.983085,0.0039533284,0.00012397845,0.0008700197,0.002482608,0.000015531763,0.0031792826,0.0013596773,0.004461806,0.00005573356,0.00002951885,0.0003835204],"about_ca_topic_score_codex":0.00040589366,"about_ca_topic_score_gemma":0.00011805724,"teacher_disagreement_score":0.02011162,"about_ca_system_score_codex":0.0000723145,"about_ca_system_score_gemma":0.0003376109,"threshold_uncertainty_score":0.9998725},"labels":[],"label_agreement":null},{"id":"W2983793192","doi":"10.1182/blood.v110.11.925.925","title":"RGD-Substituted High Molecular Weight Hyper-Branched Polyglycerols (HPG) Are Effective Platelet Inhibitors.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Dendrimers and Hyperbranched Polymers","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services","funders":"","keywords":"Fibrinogen; Chemistry; Peptide; Conjugate; Platelet; Biochemistry; Stereochemistry; Immunology; Medicine","score_opus":0.004291383309493148,"score_gpt":0.20910348993509814,"score_spread":0.204812106625605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983793192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912856,0.0019211645,0.0003704057,0.00013435043,0.0016330907,0.00053584646,0.000055072393,0.00026782963,0.0037966105],"genre_scores_gemma":[0.9978397,0.000012088788,0.0010961724,0.00033745216,0.00044934353,0.00004158978,0.00002552542,0.00006402461,0.0001340909],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974371,0.00009146189,0.00044695628,0.0006678784,0.00051784667,0.0008387118],"domain_scores_gemma":[0.9987157,0.00012561555,0.00022239207,0.00053952483,0.00008753731,0.00030920422],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048597064,0.00039335398,0.0005349199,0.00017866811,0.0002168587,0.00011199424,0.0003909157,0.00026744697,0.00056313333],"category_scores_gemma":[0.00007064364,0.00036122833,0.0001767951,0.00040330066,0.00020126057,0.00026876412,0.00010651729,0.0002599046,0.00077541627],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015028202,0.00040458204,0.0014672187,0.000032604174,0.00007416532,0.00040974244,0.00024861112,0.0000105745785,0.99508685,0.0006495133,0.00027558752,0.0011902637],"study_design_scores_gemma":[0.0036956805,0.00011153634,0.0075031975,0.000068258014,0.00013435334,0.00008294105,0.00005279651,0.0000026918062,0.9845673,0.00014776854,0.0031678178,0.00046568745],"about_ca_topic_score_codex":0.00022855702,"about_ca_topic_score_gemma":0.000054274744,"teacher_disagreement_score":0.010519584,"about_ca_system_score_codex":0.000047746464,"about_ca_system_score_gemma":0.000054764136,"threshold_uncertainty_score":0.99988395},"labels":[],"label_agreement":null},{"id":"W2983803118","doi":"10.1182/blood-2019-128302","title":"Impact of Tisagenlecleucel Chimeric Antigen Receptor (CAR)-T Cell Therapy Product Attributes on Clinical Outcomes in Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (r/r DLBCL)","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont; Hamilton Health Sciences","funders":"","keywords":"Chimeric antigen receptor; Diffuse large B-cell lymphoma; Medicine; Refractory (planetary science); Lymphoma; Cytokine release syndrome; Internal medicine; Oncology; Cancer research; Immunotherapy; Immunology; Biology; Cancer","score_opus":0.03243113997427867,"score_gpt":0.3346661829572612,"score_spread":0.30223504298298254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983803118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949114,0.0008364272,8.4313666e-7,0.000112246045,0.00018089771,0.0023686648,0.00011135964,0.00008333188,0.0013948699],"genre_scores_gemma":[0.9874618,0.002709386,0.00025726575,0.00015186402,0.00019480744,0.000047242058,0.00011305684,0.0001427334,0.008921841],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961808,0.00038847458,0.0008604352,0.00089840527,0.0008470252,0.00082491484],"domain_scores_gemma":[0.99705464,0.0006165986,0.00036573884,0.0014396247,0.00020749841,0.00031590278],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00089947175,0.00047584152,0.0012702959,0.00033904397,0.00004791197,0.00002180389,0.00037239128,0.00022613876,0.0019511477],"category_scores_gemma":[0.0002187583,0.00029240994,0.00046518398,0.00071082485,0.000131575,0.00011629824,0.00007891185,0.0005735128,0.00029318492],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015791975,0.054387517,0.7921435,0.00014219232,0.00043414306,0.00009260342,0.00043869516,6.203477e-7,0.13152227,6.806186e-7,0.0004533818,0.004592382],"study_design_scores_gemma":[0.13743486,0.018692918,0.76900697,0.0002580939,0.00006005897,0.000019482635,0.00010795891,0.000011412686,0.07234976,0.0000014086124,0.0016958266,0.0003612342],"about_ca_topic_score_codex":0.000317724,"about_ca_topic_score_gemma":0.00004275383,"teacher_disagreement_score":0.12164288,"about_ca_system_score_codex":0.00014686202,"about_ca_system_score_gemma":0.0007245301,"threshold_uncertainty_score":0.9999528},"labels":[],"label_agreement":null},{"id":"W2983814742","doi":"10.1182/blood-2019-127593","title":"Mutations and Copy Number Gains of the BCL2 Family Members Mediate Resistance to Venetoclax in Multiple Myeloma (MM) Patients","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Venetoclax; Carfilzomib; Bortezomib; Cancer research; Biology; Multiple myeloma; Somatic evolution in cancer; Oncology; Internal medicine; Medicine; Immunology; Leukemia; Cancer; Chronic lymphocytic leukemia","score_opus":0.019343761079217137,"score_gpt":0.285565816716774,"score_spread":0.26622205563755685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983814742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99475116,0.0000853979,0.0000011883112,0.0001449111,0.0000630216,0.001096288,0.00007903995,0.0000115358,0.003767459],"genre_scores_gemma":[0.9981712,0.000024607974,0.0006590572,0.00012277094,0.000015643718,0.000063616004,0.00003431231,0.000017277149,0.0008915282],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988782,0.00006061788,0.00021701641,0.00022500643,0.00036628067,0.00025289206],"domain_scores_gemma":[0.99922514,0.00015198877,0.000058797785,0.0003128892,0.000096085736,0.00015507745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009387207,0.00011226008,0.00021630546,0.00006939023,0.00004354351,0.000007856853,0.00009250871,0.00005191283,0.000052333267],"category_scores_gemma":[0.00027701873,0.00008026214,0.00004742992,0.00027809647,0.000060019738,0.000044697063,0.00006648894,0.00010832406,0.000074348914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021921637,0.0003414814,0.9954203,0.00007155011,0.00006950662,0.000013479668,0.00053697923,0.000010496575,0.0027303374,0.000019883151,0.00016308221,0.00040369297],"study_design_scores_gemma":[0.009317543,0.00011905271,0.981253,0.00015981632,0.000039756454,0.0000016831708,0.00012636614,0.000062846055,0.008220614,0.000031244013,0.00059465726,0.00007337708],"about_ca_topic_score_codex":0.00023287052,"about_ca_topic_score_gemma":0.000701719,"teacher_disagreement_score":0.014167251,"about_ca_system_score_codex":0.00007138125,"about_ca_system_score_gemma":0.00011993079,"threshold_uncertainty_score":0.3272995},"labels":[],"label_agreement":null},{"id":"W2983824567","doi":"10.1182/blood-2019-125648","title":"The Identification of Novel Epigenetic Therapies for ALK-Driven Haematological Malignancies","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Anaplastic lymphoma kinase; Romidepsin; Anaplastic large-cell lymphoma; Cancer research; Context (archaeology); Brentuximab vedotin; Medicine; ALK inhibitor; Mitoxantrone; Panobinostat; Crizotinib; Lymphoma; Biology; Oncology; Internal medicine; Chemotherapy; Lung cancer; CD30","score_opus":0.02101724006020656,"score_gpt":0.3118811343708165,"score_spread":0.29086389431060994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983824567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99504215,0.0016950761,0.0010692328,0.0008813576,0.00009778737,0.0007254993,0.000023644387,0.000015469033,0.00044977514],"genre_scores_gemma":[0.99720025,0.00011019596,0.00119912,0.000043935455,0.000021856371,0.000113892245,0.000015643102,0.000006376762,0.0012887033],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9995787,0.000006047029,0.00016374269,0.00009124981,0.0000786626,0.00008160615],"domain_scores_gemma":[0.9995644,0.00009069185,0.000079163634,0.00016784125,0.000081492486,0.000016384107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000058549995,0.0000472076,0.000108531225,0.000014860738,0.00005558401,0.000009194273,0.00004717006,0.000026503849,0.000010388566],"category_scores_gemma":[0.000030468133,0.000026127775,0.000056465215,0.00004145339,0.000040638908,0.000016539234,0.000007345857,0.000017550186,0.0000089346195],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016576903,0.0027947552,0.16304533,0.00038406564,0.0015987906,0.0000034689442,0.0029015017,0.000055861216,0.78681886,0.035891082,0.0005930285,0.0057474845],"study_design_scores_gemma":[0.019107105,0.0015918962,0.5375322,0.00023975989,0.0023547236,0.000098606935,0.0024172622,0.00076897955,0.40502647,0.002500892,0.028083779,0.00027830456],"about_ca_topic_score_codex":0.0000058845376,"about_ca_topic_score_gemma":0.000004276572,"teacher_disagreement_score":0.3817924,"about_ca_system_score_codex":0.000007371646,"about_ca_system_score_gemma":0.000040456503,"threshold_uncertainty_score":0.10654597},"labels":[],"label_agreement":null},{"id":"W2983883026","doi":"10.1182/blood-2019-122919","title":"Systematic Literature Review of the Economic Burden and Cost of Illness in Patients with Myelofibrosis","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Myelofibrosis; MEDLINE; Systematic review; EconLit; Family medicine; Internal medicine; Bone marrow","score_opus":0.0033529788702524902,"score_gpt":0.20625138231941714,"score_spread":0.20289840344916465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983883026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982535,0.014765182,8.659694e-8,0.00013492895,0.000026917765,0.002115173,0.000033920413,0.0000016987966,0.00038709794],"genre_scores_gemma":[0.99550664,0.0041821683,0.00003978724,0.0000764666,0.000009822636,0.000087798035,0.000011998064,0.000007692698,0.00007761649],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99936974,0.000049945713,0.00027446836,0.0001232782,0.000113241265,0.00006933654],"domain_scores_gemma":[0.99942005,0.000062969906,0.00017083946,0.00025372973,0.000065791544,0.00002664124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000088830406,0.00009385189,0.00049652276,0.0000328561,0.000009866222,0.0000045476563,0.00004297479,0.00003124022,0.00003810635],"category_scores_gemma":[0.000028343089,0.000046105393,0.000042600313,0.00008911804,0.000022418191,0.00003084478,0.000022539985,0.000046818346,0.000005700516],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000362541,0.00019437283,0.881827,0.117143534,0.00014650391,0.0000013041789,0.00035396105,0.0000011989328,0.00002382483,0.00011800417,0.00001834821,0.00013571649],"study_design_scores_gemma":[0.0051244805,0.00045541683,0.6483331,0.34276986,0.00045801594,0.00000960839,0.00003783382,0.0000048964403,0.0026966033,0.0000029436944,0.000033214954,0.000074069925],"about_ca_topic_score_codex":0.000014180322,"about_ca_topic_score_gemma":0.000009955302,"teacher_disagreement_score":0.23349391,"about_ca_system_score_codex":0.000023564438,"about_ca_system_score_gemma":0.000036851357,"threshold_uncertainty_score":0.18801235},"labels":[],"label_agreement":null},{"id":"W2983925590","doi":"10.1182/blood-2019-124989","title":"Allogeneic Hematopoietic Stem Cell Transplant Versus Gene Therapy in Sickle Cell Disease: A Systematic Review","year":2019,"lang":"en","type":"review","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Hematopoietic stem cell transplantation; Internal medicine; Hematology; Transplantation; Graft-versus-host disease; Regimen; Stem cell; Disease; Clinical trial; Oncology; Immunology; Biology","score_opus":0.030068532734041024,"score_gpt":0.2759730859637762,"score_spread":0.24590455322973515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983925590","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014689131,0.9898759,0.0000020060193,0.000046921174,0.00031005737,0.008506305,0.000092572875,0.000076208926,0.00094312936],"genre_scores_gemma":[0.00018071252,0.9970787,0.0000148183135,0.00021244933,0.00005346823,0.00061734865,0.00031268495,0.00015510787,0.0013747163],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9962509,0.000420758,0.0015142615,0.000720347,0.00051343563,0.00058025384],"domain_scores_gemma":[0.9976328,0.00020263193,0.0005271614,0.0012397544,0.000047611567,0.00035002377],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042134582,0.0007699498,0.004883742,0.00021382234,0.000043307457,0.000021298627,0.00038961772,0.00049351715,0.00012075264],"category_scores_gemma":[0.000012359424,0.0005236862,0.0012845455,0.00053572713,0.000041675896,0.00003115584,0.00003687361,0.00065868185,0.0007058878],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039537776,0.0010784874,0.0000040267064,0.9928564,0.00043989287,0.0006496451,0.00010343124,4.3535786e-7,0.0000043347295,0.0000037977356,0.00010785797,0.0047121625],"study_design_scores_gemma":[0.006049901,0.00037601925,6.590389e-7,0.89593905,0.028702999,0.00021391324,0.000043823627,0.0000015718265,0.000019310173,7.9265124e-7,0.06797866,0.0006732847],"about_ca_topic_score_codex":0.0000065456834,"about_ca_topic_score_gemma":0.0000012514706,"teacher_disagreement_score":0.09691732,"about_ca_system_score_codex":0.00009301255,"about_ca_system_score_gemma":0.00073889754,"threshold_uncertainty_score":0.99972147},"labels":[],"label_agreement":null},{"id":"W2983942326","doi":"10.1182/blood-2019-128886","title":"Uncertainty in the R2 Calibration Curve for High Iron Concentration","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Liver biopsy; Calibration; Biopsy; Reproducibility; Statistics; Calibration curve; Nuclear medicine; Medicine; Mathematics; Computer science; Radiology","score_opus":0.011868501061535744,"score_gpt":0.2511233617161732,"score_spread":0.23925486065463747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983942326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968121,0.00016730078,0.000012144622,0.0014402432,0.00005937938,0.0010368453,0.000023465624,0.000010282439,0.00043825305],"genre_scores_gemma":[0.99881464,0.000025644924,0.000043132794,0.0005542246,0.00007755022,0.00014064585,0.0002862918,0.0000045909605,0.000053269614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99960744,0.000025077208,0.000084542546,0.00010521711,0.00009413034,0.00008358521],"domain_scores_gemma":[0.9997362,0.00007548471,0.000025573629,0.00012027234,0.000019631416,0.000022873128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006413472,0.000050692568,0.00007842858,0.000010103553,0.00001839185,0.000013214055,0.000026238258,0.000026264017,0.000053644282],"category_scores_gemma":[0.000013800667,0.000030978852,0.000033461503,0.000041570973,0.000007416447,0.00004663236,0.0000033521171,0.000025715646,0.000015180381],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020098571,0.003276607,0.97556025,0.00013587793,0.000098920085,0.00001818155,0.0010950193,0.00012938229,0.001205598,0.015675386,0.0013265414,0.0012772362],"study_design_scores_gemma":[0.015490067,0.00095144124,0.9713838,0.0000921558,0.0005016779,0.000004691572,0.0003719744,0.0013333888,0.008062325,0.00076471275,0.00092866283,0.000115079405],"about_ca_topic_score_codex":0.00011781405,"about_ca_topic_score_gemma":0.000025960606,"teacher_disagreement_score":0.015289081,"about_ca_system_score_codex":0.000020660078,"about_ca_system_score_gemma":0.0000378504,"threshold_uncertainty_score":0.1263281},"labels":[],"label_agreement":null},{"id":"W2983947844","doi":"10.1182/blood-2019-123210","title":"Patients Experience of Living with Cancer Associated Thrombosis in France (LE PELICAN)","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer; Thrombosis; Family medicine; Nonprobability sampling; Health care; Surgery; Population; Internal medicine","score_opus":0.007992610379710845,"score_gpt":0.24594008896110583,"score_spread":0.23794747858139498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983947844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99577135,0.00015407473,0.000002016536,0.000092009825,0.000062009356,0.00041231862,0.0000053131866,0.00001879091,0.0034820957],"genre_scores_gemma":[0.99919254,0.000143475,0.00008130929,0.0002547797,0.0000130921335,0.00008023967,0.0000026692187,0.000015842274,0.00021606236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99917287,0.000018605513,0.00017562092,0.00020027434,0.0002400058,0.0001926271],"domain_scores_gemma":[0.99952525,0.000049276267,0.00010568562,0.00020054055,0.00007781202,0.00004140888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007030364,0.00009313226,0.0003545055,0.00005736329,0.00001831375,0.000005225525,0.00007761188,0.000038828413,0.00025789515],"category_scores_gemma":[0.0000690257,0.0000767329,0.000032873475,0.00022780197,0.000029595552,0.00006659635,0.000041638363,0.00006954683,0.000009831946],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000029699825,0.0028446324,0.99305207,0.00007138897,0.000088806526,0.0000012888632,0.0025551303,0.000013198902,0.0010333031,0.000044241835,0.00009976156,0.00019322653],"study_design_scores_gemma":[0.0016078628,0.00030765994,0.9938543,0.0011851869,0.0000737001,1.4614581e-7,0.00045506004,0.000017667784,0.0022769207,0.000001964059,0.00012814639,0.00009143064],"about_ca_topic_score_codex":0.002135252,"about_ca_topic_score_gemma":0.000256319,"teacher_disagreement_score":0.0034211592,"about_ca_system_score_codex":0.00002678054,"about_ca_system_score_gemma":0.00005336726,"threshold_uncertainty_score":0.32278767},"labels":[],"label_agreement":null},{"id":"W2983957075","doi":"10.1182/blood-2019-129663","title":"Clostridium Difficile Infection Among Hematopoietic Stem Cell Transplant Recipients and Subsequent Development of Graft-Versus-Host Disease","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Clostridium difficile; Hematopoietic stem cell transplantation; Transplantation; Pseudomembranous colitis; Graft-versus-host disease; Gastroenterology; Surgery; Antibiotics","score_opus":0.01930082669080541,"score_gpt":0.25060752533546277,"score_spread":0.23130669864465736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983957075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969768,0.0006169188,0.000014100209,0.000065643966,0.00026434314,0.00094556727,0.000048298953,0.0000660406,0.0010022817],"genre_scores_gemma":[0.99864775,0.0003670283,0.000058114616,0.000010372012,0.00006724451,0.0000483296,0.00008340099,0.000043775355,0.0006739959],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976703,0.000056246918,0.0005608135,0.000515246,0.0007148737,0.00048249762],"domain_scores_gemma":[0.99868464,0.00009626787,0.00014188798,0.0004567814,0.00013934521,0.00048106673],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002295061,0.00029457881,0.0004685282,0.00022484116,0.00010301077,0.000027781009,0.00011077102,0.00013756649,0.00018445739],"category_scores_gemma":[0.000016083533,0.0002647861,0.00014933464,0.0003269887,0.00010654106,0.000082426486,0.00009027334,0.00029229154,0.00009064917],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002623178,0.0044223526,0.637718,0.0021906416,0.00036458558,0.00016323302,0.0020694367,0.000009399827,0.34901685,0.000055235752,0.000095546005,0.0012715202],"study_design_scores_gemma":[0.008404616,0.00056748907,0.17594633,0.00047323568,0.0003974453,0.000019028592,0.0001806204,0.000055763412,0.8132597,0.000002047468,0.00039700032,0.00029671876],"about_ca_topic_score_codex":0.000062690546,"about_ca_topic_score_gemma":0.000025696798,"teacher_disagreement_score":0.46424285,"about_ca_system_score_codex":0.00011565395,"about_ca_system_score_gemma":0.0003423036,"threshold_uncertainty_score":0.99998045},"labels":[],"label_agreement":null},{"id":"W2983965569","doi":"10.1182/blood-2019-126232","title":"Identifying Patterns of Inappropriate Plasma Transfusion Practices Using a Novel Multicenter Electronic Data Audit: Over 80 Percent of Plasma Transfused Is Inappropriate","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Ottawa Hospital; Mount Sinai Hospital; Health Sciences Centre; Ontario Stroke Network; Sunnybrook Health Science Centre; London Health Sciences Centre; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Audit; Emergency medicine; Dosing; Blood transfusion; Fresh frozen plasma; Adverse effect; Intensive care medicine; Pediatrics; Internal medicine; Platelet","score_opus":0.05187746397454662,"score_gpt":0.309382226009115,"score_spread":0.2575047620345684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983965569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933341,0.00013924808,0.0032290474,0.00036437085,0.0003138827,0.002042038,0.0001893467,0.000058819584,0.0003291404],"genre_scores_gemma":[0.9951383,0.0013460912,0.0028938076,0.00017179275,0.00007202569,0.000016254657,0.00010488447,0.000077094584,0.00017973401],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966778,0.00009749968,0.000901349,0.0008699885,0.00087284244,0.0005805055],"domain_scores_gemma":[0.9976975,0.00007788174,0.0006548081,0.0012766722,0.0001497598,0.00014342001],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006902315,0.00037782546,0.00078257656,0.00031421144,0.00007127059,0.000033373602,0.00050600705,0.00020549107,0.00082645146],"category_scores_gemma":[0.000049793256,0.00033578853,0.00023506251,0.00032452567,0.000055069988,0.00049460446,0.00018362036,0.0004952418,0.000018362887],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001822814,0.006706832,0.04700384,0.0036988216,0.0015893973,0.000020582036,0.0051525515,0.00002548887,0.93127537,0.00018779465,0.000017702903,0.002498834],"study_design_scores_gemma":[0.11383915,0.002554843,0.10008805,0.004214284,0.011115698,0.00022043142,0.005371094,0.036749065,0.7179573,0.000033806293,0.006493851,0.0013624042],"about_ca_topic_score_codex":0.0013776079,"about_ca_topic_score_gemma":0.00041336688,"teacher_disagreement_score":0.21331804,"about_ca_system_score_codex":0.00005581895,"about_ca_system_score_gemma":0.00021488416,"threshold_uncertainty_score":0.9999094},"labels":[],"label_agreement":null},{"id":"W2983968100","doi":"10.1182/blood-2019-130591","title":"Physicians' and Patients' Perspectives on Treatments in ITP - a Multi-Country Perspective: Results from the ITP World Impact Survey (I-WISh)","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Wish; Perspective (graphical); Medicine; Sociology; Computer science","score_opus":0.012448420597998085,"score_gpt":0.27894991507563344,"score_spread":0.2665014944776353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983968100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99372536,0.0011538392,2.6715412e-7,0.00020708592,0.00006461059,0.0009012879,0.0012219705,0.000029144121,0.0026964638],"genre_scores_gemma":[0.99837285,0.00016061545,0.000042123138,0.00017911145,0.000043621443,0.000020244672,0.00041793406,0.000032329706,0.0007311494],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985095,0.00012783153,0.0002099346,0.00057759206,0.00025938297,0.00031576073],"domain_scores_gemma":[0.99892765,0.00037497422,0.000106380394,0.00042213203,0.000090757785,0.00007810266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012550039,0.00028764035,0.00043881155,0.0001085788,0.000074136056,0.000039163137,0.00008832417,0.000071513205,0.000039468283],"category_scores_gemma":[0.00019410577,0.00017983979,0.000096162745,0.0003323665,0.000065474276,0.00010856068,0.000034057393,0.0002207158,0.000078555284],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014939468,0.008273618,0.98120594,0.000003884284,0.0007998221,0.00008625477,0.007021029,0.0000030367087,0.0001142854,0.000022048882,0.00022637956,0.00074977265],"study_design_scores_gemma":[0.03320635,0.00079154444,0.961945,0.00014415452,0.00018988726,0.0000031152742,0.003287297,0.00003274414,0.00015281,0.000046161833,0.000037188995,0.00016371923],"about_ca_topic_score_codex":0.0152883725,"about_ca_topic_score_gemma":0.0032695634,"teacher_disagreement_score":0.031712405,"about_ca_system_score_codex":0.0002073954,"about_ca_system_score_gemma":0.000055045035,"threshold_uncertainty_score":0.99126893},"labels":[],"label_agreement":null},{"id":"W2983969540","doi":"10.1182/blood-2019-122580","title":"Impact of Neurocognitive Dysfunction in a Veteran Population Undergoing First Outpatient Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Multiple myeloma; Autologous stem-cell transplantation; Transplantation; Population; Hematopoietic stem cell transplantation; Internal medicine; Cohort; Depression (economics); Physical therapy","score_opus":0.01386143966150334,"score_gpt":0.25727639805820157,"score_spread":0.24341495839669824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983969540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996838,0.00007145895,0.0005088139,0.000045753175,0.00015012239,0.0021196576,0.000059492755,0.000043330787,0.00016340421],"genre_scores_gemma":[0.99948937,0.000044317767,0.00007926195,0.000023997538,0.000027339467,0.00012565142,0.00013079614,0.000025605274,0.000053672426],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898577,0.00003914288,0.00034807436,0.00025568565,0.00016232219,0.00020901999],"domain_scores_gemma":[0.9991933,0.00036433584,0.0001783671,0.0001013672,0.000121425415,0.000041193114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007848863,0.00015938208,0.00031986076,0.00019332144,0.00004706583,0.0000060723005,0.000025736495,0.00008467103,0.00001432799],"category_scores_gemma":[0.00003956336,0.0001333585,0.00014935361,0.0001746434,0.0000176978,0.00009599986,0.000009167948,0.000106691106,0.000009336374],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002117891,0.0009897085,0.9843105,0.0013372939,0.00016583876,0.000012240963,0.0038556086,0.00039963,0.0044151563,0.0000027596504,0.000007921204,0.002385417],"study_design_scores_gemma":[0.016751628,0.0042604883,0.9700087,0.0006721653,0.00040897797,0.00003948061,0.00055134826,0.0009815634,0.006168685,0.00001929877,0.0000020742764,0.00013559844],"about_ca_topic_score_codex":0.00015248488,"about_ca_topic_score_gemma":0.00021674712,"teacher_disagreement_score":0.0146337375,"about_ca_system_score_codex":0.0001338533,"about_ca_system_score_gemma":0.000051542094,"threshold_uncertainty_score":0.54382014},"labels":[],"label_agreement":null},{"id":"W2983971836","doi":"10.1182/blood-2019-129115","title":"Rare Germline Mutations in Complement Regulatory Genes Make the Antiphospholipid Syndrome Catastrophic","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Complement system; Antiphospholipid syndrome; Catastrophic antiphospholipid syndrome; Immunology; Alternative complement pathway; Atypical hemolytic uremic syndrome; Eculizumab; Complement membrane attack complex; Medicine; Lectin pathway; Antibody; Biology","score_opus":0.02060873571660707,"score_gpt":0.28122850089930085,"score_spread":0.2606197651826938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983971836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99526024,0.0017239284,0.0000060900643,0.00096986495,0.00014689732,0.0012488675,0.00004375741,0.00004313975,0.0005572119],"genre_scores_gemma":[0.99790996,0.00004583296,0.00023895543,0.0000878723,0.000087439104,0.00008645036,0.00010660914,0.000032961496,0.0014039145],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983433,0.00009155946,0.00038113233,0.00028668295,0.00053139176,0.00036592086],"domain_scores_gemma":[0.9988553,0.000107172404,0.00007676203,0.00077380973,0.000091653535,0.00009533168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003782762,0.00014250386,0.00032446586,0.00015212115,0.00006221391,0.000019695166,0.00021009492,0.000060468785,0.00042513153],"category_scores_gemma":[0.00004272089,0.00009841056,0.00007887159,0.0003327683,0.00007793894,0.000032832642,0.00010316383,0.00021547955,0.0004231491],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000400301,0.0004235857,0.9854645,0.00047492536,0.000116087496,0.0004515477,0.000606851,0.00002106233,0.011435611,0.00028795603,0.00035136822,0.00032644506],"study_design_scores_gemma":[0.018845936,0.0006142747,0.89473855,0.0016015547,0.0002649792,0.061768487,0.003269764,0.00054966606,0.0105992695,0.00013411864,0.0071680495,0.0004453634],"about_ca_topic_score_codex":0.000114087336,"about_ca_topic_score_gemma":0.00007313946,"teacher_disagreement_score":0.090725996,"about_ca_system_score_codex":0.00006980289,"about_ca_system_score_gemma":0.000178363,"threshold_uncertainty_score":0.54388666},"labels":[],"label_agreement":null},{"id":"W2983973124","doi":"10.1182/blood-2019-125265","title":"Augmenting the Patient Experience: Therapeutic Arts Interventions for Patients Undergoing Chemotherapy/Infusion","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Art Therapy and Mental Health","field":"Arts and Humanities","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Painting; Psychological intervention; Medicine; Modalities; Patient experience; Psychology; Health care; Nursing; Visual arts; Art","score_opus":0.04532898358198985,"score_gpt":0.2913432986791575,"score_spread":0.24601431509716765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983973124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99091357,0.00033109038,0.00004972034,0.0002361692,0.00080538023,0.001024172,0.000012052312,0.00004737657,0.0065804515],"genre_scores_gemma":[0.99614424,0.000052608237,0.000046120902,0.0011721529,0.00015106416,0.00013026339,0.00002096173,0.000021010332,0.002261562],"study_design_codex":"qualitative","study_design_gemma":"not_applicable","domain_scores_codex":[0.99915737,0.00002928626,0.0002526101,0.00017192721,0.00014589184,0.0002429184],"domain_scores_gemma":[0.9995058,0.00009806769,0.00012846138,0.00018254748,0.000050602208,0.00003451429],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00010884768,0.00011506415,0.00011417702,0.000032893506,0.0006616186,0.00008506178,0.000122020414,0.00002380072,0.0010823235],"category_scores_gemma":[0.0000052785354,0.000076416116,0.0001601994,0.00002114252,0.00005786982,0.00014729955,0.000035412984,0.00006514452,0.000056273162],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036261923,0.0074743493,0.034995332,0.0010100456,0.0004681521,9.4703944e-7,0.58903146,0.000009776797,0.0013096718,0.17438893,0.0019318672,0.18901688],"study_design_scores_gemma":[0.016467959,0.007417365,0.0071100863,0.0017393428,0.00021407809,0.000004383314,0.092518,0.00025572113,0.007948039,0.009282662,0.8559623,0.001080076],"about_ca_topic_score_codex":0.0000219746,"about_ca_topic_score_gemma":0.00011943726,"teacher_disagreement_score":0.85403043,"about_ca_system_score_codex":0.000024192064,"about_ca_system_score_gemma":0.000018369217,"threshold_uncertainty_score":0.99983084},"labels":[],"label_agreement":null},{"id":"W2983979814","doi":"10.1182/blood-2019-123652","title":"Dynamics of Activated CD8+ T-cells and Decreased Osteoclasts in the Tumor Microenvironment are Associated with Clinical Efficacy of Anti-PD-L1 and Anti-CD38 Combination Treatment in Relapsed or Refractory Multiple Myeloma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada)","funders":"","keywords":"CD8; Cytotoxic T cell; CD38; Tumor microenvironment; Bone marrow; Daratumumab; Cancer research; Medicine; T cell; Internal medicine; Immunology; Multiple myeloma; Immune system; Oncology; Biology; CD34; Bortezomib; Stem cell; In vitro","score_opus":0.019420840708481643,"score_gpt":0.28026496286632224,"score_spread":0.2608441221578406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983979814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978531,0.00007894924,4.934472e-7,0.0001309331,0.00001481208,0.0018006674,0.00008315531,0.000009717858,0.000028186667],"genre_scores_gemma":[0.99940246,0.00019200884,0.00012255796,0.000020625434,0.000005215148,0.000023546907,0.00015864662,0.00002326817,0.00005164279],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982212,0.00035071015,0.0004901884,0.00035077747,0.00032449106,0.00026263052],"domain_scores_gemma":[0.9980367,0.0011544036,0.00032918472,0.00031848825,0.00004636555,0.000114850416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003598117,0.00021013367,0.0006540331,0.0001689334,0.000027866812,0.000009059764,0.00007393904,0.00011557981,0.0000125945],"category_scores_gemma":[0.00036751406,0.00012558962,0.00005631724,0.00023628192,0.0001651553,0.000048503025,0.0000373799,0.00019914542,0.0000021230737],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024402847,0.012187752,0.9159784,0.000086009284,0.00028549283,0.00021760243,0.00026187138,0.0000040469295,0.0676771,0.0000015001659,0.0000016884909,0.00085826707],"study_design_scores_gemma":[0.064100415,0.003409574,0.900018,0.000487387,0.000160663,0.000019256979,0.00041583428,0.00075434474,0.030530103,0.0000016924496,0.000003246438,0.000099518475],"about_ca_topic_score_codex":0.0002558218,"about_ca_topic_score_gemma":0.0006415478,"teacher_disagreement_score":0.061660126,"about_ca_system_score_codex":0.0001383036,"about_ca_system_score_gemma":0.00011589786,"threshold_uncertainty_score":0.5121396},"labels":[],"label_agreement":null},{"id":"W2984003257","doi":"10.1182/blood-2019-123124","title":"Narratives of Patients with Fatal Outcomes During the Phase 2 TITAN and Phase 3 HERCULES Studies","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Internal medicine; Rituximab; Gastroenterology; Cyclophosphamide; Placebo; Surgery; Chemotherapy; Pathology; Lymphoma","score_opus":0.014144100571240409,"score_gpt":0.28604684897716254,"score_spread":0.2719027484059221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984003257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961127,0.0030638676,6.236577e-7,0.000047494774,0.000093900824,0.00038882336,0.00018953413,0.000015545214,0.000087526634],"genre_scores_gemma":[0.999601,0.000009200212,0.000012771457,0.000010483061,0.0000050771114,0.00001791462,0.000034355744,0.000006468768,0.00030269398],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99946725,0.00007868511,0.00015892518,0.00014074429,0.00003330477,0.00012107702],"domain_scores_gemma":[0.9995688,0.000081338374,0.00010016895,0.00018744364,0.000053904463,0.000008328345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000047234305,0.00010588146,0.00022118253,0.000030088855,0.0000969275,0.0000052232763,0.00009261994,0.000021847633,0.00018184062],"category_scores_gemma":[0.000024525878,0.000057345416,0.000031259457,0.000034593366,0.00015783605,0.000057700487,0.00007503846,0.000044557455,0.000024927167],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024199541,0.0015438639,0.96249956,0.000119987,0.0012579244,0.0000015142488,0.0031105364,2.2567869e-7,0.030896328,0.00010725771,0.000088387234,0.00013239705],"study_design_scores_gemma":[0.051469788,0.0015299307,0.8805979,0.00016569975,0.00028877435,0.0000101946,0.019184375,1.6752539e-7,0.045371544,0.00005737619,0.0010504304,0.0002738175],"about_ca_topic_score_codex":0.000004099383,"about_ca_topic_score_gemma":0.0000115263665,"teacher_disagreement_score":0.081901684,"about_ca_system_score_codex":0.0000052925625,"about_ca_system_score_gemma":0.000009403717,"threshold_uncertainty_score":0.23384781},"labels":[],"label_agreement":null},{"id":"W2984022819","doi":"10.1182/blood-2019-122751","title":"Potential and Realized Cost Savings with the Use of the Biosimilar Grastofil Vs Neupogen","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of Saskatchewan","funders":"","keywords":"Biosimilar; Filgrastim; Drug Utilization Review; Medicine; Reimbursement; Business; Health care; Drug; Pharmacology; Neutropenia; Economics; Internal medicine; Economic growth","score_opus":0.01717087098169331,"score_gpt":0.22453129569567026,"score_spread":0.20736042471397695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984022819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946693,0.00049892196,0.000049822236,0.0039128643,0.00016840138,0.00040583636,0.00006374572,0.000015848815,0.00021525196],"genre_scores_gemma":[0.9963343,0.000076219854,0.0005410016,0.0013664841,0.00001496389,0.000005879901,0.000004679789,0.000011216868,0.0016452351],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99920565,0.00023193184,0.00013864727,0.00018908587,0.000040205072,0.00019447732],"domain_scores_gemma":[0.99933904,0.00015137575,0.00009696151,0.00035101656,0.000046306533,0.000015273306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018992151,0.00011698353,0.00020626195,0.00002055822,0.00010866181,0.000017469942,0.00020021247,0.00015113177,0.00016931178],"category_scores_gemma":[0.000040346942,0.000050121864,0.00007441988,0.000120829915,0.00042027017,0.000036206737,0.0001288864,0.00019336028,0.000009109951],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065061136,0.00033847024,0.05264307,0.000038587532,0.0006911445,0.0000041376124,0.00017311516,0.0000026492712,0.93348515,0.0009809171,0.0076894048,0.0033027327],"study_design_scores_gemma":[0.0077302256,0.00085657556,0.22049057,0.0001056797,0.0014257819,0.00030670644,0.00017089641,0.000027206279,0.516034,0.00014996497,0.25231028,0.00039208587],"about_ca_topic_score_codex":0.000066263055,"about_ca_topic_score_gemma":0.000023138035,"teacher_disagreement_score":0.4174511,"about_ca_system_score_codex":0.000002963201,"about_ca_system_score_gemma":0.00002287083,"threshold_uncertainty_score":0.20439103},"labels":[],"label_agreement":null},{"id":"W2984023454","doi":"10.1182/blood-2019-131018","title":"Sirpαfc Treatment Targets Human Acute Myeloid Leukemia Stem Cells","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Trillium Therapeutics (Canada); Hospital for Sick Children; Princess Margaret Cancer Centre","funders":"","keywords":"CD47; Leukemia; Myeloid leukemia; Immunology; Cancer research; Myeloid; Stem cell; Cancer; Haematopoiesis; Biology; Medicine; Immune system; Internal medicine; Cell biology","score_opus":0.010870567476421867,"score_gpt":0.2235741118755954,"score_spread":0.21270354439917352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984023454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99258226,0.0030176973,0.000006088516,0.000029594412,0.00050152134,0.0003105753,0.00002651998,0.000078500794,0.0034472505],"genre_scores_gemma":[0.96999747,0.00014276027,0.000021267366,0.000040018364,0.00003311217,0.000020096615,0.0001325393,0.000019409452,0.029593341],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990895,0.00007578423,0.00022597997,0.00027871112,0.000027928676,0.0003020902],"domain_scores_gemma":[0.99945474,0.000025470792,0.00010471027,0.0003705335,0.00002661933,0.000017941897],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00006569653,0.00018601355,0.00028558035,0.00005841752,0.00014373218,0.000015811933,0.00014453992,0.00019317183,0.00061656913],"category_scores_gemma":[6.614091e-7,0.00015065978,0.00012989163,0.000057783334,0.000042066025,0.00008797087,0.000047172267,0.000097827826,0.0029219142],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002374457,0.00027394117,0.0016464856,0.0000064117125,0.00050420477,0.0000032259777,0.00025345336,0.0000049993155,0.9940666,0.00025564554,0.00051527313,0.002446007],"study_design_scores_gemma":[0.0038645007,0.00053585897,0.0073013757,0.00001362855,0.00018515528,0.00002625783,0.000052248215,0.0000018732273,0.943187,0.000027377899,0.04463152,0.00017322844],"about_ca_topic_score_codex":0.00005860597,"about_ca_topic_score_gemma":0.0000055842725,"teacher_disagreement_score":0.05087963,"about_ca_system_score_codex":0.00010179757,"about_ca_system_score_gemma":0.000051415343,"threshold_uncertainty_score":0.9978544},"labels":[],"label_agreement":null},{"id":"W2984034670","doi":"10.1182/blood-2019-122284","title":"IPO11 Is Upregulated in Relapsed AML and Supports Survival of Leukemic Stem Cells","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Myeloid leukemia; Downregulation and upregulation; CD34; Cancer research; Biology; Myeloid; Gene; Leukemia; Stem cell; CRISPR; Immunology; Genetics","score_opus":0.012393534658543051,"score_gpt":0.2503106831305267,"score_spread":0.23791714847198364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984034670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99537545,0.00027744134,0.0000013222186,0.00020877096,0.00007843714,0.00056740467,0.00001639788,0.000030727566,0.0034440588],"genre_scores_gemma":[0.99129164,0.00009211208,0.00012222561,0.000088346096,0.000032255142,0.0000060380557,0.000011625671,0.00003327597,0.008322491],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998536,0.000071156675,0.00034897964,0.00033298886,0.0003700489,0.00034085626],"domain_scores_gemma":[0.999117,0.000109874454,0.0000829617,0.0004670484,0.00008298804,0.0001401222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039653294,0.00014638029,0.0004495371,0.00019235819,0.00001326554,0.000007705102,0.00011157644,0.00017634784,0.00038790627],"category_scores_gemma":[0.000017958706,0.00012959549,0.000057212856,0.00030918402,0.000077366254,0.000046643778,0.00010346435,0.0003130617,0.00010160311],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033918087,0.00037708992,0.2988123,0.0004510876,0.00014701742,0.00022285036,0.000993577,0.0000040614277,0.6959018,0.000046824458,0.0013823365,0.0013218748],"study_design_scores_gemma":[0.022366608,0.00078135036,0.19819617,0.0003452113,0.000167191,0.00015432575,0.00045288805,0.00064580113,0.7754668,0.00005192208,0.0010961979,0.00027554118],"about_ca_topic_score_codex":0.000209763,"about_ca_topic_score_gemma":0.000010989412,"teacher_disagreement_score":0.100616135,"about_ca_system_score_codex":0.00009384974,"about_ca_system_score_gemma":0.0003311692,"threshold_uncertainty_score":0.52847505},"labels":[],"label_agreement":null},{"id":"W2984052520","doi":"10.1182/blood-2019-121750","title":"Cold Agglutinin Disease Shows Highly Recurrent Gains of Chromosome 3, 12 and 18","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Biology; Molecular biology; Exome sequencing; Exome; Chromosome; Copy-number variation; Genetics; Gene; Mutation","score_opus":0.018052920730352025,"score_gpt":0.25023663184823486,"score_spread":0.23218371111788283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984052520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99437517,0.001995389,0.0000039409397,0.00032675496,0.000140549,0.00044235564,0.000053721003,0.000032672753,0.0026294691],"genre_scores_gemma":[0.9986596,0.00028870115,0.0001303187,0.00014506018,0.00010528361,0.000009577329,0.000022977803,0.000017381399,0.0006210959],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99919873,0.000018696348,0.00018910109,0.00022534558,0.00019972933,0.0001684083],"domain_scores_gemma":[0.9994074,0.000030347772,0.000049734474,0.0002626916,0.00003540453,0.00021438561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008137769,0.000113873975,0.00026150182,0.000052202562,0.000024287974,0.0000060766965,0.000046712878,0.000054794727,0.0002356866],"category_scores_gemma":[0.000017059234,0.00009313787,0.00007128993,0.00007576924,0.000042735584,0.000039111605,0.000030081868,0.000109360124,0.000026157966],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071811787,0.005361552,0.70479196,0.0015710556,0.000320374,0.00017099097,0.00048328162,9.4874173e-7,0.2769028,0.0035943426,0.0010215212,0.005063061],"study_design_scores_gemma":[0.029738804,0.0033296398,0.85010684,0.0014875124,0.0021081143,0.00007511098,0.0001045157,0.0001583724,0.09422687,0.00019199232,0.017953863,0.0005183941],"about_ca_topic_score_codex":0.000016646065,"about_ca_topic_score_gemma":0.0000103988,"teacher_disagreement_score":0.18267591,"about_ca_system_score_codex":0.000005548943,"about_ca_system_score_gemma":0.000053728167,"threshold_uncertainty_score":0.3798052},"labels":[],"label_agreement":null},{"id":"W2984054442","doi":"10.1182/blood-2019-131394","title":"Durable Remission and Long-Term Survival in Relapsed/Refractory (r/r) AML Patients Treated with Guadecitabine, Median Survival Not Reached for Responders after Long Term Follow up from Phase 2 Study of 103 Patients","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Internal medicine; Regimen; Medicine; Gastroenterology; Population; Neutropenia; Phases of clinical research; Median follow-up; Surgery; Chemotherapy","score_opus":0.019917274655099692,"score_gpt":0.2872504440037494,"score_spread":0.2673331693486497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984054442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99535745,0.00006187418,0.000004225096,0.000057214344,0.00021921916,0.0039218487,0.0002334744,0.000043617216,0.00010106958],"genre_scores_gemma":[0.9976888,0.000026904343,0.00009482057,0.000031729447,0.00006948831,0.00016285872,0.00095746724,0.000117357704,0.0008505872],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961803,0.0003372911,0.0007743853,0.00091474043,0.0011403692,0.00065289927],"domain_scores_gemma":[0.99747896,0.000530466,0.00030374652,0.0008698542,0.00042085856,0.0003960918],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00055213645,0.00044759075,0.0009843743,0.00047958276,0.00006598673,0.00003117745,0.0002514598,0.0002927551,0.00014225663],"category_scores_gemma":[0.0004995527,0.0003475713,0.00010159316,0.0004456417,0.00010486312,0.00023679524,0.00014362807,0.00050142227,0.000010084197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035111304,0.009355767,0.94230556,0.00019106889,0.0003917507,0.00018091415,0.001994408,2.739403e-7,0.008400841,1.6900151e-7,0.00003247626,0.0020354583],"study_design_scores_gemma":[0.15185294,0.007895166,0.833968,0.00041932997,0.00037302088,0.0000019462434,0.00040698724,0.00001615404,0.004756726,0.00000149529,0.0000071929326,0.000301093],"about_ca_topic_score_codex":0.00057737785,"about_ca_topic_score_gemma":0.0008384554,"teacher_disagreement_score":0.11674163,"about_ca_system_score_codex":0.00027624995,"about_ca_system_score_gemma":0.00025430816,"threshold_uncertainty_score":0.9998976},"labels":[],"label_agreement":null},{"id":"W2984110345","doi":"10.1182/blood-2019-122072","title":"Rate of Sickle Hemoglobin Recovery in Sickle Cell Disease Patients Undergoing Red Blood Cell (RBC) Exchange Transfusion Is Associated with Age of Patients and Number of RBC Units Transfused","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Exchange transfusion; Hematocrit; Sickle cell anemia; Internal medicine; Hemoglobin; Anemia; Erythropoietin; Hemolysis; Blood transfusion; Gastroenterology; Disease","score_opus":0.005519454940457911,"score_gpt":0.18843782372090345,"score_spread":0.18291836878044554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984110345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955484,0.00028319962,0.0000036639879,0.000044826556,0.00006591251,0.0012101984,0.00028001543,0.000021429665,0.00254231],"genre_scores_gemma":[0.9980507,0.00093746284,0.000052152533,0.00008575096,0.0000054235584,0.000009521286,0.00028254217,0.000054285043,0.0005221811],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99811774,0.00015218723,0.0006335403,0.00038206344,0.0003807751,0.0003336833],"domain_scores_gemma":[0.99878275,0.00013989359,0.00033342993,0.00030071547,0.00026524672,0.00017795761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001874366,0.00027779094,0.00070027064,0.00016679667,0.000032544645,0.0000054118323,0.00009496825,0.000228262,0.00016475437],"category_scores_gemma":[0.00006725117,0.0002374193,0.00011253741,0.00067247084,0.00009830398,0.000116654686,0.000028556336,0.00022186417,0.000003274924],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019251504,0.009804056,0.9604735,0.0025751933,0.00022840666,0.00003770878,0.0031366686,0.00002597477,0.021500794,0.0000024518793,0.000057232963,0.00023285992],"study_design_scores_gemma":[0.15852906,0.0064084935,0.6037458,0.0038952073,0.0027417722,0.0000024487208,0.0013760981,0.00009962766,0.22217643,0.000100113844,0.0000804217,0.0008445037],"about_ca_topic_score_codex":0.00024227952,"about_ca_topic_score_gemma":0.00010776861,"teacher_disagreement_score":0.3567277,"about_ca_system_score_codex":0.000027615342,"about_ca_system_score_gemma":0.0001805335,"threshold_uncertainty_score":0.96816784},"labels":[],"label_agreement":null},{"id":"W2984122717","doi":"10.1182/blood-2019-123520","title":"Study Design of an Open-Label, Single-Arm, Multicenter, Phase 2 Study to Evaluate the Safety and Efficacy of Defibrotide in Adult Patients with Transplant-Associated Thrombotic Microangiopathy","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Defibrotide; Medicine; Thrombotic microangiopathy; Internal medicine; Calcineurin; Hepatic veno-occlusive disease; Eculizumab; Transplantation; Gastroenterology; Phases of clinical research; Surgery; Hematopoietic stem cell transplantation; Complement system; Immunology; Clinical trial; Immune system; Disease","score_opus":0.03255554137823226,"score_gpt":0.29480561128740146,"score_spread":0.2622500699091692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984122717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907008,0.0001176769,0.000012145687,0.0000067095325,0.00007613692,0.008855548,0.00020356555,0.000015905325,0.00001155535],"genre_scores_gemma":[0.999756,0.0000019704682,0.000059493053,0.000016634142,0.000001800206,0.000057987712,0.00007474093,0.000022009568,0.0000093964445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971073,0.0015187747,0.00060609606,0.0003900819,0.000108169275,0.00026956547],"domain_scores_gemma":[0.99872524,0.00037644032,0.00022049784,0.0004720946,0.0001758292,0.000029931709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006501631,0.00021503611,0.00056734035,0.00010028323,0.000075664044,0.000016643131,0.00047842404,0.000038781764,0.000046015248],"category_scores_gemma":[0.000096167125,0.00014757375,0.000021020574,0.0002049754,0.000059854643,0.000095606745,0.00015398742,0.000092583614,0.000012732344],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0086867465,0.18753012,0.7259588,0.000036570254,0.000803943,0.0000057238894,0.008942943,0.000046901903,0.06775513,0.0000024196722,0.0000052477353,0.00022541564],"study_design_scores_gemma":[0.15292618,0.04426152,0.790552,0.00031177312,0.0008836367,0.0000025846311,0.0039036619,0.000007356468,0.006953172,0.000001184212,7.142289e-7,0.00019617692],"about_ca_topic_score_codex":0.00034154137,"about_ca_topic_score_gemma":0.000450503,"teacher_disagreement_score":0.14423943,"about_ca_system_score_codex":0.00002462718,"about_ca_system_score_gemma":0.00004240735,"threshold_uncertainty_score":0.6017883},"labels":[],"label_agreement":null},{"id":"W2984163037","doi":"10.1182/blood-2019-123449","title":"Polatuzumab Vedotin Plus Bendamustine with Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Updated Results of a Phase Ib/II Randomized Study","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Jewish General Hospital; Spinal Cord Injury BC","funders":"","keywords":"Bendamustine; Rituximab; Medicine; Internal medicine; Refractory (planetary science); Phases of clinical research; Oncology; Diffuse large B-cell lymphoma; Lymphoma; Clinical trial","score_opus":0.014116232482786045,"score_gpt":0.3040344386412057,"score_spread":0.2899182061584197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984163037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897529,0.0009658763,0.000006666386,0.00018474125,0.00012557583,0.004465839,0.0001775993,0.00010356024,0.0042172787],"genre_scores_gemma":[0.99639463,0.00006360952,0.0002950473,0.00008089028,0.00009938108,0.00015562064,0.00017890311,0.000102953934,0.0026289492],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9955451,0.0005718496,0.0011502295,0.0008012601,0.0011513089,0.0007802471],"domain_scores_gemma":[0.99730814,0.00046538355,0.0003870318,0.0012381654,0.0003056113,0.0002956721],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001957974,0.00040711014,0.0018373735,0.0005509393,0.00007801807,0.00002107344,0.00035132043,0.00020906825,0.00022382473],"category_scores_gemma":[0.0006757367,0.00030994075,0.00017585163,0.00092153257,0.00016462318,0.00009935851,0.00023963708,0.00062093505,0.00010389948],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.616103,0.34822497,0.0075993137,0.0006097293,0.0007999713,0.0015637169,0.008365246,0.0000070779047,0.014954546,0.000029018269,0.0010288602,0.00071453926],"study_design_scores_gemma":[0.97990686,0.006986747,0.0013909767,0.00040430028,0.0005443062,0.000044376997,0.001248464,0.00074184587,0.0067547862,0.000005573764,0.0016608421,0.00031090758],"about_ca_topic_score_codex":0.0010554497,"about_ca_topic_score_gemma":0.00031873363,"teacher_disagreement_score":0.36380386,"about_ca_system_score_codex":0.00028940284,"about_ca_system_score_gemma":0.0011952156,"threshold_uncertainty_score":0.99993527},"labels":[],"label_agreement":null},{"id":"W2984163765","doi":"10.1182/blood-2019-130428","title":"High Residual Allelic Burden Increases Leukemic Transformation Irrespective of Clinical Response in Patients with Lower Risk Myelodysplastic Syndrome Treated with Azacitidine","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Azacitidine; Internal medicine; International Prognostic Scoring System; Cumulative incidence; Myelodysplastic syndromes; Medicine; Proportional hazards model; Hazard ratio; Oncology; Decitabine; Lower risk; Bone marrow; Cohort; Biology; Gene; Genetics; Confidence interval; DNA methylation","score_opus":0.009027896857375478,"score_gpt":0.26179176225880574,"score_spread":0.25276386540143025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984163765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99782574,0.000029587187,0.000014935108,0.00012496802,0.000024555635,0.0015842908,0.00012881962,0.000059550905,0.0002075417],"genre_scores_gemma":[0.99888486,0.00004301118,0.00045062124,0.000024052282,0.000050697276,0.00004375364,0.00016772705,0.000057330097,0.00027795826],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99692553,0.00058624335,0.00072684785,0.00049072556,0.0008396229,0.00043103454],"domain_scores_gemma":[0.99765337,0.00094818795,0.000283489,0.00053283304,0.0003688937,0.00021322115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009695045,0.0002904844,0.0008669316,0.00048289084,0.000041042316,0.00001331931,0.00017284665,0.00021524912,0.00017304662],"category_scores_gemma":[0.0006691663,0.0002009426,0.00008079435,0.00066336186,0.00021167651,0.00022443627,0.000039578037,0.00068589806,0.000084546744],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12817836,0.0022632827,0.8672178,0.00011951732,0.00058548525,0.00038644098,0.00034158022,0.00019991715,0.00045554028,0.000014308434,0.00003695839,0.00020084626],"study_design_scores_gemma":[0.054127768,0.021177571,0.9220497,0.00056052976,0.00044016624,0.0001193443,0.00017317389,0.00014800005,0.00095395924,0.0000071257546,0.00002106383,0.00022160751],"about_ca_topic_score_codex":0.0013634912,"about_ca_topic_score_gemma":0.00007830949,"teacher_disagreement_score":0.07405059,"about_ca_system_score_codex":0.0002538383,"about_ca_system_score_gemma":0.00080152304,"threshold_uncertainty_score":0.8194201},"labels":[],"label_agreement":null},{"id":"W2984169696","doi":"10.1182/blood-2019-126288","title":"Barriers to Care Amongst Patients with Inherited Bleeding Disorders: Results from Two Nation-Wide Canadian Surveys","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; North York General Hospital; St. Michael's Hospital; Canadian Hemophilia Society; University of Toronto","funders":"","keywords":"Medicine; Family medicine; Health care; Socioeconomic status; Population; Immigration; Environmental health","score_opus":0.011722553754192611,"score_gpt":0.24617440715692496,"score_spread":0.23445185340273234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984169696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910587,0.00004532678,0.0000011073723,0.0011342192,0.000106323016,0.00091815984,0.00035762947,0.000035618745,0.006342933],"genre_scores_gemma":[0.9976877,0.0000067476503,0.00018428593,0.0001607407,0.00008302158,0.000017044937,0.0011440215,0.000030052735,0.0006864091],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986815,0.00007054879,0.00015829343,0.0003324344,0.000389297,0.00036791168],"domain_scores_gemma":[0.9985005,0.00011946627,0.000029648625,0.00028462277,0.00023350836,0.00083224184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016029799,0.00014094959,0.00018819593,0.00021701689,0.0001342002,0.000034992092,0.00009542851,0.00007129427,0.00020665745],"category_scores_gemma":[0.00043533611,0.000106808184,0.000035472123,0.00037109296,0.000026550302,0.000076486496,0.000024451218,0.00014264655,0.000159154],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000105012194,0.0000573762,0.99630284,0.000011839387,0.00013384235,0.000018656112,0.0017995551,0.000008169401,0.00006939406,0.0000013905471,0.00023072901,0.0012611968],"study_design_scores_gemma":[0.012811498,0.0004741798,0.98269194,0.00014709144,0.00007640494,3.0934797e-7,0.0012369903,0.000017174712,0.0004996556,0.0000044469753,0.001882794,0.00015752361],"about_ca_topic_score_codex":0.20334095,"about_ca_topic_score_gemma":0.339338,"teacher_disagreement_score":0.13599704,"about_ca_system_score_codex":0.00014695011,"about_ca_system_score_gemma":0.0004551625,"threshold_uncertainty_score":0.80196404},"labels":[],"label_agreement":null},{"id":"W2984217605","doi":"10.1182/blood-2019-131243","title":"Altered Genomic and Epigenetic Profiling of Myeloma Bone Marrow Stromal Cells Identifies Targets for Current and Future Immunotherapeutic Approaches","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Bone marrow; Epigenetics; Stromal cell; Multiple myeloma; Biology; Cancer research; Gene; Immunology; Genetics","score_opus":0.03152449185201439,"score_gpt":0.2724274557066791,"score_spread":0.2409029638546647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984217605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9632644,0.034920774,0.000030117288,0.00007383685,0.0001241937,0.001466818,0.00006302031,0.0000132073155,0.000043619646],"genre_scores_gemma":[0.9951839,0.0010779576,0.003278634,0.0000065333916,0.00016763617,0.000074610536,0.000058810554,0.000026220563,0.00012573332],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990221,0.00003204306,0.00022108795,0.00029128132,0.00015725209,0.00027620696],"domain_scores_gemma":[0.999501,0.000050486604,0.00008192998,0.00021894653,0.000043035383,0.00010461711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012453517,0.00015503979,0.0003248373,0.000089588946,0.000049813,0.000022743077,0.00005041871,0.000057370416,0.000021676506],"category_scores_gemma":[0.0000075340718,0.0001247495,0.00006585015,0.000044409564,0.00006585932,0.00004168998,0.000048022204,0.00009152318,0.000005055173],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005410874,0.00062464474,0.101296045,0.0015959978,0.0004772145,0.0000066792268,0.00036756205,5.7071736e-7,0.85976326,0.00005306289,0.0000067625897,0.035267126],"study_design_scores_gemma":[0.014740802,0.0010942534,0.45667264,0.00012760003,0.00038942072,0.000050742183,0.00038556475,0.0005501921,0.5252052,0.00012698004,0.00046309707,0.00019351802],"about_ca_topic_score_codex":0.0000071219656,"about_ca_topic_score_gemma":0.0000024786068,"teacher_disagreement_score":0.35537657,"about_ca_system_score_codex":0.000012621059,"about_ca_system_score_gemma":0.00005093357,"threshold_uncertainty_score":0.50871366},"labels":[],"label_agreement":null},{"id":"W2984252518","doi":"10.1182/blood-2019-122521","title":"Take Control. Period. - Needs Assessment Leading to the Development of a Digital Quality Improvement Intervention Designed to Enhance Adherence to Tranexamic Acid and Iron Supplementation in Women with Heavy Menstrual Bleeding","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; St. Michael's Hospital; University of Toronto","funders":"","keywords":"Medicine; Tranexamic acid; Outpatient clinic; Pediatrics; Iron-deficiency anemia; Clinical audit; Physical therapy; Anemia; Internal medicine; Audit; Surgery","score_opus":0.016213452274287023,"score_gpt":0.3159375886643092,"score_spread":0.2997241363900222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984252518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99345523,0.000010981128,0.0039813505,0.00040898024,0.000037239737,0.0019812037,0.000022895203,0.00001197508,0.00009016823],"genre_scores_gemma":[0.99452764,9.228995e-7,0.004716156,0.00010954329,0.000013486728,0.00046116282,0.000018081373,0.000012942288,0.00014007947],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987295,0.00002800681,0.00043669913,0.00026177516,0.00027974628,0.00026426703],"domain_scores_gemma":[0.99955857,0.00002208486,0.00009540905,0.00014812188,0.00004830215,0.00012749036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036269825,0.0001575704,0.00030006288,0.00012976093,0.000041363644,0.000052286807,0.000066045955,0.000022886226,0.00004576271],"category_scores_gemma":[0.000011341159,0.0001121734,0.000022087039,0.00020205315,0.000010713937,0.00011603084,0.000048679813,0.000056385747,0.00000778808],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002362181,0.0010959514,0.14064167,0.00029956564,0.00029565155,0.000007009915,0.025376001,0.000020044821,0.7043076,0.000025116167,0.0000053206713,0.12556385],"study_design_scores_gemma":[0.021095311,0.023651872,0.56893176,0.0009979847,0.0001648197,0.0000189955,0.021820333,0.000031057323,0.36271027,0.0000068471886,0.00015183707,0.000418942],"about_ca_topic_score_codex":0.000058533784,"about_ca_topic_score_gemma":0.00021486805,"teacher_disagreement_score":0.42829007,"about_ca_system_score_codex":0.00021801233,"about_ca_system_score_gemma":0.000068360576,"threshold_uncertainty_score":0.45742986},"labels":[],"label_agreement":null},{"id":"W2984292213","doi":"10.1182/blood-2019-127148","title":"BIM Regulation Is BTK Dependent and Can be Targeted By Entospletinib in Ibrutinib Refractory Mutants","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Ibrutinib; Bruton's tyrosine kinase; IGHV@; Phosphorylation; breakpoint cluster region; Cancer research; Chronic lymphocytic leukemia; Biology; Leukemia; Signal transduction; Cell biology; Immunology; Tyrosine kinase; Receptor; Biochemistry","score_opus":0.012174466878156345,"score_gpt":0.2676658743114875,"score_spread":0.25549140743333115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984292213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955765,0.00082585885,0.0000018808464,0.0008291489,0.00007331463,0.0006327036,0.0000545928,0.000039548722,0.0019664753],"genre_scores_gemma":[0.9957165,0.00016916801,0.000109229855,0.0004650329,0.000068938185,0.00001746322,0.00009661447,0.00003276087,0.0033242975],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99821615,0.00006374564,0.00030168585,0.000427043,0.0005824282,0.00040895105],"domain_scores_gemma":[0.9991285,0.00010814882,0.00007707287,0.0004352067,0.000062403305,0.00018865908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003201785,0.0001582726,0.00028916026,0.00014302578,0.000030664316,0.00002309989,0.0000986594,0.00017168399,0.00080174505],"category_scores_gemma":[0.00014330127,0.00014584279,0.000037350736,0.00022029055,0.000057210073,0.00006747129,0.00008798873,0.00024028846,0.00007327586],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014454017,0.003834102,0.30812,0.0011479382,0.00051328336,0.00071639573,0.0056109144,0.000005545925,0.6544543,0.0002236703,0.015280519,0.008647919],"study_design_scores_gemma":[0.21189095,0.0013722988,0.17918307,0.0006770662,0.0002952728,0.0007666871,0.0009231997,0.003658108,0.5601414,0.00023451632,0.039951924,0.00090549974],"about_ca_topic_score_codex":0.0012909523,"about_ca_topic_score_gemma":0.00015271638,"teacher_disagreement_score":0.21044555,"about_ca_system_score_codex":0.0015105943,"about_ca_system_score_gemma":0.0016269987,"threshold_uncertainty_score":0.8778546},"labels":[],"label_agreement":null},{"id":"W2984313633","doi":"10.1182/blood-2019-126746","title":"Lentiviral Gene Therapy with Low Dose Busulfan for Infants with X-SCID Results in the Development of a Functional Normal Immune System: Interim Results of an Ongoing Phase I/II Clinical Study","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Busulfan; Medicine; Genetic enhancement; Severe combined immunodeficiency; Adverse effect; Bone marrow; Internal medicine; Hematopoietic stem cell transplantation; Viral vector; Gastroenterology; Transplantation; Surgery; Oncology; Immunology; Biology; In vivo","score_opus":0.036863699801998766,"score_gpt":0.3412326804800742,"score_spread":0.30436898067807544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984313633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99794877,0.0001273854,0.000080736114,0.000017255577,0.00004664965,0.0015810138,0.00009666628,0.0000063892385,0.000095142546],"genre_scores_gemma":[0.9985967,0.000010909686,0.0008405186,0.000016634334,0.00008160734,0.00011498519,0.00026386423,0.000025945506,0.000048825244],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99776906,0.00030441882,0.0008130201,0.0004607927,0.00037898167,0.00027372796],"domain_scores_gemma":[0.99868405,0.00005673339,0.00032000255,0.0006642646,0.000226769,0.000048163878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023956017,0.00018816121,0.00031980308,0.0000859808,0.0000822196,0.000015888894,0.00037944972,0.00009041845,0.0000022915478],"category_scores_gemma":[0.00003951885,0.000118418386,0.000064430526,0.00018935424,0.00009832199,0.000012681331,0.00008902688,0.00013521995,9.1560656e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19483079,0.0097907055,0.0051438888,0.000058568447,0.0005519527,0.0000075458934,0.0019085975,0.000119729215,0.7804731,0.0000013135515,0.000005966674,0.0071078474],"study_design_scores_gemma":[0.07548948,0.07913845,0.029826054,0.00010415686,0.000030388877,0.000013883751,0.0015750192,0.00006442483,0.81349754,3.991997e-7,0.00006724205,0.00019293853],"about_ca_topic_score_codex":0.000029095387,"about_ca_topic_score_gemma":0.00071181793,"teacher_disagreement_score":0.11934132,"about_ca_system_score_codex":0.00001110638,"about_ca_system_score_gemma":0.0004486579,"threshold_uncertainty_score":0.48289615},"labels":[],"label_agreement":null},{"id":"W2984313796","doi":"10.1182/blood-2019-130670","title":"Sex Differences in Faculty Rank and Leadership Positions Amongst Hematologists and Oncologists in United States: A Cross-Sectional Study","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Diversity and Career in Medicine","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Medicine; Confidence interval; Family medicine; Logistic regression; Univariate analysis; Scopus; Demographics; Demography; Internal medicine; MEDLINE; Multivariate analysis","score_opus":0.1276423756008817,"score_gpt":0.3453626110027054,"score_spread":0.21772023540182367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984313796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99790716,0.000096070034,0.000001309178,0.0004757097,0.00006332034,0.00034834025,0.00002163987,0.000025211117,0.0010612205],"genre_scores_gemma":[0.99920446,0.000043051263,0.00001090538,0.00014376783,0.00001807003,0.000010030732,0.000027102355,0.0000020480938,0.00054058194],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989192,0.00020034234,0.00014017208,0.00021722159,0.00031565913,0.00020743386],"domain_scores_gemma":[0.99958235,0.0002126355,0.000039795068,0.00005787355,0.000040409454,0.000066938774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007699414,0.00007529562,0.00017217905,0.00014117493,0.0001640422,0.00010800863,0.00014438095,0.00009608271,0.000047995556],"category_scores_gemma":[0.00011717339,0.0000677137,0.000012736166,0.00032505512,0.00049808994,0.00012555667,0.0000576651,0.00016682189,0.0000054571515],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018490246,0.00045108754,0.97483236,0.000018474146,0.0000136953795,0.00003608028,0.024349287,0.0000034015686,0.0000038061185,0.00022224705,0.00002241538,0.000028680717],"study_design_scores_gemma":[0.0022079672,0.00017814914,0.8598855,0.000025758176,0.000010239541,0.0000028852683,0.13734262,0.000011807352,0.0000034867157,0.00020869885,0.00005019545,0.00007267066],"about_ca_topic_score_codex":0.008466876,"about_ca_topic_score_gemma":0.017165653,"teacher_disagreement_score":0.11494682,"about_ca_system_score_codex":0.000033772903,"about_ca_system_score_gemma":0.000043782788,"threshold_uncertainty_score":0.9981358},"labels":[],"label_agreement":null},{"id":"W2984415114","doi":"10.1182/blood-2019-123207","title":"Immediate and Long-Term Outcomes Following Orthopedic Procedures in Patients with Hemophilia: A Three-Decade Retrospective Review","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton; University of Calgary; University of Alberta","funders":"","keywords":"Medicine; Orthopedic surgery; Retrospective cohort study; Perioperative; Interquartile range; Surgery; Haemophilia","score_opus":0.012568373602923809,"score_gpt":0.28463828864308705,"score_spread":0.27206991504016326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984415114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98934114,0.007240007,2.4291256e-7,0.00085644587,0.000044926554,0.002077241,0.000004601729,0.00003434843,0.00040106953],"genre_scores_gemma":[0.99764144,0.0013227706,0.00005293156,0.00024821455,0.000030479503,0.00006489554,0.000027954915,0.00003155872,0.0005797727],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847674,0.000025961033,0.00023476714,0.0003924204,0.000521169,0.00034893464],"domain_scores_gemma":[0.99939525,0.0000429985,0.000058611906,0.00027883306,0.00007163749,0.00015265534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018420679,0.00019963329,0.0005787816,0.00012912517,0.0000394586,0.000013796327,0.000069818045,0.00008191138,0.0000493031],"category_scores_gemma":[0.00015832948,0.00012398542,0.000090403126,0.0002904321,0.000044206983,0.0001091614,0.000060822542,0.00025666895,0.000045732064],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076109005,0.0006700969,0.9964514,0.0013356154,0.00023302593,0.00016778687,0.00006320074,1.7134884e-8,0.000019479074,0.000004614903,0.000012068649,0.00096658774],"study_design_scores_gemma":[0.011158833,0.00079695915,0.9842615,0.00324289,0.00031247895,0.0000091999755,0.000005671656,5.348036e-7,0.00005207918,0.000016256563,0.0000048084767,0.00013876411],"about_ca_topic_score_codex":0.000010299984,"about_ca_topic_score_gemma":0.00007087495,"teacher_disagreement_score":0.0121898735,"about_ca_system_score_codex":0.000049290862,"about_ca_system_score_gemma":0.00012409507,"threshold_uncertainty_score":0.5055979},"labels":[],"label_agreement":null},{"id":"W2984466377","doi":"10.1182/blood-2019-122930","title":"Association of Bleeding Severity with Mortality with in-Hospital and Extended Thromboprophylaxis in the Medically Ill in the Magellan Trial","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Medicine; Rivaroxaban; Placebo; Population; Asymptomatic; Deep vein; Internal medicine; Thrombosis; Surgery; Major bleeding; Randomization; Randomized controlled trial; Warfarin; Myocardial infarction","score_opus":0.007323466586280876,"score_gpt":0.24024172504653715,"score_spread":0.23291825846025627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984466377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923705,0.000054248445,0.0000012291075,0.0018840759,0.000045457626,0.0015010374,0.0000027328272,0.0000062729323,0.0041344394],"genre_scores_gemma":[0.99939924,0.00008052035,0.00007035434,0.00031315815,0.0000553927,0.000051533345,0.000005247541,0.000007793318,0.000016784079],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986911,0.000117863674,0.00024681943,0.00020482102,0.0005511969,0.00018824021],"domain_scores_gemma":[0.99944305,0.00012546172,0.00012800685,0.00023948502,0.000040934032,0.000023050372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013727475,0.00010477242,0.00036635768,0.000063241554,0.000021739275,0.000018722762,0.00011742238,0.0000630798,0.000024351466],"category_scores_gemma":[0.000098376266,0.000052015766,0.000025380241,0.00026923398,0.000047770132,0.00005594311,0.000029217677,0.00022175882,0.0000013694762],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007934222,0.005603593,0.98327625,0.00017890807,0.00020282363,0.00009033173,0.00863092,0.0000022233196,0.00009994166,0.00046308813,0.000120837096,0.0005376927],"study_design_scores_gemma":[0.0249088,0.0026618005,0.96856624,0.00013360786,0.00017023453,0.0000041646404,0.0032281238,0.000014426051,0.00006335521,0.00012822547,0.000045927165,0.000075105396],"about_ca_topic_score_codex":0.0008142848,"about_ca_topic_score_gemma":0.0017455632,"teacher_disagreement_score":0.024115378,"about_ca_system_score_codex":0.000034650104,"about_ca_system_score_gemma":0.000048947815,"threshold_uncertainty_score":0.21211414},"labels":[],"label_agreement":null},{"id":"W2984501600","doi":"10.1182/blood.v104.11.3126.3126","title":"Addition of Rituximab to CHOP Is an Attractive Strategy as Primary Therapy for Diffuse Large B Cell Lymphoma (DLBCL) in Patients Age &amp;lt;60 Years: An Economic Analysis.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; CHOP; Rituximab; Vincristine; Internal medicine; Diffuse large B-cell lymphoma; Oncology; Surgery; Autologous stem-cell transplantation; Prednisone; Chemotherapy; Cyclophosphamide; Lymphoma","score_opus":0.017720453440519014,"score_gpt":0.2756589028839406,"score_spread":0.2579384494434216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984501600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99758625,0.00014015906,0.000009352629,0.000040909825,0.000030735235,0.0009476466,0.0008345342,0.000022448965,0.0003879681],"genre_scores_gemma":[0.99642247,0.000103516504,0.0007991207,0.0005531418,0.00006515296,0.00018574746,0.001812222,0.00002952536,0.000029076282],"study_design_codex":"nonrandomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99876493,0.00003602831,0.00033338254,0.0004230125,0.0001699448,0.00027271252],"domain_scores_gemma":[0.99915963,0.000036644564,0.00014472513,0.0004164696,0.000056531906,0.00018600667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009622233,0.0001950179,0.0005097728,0.00026118744,0.000038519847,0.000025963547,0.00009243304,0.00010822119,0.00009960586],"category_scores_gemma":[0.000007680836,0.00018011384,0.00019150204,0.00018222697,0.000019388752,0.00020495517,0.00001666024,0.000035037352,0.0000507392],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038877348,0.66306037,0.28239822,0.00013480497,0.0037721521,0.00029846784,0.00807419,0.0001353659,0.003128816,0.00030706124,0.0004540389,0.034348786],"study_design_scores_gemma":[0.10882713,0.0029714305,0.8790335,0.00002985292,0.0006554389,0.0000018036293,0.000078586396,0.0000063307302,0.0075176787,0.00018258399,0.00052834675,0.00016732204],"about_ca_topic_score_codex":0.00080768537,"about_ca_topic_score_gemma":0.0007172345,"teacher_disagreement_score":0.66008896,"about_ca_system_score_codex":0.0003560818,"about_ca_system_score_gemma":0.00018764082,"threshold_uncertainty_score":0.73448294},"labels":[],"label_agreement":null},{"id":"W2984521104","doi":"10.1182/blood-2019-126745","title":"Prediction of High-Risk Group of Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients Using a CT-Based Radiomics Model with Machine Learning","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut universitaire en santé mentale de Montréal; Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre; McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Rituximab; Regimen; Vincristine; Internal medicine; Chemotherapy regimen; Univariate analysis; CHOP; Refractory (planetary science); Lymphoma; Surgery; Cyclophosphamide; Oncology; Chemotherapy; Multivariate analysis","score_opus":0.009023547200362659,"score_gpt":0.19034204825056714,"score_spread":0.18131850105020447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984521104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99786204,0.00042827363,0.00068407325,0.000003921492,0.00005125794,0.000522162,0.00025075683,0.000038926602,0.00015858919],"genre_scores_gemma":[0.99642116,0.00012946226,0.0028461784,0.00004138552,0.000020867845,0.000014370498,0.0004408108,0.00004479734,0.00004097615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873954,0.000057035555,0.0003481104,0.00028149228,0.00035935122,0.00021446808],"domain_scores_gemma":[0.9989775,0.00006809268,0.00041569184,0.00034532827,0.00009956201,0.00009381401],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011526577,0.00019869581,0.00048594028,0.00013482147,0.000048765905,0.000005401664,0.000059274087,0.00006875226,0.000008096452],"category_scores_gemma":[0.000018862242,0.00015170671,0.000110029505,0.00013212158,0.000034156983,0.00008346281,0.00003419403,0.00008585052,0.000002335702],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059658755,0.045520753,0.94726354,0.0002942954,0.00025164752,0.000019716816,0.00009880472,0.0018711531,0.0031124977,0.000014074157,0.000005714963,0.0009511969],"study_design_scores_gemma":[0.21725114,0.0039669396,0.56996435,0.0004220951,0.0020105094,0.000020343745,0.000028180282,0.18352346,0.022533042,0.0000048668444,0.00006269467,0.00021239389],"about_ca_topic_score_codex":0.0004530869,"about_ca_topic_score_gemma":0.000007564472,"teacher_disagreement_score":0.37729922,"about_ca_system_score_codex":0.00019062031,"about_ca_system_score_gemma":0.00015325322,"threshold_uncertainty_score":0.61864203},"labels":[],"label_agreement":null},{"id":"W2984527456","doi":"10.1182/blood-2019-123709","title":"Targeted Inhibition of the NUP98-NSD1 Fusion Oncogene in AML","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Cancer research; Suramin; Transplantation; Medicine; Chemistry; Molecular biology; Biology; Internal medicine; Receptor","score_opus":0.010899445987555285,"score_gpt":0.25809169288670486,"score_spread":0.24719224689914956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984527456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912924,0.000167863,0.0000030481758,0.00082883297,0.00006462617,0.0005504944,0.0000068522845,0.000016240958,0.007069614],"genre_scores_gemma":[0.9982677,0.000039449318,0.00020607436,0.00021377105,0.000067926645,0.00001012943,0.000017873755,0.000015053859,0.0011620334],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990699,0.00006226341,0.0001956397,0.0001578313,0.0003288332,0.00018552179],"domain_scores_gemma":[0.99942774,0.000040789808,0.0000561115,0.00035616022,0.000071670336,0.00004751132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023738346,0.00007487923,0.00017809274,0.0001020526,0.000018148867,0.0000033042281,0.000087129214,0.000093095936,0.00034672665],"category_scores_gemma":[0.00010824149,0.0000497411,0.00006341609,0.00038336188,0.000041617823,0.00003724615,0.000107337895,0.00024559489,0.00013930832],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009418498,0.00034462064,0.0808978,0.00007976604,0.000019485518,0.000019941166,0.0001960451,0.0000036039787,0.9172297,0.000087766355,0.00038602328,0.00064104743],"study_design_scores_gemma":[0.006954976,0.0002411716,0.17752299,0.00021948873,0.000038815495,0.000034371715,0.00011724269,0.000146512,0.81338286,0.00012796189,0.0011429,0.00007073284],"about_ca_topic_score_codex":0.00012328521,"about_ca_topic_score_gemma":0.000026424452,"teacher_disagreement_score":0.10384687,"about_ca_system_score_codex":0.000087711014,"about_ca_system_score_gemma":0.00020997626,"threshold_uncertainty_score":0.37964135},"labels":[],"label_agreement":null},{"id":"W2984545918","doi":"10.1182/blood-2019-128604","title":"A Phase 2 Study of MT-3724 to Evaluate Safety, Pharmacodynamics and Efficacy of MT-3724 for the Treatment of Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Immunotoxin; Medicine; Lymphoma; Diffuse large B-cell lymphoma; CD20; Refractory (planetary science); Population; Aggressive lymphoma; Cytotoxic T cell; Internal medicine; Oncology; Cancer research; Immunology; Antibody; Rituximab; Biology; Monoclonal antibody; In vitro","score_opus":0.010439083545571508,"score_gpt":0.26636436619855214,"score_spread":0.25592528265298065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984545918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947936,0.00086781156,0.00009471565,0.000011065598,0.0002499824,0.0032855645,0.0006554551,0.000014499247,0.000027293216],"genre_scores_gemma":[0.99863696,0.0002380155,0.00012715916,0.000023106024,0.000008236846,0.00009222436,0.00008290659,0.000033875327,0.0007575057],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9986697,0.00015433831,0.00048813125,0.0003154802,0.000087619126,0.00028474096],"domain_scores_gemma":[0.9985527,0.00039168578,0.00035888414,0.0005230156,0.00014544693,0.000028288192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002179896,0.00024524427,0.00054843887,0.000095698546,0.000099669414,0.0000047408685,0.00021720011,0.00011430608,0.00010190924],"category_scores_gemma":[0.00003114529,0.0001403754,0.00009811818,0.0001288872,0.00006470495,0.00004749317,0.0000719167,0.000063385036,0.000009847245],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025372248,0.34791937,0.0037482001,0.00011299759,0.002150899,0.0000023861676,0.0073255915,0.000007448885,0.5999615,0.00004558118,0.00003172114,0.013322043],"study_design_scores_gemma":[0.6120481,0.1265405,0.01640413,0.00008607251,0.0023581607,0.000004316391,0.0020739622,0.000088775945,0.23398773,0.0000076137317,0.0060378555,0.00036277424],"about_ca_topic_score_codex":0.000050559272,"about_ca_topic_score_gemma":0.000030443229,"teacher_disagreement_score":0.5866759,"about_ca_system_score_codex":0.00003140495,"about_ca_system_score_gemma":0.00007542975,"threshold_uncertainty_score":0.57243425},"labels":[],"label_agreement":null},{"id":"W2984572074","doi":"10.1182/blood-2019-126119","title":"Survival Pattern Among Venous Thromboembolism (VTE) Patients with Hematologic Malignancy in Alberta, Canada from 2003 to 2015","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Internal medicine; Hematologic malignancy; Malignancy; Hazard ratio; Pulmonary embolism; Proportional hazards model; Cancer; Thrombosis; Gastroenterology; Deep vein; Surgery; Confidence interval","score_opus":0.004258261100498021,"score_gpt":0.1975509697108655,"score_spread":0.1932927086103675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984572074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935871,0.00011246706,0.000009498241,0.00054905715,0.00055127195,0.0016338085,0.00005009816,0.000029351702,0.0034773804],"genre_scores_gemma":[0.99759066,0.000018614819,0.0001141996,0.0015271959,0.00006971613,0.00009086477,0.0001491073,0.00005257178,0.0003870656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979087,0.00005322529,0.0003614967,0.0005561617,0.00054839574,0.0005720349],"domain_scores_gemma":[0.99882984,0.00006171673,0.0001161919,0.0005996816,0.00014141889,0.00025115843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000088251116,0.00030055465,0.0009747582,0.00010236808,0.000042110965,0.000024917526,0.000203718,0.00009743339,0.00050236663],"category_scores_gemma":[0.000047349036,0.00024354555,0.000041480296,0.0003451662,0.000023356479,0.00007993281,0.000111070854,0.00017426709,0.00019691602],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025098956,0.0027058856,0.9908464,0.00007812604,0.00022902337,0.00016431877,0.00043151868,0.000019266132,0.000017648643,0.000062259045,0.005073511,0.00034692432],"study_design_scores_gemma":[0.0044520414,0.0005297291,0.99193496,0.00038079458,0.00023717021,0.0000022687586,0.0001672752,0.0000072088656,0.00030700307,0.000021515143,0.0016383287,0.0003217051],"about_ca_topic_score_codex":0.83861357,"about_ca_topic_score_gemma":0.85861045,"teacher_disagreement_score":0.01999692,"about_ca_system_score_codex":0.00012261943,"about_ca_system_score_gemma":0.00029542728,"threshold_uncertainty_score":0.99314994},"labels":[],"label_agreement":null},{"id":"W2984573171","doi":"10.1182/blood.v128.22.1386.1386","title":"Development of Platforms to Phenotype Variants of Uncertain Significance in VWF","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Von Willebrand disease; Von Willebrand factor; Phage display; Mutant; Peptide library; Genetics; Biology; Molecular biology; Platelet; Point mutation; DNA; Chemistry; Mutation; Gene; Peptide sequence; Antibody; Immunology","score_opus":0.02189263673024712,"score_gpt":0.26285408144977,"score_spread":0.2409614447195229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984573171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99748796,0.000050040806,0.00012973111,0.00007474171,0.000019092364,0.00021669407,0.000008585578,0.0000062139447,0.0020069494],"genre_scores_gemma":[0.9932258,0.000010400052,0.0065407213,0.000035034933,0.0000054951547,0.000014239184,0.0000032228888,0.0000068390004,0.0001582173],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9994021,0.0000027425856,0.00022211685,0.00011680281,0.00012564269,0.00013061186],"domain_scores_gemma":[0.99971914,0.000023712117,0.000051986608,0.00012232165,0.000030609175,0.000052206386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006975476,0.000067244386,0.00022260392,0.000069211346,0.000008477178,7.0532e-7,0.000047145255,0.00003394183,0.00004931711],"category_scores_gemma":[0.000038512528,0.000041031504,0.000019277031,0.00013129301,0.000014996319,0.000024583353,0.000017052727,0.000019810715,0.000023212175],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010456032,0.006608163,0.25891656,0.00028240657,0.00059445965,0.00039927245,0.0037016238,0.000005058242,0.6110442,0.0022778413,0.00011036819,0.11501446],"study_design_scores_gemma":[0.015269559,0.0005653429,0.5948885,0.0007696691,0.000091302514,0.0000145738695,0.00019365315,0.000003081197,0.38613465,0.0009931371,0.00088660873,0.0001899335],"about_ca_topic_score_codex":0.000039228245,"about_ca_topic_score_gemma":0.0001045044,"teacher_disagreement_score":0.33597195,"about_ca_system_score_codex":0.00001874842,"about_ca_system_score_gemma":0.00016077342,"threshold_uncertainty_score":0.16732162},"labels":[],"label_agreement":null},{"id":"W2984618102","doi":"10.1182/blood-2019-122389","title":"Treatment and Outcomes in Heparin-Induced Thrombocytopenia (HIT) in Patients with Neoplasm: A Single Centre Experience","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Cancer; Internal medicine; Thrombosis; Heparin; Retrospective cohort study; Heparin-induced thrombocytopenia; Cancer registry; Surgery","score_opus":0.015891096357539936,"score_gpt":0.24811208335986107,"score_spread":0.23222098700232113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984618102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949387,0.000022387214,2.3360721e-7,0.00022710102,0.000088986584,0.0014231537,0.0000062953404,0.000046187623,0.0032469623],"genre_scores_gemma":[0.9990644,0.000011899676,0.0003119866,0.00011172384,0.000014627066,0.000049585706,0.000019780726,0.000041686635,0.00037429968],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981359,0.000057449233,0.00039048397,0.00062808103,0.00025474594,0.0005333023],"domain_scores_gemma":[0.99907905,0.00007209478,0.00009108169,0.0005079673,0.000046707988,0.00020307972],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000057819452,0.00036046037,0.0009826887,0.00020104382,0.000041295552,0.000042286316,0.00011225284,0.0001479522,0.000109508226],"category_scores_gemma":[0.000033861663,0.00026352494,0.00006027885,0.00033089722,0.000050113045,0.00022405776,0.00008665053,0.00018423644,0.00008825529],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016475559,0.004002456,0.982668,0.000031064374,0.00010115418,0.000054339445,0.0025572954,7.846711e-7,0.009542012,0.000051055842,0.0000011205531,0.00082599994],"study_design_scores_gemma":[0.023222528,0.0017414178,0.9581948,0.00015386124,0.00009882849,0.000014993857,0.00056033203,0.000007796153,0.015577198,0.0000069712746,0.000121666206,0.00029963095],"about_ca_topic_score_codex":0.0006673402,"about_ca_topic_score_gemma":0.0014094814,"teacher_disagreement_score":0.024473187,"about_ca_system_score_codex":0.00021726689,"about_ca_system_score_gemma":0.00011835397,"threshold_uncertainty_score":0.9999817},"labels":[],"label_agreement":null},{"id":"W2984625937","doi":"10.1182/blood-2019-123433","title":"Final Analysis of GOYA: A Randomized, Open-Label, Phase III Study of Obinutuzumab or Rituximab Plus CHOP in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Obinutuzumab; Medicine; Diffuse large B-cell lymphoma; Rituximab; Internal medicine; CHOP; International Prognostic Index; Neutropenia; Gastroenterology; Febrile neutropenia; Oncology; Lymphoma; Surgery; Chemotherapy","score_opus":0.01666141507619155,"score_gpt":0.2813330558796354,"score_spread":0.26467164080344385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984625937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928077,0.00032061027,0.0000021745177,0.000009343643,0.000025521029,0.0062462087,0.00012035163,0.000019558558,0.0004485314],"genre_scores_gemma":[0.9986142,0.00006530819,0.00013810408,0.000041025738,0.000007523012,0.0004011021,0.00018807,0.000031644056,0.0005130277],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99743897,0.0002120368,0.0009080472,0.00053982914,0.0005305123,0.00037060227],"domain_scores_gemma":[0.99807537,0.00024291156,0.00052848435,0.00078445626,0.00022859617,0.00014016936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003169287,0.00034693314,0.0028214778,0.0004597304,0.00003832083,0.00002518552,0.00024776848,0.00009220848,0.00013932769],"category_scores_gemma":[0.000065091444,0.00020947643,0.00016627085,0.0012707585,0.00005333523,0.00011811049,0.00015447757,0.00005988342,0.000014386076],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2354273,0.39948517,0.35562417,0.000117618685,0.006796405,0.00017258356,0.0018835996,0.000008304941,0.000018001778,0.000009800768,0.000022008848,0.0004350437],"study_design_scores_gemma":[0.8963883,0.010477666,0.073482536,0.00022252835,0.01776345,0.0000036132005,0.00036772445,0.0005353724,0.0005517342,7.645072e-7,0.000012817969,0.00019349856],"about_ca_topic_score_codex":0.0025606386,"about_ca_topic_score_gemma":0.00074812124,"teacher_disagreement_score":0.660961,"about_ca_system_score_codex":0.0003160956,"about_ca_system_score_gemma":0.00046323834,"threshold_uncertainty_score":0.8542201},"labels":[],"label_agreement":null},{"id":"W2984633038","doi":"10.1182/blood.v124.21.2757.2757","title":"Low Level Platelet-Activating Antibodies in Patients Suspected of Having Heparin-Induced Thrombocytopenia but Testing Negative in the ”Gold Standard” Functional Test","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Blood Services; McMaster University","funders":"","keywords":"Heparin-induced thrombocytopenia; Platelet factor 4; Heparin; Antibody; Medicine; Platelet activation; Platelet; Immunology; Thrombosis; Internal medicine","score_opus":0.056712576559342656,"score_gpt":0.2732869475242461,"score_spread":0.21657437096490345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984633038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99263024,0.000009287841,0.000023689148,0.00013747058,0.00011776697,0.0008630343,0.000039152677,0.000057300225,0.0061220513],"genre_scores_gemma":[0.9980984,0.00000429666,0.0014890574,0.00012501763,0.00012832279,0.00003888342,0.00004163588,0.000050233255,0.000024173842],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970908,0.00022833087,0.00086900167,0.00054934033,0.00067474693,0.00058777817],"domain_scores_gemma":[0.9968894,0.0017684781,0.00037016746,0.000483513,0.00038482028,0.000103605125],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00081683195,0.00037813862,0.001025049,0.0003077015,0.00016039766,0.00005619123,0.00026603325,0.00019209905,0.00004460491],"category_scores_gemma":[0.0048739184,0.0002979647,0.00010285225,0.0009938835,0.00012834034,0.0002863854,0.00015465505,0.0007122326,0.000012718566],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012551392,0.001548307,0.78779334,0.00011394458,0.000084546584,0.000020767346,0.0012033641,0.000010064753,0.20543237,0.00012352307,0.0000145510185,0.0035297247],"study_design_scores_gemma":[0.007293925,0.00087942916,0.7970276,0.0006172109,0.000052772437,0.000018355031,0.0006339554,0.0001329862,0.19292,0.00016561298,0.0000088014,0.00024937355],"about_ca_topic_score_codex":0.0012350008,"about_ca_topic_score_gemma":0.0005990623,"teacher_disagreement_score":0.012512363,"about_ca_system_score_codex":0.00016075763,"about_ca_system_score_gemma":0.00026017692,"threshold_uncertainty_score":0.99994725},"labels":[],"label_agreement":null},{"id":"W2984707601","doi":"10.1182/blood-2019-123904","title":"A 10-Color Flow Cytometry Panel for Both Diagnosis and Minimal Residual Disease Measurement in Chronic Lymphocytic Leukemia","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Becton Dickinson (Canada); Jewish General Hospital","funders":"","keywords":"Chronic lymphocytic leukemia; Minimal residual disease; Medicine; Immunophenotyping; CD20; CD5; Cytometry; Antibody; Immunology; Antigen; Leukemia; Pathology; Flow cytometry","score_opus":0.046441808139611,"score_gpt":0.28936821965014203,"score_spread":0.24292641151053104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984707601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904057,0.0062295306,0.000011153073,0.00016874712,0.000073746996,0.0025200255,0.000068916146,0.00007295232,0.00044927344],"genre_scores_gemma":[0.9954002,0.00032133303,0.0006334587,0.00015252818,0.000363392,0.00096806785,0.00004055972,0.00007609059,0.0020443634],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.996796,0.00007583327,0.00046507013,0.00075702375,0.0010475462,0.0008585397],"domain_scores_gemma":[0.99816406,0.0004180756,0.00008423093,0.00065608503,0.00016114402,0.0005163861],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008476249,0.00031424707,0.00059626467,0.00035868157,0.00006804148,0.000053223885,0.00020992901,0.00017559872,0.0005762134],"category_scores_gemma":[0.0009881642,0.00028319284,0.00013941772,0.00040901484,0.00012760716,0.000117457574,0.0001761751,0.00018406242,0.00026592254],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.10601103,0.017002076,0.38416654,0.091555774,0.009841552,0.015286801,0.0064876582,0.006603623,0.13124071,0.0008380837,0.09296764,0.13799849],"study_design_scores_gemma":[0.5308663,0.007497302,0.17908747,0.0037460842,0.0022354145,0.00046096652,0.00035069024,0.22370635,0.030662447,0.000159,0.019498145,0.0017297935],"about_ca_topic_score_codex":0.0003640242,"about_ca_topic_score_gemma":0.00012476051,"teacher_disagreement_score":0.42485532,"about_ca_system_score_codex":0.06940399,"about_ca_system_score_gemma":0.043314144,"threshold_uncertainty_score":0.99996203},"labels":[],"label_agreement":null},{"id":"W2984727839","doi":"10.1182/blood-2019-128140","title":"Real-World Effectiveness and Safety of BAY 94-9027 (Damoctocog Alfa Pegol) in Previously Treated Patients with Hemophilia A (HEM-POWR): Online Patient Portal and LIFE-ACTIVE Sub-Study","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Clinical trial; Factor IX; Internal medicine; Surgery; Pediatrics","score_opus":0.008807218025529319,"score_gpt":0.2626038648760374,"score_spread":0.25379664685050807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984727839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99262935,0.00015255023,1.2081367e-7,0.000049068894,0.000025235131,0.00630729,0.0000900109,0.000028875056,0.0007174706],"genre_scores_gemma":[0.9993083,0.00012966966,0.0000396739,0.000010890868,0.000025471174,0.000121858735,0.00018101475,0.000043284203,0.00013983366],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99793124,0.0002060437,0.00042267732,0.0005741017,0.0004808025,0.00038513518],"domain_scores_gemma":[0.9988152,0.00020221254,0.00014747675,0.00036187013,0.00019798355,0.0002753007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017139896,0.00032123385,0.0007973166,0.0003029845,0.00005143095,0.000011996608,0.000062863604,0.00009584152,0.00004196767],"category_scores_gemma":[0.00007081801,0.00021810917,0.000057392022,0.00048359038,0.00012329507,0.00010773293,0.00009774348,0.00024939558,0.000004240695],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006297605,0.010492381,0.97702014,0.00035723497,0.0004885206,0.00022806943,0.0009627822,9.937814e-7,0.00073433534,0.0000049894015,0.0000033195886,0.0034096],"study_design_scores_gemma":[0.029526763,0.010181867,0.95499724,0.00054405443,0.00035181592,0.000015157754,0.00034200287,0.000014624504,0.0038059505,0.0000061528035,0.000009808522,0.0002045423],"about_ca_topic_score_codex":0.00053759577,"about_ca_topic_score_gemma":0.00091856037,"teacher_disagreement_score":0.023229158,"about_ca_system_score_codex":0.0000666349,"about_ca_system_score_gemma":0.00014366317,"threshold_uncertainty_score":0.88942343},"labels":[],"label_agreement":null},{"id":"W2984742939","doi":"10.1182/blood-2019-123933","title":"Pharmacodynamic Effects and Immune Correlates of Response to the CD20/CD3 Bispecific Antibody Mosunetuzumab in Relapsed or Refractory Non-Hodgkin Lymphoma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Lymphoma; Refractory (planetary science); Immune system; Pharmacodynamics; CD20; Immunology; Antibody; Rituximab; Internal medicine; Biology; Pharmacokinetics","score_opus":0.008845170917509613,"score_gpt":0.3011369814536146,"score_spread":0.292291810536105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984742939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941559,0.0026100718,0.0000034537106,0.0008960658,0.0002454582,0.0011829092,0.000022972723,0.000023090053,0.0008601076],"genre_scores_gemma":[0.99223274,0.0006188337,0.00013076601,0.00015470509,0.000072027644,0.000030156085,0.000022161037,0.00003716911,0.0067014266],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980479,0.00027015983,0.00043553716,0.0003753679,0.00044594397,0.00042510228],"domain_scores_gemma":[0.9979818,0.0012087985,0.00010203625,0.00046107644,0.0000824826,0.0001638343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081512175,0.00023270157,0.0005337664,0.00030139813,0.00007037557,0.00001733706,0.00023720328,0.00012303337,0.00017590342],"category_scores_gemma":[0.00024313194,0.00014127171,0.00010222516,0.00054753537,0.00012854405,0.000051878844,0.00018262998,0.00031139055,0.00020429329],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024988666,0.0010370868,0.103957556,0.00051913003,0.00019465754,0.00048000482,0.0009920907,0.0000136577255,0.86003786,0.000038811697,0.00017259695,0.007567875],"study_design_scores_gemma":[0.013605111,0.0034499648,0.9296964,0.00072992453,0.00010887712,0.00025445875,0.00019317638,0.0012652123,0.04509982,0.000018480527,0.00534149,0.00023711778],"about_ca_topic_score_codex":0.00030865346,"about_ca_topic_score_gemma":0.00002971201,"teacher_disagreement_score":0.8257388,"about_ca_system_score_codex":0.000052454983,"about_ca_system_score_gemma":0.00021809094,"threshold_uncertainty_score":0.5760893},"labels":[],"label_agreement":null},{"id":"W2984746243","doi":"10.1182/blood-2019-131441","title":"Anti-FVIII Antibody and Inhibitor Development Patterns in Hemophilia A Mouse Models: A Systematic Review","year":2019,"lang":"en","type":"review","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Antibody; Medicine; Immunology; Titer","score_opus":0.07714618708812462,"score_gpt":0.36170551145608587,"score_spread":0.2845593243679613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984746243","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023529064,0.98840666,0.000002510734,0.000058062702,0.000051647658,0.0088486485,0.00003576627,0.000049606442,0.00019421185],"genre_scores_gemma":[0.00019538005,0.99634886,0.0001374334,0.0000785642,0.000081433696,0.0006247594,0.00038743467,0.000101300546,0.0020448405],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9964287,0.0002740682,0.0014019574,0.0007189837,0.0006357558,0.0005405021],"domain_scores_gemma":[0.99842924,0.00014148446,0.0003059605,0.00078577665,0.00008562946,0.0002519128],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00073480885,0.0006249592,0.005421321,0.0004727098,0.00005042923,0.000040588315,0.00021859726,0.00036156416,0.00002778089],"category_scores_gemma":[0.00012984354,0.0004086372,0.00037873187,0.0004171858,0.000037734753,0.00008508738,0.00020767888,0.0005587186,0.00031475557],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000024242022,0.0006888872,0.00021478788,0.9857521,0.00058753625,0.00043270385,0.00007107387,1.6230844e-8,0.0000024119392,0.0000067517594,0.000034022123,0.012207272],"study_design_scores_gemma":[0.0016612707,0.00008456975,0.000013383444,0.9812995,0.0056523797,0.0005389054,0.000012171395,0.0000069214484,0.000012603484,0.0000020109208,0.010295612,0.00042066583],"about_ca_topic_score_codex":0.000010962995,"about_ca_topic_score_gemma":0.000004014709,"teacher_disagreement_score":0.011786607,"about_ca_system_score_codex":0.0001500959,"about_ca_system_score_gemma":0.0007482331,"threshold_uncertainty_score":0.99983656},"labels":[],"label_agreement":null},{"id":"W2984791646","doi":"10.1182/blood-2020-141087","title":"A Randomized Phase II, Open Label, Study of Daratumumab, Weekly Low-Dose Oral Dexamethasone and Cyclophosphamide with or without Pomalidomide in Patients with Relapsed and Refractory Multiple Myeloma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of New Brunswick; Thunder Bay Regional Research Institute; Dalhousie University; Princess Margaret Cancer Centre; University of Calgary; Thunder Bay Regional Health Sciences Centre; University Health Network; Ottawa Hospital; CancerCare Manitoba; McGill University Health Centre; Juravinski Cancer Centre; Saint John Regional Hospital; BC Cancer Agency; Queen Elizabeth II Health Sciences Centre; University of Alberta","funders":"","keywords":"Pomalidomide; Medicine; Lenalidomide; Daratumumab; Dexamethasone; Internal medicine; Cyclophosphamide; Clinical endpoint; Regimen; Multiple myeloma; Progressive disease; Refractory (planetary science); Oncology; Surgery; Gastroenterology; Urology; Clinical trial; Chemotherapy; Biology","score_opus":0.03769247981951125,"score_gpt":0.3218313031854524,"score_spread":0.28413882336594115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984791646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917716,0.00029828143,0.0000065265644,0.00013685806,0.000011444776,0.007580238,0.00004783726,0.00003614501,0.000111098045],"genre_scores_gemma":[0.9951735,0.000056024754,0.004035659,0.00010481223,0.000016990061,0.00034427125,0.000061891544,0.0000615576,0.00014525234],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.997363,0.0003824271,0.00055710616,0.0006866909,0.00059259025,0.0004182013],"domain_scores_gemma":[0.99820966,0.00040604232,0.00026585447,0.00040446175,0.00018466335,0.0005293251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043579878,0.00038370403,0.0016047109,0.00015329415,0.00013745972,0.000055574325,0.00018045574,0.000088020024,0.000031186428],"category_scores_gemma":[0.00087187055,0.00022659455,0.000028453385,0.00046551146,0.00027529756,0.0002879736,0.00029578814,0.00032227387,0.0000017948482],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48511636,0.018868452,0.49015096,0.000103337465,0.0007938153,0.0005102412,0.0018753815,4.2257523e-7,0.00040993319,8.336078e-7,0.000010399166,0.0021598758],"study_design_scores_gemma":[0.76795614,0.03074054,0.19843107,0.000296798,0.00057780143,0.000017603543,0.0006701393,0.0002701655,0.00080787885,0.0000016854545,0.000015311827,0.00021485987],"about_ca_topic_score_codex":0.0009812912,"about_ca_topic_score_gemma":0.0009036986,"teacher_disagreement_score":0.29171985,"about_ca_system_score_codex":0.0000329822,"about_ca_system_score_gemma":0.00020501217,"threshold_uncertainty_score":0.9240258},"labels":[],"label_agreement":null},{"id":"W2984844451","doi":"10.1182/blood-2019-123948","title":"Quality of Life Was Not Negatively Impacted By the Addition of Lenalidomide to R-CHOP Chemotherapy (R2-CHOP) Compared with Placebo Plus R-CHOP Chemotherapy in Patients with Previously Untreated Activated B-Cell (ABC)-Type Diffuse Large B-Cell Lymphoma (DLBCL): Health-Related Quality of Life (HRQoL) Analysis of the International Robust Study","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC","funders":"","keywords":"CHOP; Medicine; Lenalidomide; Chemotherapy; Internal medicine; Placebo; Vincristine; Chemotherapy regimen; Quality of life (healthcare); Oncology; Gastroenterology; Cyclophosphamide; Multiple myeloma; Nursing; Pathology","score_opus":0.01924093849634835,"score_gpt":0.26770726773550924,"score_spread":0.2484663292391609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984844451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937762,0.00012190393,0.000008927933,0.0005441825,0.000042425978,0.004339565,0.0010201308,0.00003111915,0.00011556029],"genre_scores_gemma":[0.9985565,0.00006187372,0.000101680096,0.00053760794,0.000010683327,0.00008452027,0.0005077554,0.00005574897,0.00008363962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947848,0.00088549213,0.0019512265,0.0006188782,0.0013385813,0.0004210418],"domain_scores_gemma":[0.9943689,0.0007332469,0.0026917981,0.0010364451,0.00092035497,0.00024923682],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009847711,0.0005007527,0.0021712317,0.00035390558,0.000074854834,0.000019115218,0.00044568864,0.00015735872,0.00020235222],"category_scores_gemma":[0.0002642397,0.00028558957,0.00031378158,0.0021279305,0.00016393914,0.0001228557,0.00007767006,0.00017158854,0.0000022726122],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047752846,0.07354622,0.8570236,0.00018802697,0.0073527563,9.927687e-7,0.0058883782,0.0004588857,0.007422946,0.000006043492,0.00021414743,0.0001451435],"study_design_scores_gemma":[0.2133945,0.002368411,0.7565041,0.0002369745,0.0007206669,4.3962174e-7,0.0011955858,0.00018288851,0.02517668,0.0000010581699,0.000008297195,0.00021036403],"about_ca_topic_score_codex":0.010180696,"about_ca_topic_score_gemma":0.0011640199,"teacher_disagreement_score":0.16564164,"about_ca_system_score_codex":0.00046372812,"about_ca_system_score_gemma":0.0007818827,"threshold_uncertainty_score":0.99995965},"labels":[],"label_agreement":null},{"id":"W2984888430","doi":"10.1182/blood-2019-130087","title":"Prediction of Risk for Adverse Pregnancy Outcomes in Women with Sickle Cell Disease","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Toronto General Hospital; Canadian Blood Services; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Medicine; Pregnancy; Obstetrics; Adverse effect; Retrospective cohort study; Gestational age; Anemia; Gestational hypertension; Pediatrics; Disease; Acute chest syndrome; Preeclampsia; Sickle cell anemia; Surgery; Internal medicine","score_opus":0.004997376129940214,"score_gpt":0.198306997466933,"score_spread":0.19330962133699278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984888430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99750394,0.00040892855,0.00001922725,0.00005136449,0.000054057597,0.0007923535,0.000093850795,0.000024937086,0.0010513294],"genre_scores_gemma":[0.99885863,0.00012716849,0.00017487054,0.000029221808,0.000007827681,0.00004018258,0.000014303645,0.000014807256,0.00073297793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994165,0.000011497588,0.00015468473,0.00014170125,0.00010999154,0.00016563287],"domain_scores_gemma":[0.99958664,0.000032958535,0.000069943446,0.00018625573,0.00003167631,0.000092541886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000052201092,0.000080927945,0.00019357073,0.000059588758,0.0000138960295,0.0000013442877,0.000031923813,0.00005347303,0.000044393313],"category_scores_gemma":[0.000033900295,0.000055509056,0.000043906806,0.00009146281,0.000021582899,0.000039862378,0.000009747164,0.000082226536,0.000010780459],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005193878,0.0013740549,0.9954264,0.00041064166,0.000066647706,0.000009549588,0.0010248288,0.000080913866,0.000420765,0.000012642119,0.000019427736,0.0006347065],"study_design_scores_gemma":[0.024181204,0.0012301856,0.9700061,0.00063473545,0.00037160923,0.0000014380378,0.0018837936,0.00018334895,0.0010367878,0.00010035374,0.00026331437,0.00010712975],"about_ca_topic_score_codex":0.00001879836,"about_ca_topic_score_gemma":0.0000028856127,"teacher_disagreement_score":0.025420336,"about_ca_system_score_codex":0.000016406206,"about_ca_system_score_gemma":0.00007055941,"threshold_uncertainty_score":0.22635935},"labels":[],"label_agreement":null},{"id":"W2984890091","doi":"10.1182/blood-2019-130337","title":"A Phase I/II Study to Investigate the Safety and Clinical Activity of the Protein Arginine Methyltransferase 5 Inhibitor GSK3326595 in Subjects with Myelodysplastic Syndrome and Acute Myeloid Leukemia","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Myelodysplastic syndromes; Myeloid leukemia; Protein arginine methyltransferase 5; Cancer research; Myeloid; Chronic myelomonocytic leukemia; Population; Methyltransferase; Leukemia; Medicine; Biology; Immunology; Methylation; Bone marrow; Genetics; Gene","score_opus":0.00679248078787135,"score_gpt":0.2529946812124443,"score_spread":0.24620220042457294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984890091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976326,0.00012360928,0.00004035606,0.0002686981,0.000052205458,0.0018366888,0.000026809152,0.000005687987,0.000013304702],"genre_scores_gemma":[0.9996476,0.000035017474,0.00007860915,0.00003859355,0.000039265313,0.000038451468,0.000005764533,0.000018724673,0.00009793039],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987977,0.00022138642,0.0002668007,0.00039216358,0.00015367828,0.00016826035],"domain_scores_gemma":[0.9993579,0.00004207822,0.00009502482,0.0003829658,0.000039347964,0.00008272347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042490542,0.00016496277,0.00025990212,0.000037791076,0.000069988055,0.000012336788,0.000121505574,0.000101237914,0.0000020848322],"category_scores_gemma":[0.00007065743,0.00010091793,0.000039072114,0.00022423179,0.00015462647,0.000007663103,0.00014782538,0.00019693823,6.312305e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018939755,0.0009704891,0.021458924,0.000034061937,0.00031657476,0.0000080097125,0.00036998343,0.0001239598,0.9733565,0.0000055044015,0.000004144745,0.0014578596],"study_design_scores_gemma":[0.019484123,0.014174091,0.2923886,0.00016207228,0.00039981684,0.00010656475,0.00011714194,0.0001542776,0.67259604,0.000013521888,0.00011440549,0.00028938503],"about_ca_topic_score_codex":0.00006604057,"about_ca_topic_score_gemma":0.0004803054,"teacher_disagreement_score":0.3007605,"about_ca_system_score_codex":0.000017282444,"about_ca_system_score_gemma":0.00020597345,"threshold_uncertainty_score":0.4115314},"labels":[],"label_agreement":null},{"id":"W2984893852","doi":"10.1182/blood-2019-131967","title":"Studying the Role of ETV6 in Megakaryopoiesis and Thrombopoiesis Using a Novel CRISPR-Cas9 Halotag Genome Editing Strategy","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Thrombopoiesis; Biology; ETV6; Megakaryocyte; Thrombopoietin; Genetics; Platelet disorder; Cancer research; Mutation; Cell biology; Zebrafish; Molecular biology; Stem cell; Platelet; Progenitor cell; Gene; Haematopoiesis; Immunology; Chromosomal translocation","score_opus":0.022900273090708835,"score_gpt":0.26236878010863995,"score_spread":0.23946850701793113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984893852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99457467,0.0023536447,0.000010644453,0.00007235983,0.00003508776,0.00043791477,0.000016295207,0.0000144316355,0.0024849307],"genre_scores_gemma":[0.99914414,0.000064224856,0.00063483394,0.000046017514,0.00004560862,0.000008165937,0.000006078723,0.000020889469,0.000030071491],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990795,0.00002277433,0.0002479627,0.00022295305,0.00018700222,0.00023975805],"domain_scores_gemma":[0.9995213,0.000079083235,0.00010113942,0.00021413079,0.000039287883,0.00004505298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016259529,0.00014503056,0.00038678985,0.00009134304,0.00006522134,0.000016971735,0.00006315806,0.00006374581,0.000046334302],"category_scores_gemma":[0.00002993854,0.00010316252,0.000052171832,0.00018702917,0.00004763771,0.000093202136,0.000062908315,0.00012327536,0.0000045884426],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000756974,0.0021715644,0.72201943,0.00019585477,0.00077088294,0.00011091517,0.0030733936,0.00008656218,0.2694998,0.00036607357,0.0000027589547,0.001627041],"study_design_scores_gemma":[0.019212654,0.00093805726,0.91738224,0.0005322589,0.0015232114,0.00055059115,0.029356614,0.0022023083,0.026672507,0.00091966626,0.00024292932,0.00046698327],"about_ca_topic_score_codex":0.00079108914,"about_ca_topic_score_gemma":0.00009049211,"teacher_disagreement_score":0.24282731,"about_ca_system_score_codex":0.000020577849,"about_ca_system_score_gemma":0.00005263586,"threshold_uncertainty_score":0.42068455},"labels":[],"label_agreement":null},{"id":"W2984904232","doi":"10.1182/blood-2019-123870","title":"Bleeding Risk in Non-Valvular Atrial Fibrillation Patients Receiving Direct Oral Anticoagulants and Warfarin: A Systematic Review and Meta-Analysis of Observational Studies","year":2019,"lang":"en","type":"review","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Warfarin; Observational study; Randomized controlled trial; Edoxaban; Rivaroxaban; Internal medicine; Apixaban; Vitamin K antagonist; Atrial fibrillation; Meta-analysis; Intensive care medicine","score_opus":0.3278903985656647,"score_gpt":0.4283197523843209,"score_spread":0.1004293538186562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984904232","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022844009,0.9934527,0.0000025220522,0.000040158342,0.000065398584,0.0040336256,0.00007000558,0.000014714895,0.000036467678],"genre_scores_gemma":[0.0016915777,0.99748474,0.0002593277,0.000018432505,0.000091381226,0.000012102141,0.00021686191,0.00002695718,0.00019862743],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99676156,0.0004228069,0.0017202364,0.00046019128,0.0004636828,0.00017154396],"domain_scores_gemma":[0.9967046,0.0010808274,0.0016278866,0.00034129826,0.00019580207,0.00004961971],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001622867,0.0003947848,0.011416172,0.00065572554,0.000051430692,0.000026381085,0.000070469,0.00014515987,0.000014868001],"category_scores_gemma":[0.0021004041,0.00026158502,0.0017802838,0.0011078786,0.000032599673,0.00013117852,0.00014813889,0.0001265497,0.000003314994],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006831805,0.000007448491,0.09779407,0.6718637,0.22900853,0.0000015579476,0.000059248032,0.000009615205,3.8147295e-8,0.000008855668,0.0000079958,0.0012321454],"study_design_scores_gemma":[0.00087445526,0.000058787144,0.012066903,0.038552552,0.94736093,0.0000018703886,0.00001217333,0.00006757781,8.64703e-8,0.0000038283374,0.00078601827,0.00021481354],"about_ca_topic_score_codex":0.000022874669,"about_ca_topic_score_gemma":0.000010643401,"teacher_disagreement_score":0.7183524,"about_ca_system_score_codex":0.000039721475,"about_ca_system_score_gemma":0.000040161274,"threshold_uncertainty_score":0.9999836},"labels":[],"label_agreement":null},{"id":"W2984904736","doi":"10.1182/blood-2019-124381","title":"Prevalence of Red Cell Pyruvate Kinase Deficiency: A Systematic Literature Review","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pyruvate kinase deficiency; Medicine; Pyruvate kinase; Population; Incidence (geometry); Pediatrics; MEDLINE; Epidemiology; Internal medicine; Biology; Environmental health; Glycolysis","score_opus":0.009625471497268438,"score_gpt":0.23510255930327234,"score_spread":0.2254770878060039,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984904736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7320518,0.25941795,0.000005373407,0.00015569532,0.00022338674,0.0014021267,0.000013572165,0.000047052872,0.0066830665],"genre_scores_gemma":[0.93216455,0.059019785,0.00025093343,0.00090898614,0.000055626177,0.000039448765,0.000015814025,0.000015119406,0.007529756],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9991566,0.000087269815,0.00030414702,0.00019551007,0.00013040291,0.00012604661],"domain_scores_gemma":[0.9991477,0.00005069211,0.00015880531,0.00046752786,0.000120235665,0.00005505342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015511371,0.00010392754,0.00046145296,0.000050715378,0.000013669654,0.00000312053,0.00006815396,0.000070671354,0.00021130146],"category_scores_gemma":[0.00009741723,0.000073534764,0.00011926444,0.00023307872,0.000020033733,0.000030877614,0.000016267095,0.00009488116,0.00019437521],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032597967,0.0004274583,0.002199164,0.748266,0.000018419667,0.000029608447,0.00014331778,4.4543978e-7,0.24850798,0.00006446447,0.00028703734,0.00002353674],"study_design_scores_gemma":[0.010597475,0.0064041964,0.019072399,0.84071726,0.0040133516,0.0006636414,0.000102069345,0.00009373573,0.11553909,0.00008661939,0.0020808522,0.00062931486],"about_ca_topic_score_codex":8.34362e-7,"about_ca_topic_score_gemma":1.1539262e-7,"teacher_disagreement_score":0.20039816,"about_ca_system_score_codex":0.000008402537,"about_ca_system_score_gemma":0.00005324092,"threshold_uncertainty_score":0.29986605},"labels":[],"label_agreement":null},{"id":"W2984908450","doi":"10.1182/blood-2019-125183","title":"Factors Associated with Health Care Resource Utilization in Myeloproliferative Neoplasms: A Population-Based Cost Study","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Population; Polycythemia vera; Disease burden; Essential thrombocythemia; Health care; Cohort; Myelofibrosis; Internal medicine; Pediatrics; Environmental health; Bone marrow","score_opus":0.045304747024475865,"score_gpt":0.30745085778094183,"score_spread":0.262146110756466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984908450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944534,0.00023579599,0.0000083245695,0.00034279632,0.000036063746,0.0043845247,0.000060752333,0.00008632983,0.00039202315],"genre_scores_gemma":[0.9976434,0.0000035538396,0.000057201596,0.00047431112,0.000024095061,0.0002825529,0.0013803908,0.000043951753,0.000090561494],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979997,0.00025780802,0.00040322513,0.00050448824,0.00048807435,0.00034669615],"domain_scores_gemma":[0.99888057,0.00025104106,0.00021592923,0.000308347,0.00017861165,0.00016548287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016592567,0.00030947055,0.00063590135,0.00022648877,0.0001266215,0.00003574825,0.00005897317,0.00009487549,0.00009222307],"category_scores_gemma":[0.0001415197,0.0002208748,0.00006018633,0.00054077426,0.000017190972,0.00007386431,0.00001652993,0.00020315137,0.00001204214],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001661771,0.0037665055,0.9884237,0.000047930047,0.0002142805,0.000022066906,0.0067511313,0.0002603594,0.0000037366003,0.000040948144,0.000027245536,0.00027592733],"study_design_scores_gemma":[0.015302537,0.0036172075,0.9728539,0.00035065293,0.00014813835,0.0000014533696,0.0065584,0.00018411854,0.0007112857,0.0000016828237,0.000073050636,0.00019756949],"about_ca_topic_score_codex":0.00038901813,"about_ca_topic_score_gemma":0.005152651,"teacher_disagreement_score":0.015569788,"about_ca_system_score_codex":0.00044646012,"about_ca_system_score_gemma":0.00043232224,"threshold_uncertainty_score":0.90070134},"labels":[],"label_agreement":null},{"id":"W2984965143","doi":"10.1182/blood-2019-130615","title":"Registration Errors Among Patients Receiving Blood Transfusions: A National Analysis from 2008-2017","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Island Health; McGill University Health Centre; Sunnybrook Health Science Centre; Health Sciences Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Blood transfusion; Medical record; Emergency medicine; Blood product; Medical emergency; Surgery","score_opus":0.013109833222987784,"score_gpt":0.24293421601619256,"score_spread":0.22982438279320477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984965143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9726389,0.0001039325,0.0002357167,0.0005112263,0.00017419104,0.000774429,0.00004992058,0.00010356753,0.025408134],"genre_scores_gemma":[0.9960154,0.0001707539,0.0010441281,0.00041328682,0.00008897303,0.00003981533,0.0004742424,0.000021551765,0.0017318],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980411,0.00005298408,0.00040639532,0.00048525268,0.0007832837,0.00023096678],"domain_scores_gemma":[0.99905187,0.000056429304,0.00013051115,0.00040408166,0.00020569062,0.00015143106],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022540662,0.00019090249,0.00036289255,0.0003598454,0.00010476454,0.000035735255,0.00012637858,0.0001306329,0.0011432659],"category_scores_gemma":[0.000075982694,0.00017719355,0.0002764362,0.00066300813,0.000036642115,0.00016593073,0.00002380521,0.00019387435,0.00011214978],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008880614,0.0035036888,0.9867433,0.000059357106,0.0033454364,0.000025177698,0.0005873878,0.00004832769,0.0033666762,0.00027469458,0.0010609573,0.0008962064],"study_design_scores_gemma":[0.008703397,0.00021592539,0.9815123,0.00010431084,0.005948151,0.0000024671865,0.00013077309,0.0002619971,0.001174105,0.00008864189,0.0016452862,0.00021262547],"about_ca_topic_score_codex":0.00069752085,"about_ca_topic_score_gemma":0.0010237197,"teacher_disagreement_score":0.023676334,"about_ca_system_score_codex":0.000030215444,"about_ca_system_score_gemma":0.000068486916,"threshold_uncertainty_score":0.9997698},"labels":[],"label_agreement":null},{"id":"W2985030816","doi":"10.1182/blood-2019-121743","title":"The Impact of Identifying the Syndromic and Genetic Diagnoses on Hematopoietic Stem Cell Transplantation Outcome in Patients with Inherited Bone Marrow Failure Syndromes","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; Janeway Children's Health and Rehabilitation Centre; London Health Sciences Centre; McMaster Children's Hospital; University of Alberta; Centre hospitalier de l'Université Laval; Centre Hospitalier Universitaire de Sherbrooke; Queen's University; Stollery Children's Hospital; Izaak Walton Killam Health Centre; Alberta Children's Hospital; Children's Hospital of Eastern Ontario; University Health Network; BC Children's Hospital; Royal University Hospital; Montreal Children's Hospital; University of Toronto; SickKids Foundation; University of Manitoba; Kingston General Hospital; Princess Margaret Cancer Centre; University of Saskatchewan; Hospital for Sick Children","funders":"","keywords":"Medicine; Fanconi anemia; Bone marrow failure; Bone marrow; Hematopoietic stem cell transplantation; Transplantation; Pediatrics; Internal medicine; Stem cell; Haematopoiesis; Genetics","score_opus":0.01327975693376609,"score_gpt":0.26361215470471355,"score_spread":0.25033239777094746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985030816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99822533,0.00046800933,0.0000024434344,0.00014171537,0.000017785716,0.0010710268,0.00001654915,0.000013182699,0.000043968543],"genre_scores_gemma":[0.99957937,0.00017269189,0.000046173067,0.000018246885,0.000006675508,0.0000307138,0.000012954428,0.000028781085,0.000104375256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987586,0.00010317603,0.00029483953,0.0002097359,0.00037592874,0.0002577094],"domain_scores_gemma":[0.99908084,0.00034489145,0.00010846702,0.00035055671,0.0000535207,0.00006172084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017587675,0.00015708462,0.0002970884,0.00011571307,0.000060408147,0.00003464593,0.00012838494,0.000066573855,0.000018316785],"category_scores_gemma":[0.000015809404,0.000077114535,0.000060205894,0.0002395187,0.00008385527,0.00005932323,0.00002711301,0.00026246466,0.000017648958],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028371668,0.00026044497,0.9959511,0.00039596806,0.00008983499,0.00009929891,0.00079893105,0.00002993503,0.0018622143,0.000003950153,0.000019842832,0.0002047493],"study_design_scores_gemma":[0.0066869846,0.00095675123,0.989377,0.00030566676,0.00012043284,0.00018634641,0.00037119637,0.000043309927,0.0018535169,0.0000074934483,0.000001714303,0.00008959114],"about_ca_topic_score_codex":0.00010800794,"about_ca_topic_score_gemma":0.000027958458,"teacher_disagreement_score":0.006574118,"about_ca_system_score_codex":0.00006901175,"about_ca_system_score_gemma":0.000077918776,"threshold_uncertainty_score":0.31446394},"labels":[],"label_agreement":null},{"id":"W2985043553","doi":"10.1182/blood.2019004664","title":"β-Catenin–TCF/LEF signaling promotes steady-state and emergency granulopoiesis via G-CSF receptor upregulation","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; European Hematology Association","keywords":"Granulopoiesis; Myelopoiesis; Wnt signaling pathway; Biology; Cell biology; Transcription factor; Signal transduction; Progenitor cell; Enhancer; Cancer research; Molecular biology; Stem cell; Genetics; Gene","score_opus":0.01190225636332856,"score_gpt":0.21672320013675817,"score_spread":0.2048209437734296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985043553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99490577,0.0018653692,0.0019891665,0.0005034967,0.00015091647,0.00023595696,0.000016452132,0.000038190163,0.00029469962],"genre_scores_gemma":[0.99547297,0.00037377197,0.0026132409,0.00014087703,0.00034705407,0.000039413586,0.00015495278,0.000038964434,0.00081873994],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99874175,0.0000507594,0.00030604133,0.0004679987,0.00016845006,0.0002650061],"domain_scores_gemma":[0.99947834,0.00000735339,0.000118454765,0.00014208826,0.00011533297,0.00013845669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013646028,0.00021573431,0.00017533722,0.000028959594,0.00012779274,0.00003211152,0.00015828895,0.00012394412,0.00026746214],"category_scores_gemma":[0.000050035138,0.00021117773,0.00007136205,0.00014579795,0.00005191992,0.000011436788,0.00010421433,0.000083048,0.000038635695],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006808349,0.000055400844,0.012125601,0.000059787395,0.00013146442,0.0000018470607,0.0005689683,0.000025955516,0.98315865,0.00000572933,0.0014532092,0.002345285],"study_design_scores_gemma":[0.00094538473,0.00022424593,0.0021976766,0.000022385895,0.000076973745,0.0000050582053,0.00006842921,0.0000853268,0.9916635,0.00022499861,0.004113412,0.00037256966],"about_ca_topic_score_codex":0.000009874223,"about_ca_topic_score_gemma":0.0000041813473,"teacher_disagreement_score":0.009927924,"about_ca_system_score_codex":0.000005666721,"about_ca_system_score_gemma":0.00004358482,"threshold_uncertainty_score":0.8611578},"labels":[],"label_agreement":null},{"id":"W2985054898","doi":"10.1182/blood-2019-130298","title":"An Update on rFVIIa Use in Females with Rare Bleeding Disorders","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Hospital for Sick Children","funders":"","keywords":"Medicine; Bleeding diathesis; Factor VIIa; Surgery; Platelet; Internal medicine","score_opus":0.029581795344463185,"score_gpt":0.29642513593097264,"score_spread":0.26684334058650944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985054898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953238,0.000056662848,6.090072e-7,0.0008435573,0.000020047197,0.00035578708,0.000002556155,0.000033547105,0.0033634312],"genre_scores_gemma":[0.9983883,0.000072482115,0.00021351517,0.000082392806,0.00004042817,0.000010936049,0.000034248158,0.00001913097,0.0011385984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99927455,0.000021175334,0.00007701685,0.00020173079,0.00020382507,0.00022167059],"domain_scores_gemma":[0.99960524,0.00003476409,0.000014244066,0.0002329112,0.000018385887,0.00009447768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000073677846,0.00009317863,0.00014665001,0.00012389723,0.00002674849,0.000021894897,0.000053147956,0.00004852572,0.00013137779],"category_scores_gemma":[0.000013369709,0.00005898504,0.000023891153,0.00015279112,0.000026599235,0.00010786428,0.000012965585,0.00013554642,0.00017227259],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020559921,0.00085316924,0.9950495,0.000040228053,0.000048302074,0.00010993808,0.00013235345,0.000004843277,0.002699435,0.0001137417,0.00002416116,0.00071874744],"study_design_scores_gemma":[0.011288687,0.0026451184,0.9714935,0.00039044648,0.000084950196,0.00002474093,0.0006218825,0.00010435376,0.012162778,0.00004695007,0.0009480679,0.00018854543],"about_ca_topic_score_codex":0.000070290684,"about_ca_topic_score_gemma":0.00018790437,"teacher_disagreement_score":0.023556001,"about_ca_system_score_codex":0.000022525766,"about_ca_system_score_gemma":0.00004068804,"threshold_uncertainty_score":0.24053401},"labels":[],"label_agreement":null},{"id":"W2985072184","doi":"10.1182/blood-2019-129357","title":"Bortezomib-Based Induction, Augmented Conditioning with Busulfan and Melphalan + ASCT and Lenalidomide Maintenance for Newly Diagnosed Multiple Myeloma: Long-Term Results of the National Canadian Mcrn-001 Study","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; London Health Sciences Centre; Hôpital Maisonneuve-Rosemont; Université de Montréal; Leukemia & Lymphoma Society of Canada; University of British Columbia; Saint John Regional Hospital; University of Ottawa; McGill University Health Centre; University of Alberta; Queen Elizabeth II Health Sciences Centre; Dalhousie University; Princess Margaret Cancer Centre","funders":"","keywords":"Lenalidomide; Melphalan; Multiple myeloma; Bortezomib; Busulfan; Medicine; Maintenance therapy; Oncology; Internal medicine; Hematopoietic stem cell transplantation; Transplantation; Chemotherapy","score_opus":0.02046326695381915,"score_gpt":0.27650298483389574,"score_spread":0.25603971788007657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985072184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959819,0.00006730455,0.000012366068,0.0006121499,0.000039694667,0.0026226968,0.00048350292,0.000016042517,0.00016436573],"genre_scores_gemma":[0.9987193,0.000006959443,0.00030453462,0.00011463967,0.000050519833,0.00017433606,0.00031289682,0.000022086806,0.00029475815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998628,0.00006866668,0.0002605616,0.00034814747,0.00038268615,0.0003119195],"domain_scores_gemma":[0.9987335,0.00028872295,0.0001375418,0.00021420566,0.00037739324,0.00024863513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028972796,0.00016504213,0.0002692852,0.0001572354,0.00018810338,0.00003086678,0.000075556796,0.000056177767,0.000016249189],"category_scores_gemma":[0.00048491597,0.00010814111,0.000038213377,0.00017049353,0.00010255366,0.00008543404,0.00002289863,0.00012438017,0.0000020528264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015934032,0.0009004335,0.99487954,0.00008410201,0.00044864637,0.000051662675,0.00018085909,0.000013379119,0.0011643518,0.000013151203,0.00017920468,0.0004912922],"study_design_scores_gemma":[0.075894855,0.0009930326,0.9183793,0.00019733745,0.00016798488,0.0000519984,0.00021464049,0.00030549377,0.0036302833,0.000007138833,0.00005434459,0.00010355787],"about_ca_topic_score_codex":0.012086208,"about_ca_topic_score_gemma":0.07212848,"teacher_disagreement_score":0.07650018,"about_ca_system_score_codex":0.00009068434,"about_ca_system_score_gemma":0.00044924713,"threshold_uncertainty_score":0.9944924},"labels":[],"label_agreement":null},{"id":"W2985107893","doi":"10.1182/blood-2019-129962","title":"Landmark Response and Survival Analyses from 102 MDS and CMML Patients Treated with Guadecitabine in a Phase 2 Study Showing That Maximum Response and Survival Is Best Achieved with Adequate Treatment Duration","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Internal medicine; Survival analysis; Oncology; Medicine; Biology","score_opus":0.04732996390358868,"score_gpt":0.32995276029831666,"score_spread":0.282622796394728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985107893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975667,0.0002688675,0.00000742837,0.00040592448,0.000019115789,0.0014845942,0.00014939082,0.00003554902,0.00006245958],"genre_scores_gemma":[0.99854463,0.00008293447,0.00022293816,0.000032229138,0.000028904242,0.00007915811,0.00014280739,0.00005535147,0.0008110295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99691975,0.0009881022,0.00034580703,0.00075726234,0.00058283075,0.0004062499],"domain_scores_gemma":[0.99809086,0.0009225678,0.00012366858,0.00047965872,0.000118118216,0.00026513048],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008349709,0.00039495894,0.0007473551,0.0003835546,0.00010906813,0.000098530516,0.000072696486,0.00011523512,0.000055215143],"category_scores_gemma":[0.00017274983,0.0002581695,0.00003129388,0.00043690533,0.00011575483,0.000234325,0.00008148989,0.00022615408,0.0000071489517],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13424681,0.003111033,0.8416231,0.00001862434,0.00073931785,0.0006166636,0.003582226,6.9405087e-7,0.014614611,2.361859e-7,0.0000040643977,0.001442565],"study_design_scores_gemma":[0.09404388,0.020530479,0.87572753,0.0001486973,0.0008127108,0.000035211284,0.004146384,0.00017969192,0.004075392,0.0000013156009,0.000031111944,0.00026758073],"about_ca_topic_score_codex":0.0024577286,"about_ca_topic_score_gemma":0.0009143244,"teacher_disagreement_score":0.040202934,"about_ca_system_score_codex":0.00017063605,"about_ca_system_score_gemma":0.00019779586,"threshold_uncertainty_score":0.99998707},"labels":[],"label_agreement":null},{"id":"W2985115696","doi":"10.1182/blood-2019-123081","title":"Describing the Point Prevalence and Characteristics of Venous Thromboembolism in Patients with Thrombotic Thrombocytopenic Purpura","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Thrombotic thrombocytopenic purpura; Pulmonary embolism; Rituximab; Deep vein; Thrombosis; Microangiopathic hemolytic anemia; ADAMTS13; Population; Internal medicine; Warfarin; Schistocyte; Surgery; Venous thrombosis; Pediatrics; Atrial fibrillation; Platelet","score_opus":0.013835558861764663,"score_gpt":0.19955521459402,"score_spread":0.18571965573225535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985115696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99785113,0.0008474233,0.0000019617573,0.000029276394,0.00016472893,0.0008747647,0.000057493497,0.000017477909,0.00015572322],"genre_scores_gemma":[0.99981666,0.000029698138,0.0000166005,0.000036645797,0.000006937718,0.00001787779,0.000029533849,0.000014072654,0.000032000495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901855,0.00013908245,0.0003006065,0.00023749715,0.000059781752,0.00024446155],"domain_scores_gemma":[0.9992296,0.00012284545,0.00018070286,0.00039444567,0.000056607914,0.000015795213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015417604,0.00014322391,0.00039415245,0.000047996284,0.00006159703,0.000013727441,0.00023877968,0.000057843357,0.0003252431],"category_scores_gemma":[0.00004656137,0.00009466332,0.00003063427,0.00008964286,0.00014643249,0.00009395342,0.0001412765,0.00012718744,0.00005708626],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054019783,0.000777486,0.9906773,0.00016120671,0.00014766185,0.0000011451302,0.00062995264,6.4947676e-7,0.0069661518,0.00029118828,0.00001674587,0.00027646913],"study_design_scores_gemma":[0.0027564848,0.00046273324,0.9940685,0.0003660521,0.00014933106,0.000009522457,0.00013434964,6.6686454e-7,0.0018781032,0.000035243935,0.000017136648,0.000121884725],"about_ca_topic_score_codex":0.000040213563,"about_ca_topic_score_gemma":0.000010313574,"teacher_disagreement_score":0.0050880485,"about_ca_system_score_codex":0.000015714,"about_ca_system_score_gemma":0.000047415448,"threshold_uncertainty_score":0.38602585},"labels":[],"label_agreement":null},{"id":"W2985160385","doi":"10.1182/blood-2019-123083","title":"Potential Factors That Impact Lenalidomide/R-CHOP Efficacy in Previously Untreated Diffuse Large B-Cell Lymphoma in the ROBUST and ECOG-ACRIN 1412 Studies","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC","funders":"","keywords":"Lenalidomide; Medicine; CHOP; Internal medicine; Diffuse large B-cell lymphoma; Oncology; Placebo; Regimen; Prednisone; Lymphoma; Multiple myeloma; Pathology","score_opus":0.023142996810195052,"score_gpt":0.27696555880415885,"score_spread":0.2538225619939638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985160385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923966,0.005740163,2.5500572e-7,0.00021667051,0.000069611684,0.001248057,0.00003119727,0.00003475917,0.0002627191],"genre_scores_gemma":[0.9977084,0.001832846,0.00001760386,0.00014381594,0.000039356702,0.00005619597,0.000039832998,0.00002971781,0.00013222956],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99834114,0.00014914277,0.00031280957,0.00041449408,0.00026749275,0.0005149408],"domain_scores_gemma":[0.999061,0.0003066325,0.00012708538,0.00036149993,0.000031889376,0.00011188455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000238556,0.00034129948,0.00062306685,0.00016540448,0.00006115247,0.000055819266,0.00011869423,0.000106917396,0.00004796557],"category_scores_gemma":[0.00008204919,0.00018791847,0.00016581659,0.00022948887,0.000048552465,0.00010592337,0.00008554764,0.00009837708,0.0000402375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002334597,0.019709775,0.9743601,0.0001022011,0.0003599138,0.0005427765,0.0037080387,0.000011653506,0.00032512654,0.000009917757,0.00013081939,0.00050620426],"study_design_scores_gemma":[0.08699776,0.0006025497,0.9068684,0.0002176211,0.0004373364,0.00009487743,0.00209319,0.000030673535,0.002386206,0.0000071328204,0.00007890782,0.00018534655],"about_ca_topic_score_codex":0.00074152526,"about_ca_topic_score_gemma":0.00033873983,"teacher_disagreement_score":0.086764306,"about_ca_system_score_codex":0.00017795058,"about_ca_system_score_gemma":0.000079112804,"threshold_uncertainty_score":0.7663093},"labels":[],"label_agreement":null},{"id":"W2985184701","doi":"10.1182/blood-2019-129730","title":"PRAME Expression Is Correlated with Treatment Outcome and Specific Features of the Tumor Microenvironment in Classical Hodgkin Lymphoma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Tumor microenvironment; Mantle cell lymphoma; Diffuse large B-cell lymphoma; Cancer research; Lymphoma; Follicular lymphoma; Medicine; Oncology; Internal medicine; Cancer; Biology","score_opus":0.014522705365294505,"score_gpt":0.2547452761588659,"score_spread":0.24022257079357137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985184701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964751,0.000686075,6.050757e-7,0.00065801805,0.000034813263,0.00085728004,0.000007769994,0.000008705676,0.0012716034],"genre_scores_gemma":[0.99062335,0.00014390057,0.00016177184,0.00010204809,0.000024566887,0.000020317633,0.00000398085,0.000022138303,0.0088979425],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989929,0.00006251626,0.00017926027,0.00025825272,0.00031002163,0.00019702892],"domain_scores_gemma":[0.99936795,0.00006320762,0.000063180545,0.0004240619,0.000011025812,0.00007057844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000076728895,0.00013900449,0.00028837565,0.00005870134,0.000020697873,0.000009813803,0.00007560572,0.00006456685,0.00062926585],"category_scores_gemma":[0.000006191539,0.00007228277,0.000058364225,0.00011072712,0.00011232522,0.000019456531,0.000059151705,0.00012873577,0.000017578477],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007611576,0.0011432732,0.4864437,0.000028742312,0.00005360813,0.0000535402,0.00042197257,0.0000011400165,0.50787926,0.000005700648,0.00013417775,0.0030737594],"study_design_scores_gemma":[0.011245636,0.0009927694,0.685468,0.00016080837,0.000046276884,0.00015647642,0.00011797797,0.000008736012,0.2976944,0.0000036741046,0.0040343986,0.00007081051],"about_ca_topic_score_codex":0.000031289135,"about_ca_topic_score_gemma":0.000008457351,"teacher_disagreement_score":0.21018484,"about_ca_system_score_codex":0.000108817396,"about_ca_system_score_gemma":0.0000415284,"threshold_uncertainty_score":0.689002},"labels":[],"label_agreement":null},{"id":"W2985191819","doi":"10.1182/blood-2019-126806","title":"Anabolic Steroids in Myelodysplastic Syndromes: A Systematic Review","year":2019,"lang":"en","type":"review","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Medicine; Danazol; Myelodysplastic syndromes; Randomized controlled trial; Internal medicine; Systematic review; Observational study; Pediatrics; MEDLINE; Bone marrow","score_opus":0.06386093926992038,"score_gpt":0.3681208677657144,"score_spread":0.30425992849579403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985191819","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000014780177,0.98724705,0.0000025638801,0.000045663914,0.00012456317,0.011192208,0.000042579133,0.000081257655,0.0012493466],"genre_scores_gemma":[0.000005364693,0.9942257,0.00007564748,0.00027336166,0.00012866875,0.0014396681,0.00019910153,0.00018661733,0.003465869],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99485976,0.000723907,0.0019484041,0.0008279866,0.00084317185,0.0007967505],"domain_scores_gemma":[0.9964531,0.00068020314,0.0005569739,0.0018880689,0.00011895535,0.00030271203],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012019232,0.0007432783,0.009270986,0.00089085056,0.000028751549,0.000039395254,0.00069737923,0.0005234061,0.00016060448],"category_scores_gemma":[0.0016271076,0.0005338972,0.00086674903,0.0015911495,0.00006432654,0.00007378854,0.00026136695,0.0014768495,0.0047293487],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000002370825,0.00023528362,0.0000052741293,0.9842101,0.00072666176,0.0011839647,0.00001552539,1.3039523e-8,1.6836826e-7,0.000017615992,0.00043802243,0.013165028],"study_design_scores_gemma":[0.0014881403,0.00020560554,0.000004716653,0.8735872,0.019155871,0.004836514,0.000008945674,0.0000022395466,1.0001341e-7,0.0000014944479,0.100326985,0.000382214],"about_ca_topic_score_codex":0.000017860864,"about_ca_topic_score_gemma":0.0000036053968,"teacher_disagreement_score":0.1106229,"about_ca_system_score_codex":0.0006043377,"about_ca_system_score_gemma":0.002062362,"threshold_uncertainty_score":0.9997113},"labels":[],"label_agreement":null},{"id":"W2985196709","doi":"10.1182/blood.v106.11.1532.1532","title":"Characterization of Gene Expression Associated with Cyclophosphamide Resistance in Chronic Myeloid Leukemia (CML).","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Biology; Fluorescence in situ hybridization; Molecular biology; Myeloid leukemia; Chromosomal translocation; Leukemia; Cancer research; Gene; Genetics; Chromosome","score_opus":0.008037697384282326,"score_gpt":0.22493923227944498,"score_spread":0.21690153489516265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985196709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972972,0.00068701344,0.000043711494,0.00008385528,0.000027249545,0.00046971094,0.00002614557,0.00006805352,0.0012970403],"genre_scores_gemma":[0.99596256,0.00016898697,0.0014925421,0.000062402876,0.00013853714,0.000054345517,0.00031387727,0.00004325804,0.00176347],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985776,0.00006877788,0.00040318645,0.00029513016,0.00034395533,0.00031135915],"domain_scores_gemma":[0.9991274,0.00005169514,0.0002621158,0.00039059084,0.000079333826,0.00008890388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016506821,0.00020128067,0.00038970975,0.000111715024,0.000048903617,0.0000067727688,0.00009570902,0.0001465339,0.000079492536],"category_scores_gemma":[0.00009026993,0.00017024495,0.00005006174,0.00034910298,0.000053907883,0.00013665503,0.000023952236,0.00024510635,0.000016303728],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002577407,0.00059175404,0.03144392,0.0000981187,0.0000966915,0.00006429101,0.00041073348,0.000035588982,0.9663565,0.00000874805,0.000025683863,0.00061024266],"study_design_scores_gemma":[0.010557393,0.00020749313,0.3320315,0.00088514993,0.00010969444,0.000011962598,0.000010706856,0.0000308767,0.6557379,0.0000049724413,0.0002933007,0.000119067554],"about_ca_topic_score_codex":0.000056218192,"about_ca_topic_score_gemma":0.000577318,"teacher_disagreement_score":0.3106186,"about_ca_system_score_codex":0.0027918743,"about_ca_system_score_gemma":0.0009582029,"threshold_uncertainty_score":0.7300654},"labels":[],"label_agreement":null},{"id":"W2985202786","doi":"10.1182/blood-2019-130257","title":"Small-Volume Tubes to Reduce Anemia and Transfusion (STRATUS): A Pragmatic Stepped Wedge Cluster Randomized Trial","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Université de Sherbrooke; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Intensive care unit; Randomized controlled trial; Anemia; Blood transfusion; Randomization; Venipuncture; Blood volume; Emergency medicine; Intensive care medicine; Surgery; Internal medicine","score_opus":0.011265964662348693,"score_gpt":0.2433015280108974,"score_spread":0.23203556334854872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985202786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97374165,0.00024229373,0.0003252274,0.004140283,0.00045138432,0.011106848,0.0000045834117,0.00011936088,0.009868378],"genre_scores_gemma":[0.98468584,0.00030423212,0.0022767903,0.0017665271,0.00023741022,0.00038779504,0.00002564103,0.000047830108,0.010267914],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982119,0.00019631094,0.0005036445,0.0004580356,0.00030637372,0.0003237024],"domain_scores_gemma":[0.9990716,0.00015033444,0.00004217777,0.00040083996,0.000055677912,0.0002793645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076319015,0.00024998112,0.00083588203,0.00017590685,0.00006286814,0.000051936502,0.000099991135,0.00014211357,0.0005380152],"category_scores_gemma":[0.00010459661,0.00019395837,0.00019814672,0.00020178394,0.000052095973,0.00006275125,0.000046606652,0.00021641547,0.0001968001],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93512803,0.0023961863,0.0004802491,0.0011785703,0.0005221338,0.00006954549,0.0020709583,0.0000028473219,0.050799705,0.00042743917,0.0021301,0.004794246],"study_design_scores_gemma":[0.9880857,0.0011934019,0.0006733202,0.00028888078,0.0015235158,0.00006393427,0.00024474668,0.000104366954,0.0046734605,0.00003833056,0.0028640705,0.00024626974],"about_ca_topic_score_codex":0.00008565903,"about_ca_topic_score_gemma":0.000044378787,"teacher_disagreement_score":0.05295768,"about_ca_system_score_codex":0.0000130154995,"about_ca_system_score_gemma":0.00006817695,"threshold_uncertainty_score":0.7909393},"labels":[],"label_agreement":null},{"id":"W2985204563","doi":"10.1182/blood-2019-127946","title":"Cross-Sectional Comparative Study of PK-Guided Switch between Standard Half-Life and Extended Half-Life Factor VIII Products","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Interquartile range; Pharmacokinetics; Half-life; Haemophilia; Trough level; Internal medicine; Gastroenterology; Nuclear medicine; Surgery; Transplantation","score_opus":0.10327416462246716,"score_gpt":0.38989792731273165,"score_spread":0.28662376269026446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985204563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956408,0.0003022422,0.0000030849133,0.0004130583,0.00011059302,0.002112083,0.000074417985,0.000052334235,0.0012913966],"genre_scores_gemma":[0.9972971,0.000015898855,0.00014933416,0.000021795599,0.00030572354,0.00003568634,0.00005567881,0.000025390258,0.002093382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99752825,0.00011071936,0.00050286617,0.0005635777,0.00093893067,0.00035565582],"domain_scores_gemma":[0.99837005,0.00016647353,0.00013468038,0.00043772825,0.00055070856,0.00034038277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033152726,0.00024664882,0.0007457619,0.00017365754,0.00013206097,0.000048001824,0.00011937598,0.00011996996,0.00036451942],"category_scores_gemma":[0.00025321817,0.00017982227,0.00007263624,0.00028567386,0.00014486347,0.000120025434,0.00010387861,0.00028799174,0.000068095986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005103747,0.0023996506,0.9873336,0.00018528564,0.0009870474,0.000023915713,0.0015559609,0.0000016177304,0.006733274,0.00002493299,0.00015859926,0.00008576687],"study_design_scores_gemma":[0.016239362,0.0034559777,0.95376873,0.000042458854,0.00016390944,0.000016975022,0.0007289918,0.000009021878,0.025022097,0.000020281423,0.00036654464,0.00016567728],"about_ca_topic_score_codex":0.000116141404,"about_ca_topic_score_gemma":0.000016028822,"teacher_disagreement_score":0.033564873,"about_ca_system_score_codex":0.00004913516,"about_ca_system_score_gemma":0.0004928438,"threshold_uncertainty_score":0.73329395},"labels":[],"label_agreement":null},{"id":"W2985216272","doi":"10.1182/blood-2019-128884","title":"Analysis of the Eligibility of Patients with Sickle Cell Disease for Palliative Care","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Psychosocial; Quality of life (healthcare); Disease; Palliative care; Univariate analysis; Delirium; Multivariate analysis; Adverse effect; Pediatrics; Physical therapy; Intensive care medicine; Internal medicine; Psychiatry","score_opus":0.004496675770891952,"score_gpt":0.23258858615794412,"score_spread":0.22809191038705218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985216272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99810576,0.0003130451,0.000009406933,0.000037582387,0.000020438447,0.0006606425,0.0002028016,0.0000043852115,0.0006459202],"genre_scores_gemma":[0.9997314,0.000009257448,0.00005300466,0.000035414287,0.0000030485241,0.0000067033957,0.00006416972,0.0000058955084,0.00009106757],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994859,0.000013587276,0.00013752963,0.00012412234,0.00015734894,0.000081473576],"domain_scores_gemma":[0.9992944,0.000032088214,0.00010512625,0.00030545998,0.00021642262,0.000046523393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000028794366,0.00006090287,0.00022016875,0.00003624758,0.000016622733,0.0000010265751,0.000052450745,0.000034085897,0.000029348683],"category_scores_gemma":[0.00003139164,0.000031900963,0.0001745952,0.00029308654,0.00004306973,0.000010423679,0.000016987116,0.00004253728,9.463233e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000232762,0.0007337494,0.9972013,0.00034183898,0.00048146606,1.5184328e-7,0.00069118594,0.00011353219,0.00010786857,0.000009325884,0.00000999593,0.000076783974],"study_design_scores_gemma":[0.0039338,0.00027645688,0.9871602,0.00004820326,0.0048382706,5.1653766e-9,0.00066652434,0.000091196685,0.0028637622,0.000009346658,0.00006751339,0.000044700802],"about_ca_topic_score_codex":0.000026883912,"about_ca_topic_score_gemma":0.000010741266,"teacher_disagreement_score":0.0100411195,"about_ca_system_score_codex":0.0000085350275,"about_ca_system_score_gemma":0.00007157576,"threshold_uncertainty_score":0.13008836},"labels":[],"label_agreement":null},{"id":"W2985248532","doi":"10.1182/blood-2019-129805","title":"Safety, Efficacy, and PK of the BCL2 Inhibitor Venetoclax in Combination with Chemotherapy in Pediatric and Young Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Phase 1 Study","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Venetoclax; Ven; Internal medicine; Population; Tumor lysis syndrome; Refractory (planetary science); Gastroenterology; Oncology; Chemotherapy; Leukemia; Chronic lymphocytic leukemia","score_opus":0.004360733275188402,"score_gpt":0.23479103143714344,"score_spread":0.23043029816195504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985248532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99656063,0.00019552109,0.0000034818258,0.00008659497,0.000048465634,0.002963671,0.000024688014,0.000021281869,0.00009568576],"genre_scores_gemma":[0.998808,0.00071066746,0.00011083728,0.000074284384,0.00004357795,0.000053440264,0.000027378619,0.00006125353,0.0001105629],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99782634,0.00013854595,0.00045257647,0.00056612864,0.0006374073,0.0003790175],"domain_scores_gemma":[0.99881154,0.00019216914,0.00022948372,0.00042949518,0.00019037267,0.0001469408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003004873,0.0003212622,0.00058136164,0.0003520191,0.00006904787,0.000029079141,0.00014909462,0.00017689235,0.0000061425458],"category_scores_gemma":[0.0000719498,0.0002111323,0.000024237374,0.00070457807,0.0001891068,0.00020549522,0.00015158794,0.0005561118,0.0000020269833],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006777628,0.0017990795,0.98538953,0.00017894166,0.00024856496,0.00006984962,0.0021335282,0.000009135395,0.0019469144,0.000007592196,0.000024571675,0.0014146524],"study_design_scores_gemma":[0.15748627,0.0069147367,0.8331204,0.00023522894,0.0004601672,0.00006370362,0.00029033367,0.00029116505,0.0009165514,0.0000052244905,0.0000074962963,0.00020871358],"about_ca_topic_score_codex":0.00029027613,"about_ca_topic_score_gemma":0.00017322699,"teacher_disagreement_score":0.15226912,"about_ca_system_score_codex":0.0009012814,"about_ca_system_score_gemma":0.0010051469,"threshold_uncertainty_score":0.8609725},"labels":[],"label_agreement":null},{"id":"W2985271579","doi":"10.1182/blood-2019-124739","title":"Baseline Mutational Status of Patients with Myelofibrosis and Anemia in the Realise Trial and Impact on Outcome","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Myelofibrosis; Medicine; Ruxolitinib; Internal medicine; Clinical endpoint; Anemia; Essential thrombocythemia; Surrogate endpoint; Polycythemia vera; Adverse effect; Gastroenterology; Thrombocytosis; Clinical trial; Bone marrow; Platelet","score_opus":0.012504991271558307,"score_gpt":0.28133805204773327,"score_spread":0.26883306077617497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985271579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984276,0.00007499808,4.7680734e-7,0.00016279821,0.000013973606,0.00090213626,0.00015904316,0.000003526766,0.00025543247],"genre_scores_gemma":[0.9994021,0.000048414255,0.00017670174,0.00014881954,0.000023216826,0.000035275854,0.00014419614,0.0000073223805,0.000013941761],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992592,0.00005587441,0.00017853241,0.00015065323,0.00022888882,0.00012686595],"domain_scores_gemma":[0.9993915,0.00030605675,0.00006768068,0.00012157586,0.000048311627,0.000064853055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012778952,0.000106427025,0.00023109774,0.000058634334,0.000017681748,0.000009488372,0.00001733833,0.00003119525,0.00005558026],"category_scores_gemma":[0.0000690431,0.00005082178,0.000025245463,0.00007626211,0.000028292861,0.000031601263,0.000007990983,0.00006305028,0.0000020358411],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00888962,0.0013939537,0.98832977,0.00003562882,0.000054023112,0.000008796155,0.00031101366,0.0000040406358,0.00001690532,0.00007478942,0.000035893732,0.0008455901],"study_design_scores_gemma":[0.07414079,0.0045678173,0.92068404,0.000054770735,0.00012304798,0.000004211801,0.000053333682,0.000011140098,0.00027437008,0.00001012712,0.00002745564,0.000048877304],"about_ca_topic_score_codex":0.00012385624,"about_ca_topic_score_gemma":0.000022841863,"teacher_disagreement_score":0.067645684,"about_ca_system_score_codex":0.000016979853,"about_ca_system_score_gemma":0.000045328838,"threshold_uncertainty_score":0.20724522},"labels":[],"label_agreement":null},{"id":"W2985324256","doi":"10.1182/blood-2019-127046","title":"Correlations between von Willebrand Factor Antigen Levels and Factor VIII Pharmacokinetics Are Similar across Different FVIII Products in Patients with Severe Hemophilia A","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Von Willebrand factor; Recombinant DNA; Pharmacokinetics; Internal medicine; Factor IX; Gastroenterology; Immunology; Pharmacology; Platelet; Chemistry","score_opus":0.029487969675342566,"score_gpt":0.2877102531523274,"score_spread":0.25822228347698484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985324256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964345,0.00018379127,0.0000021037977,0.00061671535,0.00007507335,0.0019156712,0.0006412557,0.000041163108,0.00008969784],"genre_scores_gemma":[0.9983625,0.000047776364,0.00006910508,0.00003760596,0.00011673063,0.000017276601,0.00017136891,0.00004358132,0.0011340897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820036,0.000051154835,0.0002687752,0.00048561048,0.0005126181,0.0004815045],"domain_scores_gemma":[0.99909806,0.000084842664,0.00009207859,0.00033327998,0.0001662469,0.00022551559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005380336,0.0002940433,0.0005007121,0.00011849616,0.00010545131,0.000037366273,0.000092846814,0.00013758517,0.00013701919],"category_scores_gemma":[0.00005352652,0.00019537816,0.000045615572,0.00025909938,0.000080009486,0.00012507345,0.000089558846,0.0003318825,0.000033475462],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018374034,0.00096592563,0.99498075,0.00021248945,0.00023330387,0.000022491828,0.000886544,0.0000018382543,0.0014696082,7.462038e-7,0.000030167037,0.0010124145],"study_design_scores_gemma":[0.016303131,0.00065557857,0.9728939,0.00023290569,0.00011067489,0.0000050581407,0.00006094549,0.000015069842,0.009219521,0.000005002767,0.0002641679,0.0002340656],"about_ca_topic_score_codex":0.0000071042195,"about_ca_topic_score_gemma":0.000008604264,"teacher_disagreement_score":0.022086851,"about_ca_system_score_codex":0.000050745686,"about_ca_system_score_gemma":0.000065205124,"threshold_uncertainty_score":0.79672897},"labels":[],"label_agreement":null},{"id":"W2985350284","doi":"10.1182/blood-2019-122511","title":"Evaluation of the Role of Plerixafor in Peripheral Blood Progenitor Cell Mobilization and Collection in Autologous Donors with Multiple Myeloma and Non-Hodgkin Lymphoma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec; Université Laval; Hôpital de l'Enfant-Jésus","funders":"","keywords":"Plerixafor; Medicine; Multiple myeloma; Population; Autologous stem-cell transplantation; Mobilization; Transplantation; Regimen; CD34; Oncology; Internal medicine; Surgery; CXCR4; Stem cell; Biology","score_opus":0.006273364140440253,"score_gpt":0.22059654539868134,"score_spread":0.2143231812582411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985350284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99760294,0.0002477541,0.000013603532,0.000010916389,0.000028328775,0.0017551678,0.000003941409,0.0000071581785,0.00033018622],"genre_scores_gemma":[0.999178,0.000028814013,0.00065779226,0.0000039117976,0.0000077209725,0.00008310553,0.000008064396,0.000013175099,0.0000194414],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990277,0.000108448294,0.0002702383,0.00018148581,0.00030852034,0.000103561295],"domain_scores_gemma":[0.9995333,0.000056752197,0.00012422676,0.00013409494,0.00012657217,0.000025084004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003932952,0.0000938397,0.00021597811,0.00010764141,0.000017395605,0.000004564221,0.000030605166,0.000086824264,0.000010506802],"category_scores_gemma":[0.000034161818,0.000070035094,0.00001810105,0.0002906258,0.000046294612,0.000053226515,0.000009633809,0.000043191274,2.9143604e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018659825,0.00046832307,0.8077851,0.00027884534,0.000024539157,0.0000011467276,0.0026787918,0.00011473821,0.1874007,0.0000030659057,1.5618687e-7,0.001057995],"study_design_scores_gemma":[0.011251981,0.00038269017,0.6221761,0.00018724737,0.00025061186,0.000054969376,0.00076089357,0.015368945,0.34950033,0.000014760583,7.6810824e-7,0.000050674793],"about_ca_topic_score_codex":0.00025251138,"about_ca_topic_score_gemma":0.0006674103,"teacher_disagreement_score":0.18560898,"about_ca_system_score_codex":0.00003421974,"about_ca_system_score_gemma":0.00018701302,"threshold_uncertainty_score":0.28559482},"labels":[],"label_agreement":null},{"id":"W2985360588","doi":"10.1182/blood-2019-131113","title":"A 14q32.31 Genomic-Imprinted DLK1-DIO3 microrna promotes Leukemogenesis By Inducing Stem Cell Quiescence and Inhibiting NK Cell Anti-Cancer Immunity","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Biology; Cancer research; Stem cell; Progenitor cell; Leukemia; Cancer stem cell; Myeloid leukemia; Immunology; Cell biology","score_opus":0.006716482177546588,"score_gpt":0.20570398636999276,"score_spread":0.19898750419244618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985360588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926451,0.0063821347,0.00006845761,0.000020307321,0.00006142775,0.00045343186,0.00006546678,0.000026741027,0.00027697458],"genre_scores_gemma":[0.9981897,0.00039455903,0.00044361452,0.000062961626,0.00008865192,0.000020364114,0.00010396015,0.000047400154,0.00064881134],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986474,0.000083766274,0.00028923666,0.0005328373,0.000108038505,0.00033870348],"domain_scores_gemma":[0.9991434,0.000014359812,0.00022060901,0.00042209757,0.00009257593,0.000106940905],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017970178,0.00024883627,0.0002211576,0.000046730456,0.00011828757,0.000059474707,0.00021108959,0.00019925385,0.000018413422],"category_scores_gemma":[0.000010003345,0.0002658878,0.00008029584,0.000098224555,0.000063117426,0.000011693001,0.00029989652,0.00013430031,0.000018932884],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021432064,0.00018074752,0.02029441,0.00022604503,0.000048971877,0.0000013224708,0.00011963581,0.000011467939,0.9785353,5.3317666e-7,0.000079990416,0.00048014676],"study_design_scores_gemma":[0.0015387274,0.000077413555,0.0063894643,0.00007195639,0.000068584755,0.000010148391,0.00014684183,0.000045959245,0.99094003,0.0000017151647,0.0003855523,0.00032361504],"about_ca_topic_score_codex":0.00007503416,"about_ca_topic_score_gemma":0.000007060617,"teacher_disagreement_score":0.013904945,"about_ca_system_score_codex":0.000036213565,"about_ca_system_score_gemma":0.00014434101,"threshold_uncertainty_score":0.9999793},"labels":[],"label_agreement":null},{"id":"W2985365762","doi":"10.1182/blood-2019-127524","title":"Routine Double Filtration Plasmapheresis Affects Hemostatic Proteins and Prolongs Clotting Tests","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; McMaster University","funders":"","keywords":"Medicine; Partial thromboplastin time; Plasmapheresis; Hemostasis; Antithrombin; Fibrinogen; Hemostatics; Prothrombin time; Internal medicine; Coagulation; Gastroenterology; Pharmacology; Heparin; Immunology","score_opus":0.01829082684667323,"score_gpt":0.2798472543605583,"score_spread":0.2615564275138851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985365762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99060243,0.00018902271,0.0000017994648,0.0014991366,0.000024493627,0.0017596227,0.0000020267905,0.00006696925,0.005854492],"genre_scores_gemma":[0.99441165,0.00001556384,0.0011280641,0.000055936027,0.00006632818,0.00007574844,0.00002493729,0.00001924639,0.0042025256],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991569,0.000025206751,0.00011075665,0.00022854039,0.00023015628,0.00024846388],"domain_scores_gemma":[0.9995645,0.000065401335,0.000038376187,0.00017571154,0.00004280496,0.00011317811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015982134,0.00011177813,0.00018351048,0.000059298192,0.00006381147,0.000030494588,0.00003445408,0.00007103308,0.00011369597],"category_scores_gemma":[0.000067472494,0.000081627324,0.000031626372,0.0001447087,0.000029180048,0.00007797328,0.00002165998,0.00012564968,0.00011952781],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032702764,0.0008443757,0.835046,0.0006608099,0.00014325039,0.000114989634,0.0004988888,9.4873116e-7,0.15913254,0.000101249716,0.0002282512,0.0029016596],"study_design_scores_gemma":[0.028363025,0.003292618,0.25915557,0.00061189156,0.0003021427,0.0002864964,0.0002405147,0.000443461,0.7063061,0.00009323782,0.0006076734,0.00029724374],"about_ca_topic_score_codex":0.000030073064,"about_ca_topic_score_gemma":0.00001597554,"teacher_disagreement_score":0.5758904,"about_ca_system_score_codex":0.00001584066,"about_ca_system_score_gemma":0.00007357968,"threshold_uncertainty_score":0.33286658},"labels":[],"label_agreement":null},{"id":"W2985415858","doi":"10.1182/blood-2019-126090","title":"Deformability Based Sorting of Stored Red Blood Cells Reveals Donor-Dependent Aging Curves","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Biophysics; Microfluidics; Constriction; Chemistry; Biomedical engineering; Mechanics; Nanotechnology; Materials science; Biology; Medicine; Physics","score_opus":0.014465261209474169,"score_gpt":0.24608285310559133,"score_spread":0.23161759189611716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985415858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99531037,0.00046682375,0.000036178648,0.00028879035,0.000306004,0.000525854,0.000013051758,0.000082206956,0.0029707104],"genre_scores_gemma":[0.99725604,0.000072903254,0.001024606,0.0007500832,0.00011395327,0.000012759965,0.000038875747,0.00002099915,0.0007097848],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99852484,0.000118964796,0.00051001884,0.00032501473,0.00024941034,0.00027171898],"domain_scores_gemma":[0.9987882,0.00012748527,0.00027885847,0.0005457258,0.00014840838,0.000111321555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050004775,0.00015883674,0.00049566716,0.000086377106,0.00004082369,0.000004303067,0.00009199959,0.00011054218,0.0005485859],"category_scores_gemma":[0.00014943161,0.00013609567,0.00017355545,0.00015103543,0.000047820282,0.000060417286,0.00004433311,0.00021166031,0.000059415015],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001336921,0.0007776198,0.16603221,0.0014545984,0.00010307684,0.000012344302,0.00008486756,0.00002795555,0.831,0.000014179133,0.00019804791,0.00016142457],"study_design_scores_gemma":[0.010186134,0.0011037354,0.09403011,0.00094553595,0.00069159747,0.00005420892,0.00019751208,0.00016969415,0.89196277,0.000078590376,0.00030418503,0.00027594666],"about_ca_topic_score_codex":0.00004010193,"about_ca_topic_score_gemma":0.0000065066392,"teacher_disagreement_score":0.0720021,"about_ca_system_score_codex":0.000019911007,"about_ca_system_score_gemma":0.00011388552,"threshold_uncertainty_score":0.60066307},"labels":[],"label_agreement":null},{"id":"W2985424375","doi":"10.1182/blood-2019-125479","title":"Treatment of Multiple Myeloma Patients Progressing on Lenalidomide-Based Regimens","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Saint John Regional Hospital; Queen Elizabeth II Health Sciences Centre; Dalhousie University; London Health Sciences Centre; Hôpital Maisonneuve-Rosemont; University of Ottawa; McGill University Health Centre; University of New Brunswick; Leukemia & Lymphoma Society of Canada; University of British Columbia; University of Calgary; Princess Margaret Cancer Centre; CancerCare Manitoba; Ottawa Hospital","funders":"","keywords":"Lenalidomide; Carfilzomib; Medicine; Regimen; Multiple myeloma; Ixazomib; Bortezomib; Internal medicine; Thalidomide; Oncology; Surgery; Gastroenterology","score_opus":0.024710324022573435,"score_gpt":0.29131473213418857,"score_spread":0.2666044081116151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985424375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955863,0.00014165531,0.0000025447046,0.00011874907,0.000055068213,0.0013631654,0.000036816866,0.00004535781,0.0026503853],"genre_scores_gemma":[0.99783176,0.000011358721,0.0011691201,0.00003395316,0.00004325756,0.00007536844,0.00014659979,0.000029719457,0.0006588313],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998634,0.00005161888,0.00023190299,0.00030366864,0.00044654214,0.00033227232],"domain_scores_gemma":[0.9989859,0.00014000403,0.00010841257,0.00045984946,0.00012157337,0.00018424718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000042070904,0.00019060193,0.0003645786,0.00014145685,0.000045270303,0.000011748609,0.00005640201,0.00006762776,0.000103765764],"category_scores_gemma":[0.00007885364,0.00013206578,0.00015586973,0.00012505743,0.000048068323,0.00003638497,0.000014079372,0.000057739166,0.00019967894],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017147278,0.01015063,0.9613425,0.00010090127,0.00030915727,0.0000952058,0.00008136774,0.0000045635306,0.0047365734,0.000011348386,0.000023841576,0.021429189],"study_design_scores_gemma":[0.07201205,0.010439337,0.622169,0.0002996016,0.00019898482,0.00000837963,0.000022063747,0.00042224964,0.29324448,0.0000055587057,0.0010298144,0.00014843777],"about_ca_topic_score_codex":0.000050957962,"about_ca_topic_score_gemma":0.0000043027044,"teacher_disagreement_score":0.33917347,"about_ca_system_score_codex":0.00009908758,"about_ca_system_score_gemma":0.00011926019,"threshold_uncertainty_score":0.5385486},"labels":[],"label_agreement":null},{"id":"W2985424883","doi":"10.1182/blood-2019-124934","title":"Initial Characterization and Toxicology of an Nmt Inhibitor in Development for Hematologic Malignancies","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Myristoylation; Dasatinib; Kinase; LYN; Cancer research; Proto-oncogene tyrosine-protein kinase Src; Ibrutinib; Apoptosis; Chemistry; Biology; Cell growth; Leukemia; Pharmacology; Chronic lymphocytic leukemia; Myeloid leukemia; Biochemistry; Immunology; Phosphorylation","score_opus":0.017481372173402985,"score_gpt":0.2693090047003008,"score_spread":0.25182763252689777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985424883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99908656,0.00004197985,0.000019902498,0.000048805552,0.000058648006,0.00063743786,0.000007994492,0.000013537791,0.00008511066],"genre_scores_gemma":[0.9974895,0.00000721393,0.0020932013,0.00007418929,0.000029399876,0.000064560416,0.00012675664,0.000008489446,0.00010666306],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994522,0.000014090739,0.00019992057,0.00014974813,0.00006182621,0.00012225016],"domain_scores_gemma":[0.9997473,0.000031102398,0.00006512289,0.000093146686,0.000029631221,0.00003371806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007175638,0.000073429386,0.0002262439,0.00006873207,0.000011065836,0.000002718022,0.000024216133,0.00008015825,0.000030780586],"category_scores_gemma":[0.00003371486,0.0000635139,0.000013724889,0.00004975357,0.000020709598,0.000048613063,0.00002081671,0.000032555858,0.000005030852],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023601294,0.0011314559,0.20807227,0.0004825825,0.000059212714,0.000032627264,0.0010052313,2.8768747e-7,0.7852207,0.00021736992,0.000003073503,0.0035391648],"study_design_scores_gemma":[0.01076556,0.00083747285,0.3449694,0.00012898014,0.000043535423,0.00010383126,0.000079029865,0.000032350683,0.64258826,0.000021136206,0.00035211706,0.00007831935],"about_ca_topic_score_codex":0.000004322218,"about_ca_topic_score_gemma":0.000015793099,"teacher_disagreement_score":0.14263244,"about_ca_system_score_codex":0.00006134505,"about_ca_system_score_gemma":0.00022137549,"threshold_uncertainty_score":0.25900218},"labels":[],"label_agreement":null},{"id":"W2985480179","doi":"10.1182/blood-2019-129845","title":"Landmark Response and Survival Analyses from 206 AML Patients Treated with Guadecitabine in a Phase 2 Study Demonstrate the Importance of Adequate Treatment Duration to Maximize Response and Survival Benefit. Survival Benefit Not Restricted to Patients with Objective Response","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Survival analysis; Cell survival; Overall survival; Medicine; Internal medicine; Oncology; Biology; Apoptosis; Genetics","score_opus":0.01624265700697788,"score_gpt":0.290430284858995,"score_spread":0.27418762785201717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985480179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996142,0.00007718374,0.000009190137,0.00012015361,0.000043126045,0.002473673,0.001106533,0.000014575292,0.0000135069595],"genre_scores_gemma":[0.9990353,0.00001638493,0.00015171377,0.000020623851,0.000024016894,0.00018550096,0.00029290808,0.000055485074,0.00021804546],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956557,0.0016351826,0.0006166027,0.0009760742,0.00065869663,0.0004577551],"domain_scores_gemma":[0.99744684,0.0007520501,0.00026445056,0.00079900876,0.0004799329,0.00025772103],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00094276515,0.00044455394,0.00061429833,0.00033219586,0.00012997931,0.00006003491,0.00020984918,0.00014492855,0.000011315574],"category_scores_gemma":[0.0007407294,0.0003044025,0.00005472724,0.0007995088,0.00011467044,0.000026074991,0.00015027421,0.00014932234,0.0000035465443],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2510979,0.0021334565,0.5786661,0.0000035851724,0.0002932453,0.00003756797,0.0007409692,0.000053793297,0.16674845,3.6279488e-7,0.0000030026201,0.00022156718],"study_design_scores_gemma":[0.025621373,0.018763931,0.84659827,0.00004629098,0.00014530109,0.0000019987,0.00065804424,0.000011140934,0.10782015,8.8487445e-7,0.000015272211,0.00031735236],"about_ca_topic_score_codex":0.0017020053,"about_ca_topic_score_gemma":0.006583188,"teacher_disagreement_score":0.26793215,"about_ca_system_score_codex":0.00011218314,"about_ca_system_score_gemma":0.00021622865,"threshold_uncertainty_score":0.9999408},"labels":[],"label_agreement":null},{"id":"W2985481325","doi":"10.1182/blood-2019-130532","title":"Trial in Progress: Feasibility and Validation Study of the LSC17 Score in Acute Myeloid Leukemia Patients","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Juravinski Cancer Centre; Ottawa Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Oncology; Induction chemotherapy; Myeloid leukemia; Clinical endpoint; Multivariate analysis; Clinical trial; Stem cell; Chemotherapy regimen; Chemotherapy; Biology","score_opus":0.030265238646037113,"score_gpt":0.3108536707774006,"score_spread":0.28058843213136353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985481325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940175,0.00005407186,9.133178e-8,0.000086515414,0.00008245296,0.0055653136,0.000006854257,0.000010669664,0.000176539],"genre_scores_gemma":[0.99969345,0.000013843327,0.0000394896,0.000020566597,0.000031948908,0.00008315868,0.000012716864,0.000014345506,0.00009045281],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983303,0.00022507079,0.00039376417,0.0003298002,0.0004990118,0.00022205806],"domain_scores_gemma":[0.99915165,0.00007028902,0.00011454282,0.0005134469,0.000096838354,0.00005324109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005990391,0.00011899812,0.0003314832,0.00014371857,0.000022123017,0.000012744673,0.00016601071,0.000095544514,0.000017888182],"category_scores_gemma":[0.00023714312,0.00008029492,0.000038644313,0.00045277184,0.000075106655,0.0000959342,0.00018966218,0.00034780026,0.0000061309506],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061558397,0.0027954862,0.9882576,0.00007146472,0.000048417012,0.000008413777,0.0010960806,0.0000013568108,0.00054332643,0.0000037379252,0.000017843638,0.0010004413],"study_design_scores_gemma":[0.15044813,0.0019004735,0.84463793,0.00009076574,0.00007111569,0.0000026389669,0.00029958933,0.00003491352,0.0024224333,0.000023147602,0.0000070448004,0.00006184102],"about_ca_topic_score_codex":0.00021305785,"about_ca_topic_score_gemma":0.00013613331,"teacher_disagreement_score":0.1442923,"about_ca_system_score_codex":0.00032126406,"about_ca_system_score_gemma":0.00034940089,"threshold_uncertainty_score":0.3274332},"labels":[],"label_agreement":null},{"id":"W2985546444","doi":"10.1182/blood-2019-127826","title":"Inhibition of the MiR-185-PAK6-Mediated Survival and Metabolic Pathways Selectively Targets Drug-Resistant CML Stem/Progenitor Cells","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; BC Cancer Agency; Terry Fox Research Institute","funders":"","keywords":"Cancer research; Stem cell; Biology; Myeloid leukemia; CD34; Progenitor cell; microRNA; Transcriptome; Tyrosine kinase; Gene expression profiling; Signal transduction; Gene expression; Cell biology; Gene; Genetics","score_opus":0.010034371061484203,"score_gpt":0.20809709615340616,"score_spread":0.19806272509192197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985546444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947592,0.0025574889,0.0000014650866,0.000079551515,0.00026965013,0.0011113925,0.00016259341,0.00005325075,0.0010054155],"genre_scores_gemma":[0.9988578,0.00011169408,0.00012939177,0.00004651913,0.00010952108,0.00003743641,0.000039061128,0.00004047687,0.0006281013],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99838823,0.0001335177,0.00034014805,0.00036577095,0.00044515962,0.00032717295],"domain_scores_gemma":[0.9989856,0.00012951034,0.00020223463,0.00040555888,0.00014602592,0.000131104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002230577,0.00023555984,0.00048340717,0.0000780963,0.00006546351,0.0000122743495,0.000089006615,0.00011209463,0.00007011185],"category_scores_gemma":[0.000042964086,0.00016266124,0.00012750509,0.00030571118,0.00007688528,0.000065641376,0.00008509337,0.00019344952,0.000070701746],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018909854,0.0007789944,0.03777781,0.00020833628,0.00046190716,0.000025058815,0.00081279746,0.000001028364,0.9592588,0.00011654398,0.0001367519,0.0002328872],"study_design_scores_gemma":[0.010530326,0.00021133218,0.10800892,0.00013107335,0.0005858709,0.000022684017,0.00030201263,0.000029444773,0.8791876,0.000028881443,0.0008022656,0.00015959516],"about_ca_topic_score_codex":0.0001774216,"about_ca_topic_score_gemma":0.000053017116,"teacher_disagreement_score":0.08007119,"about_ca_system_score_codex":0.00012153757,"about_ca_system_score_gemma":0.00040401713,"threshold_uncertainty_score":0.66331327},"labels":[],"label_agreement":null},{"id":"W2985586814","doi":"10.1182/blood-2019-123947","title":"Improvement in Quality of Life Outcomes and Bleeding Rates among Patients Switching from On-demand FVIII to Prophylactic BAY 94-9027 in the PROTECT VIII Study","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Randomization; Randomized controlled trial; Quality of life (healthcare); Surgery; Dosing; Internal medicine; Bay","score_opus":0.0302128096853237,"score_gpt":0.3263160139848239,"score_spread":0.2961032042995002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985586814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99435115,0.000035544264,5.0538137e-7,0.00045976817,0.000035911664,0.0049160947,0.0000040944237,0.00000831013,0.00018859384],"genre_scores_gemma":[0.99959195,0.0000031054904,0.000029198754,0.00009294277,0.000025426978,0.00017796826,0.0000037738664,0.000012804381,0.00006285121],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983197,0.00019288038,0.00041625352,0.0003118361,0.0005215062,0.00023784803],"domain_scores_gemma":[0.9991788,0.00030816186,0.0000907865,0.000289891,0.000044991342,0.00008732995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009864316,0.0001525727,0.0004301832,0.00017052284,0.000042471835,0.000027389859,0.000107510576,0.000050993032,0.000015493446],"category_scores_gemma":[0.00041383432,0.00008345543,0.00004019988,0.000213019,0.000018796823,0.00006781481,0.000086101994,0.00025167907,0.000008478531],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038043025,0.003967252,0.9839994,0.00013741163,0.00010855265,0.0000102817485,0.0048494046,0.000001432808,0.0058232574,0.0000034200075,0.0000010393119,0.0007181328],"study_design_scores_gemma":[0.0114846,0.0033005287,0.9783101,0.00014119418,0.000043120148,9.273236e-8,0.0028379015,0.000016810503,0.0037458006,0.00003173614,8.0170287e-7,0.00008732758],"about_ca_topic_score_codex":0.0015445115,"about_ca_topic_score_gemma":0.0004114475,"teacher_disagreement_score":0.011104169,"about_ca_system_score_codex":0.000037282294,"about_ca_system_score_gemma":0.000049613864,"threshold_uncertainty_score":0.3403214},"labels":[],"label_agreement":null},{"id":"W2985611003","doi":"10.1182/blood-2019-127443","title":"Comparison of Lost Productivity Due to Eculizumab and Ravulizumab Treatments for Paroxysmal Nocturnal Hemoglobinuria in France, Germany, Italy, Russia, Spain, the United Kingdom, and the United States","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Presenteeism; Medicine; Productivity; Eculizumab; Population; Absenteeism; Demography; Pediatrics; Environmental health; Economic growth; Economics; Internal medicine","score_opus":0.018426829886716477,"score_gpt":0.28214185991194046,"score_spread":0.263715030025224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985611003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99514997,0.0012721817,0.000026940748,0.0007846551,0.00017612823,0.002299659,0.00020723663,0.000019005733,0.00006425198],"genre_scores_gemma":[0.99925405,0.000011262406,0.000033257656,0.000101681595,0.000024051178,0.00011258248,0.00021983324,0.000016501348,0.00022679243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840677,0.00044769945,0.00041934865,0.00034118377,0.00006334292,0.00032165082],"domain_scores_gemma":[0.99867153,0.00058406784,0.00022854314,0.0004020094,0.0000840042,0.000029843452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037714123,0.00022953273,0.0005223776,0.00017976035,0.00016064016,0.000029790852,0.0002378916,0.00008509467,0.0000655779],"category_scores_gemma":[0.000081594546,0.0001356885,0.00006455342,0.00032518958,0.0002946207,0.000054542947,0.00015537285,0.0001500413,0.000020130235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043931464,0.0024565568,0.95706767,0.00037243374,0.0022970273,0.000010835951,0.0065266546,0.0002933048,0.020421002,0.0039901286,0.0014358357,0.00073543296],"study_design_scores_gemma":[0.0562523,0.0014436361,0.88357806,0.00036082263,0.0011299094,0.00020672729,0.0022750092,0.0005236373,0.03248956,0.0007055081,0.020442817,0.0005920103],"about_ca_topic_score_codex":0.0010199965,"about_ca_topic_score_gemma":0.00013292907,"teacher_disagreement_score":0.073489584,"about_ca_system_score_codex":0.000023446506,"about_ca_system_score_gemma":0.00003812716,"threshold_uncertainty_score":0.55332166},"labels":[],"label_agreement":null},{"id":"W2985622627","doi":"10.1182/blood-2019-129385","title":"Can an Online Educational Module Improve Medical Trainee Confidence and Knowledge of Coagulation?","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Clinical Laboratory Practices and Quality Control","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; University Health Network; Sunnybrook Health Science Centre; St. Michael's Hospital; University of Toronto","funders":"","keywords":"Coagulation testing; Partial thromboplastin time; Medicine; Prothrombin time; Coagulation; Medical education; Surgery; Internal medicine","score_opus":0.04358376671368685,"score_gpt":0.3778793197249421,"score_spread":0.33429555301125524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985622627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904076,0.00033738566,0.00001212679,0.008133758,0.00012326743,0.00023441818,0.00007278307,0.000011293581,0.00066737516],"genre_scores_gemma":[0.9979897,0.000024996825,0.00035584398,0.00071935426,0.0003286013,0.0000043768446,0.00006448716,0.000007946295,0.0005046626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911547,0.00007135952,0.00032126735,0.0001957461,0.00019992465,0.00009624698],"domain_scores_gemma":[0.99860764,0.00058411225,0.00011293169,0.00022848083,0.00024229752,0.00022451847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004698668,0.00007166848,0.0002479599,0.00002989617,0.000018120218,0.000007917933,0.00005934573,0.00009536379,0.00085398916],"category_scores_gemma":[0.0012779455,0.000060109567,0.00003151338,0.00007582548,0.000075082666,0.000088774286,0.000020131405,0.00015901252,0.00001021159],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011042451,0.03326693,0.644853,0.0015505307,0.00092350505,0.000020873424,0.004246504,0.000004990033,0.121755145,0.14579257,0.0006148739,0.04586683],"study_design_scores_gemma":[0.017582938,0.0021733176,0.9591281,0.00025825456,0.00056916074,0.00006696347,0.0007451279,0.011052836,0.0016234434,0.0024709825,0.004036501,0.0002924174],"about_ca_topic_score_codex":0.00011034386,"about_ca_topic_score_gemma":0.00027301093,"teacher_disagreement_score":0.31427506,"about_ca_system_score_codex":0.0000060673547,"about_ca_system_score_gemma":0.00063723145,"threshold_uncertainty_score":0.93505824},"labels":[],"label_agreement":null},{"id":"W2985638537","doi":"10.1182/blood-2019-130332","title":"Quantitative Modeling of Azacitidine Resistance in Patients with Myelodysplastic Syndrome Identifies Distinct Phenotypes of Disease Progression: Evidence for the Presence of a Disease Versus Native Clone Effect","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Myelodysplastic syndromes; Azacitidine; Bone marrow; Haematopoiesis; International Prognostic Scoring System; clone (Java method); Immunology; Leukemia; Disease; Oncology; Stem cell; Medicine; Biology; Internal medicine; Genetics; Gene","score_opus":0.028571509215519278,"score_gpt":0.3231478633011585,"score_spread":0.29457635408563926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985638537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936485,0.0024771593,0.0005294264,0.000102392696,0.00005985852,0.0029641532,0.00018526026,0.000011053903,0.000022187778],"genre_scores_gemma":[0.9988922,0.00003672106,0.0007060419,0.000002222906,0.000012035747,0.00023703981,0.000029928258,0.000025856272,0.000057978963],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978956,0.00016545985,0.00043282012,0.00037266995,0.0008674267,0.00026601806],"domain_scores_gemma":[0.99402565,0.0043644565,0.00030320187,0.00050802383,0.0006587234,0.0001399666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048406504,0.00018678974,0.00051978754,0.00014620116,0.00004728402,0.00000824399,0.000273296,0.000036408444,0.000011051357],"category_scores_gemma":[0.005184834,0.00011650367,0.000097351774,0.0004758348,0.00036272453,0.00020621307,0.00011900624,0.00016805057,0.0000017211073],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3047935,0.0021061539,0.6718358,0.0137799885,0.0008633537,0.00005448738,0.0012989885,0.002697653,0.0015741684,0.00077527994,0.000019789544,0.0002008316],"study_design_scores_gemma":[0.024967948,0.007824024,0.9239444,0.015445602,0.0013324554,6.552253e-7,0.0002604947,0.02277296,0.0029937127,0.00020895633,8.300307e-7,0.000247974],"about_ca_topic_score_codex":0.000037143906,"about_ca_topic_score_gemma":0.00002904876,"teacher_disagreement_score":0.27982554,"about_ca_system_score_codex":0.00006471412,"about_ca_system_score_gemma":0.0004442983,"threshold_uncertainty_score":0.6207105},"labels":[],"label_agreement":null},{"id":"W2985638866","doi":"10.1182/blood-2019-129665","title":"Case Series: Outcome and Cost Analysis of Rituximab Versus Non-Targeted Immunosuppression As First Line Inhibitor Eradication in Acquired Hemophilia a","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; University of Calgary","funders":"","keywords":"Medicine; Rituximab; Internal medicine; Emergency department; Immunosuppression; Retrospective cohort study; Adverse effect; Pediatrics; Surgery","score_opus":0.024245315588086645,"score_gpt":0.3135780220956239,"score_spread":0.2893327065075373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985638866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997518,0.00042640508,0.0000014624254,0.00072535966,0.00008290478,0.0008032652,0.000037893704,0.000020249063,0.0003844768],"genre_scores_gemma":[0.9985162,0.00019522784,0.0001794213,0.000018295841,0.000045011657,0.00003801251,0.00021825724,0.000016672086,0.0007729048],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987289,0.00003977792,0.0004056997,0.00030647242,0.00028539207,0.00023379916],"domain_scores_gemma":[0.9991258,0.00013163988,0.000095890915,0.00041838977,0.000097682874,0.00013061528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019756146,0.00015813259,0.0005692824,0.0005126112,0.00005708021,0.0000134389775,0.00006362673,0.00014580406,0.00026087102],"category_scores_gemma":[0.00015235196,0.00012360733,0.00011835416,0.0008836859,0.000077137585,0.00012069138,0.00006801024,0.00012005105,0.00004106793],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036378358,0.0035894148,0.9281399,0.0004173017,0.0017495888,0.002245647,0.0011910601,0.000017331782,0.057664577,0.000012985763,0.000037689093,0.0012966588],"study_design_scores_gemma":[0.19840215,0.008016377,0.5509401,0.00089166005,0.010089387,0.0021254017,0.0017758297,0.008711105,0.2168641,0.000033913722,0.0011728362,0.0009771751],"about_ca_topic_score_codex":0.00022923708,"about_ca_topic_score_gemma":0.00013484196,"teacher_disagreement_score":0.37719983,"about_ca_system_score_codex":0.000054959844,"about_ca_system_score_gemma":0.00006912964,"threshold_uncertainty_score":0.5040561},"labels":[],"label_agreement":null},{"id":"W2985653147","doi":"10.1182/blood-2019-123669","title":"Polatuzumab Vedotin Plus Obinutuzumab and Lenalidomide in Patients With Relapsed/Refractory Follicular Lymphoma: Primary Analysis of the Full Efficacy Population in a Phase Ib/II Trial","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Lenalidomide; Internal medicine; Follicular lymphoma; Tolerability; Obinutuzumab; Population; Regimen; Oncology; Clinical endpoint; Neutropenia; Phases of clinical research; Gastroenterology; Rituximab; Adverse effect; Lymphoma; Clinical trial; Multiple myeloma; Chemotherapy","score_opus":0.006201895072607609,"score_gpt":0.22832750612297756,"score_spread":0.22212561105036996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985653147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976631,0.00046919548,4.6488898e-7,0.000034279747,0.000069408845,0.0016179053,0.000021940288,0.000012564249,0.000111189336],"genre_scores_gemma":[0.9995291,0.000021289348,0.00006854479,0.00005688164,0.000024052444,0.000046627494,0.00020399198,0.000019448447,0.000030046314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839115,0.000111807676,0.0005064059,0.0003664005,0.00041032323,0.00021391804],"domain_scores_gemma":[0.99903196,0.0001151609,0.0002663002,0.00046780458,0.000047528232,0.000071226415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001499329,0.00020678419,0.0007532887,0.00037353914,0.000042596963,0.000011414685,0.000080445214,0.00011514912,0.000018011306],"category_scores_gemma":[0.00006635686,0.00013088934,0.0001851079,0.00082016736,0.000034895642,0.000093997674,0.00006606536,0.000081361104,0.0000021378728],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03350881,0.0104190195,0.9518174,0.00005182777,0.0011322541,0.000029863346,0.0005821787,0.00019657458,0.0002504347,0.000027098344,0.0000060978005,0.0019784255],"study_design_scores_gemma":[0.34033707,0.00198361,0.6553192,0.00013474566,0.0017304139,0.000002180399,0.00002262599,0.0001584284,0.00019240701,0.000003329113,0.000022233153,0.000093709335],"about_ca_topic_score_codex":0.0011189949,"about_ca_topic_score_gemma":0.00023297401,"teacher_disagreement_score":0.30682826,"about_ca_system_score_codex":0.00093599013,"about_ca_system_score_gemma":0.00032626803,"threshold_uncertainty_score":0.53375125},"labels":[],"label_agreement":null},{"id":"W2985698126","doi":"10.1182/blood-2019-124291","title":"Pharmacodynamic Responses to CC-90009, a Novel Cereblon E3 Ligase Modulator, in a Phase I Dose-Escalation Study in Relapsed or Refractory Acute Myeloid Leukemia (R/R AML)","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pharmacodynamics; Refractory (planetary science); Cereblon; Phases of clinical research; Pharmacology; Internal medicine; Ubiquitin ligase; Pharmacokinetics; Chemistry; Clinical trial; Biology","score_opus":0.013819812023389305,"score_gpt":0.29966911229135323,"score_spread":0.28584930026796396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985698126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979346,0.000095976975,0.00005515854,0.00009014167,0.00016135328,0.0014292329,0.000048461126,0.000029501627,0.00015556627],"genre_scores_gemma":[0.99747777,0.000038195958,0.00033663432,0.00027842182,0.00010170981,0.00013658986,0.000099969286,0.000040647967,0.0014900347],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99822,0.0001543256,0.00047439273,0.0006080225,0.00022602084,0.00031719395],"domain_scores_gemma":[0.99917287,0.000026432275,0.0001291161,0.00048634643,0.000056461224,0.00012879955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038253193,0.00024717292,0.0002623672,0.00027528606,0.000040103845,0.00003063149,0.00022998739,0.0001889279,0.000033140273],"category_scores_gemma":[0.0001597971,0.00023190929,0.00006783081,0.00040047208,0.000021435293,0.000018326713,0.00012427387,0.00022211426,0.000047685684],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027989133,0.0061050183,0.00778544,0.000014250322,0.000062318526,0.000035331384,0.0002397224,0.000056265242,0.9811866,0.0000037651146,0.00011288249,0.0015994358],"study_design_scores_gemma":[0.073079824,0.004102081,0.035379484,0.00009224653,0.00007941657,0.000028835648,0.00027860585,0.0012567955,0.8823766,0.0000071011323,0.0027015689,0.0006174523],"about_ca_topic_score_codex":0.000119628006,"about_ca_topic_score_gemma":0.00026138424,"teacher_disagreement_score":0.09881007,"about_ca_system_score_codex":0.00011598962,"about_ca_system_score_gemma":0.0002801318,"threshold_uncertainty_score":0.9456986},"labels":[],"label_agreement":null},{"id":"W2985702191","doi":"10.1182/blood-2019-125338","title":"Novel Therapeutics That Can Target and Eradicate Leukemic Stem Cells in Acute Myeloid Leukemia: Investigating FDA-Approved Anti-Inflammatory Compounds","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec; Princess Margaret Cancer Centre; University Health Network; McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Acute promyelocytic leukemia; Stem cell; Myeloid leukemia; Leukemia; CD34; Cancer research; Myeloid; Haematopoiesis; Internal medicine; Acute leukemia; Immunology; Bone marrow; Progenitor cell; Oncology; Retinoic acid; Biology; Cell culture","score_opus":0.02704096117162999,"score_gpt":0.25375537533831205,"score_spread":0.22671441416668206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985702191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953033,0.0006264736,0.000036421305,0.0011611321,0.00015319264,0.0012540615,0.00006012458,0.00015089008,0.0012544346],"genre_scores_gemma":[0.9924044,0.00045438687,0.0039086854,0.001564819,0.00013956462,0.000046767815,0.000057806672,0.00013044737,0.0012930946],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968687,0.00012505183,0.0005993669,0.0007945511,0.00068256736,0.00092971546],"domain_scores_gemma":[0.99823457,0.00023669952,0.0002478784,0.00079442794,0.00007717641,0.0004092242],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00070672046,0.00047544148,0.0008459881,0.0003578859,0.00012507098,0.00009346343,0.00039426162,0.00039350675,0.000020754034],"category_scores_gemma":[0.000017887196,0.00043307585,0.00011321257,0.00046089623,0.00034753865,0.00020064294,0.00029088883,0.0013649514,0.000052593143],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000061992534,0.00014013021,0.19661142,0.0002950331,0.00037094962,0.00012133032,0.0010804944,0.00002625932,0.800639,0.00008312559,0.00019765836,0.00037263797],"study_design_scores_gemma":[0.027069455,0.00052230974,0.13487805,0.00060141255,0.00058145577,0.00085207366,0.0012820837,0.010160752,0.81837505,0.00010190349,0.0045603504,0.0010151156],"about_ca_topic_score_codex":0.00022295916,"about_ca_topic_score_gemma":0.00004167168,"teacher_disagreement_score":0.061733365,"about_ca_system_score_codex":0.00083317363,"about_ca_system_score_gemma":0.0016580375,"threshold_uncertainty_score":0.9998121},"labels":[],"label_agreement":null},{"id":"W2985736759","doi":"10.1182/blood-2019-123069","title":"Comorbidities and Complications in Adults with Pyruvate Kinase Deficiency","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Pyruvate kinase deficiency; Comorbidity; Population; Cohort; Pyruvate kinase; Pediatrics; Anemia; Retrospective cohort study; Natural history; Cohort study; Blood transfusion; Internal medicine","score_opus":0.011749180762004456,"score_gpt":0.2298522245483845,"score_spread":0.21810304378638004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985736759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883963,0.00020898512,0.000009594171,0.00030339306,0.000031179265,0.00019506714,0.0000046744544,0.000026513131,0.010824307],"genre_scores_gemma":[0.9988334,0.00006672164,0.00027366643,0.00043312437,0.000017377424,0.000013945433,0.000022668426,0.0000057984394,0.0003333005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99964505,0.0000113439155,0.00007502372,0.0001304376,0.000048150436,0.000089961926],"domain_scores_gemma":[0.99974686,0.000026374515,0.000021751603,0.00014059394,0.000027862921,0.000036545774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000024966064,0.0000536825,0.000108715336,0.0000511249,0.000021723214,0.0000031020402,0.00001972087,0.000028304914,0.00007042336],"category_scores_gemma":[0.0000073348115,0.000040644096,0.00001022504,0.00008908387,0.000048628823,0.000023570074,0.000011208781,0.00007266797,0.0000728349],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039193532,0.0010619628,0.95664674,0.00035366885,0.000020731912,0.000041370364,0.0011744732,0.000008333672,0.034623433,0.0045912773,0.00023927492,0.0008467753],"study_design_scores_gemma":[0.005675969,0.00080726645,0.9898578,0.00018322149,0.000028515908,0.00008419444,0.00058023806,0.000071143026,0.0013961102,0.000098767945,0.0011284634,0.00008832322],"about_ca_topic_score_codex":0.00004529265,"about_ca_topic_score_gemma":0.000041940682,"teacher_disagreement_score":0.03322732,"about_ca_system_score_codex":0.0000043993177,"about_ca_system_score_gemma":0.000023773731,"threshold_uncertainty_score":0.16574182},"labels":[],"label_agreement":null},{"id":"W2985741206","doi":"10.1182/blood-2019-130251","title":"Targeted Mass Spectrometry-Based Serum M-Protein Monitoring for Early Relapse Detection","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Waterloo","funders":"","keywords":"Medicine; Melphalan; Internal medicine; Serum protein electrophoresis; Multiple myeloma; Gastroenterology; Immunology; Monoclonal; Antibody","score_opus":0.01634477426913836,"score_gpt":0.27100696641800276,"score_spread":0.2546621921488644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985741206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99628294,0.0001425771,0.0012974786,0.0001033805,0.00014561355,0.0014917573,0.00002373989,0.00010641533,0.00040607282],"genre_scores_gemma":[0.98173743,0.000002890565,0.01619143,0.00000944112,0.00021431434,0.00016640285,0.000018463219,0.00003567435,0.0016239303],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988719,0.000026987713,0.00014494002,0.00027364717,0.00029549072,0.00038701444],"domain_scores_gemma":[0.99933356,0.000053017986,0.000046555313,0.00030124243,0.00008871428,0.00017692328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012631193,0.00013349058,0.00019926344,0.00018277962,0.00006845795,0.000025084108,0.00006171677,0.00009139775,0.000106665306],"category_scores_gemma":[0.00012936196,0.00011570182,0.000116726405,0.00022979367,0.000013138637,0.00006558535,0.000012371298,0.00015934947,0.00022308661],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048034525,0.00030064466,0.28168133,0.00011600374,0.00015891057,0.000039916562,0.000013451555,0.0000014575821,0.7157497,0.000005346991,0.0000028188201,0.0014500808],"study_design_scores_gemma":[0.010959731,0.0014717496,0.24566022,0.00007032564,0.00007012878,0.000004915371,0.000016334927,0.0002197603,0.7413157,0.000049206043,0.00007567809,0.0000862368],"about_ca_topic_score_codex":0.000063182975,"about_ca_topic_score_gemma":0.0000031676614,"teacher_disagreement_score":0.03602112,"about_ca_system_score_codex":0.00007868213,"about_ca_system_score_gemma":0.000064132284,"threshold_uncertainty_score":0.47181833},"labels":[],"label_agreement":null},{"id":"W2985747570","doi":"10.1182/blood.v112.11.1325.1325","title":"Polycomb Group Ring Finger 5 (PCGF5) Is a Notch Transcriptional Target and Regulates Cell Size and Cell Cycle in Hematopoietic Progenitors.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Notch signaling pathway; Biology; HES1; Notch proteins; Chromatin; Molecular biology; Cell biology; Gene; Genetics; Signal transduction","score_opus":0.004290762229019077,"score_gpt":0.18514223314628206,"score_spread":0.18085147091726297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985747570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99124557,0.0080861095,0.000029960365,0.00013355524,0.00005854866,0.00019821542,0.000013495959,0.000012254884,0.00022226707],"genre_scores_gemma":[0.9975909,0.00044946914,0.00141968,0.00005649788,0.00013985402,0.000021077032,0.000029592478,0.000025202095,0.00026773458],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999099,0.000027685226,0.00019408339,0.00035545073,0.00011183287,0.00021191189],"domain_scores_gemma":[0.9996895,0.000012580682,0.000053168133,0.00015670393,0.000016456823,0.000071561786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000068272646,0.00015301132,0.00013944594,0.000039955685,0.00008249891,0.000015601314,0.000057492252,0.00017776211,0.000020120016],"category_scores_gemma":[0.000007358284,0.00016557876,0.0000497692,0.00008430871,0.00007998051,0.000007993073,0.000040249823,0.00008526896,0.0000017068492],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041755604,0.00021516456,0.009084429,0.00006280319,0.000020457821,0.0000061148717,0.00041377769,0.000047037418,0.9899171,0.0000069081498,0.000091024,0.00009343184],"study_design_scores_gemma":[0.0024578797,0.0001435204,0.04603535,0.000022866203,0.000036003745,0.00012325746,0.000035300454,0.00021068893,0.9493564,0.000121549274,0.001209213,0.00024796894],"about_ca_topic_score_codex":0.000029739478,"about_ca_topic_score_gemma":0.000014493255,"teacher_disagreement_score":0.040560693,"about_ca_system_score_codex":0.000009170461,"about_ca_system_score_gemma":0.000034329918,"threshold_uncertainty_score":0.6752106},"labels":[],"label_agreement":null},{"id":"W2985753547","doi":"10.1182/blood-2019-129614","title":"Progression Free Survival (PFS), and Event Free Survival (EFS) from a Global Randomized Phase 3 Study of Guadecitabine (G) Vs Treatment Choice (TC) in 815 Patients with Treatment Naïve (TN) AML Unfit for Intensive Chemotherapy (IC): ASTRAL-1 Study","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Alberta","funders":"","keywords":"Decitabine; Internal medicine; Medicine; Oncology; Discontinuation; Clinical endpoint; Population; Randomization; Progression-free survival; Surrogate endpoint; Phases of clinical research; Cytarabine; Adverse effect; Randomized controlled trial; Gastroenterology; Clinical trial; Leukemia; Chemotherapy; Biology","score_opus":0.01945934543131652,"score_gpt":0.3314044302722122,"score_spread":0.3119450848408957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985753547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97402924,0.0003526862,0.00003578411,0.00032988546,0.00017408314,0.024244472,0.0007268296,0.000052635394,0.000054383687],"genre_scores_gemma":[0.996914,0.00007240419,0.00078355067,0.000038859147,0.0001527304,0.001507365,0.00032444342,0.00008330553,0.00012330762],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9953556,0.0005857382,0.0009932112,0.0010881182,0.0012969295,0.0006804095],"domain_scores_gemma":[0.9961384,0.0010412545,0.00042995557,0.0013563508,0.00070760015,0.00032642393],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00069125096,0.000705791,0.0024983766,0.00021563935,0.000080408696,0.000041425898,0.0003684313,0.00016520785,0.00006622594],"category_scores_gemma":[0.00059525087,0.00044254327,0.00024031804,0.00043790523,0.00015202611,0.00013373609,0.00019650265,0.00021170737,0.0000049106798],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.25449494,0.062045913,0.6668465,0.00005199079,0.0040290495,0.00010602288,0.00475466,0.000004213647,0.00029198593,0.0000039727074,0.000035819743,0.0073349243],"study_design_scores_gemma":[0.6845971,0.056995634,0.24998355,0.0001830412,0.0013493742,0.0000034371892,0.005383237,0.0001231757,0.0010380342,0.000035621917,0.000030718016,0.00027707804],"about_ca_topic_score_codex":0.005563291,"about_ca_topic_score_gemma":0.0040142713,"teacher_disagreement_score":0.43010217,"about_ca_system_score_codex":0.0008749977,"about_ca_system_score_gemma":0.0003933633,"threshold_uncertainty_score":0.99980265},"labels":[],"label_agreement":null},{"id":"W2985753725","doi":"10.1182/blood-2019-128740","title":"Proteasome Inhibitors Impair the Innate Antiviral Immune Response and Potentiate Pelareorep-Based Viral Therapy in Multiple Myeloma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Carfilzomib; Peripheral blood mononuclear cell; Apoptosis; Proteasome inhibitor; Bortezomib; Bone marrow; Biology; Cancer research; Multiple myeloma; Immunology; CD14; Immune system; Cancer cell; Virology; Medicine; Cancer; In vitro","score_opus":0.01472598400586088,"score_gpt":0.26685056660261985,"score_spread":0.25212458259675896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985753725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99529004,0.0012613642,0.0000018382595,0.00125477,0.00006452533,0.0019026975,0.000017093362,0.00005193551,0.00015572758],"genre_scores_gemma":[0.99866545,0.000120816156,0.000080162,0.00028100127,0.00008650016,0.00009076548,0.000012650221,0.000045674074,0.00061695714],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99805003,0.00033638146,0.0003354926,0.00037815626,0.00042268608,0.0004772685],"domain_scores_gemma":[0.9990494,0.00017648489,0.0000803012,0.0005241303,0.00007106041,0.0000985775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001350369,0.00021729364,0.00034632214,0.00028061608,0.00011961932,0.00007085731,0.00016145427,0.00013237713,0.0000769646],"category_scores_gemma":[0.00016646444,0.00014302287,0.00013043731,0.00038001136,0.00016847241,0.00010297972,0.0001070483,0.000500727,0.00008558916],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00938521,0.0007435827,0.4294217,0.00005901983,0.00008125038,0.00014817172,0.00045079604,0.0000032533042,0.5533143,0.000013564355,0.00004068016,0.006338478],"study_design_scores_gemma":[0.015172306,0.0014753197,0.82643044,0.00013188602,0.000019294754,0.000030782063,0.00011929297,0.0006531207,0.15345134,0.000029922518,0.0022984257,0.00018789082],"about_ca_topic_score_codex":0.00035666683,"about_ca_topic_score_gemma":0.0000386398,"teacher_disagreement_score":0.39986297,"about_ca_system_score_codex":0.00003534572,"about_ca_system_score_gemma":0.00022906715,"threshold_uncertainty_score":0.5832303},"labels":[],"label_agreement":null},{"id":"W2985760920","doi":"10.1182/blood-2019-122255","title":"Beliefs and Practices Among Adults with Sickle Cell Disease Regarding Reproductive Health Decisions and Family Planning","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reproductive health; Disease; Population; Medicine; Family medicine; Genetic counseling; Family planning; Gerontology; Environmental health","score_opus":0.01113876366437918,"score_gpt":0.26337525493918007,"score_spread":0.2522364912748009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985760920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824751,0.012916832,0.00001225545,0.0013074097,0.000048097027,0.00060164934,0.000005894542,0.000046731173,0.0025860332],"genre_scores_gemma":[0.99702054,0.0014020959,0.0007674325,0.00029851976,0.0000681902,0.000008309424,0.000012042798,0.000022185508,0.00040070136],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892735,0.000037679,0.0001613402,0.00046496888,0.00018407824,0.00022459641],"domain_scores_gemma":[0.99901474,0.00011463641,0.00021806905,0.0002952113,0.000055277756,0.0003020546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002083912,0.00013014035,0.00023417732,0.00006805641,0.00014436422,0.00002799065,0.00003215582,0.000054648925,0.000004216726],"category_scores_gemma":[0.00025227724,0.00009170191,0.000022097987,0.0001272553,0.00007489842,0.00015850186,0.000047393787,0.00023426954,0.0000060072257],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010351025,0.00057647075,0.9881531,0.00040061158,0.00013281828,0.00019666227,0.0056111603,0.000037146077,0.00056278665,0.000030006577,0.000569884,0.002694222],"study_design_scores_gemma":[0.012825236,0.0017525913,0.96004885,0.003212161,0.00045687842,0.00014736957,0.018458527,0.0002155571,0.0002967468,0.000054798023,0.002201463,0.0003298435],"about_ca_topic_score_codex":0.00015812853,"about_ca_topic_score_gemma":0.0000063333164,"teacher_disagreement_score":0.0281043,"about_ca_system_score_codex":0.000010270895,"about_ca_system_score_gemma":0.00012176804,"threshold_uncertainty_score":0.37394953},"labels":[],"label_agreement":null},{"id":"W2985777859","doi":"10.1182/blood-2019-132008","title":"Transcriptome Analysis of Pediatric AML Reveals Non Protein-Coding RNAs Associated with Poor Survival Outcome and Treatment Resistance","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Transcriptome; Biology; Gene; Pseudogene; Bortezomib; Bioinformatics; Oncology; Genetics; Medicine; Gene expression; Genome; Immunology; Multiple myeloma","score_opus":0.02426977544349258,"score_gpt":0.28296859571622957,"score_spread":0.258698820272737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985777859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99671996,0.00028581533,0.00003063699,0.00028998952,0.000018040075,0.001104381,0.00007305459,0.000036647903,0.0014414779],"genre_scores_gemma":[0.9912101,0.000091940456,0.00040035823,0.00002820908,0.000057843034,0.00004632654,0.000050231818,0.000032080457,0.0080829235],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981941,0.00010072016,0.0004063485,0.0003883841,0.00054338126,0.00036707966],"domain_scores_gemma":[0.99895567,0.00014930274,0.0001924006,0.0003747062,0.00017007165,0.0001578243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049088505,0.00020794634,0.0009138646,0.00048571287,0.000046500776,0.000016898142,0.00010051924,0.000113974114,0.00006791122],"category_scores_gemma":[0.00012578689,0.00014904041,0.00016567015,0.0014146863,0.00004741986,0.000067240835,0.000020373609,0.00017460236,0.000008156527],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045260144,0.0005606762,0.9004282,0.00016705655,0.0034145392,0.00008479058,0.00032985557,0.0000025242725,0.09443169,0.000053395375,0.000022559669,0.00005213802],"study_design_scores_gemma":[0.014366997,0.0013749832,0.96039444,0.00011336908,0.009645966,0.000004196276,0.00017238264,0.00009742004,0.013509052,0.000005169933,0.00006908408,0.00024695325],"about_ca_topic_score_codex":0.00010158865,"about_ca_topic_score_gemma":0.00018500516,"teacher_disagreement_score":0.08092263,"about_ca_system_score_codex":0.00022912589,"about_ca_system_score_gemma":0.00016265416,"threshold_uncertainty_score":0.60776913},"labels":[],"label_agreement":null},{"id":"W2985802457","doi":"10.1182/blood.v128.22.1306.1306","title":"Pediatric Emergency Department Use of Intranasal Fentanyl to Treat Pain in Children with Sickel Cell Disease and Its Impact on Discharge Rates: A Multicenter Perspective","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Pediatric Pain Management Techniques","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Emergency department; Triage; Vaso-occlusive crisis; Hydromorphone; Emergency medicine; Anesthesia; Pediatrics; Opioid; Sickle cell anemia; Disease; Internal medicine","score_opus":0.008935523697031423,"score_gpt":0.26918240245483754,"score_spread":0.2602468787578061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985802457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99678594,0.00042756338,0.00025563437,0.00033823907,0.000009106614,0.0019177799,0.0001500346,0.0000667302,0.000048978218],"genre_scores_gemma":[0.9981151,0.0011115061,0.000309446,0.00008590814,0.00011121174,0.00011934144,0.000014599664,0.000031483505,0.00010141075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986644,0.0001268278,0.0002473304,0.00039749042,0.000254732,0.00030921755],"domain_scores_gemma":[0.99919283,0.00008412484,0.00009087547,0.00026860903,0.00006171218,0.00030186033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022247342,0.00024270071,0.00027612312,0.00034246536,0.000022251508,0.000007949035,0.00007843398,0.000037436777,0.00005516214],"category_scores_gemma":[0.00017037909,0.00014092884,0.00007372412,0.00028959336,0.000018053497,0.0001324465,0.000048765327,0.000073929514,0.000008260972],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007751678,0.0023547516,0.994634,0.00006741427,0.00009477504,0.00003775363,0.00017057557,0.0000016214301,0.001006697,0.000014821632,0.00070053374,0.00014190598],"study_design_scores_gemma":[0.0049850815,0.0018009512,0.99078095,0.000066266024,0.0007078688,0.000001576282,0.000041317027,0.000030654788,0.0013689284,0.000017554368,0.000004762409,0.00019411452],"about_ca_topic_score_codex":0.00008379932,"about_ca_topic_score_gemma":0.0000148146655,"teacher_disagreement_score":0.004209914,"about_ca_system_score_codex":0.000115337934,"about_ca_system_score_gemma":0.000045338766,"threshold_uncertainty_score":0.5746911},"labels":[],"label_agreement":null},{"id":"W2985818748","doi":"10.1182/blood-2019-130053","title":"Contributions to Global Hematology from Low and Middle-Income Countries: Insights from ASH 2018","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Global Health and Surgery","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Gross national income; Hematology; Medicine; Developing country; Family medicine; Political science; Internal medicine; Economic growth","score_opus":0.00766220152782182,"score_gpt":0.26664131607994157,"score_spread":0.25897911455211975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985818748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893016,0.0042493516,0.000042696207,0.0022126797,0.00067083153,0.00044934906,0.0013787121,0.00006870656,0.0016260628],"genre_scores_gemma":[0.9948908,0.00008286097,0.00029947987,0.004222208,0.00022004978,0.000013382041,0.00015920833,0.000008206248,0.00010377451],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99874043,0.00004117914,0.00030349477,0.00032409374,0.00019662223,0.00039415533],"domain_scores_gemma":[0.9987192,0.00022438276,0.000059167127,0.00033296092,0.00013807067,0.00052619376],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000066141074,0.0001483357,0.0005010067,0.000038405222,0.00006879931,0.000017412205,0.000067005676,0.00019201619,0.00024012207],"category_scores_gemma":[0.00017574178,0.00012794833,0.000052888925,0.00014544441,0.00004980026,0.000049631075,0.0000574543,0.0001106904,0.0013851159],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005097255,0.000441801,0.985505,0.00023256999,0.00023068942,0.00028402577,0.00020793175,3.6760724e-7,0.00030803346,0.0074860496,0.0047396105,0.00005423984],"study_design_scores_gemma":[0.013861512,0.00063908694,0.90587366,0.0018355901,0.00039276437,0.0002109078,0.0002154951,0.000037730304,0.0032546096,0.006994966,0.06622853,0.00045517055],"about_ca_topic_score_codex":0.0015163203,"about_ca_topic_score_gemma":0.00030169703,"teacher_disagreement_score":0.07963132,"about_ca_system_score_codex":0.00007171121,"about_ca_system_score_gemma":0.0002373731,"threshold_uncertainty_score":0.99939245},"labels":[],"label_agreement":null},{"id":"W2985832268","doi":"10.1182/blood-2019-124834","title":"Outcomes of Therapy Related Acute Lymphoblastic Leukemia in Adults after Allogeneic Stem Cell Transplantation - Twenty-Year Experience from a Tertiary Care Center","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Hematopoietic stem cell transplantation; Malignancy; Transplantation; Internal medicine; Single Center; Oncology; Surgery","score_opus":0.005472880601141045,"score_gpt":0.23558631647882242,"score_spread":0.23011343587768138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985832268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99771994,0.00059847726,0.000019842553,0.000030147856,0.00014397418,0.00090393523,0.00017991067,0.000045071865,0.00035870617],"genre_scores_gemma":[0.99842894,0.0005184321,0.00024111733,0.00018105007,0.000025206671,0.000105726285,0.00018236766,0.000052624622,0.00026454288],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978852,0.0000933803,0.00054020184,0.0005117811,0.00055513915,0.00041427978],"domain_scores_gemma":[0.9989896,0.00015235269,0.00011858558,0.0005019491,0.000098245524,0.00013926932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006460026,0.00026950025,0.00047530225,0.00020243906,0.000019074565,0.000011550858,0.00022506202,0.0002265378,0.00031546137],"category_scores_gemma":[0.0000068332715,0.00021326881,0.00014743273,0.00022653835,0.00009184955,0.00013772608,0.00004857982,0.00020062074,0.00013927718],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002111876,0.00033363557,0.94672024,0.0002504751,0.00021922465,0.00046147883,0.01973314,0.000016522263,0.029723186,0.0000011450256,0.0000088133,0.0004202848],"study_design_scores_gemma":[0.038698614,0.00037561212,0.8761383,0.00061317085,0.00015877091,0.000048711212,0.0022030824,0.00020183579,0.08130662,0.0000041800013,0.000019308147,0.00023174309],"about_ca_topic_score_codex":0.0003918028,"about_ca_topic_score_gemma":0.00003299449,"teacher_disagreement_score":0.07058187,"about_ca_system_score_codex":0.0005142646,"about_ca_system_score_gemma":0.00046232127,"threshold_uncertainty_score":0.86968493},"labels":[],"label_agreement":null},{"id":"W2985838089","doi":"10.1182/blood-2019-128395","title":"The Peri-Operative Management of Anticoagulants: Systemic Review of Guidelines","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Guideline; Atrial fibrillation; MEDLINE; Perioperative; Intensive care medicine; Rivaroxaban; Venous thromboembolism; Dabigatran; Systematic review; Warfarin; Emergency medicine; Surgery; Internal medicine; Thrombosis","score_opus":0.023557682378642034,"score_gpt":0.32619226511033933,"score_spread":0.3026345827316973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985838089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78963214,0.1815802,0.000030088959,0.002369466,0.00029588098,0.0028352116,0.000013174654,0.000024657389,0.023219205],"genre_scores_gemma":[0.7723632,0.22512092,0.00055051415,0.0006593528,0.00003907389,0.000045910285,0.000007844169,0.000013725494,0.0011994716],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99891293,0.00003442798,0.000501809,0.00014460227,0.00027738098,0.00012883813],"domain_scores_gemma":[0.9990648,0.000028336746,0.00017544108,0.0004680264,0.00023486564,0.000028506407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042255822,0.00009711121,0.0005272416,0.000027230837,0.000027894237,0.0000046895775,0.00013424379,0.000020721442,0.00010519833],"category_scores_gemma":[0.0000325934,0.000056524106,0.00010573108,0.00011684976,0.000034549223,0.000022809789,0.00008366142,0.00003839618,0.00004416774],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020239709,0.01134012,0.06706273,0.5571511,0.018317014,0.000250157,0.0019129148,0.00005069052,0.036035396,0.11811267,0.12799552,0.06156934],"study_design_scores_gemma":[0.01956735,0.0040643984,0.19029482,0.5457638,0.018114079,0.00032143784,0.011301671,0.00021432465,0.05922543,0.00024135434,0.14973398,0.0011573831],"about_ca_topic_score_codex":0.000018369376,"about_ca_topic_score_gemma":7.971837e-7,"teacher_disagreement_score":0.12323208,"about_ca_system_score_codex":0.0000091006395,"about_ca_system_score_gemma":0.000022237371,"threshold_uncertainty_score":0.23049861},"labels":[],"label_agreement":null},{"id":"W2985852779","doi":"10.1182/blood-2019-125189","title":"Oral Fludarabine and Intravenous Rituximab (FR) for Chronic Lymphocytic Leukemia (CLL): Long Term Outcomes and Secondary Malignancies in 673 Patients Treated in British Columbia (BC)","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Leukemia & Lymphoma Society of Canada; Providence Health Care; Vancouver General Hospital; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Fludarabine; Chemoimmunotherapy; Alemtuzumab; Chronic lymphocytic leukemia; Rituximab; Internal medicine; Ibrutinib; Bendamustine; Hazard ratio; Population; Proportional hazards model; Oncology; Univariate analysis; Neutropenia; Leukemia; Lymphoma; Multivariate analysis; Chemotherapy; Transplantation; Confidence interval; Cyclophosphamide","score_opus":0.010420385141144434,"score_gpt":0.2485973792946909,"score_spread":0.23817699415354646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985852779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952046,0.002095807,0.0000010862215,0.000020380197,0.00008457085,0.0022819052,0.00009056335,0.00005474331,0.0001663313],"genre_scores_gemma":[0.9975917,0.00036155307,0.00012284711,0.00011352956,0.00004612385,0.0001554873,0.00016720314,0.00006923968,0.00137237],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99750584,0.000064058884,0.0005830003,0.00068645255,0.00034976084,0.0008108836],"domain_scores_gemma":[0.9990134,0.00019378791,0.0000962745,0.0003787594,0.0001089443,0.00020883638],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030169488,0.00025445793,0.0009176912,0.00019241635,0.00007203941,0.00018387064,0.00014686564,0.0002471258,0.00015650371],"category_scores_gemma":[0.00017702751,0.00032406324,0.000076399345,0.00029244644,0.00021561715,0.00020000925,0.0001702048,0.00026883726,0.000018200964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00019853366,0.0006495152,0.970666,0.0015582654,0.00011384621,0.00059950154,0.0002600941,0.0000030254553,0.0003473073,0.0000027162982,0.000115527,0.025485683],"study_design_scores_gemma":[0.18390098,0.00097099843,0.81172746,0.00073242583,0.00010663344,0.00043734018,0.000048697195,0.0012491455,0.00042963328,0.00002937271,0.000077188975,0.00029009566],"about_ca_topic_score_codex":0.06713147,"about_ca_topic_score_gemma":0.13961019,"teacher_disagreement_score":0.18370244,"about_ca_system_score_codex":0.01819754,"about_ca_system_score_gemma":0.0073770355,"threshold_uncertainty_score":0.99992114},"labels":[],"label_agreement":null},{"id":"W2985861192","doi":"10.1182/blood-2019-129107","title":"Correlative Analyses of Patient and Clinical Characteristics Associated with Efficacy in Tisagenlecleucel-Treated Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients in the Juliet Trial","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Cytokine release syndrome; Internal medicine; Diffuse large B-cell lymphoma; Univariate analysis; Refractory (planetary science); Oncology; Gastroenterology; Salvage therapy; Chemotherapy regimen; Lymphoma; Chemotherapy; Immunotherapy; Multivariate analysis; Cancer; Chimeric antigen receptor; Biology","score_opus":0.03230198785502725,"score_gpt":0.3277322746081032,"score_spread":0.295430286753076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985861192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99711263,0.0000673384,3.540773e-7,0.00001717874,0.00008000747,0.0017089111,0.000059498856,0.000013734744,0.00094034127],"genre_scores_gemma":[0.9991461,0.00013661088,0.000008973084,0.00008597389,0.000030983945,0.000020414956,0.00019567946,0.00003102712,0.0003442189],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973511,0.0006912601,0.00072150317,0.00034550848,0.0005620314,0.0003285846],"domain_scores_gemma":[0.9977026,0.0013152547,0.00034891808,0.00039366237,0.00014291769,0.000096667194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066879403,0.00019774382,0.00067182543,0.00018496608,0.000027958644,0.00001602601,0.00012517824,0.00020784739,0.00011143678],"category_scores_gemma":[0.00069483265,0.00012824078,0.00010685746,0.0005016153,0.000108680935,0.000053278876,0.00006019909,0.0004194796,0.000015516065],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01900001,0.06217926,0.9139766,0.00002463156,0.00023810686,0.00008111671,0.0014770334,2.5231873e-7,0.0010758798,0.0000016195834,0.000026617136,0.0019188494],"study_design_scores_gemma":[0.27289435,0.0060101687,0.71973825,0.00013607448,0.00020622577,0.0000015797654,0.00014282741,0.00006380702,0.0006121801,0.0000014629106,0.00008761042,0.000105456966],"about_ca_topic_score_codex":0.00013077311,"about_ca_topic_score_gemma":0.00009001468,"teacher_disagreement_score":0.25389436,"about_ca_system_score_codex":0.000079958474,"about_ca_system_score_gemma":0.00013689334,"threshold_uncertainty_score":0.5229507},"labels":[],"label_agreement":null},{"id":"W2985908233","doi":"10.1182/blood-2019-128281","title":"The 17-Gene Leukemic Stemess Score Can Predict Treatment Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Occupational Cancer Research Centre; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Transplantation; Myeloid leukemia; Hematopoietic stem cell transplantation; Leukemia; Cohort; Cyclophosphamide; Acute leukemia; Regimen; Gastroenterology; Oncology; Chemotherapy","score_opus":0.015775002157433028,"score_gpt":0.26094240680712694,"score_spread":0.24516740464969392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985908233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99435025,0.0012227516,0.000019197303,0.0005235816,0.00024499098,0.002195242,0.00006790646,0.000119676806,0.0012564126],"genre_scores_gemma":[0.9866107,0.0012555034,0.00014649199,0.00018305666,0.00006619413,0.00027780913,0.00017070663,0.000093386654,0.011196131],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968296,0.00017420703,0.00067008147,0.00066284003,0.00077438925,0.0008888513],"domain_scores_gemma":[0.99828535,0.00034146287,0.00014561863,0.0009055008,0.00006336785,0.0002587009],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046136376,0.00046129452,0.0007842907,0.00023965612,0.00018550857,0.00006841778,0.00040622495,0.00023752623,0.000029005574],"category_scores_gemma":[0.0000092871105,0.0003048648,0.00036253143,0.0004274647,0.00007266955,0.00011848446,0.0000660802,0.0004297651,0.00011059855],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003638091,0.00041735612,0.85996544,0.0003444021,0.0012115039,0.0015028893,0.0029548283,0.00015254757,0.13088237,0.00003215163,0.00011603417,0.0020566615],"study_design_scores_gemma":[0.04949368,0.0021562537,0.5223938,0.0006519364,0.0031218654,0.00080308603,0.0023669624,0.00037272737,0.41695288,0.00004615496,0.0006984925,0.00094217755],"about_ca_topic_score_codex":0.00040236147,"about_ca_topic_score_gemma":0.0003772642,"teacher_disagreement_score":0.33757165,"about_ca_system_score_codex":0.0018715175,"about_ca_system_score_gemma":0.0015155391,"threshold_uncertainty_score":0.99994034},"labels":[],"label_agreement":null},{"id":"W2985925973","doi":"10.1182/blood-2019-122621","title":"Association of Bleeding Severity with Mortality with Extended Thromboprophylaxis in the Medically Ill in the Mariner Trial","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Rivaroxaban; Placebo; Internal medicine; Population; Randomization; Stroke (engine); Major bleeding; Venous thromboembolism; Surgery; Randomized controlled trial; Warfarin; Myocardial infarction; Thrombosis; Atrial fibrillation","score_opus":0.011410115120531247,"score_gpt":0.25356863479897995,"score_spread":0.2421585196784487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985925973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98604155,0.000021939652,0.000004589735,0.002079162,0.000059009475,0.0015754998,0.0000026663993,0.0000104415885,0.010205175],"genre_scores_gemma":[0.9987328,0.000043487566,0.00011063175,0.00082907995,0.00009678967,0.00008472094,0.000009027468,0.000009864605,0.0000835763],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983333,0.00014600859,0.00027645542,0.00020931706,0.00082136254,0.00021357142],"domain_scores_gemma":[0.99921465,0.00014767713,0.00016889306,0.000368992,0.0000751081,0.000024708746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017167927,0.00011642356,0.00040099092,0.000059466365,0.000026563974,0.000018177536,0.00018173868,0.000069052956,0.00008667238],"category_scores_gemma":[0.00012146379,0.000053167896,0.000046399524,0.00034715104,0.0000417038,0.00006156235,0.000035027013,0.0002502901,0.00000456293],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019334729,0.008170509,0.9806868,0.00026037075,0.0006455678,0.000090012516,0.005134362,0.000010294466,0.0002474174,0.0011878809,0.00059223693,0.001041066],"study_design_scores_gemma":[0.02672982,0.0016841444,0.9691818,0.00010820793,0.00036965794,0.000006203406,0.0013536736,0.000016743268,0.00009786023,0.00012351778,0.00024846618,0.000079933685],"about_ca_topic_score_codex":0.0009641597,"about_ca_topic_score_gemma":0.0013557003,"teacher_disagreement_score":0.024796348,"about_ca_system_score_codex":0.0000441937,"about_ca_system_score_gemma":0.00007506502,"threshold_uncertainty_score":0.21681239},"labels":[],"label_agreement":null},{"id":"W2985926102","doi":"10.1182/blood.v104.11.2603.2603","title":"Comparison of Compression Ultrasound vs Ascending Contrast Venography for Proximal DVT in Medical-Surgical ICU Patients.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Medicine; Venography; Radiology; Asymptomatic; Ultrasound; Thrombosis; Surgery","score_opus":0.016975421194904673,"score_gpt":0.32096615923719524,"score_spread":0.30399073804229054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985926102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965594,0.00038717556,0.00016837515,0.00031128785,0.00014680722,0.001171002,0.000017253431,0.000034845325,0.0012038718],"genre_scores_gemma":[0.99871,0.00009841889,0.0007469167,0.00012935828,0.00010164893,0.00009774493,0.00009161811,0.000019882295,0.0000044250332],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983939,0.000028956796,0.0005090413,0.0002528215,0.0005020495,0.00031323198],"domain_scores_gemma":[0.9992926,0.00014543119,0.00014683288,0.00018002327,0.00007381542,0.00016129676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024628756,0.00014893206,0.0006932046,0.00015959586,0.000058521586,0.0000105005265,0.000119258286,0.00012175652,0.00006788318],"category_scores_gemma":[0.00013303985,0.00012402493,0.00014756162,0.00016474216,0.000090573965,0.000046259534,0.000042206288,0.00016432005,0.0000033300962],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049561606,0.03704578,0.95029604,0.0007701498,0.0003184321,0.00006115753,0.0013466045,0.000053278636,0.0015125207,0.0037363817,0.000900353,0.0034636904],"study_design_scores_gemma":[0.045336183,0.0031043394,0.91724396,0.0019614676,0.0005362822,0.000018041366,0.00028953474,0.00007072541,0.023751242,0.00031228518,0.007084053,0.00029186337],"about_ca_topic_score_codex":0.000059433885,"about_ca_topic_score_gemma":0.000028126897,"teacher_disagreement_score":0.044840567,"about_ca_system_score_codex":0.000029878247,"about_ca_system_score_gemma":0.000051248124,"threshold_uncertainty_score":0.50575894},"labels":[],"label_agreement":null},{"id":"W2985936603","doi":"10.1182/blood-2019-124235","title":"Molecular Correlates of Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Spinal Cord Injury BC; Canada's Michael Smith Genome Sciences Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Diffuse large B-cell lymphoma; Medicine; Oncology; Internal medicine; International Prognostic Index; Lymphoma; Gene expression profiling; Pathology; Gene expression; Biology; Gene","score_opus":0.0026111244628041624,"score_gpt":0.19179729734243645,"score_spread":0.1891861728796323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985936603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99562144,0.00088272995,0.000110627625,0.0000113924625,0.00024679417,0.00028855787,0.000029880714,0.000015620708,0.0027929617],"genre_scores_gemma":[0.99914575,0.000026613057,0.00015848305,0.00002854893,0.000036139558,0.000023174316,0.000050976654,0.000027375847,0.0005029208],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990389,0.00006119623,0.00024386166,0.00026834517,0.00010272114,0.00028498378],"domain_scores_gemma":[0.9993535,0.000010642916,0.000107526066,0.0004245853,0.000045068937,0.000058626556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007508294,0.00013048423,0.00016356955,0.000051635114,0.000017817441,0.000009854049,0.00017413068,0.00016518534,0.000013158957],"category_scores_gemma":[0.00003296993,0.00013280853,0.00010483784,0.00008636681,0.00001894889,0.000003949644,0.00009865385,0.00007367328,0.000055805172],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057779656,0.003175024,0.046359736,0.00012319768,0.000061225015,0.000040613148,0.00007553177,0.00005577825,0.94952035,0.0003833941,0.00007389583,0.00007346184],"study_design_scores_gemma":[0.009973492,0.00025070008,0.009807703,0.00009541906,0.00004709799,0.00006150422,0.00023097529,0.00015601765,0.97778165,0.000010000566,0.0013845273,0.00020089815],"about_ca_topic_score_codex":0.000054797816,"about_ca_topic_score_gemma":0.0000182462,"teacher_disagreement_score":0.036552034,"about_ca_system_score_codex":0.000019694397,"about_ca_system_score_gemma":0.000051204504,"threshold_uncertainty_score":0.54157746},"labels":[],"label_agreement":null},{"id":"W2985949593","doi":"10.1182/blood-2019-127399","title":"Recurrent Patterns of Clonal Evolution in Relapsed-Refractory DLBCL Following Treatment with R-CHOP","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Spinal Cord Injury BC; McGill University; Queen's University; Simon Fraser University","funders":"","keywords":"Diffuse large B-cell lymphoma; Oncology; Lymphoma; Internal medicine; Exome sequencing; Follicular lymphoma; Exome; Medicine; Cancer research; Mutation; Biology; Gene; Genetics","score_opus":0.009572199138379733,"score_gpt":0.24216311004469607,"score_spread":0.23259091090631634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985949593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99699545,0.0011809962,0.0000031768416,0.000092869945,0.00013046882,0.00050082314,0.000015786618,0.000019059169,0.0010613544],"genre_scores_gemma":[0.9993764,0.00009350059,0.00013103079,0.000023258739,0.000040640316,0.00006761955,0.000036466965,0.000015301966,0.00021576474],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909943,0.000026064208,0.00021435745,0.00023891381,0.00023805753,0.00018319263],"domain_scores_gemma":[0.9995221,0.000049076818,0.00007937554,0.00025386835,0.0000246915,0.000070894115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000055483804,0.00014744488,0.0003151594,0.00009783291,0.000014823075,0.0000041598537,0.00003243672,0.000059075246,0.000056428766],"category_scores_gemma":[0.00000656729,0.000098930956,0.00012762123,0.000093008195,0.0000092265345,0.00003863947,0.000012614004,0.000051087827,0.000041020547],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019397191,0.0077189687,0.98639745,0.00004435167,0.00028881253,0.00014161991,0.00022542087,0.0000022531372,0.00089483307,0.0000799121,0.0000075447174,0.004004893],"study_design_scores_gemma":[0.0295246,0.004607372,0.9599012,0.00055549736,0.000419301,0.000032452994,0.00012070412,0.000010621024,0.0042828806,0.000009616282,0.00043152392,0.00010419647],"about_ca_topic_score_codex":0.00042746257,"about_ca_topic_score_gemma":0.0001298194,"teacher_disagreement_score":0.029330628,"about_ca_system_score_codex":0.0003373154,"about_ca_system_score_gemma":0.0001327596,"threshold_uncertainty_score":0.40342873},"labels":[],"label_agreement":null},{"id":"W2985960451","doi":"10.1182/blood-2019-126810","title":"Baseline Characteristics and Clinical Outcomes from the Cancer Associated Thrombosis - Patient Reported Outcomes with Rivaroxaban (COSIMO) Trial","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Rivaroxaban; Concomitant; Pulmonary embolism; Thrombosis; Internal medicine; Low molecular weight heparin; Deep vein; Cancer; Population; Warfarin; Surgery; Atrial fibrillation","score_opus":0.0410622106438997,"score_gpt":0.3204031793715431,"score_spread":0.2793409687276434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985960451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937072,0.00006951946,0.0000036716108,0.0031796189,0.00072586094,0.0017891478,0.00014690505,0.00008205366,0.00029605275],"genre_scores_gemma":[0.99461937,0.00036436398,0.00014410396,0.004203898,0.00020016951,0.00008794399,0.00018465666,0.00004323487,0.00015225499],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99779046,0.00014950348,0.00079052354,0.00050241273,0.00047244717,0.00029468277],"domain_scores_gemma":[0.9977416,0.0007772347,0.00049570523,0.0006731896,0.0001708203,0.00014146889],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005442797,0.00026872943,0.0011212049,0.00003678006,0.00009835366,0.00006019096,0.00013053387,0.00013335807,0.000386546],"category_scores_gemma":[0.0009089862,0.00014578819,0.00020442969,0.000116725336,0.000079733676,0.000061960716,0.00013012836,0.0002688608,0.000021118725],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006108322,0.0043478687,0.9883288,0.000012608542,0.0030975523,0.000017431912,0.00016068546,2.1416498e-7,0.000009750746,0.000017795797,0.0017959905,0.0016004689],"study_design_scores_gemma":[0.048058216,0.001381943,0.94511086,0.0001218986,0.0035975468,6.358385e-7,0.00007290795,0.000014279089,0.000024691422,0.00000969415,0.0014119203,0.00019539232],"about_ca_topic_score_codex":0.0013546711,"about_ca_topic_score_gemma":0.00029599597,"teacher_disagreement_score":0.047447383,"about_ca_system_score_codex":0.000038910846,"about_ca_system_score_gemma":0.00009062158,"threshold_uncertainty_score":0.594507},"labels":[],"label_agreement":null},{"id":"W2985973719","doi":"10.1182/blood-2019-130543","title":"Pediatric Hematologist/Oncologists' Beliefs about Hematopoietic Stem Cell Transplant for Children with Sickle Cell Disease: A Sickle Cell Transplant Advocacy and Research Alliance (STAR) Study","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"","keywords":"Medicine; Hematopoietic stem cell transplantation; Hematologist; Hematology; Transplantation; Disease; Hematopoietic cell; Sickle cell anemia; Pediatrics; Family medicine; Internal medicine; Intensive care medicine; Stem cell; Haematopoiesis","score_opus":0.012540066089846124,"score_gpt":0.2599106654864932,"score_spread":0.2473705993966471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985973719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9741244,0.017996857,0.00006709012,0.00030708386,0.000086838525,0.0061109723,0.00018733322,0.00015189372,0.0009675365],"genre_scores_gemma":[0.9928846,0.0042094104,0.00025701386,0.00010469062,0.000112471775,0.00033336892,0.000117057716,0.00010516759,0.0018762604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961825,0.00019540395,0.0006247051,0.0010835754,0.0008070412,0.0011067999],"domain_scores_gemma":[0.9979366,0.0003345167,0.00017926542,0.00076520856,0.00017432799,0.0006100597],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006631792,0.0005195581,0.00088569673,0.00018511259,0.00031923092,0.00006443744,0.00035680155,0.0002923911,0.00005849427],"category_scores_gemma":[0.0000087671715,0.00038082423,0.00018661104,0.00051185925,0.00023179216,0.0000999889,0.00005705382,0.00077863166,0.00009716349],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026990587,0.019614149,0.95029646,0.0077357464,0.00031763015,0.0010789814,0.0151325725,0.00008486268,0.0017160531,0.000052034145,0.0011096017,0.0001628457],"study_design_scores_gemma":[0.24705765,0.051358216,0.5921692,0.0029698624,0.017521687,0.0016035849,0.037398633,0.00065818254,0.039847314,0.00027249684,0.0034131429,0.0057300297],"about_ca_topic_score_codex":0.00013354834,"about_ca_topic_score_gemma":0.000032349624,"teacher_disagreement_score":0.35812727,"about_ca_system_score_codex":0.000046255383,"about_ca_system_score_gemma":0.0006562802,"threshold_uncertainty_score":0.99986434},"labels":[],"label_agreement":null},{"id":"W2986009645","doi":"10.1182/blood-2019-131769","title":"In-Hospital Mortality and Morbidity Among Patients Presenting with Intracranial Hemorrhage: A Single Center's Experience with Vitamin K Antagonists and the Direct Oral Anticoagulants","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Intracerebral and Subarachnoid Hemorrhage Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Stroke (engine); Modified Rankin Scale; Single Center; Atrial fibrillation; Adverse effect; Warfarin; Retrospective cohort study; Medical record; Incidence (geometry); Emergency medicine; Pediatrics; Intensive care medicine; Internal medicine; Ischemic stroke","score_opus":0.011288294343514346,"score_gpt":0.25588816299846434,"score_spread":0.24459986865494998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986009645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99790037,0.000050687264,0.0000056897943,0.0001914914,0.000062677864,0.0010813533,0.000014327284,0.000027419565,0.0006660079],"genre_scores_gemma":[0.999086,0.000013331667,0.0005986533,0.000044226494,0.000066379565,0.000032640928,0.000012621103,0.00002280967,0.00012333525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830216,0.00009416229,0.0002286996,0.00044496998,0.00048312484,0.00044688716],"domain_scores_gemma":[0.99931395,0.000072896066,0.00008497788,0.00029659134,0.000094062176,0.00013751701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025835808,0.00021310478,0.00045828917,0.000058852966,0.00011959347,0.00010033138,0.00010481213,0.0000723964,0.000027486487],"category_scores_gemma":[0.00008332608,0.000119160206,0.000029649642,0.0001870904,0.0005206261,0.0003107321,0.00012526827,0.00031760315,0.000003444358],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000548342,0.0013528181,0.9948057,0.00019994233,0.000053316784,0.00066924124,0.0012626766,4.6899714e-7,0.0005223328,0.000008296962,0.000003618915,0.0005732751],"study_design_scores_gemma":[0.014319712,0.000835588,0.9748622,0.00008601889,0.000095359734,0.00027401638,0.00041199278,0.0049968124,0.0039061739,0.0000064938467,0.0000027239153,0.0002028952],"about_ca_topic_score_codex":0.0008769624,"about_ca_topic_score_gemma":0.00024946852,"teacher_disagreement_score":0.019943457,"about_ca_system_score_codex":0.000022048021,"about_ca_system_score_gemma":0.00003760935,"threshold_uncertainty_score":0.4859212},"labels":[],"label_agreement":null},{"id":"W2986010331","doi":"10.1182/blood-2019-129024","title":"Validation of the PRIMA-Prognostic Index for Patients Treated with Rituximab Plus Chemotherapy and Refinement of Prognostic Parameters for Patients on Rituximab Plus Lenalidomide in the Phase III Relevance Trial","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Hôpital de l'Enfant-Jésus; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Rituximab; Internal medicine; Lenalidomide; Population; Follicular lymphoma; Oncology; Cohort; Surgery; Multiple myeloma; Lymphoma","score_opus":0.014405276617013145,"score_gpt":0.26219586497157554,"score_spread":0.24779058835456239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986010331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873805,0.00006190682,0.000017124292,0.00017364955,0.00006791664,0.012135061,0.00012309231,0.000009606368,0.00003111678],"genre_scores_gemma":[0.9977387,0.00003178431,0.00038460104,0.0001413309,0.000021176607,0.0014457774,0.00019419589,0.000026367064,0.00001606111],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9984527,0.000069960755,0.0005049633,0.0003330512,0.0004096078,0.00022970504],"domain_scores_gemma":[0.9981649,0.0008081328,0.0004247811,0.00036567386,0.00019638872,0.000040145176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019761497,0.00022627303,0.00059553946,0.000080154154,0.000052732805,0.000015149116,0.0001150834,0.00007417932,0.0000033292317],"category_scores_gemma":[0.00034581628,0.00011857956,0.00012134545,0.00017873375,0.000071209426,0.00005216057,0.000017553395,0.00006006604,6.7748505e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14753917,0.059244934,0.7813785,0.0005812216,0.00059762044,0.0000025013364,0.0013058971,0.000033986224,0.00013856322,0.00007015008,0.000082433,0.0090250205],"study_design_scores_gemma":[0.8226013,0.022463482,0.13442965,0.00067129947,0.00086938374,0.0000017256249,0.000065776745,0.0002399133,0.018390195,0.00004019384,0.00007981871,0.00014727638],"about_ca_topic_score_codex":0.00007901493,"about_ca_topic_score_gemma":0.00000843641,"teacher_disagreement_score":0.6750621,"about_ca_system_score_codex":0.00011997194,"about_ca_system_score_gemma":0.00012719605,"threshold_uncertainty_score":0.4835534},"labels":[],"label_agreement":null},{"id":"W2986011956","doi":"10.1182/blood-2019-121698","title":"UM171 Modified Cord Blood Achieves Excellent Survival and Disease Control after 2 Years of Follow-up in High and Very High Risk Malignancies","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Research in Immunology and Cancer; Université de Montréal; Université Laval; Hôpital de l'Enfant-Jésus; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Cord blood; Transplantation; CD34; Internal medicine; Progenitor cell; Stem cell; Regimen; Immunology; Surgery; Gastroenterology; Biology","score_opus":0.0074625108315202774,"score_gpt":0.21100325776971357,"score_spread":0.2035407469381933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986011956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99780303,0.0010139152,0.000043952998,0.00009224046,0.00017339186,0.00061128463,0.00015136221,0.00002129894,0.00008954696],"genre_scores_gemma":[0.998852,0.0005803993,0.00017441464,0.000043459313,0.000034652257,0.00003526891,0.000022604796,0.000023275823,0.00023392821],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988531,0.00008899896,0.0003052394,0.00028904816,0.0002594332,0.00020419249],"domain_scores_gemma":[0.99923193,0.00021881575,0.000089764886,0.00024547268,0.000035302524,0.00017870372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002025312,0.00015395775,0.00043192707,0.00010152428,0.000015033507,0.000012131395,0.00004511161,0.00008274732,0.000044207176],"category_scores_gemma":[0.00005627202,0.00014411692,0.000052485193,0.000078991055,0.000073092306,0.00005719677,0.000020714493,0.00010935646,0.000010452649],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027564077,0.0005612504,0.9801069,0.00081549736,0.00020746184,0.00024270764,0.0005017988,0.0000061376245,0.0141258575,0.0003526352,0.0000069177704,0.00031644173],"study_design_scores_gemma":[0.02450436,0.00037317476,0.97032857,0.00035377606,0.0010724424,0.000017628086,0.00012527333,0.00003854763,0.0028420852,0.00018466645,0.000010489861,0.00014896752],"about_ca_topic_score_codex":0.000291715,"about_ca_topic_score_gemma":0.00003669058,"teacher_disagreement_score":0.021747952,"about_ca_system_score_codex":0.0000064195747,"about_ca_system_score_gemma":0.00005769804,"threshold_uncertainty_score":0.5876917},"labels":[],"label_agreement":null},{"id":"W2986030647","doi":"10.1182/blood-2019-127005","title":"Prophylactic Antibiotic Use and Risk of Meningococcal Infections in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Treated with Eculizumab Who Received Meningococcal Vaccination: Results from the International PNH Registry","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Eculizumab; Medicine; Paroxysmal nocturnal hemoglobinuria; Vaccination; Internal medicine; Pediatrics; Neisseria meningitidis; Meningococcal vaccine; Immunology; Immunization; Antibody","score_opus":0.006851578380216747,"score_gpt":0.1993162677628336,"score_spread":0.19246468938261685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986030647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979824,0.00009756567,0.000006868476,0.00007158669,0.0001312884,0.00087562535,0.00055713335,0.000033678727,0.00024386575],"genre_scores_gemma":[0.9992133,0.000009920804,0.00008403991,0.000010411554,0.000026429452,0.000017114558,0.00045096132,0.000017476963,0.00017037164],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985049,0.00031751563,0.00043070575,0.000413847,0.00011393713,0.00021909815],"domain_scores_gemma":[0.9984646,0.0004151846,0.00049020036,0.00039979105,0.00020150986,0.000028728311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016054885,0.00021656834,0.0003026282,0.00009535516,0.0001217635,0.000057894602,0.00022924064,0.00011572495,0.0001521089],"category_scores_gemma":[0.00023089016,0.00013822247,0.00004299644,0.00018865665,0.000102186445,0.0002137206,0.00009302383,0.00027619282,0.000015306674],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030243383,0.0007633953,0.99297935,0.000019237206,0.0006099709,0.0000042292186,0.00036211064,0.00005121855,0.0019168581,0.000016702927,0.00011249067,0.00014009353],"study_design_scores_gemma":[0.022182478,0.00093517255,0.97183746,0.00018754839,0.00030705964,0.000027288004,0.00015514731,0.000023032133,0.003979565,0.000008430339,0.00018080154,0.00017602117],"about_ca_topic_score_codex":0.0013837126,"about_ca_topic_score_gemma":0.0005020391,"teacher_disagreement_score":0.021141898,"about_ca_system_score_codex":0.00006183308,"about_ca_system_score_gemma":0.00008526905,"threshold_uncertainty_score":0.56365484},"labels":[],"label_agreement":null},{"id":"W2986040087","doi":"10.1182/blood-2019-128211","title":"Preliminary Report of MANIFEST, a Phase 2 Study of CPI-0610, a Bromodomain and Extraterminal Domain Inhibitor (BETi), in Combination with Ruxolitinib, in JAK Inhibitor (JAKi) Treatment Naïve Myelofibrosis Patients","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; McMaster University","funders":"","keywords":"Ruxolitinib; Medicine; Myelofibrosis; Tofacitinib; Myeloproliferative neoplasm; Janus kinase; Internal medicine; Venetoclax; Cancer research; Bone marrow; Leukemia; Cytokine","score_opus":0.010544082203607513,"score_gpt":0.2641798675588689,"score_spread":0.2536357853552614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986040087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99540496,0.00011591699,0.0000010416838,0.00006804897,0.000047405432,0.0039386805,0.000051132636,0.0000141812525,0.00035860526],"genre_scores_gemma":[0.99856246,0.000024744615,0.0006293883,0.0000115533785,0.000029563436,0.0005046193,0.00012362475,0.000033843164,0.00008019092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975337,0.00017310442,0.0009238015,0.0005857327,0.0004907899,0.00029291608],"domain_scores_gemma":[0.99875253,0.00015123718,0.0004293268,0.00038711645,0.00015190018,0.00012789493],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025033078,0.00034424633,0.0008679253,0.00035995652,0.00003144076,0.000013546958,0.0000529463,0.00011210616,0.000027786324],"category_scores_gemma":[0.000035966048,0.0002611286,0.00006608662,0.0003037246,0.00007315599,0.00013317945,0.000049694812,0.000116749805,0.0000026486032],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003296133,0.07362337,0.9123667,0.00025752213,0.0002045947,0.0015331273,0.0047348114,0.0000020808109,0.0027698134,0.00004153614,0.000008674765,0.0011616444],"study_design_scores_gemma":[0.091901995,0.06404431,0.80715936,0.0009288018,0.00031779727,0.00028792766,0.0019268773,0.00001829233,0.03315871,0.00003575583,0.000014116412,0.00020605295],"about_ca_topic_score_codex":0.00043158248,"about_ca_topic_score_gemma":0.00023035001,"teacher_disagreement_score":0.10520733,"about_ca_system_score_codex":0.00015140214,"about_ca_system_score_gemma":0.00014650082,"threshold_uncertainty_score":0.9999841},"labels":[],"label_agreement":null},{"id":"W2986040534","doi":"10.1182/blood-2019-130282","title":"The Impact of Age on the Outcome of Primary Treatment for Classical Hodgkin's Lymphoma: 70 Years of Age Is a Clinical Relevant Cutpoint and the Most Important Predictor of Overall Survival","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; ABVD; Internal medicine; Population; Comorbidity; Chemotherapy; Vincristine","score_opus":0.03604234934206093,"score_gpt":0.31924731666894063,"score_spread":0.2832049673268797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986040534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99565846,0.0006794908,7.0783443e-7,0.0008706534,0.000100165584,0.0017795366,0.00039732977,0.000006988119,0.0005066821],"genre_scores_gemma":[0.9982595,0.0012096483,0.000071574665,0.00009655704,0.00006106426,0.0000732022,0.00002238572,0.000023278984,0.00018282965],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99788433,0.00016429981,0.0010610331,0.0002585132,0.00040756457,0.00022426982],"domain_scores_gemma":[0.9952129,0.0032105409,0.00063114916,0.00077536266,0.00008297107,0.00008707134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083829125,0.00021499976,0.0010668371,0.00003445602,0.00003545108,0.00000871677,0.00015782924,0.000108002714,0.000015607122],"category_scores_gemma":[0.00030966938,0.0000829879,0.0007537065,0.00007921498,0.00047043827,0.000019223573,0.00007610507,0.00006434569,0.0000013036306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062894067,0.010122778,0.9663179,0.00016327943,0.0038670124,0.00006759916,0.00090305414,0.000001325765,0.0012996085,0.0050025615,0.0007375544,0.005227941],"study_design_scores_gemma":[0.036506683,0.0072372966,0.9507643,0.00015307737,0.0011278023,0.000015532125,0.000093343995,0.000063456224,0.0032946717,0.0003602318,0.000305928,0.0000777038],"about_ca_topic_score_codex":0.00051570806,"about_ca_topic_score_gemma":0.000024129038,"teacher_disagreement_score":0.030217277,"about_ca_system_score_codex":0.00010099011,"about_ca_system_score_gemma":0.00026624586,"threshold_uncertainty_score":0.33841482},"labels":[],"label_agreement":null},{"id":"W2986061480","doi":"10.1182/blood-2019-124743","title":"Neutralizing and Non-Neutralizing Anti-FVIII Antibodies in Black and White Hemophilia A Subjects: A Natural History Profile","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Hemophilia Society","funders":"","keywords":"Antibody; Epitope; Population; Haplotype; Immunology; Titer; Molecular biology; Biology; Virology; Medicine; Genotype; Genetics; Gene","score_opus":0.017015709896284044,"score_gpt":0.26570685507122094,"score_spread":0.2486911451749369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986061480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990285,0.0035038712,1.1117813e-7,0.0006907389,0.000120653494,0.0008311118,0.0000043343375,0.000049470033,0.0045147142],"genre_scores_gemma":[0.994875,0.0007610803,0.0003299934,0.0001296517,0.000091135276,0.0000150005135,0.000019508212,0.00003337368,0.0037452253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985359,0.000045945417,0.00024467736,0.0004574676,0.00023459861,0.00048143027],"domain_scores_gemma":[0.99943197,0.000059344253,0.000050785617,0.00024983767,0.00005155377,0.00015651187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021509388,0.00023376795,0.0004692655,0.0002896734,0.000052226296,0.000030290275,0.00006837379,0.0001272896,0.000056503293],"category_scores_gemma":[0.000032088203,0.00018713615,0.00006235718,0.00017814216,0.00019341309,0.00018427499,0.00009207056,0.00036088892,0.000039908216],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008730879,0.0002808268,0.92627597,0.0006877682,0.00008030205,0.0002851717,0.0020564143,3.5988853e-7,0.0697799,0.000029971967,0.00021723977,0.00021875405],"study_design_scores_gemma":[0.0071918136,0.00034459677,0.9771668,0.0006020558,0.000114955095,0.00018514042,0.0005236152,0.00028321287,0.012815305,0.000020024794,0.0004902594,0.00026225531],"about_ca_topic_score_codex":0.00012493954,"about_ca_topic_score_gemma":0.00003486443,"teacher_disagreement_score":0.0569646,"about_ca_system_score_codex":0.00007876393,"about_ca_system_score_gemma":0.000105809486,"threshold_uncertainty_score":0.7631191},"labels":[],"label_agreement":null},{"id":"W2986069530","doi":"10.1182/blood-2019-121467","title":"The DLBCL90 Double-Hit Gene Expression Signature Is Not Associated with Inferior Survival in Young High-Risk Patients with Diffuse Large B-Cell Lymphoma Treated with Dose-Intensive Immunochemotherapy","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"BCL6; Lymphoma; Diffuse large B-cell lymphoma; Medicine; Internal medicine; Oncology; Germinal center; Gastroenterology; Pathology; Immunology; B cell","score_opus":0.0047241167163117525,"score_gpt":0.19958277031844837,"score_spread":0.1948586536021366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986069530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970983,0.0003268285,0.0000020853695,0.00015543928,0.00007479803,0.0017993911,0.0001769208,0.00008724606,0.000278976],"genre_scores_gemma":[0.99809456,0.00022523126,0.00010339083,0.00034564149,0.000035129626,0.00016922152,0.0003799442,0.00010593158,0.0005409253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975752,0.00011559809,0.0003381942,0.00061507704,0.00072928856,0.0006266389],"domain_scores_gemma":[0.99795467,0.00019328238,0.000387547,0.00073210755,0.00057908404,0.00015332917],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013983426,0.0005203749,0.0007035398,0.000102817015,0.00020798772,0.0000831985,0.00017381513,0.0002449374,0.000037679365],"category_scores_gemma":[0.000021624408,0.0002506981,0.000096575546,0.00041422207,0.00007449869,0.00012496355,0.000051474894,0.000215589,0.000026321784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009363465,0.016116899,0.9694025,0.000016266928,0.00095027976,0.00014408746,0.0009270618,0.0000018426744,0.0027522824,0.000005517636,0.000051231662,0.0002685989],"study_design_scores_gemma":[0.2214177,0.002410264,0.6709412,0.0003722245,0.00046910188,0.0000096997355,0.0002407749,0.000010341152,0.10381491,0.0000012138332,0.00003793656,0.0002746789],"about_ca_topic_score_codex":0.0012409616,"about_ca_topic_score_gemma":0.00061204884,"teacher_disagreement_score":0.2984613,"about_ca_system_score_codex":0.00025969621,"about_ca_system_score_gemma":0.00018112168,"threshold_uncertainty_score":0.9999945},"labels":[],"label_agreement":null},{"id":"W2986070722","doi":"10.1182/blood.v106.11.4231.4231","title":"Mobilization of Endothelial Progenitor Cells in Autologous and Allogeneic Peripheral Blood Stem Cell Grafts.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Progenitor cell; Stem cell; CD34; Endothelial stem cell; Immunology; Transplantation; Peripheral blood mononuclear cell; Vasculogenesis; Biology; CD31; Pathology; Medicine; Angiogenesis; Cancer research; Cell biology; Internal medicine; In vitro","score_opus":0.006408063396237579,"score_gpt":0.2171326526074843,"score_spread":0.2107245892112467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986070722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943651,0.005047257,0.00007647271,0.000014208792,0.00005456729,0.00019159644,0.000042685202,0.0000073900405,0.00020073948],"genre_scores_gemma":[0.9975785,0.0006799016,0.0010631159,0.00005171219,0.00022302184,0.000034436525,0.000018080444,0.00001958471,0.00033163125],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99923927,0.000039018483,0.00020863934,0.0002618184,0.00007658063,0.00017466249],"domain_scores_gemma":[0.9996715,0.000004807837,0.00007477274,0.00016700262,0.00003745114,0.000044434262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007642481,0.000121966776,0.00014175648,0.000031917545,0.000025124644,0.00000795388,0.000092988776,0.00013820048,0.000014240574],"category_scores_gemma":[0.000002516529,0.00011569606,0.00006360497,0.00005586076,0.000054023723,0.0000032328016,0.000048272992,0.000033606368,0.0000015254516],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002921244,0.00038818282,0.029191919,0.00003155446,0.00003597453,0.0000026737014,0.00007685011,0.00010773503,0.96715266,0.000009376335,0.00003584203,0.0029380326],"study_design_scores_gemma":[0.0014741475,0.00025929764,0.0020537218,0.000007057317,0.000057951704,0.000015349988,0.000042752745,0.00003000931,0.9913051,0.0000026581936,0.0046199174,0.00013199566],"about_ca_topic_score_codex":0.000013989861,"about_ca_topic_score_gemma":0.000059331283,"teacher_disagreement_score":0.027138198,"about_ca_system_score_codex":0.000005424704,"about_ca_system_score_gemma":0.000054246757,"threshold_uncertainty_score":0.4717948},"labels":[],"label_agreement":null},{"id":"W2986080996","doi":"10.1182/blood-2019-122311","title":"Value of Flow Cytometry for MRD-Based Relapse Prediction in B-Cell Precursor Acute Lymphoblastic Leukemia in a Multi-Center Setting","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Minimal residual disease; Internal medicine; Oncology; Risk stratification; Single Center; Leukemia; Immunology","score_opus":0.01150087295087758,"score_gpt":0.26949100267758774,"score_spread":0.25799012972671015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986080996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915291,0.000092740745,0.00517622,0.000076311764,0.00019410018,0.0021483577,0.00022864422,0.00006135249,0.00049319485],"genre_scores_gemma":[0.97694194,0.000013501348,0.021571442,0.00016776145,0.00007765229,0.00019509629,0.00016016664,0.0000786517,0.00079377135],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9973995,0.00010954468,0.0007175313,0.0005699456,0.0005551796,0.0006483087],"domain_scores_gemma":[0.9983546,0.0006452071,0.00017923745,0.0004986276,0.0001571244,0.00016521575],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006628868,0.00026940997,0.0005781983,0.0007953535,0.000026288159,0.000014509045,0.00021653641,0.00030844487,0.00004823518],"category_scores_gemma":[0.00059341185,0.00025176915,0.00016757793,0.00076786557,0.000067735775,0.00012869606,0.00008869273,0.00034433886,0.00008272394],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063392357,0.010139481,0.701426,0.0048956047,0.00047121427,0.00037812543,0.0015003177,0.009296794,0.26307654,0.000026391814,0.0013398716,0.0011103713],"study_design_scores_gemma":[0.14157583,0.0015305815,0.0357044,0.0014889897,0.00030246848,0.00008179975,0.00013126856,0.7335362,0.08523884,0.00001341337,0.00012902924,0.00026723006],"about_ca_topic_score_codex":0.00008255761,"about_ca_topic_score_gemma":0.000019135845,"teacher_disagreement_score":0.72423935,"about_ca_system_score_codex":0.0018155212,"about_ca_system_score_gemma":0.0018894009,"threshold_uncertainty_score":0.99999344},"labels":[],"label_agreement":null},{"id":"W2986130636","doi":"10.1182/blood-2019-124516","title":"Outcomes in Patients with Acute Myeloid Leukemia with Myelodysplasia-Related Changes (AML-MRC) Who Achieved Remission with CPX-351 Versus 7+3: Phase 3 Exploratory Analysis","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada","funders":"","keywords":"Medicine; Internal medicine; Cytarabine; Hazard ratio; Chemotherapy regimen; Gastroenterology; Induction chemotherapy; Neutropenia; Oncology; Myeloid leukemia; Surgery; Chemotherapy; Confidence interval","score_opus":0.011055303030863606,"score_gpt":0.2642811907120414,"score_spread":0.2532258876811778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986130636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99554116,0.00007830165,0.000023847095,0.000617031,0.0000668972,0.0018208061,0.000066067245,0.00024503033,0.0015408493],"genre_scores_gemma":[0.9948242,0.00008387169,0.001205009,0.00019135071,0.000050360366,0.00014273098,0.0005930937,0.00016136726,0.0027480314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99554247,0.00018933802,0.00052770274,0.0011368878,0.0015824819,0.0010211278],"domain_scores_gemma":[0.9970873,0.00019748995,0.0003458846,0.0013822885,0.0004219434,0.000565089],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003789547,0.0007104352,0.0015019797,0.0011546434,0.0001377827,0.00006107932,0.00041452143,0.00035088864,0.0002650544],"category_scores_gemma":[0.000080175,0.00044231513,0.00014528424,0.0030042185,0.00021722987,0.00040694026,0.00015783845,0.0010769608,0.00012188825],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029442439,0.0020380816,0.95255816,0.00013100274,0.009626715,0.0008745418,0.0014711621,0.000105576146,0.002355208,0.000010711782,0.00017774428,0.0012086646],"study_design_scores_gemma":[0.22794136,0.017799538,0.73090976,0.00075218285,0.00897116,0.00004853634,0.0012193363,0.0008252623,0.009668882,0.0000025340648,0.00063630333,0.0012251162],"about_ca_topic_score_codex":0.00013238747,"about_ca_topic_score_gemma":0.00045995062,"teacher_disagreement_score":0.22164837,"about_ca_system_score_codex":0.0008122535,"about_ca_system_score_gemma":0.0010470815,"threshold_uncertainty_score":0.9998029},"labels":[],"label_agreement":null},{"id":"W2986156035","doi":"10.1182/blood-2019-131497","title":"Retrospective Study of Patients with Upper Extremity Clots Presenting to Emergency Departments in Tertiary Care Hospitals in a Major Canadian City in the Last Five Years","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Medicine; Deep vein; Thrombosis; Retrospective cohort study; Emergency department; Venous thrombosis; Population; Medical record; Thrombophilia; Surgery; Pediatrics","score_opus":0.005267928662454397,"score_gpt":0.23460873453595088,"score_spread":0.22934080587349648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986156035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99562734,0.00004247862,4.256974e-8,0.000058224457,0.000063254745,0.003358851,0.000021270194,0.000004799416,0.0008237371],"genre_scores_gemma":[0.9996634,0.000006652465,0.000017336404,0.00008930517,0.0000144496935,0.00016019896,0.00001586549,0.000014078444,0.000018717312],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987658,0.00007162399,0.00026474355,0.00029603133,0.00030514502,0.00029662816],"domain_scores_gemma":[0.9994857,0.000009315375,0.000064106556,0.00030565308,0.00006044169,0.00007479285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015802507,0.000119594435,0.00030288362,0.00025420557,0.000020133939,0.0000071451277,0.0001393274,0.0000375896,0.000056188437],"category_scores_gemma":[0.0000421312,0.0000916184,0.000028172786,0.00038320775,0.000008495033,0.00006094985,0.000072541545,0.00012998353,0.000007307618],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016354534,0.0030436064,0.9741285,0.000037526443,0.000059215115,0.000060202812,0.022484774,0.000009707918,0.0000033746296,0.0000047623016,0.00008138894,0.00007061428],"study_design_scores_gemma":[0.0040332098,0.0004557079,0.98674095,0.00008950818,0.000067863795,2.1387464e-7,0.008481839,0.0000011316346,0.000015238199,0.0000066959415,0.000012232772,0.0000954075],"about_ca_topic_score_codex":0.08727758,"about_ca_topic_score_gemma":0.5733837,"teacher_disagreement_score":0.4861061,"about_ca_system_score_codex":0.0001525124,"about_ca_system_score_gemma":0.00004648499,"threshold_uncertainty_score":0.9188003},"labels":[],"label_agreement":null},{"id":"W2986177105","doi":"10.1182/blood-2019-127800","title":"Characterization of the \"Immune Evasion\" Phenotype of Richter Syndrome and the Implications for Immune-Checkpoint Inhibitor Therapy","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Immune checkpoint; Ibrutinib; Immune system; Immunology; Medicine; Chronic lymphocytic leukemia; Oncology; Immunotherapy; Cancer research; Internal medicine; Biology; Leukemia","score_opus":0.015573047606273784,"score_gpt":0.26546220049634944,"score_spread":0.24988915289007566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986177105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99512136,0.0010412143,0.000033484834,0.0017166422,0.000075243086,0.0018290586,0.00002222736,0.000008929482,0.00015181213],"genre_scores_gemma":[0.9990063,0.00023180316,0.000070691836,0.00006105306,0.000038665716,0.00009636216,0.000021286236,0.000018637018,0.00045520352],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99914247,0.000052438052,0.00034604,0.00014061107,0.00018232457,0.00013609987],"domain_scores_gemma":[0.9987689,0.00020982568,0.0001868631,0.00062932936,0.00017980373,0.000025279187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039619618,0.000085257445,0.0002735148,0.000039171548,0.00005207931,0.0000071511795,0.00016181808,0.00006190051,0.000036854937],"category_scores_gemma":[0.000119140204,0.00004316736,0.00012684535,0.00017950092,0.00017712546,0.000040029583,0.000088336026,0.00008426129,0.000005357701],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041379573,0.0002985014,0.002203431,0.00016708119,0.00015764174,2.0371101e-7,0.00048055264,3.8391363e-7,0.9943495,0.0009630339,0.0000044401554,0.0009614374],"study_design_scores_gemma":[0.053122412,0.00032552634,0.41209978,0.00020837523,0.00016539659,0.00011224365,0.000054765413,0.00025448203,0.5328299,0.000406602,0.0003428443,0.00007771263],"about_ca_topic_score_codex":0.00006992287,"about_ca_topic_score_gemma":0.0000010582677,"teacher_disagreement_score":0.46151963,"about_ca_system_score_codex":0.00014746994,"about_ca_system_score_gemma":0.00065762055,"threshold_uncertainty_score":0.1760314},"labels":[],"label_agreement":null},{"id":"W2986188404","doi":"10.1182/blood-2019-129497","title":"No Impact of Donor's Age-Related Clonal Hematopoiesis (ARCH) Observed on Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation: Result from Bar-Coded Error Corrected Sequencing in 33 Gene Mutations on 372 Pairs of Donor and Recipient","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Transplantation; Hematopoietic stem cell transplantation; Graft-versus-host disease; Oncology; Stem cell; Deep sequencing; Medicine; Internal medicine; Immunology; Biology; Gene; Genetics; Genome","score_opus":0.017499357692782727,"score_gpt":0.23852636307286743,"score_spread":0.22102700538008468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986188404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99730575,0.0005653441,0.000017273203,0.000023270135,0.0002628148,0.00045878027,0.0012085093,0.000010954653,0.0001473203],"genre_scores_gemma":[0.9980141,0.00027357,0.00033613454,0.0000339689,0.000035314195,0.000026257834,0.0011965585,0.000036319685,0.00004777324],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99846244,0.00009800133,0.0005283766,0.00047132268,0.0001924994,0.00024734068],"domain_scores_gemma":[0.9989223,0.00022586551,0.00022448388,0.0003918617,0.000080774174,0.00015470323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013780162,0.00024815163,0.00035991834,0.000096840005,0.000048295504,0.000017725253,0.00015438261,0.00015133175,0.000021588055],"category_scores_gemma":[0.000059472746,0.00024419103,0.0002529798,0.0001530497,0.000059211594,0.0000078274925,0.000044348293,0.00011286209,0.0000054136676],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002882026,0.00047468708,0.042584598,0.00015291246,0.00039352672,0.00008978122,0.0009796156,0.008944871,0.943401,0.00002388527,0.00003244665,0.000040679304],"study_design_scores_gemma":[0.015758857,0.001957706,0.17561108,0.0004918649,0.0006360717,0.000008289707,0.00046274686,0.0005376522,0.80383563,0.000068140966,0.000023040033,0.00060893304],"about_ca_topic_score_codex":0.00064492703,"about_ca_topic_score_gemma":0.0002918829,"teacher_disagreement_score":0.13956535,"about_ca_system_score_codex":0.00008091571,"about_ca_system_score_gemma":0.00025940125,"threshold_uncertainty_score":0.99578214},"labels":[],"label_agreement":null},{"id":"W2986196170","doi":"10.1182/blood-2019-123742","title":"Mosunetuzumab Induces Complete Remissions in Poor Prognosis Non-Hodgkin Lymphoma Patients, Including Those Who Are Resistant to or Relapsing After Chimeric Antigen Receptor T-Cell (CAR-T) Therapies, and Is Active in Treatment through Multiple Lines","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":182,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Spinal Cord Injury BC; University of British Columbia; Jewish General Hospital","funders":"","keywords":"Medicine; Tolerability; Internal medicine; Follicular lymphoma; Lymphoma; Gastroenterology; Rituximab; Dosing; Oncology; Immunology; Adverse effect","score_opus":0.04627110153982159,"score_gpt":0.3115243581487076,"score_spread":0.265253256608886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986196170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939201,0.001703456,0.0000013426394,0.00069225277,0.000088304034,0.0030362422,0.00013845578,0.000038691185,0.0003811865],"genre_scores_gemma":[0.99251705,0.0025424948,0.0026326173,0.0003233291,0.000089345434,0.00038055613,0.00005412226,0.00009299454,0.001367472],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974005,0.0001940966,0.000529598,0.0007965088,0.00046605335,0.0006132277],"domain_scores_gemma":[0.9987523,0.00029266495,0.00017118559,0.00044275587,0.0001330094,0.00020806538],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002056695,0.00040771786,0.0008081928,0.00035936615,0.000120524215,0.000059549155,0.00015939945,0.00019478278,0.00043555853],"category_scores_gemma":[0.00012136357,0.0003020106,0.00010352003,0.000901652,0.000065269436,0.00019025216,0.00019691189,0.00022840936,0.000023590186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070636272,0.0030255527,0.5305826,0.0001500349,0.00020477701,0.00007509126,0.02112888,0.0000014144364,0.41216663,3.590228e-7,0.0001460276,0.025455024],"study_design_scores_gemma":[0.030349685,0.0041544554,0.66055644,0.004099938,0.00010942418,0.000010204232,0.0050864066,0.00016145785,0.28373712,0.000014573988,0.011057426,0.00066289096],"about_ca_topic_score_codex":0.0016001489,"about_ca_topic_score_gemma":0.00080311135,"teacher_disagreement_score":0.12997384,"about_ca_system_score_codex":0.0005010746,"about_ca_system_score_gemma":0.00023953739,"threshold_uncertainty_score":0.9999432},"labels":[],"label_agreement":null},{"id":"W2986211227","doi":"10.1182/blood-2019-127119","title":"MANIFEST, a Phase 2 Study of CPI-0610, a Bromodomain and Extraterminal Domain Inhibitor (BETi), As Monotherapy or \"Add-on\" to Ruxolitinib, in Patients with Refractory or Intolerant Advanced Myelofibrosis","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McMaster University; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Ruxolitinib; Myelofibrosis; Bromodomain; Medicine; Internal medicine; Refractory (planetary science); Phases of clinical research; Oncology; Pharmacology; Clinical trial; Chemistry; Biology; Biochemistry","score_opus":0.010333862447035776,"score_gpt":0.2845839353661351,"score_spread":0.2742500729190993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986211227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954991,0.000044523433,0.000002311204,0.000097656346,0.00004965756,0.003959441,0.00005973891,0.000022473658,0.00026509474],"genre_scores_gemma":[0.997115,0.000024097404,0.0015573443,0.00033556295,0.000052757994,0.00051645,0.000021781354,0.000055191656,0.0003218155],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977884,0.00013542883,0.0005438631,0.0006584668,0.00050552114,0.0003682794],"domain_scores_gemma":[0.99879485,0.00019965137,0.00018393104,0.00044783432,0.00011174035,0.00026198226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015021654,0.00039204932,0.0007978619,0.000254909,0.000053392094,0.000026744043,0.00008816874,0.000089883135,0.00038419597],"category_scores_gemma":[0.000039476083,0.00023854099,0.00004818754,0.00028566943,0.000043814773,0.00011504778,0.000039239974,0.00016872684,0.000036055942],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06468765,0.05450607,0.85729444,0.00019303718,0.00042276643,0.0007742458,0.0071181534,0.000004831001,0.0053516477,0.00003766789,0.00004664872,0.009562864],"study_design_scores_gemma":[0.14988129,0.12781216,0.70292574,0.0011554604,0.00019514619,0.000059199607,0.0018650158,0.000003952822,0.0152914915,0.000016615168,0.00039114055,0.00040276075],"about_ca_topic_score_codex":0.00011200325,"about_ca_topic_score_gemma":0.000338889,"teacher_disagreement_score":0.15436865,"about_ca_system_score_codex":0.00008156541,"about_ca_system_score_gemma":0.00015242488,"threshold_uncertainty_score":0.9727419},"labels":[],"label_agreement":null},{"id":"W2986256604","doi":"10.1182/blood.v124.21.2450.2450","title":"Plerixafor Successfully Rescues Poor Mobilizers Resulting in Adequate CD34 Cell Numbers However Stem Cell Products Yield Lower Numbers of CFU/CD34 and Delayed Neutrophil Engraftment","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Plerixafor; Autologous stem-cell transplantation; CD34; Multiple myeloma; Medicine; Filgrastim; Population; Stem cell; Apheresis; Internal medicine; Granulocyte colony-stimulating factor; Immunology; CXCR4; Oncology; Chemotherapy; Biology; Platelet; Receptor","score_opus":0.013928645510601773,"score_gpt":0.2421309664262493,"score_spread":0.22820232091564752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986256604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903152,0.0005618858,0.00001455847,0.0013662175,0.00017771382,0.0015268928,0.000031479012,0.00008511678,0.005920959],"genre_scores_gemma":[0.9938805,0.00022813419,0.0016826557,0.000265493,0.0002147599,0.000105743246,0.000029061375,0.000103485334,0.0034901444],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962459,0.0002374276,0.00084598974,0.00095873704,0.0007767158,0.00093523046],"domain_scores_gemma":[0.99771005,0.00045487972,0.0003056375,0.0008676613,0.00029790035,0.0003638632],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011435533,0.00043998926,0.00076768216,0.00031603526,0.00010351848,0.00004742406,0.00033765586,0.00027396932,0.00007335446],"category_scores_gemma":[0.00028845127,0.00038955404,0.00013689845,0.00057533593,0.00025154155,0.00021130724,0.00025600076,0.0007236331,0.00004462893],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00892956,0.0070351935,0.08676389,0.004957287,0.0009040269,0.0011467778,0.012543118,0.00036136317,0.857251,0.00019517045,0.014929419,0.004983229],"study_design_scores_gemma":[0.03331517,0.003852452,0.015810756,0.0008261051,0.00075537246,0.00013170851,0.0058283135,0.0011160201,0.93165374,0.00004123261,0.005493964,0.001175136],"about_ca_topic_score_codex":0.001952809,"about_ca_topic_score_gemma":0.00016834053,"teacher_disagreement_score":0.0744028,"about_ca_system_score_codex":0.0002127106,"about_ca_system_score_gemma":0.00036985724,"threshold_uncertainty_score":0.99985564},"labels":[],"label_agreement":null},{"id":"W2986279153","doi":"10.1182/blood-2019-125182","title":"Factor-Associated Risk Factors of Mild Cognitive Impairment in Thalassemia Patients : Probable Role of FGF21","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Thalassemia; Montreal Cognitive Assessment; Internal medicine; Risk factor; Complete blood count; Ferritin; Pediatrics; Dementia; Disease","score_opus":0.0049071989651647725,"score_gpt":0.2117817356943824,"score_spread":0.20687453672921763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986279153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996375,0.00027075168,2.2526459e-7,0.0000075564917,0.0000563316,0.00090178923,0.00015747594,0.00001826277,0.0022126052],"genre_scores_gemma":[0.9996414,0.00012553154,0.000012938595,0.000010006876,0.000003688772,0.000006899649,0.00006838471,0.000017936734,0.00011321619],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885476,0.00005781435,0.00036794203,0.00019006134,0.0002802901,0.00024912195],"domain_scores_gemma":[0.9992836,0.00007623003,0.00027169444,0.00014096714,0.00015358924,0.000073883624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009074764,0.00014503284,0.00040860174,0.00011580605,0.000016550786,0.000002482602,0.00005779585,0.0001975983,0.00013279171],"category_scores_gemma":[0.00013564627,0.000111815556,0.00011452032,0.00026193593,0.00003539142,0.00004367906,0.00003610202,0.00022664595,0.000013858071],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009552654,0.003759076,0.9919275,0.00009156438,0.00024868583,0.0000015310105,0.0017674966,0.000007398485,0.0018600671,0.0000029599234,0.000014400574,0.00022379954],"study_design_scores_gemma":[0.009624711,0.0012617535,0.9490564,0.00050137274,0.00020708014,3.8628312e-7,0.0019774982,0.00002845296,0.037191268,0.00003269818,0.000011484372,0.000106916414],"about_ca_topic_score_codex":0.0004917672,"about_ca_topic_score_gemma":0.000035578592,"teacher_disagreement_score":0.042871114,"about_ca_system_score_codex":0.000041944706,"about_ca_system_score_gemma":0.00008965099,"threshold_uncertainty_score":0.4559706},"labels":[],"label_agreement":null},{"id":"W2986296009","doi":"10.1182/blood-2019-128949","title":"Prognostic Performance of Frailty Measures in MDS Patients Treated with Hypomethylating Agents","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Dr. Georges-L.-Dumont University Hospital Centre; St. Paul's Hospital; Alberta Hospital Edmonton; University of British Columbia; Saskatchewan Cancer Agency; CancerCare Manitoba; University Health Network; Health Sciences Centre; University of Alberta Hospital; Ottawa Hospital; McGill University Health Centre; University of Ottawa; Hamilton Health Sciences; Dalhousie University; Hôpital de l'Enfant-Jésus; Juravinski Cancer Centre; Jewish General Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Decitabine; Myelodysplastic syndromes; International Prognostic Scoring System; Internal medicine; Azacitidine; Comorbidity; Proportional hazards model; Quality of life (healthcare)","score_opus":0.025674913556442622,"score_gpt":0.267788450369429,"score_spread":0.24211353681298636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986296009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99505305,0.000051384155,0.0000010561855,0.000017231136,0.000012349721,0.0007850171,0.000004930649,0.000023869423,0.0040511107],"genre_scores_gemma":[0.99902534,0.000015398784,0.00043055217,0.00002611437,0.000016840793,0.00002466586,0.000025902813,0.000024680981,0.00041050502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99872535,0.000044643482,0.0002324075,0.00020875994,0.0005074191,0.00028142318],"domain_scores_gemma":[0.999324,0.00007445389,0.0000809469,0.00025823887,0.00018313326,0.000079202844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019610868,0.00011940565,0.00027673814,0.00018893677,0.000018785782,0.0000055288974,0.00009893238,0.00007065521,0.000067196255],"category_scores_gemma":[0.00022922328,0.00008600917,0.000028446319,0.0004759705,0.000041911968,0.00007697652,0.00004334713,0.00023224771,0.000048818907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002648631,0.00060440553,0.99041456,0.00019474037,0.00007241602,0.000014347426,0.00018724141,0.000012244805,0.0051823426,0.0000011013765,0.000016597456,0.003035115],"study_design_scores_gemma":[0.008720417,0.0016700487,0.96279246,0.00035984552,0.000064545224,0.000006899082,0.000032859236,0.0005669475,0.025655156,8.074669e-7,0.000041798903,0.00008820136],"about_ca_topic_score_codex":0.00009659483,"about_ca_topic_score_gemma":0.000007896996,"teacher_disagreement_score":0.027622111,"about_ca_system_score_codex":0.000071030605,"about_ca_system_score_gemma":0.00014803703,"threshold_uncertainty_score":0.35073522},"labels":[],"label_agreement":null},{"id":"W2986303745","doi":"10.1182/blood-2019-129529","title":"BCL-2 Inhibitor Venetoclax Enhances Temozolomide Sensitivity in AML","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Temozolomide; Methyltransferase; Venetoclax; Cancer research; Myeloid leukemia; Decitabine; O-6-methylguanine-DNA methyltransferase; Viability assay; Apoptosis; Biology; Medicine; Leukemia; DNA methylation; Immunology; Methylation; Chronic lymphocytic leukemia; DNA; Gene expression; Biochemistry; Glioma","score_opus":0.011046485691227821,"score_gpt":0.2722078270885017,"score_spread":0.26116134139727387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986303745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895897,0.0002251776,0.000007741294,0.0005818338,0.00012497816,0.000603866,0.0000057602533,0.000061438885,0.008799501],"genre_scores_gemma":[0.99605924,0.0000614407,0.00046948213,0.0002908583,0.00031445877,0.000020508807,0.000014577118,0.000026859223,0.0027425538],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986023,0.000089627814,0.0002196962,0.0003445799,0.00033418584,0.00040964942],"domain_scores_gemma":[0.9992075,0.00015663271,0.000046141133,0.000397178,0.000061520725,0.00013103784],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000505068,0.00014087703,0.00034274117,0.00015681065,0.0000243997,0.000015526435,0.00007570241,0.00013647003,0.00015222607],"category_scores_gemma":[0.00016320485,0.00012284028,0.00006811911,0.00029468647,0.000059896523,0.00009044386,0.000095111325,0.00042245036,0.0011520039],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023456452,0.00033696298,0.21446927,0.00017275188,0.000069676506,0.0007240281,0.00023980989,0.00000982085,0.7804865,0.00007248608,0.0013345964,0.0018495386],"study_design_scores_gemma":[0.009831088,0.0005668102,0.19790083,0.00031580043,0.0000638073,0.00032270097,0.00022826623,0.00064741244,0.78273135,0.0000722794,0.0070260996,0.00029352173],"about_ca_topic_score_codex":0.00025069618,"about_ca_topic_score_gemma":0.00015746162,"teacher_disagreement_score":0.016568437,"about_ca_system_score_codex":0.00027044356,"about_ca_system_score_gemma":0.00047880737,"threshold_uncertainty_score":0.99962574},"labels":[],"label_agreement":null},{"id":"W2986336771","doi":"10.1182/blood-2019-124117","title":"Risk of Thrombosis in Adult Philadelphia-Positive ALL Treated with an Asparaginase-Free Pediatric-Inspired ALL Regimen with Imatinib","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Regimen; Asparaginase; Incidence (geometry); Imatinib mesylate; Internal medicine; Transplantation; Acute lymphocytic leukemia; Surgery; Thrombosis; Pediatrics; Imatinib; Leukemia; Lymphoblastic Leukemia","score_opus":0.012931702329570301,"score_gpt":0.26529691160730784,"score_spread":0.25236520927773753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986336771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99457985,0.0000675843,0.000029164465,0.0006882126,0.000012015114,0.0013673003,0.00014078905,0.00009226369,0.0030228037],"genre_scores_gemma":[0.99460757,0.00015163339,0.0044640773,0.00021734627,0.00010097167,0.00007563262,0.00015661182,0.0000875521,0.00013858087],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99733025,0.00017236974,0.0004161829,0.0006269272,0.00085621804,0.00059807964],"domain_scores_gemma":[0.99760216,0.00025914586,0.00029707808,0.0011231833,0.00042447975,0.00029392168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026527056,0.00034788845,0.00072500855,0.00032135626,0.000030365069,0.000019908528,0.0003668573,0.00018353242,0.000072535164],"category_scores_gemma":[0.00015018595,0.00023943635,0.00006623385,0.0006612159,0.00014182043,0.00022708676,0.00010157225,0.00039231518,0.000050046252],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053480044,0.0039981725,0.9788925,0.00039537245,0.0015975153,0.0006116137,0.002804413,0.00007552828,0.0052792975,0.00010655834,0.00079621625,0.00009477498],"study_design_scores_gemma":[0.1150298,0.022712305,0.806843,0.0007628985,0.004904933,0.0004637313,0.0012113283,0.0035122596,0.04353347,0.00007615343,0.000042796717,0.000907364],"about_ca_topic_score_codex":0.0024257468,"about_ca_topic_score_gemma":0.00028117409,"teacher_disagreement_score":0.17204957,"about_ca_system_score_codex":0.0002197116,"about_ca_system_score_gemma":0.00053879066,"threshold_uncertainty_score":0.9763931},"labels":[],"label_agreement":null},{"id":"W2986356818","doi":"10.1182/blood-2019-123113","title":"Mitapivat (AG-348), an Oral PK-R Activator, in Adults with Non-Transfusion Dependent Thalassemia: A Phase 2, Open-Label, Multicenter Study in Progress","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Ineffective erythropoiesis; Thalassemia; Pyruvate kinase deficiency; Erythropoiesis; Hemolysis; Pyruvate kinase; Anemia; Internal medicine; Medicine; Glycolysis; Endocrinology; Biology; Metabolism","score_opus":0.012553871971411217,"score_gpt":0.30012243695267893,"score_spread":0.2875685649812677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986356818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993323,0.00022310414,0.0000024918377,0.00027785246,0.000104485516,0.0053792107,0.0000073644223,0.00004242811,0.0006400375],"genre_scores_gemma":[0.9990309,0.000092690716,0.00032649294,0.00013895238,0.000020825039,0.00018204887,0.000034811557,0.00005512911,0.00011818729],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9979208,0.0001164831,0.0004052815,0.0006489893,0.00041433793,0.000494108],"domain_scores_gemma":[0.9991039,0.000025992582,0.000087467684,0.00050417474,0.000070951435,0.00020750247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002904376,0.0003015084,0.0005295632,0.00020169778,0.000049509807,0.00005553174,0.00027778177,0.00022675663,0.000079597645],"category_scores_gemma":[0.000017204133,0.00021510648,0.000029111694,0.00043404975,0.0000467547,0.0003693942,0.00011330592,0.0006214966,0.00003430211],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006580415,0.071862586,0.90259516,0.00019044068,0.0001382563,0.001288272,0.006227963,0.0000062146564,0.0066638286,0.0000021450687,0.00002017795,0.0044245343],"study_design_scores_gemma":[0.6086318,0.02521068,0.32113585,0.0039607263,0.00046482065,0.00014364239,0.027033856,0.0014635042,0.010874697,0.000004712228,0.00018524182,0.0008904612],"about_ca_topic_score_codex":0.0009669931,"about_ca_topic_score_gemma":0.0023290988,"teacher_disagreement_score":0.6020514,"about_ca_system_score_codex":0.0000693409,"about_ca_system_score_gemma":0.0001441339,"threshold_uncertainty_score":0.8771788},"labels":[],"label_agreement":null},{"id":"W2986415010","doi":"10.1182/blood-2019-127106","title":"One-Year Outcomes with Once or Twice Daily Enoxaparin","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; Université de Montréal; Sanofi (Canada); Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Discontinuation; Enoxaparin sodium; Cohort; Population; Internal medicine; Low molecular weight heparin; Thrombosis","score_opus":0.018083815251853257,"score_gpt":0.25714858019878906,"score_spread":0.2390647649469358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986415010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94535685,0.000066868655,0.000017297614,0.00095330045,0.00008660446,0.00059188594,0.0000027205729,0.00009012907,0.05283435],"genre_scores_gemma":[0.9880915,0.00006802115,0.0018800257,0.0018058176,0.000083417355,0.000033880617,0.000007770535,0.000031555268,0.007997987],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990121,0.000014111077,0.00015349894,0.00026958637,0.00029342697,0.00025727888],"domain_scores_gemma":[0.999305,0.000044726567,0.000057094265,0.00045259058,0.000040890805,0.00009970285],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009704734,0.0001325249,0.00043965995,0.00005775109,0.000035121953,0.000023934133,0.000109013046,0.000045089408,0.0007419549],"category_scores_gemma":[0.000024398953,0.000090124886,0.000052491185,0.00012459696,0.000024038314,0.0000668245,0.00006630522,0.00010935392,0.00084990036],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003794404,0.007833822,0.96895266,0.0005963815,0.0017332396,0.00016060515,0.0011224636,0.000011630165,0.0026047917,0.009332721,0.003645486,0.0036267755],"study_design_scores_gemma":[0.0073989877,0.0017678748,0.9658048,0.00022784037,0.0007678725,0.0000105938,0.0003938736,0.0000049357955,0.0024746992,0.000032147043,0.020893522,0.00022281248],"about_ca_topic_score_codex":0.00011708394,"about_ca_topic_score_gemma":0.00007048204,"teacher_disagreement_score":0.04483636,"about_ca_system_score_codex":0.000018990608,"about_ca_system_score_gemma":0.000058674632,"threshold_uncertainty_score":0.99992806},"labels":[],"label_agreement":null},{"id":"W2986418166","doi":"10.1182/blood-2019-127248","title":"Patient-Reported Outcome Measures (PROMs) in Pediatric Non-Malignant Hematology: A Systematic Review","year":2019,"lang":"en","type":"review","venue":"Blood","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; University of Ottawa; Children's Hospital of Eastern Ontario","funders":"","keywords":"Medicine; Patient-reported outcome; CINAHL; MEDLINE; Disease; Population; Systematic review; Pediatrics; Quality of life (healthcare); Family medicine; Intensive care medicine; Internal medicine; Psychological intervention; Psychiatry","score_opus":0.08279221030505673,"score_gpt":0.35961915482631,"score_spread":0.2768269445212533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986418166","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011201605,0.98411375,0.000004108143,0.00016856541,0.0006043758,0.014271085,0.000037332076,0.00014171792,0.0005470562],"genre_scores_gemma":[0.00015448735,0.99650514,0.00009881158,0.0009918028,0.00024520583,0.0015066082,0.00014800436,0.00018373442,0.00016617836],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9895234,0.0010680405,0.0060821814,0.0011917844,0.0013935564,0.00074104406],"domain_scores_gemma":[0.9928701,0.000662134,0.003469423,0.0024447017,0.00023112039,0.00032254035],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0027565036,0.0010308925,0.013772094,0.0007076699,0.0000445778,0.000029850262,0.0004974842,0.00067697675,0.000048184895],"category_scores_gemma":[0.0038245742,0.0007743151,0.0017659414,0.0012931646,0.000044889483,0.00007712562,0.000207176,0.0010773629,0.00068593444],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000043125324,0.0008262843,0.0014996877,0.9920969,0.00089587265,0.00063983415,0.0001467848,1.2382653e-8,3.1935453e-8,0.000010557564,0.00039885278,0.0034808533],"study_design_scores_gemma":[0.0016385497,0.00024803542,0.00010958928,0.9259492,0.050336797,0.0027767082,0.00002975715,2.0492007e-7,5.909679e-7,0.000005331203,0.018119466,0.00078574166],"about_ca_topic_score_codex":0.00010661493,"about_ca_topic_score_gemma":0.0000640396,"teacher_disagreement_score":0.066147685,"about_ca_system_score_codex":0.00020602568,"about_ca_system_score_gemma":0.0013602434,"threshold_uncertainty_score":0.9994708},"labels":[],"label_agreement":null},{"id":"W2986442725","doi":"10.1182/blood-2019-131981","title":"IGLL5-BCL2L1 Rearrangement with Loss of BCL2 Dependency As Mechanism of Venetoclax Resistance in Multiple Myeloma (MM)","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Venetoclax; Multiple myeloma; Chromatin; Cancer research; BRD4; Gene expression profiling; Biology; Gene; Computational biology; Gene expression; Epigenetics; Molecular biology; Genetics; Immunology; Leukemia; Bromodomain; Chronic lymphocytic leukemia","score_opus":0.015862646985682915,"score_gpt":0.26327378389975636,"score_spread":0.24741113691407346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986442725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99056196,0.00055776694,0.00002016668,0.000064819134,0.000030148047,0.0011614005,0.00003376587,0.000018521849,0.007551452],"genre_scores_gemma":[0.9948281,0.00009764408,0.0030853322,0.000019176932,0.00002134469,0.00006359243,0.000029144547,0.000029529403,0.0018261013],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982207,0.000059207647,0.00035120317,0.00033507284,0.00067351345,0.00036030688],"domain_scores_gemma":[0.9989039,0.00009145864,0.00014639615,0.00056576467,0.00014731979,0.00014521102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020063056,0.00017465626,0.00045926552,0.00018451919,0.000021903737,0.000004958495,0.00014793692,0.00008783603,0.00025458823],"category_scores_gemma":[0.00010309396,0.00013651914,0.00007684772,0.00027394714,0.00006237203,0.00006237374,0.00005783859,0.00015072514,0.00007421412],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042281,0.0023076723,0.88015366,0.0010968139,0.0006108067,0.00095065247,0.00069424347,0.000007658807,0.10625384,0.0025822236,0.000023320576,0.0010910378],"study_design_scores_gemma":[0.035625312,0.0027368332,0.5274474,0.0012669397,0.00018883697,0.000059328675,0.000314357,0.00008473349,0.43075216,0.0010226419,0.00025557453,0.00024588115],"about_ca_topic_score_codex":0.000605712,"about_ca_topic_score_gemma":0.001002221,"teacher_disagreement_score":0.35270622,"about_ca_system_score_codex":0.00008905708,"about_ca_system_score_gemma":0.00028428802,"threshold_uncertainty_score":0.55670893},"labels":[],"label_agreement":null},{"id":"W2986452922","doi":"10.1182/blood-2019-127917","title":"Meta-Analysis and Cost-Effectiveness Analysis of Low-Dose Direct Oral Anticoagulant for the Prevention of Cancer Associated Thrombosis","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Apixaban; Meta-analysis; Rivaroxaban; Relative risk; Randomized controlled trial; Internal medicine; Placebo; Subgroup analysis; Warfarin; Confidence interval; Atrial fibrillation","score_opus":0.11367015810697412,"score_gpt":0.4163979681811051,"score_spread":0.30272781007413097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986452922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99418205,0.004109432,0.000052179534,0.00007917066,0.000038957372,0.0012036479,0.00026625188,0.000007787844,0.000060532704],"genre_scores_gemma":[0.99886835,0.00039540796,0.000031180127,0.000027476199,0.000009207419,0.00025206155,0.00009384287,0.000007703653,0.0003148033],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99918574,0.00014168565,0.0002258112,0.00019099945,0.00014095349,0.00011479743],"domain_scores_gemma":[0.9988565,0.00054857176,0.00023555195,0.00018077459,0.00014947561,0.000029170013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004187615,0.00010694523,0.0013708678,0.00021070988,0.000026891912,0.0000041317207,0.000044616365,0.000052817963,0.00045358003],"category_scores_gemma":[0.000020730104,0.00006391372,0.0010807684,0.0009961581,0.000042750045,0.000026179621,0.000017429691,0.000038356164,3.6056096e-7],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001653757,0.0008305169,0.43739152,0.00008198658,0.5368174,3.5372412e-7,0.00008026388,0.00019282677,0.024165414,0.0000047163126,0.000007104893,0.00026258992],"study_design_scores_gemma":[0.0021477945,0.00018723164,0.45272347,0.000005459519,0.5069824,8.766947e-8,0.000009641726,0.00071320933,0.037184842,0.00000407052,0.000008882135,0.000032891803],"about_ca_topic_score_codex":0.0017058147,"about_ca_topic_score_gemma":0.0015359754,"teacher_disagreement_score":0.029834928,"about_ca_system_score_codex":0.00002699388,"about_ca_system_score_gemma":0.00004360836,"threshold_uncertainty_score":0.49663833},"labels":[],"label_agreement":null},{"id":"W2986503145","doi":"10.1182/blood-2019-124208","title":"Risk Factors for Primary and Secondary Graft Failure in Allogenic Hematopoietic Cell Transplantation: A Single Center Study","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Transplantation; Cumulative incidence; Hematopoietic stem cell transplantation; Single Center; Population; Donor lymphocyte infusion; Internal medicine; Graft-versus-host disease; Incidence (geometry); Surgery","score_opus":0.009703587887779816,"score_gpt":0.22540725037798112,"score_spread":0.21570366249020131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986503145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960255,0.00013103282,0.00015425128,0.00005570034,0.00008222446,0.0023184402,0.00010718921,0.000047289188,0.0010783795],"genre_scores_gemma":[0.99837637,0.000060146853,0.0009893114,0.00007265486,0.000026287216,0.00006779551,0.00019483342,0.000038837457,0.00017378032],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986937,0.0000669068,0.0003720203,0.00039251783,0.00021228522,0.00026254516],"domain_scores_gemma":[0.9993112,0.00023453891,0.00008768355,0.00022839433,0.00003590819,0.000102294456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018217562,0.00020736325,0.00039440655,0.00013903122,0.000039666378,0.000020446862,0.00006536555,0.00011259385,0.00010518122],"category_scores_gemma":[0.000007909495,0.00018491762,0.00008761943,0.00012100372,0.000024435216,0.00009225184,0.000009428002,0.00018640097,0.00001927395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018195198,0.0022767356,0.96647847,0.001988583,0.000099650075,0.000068328634,0.008414347,0.0000017975038,0.02039271,0.0000072987714,0.000014921581,0.00007520776],"study_design_scores_gemma":[0.0416511,0.0022218016,0.9025361,0.00036240544,0.0013485248,0.0005469562,0.0056325216,0.000015809801,0.044960957,0.000062294326,0.00021134193,0.0004502122],"about_ca_topic_score_codex":0.000021024285,"about_ca_topic_score_gemma":0.00009245546,"teacher_disagreement_score":0.063942395,"about_ca_system_score_codex":0.000024720905,"about_ca_system_score_gemma":0.00006058996,"threshold_uncertainty_score":0.7540721},"labels":[],"label_agreement":null},{"id":"W2986512677","doi":"10.1182/blood-2019-124370","title":"Safety and Efficacy of the Combination of Selinexor, Lenalidomide and Dexamethasone (SRd) in Patients with Newly Diagnosed Multiple Myeloma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Vancouver General Hospital; CancerCare Manitoba; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; Royal Victoria Hospital; Dalhousie University","funders":"","keywords":"Lenalidomide; Medicine; Multiple myeloma; Dexamethasone; Internal medicine; Oncology; Neutropenia; Gastroenterology; Toxicity","score_opus":0.002596474345135328,"score_gpt":0.1776408271969165,"score_spread":0.1750443528517812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986512677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995756,0.00009287904,0.000020366544,0.000016122864,0.000028014962,0.00019910856,0.0000071464965,0.0000012685704,0.0000594731],"genre_scores_gemma":[0.99961925,0.00002700697,0.00028014797,0.000022451053,0.000009033222,8.055853e-7,0.000018234075,0.0000061207393,0.000016980188],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99964726,0.000029918478,0.00010325816,0.00010937075,0.00005910553,0.00005108641],"domain_scores_gemma":[0.9997267,0.000026122869,0.00007313589,0.00012231819,0.00003905517,0.000012676398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005424152,0.0000526872,0.00008876391,0.00001553905,0.000012170023,0.0000024571923,0.000034783403,0.000050952753,0.000002442071],"category_scores_gemma":[0.00006185455,0.000035408408,0.000014054539,0.000047077683,0.00003705076,0.0000026411992,0.000035299054,0.000033212134,1.4698232e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062878855,0.00016004084,0.9188622,0.000021428212,0.000028606974,8.8378364e-8,0.00006201651,0.000018422326,0.07740589,0.000023934865,0.000005585341,0.0027829986],"study_design_scores_gemma":[0.010820749,0.0003589874,0.92847246,0.000018985103,0.000021847703,6.97587e-7,0.000019470877,0.000020414713,0.060086746,0.000008341655,0.00012751632,0.000043779568],"about_ca_topic_score_codex":0.000025960691,"about_ca_topic_score_gemma":0.000034623048,"teacher_disagreement_score":0.017319145,"about_ca_system_score_codex":0.0000014941166,"about_ca_system_score_gemma":0.000008965573,"threshold_uncertainty_score":0.1443913},"labels":[],"label_agreement":null},{"id":"W2986516670","doi":"10.1182/blood-2019-130647","title":"Evaluation of T-Cell Compartment By Complex Multiparameter Flow Cytometry Reveals Distinct Patterns of T-Cell Exhaustion in DLBCL, FL and HL Patients","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Lymphoma; Immunophenotyping; CD8; Cancer research; T cell; Follicular lymphoma; Diffuse large B-cell lymphoma; Medicine; Flow cytometry; Immunotherapy; Immunology; Oncology; Internal medicine; Immune system","score_opus":0.02785331893501828,"score_gpt":0.2852168885162989,"score_spread":0.2573635695812806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986516670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99809456,0.00038504982,0.000032074615,0.000014714911,0.00007397946,0.0009550496,0.00014892063,0.0000062649683,0.00028941213],"genre_scores_gemma":[0.99912214,0.000042879426,0.00039518718,0.00004719703,0.000011594831,0.000019829731,0.00028628766,0.000012141973,0.00006276206],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986127,0.00011193777,0.00041716956,0.00020282618,0.0005215282,0.0001338559],"domain_scores_gemma":[0.9993005,0.000060695853,0.00021647237,0.00021731092,0.00016395222,0.000041092593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058278197,0.00011987575,0.00032075495,0.00011673761,0.000011811206,0.000004817075,0.000049198614,0.00006326922,0.00020386945],"category_scores_gemma":[0.000025109926,0.000104712584,0.000058143723,0.00013186966,0.000032400676,0.00004089593,0.000022890516,0.00006508825,0.000004887779],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034902783,0.0024862376,0.7031575,0.00028545654,0.00005640078,3.3289749e-7,0.00016111493,0.000003333171,0.29091835,1.17739006e-7,0.00013347054,0.0024486682],"study_design_scores_gemma":[0.02679547,0.0007250728,0.84758097,0.00019922406,0.00027441554,0.0000011033385,0.00006708862,0.0013792454,0.12282318,0.0000036928832,0.000051237905,0.00009927874],"about_ca_topic_score_codex":0.00013233066,"about_ca_topic_score_gemma":0.000017776523,"teacher_disagreement_score":0.16809516,"about_ca_system_score_codex":0.00006240282,"about_ca_system_score_gemma":0.000030007457,"threshold_uncertainty_score":0.42700553},"labels":[],"label_agreement":null},{"id":"W2986533559","doi":"10.1182/blood-2019-128639","title":"Largest Single Center Experience Using Dual T-Cell Depletion with ATG and Ptcy for Gvhd Prophylaxis in Peripheral Blood RIC Allo-HSCT","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Fludarabine; Busulfan; Univariate analysis; Internal medicine; Cumulative incidence; Gastroenterology; Total body irradiation; Graft-versus-host disease; Incidence (geometry); Regimen; Hematopoietic stem cell transplantation; Single Center; Multivariate analysis; Transplantation; Surgery; Cyclophosphamide; Chemotherapy","score_opus":0.016565981001770137,"score_gpt":0.24306588051922323,"score_spread":0.22649989951745308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986533559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974987,0.00016823238,0.0005397004,0.00003135568,0.00007441229,0.0010666553,0.0000101004935,0.0000326808,0.0005781945],"genre_scores_gemma":[0.99328744,0.000012696257,0.0063226004,0.000063183325,0.000054432727,0.000049683007,0.000033464985,0.000035422836,0.00014105522],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988917,0.00003015195,0.0002308657,0.00034760401,0.00021445911,0.00028521207],"domain_scores_gemma":[0.999572,0.000040871135,0.00006733067,0.00018004134,0.000055227407,0.000084543615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010301503,0.00016465243,0.0002479434,0.00008324639,0.000042159918,0.000027121496,0.000040301024,0.00009385507,0.00006204611],"category_scores_gemma":[0.000012115257,0.00013752122,0.000035943132,0.00014414452,0.00004147936,0.00011143699,0.000011518688,0.00010031492,0.000005110204],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021311999,0.0013904995,0.68899494,0.0006927235,0.000030032192,0.00007721622,0.003153999,0.000009538568,0.30526683,0.000017190208,0.0000012793197,0.0001526426],"study_design_scores_gemma":[0.07517001,0.0084870355,0.3660224,0.0013717364,0.0008564692,0.003591679,0.0026343404,0.0010169377,0.53921145,0.00002334077,0.0005048071,0.0011097861],"about_ca_topic_score_codex":0.000050867464,"about_ca_topic_score_gemma":0.000028861645,"teacher_disagreement_score":0.32297254,"about_ca_system_score_codex":0.000029196643,"about_ca_system_score_gemma":0.00005285015,"threshold_uncertainty_score":0.56079525},"labels":[],"label_agreement":null},{"id":"W2986556352","doi":"10.1182/blood-2019-125248","title":"Pyruvate Kinase (PK) Protein and Enzyme Levels in the Diagnosis and Clinical Phenotype of PK Deficiency","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Pyruvate kinase deficiency; Pyruvate kinase; Reticulocytosis; Medicine; Hemolytic anemia; Enzyme; Biology; Internal medicine; Glycolysis; Anemia; Biochemistry","score_opus":0.04367268598531297,"score_gpt":0.30447938431466254,"score_spread":0.26080669832934955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986556352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99716115,0.00083456753,0.0000038867593,0.00045311297,0.000063425476,0.0004746899,0.000005609981,0.000008978726,0.0009946001],"genre_scores_gemma":[0.99889344,0.00018613927,0.00016575269,0.0005502825,0.00005823151,0.000022322445,0.0000026340886,0.0000062362824,0.000114940565],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99929094,0.00010157618,0.00022394776,0.00018254135,0.00008733857,0.000113636415],"domain_scores_gemma":[0.9994885,0.00019249374,0.000060691353,0.00018917125,0.00002885761,0.000040316005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033603053,0.000073336494,0.00022278406,0.000039805534,0.000019199913,0.0000040508326,0.000043047115,0.00008234724,0.000092976916],"category_scores_gemma":[0.00017758942,0.000046792768,0.000033051667,0.00010486417,0.0000976593,0.000024929472,0.00003123856,0.00015524881,0.000019734442],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002495332,0.0018541606,0.91779804,0.0003046928,0.000039353312,0.00003771334,0.00079048966,5.716735e-7,0.07006865,0.0014499972,0.00016386171,0.0072429534],"study_design_scores_gemma":[0.004344945,0.0017003352,0.9852257,0.000108794375,0.00008770384,0.000015543423,0.000197056,0.000021548607,0.0069702123,0.0003098348,0.00093737175,0.00008096978],"about_ca_topic_score_codex":0.00003671561,"about_ca_topic_score_gemma":0.000017016906,"teacher_disagreement_score":0.06742766,"about_ca_system_score_codex":0.0000024525725,"about_ca_system_score_gemma":0.000033071763,"threshold_uncertainty_score":0.19081536},"labels":[],"label_agreement":null},{"id":"W2986567088","doi":"10.1182/blood-2019-126035","title":"Pioneer: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Avapritinib in Patients with Indolent or Smoldering Systemic Mastocytosis with Symptoms Inadequately Controlled with Standard Therapy","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Systemic mastocytosis; Tolerability; Adverse effect; Internal medicine; Mast cell; Mucositis; Cutaneous Mastocytosis; Neutropenia; Gastroenterology; Oncology; Pharmacology; Immunology; Toxicity","score_opus":0.010874799468305184,"score_gpt":0.230279191628839,"score_spread":0.2194043921605338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986567088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821428,0.0009183411,0.0000747447,0.000013984433,0.000101926176,0.016343262,0.000037791226,0.000051213476,0.00031590648],"genre_scores_gemma":[0.9974107,0.00004341325,0.000036541824,0.000020570431,0.000013065627,0.0017341496,0.000053220003,0.00006044152,0.0006278813],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.997173,0.0005019925,0.0010003657,0.0005695596,0.00024342247,0.00051165663],"domain_scores_gemma":[0.9980185,0.00040819024,0.0007440242,0.0005026865,0.0002762033,0.000050368726],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007681184,0.0005065844,0.0028938248,0.00037466895,0.00010139061,0.000035240962,0.00024579145,0.0001883357,0.00032207707],"category_scores_gemma":[0.000019504952,0.0002643791,0.00012832716,0.0002939492,0.00017251038,0.000113443275,0.000045754176,0.00036504806,0.00001841043],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94184744,0.007841376,0.04176751,0.00010844534,0.0038550629,0.000029586052,0.0026928296,0.00017190649,0.0013241039,0.000033485816,0.0000024085898,0.00032583805],"study_design_scores_gemma":[0.9705075,0.023517773,0.000432173,0.00052943913,0.0007954171,0.00003863146,0.0015019086,0.000008179056,0.0022451365,5.368688e-7,0.000033390173,0.00038988577],"about_ca_topic_score_codex":0.00026902262,"about_ca_topic_score_gemma":0.00028750184,"teacher_disagreement_score":0.041335337,"about_ca_system_score_codex":0.00006554084,"about_ca_system_score_gemma":0.00019674026,"threshold_uncertainty_score":0.99998087},"labels":[],"label_agreement":null},{"id":"W2986575254","doi":"10.1182/blood-2019-122980","title":"Pharmacokinetic Exposure Equivalence and Preliminary Efficacy and Safety from a Randomized Cross over Phase 3 Study (ASCERTAIN study) of an Oral Hypomethylating Agent ASTX727 (cedazuridine/decitabine) Compared to IV Decitabine","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Queen Elizabeth II Health Sciences Centre; Ottawa Hospital; University of Ottawa; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Decitabine; Pharmacokinetics; Adverse effect; Pharmacology; Dosing; Hypomethylating agent; Azacitidine; Tolerability; Bioavailability; Phases of clinical research; Population; Clinical endpoint; Bioequivalence; Cmax; Internal medicine; Nausea; Clinical trial","score_opus":0.030169310328721388,"score_gpt":0.3654661771086529,"score_spread":0.33529686677993153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986575254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886454,0.0010062567,0.000064150394,0.00008950095,0.00010785796,0.009827082,0.00009111572,0.000078283534,0.000090353526],"genre_scores_gemma":[0.9974985,0.000051646188,0.0017114087,0.00008602781,0.0001554961,0.00019346646,0.00005721909,0.000082193255,0.00016404288],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9952043,0.00093519746,0.0011554427,0.001058626,0.0010284998,0.00061787904],"domain_scores_gemma":[0.99606943,0.0017931241,0.00027449543,0.0008866069,0.00035995664,0.00061637483],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00195693,0.0005008655,0.0018726895,0.00035881257,0.00014595366,0.00008827427,0.00034998803,0.00010620588,0.00030805933],"category_scores_gemma":[0.001282143,0.00040996756,0.00010237904,0.0006695652,0.00018756275,0.00023566894,0.0006057558,0.00048368698,0.000012858786],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.53490704,0.03584479,0.18767473,0.0003741468,0.00261315,0.0007525149,0.023037447,0.00045714105,0.19962008,0.0000038007765,0.0000738989,0.014641271],"study_design_scores_gemma":[0.70583147,0.015076987,0.26473805,0.00019024154,0.0012692196,0.00004102125,0.0033686631,0.0055144215,0.0035632541,0.000006047805,0.000027505088,0.00037308314],"about_ca_topic_score_codex":0.000805426,"about_ca_topic_score_gemma":0.000026055273,"teacher_disagreement_score":0.19605683,"about_ca_system_score_codex":0.00009002057,"about_ca_system_score_gemma":0.00015452912,"threshold_uncertainty_score":0.9998352},"labels":[],"label_agreement":null},{"id":"W2986592300","doi":"10.1182/blood-2019-122019","title":"Outcome of Limited Stage Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) and Evaluation of a PET-Adapted Approach","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"ABVD; Medicine; Stage (stratigraphy); Positron emission tomography; Nuclear medicine; Radiation therapy; Lymphoma; Oncology; Chemotherapy; Internal medicine; Vincristine; Cyclophosphamide","score_opus":0.03202130380728589,"score_gpt":0.28188593152165403,"score_spread":0.24986462771436813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986592300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938378,0.0017531362,0.000009380042,0.000037925984,0.000050342496,0.0012963668,0.000046850768,0.00002293013,0.0029452806],"genre_scores_gemma":[0.99768066,0.00011266505,0.0016863217,0.000035738343,0.000020893234,0.00007566874,0.000065587796,0.000023915236,0.00029857337],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981396,0.00011593892,0.0005141218,0.0003403655,0.00069502223,0.00019493914],"domain_scores_gemma":[0.99874127,0.000089077796,0.0002771906,0.0005140096,0.00027763649,0.00010083418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060092093,0.00019594279,0.0006509001,0.0001474282,0.000022521468,0.000008234855,0.00007078208,0.00007839579,0.000102491875],"category_scores_gemma":[0.00011779744,0.00015033339,0.00013462479,0.00019083785,0.000057620044,0.000056822344,0.00005631181,0.000026770238,0.0000129239015],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005326658,0.0069772685,0.9621938,0.00075327954,0.0008507755,0.000043553136,0.00051679375,0.000048072678,0.0147531815,0.0005050963,0.000020999927,0.012804527],"study_design_scores_gemma":[0.05829434,0.0010840378,0.84935904,0.0002222263,0.002448235,0.00017404532,0.0003158493,0.009208784,0.07845586,0.000019304818,0.00022574734,0.00019251466],"about_ca_topic_score_codex":0.00021855782,"about_ca_topic_score_gemma":0.000004988828,"teacher_disagreement_score":0.11283473,"about_ca_system_score_codex":0.00012871817,"about_ca_system_score_gemma":0.0002309638,"threshold_uncertainty_score":0.6130418},"labels":[],"label_agreement":null},{"id":"W2986606277","doi":"10.1182/blood-2019-124186","title":"Megakaryocyte-Driven Myelofibrosis Leads to Progressive Osteosclerosis in G6b-B Knockout Mice","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Osteosclerosis; Bone marrow; Myelofibrosis; Megakaryocyte; Medicine; Extramedullary hematopoiesis; Haematopoiesis; Internal medicine; Conditional gene knockout; Endocrinology; Knockout mouse; Pathology; Biology; Receptor; Stem cell; Phenotype","score_opus":0.011696817313044448,"score_gpt":0.2583691168683439,"score_spread":0.24667229955529946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986606277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908953,0.0006412425,0.000001685765,0.0020947203,0.00013086974,0.0020210738,0.00003161604,0.0000830556,0.0041004806],"genre_scores_gemma":[0.99447566,0.000077952674,0.0027285337,0.0009884705,0.00013666632,0.0005898159,0.000046092995,0.000053656106,0.00090315606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980104,0.00006785809,0.00039537007,0.0006325516,0.00039052198,0.0005032958],"domain_scores_gemma":[0.99891865,0.00012582199,0.00009803054,0.00043612186,0.00012614834,0.00029522963],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00010318311,0.00032576386,0.00062522513,0.0002349454,0.000057051646,0.000040855146,0.0001407091,0.000147726,0.00048015555],"category_scores_gemma":[0.00007484746,0.00026751513,0.00015314946,0.00044579525,0.000043311327,0.0001063082,0.00010971631,0.0001991626,0.001509159],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003030069,0.0022286547,0.92443585,0.00012080509,0.00020412866,0.00013174601,0.0011752989,0.000013611618,0.06867649,0.00017890101,0.00062892825,0.0019026046],"study_design_scores_gemma":[0.008618957,0.0026131582,0.63745403,0.0007739043,0.00028943268,0.00005443463,0.00019442526,0.00002556507,0.34802082,0.000008843535,0.0016161101,0.0003303305],"about_ca_topic_score_codex":0.000083051214,"about_ca_topic_score_gemma":0.000086910055,"teacher_disagreement_score":0.28698182,"about_ca_system_score_codex":0.00012281316,"about_ca_system_score_gemma":0.0001235063,"threshold_uncertainty_score":0.9999777},"labels":[],"label_agreement":null},{"id":"W2986637688","doi":"10.1182/blood-2019-122302","title":"A Matching-Adjusted Indirect Comparison of Nivolumab Versus Brentuximab Vedotin for Relapsed/Refractory Classical Hodgkin Lymphoma after Failure of Autologous Hematopoietic Cell Transplantation","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; Vancouver Coastal Health","funders":"","keywords":"Brentuximab vedotin; Medicine; Nivolumab; Internal medicine; Oncology; Cohort; Population; Transplantation; Hematopoietic stem cell transplantation; Lymphoma; Surgery; Cancer; Hodgkin lymphoma; Immunotherapy","score_opus":0.014828383432838899,"score_gpt":0.25849113698388543,"score_spread":0.24366275355104652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986637688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972528,0.0008146124,0.000055960794,0.00012247732,0.00022525061,0.0009305029,0.000105595514,0.000050372288,0.00044241647],"genre_scores_gemma":[0.9977808,0.00003415057,0.0017054728,0.00002146137,0.000036852096,0.00012768045,0.00015086753,0.000035863814,0.000106850515],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984729,0.000062122235,0.0005391779,0.00033661484,0.00032130835,0.0002678294],"domain_scores_gemma":[0.998828,0.0003473942,0.0003038082,0.00033171687,0.000093118186,0.00009594423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008908756,0.00023372687,0.00081383396,0.00013429092,0.000029058083,0.000008531646,0.000093826384,0.00022193184,0.00007793282],"category_scores_gemma":[0.000014687628,0.00020093183,0.00027088315,0.00013884548,0.000061409984,0.000059296086,0.000018495843,0.00008128575,0.00003170575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030370211,0.061700698,0.7980115,0.010737908,0.0026217743,0.0003471439,0.017352171,0.000047377507,0.057283964,0.000640208,0.0013461191,0.01954094],"study_design_scores_gemma":[0.12537916,0.008228751,0.4721573,0.00088049925,0.0040450506,0.00012276694,0.0011284198,0.00016731817,0.38684967,0.00006807679,0.00056391465,0.00040905966],"about_ca_topic_score_codex":0.00006742348,"about_ca_topic_score_gemma":0.00006647523,"teacher_disagreement_score":0.3295657,"about_ca_system_score_codex":0.000089858135,"about_ca_system_score_gemma":0.00017372584,"threshold_uncertainty_score":0.81937623},"labels":[],"label_agreement":null},{"id":"W2986664629","doi":"10.1182/blood-2019-131595","title":"Arsenic Trioxide Abrogate MN1 Mediated RA-Resistance in Acute Promyelocytic Leukemia","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Arsenic trioxide; Acute promyelocytic leukemia; Medicine; Leukemia; Arsenic; Cancer research; Immunology; Chemistry; Biology; Retinoic acid; Genetics; Cell culture","score_opus":0.0035379509034330495,"score_gpt":0.20892782585128494,"score_spread":0.20538987494785188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986664629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903409,0.0029476397,0.000037196056,0.000049537186,0.00012443218,0.0003362286,0.0000120672,0.000029068351,0.0061229304],"genre_scores_gemma":[0.99172425,0.0006440452,0.00057784654,0.0001504359,0.00009812249,0.00005025448,0.00013674005,0.00003813354,0.0065801977],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99853426,0.0000614935,0.0003093802,0.0005117177,0.00018729786,0.00039585563],"domain_scores_gemma":[0.99923235,0.000023309784,0.000113058195,0.00048743718,0.000059447284,0.00008437715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018723847,0.0002229454,0.00025601676,0.00006053748,0.000034211327,0.000027231143,0.00033931644,0.00024616974,0.000047689693],"category_scores_gemma":[0.00009450308,0.00021088026,0.00009642733,0.00021806794,0.00006354793,0.0000072809116,0.00009486212,0.00018603104,0.00016139861],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012953914,0.00009707667,0.008248671,0.00010957978,0.00011707591,0.000060844566,0.00006310188,0.000018124138,0.9906634,0.00006601477,0.0003081653,0.00011838441],"study_design_scores_gemma":[0.004944323,0.00018136966,0.0031339214,0.00007876026,0.00008128665,0.00003426533,0.000047081154,0.0000310751,0.97134084,0.00019519874,0.019528313,0.00040358977],"about_ca_topic_score_codex":0.000010775481,"about_ca_topic_score_gemma":0.00005924034,"teacher_disagreement_score":0.019322606,"about_ca_system_score_codex":0.00005693143,"about_ca_system_score_gemma":0.00041935514,"threshold_uncertainty_score":0.8599447},"labels":[],"label_agreement":null},{"id":"W2986754299","doi":"10.1182/blood-2019-127654","title":"Impact of Hematopoeitic Cell Transplantation-Co-Morbidity Index (HCT-CI) and Its Individual Components on Allogeneic Transplant Outcomes","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Transplantation; Internal medicine; Univariate analysis; Cohort; Prospective cohort study; Surgery; Cancer; Multivariate analysis","score_opus":0.028108730045649583,"score_gpt":0.29368337501844893,"score_spread":0.26557464497279937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986754299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99610746,0.00014352301,0.000053403266,0.000040093768,0.000078837,0.0008837723,0.0006386585,0.00005140409,0.002002843],"genre_scores_gemma":[0.998988,0.00023295452,0.00008904082,0.00007925846,0.000023133101,0.000016438027,0.00044290742,0.00003971019,0.00008861367],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99810064,0.00007922136,0.0005124877,0.0003750433,0.00060087576,0.00033172284],"domain_scores_gemma":[0.9990448,0.00026557132,0.00014718939,0.00027592803,0.000055848595,0.00021069616],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002148069,0.00030829312,0.0006472444,0.00022586543,0.000043469438,0.00001413352,0.00012498791,0.00018714837,0.00029487145],"category_scores_gemma":[0.0000072022535,0.00024790686,0.00021547824,0.00013172004,0.000042591026,0.000079920435,0.0000060307652,0.00021951355,0.00013518582],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000289487,0.0010861891,0.8910927,0.0015734689,0.00036357524,0.00011812974,0.0013965868,0.0000246368,0.10397344,0.000047562797,0.000008182225,0.000026046313],"study_design_scores_gemma":[0.008818163,0.0006127372,0.82417005,0.00034698157,0.00068412325,0.0003746614,0.000041455805,0.00004103266,0.16469146,0.000013371005,0.0000031512766,0.00020279444],"about_ca_topic_score_codex":0.0000714979,"about_ca_topic_score_gemma":0.000006153563,"teacher_disagreement_score":0.06692263,"about_ca_system_score_codex":0.000021863554,"about_ca_system_score_gemma":0.000099629986,"threshold_uncertainty_score":0.9999973},"labels":[],"label_agreement":null},{"id":"W2986761552","doi":"10.1182/blood-2019-127259","title":"Iron-Chelating Potential of Novel Phytochemicals in Poplar and Cedar Trees","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Plant Micronutrient Interactions and Effects","field":"Agricultural and Biological Sciences","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"","keywords":"Chelation; Deferiprone; Chemistry; Deferasirox; Iron deficiency; Environmental chemistry; Deferoxamine; Biochemistry; Botany; Biology; Medicine; Anemia; Internal medicine; Thalassemia","score_opus":0.007703557454048838,"score_gpt":0.19495176501123324,"score_spread":0.1872482075571844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986761552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99926054,0.00010592547,7.714081e-7,0.000054289383,0.000033084783,0.00008896761,0.000033986744,0.0000073520428,0.00041510156],"genre_scores_gemma":[0.9997617,0.00001593511,0.000100781595,0.000016173744,0.000034783363,0.0000019298548,0.000020037462,3.0553252e-7,0.00004835393],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996253,0.000009578375,0.00010065301,0.000114589595,0.000050630402,0.00009924261],"domain_scores_gemma":[0.99982756,0.00008033648,0.00004239125,0.000020083873,0.000008817472,0.00002083294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000056630503,0.00005125699,0.000096278935,0.000008453873,0.000017778517,0.00000950932,0.00004815389,0.000042571213,0.00006143627],"category_scores_gemma":[0.000012940463,0.000020901432,0.000025960037,0.000075576056,0.00001083567,0.000054858854,0.000028477103,0.000053831074,0.0000068440354],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009527407,0.00021118025,0.022735756,0.0000073618926,0.0000035478004,0.0000013996632,0.00001674303,0.000004402764,0.9761627,0.000016708433,0.000011487765,0.0008191844],"study_design_scores_gemma":[0.0016014517,0.00032698896,0.24861458,0.00017131474,0.000024712803,0.000075765274,0.00032794004,0.00035209782,0.7474327,0.000038936734,0.00082338706,0.00021014609],"about_ca_topic_score_codex":0.00008868554,"about_ca_topic_score_gemma":0.000042757525,"teacher_disagreement_score":0.22873002,"about_ca_system_score_codex":0.0000024047815,"about_ca_system_score_gemma":0.0000012840871,"threshold_uncertainty_score":0.08523356},"labels":[],"label_agreement":null},{"id":"W2986774652","doi":"10.1182/blood-2019-122776","title":"Re-Induction and Targeted Conditioning with Anti-CD45 Iodine (131I) Apamistamab [Iomab-B] Leads to High Rates of Transplantation and Successful Engraftment in Older Patients with Active, Relapsed or Refractory (rel/ref) AML after Failure of Chemotherapy and Targeted Agents: Preliminary Midpoint Results from the Prospective, Randomized Phase 3 Sierra Trial","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Venetoclax; Transplantation; Internal medicine; Salvage therapy; Fludarabine; Refractory (planetary science); Oncology; Clinical trial; Surgery; Chemotherapy; Leukemia; Cyclophosphamide; Chronic lymphocytic leukemia","score_opus":0.006996525404728251,"score_gpt":0.24443844982530505,"score_spread":0.2374419244205768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986774652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931745,0.00012365085,0.00012049177,0.00027258735,0.000050439416,0.0057871966,0.00042842346,0.000028717168,0.000014020646],"genre_scores_gemma":[0.9970708,0.00019409835,0.0015393735,0.000052670766,0.000028702545,0.00024548575,0.00080445217,0.00004469094,0.000019747222],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9979277,0.00025289907,0.0006924278,0.0005277396,0.0004021624,0.00019706707],"domain_scores_gemma":[0.99847144,0.0005545484,0.0004350732,0.00023795357,0.00020948189,0.00009148658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033327113,0.00029706606,0.0008312163,0.0001808792,0.00005699888,0.000021408267,0.00004912878,0.00014590567,0.000055760054],"category_scores_gemma":[0.000080472826,0.00018055941,0.000040733423,0.00027603007,0.00018670554,0.0002457719,0.000008494083,0.00019478348,4.7405896e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9035686,0.0019801182,0.04237036,0.0005138023,0.0004926426,0.00003545032,0.014448903,0.000010943196,0.036417473,0.000002758765,0.00000938104,0.00014951886],"study_design_scores_gemma":[0.52831125,0.0036257033,0.34259027,0.001027501,0.0005970373,0.000011292438,0.00087325164,0.000036403777,0.12277139,0.000006355742,0.0000015888735,0.00014798873],"about_ca_topic_score_codex":0.00019571019,"about_ca_topic_score_gemma":0.0000927516,"teacher_disagreement_score":0.37525743,"about_ca_system_score_codex":0.000039620754,"about_ca_system_score_gemma":0.000078526966,"threshold_uncertainty_score":0.7362999},"labels":[],"label_agreement":null},{"id":"W2986822804","doi":"10.1182/blood-2019-123655","title":"Luspatercept Significantly Reduces Red Blood Cell (RBC) Transfusion Burden, Regardless of Gene Mutation Frequency, Spectrum, and Prognostic Significance, Among Patients (Pts) with LR-MDS Enrolled in the MEDALIST Trial","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Population; Bone marrow; Erythropoiesis; Allele frequency; Gastroenterology; Oncology; Anemia; Gene; Allele; Biology; Genetics","score_opus":0.008232281644924646,"score_gpt":0.20931624571041677,"score_spread":0.20108396406549212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986822804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99438787,0.00009429384,0.0000172522,0.00014910266,0.00021336741,0.0031635542,0.000022254715,0.000033658183,0.001918652],"genre_scores_gemma":[0.998776,0.0001239437,0.00030937613,0.000060371818,0.00019607096,0.00014215076,0.0001500984,0.000032585125,0.00020938029],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9979326,0.0003206346,0.00053756963,0.0005024022,0.00042592658,0.00028085298],"domain_scores_gemma":[0.9989712,0.0001893181,0.00028181262,0.0003453927,0.00012550678,0.000086737506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000333723,0.00025346453,0.0005598501,0.00017838606,0.00006741478,0.000019461684,0.00013252936,0.00017873597,0.00012515429],"category_scores_gemma":[0.00006199092,0.00016606672,0.00008520366,0.00036684863,0.00017239297,0.00008749763,0.000011960186,0.00027361812,0.000006491695],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0252854,0.0047379103,0.21648932,0.0004901223,0.00021476671,0.00016402625,0.007743539,0.000055105418,0.7442839,0.000020813848,0.000042753436,0.00047233753],"study_design_scores_gemma":[0.24348818,0.020148069,0.4530988,0.00047465315,0.0014272567,0.00007707391,0.0027433848,0.00008802204,0.2777427,0.00014066049,0.000026236537,0.0005449345],"about_ca_topic_score_codex":0.0005216633,"about_ca_topic_score_gemma":0.00019057153,"teacher_disagreement_score":0.46654117,"about_ca_system_score_codex":0.000017993169,"about_ca_system_score_gemma":0.0001149578,"threshold_uncertainty_score":0.67720044},"labels":[],"label_agreement":null},{"id":"W2986843470","doi":"10.1182/blood-2019-127602","title":"Prevalence of Iron Deficiency and Iron Deficiency Anemia during Pregnancy: A Single Centre Canadian Study","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University Health Network; St. Michael's Hospital","funders":"","keywords":"Pregnancy; Medicine; Iron-deficiency anemia; Anemia; Iron deficiency; Pediatrics; Obstetrics; Psychiatry","score_opus":0.007024145692971614,"score_gpt":0.21088531489269072,"score_spread":0.2038611691997191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986843470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825107,0.009207316,5.876842e-7,0.00005347096,0.00008169209,0.0008423757,0.00001597741,0.00002498353,0.007262937],"genre_scores_gemma":[0.99848396,0.00013129627,0.00009663426,0.000019630028,0.000016977336,0.000005244485,0.000002942414,0.000018047078,0.0012252837],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987438,0.000033937173,0.00022633429,0.00035310513,0.00025699564,0.0003858502],"domain_scores_gemma":[0.99929404,0.00001621136,0.000075548276,0.00037287278,0.000045713437,0.00019562228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007390871,0.00015220573,0.00022103502,0.00013984017,0.00007244122,0.000011844534,0.00010863067,0.00006545461,0.00016220089],"category_scores_gemma":[0.000058129313,0.0001376589,0.00003505759,0.0001750279,0.00005663582,0.000082470164,0.000041836414,0.000102183134,0.000024753632],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021874039,0.0013689504,0.98116934,0.0029441277,0.0000016093647,0.000034602162,0.0027216221,0.0000043867426,0.011025239,0.00005587959,0.000006771541,0.0006455672],"study_design_scores_gemma":[0.0046572057,0.00055258407,0.9887956,0.00028960052,0.0003676875,0.000035694567,0.0024606404,0.000002141868,0.002635999,0.000009831495,0.0000101380465,0.0001828785],"about_ca_topic_score_codex":0.0051890253,"about_ca_topic_score_gemma":0.004217154,"teacher_disagreement_score":0.015973285,"about_ca_system_score_codex":0.000024942869,"about_ca_system_score_gemma":0.00014253538,"threshold_uncertainty_score":0.7844289},"labels":[],"label_agreement":null},{"id":"W2986852082","doi":"10.1182/blood.v128.22.1273.1273","title":"Argonaute 2 Silencing of Band 3 in Early Reticulocytes","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto","funders":"","keywords":"Argonaute; Reticulocyte; Gene silencing; Biology; Erythropoiesis; Molecular biology; RNA; RNA-induced silencing complex; microRNA; Cell biology; RNA interference; Gene; Genetics; Medicine; Internal medicine","score_opus":0.012104908157390123,"score_gpt":0.2313061913708263,"score_spread":0.21920128321343618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986852082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99473315,0.00021656894,0.00004044999,0.00032156173,0.000083139035,0.00008409979,0.0000024616763,0.000018918148,0.0044996706],"genre_scores_gemma":[0.99856067,0.00013978573,0.00024301725,0.00011199857,0.00010316272,0.0000043253913,0.0000010929957,0.0000063053258,0.0008296203],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9995326,0.000028614639,0.00014000869,0.00010744168,0.00007426514,0.00011707341],"domain_scores_gemma":[0.99965847,0.00008406679,0.000036598205,0.00013270343,0.000042595413,0.000045554312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008500884,0.0000497458,0.00015381638,0.00007226338,0.000011489887,0.0000011396523,0.000025992013,0.00006135982,0.00016681208],"category_scores_gemma":[0.00015074323,0.000032426313,0.000036235306,0.00007729721,0.000054101267,0.000027224898,0.000008545089,0.000049332688,0.000036955455],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012881859,0.00020240914,0.14643067,0.000042226784,0.00002142056,0.000036104062,0.00036811078,1.9088583e-7,0.8509442,0.0003852931,0.000110527784,0.0013300029],"study_design_scores_gemma":[0.0044922284,0.00047545307,0.5488357,0.00030154883,0.00004153327,0.00002309203,0.000052610507,0.0000010504641,0.44452378,0.00022605053,0.00096246303,0.000064459935],"about_ca_topic_score_codex":0.000044015083,"about_ca_topic_score_gemma":0.000013973849,"teacher_disagreement_score":0.40642044,"about_ca_system_score_codex":0.000011422669,"about_ca_system_score_gemma":0.000052770974,"threshold_uncertainty_score":0.18264753},"labels":[],"label_agreement":null},{"id":"W2986865196","doi":"10.1182/blood-2019-131718","title":"Patient Education Interventions for Improving Self-Management in Adults with Hemoglobinopathies: A Systematic Review and Meta-Analysis","year":2019,"lang":"en","type":"review","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Medicine; MEDLINE; Meta-analysis; Psychological intervention; PsycINFO; Randomized controlled trial; Systematic review; Cochrane Library; Physical therapy; Pediatrics; Internal medicine; Psychiatry","score_opus":0.026045405003944477,"score_gpt":0.3074207765779954,"score_spread":0.2813753715740509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986865196","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000071043623,0.9808731,0.00003686583,0.00007753583,0.000036548998,0.01851467,0.000059905502,0.000045650588,0.00034860586],"genre_scores_gemma":[0.000059658516,0.99063134,0.0015647267,0.0002142805,0.000008308563,0.0066440236,0.00027370919,0.0000544173,0.00054952415],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99718076,0.00018394423,0.0014669403,0.0006444705,0.00024751623,0.00027639145],"domain_scores_gemma":[0.9979753,0.00008580311,0.0009241249,0.0007499009,0.0001520596,0.00011280362],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044519184,0.00049864524,0.0064443755,0.0006733226,0.00005256439,0.000034368466,0.00012327681,0.00020728284,0.00002221908],"category_scores_gemma":[0.00008400087,0.0002918849,0.0026593101,0.0010780633,0.000021809004,0.00005845964,0.00007482776,0.00026885874,0.000013321709],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000044099374,0.00093498494,8.71488e-7,0.8781294,0.111240834,0.000008543074,0.00011013986,1.9510115e-7,2.5227285e-9,0.000035813166,0.000032092004,0.009502714],"study_design_scores_gemma":[0.0005104285,0.00026571567,2.5445314e-7,0.29143217,0.70347136,0.00007273221,0.00026404616,0.000003698441,4.2884654e-8,0.0000016960623,0.0037626517,0.00021522005],"about_ca_topic_score_codex":0.000026840105,"about_ca_topic_score_gemma":0.000019956702,"teacher_disagreement_score":0.5922305,"about_ca_system_score_codex":0.00009964402,"about_ca_system_score_gemma":0.000242375,"threshold_uncertainty_score":0.9999533},"labels":[],"label_agreement":null},{"id":"W2986873951","doi":"10.1182/blood.v128.22.3728.3728","title":"Bleeding Risks Associated with Confirmed Platelet Dense Granule Deficiency and/or Impaired Aggregation Responses","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; Hamilton Regional Laboratory Medicine Program; Centre Hospitalier Universitaire Sainte-Justine; McMaster University","funders":"","keywords":"Medicine; Platelet; Platelet disorder; Internal medicine; Odds ratio; Population; Cohort; Von Willebrand disease; Bleeding diathesis; Platelet activation; Immunology; Von Willebrand factor","score_opus":0.03315818147461965,"score_gpt":0.2771695558465905,"score_spread":0.24401137437197082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986873951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981442,0.0004458709,0.000023906276,0.00035806186,0.00002610425,0.0003487382,0.00003605558,0.000105764186,0.00051128876],"genre_scores_gemma":[0.9982498,0.00025662727,0.0001373194,0.00007649019,0.000016433365,0.0000249752,0.000019346919,0.00002101613,0.0011979482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99907345,0.0000419612,0.00016539817,0.00024304898,0.0002024559,0.0002737002],"domain_scores_gemma":[0.9993156,0.00025120503,0.000103521415,0.00013631907,0.0000760895,0.000117261465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015177816,0.00015392271,0.0002699457,0.000095585034,0.00012299963,0.00001935436,0.000035284524,0.00009366371,0.000057111487],"category_scores_gemma":[0.00041382454,0.00008075778,0.000034595738,0.00016186215,0.00008535372,0.00008990363,0.000014446592,0.000057949856,0.000016814956],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008771395,0.0043241363,0.8937067,0.00009522451,0.0013328312,0.007470744,0.0011747355,4.942351e-7,0.04445612,0.00012209061,0.0007507089,0.03779482],"study_design_scores_gemma":[0.07449051,0.005619203,0.8284275,0.0015495067,0.0015492218,0.002664127,0.00037312612,0.00004825329,0.08393611,0.00035289294,0.0003976364,0.00059192773],"about_ca_topic_score_codex":0.00007266826,"about_ca_topic_score_gemma":0.00010849679,"teacher_disagreement_score":0.06571912,"about_ca_system_score_codex":0.00003286838,"about_ca_system_score_gemma":0.00009707768,"threshold_uncertainty_score":0.3293207},"labels":[],"label_agreement":null},{"id":"W2986878655","doi":"10.1182/blood-2019-122099","title":"Functional Impact of MacroH2A Histone Variants in Acute Myeloid Leukemia","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Biology; Myeloid leukemia; Stem cell; Haematopoiesis; Histone; Leukemia; Myeloid; Cancer research; Molecular biology; Genetics; Gene","score_opus":0.01506496602228948,"score_gpt":0.3005780907606493,"score_spread":0.2855131247383598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986878655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893777,0.00022531867,0.000025697229,0.00016575813,0.00010814823,0.00045354568,0.00003892143,0.00003404666,0.0095708845],"genre_scores_gemma":[0.99143016,0.000075469856,0.00057741633,0.00009576526,0.000120221885,0.000015898502,0.00007528892,0.000036507456,0.0075732977],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99838275,0.00004753328,0.0003434866,0.00032527157,0.00047492917,0.0004260451],"domain_scores_gemma":[0.9990368,0.000084786574,0.000088869674,0.0004939004,0.00012805001,0.00016760417],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030062685,0.00017598415,0.00047261128,0.0003202822,0.00002095047,0.000007720159,0.00015199615,0.00016343551,0.0024074442],"category_scores_gemma":[0.0000852368,0.00014551304,0.00018585433,0.00046600046,0.0000735614,0.000106867876,0.000099321645,0.00045196252,0.0006501662],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014369709,0.0007867801,0.37404183,0.00014106224,0.0008791666,0.00044496,0.00024221883,0.000074958065,0.61338574,0.00017403418,0.0070248316,0.0013674768],"study_design_scores_gemma":[0.013139997,0.0007873043,0.966077,0.00009375684,0.00016228267,0.00048233464,0.000031928237,0.0004068087,0.018283904,0.000068404865,0.00030516039,0.00016108151],"about_ca_topic_score_codex":0.00069352135,"about_ca_topic_score_gemma":0.000012825953,"teacher_disagreement_score":0.59510183,"about_ca_system_score_codex":0.0010222446,"about_ca_system_score_gemma":0.0015701622,"threshold_uncertainty_score":0.9985045},"labels":[],"label_agreement":null},{"id":"W2986907937","doi":"10.1182/blood-2019-126088","title":"Association between a Polygenic Risk Score for Multiple Myeloma Risk and Overall Survival","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Genome-wide association study; Single-nucleotide polymorphism; Imputation (statistics); Internal medicine; Haplotype; Oncology; Genetic association; Medicine; Multiple myeloma; Biology; Genetics; Genotype; Gene; Missing data","score_opus":0.022588753423883716,"score_gpt":0.280045564926497,"score_spread":0.2574568115026133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986907937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997117,0.00033732492,0.00006750596,0.00011735364,0.00007475985,0.0012658759,0.0005843313,0.000054099237,0.00038175634],"genre_scores_gemma":[0.9961185,0.0002307044,0.0010199295,0.000018857076,0.00025972823,0.00005650484,0.00019324306,0.000030019375,0.0020725022],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998649,0.00009155279,0.00018998083,0.00031582714,0.00035037962,0.00040326413],"domain_scores_gemma":[0.998573,0.00070606725,0.00015203762,0.00024954288,0.000101269485,0.00021808808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037363992,0.00015121631,0.00033360653,0.00008189262,0.00011207979,0.00003083881,0.00005789303,0.00013009403,0.000056237906],"category_scores_gemma":[0.0009223677,0.0001258951,0.00012639297,0.0000794074,0.00001587581,0.00007411981,0.000046908055,0.00019395542,0.00010377905],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024986308,0.00024254838,0.9900986,0.000062403866,0.0010819036,0.000005597117,0.000074152704,3.3070756e-7,0.0007111231,0.0000076276087,0.000111122274,0.0073547177],"study_design_scores_gemma":[0.02192473,0.0006629033,0.97302365,0.000033513832,0.0007534625,0.0000032852854,0.000022130973,0.00025587896,0.0021810825,0.0001292246,0.00089305115,0.00011708178],"about_ca_topic_score_codex":0.00060288707,"about_ca_topic_score_gemma":0.00013862667,"teacher_disagreement_score":0.021674866,"about_ca_system_score_codex":0.00007838093,"about_ca_system_score_gemma":0.00006668714,"threshold_uncertainty_score":0.5133853},"labels":[],"label_agreement":null},{"id":"W2986910756","doi":"10.1182/blood-2019-132021","title":"Low-Dose Immune Tolerance Induction for Hemophilia a Children with Poor-Risk High-Titer Inhibitors","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Immunosuppression; Prednisone; Internal medicine; Rituximab; Immune tolerance; Titer; Prospective cohort study; Single Center; Gastroenterology; Surgery; Immunology; Immune system; Antibody","score_opus":0.007972454926167896,"score_gpt":0.2422941555983044,"score_spread":0.23432170067213648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986910756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99632686,0.00031737614,0.000008011279,0.0010063949,0.00017905777,0.0017643481,0.000027707743,0.0000714257,0.00029880612],"genre_scores_gemma":[0.9940327,0.00007034739,0.00076350744,0.000072864466,0.0006070086,0.00009897108,0.00012662304,0.000044406588,0.0041835997],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873483,0.00002659731,0.00020627333,0.00036426968,0.00031377745,0.00035422345],"domain_scores_gemma":[0.9992746,0.000032659653,0.000075503405,0.00037998083,0.000111097834,0.0001261746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015036756,0.00018958718,0.00031700832,0.00012475539,0.000093535586,0.000024045723,0.00008064833,0.00012817576,0.00010853112],"category_scores_gemma":[0.000028768975,0.0001265415,0.000109832086,0.00022573609,0.000058162546,0.00011406031,0.000030387899,0.00024119834,0.00019062035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014521553,0.0027324536,0.9046275,0.00023918056,0.00090252043,0.000035004607,0.00036490717,0.000013363973,0.07798224,0.00007056736,0.0006192899,0.010960821],"study_design_scores_gemma":[0.025509095,0.0029107996,0.6528599,0.00037066717,0.00045604137,0.00016628946,0.00004868738,0.000038751943,0.31661958,0.000093878756,0.00062750455,0.0002987799],"about_ca_topic_score_codex":0.00009349648,"about_ca_topic_score_gemma":0.000005697217,"teacher_disagreement_score":0.25176755,"about_ca_system_score_codex":0.0000360862,"about_ca_system_score_gemma":0.00009389138,"threshold_uncertainty_score":0.5160213},"labels":[],"label_agreement":null},{"id":"W2986925076","doi":"10.1182/blood.v128.22.3929.3929","title":"INPP4B is a Biomarker of Poor Prognosis in AML Which is Associated with EVI1 Overexpression and a LSC Signature","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Myeloid leukemia; Cancer research; PTEN; NPM1; Downregulation and upregulation; PI3K/AKT/mTOR pathway; Leukemia; Medicine; Oncology; Internal medicine; Prostate cancer; Cancer; Biology; Apoptosis; Gene; Karyotype; Genetics","score_opus":0.013749528940899574,"score_gpt":0.24516038166508405,"score_spread":0.2314108527241845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986925076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99518186,0.0017943956,0.000004539414,0.0021155633,0.000017746064,0.0003701675,0.00005107922,0.000035687524,0.00042896025],"genre_scores_gemma":[0.9985703,0.00009411901,0.00012928531,0.00033552933,0.000033789656,0.00002237195,0.000013406426,0.000023607286,0.0007775615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989386,0.000038179904,0.00025005816,0.00028101887,0.00027572075,0.00021638042],"domain_scores_gemma":[0.9993226,0.0001215781,0.00015171446,0.00015035819,0.00015902838,0.000094743606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015024867,0.00015784948,0.0003273276,0.00012471681,0.00003261958,0.0000099883055,0.00005271411,0.00019020926,0.00019813038],"category_scores_gemma":[0.0001951197,0.00009358513,0.000048823833,0.00039128988,0.000057320984,0.000105598454,0.000037325528,0.0000802393,0.0000030399901],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028669875,0.0007989053,0.8946295,0.00009267916,0.00021450732,0.000017335786,0.0010938314,2.742731e-8,0.09562168,0.000017042204,0.0025931506,0.0046346574],"study_design_scores_gemma":[0.00882594,0.0004487551,0.82612383,0.0035760622,0.0002272487,0.000022559823,0.000057836904,0.00006007396,0.15999725,0.00008480465,0.00039546815,0.000180141],"about_ca_topic_score_codex":0.00006990293,"about_ca_topic_score_gemma":0.00006236913,"teacher_disagreement_score":0.06850562,"about_ca_system_score_codex":0.000018577906,"about_ca_system_score_gemma":0.000084825304,"threshold_uncertainty_score":0.38162908},"labels":[],"label_agreement":null},{"id":"W2986940115","doi":"10.1182/blood-2019-128773","title":"A Phase 1b/2 Study of TAK-981, a First-in-Class Sumoylation Inhibitor, in Combination with Rituximab in Patients with Relapsed/Refractory (r/r) CD20-Positive Non-Hodgkin Lymphoma (NHL)","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Antibody-dependent cell-mediated cytotoxicity; Cancer research; Innate immune system; Degranulation; Immune system; Immunology; In vivo; Antibody; Monoclonal antibody; Biology; Receptor","score_opus":0.004415805888835392,"score_gpt":0.2108316835450981,"score_spread":0.2064158776562627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986940115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978318,0.00006111806,0.000015358448,0.000011728921,0.000040047096,0.0015768416,0.000027728656,0.000006559035,0.00042881415],"genre_scores_gemma":[0.9994947,0.000007085285,0.00009141264,0.000022096197,0.000019076218,0.00010636995,0.0002006098,0.000029144956,0.0000295296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986296,0.00012168065,0.00033688435,0.00042405768,0.00025056666,0.00023720083],"domain_scores_gemma":[0.99932265,0.000024989782,0.00020075974,0.0002893419,0.00011882576,0.00004341379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020435458,0.0002028887,0.0002863578,0.00019176606,0.000026495392,0.000013424808,0.000120387354,0.00015197953,0.0000055528253],"category_scores_gemma":[0.00002657559,0.00018198829,0.000026836227,0.0003002287,0.00003663395,0.000021803979,0.000054750693,0.00011753419,0.0000048503402],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032586104,0.07194616,0.90078485,0.00007899301,0.00006399552,0.0000248375,0.001926128,0.00004705979,0.020369843,0.000011927273,0.000007713033,0.0014798942],"study_design_scores_gemma":[0.23511827,0.025036486,0.60182166,0.00035315668,0.00004231837,0.000003243883,0.00065082853,0.00014345987,0.13632978,0.000015384481,0.00006903867,0.00041637133],"about_ca_topic_score_codex":0.00022736119,"about_ca_topic_score_gemma":0.0015221067,"teacher_disagreement_score":0.2989632,"about_ca_system_score_codex":0.000049232593,"about_ca_system_score_gemma":0.00010727217,"threshold_uncertainty_score":0.7421267},"labels":[],"label_agreement":null},{"id":"W2986944351","doi":"10.1182/blood-2019-122309","title":"Front-Line Treatment with Obinutuzumab ± Chlorambucil for Chronic Lymphocytic Leukemia in Real-World Clinical Practice: Results of a Multinational, Multicenter Study By Eric and Icllsg","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Chlorambucil; Obinutuzumab; Venetoclax; Medicine; IGHV@; Ibrutinib; Internal medicine; Rituximab; Chronic lymphocytic leukemia; Oncology; Population; Progression-free survival; Chemotherapy; Leukemia; Cyclophosphamide; Lymphoma","score_opus":0.03753508059196313,"score_gpt":0.3754278861985978,"score_spread":0.33789280560663465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986944351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926821,0.00091989705,0.00001065217,0.00011580457,0.00008172487,0.005058221,0.00010169453,0.000044791126,0.0009851112],"genre_scores_gemma":[0.99079275,0.0007253421,0.0027102295,0.00007494927,0.00016959765,0.00035366815,0.00014703815,0.0000644785,0.004961949],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9965553,0.00018436418,0.0011336722,0.00086797733,0.00071094517,0.00054770743],"domain_scores_gemma":[0.99627686,0.0019369063,0.00041035435,0.00077036215,0.00037569148,0.00022983369],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011384926,0.00033677035,0.00090074167,0.0002343488,0.000048304402,0.000029877061,0.0001615494,0.00014658186,0.000042020507],"category_scores_gemma":[0.0007973143,0.0002499289,0.00011532017,0.00033792123,0.00016840678,0.00018756656,0.00010318556,0.00022404894,0.00004105429],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.41155475,0.10595699,0.31357053,0.010606445,0.020383673,0.005859835,0.02741522,0.0065145507,0.012550868,0.0002253149,0.011221547,0.07414029],"study_design_scores_gemma":[0.8029335,0.028448995,0.018900985,0.0007528613,0.0013472144,0.00016594783,0.0015198124,0.13447621,0.003254603,0.0000053740914,0.00771805,0.00047645683],"about_ca_topic_score_codex":0.010945283,"about_ca_topic_score_gemma":0.0032485153,"teacher_disagreement_score":0.39137873,"about_ca_system_score_codex":0.0669324,"about_ca_system_score_gemma":0.029657561,"threshold_uncertainty_score":0.9999953},"labels":[],"label_agreement":null},{"id":"W2986977198","doi":"10.1182/blood-2019-123590","title":"Clinical and Laboratory Features Associated with Flow Cytometric CD49f Expression in Pediatric B Cell Acute Lymphoblastic Leukemia","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Malignancy; Population; Minimal residual disease; Pathology; Immunophenotyping; Flow cytometry; Fluorescence in situ hybridization; Bone marrow; Internal medicine; Oncology; Cancer research; Immunology; Biology","score_opus":0.008172771795055465,"score_gpt":0.2658896957653816,"score_spread":0.2577169239703261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986977198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965586,0.0010345455,0.00003561874,0.000046311066,0.0001335698,0.00065670215,0.00004262052,0.00009756588,0.0013944816],"genre_scores_gemma":[0.9958257,0.0006879343,0.0015581967,0.00021957012,0.0002605687,0.000030018016,0.000048535763,0.00007289107,0.001296595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99709547,0.00022439194,0.0005026989,0.00069986936,0.00084329466,0.00063429336],"domain_scores_gemma":[0.9975334,0.00116074,0.0001749396,0.000498687,0.00022708734,0.00040518498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070001394,0.00031303588,0.000717846,0.00077531143,0.000057024583,0.000045154593,0.00020873097,0.0004625546,0.00007271445],"category_scores_gemma":[0.000880466,0.00023214995,0.00007672386,0.0022182758,0.00012800968,0.00014911788,0.00018810123,0.0007051023,0.00013261598],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068963924,0.0009869919,0.988813,0.00021862808,0.00014537017,0.00093863666,0.0001235403,0.00002532572,0.005323734,0.00000217446,0.0023722483,0.00036073837],"study_design_scores_gemma":[0.039571222,0.0016158684,0.9506779,0.0002728063,0.00068521645,0.00011561728,0.000059610793,0.0008177834,0.005720492,0.0000075968073,0.0000971328,0.00035876842],"about_ca_topic_score_codex":0.000015254357,"about_ca_topic_score_gemma":0.000009715853,"teacher_disagreement_score":0.03888158,"about_ca_system_score_codex":0.00049153384,"about_ca_system_score_gemma":0.001992285,"threshold_uncertainty_score":0.94668},"labels":[],"label_agreement":null},{"id":"W2987006660","doi":"10.1182/blood-2019-122617","title":"A Review of Inappropriate D-Dimer Ordering at a Canadian Tertiary Care Centre","year":2019,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Pulmonary embolism; Pre- and post-test probability; D-dimer; Deep vein; Emergency department; Venous thromboembolism; Pulmonary angiography; Thrombosis; Radiology; Emergency medicine; Surgery; Pediatrics","score_opus":0.025245502894904064,"score_gpt":0.29267847267145974,"score_spread":0.2674329697765557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987006660","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002522782,0.98906475,1.3234737e-7,0.0001246229,0.00021211445,0.003229919,0.00008517463,0.000027375821,0.007230673],"genre_scores_gemma":[0.000013178213,0.9973533,0.00009588646,0.0010866884,0.00012384146,0.00012134927,0.00046715882,0.00008956505,0.0006490188],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99814314,0.000076844706,0.0006552436,0.00045185225,0.00023730753,0.00043559456],"domain_scores_gemma":[0.9984177,0.000025324895,0.00032981235,0.00082843273,0.00012013672,0.00027859356],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001479974,0.00040436117,0.0028361038,0.00023027748,0.000046481437,0.000008270849,0.00021922402,0.00021606586,0.00063394883],"category_scores_gemma":[0.00005718541,0.00031301109,0.00064078654,0.00025063782,0.000024453993,0.000023225337,0.0001882186,0.00024519602,0.0003750482],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[5.011905e-7,0.0001686008,0.0000696692,0.6872739,0.0008084965,0.000093370996,0.000112046604,2.2100798e-8,2.143674e-7,0.000019354948,0.008877063,0.30257672],"study_design_scores_gemma":[0.00032917198,0.0000355985,0.00004522869,0.3062552,0.00988856,0.000045598732,0.000017707593,4.8568843e-8,0.0000017612267,3.1642833e-7,0.6831908,0.00018999893],"about_ca_topic_score_codex":0.011678674,"about_ca_topic_score_gemma":0.007903817,"teacher_disagreement_score":0.6743138,"about_ca_system_score_codex":0.00026357218,"about_ca_system_score_gemma":0.00086738844,"threshold_uncertainty_score":0.99993217},"labels":[],"label_agreement":null},{"id":"W2987021886","doi":"10.1182/blood-2019-122890","title":"High Interpatient Variability in Molecular MRD Response to Consolidation Chemotherapy in Acute Myeloid Leukemia","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto; University Health Network","funders":"","keywords":"Minimal residual disease; Medicine; Internal medicine; Chemotherapy; Oncology; Induction chemotherapy; Myeloid leukemia; Leukemia; Bone marrow; Chemotherapy regimen","score_opus":0.007006892470617845,"score_gpt":0.27194819545318316,"score_spread":0.2649413029825653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987021886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942456,0.000016474618,0.00035908626,0.0028851712,0.00008716006,0.00165281,0.000013033392,0.000046462166,0.0006942343],"genre_scores_gemma":[0.99383044,0.000018434288,0.0038001724,0.0016724705,0.000028797373,0.000107640575,0.000034653087,0.000040300987,0.00046709107],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976597,0.00046263819,0.00046371433,0.0005465946,0.0004121032,0.00045529456],"domain_scores_gemma":[0.99859476,0.00030507162,0.000061709,0.0007417971,0.000113708156,0.0001829567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018183168,0.00020204298,0.00045776542,0.00046808555,0.000014545827,0.000020988267,0.00021694691,0.00018338466,0.00030826306],"category_scores_gemma":[0.0006713006,0.00019394173,0.00006698901,0.00072415936,0.00004623567,0.00008806005,0.00013153409,0.00048590117,0.00030905823],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010320363,0.0008399023,0.09580544,0.00008045624,0.00012159803,0.00038938972,0.0014881495,0.000099443576,0.88739413,0.00022792572,0.0002226743,0.0030105347],"study_design_scores_gemma":[0.02746372,0.00183204,0.3788178,0.00032697403,0.00006609374,0.00008317341,0.0001764719,0.0010272098,0.587611,0.0003211909,0.0018533991,0.00042095035],"about_ca_topic_score_codex":0.00035050826,"about_ca_topic_score_gemma":0.000026654532,"teacher_disagreement_score":0.29978314,"about_ca_system_score_codex":0.0014159725,"about_ca_system_score_gemma":0.00078960846,"threshold_uncertainty_score":0.7908714},"labels":[],"label_agreement":null},{"id":"W2987033702","doi":"10.1182/blood-2019-124946","title":"Prognostic Value of Disease Risk Score Versus Gait Speed in Older Adults with Lymphoma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Frailty in Older Adults","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; International Prognostic Index; Hazard ratio; Follicular lymphoma; Proportional hazards model; Univariate analysis; Diffuse large B-cell lymphoma; Cohort; Oncology; Lymphoma; Confidence interval; Multivariate analysis","score_opus":0.008545224306351289,"score_gpt":0.2303002005054496,"score_spread":0.2217549761990983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987033702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964969,0.00034809514,0.0000035640046,0.00015467909,0.0001493537,0.0013874952,0.000040343944,0.000053401003,0.0013661345],"genre_scores_gemma":[0.9990496,0.000028059281,0.0003353603,0.0000500241,0.00007439803,0.000020487167,0.00004554915,0.00003960073,0.0003568946],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863297,0.000042380783,0.0002584122,0.0003621707,0.00040947934,0.00029460844],"domain_scores_gemma":[0.99885434,0.00016165328,0.00012342838,0.0005447012,0.00010268833,0.0002132034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008730647,0.00018572336,0.00032498434,0.00012363013,0.000014635746,0.000007317237,0.00011958325,0.00006903367,0.00012804421],"category_scores_gemma":[0.0003843831,0.00014803685,0.00006783523,0.0002897004,0.00007319041,0.00007129629,0.00004194953,0.0001196846,0.0001283785],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045949467,0.002153582,0.9898972,0.0006088571,0.00012630841,0.0002079391,0.0006549548,0.00003664975,0.000106548934,0.000043593984,0.00008184219,0.001487572],"study_design_scores_gemma":[0.0541087,0.0012509975,0.93965846,0.0022745673,0.0005157277,0.000018509678,0.00020443034,0.0004058378,0.0013471164,0.00001581677,0.000028431677,0.00017140798],"about_ca_topic_score_codex":0.00024241814,"about_ca_topic_score_gemma":0.00006589044,"teacher_disagreement_score":0.050238747,"about_ca_system_score_codex":0.00003715268,"about_ca_system_score_gemma":0.00021677342,"threshold_uncertainty_score":0.6036768},"labels":[],"label_agreement":null},{"id":"W2987036376","doi":"10.1182/blood-2019-124917","title":"Distal Enhancer Elements in ASXL1-Mutant Chronic Myelomonocytic Leukemia","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"","keywords":"Epigenomics; Biology; H3K4me3; DNA methylation; Histone; Chromatin immunoprecipitation; Epigenetics; Enhancer; Transcriptome; Genetics; Cancer research; Molecular biology; Gene; Promoter; Gene expression","score_opus":0.010919165727189047,"score_gpt":0.28327098521048377,"score_spread":0.27235181948329473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987036376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98297125,0.00062436657,0.000020256897,0.0002119822,0.00012068172,0.0008847081,0.000010885499,0.000060560236,0.015095333],"genre_scores_gemma":[0.9939538,0.00017776787,0.00028918826,0.00015656555,0.0002531846,0.00006985422,0.000045461853,0.000049654285,0.0050045145],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99791074,0.000048513877,0.00039337605,0.0004588471,0.0004999711,0.0006885547],"domain_scores_gemma":[0.9990499,0.000060894632,0.000069936126,0.00058086024,0.000055314227,0.00018311481],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00030698266,0.00020750666,0.00039999132,0.00019675275,0.00003242924,0.000024368852,0.00021892476,0.00013675625,0.0015191718],"category_scores_gemma":[0.00007771912,0.00018185945,0.000092450115,0.00038435234,0.000059583024,0.00011309946,0.00016227328,0.0005403335,0.00201423],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044311816,0.0007889512,0.16542946,0.0006220389,0.000358935,0.00095693825,0.0004895342,0.000022918783,0.8174021,0.0003826018,0.0009602101,0.012143138],"study_design_scores_gemma":[0.06571068,0.0030036713,0.18425784,0.0011216484,0.00039076357,0.0004767784,0.00050192943,0.0056694746,0.70438164,0.00027784015,0.033097934,0.0011098261],"about_ca_topic_score_codex":0.00015440295,"about_ca_topic_score_gemma":0.000092138216,"teacher_disagreement_score":0.11302053,"about_ca_system_score_codex":0.0024895833,"about_ca_system_score_gemma":0.0015921881,"threshold_uncertainty_score":0.9993936},"labels":[],"label_agreement":null},{"id":"W2987061088","doi":"10.1182/blood-2019-123059","title":"An Ongoing Global, Longitudinal, Observational Study of Patients with Pyruvate Kinase Deficiency: The PEAK Registry","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pyruvate kinase deficiency; Medicine; Anemia; Pediatrics; Observational study; Pyruvate kinase; Jaundice; Newborn screening; Internal medicine; Glycolysis","score_opus":0.037937024317739515,"score_gpt":0.2797209790582473,"score_spread":0.24178395474050776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987061088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99839234,0.00004238843,0.000009609451,0.00007330992,0.00011148225,0.00049883995,0.000015439233,0.0000282691,0.0008283145],"genre_scores_gemma":[0.99943745,0.0000028936004,0.00011314838,0.00021766099,0.00005194838,0.000010851518,0.000059493497,0.000008935278,0.0000975964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990945,0.00005048932,0.00018380437,0.00024091561,0.00029041196,0.00013989654],"domain_scores_gemma":[0.99908173,0.000036217752,0.00013325473,0.0004924223,0.00020409965,0.000052261435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009680754,0.00010609845,0.00019094467,0.00002264486,0.00007397436,0.000008438831,0.00010944963,0.00004145961,0.00009404812],"category_scores_gemma":[0.000034882116,0.0000638263,0.00003267399,0.00023246188,0.000054654,0.00006840693,0.000028209075,0.00010181739,0.000023685428],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028181574,0.0037483722,0.9942997,0.00003815527,0.00004913545,0.0000068525196,0.0002032665,0.00005630365,0.0010200696,0.0001488082,0.00008322972,0.0000642756],"study_design_scores_gemma":[0.004614442,0.0037238768,0.99045235,0.00003120009,0.00014892877,0.0000051323673,0.0006638543,0.00002444212,0.00010804854,0.000019255116,0.00013505983,0.00007340551],"about_ca_topic_score_codex":0.00007262936,"about_ca_topic_score_gemma":0.00006689439,"teacher_disagreement_score":0.0043326262,"about_ca_system_score_codex":0.00001602844,"about_ca_system_score_gemma":0.00009271547,"threshold_uncertainty_score":0.2602761},"labels":[],"label_agreement":null},{"id":"W2987077693","doi":"10.1182/blood-2019-121814","title":"The Impact of Hematopoietic Stem Cell Transplantation on Work and Productivity Loss in Patients with Acute Leukemia: Results from a Rapid Review","year":2019,"lang":"en","type":"review","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Medicine; Hematopoietic stem cell transplantation; Leukemia; Transplantation; Internal medicine; Productivity; Acute leukemia; Cancer; Oncology; Population; Acute lymphocytic leukemia; Immunology; Environmental health; Lymphoblastic Leukemia","score_opus":0.02305046945282402,"score_gpt":0.29533894153450496,"score_spread":0.27228847208168094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987077693","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08530557,0.9096052,0.000001812188,0.00004148816,0.00003592761,0.0042499965,0.0005855487,0.000014166867,0.00016026439],"genre_scores_gemma":[0.010835608,0.9882647,0.000030748848,0.000010604136,0.000049812046,0.00009895044,0.00053356925,0.00006359982,0.00011241953],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9970684,0.00037913743,0.00082865707,0.00066696526,0.00069065817,0.00036620145],"domain_scores_gemma":[0.9971194,0.0010530353,0.00060053176,0.0009724297,0.00013111587,0.00012344196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006018038,0.00044494908,0.0020418512,0.00013234929,0.00004108591,0.000017963026,0.00023528497,0.00024643439,0.000005020784],"category_scores_gemma":[0.00008008763,0.00022463062,0.0002639509,0.00061155914,0.00012879791,0.000058322694,0.00004789441,0.0006798929,0.00002019832],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069952495,0.0021225105,0.0030721899,0.21233486,0.0030645223,0.0005046049,0.00067602476,0.0000025474278,0.0000014874961,0.0000039186466,0.0010773297,0.77014476],"study_design_scores_gemma":[0.06638242,0.008409247,0.033818394,0.83535844,0.031893693,0.00042167623,0.000020131452,0.0000040311174,0.00013723088,0.000011227921,0.022058401,0.0014851188],"about_ca_topic_score_codex":0.00008055835,"about_ca_topic_score_gemma":0.0000037053767,"teacher_disagreement_score":0.76865965,"about_ca_system_score_codex":0.0006145846,"about_ca_system_score_gemma":0.001971114,"threshold_uncertainty_score":0.9160171},"labels":[],"label_agreement":null},{"id":"W2987079738","doi":"10.1182/blood-2019-125178","title":"An Epigenetic Screen Identifies PRMT5 As a Target for Inhibition of FLT3-ITD AML Cell Growth in Combination with Tyrosine Kinase Inhibitors","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Epigenetics; Fms-Like Tyrosine Kinase 3; Biology; Cancer research; Myeloid leukemia; Epigenetic therapy; DNA methylation; Mutation; Genetics; Gene expression","score_opus":0.008507773728075372,"score_gpt":0.2550562845008642,"score_spread":0.24654851077278883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987079738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963408,0.0001987248,0.00024446414,0.0003183377,0.000041763884,0.0019197993,0.000037675065,0.000037916885,0.00086050347],"genre_scores_gemma":[0.9963681,0.000027309214,0.002389357,0.000055905766,0.00007919805,0.000098021046,0.00039399724,0.000048934762,0.000539185],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99844646,0.000076206095,0.00035244427,0.00035759812,0.00045098487,0.00031631283],"domain_scores_gemma":[0.99896866,0.00007898345,0.00014098249,0.00031898374,0.00036694357,0.00012541967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041458083,0.00017002245,0.0003391414,0.0003893366,0.000037599995,0.000024601482,0.000102113045,0.0001293749,0.000059144117],"category_scores_gemma":[0.000103126586,0.000148579,0.000058572878,0.00044846645,0.000090250665,0.00021731447,0.00004105787,0.00019609026,0.000035510562],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011551925,0.0032496422,0.12406308,0.0011336555,0.0000598173,0.000072419585,0.000700774,0.000026968766,0.86836696,0.00052618654,0.00032831164,0.0003170011],"study_design_scores_gemma":[0.016175646,0.0046106023,0.037046995,0.0003165211,0.0000949418,0.000021691223,0.00031812338,0.00036591254,0.94022685,0.0006175023,0.000038609247,0.00016661095],"about_ca_topic_score_codex":0.00045153074,"about_ca_topic_score_gemma":0.00005261602,"teacher_disagreement_score":0.08701608,"about_ca_system_score_codex":0.00009993137,"about_ca_system_score_gemma":0.00027071655,"threshold_uncertainty_score":0.6058876},"labels":[],"label_agreement":null},{"id":"W2987081466","doi":"10.1182/blood-2019-123711","title":"Updated Results from the Venetoclax (Ven) in Combination with Idasanutlin (Idasa) Arm of a Phase 1b Trial in Elderly Patients (Pts) with Relapsed or Refractory (R/R) AML Ineligible for Cytotoxic Chemotherapy","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Alberta; McGill University; Jewish General Hospital","funders":"","keywords":"Ven; Medicine; Tolerability; Internal medicine; Venetoclax; Gastroenterology; Oncology; Mucositis; Surgery; Adverse effect; Chemotherapy; Leukemia; Chronic lymphocytic leukemia","score_opus":0.019847388844180358,"score_gpt":0.29822986088865505,"score_spread":0.2783824720444747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987081466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930764,0.000032852702,0.000024830673,0.00043157552,0.0000619305,0.006045226,0.00015156482,0.00003208594,0.00014353271],"genre_scores_gemma":[0.9974674,0.00003498589,0.00074370677,0.00020453436,0.000093503295,0.0002727544,0.0008071869,0.000063841704,0.00031210989],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9977093,0.00016230231,0.00067151024,0.00048257914,0.000591735,0.0003825963],"domain_scores_gemma":[0.9980344,0.00055585214,0.00035364568,0.0006511439,0.00031569222,0.000089241235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006736925,0.0002407455,0.00057355367,0.0002660969,0.00004576964,0.000017739336,0.0002594073,0.00019718456,0.00004850377],"category_scores_gemma":[0.00044800414,0.00014253584,0.000056408586,0.0007683626,0.00008773117,0.00014962559,0.00003877334,0.00047974839,0.0000095628875],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9265573,0.021173399,0.023241477,0.00012594106,0.000365268,0.00006193094,0.0033965176,0.0000364669,0.019504923,0.000020375968,0.0013936729,0.004122698],"study_design_scores_gemma":[0.9163699,0.037551653,0.014586727,0.0005873891,0.00010434381,0.0000037111997,0.00027264265,0.00088075065,0.028204244,0.00006220451,0.0011453923,0.00023105902],"about_ca_topic_score_codex":0.0007577601,"about_ca_topic_score_gemma":0.00043855718,"teacher_disagreement_score":0.016378252,"about_ca_system_score_codex":0.00038366014,"about_ca_system_score_gemma":0.0009702155,"threshold_uncertainty_score":0.5812443},"labels":[],"label_agreement":null},{"id":"W2987093888","doi":"10.1182/blood-2019-130263","title":"CPX-351 As First Intensive Therapy for Elderly Patients with AML","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Cytarabine; Clinical endpoint; Oncology; Leukemia; Performance status; Cancer; Randomized controlled trial","score_opus":0.011078387135582261,"score_gpt":0.2631724838861474,"score_spread":0.25209409675056516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987093888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932099,0.000120368284,0.000025284555,0.0014831019,0.00007448065,0.0019629432,0.00001929607,0.00005037776,0.0030542724],"genre_scores_gemma":[0.993324,0.00005009921,0.00073836796,0.0017708425,0.00012951707,0.00010701671,0.00008961496,0.000053559073,0.003737028],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988702,0.00001463041,0.00013859606,0.00029581104,0.00033531224,0.00034546189],"domain_scores_gemma":[0.998538,0.00013303386,0.000053518444,0.0004072759,0.0007342338,0.00013390879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000084528874,0.00014846775,0.0002622836,0.000084608066,0.00005591769,0.000019055213,0.00013124546,0.000090320566,0.00027584273],"category_scores_gemma":[0.00016372529,0.000099975674,0.00007126746,0.00013979689,0.000050038347,0.00006781399,0.000034139677,0.00020021253,0.00042687968],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007276958,0.0024158366,0.93500036,0.0003213502,0.0013212772,0.00008973245,0.002126067,0.0000024831668,0.0035687296,0.00031823214,0.027173609,0.020385392],"study_design_scores_gemma":[0.17178446,0.048243843,0.50224143,0.0006305127,0.00043894505,0.00013770889,0.0015129942,0.00013132021,0.044466157,0.00033191053,0.2291653,0.00091544853],"about_ca_topic_score_codex":0.000066149056,"about_ca_topic_score_gemma":0.000011478933,"teacher_disagreement_score":0.43275893,"about_ca_system_score_codex":0.00006289676,"about_ca_system_score_gemma":0.00021471862,"threshold_uncertainty_score":0.54868174},"labels":[],"label_agreement":null},{"id":"W2987120568","doi":"10.1182/blood-2019-129464","title":"Intermittent Transfusion Independence Is Associated with Improved Overall Survival in Patients with Transfusion Dependent MDS","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Hospital; McGill University Health Centre; University of British Columbia; Dr. Georges-L.-Dumont University Hospital Centre; St. Paul's Hospital; McMaster University; CancerCare Manitoba; Health Sciences Centre; Ottawa Hospital; University Health Network; Dalhousie University; University of Alberta; Princess Margaret Cancer Centre; Hôpital de l'Enfant-Jésus; Juravinski Cancer Centre; Jewish General Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Blood transfusion; Intensive care medicine; Internal medicine","score_opus":0.007673527807746279,"score_gpt":0.2285183155862673,"score_spread":0.22084478777852104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987120568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99631715,0.000023082252,0.00008580097,0.00025288144,0.00008113799,0.0018974057,0.000033067066,0.000065758904,0.0012437084],"genre_scores_gemma":[0.9983903,0.000058119993,0.00011708086,0.0002556088,0.000027870856,0.000040320567,0.000092088776,0.0000655836,0.0009529832],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970159,0.00011711073,0.00035202608,0.000641778,0.0012902111,0.00058299315],"domain_scores_gemma":[0.9988565,0.000077756595,0.00009318936,0.00047667278,0.00028648533,0.00020940711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041103218,0.00030856088,0.00052685017,0.00023050031,0.000053088115,0.000031130603,0.00022751027,0.00026327977,0.00033719934],"category_scores_gemma":[0.000043607393,0.00021533779,0.00007907208,0.00037427648,0.00005465862,0.00019870252,0.00005879931,0.00088645244,0.000038356167],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035122095,0.0022560472,0.9765877,0.00007992282,0.00023250029,0.00013338377,0.0009092104,0.000004972094,0.014386331,0.0000053355357,0.000015868909,0.0018764929],"study_design_scores_gemma":[0.051091548,0.0040896107,0.9316033,0.00054577267,0.00016936271,0.000021282676,0.00014459858,0.0002928563,0.011699775,0.000005699098,0.000021213998,0.00031497466],"about_ca_topic_score_codex":0.00088617165,"about_ca_topic_score_gemma":0.0010994081,"teacher_disagreement_score":0.047579337,"about_ca_system_score_codex":0.00037251433,"about_ca_system_score_gemma":0.00037352764,"threshold_uncertainty_score":0.878122},"labels":[],"label_agreement":null},{"id":"W2987182583","doi":"10.1182/blood-2019-123284","title":"Exploring the Basis and Acceptability of Practice Variation Among Thrombosis Medicine Specialists: A Mixed-Methods Study","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Clinical Reasoning and Diagnostic Skills","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Calgary","funders":"","keywords":"Medicine; Thrombosis; Subspecialty; Venous thrombosis; Pulmonary embolism; Family medicine; Deep vein; Intensive care medicine; Surgery","score_opus":0.07118699647964441,"score_gpt":0.40732098251271126,"score_spread":0.3361339860330669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987182583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929043,0.00012773402,0.00015111368,0.0016726971,0.00042143377,0.00071225344,0.0000024759256,0.00002890801,0.00397909],"genre_scores_gemma":[0.9946687,0.00018805944,0.0045713265,0.00016588732,0.0003109802,0.000045412482,0.0000029844955,0.00001303886,0.000033573066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982581,0.00050870306,0.000446991,0.00029992146,0.00034716766,0.00013909694],"domain_scores_gemma":[0.9716314,0.027312638,0.00022298393,0.00054480205,0.00018803425,0.00010011609],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0034116362,0.000117661104,0.00044424622,0.00004644827,0.000050894265,0.000012936209,0.00008802996,0.000047408626,0.0003720673],"category_scores_gemma":[0.110042654,0.00007206925,0.000059443064,0.00027283205,0.00014199966,0.00016136034,0.00008568892,0.00020018124,0.0000068812706],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000849768,0.0024241353,0.9523748,0.00004258914,0.00030748363,0.0000044769117,0.0072079846,0.000001115398,0.00035032525,0.00019098431,0.000072283736,0.03693882],"study_design_scores_gemma":[0.0032326025,0.000945145,0.9847175,0.00021907156,0.0013100373,0.000007821228,0.008563883,0.000015146366,0.000658388,0.00009456053,0.0001675118,0.000068365436],"about_ca_topic_score_codex":0.0011409404,"about_ca_topic_score_gemma":0.00003393959,"teacher_disagreement_score":0.10663102,"about_ca_system_score_codex":0.000017594539,"about_ca_system_score_gemma":0.000041905318,"threshold_uncertainty_score":0.89745384},"labels":[],"label_agreement":null},{"id":"W2987232427","doi":"10.1182/blood.v128.22.1371.1371","title":"Cytokine and Chemokine Levels Correlate with Apoptosis Markers in Platelets of Pediatric Patients with Immune Thrombocytopenia","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Chemokine; Immunology; Cytokine; Platelet; Medicine; Immune system; Platelet activation; Flow cytometry","score_opus":0.007229126227629663,"score_gpt":0.20429980583810586,"score_spread":0.1970706796104762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987232427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984954,0.00021021743,0.000007605268,0.00011419031,0.000018024988,0.00047665572,0.000061902676,0.000018518002,0.00059748354],"genre_scores_gemma":[0.9991855,0.000182936,0.0004064985,0.00002298821,0.000012359339,0.000016642416,0.000025743957,0.000029325956,0.00011799155],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989874,0.000014659208,0.00025097546,0.00026600983,0.00023033455,0.00025065808],"domain_scores_gemma":[0.9994411,0.00005004406,0.00013908125,0.00021397512,0.00006880565,0.00008702047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006202659,0.00019996999,0.0005328167,0.00013648673,0.000025874477,0.000005164438,0.000053165717,0.00007656801,0.000076417185],"category_scores_gemma":[0.000020228566,0.0001060828,0.000028264576,0.00025326552,0.00007205698,0.000105399915,0.000033480675,0.00008042497,0.0000058635496],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013365729,0.001564602,0.99147964,0.00007516756,0.00033354206,0.00013509036,0.000082562205,3.8415314e-7,0.0023067535,0.0000061824135,0.000017362358,0.002662144],"study_design_scores_gemma":[0.039861728,0.0015395164,0.94396895,0.00021253206,0.00048125265,0.00004096973,0.000014869918,0.0000010760608,0.013691739,0.0000141281735,0.000017167667,0.00015609134],"about_ca_topic_score_codex":0.000057134854,"about_ca_topic_score_gemma":0.000017590704,"teacher_disagreement_score":0.04751071,"about_ca_system_score_codex":0.0000221729,"about_ca_system_score_gemma":0.000050249066,"threshold_uncertainty_score":0.43259308},"labels":[],"label_agreement":null},{"id":"W2987257444","doi":"10.1182/blood-2019-124004","title":"Safety of Caplacizumab in Patients Without Documented Severe ADAMTS13 Deficiency During the HERCULES Study","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"ADAMTS13; Thrombotic microangiopathy; Medicine; Von Willebrand factor; Microangiopathic hemolytic anemia; Thrombotic thrombocytopenic purpura; Internal medicine; Gastroenterology; Surgery; Platelet; Disease","score_opus":0.005150277023754714,"score_gpt":0.21863534918101396,"score_spread":0.21348507215725926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987257444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969805,0.0004574604,2.8814196e-7,0.000009488898,0.0001813643,0.0012147777,0.000050896346,0.00002172099,0.0010835024],"genre_scores_gemma":[0.9994266,0.0000034572602,0.0000030174203,0.000008271346,0.000004025619,0.0000302702,0.000026809585,0.000009566176,0.0004879575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998825,0.00027086574,0.00037597833,0.00022744267,0.000069487796,0.00023120387],"domain_scores_gemma":[0.9993255,0.00006913205,0.00014016993,0.0004095877,0.00004771392,0.000007898069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016492547,0.00012813715,0.00023832307,0.00006752765,0.000081620856,0.000006337044,0.0002829166,0.00004655587,0.0007157012],"category_scores_gemma":[0.000032830954,0.0000905121,0.00005113144,0.00012548693,0.000042134678,0.000058368038,0.00015492727,0.0001042652,0.00020112684],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024040973,0.0018946446,0.99350786,0.000046694022,0.000115868046,9.919904e-7,0.0008010784,0.000013500773,0.0032642512,0.000025575073,0.000034584227,0.00005455198],"study_design_scores_gemma":[0.010599495,0.0002611804,0.98524636,0.000061370054,0.000061664054,0.000005248598,0.0019164806,3.3690245e-7,0.0016077592,0.0000060414595,0.0001258735,0.00010816584],"about_ca_topic_score_codex":0.00022972071,"about_ca_topic_score_gemma":0.00018976437,"teacher_disagreement_score":0.010359085,"about_ca_system_score_codex":0.00003515797,"about_ca_system_score_gemma":0.000031360018,"threshold_uncertainty_score":0.78364265},"labels":[],"label_agreement":null},{"id":"W2987282083","doi":"10.1182/blood-2019-126723","title":"High-Dose Cytarabine Is Indispensable for the Survival of Children with Myeloid Leukemia of Down Syndrome Despite Negative Minimal Residual Disease Post-Induction","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Hospital for Sick Children","funders":"","keywords":"Cytarabine; Medicine; Internal medicine; Myeloid leukemia; Leukemia; Gastroenterology; Oncology; Pediatrics","score_opus":0.012186301892589563,"score_gpt":0.25034833818686847,"score_spread":0.2381620362942789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987282083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99515504,0.00016964832,0.00001909693,0.0012854817,0.0000798477,0.0025806318,0.0005839009,0.000029439318,0.00009689549],"genre_scores_gemma":[0.9968428,0.000031609266,0.0013114013,0.00011008434,0.0001675899,0.00008348841,0.00019486429,0.00006152698,0.0011966123],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978019,0.00009011197,0.0004342267,0.000461416,0.00075753086,0.00045480148],"domain_scores_gemma":[0.99773973,0.0004821843,0.00028554743,0.000763032,0.00051628664,0.00021320063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004678476,0.00026759805,0.0006070811,0.00019518529,0.000092322145,0.000016680764,0.00030973007,0.00012534317,0.00024945254],"category_scores_gemma":[0.0003503867,0.00017103674,0.00014726687,0.00044407567,0.00031704028,0.00017868722,0.00012317489,0.00035849077,0.00003265104],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03668793,0.002861622,0.71337944,0.0016841859,0.0060732886,0.00017038964,0.0030231944,0.00031044165,0.2306103,0.0009621106,0.002379631,0.0018574534],"study_design_scores_gemma":[0.016194334,0.00351168,0.8921324,0.00016653781,0.0010448085,0.00015637813,0.0004168141,0.00007119887,0.08600801,0.000059368685,0.00002974424,0.0002087297],"about_ca_topic_score_codex":0.001143817,"about_ca_topic_score_gemma":0.000043187305,"teacher_disagreement_score":0.17875294,"about_ca_system_score_codex":0.00017316823,"about_ca_system_score_gemma":0.0012878628,"threshold_uncertainty_score":0.69746757},"labels":[],"label_agreement":null},{"id":"W2987311726","doi":"10.1182/blood-2019-127933","title":"Neutropenia in Children Treated with Deferiprone or Deferasirox: A Report of the Largest Randomized Trial of Oral Chelators in Transfusion-Dependent Pediatric Patients","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Apotex (Canada)","funders":"","keywords":"Neutropenia; Deferiprone; Medicine; Deferasirox; Absolute neutrophil count; Internal medicine; Randomized controlled trial; Adverse effect; Cumulative incidence; Pediatrics; Gastroenterology; Thalassemia; Chemotherapy; Transplantation","score_opus":0.003159632183338637,"score_gpt":0.19757549442043015,"score_spread":0.1944158622370915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987311726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99741256,0.00020118816,0.0000011367042,0.0000062645227,0.000030467441,0.0021629436,0.000024689942,0.000002713756,0.00015805857],"genre_scores_gemma":[0.9995181,0.00013815537,0.000043220192,0.000007872126,0.000011655521,0.00007868611,0.000088618246,0.00001797816,0.00009574055],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99880946,0.00013110679,0.00044492207,0.00028015347,0.00017339473,0.00016096937],"domain_scores_gemma":[0.9993738,0.000012336606,0.00021916094,0.00032209884,0.00004383168,0.000028769326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001834802,0.00015744413,0.0004531472,0.000062383566,0.000014397377,0.0000042017273,0.00013340186,0.00012087207,0.000015150778],"category_scores_gemma":[0.00004289114,0.00008798666,0.00012243006,0.00023639729,0.00003781809,0.0000042369024,0.000042903877,0.00007215252,7.7337353e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.119213864,0.0029757018,0.8766559,0.000011711037,0.0001516004,0.000005360392,0.00002356565,0.000011512224,0.00088939193,0.0000018119235,0.0000013652344,0.000058218542],"study_design_scores_gemma":[0.66791004,0.0008811106,0.30841583,0.000012997717,0.00025180026,0.000010648864,0.000008374574,7.915614e-7,0.02240475,0.0000036763208,0.0000017703339,0.00009817451],"about_ca_topic_score_codex":0.00048664658,"about_ca_topic_score_gemma":0.00043086914,"teacher_disagreement_score":0.56824005,"about_ca_system_score_codex":0.0000054764596,"about_ca_system_score_gemma":0.0000981923,"threshold_uncertainty_score":0.3587992},"labels":[],"label_agreement":null},{"id":"W2987355547","doi":"10.1182/blood-2019-127129","title":"CD20 Is an Unstable Target in Primary-Refractory High-Grade Lymphomas","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; McGill University; Jewish General Hospital","funders":"","keywords":"Rituximab; Lymphoma; Medicine; CD20; Diffuse large B-cell lymphoma; Internal medicine; Vincristine; Biopsy; Oncology; BCL6; CHOP; Prednisone; Cyclophosphamide; Pathology; B cell; Immunology; Chemotherapy; Antibody; Germinal center","score_opus":0.010313964620829121,"score_gpt":0.22965886677576694,"score_spread":0.21934490215493782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987355547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98608047,0.0012391072,7.404724e-7,0.0004978967,0.00015200002,0.00044821156,0.000027235053,0.00006361473,0.011490732],"genre_scores_gemma":[0.99532694,0.0001592146,0.0011436119,0.0014842171,0.00010833329,0.000047857313,0.0001278305,0.00003162029,0.0015703898],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875456,0.000032040236,0.00023048765,0.000377487,0.00027156496,0.00033386875],"domain_scores_gemma":[0.99918985,0.000042623316,0.0000611321,0.00050456065,0.0000304546,0.0001713807],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009337862,0.00018823457,0.0003831721,0.00010957396,0.000028904342,0.000020770245,0.000090064634,0.00011507083,0.00092325354],"category_scores_gemma":[0.000009294842,0.00015277555,0.00007798409,0.00016424664,0.000023047667,0.00015405803,0.000036837806,0.00007370976,0.000510363],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007310921,0.008732945,0.98101735,0.00008374035,0.00014684258,0.00027267958,0.0003445918,0.0000026672278,0.0061212997,0.00044954053,0.0012856305,0.0014696104],"study_design_scores_gemma":[0.021300135,0.0009178408,0.90065145,0.000109357534,0.00017491638,0.000058793168,0.000073766525,0.000018352433,0.051650062,0.0002005082,0.024618002,0.0002267987],"about_ca_topic_score_codex":0.00069511076,"about_ca_topic_score_gemma":0.00002295798,"teacher_disagreement_score":0.080365874,"about_ca_system_score_codex":0.00021783002,"about_ca_system_score_gemma":0.00022342747,"threshold_uncertainty_score":0.99999005},"labels":[],"label_agreement":null},{"id":"W2987411033","doi":"10.1182/blood-2019-121501","title":"A Regional Massive Hemorrhage Protocol: Designed with a Modified Delphi Technique to Obtain Consensus","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Neonatal Respiratory Health Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences North; Lakeridge Health; William Osler Health System; University of Ottawa; McGill University; Toronto General Hospital; Ontario Stroke Network; McMaster University; Hospital for Sick Children; Canadian Blood Services; St. Michael's Hospital; Sunnybrook Health Science Centre; Ottawa Hospital; Health Sciences Centre; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Likert scale; Protocol (science); Delphi method; Patient safety; Emergency medicine; Medical emergency; Health care; Psychology","score_opus":0.05099212137115059,"score_gpt":0.35883549066986953,"score_spread":0.3078433692987189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987411033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.62415797,0.000059967522,0.0035143124,0.005604068,0.000022819968,0.3582834,0.000022715301,0.000335258,0.007999492],"genre_scores_gemma":[0.6596517,9.999818e-7,0.04856155,0.004047274,0.00014880534,0.2841655,0.000010409155,0.000121700214,0.0032920425],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977802,0.00013500423,0.00029652318,0.00048588592,0.0007380615,0.00056434737],"domain_scores_gemma":[0.99819446,0.00020415377,0.00008753314,0.0006084549,0.0003404613,0.0005649691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005282898,0.00020931417,0.00035340327,0.00024575056,0.00006920724,0.000018199273,0.00016885372,0.00014537049,0.00015110301],"category_scores_gemma":[0.0002744635,0.00015988186,0.000054002066,0.0004761434,0.00008405626,0.000039619972,0.00007303546,0.0003889866,0.00028552455],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03602471,0.0036528965,0.006141724,0.008134764,0.0002997325,0.011337059,0.00060504867,0.000048274724,0.9104294,0.003992848,0.0023744165,0.016959112],"study_design_scores_gemma":[0.09487462,0.047774546,0.009701865,0.0034172435,0.00033150872,0.006960561,0.0008306012,0.0009314867,0.7009082,0.0010564703,0.13102944,0.0021834658],"about_ca_topic_score_codex":0.000051894538,"about_ca_topic_score_gemma":0.00001252788,"teacher_disagreement_score":0.20952122,"about_ca_system_score_codex":0.00011240226,"about_ca_system_score_gemma":0.0013286185,"threshold_uncertainty_score":0.6519793},"labels":[],"label_agreement":null},{"id":"W2987417079","doi":"10.1182/blood-2019-124392","title":"Combination of Venetoclax and Ibrutinib Increases bcl2-Dependent Apoptotic Priming, Reduces ITK-Phosphorylation and Is Clinically Promising in Relapsed/Refractory T-Prolymphocytic Leukemia","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Venetoclax; Ibrutinib; Prolymphocytic leukemia; Cancer research; Idelalisib; Medicine; Pharmacology; Leukemia; Oncology; Internal medicine; Chronic lymphocytic leukemia","score_opus":0.016006190310981563,"score_gpt":0.28668627713611833,"score_spread":0.2706800868251368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987417079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99596304,0.0019350369,0.0000017147291,0.000054075812,0.000065182074,0.0011809638,0.0000047987064,0.000034943216,0.00076025765],"genre_scores_gemma":[0.9984818,0.0005398264,0.00038861204,0.0000806848,0.00004626117,0.000025712256,0.00001813392,0.000038257043,0.00038073014],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99765766,0.00012387102,0.0007449414,0.0005417051,0.0005914411,0.00034037716],"domain_scores_gemma":[0.9984723,0.00051392236,0.0002996165,0.00039711344,0.00014177956,0.00017528355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009062515,0.00021172775,0.00054616516,0.00023742429,0.000048247857,0.000035206693,0.00011296048,0.00025304267,0.000054030676],"category_scores_gemma":[0.0007218873,0.00020110588,0.00005732071,0.00022304438,0.00017977854,0.0001444242,0.00014796751,0.00029208144,0.00001654333],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.010475827,0.0062563843,0.5282608,0.009309235,0.0011030559,0.00054263865,0.012925584,0.00015679441,0.35834712,0.00036003397,0.0003250272,0.07193746],"study_design_scores_gemma":[0.25857872,0.0052848267,0.340059,0.0044867788,0.00088152406,0.0010624297,0.0011284206,0.042387545,0.3445272,0.0005103965,0.00015907857,0.0009340746],"about_ca_topic_score_codex":0.0010912801,"about_ca_topic_score_gemma":0.00001709284,"teacher_disagreement_score":0.24810289,"about_ca_system_score_codex":0.0044393297,"about_ca_system_score_gemma":0.0066200118,"threshold_uncertainty_score":0.99938244},"labels":[],"label_agreement":null},{"id":"W2987424626","doi":"10.1182/blood-2019-129219","title":"The Impact of Red Blood Cell Transfusion on Mortality and Treatment Efficacy in Patients Treated with Radiation: A Systematic Review of the Literature","year":2019,"lang":"en","type":"review","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Radiation therapy; Blood transfusion; Hemoglobin; Internal medicine; Adverse effect; Cochrane Library; Randomized controlled trial; Cancer; Oncology; Surgery","score_opus":0.024914508634096146,"score_gpt":0.29946570887030916,"score_spread":0.274551200236213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987424626","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09419654,0.90018225,1.4751902e-8,0.0000080011605,0.000033766475,0.005349887,0.000079528276,0.000005930003,0.00014409558],"genre_scores_gemma":[0.006629044,0.9928868,0.0000016085663,0.000016625327,0.000022967837,0.00010657037,0.00018800421,0.00002075271,0.0001276381],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9981084,0.0005930523,0.00072279543,0.00025126763,0.00020288033,0.00012160335],"domain_scores_gemma":[0.9981999,0.00026445548,0.00067432906,0.0007242311,0.000092433555,0.00004465064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017539429,0.00031789058,0.0022018992,0.00007093501,0.000033297747,0.0000054948346,0.00008599383,0.00017795495,0.000009548159],"category_scores_gemma":[0.000078687706,0.000110377005,0.00053478923,0.00043107988,0.00004163963,0.000013944283,0.0000098410865,0.00019674885,0.0000016146387],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016224482,0.0032596947,0.0028231945,0.98717105,0.0012111686,0.0000062059694,0.00014684974,4.153084e-7,0.0000073490364,0.0000017412351,0.00001885998,0.005191209],"study_design_scores_gemma":[0.008150619,0.006067149,0.019203989,0.9475281,0.01825076,0.000036213172,0.0000042589068,5.686982e-7,0.000037093745,2.942924e-7,0.00057617744,0.00014475729],"about_ca_topic_score_codex":0.000029812329,"about_ca_topic_score_gemma":0.000003985547,"teacher_disagreement_score":0.09270456,"about_ca_system_score_codex":0.000055327135,"about_ca_system_score_gemma":0.00018548412,"threshold_uncertainty_score":0.4501044},"labels":[],"label_agreement":null},{"id":"W2987444835","doi":"10.1182/blood-2019-128450","title":"A Novel Cereblon E3 Ligase Modulator Eradicates Acute Myeloid Leukemia Stem Cells through Degradation of Translation Termination Factor GSPT1","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Stem cell; Haematopoiesis; Progenitor cell; Cancer research; Biology; Integrated stress response; Leukemia; Myeloid leukemia; Cell biology; Myeloid; Immunology; Translation (biology); Genetics","score_opus":0.01307800624209271,"score_gpt":0.2291679705986738,"score_spread":0.2160899643565811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987444835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946179,0.00024671553,0.003974445,0.00007008453,0.00015341563,0.0004779287,0.00012233187,0.000023812787,0.00031338717],"genre_scores_gemma":[0.9958625,0.00011207081,0.0026884375,0.00006615285,0.00009950715,0.000020796471,0.00032524482,0.000025958789,0.0007993204],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99893755,0.000034634973,0.000323795,0.00033575,0.00020348896,0.00016478248],"domain_scores_gemma":[0.99931,0.000011010415,0.00022173226,0.0003139526,0.00009264334,0.000050668088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000077672215,0.0001718057,0.00017043274,0.00005648747,0.000043243643,0.000022335851,0.00014587701,0.00020266735,0.000029744373],"category_scores_gemma":[0.000008213896,0.00016631228,0.000106198844,0.00011685267,0.000034547305,0.000032414784,0.000027363118,0.0000763636,0.000019797219],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037522135,0.0001505659,0.0005752927,0.00004123997,0.000072816314,3.235311e-7,0.00009022424,0.000037713675,0.99333084,0.00005301932,0.00007252421,0.0055379444],"study_design_scores_gemma":[0.0018112359,0.0002445545,0.0011008945,0.000027237877,0.000058956215,0.000006187808,0.000026731164,0.00055599475,0.9941592,0.000014620521,0.0018055902,0.00018878447],"about_ca_topic_score_codex":0.000025724188,"about_ca_topic_score_gemma":0.000005196577,"teacher_disagreement_score":0.0053491597,"about_ca_system_score_codex":0.000023665852,"about_ca_system_score_gemma":0.00009658796,"threshold_uncertainty_score":0.6782018},"labels":[],"label_agreement":null},{"id":"W2987515732","doi":"10.1182/blood-2019-124375","title":"Integrating Geriatric Assessment and Genetic Profiling to Personalize Therapy Selection in Older Adults with Acute Myeloid Leukemia (AML)","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Frailty in Older Adults","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Oncology; Chemotherapy regimen; Myeloid leukemia; Performance status; Intensive care medicine; Chemotherapy","score_opus":0.007100822044853813,"score_gpt":0.2617404277663108,"score_spread":0.254639605721457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987515732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966817,0.0003849624,0.0002686627,0.00028713015,0.000056348385,0.0016839401,0.0000031668174,0.00006376282,0.00057033746],"genre_scores_gemma":[0.9613843,0.00015589673,0.037433147,0.0002950743,0.00011321899,0.0001270071,0.000012183551,0.000039403185,0.00043978053],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987326,0.00004251574,0.00022886058,0.00042866287,0.0002782917,0.00028903136],"domain_scores_gemma":[0.99952024,0.000045208177,0.000069974034,0.00015662727,0.00009570233,0.00011223419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010709256,0.00019962837,0.000278047,0.00017752819,0.00003933624,0.00003481217,0.00006237417,0.00008714512,0.00006327057],"category_scores_gemma":[0.000017185097,0.00015302665,0.00003150819,0.00042466164,0.000015880018,0.0000791078,0.00002566895,0.00027868766,0.000013605762],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005956931,0.00040776882,0.8559518,0.000238949,0.00022633208,0.000109214845,0.0045293234,0.000043645716,0.11304209,0.00001956593,0.00005934167,0.024776315],"study_design_scores_gemma":[0.016337398,0.0021190888,0.9557027,0.00076767657,0.00013422198,0.0006637999,0.0011701501,0.0018042478,0.020917688,0.0000069154826,0.00007347251,0.00030261668],"about_ca_topic_score_codex":0.00020145204,"about_ca_topic_score_gemma":0.00011182148,"teacher_disagreement_score":0.099750966,"about_ca_system_score_codex":0.0001848816,"about_ca_system_score_gemma":0.00029072867,"threshold_uncertainty_score":0.6240245},"labels":[],"label_agreement":null},{"id":"W2987552010","doi":"10.1182/blood-2019-128404","title":"ELEVATE TN: Phase 3 Study of Acalabrutinib Combined with Obinutuzumab (O) or Alone Vs O Plus Chlorambucil (Clb) in Patients (Pts) with Treatment-Naive Chronic Lymphocytic Leukemia (CLL)","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology","funders":"","keywords":"Medicine; Internal medicine; Chlorambucil; Gastroenterology; Clinical endpoint; Neutropenia; Obinutuzumab; Phases of clinical research; Adverse effect; Chronic lymphocytic leukemia; Pharmacology; Clinical trial; Leukemia; Toxicity; Chemotherapy","score_opus":0.01791496854483397,"score_gpt":0.2841616989684662,"score_spread":0.2662467304236322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987552010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925452,0.00015662398,0.0000026068112,0.000020947838,0.00008349316,0.0063774767,0.000043249118,0.00012340918,0.000647003],"genre_scores_gemma":[0.9962123,0.00007893407,0.00009639808,0.00006355776,0.00009139404,0.0003494439,0.000164428,0.00015962815,0.002783941],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9949236,0.00017573021,0.0009184892,0.0011387179,0.0016482793,0.0011951808],"domain_scores_gemma":[0.9968725,0.00028160895,0.0004045579,0.0016096262,0.00040781783,0.00042390646],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031408027,0.0007288535,0.0017276602,0.00044103697,0.0000922781,0.000049174098,0.00045989567,0.00024194764,0.00039088412],"category_scores_gemma":[0.00010261414,0.00046474492,0.00011786504,0.001282073,0.00026418437,0.00023224819,0.00019176467,0.00038779396,0.00021348195],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.5918795,0.08273696,0.2495935,0.005240117,0.012523812,0.012516633,0.02348252,0.008516665,0.0025548048,0.00008558852,0.00047739447,0.010392499],"study_design_scores_gemma":[0.822529,0.14203069,0.010352526,0.0009431696,0.0011330957,0.00023815216,0.0012646561,0.011297028,0.009422431,0.0000031906193,0.0001803842,0.0006056659],"about_ca_topic_score_codex":0.006888743,"about_ca_topic_score_gemma":0.0021026004,"teacher_disagreement_score":0.23924097,"about_ca_system_score_codex":0.13663273,"about_ca_system_score_gemma":0.067770325,"threshold_uncertainty_score":0.9997804},"labels":[],"label_agreement":null},{"id":"W2987570039","doi":"10.1182/blood-2019-125865","title":"Allogeneic Transplantation for Myelodysplastic Syndrome in Adults over 50 Years Old Using Reduced Intensity/Non-Myeloablative Conditioning: Haploidentical Relative Versus Matched Unrelated Donor","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre; University of Ottawa","funders":"","keywords":"Fludarabine; Medicine; Busulfan; Transplantation; Melphalan; Internal medicine; Cyclophosphamide; Total body irradiation; Graft-versus-host disease; Surgery; Regimen; Cumulative incidence; Proportional hazards model; Hematopoietic stem cell transplantation; Gastroenterology; Oncology; Chemotherapy","score_opus":0.019231755795442635,"score_gpt":0.2904326922343814,"score_spread":0.2712009364389388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987570039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964527,0.000039985578,0.00066639844,0.00014222172,0.00031940948,0.001971065,0.00006900794,0.00006871471,0.00027053573],"genre_scores_gemma":[0.99631256,0.000031983844,0.002481675,0.00006909495,0.00006286226,0.00007135316,0.00038202334,0.00007350163,0.00051494024],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9978089,0.00008637881,0.00051278895,0.0006059005,0.0004204827,0.00056554907],"domain_scores_gemma":[0.9984526,0.00067161315,0.00015016223,0.0002906242,0.00023960668,0.00019536873],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003100249,0.00027510838,0.0005976153,0.00045069974,0.00006974251,0.00003182735,0.00013464183,0.0003532707,0.00016568386],"category_scores_gemma":[0.00034739324,0.00028531248,0.00015183185,0.00052236795,0.00013300129,0.00031318775,0.000045216708,0.0006227459,0.00015471685],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07389367,0.002682912,0.14142214,0.0026521578,0.0053433743,0.0054504215,0.018417843,0.0016009093,0.7453208,0.0026737398,0.00021301922,0.00032902774],"study_design_scores_gemma":[0.07672446,0.0025975974,0.8779978,0.0024728335,0.0014967277,0.0009747088,0.0010028385,0.015250355,0.020382382,0.0004278831,0.000016648371,0.0006557467],"about_ca_topic_score_codex":0.00021834053,"about_ca_topic_score_gemma":0.000029812149,"teacher_disagreement_score":0.73657566,"about_ca_system_score_codex":0.00048057735,"about_ca_system_score_gemma":0.00034405204,"threshold_uncertainty_score":0.9999599},"labels":[],"label_agreement":null},{"id":"W2987582517","doi":"10.1182/blood-2019-124130","title":"Evaluating the Quality of Systematic Reviews &amp; Meta-Analyses Published on Direct Oral Anticoagulants in the Past 5 Years","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Systematic review; Data extraction; MEDLINE; Meta-analysis; Publication bias; Impact factor; Alternative medicine; Family medicine; Medical physics; Internal medicine; Pathology","score_opus":0.9485955113618197,"score_gpt":0.6481828709524847,"score_spread":0.300412640409335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987582517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98207366,0.007727354,0.000079302685,0.00042422386,0.00014543284,0.0042510442,0.000015191887,0.000003967621,0.0052798046],"genre_scores_gemma":[0.9957829,0.000036666028,0.000994114,0.00039413717,0.00003076341,0.00022823414,0.0000049673927,0.000009968876,0.0025182297],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.85699433,0.11484774,0.016828068,0.0010915948,0.009891599,0.0003466535],"domain_scores_gemma":[0.9483497,0.028871069,0.012035203,0.009970773,0.00070567016,0.00006754326],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":["metaresearch","insufficient_payload"],"category_scores_codex":[0.47370493,0.0003376935,0.009796607,0.00031237185,0.00008072471,0.0009785407,0.0035574462,0.00006737928,0.0039035974],"category_scores_gemma":[0.15601136,0.00009444071,0.0041941633,0.0024351862,0.000054455053,0.00021590224,0.00013387657,0.00022200763,0.0030022839],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000122097,0.0064301034,0.71498483,0.05766631,0.06474115,0.000024511717,0.024344193,0.003359634,0.009517306,0.00838214,0.10372334,0.0067043602],"study_design_scores_gemma":[0.0058899876,0.0011899569,0.7331358,0.008024779,0.19738762,0.00009728445,0.013504728,0.008693993,0.0004979991,0.010507847,0.018251983,0.0028180243],"about_ca_topic_score_codex":0.000108073575,"about_ca_topic_score_gemma":0.0001239174,"teacher_disagreement_score":0.31769356,"about_ca_system_score_codex":0.0000113091455,"about_ca_system_score_gemma":0.000041115178,"threshold_uncertainty_score":0.997774},"labels":[],"label_agreement":null},{"id":"W2987592445","doi":"10.1182/blood-2019-123422","title":"Sustained Overall Survival Benefit of Obinutuzumab Plus Bendamustine Followed By Obinutuzumab Maintenance Compared with Bendamustine Alone in Patients with Rituximab-Refractory Indolent Non-Hodgkin Lymphoma: Final Results of the Gadolin Study","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia, Okanagan Campus; Kelowna General Hospital; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Bendamustine; Obinutuzumab; Rituximab; Internal medicine; Neutropenia; Hazard ratio; Refractory (planetary science); Oncology; Surgery; Gastroenterology; Confidence interval; Lymphoma; Chemotherapy","score_opus":0.007766365193135204,"score_gpt":0.2157758252711723,"score_spread":0.2080094600780371,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987592445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994654,0.0001499552,0.0000042088404,0.00007913622,0.00015358774,0.0037984627,0.0005957056,0.000034149984,0.000530806],"genre_scores_gemma":[0.99856275,0.000015621761,0.00031275142,0.000055200737,0.000040181614,0.0000972986,0.00037535638,0.00007466072,0.0004661987],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958257,0.00013475648,0.0011839083,0.00084099674,0.0013099496,0.0007046619],"domain_scores_gemma":[0.99684715,0.00022822879,0.0009022264,0.0012211935,0.0006107973,0.00019040096],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034781577,0.0006263167,0.0016735818,0.00021136946,0.00007826307,0.000019834388,0.00039248998,0.00014717146,0.00003375328],"category_scores_gemma":[0.00009606537,0.00038151303,0.0001919611,0.0006399213,0.00017343908,0.00013368874,0.0002584743,0.00022818061,0.0000065806253],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03566912,0.030077789,0.9293364,0.00031316778,0.0009890471,0.0001651221,0.0016993906,0.0005518604,0.000299112,0.000029045303,0.0004483343,0.00042156948],"study_design_scores_gemma":[0.29246944,0.0083039645,0.69417244,0.0008969609,0.0006488589,0.000013284933,0.0007279196,0.00012899135,0.0022522078,0.0000039800952,0.000066861045,0.00031510377],"about_ca_topic_score_codex":0.0046462696,"about_ca_topic_score_gemma":0.0012708335,"teacher_disagreement_score":0.25680032,"about_ca_system_score_codex":0.0014839132,"about_ca_system_score_gemma":0.001254009,"threshold_uncertainty_score":0.9998637},"labels":[],"label_agreement":null},{"id":"W2987604528","doi":"10.1182/blood-2019-122261","title":"Geriatric Assessment and Frailty Changes in Older Patients with Newly-Diagnosed Multiple Myeloma Undergoing Treatment","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Polypharmacy; Multiple myeloma; Geriatric oncology; Prospective cohort study; Geriatrics; Activities of daily living; Physical therapy; Internal medicine; Cancer","score_opus":0.018296552407680286,"score_gpt":0.2864020806162066,"score_spread":0.2681055282085263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987604528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966584,0.0002304554,0.000007630283,0.00019751734,0.00003917708,0.0019078113,0.00002500197,0.00004088897,0.00089313],"genre_scores_gemma":[0.99677426,0.0002231444,0.0020968108,0.000059199272,0.00004583532,0.00018091657,0.00013258733,0.0000336256,0.00045360863],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858975,0.00005338864,0.00016111866,0.00041906716,0.00035229183,0.00042436123],"domain_scores_gemma":[0.99910164,0.00024426024,0.00006325182,0.00031061645,0.000055447457,0.00022477219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006133115,0.00023426929,0.00035706157,0.00021477684,0.000054349377,0.000031598476,0.00004850942,0.00007712151,0.00014597834],"category_scores_gemma":[0.000034882265,0.00016001378,0.000037836457,0.00021754322,0.000027451606,0.00007984703,0.000046093613,0.0001071881,0.00003601619],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003041,0.0031915647,0.981481,0.00009160677,0.00023088732,0.00018372756,0.00018363705,0.0000028104128,0.00026141558,0.000006065196,0.000010880724,0.0140522625],"study_design_scores_gemma":[0.06754478,0.0026756737,0.9278648,0.00013867872,0.00011287157,0.000009064479,0.000107359774,0.00012530183,0.0011320601,0.000004201884,0.00013690567,0.00014828998],"about_ca_topic_score_codex":0.00033372466,"about_ca_topic_score_gemma":0.0016114631,"teacher_disagreement_score":0.067240685,"about_ca_system_score_codex":0.000188324,"about_ca_system_score_gemma":0.00017855372,"threshold_uncertainty_score":0.6525172},"labels":[],"label_agreement":null},{"id":"W2987620291","doi":"10.1182/blood-2019-124352","title":"Longitudinal Analyses of Diagnostic-Relapse Biopsies of Diffuse Large B Cell Lymphoma Reveal a Poor Risk Subset of ABC Patients Based on the Expression of a 30 Gene Panel","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Gene expression profiling; Germinal center; Cancer research; Oncology; Biopsy; Biology; Internal medicine; B cell; Medicine; Gene; Pathology; Gene expression; Immunology; Antibody; Genetics","score_opus":0.033768194364330206,"score_gpt":0.2893187856528634,"score_spread":0.2555505912885332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987620291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99786043,0.00037528755,0.000012056324,0.000024986768,0.000039573206,0.0007474392,0.00063685945,0.000008470509,0.00029489247],"genre_scores_gemma":[0.99928653,0.00020849315,0.00017317261,0.000022359667,0.000026436006,0.000020016021,0.00006116314,0.000029990133,0.00017186375],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99774814,0.0002538005,0.0005836666,0.00027097578,0.0008721724,0.0002712755],"domain_scores_gemma":[0.99651176,0.0016637567,0.00053828245,0.0008268174,0.00036868188,0.00009071257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046738086,0.0001884939,0.00063495967,0.00022763,0.00003149395,0.0000036992662,0.00024666684,0.00011062077,0.00074496894],"category_scores_gemma":[0.0009523263,0.000119621145,0.00026477454,0.0003555016,0.00016228126,0.000030302319,0.00008335175,0.00013041419,0.000009950688],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000877765,0.009937828,0.4567441,0.00031967487,0.000109996225,0.0000064560923,0.00022224893,0.000008139067,0.53153926,0.0000017905871,0.00010197396,0.00013073276],"study_design_scores_gemma":[0.015364906,0.0013937126,0.31763595,0.00035382627,0.00030000132,9.326623e-7,0.000087294015,0.00010215485,0.66467756,0.00000596117,0.000011033604,0.00006662331],"about_ca_topic_score_codex":0.0003561454,"about_ca_topic_score_gemma":0.0000060850684,"teacher_disagreement_score":0.13910815,"about_ca_system_score_codex":0.000020895144,"about_ca_system_score_gemma":0.00011245133,"threshold_uncertainty_score":0.8156887},"labels":[],"label_agreement":null},{"id":"W2987642284","doi":"10.1182/blood.v112.11.3126.3126","title":"High Prevalence of TERT Mutations in Chronic Lymphocytic Leukemia","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; BC Cancer Agency","funders":"","keywords":"Dyskeratosis congenita; Telomere; Telomerase; Bone marrow failure; Cancer research; Myeloid leukemia; Telomerase reverse transcriptase; Biology; Chronic lymphocytic leukemia; Fanconi anemia; Leukemia; Immunology; DNA repair; Genetics; Gene; Haematopoiesis; Stem cell","score_opus":0.016030706181260818,"score_gpt":0.24683300195648694,"score_spread":0.23080229577522612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987642284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99771905,0.0015074203,0.000023139575,0.000036089314,0.00005711842,0.00020454521,0.000009770512,0.000045265282,0.00039759502],"genre_scores_gemma":[0.9974614,0.00079253747,0.0006734427,0.0000718448,0.000087514854,0.000017352062,0.000010185858,0.0000132947625,0.0008724545],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990903,0.000020907202,0.0002787015,0.00019872391,0.00020555573,0.00020577313],"domain_scores_gemma":[0.9994751,0.00005092887,0.00006418803,0.0002833424,0.000050675037,0.00007576491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000060206166,0.00010335147,0.00023955104,0.00013036827,0.000037491667,0.000002112928,0.00009632967,0.00006270648,0.0001293418],"category_scores_gemma":[0.0000629991,0.00009541944,0.000050935854,0.0002811423,0.00013414548,0.00006106295,0.000019718529,0.000093711074,0.000043051423],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028261737,0.0012943721,0.66180736,0.0053027957,0.00031024168,0.00242607,0.006109607,0.0012515538,0.31215096,0.00072004454,0.0006488615,0.00769554],"study_design_scores_gemma":[0.007453161,0.0003872775,0.8718547,0.0005250626,0.00018936372,0.0006185953,0.00005186184,0.0004767326,0.117973484,0.0000742687,0.00021240188,0.00018306862],"about_ca_topic_score_codex":0.0005506968,"about_ca_topic_score_gemma":0.0000418752,"teacher_disagreement_score":0.2100474,"about_ca_system_score_codex":0.0007110485,"about_ca_system_score_gemma":0.0019848712,"threshold_uncertainty_score":0.3891092},"labels":[],"label_agreement":null},{"id":"W2987654817","doi":"10.1182/blood-2019-130751","title":"Venous Thromboembolism in Lower Extremity Amputees: A Systematic Review of the Literature","year":2019,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Pulmonary embolism; Amputation; Deep vein; Asymptomatic; Thrombosis; Adverse effect; Incidence (geometry); Surgery; Venous thrombosis; Internal medicine","score_opus":0.023583976301312697,"score_gpt":0.30171272818011535,"score_spread":0.27812875187880265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987654817","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000017647233,0.98790455,7.1575477e-7,0.0000768543,0.00052956777,0.009248927,0.00006547518,0.000031523905,0.0021247594],"genre_scores_gemma":[0.000033765704,0.9979311,0.000033930482,0.0007408666,0.00015237038,0.0004389053,0.00007609647,0.000081088125,0.00051184563],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99662006,0.0003196641,0.0015380795,0.0005474105,0.000599,0.00037578424],"domain_scores_gemma":[0.9965192,0.0001785748,0.0010261716,0.002059677,0.00013242238,0.00008396789],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000666887,0.0005785292,0.008493388,0.00021098976,0.000034889308,0.00004315525,0.00065213256,0.00038078733,0.00007120212],"category_scores_gemma":[0.000441807,0.000316256,0.0015035061,0.0010157696,0.000053349137,0.000064674474,0.00030400153,0.00070546253,0.00011728281],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[8.0172504e-7,0.0024207414,0.0000050938806,0.9876775,0.0007679017,0.00006223514,0.00014839252,4.2740872e-8,7.0118006e-8,0.00017570183,0.0012303524,0.0075111804],"study_design_scores_gemma":[0.00042410413,0.00008498542,0.000042338168,0.8522338,0.019208672,0.00013789586,0.000009220744,1.8173134e-7,2.3306968e-7,0.000015163502,0.1276128,0.00023057371],"about_ca_topic_score_codex":0.000009954638,"about_ca_topic_score_gemma":0.0000024688,"teacher_disagreement_score":0.13544364,"about_ca_system_score_codex":0.00010216923,"about_ca_system_score_gemma":0.00036257302,"threshold_uncertainty_score":0.99992895},"labels":[],"label_agreement":null},{"id":"W2987673838","doi":"10.1182/blood-2019-126509","title":"Fostamatinib, a Spleen Tyrosine Kinase (SYK) Inhibitor, for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (wAIHA): Final Results of the Phase 2, Multicenter, Open-Label Study","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Syk; Medicine; Autoimmune hemolytic anemia; Anemia; Internal medicine; Gastroenterology; Tolerability; Rituximab; Immunology; Pharmacology; Adverse effect; Tyrosine kinase; Antibody; Receptor","score_opus":0.06174651898453552,"score_gpt":0.38670916954462203,"score_spread":0.3249626505600865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987673838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98754936,0.0012833116,0.000008565692,0.0005983652,0.00024506118,0.009750777,0.00028882068,0.000023035562,0.00025267052],"genre_scores_gemma":[0.99635386,0.0001355597,0.00045144514,0.000053141186,0.000113381444,0.0002112549,0.00008004031,0.000050369752,0.0025509326],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99726945,0.00013426661,0.00091807847,0.00049415854,0.00070146477,0.00048255152],"domain_scores_gemma":[0.99654067,0.00085436786,0.0004140903,0.001778538,0.0003065739,0.00010574629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007272317,0.00030638673,0.00075568724,0.00008943304,0.00013351649,0.00003883588,0.0007113659,0.00009872318,0.000040115665],"category_scores_gemma":[0.0004378674,0.00016428485,0.00018031412,0.00040359405,0.00020825534,0.00008397825,0.0003554185,0.00016081323,0.000016075808],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051422298,0.3575176,0.007876558,0.0025091798,0.0031523318,0.000322069,0.01590776,0.00004038166,0.52671796,0.000095315554,0.0021996694,0.032238893],"study_design_scores_gemma":[0.69325286,0.016043589,0.0032878628,0.00059674104,0.0013550009,0.00006727322,0.0011013073,0.008433833,0.2735198,0.0000079528945,0.002137085,0.00019668801],"about_ca_topic_score_codex":0.0019059371,"about_ca_topic_score_gemma":0.00005905853,"teacher_disagreement_score":0.64183056,"about_ca_system_score_codex":0.0011701323,"about_ca_system_score_gemma":0.0024920278,"threshold_uncertainty_score":0.66993415},"labels":[],"label_agreement":null},{"id":"W2987676188","doi":"10.1182/blood-2019-128524","title":"Development of Patient-Reported Outcome Measures (Symptoms and Impacts) in Adults with Pyruvate Kinase Deficiency","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Medicine; Pyruvate kinase deficiency; Population; Disease; Patient-reported outcome; Pyruvate kinase; Pediatrics; Quality of life (healthcare); Internal medicine; Environmental health","score_opus":0.015591181306614974,"score_gpt":0.2391034139241878,"score_spread":0.22351223261757283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987676188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986246,0.0001550268,0.0000069972943,0.00002135387,0.00005873017,0.00030994133,0.0000013393,0.00002116139,0.00080082053],"genre_scores_gemma":[0.99890244,0.000013167892,0.0008812375,0.00011576644,0.000008047804,0.000008851973,0.000010847345,0.000010024248,0.000049616014],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911773,0.000017169765,0.00033644948,0.00019714798,0.00016974406,0.00016174068],"domain_scores_gemma":[0.9995355,0.000018159928,0.00012684902,0.00017100331,0.00007263817,0.00007586598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000094301664,0.000106907224,0.0002619052,0.00010521185,0.000017727145,0.0000023807916,0.000024528645,0.000056833516,0.000043194184],"category_scores_gemma":[0.00004645478,0.000073814386,0.000021501322,0.00015068406,0.000034106568,0.000031884432,0.000020340325,0.000088637964,0.000012798785],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005784465,0.00052179553,0.9327195,0.00017864276,0.00004064124,0.000038834445,0.0018817964,0.000002291176,0.06121017,0.000022242028,0.000003213532,0.0028024241],"study_design_scores_gemma":[0.008396549,0.0011202669,0.9624293,0.0003075357,0.000058670103,0.000061594896,0.00058103824,0.000010151182,0.026690127,0.0000055195633,0.00020785867,0.00013139397],"about_ca_topic_score_codex":0.000030221448,"about_ca_topic_score_gemma":0.00005567797,"teacher_disagreement_score":0.034520045,"about_ca_system_score_codex":0.000014323661,"about_ca_system_score_gemma":0.0001156289,"threshold_uncertainty_score":0.30100635},"labels":[],"label_agreement":null},{"id":"W2987688462","doi":"10.1182/blood-2019-131222","title":"Hispanic Ethnicity Is Associated with Low End of Induction Absolute Lymphocyte Count in Pediatric Acute Lymphoblastic Leukemia","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Population; Minimal residual disease; Immunology; Lymphocyte; Internal medicine; Oncology; Leukemia","score_opus":0.009904214239266268,"score_gpt":0.24550385228573274,"score_spread":0.23559963804646647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987688462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99710023,0.0002947545,0.000050562936,0.00008977706,0.0001677809,0.0008154085,0.00005927256,0.0000813848,0.001340844],"genre_scores_gemma":[0.997456,0.00047010544,0.00017052515,0.00022536275,0.00016069766,0.000037336158,0.000062251136,0.000079451995,0.0013382661],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966316,0.000109716646,0.0006406522,0.00063506985,0.0012345673,0.0007483849],"domain_scores_gemma":[0.99803406,0.00035454804,0.00036304712,0.00064971094,0.00036339063,0.00023522192],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00051566603,0.00035374062,0.00083648885,0.00050868525,0.000045896857,0.000019608788,0.00027392793,0.00041069536,0.0003444136],"category_scores_gemma":[0.00028907845,0.00029647272,0.0001290217,0.001411652,0.00015213585,0.00019467388,0.00013481575,0.00043988903,0.00022372765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008432041,0.008348319,0.7883715,0.0032007142,0.00527429,0.003165792,0.0049114325,0.00086573407,0.16988295,0.00022226026,0.004366985,0.0029579408],"study_design_scores_gemma":[0.06738504,0.0032841759,0.8790929,0.00095182814,0.002343352,0.00081418914,0.00015557634,0.008770661,0.036268216,0.00005503459,0.00010446239,0.0007745674],"about_ca_topic_score_codex":0.0006271877,"about_ca_topic_score_gemma":0.00009606808,"teacher_disagreement_score":0.13361475,"about_ca_system_score_codex":0.004077421,"about_ca_system_score_gemma":0.0047648214,"threshold_uncertainty_score":0.99994874},"labels":[],"label_agreement":null},{"id":"W2987691693","doi":"10.1182/blood-2019-130733","title":"Salvage Autologous Stem Cell Transplant in Relapsed Myeloma Patients in the Era of Modern Treatment: Is There a Role?","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lenalidomide; Autologous stem-cell transplantation; Multiple myeloma; Bortezomib; Internal medicine; Oncology; Salvage therapy; Surgery; Chemotherapy","score_opus":0.012340157504084022,"score_gpt":0.24139123968674592,"score_spread":0.2290510821826619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987691693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932233,0.0010283015,7.0482514e-7,0.00014215954,0.000017885372,0.0012843255,0.00010146993,0.000015523343,0.0041863355],"genre_scores_gemma":[0.99921316,0.00017882037,0.000045876637,0.00005991291,0.000009195839,0.00007497656,0.000054305197,0.000020697094,0.00034306519],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986226,0.00013485488,0.00028320053,0.00027209,0.0003419877,0.00034526447],"domain_scores_gemma":[0.9993087,0.00011163229,0.00006475033,0.00041548302,0.000026780595,0.000072649425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010071432,0.00018123901,0.00036536096,0.00010635637,0.000020753258,0.00000774445,0.00013827306,0.000105007515,0.000067237306],"category_scores_gemma":[0.000003923158,0.00010702501,0.00010428125,0.00018237699,0.00002739698,0.000034709494,0.0000134078,0.00020713733,0.00007332097],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062987936,0.005326553,0.9563849,0.00010662799,0.000118791875,0.00036028403,0.009114293,0.000004152817,0.0018858054,0.000008430184,0.0000049069054,0.026055377],"study_design_scores_gemma":[0.02812282,0.0019820717,0.9531546,0.00018026447,0.000097394746,0.000016348436,0.0002873856,0.0005472906,0.015421776,0.00005280866,0.000040339324,0.000096863914],"about_ca_topic_score_codex":0.0005702674,"about_ca_topic_score_gemma":0.00026029788,"teacher_disagreement_score":0.02749294,"about_ca_system_score_codex":0.00005961482,"about_ca_system_score_gemma":0.00008328423,"threshold_uncertainty_score":0.4364353},"labels":[],"label_agreement":null},{"id":"W2987692177","doi":"10.1182/blood-2019-131444","title":"Establishing a Novel in Vitro Informed Precision Clinical Trial Pathway for Refractory Pediatric Leukemia","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Lethbridge; University of Calgary","funders":"","keywords":"Druggability; Medicine; Leukemia; Clinical trial; Stromal cell; Bone marrow; Cancer research; Bioinformatics; Oncology; Immunology; Biology; Internal medicine; Gene","score_opus":0.048317325542838845,"score_gpt":0.35226346640462824,"score_spread":0.3039461408617894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987692177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99383974,0.00012069804,0.00046784966,0.000076977754,0.0007722602,0.0028697124,0.000034821944,0.000066900844,0.0017510212],"genre_scores_gemma":[0.98882014,0.00008486565,0.0071292925,0.0002662583,0.0022121633,0.00017442965,0.00009881032,0.000059620663,0.0011544351],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9970473,0.00006941636,0.0010188402,0.00052120636,0.00072956143,0.000613649],"domain_scores_gemma":[0.99431276,0.0043559833,0.00022570523,0.0005956612,0.0002290673,0.00028084384],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0018768318,0.00021250518,0.0006646327,0.00037215647,0.000041719213,0.00005892537,0.00030010616,0.00044533965,0.00004609558],"category_scores_gemma":[0.011365143,0.00017483826,0.00022002574,0.00056040136,0.00004207743,0.00034051336,0.0001807365,0.0006753971,0.00012314474],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6656109,0.017605152,0.10537674,0.0036006905,0.0006196527,0.00040926866,0.0020474845,0.0000722989,0.104288705,0.0002497406,0.015048697,0.08507068],"study_design_scores_gemma":[0.9319294,0.007210853,0.022769658,0.00029062227,0.00037749452,0.00009124298,0.00021344775,0.004466391,0.007837977,0.00007848515,0.024153873,0.00058055314],"about_ca_topic_score_codex":0.00005979595,"about_ca_topic_score_gemma":0.000010662447,"teacher_disagreement_score":0.26631853,"about_ca_system_score_codex":0.00081214885,"about_ca_system_score_gemma":0.006079622,"threshold_uncertainty_score":0.999555},"labels":[],"label_agreement":null},{"id":"W2987698787","doi":"10.1182/blood-2019-123686","title":"A Meta-Analysis Evaluating the Risk of Bleeding-Related Adverse Events with Defibrotide Treatment","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Defibrotide; Medicine; Adverse effect; Internal medicine; Hepatic veno-occlusive disease; Transplantation; Incidence (geometry); Retrospective cohort study; Thymoglobulin; Surgery; Fibrinolytic agent; Hematopoietic stem cell transplantation; Antithrombotic; Tacrolimus","score_opus":0.054626088935032215,"score_gpt":0.30365091866367233,"score_spread":0.24902482972864012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987698787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99623305,0.00025174054,0.00010936238,0.0000700847,0.000015051791,0.000860573,0.000020463687,0.000023353366,0.0024163395],"genre_scores_gemma":[0.9962249,0.000030906853,0.0024997862,0.000014414711,0.0000066829875,0.000049275273,0.000026661897,0.000015597883,0.0011318051],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99869823,0.00014272709,0.00035514857,0.00021980167,0.00043982232,0.00014428936],"domain_scores_gemma":[0.9989212,0.00026275453,0.00026461208,0.00040552585,0.00009387348,0.00005202742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050930196,0.00014541473,0.0006681041,0.00010510283,0.000038355964,0.0000021353571,0.000056159082,0.000047421086,0.00059508416],"category_scores_gemma":[0.000022246593,0.00007045189,0.000608056,0.00047428865,0.000022648579,0.000031064214,0.0000065914255,0.00007580525,0.00007532673],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019998974,0.00055602554,0.62126863,0.0001133754,0.3676138,0.000011073757,0.0021447665,0.0023589511,0.0056379545,0.00004742029,8.6630945e-7,0.000047146685],"study_design_scores_gemma":[0.005843428,0.001468885,0.073282875,0.00003764866,0.89738685,0.000057544887,0.0003956594,0.0012525831,0.020147491,0.000030264817,0.0000028137244,0.00009397878],"about_ca_topic_score_codex":0.00021280553,"about_ca_topic_score_gemma":0.000026762267,"teacher_disagreement_score":0.5479858,"about_ca_system_score_codex":0.000021474036,"about_ca_system_score_gemma":0.00006661757,"threshold_uncertainty_score":0.65157545},"labels":[],"label_agreement":null},{"id":"W2987713462","doi":"10.1182/blood-2019-126196","title":"Spontaneous Bleeding and Poor Bleeding Response with Extended Half-Life Factor IX Products: A Survey of Select US and Canadian Hemophilia Treatment Centers","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Factor IX; Medicine; Cohort; Single Center; Hemostasis; Surgery; Internal medicine","score_opus":0.026234242764780234,"score_gpt":0.2664876051533872,"score_spread":0.24025336238860698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987713462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99630904,0.00081117597,1.4658869e-7,0.001325188,0.000044731798,0.0011464169,0.00008959224,0.000028955192,0.00024472733],"genre_scores_gemma":[0.99785984,0.00021679803,0.00016092112,0.000052849104,0.000046352277,0.000015753505,0.000040028055,0.000039955885,0.0015674984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982921,0.00013306954,0.000228871,0.00049412943,0.00031093758,0.0005409233],"domain_scores_gemma":[0.99862605,0.00022884533,0.000066569664,0.00026562955,0.00019659921,0.00061631243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040033096,0.00026645922,0.0004983975,0.00033395077,0.00010075184,0.000036746398,0.00006170316,0.0000989686,0.000057212976],"category_scores_gemma":[0.00030936726,0.00018206004,0.000033656164,0.00033467432,0.00010409656,0.000072944575,0.000026587433,0.00013486884,0.00000813871],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007784976,0.0005975937,0.91902643,0.00024166288,0.00085224,0.0022207876,0.0008932291,6.6230825e-7,0.067431256,0.0000052007704,0.000028858514,0.0009170813],"study_design_scores_gemma":[0.01009291,0.005874948,0.9513717,0.00024272615,0.0003587303,0.0028724766,0.00026657397,0.00007316113,0.028270429,0.000001331117,0.0003212117,0.0002537443],"about_ca_topic_score_codex":0.041363347,"about_ca_topic_score_gemma":0.022304224,"teacher_disagreement_score":0.03916083,"about_ca_system_score_codex":0.0001956121,"about_ca_system_score_gemma":0.0009484566,"threshold_uncertainty_score":0.99553615},"labels":[],"label_agreement":null},{"id":"W2987742353","doi":"10.1182/blood-2019-129120","title":"Portia: A Phase 1b Study Evaluating Safety and Efficacy of Tisagenlecleucel and Pembrolizumab in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Oncology; Salvage therapy; Fludarabine; Diffuse large B-cell lymphoma; Lymphoma; Cyclophosphamide; Immunotherapy; Chemotherapy; Cancer","score_opus":0.014852087663057753,"score_gpt":0.30483676064559595,"score_spread":0.2899846729825382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987742353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963641,0.0004263168,0.0000016180178,0.000011429538,0.000024590898,0.0020663452,0.000019180128,0.000020399071,0.0010660181],"genre_scores_gemma":[0.99893767,0.000055061268,0.000064812804,0.000027936809,0.000022064822,0.000015685206,0.00002424499,0.000046883517,0.00080563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980021,0.00016019493,0.00041277712,0.00042825515,0.000651109,0.0003455424],"domain_scores_gemma":[0.9989187,0.00018626187,0.0001564658,0.00046012673,0.00011895148,0.00015950049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005882411,0.0001949059,0.0004933773,0.00018691702,0.0000457954,0.000014777272,0.00007909507,0.000082014965,0.00021357917],"category_scores_gemma":[0.00010761336,0.00015738735,0.00003686989,0.00023222515,0.000058700578,0.00008402346,0.000110139954,0.00020333912,0.000007468752],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011790689,0.108240396,0.84121954,0.00018888284,0.00019002297,0.000071880335,0.0026138825,3.626155e-7,0.018595278,0.0000021613748,0.000005329578,0.0170816],"study_design_scores_gemma":[0.39105365,0.010725958,0.5963656,0.00009258924,0.00017725964,0.000009781086,0.00029987583,0.000089021225,0.0010140464,0.0000014559627,0.000049659477,0.00012115309],"about_ca_topic_score_codex":0.000060094517,"about_ca_topic_score_gemma":0.000024650408,"teacher_disagreement_score":0.37926295,"about_ca_system_score_codex":0.00005259227,"about_ca_system_score_gemma":0.00014317577,"threshold_uncertainty_score":0.641807},"labels":[],"label_agreement":null},{"id":"W2987746919","doi":"10.1182/blood-2019-129554","title":"Regional Differences in the Beliefs and Practices Among Adults with Sickle Cell Disease Regarding Reproductive Health and Family Planning: A Sub-Analysis","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reproductive health; Disease; Population; Medicine; Family medicine; Genetic counseling; Family planning; Young adult; Gerontology; Demography; Environmental health","score_opus":0.015302838477933551,"score_gpt":0.2531508061442443,"score_spread":0.23784796766631075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987746919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98453164,0.010894069,0.000002822333,0.0034926462,0.000012308661,0.00048388864,0.0000031767372,0.000015527383,0.00056391803],"genre_scores_gemma":[0.9981786,0.0011174942,0.000057347934,0.00046050185,0.000039905568,0.000014770518,0.000017643795,0.000008489058,0.00010525215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988859,0.00010292113,0.0001620653,0.00042208243,0.00023984077,0.00018718714],"domain_scores_gemma":[0.9991855,0.00012655449,0.00023998083,0.00026427314,0.000035994013,0.00014768208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029380043,0.00012285743,0.0002911187,0.00011879188,0.00009193423,0.000032187465,0.00005129868,0.000045100518,0.0000018898971],"category_scores_gemma":[0.000097398224,0.000068041845,0.000037987294,0.0003550214,0.00010872597,0.00010287395,0.000023231321,0.00023351255,0.0000010277284],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045953263,0.0003246369,0.9895304,0.00016577689,0.00025836696,0.000059778624,0.00893533,0.00000860331,0.000039811835,0.000018828985,0.00008294145,0.00011598882],"study_design_scores_gemma":[0.0030294766,0.0005428637,0.9696049,0.00034697715,0.00081530464,0.000024796183,0.025212845,0.00017079056,0.000015802627,0.000023764353,0.00010041823,0.00011202424],"about_ca_topic_score_codex":0.0004189928,"about_ca_topic_score_gemma":0.000046268004,"teacher_disagreement_score":0.019925466,"about_ca_system_score_codex":0.000008012323,"about_ca_system_score_gemma":0.00010275609,"threshold_uncertainty_score":0.2774666},"labels":[],"label_agreement":null},{"id":"W2987785410","doi":"10.1182/blood-2019-124320","title":"Accrual Barriers and Detection of Early Toxicity Signal in Older Less-Fit Patients Treated with Azacitidine and Nivolumab for Newly Diagnosed Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS) in the SWOG 1612 Platform Randomized Phase II/III Clinical Trial","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University; Queen's University","funders":"","keywords":"Azacitidine; Medicine; Decitabine; Nivolumab; Internal medicine; Oncology; Myeloid leukemia; Hypomethylating agent; Myelodysplastic syndromes; Clinical trial; Cancer; Immunotherapy; Bone marrow; Biology","score_opus":0.021086858927390557,"score_gpt":0.29716861099669034,"score_spread":0.2760817520692998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987785410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908249,0.000056770765,0.00018625791,0.00004442369,0.00009481952,0.008558862,0.00018133168,0.000036701666,0.000015960466],"genre_scores_gemma":[0.9985128,0.00022316382,0.00021210693,0.00006565691,0.00011440514,0.0006004045,0.00008946378,0.000059607584,0.00012237683],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99617255,0.00046703,0.0012832624,0.00073682325,0.0006651108,0.00067520683],"domain_scores_gemma":[0.9950401,0.0035544813,0.0004697971,0.00040752382,0.00018821796,0.00033986615],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022880158,0.00043705624,0.0017976634,0.00044599778,0.000160552,0.000054997392,0.00023192744,0.00042500772,0.000059764083],"category_scores_gemma":[0.0014891373,0.00026766825,0.00018206838,0.0006165097,0.00043544156,0.00034029875,0.0001166606,0.00087415136,0.0000020938903],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93200505,0.0020928828,0.053938355,0.00014322388,0.00088715984,0.00027158807,0.001216294,0.000010103654,0.0021303867,0.000007699469,0.000021725346,0.0072755255],"study_design_scores_gemma":[0.9013213,0.02999192,0.061116815,0.00026654993,0.0013390927,0.000118122894,0.0004426242,0.001698065,0.0033745158,0.000023464532,0.0000059479157,0.00030161111],"about_ca_topic_score_codex":0.0014459605,"about_ca_topic_score_gemma":0.00064353,"teacher_disagreement_score":0.030683782,"about_ca_system_score_codex":0.00026399567,"about_ca_system_score_gemma":0.0007904508,"threshold_uncertainty_score":0.9999775},"labels":[],"label_agreement":null},{"id":"W2987820069","doi":"10.1182/blood-2019-122700","title":"Improved Overall Survival with Enasidenib Compared with Standard of Care Among Patients with Relapsed or Refractory Acute Myeloid Leukemia and IDH2 Mutations: A Propensity Score Matching Analysis Using Data from the AG221-C-001 Trial and Two Data Sources from France and Germany","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Propensity score matching; Medicine; Internal medicine; Oncology","score_opus":0.03812831733009498,"score_gpt":0.29008553625595207,"score_spread":0.2519572189258571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987820069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922662,0.0005615575,0.00020186737,0.000029708575,0.00002499582,0.0021497498,0.004724745,0.000031038322,0.0000101584155],"genre_scores_gemma":[0.9902676,0.00008838442,0.004630662,0.000039904116,0.00009077041,0.000012422656,0.004787258,0.000055490385,0.00002753612],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99708736,0.00023934241,0.00043477604,0.0010535533,0.00085594767,0.00032900478],"domain_scores_gemma":[0.9965008,0.0005565396,0.0004836271,0.0019271679,0.0003491782,0.00018270935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040694646,0.00035141993,0.001083363,0.00012529088,0.00023887416,0.00018085429,0.0005145876,0.00010155212,0.000025865667],"category_scores_gemma":[0.000103878585,0.00018908837,0.000025131243,0.0003824805,0.0004731753,0.00080728816,0.00077711546,0.0005329797,4.5740458e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06649414,0.00014621398,0.922431,0.0001170654,0.004409632,0.00007926089,0.003666468,0.000035399135,0.0023518982,4.086195e-7,0.0000098189585,0.00025871015],"study_design_scores_gemma":[0.14311405,0.001861244,0.83904606,0.00064774574,0.0076600797,0.000014635303,0.0020054989,0.0049301996,0.0003281773,0.0000038460594,0.000027324904,0.00036115438],"about_ca_topic_score_codex":0.015105802,"about_ca_topic_score_gemma":0.010090785,"teacher_disagreement_score":0.08338494,"about_ca_system_score_codex":0.00012322505,"about_ca_system_score_gemma":0.0007866774,"threshold_uncertainty_score":0.9914527},"labels":[],"label_agreement":null},{"id":"W2987851473","doi":"10.1182/blood-2019-131407","title":"Resource Utilization and Costs in the Care of Patients with Hematologic Malignancies","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health; Institute for Clinical Evaluative Sciences; Sunnybrook Hospital; University of Toronto","funders":"","keywords":"Medicine; Interquartile range; Diffuse large B-cell lymphoma; Population; Cancer registry; Cohort; Lymphoma; Health care; Cancer; Internal medicine; Pediatrics","score_opus":0.015560769291183338,"score_gpt":0.19342386798329672,"score_spread":0.1778630986921134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987851473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799242,0.0025447714,0.0000110240635,0.000047680325,0.000023761659,0.00021359442,0.000052235097,0.0000040433783,0.017178718],"genre_scores_gemma":[0.9996805,0.00007719903,0.000047239086,0.00012787235,0.0000074531185,0.0000068332806,0.00001210217,0.0000062193785,0.00003457745],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99952954,0.0000064938217,0.00020251468,0.00013871783,0.000017364431,0.00010538482],"domain_scores_gemma":[0.999635,0.000026157519,0.00015667129,0.00014961472,0.000019166137,0.000013433196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010121607,0.00006252232,0.00018507973,0.000058114143,0.0000187944,0.00001551805,0.000092082984,0.000042980577,0.00002438279],"category_scores_gemma":[0.00002633482,0.0000489565,0.000016341899,0.000086518674,0.00003539639,0.000098895944,0.00001717453,0.000042230517,0.000016307311],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013946827,0.000056291497,0.96151346,0.000026072152,0.0000054395387,3.4199311e-7,0.00083937176,0.0000046595865,9.094305e-7,0.037148084,0.000023584078,0.00036786258],"study_design_scores_gemma":[0.0013373945,0.00013943537,0.9922837,0.000028788145,0.0000041678327,7.831047e-7,0.00049299555,0.000007914948,0.000078028366,0.0007240286,0.0048166164,0.00008615057],"about_ca_topic_score_codex":0.00005841625,"about_ca_topic_score_gemma":0.000042717773,"teacher_disagreement_score":0.036424056,"about_ca_system_score_codex":0.00001674999,"about_ca_system_score_gemma":0.000008222597,"threshold_uncertainty_score":0.19963881},"labels":[],"label_agreement":null},{"id":"W2987880211","doi":"10.1182/blood-2019-127995","title":"Inferior Outcomes for Older Patients in the Adolescent and Young Adult (AYA) Population with Burkitt Lymphoma Treated with Intensive Immunochemotherapy: An International Study of 108 Patients","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Leukemia & Lymphoma Society of Canada; University of British Columbia","funders":"","keywords":"Medicine; Population; Rituximab; Cumulative incidence; Pediatrics; Young adult; Survival analysis; Internal medicine; Lymphoma; Relative survival; Transplantation; Epidemiology; Cancer registry","score_opus":0.006935902756192617,"score_gpt":0.24502794897073754,"score_spread":0.2380920462145449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987880211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972524,0.000010766493,8.9453846e-7,0.00006435146,0.000041891086,0.0025688293,0.000022364868,0.000010554553,0.000027963582],"genre_scores_gemma":[0.99921393,0.000010895388,0.00007380785,0.00025354675,0.0000123138725,0.00016076972,0.00024088506,0.000019892825,0.000013938143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990795,0.00003219186,0.00023066685,0.00023773676,0.00029785975,0.00012200969],"domain_scores_gemma":[0.9990544,0.000030885865,0.00014751595,0.00023542384,0.00049868686,0.00003310141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003971154,0.00016432995,0.00028211385,0.000088615176,0.000028311457,0.000019795356,0.00006817432,0.000037315116,0.0000044147414],"category_scores_gemma":[0.000022882536,0.00008580892,0.000030177434,0.00008620345,0.00001855966,0.00011084756,0.000014800835,0.000027139591,6.858704e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010527428,0.015711498,0.9760579,0.000026694652,0.0003556145,0.000004490515,0.0030291441,9.230014e-7,0.000009424222,0.000006687185,0.0000033505241,0.0037415735],"study_design_scores_gemma":[0.06588057,0.005491012,0.925889,0.00018198678,0.00024172795,0.0000052816335,0.0019759506,0.000019786068,0.00021574849,0.0000012348784,0.0000028211703,0.00009485028],"about_ca_topic_score_codex":0.001378466,"about_ca_topic_score_gemma":0.00029582475,"teacher_disagreement_score":0.06482783,"about_ca_system_score_codex":0.0000657705,"about_ca_system_score_gemma":0.000020325073,"threshold_uncertainty_score":0.3499186},"labels":[],"label_agreement":null},{"id":"W2987889066","doi":"10.1182/blood-2019-123048","title":"Hematologic Improvement-Neutrophil and -Platelet in the MEDALIST Trial: Multilineage Data from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Luspatercept to Treat Anemia in Patients with Very Low-, Low-, or Intermediate-Risk Myelodysplastic Syndromes (MDS) with Ring Sideroblasts (RS) Who Require Red Blood Cell (RBC) Transfusions","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hematological disorders and diagnostics","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Anemia; Myelodysplastic syndromes; Placebo; Cytopenia; Erythropoiesis; International Prognostic Scoring System; Surrogate endpoint; Gastroenterology; Surgery; Bone marrow; Pathology","score_opus":0.022201097482293722,"score_gpt":0.27823726669445287,"score_spread":0.25603616921215916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987889066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817362,0.00008704862,0.000027479906,0.00007648337,0.00006293721,0.017621154,0.00029336082,0.000044187007,0.000051165505],"genre_scores_gemma":[0.99837035,0.00015610535,0.00014841267,0.000100208716,0.000024922183,0.0008495025,0.00027026798,0.000057409798,0.000022805905],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99588037,0.00048868207,0.0014292867,0.0010266883,0.00062280096,0.0005521621],"domain_scores_gemma":[0.99485457,0.0032324397,0.00047154145,0.0011034261,0.000102551945,0.00023545131],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007464048,0.000601084,0.0027691473,0.00034088746,0.00008177937,0.0000662365,0.0004834485,0.00022984808,0.00011028555],"category_scores_gemma":[0.000912592,0.00030151423,0.00010320274,0.0004756757,0.0001690166,0.00022563648,0.00019510306,0.0004978285,0.000006598119],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.925716,0.026442783,0.042662982,0.00051205984,0.00037919357,0.00097019644,0.002716709,0.00013285156,0.00038750187,0.0000013848454,0.00000806036,0.00007027926],"study_design_scores_gemma":[0.97144973,0.016719075,0.003961594,0.0011390331,0.0021849945,0.000023247485,0.0026866444,0.00060302805,0.00085346046,0.000008046436,5.4441807e-7,0.0003706138],"about_ca_topic_score_codex":0.0008168792,"about_ca_topic_score_gemma":0.0025788664,"teacher_disagreement_score":0.04573372,"about_ca_system_score_codex":0.000024115661,"about_ca_system_score_gemma":0.0001200998,"threshold_uncertainty_score":0.9999437},"labels":[],"label_agreement":null},{"id":"W2987891747","doi":"10.1182/blood-2019-126287","title":"The Splicing Factor RBM17 Supports Leukemia Stem Cell Self-Renewal","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Spliceosome; RNA splicing; Biology; Splicing factor; Myeloid leukemia; Stem cell; Alternative splicing; Genetics; Intron; Leukemia; SR protein; Cancer research; Gene; RNA; Messenger RNA","score_opus":0.005504000948988499,"score_gpt":0.22169131489555818,"score_spread":0.21618731394656968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987891747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99457437,0.00056637614,0.00001636887,0.000040752147,0.00011188051,0.00020867669,0.0000074469513,0.000020561378,0.0044535506],"genre_scores_gemma":[0.98480266,0.00020924842,0.00006547193,0.00006876211,0.0001723933,0.000010183985,0.000017031425,0.000022555647,0.014631684],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989446,0.000037473237,0.00014733593,0.0002795566,0.00018407677,0.0004070016],"domain_scores_gemma":[0.99929196,0.000025907777,0.0000534792,0.00046913588,0.000045188823,0.00011434798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015866096,0.00012643228,0.00010190911,0.000018429537,0.00013620676,0.000063406645,0.0002664318,0.00010272581,0.000026248565],"category_scores_gemma":[0.000008867482,0.000089130044,0.00008478114,0.00005045199,0.000022184093,0.0000031226405,0.00013901139,0.000116364026,0.000101863836],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018544166,0.00004413069,0.019240567,0.000020550526,0.000048771013,0.000007099042,0.00003411945,0.000007758761,0.9791174,0.000016338354,0.0005195417,0.00092521],"study_design_scores_gemma":[0.0009695867,0.00027035628,0.0021808685,0.0000083144205,0.000015851525,0.000018059904,0.00012155695,0.000048174086,0.9774283,0.000009197641,0.01876406,0.00016565553],"about_ca_topic_score_codex":0.000049423234,"about_ca_topic_score_gemma":0.000031346895,"teacher_disagreement_score":0.018244518,"about_ca_system_score_codex":0.000018381312,"about_ca_system_score_gemma":0.0001741603,"threshold_uncertainty_score":0.3634618},"labels":[],"label_agreement":null},{"id":"W2987959908","doi":"10.1182/blood-2019-129914","title":"Epidemiology, Diagnosis and Management of Neonatal Thrombosis","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster Children's Hospital","funders":"","keywords":"Medicine; Thrombosis; Epidemiology; Pediatrics; Retrospective cohort study; Deep vein; Surgery; Venous thrombosis; Internal medicine","score_opus":0.04760554958259403,"score_gpt":0.3113021781461457,"score_spread":0.26369662856355164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987959908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932852,0.0015976283,0.00013306498,0.0006645889,0.00009964475,0.00042702115,0.0000056665313,0.00003684507,0.0037503466],"genre_scores_gemma":[0.9904509,0.0012166114,0.0076024127,0.00044209842,0.000021208356,0.00002943743,0.000009964111,0.0000116033725,0.00021573574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99930775,0.00003320415,0.0002204915,0.00020161357,0.00009782435,0.0001391087],"domain_scores_gemma":[0.99949455,0.00008919924,0.000075145435,0.00024155903,0.000026215012,0.00007332354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021210844,0.00008970734,0.000337261,0.000053491476,0.000017776783,0.0000014309692,0.000045473585,0.00006854272,0.0003987379],"category_scores_gemma":[0.000015325451,0.00007669372,0.0000636687,0.00009120334,0.000038980055,0.00003361193,0.00006446805,0.00005903104,0.000055902026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015111776,0.0005034664,0.95367223,0.00049660134,0.0005645552,0.0000059566746,0.00008020122,8.25769e-7,0.0020194885,0.034831036,0.00019516806,0.0076153516],"study_design_scores_gemma":[0.003687567,0.00039993707,0.9669616,0.00027058364,0.0006282467,0.000022334849,0.00017262,0.000038510563,0.024845654,0.0014380218,0.0014237098,0.000111197136],"about_ca_topic_score_codex":0.000013355544,"about_ca_topic_score_gemma":0.0000012102865,"teacher_disagreement_score":0.033393014,"about_ca_system_score_codex":0.0000034582151,"about_ca_system_score_gemma":0.000006768765,"threshold_uncertainty_score":0.43659005},"labels":[],"label_agreement":null},{"id":"W2988003492","doi":"10.1182/blood-2019-122590","title":"High Rate of IDH1 Mutation Clearance and Measurable Residual Disease Negativity in Patients with IDH1-Mutant Newly Diagnosed Acute Myeloid Leukemia Treated with Ivosidenib (AG-120) and Azacitidine","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Myeloid leukemia; IDH1; Medicine; Isocitrate dehydrogenase; Internal medicine; Myeloid; Peripheral blood mononuclear cell; Minimal residual disease; Bone marrow; Azacitidine; Oncology; Gastroenterology; Mutation; Biology; Gene; Genetics","score_opus":0.006214044789194348,"score_gpt":0.21711064744236075,"score_spread":0.2108966026531664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988003492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99760413,0.00015905767,0.000011548543,0.00029856805,0.00001416893,0.0016622319,0.00012353226,0.000050348983,0.00007639094],"genre_scores_gemma":[0.99875414,0.00016276618,0.00057206285,0.000098345845,0.000030916075,0.00006186396,0.00013303717,0.000062509804,0.00012434275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99775547,0.00020256202,0.00037605315,0.0006182241,0.00058474933,0.00046293245],"domain_scores_gemma":[0.99845546,0.00022858994,0.00020749046,0.00044369273,0.00031926308,0.00034549367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033228524,0.000327824,0.00065807044,0.0002448627,0.00007179682,0.000042232936,0.00010254813,0.00011160066,0.00002804172],"category_scores_gemma":[0.00019194765,0.00024023089,0.000029687595,0.0005756442,0.00025310516,0.0003981625,0.00006722274,0.00036753152,0.000008697614],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014286488,0.0005717068,0.94137585,0.00035820456,0.00034700026,0.00070665614,0.00031914486,0.00009665016,0.04091021,0.000038420243,0.000041354244,0.0009482846],"study_design_scores_gemma":[0.04481789,0.0021360603,0.8959907,0.00060264685,0.0004473703,0.00003302788,0.00008228811,0.00028932316,0.055282265,0.000043748263,0.0000070801157,0.00026758004],"about_ca_topic_score_codex":0.0012634258,"about_ca_topic_score_gemma":0.0002123832,"teacher_disagreement_score":0.04538516,"about_ca_system_score_codex":0.00021682284,"about_ca_system_score_gemma":0.00054654526,"threshold_uncertainty_score":0.97963315},"labels":[],"label_agreement":null},{"id":"W2988013001","doi":"10.1182/blood-2019-130602","title":"Fas Mutations in Non-Hodgkin's Lymphoma (NHL): Implications for Disease Progression and Therapeutic Resistance","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Lymphoma; Fas receptor; Cancer research; Fas ligand; Immunology; Biology; Immune system; Aggressive lymphoma; Diffuse large B-cell lymphoma; Programmed cell death; Apoptosis; Medicine; Rituximab; Genetics","score_opus":0.006630428746452567,"score_gpt":0.26185847500352366,"score_spread":0.2552280462570711,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988013001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99505764,0.0015605632,0.0021345092,0.00032109444,0.000038574395,0.00060705794,0.000025656986,0.0000070596243,0.00024781813],"genre_scores_gemma":[0.99752486,0.000094409006,0.0012557063,0.00005554072,0.0000415062,0.00015233061,0.00015355407,0.000012395286,0.0007096789],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99953866,0.000011802468,0.0000942832,0.00021324061,0.000035428988,0.000106608364],"domain_scores_gemma":[0.99969035,0.000009634407,0.000039214407,0.00018334015,0.0000330986,0.000044334898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000053519674,0.000068261645,0.00005905567,0.000026482163,0.000054506614,0.000014574327,0.00004810462,0.00005683359,0.0000024304736],"category_scores_gemma":[0.000007343967,0.000060839444,0.000030970183,0.000048760256,0.000018435461,0.0000025273123,0.000020883434,0.000013069096,0.0000014928646],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001297933,0.00037241727,0.025964027,0.00008700234,0.000030097459,7.1540285e-7,0.00006228459,0.000028652325,0.9367514,0.0032252097,0.00004734996,0.033301007],"study_design_scores_gemma":[0.005117361,0.0002706396,0.90444577,0.00007855371,0.00009678045,0.0000052693595,0.00005032926,0.00056474993,0.065586336,0.008170865,0.015290103,0.00032326116],"about_ca_topic_score_codex":0.0000011666053,"about_ca_topic_score_gemma":0.000018620533,"teacher_disagreement_score":0.87848175,"about_ca_system_score_codex":0.0000044033213,"about_ca_system_score_gemma":0.00003497261,"threshold_uncertainty_score":0.24809605},"labels":[],"label_agreement":null},{"id":"W2988018214","doi":"10.1182/blood-2019-122053","title":"Pulmonary Embolism Home Treatment: What GP Want?","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Healthcare Systems and Practices","field":"Health Professions","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Pulmonary embolism; Pediatrics; Clinical trial; Family medicine; Emergency medicine; Outpatient clinic; Internal medicine","score_opus":0.07305769164123779,"score_gpt":0.42413232643233456,"score_spread":0.3510746347910968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988018214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9087071,0.0043627103,0.0000014419473,0.0060942727,0.0031107762,0.0011934413,0.000026265652,0.00014369155,0.076360315],"genre_scores_gemma":[0.9685959,0.002633614,0.00006878147,0.00086443184,0.0009746421,0.0001431168,0.000025689707,0.000038093076,0.026655722],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99759614,0.00086093025,0.00044051794,0.00032173397,0.0002060798,0.0005745656],"domain_scores_gemma":[0.99825484,0.0006953618,0.00023496097,0.0005203357,0.00008081682,0.00021366814],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005576236,0.00017540513,0.0003619951,0.000075805016,0.00040083638,0.000035203237,0.00013745925,0.00026916075,0.0020177204],"category_scores_gemma":[0.000043954446,0.00013130478,0.00007754601,0.00014197825,0.000013621946,0.00071885483,0.000053399246,0.0003488125,0.009240687],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031033155,0.0028981052,0.6718884,0.0036519114,0.00063848554,0.0006432892,0.046881244,0.0000020682805,0.0043563335,0.017341599,0.0035209302,0.2478673],"study_design_scores_gemma":[0.002447927,0.00033011223,0.04212986,0.0006362881,0.000076130054,0.000060086102,0.011399205,0.000014968574,0.00008818973,0.0005497701,0.94198,0.00028748132],"about_ca_topic_score_codex":0.0011359451,"about_ca_topic_score_gemma":0.00009576138,"teacher_disagreement_score":0.93845904,"about_ca_system_score_codex":0.00006684378,"about_ca_system_score_gemma":0.00034565167,"threshold_uncertainty_score":0.9988946},"labels":[],"label_agreement":null},{"id":"W2988036010","doi":"10.1182/blood-2019-122970","title":"Thromboprophylaxis for Patients with Newly Diagnosed Vs. Recurrent Cancers: A Post-Hoc Analysis of the Avert Trial","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Placebo; Apixaban; Post-hoc analysis; Randomized controlled trial; Chemotherapy; Cancer; Proportional hazards model; Surgery; Clinical endpoint; Warfarin; Confidence interval; Rivaroxaban","score_opus":0.007824736861508114,"score_gpt":0.23928304304930934,"score_spread":0.23145830618780122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988036010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99482936,0.0001244252,0.000011345655,0.00026925924,0.0004322632,0.0037647623,0.000115084156,0.000019698542,0.00043379146],"genre_scores_gemma":[0.9986277,0.000082468534,0.00027824394,0.00044516881,0.000093860566,0.00023858741,0.00009560126,0.000024402643,0.00011397221],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986269,0.0000328516,0.00031409963,0.0003286802,0.0004456508,0.00025185474],"domain_scores_gemma":[0.99873257,0.00009462546,0.00022919539,0.0006066284,0.0002635488,0.000073424955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012301038,0.00017164924,0.00075013016,0.0001563468,0.0000563335,0.000015304851,0.00017567522,0.000058305985,0.00019085915],"category_scores_gemma":[0.00007705142,0.00010082937,0.0003698831,0.0006029216,0.00004502792,0.00004872289,0.000065195476,0.00008117225,0.000008049839],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.093917325,0.04297828,0.7748358,0.0015898793,0.040291872,0.000012257863,0.005112233,0.00040930804,0.00056862977,0.0013395807,0.008100434,0.030844366],"study_design_scores_gemma":[0.12725203,0.021634422,0.83445066,0.00021747217,0.012196671,2.1684694e-7,0.0001696248,0.00009161772,0.0004255115,0.000017087812,0.0033173708,0.00022733991],"about_ca_topic_score_codex":0.0004225111,"about_ca_topic_score_gemma":0.0003815362,"teacher_disagreement_score":0.0596148,"about_ca_system_score_codex":0.000073005795,"about_ca_system_score_gemma":0.00014763616,"threshold_uncertainty_score":0.4111702},"labels":[],"label_agreement":null},{"id":"W2988051942","doi":"10.1182/blood-2019-126837","title":"The Global State of Hematopoietic Stem Cell Transplantation for Multiple Myeloma: An Analysis of the Worldwide Network of Blood and Marrow Transplantation (WBMT) Database and the Global Burden of Disease Study","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Multiple myeloma; Transplantation; Disease burden; Internal medicine; Incidence (geometry); Hematopoietic stem cell transplantation; Disease; Oncology","score_opus":0.010122058805244702,"score_gpt":0.26638751228712243,"score_spread":0.25626545348187774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988051942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99384266,0.0012106762,0.00012297566,0.00007398431,0.00002189303,0.0023208088,0.0023707985,0.0000055721603,0.00003064281],"genre_scores_gemma":[0.9991444,0.00044301103,0.00015757763,0.0000055580726,0.000012804118,0.000050939063,0.00015643408,0.000008562704,0.000020751873],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833393,0.00027680982,0.00048146423,0.00024318956,0.00045572218,0.00020888587],"domain_scores_gemma":[0.99842715,0.00052402617,0.0002956134,0.00048299256,0.00015148195,0.00011873902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050463836,0.00015225296,0.00047292348,0.00003604407,0.000096312855,0.000011794981,0.00016500763,0.000025375663,0.0000032926873],"category_scores_gemma":[0.000028042608,0.00007914698,0.00015386983,0.00047133357,0.0002387236,0.000068982175,0.0000294267,0.000053601685,1.2925761e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009013199,0.0012120502,0.98147047,0.0011962755,0.002423291,0.000011136699,0.0017112031,0.0006026544,0.0010740428,0.00014164654,9.65176e-7,0.0011430929],"study_design_scores_gemma":[0.028135043,0.000686258,0.94391423,0.00016768524,0.015926158,0.0000073682513,0.0012335213,0.004722703,0.004972275,0.00015179689,0.0000012528633,0.000081722144],"about_ca_topic_score_codex":0.0006182927,"about_ca_topic_score_gemma":0.0013883325,"teacher_disagreement_score":0.037556227,"about_ca_system_score_codex":0.000012156485,"about_ca_system_score_gemma":0.000089002984,"threshold_uncertainty_score":0.322752},"labels":[],"label_agreement":null},{"id":"W2988058666","doi":"10.1182/blood-2019-122663","title":"Aberrant Cathepsin S Induces a Supportive Immune Microenvironment in Follicular Lymphoma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Spinal Cord Injury BC","funders":"","keywords":"Biology; Molecular biology; Antigen; Genetics","score_opus":0.006916113880574834,"score_gpt":0.20664285257259388,"score_spread":0.19972673869201904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988058666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99550754,0.0020035764,0.000008031865,0.000064405605,0.00006832679,0.00034859302,0.000017933493,0.0000073713786,0.001974209],"genre_scores_gemma":[0.9986303,0.00015926415,0.00022811761,0.00013597398,0.00005526084,0.000050204297,0.000079453435,0.000020950325,0.0006404967],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990583,0.000053178897,0.00020080218,0.00032274832,0.000099777615,0.0002651737],"domain_scores_gemma":[0.99953043,0.0000048593174,0.00006945135,0.00033377207,0.000010509429,0.00005095991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015723586,0.00014582937,0.00015736811,0.000036147943,0.000023872944,0.000012565713,0.00016227752,0.00013040497,0.00012287767],"category_scores_gemma":[0.00001262384,0.00013751195,0.0000887317,0.000054892902,0.00003286341,0.0000027816698,0.00010592847,0.00005428879,0.00013966813],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003325798,0.00041206315,0.009037213,0.000015433057,0.00004734875,0.000017899178,0.00016536732,0.0000029058363,0.9892239,0.000019082901,0.000026588825,0.0009989624],"study_design_scores_gemma":[0.0021948633,0.00026612345,0.033285644,0.000023862412,0.000016428698,0.00003268739,0.00010912344,0.0000023011496,0.9574166,0.000030542145,0.0064357403,0.00018607893],"about_ca_topic_score_codex":0.00005721582,"about_ca_topic_score_gemma":0.000012487469,"teacher_disagreement_score":0.031807274,"about_ca_system_score_codex":0.000012862487,"about_ca_system_score_gemma":0.00004968869,"threshold_uncertainty_score":0.56075746},"labels":[],"label_agreement":null},{"id":"W2988071951","doi":"10.1182/blood-2019-128720","title":"Improved Gvhd Free, Relapse Free Survival Using Dual T-Cell Depletion with ATG and Ptcy in Matched Unrelated Donor RIC Allo-HSCT","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Thymoglobulin; Fludarabine; Busulfan; Internal medicine; Total body irradiation; Gastroenterology; Graft-versus-host disease; Surgery; Cyclophosphamide; Hematopoietic stem cell transplantation; Regimen; Transplantation; Chemotherapy; Tacrolimus","score_opus":0.011807486641891159,"score_gpt":0.22370465771309075,"score_spread":0.2118971710711996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988071951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957045,0.00020245738,0.00040593668,0.0001223819,0.00015128053,0.0008790549,0.000015941881,0.000082925915,0.0024355524],"genre_scores_gemma":[0.9946143,0.000051156792,0.0047790855,0.00005356792,0.00004546751,0.000013322598,0.00006295669,0.000057023255,0.00032311652],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984863,0.00008881046,0.00038217715,0.00041199217,0.0003072832,0.00032344394],"domain_scores_gemma":[0.99900895,0.0001423852,0.00012489731,0.00052500947,0.00006655,0.00013222922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033801293,0.00023173222,0.0004196799,0.00016314872,0.000036894577,0.000023734563,0.0000941472,0.0002167405,0.000105073166],"category_scores_gemma":[0.000045104844,0.000198602,0.000043337706,0.0003154258,0.00004325281,0.00011289393,0.000038462305,0.00028550913,0.000025805892],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006469256,0.0008783304,0.5792797,0.000974531,0.00016689283,0.0003233454,0.0015536648,0.00003932249,0.41594157,0.00009000183,0.000019396972,0.00008632564],"study_design_scores_gemma":[0.09822764,0.002028187,0.775437,0.0010623062,0.0018759724,0.0012447626,0.0012022508,0.0043789893,0.11330757,0.00021404409,0.00004618934,0.0009750977],"about_ca_topic_score_codex":0.0006867856,"about_ca_topic_score_gemma":0.00027394327,"teacher_disagreement_score":0.30263397,"about_ca_system_score_codex":0.000048498583,"about_ca_system_score_gemma":0.00011325356,"threshold_uncertainty_score":0.8098755},"labels":[],"label_agreement":null},{"id":"W2988075996","doi":"10.1182/blood-2019-125963","title":"Combination of DPX-Survivac, Low Dose Cyclophosphamide, and Pembrolizumab in Recurrent/Refractory DLBCL: The Spirel Study","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Health Authority; Queen Elizabeth II Health Sciences Centre; Sunnybrook Health Science Centre; McGill University Health Centre; Ottawa Hospital; Health Sciences Centre","funders":"","keywords":"Medicine; Internal medicine; Cyclophosphamide; Oncology; Pembrolizumab; Refractory (planetary science); Gastroenterology; Chemotherapy; Cancer; Immunotherapy","score_opus":0.0162301028643446,"score_gpt":0.29289021987244734,"score_spread":0.2766601170081027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988075996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921489,0.0011227797,4.195945e-7,0.0001860169,0.00014967982,0.0015895388,0.000003832379,0.000020021365,0.0047788373],"genre_scores_gemma":[0.99799716,0.0003151079,0.000008026279,0.00004294611,0.000043062646,0.000034771936,0.000008075851,0.0000255957,0.0015252486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998544,0.00015948294,0.00030100963,0.00026829142,0.00049736706,0.0002298623],"domain_scores_gemma":[0.9990208,0.00021151059,0.00009209359,0.0004976414,0.000106143125,0.00007181243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006622051,0.0001351899,0.0003240936,0.00014428349,0.000030714935,0.000015852534,0.00014867022,0.00007252036,0.00041781907],"category_scores_gemma":[0.00010797882,0.00009840784,0.000054241787,0.00031873552,0.000073614494,0.00006668942,0.000093435476,0.0003466276,0.000032453914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013443258,0.011521378,0.9261753,0.00024200599,0.00016771414,0.000044467233,0.0024314616,0.0000012552487,0.030575212,0.00013244784,0.000075900345,0.027288519],"study_design_scores_gemma":[0.026968542,0.0022299152,0.96521336,0.000117850555,0.00006909659,0.00001653713,0.0006629752,0.00007691272,0.0038038401,0.00011624188,0.0006121241,0.000112580594],"about_ca_topic_score_codex":0.00026092693,"about_ca_topic_score_gemma":0.000096154676,"teacher_disagreement_score":0.03903807,"about_ca_system_score_codex":0.000042645308,"about_ca_system_score_gemma":0.00009357898,"threshold_uncertainty_score":0.45748258},"labels":[],"label_agreement":null},{"id":"W2988081637","doi":"10.1182/blood.v104.11.4311.4311","title":"Disordered Expression of HIPK Family Members in MDS and AML.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Ontario Institute for Cancer Research","funders":"","keywords":"Cancer research; Chronic myelomonocytic leukemia; Biology; Decitabine; Progenitor cell; Leukemia; Homeobox; Myelodysplastic syndromes; Bone marrow; Haematopoiesis; Wnt signaling pathway; Myeloid; Kinase; Transcription factor; Stem cell; Immunology; Gene expression; Signal transduction; Gene; DNA methylation; Genetics","score_opus":0.01518243877398224,"score_gpt":0.27821898739353446,"score_spread":0.2630365486195522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988081637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99366856,0.0008018989,0.000018720115,0.00043280987,0.000015206647,0.00023645432,0.0000036586325,0.000018558538,0.004804146],"genre_scores_gemma":[0.9977423,0.00026130432,0.0016975239,0.00007061715,0.00002741089,0.000012573237,0.000007017114,0.000014491108,0.00016678964],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992424,0.00002257259,0.00016578057,0.00016704491,0.00021832071,0.0001838527],"domain_scores_gemma":[0.9996104,0.00003705252,0.000030974552,0.00020015716,0.00003228006,0.00008914095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013046767,0.00007894381,0.00019788468,0.000121762736,0.000016888525,0.000004059573,0.00006269368,0.00007927489,0.000026490678],"category_scores_gemma":[0.00011042693,0.00006438134,0.000027123247,0.00018149671,0.00007795952,0.000045267716,0.00006732693,0.00017607218,0.000005731563],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029621995,0.0010268415,0.074958235,0.00027376745,0.000040983476,0.00018503526,0.0014700602,0.000020909227,0.9180979,0.00025466512,0.0004158179,0.0029595806],"study_design_scores_gemma":[0.04316693,0.0008401613,0.3667233,0.0008392764,0.000110678884,0.000092882416,0.0018968473,0.00005935699,0.58325326,0.0013963437,0.0013549046,0.0002660692],"about_ca_topic_score_codex":0.00038103023,"about_ca_topic_score_gemma":0.00003212504,"teacher_disagreement_score":0.33484462,"about_ca_system_score_codex":0.000045090244,"about_ca_system_score_gemma":0.00014016984,"threshold_uncertainty_score":0.26253948},"labels":[],"label_agreement":null},{"id":"W2988107977","doi":"10.1182/blood-2019-126354","title":"Validation of the Plasmic Score for Predicting ADAMTS13 Activity &lt; 10% in Patients Admitted to Hospitals in Alberta with Suspected Thrombotic Thrombocytopenic Purpura","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Alberta","funders":"","keywords":"ADAMTS13; Thrombotic thrombocytopenic purpura; Medicine; Thrombotic microangiopathy; Internal medicine; Population; Thrombosis; Cohort; Apheresis; Retrospective cohort study; Gastroenterology; Platelet; Pediatrics; Disease","score_opus":0.00964482655319915,"score_gpt":0.22571565814666983,"score_spread":0.21607083159347068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988107977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963456,0.000029804083,0.0000027140206,0.00008771089,0.00020251141,0.0030878577,0.00007680297,0.00001845485,0.00014856666],"genre_scores_gemma":[0.9995262,5.5066687e-7,0.000015413398,0.00001679632,0.000006532522,0.00014197135,0.00009559847,0.000019425466,0.00017750653],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878234,0.00018374113,0.00034133976,0.00032452046,0.000072135714,0.0002959067],"domain_scores_gemma":[0.9989415,0.0003110224,0.00023155226,0.00041134757,0.000088401306,0.000016181442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014103319,0.00016340292,0.00036565354,0.00011497866,0.000049194347,0.000010127119,0.00029876071,0.00009133871,0.0002541238],"category_scores_gemma":[0.00025104437,0.00012132307,0.00005884081,0.0003249712,0.000038282986,0.00012308838,0.00013058585,0.00010626388,0.0000468912],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003203463,0.0006933338,0.9471686,0.00007275634,0.000109873625,1.8149196e-7,0.00029834907,0.00006372497,0.05112227,0.000038886912,0.00007329974,0.000038413247],"study_design_scores_gemma":[0.006308239,0.0006467866,0.8783753,0.0003454079,0.00006758051,0.0000013021096,0.00007671142,0.0000079865895,0.11400677,0.000022288612,0.00001317503,0.00012845904],"about_ca_topic_score_codex":0.000440013,"about_ca_topic_score_gemma":0.001331597,"teacher_disagreement_score":0.068793274,"about_ca_system_score_codex":0.0000661662,"about_ca_system_score_gemma":0.00009635216,"threshold_uncertainty_score":0.4947411},"labels":[],"label_agreement":null},{"id":"W2988147901","doi":"10.1182/blood-2019-123488","title":"Ofatumumab Plus Hypercvad/MA Induction Leads to High Rates of Minimal Residual Disease (MRD) Negativity in Patients with Newly Diagnosed Mantle Cell Lymphoma, Results of a Phase 2 Study","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre","funders":"","keywords":"Medicine; Ofatumumab; Rituximab; Mantle cell lymphoma; Internal medicine; Minimal residual disease; Autologous stem-cell transplantation; Oncology; Surgery; Gastroenterology; Transplantation; Lymphoma; Leukemia","score_opus":0.012344596887827346,"score_gpt":0.2569605922094742,"score_spread":0.24461599532164685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988147901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971138,0.00007082793,3.0636397e-7,0.0001075523,0.00007771723,0.002192333,0.00025942962,0.000018128436,0.00015986677],"genre_scores_gemma":[0.9992539,0.000006858996,0.00025389955,0.000034662226,0.00004096035,0.00011054152,0.00014492807,0.00002797659,0.00012623581],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981444,0.00010798488,0.00050440343,0.00047086878,0.0005138464,0.00025849533],"domain_scores_gemma":[0.998717,0.00015395318,0.00022873348,0.0005314792,0.00016442251,0.00020441518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013986725,0.00024405279,0.00060168246,0.00021513202,0.000027420918,0.000010383901,0.00009585656,0.00006472249,0.000023784734],"category_scores_gemma":[0.00011856576,0.0001835541,0.0000653188,0.00036866142,0.00004859408,0.00011714875,0.000064395565,0.000055653272,0.000021533915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015387342,0.06979339,0.9102364,0.00012256113,0.00014038137,0.00015677065,0.0012733763,0.000026707201,0.0010673692,0.000004316737,0.00015087191,0.0016405177],"study_design_scores_gemma":[0.1786466,0.009891187,0.7775087,0.0001982093,0.00042817998,0.0000011038995,0.00039012276,0.0000059213003,0.03277781,0.0000025974346,0.000009722304,0.00013988964],"about_ca_topic_score_codex":0.0014875883,"about_ca_topic_score_gemma":0.00015368812,"teacher_disagreement_score":0.16325925,"about_ca_system_score_codex":0.00013399764,"about_ca_system_score_gemma":0.00029608633,"threshold_uncertainty_score":0.7485119},"labels":[],"label_agreement":null},{"id":"W2988183880","doi":"10.1182/blood-2019-123949","title":"Dual CD20-Targeted Therapy With Concurrent CD20-TCB and Obinutuzumab Shows Highly Promising Clinical Activity and Manageable Safety in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma: Preliminary Results From a Phase Ib Trial","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Obinutuzumab; Medicine; CD20; Refractory (planetary science); Lymphoma; Oncology; Phases of clinical research; Rituximab; Internal medicine; Clinical trial; Cancer research; Biology","score_opus":0.03937115457596355,"score_gpt":0.3341516338312315,"score_spread":0.2947804792552679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988183880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922467,0.0010882515,0.000009837224,0.00020591546,0.00038705085,0.004624959,0.00020377069,0.0000852047,0.0011483368],"genre_scores_gemma":[0.99339616,0.0013379694,0.00055048225,0.000096948854,0.0005358173,0.00008955061,0.00016439825,0.00009643888,0.0037322429],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99576664,0.00063708704,0.0009441997,0.001282282,0.0007091835,0.0006605863],"domain_scores_gemma":[0.9966484,0.0016071815,0.00036079923,0.0008771428,0.00010902871,0.00039750212],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017435937,0.0004761628,0.0011973889,0.00023449406,0.0001161902,0.000086059605,0.0001741833,0.0004202121,0.0003399439],"category_scores_gemma":[0.00025242846,0.0003507831,0.00013403925,0.00035851635,0.00027733773,0.0002272632,0.00016540142,0.00082097086,0.000014495958],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.803779,0.0106932605,0.002429284,0.0001438017,0.00044024183,0.0007318343,0.0013660201,0.0000025949569,0.10198113,0.0000017266881,0.00027445322,0.07815664],"study_design_scores_gemma":[0.88491124,0.051380727,0.028874686,0.0005232602,0.0003020825,0.0001030739,0.00025884266,0.0019582293,0.025629591,0.000011642286,0.0054463213,0.0006003303],"about_ca_topic_score_codex":0.00081233314,"about_ca_topic_score_gemma":0.00016012718,"teacher_disagreement_score":0.08113221,"about_ca_system_score_codex":0.00025625262,"about_ca_system_score_gemma":0.0010462998,"threshold_uncertainty_score":0.99989444},"labels":[],"label_agreement":null},{"id":"W2988190468","doi":"10.1182/blood-2019-127839","title":"NUP98-HOXA9-Initiates Molecular and Biologic Features of Disease Progression in a Humanized Model of CML","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Clonogenic assay; Myeloid leukemia; Haematopoiesis; Cancer research; Myeloid; Stem cell; Biology; CD34; Progenitor cell; Immunology; Leukemia; clone (Java method); Cell culture; Cell biology; Gene","score_opus":0.013251522429729034,"score_gpt":0.27452625005757514,"score_spread":0.2612747276278461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988190468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99544203,0.0034198167,0.0000034548218,0.00005631327,0.000010874031,0.00056222355,0.000021507174,0.000017030037,0.00046673953],"genre_scores_gemma":[0.9985502,0.00009912932,0.0011565265,0.000038090817,0.000006935594,0.000021669002,0.000037497808,0.000012693954,0.00007728013],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9993124,0.00002906755,0.00018744596,0.00019750072,0.00013980934,0.00013379859],"domain_scores_gemma":[0.9995333,0.000030785806,0.0000910296,0.00023934558,0.000035333152,0.00007021669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000063228625,0.00010769699,0.0003036452,0.0000838169,0.000007668316,0.0000023520722,0.00005089988,0.000066297966,0.000023101831],"category_scores_gemma":[0.000058366208,0.000080240956,0.000052162886,0.000077958364,0.00005625292,0.000026504285,0.000052995427,0.000077018885,0.000002668986],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013022155,0.0029603643,0.4725977,0.0012602474,0.00024816487,0.00012672054,0.00048223237,0.00005955725,0.5174897,0.00077877246,0.000026596836,0.0026677775],"study_design_scores_gemma":[0.058873236,0.0022446522,0.49467352,0.0025969748,0.0010162866,0.00003125496,0.00015384688,0.004050446,0.43304187,0.0029172373,0.000013252653,0.00038741922],"about_ca_topic_score_codex":0.00001867266,"about_ca_topic_score_gemma":0.0000024264525,"teacher_disagreement_score":0.08444778,"about_ca_system_score_codex":0.000030191813,"about_ca_system_score_gemma":0.00013897727,"threshold_uncertainty_score":0.3272131},"labels":[],"label_agreement":null},{"id":"W2988198068","doi":"10.1182/blood-2019-130923","title":"HSCs Fated to Progress to Blast Phase Can be Detected in Myelofibrosis Patients Several Years Prior to Leukemic Transformation","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Princess Margaret Cancer Centre; Health Sciences Centre; University Health Network","funders":"","keywords":"Myelofibrosis; Myeloid leukemia; Biology; clone (Java method); Germline mutation; Myeloid; Mutation; Somatic cell; Genetics; Leukemia; Cancer research; Bone marrow; Gene; Immunology","score_opus":0.009582577477515187,"score_gpt":0.26604903559907406,"score_spread":0.2564664581215589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988198068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947609,0.0000107248015,0.000016140197,0.0011487524,0.00008319388,0.0036406238,0.00015085815,0.00006258626,0.00012627266],"genre_scores_gemma":[0.99698406,0.0000040011605,0.0012304594,0.0009279082,0.000031069147,0.00050396007,0.00017666309,0.0000311001,0.000110752044],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985677,0.000038150785,0.00034054415,0.00034856627,0.0003417644,0.00036329383],"domain_scores_gemma":[0.9992175,0.000025486597,0.000043663735,0.00022679256,0.00013684784,0.00034970124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006648583,0.00021114644,0.00033624383,0.00028314572,0.000036054083,0.000031973756,0.00007927818,0.00008207607,0.00008283367],"category_scores_gemma":[0.00004399671,0.00018927133,0.000052145322,0.0005857172,0.0000092257715,0.00007872998,0.000028678664,0.00010103693,0.00018672345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028754692,0.008959041,0.85679364,0.00022000198,0.0003446133,0.000076235454,0.025107298,0.00018666431,0.038032643,0.000023664237,0.00075600983,0.0666247],"study_design_scores_gemma":[0.02258294,0.0055470085,0.827166,0.00038111518,0.00013245243,0.000007660901,0.00015447768,0.000081023565,0.14213608,0.0000013463106,0.0015172211,0.00029264358],"about_ca_topic_score_codex":0.0001563804,"about_ca_topic_score_gemma":0.00045062898,"teacher_disagreement_score":0.104103446,"about_ca_system_score_codex":0.00023291055,"about_ca_system_score_gemma":0.000121030986,"threshold_uncertainty_score":0.7718261},"labels":[],"label_agreement":null},{"id":"W2988207531","doi":"10.1182/blood-2019-128283","title":"The Canadian Tyrosine Kinase Inhibitor Discontinuation Trial with Imatinib Discontinuation As a First Attempt and with Dasatinib Discontinuation As a Second Attempt of Treatment-Free Remission: Results of 4 Years of Follow-up","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; McGill University Health Centre; London Health Sciences Centre; University of Toronto; Western University; Juravinski Cancer Centre; Hôpital de l'Enfant-Jésus; Princess Margaret Cancer Centre; Vancouver General Hospital; University of Calgary; BC Cancer Agency; Alberta Health Services; Alberta Hospital Edmonton; University of British Columbia; Université de Montréal; Hôpital Maisonneuve-Rosemont; CancerCare Manitoba; University of Alberta Hospital; University Health Network; Ottawa Hospital; Dalhousie University","funders":"","keywords":"Discontinuation; Medicine; Dasatinib; Internal medicine; Imatinib; Oncology","score_opus":0.010774978578036299,"score_gpt":0.2412208297980505,"score_spread":0.2304458512200142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988207531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936111,0.0002167153,0.0000022995491,0.00077068276,0.00011355068,0.0031043766,0.00026224655,0.000018176195,0.0019008416],"genre_scores_gemma":[0.99451697,0.00003937492,0.0004655845,0.00001540819,0.000117759744,0.000120575656,0.00040426725,0.000048169666,0.0042718975],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99758345,0.0000946948,0.00089531287,0.0005039554,0.00059739035,0.00032518955],"domain_scores_gemma":[0.99709857,0.00038855852,0.0010127854,0.0010226055,0.00026270878,0.0002147762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045272766,0.0003227955,0.00073025835,0.00018023505,0.00012818557,0.000038978094,0.00016134263,0.00014842938,0.00007277688],"category_scores_gemma":[0.0005737786,0.00020342259,0.00011610011,0.00032902858,0.00023158197,0.00022955023,0.000048507456,0.00013443868,0.0000065813774],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34085247,0.0110368375,0.4539816,0.0014242952,0.0071023973,0.00027916723,0.04836717,0.00006319789,0.07091013,0.0015181642,0.0025878963,0.061876677],"study_design_scores_gemma":[0.6641453,0.04291554,0.15271065,0.0042521404,0.002716694,0.00013168053,0.002840362,0.00020097001,0.12736225,0.00012569342,0.0019127389,0.00068601116],"about_ca_topic_score_codex":0.041721903,"about_ca_topic_score_gemma":0.25349808,"teacher_disagreement_score":0.32329282,"about_ca_system_score_codex":0.00038622695,"about_ca_system_score_gemma":0.0016215981,"threshold_uncertainty_score":0.96465933},"labels":[],"label_agreement":null},{"id":"W2988213207","doi":"10.1182/blood-2019-131211","title":"Clinical and Functional Studies Reveal That TP73 Isoforms Levels Are Associated with Prognosis and RA-Resistance in Acute Promyelocytic Leukemia","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Acute promyelocytic leukemia; Hazard ratio; Biology; Bone marrow; Survival analysis; Internal medicine; Leukemia; Oncology; Gene isoform; Proportional hazards model; Clinical significance; Immunology; Peripheral blood mononuclear cell; Cancer research; Medicine; Gastroenterology; In vitro; Cell culture; Confidence interval; Gene; Genetics; Retinoic acid","score_opus":0.025282079584638222,"score_gpt":0.26895799484760224,"score_spread":0.24367591526296403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988213207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936514,0.0056732427,0.000014601098,0.00008122089,0.0000561297,0.0003126088,0.000015732337,0.000012531728,0.00018253978],"genre_scores_gemma":[0.9965245,0.0009151849,0.00031014206,0.000114366194,0.00006476554,0.000053641626,0.000032021788,0.000019058978,0.001966297],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988781,0.000047179026,0.0002326829,0.00046158727,0.00015328379,0.00022713107],"domain_scores_gemma":[0.9994836,0.00004786267,0.00014988559,0.000161372,0.00010007196,0.000057210913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003096511,0.00017889,0.00030257,0.00002731952,0.000063631014,0.000028434699,0.00007700845,0.00019052796,0.000003231714],"category_scores_gemma":[0.00014393085,0.00013220981,0.000038086746,0.00008822982,0.0002142673,0.000011496607,0.00010082337,0.00015941438,0.0000016750394],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015692896,0.00010271663,0.985652,0.00016433866,0.00045304757,0.000019135743,0.000069947055,0.0000015115227,0.012889084,0.000017849477,0.00026733289,0.00020605107],"study_design_scores_gemma":[0.0056464975,0.00056217745,0.9228642,0.00040483716,0.00021890442,0.000037687747,0.000347199,0.0000070923493,0.06883211,0.00023966245,0.0004625168,0.0003770985],"about_ca_topic_score_codex":0.0000015582781,"about_ca_topic_score_gemma":0.00005730265,"teacher_disagreement_score":0.06278784,"about_ca_system_score_codex":0.000025351084,"about_ca_system_score_gemma":0.00016183958,"threshold_uncertainty_score":0.53913593},"labels":[],"label_agreement":null},{"id":"W2988213253","doi":"10.1182/blood-2019-124663","title":"The Diagnostic Performance of a Non-Emergency Department-Based Deep Vein Thrombosis Ambulatory Care Pathway","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; McGill University; Université de Montréal","funders":"","keywords":"Medicine; Emergency department; Ambulatory; Deep vein; Ambulatory care; Emergency medicine; Thrombosis; Intensive care medicine; Internal medicine; Health care","score_opus":0.006433805893343031,"score_gpt":0.23128198119469118,"score_spread":0.22484817530134815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988213253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99166006,0.0023323656,0.0000115520415,0.00013352143,0.0004037371,0.001067159,0.000013041019,0.000040496634,0.004338069],"genre_scores_gemma":[0.9981719,0.0011403711,0.00013046073,0.00014749182,0.00007795309,0.0001579792,0.000038302867,0.00003187118,0.000103672675],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986862,0.000028969685,0.00033443805,0.00025984505,0.0003586374,0.00033192715],"domain_scores_gemma":[0.9988878,0.00013110116,0.00013861635,0.00062728813,0.00012137907,0.000093855946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014758049,0.00018153907,0.0003852804,0.000061716215,0.00013055181,0.000010446333,0.00018283461,0.000064411346,0.00026000626],"category_scores_gemma":[0.0000602858,0.00012869056,0.00015953674,0.0001719762,0.000048923204,0.00005090667,0.000069353104,0.00010939435,0.00017385013],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058188903,0.0033479957,0.97477084,0.0017790268,0.0006955375,0.00001943213,0.0014337535,0.0003999918,0.007973773,0.00037073647,0.0016497918,0.0075009074],"study_design_scores_gemma":[0.0031090626,0.0016715996,0.95045626,0.00030374096,0.0007094951,0.0000017834656,0.0006846761,0.00060490135,0.036006905,0.000007685867,0.0062143896,0.0002295026],"about_ca_topic_score_codex":0.000045296918,"about_ca_topic_score_gemma":0.000036174468,"teacher_disagreement_score":0.02803313,"about_ca_system_score_codex":0.00003781787,"about_ca_system_score_gemma":0.00009894416,"threshold_uncertainty_score":0.52478486},"labels":[],"label_agreement":null},{"id":"W2988223869","doi":"10.1182/blood-2019-126893","title":"The Clinical Application of Oncomine Myeloid Next Generation Sequencing (NGS): Comparison of Cytogenetics and NGS in Patients with Suspected Myelodysplastic Syndrome","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Medicine; Myelodysplastic syndromes; Cytopenia; Internal medicine; Oncology; Myeloid leukemia; Cytogenetics; Population; Bone marrow; Biology","score_opus":0.04062848644944022,"score_gpt":0.31365860310070515,"score_spread":0.2730301166512649,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988223869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984723,0.0001511363,0.00017664694,0.000074026335,0.000029275576,0.000986658,0.000006412871,0.000010761069,0.00009282619],"genre_scores_gemma":[0.9982289,0.00005604135,0.0015262645,0.000016406679,0.000037526188,0.000018239862,0.000061702805,0.000021015829,0.000033887976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840575,0.00009750493,0.0006418762,0.00025515782,0.00040294568,0.00019676758],"domain_scores_gemma":[0.9986704,0.00033383258,0.00026880138,0.0003771509,0.0002713118,0.00007851043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040844714,0.00012001351,0.0004318899,0.0001023999,0.000036439906,0.000011284469,0.00011638086,0.00011212811,0.0000062299587],"category_scores_gemma":[0.00017828187,0.00008276752,0.00003076079,0.00031222586,0.00016085437,0.00005134767,0.00006583519,0.00027352248,0.000006866617],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041573503,0.0005679892,0.9550653,0.000102146776,0.000080926606,0.000002755432,0.00015075464,0.00004727745,0.04106498,0.00006313286,0.000014462706,0.0024245558],"study_design_scores_gemma":[0.010393404,0.0030087545,0.95729464,0.00010485167,0.00014111286,0.000018170691,0.00016077734,0.011562506,0.017168285,0.00001012127,0.000036858055,0.00010049396],"about_ca_topic_score_codex":0.000079631456,"about_ca_topic_score_gemma":0.00009864721,"teacher_disagreement_score":0.023896694,"about_ca_system_score_codex":0.000101981386,"about_ca_system_score_gemma":0.0002586591,"threshold_uncertainty_score":0.33751613},"labels":[],"label_agreement":null},{"id":"W2988244627","doi":"10.1182/blood-2019-131599","title":"Comprehensive Analysis of Hematological Parameter Changes after TKI Discontinuation for Treatment-Free Remission Attempt","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; McGill University Health Centre; London Health Sciences Centre; Juravinski Cancer Centre; Hôpital de l'Enfant-Jésus; Dalhousie University; Princess Margaret Cancer Centre; Vancouver General Hospital; University of Calgary; BC Cancer Agency; Alberta Health Services; Alberta Hospital Edmonton; University of British Columbia; Université de Montréal; Hôpital Maisonneuve-Rosemont; CancerCare Manitoba; University of Alberta Hospital; University Health Network; Ottawa Hospital; Western University; University of Toronto","funders":"","keywords":"Discontinuation; Medicine; Leukopenia; Adverse effect; Internal medicine; Dasatinib; Gastroenterology; Imatinib; Immunology; Chemotherapy","score_opus":0.028937070154508786,"score_gpt":0.29384906614162654,"score_spread":0.26491199598711773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988244627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99746513,0.00060566637,0.00004169236,0.00044920112,0.00004334152,0.0010340583,0.00008465489,0.00003156614,0.00024466735],"genre_scores_gemma":[0.9956377,0.000056123892,0.00248028,0.00009892367,0.000041277624,0.00019590212,0.0002907132,0.000016384558,0.0011827077],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989904,0.00003303023,0.0002465838,0.0003403699,0.00018706123,0.00020256621],"domain_scores_gemma":[0.9987618,0.00028208917,0.0001415431,0.0006425655,0.00009285685,0.00007919234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000043727712,0.0001790523,0.0007185348,0.0001690589,0.000018883085,0.0000067981,0.000071799484,0.00011883349,0.00031623358],"category_scores_gemma":[0.00008009912,0.00011886623,0.0002946961,0.00023445164,0.0000338305,0.000034224162,0.000041090094,0.00003356484,0.000018612593],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014924922,0.0034130272,0.94884175,0.00033272145,0.009273244,0.00006282627,0.0007728733,0.000011102775,0.029086914,0.00006560818,0.00029546756,0.0063519534],"study_design_scores_gemma":[0.05116908,0.006239133,0.7423397,0.00042188098,0.030433407,0.00006601238,0.0003716061,0.0022202006,0.16142699,0.00020557053,0.004615841,0.0004905904],"about_ca_topic_score_codex":0.000044279313,"about_ca_topic_score_gemma":0.000045379693,"teacher_disagreement_score":0.20650208,"about_ca_system_score_codex":0.00013355193,"about_ca_system_score_gemma":0.000047566584,"threshold_uncertainty_score":0.4847224},"labels":[],"label_agreement":null},{"id":"W2988276663","doi":"10.1182/blood.v112.11.4683.4683","title":"“Painless” Bone Marrow Aspiration by Slow Suctioning Does Not Affect Peripheral Blood Contamination of the Specimen: Randomized Prospective Crossover Trials","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Hematological disorders and diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Syringe; Crossover study; Anesthesia; Surgery; Randomized controlled trial; Visual analogue scale; Suction; Pulmonary aspiration; Placebo","score_opus":0.019268882897720222,"score_gpt":0.2693426660411734,"score_spread":0.2500737831434532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988276663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99375486,0.00077224796,0.00061088067,0.0007128774,0.00020011647,0.002089979,0.000037778533,0.000047803074,0.0017734512],"genre_scores_gemma":[0.9975568,0.00013851988,0.00035378817,0.00029136732,0.00015559928,0.00014244612,0.000030790026,0.000016795364,0.001313869],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99803066,0.0004698742,0.0006488255,0.00025953347,0.00039548383,0.00019562212],"domain_scores_gemma":[0.99790305,0.0012072508,0.000405563,0.00021587788,0.00020607511,0.00006217868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010973365,0.00018159936,0.0010379932,0.00003988243,0.00019892011,0.000025386174,0.00006639892,0.00015279072,0.00019026014],"category_scores_gemma":[0.007941075,0.00009698864,0.00034851753,0.00016894452,0.00029870524,0.000094785646,0.000027143959,0.00016843544,0.0000052093524],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12779582,0.019521605,0.3273313,0.0008579739,0.003291691,0.00030145634,0.0065732743,0.00007383517,0.48602054,0.018604351,0.007968923,0.001659215],"study_design_scores_gemma":[0.4188964,0.0011460725,0.057968564,0.00025453855,0.0018056688,0.00018133536,0.00025789632,0.00017867409,0.5181873,0.0006135449,0.00019909958,0.00031090758],"about_ca_topic_score_codex":0.00003873012,"about_ca_topic_score_gemma":0.000013682087,"teacher_disagreement_score":0.2911006,"about_ca_system_score_codex":0.000025329016,"about_ca_system_score_gemma":0.00007935342,"threshold_uncertainty_score":0.9506782},"labels":[],"label_agreement":null},{"id":"W2988277843","doi":"10.1182/blood-2019-124349","title":"Pomalidomide + Bortezomib + Low-Dose Dexamethasone after 1 Prior Line of Therapy in Patients with Lenalidomide-Pretreated Multiple Myeloma: Subanalysis of the Phase 3 Optimismm Trial By Patient Age and Prior Stem Cell Transplant","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Fleurimont; Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Lenalidomide; Medicine; Pomalidomide; Bortezomib; Population; Dexamethasone; Internal medicine; Clinical endpoint; Multiple myeloma; Phases of clinical research; Surgery; Gastroenterology; Clinical trial","score_opus":0.009879637305894647,"score_gpt":0.23855475843797677,"score_spread":0.22867512113208213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988277843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99453366,0.00070302124,0.000007786736,0.000033143384,0.000031212487,0.0041568656,0.00049828045,0.000014201226,0.000021802784],"genre_scores_gemma":[0.99889153,0.00015377933,0.0004428751,0.000033660122,0.000013397203,0.0001480476,0.00015569617,0.000046012727,0.00011499348],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99738514,0.00025896277,0.0007479935,0.00048295478,0.00071271893,0.0004122414],"domain_scores_gemma":[0.9983834,0.00024788757,0.0003504058,0.0006363592,0.00017215159,0.00020978332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002253225,0.00034505615,0.0009391888,0.00021130852,0.000038419243,0.00001563023,0.00015451289,0.00013566317,0.00007715653],"category_scores_gemma":[0.000035498575,0.0002002275,0.00021676855,0.00042551977,0.00013619818,0.0000887876,0.000044964305,0.00021766525,0.0000024361123],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26041377,0.017752936,0.6778297,0.0002753649,0.0011175316,0.0001692384,0.0015265773,0.000019845935,0.027354969,1.7408968e-7,0.000005973774,0.013533934],"study_design_scores_gemma":[0.49186844,0.007969355,0.22457469,0.00032511703,0.0005924334,0.0000041282096,0.00009702267,0.00034649178,0.27400833,5.493449e-7,0.000010514646,0.00020290623],"about_ca_topic_score_codex":0.0003338195,"about_ca_topic_score_gemma":0.00007606987,"teacher_disagreement_score":0.453255,"about_ca_system_score_codex":0.000049515245,"about_ca_system_score_gemma":0.00012319375,"threshold_uncertainty_score":0.81650406},"labels":[],"label_agreement":null},{"id":"W2988309127","doi":"10.1182/blood-2019-128746","title":"One-Year Efficacy and Safety from a Phase 3 Trial of Ravulizumab in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria Receiving Prior Eculizumab Treatment","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Eculizumab; Medicine; Hemoglobinuria; Clinical trial; Internal medicine; Pediatrics; Anemia; Immunology; Antibody","score_opus":0.009088850169246068,"score_gpt":0.23724683893009055,"score_spread":0.22815798876084448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988309127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99689394,0.00035466853,0.0000029329194,0.000024187422,0.00024763346,0.0018450302,0.0003814236,0.000027046452,0.0002231273],"genre_scores_gemma":[0.9993207,0.00002795719,0.00013734658,0.000010251953,0.00003501225,0.000042308064,0.0003407315,0.000018735009,0.00006699208],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9984837,0.00023789285,0.0005120396,0.0003969834,0.00008201431,0.00028738054],"domain_scores_gemma":[0.99905574,0.00021851264,0.00025939546,0.00035996657,0.000067985624,0.00003840015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000076718046,0.00022293604,0.0005358545,0.00008840153,0.000057457357,0.000013449333,0.00014552491,0.00011675713,0.00068553194],"category_scores_gemma":[0.000064711334,0.000181716,0.00007040296,0.00009236549,0.00006933815,0.00007100213,0.00006490226,0.00010661607,0.000062810854],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34211454,0.027873058,0.58685285,0.00014149559,0.0021409108,0.000014454978,0.0025231927,0.000008234529,0.019137908,0.00010718135,0.00007185704,0.01901434],"study_design_scores_gemma":[0.6965963,0.0062813335,0.28667787,0.00035072252,0.0003510841,0.0000037882141,0.00016513784,0.000001620988,0.008885676,0.000013795945,0.0004151388,0.00025754515],"about_ca_topic_score_codex":0.00032827296,"about_ca_topic_score_gemma":0.00012614,"teacher_disagreement_score":0.35448176,"about_ca_system_score_codex":0.00007528144,"about_ca_system_score_gemma":0.000107682674,"threshold_uncertainty_score":0.7506094},"labels":[],"label_agreement":null},{"id":"W2988313448","doi":"10.1182/blood-2019-123406","title":"Long-Term Safety and Efficacy of Mitapivat (AG-348), a Pyruvate Kinase Activator, in Patients with Pyruvate Kinase Deficiency: The DRIVE PK Study","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pyruvate kinase deficiency; Medicine; Pyruvate kinase; Adverse effect; Internal medicine; Anemia; Glucose-6-phosphate dehydrogenase deficiency; Gastroenterology; Pediatrics; Glycolysis; Metabolism","score_opus":0.00802904632412506,"score_gpt":0.2297125436749147,"score_spread":0.22168349735078963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988313448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997551,0.00014609928,0.0000042502784,0.00010601331,0.00013575921,0.0016526524,0.000014438608,0.00003266514,0.0003570697],"genre_scores_gemma":[0.99943566,0.000033944103,0.000031709787,0.00023666605,0.00003278563,0.000019165675,0.000032318327,0.000028880562,0.00014886353],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845886,0.00013370981,0.00035947477,0.00044319785,0.00030033558,0.00030442575],"domain_scores_gemma":[0.9988318,0.00017868463,0.00018611357,0.00057740236,0.00012023379,0.00010573973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016871518,0.00024142227,0.0004865393,0.0001332733,0.00007762215,0.000010452704,0.00012513742,0.00009182289,0.00009283136],"category_scores_gemma":[0.000082167884,0.00014804438,0.00006108586,0.0003678114,0.00015376056,0.00008459712,0.00010159875,0.000287729,0.000029626066],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031186794,0.0050452496,0.9770894,0.00009102378,0.000109639914,0.00004427979,0.0016026146,0.00000833535,0.01193742,0.000036027388,0.000010739816,0.0009065597],"study_design_scores_gemma":[0.02501709,0.0041224933,0.9666077,0.00015676503,0.00019978257,0.0000038930407,0.00043870872,0.0000059344306,0.00322471,0.0000066376538,0.000051247727,0.00016506869],"about_ca_topic_score_codex":0.00005485492,"about_ca_topic_score_gemma":0.00004141241,"teacher_disagreement_score":0.021898411,"about_ca_system_score_codex":0.000029702409,"about_ca_system_score_gemma":0.00008260635,"threshold_uncertainty_score":0.60370743},"labels":[],"label_agreement":null},{"id":"W2988337912","doi":"10.1182/blood-2019-131526","title":"Mutation of Murine Rpl5 reveals a New Model for Diamond Blackfan Anemia Characterized By Defective Erythropoiesis","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Diamond–Blackfan anemia; Haploinsufficiency; Erythropoiesis; Biology; Ineffective erythropoiesis; Mutant; Genetics; Mutation; Anemia; Molecular biology; Ribosome; Gene; Internal medicine; Medicine; RNA; Phenotype","score_opus":0.008289171235578846,"score_gpt":0.2428087620234283,"score_spread":0.23451959078784945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988337912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97894317,0.0005501714,0.019481964,0.00006392179,0.00002874752,0.00050320325,0.00017006692,0.0000064013016,0.00025232774],"genre_scores_gemma":[0.9935091,0.00013644269,0.0017782322,0.000081856364,0.00008117781,0.0001027027,0.00034671772,0.000018718896,0.0039450587],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994143,0.000014813544,0.0001602389,0.00022846348,0.00006144307,0.00012073095],"domain_scores_gemma":[0.9994977,0.000009030915,0.00011964866,0.00024363243,0.000086087064,0.00004385982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006396937,0.00009295449,0.00013667047,0.000021140144,0.000024947432,0.000008494796,0.000085034706,0.00008857526,0.00002264051],"category_scores_gemma":[0.00001911123,0.00009068952,0.00008160953,0.000046483015,0.000024548348,0.0000049254672,0.000021223386,0.000026608408,0.0000045723204],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008505143,0.000121665274,0.0007732378,0.000050401315,0.000054932687,8.873038e-8,0.00007177393,0.00004973034,0.99608195,0.000051484018,0.0016112279,0.0010484292],"study_design_scores_gemma":[0.0038088798,0.000390135,0.0021432848,0.00002002369,0.00012382148,0.000003129941,0.000054912358,0.0007268747,0.9894422,0.0007740241,0.0022853473,0.00022735016],"about_ca_topic_score_codex":0.000020003248,"about_ca_topic_score_gemma":0.0000051607667,"teacher_disagreement_score":0.017703732,"about_ca_system_score_codex":0.000006818548,"about_ca_system_score_gemma":0.000068751244,"threshold_uncertainty_score":0.36982113},"labels":[],"label_agreement":null},{"id":"W2988391175","doi":"10.1182/blood-2019-124467","title":"National Emergency Cards for Sickle Cell Disease: A Survey on Usefulness from the Patient Perspective","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Alberta Health Services; MacEwan University; Stollery Children's Hospital; University of Alberta","funders":"","keywords":"Medicine; Disease; Medical emergency; Readability; Emergency department; Vaso-occlusive crisis; Family medicine; Emergency medicine; Sickle cell anemia; Psychiatry; Pathology","score_opus":0.013966326297907025,"score_gpt":0.24981889840604815,"score_spread":0.23585257210814112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988391175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908674,0.0011296829,0.000012701243,0.0008605475,0.00047640904,0.00080645795,0.0007578443,0.00002488016,0.0050641038],"genre_scores_gemma":[0.9983817,0.00005026622,0.000017475113,0.0003112876,0.00012397666,0.00005210786,0.00023850858,0.000019651676,0.0008050242],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99910563,0.00005053504,0.00013541436,0.00023272775,0.00031963244,0.0001560507],"domain_scores_gemma":[0.9992331,0.00014156112,0.000049403636,0.00020389773,0.00028557106,0.0000864162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012481166,0.00010755717,0.00013645772,0.000022976403,0.00008218848,0.0000071208938,0.00006940486,0.000059906117,0.0003140511],"category_scores_gemma":[0.0002115377,0.00006783101,0.000121848956,0.000107994994,0.000019921845,0.000020518475,0.000020590684,0.00012035369,0.00010548581],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031652346,0.010825273,0.8330653,0.00021890395,0.0014970078,0.000034167926,0.0105198175,0.00061509706,0.0019783042,0.005123973,0.13181648,0.00114046],"study_design_scores_gemma":[0.0076337988,0.00082854537,0.9748799,0.000092106835,0.00041180235,0.000001343321,0.0029586246,0.0002930555,0.0019792032,0.001647164,0.008973715,0.00030074292],"about_ca_topic_score_codex":0.0005625682,"about_ca_topic_score_gemma":0.00004728623,"teacher_disagreement_score":0.14181462,"about_ca_system_score_codex":0.000040301926,"about_ca_system_score_gemma":0.0001814847,"threshold_uncertainty_score":0.34386396},"labels":[],"label_agreement":null},{"id":"W2988395523","doi":"10.1182/blood-2019-128532","title":"Dual T-Cell Depletion with a Very Low Dose of ATG and Ptcy Provides an Effective Control of Acute Gvhd in PBSC RIC Allo-HSCT","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Thymoglobulin; Medicine; Fludarabine; Busulfan; Graft-versus-host disease; Internal medicine; Gastroenterology; Cyclophosphamide; Alemtuzumab; Regimen; Surgery; Transplantation; Chemotherapy; Tacrolimus","score_opus":0.00388496672690422,"score_gpt":0.21645473499223133,"score_spread":0.2125697682653271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988395523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975521,0.00012063982,0.00022075203,0.000022851213,0.000023294271,0.0014613534,0.000018263914,0.000015404603,0.00056533545],"genre_scores_gemma":[0.9993752,0.00002725496,0.00044757503,0.000027587246,0.000015314261,0.00003923949,0.000023625224,0.00001765309,0.000026515294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999136,0.00008507941,0.00023361167,0.00020650939,0.00020385096,0.00013495122],"domain_scores_gemma":[0.9994161,0.00016613619,0.00011661221,0.00017410556,0.00006712663,0.00005990172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019963164,0.00011904889,0.00037456956,0.0001148531,0.000008356947,0.0000041270673,0.00003123656,0.000077211946,0.000016637525],"category_scores_gemma":[0.000012713875,0.000092680755,0.00003212796,0.00013089448,0.000050166167,0.0000851198,0.0000053630715,0.000089290785,0.0000046641608],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017501843,0.001211237,0.61451954,0.001971393,0.00022643626,0.000094338546,0.0017457851,0.000014145345,0.37791148,0.00004378072,0.0000011500888,0.0005105456],"study_design_scores_gemma":[0.029733298,0.0033862258,0.69787437,0.000520696,0.0009320016,0.00015327844,0.00018156023,0.00027624532,0.26679513,0.000020497377,0.0000027136055,0.00012399514],"about_ca_topic_score_codex":0.00009327835,"about_ca_topic_score_gemma":0.00002805853,"teacher_disagreement_score":0.11111634,"about_ca_system_score_codex":0.000014483458,"about_ca_system_score_gemma":0.000062389794,"threshold_uncertainty_score":0.37794113},"labels":[],"label_agreement":null},{"id":"W2988422067","doi":"10.1182/blood-2019-126809","title":"Review of Therapeutic Erythrocytapheresis in Patients with Thalassemia Major","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; University of Alberta","funders":"","keywords":"Thalassemia; Medicine; Chelation therapy; Blood transfusion; Hemoglobin electrophoresis; Beta thalassemia; Internal medicine; Transfusion therapy; Pediatrics; Surgery","score_opus":0.004117034856086409,"score_gpt":0.21356723104042646,"score_spread":0.20945019618434005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988422067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95993096,0.03334469,8.607104e-7,0.00022032762,0.00002788699,0.0005867084,0.0000023199393,0.00001283867,0.0058733965],"genre_scores_gemma":[0.9926543,0.006063404,0.000084948275,0.0009364993,0.0000056977597,0.0000067241476,0.000011606884,0.00001574536,0.00022104877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99936503,0.000021141479,0.00018786953,0.00012923345,0.00016166535,0.00013505078],"domain_scores_gemma":[0.99959576,0.000017148459,0.00006632603,0.00022548425,0.000057600424,0.000037658865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006850163,0.00008721611,0.00028343647,0.00004132617,0.000007284789,0.0000015371676,0.000047084566,0.000065325075,0.0003399226],"category_scores_gemma":[0.00001364909,0.000055293458,0.00004846828,0.00022023458,0.00002208805,0.000028868253,0.000012107199,0.00011296831,0.000047744383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010329296,0.0009828655,0.9910968,0.0048583806,0.00013515812,0.0000049072796,0.000055138215,3.8028995e-7,0.0002467594,0.000023659779,0.00036824535,0.0021244404],"study_design_scores_gemma":[0.018179612,0.0014243617,0.9487648,0.02524927,0.0006674739,0.000011063968,0.00012935138,0.0000031203137,0.00149168,0.000024145802,0.0038424188,0.00021267463],"about_ca_topic_score_codex":0.000019171852,"about_ca_topic_score_gemma":0.0000032445714,"teacher_disagreement_score":0.042331945,"about_ca_system_score_codex":0.000011097082,"about_ca_system_score_gemma":0.000058241745,"threshold_uncertainty_score":0.37219143},"labels":[],"label_agreement":null},{"id":"W2988436340","doi":"10.1182/blood.v130.suppl_1.1113.1113","title":"Effectiveness and Safety of Rivaroxaban Versus Warfarin for Treatment of Venous Thromboembolism in Patients with Known Primary Hypercoagulable States","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Medicine; Rivaroxaban; Warfarin; Pulmonary embolism; Vitamin K antagonist; Deep vein; Fondaparinux; Thrombosis; Population; Emergency department; Internal medicine; Surgery; Venous thromboembolism; Atrial fibrillation","score_opus":0.014107573569379854,"score_gpt":0.2608388241859538,"score_spread":0.24673125061657392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988436340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99683505,0.00033502572,0.00001156683,0.000035999645,0.00008658598,0.001780616,0.00006319261,0.000010508429,0.000841431],"genre_scores_gemma":[0.9986806,0.00044986547,0.00064346247,0.0000071360582,0.000021807859,0.0001036408,0.00005466025,0.000024440307,0.000014418299],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991065,0.000026465188,0.00023349449,0.0002549229,0.00016240585,0.00021620053],"domain_scores_gemma":[0.9990761,0.00012858253,0.00018234727,0.00045485617,0.00009788022,0.000060232873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013226355,0.0001667324,0.000905834,0.00007911197,0.00009710556,0.000011417771,0.00008762489,0.00005482616,0.00000624],"category_scores_gemma":[0.000032285385,0.0001248467,0.000059377515,0.000040956376,0.00012697856,0.00008319515,0.00005768637,0.00002692677,6.082569e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008589933,0.03845872,0.9024983,0.0031673678,0.0023039337,0.000020371008,0.0017537335,0.000055421708,0.0016274928,0.00084384286,0.00003187348,0.040648993],"study_design_scores_gemma":[0.037915,0.009124911,0.9428203,0.00033799745,0.000820498,6.979639e-7,0.000048233323,0.0000058109486,0.008539212,0.000075496675,0.0001976343,0.000114206836],"about_ca_topic_score_codex":0.00071340473,"about_ca_topic_score_gemma":0.000066318134,"teacher_disagreement_score":0.040534787,"about_ca_system_score_codex":0.00006550711,"about_ca_system_score_gemma":0.00005777486,"threshold_uncertainty_score":0.5091101},"labels":[],"label_agreement":null},{"id":"W2988465249","doi":"10.1182/blood-2019-127185","title":"Clinical Utility of Telomere Length-Directed Genomic Assessment in Patients with Short Telomere Syndromes","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Telomere; Medicine; Genetic testing; Telomerase; Internal medicine; Biology; Genetics; Gene","score_opus":0.01938371925959553,"score_gpt":0.2956137867808679,"score_spread":0.2762300675212724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988465249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948823,0.0002170048,0.0000034155753,0.000056450364,0.00021031577,0.0011720153,0.000043639928,0.00011903296,0.0032958335],"genre_scores_gemma":[0.99713176,0.000081062084,0.002315811,0.000087266875,0.000051718675,0.000019358788,0.00007410272,0.0000478963,0.00019099494],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970295,0.00016040153,0.0009908046,0.0006964182,0.0006369464,0.00048592992],"domain_scores_gemma":[0.99826354,0.00019140166,0.0001959411,0.0008803615,0.00023088377,0.00023785674],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000515502,0.0003251367,0.0010834677,0.00023947652,0.0000372989,0.000012888794,0.000237007,0.00023091823,0.00046099976],"category_scores_gemma":[0.00009938566,0.00025783957,0.00016880398,0.0004970448,0.00017706167,0.00012369575,0.000096748074,0.000597656,0.000053595213],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039024983,0.003915185,0.9882884,0.00024795468,0.0002484314,0.0000429084,0.000098313845,7.308405e-7,0.0005429139,0.000019897769,0.000068666304,0.0061363406],"study_design_scores_gemma":[0.0076190964,0.0012940236,0.9889132,0.00028510406,0.00021560378,0.000019168174,0.00013508301,0.00007322726,0.0008750223,0.000010404292,0.00027520116,0.00028488194],"about_ca_topic_score_codex":0.000084031955,"about_ca_topic_score_gemma":0.000045102184,"teacher_disagreement_score":0.0072288467,"about_ca_system_score_codex":0.000054114727,"about_ca_system_score_gemma":0.0004089993,"threshold_uncertainty_score":0.99998736},"labels":[],"label_agreement":null},{"id":"W2988468277","doi":"10.1182/blood-2019-124553","title":"Phase 3 Exploratory Analysis of Outcomes in Patients with Acute Myeloid Leukemia with Myelodysplasia-Related Changes (AML-MRC) Who Received Consolidation with CPX-351 Versus Conventional Chemotherapy","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada","funders":"","keywords":"Medicine; Cytarabine; Internal medicine; Hazard ratio; Daunorubicin; Induction chemotherapy; Oncology; Chemotherapy regimen; Population; Leukemia; Gastroenterology; Surgery; Chemotherapy; Confidence interval","score_opus":0.012615997853200212,"score_gpt":0.27286611700930713,"score_spread":0.2602501191561069,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988468277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971534,0.000037905556,0.000031150896,0.0003793596,0.00004613855,0.0014504245,0.00012725129,0.00008154959,0.0006928184],"genre_scores_gemma":[0.99683046,0.000086933025,0.0008093508,0.00014816236,0.000021304142,0.00010915537,0.001118611,0.00007738158,0.0007986254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99722785,0.00012391993,0.00046821183,0.0006277385,0.0010656591,0.00048665114],"domain_scores_gemma":[0.9979595,0.00018303792,0.00041272218,0.00065697846,0.00058677525,0.00020101933],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027974127,0.00039762416,0.0011343253,0.0010181675,0.000056158995,0.000024713145,0.00021119269,0.0002012604,0.00048240644],"category_scores_gemma":[0.00003911297,0.00027464514,0.00011403217,0.001954691,0.00026943613,0.00026833185,0.00004164265,0.00043771724,0.000032094922],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030549668,0.003064591,0.94085896,0.00012120646,0.01941741,0.000115191935,0.0013299506,0.00013366726,0.0034670287,0.000046857025,0.0001009348,0.0007945322],"study_design_scores_gemma":[0.24393088,0.0126205515,0.7170691,0.00040176656,0.0058109798,0.000014245283,0.0008017212,0.0010863097,0.017514529,0.0000033570195,0.00017400307,0.00057254813],"about_ca_topic_score_codex":0.000073286246,"about_ca_topic_score_gemma":0.00024480335,"teacher_disagreement_score":0.22378986,"about_ca_system_score_codex":0.00044632057,"about_ca_system_score_gemma":0.0008602932,"threshold_uncertainty_score":0.99997056},"labels":[],"label_agreement":null},{"id":"W2988504053","doi":"10.1182/blood-2019-123966","title":"Clinical Activity of CC-90009, a Cereblon E3 Ligase Modulator and First-in-Class GSPT1 Degrader, As a Single Agent in Patients with Relapsed or Refractory Acute Myeloid Leukemia (R/R AML): First Results from a Phase I Dose-Finding Study","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cereblon; Refractory (planetary science); Ubiquitin ligase; Myeloid leukemia; Internal medicine; Leukemia; Cancer research; Oncology; Chemistry; Ubiquitin; Biology","score_opus":0.018672402061630476,"score_gpt":0.2764418979414694,"score_spread":0.25776949587983894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988504053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99834996,0.00008059725,0.0000045508546,0.000052756477,0.000113281385,0.0011585827,0.00015563407,0.000013918975,0.0000707342],"genre_scores_gemma":[0.99920297,0.000078581965,0.00022875775,0.000049254544,0.000065654174,0.00003788035,0.00016487301,0.000033497687,0.0001385133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99786115,0.00016995928,0.000636134,0.0007680171,0.000280442,0.00028427964],"domain_scores_gemma":[0.9987147,0.00009850948,0.0003886039,0.0005897149,0.00006325425,0.00014525342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032396681,0.00027004568,0.00043764373,0.00011001218,0.000061845836,0.000028221599,0.00018439139,0.0002700005,0.000009677001],"category_scores_gemma":[0.00032462217,0.00022147724,0.00007801073,0.00019836912,0.00007364251,0.000027417775,0.00015219688,0.00026975144,0.0000055771134],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038242362,0.09059665,0.6920609,0.00012490804,0.00093848316,0.00016937422,0.0018576847,0.000028183113,0.16482332,0.0000024570397,0.00037034994,0.010785318],"study_design_scores_gemma":[0.2382533,0.019041922,0.3793043,0.00040726527,0.00022272143,0.0000055055325,0.0002793136,0.00019162138,0.3595949,0.000007633813,0.001947945,0.0007435651],"about_ca_topic_score_codex":0.00042949556,"about_ca_topic_score_gemma":0.0010925576,"teacher_disagreement_score":0.3127566,"about_ca_system_score_codex":0.000072914816,"about_ca_system_score_gemma":0.0001764272,"threshold_uncertainty_score":0.903158},"labels":[],"label_agreement":null},{"id":"W2988516843","doi":"10.1182/blood-2019-128507","title":"Reevaluating the Role of Cytogenetic Testing in Patients with Suspected Myelodysplastic Syndrome in the Era of Next Generation Sequencing","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Medicine; Internal medicine; Myelodysplastic syndromes; Oncology; Pathology; Bone marrow","score_opus":0.03683705881793722,"score_gpt":0.2573519207241492,"score_spread":0.22051486190621197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988516843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983137,0.00012459104,0.000004504464,0.00005752483,0.000011487752,0.00095313496,0.0000024441933,0.00000686858,0.0005257381],"genre_scores_gemma":[0.9986527,0.000002442542,0.0012262496,0.000029629444,0.000025077743,0.000024324147,0.000014406503,0.000017645985,0.000007527334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844897,0.00020601525,0.0003559693,0.00018349066,0.0005801712,0.00022539322],"domain_scores_gemma":[0.9987845,0.0004777812,0.00015065336,0.00035265565,0.00021094081,0.00002347904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007467491,0.00010225694,0.00022754855,0.0001137745,0.000031088224,0.000011423756,0.000172091,0.00004932717,0.000020114367],"category_scores_gemma":[0.00078867876,0.000057573645,0.000020698772,0.0007795158,0.00005353322,0.0000587989,0.00004681795,0.0003718761,0.0000052955543],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054947654,0.00014862094,0.81825465,0.00006191872,0.000026619184,0.0000139921685,0.0010904466,0.0008646136,0.17840308,0.00002277182,6.6646925e-7,0.0010576479],"study_design_scores_gemma":[0.0045269704,0.001053992,0.95407754,0.00044353207,0.000077624136,0.000060035956,0.00090848363,0.02366742,0.015079316,0.000032851935,4.6260075e-7,0.00007177753],"about_ca_topic_score_codex":0.0004024127,"about_ca_topic_score_gemma":0.000112679,"teacher_disagreement_score":0.16332377,"about_ca_system_score_codex":0.00012075607,"about_ca_system_score_gemma":0.00039475318,"threshold_uncertainty_score":0.23477851},"labels":[],"label_agreement":null},{"id":"W2988560554","doi":"10.1182/blood-2019-132223","title":"Targeting Neurotrophic Receptor Tyrosine Kinase (NTRK) Fusion Structural Homologs in Refractory Pediatric Acute Lymphoblastic Leukemia (ALL)","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Trk receptor; Tyrosine kinase; Cancer research; Medicine; Fusion gene; Biology; Bioinformatics; Receptor; Internal medicine; Neurotrophin; Gene; Genetics","score_opus":0.009000108683016757,"score_gpt":0.25297210136260273,"score_spread":0.24397199267958597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988560554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964543,0.0008731931,0.000019724588,0.00027357598,0.0006634311,0.0010617339,0.000039042432,0.0001773001,0.0004377039],"genre_scores_gemma":[0.9954153,0.00065632316,0.0012455891,0.0004293251,0.0008813651,0.000048458052,0.00019438467,0.000122953,0.0010063245],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9961126,0.00019961405,0.0007377872,0.00091050554,0.00092908216,0.0011104025],"domain_scores_gemma":[0.9980096,0.0003908525,0.0002346556,0.00074679434,0.00019915096,0.00041894053],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00036001636,0.00047461147,0.0007214621,0.0006060089,0.00010402582,0.000051833078,0.00041035688,0.0003872023,0.0009192339],"category_scores_gemma":[0.0006817702,0.00040773425,0.00016160363,0.0009277255,0.00011200521,0.00024759682,0.0003759469,0.00087132043,0.0009974132],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022084536,0.0008027336,0.18904345,0.00082608947,0.00025719646,0.003445135,0.00047410335,0.00029362235,0.7977676,0.000088845794,0.0034561283,0.0013366548],"study_design_scores_gemma":[0.18986295,0.013943599,0.6691969,0.0013548821,0.0042839,0.005352833,0.0005356647,0.05146093,0.05278525,0.0004255211,0.006035793,0.0047617615],"about_ca_topic_score_codex":0.00019714773,"about_ca_topic_score_gemma":0.000004574045,"teacher_disagreement_score":0.74498236,"about_ca_system_score_codex":0.0014858354,"about_ca_system_score_gemma":0.0015015189,"threshold_uncertainty_score":0.99999404},"labels":[],"label_agreement":null},{"id":"W2988589642","doi":"10.1182/blood-2019-124191","title":"Expanded Meta-Analyses Confirms the Association between MRD and Long-Term Survival Outcomes in Multiple Myeloma (MM)","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Medicine; Internal medicine; Oncology; Hazard ratio; Progression-free survival; Meta-analysis; Multiple myeloma; Transplantation; Surrogate endpoint; Overall survival; Confidence interval","score_opus":0.13571165768311683,"score_gpt":0.377394655627346,"score_spread":0.24168299794422915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988589642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972489,0.0004880794,0.00000555812,0.0006952459,0.000044968136,0.00081564684,0.000047650057,0.000029251049,0.0006246987],"genre_scores_gemma":[0.9970801,0.000047616526,0.00006376001,0.00006151969,0.000056780034,0.00005991217,0.00008753875,0.000018051473,0.0025247624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982785,0.00020489926,0.00030130206,0.0002948975,0.00056506466,0.00035535582],"domain_scores_gemma":[0.9982422,0.0010664153,0.00012307767,0.0003560275,0.00007781334,0.00013448484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005084826,0.00019113571,0.00079275283,0.00011603999,0.00006710591,0.000049994273,0.00010614475,0.00010292745,0.00020231889],"category_scores_gemma":[0.00051197695,0.00010313933,0.00022781888,0.00015509222,0.000035768335,0.00008289533,0.00006916941,0.00020358161,0.00010257554],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005250839,0.00031931323,0.98897165,0.00003119761,0.008330932,0.000043474414,0.00011827503,3.0278738e-7,0.001275327,0.0000070027013,0.000006960238,0.00084305124],"study_design_scores_gemma":[0.009343874,0.00015513091,0.9813893,0.000011436486,0.003711023,0.000004629463,0.000060209382,0.000014127526,0.0051625664,0.000016381304,0.000033014177,0.00009832947],"about_ca_topic_score_codex":0.00040630074,"about_ca_topic_score_gemma":0.0006074605,"teacher_disagreement_score":0.009291366,"about_ca_system_score_codex":0.000059206195,"about_ca_system_score_gemma":0.000048804566,"threshold_uncertainty_score":0.42059},"labels":[],"label_agreement":null},{"id":"W2988593522","doi":"10.1182/blood-2019-128849","title":"Delayed Time to Emergency Hip Surgery in Patients Taking Oral Anticoagulants","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; Université de Montréal","funders":"","keywords":"Medicine; Interquartile range; Retrospective cohort study; Surgery; Vitamin K antagonist; Hip fracture; Warfarin; Anticoagulant; Atrial fibrillation; Internal medicine; Osteoporosis","score_opus":0.04589984063685427,"score_gpt":0.30257465099683334,"score_spread":0.2566748103599791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988593522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99578756,0.000021744161,0.0000042442625,0.00030452406,0.00027059458,0.0004420155,0.0000023680782,0.000039132672,0.0031278057],"genre_scores_gemma":[0.9954798,0.000006413962,0.00013074574,0.00012085524,0.00013646454,9.585232e-7,0.00004099601,0.000014700258,0.0040690475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914205,0.00002541689,0.00026998812,0.00016488288,0.00020325264,0.00019438379],"domain_scores_gemma":[0.9996229,0.000037006164,0.00007677566,0.00016416582,0.00003547221,0.00006369713],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00016578744,0.00009040035,0.00028663222,0.00018840012,0.000016047165,0.0000067544647,0.00004066482,0.000041028536,0.001859021],"category_scores_gemma":[0.0001261207,0.00008130566,0.00008103512,0.0002659802,0.000003056039,0.000062542276,0.000042862088,0.000039906805,0.0024303459],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000096970834,0.00004408404,0.9963255,0.00002258314,0.000050640883,0.0000058959804,0.000038094862,0.0000052096298,0.00051206327,0.0000127239755,0.001112064,0.0017741973],"study_design_scores_gemma":[0.0017796101,0.00008551381,0.9953636,0.000036320213,0.00006640777,4.6513938e-7,0.0000065615905,0.000040550385,0.00024198713,0.0000075092107,0.0022693237,0.00010213698],"about_ca_topic_score_codex":0.00002528824,"about_ca_topic_score_gemma":0.0000030256774,"teacher_disagreement_score":0.0016826392,"about_ca_system_score_codex":0.000013152254,"about_ca_system_score_gemma":0.000012541598,"threshold_uncertainty_score":0.9990534},"labels":[],"label_agreement":null},{"id":"W2988594495","doi":"10.1182/blood-2019-130052","title":"The U1 Spliceosomal RNA: A Novel Non-Coding Hotspot Driver Mutation Independently Associated with Clinical Outcome in Chronic Lymphocytic Leukemia","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"IGHV@; Biology; Genetics; Chronic lymphocytic leukemia; Spliceosome; RNA; RNA splicing; Small nuclear RNA; Mutation; Epigenetics; Intron; Gene; Leukemia; Non-coding RNA","score_opus":0.02937847671128769,"score_gpt":0.32498329601110626,"score_spread":0.2956048192998186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988594495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955804,0.00016917178,0.000081595324,0.0000927579,0.00023260758,0.0013618565,0.000007069914,0.00008705053,0.002387521],"genre_scores_gemma":[0.9963362,0.00007134779,0.000109814355,0.00020096013,0.0002663591,0.00007135413,0.00003385348,0.00007735851,0.002832751],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961644,0.00012616711,0.0009281224,0.000679483,0.001169785,0.00093207037],"domain_scores_gemma":[0.99727154,0.0011849927,0.0003074868,0.00078750553,0.00019914676,0.00024934858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015870843,0.000323853,0.00070898834,0.00019613557,0.0001464093,0.00009198498,0.00041326624,0.00037319597,0.0000705207],"category_scores_gemma":[0.0007632746,0.00022209833,0.00019385233,0.0006794144,0.00023051696,0.00018570635,0.00019415612,0.0008538558,0.00038914807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00513544,0.0030106974,0.931227,0.0011728706,0.004030911,0.0065500587,0.0023410553,0.0047319117,0.032750424,0.0011966499,0.00041885296,0.007434092],"study_design_scores_gemma":[0.2342254,0.001417829,0.6359524,0.0009274249,0.0005017981,0.0007526623,0.00032965734,0.121911615,0.0032303075,0.000028835575,0.00017707003,0.00054499233],"about_ca_topic_score_codex":0.0011643252,"about_ca_topic_score_gemma":0.00097465457,"teacher_disagreement_score":0.29527462,"about_ca_system_score_codex":0.06378188,"about_ca_system_score_gemma":0.0327354,"threshold_uncertainty_score":0.9727481},"labels":[],"label_agreement":null},{"id":"W2988597345","doi":"10.1182/blood-2019-131779","title":"Copanlisib, a PI3K Inhibitor, Demonstrates a Favorable Long-Term Safety Profile in a Pooled Analysis of Patients with Hematologic Malignancies","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Hematologic Neoplasms; Term (time); Internal medicine; Oncology; Cancer","score_opus":0.007933062820561141,"score_gpt":0.24588445209358917,"score_spread":0.23795138927302803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988597345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997388,0.00034059296,0.00000972088,0.000027144804,0.000019107481,0.0011550961,0.000051704574,0.00003590026,0.00097275345],"genre_scores_gemma":[0.9989904,0.000021810029,0.0003379394,0.000032225624,0.000010837364,0.000050470484,0.0001801033,0.000022346412,0.00035383966],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99793637,0.00007109895,0.00049732666,0.00041508273,0.00061459426,0.00046555174],"domain_scores_gemma":[0.9987758,0.00015328977,0.00017252893,0.0005313745,0.00024608642,0.00012094986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002505442,0.0002045679,0.0008633702,0.0004914895,0.000027828548,0.000017460558,0.0001579179,0.0001317619,0.0003731186],"category_scores_gemma":[0.000114304225,0.0001465271,0.00013392665,0.0017024557,0.00013421505,0.000102793136,0.00009377203,0.00017785234,0.000049998143],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076095725,0.0020216943,0.993044,0.000557894,0.0011896775,0.00014965447,0.00021820486,0.000030776897,0.0018932642,0.00003500179,0.000014079567,0.00008475394],"study_design_scores_gemma":[0.045153458,0.0009379348,0.92774427,0.0006089385,0.0020766524,0.000037366284,0.00016535496,0.00085727405,0.022196738,0.000007772806,0.000003848403,0.00021036863],"about_ca_topic_score_codex":0.0002780331,"about_ca_topic_score_gemma":0.0002646466,"teacher_disagreement_score":0.06529975,"about_ca_system_score_codex":0.0009928527,"about_ca_system_score_gemma":0.0023435615,"threshold_uncertainty_score":0.5975202},"labels":[],"label_agreement":null},{"id":"W2988645140","doi":"10.1182/blood-2019-130145","title":"Outcome Among Adolescents and Young Adults with Acute Myeloid Leukemia at Pediatric Versus Adult Centers: A Population-Based Study Using the IMPACT Cohort","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; Occupational Cancer Research Centre; University of Toronto; Pediatric Oncology Group; St. Michael's Hospital; Institute for Clinical Evaluative Sciences","funders":"","keywords":"Medicine; Hazard ratio; Population; Cohort; Young adult; Proportional hazards model; Myeloid leukemia; Internal medicine; Pediatrics; Cancer; Survival analysis; Oncology; Confidence interval","score_opus":0.015394312761678053,"score_gpt":0.2944079610355624,"score_spread":0.2790136482738843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988645140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99702096,0.00009048952,0.0000070970973,0.000044574826,0.00032877526,0.002337556,0.000038914954,0.000084633706,0.000046994177],"genre_scores_gemma":[0.9992735,0.000011125022,0.000085275475,0.00017193216,0.00028591778,0.000021930815,0.000054229615,0.000058973477,0.000037156587],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977181,0.00013323505,0.00046469187,0.0005253567,0.00076210033,0.00039654094],"domain_scores_gemma":[0.9986106,0.000083709696,0.00028339805,0.0006573092,0.00013857674,0.00022636971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028816244,0.00033357172,0.0005233531,0.00012777312,0.00016576317,0.00005353726,0.00015582654,0.00008929413,0.000027298063],"category_scores_gemma":[0.00007510176,0.00022061249,0.00013070047,0.000306536,0.00003865362,0.00014496408,0.000089196736,0.0002947417,0.000013333887],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026778865,0.00053645705,0.9941529,0.00016460266,0.0005081566,0.000042025422,0.0018182505,0.000052830874,0.00001873275,2.2692836e-7,0.000013091755,0.00001484164],"study_design_scores_gemma":[0.027566388,0.0011011407,0.9671585,0.0002677422,0.0018172963,0.000034656594,0.0012830627,0.00048982253,0.000023631064,3.1221077e-7,3.5492008e-7,0.0002570678],"about_ca_topic_score_codex":0.0122568,"about_ca_topic_score_gemma":0.0025870078,"teacher_disagreement_score":0.026994374,"about_ca_system_score_codex":0.0004278301,"about_ca_system_score_gemma":0.00019300953,"threshold_uncertainty_score":0.9943207},"labels":[],"label_agreement":null},{"id":"W2988650606","doi":"10.1182/blood-2019-129384","title":"Hematopoietic Cell Transplantation Donor Selection Reimagined: KIR-KIR Ligand Interactions and a Formalized Donor Risk Index Effective at Predicting Survival","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Human leukocyte antigen; ABO blood group system; Transplantation; Immunology; Genotyping; Hematopoietic stem cell transplantation; Biology; Genotype; Oncology; Medicine; Internal medicine; Genetics; Antigen; Gene","score_opus":0.0037616987644203456,"score_gpt":0.205256570183611,"score_spread":0.20149487141919065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988650606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99106073,0.00046109455,0.0009463623,0.000043933633,0.0028357615,0.0006984209,0.000017695354,0.0001551176,0.0037809033],"genre_scores_gemma":[0.9919757,0.00031054334,0.000035277517,0.000051763676,0.00005752316,0.00008353726,0.00018668766,0.000027329086,0.0072716414],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986576,0.00027704125,0.00034694278,0.00037832445,0.000048695325,0.0002914203],"domain_scores_gemma":[0.99916244,0.00028972066,0.00025836358,0.00016407821,0.00009553176,0.00002984837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002508728,0.00022992764,0.00028164082,0.00018294372,0.00036128768,0.000042337942,0.00006940112,0.00019189424,0.00062739424],"category_scores_gemma":[0.000036851026,0.00021758303,0.000108102446,0.00015311781,0.00004984259,0.0004289777,0.000038710245,0.0005267903,0.0005170103],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015509841,0.00037498458,0.20835304,0.00015851638,0.00038770167,0.0000019673305,0.0023211273,0.000029990588,0.78551507,0.000021634107,0.0005094467,0.00077551976],"study_design_scores_gemma":[0.013513933,0.0008053619,0.12689403,0.00012548362,0.00076360616,0.000842948,0.0009957545,0.00035313104,0.8449138,0.000030595253,0.010318698,0.0004426544],"about_ca_topic_score_codex":0.00045814613,"about_ca_topic_score_gemma":0.00020622443,"teacher_disagreement_score":0.08145901,"about_ca_system_score_codex":0.00006705856,"about_ca_system_score_gemma":0.000023279015,"threshold_uncertainty_score":0.88727784},"labels":[],"label_agreement":null},{"id":"W2988655118","doi":"10.1182/blood.v128.22.3828.3828","title":"Incidence and Outcomes of Catheter Related Thrombosis in Acute Leukemia: Single Centre Experience","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Central Venous Catheters and Hemodialysis","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Incidence (geometry); Thrombosis; Surgery; Acute leukemia; Complication; Catheter; Venous thrombosis; Central venous catheter; Leukemia; Pediatrics; Internal medicine","score_opus":0.028922242575420715,"score_gpt":0.3250430530870083,"score_spread":0.2961208105115876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988655118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983272,0.00009789166,0.000011780428,0.0006705635,0.00009320967,0.0002275373,0.000019900826,0.000026437609,0.00052548625],"genre_scores_gemma":[0.9987829,0.00020646749,0.00018356656,0.00014117005,0.000012274213,0.000017285844,0.0000013648474,0.0000128876945,0.00064213097],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987445,0.000107570566,0.0004179583,0.00023587586,0.000135197,0.00035888102],"domain_scores_gemma":[0.99915695,0.00030324192,0.00016072694,0.00025355633,0.000044108107,0.00008139514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015200014,0.00011465821,0.00033512953,0.000074113064,0.000112208225,0.0000032010807,0.000121825644,0.00014992223,0.00023378142],"category_scores_gemma":[0.000114271585,0.0000720158,0.00006736907,0.00013696942,0.00009268169,0.00012305116,0.0001073219,0.00013840811,0.000032794025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008926888,0.00026424346,0.94870895,0.000021045631,0.000055042106,0.0000059505933,0.018770434,1.0209492e-7,0.031424575,0.00011706334,0.000042290525,0.00058138336],"study_design_scores_gemma":[0.002776794,0.00012755155,0.9841221,0.0004895431,0.00017241892,0.0000024026099,0.0020574355,0.000006185905,0.009413017,0.00043652937,0.00017596623,0.00022006528],"about_ca_topic_score_codex":0.00028603958,"about_ca_topic_score_gemma":0.0003542076,"teacher_disagreement_score":0.035413146,"about_ca_system_score_codex":0.00010235654,"about_ca_system_score_gemma":0.00007238462,"threshold_uncertainty_score":0.2936719},"labels":[],"label_agreement":null},{"id":"W2988688877","doi":"10.1182/blood-2019-129342","title":"Predictors of the Rowland Universal Dementia Assessment Scale (RUDAS) Performance in Adults with Sickle Cell Disease","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Université Laval; University of Toronto; Centre Hospitalier de l’Université de Montréal; University Health Network","funders":"","keywords":"Medicine; Dementia; Disease; Anxiety; Cognition; Gerontology; Internal medicine; Psychiatry","score_opus":0.0016598232487996106,"score_gpt":0.172026156313524,"score_spread":0.17036633306472437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988688877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989558,0.00026443627,0.0000024875897,0.00013592884,0.00007711053,0.00044362573,0.000007455211,0.000012661372,0.00949829],"genre_scores_gemma":[0.99925303,0.00012553559,0.000054501987,0.00003612352,0.000013974757,0.0000043436335,0.000009235268,0.000010654323,0.0004926104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993513,0.000019450863,0.00012605936,0.00014020593,0.00021129055,0.00015167905],"domain_scores_gemma":[0.9995926,0.000008509253,0.000057892288,0.0002318929,0.000029995907,0.000079090394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000551796,0.00008578556,0.0001291761,0.000038198785,0.000026034078,0.000003071801,0.00007870589,0.000044050994,0.00006791299],"category_scores_gemma":[0.000002354735,0.00005007028,0.000040024905,0.00016151588,0.0000499322,0.000045798293,0.000036373232,0.00014339482,0.000007773718],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020548997,0.00065358373,0.99803525,0.00027943536,0.000051289793,0.00000767428,0.00028432487,0.00013246911,0.0002522536,0.0000068356976,0.000036902053,0.00005446223],"study_design_scores_gemma":[0.008850435,0.0003927515,0.9869446,0.0005417653,0.00031509073,0.0000031437585,0.000575369,0.0007898715,0.0011907879,0.0000012208554,0.00031802192,0.0000769174],"about_ca_topic_score_codex":0.000031866013,"about_ca_topic_score_gemma":0.000015414875,"teacher_disagreement_score":0.011090654,"about_ca_system_score_codex":0.000016323665,"about_ca_system_score_gemma":0.00016752412,"threshold_uncertainty_score":0.20418067},"labels":[],"label_agreement":null},{"id":"W2988701053","doi":"10.1182/blood-2019-125716","title":"Ibrutinib Therapy Downregulates Toso, the Fcr for IgM, Expression in CLL Patients","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ibrutinib; breakpoint cluster region; B-cell receptor; Internal medicine; Bruton's tyrosine kinase; B cell; IGHV@; Waldenstrom macroglobulinemia; Rituximab; Chemistry; Cancer research; Immunology; Chronic lymphocytic leukemia; Leukemia; Medicine; Receptor; Lymphoma; Antibody; Tyrosine kinase","score_opus":0.01511424877564102,"score_gpt":0.28228305342772025,"score_spread":0.26716880465207926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988701053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99505764,0.00056166097,0.0000036434062,0.00031402748,0.00011110784,0.0017702747,0.000008460489,0.000029535142,0.0021436603],"genre_scores_gemma":[0.99766403,0.000096351,0.00023120343,0.0002793055,0.00013261796,0.00012016017,0.000037797,0.000028889568,0.001409653],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987385,0.000046871115,0.00022156654,0.000270062,0.0003566438,0.00036630937],"domain_scores_gemma":[0.99896985,0.00030251077,0.00005216676,0.00051833276,0.0000844779,0.00007265124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027808137,0.00012621928,0.00021538872,0.000064992295,0.0000462481,0.000020231866,0.00019229652,0.000104179104,0.00020403693],"category_scores_gemma":[0.00012081535,0.000072230345,0.00008787287,0.00014909072,0.00004647036,0.00005696019,0.000072812705,0.00013987151,0.000103699866],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010952221,0.016604036,0.47515887,0.001497786,0.00069067575,0.00009582802,0.009173773,0.00009626945,0.35625568,0.0008963831,0.029101672,0.0994768],"study_design_scores_gemma":[0.3234511,0.002119244,0.19732957,0.00070909614,0.00007310067,0.000042820197,0.00038112843,0.0018697337,0.42829612,0.000705652,0.044579748,0.00044269528],"about_ca_topic_score_codex":0.00007309109,"about_ca_topic_score_gemma":0.00000871154,"teacher_disagreement_score":0.31249887,"about_ca_system_score_codex":0.0005646634,"about_ca_system_score_gemma":0.00077863183,"threshold_uncertainty_score":0.29454678},"labels":[],"label_agreement":null},{"id":"W2988718290","doi":"10.1182/blood-2019-131791","title":"Moral Distress, Anxiety, and Others Physical Symptoms Related to Hematopoietic Stem Cell Donation","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Anxiety; Medicine; Distress; Transplantation; Feeling; Psychiatry; Psychology; Internal medicine; Clinical psychology; Social psychology","score_opus":0.02360963343968811,"score_gpt":0.31005010788403303,"score_spread":0.28644047444434495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988718290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99135643,0.0006820238,0.0000059121435,0.00021584996,0.000046498444,0.00021870162,0.000011400534,0.000032436637,0.007430758],"genre_scores_gemma":[0.99849164,0.000072816176,0.00011782222,0.00007086639,0.000032599975,0.0000056100876,0.000016172704,0.0000141548835,0.0011783023],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994283,0.000015964613,0.00011773346,0.00016601104,0.00015856295,0.00011347196],"domain_scores_gemma":[0.99964714,0.00003538506,0.000043307562,0.00015186646,0.000042170068,0.00008015864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000038291502,0.00008980035,0.00021081019,0.00003283741,0.000012406773,0.0000063450266,0.00003943868,0.000047764428,0.000023730292],"category_scores_gemma":[0.00000676104,0.00007410212,0.00004600545,0.00010991974,0.00002725759,0.00003636123,0.000024868896,0.00006830392,0.000067760375],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007638486,0.00071569276,0.9427683,0.00046850558,0.0001428938,0.00001384196,0.0088336915,0.000010108268,0.04162601,0.001476152,0.000371514,0.003496926],"study_design_scores_gemma":[0.023568822,0.0026871974,0.22981276,0.0035521009,0.0013774898,0.000088995694,0.006662525,0.0011160198,0.7131589,0.0017781716,0.015131772,0.0010652546],"about_ca_topic_score_codex":0.0000145560625,"about_ca_topic_score_gemma":9.848984e-7,"teacher_disagreement_score":0.71295553,"about_ca_system_score_codex":0.000011726448,"about_ca_system_score_gemma":0.000013334796,"threshold_uncertainty_score":0.3021797},"labels":[],"label_agreement":null},{"id":"W2988726130","doi":"10.1182/blood-2019-121796","title":"Training Pediatric Hematologists / Oncologists for Capacity Building in Ethiopia","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Global Health and Surgery","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Capacity building; Medicine; Psychological intervention; Workforce; Developing country; Global health; Family medicine; Nursing; Economic growth; Public health","score_opus":0.06533702244886798,"score_gpt":0.33782648821614686,"score_spread":0.2724894657672789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988726130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99523544,0.00036384867,0.00006256714,0.00038155398,0.00037893938,0.00063023635,0.0000074496866,0.000062834886,0.0028771376],"genre_scores_gemma":[0.9941202,0.000035702877,0.004722891,0.00078662694,0.00017935794,0.00004270197,0.000006830435,0.0000112548005,0.00009445699],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987685,0.000034112578,0.00030353226,0.00024422962,0.00013807032,0.0005115526],"domain_scores_gemma":[0.9991691,0.00037387188,0.00007844333,0.00016724023,0.000049119535,0.0001622229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006655651,0.00010798243,0.00039938724,0.000121213736,0.000032696862,0.0000059535123,0.000059591897,0.00018912811,0.000023132061],"category_scores_gemma":[0.0006438498,0.00009584881,0.00008705667,0.00021104518,0.000021403317,0.000037074955,0.000016953121,0.00022965904,0.000029959907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010898898,0.0003179672,0.9949545,0.0008154834,0.000010211851,0.00006714985,0.00030756998,0.0000027613662,0.00054067606,0.001753751,0.00026864404,0.00085225876],"study_design_scores_gemma":[0.019787995,0.0014421436,0.9609167,0.0003941995,0.0001989893,0.00071979687,0.00059694867,0.00026730297,0.0029395588,0.0027410367,0.009392025,0.00060332555],"about_ca_topic_score_codex":0.000066580746,"about_ca_topic_score_gemma":0.000029343266,"teacher_disagreement_score":0.03403786,"about_ca_system_score_codex":0.00005332721,"about_ca_system_score_gemma":0.00025328863,"threshold_uncertainty_score":0.3908601},"labels":[],"label_agreement":null},{"id":"W2988727246","doi":"10.1182/blood-2019-128678","title":"Preclinical Development of an Actinium-225-Labeled Antibody Radio-Conjugate Directed Against CD45 for Targeted Conditioning and Radioimmunotherapy","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Radioimmunotherapy; Monoclonal antibody; Antibody; Cancer research; Biodistribution; Multiple myeloma; Bone marrow; Chemistry; Medicine; Immunology","score_opus":0.02444709187363405,"score_gpt":0.35295319673069353,"score_spread":0.3285061048570595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988727246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977703,0.0004333456,0.0001366443,0.00014643499,0.00004399729,0.0008507035,0.00003209006,0.00010363496,0.00048284384],"genre_scores_gemma":[0.9841953,0.00008583448,0.01464043,0.00014404843,0.000089836954,0.00008280307,0.0004980267,0.00002653906,0.0002371887],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989087,0.00002707343,0.00042665278,0.00030569176,0.00012541798,0.00020646704],"domain_scores_gemma":[0.99917245,0.00019433904,0.00013486765,0.00024926258,0.000094362236,0.00015473271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022815468,0.00014505719,0.00036200395,0.00003420226,0.00010049115,0.000014014708,0.000077468416,0.00011754359,0.000088923625],"category_scores_gemma":[0.00007238327,0.00013443867,0.00006171347,0.000114212846,0.00008054099,0.00007085368,0.0000133709755,0.00015889312,0.0000058739524],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000341006,0.00081004755,0.0053620483,0.00017866147,0.00027351954,0.0000018264258,0.00019143274,0.0000017347858,0.99020857,0.000041886655,0.000014857028,0.0025744394],"study_design_scores_gemma":[0.0119137075,0.00020758204,0.027473997,0.000100432124,0.00016459786,0.00002615847,0.00004133746,0.00083624775,0.9548697,0.000022038394,0.0041687503,0.00017545806],"about_ca_topic_score_codex":7.847348e-7,"about_ca_topic_score_gemma":1.7365485e-7,"teacher_disagreement_score":0.03533885,"about_ca_system_score_codex":0.000015326339,"about_ca_system_score_gemma":0.00012459866,"threshold_uncertainty_score":0.548225},"labels":[],"label_agreement":null},{"id":"W2988733311","doi":"10.1182/blood-2019-124559","title":"3D Telomeric Fingerprint of Advanced Cutaneous T-Cell Lymphoma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Institute in Oncology and Hematology; University of Manitoba; McGill University; CancerCare Manitoba; Jewish General Hospital","funders":"","keywords":"Mycosis fungoides; CD30; Telomere; Malignancy; Fluorescence in situ hybridization; Cutaneous T-cell lymphoma; Pathology; Biology; Medicine; Lymphoma; Cancer research; Genetics; DNA","score_opus":0.007277460684648129,"score_gpt":0.2537911913881701,"score_spread":0.24651373070352195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988733311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9573187,0.00076141814,0.000017089307,0.00008856834,0.00006828348,0.0007130254,0.000008622905,0.000054910597,0.04096934],"genre_scores_gemma":[0.99203986,0.00016120427,0.0017672859,0.00013436115,0.000034567583,0.000022029004,0.000012502465,0.000041796215,0.005786411],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984986,0.000036198424,0.000286374,0.00033890238,0.0004787434,0.00036117595],"domain_scores_gemma":[0.998937,0.00011619981,0.00009197754,0.00052697904,0.00019427511,0.00013356235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007938729,0.00017182193,0.0004221644,0.0001527467,0.000031504715,0.000009375083,0.0001499702,0.000083876905,0.00076852617],"category_scores_gemma":[0.00013080523,0.00015478367,0.000120999415,0.0003128559,0.00007976884,0.000033748358,0.00008905261,0.000099062105,0.00054407644],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090430066,0.005114747,0.13004027,0.0007630062,0.00021078139,0.00070088747,0.0007724931,0.000082091,0.8166166,0.00006311174,0.0001184664,0.044613257],"study_design_scores_gemma":[0.034619387,0.0053634215,0.016336527,0.0003960484,0.0003309661,0.009989547,0.0013206751,0.0011890888,0.9176691,0.0001538677,0.011837758,0.0007935868],"about_ca_topic_score_codex":0.00003947909,"about_ca_topic_score_gemma":0.0000042782503,"teacher_disagreement_score":0.11370375,"about_ca_system_score_codex":0.000059261343,"about_ca_system_score_gemma":0.0002859772,"threshold_uncertainty_score":0.8414822},"labels":[],"label_agreement":null},{"id":"W2988739382","doi":"10.1182/blood-2019-130147","title":"Characterizing Dyskeratosis Congenita Caused By Parn Mutations in the Zebrafish","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Zebrafish Biomedical Research Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children; Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Dyskeratosis congenita; Zebrafish; Biology; Genetics; Gene; Danio; Cancer research; Telomere","score_opus":0.009561303699251825,"score_gpt":0.26118264534622226,"score_spread":0.2516213416469704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988739382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950497,0.0001670633,0.000056655907,0.0020876445,0.000023626699,0.0004210451,0.00008382229,0.000009898586,0.0021005203],"genre_scores_gemma":[0.9975705,0.00005303368,0.000055082604,0.0011440166,0.000069050424,0.00020685332,0.00058463425,0.000013767284,0.00030303188],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990621,0.0000835981,0.00015381826,0.00025344678,0.00019500211,0.00025202648],"domain_scores_gemma":[0.9994088,0.000051927607,0.000036968195,0.0003859326,0.000041953215,0.00007446359],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002385567,0.000088618726,0.00008351982,0.00003313204,0.000058867932,0.000048614504,0.00032631375,0.00009490064,0.00007717331],"category_scores_gemma":[0.00014387548,0.000070520975,0.00004148732,0.00020134068,0.00007293915,0.0000046202354,0.000064973174,0.00013101602,0.00012710919],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000041404905,0.00024117781,0.0068619745,0.000006581875,0.000031026826,0.0000017413132,0.0000678368,1.2517734e-7,0.98910487,0.000074760515,0.003260182,0.00034555764],"study_design_scores_gemma":[0.0028026535,0.000298211,0.055139128,0.00001688023,0.00004150302,0.000014608698,0.00042755358,0.000034751632,0.7503162,0.00014113128,0.19045116,0.00031623326],"about_ca_topic_score_codex":0.000021821852,"about_ca_topic_score_gemma":0.000045495555,"teacher_disagreement_score":0.23878871,"about_ca_system_score_codex":0.0000058038686,"about_ca_system_score_gemma":0.00006581888,"threshold_uncertainty_score":0.28757617},"labels":[],"label_agreement":null},{"id":"W2988746454","doi":"10.1182/blood-2019-129545","title":"Myeloproliferative Neoplasm (MPN) Patient Online Questionnaire: Assessing Patients' Disease Knowledge in a Rare Hematologic Malignancy in the Modern Digital Information Era","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Population; Social media; The Internet; Disease; Family medicine; Internal medicine; World Wide Web; Computer science; Environmental health","score_opus":0.007325194631079829,"score_gpt":0.24303595928560537,"score_spread":0.23571076465452553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988746454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962864,0.00045457482,0.000025346782,0.00024313724,0.000095458476,0.0014469858,0.00006585751,0.000050484126,0.0013317624],"genre_scores_gemma":[0.9985614,0.000016156318,0.00014779335,0.00028655233,0.000029301884,0.00013903377,0.0007607357,0.000015950136,0.00004310956],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848825,0.00009230586,0.0005185144,0.0002576721,0.00033233975,0.00031093552],"domain_scores_gemma":[0.99917173,0.000086800355,0.00016003521,0.00035833407,0.00011941776,0.00010366949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000084332256,0.00024126886,0.00031685625,0.00018037634,0.000047216017,0.00009671819,0.000114262606,0.00009645013,0.000015871325],"category_scores_gemma":[0.00023518149,0.00016650528,0.000072627234,0.0003404326,0.000032389726,0.0009677961,0.000070825416,0.00029477917,0.0001241079],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012548022,0.0042553507,0.967525,0.00026611311,0.00003604204,0.00010835793,0.006848082,0.00006592925,0.0000074855675,0.00011825868,0.00003432475,0.020609582],"study_design_scores_gemma":[0.01413686,0.00037203214,0.9783474,0.0015322494,0.00008254173,0.000055822817,0.0007961618,0.0037338706,0.00008549666,0.00047894672,0.00012674743,0.00025185812],"about_ca_topic_score_codex":0.000027951666,"about_ca_topic_score_gemma":0.0000478027,"teacher_disagreement_score":0.020357724,"about_ca_system_score_codex":0.0004557618,"about_ca_system_score_gemma":0.00056930166,"threshold_uncertainty_score":0.6789889},"labels":[],"label_agreement":null},{"id":"W2988770565","doi":"10.1182/blood-2019-122988","title":"Impact of Modifying Conditioning and Immunosuppressive Strategies in Allogeneic Hematopoietic Stem Cell Transplantation in Children with Acute Lymphoblastic Leukemia","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Fludarabine; Hematopoietic stem cell transplantation; Internal medicine; Transplantation; Acute lymphocytic leukemia; Total body irradiation; Anti-thymocyte globulin; Gastroenterology; Etoposide; Regimen; Leukemia; Surgery; Immunology; Chemotherapy; Cyclophosphamide; Lymphoblastic Leukemia","score_opus":0.006687594679020964,"score_gpt":0.2519741519159678,"score_spread":0.2452865572369468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988770565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99834836,0.0003250827,0.00016885869,0.0000058085825,0.000008656803,0.00071914366,0.00004099343,0.000018488272,0.00036461657],"genre_scores_gemma":[0.9993956,0.0001759971,0.00023386226,0.000007280291,0.000010693299,0.000032758453,0.000079265585,0.000030921423,0.000033618544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986479,0.00005984563,0.0003343279,0.00031161399,0.0003018751,0.00034440673],"domain_scores_gemma":[0.9993818,0.00014096689,0.000121249795,0.00021768159,0.000056012665,0.00008232014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001112979,0.00020367398,0.0004426862,0.0003080176,0.000024126179,0.000029766514,0.00009834597,0.00011962196,0.000031914722],"category_scores_gemma":[0.0000045113115,0.00015935383,0.00005245927,0.00029455614,0.00009660108,0.00022096194,0.000027811106,0.0001986454,0.0000073933948],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007672702,0.00028185552,0.84896207,0.0004505309,0.00040981072,0.0002994614,0.002451457,0.0042719645,0.14197013,0.000050160008,0.0000019531574,0.000083351726],"study_design_scores_gemma":[0.023806272,0.0010782102,0.9335253,0.0007617043,0.00032731236,0.0019513392,0.0008235722,0.0013429519,0.03614512,0.000043081796,4.9918725e-8,0.0001950838],"about_ca_topic_score_codex":0.0004933074,"about_ca_topic_score_gemma":0.000023953575,"teacher_disagreement_score":0.10582501,"about_ca_system_score_codex":0.0003819175,"about_ca_system_score_gemma":0.0012586014,"threshold_uncertainty_score":0.64982605},"labels":[],"label_agreement":null},{"id":"W2988772156","doi":"10.1182/blood.2019002804","title":"Reducing the burden of MPN","year":2019,"lang":"en","type":"letter","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine","score_opus":0.019381403932945313,"score_gpt":0.2577189647935971,"score_spread":0.2383375608606518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988772156","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08873484,0.0016744357,0.0000013787256,0.8885774,0.00034990825,0.0011129322,0.000065261265,0.000029896622,0.019453954],"genre_scores_gemma":[0.18714182,0.00089797535,0.0008670051,0.73645383,0.0256493,0.00042172786,0.0008545837,0.0002188319,0.047494937],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987859,0.00005719631,0.0002733781,0.00029882096,0.00036336685,0.00022130735],"domain_scores_gemma":[0.99875796,0.0002933367,0.00017901153,0.00064498873,0.00009981411,0.00002492005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000094033254,0.00023030944,0.0005410378,0.000067795845,0.00004042131,0.0000134962165,0.00012787318,0.00031566186,0.00035578592],"category_scores_gemma":[0.00006831765,0.00012791312,0.00020698897,0.00007983653,0.00005429884,0.000014534974,0.00004674604,0.0006910162,0.00018482984],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011533346,0.00019105196,0.001794058,0.00034751982,0.00088216685,0.00029717435,0.00045356943,0.0000030877093,0.00030533943,0.000019781599,0.9952329,0.0004618389],"study_design_scores_gemma":[0.0026527701,0.0005279415,0.0011657699,0.0008973959,0.0019451604,0.00019233368,0.000045648834,0.000008287978,0.01469475,0.00002846257,0.97766036,0.0001811382],"about_ca_topic_score_codex":0.00020377322,"about_ca_topic_score_gemma":8.670385e-7,"teacher_disagreement_score":0.15212357,"about_ca_system_score_codex":0.000025396754,"about_ca_system_score_gemma":0.00015066676,"threshold_uncertainty_score":0.5216146},"labels":[],"label_agreement":null},{"id":"W2988792442","doi":"10.1182/blood-2019-124587","title":"Correlation of CD123 Expression Level with Disease Characteristics and Outcomes in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Oncology; Interleukin-3 receptor; Internal medicine; Minimal residual disease; Induction chemotherapy; Myeloid leukemia; Hematology; Hematopoietic stem cell transplantation; Transplantation; Chemotherapy; Chemotherapy regimen; Hazard ratio; Population; Leukemia; Sorafenib; Immunology; Confidence interval","score_opus":0.011934038446141229,"score_gpt":0.265790608247545,"score_spread":0.2538565698014038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988792442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978585,0.00017867974,0.00014990772,0.00052101206,0.00007266994,0.00091947336,0.000120253426,0.000023400715,0.00015610764],"genre_scores_gemma":[0.99767387,0.00032312595,0.0008579632,0.0001394183,0.0001668699,0.000037832724,0.00039532906,0.000028953902,0.00037663852],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984984,0.00009510343,0.00040594678,0.00036438784,0.00039771144,0.00023848235],"domain_scores_gemma":[0.9985453,0.0004227367,0.00027893746,0.0005204853,0.00008131196,0.00015126687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002923126,0.00017231522,0.00046261764,0.00012017115,0.00004152916,0.0000118079315,0.00013198076,0.00015124613,0.000035028057],"category_scores_gemma":[0.00030058366,0.00010327354,0.00005059559,0.00020886923,0.00008583535,0.00009924522,0.00014450368,0.00047853723,0.000014807061],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070555165,0.00031147664,0.9949191,0.000038064354,0.00010545578,0.0005693781,0.0002079888,0.0000019598394,0.0023557232,0.000012437,0.000148954,0.0006238649],"study_design_scores_gemma":[0.0071332366,0.00033510008,0.9911245,0.00006872166,0.0005348662,0.00017814527,0.00005301773,0.00012882413,0.00025227986,0.00002525403,0.000052356776,0.000113657785],"about_ca_topic_score_codex":0.00024440573,"about_ca_topic_score_gemma":0.000022821421,"teacher_disagreement_score":0.006427685,"about_ca_system_score_codex":0.00015587805,"about_ca_system_score_gemma":0.0006137294,"threshold_uncertainty_score":0.42113727},"labels":[],"label_agreement":null},{"id":"W2988805122","doi":"10.1182/blood-2019-122558","title":"\"Identification of Mechanisms By Which Mesenchymal Stem/Stromal Cells Contribute to Acute Myeloid Leukemia\"","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; Health Canada","funders":"","keywords":"Mesenchymal stem cell; Myeloid leukemia; Haematopoiesis; Cancer research; Bone marrow; Leukemia; Stromal cell; Stem cell; Biology; Medicine; Immunology; Pathology; Cell biology","score_opus":0.00796163129554561,"score_gpt":0.25217984322045406,"score_spread":0.24421821192490845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988805122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99309766,0.00012517284,0.0024351662,0.0010450925,0.0002527932,0.001567037,0.00036447227,0.0000896066,0.0010229906],"genre_scores_gemma":[0.983822,0.00006177398,0.0014556841,0.00025969377,0.00010399499,0.000066253204,0.00014638736,0.000059296657,0.014024902],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99710095,0.000097882265,0.00066040934,0.0005907978,0.0009289314,0.0006210019],"domain_scores_gemma":[0.99778795,0.00011444828,0.00021380845,0.00089517864,0.0006130831,0.00037555772],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007222046,0.00025785592,0.0006329816,0.00022773074,0.000060418104,0.000040237108,0.00039948846,0.00024609413,0.00026582304],"category_scores_gemma":[0.00009399699,0.00023887187,0.00013171809,0.00067084504,0.000041527866,0.00014120674,0.00019608888,0.0003965074,0.0013438144],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024286358,0.0002421788,0.0008477799,0.00011508828,0.00036186943,0.000027379043,0.00015438427,0.00001093312,0.9897486,0.00041254805,0.0075324546,0.00030391262],"study_design_scores_gemma":[0.0056605227,0.0008851669,0.0015083434,0.00007377807,0.0003842273,0.00007955102,0.00017382833,0.0003764399,0.9888326,0.00004885685,0.0017566703,0.00022003443],"about_ca_topic_score_codex":0.000082263585,"about_ca_topic_score_gemma":0.0000069424455,"teacher_disagreement_score":0.013001911,"about_ca_system_score_codex":0.00034745544,"about_ca_system_score_gemma":0.0006579835,"threshold_uncertainty_score":0.99943376},"labels":[],"label_agreement":null},{"id":"W2988863151","doi":"10.1182/blood-2019-128834","title":"Safety and Efficacy of Apixaban Thromboprophylaxis in Cancer Patients with Metastatic Disease: A Subgroup Analysis of the Avert Trial","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Apixaban; Pulmonary embolism; Randomization; Placebo; Surgery; Internal medicine; Population; Randomized controlled trial; Warfarin; Rivaroxaban","score_opus":0.008199239268331897,"score_gpt":0.2487766025246794,"score_spread":0.2405773632563475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988863151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979963,0.00023646047,0.000002911945,0.00008387213,0.00007001517,0.0014047048,0.000055353055,0.00000435635,0.00014605078],"genre_scores_gemma":[0.9996569,0.00011916743,0.000043752552,0.000053802843,0.00001025463,0.000025666768,0.000019687594,0.000010363189,0.000060377555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989993,0.000048401682,0.00029452977,0.00020114989,0.00033045924,0.00012618647],"domain_scores_gemma":[0.9993218,0.000061262675,0.00016541829,0.00034019822,0.000055912045,0.000055367746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011896153,0.00010428964,0.00065214967,0.00015283324,0.000016810362,0.000004071309,0.00007729734,0.000015310645,0.00013356943],"category_scores_gemma":[0.000040020284,0.000060184182,0.000121300705,0.00064801006,0.00006120943,0.00003093611,0.000056519282,0.000056589197,7.819701e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004783748,0.0064230203,0.9836499,0.00028152327,0.0033347313,0.0000025157963,0.00048741384,0.000114402974,0.00009579631,0.00014953363,0.000012561059,0.0006648213],"study_design_scores_gemma":[0.045891598,0.00074925215,0.9460738,0.0001395627,0.006794715,5.6728386e-8,0.000034909663,0.00005296973,0.00014129131,0.000006633185,0.000051778035,0.00006348116],"about_ca_topic_score_codex":0.0005003093,"about_ca_topic_score_gemma":0.00028359288,"teacher_disagreement_score":0.04110785,"about_ca_system_score_codex":0.000019623936,"about_ca_system_score_gemma":0.00005469071,"threshold_uncertainty_score":0.24542397},"labels":[],"label_agreement":null},{"id":"W2988868939","doi":"10.1182/blood-2019-128769","title":"First Review of Multiple Myeloma Patients in Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Abu dhabi; Medicine; Incidence (geometry); Multiple myeloma; Demography; Internal medicine; Pathology; Metropolitan area","score_opus":0.02189552262397528,"score_gpt":0.2940192232792801,"score_spread":0.27212370065530483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988868939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922406,0.0036063606,0.0000013431019,0.00059047056,0.000064313565,0.0012919361,0.000056503937,0.000034076802,0.002114373],"genre_scores_gemma":[0.9920717,0.006344064,0.00020994229,0.0005286018,0.000040800373,0.00006360646,0.00045253735,0.000026370131,0.00026239714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975666,0.000105711,0.0005554103,0.00034172097,0.001009079,0.00042149064],"domain_scores_gemma":[0.9984709,0.0003107779,0.00012267726,0.00049597805,0.0002376154,0.000362031],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037033457,0.0002079363,0.0006059548,0.0002606024,0.00003184701,0.00000721985,0.00021164256,0.00014958114,0.0016950942],"category_scores_gemma":[0.0018031265,0.00015909405,0.00013155614,0.00061959267,0.00007966131,0.00006896366,0.00013672563,0.00028275198,0.0002187059],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001428027,0.0029083563,0.9902079,0.0040434846,0.00015608768,0.00013383529,0.00006069824,2.4079344e-7,0.00008014816,0.000009818709,0.00048681308,0.001769788],"study_design_scores_gemma":[0.020128537,0.00072755554,0.96071947,0.012743034,0.00010467207,0.000024054796,0.000020180789,0.00033407006,0.002261374,0.000013521965,0.0027556291,0.00016789766],"about_ca_topic_score_codex":0.0006098833,"about_ca_topic_score_gemma":0.00026629918,"teacher_disagreement_score":0.029488454,"about_ca_system_score_codex":0.00005175679,"about_ca_system_score_gemma":0.0001616048,"threshold_uncertainty_score":0.9992175},"labels":[],"label_agreement":null},{"id":"W2988924036","doi":"10.1182/blood-2019-122784","title":"The Mitochondrial Protease, Neurolysin (NLN), Regulates Respiratory Chain Complex and Supercomplex Formation and Is Necessary for AML Viability","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Respiratory chain; Gene knockdown; Biology; Haematopoiesis; Stem cell; Myeloid leukemia; Mitochondrial respiratory chain; Mitochondrion; Leukemia; Myeloid; Small hairpin RNA; Molecular biology; Cancer research; Cell culture; Cell biology; Immunology; Genetics","score_opus":0.01626558467352507,"score_gpt":0.262568239818473,"score_spread":0.24630265514494792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988924036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99700516,0.0006383327,0.000073509545,0.00059972855,0.00006346563,0.0014125617,0.00007072219,0.00001164204,0.00012488023],"genre_scores_gemma":[0.99848604,0.00003385423,0.0004535569,0.00025214461,0.00026273818,0.00014196637,0.00008396987,0.000022956592,0.0002627656],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988657,0.00014469051,0.00021749017,0.00036560034,0.00015430813,0.0002522045],"domain_scores_gemma":[0.99927706,0.00006879019,0.00005602779,0.00041016453,0.000105596846,0.00008237102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032587757,0.00013526596,0.0001373131,0.000031623706,0.00025430485,0.0000695015,0.00013956208,0.00011405297,0.000010553148],"category_scores_gemma":[0.00016187699,0.00010792298,0.000055909237,0.00005662659,0.00018735745,0.000013194315,0.00013583007,0.00009424171,0.000004564457],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021235214,0.000069840265,0.0009345089,0.00008826277,0.000021939306,4.941099e-7,0.000090840964,0.0000010141839,0.99396676,0.000026616473,0.0031545048,0.0014328472],"study_design_scores_gemma":[0.0031649438,0.0007650299,0.005372799,0.000012723483,0.000024757052,0.000021145368,0.00010236854,0.00059718365,0.8893764,0.00023062614,0.100112736,0.0002193005],"about_ca_topic_score_codex":0.000014967317,"about_ca_topic_score_gemma":0.000029694493,"teacher_disagreement_score":0.10459039,"about_ca_system_score_codex":0.000008255487,"about_ca_system_score_gemma":0.00004888591,"threshold_uncertainty_score":0.44009712},"labels":[],"label_agreement":null},{"id":"W2988926823","doi":"10.1182/blood-2019-125941","title":"Patient Age and Donor HLA Matching Can Stratify Allogeneic Hematopoietic Cell Transplantation (HCT) Patients into Prognostic Groups: A Collaborative Study","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Transplantation; Population; Internal medicine; Hematopoietic cell; Cohort; Hematopoietic stem cell transplantation; Retrospective cohort study; Propensity score matching; Surgery; Haematopoiesis; Stem cell","score_opus":0.005541743676965089,"score_gpt":0.2276902146287002,"score_spread":0.22214847095173512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988926823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99492264,0.00026345905,0.0000062840595,0.00003591904,0.000107690495,0.0040034195,0.000046401685,0.000058698857,0.00055551],"genre_scores_gemma":[0.99858844,0.000050050345,0.0006719942,0.0000686887,0.000026458305,0.00021738846,0.00023003232,0.000041679064,0.00010529175],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998305,0.000112430724,0.0003916098,0.0004975602,0.00040184736,0.00029155612],"domain_scores_gemma":[0.99918175,0.000090674956,0.00015472034,0.00029677714,0.000105627274,0.00017045155],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000081305865,0.00029210138,0.0004046223,0.00009795662,0.00009241551,0.00004591658,0.000065227665,0.0000904203,0.0000471054],"category_scores_gemma":[0.000018139717,0.0002482759,0.000045419034,0.00021679787,0.000035400393,0.00009023044,0.000035184177,0.00017040098,0.000046394685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022504877,0.0056071407,0.9404742,0.00080757344,0.00034566195,0.0006539624,0.047018915,0.000010515067,0.003968073,0.000020149431,0.000016013028,0.00085271563],"study_design_scores_gemma":[0.03575616,0.008169928,0.93116766,0.0004605901,0.0018129727,0.00007797839,0.012985041,0.000013639058,0.008902992,0.00014674167,0.0000229931,0.00048328502],"about_ca_topic_score_codex":0.00033794774,"about_ca_topic_score_gemma":0.0004933783,"teacher_disagreement_score":0.03553111,"about_ca_system_score_codex":0.00022556164,"about_ca_system_score_gemma":0.00025529906,"threshold_uncertainty_score":0.99999696},"labels":[],"label_agreement":null},{"id":"W2988933746","doi":"10.1182/blood.2019004415","title":"The neurotransmitter receptor Gabbr1 regulates proliferation and function of hematopoietic stem and progenitor cells","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Center for Advancing Translational Sciences; National Institute of General Medical Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; Northwestern University; National Heart, Lung, and Blood Institute; University of Illinois at Chicago; University of Illinois at Urbana-Champaign; Chicago Biomedical Consortium; National Cancer Institute; National Institutes of Health; University of Chicago; Chicago Community Trust","keywords":"Progenitor cell; Haematopoiesis; Cell biology; Biology; Transplantation; Stem cell; Bone marrow; Immunology; Internal medicine; Medicine","score_opus":0.014591087665377438,"score_gpt":0.21278314830747505,"score_spread":0.1981920606420976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988933746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99602556,0.0005838194,0.00030177375,0.0021310004,0.00006199602,0.0007542806,0.0000047304084,0.00003868358,0.00009813744],"genre_scores_gemma":[0.9990516,0.00017942161,0.0003347979,0.00019915563,0.00010066716,0.000032870845,0.0000061857363,0.000017986391,0.000077317694],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99921775,0.000050622577,0.00025298476,0.00019200965,0.00017556947,0.0001110804],"domain_scores_gemma":[0.99958324,0.000085343,0.00006675828,0.000109553315,0.000057001856,0.000098089185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000105588755,0.0001028339,0.00016743787,0.000019627678,0.00006955727,0.000023874798,0.000027735367,0.000059768583,0.000011554555],"category_scores_gemma":[0.000009734752,0.00007170532,0.000029631921,0.00008546769,0.000068255285,0.000049474005,0.000007641145,0.00008076884,0.0000069104185],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044245739,0.00012664132,0.021566331,0.0018434618,0.00011141819,0.000007579086,0.0032445297,8.907327e-7,0.96953166,0.00021388363,0.00017103771,0.002740133],"study_design_scores_gemma":[0.0023363568,0.00059644785,0.010013624,0.00013096092,0.0004045174,0.00008375529,0.0002894063,0.00016989007,0.98513705,0.000032828488,0.0007146908,0.00009044653],"about_ca_topic_score_codex":9.583567e-7,"about_ca_topic_score_gemma":5.014511e-7,"teacher_disagreement_score":0.015605439,"about_ca_system_score_codex":0.0000025807915,"about_ca_system_score_gemma":0.000025054698,"threshold_uncertainty_score":0.2924058},"labels":[],"label_agreement":null},{"id":"W2988950881","doi":"10.1182/blood-2019-128095","title":"Patient Preferences Regarding Anticoagulation Therapy in Patients with Cancer Having a VTE Event - a Discrete Choice Experiment in the Cosimo Study","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Vitamin K antagonist; Dosing; Rivaroxaban; Observational study; Regimen; Warfarin; Cancer; Intensive care medicine; Internal medicine","score_opus":0.23682945469600813,"score_gpt":0.5027215121136029,"score_spread":0.2658920574175948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988950881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957958,0.0004477533,7.6103845e-7,0.00040799158,0.00028255957,0.0026924012,0.00001617676,0.000020807547,0.0003357887],"genre_scores_gemma":[0.9984282,0.00007230208,0.00000752313,0.0009284721,0.00006476616,0.0004481738,0.000013157033,0.000014399602,0.00002296123],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975614,0.0009600587,0.00037865524,0.0003575299,0.0003090247,0.00043334623],"domain_scores_gemma":[0.99924684,0.00025225864,0.00013883962,0.00020289935,0.00005746481,0.00010170537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056246424,0.00020657433,0.00025220177,0.00008473051,0.00014023924,0.000029896972,0.00021447544,0.00016965304,0.0003126681],"category_scores_gemma":[0.000021379761,0.00013313598,0.000034023637,0.0002864099,0.000044664444,0.00016556571,0.00005243812,0.00095725176,0.000009285002],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057481485,0.0035182748,0.9813962,0.000021944772,0.000087252636,0.000008974257,0.008321473,0.0007144127,0.00048362062,0.000020758236,0.000018949358,0.004833344],"study_design_scores_gemma":[0.011098784,0.0014138983,0.9795619,0.0001148017,0.000066496126,7.0558747e-7,0.002417726,0.0004985736,0.0034807627,0.000019421082,0.0011012838,0.0002256093],"about_ca_topic_score_codex":0.0003864236,"about_ca_topic_score_gemma":0.00041529557,"teacher_disagreement_score":0.010523969,"about_ca_system_score_codex":0.0000836657,"about_ca_system_score_gemma":0.00007256218,"threshold_uncertainty_score":0.5429128},"labels":[],"label_agreement":null},{"id":"W2988955792","doi":"10.1182/blood-2019-125686","title":"The Effect of \"Pathway\" to Diagnosis for Childhood ITP on Caregiver Quality of Life at Time of Diagnosis","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Medicine; Quality of life (healthcare); Pediatrics; Observational study; Asymptomatic; Prospective cohort study; Immune thrombocytopenia; Specialty; Disease; Family medicine; Internal medicine","score_opus":0.00927170407427827,"score_gpt":0.25937008953590135,"score_spread":0.2500983854616231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988955792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99641746,0.0006687773,4.0144238e-7,0.000270657,0.000047500707,0.0015304381,0.0002488654,0.000009261078,0.00080660847],"genre_scores_gemma":[0.9992617,0.0000996083,0.000023831619,0.00007811208,0.000018226172,0.00021564374,0.000026767344,0.000017253096,0.00025886728],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990494,0.00006461847,0.00029633899,0.00018574938,0.00023903915,0.00016484287],"domain_scores_gemma":[0.99784744,0.0014424385,0.0001766818,0.0003864549,0.000063010455,0.00008395788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022200406,0.00013369929,0.00060531625,0.000045826204,0.000031131745,0.0000021344563,0.00009763911,0.0000660417,0.00006578547],"category_scores_gemma":[0.00048043573,0.00008138081,0.00023672452,0.0000985176,0.000033770888,0.000016048385,0.000043634303,0.000040094677,0.00005384769],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010827323,0.002209293,0.98756,0.00043285993,0.00090657285,0.0000039171314,0.0006464971,0.000005235696,0.0023920992,0.00004825924,0.0011528308,0.0035597289],"study_design_scores_gemma":[0.013652845,0.0076168645,0.48430768,0.00029572917,0.0004459331,0.0000017090067,0.00004837411,0.0000022508477,0.4926852,0.000020548887,0.00081402715,0.00010883911],"about_ca_topic_score_codex":0.00012588792,"about_ca_topic_score_gemma":0.000024517467,"teacher_disagreement_score":0.5032523,"about_ca_system_score_codex":0.000017243712,"about_ca_system_score_gemma":0.000031936,"threshold_uncertainty_score":0.3318613},"labels":[],"label_agreement":null},{"id":"W2988975841","doi":"10.1182/blood-2019-122436","title":"Intermediate Vs High Dose Busulfan-Based Conditioning for Allogeneic Cell Transplantation in Patients with Acute Leukemia or Myelodysplastic Syndromes from HLA Matched Related or Unrelated Donors: Achieving the Same with Less","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Kingston General Hospital; Northeast Cancer Centre; Thunder Bay Regional Research Institute; Ottawa Hospital","funders":"","keywords":"Medicine; Busulfan; Transplantation; Tolerability; Internal medicine; Myelodysplastic syndromes; Acute leukemia; Hematopoietic stem cell transplantation; Fludarabine; Surgery; Oncology; Leukemia; Chemotherapy; Gastroenterology; Cyclophosphamide; Adverse effect; Bone marrow","score_opus":0.009633156813633522,"score_gpt":0.23451748974964154,"score_spread":0.224884332936008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988975841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955951,0.000026495696,0.00047444968,0.00034707575,0.000104154904,0.0029224125,0.0003733202,0.00012295031,0.000034062734],"genre_scores_gemma":[0.99386615,0.000053889704,0.0018222124,0.0002529378,0.000038326518,0.00027846475,0.002974171,0.00012901798,0.00058485783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974136,0.00017574175,0.0005437452,0.0006629598,0.00056643435,0.00063756],"domain_scores_gemma":[0.99750304,0.0013007716,0.0003028465,0.00050650095,0.00021197692,0.00017484916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028209272,0.00043168283,0.00070105976,0.0003110712,0.00014552154,0.000074469724,0.00032263552,0.00029355625,0.00019474635],"category_scores_gemma":[0.00008109542,0.00023533753,0.000076838114,0.0006936879,0.00017044261,0.00022810564,0.000035242225,0.0007327487,0.000054637465],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13329907,0.0018907057,0.81913483,0.001868643,0.004009943,0.0027651964,0.005136767,0.0066070943,0.024062945,0.000033042463,0.00011741849,0.0010743183],"study_design_scores_gemma":[0.081126966,0.0047075236,0.90034837,0.002009677,0.002125069,0.00011057353,0.0005252959,0.0018755211,0.006647818,0.000015945529,0.000012821068,0.0004944339],"about_ca_topic_score_codex":0.00044806977,"about_ca_topic_score_gemma":0.00037093798,"teacher_disagreement_score":0.0812135,"about_ca_system_score_codex":0.0004512706,"about_ca_system_score_gemma":0.0012028828,"threshold_uncertainty_score":0.9596786},"labels":[],"label_agreement":null},{"id":"W2989035987","doi":"10.1182/blood-2019-121943","title":"TP53 Expression Correlates with TP53 Mutations and Is an Independent Predictor of Clinical Outcome in Patients with DLBCL Treated with R-CHOP","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Diffuse large B-cell lymphoma; CHOP; Tissue microarray; Oncology; Population; Lymphoma; Internal medicine; Biology; Immunohistochemistry; Pathology; Medicine; Cancer research","score_opus":0.016924340947942835,"score_gpt":0.2831427425900293,"score_spread":0.2662184016420865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989035987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99866563,0.000050523493,0.0000020594193,0.000042465777,0.00002181677,0.0008772031,0.000048248323,0.00002591586,0.00026611084],"genre_scores_gemma":[0.99913853,0.000011867269,0.0004782974,0.000067199115,0.000013825441,0.000047129208,0.00010657615,0.000024518535,0.00011205525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869156,0.00004436367,0.0003964157,0.0003546889,0.0003489514,0.00016403559],"domain_scores_gemma":[0.999122,0.00009378268,0.00019154807,0.00031394436,0.000112654765,0.00016604621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008173314,0.00017896417,0.00047102213,0.00008992666,0.000026161393,0.000011864931,0.00004515628,0.00010504695,0.000055536744],"category_scores_gemma":[0.000018293553,0.000095227544,0.00003190771,0.00013349662,0.000073997886,0.0001222653,0.000021639382,0.00011089591,0.000007505392],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013690344,0.007982387,0.98942524,0.000042729633,0.00021880337,0.000047802503,0.00042709408,0.000005106457,0.000022512751,0.0000060554657,0.000009149949,0.0004440899],"study_design_scores_gemma":[0.054199345,0.0073023895,0.936001,0.0004451319,0.0005383851,0.000015006547,0.00015645268,0.00002967615,0.0011854983,0.0000026159778,0.000010200577,0.00011427168],"about_ca_topic_score_codex":0.00011880574,"about_ca_topic_score_gemma":0.000047180823,"teacher_disagreement_score":0.053424206,"about_ca_system_score_codex":0.000023757577,"about_ca_system_score_gemma":0.00008262131,"threshold_uncertainty_score":0.38832667},"labels":[],"label_agreement":null},{"id":"W2989077172","doi":"10.1182/blood-2019-123426","title":"Daratumumab Plus Lenalidomide and Dexamethasone (D-Rd) Versus Lenalidomide and Dexamethasone (Rd) in Patients with Newly Diagnosed Multiple Myeloma (NDMM) Ineligible for Transplant: Updated Analysis of Maia","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Alberta; University of Calgary","funders":"","keywords":"Medicine; Lenalidomide; Internal medicine; Daratumumab; Hazard ratio; Multiple myeloma; Transplantation; Oncology; Surgery; Confidence interval","score_opus":0.016260619452254294,"score_gpt":0.2651019646184587,"score_spread":0.2488413451662044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989077172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99570733,0.0008130286,0.0001781258,0.00010525305,0.00004970975,0.0023974814,0.00056150503,0.000040524727,0.00014700927],"genre_scores_gemma":[0.9923289,0.00026053813,0.005880533,0.000041282972,0.000026646117,0.00015096024,0.0011656873,0.00006041548,0.00008503653],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971304,0.00014917384,0.0006191164,0.00079012953,0.00060414325,0.00070702395],"domain_scores_gemma":[0.9973503,0.0012135194,0.00023011502,0.0005585324,0.00024704402,0.0004005023],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038881495,0.00044099122,0.0013777113,0.0008971597,0.000091048736,0.000044270782,0.00015230494,0.00020154502,0.000078632074],"category_scores_gemma":[0.00033983582,0.00034733771,0.00017643986,0.0011525397,0.00017365879,0.00021094923,0.00006690031,0.00025959002,0.0000064592064],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044307727,0.0014595218,0.94362146,0.0003014831,0.004955048,0.0001148017,0.0005794785,0.00009956436,0.0023208144,0.0000122480515,0.00003286713,0.0021949667],"study_design_scores_gemma":[0.22076568,0.002300617,0.75769645,0.00024822954,0.0039124344,0.000008896505,0.00020444674,0.003277801,0.011146661,0.000007633015,0.00008158599,0.00034955592],"about_ca_topic_score_codex":0.0012924501,"about_ca_topic_score_gemma":0.0019688876,"teacher_disagreement_score":0.18592502,"about_ca_system_score_codex":0.000095750154,"about_ca_system_score_gemma":0.00015496576,"threshold_uncertainty_score":0.99989784},"labels":[],"label_agreement":null},{"id":"W2989078371","doi":"10.1182/blood-2019-129340","title":"The Incidence of Heparin Induced Thrombocytopenia before and after the Implementation of the Venous Thromboembolism Thromboprophylaxis Protocols within Eastern Health","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. John’s Health Sciences Centre; Memorial University of Newfoundland","funders":"","keywords":"Medicine; Heparin; Heparin-induced thrombocytopenia; Thrombosis; Low molecular weight heparin; Incidence (geometry); Venous thromboembolism; Anticoagulant; Venous thrombosis; Fondaparinux; Intensive care medicine; Surgery","score_opus":0.0178979733533866,"score_gpt":0.31818099946851164,"score_spread":0.30028302611512503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989078371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98097354,0.00011880404,0.000001994148,0.0015981125,0.00020476153,0.016746778,0.000026113485,0.000026475003,0.00030343872],"genre_scores_gemma":[0.99765044,0.000035272962,0.00011401727,0.00038968746,0.00008283791,0.0015937305,0.000005001746,0.00005019177,0.00007880241],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969474,0.00031916672,0.0010075816,0.00047152385,0.0007452883,0.0005090139],"domain_scores_gemma":[0.9972852,0.00013233056,0.00081659,0.0014041067,0.00022616205,0.0001356183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010488335,0.00034072084,0.0010542779,0.000063648025,0.0003485798,0.00006591773,0.00059847924,0.00014831708,0.000075683856],"category_scores_gemma":[0.000069341266,0.00016812865,0.00019192176,0.00047995662,0.00040486443,0.00019536313,0.0004739342,0.00049234973,0.000021880904],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023119453,0.0008047834,0.8823011,0.0007356061,0.00065497134,0.000003971915,0.017055385,9.1518984e-7,0.08866765,0.0024904197,0.00002243717,0.007031551],"study_design_scores_gemma":[0.0026518176,0.0021851093,0.9176991,0.00046183664,0.00020384928,0.00007917422,0.0023035584,0.000014264621,0.073406205,0.0007301684,0.00010433997,0.00016060658],"about_ca_topic_score_codex":0.001828457,"about_ca_topic_score_gemma":0.0036104005,"teacher_disagreement_score":0.035397958,"about_ca_system_score_codex":0.000073200914,"about_ca_system_score_gemma":0.0007862005,"threshold_uncertainty_score":0.68560874},"labels":[],"label_agreement":null},{"id":"W2989089017","doi":"10.1182/blood-2019-124842","title":"Clingen Coagulation Factor Deficiency Variant Curation Expert Panel: Meeting the Need for Recommendations to Curate Variants in the Coagulation Factor Genes","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Genetics; Coagulation; Gene; Computational biology; Medical genetics; Bioinformatics; Medicine; Biology; Internal medicine","score_opus":0.1138890599669322,"score_gpt":0.3643568991763542,"score_spread":0.250467839209422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989089017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98408276,0.0002894907,0.0013253061,0.010743006,0.00022058406,0.0029308952,0.0000404495,0.000037293077,0.0003302351],"genre_scores_gemma":[0.9981289,0.000075294374,0.00070674997,0.00026276705,0.00015889251,0.00020624371,0.0002201034,0.000020987054,0.00022009517],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985458,0.00017545938,0.00036113398,0.000273096,0.00033137342,0.0003130989],"domain_scores_gemma":[0.9988597,0.00051143643,0.000100668105,0.00032567422,0.00015437813,0.000048116475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005724493,0.00014615097,0.00018733255,0.00013283672,0.00025195765,0.00008197826,0.00014433026,0.00009310017,0.00010449569],"category_scores_gemma":[0.0002926428,0.00008102601,0.00007427752,0.00035871688,0.000017373457,0.00019510336,0.000028226048,0.000120465455,0.000053172414],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008620425,0.0037992543,0.39837414,0.00027343264,0.0003981778,0.000022540078,0.049885403,0.0007858094,0.43327224,0.002543443,0.00086633133,0.10891718],"study_design_scores_gemma":[0.011070973,0.0014723979,0.9098922,0.00036474408,0.00030197666,0.000060144095,0.0061643193,0.03322135,0.02564074,0.00062579376,0.010594133,0.00059122295],"about_ca_topic_score_codex":0.00014122242,"about_ca_topic_score_gemma":0.0000563016,"teacher_disagreement_score":0.51151806,"about_ca_system_score_codex":0.000058029334,"about_ca_system_score_gemma":0.00010456633,"threshold_uncertainty_score":0.33041447},"labels":[],"label_agreement":null},{"id":"W2989094582","doi":"10.1182/blood-2019-127101","title":"Dual Targeting of Mitochondrial Unfolded Protein Response and BCL2 in Acute Myeloid Leukemia","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Myeloid leukemia; Unfolded protein response; Myeloid; Cancer research; Venetoclax; Leukemia; Medicine; Biology; Immunology; Apoptosis; Chronic lymphocytic leukemia; Genetics","score_opus":0.0054530200545782805,"score_gpt":0.21779367267502162,"score_spread":0.21234065262044333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989094582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99862546,0.00021248059,0.000053374442,0.00005475274,0.00029320418,0.00036771834,0.000016430926,0.0000074816994,0.00036908913],"genre_scores_gemma":[0.9950734,0.000030979965,0.0028270304,0.00007220811,0.0002107682,0.000025361564,0.000049160284,0.000016355682,0.0016947401],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99904376,0.00016696048,0.00023396128,0.00029754164,0.00008024216,0.00017751865],"domain_scores_gemma":[0.9995955,0.000021026684,0.000084001455,0.00021445424,0.000037368314,0.000047628793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019848108,0.00011432491,0.0001827452,0.000061961815,0.000020158184,0.000007863912,0.000073566174,0.00019855975,0.000051495394],"category_scores_gemma":[0.00017037978,0.00011089114,0.00004783298,0.00007869744,0.000044391632,0.0000035105338,0.000081490674,0.000098300115,0.000015252613],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001783117,0.000053074295,0.0032561815,0.000016040289,0.000031817748,0.00001274091,0.000073060306,0.000005263929,0.994396,0.000039401584,0.00023485212,0.000098502285],"study_design_scores_gemma":[0.0043451907,0.00072426075,0.002759337,0.000020402907,0.000023802608,0.00004380991,0.000060500894,0.000008761103,0.9857029,0.00004346654,0.0061122305,0.00015535859],"about_ca_topic_score_codex":0.00001865943,"about_ca_topic_score_gemma":0.000015487532,"teacher_disagreement_score":0.008693069,"about_ca_system_score_codex":0.000006850143,"about_ca_system_score_gemma":0.00011255363,"threshold_uncertainty_score":0.45220095},"labels":[],"label_agreement":null},{"id":"W2989143285","doi":"10.1182/blood-2019-129197","title":"Diagnosing Absolute Iron-Deficiency Anemia in Patients on Hemodialysis in a Tertiary Care Centre: A Retrospective Chart Review","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hematological disorders and diagnostics","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"","keywords":"Medicine; Transferrin saturation; Hemodialysis; Anemia; Internal medicine; Iron deficiency; Ferritin; Gastroenterology; Population; Iron-deficiency anemia; Bone marrow examination; Surgery; Pediatrics; Bone marrow","score_opus":0.005193051394859314,"score_gpt":0.23206151445740603,"score_spread":0.2268684630625467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989143285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98697823,0.007819497,4.0559942e-7,0.000611683,0.000059116326,0.0010224424,0.000014193625,0.000024269762,0.0034701426],"genre_scores_gemma":[0.9948992,0.0028712547,0.000052204312,0.002037953,0.000016866583,0.000030556843,0.000058952843,0.000015145709,0.00001785342],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986096,0.00005198011,0.0003517857,0.00038211362,0.00027508053,0.0003294387],"domain_scores_gemma":[0.99935865,0.000119161836,0.00007488254,0.00029533965,0.00006244343,0.00008949151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009770878,0.00016055812,0.00048453148,0.000111581045,0.000020529633,0.00000816316,0.000078329336,0.000106023675,0.00015974982],"category_scores_gemma":[0.0008190041,0.00013480143,0.00009266155,0.00035637798,0.000022393433,0.00004227305,0.000043132368,0.00023608026,0.00017759977],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024571735,0.0017687853,0.995235,0.0011467998,0.0000031064728,0.00007980252,0.00034888877,0.0000015571329,0.0000117005875,0.000045823588,0.00029220074,0.0010417376],"study_design_scores_gemma":[0.0043078577,0.00033210253,0.99120474,0.0036006018,0.00008986366,0.0000015415673,0.00011839281,0.000005537365,0.000092562055,0.000035943354,0.000056031764,0.00015479844],"about_ca_topic_score_codex":0.000059231395,"about_ca_topic_score_gemma":0.00004278015,"teacher_disagreement_score":0.007920964,"about_ca_system_score_codex":0.00010650546,"about_ca_system_score_gemma":0.000039999748,"threshold_uncertainty_score":0.5497043},"labels":[],"label_agreement":null},{"id":"W2989166112","doi":"10.1182/blood-2019-125344","title":"Epidemiology of Post-Transplant Lymphoproliferative Disorders in Children with Solid Organ Transplant over 34 Years of a Single Center Experience","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Stollery Children's Hospital","funders":"","keywords":"Immunosuppression; Medicine; Lymphoproliferative disorders; Transplantation; Serostatus; Single Center; Population; Pediatrics; Internal medicine; Epidemiology; Incidence (geometry); Immunology; Viral load; Lymphoma; Human immunodeficiency virus (HIV)","score_opus":0.007069978831900566,"score_gpt":0.24291734760882788,"score_spread":0.23584736877692733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989166112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984771,0.00035939732,0.000020825622,0.000108115455,0.000029550207,0.00046995745,0.00011678377,0.000013071069,0.00040519252],"genre_scores_gemma":[0.9992895,0.00021159147,0.00007769063,0.00027927727,0.00001103804,0.0000151181775,0.00006928173,0.000019736013,0.000026776326],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989152,0.000059776678,0.00033924115,0.00025181085,0.00015078687,0.00028316007],"domain_scores_gemma":[0.99952036,0.000050395913,0.00014667625,0.0001836236,0.00003674572,0.000062210056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000100922385,0.00013943769,0.0005189385,0.00009709979,0.000011361943,9.638027e-7,0.00008610219,0.00010668919,0.00009214697],"category_scores_gemma":[0.00002559866,0.00011363996,0.00008116517,0.00017048238,0.000118926444,0.000055474473,0.000008575421,0.000101664424,0.000003200903],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064563035,0.0010518141,0.9814776,0.00004557129,0.0001929334,0.0000043704285,0.005673918,0.000022586071,0.010688966,0.00003881336,0.000003001505,0.00015479451],"study_design_scores_gemma":[0.013025509,0.0014812443,0.97702396,0.00029800317,0.00011600393,0.000045294295,0.00069663895,0.0000135696855,0.007125022,0.000025673717,0.0000069985103,0.00014209228],"about_ca_topic_score_codex":0.0009683336,"about_ca_topic_score_gemma":0.00066142075,"teacher_disagreement_score":0.012379879,"about_ca_system_score_codex":0.000033390686,"about_ca_system_score_gemma":0.000104500126,"threshold_uncertainty_score":0.4634103},"labels":[],"label_agreement":null},{"id":"W2989214568","doi":"10.1182/blood-2019-128692","title":"Stringent Small Molecule Dose Requirements for the Optimal Expansion of Hematopoietic Stem Cells Revealed By Predictive Analytics and Xenotransplants","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"3D Printing in Biomedical Research","field":"Engineering","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Canadian Blood Services","funders":"","keywords":"Chemistry; CD34; Stem cell; Haematopoiesis; Transplantation; Hematopoietic stem cell; Cord blood; Cell biology; Immunology; Internal medicine; Medicine; Biology","score_opus":0.02208833288746773,"score_gpt":0.24809888092956314,"score_spread":0.22601054804209542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989214568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867249,0.0008519614,0.011436146,0.000018901324,0.00008072632,0.00064785994,0.00008077222,0.000039831528,0.00011888037],"genre_scores_gemma":[0.99858254,0.00030257303,0.000881403,0.0000054914885,0.00001663446,0.000026802823,0.000005772641,0.000024169176,0.00015458562],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99903846,0.000021171474,0.00022820798,0.00017053388,0.00028572744,0.00025591167],"domain_scores_gemma":[0.99935097,0.00024002588,0.00003642338,0.00024205618,0.000045732337,0.00008480334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031530502,0.00011032363,0.00016572104,0.000040335904,0.000030729832,0.000015544889,0.00020501296,0.00007398517,0.000018450468],"category_scores_gemma":[0.0000147244145,0.00008493747,0.000041848125,0.00009973093,0.000047774145,0.00002745601,0.000059457598,0.000122020516,0.0000062240642],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012982177,0.00027579436,0.0044901734,0.0022386569,0.000649667,0.000007891065,0.00084054685,0.0055098743,0.98302597,0.00005209377,0.0005687665,0.002210717],"study_design_scores_gemma":[0.0028118333,0.00034312083,0.00129284,0.00030237716,0.00018261115,0.0000039494344,0.00015310706,0.073452964,0.9210719,0.000016188991,0.00019375603,0.00017537286],"about_ca_topic_score_codex":0.0000049452487,"about_ca_topic_score_gemma":4.0003331e-7,"teacher_disagreement_score":0.06794309,"about_ca_system_score_codex":0.000017156988,"about_ca_system_score_gemma":0.000018884966,"threshold_uncertainty_score":0.34636495},"labels":[],"label_agreement":null},{"id":"W2989262627","doi":"10.1182/blood-2019-125487","title":"A Phase 3 Study of Eltrombopag Vs. Standard First-Line Management for Newly Diagnosed Immune Thrombocytopenia in Children","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Eltrombopag; Medicine; Cytopenia; Romiplostim; Pediatrics; Internal medicine; Immune thrombocytopenia; Thrombopoietin receptor; Rituximab; Clinical endpoint; Thrombopoietin; Randomized controlled trial; Platelet","score_opus":0.010403040976831028,"score_gpt":0.2818046469509535,"score_spread":0.27140160597412244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989262627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99407476,0.00042180988,0.000014002146,0.00009975186,0.000045390767,0.004811565,0.00008155445,0.0000247097,0.00042648247],"genre_scores_gemma":[0.9988074,0.00019224381,0.00040623618,0.000043505243,0.000016978887,0.00018748241,0.000120486766,0.000027341694,0.00019835499],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988593,0.000016670556,0.00035917226,0.00029487777,0.00022448419,0.0002455015],"domain_scores_gemma":[0.9993819,0.000038977916,0.00010245533,0.00038264663,0.00003894432,0.00005506865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012319225,0.00017435204,0.00072107615,0.00012721993,0.000031715972,0.00000955015,0.00010668232,0.000045655896,0.00008893054],"category_scores_gemma":[0.000015071159,0.00014491781,0.00009086472,0.00017095292,0.000014425684,0.000053872387,0.000052934975,0.000071439965,0.00001822426],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039716694,0.0881554,0.89293367,0.0003018016,0.0029779929,0.0005795793,0.0010589849,0.000024416722,0.0008031767,0.000062174324,0.00016050365,0.008970626],"study_design_scores_gemma":[0.37310353,0.02155406,0.5995376,0.00021381323,0.0012504881,0.00002837618,0.00048800878,0.000029249984,0.0031501555,0.0001071668,0.00031818775,0.00021939247],"about_ca_topic_score_codex":0.00019944474,"about_ca_topic_score_gemma":0.000112828726,"teacher_disagreement_score":0.36913183,"about_ca_system_score_codex":0.00003141271,"about_ca_system_score_gemma":0.000025141662,"threshold_uncertainty_score":0.5909577},"labels":[],"label_agreement":null},{"id":"W2989265170","doi":"10.1182/blood-2019-127562","title":"Ibrutinib in Combination with Venetoclax Decreases Mitochondrial Bioenergetics through the Impaired BTK, AKT and AMPK/SIRT/PGC-1α Signaling Pathway in CLL","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"","keywords":"Ibrutinib; Bruton's tyrosine kinase; AMPK; Protein kinase B; Chronic lymphocytic leukemia; Cancer research; Venetoclax; Signal transduction; Biology; AMP-activated protein kinase; Cell biology; Phosphorylation; Tyrosine kinase; Protein kinase A; Leukemia; Immunology","score_opus":0.015499333024374284,"score_gpt":0.26005913172775913,"score_spread":0.24455979870338485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989265170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99700296,0.000781079,0.000022899647,0.0002972555,0.000106339015,0.0011413408,0.000005971101,0.000035739522,0.0006063941],"genre_scores_gemma":[0.9985357,0.00006324199,0.00077250786,0.00015904846,0.00014771456,0.00006268974,0.00004025276,0.00003851892,0.00018035684],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99810755,0.00015239266,0.00035281197,0.00038515026,0.00054395024,0.00045811888],"domain_scores_gemma":[0.99884725,0.00043611226,0.00009291227,0.00043409105,0.00008341136,0.00010622456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003189965,0.00020279297,0.00035819752,0.00013014619,0.000053287262,0.000051128012,0.00017290565,0.00014814771,0.00004673474],"category_scores_gemma":[0.0002437878,0.0001370323,0.00004896912,0.00046436768,0.0001598137,0.00011578682,0.0001035532,0.00029512052,0.00001984873],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021735208,0.02233777,0.40189788,0.0042762533,0.0016621407,0.005416791,0.040834136,0.006414243,0.46816093,0.014443388,0.0018844426,0.010936843],"study_design_scores_gemma":[0.43940923,0.007292529,0.022850234,0.0032257317,0.00038714806,0.0012856234,0.0047605094,0.021903722,0.4900771,0.0027360553,0.00477744,0.0012946528],"about_ca_topic_score_codex":0.0021237973,"about_ca_topic_score_gemma":0.00056225655,"teacher_disagreement_score":0.41767403,"about_ca_system_score_codex":0.0015765161,"about_ca_system_score_gemma":0.0033457493,"threshold_uncertainty_score":0.59352154},"labels":[],"label_agreement":null},{"id":"W2989267509","doi":"10.1182/blood-2019-123769","title":"Single Cell Transcriptomic Analysis of the Histone H3 K27M Mutation in Pre-Leukemic Hematopoietic Stem Cells","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University Health Centre","funders":"","keywords":"Biology; Haematopoiesis; Stem cell; CD34; Cancer research; Myeloid leukemia; Histone H3; Leukemia; Myeloid; Epigenomics; Molecular biology; Epigenetics; DNA methylation; Genetics; Gene expression; Gene","score_opus":0.011595625515455848,"score_gpt":0.25312205758733175,"score_spread":0.2415264320718759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989267509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99644196,0.0004772423,0.00004420512,0.00016508372,0.00008120389,0.00071946386,0.000015005751,0.000024591802,0.0020312634],"genre_scores_gemma":[0.9946974,0.000022785884,0.00013043238,0.00009039048,0.000018228211,0.000017261313,0.000015007139,0.000027933922,0.004980574],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983989,0.00011663021,0.0004312597,0.0003071146,0.0004591813,0.00028693606],"domain_scores_gemma":[0.99894434,0.00010838272,0.00013818509,0.0006365705,0.00009855277,0.000073986615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029241896,0.00014600519,0.00049831986,0.00042026027,0.000023387809,0.000009131802,0.00024170446,0.00012445434,0.00018617416],"category_scores_gemma":[0.00001408926,0.00011092967,0.00022690161,0.0016066376,0.0000751609,0.000057205954,0.000041186835,0.00030188536,0.000060742736],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010862372,0.0007789769,0.019225536,0.00034780035,0.0003269453,0.000021999218,0.003638997,0.0003821746,0.9748123,0.000017009386,0.0001255894,0.00021403693],"study_design_scores_gemma":[0.0058638053,0.00024722083,0.037483186,0.00011227696,0.0020479718,0.000022188437,0.0005581338,0.0032043825,0.95015323,0.000014221348,0.00015220766,0.00014114774],"about_ca_topic_score_codex":0.00027245964,"about_ca_topic_score_gemma":0.00008440434,"teacher_disagreement_score":0.024659052,"about_ca_system_score_codex":0.00042204233,"about_ca_system_score_gemma":0.00031760306,"threshold_uncertainty_score":0.45235807},"labels":[],"label_agreement":null},{"id":"W2989272704","doi":"10.1182/blood.v128.22.1184.1184","title":"Cost Analysis of Stored Autologous Peripheral Blood Stem Cells for a Second Autologous Transplantation in Multiple Myeloma Patients: A Markov Model","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Multiple myeloma; Autologous stem-cell transplantation; Lenalidomide; Transplantation; Cohort; Surgery; Stem cell; Oncology; Internal medicine","score_opus":0.026623454237661694,"score_gpt":0.2763678617771729,"score_spread":0.2497444075395112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989272704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99397695,0.00009151725,0.002196531,0.000051862087,0.000034878187,0.0016685957,0.0018318298,0.00004679744,0.0001010199],"genre_scores_gemma":[0.9943875,0.000047450514,0.0042994125,0.000030099674,0.000015123905,0.00037968723,0.0002643378,0.000030263485,0.00054613134],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981346,0.000090640206,0.0005101188,0.00044810586,0.00032559808,0.0004909159],"domain_scores_gemma":[0.9987988,0.0003069976,0.00016053667,0.00033667235,0.00020108357,0.00019595027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016120252,0.00023206319,0.00068841496,0.0005041548,0.00005714618,0.000010106667,0.00012247128,0.00016167978,0.00010029772],"category_scores_gemma":[0.00006094543,0.00016453961,0.0002789582,0.00040735689,0.00008616951,0.00010618978,0.000019960302,0.00008862053,0.0000039486913],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047600446,0.0066900626,0.8636521,0.0005311352,0.005421382,0.00024531974,0.0016512189,0.00020388718,0.07190796,0.000016292493,0.00005330848,0.044867277],"study_design_scores_gemma":[0.073895656,0.0018115981,0.75451964,0.00017879279,0.00527501,0.000023268247,0.00010654841,0.05147107,0.11233795,0.000018037981,0.000030587034,0.00033183827],"about_ca_topic_score_codex":0.00008092549,"about_ca_topic_score_gemma":0.0010628157,"teacher_disagreement_score":0.109132476,"about_ca_system_score_codex":0.00009826262,"about_ca_system_score_gemma":0.0001471985,"threshold_uncertainty_score":0.67097306},"labels":[],"label_agreement":null},{"id":"W2989313364","doi":"10.1182/blood-2019-122822","title":"Management Algorithms for Gaucher Disease Type 1 in Saudi Arabia: A Consensus Result from a National Meeting","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"","keywords":"Medicine; Disease; Pediatrics; Guideline; Multiple myeloma; Hematology; Malignancy; Anemia; Family medicine; Internal medicine; Intensive care medicine; Pathology","score_opus":0.03427788875596861,"score_gpt":0.31627566190584666,"score_spread":0.28199777314987806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989313364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97369367,0.0007254572,0.000015494837,0.0015152988,0.00009317432,0.0012822151,0.0000765307,0.000034827848,0.022563353],"genre_scores_gemma":[0.99160874,0.00003746717,0.0048510917,0.00029438754,0.00013297236,0.000103642895,0.00014889661,0.00002743525,0.0027953503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987168,0.00003472013,0.00019504815,0.00032065116,0.00047535295,0.00025744858],"domain_scores_gemma":[0.99929684,0.00016079977,0.000038586786,0.00019231795,0.00019166998,0.00011978692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025859592,0.00010048319,0.00017176931,0.00011497853,0.000028615905,0.000016141526,0.00008402183,0.000052366682,0.0002322805],"category_scores_gemma":[0.00048019958,0.00009380327,0.000058850022,0.00022418567,0.000027649088,0.000021759006,0.00005926941,0.000117762174,0.00015989188],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011185337,0.009588417,0.9200192,0.0021401618,0.0022345919,0.0029965497,0.0012048875,0.00024682333,0.014225555,0.0037131046,0.018619694,0.013825656],"study_design_scores_gemma":[0.072490886,0.0008252737,0.8705285,0.0011373177,0.00060741114,0.000023322844,0.0013419508,0.011615807,0.0019232141,0.009288631,0.02938181,0.0008358798],"about_ca_topic_score_codex":0.0001252584,"about_ca_topic_score_gemma":0.000029798337,"teacher_disagreement_score":0.061305553,"about_ca_system_score_codex":0.00007469292,"about_ca_system_score_gemma":0.00013207945,"threshold_uncertainty_score":0.38251862},"labels":[],"label_agreement":null},{"id":"W2989326485","doi":"10.1182/blood-2019-129430","title":"Downregulation of MDM2 Leads to Anti-Proliferative Effects through Activation of p53-Associated Pathway Mediated By Both Dual Inhibitor MX69 and Mir-548c-3p in Multiple Myeloma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"XIAP; Cancer research; Mdm2; Downregulation and upregulation; Multiple myeloma; Apoptosis; Inhibitor of apoptosis; Cancer; Oncogene; Bone marrow; Bortezomib; Biology; Cancer cell; Medicine; Immunology; Cell cycle; Programmed cell death; Caspase; Internal medicine","score_opus":0.013879027734276525,"score_gpt":0.2652097219441933,"score_spread":0.25133069420991677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989326485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975966,0.000113659575,0.000017596913,0.00014205152,0.000034660996,0.0017984961,0.0001225607,0.000028623794,0.00014572096],"genre_scores_gemma":[0.99890774,0.000016517526,0.00037813303,0.000041651936,0.000029360273,0.00006060761,0.0004468525,0.000025520229,0.000093617666],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983283,0.00016662954,0.00039384537,0.00032822374,0.00047871072,0.0003042333],"domain_scores_gemma":[0.9988555,0.00045286684,0.00018967953,0.00020783074,0.0001655717,0.00012858401],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020980973,0.00019802486,0.0005533198,0.0001789883,0.000034845667,0.000009647557,0.00004723637,0.00017456815,0.000021537542],"category_scores_gemma":[0.0008824003,0.00016649526,0.000054476517,0.0004315506,0.000060636627,0.00018992306,0.000050089588,0.00014826733,0.000012662819],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003858303,0.0010616856,0.4152546,0.00015016829,0.00013385387,0.000009527445,0.0008033037,0.0000037054472,0.5817433,0.000011195616,0.000059978527,0.0003828567],"study_design_scores_gemma":[0.010930223,0.0008825682,0.49933997,0.0002538273,0.000030440311,0.0000019028591,0.00005718995,0.00021488269,0.48819292,0.00000853112,0.00001086977,0.00007668181],"about_ca_topic_score_codex":0.0003228192,"about_ca_topic_score_gemma":0.00007328639,"teacher_disagreement_score":0.09355038,"about_ca_system_score_codex":0.00007393038,"about_ca_system_score_gemma":0.00010189303,"threshold_uncertainty_score":0.678948},"labels":[],"label_agreement":null},{"id":"W2989332698","doi":"10.1182/blood-2019-129140","title":"The Development and Application of a Clinical Severity Scoring Model for Post-Operative Venous Thromboembolism (VTE)","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Health Authority; Dalhousie University","funders":"","keywords":"Medicine; Rivaroxaban; Pulmonary embolism; Deep vein; Venous thrombosis; Clinical trial; Thrombosis; Physical therapy; Severity of illness; Compression stockings; Internal medicine; Surgery; Emergency medicine; Warfarin","score_opus":0.028327728703690856,"score_gpt":0.335795548267351,"score_spread":0.3074678195636601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989332698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933239,0.00029544244,0.0032353168,0.00034446607,0.00008943826,0.0016485783,0.0000063837,0.000022656932,0.0010337734],"genre_scores_gemma":[0.99185604,0.00018454013,0.007182646,0.00028789922,0.0000714129,0.00018779327,0.000013147578,0.000016633687,0.00019991603],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99895585,0.000021342448,0.00042714903,0.0002574718,0.00015754688,0.0001806651],"domain_scores_gemma":[0.99923533,0.00013696901,0.00013360786,0.00027481516,0.00015219804,0.0000670926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058561086,0.00010785085,0.00047657776,0.000026394087,0.00013054957,0.000015703728,0.00008600975,0.00006384835,0.000002514254],"category_scores_gemma":[0.00007132072,0.00007553059,0.00007107817,0.000048870646,0.000055322205,0.00004550518,0.00008345253,0.00009077932,0.000009498849],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010407852,0.024729203,0.11208465,0.0031425795,0.0051299604,0.000007824896,0.034089148,0.0007362418,0.02070838,0.07071932,0.0012269805,0.72638494],"study_design_scores_gemma":[0.0097329,0.0016624759,0.91176224,0.00032776728,0.0010923428,0.000012452755,0.0015852295,0.04779457,0.01506721,0.0013308283,0.009189425,0.00044254088],"about_ca_topic_score_codex":0.000025123276,"about_ca_topic_score_gemma":0.000036039397,"teacher_disagreement_score":0.7996776,"about_ca_system_score_codex":0.000013571779,"about_ca_system_score_gemma":0.00016874322,"threshold_uncertainty_score":0.3080048},"labels":[],"label_agreement":null},{"id":"W2989357527","doi":"10.1182/blood-2019-122207","title":"Changes in Tumor Immune Micro-Environment in Diffuse Large B-Cell Lymphoma (DLBCL): A Comparative Study of Relapsed Versus Diagnostic DLBCL","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Diffuse large B-cell lymphoma; Tumor microenvironment; Immune system; CD8; Lymphoma; Cancer research; Medicine; Immune checkpoint; Biology; Oncology; Pathology; Immunology; Immunotherapy","score_opus":0.024342179237805326,"score_gpt":0.2834009129939009,"score_spread":0.25905873375609556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989357527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949062,0.0011082938,2.875393e-7,0.00009954349,0.00010555077,0.0025507598,0.000017872406,0.00001708793,0.0011943922],"genre_scores_gemma":[0.9982561,0.0002529341,0.000035240566,0.000033088807,0.000036281865,0.00017641572,0.000022485596,0.00003847685,0.0011490132],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794775,0.00023184501,0.00042025527,0.00042416557,0.00048638735,0.00048962113],"domain_scores_gemma":[0.9984044,0.000700299,0.0001243558,0.00063901587,0.000027688155,0.00010423687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042718815,0.00023204478,0.00071854086,0.00032754452,0.000022774117,0.000009886154,0.0002056801,0.00007624477,0.00056433934],"category_scores_gemma":[0.000084162006,0.00021620875,0.00007458042,0.00034298457,0.000060283277,0.000040284172,0.00018005086,0.00026198736,0.00019562602],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004016848,0.20366476,0.41223562,0.00018537238,0.00022972668,0.0006465282,0.012159338,0.0000048440834,0.36647594,0.0000062971926,0.000030682335,0.0003440438],"study_design_scores_gemma":[0.3983393,0.0064209257,0.46719307,0.00021173866,0.00013821496,0.00001451664,0.009522082,0.0000619663,0.11730426,0.000004818448,0.00052316877,0.00026593267],"about_ca_topic_score_codex":0.00037619658,"about_ca_topic_score_gemma":0.0006743228,"teacher_disagreement_score":0.39432245,"about_ca_system_score_codex":0.00018924056,"about_ca_system_score_gemma":0.000070066344,"threshold_uncertainty_score":0.88167363},"labels":[],"label_agreement":null},{"id":"W2989359658","doi":"10.1182/blood-2019-124091","title":"Efficacy and Safety in 15 Hemophilia B Patients Treated with the AAV Gene Therapy Vector Fidanacogene Elaparvovec and Followed for at Least 1 Year","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Dosing; Tolerability; Factor IX; Genetic enhancement; Adverse effect; Internal medicine; Pharmacokinetics; Gastroenterology; Pharmacology; Immunology; Urology; Biology; Gene","score_opus":0.00762021038364892,"score_gpt":0.23410768859240072,"score_spread":0.2264874782087518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989359658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973975,0.0012978441,0.0000024553476,0.00013052639,0.000014883723,0.0010186124,0.0000618009,0.00000613403,0.00007023612],"genre_scores_gemma":[0.99853384,0.00041722495,0.00005673013,0.00012556695,0.000049970946,0.00004959983,0.00012855088,0.000034561126,0.0006039403],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990921,0.00006449465,0.00011444327,0.00035499368,0.0001218375,0.00025212977],"domain_scores_gemma":[0.99950504,0.000030129711,0.000042036314,0.0003071805,0.000050931958,0.0000646578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014116941,0.00015565124,0.00015435288,0.00003039071,0.000072825445,0.000018206267,0.00012238337,0.000090865215,0.000020881538],"category_scores_gemma":[0.000013070942,0.00010402673,0.00003550999,0.00008310352,0.00006893596,0.0000030832346,0.00006451257,0.000058232916,0.0000060577154],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01263712,0.00030395365,0.1253416,0.000012427698,0.00018925333,0.0000015265429,0.00007708136,0.000011217624,0.85919636,0.0000022342826,0.00010857308,0.002118649],"study_design_scores_gemma":[0.026923688,0.006725824,0.1729257,0.000012954833,0.000031019925,0.0000054976263,0.000017503417,0.00001783368,0.78946286,0.0000029272096,0.003623006,0.00025116603],"about_ca_topic_score_codex":0.00001229389,"about_ca_topic_score_gemma":0.00019517721,"teacher_disagreement_score":0.06973348,"about_ca_system_score_codex":0.000011342625,"about_ca_system_score_gemma":0.000034800403,"threshold_uncertainty_score":0.4242087},"labels":[],"label_agreement":null},{"id":"W2989404845","doi":"10.1182/blood-2019-128917","title":"Overexpression of Mir-21-5p Induces Apoptosis and Cell Cycle Arrest By Down-Regulating SKP2 and Overcomes Bortezomib Resistance in Multiple Myeloma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"microRNA; SKP2; Bortezomib; Apoptosis; Cancer research; Multiple myeloma; Cell cycle; Drug resistance; Downregulation and upregulation; Cell cycle checkpoint; Medicine; Biology; Internal medicine; Gene; Ubiquitin; Genetics","score_opus":0.011484384534491441,"score_gpt":0.2529445803804797,"score_spread":0.24146019584598824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989404845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955576,0.0023759173,8.1011666e-7,0.00011778092,0.000024467921,0.0005695977,0.00006606341,0.000019735435,0.001268006],"genre_scores_gemma":[0.9978005,0.00024334776,0.001378516,0.000021149572,0.000023322811,0.00002428236,0.00004114877,0.00002260889,0.00044510377],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986354,0.0000591798,0.00028729494,0.00037783236,0.0003205717,0.00031970805],"domain_scores_gemma":[0.99913144,0.00024444188,0.000119288685,0.00028871605,0.000039085407,0.00017703221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013156427,0.00018297802,0.0003826747,0.000118276505,0.000058360652,0.000022271122,0.000067830566,0.000112833404,0.000036600166],"category_scores_gemma":[0.00010908553,0.00015015875,0.00004037821,0.00014407745,0.00007857679,0.00014512484,0.0000985411,0.00015885648,0.0000054696748],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002803512,0.0004780303,0.4897083,0.0003155241,0.00004123437,0.000005876176,0.00022696363,5.4853956e-7,0.50809187,0.0000061794167,0.00011784708,0.00072725007],"study_design_scores_gemma":[0.010983615,0.0001662519,0.5727555,0.0005551126,0.000033834185,0.0000029194016,0.00017758607,0.000109416666,0.41493255,0.000043996544,0.00011455154,0.00012466239],"about_ca_topic_score_codex":0.0004693826,"about_ca_topic_score_gemma":0.00009741645,"teacher_disagreement_score":0.09315935,"about_ca_system_score_codex":0.000023142307,"about_ca_system_score_gemma":0.000035247518,"threshold_uncertainty_score":0.6123296},"labels":[],"label_agreement":null},{"id":"W2989406729","doi":"10.1182/blood-2019-131775","title":"Aberrant RHAMM Splicing in Multiple Myeloma (MM) and Its Implications for Immunotherapy","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"RNA splicing; Alternative splicing; Biology; Cancer research; Immune system; Bone marrow; Immunotherapy; Gene; Immunology; Genetics; Messenger RNA; RNA","score_opus":0.031245226363314733,"score_gpt":0.3113976359272081,"score_spread":0.28015240956389337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989406729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955296,0.0010824552,0.000076117845,0.0011974282,0.0000201755,0.0012631587,0.000009619888,0.000023943898,0.000797482],"genre_scores_gemma":[0.99689275,0.00019760986,0.0010224115,0.00018184954,0.00003439048,0.000120822944,0.000016009322,0.000027196527,0.0015069332],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99923825,0.000016299682,0.00017214012,0.00023383091,0.000103333485,0.00023614115],"domain_scores_gemma":[0.99939245,0.00017009804,0.000029485283,0.0002679807,0.000066008935,0.00007396832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015318737,0.0000855799,0.00018047474,0.00012150738,0.00004107422,0.000012762529,0.00007127857,0.000060490573,0.000068092915],"category_scores_gemma":[0.0000864941,0.00007630653,0.00004530713,0.00014656431,0.000015233881,0.00003194052,0.000034235734,0.00011321625,0.00005094347],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010066324,0.0002366193,0.089755535,0.00008185085,0.000025813555,0.0000030238348,0.00014937189,0.000001115744,0.90316355,0.00018036063,0.00004821859,0.0062538534],"study_design_scores_gemma":[0.013038925,0.0004037752,0.7569943,0.00010393407,0.000025536621,0.00006437582,0.000080919686,0.0011529885,0.22308908,0.0001378037,0.004757528,0.00015080957],"about_ca_topic_score_codex":0.000034427976,"about_ca_topic_score_gemma":0.000026325473,"teacher_disagreement_score":0.6800745,"about_ca_system_score_codex":0.00002138596,"about_ca_system_score_gemma":0.00005194594,"threshold_uncertainty_score":0.311169},"labels":[],"label_agreement":null},{"id":"W2989409772","doi":"10.1182/blood-2019-123126","title":"Efficacy of Caplacizumab in Patients with aTTP in the HERCULES Study According to Initial Immunosuppression Regimen","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Immunosuppression; Medicine; Rituximab; Regimen; Thrombotic microangiopathy; Internal medicine; Alemtuzumab; Calcineurin; Gastroenterology; Immunology; Surgery; Transplantation","score_opus":0.01054523873535073,"score_gpt":0.25967976536682935,"score_spread":0.24913452663147861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989409772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976949,0.000140519,4.48908e-7,0.000019346326,0.00010851588,0.001658761,0.000016402935,0.000009930743,0.0003511563],"genre_scores_gemma":[0.99983466,4.647707e-7,0.000007058757,0.000022829867,0.0000054444304,0.000057157566,0.000038887265,0.00000904376,0.00002443035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988547,0.00038335583,0.00028726153,0.00020950659,0.00006804588,0.00019711578],"domain_scores_gemma":[0.9992773,0.00019975028,0.00009217634,0.00039474524,0.000029374787,0.0000066302337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020832666,0.00011420549,0.00023620267,0.00012566146,0.000034293313,0.000008123863,0.00032161066,0.000045128992,0.00012185181],"category_scores_gemma":[0.000047371228,0.00007402952,0.000027537037,0.00017241057,0.000022078128,0.000055311175,0.00012795332,0.00011375323,0.00009518827],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001004593,0.0034280212,0.98864937,0.00001715828,0.00007856692,0.000004554139,0.0027656402,0.0000118584585,0.0036639061,0.000010254021,0.000071897484,0.00029416184],"study_design_scores_gemma":[0.015788132,0.0010074099,0.9753963,0.00018499952,0.00003878942,0.0000023620385,0.0051103486,1.1765379e-7,0.002292878,0.0000025380473,0.000077062505,0.00009909187],"about_ca_topic_score_codex":0.00024481962,"about_ca_topic_score_gemma":0.00008334619,"teacher_disagreement_score":0.01478354,"about_ca_system_score_codex":0.000018280734,"about_ca_system_score_gemma":0.000025990343,"threshold_uncertainty_score":0.3018836},"labels":[],"label_agreement":null},{"id":"W2989418474","doi":"10.1182/blood-2019-123961","title":"Exposure-Response Analyses Indicate a Promising Benefit/Risk Profile of Mosunetuzumab in Relapsed and Refractory Non-Hodgkin Lymphoma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Cmax; Medicine; Dosing; Rituximab; Internal medicine; Refractory (planetary science); Population; Regimen; Pharmacodynamics; Pharmacokinetics; Oncology; Pharmacology; Lymphoma; Gastroenterology; Biology","score_opus":0.020903894195676703,"score_gpt":0.3141236991618455,"score_spread":0.29321980496616884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989418474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963943,0.0015134438,0.0000010332703,0.00014463367,0.00003243466,0.0006184279,0.000044363118,0.000018263956,0.001233138],"genre_scores_gemma":[0.9967112,0.00024807212,0.0007904109,0.000042165364,0.00004368562,0.000025567879,0.000020551008,0.000025556837,0.0020927673],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998302,0.00014190435,0.00042982103,0.00035674803,0.00043345607,0.00033607337],"domain_scores_gemma":[0.9989397,0.00030772493,0.00018416844,0.0003315448,0.000082559345,0.00015429045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062482775,0.00018204589,0.0005062615,0.00036589568,0.000047019814,0.000014150876,0.00011879529,0.00013826606,0.00015553128],"category_scores_gemma":[0.00020992568,0.00014266255,0.00009547313,0.00036603233,0.000112588576,0.00006256501,0.00010637448,0.0002287038,0.00004415703],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008135037,0.0012116393,0.61314493,0.00037292624,0.00025098788,0.00014863539,0.0011447367,0.000006216973,0.3653838,0.000014604894,0.000041473675,0.010145043],"study_design_scores_gemma":[0.008401796,0.0018877174,0.8860937,0.0003396125,0.00011941436,0.00007009285,0.00019108604,0.00033817222,0.10202084,0.00004607423,0.00033205203,0.00015950108],"about_ca_topic_score_codex":0.0006112677,"about_ca_topic_score_gemma":0.000028005345,"teacher_disagreement_score":0.27294874,"about_ca_system_score_codex":0.000037802532,"about_ca_system_score_gemma":0.00021848652,"threshold_uncertainty_score":0.581761},"labels":[],"label_agreement":null},{"id":"W2989436630","doi":"10.1182/blood-2019-122501","title":"Randomized, Open-Label, Non-Inferiority, Phase 3 Study of Subcutaneous (SC) Versus Intravenous (IV) Daratumumab (DARA) Administration in Patients (Pts) with Relapsed or Refractory Multiple Myeloma (RRMM): Body Weight Subgroup Analysis of Columba","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Daratumumab; Medicine; Subgroup analysis; Internal medicine; Multiple myeloma; Oncology; Lenalidomide; Confidence interval","score_opus":0.0251781818217981,"score_gpt":0.3245696725637161,"score_spread":0.299391490741918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989436630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991524,0.0000585915,0.000009026978,0.0000116580695,0.00012238105,0.007371832,0.00016947728,0.000025150477,0.0007078893],"genre_scores_gemma":[0.9982755,0.00004826357,0.00044602423,0.000007591446,0.00002528766,0.00023554069,0.0006685076,0.000049511767,0.00024373364],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9960959,0.00043110785,0.0011344312,0.0007123158,0.0011186844,0.00050756935],"domain_scores_gemma":[0.99689716,0.000714886,0.00063570373,0.0009845291,0.00048300112,0.00028470982],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00057581393,0.00039595057,0.0021890474,0.0006993201,0.00009305779,0.000052990334,0.00038403476,0.00018213135,0.00021713556],"category_scores_gemma":[0.00047086907,0.00029821714,0.00014774932,0.0014451548,0.00015854572,0.00023984184,0.00015970379,0.00035798483,0.000016806254],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.60126096,0.06955839,0.3172153,0.00013210686,0.0065900423,0.001089166,0.0008043184,0.000003789511,0.001979008,0.0000038676367,0.000007008698,0.0013560419],"study_design_scores_gemma":[0.78732926,0.06641691,0.13712929,0.00014037795,0.0046503446,0.000018490095,0.0003654703,0.0017926649,0.0018837918,0.0000010556313,0.000011800723,0.00026052934],"about_ca_topic_score_codex":0.0021569207,"about_ca_topic_score_gemma":0.0070766006,"teacher_disagreement_score":0.1860683,"about_ca_system_score_codex":0.00018154648,"about_ca_system_score_gemma":0.0005770496,"threshold_uncertainty_score":0.999947},"labels":[],"label_agreement":null},{"id":"W2989439927","doi":"10.1182/blood-2019-127156","title":"Statin and COX-2 Inhibitor Exposure Is Associated with Improved Survival in 4913 Newly Diagnosed DLBCL Patients: A Large Population Based Study","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Rituximab; Oncology; Diffuse large B-cell lymphoma; Internal medicine; Population; Proportional hazards model; Regimen; Lymphoma; Immunology","score_opus":0.004045486375730004,"score_gpt":0.2111258923762803,"score_spread":0.20708040600055028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989439927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99809784,0.00016126764,0.000016681692,0.000013715461,0.0007321695,0.0007552814,0.00017911327,0.000012248705,0.00003167608],"genre_scores_gemma":[0.9986011,0.000011031254,0.00005714019,0.00021727468,0.0005052674,0.000051417162,0.0004282875,0.000026933474,0.00010158234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99889404,0.0001157619,0.00021702003,0.00036794646,0.00016241582,0.00024284677],"domain_scores_gemma":[0.99947333,0.000023373821,0.00011979524,0.00022456255,0.0000958122,0.000063141684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001989501,0.00016425084,0.00023340395,0.000046922847,0.00003813116,0.000026846234,0.000066335604,0.000116805655,0.00001514793],"category_scores_gemma":[0.0001044205,0.00014733615,0.000034204295,0.00011120156,0.000009730535,0.000008319567,0.000041856318,0.000084253516,0.0000014846204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001612916,0.0019711016,0.9856566,0.000012549345,0.00006393571,3.1062766e-7,0.0002719562,0.0000023663838,0.011350159,0.0000015853943,0.0001889123,0.0003192117],"study_design_scores_gemma":[0.02804204,0.0012667178,0.9658227,0.000023251125,0.00006183625,1.7780167e-7,0.00032654556,0.000031136646,0.0023499462,0.0000019223503,0.0018523702,0.00022138332],"about_ca_topic_score_codex":0.00034090717,"about_ca_topic_score_gemma":0.0032084933,"teacher_disagreement_score":0.027880749,"about_ca_system_score_codex":0.000013521962,"about_ca_system_score_gemma":0.00006677688,"threshold_uncertainty_score":0.60081935},"labels":[],"label_agreement":null},{"id":"W2989468714","doi":"10.1182/blood-2019-122260","title":"The Frequency and Effect of Baseline Cross-Reacting and De Novo Inhibitors to Recombinant Porcine FVIII in Patients with Congenital and Acquired Hemophilia a","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Medicine; Antibody; Recombinant factor VIIa; Recombinant DNA; Isoantibodies; Autoantibody; Immunology; Coagulation; Nijmegen breakage syndrome; Internal medicine; Biochemistry; Chemistry","score_opus":0.00570151503086418,"score_gpt":0.2569814686705513,"score_spread":0.25127995363968714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989468714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981688,0.00043019722,1.5744362e-7,0.00031598198,0.00003190025,0.00092411204,0.000005776634,0.000008070751,0.00011500588],"genre_scores_gemma":[0.99959093,0.0000423306,0.00009417899,0.000018162014,0.000024669864,0.000015501279,0.0000087467,0.000014863082,0.00019062549],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991101,0.000058675505,0.00018398248,0.00021495177,0.00017600713,0.00025629307],"domain_scores_gemma":[0.99930143,0.00029022593,0.000042529533,0.0001520697,0.00006549585,0.00014824311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005469796,0.00012640934,0.0002596513,0.00008091646,0.0000618064,0.000021805776,0.000031464355,0.00005668858,0.0000056110257],"category_scores_gemma":[0.0002600351,0.000067245026,0.000016475708,0.00013676465,0.000103067854,0.000057857204,0.00005344821,0.000088636974,0.0000016272405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082211365,0.00021901171,0.98593587,0.00011734265,0.00006707727,0.000037347098,0.00023707624,6.902057e-8,0.009516387,0.0000037894,0.00000298899,0.0030409347],"study_design_scores_gemma":[0.016673135,0.004084411,0.96003515,0.00021442976,0.00008771189,0.000046391193,0.00004659314,0.000015872321,0.018689731,0.000011813026,0.000011685431,0.00008310324],"about_ca_topic_score_codex":0.00009102325,"about_ca_topic_score_gemma":0.00003514875,"teacher_disagreement_score":0.025900738,"about_ca_system_score_codex":0.00002024553,"about_ca_system_score_gemma":0.000042720127,"threshold_uncertainty_score":0.27421725},"labels":[],"label_agreement":null},{"id":"W2989507932","doi":"10.1182/blood-2019-127421","title":"NFKBIZ3′ UTR Mutations Confer Selective Growth Advantage and Activate Genes with Therapeutic Implications in Diffuse Large B-Cell Lymphoma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; Simon Fraser University","funders":"","keywords":"Diffuse large B-cell lymphoma; Biology; Untranslated region; Mutation; Gene; Three prime untranslated region; Cancer research; Signal transduction; B cell; Genetics; Lymphoma; Messenger RNA; Molecular biology; Immunology","score_opus":0.007060586903819591,"score_gpt":0.2375397344838326,"score_spread":0.230479147580013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989507932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99456805,0.00062515883,0.000029460884,0.0005287624,0.000011613941,0.00073110353,0.000047466787,0.000039530376,0.0034188349],"genre_scores_gemma":[0.9984977,0.0002779158,0.00022723924,0.0003013107,0.000018100467,0.00021575541,0.000062572624,0.00002535355,0.00037400308],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992227,0.00002790332,0.00013173207,0.00028836224,0.00010061574,0.0002286963],"domain_scores_gemma":[0.9994674,0.000102321486,0.000054568132,0.00021462193,0.00007367161,0.00008743932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000036008245,0.00015587242,0.00022521213,0.00009805499,0.0000617641,0.000021025367,0.000039662114,0.00005433598,0.000022247326],"category_scores_gemma":[0.000005235768,0.00011215299,0.00003478417,0.00019208874,0.00003183166,0.000090194524,0.000020474827,0.00004338055,0.00004389246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009500578,0.014444384,0.9730587,0.000043401928,0.00020049841,0.0000311294,0.0005586591,2.5712316e-7,0.008221382,0.0025016335,0.00000985342,0.00083508337],"study_design_scores_gemma":[0.047363024,0.00039819462,0.89226824,0.00004485376,0.00032850957,0.00010222397,0.00033593783,0.000021091726,0.058427367,0.00016197452,0.00040497686,0.00014361666],"about_ca_topic_score_codex":0.000049444436,"about_ca_topic_score_gemma":0.00004446895,"teacher_disagreement_score":0.08079048,"about_ca_system_score_codex":0.00006186191,"about_ca_system_score_gemma":0.00011684242,"threshold_uncertainty_score":0.45734665},"labels":[],"label_agreement":null},{"id":"W2989524178","doi":"10.1182/blood-2019-123877","title":"Clinical Categorization of Chronic Myelomonocytic Leukemia into Proliferative and Dysplastic Subtypes Correlates with Distinct Genomic, Transcriptomic and Epigenomic Signatures","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"","keywords":"Epigenomics; H3K4me3; Biology; Epigenetics; Chronic myelomonocytic leukemia; DNA methylation; Genetics; Medicine; Bone marrow; Immunology; Gene; Myelodysplastic syndromes; Gene expression","score_opus":0.008778857484765272,"score_gpt":0.2630572344972183,"score_spread":0.25427837701245304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989524178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994875,0.0032786634,0.00038285326,0.0000865766,0.000068274254,0.0010855568,0.000010738728,0.00003450855,0.00017782104],"genre_scores_gemma":[0.99834853,0.00058653665,0.0005092643,0.000032449883,0.00012934524,0.000023537525,0.000048983155,0.000047039455,0.00027433853],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850935,0.00010432213,0.0004243191,0.0004834653,0.0001908674,0.00028769387],"domain_scores_gemma":[0.99897623,0.0003429414,0.00014335284,0.0002563216,0.00010339632,0.00017778638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029039328,0.00023101436,0.00056907407,0.00013431809,0.0000690165,0.00002517704,0.000099128505,0.00020256279,0.000040490835],"category_scores_gemma":[0.00009466303,0.0001723183,0.000046990543,0.00013889668,0.00037877331,0.000098530545,0.000057592657,0.00048979005,0.00002236774],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021135386,0.00031292855,0.81908655,0.0011822094,0.00076752383,0.000066113134,0.0017727384,0.00016920062,0.17060217,0.0004574633,0.00003680031,0.0034327765],"study_design_scores_gemma":[0.024757292,0.007571449,0.9120891,0.00046318196,0.0014387334,0.00031496675,0.00034763702,0.023998545,0.0279516,0.00036455027,0.00015863407,0.0005443165],"about_ca_topic_score_codex":0.00009334845,"about_ca_topic_score_gemma":0.00010279829,"teacher_disagreement_score":0.14265057,"about_ca_system_score_codex":0.0003114242,"about_ca_system_score_gemma":0.0010672936,"threshold_uncertainty_score":0.7026936},"labels":[],"label_agreement":null},{"id":"W2989530312","doi":"10.1182/blood-2019-128336","title":"Second-Line Therapy for Immune Thrombocytopenia: Real-World Experience","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Rituximab; Romiplostim; Azathioprine; Eltrombopag; Pediatrics; Danazol; Cohort; Internal medicine; Splenectomy; Population; Discontinuation; Thrombopoietin receptor; Thrombopoietin; Immune thrombocytopenia; Surgery; Disease; Platelet; Lymphoma","score_opus":0.023299949367226427,"score_gpt":0.3056012061352145,"score_spread":0.2823012567679881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989530312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980252,0.000833562,0.00000675898,0.00021079119,0.00012462256,0.0009277182,0.000017464186,0.000050423918,0.017576648],"genre_scores_gemma":[0.9866813,0.0003536956,0.00055797613,0.00033729422,0.00005404084,0.00010603857,0.00006288563,0.000024384668,0.011822405],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992644,0.0000072738776,0.00016925724,0.0002324337,0.00010527888,0.00022131702],"domain_scores_gemma":[0.9994977,0.000038168404,0.000051099494,0.0003141111,0.000039221075,0.0000596783],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000048960028,0.0001304419,0.00038608979,0.00004705134,0.000045998655,0.000012729624,0.000076663986,0.00004692787,0.0011632453],"category_scores_gemma":[0.000006594645,0.00009771769,0.00010280087,0.00010464664,0.000022676079,0.00006878557,0.000017146931,0.000062110164,0.00013028078],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032362773,0.013648362,0.40083364,0.00039129294,0.0025437057,0.00072737,0.0048598214,0.0000025687254,0.5443299,0.0029365027,0.0024196536,0.024070932],"study_design_scores_gemma":[0.06458189,0.0038628844,0.33569142,0.00015239668,0.00027152413,0.00018331986,0.00041453296,0.00006462884,0.5408099,0.0007945393,0.05263956,0.0005333734],"about_ca_topic_score_codex":0.000052638206,"about_ca_topic_score_gemma":0.000044833178,"teacher_disagreement_score":0.0651422,"about_ca_system_score_codex":0.000013735609,"about_ca_system_score_gemma":0.00004356849,"threshold_uncertainty_score":0.99974984},"labels":[],"label_agreement":null},{"id":"W2989572446","doi":"10.1182/blood.v112.11.2173.2173","title":"Comparison of Outcome Between Refractory/Relapsed De Novo Diffuse Large B-Cell and Transformed Lymphoma Using Related and Unrelated Allogeneic Hematopoietic SCT.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency; Leukemia & Lymphoma Society of Canada; St. Paul's Hospital","funders":"","keywords":"Medicine; Internal medicine; Diffuse large B-cell lymphoma; Rituximab; Cumulative incidence; Lymphoma; Gastroenterology; Population; Regimen; Refractory (planetary science); Surgery; Oncology; Transplantation; Biology","score_opus":0.04099135968089607,"score_gpt":0.30780328600167867,"score_spread":0.2668119263207826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989572446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945087,0.0045947963,0.000025081554,0.00009002757,0.000029522676,0.00043245236,0.00003141541,0.000058926682,0.00022906391],"genre_scores_gemma":[0.99865353,0.00043580824,0.0006669481,0.000051994535,0.000018750632,0.000010716613,0.00004465575,0.00003877887,0.00007882541],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983808,0.000061577986,0.00063432386,0.0003168682,0.00023338624,0.00037307493],"domain_scores_gemma":[0.99909216,0.000161862,0.00017806268,0.00025064367,0.00004964396,0.00026764232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013975897,0.00025985707,0.000806866,0.00013368738,0.00015160427,0.000009350209,0.000055861306,0.00026588805,0.00001806591],"category_scores_gemma":[0.000036291247,0.00021559998,0.00011263175,0.00019140558,0.00013713686,0.00006267933,0.000032225013,0.00010845634,0.0000049328237],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007119982,0.007892248,0.98132634,0.00018185264,0.000386736,0.00025529924,0.0019054324,6.94269e-7,0.007691997,0.000025576363,0.000007825465,0.00025477263],"study_design_scores_gemma":[0.06292666,0.00066192506,0.8755957,0.0001829969,0.0019510679,0.0007814798,0.00016667324,0.00011067686,0.057260327,0.000023746512,0.00010495823,0.00023381063],"about_ca_topic_score_codex":0.00008779061,"about_ca_topic_score_gemma":0.000008996778,"teacher_disagreement_score":0.10573068,"about_ca_system_score_codex":0.00008795724,"about_ca_system_score_gemma":0.000106329484,"threshold_uncertainty_score":0.8791912},"labels":[],"label_agreement":null},{"id":"W2989608063","doi":"10.1182/blood-2019-128722","title":"Long-Term Follow-up of a PET-Guided Approach to Treatment of Limited-Stage Diffuse Large B-Cell Lymphoma (DLBCL) in British Columbia (BC)","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC","funders":"","keywords":"Medicine; Stage (stratigraphy); Diffuse large B-cell lymphoma; Lymphoma; Population; Nuclear medicine; Internal medicine; Cancer; Oncology","score_opus":0.016792122963075543,"score_gpt":0.24133957572786305,"score_spread":0.2245474527647875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989608063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922696,0.00077631784,0.000002438913,0.000022633512,0.00010231762,0.0018203744,0.000215665,0.00003681865,0.0047538835],"genre_scores_gemma":[0.98985964,0.00031250925,0.0004885353,0.00007909549,0.00003506084,0.00022573954,0.00017900819,0.00004700452,0.00877338],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980578,0.000051423394,0.00057946896,0.00051370007,0.00035876955,0.00043885154],"domain_scores_gemma":[0.998762,0.000072623654,0.00017693816,0.0006693479,0.00009326197,0.000225829],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009653441,0.00022367145,0.00088897493,0.00012478499,0.000029966155,0.00004204075,0.00012832077,0.00010528178,0.00012596352],"category_scores_gemma":[0.000027020655,0.00026429,0.0003027524,0.0003191118,0.00003212968,0.00005447217,0.00006803108,0.000031360374,0.00004666664],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009619839,0.12129234,0.8731711,0.00036324415,0.00030375674,0.0005581099,0.00053949706,6.444778e-7,0.0009308191,0.000012239622,0.00024804723,0.0024840322],"study_design_scores_gemma":[0.15009905,0.002114524,0.83613354,0.00031232304,0.0004934586,0.00016409747,0.00016690993,0.000023832376,0.009829543,0.0000021145609,0.00045576892,0.00020485537],"about_ca_topic_score_codex":0.014026363,"about_ca_topic_score_gemma":0.00992434,"teacher_disagreement_score":0.15000285,"about_ca_system_score_codex":0.00023023947,"about_ca_system_score_gemma":0.00017184734,"threshold_uncertainty_score":0.9999809},"labels":[],"label_agreement":null},{"id":"W2989629378","doi":"10.1182/blood-2019-123636","title":"Lenalidomide Plus Bortezomib and Dexamethasone in the Treatment of Newly Diagnosed Multiple Myeloma: Results from a Canadian Cost-Effectiveness Analysis","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Sherbrooke; Saskatchewan Cancer Agency; McGill University; Royal Victoria Hospital","funders":"","keywords":"Lenalidomide; Medicine; Internal medicine; Multiple myeloma; Melphalan; Bortezomib; Oncology; Autologous stem-cell transplantation; Progression-free survival; Thalidomide; Ixazomib; Hazard ratio; Daratumumab; Transplantation; Surgery; Chemotherapy; Carfilzomib; Confidence interval","score_opus":0.031122734644931028,"score_gpt":0.3019089109276732,"score_spread":0.27078617628274215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989629378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99520224,0.000990579,0.000007772101,0.0001987055,0.000024163515,0.0024559859,0.0006421376,0.000011250201,0.00046714186],"genre_scores_gemma":[0.9983678,0.0003565735,0.00035572497,0.00004104733,0.000037170204,0.0002572274,0.0004992836,0.000016188207,0.00006900151],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820656,0.00032392863,0.0003132687,0.0004398435,0.00030964412,0.00040674623],"domain_scores_gemma":[0.99675065,0.0021872441,0.00008713725,0.00059648766,0.000071501905,0.00030700417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035352216,0.00021178642,0.0006813544,0.00041123477,0.000053079984,0.000024732508,0.00010520999,0.00009922242,0.000041633673],"category_scores_gemma":[0.00037807104,0.00013590408,0.00017045747,0.00066311326,0.000066734625,0.000051655217,0.000015764139,0.00010477533,0.000019351539],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029716836,0.0015618061,0.97980833,0.000026329546,0.0024977466,0.0008373355,0.0018319964,0.00006982716,0.0011407832,0.0000053016593,0.000007446389,0.009241433],"study_design_scores_gemma":[0.06596119,0.00088149245,0.92385197,0.000060865284,0.0012952894,0.000009440384,0.00040558403,0.0012466143,0.005806138,0.000009325571,0.00036293874,0.000109170884],"about_ca_topic_score_codex":0.5623028,"about_ca_topic_score_gemma":0.45276242,"teacher_disagreement_score":0.10954042,"about_ca_system_score_codex":0.00026915994,"about_ca_system_score_gemma":0.00032233156,"threshold_uncertainty_score":0.5572232},"labels":[],"label_agreement":null},{"id":"W2989730327","doi":"10.1182/blood-2019-122907","title":"Selinexor, Pomalidomide, and Dexamethasone (SPd) in Patients with Relapsed or Refractory Multiple Myeloma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Hôpital Maisonneuve-Rosemont; Vancouver General Hospital; CancerCare Manitoba; University of Calgary; Dalhousie University; Royal Victoria Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Pomalidomide; Dexamethasone; Multiple myeloma; Medicine; Refractory (planetary science); Carfilzomib; Lenalidomide; Internal medicine; Oncology; Biology","score_opus":0.0034143049797447124,"score_gpt":0.1841503106772818,"score_spread":0.1807360056975371,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989730327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992275,0.000116452284,0.000013961314,0.000012485143,0.00007847055,0.00019182681,0.000007004321,0.000008832925,0.00034342162],"genre_scores_gemma":[0.9978471,0.000023156897,0.0014072129,0.00013289633,0.00006277434,0.000004054955,0.000062577965,0.000020636215,0.00043958653],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99940586,0.000028912338,0.000106629246,0.00024990365,0.00007739606,0.00013127626],"domain_scores_gemma":[0.99965614,0.000013485371,0.000048336497,0.00020550551,0.000036565663,0.00003994745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000554171,0.00010234257,0.000109016124,0.000031792562,0.000020718839,0.000010489197,0.000049928076,0.00011824326,0.00003444617],"category_scores_gemma":[0.000053405067,0.0000741306,0.000017175034,0.000061587816,0.000021972779,0.0000051869383,0.00003798297,0.00007797493,0.000009987032],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015074911,0.0001980384,0.89857864,0.000018423028,0.000048215014,0.0000036340923,0.000036474008,0.0000036152635,0.09650661,0.000005086709,0.00015081733,0.002942957],"study_design_scores_gemma":[0.011861105,0.001764216,0.95623344,0.000021586493,0.000031758445,0.000008475376,0.000040916562,0.000014612539,0.019826131,0.000007658487,0.00997924,0.00021087205],"about_ca_topic_score_codex":0.000015019756,"about_ca_topic_score_gemma":0.00007027739,"teacher_disagreement_score":0.07668048,"about_ca_system_score_codex":0.0000040501595,"about_ca_system_score_gemma":0.00002035439,"threshold_uncertainty_score":0.3022958},"labels":[],"label_agreement":null},{"id":"W2989764345","doi":"10.1182/blood-2019-132405","title":"The QUAZAR AML-001 Maintenance Trial: Results of a Phase III International, Randomized, Double-Blind, Placebo-Controlled Study of CC-486 (Oral Formulation of Azacitidine) in Patients with Acute Myeloid Leukemia (AML) in First Remission","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton","funders":"","keywords":"Azacitidine; Medicine; Myeloid leukemia; Internal medicine; Placebo; Randomized controlled trial; Randomization; Leukemia; Oncology; Alternative medicine; Biology; Pathology","score_opus":0.019090086419738677,"score_gpt":0.30559701496171765,"score_spread":0.28650692854197896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989764345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851899,0.00003847086,0.000021157615,0.00025118463,0.00011445307,0.01330136,0.00003875919,0.000015062229,0.0010296444],"genre_scores_gemma":[0.9983276,0.00010866563,0.00015587712,0.000014541083,0.000043705204,0.00038591088,0.00017110334,0.000035939393,0.0007566569],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99565864,0.00033433063,0.0020080903,0.00043829554,0.0011826887,0.00037797698],"domain_scores_gemma":[0.9961559,0.0011634813,0.0011991657,0.000674423,0.00071220024,0.000094829564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003251122,0.00027835686,0.0016381835,0.0005603748,0.000045580888,0.000016624623,0.00040552055,0.00015958815,0.000016204225],"category_scores_gemma":[0.0010866293,0.00016547646,0.00017742465,0.00062122056,0.00012529704,0.00021882851,0.00013229257,0.00041779684,0.0000031948505],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97617704,0.014277918,0.0057137776,0.00007132049,0.0008845706,0.00001993212,0.0013706074,0.00009997115,0.00078520615,0.000057120524,0.0000967688,0.00044578148],"study_design_scores_gemma":[0.9866843,0.004168522,0.0012687282,0.0005210724,0.00039766968,0.0000034888533,0.00058106723,0.0035860762,0.0025606316,0.00002062325,0.000060154824,0.00014765678],"about_ca_topic_score_codex":0.0013883325,"about_ca_topic_score_gemma":0.0006085883,"teacher_disagreement_score":0.013137693,"about_ca_system_score_codex":0.00038324372,"about_ca_system_score_gemma":0.0004927466,"threshold_uncertainty_score":0.6747935},"labels":[],"label_agreement":null},{"id":"W2989804639","doi":"10.1182/blood-2019-122934","title":"Increased Risk of Death in Acutely Ill Medical Patients with Asymptomatic Proximal Deep Vein Thrombosis or Symptomatic Venous Thromboembolism: Insights from the Magellan Study","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Medicine; Deep vein; Stroke (engine); Asymptomatic; Internal medicine; Population; Thrombosis; Pulmonary embolism; Venous thrombosis; Surgery; Hazard ratio; Placebo; Confidence interval","score_opus":0.00886389298008495,"score_gpt":0.23801832338908527,"score_spread":0.22915443040900033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989804639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99337894,0.00017424594,0.00001028844,0.00012692447,0.0001281029,0.0047751605,0.000036751175,0.00009049341,0.0012791068],"genre_scores_gemma":[0.9984027,0.00010923469,0.0004587104,0.0005562318,0.00009001663,0.00021180912,0.00007997543,0.00007884608,0.000012434567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959955,0.00043839525,0.00086386106,0.0006316755,0.0015715911,0.0004989593],"domain_scores_gemma":[0.9973992,0.00061954494,0.00042888257,0.0011174602,0.00019125243,0.00024362933],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044516602,0.0004513941,0.0016364598,0.0001972313,0.00011393521,0.00004482998,0.00055367086,0.00017522914,0.0006188478],"category_scores_gemma":[0.00039807707,0.00024543185,0.00013215054,0.00054225937,0.00011774208,0.00013763786,0.00025170154,0.00041188227,0.000107762426],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022884787,0.030494727,0.95978045,0.0002418123,0.0023720516,0.000097251504,0.0060297283,0.000008269837,0.000044728222,0.00007295363,0.000082095794,0.0005471011],"study_design_scores_gemma":[0.016493667,0.0051564453,0.9714147,0.00086059334,0.0030131156,0.0000058064597,0.0020702532,0.0003318707,0.00020587549,0.00011632691,0.000022541726,0.00030880264],"about_ca_topic_score_codex":0.002883173,"about_ca_topic_score_gemma":0.0015630216,"teacher_disagreement_score":0.025338283,"about_ca_system_score_codex":0.00007691859,"about_ca_system_score_gemma":0.00025651854,"threshold_uncertainty_score":0.9999998},"labels":[],"label_agreement":null},{"id":"W2989880289","doi":"10.1182/blood-2019-124219","title":"Use of Routine Bloodwork on General Internal Medicine Inpatients: A Retrospective Cohort Study","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Healthcare cost, quality, practices","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Women in Science and Engineering Newfoundland and Labrador; Women's College Hospital; St. Michael's Hospital; University of Toronto; University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Retrospective cohort study; Intensive care unit; Emergency medicine; Cohort; Population; Blood transfusion; Cohort study; Anemia; Internal medicine","score_opus":0.37828875926406735,"score_gpt":0.5048696944165416,"score_spread":0.12658093515247426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989880289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98715264,0.00004615411,0.000009679411,0.0013031,0.0015391159,0.003322561,0.00004227879,0.00009055113,0.0064939153],"genre_scores_gemma":[0.9927846,0.00003726295,0.00021422432,0.0028714715,0.00067508273,0.0001387142,0.000021915954,0.000047789865,0.0032089385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9938334,0.002802968,0.0012578284,0.0005811601,0.0009830039,0.0005416331],"domain_scores_gemma":[0.995731,0.0014790671,0.0009971746,0.00093099836,0.00064007455,0.00022168538],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003116943,0.00025627724,0.0007955629,0.00020080106,0.0002158851,0.000008168928,0.0003075838,0.00020561779,0.0011539834],"category_scores_gemma":[0.003459623,0.00020304092,0.00006404237,0.00040153365,0.00008558798,0.00027540742,0.00023885712,0.0012985859,0.00041586632],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002611307,0.0022770648,0.98877674,0.00012391392,0.00028835287,0.0000106000725,0.006109009,0.0000015184422,0.00014027764,0.0008409133,0.0010577338,0.00011272099],"study_design_scores_gemma":[0.004962871,0.0032998617,0.9872789,0.0006591685,0.00019591629,0.0000019411336,0.0021526897,0.000015774722,0.0000845707,0.00008858481,0.0010887467,0.00017100306],"about_ca_topic_score_codex":0.011046774,"about_ca_topic_score_gemma":0.0008442703,"teacher_disagreement_score":0.010202503,"about_ca_system_score_codex":0.00021666588,"about_ca_system_score_gemma":0.00023265318,"threshold_uncertainty_score":0.9997591},"labels":[],"label_agreement":null},{"id":"W2989899656","doi":"10.1182/blood-2019-129557","title":"Sorafenib in Combination with Standard Chemotherapy for Children with High Allelic Ratio FLT3/ITD+ AML Improves Event-Free Survival and Reduces Relapse Risk: A Report from the Children's Oncology Group Protocol AAML1031","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Sorafenib; Medicine; Internal medicine; Oncology; Cohort; Fms-Like Tyrosine Kinase 3; Induction chemotherapy; Chemotherapy; Chemotherapy regimen; Interim analysis; Clinical trial; Biology; Hepatocellular carcinoma; Mutation","score_opus":0.007366758900743348,"score_gpt":0.2755143311586557,"score_spread":0.26814757225791236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989899656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9184593,0.00004613752,0.000249719,0.0032436643,0.000034729648,0.07766199,0.00011465849,0.000064271895,0.00012551216],"genre_scores_gemma":[0.96070856,0.000048866677,0.0060682385,0.00018140193,0.00031143718,0.0316558,0.00056517986,0.000108278815,0.0003522473],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99747,0.00024333592,0.00048441708,0.0007239009,0.00063822785,0.00044010035],"domain_scores_gemma":[0.9979915,0.0003098261,0.0004335774,0.0009158682,0.00022248973,0.00012675041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011702309,0.00031934216,0.0006317453,0.00011605499,0.00014688194,0.000069414986,0.0003280627,0.00021599479,0.000037493905],"category_scores_gemma":[0.00026359916,0.00019094045,0.00006339543,0.00027918094,0.00021956829,0.00018612682,0.0001068994,0.0006003819,0.000003102271],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01955132,0.0023979214,0.9475489,0.00008729036,0.0018673538,0.00011083083,0.0017221281,0.000008568286,0.013520123,0.000469247,0.0021112508,0.010605034],"study_design_scores_gemma":[0.09709148,0.009384005,0.8753475,0.00015679904,0.00027849287,0.00035846073,0.00030101492,0.000059552804,0.015353659,0.0005406582,0.0008063214,0.00032207105],"about_ca_topic_score_codex":0.0020645545,"about_ca_topic_score_gemma":0.0008843348,"teacher_disagreement_score":0.07754016,"about_ca_system_score_codex":0.0002575123,"about_ca_system_score_gemma":0.00080720003,"threshold_uncertainty_score":0.7786326},"labels":[],"label_agreement":null},{"id":"W2990138720","doi":"10.1182/blood-2019-124879","title":"Event-Free Survival As a Surrogate for Overall Survival in Relapsed DLBCL after Autologous Transplant: A Subgroup Analysis of LY.12 and Coral","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; CancerCare Manitoba; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; Kingston Health Sciences Centre; Juravinski Hospital; Queen's University; McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Internal medicine; Diffuse large B-cell lymphoma; Cohort; Oncology; Rituximab; Progression-free survival; Median follow-up; Regimen; Surgery; Lymphoma; Overall survival","score_opus":0.010169980393006909,"score_gpt":0.24777238641895175,"score_spread":0.23760240602594485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990138720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974796,0.0006521347,0.0000067515675,0.0002566753,0.00012856055,0.00070783467,0.00030148646,0.000024240873,0.0004426971],"genre_scores_gemma":[0.99905634,0.00011775712,0.00017955816,0.00008273803,0.000024368692,0.00010903846,0.0001350031,0.000021378912,0.00027383634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985633,0.000074258336,0.00039014628,0.00038551824,0.00027083073,0.00031595447],"domain_scores_gemma":[0.9990053,0.0002798069,0.0001059949,0.00043808966,0.000051939096,0.00011885264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002722965,0.00021221126,0.0008632471,0.00025285443,0.000020207735,0.0000122824395,0.00009121112,0.00013540832,0.00010031665],"category_scores_gemma":[0.000046333553,0.00017336161,0.00030396294,0.00025838078,0.000043588443,0.000045205965,0.000033781915,0.0000680905,0.000009222854],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016463994,0.0025748494,0.9914741,0.00015104175,0.0021232078,0.00024623497,0.00052678445,0.000007602228,0.00047434962,0.0005121205,0.000011057894,0.00025223292],"study_design_scores_gemma":[0.03543388,0.0010831662,0.95708114,0.00013151631,0.004504945,0.000026940172,0.000050729013,0.00033208833,0.0010011601,0.00012132058,0.00006792783,0.00016517245],"about_ca_topic_score_codex":0.001109994,"about_ca_topic_score_gemma":0.003051388,"teacher_disagreement_score":0.034392964,"about_ca_system_score_codex":0.000044515684,"about_ca_system_score_gemma":0.00008102151,"threshold_uncertainty_score":0.7069481},"labels":[],"label_agreement":null},{"id":"W2990138864","doi":"10.1182/blood.2019002699","title":"Distinct molecular profile of IRF4-rearranged large B-cell lymphoma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"National Center for Advancing Translational Sciences; European Regional Development Fund; National Cancer Institute; Generalitat de Catalunya; Ministerio de Economía y Competitividad; Agència de Gestió d'Ajuts Universitaris i de Recerca; Instituto de Salud Carlos III","keywords":"IRF4; Cancer research; Biology; CDKN2A; Germinal center; Lymphoma; Diffuse large B-cell lymphoma; B cell; Aggressive lymphoma; Gene expression profiling; B-cell lymphoma; Genetics; Gene; Immunology; Gene expression; Transcription factor; Antibody","score_opus":0.0053596945444788074,"score_gpt":0.22033434539175295,"score_spread":0.21497465084727413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990138864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95151174,0.00092746044,0.0000045163797,0.00008884225,0.000059665996,0.00049291877,0.000048031205,0.000035869245,0.046830937],"genre_scores_gemma":[0.99794346,0.000015745163,0.00041548404,0.00011173611,0.000031376254,0.00004444058,0.000071831666,0.000021721682,0.001344182],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991515,0.000021371472,0.00017636362,0.0002133288,0.00022348532,0.00021391943],"domain_scores_gemma":[0.9993745,0.000029314448,0.000071129536,0.00037943106,0.000053469284,0.00009217571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000673797,0.00012698772,0.00028810118,0.00004378101,0.000018971325,0.000005856544,0.00006000021,0.00006335202,0.00042495134],"category_scores_gemma":[0.000018362658,0.0000974864,0.00013750387,0.00010367317,0.000017173303,0.000023008983,0.000036448502,0.000025611214,0.000470357],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015003323,0.027078789,0.8571533,0.00048468699,0.0004176726,0.00045937853,0.00022938784,1.5967014e-7,0.108888105,0.0007728894,0.0009786943,0.003386883],"study_design_scores_gemma":[0.036298808,0.0006798612,0.32809186,0.00011518719,0.00048059958,0.000046712088,0.000050838524,0.000016916898,0.6296394,0.00002290731,0.004420261,0.00013665819],"about_ca_topic_score_codex":0.000044196033,"about_ca_topic_score_gemma":0.0000021817643,"teacher_disagreement_score":0.52906144,"about_ca_system_score_codex":0.00002844538,"about_ca_system_score_gemma":0.00007842347,"threshold_uncertainty_score":0.6045644},"labels":[],"label_agreement":null},{"id":"W2990180825","doi":"10.1182/blood-2019-124122","title":"Evaluation of Efficacy and Safety of Cold-Stored Platelets in Healthy Human Subjects Treated with Dual Antiplatelet Therapy","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Platelet; Medicine; Platelet transfusion; Apheresis; Clopidogrel; Bleeding time; Clinical endpoint; Pharmacology; Surgery; Immunology; Andrology; Internal medicine; Clinical trial; Aspirin; Platelet aggregation","score_opus":0.023351712030556,"score_gpt":0.29143497111147476,"score_spread":0.2680832590809188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990180825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968468,0.0009229877,1.7869775e-7,0.00003624341,0.00001210518,0.0013353503,0.000014978928,0.000013521379,0.00081782305],"genre_scores_gemma":[0.9995818,0.00022256847,0.000042267537,0.00002216885,0.000006708111,0.000011572098,0.00006758995,0.0000173118,0.00002799148],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988512,0.000085222666,0.000279895,0.0002152831,0.00040311928,0.0001653192],"domain_scores_gemma":[0.9994163,0.00005040389,0.00014793106,0.0001919383,0.00013910866,0.00005434906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036203672,0.00013542049,0.00047684248,0.00013854266,0.000023251767,0.0000028763454,0.00002743374,0.00008343823,0.00003824704],"category_scores_gemma":[0.00001575579,0.00010067716,0.000026641837,0.00020453315,0.000045942597,0.000044990844,0.000008319158,0.00007421142,0.0000024486594],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009328911,0.0062227533,0.88534975,0.00016622424,0.00092323043,0.00022352996,0.0009358715,0.000035104862,0.09096221,0.00008843866,0.0000106477255,0.0057533574],"study_design_scores_gemma":[0.11650329,0.0063151103,0.8127332,0.00023701353,0.00031705428,0.00009390504,0.000065522334,0.0000735945,0.063503526,0.000016830763,0.000025131718,0.0001158452],"about_ca_topic_score_codex":0.00026655968,"about_ca_topic_score_gemma":0.00008954365,"teacher_disagreement_score":0.10717438,"about_ca_system_score_codex":0.000028445724,"about_ca_system_score_gemma":0.00012457494,"threshold_uncertainty_score":0.41054958},"labels":[],"label_agreement":null},{"id":"W2990206078","doi":"10.1182/blood-2019-124443","title":"Clinical Impact of Ibrutinib with R-CHOP in Untreated Non-GCB DLBCL Co-Expressing BCL2 and MYC Genes in the Phase 3 Phoenix Trial","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Hazard ratio; Internal medicine; Medicine; Population; Oncology; CHOP; Diffuse large B-cell lymphoma; Ibrutinib; Vincristine; Rituximab; Cyclophosphamide; Lymphoma; Confidence interval; Leukemia; Chronic lymphocytic leukemia; Chemotherapy","score_opus":0.03553825901606996,"score_gpt":0.4167700193018046,"score_spread":0.38123176028573463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990206078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968,0.00035588574,0.0000020758823,0.00006038712,0.000035490695,0.0013563959,0.000013481872,0.000012338187,0.0013639216],"genre_scores_gemma":[0.9993843,0.00011148001,0.0001107871,0.000045490127,0.00019618114,0.000022366494,0.000021953369,0.00002482343,0.00008261303],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99803185,0.00023122721,0.00056351017,0.0003479497,0.00043133018,0.00039413024],"domain_scores_gemma":[0.99840784,0.0007616532,0.00013520662,0.0005252552,0.0000459948,0.0001240227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011458831,0.00017894767,0.0006055542,0.00016577065,0.000023395873,0.000028128201,0.00016866771,0.00015703075,0.00007706062],"category_scores_gemma":[0.000222089,0.000100525656,0.00010951899,0.00037140245,0.00021124157,0.00007683047,0.00005005146,0.00035694576,0.000015403331],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19150822,0.021367926,0.71417207,0.0004838965,0.00079731387,0.0018367765,0.0051895995,0.000033525874,0.039066114,0.000007327511,0.0006176827,0.02491956],"study_design_scores_gemma":[0.9342444,0.0053540226,0.049886696,0.00045729722,0.00016194687,0.0002851103,0.0003282578,0.0021942987,0.006760939,0.000006397371,0.00016207293,0.00015854364],"about_ca_topic_score_codex":0.0016500152,"about_ca_topic_score_gemma":0.000058856946,"teacher_disagreement_score":0.7427362,"about_ca_system_score_codex":0.00052685256,"about_ca_system_score_gemma":0.0037782001,"threshold_uncertainty_score":0.67023647},"labels":[],"label_agreement":null},{"id":"W2990213700","doi":"10.1182/blood-2019-123275","title":"Less Chronic Graft-Versus-Host Disease, Immunosuppressive Therapy and Better Survival after Anti-Thymocyte Globulin in Unrelated Donor Stem Cell Transplant Recipients: Longer Follow-up of a Multicentre Cell Therapy Transplant Canada Randomized Trial","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; McGill University Health Centre; Université de Montréal; Leukemia & Lymphoma Society of Canada; Hôpital de l'Enfant-Jésus; McMaster University; Hôpital Maisonneuve-Rosemont; Juravinski Hospital; Université Laval; BC Children's Hospital; Dalhousie University; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Thymoglobulin; Graft-versus-host disease; Transplantation; Internal medicine; Anti-thymocyte globulin; Tacrolimus; Cumulative incidence; Clinical endpoint; Cyclophosphamide; Hematopoietic stem cell transplantation; Immunology; Surgery; Gastroenterology; Randomized controlled trial; Chemotherapy","score_opus":0.011412346563578866,"score_gpt":0.21725542348924382,"score_spread":0.20584307692566495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990213700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825981,0.010076604,0.000026877866,0.00014766927,0.0012874332,0.0051825936,0.00049972563,0.00003510617,0.0001458733],"genre_scores_gemma":[0.9893725,0.009618123,0.00003822653,0.00008752724,0.00008610864,0.000217017,0.00028359093,0.00008046555,0.00021644549],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99625,0.0005919154,0.0011134685,0.0006983292,0.0007285956,0.0006177453],"domain_scores_gemma":[0.9979454,0.0008373471,0.00030457813,0.00052391615,0.00010958158,0.00027912227],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045956968,0.0005565821,0.0015431459,0.00017424642,0.00004785347,0.000030896703,0.00020944852,0.00025864056,0.00021971318],"category_scores_gemma":[0.000005532713,0.00043513725,0.0003455181,0.00025509892,0.00012043472,0.00014218602,0.000011987556,0.00038052312,0.000008336153],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9074991,0.0015432875,0.056350093,0.00078494806,0.0008307553,0.00064311706,0.0050294315,0.00001949031,0.026901627,0.0000022613274,0.0000069490607,0.00038898233],"study_design_scores_gemma":[0.8973781,0.0005899805,0.03234853,0.001090234,0.0010489161,0.00001097374,0.00035085875,0.00015272989,0.06651421,0.0000010398844,0.000053532272,0.00046093066],"about_ca_topic_score_codex":0.016075928,"about_ca_topic_score_gemma":0.013863389,"teacher_disagreement_score":0.039612584,"about_ca_system_score_codex":0.000121886114,"about_ca_system_score_gemma":0.0007137666,"threshold_uncertainty_score":0.99981004},"labels":[],"label_agreement":null},{"id":"W2990232535","doi":"10.1182/blood-2019-121996","title":"Loss of Phospholipase C Gamma 1 (PLCG1) Impairs AML1-ETO Induced Leukemia Stem Cell Self-Renewal","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Biology; Stem cell; Cancer research; Leukemia; Embryonic stem cell; Myeloid leukemia; Fusion protein; Immunology; Cell biology; Genetics; Gene","score_opus":0.01256435116694218,"score_gpt":0.25294634414771117,"score_spread":0.24038199298076898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990232535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823339,0.00041487478,0.000003590863,0.00016914883,0.0001809144,0.0010148872,0.00003177878,0.00018439972,0.015666518],"genre_scores_gemma":[0.99345875,0.000090013884,0.00064210896,0.00020844502,0.00024534753,0.000038793758,0.000034021134,0.0000948136,0.005187725],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971255,0.0000996718,0.00056777056,0.0005841303,0.00085157086,0.00077136257],"domain_scores_gemma":[0.9977554,0.00016420895,0.00020930813,0.0011319967,0.00027630248,0.0004628022],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00047210438,0.00034542693,0.0007162871,0.00024948418,0.000053132193,0.000023605593,0.00042185435,0.00034546736,0.0005003183],"category_scores_gemma":[0.000038941667,0.00030349524,0.0002473195,0.0005621946,0.00007987887,0.00012262978,0.00025054018,0.0006823895,0.0009608311],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011845821,0.0026351905,0.18020013,0.00180974,0.0009910202,0.0011083502,0.002656955,0.000013668622,0.80241853,0.00021773999,0.004475025,0.0022890808],"study_design_scores_gemma":[0.020605689,0.0017984705,0.0154785365,0.00019763749,0.00054123363,0.000298433,0.000674344,0.00017835663,0.95706224,0.00003161288,0.0026813352,0.00045209113],"about_ca_topic_score_codex":0.0005024517,"about_ca_topic_score_gemma":0.000012429946,"teacher_disagreement_score":0.1647216,"about_ca_system_score_codex":0.0005791922,"about_ca_system_score_gemma":0.0018168527,"threshold_uncertainty_score":0.9999417},"labels":[],"label_agreement":null},{"id":"W2990380228","doi":"10.1182/blood-2019-131450","title":"Diffuse Large B-Cell Lymphomas with a Molecular PMBCL Expression Signature Represent a Distinct Molecular Subtype Associated with Poor Clinical Outcome","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; BC Cancer Agency; Spinal Cord Injury BC","funders":"","keywords":"Lymphoma; Cancer research; Diffuse large B-cell lymphoma; Medicine; Immunophenotyping; Phenotype; Biology; Oncology; Internal medicine; Pathology; Gene; Immunology; Genetics; Flow cytometry","score_opus":0.011188841456222294,"score_gpt":0.27004366637686683,"score_spread":0.25885482492064454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990380228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99392676,0.0009216877,0.00005253214,0.00036752428,0.00007848159,0.0012004373,0.000047965867,0.00015316207,0.0032514709],"genre_scores_gemma":[0.99710774,0.000019682424,0.0005981907,0.00085786864,0.000047877693,0.00010413206,0.0002199041,0.00009292608,0.0009516921],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99714714,0.00018248512,0.00050622196,0.000838933,0.0007592831,0.00056593143],"domain_scores_gemma":[0.9979844,0.0001975782,0.00030779772,0.00096243306,0.00017213762,0.00037562405],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002651002,0.0004292211,0.00082143786,0.00008064482,0.00007257445,0.000044679087,0.00017161919,0.00030966027,0.00011740277],"category_scores_gemma":[0.00019473683,0.00025868908,0.0002823388,0.0002826437,0.00006323375,0.000064733154,0.00012503828,0.0002780409,0.000108982385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078327884,0.028928671,0.9486418,0.00007518072,0.0007106316,0.005424182,0.00006529216,0.0000026422913,0.014965676,0.0000835052,0.00025310542,0.00006605899],"study_design_scores_gemma":[0.14321686,0.0046346835,0.71050936,0.0008878143,0.0026540952,0.00019001521,0.0000923116,0.000079313955,0.13587147,0.000025784975,0.0011375769,0.000700719],"about_ca_topic_score_codex":0.000037528258,"about_ca_topic_score_gemma":0.00001251722,"teacher_disagreement_score":0.23813242,"about_ca_system_score_codex":0.00011129973,"about_ca_system_score_gemma":0.0002096042,"threshold_uncertainty_score":0.9999865},"labels":[],"label_agreement":null},{"id":"W2990384780","doi":"10.1182/blood-2019-126306","title":"Enhanced VTE Risk Stratification in Ambulatory Patients with Cancer","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Internal medicine; Ambulatory; Hazard ratio; Framingham Risk Score; Apixaban; Proportional hazards model; Incidence (geometry); Placebo; Confidence interval; Disease; Warfarin; Atrial fibrillation; Pathology","score_opus":0.006589515201571565,"score_gpt":0.2688415012112273,"score_spread":0.2622519860096557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990384780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99711347,0.00020750897,0.0000034841446,0.00004829727,0.000097849144,0.00045510294,0.00001290037,0.00001651088,0.0020448964],"genre_scores_gemma":[0.99887896,0.000089170244,0.00006792875,0.00010330724,0.000047441048,0.00006428441,0.00003752856,0.000008803741,0.0007025692],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995728,0.000012852993,0.000085332256,0.00014393343,0.00008488932,0.00010016003],"domain_scores_gemma":[0.9997557,0.000012642423,0.00005165996,0.00011195255,0.00003416927,0.00003387939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000024524348,0.00006440188,0.000112000336,0.00003204073,0.0000117718755,0.000002779876,0.000021306898,0.000033008815,0.0004844297],"category_scores_gemma":[0.0000016930379,0.000049194437,0.000019178919,0.000086454645,0.000012453604,0.000035865723,0.000004169546,0.0000776485,0.00004387852],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024130914,0.0008378175,0.98605484,0.00002369132,0.00009468323,0.0000013890894,0.00024312105,0.000012937337,0.0101107685,0.00000895395,0.000084821186,0.0022856875],"study_design_scores_gemma":[0.010971126,0.00042472433,0.95743996,0.00003616752,0.00019317801,3.2107098e-7,0.000014211498,0.000014745531,0.030454868,0.000007520195,0.00038211956,0.000061051935],"about_ca_topic_score_codex":0.00022317932,"about_ca_topic_score_gemma":0.00025949586,"teacher_disagreement_score":0.028614856,"about_ca_system_score_codex":0.000040492192,"about_ca_system_score_gemma":0.00006938245,"threshold_uncertainty_score":0.53041655},"labels":[],"label_agreement":null},{"id":"W2990451347","doi":"10.1182/blood-2019-122609","title":"Perioperative Eltrombopag or Intravenous Immune Globulin for Patients with Immune Thrombocytopenia: A Multicenter Randomized Trial","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; University of Alberta; University of Toronto; Hôpital Maisonneuve-Rosemont; Canadian Blood Services; Sunnybrook Health Science Centre; St. Michael's Hospital; Jewish General Hospital; McMaster University; London Health Sciences Centre; University of Waterloo; Health Sciences Centre","funders":"","keywords":"Medicine; Eltrombopag; Perioperative; Surgery; Hemostasis; Adverse effect; Platelet; Tranexamic acid; Clinical endpoint; Randomized controlled trial; Immune thrombocytopenia; Anesthesia; Internal medicine","score_opus":0.00707038287196351,"score_gpt":0.24392821493118796,"score_spread":0.23685783205922445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990451347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872897,0.00032386652,0.000045261928,0.00013413785,0.00023823377,0.010967579,0.000062331244,0.00004531256,0.0008935296],"genre_scores_gemma":[0.9952064,0.000058459325,0.0020123487,0.000112809445,0.00006494426,0.00057084265,0.00030967046,0.00005002247,0.0016145016],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9984546,0.00007651916,0.00047386542,0.00037376955,0.00025132886,0.00036997232],"domain_scores_gemma":[0.9990121,0.000198848,0.00017172877,0.00033997418,0.0001838712,0.00009348578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017276045,0.00030087784,0.0016232467,0.000059319314,0.000098372366,0.000042002837,0.00010203007,0.000107453496,0.00042866857],"category_scores_gemma":[0.00015594544,0.00016880335,0.00025949941,0.00010321419,0.00008144673,0.00011088643,0.00003551733,0.00013579887,0.00011046673],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98499495,0.008318535,0.0021831654,0.00007411349,0.0020162384,0.00008538797,0.00072476134,9.923009e-7,0.0009823757,0.000032775806,0.000011308142,0.00057539047],"study_design_scores_gemma":[0.9828743,0.007913427,0.0047194925,0.00014318513,0.0014139364,0.000026414842,0.00012992705,0.00005464734,0.0022959865,0.000010029804,0.00019845874,0.00022022723],"about_ca_topic_score_codex":0.00007376524,"about_ca_topic_score_gemma":0.000014090384,"teacher_disagreement_score":0.010396736,"about_ca_system_score_codex":0.00004367286,"about_ca_system_score_gemma":0.00014616245,"threshold_uncertainty_score":0.6883601},"labels":[],"label_agreement":null},{"id":"W2990490360","doi":"10.1182/blood-2019-122269","title":"Impact of Iron Supplementation on Patient Outcomes in Women Undergoing Gynecological Procedures: Systematic Review and Meta-Analysis of Randomized Trials","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Cardiac, Anesthesia and Surgical Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Blood Services; McMaster University","funders":"","keywords":"Medicine; Randomized controlled trial; Meta-analysis; Perioperative; Blood transfusion; Anemia; Relative risk; Cochrane Library; Placebo; MEDLINE; Surgery; Internal medicine; Confidence interval","score_opus":0.040482662037458324,"score_gpt":0.3500762998858869,"score_spread":0.3095936378484286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990490360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884553,0.0064152936,0.0000016505326,0.00035163856,0.0000062493427,0.0044779545,0.00001953284,0.0000062850872,0.00026609583],"genre_scores_gemma":[0.9977789,0.0013131461,0.00005710003,0.0003784326,0.0000014830127,0.0003193951,0.000016879965,0.000006263175,0.00012841373],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9964829,0.0012971555,0.001568291,0.00017842374,0.0003358234,0.00013742023],"domain_scores_gemma":[0.98939717,0.009560994,0.00069882086,0.00022542063,0.000057375757,0.00006020504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038287577,0.00015861429,0.011672033,0.00025384864,0.0000072969488,0.0000055873656,0.000037383994,0.000053284715,0.00068098615],"category_scores_gemma":[0.008172808,0.000074305804,0.0031435238,0.00028833403,0.000025714451,0.00002808799,0.00001279745,0.000050833918,0.0000022369181],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014950394,0.0029100198,0.1935606,0.20294665,0.5824618,0.000029814491,0.0019379646,0.00013412298,0.00019916326,0.0008367448,0.000016554332,0.000016212367],"study_design_scores_gemma":[0.08082922,0.0011059502,0.039749563,0.001235839,0.876566,0.0000062420972,0.00027684518,0.000009626753,0.00007959318,0.000016683962,7.9693683e-7,0.00012365122],"about_ca_topic_score_codex":0.000023915292,"about_ca_topic_score_gemma":0.000006907813,"teacher_disagreement_score":0.29410422,"about_ca_system_score_codex":0.000045416742,"about_ca_system_score_gemma":0.00005872329,"threshold_uncertainty_score":0.97842056},"labels":[],"label_agreement":null},{"id":"W2990534398","doi":"10.1182/blood-2019-124082","title":"The Multidrug Transporter MRP4/ABCC4 Involved in the Leukemia Clinical Course Specifies the Novel PEL Human Blood Group System","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Héma-Québec","funders":"Agence Nationale de la Recherche","keywords":"Biology; Population; Molecular biology; Antibody; Genetics; Medicine","score_opus":0.024380476908544946,"score_gpt":0.277813963776751,"score_spread":0.25343348686820605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990534398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911962,0.0008888667,0.0000619475,0.0014161709,0.000682728,0.0016866314,0.000024329203,0.00009574797,0.0039473902],"genre_scores_gemma":[0.99648464,0.00017258138,0.00013924699,0.00049773464,0.0006426398,0.00008468786,0.00004808238,0.000053009415,0.0018773603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972045,0.00015517457,0.0009157261,0.00048174578,0.00070243014,0.0005404198],"domain_scores_gemma":[0.99805063,0.0003725514,0.00020780372,0.0011868954,0.00007240335,0.00010969046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002239928,0.00033121437,0.0005699439,0.00004527,0.00034827646,0.000071067545,0.0007297854,0.00022612452,0.00003829407],"category_scores_gemma":[0.00001486963,0.00014390225,0.00041686016,0.00023601938,0.00030532567,0.00007656755,0.000022603734,0.000891283,0.00007010702],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016812772,0.013659174,0.7813815,0.0018196893,0.0028572152,0.0017037166,0.017560171,0.000026448179,0.0637357,0.11231545,0.001877912,0.0013817789],"study_design_scores_gemma":[0.027079925,0.0006971092,0.91900057,0.0010158102,0.0027525404,0.00014919846,0.028372543,0.00015088168,0.0029323355,0.0001784458,0.017087048,0.0005836073],"about_ca_topic_score_codex":0.000109574255,"about_ca_topic_score_gemma":0.0017688465,"teacher_disagreement_score":0.1376191,"about_ca_system_score_codex":0.0000355761,"about_ca_system_score_gemma":0.00014611192,"threshold_uncertainty_score":0.5868163},"labels":[],"label_agreement":null},{"id":"W2990595177","doi":"10.1182/blood-2019-132435","title":"A Randomized Phase 3 Trial of Blinatumomab Vs. Chemotherapy As Post-Reinduction Therapy in High and Intermediate Risk (HR/IR) First Relapse of B-Acute Lymphoblastic Leukemia (B-ALL) in Children and Adolescents/Young Adults (AYAs) Demonstrates Superior Efficacy and Tolerability of Blinatumomab: A Report from Children's Oncology Group Study AALL1331","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Blinatumomab; Medicine; Internal medicine; Mitoxantrone; Oncology; Chemotherapy; Population; Minimal residual disease; Acute lymphocytic leukemia; Hematopoietic stem cell transplantation; Surgery; Transplantation; Leukemia; Lymphoblastic Leukemia","score_opus":0.00622691995846594,"score_gpt":0.27433691092720547,"score_spread":0.26810999096873955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990595177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99043196,0.0005821663,0.0000051324946,0.00008842146,0.00015055914,0.008553332,0.00015108257,0.000031251064,0.000006115234],"genre_scores_gemma":[0.99674946,0.0025325725,0.00022519298,0.000025846712,0.00009631311,0.00013920815,0.00016198098,0.00006431832,0.0000051305765],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99485636,0.000819459,0.0020877859,0.0011016356,0.00065222476,0.00048256063],"domain_scores_gemma":[0.9965221,0.0012102441,0.0010623401,0.0007033929,0.00026845353,0.00023346089],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018679112,0.00052700745,0.0027511274,0.0006565263,0.000045785586,0.000025400373,0.00023866846,0.00044894547,0.00003039805],"category_scores_gemma":[0.0014878104,0.0004337455,0.0001829027,0.00049888436,0.00085341005,0.00021823864,0.00018997847,0.0006608288,9.78693e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.50535333,0.009118943,0.47276014,0.000103736464,0.0011376771,0.00016071288,0.0020724947,0.0000018790154,0.0064399964,0.0000018037948,0.0000014990982,0.0028477646],"study_design_scores_gemma":[0.49790788,0.010636368,0.48681012,0.00044385254,0.0005475492,0.00045276756,0.00017238242,0.00025767615,0.0025717383,0.000026833968,1.444691e-7,0.00017268572],"about_ca_topic_score_codex":0.01044373,"about_ca_topic_score_gemma":0.00036355352,"teacher_disagreement_score":0.014049983,"about_ca_system_score_codex":0.00035654614,"about_ca_system_score_gemma":0.0008826825,"threshold_uncertainty_score":0.9998114},"labels":[],"label_agreement":null},{"id":"W2990635370","doi":"10.1182/blood-2019-121672","title":"Undertreatment of Older Patients with Newly-Diagnosed Multiple Myeloma: Real World Evidence from a Canadian Registry Cohort","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Juravinski Cancer Centre; McMaster University","funders":"","keywords":"Medicine; Lenalidomide; Multiple myeloma; Cohort; Population; Thalidomide; Clinical trial; Bortezomib; Retrospective cohort study; Diagnosis code; Pediatrics; Internal medicine","score_opus":0.015836852575690806,"score_gpt":0.2602950482790833,"score_spread":0.24445819570339247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990635370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944351,0.000225433,0.0000035110722,0.00016026823,0.00005229272,0.0018437786,0.00018960502,0.000034818037,0.0030552365],"genre_scores_gemma":[0.9960365,0.0000824519,0.0015608777,0.000062760286,0.00004654533,0.00010355193,0.00043665298,0.000037616457,0.0016330382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99809366,0.0000519466,0.00026671056,0.0004824276,0.00060956914,0.0004956545],"domain_scores_gemma":[0.9979472,0.00031854055,0.00011774277,0.00078483357,0.00019899517,0.00063267007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006942187,0.00024084629,0.00044047824,0.00019629468,0.000060771876,0.000019799125,0.00014160803,0.00008541538,0.0004969679],"category_scores_gemma":[0.00013571426,0.00017678551,0.00008653925,0.00027978903,0.0000719817,0.00010737551,0.000037967115,0.00015035034,0.00014994407],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006064797,0.0013479358,0.99506867,0.000062103456,0.000842563,0.00038418945,0.00014730281,0.000002292628,0.00018748849,0.000004532648,0.00025007024,0.0010963889],"study_design_scores_gemma":[0.021363365,0.0006799058,0.97294056,0.0006974153,0.00036299916,0.0000037985553,0.000054543747,0.00003913678,0.0035903829,0.0000047507156,0.00010884461,0.00015430964],"about_ca_topic_score_codex":0.48487177,"about_ca_topic_score_gemma":0.3793254,"teacher_disagreement_score":0.10554638,"about_ca_system_score_codex":0.00028726517,"about_ca_system_score_gemma":0.0007433838,"threshold_uncertainty_score":0.72091043},"labels":[],"label_agreement":null},{"id":"W2990636216","doi":"10.1182/blood.v112.11.2020.2020","title":"Recombinant Protein Infusion and Hydrodynamic Plasmid Delivery Strategies Provide Distinct and Complementary Approaches to the Characterization of Variant Forms of Von Willeband Factor (VWF) in VWF Knockout Mice.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Von Willebrand factor; ADAMTS13; Von Willebrand disease; Platelet; Knockout mouse; Chemistry; Hemostasis; Cleavage (geology); Recombinant DNA; Phenotype; Wild type; Molecular biology; Bleeding time; In vivo; Metalloproteinase; Immunology; Mutant; Biology; Gene; Matrix metalloproteinase; Internal medicine; Genetics; Biochemistry; Medicine; Platelet aggregation","score_opus":0.030185907465615374,"score_gpt":0.21349850282245442,"score_spread":0.18331259535683905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990636216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980617,0.00007873712,0.000020676116,0.00024764022,0.0000128176225,0.0013693396,0.00009095204,0.000007843079,0.00011028812],"genre_scores_gemma":[0.9994562,0.00011597419,0.0001302425,0.000016164746,0.000005818424,0.00004953731,0.00019753492,0.000010328584,0.000018165912],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9992648,0.000025556681,0.00027489473,0.00018068557,0.00012170537,0.00013237975],"domain_scores_gemma":[0.9996822,0.000021559166,0.0001216189,0.00011311804,0.000018331346,0.000043191718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005837169,0.00012558828,0.00028809623,0.000083200495,0.00006306135,0.0000076001415,0.000041225412,0.00004206562,0.0000050319395],"category_scores_gemma":[0.000011051487,0.00008104115,0.000022639273,0.000094145966,0.000072293,0.000120767785,0.00005271997,0.0000623824,3.6517272e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021318619,0.0059951167,0.42112136,0.0016472611,0.0005936931,0.00038286395,0.014540333,0.000012040115,0.5408182,0.0009145459,0.000008982514,0.011833713],"study_design_scores_gemma":[0.008540779,0.001739918,0.9608172,0.00043832508,0.00015533701,0.00023380044,0.0009761266,0.0008584967,0.025718816,0.00024361335,0.00008482074,0.00019272504],"about_ca_topic_score_codex":0.00035404216,"about_ca_topic_score_gemma":0.00090285693,"teacher_disagreement_score":0.5396959,"about_ca_system_score_codex":0.000011846111,"about_ca_system_score_gemma":0.00007909682,"threshold_uncertainty_score":0.33047622},"labels":[],"label_agreement":null},{"id":"W2990706354","doi":"10.1182/blood-2019-125226","title":"Increased Tumour Burden over a 36 Month Period in Chronic Myeloid Leukemia Patients Following Imatinib Discontinuation: Role of Digital PCR","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Imatinib; Discontinuation; Medicine; Myeloid leukemia; Imatinib mesylate; Internal medicine; Digital polymerase chain reaction; Oncology; Gastroenterology; Polymerase chain reaction; Biology","score_opus":0.005623635596803564,"score_gpt":0.22542339872005393,"score_spread":0.21979976312325036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990706354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99203557,0.00063832186,0.0000012470842,0.00003397743,0.00008753165,0.0011393201,0.00005866223,0.00005436192,0.00595101],"genre_scores_gemma":[0.99858105,0.000009961516,0.00015211492,0.000018093422,0.00015020111,0.00006521354,0.00034257508,0.000056932928,0.0006238843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978691,0.000039121227,0.00060218386,0.0004585488,0.0005899538,0.00044113645],"domain_scores_gemma":[0.9989541,0.00007085924,0.00023594109,0.00052736065,0.000065312284,0.00014639366],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012318855,0.0003057797,0.0006463932,0.00017332683,0.000034803463,0.000042011165,0.00017090503,0.00013398443,0.00028342355],"category_scores_gemma":[0.00015540485,0.00027653357,0.00025132188,0.00027877605,0.00003798445,0.0003792861,0.000119384866,0.00022137242,0.00014441],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029709746,0.0010427431,0.96128684,0.00016203595,0.00037488906,0.00008323079,0.001596431,0.000044493445,0.031110644,0.000022477287,0.000039194452,0.0039399336],"study_design_scores_gemma":[0.061158966,0.0014523709,0.9176667,0.0010361903,0.00048182192,0.000025862313,0.0006414186,0.0019643109,0.014693581,0.00006137183,0.00036723237,0.00045017328],"about_ca_topic_score_codex":0.0007676001,"about_ca_topic_score_gemma":0.00007205163,"teacher_disagreement_score":0.060861867,"about_ca_system_score_codex":0.0017709044,"about_ca_system_score_gemma":0.0011772644,"threshold_uncertainty_score":0.9999687},"labels":[],"label_agreement":null},{"id":"W2990707530","doi":"10.1182/blood-2019-124407","title":"First Analysis from a Phase 1/2 Study of Venetoclax in Combination with Daratumumab and Dexamethasone, +/- Bortezomib, in Patients with Relapsed/Refractory Multiple Myeloma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Daratumumab; Medicine; Venetoclax; Bortezomib; Tolerability; Internal medicine; Ven; Regimen; Oncology; Proteasome inhibitor; Lenalidomide; Dexamethasone; Carfilzomib; Combination therapy; Phases of clinical research; Multiple myeloma; Pharmacology; Clinical trial; Adverse effect; Leukemia; Chronic lymphocytic leukemia","score_opus":0.0109241296040956,"score_gpt":0.26254022716365166,"score_spread":0.25161609755955605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990707530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979174,0.00010187792,0.00000636835,0.00000893699,0.00000924895,0.0018218416,0.000055457807,0.000012387592,0.00006646979],"genre_scores_gemma":[0.99911886,0.000009588156,0.00046407268,0.0000059665726,0.000004979788,0.00007818066,0.00027283368,0.00002141713,0.000024090923],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984496,0.00009903709,0.0002996717,0.00041658367,0.0004952679,0.0002398129],"domain_scores_gemma":[0.9990125,0.00020304396,0.00014064285,0.00040994846,0.00011037415,0.00012353252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012393242,0.00018284081,0.000564294,0.0005417096,0.00003110202,0.0000131621555,0.00007020678,0.00006819102,0.00003985688],"category_scores_gemma":[0.000077234894,0.00013353417,0.000031925545,0.0008629572,0.000044100798,0.0001313792,0.00003649242,0.00019807747,0.000003771615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061240555,0.020056512,0.9699119,0.000039623923,0.0012331206,0.00012429376,0.0011708714,0.000054281205,0.000083941966,8.1817103e-7,9.606898e-7,0.0011996357],"study_design_scores_gemma":[0.16061865,0.0095006265,0.8270046,0.00011548846,0.0005760766,7.6434054e-7,0.00041117176,0.0014262256,0.0002314257,0.000002006269,0.000004725135,0.00010824702],"about_ca_topic_score_codex":0.003984956,"about_ca_topic_score_gemma":0.010128103,"teacher_disagreement_score":0.15449458,"about_ca_system_score_codex":0.00011267689,"about_ca_system_score_gemma":0.00008942974,"threshold_uncertainty_score":0.60240877},"labels":[],"label_agreement":null},{"id":"W2990732386","doi":"10.1182/blood-2019-129323","title":"Minimal Residual Disease (MRD) Assessment in the ECOG1411 Randomized Phase 2 Trial of Front-Line Bendamustine-Rituximab (BR)-Based Induction Followed By Rituximab (R) ± Lenalidomide (L) Consolidation for Mantle Cell Lymphoma (MCL)","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Bendamustine; Medicine; Mantle cell lymphoma; Minimal residual disease; Rituximab; Lenalidomide; Internal medicine; Oncology; Bortezomib; Progression-free survival; Multiple myeloma; Surgery; Lymphoma; Chemotherapy; Leukemia","score_opus":0.016779149720129456,"score_gpt":0.299942393250783,"score_spread":0.28316324353065353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990732386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888484,0.0008142489,0.00024722377,0.0015729996,0.00035631852,0.0071521583,0.0005948162,0.000036544367,0.0003773319],"genre_scores_gemma":[0.99402475,0.00006261793,0.0016980924,0.00027274975,0.00023286519,0.0015872824,0.0019060306,0.000040907034,0.00017469208],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99705416,0.00041965072,0.0010112828,0.00054018735,0.0005891028,0.00038561545],"domain_scores_gemma":[0.99752796,0.0011263705,0.00050349504,0.0005485756,0.00015706429,0.00013654926],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011801533,0.0003593963,0.0012403181,0.00020107938,0.000086412816,0.00004552766,0.00016404675,0.00015091534,0.00016568293],"category_scores_gemma":[0.00032499727,0.00025037248,0.0004905536,0.00015925553,0.00008720565,0.00012858414,0.00002854384,0.00010604556,0.000023028251],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8682367,0.114473954,0.0021884025,0.00048474927,0.00054149656,0.000075857446,0.0003406602,0.000015839327,0.008078523,0.00019494609,0.003563155,0.0018056968],"study_design_scores_gemma":[0.93990195,0.0026215329,0.000717708,0.00016693554,0.0027499865,0.000008184166,0.00031677622,0.0012327433,0.05131216,0.000075423806,0.0006604059,0.00023621491],"about_ca_topic_score_codex":0.00019923152,"about_ca_topic_score_gemma":0.000023791268,"teacher_disagreement_score":0.11185242,"about_ca_system_score_codex":0.00015854948,"about_ca_system_score_gemma":0.0007113437,"threshold_uncertainty_score":0.9999949},"labels":[],"label_agreement":null},{"id":"W2990744660","doi":"10.1182/blood-2019-131462","title":"Pathogenic Antibodies in Heparin-Induced Thrombocytopenia Specifically Target an Immunodominant Region on Platelet Factor 4","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; McMaster University","funders":"","keywords":"Platelet factor 4; Heparin-induced thrombocytopenia; Heparin; Polyclonal antibodies; Antibody; Platelet activation; Platelet; Medicine; Immunology; Immunoassay; Internal medicine","score_opus":0.0424068909854136,"score_gpt":0.2869501375084321,"score_spread":0.2445432465230185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990744660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98955107,0.00014608534,0.0000047615067,0.00028542182,0.00051595556,0.0015024188,0.00002383525,0.00017249405,0.00779797],"genre_scores_gemma":[0.9979826,0.00026796237,0.00065306685,0.00031435656,0.00021465597,0.000035770187,0.00009800913,0.00012177182,0.00031179146],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99642825,0.00020178045,0.0008236944,0.0010894368,0.0005380398,0.000918805],"domain_scores_gemma":[0.99776214,0.00012281975,0.00021773127,0.0014348057,0.00011223377,0.00035023916],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032789196,0.0005937833,0.001529909,0.00037531607,0.00011873967,0.00007929505,0.0004349689,0.0004429954,0.0006472544],"category_scores_gemma":[0.00010342887,0.00050641585,0.00028119437,0.00044995136,0.000077744444,0.00030465634,0.00015873325,0.0007954882,0.001419767],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063625147,0.0024095804,0.15250166,0.00009616903,0.00023027707,0.0007138174,0.00097517535,0.0000021262188,0.83928484,0.00084741105,0.000028699555,0.002274012],"study_design_scores_gemma":[0.008776936,0.0022933816,0.7475358,0.0003162059,0.000101264886,0.00028359218,0.00024061112,0.000039995753,0.23861833,0.00018185814,0.0010066117,0.0006053599],"about_ca_topic_score_codex":0.0002125583,"about_ca_topic_score_gemma":0.00008406148,"teacher_disagreement_score":0.6006665,"about_ca_system_score_codex":0.00017633106,"about_ca_system_score_gemma":0.00026471206,"threshold_uncertainty_score":0.99973875},"labels":[],"label_agreement":null},{"id":"W2990884440","doi":"10.1182/blood-2019-127394","title":"Patient Harm from Repetitive Blood Draws and Blood Waste in the ICU: A Retrospective Cohort Study","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Healthcare cost, quality, practices","field":"Health Professions","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Phlebotomy; Medicine; Intensive care unit; Emergency medicine; Retrospective cohort study; Intensive care medicine; Anemia; Population; Cohort; Cohort study; Blood transfusion; Surgery; Internal medicine","score_opus":0.1804067017863842,"score_gpt":0.44593057856344664,"score_spread":0.26552387677706246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990884440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814103,0.00055419025,0.0000015551191,0.0019754865,0.0005768352,0.00701826,0.00017596195,0.000096074196,0.008191286],"genre_scores_gemma":[0.9950716,0.00016045179,0.00012498607,0.0031079613,0.00036128418,0.0008135176,0.00003055532,0.00005430047,0.0002753679],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99011034,0.0059533347,0.0011265173,0.0010757957,0.0009367113,0.0007973182],"domain_scores_gemma":[0.9945176,0.0029315841,0.0007256698,0.0012578457,0.00035637117,0.00021089205],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004373116,0.0003575214,0.00073957816,0.00014832347,0.00060257193,0.000058171405,0.0003787742,0.00029806813,0.00039885702],"category_scores_gemma":[0.0018249146,0.00026881133,0.000074253294,0.00046830648,0.000097203076,0.00035558452,0.00038612465,0.002020935,0.0003160369],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000086087515,0.0035919733,0.9353635,0.000086433705,0.00032880355,0.00013450849,0.059540004,1.4787342e-7,0.00021703735,0.00042938656,0.00009605669,0.00012606347],"study_design_scores_gemma":[0.0060083074,0.0014399986,0.9104323,0.0002963088,0.0005881767,0.000010224895,0.07950986,0.0000038443645,0.00021991273,0.0005629445,0.00062967004,0.00029844345],"about_ca_topic_score_codex":0.0122487955,"about_ca_topic_score_gemma":0.005602305,"teacher_disagreement_score":0.024931194,"about_ca_system_score_codex":0.000107276595,"about_ca_system_score_gemma":0.00040593327,"threshold_uncertainty_score":0.9999764},"labels":[],"label_agreement":null},{"id":"W2991033128","doi":"10.1182/blood.2019003407","title":"Predicting success of desensitization after pegaspargase allergy","year":2019,"lang":"en","type":"letter","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; National Cancer Institute; Servier; American Lebanese Syrian Associated Charities; McGill University","keywords":"Desensitization (medicine); Medicine; Allergy; Immunology; Pharmacology; Internal medicine; Receptor","score_opus":0.011151572913334087,"score_gpt":0.2509729966064422,"score_spread":0.2398214236931081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991033128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.765152,0.0010343784,0.00066630583,0.2162903,0.00081932236,0.0022295476,0.0003350523,0.00025634057,0.013216772],"genre_scores_gemma":[0.6224425,0.0001906844,0.0015693756,0.34400892,0.011339849,0.00014174674,0.002248455,0.00040108323,0.017657388],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99743664,0.00010086391,0.0004583833,0.00048056233,0.0010196022,0.0005039613],"domain_scores_gemma":[0.99821776,0.00033966795,0.00022913452,0.0007142021,0.00041793016,0.000081305494],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016771667,0.00029901843,0.0006317633,0.00030167066,0.000027030574,0.000023124812,0.0001952717,0.0008482665,0.0003484954],"category_scores_gemma":[0.00036262593,0.00026285276,0.00016876176,0.00023899549,0.00010945157,0.00007216014,0.00015691799,0.0010811983,0.00015219733],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003483074,0.0003568365,0.039359886,0.0033941597,0.0013348933,0.007425152,0.00025570882,0.0000127721205,0.0017696517,0.0000043331033,0.9455684,0.00016992472],"study_design_scores_gemma":[0.058775973,0.0035023282,0.04121633,0.01063373,0.00683706,0.00955485,0.00016180791,0.007482203,0.060742483,0.00010080515,0.7981061,0.0028863284],"about_ca_topic_score_codex":0.00019025676,"about_ca_topic_score_gemma":0.00000908978,"teacher_disagreement_score":0.14746228,"about_ca_system_score_codex":0.00018131468,"about_ca_system_score_gemma":0.0008495517,"threshold_uncertainty_score":0.99998236},"labels":[],"label_agreement":null},{"id":"W2991046473","doi":"10.1182/blood.v130.suppl_1.63.63","title":"Transcriptional Plasticity Compensates for Ikaros and Aiolos Proteasomal Degradation and Mediates Resistance to IMiDs in Multiple Myeloma (MM)","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Enhancer; BRD4; Biology; Transcription factor; Chromatin immunoprecipitation; Chromatin; Histone; Bromodomain; Cancer research; Genetics; Gene; Promoter; Gene expression","score_opus":0.0175224048420515,"score_gpt":0.24392995776818457,"score_spread":0.22640755292613307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991046473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99777627,0.00026885283,0.0006960695,0.0004781896,0.000039699287,0.0005952511,0.0000850505,0.000006755475,0.00005388064],"genre_scores_gemma":[0.9948644,0.000032793996,0.0045201317,0.00006691126,0.00010530793,0.00016666536,0.00007621458,0.000009053205,0.00015848837],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99939024,0.000020625492,0.00013415486,0.00025499024,0.000066196844,0.00013380047],"domain_scores_gemma":[0.99968135,0.000023151628,0.000058180314,0.0001232052,0.0000458656,0.00006824047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000102013306,0.00009774986,0.000100963436,0.00002930001,0.00018824292,0.00005501533,0.00009098424,0.0000826084,0.0000019652693],"category_scores_gemma":[0.00044271306,0.00009363971,0.000020911744,0.000015514906,0.00008702176,0.000012185167,0.00003894071,0.000039595227,6.7049564e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022634462,0.00008185281,0.05512833,0.000040444844,0.000014855037,7.324644e-7,0.000042882337,0.0000013861622,0.9433848,0.00030285312,0.00011303609,0.0006624735],"study_design_scores_gemma":[0.0023387696,0.00017923076,0.26791736,0.000034525237,0.00001149475,0.0000029765258,0.000022267612,0.0000926077,0.7262324,0.00017291761,0.0028568495,0.00013862751],"about_ca_topic_score_codex":0.000014447935,"about_ca_topic_score_gemma":0.00056284596,"teacher_disagreement_score":0.21715243,"about_ca_system_score_codex":0.000003955897,"about_ca_system_score_gemma":0.00002329264,"threshold_uncertainty_score":0.38185164},"labels":[],"label_agreement":null},{"id":"W2991057190","doi":"10.1182/blood.v130.suppl_1.3124.3124","title":"Daratumumab in Combination with Lenalidomide Plus Dexamethasone Results in Persistent Natural Killer (NK) Cells with a Distinct Phenotype and Expansion of Effector Memory T-Cells in Pollux, a Phase 3 Randomized Study","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Daratumumab; CD38; Lenalidomide; Immunophenotyping; Antibody-dependent cell-mediated cytotoxicity; Immune system; Immunology; Antibody; Cytotoxic T cell; Biology; Cancer research; Monoclonal antibody; Multiple myeloma; Flow cytometry; CD34; Stem cell; In vitro; Cell biology","score_opus":0.018384776695571065,"score_gpt":0.29785285607191003,"score_spread":0.279468079376339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991057190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958838,0.0006500372,0.0000031880077,0.0002451552,0.00007254099,0.0026295169,0.00001903317,0.000008151866,0.00048857037],"genre_scores_gemma":[0.9989101,0.00007043063,0.00029323294,0.000016341739,0.000028281707,0.00008197509,0.000029537627,0.000020587155,0.00054951373],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99777913,0.00043494493,0.00049261906,0.0004258416,0.00054939074,0.00031809945],"domain_scores_gemma":[0.99858713,0.00057006464,0.00024085227,0.00037996162,0.000107968095,0.00011401335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013054967,0.00024421542,0.0010258855,0.0003155088,0.00009206819,0.000035128403,0.00014973935,0.000069866,0.000009905954],"category_scores_gemma":[0.00034314752,0.00015060678,0.00007834183,0.00019447532,0.0003391741,0.00011267678,0.000098422795,0.00040902453,0.0000021895687],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9012757,0.0085893525,0.0267559,0.00058876415,0.00038384268,0.0014137554,0.007042956,0.000042322044,0.051449545,0.000010052952,0.000019326593,0.0024284672],"study_design_scores_gemma":[0.9001376,0.007004966,0.067578465,0.001276733,0.00027464758,0.000038634713,0.0011101494,0.0021094303,0.02019771,0.0000071345303,0.0000078197645,0.00025673085],"about_ca_topic_score_codex":0.003980991,"about_ca_topic_score_gemma":0.003038379,"teacher_disagreement_score":0.040822566,"about_ca_system_score_codex":0.000068287016,"about_ca_system_score_gemma":0.00015518173,"threshold_uncertainty_score":0.6141566},"labels":[],"label_agreement":null},{"id":"W2991203221","doi":"10.1182/blood-2019-123678","title":"Genome and Exome-Wide Studies Reveal Potential Predictive Efficacy Markers for Venetoclax and Rituximab (VenR) in Relapsed/Refractory Chronic Lymphocytic Leukemia (R/R CLL): Subgroup Analyses of the Murano Trial","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Venetoclax; Rituximab; Medicine; Chronic lymphocytic leukemia; Oncology; Internal medicine; Refractory (planetary science); Exome; Alemtuzumab; Exome sequencing; Leukemia; Immunology; Lymphoma; Antibody; Biology; Genetics; Mutation; Gene","score_opus":0.02810904450633598,"score_gpt":0.31883405356654804,"score_spread":0.29072500906021204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991203221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9811928,0.014668174,0.0000074894983,0.000050513936,0.00025487773,0.0036316295,0.000039659135,0.000029769339,0.0001250341],"genre_scores_gemma":[0.99750525,0.0013205287,0.0001043603,0.000042030068,0.00030789376,0.0001552364,0.000018623428,0.00005348037,0.0004925738],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972376,0.0002195919,0.0007012023,0.00065768394,0.000591181,0.00059273065],"domain_scores_gemma":[0.9976342,0.0011365096,0.00026513386,0.0006502477,0.0001569731,0.00015694431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080797274,0.00032236608,0.0009962308,0.0002553963,0.000107459506,0.000023436696,0.00024169155,0.0002337372,0.000018708753],"category_scores_gemma":[0.00089519087,0.00023576508,0.00023199093,0.00037347563,0.0005450915,0.000102740254,0.00029660802,0.00032860792,0.000005652401],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.523201,0.0061501605,0.022476029,0.022794591,0.019700395,0.0010651583,0.011778807,0.009364235,0.37370068,0.00014746403,0.001319682,0.008301808],"study_design_scores_gemma":[0.90187633,0.0049980953,0.07336645,0.0009887841,0.0017587035,0.00022372737,0.0008311415,0.009906367,0.0053121313,0.0001212487,0.0002281544,0.00038886414],"about_ca_topic_score_codex":0.00053903594,"about_ca_topic_score_gemma":0.000052087747,"teacher_disagreement_score":0.37867534,"about_ca_system_score_codex":0.023516519,"about_ca_system_score_gemma":0.013774784,"threshold_uncertainty_score":0.9918162},"labels":[],"label_agreement":null},{"id":"W2991255594","doi":"10.1182/blood-2019-121584","title":"Single Cell Transcriptome Analysis Reveals Disease-Defining T Cell Subsets in the Tumor Microenvironment of Classic Hodgkin Lymphoma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; BC Cancer Agency; Terry Fox Research Institute; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"FOXP3; Tumor microenvironment; Biology; Immune system; Population; T cell; Cancer research; Mass cytometry; Immunology; Phenotype; Medicine; Genetics","score_opus":0.009301428537718532,"score_gpt":0.2095377803471642,"score_spread":0.20023635180944566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991255594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99306226,0.0035731671,0.000001935449,0.00030097627,0.000036880298,0.0005313138,0.000066573484,0.000014647478,0.0024122458],"genre_scores_gemma":[0.99877614,0.0001123291,0.00022002452,0.00043961767,0.000019580315,0.00006180724,0.000073859155,0.000022736927,0.0002738885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845374,0.00010932168,0.00040031117,0.00036168544,0.00037248145,0.00030246476],"domain_scores_gemma":[0.9989932,0.00012669695,0.0001533579,0.0005901382,0.000014543336,0.00012205734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019151918,0.0002088601,0.00051151117,0.00019071235,0.00003088109,0.000017666638,0.00015011204,0.000045529872,0.00017097515],"category_scores_gemma":[0.000007801746,0.0001431166,0.0003565175,0.00044688728,0.000045414552,0.000040820792,0.000022690023,0.000051088802,0.00012888623],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000099614044,0.0103486795,0.90720725,0.0001797261,0.00031283608,0.00027981764,0.0006864376,0.000021689899,0.08037327,0.00002132044,0.00013045443,0.00033891058],"study_design_scores_gemma":[0.008966836,0.00040887465,0.91499555,0.000095763324,0.0037088706,0.0000121370895,0.0003216971,0.000026534479,0.07064396,0.000015213591,0.0006557949,0.00014877047],"about_ca_topic_score_codex":0.00007517279,"about_ca_topic_score_gemma":0.000012820786,"teacher_disagreement_score":0.009939805,"about_ca_system_score_codex":0.000107068816,"about_ca_system_score_gemma":0.00005687857,"threshold_uncertainty_score":0.58361256},"labels":[],"label_agreement":null},{"id":"W2991263669","doi":"10.1182/blood-2019-128344","title":"Addition of ATIR101, an Adjunctive Treatment Following T-Cell-Depleted Haploidentical HSCT, May Decrease Non-Relapse Mortality and May Improve Survival of Patients with Hematologic Malignancies, Irrespective of Prognostic Risk Factors","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Juravinski Hospital; Université de Montréal; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Internal medicine; Hematopoietic stem cell transplantation; Transplantation; Oncology; Gastroenterology; Immunology","score_opus":0.02022450016857597,"score_gpt":0.2773847017286881,"score_spread":0.25716020156011216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991263669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965084,0.000072888106,0.00002107183,0.0000038065434,0.000081093596,0.0023351784,0.0006499945,0.00002267337,0.00030485034],"genre_scores_gemma":[0.9992295,0.000019334428,0.00020268779,0.0000024420692,0.000015910755,0.00005836108,0.00031360463,0.000038765385,0.00011943105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978026,0.00021413268,0.00048234337,0.00048238938,0.00070867816,0.00030986665],"domain_scores_gemma":[0.9980318,0.00046087534,0.00038066122,0.0004839504,0.00039157888,0.00025113655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026085606,0.0002848656,0.0008579507,0.00015389003,0.0000402134,0.000009181071,0.000090392656,0.00013131059,0.00021435706],"category_scores_gemma":[0.00037017008,0.00019895309,0.0001923364,0.00026638896,0.0002238881,0.00012505603,0.00005249504,0.00016187076,0.000001982233],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016918044,0.0054265116,0.92622364,0.00024418975,0.000988488,0.000028768798,0.00068867236,0.000001473279,0.06454888,0.000023440321,0.0000020193443,0.00013210987],"study_design_scores_gemma":[0.013385075,0.008002453,0.797069,0.00016571707,0.0012187557,0.0000023510052,0.0006448967,0.000059689934,0.17924802,0.000049409256,0.0000015579179,0.00015302547],"about_ca_topic_score_codex":0.0014696618,"about_ca_topic_score_gemma":0.00012522315,"teacher_disagreement_score":0.12915461,"about_ca_system_score_codex":0.00009760819,"about_ca_system_score_gemma":0.00026353772,"threshold_uncertainty_score":0.81130713},"labels":[],"label_agreement":null},{"id":"W2991303986","doi":"10.1182/blood-2019-122011","title":"The MAGIC Algorithm Probability (MAP): A Novel Laboratory Biomarker for the Response to Treatment of Acute Graft-Versus-Host Disease","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Graft-versus-host disease; Biomarker; Internal medicine; Disease; Clinical endpoint; Transplantation; Clinical trial; Hematopoietic stem cell transplantation; Oncology; Immunology; Gastroenterology; Biology","score_opus":0.02236009697963524,"score_gpt":0.2864290943989484,"score_spread":0.26406899741931317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991303986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874159,0.00046865043,0.0015860605,0.00485414,0.0003416793,0.0042802724,0.0009438946,0.000037518963,0.00007186421],"genre_scores_gemma":[0.98880935,0.00012394159,0.008223027,0.0002270001,0.000104578576,0.00076991844,0.0000670723,0.000054862234,0.0016202795],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989501,0.000079273115,0.0002520939,0.00025292463,0.00025024576,0.00021535385],"domain_scores_gemma":[0.99773896,0.001230851,0.00006828507,0.00064948684,0.0001638314,0.0001485965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048217914,0.00014768844,0.00020473711,0.00003722701,0.000079356636,0.000015092164,0.00010908765,0.000044704437,0.000023183355],"category_scores_gemma":[0.000087349035,0.000077342855,0.00013172533,0.00018918018,0.000077216646,0.00002858514,0.000013127625,0.000034852357,0.000047997295],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17973956,0.014816984,0.061116878,0.0019823818,0.008485915,0.00016772575,0.00805707,0.000011515293,0.70645505,0.0012415054,0.0010568682,0.016868558],"study_design_scores_gemma":[0.07884036,0.007801968,0.68653584,0.00045205033,0.010634985,0.00004667203,0.0010213302,0.0015549312,0.13502952,0.00014461167,0.07729742,0.00064029504],"about_ca_topic_score_codex":0.000012703856,"about_ca_topic_score_gemma":0.0000066997077,"teacher_disagreement_score":0.62541896,"about_ca_system_score_codex":0.000060350387,"about_ca_system_score_gemma":0.00028000036,"threshold_uncertainty_score":0.31539503},"labels":[],"label_agreement":null},{"id":"W2991336532","doi":"10.1182/blood-2019-123626","title":"Complete Response Status According to RECIL 2017 Criteria Shows High Concordance with Lugano 2014 Criteria and Is Highly Prognostic for Outcome in Previously Untreated Patients with CD20-Positive Diffuse Large B-Cell Lymphoma (DLBCL)","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Rituximab; Nuclear medicine; Internal medicine; CHOP; Lymphoma; Concordance; International Prognostic Index; Oncology","score_opus":0.012215117717472853,"score_gpt":0.26138917562386216,"score_spread":0.2491740579063893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991336532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992035,0.0002988771,0.000020865444,0.00035173717,0.00012112042,0.0050394256,0.0019484939,0.00006947837,0.00011505438],"genre_scores_gemma":[0.9950643,0.000039425362,0.0023473327,0.0010129818,0.000038310092,0.00061960844,0.0004120804,0.00008940899,0.00037656268],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99725676,0.00016016811,0.0005063188,0.0008741586,0.00035349364,0.00084912503],"domain_scores_gemma":[0.9978689,0.00058205286,0.00022838499,0.00059398805,0.0003290893,0.00039756607],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002395065,0.0005123887,0.00094529963,0.00020733858,0.00012481825,0.00012387944,0.00012896354,0.00011558243,0.000037658407],"category_scores_gemma":[0.00013643634,0.00036389733,0.00007078055,0.0002244717,0.00006290605,0.00020639844,0.000100269506,0.000074013566,0.00005419611],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016291678,0.010669693,0.96780026,0.00026639277,0.00025256976,0.00026507906,0.0010901138,2.687455e-7,0.0025243808,0.000015305168,0.0005053785,0.00031890714],"study_design_scores_gemma":[0.1395419,0.008718676,0.84472466,0.0009083521,0.0006561272,0.00004846399,0.00015840471,0.000032286796,0.003950609,0.0000050169856,0.00081066205,0.0004448259],"about_ca_topic_score_codex":0.0003987941,"about_ca_topic_score_gemma":0.0001265678,"teacher_disagreement_score":0.12325022,"about_ca_system_score_codex":0.00027297554,"about_ca_system_score_gemma":0.00019924289,"threshold_uncertainty_score":0.9998813},"labels":[],"label_agreement":null},{"id":"W2991372896","doi":"10.1182/blood-2019-123930","title":"Four-Year Analysis of Murano Study Confirms Sustained Benefit of Time-Limited Venetoclax-Rituximab (VenR) in Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Jewish General Hospital","funders":"","keywords":"Medicine; Venetoclax; Bendamustine; Internal medicine; Rituximab; Ven; Adverse effect; Chronic lymphocytic leukemia; Neutropenia; Gastroenterology; Tolerability; Oncology; Leukemia; Chemotherapy; Lymphoma","score_opus":0.012152290230249047,"score_gpt":0.2636337928031795,"score_spread":0.25148150257293045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991372896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946074,0.0010007364,0.000003272463,0.000015922706,0.00007043251,0.002212791,0.00004214785,0.00007002,0.001977305],"genre_scores_gemma":[0.9972435,0.00011553706,0.00007576971,0.000028111792,0.00007642883,0.000061173574,0.000102116916,0.00008845326,0.0022089113],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9953165,0.00020247042,0.0013411421,0.00082912855,0.0014520609,0.000858703],"domain_scores_gemma":[0.99640644,0.00060660485,0.00047718929,0.0017755979,0.00047622292,0.0002579655],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010485264,0.00043221365,0.0020324138,0.0016762721,0.000040746425,0.000019863224,0.0005859858,0.00034731659,0.001274462],"category_scores_gemma":[0.00035995137,0.00040502948,0.0004959191,0.0031116214,0.00022063119,0.00010588917,0.0002729842,0.00044464893,0.00021521302],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.018998014,0.0246662,0.55799496,0.009389948,0.0513967,0.0049214354,0.013269105,0.09600343,0.2171929,0.00079003326,0.0005390934,0.0048381784],"study_design_scores_gemma":[0.54572153,0.010154995,0.15010752,0.0011671735,0.01332862,0.0001516867,0.004363447,0.24788168,0.025581744,0.00007112886,0.0002860238,0.0011844346],"about_ca_topic_score_codex":0.0061534336,"about_ca_topic_score_gemma":0.00051334506,"teacher_disagreement_score":0.5267235,"about_ca_system_score_codex":0.049300574,"about_ca_system_score_gemma":0.028388375,"threshold_uncertainty_score":0.99984014},"labels":[],"label_agreement":null},{"id":"W2991436030","doi":"10.1182/blood-2019-130362","title":"Enasidenib Plus Azacitidine Significantly Improves Complete Remission and Overall Response Compared with Azacitidine Alone in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) with Isocitrate Dehydrogenase 2 (IDH2) Mutations: Interim Phase II Results from an Ongoing, Randomized Study","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Azacitidine; IDH2; Isocitrate dehydrogenase; Medicine; Myeloid leukemia; Internal medicine; Interim; Complete remission; Interim analysis; Oncology; Leukemia; IDH1; Gastroenterology; Clinical trial; Biology; Mutation; Chemotherapy; Enzyme; Genetics","score_opus":0.015781389020248802,"score_gpt":0.2809179710155977,"score_spread":0.2651365819953489,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991436030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892067,0.00009888631,0.00010172668,0.00032029822,0.00003383935,0.0090767285,0.0008830244,0.00019627843,0.00008253542],"genre_scores_gemma":[0.9918967,0.000050670144,0.0041251034,0.000278994,0.00007906243,0.00042850236,0.0026228267,0.00018123165,0.0003369148],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99336255,0.0013219446,0.0013563301,0.0016725014,0.0013363595,0.0009502997],"domain_scores_gemma":[0.99498576,0.0016293199,0.00070609053,0.0012931385,0.00059478695,0.00079089584],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015765695,0.0008994039,0.002383231,0.0006243594,0.00031575005,0.00017962315,0.00039693003,0.000210766,0.000058878155],"category_scores_gemma":[0.00059658394,0.00060955365,0.00011701143,0.00075413927,0.0005391261,0.0007026624,0.0002182206,0.000953701,0.00001459701],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.82601625,0.0054267906,0.010772706,0.00007199512,0.0017555865,0.0026118138,0.00937061,0.0001871687,0.14346163,0.000002788442,0.00005995495,0.00026268652],"study_design_scores_gemma":[0.8988561,0.032566372,0.03659599,0.0010744138,0.0015144031,0.00012263343,0.0027462642,0.005290519,0.020298427,0.000017601024,0.000031634016,0.00088561646],"about_ca_topic_score_codex":0.0031398176,"about_ca_topic_score_gemma":0.0009299652,"teacher_disagreement_score":0.12316321,"about_ca_system_score_codex":0.00072610396,"about_ca_system_score_gemma":0.0015362821,"threshold_uncertainty_score":0.9996356},"labels":[],"label_agreement":null},{"id":"W2991543587","doi":"10.1182/blood-2019-123799","title":"The Use of Chromogenic Factor VIII Assay Changes Treatment Approach in a Portion of Mild Hemophilia A Patients with Factor VIII Assay Discrepancy","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Concomitant; Internal medicine; Coagulation; Factor IX; Gastroenterology; Pediatrics; Immunology","score_opus":0.04469764925384994,"score_gpt":0.27394465834382126,"score_spread":0.2292470090899713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991543587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99684066,0.00032240458,0.0000048482607,0.00024161118,0.000043568827,0.0020911356,0.00016760895,0.000020970094,0.00026719886],"genre_scores_gemma":[0.9973067,0.0001921207,0.00029678608,0.000010093295,0.00003986872,0.0001072057,0.00017631041,0.00003573432,0.0018351886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980281,0.00015931371,0.00037731504,0.000371804,0.0006650832,0.00039839058],"domain_scores_gemma":[0.9986939,0.00020556532,0.0002130248,0.0006024232,0.00015453166,0.000130559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016515703,0.00026510292,0.00055601896,0.00017865562,0.000053409138,0.000015269681,0.00011482857,0.00014535958,0.0000759726],"category_scores_gemma":[0.00007592499,0.00013350579,0.0001462881,0.00032188545,0.00010453456,0.00009428515,0.000048291055,0.00015365914,0.000011505476],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063991756,0.0058399346,0.979546,0.00018380836,0.0006229369,0.000012916916,0.00087467686,0.000001331449,0.0071547823,0.000017820876,0.000013437496,0.005092431],"study_design_scores_gemma":[0.01316813,0.0043600453,0.94235736,0.00024524072,0.00027745022,0.000007153821,0.00015163388,0.00009913242,0.03872363,0.000005211395,0.00041394445,0.00019107744],"about_ca_topic_score_codex":0.00022454356,"about_ca_topic_score_gemma":0.00014548139,"teacher_disagreement_score":0.037188653,"about_ca_system_score_codex":0.00012357123,"about_ca_system_score_gemma":0.0001485924,"threshold_uncertainty_score":0.5444208},"labels":[],"label_agreement":null},{"id":"W2991549326","doi":"10.1182/blood-2019-127375","title":"Mutational Landscape of Grey Zone Lymphoma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC","funders":"","keywords":"Exome sequencing; Exome; Lymphoma; Indel; Biology; Pathology; Medicine; Cancer research; Genetics; Gene; Single-nucleotide polymorphism; Mutation","score_opus":0.007585221847896805,"score_gpt":0.2292341970435312,"score_spread":0.2216489751956344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991549326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851708,0.00046925078,0.0000022426213,0.00017471654,0.000056020694,0.00015490247,0.000012186322,0.000016787682,0.013943111],"genre_scores_gemma":[0.99844766,0.000019215737,0.0004532338,0.000116220064,0.00004934556,0.000012489223,0.00004715092,0.0000071089758,0.00084757374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995301,0.0000064780957,0.00011381947,0.000107298794,0.00015746157,0.000084890475],"domain_scores_gemma":[0.9996769,0.000039901945,0.000040424988,0.00014315468,0.000052618765,0.000047024507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003071792,0.00006034002,0.00015401232,0.000039176288,0.000009876854,0.0000035434841,0.000025583673,0.00003249288,0.00051875843],"category_scores_gemma":[0.000011390366,0.000045377332,0.00006129132,0.00006502291,0.000011367106,0.00002373606,0.000011750376,0.0000105213,0.0002823459],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052056766,0.002434853,0.9896651,0.00005431515,0.0002251637,0.00007831394,0.000097169344,0.0000016879967,0.0013497507,0.0010378371,0.00041232427,0.0045914548],"study_design_scores_gemma":[0.012836571,0.00037804374,0.9571426,0.000053972846,0.0001963341,0.00015248825,0.000043893822,0.000022968981,0.027807198,0.000039360293,0.0012739467,0.00005265041],"about_ca_topic_score_codex":0.000027676688,"about_ca_topic_score_gemma":0.0000022334325,"teacher_disagreement_score":0.0325225,"about_ca_system_score_codex":0.000011745441,"about_ca_system_score_gemma":0.00007279471,"threshold_uncertainty_score":0.56800413},"labels":[],"label_agreement":null},{"id":"W2991566266","doi":"10.1182/blood-2019-126081","title":"Earlier Steroid Use with Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed/Refractory Large B Cell Lymphoma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of British Columbia","funders":"","keywords":"Medicine; Lymphoma; Refractory (planetary science); Internal medicine; Oncology; Cancer research; Biology","score_opus":0.010129602824365593,"score_gpt":0.2240935531776961,"score_spread":0.21396395035333052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991566266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99135476,0.00015820698,0.0000065758336,0.00004106951,0.00006768443,0.0011641463,0.000031870208,0.000059805196,0.007115881],"genre_scores_gemma":[0.97293794,0.000040815543,0.0003043705,0.0003072595,0.00006506242,0.000035316014,0.00007967157,0.00011151299,0.026118038],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99747264,0.00009731593,0.00028095252,0.00055845926,0.0009072101,0.0006834092],"domain_scores_gemma":[0.99845046,0.00008812389,0.000101507314,0.00091772486,0.00017902115,0.00026317337],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002398206,0.0002925892,0.00044887885,0.0002475075,0.00004611295,0.000049462524,0.0001850984,0.00016520829,0.0015883923],"category_scores_gemma":[0.000019898938,0.00021310861,0.00006989207,0.0003818779,0.00006545909,0.00023589759,0.000090236936,0.000354445,0.00042170583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003471362,0.0102639515,0.96331614,0.0001224008,0.00014589576,0.00017804024,0.00047372683,0.0000020029643,0.020460641,0.000005175897,0.00017894543,0.00138171],"study_design_scores_gemma":[0.09772444,0.005551506,0.8598717,0.00022046878,0.00011643358,0.000018036624,0.00011534946,0.000013946911,0.019929515,0.0000023603184,0.016045906,0.00039035897],"about_ca_topic_score_codex":0.000099706755,"about_ca_topic_score_gemma":0.00007136999,"teacher_disagreement_score":0.103444465,"about_ca_system_score_codex":0.00013160956,"about_ca_system_score_gemma":0.00023716142,"threshold_uncertainty_score":0.99932426},"labels":[],"label_agreement":null},{"id":"W2991697479","doi":"10.1182/blood.v106.11.2929.2929","title":"A Randomized Trial Comparing the Effectiveness of Peripheral Blood Stem Cell Mobilization with Chemotherapy and Early vs Delayed Initiation of Granulocyte Colony-Stimulating Factor (G-CSF) in Patients with Lymphoma and Multiple Myeloma.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Granulocyte colony-stimulating factor; Leukapheresis; Chemotherapy; Cyclophosphamide; Internal medicine; Neutropenia; Multiple myeloma; Absolute neutrophil count; Febrile neutropenia; Gastroenterology; Lymphoma; Surgery; Oncology; Urology; CD34; Stem cell","score_opus":0.009082124373721617,"score_gpt":0.2287742920765005,"score_spread":0.21969216770277888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991697479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99692774,0.000085260894,0.00017635449,0.000006640017,0.000015952446,0.0027110837,0.000006148455,0.000014628451,0.00005621815],"genre_scores_gemma":[0.9996611,0.000014699648,0.00015938257,0.000011604111,0.00002403181,0.00009864041,0.000008486495,0.000018932999,0.0000031622226],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9989917,0.00024879366,0.00030064234,0.00017364066,0.00017582047,0.0001093948],"domain_scores_gemma":[0.99911445,0.0003901385,0.00021384229,0.0001143469,0.0001316537,0.000035540153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026937996,0.00013240709,0.0005461511,0.00006797157,0.000058397232,0.000015347663,0.000029364766,0.000048430466,0.000002650374],"category_scores_gemma":[0.000020005593,0.00008335268,0.00003647914,0.00016706741,0.00010596477,0.00011458702,0.000011244833,0.00006177143,5.0732993e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3791725,0.0006542176,0.6162825,0.000099796074,0.00011709395,4.571856e-7,0.0007392531,0.0003023895,0.0023473215,0.000004328259,3.509946e-8,0.0002800944],"study_design_scores_gemma":[0.49972904,0.0014910094,0.48191625,0.00011932686,0.0002272161,0.0000025031973,0.00002399349,0.0005270515,0.01590838,0.00000104346,4.107687e-7,0.00005377063],"about_ca_topic_score_codex":0.00016500399,"about_ca_topic_score_gemma":0.00011730051,"teacher_disagreement_score":0.13436626,"about_ca_system_score_codex":0.000025464236,"about_ca_system_score_gemma":0.000050586892,"threshold_uncertainty_score":0.33990237},"labels":[],"label_agreement":null},{"id":"W2991704241","doi":"10.1182/blood.v110.11.3573.3573","title":"Prognostic Factors in Primary Cutaneous Anaplastic Large Cell Lymphoma: Clinical and Molecular Characterization of a Subset with Worse Outcome.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Services and Policy Research","funders":"","keywords":"Internal medicine; Medicine; Univariate analysis; Proportional hazards model; Oncology; Retrospective cohort study; Logistic regression; Multivariate analysis; Gastroenterology","score_opus":0.01575932543367508,"score_gpt":0.29380167001606133,"score_spread":0.27804234458238625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991704241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980906,0.00009775381,0.0004643108,0.000037872614,0.000024551722,0.00089895626,0.000035269324,0.000028379704,0.00032230554],"genre_scores_gemma":[0.9992883,0.000044078,0.00024031344,0.00011696853,0.000020521875,0.000010760736,0.00016318093,0.000037555867,0.00007832379],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99814904,0.00008214418,0.0005846211,0.00035493827,0.00041480138,0.00041443843],"domain_scores_gemma":[0.9990159,0.00028926722,0.00013063599,0.00023099028,0.00013899116,0.00019417664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035524386,0.00019598221,0.00050451636,0.00025706977,0.000032086024,0.000013225007,0.000074688294,0.0001398902,0.000019824074],"category_scores_gemma":[0.00037566948,0.00015684038,0.00005906481,0.00040528996,0.00016499402,0.00004549272,0.000054620938,0.00016249031,0.0000044281965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001098515,0.0045082206,0.962018,0.0003037413,0.00006209146,0.0024754487,0.00027135797,3.0620527e-7,0.028893527,0.0000115244975,0.0000011555207,0.00035610166],"study_design_scores_gemma":[0.012014956,0.0016050881,0.97123575,0.000112791386,0.00016201184,0.0009280312,0.00015093535,0.00007790115,0.013503877,0.000005075986,0.000031856845,0.00017171507],"about_ca_topic_score_codex":0.000016847176,"about_ca_topic_score_gemma":0.00009895156,"teacher_disagreement_score":0.015389649,"about_ca_system_score_codex":0.000042417207,"about_ca_system_score_gemma":0.00021727613,"threshold_uncertainty_score":0.6395765},"labels":[],"label_agreement":null},{"id":"W2991722544","doi":"10.1182/blood.v106.11.795.795","title":"High Resolution Time-Lapse Monitoring of Individual Hematopoietic Stem Cells Reveals New Biomarkers of Self-Renewal.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Waterloo; BC Cancer Agency","funders":"","keywords":"Haematopoiesis; Stem cell; Biology; Bone marrow; Cell division; Lamellipodium; Cell biology; Cell; Molecular biology; Andrology; Immunology; Genetics; Cell migration; Medicine","score_opus":0.01639214468179453,"score_gpt":0.24371943239753813,"score_spread":0.2273272877157436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991722544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99749756,0.00068870053,0.00017701827,0.00013660705,0.00014041482,0.0004967454,0.00003086255,0.00009532036,0.0007367894],"genre_scores_gemma":[0.9718321,0.00011166544,0.027203634,0.000015241202,0.00023400175,0.000009026133,0.00002053832,0.000035552013,0.0005382289],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99799675,0.000078656005,0.00074876496,0.0002725841,0.00062746654,0.00027578056],"domain_scores_gemma":[0.99885404,0.00015454639,0.0003065518,0.00039243503,0.000105645,0.00018676689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004326665,0.00019545598,0.00050866517,0.00020327288,0.000031227133,0.00000850989,0.0001542589,0.00017639111,0.00009413804],"category_scores_gemma":[0.000013831533,0.00019137327,0.00012536075,0.0003173199,0.00004558388,0.00008242675,0.000027690608,0.00010671206,0.0000669869],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018974183,0.0013450815,0.023561282,0.0019577278,0.0009229434,0.000034521745,0.004049824,0.000051781382,0.96495295,0.00017639041,0.000960623,0.0017971215],"study_design_scores_gemma":[0.0046791635,0.00027035238,0.006652564,0.0010285578,0.0012408996,0.00010434015,0.00023118222,0.000016349039,0.9854959,0.00006096894,0.00005808445,0.00016162205],"about_ca_topic_score_codex":0.00004620122,"about_ca_topic_score_gemma":0.0000011192752,"teacher_disagreement_score":0.027026616,"about_ca_system_score_codex":0.000040032264,"about_ca_system_score_gemma":0.00015190059,"threshold_uncertainty_score":0.78039753},"labels":[],"label_agreement":null},{"id":"W2991835787","doi":"10.1182/blood-2019-123450","title":"A Prognostic Model Integrating PET-Derived Quantitative Parameters and Image Texture Analyses Using Radiomics in a Large Prospective Phase III Trial, GOYA","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Proportional hazards model; Logistic regression; Progression-free survival; Oncology; Nuclear medicine; Internal medicine; Radiology; Overall survival","score_opus":0.0341315135952375,"score_gpt":0.3748559315591447,"score_spread":0.3407244179639072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991835787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808241,0.00045560166,0.016554374,0.0001804668,0.00007400088,0.0015782447,0.00001268877,0.00005067594,0.00026983808],"genre_scores_gemma":[0.9251461,0.00004699592,0.07446563,0.00017080319,0.000042866755,0.00003486047,0.000022325929,0.000038943497,0.000031453845],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9983839,0.00010976858,0.00042001918,0.00046938026,0.00023514057,0.0003818259],"domain_scores_gemma":[0.99907684,0.00027567663,0.0001965547,0.00020972124,0.00008691336,0.00015429217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005303871,0.0002472221,0.00068244885,0.00024727982,0.00008340315,0.00007761914,0.000085278094,0.000071891,0.000012977097],"category_scores_gemma":[0.001553862,0.00019866074,0.00010941742,0.0003333877,0.000121568366,0.00017180985,0.00005909857,0.0006891169,0.0000026866264],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020141011,0.0070865564,0.08416638,0.00068027386,0.001433358,0.0011923151,0.016274974,0.0028033722,0.8610701,0.0017713921,0.000038820748,0.0033414387],"study_design_scores_gemma":[0.11858049,0.0008384365,0.000728662,0.00043850564,0.0005277538,0.00013268468,0.002128794,0.8752552,0.0007664291,0.00037375005,0.0000031330176,0.00022615088],"about_ca_topic_score_codex":0.00009896498,"about_ca_topic_score_gemma":0.000012133565,"teacher_disagreement_score":0.87245184,"about_ca_system_score_codex":0.00006751658,"about_ca_system_score_gemma":0.0001790606,"threshold_uncertainty_score":0.810115},"labels":[],"label_agreement":null},{"id":"W2991848929","doi":"10.1182/blood.v110.11.3900.3900","title":"Proteomics in the Study of Qualitative Platelet Defects: Validation of the Approach in the Gray Platelet Syndrome and Quebec Platelet Disorder.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Platelet; Proteome; Blood Platelet Disorders; Proteomics; Von Willebrand factor; Platelet disorder; Biology; Medicine; Internal medicine; Pathology; Immunology; Bioinformatics; Biochemistry; Platelet aggregation","score_opus":0.025494306381346744,"score_gpt":0.29964435431601666,"score_spread":0.2741500479346699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991848929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954218,0.00026780457,0.00002790936,0.00015862512,0.000023275072,0.0036878036,0.000022138367,0.000008703808,0.00038189278],"genre_scores_gemma":[0.9995363,0.000023107688,0.00014891295,0.00007427007,0.000008660411,0.0001356213,0.000038143124,0.00001796893,0.000017054555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978513,0.0005388368,0.0005736767,0.0002804693,0.00047177746,0.000283956],"domain_scores_gemma":[0.9986817,0.0005504479,0.00026287846,0.00043306188,0.000042607033,0.000029281297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019446387,0.0002249831,0.00050254725,0.00015331314,0.000083912506,0.000017818697,0.000266055,0.000116790514,0.0000032216738],"category_scores_gemma":[0.00013819884,0.000109581495,0.00007388762,0.0006862471,0.00014944062,0.00008835415,0.000049980037,0.00034145734,0.000001028227],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012794862,0.037339374,0.5553827,0.0006229089,0.0009548137,0.0014873807,0.3977807,0.0002006368,0.0012508214,0.00088918494,0.000050905055,0.002761093],"study_design_scores_gemma":[0.029240865,0.0027749399,0.77229613,0.00023551259,0.00037240062,0.0012244842,0.18418258,0.00006079025,0.007997714,0.0012417043,0.000051835028,0.00032104916],"about_ca_topic_score_codex":0.0044551245,"about_ca_topic_score_gemma":0.0059400788,"teacher_disagreement_score":0.21691342,"about_ca_system_score_codex":0.00002659499,"about_ca_system_score_gemma":0.000056160436,"threshold_uncertainty_score":0.67348456},"labels":[],"label_agreement":null},{"id":"W2991977565","doi":"10.1182/blood.v106.11.2932.2932","title":"Dose Intensive Induction Chemotherapy Does Not Decrease Tumor Contamination of Autograft or Improve Survival for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplant.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Multiple myeloma; Internal medicine; Etoposide; Autologous stem-cell transplantation; Chemotherapy; Melphalan; Transplantation; Surgery; Cyclophosphamide; Gastroenterology; Urology; Oncology","score_opus":0.019727672655474603,"score_gpt":0.2706630612648186,"score_spread":0.250935388609344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991977565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967548,0.000036260484,0.00035675292,0.00030958455,0.00019756508,0.0019179106,0.00029184902,0.00007590824,0.000059350714],"genre_scores_gemma":[0.99670225,0.00004544897,0.001903878,0.0001610469,0.00014095088,0.00016515514,0.0002428225,0.00004327169,0.00059519516],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99840975,0.00006658638,0.0004098161,0.00037219367,0.00035684553,0.00038483832],"domain_scores_gemma":[0.9983497,0.0003828261,0.00021103186,0.00023881717,0.0005663554,0.0002512676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015214142,0.00023629752,0.0004275757,0.00016710661,0.0000962333,0.000016417263,0.00008742109,0.00011643374,0.0000412396],"category_scores_gemma":[0.00023853985,0.00015889066,0.00015013535,0.00012407066,0.00007119782,0.00014121682,0.000016405706,0.00013193543,0.0000070468373],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028487602,0.015390538,0.3258837,0.0018493755,0.0016147872,0.00020507484,0.0048724962,0.0000087189555,0.29746574,0.000034074084,0.000109494424,0.3240784],"study_design_scores_gemma":[0.053627186,0.0029600868,0.2136623,0.00015165286,0.00032495736,0.000021802343,0.00077856105,0.0013563349,0.7267577,0.000007026598,0.0001473264,0.00020504721],"about_ca_topic_score_codex":0.00012697013,"about_ca_topic_score_gemma":0.00048892776,"teacher_disagreement_score":0.42929196,"about_ca_system_score_codex":0.00010112805,"about_ca_system_score_gemma":0.00024862113,"threshold_uncertainty_score":0.6479373},"labels":[],"label_agreement":null},{"id":"W2992036842","doi":"10.1182/blood-2019-128855","title":"Venous Thromboembolism (VTE) in Sickle Cell Disease (SCD) Is Associated with Neutrophilia","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hematological disorders and diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Medicine; Acute chest syndrome; Thrombophilia; Neutrophilia; Thrombosis; Internal medicine; Medical record; Retrospective cohort study; Venous thrombosis; Incidence (geometry); Anemia; Disease; Complication; Sickle cell anemia; Pulmonary embolism; Cancer; Deep vein; Pediatrics","score_opus":0.007355313094986849,"score_gpt":0.21419241230451275,"score_spread":0.2068370992095259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992036842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880615,0.00060591527,0.000002565938,0.0006434941,0.000043334006,0.00044007244,0.000022500728,0.000056804052,0.0101238275],"genre_scores_gemma":[0.99755603,0.00007059865,0.00004789806,0.0017189621,0.00002648044,0.000014111794,0.000037944097,0.000022381959,0.00050560915],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990398,0.000025963644,0.00016713458,0.00025343883,0.00021065462,0.00030300612],"domain_scores_gemma":[0.9993147,0.00011738185,0.000051701696,0.00026486552,0.00004734712,0.00020395564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005308959,0.00014192834,0.0004190679,0.000046175148,0.000024545394,0.000012350498,0.000072826006,0.00009631656,0.0003819056],"category_scores_gemma":[0.0001619428,0.00010308058,0.000059318103,0.00019374116,0.00003927732,0.000033723605,0.000029620447,0.00017645353,0.00030588364],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025316473,0.016335266,0.9764419,0.0002682593,0.000116409996,0.0017906731,0.0006462999,0.000022355207,0.001077985,0.00073810713,0.0021619087,0.0001476691],"study_design_scores_gemma":[0.009351156,0.0012400001,0.9855535,0.0002835838,0.00036258844,0.000011086902,0.00012370344,0.0000971539,0.0011812842,0.00097525615,0.00055558025,0.0002651216],"about_ca_topic_score_codex":0.00003345265,"about_ca_topic_score_gemma":0.000011972544,"teacher_disagreement_score":0.015095265,"about_ca_system_score_codex":0.000016298842,"about_ca_system_score_gemma":0.00010222238,"threshold_uncertainty_score":0.4203504},"labels":[],"label_agreement":null},{"id":"W2992122126","doi":"10.1182/blood-2019-122062","title":"Randomized Controlled Trial of the Efficacy and Safety of Deferiprone in Iron-Overloaded Patients with Sickle Cell Disease or Other Anemias","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Deferiprone; Deferasirox; Medicine; Deferoxamine; Clinical endpoint; Randomized controlled trial; Internal medicine; Ferritin; Gastroenterology; Thalassemia; Confidence interval; Anemia; Adverse effect; Surgery","score_opus":0.00362152454194075,"score_gpt":0.19824250582341224,"score_spread":0.19462098128147148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992122126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99100035,0.00040934794,0.0000011235494,0.00008778467,0.00006480553,0.0064289146,0.000011634941,0.000006464358,0.0019895576],"genre_scores_gemma":[0.99913305,0.00007192691,0.000025841511,0.00006262237,0.000011686358,0.00003566914,0.0000044996423,0.000014964006,0.0006397127],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998935,0.00014852943,0.00042037538,0.0001436826,0.00022527359,0.00012714625],"domain_scores_gemma":[0.9991501,0.0002809832,0.00022151794,0.00023928548,0.00004187826,0.00006622854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023752074,0.000120435834,0.0009062394,0.00004009228,0.000014872777,0.0000024776166,0.00005304359,0.00007481848,0.00010719147],"category_scores_gemma":[0.00023866129,0.000052165036,0.00012410614,0.00012518266,0.00012659852,0.000018578465,0.00002313239,0.000108155364,0.0000023753091],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.977628,0.0027142474,0.018586688,0.00015908477,0.00012902208,0.0000020478044,0.00028599548,0.000019460176,0.00038433354,0.000014228969,0.000008857508,0.00006803376],"study_design_scores_gemma":[0.9869295,0.0006818277,0.010715172,0.00021841814,0.00080604065,4.5021721e-7,0.00007506413,0.00003022877,0.00043772816,0.0000052670134,0.000029783101,0.00007052717],"about_ca_topic_score_codex":0.000035410674,"about_ca_topic_score_gemma":0.0000041143217,"teacher_disagreement_score":0.009301493,"about_ca_system_score_codex":0.0000068581307,"about_ca_system_score_gemma":0.000116190145,"threshold_uncertainty_score":0.21272285},"labels":[],"label_agreement":null},{"id":"W2992123204","doi":"10.1182/blood.v112.11.2179.2179","title":"Outcome of Transplant-Eligible Patients with Hodgkin Lymphoma with An Inadequate Response to Second Line Chemotherapy with Gemcitabine, Dexamethasone, Cisplatin (GDP).","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Etoposide; Chemotherapy regimen; Chemotherapy; Gemcitabine; Melphalan; Internal medicine; Salvage therapy; Oncology; Progressive disease; Dacarbazine; Carmustine; Surgery","score_opus":0.01578763191336332,"score_gpt":0.24775741828504852,"score_spread":0.2319697863716852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992123204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978626,0.00007702876,0.00012254251,0.00029670197,0.000016952232,0.0011165086,0.00015522212,0.00006772677,0.00028473593],"genre_scores_gemma":[0.9858253,0.000026168915,0.0128067685,0.00059843843,0.000035718087,0.00012327611,0.000088391644,0.00008358939,0.00041232273],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979377,0.00008507015,0.00043067752,0.0005279138,0.0005935543,0.00042510362],"domain_scores_gemma":[0.99844587,0.00015687985,0.00017515942,0.00062504935,0.0002221763,0.00037488635],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017792183,0.00040853964,0.00074485544,0.00023227712,0.00009668925,0.000014697794,0.00013297386,0.00010375535,0.00011626351],"category_scores_gemma":[0.000019976394,0.00024584023,0.00006770311,0.0004881494,0.000118620825,0.00013796511,0.000012423391,0.00007718562,0.000015510452],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03275776,0.006825905,0.9542869,0.000086009066,0.0005417705,0.00059288286,0.0013763444,0.000020742507,0.0007057238,0.000010325771,0.000039323433,0.0027563649],"study_design_scores_gemma":[0.061204176,0.01984897,0.8660552,0.00026164923,0.0004305307,0.00035672053,0.000051605643,0.000009859398,0.051137656,0.000002148054,0.00031610648,0.00032539121],"about_ca_topic_score_codex":0.00025254287,"about_ca_topic_score_gemma":0.00040583021,"teacher_disagreement_score":0.08823166,"about_ca_system_score_codex":0.00008072829,"about_ca_system_score_gemma":0.00025929607,"threshold_uncertainty_score":0.9999994},"labels":[],"label_agreement":null},{"id":"W2992227344","doi":"10.1182/blood.v110.11.180.180","title":"Genomic, Proteomic and Functional Screens Identify PAI-1 as an Important Factor Influencing Mesenchymal Stromal Cell Survival Post-Transplantation In Vivo.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Mesenchymal stem cell; Transplantation; Biology; In vivo; Oxygen tension; Immunology; Immunophenotyping; Stromal cell; Cancer research; Cell biology; Flow cytometry; Medicine; Chemistry; Internal medicine","score_opus":0.02353101763403896,"score_gpt":0.29320976728880055,"score_spread":0.2696787496547616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992227344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966501,0.00015837993,0.00011963637,0.000052424693,0.0000946705,0.0010352227,0.00006452049,0.000052131443,0.0017728928],"genre_scores_gemma":[0.9982791,0.000058205685,0.00087749487,0.00006181848,0.000240823,0.000018618686,0.00008727106,0.000040241957,0.00033645355],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99734414,0.00011164436,0.000608679,0.0005282934,0.0007783559,0.0006288911],"domain_scores_gemma":[0.9988726,0.00013496928,0.00012415329,0.00026532687,0.0001682457,0.00043473704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012098955,0.00024006926,0.0003266289,0.000355282,0.00011259345,0.000059205424,0.00010177936,0.0001914498,0.0006071726],"category_scores_gemma":[0.00010030034,0.00022600027,0.00006971115,0.0002200389,0.00008084017,0.000255002,0.000051187868,0.00044655259,0.000039631734],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005070651,0.00023317889,0.43984976,0.00013188817,0.000024372353,0.00049406535,0.0003566006,0.0000015140308,0.558278,0.000038288246,0.0000020660918,0.00008320521],"study_design_scores_gemma":[0.0036128203,0.00069029134,0.76810205,0.000051524323,0.00006159023,0.00028826378,0.0004836258,0.000047770278,0.22644036,0.00002659175,0.00002080702,0.00017431853],"about_ca_topic_score_codex":0.001813076,"about_ca_topic_score_gemma":0.0013372933,"teacher_disagreement_score":0.33183765,"about_ca_system_score_codex":0.000098040015,"about_ca_system_score_gemma":0.0003238747,"threshold_uncertainty_score":0.9216023},"labels":[],"label_agreement":null},{"id":"W2992277868","doi":"10.1182/blood.v106.11.2982.2982","title":"The Induction of Apoptosis by Histone Deacetylase Inhibition in Chronic Lymphocytic Leukemia (CLL) Cells Is Mediated through the TNF-Related Apoptosis-Inducing Ligand (TRAIL) Pathway.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Apoptosis; Histone deacetylase; Viability assay; Acridine orange; MTT assay; Molecular biology; Trichostatin A; Histone deacetylase inhibitor; Cell cycle; Jurkat cells; Cancer research; Chemistry; Biology; Immunology; Histone; Biochemistry; T cell; Immune system","score_opus":0.013721897743171809,"score_gpt":0.2652038972538385,"score_spread":0.25148199951066674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992277868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913178,0.004590275,0.000017766868,0.0014462393,0.00020978351,0.0012426219,0.000036765403,0.000111013185,0.0010277189],"genre_scores_gemma":[0.9956245,0.002414465,0.00007751976,0.0003464807,0.0003052779,0.00015110872,0.00009240807,0.000089137626,0.000899141],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958999,0.00024896648,0.0011630589,0.0006752931,0.0010910974,0.00092168467],"domain_scores_gemma":[0.9975786,0.0006096896,0.0004232616,0.0009993318,0.00019828136,0.0001907948],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010425617,0.0004260577,0.0006058793,0.00018416088,0.0003586444,0.000057354595,0.00030810793,0.00049528654,0.00010536999],"category_scores_gemma":[0.00031693582,0.00028872647,0.00022538866,0.0011735829,0.0005871088,0.00031495283,0.00015637462,0.0008393794,0.00015542025],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0002660788,0.00046510526,0.000009611068,0.00023501816,0.00036303396,0.000019568719,0.0046179234,0.0006777344,0.98025393,0.00011579895,0.0064208964,0.0065553105],"study_design_scores_gemma":[0.033219058,0.00032676948,0.000034504203,0.00046837583,0.0002731673,0.000152648,0.000665598,0.0061943084,0.95506126,0.000074647076,0.0032466613,0.0002830271],"about_ca_topic_score_codex":0.0046998574,"about_ca_topic_score_gemma":0.00033103896,"teacher_disagreement_score":0.040625546,"about_ca_system_score_codex":0.05671588,"about_ca_system_score_gemma":0.016090335,"threshold_uncertainty_score":0.9999565},"labels":[],"label_agreement":null},{"id":"W2992279139","doi":"10.1182/blood.v112.11.1374.1374","title":"The Cbl E3 Ubiquitin Ligase Negatively Regulates Erythropoiesis through Expression of the Foxo3a Transcription Factor.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Kruppel-like factors research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Erythropoiesis; Erythropoietin; Biology; Signal transduction; Erythropoietin receptor; Cell biology; Stem cell factor; Ubiquitin ligase; Thrombopoiesis; Progenitor cell; Transferrin receptor; Megakaryocyte; Molecular biology; Endocrinology; Internal medicine; Stem cell; Ubiquitin; Transferrin; Anemia; Biochemistry; Medicine","score_opus":0.022830715419156256,"score_gpt":0.26081865758318323,"score_spread":0.23798794216402697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992279139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99720657,0.0012163264,0.00010128233,0.00046143655,0.000098722834,0.00028647901,0.000055625023,0.000012912734,0.000560667],"genre_scores_gemma":[0.9975373,0.0009409611,0.00020257747,0.00004639906,0.00012519614,0.000023826255,0.000019813282,0.000025169971,0.0010787509],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998639,0.00019234631,0.00024647685,0.00028191146,0.00033704107,0.00030324954],"domain_scores_gemma":[0.99905276,0.000053521322,0.00011620592,0.00058042497,0.00014639356,0.00005066764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011598079,0.00016326018,0.00014259128,0.00001700853,0.00042017127,0.000020140997,0.00043973976,0.00015938265,0.00003177793],"category_scores_gemma":[0.00019611251,0.00009412004,0.0001810629,0.00013405515,0.0004687991,0.000010535368,0.00014924505,0.0001488954,0.000005626672],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006252836,0.00015222337,0.003074146,0.000015685055,0.000043049848,0.0000016584388,0.0004942673,0.0000035166431,0.9943465,0.00003424116,0.0015261142,0.00024605013],"study_design_scores_gemma":[0.00070153014,0.000170228,0.02278878,0.000029632803,0.00001719673,0.000017124208,0.00022150208,0.0000023746506,0.96948373,0.0001472568,0.006307203,0.00011340997],"about_ca_topic_score_codex":0.000077936245,"about_ca_topic_score_gemma":0.000044638306,"teacher_disagreement_score":0.024862759,"about_ca_system_score_codex":0.000011343887,"about_ca_system_score_gemma":0.00010906905,"threshold_uncertainty_score":0.3838104},"labels":[],"label_agreement":null},{"id":"W2992295706","doi":"10.1182/blood.v104.11.519.519","title":"Biology-Driven Classification of Childhood Acute Lymphoblastic Leukemia: A Combined Analysis of Prognostic Markers from the Pediatric Oncology Group (POG) and Children’s Cancer Group (CCG).","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Internal medicine; Medicine; Oncology; Lymphoblastic Leukemia; Pediatrics; Cancer; Leukemia","score_opus":0.010464534004356641,"score_gpt":0.26987459662467594,"score_spread":0.2594100626203193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992295706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99567324,0.0011012694,0.0006972824,0.0005967766,0.00007623237,0.0012052986,0.000502534,0.000047183217,0.000100164085],"genre_scores_gemma":[0.99610645,0.0015471828,0.0012150265,0.00014078454,0.00019347921,0.0001951086,0.00055623817,0.000038561247,0.000007147328],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975621,0.00019984687,0.00074164406,0.00060832256,0.00044059564,0.00044750154],"domain_scores_gemma":[0.99736726,0.0010926449,0.00052637694,0.0006037632,0.00020618051,0.00020379538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031077416,0.0002998018,0.00096155977,0.00048741844,0.00010799455,0.000013459436,0.0003684599,0.00036334683,0.000072786104],"category_scores_gemma":[0.00044567636,0.00021313966,0.0002471758,0.0016144902,0.00053666567,0.00006909398,0.0001949573,0.00034106078,0.0000051893207],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065913034,0.0016989148,0.97588116,0.000059857615,0.008822356,0.000023116587,0.00063916825,0.00009180979,0.009993277,0.00056606415,0.00007743992,0.0014876768],"study_design_scores_gemma":[0.016226614,0.0017496131,0.9578527,0.00006537259,0.021897994,0.000049333376,0.00012318137,0.0012972722,0.00030615975,0.00025030287,0.000005404927,0.00017602227],"about_ca_topic_score_codex":0.0024932357,"about_ca_topic_score_gemma":0.00042614798,"teacher_disagreement_score":0.01802846,"about_ca_system_score_codex":0.0007573789,"about_ca_system_score_gemma":0.0014925025,"threshold_uncertainty_score":0.86915827},"labels":[],"label_agreement":null},{"id":"W2992298562","doi":"10.1182/blood.v106.11.558.558","title":"The Mechanism of Rh-Immune Globulin Prophylaxis Involves Significant Increases in the Immunosuppressive Cytokines TGFβ and PGE2.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Canadian Blood Services; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Immune system; Immunology; Immunosuppression; Cytokine; Antibody; Globulin; Medicine; Mechanism of action; Immune tolerance; Interleukin 10; Internal medicine; Endocrinology; Biology","score_opus":0.0075524802604720765,"score_gpt":0.21866513890395045,"score_spread":0.21111265864347836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992298562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98803633,0.009473839,0.000013441429,0.0013441531,0.000028246437,0.00063895027,0.000016493625,0.000019016577,0.00042949934],"genre_scores_gemma":[0.99758285,0.0017620483,0.0002830666,0.00012848049,0.000119950906,0.000052573065,0.0000091665215,0.000014957506,0.000046926256],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99885076,0.00011578444,0.00035138044,0.00019668395,0.00027432243,0.00021105642],"domain_scores_gemma":[0.999145,0.00025995862,0.00009789521,0.0003845491,0.000069651294,0.000042973774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004088938,0.00015538589,0.00027392426,0.000055986464,0.00014239417,0.00002780843,0.0001871501,0.00008718957,0.00001665427],"category_scores_gemma":[0.000109997,0.000077609686,0.00007766365,0.00021258002,0.00016383284,0.00006424059,0.000052797608,0.00021771625,0.0000031962827],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009950222,0.006862303,0.03246797,0.00045723448,0.0005497111,0.00021058544,0.0058167297,0.00000384654,0.8978172,0.019825608,0.000118642805,0.034875136],"study_design_scores_gemma":[0.013656728,0.0027571463,0.31216052,0.0006878637,0.0008469848,0.00037558808,0.0046405625,0.00011754432,0.65856844,0.0034673328,0.0023303,0.00039099585],"about_ca_topic_score_codex":0.00066658953,"about_ca_topic_score_gemma":0.00011989416,"teacher_disagreement_score":0.27969253,"about_ca_system_score_codex":0.0000062386357,"about_ca_system_score_gemma":0.00004762088,"threshold_uncertainty_score":0.31648314},"labels":[],"label_agreement":null},{"id":"W2992307477","doi":"10.1182/blood.2019003863","title":"Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":226,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Heart, Lung, and Blood Institute; National Institutes of Health; European Hematology Association","keywords":"Complement system; Antiphospholipid syndrome; Lupus anticoagulant; Antibody; Immunology; Atypical hemolytic uremic syndrome; Alternative complement pathway; Biology; Complement membrane attack complex; Eculizumab","score_opus":0.037527666170501794,"score_gpt":0.30107678772154345,"score_spread":0.26354912155104165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992307477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99766576,0.00021342955,0.000006948901,0.00035432674,0.00001753283,0.0010874696,0.000047109945,0.00002751816,0.0005798901],"genre_scores_gemma":[0.9994542,0.000026137985,0.00021831633,0.000042959735,0.000016706914,0.000053534528,0.000040973227,0.000019688152,0.00012747681],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987486,0.00009640268,0.00018857718,0.00028019125,0.0004227473,0.00026347925],"domain_scores_gemma":[0.9993228,0.0001300393,0.0001002866,0.00024893033,0.00008407054,0.000113911236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039402556,0.00012463676,0.00036266458,0.0001193097,0.000058511974,0.000020019133,0.000046757705,0.0000483874,0.00007696924],"category_scores_gemma":[0.000042242424,0.000101161684,0.00001880665,0.0001627578,0.00007200735,0.000048916907,0.00010100584,0.0001312766,0.000007170831],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028792649,0.00045037054,0.97964513,0.00024734103,0.00021841792,0.000019004365,0.00091276603,0.0000013827233,0.018247254,0.000050265375,0.00009703281,0.00008224642],"study_design_scores_gemma":[0.008898249,0.00027850844,0.9831275,0.00060561934,0.00010682414,0.00029165563,0.0016289824,0.0001478411,0.0047282376,0.00002999923,0.00003829125,0.000118333184],"about_ca_topic_score_codex":0.00023383046,"about_ca_topic_score_gemma":0.0010222694,"teacher_disagreement_score":0.013519016,"about_ca_system_score_codex":0.00012178707,"about_ca_system_score_gemma":0.000081875434,"threshold_uncertainty_score":0.41252536},"labels":[],"label_agreement":null},{"id":"W2992334141","doi":"10.1182/blood.v104.11.415.415","title":"Chromosomal Imbalances in Germinal Center B-Cell-Like and Activated B-Cell-Like Diffuse Large B-Cell Lymphoma Influence Gene Expression Signatures and Improve Gene Expression-Based Survival Prediction(the First Two Authors Contributed Equally to This Work).","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Biology; Germinal center; Comparative genomic hybridization; Cancer research; Chromosome; Large-cell lymphoma; Lymphoma; BCL6; Gene; Chromosomal translocation; Molecular biology; B cell; Genetics; Immunology","score_opus":0.005580039943411296,"score_gpt":0.22384367105558137,"score_spread":0.21826363111217006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992334141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945544,0.002490131,0.00006080867,0.0004992652,0.0003237787,0.0014676175,0.00039827323,0.0001263719,0.00007933757],"genre_scores_gemma":[0.9969628,0.00024663156,0.0009221393,0.0008894775,0.00018616846,0.00039099713,0.0002392381,0.000060841776,0.00010171688],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968246,0.00015055416,0.00061501964,0.00096331496,0.0006334646,0.00081303186],"domain_scores_gemma":[0.99815565,0.00033008668,0.00026776807,0.0005933427,0.00014397709,0.00050914346],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002952561,0.00058884674,0.0006586977,0.00019858716,0.00041329197,0.00013044261,0.00023836379,0.00033017533,0.000030614025],"category_scores_gemma":[0.00006589413,0.00040816193,0.00012241388,0.00039882242,0.00013890925,0.00019375271,0.00023589104,0.0002799095,0.000012297455],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016374479,0.022188252,0.26627874,0.00014842601,0.0000966778,0.0006854376,0.0010305595,0.0001787777,0.70705634,0.0000035499468,0.00039121925,0.0003045605],"study_design_scores_gemma":[0.09696261,0.00076124084,0.13563299,0.0005993416,0.0002422233,0.000039241026,0.00009341628,0.00008145814,0.7644158,0.000008147715,0.00076978,0.00039374022],"about_ca_topic_score_codex":0.00021963673,"about_ca_topic_score_gemma":0.00007486774,"teacher_disagreement_score":0.13064575,"about_ca_system_score_codex":0.00021628,"about_ca_system_score_gemma":0.0002559681,"threshold_uncertainty_score":0.99983704},"labels":[],"label_agreement":null},{"id":"W2992360190","doi":"10.1182/blood.v104.11.3.3","title":"Mutations in TERT, the Gene Encoding Telomerase Reverse Transcriptase, in “Acquired” Aplastic Anemia Inhibit Enzymatic Function by a Dominant Negative Mechanism of Action.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; University of British Columbia","funders":"","keywords":"Telomere; Telomerase; Biology; Molecular biology; Telomerase reverse transcriptase; Nonsynonymous substitution; Gene; Mutation; Exon; Reverse transcriptase; Telomerase RNA component; Aplastic anemia; Genetics; Immunology; Polymerase chain reaction; Bone marrow","score_opus":0.017130650272110057,"score_gpt":0.24455388165653744,"score_spread":0.22742323138442738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992360190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957367,0.00038461277,0.002211564,0.0005299713,0.00017721475,0.0007703354,0.000046177476,0.000032298623,0.000111087946],"genre_scores_gemma":[0.99836797,0.00015737976,0.00089225394,0.0002687094,0.00005150541,0.000099752826,0.00004633393,0.000024438485,0.00009163974],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998339,0.000096688345,0.0006008917,0.00032639128,0.00031897987,0.0003180503],"domain_scores_gemma":[0.9992143,0.00018206182,0.00016706942,0.00026838915,0.00006675092,0.000101411366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028425682,0.00022113575,0.00038570535,0.00034503586,0.00009872845,0.000014266453,0.00009949768,0.00011822127,0.00007101921],"category_scores_gemma":[0.00024912955,0.00017315696,0.00008990871,0.0008187645,0.00012414303,0.00020039028,0.000015684956,0.00024364542,0.0000142567105],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033116134,0.0013039545,0.0012826135,0.00026663073,0.000053511354,0.00018529377,0.00555842,0.00013072604,0.98947614,0.00049581856,0.000082145176,0.00083360815],"study_design_scores_gemma":[0.012904751,0.0005793069,0.008313224,0.0008575139,0.0004411507,0.00025566644,0.0051777395,0.00018717442,0.96907175,0.0018433103,0.00007688356,0.00029153386],"about_ca_topic_score_codex":0.00089119567,"about_ca_topic_score_gemma":0.00047472367,"teacher_disagreement_score":0.020404372,"about_ca_system_score_codex":0.00014179008,"about_ca_system_score_gemma":0.00019671312,"threshold_uncertainty_score":0.70611364},"labels":[],"label_agreement":null},{"id":"W2992371904","doi":"10.1182/blood.v110.11.2221.2221","title":"Loss of Gfi1 Impedes Development of T-Cell Lymphoma upon Exposure to N-ethyl-N-nitrosourea but Predisposes to Severe Myleodysplastic Changes.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"","keywords":"Bone marrow; Cancer research; Biology; Myeloid; Lymphoma; Haematopoiesis; Leukemia; Molecular biology; Immunology; Stem cell; Genetics","score_opus":0.006498359288507926,"score_gpt":0.21842193970217955,"score_spread":0.21192358041367163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992371904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99744993,0.0007958488,0.000533502,0.000025837388,0.00007221973,0.0003342801,0.00008007518,0.0000101358655,0.0006981843],"genre_scores_gemma":[0.99515516,0.000033406486,0.0042291535,0.000088824476,0.0000723204,0.00002862486,0.000081940845,0.000027916543,0.0002826358],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988011,0.0000148403615,0.00030986615,0.0003352514,0.0001998154,0.0003391057],"domain_scores_gemma":[0.9992627,0.000016327893,0.00011416125,0.0003055817,0.00011997134,0.00018127543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012455354,0.00021932516,0.00024561165,0.00008832642,0.000052912845,0.0000080719565,0.00019935645,0.00015535128,0.000010719918],"category_scores_gemma":[0.000036694673,0.00020304373,0.00006886949,0.00014670592,0.00002704678,0.0000026915593,0.0001489644,0.000027758164,0.000010632492],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041778953,0.0023655323,0.026823606,0.00013979958,0.00029834756,0.000018820909,0.0006768338,0.000022890794,0.9622269,0.000009446824,0.000108625274,0.006891403],"study_design_scores_gemma":[0.003144571,0.0012617256,0.019804534,0.000044380107,0.000100684134,0.00001621058,0.00026158834,2.3773444e-7,0.9740362,0.000008526663,0.0011044269,0.00021689177],"about_ca_topic_score_codex":0.000026487687,"about_ca_topic_score_gemma":0.00043073343,"teacher_disagreement_score":0.011809318,"about_ca_system_score_codex":0.000010440142,"about_ca_system_score_gemma":0.0001205508,"threshold_uncertainty_score":0.82798827},"labels":[],"label_agreement":null},{"id":"W2992382935","doi":"10.1182/blood.v108.11.791.791","title":"Serum Ferritin in Children with Sickle Cell Disease on Chronic Transfusion: Measure of Iron Overload or End Organ Injury? STOP/STOP II Liver Iron Ancillary Study.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Blood transfusion; Ferritin; Transfusion therapy; Liver biopsy; Stroke (engine); Internal medicine; Gastroenterology; Surgery; Biopsy","score_opus":0.004234491780186882,"score_gpt":0.19571288738064482,"score_spread":0.19147839560045793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992382935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99302953,0.0038286657,0.0000013853229,0.00029097922,0.00003919034,0.0014876099,0.00007959634,0.00006466807,0.0011783746],"genre_scores_gemma":[0.9982899,0.00061151956,0.000022545413,0.0001174277,0.00012954208,0.00002227025,0.000051455325,0.000055118442,0.0007002133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981155,0.00008683545,0.000363045,0.00046219354,0.0005693944,0.0004030425],"domain_scores_gemma":[0.99920017,0.000021151469,0.0000938324,0.0004403815,0.000055335484,0.00018914536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015157972,0.0003109358,0.00043137514,0.00014555862,0.00012698787,0.000008766854,0.000121613455,0.0001529555,0.0003505143],"category_scores_gemma":[0.000017936041,0.00022048286,0.00009032196,0.0003974148,0.000096470896,0.00006609072,0.00004038268,0.00040866015,0.000013883135],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005071906,0.032872338,0.93361527,0.00086889334,0.00021590124,0.0012127646,0.0029443991,0.0004121065,0.013281428,0.000025382635,0.0007618308,0.00871779],"study_design_scores_gemma":[0.031116784,0.013105104,0.9409523,0.0007711541,0.0011629844,0.000085387364,0.0011534264,0.000031467047,0.010673667,0.0000054552283,0.00039843377,0.0005438567],"about_ca_topic_score_codex":0.0008075291,"about_ca_topic_score_gemma":0.0010014876,"teacher_disagreement_score":0.026044877,"about_ca_system_score_codex":0.00010506126,"about_ca_system_score_gemma":0.00040430448,"threshold_uncertainty_score":0.899103},"labels":[],"label_agreement":null},{"id":"W2992384315","doi":"10.1182/blood.v110.11.2148.2148","title":"Gender Differences in Bleeding Problems and Implications for the Assessment of a Bleeding Disorder.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Regional Laboratory Medicine Program; University of Waterloo; McMaster University","funders":"","keywords":"Medicine; Sexual intercourse; Odds ratio; Von Willebrand disease; Internal medicine; Platelet; Von Willebrand factor; Population","score_opus":0.042698319565605575,"score_gpt":0.31555413385765985,"score_spread":0.2728558142920543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992384315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801519,0.0008270131,0.013707505,0.0021088023,0.00003683633,0.0006246555,0.000007653761,0.000016135487,0.0025194816],"genre_scores_gemma":[0.9984557,0.00020519698,0.0011492734,0.000026785854,0.000034781766,0.000075059885,0.000005100605,0.0000059627346,0.000042159358],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99952525,0.0000042886763,0.00017670967,0.000100202975,0.000059997725,0.00013355627],"domain_scores_gemma":[0.99955285,0.00023937035,0.000043797645,0.00008785732,0.000040474686,0.000035682744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018014532,0.00005252311,0.00010808363,0.00006866836,0.00008765094,0.0000080337695,0.00003858992,0.000048483595,0.000008105364],"category_scores_gemma":[0.0000261566,0.000032517037,0.000029711995,0.00014395412,0.000053119817,0.000024906509,0.000016075328,0.00009608145,1.4027398e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004032308,0.0003815255,0.9551631,0.000045392957,0.00031682677,5.099708e-7,0.00065294554,0.00000410339,0.022907965,0.019680645,0.000011876158,0.000831057],"study_design_scores_gemma":[0.0015772111,0.00010095182,0.9937773,0.000058462934,0.0007954772,0.000017706388,0.00065733003,0.0005528173,0.00028344177,0.0020724677,0.00006299015,0.000043852477],"about_ca_topic_score_codex":0.000019872516,"about_ca_topic_score_gemma":0.000025428477,"teacher_disagreement_score":0.038614172,"about_ca_system_score_codex":0.000007528291,"about_ca_system_score_gemma":0.00003182376,"threshold_uncertainty_score":0.13260064},"labels":[],"label_agreement":null},{"id":"W2992423763","doi":"10.1182/blood.v108.11.773.773","title":"LMO2 and TAL1 Cooperate in a Model of Human T−Cell Leukemogenesis.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Biology; Lymphopoiesis; CD8; Population; Haematopoiesis; T cell; Cytotoxic T cell; Cancer research; Cell biology; Molecular biology; Immunology; Stem cell; Genetics; Antigen; Immune system; Medicine; In vitro","score_opus":0.02752861885774754,"score_gpt":0.2839941180286129,"score_spread":0.25646549917086536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992423763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9777423,0.0007277047,0.000009569599,0.000057079484,0.0000053987305,0.00023143717,0.0000056499316,0.00001381519,0.021207055],"genre_scores_gemma":[0.98649645,0.00007021236,0.00021748916,0.000042168595,0.000048257127,0.000011403486,0.000010136526,0.000019988893,0.013083881],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99926853,0.000024031706,0.00018577438,0.00016572795,0.00017331511,0.00018260027],"domain_scores_gemma":[0.99965906,0.000017481614,0.000025741867,0.00019273485,0.00005273912,0.000052231946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001634905,0.000082654915,0.00021613551,0.0001168651,0.000021973812,0.0000073802635,0.00005094632,0.000058082456,0.00017235946],"category_scores_gemma":[0.0000067988103,0.00007508055,0.000032933967,0.00014740224,0.000065043554,0.000023456165,0.000034157667,0.000099705154,0.000005089701],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060474147,0.0006019516,0.017819801,0.00008724781,0.000012917703,0.00003281006,0.000082313294,0.00018053451,0.9805878,0.000112147005,0.00011142012,0.00031060647],"study_design_scores_gemma":[0.010935892,0.0004147731,0.016127825,0.000058713285,0.00006928184,0.00003121402,0.000033973953,0.0056708525,0.9659684,0.00034377584,0.00019975523,0.00014558165],"about_ca_topic_score_codex":0.0004746183,"about_ca_topic_score_gemma":0.0001703672,"teacher_disagreement_score":0.014619414,"about_ca_system_score_codex":0.000019686244,"about_ca_system_score_gemma":0.00008175876,"threshold_uncertainty_score":0.3061696},"labels":[],"label_agreement":null},{"id":"W2992609042","doi":"10.1182/blood.v104.11.4157.4157","title":"A Novel hTERC Deletion Manifesting with Features of Dyskeratosis Congenita and Genetic Anticipation.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Dyskeratosis congenita; Anticipation (artificial intelligence); Proband; Bone marrow failure; Compound heterozygosity; Biology; Pathology; Medicine; Genetics; Mutation; Telomerase","score_opus":0.014233702284859071,"score_gpt":0.2353138773426955,"score_spread":0.22108017505783642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992609042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974127,0.00071650615,0.0009853047,0.00018869844,0.000026164076,0.00020958665,0.0000066165585,0.000034142733,0.00042029624],"genre_scores_gemma":[0.98075837,0.0000749857,0.018909343,0.00012377059,0.000061374674,0.000008282992,0.000008222698,0.000015143534,0.000040478488],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9993174,0.000008920029,0.000165622,0.00018452694,0.00017600002,0.00014751613],"domain_scores_gemma":[0.99956566,0.00002590018,0.00006978626,0.00015004874,0.000109459455,0.00007912486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000419308,0.00010757504,0.0001857233,0.00007624607,0.00005274829,0.000013075954,0.00003570236,0.000051960615,0.0000070496944],"category_scores_gemma":[0.00005232175,0.00008588776,0.000021869273,0.00014537376,0.00007675608,0.00004376281,0.000013888393,0.00007959242,0.0000018044557],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001543549,0.0009023704,0.24496385,0.00036405685,0.00017182728,0.00021421528,0.0011669635,0.000030020936,0.7473371,0.00025931376,0.000011947064,0.004423947],"study_design_scores_gemma":[0.005203379,0.0005517134,0.8383886,0.00032100396,0.00038456736,0.0021037909,0.00012310347,0.000018019891,0.15272437,0.00002985464,0.000012400539,0.00013915494],"about_ca_topic_score_codex":0.00019451125,"about_ca_topic_score_gemma":0.00005322036,"teacher_disagreement_score":0.5946128,"about_ca_system_score_codex":0.0000092745695,"about_ca_system_score_gemma":0.000069588175,"threshold_uncertainty_score":0.35024014},"labels":[],"label_agreement":null},{"id":"W2992673177","doi":"10.1182/blood-2019-128929","title":"Breakthrough Hemolysis in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Ravulizumab: Results of a 52-Week Extension from Two Phase 3 Studies","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Medicine; Eculizumab; Hemoglobinuria; Internal medicine; Adverse effect; Anemia; Surrogate endpoint; Gastroenterology; Surgery; Immunology; Complement system; Antibody","score_opus":0.013033569721504141,"score_gpt":0.25791353373765896,"score_spread":0.24487996401615483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992673177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99672836,0.0013634592,0.00000325428,0.00003919168,0.00012039579,0.00077752623,0.00077500957,0.0000487319,0.00014404597],"genre_scores_gemma":[0.99878,0.000022435977,0.00017125087,0.000037749673,0.000020758316,0.000032044296,0.00076589134,0.00002547027,0.00014439033],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99808544,0.00025091163,0.0006195443,0.00055936206,0.00012481655,0.00035993193],"domain_scores_gemma":[0.9983889,0.00022437952,0.00041892848,0.00056135777,0.0003744861,0.00003198137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009653788,0.0003129387,0.0007206211,0.00012743485,0.00006665159,0.000009854875,0.00020460937,0.000089514055,0.00018743657],"category_scores_gemma":[0.00007591574,0.00021233613,0.00008070526,0.00026983753,0.0001601915,0.00011719857,0.00009271296,0.00014899224,0.00008315257],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024228426,0.0072337887,0.93064934,0.000115211165,0.0026343698,0.00007922107,0.0016908575,0.00004965611,0.03163661,0.000015653131,0.00057143025,0.0010954661],"study_design_scores_gemma":[0.35144484,0.008255269,0.5215556,0.0019635381,0.0016744896,0.00006433627,0.0023732558,0.000014764172,0.11129482,0.00006190701,0.0003996342,0.0008975399],"about_ca_topic_score_codex":0.0019035354,"about_ca_topic_score_gemma":0.00074362295,"teacher_disagreement_score":0.4090937,"about_ca_system_score_codex":0.000047388454,"about_ca_system_score_gemma":0.00006211342,"threshold_uncertainty_score":0.8658816},"labels":[],"label_agreement":null},{"id":"W2992677242","doi":"10.1182/blood.v106.11.3062.3062","title":"A Novel 2′-Deoxy-2′-Fluoro (2′F-ANA) Ribose Modification Significantly Enhances the Duration, and Efficiency, of Nucleic Acid Mediated Gene Silencing.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Nucleic acid; Gene silencing; Oligonucleotide; Biology; Molecular biology; Gene knockdown; Biochemistry; RNA interference; DNA; Nucleotide; RNA; Gene","score_opus":0.011448513497427633,"score_gpt":0.23041394059646697,"score_spread":0.21896542709903935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992677242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995236,0.0015062835,0.0026219038,0.00024725244,0.00004058655,0.00015395392,0.000038133014,0.000009780316,0.00014612825],"genre_scores_gemma":[0.9984073,0.00053380517,0.0005907083,0.00014846938,0.00015066112,0.000019890766,0.000067568,0.0000102797085,0.00007132109],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99911946,0.000032126452,0.00028867793,0.00027228871,0.00013381729,0.00015360505],"domain_scores_gemma":[0.9993538,0.000019421119,0.00015761003,0.00029193584,0.00013365668,0.00004357483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019629228,0.000120635435,0.000115794406,0.000032724874,0.00008852377,0.000021622447,0.00020068172,0.00009590107,0.000012782704],"category_scores_gemma":[0.000093192626,0.0000905213,0.00004808793,0.000094303985,0.000115686744,0.000008431383,0.000047898673,0.000055469965,0.000010428327],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002331007,0.00019330932,0.00014128393,0.00000732594,0.000043676373,2.891405e-7,0.00025970102,0.0000310365,0.9982995,0.000017587612,0.00013074315,0.00085224194],"study_design_scores_gemma":[0.0005026935,0.00021179955,0.0028795798,0.000008586088,0.000049216673,0.000013231389,0.00016689261,0.000492254,0.9952348,0.000009120048,0.00031723714,0.00011459789],"about_ca_topic_score_codex":0.00003429149,"about_ca_topic_score_gemma":0.000056768677,"teacher_disagreement_score":0.0031713182,"about_ca_system_score_codex":0.000004139423,"about_ca_system_score_gemma":0.0000614056,"threshold_uncertainty_score":0.36913514},"labels":[],"label_agreement":null},{"id":"W2992713422","doi":"10.1182/blood.v112.11.4690.4690","title":"Outcomes of Elderly Patients with AML in the Hamilton Area: How Are We Doing?","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Myeloid leukemia; Pediatrics; Population; Internal medicine; Leukemia; Myelodysplastic syndromes; Bone marrow","score_opus":0.02285769125545625,"score_gpt":0.25570930491907473,"score_spread":0.23285161366361848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992713422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99511564,0.00012913987,0.000013195383,0.0026980424,0.000016525937,0.00047843673,0.000012042011,0.000018698136,0.0015182742],"genre_scores_gemma":[0.99848646,0.00009795487,0.00049956964,0.00026955587,0.000028549168,0.000026254691,0.00001420826,0.00001850359,0.00055895833],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987772,0.00005612065,0.00014970503,0.00017928792,0.00058096944,0.00025668895],"domain_scores_gemma":[0.99918467,0.00012798297,0.000085467385,0.00041994706,0.00012288445,0.00005903164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012563053,0.00012662665,0.00030528096,0.0001242167,0.000048582893,0.0000072305297,0.00018554933,0.00006676913,0.00001699143],"category_scores_gemma":[0.00008510477,0.00006715466,0.000053245836,0.0002957687,0.00012342165,0.000058706242,0.000029128496,0.0002911589,0.0000072423536],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000089751295,0.00077681994,0.9952019,0.000050417333,0.000078413745,0.00020540798,0.001438873,7.522977e-7,0.00007973825,0.000007930625,0.0015938458,0.00047617103],"study_design_scores_gemma":[0.008217699,0.0007208748,0.98703736,0.00011143237,0.00006211581,0.000045911198,0.0005360822,0.000005747496,0.001037473,0.0000057145894,0.0021384237,0.00008113679],"about_ca_topic_score_codex":0.00006412868,"about_ca_topic_score_gemma":0.00006926399,"teacher_disagreement_score":0.008164489,"about_ca_system_score_codex":0.000041269155,"about_ca_system_score_gemma":0.000111989284,"threshold_uncertainty_score":0.27384874},"labels":[],"label_agreement":null},{"id":"W2992718267","doi":"10.1182/blood.v106.11.3888.3888","title":"Intravenous gamma Globulin Does Not Increase RNA Expression of FcgRIIb in Purified Human Monocytes.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; McMaster University","funders":"","keywords":"CD14; Peripheral blood mononuclear cell; Monocyte; Ficoll; Molecular biology; Immunology; Antibody; Trizol; In vitro; Biology; Andrology; Chemistry; Medicine; Flow cytometry; RNA; RNA extraction; Biochemistry","score_opus":0.008209655605260201,"score_gpt":0.22347073133166906,"score_spread":0.21526107572640885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992718267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98596007,0.010830576,0.0000124135695,0.00010437546,0.00014492113,0.00021717601,0.000025578962,0.000055552446,0.0026493175],"genre_scores_gemma":[0.9987795,0.00014423503,0.00006487764,0.00008938522,0.000009999412,0.000022689557,0.00007023249,0.000016450012,0.0008026445],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985822,0.0001573255,0.00052321993,0.00029093074,0.000047408765,0.00039890126],"domain_scores_gemma":[0.99933046,0.00006326768,0.00017496989,0.00038618068,0.000036303212,0.000008844339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026923825,0.00019921818,0.00035036748,0.00015536608,0.00014793663,0.000009581434,0.0003568163,0.00026517443,0.00043470773],"category_scores_gemma":[0.00006579311,0.00015822591,0.00009963623,0.00014244673,0.00019879983,0.000108612505,0.00010478814,0.00031898523,0.00012476376],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001522151,0.0017510285,0.0005646096,0.000022117978,0.00004177099,0.0000071337504,0.001045369,0.000024125246,0.98544466,0.00038003948,0.00002794056,0.010538999],"study_design_scores_gemma":[0.004513954,0.00013348591,0.014099012,0.00008574265,0.00004429352,0.000014582801,0.00040735674,0.0000019012641,0.97771233,0.00013269273,0.0026421195,0.00021249938],"about_ca_topic_score_codex":0.00057936873,"about_ca_topic_score_gemma":0.000043051994,"teacher_disagreement_score":0.0135344025,"about_ca_system_score_codex":0.000019462686,"about_ca_system_score_gemma":0.00004887296,"threshold_uncertainty_score":0.64522654},"labels":[],"label_agreement":null},{"id":"W2992748477","doi":"10.1182/blood.v110.11.161.161","title":"CD123 (IL-3 Receptor α Chain) Neutralization by a Monoclonal Antibody Selectively Eliminates Human Acute Myeloid Leukemic Stem Cells.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Ex vivo; Stem cell; CD34; Severe combined immunodeficiency; Myeloid leukemia; Myeloid; Bone marrow; Cancer research; Immunology; Biology; Leukemia; Homing (biology); In vivo; Molecular biology; Cell biology","score_opus":0.013772845104321387,"score_gpt":0.2943200173901909,"score_spread":0.28054717228586956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992748477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99459267,0.00054725155,0.0010614924,0.0004919574,0.00013154614,0.00095473137,0.00012592187,0.00029786825,0.0017965361],"genre_scores_gemma":[0.985151,0.00054828636,0.001185862,0.0004530189,0.000561016,0.00004273047,0.0007167037,0.00014130873,0.011200093],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968067,0.000107644766,0.000578367,0.0007341602,0.00072913885,0.0010439807],"domain_scores_gemma":[0.9983978,0.00013929409,0.00019293261,0.00045484415,0.00037679763,0.0004383012],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000789355,0.00041344523,0.00053173007,0.00039669857,0.0002969432,0.00006468224,0.00034008,0.00035337944,0.00016489165],"category_scores_gemma":[0.000030117157,0.00039483883,0.00016633156,0.0008770099,0.00016841332,0.00021334227,0.0001243977,0.0007232779,0.00024150604],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027016798,0.0006294848,0.006553512,0.00011479898,0.00041589967,0.00015777664,0.0006028528,0.0000019975007,0.978991,0.0002745435,0.01013423,0.0018537604],"study_design_scores_gemma":[0.006085789,0.0010587063,0.010638458,0.000106049556,0.0003758073,0.00020755555,0.00029339956,0.00015202758,0.96988285,0.00002651499,0.010747298,0.00042551997],"about_ca_topic_score_codex":0.00017700673,"about_ca_topic_score_gemma":0.000017356992,"teacher_disagreement_score":0.009441714,"about_ca_system_score_codex":0.00060806784,"about_ca_system_score_gemma":0.0003820528,"threshold_uncertainty_score":0.99985033},"labels":[],"label_agreement":null},{"id":"W2992816860","doi":"10.1182/blood.v110.11.1864.1864","title":"Confirmation of the Safety and Efficacy of the Kovacs 10 mg Warfarin Initiation Nomogram for Venous Thromboembolism and Derivation of a Rule To Predict the Weekly Maintenance Dose.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Nomogram; Medicine; Warfarin; Surgery; Retrospective cohort study; Venous thrombosis; Major bleeding; Anticoagulant; Thrombosis; Internal medicine; Atrial fibrillation","score_opus":0.013550117476461067,"score_gpt":0.2575384028918726,"score_spread":0.2439882854154115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992816860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937467,0.00017118592,0.0010788593,0.0020650157,0.00009597372,0.0020064942,0.00003118397,0.000010182398,0.00079441996],"genre_scores_gemma":[0.9990957,0.00011446978,0.00035263208,0.00029986817,0.000053642554,0.000028255508,0.000009677091,0.000011760292,0.000034038916],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990316,0.000039605187,0.0004124403,0.00013802844,0.00022720893,0.00015111793],"domain_scores_gemma":[0.998952,0.00020462622,0.0003127669,0.0003212901,0.00017611432,0.000033205757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006160547,0.000100025936,0.0003207738,0.00004729018,0.000109650544,0.000008072349,0.0001234136,0.000057520665,0.000005848066],"category_scores_gemma":[0.00030830665,0.000054759596,0.00007000853,0.00020571469,0.00013671374,0.000044087854,0.000096472395,0.00006695511,2.7910957e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004523866,0.025191905,0.14164819,0.007991786,0.004068952,0.000006767023,0.071905166,0.0008150932,0.34232315,0.14520307,0.0065587796,0.2497633],"study_design_scores_gemma":[0.003020433,0.00045479034,0.9687432,0.00026859296,0.00047777581,0.000007109858,0.00047334473,0.00009304338,0.024514887,0.00028569362,0.0016057076,0.00005543543],"about_ca_topic_score_codex":0.00009938453,"about_ca_topic_score_gemma":0.000052074025,"teacher_disagreement_score":0.82709503,"about_ca_system_score_codex":0.000015170412,"about_ca_system_score_gemma":0.00004177822,"threshold_uncertainty_score":0.22330315},"labels":[],"label_agreement":null},{"id":"W2992861880","doi":"10.1182/blood.v108.11.1216.1216","title":"Constitutive Activation of Hemostasis in Children with Sickle Cell Disease.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Hospital for Sick Children","funders":"","keywords":"Thromboelastography; Medicine; Hemostasis; Platelet; Platelet activation; Internal medicine; Tissue factor; Whole blood; Aspirin; Gastroenterology; Coagulation; Pathophysiology; Immunology; Anesthesia","score_opus":0.0035121001183372005,"score_gpt":0.19288753711173665,"score_spread":0.18937543699339945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992861880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856251,0.00031056444,0.000037181864,0.00017507315,0.0000066154407,0.000284101,0.000013709196,0.000017746042,0.013529928],"genre_scores_gemma":[0.99950415,0.0000265688,0.00018257603,0.000056557223,0.00001743224,0.000005446771,0.00005139096,0.0000074057452,0.00014846305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999545,0.000009664324,0.00011725352,0.000111494155,0.00010995012,0.00010664605],"domain_scores_gemma":[0.99976563,0.000010207974,0.000046751742,0.00010339416,0.000030823474,0.000043167885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000026073692,0.00006949949,0.0001236911,0.000059392205,0.00001881587,0.0000024454328,0.000022952096,0.000043887663,0.000021761061],"category_scores_gemma":[0.000009915095,0.000051865307,0.000026934173,0.00017065248,0.000082245795,0.000033285192,0.0000075252847,0.00007979958,0.000004511357],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001265775,0.0014689933,0.99393016,0.00003861478,0.00004484424,0.000014063749,0.00005743835,0.00011037843,0.0033898992,0.00030119086,0.00011934059,0.00039848732],"study_design_scores_gemma":[0.008311922,0.00019940441,0.874479,0.00017604255,0.0002765007,0.000016148415,0.0001723176,0.000021418606,0.11594792,0.000119489574,0.00015753366,0.00012230227],"about_ca_topic_score_codex":0.0002772269,"about_ca_topic_score_gemma":0.000007022722,"teacher_disagreement_score":0.119451165,"about_ca_system_score_codex":0.000011080704,"about_ca_system_score_gemma":0.0001047823,"threshold_uncertainty_score":0.21150059},"labels":[],"label_agreement":null},{"id":"W2992900148","doi":"10.1182/blood.v110.11.3926.3926","title":"An Individual Platelet Count Set-Point in ITP: A Concept Learned from Patients with Mild Thrombocytopenia and a Good Response to IVIg or Corticosteroids.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Platelet; Medicine; Thrombocytopenic purpura; Prednisone; Internal medicine; Gastroenterology; Autoantibody; Mean platelet volume; Immunology; Corticosteroid; Antibody","score_opus":0.02489775200250423,"score_gpt":0.2814412747134878,"score_spread":0.2565435227109836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992900148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981539,0.00017303976,0.000017879367,0.00020986397,0.000033429817,0.0010175309,0.00027964957,0.000042928306,0.00007174515],"genre_scores_gemma":[0.9975789,0.000012841909,0.0011250125,0.0008302842,0.000021788168,0.000025178884,0.0002992554,0.000037307007,0.000069429705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983223,0.00007326639,0.000325067,0.00047506028,0.00038456713,0.000419759],"domain_scores_gemma":[0.9990411,0.00016511205,0.00008653985,0.0003201061,0.00005785126,0.00032930318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024593645,0.0002531627,0.00052532594,0.00014643231,0.00006356087,0.000049024005,0.00009677044,0.00012476943,0.000088884946],"category_scores_gemma":[0.00008121377,0.00017958744,0.000024701936,0.00023345178,0.000066456145,0.00014029419,0.000054582422,0.0001869498,0.000024388464],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03464263,0.0056640524,0.93063,0.000019914922,0.0005732672,0.0054543354,0.01003672,0.0000028414436,0.0019935416,0.0000043198293,0.000119896795,0.010858466],"study_design_scores_gemma":[0.039508026,0.006409431,0.9472825,0.00017471415,0.00023683503,0.00007934729,0.00077150186,0.000005814835,0.004756614,0.00002285017,0.00050100486,0.00025134193],"about_ca_topic_score_codex":0.00041749564,"about_ca_topic_score_gemma":0.0013583674,"teacher_disagreement_score":0.016652502,"about_ca_system_score_codex":0.0000539711,"about_ca_system_score_gemma":0.00011151358,"threshold_uncertainty_score":0.73233634},"labels":[],"label_agreement":null},{"id":"W2992903207","doi":"10.1182/blood.v112.11.4445.4445","title":"Outcomes of Second-Line Chemotherapy and Autologous Stem Cell Transplantation for Primary Refractory Diffuse Large B Cell Lymphoma","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Salvage therapy; Autologous stem-cell transplantation; Melphalan; Surgery; Internal medicine; Transplantation; Diffuse large B-cell lymphoma; Oncology; Chemotherapy","score_opus":0.012277405775385214,"score_gpt":0.2345383361343153,"score_spread":0.22226093035893008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992903207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965696,0.0017186977,0.000035328652,0.000103625396,0.000045582543,0.0005194686,0.00018143699,0.00003972533,0.00078656495],"genre_scores_gemma":[0.9956061,0.0017467148,0.00086899544,0.00048291145,0.00003236217,0.000059165555,0.00010534199,0.00002471183,0.0010736816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992186,0.000016297481,0.00024993625,0.00021138614,0.0001250033,0.00017878332],"domain_scores_gemma":[0.99944955,0.00013498169,0.00011295392,0.00018187966,0.000040050993,0.00008057776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000052695283,0.00015586389,0.0003984167,0.000056989946,0.000057699664,0.0000034392383,0.00003743427,0.00009525961,0.000020343856],"category_scores_gemma":[0.0000018274721,0.00011908465,0.00010910016,0.000040311446,0.000035310542,0.00004442117,0.000006498598,0.000024913275,0.0000031303568],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009474881,0.051584493,0.8928411,0.0019910175,0.0004949331,0.00038429172,0.0032982666,2.1671528e-7,0.031393435,0.000041558756,0.00046213914,0.01656105],"study_design_scores_gemma":[0.056772478,0.0007525728,0.74755114,0.00002230431,0.0003253124,0.00010728779,0.000037957045,0.000004243952,0.19322984,0.0000055783266,0.001094612,0.00009663936],"about_ca_topic_score_codex":0.000011646559,"about_ca_topic_score_gemma":0.0000070138312,"teacher_disagreement_score":0.16183642,"about_ca_system_score_codex":0.000034474404,"about_ca_system_score_gemma":0.00008147742,"threshold_uncertainty_score":0.4856131},"labels":[],"label_agreement":null},{"id":"W2992937776","doi":"10.1182/blood.v110.11.1559.1559","title":"Both Discordant and Concordant Bone Marrow (BM) Involvement Predict for a Poorer Outcome Independent of the IPI in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Diffuse large B-cell lymphoma; Rituximab; Gastroenterology; B symptoms; Bone marrow; CHOP; Lymphoma; Histology; Stage (stratigraphy); Oncology","score_opus":0.0073523360818314315,"score_gpt":0.21575489421500413,"score_spread":0.2084025581331727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992937776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99676603,0.00027291465,0.000026521962,0.00010255812,0.0000359395,0.0024543921,0.00017998363,0.000022937857,0.00013869918],"genre_scores_gemma":[0.9988998,0.000026177247,0.0003202244,0.0002684725,0.00002441947,0.00018780086,0.00006944114,0.00004461143,0.0001590261],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980461,0.000031721233,0.000519096,0.00041325387,0.00052257127,0.00046723103],"domain_scores_gemma":[0.9989218,0.0000909455,0.00026248107,0.00044419212,0.000093434166,0.00018714258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023908463,0.0003185852,0.00055704237,0.000121563025,0.00007512926,0.000017830487,0.00009386159,0.0000655621,0.0000066385883],"category_scores_gemma":[0.000019067966,0.00015980554,0.00009684438,0.00020506055,0.00010082674,0.00006282554,0.000080921294,0.0000678542,8.4814906e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021865321,0.03809409,0.9582167,0.00015506533,0.00028737422,0.00013873847,0.0002569644,4.350986e-7,0.0001487248,0.000048008522,0.000025796182,0.0004415241],"study_design_scores_gemma":[0.17446955,0.0026894335,0.81368893,0.0002843295,0.0006934425,0.00002295012,0.00022216678,0.0000121534,0.007645297,0.000005210595,0.00010260406,0.00016390467],"about_ca_topic_score_codex":0.00047262982,"about_ca_topic_score_gemma":0.0010319921,"teacher_disagreement_score":0.17228302,"about_ca_system_score_codex":0.00016879692,"about_ca_system_score_gemma":0.00011062367,"threshold_uncertainty_score":0.6516681},"labels":[],"label_agreement":null},{"id":"W2992951216","doi":"10.1182/blood-2019-131281","title":"Quality of Life and Caregiver Burden in Patients and Their Caregivers Undergoing Outpatient Autologous Stem Cell Transplantation Compared to Inpatient Transplantation","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Family Support in Illness","field":"Social Sciences","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Transplantation; Quality of life (healthcare); Distress; Caregiver burden; Ambulatory care; Emergency medicine; Physical therapy; Family medicine; Internal medicine; Health care; Disease; Nursing; Clinical psychology","score_opus":0.01847094816775894,"score_gpt":0.24703112727045312,"score_spread":0.2285601791026942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992951216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972657,0.00006472174,0.000059924954,0.0000626383,0.00018431322,0.00074446894,0.00010591304,0.00002262532,0.0014896779],"genre_scores_gemma":[0.9997123,0.00009908758,0.00005557056,0.000038592683,0.000009143601,0.000011975881,0.0000397598,0.000009104394,0.000024497609],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858016,0.00028193076,0.00034136878,0.00027716634,0.00030801198,0.000211355],"domain_scores_gemma":[0.99930155,0.00022866212,0.00015465888,0.00010715048,0.00008905128,0.000118907854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027695613,0.00012676348,0.00027070433,0.00012065729,0.000092477174,0.000021403117,0.00010608545,0.00009765486,0.0000076160713],"category_scores_gemma":[0.00001537827,0.00012478775,0.000029249417,0.00016859459,0.000082250655,0.00016816772,0.000017185166,0.00007481848,0.0000028137158],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012961969,0.00013820195,0.6573658,0.0003352745,0.00001528791,0.0000013148692,0.34027526,0.00023785917,0.00020289209,0.00013056384,0.00000545057,0.0011624675],"study_design_scores_gemma":[0.004522141,0.00025629997,0.9084106,0.00009911387,0.00003171976,2.5275185e-7,0.085327275,0.000023540062,0.0010217496,0.000034256424,0.00003799562,0.00023503022],"about_ca_topic_score_codex":0.0050995867,"about_ca_topic_score_gemma":0.0046399185,"teacher_disagreement_score":0.254948,"about_ca_system_score_codex":0.00005823761,"about_ca_system_score_gemma":0.00012621841,"threshold_uncertainty_score":0.7709084},"labels":[],"label_agreement":null},{"id":"W2992964980","doi":"10.1182/blood.v112.11.415.415","title":"Nramp1 Promotes Efficient Macrophage Recycling of Iron Following Phenylhydrazine-Induced Hemolytic Anemia","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Phenylhydrazine; Hepcidin; Mononuclear phagocyte system; Spleen; Endocrinology; Iron deficiency; Macrophage; Internal medicine; Hemolytic anemia; Phagocytosis; DMT1; Anemia; Transferrin saturation; Anemia of chronic disease; Erythropoiesis; Ferritin; Immunology; Chemistry; Biology; Biochemistry; Medicine; In vitro; Transporter","score_opus":0.015698067648431877,"score_gpt":0.25535209216857,"score_spread":0.23965402452013815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992964980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928306,0.0015823822,0.00005595399,0.00008958585,0.00022602222,0.0004193389,0.0000028168085,0.000085385145,0.0047079325],"genre_scores_gemma":[0.99724394,0.000038622748,0.0020355938,0.000111908776,0.00013393853,0.00000959464,0.00001318687,0.000037822843,0.00037541325],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985476,0.000036400277,0.00037257606,0.00030519287,0.0003871505,0.0003510672],"domain_scores_gemma":[0.9992592,0.000050825667,0.00011019643,0.00038791238,0.000047183126,0.00014470899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019159922,0.00019348909,0.00042523645,0.00011929392,0.00010871651,0.000006013484,0.000106174695,0.00011680467,0.000053957792],"category_scores_gemma":[0.00025659282,0.00016992216,0.00020376373,0.00027319358,0.00005639978,0.00003863231,0.000043006137,0.00018629724,0.000041115873],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013268167,0.0024784124,0.025857631,0.00053621386,0.000057465077,0.00073255453,0.0022473347,0.00005737968,0.96461165,0.00005782186,0.00008333271,0.0031474996],"study_design_scores_gemma":[0.021071767,0.00069179415,0.06915598,0.00037957315,0.0012499561,0.00045183455,0.0005448856,0.00034941416,0.9052728,0.0000462391,0.00020169308,0.0005840544],"about_ca_topic_score_codex":0.00005036748,"about_ca_topic_score_gemma":0.0000016307982,"teacher_disagreement_score":0.059338868,"about_ca_system_score_codex":0.000014316233,"about_ca_system_score_gemma":0.00011094825,"threshold_uncertainty_score":0.6929225},"labels":[],"label_agreement":null},{"id":"W2992975791","doi":"10.1182/blood.v112.11.3099.3099","title":"BMI1 Interacts with FANCD2 at DNA Lesions and Prevents Chromosome Breaks","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont; Institute for Research in Immunology and Cancer","funders":"","keywords":"BMI1; Biology; FANCD2; DNA damage; DNA repair; Stem cell; Chromatin; Fanconi anemia; Cell biology; Cell cycle; Cancer research; Genetics; Cell; DNA","score_opus":0.00822683061087612,"score_gpt":0.2142421978269938,"score_spread":0.20601536721611768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992975791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981036,0.0003272756,0.000057068184,0.000028830511,0.00004310849,0.00014112846,0.000013445432,0.000020509031,0.0012650072],"genre_scores_gemma":[0.9958946,0.00014089096,0.0007734441,0.0001163827,0.000082445775,0.000019769748,0.000046857207,0.000022638518,0.0029029718],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993267,0.000023668379,0.00009649919,0.00028380222,0.00009337884,0.00017596611],"domain_scores_gemma":[0.9995583,0.0000052365913,0.000044771412,0.00027223458,0.00002396032,0.0000954508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000034140598,0.000122036916,0.00010346514,0.000019173813,0.000092903945,0.00000708649,0.00009389593,0.000085587446,0.000025743206],"category_scores_gemma":[0.000017183429,0.000102712984,0.000034331068,0.00003608809,0.000053577984,0.0000035946023,0.00016124862,0.000048178623,0.000019463196],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002682301,0.0001943944,0.003155157,0.000010878117,0.00006644672,0.00005173981,0.00006370373,7.987613e-7,0.9957827,0.000011147776,0.00035475314,0.0002815084],"study_design_scores_gemma":[0.0012682329,0.0004406104,0.0064743175,0.000026411213,0.00003491569,0.0008849139,0.000011384548,0.0000027673195,0.9866115,0.000016702841,0.0040722215,0.00015605605],"about_ca_topic_score_codex":0.0000059268104,"about_ca_topic_score_gemma":0.000025615042,"teacher_disagreement_score":0.009171183,"about_ca_system_score_codex":0.0000055435994,"about_ca_system_score_gemma":0.00003297564,"threshold_uncertainty_score":0.41885138},"labels":[],"label_agreement":null},{"id":"W2992983202","doi":"10.1182/blood.v106.11.1621.1621","title":"Long-Term Outcomes of Post-Surgical Deep-Vein Thrombosis in Asia: The AIDA-Extension Study.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Deep vein; Incidence (geometry); Pulmonary embolism; Thrombosis; Post-thrombotic syndrome; Orthopedic surgery; Cumulative incidence; Surgery; Complication; Confidence interval; Internal medicine; Transplantation","score_opus":0.02370660641343708,"score_gpt":0.30534395574806317,"score_spread":0.2816373493346261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992983202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99109256,0.00055484084,0.0000037500722,0.0048567485,0.00008234114,0.0010683271,0.0000023837576,0.000038198195,0.0023008222],"genre_scores_gemma":[0.9986956,0.00023400965,0.00012380909,0.00058486784,0.00011977833,0.000057224832,0.0000075417993,0.000023817542,0.00015332276],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984867,0.00008278377,0.0004351573,0.0002976156,0.00041162028,0.0002861319],"domain_scores_gemma":[0.9990685,0.000109285895,0.00010287579,0.0005593692,0.00008277918,0.00007719715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003864507,0.00018517594,0.0006641426,0.00012405652,0.000059955895,0.000015808546,0.00017994837,0.00007239499,0.00025986056],"category_scores_gemma":[0.00007073249,0.00011321794,0.00015682439,0.0002081429,0.00006361737,0.00006956176,0.00015190626,0.00018261,0.000056707377],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000337622,0.01657615,0.973667,0.000053874483,0.0004446197,0.00019486669,0.0014472604,0.000012759815,0.0004452245,0.00031405536,0.0001950228,0.0066154],"study_design_scores_gemma":[0.0050172815,0.0007743545,0.9916266,0.000074574215,0.000638653,0.000022941133,0.00065679033,0.000011995233,0.00079215324,0.000010079277,0.0002611632,0.00011340253],"about_ca_topic_score_codex":0.00014266862,"about_ca_topic_score_gemma":0.0006392046,"teacher_disagreement_score":0.017959608,"about_ca_system_score_codex":0.000028732591,"about_ca_system_score_gemma":0.00002784881,"threshold_uncertainty_score":0.46168935},"labels":[],"label_agreement":null},{"id":"W2993011273","doi":"10.1182/blood.v112.11.2169.2169","title":"Hematopoietic Recovery and Overall Survival after HLA-Matched Sibling Transplants for Older Patients with Severe Aplastic Anemia (SAA).","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Fludarabine; Transplantation; Internal medicine; Sibling; Hematopoietic stem cell transplantation; Gastroenterology; Cyclophosphamide; Surgery; Chemotherapy","score_opus":0.011144309671053055,"score_gpt":0.21855871016214784,"score_spread":0.20741440049109477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2993011273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955849,0.00015828667,0.0023994509,0.00005924884,0.000125672,0.0010753074,0.000121288555,0.00007885378,0.00039697267],"genre_scores_gemma":[0.99565977,0.00011844632,0.003372031,0.00015853324,0.00007493478,0.000103077924,0.00018169655,0.00006600432,0.00026553622],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983944,0.000032134023,0.00035734248,0.0004299826,0.00039939294,0.00038671825],"domain_scores_gemma":[0.9990625,0.00030182165,0.00008370097,0.00023259017,0.00011895939,0.00020047041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010213671,0.0002816405,0.00047563532,0.00012111007,0.00009786559,0.000019343124,0.00005756897,0.00016004384,0.00009080487],"category_scores_gemma":[0.000025598196,0.00023231807,0.00008021022,0.00012527194,0.00006422693,0.00014088664,0.000008308425,0.00014516349,0.000015825],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034372977,0.0012780937,0.98506165,0.0044130045,0.00032656506,0.00042474043,0.0035339089,0.000018742092,0.001226037,0.00002095005,0.00007320498,0.00018583595],"study_design_scores_gemma":[0.039005645,0.0010744745,0.94711167,0.0018254963,0.0015214831,0.0017570754,0.00013266705,0.00004778316,0.0067272508,0.00008336713,0.00005918153,0.0006538954],"about_ca_topic_score_codex":0.00001038885,"about_ca_topic_score_gemma":0.000011783587,"teacher_disagreement_score":0.03794994,"about_ca_system_score_codex":0.000021280533,"about_ca_system_score_gemma":0.00009227642,"threshold_uncertainty_score":0.9473656},"labels":[],"label_agreement":null},{"id":"W2993079484","doi":"10.1182/blood-2019-131227","title":"Occurrence and Resolution of Anthracycline Cardiotoxicity and Impact on Treatment Outcomes Among Children Treated on the AAML1031 Clinical Trial: A Report from the Children's Oncology Group","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Cardiotoxicity; Anthracycline; Internal medicine; Ejection fraction; Proportional hazards model; Chemotherapy; Cancer; Heart failure; Breast cancer","score_opus":0.04777964626726874,"score_gpt":0.38421845918334074,"score_spread":0.336438812916072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2993079484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99374884,0.0003903251,0.0000017268708,0.0021963557,0.00018773616,0.0027351757,0.0005017089,0.00005080471,0.00018733178],"genre_scores_gemma":[0.99825454,0.0004693767,0.000029802057,0.000534734,0.00035660047,0.00003767339,0.0002787334,0.000016682667,0.000021867918],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969372,0.00081033626,0.00092999043,0.0006403741,0.0004200468,0.00026205558],"domain_scores_gemma":[0.99533826,0.002782257,0.00061980536,0.0010503421,0.00004802417,0.0001613171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016482846,0.0003361491,0.0011957824,0.00005663545,0.000112639726,0.000021938911,0.00014264537,0.00021856539,0.000033095333],"category_scores_gemma":[0.0009720233,0.00015765791,0.00038702626,0.0001358687,0.00040113038,0.000049944,0.00007451626,0.00039960217,0.0000067746523],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005795524,0.0024427078,0.9873921,0.000004846294,0.0014110545,0.000018844916,0.00031918165,0.0000016117672,0.000029949835,0.0000097425855,0.00039393274,0.002180471],"study_design_scores_gemma":[0.041483246,0.0088085765,0.94799006,0.0001259782,0.0008997293,0.000082542865,0.00006949734,0.000009419697,0.00031136654,0.00002186343,0.000053167176,0.00014453582],"about_ca_topic_score_codex":0.007623934,"about_ca_topic_score_gemma":0.000354827,"teacher_disagreement_score":0.039402053,"about_ca_system_score_codex":0.00008379283,"about_ca_system_score_gemma":0.00013423293,"threshold_uncertainty_score":0.9989844},"labels":[],"label_agreement":null},{"id":"W2993113471","doi":"10.1182/blood.v110.11.1950.1950","title":"No Significance of Derivative Chromosome 9 Deletion on the Clearance Kinetics of BCR/ABL Fusion Transcripts, Cytogenetic or Molecular Response, Loss of Response or Treatment Failure to Imatinib Mesylate Therapy for Chronic Myeloid Leukemia.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Imatinib mesylate; Internal medicine; Medicine; Imatinib; Myeloid leukemia; breakpoint cluster region; Oncology; Philadelphia chromosome; Gastroenterology; Immunology; Chromosomal translocation; Biology; Genetics; Gene; Receptor","score_opus":0.025823373421198916,"score_gpt":0.2909204147503886,"score_spread":0.2650970413291897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2993113471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99232846,0.0009618928,0.001437814,0.0006560357,0.000058230755,0.0042776535,0.00020590369,0.000032736018,0.000041283693],"genre_scores_gemma":[0.9922988,0.00065028155,0.0057667918,0.00018128542,0.000071699185,0.00030733668,0.000028039993,0.00008736543,0.00060838996],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99706596,0.00037000334,0.00094029756,0.00052858464,0.0005911694,0.0005039821],"domain_scores_gemma":[0.99660486,0.0014091372,0.0004868196,0.00091501157,0.00043106164,0.0001530956],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00083577726,0.00044104145,0.00085753185,0.00021972893,0.00006804217,0.000006908885,0.00027041213,0.00020427933,0.00014046983],"category_scores_gemma":[0.00060580997,0.00026972577,0.0002731056,0.00064624276,0.0002450517,0.000037818645,0.000026373977,0.00014438026,0.000009349127],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14782515,0.0013580767,0.00012224086,0.00025109312,0.0004613709,0.00008380859,0.00136042,0.00024865175,0.8445511,0.000028766248,0.00003742227,0.003671911],"study_design_scores_gemma":[0.020742688,0.03446048,0.01436753,0.0007768887,0.00032505108,0.00004610309,0.00016583258,0.00007322312,0.92585504,0.00001487443,0.00295065,0.00022166116],"about_ca_topic_score_codex":0.00006715763,"about_ca_topic_score_gemma":0.000078043675,"teacher_disagreement_score":0.12708245,"about_ca_system_score_codex":0.0012600956,"about_ca_system_score_gemma":0.0013860499,"threshold_uncertainty_score":0.9999755},"labels":[],"label_agreement":null},{"id":"W2993214242","doi":"10.1182/blood.v106.11.4114.4114","title":"Comparison of Performance of Two Clinical Scales To Diagnose the Post-Thrombotic Syndrome: Correlation with Patient-Reported Disease Burden and Valvular Reflux.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Jewish General Hospital","funders":"","keywords":"Post-thrombotic syndrome; Medicine; Reflux; Deep vein; Cohort; Internal medicine; Disease; Thrombosis; Quality of life (healthcare); Prospective cohort study; Physical therapy; Surgery","score_opus":0.022045548618931467,"score_gpt":0.3294944478195919,"score_spread":0.30744889920066043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2993214242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99703926,0.00060355954,0.000035411933,0.001183537,0.000051434366,0.0009125239,0.000007406033,0.00002137763,0.00014546185],"genre_scores_gemma":[0.9987251,0.0001587611,0.0007357041,0.00021427475,0.00006751264,0.000035782305,0.000024886001,0.000017555132,0.000020413097],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985712,0.00005591764,0.0006229173,0.00023478735,0.00035250085,0.0001626597],"domain_scores_gemma":[0.9988428,0.00012864983,0.00028367373,0.00041373426,0.00015636769,0.0001747738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025572555,0.0001318909,0.00053730165,0.00006992421,0.000062197694,0.00000845704,0.000078064986,0.000037406153,0.000030033876],"category_scores_gemma":[0.0001466122,0.00008566371,0.000069140115,0.00015666951,0.00014394402,0.00007132907,0.000075879434,0.00011547586,0.0000068590903],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017154143,0.0026009108,0.981595,0.00017988875,0.000343268,0.000029882247,0.00078226725,0.0012914059,0.00018148482,0.000108670494,0.00017646562,0.012539236],"study_design_scores_gemma":[0.0024218967,0.0027757646,0.9903131,0.00040751373,0.001484143,0.000025315214,0.00020708151,0.001261837,0.00060044904,0.000005291842,0.0003954817,0.00010210448],"about_ca_topic_score_codex":0.000073713774,"about_ca_topic_score_gemma":0.00004367682,"teacher_disagreement_score":0.012437131,"about_ca_system_score_codex":0.000011947571,"about_ca_system_score_gemma":0.000040485706,"threshold_uncertainty_score":0.3493265},"labels":[],"label_agreement":null},{"id":"W2993279857","doi":"10.1182/blood.v104.11.2995.2995","title":"Functional Assessment of the Mitochondrial Pathway of Caspase Activation in Patients with Acute Myeloid Leukemia (AML).","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"XIAP; Caspase; Etoposide; Apoptosis; Effector; Caspase 3; Caspase-9; Cytochrome c; Myeloid leukemia; Cytarabine; Biology; Caspase 8; Cancer research; Leukemia; Molecular biology; Chemistry; Cell biology; Immunology; Programmed cell death; Biochemistry; Chemotherapy","score_opus":0.010523563475654144,"score_gpt":0.25172101571666783,"score_spread":0.2411974522410137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2993279857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99777967,0.00000472145,0.00041505077,0.00027221531,0.000096164,0.0007453737,0.00002987467,0.000010889217,0.0006460722],"genre_scores_gemma":[0.9970126,0.0000030065437,0.0025540446,0.00006932044,0.00010277209,0.00003751274,0.00007130037,0.000020241674,0.00012921561],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984062,0.000050914703,0.00031279417,0.00021600175,0.0008077157,0.00020641378],"domain_scores_gemma":[0.99906445,0.000053891028,0.00017879538,0.00037481874,0.0002620246,0.000066022774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011507733,0.00013061297,0.0002607644,0.00014126624,0.000039139148,0.0000050129906,0.00012361555,0.000099568344,0.00004576244],"category_scores_gemma":[0.000082321174,0.00008295253,0.00007273673,0.00043717638,0.00011373782,0.00010080804,0.00007210025,0.00034144486,0.0000025919128],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031072414,0.0041190656,0.53235227,0.00020930091,0.0007686383,0.00004112379,0.00048511897,0.00091747707,0.45536926,0.0009772931,0.000281402,0.001371823],"study_design_scores_gemma":[0.022103587,0.0007106538,0.76950127,0.00016938863,0.000108827975,0.000008602926,0.00004150779,0.000012124425,0.20716532,0.00006903251,0.000033838078,0.00007585868],"about_ca_topic_score_codex":0.00026945162,"about_ca_topic_score_gemma":0.000040012834,"teacher_disagreement_score":0.24820395,"about_ca_system_score_codex":0.0006077413,"about_ca_system_score_gemma":0.0022304638,"threshold_uncertainty_score":0.3956747},"labels":[],"label_agreement":null},{"id":"W2993311615","doi":"10.1182/blood.v110.11.2102.2102","title":"Platelet Apoptosis in Fluid-Phase and Adherent Platelets and Thrombi-Like Platelet Aggregates.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Platelet; Apoptosis; Phosphatidylserine; Cell biology; Biology; Flow cytometry; Annexin; Thrombin; Platelet activation; Molecular biology; Biophysics; Chemistry; Immunology; Biochemistry; Membrane; Phospholipid","score_opus":0.014394484709187047,"score_gpt":0.2796373846659452,"score_spread":0.26524289995675815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2993311615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920046,0.005506764,0.000006598548,0.00021652393,0.0000976245,0.00067730935,0.00003563983,0.00007930152,0.001375654],"genre_scores_gemma":[0.9972162,0.0015860557,0.00042769552,0.00037922486,0.00004814784,0.000022453458,0.00009362479,0.000044574408,0.00018199884],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998153,0.000021347556,0.0004339791,0.0005301069,0.0002562608,0.0006053497],"domain_scores_gemma":[0.99916595,0.0001022424,0.00009537679,0.00026192926,0.000034999037,0.0003395253],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002449303,0.0003472097,0.00063777814,0.00025378168,0.00009576531,0.000038192797,0.00006595827,0.00023468658,0.00009381465],"category_scores_gemma":[0.000038011327,0.00030035217,0.000062084844,0.00024999547,0.00012168888,0.0001002842,0.000071056675,0.00024626698,0.000028139773],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058622076,0.029432759,0.23622267,0.0012014386,0.0034719072,0.047348738,0.005472407,0.000005134299,0.114701144,0.00059493975,0.0028895652,0.5527971],"study_design_scores_gemma":[0.2403971,0.006848599,0.1352589,0.0013980515,0.0011616406,0.010908522,0.0013087101,0.00026449337,0.57749075,0.0014045587,0.021441616,0.0021170797],"about_ca_topic_score_codex":0.00020313701,"about_ca_topic_score_gemma":0.00015074086,"teacher_disagreement_score":0.55068,"about_ca_system_score_codex":0.000036510275,"about_ca_system_score_gemma":0.000041493895,"threshold_uncertainty_score":0.99994487},"labels":[],"label_agreement":null},{"id":"W2993344323","doi":"10.1182/blood.v110.11.2631.2631","title":"Distinct Genetic Aberrations in Molecular Subtypes of Diffuse Large B Cell Lymphoma Detected by Array CGH.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Comparative genomic hybridization; Diffuse large B-cell lymphoma; Biology; Lymphoma; Germinal center; Gene expression profiling; Cancer research; Locus (genetics); Copy-number variation; B cell; Genetics; Gene; Molecular biology; Gene expression; Genome; Immunology; Antibody","score_opus":0.004870220772332295,"score_gpt":0.22123690854469538,"score_spread":0.2163666877723631,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2993344323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952009,0.0018510399,0.00040293857,0.000050273862,0.000031900712,0.00028465074,0.00003715433,0.000028094162,0.0021130913],"genre_scores_gemma":[0.9985637,0.00004591164,0.0010781337,0.00006834974,0.000021833002,0.000028158443,0.00005177309,0.000019337764,0.00012281189],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990489,0.000022983,0.00028510747,0.00020354982,0.00017872828,0.0002607218],"domain_scores_gemma":[0.99944204,0.000061855375,0.00007266563,0.0002679305,0.000044848377,0.00011064907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000076892,0.00013395296,0.00022440098,0.00008951521,0.00002992054,0.000006596046,0.0000555986,0.000076776865,0.000034959852],"category_scores_gemma":[0.00004075674,0.000113882954,0.00007622534,0.0002111894,0.000028518585,0.00001777656,0.00001530735,0.000032415675,0.00001869415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006453134,0.03022907,0.72376496,0.00006566005,0.00011424561,0.00043438422,0.0002837284,3.5679497e-7,0.24345043,0.00003913926,0.00017940023,0.0013741229],"study_design_scores_gemma":[0.014130669,0.00017988349,0.52732444,0.000027293594,0.00016751266,0.0000162773,0.000029205255,0.000005089488,0.45771948,0.00001447489,0.00031444384,0.00007121201],"about_ca_topic_score_codex":0.00014102859,"about_ca_topic_score_gemma":0.00025567276,"teacher_disagreement_score":0.21426906,"about_ca_system_score_codex":0.000051035564,"about_ca_system_score_gemma":0.00005951606,"threshold_uncertainty_score":0.46440122},"labels":[],"label_agreement":null},{"id":"W2993371734","doi":"10.1182/blood.v110.11.2610.2610","title":"Developing a Multidimensional Prognostic Test for Follicular Lymphoma.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Follicular lymphoma; Gene expression profiling; Lymphoma; Significance analysis of microarrays; Carcinogenesis; Oncology; Microarray; DNA microarray; Survival analysis; Microarray analysis techniques; Clinical significance; Gene; Internal medicine; Gene expression; Gene signature; Medicine; Tissue microarray; Biology; Immunohistochemistry; Cancer; Genetics","score_opus":0.02119330908128852,"score_gpt":0.2797847300895112,"score_spread":0.2585914210082227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2993371734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959835,0.00077114475,0.001188831,0.00051758357,0.000079132675,0.00090489775,0.000011714746,0.00007630918,0.00046690556],"genre_scores_gemma":[0.9417755,0.000017170061,0.05716663,0.0005214033,0.00015619575,0.00014969305,0.000056707868,0.000021108957,0.00013559888],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990711,0.000004413211,0.00020646477,0.00023358919,0.00018160953,0.00030281965],"domain_scores_gemma":[0.99907184,0.0004905552,0.000046151523,0.00015029985,0.00011148079,0.00012969808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001598257,0.0001356639,0.0001978856,0.00006282177,0.0000909138,0.000008696023,0.000032026295,0.000066977795,0.000010123115],"category_scores_gemma":[0.00036346947,0.00010440997,0.00011279335,0.000112189584,0.000021472326,0.000025786783,0.00002238755,0.000017534634,0.000042709096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000108850036,0.0065051517,0.9620224,0.00013720186,0.00043779946,0.00077021675,0.00011247465,4.9018297e-7,0.0050695133,0.0040221373,0.00043762577,0.020376133],"study_design_scores_gemma":[0.01921808,0.00056259485,0.8389576,0.00023996267,0.0006133457,0.00042003748,0.00004049774,0.000035026504,0.12420468,0.00011854035,0.015402669,0.00018694824],"about_ca_topic_score_codex":0.000016250024,"about_ca_topic_score_gemma":0.00001033631,"teacher_disagreement_score":0.123064786,"about_ca_system_score_codex":0.000097870674,"about_ca_system_score_gemma":0.00019146927,"threshold_uncertainty_score":0.4257715},"labels":[],"label_agreement":null},{"id":"W2993502781","doi":"10.1182/blood.v110.11.1756.1756","title":"Newborns Are Hyperfibrinolytic at Physiologic tPA Concentrations and the Increased Fibrinolysis Is Related to Decreased Apparent TAFIa.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stollery Children's Hospital","funders":"","keywords":"Fibrinolysis; Fibrin; Lysis; Chemistry; Medicine; Internal medicine; Andrology; Biochemistry; Immunology","score_opus":0.017656942341686552,"score_gpt":0.2585737468864148,"score_spread":0.24091680454472827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2993502781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942425,0.00043701215,0.00016291365,0.0019400128,0.00006354089,0.00085689797,0.000018814571,0.00013215703,0.002146151],"genre_scores_gemma":[0.99576104,0.00006210376,0.00055829145,0.0029900633,0.000074682386,0.000031211344,0.00004778738,0.000023459625,0.00045134654],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985018,0.000075757845,0.00038346305,0.00038840802,0.00028978876,0.0003607816],"domain_scores_gemma":[0.99872154,0.00020222772,0.00014014031,0.00046859094,0.000108543994,0.00035897936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026423502,0.00021696111,0.00043844452,0.000095228934,0.00026671743,0.000029920035,0.000100790785,0.00012574386,0.0002959442],"category_scores_gemma":[0.00014907656,0.0001502661,0.00013987947,0.0004071807,0.00012996288,0.00004210255,0.00009690035,0.00013953331,0.00011980641],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021364512,0.002656413,0.22608916,0.00018037371,0.002221073,0.00015742322,0.003512116,0.000040927513,0.74133426,0.015922263,0.0016362438,0.0041132807],"study_design_scores_gemma":[0.0199947,0.0003993853,0.7862388,0.00017519202,0.001858797,0.00019324705,0.00076360744,0.0005489592,0.18704163,0.0007060245,0.0016824247,0.00039725113],"about_ca_topic_score_codex":0.000109128574,"about_ca_topic_score_gemma":0.000056360295,"teacher_disagreement_score":0.5601496,"about_ca_system_score_codex":0.000043108703,"about_ca_system_score_gemma":0.00005087296,"threshold_uncertainty_score":0.6127674},"labels":[],"label_agreement":null},{"id":"W2993543693","doi":"10.1182/blood.v108.11.678.678","title":"The Phosphoinositide-Binding Protein p40phox Regulates NADPH Oxidase Activation Rather Than Assembly during FcγIIA Receptor-Induced Phagocytosis.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"NADPH oxidase; Cell biology; Superoxide; Rac GTP-Binding Proteins; Biology; Chemistry; Biochemistry; Signal transduction; Reactive oxygen species; Enzyme","score_opus":0.008683707483530935,"score_gpt":0.20446883769949484,"score_spread":0.19578513021596392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2993543693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972128,0.00048133332,0.000021932352,0.00038503326,0.000306724,0.0008010719,0.000020811367,0.00020738563,0.0005629013],"genre_scores_gemma":[0.9920978,0.00002222021,0.0001155843,0.00004300542,0.00016103494,0.00019478775,0.00012216032,0.000066112785,0.0071772784],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977943,0.00034428455,0.00045877823,0.00056294346,0.00010735886,0.0007323904],"domain_scores_gemma":[0.9988909,0.00015206767,0.00029437078,0.0005072474,0.00011746915,0.000037988022],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037093504,0.0003956849,0.00034240805,0.00011823198,0.0011958038,0.00011145935,0.00038320964,0.00030947034,0.00018095832],"category_scores_gemma":[0.00006422046,0.00029629745,0.00016447701,0.00030073355,0.00011666223,0.00029264178,0.0001310561,0.00043382042,0.000536902],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018759337,0.0003033706,0.00048237504,0.000015290409,0.00019108075,0.000012379489,0.000086316475,7.768308e-7,0.9958949,0.0022078785,0.00023396731,0.00038405793],"study_design_scores_gemma":[0.0029868886,0.00014997972,0.004516596,0.000121164376,0.00006629836,0.000039412276,0.00017223058,3.466124e-7,0.98989224,0.0003217195,0.0013484678,0.00038465468],"about_ca_topic_score_codex":0.00030931758,"about_ca_topic_score_gemma":0.0000612066,"teacher_disagreement_score":0.006614377,"about_ca_system_score_codex":0.000088039866,"about_ca_system_score_gemma":0.00006976612,"threshold_uncertainty_score":0.9999489},"labels":[],"label_agreement":null},{"id":"W2993597993","doi":"10.1182/blood.v106.11.388.388","title":"Role of Otx1 in the Differentiation of Myelo-Monocytic Precursors.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer","funders":"","keywords":"Myeloid; Haematopoiesis; Biology; Progenitor cell; Erythropoiesis; Bone marrow; Myelopoiesis; Cell biology; Cellular differentiation; Homeobox; Molecular biology; Cancer research; Transcription factor; Immunology; Stem cell; Gene; Internal medicine; Genetics; Medicine","score_opus":0.012221089827308814,"score_gpt":0.24273029121879236,"score_spread":0.23050920139148354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2993597993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955354,0.00034199274,0.000013258791,0.00020079408,0.000027693763,0.00013782212,0.0000020750228,0.000006856567,0.0037341262],"genre_scores_gemma":[0.99943227,0.000058050766,0.00015838124,0.00013539122,0.000091994836,0.0000074218665,0.000011083297,0.000003939279,0.000101480415],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9995649,0.000045028493,0.0001663494,0.000070406626,0.00008576263,0.00006755155],"domain_scores_gemma":[0.9996972,0.000047242935,0.00006850856,0.0001457511,0.000027365944,0.000013945094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007582152,0.000045242225,0.00014004059,0.00005286205,0.000008022418,8.918913e-7,0.00004331112,0.00004499883,0.00008751196],"category_scores_gemma":[0.000035402663,0.000029887451,0.000043138094,0.00009564358,0.000026112624,0.000019259267,0.000008204944,0.00006878151,0.000010950105],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041204633,0.00359313,0.0972837,0.00022800783,0.00011924601,0.000002823618,0.0059111146,0.000050974268,0.8695856,0.002132881,0.00031398088,0.02036655],"study_design_scores_gemma":[0.0034659202,0.000538143,0.8592655,0.00006198179,0.00015592107,0.00001779073,0.00048758666,0.000355493,0.133815,0.00038270483,0.0013990995,0.000054859167],"about_ca_topic_score_codex":0.000016856255,"about_ca_topic_score_gemma":0.000025344372,"teacher_disagreement_score":0.7619818,"about_ca_system_score_codex":0.0000060270136,"about_ca_system_score_gemma":0.000021486347,"threshold_uncertainty_score":0.12187749},"labels":[],"label_agreement":null},{"id":"W2993646328","doi":"10.1182/blood.v112.11.2681.2681","title":"Implementation of Standardized International Karyotype Scoring Practices Is Needed to Provide Uniform and Systematic Evaluation for Patients with Myelodysplastic Syndrome Using IPSS Criteria: An International Working Group on MDS Cytogenetics Study","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North York General Hospital","funders":"","keywords":"International Prognostic Scoring System; Karyotype; Cytogenetics; Medicine; Myelodysplastic syndromes; Oncology; Internal medicine; Pediatrics; Biology; Chromosome; Bone marrow; Genetics","score_opus":0.07986410325240176,"score_gpt":0.40107258030197224,"score_spread":0.32120847704957045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2993646328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99374366,0.0000130257995,0.0010904878,0.00008658234,0.00017444877,0.004788793,0.000053492327,0.000019187508,0.000030328332],"genre_scores_gemma":[0.9898221,0.000007698334,0.009621685,0.000060244707,0.00008897712,0.00024059038,0.00011589226,0.000034434903,0.000008397304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975658,0.00012240578,0.00050093734,0.00034668043,0.0012668298,0.00019734284],"domain_scores_gemma":[0.99809915,0.00020981838,0.00049326156,0.00022558286,0.0008634705,0.00010872014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008362196,0.00016819593,0.00033673516,0.00039511122,0.00012782974,0.00006641223,0.00015207262,0.000044281034,0.000028649962],"category_scores_gemma":[0.00058940327,0.0001412038,0.000030124753,0.00021838791,0.0000312448,0.00035128003,0.00007782596,0.00010141648,8.692171e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043445867,0.0022184865,0.97619236,0.0018587457,0.0016024075,0.00004804946,0.006670074,0.00015386347,0.005697033,0.00002564142,0.000012990549,0.0011757624],"study_design_scores_gemma":[0.06498072,0.021424,0.8564216,0.0056971996,0.0035172973,0.00046381296,0.016523995,0.02253933,0.0077781035,0.000028914337,0.000029589997,0.00059547456],"about_ca_topic_score_codex":0.00015304433,"about_ca_topic_score_gemma":0.000052943862,"teacher_disagreement_score":0.119770795,"about_ca_system_score_codex":0.00038625242,"about_ca_system_score_gemma":0.00027492995,"threshold_uncertainty_score":0.57581234},"labels":[],"label_agreement":null},{"id":"W2993649022","doi":"10.1182/blood.v122.21.1017.1017","title":"Determinants Of Tissue Iron Loading In Transfused and Non-Transfused β-Thalassemia and Sickle Cell Disease Patients – Biomarkers Of Iron Regulation and Inflammation","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"","keywords":"Hepcidin; Medicine; Internal medicine; Ferritin; Thalassemia; Transferrin saturation; Gastroenterology; Inflammation; Soluble transferrin receptor; Beta thalassemia; Chelation therapy; Anemia; GDF15; Siderosis; Iron deficiency; Immunology; Endocrinology; Iron status","score_opus":0.0032097901571435466,"score_gpt":0.20195743200562577,"score_spread":0.19874764184848223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2993649022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987074,0.00032787805,0.000011475773,0.000056448465,0.00001928363,0.00073999166,0.0000061367073,0.000007698725,0.00012367209],"genre_scores_gemma":[0.9994674,0.0003542631,0.00011151896,0.0000048414922,0.0000062160693,0.000010111524,0.000015519898,0.000012991242,0.000017160643],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99925995,0.000026960377,0.00029847998,0.00017297146,0.000119949866,0.00012171223],"domain_scores_gemma":[0.99963236,0.000032161606,0.00008944873,0.00009979126,0.000038969407,0.000107258005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007530843,0.00010852305,0.00021591342,0.00012504589,0.000025110254,0.0000071296213,0.000019170644,0.00010655295,0.000010566404],"category_scores_gemma":[0.00002204218,0.00009648905,0.000017795775,0.00010355835,0.000082192855,0.00013443707,0.00000884696,0.00005789276,5.7435096e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012078614,0.00022716443,0.75064844,0.0010039188,0.000009493007,0.0000030613076,0.0010315469,0.0000033753488,0.23908503,7.8540387e-7,0.0000032427142,0.007863147],"study_design_scores_gemma":[0.007551405,0.00028504335,0.8886787,0.00031272156,0.00016791643,0.0000019369957,0.00020347837,0.000941611,0.10174094,0.000022492479,0.0000036489846,0.000090102396],"about_ca_topic_score_codex":0.00018906196,"about_ca_topic_score_gemma":0.000027167558,"teacher_disagreement_score":0.13803026,"about_ca_system_score_codex":0.000007882021,"about_ca_system_score_gemma":0.00001929702,"threshold_uncertainty_score":0.3934709},"labels":[],"label_agreement":null},{"id":"W2993664670","doi":"10.1182/blood.v110.11.1713.1713","title":"A New Model of Hereditary Spherocytosis Demonstrates Profound Homeostatic Compensation in Severely Anemic Mice.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of British Columbia","funders":"","keywords":"Hereditary spherocytosis; Biology; Band 3; Ankyrin; Molecular biology; Mutant; Nonsense mutation; Genetics; Point mutation; Spherocytosis; Mutation; Missense mutation; Gene; Membrane protein; Immunology","score_opus":0.02397095523672337,"score_gpt":0.25843991076190853,"score_spread":0.23446895552518515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2993664670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99417144,0.00028198672,0.003155238,0.000111398134,0.00008641829,0.0002741494,0.0000051601396,0.00003328265,0.0018809381],"genre_scores_gemma":[0.98348814,0.000041882784,0.015630746,0.00025477345,0.00009806005,0.0000034041116,0.00003914241,0.000013871723,0.00043000348],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991514,0.00002232392,0.0003267679,0.00017530588,0.00013213689,0.00019207923],"domain_scores_gemma":[0.9995361,0.00008807361,0.00009242816,0.00013393136,0.00005535117,0.000094112154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013745806,0.00011029337,0.00026873683,0.000111387504,0.00001545131,0.000002636506,0.00004336524,0.000110453475,0.00007156554],"category_scores_gemma":[0.000035046523,0.00010325324,0.00005033791,0.00020693136,0.000039941242,0.000057789734,0.00001305036,0.00015199665,0.000022044676],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002329013,0.0018004337,0.11150645,0.00071079587,0.00018954281,0.0001811853,0.0017366195,0.0007215184,0.8734176,0.00041606303,0.0018764973,0.0051142788],"study_design_scores_gemma":[0.03195824,0.0031915081,0.5942402,0.0009605342,0.00087126193,0.0009809486,0.002605335,0.016941877,0.34160584,0.0056957505,0.00013596224,0.00081256544],"about_ca_topic_score_codex":0.00017132847,"about_ca_topic_score_gemma":0.00022802452,"teacher_disagreement_score":0.5318118,"about_ca_system_score_codex":0.000026928486,"about_ca_system_score_gemma":0.00018457456,"threshold_uncertainty_score":0.42105448},"labels":[],"label_agreement":null},{"id":"W2993710538","doi":"10.1182/blood.2019000998","title":"Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Children's Hospital of Eastern Ontario; University of Ottawa; Hospital for Sick Children","funders":"","keywords":"Medicine; Dabigatran; Thrombosis; Internal medicine; Venous thrombosis; Deep vein; Clinical trial; Pediatrics; Surgery; Warfarin; Atrial fibrillation","score_opus":0.00874937767241,"score_gpt":0.25164520272626445,"score_spread":0.24289582505385446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2993710538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99360716,0.0009038748,0.00004709714,0.00021518074,0.00010984053,0.0021538106,0.000035081586,0.000012907483,0.0029150422],"genre_scores_gemma":[0.9988694,0.00043250312,0.00029646806,0.000102048725,0.000057713678,0.000046264002,0.000036800597,0.000020300839,0.00013849928],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99906427,0.000026058906,0.0003826463,0.00018111806,0.00016499136,0.00018090346],"domain_scores_gemma":[0.99931735,0.000072243034,0.00016236182,0.00037086406,0.000047730795,0.000029462542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035002656,0.00010683462,0.00055255607,0.00007890396,0.000026284299,0.0000036394526,0.0001323411,0.00006596104,0.00015123257],"category_scores_gemma":[0.000019625197,0.00007823911,0.00016803388,0.00012639762,0.000045912897,0.00004643499,0.00004484132,0.00010630143,0.000006966466],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012219028,0.046217427,0.5444457,0.005976903,0.00989872,0.000013173408,0.009204874,0.00059908035,0.10313595,0.03386128,0.0019095386,0.24351543],"study_design_scores_gemma":[0.006085544,0.0009671542,0.9758634,0.00024403648,0.0006978129,0.0000100970565,0.00012292319,0.000025860625,0.014619622,0.00061077677,0.00066886155,0.00008390014],"about_ca_topic_score_codex":0.00012214536,"about_ca_topic_score_gemma":0.000026268526,"teacher_disagreement_score":0.4314177,"about_ca_system_score_codex":0.000012155156,"about_ca_system_score_gemma":0.0000741275,"threshold_uncertainty_score":0.3190498},"labels":[],"label_agreement":null},{"id":"W2993786117","doi":"10.1182/blood-2019-122634","title":"Assessing Feasibility of a Focused Geriatric Assessment in Older Adults with Sickle Cell Disease to Address Functional Risk Factors for Morbidity and Mortality","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Life expectancy; Population; Cohort; Psychological intervention; Clinical endpoint; Gerontology; Geriatrics; Disease; Prospective cohort study; Activities of daily living; Physical therapy; Pediatrics; Internal medicine; Clinical trial","score_opus":0.020295819214689724,"score_gpt":0.28779563835297856,"score_spread":0.26749981913828885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2993786117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99707043,0.00015510307,0.00031875484,0.00004871898,0.00008113012,0.0019483608,0.00010185999,0.000022476357,0.00025315356],"genre_scores_gemma":[0.9991677,0.00001908107,0.00061888306,0.000024946288,0.00002365923,0.000043985114,0.00005178127,0.000017215814,0.000032775148],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998825,0.000055526398,0.0002657506,0.00038029853,0.0002605254,0.00021286574],"domain_scores_gemma":[0.99915206,0.00011251387,0.00013029706,0.00028283763,0.00010318471,0.00021910254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024172109,0.00015411562,0.0003222964,0.00008905929,0.000045519213,0.00001831105,0.00004007022,0.00008464937,0.000052541112],"category_scores_gemma":[0.00007587805,0.000111365116,0.000075942815,0.00021266528,0.000036522215,0.000105817075,0.000031967684,0.00017901852,0.0000010148918],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044316688,0.0020424032,0.9957798,0.00063740637,0.000054945107,0.000005406262,0.0002662374,0.00011180681,0.00046429294,0.0000051723737,0.0000199809,0.00016935053],"study_design_scores_gemma":[0.011774897,0.00038104967,0.98517394,0.00016979445,0.00039233174,0.000001004393,0.0008687568,0.00042026874,0.00065262005,0.000023006254,0.0000060532543,0.00013629244],"about_ca_topic_score_codex":0.00045967122,"about_ca_topic_score_gemma":0.00006460956,"teacher_disagreement_score":0.01133173,"about_ca_system_score_codex":0.00004078374,"about_ca_system_score_gemma":0.0002616759,"threshold_uncertainty_score":0.45413378},"labels":[],"label_agreement":null},{"id":"W2993788195","doi":"10.1182/blood.v108.11.779.779","title":"The SCL-LMO2 Interaction Nucleates Hematopoietic Transcription Factor Complexes: Coupling Protein Stability and Complex Assembly.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; Montreal Clinical Research Institute; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Transcription factor; Glycophorin; Haematopoiesis; Biology; Transactivation; Cell biology; Molecular biology; Immunoprecipitation; Mutant; Plasma protein binding; Gene; Stem cell; Genetics","score_opus":0.028216322313329264,"score_gpt":0.27456589081562643,"score_spread":0.24634956850229717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2993788195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99777704,0.0003434982,0.00050607865,0.00029161363,0.000034522287,0.00054486276,0.000016307018,0.00002484703,0.00046121623],"genre_scores_gemma":[0.99929863,0.000031937794,0.00021588999,0.000017513947,0.00009045715,0.000051496296,0.000086176435,0.000016754415,0.00019111566],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99905014,0.000060600636,0.00021587861,0.00027255598,0.000176906,0.00022389219],"domain_scores_gemma":[0.9995174,0.000022924549,0.000060020302,0.00023918186,0.00010795569,0.000052529376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001903759,0.00012647294,0.00010380674,0.000025225829,0.0003111501,0.0001307146,0.00011129687,0.00008289725,0.00005936982],"category_scores_gemma":[0.000046978523,0.00009823469,0.000055673278,0.00006785015,0.00011536743,0.000009590818,0.000043708143,0.00011191507,0.000010239221],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000063445485,0.00015773735,0.0016702245,0.00003737192,0.000018887506,7.8842527e-7,0.000030129151,0.000010684928,0.99732685,0.00029665852,0.000070902955,0.00031631012],"study_design_scores_gemma":[0.0013320541,0.00025583833,0.023998456,0.000025533003,0.00001570474,0.00002120813,0.00027281922,0.0018877925,0.95608336,0.00025034058,0.015654745,0.00020213301],"about_ca_topic_score_codex":0.00012385543,"about_ca_topic_score_gemma":0.0002655472,"teacher_disagreement_score":0.041243486,"about_ca_system_score_codex":0.000011978643,"about_ca_system_score_gemma":0.00002531811,"threshold_uncertainty_score":0.40058944},"labels":[],"label_agreement":null},{"id":"W2993800134","doi":"10.1182/blood.v106.11.913.913","title":"Ximelagatran in Major Orthopedic Surgery: A Systematic Review and Meta-Analysis of Efficacy and Safety.","year":2005,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Ximelagatran; Fondaparinux; Randomized controlled trial; Cochrane Library; Knee replacement; Direct thrombin inhibitor; Surgery; Low molecular weight heparin; Warfarin; Orthopedic surgery; Meta-analysis; Discontinuation; Internal medicine; Venous thromboembolism; Heparin; Thrombosis; Dabigatran","score_opus":0.06485754374302347,"score_gpt":0.3384475192773432,"score_spread":0.27358997553431974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2993800134","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000023138655,0.9943854,0.0000013068145,0.00021698448,0.000011221511,0.005054652,0.000068961104,0.000018446644,0.00021984056],"genre_scores_gemma":[0.000087646644,0.99860847,0.00007283923,0.00036027606,0.000022512479,0.00048303365,0.000112959235,0.000045144305,0.00020711267],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9964346,0.00041555538,0.0020175069,0.00053580024,0.00033355848,0.00026296845],"domain_scores_gemma":[0.9975546,0.0006747571,0.00082809053,0.0007371535,0.00005040102,0.00015497049],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.001706508,0.0004868049,0.020813495,0.00093445583,0.00002822487,0.000016283553,0.00011099787,0.00016968683,0.00028686554],"category_scores_gemma":[0.00029051572,0.00031024416,0.0021080077,0.0012798036,0.00005668921,0.000037127054,0.00008991675,0.00021381208,0.0000088265415],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000012790468,0.00063243293,0.0000067432024,0.7760187,0.21560906,0.000040841307,0.000025832256,4.885521e-8,8.860995e-9,0.000044476776,0.00009976429,0.0075208107],"study_design_scores_gemma":[0.000413363,0.000042214797,0.000093389724,0.10298562,0.8614006,0.000044154018,0.0000052285086,2.5929808e-7,3.887554e-8,6.066588e-7,0.03481153,0.00020300118],"about_ca_topic_score_codex":0.000047316444,"about_ca_topic_score_gemma":0.0000826621,"teacher_disagreement_score":0.67303306,"about_ca_system_score_codex":0.000023423698,"about_ca_system_score_gemma":0.000095778014,"threshold_uncertainty_score":0.999935},"labels":[],"label_agreement":null},{"id":"W2993808621","doi":"10.1182/blood.v112.11.1042.1042","title":"Subcutaneous Alemtuzumab Is a Safe and Effective Treatment for Global or Single-Lineage Immune-Mediated Marrow Failures: a Survey from the EBMT-WPSAA","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Alemtuzumab; Neutropenia; Internal medicine; Immunosuppression; Gastroenterology; Rash; Regimen; Aplastic anemia; Bone marrow; Bone marrow failure; Anemia; Surgery; Transplantation; Chemotherapy; Haematopoiesis; Stem cell","score_opus":0.03254866610517325,"score_gpt":0.2686693954136717,"score_spread":0.23612072930849842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2993808621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935446,0.0010928091,0.00045642327,0.00041855665,0.00010117937,0.002365256,0.0016479609,0.00007735225,0.00029586913],"genre_scores_gemma":[0.9967458,0.00031126064,0.0012847709,0.00025064513,0.00012562839,0.00019565251,0.0007428011,0.000035215726,0.00030822173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984725,0.00018361419,0.00036291493,0.00040956307,0.00025290748,0.00031846738],"domain_scores_gemma":[0.9968383,0.0024530129,0.000108471846,0.00035423905,0.00010851377,0.00013746378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001859584,0.0002870269,0.0005016312,0.000028271774,0.00017170128,0.000023116372,0.00008968743,0.00015658463,0.0000853393],"category_scores_gemma":[0.00026519873,0.00017550774,0.00012822934,0.00018669406,0.00012256285,0.000037194437,0.0000149916405,0.000083096966,0.000031507498],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04613417,0.012107769,0.75857216,0.0012737227,0.009473599,0.010865411,0.04028475,0.0000073395477,0.102970175,0.00007811396,0.0029933648,0.015239444],"study_design_scores_gemma":[0.088346004,0.016581057,0.6932003,0.0010096092,0.0048783785,0.0134859,0.0011878883,0.0004869557,0.17369339,0.00008812157,0.0058998493,0.0011425376],"about_ca_topic_score_codex":0.0019796954,"about_ca_topic_score_gemma":0.0013179102,"teacher_disagreement_score":0.07072321,"about_ca_system_score_codex":0.00012792689,"about_ca_system_score_gemma":0.00017912313,"threshold_uncertainty_score":0.7156998},"labels":[],"label_agreement":null},{"id":"W2993826539","doi":"10.1182/blood.v106.11.833.833","title":"Otx1 Enhances Erythroid Differenciation through Activation of the SCL Gene.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer","funders":"","keywords":"Homeobox; Chromatin immunoprecipitation; Biology; Haematopoiesis; Embryonic stem cell; Immunoprecipitation; Myeloid; Yolk sac; Transcription factor; Molecular biology; Chromatin; Cell biology; Stem cell; Promoter; Cancer research; Gene; Embryo; Gene expression; Genetics","score_opus":0.007349921606161561,"score_gpt":0.22312735105304407,"score_spread":0.2157774294468825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2993826539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99690974,0.00047178945,0.0014202992,0.00030387018,0.00009448429,0.00013750486,0.0000058995847,0.000007578363,0.0006488332],"genre_scores_gemma":[0.9984024,0.00014556035,0.00057314965,0.00007001847,0.00045273753,0.000010657067,0.00004421809,0.000009741391,0.00029152233],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994538,0.000030350417,0.00014616454,0.00015540459,0.00012181201,0.00009246528],"domain_scores_gemma":[0.99954945,0.000005487133,0.0001362698,0.00023575712,0.000061197265,0.000011868628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000046250094,0.00007558668,0.00006742431,0.00001228589,0.000053251708,0.0000064845613,0.000098515105,0.00010872639,0.000014328814],"category_scores_gemma":[0.000032144,0.00005997449,0.000060278457,0.00008680153,0.000034394398,0.000006968652,0.000037542868,0.000040687024,0.0000032427852],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001211672,0.00007841231,0.0011017177,0.0000052953574,0.000036341477,1.0774941e-8,0.00007369675,0.00031273684,0.9952133,0.00004130506,0.0001915674,0.0029334899],"study_design_scores_gemma":[0.00046892016,0.000048925478,0.031149967,0.000012593789,0.000030462252,0.0000020915938,0.000011078705,0.000049658778,0.96488726,0.00010246043,0.0031667883,0.00006977459],"about_ca_topic_score_codex":0.000014203444,"about_ca_topic_score_gemma":0.000045290042,"teacher_disagreement_score":0.030326031,"about_ca_system_score_codex":0.000014647209,"about_ca_system_score_gemma":0.00004798712,"threshold_uncertainty_score":0.24456887},"labels":[],"label_agreement":null},{"id":"W2993859736","doi":"10.1182/blood.v106.11.3594.3594","title":"Nitric Oxide Upregulates Ferritin Synthesis Independently of Iron Regulatory Protein-Iron Responsive Element Binding Activity.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Ferritin; Transferrin receptor; Intracellular; Nitric oxide; Chemistry; Cell biology; Untranslated region; Translation (biology); Messenger RNA; Protein biosynthesis; RNA-binding protein; Biochemistry; Downregulation and upregulation; Transferrin; Biology; Gene","score_opus":0.00972773458142674,"score_gpt":0.23886687181511643,"score_spread":0.2291391372336897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2993859736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99582267,0.0010807996,0.000016211077,0.00038763203,0.000025803312,0.0008356071,0.000021173075,0.00007342494,0.0017366636],"genre_scores_gemma":[0.99598885,0.00005868389,0.0018179265,0.00007020101,0.00013905334,0.000091264184,0.000008716354,0.00004652872,0.0017787848],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980685,0.00014950345,0.00039367896,0.00038170235,0.0005929332,0.000413699],"domain_scores_gemma":[0.9989001,0.000114958035,0.00023442211,0.00050999125,0.000082462364,0.00015807243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044389215,0.0002488996,0.00046134036,0.0003884994,0.00009307071,0.000015207847,0.00014584207,0.00017228561,0.00025843477],"category_scores_gemma":[0.00036353397,0.00023442229,0.00015313327,0.00027816897,0.0000949379,0.00016170094,0.000080242266,0.00021159228,0.000055487202],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006951346,0.0016437317,0.0130199725,0.00042861517,0.00007040748,0.000024196628,0.00020295136,0.000021795882,0.9692871,0.00031376557,0.00018635031,0.014105961],"study_design_scores_gemma":[0.003287722,0.00011594998,0.17158197,0.0002083817,0.00049614377,0.000027207885,0.00042818536,0.000010494919,0.82297534,0.00003522172,0.00060331187,0.00023004963],"about_ca_topic_score_codex":0.0000622682,"about_ca_topic_score_gemma":0.000019265104,"teacher_disagreement_score":0.158562,"about_ca_system_score_codex":0.000062665684,"about_ca_system_score_gemma":0.00015597149,"threshold_uncertainty_score":0.9559464},"labels":[],"label_agreement":null},{"id":"W2993867054","doi":"10.1182/blood.v108.11.1306.1306","title":"A Phase 2, Randomized, Open-Label Study To Assess the Efficacy of Extended Dose Schedule Administration of Darbepoetin Alfa (DA) in Cancer Patients (pts) with Chemotherapy-Induced Anemia (CIA).","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Dosing; Clinical endpoint; Anemia; Interim analysis; Internal medicine; Cancer; Chemotherapy; Darbepoetin alfa; Phases of clinical research; Randomized controlled trial; Surgery","score_opus":0.04351410603591899,"score_gpt":0.36939494383840715,"score_spread":0.32588083780248817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2993867054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99369115,0.00009732054,0.0000070888145,0.0005641043,0.000033132066,0.0045894976,0.000015923753,0.000014241587,0.0009875353],"genre_scores_gemma":[0.9982687,0.000014270313,0.0010657657,0.00010073305,0.00005058648,0.00032623133,0.00003563288,0.000027925575,0.00011011588],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983157,0.00017736618,0.00057165645,0.00032079572,0.00041196818,0.00020254338],"domain_scores_gemma":[0.99889857,0.00017008316,0.00030184267,0.0003862867,0.0001707732,0.0000724407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039845938,0.000213453,0.00072072755,0.000082570295,0.000047988033,0.000024657198,0.00018194491,0.00005577395,0.000048327212],"category_scores_gemma":[0.000090845184,0.00012827369,0.00005274778,0.00034344656,0.00008669901,0.00005279733,0.000044030276,0.0001319235,0.0000018681709],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.25876915,0.5709278,0.060768127,0.0002425609,0.000872854,0.00012601534,0.0037801033,0.000009773713,0.09327872,0.00016613898,0.0002508589,0.010807915],"study_design_scores_gemma":[0.8010273,0.008732412,0.035981927,0.00030875963,0.0005367118,0.000007107249,0.0006184403,0.000013231197,0.152598,0.000010807694,0.000016196336,0.00014913293],"about_ca_topic_score_codex":0.0010502489,"about_ca_topic_score_gemma":0.0005571386,"teacher_disagreement_score":0.56219536,"about_ca_system_score_codex":0.000050932566,"about_ca_system_score_gemma":0.00028517708,"threshold_uncertainty_score":0.52308494},"labels":[],"label_agreement":null},{"id":"W2993955374","doi":"10.1182/blood.v108.11.947.947","title":"Generation of Kinins during Preparation and Storage of Leukoreduced Platelet Concentrates.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Institut National de Santé Publique du Québec; Centre hospitalier universitaire de Québec; Héma-Québec; Université de Montréal","funders":"","keywords":"Leukoreduction; Bradykinin; Platelet; Chemistry; Kinin; Whole blood; Andrology; Immunology; Biochemistry; Medicine; Receptor","score_opus":0.017736346591982234,"score_gpt":0.2548970593975811,"score_spread":0.2371607128055989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2993955374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985174,0.0005090746,0.000011801488,0.00001692344,0.000018693156,0.00017665775,0.000011826203,0.000010138214,0.0007274691],"genre_scores_gemma":[0.99953556,0.000048803107,0.00018490046,0.0000043452496,0.00003454523,0.0000044619883,0.000084265375,0.0000056167128,0.00009747273],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99959093,0.000008104316,0.00015764243,0.000094704264,0.00007961654,0.000069001406],"domain_scores_gemma":[0.9997894,0.0000061117244,0.00007836017,0.00007252299,0.000033039032,0.000020524383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000022495693,0.00005709401,0.00015855588,0.000030777064,0.000019536532,0.0000033212905,0.000011053382,0.00003761925,0.0000112912685],"category_scores_gemma":[0.0000062519534,0.000050446324,0.000020615285,0.00004602808,0.000025500858,0.000043667944,0.0000051088878,0.000022099499,6.9082864e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010077272,0.00081778795,0.041876357,0.0000883021,0.00010519101,0.00006848918,0.00023348854,0.00007531646,0.95616615,0.00018308611,0.000050913328,0.00023412675],"study_design_scores_gemma":[0.0049323863,0.00021484891,0.09994082,0.000027716022,0.000104821316,0.00006183303,0.00001923287,0.00034619478,0.89426875,0.000023807099,0.000017148144,0.00004242826],"about_ca_topic_score_codex":0.00008941805,"about_ca_topic_score_gemma":0.00002597378,"teacher_disagreement_score":0.061897404,"about_ca_system_score_codex":0.0000075583202,"about_ca_system_score_gemma":0.000026212887,"threshold_uncertainty_score":0.20571414},"labels":[],"label_agreement":null},{"id":"W2994020356","doi":"10.1182/blood.v108.11.830.830","title":"Bortezomib Induces an Antioxidant and ER-Stress Response Gene Expression Signature in Mantle Cell Lymphoma: Implications for Response Prediction and Optimized Chemotherapy Regimens.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Bortezomib; Mantle cell lymphoma; Medicine; Proteasome inhibitor; Gene expression; Gene expression profiling; Cancer research; Gene signature; Lymphoma; Internal medicine; Biology; Oncology; Immunology; Gene; Multiple myeloma; Genetics","score_opus":0.009327423891404257,"score_gpt":0.24968282173459902,"score_spread":0.24035539784319476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994020356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99423224,0.0027790994,0.00006799946,0.0015169047,0.000028002638,0.0010321896,0.00024483792,0.000059369835,0.000039357845],"genre_scores_gemma":[0.9894188,0.0005253795,0.009177678,0.00013337455,0.00007970567,0.00033047784,0.00012537853,0.00003179529,0.00017737907],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998801,0.00014161912,0.00027317324,0.00044799762,0.000112146685,0.00022407318],"domain_scores_gemma":[0.99913126,0.00025459664,0.00010888226,0.00032595053,0.00006182698,0.000117484924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034640272,0.00019700886,0.00028712384,0.00016637855,0.00012581052,0.00003952201,0.00004880383,0.00018940789,0.0000039266947],"category_scores_gemma":[0.00003872793,0.00016082423,0.000047919024,0.00012715999,0.000055145614,0.00014706719,0.000022861455,0.00005060159,4.603767e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0129949665,0.0045167757,0.039779074,0.000040404608,0.000037228427,0.000039577048,0.00024353071,0.0000091928,0.94075304,0.000017864008,0.00033509897,0.0012332352],"study_design_scores_gemma":[0.024994317,0.0005532797,0.5304687,0.000084209656,0.00010435097,0.00007120613,0.00006201803,0.000035004585,0.4431287,0.000053662738,0.00034547388,0.00009910444],"about_ca_topic_score_codex":0.000056745524,"about_ca_topic_score_gemma":0.000006318713,"teacher_disagreement_score":0.49762437,"about_ca_system_score_codex":0.0000646555,"about_ca_system_score_gemma":0.00009989709,"threshold_uncertainty_score":0.65582216},"labels":[],"label_agreement":null},{"id":"W2994024326","doi":"10.1182/blood.v104.11.5.5","title":"Specific Peptide Disruption of the Bcl-6 Repression Complex Reveals Its Transcriptional Mechanism of Action in Normal and Malignant B-Cells and Is a Novel Therapeutic Approach for Diffuse Large B-Cell Lymphoma.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Psychological repression; Repressor; Biology; Corepressor; Cell biology; Germinal center; Endogeny; Gene; Transcriptional regulation; Promoter; Cancer research; Transcription factor; Molecular biology; B cell; Gene expression; Genetics; Antibody; Biochemistry","score_opus":0.04470785498235028,"score_gpt":0.2648452568291223,"score_spread":0.22013740184677202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994024326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961204,0.0011450824,0.0012884061,0.00015627638,0.000033509943,0.00094529917,0.0002020596,0.000007252938,0.00010171934],"genre_scores_gemma":[0.99663,0.00082485547,0.002240144,0.00009417562,0.000023504264,0.00007662243,0.000034762303,0.000014486663,0.00006140873],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990554,0.000025180185,0.00029959323,0.00026233972,0.00019872957,0.00015874793],"domain_scores_gemma":[0.99953055,0.000040740022,0.00014469193,0.00018634372,0.000047622856,0.000050072962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015022955,0.00013739504,0.00027526208,0.00006436038,0.000059458973,0.0000081262515,0.00004402537,0.000081370665,0.0000061648975],"category_scores_gemma":[0.0000048400734,0.000090602676,0.00009622679,0.0000887173,0.00003958528,0.0000628805,0.000022830118,0.000033478886,3.3372172e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002901649,0.019170584,0.0054826112,0.00040919657,0.00007374497,0.0000019271258,0.001092233,0.0000052066985,0.9693493,0.0035793039,0.0000087974995,0.0005369112],"study_design_scores_gemma":[0.07566064,0.00046739046,0.30738357,0.00034266373,0.0003883356,0.00008077714,0.000366194,0.00045916275,0.61411715,0.0004663488,0.00013328913,0.00013447506],"about_ca_topic_score_codex":0.00003235788,"about_ca_topic_score_gemma":0.00000505357,"teacher_disagreement_score":0.35523215,"about_ca_system_score_codex":0.00004383111,"about_ca_system_score_gemma":0.000034144174,"threshold_uncertainty_score":0.369467},"labels":[],"label_agreement":null},{"id":"W2994047002","doi":"10.1182/blood.v112.11.3052.3052","title":"Phase II Trial of Lenalidomide in Patients with Relapsed or Refractory Hodgkin Lymphoma","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Lenalidomide; Medicine; Internal medicine; Autologous stem-cell transplantation; Refractory (planetary science); Thalidomide; Transplantation; Regimen; Phases of clinical research; Gastroenterology; Surgery; Oncology; Clinical trial; Multiple myeloma","score_opus":0.020010048282270283,"score_gpt":0.26208813616875676,"score_spread":0.24207808788648646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994047002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99818105,0.00011441196,5.499003e-7,0.000058950187,0.00006914372,0.0007518048,0.00001936622,0.000021655303,0.0007830845],"genre_scores_gemma":[0.99901927,0.000075612545,0.00034470423,0.000087700246,0.0000694728,0.00007109266,0.000046325804,0.000019204263,0.00026662846],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99890774,0.00003977976,0.00033401378,0.00021691949,0.0003181271,0.00018344351],"domain_scores_gemma":[0.99932754,0.000075194155,0.00013860124,0.0002977512,0.0000646461,0.000096295655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007057654,0.00014741156,0.00041154673,0.000112899696,0.000049979,0.0000023123698,0.00005101407,0.000074521304,0.00007262814],"category_scores_gemma":[0.00009238077,0.00009090931,0.00007357912,0.00018143255,0.00006146975,0.00005756054,0.000022902892,0.00003904449,0.000009124551],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29219118,0.25743276,0.42739898,0.00005824839,0.00054240075,0.0013545081,0.00085605483,6.04253e-7,0.00028310856,0.00002367104,0.00096150144,0.018896997],"study_design_scores_gemma":[0.73679703,0.03274011,0.22039877,0.00013679393,0.0002466514,0.000028993094,0.000015267453,9.268395e-7,0.008553804,0.0000026048533,0.0009792795,0.000099787096],"about_ca_topic_score_codex":0.00011087697,"about_ca_topic_score_gemma":0.000018984647,"teacher_disagreement_score":0.44460586,"about_ca_system_score_codex":0.00008325628,"about_ca_system_score_gemma":0.0002718411,"threshold_uncertainty_score":0.37071738},"labels":[],"label_agreement":null},{"id":"W2994052225","doi":"10.1182/blood.v104.11.2867.2867","title":"Most of the Short Term Repopulating Cells in Human Mobilized Peripheral Blood Do Not Have a Side Population (SP) Phenotype.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Side population; Biology; Bone marrow; Population; Haematopoiesis; Stem cell; Myeloid; Immunology; Molecular biology; Cell biology; Medicine; Cancer stem cell","score_opus":0.012053517009391777,"score_gpt":0.2545407561340284,"score_spread":0.2424872391246366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994052225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99889,0.00011953722,0.000015829773,0.000021210573,0.00007438522,0.0002243943,0.000012074113,0.000006905491,0.0006356981],"genre_scores_gemma":[0.99933565,0.00001706855,0.0002548596,0.000078612415,0.000106126485,0.000016753092,0.000056790286,0.000018069002,0.00011607914],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998969,0.00004380224,0.00036230174,0.00030082624,0.00013491507,0.00018915851],"domain_scores_gemma":[0.999374,0.0000039026454,0.00010987397,0.000423348,0.00005797353,0.00003095151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011006762,0.00014230935,0.00016721745,0.000031024003,0.00006989283,0.00001959569,0.00019920271,0.00013349559,0.000008243491],"category_scores_gemma":[0.00003696321,0.00011711812,0.00009904471,0.0000816473,0.000041955354,0.0000057620246,0.00010440816,0.00009959542,7.481644e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029227722,0.0002778581,0.08349315,0.000014512143,0.00003665629,0.0000050209924,0.0001477261,0.00073471403,0.914955,0.000023015979,0.000003897052,0.00027921793],"study_design_scores_gemma":[0.0014983438,0.00021600489,0.10406918,0.00006264845,0.000055712073,0.000010291353,0.0000839706,0.000011513709,0.8937098,0.00012198393,0.000014072724,0.00014647265],"about_ca_topic_score_codex":0.00056644285,"about_ca_topic_score_gemma":0.0007950588,"teacher_disagreement_score":0.021245202,"about_ca_system_score_codex":0.00001253877,"about_ca_system_score_gemma":0.00003831689,"threshold_uncertainty_score":0.47759384},"labels":[],"label_agreement":null},{"id":"W2994061399","doi":"10.1182/blood.v112.11.4591.4591","title":"Transplanted CD34+ Cells Stimulated with Flt3 Ligand and Granulocyte-Colony Stimulating Factor Display An Impaired Early Reconstitution Capacity","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stemcell Technologies","funders":"","keywords":"Stem cell factor; Granulocyte colony-stimulating factor; Haematopoiesis; Hematopoietic growth factor; Bone marrow; CD34; Transplantation; Total body irradiation; Internal medicine; White blood cell; Stem cell; Endocrinology; Andrology; Biology; Immunology; Chemistry; Medicine; Chemotherapy; Cyclophosphamide; Cell biology","score_opus":0.028547581924231024,"score_gpt":0.23836607899400064,"score_spread":0.20981849706976963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994061399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964675,0.00004325073,0.0018183207,0.000025337004,0.00006967309,0.0009081321,0.00012828683,0.00020720027,0.00033233868],"genre_scores_gemma":[0.9970824,0.000065933156,0.0025394561,0.000033507746,0.000054049862,0.000017668097,0.00011525431,0.00003646225,0.000055243065],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983827,0.000077048644,0.0003847914,0.00044706863,0.00035861315,0.00034981794],"domain_scores_gemma":[0.99908286,0.00013324615,0.000103905404,0.0002630029,0.000109296925,0.00030771256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001335518,0.0002889015,0.00045354382,0.00012608567,0.00024631163,0.000028431943,0.000065836844,0.00019631583,0.00003050863],"category_scores_gemma":[0.00001664453,0.00023543676,0.00005657958,0.00021873922,0.0002247088,0.00024389103,0.0000051832126,0.00024498955,0.000013021384],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008485264,0.0006076175,0.511426,0.00047027337,0.00019143023,0.0006432311,0.006083755,0.000117629694,0.47944435,0.000012473875,0.0000023713535,0.00015233397],"study_design_scores_gemma":[0.013033178,0.001558745,0.6527913,0.00074535934,0.0007006661,0.0024258078,0.000060887658,0.0024332341,0.3258459,0.0000065499817,0.000008114094,0.00039021656],"about_ca_topic_score_codex":0.0003161632,"about_ca_topic_score_gemma":0.00010311445,"teacher_disagreement_score":0.15359847,"about_ca_system_score_codex":0.000029674535,"about_ca_system_score_gemma":0.00011527569,"threshold_uncertainty_score":0.96008325},"labels":[],"label_agreement":null},{"id":"W2994089043","doi":"10.1182/blood-2019-123064","title":"Assessment of Longer-Term Efficacy and Safety in the Phase 3, Randomized, Double-Blind, Placebo-Controlled MEDALIST Trial of Luspatercept to Treat Anemia in Patients (Pts) with Revised International Prognostic Scoring System (IPSS-R) Very Low-, Low-, or Intermediate-Risk Myelodysplastic Syndromes (MDS) with Ring Sideroblasts (RS) Who Require Red Blood Cell (RBC) Transfusions","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Discontinuation; Adverse effect; Anemia; Placebo; Internal medicine; Erythropoiesis; International Prognostic Scoring System; Randomized controlled trial; Clinical trial; Erythropoietin; Myelodysplastic syndromes; Bone marrow","score_opus":0.012884303396123906,"score_gpt":0.28567389401471494,"score_spread":0.27278959061859104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994089043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9811134,0.000036515798,0.00013884898,0.00006620231,0.0001296287,0.01797135,0.0000737865,0.00003837302,0.00043193836],"genre_scores_gemma":[0.9981585,0.00014373602,0.0002926371,0.0000132732475,0.000087595734,0.0010475775,0.000090497946,0.00007987783,0.00008627932],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9947628,0.0007923833,0.0017305661,0.00080604665,0.0013235337,0.00058470503],"domain_scores_gemma":[0.99532866,0.0027554017,0.000696691,0.0006768697,0.00029698,0.00024541334],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020039633,0.0005492426,0.002376144,0.00086847274,0.00007753108,0.000073161784,0.00046917738,0.00019540134,0.000057776328],"category_scores_gemma":[0.00057890953,0.00031642485,0.00018329974,0.0006788278,0.00023303175,0.0002737918,0.00014044253,0.0006882641,0.0000033921713],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94286376,0.005182113,0.04144203,0.0030207096,0.00063876924,0.0004386267,0.0027008934,0.00047899227,0.002938702,0.000010796839,0.0000017293411,0.00028285146],"study_design_scores_gemma":[0.9546488,0.007617254,0.020937808,0.010856818,0.0018236819,0.000099629906,0.0008074639,0.0013044298,0.0015917682,4.3515854e-7,2.9289006e-7,0.00031164917],"about_ca_topic_score_codex":0.0001308236,"about_ca_topic_score_gemma":0.00016330018,"teacher_disagreement_score":0.02050422,"about_ca_system_score_codex":0.0003269119,"about_ca_system_score_gemma":0.00064402237,"threshold_uncertainty_score":0.9999288},"labels":[],"label_agreement":null},{"id":"W2994147959","doi":"10.1182/blood.v104.11.26.26","title":"Mechanisms of Bcl-2 Protein Expression in Diffuse Large B-Cell Lymphoma (DLBCL).","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Tissue microarray; Gene expression profiling; Biology; Biomarker; Immunohistochemistry; Lymphoma; Oncology; Internal medicine; Cancer research; Pathology; Medicine; Gene expression; Gene; Genetics","score_opus":0.007736694115331765,"score_gpt":0.22432546442844234,"score_spread":0.21658877031311058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994147959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99686587,0.00064834196,0.00013018158,0.00017373789,0.000032169286,0.0006609603,0.000015140981,0.000036295853,0.0014372945],"genre_scores_gemma":[0.99625826,0.000039458442,0.0031943722,0.00009891453,0.000022482716,0.00015405717,0.00001741049,0.000020590456,0.00019446312],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99899787,0.000022328268,0.00025772981,0.00023361934,0.00024207564,0.0002463751],"domain_scores_gemma":[0.99945647,0.000015452952,0.000084191604,0.000310209,0.000029405177,0.00010425539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008629697,0.00014660764,0.00029125414,0.00009664852,0.000027628352,0.0000061675264,0.00006691392,0.00009842904,0.000028443848],"category_scores_gemma":[0.000023288876,0.00010999113,0.0000927769,0.00013443682,0.000015623425,0.00004526029,0.000046956033,0.000036261816,0.000043495613],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002093483,0.2634354,0.013547065,0.00033016305,0.00008122164,0.0010035598,0.00066869054,0.0000012120844,0.71409255,0.0049465923,0.00006564702,0.0016185557],"study_design_scores_gemma":[0.11976136,0.00047128997,0.020877982,0.000478972,0.000080255864,0.000024372946,0.00008233331,0.0000019460092,0.8567142,0.0012296567,0.00018243336,0.00009517454],"about_ca_topic_score_codex":0.000092008166,"about_ca_topic_score_gemma":0.000021953407,"teacher_disagreement_score":0.2629641,"about_ca_system_score_codex":0.0000837714,"about_ca_system_score_gemma":0.000110717,"threshold_uncertainty_score":0.44853082},"labels":[],"label_agreement":null},{"id":"W2994177727","doi":"10.1182/blood-2019-124596","title":"Effects of Andexanet Alfa on Thrombin Generation in Bleeding Associated with Factor Xa Inhibitors","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Hemostasis; Rivaroxaban; Apixaban; Bolus (digestion); Thrombin; Anesthesia; Internal medicine; Pharmacology; Warfarin; Atrial fibrillation; Platelet","score_opus":0.0276044356218769,"score_gpt":0.2677975906739058,"score_spread":0.2401931550520289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994177727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99819595,0.000037140788,0.0000032956198,0.00012182,0.00011387319,0.00052281516,0.000001159557,0.000022836764,0.0009811296],"genre_scores_gemma":[0.9991582,0.000008890477,0.00004682977,0.0000446305,0.00017334011,0.0000011829222,0.00003475949,0.000010622343,0.0005215134],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99941796,0.000025963634,0.00014666608,0.00011975209,0.0001926138,0.00009703473],"domain_scores_gemma":[0.9996961,0.00009510202,0.000087090644,0.00007441299,0.000023395874,0.00002393109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008418552,0.000078530684,0.00021219603,0.000106701205,0.000011940883,0.000007145494,0.00001981335,0.000055331184,0.00004181313],"category_scores_gemma":[0.00008422449,0.000059147627,0.0000334539,0.00016355365,0.00000811121,0.00005349163,0.000010175884,0.000054892782,0.000012823607],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055974462,0.000066074135,0.8599071,0.00007364548,0.000102208694,0.000006077805,0.0001451287,0.000059938662,0.13920979,0.00013244296,0.000087669716,0.00015393503],"study_design_scores_gemma":[0.007943471,0.0007228366,0.7571544,0.00019735786,0.0001228976,6.151467e-7,0.000024991718,0.0002814998,0.23339401,0.000007540513,0.00006371434,0.00008667014],"about_ca_topic_score_codex":0.000013409915,"about_ca_topic_score_gemma":0.000011915865,"teacher_disagreement_score":0.10275272,"about_ca_system_score_codex":0.000022590357,"about_ca_system_score_gemma":0.000013900223,"threshold_uncertainty_score":0.24119703},"labels":[],"label_agreement":null},{"id":"W2994178787","doi":"10.1182/blood.v108.11.847.847","title":"Aurora Kinases as Therapeutic Targets in Multiple Myeloma.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Aurora inhibitor; Aurora A kinase; Aurora kinase; Cancer research; Bone marrow; Aurora B kinase; Multiple myeloma; Biology; Kinase; Plasma cell; Centrosome; Mitosis; Gene knockdown; Plasma Cell Myeloma; Cytokinesis; Cell cycle; Cell biology; Cell culture; Cell; Immunology; Cell division; Genetics","score_opus":0.006634941425975072,"score_gpt":0.2174251598838858,"score_spread":0.21079021845791074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994178787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99468356,0.0030543813,0.00014976645,0.000041488838,0.00006484477,0.0001373644,0.000011464299,0.000013501001,0.0018435961],"genre_scores_gemma":[0.9981934,0.000101258585,0.00032398404,0.00026060746,0.00015686269,0.000021179269,0.00015734087,0.000019943447,0.00076542015],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993189,0.000028022228,0.00013934405,0.00023822962,0.000059043683,0.00021647535],"domain_scores_gemma":[0.99968505,0.0000069473426,0.00003514548,0.00022198894,0.000022616437,0.00002823603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000051280535,0.00011685764,0.00009590663,0.000035139412,0.00003614095,0.000014518948,0.00012121007,0.00011238373,0.00001989444],"category_scores_gemma":[0.000018962506,0.00011443726,0.00005777993,0.00006249573,0.000032393265,0.0000020317289,0.000048071634,0.00005617268,0.000028580724],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021136466,0.00040488868,0.03539144,0.000007925913,0.000021336778,0.000015489746,0.000011790706,0.000022121047,0.9626141,0.00012632627,0.0004308044,0.0009326353],"study_design_scores_gemma":[0.0017048452,0.00015326383,0.03452497,0.000009111664,0.000024384824,0.000025130841,0.000024760553,0.00003590493,0.9249865,0.0002822797,0.038005028,0.00022386813],"about_ca_topic_score_codex":0.00019042543,"about_ca_topic_score_gemma":0.0007663226,"teacher_disagreement_score":0.037627656,"about_ca_system_score_codex":0.0000049022733,"about_ca_system_score_gemma":0.000035026078,"threshold_uncertainty_score":0.46666157},"labels":[],"label_agreement":null},{"id":"W2994201103","doi":"10.1182/blood.v106.11.3474.3474","title":"Hematologic Profiles in the Phase 3 APEX Trial.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Neutropenia; Adverse effect; Internal medicine; Multiple myeloma; Anemia; Dexamethasone; Bortezomib; Phases of clinical research; Gastroenterology; Placebo; Refractory (planetary science); Clinical trial; Surgery; Toxicity; Pathology","score_opus":0.05441622732473057,"score_gpt":0.37136239892328415,"score_spread":0.3169461715985536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994201103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98880845,0.00048091437,0.0000025832867,0.0022967656,0.000013513607,0.0010812258,0.0000050032772,0.000025611696,0.007285932],"genre_scores_gemma":[0.9983635,0.000038383354,0.00056800497,0.00024926188,0.0001646994,0.00019806817,0.000023439046,0.000005866492,0.00038880977],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992505,0.000064713364,0.00013422385,0.0001276949,0.00021174192,0.0002111756],"domain_scores_gemma":[0.99959207,0.000092229755,0.000021968046,0.00021584445,0.000016294762,0.00006160617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019013438,0.00007291895,0.00014806545,0.000055538418,0.000034760833,0.000012197875,0.00008176987,0.000037516555,0.00018634164],"category_scores_gemma":[0.00018379287,0.000038153332,0.000049258055,0.00012191812,0.000029625604,0.000030780426,0.00001441519,0.00011319071,0.00020714109],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.100880414,0.217671,0.26269302,0.0006656071,0.0015616055,0.0136571005,0.005168821,0.000002731446,0.024402538,0.004574398,0.020017566,0.3487052],"study_design_scores_gemma":[0.89987594,0.004181192,0.02478349,0.00009971232,0.00023150482,0.00066476775,0.00045093606,0.00023796296,0.04764998,0.00024367153,0.021376533,0.0002043226],"about_ca_topic_score_codex":0.000016697875,"about_ca_topic_score_gemma":0.00001618597,"teacher_disagreement_score":0.7989955,"about_ca_system_score_codex":0.00001305827,"about_ca_system_score_gemma":0.000045993183,"threshold_uncertainty_score":0.26624486},"labels":[],"label_agreement":null},{"id":"W2994442551","doi":"10.1182/blood.v112.11.1078.1078","title":"A Novel Strategy for Expanding Primitive Leukemic Cells from Chronic Phase CML Patients by Forced Overexpression of a NUP98-HOXA10 Homeodomain Fusion Gene.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute","funders":"","keywords":"Bone marrow; Haematopoiesis; CD34; Stem cell; Biology; Homeobox; Fusion gene; Leukemia; Immunology; Cancer research; Molecular biology; Gene; Cell biology; Gene expression; Genetics","score_opus":0.024252556526667905,"score_gpt":0.28433722553601887,"score_spread":0.26008466900935096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994442551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935273,0.0008746529,0.0018569359,0.000007674053,0.00010156901,0.0018942808,0.0014455982,0.00006556496,0.00022645775],"genre_scores_gemma":[0.9941224,0.00030713342,0.0030092725,0.000044946002,0.00019552812,0.0001622408,0.0016724452,0.000078619385,0.00040744757],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99780667,0.000036398655,0.0005693194,0.00060603,0.00047394665,0.00050764775],"domain_scores_gemma":[0.99858254,0.00020526854,0.00038342035,0.00047582985,0.00012857535,0.00022438577],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00007603146,0.00036737492,0.00063568534,0.00011860309,0.0001563891,0.0000094904235,0.00015445727,0.00023844441,0.00014204816],"category_scores_gemma":[0.000053879485,0.00032411018,0.00022717143,0.00015153838,0.00009626191,0.0001453417,0.00008925093,0.00018243512,0.000012831445],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007482819,0.0038220657,0.0014618802,0.0001351901,0.00027585423,0.000014940576,0.0005467596,0.000012325928,0.9898342,0.0000035885682,0.0011757248,0.001969215],"study_design_scores_gemma":[0.10467151,0.0028108924,0.0030341009,0.0007050403,0.00041179731,0.000023569068,0.000086655484,0.00064361363,0.8871299,0.000020944351,0.00018974599,0.00027223598],"about_ca_topic_score_codex":0.00032010674,"about_ca_topic_score_gemma":0.000006868289,"teacher_disagreement_score":0.10392323,"about_ca_system_score_codex":0.0011173581,"about_ca_system_score_gemma":0.0007818043,"threshold_uncertainty_score":0.9999211},"labels":[],"label_agreement":null},{"id":"W2994447848","doi":"10.1182/blood.v106.11.2382.2382","title":"A Simple Two-Step Method for the Isolation of Human CD4+CD25+bright / FOXP3+ Regulatory T Cells Directly from Whole Blood.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; Vancouver Coastal Health Research Institute; Vancouver Coastal Health; Stemcell Technologies","funders":"","keywords":"Ficoll; IL-2 receptor; Cell sorting; Immunomagnetic separation; Biology; Molecular biology; FOXP3; Centrifugation; T cell; Differential centrifugation; Antibody; Peripheral blood mononuclear cell; Cell biology; Immune system; Immunology; Flow cytometry; In vitro; Biochemistry","score_opus":0.011150155675776494,"score_gpt":0.2521791336102049,"score_spread":0.2410289779344284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994447848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843722,0.00924572,0.0035999995,0.00028542057,0.0004835849,0.0006504968,0.00024287547,0.00011831329,0.0010014186],"genre_scores_gemma":[0.988859,0.0000457375,0.004511085,0.00021395032,0.00023357708,0.00007649504,0.0002969405,0.000042349922,0.0057208748],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981553,0.00032687857,0.0005516947,0.00045193272,0.00005091035,0.00046326322],"domain_scores_gemma":[0.9980792,0.0007630802,0.00033145846,0.00069557445,0.00010698436,0.000023702336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043434114,0.00027320164,0.00048170725,0.00009427181,0.000416083,0.00001683447,0.0004591488,0.0003700454,0.0006115061],"category_scores_gemma":[0.000033192522,0.00020477793,0.00025813247,0.00012282513,0.0002489738,0.000096062686,0.0001223114,0.0002974081,0.00018738538],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009037764,0.0007708367,0.00037532533,0.000013503308,0.0007877485,0.0000012404411,0.00037340994,0.000018338067,0.9896695,0.0007611852,0.003717035,0.0034214912],"study_design_scores_gemma":[0.005648515,0.00027006998,0.0008527741,0.000016002794,0.000730799,0.000016503904,0.00010508477,0.000059447208,0.8865031,0.0005050993,0.105066985,0.00022563634],"about_ca_topic_score_codex":0.0006627686,"about_ca_topic_score_gemma":0.00040515832,"teacher_disagreement_score":0.103166424,"about_ca_system_score_codex":0.000016183101,"about_ca_system_score_gemma":0.000051689563,"threshold_uncertainty_score":0.8350601},"labels":[],"label_agreement":null},{"id":"W2994451878","doi":"10.1182/blood-2019-131521","title":"Alpha-Dystroglycan Supports Platelet Aggregation and Thrombus Formation","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Blood properties and coagulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; Hospital for Sick Children; St. Michael's Hospital","funders":"","keywords":"Platelet; Integrin; Platelet membrane glycoprotein; Fibronectin; Molecular biology; Von Willebrand factor; Chemistry; Platelet activation; Cell biology; Laminin; Dystrophin; Duchenne muscular dystrophy; Extracellular matrix; Biology; Immunology; Biochemistry; Receptor","score_opus":0.00888047071166133,"score_gpt":0.21466983284764216,"score_spread":0.2057893621359808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994451878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958645,0.00038898722,0.000037336868,0.00041943142,0.00006974239,0.00034674627,0.0000022071895,0.00005086664,0.0028201442],"genre_scores_gemma":[0.99871325,0.000057861183,0.0003188413,0.00020043856,0.00007739878,0.0000056535496,0.00006703935,0.000010981303,0.00054851675],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99945885,0.000010714303,0.00014732711,0.00012459746,0.00013759681,0.00012093414],"domain_scores_gemma":[0.9996981,0.000007874218,0.00005896179,0.00013945512,0.000041960753,0.00005365967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000746109,0.00007612451,0.0001313805,0.0000412139,0.00003705788,0.000020946067,0.000019787552,0.000059613947,0.00015106153],"category_scores_gemma":[0.000008732398,0.00006197741,0.000026057265,0.00005739645,0.000013458591,0.00020723435,0.0000155385,0.000062809806,0.000063075444],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005489909,0.0011047189,0.62301624,0.0012053361,0.00042937294,0.00009024374,0.0034566536,0.000022423596,0.09931102,0.0020099762,0.0021705478,0.2666345],"study_design_scores_gemma":[0.017086847,0.0024329098,0.42044362,0.00050803187,0.000686476,0.0020518035,0.000763106,0.0036147973,0.53739876,0.0007777778,0.013699828,0.00053602795],"about_ca_topic_score_codex":0.000026367301,"about_ca_topic_score_gemma":0.000005333159,"teacher_disagreement_score":0.43808776,"about_ca_system_score_codex":0.000009065,"about_ca_system_score_gemma":0.000020582738,"threshold_uncertainty_score":0.2527365},"labels":[],"label_agreement":null},{"id":"W2994454378","doi":"10.1182/blood.v108.11.812.812","title":"Strong p53 Expression Is an Independent Predictor of Outcome in De Novo Diffuse Large B Cell Lymphoma (DLBCL) Treated with Either CHOP or CHOP-R.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Tissue microarray; CHOP; Rituximab; Lymphoma; Immunohistochemistry; Internal medicine; Population; Oncology; Medicine; clone (Java method); Pathology; Cancer research; Biology","score_opus":0.014465876877807768,"score_gpt":0.2524514469081901,"score_spread":0.23798557003038234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994454378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99770886,0.00025201327,0.000011931162,0.000050109007,0.000022880344,0.00058920536,0.00013283396,0.00006442557,0.0011677438],"genre_scores_gemma":[0.9979396,0.000027845059,0.0005182897,0.00010306807,0.000093057155,0.00012186421,0.00006256202,0.000052738244,0.0010810079],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982826,0.000046939782,0.0004273181,0.00040041187,0.00040235906,0.00044033027],"domain_scores_gemma":[0.99906856,0.00004146953,0.00016158434,0.00048449248,0.000054717413,0.00018919747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010278377,0.00028369224,0.0004843761,0.00015194857,0.000044521083,0.000019642768,0.00011272065,0.00016685031,0.00019268903],"category_scores_gemma":[0.000011043648,0.00017441963,0.000088034096,0.00019096515,0.0000349893,0.00010749918,0.000042782387,0.00007071326,0.000011962543],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054373767,0.05738108,0.93465465,0.00007799571,0.00008121191,0.000628072,0.00042910635,0.0000022796714,0.0058927136,0.000011215917,0.00007499058,0.00022292028],"study_design_scores_gemma":[0.09447419,0.0009983444,0.77156603,0.00019894747,0.0003195324,0.000072049144,0.00019075595,0.00004155522,0.13177824,0.0000027666579,0.0002011082,0.00015647255],"about_ca_topic_score_codex":0.001351177,"about_ca_topic_score_gemma":0.0006726285,"teacher_disagreement_score":0.16308865,"about_ca_system_score_codex":0.00019182528,"about_ca_system_score_gemma":0.0001355285,"threshold_uncertainty_score":0.71126264},"labels":[],"label_agreement":null},{"id":"W2994476126","doi":"10.1182/blood.v112.11.5074.5074","title":"Higher Erythroid Response Rates with Epoetin Alfa Versus Other Agents in Treatment-Naive Low/Int-1 Myelodysplastic Syndrome Patients: A Comparative Meta-Analysis","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Internal medicine; Anemia; Myelodysplastic syndromes; Epoetin alfa; International Prognostic Scoring System; Meta-analysis; Gastroenterology; Oncology","score_opus":0.10796453864746312,"score_gpt":0.3250083296343722,"score_spread":0.21704379098690907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994476126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99633074,0.0010073027,0.0000036970196,0.00056005403,0.00006292348,0.00078722474,0.00009653468,0.0000624662,0.0010890698],"genre_scores_gemma":[0.9928024,0.000119430886,0.0007119328,0.00016763929,0.000026629288,0.00023879421,0.0001368409,0.000045467274,0.0057508596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99762434,0.0003337182,0.0004681319,0.0006455475,0.0004725099,0.00045573912],"domain_scores_gemma":[0.99844474,0.0004808969,0.00020356978,0.00051482284,0.00013270431,0.00022328847],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011702283,0.000506208,0.001586524,0.00038672524,0.00013016444,0.000019930434,0.000096648386,0.00011878044,0.0019505199],"category_scores_gemma":[0.000040922878,0.00031938768,0.00060112803,0.0008762846,0.00024534832,0.000092804934,0.000029675219,0.00015716939,0.00029467858],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032633778,0.033687852,0.4828976,0.00008551859,0.42923245,0.010405549,0.008657656,0.00033238254,0.00032572955,0.000026564634,0.0016763043,0.000038629823],"study_design_scores_gemma":[0.07236069,0.014898009,0.65325063,0.00008469984,0.25087097,0.00023780065,0.0007818114,0.000035782672,0.004608865,0.0000051870225,0.0020824354,0.00078311784],"about_ca_topic_score_codex":0.00031656076,"about_ca_topic_score_gemma":0.00017946077,"teacher_disagreement_score":0.17836146,"about_ca_system_score_codex":0.00024786117,"about_ca_system_score_gemma":0.0001368602,"threshold_uncertainty_score":0.9999258},"labels":[],"label_agreement":null},{"id":"W2994510987","doi":"10.1182/blood.v106.11.3940.3940","title":"Platelet Apoptosis Events Can Be Triggered by Shear Stresses and Chemical Agonists.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Platelet; Apoptosis; Thrombopoiesis; Platelet activation; Chemistry; Cell biology; Programmed cell death; Immunology; Biology; Haematopoiesis; Biochemistry; Stem cell; Megakaryocyte","score_opus":0.01009766994959993,"score_gpt":0.2433214371886463,"score_spread":0.23322376723904636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994510987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948619,0.0014341979,7.5177604e-7,0.002396145,0.000019503672,0.00020588179,0.0001247485,0.000047745434,0.0009091187],"genre_scores_gemma":[0.99782956,0.0004875521,0.00042353937,0.00043200408,0.000055218105,0.000019168341,0.00022137324,0.000020586154,0.00051098625],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991713,0.000010089682,0.00015910337,0.00024313747,0.00016829644,0.00024803318],"domain_scores_gemma":[0.9995887,0.000024359522,0.000037748698,0.00015294421,0.000018852998,0.00017736071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000028465005,0.0001539614,0.00030124054,0.00003484635,0.000053397962,0.000013719563,0.000046039473,0.0000984155,0.000096395575],"category_scores_gemma":[0.000025011903,0.00012923623,0.000050418366,0.000071944545,0.000037461967,0.00004140783,0.000024251918,0.00009639198,0.000014645251],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019253156,0.04089688,0.15019378,0.00083043147,0.007848998,0.0013541506,0.0029312875,0.0000031962275,0.4356505,0.0001600291,0.11718266,0.24102277],"study_design_scores_gemma":[0.025148576,0.00041697288,0.0032162697,0.000109454486,0.00079100434,0.00037235313,0.0001156671,0.00001993373,0.935874,0.00008356213,0.033484742,0.0003674703],"about_ca_topic_score_codex":0.00009930624,"about_ca_topic_score_gemma":0.000012308374,"teacher_disagreement_score":0.5002235,"about_ca_system_score_codex":0.000019329416,"about_ca_system_score_gemma":0.000034948076,"threshold_uncertainty_score":0.52701},"labels":[],"label_agreement":null},{"id":"W2994524883","doi":"10.1182/blood.v110.11.1595.1595","title":"The Oral Off-Patent Antimicrobial Clioquinol Inhibits the Proteasome and Induces Cell Death in AML and Myeloma Cells through a Copper-Dependent Mechanism.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Proteasome; Clioquinol; Chemistry; Bortezomib; Multiple myeloma; Myeloid leukemia; Proteasome inhibitor; Cancer research; Pharmacology; Biology; Biochemistry; Immunology","score_opus":0.02108747407027793,"score_gpt":0.23554373209943463,"score_spread":0.2144562580291567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994524883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958527,0.002138387,0.00004181146,0.00021127924,0.00009415005,0.00086396275,0.000024066563,0.000012302383,0.000761327],"genre_scores_gemma":[0.9975181,0.0013564291,0.0003885294,0.00036133203,0.00013262953,0.000044629134,0.000010318816,0.000024172457,0.00016384435],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986572,0.00011624429,0.0002631225,0.00038731517,0.00014943855,0.0004266449],"domain_scores_gemma":[0.99947435,0.00003116199,0.0001040413,0.0002755701,0.00004198718,0.0000728761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066380866,0.0002128613,0.00015690547,0.0000282152,0.00024929008,0.000092069575,0.0002084706,0.00019446216,0.000002833753],"category_scores_gemma":[0.000023425067,0.00013525042,0.000046059344,0.00008050514,0.0001258621,0.000008293202,0.00028531125,0.00020910779,0.000004922347],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009449816,0.00015788348,0.0012836771,0.000027499493,0.000025865418,0.000017241662,0.00030962413,5.1122475e-7,0.9962761,0.000289135,0.000050049595,0.0014679092],"study_design_scores_gemma":[0.0016166838,0.0003343572,0.0015877555,0.000027813598,0.000027219417,0.000079081736,0.00026123878,0.0000030605856,0.9937392,0.00026342538,0.0018609677,0.0001991998],"about_ca_topic_score_codex":0.00006916575,"about_ca_topic_score_gemma":0.00020402206,"teacher_disagreement_score":0.0025369092,"about_ca_system_score_codex":0.000008510926,"about_ca_system_score_gemma":0.000054726046,"threshold_uncertainty_score":0.5515352},"labels":[],"label_agreement":null},{"id":"W2994600119","doi":"10.1182/blood.v108.11.1151.1151","title":"Macrophage-Stimulating Protein Stimulates Erythropoietin Receptor Phosphorylation To Promote Enhanced Erk1/2 and Akt Activation in a Gab2-Dependent Pathway.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Phosphorylation; Tyrosine phosphorylation; Receptor tyrosine kinase; Signal transduction; Protein kinase B; Biology; Erythropoietin; Cell biology; Kinase; Autophosphorylation; Cancer research; Tyrosine kinase; Molecular biology; Protein kinase A; Endocrinology","score_opus":0.009634697270871358,"score_gpt":0.2623673144434139,"score_spread":0.25273261717254253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994600119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954392,0.00014695384,0.00082352216,0.00033742416,0.000031615906,0.0024833381,0.000006784626,0.00010088922,0.0006303274],"genre_scores_gemma":[0.9905702,0.0000044050503,0.007650569,0.000044300345,0.00018640055,0.00019181862,0.0000520198,0.00005331854,0.0012469613],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978368,0.000071337774,0.00047301926,0.00055878895,0.00057394075,0.0004860582],"domain_scores_gemma":[0.9991739,0.000093913986,0.00011031414,0.0003195756,0.00014648969,0.00015583888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004397891,0.00023307306,0.00032646648,0.0002067462,0.00009501393,0.000057416557,0.00008477972,0.00017259162,0.00015213688],"category_scores_gemma":[0.00047394636,0.00022159729,0.000043760312,0.00045736777,0.000052805488,0.0001379626,0.00010659852,0.00027884386,0.000070821734],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004599389,0.00072499015,0.00079535786,0.00023521578,0.00002708373,0.000048057245,0.0005905357,0.0006968232,0.9830822,0.000034318233,0.000030341256,0.013275169],"study_design_scores_gemma":[0.023147902,0.00051672134,0.0036594875,0.0006718685,0.000026126807,0.00002123129,0.00008198967,0.007635225,0.9637217,0.0001668717,0.0001106489,0.00024024717],"about_ca_topic_score_codex":0.0013992077,"about_ca_topic_score_gemma":0.00009044587,"teacher_disagreement_score":0.022687962,"about_ca_system_score_codex":0.0022047325,"about_ca_system_score_gemma":0.0009157544,"threshold_uncertainty_score":0.90364754},"labels":[],"label_agreement":null},{"id":"W2994880414","doi":"10.1182/blood.2019002697","title":"Impact of NPM1/FLT3-ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemia","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":193,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Daiichi Sankyo Europe; National Cancer Institute; Genentech; Servier; Astellas Pharma; National Institutes of Health; Argenx; Incyte; MacroGenics; BeiGene; Deutsche Forschungsgemeinschaft; Agios Pharmaceuticals; Celgene; Daiichi-Sankyo; Teva Pharmaceutical Industries; Jazz Pharmaceuticals; Pfizer; Amgen","keywords":"Medicine; NPM1; Internal medicine; Oncology; Midostaurin; Myeloid leukemia; Transplantation; White blood cell; Leukemia; Hazard ratio; Confidence interval; Biology","score_opus":0.007989854079912853,"score_gpt":0.2483052702837311,"score_spread":0.24031541620381824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994880414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847838,0.00024264636,0.0000054942075,0.00012175553,0.000040657036,0.0010249912,0.00012933179,0.000045126748,0.013606145],"genre_scores_gemma":[0.99710256,0.00008389982,0.00030308252,0.00013459285,0.000069367954,0.000013470689,0.00026705553,0.000087424836,0.001938543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976108,0.0001952699,0.00042313972,0.00045188915,0.00068328745,0.0006355957],"domain_scores_gemma":[0.99821895,0.00014032639,0.00020468568,0.0010360436,0.00020121998,0.00019874163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046320038,0.00032344347,0.00055359985,0.00018628317,0.0000607965,0.000030416028,0.00051628303,0.00012186206,0.00022457377],"category_scores_gemma":[0.000104438535,0.00018705391,0.00014572039,0.00046647864,0.00016945263,0.00013554894,0.00018841635,0.00064476934,0.00044892007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015362098,0.0007166455,0.9658699,0.00007575791,0.00088162266,0.0001317654,0.0004508664,0.000039969298,0.016257893,0.00001956862,0.01240597,0.0016138456],"study_design_scores_gemma":[0.017707674,0.002418945,0.97546875,0.00011533412,0.0002700898,0.00007181557,0.000039219478,0.00006582946,0.0027690197,0.000007994317,0.0008176449,0.00024767904],"about_ca_topic_score_codex":0.0009058695,"about_ca_topic_score_gemma":0.000030572068,"teacher_disagreement_score":0.016171463,"about_ca_system_score_codex":0.00063485286,"about_ca_system_score_gemma":0.0010327719,"threshold_uncertainty_score":0.7627837},"labels":[],"label_agreement":null},{"id":"W2994947009","doi":"10.1182/blood-2019-129087","title":"Validation of the Ottawa Score in Cancer Patients with Venous Thromboembolism. the Predicare Cohort Study","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pulmonary embolism; Internal medicine; Cancer; Low molecular weight heparin; Clinical endpoint; Cohort; Surgery; Deep vein; Asymptomatic; Thrombosis; Clinical trial","score_opus":0.007953915832599648,"score_gpt":0.23824336319531855,"score_spread":0.2302894473627189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994947009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933917,0.00010223053,4.223511e-7,0.00025269896,0.00020208288,0.004139509,0.000014124828,0.000016444725,0.0018808098],"genre_scores_gemma":[0.99936724,0.000027834245,0.0000066063044,0.00021375387,0.00005067065,0.00022363671,0.000013157062,0.00002171465,0.00007538899],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986827,0.00007576168,0.00025162916,0.000239413,0.000564486,0.00018601767],"domain_scores_gemma":[0.999102,0.000031254196,0.00015448514,0.00056012714,0.00011978068,0.00003236659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023872031,0.0001281902,0.00041462667,0.000048700855,0.000057072855,0.000011944553,0.00020573415,0.00003943233,0.00012296901],"category_scores_gemma":[0.000026809836,0.000063264204,0.000050297975,0.00028531582,0.000051028994,0.00005055517,0.000093056355,0.00014419884,0.000008505604],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001693019,0.007266675,0.9900221,0.00007842032,0.00033031596,0.0000018273197,0.0016213685,0.00007948912,0.000045842822,0.000046111923,0.00028914813,0.0002017372],"study_design_scores_gemma":[0.003554494,0.0009533068,0.9928035,0.00023282955,0.00078725937,6.0836146e-7,0.00052163826,0.0000040604027,0.0009150824,0.000011069882,0.0001401653,0.000075976364],"about_ca_topic_score_codex":0.00094442425,"about_ca_topic_score_gemma":0.00036076843,"teacher_disagreement_score":0.006313368,"about_ca_system_score_codex":0.000039784092,"about_ca_system_score_gemma":0.00008649595,"threshold_uncertainty_score":0.25798392},"labels":[],"label_agreement":null},{"id":"W2995207676","doi":"10.1182/blood.2019002320","title":"Lack of the multidrug transporter MRP4/ABCC4 defines the PEL-negative blood group and impairs platelet aggregation","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Héma-Québec","funders":"Institut National de la Transfusion Sanguine; Agence Nationale de la Recherche","keywords":"Transporter; ATP-binding cassette transporter; Pharmacology; Platelet aggregation; Medicine; Platelet; Internal medicine; Biology; Genetics; Gene","score_opus":0.011229439365626937,"score_gpt":0.22465540536446904,"score_spread":0.21342596599884212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995207676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964282,0.00046866626,0.000030381843,0.0007986465,0.00016325322,0.000899171,0.000035585315,0.00003406187,0.001142025],"genre_scores_gemma":[0.99799573,0.00013884179,0.00040772048,0.00021597401,0.00007096953,0.000018628085,0.000019107745,0.00002613013,0.0011069174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988889,0.000036044952,0.00030832144,0.00024613165,0.00030877133,0.00021183571],"domain_scores_gemma":[0.99927765,0.000077465025,0.0001515764,0.0003745938,0.000058835347,0.00005990075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021780899,0.00018486584,0.00032242533,0.000041608047,0.00008437778,0.000010538439,0.00012858267,0.00010071463,0.000081348735],"category_scores_gemma":[0.000014322227,0.00009232469,0.00016506831,0.00017733351,0.00014845275,0.00007263741,0.000013679548,0.00020083973,0.00000901037],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010473388,0.003214203,0.75342226,0.0017543142,0.0016591905,0.00013146175,0.017566312,0.000025173747,0.20870942,0.0068330127,0.000162141,0.0054751635],"study_design_scores_gemma":[0.014386218,0.00045725805,0.6121103,0.0007062609,0.001561946,0.000120363635,0.0017668786,0.00008087119,0.3663047,0.0012313194,0.00096081453,0.0003130767],"about_ca_topic_score_codex":0.000063674095,"about_ca_topic_score_gemma":0.00018202426,"teacher_disagreement_score":0.15759529,"about_ca_system_score_codex":0.0000053206472,"about_ca_system_score_gemma":0.000038260114,"threshold_uncertainty_score":0.37648916},"labels":[],"label_agreement":null},{"id":"W2995855860","doi":"10.1182/blood-2019-127286","title":"Cost-Utility Analysis of Apixaban Compared to Usual Care for the Primary Thromboprophylaxis of Ambulatory Cancer Patients Initiating Chemotherapy","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Apixaban; Ambulatory; Hazard ratio; Population; Quality-adjusted life year; Internal medicine; Intensive care medicine; Absolute risk reduction; Pulmonary embolism; Cancer; Confidence interval; Surgery; Cost effectiveness; Warfarin","score_opus":0.02431862696952562,"score_gpt":0.3031005341326384,"score_spread":0.27878190716311274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995855860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99610054,0.00047907847,0.00006283307,0.000072171926,0.00011210176,0.0023549877,0.00021599802,0.000014428847,0.0005878571],"genre_scores_gemma":[0.998643,0.00005762007,0.00030357012,0.000669311,0.00003853041,0.00015322088,0.00010170333,0.000019060488,0.000013991403],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988471,0.000024003355,0.00037443457,0.00024666285,0.00031951012,0.00018826434],"domain_scores_gemma":[0.99883443,0.00011466213,0.00021225835,0.00043581877,0.00034399566,0.00005883754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001514128,0.00013099547,0.00078678667,0.00013600473,0.000051171643,0.0000061690926,0.00014110311,0.000045832538,0.00017282167],"category_scores_gemma":[0.000031374773,0.00009571542,0.00024687592,0.00042524494,0.00004349941,0.00003084775,0.000061242514,0.00005953456,0.000001772753],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001456115,0.0022566093,0.97276866,0.0009063479,0.0044838255,2.5904967e-7,0.0059668208,0.00021064335,0.0027350844,0.000029675704,0.0002658215,0.010230647],"study_design_scores_gemma":[0.0030549779,0.00050709717,0.98163724,0.00008596056,0.0028030067,3.935421e-8,0.0009586789,0.00020895846,0.010141325,0.0000027250464,0.0005064594,0.000093546725],"about_ca_topic_score_codex":0.00053243164,"about_ca_topic_score_gemma":0.00014708718,"teacher_disagreement_score":0.010137101,"about_ca_system_score_codex":0.000052616273,"about_ca_system_score_gemma":0.000071027265,"threshold_uncertainty_score":0.39031616},"labels":[],"label_agreement":null},{"id":"W2996535411","doi":"10.1182/blood-2019-125292","title":"Predictors of Bleeding in the Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Dabigatran; Rivaroxaban; Apixaban; Perioperative; Atrial fibrillation; Logistic regression; Anticoagulant; Warfarin; Surgery; Internal medicine; Anesthesia","score_opus":0.15023587217331755,"score_gpt":0.36537672540254357,"score_spread":0.21514085322922602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996535411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99659514,0.000035998815,0.000012354042,0.0003080766,0.00017080917,0.002666944,0.0000026598366,0.000009889179,0.00019814093],"genre_scores_gemma":[0.9994995,0.000008243037,0.00005379834,0.000036806145,0.00017728338,0.000014247422,0.000017884191,0.0000070313463,0.00018523601],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991715,0.00008374691,0.00023923739,0.00011549246,0.00030275623,0.000087247885],"domain_scores_gemma":[0.9991854,0.00048058282,0.000076027645,0.00014601875,0.00009951328,0.0000124719145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011841872,0.000063917316,0.00022380048,0.000109004504,0.0000239407,0.000017745695,0.000035115856,0.000022933798,0.00003352911],"category_scores_gemma":[0.0004162929,0.00004017024,0.00006908574,0.00015626376,0.000010044845,0.000102972925,0.000013762459,0.000033015654,0.0000036046738],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007847123,0.00009495393,0.9959964,0.000035457022,0.00011695477,0.000001092067,0.0019899905,0.000031429696,0.0013965097,0.00008884074,0.00006258554,0.00010727425],"study_design_scores_gemma":[0.0035837675,0.00027935606,0.9916467,0.000033080043,0.00049902167,0.0000010370458,0.0025367013,0.00046943224,0.0005347647,0.000005076502,0.00036502542,0.00004604457],"about_ca_topic_score_codex":0.000030083369,"about_ca_topic_score_gemma":0.000016161292,"teacher_disagreement_score":0.0043497477,"about_ca_system_score_codex":0.000010823777,"about_ca_system_score_gemma":0.00003874843,"threshold_uncertainty_score":0.16380948},"labels":[],"label_agreement":null},{"id":"W2997516778","doi":"10.1182/blood-2019-125352","title":"Characterization of the Severe Phenotype of Pyruvate Kinase Deficiency","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; McMaster Children's Hospital; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; University Health Network","funders":"","keywords":"Medicine; Splenectomy; Pyruvate kinase deficiency; Anemia; Internal medicine; Blood transfusion; Hemolytic anemia; Gastroenterology; Pediatrics; Immunology; Pyruvate kinase; Spleen","score_opus":0.009367435623021565,"score_gpt":0.2134937872027081,"score_spread":0.20412635157968653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2997516778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99577165,0.000029026054,0.000010869774,0.00008455502,0.00021449811,0.0001547262,0.000008306126,0.000009010144,0.003717375],"genre_scores_gemma":[0.99881154,0.0000154538,0.000035155565,0.00018970594,0.000033070046,0.0000013638108,0.000015531034,0.0000051995758,0.0008929555],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9996447,0.000019700643,0.00012073625,0.00007577749,0.00008020581,0.000058868645],"domain_scores_gemma":[0.99961144,0.000011488567,0.000093623676,0.00020335004,0.00006504321,0.0000150281785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000037924652,0.00004206914,0.00012225029,0.000022287824,0.000011658652,6.3676276e-7,0.000041105734,0.000039944047,0.00027636107],"category_scores_gemma":[0.000023545392,0.000027007292,0.00004575072,0.00012497218,0.000028135139,0.000017588438,0.000019240886,0.000047956688,0.000037817732],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004925375,0.00020175117,0.03892728,0.000101948695,0.000009333569,3.4750124e-7,0.00010970568,0.0000013154676,0.9600033,0.0003375613,0.000008667972,0.00024953537],"study_design_scores_gemma":[0.0015036633,0.00030210774,0.57988995,0.00006248434,0.00007497585,0.0000067804453,0.000031364074,0.000017721917,0.4174423,0.000045079098,0.0005827665,0.0000408365],"about_ca_topic_score_codex":0.000005637576,"about_ca_topic_score_gemma":6.5925246e-7,"teacher_disagreement_score":0.542561,"about_ca_system_score_codex":0.0000028020002,"about_ca_system_score_gemma":0.000039801977,"threshold_uncertainty_score":0.30259597},"labels":[],"label_agreement":null},{"id":"W2997716483","doi":"10.1182/blood-2019-125128","title":"Optimizing Hydroxyurea Dosing in Sickle Cell Anemia: The Uganda MTD Study","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Dosing; Fetal hemoglobin; Anemia; Adverse effect; Clinical trial; Sickle cell anemia; Malaria; Regimen; Hydroxycarbamide; Randomization; Internal medicine; Pediatrics; Chemotherapy; Pregnancy; Disease; Immunology; Fetus","score_opus":0.006402008366457667,"score_gpt":0.22269169967933763,"score_spread":0.21628969131287998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2997716483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96933824,0.0012682528,0.000004058496,0.00044440417,0.00013095576,0.00073876977,7.480654e-7,0.00004305934,0.028031515],"genre_scores_gemma":[0.9984308,0.0000910752,0.00012084952,0.000281751,0.00004812357,0.000009095802,0.0000034385644,0.000022181719,0.000992718],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990525,0.00004380205,0.00022894195,0.00021678508,0.00019296532,0.0002649532],"domain_scores_gemma":[0.99948615,0.000051592182,0.000052237294,0.00032968717,0.000020986881,0.000059345744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026408554,0.0001265905,0.00022051454,0.00006397065,0.00006713531,0.000021683913,0.000101774196,0.000107292064,0.000094809766],"category_scores_gemma":[0.000021751139,0.00007954499,0.0000576835,0.000245726,0.00002748977,0.00004242461,0.000053231888,0.00041027987,0.00013163996],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023746018,0.008891127,0.9214103,0.00033235986,0.0002054696,0.00071182253,0.02324051,0.0029811948,0.03835315,0.000046333465,0.0009802494,0.002610015],"study_design_scores_gemma":[0.25918365,0.013191637,0.34241417,0.0027745801,0.005605828,0.0009986679,0.23505485,0.0103117,0.08963855,0.00034071013,0.036760215,0.0037254326],"about_ca_topic_score_codex":0.00013216815,"about_ca_topic_score_gemma":0.000017197746,"teacher_disagreement_score":0.5789961,"about_ca_system_score_codex":0.000021279326,"about_ca_system_score_gemma":0.00006124661,"threshold_uncertainty_score":0.32437506},"labels":[],"label_agreement":null},{"id":"W2998292493","doi":"10.1182/blood-2019-123355","title":"Double-Blind, Randomized Study of Canakinumab Treatment in Pediatric and Young Adult Patients with Sickle Cell Anemia","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Medicine; Canakinumab; Acute chest syndrome; Gastroenterology; Fetal hemoglobin; Internal medicine; Sickle cell anemia; Inflammation; Immunology; Anakinra; Disease","score_opus":0.004733887956480095,"score_gpt":0.21103376991868966,"score_spread":0.20629988196220958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998292493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936693,0.00040224523,2.318951e-7,0.00001891292,0.000055610122,0.0031628415,0.000003204032,0.0000129754,0.002674717],"genre_scores_gemma":[0.9992597,0.0002453653,0.00002695669,0.000012795139,0.000015761458,0.000056871337,0.000016507336,0.000016884791,0.0003491742],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99907136,0.000045006524,0.00028287986,0.00022144997,0.00020459323,0.00017472562],"domain_scores_gemma":[0.9994995,0.000037285416,0.00011220491,0.00019327331,0.00008226035,0.00007545832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000081561535,0.000149816,0.0005354895,0.00013789149,0.0000194762,0.000005654626,0.00003413197,0.00007870277,0.000022180464],"category_scores_gemma":[0.000009199132,0.00009164278,0.000041147217,0.00021656079,0.000024097437,0.000030122794,0.00001578371,0.000099685996,0.00000630678],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.071871206,0.006276513,0.9185393,0.00011461667,0.00009534729,0.00002632305,0.0029342729,0.000014022138,0.000012572,0.0000030881981,0.0000059104023,0.000106859145],"study_design_scores_gemma":[0.9173664,0.0027571856,0.076833636,0.00003084877,0.0010569294,0.0000044728927,0.0016591104,0.000014718051,0.00016261116,0.0000013280966,0.0000034269099,0.00010932823],"about_ca_topic_score_codex":0.005141948,"about_ca_topic_score_gemma":0.0012585055,"teacher_disagreement_score":0.8454952,"about_ca_system_score_codex":0.00002759949,"about_ca_system_score_gemma":0.00008974134,"threshold_uncertainty_score":0.7773121},"labels":[],"label_agreement":null},{"id":"W2998426349","doi":"10.1182/blood-2019-129251","title":"Effects of Hydroxyurea Treatment on Malaria Infections in Sub-Saharan Africa","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"Malaria; Medicine; Mean corpuscular volume; Anemia; Rate ratio; Confidence interval; Internal medicine; Pediatrics; Incidence (geometry); Clinical trial; Immunology; Hemoglobin","score_opus":0.00492414486345882,"score_gpt":0.2106218118723559,"score_spread":0.20569766700889708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998426349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97812784,0.0014627805,0.0000013773234,0.00020718666,0.000113778,0.0006427167,0.0000026034372,0.000029386274,0.019412339],"genre_scores_gemma":[0.9983418,0.0009683683,0.000018578792,0.0000364153,0.00001861781,0.000027039865,0.000007116931,0.000012882914,0.000569211],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99943405,0.000025881123,0.00014296455,0.00014157096,0.00009713195,0.00015842722],"domain_scores_gemma":[0.9996509,0.00007163043,0.00003422744,0.00017297974,0.000013606743,0.000056667694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003925861,0.00010234449,0.00022976857,0.00012916236,0.000015667996,0.0000026635046,0.000024912337,0.00011464932,0.000044316603],"category_scores_gemma":[0.000029649906,0.000074865704,0.00008425787,0.00020029984,0.000017880733,0.000017105789,0.000008011826,0.00010966551,0.00018269655],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007047219,0.044732824,0.3111451,0.001431705,0.0014037888,0.000593553,0.0022006587,0.00031400635,0.62272626,0.0015052236,0.0017318799,0.011510272],"study_design_scores_gemma":[0.075999886,0.019698497,0.41414297,0.0019471189,0.0016793184,0.00014463405,0.0001205889,0.000267572,0.44505486,0.0002670028,0.04007827,0.00059929263],"about_ca_topic_score_codex":0.00008391664,"about_ca_topic_score_gemma":0.0000085309475,"teacher_disagreement_score":0.1776714,"about_ca_system_score_codex":0.00003179016,"about_ca_system_score_gemma":0.000042999633,"threshold_uncertainty_score":0.30529347},"labels":[],"label_agreement":null},{"id":"W2998554333","doi":"10.1182/blood-2019-129937","title":"Splenomegaly in Children with Sickle Cell Anemia Receiving Hydroxyurea in Sub-Saharan Africa","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"Medicine; Splenectomy; Malaria; Fetal hemoglobin; Sickle cell anemia; Anemia; Thalassemia; Pediatrics; Spleen; Alpha-thalassemia; Sepsis; Internal medicine; Immunology; Disease; Pregnancy; Genotype","score_opus":0.0037155874635277533,"score_gpt":0.1827981875596651,"score_spread":0.17908260009613733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998554333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96288127,0.00315025,0.0000010372538,0.00021386633,0.000030228632,0.0006038724,0.0000039883207,0.000043878772,0.0330716],"genre_scores_gemma":[0.9983778,0.00063917076,0.000119501754,0.000109881206,0.000030191026,0.0000116858255,0.000025975967,0.000033497294,0.00065229303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886715,0.000029244493,0.00023713522,0.00030633216,0.00017801198,0.0003821033],"domain_scores_gemma":[0.9995127,0.000022831638,0.00005573715,0.0002951985,0.0000168962,0.00009667895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015446695,0.00016618251,0.00030799792,0.00019585944,0.000020781803,0.000012220479,0.00009329096,0.00016207327,0.00011029671],"category_scores_gemma":[0.000015295971,0.00013061217,0.0000447264,0.00046704724,0.000031553765,0.0000674717,0.000028019509,0.00041734258,0.00020941108],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000086630695,0.0009433249,0.9868204,0.00008233687,0.00003688525,0.00008016366,0.0005836448,0.0001255699,0.010257771,0.000004083102,0.0004004898,0.00057872356],"study_design_scores_gemma":[0.021266645,0.00087537133,0.96524775,0.000608631,0.0001795106,0.0001695373,0.000264406,0.00013317783,0.008091119,0.00003083915,0.0026639854,0.0004690083],"about_ca_topic_score_codex":0.00020321779,"about_ca_topic_score_gemma":0.000082806764,"teacher_disagreement_score":0.035496525,"about_ca_system_score_codex":0.000036712074,"about_ca_system_score_gemma":0.00009515237,"threshold_uncertainty_score":0.53262097},"labels":[],"label_agreement":null},{"id":"W2998721977","doi":"10.1182/blood-2019-126071","title":"Pilot Study on Frailty and Functionality on Routine Clinical Assessment in Allogeneichematopoietic Cell Transplantation to Predict Outcomes","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Frailty in Older Adults","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Transplantation; Activities of daily living; Physical therapy; Test (biology); Internal medicine","score_opus":0.05941892035920098,"score_gpt":0.3633268309872777,"score_spread":0.3039079106280767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998721977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938884,0.000010789463,0.000039492195,0.0013862988,0.00027158437,0.001615958,0.000025785077,0.000049391332,0.0027123068],"genre_scores_gemma":[0.9976344,0.000010142709,0.00034616527,0.0011423738,0.00006771183,0.00006093219,0.00003873244,0.000019681049,0.0006798717],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982442,0.00015114214,0.0004851486,0.00046899397,0.0004588705,0.00019161559],"domain_scores_gemma":[0.99894655,0.00042094936,0.000064598215,0.00037631384,0.00004018596,0.00015141179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006358127,0.0001784293,0.00040227323,0.00009537638,0.000023878103,0.00001207949,0.00007018235,0.00005303467,0.000091600414],"category_scores_gemma":[0.000093639945,0.00014411767,0.00004962928,0.000110411056,0.000019641257,0.00003242089,0.00002362937,0.00033687658,0.00010984758],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005533469,0.01132696,0.9863447,0.00009877873,0.00008704538,0.000041721312,0.00028236193,0.000021903026,0.00094360556,0.00003590745,0.00010127021,0.00016242402],"study_design_scores_gemma":[0.017013062,0.015399297,0.96611965,0.00012107565,0.00018980927,0.000011028328,0.00018041203,0.000017209804,0.00076511694,0.000020021902,0.000037131536,0.0001261975],"about_ca_topic_score_codex":0.00007134027,"about_ca_topic_score_gemma":0.00012000295,"teacher_disagreement_score":0.020225037,"about_ca_system_score_codex":0.00004027785,"about_ca_system_score_gemma":0.00006481677,"threshold_uncertainty_score":0.5876948},"labels":[],"label_agreement":null},{"id":"W2999034462","doi":"10.1182/blood.2019002364","title":"Long-term treatment of venous thromboembolism","year":2020,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Contraindication; Pulmonary embolism; Compression stockings; Concomitant; Thrombosis; Low molecular weight heparin; Surgery; Deep vein; Venous thrombosis; Internal medicine","score_opus":0.053591192113788794,"score_gpt":0.33942825086814854,"score_spread":0.2858370587543597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999034462","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00037181657,0.992671,0.0000038499215,0.000059725546,0.00027810576,0.0023962844,0.00007176736,0.000100827376,0.0040465966],"genre_scores_gemma":[0.00018891998,0.99796075,0.0001396445,0.000065339074,0.00071370124,0.0002808029,0.0002813038,0.00012409396,0.00024545172],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99784535,0.00006737,0.0007840382,0.0005827158,0.0003415483,0.00037896153],"domain_scores_gemma":[0.9984181,0.000065165084,0.00043811343,0.0007770751,0.0000517718,0.00024979937],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00005790745,0.00060149666,0.005904141,0.00019374253,0.00004904665,0.000019568794,0.00021276339,0.00028099853,0.00027526633],"category_scores_gemma":[0.000021250471,0.0004418778,0.0011772813,0.00029864648,0.00007174232,0.000027612508,0.00009774611,0.00016061874,0.0003039857],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000450855,0.011092063,0.000055102453,0.030329619,0.004524142,0.00087728543,0.00021759555,3.045129e-8,0.0000014659024,0.00021044348,0.00038089097,0.95230687],"study_design_scores_gemma":[0.0017961663,0.002983271,0.0014422231,0.010787895,0.034577098,0.00020344976,0.000007859282,9.607121e-8,0.000033811375,0.000008885641,0.9478171,0.00034216495],"about_ca_topic_score_codex":0.00003451275,"about_ca_topic_score_gemma":0.0000049337405,"teacher_disagreement_score":0.9519647,"about_ca_system_score_codex":0.00012671945,"about_ca_system_score_gemma":0.00037830404,"threshold_uncertainty_score":0.9998033},"labels":[],"label_agreement":null},{"id":"W2999263652","doi":"10.1182/blood.2019002783","title":"Acetylsalicylic acid inhibits intravascular coagulation during Staphylococcus aureus–induced sepsis in mice","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Natural Sciences and Engineering Research Council of Canada; Cumming School of Medicine, University of Calgary; Heart and Stroke Foundation of Canada; University of Calgary; Alberta Innovates; Canadian Liver Foundation; Canada Research Chairs","keywords":"Disseminated intravascular coagulation; Staphylococcus aureus; Sepsis; Spleen; Neutrophil extracellular traps; Platelet; Coagulation; Immune system; Medicine; Thromboplastin; Coagulopathy; Immunology; Pharmacology; Inflammation; Platelet activation; Staphylococcal infections; Biology; Internal medicine","score_opus":0.018231998598912478,"score_gpt":0.22245297371172001,"score_spread":0.20422097511280754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999263652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972958,0.0009876544,0.00006883417,0.0008089641,0.00013350035,0.00040739347,0.000023715616,0.00012552126,0.00014863149],"genre_scores_gemma":[0.9989568,0.000050365896,0.0001061012,0.0005914063,0.00009302311,0.000040017272,0.00007913061,0.000033997683,0.000049169867],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99839973,0.00024122559,0.00035899083,0.0005027064,0.000060151768,0.00043718106],"domain_scores_gemma":[0.99951786,0.000030944706,0.000108065884,0.00023318823,0.000053469736,0.000056474557],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013263074,0.0002612073,0.00037122486,0.00014029189,0.00013177442,0.000021087462,0.00023485329,0.00027479965,0.00024307349],"category_scores_gemma":[0.00007550656,0.00025683222,0.000108361135,0.00040578147,0.000049652095,0.00016141849,0.00013762184,0.00040939226,0.0005242274],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007883183,0.0001943754,0.0009596156,0.000036610916,0.00017106833,0.000034214732,0.0011189007,0.000010191634,0.99675167,0.00024739615,0.000046735044,0.0003504124],"study_design_scores_gemma":[0.0044589094,0.0001978696,0.009398394,0.000040954892,0.00007470726,0.00001102221,0.00026128304,0.0000033350354,0.9846977,0.000057547277,0.0005134092,0.0002848592],"about_ca_topic_score_codex":0.000046813602,"about_ca_topic_score_gemma":0.00003634258,"teacher_disagreement_score":0.012053939,"about_ca_system_score_codex":0.00002904471,"about_ca_system_score_gemma":0.000042671665,"threshold_uncertainty_score":0.9999884},"labels":[],"label_agreement":null},{"id":"W2999942872","doi":"10.1182/blood-2019-128712","title":"The AHI-1-BCR-ABL-DNM2 Complex Mediates Mitochondrial Dynamics in Drug-Resistant BCR-ABL+ Cells","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; Kinexus Bioinformatics Corporation (Canada); University of British Columbia","funders":"","keywords":"Tyrosine kinase; Protein kinase domain; SH3 domain; Biology; ABL; Ponatinib; Cancer research; Philadelphia chromosome; Cell biology; Kinase; Chemistry; Signal transduction; Nilotinib; Mutant; Biochemistry; Chromosomal translocation","score_opus":0.008218869422463049,"score_gpt":0.232257251863164,"score_spread":0.22403838244070096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999942872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9806164,0.00089763175,0.0000032472865,0.0009332087,0.0010184963,0.0014127818,0.000085094805,0.00010352822,0.014929602],"genre_scores_gemma":[0.9868657,0.00033458293,0.00096682645,0.00024844444,0.0005240946,0.00008379963,0.00025933687,0.00008350001,0.010633745],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99740344,0.00011750202,0.00059076934,0.0005479691,0.0006133536,0.0007269674],"domain_scores_gemma":[0.99800605,0.0005570102,0.00018546656,0.0009608032,0.00007827395,0.00021242292],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024622862,0.00036530333,0.00058734824,0.00012017874,0.00013134487,0.000059768037,0.00036250465,0.0001729851,0.0003955007],"category_scores_gemma":[0.00011783123,0.00025863462,0.00017808942,0.0003177596,0.00014133261,0.00007914813,0.00014363401,0.00041638123,0.0007980102],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064899297,0.014287518,0.24991882,0.0018030355,0.004257888,0.002904005,0.0065211053,0.00022318326,0.6212749,0.010994436,0.06974303,0.011582147],"study_design_scores_gemma":[0.28204918,0.0041184006,0.16244222,0.0025037182,0.004340408,0.0005358178,0.010015242,0.023311527,0.20164795,0.0024568222,0.30238524,0.004193459],"about_ca_topic_score_codex":0.0009491081,"about_ca_topic_score_gemma":0.003384128,"teacher_disagreement_score":0.41962695,"about_ca_system_score_codex":0.001120306,"about_ca_system_score_gemma":0.0005008401,"threshold_uncertainty_score":0.9999866},"labels":[],"label_agreement":null},{"id":"W3000214603","doi":"10.1182/blood.2019000919","title":"Novel antithrombotic strategies for treatment of venous thromboembolism","year":2020,"lang":"en","type":"review","venue":"Blood","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Antithrombotic; Fibrinolysis; Pulmonary embolism; Thrombosis; Deep vein; Warfarin; Intensive care medicine; Fibrinolytic agent; Internal medicine; Atrial fibrillation","score_opus":0.09059949197918069,"score_gpt":0.3545294540627351,"score_spread":0.26392996208355446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000214603","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017569688,0.99661154,0.00018859563,0.000042107557,0.00024781932,0.0018106935,0.0002500291,0.00007960663,0.0005939423],"genre_scores_gemma":[0.0006161333,0.99619037,0.0015966812,0.000022867502,0.0007556241,0.00012440585,0.00040434027,0.00009377604,0.00019578081],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984213,0.000019245263,0.00065798213,0.00041792807,0.00019842183,0.00028508177],"domain_scores_gemma":[0.99886745,0.00015420215,0.000375356,0.00038265868,0.000084627485,0.00013568865],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00004878957,0.00044884722,0.0033809382,0.0001141175,0.000060582937,0.000027520282,0.00011739489,0.0002531875,0.00004505623],"category_scores_gemma":[0.000031407057,0.00033895657,0.0009326,0.00022027393,0.0000813473,0.00005364154,0.00002109565,0.00006053509,0.000021849977],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026875012,0.006341207,0.000033793393,0.04202557,0.004055842,0.000059095062,0.00095606555,0.0000010960094,0.000085951346,0.0048038107,0.00020145588,0.94140923],"study_design_scores_gemma":[0.003971622,0.002985044,0.00026439235,0.0075734407,0.017959546,0.0002673705,0.00010330613,0.0000102444565,0.000109722336,0.00020952547,0.9661488,0.00039701012],"about_ca_topic_score_codex":0.00006910036,"about_ca_topic_score_gemma":0.00000886301,"teacher_disagreement_score":0.96594733,"about_ca_system_score_codex":0.000052019088,"about_ca_system_score_gemma":0.0010722644,"threshold_uncertainty_score":0.99990624},"labels":[],"label_agreement":null},{"id":"W3001407138","doi":"10.1182/blood.2019002395","title":"Avadomide monotherapy in relapsed/refractory DLBCL: safety, efficacy, and a predictive gene classifier","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Genentech; Servier; Eisai; Celltrion; Incyte; Teva Pharmaceutical Industries; Gilead Sciences; Amgen; Pfizer; MorphoSys; PharmaMar; Celgene; BC Cancer Agency; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Oncology; Medicine; Internal medicine; Refractory (planetary science); Biology","score_opus":0.011037224303274357,"score_gpt":0.22205987805671243,"score_spread":0.21102265375343807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3001407138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957448,0.0015675576,0.0004817294,0.0007643575,0.00004800325,0.00026649694,0.000025969575,0.000017327535,0.0010837168],"genre_scores_gemma":[0.99734235,0.00065493636,0.0004506551,0.0010402134,0.0002482667,0.000020316815,0.00006210805,0.000020563306,0.00016056381],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99923694,0.000058892492,0.00017752942,0.00030540308,0.00008088629,0.00014031808],"domain_scores_gemma":[0.99966025,0.000011018853,0.00005256852,0.00015097322,0.000021200014,0.00010399206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007724559,0.000116780444,0.00012062413,0.000026435724,0.000033983033,0.000013303646,0.0000911198,0.00013793334,0.00001773313],"category_scores_gemma":[0.000090693844,0.00011206531,0.000035938367,0.0000709628,0.000053479922,0.000003508073,0.000058160716,0.000114776405,0.000008338636],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076895836,0.00038572928,0.0049979426,0.000010621774,0.00007229318,0.000010051124,0.00024997446,0.000016567683,0.98918915,0.000025796719,0.001210647,0.0030622834],"study_design_scores_gemma":[0.015396938,0.0011901562,0.023687515,0.000020998503,0.000028876304,0.000011072886,0.00006321056,0.00018095263,0.8843328,0.00003491239,0.074755676,0.00029690974],"about_ca_topic_score_codex":0.0000058480327,"about_ca_topic_score_gemma":0.0000064011797,"teacher_disagreement_score":0.10485635,"about_ca_system_score_codex":0.000006181374,"about_ca_system_score_gemma":0.000045576187,"threshold_uncertainty_score":0.45698908},"labels":[],"label_agreement":null},{"id":"W3001625912","doi":"10.1182/blood-2019-121932","title":"Long-Term Efficacy and Safety of Copanlisib in Multiply Relapsed or Refractory Patients with Marginal Zone Lymphoma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Refractory (planetary science); Term (time); Medicine; Lymphoma; Oncology; Internal medicine; Materials science; Metallurgy","score_opus":0.01007010945681047,"score_gpt":0.258710851230747,"score_spread":0.24864074177393652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3001625912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980084,0.00025086314,0.0000048217166,0.000026354497,0.000042769723,0.0010685307,0.000014586692,0.000023324947,0.0005603734],"genre_scores_gemma":[0.9983074,0.0000888138,0.00037625883,0.000040901254,0.000034383047,0.000012199942,0.00004874655,0.0000372747,0.001053988],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831307,0.00005861172,0.0003533528,0.0003634422,0.00055853097,0.0003529811],"domain_scores_gemma":[0.9987965,0.00030167718,0.00011428341,0.000497644,0.00012782394,0.00016204432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019974029,0.00017593206,0.00044586236,0.00016403048,0.000022649774,0.00000920165,0.00011913405,0.00012305328,0.00017939182],"category_scores_gemma":[0.00016769928,0.00012226477,0.000032654825,0.00026529082,0.00014241638,0.00009276481,0.00009949249,0.00015596529,0.000041737436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020134032,0.004744308,0.96005535,0.0007896392,0.00017600619,0.0004541634,0.0004454549,0.0000032036505,0.0012113698,0.000009014146,0.00003121218,0.011946241],"study_design_scores_gemma":[0.23243168,0.0017464729,0.7635928,0.0006521017,0.000077661534,0.000090953465,0.00002647745,0.00008229366,0.001069643,3.7685527e-7,0.00010978295,0.00011979142],"about_ca_topic_score_codex":0.00021121721,"about_ca_topic_score_gemma":0.00008814345,"teacher_disagreement_score":0.21229765,"about_ca_system_score_codex":0.0013436785,"about_ca_system_score_gemma":0.0022340948,"threshold_uncertainty_score":0.49858126},"labels":[],"label_agreement":null},{"id":"W3002249367","doi":"10.1182/blood.2019002414","title":"Leveraging Gene Expression Subgroups to Classify DLBCL Patients and Enrich for Clinical Benefit to a Novel Agent","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Prince Edward Island","funders":"","keywords":"Diffuse large B-cell lymphoma; Gene expression profiling; Lymphoma; Oncology; Immune system; Internal medicine; Medicine; Biology; Cancer research; Gene expression; Immunology; Gene","score_opus":0.08255488850708192,"score_gpt":0.3271549367700174,"score_spread":0.24460004826293547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3002249367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994147,0.00018684889,0.0007103541,0.0036783437,0.00011413883,0.001006726,0.00004682363,0.000035793968,0.00007396118],"genre_scores_gemma":[0.9780939,0.000048959937,0.014220559,0.007067032,0.00026892047,0.00018902749,0.00004744256,0.000023274602,0.0000408831],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988567,0.000009660657,0.00029632318,0.00042743885,0.00018967049,0.00022018563],"domain_scores_gemma":[0.99905276,0.000099350895,0.000047644917,0.00016319989,0.00007545802,0.0005615743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007723128,0.00014426805,0.00030853465,0.00003584264,0.000064886735,0.000022842038,0.000055843557,0.00006865187,0.000013747386],"category_scores_gemma":[0.00017423178,0.00011259217,0.00009326203,0.00009173195,0.000008237602,0.000027309148,0.00011656066,0.000047429476,0.00003773131],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039175543,0.0064455406,0.9624794,0.000063676765,0.00014868149,0.000025648558,0.0009856441,0.0000021009405,0.009360427,0.000029301556,0.004495161,0.015572629],"study_design_scores_gemma":[0.026593411,0.002413458,0.9194184,0.000116685966,0.00032459924,0.000006161993,0.00005515484,0.000045151344,0.03794936,0.00000814229,0.012892212,0.00017729726],"about_ca_topic_score_codex":0.000011899162,"about_ca_topic_score_gemma":0.000002128177,"teacher_disagreement_score":0.04306107,"about_ca_system_score_codex":0.000035033114,"about_ca_system_score_gemma":0.000028345676,"threshold_uncertainty_score":0.45913753},"labels":[],"label_agreement":null},{"id":"W3002307260","doi":"10.1182/blood.2019003528","title":"How I treat obese patients with oral anticoagulants","year":2020,"lang":"en","type":"review","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Obesity; Antithrombotic; Intensive care medicine; Atrial fibrillation; Population; Anticoagulant; Surgery; Internal medicine; Environmental health","score_opus":0.09661798822115893,"score_gpt":0.33998084450212873,"score_spread":0.24336285628096982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3002307260","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004148199,0.99663377,0.0000068568365,0.00025916545,0.00010139935,0.0013437443,0.000033020202,0.000099844474,0.0011073605],"genre_scores_gemma":[0.0001787385,0.9945121,0.00030743412,0.000041709805,0.0006982449,0.000004968788,0.00054146326,0.000060569066,0.003654774],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99888045,0.000046791298,0.00023832156,0.00031589434,0.00032626014,0.0001923078],"domain_scores_gemma":[0.99930704,0.000043997912,0.00019318526,0.00027669102,0.000045119355,0.00013399395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000035761812,0.00032765215,0.0017153369,0.000115487885,0.00003667372,0.000059141203,0.00009004977,0.00013012529,0.000045899636],"category_scores_gemma":[0.00007276738,0.00019487894,0.0003349953,0.00028913494,0.000023594186,0.00006255695,0.00005967046,0.00013660063,0.00012164336],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031652995,0.00006106506,0.0487644,0.011092482,0.00090931734,0.00012909397,0.000012198662,1.0761595e-8,4.630843e-8,0.000032287862,0.00057253614,0.9383949],"study_design_scores_gemma":[0.003217501,0.0002690052,0.002260192,0.0034375903,0.008989781,0.000008988856,0.000003832363,3.264637e-7,5.275322e-7,0.0000024328797,0.98159146,0.00021835012],"about_ca_topic_score_codex":0.0000025640309,"about_ca_topic_score_gemma":0.0000015132745,"teacher_disagreement_score":0.98101896,"about_ca_system_score_codex":0.000021100426,"about_ca_system_score_gemma":0.00007600233,"threshold_uncertainty_score":0.7946933},"labels":[],"label_agreement":null},{"id":"W30025801","doi":"10.1182/blood.v122.21.5216.5216","title":"Dandelion Root and Chronic Myelomonocytic Leukemia","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Windsor Regional Hospital; University of Windsor; Western University","funders":"","keywords":"Chronic myelomonocytic leukemia; Medicine; Leukemia; Acute leukemia; Bone marrow; Internal medicine; Induction chemotherapy; White blood cell; Gastroenterology; Surgery; Chemotherapy; Immunology; Myelodysplastic syndromes","score_opus":0.014025918575610705,"score_gpt":0.2659187667865284,"score_spread":0.25189284821091773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W30025801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856762,0.002375132,0.00005854607,0.0009368968,0.000034387424,0.0005030206,0.0000013521399,0.000088023764,0.0103264],"genre_scores_gemma":[0.99533993,0.00023779563,0.00050699804,0.00018726785,0.0003364009,0.00006685022,0.000013160411,0.000030438008,0.003281181],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989222,0.000027901178,0.00017120094,0.00027542553,0.00023550948,0.00036771563],"domain_scores_gemma":[0.9992388,0.00005367632,0.000031269275,0.00034296585,0.000085516665,0.0002477671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012616722,0.00013463685,0.00022651107,0.00011477558,0.00006939206,0.000041926745,0.0000915915,0.000111380476,0.0004665548],"category_scores_gemma":[0.000085439075,0.00010882613,0.000042532458,0.00016881705,0.00009373441,0.00012312472,0.00010852441,0.00030034548,0.0007054265],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026149364,0.0009716342,0.17190412,0.0016240719,0.0011316316,0.0009204972,0.0011275385,0.000013704462,0.52164006,0.0016306775,0.06399307,0.23478149],"study_design_scores_gemma":[0.03965702,0.0030045453,0.7336959,0.00051665894,0.0008126151,0.0028125783,0.00033996417,0.011311228,0.17685112,0.0014327714,0.028617045,0.0009485456],"about_ca_topic_score_codex":0.00026824264,"about_ca_topic_score_gemma":0.000024453357,"teacher_disagreement_score":0.5617918,"about_ca_system_score_codex":0.00045421932,"about_ca_system_score_gemma":0.00056276907,"threshold_uncertainty_score":0.90670663},"labels":[],"label_agreement":null},{"id":"W3005551881","doi":"10.1182/blood.2019003186","title":"Immune profile differences between chronic GVHD and late acute GVHD: results of the ABLE/PBMTC 1202 studies","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba; Montreal Children's Hospital; Centre Hospitalier Universitaire Sainte-Justine; Alberta Children's Hospital; University of Calgary; SickKids Foundation; University of Toronto; BC Children's Hospital; Hospital for Sick Children; University of British Columbia","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; Hospital for Sick Children; National Cancer Institute; National Institutes of Health; Pediatric Oncology Group of Ontario; C17 Council","keywords":"Immunology; Hematopoietic stem cell transplantation; Graft-versus-host disease; Immune system; Medicine; Biomarker; Transplantation; Internal medicine; Biology","score_opus":0.039719763895898576,"score_gpt":0.2804991538249005,"score_spread":0.2407793899290019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005551881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916032,0.0028367941,0.000010218816,0.002623346,0.0000737071,0.0005146372,0.000112492766,0.000039196224,0.0021863952],"genre_scores_gemma":[0.998352,0.0007977012,0.00022429784,0.00005706563,0.00010090365,0.000017941911,0.000022638222,0.000013180166,0.0004142601],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989497,0.00005353728,0.00037232635,0.00022132782,0.00023754868,0.00016557741],"domain_scores_gemma":[0.9993546,0.00017351731,0.00013502703,0.00020908983,0.000059936123,0.000067840374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013001972,0.00013157378,0.00040952346,0.000023651584,0.00006392704,0.000007648115,0.00010538986,0.00006256898,0.000048558763],"category_scores_gemma":[0.00008333151,0.00008124722,0.000059437247,0.00017448227,0.00012678311,0.000034881974,0.00005671054,0.00013893671,0.000012684641],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076501805,0.0007002601,0.6326447,0.010928757,0.0083674835,0.00024317471,0.04771945,0.0000048030006,0.28174713,0.00025281293,0.0010620104,0.015564393],"study_design_scores_gemma":[0.0061390363,0.00058943836,0.7295477,0.00032637618,0.001623628,0.000016401513,0.00047506293,0.000025171408,0.2609727,0.000055918063,0.000107139975,0.000121415644],"about_ca_topic_score_codex":0.000018056007,"about_ca_topic_score_gemma":0.0000038553576,"teacher_disagreement_score":0.09690298,"about_ca_system_score_codex":0.000011406658,"about_ca_system_score_gemma":0.00007292742,"threshold_uncertainty_score":0.33131656},"labels":[],"label_agreement":null},{"id":"W3005762182","doi":"10.1182/blood.2019003191","title":"A validated novel continuous prognostic index to deliver stratified medicine in pediatric acute lymphoblastic leukemia","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Blood Cancer UK; Hospital for Sick Children; Cancer Research UK","keywords":"Medicine; Lymphoblastic Leukemia; Hematologic Neoplasms; Leukemia; Acute lymphocytic leukemia; Internal medicine; Oncology; Intensive care medicine; Cancer","score_opus":0.02139332782669068,"score_gpt":0.2725536272240376,"score_spread":0.2511602993973469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005762182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98758703,0.00015250726,0.0048530283,0.0035569754,0.000108069726,0.0017760863,0.00004356197,0.00022935541,0.0016933548],"genre_scores_gemma":[0.9944894,0.00005468698,0.0013430505,0.0027235902,0.000827304,0.00013445898,0.00008062896,0.00009070853,0.00025620096],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962605,0.00007650833,0.0008196467,0.00086022285,0.0010851684,0.0008979421],"domain_scores_gemma":[0.99752456,0.00048716832,0.00013870928,0.00045719414,0.00033453133,0.0010578118],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029233872,0.0004376067,0.00091566157,0.00048094668,0.00006430388,0.000040396415,0.00041868203,0.00027154622,0.0002509735],"category_scores_gemma":[0.002406202,0.0003668246,0.00009483118,0.0021600425,0.00012844983,0.00011499709,0.00024348336,0.0005201307,0.0003873199],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007925893,0.00463431,0.5408896,0.0022026862,0.0020376132,0.01777653,0.009949083,0.00094703864,0.38348237,0.0004987442,0.026128767,0.0035273614],"study_design_scores_gemma":[0.16793399,0.012584857,0.74884385,0.0012358271,0.0062086876,0.0022361493,0.0011208205,0.03851717,0.017761331,0.00008466166,0.0013568683,0.002115774],"about_ca_topic_score_codex":0.00041006936,"about_ca_topic_score_gemma":0.000043757183,"teacher_disagreement_score":0.36572105,"about_ca_system_score_codex":0.00059347955,"about_ca_system_score_gemma":0.0015829814,"threshold_uncertainty_score":0.99987835},"labels":[],"label_agreement":null},{"id":"W3005879325","doi":"10.1182/blood.2019003357","title":"High frequency of germline <i>RUNX1</i> mutations in patients with<i> RUNX1</i>-mutated AML","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"RUNX1; Germline; CEBPA; Germline mutation; Neuroblastoma RAS viral oncogene homolog; Myeloid leukemia; Cancer research; Biology; Platelet disorder; Genetics; Medicine; Mutation; Stem cell; Immunology; Haematopoiesis; Gene; KRAS","score_opus":0.0110456980150944,"score_gpt":0.242826236569886,"score_spread":0.2317805385547916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005879325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99602294,0.00007951898,0.000049234568,0.0020700803,0.000025780766,0.0007365416,0.00010097842,0.00007293154,0.0008419878],"genre_scores_gemma":[0.9944982,0.000011998544,0.0040518357,0.00080817234,0.00008504159,0.000036981168,0.00039875275,0.000045423007,0.00006358697],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982707,0.000059025027,0.00045398023,0.00033640777,0.00052579044,0.00035411277],"domain_scores_gemma":[0.9989231,0.0000796748,0.000121388824,0.00030716803,0.00031176145,0.00025685868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000106162224,0.00018132676,0.00042756434,0.00015894858,0.00003453591,0.000009269378,0.00016999716,0.00010017352,0.00017805625],"category_scores_gemma":[0.0002729715,0.00014930384,0.000059297792,0.0009656435,0.00012614981,0.00010733958,0.00006183989,0.0003991303,0.00006641668],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061608566,0.0023017589,0.96722233,0.00029185554,0.00029801062,0.00036355315,0.0010140077,0.000059990572,0.026108732,0.00023041278,0.00075815956,0.00073511386],"study_design_scores_gemma":[0.039632943,0.0019795445,0.909872,0.00020309453,0.0003817906,0.000017597138,0.0001343438,0.00012929461,0.04698175,0.00012480264,0.00020745318,0.00033539673],"about_ca_topic_score_codex":0.00034147882,"about_ca_topic_score_gemma":0.00003479862,"teacher_disagreement_score":0.05735033,"about_ca_system_score_codex":0.00007233363,"about_ca_system_score_gemma":0.00036336997,"threshold_uncertainty_score":0.6088434},"labels":[],"label_agreement":null},{"id":"W3006487497","doi":"10.1182/blood.2019003928","title":"CML in megakaryocytic transformation and extramedullary infiltration","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Infiltration (HVAC); Medicine; Physics","score_opus":0.018079431160512777,"score_gpt":0.244336848639094,"score_spread":0.22625741747858122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006487497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99408233,0.0005304177,0.000082399085,0.0019873467,0.0000141338605,0.00032455957,0.0000026962814,0.000042328847,0.0029337632],"genre_scores_gemma":[0.9986265,0.00016342694,0.00048547873,0.0005883858,0.000054504242,0.000014658384,0.000041490868,0.000008450253,0.00001711258],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99949104,0.000014467302,0.0001595085,0.00012138014,0.000110998546,0.000102607126],"domain_scores_gemma":[0.99978864,0.000019394476,0.000021283195,0.00006965039,0.000010404162,0.00009061141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000041282685,0.00007436072,0.00012783984,0.000038726244,0.000015276204,0.000008586256,0.00001927697,0.000053692915,0.00003548812],"category_scores_gemma":[0.00003763941,0.000068353955,0.0000198236,0.0001203988,0.000016038539,0.00011370712,0.000005330622,0.000099718585,0.000020714422],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016037561,0.0035954933,0.5680142,0.0036634663,0.00079761626,0.00165185,0.058400325,0.0001403453,0.22309342,0.0034325428,0.00096353836,0.13464345],"study_design_scores_gemma":[0.09919999,0.003057699,0.7156179,0.00062256615,0.0012540432,0.0012397261,0.0015170242,0.016956333,0.15351674,0.0005240418,0.0057623265,0.0007316112],"about_ca_topic_score_codex":0.000026918484,"about_ca_topic_score_gemma":0.000014235956,"teacher_disagreement_score":0.1476037,"about_ca_system_score_codex":0.00006562782,"about_ca_system_score_gemma":0.0001090069,"threshold_uncertainty_score":0.27873933},"labels":[],"label_agreement":null},{"id":"W3007071335","doi":"10.1182/blood.v130.suppl_1.2553.2553","title":"Pharmacokinetics and Pharmacodynamics of Tocilizumab for the Management of Cytokine Release Syndrome (CRS) in Pediatric and Young Adult Patients with Relapsed/Refractory (R/R) B-Cell Acute Lymphoblastic Leukemia (B-ALL) Treated with CAR T-Cell Therapy, CTL019","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Pharmacodynamics; Medicine; Cytokine release syndrome; Pharmacokinetics; Tocilizumab; Internal medicine; Pharmacology; Oncology; Cancer; Immunotherapy","score_opus":0.009843819103986807,"score_gpt":0.2545859916300531,"score_spread":0.24474217252606628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007071335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957536,0.0010600637,0.000026754804,0.000030666706,0.000037632468,0.002435303,0.00014818471,0.000017163891,0.0004906205],"genre_scores_gemma":[0.98408157,0.014488347,0.00032602795,0.000026600808,0.000029232644,0.000117378375,0.000045974743,0.00007589934,0.0008089539],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982548,0.000046090317,0.00038221604,0.000420425,0.000522587,0.0003738817],"domain_scores_gemma":[0.9984406,0.00014007052,0.0003680044,0.0006136594,0.0002866103,0.00015106078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017410495,0.00031115933,0.00048628563,0.00018331266,0.00011057488,0.000029539773,0.00026837664,0.00009028647,0.000024375091],"category_scores_gemma":[0.000010373035,0.0002018006,0.000063072315,0.00018396966,0.00024070553,0.000100428944,0.00010701237,0.00023198797,5.644788e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032279376,0.0064599314,0.8618483,0.004569006,0.003385681,0.0008149001,0.0010106313,0.00012984518,0.077212356,0.000016088447,0.00008189066,0.0121920165],"study_design_scores_gemma":[0.31256837,0.013042017,0.61025125,0.000533632,0.008739258,0.00019353523,0.00030422566,0.0048460024,0.048569594,0.00001219678,0.0001824583,0.0007574986],"about_ca_topic_score_codex":0.00024891685,"about_ca_topic_score_gemma":0.000031329862,"teacher_disagreement_score":0.28028896,"about_ca_system_score_codex":0.00011288206,"about_ca_system_score_gemma":0.0001287507,"threshold_uncertainty_score":0.822919},"labels":[],"label_agreement":null},{"id":"W3007799710","doi":"10.1182/blood.v110.11.2137.2137","title":"Quantitation of Bleeding Symptoms in Children with von Willebrand Disease (VWD) or a Platelet Function Disorder: Use of a Standardized Pediatric Bleeding Score.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; Hospital for Sick Children","funders":"","keywords":"Medicine; Thrombasthenia; Bleeding diathesis; Von Willebrand disease; Platelet disorder; Pediatrics; Bleeding time; Platelet; Surgery; Von Willebrand factor; Internal medicine; Platelet aggregation","score_opus":0.013231232692492146,"score_gpt":0.24428562231247533,"score_spread":0.23105438961998317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007799710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99762076,0.00083163526,0.0005714452,0.000017652468,0.00003656385,0.0007856279,0.000056137513,0.00003429819,0.00004588951],"genre_scores_gemma":[0.998892,0.00037304487,0.00049947156,0.000014160744,0.00004302532,0.00001397179,0.000109045235,0.000030478097,0.000024819436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986223,0.000018728202,0.00043418485,0.0002667204,0.00038634194,0.0002717522],"domain_scores_gemma":[0.9992607,0.00010206208,0.00024059649,0.00016118732,0.00010628755,0.0001291245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021198283,0.00019152857,0.00046662838,0.00044624018,0.000046648558,0.0000142068375,0.000041609455,0.00007673907,0.000022542745],"category_scores_gemma":[0.0001125893,0.00013883882,0.00007804783,0.0006715168,0.000047139132,0.00024718978,0.000017825127,0.00010758771,0.0000012350837],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070195873,0.0013923096,0.9882583,0.00017604374,0.00042406502,0.000106486616,0.00017765176,0.00004977087,0.00067965756,0.000045781788,0.000007989466,0.0016623533],"study_design_scores_gemma":[0.025790278,0.0015877057,0.96884453,0.00031589178,0.0015076539,0.000056855086,0.00012789361,0.0000812704,0.0014742401,0.0000359552,0.000011126598,0.00016662429],"about_ca_topic_score_codex":0.00013951273,"about_ca_topic_score_gemma":0.00012992694,"teacher_disagreement_score":0.019413799,"about_ca_system_score_codex":0.00002900725,"about_ca_system_score_gemma":0.00011658326,"threshold_uncertainty_score":0.5661683},"labels":[],"label_agreement":null},{"id":"W3007925874","doi":"10.1182/blood.2019002936","title":"Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failure","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":320,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; National Institutes of Health; Juno Therapeutics; University of British Columbia; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Celgene","keywords":"Ibrutinib; Bruton's tyrosine kinase; Medicine; Internal medicine; Oncology; Chronic lymphocytic leukemia; Leukemia; Tyrosine kinase; Receptor","score_opus":0.029870956478100286,"score_gpt":0.2892506916692684,"score_spread":0.25937973519116814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007925874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960261,0.001006915,0.000118866934,0.00061589095,0.000041018036,0.0018698599,0.00014947283,0.000055933935,0.00011594425],"genre_scores_gemma":[0.9974024,0.000029319663,0.0019449709,0.00022440041,0.00019102907,0.00006575212,0.000045303717,0.000038638726,0.000058167563],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99822384,0.000053766707,0.00035836294,0.00053621456,0.000409848,0.00041799207],"domain_scores_gemma":[0.9985838,0.00029515728,0.00009986978,0.00039875155,0.00020960341,0.00041281973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019821108,0.00021989045,0.0005267954,0.000044156048,0.000037783597,0.000017777462,0.00012376047,0.00012575902,0.00011270952],"category_scores_gemma":[0.00031418388,0.00016513042,0.00011852773,0.00021478295,0.00026479003,0.000048052447,0.000102669444,0.00021130222,0.000012977385],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06351136,0.019326817,0.27028337,0.03422838,0.0055226358,0.0015894764,0.026429651,0.00008459884,0.54721165,0.0005647201,0.020044046,0.011203285],"study_design_scores_gemma":[0.39337143,0.0065784105,0.03625388,0.00068269426,0.0018038654,0.00022828678,0.000688046,0.0023980294,0.5411191,0.000028919363,0.016071098,0.00077626016],"about_ca_topic_score_codex":0.000036588925,"about_ca_topic_score_gemma":0.000017114271,"teacher_disagreement_score":0.32986006,"about_ca_system_score_codex":0.0003928822,"about_ca_system_score_gemma":0.00219429,"threshold_uncertainty_score":0.67338234},"labels":[],"label_agreement":null},{"id":"W3008184725","doi":"10.1182/blood.2019003603","title":"Prognostic factors for VTE and bleeding in hospitalized medical patients: a systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University; Impact; St. Joseph’s Healthcare Hamilton; Cochrane","funders":"Centers for Disease Control and Prevention","keywords":"Medicine; Internal medicine; Thrombocytosis; Leukocytosis; Anemia; Aspirin; Intensive care medicine","score_opus":0.05823692839298742,"score_gpt":0.33721596642573815,"score_spread":0.2789790380327507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008184725","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000058229958,0.98731107,0.000010974753,0.0003687467,0.000021790536,0.012086095,0.00007463516,0.000031171836,0.000037271944],"genre_scores_gemma":[0.00020337764,0.99558705,0.00010987591,0.0005343937,0.000022233777,0.0032482927,0.00021641071,0.00004969802,0.000028670998],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99711525,0.00018395815,0.0013168369,0.0006211298,0.00048573257,0.00027711177],"domain_scores_gemma":[0.9982212,0.0005388698,0.00055012887,0.00031561885,0.00007547359,0.00029869968],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000673643,0.00050032407,0.01347778,0.0003103456,0.00004185159,0.000043045806,0.00014896506,0.00019498385,0.000093830866],"category_scores_gemma":[0.0026975658,0.00029639568,0.0015347457,0.00065183645,0.00003928359,0.00004458051,0.00015110055,0.00021134608,0.0000033121114],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[5.329993e-7,0.00045563208,0.0001613135,0.84847575,0.15006475,0.000022465369,0.000060237788,2.5293971e-9,8.6207397e-10,0.00005374525,0.000096118536,0.00060944713],"study_design_scores_gemma":[0.0007172916,0.00021956494,0.000113143484,0.091078386,0.8939649,0.0000063357456,0.000015764408,0.0000019461484,1.8402337e-8,0.0000046759706,0.013645187,0.00023280908],"about_ca_topic_score_codex":0.00001730781,"about_ca_topic_score_gemma":0.000008876504,"teacher_disagreement_score":0.75739735,"about_ca_system_score_codex":0.000031787775,"about_ca_system_score_gemma":0.000080787344,"threshold_uncertainty_score":0.9999488},"labels":[],"label_agreement":null},{"id":"W3011866243","doi":"10.1182/blood.2019002385","title":"Coding and noncoding drivers of mantle cell lymphoma identified through exome and genome sequencing","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Canada's Michael Smith Genome Sciences Centre; Simon Fraser University","funders":"Canadian Institutes of Health Research","keywords":"Exome sequencing; Biology; Exome; Mantle cell lymphoma; Genetics; Exon; Cancer research; Lymphoma; Gene; Mutation; Immunology","score_opus":0.021192712445945887,"score_gpt":0.23864096588875539,"score_spread":0.2174482534428095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011866243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970921,0.001233503,0.0005066738,0.0000570087,0.000014621436,0.000081126,0.000008809263,0.000005735095,0.0010004081],"genre_scores_gemma":[0.99833405,0.0005881904,0.0006939385,0.00008847415,0.000063368105,0.0000023949685,0.000009497225,0.000010600712,0.00020949653],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99938995,0.00001955189,0.00011281007,0.0002246408,0.00008549274,0.00016754253],"domain_scores_gemma":[0.99973404,0.000009876069,0.000044309738,0.00009750053,0.000025285828,0.00008899617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000073735464,0.00007736954,0.000110263645,0.000016332213,0.000062077146,0.000023931427,0.000077211036,0.000053009935,0.000006276966],"category_scores_gemma":[0.000027947186,0.00007780852,0.000027184378,0.000051046372,0.0000583496,0.0000070616584,0.00014159114,0.00003461514,0.0000016613693],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015643249,0.000016903965,0.002189299,0.000078063706,0.000031346994,0.000018857847,0.00042058292,0.000003147381,0.9970203,0.00004029496,0.00001585095,0.0001497045],"study_design_scores_gemma":[0.0016926884,0.00019455548,0.0025804944,0.000016710375,0.000029065228,0.000021978583,0.0009910151,0.00011260373,0.99389327,0.000016331403,0.00032931002,0.00012197804],"about_ca_topic_score_codex":0.000035004316,"about_ca_topic_score_gemma":0.0000030767253,"teacher_disagreement_score":0.0031270352,"about_ca_system_score_codex":0.000005054537,"about_ca_system_score_gemma":0.000031719654,"threshold_uncertainty_score":0.31729394},"labels":[],"label_agreement":null},{"id":"W3012328912","doi":"10.1182/blood.2019003807","title":"Clinicopathologic predictors of renal outcomes in light chain cast nephropathy: a multicenter retrospective study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; University of Alberta; Hôpital du Sacré-Cœur de Montréal; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Clinical Science Research and Development; National Institutes of Health; University of Alberta; National Institute of Diabetes and Digestive and Kidney Diseases; Brigham and Women's Hospital; U.S. Department of Veterans Affairs","keywords":"Medicine; Renal function; Nephropathy; Acute kidney injury; Kidney disease; Renal biopsy; Biopsy; Urology; Retrospective cohort study; Internal medicine; Gastroenterology; Pathology; Diabetes mellitus; Endocrinology","score_opus":0.032103755660853675,"score_gpt":0.3161329453192187,"score_spread":0.28402918965836504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012328912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99714774,0.00009774828,0.000005138972,0.0006780749,0.00004641277,0.0013621214,0.00004126837,0.000043105603,0.0005783693],"genre_scores_gemma":[0.9993551,0.00001652,0.00019231923,0.00013589895,0.00009599806,0.00006648462,0.000011869128,0.000018660015,0.00010719783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837345,0.0001522889,0.00041604822,0.00036966192,0.00040188737,0.0002866691],"domain_scores_gemma":[0.99927336,0.00005702073,0.00010336654,0.000260636,0.00008289942,0.0002227439],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022504905,0.0001665157,0.00055141404,0.00011567162,0.0000270035,0.000007713256,0.00010506362,0.00006462198,0.000065740205],"category_scores_gemma":[0.0008623016,0.000117662836,0.000111003574,0.00025839717,0.000049646016,0.000046720383,0.00010148157,0.00025728287,0.000035291774],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066239206,0.006415174,0.9842896,0.00003394599,0.00027395017,0.0022177575,0.0028723532,7.156825e-7,0.0030405573,0.0000030002345,0.00002290051,0.00016766432],"study_design_scores_gemma":[0.021713404,0.0045104944,0.969879,0.000041696192,0.00016779212,0.000011562904,0.0007419863,0.000108177795,0.002718336,0.0000032393934,0.00002517567,0.00007916591],"about_ca_topic_score_codex":0.000067815374,"about_ca_topic_score_gemma":0.00007781431,"teacher_disagreement_score":0.02105101,"about_ca_system_score_codex":0.000042612486,"about_ca_system_score_gemma":0.000065395674,"threshold_uncertainty_score":0.4798151},"labels":[],"label_agreement":null},{"id":"W3013244600","doi":"10.1182/blood.2019003877","title":"Stage I-II nodular lymphocyte-predominant Hodgkin lymphoma: a multi-institutional study of adult patients by ILROG","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Rituximab; Medicine; Interquartile range; Internal medicine; Cohort; Radiation therapy; Retrospective cohort study; Stage (stratigraphy); Gastroenterology; Progression-free survival; Chemotherapy regimen; Lymphoma; Chemotherapy; Median follow-up; Oncology; Surgery","score_opus":0.014894463093366981,"score_gpt":0.24182051176096347,"score_spread":0.2269260486675965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013244600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99731725,0.0005747424,0.000022917135,0.0001959215,0.00009376531,0.0012213521,0.00030611485,0.00006420468,0.000203698],"genre_scores_gemma":[0.9981785,0.00007993128,0.00067486643,0.00052822084,0.00006914438,0.0001538299,0.0001773361,0.000028116863,0.00011009551],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99809957,0.000052007315,0.00048507596,0.0004959332,0.00057934114,0.0002880967],"domain_scores_gemma":[0.99891645,0.000035880137,0.00017406966,0.00034686743,0.00023518609,0.0002915372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000050552575,0.00029638968,0.0005622971,0.000046072608,0.00015678348,0.0000130137005,0.00014182787,0.00009020959,0.00008990324],"category_scores_gemma":[0.00016519135,0.00022023405,0.00016291416,0.0002228551,0.000073267525,0.0000746331,0.00014961601,0.00004305689,0.00005878536],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007118643,0.10328761,0.88086534,0.00017776871,0.0011615165,0.00052396656,0.0032138233,0.000012220734,0.0022732208,0.000079973535,0.0014575437,0.006235151],"study_design_scores_gemma":[0.3045262,0.013037669,0.57704115,0.00024657493,0.0020279323,0.000036547633,0.0013459657,0.0007007225,0.09355184,0.0000019937934,0.00692064,0.0005627718],"about_ca_topic_score_codex":0.0005270665,"about_ca_topic_score_gemma":0.000030043866,"teacher_disagreement_score":0.3038242,"about_ca_system_score_codex":0.0001676793,"about_ca_system_score_gemma":0.00024491185,"threshold_uncertainty_score":0.8980884},"labels":[],"label_agreement":null},{"id":"W3013447738","doi":"10.1182/blood.2020004856","title":"Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":756,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré universitaire de santé et de services sociaux de l'Est-de-l'Île-de-Montréal; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal","funders":"Genentech","keywords":"Venetoclax; Medicine; Internal medicine; Neutropenia; Febrile neutropenia; Hazard ratio; Chemotherapy regimen; Cytarabine; Adverse effect; Chemotherapy; Surgery; Oncology; Leukemia; Confidence interval; Chronic lymphocytic leukemia","score_opus":0.0321181257161765,"score_gpt":0.33604205071564375,"score_spread":0.30392392499946724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013447738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8676347,0.0010436805,0.026320072,0.022877384,0.0004688317,0.080313854,0.00018769012,0.0003557953,0.0007979897],"genre_scores_gemma":[0.90641683,0.00048292163,0.015262539,0.026021186,0.0078011723,0.03992403,0.0005897361,0.00037172477,0.0031298297],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9974532,0.00016373995,0.0007705097,0.0005849138,0.00037884488,0.00064880576],"domain_scores_gemma":[0.9947076,0.0034738267,0.00025186062,0.00036642657,0.0007444406,0.0004558564],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00097486755,0.00035989485,0.00233117,0.00015745705,0.00011176119,0.000054443604,0.0002536941,0.00023037787,0.00012047937],"category_scores_gemma":[0.012920507,0.00027467753,0.00097497145,0.00026762288,0.00013998071,0.00007345288,0.000055598848,0.00031833097,0.000031597094],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9580711,0.0003708548,0.000001559768,0.00018601023,0.001649222,0.00006141707,0.0011942846,0.000025942329,0.008039362,0.000088491244,0.02929752,0.0010142287],"study_design_scores_gemma":[0.9307827,0.004234286,3.4332746e-7,0.000059926508,0.0014774159,0.000014421529,0.00025629043,0.03879286,0.014620157,0.00017700942,0.009336777,0.00024783713],"about_ca_topic_score_codex":0.000047673613,"about_ca_topic_score_gemma":0.000003936445,"teacher_disagreement_score":0.040389825,"about_ca_system_score_codex":0.0003301485,"about_ca_system_score_gemma":0.002148186,"threshold_uncertainty_score":0.99997056},"labels":[],"label_agreement":null},{"id":"W3013752477","doi":"10.1182/blood.2019004116","title":"An intestinal organoid–based platform that recreates susceptibility to T-cell–mediated tissue injury","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; York University; Crohn's and Colitis Foundation; National Institute on Aging; Parker Institute for Cancer Immunotherapy; National Heart, Lung, and Blood Institute; National Cancer Institute; Kenneth Rainin Foundation; Memorial Sloan-Kettering Cancer Center; National Institutes of Health; Stony Wold-Herbert Fund; Japan Society for the Promotion of Science; National Institute of Allergy and Infectious Diseases; Howard Hughes Medical Institute","keywords":"Necroptosis; ATG16L1; Organoid; Autophagy; Transplantation; Hematopoietic stem cell transplantation; Biology; Programmed cell death; Cancer research; Immunology; Stem cell; Medicine; Apoptosis; Cell biology; Genetics","score_opus":0.024859003233981304,"score_gpt":0.25417394122858916,"score_spread":0.22931493799460786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013752477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99752045,0.00039947854,0.00044475842,0.0005538468,0.00013199986,0.0003368002,0.00005475932,0.00020660301,0.00035132488],"genre_scores_gemma":[0.99814314,0.000006915888,0.00043942835,0.00067431206,0.000048820973,0.000018156526,0.00054111506,0.00002395756,0.00010417046],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99887776,0.0001076634,0.0002595928,0.00039788397,0.00004536192,0.0003117255],"domain_scores_gemma":[0.9993141,0.00009091203,0.00009118023,0.00033748389,0.0000747865,0.00009148948],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00016351447,0.00019948545,0.00027322728,0.00006299902,0.00013186218,0.000026942085,0.0002680083,0.0001950204,0.0010051306],"category_scores_gemma":[0.00017633075,0.00017895071,0.000051807452,0.00023963134,0.00007825991,0.00016115046,0.000063343316,0.00021354838,0.0009399794],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002470893,0.00048631596,0.020535141,0.000019888901,0.000029810335,0.0000026356217,0.00036435758,0.0000046976165,0.9751354,0.000012151801,0.00078482926,0.0023776805],"study_design_scores_gemma":[0.0016566215,0.0014812828,0.02208561,0.000019351482,0.00006027043,0.0000072765106,0.00012842285,0.000031116844,0.96974236,0.000016219297,0.00455476,0.00021668569],"about_ca_topic_score_codex":0.000068118075,"about_ca_topic_score_gemma":0.000014916262,"teacher_disagreement_score":0.0053930217,"about_ca_system_score_codex":0.000023410921,"about_ca_system_score_gemma":0.00008198041,"threshold_uncertainty_score":0.9999081},"labels":[],"label_agreement":null},{"id":"W3014992883","doi":"10.1182/blood.2019002939","title":"Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Children's & Women's Health Centre of British Columbia; Centre Hospitalier Universitaire Sainte-Justine; University of Manitoba; CancerCare Manitoba","funders":"National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; National Institute of Allergy and Infectious Diseases; National Institutes of Health; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Medicine; Wiskott–Aldrich syndrome; Fludarabine; Transplantation; Internal medicine; Melphalan; Myeloid; Hematopoietic stem cell transplantation; Busulfan; Alemtuzumab; Oncology; Immunology; Gastroenterology; Cyclophosphamide; Chemotherapy","score_opus":0.021705405759152252,"score_gpt":0.26897443021830786,"score_spread":0.2472690244591556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014992883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9711294,0.00024404391,0.021611974,0.002332593,0.00025131615,0.0016413685,0.000031901956,0.00024986902,0.0025075183],"genre_scores_gemma":[0.98992825,0.000047929607,0.008288344,0.00064533873,0.000064212734,0.00018614916,0.0002428106,0.00007342604,0.0005235562],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978178,0.000036027388,0.000717494,0.0005436909,0.00050472573,0.000380232],"domain_scores_gemma":[0.9989175,0.00022253009,0.00016521924,0.00031778743,0.00006871011,0.0003082055],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002345358,0.0002879762,0.00062909885,0.000085791406,0.00009886387,0.000027909982,0.000114982344,0.00014997604,0.00007517263],"category_scores_gemma":[0.000067623376,0.0002647891,0.0004116255,0.00023926348,0.000023183055,0.00009556418,0.000010100084,0.0001560331,0.00008420876],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055505335,0.003261546,0.799421,0.020501757,0.0015976897,0.034034576,0.018113328,0.000048867336,0.12048057,0.0003800318,0.0011610957,0.0004444528],"study_design_scores_gemma":[0.06892474,0.003751116,0.34343565,0.0020381187,0.018694852,0.01694533,0.0029919366,0.0004929147,0.53608745,0.0005028934,0.0036673755,0.0024675978],"about_ca_topic_score_codex":0.000014514078,"about_ca_topic_score_gemma":0.0000026528355,"teacher_disagreement_score":0.4559854,"about_ca_system_score_codex":0.000023670213,"about_ca_system_score_gemma":0.000113403876,"threshold_uncertainty_score":0.99998045},"labels":[],"label_agreement":null},{"id":"W3015526907","doi":"10.1182/blood.2019003636","title":"The miR-185/PAK6 axis predicts therapy response and regulates survival of drug-resistant leukemic stem cells in CML","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada; Canada's Michael Smith Genome Sciences Centre; University of British Columbia; Terry Fox Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Cancer research; Stem cell; Myeloid leukemia; Biology; Targeted therapy; Cancer stem cell; Progenitor cell; microRNA; Leukemia; Drug resistance; Transcriptome; Cancer; Immunology; Cell biology; Gene expression","score_opus":0.018334693448379697,"score_gpt":0.23717166788424407,"score_spread":0.21883697443586436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015526907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905417,0.0068205753,7.2243176e-7,0.001670397,0.00006878211,0.0006435556,0.000041319476,0.00004768191,0.00016524589],"genre_scores_gemma":[0.99743265,0.0013134073,0.00006217987,0.00012542114,0.00006898867,0.000025514966,0.0000061425285,0.000034902874,0.00093080103],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983038,0.00026953043,0.00041535575,0.00034712945,0.00035240623,0.0003118046],"domain_scores_gemma":[0.9985259,0.00069112884,0.00013051085,0.00043087793,0.000051106515,0.00017044539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052980403,0.00020802184,0.00040848917,0.000055636658,0.000064836095,0.000017158003,0.00015379758,0.00008964969,0.000020883224],"category_scores_gemma":[0.00009150947,0.0001407886,0.000077025674,0.00025175427,0.0001589043,0.000041820716,0.000068639834,0.00018892792,0.0000097683605],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020703774,0.0008144266,0.044256337,0.00028909202,0.0006837155,0.00039744412,0.008381274,0.0000147351375,0.9176722,0.00005865591,0.0014184975,0.0053098467],"study_design_scores_gemma":[0.039622385,0.0018033066,0.22737633,0.00037956124,0.00025135095,0.000038961065,0.0017597595,0.0003029576,0.7213146,0.000051266245,0.006818329,0.00028120118],"about_ca_topic_score_codex":0.00017092055,"about_ca_topic_score_gemma":0.0000703026,"teacher_disagreement_score":0.19635761,"about_ca_system_score_codex":0.00017232489,"about_ca_system_score_gemma":0.0004701174,"threshold_uncertainty_score":0.57411927},"labels":[],"label_agreement":null},{"id":"W3015862482","doi":"10.1182/blood.2020005157","title":"HIT: still stringing us along","year":2020,"lang":"en","type":"letter","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine","score_opus":0.03662812024889811,"score_gpt":0.2667926787074205,"score_spread":0.2301645584585224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015862482","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28770933,0.00043354166,0.000022347624,0.68878484,0.000927093,0.0009976645,0.00010340606,0.00059253664,0.020429283],"genre_scores_gemma":[0.39099246,0.00008905649,0.0006736616,0.5978078,0.008289144,0.00004192445,0.0005013161,0.00020718254,0.0013974231],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99737453,0.0000658537,0.00050226646,0.00079253106,0.0005482682,0.00071654713],"domain_scores_gemma":[0.99861425,0.00010890554,0.00018154387,0.0007439343,0.000085469146,0.00026591486],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0000826409,0.0005328529,0.0012023179,0.0002003424,0.00009147481,0.00007250886,0.00031363964,0.00080085645,0.00048160861],"category_scores_gemma":[0.00015395314,0.00050409744,0.00035508518,0.0003037515,0.00006843871,0.00007605984,0.00019814295,0.0027985391,0.00090287026],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002879759,0.0004265843,0.024775911,0.0017169588,0.002613096,0.021648472,0.00047105143,6.0963094e-7,0.010527357,0.000046488854,0.93621016,0.0015345438],"study_design_scores_gemma":[0.0030728492,0.0003013777,0.008989265,0.00061634235,0.0026107042,0.0004797842,0.000018656772,0.000009479791,0.009945388,0.00006066463,0.97322935,0.000666116],"about_ca_topic_score_codex":0.00018850647,"about_ca_topic_score_gemma":0.000008318113,"teacher_disagreement_score":0.10328314,"about_ca_system_score_codex":0.00008428851,"about_ca_system_score_gemma":0.00032596997,"threshold_uncertainty_score":0.99987507},"labels":[],"label_agreement":null},{"id":"W3015984203","doi":"10.1182/blood.2019004143","title":"Oral cedazuridine/decitabine for MDS and CMML: a phase 2 pharmacokinetic/pharmacodynamic randomized crossover study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":210,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Health Sciences Centre; Alberta Hospital Edmonton; Hôpital Maisonneuve-Rosemont; Princess Margaret Cancer Centre; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Astex Pharmaceuticals","keywords":"Decitabine; Medicine; Neutropenia; Chronic myelomonocytic leukemia; Febrile neutropenia; Internal medicine; Adverse effect; Confidence interval; Gastroenterology; Pharmacodynamics; Azacitidine; Pharmacology; Myelodysplastic syndromes; Pharmacokinetics; Toxicity; Bone marrow","score_opus":0.03744326903252199,"score_gpt":0.37880241463902276,"score_spread":0.34135914560650077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015984203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98783314,0.00069862406,0.0009088281,0.0040921164,0.00009523072,0.0054882145,0.00011484301,0.00016067718,0.0006083054],"genre_scores_gemma":[0.99472386,0.0001512673,0.0014757812,0.0017267382,0.0005886706,0.00056461926,0.00006854549,0.00008569576,0.0006148436],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99775094,0.00017327305,0.0005032788,0.00058496895,0.0004553701,0.0005321651],"domain_scores_gemma":[0.9984375,0.00045148094,0.000102969425,0.0002459211,0.00021307706,0.0005489989],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007126293,0.0003135667,0.0009992449,0.00012719815,0.0001232604,0.0000656692,0.0001890375,0.00007703456,0.0005034677],"category_scores_gemma":[0.0008373312,0.0002526803,0.00022171112,0.00034681917,0.00019877488,0.0001189033,0.0001678637,0.0003813935,0.000043349723],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6133375,0.0091978535,0.0017062259,0.00081135303,0.0038466286,0.0012242108,0.00366764,0.000013446787,0.33813396,0.0001338541,0.019652056,0.008275227],"study_design_scores_gemma":[0.94437176,0.0022740453,0.00016246957,0.00002269855,0.0024346742,0.000093957184,0.00021945284,0.023550468,0.021055406,0.000027008547,0.0055090827,0.0002789759],"about_ca_topic_score_codex":0.00003279107,"about_ca_topic_score_gemma":0.0000016749171,"teacher_disagreement_score":0.3310342,"about_ca_system_score_codex":0.00004622868,"about_ca_system_score_gemma":0.00020815496,"threshold_uncertainty_score":0.99999255},"labels":[],"label_agreement":null},{"id":"W3016016533","doi":"10.1182/blood.v130.suppl_1.943.943","title":"Systemic Biomarkers Show Elevated Oxidative Stress and Chronic Inflammation in Two Disorders of Neurodegeneration with Brain Iron Accumulation (NBIA)","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Neurological diseases and metabolism","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"","keywords":"Neurodegeneration; Oxidative stress; Inflammation; Systemic inflammation; Medicine; Disease; Internal medicine; Pathology","score_opus":0.02476678549363779,"score_gpt":0.28840740779785884,"score_spread":0.26364062230422103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016016533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99890524,0.00006587103,0.000121054276,0.00027077793,0.000049699996,0.0004621782,0.000023910947,0.00002381089,0.000077435034],"genre_scores_gemma":[0.9997498,0.00010512489,0.00001945841,0.0000333863,0.000037599315,0.00002392097,0.000010873276,0.00001039979,0.00000948417],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99900854,0.00018399989,0.00018848201,0.00031952778,0.00014927324,0.00015016722],"domain_scores_gemma":[0.99930835,0.00009477807,0.00026551614,0.00026196876,0.000022366738,0.000047001555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000093082126,0.00011303299,0.00014154326,0.00007719268,0.00013097,0.00007403456,0.00014289563,0.00003350592,0.000004238467],"category_scores_gemma":[0.00039950237,0.00009324366,0.000021000842,0.00009713284,0.00012397798,0.00037721352,0.00004911865,0.00006868437,0.0000010452904],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008906211,0.00009685966,0.038182933,0.00006657672,0.000003962805,0.000005430472,0.00005685635,0.0013848672,0.9566732,0.0006750456,9.547092e-7,0.0027642578],"study_design_scores_gemma":[0.0033412778,0.00022815492,0.40545082,0.000076622804,0.000040522416,0.0000044481512,0.000015263971,0.0071056467,0.5833883,0.00020211375,0.000008002035,0.00013880696],"about_ca_topic_score_codex":0.000073964686,"about_ca_topic_score_gemma":0.00043115162,"teacher_disagreement_score":0.37328488,"about_ca_system_score_codex":0.000009309297,"about_ca_system_score_gemma":0.00003000427,"threshold_uncertainty_score":0.3802366},"labels":[],"label_agreement":null},{"id":"W3016294715","doi":"10.1182/blood.v106.11.3020.3020","title":"A Revisit of the Criteria To Define Remission in Patients with Idiopathic Thrombocytopenia Undergoing Splenectomy.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; McMaster University","funders":"","keywords":"Splenectomy; Medicine; Cohort; Retrospective cohort study; Thrombocytopenic purpura; Platelet; Internal medicine; Immune thrombocytopenia; Pediatrics; Surgery; Spleen","score_opus":0.008519447660276272,"score_gpt":0.24292025038362214,"score_spread":0.23440080272334587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016294715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99772674,0.00032982603,0.0000036121933,0.0006065634,0.000016246175,0.00041826945,0.000003849654,0.000011020919,0.00088390347],"genre_scores_gemma":[0.99886334,0.00002200344,0.0007548568,0.00025856326,0.000017584645,0.0000069275306,0.0000051743773,0.0000138094,0.000057738373],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99928236,0.000025572994,0.00018654158,0.00016514993,0.00019066148,0.0001497284],"domain_scores_gemma":[0.9995728,0.000011815483,0.000058482907,0.00025693537,0.000041352087,0.000058611447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007303222,0.00010255574,0.00028650195,0.00005003274,0.000032440694,0.000006092213,0.00006810363,0.000040031577,0.00003546685],"category_scores_gemma":[0.00007102001,0.000058920978,0.000034998073,0.00022087971,0.000013368642,0.000045798966,0.000043873442,0.00007392309,0.000012637016],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003609541,0.0017898271,0.9907988,0.00013539715,0.00006375727,0.0000309604,0.00030077086,0.0000057340835,0.0036468478,0.000024251034,0.00008313052,0.0027596198],"study_design_scores_gemma":[0.011074918,0.0006854394,0.9741604,0.0020049934,0.00014736972,0.000017803943,0.000017339105,0.000005388094,0.01149102,0.000030152307,0.00027188077,0.00009329808],"about_ca_topic_score_codex":0.000028218448,"about_ca_topic_score_gemma":0.000118647,"teacher_disagreement_score":0.016638353,"about_ca_system_score_codex":0.00003179777,"about_ca_system_score_gemma":0.00006681756,"threshold_uncertainty_score":0.24027278},"labels":[],"label_agreement":null},{"id":"W3016305930","doi":"10.1182/blood.v130.suppl_1.98.98","title":"CA180-372: An International Collaborative Phase 2 Trial of Dasatinib and Chemotherapy in Pediatric Patients with Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Dasatinib; Medicine; Internal medicine; Imatinib; Oncology; Minimal residual disease; Chemotherapy; Philadelphia chromosome; Imatinib mesylate; Acute lymphocytic leukemia; Clinical trial; Hematopoietic stem cell transplantation; Chemotherapy regimen; Leukemia; Transplantation; Lymphoblastic Leukemia; Chromosomal translocation; Myeloid leukemia; Biology","score_opus":0.010661051771750417,"score_gpt":0.2896659076061985,"score_spread":0.27900485583444806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016305930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970706,0.000056401394,0.0000058565956,0.00026611803,0.00016204204,0.0016144942,0.00042310698,0.000024223928,0.00037715444],"genre_scores_gemma":[0.99791026,0.00039141817,0.0006074735,0.00012238105,0.00037334286,0.00010447558,0.00041406634,0.000045115856,0.00003144273],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982585,0.00005799343,0.0004230872,0.0004928653,0.0004848253,0.00028276924],"domain_scores_gemma":[0.9983561,0.00013509704,0.00051681726,0.0005285351,0.00026348128,0.00019996616],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010573464,0.00030430013,0.0005485637,0.00019275432,0.00009566252,0.00005649248,0.00024279553,0.00013894186,0.00005931449],"category_scores_gemma":[0.00018779379,0.0002513853,0.00004977289,0.0001574552,0.0001683871,0.00040044487,0.00006494934,0.00015550356,0.000003938946],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1393547,0.024192078,0.81494033,0.00014274253,0.00359858,0.0013831638,0.0064245537,0.000019494464,0.0027569034,0.00008511134,0.00018869594,0.006913632],"study_design_scores_gemma":[0.5337425,0.0065580118,0.45613843,0.0001101673,0.00075480534,0.000017338196,0.000049809558,0.00013759118,0.0022357968,0.000013441557,0.000031735457,0.00021036353],"about_ca_topic_score_codex":0.00020181632,"about_ca_topic_score_gemma":0.000102952756,"teacher_disagreement_score":0.39438778,"about_ca_system_score_codex":0.00059365167,"about_ca_system_score_gemma":0.0010286596,"threshold_uncertainty_score":0.99999386},"labels":[],"label_agreement":null},{"id":"W3016331040","doi":"10.1182/blood.2019004588","title":"Long-term outcomes for patients with limited-stage follicular lymphoma: update of a population-based study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Follicular lymphoma; Medicine; Term (time); Stage (stratigraphy); Lymphoma; Population; Radiation therapy; Follicular phase; Oncology; Internal medicine; Pediatrics; Biology","score_opus":0.019311338204259124,"score_gpt":0.26443598825763165,"score_spread":0.24512465005337253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016331040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99749213,0.000055673314,0.00003131548,0.0003768642,0.000023074741,0.0018568473,0.0001029667,0.00004380329,0.000017325723],"genre_scores_gemma":[0.99817663,0.0000014551413,0.0005877748,0.0005299287,0.000023074213,0.00018699699,0.00044866605,0.000026351558,0.000019098135],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99904585,0.000018388526,0.00025072595,0.00025729087,0.00027614812,0.0001515887],"domain_scores_gemma":[0.9993189,0.00006889587,0.00012785368,0.00025092388,0.00010776522,0.00012565608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000030524345,0.00016471323,0.0003947343,0.000047024165,0.000042461044,0.00001129632,0.000057355177,0.000036085476,0.000022141821],"category_scores_gemma":[0.00005565023,0.00010882843,0.00012676255,0.0001276706,0.000009682702,0.000036741232,0.000017554255,0.00001568317,0.000005716403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032578045,0.014360878,0.98367375,0.000118250726,0.00066225225,0.000058604925,0.0001072685,0.000008508385,0.000004597772,0.000017285885,0.000016770395,0.00064603664],"study_design_scores_gemma":[0.049448084,0.002909717,0.94560534,0.000043324624,0.0012251367,4.2225324e-7,0.000023983455,0.00002782395,0.0005723563,9.941587e-7,0.000037448972,0.000105362],"about_ca_topic_score_codex":0.000051971834,"about_ca_topic_score_gemma":0.00002247069,"teacher_disagreement_score":0.049122304,"about_ca_system_score_codex":0.00003429342,"about_ca_system_score_gemma":0.000054302,"threshold_uncertainty_score":0.44378945},"labels":[],"label_agreement":null},{"id":"W3016333719","doi":"10.1182/blood.v110.11.1505.1505","title":"Potentiated Phospho-Protein Network Profiling of Multiple Myeloma Cell Lines and Primary Patient Samples by Multi-Parameter Flow Cytometry.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Flow cytometry; Signal transduction; Biology; Cancer research; Cell culture; PI3K/AKT/mTOR pathway; Cell biology; Cytokine; Molecular biology; Immunology; Genetics","score_opus":0.019103842475807594,"score_gpt":0.2561482182932446,"score_spread":0.23704437581743698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016333719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99163204,0.004136749,0.0023732241,0.000022508888,0.000053779586,0.0013905987,0.00015798233,0.00007113834,0.0001619828],"genre_scores_gemma":[0.84714407,0.000086968066,0.15199491,0.000054583958,0.00006604922,0.000042746364,0.00038687608,0.00004168255,0.00018208375],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99786115,0.000054523676,0.00051344966,0.00043887398,0.00047198625,0.00066000636],"domain_scores_gemma":[0.99867463,0.0002658269,0.00017195469,0.0003494279,0.0001889247,0.00034924716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028669983,0.00027616156,0.00048182337,0.0001573726,0.000109797584,0.000022127566,0.00009327495,0.00015803307,0.0000451697],"category_scores_gemma":[0.00033333313,0.00022339042,0.00012014031,0.0003888701,0.00011283784,0.00007250454,0.00012236077,0.00022101706,0.000009155014],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012999892,0.003599068,0.47686112,0.00047228672,0.00043169438,0.00022805734,0.00013936289,0.000010600349,0.48657733,0.0000012085078,0.00015444885,0.03022483],"study_design_scores_gemma":[0.012221196,0.0008244571,0.16709682,0.00017396203,0.00015931846,0.000026818016,0.000072495146,0.0014404953,0.817604,0.000005874289,0.00017213417,0.00020244712],"about_ca_topic_score_codex":0.00020454623,"about_ca_topic_score_gemma":0.000023883053,"teacher_disagreement_score":0.33102664,"about_ca_system_score_codex":0.000039036582,"about_ca_system_score_gemma":0.000064599604,"threshold_uncertainty_score":0.9109597},"labels":[],"label_agreement":null},{"id":"W3016358258","doi":"10.1182/blood.2019000106","title":"Mitochondrial carrier homolog 2 is necessary for AML survival","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Ontario Ministry of Research and Innovation; Leukemia and Lymphoma Society; Canadian Institutes of Health Research; Leukemia and Lymphoma Society of Canada; Tel Aviv University; Ontario Institute for Cancer Research","keywords":"Mitochondrion; Stem cell; Biology; Gene knockdown; Cell biology; Myeloid; Cancer research; Myeloid leukemia; Molecular biology; Gene; Genetics","score_opus":0.019268030445576217,"score_gpt":0.2591687659446876,"score_spread":0.23990073549911137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016358258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98751056,0.0018107195,0.0074599935,0.0010082098,0.0003928645,0.00027107925,0.0001921525,0.00001544388,0.0013389579],"genre_scores_gemma":[0.9942094,0.00013509385,0.0026988012,0.0006159543,0.0017445339,0.000033864028,0.00023769592,0.000027236701,0.00029741164],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992963,0.000028070888,0.0001368884,0.00029200196,0.000082163715,0.00016457895],"domain_scores_gemma":[0.9996028,0.00001333645,0.000046783083,0.00017335374,0.000064807435,0.0000989384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000050960174,0.00010370821,0.000112638045,0.000010668998,0.000057272864,0.000018749153,0.00012539614,0.00013932584,0.000025224252],"category_scores_gemma":[0.00010850734,0.000103865474,0.00010023989,0.00004728513,0.000027297432,0.0000016696473,0.000055348683,0.00004507771,0.0000060140937],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007096045,0.00005652394,0.003244787,0.000018161296,0.0000649407,0.00000152007,0.00007988473,0.000011307326,0.99364793,0.00003915619,0.0020798773,0.00068497105],"study_design_scores_gemma":[0.0015841064,0.0004357264,0.00061701157,0.0000017882156,0.00005446724,6.830459e-7,0.000028885655,0.000037155354,0.8947322,0.00021144669,0.10214385,0.00015270355],"about_ca_topic_score_codex":0.0000070010765,"about_ca_topic_score_gemma":0.0000069686025,"teacher_disagreement_score":0.10006397,"about_ca_system_score_codex":0.0000016364643,"about_ca_system_score_gemma":0.00004500705,"threshold_uncertainty_score":0.4235511},"labels":[],"label_agreement":null},{"id":"W3016429588","doi":"10.1182/blood.v112.11.3006.3006","title":"Impact of Conditioning Regimen in Allogeneic Hematopoetic Stem Cell Tansplant for Children with AML beyond the First Complete Remission: Total Body Irradiation Versus Busulfan- a Pediatric Blood and Marrow Transplant Consortium (PBMTC) Study","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Busulfan; Medicine; Total body irradiation; Regimen; Surgery; Cyclophosphamide; Population; Transplantation; Internal medicine; Cord blood; Hematopoietic stem cell transplantation; Chemotherapy","score_opus":0.01626836253178911,"score_gpt":0.24315158993378172,"score_spread":0.2268832274019926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016429588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960412,0.0005908742,0.000058047415,0.00007019489,0.000047520673,0.0027331298,0.00028807417,0.000039999937,0.00013100571],"genre_scores_gemma":[0.99896586,0.0001969633,0.0002606882,0.000016834278,0.00008139423,0.00014989737,0.0002539877,0.000044664608,0.000029696386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99803627,0.0000933715,0.00062498613,0.0004514787,0.0004242075,0.0003696732],"domain_scores_gemma":[0.9987267,0.00037988642,0.00029577056,0.00034794435,0.00008995303,0.00015970918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029035346,0.00031586594,0.0005768775,0.00019748847,0.0002166503,0.000016884054,0.0001161002,0.000116902884,0.000022255423],"category_scores_gemma":[0.000010220148,0.0002214662,0.00011658694,0.00031901104,0.00011060915,0.0000822314,0.000011614653,0.00019631986,0.0000020198459],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015433717,0.0016654814,0.985098,0.00047646038,0.0005001806,0.00023136275,0.0050065406,0.00010824899,0.005312,0.000017997549,0.000032658496,0.000007701757],"study_design_scores_gemma":[0.03307066,0.003841993,0.9513914,0.00018593257,0.0028919368,0.0026814353,0.0004921506,0.00011930607,0.005046216,0.0000039355723,0.000001123971,0.0002739284],"about_ca_topic_score_codex":0.00011516979,"about_ca_topic_score_gemma":0.00005087559,"teacher_disagreement_score":0.033706613,"about_ca_system_score_codex":0.00003787672,"about_ca_system_score_gemma":0.00021523894,"threshold_uncertainty_score":0.90311295},"labels":[],"label_agreement":null},{"id":"W3016493833","doi":"10.1182/blood.v104.11.2832.2832","title":"Functional Characterization of Telomerase RNA Variants Found in Patients with Hematological Disorders.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; University of British Columbia","funders":"","keywords":"Telomerase; Telomere; Aplastic anemia; RNA; Biology; Telomerase RNA component; Mutation; Bone marrow; Genetics; Telomerase reverse transcriptase; Cancer research; DNA; Immunology; Gene","score_opus":0.008864904266077589,"score_gpt":0.20381609180276788,"score_spread":0.1949511875366903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016493833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987952,0.00002688764,0.000356384,0.00018787176,0.00006950916,0.00031530927,0.000013048394,0.00003114387,0.00020463314],"genre_scores_gemma":[0.9991738,0.00001764396,0.00041073968,0.00013710013,0.000037809332,0.000012983629,0.00016199515,0.000014035371,0.000033887165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989923,0.000018805773,0.0002674076,0.00023121695,0.000299208,0.00019105358],"domain_scores_gemma":[0.9995295,0.000019250701,0.00009850613,0.00017498313,0.00009666031,0.000081135106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005648478,0.000130254,0.0002703459,0.0001270578,0.000035147983,0.0000067201577,0.000050037743,0.00008082687,0.00010098629],"category_scores_gemma":[0.0000618515,0.00009900562,0.000032667656,0.00037337976,0.00007440166,0.00011214389,0.000017035069,0.00011646962,0.000015966352],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055586395,0.004535425,0.98342836,0.00010400303,0.000052873373,0.000032629552,0.00016324401,0.000008620264,0.0095551815,0.00042541107,0.00000387331,0.0011345082],"study_design_scores_gemma":[0.010045218,0.00047269618,0.9853449,0.0001409138,0.00005297647,0.000015967868,0.00001854137,0.0000029681062,0.0036527133,0.00011165207,0.000028235088,0.00011324482],"about_ca_topic_score_codex":0.000033972596,"about_ca_topic_score_gemma":0.000023128405,"teacher_disagreement_score":0.009489354,"about_ca_system_score_codex":0.0000236912,"about_ca_system_score_gemma":0.000098957804,"threshold_uncertainty_score":0.40373322},"labels":[],"label_agreement":null},{"id":"W3016526709","doi":"10.1182/blood.v130.suppl_1.1114.1114","title":"Treatment of Venous Thromboembolism in Acute Leukemia: A Systematic Review","year":2017,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Internal medicine; Population; Observational study; Acute promyelocytic leukemia; Acute leukemia; Randomized controlled trial; Heparin; Myeloid leukemia; Leukemia; Intensive care medicine; Surgery","score_opus":0.06914135379366543,"score_gpt":0.3745869498414721,"score_spread":0.3054455960478067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016526709","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000023443416,0.9865526,4.73609e-7,0.000045470253,0.00017998858,0.009994441,0.00005642285,0.000041872197,0.0031053189],"genre_scores_gemma":[0.000029369545,0.99672914,0.00007247557,0.00008302019,0.00012522441,0.0022097626,0.0001405829,0.00009720849,0.000513242],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9966727,0.0001882953,0.0017116853,0.0005771198,0.00040761984,0.00044257846],"domain_scores_gemma":[0.99613893,0.00010657036,0.0014563384,0.0020800703,0.00007176724,0.00014630464],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00032217352,0.0006634215,0.015022553,0.00032334134,0.00006469741,0.000026107284,0.00042952783,0.00033258175,0.00004191093],"category_scores_gemma":[0.00013667168,0.00045998013,0.0013699337,0.00022254128,0.00007213921,0.00005127374,0.00011005248,0.00022006663,0.00015873609],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000013623177,0.0037871802,0.0000012824024,0.90659624,0.0044202055,0.00080746337,0.000086495595,1.65153e-8,1.2759277e-7,0.000121234276,0.00018867335,0.08398973],"study_design_scores_gemma":[0.0012616011,0.00089934183,0.000032042302,0.7295476,0.105284594,0.0004116975,0.000006070623,1.8363063e-7,0.0000015076636,0.000008479287,0.16227494,0.00027189744],"about_ca_topic_score_codex":0.00015842021,"about_ca_topic_score_gemma":0.00001764757,"teacher_disagreement_score":0.17704858,"about_ca_system_score_codex":0.0004891399,"about_ca_system_score_gemma":0.0007366551,"threshold_uncertainty_score":0.9997852},"labels":[],"label_agreement":null},{"id":"W3016622824","doi":"10.1182/blood.v112.11.2868.2868","title":"Engagement of Fibrinogen and β3 Integrin Is Required for Maintenance of Platelet Intracellular and Cell Surface P-Selectin Expression","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto; Canadian Blood Services; St. Michael's Hospital","funders":"","keywords":"Platelet; Fibrinogen; Internal medicine; Endocrinology; Von Willebrand factor; P-selectin; Platelet activation; Chemistry; Immunology; Biology; Medicine","score_opus":0.021180013577994913,"score_gpt":0.2405634323944094,"score_spread":0.2193834188164145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016622824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99656236,0.0024408249,0.0001127371,0.00007073404,0.000014714466,0.00047121695,0.000036267404,0.000010369676,0.00028078357],"genre_scores_gemma":[0.99231994,0.0011463463,0.006013304,0.000023619585,0.000008915949,0.0000084144895,0.000015389227,0.000013887815,0.00045016775],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993022,0.000018830762,0.00021935582,0.00019871406,0.00010473679,0.0001561486],"domain_scores_gemma":[0.99956983,0.0000638586,0.00011125127,0.00013922012,0.000056180812,0.000059653117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010123546,0.00011456829,0.00032324812,0.000034816443,0.00004635873,0.0000022677968,0.000032559325,0.000064533815,0.000015899683],"category_scores_gemma":[0.000032998425,0.00009089565,0.00004145031,0.00005765238,0.00006464914,0.000036182944,0.000035049616,0.00006591321,7.176743e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034716583,0.0007765575,0.021163289,0.0003755557,0.00012321133,0.00011290603,0.0013187361,0.0000019136596,0.9742391,0.000011982021,0.00069624296,0.0008333122],"study_design_scores_gemma":[0.00689991,0.0006705642,0.0035032362,0.00014842715,0.000101447324,0.000114706774,0.00016048708,0.000051642117,0.9876087,0.00006401415,0.000600109,0.00007676475],"about_ca_topic_score_codex":0.000040450763,"about_ca_topic_score_gemma":0.0000018617061,"teacher_disagreement_score":0.017660053,"about_ca_system_score_codex":0.000006772476,"about_ca_system_score_gemma":0.000030437419,"threshold_uncertainty_score":0.3706617},"labels":[],"label_agreement":null},{"id":"W3016675771","doi":"10.1182/blood.v106.11.2625.2625","title":"Bim Promoter Is Highly Methylated in Malignant Lymphoid Cell Lines, Leading to Downregulation of Bim Expression and Protection from Apoptosis.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Demethylating agent; Methylation; Cancer research; Biology; DNA methylation; Molecular biology; Apoptosis; Cell culture; Myeloid; Gene expression; Genetics; Gene","score_opus":0.010797830202892107,"score_gpt":0.23185569945560902,"score_spread":0.22105786925271692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016675771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964229,0.0007412529,0.002229801,0.00021493013,0.000020666923,0.00028965934,0.000016780778,0.0000069056578,0.00005712671],"genre_scores_gemma":[0.99562585,0.0001189607,0.0038374725,0.000054590946,0.0001027941,0.00006418649,0.000041762265,0.000011833703,0.00014255021],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993343,0.000032234002,0.00019389132,0.0002651345,0.00007151102,0.000102964164],"domain_scores_gemma":[0.9996431,0.0000028340037,0.00007706606,0.00019261181,0.000047010693,0.0000373638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008399784,0.00008953956,0.00010067417,0.00006679769,0.0000298343,0.000012316142,0.000058011203,0.000115226394,0.000011496983],"category_scores_gemma":[0.0000094611205,0.00007947131,0.000025665386,0.00011819124,0.0000135053415,0.0000072681623,0.000034853347,0.00003118564,0.0000033838976],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035211146,0.00014262773,0.0007626058,0.000011543744,0.000008943785,8.525854e-8,0.00010465819,0.00010115906,0.993599,0.000003679365,0.000036524245,0.0051939418],"study_design_scores_gemma":[0.0008424823,0.00009705322,0.0044508413,0.000042948825,0.000016581263,0.0000010188867,0.000018567807,0.00013933043,0.99236804,0.000029885423,0.0018913937,0.00010188034],"about_ca_topic_score_codex":0.00011959341,"about_ca_topic_score_gemma":0.000023179533,"teacher_disagreement_score":0.0050920616,"about_ca_system_score_codex":0.000011113468,"about_ca_system_score_gemma":0.00002220925,"threshold_uncertainty_score":0.3240746},"labels":[],"label_agreement":null},{"id":"W3016681923","doi":"10.1182/blood.v112.11.438.438","title":"The Impact of Age on the Efficacy and Safety of Extended-Duration Thromboprophylaxis in Acutely Ill Medical Patients with Recent Immobility: A Sub-Group Analysis from the EXCLAIM Study","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Foothills Medical Centre; University of Calgary","funders":"","keywords":"Medicine; Placebo; Internal medicine; Randomized controlled trial; Clinical trial; Absolute risk reduction; Pediatrics; Surgery; Confidence interval; Pathology","score_opus":0.01510879548702747,"score_gpt":0.26776460321043527,"score_spread":0.2526558077234078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016681923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970818,0.00022821408,0.000009003234,0.0005755091,0.000023618803,0.0019120222,0.000027419615,0.000009403313,0.00013296847],"genre_scores_gemma":[0.9982536,0.001477718,0.000014067543,0.00011456544,0.00002896488,0.000058830992,0.000036631434,0.000013020646,0.0000026402254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978268,0.00031486023,0.00053309964,0.0003023188,0.0008238265,0.00019905718],"domain_scores_gemma":[0.9980431,0.00078141846,0.00023769958,0.0007254434,0.00013918839,0.00007312761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008028169,0.0001808406,0.0005957651,0.000075163436,0.00018137682,0.0000131081615,0.00021382286,0.00006038685,0.0000696626],"category_scores_gemma":[0.00044907167,0.00006948071,0.00013239008,0.00068523077,0.00029386842,0.000036726324,0.00010050418,0.00022102208,0.0000010849375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014646557,0.02640154,0.944663,0.000017003791,0.00641176,0.000049753453,0.0067434753,0.000027232143,0.00021042714,0.00009802682,0.00019832613,0.013714782],"study_design_scores_gemma":[0.005073423,0.003648731,0.9888399,0.00006106384,0.001217473,0.0000010665219,0.00081141177,0.000029916606,0.00018494575,0.00003097556,0.00002742804,0.00007366219],"about_ca_topic_score_codex":0.0017727194,"about_ca_topic_score_gemma":0.0013610015,"teacher_disagreement_score":0.044176884,"about_ca_system_score_codex":0.000046634672,"about_ca_system_score_gemma":0.00007343786,"threshold_uncertainty_score":0.2833341},"labels":[],"label_agreement":null},{"id":"W3016845921","doi":"10.1182/blood.v110.11.3553.3553","title":"A Phase II Trial of the Small Molecule Pan-Bcl-2 Family Inhibitor Obatoclax Mesylate (GX15-070) Administered by a 24-h Continuous Infusion Every 2 Weeks to Patients with Chronic Idiopathic Myelofibrosis (CIMF).","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Chills; Nausea; Anemia; Internal medicine; Peripheral edema; Erythropoietin; Adverse effect; Gastroenterology; Rash","score_opus":0.01368548042332383,"score_gpt":0.2639499997712481,"score_spread":0.25026451934792426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016845921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99351984,0.0008778694,0.00005884984,0.00016921062,0.00036751348,0.0042670756,0.000104285275,0.00008516071,0.0005501846],"genre_scores_gemma":[0.9978411,0.000045725963,0.00017748066,0.00032043413,0.00037946439,0.00015377263,0.000056662488,0.00010194695,0.00092339574],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9955858,0.00018177013,0.0010429298,0.00072754815,0.0014790692,0.0009828745],"domain_scores_gemma":[0.9973135,0.00016114215,0.0004080081,0.0011965154,0.00043176394,0.00048906775],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00087110314,0.0004641619,0.0008911367,0.0002255901,0.00022378395,0.000041177384,0.0004840455,0.00033397332,0.000026667662],"category_scores_gemma":[0.0005041937,0.00031590927,0.0002706364,0.0008479225,0.0002510395,0.000090531874,0.0005228849,0.00049652846,0.000033687917],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21689558,0.03846373,0.003472037,0.0013330863,0.0011250746,0.0004808891,0.0031385012,0.0000037042084,0.6955983,0.000026313877,0.00398146,0.035481323],"study_design_scores_gemma":[0.68938154,0.04250898,0.0023431303,0.001668431,0.0006220263,0.000067198955,0.0001345827,0.000096611424,0.259896,0.000006362733,0.0027676425,0.0005074623],"about_ca_topic_score_codex":0.00068765145,"about_ca_topic_score_gemma":0.00024550437,"teacher_disagreement_score":0.472486,"about_ca_system_score_codex":0.0031112046,"about_ca_system_score_gemma":0.0067283357,"threshold_uncertainty_score":0.9999293},"labels":[],"label_agreement":null},{"id":"W3016922132","doi":"10.1182/blood.v130.suppl_1.1845.1845","title":"Superior Efficacy of Carfilzomib and Dexamethasone (Kd56) Vs Bortezomib and Dexamethasone (Vd) in Multiple Myeloma (MM) Patients with Moderate or Serious Renal Failure: A Subgroup Analysis of the Phase 3 Endeavor Study","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Carfilzomib; Medicine; Dexamethasone; Multiple myeloma; Internal medicine; Hazard ratio; Bortezomib; Clinical endpoint; Renal function; Creatinine; Adverse effect; Urology; Surgery; Confidence interval; Gastroenterology; Randomized controlled trial","score_opus":0.024720765597734652,"score_gpt":0.2989913116747137,"score_spread":0.27427054607697904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016922132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970453,0.0001994425,0.000016619582,0.000072953124,0.000012593663,0.0024113806,0.0002025528,0.000014744924,0.000024454339],"genre_scores_gemma":[0.9980259,0.000041718373,0.0016352924,0.0000129688615,0.000018691711,0.0001142986,0.000043118787,0.000037054673,0.00007097064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973954,0.00027459834,0.00054660277,0.0006210519,0.00067249854,0.00048987864],"domain_scores_gemma":[0.99745804,0.00049886154,0.00036499955,0.0011279616,0.00026023033,0.00028990113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047582935,0.00034735785,0.0011914715,0.00039383298,0.00027546898,0.000075125296,0.00026291807,0.00011761687,0.00003062796],"category_scores_gemma":[0.0014596911,0.00020286912,0.00013309947,0.0005771659,0.0004293824,0.00018999702,0.00027361733,0.00028001456,5.2071834e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013819289,0.009011898,0.9581169,0.00011123078,0.0040512322,0.0002462361,0.0018409534,0.000008116291,0.0045209145,0.0000018120408,0.0000019807576,0.008269449],"study_design_scores_gemma":[0.09493576,0.0036200078,0.8869079,0.00011774502,0.0032159765,0.000015424981,0.00042111002,0.0012257856,0.009356624,0.0000020320579,0.000005164218,0.00017649001],"about_ca_topic_score_codex":0.002216933,"about_ca_topic_score_gemma":0.007591407,"teacher_disagreement_score":0.081116475,"about_ca_system_score_codex":0.00004250454,"about_ca_system_score_gemma":0.00017212503,"threshold_uncertainty_score":0.8272763},"labels":[],"label_agreement":null},{"id":"W3016971194","doi":"10.1182/blood.v112.11.412.412","title":"Genetic Disruption of □pdl and □pdlr Phospholipases in Mice Leads to Impaired Platelet Adhesion and Aggregation","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Princess Margaret Cancer Centre; Canadian Blood Services; University of Toronto; University Health Network","funders":"","keywords":"Phospholipase; Platelet; Platelet activation; Chemistry; Lipid raft; Biochemistry; Phospholipase C; GPVI; Cell biology; Phospholipase A2; Phospholipase A1; Phospholipase D; Biology; Enzyme; Signal transduction; Immunology","score_opus":0.01831227749107573,"score_gpt":0.24730237909405445,"score_spread":0.22899010160297872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016971194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986405,0.0008865181,0.000018865454,0.000122062935,0.00005080948,0.00020638396,0.000004051514,0.000016922253,0.000053900654],"genre_scores_gemma":[0.99791133,0.0009058363,0.0008137153,0.00019844559,0.00006066705,0.000009256239,0.000012432605,0.000007971792,0.00008035546],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9994741,0.000026703538,0.00016546913,0.0001635676,0.00007223772,0.000097921766],"domain_scores_gemma":[0.9997332,0.00003688479,0.000044878852,0.00008332725,0.000030716645,0.00007095658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004325516,0.000076381475,0.00018097687,0.00009516503,0.000030181336,0.0000018147042,0.000014615604,0.000070404894,0.00001905438],"category_scores_gemma":[0.00005696645,0.00006839554,0.000018537696,0.00012087428,0.00005066453,0.000032487733,0.000017322427,0.000056481626,0.0000065561303],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005538333,0.00036601786,0.31015143,0.00013508272,0.000014305964,0.00008255813,0.0011309491,0.0000089836085,0.6797981,0.000010881261,0.00015495667,0.0075928653],"study_design_scores_gemma":[0.0029480732,0.00091410824,0.86034256,0.00010085692,0.00003299548,0.000411198,0.000059728576,0.00006478765,0.13489228,0.000021511038,0.0001401955,0.000071714814],"about_ca_topic_score_codex":0.00008159058,"about_ca_topic_score_gemma":0.000031528165,"teacher_disagreement_score":0.5501911,"about_ca_system_score_codex":0.000008195634,"about_ca_system_score_gemma":0.000021774023,"threshold_uncertainty_score":0.2789089},"labels":[],"label_agreement":null},{"id":"W3016996446","doi":"10.1182/blood.v112.11.4050.4050","title":"Dose Escalation of Low Molecular Weight Heparin to Manage VTE Treatment Failure in Cancer Patients","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Low molecular weight heparin; Cancer; Thrombosis; Surgery; Heparin; Retrospective cohort study; Internal medicine","score_opus":0.010044156597004115,"score_gpt":0.248805326042277,"score_spread":0.2387611694452729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016996446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99680597,0.00012334577,0.000020245569,0.00045851755,0.00005236179,0.0008266498,0.0000085215315,0.000018196906,0.0016862195],"genre_scores_gemma":[0.9984836,0.00035727484,0.00045752453,0.00027162317,0.0000341301,0.00015213722,0.00002836456,0.000017006281,0.0001983337],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991713,0.000017951968,0.0002173347,0.00021084127,0.00020336838,0.00017916242],"domain_scores_gemma":[0.9995954,0.0000071736495,0.0000539638,0.00021786103,0.0000410996,0.00008449538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003138202,0.000121925215,0.00031480406,0.00014772218,0.000023463543,0.0000031440952,0.000049699407,0.00004424878,0.00007415209],"category_scores_gemma":[0.00000918233,0.00010364997,0.000065584165,0.00020653351,0.000015412179,0.000034029086,0.00003590039,0.000036979603,0.000022528498],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000121187346,0.022530364,0.9528118,0.000303318,0.0005516355,0.00041497473,0.0032136857,0.00045154188,0.006213999,0.000405823,0.0019311979,0.011050469],"study_design_scores_gemma":[0.005667613,0.0007723796,0.9653145,0.0001730095,0.0002245049,0.0000017223032,0.000021183643,0.000031389976,0.024630709,0.000018236888,0.0030268703,0.00011785371],"about_ca_topic_score_codex":0.0007465843,"about_ca_topic_score_gemma":0.0004890806,"teacher_disagreement_score":0.021757985,"about_ca_system_score_codex":0.00008576016,"about_ca_system_score_gemma":0.000022191236,"threshold_uncertainty_score":0.4226723},"labels":[],"label_agreement":null},{"id":"W3017091259","doi":"10.1182/blood.v112.11.477.477","title":"Deletion in Chromosome 17p12 and Gains in Chromosome 9q33.3 by Array Comparative Hybridization Are Associated with R-CHOP Treatment Failure in Patients with Diffuse Large B Cell Lymphoma","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Comparative genomic hybridization; Diffuse large B-cell lymphoma; CHOP; Oncology; PMS2; Internal medicine; Biology; International Prognostic Index; Lymphoma; Chromosome; Medicine; Bioinformatics; Cancer research; Genetics; Gene; Mutation; Germline mutation","score_opus":0.01106881339332029,"score_gpt":0.21394459496519422,"score_spread":0.20287578157187391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3017091259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980243,0.00031505057,0.0000032538953,0.00010899824,0.000012015223,0.0012050518,0.00017061843,0.00003490437,0.00012583287],"genre_scores_gemma":[0.9983251,0.0001975984,0.000074351585,0.00008164813,0.000015840098,0.000252542,0.00097191223,0.00003220686,0.000048801543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983928,0.000107321524,0.00032623988,0.00046773907,0.0003136163,0.00039224466],"domain_scores_gemma":[0.99931043,0.00006594862,0.00019785647,0.00020238591,0.00009219034,0.00013117203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000053662436,0.00033951798,0.0006280208,0.00020471367,0.00007626145,0.000017578619,0.000041066327,0.00011559238,0.000009951002],"category_scores_gemma":[0.000018756687,0.00024362693,0.000031312695,0.00055206474,0.000060306138,0.00016029389,0.000013677673,0.00007394893,0.000006440943],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028981175,0.04910386,0.9477094,0.00002185053,0.00012029429,0.00040933242,0.001937969,0.0000102856575,0.00027384548,0.0000029869404,0.00006485992,0.000055542594],"study_design_scores_gemma":[0.12648733,0.0021227372,0.863229,0.00040578583,0.00012460224,0.000019197749,0.00022972914,0.000036832098,0.0070460285,0.0000018003796,0.0000667778,0.00023019568],"about_ca_topic_score_codex":0.00025835773,"about_ca_topic_score_gemma":0.0036957653,"teacher_disagreement_score":0.12619752,"about_ca_system_score_codex":0.00081763876,"about_ca_system_score_gemma":0.00012796093,"threshold_uncertainty_score":0.99348176},"labels":[],"label_agreement":null},{"id":"W3017092769","doi":"10.1182/blood.v108.11.5081.5081","title":"Bortezomib Therapy Response Is Independent of Cytogenetic Abnormalities in Relapsed/Refractory Multiple Myeloma.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Bortezomib; Multiple myeloma; Internal medicine; Fluorescence in situ hybridization; Gastroenterology; Cytogenetics; Refractory (planetary science); Biology; Medicine; Chromosome","score_opus":0.02416553443200218,"score_gpt":0.2830395228515201,"score_spread":0.2588739884195179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3017092769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99482435,0.0028288786,0.0000035980568,0.00015658422,0.000034365985,0.0006044651,0.00006489119,0.000035550507,0.0014473285],"genre_scores_gemma":[0.99725556,0.00028330984,0.0004589695,0.00008686631,0.00007131211,0.000072528645,0.0000379154,0.000033245353,0.0017003048],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980971,0.00018896183,0.00044185165,0.00030051148,0.00054759375,0.0004239622],"domain_scores_gemma":[0.99893165,0.00026832044,0.000102651524,0.0004623095,0.000100759906,0.00013429584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038101763,0.00019943021,0.0003685255,0.00032243202,0.00004501968,0.0000122430565,0.00012159725,0.00013793656,0.00023056373],"category_scores_gemma":[0.00013593896,0.00016633139,0.0001286867,0.00022904208,0.00010198423,0.000052532967,0.00004351261,0.00020722972,0.000042088326],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062397197,0.0033777584,0.9043134,0.000052382067,0.0001686948,0.00057479047,0.0004977187,0.000005623258,0.0821621,0.0000176968,0.00016693817,0.0024231966],"study_design_scores_gemma":[0.020639593,0.0008407792,0.7915715,0.000069324626,0.00003133798,0.00005198246,0.00013642236,0.000032727323,0.18558775,0.000063122,0.0008615428,0.00011393109],"about_ca_topic_score_codex":0.0016056228,"about_ca_topic_score_gemma":0.00027219544,"teacher_disagreement_score":0.11274189,"about_ca_system_score_codex":0.000072283045,"about_ca_system_score_gemma":0.00023483128,"threshold_uncertainty_score":0.6782797},"labels":[],"label_agreement":null},{"id":"W3017155299","doi":"10.1182/blood.v112.11.273.273","title":"Genotyp-Phenotype Correlation in Congenital ADAMTS13 Deficient Patients","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"ADAMTS13; Microangiopathic hemolytic anemia; Medicine; Gastroenterology; Thrombotic thrombocytopenic purpura; Genotype; Internal medicine; Age of onset; Genotype-phenotype distinction; Pediatrics; Phenotype; Gene mutation; Mutation; Disease; Genetics; Gene; Biology; Platelet","score_opus":0.013867985624496286,"score_gpt":0.2091986922860254,"score_spread":0.1953307066615291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3017155299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99597716,0.0014190624,0.000028318338,0.0000110533865,0.0005201868,0.00032071132,0.000049039878,0.00004993147,0.0016245134],"genre_scores_gemma":[0.9991746,0.00001057419,0.000027202863,0.00003413756,0.000014692251,0.000026606514,0.0002590874,0.000010472364,0.00044261233],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991592,0.000096574564,0.00026171215,0.00020358557,0.000044914163,0.00023402447],"domain_scores_gemma":[0.99960184,0.000060856783,0.0000743646,0.00018876762,0.00005756125,0.00001661953],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000057604426,0.00010838089,0.0001419042,0.00009198063,0.00011382506,0.0000038030212,0.00011865411,0.00008234362,0.00064867805],"category_scores_gemma":[0.000050760274,0.00010714093,0.000045012952,0.00011196302,0.00006325996,0.000051282288,0.00004416753,0.000091874244,0.0012329702],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058881815,0.0012232362,0.99218607,0.000007785596,0.000062596904,0.000009868184,0.0005636936,0.000022837885,0.003945019,0.00020271109,0.0015271786,0.00019010782],"study_design_scores_gemma":[0.0041918233,0.000114010305,0.99097484,0.000014171781,0.000045348068,0.00001845956,0.000061930725,0.0000056849053,0.0016579467,0.000029575245,0.00273637,0.00014984152],"about_ca_topic_score_codex":0.00008061907,"about_ca_topic_score_gemma":0.000094577284,"teacher_disagreement_score":0.0041329414,"about_ca_system_score_codex":0.000029682391,"about_ca_system_score_gemma":0.00003782385,"threshold_uncertainty_score":0.9995447},"labels":[],"label_agreement":null},{"id":"W3017257749","doi":"10.1182/blood.v110.11.1825.1825","title":"The RARa-PLZF Oncogenic Protein Inhibits C/EBPa Function in Myeloid Cells.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"CEBPA; Biology; Myeloid; Myelopoiesis; Histone; Fusion protein; Molecular biology; Cancer research; Histone deacetylase; Chromatin; Acetylation; Retinoic acid; Gene; Cell biology; Haematopoiesis; Transcription factor; Genetics; Stem cell; Recombinant DNA","score_opus":0.004175071065503192,"score_gpt":0.20540867467338353,"score_spread":0.20123360360788034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3017257749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898304,0.0033285841,0.00061153824,0.000049728038,0.00014822264,0.00025596368,0.0000016789286,0.000014792256,0.005759117],"genre_scores_gemma":[0.99679214,0.0002630668,0.00016840766,0.000104594925,0.00033672262,0.000034846325,0.000024964555,0.000021314276,0.0022539482],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989605,0.00004478849,0.00024268686,0.00028731223,0.00013974107,0.00032497314],"domain_scores_gemma":[0.9995055,0.000016139895,0.00007642363,0.0002923984,0.000054373708,0.000055127337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052210176,0.00013657188,0.00009008356,0.00003242475,0.00011988427,0.000031355306,0.00019112274,0.00018715848,0.00000877446],"category_scores_gemma":[0.00006388567,0.0001054527,0.00006577493,0.00012105888,0.000075654876,0.0000047059843,0.00007219306,0.00015481786,0.000028851158],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009779044,0.000108053915,0.0012018146,0.000018953173,0.000022881093,0.000008389075,0.00002742493,0.000003991507,0.99471307,0.00007233736,0.00014978615,0.003575505],"study_design_scores_gemma":[0.0009354402,0.0001986572,0.0008811596,0.000013721534,0.000017233559,0.000014929308,0.00006899136,0.000001583966,0.9510663,0.00013604978,0.046525627,0.00014027921],"about_ca_topic_score_codex":0.0000124722865,"about_ca_topic_score_gemma":0.00013097863,"teacher_disagreement_score":0.04637584,"about_ca_system_score_codex":0.00001373828,"about_ca_system_score_gemma":0.00010435827,"threshold_uncertainty_score":0.43002364},"labels":[],"label_agreement":null},{"id":"W3017378959","doi":"10.1182/blood.v112.11.229.229","title":"Post-Transplant Lymphoproliferative Disorder: Evaluation of Effectiveness of Reduction of Immunosuppression or Systemic Chemotherapy","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Immunosuppression; Rituximab; Internal medicine; Azathioprine; Gastroenterology; Post-transplant lymphoproliferative disorder; Transplantation; Organ transplantation; Prednisone; Lymphoproliferative disorders; Lymphoma; Surgery; Oncology; Disease","score_opus":0.01289088469298579,"score_gpt":0.2730501458589263,"score_spread":0.2601592611659405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3017378959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99541575,0.0032721749,0.000047539223,0.000021437816,0.00008224413,0.00085476117,0.000041731044,0.000013758939,0.00025063122],"genre_scores_gemma":[0.9983335,0.0014529069,0.000037373047,0.0000058976116,0.000018749251,0.000045878955,0.00006558809,0.000015370919,0.00002472557],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99871016,0.00022458224,0.00034623843,0.00015221722,0.00046300772,0.00010382704],"domain_scores_gemma":[0.9988992,0.00005027261,0.0002833126,0.00017959333,0.0005615678,0.000026055859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048410057,0.00011081688,0.00042307485,0.000091540984,0.000037738897,9.1594967e-7,0.000048930386,0.000106828295,0.00003893432],"category_scores_gemma":[0.00006265224,0.00008208792,0.000108086206,0.0001959802,0.00008733488,0.000057903486,0.0000054177485,0.000054026892,5.44277e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005032655,0.0013539089,0.057088528,0.0011684994,0.00039626972,0.0000020746768,0.0029781272,0.00013196503,0.92993,0.000012849195,0.0000064030687,0.0018987647],"study_design_scores_gemma":[0.02573147,0.0016845282,0.1107948,0.0021140135,0.0007479022,0.00017825415,0.0009861911,0.00013583453,0.85748315,0.000038632224,0.0000020991956,0.0001031062],"about_ca_topic_score_codex":0.000330508,"about_ca_topic_score_gemma":0.000005088136,"teacher_disagreement_score":0.072446786,"about_ca_system_score_codex":0.000061957726,"about_ca_system_score_gemma":0.0004104796,"threshold_uncertainty_score":0.33474484},"labels":[],"label_agreement":null},{"id":"W3017704884","doi":"10.1182/blood.2020004850","title":"<i>SF3B1</i>-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS","year":2020,"lang":"en","type":"review","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":293,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Daiichi Sankyo Europe; National Cancer Institute; Blood Cancer UK; Astellas Pharma; Pfizer; Daiichi-Sankyo; Associazione Italiana per la Ricerca sul Cancro; Celgene; Astex Pharmaceuticals","keywords":"Cytopenia; Myelodysplastic syndromes; International Prognostic Scoring System; Dysplasia; Medicine; Bone marrow; Concomitant; Bone marrow failure; Internal medicine; Oncology; Biology; Genetics; Haematopoiesis; Stem cell","score_opus":0.05206029764664723,"score_gpt":0.3366729119210564,"score_spread":0.2846126142744092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3017704884","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025820997,0.9866983,0.00012157272,0.005724714,0.0003100962,0.005573455,0.000850807,0.000069384456,0.0003934023],"genre_scores_gemma":[0.004917527,0.98731047,0.0006933572,0.0003419818,0.002813256,0.0024115837,0.0011459066,0.00014975986,0.00021614514],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99706995,0.00019495252,0.00071652845,0.0006285094,0.0009920382,0.00039802253],"domain_scores_gemma":[0.99623704,0.0021529007,0.00045608572,0.0007209005,0.00017604267,0.00025700332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060428,0.00044141294,0.001196143,0.00007457418,0.00015825305,0.000099044,0.0012912324,0.00018667143,0.00014446577],"category_scores_gemma":[0.0019897614,0.00021178399,0.0008856576,0.0004759753,0.00024566735,0.000038769198,0.000551203,0.00089383585,0.000049566795],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008219856,0.001056134,0.003014578,0.008405227,0.005381155,0.0004612561,0.000285586,7.398893e-8,0.000028182201,0.0012485404,0.0055506625,0.9737466],"study_design_scores_gemma":[0.0019151266,0.00022322574,0.00036481055,0.009457082,0.008104632,0.00007193944,0.000047396148,0.00008826746,0.000020341198,0.00014783545,0.97933316,0.00022620198],"about_ca_topic_score_codex":0.00015861729,"about_ca_topic_score_gemma":0.00003319121,"teacher_disagreement_score":0.9737825,"about_ca_system_score_codex":0.00020646557,"about_ca_system_score_gemma":0.0023919344,"threshold_uncertainty_score":0.86363006},"labels":[],"label_agreement":null},{"id":"W3020515492","doi":"10.1182/blood.v130.suppl_1.3815.3815","title":"Leukemic Stem Cell Expression Signatures Identify Novel Therapeutics for Acute Myeloid Leukemia","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Centre hospitalier universitaire de Québec; Princess Margaret Cancer Centre; Université Laval; McGill University Health Centre","funders":"","keywords":"Stem cell; Myeloid leukemia; CD33; CD34; Haematopoiesis; Population; Leukemia; Medicine; Myeloid; Cancer research; Immunology; CD38; Oncology; Biology; Genetics","score_opus":0.03937321126884538,"score_gpt":0.33999775771265445,"score_spread":0.3006245464438091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3020515492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894678,0.0012020968,0.00227118,0.0006927495,0.0003752882,0.0014991426,0.00013411121,0.0001711334,0.004186477],"genre_scores_gemma":[0.97750247,0.00048817883,0.0058055427,0.0006631383,0.00076007406,0.00017710599,0.000076929035,0.00013495293,0.014391595],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99747515,0.000036160407,0.00040575175,0.0006637028,0.0006473217,0.0007719417],"domain_scores_gemma":[0.9971917,0.00019625013,0.0003212671,0.0016982834,0.00030044775,0.00029202984],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041577735,0.0003726211,0.00056752394,0.00016656844,0.0007370466,0.00024577772,0.0009594833,0.00046999328,0.00004376499],"category_scores_gemma":[0.00006250317,0.0003035328,0.00029210726,0.000088098706,0.00020849003,0.0002942458,0.0003756107,0.0007721697,0.000088149005],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045743867,0.00032312164,0.0012566522,0.00019545802,0.0003938846,0.00008292243,0.00026424605,0.0000049856044,0.9893894,0.000070095586,0.0046271523,0.0029346156],"study_design_scores_gemma":[0.01611964,0.0004452714,0.011985517,0.00022001006,0.0011192654,0.00010444383,0.00016504231,0.0006263109,0.95508707,0.000116153875,0.013620107,0.00039116663],"about_ca_topic_score_codex":0.000043503278,"about_ca_topic_score_gemma":0.0000052709806,"teacher_disagreement_score":0.034302358,"about_ca_system_score_codex":0.00044399925,"about_ca_system_score_gemma":0.00094815553,"threshold_uncertainty_score":0.9999417},"labels":[],"label_agreement":null},{"id":"W3021024502","doi":"10.1182/blood.2019003646","title":"Inhibition of platelet phagocytosis as an in vitro predictor for therapeutic potential of RBC antibodies in murine ITP","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Phagocytosis; Antibody; In vitro; In vivo; Immunology; Polyclonal antibodies; Platelet; Monoclonal antibody; Immune system; Antigen; Biology; Biochemistry","score_opus":0.017550445650066377,"score_gpt":0.26540666957134146,"score_spread":0.24785622392127507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021024502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984759,0.00042984658,0.000023626286,0.0003154028,0.000018536432,0.000513859,0.00010826698,0.000014569466,0.00009999875],"genre_scores_gemma":[0.9991377,0.00013478633,0.00034282455,0.00013686293,0.000031018884,0.000023467452,0.00017324314,0.0000143474,0.0000057260763],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992736,0.000018676503,0.00027349635,0.00016723521,0.00012594482,0.00014107689],"domain_scores_gemma":[0.99972755,0.000020324154,0.00007907446,0.000087921675,0.000033843484,0.000051316572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000049265625,0.000101709076,0.00036722686,0.00009917224,0.000010177534,0.0000026873931,0.000033839155,0.00006469671,0.000021372733],"category_scores_gemma":[0.00002290771,0.00008892368,0.0000649105,0.00013692342,0.00003205976,0.000067692556,0.000014040799,0.000059523612,0.0000014879234],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030125622,0.0040829806,0.028594075,0.00041458587,0.00025337946,0.00030950728,0.001140158,0.000010845651,0.9592035,0.000030209128,0.00001204282,0.002936193],"study_design_scores_gemma":[0.020690503,0.0017276199,0.024812743,0.00010179223,0.00019942016,0.000025500756,0.00024573805,0.0004497243,0.9512634,0.0003799472,0.000021439859,0.00008212925],"about_ca_topic_score_codex":0.00009511231,"about_ca_topic_score_gemma":0.000020525651,"teacher_disagreement_score":0.01767794,"about_ca_system_score_codex":0.000008817008,"about_ca_system_score_gemma":0.000039458384,"threshold_uncertainty_score":0.36262026},"labels":[],"label_agreement":null},{"id":"W3021337000","doi":"10.1182/blood.2019004276","title":"The endoplasmic reticulum protein SEC22B interacts with NBEAL2 and is required for megakaryocyte α-granule biogenesis","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"Canadian Institutes of Health Research","keywords":"Endoplasmic reticulum; Cell biology; Biogenesis; Biology; Immunoprecipitation; ER retention; Megakaryocyte; Organelle biogenesis; Chemistry; Progenitor cell; Biochemistry; Stem cell; Gene; Mutant","score_opus":0.01402006598845297,"score_gpt":0.22978243574509088,"score_spread":0.21576236975663793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021337000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889847,0.00092110416,0.000032978016,0.007987852,0.000018557375,0.0012248108,0.000051195126,0.000043815344,0.0007349892],"genre_scores_gemma":[0.9972878,0.00013401054,0.0010635236,0.0008732265,0.000047202255,0.00017673825,0.00002964342,0.000026480197,0.00036133922],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99924123,0.000015313175,0.00014365748,0.00025293656,0.00012581548,0.00022103987],"domain_scores_gemma":[0.9995322,0.000054679367,0.00006126802,0.00016352815,0.000047198657,0.00014109189],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004742228,0.00014512448,0.00023244164,0.000020141564,0.00013845219,0.00003433445,0.00005747409,0.00004514138,0.0000097559705],"category_scores_gemma":[0.000056745193,0.000083309424,0.000054692384,0.00010284504,0.000060618164,0.000050548144,0.0000257774,0.000058188016,0.0000118887065],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036289208,0.008246193,0.07578412,0.003704359,0.015259919,0.00739616,0.017102107,0.0000034933028,0.7205706,0.0024396542,0.023825591,0.08937859],"study_design_scores_gemma":[0.02577451,0.0037996059,0.0018898337,0.0002413336,0.0010827495,0.00044650483,0.00039134285,0.0003196633,0.9424404,0.00028688487,0.02303676,0.0002904095],"about_ca_topic_score_codex":0.000030078962,"about_ca_topic_score_gemma":0.000030943378,"teacher_disagreement_score":0.2218698,"about_ca_system_score_codex":0.0000065851245,"about_ca_system_score_gemma":0.000047390375,"threshold_uncertainty_score":0.33972597},"labels":[],"label_agreement":null},{"id":"W3021377140","doi":"10.1182/blood.v120.21.4749.4749","title":"Hematopoietic Stem Cells Have an Intrinsic Expansion Limit","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Stem cell; Haematopoiesis; Biology; Cancer research; Transplantation; Hematopoietic stem cell; Immunology; Cell biology; Medicine; Internal medicine","score_opus":0.03225873345551179,"score_gpt":0.2869926830800133,"score_spread":0.2547339496245015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021377140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945354,0.0007487777,0.000048951686,0.000319185,0.00013380974,0.00040793922,0.0000036968968,0.000119355835,0.0036829256],"genre_scores_gemma":[0.99542165,0.00007564381,0.0008745575,0.00036904393,0.00070453255,0.000027628115,0.000012218475,0.000049145572,0.0024655752],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984479,0.00008008451,0.00022042076,0.00024634882,0.0004245242,0.00058071106],"domain_scores_gemma":[0.9986416,0.00007054574,0.000046836965,0.00062718,0.00008648767,0.00052732107],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034881136,0.0001626758,0.0002776216,0.00012984188,0.00007022792,0.000020881002,0.00014639748,0.00014604845,0.00023430995],"category_scores_gemma":[0.000024407767,0.00013382852,0.00007466318,0.00015888536,0.00006234025,0.00019349613,0.00011341702,0.00035076364,0.00084389275],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005065453,0.009105318,0.12835826,0.0009479112,0.00045271317,0.0008045599,0.011456253,0.0000024192,0.7708261,0.0011946727,0.01566296,0.060682263],"study_design_scores_gemma":[0.0061163967,0.0007617171,0.014256519,0.00013484823,0.0003248388,0.00068176404,0.0018014049,0.00007224761,0.96494055,0.000034933102,0.010555594,0.00031917135],"about_ca_topic_score_codex":0.000026980484,"about_ca_topic_score_gemma":0.000003246891,"teacher_disagreement_score":0.19411443,"about_ca_system_score_codex":0.00009595634,"about_ca_system_score_gemma":0.00014247488,"threshold_uncertainty_score":0.9999341},"labels":[],"label_agreement":null},{"id":"W3021578901","doi":"10.1182/blood.2020004897","title":"MDS/MPN-U with persistent monocytosis, del(20q), and CALR mutation, the great masquerader","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Jubilee Hospital","funders":"","keywords":"Monocytosis; Genetics; Mutation; Biology; Medicine; Gene; Internal medicine; Bone marrow","score_opus":0.023451608979030526,"score_gpt":0.23241138344701753,"score_spread":0.208959774467987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021578901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9687388,0.0021524332,0.000060022237,0.026960464,0.000017382137,0.0006293394,0.000009979894,0.000045697576,0.0013858787],"genre_scores_gemma":[0.9948249,0.00019111355,0.00090337335,0.0035901421,0.00012902045,0.00013726766,0.000024244391,0.000021446082,0.00017851597],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99912864,0.000038452687,0.0001471503,0.000293347,0.00021878968,0.00017361787],"domain_scores_gemma":[0.9994345,0.000071078604,0.000046277863,0.00016684872,0.00008834463,0.00019298136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000043054126,0.00017369069,0.00023340693,0.00002229325,0.00014337336,0.00005038059,0.00004500524,0.000044576485,0.00011364491],"category_scores_gemma":[0.000035946832,0.00009298963,0.00006855006,0.00011883128,0.00007179993,0.000059998394,0.00002586933,0.000115345305,0.00002966002],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006397394,0.0016582811,0.96478117,0.00027356145,0.0035033638,0.0012057243,0.013439762,0.000076765165,0.0007513283,0.0011886654,0.0058163297,0.006665285],"study_design_scores_gemma":[0.038842652,0.010566789,0.85473937,0.00041179627,0.008488496,0.0030368036,0.00686546,0.0015744444,0.047713254,0.00011978017,0.026696894,0.00094423804],"about_ca_topic_score_codex":0.000049367285,"about_ca_topic_score_gemma":0.000023612823,"teacher_disagreement_score":0.1100418,"about_ca_system_score_codex":0.000021572441,"about_ca_system_score_gemma":0.000058252335,"threshold_uncertainty_score":0.3792007},"labels":[],"label_agreement":null},{"id":"W3022145240","doi":"10.1182/blood.2019003105","title":"Altered microRNA expression links IL6 and TNF-induced inflammaging with myeloid malignancy in humans and mice","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; University of British Columbia; Canada's Michael Smith Genome Sciences Centre","funders":"Canadian Institutes of Health Research","keywords":"Inflammation; Biology; Myeloid; Immunology; Stem cell; Hematopoietic stem cell; Haematopoiesis; Cancer research; Cell biology","score_opus":0.009757237074928593,"score_gpt":0.21661936915045588,"score_spread":0.20686213207552728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022145240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980278,0.001338864,0.00007591449,0.0002432003,0.000012595149,0.00017766638,0.000006637804,0.00001112582,0.0001061841],"genre_scores_gemma":[0.9986099,0.00006877975,0.0009078727,0.00019674518,0.00013751861,0.000010743579,0.000037737143,0.00001933809,0.000011339605],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992939,0.000034392557,0.0001366582,0.000334137,0.00005766836,0.00014324397],"domain_scores_gemma":[0.9996875,0.0000045599563,0.000060811682,0.00013159157,0.000024172308,0.000091376816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000043561333,0.00012332597,0.00010493124,0.000025498233,0.00004093281,0.000026053733,0.00006492315,0.00012229038,0.0000034972738],"category_scores_gemma":[0.000019056557,0.00011472742,0.000016135977,0.000050684852,0.000032047752,0.000006647519,0.00009385705,0.00009722,0.0000010187059],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005955235,0.000034106844,0.017964354,0.000060214523,0.000013878568,0.000010212401,0.00023622235,0.0000043148148,0.981125,0.0000035727448,0.00002424726,0.00046435118],"study_design_scores_gemma":[0.0019694795,0.0001272624,0.048177198,0.00008121682,0.000028600229,0.000013561958,0.000059177186,0.00002755341,0.9488927,0.000015517182,0.00043886836,0.00016885578],"about_ca_topic_score_codex":0.000007774389,"about_ca_topic_score_gemma":0.000016697593,"teacher_disagreement_score":0.032232266,"about_ca_system_score_codex":0.000003032262,"about_ca_system_score_gemma":0.000026770724,"threshold_uncertainty_score":0.46784484},"labels":[],"label_agreement":null},{"id":"W3022151429","doi":"10.1182/blood.v130.suppl_1.5593.5593","title":"Oral Anticoagulant Dosing, Administration, and Storage: A Cross-Sectional Survey of Canadian Health Care Providers","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Apixaban; Rivaroxaban; Dabigatran; Edoxaban; Dosing; Warfarin; Anticoagulant; Oral anticoagulant; Pharmacist; Intensive care medicine; Emergency medicine; Family medicine; Internal medicine; Pharmacy; Atrial fibrillation","score_opus":0.04992518281768232,"score_gpt":0.34334235282793135,"score_spread":0.29341717001024903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022151429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971891,0.0005206617,0.000004701306,0.0007783578,0.0001343276,0.00040951287,0.00011596058,0.000011699967,0.00083569664],"genre_scores_gemma":[0.9991351,0.00011442362,0.00021661705,0.000276183,0.000048979484,0.00000901357,0.00011378139,0.0000112423,0.000074693235],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991946,0.000031783464,0.00020549816,0.00020143823,0.00016224514,0.0002044219],"domain_scores_gemma":[0.99912363,0.000012716685,0.00015564087,0.00030802985,0.00016585056,0.0002341381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029794613,0.00008864423,0.00026996416,0.00014108884,0.0003791392,0.000118824195,0.000079063546,0.000047771333,0.000025870866],"category_scores_gemma":[0.00014559017,0.00008322179,0.000028915474,0.000055580185,0.000113167145,0.00007995905,0.00002839589,0.00006755433,0.0000021595342],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017926513,0.00023466225,0.9970881,0.00018481835,0.00008541748,0.00002563373,0.00036045106,9.3894903e-7,0.000027990094,0.00021094849,0.0013739025,0.00038922514],"study_design_scores_gemma":[0.0014531125,0.00045577652,0.99646616,0.000043527347,0.000043931213,0.00002267573,0.000071373186,0.000005097808,0.00022329307,0.000005014417,0.0011377404,0.00007231532],"about_ca_topic_score_codex":0.43427902,"about_ca_topic_score_gemma":0.5417037,"teacher_disagreement_score":0.10742467,"about_ca_system_score_codex":0.000043423363,"about_ca_system_score_gemma":0.0009238411,"threshold_uncertainty_score":0.56948817},"labels":[],"label_agreement":null},{"id":"W3022210151","doi":"10.1182/blood.2019002548","title":"The EMT modulator SNAI1 contributes to AML pathogenesis via its interaction with LSD1","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"Medical Research Council; Translational Cancer Research Network; Fondation contre le Cancer; National Health and Medical Research Council; Vlaamse regering; Universiteit Gent; European Hematology Association; Cancer Institute NSW; Monash University; Fonds Wetenschappelijk Onderzoek; NSW Health Pathology","keywords":"SNAI1; Myeloid leukemia; Leukemia; Cancer research; Biology; Epithelial–mesenchymal transition; Ectopic expression; Pathogenesis; Demethylase; Haematopoiesis; Immunology; Histone; Stem cell; Cancer; Cell biology; Genetics; Cell culture; Gene; Metastasis","score_opus":0.009988379536215715,"score_gpt":0.229886325222753,"score_spread":0.2198979456865373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022210151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98689884,0.0018410722,0.009327419,0.0014075956,0.00008484383,0.00021430645,0.000015303956,0.000012208487,0.00019839623],"genre_scores_gemma":[0.99875396,0.00013041707,0.00031678868,0.0004092898,0.00022305784,0.000030158608,0.000036422814,0.000017594932,0.00008230745],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993595,0.000040513572,0.00012953914,0.00023193272,0.00008945701,0.00014905143],"domain_scores_gemma":[0.99954885,0.0000165739,0.000053737378,0.00017993768,0.00010945287,0.000091416165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008296695,0.00010142563,0.00008368239,0.000012334997,0.00011044706,0.000041491207,0.00011371079,0.00006542142,0.000004111129],"category_scores_gemma":[0.00010136503,0.000071828574,0.000040853407,0.000095988114,0.000015395935,0.000002439332,0.00004471608,0.000045220742,0.000019122454],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000090264766,0.00003874605,0.0033228798,0.0000056451336,0.00006569649,0.0000015584242,0.000038079925,0.00019644694,0.99287444,0.000026178548,0.00009322143,0.0032468564],"study_design_scores_gemma":[0.00054371957,0.00040907014,0.0065546636,0.000005471317,0.00004449486,0.0000014992792,0.00003650091,0.00017785783,0.95462674,0.00002467684,0.03746528,0.00011000474],"about_ca_topic_score_codex":0.000004229048,"about_ca_topic_score_gemma":0.000027718344,"teacher_disagreement_score":0.038247664,"about_ca_system_score_codex":0.0000042510546,"about_ca_system_score_gemma":0.00002396029,"threshold_uncertainty_score":0.29290843},"labels":[],"label_agreement":null},{"id":"W3022402846","doi":"10.1182/blood.v130.suppl_1.231.231","title":"Erythrocyte-Specific Antibodies As a Potential New Therapeutic Modality in Autoimmune and Inflammatory Disorders Beyond Immune Thrombocytopenia (ITP)","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Blood Services; St. Michael's Hospital","funders":"","keywords":"Platelet; Antibody; Immunology; Phagocytosis; Medicine; Immune system; Opsonin; Rheumatoid arthritis; Autoimmune hemolytic anemia; Arthritis","score_opus":0.013232304688442664,"score_gpt":0.26414650981180127,"score_spread":0.2509142051233586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022402846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97783434,0.014877888,0.000013665319,0.0016132236,0.00015426576,0.00058176566,0.00000739158,0.000060366292,0.004857113],"genre_scores_gemma":[0.99336797,0.005622589,0.00018404874,0.00008466881,0.000053486303,0.000016168064,0.000027245967,0.00003653772,0.0006072739],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985525,0.000036619713,0.00035495896,0.0004176634,0.00024168618,0.0003965984],"domain_scores_gemma":[0.9988909,0.000024100817,0.0001754561,0.0007578527,0.000027875105,0.00012385825],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014151147,0.0002930544,0.0006839977,0.00010514877,0.0003691438,0.00013742188,0.00020704289,0.00015387007,0.00010167025],"category_scores_gemma":[0.00002912748,0.00025320263,0.00012087336,0.00005827044,0.00026320928,0.00029778082,0.0001631721,0.00023740796,0.000054097316],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016214178,0.0051183295,0.79435897,0.000312423,0.0020906045,0.0032854166,0.0029782215,0.0000095161595,0.08684979,0.0035415022,0.00015548893,0.09967831],"study_design_scores_gemma":[0.014622803,0.00026085204,0.97199935,0.00011175675,0.00023995544,0.0001754993,0.00017551475,0.000032246207,0.0024780252,0.008851492,0.00079004106,0.00026247322],"about_ca_topic_score_codex":0.0011411924,"about_ca_topic_score_gemma":0.00030950035,"teacher_disagreement_score":0.17764035,"about_ca_system_score_codex":0.000030746658,"about_ca_system_score_gemma":0.00014106421,"threshold_uncertainty_score":0.999992},"labels":[],"label_agreement":null},{"id":"W3022990851","doi":"10.1182/blood.v120.21.1603.1603","title":"Elevated Risk of Venous but Not Arterial Thrombosis in Waldenstrom's Macroglobulinemia and Lymphoplasmacytic Lymphoma","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Venous thrombosis; Hyperviscosity syndrome; Internal medicine; Population; Thrombosis; Waldenstrom macroglobulinemia; Macroglobulinemia; Pulmonary embolism; Monoclonal gammopathy of undetermined significance; Surgery; Multiple myeloma; Lymphoma; Immunology; Monoclonal","score_opus":0.016331595068018234,"score_gpt":0.2706823743605549,"score_spread":0.2543507792925367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022990851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982288,0.00052400056,0.0000047691146,0.000056531193,0.00017613122,0.00045546298,0.00006154859,0.000049140614,0.0004436437],"genre_scores_gemma":[0.99830127,0.00042914881,0.0006994624,0.00006170669,0.00031978285,0.000027677243,0.000023539667,0.000044645316,0.00009274933],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978142,0.00011010744,0.00050619984,0.00032467395,0.0005006291,0.00074423215],"domain_scores_gemma":[0.9987287,0.00022913924,0.00015259653,0.00048427383,0.00008990047,0.0003154257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046713246,0.00023840643,0.00061909354,0.00019413634,0.00005195413,0.00001757333,0.00013701597,0.00021157677,0.000106803265],"category_scores_gemma":[0.00040515926,0.00021401736,0.000093844195,0.00032924034,0.00022317983,0.00010768825,0.00014172765,0.00014563104,0.000064505126],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040748892,0.015872834,0.3262014,0.0016990681,0.0016889415,0.0008108105,0.004344587,0.000013058287,0.6247852,0.00022567804,0.00046196245,0.019821564],"study_design_scores_gemma":[0.15044151,0.0007664326,0.40143713,0.00034869704,0.0009946693,0.0024025687,0.0003205164,0.0017772131,0.44074255,0.000047080888,0.00029815166,0.00042344496],"about_ca_topic_score_codex":0.0020836645,"about_ca_topic_score_gemma":0.000049902,"teacher_disagreement_score":0.18404265,"about_ca_system_score_codex":0.0020939503,"about_ca_system_score_gemma":0.002060689,"threshold_uncertainty_score":0.87273747},"labels":[],"label_agreement":null},{"id":"W3023118053","doi":"10.1182/blood.v130.suppl_1.4597.4597","title":"Successful Treatment of Mature T-Cell Lymphoma with Allogeneic Stem Cell Transplantation: The Largest Multicenter Retrospective Analysis","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Anaplastic large-cell lymphoma; Medicine; Transplantation; Lymphoma; Anaplastic lymphoma kinase; Internal medicine; Hematopoietic stem cell transplantation; Oncology; Gastroenterology; Pleural effusion","score_opus":0.012407910650914782,"score_gpt":0.24785431102826708,"score_spread":0.2354464003773523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023118053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99468565,0.0012078544,0.0001405593,0.0011467317,0.000009242279,0.00077323255,0.00014777882,0.000029819546,0.0018591443],"genre_scores_gemma":[0.99823976,0.0006272198,0.00018159898,0.0002107885,0.000054983793,0.00005057169,0.00009658479,0.000027208504,0.0005112955],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99861676,0.00009524986,0.00021892578,0.0003644519,0.00046155843,0.00024304507],"domain_scores_gemma":[0.99917805,0.00006807317,0.00009814703,0.000306311,0.00020764835,0.00014178925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004803245,0.0002050008,0.00044466485,0.00008993588,0.00008354687,0.000022995822,0.00012601301,0.00007467619,0.00015305761],"category_scores_gemma":[0.0000042987826,0.00011754574,0.00020539977,0.000768347,0.00009359278,0.000033230524,0.000012421992,0.00006920295,0.000017367358],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015314118,0.0032828236,0.97112,0.00024257158,0.0020371594,0.00060147216,0.00619042,0.0000670649,0.014648922,0.0000068307877,0.000025648678,0.0002456796],"study_design_scores_gemma":[0.034675874,0.005604561,0.40847266,0.000048320922,0.011519197,0.00028292055,0.0040427237,0.000977358,0.5336525,0.000002393339,0.00038540826,0.00033607607],"about_ca_topic_score_codex":0.00010586247,"about_ca_topic_score_gemma":0.00024680773,"teacher_disagreement_score":0.56264734,"about_ca_system_score_codex":0.00007409936,"about_ca_system_score_gemma":0.00013686817,"threshold_uncertainty_score":0.4793376},"labels":[],"label_agreement":null},{"id":"W3023240913","doi":"10.1182/blood.2019004334","title":"A hemophilia A mouse model for the in vivo assessment of emicizumab function","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Agence Nationale de la Recherche; Ottawa Hospital Research Institute","keywords":"In vivo; Thromboplastin; Partial thromboplastin time; Bleeding diathesis; Chemistry; Internal medicine; Coagulation; Medicine; Immunology; Endocrinology; Platelet; Biology","score_opus":0.05238573724199593,"score_gpt":0.3280100880371267,"score_spread":0.2756243507951308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023240913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886645,0.0001449933,0.0032881119,0.006026821,0.00001675006,0.0009512525,0.000025254707,0.00002254827,0.0008597469],"genre_scores_gemma":[0.9971002,0.00005465611,0.0011045914,0.0002618729,0.000077414385,0.00010149241,0.0000073180836,0.0000128964875,0.0012796043],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9993414,0.000013325368,0.00015665522,0.00014258781,0.00019911004,0.00014688956],"domain_scores_gemma":[0.99962574,0.00007403792,0.00002846798,0.00015301789,0.000052882187,0.00006585761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011813921,0.00007225871,0.00016816914,0.000039754712,0.00003069244,0.000004118135,0.000055557797,0.00004735934,0.00003880216],"category_scores_gemma":[0.000054275548,0.000043527456,0.000079946425,0.00013101305,0.000028412913,0.000023688748,0.000026006046,0.00010824657,0.000002300462],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002667016,0.005536534,0.13131844,0.0013076769,0.0010725972,0.000048989008,0.0031829071,0.0023545453,0.8395276,0.003673335,0.0039018164,0.0054085734],"study_design_scores_gemma":[0.020346472,0.0022095363,0.006518443,0.00008194299,0.00062483444,0.000008653282,0.0003931442,0.8628374,0.10574818,0.00034605595,0.0007347403,0.0001506495],"about_ca_topic_score_codex":0.000009983113,"about_ca_topic_score_gemma":0.000007562344,"teacher_disagreement_score":0.8604828,"about_ca_system_score_codex":0.000023192973,"about_ca_system_score_gemma":0.00014635533,"threshold_uncertainty_score":0.17749982},"labels":[],"label_agreement":null},{"id":"W302337192","doi":"10.1182/blood.v122.21.4825.4825","title":"Are We Appropriately Using Intravenous Immunoglobulin In The Saskatoon Health Region?","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Medicine; Off-label use; Clinical endpoint; Pediatrics; Adverse effect; Family medicine; Internal medicine; Clinical trial","score_opus":0.044378947498096004,"score_gpt":0.28259794491408624,"score_spread":0.23821899741599023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W302337192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98841184,0.0031737932,0.000018372875,0.007000366,0.000039350394,0.0007326959,0.0000020901355,0.000025636073,0.00059584953],"genre_scores_gemma":[0.9977419,0.00032420497,0.00043470692,0.001303972,0.000045086595,0.000030239968,0.000010191547,0.000014958038,0.00009474585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914217,0.000061419785,0.00020192386,0.00017099195,0.00014939434,0.00027410017],"domain_scores_gemma":[0.9995017,0.000020232172,0.00012586088,0.00026974766,0.000024673443,0.0000578033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010188943,0.00011908352,0.0002680971,0.00005569965,0.00007924934,0.000027485425,0.00008399911,0.000059099755,0.000024403122],"category_scores_gemma":[0.000013548416,0.00007502202,0.000048693782,0.00017330526,0.000029419009,0.000053855576,0.0000166044,0.00015700285,0.000061397644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006466277,0.051593877,0.6803867,0.0016404324,0.002007578,0.017526403,0.03700689,0.000076975535,0.0031693925,0.00071760337,0.018518869,0.18670864],"study_design_scores_gemma":[0.027111791,0.0020608988,0.93723565,0.0013667971,0.00041100988,0.007318079,0.012996455,0.0004157758,0.0007143288,0.0044042887,0.0053611426,0.00060377514],"about_ca_topic_score_codex":0.0012976144,"about_ca_topic_score_gemma":0.000121056226,"teacher_disagreement_score":0.25684896,"about_ca_system_score_codex":0.000040172556,"about_ca_system_score_gemma":0.00007882307,"threshold_uncertainty_score":0.3059309},"labels":[],"label_agreement":null},{"id":"W3024233645","doi":"10.1182/blood.2020005819","title":"Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":174,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Venous thromboembolism; Medicine; Meta-analysis; Cancer; Intensive care medicine; Venous thrombosis; Rivaroxaban; Internal medicine; Thrombosis; Warfarin; Atrial fibrillation","score_opus":0.10979577461001094,"score_gpt":0.3760204977258376,"score_spread":0.2662247231158267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3024233645","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000019375764,0.9862124,0.000007849256,0.000420966,0.00006158631,0.011884035,0.0010326244,0.00013410793,0.00024453903],"genre_scores_gemma":[0.000044306515,0.99157965,0.00013204735,0.0016136089,0.00007280668,0.0056045516,0.00047175947,0.00012911299,0.00035217943],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99611694,0.00041617762,0.0015074424,0.0009454899,0.00047296257,0.00054098846],"domain_scores_gemma":[0.9971998,0.00031386968,0.0012038935,0.00080180634,0.00018056517,0.0003000914],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00082251575,0.0008596945,0.038115315,0.00030454263,0.00013708949,0.00008069212,0.00031036529,0.00028100205,0.00020118248],"category_scores_gemma":[0.0005224914,0.0005637193,0.004924647,0.0012271007,0.000048766684,0.000049109298,0.0001552883,0.00025698572,0.000038715047],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[6.302005e-7,0.0008439407,5.3917705e-7,0.5584941,0.43878734,0.0000436713,0.000028575369,5.5683945e-8,4.1529063e-8,0.000022728656,0.0010752216,0.000703144],"study_design_scores_gemma":[0.00040691692,0.00019137992,0.0000065434087,0.06071088,0.86392915,0.00002391097,0.0000063254306,0.0000020918937,7.3527576e-7,0.000004671042,0.07428552,0.00043184924],"about_ca_topic_score_codex":0.00018507359,"about_ca_topic_score_gemma":0.000103849394,"teacher_disagreement_score":0.4977832,"about_ca_system_score_codex":0.00009852991,"about_ca_system_score_gemma":0.00024802107,"threshold_uncertainty_score":0.9996814},"labels":[],"label_agreement":null},{"id":"W3025325957","doi":"10.1182/blood.2020005335","title":"DLBCL subclassification: divide and conquer?","year":2020,"lang":"en","type":"letter","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; Canada's Michael Smith Genome Sciences Centre","funders":"Genentech; Celgene","keywords":"Medicine; Ruxolitinib; Immunology; Clinical trial; Intensive care medicine; Internal medicine; Bone marrow; Myelofibrosis","score_opus":0.03211092465470565,"score_gpt":0.25524510404347345,"score_spread":0.22313417938876778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025325957","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0068696127,0.0016671262,0.0000122792335,0.98495406,0.00012775819,0.00067970203,0.00010686527,0.000099280616,0.0054832934],"genre_scores_gemma":[0.052630164,0.001005413,0.00053551357,0.93631786,0.0049648667,0.0003405093,0.0013552869,0.000081136095,0.0027692483],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986273,0.000051243827,0.00025696744,0.0005276666,0.0003029988,0.00023383302],"domain_scores_gemma":[0.99915993,0.00016773233,0.000116581046,0.00033064897,0.00008142159,0.00014366322],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00003423289,0.00031306242,0.000565177,0.000064369015,0.000080153826,0.00005021054,0.000066573186,0.000332659,0.00020646841],"category_scores_gemma":[0.000070177106,0.00024735692,0.00010392664,0.00008392549,0.00008694805,0.000029431774,0.00004668523,0.00072692434,0.00022210443],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014831907,0.00034882146,0.03140606,0.00031976638,0.0005778307,0.002737424,0.00010295957,5.9659535e-9,0.00008710262,0.0001390304,0.96342546,0.0008407368],"study_design_scores_gemma":[0.0038262017,0.00038328784,0.012338091,0.00017958642,0.0012915612,0.0002743706,0.0000069564967,0.000002524355,0.0022146262,0.00012617491,0.9791222,0.00023438585],"about_ca_topic_score_codex":0.000011717534,"about_ca_topic_score_gemma":0.000003087923,"teacher_disagreement_score":0.04863622,"about_ca_system_score_codex":0.000029642695,"about_ca_system_score_gemma":0.00011921439,"threshold_uncertainty_score":0.99999785},"labels":[],"label_agreement":null},{"id":"W3025640951","doi":"10.1182/blood.v124.21.4217.4217","title":"Inhibition of Plasmin Generation in Plasma By Heparin, Low Molecular Weight Heparin and a Covalent Antithrombin-Heparin Complex (ATH)","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; McMaster University","funders":"","keywords":"Plasmin; Heparin; Antithrombin; Fibrin; Fibrinolysis; Chemistry; Pharmacology; Thrombosis; Low molecular weight heparin; Anticoagulant; Thrombin; Coagulation; Medicine; Platelet; Internal medicine; Biochemistry; Immunology; Enzyme","score_opus":0.011317716630030493,"score_gpt":0.23174788384367856,"score_spread":0.22043016721364805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025640951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99560386,0.00022657217,0.0004090707,0.00034493057,0.00006800969,0.0006551863,0.000016639373,0.000035248395,0.002640456],"genre_scores_gemma":[0.9975309,0.00046871157,0.0011337111,0.0003981331,0.00007048527,0.000060939703,0.0002462244,0.000030032752,0.000060886832],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984525,0.00008513216,0.00046309843,0.00040268115,0.00031725413,0.00027934925],"domain_scores_gemma":[0.999348,0.000029668996,0.00014792866,0.00029871022,0.000059296748,0.0001164052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029018128,0.00021201509,0.00058520475,0.00017318089,0.00005142139,0.000026626525,0.00006365879,0.00011029884,0.000066927314],"category_scores_gemma":[0.000046407375,0.00021105233,0.00006766088,0.00017390258,0.00008521239,0.00008195164,0.00009803182,0.00012377818,0.000016574126],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009448978,0.008153259,0.04597265,0.0008146118,0.00032315147,0.00008974759,0.0005962444,0.0001547759,0.9145606,0.0085652275,0.016572595,0.0041026543],"study_design_scores_gemma":[0.014989396,0.0014689559,0.1497742,0.00045153822,0.0006047277,0.000055315173,0.000075980395,0.017847952,0.8081738,0.0002952933,0.005747485,0.0005153548],"about_ca_topic_score_codex":0.0004020368,"about_ca_topic_score_gemma":0.0002614894,"teacher_disagreement_score":0.10638679,"about_ca_system_score_codex":0.000038367918,"about_ca_system_score_gemma":0.000027450304,"threshold_uncertainty_score":0.8606464},"labels":[],"label_agreement":null},{"id":"W3028017622","doi":"10.1182/blood.2020005457","title":"Intravascular large B-cell lymphoma presenting with acute encephalopathy","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Intravascular large B-cell lymphoma; Medicine; Lymphoma; Pathology; Internal medicine","score_opus":0.008498069028409232,"score_gpt":0.21705499518471774,"score_spread":0.2085569261563085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028017622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933004,0.0010597365,0.00008923897,0.00089275907,0.000024166793,0.00036454195,0.000016708533,0.00010947083,0.0041430076],"genre_scores_gemma":[0.9971779,0.00017568535,0.0012781313,0.00094483903,0.00019310018,0.00005505821,0.00003951243,0.00003247179,0.0001033291],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989052,0.000019794197,0.00015717342,0.00033210096,0.00028087237,0.00030486842],"domain_scores_gemma":[0.99937314,0.000023061652,0.00005332226,0.00025045936,0.000047235924,0.0002527601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004722054,0.00017007982,0.000274591,0.000029939447,0.00007155717,0.000028882112,0.00007600329,0.000051040257,0.00008960228],"category_scores_gemma":[0.000017693128,0.00012318767,0.00011372979,0.00018815165,0.000025533167,0.000055261065,0.000057495432,0.0000489143,0.00013493697],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045126537,0.030117242,0.9067222,0.0004332587,0.003843387,0.022607647,0.0055303937,0.000003662286,0.011981988,0.0004457228,0.0023888072,0.015474446],"study_design_scores_gemma":[0.111623116,0.003125782,0.4325543,0.00019518155,0.0072005503,0.0015343282,0.00084594573,0.00043997692,0.40520334,0.000027294203,0.03651615,0.0007340384],"about_ca_topic_score_codex":0.00002053554,"about_ca_topic_score_gemma":0.000002769256,"teacher_disagreement_score":0.47416788,"about_ca_system_score_codex":0.000020857186,"about_ca_system_score_gemma":0.00009709596,"threshold_uncertainty_score":0.5023447},"labels":[],"label_agreement":null},{"id":"W30310674","doi":"10.1182/blood.v95.9.2770.009k16_2770_2775","title":"Secondary neoplasms subsequent to Berlin-Frankfurt-Munster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":266,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Medicine; Confidence interval; Radiation therapy; Pediatrics; Cumulative incidence; Incidence (geometry); Leukemia; Internal medicine; Surgery; Cohort","score_opus":0.007046606866034718,"score_gpt":0.24869665022892645,"score_spread":0.24165004336289173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W30310674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99437803,0.00060844945,0.00029087954,0.0003217797,0.00020150341,0.0017921908,0.00018357315,0.00011073473,0.00211285],"genre_scores_gemma":[0.99069977,0.0024202855,0.0033884775,0.0013850562,0.0004618605,0.0001237466,0.00004612838,0.00017167462,0.0013030282],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99586785,0.000237505,0.00091314944,0.00090168585,0.0010478644,0.0010319462],"domain_scores_gemma":[0.99773276,0.000313816,0.00018528495,0.0010444521,0.0001588026,0.0005649089],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005412791,0.00058410736,0.0011459367,0.0005025956,0.00010166582,0.0000509748,0.0005304617,0.00036794506,0.003569846],"category_scores_gemma":[0.000072208284,0.00048763066,0.00032467407,0.0008643274,0.0002631899,0.00017101773,0.000057242592,0.0006765609,0.00026322732],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049681664,0.013347994,0.1738689,0.00041441133,0.010226995,0.0058765835,0.02133473,0.0024837304,0.45811865,0.00006298507,0.0058576805,0.2587257],"study_design_scores_gemma":[0.23969138,0.015941469,0.56658685,0.0013481784,0.0015719401,0.0029627737,0.00031950354,0.0045204833,0.14734282,0.00021904525,0.016845044,0.0026505098],"about_ca_topic_score_codex":0.0007590196,"about_ca_topic_score_gemma":0.00009745935,"teacher_disagreement_score":0.39271796,"about_ca_system_score_codex":0.0011806007,"about_ca_system_score_gemma":0.0030962348,"threshold_uncertainty_score":0.9997575},"labels":[],"label_agreement":null},{"id":"W3032222154","doi":"10.1182/blood.v130.suppl_1.2294.2294","title":"Utility of Computed Tomography for the Diagnosis of Invasive Aspergillosis in Hematological Malignancy","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Aspergillosis; Computed tomography; Medicine; Hematologic Neoplasms; Malignancy; Hematological malignancy; Hematologic malignancy; Pathogenic organism; Radiology; Pathology; Internal medicine; Cancer; Immunology; Biology","score_opus":0.04858335193690119,"score_gpt":0.30680890834436825,"score_spread":0.258225556407467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032222154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971192,0.0010608038,0.00007370602,0.0004253,0.00003421224,0.00056552066,0.000043789023,0.000007539688,0.00066994573],"genre_scores_gemma":[0.9991374,0.00018552996,0.00055045367,0.00004267532,0.000016148135,0.000047242047,0.0000039060924,0.000004762759,0.000011862706],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991778,0.000030349387,0.0003131916,0.00018828196,0.00014770214,0.00014265742],"domain_scores_gemma":[0.99842656,0.0005776355,0.0001850479,0.0006255174,0.00014701979,0.000038247177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026736152,0.00008611415,0.00040671203,0.000037760696,0.0000835768,0.000005614436,0.00021176098,0.00008334395,0.00004778279],"category_scores_gemma":[0.0010624224,0.000053170876,0.00022509249,0.00008502465,0.00032631756,0.00003557472,0.000059103502,0.000077518634,6.0902937e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017776334,0.0010934409,0.995832,0.00037667836,0.000090029585,0.000008435004,0.00008369927,1.0228154e-7,0.0009946042,0.00059492525,0.000116404924,0.0006318865],"study_design_scores_gemma":[0.001639207,0.0001826518,0.9006355,0.00024804974,0.00014121734,0.0000020840619,0.00010875306,0.000022018643,0.09648972,0.00046355664,0.00002317099,0.000044088854],"about_ca_topic_score_codex":0.00011545705,"about_ca_topic_score_gemma":0.0003982816,"teacher_disagreement_score":0.09549512,"about_ca_system_score_codex":0.0000026975167,"about_ca_system_score_gemma":0.000049456237,"threshold_uncertainty_score":0.21682455},"labels":[],"label_agreement":null},{"id":"W3032423683","doi":"10.1182/blood.2020005803","title":"Management of ECD: the era of targeted therapies","year":2020,"lang":"en","type":"letter","venue":"Blood","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Intensive care medicine; Internal medicine","score_opus":0.011441057897644035,"score_gpt":0.2298361489790026,"score_spread":0.21839509108135854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032423683","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017860444,0.010176185,0.000024426367,0.92861617,0.00023418448,0.0013813442,0.00018011704,0.000053837866,0.04147329],"genre_scores_gemma":[0.39778545,0.0039908253,0.0035676484,0.57624716,0.0012061903,0.00018479221,0.0012539608,0.00017763517,0.015586326],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992256,0.000022283946,0.00021401451,0.00015310256,0.00027089886,0.000114058166],"domain_scores_gemma":[0.9994633,0.00002471677,0.00013611045,0.00032314632,0.000035118584,0.000017616605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00002367787,0.0001441193,0.00035403154,0.000026101467,0.000022511787,0.0000031103025,0.000115808434,0.00009923775,0.0002220915],"category_scores_gemma":[0.0000045791826,0.00008538886,0.00014348647,0.00009540411,0.00008095822,0.0000069082143,0.00003130881,0.00031881523,0.00002267398],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007888727,0.0011653681,0.0011709752,0.0025810117,0.010517721,0.0026904622,0.0012033173,4.0186555e-7,0.000062413485,0.00019603438,0.9692697,0.011063719],"study_design_scores_gemma":[0.0064798836,0.00059273175,0.002869069,0.0007223665,0.0047422843,0.000017662058,0.00024963808,0.0000035855028,0.00084672007,0.00047707767,0.98282665,0.00017233583],"about_ca_topic_score_codex":0.000032963046,"about_ca_topic_score_gemma":5.769754e-7,"teacher_disagreement_score":0.37992498,"about_ca_system_score_codex":0.000008003462,"about_ca_system_score_gemma":0.000035264107,"threshold_uncertainty_score":0.34820566},"labels":[],"label_agreement":null},{"id":"W3032605465","doi":"10.1182/blood.2019004161","title":"Whole-exome sequencing identifies rare variants in STAB2 associated with venous thromboembolic disease","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McMaster University","funders":"National Heart, Lung, and Blood Institute; Medical Research Council; National Institutes of Health; European Commission; Université de Bordeaux; King's College London; National Institute for Health and Care Research; Wellcome Trust; University of Michigan","keywords":"Exome sequencing; Genome-wide association study; Exome; Pulmonary embolism; Von Willebrand factor; Medicine; Venous thrombosis; Von Willebrand disease; Internal medicine; Thrombosis; Genetics; Biology; Single-nucleotide polymorphism; Mutation; Gene; Genotype","score_opus":0.037914424869231036,"score_gpt":0.2542965633413689,"score_spread":0.21638213847213789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032605465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968095,0.0002253373,0.00011199489,0.0014233291,0.00006711693,0.00042037602,0.00004288718,0.00018969996,0.0007097847],"genre_scores_gemma":[0.99793464,0.000012299647,0.0001284998,0.0015493677,0.000097732416,0.000022961352,0.00011414203,0.000043306685,0.00009703004],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99858403,0.00007525349,0.00027436548,0.00036156728,0.00039066834,0.00031409302],"domain_scores_gemma":[0.9991825,0.000035577512,0.00010544372,0.00024517422,0.00008558824,0.00034566617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013181246,0.00018910946,0.00045536677,0.000094373005,0.000078334844,0.00004705484,0.00010383256,0.00008479838,0.00015509402],"category_scores_gemma":[0.0002403648,0.00016763939,0.00006423966,0.00051827176,0.000037637026,0.00015328478,0.000047325597,0.00022085661,0.00007204947],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086497905,0.0120277265,0.35770884,0.001252505,0.0030632059,0.008886549,0.021364847,0.0003388874,0.58793986,0.0048749344,0.0007604211,0.0009172524],"study_design_scores_gemma":[0.009417551,0.00070041063,0.9734677,0.0006950615,0.0009057196,0.000026377693,0.0008512962,0.0007700477,0.012058493,0.0006669542,0.000070875285,0.00036951713],"about_ca_topic_score_codex":0.00002786541,"about_ca_topic_score_gemma":0.000046798345,"teacher_disagreement_score":0.61575884,"about_ca_system_score_codex":0.00005583209,"about_ca_system_score_gemma":0.00027449938,"threshold_uncertainty_score":0.6836136},"labels":[],"label_agreement":null},{"id":"W3032905303","doi":"10.1182/blood.v130.suppl_1.658.658","title":"Single UM171 Expanded Cord Blood Transplant Is Feasible, Safe, and Permits Transplantation of Better HLA Matched Cords with Very Low Transplant Related Mortality","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Heart and Stroke Foundation; University of Toronto; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; University Health Network; Institute for Research in Immunology and Cancer; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Cord blood; Transplantation; Medicine; CD34; Internal medicine; Urology; Immunology; Stem cell; Surgery; Andrology; Biology","score_opus":0.0245010043087037,"score_gpt":0.26708851155609736,"score_spread":0.24258750724739367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032905303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99321795,0.00020700275,0.00050826697,0.00032489182,0.00012025636,0.00096492964,0.0004873808,0.00009749857,0.0040718224],"genre_scores_gemma":[0.99687034,0.0010290396,0.0012378676,0.00014777404,0.0000514659,0.00004130712,0.00034063467,0.00007331069,0.00020825937],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99730897,0.00008794521,0.0008063758,0.00064912136,0.0006875629,0.00046000522],"domain_scores_gemma":[0.9982892,0.0001237951,0.00039365346,0.00077355554,0.00014174111,0.00027800066],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003059441,0.00045465736,0.00088052126,0.00016823121,0.00025164086,0.00006428252,0.00021802013,0.0003303656,0.00015296774],"category_scores_gemma":[0.000011078539,0.0003862872,0.0001628013,0.00014041233,0.0003308091,0.00029326318,0.000007980748,0.00031627546,0.000010033368],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027378013,0.0021434613,0.73365915,0.0048351255,0.0013302714,0.0020087217,0.008168752,0.0000019499969,0.24431182,0.00006743408,0.000013005191,0.00072246866],"study_design_scores_gemma":[0.01900633,0.0011630803,0.5243472,0.002523743,0.005641385,0.0034569143,0.0001221451,0.00004210576,0.44320667,0.000063530555,0.000010650255,0.00041622872],"about_ca_topic_score_codex":0.0002377766,"about_ca_topic_score_gemma":0.00018588785,"teacher_disagreement_score":0.20931198,"about_ca_system_score_codex":0.000019715504,"about_ca_system_score_gemma":0.00014092452,"threshold_uncertainty_score":0.9998589},"labels":[],"label_agreement":null},{"id":"W3033636562","doi":"10.1182/blood.2019004371","title":"Increased tumor burden in patients with chronic myeloid leukemia after 36 months of imatinib discontinuation","year":2020,"lang":"en","type":"letter","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Imatinib; Discontinuation; Medicine; Myeloid leukemia; Internal medicine; Imatinib mesylate; Oncology","score_opus":0.006081803957819466,"score_gpt":0.20998298433039336,"score_spread":0.2039011803725739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033636562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793728,0.0005650704,0.000003807021,0.016204793,0.000093953044,0.002611574,0.000331825,0.000086325206,0.000729824],"genre_scores_gemma":[0.94276184,0.00002276424,0.0008901898,0.048663735,0.0023288669,0.00064241415,0.003976366,0.00025199377,0.0004618156],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996605,0.0001256216,0.00086333277,0.0008145323,0.0009990102,0.0005925399],"domain_scores_gemma":[0.99812734,0.000115179275,0.00060097664,0.0008503666,0.0001608279,0.00014532376],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008456552,0.0006599984,0.0012761962,0.00029763026,0.000029026829,0.000024631072,0.00024959072,0.0004130701,0.00037739318],"category_scores_gemma":[0.00013189664,0.000531471,0.00020465752,0.00036530916,0.00013434915,0.00013582296,0.000116041076,0.0013490843,0.00009282931],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006968468,0.0028623892,0.80810463,0.007409914,0.0039274697,0.011761429,0.0021493472,0.000029989576,0.0006615895,0.0000025892125,0.15145704,0.0046651335],"study_design_scores_gemma":[0.12150173,0.005950025,0.81458694,0.007849821,0.0050359434,0.000075254844,0.000046378726,0.00026096223,0.0032450208,0.00002744592,0.039761495,0.001659001],"about_ca_topic_score_codex":0.0013618936,"about_ca_topic_score_gemma":0.00014615845,"teacher_disagreement_score":0.11453326,"about_ca_system_score_codex":0.0022862132,"about_ca_system_score_gemma":0.0021665173,"threshold_uncertainty_score":0.99971366},"labels":[],"label_agreement":null},{"id":"W3034137463","doi":"10.1182/blood.v130.suppl_1.4156.4156","title":"Treatment Outcomes in the Management of Lymphoblastic Lymphoma (LBL) in Adults: An Institutional Review","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; London Health Sciences Centre","funders":"","keywords":"Lymphoblastic lymphoma; Lymphoma; Medicine; Oncology; Clinical endpoint; Internal medicine; Immunology; Randomized controlled trial","score_opus":0.02526569438762266,"score_gpt":0.32127024182601216,"score_spread":0.2960045474383895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034137463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98719555,0.001993544,0.000017215794,0.0015174532,0.00005565362,0.001301627,0.000020795076,0.000014163218,0.007884004],"genre_scores_gemma":[0.99279034,0.005682635,0.0007444096,0.00029878918,0.000039278282,0.0002333436,0.000026364014,0.000013015088,0.0001718385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983855,0.00007489581,0.00041527327,0.0002910947,0.0005393898,0.0002938734],"domain_scores_gemma":[0.9986222,0.00009039315,0.00012773118,0.001027707,0.00004928218,0.00008270131],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033299715,0.00017226889,0.00044485397,0.00011981903,0.00009652216,0.000020510344,0.00046943393,0.000059280505,0.000033248023],"category_scores_gemma":[0.00013809594,0.00010597353,0.00009374565,0.00014232536,0.00018801115,0.000125757,0.00010456171,0.000056141485,0.00003521614],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011008116,0.024519375,0.777115,0.010500979,0.0011203225,0.01020602,0.0015367318,0.000012235349,0.00009103898,0.010240868,0.00014263207,0.16341399],"study_design_scores_gemma":[0.029064368,0.0006888734,0.9623425,0.0057870136,0.00032407106,0.00027405008,0.00019179008,0.00023074108,0.0001218741,0.00007989663,0.00076616474,0.00012863062],"about_ca_topic_score_codex":0.0006516743,"about_ca_topic_score_gemma":0.00015900987,"teacher_disagreement_score":0.18522753,"about_ca_system_score_codex":0.00052341574,"about_ca_system_score_gemma":0.00041223434,"threshold_uncertainty_score":0.4321475},"labels":[],"label_agreement":null},{"id":"W3034213215","doi":"10.1182/blood.2019000951","title":"Cellular therapies for graft-versus-host disease: a tale of tissue repair and tolerance","year":2020,"lang":"en","type":"review","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Immunology; Immune system; Graft-versus-host disease; Context (archaeology); Stromal cell; Disease; Medicine; Transplantation; Haematopoiesis; Immune tolerance; Innate lymphoid cell; Biology; Cancer research; Stem cell; Immunity; Pathology; Cell biology; Internal medicine","score_opus":0.033096058445646594,"score_gpt":0.3108028841132706,"score_spread":0.277706825667624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034213215","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021566729,0.99681574,0.0002103168,0.0000657896,0.00011930471,0.002025859,0.000283574,0.00007756354,0.00018619267],"genre_scores_gemma":[0.00030075276,0.99673605,0.0019887087,0.00001889304,0.00019284319,0.00022349406,0.0002459937,0.0000614027,0.00023187292],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99880266,0.000046357338,0.00044409005,0.00035782668,0.00019435427,0.00015471951],"domain_scores_gemma":[0.99905866,0.00024860582,0.00018385754,0.00029872052,0.00005037053,0.00015978087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009608829,0.00026245366,0.0012558947,0.0000597826,0.000029859028,0.0000075210182,0.00007519262,0.00013694953,0.00003477969],"category_scores_gemma":[0.00005355334,0.00021470168,0.0003210418,0.00013618395,0.00006607857,0.000024618497,0.000013963134,0.000109147055,0.000009994657],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006352566,0.0008525835,0.00015390471,0.7582987,0.002768492,0.0006462269,0.001336601,7.2594e-8,0.00072215905,0.0007693169,0.00047972178,0.23333699],"study_design_scores_gemma":[0.0028951298,0.00033130214,0.000023331415,0.014541227,0.007915064,0.000042999014,0.000027076812,0.0000043124355,0.0005342405,0.000009556793,0.9734661,0.00020964385],"about_ca_topic_score_codex":0.0000031771103,"about_ca_topic_score_gemma":9.811951e-7,"teacher_disagreement_score":0.9729864,"about_ca_system_score_codex":0.0000105013505,"about_ca_system_score_gemma":0.00017685402,"threshold_uncertainty_score":0.87552804},"labels":[],"label_agreement":null},{"id":"W3035059775","doi":"10.1182/blood.v130.suppl_1.297.297","title":"Targeting Mitochondrial Translation Overcomes Venetoclax Resistance in Acute Myeloid Leukemia (AML) through Activation of the Integrated Stress Response","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Advanced biosensing and bioanalysis techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Venetoclax; Cancer research; Myeloid leukemia; Biology; CRISPR; Myeloid; Leukemia; Gene; Computational biology; Genetics; Chronic lymphocytic leukemia","score_opus":0.01083451402820293,"score_gpt":0.271009265729549,"score_spread":0.2601747517013461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035059775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982511,0.00017568802,0.0007984424,0.0003662155,0.00006229292,0.0001923403,0.00003315911,0.0000104662295,0.00011031157],"genre_scores_gemma":[0.993749,0.00013027298,0.0057635945,0.00003949548,0.000088611014,0.000009015811,0.000045233217,0.000010424364,0.00016434197],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991516,0.0001514053,0.00022077505,0.0002189778,0.0001277242,0.00012955883],"domain_scores_gemma":[0.99907196,0.000033221993,0.00027184765,0.00053827866,0.000073238276,0.000011468442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001823037,0.00011316689,0.00012754931,0.000019905347,0.00021554573,0.000031059117,0.00031293664,0.00013499445,4.6972582e-7],"category_scores_gemma":[0.0002951124,0.00007228539,0.00008849545,0.000090298476,0.00015177972,0.000013659309,0.000056299014,0.00012428452,1.2414982e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065070257,0.000024878611,0.0013318168,0.0000062973345,0.000050556253,9.0387147e-7,0.000085292915,0.000033551372,0.99744487,0.000013977168,0.00009214855,0.00026499876],"study_design_scores_gemma":[0.000635321,0.000042882533,0.009338664,0.00008039982,0.000047694204,9.2685065e-7,0.000054463027,0.000030167741,0.9873979,0.00014569008,0.0021313224,0.0000945455],"about_ca_topic_score_codex":0.00008179383,"about_ca_topic_score_gemma":0.000318051,"teacher_disagreement_score":0.010046953,"about_ca_system_score_codex":0.00003719772,"about_ca_system_score_gemma":0.0001241982,"threshold_uncertainty_score":0.29477125},"labels":[],"label_agreement":null},{"id":"W3035482992","doi":"10.1182/blood.v130.suppl_1.3132.3132","title":"The Survival Impact of Lenalidomide Maintenance Chemotherapy in Multiple Myeloma Patients Treated with Autologous Stem Cell Transplant and Bortezomib-Based Induction: An Analysis of Real World Data","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Lenalidomide; Multiple myeloma; Bortezomib; Medicine; Oncology; Autologous stem-cell transplantation; Stem cell; Induction chemotherapy; Internal medicine; Thalidomide; Chemotherapy; Biology","score_opus":0.0451861496722879,"score_gpt":0.3158915809301914,"score_spread":0.2707054312579035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035482992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987522,0.00003782615,0.000008435377,0.0000522067,0.00000894953,0.00046548684,0.0005511029,0.00001133732,0.000112475],"genre_scores_gemma":[0.99921435,0.00014450795,0.00013651371,0.0000032157736,0.0000119010565,0.000013899621,0.0004073249,0.00001698843,0.000051271294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986301,0.00011849578,0.00031250934,0.00034263285,0.0003087528,0.00028751857],"domain_scores_gemma":[0.99804103,0.00015797337,0.00031572965,0.0012128752,0.00012790933,0.0001444595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030094417,0.00017430964,0.0005775875,0.00023027671,0.00013408723,0.00002638482,0.00029362884,0.000045314806,0.0000062790264],"category_scores_gemma":[0.00002718548,0.00009576612,0.00008510497,0.00030536077,0.00026611058,0.00012005752,0.000028061246,0.000116842275,2.4137003e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063917884,0.0015492785,0.9809931,0.000033672113,0.0015868964,0.000068588764,0.00012719788,0.00001847885,0.001113527,0.0000015123837,0.0000027322244,0.008113221],"study_design_scores_gemma":[0.0211439,0.0012068164,0.96270853,0.00006884858,0.0007963226,0.0000026612747,0.00005490472,0.005882713,0.008047332,5.3509666e-7,0.0000026602518,0.00008478794],"about_ca_topic_score_codex":0.0119804805,"about_ca_topic_score_gemma":0.022128005,"teacher_disagreement_score":0.018284589,"about_ca_system_score_codex":0.000045318317,"about_ca_system_score_gemma":0.00014057882,"threshold_uncertainty_score":0.9957156},"labels":[],"label_agreement":null},{"id":"W3035620538","doi":"10.1182/blood.v130.suppl_1.1070.1070","title":"Evaluation of Plasma-Derived FVII Efficacy for the Treatment of Bleeding in a Murine Model of Hemophilia a","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"","keywords":"Hemostasis; Titer; Medicine; Antibody; Factor IX; Coagulation; Saline; Recombinant factor VIIa; Bleeding time; Recombinant DNA; Factor VII; Pharmacology; Coagulopathy; Immunology; Antibody titer; Internal medicine; Chemistry; Platelet; Biochemistry","score_opus":0.14637282332198817,"score_gpt":0.3859753216586265,"score_spread":0.23960249833663835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035620538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969021,0.00034986864,0.0000124442095,0.0004987035,0.000021643882,0.0014922321,0.000017731401,0.0000038388484,0.0007014482],"genre_scores_gemma":[0.9987262,0.00029452634,0.00057744095,0.0000013637646,0.0000426153,0.0001166503,0.000007077003,0.00001048396,0.00022366917],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99898547,0.00002579733,0.00025997192,0.0001329607,0.0004553546,0.0001404743],"domain_scores_gemma":[0.99891204,0.00017120272,0.00015983992,0.00042436275,0.0002959663,0.000036576734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005785017,0.00009021755,0.0003140672,0.00009094416,0.000061268605,0.0000039638153,0.00010686301,0.000051598403,0.000015948099],"category_scores_gemma":[0.0003260484,0.00005262747,0.00012479482,0.000049508868,0.00011007684,0.000030648087,0.000021755242,0.00003363795,6.492197e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021454946,0.018097563,0.05712808,0.0005931627,0.001930901,0.000009063873,0.0051672305,0.0021965802,0.821759,0.00023584192,0.00001961564,0.090717494],"study_design_scores_gemma":[0.035931487,0.0020056171,0.0384113,0.00022230948,0.0016749259,0.0000031105028,0.00012996169,0.16497116,0.756307,0.00027643866,0.000009662847,0.00005703094],"about_ca_topic_score_codex":0.00007863025,"about_ca_topic_score_gemma":0.00003184351,"teacher_disagreement_score":0.16277458,"about_ca_system_score_codex":0.000046346937,"about_ca_system_score_gemma":0.00019866519,"threshold_uncertainty_score":0.2146086},"labels":[],"label_agreement":null},{"id":"W3037354931","doi":"10.1182/blood.2019003846","title":"Interleukin-18 and cytotoxic impairment are independent and synergistic causes of murine virus-induced hyperinflammation","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Child Health and Human Development; National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Institutes of Health; Rheumatology Research Foundation","keywords":"Immunology; Cytotoxic T cell; Perforin; Hemophagocytic lymphohistiocytosis; Biology; CD8; Immunopathology; Medicine; Antigen; Internal medicine","score_opus":0.03178143133559298,"score_gpt":0.2754787291162499,"score_spread":0.2436972977806569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037354931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980833,0.0005935794,0.00001604136,0.00049971073,0.000015760406,0.00037703695,0.0000063826524,0.00003523975,0.00037296102],"genre_scores_gemma":[0.9994344,0.00025225364,0.000042049378,0.000112032205,0.00005073501,0.000023091625,0.000007814758,0.000017102866,0.00006049803],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990472,0.000032899436,0.0003080364,0.00020738994,0.00024499244,0.00015944106],"domain_scores_gemma":[0.99950004,0.00002834677,0.00010935215,0.00015482216,0.00006569006,0.00014172656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010759455,0.00012543093,0.00031517097,0.00007926201,0.000043513668,0.000016778617,0.000054362703,0.00006590655,0.0001287157],"category_scores_gemma":[0.00015153033,0.000108246495,0.00003608688,0.00009914609,0.00006653853,0.00007478968,0.00012356044,0.00015539222,0.000010055466],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025730793,0.00034323212,0.054424647,0.0009549517,0.00018471522,0.0001624672,0.001172567,0.0000018565103,0.94058406,0.000067442066,0.000084436164,0.0017622933],"study_design_scores_gemma":[0.006207376,0.0016584577,0.41124395,0.0002574345,0.00018979285,0.00007977526,0.0013737506,0.00031712258,0.57794815,0.00003015788,0.0005024704,0.00019156442],"about_ca_topic_score_codex":0.00003924242,"about_ca_topic_score_gemma":0.00001413565,"teacher_disagreement_score":0.3626359,"about_ca_system_score_codex":0.000013894415,"about_ca_system_score_gemma":0.00006621563,"threshold_uncertainty_score":0.44141638},"labels":[],"label_agreement":null},{"id":"W3037451731","doi":"10.1182/blood.2019002314","title":"The 14-3-3ζ–c-Src–integrin-β3 complex is vital for platelet activation","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"Canadian Institutes of Health Research","keywords":"Integrin; Proto-oncogene tyrosine-protein kinase Src; CD49c; Platelet activation; Platelet; Cell biology; Integrin, beta 6; Platelet adhesiveness; Signal transducing adaptor protein; Hemostasis; Chemistry; Collagen receptor; Clot retraction; Antithrombotic; Signal transduction; Biology; Receptor; Biochemistry; Medicine; Immunology; Thrombin; Internal medicine; Platelet aggregation","score_opus":0.02605567643696568,"score_gpt":0.26985075583258844,"score_spread":0.24379507939562275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037451731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9760274,0.00017723696,0.009532868,0.010176018,0.00021653241,0.00082795834,0.00017306121,0.000047461617,0.0028214313],"genre_scores_gemma":[0.9959523,0.00002725115,0.0010410142,0.0015055706,0.00055759575,0.000114837894,0.00017306514,0.00002475432,0.0006035833],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99930286,0.00002222136,0.00015254621,0.00025269185,0.00008689126,0.00018279077],"domain_scores_gemma":[0.9994937,0.000041414103,0.000074093725,0.00022726822,0.00010033103,0.00006320325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000058017293,0.0001153591,0.00008544841,0.000010484396,0.00018539322,0.000050861167,0.00019493836,0.00009267824,0.000054161967],"category_scores_gemma":[0.00023443779,0.00009189586,0.000109547276,0.000053470678,0.000042069656,0.0000051072952,0.00007752965,0.00010395129,0.000035996694],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000109184344,0.00007594284,0.000100841375,0.000010983781,0.000121661644,6.6114086e-7,0.00009929374,0.000004494878,0.9660041,0.00017144936,0.031367067,0.0019343481],"study_design_scores_gemma":[0.0006489053,0.00021470504,0.00021855811,0.000004203461,0.000015613106,0.000007373946,0.00007929919,0.000054097785,0.6574315,0.00008112433,0.3411554,0.000089205234],"about_ca_topic_score_codex":0.000011409598,"about_ca_topic_score_gemma":0.000012336164,"teacher_disagreement_score":0.30978835,"about_ca_system_score_codex":0.000006916923,"about_ca_system_score_gemma":0.000036202906,"threshold_uncertainty_score":0.37474045},"labels":[],"label_agreement":null},{"id":"W3037540119","doi":"10.1182/blood.2019004292","title":"Hematopoietic stem cells acquire survival advantage by loss of RUNX1 methylation identified in familial leukemia","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"RUNX1; Leukemia; Stem cell; Haematopoiesis; Biology; Cancer research; Genetics; Immunology","score_opus":0.02172580617951951,"score_gpt":0.2808943614331022,"score_spread":0.2591685552535827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037540119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99648917,0.00056684465,0.00029111552,0.00058368297,0.000109074,0.0005838388,0.000059739807,0.000059350583,0.0012572105],"genre_scores_gemma":[0.99856275,0.00013155298,0.00019318105,0.0001808676,0.0001387779,0.000018100378,0.000054011656,0.000044603403,0.00067617174],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99785054,0.00015169744,0.0005469113,0.00040913303,0.00066737336,0.00037432948],"domain_scores_gemma":[0.9990196,0.0001660534,0.00012924353,0.00034969102,0.00010161553,0.00023377397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004113786,0.00019523525,0.00057665445,0.00011967982,0.000031249587,0.000015857342,0.00023580401,0.00017774857,0.00010762335],"category_scores_gemma":[0.000086003165,0.00018733609,0.00011521668,0.000534265,0.00010917839,0.0001325124,0.00014135492,0.00037600155,0.00010259117],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004382938,0.00029847806,0.017286548,0.0007154177,0.00011283376,0.00033065342,0.0016295352,0.000015072259,0.97682196,0.00011964372,0.0013432372,0.0008883386],"study_design_scores_gemma":[0.010844718,0.0003682652,0.0032351324,0.00012037705,0.00016473046,0.000021727503,0.0021216462,0.00062761846,0.9816024,0.000035902616,0.0006340267,0.00022346666],"about_ca_topic_score_codex":0.00009573348,"about_ca_topic_score_gemma":0.000012733321,"teacher_disagreement_score":0.014051416,"about_ca_system_score_codex":0.00020145175,"about_ca_system_score_gemma":0.00037409263,"threshold_uncertainty_score":0.76393443},"labels":[],"label_agreement":null},{"id":"W3037949817","doi":"10.1182/blood.2019004177","title":"Direct oral anticoagulants and cancer-associated VTE: good for all, or just some?","year":2020,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Venous thromboembolism; Intensive care medicine; Cancer; Thrombosis; Low molecular weight heparin; Rivaroxaban; Heparin; Drug; Venous thrombosis; Major bleeding; Warfarin; Internal medicine; Pharmacology; Myocardial infarction","score_opus":0.10340666058463154,"score_gpt":0.38411489063903914,"score_spread":0.2807082300544076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037949817","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019082993,0.99485093,0.0000012551941,0.00036102446,0.0003431045,0.0029800488,0.00051526644,0.0001346563,0.0006228762],"genre_scores_gemma":[0.00015527994,0.99630773,0.00014178512,0.00072219275,0.00056812604,0.0007591329,0.0003833305,0.00012053877,0.000841874],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980524,0.00007103967,0.0005158696,0.0006174992,0.0002568265,0.0004863498],"domain_scores_gemma":[0.9989091,0.00016263132,0.00032497148,0.00029515088,0.000054863147,0.00025325728],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002052884,0.00048794606,0.003867018,0.00011466694,0.000092635535,0.000058102287,0.00017217068,0.00029625423,0.000079430996],"category_scores_gemma":[0.00021033951,0.00034291693,0.0003862116,0.00022580256,0.00003985751,0.00005466044,0.00015133306,0.0002208542,0.000023351964],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003209193,0.0028239512,0.000075443415,0.05016566,0.009486921,0.0003268661,0.00012949998,5.3012272e-8,0.000003437081,0.00025942095,0.028728886,0.90796775],"study_design_scores_gemma":[0.0026414392,0.0006224374,0.00019463726,0.010601393,0.031153286,0.000024272687,0.000017269092,0.0000027131778,0.000014920744,0.0000068364484,0.9543449,0.00037587446],"about_ca_topic_score_codex":0.00014070967,"about_ca_topic_score_gemma":0.00009365534,"teacher_disagreement_score":0.925616,"about_ca_system_score_codex":0.00008819881,"about_ca_system_score_gemma":0.0003628906,"threshold_uncertainty_score":0.9999023},"labels":[],"label_agreement":null},{"id":"W3039967857","doi":"10.1182/blood.2019004296","title":"Outcome of primary mediastinal large B-cell lymphoma using R-CHOP: impact of a PET-adapted approach","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Spinal Cord Injury BC; St. Francis Xavier University","funders":"","keywords":"Medicine; Rituximab; Vincristine; CHOP; Prednisone; Nuclear medicine; Positron emission tomography; Diffuse large B-cell lymphoma; Lymphoma; Internal medicine; Single Center; Cyclophosphamide; Chemotherapy; Oncology; Radiology","score_opus":0.045517969657952316,"score_gpt":0.28407290206333735,"score_spread":0.23855493240538503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3039967857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946244,0.0007889744,0.00008437121,0.000057278365,0.000022465521,0.00033641813,0.00010345623,0.000031006923,0.003951633],"genre_scores_gemma":[0.9945285,0.00002338148,0.0051069725,0.00014489789,0.000090302645,0.000009558719,0.000053658277,0.000025923035,0.000016858367],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986752,0.000034585835,0.00043901842,0.00024751094,0.0003527113,0.00025093424],"domain_scores_gemma":[0.9991601,0.000060204467,0.00020897873,0.00024471848,0.00008934358,0.0002366374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009316873,0.00019545916,0.0006632373,0.00006983038,0.00002539446,0.000004971337,0.00008868558,0.000055144294,0.00006363319],"category_scores_gemma":[0.00007173195,0.00014358446,0.00034199233,0.00023879131,0.000042353946,0.000044754383,0.00006955092,0.000048987982,0.0000070206356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038019463,0.017469706,0.95879406,0.0006869133,0.00062427064,0.00030918166,0.00053047086,0.000013255781,0.02038811,0.000037859667,0.00010223117,0.00066372374],"study_design_scores_gemma":[0.053140648,0.0017429435,0.91751003,0.0001235397,0.0017901713,0.0003592511,0.00016465937,0.0015964246,0.023284698,0.0000044729604,0.000067602065,0.00021555964],"about_ca_topic_score_codex":0.00016192613,"about_ca_topic_score_gemma":8.520721e-7,"teacher_disagreement_score":0.052760452,"about_ca_system_score_codex":0.000100438614,"about_ca_system_score_gemma":0.00029571698,"threshold_uncertainty_score":0.58552045},"labels":[],"label_agreement":null},{"id":"W3040327021","doi":"10.1182/blood.v130.suppl_1.5594.5594","title":"Using Automatic Cell Counts to Calculate the I:T Ratio for Investigation of Early Onset Neonatal Sepsis","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Sepsis Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Regional Laboratory Medicine Program; McMaster University","funders":"","keywords":"Sepsis; Medicine; Neonatal sepsis; Pediatrics; Immunology; Internal medicine","score_opus":0.11540318931660543,"score_gpt":0.3555791494224811,"score_spread":0.24017596010587566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3040327021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986124,0.00007502104,0.0000684254,0.0005220468,0.000057011555,0.00038823084,0.000021773469,0.000008525172,0.00024655845],"genre_scores_gemma":[0.9972036,0.000002810262,0.0023969272,0.0002026295,0.000036455498,0.000029478044,0.000008751542,0.0000076224837,0.00011176646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996667,0.000008140943,0.00009391825,0.00007351797,0.000091523005,0.000066231034],"domain_scores_gemma":[0.9995605,0.000043388198,0.000072755116,0.00024112733,0.00004267336,0.000039592775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006707891,0.000048927763,0.000096516305,0.000018876113,0.00010001182,0.000021792212,0.000049559218,0.00002358595,0.000025138668],"category_scores_gemma":[0.00005377356,0.000032326283,0.00004288619,0.00001993459,0.000025521542,0.00002768152,0.0000134757875,0.00001906842,0.000021008173],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038791743,0.00051434356,0.9779429,0.00024873094,0.00042612583,0.000020192841,0.002605322,0.000023646835,0.008530546,0.0002551147,0.004075775,0.0053185206],"study_design_scores_gemma":[0.0025047222,0.00030204913,0.86097264,0.00017212133,0.00073856575,0.000010334797,0.000042278793,0.0019192327,0.13254389,0.00019235919,0.0005211792,0.0000806152],"about_ca_topic_score_codex":0.000107342086,"about_ca_topic_score_gemma":0.000009082723,"teacher_disagreement_score":0.12401335,"about_ca_system_score_codex":0.000012386208,"about_ca_system_score_gemma":0.00004591496,"threshold_uncertainty_score":0.13182276},"labels":[],"label_agreement":null},{"id":"W3040519582","doi":"10.1182/blood.2020006374","title":"MYC-induced human acute myeloid leukemia requires a continuing IL-3/GM-CSF costimulus","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Canada's Michael Smith Genome Sciences Centre; Institute for Research in Immunology and Cancer; University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Haematopoiesis; Myeloid; Biology; Immunology; CD34; Cancer research; Population; Stem cell; Leukemia; Granulocyte macrophage colony-stimulating factor; Progenitor cell; Myeloid leukemia; Interleukin 3; Cytokine; T cell; Medicine; Cell biology; Immune system; Interleukin 21","score_opus":0.033861214649666155,"score_gpt":0.3071939903723446,"score_spread":0.27333277572267844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3040519582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98036397,0.00024835748,0.000069238056,0.0047335895,0.00010083273,0.0009664279,0.000050761435,0.0005008348,0.012965987],"genre_scores_gemma":[0.9923494,0.0000848135,0.0011361288,0.0029562186,0.0012085156,0.000075247,0.00012278341,0.00012977276,0.0019371068],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99666035,0.00012251973,0.0006112805,0.0008221214,0.00083384715,0.00094989577],"domain_scores_gemma":[0.9978156,0.00015845812,0.00016719727,0.000724591,0.00028383106,0.0008503066],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034921814,0.00041862935,0.00079119095,0.00018024887,0.00021604924,0.00011169978,0.00050140504,0.00030644238,0.00046790455],"category_scores_gemma":[0.00073765515,0.0003873654,0.00025195268,0.00064036355,0.0001596529,0.0002347538,0.0003844043,0.0011042161,0.0007201609],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039300768,0.00021300314,0.002569825,0.00017247407,0.00070147915,0.0025226446,0.0023849928,0.0000028684276,0.97161335,0.00021693141,0.013099303,0.006110136],"study_design_scores_gemma":[0.049425185,0.0053188605,0.018629782,0.0007997838,0.0028173372,0.0011955163,0.001461592,0.0017506483,0.86457235,0.00025717253,0.052116867,0.0016549067],"about_ca_topic_score_codex":0.00018466091,"about_ca_topic_score_gemma":0.000019223637,"teacher_disagreement_score":0.10704099,"about_ca_system_score_codex":0.0004219359,"about_ca_system_score_gemma":0.0005900524,"threshold_uncertainty_score":0.99985784},"labels":[],"label_agreement":null},{"id":"W3040840390","doi":"10.1182/blood.v130.suppl_1.1104.1104","title":"The Effects of Rivaroxaban Exposure and Clinical Risk Factors on Efficacy and Safety Outcomes in Patients Treated for Venous Thromboembolism","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Rivaroxaban; Medicine; Pulmonary embolism; Population; Cmax; Pharmacodynamics; Internal medicine; Clinical trial; Regimen; Surgery; Anesthesia; Pharmacokinetics; Warfarin; Atrial fibrillation","score_opus":0.03137041980079789,"score_gpt":0.33696936616983203,"score_spread":0.3055989463690341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3040840390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99835014,0.00006732609,0.0000012091452,0.00016255214,0.00019293702,0.0010961117,0.000011484555,0.000012446869,0.00010581456],"genre_scores_gemma":[0.99948466,0.00027894118,0.00002581189,0.000013703052,0.00007903891,0.0000018589977,0.000008976671,0.000010770348,0.000096216994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99926686,0.000056674817,0.00028624077,0.00015936226,0.00011050719,0.00012036957],"domain_scores_gemma":[0.9979123,0.0014972879,0.00022441133,0.00028875793,0.000026283771,0.000050975428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021199282,0.00010838624,0.0004357384,0.00003628272,0.00022145221,0.000023559653,0.00006348872,0.0000735717,7.4097255e-7],"category_scores_gemma":[0.0022026647,0.00006221543,0.000085031126,0.000019924119,0.0000959094,0.000037398175,0.00004881756,0.00007563302,5.580664e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003871281,0.00019237986,0.99154824,0.0000449314,0.00025355144,9.320733e-7,0.000121794146,1.2735728e-7,0.000007794264,0.00008930193,0.000009781639,0.0073440135],"study_design_scores_gemma":[0.018772015,0.0020515576,0.9781819,0.000050701776,0.00047172612,8.1634916e-8,0.000013426604,0.000004113254,0.00017740611,0.000048411825,0.00016787848,0.000060757262],"about_ca_topic_score_codex":0.000041375013,"about_ca_topic_score_gemma":0.0000132630585,"teacher_disagreement_score":0.018384887,"about_ca_system_score_codex":0.000005234217,"about_ca_system_score_gemma":0.0000067106985,"threshold_uncertainty_score":0.26369545},"labels":[],"label_agreement":null},{"id":"W3040907513","doi":"10.1182/blood.v130.suppl_1.3725.3725","title":"Optimal Timing of Starting Thromboprophylaxis for Patients with Acute Spinal Cord Injury: A Cross-Sectional Survey of Canadian Spine Surgeons","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Cross-sectional study; Spinal cord injury; SPINE (molecular biology); Surgery; Emergency medicine; Spinal cord; Pathology","score_opus":0.04067112938370865,"score_gpt":0.32156564139805366,"score_spread":0.280894512014345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3040907513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99721676,0.000011611489,0.0001588513,0.000040863968,0.000108470354,0.00061482686,0.00070837786,0.000010468203,0.0011297939],"genre_scores_gemma":[0.990335,0.0000035883093,0.009191933,0.000024467994,0.000040219275,0.000022959579,0.00018411806,0.000026013176,0.00017173459],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873316,0.0000118592925,0.0003657044,0.0002610674,0.0003118341,0.00031636623],"domain_scores_gemma":[0.99833786,0.000024814548,0.00043259282,0.000467891,0.00058509264,0.00015176175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033395778,0.00014658584,0.0003573315,0.00024289725,0.0001922782,0.000027043789,0.00018988032,0.0000644975,0.000046675126],"category_scores_gemma":[0.00039848106,0.00012827969,0.00007446703,0.0001420879,0.00017602659,0.00009231904,0.00008607075,0.0000970571,0.0000013457658],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014870754,0.00028250605,0.9955492,0.00013662312,0.00056936435,0.000009277517,0.000016516435,0.0000019994143,0.0011203075,0.000009401193,0.00032558787,0.0004921216],"study_design_scores_gemma":[0.0034002608,0.0039381897,0.9854558,0.000083665305,0.00019202405,0.0000034130514,0.000008370559,0.000041049952,0.0065433234,0.0000012445057,0.00021759326,0.00011505157],"about_ca_topic_score_codex":0.054546047,"about_ca_topic_score_gemma":0.010194642,"teacher_disagreement_score":0.044351403,"about_ca_system_score_codex":0.000048229496,"about_ca_system_score_gemma":0.00028915147,"threshold_uncertainty_score":0.9517498},"labels":[],"label_agreement":null},{"id":"W3041001077","doi":"10.1182/blood.v130.suppl_1.3462.3462","title":"Tolerability and Efficacy of Post Transplant Lenalidomide Maintenance Therapy in Multiple Myeloma: A Real World Single Centre Experience","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Lenalidomide; Tolerability; Discontinuation; Maintenance therapy; Regimen; Salvage therapy; Multiple myeloma; Internal medicine; Neutropenia; Surgery; Melphalan; Oncology; Adverse effect; Chemotherapy","score_opus":0.04049360258884416,"score_gpt":0.3047032085685599,"score_spread":0.26420960597971577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3041001077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99770457,0.00019775004,0.000002454583,0.00045811135,0.000025166624,0.0006117377,0.00004503697,0.000017307952,0.0009378763],"genre_scores_gemma":[0.9990283,0.0002311782,0.00042942635,0.000026139765,0.000030377018,0.000023584595,0.000015169479,0.000012901385,0.00020289519],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878407,0.000052652937,0.00027007025,0.00032523085,0.0002255205,0.00034247208],"domain_scores_gemma":[0.998938,0.00016803459,0.00010078521,0.0005391247,0.00007960316,0.00017440098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014107968,0.00014775502,0.0003647398,0.00007857347,0.000115812574,0.000027660566,0.00014468419,0.000045671422,0.000039514194],"category_scores_gemma":[0.0003151118,0.00010952247,0.00007003113,0.000064349224,0.00027222856,0.00010015699,0.000037018024,0.000121132965,0.0000030745505],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025946898,0.0027328902,0.9247675,0.000056524776,0.000061570696,0.0002972108,0.0018553311,2.1148423e-7,0.055582497,0.000015852098,0.0000036881477,0.01203203],"study_design_scores_gemma":[0.023392892,0.00034597307,0.90244687,0.00024693165,0.000018704515,0.00001912953,0.00012723455,0.000042176198,0.07321015,0.000010393571,0.00005360808,0.000085952124],"about_ca_topic_score_codex":0.0025924705,"about_ca_topic_score_gemma":0.0035073983,"teacher_disagreement_score":0.022320649,"about_ca_system_score_codex":0.000033704335,"about_ca_system_score_gemma":0.000058234902,"threshold_uncertainty_score":0.4466197},"labels":[],"label_agreement":null},{"id":"W3041200265","doi":"10.1182/blood.2020006890","title":"HIV antiretroviral therapy and prevention use in US blood donors: a new blood safety concern","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; Office of the Assistant Secretary for Health; Centers for Disease Control and Prevention; U.S. Department of Health and Human Services; National Institutes of Health; U.S. Food and Drug Administration; Hamilton Health Sciences Foundation","keywords":"Emtricitabine; Medicine; Pre-exposure prophylaxis; Human immunodeficiency virus (HIV); Internal medicine; Blood donor; Confidence interval; Men who have sex with men; Antiretroviral therapy; Immunology; Viral load","score_opus":0.05816386232044767,"score_gpt":0.3162417968756487,"score_spread":0.258077934555201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3041200265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937602,0.0021068766,0.00017816007,0.001473574,0.00001626471,0.0006420888,0.00004603846,0.000074194904,0.0017025694],"genre_scores_gemma":[0.982783,0.0029173596,0.0013051808,0.0003979747,0.00036325777,0.000024314535,0.00007694652,0.000038573224,0.012093355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984591,0.00012456234,0.00038960838,0.0003806533,0.00028226755,0.0003638016],"domain_scores_gemma":[0.9991578,0.000054471857,0.00007154887,0.0002351488,0.00005569939,0.00042534448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015937505,0.00017815523,0.0003443325,0.00012308342,0.000061828396,0.00007531503,0.000115984505,0.00010425892,0.00069787266],"category_scores_gemma":[0.00030140474,0.00015774486,0.0001766548,0.00033707413,0.00008145815,0.00027589663,0.00007182779,0.0003435421,0.000063996915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090611546,0.0029935848,0.91720253,0.00020493133,0.0008240672,0.00044117376,0.0012813263,9.2216106e-7,0.04573753,0.00036590055,0.0066439062,0.023398023],"study_design_scores_gemma":[0.15064356,0.06014936,0.66430205,0.0022273983,0.0018809565,0.0006227746,0.0006785467,0.0010681655,0.08092308,0.0004373156,0.035877332,0.0011894456],"about_ca_topic_score_codex":0.0006690498,"about_ca_topic_score_gemma":0.00020891777,"teacher_disagreement_score":0.25290045,"about_ca_system_score_codex":0.0000115231915,"about_ca_system_score_gemma":0.00017521248,"threshold_uncertainty_score":0.76412165},"labels":[],"label_agreement":null},{"id":"W3042543262","doi":"10.1182/blood.2020005394","title":"Enhancer-gene rewiring in the pathogenesis of Quebec Platelet Disorder","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Ontario; Hospital for Sick Children; University of Toronto; SickKids Foundation; Amgen (Canada); Centre Hospitalier Universitaire Sainte-Justine; McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Biology; Chromatin; Megakaryocyte; Gene duplication; Platelet; Platelet disorder; Fibrinolysis; Gene; Ectopic expression; Plasminogen activator; Genetics; Cell biology; Molecular biology; Cancer research; Immunology; Medicine; Haematopoiesis; Internal medicine; Stem cell","score_opus":0.015096659726241062,"score_gpt":0.23945573790047342,"score_spread":0.22435907817423237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042543262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956417,0.001515604,0.000020192692,0.001567946,0.000015037777,0.00024152551,0.000013119827,0.000015859654,0.00096898794],"genre_scores_gemma":[0.9989528,0.00018458505,0.00020759509,0.00050426973,0.000035677233,0.000021771479,0.000023942592,0.00001201735,0.000057340156],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993452,0.00002554131,0.00017590281,0.00015674354,0.00014997541,0.00014665072],"domain_scores_gemma":[0.9997033,0.000033614822,0.000045134417,0.00015733343,0.000016257949,0.000044380533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000056805795,0.000095269424,0.00023588058,0.000028508886,0.00002251137,0.0000053575795,0.000080199905,0.00004466992,0.000044637352],"category_scores_gemma":[0.000038938288,0.000062963365,0.00006159813,0.00021507677,0.000022015989,0.000029453211,0.00002047697,0.000073539755,0.00001895515],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069934333,0.007540843,0.44626614,0.0005819829,0.00089283584,0.005468546,0.013650291,0.000060376362,0.4302617,0.0002487141,0.00062301004,0.093706205],"study_design_scores_gemma":[0.025652418,0.0013337433,0.6025314,0.00021547925,0.00078037183,0.0002782741,0.0021736186,0.00017086288,0.35941002,0.00021705391,0.0067681507,0.0004686525],"about_ca_topic_score_codex":0.00086909183,"about_ca_topic_score_gemma":0.0008786805,"teacher_disagreement_score":0.15626521,"about_ca_system_score_codex":0.0000066107787,"about_ca_system_score_gemma":0.00004188618,"threshold_uncertainty_score":0.25675717},"labels":[],"label_agreement":null},{"id":"W3042924866","doi":"10.1182/blood.2020004976","title":"Sustained depletion of FXIII-A by inducing acquired FXIII-B deficiency","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Blood properties and coagulation","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; Canadian Institutes of Health Research; Michael Smith Health Research BC; Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs; Heart and Stroke Foundation of Canada","keywords":"Fibrinolysis; Factor XIII; Fibrin; In vivo; Ex vivo; Medicine; Pharmacology; Coagulation; Platelet; Antifibrinolytic; Chemistry; Immunology; In vitro; Internal medicine; Biochemistry; Biology; Surgery; Tranexamic acid; Blood loss","score_opus":0.019927395972515208,"score_gpt":0.2291123445124759,"score_spread":0.20918494853996067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042924866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993468,0.0012111543,0.00044361537,0.002225203,0.0000333724,0.00025755476,0.0000068595136,0.00007185402,0.0022824064],"genre_scores_gemma":[0.9986892,0.000023917706,0.00029944043,0.00069458026,0.000112688205,0.000007641225,0.000044320666,0.000018029577,0.00011020011],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99911845,0.000025428977,0.00025754992,0.00019981094,0.00022418323,0.00017459813],"domain_scores_gemma":[0.9995287,0.000014884111,0.000090319256,0.00015996148,0.000102814905,0.00010329751],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000087628185,0.00009909855,0.0002138498,0.000034017616,0.000047242178,0.000009486714,0.00006574356,0.00008164643,0.00010521054],"category_scores_gemma":[0.00012202814,0.00008433985,0.000062236,0.00024371779,0.000032227545,0.00006977087,0.000050940118,0.00006761617,0.000016562753],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039105272,0.0010075144,0.05733234,0.00059492874,0.00012037293,0.000021181371,0.0026540896,0.000018534754,0.9239899,0.00039132766,0.0029772613,0.010501485],"study_design_scores_gemma":[0.018444436,0.0043064444,0.057525504,0.00033606807,0.0013113805,0.00008259951,0.004021464,0.0018857827,0.90661275,0.00033069265,0.0044706115,0.0006722345],"about_ca_topic_score_codex":0.00006096511,"about_ca_topic_score_gemma":0.0000011983051,"teacher_disagreement_score":0.018053384,"about_ca_system_score_codex":0.000010921032,"about_ca_system_score_gemma":0.000064922504,"threshold_uncertainty_score":0.34392792},"labels":[],"label_agreement":null},{"id":"W3043854567","doi":"10.1182/blood.2020007335","title":"COVID-19 coagulopathy, thrombosis, and bleeding","year":2020,"lang":"en","type":"letter","venue":"Blood","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Alexion Pharmaceuticals; Apellis Pharmaceuticals; Sanofi","keywords":"Coagulopathy; Medicine; Coronavirus disease 2019 (COVID-19); Thrombosis; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Pandemic; Intensive care medicine; Virology; Surgery; Internal medicine; Outbreak; Disease; Infectious disease (medical specialty)","score_opus":0.11760258509516515,"score_gpt":0.42329101309825645,"score_spread":0.3056884280030913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043854567","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005686607,0.0010936683,0.000060269223,0.9958957,0.00016858449,0.0007699401,0.000108797154,0.00023599969,0.0010983705],"genre_scores_gemma":[0.006958536,0.0054131243,0.0002770307,0.9802389,0.0058012325,0.00008444476,0.00013854948,0.00008223598,0.0010059455],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99686134,0.00012084046,0.00048742458,0.00091652543,0.0009817556,0.0006321343],"domain_scores_gemma":[0.9920402,0.0063079176,0.00015414906,0.0004996729,0.00012515945,0.0008728902],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00039268803,0.00040927334,0.001155272,0.00016900884,0.00020848229,0.000060921375,0.00025226572,0.00055947783,0.0003217495],"category_scores_gemma":[0.05032734,0.0003417173,0.0002381684,0.00027797694,0.00046251933,0.000042522206,0.0006835533,0.0029251424,0.00012703169],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024697945,0.00012186372,0.009985441,0.005767903,0.0006816904,0.0024091378,0.00020623475,1.2303539e-7,0.00026392343,0.000012836962,0.980391,0.00013510314],"study_design_scores_gemma":[0.0032732654,0.00058996264,0.0017345417,0.00031479288,0.0011942629,0.000015907492,0.000028770157,0.000014097901,0.000055138422,0.00034236684,0.99211687,0.00032001061],"about_ca_topic_score_codex":0.00013986236,"about_ca_topic_score_gemma":0.0000046413024,"teacher_disagreement_score":0.049934648,"about_ca_system_score_codex":0.00014970227,"about_ca_system_score_gemma":0.0013281927,"threshold_uncertainty_score":0.9999035},"labels":[],"label_agreement":null},{"id":"W3044080374","doi":"10.1182/blood.v130.suppl_1.752.752","title":"Health Related Quality of Life and Fatigue Improve on Second Line Treatments in Pediatric Immune Thrombocytopenia (ITP)","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; McMaster University; Children's Hospital of Eastern Ontario","funders":"","keywords":"Medicine; Immune thrombocytopenia; Quality of life (healthcare); Pediatrics; Observational study; Physical therapy; Internal medicine","score_opus":0.0354213409396581,"score_gpt":0.29816086577516826,"score_spread":0.26273952483551016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044080374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922625,0.005960953,0.000003115402,0.00022977889,0.00036804538,0.00039668783,0.00011630211,0.00002021175,0.0006424263],"genre_scores_gemma":[0.99783695,0.000746344,0.00008163433,0.000057114125,0.000016699165,0.000015474312,0.00004829888,0.000015915062,0.0011816022],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984757,0.00020617597,0.00067660486,0.0003107348,0.000034689347,0.0002961228],"domain_scores_gemma":[0.9985775,0.00008296366,0.0006533336,0.00062742643,0.00002605057,0.000032752334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005008217,0.00018497519,0.0006991293,0.00009355315,0.000257675,0.00001830704,0.00024802898,0.00024595912,0.00020176546],"category_scores_gemma":[0.00019075457,0.00015838213,0.00007201351,0.00004915825,0.0001021007,0.000104778046,0.00012548531,0.00028875715,0.000043876564],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005218001,0.0029098634,0.07245491,0.00019535363,0.0005083021,0.000007807586,0.0011903519,8.2234413e-7,0.9142764,0.002299288,0.00007460899,0.0055604842],"study_design_scores_gemma":[0.012564472,0.0014643052,0.8559759,0.000035169967,0.00004523869,0.000006481663,0.00007434038,7.793345e-7,0.12924801,0.0003467633,0.000055107743,0.00018344035],"about_ca_topic_score_codex":0.001157327,"about_ca_topic_score_gemma":0.000284038,"teacher_disagreement_score":0.7850284,"about_ca_system_score_codex":0.000021031276,"about_ca_system_score_gemma":0.00010636991,"threshold_uncertainty_score":0.64586353},"labels":[],"label_agreement":null},{"id":"W3044435121","doi":"10.1182/blood.v130.suppl_1.1132.1132","title":"Epidemiologic Characterization of Transfusion Recipients with Red Blood Cell Alloantibodies from Four US Regions: Evidence from the REDS-III Recipient Database","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Blood transfusion; Medicine; Isoantibodies; Red blood cell; Immunology; Database; Antibody; Computer science","score_opus":0.05435064824587471,"score_gpt":0.2703902595938246,"score_spread":0.2160396113479499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044435121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926424,0.0010702127,0.00093629345,0.0033911136,0.00029783987,0.0010120184,0.00033984438,0.00006284311,0.0002474432],"genre_scores_gemma":[0.9815271,0.01388981,0.0030374173,0.00029579795,0.00034327907,0.00004775347,0.0006750604,0.00003873191,0.00014504784],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99750346,0.00024280156,0.0006526502,0.00074478256,0.00051575224,0.00034055763],"domain_scores_gemma":[0.9965627,0.00047755818,0.00063189067,0.0019621828,0.00020700105,0.00015862458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006596933,0.00032911063,0.0006861534,0.000061301915,0.0005558275,0.000051284445,0.0005378749,0.00020135057,0.0001022659],"category_scores_gemma":[0.0004726071,0.00019863466,0.0001728293,0.0001273057,0.00026058627,0.00039703408,0.0001224275,0.00037628252,0.0000100303605],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011167609,0.0010138421,0.41995186,0.000047068654,0.00024056736,0.00009831062,0.00056240696,6.8915654e-7,0.5761932,0.000014167704,0.00007400368,0.0006871109],"study_design_scores_gemma":[0.0077871764,0.0007928294,0.81345415,0.003378863,0.0023858906,0.00003169649,0.00006678977,0.000046195135,0.17137848,0.000112646114,0.00032849525,0.00023679843],"about_ca_topic_score_codex":0.0047619515,"about_ca_topic_score_gemma":0.00058765645,"teacher_disagreement_score":0.40481475,"about_ca_system_score_codex":0.0000133215,"about_ca_system_score_gemma":0.00007935964,"threshold_uncertainty_score":0.81000865},"labels":[],"label_agreement":null},{"id":"W3044713593","doi":"10.1182/blood.2019004776","title":"Novel manifestations of immune dysregulation and granule defects in gray platelet syndrome","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia; University of Calgary","funders":"National Heart, Lung, and Blood Institute; Wellcome Trust; University College London; Cancer Research UK; Biotechnology and Biological Sciences Research Council; Department of Health and Social Care; Medical Research Council; Fondazione Umberto Veronesi; Swedish Orphan Biovitrum; Cambridge University Hospitals; Dell EMC; Deutsche Forschungsgemeinschaft; Rosetrees Trust; Science and Technology Facilities Council; British Society for Haematology; NIHR BioResource; British Heart Foundation; University of Cambridge; Isaac Newton Trust; CSL Behring; NHS Blood and Transplant; National Institute for Health and Care Research; Engineering and Physical Sciences Research Council; European Hematology Association","keywords":"Immunology; Immune system; Immune dysregulation; Biology; Bone marrow; Haematopoiesis; Medicine; Stem cell; Genetics","score_opus":0.01348502694764777,"score_gpt":0.2305039953033008,"score_spread":0.217018968355653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044713593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986941,0.00032512328,0.000039398346,0.00028984123,0.0000104947985,0.00023059775,0.00001826378,0.000016382037,0.00037577495],"genre_scores_gemma":[0.9991516,0.00003758603,0.0006458079,0.000059414495,0.0000046141276,0.000007796895,0.00006585042,0.000008898146,0.000018425284],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995484,0.0000066384073,0.0001586811,0.000116415315,0.000080546015,0.000089366564],"domain_scores_gemma":[0.9997998,0.000021818763,0.00004486363,0.00006682169,0.000015644977,0.00005103407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000028033344,0.00006967129,0.0001924338,0.000052902855,0.00001821689,0.0000036511756,0.000018894229,0.000038083093,0.000012967606],"category_scores_gemma":[0.00002570435,0.00006300756,0.000028481032,0.00014018845,0.00002100407,0.000045221383,0.000011577775,0.000048490754,0.000005483306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005336212,0.0067114593,0.62870586,0.0010914117,0.0007452168,0.009970778,0.004872831,0.000093594455,0.34103522,0.0012084128,0.000056877714,0.0049747135],"study_design_scores_gemma":[0.009880136,0.0004982756,0.97893256,0.000073637166,0.00013982349,0.0012066333,0.00009422387,0.0001779852,0.008707531,0.00019532345,0.000019652029,0.00007423875],"about_ca_topic_score_codex":0.00007305753,"about_ca_topic_score_gemma":0.000024841054,"teacher_disagreement_score":0.35022667,"about_ca_system_score_codex":0.000004712855,"about_ca_system_score_gemma":0.000016888474,"threshold_uncertainty_score":0.25693735},"labels":[],"label_agreement":null},{"id":"W3045089462","doi":"10.1182/blood.v130.suppl_1.426.426","title":"Feeding the Fire: The Comorbid and Inflammatory Backdrop of Clonal Hematopoiesis of Indeterminate Potential (CHIP) By Mutation Subtype","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baycrest Hospital; Sunnybrook Health Science Centre; University of Toronto; Health Sciences Centre; Queen's University","funders":"","keywords":"Mutation; Haematopoiesis; Biology; Indeterminate; Genetics; Cancer research; Stem cell; Gene","score_opus":0.012135600731142783,"score_gpt":0.24653478409270552,"score_spread":0.23439918336156274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045089462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982517,0.00027158167,0.000011402268,0.00058985606,0.0001460328,0.00013635796,0.000009710072,0.000007416236,0.000575995],"genre_scores_gemma":[0.9994923,0.00009462715,0.00004224373,0.00009928625,0.0000969487,0.000004846991,0.000008314521,0.000007463031,0.00015401024],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9994741,0.000041376486,0.00017743668,0.0000968322,0.0001256485,0.00008456923],"domain_scores_gemma":[0.99931693,0.00007017731,0.00024912818,0.00026930062,0.000066941175,0.000027549744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017450351,0.00007095099,0.00016650168,0.000016619231,0.00018542825,0.000010402269,0.000100580764,0.0000636627,0.00004641191],"category_scores_gemma":[0.000102496146,0.000040971598,0.00004982452,0.000024659887,0.00031041497,0.000044924403,0.000057857924,0.00011173945,0.000003496428],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000589684,0.00036884987,0.071150936,0.0005132222,0.00033549342,0.00005152379,0.0016300526,0.0000031270329,0.9172587,0.0006707215,0.0018618341,0.0055658864],"study_design_scores_gemma":[0.004084326,0.0005422387,0.80735135,0.00014139619,0.00045298753,0.00040062735,0.0005532456,0.00042290546,0.18488602,0.00043476277,0.0006068085,0.00012335618],"about_ca_topic_score_codex":0.00003728034,"about_ca_topic_score_gemma":0.000005968621,"teacher_disagreement_score":0.7362004,"about_ca_system_score_codex":0.0000029751081,"about_ca_system_score_gemma":0.00003086259,"threshold_uncertainty_score":0.16707732},"labels":[],"label_agreement":null},{"id":"W3045441206","doi":"10.1182/blood.2020007003","title":"HIV incidence in US first-time blood donors and transfusion risk with a 12-month deferral for men who have sex with men","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Blood donation and transfusion practices","field":"Business, Management and Accounting","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Office of the Assistant Secretary for Health; U.S. Food and Drug Administration; National Institutes of Health; U.S. Department of Health and Human Services; Universiteit Stellenbosch; Public Health England; Department of Science and Technology, Ministry of Science and Technology, India; Hamilton Health Sciences Foundation; Johns Hopkins University","keywords":"Residual risk; Medicine; Deferral; Incidence (geometry); Men who have sex with men; Poisson regression; Window period; Blood transfusion; Confidence interval; Human immunodeficiency virus (HIV); Internal medicine; Immunology; Population; Environmental health","score_opus":0.010981742865511006,"score_gpt":0.20182612222747603,"score_spread":0.19084437936196502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045441206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96468896,0.00011568168,0.000626615,0.0054245186,0.000008004222,0.001097807,0.000020121244,0.00012698615,0.027891325],"genre_scores_gemma":[0.9965589,0.00028549082,0.00095461914,0.0011884242,0.00022831955,0.00013780007,0.000033709995,0.000054949112,0.00055775343],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998527,0.00002477773,0.00028447196,0.0005385037,0.00032187256,0.00030337917],"domain_scores_gemma":[0.99935544,0.00012221192,0.0002108376,0.00016694212,0.00009307159,0.000051507184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030080878,0.00027171185,0.00032984043,0.00015518871,0.00027276564,0.00029443554,0.00019410707,0.00008849731,0.00012270226],"category_scores_gemma":[0.000069563015,0.00021048315,0.00004206198,0.00033203413,0.00007615167,0.00140494,0.00005409732,0.00022167845,0.000018037666],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014734695,0.0007931238,0.9913581,0.00040088815,0.00024962725,0.00008053631,0.001986889,0.00029181238,0.0003634777,0.0004251287,0.0011792273,0.001397723],"study_design_scores_gemma":[0.11018324,0.0024684626,0.631288,0.00089804176,0.008335529,0.0001228386,0.008166354,0.17283021,0.004746766,0.001023802,0.056538,0.0033987588],"about_ca_topic_score_codex":0.0025224271,"about_ca_topic_score_gemma":0.0077866237,"teacher_disagreement_score":0.3600701,"about_ca_system_score_codex":0.0000056349036,"about_ca_system_score_gemma":0.000033451757,"threshold_uncertainty_score":0.85832536},"labels":[],"label_agreement":null},{"id":"W3046025409","doi":"10.1182/blood.2019002973","title":"Assembly of alternative prothrombinase by extracellular histones initiates and disseminates intravascular coagulation","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Academy of Medical Sciences; University of Liverpool; University of Manchester; British Heart Foundation; National Institute for Health and Care Research","keywords":"Prothrombinase; Thrombin; Disseminated intravascular coagulation; Coagulation; Histone; Chemistry; Thromboplastin; Cell biology; Immunology; Biochemistry; Medicine; Internal medicine; Biology; Platelet","score_opus":0.022667006032343735,"score_gpt":0.2592546481031574,"score_spread":0.23658764207081368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046025409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99412835,0.0027673333,0.0012601444,0.0009538996,0.0000334188,0.0005297478,0.0000139469,0.00006186651,0.00025128256],"genre_scores_gemma":[0.998544,0.000120210934,0.0009694106,0.00015265135,0.000046597434,0.000023924342,0.000068622234,0.000024484929,0.00005011933],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990377,0.00004708315,0.0002802581,0.00026110513,0.00024147243,0.00013240098],"domain_scores_gemma":[0.9994201,0.000042360003,0.0001392138,0.00013706493,0.000103479084,0.00015778055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010878353,0.00014898975,0.00034375343,0.00004764589,0.000044153894,0.000013681279,0.00005514669,0.00008208502,0.000073410316],"category_scores_gemma":[0.000106929765,0.00013837998,0.00006196176,0.00013691028,0.00007749574,0.000106363,0.000033177577,0.00010002857,0.0000062723657],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043381,0.0006947277,0.0042576273,0.00024965097,0.00022057524,0.000021084334,0.0011280392,0.0000015749446,0.9892867,0.0029557957,0.00012319343,0.0010176271],"study_design_scores_gemma":[0.0029668703,0.0006838287,0.006124961,0.00011513978,0.0004423165,0.000022478245,0.00025867712,0.0010649591,0.987465,0.00047300282,0.00023362202,0.00014914497],"about_ca_topic_score_codex":0.000023604853,"about_ca_topic_score_gemma":7.63231e-7,"teacher_disagreement_score":0.0044156187,"about_ca_system_score_codex":0.00000749718,"about_ca_system_score_gemma":0.000023846202,"threshold_uncertainty_score":0.5642972},"labels":[],"label_agreement":null},{"id":"W3046566558","doi":"10.1182/blood.2020007522","title":"Carfilzomib, lenalidomide, and dexamethasone plus transplant in newly diagnosed multiple myeloma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Lenalidomide; Medicine; Carfilzomib; Internal medicine; Multiple myeloma; Minimal residual disease; Neutropenia; Autologous stem-cell transplantation; Transplantation; Regimen; Surgery; Oncology; Clinical endpoint; Chemotherapy; Clinical trial; Leukemia","score_opus":0.03450849152160632,"score_gpt":0.2749467073629789,"score_spread":0.24043821584137257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046566558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954985,0.0014861576,0.00006116048,0.0015617643,0.000020728317,0.0007290966,0.000066342844,0.0000639614,0.00051228225],"genre_scores_gemma":[0.99665976,0.00047724327,0.0020534883,0.00045676812,0.000112730966,0.00008031275,0.000063942854,0.000029081193,0.00006667528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858254,0.000076396595,0.0002514549,0.00039101325,0.0002895655,0.0004090117],"domain_scores_gemma":[0.99892396,0.0003017981,0.000034825287,0.00018181102,0.000033617158,0.00052401214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010892931,0.00019443333,0.0004301304,0.00009626118,0.000046718847,0.000022809689,0.0000799556,0.00009178273,0.00007834346],"category_scores_gemma":[0.00039086127,0.00016059908,0.00007332679,0.00023876697,0.00006663068,0.00007132707,0.000038799986,0.00023931706,0.000046671845],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003066656,0.0007969007,0.95444053,0.00027222454,0.00030812938,0.0067276377,0.0023047212,0.0000090419135,0.020384764,0.00001973936,0.00013906688,0.011530563],"study_design_scores_gemma":[0.10397363,0.0009296242,0.8498314,0.00020406152,0.00024926523,0.00019196328,0.00027028954,0.00287005,0.040448762,0.000016856904,0.0007390189,0.00027505396],"about_ca_topic_score_codex":0.00065159425,"about_ca_topic_score_gemma":0.00039457856,"teacher_disagreement_score":0.104609124,"about_ca_system_score_codex":0.000035319914,"about_ca_system_score_gemma":0.000119579745,"threshold_uncertainty_score":0.65490407},"labels":[],"label_agreement":null},{"id":"W3047048853","doi":"10.1182/blood.2020007081","title":"Multiple cereblon genetic changes are associated with acquired resistance to lenalidomide or pomalidomide in multiple myeloma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":159,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"NIHR Oxford Biomedical Research Centre; Medical Research Council; National Institute for Health and Care Research; Celgene","keywords":"Pomalidomide; Cereblon; Lenalidomide; Multiple myeloma; Cancer research; Medicine; Biology; Genetics; Oncology; Gene; Ubiquitin ligase; Internal medicine; Ubiquitin","score_opus":0.020325064064382784,"score_gpt":0.22025337954297763,"score_spread":0.19992831547859485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047048853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967102,0.0004140507,0.0001785243,0.0018510466,0.00004039803,0.00055827486,0.00007397392,0.00004285496,0.00013069273],"genre_scores_gemma":[0.9950401,0.00003644998,0.0018939741,0.0018635694,0.00021674231,0.00012411724,0.00010062307,0.000042939515,0.0006814617],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986302,0.00010780189,0.00024010395,0.0005039639,0.00018711477,0.00033077435],"domain_scores_gemma":[0.9992754,0.000036153564,0.00014298549,0.00027272748,0.00008087773,0.00019186687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008412067,0.00021714003,0.00024430512,0.0000536535,0.000069455935,0.0000341751,0.00022718676,0.00014990958,0.00002062859],"category_scores_gemma":[0.0011183707,0.00018352951,0.00004745136,0.00028820924,0.000043124757,0.000005660571,0.00010028024,0.000067486646,0.000014463158],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001828901,0.00028284948,0.112787135,0.000043410102,0.00010454888,0.000086896,0.00019094482,0.00006970757,0.88128084,0.000003001823,0.0029813047,0.00034048234],"study_design_scores_gemma":[0.006725409,0.0005263132,0.07927676,0.00012894617,0.000029437324,0.000005601056,0.00016427576,0.000056267127,0.9025285,0.000003190938,0.010181335,0.00037394103],"about_ca_topic_score_codex":0.000021799013,"about_ca_topic_score_gemma":0.0075810333,"teacher_disagreement_score":0.033510372,"about_ca_system_score_codex":0.000019640704,"about_ca_system_score_gemma":0.0000644759,"threshold_uncertainty_score":0.74841166},"labels":[],"label_agreement":null},{"id":"W3047237087","doi":"10.1182/blood.v130.suppl_1.2516.2516","title":"Loss of Ahi-1 Impairs the Self-Renewal Activity of Normal and BCR-ABL+ Stem Cells in Vitro and in Vivo","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Stem cell; Biology; Haematopoiesis; Cancer research; Progenitor cell; Embryonic stem cell; Chronic myelogenous leukemia; ABL; Myeloid; Cell biology; Imatinib mesylate; Leukemia; Tyrosine kinase; Myeloid leukemia; Immunology; Molecular biology; Imatinib; Signal transduction; Genetics","score_opus":0.010177606323744108,"score_gpt":0.24117322254109022,"score_spread":0.2309956162173461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047237087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984918,0.00023849861,3.2890782e-7,0.00009653691,0.000028889983,0.0003089515,0.000027747312,0.000006829365,0.00080037693],"genre_scores_gemma":[0.99959123,0.0001515451,0.000103913546,0.000009101217,0.000025431134,0.000008895936,6.401504e-7,0.000009794158,0.000099457364],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99928707,0.000041599513,0.00018178641,0.00016967893,0.00014405996,0.00017580531],"domain_scores_gemma":[0.9992713,0.00009299119,0.00015768514,0.00040479616,0.000017457496,0.00005582613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020945827,0.00011330791,0.00032162043,0.000056202796,0.000039005256,0.000008866836,0.000094929645,0.00007594616,0.000009989695],"category_scores_gemma":[0.00001837706,0.00008036928,0.00003197145,0.000044801352,0.00013839816,0.00008197066,0.000110566216,0.00012168814,5.6701384e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005781418,0.0011780951,0.6215103,0.00032833283,0.00016185209,0.00011497331,0.0012393439,0.0000016836259,0.37207878,0.000006153782,0.000014599077,0.002787741],"study_design_scores_gemma":[0.010639908,0.00018362748,0.22293785,0.000095663185,0.00013156205,0.00004498327,0.00009001014,0.00009773805,0.76568425,0.0000092318005,0.000024208957,0.000060984978],"about_ca_topic_score_codex":0.0016440524,"about_ca_topic_score_gemma":0.0006368231,"teacher_disagreement_score":0.39857247,"about_ca_system_score_codex":0.00007134294,"about_ca_system_score_gemma":0.00016223738,"threshold_uncertainty_score":0.3277364},"labels":[],"label_agreement":null},{"id":"W3047800702","doi":"10.1182/blood.v130.suppl_1.4682.4682","title":"The Utility of Early Broncholaveolar Lavage in Prolonged Neutropenic Patients with Pulmonary Nodules","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Induction chemotherapy; Internal medicine; Bronchoalveolar lavage; Chemotherapy; Acute promyelocytic leukemia; Surgery; Neutropenia; Chemotherapy regimen; Febrile neutropenia; Lung","score_opus":0.011098233888317563,"score_gpt":0.24658080801978485,"score_spread":0.23548257413146728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047800702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99031264,0.00012494941,7.348606e-7,0.00017476498,0.00007304704,0.0005165974,0.000010359754,0.000014183801,0.008772735],"genre_scores_gemma":[0.9996214,0.000031516003,0.000025869162,0.000025291514,0.000043148462,0.00004518661,0.0000041741637,0.000013193716,0.00019025075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992575,0.000039907536,0.00016823385,0.00018011851,0.0001786389,0.00017560313],"domain_scores_gemma":[0.99896604,0.000025453013,0.00013234127,0.0007282212,0.000094651004,0.00005328952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013445149,0.0000920097,0.00017892181,0.000027324902,0.00026821613,0.0000372814,0.00019667252,0.000041782194,0.000026119274],"category_scores_gemma":[0.000047714577,0.000055397646,0.000045451263,0.000058224115,0.00017063889,0.00014261578,0.00006384238,0.000210074,0.00000907669],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039815714,0.00083962904,0.9948093,0.000026108504,0.000040384828,0.000018745848,0.000053943077,7.456695e-8,0.0009117866,0.000026058906,0.000026693406,0.002849062],"study_design_scores_gemma":[0.0030558659,0.0004247121,0.99232936,0.00006525791,0.00009713495,0.000006916307,0.000010826867,0.0000019123129,0.0033064992,0.000025675972,0.0006165249,0.000059318816],"about_ca_topic_score_codex":0.0003461947,"about_ca_topic_score_gemma":0.0004257445,"teacher_disagreement_score":0.009308741,"about_ca_system_score_codex":0.000009945327,"about_ca_system_score_gemma":0.00005337851,"threshold_uncertainty_score":0.22590505},"labels":[],"label_agreement":null},{"id":"W3048089466","doi":"10.1182/blood.2020004974","title":"FcγRIIA expression accelerates nephritis and increases platelet activation in systemic lupus erythematosus","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; McGill University; Centre hospitalier de l'Université Laval; Université de Montréal; Université Laval; McGill University Health Centre; Centre hospitalier universitaire de Québec","funders":"National Center for Advancing Translational Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; National Institute on Aging; Canadian Institutes of Health Research; U.S. Department of Veterans Affairs","keywords":"Immunology; Lupus nephritis; Platelet; Platelet activation; Nephritis; Immune system; Systemic lupus erythematosus; Medicine; Antibody; Autoimmune disease; Biology; Disease; Internal medicine","score_opus":0.028053999310926416,"score_gpt":0.2739105894797886,"score_spread":0.24585659016886216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048089466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99603593,0.0014847232,0.0000067032593,0.0015539804,0.000018312896,0.0002879222,0.000010509928,0.000039739454,0.00056216266],"genre_scores_gemma":[0.9984715,0.00051647594,0.00020545072,0.00039358257,0.00018158687,0.000023567607,0.000039548653,0.000014355344,0.00015395075],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99910796,0.00004697047,0.00019805685,0.00022382278,0.00022339291,0.00019979346],"domain_scores_gemma":[0.9995356,0.000118197524,0.000039599738,0.000084057196,0.000037944465,0.0001845969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000069830516,0.000117147596,0.00025202247,0.000069548056,0.000054160202,0.000028507415,0.000057685407,0.000075351425,0.000092955124],"category_scores_gemma":[0.0001220869,0.000091760136,0.0000318689,0.000158084,0.00003790956,0.000103803344,0.00008361836,0.00018368733,0.000021896525],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008589334,0.00033673542,0.28996855,0.00091834523,0.000049222377,0.00036688152,0.0007220827,0.0000014830844,0.7028462,0.00013846123,0.0009842525,0.0028088624],"study_design_scores_gemma":[0.013234677,0.0010217894,0.07575457,0.002702843,0.00006709396,0.004515712,0.0010641542,0.0004923272,0.89641935,0.00021706056,0.0040647634,0.00044567246],"about_ca_topic_score_codex":0.00025294305,"about_ca_topic_score_gemma":0.0000078352095,"teacher_disagreement_score":0.21421397,"about_ca_system_score_codex":0.000009901699,"about_ca_system_score_gemma":0.00004096199,"threshold_uncertainty_score":0.37418696},"labels":[],"label_agreement":null},{"id":"W3048784631","doi":"10.1182/blood.v130.suppl_1.2748.2748","title":"FOXP1 Expression Is a Prognostic Biomarker in Follicular Lymphoma Treated with Immunochemotherapy and Is Associated with Distinct Molecular Features","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Follicular lymphoma; Biomarker; Lymphoma; Oncology; Internal medicine; Medicine; Cancer research; Biology; Immunology; Computational biology; Genetics","score_opus":0.008895849934635896,"score_gpt":0.24300157064788916,"score_spread":0.23410572071325325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048784631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956758,0.002130509,0.000003466756,0.00059665594,0.000007842405,0.0007748791,0.000026080479,0.000045774883,0.0007390035],"genre_scores_gemma":[0.99887186,0.000104845974,0.00027901077,0.0002734552,0.000009148339,0.00017416832,0.000053634907,0.000044470777,0.0001894059],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987879,0.000037377562,0.0001592318,0.0004362499,0.00028524938,0.00029399284],"domain_scores_gemma":[0.99900484,0.000048675553,0.00016971535,0.00057929603,0.00007429852,0.00012315215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000069055954,0.00029491013,0.00042002596,0.0000777867,0.00018272287,0.00011019788,0.000098227836,0.00013293949,0.000024209618],"category_scores_gemma":[0.000065724285,0.00017527124,0.00006671562,0.00010988594,0.000119088996,0.000079860634,0.000038165654,0.000049201302,0.0000027102167],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061675854,0.0028633287,0.97077465,0.000031706477,0.0009441788,0.0023051358,0.00031029456,4.5124533e-8,0.017607087,0.000004129957,0.00013889936,0.0044037546],"study_design_scores_gemma":[0.026271604,0.00077436696,0.78478605,0.0010095634,0.0005364525,0.00018578186,0.000023275843,0.000011335378,0.18613847,0.000011862502,0.00006588109,0.00018537039],"about_ca_topic_score_codex":0.00042649958,"about_ca_topic_score_gemma":0.000047731653,"teacher_disagreement_score":0.18598863,"about_ca_system_score_codex":0.00006785323,"about_ca_system_score_gemma":0.000075571465,"threshold_uncertainty_score":0.7147354},"labels":[],"label_agreement":null},{"id":"W3049528881","doi":"10.1182/blood.v130.suppl_1.4673.4673","title":"Evaluating the Indirect Costs of Care Associated with Salvage Chemotherapy for Relapsed and Refractory Aggressive-Histology Lymphoma: A Subset Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Clinical Trial","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Queen's University; Juravinski Hospital; Cancer Care Ontario; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Population; Chemotherapy regimen; Internal medicine; Oncology; Cancer","score_opus":0.4746242102734025,"score_gpt":0.5114919032731599,"score_spread":0.03686769299975734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049528881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879641,0.0033584507,0.000013527483,0.0038820414,0.00056525227,0.002048475,0.0019211232,0.000007667929,0.0002393451],"genre_scores_gemma":[0.99797475,0.00021554524,0.00020134755,0.0009535583,0.00021368211,0.00028973844,0.00006486858,0.000027693033,0.000058825946],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9936577,0.0017753661,0.0036292253,0.00047783897,0.00013770643,0.00032216226],"domain_scores_gemma":[0.9794178,0.0055893073,0.013717618,0.0009357843,0.00021114651,0.00012834863],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.034507524,0.00018303138,0.0022528125,0.00026739325,0.0007338162,0.00006571323,0.00055116054,0.00031587709,0.0000450106],"category_scores_gemma":[0.0391115,0.00013916129,0.00042135472,0.00019066076,0.00038129848,0.00011972529,0.000039243718,0.00014972847,0.0000012488152],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036699101,0.0004942279,0.9744389,0.00016373582,0.008014455,0.0000011984331,0.0054283845,0.000048522015,0.00001070545,0.002099174,0.0012019814,0.0044288067],"study_design_scores_gemma":[0.06656857,0.0011584639,0.92648375,0.00023249062,0.0017779983,0.0000010049349,0.00054431317,0.0013795643,0.000024229263,0.00035540882,0.0011889188,0.000285265],"about_ca_topic_score_codex":0.07577929,"about_ca_topic_score_gemma":0.58627164,"teacher_disagreement_score":0.5104924,"about_ca_system_score_codex":0.000598914,"about_ca_system_score_gemma":0.0011790713,"threshold_uncertainty_score":0.9941777},"labels":[],"label_agreement":null},{"id":"W3055615651","doi":"10.1182/blood.v130.suppl_1.4069.4069","title":"Prolonged Molecular and Clinical Remissions in Follicular Lymphoma Patients Treated with HDT/ASCT and Combination Immunotherapy with Rituximab and Interferon α","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Rituximab; Follicular lymphoma; Medicine; Immunotherapy; Internal medicine; Lymphoma; Oncology; Interferon; Immunology; Cancer","score_opus":0.009970470727453681,"score_gpt":0.2710702917893195,"score_spread":0.26109982106186586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3055615651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99791884,0.00081427966,0.0000027882106,0.0003689226,0.000008906917,0.000670172,0.000003998972,0.000016590891,0.00019547674],"genre_scores_gemma":[0.99906445,0.00044545488,0.00029025218,0.00007349734,0.0000068235095,0.0000557041,0.000021858987,0.0000187912,0.000023177972],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99918646,0.000048813476,0.0001835113,0.00030994334,0.00013314324,0.00013812979],"domain_scores_gemma":[0.99938506,0.00003496858,0.000113179856,0.00029976678,0.00005549406,0.00011155088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000100857505,0.00015776325,0.00032771117,0.000052204137,0.00012538553,0.000060361814,0.00003954996,0.00008482162,0.0000021050685],"category_scores_gemma":[0.000037635633,0.00009833635,0.000022898146,0.000034810542,0.00014656263,0.00008537668,0.00003464311,0.000050693394,5.6493013e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010124996,0.004810725,0.9714543,0.00002142038,0.00026884268,0.00021535436,0.00010708287,1.8396921e-8,0.0001924416,0.000024565572,0.000004053853,0.021888677],"study_design_scores_gemma":[0.081669584,0.004646676,0.9096572,0.00035360595,0.00031054372,0.00007678111,0.000018505489,0.000026426304,0.0030692199,0.000017845343,0.00004457683,0.000109039574],"about_ca_topic_score_codex":0.00017374818,"about_ca_topic_score_gemma":0.000054073196,"teacher_disagreement_score":0.08065708,"about_ca_system_score_codex":0.000026909409,"about_ca_system_score_gemma":0.000035341247,"threshold_uncertainty_score":0.40100402},"labels":[],"label_agreement":null},{"id":"W305719300","doi":"10.1182/blood.v124.21.4269.4269","title":"A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial Demonstrating Reversal of Edoxaban-Induced Anticoagulation in Healthy Subjects By Andexanet Alfa (PRT064445), a Universal Antidote for Factor Xa (fXa) Inhibitors","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; St. Joseph's Hospital","funders":"","keywords":"Medicine; Edoxaban; Rivaroxaban; Apixaban; Pharmacodynamics; Placebo; Warfarin; Pharmacology; Dabigatran; Anticoagulant; Pharmacokinetics; Antidote; Anesthesia; Internal medicine; Atrial fibrillation; Toxicity; Pathology","score_opus":0.050923953647839394,"score_gpt":0.3414302909452548,"score_spread":0.2905063372974154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W305719300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985889,0.000080794605,0.0013637588,0.00070746685,0.00045994946,0.0109585365,0.000020228945,0.000066121276,0.00045411717],"genre_scores_gemma":[0.9977909,0.000022245194,0.00078323024,0.000059017148,0.00093330356,0.000052513442,0.00017436476,0.000032943928,0.00015153701],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99742925,0.00031792338,0.0011037872,0.0003845384,0.00040259658,0.00036188526],"domain_scores_gemma":[0.9976929,0.0011334193,0.0006943253,0.00022389613,0.000116494564,0.00013899946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014458816,0.00028141358,0.0016002371,0.0003960294,0.000097365846,0.000033715743,0.00008339425,0.00021324378,0.000028942817],"category_scores_gemma":[0.00089154573,0.00024291073,0.0004029427,0.00032113746,0.00006311781,0.00021103251,0.000027425676,0.00016182884,0.0000028593915],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9770768,0.00038739666,0.003911341,0.0001370609,0.00034133726,0.0000028531488,0.00019713321,0.000014670235,0.016930783,0.00023550174,0.000082984305,0.0006821024],"study_design_scores_gemma":[0.9822971,0.0026256116,0.00006021897,0.000093885516,0.0008816076,0.0000026793036,0.000107342195,0.004325957,0.009202361,0.000035557146,0.0001497869,0.00021788239],"about_ca_topic_score_codex":0.00011783035,"about_ca_topic_score_gemma":0.000041911648,"teacher_disagreement_score":0.011901818,"about_ca_system_score_codex":0.000043025062,"about_ca_system_score_gemma":0.00016544288,"threshold_uncertainty_score":0.99056125},"labels":[],"label_agreement":null},{"id":"W3080206549","doi":"10.1182/blood.2020005199","title":"Targeting the Otub1/c-Maf axis for the treatment of multiple myeloma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Deubiquitinating enzyme; Apoptosis; Transcription factor; Cancer research; Biology; Ubiquitin; Cell biology; Biochemistry; Gene","score_opus":0.04419274333353106,"score_gpt":0.3010571760965666,"score_spread":0.25686443276303556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3080206549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815192,0.0045120753,0.00041549501,0.00992075,0.00006466433,0.0028986728,0.00013959943,0.000057070334,0.00047243302],"genre_scores_gemma":[0.9972708,0.00040317807,0.0011695802,0.0002115051,0.0003271631,0.00030522043,0.000044956836,0.000021586431,0.0002459617],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999064,0.000037437076,0.00019639892,0.00019477325,0.00023318964,0.00027417165],"domain_scores_gemma":[0.9987121,0.0007316911,0.000060923423,0.0002754411,0.00008292562,0.00013687578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009081492,0.00013300811,0.00022618972,0.000017940802,0.00017465054,0.000012859575,0.00012214415,0.00003710016,0.00007235052],"category_scores_gemma":[0.0004278394,0.000058964826,0.00018679789,0.0001250678,0.000077530385,0.000021520516,0.000025228088,0.000059406102,0.000029237528],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004953421,0.010365727,0.6150897,0.0006074429,0.0077318517,0.00027127066,0.013783322,0.00009414567,0.10486086,0.00028594397,0.006672554,0.23528372],"study_design_scores_gemma":[0.07534768,0.015838098,0.20817302,0.000108687236,0.0025789319,0.00005542965,0.0034495054,0.028005235,0.4501868,0.000083204955,0.21575034,0.0004230782],"about_ca_topic_score_codex":0.00010939007,"about_ca_topic_score_gemma":0.000015151689,"teacher_disagreement_score":0.4069167,"about_ca_system_score_codex":0.00002154639,"about_ca_system_score_gemma":0.00006233788,"threshold_uncertainty_score":0.24045159},"labels":[],"label_agreement":null},{"id":"W3080510081","doi":"10.1182/blood.2020006881","title":"Human TET2 bridges cancer and immunity","year":2020,"lang":"en","type":"letter","venue":"Blood","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Immunity; Cancer; Medicine; Immunology; Biology; Cancer research; Immune system; Internal medicine","score_opus":0.018167176505086514,"score_gpt":0.2630808933331395,"score_spread":0.244913716828053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3080510081","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.50854826,0.02426941,0.00004096064,0.46217814,0.00029693017,0.00041306438,0.00050754397,0.000049325205,0.003696378],"genre_scores_gemma":[0.29838437,0.0058616656,0.0001572315,0.6672561,0.011001849,0.00029275296,0.0023319444,0.00013452869,0.014579552],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99929243,0.000032431275,0.00011888335,0.00032160615,0.000080200145,0.00015442728],"domain_scores_gemma":[0.9994971,0.0000027743024,0.000072996714,0.00034837614,0.00004210135,0.000036631838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000025175617,0.00016232947,0.000145831,0.000018448265,0.00011579379,0.00003490843,0.00018588093,0.00030160468,0.000037747617],"category_scores_gemma":[0.000009027259,0.00015845682,0.00006108361,0.000031124364,0.000078378376,0.0000011057152,0.000100578756,0.00037804982,0.0000055101395],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000022500767,0.000029664789,0.00047919335,0.000059725873,0.00014384842,0.000017453165,0.000018944576,4.1724022e-7,0.14893077,0.000005674911,0.8495223,0.00078978646],"study_design_scores_gemma":[0.0003993167,0.000068539244,0.0012632387,0.00002221673,0.00011254898,0.000009356557,0.000009603073,5.709553e-7,0.034274884,0.000024676938,0.96358633,0.00022870666],"about_ca_topic_score_codex":0.00016260275,"about_ca_topic_score_gemma":0.000027963772,"teacher_disagreement_score":0.21016388,"about_ca_system_score_codex":0.0000055843475,"about_ca_system_score_gemma":0.000062313105,"threshold_uncertainty_score":0.6461682},"labels":[],"label_agreement":null},{"id":"W3081130755","doi":"10.1182/blood.v130.suppl_1.1278.1278","title":"Age and ABO Blood Group Are Significant Predictors of Thrombosis in Children with Acute Lymphoblastic Leukemia (ALL): Results from Dana-Farber Cancer Institute (DFCI) ALL Consortium Trial 05-001","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Hamilton Health Sciences; Centre hospitalier universitaire de Québec; Université de Montréal; McMaster Children's Hospital","funders":"","keywords":"Medicine; Internal medicine; Blood cancer; Population; Asparaginase; Pediatric cancer; Cancer; Pediatrics; Randomized controlled trial; Clinical trial; ABO blood group system; Thrombosis; Surgery; Leukemia; Lymphoblastic Leukemia","score_opus":0.02481211265689869,"score_gpt":0.2873753059174601,"score_spread":0.2625631932605614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081130755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99444103,0.00021444695,0.000018223784,0.00031429037,0.00034366793,0.002043612,0.0019604731,0.00008276686,0.0005814787],"genre_scores_gemma":[0.99647623,0.0010157466,0.0005508298,0.00018673668,0.00069414225,0.00020485735,0.0005508007,0.00009680907,0.00022381677],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957219,0.00012589099,0.0010156606,0.0011639077,0.0010964829,0.00087620947],"domain_scores_gemma":[0.9965785,0.0003173976,0.0008364994,0.0015454219,0.00017597945,0.0005461694],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043271686,0.0005769862,0.0012969385,0.00028580893,0.00019829461,0.00013350038,0.00069439795,0.00041593204,0.00004740847],"category_scores_gemma":[0.00074166467,0.00044642718,0.00012670942,0.00022954134,0.0012541144,0.00038859717,0.00039178747,0.0005403149,0.000009041847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07400584,0.008323852,0.8328271,0.00033401683,0.023803415,0.007569999,0.0020853553,0.00007976083,0.046155486,0.00012521315,0.004023998,0.00066594814],"study_design_scores_gemma":[0.32531705,0.001768417,0.6599552,0.0007759391,0.0052762814,0.00016484418,0.000064273096,0.00017158335,0.0057246364,0.000026988973,0.00026629504,0.0004885115],"about_ca_topic_score_codex":0.024377314,"about_ca_topic_score_gemma":0.0041028014,"teacher_disagreement_score":0.2513112,"about_ca_system_score_codex":0.00052806956,"about_ca_system_score_gemma":0.0017779298,"threshold_uncertainty_score":0.9997988},"labels":[],"label_agreement":null},{"id":"W3081404079","doi":"10.1182/blood.v130.suppl_1.2186.2186","title":"Treatment Patterns and Healthcare Resource Utilization in Patients with FLT3-Mut and FLT3-Wt Acute Myeloid Leukemia: A Multi-Country Medical Chart Study","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Myeloid leukemia; Internal medicine; Health care; Oncology; Family medicine; Pediatrics","score_opus":0.029213906063698714,"score_gpt":0.3212941490099947,"score_spread":0.292080242946296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081404079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963729,0.00021190918,0.000010885755,0.0012980906,0.000030654894,0.0018741032,0.00007114651,0.00004360004,0.000086703185],"genre_scores_gemma":[0.9985304,0.00046981336,0.000111189904,0.00020131844,0.00010938514,0.00012867266,0.00015344543,0.000049230188,0.00024655228],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99761605,0.00012902867,0.00032602082,0.00063335424,0.00081946055,0.00047608447],"domain_scores_gemma":[0.9984957,0.000059113925,0.00013899381,0.000715528,0.0001174487,0.00047324738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002887025,0.00029185016,0.0005121064,0.00016692869,0.00032353165,0.00008602081,0.0001830482,0.00022319648,0.000021600363],"category_scores_gemma":[0.00018390923,0.00020905519,0.000024963287,0.000101514066,0.00016674296,0.00015237457,0.00022474123,0.00041838363,0.0000057130046],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006266715,0.0017121583,0.98304343,0.00010823451,0.00024366628,0.0006582039,0.0017673491,1.2292041e-7,0.000014168498,0.0000035296025,0.000028302848,0.01179413],"study_design_scores_gemma":[0.0440348,0.0033444627,0.95046943,0.0002644154,0.00024117016,0.00009240425,0.0006894441,0.00027996226,0.00012578223,0.0000011083043,0.00027896452,0.00017803318],"about_ca_topic_score_codex":0.002483435,"about_ca_topic_score_gemma":0.0031996884,"teacher_disagreement_score":0.043408133,"about_ca_system_score_codex":0.00042084907,"about_ca_system_score_gemma":0.0004915575,"threshold_uncertainty_score":0.8525023},"labels":[],"label_agreement":null},{"id":"W3081758085","doi":"10.1182/blood.v130.suppl_1.3639.3639","title":"Antibodies Against Macrophage CD44 Protect Platelets from FcγR-Mediated Phagocytosis: A Potential Mechanism for CD44 Antibody Amelioration of Murine Immune Thrombocytopenia","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Antibody; Phagocytosis; Macrophage; CD44; Immune system; Opsonin; Biology; Fc receptor; Immunology; Monoclonal antibody; Platelet; Molecular biology; In vitro; Biochemistry","score_opus":0.015329682660991224,"score_gpt":0.2866288644695904,"score_spread":0.2712991818085992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081758085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99476314,0.0007987634,0.0004878196,0.0002608199,0.00025617587,0.0022923846,0.0006806379,0.00009801913,0.0003622674],"genre_scores_gemma":[0.9949067,0.0006761265,0.002394929,0.000077620636,0.00015827073,0.0001426347,0.0014672172,0.000067179346,0.000109281704],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99807745,0.000038660306,0.00056864443,0.00051532214,0.00036206486,0.00043787924],"domain_scores_gemma":[0.99818027,0.00004219982,0.0005949014,0.00080042495,0.00025361544,0.00012856966],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015251977,0.0003784795,0.0010693809,0.00013960502,0.0004501754,0.00009760411,0.0002906526,0.0002372481,0.000057141995],"category_scores_gemma":[0.00022456604,0.00032134174,0.00026964533,0.00008561157,0.00013015236,0.0002848928,0.00012890047,0.00018166359,0.00004397419],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008324008,0.0020579034,0.0018312389,0.00019894727,0.0013209835,0.001059241,0.00019854949,0.000003010528,0.99021125,0.00008344574,0.00003126566,0.0021717486],"study_design_scores_gemma":[0.028156677,0.0010815134,0.047447063,0.0004129487,0.0011323206,0.00007806451,0.000107633045,0.0006843829,0.91954654,0.00093949435,0.00004877133,0.0003645735],"about_ca_topic_score_codex":0.0007246208,"about_ca_topic_score_gemma":0.000053937678,"teacher_disagreement_score":0.070664704,"about_ca_system_score_codex":0.000027680557,"about_ca_system_score_gemma":0.00011120548,"threshold_uncertainty_score":0.9999239},"labels":[],"label_agreement":null},{"id":"W3081859925","doi":"10.1182/blood.v130.suppl_1.3734.3734","title":"A Systematic Review and Meta-Analysis of the Effect of Iron Chelation Therapy on Survival in Patients with Lower Risk Myelodysplastic Syndrome","year":2017,"lang":"en","type":"review","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Myelodysplastic syndromes; Hazard ratio; Internal medicine; Meta-analysis; Cochrane Library; Randomized controlled trial; Systematic review; Observational study; Odds ratio; Clinical trial; International Prognostic Scoring System; MEDLINE; Intensive care medicine; Confidence interval; Bone marrow","score_opus":0.04061473739776392,"score_gpt":0.3321727445137441,"score_spread":0.29155800711598023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081859925","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015929135,0.97661394,6.9020757e-7,0.000010584151,0.000016485927,0.007235551,0.00012875757,0.000004879517,0.000059990824],"genre_scores_gemma":[0.014983638,0.98437095,0.00000672199,0.00000763477,0.000004873897,0.00036419457,0.00006587679,0.000044106564,0.00015199087],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99583,0.0018156685,0.0009308728,0.0003863476,0.0008471377,0.0001899472],"domain_scores_gemma":[0.9953067,0.0011521054,0.0018527199,0.0015028572,0.00012356932,0.000062104096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020358588,0.0004257321,0.009968987,0.00043402932,0.00004200326,0.000010971654,0.0003403694,0.0001918365,0.00005111316],"category_scores_gemma":[0.0013124841,0.00017012346,0.001431367,0.000788327,0.00011400508,0.00003584349,0.00007201585,0.0005187171,0.000005606358],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000082367274,0.0002483104,0.002501608,0.8317487,0.16457564,0.000012136377,0.000013509726,0.0000010151348,3.625652e-8,0.0000013616495,0.0000024293192,0.0008128641],"study_design_scores_gemma":[0.0020407431,0.0015927099,0.0076023624,0.100981526,0.8875466,0.000010650822,3.7631227e-7,0.000002929457,6.8976044e-7,1.9494072e-7,0.00008964576,0.00013158371],"about_ca_topic_score_codex":0.000045328223,"about_ca_topic_score_gemma":0.0000108531885,"teacher_disagreement_score":0.7307672,"about_ca_system_score_codex":0.00008795363,"about_ca_system_score_gemma":0.00014610897,"threshold_uncertainty_score":0.69374335},"labels":[],"label_agreement":null},{"id":"W3082392838","doi":"10.1182/blood.2020005846","title":"Long-term results of PET-guided radiation in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOP","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Hôpital Charles-Le Moyne; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Diffuse large B-cell lymphoma; Medicine; Stage (stratigraphy); Lymphoma; Term (time); Nuclear medicine; Radiation therapy; Internal medicine; Oncology; Cancer research; Biology; Physics","score_opus":0.008668479568378662,"score_gpt":0.22485522056927543,"score_spread":0.21618674100089677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082392838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99792796,0.00017100961,0.0000032326677,0.00013388877,0.000010982215,0.00079247914,0.00018101078,0.000046617482,0.0007328236],"genre_scores_gemma":[0.99885195,0.000080177015,0.00020872802,0.00017933146,0.000023382005,0.00004795345,0.00046440022,0.00003177034,0.00011229423],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987232,0.000031771306,0.00033353784,0.00035664378,0.00030920602,0.0002456095],"domain_scores_gemma":[0.99920744,0.000041279385,0.00020189439,0.0002882603,0.000091893286,0.00016922722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000037179845,0.00021027961,0.0003793853,0.00007811521,0.000027704295,0.000009959848,0.00006018271,0.000044441684,0.00001457192],"category_scores_gemma":[0.000037319944,0.00014114281,0.00004817719,0.0002993964,0.000028343049,0.000093634735,0.000021495145,0.000040377214,0.00001135377],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003073312,0.022571823,0.97130424,0.00011643642,0.00013624642,0.0004816561,0.00037291096,0.000005715893,0.0001341291,0.000005475176,0.00004463171,0.0017534525],"study_design_scores_gemma":[0.22322851,0.0027163222,0.7567941,0.00015107657,0.00025068116,0.0000053966583,0.00002490802,0.000017780094,0.016616087,1.6115544e-7,0.00007518938,0.00011978412],"about_ca_topic_score_codex":0.00006214673,"about_ca_topic_score_gemma":0.00004090311,"teacher_disagreement_score":0.2201552,"about_ca_system_score_codex":0.000087940265,"about_ca_system_score_gemma":0.00008934767,"threshold_uncertainty_score":0.57556367},"labels":[],"label_agreement":null},{"id":"W3082973326","doi":"10.1182/blood.v130.suppl_1.4666.4666","title":"Pharmacy Hydroxyurea Education Materials for Patients with Sickle Cell Disease: An Environmental Scan and Assessment of Accuracy","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; University of Toronto; McMaster University","funders":"","keywords":"Medicine; Pharmacy; Medical prescription; Family medicine; Pharmacology","score_opus":0.00759470478594008,"score_gpt":0.28598216166857043,"score_spread":0.27838745688263034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082973326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980742,0.00017470011,0.000004205779,0.00015282845,0.00007685514,0.0007177486,0.000120731915,0.000007837969,0.0006709029],"genre_scores_gemma":[0.99878013,0.00020025627,0.00052241853,0.000051390147,0.00004598493,0.000040552914,0.00024030909,0.000015985097,0.000102996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99945897,0.000011746795,0.00012478667,0.00015133542,0.0001456658,0.0001075038],"domain_scores_gemma":[0.99941456,0.0000105440295,0.0001560507,0.00025366753,0.00002427609,0.00014088863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000056797613,0.0000894874,0.00013566054,0.000022599308,0.0001308424,0.000026473772,0.000059023314,0.00002477706,0.000058977566],"category_scores_gemma":[0.000018211887,0.00006664505,0.000020070012,0.000008036208,0.00007016596,0.00013897351,0.000024640618,0.000036802456,9.4155274e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033953346,0.008192544,0.92575663,0.00038495043,0.000092416354,0.0000024471,0.0001686887,9.032521e-7,0.05279307,0.00003076139,0.0001304098,0.012107666],"study_design_scores_gemma":[0.010925296,0.0006189934,0.9604433,0.00010744878,0.0006308025,0.0000017941861,0.0001332476,0.000040180887,0.024723567,0.000030128012,0.0022118946,0.00013333284],"about_ca_topic_score_codex":0.000046591296,"about_ca_topic_score_gemma":0.0000010453592,"teacher_disagreement_score":0.034686703,"about_ca_system_score_codex":0.00001514784,"about_ca_system_score_gemma":0.00015352404,"threshold_uncertainty_score":0.27177063},"labels":[],"label_agreement":null},{"id":"W3083459928","doi":"10.1182/blood.v130.suppl_1.120.120","title":"Functional and Biological Implications of CUX1 Mutations and Deletions in Myeloid Neoplasms","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Biology; Myeloid; Genetics; Mutation; Cancer research; Medicine; Gene","score_opus":0.04673571938378319,"score_gpt":0.31604310472582625,"score_spread":0.26930738534204307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083459928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923974,0.00015533394,0.00014601201,0.004455142,0.00001256155,0.00020770896,0.00003324068,0.0000128816955,0.0025797032],"genre_scores_gemma":[0.99764633,0.00021659247,0.0017500015,0.00006354738,0.00004214768,0.000047981106,0.000038469243,0.0000056267654,0.00018928749],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994673,0.000018748786,0.00014346784,0.00016693649,0.00007790585,0.00012560502],"domain_scores_gemma":[0.99940085,0.00012995434,0.000051575746,0.00025047731,0.00007812175,0.00008901528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012518876,0.000060072416,0.00013591468,0.000099833844,0.0001846128,0.000018170676,0.000059764854,0.000072918294,0.000054389497],"category_scores_gemma":[0.00041430033,0.00004974113,0.000020965117,0.00006664818,0.00032406364,0.000058998157,0.000082698265,0.00014541435,0.000007349048],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039410363,0.00032363334,0.9504415,0.000025864445,0.000049605664,0.000010186847,0.00011069597,0.0000013483967,0.039557748,0.0057501267,0.0003093133,0.0033805948],"study_design_scores_gemma":[0.0022238833,0.00011367996,0.9942959,0.00001799949,0.000037094254,0.00017138818,0.00007152686,0.000050049883,0.0013291687,0.0012653036,0.00037831257,0.000045672234],"about_ca_topic_score_codex":0.000091136535,"about_ca_topic_score_gemma":0.00006817183,"teacher_disagreement_score":0.04385445,"about_ca_system_score_codex":0.000017582413,"about_ca_system_score_gemma":0.00011163152,"threshold_uncertainty_score":0.20283844},"labels":[],"label_agreement":null},{"id":"W3083482298","doi":"10.1182/blood.2020005382","title":"Thrombospondin-1 promotes hemostasis through modulation of cAMP signaling in blood platelets","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"RWTH Aachen University; British Heart Foundation","keywords":"Platelet; Platelet activation; Hemostasis; Prostacyclin; Thrombospondin; Endocrinology; Chemistry; Internal medicine; Biology; Biochemistry; Medicine; Enzyme","score_opus":0.03139389194408911,"score_gpt":0.27039869919874243,"score_spread":0.2390048072546533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083482298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973549,0.00056841626,0.000027157637,0.0006568299,0.000018423145,0.00042765288,0.000022500939,0.00004505555,0.0008790466],"genre_scores_gemma":[0.99759173,0.000071985436,0.0020076826,0.00017778146,0.000033046195,0.000010696447,0.0000698264,0.000022664512,0.00001457718],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99901825,0.000021605747,0.00029627106,0.0002553226,0.00020634559,0.00020220804],"domain_scores_gemma":[0.99961644,0.000036461635,0.00009695663,0.00013781016,0.000039668645,0.000072659794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000050876035,0.00014895723,0.00041538486,0.00005034347,0.000028542561,0.00000736392,0.000054993525,0.00009178215,0.00008987091],"category_scores_gemma":[0.00006894689,0.00013112051,0.00007570217,0.00031637674,0.000027801128,0.00010435015,0.000024443345,0.00011228,0.000018099272],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033866623,0.006590377,0.2833539,0.00056515186,0.0012350008,0.003403818,0.008279679,0.00012954426,0.69247925,0.00026226378,0.00005424826,0.0033080883],"study_design_scores_gemma":[0.014723412,0.0010796739,0.036084615,0.00023845074,0.00065027026,0.00017440248,0.00033164662,0.0002717083,0.9455095,0.0006480891,0.00005859682,0.00022966223],"about_ca_topic_score_codex":0.00008792304,"about_ca_topic_score_gemma":0.000008487427,"teacher_disagreement_score":0.2530302,"about_ca_system_score_codex":0.000009654512,"about_ca_system_score_gemma":0.000047298287,"threshold_uncertainty_score":0.53469396},"labels":[],"label_agreement":null},{"id":"W3087179831","doi":"10.1182/blood.2020006578","title":"A phase 2 study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":169,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital de l'Enfant-Jésus; Jewish General Hospital","funders":"Cilag; Janssen Pharmaceuticals; Genentech; Daiichi Sankyo Europe; National Cancer Institute; Calithera Biosciences; Gilead Sciences; Servier; Juno Therapeutics; Eisai; TG Therapeutics; H. Lundbeck A/S; BeiGene; Bristol-Myers Squibb; Constellation Pharmaceuticals; Pharmacyclics; Agios Pharmaceuticals; Pfizer; Incyte; F. Hoffmann-La Roche; Teva Pharmaceutical Industries; Karyopharm Therapeutics; Kite Pharma; Unum Therapeutics; Sanofi; MorphoSys; Celgene; AstraZeneca; Amgen","keywords":"Venetoclax; International Prognostic Index; Medicine; Internal medicine; Diffuse large B-cell lymphoma; Rituximab; Vincristine; CHOP; Prednisone; Hazard ratio; Population; Tolerability; Oncology; Cyclophosphamide; Lymphoma; Gastroenterology; Adverse effect; Confidence interval; Chemotherapy; Leukemia; Chronic lymphocytic leukemia","score_opus":0.01977755846897808,"score_gpt":0.27365886025117026,"score_spread":0.25388130178219215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087179831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99593925,0.00024446024,0.000008745074,0.00014868806,0.000030376412,0.0031794403,0.00022150959,0.00004526921,0.00018228215],"genre_scores_gemma":[0.99849373,0.000048668822,0.00016786181,0.00022178613,0.000089126006,0.0006599289,0.00017239999,0.0000397706,0.00010670836],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9987935,0.000018170196,0.00028569676,0.00037045672,0.00027091082,0.00026128587],"domain_scores_gemma":[0.99911344,0.0000802173,0.0001359074,0.0003151365,0.00010397816,0.0002513235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000023367744,0.00025224852,0.0005163269,0.00004344677,0.000076321434,0.000011106483,0.00006578492,0.000049933107,0.000027227568],"category_scores_gemma":[0.000030071957,0.0001655812,0.0001228003,0.0001356056,0.000016523007,0.00003439668,0.000030788542,0.000018861068,0.00002025705],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008195657,0.7271551,0.24969587,0.00024505315,0.0019406477,0.00041128497,0.0064947056,0.000013909256,0.00006694672,0.000021406524,0.00025434291,0.0055050557],"study_design_scores_gemma":[0.82466704,0.135794,0.023578139,0.0000741495,0.0030308054,0.000006487524,0.00044932318,0.00022855146,0.008022279,0.000003523685,0.0039394074,0.00020628193],"about_ca_topic_score_codex":0.00018937897,"about_ca_topic_score_gemma":0.00005477077,"teacher_disagreement_score":0.8164714,"about_ca_system_score_codex":0.00028121096,"about_ca_system_score_gemma":0.0002474185,"threshold_uncertainty_score":0.6752205},"labels":[],"label_agreement":null},{"id":"W3087908385","doi":"10.1182/blood.v130.suppl_1.788.788","title":"Tafazzin (TAZ) Regulates the Differentiation of AML Cells By Reducing Levels of the Phospholipid Phosphatidylethanolamine","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brock University; Princess Margaret Cancer Centre; University of Waterloo; University of Toronto; University Health Network","funders":"","keywords":"Biology; Gene knockdown; Haematopoiesis; Stem cell; Cardiolipin; Molecular biology; Cell biology; Leukemia; Cancer research; Apoptosis; Immunology; Genetics","score_opus":0.01002092388456584,"score_gpt":0.22461819062328806,"score_spread":0.2145972667387222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087908385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981219,0.0007854765,0.000039242328,0.00016347368,0.0002189768,0.0001314259,0.0000855887,0.0000023277203,0.0004515954],"genre_scores_gemma":[0.99839866,0.00015587905,0.000039677776,0.000050985094,0.0000861723,0.0000061947244,0.000017829303,0.000010536089,0.0012340754],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993226,0.000036734415,0.00021128537,0.00018020735,0.00011991336,0.00012924115],"domain_scores_gemma":[0.9986739,0.000011659218,0.00035761073,0.0008271001,0.00011112712,0.000018580122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012222708,0.00010679063,0.00012965246,0.000008933507,0.00014663948,0.000022811812,0.0005747279,0.00009044169,0.000026207876],"category_scores_gemma":[0.00008935613,0.00006458491,0.000110198685,0.000026256468,0.00016072931,0.000005385767,0.00018993214,0.00005881108,0.0000016899552],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016383505,0.00010200759,0.0016406066,0.000015864733,0.0000776929,9.449184e-8,0.00008410343,0.0000065044137,0.9957543,0.000016237549,0.0011842744,0.001101943],"study_design_scores_gemma":[0.00046657343,0.00010042801,0.036443666,0.000041206906,0.000057763707,0.0000015086011,0.00003594139,0.000017059998,0.96225643,0.00003591226,0.000468086,0.00007540087],"about_ca_topic_score_codex":0.000106556865,"about_ca_topic_score_gemma":0.000015189451,"teacher_disagreement_score":0.03480306,"about_ca_system_score_codex":0.0000024953686,"about_ca_system_score_gemma":0.00002724435,"threshold_uncertainty_score":0.26336962},"labels":[],"label_agreement":null},{"id":"W3088378522","doi":"10.1182/blood.2020006338","title":"Genomic predictors of central nervous system relapse in primary testicular diffuse large B-cell lymphoma","year":2020,"lang":"en","type":"letter","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Francis Xavier University; Spinal Cord Injury BC; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Diffuse large B-cell lymphoma; Primary central nervous system lymphoma; Lymphoma; Central nervous system; Medicine; Biology; Pathology; Oncology; Internal medicine","score_opus":0.006505323169240855,"score_gpt":0.1836649054443916,"score_spread":0.17715958227515075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088378522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9680825,0.0045775664,0.000002173504,0.022530165,0.00052303483,0.0014811511,0.0005815287,0.00017093561,0.002050931],"genre_scores_gemma":[0.91081697,0.0003270474,0.00027798826,0.0835105,0.0024065375,0.00020226788,0.0018922513,0.00018021963,0.00038624313],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99716675,0.00011538109,0.0007755249,0.00067668606,0.00055626046,0.00070940086],"domain_scores_gemma":[0.9985256,0.00014657226,0.00034941325,0.0007016234,0.000052350453,0.00022442071],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0000687766,0.00053043384,0.001271847,0.00019762106,0.000038545466,0.000020370697,0.00022737359,0.0006233301,0.000015290556],"category_scores_gemma":[0.00004474578,0.00044307098,0.00039564725,0.0002144334,0.000055948294,0.000033680553,0.00014180996,0.00041141204,0.00007325697],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017165056,0.02578594,0.54648983,0.0101854205,0.0014662482,0.0763461,0.00055169524,0.000001695453,0.00093167386,0.000016148671,0.33779472,0.0002588905],"study_design_scores_gemma":[0.12378284,0.001513304,0.7108019,0.003257593,0.00757608,0.0011298792,0.00009033843,0.000059030473,0.0037336922,0.000005073173,0.14712468,0.00092556915],"about_ca_topic_score_codex":0.00014730734,"about_ca_topic_score_gemma":0.0000032823928,"teacher_disagreement_score":0.19067006,"about_ca_system_score_codex":0.00079129904,"about_ca_system_score_gemma":0.0005514899,"threshold_uncertainty_score":0.9998021},"labels":[],"label_agreement":null},{"id":"W3088601623","doi":"10.1182/blood.2020006892","title":"A randomized phase 2 trial of pomalidomide in subjects failing prior therapy for chronic graft-versus-host disease","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Pomalidomide; Medicine; Graft-versus-host disease; Randomized controlled trial; Internal medicine; Disease; Oncology; Surgery; Multiple myeloma; Lenalidomide","score_opus":0.039138855455176584,"score_gpt":0.3221142296923336,"score_spread":0.282975374237157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088601623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99165,0.0009964984,0.00094798574,0.00085100555,0.00013987359,0.0052215676,0.000034507688,0.000044364206,0.0001142228],"genre_scores_gemma":[0.99814886,0.00032387202,0.00064563745,0.00011913195,0.00030186877,0.00035026422,0.00006592257,0.000029947685,0.000014490743],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99864465,0.00012095277,0.0005395901,0.00025796643,0.00022846687,0.00020839562],"domain_scores_gemma":[0.99866277,0.00078924163,0.00013788589,0.00016746629,0.00005186814,0.0001907805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043324323,0.00015111273,0.0007143939,0.000080817175,0.000022731334,0.000008765936,0.000072150964,0.000063350344,0.000052116262],"category_scores_gemma":[0.00057224307,0.00012609066,0.00027999948,0.00017875918,0.000055389013,0.000048326092,0.0000062370523,0.000086004635,0.000004655002],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9581432,0.0011343071,0.00009571469,0.0006447962,0.0001926086,0.000058022237,0.001071488,0.0000031829625,0.038174886,0.00008564305,0.000006250477,0.00038994927],"study_design_scores_gemma":[0.9119332,0.0018841362,0.000050036262,0.00019579356,0.00062663626,0.0000024121928,0.00006720746,0.00066234235,0.08438698,0.000023186598,0.000062935,0.00010515569],"about_ca_topic_score_codex":0.000013012486,"about_ca_topic_score_gemma":0.000006527653,"teacher_disagreement_score":0.046212096,"about_ca_system_score_codex":0.000023188175,"about_ca_system_score_gemma":0.00035557267,"threshold_uncertainty_score":0.5141828},"labels":[],"label_agreement":null},{"id":"W3090015418","doi":"10.1182/blood.2020008367","title":"Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset","year":2020,"lang":"en","type":"letter","venue":"Blood","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; Centre Hospitalier Universitaire Sainte-Justine; McGill University; Centre Hospitalier de l’Université de Montréal; Université de Montréal; Héma-Québec","funders":"Canadian Institutes of Health Research","keywords":"Convalescent plasma; Antibody; Seroprevalence; Virology; Titer; Coronavirus disease 2019 (COVID-19); Medicine; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Antibody titer; Immunology; 2019-20 coronavirus outbreak; Neutralizing antibody; Serology; Internal medicine; Disease; Outbreak; Infectious disease (medical specialty)","score_opus":0.06558870194330219,"score_gpt":0.32812271444745716,"score_spread":0.262534012504155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3090015418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94136685,0.0012862673,0.000017171995,0.05514945,0.00023316646,0.000856258,0.00039000539,0.00010250932,0.0005983224],"genre_scores_gemma":[0.5650781,0.000033182398,0.00034871724,0.43304113,0.001173843,0.00010103603,0.000072951756,0.000119638404,0.000031400454],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99595255,0.00018297829,0.00092062424,0.0009478721,0.0011711041,0.00082484604],"domain_scores_gemma":[0.99831367,0.00044053406,0.0002954959,0.0007036791,0.00020183953,0.000044765155],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028096762,0.00062068674,0.0013985377,0.00059060694,0.000055599034,0.000057509587,0.00042651428,0.0006575544,0.000021181382],"category_scores_gemma":[0.00043398154,0.0005093402,0.00035182774,0.00038720027,0.0004110321,0.00009164957,0.0002968714,0.0019729303,0.00011564023],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012317846,0.00056256127,0.82868147,0.0036714803,0.00096736685,0.018049898,0.0012810983,1.02990214e-7,0.05786737,0.000012259214,0.08744667,0.0002279359],"study_design_scores_gemma":[0.011127716,0.001101523,0.04431614,0.00683178,0.0010887262,0.0006376508,0.00019884555,0.00005714688,0.73502326,0.00016595652,0.19824497,0.0012062716],"about_ca_topic_score_codex":0.00053887087,"about_ca_topic_score_gemma":0.0002970348,"teacher_disagreement_score":0.78436536,"about_ca_system_score_codex":0.00013100277,"about_ca_system_score_gemma":0.0006437545,"threshold_uncertainty_score":0.99973583},"labels":[],"label_agreement":null},{"id":"W3092735206","doi":"10.1182/blood.2020005867","title":"Overcoming T-cell exhaustion in LCH: PD-1 blockade and targeted MAPK inhibition are synergistic in a mouse model of LCH","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"National Cancer Institute; European Hematology Association","keywords":"Cancer research; Myeloid; CD8; Immune system; Immunotherapy; Inflammation; MAPK/ERK pathway; Tumor microenvironment; T cell; Immune checkpoint; Immunology; Biology; Cytotoxic T cell; Medicine; Cell biology; Kinase; In vitro","score_opus":0.02048758229438218,"score_gpt":0.22551581612645308,"score_spread":0.2050282338320709,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092735206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99842846,0.00031519678,0.00019916006,0.00020673274,0.000008014359,0.00025901076,0.000032991444,0.00001865893,0.0005317549],"genre_scores_gemma":[0.9989384,0.00005221451,0.00067166955,0.000106569256,0.0000143798125,0.000017834269,0.000039376082,0.000014997466,0.00014460352],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99927706,0.000016466483,0.00023977867,0.00020392417,0.000127413,0.0001353675],"domain_scores_gemma":[0.9997192,0.000017565164,0.00007224512,0.00009034113,0.000022196706,0.00007846451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004584836,0.00010758098,0.00025163134,0.00010494217,0.000016350592,0.0000048496604,0.000020025385,0.00007423516,0.0000126829],"category_scores_gemma":[0.000074776784,0.00010641368,0.000027289329,0.00015925732,0.000025498706,0.000042449145,0.000021036529,0.00010659485,0.000004160971],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008967395,0.0076045133,0.18880989,0.0019293986,0.00012000898,0.0006049332,0.0051165204,0.0060816156,0.7877972,0.00027270953,0.00016708641,0.000599382],"study_design_scores_gemma":[0.09262739,0.0015146439,0.038510866,0.0018174936,0.0010368512,0.000027947623,0.0022877017,0.30538628,0.5549003,0.0010190376,0.000057398083,0.00081411796],"about_ca_topic_score_codex":0.00012826642,"about_ca_topic_score_gemma":0.000058841422,"teacher_disagreement_score":0.29930466,"about_ca_system_score_codex":0.000034953115,"about_ca_system_score_gemma":0.000043828062,"threshold_uncertainty_score":0.43394238},"labels":[],"label_agreement":null},{"id":"W3093017431","doi":"10.1182/blood.v130.suppl_1.415.415","title":"Impact of Immunohistochemistry-Defined Cell of Origin and MYC Rearrangements on Outcomes in Patients with PET-Defined Stage I/II Diffuse Large B-Cell Lymphoma Treated with R-CHOP ± Radiotherapy: An International Multi-Center Retrospective Study","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Stage (stratigraphy); Immunohistochemistry; Diffuse large B-cell lymphoma; Lymphoma; Medicine; Radiation therapy; Internal medicine; Oncology; CHOP; Pathology; Cancer research; Biology","score_opus":0.010917304930278567,"score_gpt":0.28692304630382687,"score_spread":0.2760057413735483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093017431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980157,0.00002842089,7.130928e-7,0.000013182956,0.000022880538,0.001036692,0.00043869452,0.000016691625,0.00042702074],"genre_scores_gemma":[0.99912125,0.000027474656,0.00027584698,0.000010807877,0.000010917498,0.0000570769,0.00012182958,0.000038988383,0.0003358256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986027,0.00003410599,0.00031592464,0.00041274275,0.0004049416,0.00022957813],"domain_scores_gemma":[0.99855,0.000020055293,0.00043597823,0.0007292448,0.00016067833,0.00010406145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000078060344,0.0003130539,0.0006190765,0.00013075674,0.00009536371,0.000028116812,0.00016918436,0.00004845111,0.000032804888],"category_scores_gemma":[0.000021726413,0.00019600097,0.00008422841,0.00006144039,0.000073457,0.0001322776,0.000052488573,0.00006078477,7.198944e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036505982,0.17695531,0.81589264,0.000025405847,0.00095452886,0.000084453626,0.00063527026,3.429131e-7,0.0017228489,0.000001666488,0.0000036638394,0.00007326815],"study_design_scores_gemma":[0.250235,0.009411411,0.73757917,0.00008892681,0.000196434,0.0000022339873,0.00007241906,0.0000097616885,0.0022705218,2.0777973e-7,0.0000031486995,0.00013079308],"about_ca_topic_score_codex":0.0014676661,"about_ca_topic_score_gemma":0.00006268908,"teacher_disagreement_score":0.24658439,"about_ca_system_score_codex":0.00034237068,"about_ca_system_score_gemma":0.000083545376,"threshold_uncertainty_score":0.7992687},"labels":[],"label_agreement":null},{"id":"W3094563503","doi":"10.1182/blood.2020006252","title":"Neighborhood poverty and pediatric allogeneic hematopoietic cell transplantation outcomes: a CIBMTR analysis","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Homelessness and Social Issues","field":"Health Professions","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba; University of Calgary","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Medicine; Transplantation; Poverty; Hematopoietic cell; Hematopoietic stem cell transplantation; Disease; Medicaid; Pediatrics; Internal medicine; Health care; Haematopoiesis; Biology; Stem cell","score_opus":0.02949501602372193,"score_gpt":0.329971682981074,"score_spread":0.30047666695735203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094563503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953275,0.0008692293,0.00066176656,0.0009626957,0.00006552517,0.0002993532,0.000058124948,0.00009684217,0.001659003],"genre_scores_gemma":[0.9971247,0.0011261464,0.00012197428,0.0012498872,0.00019759928,0.000043544187,0.000045092707,0.000020269672,0.000070840906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861616,0.00022943506,0.00036959964,0.00028540017,0.00019553436,0.0003038702],"domain_scores_gemma":[0.99926525,0.00020235822,0.00013291369,0.00013568725,0.000052823103,0.00021095878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014545955,0.00015371283,0.0005361441,0.00009255728,0.00031577412,0.000013957313,0.0001082006,0.00016942162,0.000291498],"category_scores_gemma":[0.000032622665,0.00012713361,0.00013052957,0.0006337253,0.000013179254,0.00007314936,0.0000325014,0.00022684295,0.00008991985],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009238016,0.00011036821,0.97545713,0.0005048382,0.00015282133,0.00001648338,0.023330342,0.0000023116247,0.000075187185,0.00027529243,0.000018939223,0.000047038593],"study_design_scores_gemma":[0.0026351672,0.000075984455,0.9820017,0.000009889845,0.00435431,2.1596746e-7,0.01013831,0.00003182241,0.00011724586,0.00026070612,0.00009007446,0.00028457228],"about_ca_topic_score_codex":0.00015047842,"about_ca_topic_score_gemma":0.00048558577,"teacher_disagreement_score":0.013192033,"about_ca_system_score_codex":0.000009457102,"about_ca_system_score_gemma":0.000072744304,"threshold_uncertainty_score":0.5184358},"labels":[],"label_agreement":null},{"id":"W3094564739","doi":"10.1182/blood.v130.suppl_1.4606.4606","title":"Long Term Followup of Sickle Cell Disease Post Hematopoietic Stem Cell Transplant from Uganda","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Busulfan; Fludarabine; ThioTEPA; Surgery; Hematopoietic stem cell transplantation; Internal medicine; Gastroenterology; Bone marrow; Transplantation; Cyclophosphamide; Chemotherapy","score_opus":0.0069945127878002335,"score_gpt":0.21395083217655028,"score_spread":0.20695631938875006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094564739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908453,0.0033559215,0.000022979852,0.00036363164,0.00017305106,0.0003066751,0.00018685046,0.000039281214,0.0047062766],"genre_scores_gemma":[0.9978232,0.00030612282,0.0000363364,0.0000953643,0.000060378945,0.0000064420597,0.00006543569,0.000031531064,0.0015752333],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989455,0.000019562365,0.00027312842,0.0002637563,0.00024351243,0.00025458753],"domain_scores_gemma":[0.99873525,0.000038741473,0.00015736553,0.0007221208,0.000046625668,0.0002998868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000057327845,0.00017881225,0.00034492774,0.00004020452,0.00015901409,0.000028417267,0.00020968005,0.000125783,0.00015689828],"category_scores_gemma":[0.000009388712,0.00014034928,0.00021466332,0.00003166019,0.000102926875,0.00006258161,0.000038506467,0.0001714375,0.00006310276],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079860847,0.0054817097,0.82449824,0.0026117414,0.00034653425,0.0028754745,0.0040315567,0.000004252604,0.1572179,0.00002974801,0.00030865255,0.0017955982],"study_design_scores_gemma":[0.024938604,0.0006408318,0.6403193,0.0015716401,0.0037781312,0.000048496047,0.00082155096,0.000047965,0.32670048,0.00008350123,0.0004455587,0.0006039787],"about_ca_topic_score_codex":0.00018980478,"about_ca_topic_score_gemma":0.000016761805,"teacher_disagreement_score":0.18417895,"about_ca_system_score_codex":0.000007895572,"about_ca_system_score_gemma":0.00011525842,"threshold_uncertainty_score":0.57232773},"labels":[],"label_agreement":null},{"id":"W3094639681","doi":"10.1182/blood-2020-134319","title":"Idecabtagene Vicleucel (ide-cel, bb2121) in Relapsed and Refractory Multiple Myeloma: Analyses of High-Risk Subgroups in the KarMMa Study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Multiple myeloma; Medicine; Internal medicine; Refractory (planetary science); Pomalidomide; Lenalidomide; Oncology; Hematologic Neoplasms; Transplantation; Biology","score_opus":0.056192869041160075,"score_gpt":0.3303340735496066,"score_spread":0.27414120450844653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094639681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99665946,0.0012619765,0.0000038296444,0.0005871354,0.000024893432,0.001088078,0.000014104247,0.000027161173,0.00033334858],"genre_scores_gemma":[0.9990231,0.00030363488,0.00014242725,0.00023058956,0.000108140564,0.00005284266,0.000010614062,0.00003451503,0.00009414066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975812,0.0005399736,0.00053385034,0.00043263505,0.00060108054,0.00031125627],"domain_scores_gemma":[0.9984859,0.000649729,0.00013063266,0.0005175635,0.00007703422,0.00013913252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010155574,0.00019255835,0.0005546679,0.00023922951,0.000045760633,0.00002028319,0.0002475028,0.00009848933,0.0001811041],"category_scores_gemma":[0.0007623461,0.00014009832,0.00007980078,0.00093034713,0.00010330318,0.00006002015,0.00011668594,0.00059731887,0.00001098777],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009410532,0.002818398,0.62968045,0.00007157971,0.00019350162,0.00041347434,0.0074128658,0.0000139409285,0.3553771,0.0000034822726,0.00006323954,0.0030108988],"study_design_scores_gemma":[0.02138581,0.002326088,0.9143828,0.000044895663,0.00025940334,0.000014566152,0.0042631743,0.00023210839,0.05670284,0.00003480707,0.00019934439,0.00015413885],"about_ca_topic_score_codex":0.0031855456,"about_ca_topic_score_gemma":0.0015164273,"teacher_disagreement_score":0.2986743,"about_ca_system_score_codex":0.00003418799,"about_ca_system_score_gemma":0.00008161966,"threshold_uncertainty_score":0.5713043},"labels":[],"label_agreement":null},{"id":"W3094642003","doi":"10.1182/blood-2020-136255","title":"Single-Agent Mosunetuzumab Is a Promising Safe and Efficacious Chemotherapy-Free Regimen for Elderly/Unfit Patients with Previously Untreated Diffuse Large B-Cell Lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Chemotherapy regimen; Diffuse large B-cell lymphoma; Chemotherapy; Regimen; Lymphoma; Internal medicine; Surgery; Oncology","score_opus":0.015391288486337012,"score_gpt":0.2378056077934872,"score_spread":0.2224143193071502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094642003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924176,0.00071548193,0.00012876632,0.001793668,0.000020569354,0.003598811,0.00008749262,0.00014948327,0.0010881609],"genre_scores_gemma":[0.99315816,0.000116254,0.0018421898,0.0015064004,0.00016581679,0.00013485855,0.00011827577,0.00017249065,0.002785532],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99764806,0.0000565884,0.0003451705,0.00070010463,0.0005576496,0.00069241005],"domain_scores_gemma":[0.99840677,0.00010214254,0.00014409685,0.00066778954,0.00021386072,0.00046534068],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014448103,0.00036410856,0.0005655447,0.00008899887,0.00014390817,0.000086391825,0.00022440651,0.000156349,0.00024974154],"category_scores_gemma":[0.0000982392,0.00029232923,0.00012272433,0.0003039947,0.00008302175,0.00007143825,0.000103912724,0.00015012118,0.000013321012],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06348469,0.119867206,0.11247887,0.0060636867,0.0057888073,0.0006717917,0.0466918,0.0000031336956,0.29802394,0.000050330018,0.018104885,0.32877085],"study_design_scores_gemma":[0.6581965,0.029398853,0.008486749,0.00066891353,0.0015448963,0.00010185307,0.00031936207,0.0008462043,0.22899468,0.00008230501,0.07013742,0.0012222729],"about_ca_topic_score_codex":0.000026072585,"about_ca_topic_score_gemma":0.000010513991,"teacher_disagreement_score":0.5947118,"about_ca_system_score_codex":0.000118477146,"about_ca_system_score_gemma":0.00014795865,"threshold_uncertainty_score":0.9999529},"labels":[],"label_agreement":null},{"id":"W3094659087","doi":"10.1182/blood.v130.suppl_1.4705.4705","title":"Economic Burden in US Patients with Relapsed or Refractory Classical Hodgkin Lymphoma Treated with Brentuximab Vedotin or Chemotherapy after Failure of Autologous Hematopoietic Cell Transplantation","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Brentuximab vedotin; Cohort; Internal medicine; Oncology; Transplantation; Anaplastic large-cell lymphoma; Salvage therapy; Chemotherapy; Lymphoma; Surgery; Hodgkin lymphoma","score_opus":0.006104071765334962,"score_gpt":0.22062061463429947,"score_spread":0.21451654286896452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094659087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985762,0.000052065698,0.0000022736028,0.0002873844,0.000023566201,0.0006965077,0.000055244636,0.000031699255,0.00027506065],"genre_scores_gemma":[0.99873203,0.00008498353,0.0006011593,0.000051515755,0.000034598645,0.00014246273,0.0000675001,0.00004376991,0.00024196011],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988203,0.000038129372,0.00031999472,0.00037652501,0.00019000503,0.00025504234],"domain_scores_gemma":[0.999012,0.00006458665,0.00027269014,0.0005000625,0.000044398323,0.00010625272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004245766,0.00026652502,0.00054088933,0.000095095915,0.000060052083,0.000031024716,0.000114839815,0.00015087913,0.00014803704],"category_scores_gemma":[0.0000072837006,0.00015067772,0.00006338543,0.000050921655,0.00012233548,0.00011469784,0.000010862712,0.00006471843,0.000018421422],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014270463,0.0055024284,0.97441286,0.00021003587,0.0002431609,0.0010203264,0.0006557171,0.0000031892148,0.00018027374,0.0000026928155,0.000038078906,0.0034608003],"study_design_scores_gemma":[0.07664234,0.0039565694,0.9026961,0.00045858586,0.0005383665,0.00012127871,0.000042934924,0.000014828058,0.0152055845,0.0000017304641,0.00013369974,0.00018801316],"about_ca_topic_score_codex":0.0003518327,"about_ca_topic_score_gemma":0.0009625243,"teacher_disagreement_score":0.07171676,"about_ca_system_score_codex":0.00015750059,"about_ca_system_score_gemma":0.00026949626,"threshold_uncertainty_score":0.6144459},"labels":[],"label_agreement":null},{"id":"W3094679970","doi":"10.1182/blood-2020-137650","title":"Cite-Seq Profiling of T Cells in Multiple Myeloma Patients Undergoing BCMA Targeting CAR-T or Bites Immunotherapy","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Bone marrow; T cell; Immunology; CD8; Immune system; Immunotherapy; Antigen; Peripheral blood mononuclear cell; Cell therapy; Medicine; CD19; Biology; Cell","score_opus":0.030619094088624794,"score_gpt":0.27625283518110105,"score_spread":0.24563374109247627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094679970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99759996,0.00050522364,0.00003836365,0.00019064336,0.00006522936,0.00086807896,0.000018845225,0.00005962143,0.00065401715],"genre_scores_gemma":[0.9947307,0.00022174136,0.004199731,0.0002581651,0.00015359587,0.000027112126,0.000041229527,0.00006880064,0.00029890842],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981656,0.000097181735,0.000514744,0.00034805146,0.00046491806,0.00040951316],"domain_scores_gemma":[0.9988988,0.00044040685,0.00013361189,0.00024582367,0.00014348135,0.00013784721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026222595,0.00018835986,0.00044217007,0.00016645071,0.00005079592,0.00001934613,0.00016739358,0.00010590665,0.0006241723],"category_scores_gemma":[0.0005472267,0.00015902088,0.000119986515,0.00058756146,0.000058975194,0.00007590952,0.00007987496,0.00030986915,0.000022244249],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074277935,0.00044201917,0.3157526,0.00027231424,0.000086440596,0.000034862995,0.0012208663,0.000021897422,0.6786628,0.0000027723715,0.000029788835,0.0027309156],"study_design_scores_gemma":[0.013656679,0.0011131325,0.014609064,0.0002155338,0.000030945914,0.0000026775583,0.0005450856,0.0008831884,0.9682386,0.000010281361,0.0005082057,0.00018661025],"about_ca_topic_score_codex":0.000080494254,"about_ca_topic_score_gemma":0.000029860725,"teacher_disagreement_score":0.30114353,"about_ca_system_score_codex":0.000051772404,"about_ca_system_score_gemma":0.00020411267,"threshold_uncertainty_score":0.6834249},"labels":[],"label_agreement":null},{"id":"W3094696466","doi":"10.1182/blood-2020-141339","title":"Experience with Continuous Infusion of Recombinant Porcine FVIII in Patients with Acquired Hemophilia a","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Bolus (digestion); Hemostasis; Thrombosis; Internal medicine; Surgery; Gastroenterology","score_opus":0.01459917797348336,"score_gpt":0.24716219093691943,"score_spread":0.23256301296343607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094696466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99765223,0.00006188445,0.0000017967923,0.0009449622,0.00001670638,0.00066656375,0.000002566594,0.000023911029,0.00062935706],"genre_scores_gemma":[0.9991774,0.000017864055,0.00033604668,0.00011110994,0.000021679483,0.00002563448,0.000026960497,0.000017815373,0.0002654916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988717,0.000023032759,0.00021775918,0.00024837733,0.00038785153,0.00025130398],"domain_scores_gemma":[0.99940544,0.000019776455,0.00006567867,0.0002060354,0.00012316168,0.00017990441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000055356453,0.00013160176,0.00035511714,0.0000736617,0.00002621613,0.0000050616527,0.000076305296,0.000051035393,0.00007341187],"category_scores_gemma":[0.000059395283,0.0000759791,0.00002748451,0.00039313477,0.00009612035,0.000058792688,0.000044032487,0.000082932405,0.000007683679],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020718612,0.0018090799,0.9900554,0.00008777387,0.000044603814,0.00021681224,0.0019066775,4.596184e-7,0.0027885742,0.0000101994565,0.000034439745,0.0009741119],"study_design_scores_gemma":[0.02824672,0.009356455,0.93579966,0.0003936736,0.00007908555,0.000012331591,0.00034399313,0.000021849362,0.025500514,0.000005283095,0.000107754095,0.00013265418],"about_ca_topic_score_codex":0.00003568334,"about_ca_topic_score_gemma":0.000007008928,"teacher_disagreement_score":0.05425572,"about_ca_system_score_codex":0.000017455264,"about_ca_system_score_gemma":0.00008942918,"threshold_uncertainty_score":0.30983377},"labels":[],"label_agreement":null},{"id":"W3094699495","doi":"10.1182/blood-2020-140135","title":"Rapid Turnaround ADAMTS13 Testing Is Likely to Improve Diagnosis of Thrombotic Thrombocytopenic Purpura and Avoid Unnecessary Plasma Exchange","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"ADAMTS13; Medicine; Thrombotic thrombocytopenic purpura; Thrombotic microangiopathy; Internal medicine; Gastroenterology; Creatinine; Platelet; Disease","score_opus":0.0468175798690538,"score_gpt":0.2518669942149436,"score_spread":0.20504941434588977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094699495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885381,0.008230838,0.000009771873,0.0012947272,0.00026963925,0.000823023,0.00032553493,0.000092971575,0.0004153839],"genre_scores_gemma":[0.9983545,0.00020513353,0.00024952122,0.00082690385,0.00009155516,0.0001442996,0.00003351226,0.00003266962,0.00006190033],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99834573,0.00016482138,0.0004805973,0.00052927365,0.000077365796,0.00040220682],"domain_scores_gemma":[0.99860704,0.0006326974,0.00022255833,0.00034406583,0.00009339199,0.00010025389],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015255307,0.0002689129,0.00056487235,0.00008183737,0.00015795646,0.000033560595,0.00037049555,0.00012709865,0.0012827246],"category_scores_gemma":[0.00048663458,0.00025337088,0.000091481656,0.00028991085,0.00012128714,0.00014113373,0.0004498095,0.00017961634,0.00021625744],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017526349,0.0010089962,0.25793758,0.0013076712,0.0012612249,0.000036785445,0.004377022,0.000003976288,0.7057635,0.00009885515,0.018326372,0.009702718],"study_design_scores_gemma":[0.011093716,0.0043652873,0.20718284,0.00077314966,0.0011432067,0.000121574514,0.0018431095,0.00003633769,0.75621474,0.00016902466,0.015897859,0.0011591344],"about_ca_topic_score_codex":0.00012827913,"about_ca_topic_score_gemma":0.000018746576,"teacher_disagreement_score":0.050754722,"about_ca_system_score_codex":0.000017712397,"about_ca_system_score_gemma":0.00006420011,"threshold_uncertainty_score":0.99999183},"labels":[],"label_agreement":null},{"id":"W3094714150","doi":"10.1182/blood-2020-136135","title":"Molecular Response Patterns in Hydroxyurea (HU)-Resistant or Intolerant Polycythemia Vera (PV) during Treatment with Idasanutlin: Results of an Open-Label, Single-Arm Phase 2 Study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Polycythemia vera; Medicine; Open label; Internal medicine; Gastroenterology; Immunology; Clinical trial","score_opus":0.05130384645611689,"score_gpt":0.3253553041844848,"score_spread":0.27405145772836786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094714150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950115,0.00018265018,0.000006452078,0.0012751516,0.000018421988,0.003081825,0.00022990479,0.000054857213,0.00013924914],"genre_scores_gemma":[0.9983642,0.000038081762,0.000694971,0.00022570971,0.000055574405,0.0004177466,0.000085249834,0.0000689507,0.000049481096],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971631,0.00032999107,0.0007690892,0.0008422504,0.0004940368,0.0004015288],"domain_scores_gemma":[0.9984263,0.00015261862,0.0002432807,0.0006750091,0.00009495498,0.00040782025],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002418313,0.00046988463,0.000952478,0.00016198853,0.000088015535,0.00006924944,0.00023073603,0.00008484881,0.00005262634],"category_scores_gemma":[0.00012410792,0.0003085014,0.0000527875,0.00040431082,0.00005009902,0.00013770415,0.00011452772,0.00017057444,0.000005899824],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.31239226,0.20654541,0.03950842,0.00015681409,0.0015673921,0.028451936,0.013698819,0.000041597086,0.39541215,0.000006343761,0.0000067576775,0.0022121011],"study_design_scores_gemma":[0.209625,0.16363728,0.020173347,0.000478052,0.00078590657,0.000093311995,0.0012063059,0.0001204734,0.6034437,0.0000016061438,0.00010410683,0.0003309313],"about_ca_topic_score_codex":0.00047882102,"about_ca_topic_score_gemma":0.000503627,"teacher_disagreement_score":0.20803154,"about_ca_system_score_codex":0.00020302883,"about_ca_system_score_gemma":0.00029070603,"threshold_uncertainty_score":0.9999367},"labels":[],"label_agreement":null},{"id":"W3094760802","doi":"10.1182/blood-2020-140612","title":"Three-Dimensional Telomere Analysis Using Teloview® Technology Identifies Smouldering Myeloma Patients with High Risk of Progression to Full Stage Multiple Myeloma in a Proof of Concept Cohort","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Jewish General Hospital; CancerCare Manitoba","funders":"","keywords":"Multiple myeloma; Medicine; Monoclonal gammopathy of undetermined significance; Stage (stratigraphy); Asymptomatic; Internal medicine; Cohort; Oncology; Prospective cohort study; Surgery; Immunology; Monoclonal","score_opus":0.017747565847662444,"score_gpt":0.2808727619215524,"score_spread":0.26312519607388996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094760802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99664074,0.0003026456,0.00059138145,0.00009702278,0.000015265068,0.002078316,0.0002185258,0.00004589159,0.000010186198],"genre_scores_gemma":[0.98416567,0.0000040754235,0.015553608,0.000014465907,0.000017367904,0.000093555296,0.00011022924,0.00003408119,0.0000069491207],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974746,0.00006934055,0.00063013844,0.00056810427,0.0008318981,0.00042592466],"domain_scores_gemma":[0.99844676,0.00008869587,0.0003664583,0.00042788888,0.00041439966,0.00025581752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001537035,0.00027319597,0.0009321578,0.00073618436,0.00007129767,0.000010695604,0.00017218795,0.00014696317,0.00007013712],"category_scores_gemma":[0.00048384265,0.00020333068,0.0001344239,0.0022441123,0.00020381322,0.00009655307,0.00022864882,0.0002633868,0.0000025758243],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013717677,0.0015303134,0.97444236,0.00024482602,0.0021986123,0.00013576678,0.00025907892,0.0008010873,0.0115431575,0.0000035679313,0.0000036334643,0.007465838],"study_design_scores_gemma":[0.008076656,0.001702613,0.7820844,0.00034997612,0.0011681439,0.000003942358,0.0001105933,0.0027202365,0.20361243,0.000006894453,0.0000039579163,0.00016012759],"about_ca_topic_score_codex":0.00048095084,"about_ca_topic_score_gemma":0.0006999807,"teacher_disagreement_score":0.19235793,"about_ca_system_score_codex":0.000056232613,"about_ca_system_score_gemma":0.00014636261,"threshold_uncertainty_score":0.8291584},"labels":[],"label_agreement":null},{"id":"W3094771674","doi":"10.1182/blood-2020-137541","title":"Generalizability of Landmark Clinical Trials in Diffuse Large B Cell Lymphoma to Real-World Patients: A Single-Centre Retrospective Cohort Study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Foothills Medical Centre; Princess Margaret Cancer Centre; University of British Columbia; University Health Network","funders":"","keywords":"Medicine; Rituximab; Diffuse large B-cell lymphoma; Clinical trial; Internal medicine; Vincristine; CHOP; Prednisone; Oncology; Obinutuzumab; Retrospective cohort study; Lymphoma; Cyclophosphamide; Chemotherapy","score_opus":0.05990953475912904,"score_gpt":0.3462665462617078,"score_spread":0.28635701150257875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094771674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99412936,0.000049734048,0.0000016838734,0.0006093401,0.00011319416,0.0034645887,0.00015542514,0.000040093375,0.0014365664],"genre_scores_gemma":[0.9987284,0.000030204186,0.00017981627,0.0006147237,0.00016217133,0.00011787068,0.00005997778,0.00002379906,0.00008303831],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99627346,0.0009807677,0.0014045415,0.0006229587,0.0004300185,0.00028823994],"domain_scores_gemma":[0.99819094,0.0005212248,0.00031622098,0.00044488272,0.00017213594,0.00035461294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018242372,0.00021966596,0.0015694252,0.00008699113,0.000029077843,0.0000142089475,0.00009937591,0.0000853466,0.00007365073],"category_scores_gemma":[0.0023659237,0.0001668294,0.00029746108,0.0004598878,0.000026411919,0.00003454516,0.00010712557,0.000071334405,0.00002437352],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071230513,0.17657225,0.8199103,0.00003753897,0.0002819524,0.00008201043,0.00079636753,1.6823074e-7,0.00004198376,0.0000141256,0.0012550957,0.00029594667],"study_design_scores_gemma":[0.10231708,0.00303367,0.8920206,0.000044396806,0.0007624295,2.7644373e-7,0.00013914944,0.000007842558,0.0012180804,0.000007928209,0.00032340843,0.00012513506],"about_ca_topic_score_codex":0.00060863566,"about_ca_topic_score_gemma":0.001012978,"teacher_disagreement_score":0.17353858,"about_ca_system_score_codex":0.00025341936,"about_ca_system_score_gemma":0.00010618484,"threshold_uncertainty_score":0.68031055},"labels":[],"label_agreement":null},{"id":"W3094776043","doi":"10.1182/blood.v130.suppl_1.3745.3745","title":"Transfusion of Sickle Cell Anemia Patients in Quebec: Challenges and Opportunities","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Héma-Québec","funders":"","keywords":"Medicine; Population; Anemia; Incidence (geometry); Sickle cell anemia; Blood transfusion; Demography; Blood donor; Per capita; Ethnic group; Gerontology; Family medicine; Environmental health; Immunology; Internal medicine; Political science; Disease","score_opus":0.02263128879549564,"score_gpt":0.23155530854428347,"score_spread":0.20892401974878783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094776043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9680031,0.004721709,3.0095686e-7,0.00077373785,0.00003760059,0.00013926518,0.0000038695866,0.00000824178,0.02631221],"genre_scores_gemma":[0.96237963,0.036679216,0.000020693198,0.00003104308,0.0000109742405,0.0000024663266,0.0000049320456,0.000007623247,0.00086343364],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99956715,0.000011962402,0.00012720218,0.00010237906,0.00009041942,0.00010090136],"domain_scores_gemma":[0.99966586,0.000010270284,0.000056081346,0.00018462453,0.000028160242,0.000054984375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005774905,0.000067368535,0.00015874433,0.00004530812,0.000046572884,0.0000059213844,0.000045873276,0.00009344038,0.000018052715],"category_scores_gemma":[0.000016651304,0.000054324082,0.00002453993,0.000008139122,0.00008429797,0.00005663807,0.000020380223,0.00008402312,0.0000012656384],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041156722,0.007217803,0.37266746,0.0036941615,0.00009437165,0.0003101872,0.022342455,0.0000015902855,0.011201368,0.000908209,0.0002930849,0.58085775],"study_design_scores_gemma":[0.01836798,0.0009018671,0.95425755,0.000645711,0.00020589642,0.000010520544,0.0052599725,0.000015004067,0.015562362,0.0001417251,0.004400568,0.00023083162],"about_ca_topic_score_codex":0.0021427986,"about_ca_topic_score_gemma":0.0014842112,"teacher_disagreement_score":0.5815901,"about_ca_system_score_codex":0.000003985337,"about_ca_system_score_gemma":0.0000330315,"threshold_uncertainty_score":0.32392848},"labels":[],"label_agreement":null},{"id":"W3094788775","doi":"10.1182/blood-2020-136999","title":"Venetoclax Alone or in Combination with Chemotherapy: Responses in Pediatric Patients with Relapsed/Refractory Acute Myeloid Leukemia with Heterogeneous Genomic Profiles","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Venetoclax; Medicine; Internal medicine; Oncology; Ven; Chemotherapy regimen; Induction chemotherapy; Regimen; Chemotherapy; Leukemia; Gastroenterology; Chronic lymphocytic leukemia","score_opus":0.012494036776238528,"score_gpt":0.24334769243042906,"score_spread":0.23085365565419053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094788775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99683225,0.00020281767,0.000020598462,0.0006897445,0.000012849205,0.0020252087,0.000028612852,0.00009229311,0.00009564918],"genre_scores_gemma":[0.99614257,0.00027195978,0.0020392234,0.0007422557,0.000111931266,0.00019990063,0.00013388273,0.00013567995,0.00022260554],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974863,0.00016990889,0.00041372786,0.0006590517,0.00070667727,0.000564325],"domain_scores_gemma":[0.99881357,0.0001528045,0.0001966526,0.00040537879,0.0001677301,0.00026384377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020484014,0.00036479317,0.0005841156,0.00041588163,0.00005918066,0.00003301829,0.00023508024,0.00017539033,0.00004908611],"category_scores_gemma":[0.00009293666,0.00024077269,0.000035573856,0.0011194424,0.00012032113,0.00017256479,0.000065934495,0.00068529305,0.000030467023],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050733224,0.0010884334,0.9391033,0.0002786938,0.00028436282,0.002233274,0.0015085662,0.00017058989,0.0035703215,0.000002636546,0.00015285393,0.0008737116],"study_design_scores_gemma":[0.0761067,0.015445988,0.89608544,0.00021121839,0.0003326306,0.00017425543,0.000121822566,0.000310117,0.01037013,0.000003529033,0.000326203,0.00051197],"about_ca_topic_score_codex":0.000098954144,"about_ca_topic_score_gemma":0.00017976518,"teacher_disagreement_score":0.04301789,"about_ca_system_score_codex":0.0011598979,"about_ca_system_score_gemma":0.002656066,"threshold_uncertainty_score":0.9818425},"labels":[],"label_agreement":null},{"id":"W3094795635","doi":"10.1182/blood-2020-133869","title":"Trajectory of Symptoms after Autologous Stem Cell Transplant Among Patients with Multiple Myeloma: A Population-Based Study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Multiple myeloma; Nausea; Population; Depression (economics); Autologous stem-cell transplantation; Internal medicine; Physical therapy","score_opus":0.01073587474739432,"score_gpt":0.22392859511486665,"score_spread":0.21319272036747233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094795635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979482,0.000065200504,0.000030227018,0.00002302163,0.00001681282,0.0016403354,0.00014288547,0.00007066349,0.00006261423],"genre_scores_gemma":[0.9993869,6.285496e-7,0.00019325918,0.000044231845,0.000023518021,0.00014472619,0.00014702261,0.000033852706,0.000025835025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984981,0.00008437064,0.00028291187,0.00033518957,0.00052035425,0.00027906534],"domain_scores_gemma":[0.9991988,0.00008690014,0.00008765058,0.00024425078,0.00009029712,0.00029207778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000043477234,0.00019973733,0.00038343045,0.000087748514,0.00004339309,0.0000086042555,0.00008027294,0.00006183545,0.00005682808],"category_scores_gemma":[0.00001235977,0.0001418192,0.00008695691,0.00018344987,0.000035472913,0.000049605154,0.000012564354,0.00013750658,0.000011529102],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023237874,0.0058348402,0.98881626,0.00021656966,0.00031448118,0.0003650437,0.0011503703,0.00002342177,0.00014897891,1.1571364e-7,0.0000022722563,0.00080385513],"study_design_scores_gemma":[0.028219063,0.0038239718,0.9641505,0.00007346571,0.00044168226,0.0000012038186,0.00009984275,0.00042796275,0.002633423,1.14264246e-7,0.0000023582538,0.000126404],"about_ca_topic_score_codex":0.0002130534,"about_ca_topic_score_gemma":0.00014838458,"teacher_disagreement_score":0.025895275,"about_ca_system_score_codex":0.000026787751,"about_ca_system_score_gemma":0.00008172893,"threshold_uncertainty_score":0.57832193},"labels":[],"label_agreement":null},{"id":"W3094810190","doi":"10.1182/blood-2020-140895","title":"Variation in Stem Cell Driven Hierarchies Underlies Clinical Outcome and Drug Response in AML","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of Toronto; Health Sciences Centre; University Health Network","funders":"","keywords":"Stem cell; Biology; Progenitor cell; Population; Myeloid leukemia; Leukemia; Immunology; Cancer stem cell; Oncology; Cancer research; Medicine; Genetics","score_opus":0.05312269468960214,"score_gpt":0.3386781360173143,"score_spread":0.28555544132771216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094810190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98560303,0.00017553999,0.000033520893,0.013327739,0.000026938147,0.00037095157,0.000005650279,0.000036867466,0.00041977366],"genre_scores_gemma":[0.9972774,0.0001311226,0.0011106961,0.0008443307,0.00009327455,0.000014563749,0.0000047964777,0.000019408355,0.00050440955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822223,0.0005296793,0.00047550545,0.00030921152,0.00023006067,0.00023330595],"domain_scores_gemma":[0.9986547,0.0009065932,0.000054808996,0.0001852461,0.000026918298,0.00017172926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010362109,0.000108771455,0.00034639172,0.0001843036,0.00002387439,0.000020538298,0.00010046859,0.00010179394,0.000016958007],"category_scores_gemma":[0.0004925582,0.00009717243,0.00004299679,0.00031543852,0.00009042152,0.000072431976,0.00013181152,0.00057770923,0.000039287017],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002928626,0.00041280602,0.9828925,0.0001569336,0.000030457826,0.000465038,0.0058290437,0.00001106292,0.0060742525,0.00010837043,0.00022758081,0.00086333876],"study_design_scores_gemma":[0.00991812,0.00049280113,0.9863359,0.000043722113,0.000037006408,0.000011416227,0.0008351936,0.0010641898,0.0005184319,0.0000575445,0.0005789867,0.00010668478],"about_ca_topic_score_codex":0.00005284691,"about_ca_topic_score_gemma":0.00005494999,"teacher_disagreement_score":0.012483409,"about_ca_system_score_codex":0.00007068912,"about_ca_system_score_gemma":0.00024679737,"threshold_uncertainty_score":0.39625767},"labels":[],"label_agreement":null},{"id":"W3094816564","doi":"10.1182/blood-2020-142982","title":"Donor Selection May Predict Improved Survival Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Chronic Myelomonocytic Leukemia - Experience from a Tertiary Care Centre","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Chronic myelomonocytic leukemia; Hematopoietic stem cell transplantation; Transplantation; Proportional hazards model; Oncology; Cyclophosphamide; Myelodysplastic syndromes; Chemotherapy; Bone marrow","score_opus":0.012133306750545218,"score_gpt":0.2523974214637173,"score_spread":0.24026411471317208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094816564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99654865,0.001212197,0.0002459133,0.000488824,0.00008906542,0.0010477749,0.00008423363,0.00014885796,0.00013450345],"genre_scores_gemma":[0.9982617,0.00021560639,0.0003195892,0.0003418965,0.00022678924,0.00020916719,0.00017546368,0.000064761974,0.00018503539],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99766636,0.00015270949,0.00048238525,0.0007026466,0.00042599268,0.00056988874],"domain_scores_gemma":[0.9991145,0.00010495684,0.00008582893,0.00030526292,0.00007692033,0.00031253143],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000082098755,0.00032900798,0.00048966863,0.00012370375,0.000058480713,0.000037248905,0.00021416415,0.00022515058,0.00018062942],"category_scores_gemma":[0.00001735164,0.00029401117,0.00014461174,0.00034418155,0.00007864102,0.00017204283,0.00006335618,0.0004931531,0.00006576139],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006803587,0.0001405709,0.83317846,0.0010919208,0.00012659619,0.0006143416,0.029974619,0.0000682642,0.13305517,0.0000012990812,0.000027298003,0.0010411233],"study_design_scores_gemma":[0.018409643,0.00045488903,0.6742129,0.00029047212,0.00057440484,0.000058742247,0.007978865,0.0041758595,0.29312843,0.000003183873,0.00017005252,0.0005426153],"about_ca_topic_score_codex":0.0007734296,"about_ca_topic_score_gemma":0.0006156498,"teacher_disagreement_score":0.16007325,"about_ca_system_score_codex":0.0014142091,"about_ca_system_score_gemma":0.0010817194,"threshold_uncertainty_score":0.9999512},"labels":[],"label_agreement":null},{"id":"W3094818118","doi":"10.1182/blood-2020-136356","title":"Survival Outcomes for US and Canadian Patients Diagnosed with Hodgkin Lymphoma before and after Brentuximab Vedotin Approval for Relapsed/Refractory Disease: A Retrospective Cohort Study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Brentuximab vedotin; Internal medicine; Retrospective cohort study; Cohort; Oncology; Lymphoma; Hodgkin lymphoma","score_opus":0.007622796488313747,"score_gpt":0.2232466161384331,"score_spread":0.21562381965011937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094818118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99299985,0.00021599744,0.000004852646,0.0005487979,0.00007850642,0.005217304,0.00085815764,0.000037168236,0.00003935777],"genre_scores_gemma":[0.9965526,0.000016249334,0.00023578382,0.00048467566,0.000098452976,0.0023201245,0.00020078014,0.000053586784,0.00003777573],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998492,0.000030783438,0.00022164645,0.0006157165,0.00027889383,0.0003609567],"domain_scores_gemma":[0.9986994,0.00011673512,0.00008188782,0.00022220692,0.00014603707,0.0007337264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008875843,0.00029336746,0.0005832294,0.00006838966,0.00013636728,0.000049225255,0.00005112483,0.00006526156,0.000007794698],"category_scores_gemma":[0.00020659121,0.00021157748,0.00008907366,0.00008911565,0.0000660473,0.00007753606,0.00003475197,0.00004524958,0.000001364568],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012763218,0.0039610816,0.9908615,0.00010460462,0.00087450154,0.00019676186,0.0008346271,7.13231e-8,5.408413e-7,0.0000192611,0.00009972221,0.0017710573],"study_design_scores_gemma":[0.052260134,0.005880066,0.9391071,0.000045529065,0.0018441993,0.0000034989266,0.00021064225,0.000018027122,0.0000101396245,0.00001349985,0.00040008943,0.0002070819],"about_ca_topic_score_codex":0.0044488134,"about_ca_topic_score_gemma":0.03143677,"teacher_disagreement_score":0.051754355,"about_ca_system_score_codex":0.00019214647,"about_ca_system_score_gemma":0.0002663252,"threshold_uncertainty_score":0.986237},"labels":[],"label_agreement":null},{"id":"W3094831999","doi":"10.1182/blood-2020-141126","title":"<i>TRAF3</i> Loss Drives Alternative NF-κB Pathway Activation in Diffuse Large B-Cell Lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Diffuse large B-cell lymphoma; Cancer research; Germinal center; Biology; Vincristine; BCL6; B cell; Lymphoma; Immunology; Cyclophosphamide; Genetics","score_opus":0.021239539836986662,"score_gpt":0.27185099652879907,"score_spread":0.2506114566918124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094831999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98953336,0.0001290064,0.0001717733,0.0014867341,0.000047432623,0.000513239,0.000021517948,0.00007557915,0.00802138],"genre_scores_gemma":[0.99647826,0.000121852376,0.00010811234,0.0013749641,0.00037336507,0.000038401526,0.000043213964,0.00004589048,0.0014159319],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984524,0.00009410313,0.00023697923,0.0003696736,0.00045521103,0.00039162353],"domain_scores_gemma":[0.9992677,0.000112513655,0.00006645594,0.00025759728,0.00007207176,0.00022369213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015755865,0.00017322064,0.00028748706,0.00010965127,0.000040758136,0.000027017484,0.00016325027,0.00009773266,0.00041303114],"category_scores_gemma":[0.00011285788,0.00015922703,0.00009499533,0.00036860112,0.000051466533,0.00011626609,0.000087500994,0.00023625979,0.000111114685],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005855755,0.011216472,0.015393235,0.0001411386,0.00011202514,0.00038487866,0.006312502,0.0000014001942,0.95944387,0.00015960331,0.00026601055,0.0059832786],"study_design_scores_gemma":[0.04972724,0.0005038001,0.0046469043,0.000075010386,0.000032536125,0.000013712403,0.0002840298,0.0002714436,0.93325627,0.00013446191,0.010867684,0.00018691814],"about_ca_topic_score_codex":0.00006886957,"about_ca_topic_score_gemma":0.000017435003,"teacher_disagreement_score":0.049141664,"about_ca_system_score_codex":0.000070739174,"about_ca_system_score_gemma":0.0001360775,"threshold_uncertainty_score":0.649309},"labels":[],"label_agreement":null},{"id":"W3094835149","doi":"10.1182/blood-2020-139229","title":"Direct Oral Anticoagulants for Myeloproliferative Neoplasms (MPN-DOACs): Results from an International Study on 442 Patients","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Polycythemia vera; Hematologic Neoplasms; Internal medicine; Myelofibrosis; Intensive care medicine; Cancer; Bone marrow","score_opus":0.051685985827309974,"score_gpt":0.3246730739206457,"score_spread":0.2729870880933357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094835149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99106747,0.00001932796,0.000018749151,0.0018187888,0.0003173267,0.0023862459,0.0021545684,0.00010782653,0.0021097113],"genre_scores_gemma":[0.9940164,0.000024455803,0.0010807257,0.0017901788,0.0005835288,0.0003229378,0.0020452086,0.000048032703,0.00008851165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976372,0.000118756885,0.0005079076,0.0008565915,0.0005729064,0.00030660382],"domain_scores_gemma":[0.9985254,0.00030998047,0.00017239997,0.00034268675,0.0002932981,0.0003562464],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012915002,0.00035697027,0.0006791825,0.00008352648,0.00014433965,0.000080064136,0.00017821317,0.00009266612,0.00008352046],"category_scores_gemma":[0.0005853571,0.00027599224,0.00012856153,0.00014004002,0.000033009084,0.00016761973,0.00006145916,0.0001617822,0.000116059964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056149126,0.019181775,0.9630958,0.000012837834,0.0019837092,0.0001534199,0.005872942,0.000015085925,0.0003725834,0.00009038301,0.0016774414,0.0019291338],"study_design_scores_gemma":[0.04878186,0.012126735,0.89468116,0.000089824,0.00080915523,0.0000032519283,0.00051075063,0.00046528428,0.040468093,0.000031156218,0.0016727094,0.0003600259],"about_ca_topic_score_codex":0.0000894558,"about_ca_topic_score_gemma":0.00007173733,"teacher_disagreement_score":0.06841462,"about_ca_system_score_codex":0.00005416666,"about_ca_system_score_gemma":0.00008801202,"threshold_uncertainty_score":0.99996924},"labels":[],"label_agreement":null},{"id":"W3094840453","doi":"10.1182/blood-2020-136162","title":"BCR-ABL1 Transcript Doubling Time after Imatinib Discontinuation for Treatment-Free Remission in Chronic Myeloid Leukemia in Chronic Phase: Predictor for Treatment-Free Remission Failure","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; McGill University Health Centre; London Health Sciences Centre; Juravinski Cancer Centre; Hôpital de l'Enfant-Jésus; Université de Montréal; Hôpital Maisonneuve-Rosemont; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; Vancouver General Hospital; University of Calgary; BC Cancer Agency; Alberta Health Services; CancerCare Manitoba; University of Alberta Hospital; Ottawa Hospital; University Health Network; University of Toronto; Alberta Hospital Edmonton; University of British Columbia","funders":"","keywords":"Discontinuation; Medicine; Imatinib; Myeloid leukemia; Internal medicine; Imatinib mesylate; Immunology; Oncology","score_opus":0.024197562769817122,"score_gpt":0.28793813815254676,"score_spread":0.26374057538272966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094840453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97939783,0.0056823315,0.0006321093,0.0037618442,0.00013911174,0.0088020405,0.0010218594,0.00030412007,0.00025875395],"genre_scores_gemma":[0.9758181,0.0007729883,0.0095119085,0.00016361538,0.0018917096,0.0050788126,0.0033415665,0.0003070461,0.0031142847],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9954431,0.00011519878,0.0012994171,0.0014411184,0.0005187211,0.0011824134],"domain_scores_gemma":[0.99726385,0.00030251165,0.00036259394,0.0014028946,0.00011166138,0.0005564896],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028770603,0.0009271902,0.0014397594,0.00035649995,0.00015825397,0.00008043015,0.00047465853,0.0005423723,0.0004024776],"category_scores_gemma":[0.00049722154,0.0007552072,0.0005649651,0.00056698767,0.00008516677,0.0004889049,0.000097408025,0.00022643147,0.000033191744],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014489931,0.0046777604,0.0040990403,0.0020870692,0.0011965232,0.00035990347,0.00591925,0.00044531934,0.90429634,0.00003631295,0.004471569,0.057920977],"study_design_scores_gemma":[0.54839283,0.029517813,0.0023299537,0.0040000034,0.0033654906,0.00009935651,0.00033690353,0.05946276,0.30310404,0.00032128833,0.047607336,0.0014622026],"about_ca_topic_score_codex":0.0002974675,"about_ca_topic_score_gemma":0.0009115162,"teacher_disagreement_score":0.6011923,"about_ca_system_score_codex":0.018631259,"about_ca_system_score_gemma":0.0045105396,"threshold_uncertainty_score":0.9994899},"labels":[],"label_agreement":null},{"id":"W3094842796","doi":"10.1182/blood-2020-143187","title":"A Case Series of <i>TERC Variant</i> telomere Biology Disorders in Unrelated Families from Eastern Canada","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Proband; Germline; Telomerase RNA component; Diamond–Blackfan anemia; Family history; Dyskeratosis congenita; Telomere; Medicine; Telomerase; Biology; Pediatrics; Genetics; Internal medicine; Mutation; Telomerase reverse transcriptase","score_opus":0.01269985592218409,"score_gpt":0.21028761773060525,"score_spread":0.19758776180842116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094842796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958943,0.0008818953,0.000025340698,0.0017725122,0.000116924835,0.00023345386,0.00019243114,0.000042525684,0.0008405941],"genre_scores_gemma":[0.99856424,0.00022793275,0.0002788241,0.0007093123,0.000064882166,0.000008758333,0.000066813154,0.000021482976,0.00005772189],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988118,0.00006746067,0.00038491542,0.00032682013,0.0001361773,0.00027285563],"domain_scores_gemma":[0.9993648,0.000095375064,0.00008804916,0.00023416885,0.000041840198,0.00017576724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000042595788,0.00019031827,0.00046588437,0.00006932861,0.000034173576,0.0000057215057,0.00010966609,0.00011773727,0.0001057373],"category_scores_gemma":[0.00013685193,0.00017084354,0.000050527826,0.0003742634,0.00011474757,0.00006209945,0.00005472954,0.00021636393,0.000007827621],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046637873,0.0004632338,0.96021384,0.00023601342,0.0002832094,0.010049245,0.0046172063,0.000009384155,0.017534722,0.00013767529,0.00029531887,0.0056937933],"study_design_scores_gemma":[0.090800405,0.008011587,0.6075052,0.0021621368,0.003563727,0.019795086,0.0659258,0.0023500645,0.12903,0.0019434172,0.063712195,0.005200421],"about_ca_topic_score_codex":0.517457,"about_ca_topic_score_gemma":0.62843466,"teacher_disagreement_score":0.35270864,"about_ca_system_score_codex":0.000020186957,"about_ca_system_score_gemma":0.00038532674,"threshold_uncertainty_score":0.6966798},"labels":[],"label_agreement":null},{"id":"W3094845574","doi":"10.1182/blood-2020-133922","title":"Efficacy and Safety of Ponatinib (PON) in Patients with Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Who Failed One or More Second-Generation (2G) Tyrosine Kinase Inhibitors (TKIs): Analyses Based on PACE and Optic","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Ponatinib; Internal medicine; Clinical trial; Population; Interim analysis; Oncology; Myeloid leukemia; Dasatinib; Imatinib","score_opus":0.02353885709393887,"score_gpt":0.2795732222064298,"score_spread":0.2560343651124909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094845574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963354,0.0011095281,0.000030296513,0.00049451785,0.00002942017,0.0017259795,0.00014178846,0.0000566182,0.00007647667],"genre_scores_gemma":[0.997584,0.0001031062,0.0009859073,0.00025117947,0.00023065173,0.00005912671,0.00064288185,0.00007286323,0.00007031009],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99745286,0.00010960919,0.0006744344,0.000780665,0.00056593417,0.0004165277],"domain_scores_gemma":[0.9985425,0.00018401313,0.00031446153,0.00046670286,0.00013119278,0.00036115342],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014385908,0.00047147987,0.0008794057,0.00025245335,0.000095777716,0.000033738554,0.0000951314,0.00018186256,0.00026193893],"category_scores_gemma":[0.00024212775,0.00036577974,0.00006845248,0.0006271378,0.00018418446,0.00017596628,0.000070876515,0.00033848957,0.0000051607285],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0851528,0.027180567,0.2632849,0.008827837,0.0046373485,0.001848213,0.005693563,0.011540046,0.5298675,0.000121365825,0.0010391597,0.06080671],"study_design_scores_gemma":[0.3284364,0.027310628,0.41174218,0.0023773143,0.0018480282,0.000020404354,0.000103723774,0.026706679,0.2003787,0.0000011182592,0.00023372719,0.0008410835],"about_ca_topic_score_codex":0.000104588704,"about_ca_topic_score_gemma":0.00033006226,"teacher_disagreement_score":0.32948878,"about_ca_system_score_codex":0.0012717571,"about_ca_system_score_gemma":0.0014503461,"threshold_uncertainty_score":0.9998794},"labels":[],"label_agreement":null},{"id":"W3094852122","doi":"10.1182/blood-2020-138887","title":"Real-World Characterization of Ibrutinib Therapy for Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL) Patients in British Columbia (BC)","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Providence Health Care; Leukemia & Lymphoma Society of Canada; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Ibrutinib; Medicine; Chronic lymphocytic leukemia; Discontinuation; Internal medicine; Fludarabine; Oncology; Leukemia; Chemotherapy; Cyclophosphamide","score_opus":0.020626480551286817,"score_gpt":0.253403528309048,"score_spread":0.23277704775776117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094852122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99629635,0.00039110158,0.000019293038,0.00005533983,0.00010147334,0.0025428217,0.00013736308,0.00011060919,0.000345677],"genre_scores_gemma":[0.9950447,0.0026035893,0.00028185316,0.0003907255,0.0002971495,0.00023979165,0.00045625502,0.00012084763,0.0005650533],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99687755,0.00010125549,0.0009102116,0.00081433856,0.00053896615,0.0007577033],"domain_scores_gemma":[0.998313,0.000237019,0.00029821132,0.00045964692,0.00028534504,0.0004067829],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028937234,0.0002881162,0.00088037737,0.00016437829,0.00010842827,0.00014861334,0.0002785054,0.00023763382,0.0001049812],"category_scores_gemma":[0.00024658343,0.00040458285,0.00016772379,0.0008147947,0.00022843633,0.00016290824,0.0001548389,0.000121642195,0.000013645455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.006984336,0.0040901722,0.54159814,0.013331161,0.0017483784,0.0011534396,0.0042736316,0.00012873586,0.11319025,0.0001308069,0.0015438001,0.31182715],"study_design_scores_gemma":[0.31641483,0.002899395,0.62010354,0.0011889138,0.00029249146,0.00016041652,0.00007262807,0.032543525,0.023311118,0.000048874546,0.0022563166,0.00070792175],"about_ca_topic_score_codex":0.065572046,"about_ca_topic_score_gemma":0.02368301,"teacher_disagreement_score":0.31111923,"about_ca_system_score_codex":0.033304434,"about_ca_system_score_gemma":0.027296342,"threshold_uncertainty_score":0.9998406},"labels":[],"label_agreement":null},{"id":"W3094853638","doi":"10.1182/blood-2020-140705","title":"Leveraging Project Echo Telementoring to Improve Sickle Cell Disease Care in the Midwest: Expanding Provider Education during a Pandemic","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Psychosocial; Family medicine; Pandemic; Health care; Disease; Coronavirus disease 2019 (COVID-19); Psychiatry; Infectious disease (medical specialty); Internal medicine","score_opus":0.012748277636690907,"score_gpt":0.26554650875420266,"score_spread":0.25279823111751176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094853638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943015,0.0016338732,0.000019350693,0.0013322744,0.00010531643,0.0014168369,0.0000032594908,0.00006900713,0.0011185675],"genre_scores_gemma":[0.99813175,0.00006464964,0.00016057884,0.0010455047,0.00026168508,0.00018756214,0.000010673605,0.000023905273,0.00011369725],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9989602,0.000039283976,0.00020930826,0.00030719794,0.00019920937,0.0002847938],"domain_scores_gemma":[0.9995496,0.000018364464,0.000046438137,0.00019034758,0.000034782643,0.00016044742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009035999,0.00013966435,0.00014279784,0.00008364883,0.00010984268,0.000039859526,0.000105056795,0.00004805884,0.0000085041565],"category_scores_gemma":[0.00009878315,0.00010245896,0.00005969045,0.0003288546,0.000010485855,0.000075340875,0.00005229957,0.000261207,0.000011259705],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052069215,0.0014799628,0.5895853,0.0042639277,0.00008499995,0.00028165767,0.23316023,0.0001463685,0.1476611,0.000012561451,0.00030089766,0.022502318],"study_design_scores_gemma":[0.03256404,0.0019339168,0.20175458,0.0038448295,0.0019958206,0.00013613855,0.6261967,0.00045159366,0.11493635,0.00008613839,0.014143109,0.0019568012],"about_ca_topic_score_codex":0.000112243004,"about_ca_topic_score_gemma":0.0000077146115,"teacher_disagreement_score":0.39303645,"about_ca_system_score_codex":0.00007886341,"about_ca_system_score_gemma":0.0003774808,"threshold_uncertainty_score":0.4178155},"labels":[],"label_agreement":null},{"id":"W3094860080","doi":"10.1182/blood-2020-139689","title":"Is Tandem ASCT Needed in MM Patients with High Risk Cytogenetics in the Era of Maintenance Therapy? Results from the Canadian Myeloma Research Group (CMRG) Database","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of Toronto; University of New Brunswick; Université de Montréal; Hôpital Maisonneuve-Rosemont; Nova Scotia Health Authority; McGill University Health Centre; McMaster University; London Health Sciences Centre; University of Calgary; Princess Margaret Cancer Centre; Saint John Regional Hospital; BC Cancer Agency; CancerCare Manitoba; University Health Network; Ottawa Hospital; University of British Columbia","funders":"","keywords":"Lenalidomide; Medicine; Bortezomib; Internal medicine; Multiple myeloma; Oncology; Regimen; Melphalan; Maintenance therapy; Autologous stem-cell transplantation; Dexamethasone; Transplantation; Surgery; Database; Chemotherapy","score_opus":0.05981702633613518,"score_gpt":0.30274829726377955,"score_spread":0.24293127092764438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094860080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98530495,0.00035196543,0.000001656023,0.010512227,0.000014333046,0.0014295855,0.002026383,0.000007310705,0.00035158516],"genre_scores_gemma":[0.996927,0.00049453543,0.00043705062,0.0014024497,0.00008255967,0.00006553886,0.0005526279,0.000025446478,0.000012749727],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970162,0.0005855958,0.00034704842,0.00041859288,0.0010231725,0.0006093705],"domain_scores_gemma":[0.9980593,0.00060018856,0.000089024485,0.0007483946,0.00020292347,0.00030020444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008621827,0.00017499228,0.00027502395,0.000107602515,0.00017144028,0.000039748415,0.00044635846,0.00008287501,0.000043544707],"category_scores_gemma":[0.000911802,0.000089000736,0.000044838074,0.0009163267,0.00019948102,0.00005466147,0.00007573563,0.0008709569,0.000018580664],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024412505,0.000802471,0.9851365,0.000010396217,0.0001880852,0.0003449259,0.004812947,0.0000025661013,0.00017436946,0.000018101673,0.0017047931,0.0043635797],"study_design_scores_gemma":[0.026267324,0.0011389294,0.9682392,0.00016415333,0.0000356105,0.000001886362,0.0010558253,0.00009136198,0.002110675,0.00005192848,0.0007513684,0.00009176466],"about_ca_topic_score_codex":0.5258651,"about_ca_topic_score_gemma":0.52225405,"teacher_disagreement_score":0.023826074,"about_ca_system_score_codex":0.00010356316,"about_ca_system_score_gemma":0.00047519535,"threshold_uncertainty_score":0.48646355},"labels":[],"label_agreement":null},{"id":"W3094903924","doi":"10.1182/blood-2020-141774","title":"Failures and Successes in Pediatric Patients with Acute Myeloid Leukemia with First Relapse: A Large International Report on Current Treatment Strategies and Outcome","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cohort; Internal medicine; Pediatrics; Cog","score_opus":0.01601178085381182,"score_gpt":0.2857167245189766,"score_spread":0.2697049436651648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094903924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952271,0.0003607161,0.000023624576,0.0033095817,0.00003096896,0.0005814059,0.000045519988,0.000044204287,0.00037688555],"genre_scores_gemma":[0.9981957,0.0008682801,0.00038024297,0.000091907,0.00014574883,0.00007073523,0.0001451626,0.00002786133,0.00007436787],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849784,0.00002203471,0.00027618115,0.0004709424,0.00046140203,0.00027161694],"domain_scores_gemma":[0.9993101,0.00008363561,0.000111508685,0.00018635835,0.00010160324,0.00020679354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007422098,0.00023053432,0.0003189344,0.00016417002,0.00006441017,0.00008996266,0.00008551649,0.00005928118,0.00001632819],"category_scores_gemma":[0.00008680868,0.00014509802,0.000023504555,0.00024539654,0.000060137478,0.00019099718,0.0000807208,0.00027147573,0.0000043390473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009141539,0.0005504224,0.9952381,0.00016652669,0.00017242224,0.001740786,0.0005823648,0.0000068245354,0.000007850586,0.000115138006,0.000082900784,0.00042248826],"study_design_scores_gemma":[0.022195218,0.0032430475,0.96765846,0.000111139525,0.0004176491,0.00020469638,0.00031997974,0.000052916264,0.00015445906,0.000007869458,0.005404501,0.00023006495],"about_ca_topic_score_codex":0.0001712741,"about_ca_topic_score_gemma":0.00064395077,"teacher_disagreement_score":0.027579663,"about_ca_system_score_codex":0.00020912284,"about_ca_system_score_gemma":0.00056063716,"threshold_uncertainty_score":0.59169257},"labels":[],"label_agreement":null},{"id":"W3094939491","doi":"10.1182/blood-2020-139850","title":"Real World Characteristics and Outcomes of Patients with Relapsed and Refractory Diffuse Large B Cell Lymphoma; A Provincial Experience","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Internal medicine; Refractory (planetary science); Diffuse large B-cell lymphoma; Lymphoma; Population; Salvage therapy; Oncology; Chemotherapy","score_opus":0.012937358606757236,"score_gpt":0.25605602392409893,"score_spread":0.2431186653173417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094939491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985301,0.00004040575,0.00000274806,0.00009563647,0.000019175686,0.0004226025,0.00006361182,0.000026316502,0.00079942675],"genre_scores_gemma":[0.9986758,0.00007842406,0.00017745484,0.00017449267,0.000056839373,0.000016194615,0.000024083427,0.00002583009,0.00077083305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989877,0.00003149956,0.00019728922,0.00024717403,0.00033256473,0.00020377048],"domain_scores_gemma":[0.99936944,0.000062623396,0.0000918957,0.00018653568,0.000077865225,0.00021162358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005956817,0.00012790186,0.0003247705,0.000057982677,0.00004029253,0.000014311131,0.000058882255,0.000047168112,0.00007605438],"category_scores_gemma":[0.00008113903,0.00009562249,0.000025216235,0.00012808523,0.000111284106,0.000057619105,0.000081120575,0.00010527461,0.0000016077144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011475795,0.0028553894,0.9750971,0.00015515981,0.00004415527,0.00003988209,0.0031937843,1.0855786e-9,0.01555082,0.00000930548,0.000018473833,0.0018883547],"study_design_scores_gemma":[0.02466184,0.0009752416,0.96741855,0.00002800579,0.00007886258,0.0000015906712,0.00013033177,0.000010136382,0.0051206946,0.0000012694159,0.0014658803,0.000107581094],"about_ca_topic_score_codex":0.00004148445,"about_ca_topic_score_gemma":0.000023803113,"teacher_disagreement_score":0.02351426,"about_ca_system_score_codex":0.000017068302,"about_ca_system_score_gemma":0.00008180185,"threshold_uncertainty_score":0.3899372},"labels":[],"label_agreement":null},{"id":"W3094943418","doi":"10.1182/blood-2020-142318","title":"Building Capacity and Assessing Stroke Risk with Transcranial Doppler Ultrasonography in Sub-Saharan Africa: The Reach Experience","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Certification; Stroke (engine); Tanzania; Transcranial Doppler; Pediatrics; Physical therapy; Internal medicine","score_opus":0.017278905225436545,"score_gpt":0.2282995341690375,"score_spread":0.21102062894360096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094943418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950556,0.0023559635,0.00061392895,0.0009962091,0.00002443471,0.0003032857,0.000014153182,0.000049108152,0.0005873164],"genre_scores_gemma":[0.9971361,0.0009936548,0.0016020237,0.0001750486,0.00005510635,0.000017704211,0.000001656111,0.000016381071,0.0000022824368],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990275,0.00006607936,0.00017652476,0.0002716369,0.00019865058,0.00025962974],"domain_scores_gemma":[0.9995925,0.000060692255,0.00005263685,0.00013266197,0.000022297047,0.00013920855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014188408,0.00014534539,0.000218567,0.000049295413,0.00014850227,0.000047230227,0.000074988806,0.00009352532,0.000008797071],"category_scores_gemma":[0.00005291474,0.000087412736,0.000056296794,0.00037633177,0.00019819383,0.00010626518,0.0000099862755,0.00048109045,9.01538e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032510993,0.00070414826,0.5728986,0.00015836931,0.00026508994,0.00018590436,0.035936,0.000039369545,0.3825448,0.00007532825,0.00014180879,0.0067254407],"study_design_scores_gemma":[0.048854046,0.0029263082,0.77500355,0.0013422444,0.0027130083,0.001166054,0.038100168,0.002180824,0.11398102,0.0001427068,0.011946117,0.001643949],"about_ca_topic_score_codex":0.00016066735,"about_ca_topic_score_gemma":0.000025299021,"teacher_disagreement_score":0.26856378,"about_ca_system_score_codex":0.000006333253,"about_ca_system_score_gemma":0.000031611882,"threshold_uncertainty_score":0.3564588},"labels":[],"label_agreement":null},{"id":"W3094944282","doi":"10.1182/blood-2020-142270","title":"Comparison of the Transcriptomic Signatures in Pediatric and Adult CML","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"CD34; Myeloid; Bone marrow; Transcriptome; Biology; Leukemia; Gene; Medicine; Immunology; Gene expression; Genetics; Stem cell","score_opus":0.017352543797186645,"score_gpt":0.2692044365278447,"score_spread":0.25185189273065806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094944282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99448776,0.0031190827,0.0000013964262,0.0014740927,0.000025340374,0.00024356393,0.0000054927773,0.000013868492,0.0006294085],"genre_scores_gemma":[0.99925333,0.00011755328,0.00010281378,0.00040323345,0.00007583827,0.00000513765,0.0000024769627,0.000008553242,0.000031090323],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99946004,0.00002166533,0.00016330875,0.00013162446,0.00012649415,0.00009687708],"domain_scores_gemma":[0.9997359,0.000037579794,0.000042793454,0.00011338029,0.000016227712,0.00005415672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000022777323,0.000074326235,0.0002063825,0.000025333342,0.00001282204,0.0000023704602,0.00005935335,0.00005569829,0.000026793035],"category_scores_gemma":[0.000076925586,0.000049408052,0.000041506773,0.000163206,0.000025720003,0.000014821527,0.000017387523,0.00016458197,0.0000026044424],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006844919,0.0003808705,0.98931205,0.0002167045,0.00003807378,0.000010957184,0.0019747321,0.000009693714,0.006694099,0.000037924878,0.0009277565,0.00032868568],"study_design_scores_gemma":[0.014752211,0.00035743054,0.937162,0.000054502078,0.00060135935,0.000007833277,0.00020388888,0.00055687124,0.045933757,0.000018503488,0.00026269804,0.00008894268],"about_ca_topic_score_codex":0.000042053503,"about_ca_topic_score_gemma":0.00004433112,"teacher_disagreement_score":0.05215005,"about_ca_system_score_codex":0.000024422687,"about_ca_system_score_gemma":0.00008793203,"threshold_uncertainty_score":0.2014802},"labels":[],"label_agreement":null},{"id":"W3094956814","doi":"10.1182/blood-2020-136746","title":"Incidence, Outcomes and Predictors of Acute Kidney Injury Post Allogeneic Stem Cell Transplant","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Incidence (geometry); Proportional hazards model; Hematopoietic stem cell transplantation; Univariate analysis; Acute kidney injury; Transplantation; Graft-versus-host disease; Multivariate analysis; Cohort; Oncology; Confidence interval","score_opus":0.01053403100205351,"score_gpt":0.23570796655876727,"score_spread":0.22517393555671378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094956814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954269,0.00022773504,0.00000574712,0.0026414467,0.000050082515,0.00040840803,0.00073979405,0.000035818106,0.00046405272],"genre_scores_gemma":[0.9966954,0.000596559,0.00021731277,0.0022154632,0.00005095534,0.000033426924,0.000075746655,0.000017197366,0.000097965574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999075,0.000029460214,0.0002665956,0.00025452106,0.0002164884,0.00015793002],"domain_scores_gemma":[0.999315,0.00004342158,0.00007529781,0.0001398025,0.00005789578,0.00036853953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000044469114,0.00017462918,0.00042027695,0.000047322777,0.000034707366,0.000007969648,0.000057988833,0.00007092292,0.00005912233],"category_scores_gemma":[0.000012072356,0.00012236237,0.000091490714,0.000093336515,0.00004740889,0.000042489886,0.000027965472,0.0000905992,0.000012234533],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016220959,0.0005769226,0.97050345,0.00017330314,0.00076876546,0.00015741766,0.0015104663,9.9747496e-8,0.025459524,0.000034918936,0.0004875014,0.00016539355],"study_design_scores_gemma":[0.004788368,0.002204375,0.648068,0.00010895818,0.0020896948,0.00004477381,0.00006463837,0.0000062978324,0.34187016,0.0000035687553,0.00061307853,0.00013808522],"about_ca_topic_score_codex":0.000017214661,"about_ca_topic_score_gemma":0.0000022687072,"teacher_disagreement_score":0.32243547,"about_ca_system_score_codex":0.000008124065,"about_ca_system_score_gemma":0.0001152881,"threshold_uncertainty_score":0.49897924},"labels":[],"label_agreement":null},{"id":"W3094979057","doi":"10.1182/blood-2020-141981","title":"Systems-Level Analysis of the Immune Repertoire in Neutropenia Reveal Arrested NK Cell Differentiation and Exhaustion","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biology; Immunology; Immune system; Innate immune system; TIGIT; Cell biology; Interleukin 21; Cytokine; T cell","score_opus":0.015004073833024701,"score_gpt":0.20193497156268148,"score_spread":0.18693089772965676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094979057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965532,0.002037715,0.000071959585,0.00019885587,0.00064586627,0.00017667752,0.00000777807,0.000016926788,0.00029103493],"genre_scores_gemma":[0.9980242,0.000071347466,0.0000040082145,0.000054109856,0.000013071868,0.00000885171,0.00010341938,0.0000061190576,0.0017148379],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991535,0.0002058204,0.00033793875,0.00017317555,0.00002859442,0.00010098424],"domain_scores_gemma":[0.99953455,0.00003709555,0.00020118119,0.00017115197,0.000046897814,0.000009132782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008592493,0.0000899358,0.00024330884,0.000107367196,0.00007246594,0.000011617017,0.000087541004,0.00011629746,0.00010273879],"category_scores_gemma":[0.000046772737,0.00006653213,0.000087899425,0.00039414573,0.000035786772,0.00006869146,0.0000496358,0.00018135749,0.000017068525],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001134442,0.00013828243,0.022515628,0.000040680443,0.00035222637,4.7723097e-7,0.00040214523,0.00008165119,0.97599334,0.000048211852,0.00021722479,0.000096662734],"study_design_scores_gemma":[0.0021241945,0.00010661178,0.6137866,0.000049818198,0.0011184731,0.0000068365166,0.00045772232,0.0004360342,0.3810456,0.0000012218292,0.0007594179,0.00010747937],"about_ca_topic_score_codex":0.00026317957,"about_ca_topic_score_gemma":0.000024527502,"teacher_disagreement_score":0.59494776,"about_ca_system_score_codex":0.000012841398,"about_ca_system_score_gemma":0.000012499996,"threshold_uncertainty_score":0.27131012},"labels":[],"label_agreement":null},{"id":"W3094984391","doi":"10.1182/blood-2020-136767","title":"Risk Factors for Thrombotic Events in Patients with PNH: A Nested Case-Control Study in the International PNH Registry","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Nested case-control study; Internal medicine; Odds ratio; Confidence interval; Univariate analysis; Paroxysmal nocturnal hemoglobinuria; Cohort; Multivariate analysis","score_opus":0.01978126543622165,"score_gpt":0.24933459517506942,"score_spread":0.2295533297388478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094984391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99732965,0.000052852323,0.000020284886,0.00011928145,0.00014393067,0.0019018537,0.00039481354,0.00001955642,0.000017769307],"genre_scores_gemma":[0.99960613,3.8189054e-7,0.0000059020117,0.0000919943,0.000017892418,0.00015647954,0.00010123199,0.000010250039,0.000009748019],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989554,0.00030342818,0.00026387128,0.00023993781,0.00005974643,0.00017761491],"domain_scores_gemma":[0.9992627,0.0003460355,0.00014180862,0.00019773003,0.00003798198,0.0000137318275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015976619,0.00012672484,0.00019854734,0.00004961675,0.000064788015,0.000009728838,0.00030940378,0.000045221484,0.00008817538],"category_scores_gemma":[0.0002582503,0.00008387823,0.000043699783,0.00010293474,0.000022918866,0.000050180708,0.000042904587,0.00013258177,0.000012959718],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024467686,0.0020315193,0.99509174,0.000010540978,0.00031685148,0.000029152443,0.0020409797,0.000018888051,0.000053561824,0.000007086433,0.00012636486,0.000028658673],"study_design_scores_gemma":[0.016978499,0.0006334076,0.97838706,0.000021132706,0.00017177334,0.000010377665,0.0036127688,0.0000078608855,0.000028994358,0.000011680363,0.00004201487,0.00009442845],"about_ca_topic_score_codex":0.00025812068,"about_ca_topic_score_gemma":0.0006389118,"teacher_disagreement_score":0.016733821,"about_ca_system_score_codex":0.000021585438,"about_ca_system_score_gemma":0.000028426835,"threshold_uncertainty_score":0.3420455},"labels":[],"label_agreement":null},{"id":"W3094986553","doi":"10.1182/blood-2020-138372","title":"Development and Evaluation of a Community of Practice to Support Stem Cell Donor Recruitment in Canada","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; University of Toronto; University of Regina; Laurentian University; University of Waterloo; Queen's University; Simon Fraser University; Wilfrid Laurier University; University of Ottawa; Stem Cell Network; Western University","funders":"","keywords":"Club; Attrition; Medicine; Psychology","score_opus":0.38543227588519857,"score_gpt":0.4357595899416244,"score_spread":0.05032731405642582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094986553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99672025,0.00040274402,0.000005167024,0.0005065949,0.000012573684,0.00042774956,0.000008538876,0.0000016411022,0.0019147146],"genre_scores_gemma":[0.9959665,0.000044425524,0.003574882,0.0003637343,0.0000054422703,0.000021921773,0.000010569001,0.000003328263,0.000009173484],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99923664,0.00012758575,0.00024005602,0.00005224569,0.00028553893,0.0000579514],"domain_scores_gemma":[0.99939716,0.00013369003,0.00010748525,0.00009131924,0.00020451893,0.00006582318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050281506,0.000046975358,0.00018609085,0.000024928855,0.000008521865,6.978681e-7,0.000036092013,0.000015227522,0.000013494706],"category_scores_gemma":[0.00018257348,0.000043211545,0.00000853759,0.000102698614,0.000007673306,0.00002051141,0.000033351407,0.00006576388,5.130722e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007977756,0.0023823017,0.54926157,0.0025537144,0.0005074059,0.00004636783,0.27888468,0.00008179392,0.04610895,0.000029389783,0.002176881,0.11716919],"study_design_scores_gemma":[0.005086176,0.00079016737,0.103370585,0.00043513428,0.00042985188,0.0000030272686,0.04632361,0.000030498351,0.813753,0.0000023081216,0.029680824,0.00009481996],"about_ca_topic_score_codex":0.15150562,"about_ca_topic_score_gemma":0.19600058,"teacher_disagreement_score":0.76764405,"about_ca_system_score_codex":0.00009016458,"about_ca_system_score_gemma":0.0012866975,"threshold_uncertainty_score":0.8541446},"labels":[],"label_agreement":null},{"id":"W3095000751","doi":"10.1182/blood-2020-136586","title":"Potency-Adjusted Analyses of a Head-to-Head Pharmacokinetic Study of Damoctocog Alfa Pegol (BAY 94-9027) and Efmoroctocog Alfa (rFVIIIFc) in Patients with Severe Hemophilia A","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Pharmacokinetics; Certolizumab pegol; Crossover study; Bioequivalence; Pharmacology; Potency; Internal medicine; Placebo; Chemistry; Infliximab; Tumor necrosis factor alpha","score_opus":0.05811308316360765,"score_gpt":0.3486165932118195,"score_spread":0.29050351004821184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095000751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939082,0.00025031963,0.0000021110916,0.00082915573,0.000016139393,0.0045230244,0.00004712025,0.00003207127,0.00039186017],"genre_scores_gemma":[0.9991334,0.000026934664,0.00024608528,0.00012912926,0.00005391923,0.00014611658,0.000043019183,0.000044342785,0.00017702892],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99733514,0.00014944682,0.00062434206,0.0005903393,0.000871627,0.00042911118],"domain_scores_gemma":[0.9986169,0.00008710209,0.00014848683,0.00039549838,0.00030168134,0.000450373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011171101,0.00033825406,0.0009352208,0.00037597588,0.000047699246,0.000011165197,0.00018762375,0.000095086856,0.00011808965],"category_scores_gemma":[0.00012803604,0.00023868344,0.00008739195,0.0012228814,0.00010060469,0.00008129662,0.0001502309,0.00028523547,0.000009277654],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034308555,0.010588067,0.9655425,0.00058565434,0.00078168174,0.0003092567,0.0027365321,0.0000336709,0.012805798,9.62638e-7,0.000061523904,0.0031234985],"study_design_scores_gemma":[0.048935503,0.016493363,0.9198426,0.00037448478,0.0012635938,0.000024361376,0.00075917935,0.00015760667,0.011831305,0.0000061335318,0.00003788468,0.0002740049],"about_ca_topic_score_codex":0.0004147041,"about_ca_topic_score_gemma":0.00021301303,"teacher_disagreement_score":0.04569992,"about_ca_system_score_codex":0.000028815846,"about_ca_system_score_gemma":0.00013601664,"threshold_uncertainty_score":0.9733228},"labels":[],"label_agreement":null},{"id":"W3095003957","doi":"10.1182/blood-2020-137628","title":"A Retrospective Cohort Study Evaluating the Safety and Efficacy of Peri-Partum Tranexamic Acid for Women with Inherited Bleeding Disorders","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Maternal and fetal healthcare","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Tranexamic acid; Medicine; Retrospective cohort study; Obstetrics; Population; Cohort; Maternal death; Cohort study; Pediatrics; Pregnancy; Gynecology; Surgery; Internal medicine; Blood loss","score_opus":0.028537103015805,"score_gpt":0.30777133431325926,"score_spread":0.2792342312974543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095003957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962342,0.0001415674,0.000037645903,0.000995584,0.000016140806,0.0022339425,0.000016060836,0.000027524977,0.00029732875],"genre_scores_gemma":[0.9995197,0.00002488499,0.000100241545,0.00012016942,0.00006604715,0.00010062514,0.000003844552,0.000017423743,0.00004703618],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991212,0.00004303316,0.00020544794,0.00022002698,0.0002362388,0.00017407433],"domain_scores_gemma":[0.99959195,0.000049451242,0.00007996298,0.0001040658,0.00007604266,0.00009853989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033383252,0.000104363346,0.00031581093,0.0000176291,0.00009750222,0.000008197969,0.000050628594,0.000026908996,0.000020348836],"category_scores_gemma":[0.000107346255,0.00006212469,0.000024513267,0.00014510418,0.000054421816,0.000026470949,0.000021022968,0.00012749617,4.1366636e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043741027,0.00039687293,0.9663778,0.00050972786,0.0003206268,0.0000042753795,0.020143459,0.0000019028513,0.0055342694,0.000019125158,0.0000010640441,0.0023167836],"study_design_scores_gemma":[0.008404059,0.011146138,0.9722972,0.000086670494,0.00027126475,0.000011958073,0.0068450947,0.0005588406,0.00027149273,0.000020021265,0.0000136662375,0.000073587726],"about_ca_topic_score_codex":0.000046466303,"about_ca_topic_score_gemma":0.000022071004,"teacher_disagreement_score":0.013298363,"about_ca_system_score_codex":0.00002330779,"about_ca_system_score_gemma":0.000040523813,"threshold_uncertainty_score":0.25333712},"labels":[],"label_agreement":null},{"id":"W3095006759","doi":"10.1182/blood-2020-135883","title":"Outcome By Mutation Status and Line of Treatment in Optic, a Dose-Ranging Study of 3 Starting Doses of Ponatinib in Patients with CP-CML","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Ponatinib; Medicine; Maximum tolerated dose; Internal medicine; Oncology; Dasatinib; Adverse effect; Imatinib; Myeloid leukemia","score_opus":0.01917147793811123,"score_gpt":0.272747336042538,"score_spread":0.25357585810442673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095006759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99865466,0.00016806292,0.0000016236299,0.000031360407,0.000005839505,0.0010519354,0.000041361345,0.000008035774,0.000037138354],"genre_scores_gemma":[0.9991687,0.00000851061,0.0007151495,0.000011751759,0.000005153041,0.000023134624,0.000045630484,0.00001548749,0.000006461552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988273,0.000041877676,0.000549556,0.00019504355,0.0002279741,0.0001582809],"domain_scores_gemma":[0.99942875,0.00009096136,0.00023650772,0.00012245867,0.000058307283,0.00006303101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000071247785,0.00013176061,0.00047886552,0.000118399665,0.000008231103,0.0000020428931,0.000027442884,0.000030069023,0.000009151569],"category_scores_gemma":[0.0001095505,0.000100894795,0.000021658769,0.0002554538,0.000025882378,0.00004767619,0.000023079183,0.000060137023,2.3694224e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007004376,0.0050982265,0.98005396,0.00019436043,0.00018206329,0.000028825172,0.010448092,0.00014220699,0.0015630265,0.0000015210464,3.7885752e-7,0.001586874],"study_design_scores_gemma":[0.07992568,0.012024402,0.8936558,0.00018761783,0.0003334563,8.9010354e-7,0.0032550278,0.00031630823,0.010214447,0.000001863574,0.0000011166679,0.0000834051],"about_ca_topic_score_codex":0.0012781727,"about_ca_topic_score_gemma":0.00019594555,"teacher_disagreement_score":0.0863982,"about_ca_system_score_codex":0.00016642603,"about_ca_system_score_gemma":0.00011391599,"threshold_uncertainty_score":0.41143703},"labels":[],"label_agreement":null},{"id":"W3095013795","doi":"10.1182/blood-2020-134928","title":"Sustained Minimal Residual Disease (MRD) Negativity and Clinical Efficacy in Transplant-Ineligible (TIE) Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts) Treated with Daratumumab-Based Regimens: Analysis of Maia and Alcyone","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Daratumumab; Multiple myeloma; Medicine; Minimal residual disease; Internal medicine; Bortezomib; Oncology; Surgery; Negativity effect; Melphalan; Bone marrow; Psychology","score_opus":0.02447451623414271,"score_gpt":0.29380934530748526,"score_spread":0.26933482907334255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095013795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99725807,0.0002722699,0.000024421393,0.0005912493,0.000006280823,0.0012814286,0.00045503073,0.000051496572,0.000059729617],"genre_scores_gemma":[0.9980356,0.00013450539,0.0007119339,0.00011451174,0.00003509582,0.000041612235,0.00086551934,0.00003516399,0.000026058648],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972723,0.0003119963,0.00064299384,0.0007551815,0.0005248221,0.00049267407],"domain_scores_gemma":[0.99735725,0.0009784718,0.00017772849,0.00036999903,0.00017137948,0.000945146],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020876403,0.00034521852,0.0010215954,0.00039738367,0.00008322937,0.00003066399,0.00010009641,0.00012415506,0.000024987034],"category_scores_gemma":[0.0009694745,0.00026418065,0.00016320763,0.0010870105,0.0002943021,0.000109191096,0.00006145515,0.0002568881,0.0000020927819],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024293628,0.006238316,0.96246094,0.00023364207,0.0020156112,0.0017335555,0.00031112367,0.000017116956,0.00026599402,0.0000028767156,0.00004259309,0.00238461],"study_design_scores_gemma":[0.0851454,0.002797883,0.90112144,0.0001718082,0.0039200033,0.0000018898432,0.000095056275,0.004881923,0.0016354556,0.0000014646225,0.0000137250445,0.00021396314],"about_ca_topic_score_codex":0.0005320585,"about_ca_topic_score_gemma":0.00061921624,"teacher_disagreement_score":0.061339505,"about_ca_system_score_codex":0.000034133085,"about_ca_system_score_gemma":0.00023171028,"threshold_uncertainty_score":0.99998105},"labels":[],"label_agreement":null},{"id":"W3095028771","doi":"10.1182/blood-2020-141318","title":"The Fares Study: A Multicenter, Randomized, Active-Control, Pragmatic, Phase 2 Pilot Study Comparing Prothrombin Complex Concentrate Versus Frozen Plasma in Bleeding Adult Cardiac Surgical Patients","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Trauma, Hemostasis, Coagulopathy, Resuscitation","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Toronto General Hospital; University of Toronto; Health Sciences Centre; University Health Network","funders":"","keywords":"Medicine; Fresh frozen plasma; Surgery; Clinical endpoint; Prothrombin complex concentrate; Randomized controlled trial; Packed red blood cells; Blood product; Hemostasis; Partial thromboplastin time; Coagulopathy; Randomization; Blood transfusion; Coagulation; Internal medicine; Warfarin; Atrial fibrillation; Platelet","score_opus":0.048691502780074454,"score_gpt":0.31634857683099105,"score_spread":0.2676570740509166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095028771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98170465,0.00009459735,0.000015188638,0.0005205506,0.00040232635,0.016537676,0.00005988597,0.00013344672,0.0005316515],"genre_scores_gemma":[0.99847883,0.000023940089,0.00010594413,0.00005732651,0.00016257649,0.0010436331,0.00007089553,0.000052741274,0.0000040925393],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9956001,0.001303746,0.0010395058,0.0006173642,0.0008677171,0.00057157455],"domain_scores_gemma":[0.9969711,0.0016965575,0.00038164158,0.00033136513,0.00033598792,0.00028335824],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008440862,0.0003968908,0.0014716942,0.00009094012,0.00026885746,0.000137811,0.00026204917,0.00004950398,0.000015887894],"category_scores_gemma":[0.0017470344,0.00029465943,0.00016087221,0.00034225546,0.00016469887,0.00019978585,0.00011324898,0.0004715726,0.000024435143],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.57919884,0.035105634,0.3599168,0.00015292829,0.0027048548,0.00023971351,0.017189804,0.000048941667,0.0009188055,0.000044694436,0.00007210048,0.0044068624],"study_design_scores_gemma":[0.8839391,0.0087294,0.08185341,0.0001231416,0.0014253093,0.0000015005855,0.01373722,0.009435459,0.00041798057,0.000003752257,0.000055209173,0.00027851635],"about_ca_topic_score_codex":0.00022088528,"about_ca_topic_score_gemma":0.0002518985,"teacher_disagreement_score":0.30474025,"about_ca_system_score_codex":0.00012603146,"about_ca_system_score_gemma":0.000089683606,"threshold_uncertainty_score":0.9999505},"labels":[],"label_agreement":null},{"id":"W3095045701","doi":"10.1182/blood-2020-140793","title":"Genotypic and Phenotypic Spectrum of Dyskeratosis Congenita: Results from the Canadian Inherited Marrow Failure Registry","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Janeway Children's Health and Rehabilitation Centre; Queen's University; Centre hospitalier de l'Université Laval; Centre Hospitalier Universitaire de Sherbrooke; London Health Sciences Centre; McMaster Children's Hospital; Centre Hospitalier Universitaire Sainte-Justine; Stollery Children's Hospital; Izaak Walton Killam Health Centre; Alberta Children's Hospital; University Health Network; CancerCare Manitoba; Princess Margaret Cancer Centre; Kingston General Hospital; University of Calgary; Children's Hospital of Eastern Ontario; Montreal Children's Hospital; University of Manitoba; BC Children's Hospital; SickKids Foundation; Université de Montréal; Hospital for Sick Children","funders":"","keywords":"Dyskeratosis congenita; Medicine; Bone marrow failure; Internal medicine; Hazard ratio; Myelodysplastic syndromes; Bone marrow; Survival analysis; Oncology; Telomere; Haematopoiesis; Biology; Stem cell","score_opus":0.018793216342855277,"score_gpt":0.21091177262469732,"score_spread":0.19211855628184205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095045701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9687746,0.002240278,0.0000046025143,0.02725562,0.00006097482,0.0003047638,0.00042868571,0.000045921715,0.0008845077],"genre_scores_gemma":[0.9963813,0.00010858758,0.0005512521,0.002346837,0.00034506587,0.000005179401,0.000117443546,0.000024644207,0.00011973671],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987492,0.000057694502,0.00032130172,0.00036251583,0.00021993865,0.00028932723],"domain_scores_gemma":[0.99884427,0.0001143117,0.00010786928,0.0004412855,0.00007143265,0.00042085027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009592264,0.00017753926,0.00032362083,0.00004431805,0.00014535154,0.000036264555,0.00017616159,0.00014501237,0.000109571316],"category_scores_gemma":[0.00037381417,0.0001359308,0.000057417343,0.00032086667,0.00018171643,0.000045310448,0.000038725095,0.00029963983,0.000022601345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023789385,0.00056851225,0.7203627,0.00046337908,0.0018041311,0.0011592639,0.02296145,0.0000040880327,0.20243892,0.001096105,0.03999281,0.0067696744],"study_design_scores_gemma":[0.011602527,0.0004988328,0.89412725,0.0002363364,0.0009311041,0.0001008607,0.002082927,0.00012419214,0.051302962,0.00024038652,0.03822572,0.000526875],"about_ca_topic_score_codex":0.06688956,"about_ca_topic_score_gemma":0.21078557,"teacher_disagreement_score":0.17376454,"about_ca_system_score_codex":0.000025120928,"about_ca_system_score_gemma":0.0003612941,"threshold_uncertainty_score":0.9393241},"labels":[],"label_agreement":null},{"id":"W3095047750","doi":"10.1182/blood-2020-138927","title":"Increased Risk of Secondary Malignancy Associated with the Use of Azathioprine for Chronic Graft-Versus-Host Disease Treatment","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Graft-versus-host disease; Azathioprine; Retrospective cohort study; Internal medicine; Hematopoietic stem cell transplantation; Transplantation; Malignancy; Single Center; Surgery; Disease; Gastroenterology","score_opus":0.035638305783618714,"score_gpt":0.24445796691176566,"score_spread":0.20881966112814696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095047750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99678475,0.00036774596,0.0003146167,0.0005230191,0.000018434826,0.001086437,0.000797234,0.00003216926,0.00007560878],"genre_scores_gemma":[0.99894446,0.00014443036,0.00041750565,0.00007028025,0.00004357646,0.00007310798,0.00023138322,0.000025831123,0.00004943534],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991677,0.000065514076,0.00024626372,0.00017913913,0.00019747615,0.00014394597],"domain_scores_gemma":[0.99884355,0.00046938885,0.00020960614,0.00022645784,0.000105899795,0.000145072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007943884,0.00013649293,0.00031325026,0.000027068578,0.000037025995,0.000004777452,0.00005504539,0.000043412332,0.000064730775],"category_scores_gemma":[0.00016799234,0.00008403566,0.00012187801,0.00015196225,0.00006462863,0.00003852275,0.00000772848,0.0000613905,0.0000023212517],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036303863,0.012346459,0.7357566,0.009115529,0.016423125,0.0006548157,0.010391139,0.00028905846,0.17337349,0.000955638,0.0008825494,0.003507745],"study_design_scores_gemma":[0.10343998,0.011927024,0.56787145,0.001314985,0.019197037,0.000014276944,0.00028885194,0.0013657457,0.29276836,0.000015245639,0.0014070997,0.00038993105],"about_ca_topic_score_codex":0.00009072171,"about_ca_topic_score_gemma":0.00007295946,"teacher_disagreement_score":0.16788514,"about_ca_system_score_codex":0.000037323163,"about_ca_system_score_gemma":0.00033895738,"threshold_uncertainty_score":0.3426875},"labels":[],"label_agreement":null},{"id":"W3095080052","doi":"10.1182/blood-2020-141535","title":"Single-Cell Transcriptional Landscapes of Human Bone Marrow Reveal Distinct Erythroid Phenotypes Underpinned By Genotype in Diamond-Blackfan Anemia","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Diamond–Blackfan anemia; Erythropoiesis; Bone marrow; Haematopoiesis; Immunophenotyping; Biology; GATA1; Phenotype; Immunology; Progenitor cell; Stem cell; Medicine; Anemia; Genetics; Internal medicine; Gene; Flow cytometry","score_opus":0.01387209411720038,"score_gpt":0.22065420074495323,"score_spread":0.20678210662775284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095080052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99401283,0.0031823418,0.00020538433,0.00053453806,0.000022831315,0.00011446771,0.00012582743,0.00001016239,0.0017916183],"genre_scores_gemma":[0.99867654,0.000054408087,0.00021375988,0.00017895627,0.00013349905,0.000014478,0.00049802207,0.000020140582,0.00021020923],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991491,0.000037363374,0.00024008045,0.00028402897,0.000108378415,0.0001810849],"domain_scores_gemma":[0.9996201,0.0000058188716,0.00008098958,0.00017402903,0.00004043807,0.000078631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005689804,0.00012354457,0.00015590769,0.000021726928,0.0000437629,0.000012103826,0.00013567267,0.000103455735,0.00005496091],"category_scores_gemma":[0.000013843102,0.000124984,0.00006478437,0.000100858946,0.000053241805,0.000004153152,0.000024598583,0.00007518904,0.0000042947063],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006159286,0.00038751675,0.0072467593,0.00005635727,0.00001887419,0.0000018011069,0.00007914418,0.00000816875,0.9900231,0.00010667754,0.0017730449,0.00023698377],"study_design_scores_gemma":[0.003082031,0.00057782576,0.011765167,0.000018996776,0.000072912895,0.0000038631833,0.00013055763,0.000023462546,0.9757063,0.00012444521,0.008179171,0.0003153093],"about_ca_topic_score_codex":0.000032310694,"about_ca_topic_score_gemma":0.00009428218,"teacher_disagreement_score":0.0143168215,"about_ca_system_score_codex":0.000008456011,"about_ca_system_score_gemma":0.00004230881,"threshold_uncertainty_score":0.50966996},"labels":[],"label_agreement":null},{"id":"W3095094264","doi":"10.1182/blood-2020-133778","title":"Pediatric-Onset Evans Syndrome Is Associated with Broad Immunopathological Manifestations, High Treatment Burden and Mortality in Long-Term Follow-up","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Cytopenia; Medicine; Evans syndrome; Pediatrics; Cohort; Proportional hazards model; Prospective cohort study; Internal medicine; Anemia; Autoimmune hemolytic anemia; Bone marrow","score_opus":0.01943471472268051,"score_gpt":0.25591005393026767,"score_spread":0.23647533920758715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095094264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973746,0.00077932555,0.000009000523,0.0009894539,0.000034461318,0.0005659802,0.000106036656,0.00007504491,0.000066100445],"genre_scores_gemma":[0.9985665,0.0007536923,0.000080656195,0.0001963723,0.00006982995,0.000041228916,0.0002049523,0.000020599078,0.00006613988],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99883157,0.000067746485,0.0002584011,0.0003772385,0.00023153776,0.00023350844],"domain_scores_gemma":[0.99951154,0.000053168773,0.0000637817,0.00017600438,0.00003669152,0.00015883135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009391424,0.00019974013,0.00040068405,0.000055246655,0.00006669463,0.000021898883,0.000052075888,0.00012798682,0.000073951094],"category_scores_gemma":[0.000032524385,0.00014512398,0.00006242458,0.00022455234,0.000039218256,0.000060541257,0.000017645974,0.00016489903,0.000012042526],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013563278,0.0007970499,0.99057275,0.00006934909,0.00020099439,0.0066989297,0.000916102,6.3244687e-7,0.00029202088,0.0000065927647,0.0000069190028,0.00030305528],"study_design_scores_gemma":[0.013678602,0.0025860036,0.980909,0.00006758266,0.0015056256,0.0007415035,0.000060443992,0.000009112525,0.00025736663,0.000025013429,0.0000031047084,0.00015664595],"about_ca_topic_score_codex":0.00031050184,"about_ca_topic_score_gemma":0.00016075565,"teacher_disagreement_score":0.013542969,"about_ca_system_score_codex":0.000032078275,"about_ca_system_score_gemma":0.000060457172,"threshold_uncertainty_score":0.5917984},"labels":[],"label_agreement":null},{"id":"W3095131012","doi":"10.1182/blood-2020-138848","title":"Real-World Outcome of Dose-Adjusted EPOCH-R, a Single-Centre Experience","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Medicine; Epoch (astronomy); Lymphoma; Internal medicine; Regimen; Oncology; Surgery","score_opus":0.07029184088477827,"score_gpt":0.2961280615567769,"score_spread":0.22583622067199863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095131012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890519,0.00019361866,0.0000017074248,0.0022503193,0.000052463278,0.00030881676,0.000010862352,0.000070206435,0.0080601135],"genre_scores_gemma":[0.9979953,0.000022109332,0.0007453052,0.000638359,0.00008527219,0.000023297143,0.000013199291,0.000015211005,0.00046191973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99903643,0.000018202214,0.0003047414,0.00023692497,0.00022200133,0.00018168891],"domain_scores_gemma":[0.9993644,0.000049579612,0.00009461721,0.00023442727,0.000053110565,0.0002039142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000023425804,0.00013015447,0.00033820368,0.000040336057,0.000020721543,0.000008319369,0.00006868538,0.000039422317,0.00023472642],"category_scores_gemma":[0.00007903878,0.000101247984,0.0001134034,0.0002602989,0.00004253666,0.00003497721,0.00004244373,0.000043468484,0.00005763233],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000883037,0.0028348893,0.9814513,0.00010307664,0.00013397295,0.00033561254,0.00239654,6.0018584e-7,0.010850599,0.0004149494,0.00044543343,0.00094474346],"study_design_scores_gemma":[0.01651024,0.00091944117,0.7431918,0.00019233998,0.00077030977,0.000030005802,0.00079195696,0.000037544545,0.23252085,0.00001622659,0.00479006,0.00022923065],"about_ca_topic_score_codex":0.00017427906,"about_ca_topic_score_gemma":0.000050512128,"teacher_disagreement_score":0.2382595,"about_ca_system_score_codex":0.000037842223,"about_ca_system_score_gemma":0.000040414452,"threshold_uncertainty_score":0.41287732},"labels":[],"label_agreement":null},{"id":"W3095134159","doi":"10.1182/blood-2020-135874","title":"Apollo: Phase 3 Randomized Study of Subcutaneous Daratumumab Plus Pomalidomide and Dexamethasone (D-Pd) Versus Pomalidomide and Dexamethasone (Pd) Alone in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM)","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pomalidomide; Daratumumab; Dexamethasone; Medicine; Internal medicine; Refractory (planetary science); Oncology; Multiple myeloma; Lenalidomide; Materials science","score_opus":0.027140993031851593,"score_gpt":0.2862342285527387,"score_spread":0.25909323552088714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095134159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99176407,0.0019085583,0.000032072538,0.0001670799,0.000086629385,0.005555429,0.00012356111,0.00009562652,0.0002669742],"genre_scores_gemma":[0.9964581,0.000259625,0.0025237224,0.00008578671,0.000085597654,0.00026164847,0.00014217253,0.00011695125,0.000066411776],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.994779,0.0010109505,0.0010869385,0.0011512192,0.0011227932,0.0008491068],"domain_scores_gemma":[0.99499714,0.002643909,0.00045773239,0.0006743252,0.0002722418,0.00095464726],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00075939513,0.0007053267,0.0024691876,0.00041706103,0.00019529613,0.00006329682,0.00022269056,0.00024156623,0.00006292481],"category_scores_gemma":[0.0034929605,0.0005536451,0.00016784786,0.0006823151,0.000494854,0.00024415803,0.00024686338,0.0007434619,0.000012359953],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7845679,0.0144131025,0.17868724,0.00030381896,0.0027174824,0.0042988425,0.0046650646,0.000010425709,0.003916136,0.000005278704,0.000028403098,0.0063862954],"study_design_scores_gemma":[0.9300741,0.023729347,0.036312245,0.0002153117,0.0016570537,0.0001745885,0.0016384289,0.00094726885,0.0047021727,0.0000063703237,0.00003905197,0.0005040654],"about_ca_topic_score_codex":0.0014271117,"about_ca_topic_score_gemma":0.0006893988,"teacher_disagreement_score":0.14550619,"about_ca_system_score_codex":0.00014995175,"about_ca_system_score_gemma":0.0002504709,"threshold_uncertainty_score":0.9996915},"labels":[],"label_agreement":null},{"id":"W3095139603","doi":"10.1182/blood-2020-134867","title":"Lymphoma Microenvironment Deconvolution Links M1 Macrophage Infiltration to Clinical Outcome in Diffuse Large B-Cell Lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Tumor microenvironment; Antibody-dependent cell-mediated cytotoxicity; Rituximab; Diffuse large B-cell lymphoma; Lymphoma; Cancer research; CD20; CHOP; Immune system; Medicine; Immunology; Biology; Antibody; Monoclonal antibody","score_opus":0.028133248983853488,"score_gpt":0.29200754168625337,"score_spread":0.26387429270239987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095139603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947376,0.0006034078,0.00009960589,0.0028826857,0.00016674989,0.00084301236,0.00004799098,0.00007412457,0.0005448043],"genre_scores_gemma":[0.98966414,0.00026177216,0.0012550256,0.008096039,0.0003130951,0.00011084331,0.00009869655,0.000037558122,0.0001628066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977558,0.00009741967,0.00083904166,0.00058684783,0.0002870188,0.000433857],"domain_scores_gemma":[0.9988518,0.00009154595,0.00012967848,0.00037780867,0.000023086215,0.0005261306],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021864501,0.0002725191,0.0005266261,0.00008678087,0.000063308085,0.000032160617,0.000119194345,0.00029854832,0.00008290234],"category_scores_gemma":[0.00012562658,0.00024357252,0.00022331398,0.00021004454,0.000033431377,0.00007754273,0.00011269204,0.00011302778,0.00094589376],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023790511,0.03588982,0.9506979,0.00006684345,0.000085041655,0.0005939112,0.00036885086,0.000002128707,0.0023153347,0.00004035863,0.00058269344,0.009119212],"study_design_scores_gemma":[0.0800451,0.0011026328,0.8904167,0.00004889194,0.0002714859,0.000038392587,0.00007714122,0.00015390402,0.016137905,0.0000061530905,0.01147445,0.00022728097],"about_ca_topic_score_codex":0.00005756629,"about_ca_topic_score_gemma":0.0000331023,"teacher_disagreement_score":0.07980719,"about_ca_system_score_codex":0.00026249106,"about_ca_system_score_gemma":0.00009862612,"threshold_uncertainty_score":0.999832},"labels":[],"label_agreement":null},{"id":"W3095151225","doi":"10.1182/blood-2020-140408","title":"Adore: A Randomized, Open-Label, Phase 1/2 Open-Platform Study Evaluating Safety and Efficacy of Novel Ruxolitinib Combinations in Patients with Myelofibrosis","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ruxolitinib; Myelofibrosis; Open label; Medicine; Phases of clinical research; Randomized controlled trial; Internal medicine; Clinical trial; Oncology; Surgery; Bone marrow","score_opus":0.07703137770199205,"score_gpt":0.3677363953716987,"score_spread":0.2907050176697067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095151225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885199,0.00005915461,0.00003589083,0.0005203739,0.000016186377,0.009465485,0.00011649016,0.000012568824,0.0012539566],"genre_scores_gemma":[0.99503684,0.000020373072,0.00393368,0.0002739332,0.00001539326,0.0005279135,0.0001396919,0.000027520273,0.000024680108],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9981021,0.0001271659,0.00068728765,0.00045510335,0.0004110965,0.00021719279],"domain_scores_gemma":[0.9984136,0.0006120775,0.00027472794,0.0002467384,0.00025118337,0.00020164848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060354546,0.00024539244,0.0011395998,0.0000810553,0.00012627123,0.00008174837,0.00019863872,0.00004726735,0.00009098157],"category_scores_gemma":[0.00072769204,0.00017239635,0.000035029418,0.00036908442,0.0000851534,0.00022795539,0.0003086859,0.00014477943,0.000004116176],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20485109,0.19663236,0.58002377,0.0001380083,0.0014825851,0.000030580213,0.005666021,0.000010465959,0.00020407914,0.0022441929,0.000028917751,0.008687953],"study_design_scores_gemma":[0.79320735,0.013546567,0.19059409,0.00028252564,0.0009603699,0.0000030343047,0.0002556564,0.0003941483,0.00058724696,0.00001099519,0.000009217331,0.00014882241],"about_ca_topic_score_codex":0.00017683773,"about_ca_topic_score_gemma":0.000049958355,"teacher_disagreement_score":0.58835626,"about_ca_system_score_codex":0.00003339517,"about_ca_system_score_gemma":0.00015692282,"threshold_uncertainty_score":0.70301193},"labels":[],"label_agreement":null},{"id":"W3095175361","doi":"10.1182/blood-2020-142275","title":"Phase I/II Dose-Escalation Study of Lenalidomide in Combination with R-GDP for Treatment of Transplant-Ineligible Relapsed/Refractory Diffuse Large B-Cell Lymphoma Followed By Maintenance Lenalidomide","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Northeast Cancer Centre","funders":"","keywords":"Lenalidomide; Medicine; Neutropenia; Gemcitabine; Internal medicine; Regimen; Febrile neutropenia; Phases of clinical research; Diffuse large B-cell lymphoma; Rituximab; Refractory (planetary science); Progressive disease; Salvage therapy; Oncology; Gastroenterology; Surgery; Dexamethasone; Lymphoma; Clinical trial; Chemotherapy; Materials science","score_opus":0.01719857402912654,"score_gpt":0.2624839824502298,"score_spread":0.24528540842110327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095175361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957502,0.0006080328,0.00014630698,0.00038364955,0.000031567786,0.0026185738,0.0003166819,0.000032904998,0.000112107526],"genre_scores_gemma":[0.9984671,0.00029089954,0.00022624014,0.00007752397,0.000028068014,0.00042893933,0.00031937196,0.000039464037,0.00012239115],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99827003,0.00006848168,0.00063563837,0.00041310262,0.0003200039,0.00029272403],"domain_scores_gemma":[0.9989876,0.00016358442,0.000321478,0.00026788792,0.00011348172,0.0001459535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011533378,0.0002892615,0.00079525186,0.0001197445,0.00006214908,0.000007870928,0.000076239514,0.0000903688,0.0000084342655],"category_scores_gemma":[0.00002680731,0.00020925733,0.0001633506,0.0002593487,0.000031195254,0.00010370256,0.000011923101,0.0000295367,0.0000017581108],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01908583,0.72827893,0.17466931,0.00043758965,0.0009126772,0.00022947608,0.008986597,0.000011630751,0.06415312,0.00008692405,0.00063010736,0.0025177994],"study_design_scores_gemma":[0.6889549,0.05436523,0.012172158,0.00023306246,0.0015991143,0.000011061178,0.00079974683,0.0002981089,0.24075851,0.000010780928,0.0005874458,0.00020991667],"about_ca_topic_score_codex":0.00029241832,"about_ca_topic_score_gemma":0.00014583,"teacher_disagreement_score":0.6739137,"about_ca_system_score_codex":0.00015905304,"about_ca_system_score_gemma":0.00012279162,"threshold_uncertainty_score":0.8533266},"labels":[],"label_agreement":null},{"id":"W3095176799","doi":"10.1182/blood-2020-139936","title":"Clinical Significance of Emergent Leukocytosis in Patients with Myelofibrosis Receiving JAK Inhibitor Therapy","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Leukocytosis; Ruxolitinib; Medicine; Myelofibrosis; Internal medicine; Clinical significance; Constitutional symptoms; Gastroenterology; Apheresis; Immunology; Bone marrow; Disease","score_opus":0.03236018264559547,"score_gpt":0.279762470930096,"score_spread":0.2474022882845005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095176799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974529,0.00024410052,0.000009355611,0.0011005311,0.00005439626,0.0008454117,0.000020080626,0.000024968302,0.00024827066],"genre_scores_gemma":[0.99718624,0.00049920374,0.0014552479,0.00055758597,0.00012980925,0.00010656603,0.000023672565,0.000026636733,0.000015014326],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844456,0.00008960709,0.00054679054,0.00038709497,0.00033153332,0.00020041152],"domain_scores_gemma":[0.9991907,0.000120736855,0.0001662377,0.00020567658,0.00012772359,0.00018894461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011899436,0.00018523443,0.00053980236,0.000048617276,0.000029542942,0.00000700599,0.0000664316,0.00007812251,0.00014286724],"category_scores_gemma":[0.00011101228,0.00012979258,0.000112849666,0.00028989246,0.00005585775,0.00005127058,0.00002676135,0.00015145734,0.000014309674],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000945653,0.0039417045,0.9850051,0.000051274015,0.00023268466,0.000011409664,0.00042623276,0.0000031412937,0.00074418535,0.000011455818,0.00025175622,0.008375448],"study_design_scores_gemma":[0.013310714,0.004508836,0.927115,0.00020766942,0.00010933022,4.2913362e-7,0.000045046047,0.000008464132,0.054118104,0.0000023517816,0.00044979833,0.00012423082],"about_ca_topic_score_codex":0.000032016284,"about_ca_topic_score_gemma":0.000014280813,"teacher_disagreement_score":0.057890028,"about_ca_system_score_codex":0.000025607322,"about_ca_system_score_gemma":0.00009268042,"threshold_uncertainty_score":0.52927876},"labels":[],"label_agreement":null},{"id":"W3095177954","doi":"10.1182/blood-2020-134189","title":"Pomalidomide, Dexamethasone, and Daratumumab after Lenalidomide Treatment in Relapsed Refractory Multiple Myeloma: Updated Results from an Open-Label, Multicenter, Phase 2 Trial","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Vancouver General Hospital; McGill University Health Centre","funders":"","keywords":"Pomalidomide; Daratumumab; Lenalidomide; Dexamethasone; Medicine; Multiple myeloma; Internal medicine; Oncology; Refractory (planetary science); Phases of clinical research; Thalidomide; Bortezomib; Surgery; Clinical trial","score_opus":0.0704919808063595,"score_gpt":0.35972674380776287,"score_spread":0.2892347630014034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095177954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917206,0.0009307109,0.0000064821756,0.0010185417,0.00011483256,0.004304451,0.0014100611,0.00011602378,0.00037828868],"genre_scores_gemma":[0.9910449,0.0002226796,0.004933157,0.0004639344,0.00032735534,0.00052601314,0.0021879,0.00008627827,0.00020777885],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99600697,0.0005614702,0.0009323701,0.0013038527,0.00049100944,0.0007043196],"domain_scores_gemma":[0.9972379,0.0005030596,0.00022613177,0.00081205514,0.0001095926,0.001111239],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032878367,0.0005359056,0.0010287915,0.00019454716,0.00013604347,0.00017746865,0.0003047928,0.0002523174,0.00016181792],"category_scores_gemma":[0.001194404,0.0004323491,0.000082057915,0.00036141445,0.00013342776,0.00041229397,0.0002550988,0.00040906857,0.00008275831],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8848211,0.036812875,0.016090732,0.00003180909,0.0009692121,0.0062763467,0.0015667565,8.1268587e-7,0.034952376,0.0000024023977,0.00024826414,0.018227274],"study_design_scores_gemma":[0.928677,0.021281948,0.023424247,0.0001337448,0.0005380596,0.00002289374,0.00020586833,0.002049423,0.020384928,0.000009065046,0.002866199,0.00040661005],"about_ca_topic_score_codex":0.0034160698,"about_ca_topic_score_gemma":0.0013108201,"teacher_disagreement_score":0.043855872,"about_ca_system_score_codex":0.00018835206,"about_ca_system_score_gemma":0.00026503034,"threshold_uncertainty_score":0.99981284},"labels":[],"label_agreement":null},{"id":"W3095178928","doi":"10.1182/blood-2020-136004","title":"A Phase 2 Open-Label, Multicenter, Dose Optimization Clinical Study of the Safety, Tolerability, and Pharmacokinetic (PK) and Pharmacodynamic (PD) Profiles of Cfi-400945 As a Single Agent or in Combination with Azacitidine or Decitabine in Patients with Acute Myeloid Leukemia","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Alberta","funders":"","keywords":"Tolerability; Medicine; Pharmacodynamics; Oncology; Myeloid leukemia; Leukemia; Internal medicine; Phases of clinical research; Cancer; Clinical trial; Pharmacology; Pharmacokinetics; Adverse effect","score_opus":0.024705301855181227,"score_gpt":0.3170932936291024,"score_spread":0.29238799177392116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095178928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976369,0.00008588513,0.00009283128,0.00008944843,0.000026584486,0.0019251956,0.00012855112,0.0000024995163,0.000012113502],"genre_scores_gemma":[0.9984601,0.00037416292,0.0008438305,0.0001352811,0.000014410928,0.000049430728,0.00009865381,0.00001800244,0.00000614167],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9988289,0.00010933059,0.00046679482,0.00034256437,0.00013152508,0.00012090857],"domain_scores_gemma":[0.99937636,0.000051975712,0.00022448176,0.00015680316,0.0001204016,0.00006996829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001419038,0.00014741092,0.000290994,0.000032698008,0.000028154614,0.000020299323,0.00016589256,0.000048612004,0.000007088743],"category_scores_gemma":[0.000120629404,0.00009535731,0.0000105289455,0.00022493243,0.00009850193,0.0000127012345,0.00029067133,0.00008583154,5.2018834e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08474044,0.082822494,0.7036776,0.000373772,0.00075377995,0.00006436387,0.0017775386,0.007261223,0.10372944,0.000006363333,0.000042269887,0.014750702],"study_design_scores_gemma":[0.5877154,0.08717845,0.21440458,0.00037647772,0.0012056796,0.000021222833,0.000682114,0.030967169,0.076616384,0.000007182756,0.00011223562,0.0007131094],"about_ca_topic_score_codex":0.00007354613,"about_ca_topic_score_gemma":0.00032307798,"teacher_disagreement_score":0.502975,"about_ca_system_score_codex":0.000022366168,"about_ca_system_score_gemma":0.0001651989,"threshold_uncertainty_score":0.38885584},"labels":[],"label_agreement":null},{"id":"W3095188934","doi":"10.1182/blood-2020-138683","title":"Identification of Prognostic Immunophenotypes at First Diagnosis in Patients with Acute Myeloid Leukemia (AML) By a Standardized Multicolor Flow Cytometry (MFC) Panel Originally Designed to Detect Measurable Residual Disease (MRD) at Follow-up","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Immunophenotyping; CD33; Minimal residual disease; Myeloid leukemia; Myeloid; Medicine; Population; Oncology; Flow cytometry; Leukemia; CD117; CD34; Immunology; Internal medicine; Biology; Genetics; Stem cell","score_opus":0.015084443704376291,"score_gpt":0.24529187410600337,"score_spread":0.23020743040162708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095188934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99339104,0.00048364303,0.00050428085,0.000854583,0.000060428567,0.0037329714,0.00083505554,0.000115454925,0.00002254143],"genre_scores_gemma":[0.99478704,0.0001245502,0.0029675988,0.00020036647,0.000053833257,0.000978553,0.00038846303,0.000119069584,0.00038050086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99561244,0.00023325994,0.0008494079,0.0009112707,0.001635058,0.0007585331],"domain_scores_gemma":[0.9970399,0.00052815716,0.00029154736,0.00070501794,0.00063829793,0.0007970912],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00053556263,0.00045044062,0.0008569178,0.0003355073,0.00024304379,0.00006270792,0.00044455516,0.0001724022,0.00012474055],"category_scores_gemma":[0.0030216677,0.0003846017,0.0001476591,0.001492312,0.00014902768,0.000217093,0.00030323904,0.00034888595,0.00013501913],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05763474,0.0010607137,0.6993727,0.00086546515,0.0013213451,0.00039514626,0.001383927,0.00018569164,0.2315454,0.0000014118652,0.004874539,0.0013588787],"study_design_scores_gemma":[0.054245085,0.0039487085,0.55385906,0.0006026895,0.0023338192,0.000009969217,0.00007790723,0.00045633395,0.38302666,0.000006066872,0.00069567503,0.0007380166],"about_ca_topic_score_codex":0.0001253844,"about_ca_topic_score_gemma":0.00014517466,"teacher_disagreement_score":0.15148126,"about_ca_system_score_codex":0.0019982676,"about_ca_system_score_gemma":0.0010859278,"threshold_uncertainty_score":0.9998606},"labels":[],"label_agreement":null},{"id":"W3095213530","doi":"10.1182/blood-2020-142671","title":"Dichotomous Regulation of Lysosomes By MYC and Tfeb Controls Hematopoietic Stem Cell Fate","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto; University Health Network","funders":"","keywords":"Cell biology; Stem cell; Haematopoiesis; Biology; Hematopoietic stem cell; Progenitor cell; Cell fate determination; Endocytosis; Cell; Biochemistry; Transcription factor","score_opus":0.008574327165201163,"score_gpt":0.2188745827493976,"score_spread":0.21030025558419646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095213530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99198985,0.00597307,0.000074950665,0.00057997665,0.000014875742,0.00028985238,0.00002151006,0.0000457097,0.0010102033],"genre_scores_gemma":[0.9987549,0.00014987114,0.000044038305,0.0006253266,0.00005302214,0.0000098838245,0.000015336656,0.000014774653,0.00033284893],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994035,0.000022186414,0.00017898786,0.00014812326,0.00014474493,0.000102481215],"domain_scores_gemma":[0.999592,0.00003260342,0.00008088399,0.00013109602,0.000028836579,0.00013457926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000036108828,0.00008911052,0.00024919794,0.000019076673,0.000021713053,0.000006754621,0.00003732608,0.000050632727,0.00007429377],"category_scores_gemma":[0.000005929387,0.000075094315,0.000050568287,0.0000689157,0.000039240946,0.000034156892,0.00001259788,0.00005159504,0.000011433349],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031222892,0.0006649055,0.011207143,0.00054486695,0.00024081655,0.000044956436,0.0016315453,0.0000017089782,0.98228323,0.0002724461,0.0011046916,0.0016914853],"study_design_scores_gemma":[0.010638473,0.00055107824,0.013328855,0.00007087144,0.00048614433,0.000019631658,0.00019112491,0.00021366175,0.9730571,0.0002860972,0.0010284939,0.00012849933],"about_ca_topic_score_codex":0.0000029801759,"about_ca_topic_score_gemma":9.6067794e-8,"teacher_disagreement_score":0.010326244,"about_ca_system_score_codex":0.0000031482355,"about_ca_system_score_gemma":0.00002187262,"threshold_uncertainty_score":0.30622572},"labels":[],"label_agreement":null},{"id":"W3095224165","doi":"10.1182/blood-2020-141740","title":"A Stemness-Based Screen Identifies PLK1 Inhibitors for Targeting Leukemia Stem Cells in AML","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Stem cell; CD38; Leukemia; Myeloid leukemia; Cancer research; CD34; PLK1; Biology; Immunology; Cell; Cell cycle; Cell biology; Genetics","score_opus":0.029531904501372382,"score_gpt":0.28002578584393223,"score_spread":0.25049388134255984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095224165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945828,0.00040881077,0.0006006551,0.0021724044,0.00010248549,0.00149642,0.00007344598,0.00014995347,0.0004130241],"genre_scores_gemma":[0.99537784,0.000014806169,0.0021303722,0.0009817617,0.0006268805,0.0001456454,0.00007155673,0.0000779499,0.00057319313],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978373,0.000085720305,0.00051308743,0.0005132773,0.00048191962,0.00056867744],"domain_scores_gemma":[0.9988593,0.0002868422,0.00011213817,0.00027974992,0.00015528561,0.0003067025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052401336,0.0002292092,0.00048381495,0.00019218761,0.000086917375,0.000058109694,0.0002400139,0.00017422678,0.00005671272],"category_scores_gemma":[0.0002269015,0.00021276924,0.00016255281,0.0005288709,0.000077872544,0.00011885334,0.00011548886,0.00043845095,0.00009255371],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016439019,0.0005887254,0.038895316,0.0030576536,0.00029369743,0.0007972396,0.002203997,0.00040452846,0.9044781,0.00008296852,0.04419114,0.0033627562],"study_design_scores_gemma":[0.016476305,0.0006030742,0.0014035619,0.00034818306,0.00017387548,0.0000077707,0.001488535,0.0072065326,0.9648766,0.000016467371,0.007060574,0.0003385193],"about_ca_topic_score_codex":0.00016214621,"about_ca_topic_score_gemma":0.000027651837,"teacher_disagreement_score":0.060398526,"about_ca_system_score_codex":0.00028353801,"about_ca_system_score_gemma":0.0008124402,"threshold_uncertainty_score":0.8676478},"labels":[],"label_agreement":null},{"id":"W3095227485","doi":"10.1182/blood-2020-139548","title":"Newly Diagnosed Acute Lymphoblastic Leukemia in a Child with COVID-19 Complicated By MIS-C: A Case Report from Kuwait","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Medicine; Pancytopenia; Pediatrics; Disseminated intravascular coagulation; Septic shock; Abdominal pain; Hepatosplenomegaly; Vomiting; Surgery; Internal medicine; Sepsis; Bone marrow; Disease","score_opus":0.016767586357689334,"score_gpt":0.2651392061213072,"score_spread":0.24837161976361788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095227485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908764,0.00022184738,0.00050769316,0.005269906,0.000037424023,0.00061127625,0.00017688355,0.00019417788,0.002104429],"genre_scores_gemma":[0.9919978,0.000023107412,0.00021291513,0.007091224,0.00014635628,0.00015405932,0.0002420264,0.000037780483,0.000094738636],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99873114,0.000033373733,0.0003143685,0.00049119495,0.00018425379,0.0002456797],"domain_scores_gemma":[0.9988342,0.00010613156,0.00011345391,0.00034718384,0.00004037861,0.00055864797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000039370676,0.00019591616,0.0003816065,0.000052989544,0.00010102272,0.000026677684,0.00008199218,0.00008004601,0.00023280868],"category_scores_gemma":[0.00012713298,0.00016553926,0.000064668086,0.0004757988,0.00006756908,0.000052223648,0.000028380324,0.00024220107,0.000052699128],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013175411,0.0010211826,0.09553291,0.000121481746,0.0009268048,0.848438,0.0014461606,0.00016773243,0.019571582,0.000020125615,0.031217963,0.00021850364],"study_design_scores_gemma":[0.11831168,0.003785269,0.044119272,0.00055942213,0.0061041666,0.70843697,0.0011065365,0.00070076884,0.02442357,0.000054910313,0.09093043,0.0014670127],"about_ca_topic_score_codex":0.0071543027,"about_ca_topic_score_gemma":0.0008000064,"teacher_disagreement_score":0.14000106,"about_ca_system_score_codex":0.00026295855,"about_ca_system_score_gemma":0.0007614467,"threshold_uncertainty_score":0.9994571},"labels":[],"label_agreement":null},{"id":"W3095231685","doi":"10.1182/blood-2020-134718","title":"The STIMULUS Program: Clinical Trials Evaluating Sabatolimab (MBG453) Combination Therapy in Patients (Pts) with Higher-Risk Myelodysplastic Syndromes (HR-MDS) or Acute Myeloid Leukemia (AML)","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Myelodysplastic syndromes; Myeloid leukemia; Internal medicine; Oncology; Clinical trial; Leukemia; Bone marrow","score_opus":0.11294187065735843,"score_gpt":0.41569162418199473,"score_spread":0.3027497535246363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095231685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905918,0.00035694678,0.000055463377,0.0025368882,0.00030936184,0.0054834136,0.000048709946,0.00028124897,0.0003361685],"genre_scores_gemma":[0.99347514,0.0011714109,0.002543329,0.00062249624,0.0004134005,0.0006676061,0.00015689734,0.00013991824,0.00080982846],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9917353,0.002584612,0.0019406701,0.0009802426,0.0017788255,0.0009803624],"domain_scores_gemma":[0.9920699,0.0051471004,0.0008467112,0.0007587003,0.00061249395,0.0005650788],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005669458,0.0005411649,0.0015189975,0.00018113967,0.00033616123,0.00020230029,0.00059590134,0.00036779232,0.00012579578],"category_scores_gemma":[0.008842823,0.00030172247,0.00028945337,0.001276752,0.00038727233,0.00023409304,0.00022100833,0.0016612546,0.00014167419],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031196756,0.004921904,0.37848845,0.00019808412,0.0031494626,0.0006211035,0.0011059759,0.000056781628,0.00054953736,0.00010407358,0.002682997,0.57692486],"study_design_scores_gemma":[0.21803729,0.06590318,0.68757814,0.0006163191,0.002785344,0.00013519019,0.00037544727,0.017023707,0.0011332481,0.0001782374,0.0051836525,0.0010502178],"about_ca_topic_score_codex":0.000095729505,"about_ca_topic_score_gemma":0.000028268087,"teacher_disagreement_score":0.5758747,"about_ca_system_score_codex":0.0006680627,"about_ca_system_score_gemma":0.0025802122,"threshold_uncertainty_score":0.9999435},"labels":[],"label_agreement":null},{"id":"W3095236197","doi":"10.1182/blood-2020-142652","title":"Elevated Expression of Mir-130a in t(8,21) AML Reinforces the Aberrant Molecular Program of AML1-ETO","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Corepressor; RUNX1; Myelopoiesis; Cancer research; Biology; Myeloid leukemia; Haematopoiesis; Myeloid; microRNA; Leukemia; Vorinostat; Stem cell; Cell biology; Repressor; Histone; Histone deacetylase; Immunology; Gene expression; Genetics; Gene","score_opus":0.008750890709371876,"score_gpt":0.23834911719587595,"score_spread":0.22959822648650408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095236197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99811405,0.000978879,0.00017843497,0.00012932805,0.000013036848,0.00038893602,0.000012166941,0.000009982657,0.00017519083],"genre_scores_gemma":[0.9988282,0.000031918447,0.00092060515,0.00006431287,0.000029511317,0.00003072307,0.00006876259,0.000013360085,0.000012619076],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99922544,0.000057427864,0.0002711386,0.00018648784,0.00013189416,0.00012762772],"domain_scores_gemma":[0.99946433,0.0000066344,0.00014979769,0.00027050427,0.000065246146,0.00004350364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000079651916,0.00009983838,0.00013273703,0.00002137491,0.000014367593,0.00000562715,0.0001941357,0.000095250274,0.000010748092],"category_scores_gemma":[0.000083007304,0.000075989825,0.00008063948,0.00014404433,0.00007119612,0.0000028232291,0.00008848207,0.000051411957,0.0000011226758],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008473218,0.00017096038,0.0010318847,0.00007625329,0.000031736126,0.0000028113566,0.00009502469,0.00014262377,0.99784786,0.000027510727,0.00009544208,0.00039313707],"study_design_scores_gemma":[0.0008904923,0.0002286648,0.0039443257,0.000045548222,0.00003378957,0.0000017414051,0.000037109505,0.0001618942,0.9935015,0.000022460501,0.0010495292,0.00008297773],"about_ca_topic_score_codex":0.000013614734,"about_ca_topic_score_gemma":0.0000030180743,"teacher_disagreement_score":0.004346417,"about_ca_system_score_codex":0.0000025078245,"about_ca_system_score_gemma":0.000042390962,"threshold_uncertainty_score":0.3098775},"labels":[],"label_agreement":null},{"id":"W3095236403","doi":"10.1182/blood-2020-139815","title":"Multicenter Validation of a Personalized Model to Predict Hypomethylating Agent Response in Myelodysplastic Syndromes (MDS)","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Decitabine; Medicine; Azacitidine; Myelodysplastic syndromes; Hypomethylating agent; Oncology; Internal medicine; Bone marrow","score_opus":0.029328972198182875,"score_gpt":0.2726898840052631,"score_spread":0.24336091180708025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095236403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986123,0.000357597,0.012968901,0.0001806687,0.000025616366,0.00023521639,0.000028932976,0.000007620725,0.00007240431],"genre_scores_gemma":[0.9943564,0.000044655557,0.00534881,0.000084032996,0.000040963325,0.000021127911,0.000039139108,0.000017541626,0.00004736079],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990368,0.00012356933,0.00027017327,0.0002668009,0.00015325777,0.00014940715],"domain_scores_gemma":[0.9995729,0.000043499833,0.000080613354,0.00014163539,0.000060884522,0.000100490266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027864118,0.00010719949,0.00014391776,0.00006470723,0.000021657554,0.000010534003,0.00010003201,0.000081374455,0.00000911278],"category_scores_gemma":[0.0007786249,0.00011042232,0.00005713572,0.00014508216,0.000020101084,0.000003383136,0.00007683538,0.000052590985,0.000004447942],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065366714,0.000114526796,0.0085852565,0.000031701067,0.000028656907,0.0000028674428,0.0007768319,0.019949168,0.9696689,0.000003536184,0.00000632767,0.00017855309],"study_design_scores_gemma":[0.0022504483,0.0007127455,0.0094377445,0.00003570226,0.000035291363,9.137613e-7,0.00011552374,0.01741439,0.96963036,0.00002342021,0.0001896181,0.0001538704],"about_ca_topic_score_codex":0.000005229965,"about_ca_topic_score_gemma":0.0000018094287,"teacher_disagreement_score":0.008233326,"about_ca_system_score_codex":0.000007725059,"about_ca_system_score_gemma":0.00005329704,"threshold_uncertainty_score":0.45028916},"labels":[],"label_agreement":null},{"id":"W3095237891","doi":"10.1182/blood-2020-133987","title":"Comprehensive Description of Monoallelic GP1BA Variants Associated with Thrombocytopenia","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Missense mutation; Platelet Glycoprotein GPIb-IX Complex; Platelet; Von Willebrand factor; Von Willebrand disease; Platelet disorder; Bernard–Soulier syndrome; Glycoprotein Ib; Platelet membrane glycoprotein; Genotype; Compound heterozygosity; Phenotype; Medicine; Genetics; Internal medicine; Immunology; Biology; Gene","score_opus":0.04394387723054756,"score_gpt":0.24572696667418842,"score_spread":0.20178308944364087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095237891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969413,0.00023369852,0.00004896523,0.0003834595,0.00001575745,0.00026717936,0.000017454684,0.000041046977,0.0020511332],"genre_scores_gemma":[0.9989431,0.00004270343,0.00041116137,0.00042534008,0.000016662167,0.0000060504603,0.000071440096,0.000014392792,0.00006916502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994153,0.000019651226,0.00013255856,0.00015476852,0.00015165412,0.00012608364],"domain_scores_gemma":[0.99962497,0.000018905437,0.00007688232,0.00010032885,0.00009045616,0.00008846627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000015749214,0.00010079398,0.00034933153,0.000021692596,0.000027454069,0.0000064874757,0.0000394429,0.00005352943,0.000053248245],"category_scores_gemma":[0.000031090767,0.000076192584,0.000040517352,0.00015361526,0.000027721357,0.000052486,0.000016189944,0.00007069146,0.000023884613],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021452785,0.012593063,0.6447606,0.000461197,0.009139574,0.004906305,0.0060579963,0.000047598965,0.3143228,0.00030627605,0.0028179842,0.0024412852],"study_design_scores_gemma":[0.025204007,0.0028702328,0.9556566,0.00019859518,0.0012835434,0.00010445124,0.00025297108,0.0002568741,0.013471532,0.0001551526,0.00034436354,0.00020166852],"about_ca_topic_score_codex":0.000041396674,"about_ca_topic_score_gemma":0.000009929319,"teacher_disagreement_score":0.31089598,"about_ca_system_score_codex":0.000011477779,"about_ca_system_score_gemma":0.00004479522,"threshold_uncertainty_score":0.31070432},"labels":[],"label_agreement":null},{"id":"W3095244907","doi":"10.1182/blood-2020-140303","title":"BAY 94-9027 Provides Safe and Effective Long-Term Prophylaxis in Pediatric Patients: Results from the PROTECT VIII Kids Extension Study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Medicine; Haemophilia; Bay; Pediatrics; Surgery; Internal medicine","score_opus":0.019260425398772048,"score_gpt":0.273362394772329,"score_spread":0.25410196937355695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095244907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905486,0.00051972916,0.0000010019413,0.0013157042,0.00003445467,0.0073835035,0.000029572067,0.000039944855,0.00012748032],"genre_scores_gemma":[0.99903435,0.00006719,0.000042451895,0.000086301785,0.00034187583,0.00029125964,0.00004342818,0.000022700293,0.00007042259],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99817944,0.00029948333,0.0002820847,0.0005377174,0.00044568788,0.0002555833],"domain_scores_gemma":[0.9989978,0.00036659447,0.0000644546,0.00029796982,0.000110551235,0.00016262374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029934812,0.00018966777,0.00030142206,0.00007710391,0.00011031057,0.000033553264,0.00010069258,0.0000883181,0.0000124401695],"category_scores_gemma":[0.001273775,0.00010238095,0.000049541217,0.00041612508,0.000058324087,0.000070267306,0.00014337196,0.00037321204,0.000037198224],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002028686,0.0029965725,0.97848624,0.00011870199,0.00008879568,0.0002971503,0.0032983595,1.9783394e-7,0.00053961074,2.1249313e-7,0.000051917646,0.012093565],"study_design_scores_gemma":[0.017973315,0.009993848,0.96999705,0.00008952544,0.00021154476,0.000002016203,0.00014943004,0.000012080172,0.0014398696,0.000006807247,0.000012998388,0.00011152086],"about_ca_topic_score_codex":0.00010484624,"about_ca_topic_score_gemma":0.000067346096,"teacher_disagreement_score":0.01594463,"about_ca_system_score_codex":0.0000328637,"about_ca_system_score_gemma":0.00008145148,"threshold_uncertainty_score":0.4174974},"labels":[],"label_agreement":null},{"id":"W3095253572","doi":"10.1182/blood-2020-143041","title":"Clonal Hematopoiesis and COVID-19 Severity in Cancer Patients","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Internal medicine; Cohort; Cancer; Proportional hazards model; Immunology; Logistic regression; Retrospective cohort study; Oncology","score_opus":0.013188512706841439,"score_gpt":0.25484881695815986,"score_spread":0.24166030425131843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095253572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974933,0.0010711848,0.0000446528,0.0009527223,0.000032049848,0.00008689607,0.0001260642,0.000003988766,0.0001890965],"genre_scores_gemma":[0.994531,0.000575139,0.000120765806,0.004576999,0.000112433125,0.000016652111,0.000047366437,0.000007799563,0.000011841005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99955255,0.000010847987,0.00009016902,0.00019434074,0.00004838025,0.00010371523],"domain_scores_gemma":[0.99973273,0.000010472891,0.00002590994,0.0000693929,0.000017333841,0.00014415903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000266535,0.00006736772,0.000078996105,0.000009382722,0.00002527527,0.000011014251,0.000057176847,0.00005492295,0.000021392418],"category_scores_gemma":[0.00015421235,0.00007154585,0.000020736981,0.000041753483,0.00002753006,0.0000011087603,0.00009254736,0.000036364,0.0000016285368],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012430143,0.00042183188,0.95983744,0.00012590649,0.00005881241,0.000013872005,0.00038773456,0.00008000273,0.029143104,0.000114438095,0.008948126,0.00074442266],"study_design_scores_gemma":[0.0166671,0.001148527,0.43274644,0.000032021493,0.0001551295,0.00001630193,0.00020624949,0.00024174855,0.2117562,0.0005563089,0.33534536,0.0011286298],"about_ca_topic_score_codex":0.00016718681,"about_ca_topic_score_gemma":0.00029870766,"teacher_disagreement_score":0.527091,"about_ca_system_score_codex":0.000009043937,"about_ca_system_score_gemma":0.000108347354,"threshold_uncertainty_score":0.29175553},"labels":[],"label_agreement":null},{"id":"W3095258628","doi":"10.1182/blood-2020-138699","title":"Association between ROTEM Hypercoagulable Profile and Outcome in a Cohort of Severely Ill COVID-19 Patients Under Mechanical Ventilation","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Toronto General Hospital; University of Toronto; Health Sciences Centre; University Health Network","funders":"","keywords":"Medicine; Thromboelastometry; Pulmonary embolism; Mechanical ventilation; Population; Thrombosis; Exact test; Dialysis; Internal medicine; Anesthesia; Coagulopathy","score_opus":0.08116799495989538,"score_gpt":0.3884281794434416,"score_spread":0.3072601844835462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095258628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900757,0.000025803221,0.00028492327,0.008515965,0.000018928911,0.00089117227,0.000056743876,0.00003327469,0.00009747744],"genre_scores_gemma":[0.997703,0.00003423943,0.0003275422,0.0016112797,0.000056981764,0.00003182691,0.00005086932,0.000012439912,0.00017178322],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830794,0.00010861394,0.0004921559,0.00029024787,0.0005886527,0.00021236681],"domain_scores_gemma":[0.99768955,0.0015750828,0.00015445225,0.0001267638,0.00018856383,0.00026561876],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00059072074,0.00010001021,0.00045743448,0.00006377993,0.00003988924,0.000007728475,0.00006220942,0.0001338589,0.00006296545],"category_scores_gemma":[0.033030186,0.00009013484,0.00006419626,0.00026720343,0.000031415202,0.000063838146,0.00014787437,0.00024032025,0.000015839361],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012822717,0.00031432312,0.9982028,0.0004163279,0.0001947394,0.00000515332,0.0001064738,0.000008175083,0.00026808566,0.000021102042,0.00016472136,0.00016987596],"study_design_scores_gemma":[0.0048653013,0.00044353527,0.99268186,0.000036500507,0.00028010042,1.19051144e-7,0.000023806091,0.00023422146,0.0006581368,0.00021187298,0.00048511548,0.000079402904],"about_ca_topic_score_codex":0.00014491541,"about_ca_topic_score_gemma":0.00001318972,"teacher_disagreement_score":0.032439467,"about_ca_system_score_codex":0.00020746487,"about_ca_system_score_gemma":0.00017253183,"threshold_uncertainty_score":0.975115},"labels":[],"label_agreement":null},{"id":"W3095264723","doi":"10.1182/blood-2020-136465","title":"A Phase I Study of Anti-ICOS Antibody MEDI-570 for Relapsed/Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL) and Angioimmunoblastic T-Cell Lymphoma (AITL) (NCI-9930)","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Angioimmunoblastic T-cell lymphoma; Lymphoma; Peripheral T-cell lymphoma; Germinal center; Mycosis fungoides; T cell; Neutropenia; Follicular lymphoma; Internal medicine; Antibody; Cancer research; Oncology; Immunology; Immune system; Chemotherapy; B cell","score_opus":0.023257575199438947,"score_gpt":0.3046426809321946,"score_spread":0.28138510573275566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095264723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99174756,0.003215753,0.00013657952,0.0002108012,0.00017922526,0.002850606,0.00009463204,0.00013948427,0.0014253496],"genre_scores_gemma":[0.99685013,0.00039256885,0.00038729492,0.00027731285,0.00041889804,0.00012897493,0.00009887996,0.00016898406,0.0012769818],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99640393,0.0001831935,0.0008266102,0.00090707256,0.00090423675,0.0007749305],"domain_scores_gemma":[0.99766254,0.0003890294,0.00028405013,0.00076424703,0.00031720495,0.0005829192],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004485323,0.00052040024,0.0011411111,0.00025084877,0.00018149814,0.00006371675,0.00039047794,0.00024503973,0.00053891056],"category_scores_gemma":[0.00024245393,0.00048281022,0.00030915183,0.0005453884,0.00023454588,0.00016624201,0.0002106955,0.00023485489,0.000029415723],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040697837,0.04574563,0.0068638776,0.00092066074,0.000571595,0.0003955116,0.00515257,0.0000027639956,0.9227059,0.000005090285,0.00047515135,0.013091461],"study_design_scores_gemma":[0.5415103,0.07681115,0.016294787,0.00034532024,0.0026496798,0.00033150404,0.00764757,0.0031089182,0.33405915,0.000026707605,0.015834343,0.0013806007],"about_ca_topic_score_codex":0.00012740768,"about_ca_topic_score_gemma":0.000008645603,"teacher_disagreement_score":0.58864677,"about_ca_system_score_codex":0.00010251817,"about_ca_system_score_gemma":0.0004941057,"threshold_uncertainty_score":0.99976236},"labels":[],"label_agreement":null},{"id":"W3095280698","doi":"10.1182/blood-2020-141504","title":"A Systematic Review of Evidence Supporting the Use of Autologous Cell Vaccines in the Treatment of Hematological Malignancies","year":2020,"lang":"en","type":"review","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Western University","funders":"","keywords":"Medicine; Adverse effect; Internal medicine; Clinical trial; Incidence (geometry); Disease; Immune system; Oncology; Immunology","score_opus":0.12338303047507732,"score_gpt":0.3340191407901926,"score_spread":0.2106361103151153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095280698","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009933969,0.99596715,0.0000020585792,0.00009214012,0.000070985785,0.0028139788,0.000041436582,0.000011165146,0.000007717913],"genre_scores_gemma":[0.00093628856,0.9984449,0.000025914176,0.000058758804,0.000004726282,0.0003464118,0.000021696835,0.000016468071,0.0001448404],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9937214,0.0033982024,0.0023115028,0.00024430908,0.00007330167,0.00025125913],"domain_scores_gemma":[0.9910988,0.005609115,0.0023858056,0.00081475184,0.00008551709,0.0000059762933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088857266,0.0003776803,0.0041693873,0.000088860965,0.00005247879,0.0000066916964,0.00073939544,0.00028011765,0.00006090803],"category_scores_gemma":[0.0014768798,0.00014124204,0.00081265677,0.00040045334,0.00021495171,0.00004392068,0.00006121889,0.00021320282,0.000017294133],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005242734,0.0009762569,0.000015244838,0.98647785,0.0010282103,0.00003318738,0.0009892716,5.913691e-8,0.00088240654,0.000065746746,0.00007642395,0.009402932],"study_design_scores_gemma":[0.0005895962,0.001584906,0.00001564406,0.85679466,0.007418876,0.0010348225,0.00021301999,9.088957e-8,0.005187815,0.000003916307,0.1269415,0.00021513505],"about_ca_topic_score_codex":0.000045869307,"about_ca_topic_score_gemma":0.00000211397,"teacher_disagreement_score":0.12968317,"about_ca_system_score_codex":0.0000165834,"about_ca_system_score_gemma":0.0002405159,"threshold_uncertainty_score":0.5759683},"labels":[],"label_agreement":null},{"id":"W3095281544","doi":"10.1182/blood-2020-140428","title":"The Effect of Crizanlizumab on the Number of Days Requiring Opioid Use for Management of Pain Associated with Vaso-Occlusive Crises in Patients with Sickle Cell Disease: Results from the Sustain Trial","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Vaso-occlusive crisis; Dosing; Opioid; Emergency department; Placebo; Disease; Acute pain; Clinical trial; Anesthesia; Intensive care medicine; Emergency medicine; Internal medicine; Sickle cell anemia; Alternative medicine","score_opus":0.009533175536930259,"score_gpt":0.2270864776537904,"score_spread":0.21755330211686014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095281544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99528164,0.00011099681,0.000021864646,0.00093952485,0.000030125413,0.0030229348,0.00027468178,0.000011697093,0.0003065143],"genre_scores_gemma":[0.99953187,0.00005424854,0.00003058164,0.00012686334,0.000021791002,0.00006188561,0.000110031804,0.000024672767,0.000038033642],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983751,0.0003820123,0.0003949117,0.00021744553,0.0004182745,0.00021223536],"domain_scores_gemma":[0.99635345,0.002688033,0.00041150636,0.00036604403,0.000121103934,0.000059841695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063946383,0.00016332127,0.00033115828,0.000016806305,0.000097170756,0.000012083867,0.00017706485,0.00005749664,0.000004776748],"category_scores_gemma":[0.0015443119,0.000065723005,0.00010043353,0.00026076892,0.00013897901,0.000031762374,0.00006493545,0.00016105804,4.1659484e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.53091794,0.0047662486,0.4457767,0.0012553866,0.0032630065,0.00008915135,0.0073414193,0.00076973485,0.000117188,0.00038519342,0.002868033,0.0024499965],"study_design_scores_gemma":[0.6150227,0.023904055,0.3286751,0.00473026,0.0060499054,2.8683343e-7,0.011032065,0.0008189523,0.008496946,0.00016843587,0.00059175934,0.00050955993],"about_ca_topic_score_codex":0.00012058008,"about_ca_topic_score_gemma":0.000012699871,"teacher_disagreement_score":0.11710162,"about_ca_system_score_codex":0.000024324876,"about_ca_system_score_gemma":0.00006373363,"threshold_uncertainty_score":0.26801065},"labels":[],"label_agreement":null},{"id":"W3095288097","doi":"10.1182/blood.2020007193","title":"Impact of MYC and BCL2 structural variants in tumors of DLBCL morphology and mechanisms of false-negative MYC IHC","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Genome British Columbia; Simon Fraser University; BC Cancer Agency; University of British Columbia; Spinal Cord Injury BC","funders":"Terry Fox Research Institute; Genome British Columbia; Michael Smith Health Research BC; BC Cancer Foundation; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Genome Canada","keywords":"BCL6; Biology; Copy-number variation; Gene duplication; Immunohistochemistry; Fluorescence in situ hybridization; Lymphoma; Cancer research; Gene dosage; Gene rearrangement; Genetics; Gene; Molecular biology; Gene expression; B cell; Antibody; Chromosome; Immunology; Genome","score_opus":0.014231407451181812,"score_gpt":0.26721038208986075,"score_spread":0.25297897463867897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095288097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991049,0.0002940786,0.000008070603,0.00013501314,0.000010093018,0.00024266593,0.00009780831,0.0000046490404,0.00010269149],"genre_scores_gemma":[0.99910384,0.000044570646,0.0007760435,0.00004288767,0.000009245096,0.000005531708,0.0000070811893,0.000008320504,0.000002459612],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99930716,0.00004133859,0.00026147158,0.00016996205,0.000102476806,0.000117588745],"domain_scores_gemma":[0.99952346,0.00009795933,0.0001419562,0.000101520665,0.000041656076,0.00009344795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000057917016,0.000113027345,0.00049101474,0.000061677165,0.00000906929,0.0000018872803,0.000033232558,0.000055176115,0.000045305027],"category_scores_gemma":[0.000113691036,0.00008045537,0.00005447322,0.000115677525,0.00010061538,0.000031775995,0.000044702094,0.000043884877,4.7423305e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036652715,0.00094290136,0.8541816,0.00019679566,0.000547777,0.00022965703,0.0020872403,0.000003184888,0.13843048,0.0018223706,0.000014677432,0.0011768102],"study_design_scores_gemma":[0.009729903,0.0016858878,0.8334764,0.00007811321,0.00019179916,0.000095975956,0.00019059576,0.000048303627,0.15312475,0.0013273009,1.4732531e-7,0.000050791474],"about_ca_topic_score_codex":0.0005900508,"about_ca_topic_score_gemma":0.0000110424035,"teacher_disagreement_score":0.020705154,"about_ca_system_score_codex":0.000014440394,"about_ca_system_score_gemma":0.00006486926,"threshold_uncertainty_score":0.32808748},"labels":[],"label_agreement":null},{"id":"W3095302273","doi":"10.1182/blood-2020-142984","title":"A Case of Pancoast Syndrome Caused By an Extramedullary Plasmacytoma in Relapsed Multiple Myeloma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Multiple myeloma; Plasmacytoma; Bortezomib; Bone marrow; Lenalidomide; Biopsy; Gastroenterology; Pathology; Surgery; Internal medicine","score_opus":0.03244839662762526,"score_gpt":0.28479863629645413,"score_spread":0.25235023966882886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095302273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99818665,0.0002631099,0.000010182516,0.0003180634,0.000021544247,0.0007172078,0.0002016497,0.00007292598,0.0002086783],"genre_scores_gemma":[0.99845177,0.00002026134,0.0010661819,0.0001258017,0.000027119024,0.00005981729,0.00014034429,0.000041278065,0.00006744834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984033,0.00010377053,0.0003743966,0.00039671414,0.0003104248,0.0004113876],"domain_scores_gemma":[0.9987768,0.00013938607,0.000078024575,0.00034128097,0.000056107972,0.000608407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010441189,0.00020242794,0.0004690084,0.0001201983,0.00004342109,0.000011526847,0.00010672203,0.00012259661,0.0001373922],"category_scores_gemma":[0.00036001,0.00018041371,0.000086198605,0.00037069418,0.00007796762,0.00008049518,0.00005791834,0.0002706581,0.0000421763],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001585862,0.006178269,0.6305048,0.000503947,0.0005051161,0.24437581,0.0017660143,0.000011812626,0.108865,0.000006603942,0.0004397627,0.005257044],"study_design_scores_gemma":[0.15250874,0.01450922,0.52552885,0.0005363337,0.00067091454,0.04163304,0.0020959673,0.016546937,0.24445798,0.000035115194,0.00054407545,0.0009328731],"about_ca_topic_score_codex":0.00047824366,"about_ca_topic_score_gemma":0.0003551962,"teacher_disagreement_score":0.20274277,"about_ca_system_score_codex":0.000032151962,"about_ca_system_score_gemma":0.00012953658,"threshold_uncertainty_score":0.7357058},"labels":[],"label_agreement":null},{"id":"W3095325518","doi":"10.1182/blood-2020-142102","title":"Investigating Gut Microbial Taxa and Asparaginase Related Genes in Children Showing Different Direction of Change in Serum Asparaginase Activity Levels during Pegasparaginase Treatment for Acute Lymphoblastic Leukemia","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Izaak Walton Killam Health Centre","funders":"","keywords":"Asparaginase; Medicine; Acute lymphocytic leukemia; Microbiome; Lymphoblastic Leukemia; Immunology; Leukemia; Pharmacology; Biology; Bioinformatics","score_opus":0.04529118937720176,"score_gpt":0.2928215539910785,"score_spread":0.24753036461387676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095325518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959375,0.000556224,0.000052508305,0.0008287818,0.00005816152,0.0022855601,0.00017576612,0.00008733138,0.000018113598],"genre_scores_gemma":[0.9984816,0.00017195202,0.0005059671,0.000095421245,0.00018310259,0.00037781903,0.0000588515,0.00008035314,0.000044963177],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9973201,0.00016353308,0.0006018305,0.00084229826,0.00033734238,0.0007348962],"domain_scores_gemma":[0.9987216,0.000220233,0.0002462946,0.0003176585,0.000074194984,0.00041999624],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019249626,0.000491594,0.0009892089,0.00041310178,0.00011362118,0.00003626974,0.0001440423,0.00024072992,0.000013601089],"category_scores_gemma":[0.0002927447,0.0004529906,0.00013844245,0.0006100699,0.00016863152,0.00028959522,0.00017464354,0.00031275844,0.0000033882307],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007403104,0.0007919866,0.48765814,0.00047476147,0.000575088,0.0003396889,0.0024393087,0.00013315085,0.50287026,0.0000094153165,0.0000055478486,0.0039623217],"study_design_scores_gemma":[0.025845867,0.0008723844,0.6517892,0.00046581475,0.00053443824,0.00040399845,0.00005058389,0.01032182,0.30940032,0.000011957576,0.0000027742506,0.00030084493],"about_ca_topic_score_codex":0.0012528484,"about_ca_topic_score_gemma":0.0001938017,"teacher_disagreement_score":0.19346996,"about_ca_system_score_codex":0.0014505348,"about_ca_system_score_gemma":0.00050916255,"threshold_uncertainty_score":0.99979216},"labels":[],"label_agreement":null},{"id":"W3095325704","doi":"10.1182/blood-2020-137393","title":"Bosutinib (BOS) Versus Imatinib for Newly Diagnosed Chronic Phase (CP) Chronic Myeloid Leukemia (CML): Final 5-Year Results from the Bfore Trial","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Bosutinib; Imatinib; Medicine; Myeloid leukemia; Nilotinib; Internal medicine; Imatinib mesylate; Oncology; Dasatinib","score_opus":0.060811541791056856,"score_gpt":0.31567383139095306,"score_spread":0.2548622895998962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095325704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98075193,0.0026818432,0.0001261341,0.0052193915,0.0010862952,0.0053717266,0.0027397037,0.00035364777,0.0016693511],"genre_scores_gemma":[0.97848064,0.0005073115,0.002152726,0.0009095989,0.012321604,0.00077293714,0.0041668555,0.00018718075,0.00050114444],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9958712,0.00013671075,0.0010826564,0.0011581491,0.0007389189,0.0010123806],"domain_scores_gemma":[0.9957159,0.0019221349,0.0004756569,0.0012288411,0.00013177362,0.0005257064],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003672626,0.0006422772,0.00092978904,0.00006038123,0.00034042753,0.0000970757,0.0006134109,0.00035039533,0.0007150835],"category_scores_gemma":[0.0023349477,0.00048689984,0.0005891876,0.00040096208,0.00021476245,0.00016608709,0.0001906821,0.000702539,0.0004374175],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7048153,0.0056980737,0.0004694039,0.00076953106,0.0065603238,0.0014152183,0.006111442,0.0002944867,0.019654648,0.0005826915,0.16491799,0.088710845],"study_design_scores_gemma":[0.87799525,0.015643332,0.00047931442,0.00028942447,0.002413064,0.000021144799,0.0002711383,0.0023702763,0.012167565,0.000052871535,0.0877748,0.00052179483],"about_ca_topic_score_codex":0.0005666763,"about_ca_topic_score_gemma":0.00033010117,"teacher_disagreement_score":0.17317992,"about_ca_system_score_codex":0.002379197,"about_ca_system_score_gemma":0.005223208,"threshold_uncertainty_score":0.99975824},"labels":[],"label_agreement":null},{"id":"W3095348717","doi":"10.1182/blood-2020-137398","title":"A Phase II Study to Assess the Sustained Response Off Treatment in Patients with ITP Receiving Eltrombopag, Who Had a Previous Insufficient Response to Corticosteroids (TAPER): A Recruitment Update","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Eltrombopag; Medicine; Internal medicine; Tolerability; Regimen; Gastroenterology; Rituximab; Thrombopoietin; Surgery; Immune thrombocytopenia; Platelet; Adverse effect; Lymphoma","score_opus":0.037788816632405596,"score_gpt":0.3148888913985598,"score_spread":0.2771000747661542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095348717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801802,0.00014050772,0.000014801901,0.0068822964,0.000039901533,0.012552517,0.000071893715,0.000086781234,0.00003110209],"genre_scores_gemma":[0.9956102,0.000018638917,0.00021092324,0.0022060976,0.00002081705,0.0015364259,0.000036550646,0.00006634184,0.00029403417],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99648595,0.0007963239,0.0006018547,0.00082139776,0.00064761174,0.00064687245],"domain_scores_gemma":[0.99812025,0.00024447337,0.00014334157,0.00075768324,0.00016768042,0.00056656136],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006277757,0.00047764342,0.0008197768,0.00026039805,0.00024386396,0.000077217475,0.00021817975,0.00005686482,0.000034016884],"category_scores_gemma":[0.0006435981,0.0002971669,0.00009710089,0.0010020928,0.00003303757,0.00008382084,0.00021285737,0.00018376223,0.00003981463],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36167577,0.2196579,0.3105046,0.000051171493,0.0017866758,0.0067480807,0.07159495,0.000102850005,0.0035377815,0.0000025628804,0.0003708785,0.023966793],"study_design_scores_gemma":[0.12834597,0.2799275,0.5777708,0.0003297925,0.0012105997,0.000039589147,0.005406361,0.000065123255,0.001260482,0.0000016321577,0.0051151477,0.0005270142],"about_ca_topic_score_codex":0.00005792272,"about_ca_topic_score_gemma":0.00012879987,"teacher_disagreement_score":0.2672662,"about_ca_system_score_codex":0.00047341856,"about_ca_system_score_gemma":0.0003634412,"threshold_uncertainty_score":0.999948},"labels":[],"label_agreement":null},{"id":"W3095349062","doi":"10.1182/blood-2020-134738","title":"Evaluation of Activation of a NCI National Clinical Trials Network (NCTN) Study S1826 for Hodgkin Lymphoma (HL) at Children's Oncology Group (COG) Institutions","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Cog; Medicine; Clinical trial; Oncology; Hodgkin lymphoma; Internal medicine; Family medicine; Lymphoma","score_opus":0.3942507021941534,"score_gpt":0.5098650826603505,"score_spread":0.11561438046619704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095349062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98924124,0.00020241473,0.0019038636,0.0030163722,0.00029525897,0.0045750197,0.00013983715,0.000046382196,0.000579638],"genre_scores_gemma":[0.9940136,0.000015894544,0.0021562313,0.0010439758,0.002106744,0.00028368854,0.00035127293,0.000021820571,0.000006746756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99355656,0.0023283218,0.0019764386,0.0004459351,0.0014920757,0.00020068407],"domain_scores_gemma":[0.994981,0.0023070872,0.0011589084,0.0002642683,0.0011279066,0.00016081009],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.017119214,0.0001743736,0.0011091951,0.00009241396,0.000109181645,0.0000063074076,0.00014615586,0.0002111404,0.000096377604],"category_scores_gemma":[0.019772062,0.00016633072,0.00036372122,0.00039739648,0.00011068849,0.000102047816,0.00008302414,0.00013160487,0.0000072041967],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017429201,0.06360232,0.74605113,0.0007039308,0.016558025,0.000006206738,0.0133252265,0.0045964792,0.0054701664,0.008123363,0.025070457,0.09906349],"study_design_scores_gemma":[0.08967609,0.009544704,0.8835928,0.0002339284,0.007833424,0.000018326877,0.000797313,0.0018308258,0.0024619773,0.001031434,0.0026726483,0.00030655993],"about_ca_topic_score_codex":0.00009387116,"about_ca_topic_score_gemma":0.0002509948,"teacher_disagreement_score":0.13754164,"about_ca_system_score_codex":0.00019655879,"about_ca_system_score_gemma":0.0020137583,"threshold_uncertainty_score":0.9884848},"labels":[],"label_agreement":null},{"id":"W3095354231","doi":"10.1182/blood-2020-136198","title":"Updates from Ongoing, First-in-Human Phase 1 Dose Escalation and Expansion Study of TTI-621, a Novel Biologic Targeting CD47, in Patients with Relapsed or Refractory Hematologic Malignancies","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Trillium Therapeutics (Canada); BC Cancer Agency; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Refractory (planetary science); CD47; Hematologic Neoplasms; Oncology; Leukapheresis; Internal medicine; Intensive care medicine; Cancer; Receptor; Stem cell; Biology","score_opus":0.0196920499174189,"score_gpt":0.2409773554635876,"score_spread":0.22128530554616868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095354231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99854255,0.00075224874,0.000013079415,0.000033853652,0.000038268277,0.00055419566,0.00002580361,0.000032116473,0.000007867097],"genre_scores_gemma":[0.99944997,0.00002255102,0.00012178764,0.000027691856,0.000007213189,0.000024910423,0.0003279612,0.000012008083,0.0000059125596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987562,0.00014516345,0.00049359835,0.0003621418,0.000045933913,0.0001969901],"domain_scores_gemma":[0.999372,0.00011642072,0.00029728963,0.0001516833,0.00004531796,0.000017287583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013859778,0.00018007851,0.00042321798,0.00010168435,0.000097095835,0.000009219508,0.000103923456,0.00016909529,0.00005762911],"category_scores_gemma":[0.00013147437,0.00012586305,0.000024880426,0.00019596516,0.00007360482,0.0001573859,0.00008151775,0.00016682083,0.0000031725206],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008514279,0.004841263,0.5147255,0.000024843475,0.000061629515,0.000004948901,0.0023995843,0.000014190046,0.47684988,0.000008358568,0.000012115809,0.00020622116],"study_design_scores_gemma":[0.03185795,0.004583943,0.9044636,0.00015451413,0.00007202649,0.0000018530488,0.0014156402,0.00003701865,0.057134945,0.000015445401,0.00005133458,0.00021176742],"about_ca_topic_score_codex":0.00019167144,"about_ca_topic_score_gemma":0.00013648014,"teacher_disagreement_score":0.41971493,"about_ca_system_score_codex":0.000017283097,"about_ca_system_score_gemma":0.000019025978,"threshold_uncertainty_score":0.51325464},"labels":[],"label_agreement":null},{"id":"W3095376160","doi":"10.1182/blood-2020-136571","title":"Phase 1 Study of CD19 Targeted 4-1BBL Costimulatory Agonist to Enhance T Cell (Glofitamab Combination) or NK Cell Effector Function (Obinutuzumab Combination) in Relapsed/Refractory B Cell Lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"CD137; Cancer research; T cell; CD19; Antibody-dependent cell-mediated cytotoxicity; Immunotherapy; Immunology; Antigen; Medicine; Antibody; Immune system; Monoclonal antibody","score_opus":0.01726297855213852,"score_gpt":0.29514716114275996,"score_spread":0.2778841825906214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095376160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913692,0.00039195816,0.000085919855,0.00019239055,0.0003390512,0.004193448,0.000048492784,0.0001610987,0.0032184445],"genre_scores_gemma":[0.9948895,0.00003479243,0.00011942869,0.00047961037,0.00014066632,0.00026170723,0.00017205648,0.00012641924,0.0037758425],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99581814,0.00048452147,0.000953714,0.0009230664,0.0012123112,0.00060825964],"domain_scores_gemma":[0.9973014,0.00053597364,0.00033362606,0.00078761746,0.00049083,0.00055053306],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00057930715,0.00047673407,0.00089634745,0.00048808238,0.000153466,0.000052181094,0.00037837023,0.00024571142,0.0017734333],"category_scores_gemma":[0.0002770413,0.000467585,0.00017745388,0.0015182992,0.00009293746,0.00018438138,0.00016133237,0.00053072075,0.00052218034],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010051297,0.064057045,0.0046981773,0.00094060914,0.00013811316,0.00029637644,0.002908088,0.000099736295,0.91206765,0.0000073555148,0.0016707177,0.003064847],"study_design_scores_gemma":[0.14845741,0.048010085,0.010997714,0.00012008192,0.00039633276,0.000008150493,0.0011256185,0.0011164764,0.78614414,0.000010980288,0.0030527478,0.0005602909],"about_ca_topic_score_codex":0.00015263872,"about_ca_topic_score_gemma":0.000039398008,"teacher_disagreement_score":0.13840611,"about_ca_system_score_codex":0.00065460755,"about_ca_system_score_gemma":0.0007584767,"threshold_uncertainty_score":0.9997776},"labels":[],"label_agreement":null},{"id":"W3095386435","doi":"10.1182/blood-2020-143103","title":"Erythropoiesis Failure in Diamond-Blackfan Anemia Starts at the Oligopotent Common Myeloid and Megakaryocyte-Erythroid Progenitor Stage","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University Health Network; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Progenitor cell; Diamond–Blackfan anemia; Myeloid; Biology; Haematopoiesis; Erythropoiesis; Bone marrow failure; Immunology; Bone marrow; GATA1; Progenitor; Megakaryocyte; Stem cell; Cancer research; Cell biology; Genetics; Anemia; Medicine; Internal medicine","score_opus":0.010517192682467731,"score_gpt":0.2281063528455683,"score_spread":0.21758916016310056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095386435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99187666,0.0041535776,0.000023431074,0.0032473772,0.000035792284,0.0003343123,0.00008400149,0.000014512857,0.00023035328],"genre_scores_gemma":[0.9974018,0.0009780818,0.00017237205,0.0005543012,0.0002086669,0.00007889799,0.00009947134,0.000025012967,0.00048144275],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99899656,0.0000651575,0.0002005517,0.00037563752,0.00013113336,0.00023094418],"domain_scores_gemma":[0.9994127,0.000010040507,0.00007111518,0.0003611167,0.000033849567,0.00011113966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008760482,0.00016412859,0.00014939276,0.000018020426,0.00014566751,0.00004127698,0.00017857278,0.000111991,0.000050532202],"category_scores_gemma":[0.000022058928,0.00012663678,0.000057851827,0.00011303693,0.00015607303,0.000006126917,0.00019104195,0.000113458525,0.000011062269],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014486132,0.00023313244,0.05790959,0.00008630717,0.00010240053,0.000024747551,0.00084578665,0.00006716155,0.9318142,0.00007609407,0.0066283536,0.0020673594],"study_design_scores_gemma":[0.0024034514,0.0004559701,0.032345235,0.000018274772,0.0000944182,0.00003008179,0.0011492791,0.000052473166,0.8164312,0.000026106076,0.14654323,0.00045026757],"about_ca_topic_score_codex":0.000073801755,"about_ca_topic_score_gemma":0.00081907096,"teacher_disagreement_score":0.13991489,"about_ca_system_score_codex":0.000017542883,"about_ca_system_score_gemma":0.00005438026,"threshold_uncertainty_score":0.5164098},"labels":[],"label_agreement":null},{"id":"W3095389126","doi":"10.1182/blood-2020-136985","title":"Initial Clinical Activity and Safety of BFCR4350A, a FcRH5/CD3 T-Cell-Engaging Bispecific Antibody, in Relapsed/Refractory Multiple Myeloma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Multiple myeloma; Medicine; Bispecific antibody; Refractory (planetary science); Antibody; Oncology; Daratumumab; Cancer research; Internal medicine; Bortezomib; Immunology; Monoclonal antibody; Physics","score_opus":0.0630330095473095,"score_gpt":0.36135556709253547,"score_spread":0.29832255754522596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095389126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925235,0.0008793492,0.000031129926,0.0017563575,0.000089716894,0.00038460447,0.000055596898,0.000035005443,0.0042447536],"genre_scores_gemma":[0.99749124,0.0010313173,0.0005226066,0.00029421295,0.00042811618,0.0000060699995,0.000029107348,0.000027648854,0.00016966913],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99783736,0.00029442663,0.0005943451,0.00047130766,0.0004234653,0.00037908586],"domain_scores_gemma":[0.99832666,0.00085315085,0.00013383654,0.00023341744,0.00007996269,0.00037298995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000602873,0.00020493554,0.00064598536,0.00012681219,0.00009068257,0.000013512843,0.00013992496,0.00018003992,0.00013053104],"category_scores_gemma":[0.0005743564,0.0001772217,0.0001684433,0.0003002643,0.00029608695,0.000082388724,0.00021581355,0.001017509,0.00003325593],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004609965,0.0021665408,0.7856654,0.0005208193,0.00012421761,0.00059423014,0.0008693299,0.0000015181745,0.18762216,0.000051179875,0.00019968666,0.017574953],"study_design_scores_gemma":[0.014138349,0.0016352553,0.93804866,0.0002368316,0.000100450736,0.00006357964,0.0002520345,0.0009670421,0.036896378,0.000028499146,0.007358512,0.0002744313],"about_ca_topic_score_codex":0.00020384016,"about_ca_topic_score_gemma":0.000046561265,"teacher_disagreement_score":0.15238324,"about_ca_system_score_codex":0.000015255466,"about_ca_system_score_gemma":0.00018943952,"threshold_uncertainty_score":0.7226891},"labels":[],"label_agreement":null},{"id":"W3095393483","doi":"10.1182/blood-2020-136632","title":"Pioneer Part 2: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate Safety and Efficacy of Avapritinib in Indolent Systemic Mastocytosis","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Systemic mastocytosis; Tolerability; Medicine; Omalizumab; Internal medicine; Placebo; Phases of clinical research; Mast cell; Adverse effect; Pharmacology; Clinical trial; Oncology; Immunology; Pathology; Immunoglobulin E","score_opus":0.025361767280824184,"score_gpt":0.2773973426336132,"score_spread":0.25203557535278903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095393483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989736,0.0029419023,0.00006442036,0.00033423028,0.00016095354,0.0060015637,0.000043650172,0.00003337527,0.00068387366],"genre_scores_gemma":[0.99889475,0.00011645871,0.000023129882,0.000108843524,0.000046083303,0.00036896285,0.000032802443,0.000019803801,0.00038914662],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9975206,0.00066025864,0.0009896473,0.00044167184,0.00008429284,0.00030350903],"domain_scores_gemma":[0.9989211,0.00045115346,0.00023050612,0.00024566604,0.0000763049,0.00007528875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013415221,0.00024860975,0.0014741925,0.00016045113,0.00007329904,0.000014073464,0.00017404452,0.000118513344,0.00041158387],"category_scores_gemma":[0.00023678021,0.00020062676,0.00015221025,0.00019828958,0.00010014646,0.000034258173,0.00013550665,0.00024292001,0.00011467661],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9632622,0.0040001883,0.00042530423,0.000099751276,0.00082505814,0.000019891377,0.006244821,0.0000701912,0.024240736,0.000089811176,0.00008332208,0.00063870574],"study_design_scores_gemma":[0.9906638,0.0012697909,0.000067884335,0.000119975935,0.0007725295,0.000026754782,0.0009726263,0.000022398963,0.0050607207,0.0000013739769,0.0008206588,0.00020146786],"about_ca_topic_score_codex":0.00008662932,"about_ca_topic_score_gemma":0.000039082795,"teacher_disagreement_score":0.027401598,"about_ca_system_score_codex":0.00001566453,"about_ca_system_score_gemma":0.0000559542,"threshold_uncertainty_score":0.81813216},"labels":[],"label_agreement":null},{"id":"W3095406040","doi":"10.1182/blood-2020-136164","title":"Multicenter, Retrospective Evaluation of Therapeutic Efficacy of Ruxolitinib for Chronic Gvhd Treatment","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Vancouver General Hospital; University of Toronto; BC Cancer Agency","funders":"","keywords":"Medicine; Ruxolitinib; Prednisone; Internal medicine; Retrospective cohort study; Graft-versus-host disease; Clinical trial; Corticosteroid; Surgery; Disease; Bone marrow","score_opus":0.07268113250373591,"score_gpt":0.34313095042758224,"score_spread":0.2704498179238463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095406040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951777,0.0007247471,0.0007421381,0.00023793995,0.00004544407,0.0019148865,0.00004935007,0.000021360047,0.0010864754],"genre_scores_gemma":[0.9990027,0.000050866776,0.0006721069,0.000032294247,0.00008336513,0.00007473329,0.00005548982,0.000015350679,0.000013109574],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991049,0.000047339654,0.000277668,0.00016529956,0.00029682886,0.000107929714],"domain_scores_gemma":[0.9993217,0.0001268749,0.00012489028,0.0001402698,0.00023157743,0.000054668002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016644606,0.000090383706,0.00027696296,0.00003107162,0.00001345707,0.0000017548691,0.00003397706,0.00004550689,0.00014010652],"category_scores_gemma":[0.00008884647,0.00007486292,0.00011438221,0.00008613769,0.000029184017,0.000018133267,0.0000029720647,0.000029191438,0.000005012689],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023058592,0.008083602,0.10141818,0.0037724422,0.0028228061,0.000009641655,0.021014126,0.00012728423,0.80895233,0.0015941123,0.000022866592,0.049876746],"study_design_scores_gemma":[0.039138243,0.0031535742,0.1798774,0.00012601166,0.0034440982,0.000005534061,0.00017901679,0.0029157375,0.77098745,0.00005265722,0.00004798436,0.00007228823],"about_ca_topic_score_codex":0.000010067815,"about_ca_topic_score_gemma":0.0000024073236,"teacher_disagreement_score":0.078459226,"about_ca_system_score_codex":0.000092261245,"about_ca_system_score_gemma":0.00017981547,"threshold_uncertainty_score":0.30528212},"labels":[],"label_agreement":null},{"id":"W3095409250","doi":"10.1182/blood-2020-136250","title":"ENESTop 5-Year Update: Durability of Treatment-Free Remission Following Second-Line Nilotinib and Exploratory Analysis of Molecular Response Regain after Nilotinib Re-Initiation in Patients with Chronic Myeloid Leukemia","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Nilotinib; Medicine; Internal medicine; Myeloid leukemia; Interim analysis; Imatinib mesylate; Imatinib; Neutropenia; Surgery; Gastroenterology; Clinical trial; Toxicity","score_opus":0.011738637734572068,"score_gpt":0.23703720142662135,"score_spread":0.2252985636920493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095409250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980379,0.00064241345,0.000018243125,0.00020516191,0.00002062669,0.0008474653,0.00012913324,0.000042485808,0.0000566161],"genre_scores_gemma":[0.99846363,0.000048549125,0.00092375674,0.00010703079,0.000025707039,0.00006854642,0.00029243997,0.00004877569,0.000021550773],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99746114,0.00034397346,0.0007845144,0.0006644816,0.0004453753,0.0003005431],"domain_scores_gemma":[0.99818015,0.0001741498,0.00036080132,0.0009143908,0.00013795588,0.00023253573],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000399889,0.00034194672,0.0010050817,0.00035679148,0.00003237458,0.000008880496,0.0001339933,0.00016707864,0.0001718057],"category_scores_gemma":[0.0005502025,0.0002842418,0.00022972941,0.0010816432,0.00008970795,0.0001730284,0.00010149766,0.00016829578,0.0000027830233],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013754546,0.001077223,0.9389762,0.00032433422,0.0020817842,0.00019174686,0.0015792218,0.00015455016,0.04123639,0.000003838394,0.0000123413965,0.0006078109],"study_design_scores_gemma":[0.045973673,0.005621088,0.80208033,0.00037436318,0.004544286,0.0000024719936,0.00019330763,0.00027838,0.14056489,0.000012185502,0.00006120272,0.00029378815],"about_ca_topic_score_codex":0.00006378883,"about_ca_topic_score_gemma":0.00015891546,"teacher_disagreement_score":0.13689585,"about_ca_system_score_codex":0.00126794,"about_ca_system_score_gemma":0.001060953,"threshold_uncertainty_score":0.99996096},"labels":[],"label_agreement":null},{"id":"W3095414066","doi":"10.1182/blood-2020-136044","title":"Glofitamab Step-up Dosing Induces High Response Rates in Patients with Hard-to-Treat Refractory or Relapsed Non-Hodgkin Lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Dosing; Medicine; Cytokine release syndrome; Tolerability; Pharmacokinetics; Obinutuzumab; Internal medicine; Refractory (planetary science); Lymphoma; Cmax; Pharmacology; Oncology; Gastroenterology; Rituximab; Cancer; Immunotherapy; Adverse effect","score_opus":0.025872373302044626,"score_gpt":0.2845159869658392,"score_spread":0.25864361366379457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095414066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968169,0.00008352223,0.000010210819,0.0014403883,0.000088573084,0.0011216043,0.000025560985,0.00008889031,0.0003243562],"genre_scores_gemma":[0.99506676,0.000020303829,0.001061529,0.0009341306,0.00015664626,0.00005947508,0.000040615192,0.00009604328,0.0025644936],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99740356,0.00030518812,0.00038112755,0.000609062,0.00077232555,0.00052874326],"domain_scores_gemma":[0.99838454,0.00037602615,0.00009465541,0.00051941467,0.00018571988,0.00043963164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041870793,0.00029866383,0.000538881,0.0003023363,0.00008096874,0.000065098866,0.00022483492,0.0001705086,0.0006897589],"category_scores_gemma":[0.00059715856,0.00021842337,0.000066382185,0.0010081629,0.00007754406,0.00015360443,0.00011227236,0.00031455013,0.00014628537],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18803063,0.0029536812,0.27337873,0.00023602694,0.00031390807,0.001128032,0.003921562,0.0000033876943,0.48812458,0.0000033767324,0.0017034591,0.040202633],"study_design_scores_gemma":[0.05011726,0.00848371,0.84336185,0.00043301875,0.00014520796,0.00001665299,0.00035526988,0.000020183228,0.09422818,0.000002574621,0.0024746812,0.0003613993],"about_ca_topic_score_codex":0.00020638261,"about_ca_topic_score_gemma":0.000026729549,"teacher_disagreement_score":0.5699831,"about_ca_system_score_codex":0.00021332742,"about_ca_system_score_gemma":0.00049325865,"threshold_uncertainty_score":0.89070463},"labels":[],"label_agreement":null},{"id":"W3095419444","doi":"10.1182/blood-2020-141505","title":"Safety and Efficacy of Ex Vivo Expanded Healthy Donor-Derived Double Negative T Cells for the Treatment of AML Relapsed after Allogeneic Stem Cell Transplantation: A First in-Human Phase I/IIa Clinical Trial","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"Medicine; Transplantation; Internal medicine; Clinical trial; Hematopoietic stem cell transplantation; Oncology; Donor lymphocyte infusion; Stem cell; Immunology","score_opus":0.0826160488270848,"score_gpt":0.38051433505101945,"score_spread":0.29789828622393466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095419444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99346465,0.00065586495,0.00006285703,0.00088572234,0.00007168464,0.004600133,0.00010813308,0.000013549425,0.00013741167],"genre_scores_gemma":[0.99521357,0.003762589,0.0001713736,0.00010698111,0.00023509546,0.00020809387,0.000025066149,0.000027978058,0.00024922728],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998167,0.00016508154,0.00083209254,0.00036157345,0.00023443789,0.00023980874],"domain_scores_gemma":[0.9979993,0.0012646755,0.0001923535,0.00028003412,0.00007334515,0.00019027609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003522959,0.0001810514,0.00068134203,0.000057487367,0.000063156556,0.000008988814,0.000097143595,0.000119696095,0.0002836339],"category_scores_gemma":[0.000011258542,0.00012529612,0.00025601836,0.00015398592,0.00017272103,0.00002450956,0.000013376962,0.00013236396,0.0000012617251],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7704435,0.009410352,0.0016023439,0.00055141246,0.00047468193,0.000054556866,0.0152362455,0.000011147336,0.19756,0.000005600551,0.000025671294,0.0046244687],"study_design_scores_gemma":[0.55971456,0.027555699,0.0019339408,0.000057451125,0.000566646,0.0000037125367,0.00031269706,0.00005730545,0.40835667,0.00000347731,0.0013334098,0.000104431405],"about_ca_topic_score_codex":0.00009569938,"about_ca_topic_score_gemma":0.00017080498,"teacher_disagreement_score":0.21079668,"about_ca_system_score_codex":0.000036979294,"about_ca_system_score_gemma":0.00015348244,"threshold_uncertainty_score":0.51094276},"labels":[],"label_agreement":null},{"id":"W3095429211","doi":"10.1182/blood-2020-139635","title":"Excellent Outcomes in Patients with Primary and Secondary Central Nervous System Lymphoma Undergoing Autologous Stem Cell Transplantation Using a Rituximab, Busulfan, Melphalan, Thiotepa Conditioning Regimen","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"ThioTEPA; Medicine; Busulfan; Primary central nervous system lymphoma; Regimen; Melphalan; Autologous stem-cell transplantation; Surgery; Rituximab; Diffuse large B-cell lymphoma; Transplantation; Chemotherapy regimen; Internal medicine; Oncology; Chemotherapy; Hematopoietic stem cell transplantation; Lymphoma; Cyclophosphamide","score_opus":0.008959614666648318,"score_gpt":0.19952298965893892,"score_spread":0.1905633749922906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095429211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99760723,0.00064757006,0.00006824782,0.0002068644,0.000050954288,0.00078926765,0.00009057162,0.00010232939,0.00043695126],"genre_scores_gemma":[0.99850255,0.000056293014,0.0008241638,0.00028540488,0.000032759945,0.00003088159,0.00021726982,0.000039885057,0.000010788075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849457,0.000069243986,0.00037235537,0.00042543342,0.0002918812,0.00034654696],"domain_scores_gemma":[0.9993245,0.000104787585,0.00016216972,0.0001572651,0.000042152817,0.000209106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000044260472,0.00026800667,0.00056295056,0.00009345712,0.00011793925,0.000045140325,0.000051633062,0.00009949644,0.000007633953],"category_scores_gemma":[0.0000032926298,0.00021936977,0.00006737061,0.00013356376,0.000038756665,0.00013440043,0.000026525702,0.00009013862,0.0000040484692],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005356151,0.00225298,0.98242515,0.0017899447,0.00033327602,0.0013875088,0.002169475,0.00008285417,0.00024063572,0.000046551348,0.00001675143,0.008719257],"study_design_scores_gemma":[0.03201984,0.000682412,0.96298826,0.0005812248,0.00077280105,0.000116705014,0.0006387626,0.0002678588,0.0017012269,0.0000012794518,0.000012043093,0.00021761154],"about_ca_topic_score_codex":0.00022035596,"about_ca_topic_score_gemma":0.000050565253,"teacher_disagreement_score":0.031484224,"about_ca_system_score_codex":0.00027958673,"about_ca_system_score_gemma":0.00022311995,"threshold_uncertainty_score":0.894564},"labels":[],"label_agreement":null},{"id":"W3095453737","doi":"10.1182/blood-2020-137719","title":"Matching-Adjusted Indirect Comparison (MAIC) of Lisocabtagene Maraleucel (liso-cel) Vs Axicabtagene Ciloleucel (axi-cel) and Tisagenlecleucel in Relapsed/Refractory (R/R) Large B-Cell Lymphoma (LBCL)","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada); Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Oncology; Population; Cytokine release syndrome; Cytopenia; Chimeric antigen receptor; Immunotherapy; Cancer","score_opus":0.03325975986869781,"score_gpt":0.2778990979638786,"score_spread":0.24463933809518082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095453737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817159,0.007913346,0.00006847133,0.00079310354,0.00016244157,0.0013207202,0.00013447765,0.00021690718,0.0076745856],"genre_scores_gemma":[0.99257284,0.0014630948,0.00093338627,0.0010472777,0.00033151545,0.0000746681,0.0001523137,0.00020669715,0.0032181935],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9945715,0.00045386818,0.0013520246,0.0011998701,0.0012233574,0.001199383],"domain_scores_gemma":[0.9971226,0.00041486142,0.00045344804,0.00096181285,0.00019907378,0.00084822543],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009615526,0.0006732839,0.0018007768,0.00057279976,0.00016422235,0.00007008715,0.00055296445,0.0005725275,0.0012657392],"category_scores_gemma":[0.00021946049,0.00070997735,0.00040062726,0.0012740785,0.0002554951,0.00017462362,0.00047665992,0.0009882066,0.00014709408],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037348373,0.015311905,0.079720415,0.0017991532,0.0006393362,0.00095307105,0.007964997,0.000018282371,0.8716519,0.000068152,0.0018979586,0.01624002],"study_design_scores_gemma":[0.12796873,0.0065491577,0.16640317,0.0007635126,0.0012874202,0.0002394913,0.002972844,0.002000345,0.6594944,0.0001714083,0.03024076,0.0019087737],"about_ca_topic_score_codex":0.0004105788,"about_ca_topic_score_gemma":0.0001962252,"teacher_disagreement_score":0.2121575,"about_ca_system_score_codex":0.00018178945,"about_ca_system_score_gemma":0.00044131975,"threshold_uncertainty_score":0.99964726},"labels":[],"label_agreement":null},{"id":"W3095487872","doi":"10.1182/blood-2020-136751","title":"Clinical Effectiveness of Combination Immunotherapy DPX-Survivac, Low Dose Cyclophosphamide, and Pembrolizumab in Recurrent/Refractory DLBCL: The Spirel Study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; London Health Sciences Centre; Western University; Nova Scotia Health Authority; Queen Elizabeth II Health Sciences Centre; Ottawa Hospital; Health Sciences Centre; McGill University Health Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Oncology; Internal medicine; Pembrolizumab; Population; Immunotherapy; Regimen; Chemotherapy regimen; Chimeric antigen receptor; Cyclophosphamide; Immunology; Cancer; Chemotherapy","score_opus":0.03329050655822488,"score_gpt":0.35096961056598397,"score_spread":0.3176791040077591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095487872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946545,0.0022039872,0.0000075172516,0.00030289986,0.00014641619,0.0020668467,0.000005141264,0.000032702428,0.00058000104],"genre_scores_gemma":[0.9984275,0.0011685283,0.0000133665935,0.00012244053,0.0000967457,0.0000732817,0.000009364231,0.000038592632,0.000050143157],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99727213,0.001068136,0.0005429745,0.0003951935,0.0004846212,0.00023695675],"domain_scores_gemma":[0.9980703,0.0011160463,0.0001343948,0.00042353247,0.00013183976,0.00012386545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020092973,0.00018270547,0.0005886644,0.00008414331,0.000050527047,0.000019774165,0.0002063994,0.00011477074,0.00012532447],"category_scores_gemma":[0.0004013129,0.00013436019,0.00012514912,0.0004345947,0.0001784031,0.000065681226,0.000097728516,0.0006047865,0.0000091678085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009140652,0.0131506855,0.88358045,0.0003529753,0.00038811605,0.000076954966,0.0016891445,0.0000010508517,0.029620416,0.000051908657,0.000018237162,0.061929405],"study_design_scores_gemma":[0.04339791,0.005128074,0.94694895,0.00015445852,0.00007670677,0.0000084006915,0.00025065793,0.000081680526,0.0034538447,0.00008145926,0.00029755037,0.00012032639],"about_ca_topic_score_codex":0.00014236882,"about_ca_topic_score_gemma":0.000022141796,"teacher_disagreement_score":0.06336848,"about_ca_system_score_codex":0.00003864398,"about_ca_system_score_gemma":0.00013543318,"threshold_uncertainty_score":0.54790497},"labels":[],"label_agreement":null},{"id":"W3095490154","doi":"10.1182/blood-2020-142990","title":"CPX351 Has Short Remission Duration but Is an Effective Bridge to Allogeneic Transplant in High Risk AML: Results from Canadian Real-World Multi-Centre Study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; McMaster University; Juravinski Cancer Centre; Sunnybrook Health Science Centre; University of Alberta; Jewish General Hospital; Princess Margaret Cancer Centre; McGill University; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Cytarabine; Oncology; Myeloid leukemia","score_opus":0.04199368743495188,"score_gpt":0.29882131363440734,"score_spread":0.2568276261994554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095490154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893367,0.000027992384,0.00003517322,0.005805605,0.000057162717,0.0030034038,0.0014870254,0.00008404409,0.00016285201],"genre_scores_gemma":[0.99695534,0.00007010399,0.0006784576,0.00078186113,0.00032027403,0.00006737565,0.00089723,0.00005673779,0.0001726543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970573,0.0004221865,0.00053652446,0.0009234979,0.0005016842,0.00055878377],"domain_scores_gemma":[0.99778455,0.00015644947,0.00006414123,0.00054906466,0.00012811764,0.0013176851],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004883559,0.00028074736,0.00047076202,0.0003071748,0.00016915645,0.000049402264,0.00024023396,0.00015417155,0.00006620764],"category_scores_gemma":[0.00042329816,0.00025609825,0.00006578249,0.00061564974,0.000033945693,0.00010365545,0.000047608442,0.0006160451,0.00009178085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032106629,0.0015919239,0.91645944,0.000034750992,0.0003279515,0.0029986799,0.028819663,0.000045970562,0.038139462,0.0000013974808,0.0024109266,0.0059591713],"study_design_scores_gemma":[0.015046623,0.00093717274,0.9505134,0.00013002005,0.00033084673,0.0000067835067,0.0006987335,0.001112095,0.030323729,0.0000016473207,0.0006379396,0.000260998],"about_ca_topic_score_codex":0.7760253,"about_ca_topic_score_gemma":0.8101173,"teacher_disagreement_score":0.034091998,"about_ca_system_score_codex":0.000576814,"about_ca_system_score_gemma":0.00064351736,"threshold_uncertainty_score":0.99998915},"labels":[],"label_agreement":null},{"id":"W3095502010","doi":"10.1182/blood-2020-143345","title":"Intravenous Iron Infusion Administration Schedule and Hematologic Response; A Single-Center Retrospective Cohort Study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Dosing; Hemoglobin; Intravenous iron; Anemia; Retrospective cohort study; Blood transfusion; Surgery; Iron deficiency; Anesthesia; Internal medicine","score_opus":0.01274495872243223,"score_gpt":0.2390073343629571,"score_spread":0.22626237564052487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095502010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954092,0.00019169779,0.000014980711,0.0022417386,0.000040344363,0.0010198283,0.000004347713,0.00009381908,0.0009840447],"genre_scores_gemma":[0.9992545,0.000036923255,0.00017680785,0.00040253223,0.00004176459,0.000019471685,0.000012365148,0.000014856748,0.00004077253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99903166,0.00008480699,0.00021211112,0.0003095343,0.00020119776,0.00016070454],"domain_scores_gemma":[0.99956703,0.000024937133,0.00006325667,0.00013992454,0.00005449106,0.00015035585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001738584,0.00012764719,0.00027148493,0.00003971165,0.00008796948,0.000022992515,0.00003684921,0.00012225738,0.000048517904],"category_scores_gemma":[0.0003151735,0.000103256316,0.00003489542,0.0001638762,0.00005495586,0.00004020526,0.000044233562,0.00022000498,0.00002037106],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016978201,0.004069609,0.96819097,0.000056561435,0.00010342939,0.00042013344,0.0019468976,4.537346e-7,0.023212403,0.000027500502,0.00007948856,0.00019473293],"study_design_scores_gemma":[0.011469439,0.017261678,0.9594631,0.00009304711,0.00050756,0.00070193,0.0034589008,0.000101851765,0.0063935444,0.000023853865,0.00028822388,0.0002368717],"about_ca_topic_score_codex":0.000006063051,"about_ca_topic_score_gemma":0.0000062010276,"teacher_disagreement_score":0.016818859,"about_ca_system_score_codex":0.000030203779,"about_ca_system_score_gemma":0.00006124783,"threshold_uncertainty_score":0.42106703},"labels":[],"label_agreement":null},{"id":"W3095539888","doi":"10.1182/blood-2020-137221","title":"Comparison of Outcomes after Haploidentical Relative and HLA Matched Unrelated Donor Transplantation with Post-Transplant Cyclophosphamide Containing Gvhd Prophylaxis Regimens","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Internal medicine; Transplantation; Graft-versus-host disease; Cyclophosphamide; Context (archaeology); Cumulative incidence; Calcineurin; Gastroenterology; Fludarabine; Surgery; Immunology; Chemotherapy","score_opus":0.016329793460863586,"score_gpt":0.26709345699555875,"score_spread":0.25076366353469515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095539888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929496,0.00030235827,0.004160727,0.0010458038,0.000033016888,0.0008726848,0.00007481912,0.00009923701,0.00046177287],"genre_scores_gemma":[0.9950442,0.00007602528,0.004398225,0.0002173865,0.000017383698,0.000042858337,0.0001254853,0.000042844338,0.000035590525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998239,0.00008125593,0.000619632,0.00039174414,0.00041186693,0.00025653772],"domain_scores_gemma":[0.99900824,0.00027743596,0.00017091082,0.00015867464,0.00014638419,0.00023837209],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012370718,0.0002681652,0.00073075894,0.00008353616,0.00005041746,0.000017105534,0.000060011487,0.0001814638,0.00007543261],"category_scores_gemma":[0.000038846545,0.0002076922,0.000084338615,0.00021690853,0.0001477634,0.00014443089,0.000007468941,0.00032180914,0.000014371142],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003822025,0.00035899167,0.9529072,0.001369641,0.00049960625,0.000613834,0.027164038,0.0000064648643,0.012926792,0.0002271636,9.262781e-7,0.000103312384],"study_design_scores_gemma":[0.010014959,0.002459969,0.9216997,0.00063245906,0.0022348175,0.00029690456,0.0014760848,0.000059150087,0.060828824,0.00002216552,0.0000052876144,0.00026970607],"about_ca_topic_score_codex":0.0000585399,"about_ca_topic_score_gemma":0.000027940656,"teacher_disagreement_score":0.047902033,"about_ca_system_score_codex":0.000016133221,"about_ca_system_score_gemma":0.00007951297,"threshold_uncertainty_score":0.84694415},"labels":[],"label_agreement":null},{"id":"W3095566884","doi":"10.1182/blood-2020-143079","title":"A Synthetic Lethal Approach to Eradicate AML Via Synergistic Activation of Pro-Apoptotic p53 By MDM2 and BET Inhibitors","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"BRD4; Bromodomain; Cancer research; Puma; Mdm2; BET inhibitor; Ubiquitin ligase; Biology; Wild type; Myeloid leukemia; Apoptosis; Ubiquitin; Gene; Mutant; Epigenetics; Genetics","score_opus":0.010296946018278203,"score_gpt":0.2093086584085076,"score_spread":0.19901171239022938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095566884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872689,0.0002162362,0.010621356,0.00068156386,0.000032863725,0.00039759206,0.000022831304,0.000019013954,0.000739645],"genre_scores_gemma":[0.9981192,0.000012517696,0.0011753361,0.00029817384,0.0001446376,0.000045829012,0.00011537702,0.000020820193,0.00006815278],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99907756,0.000050318955,0.00021857975,0.00035739064,0.0001415252,0.00015460252],"domain_scores_gemma":[0.9995242,0.000008566561,0.00009360356,0.00017765559,0.000042331154,0.00015368575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000085584485,0.00013939188,0.00015322871,0.00003444538,0.00004382671,0.000016891214,0.00011275861,0.00010890964,0.0000053434437],"category_scores_gemma":[0.00018888958,0.00013339706,0.00004363455,0.00013298949,0.00006874846,0.000005905286,0.000079135694,0.00007702653,0.000004445886],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038267302,0.00022400037,0.00022672334,0.00007083239,0.000040921193,3.9481918e-7,0.00010133352,0.000015627535,0.99673235,0.00005113148,0.0016645852,0.0008338083],"study_design_scores_gemma":[0.00061736786,0.0003817183,0.00013665365,0.00002045486,0.000038058213,0.000005345178,0.000035534216,0.00017532929,0.9953786,0.0000145700105,0.0030358646,0.00016050902],"about_ca_topic_score_codex":0.000011026063,"about_ca_topic_score_gemma":3.1603298e-7,"teacher_disagreement_score":0.010850257,"about_ca_system_score_codex":0.000004905448,"about_ca_system_score_gemma":0.0000307316,"threshold_uncertainty_score":0.54397744},"labels":[],"label_agreement":null},{"id":"W3095569147","doi":"10.1182/blood-2020-140589","title":"Psychological Distress in Young Adults with Acute Myeloid Leukemia Undergoing Induction Chemotherapy","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Cancer survivorship and care","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Quality of life (healthcare); Psychosocial; Induction chemotherapy; Myeloid leukemia; Chemotherapy regimen; Cancer; Anxiety; Depression (economics); Internal medicine; Randomized controlled trial; Chemotherapy; Pediatrics; Physical therapy; Psychiatry","score_opus":0.01471899852469317,"score_gpt":0.26339618412949417,"score_spread":0.248677185604801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095569147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99445134,0.00012803251,0.00011322583,0.002132994,0.00009713021,0.00018845459,0.0000064740893,0.00007519134,0.0028071553],"genre_scores_gemma":[0.99828506,0.0001964531,0.00014807296,0.000943641,0.0002775816,0.000022382746,0.000032437885,0.000018142136,0.00007624164],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99925256,0.000017977096,0.00012360833,0.00027942588,0.00016440859,0.00016204933],"domain_scores_gemma":[0.99968535,0.000010279349,0.000037311278,0.00013814186,0.000024727007,0.00010422251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000031183714,0.000111957335,0.0001781019,0.000027908185,0.00002343106,0.000013338563,0.000059173155,0.00008770682,0.00006123733],"category_scores_gemma":[0.000011787061,0.000085631626,0.000038729733,0.0002591276,0.000032344862,0.0000512131,0.0000119610095,0.00022771771,0.0000091868105],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0138821555,0.0018333199,0.8471686,0.0007178349,0.0007598759,0.0018827582,0.029176975,0.000025095604,0.03413634,0.0002662271,0.001363241,0.06878752],"study_design_scores_gemma":[0.035660207,0.003694259,0.93074316,0.0007813497,0.00035164802,0.0007883657,0.004907477,0.00008461545,0.021406032,0.000067416346,0.0009210244,0.0005944292],"about_ca_topic_score_codex":0.00023880384,"about_ca_topic_score_gemma":0.0018955293,"teacher_disagreement_score":0.083574526,"about_ca_system_score_codex":0.000055720324,"about_ca_system_score_gemma":0.00004325145,"threshold_uncertainty_score":0.34919563},"labels":[],"label_agreement":null},{"id":"W3095580748","doi":"10.1182/blood-2020-136784","title":"Characterizing the Process of Urgent Referrals and Transfers to a Large Tertiary Care Apheresis Centre in Ontario","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Apheresis; Referral; Rapid response team; Population; Intensive care medicine; Physical therapy; Family medicine; Emergency medicine; Environmental health; Internal medicine","score_opus":0.011419946813643935,"score_gpt":0.22881397524723987,"score_spread":0.21739402843359593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095580748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907089,0.0005326772,0.0000015470234,0.007649329,0.000018587933,0.00043623554,0.000012911262,0.000014054233,0.0006257406],"genre_scores_gemma":[0.9974189,0.00006516272,0.00001723419,0.0024199605,0.000013529436,0.000008527087,0.000010409924,0.000010606205,0.000035701105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999368,0.000019026236,0.00017607355,0.00015585372,0.00010998277,0.0001710738],"domain_scores_gemma":[0.9997051,0.000008491717,0.000020507881,0.00008756462,0.000026673017,0.00015169905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004301047,0.000087111664,0.0001799383,0.000026455957,0.00002917145,0.0000054140683,0.000049970346,0.000063653264,0.00010089705],"category_scores_gemma":[0.000028434166,0.00005674802,0.00004140563,0.00012263792,0.000015346446,0.000023884406,0.0000170478,0.0001688758,0.0000024884203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002529062,0.00043767103,0.7767456,0.0008321717,0.00014717254,0.000118484735,0.18496928,0.0000035586556,0.03417075,0.000016975913,0.00011916554,0.0021862558],"study_design_scores_gemma":[0.010275182,0.0007387157,0.8430175,0.0011403782,0.0006015832,0.000027606353,0.082974784,0.000025449313,0.052092854,0.000008976194,0.008755611,0.0003413629],"about_ca_topic_score_codex":0.0014700381,"about_ca_topic_score_gemma":0.008175147,"teacher_disagreement_score":0.10199449,"about_ca_system_score_codex":0.000013615462,"about_ca_system_score_gemma":0.000105970284,"threshold_uncertainty_score":0.45619237},"labels":[],"label_agreement":null},{"id":"W3095595977","doi":"10.1182/blood-2020-134066","title":"Chronic Lymphocytic Leukemia Treatment in México: Up to Half Patients May Not Requiere Treatment","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Chronic lymphocytic leukemia; Lymphocytosis; Internal medicine; Anemia; Malignancy; Pediatrics; Gastroenterology; Constitutional symptoms; Leukemia; Surgery; Disease","score_opus":0.03877475028026526,"score_gpt":0.3041846582855278,"score_spread":0.26540990800526254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095595977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99312794,0.00058895984,0.000005511044,0.0021074766,0.00015129118,0.0021679064,0.00004038351,0.00014405823,0.0016664773],"genre_scores_gemma":[0.9941906,0.00024019105,0.00020104714,0.0011513996,0.00057862216,0.000412313,0.00011248695,0.00008854664,0.0030247932],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99682057,0.00008979351,0.0005677405,0.00088629033,0.00068859174,0.0009470364],"domain_scores_gemma":[0.9980597,0.00012644961,0.00007992687,0.00075934856,0.00009195512,0.0008826074],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009615619,0.00046773293,0.0007614679,0.00020239415,0.00007704445,0.000044966117,0.00023497081,0.00019504606,0.00025200512],"category_scores_gemma":[0.00019215187,0.00037145967,0.00021799486,0.00061711925,0.00006939126,0.00008826597,0.00014395443,0.0001454749,0.0011782317],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.02491876,0.016921813,0.14487539,0.0053045736,0.008963138,0.028850012,0.08009217,0.008065495,0.05680251,0.0011106713,0.01633709,0.6077584],"study_design_scores_gemma":[0.59004027,0.030653195,0.018665789,0.0007220939,0.0012296946,0.00030991266,0.00048429263,0.012362045,0.22309947,0.00001773374,0.121093154,0.0013223429],"about_ca_topic_score_codex":0.0060409987,"about_ca_topic_score_gemma":0.0007556285,"teacher_disagreement_score":0.606436,"about_ca_system_score_codex":0.23055837,"about_ca_system_score_gemma":0.025251025,"threshold_uncertainty_score":0.99987376},"labels":[],"label_agreement":null},{"id":"W3095602050","doi":"10.1182/blood-2020-140864","title":"The Impact of ABO Blood Group on Clinical Outcomes and Susceptibility in COVID-19: A Retrospective Population Study of 3305 Patients","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"ABO blood group system; Medicine; Population; Asymptomatic; Immunology; Internal medicine","score_opus":0.036214330068901124,"score_gpt":0.3658493170184839,"score_spread":0.32963498694958276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095602050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985461,0.000044791042,0.0000020841042,0.00022186991,0.00003064654,0.0010764654,0.000027004871,0.000015078532,0.000035911544],"genre_scores_gemma":[0.9997614,0.000047089718,0.00002141046,0.00010481645,0.000030560703,0.000007842082,0.000014776722,0.000010936196,0.0000011810076],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984562,0.00018240775,0.0006210042,0.00031107233,0.0002980474,0.0001312736],"domain_scores_gemma":[0.9990235,0.0002829804,0.00017933758,0.0002647387,0.000068894195,0.00018056587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004940779,0.00013002924,0.0005078564,0.000044627763,0.000052636664,0.0000065818117,0.00006627321,0.000082517705,0.0000075504254],"category_scores_gemma":[0.001037804,0.00007738984,0.00014809988,0.00022123351,0.00006832399,0.000043674954,0.00003604572,0.00023383524,7.151357e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009752299,0.012095682,0.98478955,0.00004527734,0.00027345645,0.0000068630006,0.0011877726,0.000002691525,0.00010982817,0.000036211764,0.000004615028,0.00047282936],"study_design_scores_gemma":[0.023035606,0.01594347,0.9600961,0.000028782033,0.00033225596,8.598393e-7,0.00034443336,0.000016539316,0.00003198322,0.00010852681,5.030416e-7,0.000060905702],"about_ca_topic_score_codex":0.0032019417,"about_ca_topic_score_gemma":0.001215923,"teacher_disagreement_score":0.024693409,"about_ca_system_score_codex":0.000023675078,"about_ca_system_score_gemma":0.000038267804,"threshold_uncertainty_score":0.48403993},"labels":[],"label_agreement":null},{"id":"W3095604609","doi":"10.1182/blood-2020-143155","title":"A Novel VWD Variant Identified in a Multi-Generational Canadian Ojibway Kindred with a Type 2B VWD Phenotypic Expression","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Von Willebrand factor; Von Willebrand disease; Ristocetin; Genetics; Missense mutation; Compound heterozygosity; Phenotype; Bleeding diathesis; Hemostasis; Immunology; Platelet; Medicine; Biology; Gene; Internal medicine","score_opus":0.03500813971444329,"score_gpt":0.24523634215538928,"score_spread":0.21022820244094598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095604609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971608,0.0001958463,0.0004082619,0.0010149414,0.000050595885,0.00041485284,0.000045193927,0.000027722945,0.0006817733],"genre_scores_gemma":[0.99281394,0.0000073835777,0.0057324218,0.00090058584,0.000056505454,0.000029783347,0.00019244097,0.000021507822,0.00024543944],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991517,0.0000144949145,0.00015358832,0.00027682265,0.00016894,0.00023446187],"domain_scores_gemma":[0.9994807,0.000011188795,0.00003726116,0.00013443286,0.000051746592,0.00028466122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000036053345,0.00013266048,0.00021569492,0.0000881105,0.00005926706,0.000023248112,0.000056898592,0.000076425145,0.0001457885],"category_scores_gemma":[0.000049050224,0.00010481503,0.000027885246,0.000249599,0.000016727523,0.000059342325,0.000015070708,0.000116853545,0.00006109047],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002255281,0.008994776,0.14924774,0.00022338083,0.001151571,0.018247226,0.006915431,0.00033480476,0.80822784,0.00039342954,0.0022400091,0.0017685394],"study_design_scores_gemma":[0.15554987,0.0026998613,0.7322336,0.0010438841,0.0013637989,0.0017599058,0.0007848539,0.012932354,0.083674036,0.00012319024,0.0062866984,0.0015479744],"about_ca_topic_score_codex":0.011064873,"about_ca_topic_score_gemma":0.06150835,"teacher_disagreement_score":0.72455376,"about_ca_system_score_codex":0.000037753634,"about_ca_system_score_gemma":0.0004334977,"threshold_uncertainty_score":0.99552053},"labels":[],"label_agreement":null},{"id":"W3095614975","doi":"10.1182/blood-2020-141911","title":"Apixaban Anti-Xa Level Monitoring in Treatment of Provoked Acute Upper Extremity Deep Vein Thrombosis for Patient on Dialysis: A Case Report","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Apixaban; Medicine; Deep vein; Dialysis; Hemodialysis; Warfarin; Thrombosis; Low molecular weight heparin; Venous thrombosis; Rivaroxaban; Internal medicine; Surgery; Intensive care medicine; Atrial fibrillation","score_opus":0.06016131652187748,"score_gpt":0.3073241639526636,"score_spread":0.24716284743078612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095614975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963237,0.00020736227,0.000086228814,0.0009805518,0.00013213053,0.0018522842,0.000040423845,0.000046458947,0.00033088052],"genre_scores_gemma":[0.9969999,0.00021770361,0.0018184414,0.00013831948,0.00019284217,0.00053200044,0.000038645776,0.00003608107,0.000026049118],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983658,0.000033894936,0.0005536251,0.00048086213,0.00026215092,0.00030366407],"domain_scores_gemma":[0.9990934,0.000057277517,0.00021049236,0.0003999464,0.00007782032,0.00016106767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010631479,0.00023726144,0.00082634954,0.00012115245,0.000061613064,0.000014884905,0.000059854174,0.00007789772,0.000018796767],"category_scores_gemma":[0.000095487114,0.00019474786,0.00025820945,0.00022435037,0.00002527867,0.000053605425,0.000045893546,0.000067125155,0.000004441615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006580203,0.058992606,0.7484718,0.0012851572,0.008890245,0.05704688,0.039582945,0.00021129588,0.034592837,0.00021350374,0.00076358113,0.049291138],"study_design_scores_gemma":[0.023476578,0.013060243,0.527475,0.0007046383,0.010527668,0.0012028103,0.0042267637,0.0004876979,0.41560373,0.000040639414,0.0023402802,0.0008539764],"about_ca_topic_score_codex":0.000341014,"about_ca_topic_score_gemma":0.000041463594,"teacher_disagreement_score":0.3810109,"about_ca_system_score_codex":0.00010196403,"about_ca_system_score_gemma":0.00006537751,"threshold_uncertainty_score":0.7941587},"labels":[],"label_agreement":null},{"id":"W3095661021","doi":"10.1182/blood-2020-136109","title":"Five-Year Analysis of Murano Study Demonstrates Enduring Undetectable Minimal Residual Disease (uMRD) in a Subset of Relapsed/Refractory Chronic Lymphocytic Leukemia (R/R CLL) Patients (Pts) Following Fixed-Duration Venetoclax-Rituximab (VenR) Therapy (Tx)","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; University of Calgary","funders":"","keywords":"Venetoclax; Medicine; Rituximab; Minimal residual disease; Chronic lymphocytic leukemia; Refractory (planetary science); Internal medicine; Oncology; Ibrutinib; Complete remission; Leukemia; Gastroenterology; Chemotherapy; Lymphoma","score_opus":0.01908777022197527,"score_gpt":0.27137247247284646,"score_spread":0.2522847022508712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095661021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963427,0.0018276592,0.0000066551765,0.00002302425,0.000053593198,0.001509011,0.00008001274,0.00005951921,0.00009777947],"genre_scores_gemma":[0.9991959,0.00018351087,0.00011138304,0.00003090453,0.00010646352,0.00009198454,0.00017669878,0.00006596648,0.000037232257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99573344,0.00033983844,0.0012353207,0.0007868119,0.0012582564,0.0006463475],"domain_scores_gemma":[0.99793077,0.00039018225,0.00040109621,0.0007156981,0.00018864167,0.0003736111],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005154475,0.00038507662,0.0012119295,0.0006599701,0.00009218283,0.000032552973,0.00037278113,0.00018883712,0.00012140446],"category_scores_gemma":[0.0006446019,0.00037175315,0.00043891696,0.0020672476,0.00013991212,0.00026262307,0.00015697816,0.0003591018,0.000014112728],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.014005747,0.007926895,0.8832261,0.0018716282,0.010859384,0.0015062557,0.011708842,0.014153427,0.052202255,0.000017807177,0.00008961668,0.0024320378],"study_design_scores_gemma":[0.3195913,0.007466198,0.52604586,0.0008337495,0.007015798,0.000008220446,0.0042064716,0.081196435,0.05274071,0.000019817302,0.000027440117,0.0008479739],"about_ca_topic_score_codex":0.0021279592,"about_ca_topic_score_gemma":0.00036975893,"teacher_disagreement_score":0.35718024,"about_ca_system_score_codex":0.017657481,"about_ca_system_score_gemma":0.019655304,"threshold_uncertainty_score":0.99987346},"labels":[],"label_agreement":null},{"id":"W3095662261","doi":"10.1182/blood-2020-136365","title":"Healthcare Utilization and Costs Associated with Different Treatment Protocols for Newly Diagnosed Childhood Acute Lymphoblastic Leukemia: A Population-Based Study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Occupational Cancer Research Centre; University of Toronto; Queen's University; McMaster Children's Hospital; London Health Sciences Centre; McMaster University; Children's Hospital of Eastern Ontario; Institute for Clinical Evaluative Sciences; Hospital for Sick Children; Pediatric Oncology Group; SickKids Foundation; Kingston General Hospital; Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Medicine; Population; Cancer registry; Health care; Cohort; Cancer; Cog; Pediatrics; Internal medicine; Emergency medicine; Environmental health","score_opus":0.03793706898941308,"score_gpt":0.32124381749188236,"score_spread":0.2833067485024693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095662261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95347875,0.000043784916,0.0007641787,0.0012617792,0.000014047842,0.04407118,0.00017724186,0.00017726966,0.000011737924],"genre_scores_gemma":[0.97750115,0.000007803125,0.000249538,0.00060019345,0.00011774212,0.020744111,0.00067162694,0.000080418045,0.00002738609],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997794,0.00014311922,0.00039997615,0.0006254873,0.00057755236,0.00045988307],"domain_scores_gemma":[0.99823564,0.0005549467,0.00018040504,0.00029032183,0.00023779034,0.00050087477],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009101908,0.00036360163,0.0006495469,0.000106527055,0.00020108803,0.00006335106,0.00009776653,0.0001476007,0.000012020607],"category_scores_gemma":[0.0005848951,0.0002553236,0.00007976497,0.00036205788,0.000034128043,0.00006351051,0.00003709572,0.0001258903,0.0000025857016],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027509453,0.0073881648,0.98009473,0.00027037444,0.0015181894,0.00030968108,0.0016707084,0.00006361732,0.00020094373,0.000024893681,0.000094349845,0.005613387],"study_design_scores_gemma":[0.10914323,0.023768013,0.8530239,0.0005172979,0.001465199,0.000020168252,0.00029877934,0.010387916,0.0010537204,0.0000075070056,0.0000236094,0.00029065192],"about_ca_topic_score_codex":0.00026763752,"about_ca_topic_score_gemma":0.0003772825,"teacher_disagreement_score":0.12707084,"about_ca_system_score_codex":0.0020301947,"about_ca_system_score_gemma":0.0014395465,"threshold_uncertainty_score":0.9999899},"labels":[],"label_agreement":null},{"id":"W3095664040","doi":"10.1182/blood-2020-141088","title":"Comparison of Outcomes and Utilization of Therapy in Multiple Myeloma Patients in the USA and Alberta, Canada","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Lenalidomide; Multiple myeloma; Bortezomib; Internal medicine; Comorbidity; Malignancy; Pediatrics","score_opus":0.06723516495288251,"score_gpt":0.32772629891777644,"score_spread":0.26049113396489393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095664040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99902624,0.00017496487,6.039476e-7,0.00031058135,0.000004881898,0.00038184502,0.00001126914,8.488696e-7,0.00008879033],"genre_scores_gemma":[0.9997406,0.00007402751,0.000043140513,0.000101596605,0.0000029197638,0.000008338345,0.000020248055,0.0000037020882,0.0000054274574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994197,0.000044416425,0.00017492191,0.00009096579,0.00018218382,0.0000878016],"domain_scores_gemma":[0.9996269,0.00018358618,0.000043953532,0.00007118489,0.000026451718,0.000047943955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000038995484,0.000057866764,0.0002049197,0.000031864194,0.000011627762,0.0000024059623,0.00003456316,0.000020594809,0.000008314616],"category_scores_gemma":[0.0001979146,0.00003604571,0.000010331618,0.000107599466,0.000029703093,0.000019725734,0.000014902975,0.000050238144,1.5439016e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001326574,0.00053079234,0.9918277,0.00004544252,0.000030957955,0.0000048849433,0.0015524231,6.48735e-7,0.00016853864,0.0000050047033,0.000014847332,0.005686099],"study_design_scores_gemma":[0.008623935,0.00034173357,0.9863309,0.000019837245,0.000010004568,4.4851143e-7,0.00022677719,0.0005004353,0.0038718951,0.000002078274,0.000046109693,0.00002583617],"about_ca_topic_score_codex":0.37546456,"about_ca_topic_score_gemma":0.71160245,"teacher_disagreement_score":0.3361379,"about_ca_system_score_codex":0.0000074252375,"about_ca_system_score_gemma":0.000057240853,"threshold_uncertainty_score":0.6286943},"labels":[],"label_agreement":null},{"id":"W3095664609","doi":"10.1182/blood-2020-140473","title":"Integrative Analysis of Single-Cell RNA-Seq and ATAC-Seq Data across Treatment Time Points in Pediatric AML","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Chromatin; Biology; RNA-Seq; Cell; Computational biology; Cancer research; Genetics; Transcriptome; Gene; Gene expression","score_opus":0.05644610041783486,"score_gpt":0.32829218368302476,"score_spread":0.2718460832651899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095664609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955348,0.000844836,0.00003316944,0.0012029991,0.0000084466255,0.0003670906,0.00057902886,0.00002634297,0.0014032993],"genre_scores_gemma":[0.99628395,0.0006249273,0.0013257773,0.00017699604,0.00012684584,0.000011039743,0.00071166625,0.000025216239,0.00071359274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983532,0.00009644907,0.00036330093,0.0005469512,0.00031639403,0.0003237014],"domain_scores_gemma":[0.9986929,0.00021563444,0.000114280854,0.0006504434,0.00008699293,0.00023971277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024325815,0.00019854367,0.0006819649,0.00026106628,0.00003145574,0.00002233338,0.00027570446,0.000097542295,0.00013539707],"category_scores_gemma":[0.00036352745,0.00014868112,0.00009113473,0.0016366971,0.00009277228,0.00012070074,0.0004944274,0.00021578005,0.00005909578],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015402792,0.0076965485,0.83867455,0.00053314806,0.0056554307,0.0015577371,0.023377184,0.00002440484,0.10258943,0.000014267488,0.0043789656,0.013958031],"study_design_scores_gemma":[0.10294798,0.01613696,0.45167303,0.00025659477,0.04299724,0.00012505839,0.008806108,0.057233498,0.3145641,0.00008254082,0.003221244,0.0019556151],"about_ca_topic_score_codex":0.00029977804,"about_ca_topic_score_gemma":0.00015308434,"teacher_disagreement_score":0.38700154,"about_ca_system_score_codex":0.00013783875,"about_ca_system_score_gemma":0.00022230817,"threshold_uncertainty_score":0.60630405},"labels":[],"label_agreement":null},{"id":"W3095664938","doi":"10.1182/blood-2020-135818","title":"Subcutaneous Mosunetuzumab in Relapsed or Refractory B-Cell Lymphoma: Promising Safety and Encouraging Efficacy in Dose Escalation Cohorts","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Jewish General Hospital","funders":"","keywords":"Refractory (planetary science); Medicine; Lymphoma; Oncology; Internal medicine; Biology","score_opus":0.02187764696750958,"score_gpt":0.27515375808555803,"score_spread":0.25327611111804843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095664938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994368,0.001036017,0.0000038982525,0.001547302,0.000028221333,0.00053244707,0.0000053793037,0.000036928097,0.002441766],"genre_scores_gemma":[0.9982689,0.0004325252,0.00036688172,0.00024232925,0.00011002914,0.0000066962793,0.000026902479,0.000023463994,0.0005222705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985122,0.0000862642,0.00039337482,0.00036204487,0.00031893305,0.0003271512],"domain_scores_gemma":[0.9993141,0.00024643177,0.00006370608,0.00013082744,0.000033370627,0.00021154045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021697661,0.00016185317,0.00036403807,0.0001238432,0.000059234095,0.000021754637,0.00006920724,0.0001058975,0.00006358555],"category_scores_gemma":[0.00020667573,0.0001294148,0.00004177213,0.00033741037,0.00005929953,0.000058612342,0.00007317975,0.00028135843,0.000016413482],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04734153,0.012912013,0.5513425,0.0025527275,0.00021647176,0.035605624,0.01513639,0.00025792385,0.15114819,0.000118286785,0.0002764544,0.18309192],"study_design_scores_gemma":[0.067347184,0.0035718624,0.89137316,0.0010865179,0.00018610407,0.0018116109,0.0006061566,0.013680102,0.01209358,0.00005652148,0.0074240025,0.00076318876],"about_ca_topic_score_codex":0.00023364369,"about_ca_topic_score_gemma":0.00007780333,"teacher_disagreement_score":0.3400307,"about_ca_system_score_codex":0.0000776764,"about_ca_system_score_gemma":0.00019424189,"threshold_uncertainty_score":0.5277382},"labels":[],"label_agreement":null},{"id":"W3095670088","doi":"10.1182/blood-2020-143165","title":"Outcomes of Patients with Down Syndrome and <i>CRLF2</i>-Overexpressing Acute Lymphoblastic Leukemia (ALL): A Report from the Children's Oncology Group (COG)","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Internal medicine; Minimal residual disease; Oncology; Clinical significance; Cog; Down syndrome; Exact test; Leukemia","score_opus":0.01006061030812428,"score_gpt":0.24616005047421669,"score_spread":0.2360994401660924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095670088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996797,0.00016188834,0.0003143121,0.0010789408,0.000049906612,0.00090381823,0.00022644064,0.00007252733,0.00039513098],"genre_scores_gemma":[0.9952939,0.000028686783,0.002392898,0.001767088,0.000104813684,0.000038314156,0.0002723793,0.000060878207,0.000041018142],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99740404,0.00010429398,0.00057026587,0.0006265103,0.0008336553,0.00046124516],"domain_scores_gemma":[0.9978346,0.00070812437,0.0003493323,0.0005931535,0.00014582886,0.00036896486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015558519,0.00032632798,0.0008244051,0.00005893687,0.000103658014,0.0000366765,0.00029540865,0.00019059409,0.000073744486],"category_scores_gemma":[0.00050118216,0.0001930171,0.00010589152,0.00026641352,0.00038606182,0.00013749923,0.00035349917,0.0003496925,0.000016352107],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001064409,0.0006065427,0.98797566,0.000063653824,0.0030651707,0.0023675757,0.00067609455,0.000004597857,0.0022240377,0.000017359582,0.001123369,0.0008115331],"study_design_scores_gemma":[0.020898487,0.0017691642,0.97190523,0.00015664026,0.0023727678,0.0013851301,0.00006351383,0.00012617308,0.0006718419,0.000027814594,0.00039148025,0.00023174177],"about_ca_topic_score_codex":0.00047284213,"about_ca_topic_score_gemma":0.000013475716,"teacher_disagreement_score":0.019834077,"about_ca_system_score_codex":0.00026697302,"about_ca_system_score_gemma":0.0008228004,"threshold_uncertainty_score":0.78710085},"labels":[],"label_agreement":null},{"id":"W3095670170","doi":"10.1182/blood-2020-142271","title":"Monoclonal Protein Response Trajectory and Survival in Newly Diagnosed Multiple Myeloma: A Retrospective Cohort Study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; Research Institute in Oncology and Hematology; University of Manitoba","funders":"","keywords":"Multiple myeloma; Retrospective cohort study; Medicine; Cohort; Internal medicine; Bortezomib; Oncology; Trajectory; Survival analysis","score_opus":0.02536864398055786,"score_gpt":0.2831186031077861,"score_spread":0.2577499591272282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095670170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950942,0.00018059366,0.00000543652,0.0005739481,0.000019374207,0.0037955535,0.000039865034,0.00007577452,0.00021528166],"genre_scores_gemma":[0.998667,0.000012120318,0.0004725814,0.00005628717,0.000103263636,0.00052084203,0.000017034785,0.000032625645,0.00011825461],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978609,0.0003906923,0.00026331912,0.0005651913,0.0005455796,0.00037428722],"domain_scores_gemma":[0.9989506,0.00027103073,0.000048145135,0.00024109898,0.00007536911,0.00041375242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050514215,0.00021296032,0.0004885851,0.00012437868,0.000069984984,0.0000260268,0.00008289519,0.00007487146,0.00005713271],"category_scores_gemma":[0.001933791,0.00018441863,0.00006113673,0.00032701984,0.00007234579,0.00007332968,0.00008138244,0.00033015897,0.000026345586],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009750178,0.003216326,0.9697453,0.000031408126,0.00032284312,0.0037585348,0.001413906,5.992978e-7,0.011320981,0.000002806774,0.000019686384,0.00041744002],"study_design_scores_gemma":[0.035620864,0.0030910338,0.9568772,0.0000358583,0.00009041824,0.000016587312,0.00062339683,0.0001907993,0.0032756217,0.000005277819,0.000028393919,0.00014460462],"about_ca_topic_score_codex":0.0005784326,"about_ca_topic_score_gemma":0.000517064,"teacher_disagreement_score":0.025870688,"about_ca_system_score_codex":0.000096569915,"about_ca_system_score_gemma":0.00018486091,"threshold_uncertainty_score":0.75203735},"labels":[],"label_agreement":null},{"id":"W3095670265","doi":"10.1182/blood-2020-136360","title":"Cytokine Release Syndrome in Patients with Relapsed/Refractory Multiple Myeloma Treated with Ciltacabtagene Autoleucel in the Phase 1b/2 CARTITUDE-1 Study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cytokine release syndrome; Medicine; Cytokine; Multiple myeloma; Refractory (planetary science); Internal medicine; Lenalidomide; Oncology; Gastroenterology; Immunology; Cancer; Immunotherapy; Biology; Chimeric antigen receptor","score_opus":0.021718242585585707,"score_gpt":0.27168531104383725,"score_spread":0.24996706845825153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095670265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99590635,0.00009364858,0.0000029551031,0.00039650954,0.000011498693,0.0030045044,0.000036571866,0.00008159958,0.0004663528],"genre_scores_gemma":[0.9989163,0.000010446705,0.000060666705,0.00033224953,0.00004702699,0.00021209547,0.00009646519,0.00007423467,0.0002504817],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99725085,0.0002810951,0.00040357784,0.0005875159,0.0009789182,0.00049803866],"domain_scores_gemma":[0.9987105,0.00014338784,0.00009628607,0.00066592114,0.0001213976,0.00026251993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030643435,0.0003161392,0.000544038,0.00021678585,0.000066604916,0.000033926346,0.00027554925,0.00009292437,0.00023953323],"category_scores_gemma":[0.00014522762,0.00019437098,0.000055266857,0.0011751265,0.00009200322,0.000119555516,0.00005972355,0.00069951435,0.00003246884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009445517,0.030275913,0.940001,0.00006951951,0.00027444915,0.0063661058,0.003696121,0.000023937353,0.0079282615,8.6177977e-7,0.000052565767,0.0018657398],"study_design_scores_gemma":[0.14437959,0.02234796,0.82852733,0.00012999495,0.00023756384,0.00006602278,0.0008172267,0.00014902082,0.0026290843,5.2126745e-7,0.0004479825,0.00026769846],"about_ca_topic_score_codex":0.00039709243,"about_ca_topic_score_gemma":0.0004962917,"teacher_disagreement_score":0.13493407,"about_ca_system_score_codex":0.000103143335,"about_ca_system_score_gemma":0.00017694305,"threshold_uncertainty_score":0.79262185},"labels":[],"label_agreement":null},{"id":"W3095676398","doi":"10.1182/blood-2020-138654","title":"Identifying Myeloid Mutations By NGS in Patients with Unexplained Erythrocytosis","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Medicine; Myeloid; Internal medicine; Population; Hematology; Myeloproliferative neoplasm; Polycythemia vera; Immunology; Myelofibrosis; Bone marrow","score_opus":0.013268459106144373,"score_gpt":0.23176066976435036,"score_spread":0.21849221065820598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095676398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961535,0.00012619591,0.000068613816,0.0023543856,0.000018984723,0.0005621157,0.00004470987,0.000049582122,0.0006219276],"genre_scores_gemma":[0.9972943,0.000027056756,0.0011981946,0.0009734238,0.000036382764,0.0001326788,0.00026674187,0.000023482555,0.000047754693],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990223,0.000024427965,0.00021177565,0.00028907607,0.00025905063,0.00019335338],"domain_scores_gemma":[0.99953437,0.00004944085,0.000060790855,0.00011810289,0.00007389,0.00016342933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00002895222,0.0001537366,0.0002638907,0.000057602054,0.000067759865,0.000025322654,0.00004327026,0.000044475168,0.00012435472],"category_scores_gemma":[0.000058315163,0.00011869714,0.000042049163,0.00029431496,0.000027848626,0.00009482234,0.000022022337,0.000109817935,0.00006367416],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014981742,0.0017712929,0.9948043,0.000051110397,0.00019027131,0.00004566296,0.0011547717,0.0000033323183,0.0005334893,0.0000606198,0.00078233,0.00045300258],"study_design_scores_gemma":[0.024561772,0.0016719365,0.9371514,0.00018017128,0.00043920486,0.0000054846455,0.00031612962,0.00002820297,0.034574106,0.000023486527,0.0008136069,0.0002345024],"about_ca_topic_score_codex":0.000032152522,"about_ca_topic_score_gemma":0.000027232449,"teacher_disagreement_score":0.0576529,"about_ca_system_score_codex":0.000037224527,"about_ca_system_score_gemma":0.00004692281,"threshold_uncertainty_score":0.4840329},"labels":[],"label_agreement":null},{"id":"W3095689615","doi":"10.1182/blood-2020-139032","title":"Association between Genetic Mutations and Risk of Venous Thromboembolism in Patients with Solid Tumor Malignancies: A Systematic Review and Meta-Analysis","year":2020,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Internal medicine; Oncology; Lung cancer; Colorectal cancer; Venous thrombosis; Ovarian cancer; Cancer; Population; Thrombosis","score_opus":0.023923226479429606,"score_gpt":0.2833146537907563,"score_spread":0.2593914273113267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095689615","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022285925,0.99151975,0.00000870455,0.000049950762,0.0000072503476,0.005688156,0.00045060736,0.000018532197,0.000028470402],"genre_scores_gemma":[0.001916111,0.9966619,0.00031782634,0.00011584676,0.00001797723,0.000713582,0.00018722675,0.000047309535,0.000022193466],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99696046,0.00044258495,0.0013557554,0.00050245976,0.00049299863,0.00024574366],"domain_scores_gemma":[0.9970911,0.0002914198,0.0018771001,0.00044150907,0.00016677374,0.00013206677],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005186276,0.00043295356,0.013358688,0.00035047182,0.000053709962,0.000028672532,0.000118004675,0.00012094883,0.000030308616],"category_scores_gemma":[0.00037544122,0.00028424853,0.00077887013,0.0009565267,0.00003866054,0.000044412634,0.00008605901,0.00023117139,0.000006161306],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[5.415863e-7,0.0006347907,0.0035702265,0.6617895,0.3333741,0.000014300399,0.00018771115,4.992165e-7,5.067579e-9,0.000004811009,0.000020263597,0.0004032536],"study_design_scores_gemma":[0.0005838781,0.00034262773,0.03172935,0.0321291,0.9344764,0.000003465398,0.000018583529,5.515232e-7,1.4351521e-7,0.0000077973455,0.00048625327,0.00022187],"about_ca_topic_score_codex":0.00010073192,"about_ca_topic_score_gemma":0.000037038622,"teacher_disagreement_score":0.62966037,"about_ca_system_score_codex":0.00007426518,"about_ca_system_score_gemma":0.00010703475,"threshold_uncertainty_score":0.99996096},"labels":[],"label_agreement":null},{"id":"W3095704533","doi":"10.1182/blood-2020-137078","title":"Polatuzumab Vedotin Plus Bendamustine and Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Updated Results of a Phase Ib/II Randomized Study and Preliminary Results of a Single-Arm Extension","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); McGill University; Jewish General Hospital; BC Cancer Agency","funders":"","keywords":"Bendamustine; Rituximab; Medicine; Refractory (planetary science); Diffuse large B-cell lymphoma; Phases of clinical research; Lymphoma; Internal medicine; Oncology; Chemotherapy; Materials science","score_opus":0.032755742784233016,"score_gpt":0.3085714796981534,"score_spread":0.27581573691392036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095704533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911311,0.004305256,0.0000053702074,0.0007883028,0.000051285177,0.0028151656,0.00038499013,0.00006232794,0.00045618435],"genre_scores_gemma":[0.9986539,0.000344075,0.0004311509,0.00010089306,0.000080076374,0.000049196817,0.00014493556,0.00006360013,0.00013215997],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99576324,0.0006199306,0.0015073756,0.0008653608,0.0007565656,0.0004875046],"domain_scores_gemma":[0.9973947,0.0007874785,0.0004975043,0.0006414915,0.00029310407,0.00038573632],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016759298,0.00035290755,0.0016841178,0.00036499597,0.000085345346,0.000015705316,0.00017699078,0.00021363105,0.0000121657895],"category_scores_gemma":[0.003924275,0.00030294468,0.00011568144,0.00065715687,0.00029678512,0.00008946628,0.00046251493,0.0004351054,0.0000024428603],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7339652,0.17041485,0.0002390691,0.0007414269,0.00022471051,0.0010563991,0.015008768,0.0000013577636,0.075544246,0.0000032647552,0.00068110495,0.0021196094],"study_design_scores_gemma":[0.9492881,0.023947923,0.001040131,0.0005847712,0.0006409735,0.000054903874,0.0016882344,0.0029196704,0.019190786,0.000007930001,0.00039996632,0.000236632],"about_ca_topic_score_codex":0.00051686174,"about_ca_topic_score_gemma":0.00006207671,"teacher_disagreement_score":0.21532288,"about_ca_system_score_codex":0.0000942897,"about_ca_system_score_gemma":0.00041238955,"threshold_uncertainty_score":0.99994224},"labels":[],"label_agreement":null},{"id":"W3095713007","doi":"10.1182/blood-2020-136364","title":"Cytogenetic Subgroups Drive Risk Stratification and Response to Chemotherapy and Blinatumomab in Children and Young Adults with Relapsed B-ALL: A Children's Oncology Group Study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Internal medicine; Blinatumomab; Oncology; Minimal residual disease; Chemotherapy; Chemotherapy regimen; Leukemia; Lymphoblastic Leukemia","score_opus":0.00746837608847043,"score_gpt":0.2584115031790728,"score_spread":0.25094312709060235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095713007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99510866,0.00032304434,0.00006128099,0.0015545393,0.00000727701,0.002852489,0.000026566615,0.000045889145,0.000020254998],"genre_scores_gemma":[0.99763626,0.0002520309,0.0015159638,0.00034816336,0.00006516576,0.00009697799,0.000030042153,0.0000435996,0.000011785451],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804646,0.00031847545,0.0002879652,0.00071660633,0.00032080623,0.0003097172],"domain_scores_gemma":[0.9990064,0.00018377561,0.00009647677,0.00026979562,0.000064494634,0.00037904954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044512464,0.0002294619,0.00040053137,0.0001879421,0.00007455737,0.000041802985,0.000099429846,0.00013301495,0.0000055764635],"category_scores_gemma":[0.00028097464,0.00018941487,0.000016549066,0.00039641847,0.00014276651,0.00006591594,0.00009220241,0.00034876782,0.000003160347],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015182413,0.0011347872,0.9599947,0.000020692725,0.00029347755,0.00013723416,0.011956153,0.0000010735373,0.0069865542,0.0000067606265,0.000029415101,0.0042567356],"study_design_scores_gemma":[0.045262523,0.013650816,0.9377911,0.0000528953,0.00025453564,0.00062822405,0.0011238669,0.0001829236,0.0008550237,0.000009248217,0.000005377845,0.00018343558],"about_ca_topic_score_codex":0.00043096137,"about_ca_topic_score_gemma":0.00035510518,"teacher_disagreement_score":0.030080108,"about_ca_system_score_codex":0.00011308634,"about_ca_system_score_gemma":0.00022074752,"threshold_uncertainty_score":0.7724114},"labels":[],"label_agreement":null},{"id":"W3095722769","doi":"10.1182/blood.v130.suppl_1.2079.2079","title":"Supplemental Oxygen during Air Travel in Sickle Cell Disease -Common Clinical Practices","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Stollery Children's Hospital; University of Alberta","funders":"","keywords":"Medicine; Supplemental oxygen; Family medicine; MEDLINE; Disease; Air travel; Intensive care medicine; Internal medicine","score_opus":0.02445649339743672,"score_gpt":0.33357344846533177,"score_spread":0.30911695506789505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095722769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98703814,0.00040083597,5.428476e-7,0.003387416,0.00015391811,0.000330428,0.000022147715,0.000025726675,0.008640838],"genre_scores_gemma":[0.9981901,0.0003970766,0.00012295424,0.0002034802,0.00017216512,0.0000121918,0.000032357748,0.000020756685,0.00084893475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99887943,0.00004800714,0.0003489324,0.00027222556,0.00017752906,0.00027385837],"domain_scores_gemma":[0.99888194,0.000043203796,0.00029649338,0.00050361495,0.000016534783,0.000258237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024883074,0.00012421842,0.00025268638,0.0000460532,0.00019231784,0.000030376443,0.0001689903,0.00010878701,0.00017498322],"category_scores_gemma":[0.00023962492,0.00010452705,0.00012012606,0.0000340179,0.00009043085,0.00014534108,0.00009877991,0.00034378868,0.00007463654],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003617674,0.003535906,0.99057895,0.00017662879,0.00006537298,0.0009931582,0.00022574038,0.0000017052519,0.0030706923,0.000019180992,0.00039687468,0.00057400315],"study_design_scores_gemma":[0.011177199,0.000165255,0.9827231,0.000096466225,0.00027657844,0.000022591123,0.0006331407,0.000043899807,0.0030707212,0.000032502183,0.001619133,0.00013937628],"about_ca_topic_score_codex":0.0002740311,"about_ca_topic_score_gemma":0.00010987244,"teacher_disagreement_score":0.011151936,"about_ca_system_score_codex":0.000015106784,"about_ca_system_score_gemma":0.00009629775,"threshold_uncertainty_score":0.42624894},"labels":[],"label_agreement":null},{"id":"W3095738174","doi":"10.1182/blood-2020-142737","title":"Plasmacytoid Dendritic Cells Surveil Megakaryocyte Sialic Acid to Regulate Thrombopoiesis","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Thrombopoiesis; Antigen; Immune system; Biology; Immunology; Sialic acid; Megakaryocyte; Cell biology; Stem cell; Haematopoiesis; Biochemistry","score_opus":0.019060943577971622,"score_gpt":0.24347403903049153,"score_spread":0.22441309545251992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095738174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99233216,0.00047501753,0.00003090166,0.003496931,0.00011730736,0.0004381031,0.00004984461,0.0001505181,0.0029092014],"genre_scores_gemma":[0.9956259,0.00008887233,0.0009580087,0.0025468082,0.00012550826,0.00002365723,0.00004665925,0.000044689357,0.0005398611],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99868065,0.00003638067,0.00024156432,0.00039723064,0.00027132896,0.00037283424],"domain_scores_gemma":[0.99914443,0.0000388521,0.00004308136,0.00028325862,0.000047571306,0.00044280154],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00005807919,0.00022416069,0.0004912475,0.00006063444,0.00008305954,0.000030076048,0.00011745144,0.00008695594,0.00025468264],"category_scores_gemma":[0.000066412846,0.00019962697,0.00013250549,0.00030762563,0.000033887736,0.00006604137,0.000068379806,0.00011841729,0.0009406546],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000959962,0.0037159093,0.02051889,0.0004317102,0.0022496046,0.008920678,0.0028995485,0.000026335643,0.9353843,0.00014521684,0.020840824,0.0039070593],"study_design_scores_gemma":[0.012177564,0.0013042948,0.01824549,0.000094595576,0.0008418503,0.0002766215,0.00016320206,0.000064003674,0.9568517,0.00010294425,0.009443387,0.00043432345],"about_ca_topic_score_codex":0.000056175115,"about_ca_topic_score_gemma":0.000032795753,"teacher_disagreement_score":0.02146746,"about_ca_system_score_codex":0.000024068362,"about_ca_system_score_gemma":0.00007101727,"threshold_uncertainty_score":0.9998372},"labels":[],"label_agreement":null},{"id":"W3095745908","doi":"10.1182/blood-2020-141319","title":"Peripheral Neuropathy Symptoms, Pain and Functioning in Relapsed or Refractory Multiple Myeloma Patients Treated with Selinexor, Bortezomib, and Dexamethasone","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Alberta","funders":"","keywords":"Medicine; Bortezomib; Regimen; Internal medicine; Peripheral neuropathy; Dexamethasone; Oncology; Multiple myeloma; Chemotherapy regimen; Physical therapy; Cancer","score_opus":0.017770722428880992,"score_gpt":0.23925960712658134,"score_spread":0.22148888469770034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095745908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99848527,0.0003910061,0.000029928296,0.00020535808,0.00001240226,0.00068228855,0.000020747566,0.00008485952,0.00008811389],"genre_scores_gemma":[0.99802834,0.000084657884,0.0010866581,0.0004104646,0.00006345736,0.000055373202,0.000093339106,0.000046054887,0.00013163562],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984186,0.00022730921,0.0002493076,0.0004796661,0.00028183684,0.00034324767],"domain_scores_gemma":[0.9989979,0.0002553421,0.0000690856,0.00016955468,0.00008686547,0.0004212407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017190857,0.00023414366,0.00035812083,0.00009743113,0.00009366453,0.000035493955,0.000041095904,0.00008816875,0.000044769895],"category_scores_gemma":[0.0009502786,0.00016145085,0.000027561166,0.00030024347,0.00008007114,0.00009373058,0.000046706868,0.00027902177,0.0000042913343],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004156581,0.00090771145,0.96379584,0.00009527988,0.00014798847,0.00071380124,0.00041835062,0.0000017440289,0.0016919285,5.072435e-7,0.000027781844,0.02804249],"study_design_scores_gemma":[0.03661398,0.007381916,0.950153,0.00013017542,0.00013418101,0.000050515944,0.00014206591,0.0044121863,0.00047008795,5.020574e-7,0.00033770467,0.0001737185],"about_ca_topic_score_codex":0.00015834253,"about_ca_topic_score_gemma":0.00011310502,"teacher_disagreement_score":0.032457396,"about_ca_system_score_codex":0.000036626647,"about_ca_system_score_gemma":0.00007623706,"threshold_uncertainty_score":0.65837747},"labels":[],"label_agreement":null},{"id":"W3095746683","doi":"10.1182/blood-2020-137415","title":"Efficacy of Subsequent Novel Targeted Therapies, Including Repeated Venetoclax-Rituximab (VenR), in Patients (Pts) with Relapsed/Refractory Chronic Lymphocytic Leukemia (R/R CLL) Previously Treated with Fixed-Duration Venr in the Murano Study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Venetoclax; Bendamustine; Internal medicine; Rituximab; Chronic lymphocytic leukemia; Clinical endpoint; Neutropenia; Progression-free survival; Oncology; Randomized controlled trial; Surgery; Gastroenterology; Chemotherapy; Leukemia; Lymphoma","score_opus":0.026034635969122012,"score_gpt":0.2662783070529347,"score_spread":0.2402436710838127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095746683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99355865,0.0011333454,0.000012045897,0.00006486084,0.000023795721,0.004995542,0.000014249635,0.00009950431,0.0000979964],"genre_scores_gemma":[0.9989606,0.00009805587,0.00010246753,0.0001239142,0.000092658745,0.00028371706,0.00021204817,0.00010517743,0.000021348991],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99556136,0.0004439203,0.0010548988,0.00084967195,0.0013410385,0.0007490924],"domain_scores_gemma":[0.99785787,0.00033685318,0.00043396157,0.000920788,0.00025241065,0.00019814234],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00066187454,0.0004934844,0.00093512796,0.00030438005,0.00011226695,0.000044686312,0.0004824928,0.00020590182,0.000030485102],"category_scores_gemma":[0.00038579578,0.0003241224,0.000097931465,0.0018370751,0.0002039263,0.00021083631,0.000119773686,0.0006600202,0.000014294852],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.075249165,0.03816984,0.68853915,0.0036009313,0.0046484675,0.0051490506,0.10612234,0.023590993,0.0476655,0.000042784824,0.0001945626,0.007027211],"study_design_scores_gemma":[0.62473965,0.022198563,0.3202074,0.001976909,0.0009018387,0.00016015454,0.0023880354,0.018306287,0.008248706,0.0000028374307,0.00012860018,0.000741031],"about_ca_topic_score_codex":0.004467697,"about_ca_topic_score_gemma":0.00093287975,"teacher_disagreement_score":0.5494905,"about_ca_system_score_codex":0.040014174,"about_ca_system_score_gemma":0.017952831,"threshold_uncertainty_score":0.9999211},"labels":[],"label_agreement":null},{"id":"W3095758083","doi":"10.1182/blood-2020-139281","title":"Long-Term Effect of Ruxolitinib (RUX) in Inadequately Controlled Polycythemia Vera (PV) without Splenomegaly: 5-Year Results from the Phase 3 Response-2 Study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Ruxolitinib; Internal medicine; Polycythemia vera; Randomization; Phlebotomy; Gastroenterology; Myelofibrosis; Randomized controlled trial; Bone marrow","score_opus":0.027180894296659902,"score_gpt":0.3156119923488506,"score_spread":0.2884310980521907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095758083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99116266,0.0004205887,0.000002500126,0.003841274,0.000054158016,0.0037328904,0.00029684856,0.000047345722,0.0004417643],"genre_scores_gemma":[0.9986926,0.000042409756,0.000048502694,0.0004338104,0.00023767822,0.00033878392,0.0000981115,0.000039999777,0.000068139736],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99696845,0.0009050559,0.0007818461,0.0005550631,0.00045827424,0.00033129178],"domain_scores_gemma":[0.9961422,0.0027553802,0.0002690657,0.00054617226,0.000070714355,0.00021646041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009143311,0.0003509791,0.0012487359,0.00008350628,0.00007323196,0.00003266028,0.00018957359,0.000097280616,0.00011229961],"category_scores_gemma":[0.0019059236,0.00020796747,0.00020221573,0.00025837414,0.00008085481,0.000052557094,0.00007464767,0.0003245841,0.00005586215],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19038525,0.005415663,0.7918174,0.00003892055,0.0011440163,0.00077346474,0.0046281484,0.000002242221,0.0049951235,0.000013267774,0.00012939578,0.0006570892],"study_design_scores_gemma":[0.35875934,0.016837737,0.56351995,0.0002600486,0.0014609977,0.000012600125,0.0003342962,0.000040024643,0.058463853,0.0000050845633,0.00010438703,0.00020166227],"about_ca_topic_score_codex":0.00023165262,"about_ca_topic_score_gemma":0.000087050925,"teacher_disagreement_score":0.22829744,"about_ca_system_score_codex":0.000054170203,"about_ca_system_score_gemma":0.0001775921,"threshold_uncertainty_score":0.84806675},"labels":[],"label_agreement":null},{"id":"W3095808554","doi":"10.1182/blood-2020-140595","title":"Targeting AXL Kinase Sensitizes Acute Myeloid Leukemia Stem and Progenitor Cells to Venetoclax Treatment","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SignalChem (Canada); Terry Fox Research Institute; University of British Columbia","funders":"","keywords":"Venetoclax; GAS6; Myeloid leukemia; Cancer research; AXL receptor tyrosine kinase; Progenitor cell; Myeloid; Leukemia; Stem cell; Biology; Pharmacology; Medicine; Receptor tyrosine kinase; Internal medicine; Immunology; Chronic lymphocytic leukemia; Receptor; Genetics","score_opus":0.013476678117614667,"score_gpt":0.2163698897137557,"score_spread":0.20289321159614104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095808554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960792,0.002888475,0.00003308808,0.00026088295,0.0001676803,0.0003914164,0.000042277592,0.00007492147,0.00006203964],"genre_scores_gemma":[0.9988213,0.00011779857,0.00025518183,0.0001957825,0.00010095871,0.00003021757,0.00006607483,0.000018266212,0.0003944244],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991669,0.00008282562,0.00019450887,0.00028533692,0.000024307848,0.00024608814],"domain_scores_gemma":[0.99969923,0.0000311703,0.00006289836,0.00012407222,0.00002981562,0.00005278202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004803457,0.00016686511,0.00024238293,0.000030586973,0.0001378225,0.000021660586,0.00006383999,0.00011606238,0.000026618616],"category_scores_gemma":[0.0000071863205,0.00014202319,0.000057171434,0.00007958901,0.000035391444,0.000052175885,0.000064917294,0.0000736988,0.00021887178],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009809244,0.00004744347,0.00035050546,0.000011716497,0.00029225406,0.000015794632,0.0007332475,0.000021412661,0.9929669,0.00001428377,0.0005096372,0.0049387207],"study_design_scores_gemma":[0.0020053042,0.000615426,0.0009833219,0.000014376924,0.00019931601,0.00003012358,0.00015091638,0.00003284588,0.9820021,0.0000024428564,0.013804327,0.00015951952],"about_ca_topic_score_codex":0.000029394843,"about_ca_topic_score_gemma":0.0000012765488,"teacher_disagreement_score":0.01329469,"about_ca_system_score_codex":0.00008224752,"about_ca_system_score_gemma":0.00008001957,"threshold_uncertainty_score":0.5791538},"labels":[],"label_agreement":null},{"id":"W3095811344","doi":"10.1182/blood-2020-137451","title":"Preliminary Results of a Phase 2 Study of Camidanlumab Tesirine (Cami), a Novel Pyrrolobenzodiazepine-Based Antibody-Drug Conjugate, in Patients with Relapsed or Refractory Hodgkin Lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Synthesis and pharmacology of benzodiazepine derivatives","field":"Chemistry","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Brentuximab vedotin; Internal medicine; Refractory (planetary science); Oncology; Gastroenterology; Lymphoma; Surgery; Hodgkin lymphoma; Biology","score_opus":0.021129650880068202,"score_gpt":0.2759776509396197,"score_spread":0.2548480000595515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095811344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977636,0.00010635342,0.000007552548,0.00015035602,0.000030158362,0.00067297305,0.0007961901,0.00007467132,0.00039814942],"genre_scores_gemma":[0.9989544,0.000010055375,0.00046109353,0.00013114024,0.000055631357,0.00006472435,0.00022658215,0.00006473215,0.000031642943],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99715143,0.00013628363,0.0011365034,0.0007047151,0.00048735965,0.00038373345],"domain_scores_gemma":[0.9975492,0.0005912172,0.00091024226,0.0005336023,0.00023953944,0.00017620783],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023397959,0.0004262389,0.00093981344,0.00016408208,0.00005654933,0.000010735342,0.00046564592,0.00015392063,0.0002031366],"category_scores_gemma":[0.0005918359,0.000349286,0.00010128625,0.00051573577,0.00020062044,0.00014722331,0.00011558118,0.00023937579,0.0000030088468],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.109097905,0.12826912,0.23676959,0.0013086487,0.0010426642,0.00027723817,0.0071996707,0.00025007123,0.5131116,0.0000027703472,0.00038735894,0.0022833443],"study_design_scores_gemma":[0.2597528,0.01779665,0.23685011,0.00053550693,0.00057497725,0.0000036647787,0.0014647304,0.0013539954,0.480744,0.0000013771865,0.00023992927,0.00068222656],"about_ca_topic_score_codex":0.00019793799,"about_ca_topic_score_gemma":0.00003835524,"teacher_disagreement_score":0.15065491,"about_ca_system_score_codex":0.00003325431,"about_ca_system_score_gemma":0.000267348,"threshold_uncertainty_score":0.99989593},"labels":[],"label_agreement":null},{"id":"W3095894752","doi":"10.1182/blood-2020-142351","title":"Characteristics and Treatment Outcomes of Plasmablastic Lymphoma in British Columbia (BC)","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC; University of British Columbia; Vancouver General Hospital","funders":"","keywords":"Medicine; Plasmablastic lymphoma; Internal medicine; Population; B symptoms; Lymphoma; Cancer; Diffuse large B-cell lymphoma; Gastroenterology; Surgery; Pediatrics","score_opus":0.020165846459889607,"score_gpt":0.2709058721369855,"score_spread":0.2507400256770959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095894752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985778,0.0000813331,0.0000075114485,0.0002869488,0.000008209528,0.00018388033,0.00010988686,0.000012903114,0.00073154765],"genre_scores_gemma":[0.9963057,0.0001953237,0.000121171906,0.000047278332,0.000026081052,0.000016910466,0.00002341663,0.00000819918,0.0032558963],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994409,0.000018606717,0.00019071529,0.00011762792,0.00010275673,0.00012938345],"domain_scores_gemma":[0.9996833,0.000042724398,0.000028976006,0.00007026128,0.000029082154,0.0001456186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00002785608,0.00004525193,0.00024844162,0.000024082516,0.00001890102,0.000031192107,0.000029733841,0.000029084082,0.0002451444],"category_scores_gemma":[0.0002667156,0.00005728199,0.000057758036,0.000083509985,0.000045525358,0.000025891943,0.000023298024,0.0000339872,0.000014763888],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001933906,0.0010382937,0.97329533,0.0000963326,0.00010698757,0.00022309847,0.00014355063,2.0423766e-8,0.000610018,0.0000031178563,0.00076422753,0.023699677],"study_design_scores_gemma":[0.005163465,0.003151711,0.9897039,0.00013300165,0.00008619957,0.000041592037,0.00006729542,0.00019855995,0.00034938497,0.0000053395165,0.0010533548,0.00004620302],"about_ca_topic_score_codex":0.004977292,"about_ca_topic_score_gemma":0.011534447,"teacher_disagreement_score":0.023653474,"about_ca_system_score_codex":0.00001690941,"about_ca_system_score_gemma":0.00005126806,"threshold_uncertainty_score":0.75242096},"labels":[],"label_agreement":null},{"id":"W3095898239","doi":"10.1182/blood-2020-136457","title":"Rituximab Monotherapy Compared to Observation in Patients with Newly Diagnosed Asymptomatic Advanced Stage Follicular Lymphoma: A Retrospective Population-Based Analysis","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Medicine; Rituximab; Asymptomatic; Internal medicine; Follicular lymphoma; Population; Cohort; Clinical endpoint; Pediatrics; Lymphoma; Clinical trial; Surgery; Oncology","score_opus":0.010369969872694278,"score_gpt":0.23586021938761412,"score_spread":0.22549024951491983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095898239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99705535,0.00006439659,0.00043337245,0.0007302061,0.000014693032,0.0015173395,0.00006873974,0.00009050485,0.000025395293],"genre_scores_gemma":[0.9904326,0.0000036491408,0.006993783,0.0015523277,0.000021478882,0.000293567,0.0006641938,0.00003068721,0.000007718356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983911,0.00005280731,0.00037114116,0.0004756649,0.00046869137,0.00024062481],"domain_scores_gemma":[0.99907917,0.0000727616,0.00015737109,0.00033063957,0.00014300228,0.00021703479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004860443,0.00024570405,0.0007211232,0.00021642029,0.00005766695,0.000032359294,0.000076562304,0.000058222853,0.000027046939],"category_scores_gemma":[0.00008677437,0.00020000627,0.00015015661,0.001605331,0.00001070049,0.00010649811,0.000012484882,0.000039071525,0.00002655723],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007070279,0.005677572,0.98760206,0.000031040203,0.0008759372,0.00005813071,0.0003755077,0.003820519,0.000030464127,0.000019910076,0.000009988205,0.00079183397],"study_design_scores_gemma":[0.07527193,0.0009899351,0.91820365,0.000083043844,0.0010206185,1.4546386e-7,0.000045019802,0.003682473,0.00048270824,0.0000049473374,0.000019681393,0.00019582048],"about_ca_topic_score_codex":0.0009386975,"about_ca_topic_score_gemma":0.0003967707,"teacher_disagreement_score":0.0745649,"about_ca_system_score_codex":0.000372609,"about_ca_system_score_gemma":0.00008301209,"threshold_uncertainty_score":0.8156019},"labels":[],"label_agreement":null},{"id":"W3095906965","doi":"10.1182/blood-2020-134180","title":"Optimizing Hydroxyurea Therapy with Reduced Laboratory Monitoring for Children with Sickle Cell Anemia in Sub-Saharan Africa: The Reach Experience","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Anemia; Dosing; Thalassemia; Sickle cell anemia; Internal medicine; Pediatrics; Gastroenterology","score_opus":0.013534057392933476,"score_gpt":0.22387848088977924,"score_spread":0.21034442349684576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095906965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99043435,0.0071146,0.00003409094,0.00084355846,0.000027016864,0.000936546,0.0000066318253,0.00007583366,0.000527382],"genre_scores_gemma":[0.99712086,0.0010796059,0.0012502236,0.00019472698,0.00014445966,0.00013499174,0.0000095930245,0.00004437018,0.000021155123],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99896574,0.000029512468,0.00017301117,0.00031417253,0.0002020435,0.0003155156],"domain_scores_gemma":[0.9994606,0.000034136963,0.00007060288,0.0002486695,0.00005709304,0.00012891678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008104027,0.00018651591,0.00023560479,0.000035901485,0.00011802629,0.00002521022,0.00013886085,0.00009620167,0.000004574996],"category_scores_gemma":[0.000019251524,0.00010532966,0.000037357466,0.00045119703,0.00008515163,0.00007470065,0.000016511029,0.00030641278,0.0000026790985],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028105455,0.0018569796,0.14581254,0.00016082563,0.00038333365,0.00019505038,0.060585946,0.0012650645,0.7828682,0.0000099878,0.001105772,0.0029457514],"study_design_scores_gemma":[0.028383646,0.0036265114,0.035556883,0.0004801096,0.00033934377,0.00006424405,0.008402429,0.00021120465,0.91953295,0.0000036567656,0.0027073568,0.00069166766],"about_ca_topic_score_codex":0.000025499097,"about_ca_topic_score_gemma":0.0000016353714,"teacher_disagreement_score":0.13666473,"about_ca_system_score_codex":0.000017347937,"about_ca_system_score_gemma":0.00012603389,"threshold_uncertainty_score":0.4295219},"labels":[],"label_agreement":null},{"id":"W3095914190","doi":"10.1182/blood-2020-139496","title":"Preclinical Characterization of Cell-Based IL12 Immunotherapy Against Murine Acute Lymphoblastic Leukemia Using Intravital Imaging","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Interleukin 12; Bone marrow; Immunotherapy; Cancer research; Ex vivo; Immune system; Immunology; Leukemia; Medicine; Tumor microenvironment; In vivo; Biology; In vitro","score_opus":0.024411600747359298,"score_gpt":0.30081970413357145,"score_spread":0.27640810338621213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095914190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99577403,0.00010556413,0.0026932168,0.00038335405,0.00008055379,0.00048136912,0.000035465942,0.00007098192,0.00037544197],"genre_scores_gemma":[0.9967699,0.00011215459,0.0014263025,0.0009823837,0.00035234843,0.000010336344,0.00015821657,0.00006922475,0.000119108074],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984152,0.00007792841,0.00047706725,0.0003285817,0.0003992451,0.00030201767],"domain_scores_gemma":[0.999109,0.00009982666,0.00015962358,0.00030794778,0.00013616194,0.00018740508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017993899,0.0001868285,0.00040268496,0.00010256527,0.0000520544,0.00002669988,0.00015198365,0.00008360909,0.0005325387],"category_scores_gemma":[0.000068122004,0.00017993285,0.00016323871,0.00031150243,0.000114681825,0.00008677233,0.000050143382,0.00023912964,0.000016592221],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009607025,0.00043921804,0.008620954,0.00014597461,0.00016145401,0.00009868308,0.00023128626,0.000043534015,0.98373574,0.0000011889579,0.0000055382493,0.0055557513],"study_design_scores_gemma":[0.012049066,0.00053207466,0.014007312,0.00014188877,0.00022285806,0.000032365708,0.000022471622,0.026260933,0.94623417,0.000002522118,0.00030439277,0.00018996501],"about_ca_topic_score_codex":0.000013149138,"about_ca_topic_score_gemma":2.123048e-7,"teacher_disagreement_score":0.037501566,"about_ca_system_score_codex":0.00010780496,"about_ca_system_score_gemma":0.00051771005,"threshold_uncertainty_score":0.73374486},"labels":[],"label_agreement":null},{"id":"W3095935119","doi":"10.1182/blood-2020-139358","title":"Model Based Approach to Evaluate Isatuximab Monthly Dosing Regimen in Relapsed/Refractory Multiple Myeloma Patients","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pomalidomide; Lenalidomide; Medicine; Internal medicine; Regimen; Daratumumab; Oncology; Population; Multiple myeloma; Refractory (planetary science); Dosing; Dexamethasone; Carfilzomib; Gastroenterology","score_opus":0.0510870203777942,"score_gpt":0.28953908191901306,"score_spread":0.23845206154121887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095935119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98967147,0.00015071155,0.00039254798,0.00066546473,0.000026114441,0.00163658,0.000069986294,0.00010452398,0.007282617],"genre_scores_gemma":[0.9829758,0.0000040703126,0.01525267,0.0010951924,0.00006848098,0.00019048687,0.00022261323,0.00006253069,0.00012818007],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9974507,0.00012203549,0.0003705767,0.0006552951,0.00079680275,0.0006045622],"domain_scores_gemma":[0.99853027,0.00008987903,0.0000742007,0.000450123,0.0001433493,0.00071216864],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020363976,0.00028198984,0.00044622415,0.00020511117,0.000082630366,0.00003015378,0.00018252911,0.00012897424,0.000020608752],"category_scores_gemma":[0.0007446379,0.00024689763,0.00012024328,0.00042561014,0.00003665295,0.00009762606,0.000105384344,0.00034721743,0.00010950977],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00899555,0.027053896,0.90087754,0.0006480045,0.0005886084,0.00045461982,0.0043282034,0.01547847,0.015061174,0.000026126918,0.0025337532,0.023954045],"study_design_scores_gemma":[0.06717273,0.00157764,0.18410656,0.00017274747,0.00019107759,0.0000024632889,0.000096476106,0.7395496,0.0063626007,0.00001872612,0.00037548348,0.0003739181],"about_ca_topic_score_codex":0.0001070414,"about_ca_topic_score_gemma":0.000014234352,"teacher_disagreement_score":0.7240711,"about_ca_system_score_codex":0.00015245996,"about_ca_system_score_gemma":0.00024437215,"threshold_uncertainty_score":0.99999833},"labels":[],"label_agreement":null},{"id":"W3095941038","doi":"10.1182/blood-2020-134964","title":"Gene Body Methylation and Transcriptional Activity in ASXL1-Mutant Chronic Myelomonocytic Leukemia","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"","keywords":"DNA methylation; Biology; Methylation; Transcriptome; Epigenetics; Gene; Genetics; Gene expression profiling; Fold change; Gene expression; Molecular biology; Cancer research","score_opus":0.030054851466011286,"score_gpt":0.28587478888961376,"score_spread":0.2558199374236025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095941038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99398154,0.00122996,0.00054501765,0.0030244852,0.000024520437,0.00045971668,0.000017433626,0.000058013073,0.0006592895],"genre_scores_gemma":[0.9982851,0.00033345667,0.0006293189,0.00029075527,0.00030738467,0.000028452165,0.00003257245,0.000026694976,0.00006622739],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99870163,0.00008291251,0.00020328183,0.00037062174,0.0003339983,0.00030752562],"domain_scores_gemma":[0.9994486,0.000066205015,0.000039746566,0.00016429512,0.000043090582,0.00023804644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023142593,0.00015084617,0.00030287256,0.00011485945,0.000047812464,0.000020318992,0.000079917445,0.0001284195,0.00010927937],"category_scores_gemma":[0.00012207801,0.00014263288,0.00005727947,0.00033417763,0.00007337161,0.0001421517,0.00004517689,0.00047867815,0.00004115723],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027288301,0.00011357892,0.0034366634,0.00013073617,0.00008370519,0.00015144146,0.00042282615,0.000024185672,0.9895976,0.00014874998,0.00003400654,0.0055836323],"study_design_scores_gemma":[0.015192655,0.0009135651,0.2770098,0.00006880822,0.00023178438,0.00019006692,0.000061978106,0.020856675,0.6838221,0.00013233726,0.001250988,0.00026926884],"about_ca_topic_score_codex":0.00012088671,"about_ca_topic_score_gemma":0.000027988603,"teacher_disagreement_score":0.3057755,"about_ca_system_score_codex":0.00070402375,"about_ca_system_score_gemma":0.00096989097,"threshold_uncertainty_score":0.58164006},"labels":[],"label_agreement":null},{"id":"W3095944468","doi":"10.1182/blood-2020-142963","title":"Functional Investigation of the Argonaute Proteins in Human Hematopoietic Stem and Progenitor Cells","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Biology; Stem cell; Argonaute; Haematopoiesis; Cell biology; Progenitor cell; Bone marrow; Gene silencing; Immunology; RNA interference; Genetics; Gene; RNA","score_opus":0.028069813523436512,"score_gpt":0.22531756324037788,"score_spread":0.19724774971694137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095944468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99771935,0.00007293203,0.00007366845,0.0010191094,0.000032897307,0.0008313787,0.000005728844,0.00002170331,0.00022325937],"genre_scores_gemma":[0.99924403,0.0000033341814,0.00040146834,0.00016691252,0.00005830323,0.00004442492,0.000006973513,0.000011850754,0.00006271171],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992282,0.00003906985,0.00025476975,0.00015844427,0.00022797646,0.00009156807],"domain_scores_gemma":[0.99967146,0.000026583837,0.00007645301,0.000112521026,0.000035007546,0.00007796447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000092635026,0.00008169252,0.0001563511,0.000031925727,0.00003202624,0.0000058424894,0.000041700594,0.000056140343,0.000019414369],"category_scores_gemma":[0.000009418611,0.00006121071,0.000035611094,0.00018294562,0.00006845553,0.00003227894,0.000015264233,0.00010657855,0.0000058531245],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026560298,0.00009778799,0.134242,0.0010244881,0.000027641414,0.000009196611,0.0024736056,0.000003286019,0.86153245,0.0005021471,0.0000310341,0.00002980064],"study_design_scores_gemma":[0.0021113027,0.00011215139,0.11975056,0.00023891815,0.00010478676,0.00004357931,0.00016857203,0.000034507444,0.8772474,0.00011351804,0.00001813355,0.00005655744],"about_ca_topic_score_codex":0.000007065415,"about_ca_topic_score_gemma":0.0000034213012,"teacher_disagreement_score":0.015714964,"about_ca_system_score_codex":0.000008170652,"about_ca_system_score_gemma":0.000069678936,"threshold_uncertainty_score":0.24961004},"labels":[],"label_agreement":null},{"id":"W3095947961","doi":"10.1182/blood-2020-135899","title":"A Survey to Assess the Educational Needs of Clinicians in Maternal Hematology","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Mount Sinai Hospital; St. Michael's Hospital; Health Sciences Centre; University Health Network","funders":"","keywords":"Family medicine; Medicine; Descriptive statistics; Pregnancy","score_opus":0.09690927371485314,"score_gpt":0.37624842514470963,"score_spread":0.2793391514298565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095947961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9698229,0.0002662951,0.00013578888,0.028326254,0.00007816699,0.00017350134,0.000014654238,0.000007447357,0.0011749902],"genre_scores_gemma":[0.99565715,0.000016301063,0.000116652394,0.003983545,0.000085305015,0.000016302263,0.000012073418,0.0000050743383,0.000107582135],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994354,0.00007640501,0.00021902357,0.00006386656,0.000108804714,0.00009647865],"domain_scores_gemma":[0.9994379,0.00022998355,0.000055040648,0.00012521751,0.000044567198,0.000107247935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027344935,0.00004442087,0.00015739749,0.00004964514,0.000010240062,0.0000023019263,0.00009682091,0.000036498383,0.000147902],"category_scores_gemma":[0.001045889,0.000030507372,0.000025915444,0.00026167132,0.000029865801,0.000015974574,0.000019985235,0.00009550972,0.000038367754],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053087857,0.00027135323,0.99519396,0.000044893633,0.000029383975,0.0000034440786,0.0013400083,9.414904e-7,0.00062890403,0.0005958596,0.0014425723,0.00039557324],"study_design_scores_gemma":[0.0010069673,0.000116721334,0.99412936,0.00012160983,0.000027655604,0.000037341055,0.00018004264,0.000009777938,0.0039223586,0.00004378913,0.00037511415,0.000029292185],"about_ca_topic_score_codex":0.000084740925,"about_ca_topic_score_gemma":0.000043185883,"teacher_disagreement_score":0.025834262,"about_ca_system_score_codex":0.000004730685,"about_ca_system_score_gemma":0.00026352055,"threshold_uncertainty_score":0.1619423},"labels":[],"label_agreement":null},{"id":"W3095967713","doi":"10.1182/blood-2020-134460","title":"Five-Year Follow-Up of Ibrutinib Plus Rituximab Vs Placebo Plus Rituximab for Waldenstrom's Macroglobulinemia: Final Analysis From the Randomized Phase 3 iNNOVATETM Study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; Royal Victoria Regional Health Centre; Ottawa Hospital; Royal Victoria Hospital; University of Ottawa","funders":"","keywords":"Ibrutinib; Rituximab; Macroglobulinemia; Medicine; Waldenstrom macroglobulinemia; Internal medicine; Placebo; Lymphoplasmacytic Lymphoma; Fludarabine; Oncology; Gastroenterology; Lymphoma; Chronic lymphocytic leukemia; Chemotherapy; Cyclophosphamide; Leukemia; Multiple myeloma; Pathology","score_opus":0.03770505700756589,"score_gpt":0.3264207176106549,"score_spread":0.288715660603089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095967713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98794234,0.00079772534,0.0016342711,0.0023548251,0.00016410481,0.0059125614,0.00077358953,0.0001260567,0.00029451252],"genre_scores_gemma":[0.994574,0.000055327753,0.0025087108,0.000597714,0.0006661849,0.00041112164,0.00053940347,0.000079042184,0.0005684842],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99493885,0.00047938916,0.0014359414,0.0009954823,0.001341298,0.0008090342],"domain_scores_gemma":[0.9949857,0.0024606325,0.00041630215,0.0011415896,0.00063207536,0.0003637151],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015919635,0.00052227016,0.0031256003,0.00024074277,0.00021031799,0.00008697096,0.0007841962,0.0002571762,0.00055053376],"category_scores_gemma":[0.0029390021,0.00036680984,0.0011157116,0.001910634,0.00043756203,0.00009829263,0.00040221596,0.00065544335,0.00008986753],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9406231,0.011283048,0.000865171,0.0004905611,0.024454242,0.000928906,0.0100485105,0.00025219913,0.001741647,0.00015989192,0.007979331,0.0011733774],"study_design_scores_gemma":[0.92986387,0.0015284704,0.00008322401,0.00008073978,0.014697443,0.000032704153,0.0023957319,0.045709193,0.0048485934,0.000035612702,0.00040934765,0.00031506666],"about_ca_topic_score_codex":0.0031935407,"about_ca_topic_score_gemma":0.00019688178,"teacher_disagreement_score":0.045456994,"about_ca_system_score_codex":0.001371161,"about_ca_system_score_gemma":0.0054238886,"threshold_uncertainty_score":0.9998784},"labels":[],"label_agreement":null},{"id":"W3095982047","doi":"10.1182/blood-2020-139651","title":"Genome-Wide Association Study Identifies Variation in <i>ABO</i> As Risk Factor for Platelet Reactivity in Heparin-Induced Thrombocytopenia","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Genome-wide association study; Odds ratio; ABO blood group system; Cohort; Immunology; Medicine; Genetic association; Internal medicine; Biology; Genotype; Genetics; Single-nucleotide polymorphism; Gene","score_opus":0.038749492263781264,"score_gpt":0.29217213094038424,"score_spread":0.253422638676603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095982047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99397254,0.000026516884,0.000032073618,0.0012828266,0.00020489036,0.003480697,0.00009172692,0.00012636496,0.00078234536],"genre_scores_gemma":[0.99866164,0.00006022867,0.00015380676,0.00047384758,0.00021503764,0.00024839054,0.000046897407,0.00006784955,0.00007230962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99684006,0.00033734814,0.000837903,0.00085013884,0.0005290343,0.00060551835],"domain_scores_gemma":[0.99797606,0.00074436027,0.00045570705,0.00043092202,0.00015390999,0.00023900782],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00091785967,0.00037679158,0.0011965992,0.0002392807,0.00013660219,0.00011129569,0.00023248536,0.00033981373,0.00011879002],"category_scores_gemma":[0.0031412123,0.00038927275,0.00017127478,0.0007496575,0.00001555416,0.00048789906,0.00013058481,0.0006956053,0.00015134635],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029189125,0.0023511997,0.755441,0.00006651667,0.00035241334,0.000057455214,0.00823762,0.0000058283945,0.23284821,0.000013161849,0.000014367061,0.0003203039],"study_design_scores_gemma":[0.012407707,0.0011143603,0.9341801,0.00004013108,0.00037215193,0.000003180609,0.00068563764,0.00005477328,0.050360937,0.00019861915,0.00022658032,0.0003558453],"about_ca_topic_score_codex":0.0020345747,"about_ca_topic_score_gemma":0.0028244806,"teacher_disagreement_score":0.18248728,"about_ca_system_score_codex":0.000486501,"about_ca_system_score_gemma":0.000295926,"threshold_uncertainty_score":0.99985594},"labels":[],"label_agreement":null},{"id":"W3095988575","doi":"10.1182/blood-2020-137213","title":"Platelet Membrane Procoagulation in Preeclampsia","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Pregnancy and preeclampsia studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Platelet; Preeclampsia; Platelet activation; Medicine; Internal medicine; Endocrinology; Pathophysiology; Mean platelet volume; Andrology; Immunology; Pregnancy; Biology","score_opus":0.02951884712008059,"score_gpt":0.2558051089843208,"score_spread":0.2262862618642402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095988575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97722644,0.0013318049,0.000039899267,0.0049132006,0.000036248955,0.00061913586,0.0000031188918,0.00011716384,0.015712965],"genre_scores_gemma":[0.99835294,0.00008702983,0.00067431835,0.0006064139,0.0001348561,0.000043047294,0.000013278023,0.000011581946,0.00007654754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99933517,0.000020924392,0.00016690714,0.00019141722,0.00013206045,0.00015352787],"domain_scores_gemma":[0.9997331,0.000027712325,0.00003361384,0.00011537124,0.000018826218,0.00007140103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005621219,0.00009432271,0.00020983348,0.000031932726,0.000027813925,0.0000057012253,0.00004916297,0.00006385538,0.000052804447],"category_scores_gemma":[0.00009833959,0.00008315612,0.000040284594,0.00018873844,0.000023246395,0.00006321921,0.000033012984,0.00014188602,0.00004516205],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072373217,0.0018653133,0.9197165,0.0017548315,0.0004488661,0.00072530453,0.016460732,0.0000638958,0.04406092,0.001379822,0.0014771684,0.011322953],"study_design_scores_gemma":[0.022460403,0.0012401586,0.79442275,0.0008672333,0.00032677624,0.00009683226,0.0003496661,0.00080740143,0.16426149,0.0006978612,0.013937134,0.0005322954],"about_ca_topic_score_codex":0.000007217001,"about_ca_topic_score_gemma":0.000009521114,"teacher_disagreement_score":0.12529372,"about_ca_system_score_codex":0.0000068358613,"about_ca_system_score_gemma":0.0000308997,"threshold_uncertainty_score":0.3391008},"labels":[],"label_agreement":null},{"id":"W3096010167","doi":"10.1182/blood-2020-143358","title":"Association between Pre-Infusion Laboratory Characteristics and Hematologic Response in Patients Treated for Iron-Deficiency at a Tertiary Care Center","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Transferrin saturation; Anemia; Hemoglobin; Ferritin; Iron deficiency; Gastroenterology; Serum iron; Total iron-binding capacity; Iron-deficiency anemia; Internal medicine; Kidney disease; Surgery","score_opus":0.007207267055436438,"score_gpt":0.2331667474587027,"score_spread":0.22595948040326624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096010167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99825877,0.00028130325,0.0000035747012,0.0004409811,0.000029871688,0.0005798153,0.0003416942,0.000034131543,0.000029846107],"genre_scores_gemma":[0.99894077,0.000030404417,0.00006914072,0.00048059857,0.000038295962,0.000022528375,0.00037149782,0.0000138311425,0.000032911834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99918413,0.00007935492,0.00021459576,0.0002048705,0.00013969593,0.000177376],"domain_scores_gemma":[0.9995633,0.000075729826,0.00010040317,0.00009031529,0.00008338754,0.00008686849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000100106496,0.000106996624,0.00022863274,0.00005121721,0.000051158127,0.000008504694,0.000034373526,0.00011590778,0.000010186206],"category_scores_gemma":[0.0005125998,0.00009289461,0.000029834033,0.000104060324,0.000013892573,0.000043155793,0.000041123563,0.00007025965,0.000005865474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091160147,0.00023684595,0.99483335,0.00027730232,0.0000059492295,0.000004339673,0.0018879686,3.4970792e-8,0.0014855461,7.562871e-7,0.00012993145,0.0002263846],"study_design_scores_gemma":[0.008110657,0.0004072363,0.9895013,0.000030149822,0.00019186725,3.2130868e-7,0.0001235499,0.0000031813347,0.0012056496,0.000001100621,0.0003344717,0.00009049314],"about_ca_topic_score_codex":0.000004437385,"about_ca_topic_score_gemma":0.0000018523164,"teacher_disagreement_score":0.007199056,"about_ca_system_score_codex":0.000048032565,"about_ca_system_score_gemma":0.000031512278,"threshold_uncertainty_score":0.37881324},"labels":[],"label_agreement":null},{"id":"W3096017746","doi":"10.1182/blood-2020-139727","title":"Patient Experiences with Liposomal Daunorubicin and Cytarabine (CPX-351) Versus Conventional Induction Regimens: An Analysis of Patient-Reported Outcomes Data from a Prospective Trial","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Randomized controlled trial; Internal medicine; Quality of life (healthcare); Hospital Anxiety and Depression Scale; Cytarabine; Anxiety; Physical therapy; Chemotherapy; Psychiatry","score_opus":0.058997978597421785,"score_gpt":0.3198419281657854,"score_spread":0.2608439495683636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096017746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979811,0.00011838037,0.00003768719,0.0004967595,0.00009204053,0.000999949,0.00016704458,0.00004379696,0.0000632833],"genre_scores_gemma":[0.99725837,0.000010410135,0.0011990754,0.00007696712,0.00013279507,0.0000930318,0.0012010648,0.00001764175,0.000010628938],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976828,0.00011020141,0.00050218083,0.0007193374,0.00077869464,0.00020676041],"domain_scores_gemma":[0.99845815,0.00012074512,0.00032845256,0.0006386571,0.00022069768,0.00023328498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012157554,0.00019098521,0.0006154942,0.00019228777,0.00007157787,0.000025699677,0.00015428549,0.00008908733,0.00019361767],"category_scores_gemma":[0.00046146632,0.00014028474,0.000076075274,0.00075403193,0.00022335806,0.0002964015,0.00018686097,0.00022030163,0.0000020376413],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22349505,0.0051327227,0.69334626,0.00006238794,0.02326712,0.00048003506,0.041242585,0.000034777415,0.010595248,0.000064021,0.0002950563,0.0019847201],"study_design_scores_gemma":[0.37322652,0.047235485,0.41239735,0.00013417371,0.020809958,0.00005758221,0.09546379,0.008029738,0.04157238,0.000022508426,0.00022686168,0.0008236545],"about_ca_topic_score_codex":0.00077974214,"about_ca_topic_score_gemma":0.00010735411,"teacher_disagreement_score":0.28094894,"about_ca_system_score_codex":0.00006342952,"about_ca_system_score_gemma":0.00029641346,"threshold_uncertainty_score":0.5720646},"labels":[],"label_agreement":null},{"id":"W3096033732","doi":"10.1182/blood-2020-141389","title":"Perturbations in <i>HNRNPH1</i> Splicing and Abundance Affect Global Splicing and Proliferation in Mantle Cell Lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia; Simon Fraser University","funders":"","keywords":"RNA splicing; Minigene; Biology; Alternative splicing; Gene knockdown; Splicing factor; Gene; Exonic splicing enhancer; Genetics; RNA; Cell biology; Cancer research; Messenger RNA; Computational biology","score_opus":0.008286941470637537,"score_gpt":0.23895631368094414,"score_spread":0.2306693722103066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096033732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99739313,0.0012260057,0.00021057029,0.00039602543,0.0000094763145,0.0002229688,0.0000067803203,0.0000069567573,0.0005280856],"genre_scores_gemma":[0.99888074,0.00026417116,0.00034000006,0.0003301087,0.00007627385,0.000017074324,0.000016166008,0.000008862783,0.00006662442],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999254,0.00004285924,0.00013044945,0.00028837344,0.0000785567,0.00020579452],"domain_scores_gemma":[0.9997619,0.000012293811,0.000026930766,0.00009357737,0.00001570135,0.00008963254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011099636,0.00009678774,0.000109693414,0.000024424658,0.000052077827,0.000042760847,0.00005957091,0.000069836045,0.0000011405873],"category_scores_gemma":[0.00006668644,0.00009696451,0.00001647906,0.0001285231,0.000028042188,0.000009031864,0.00007762842,0.00005486467,0.0000015357582],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045243083,0.000091490336,0.22564803,0.000068110894,0.000006223456,0.000014987588,0.00015365132,0.000045275527,0.77247643,0.000049331113,0.000038808867,0.0013624443],"study_design_scores_gemma":[0.009306189,0.0008104329,0.38891757,0.00013207641,0.000026215203,0.00007875358,0.00045232355,0.01153654,0.58765936,0.00009926753,0.0005043081,0.00047697133],"about_ca_topic_score_codex":0.000121182,"about_ca_topic_score_gemma":0.00042877247,"teacher_disagreement_score":0.18481705,"about_ca_system_score_codex":0.000012169502,"about_ca_system_score_gemma":0.00004356759,"threshold_uncertainty_score":0.3954098},"labels":[],"label_agreement":null},{"id":"W3096039995","doi":"10.1182/blood-2020-136673","title":"Real-World Clinical Outcomes of Patients with Myelofibrosis Treated with Ruxolitinib: Evidence from a Multinational Medical Record Review","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ruxolitinib; Medicine; Myelofibrosis; Cytopenia; Internal medicine; Myeloproliferative neoplasm; Constitutional symptoms; Transplantation; International Prognostic Scoring System; Pediatrics; Bone marrow; Myelodysplastic syndromes","score_opus":0.05009325928629455,"score_gpt":0.33947530763554246,"score_spread":0.2893820483492479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096039995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99062246,0.00075065065,0.000015999942,0.0069837705,0.000021668753,0.0010388232,0.00014712183,0.00005838059,0.00036110004],"genre_scores_gemma":[0.97961396,0.006766364,0.009446708,0.0033821687,0.00013448637,0.00019415411,0.0003623854,0.00003850685,0.00006125117],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99733096,0.00017075535,0.00079079455,0.00051613175,0.0009843638,0.00020701082],"domain_scores_gemma":[0.99724835,0.0012337754,0.000337733,0.00029757508,0.0004152547,0.0004672846],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001949051,0.00025592023,0.0010454657,0.000044992063,0.000042143623,0.0000085338,0.00012226617,0.00008399905,0.00094206474],"category_scores_gemma":[0.0013522271,0.00015048748,0.00016221737,0.00032897326,0.0001336605,0.00008373728,0.00004873922,0.00021175164,0.000035507946],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070873555,0.0024154051,0.98851514,0.00029456525,0.00078371586,0.00007079658,0.000058887577,8.0631054e-8,0.000002969987,0.000026174226,0.0005483847,0.006575171],"study_design_scores_gemma":[0.009566598,0.0028568085,0.9778076,0.007210951,0.0014692979,0.0000020624582,0.000007238217,0.000015260537,0.000491391,0.0000026142295,0.00041484038,0.00015538509],"about_ca_topic_score_codex":0.00041480016,"about_ca_topic_score_gemma":0.00023761965,"teacher_disagreement_score":0.0110085085,"about_ca_system_score_codex":0.000026715441,"about_ca_system_score_gemma":0.00027333674,"threshold_uncertainty_score":0.9999712},"labels":[],"label_agreement":null},{"id":"W3096049589","doi":"10.1182/blood-2020-141029","title":"Daratumumab (DARA) Plus Carfilzomib, Pomalidomide, Dexamethasone (KPd) in Lenalidomide Refractory Multiple Myeloma (MM): A Multi-Center MMRC Study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Daratumumab; Pomalidomide; Carfilzomib; Medicine; Lenalidomide; Internal medicine; Cohort; Population; Refractory (planetary science); Regimen; Oncology; Dexamethasone; Surgery","score_opus":0.06429584796946747,"score_gpt":0.3207606016718996,"score_spread":0.25646475370243216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096049589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99328035,0.0011113359,0.00008090464,0.0007551741,0.00014225392,0.0032820592,0.00013847918,0.00022225278,0.0009872073],"genre_scores_gemma":[0.9947301,0.000086542146,0.003149007,0.00055774435,0.00033344762,0.0003825246,0.00015668634,0.00012671806,0.00047722168],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952743,0.00049379776,0.0008865161,0.001192521,0.0010293622,0.0011235189],"domain_scores_gemma":[0.9973552,0.00035288776,0.0001992667,0.00086420315,0.0002056709,0.0010227662],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046011427,0.00062124344,0.0012213713,0.00036326237,0.0001804078,0.00008681075,0.00040134735,0.00023105509,0.00020990445],"category_scores_gemma":[0.0015856207,0.0005366636,0.00030282114,0.00075529504,0.00014225628,0.00026602967,0.00033269895,0.0009395151,0.0004320392],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0083136745,0.022959769,0.9328772,0.00023996331,0.0013419767,0.010436678,0.0040101856,0.000016280535,0.014964823,0.0000050335384,0.000528035,0.0043063816],"study_design_scores_gemma":[0.3273273,0.0041883066,0.64432096,0.00028279284,0.0005310238,0.00025215646,0.0026409526,0.0033249096,0.013503082,0.000004737688,0.0028215735,0.00080221257],"about_ca_topic_score_codex":0.0010012793,"about_ca_topic_score_gemma":0.0012542024,"teacher_disagreement_score":0.31901363,"about_ca_system_score_codex":0.0003117721,"about_ca_system_score_gemma":0.00040023265,"threshold_uncertainty_score":0.9997085},"labels":[],"label_agreement":null},{"id":"W3096052786","doi":"10.1182/blood-2020-139438","title":"Health-Related Quality of Life in Patients with AL Amyloidosis Treated with Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone: Results from the Phase 3 Andromeda Study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Daratumumab; Bortezomib; Dexamethasone; Medicine; Cyclophosphamide; AL amyloidosis; Internal medicine; Amyloidosis; Andromeda; Melphalan; Oncology; Multiple myeloma; Immunology; Chemotherapy; Antibody","score_opus":0.017095349420484168,"score_gpt":0.26998010478609935,"score_spread":0.25288475536561517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096052786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954645,0.0013824642,0.0000028773816,0.0011500214,0.000015612759,0.0011770573,0.0007441367,0.000022108441,0.000041215633],"genre_scores_gemma":[0.9980791,0.00019283383,0.00017909214,0.0007647565,0.000017272678,0.00007403739,0.0006454258,0.00003770008,0.000009759969],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976765,0.00025679596,0.00075092295,0.0007193985,0.00029981212,0.00029660278],"domain_scores_gemma":[0.9984838,0.00015845163,0.00051083526,0.0005276336,0.00009033218,0.00022899875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002657112,0.00032413527,0.00065795024,0.000032032312,0.00009826021,0.000024335171,0.00020581581,0.000108526496,0.000007318949],"category_scores_gemma":[0.00032386082,0.00020701741,0.000054599714,0.00035035645,0.00015308769,0.000011139363,0.00010554544,0.00015917461,0.0000014306544],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005211211,0.0042278604,0.9873188,0.000012288623,0.00084617274,0.000009944624,0.00082662154,0.000008659948,0.0004633464,9.2511596e-7,0.00027197227,0.00080215465],"study_design_scores_gemma":[0.059336007,0.00588058,0.9295233,0.00003616261,0.00017413062,7.773135e-7,0.0005110037,0.0000031309057,0.0042277817,0.0000010728921,0.000069909926,0.00023617949],"about_ca_topic_score_codex":0.0041183205,"about_ca_topic_score_gemma":0.0014805467,"teacher_disagreement_score":0.057795577,"about_ca_system_score_codex":0.000017794031,"about_ca_system_score_gemma":0.00012554257,"threshold_uncertainty_score":0.8441925},"labels":[],"label_agreement":null},{"id":"W3096057643","doi":"10.1182/blood-2020-136122","title":"Allogeneic Transplant Can Abrogate the Relapse Risk in the Patients with Detectable Measureable Residual Disease By Multicolor Flow-Cytometry at the Time of Assessment of Acute Myeloid Leukemia Patients in First Remission","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Cumulative incidence; Internal medicine; Hazard ratio; Minimal residual disease; Proportional hazards model; Oncology; Myeloid leukemia; Multivariate analysis; Leukemia; Transplantation; Confidence interval","score_opus":0.00862299265594178,"score_gpt":0.23770799243929946,"score_spread":0.2290849997833577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096057643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995145,0.00018362483,0.000007571951,0.0015323843,0.000016410988,0.0020061405,0.00095356285,0.0000158029,0.00013945322],"genre_scores_gemma":[0.9985207,0.00031931905,0.00020644745,0.00030856018,0.000023352984,0.00013053248,0.00031844122,0.0000450206,0.00012764975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99647,0.00056642416,0.00059862714,0.0004488042,0.0014135808,0.0005025814],"domain_scores_gemma":[0.99809355,0.0004922339,0.00028031637,0.0007069653,0.00018633927,0.0002405906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009093969,0.00028448037,0.0004794175,0.00011538195,0.00019263601,0.000016633177,0.0005916123,0.00012359978,0.000060148253],"category_scores_gemma":[0.0003631879,0.0001336737,0.0001010792,0.0009142306,0.00021872907,0.00007238026,0.00015993672,0.0007402416,0.0000071756854],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034566678,0.0011010112,0.9815533,0.00018786309,0.00033096178,0.000066614004,0.002542772,0.00048125949,0.008418685,5.8027007e-7,0.0015998014,0.00026047815],"study_design_scores_gemma":[0.01837621,0.0012525197,0.9557406,0.00033305085,0.00097338966,0.00000398197,0.00016816406,0.0028734615,0.019779777,0.0000028022794,0.00030324265,0.00019281755],"about_ca_topic_score_codex":0.0008877598,"about_ca_topic_score_gemma":0.0005142671,"teacher_disagreement_score":0.025812725,"about_ca_system_score_codex":0.00050601043,"about_ca_system_score_gemma":0.00067870674,"threshold_uncertainty_score":0.5451056},"labels":[],"label_agreement":null},{"id":"W3096060853","doi":"10.1182/blood-2020-140310","title":"Sustained Reductions in Red Blood Cell (RBC) Transfusion Burden and Events in β-Thalassemia with Luspatercept: Longitudinal Results of the Believe Trial","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Thalassemia; Medicine; Beta thalassemia; Blood transfusion; Red blood cell; Internal medicine","score_opus":0.00996976429400253,"score_gpt":0.22131313300304867,"score_spread":0.21134336870904613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096060853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98968345,0.00022212307,0.0000022629033,0.007718408,0.000058608097,0.0010815347,0.000011025995,0.000017952043,0.0012046628],"genre_scores_gemma":[0.9991443,0.00036873057,0.000079243626,0.000035282574,0.00009944868,0.000017437409,0.000012661588,0.000018368612,0.0002245008],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9987207,0.000090701345,0.00041783796,0.00031252974,0.00023623544,0.00022197259],"domain_scores_gemma":[0.99952626,0.000029052935,0.0000950355,0.00020171666,0.000047360354,0.00010057464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001744761,0.00014749571,0.0003087207,0.00008759975,0.00004824743,0.0000041857343,0.00008570822,0.00015999033,0.000014338378],"category_scores_gemma":[0.000101388876,0.00009622656,0.000061577295,0.000562211,0.00007592601,0.000041742926,0.000048922328,0.00036519003,9.990091e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21232635,0.011788783,0.42386335,0.0017972791,0.0007978641,0.0010854614,0.060572773,0.00096426246,0.28312233,0.00005155443,0.00069935556,0.0029306214],"study_design_scores_gemma":[0.7409424,0.008130815,0.18887188,0.0015543681,0.0017199618,0.00023844406,0.013374062,0.00025371552,0.043931857,0.000105930696,0.00034115187,0.00053537934],"about_ca_topic_score_codex":0.00047594993,"about_ca_topic_score_gemma":0.00021050447,"teacher_disagreement_score":0.5286161,"about_ca_system_score_codex":0.00001760926,"about_ca_system_score_gemma":0.00014338388,"threshold_uncertainty_score":0.39240053},"labels":[],"label_agreement":null},{"id":"W3096085400","doi":"10.1182/blood-2020-142115","title":"Impact of Daratumumab on Stem Cell Collection, Graft Composition and Engraftment Among Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplant","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Autologous stem-cell transplantation; Daratumumab; Medicine; Multiple myeloma; Stem cell; Transplantation; Bortezomib; Internal medicine; Hematopoietic stem cell transplantation; Oncology; Biology","score_opus":0.016397252140872773,"score_gpt":0.24665487965510838,"score_spread":0.23025762751423562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096085400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977132,0.00019343915,0.00005148538,0.00004857743,0.000035586887,0.0011486782,0.00017311375,0.00006919014,0.0005666918],"genre_scores_gemma":[0.9993719,0.00010083328,0.00014215942,0.000026277938,0.000027391989,0.00004104451,0.0001822833,0.00003130036,0.000076837976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840754,0.000119512966,0.00033423147,0.00038507706,0.00040949817,0.00034413024],"domain_scores_gemma":[0.9989922,0.00017303866,0.00013807324,0.0001926066,0.00010181745,0.00040228784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000054546825,0.00025405045,0.00040901618,0.00012803415,0.0001741802,0.000023837918,0.00006663873,0.00010326066,0.00001647122],"category_scores_gemma":[0.000005988175,0.00020204384,0.00015165424,0.00022003922,0.000060811693,0.00007028195,0.00002785634,0.00019180807,0.000014102421],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020547411,0.004109279,0.9725937,0.00049779227,0.00047263023,0.00021451882,0.0021499724,0.000054282355,0.016005827,0.000001959658,0.00012630259,0.0017189878],"study_design_scores_gemma":[0.024683489,0.007851668,0.8151063,0.0001715989,0.00029527443,0.000017828641,0.0001557045,0.0014002114,0.15014333,0.0000012032776,0.00000675144,0.0001667003],"about_ca_topic_score_codex":0.00012691342,"about_ca_topic_score_gemma":0.000035883877,"teacher_disagreement_score":0.15748747,"about_ca_system_score_codex":0.00012515624,"about_ca_system_score_gemma":0.00011670286,"threshold_uncertainty_score":0.8239109},"labels":[],"label_agreement":null},{"id":"W3096086145","doi":"10.1182/blood-2020-141478","title":"Urgent Transfusion in a New Patient with Rare Blood Type","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Canadian Blood Services; University of Toronto","funders":"","keywords":"Medicine; Antibody; Blood type (non-human); Cord blood; Blood transfusion; Internal medicine; Surgery; Immunology; Blood typing","score_opus":0.014383164340162156,"score_gpt":0.20856607950195888,"score_spread":0.19418291516179673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096086145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927582,0.0009100673,0.00006345486,0.003943345,0.000046919078,0.0005424839,0.0000040316213,0.0000715894,0.0016599118],"genre_scores_gemma":[0.99701625,0.00027439767,0.0009176415,0.0015363528,0.00013351662,0.000006797577,0.000022108445,0.000029041576,0.000063886546],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99900204,0.000019034343,0.00020716414,0.0003001406,0.00025918963,0.00021242241],"domain_scores_gemma":[0.999355,0.0000117605205,0.00002653948,0.00016385215,0.000038256454,0.00040458812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000030648265,0.00015151392,0.00025898905,0.000052101754,0.00003080468,0.000009056072,0.000051284016,0.00008000518,0.00038561292],"category_scores_gemma":[0.00002036968,0.000111665606,0.00005909274,0.0004146829,0.0000148876925,0.00004280785,0.000013630396,0.00021440229,0.000027549195],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009042258,0.018317325,0.5484994,0.0012953075,0.0011929892,0.011699352,0.029754901,0.00006214834,0.30105165,0.0007709585,0.0025956447,0.07571806],"study_design_scores_gemma":[0.16235319,0.047766533,0.18028423,0.0027770335,0.006674913,0.0026001607,0.002076672,0.00030930212,0.5294242,0.0001662047,0.06356026,0.0020073233],"about_ca_topic_score_codex":0.00019124184,"about_ca_topic_score_gemma":0.00016218332,"teacher_disagreement_score":0.36821517,"about_ca_system_score_codex":0.0000057145076,"about_ca_system_score_gemma":0.0002119192,"threshold_uncertainty_score":0.45535913},"labels":[],"label_agreement":null},{"id":"W3096089485","doi":"10.1182/blood-2020-142237","title":"Characteristics of Hepatic Veno-Occlusive Disease from the Cell Therapy Transplant Canada Registry: A Retrospective Observational Study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Defibrotide; Hepatic veno-occlusive disease; Incidence (geometry); Retrospective cohort study; Internal medicine; Pediatrics; Transplantation; Hematopoietic stem cell transplantation","score_opus":0.033346943397106255,"score_gpt":0.24310430253046525,"score_spread":0.209757359133359,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096089485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951968,0.00016768958,0.000083379055,0.0021643166,0.00006688774,0.0008611049,0.001322801,0.000018374749,0.00011864676],"genre_scores_gemma":[0.9981646,0.000098706405,0.00008181754,0.0010418524,0.00016409479,0.000031195475,0.0003788903,0.00001954471,0.000019322955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987408,0.000074097195,0.000322241,0.00023318476,0.00050367415,0.00012598696],"domain_scores_gemma":[0.99910146,0.00021085932,0.00015284804,0.00026288885,0.00011284778,0.00015912393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006874571,0.00013835705,0.00029919218,0.00000915367,0.000057936908,0.000008261513,0.00013194392,0.000029678236,0.000089067085],"category_scores_gemma":[0.00006384139,0.00010103405,0.000055427554,0.00013844325,0.000034213543,0.00002271392,0.000008165325,0.00014067779,0.0000028088516],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049173716,0.00074657873,0.9882767,0.00012053559,0.00019174002,0.00034355148,0.005806455,0.0000013243737,0.0038499013,0.000017870354,0.00013252167,0.000021041034],"study_design_scores_gemma":[0.0037129791,0.00029907541,0.9881781,0.00009763259,0.0005978302,0.000004033545,0.0005152068,0.00009239965,0.006296661,0.000020323976,0.00008878681,0.00009701543],"about_ca_topic_score_codex":0.03643119,"about_ca_topic_score_gemma":0.007428033,"teacher_disagreement_score":0.029003158,"about_ca_system_score_codex":0.000037796366,"about_ca_system_score_gemma":0.0007474313,"threshold_uncertainty_score":0.9699853},"labels":[],"label_agreement":null},{"id":"W3096094789","doi":"10.1182/blood-2020-142202","title":"Acquired Amegakaryocytic Thrombocytopenic Purpura Associated with a Paroxysmal Nocturnal Hemoglobinuria Clone: A Case Report and Review of the Literature","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"South Bruce Grey Health Centre; London Health Sciences Centre; Western University","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Medicine; Bone marrow; Hepatosplenomegaly; Pathology; Immunology; Bone marrow examination; Population; Gastroenterology; Internal medicine","score_opus":0.013036034083405895,"score_gpt":0.24509747703253024,"score_spread":0.23206144294912434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096094789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9586901,0.037269473,7.149433e-7,0.00284201,0.000025540314,0.00072633906,0.00003979135,0.00002653453,0.0003795039],"genre_scores_gemma":[0.9953236,0.00198315,0.00011960788,0.0023052474,0.000034241453,0.000018910288,0.000058600006,0.000019069226,0.00013759604],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9989309,0.000056878867,0.00031446887,0.00026520054,0.00024962233,0.0001829456],"domain_scores_gemma":[0.9991802,0.000031821543,0.00025294878,0.00027755168,0.00011317477,0.00014428695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010495713,0.00018405808,0.0005844584,0.000016196984,0.00006977685,0.000021788117,0.00006770782,0.00008177143,0.000035675093],"category_scores_gemma":[0.00028697308,0.000099758916,0.00011090046,0.0004200997,0.00007728369,0.00006745496,0.00005197726,0.0001564533,0.0000018045417],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060947106,0.0019267707,0.07763963,0.0074657756,0.0034134965,0.9004008,0.0019182388,6.172768e-7,0.0024530268,0.000024250707,0.0031676423,0.0009802646],"study_design_scores_gemma":[0.02954875,0.002395842,0.06247224,0.028223356,0.007700536,0.8630386,0.00017675554,0.000047675985,0.0049002655,0.00007119235,0.0008961126,0.00052865705],"about_ca_topic_score_codex":0.000018754814,"about_ca_topic_score_gemma":0.000010986658,"teacher_disagreement_score":0.037362196,"about_ca_system_score_codex":0.000024319632,"about_ca_system_score_gemma":0.00017714407,"threshold_uncertainty_score":0.40680507},"labels":[],"label_agreement":null},{"id":"W3096104154","doi":"10.1182/blood-2020-138855","title":"Patient Satisfaction with Quality of Care of a New Multidisciplinary Thrombosis Service","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Patient Satisfaction in Healthcare","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. John’s Health Sciences Centre; Memorial University of Newfoundland","funders":"","keywords":"Medicine; Patient satisfaction; Family medicine; Multidisciplinary approach; Pharmacist; Thrombosis; Medical emergency; Emergency medicine; Pharmacy; Nursing; Surgery","score_opus":0.13415235029308525,"score_gpt":0.43072930135974163,"score_spread":0.2965769510666564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096104154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99628174,0.00015247757,0.00008976255,0.0014900883,0.00017274295,0.0009874173,0.00020143982,0.00007618107,0.000548159],"genre_scores_gemma":[0.9970104,0.000020082129,0.002429752,0.00035042007,0.000073717485,0.00005663475,0.000029339342,0.000023824843,0.000005792569],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99779296,0.00043678243,0.00084668613,0.0002700881,0.000416612,0.00023685233],"domain_scores_gemma":[0.99785167,0.00026842114,0.00080024026,0.00031934265,0.0005399948,0.00022030287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009291742,0.0001434734,0.00041731936,0.00005004578,0.0002073548,0.0000011048746,0.00007431481,0.00015202707,0.00021854104],"category_scores_gemma":[0.0001177674,0.00012302824,0.000054924305,0.0004088278,0.00002837243,0.00011390012,0.000103064114,0.00033485325,0.000033934393],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019559465,0.00004239916,0.93318176,0.0027892524,0.00004865199,3.8390414e-7,0.0604368,0.000045892597,0.002156676,0.0000898212,0.00010057161,0.00091220264],"study_design_scores_gemma":[0.0020187867,0.00071957626,0.966003,0.00041214112,0.00006071603,2.5809086e-7,0.02832247,0.000013604158,0.0022590903,0.000034500892,0.000038888662,0.00011694588],"about_ca_topic_score_codex":0.015567787,"about_ca_topic_score_gemma":0.006478803,"teacher_disagreement_score":0.032821268,"about_ca_system_score_codex":0.00006291194,"about_ca_system_score_gemma":0.0005190176,"threshold_uncertainty_score":0.99098766},"labels":[],"label_agreement":null},{"id":"W3096104260","doi":"10.1182/blood-2020-134853","title":"Impact of Thromboembolism on Overall and Event-Free Survival in Children with Acute Lymphoblastic","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; McMaster University; McMaster Children's Hospital; Hospital for Sick Children; Izaak Walton Killam Health Centre; Université Laval","funders":"","keywords":"Medicine; Hazard ratio; Proportional hazards model; Common Terminology Criteria for Adverse Events; Cancer; Internal medicine; Cohort; Pediatrics; Acute lymphocytic leukemia; Population; Confidence interval; Cancer registry; Univariate analysis; Malignancy; Survival analysis; Retrospective cohort study; Surgery; Leukemia; Multivariate analysis; Lymphoblastic Leukemia","score_opus":0.011891208632257847,"score_gpt":0.27440576640834696,"score_spread":0.2625145577760891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096104260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99819845,0.00006414874,0.000046887413,0.00038639051,0.000012181181,0.00044876826,0.000079894824,0.00003123827,0.0007320348],"genre_scores_gemma":[0.9992735,0.000064404274,0.0002624432,0.00018419273,0.00011959092,0.000009074171,0.000022932833,0.00003795465,0.000025920881],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850976,0.000048656097,0.00023347347,0.00033894222,0.0005244721,0.0003447095],"domain_scores_gemma":[0.9990907,0.00011566095,0.00006916114,0.00037473408,0.000056873003,0.00029288293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000093623414,0.00020647082,0.00052307814,0.00010952592,0.000021619044,0.000012987338,0.00018936387,0.00009189218,0.000060540813],"category_scores_gemma":[0.00022251958,0.00014207006,0.00007674696,0.00027954872,0.00011605603,0.00006375126,0.00014852572,0.00020389822,0.000014198463],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002016305,0.0011621729,0.9813642,0.00007946055,0.0019753915,0.00034561925,0.0005142886,0.00008430918,0.01126115,0.0002410356,0.0006433891,0.00031269906],"study_design_scores_gemma":[0.026326684,0.0038547318,0.9663922,0.000118980104,0.0003335836,0.00031089285,0.0000150022315,0.0005130133,0.0019206575,0.00006933439,0.0000025937647,0.00014232204],"about_ca_topic_score_codex":0.00034589312,"about_ca_topic_score_gemma":0.000012042532,"teacher_disagreement_score":0.02431038,"about_ca_system_score_codex":0.00013744837,"about_ca_system_score_gemma":0.0006610692,"threshold_uncertainty_score":0.57934487},"labels":[],"label_agreement":null},{"id":"W3096107020","doi":"10.1182/blood-2020-142859","title":"A Phase I Pharmacokinetic (PK) and Safety Study of Trph-222 in Patients with Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (R/R NHL): Dose-Escalation Results","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Tolerability; Pharmacokinetics; Adverse effect; Population; Internal medicine; Gastroenterology; Phases of clinical research; Pharmacodynamics; Refractory (planetary science); Antibody-drug conjugate; Diffuse large B-cell lymphoma; Toxicity; Pharmacology; Lymphoma; Urology; Antibody; Immunology; Monoclonal antibody","score_opus":0.02164718382084827,"score_gpt":0.31118856560637054,"score_spread":0.28954138178552224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096107020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99582136,0.00015608063,0.0000086519685,0.00027118283,0.000040103143,0.0020063857,0.000066305736,0.000032989275,0.0015969414],"genre_scores_gemma":[0.99934065,0.0000616848,0.00015983901,0.0001382373,0.0000927892,0.000049467897,0.00005453914,0.000045949753,0.00005685661],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99765295,0.00016604537,0.0005967123,0.0005135176,0.00076102786,0.00030974403],"domain_scores_gemma":[0.9989194,0.00012577599,0.00017578085,0.00033556166,0.00015681305,0.00028664386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034032646,0.00020872845,0.0004377323,0.0001724713,0.000042909694,0.000012856952,0.00013068366,0.00008561164,0.000050768493],"category_scores_gemma":[0.00014638626,0.00017598229,0.00003401762,0.0005867367,0.00007543696,0.00009758133,0.000084752566,0.00028164854,0.000011440919],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05690696,0.08120144,0.7523614,0.0009558801,0.00032675825,0.0004093961,0.015229051,0.000050095226,0.0158091,0.0000011714709,0.0010461423,0.075702555],"study_design_scores_gemma":[0.32295108,0.023438124,0.6443825,0.00023189846,0.0002747274,0.0000039497604,0.00050047046,0.0005515712,0.0064812577,0.0000012051655,0.0009640498,0.00021920641],"about_ca_topic_score_codex":0.00016479609,"about_ca_topic_score_gemma":0.000030871917,"teacher_disagreement_score":0.2660441,"about_ca_system_score_codex":0.00008266568,"about_ca_system_score_gemma":0.00020184407,"threshold_uncertainty_score":0.717635},"labels":[],"label_agreement":null},{"id":"W3096107683","doi":"10.1182/blood-2020-138391","title":"Effect of Prior Treatment with Proteasome Inhibitors on the Efficacy and Safety of Once-Weekly Selinexor, Bortezomib, and Dexamethasone in Comparison with Twice-Weekly Bortezomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma: Subgroup Analysis from the Boston Study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary; University of Alberta","funders":"","keywords":"Bortezomib; Medicine; Dexamethasone; Carfilzomib; Internal medicine; Multiple myeloma; Proteasome inhibitor; Oncology; Ixazomib; Refractory (planetary science); Regimen; Pharmacology; Hazard ratio; Gastroenterology; Confidence interval; Biology","score_opus":0.027538245513581347,"score_gpt":0.2955877824111594,"score_spread":0.26804953689757804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096107683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907836,0.0015436347,0.000008700971,0.00075645465,0.000007633768,0.0067568896,0.00009969126,0.000027194037,0.000016218466],"genre_scores_gemma":[0.9985504,0.00022416259,0.0006879993,0.000037093192,0.000043833967,0.00033449774,0.000057326484,0.000048634087,0.000016063726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99608123,0.0011495103,0.00077376823,0.0008433673,0.0007242895,0.00042784275],"domain_scores_gemma":[0.99346733,0.005082542,0.00041699715,0.0006339465,0.00009195736,0.0003072075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009790768,0.0005257288,0.0016491935,0.0002673009,0.0001238935,0.00003397471,0.00015315384,0.00013959147,0.000013335384],"category_scores_gemma":[0.00093250227,0.00023748721,0.0000873856,0.0013081564,0.00038666307,0.00008449215,0.00010282166,0.00052322046,8.081385e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.059498195,0.0060559288,0.90557617,0.00012959601,0.0032714193,0.00026058307,0.005528474,0.000025169868,0.00401187,7.945424e-7,0.000004235657,0.015637588],"study_design_scores_gemma":[0.079508,0.050250154,0.8493633,0.00041595986,0.003163818,0.000010059644,0.002330482,0.0015472502,0.013182924,4.9804095e-7,0.000017488048,0.00021001628],"about_ca_topic_score_codex":0.005330353,"about_ca_topic_score_gemma":0.006550235,"teacher_disagreement_score":0.056212798,"about_ca_system_score_codex":0.00010931844,"about_ca_system_score_gemma":0.00017803459,"threshold_uncertainty_score":0.9684447},"labels":[],"label_agreement":null},{"id":"W3096109600","doi":"10.1182/blood-2020-141235","title":"Outcomes of Adult and Pediatric Patients with Hematologic Malignancies and COVID-19: A Systematic Review and Meta-Analysis of 1847 Patients","year":2020,"lang":"en","type":"review","venue":"Blood","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Meta-analysis; Confidence interval; Internal medicine; Population; Malignancy; Mechanical ventilation; Cancer; Hematologic malignancy","score_opus":0.05717051616713249,"score_gpt":0.3364967403136351,"score_spread":0.2793262241465026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096109600","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029203712,0.9917357,0.0000047847684,0.00023014098,0.00000983792,0.0042620148,0.0008035926,0.000023531242,0.000010016593],"genre_scores_gemma":[0.0014281522,0.99624705,0.00022833576,0.0016244885,0.000007352238,0.00023876452,0.00016919873,0.00003826446,0.000018396804],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9957259,0.0005429198,0.002136132,0.0006413316,0.00075378246,0.00019988016],"domain_scores_gemma":[0.9951919,0.00081398955,0.002626443,0.00063561986,0.00035595975,0.00037609963],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00047249926,0.00060323195,0.016308134,0.00040915015,0.000041328163,0.000014109902,0.00016069906,0.00017025931,0.000025867868],"category_scores_gemma":[0.0030588382,0.0003408084,0.0010269829,0.0010520216,0.0001462272,0.000054173477,0.00016296156,0.00018206243,0.0000010589085],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000058619157,0.00035286063,0.052859526,0.8552452,0.091218255,0.000006189072,0.00022459,1.12333804e-8,1.3406001e-9,0.000016086937,0.00003734395,0.000034119494],"study_design_scores_gemma":[0.0014689104,0.00037643957,0.003258181,0.021290433,0.9728932,0.00001782609,0.00002894254,1.5165617e-7,9.510868e-8,0.000003414433,0.00036920124,0.00029320866],"about_ca_topic_score_codex":0.00006550827,"about_ca_topic_score_gemma":0.000033655673,"teacher_disagreement_score":0.88167495,"about_ca_system_score_codex":0.000022894163,"about_ca_system_score_gemma":0.0002331987,"threshold_uncertainty_score":0.9999044},"labels":[],"label_agreement":null},{"id":"W3096113081","doi":"10.1182/blood-2020-136454","title":"Cardiac Morbidity in Adolescents and Young Adult Survivors of Hodgkin Lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Simon Fraser University; BC Children's Hospital; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"ABVD; Medicine; Dacarbazine; Population; Internal medicine; Cancer registry; Cancer; Vinblastine; Pediatrics; Cohort; Disease; Incidence (geometry); Surgery; Chemotherapy; Vincristine; Cyclophosphamide","score_opus":0.01433556410021618,"score_gpt":0.2350748320817372,"score_spread":0.22073926798152102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096113081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985205,0.00026253308,0.000016234173,0.00025050875,0.00006519528,0.00022436377,0.000012031944,0.000022477147,0.0006261715],"genre_scores_gemma":[0.9992706,0.00017941337,0.00008024133,0.00031008577,0.00012545961,0.000004788326,0.000007891065,0.000011792935,0.000009731639],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993725,0.00003939166,0.00015549097,0.00016478068,0.0001585157,0.000109329434],"domain_scores_gemma":[0.99970174,0.000008361743,0.000042476215,0.00010890678,0.000045969,0.000092563525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008554876,0.00008240465,0.0002630326,0.00003467782,0.000012546395,0.000004395153,0.000031945656,0.00007928676,0.0000035789963],"category_scores_gemma":[0.000078203615,0.0000830534,0.00006814956,0.00015187921,0.000034077468,0.000037517526,0.00001830981,0.00007015964,0.0000024033782],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007433274,0.00019574985,0.65771645,0.00024254077,0.000053037096,0.000015326601,0.000961191,4.1530572e-7,0.33783367,0.000021735757,0.000028827533,0.0028566862],"study_design_scores_gemma":[0.0031705042,0.000086617954,0.53488934,0.000148952,0.000059876023,0.000008693305,0.00017686815,0.000024047344,0.46133333,0.000010926824,0.000028767594,0.00006206388],"about_ca_topic_score_codex":0.0006453708,"about_ca_topic_score_gemma":0.000091647664,"teacher_disagreement_score":0.123499654,"about_ca_system_score_codex":0.000014244335,"about_ca_system_score_gemma":0.000036941332,"threshold_uncertainty_score":0.33868194},"labels":[],"label_agreement":null},{"id":"W3096113916","doi":"10.1182/blood-2020-141183","title":"Hodgkin Variant of Richter's Transformation (HvRT) Among Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Patients in British Columbia (BC), Canada","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Vancouver General Hospital; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Chronic lymphocytic leukemia; Medicine; Internal medicine; Lymphoma; Diffuse large B-cell lymphoma; Population; Incidence (geometry); Hodgkin lymphoma; Gastroenterology; Oncology; Leukemia","score_opus":0.009184156539274162,"score_gpt":0.20205256935341637,"score_spread":0.19286841281414221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096113916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99568635,0.00065457897,0.00005468773,0.000058018286,0.0002018219,0.0017102183,0.00013677064,0.00010934046,0.0013881992],"genre_scores_gemma":[0.9981337,0.0003062341,0.0001715306,0.0004398219,0.0002179951,0.00012433207,0.0002555187,0.00011413315,0.00023669757],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949061,0.00019379126,0.0014516842,0.0008423377,0.0014262929,0.0011797721],"domain_scores_gemma":[0.99770314,0.00021530388,0.00034037096,0.0006567584,0.00033524024,0.0007491905],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036286766,0.0003977149,0.0010969541,0.0001583956,0.00013436303,0.00015800454,0.00056502916,0.00034942705,0.000304686],"category_scores_gemma":[0.00045532116,0.0005729093,0.00022262338,0.0012291148,0.00024336709,0.00029379755,0.00017043544,0.00028823962,0.00003663883],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.005048836,0.007993654,0.5863552,0.03619805,0.006340988,0.044879165,0.01717305,0.019502165,0.0058732405,0.00015725677,0.031670418,0.23880795],"study_design_scores_gemma":[0.34263545,0.002333725,0.43708006,0.0026917993,0.0010886899,0.0013922582,0.0006337145,0.19986592,0.008305455,0.000051519968,0.0023664527,0.0015549742],"about_ca_topic_score_codex":0.97492635,"about_ca_topic_score_gemma":0.9683395,"teacher_disagreement_score":0.3375866,"about_ca_system_score_codex":0.14665338,"about_ca_system_score_gemma":0.13176109,"threshold_uncertainty_score":0.99967223},"labels":[],"label_agreement":null},{"id":"W3096120936","doi":"10.1182/blood-2020-133476","title":"Prevalence of Thrombophilia in Transient Ischemic Attack and Ischemic Stroke Patients","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Hospital; London Health Sciences Centre; Western University","funders":"","keywords":"Thrombophilia; Medicine; Stroke (engine); Patent foramen ovale; Internal medicine; Cardiology; Pediatrics; Thrombosis; Migraine","score_opus":0.016827975590731625,"score_gpt":0.24371082024151455,"score_spread":0.22688284465078293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096120936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808407,0.00059501117,0.00001846136,0.0005796015,0.00002505849,0.00050121866,0.00004646447,0.00002847654,0.017365038],"genre_scores_gemma":[0.99812645,0.00021308038,0.0008342819,0.00042724676,0.000043287888,0.000015251389,0.000013350397,0.000019039395,0.00030799737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988155,0.000012970178,0.00033169056,0.00034143633,0.0002888901,0.00020954612],"domain_scores_gemma":[0.9994934,0.000024019024,0.000087804394,0.00022045519,0.000044701155,0.0001296199],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000063458654,0.00015526485,0.00030451812,0.00005270754,0.0000107572605,0.000003763088,0.000117115575,0.00006877934,0.00008340787],"category_scores_gemma":[0.00008019857,0.00014670358,0.00005831838,0.0001454239,0.00007702015,0.00006063643,0.00009786632,0.00017348549,0.000010879622],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012807177,0.00068474555,0.7141644,0.0018376944,0.00013517406,0.000019777528,0.0012105466,0.0000018076033,0.25249812,0.000002023147,0.0286669,0.00065075356],"study_design_scores_gemma":[0.01570779,0.00095013896,0.6336303,0.00052179635,0.00084104715,0.000012594943,0.00027447927,0.00020137876,0.3302593,4.933537e-7,0.017271314,0.0003293906],"about_ca_topic_score_codex":0.0000054621582,"about_ca_topic_score_gemma":4.6106365e-7,"teacher_disagreement_score":0.080534115,"about_ca_system_score_codex":0.000016502292,"about_ca_system_score_gemma":0.000025857124,"threshold_uncertainty_score":0.59823984},"labels":[],"label_agreement":null},{"id":"W3096121660","doi":"10.1182/blood-2020-141733","title":"Mir-125b Regulates the Self-Renewal of Acute Myeloid Leukemia Stem Cells through PTPN18 and GSK3","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Myeloid leukemia; CEBPA; Stem cell; Cancer research; Leukemia; Haematopoiesis; microRNA; Myeloid; Transplantation; Biology; NPM1; Clonogenic assay; Progenitor cell; Xenotransplantation; Immunology; Medicine; Cell culture; Internal medicine; Cell biology; Transcription factor","score_opus":0.00817080478417678,"score_gpt":0.2109488498493893,"score_spread":0.20277804506521252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096121660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997224,0.001855994,0.00004653747,0.00031735594,0.00003797665,0.00019177223,0.000050120405,0.00001942579,0.0002568433],"genre_scores_gemma":[0.99834955,0.00032254818,0.00079732476,0.00020317627,0.00017200835,0.000007915889,0.000039443734,0.000020238023,0.00008781798],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992452,0.000049054343,0.00018221934,0.0002717481,0.0001051234,0.0001466152],"domain_scores_gemma":[0.99949074,0.0000108490585,0.000105978914,0.00027858757,0.000049266888,0.00006460215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000552492,0.00013295954,0.00013207059,0.000007770017,0.000054034495,0.000018244144,0.00017021486,0.00011350189,0.000010319011],"category_scores_gemma":[0.0000051883585,0.00010335095,0.000073899864,0.00007227099,0.00007919132,0.000004597454,0.00013727014,0.000049255403,0.0000048518973],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043794742,0.0000430217,0.00036539338,0.00004808361,0.0003051602,0.0000025104841,0.00022727536,0.000015782603,0.99761146,0.000047235404,0.0011585781,0.00013168262],"study_design_scores_gemma":[0.0008354528,0.00015082488,0.0012433357,0.000010239546,0.0002734985,0.000011998847,0.000053234606,0.00004280576,0.9923889,0.00006534059,0.0048013157,0.00012307218],"about_ca_topic_score_codex":0.000009587004,"about_ca_topic_score_gemma":0.0000028144946,"teacher_disagreement_score":0.005222601,"about_ca_system_score_codex":0.000006763111,"about_ca_system_score_gemma":0.000084855616,"threshold_uncertainty_score":0.4214529},"labels":[],"label_agreement":null},{"id":"W3096123657","doi":"10.1182/blood-2020-140459","title":"Inhibition of PAK6-Mediated Survival and Cell Cycle Controls Selectively Targets Therapy-Resistant CML Stem/Progenitor Cells","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute","funders":"","keywords":"Stem cell; Progenitor cell; Cancer research; CD34; Myeloid leukemia; Biology; Medicine; Immunology; Cell biology","score_opus":0.013684772930984907,"score_gpt":0.2212394822924047,"score_spread":0.2075547093614198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096123657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950526,0.002787826,0.000017317163,0.00023779423,0.000055253793,0.00087352685,0.00014150584,0.00007537333,0.000758849],"genre_scores_gemma":[0.9989663,0.00027138565,0.00023256666,0.00017147708,0.00015817386,0.000035696485,0.000053809297,0.0000384158,0.00007220157],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986782,0.000087921544,0.00032452558,0.0003415013,0.00030539825,0.00026241652],"domain_scores_gemma":[0.9991942,0.00013328444,0.00016114925,0.00016171818,0.00012087668,0.00022875692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000105251085,0.00020900485,0.0004663368,0.000045191122,0.000045538047,0.000011592037,0.000048509333,0.00011248712,0.00007382585],"category_scores_gemma":[0.000033267308,0.00017690257,0.00008638138,0.00018806971,0.00005858203,0.0000533076,0.000030375979,0.00014808906,0.000029607116],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077127473,0.0008648514,0.008704944,0.00016327937,0.0003101948,0.00009598214,0.0006884326,0.0000014928657,0.9879267,0.00000700797,0.000120575365,0.0003452271],"study_design_scores_gemma":[0.028785033,0.0014582269,0.01157552,0.00004993909,0.00027812354,0.000007342284,0.0002224659,0.00010429241,0.95694584,0.000010519263,0.0004034748,0.00015924276],"about_ca_topic_score_codex":0.00007508068,"about_ca_topic_score_gemma":0.000007321632,"teacher_disagreement_score":0.030980919,"about_ca_system_score_codex":0.00008395091,"about_ca_system_score_gemma":0.00023942046,"threshold_uncertainty_score":0.72138774},"labels":[],"label_agreement":null},{"id":"W3096131635","doi":"10.1182/blood-2020-134779","title":"An Immune Senescence and Exhaustion-Related RNA Profile Predicts Clinical Outcomes in Acute Myeloid Leukemia","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Immune system; Medicine; Oncology; Cohort; Chemotherapy regimen; Internal medicine; Gene signature; Immunology; Chemotherapy; Biology; Gene; Gene expression","score_opus":0.027772645965498825,"score_gpt":0.32776021589427506,"score_spread":0.29998756992877623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096131635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99455196,0.00030147308,0.00003426635,0.003164855,0.00008621338,0.0008565084,0.00002942237,0.00018891034,0.0007864104],"genre_scores_gemma":[0.9958818,0.0005212658,0.001901088,0.0007765629,0.0001716575,0.000044724402,0.000094920026,0.000048231945,0.0005597408],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997519,0.00016822852,0.0007680204,0.00063305895,0.00043715737,0.00047454177],"domain_scores_gemma":[0.9985439,0.00017744595,0.00011697905,0.00047209044,0.00010621743,0.00058333745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057746476,0.00024474395,0.0006984738,0.00012115856,0.00007102154,0.00003450839,0.00025204162,0.00032412153,0.000139092],"category_scores_gemma":[0.000658042,0.00020602148,0.00010768052,0.00047509672,0.00022804756,0.00021556116,0.00018042132,0.0010321126,0.00013002008],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005698671,0.0007265179,0.91065246,0.00014896359,0.00049019407,0.001344193,0.00090344937,0.000005636005,0.07943053,0.00007123487,0.0005215379,0.005135426],"study_design_scores_gemma":[0.01461262,0.0013828505,0.9666377,0.00012408395,0.00034594262,0.00016279178,0.00022001617,0.0047906446,0.011235686,0.000025385843,0.00020114763,0.00026114786],"about_ca_topic_score_codex":0.00011027993,"about_ca_topic_score_gemma":0.000008086315,"teacher_disagreement_score":0.068194844,"about_ca_system_score_codex":0.00012127839,"about_ca_system_score_gemma":0.00068107387,"threshold_uncertainty_score":0.84013116},"labels":[],"label_agreement":null},{"id":"W3096141131","doi":"10.1182/blood-2020-143221","title":"Single-Cell Transcriptomic Profiling of De Novo and Relapsed Acute Myeloid Leukemia Identifies a Leukemic Stemness Program Shared across Diverse Phenotypes","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill Genome Centre; McGill University Health Centre; McGill University; Jewish General Hospital","funders":"","keywords":"Biology; Single-cell analysis; Transcriptome; Gene expression profiling; Myeloid leukemia; CD34; Myeloid; Leukemia; Stem cell; Cell; Cancer research; Computational biology; Gene; Molecular biology; Gene expression; Genetics","score_opus":0.03187072893759019,"score_gpt":0.28908466323465865,"score_spread":0.25721393429706846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096141131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960927,0.0008108181,0.00016069449,0.00039193587,0.000069105656,0.0015695363,0.00022240954,0.0002926001,0.00039021936],"genre_scores_gemma":[0.9908395,0.00018580392,0.007725959,0.0002497172,0.0001810082,0.00011549936,0.00013207448,0.00008972525,0.00048071213],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973718,0.000099845114,0.000559941,0.00065871753,0.00053404947,0.00077562756],"domain_scores_gemma":[0.99864393,0.000103751474,0.00017947688,0.00039904317,0.00023461813,0.000439168],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003378471,0.00034428533,0.0006967205,0.00010945411,0.00016439958,0.00010484629,0.00035279914,0.00026581896,0.000048537793],"category_scores_gemma":[0.0001825049,0.0003224589,0.00018274106,0.0005227865,0.00035377181,0.00026516474,0.00022636366,0.0006300044,0.00002856175],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012693489,0.0005231569,0.011816337,0.0016336143,0.000451234,0.00042515487,0.008060313,0.000006849482,0.9724841,0.00001260895,0.00025630507,0.0030609446],"study_design_scores_gemma":[0.020462215,0.0015170893,0.004321215,0.00031644927,0.0011054309,0.0003009138,0.0042139017,0.0015623248,0.9653306,0.000027119197,0.0004205514,0.000422202],"about_ca_topic_score_codex":0.00010492934,"about_ca_topic_score_gemma":0.00002069689,"teacher_disagreement_score":0.019192865,"about_ca_system_score_codex":0.00035788945,"about_ca_system_score_gemma":0.00085079577,"threshold_uncertainty_score":0.99992275},"labels":[],"label_agreement":null},{"id":"W3096142005","doi":"10.1182/blood-2020-138613","title":"<i>Establishing Clinical Decision Limits for Serum B12 Deficiency: Using Modified Delphi Methodology</i>","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Delphi Technique in Research","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Medicine; Vitamin B12; Comorbidity; Cobalamin; Intensive care medicine; Internal medicine; Pediatrics; Methylmalonic acid","score_opus":0.6144168797891965,"score_gpt":0.5508229174537467,"score_spread":0.06359396233544978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096142005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.61190265,0.00034349263,0.3730424,0.0064035864,0.0005252489,0.0013814037,0.00003507619,0.000452735,0.005913407],"genre_scores_gemma":[0.7027841,0.00009381713,0.2953679,0.0010000981,0.0006536891,0.000039722803,0.0000021521437,0.000029114033,0.000029378542],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99624324,0.001077723,0.0006158232,0.00059231184,0.00074713735,0.0007237941],"domain_scores_gemma":[0.9915949,0.007257591,0.00016761899,0.00029542047,0.00032785704,0.0003565947],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.009871221,0.00014881985,0.00036183494,0.00010108859,0.000663021,0.00023080253,0.0010215129,0.00037626093,0.000032603508],"category_scores_gemma":[0.02943077,0.00014896182,0.00021096406,0.0007934594,0.00033463517,0.00038945623,0.00023444148,0.00043915276,0.00001591442],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017409752,0.004245044,0.07518608,0.00045647912,0.0003771169,0.00035680112,0.04755622,0.0016389599,0.05309105,0.13115029,0.053954545,0.63024646],"study_design_scores_gemma":[0.032702927,0.006661761,0.011363726,0.0011049159,0.0022381945,0.000105367595,0.06634492,0.10217521,0.093226664,0.4013382,0.2756065,0.0071316143],"about_ca_topic_score_codex":0.00030844216,"about_ca_topic_score_gemma":0.00023445237,"teacher_disagreement_score":0.6231148,"about_ca_system_score_codex":0.000036190428,"about_ca_system_score_gemma":0.0005363442,"threshold_uncertainty_score":0.97874475},"labels":[],"label_agreement":null},{"id":"W3096145151","doi":"10.1182/blood-2020-133988","title":"Shared Expression of CD93 and Other Antigens By AML and Endothelial Cells Highlights a Need for Rational Combinatorial Targeting","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Chimeric antigen receptor; Cancer research; Progenitor cell; Myeloid leukemia; Haematopoiesis; Leukemia; Bone marrow; CD33; Antigen; Stem cell; Myeloid; Immunology; Immunotherapy; Medicine; Biology; CD34; Immune system; Cell biology","score_opus":0.020402313932488324,"score_gpt":0.2702720288376731,"score_spread":0.24986971490518478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096145151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99684006,0.00042952297,0.000100089026,0.00097276585,0.00010561728,0.0007484862,0.00033210806,0.000026015789,0.00044530662],"genre_scores_gemma":[0.9976072,0.00003999107,0.0012149286,0.00019379231,0.0005381241,0.000022295846,0.00004965942,0.000028790422,0.00030525122],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992004,0.000033934022,0.00017790639,0.0002101674,0.00022969974,0.00014790198],"domain_scores_gemma":[0.9995505,0.0001093885,0.000057637357,0.000076962926,0.00006976315,0.00013571426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000118560616,0.00009494265,0.0002224387,0.000032190736,0.000054708216,0.000018697923,0.000044909466,0.00007007835,0.0003104468],"category_scores_gemma":[0.00007368636,0.00007936582,0.000041473777,0.000056260982,0.000054686687,0.000038184106,0.000037770078,0.00007784399,0.0000015395258],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008150045,0.00017803312,0.001669016,0.00012053298,0.00004354839,0.0000030687363,0.0006883629,1.5569358e-7,0.99190074,0.00021434783,0.0043032668,0.00006391464],"study_design_scores_gemma":[0.011353853,0.0005066114,0.000082964114,0.000039490293,0.00004351954,0.0000031354127,0.00006487563,0.00019057312,0.9662135,0.00013105964,0.021292707,0.0000776759],"about_ca_topic_score_codex":0.000012915643,"about_ca_topic_score_gemma":5.360132e-7,"teacher_disagreement_score":0.025687214,"about_ca_system_score_codex":0.0000052925457,"about_ca_system_score_gemma":0.000045357636,"threshold_uncertainty_score":0.3399175},"labels":[],"label_agreement":null},{"id":"W3096161124","doi":"10.1182/blood-2020-138589","title":"External Validation of the HLH-2004 Diagnostic Criteria and H-Score for Diagnosis of Hemophagocytic Lymphohistiocytosis in Adults","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Alberta","funders":"","keywords":"Hemophagocytic lymphohistiocytosis; Medicine; Hemophagocytosis; Macrophage activation syndrome; Receiver operating characteristic; Internal medicine; Interquartile range; Pediatrics; Gold standard (test); Cohort; Bone marrow; Pancytopenia; Disease","score_opus":0.023098528478594255,"score_gpt":0.2805388921350559,"score_spread":0.2574403636564616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096161124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961894,0.0022428501,0.000053746156,0.00074303756,0.00002601245,0.00064907456,0.0000284004,0.000007242772,0.000060235547],"genre_scores_gemma":[0.9991625,0.00035417746,0.00017416824,0.00011653699,0.000036641544,0.00012208495,0.000008056979,0.000012693889,0.000013173698],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99916464,0.00003761066,0.0003353069,0.00015007338,0.00018464866,0.00012774307],"domain_scores_gemma":[0.9993305,0.00026800335,0.000106305226,0.00015697074,0.00008827762,0.0000499096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000116056464,0.00008255543,0.00026455632,0.000050516268,0.0000270846,0.000005589897,0.000095525465,0.000051706927,0.000055816854],"category_scores_gemma":[0.0015469388,0.000063153515,0.00007165408,0.00017524815,0.00008709536,0.00005392881,0.000055415603,0.00006216984,0.0000015703419],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037576523,0.0004570476,0.98022175,0.0018385168,0.000044570286,0.0000089912155,0.0013412427,0.000010543695,0.012088591,0.0000669027,0.00017726498,0.00336879],"study_design_scores_gemma":[0.009657157,0.00060843216,0.5750388,0.0011619333,0.00015763566,0.000009563836,0.00021965803,0.0004617935,0.41234943,0.00015072845,0.000094988914,0.000089917],"about_ca_topic_score_codex":0.0000615223,"about_ca_topic_score_gemma":0.0000050516105,"teacher_disagreement_score":0.40518302,"about_ca_system_score_codex":0.000016808568,"about_ca_system_score_gemma":0.00012634473,"threshold_uncertainty_score":0.25753257},"labels":[],"label_agreement":null},{"id":"W3096202787","doi":"10.1182/blood-2020-142002","title":"Sickle Cell Cerebrovascular Reactivity to a CO2 Stimulus Is Both Too Little and Too Slow","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Thornhill Medical (Canada); University of Toronto; Centre Hospitalier de l’Université de Montréal; University Health Network","funders":"","keywords":"Cerebral blood flow; Medicine; Vasodilation; Cardiology; Sickle cell anemia; Internal medicine; Stroke (engine); Anesthesia; Disease","score_opus":0.009359424005755167,"score_gpt":0.21541413853141173,"score_spread":0.20605471452565655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096202787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97709185,0.0012904408,0.00013186545,0.00899042,0.0000591422,0.00043334576,0.000017364748,0.000097732634,0.011887828],"genre_scores_gemma":[0.9897609,0.00023078249,0.00075372664,0.007439573,0.00011199671,0.000009462581,0.000008520965,0.000030351797,0.0016546919],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99896306,0.000026622005,0.0001613867,0.0003583116,0.0002196971,0.00027093195],"domain_scores_gemma":[0.99922675,0.00002596185,0.000033834913,0.00026526136,0.000038537786,0.0004096582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000087970424,0.00016161289,0.0003033896,0.00003496254,0.00006968861,0.000024971725,0.000065517925,0.00013622998,0.00010400528],"category_scores_gemma":[0.00009467221,0.00013751905,0.00010209737,0.0002240957,0.000040316438,0.00005374888,0.0000803577,0.0002350435,0.00016680552],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010102623,0.008674873,0.07814005,0.0027583274,0.0018545177,0.0012452757,0.03451061,0.00012431432,0.46267638,0.00025905363,0.3608435,0.047902837],"study_design_scores_gemma":[0.032439448,0.004998477,0.03977126,0.0003062078,0.00264757,0.00026931777,0.0031842606,0.001679304,0.25941697,0.00012552305,0.6537304,0.0014312798],"about_ca_topic_score_codex":0.00013864294,"about_ca_topic_score_gemma":0.0000023269658,"teacher_disagreement_score":0.29288688,"about_ca_system_score_codex":0.000013541602,"about_ca_system_score_gemma":0.000077292316,"threshold_uncertainty_score":0.56078637},"labels":[],"label_agreement":null},{"id":"W3096216527","doi":"10.1182/blood-2020-137320","title":"Analysis of Hemophilia a Outcomes and Treatment Patterns Using Real-World Data from the Canadian Hemophilia Bleeding Disorder Registry","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Impact; University of Calgary","funders":"","keywords":"Medicine; Bleed; Pediatrics; Surgery","score_opus":0.11057752314890645,"score_gpt":0.3489834844897812,"score_spread":0.23840596134087477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096216527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98464924,0.0002726333,0.0000035401772,0.013043615,0.00002284061,0.00037832622,0.0010852347,0.000022978586,0.00052156264],"genre_scores_gemma":[0.9976987,0.00045522698,0.00024482008,0.00031326982,0.00016252526,0.000007324352,0.0007864096,0.00002464679,0.0003070433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984208,0.000054552806,0.0003084107,0.00051896216,0.00035262015,0.00034465],"domain_scores_gemma":[0.99824333,0.00019654499,0.000102779595,0.00095779356,0.000055321423,0.00044423513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013517386,0.0002241685,0.000662191,0.00020745503,0.00020065335,0.000049744845,0.0002818276,0.00006595098,0.0001519891],"category_scores_gemma":[0.000107041575,0.00013553645,0.00014998755,0.00085852976,0.0001440904,0.00008183189,0.00016057606,0.00015120377,0.000004908005],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039105882,0.00020334341,0.99336237,0.000024125755,0.0042975885,0.00014390524,0.0005362614,0.00000543233,0.0003130923,0.000015497812,0.000048149566,0.0010111274],"study_design_scores_gemma":[0.002504774,0.00016583927,0.9822133,0.00005520502,0.0084009385,0.0000043600094,0.0004271224,0.004976294,0.0004492392,0.000007882129,0.00064633635,0.00014866321],"about_ca_topic_score_codex":0.49986798,"about_ca_topic_score_gemma":0.6637826,"teacher_disagreement_score":0.16391464,"about_ca_system_score_codex":0.00010483537,"about_ca_system_score_gemma":0.00031281405,"threshold_uncertainty_score":0.5527016},"labels":[],"label_agreement":null},{"id":"W3096217495","doi":"10.1182/blood-2020-137589","title":"Prognostic Impact of a Modified European LeukemiaNet (ELN) Genetic Risk Stratification in Predicting Outcomes for Adults with Acute Myeloid Leukemia (AML) Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HCT). a Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis for the CIBMTR Acute Leukemia Writing Committee","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Internal medicine; Cumulative incidence; Transplantation; Hazard ratio; Univariate analysis; Oncology; Hematopoietic stem cell transplantation; Clinical endpoint; Proportional hazards model; Graft-versus-host disease; Multivariate analysis; Clinical trial; Confidence interval","score_opus":0.029376311166879693,"score_gpt":0.29683783039591555,"score_spread":0.2674615192290358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096217495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95683897,0.0003051371,0.03438644,0.00031553186,0.000032106334,0.005744769,0.0022420113,0.00006727057,0.00006773797],"genre_scores_gemma":[0.9894411,0.0013202847,0.00660171,0.000049883747,0.00016665056,0.0009951689,0.001267803,0.00012679394,0.000030581527],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99574167,0.00044152877,0.0011927022,0.0009705236,0.0007971292,0.0008564628],"domain_scores_gemma":[0.99458677,0.003298799,0.00049814733,0.0004893006,0.0008312133,0.00029579873],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017634527,0.0004717862,0.00083284604,0.0005638486,0.00035876397,0.00014414739,0.000527681,0.00018954341,0.000006058688],"category_scores_gemma":[0.00038510934,0.0003470902,0.00045106784,0.0008496813,0.00019648606,0.00019059257,0.000054887627,0.0006700471,9.661784e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008129794,0.00051333854,0.92412215,0.003197535,0.011412826,0.0001694235,0.012352018,0.0082603395,0.030281596,0.000059501974,0.000045483157,0.001455962],"study_design_scores_gemma":[0.07514024,0.0066010016,0.6753326,0.001453845,0.025327316,0.00041004294,0.004942301,0.17923304,0.030574424,0.00006822401,0.000010618585,0.00090634334],"about_ca_topic_score_codex":0.00027490823,"about_ca_topic_score_gemma":0.00052273617,"teacher_disagreement_score":0.24878958,"about_ca_system_score_codex":0.0005058208,"about_ca_system_score_gemma":0.0012847643,"threshold_uncertainty_score":0.99989814},"labels":[],"label_agreement":null},{"id":"W3096220561","doi":"10.1182/blood-2020-142842","title":"Effectiveness and Safety of the Direct Oral Anticoagulants in Low-Risk Antiphospholipid Syndrome: A Case Series","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Sinai Health System; University Health Network","funders":"","keywords":"Medicine; Antiphospholipid syndrome; Lupus anticoagulant; Thrombosis; Dosing; Internal medicine; Vitamin K antagonist; Warfarin; Venous thromboembolism; Venous thrombosis; Pediatrics; Atrial fibrillation","score_opus":0.014620002789192097,"score_gpt":0.26710599489959136,"score_spread":0.25248599211039924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096220561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99783903,0.00080464844,0.000004067922,0.00015517356,0.000060782106,0.0008538356,0.000045099307,0.000025013473,0.00021236736],"genre_scores_gemma":[0.9996691,0.00017896443,0.000046048528,0.000019541849,0.000020086869,0.000016663533,0.0000014050994,0.000021237687,0.00002697751],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986647,0.00032669413,0.00026315066,0.00025619433,0.00026699295,0.00022226141],"domain_scores_gemma":[0.9992448,0.00022385741,0.00007711674,0.00028605413,0.000054260676,0.00011388098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005245712,0.00012880506,0.0005658693,0.000050667735,0.000053553726,0.000009859859,0.00009365477,0.0000740349,0.0000140880165],"category_scores_gemma":[0.000623999,0.00008377005,0.00006440062,0.00044111846,0.00014455493,0.00005337726,0.0001429712,0.00020238984,0.0000054406937],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050554087,0.00019710945,0.98541766,0.0026693647,0.00014129613,0.0042316606,0.0011339639,0.0000026918597,0.005503017,0.000009750559,0.000011375863,0.00017654961],"study_design_scores_gemma":[0.011611066,0.00056108873,0.6829196,0.003122312,0.00026877166,0.22237693,0.0008744235,0.00015296169,0.07788419,0.000015748094,0.000033180688,0.00017969412],"about_ca_topic_score_codex":0.00027029024,"about_ca_topic_score_gemma":0.000044892437,"teacher_disagreement_score":0.30249804,"about_ca_system_score_codex":0.000019418496,"about_ca_system_score_gemma":0.00009335183,"threshold_uncertainty_score":0.34160435},"labels":[],"label_agreement":null},{"id":"W3096222995","doi":"10.1182/blood-2020-134977","title":"ASXL1-Mutant Chronic Myelomonocytic Leukemia Is Associated with Increased Intratumoral Heterogeneity and Single-Cell Chromatin Co-Accessibility","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"","keywords":"Biology; Chromatin; Epigenomics; Computational biology; Genetics; Molecular biology; DNA methylation; Gene; Gene expression","score_opus":0.02894232841328798,"score_gpt":0.27607985175106414,"score_spread":0.24713752333777617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096222995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963077,0.0005657086,0.00004370812,0.0005427927,0.000015949765,0.00089265633,0.00009970154,0.00023284035,0.0012989512],"genre_scores_gemma":[0.9977087,0.000038174636,0.00048186132,0.0012608945,0.00021119668,0.000039562226,0.00014618492,0.000073878524,0.000039550792],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99720615,0.00017429431,0.00047636035,0.0008201898,0.0006345509,0.000688433],"domain_scores_gemma":[0.99818474,0.00017111062,0.00021496466,0.0005219616,0.00017232391,0.00073487894],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038913774,0.0003893979,0.00074390485,0.00008270905,0.00015814675,0.00010346027,0.0002557951,0.000228743,0.0001974936],"category_scores_gemma":[0.00046065426,0.00031697348,0.00009765236,0.00055125117,0.00033494076,0.000174931,0.00017426944,0.00071771874,0.00005838982],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008660532,0.0011045821,0.14768764,0.0008005987,0.000594212,0.001431281,0.0007107895,0.0000032788232,0.8450222,0.000005809236,0.0009379674,0.0008355667],"study_design_scores_gemma":[0.021151302,0.003859839,0.114033386,0.0002441468,0.00059142336,0.00026169422,0.00010714032,0.005168756,0.85391575,0.000018456134,0.00015476115,0.0004933705],"about_ca_topic_score_codex":0.00016475527,"about_ca_topic_score_gemma":0.00007743475,"teacher_disagreement_score":0.033654258,"about_ca_system_score_codex":0.0014755848,"about_ca_system_score_gemma":0.0020725862,"threshold_uncertainty_score":0.99992824},"labels":[],"label_agreement":null},{"id":"W3096229548","doi":"10.1182/blood-2020-135867","title":"A Human Model of Down Syndrome Associated Leukemia Reveals Different Cell of Origins for Initiation and Progression","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Acute megakaryoblastic leukemia; GATA1; Cancer research; Leukemia; Biology; Haematopoiesis; Genetics; Stem cell","score_opus":0.04213590924019751,"score_gpt":0.31392605378251354,"score_spread":0.27179014454231604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096229548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981542,0.0000993009,0.00019884367,0.00027315354,0.0000061212154,0.000864826,0.000097379794,0.000028876704,0.000277284],"genre_scores_gemma":[0.9985681,0.000024942901,0.0010333478,0.00007257565,0.00002580007,0.000049768485,0.000094630566,0.000022335047,0.000108473665],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989671,0.00003799059,0.00032414502,0.00019766175,0.00029301975,0.00018007764],"domain_scores_gemma":[0.9992993,0.00006310276,0.00019833843,0.00013889742,0.00016757089,0.00013282691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015895521,0.000110212575,0.00040177422,0.00007202387,0.00003891809,0.0000054113243,0.00007500799,0.00011978292,0.000010507352],"category_scores_gemma":[0.00019163461,0.00008745489,0.00006666905,0.00013010486,0.000051033065,0.0000435826,0.00006217937,0.00015327639,7.3290533e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017773498,0.0006588857,0.02204977,0.0016037923,0.00014523714,0.000015384401,0.0007907158,0.000019924359,0.9734891,0.00027282166,0.0006113528,0.00016527677],"study_design_scores_gemma":[0.03633676,0.006837126,0.09972377,0.001147479,0.001233063,0.000030251287,0.0001891412,0.04701799,0.80618685,0.0008814052,0.000037987404,0.00037819575],"about_ca_topic_score_codex":0.0000122765105,"about_ca_topic_score_gemma":0.000001549677,"teacher_disagreement_score":0.16730227,"about_ca_system_score_codex":0.0001411606,"about_ca_system_score_gemma":0.00019310707,"threshold_uncertainty_score":0.3566307},"labels":[],"label_agreement":null},{"id":"W3096249124","doi":"10.1182/blood-2020-141154","title":"Red Blood Cell Transfusion and the Use of Intravenous Iron in Iron Deficient Patients Presenting to the Emergency Department","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; George & Fay Yee Centre for Healthcare Innovation; University of Manitoba","funders":"","keywords":"Medicine; Mean corpuscular volume; Emergency department; Anemia; Transferrin saturation; Ferritin; Hemoglobin; Iron-deficiency anemia; Blood transfusion; Incidence (geometry); Retrospective cohort study; Population; Internal medicine; Iron deficiency; Sickle cell anemia; Pediatrics","score_opus":0.016149381757588035,"score_gpt":0.21777406438823185,"score_spread":0.20162468263064381,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096249124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957668,0.0008680869,0.00003061965,0.0017845778,0.000075179785,0.0011655694,0.000012769602,0.000011099318,0.0002852989],"genre_scores_gemma":[0.9984491,0.0008681566,0.00020636222,0.00034488074,0.00004012776,0.000028873561,0.000013996555,0.000013425296,0.000035090896],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892837,0.00009725898,0.0003090657,0.00021099516,0.00025991345,0.00019440969],"domain_scores_gemma":[0.99957514,0.000036933365,0.00006558935,0.00020573613,0.000031743028,0.0000848535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013666865,0.00011256115,0.00020058647,0.000035159846,0.000065297805,0.000008505538,0.000085938256,0.00003764421,0.000031618834],"category_scores_gemma":[0.000094522096,0.00006444916,0.00005551871,0.00019483526,0.00003759804,0.00003098636,0.000048316222,0.000107616455,0.0000034725847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026088788,0.0124067385,0.84108824,0.0015469379,0.00008150349,0.000040509472,0.09343121,0.0013938331,0.035553794,0.00026600063,0.00204042,0.009541933],"study_design_scores_gemma":[0.047227357,0.0014686222,0.9036407,0.00008165063,0.0021517326,0.0000072087687,0.002200475,0.0004943559,0.0350744,0.000038246897,0.0072109653,0.00040432138],"about_ca_topic_score_codex":0.00014673693,"about_ca_topic_score_gemma":0.00006811231,"teacher_disagreement_score":0.091230735,"about_ca_system_score_codex":0.0000029978476,"about_ca_system_score_gemma":0.000015134064,"threshold_uncertainty_score":0.26281604},"labels":[],"label_agreement":null},{"id":"W3096269916","doi":"10.1182/blood-2020-138862","title":"Prognostic Role of Multiparameter Flow Cytometry-Based Measurable Residual Disease Assessment in Patients with Acute Myeloid Leukemia Harboring DNMT3A/TET2/ASXL1 Mutation","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Minimal residual disease; Medicine; Myeloid leukemia; clone (Java method); Internal medicine; Oncology; Leukemia; Population; Flow cytometry; Myeloid; Acute leukemia; Mutation; Immunology; Cancer research; Biology; Gene; Genetics","score_opus":0.01343586611794314,"score_gpt":0.2604569212021956,"score_spread":0.24702105508425246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096269916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967819,0.000084817126,0.00059977506,0.00047164861,0.00002377905,0.001657692,0.0001254377,0.00008787533,0.00016710107],"genre_scores_gemma":[0.9783549,0.000006165746,0.020717371,0.00021375976,0.00007603409,0.00018167886,0.00035694506,0.000073284165,0.000019915598],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99690354,0.00014877645,0.0005122253,0.00058944995,0.0013000317,0.00054596417],"domain_scores_gemma":[0.9982516,0.00021498807,0.00017726097,0.00043200405,0.0003894962,0.00053461746],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028912543,0.0003000779,0.00052508694,0.0003520672,0.000063484345,0.00004006965,0.00021771518,0.00011061159,0.000051199982],"category_scores_gemma":[0.0007379491,0.00025339605,0.00009098486,0.0009983814,0.00009946929,0.00021262022,0.00008649226,0.0006033853,0.000022560895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030065528,0.0013082512,0.9788944,0.0004232142,0.00037978328,0.00049199857,0.00032012133,0.0017714999,0.01167142,0.0000058219803,0.00004562373,0.0016812909],"study_design_scores_gemma":[0.022203196,0.0016577016,0.90643954,0.0003573509,0.0007397416,0.0000037057875,0.000103344,0.038351785,0.029806703,0.000010126016,0.000033943368,0.0002928401],"about_ca_topic_score_codex":0.00008296722,"about_ca_topic_score_gemma":0.000008908086,"teacher_disagreement_score":0.07245486,"about_ca_system_score_codex":0.0005129813,"about_ca_system_score_gemma":0.001965129,"threshold_uncertainty_score":0.99999183},"labels":[],"label_agreement":null},{"id":"W3096275718","doi":"10.1182/blood-2020-140854","title":"Functional Assessment in Younger and Older Adults with Sickle Cell Disease","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Quality of life (healthcare); Cohort; Prospective cohort study; Clinical endpoint; Disease; Young adult; Adverse effect; Sickle cell anemia; Activities of daily living; Internal medicine; Physical therapy; Pediatrics; Gerontology; Clinical trial","score_opus":0.00525359119466005,"score_gpt":0.2009015331720463,"score_spread":0.19564794197738625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096275718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914343,0.0010157207,0.00004138715,0.004088751,0.000022666109,0.0002479621,0.000004762387,0.000027046766,0.003117426],"genre_scores_gemma":[0.9980646,0.000092138354,0.0001888689,0.001377523,0.000049446953,0.000013516518,0.000024911524,0.000011226459,0.00017778258],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994733,0.000009945851,0.000087074994,0.00017640078,0.00013839541,0.00011491726],"domain_scores_gemma":[0.9996737,0.000009100875,0.000017994049,0.00006870431,0.00002040586,0.00021004218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000022899309,0.000077523226,0.000103387305,0.000022208005,0.000022936414,0.0000071476743,0.000015467536,0.000037010042,0.00015061504],"category_scores_gemma":[0.000007363106,0.000054729095,0.000019498959,0.00009780673,0.000027633594,0.000038437152,0.000015521386,0.00015358381,0.000014318136],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020077217,0.0042162677,0.9811959,0.001066025,0.0001616452,0.0012933472,0.002129965,0.00007724858,0.0021347944,0.00029691562,0.0032434491,0.0021766962],"study_design_scores_gemma":[0.018137349,0.0004330346,0.97782475,0.00021378134,0.00026731438,0.000019748199,0.0012026755,0.000528653,0.00024755872,0.000012798265,0.00096120476,0.00015114003],"about_ca_topic_score_codex":0.000014044547,"about_ca_topic_score_gemma":0.0000019327447,"teacher_disagreement_score":0.016129626,"about_ca_system_score_codex":0.000006611051,"about_ca_system_score_gemma":0.00009623903,"threshold_uncertainty_score":0.22317877},"labels":[],"label_agreement":null},{"id":"W3096278560","doi":"10.1182/blood-2020-133916","title":"Long-Term Follow-up of Ibrutinib Treatment for Rituximab-Refractory Waldenström's Macroglobulinemia: Final Analysis of the Open-Label Substudy of the Phase 3 iNNOVATETM Trial","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Rituximab; Ibrutinib; Waldenstrom macroglobulinemia; Internal medicine; Macroglobulinemia; Gastroenterology; Refractory (planetary science); Neutropenia; Progression-free survival; Phases of clinical research; Median follow-up; Surgery; Oncology; Clinical trial; Chemotherapy; Lymphoma; Leukemia; Multiple myeloma; Chronic lymphocytic leukemia","score_opus":0.1374803297596642,"score_gpt":0.39884000371614575,"score_spread":0.2613596739564815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096278560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99481225,0.00037340654,0.000021621212,0.0005810455,0.00017469459,0.0034454353,0.00040517218,0.000012060346,0.00017430703],"genre_scores_gemma":[0.998909,0.000044393437,0.00017250377,0.00011240577,0.00015075752,0.00010784663,0.00007228395,0.00002986064,0.00040094025],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.997322,0.00014494355,0.0009929913,0.00042958718,0.00075170654,0.0003587407],"domain_scores_gemma":[0.99753654,0.00035048512,0.0005318862,0.0010388773,0.00041546102,0.00012677541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040938647,0.00025808017,0.0012326124,0.00012650997,0.00008836342,0.00001767739,0.00088609813,0.00015028949,0.00014782691],"category_scores_gemma":[0.00056437915,0.0001439298,0.00055054476,0.0018009224,0.00031636443,0.00005472761,0.00043407496,0.00020048332,0.0000020654015],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.38644803,0.16873984,0.062136874,0.00310199,0.056981586,0.00035879857,0.009997728,0.00007008786,0.2693519,0.0004793596,0.0020158344,0.04031799],"study_design_scores_gemma":[0.75315166,0.004720328,0.0029845282,0.00011746528,0.009533447,0.00001618294,0.00014285078,0.0010195704,0.22806631,0.0000043330174,0.00011959201,0.00012375462],"about_ca_topic_score_codex":0.00044648047,"about_ca_topic_score_gemma":0.00015047185,"teacher_disagreement_score":0.36670363,"about_ca_system_score_codex":0.000848319,"about_ca_system_score_gemma":0.0047215614,"threshold_uncertainty_score":0.83758473},"labels":[],"label_agreement":null},{"id":"W3096295193","doi":"10.1182/blood-2020-137725","title":"Divergent Levels of CD112 and INKA1 Define a Subset of Human Hematopoietic Stem Cells That Resists Regenerative Stress to Preserve Stemness","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Stem cell; Biology; Haematopoiesis; Cell biology; Hematopoietic stem cell; Histone deacetylase; Immunology; Cancer research; Histone; Genetics; Gene","score_opus":0.06441059753396607,"score_gpt":0.27580180174921015,"score_spread":0.2113912042152441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096295193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99725616,0.00047463723,0.00021610083,0.00035198734,0.000040090046,0.0008631611,0.00041965305,0.000028935727,0.0003492623],"genre_scores_gemma":[0.99898237,0.00003318112,0.00061865995,0.00007490135,0.000037281327,0.000029516794,0.000027237293,0.000029401022,0.00016745624],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982942,0.00011630983,0.0005272179,0.00036479626,0.00048712184,0.0002103846],"domain_scores_gemma":[0.998926,0.00010219836,0.0002050176,0.00032787764,0.0001634748,0.00027544264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016903762,0.00020698807,0.0006293138,0.00008687636,0.00004526692,0.000010091851,0.00014225816,0.000101076264,0.000088096356],"category_scores_gemma":[0.000018229926,0.00018453081,0.00008069267,0.00024173953,0.00007705401,0.000055269422,0.00008357514,0.000102334234,0.0000061343485],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002666646,0.0006731656,0.103141874,0.00815258,0.00034710413,0.0001194806,0.021083139,0.000021956523,0.8651122,0.0008194577,0.00019149338,0.000070878705],"study_design_scores_gemma":[0.0030182435,0.0006314363,0.037079155,0.0009392027,0.00042253674,0.000021349157,0.0011755901,0.000012764788,0.9565164,0.00002221688,0.000008657753,0.00015245432],"about_ca_topic_score_codex":0.000042800253,"about_ca_topic_score_gemma":0.000035387613,"teacher_disagreement_score":0.091404185,"about_ca_system_score_codex":0.000012262454,"about_ca_system_score_gemma":0.000062250496,"threshold_uncertainty_score":0.7524948},"labels":[],"label_agreement":null},{"id":"W3096300067","doi":"10.1182/blood-2020-139025","title":"Lack of Effectiveness of Intravenous High-Dose Methotrexate for Prevention of CNS Relapse in Patients with High-Risk DLBCL: A Retrospective Analysis from Alberta, Canada","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of Calgary","funders":"","keywords":"Medicine; Internal medicine; Methotrexate; Diffuse large B-cell lymphoma; Guideline; Retrospective cohort study; Primary central nervous system lymphoma; Lymphoma; Oncology; Pathology","score_opus":0.008229019698757953,"score_gpt":0.2323607925719577,"score_spread":0.22413177287319977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096300067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99803066,0.00008375468,0.00011620974,0.000037373848,0.000022919921,0.0009957469,0.00069083355,0.0000042383954,0.000018255276],"genre_scores_gemma":[0.9982384,0.000022381086,0.0012058656,0.000010976057,0.000012419562,0.00007544898,0.00040981383,0.000018953819,0.0000057382567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873674,0.00015315025,0.0003963726,0.0003051487,0.0002745799,0.00013403675],"domain_scores_gemma":[0.9986059,0.00044341676,0.00042035067,0.00023712513,0.00021127766,0.000081934006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011854704,0.00015228603,0.0009259601,0.000107416396,0.000014809394,0.0000019140507,0.00005787738,0.00005837775,0.000018632776],"category_scores_gemma":[0.0001831107,0.00012013359,0.00015234872,0.0005909954,0.000034078992,0.000028716035,0.000021249698,0.000058890284,2.383504e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023179096,0.0046802172,0.9855602,0.00025050214,0.0051090866,0.000010060426,0.0004022669,0.000111891866,0.00037943348,0.000093519564,0.000004938708,0.0010799753],"study_design_scores_gemma":[0.023172736,0.0031188554,0.9023293,0.00025947974,0.007487578,1.6832405e-7,0.000039602397,0.000032234257,0.063351914,0.0001214958,0.0000017323513,0.00008486993],"about_ca_topic_score_codex":0.72640264,"about_ca_topic_score_gemma":0.40605766,"teacher_disagreement_score":0.32034498,"about_ca_system_score_codex":0.00014767435,"about_ca_system_score_gemma":0.00020414259,"threshold_uncertainty_score":0.60478026},"labels":[],"label_agreement":null},{"id":"W3096307008","doi":"10.1182/blood-2020-137574","title":"Impact of Prior Therapies on the Safety and Efficacy of Once Weekly Selinexor, Bortezomib, and Dexamethasone Compared with Twice Weekly Bortezomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma: Results from the Boston Study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary; University of Alberta","funders":"","keywords":"Bortezomib; Dexamethasone; Multiple myeloma; Medicine; Carfilzomib; Refractory (planetary science); Internal medicine; Oncology; Biology","score_opus":0.047951407480157825,"score_gpt":0.3135839291236633,"score_spread":0.2656325216435055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096307008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929674,0.0018724005,0.00000694659,0.0019702776,0.000011211659,0.002663484,0.0004240875,0.000032284493,0.00005190259],"genre_scores_gemma":[0.99796563,0.0005518916,0.0011587004,0.00010164825,0.000058732676,0.000035436093,0.00005302633,0.000045639466,0.000029262192],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99698895,0.0006308032,0.0007218223,0.00067154766,0.00060382474,0.0003830581],"domain_scores_gemma":[0.99190545,0.0065841135,0.00039278835,0.0006716825,0.00015752645,0.00028845543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008402291,0.00039588302,0.00095724943,0.00009580565,0.0001577718,0.0000356423,0.00020492803,0.00010956225,0.000018284893],"category_scores_gemma":[0.0027929773,0.00018781566,0.000077411525,0.0004652584,0.0004363903,0.00008840761,0.00014000054,0.0005426381,0.000001239646],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11378057,0.0050990866,0.8273756,0.000075896634,0.0023000373,0.00021452464,0.017738668,0.000013436148,0.019309023,0.0000028407217,0.00006986037,0.0140204765],"study_design_scores_gemma":[0.07569774,0.010909635,0.90505785,0.00032763183,0.0004327971,0.00001969299,0.0045315945,0.00089643634,0.001899915,0.0000025363179,0.000049116843,0.00017504628],"about_ca_topic_score_codex":0.0042754603,"about_ca_topic_score_gemma":0.0012263536,"teacher_disagreement_score":0.07768228,"about_ca_system_score_codex":0.000047999667,"about_ca_system_score_gemma":0.00024935472,"threshold_uncertainty_score":0.76589},"labels":[],"label_agreement":null},{"id":"W3096309541","doi":"10.1182/blood-2020-139416","title":"Effect of Pembrolizumab Monotherapy Versus Brentuximab Vedotin (BV) on Symptoms Associated with Health-Related Quality of Life (HRQoL) in Relapsed/Refractory (R/R) Classical Hodgkin Lymphoma (cHL) in the Randomized, Phase 3, Keynote-204 Study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Jewish General Hospital","funders":"","keywords":"Brentuximab vedotin; Classical Hodgkin lymphoma; Pembrolizumab; Medicine; Internal medicine; Oncology; Refractory (planetary science); Quality of life (healthcare); Lymphoma; Randomized controlled trial; Hodgkin lymphoma; Cancer; Immunotherapy; Biology","score_opus":0.029197509740673918,"score_gpt":0.32031984127558516,"score_spread":0.29112233153491124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096309541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926796,0.0013432,0.0000014349125,0.001522633,0.00008111314,0.0040708194,0.00004528961,0.0000541246,0.00020176325],"genre_scores_gemma":[0.9989285,0.00008353084,0.000008288224,0.00045856577,0.000039725863,0.0003583784,0.00006871569,0.00004860933,0.0000057253787],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9924069,0.0041173957,0.0015640785,0.000574558,0.0009067081,0.00043033343],"domain_scores_gemma":[0.9933514,0.0049180486,0.0008957632,0.00053201016,0.0000726873,0.00023009369],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025153568,0.0004489053,0.002592411,0.0001936824,0.000055074615,0.000014895317,0.0002327554,0.00020406778,0.000026376772],"category_scores_gemma":[0.0017843196,0.00026703818,0.00035877895,0.00076394895,0.00019626452,0.000047286376,0.000034470173,0.00031668768,0.0000073309925],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.77495503,0.08115942,0.124544725,0.00021419096,0.002876011,0.00028266048,0.007256138,0.00003988972,0.00017446125,0.000105926774,0.00008250982,0.008309024],"study_design_scores_gemma":[0.82286745,0.041626267,0.132422,0.00036039666,0.0006425291,0.0000042722468,0.0003958583,0.00022224423,0.0012577674,0.000004221922,0.0000077126015,0.00018926352],"about_ca_topic_score_codex":0.0011967189,"about_ca_topic_score_gemma":0.00025044032,"teacher_disagreement_score":0.047912415,"about_ca_system_score_codex":0.00033970055,"about_ca_system_score_gemma":0.000483053,"threshold_uncertainty_score":0.9999782},"labels":[],"label_agreement":null},{"id":"W3096318977","doi":"10.1182/blood-2020-138943","title":"Inferior Outcomes with a High LSC17 Score Can be Improved with Flag-IDA","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; Ottawa Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Flag (linear algebra); Medicine; Internal medicine; Mathematics","score_opus":0.02171803868389241,"score_gpt":0.25923544819824573,"score_spread":0.23751740951435332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096318977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96875155,0.000049277856,0.000040724906,0.029015066,0.000018633855,0.0008032243,0.000037270074,0.0001829862,0.0011012706],"genre_scores_gemma":[0.98886216,0.000011290656,0.0038185464,0.005731784,0.00021132492,0.000084727784,0.00005087341,0.000079661535,0.0011496594],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983291,0.000031057687,0.00020297282,0.0004376183,0.0005102298,0.000489037],"domain_scores_gemma":[0.99871093,0.00006264556,0.000071833245,0.00047507058,0.00017064932,0.00050884526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008261613,0.00026401723,0.0005120895,0.000078577665,0.00007865336,0.00004265894,0.00020585192,0.000098730896,0.00015501019],"category_scores_gemma":[0.00016672116,0.00016151779,0.000058156944,0.00040708628,0.00014859354,0.00007355414,0.00011012357,0.0005010723,0.000037646536],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021622686,0.0006126021,0.90202796,0.0005151375,0.0014736287,0.0024642418,0.002207359,0.0000042183956,0.084530234,0.00023204288,0.0023053442,0.0014649672],"study_design_scores_gemma":[0.085250586,0.01525847,0.70244455,0.0004739713,0.0022617166,0.0008981256,0.0015802964,0.0003431967,0.1780375,0.00002448478,0.012032891,0.0013941998],"about_ca_topic_score_codex":0.00092601695,"about_ca_topic_score_gemma":0.00048936746,"teacher_disagreement_score":0.19958338,"about_ca_system_score_codex":0.0000867811,"about_ca_system_score_gemma":0.0010437137,"threshold_uncertainty_score":0.6586504},"labels":[],"label_agreement":null},{"id":"W3096329976","doi":"10.1182/blood-2020-137125","title":"Distinct Genetic Pathways Define Leukemia Predisposition Versus Adaptive Clonal Hematopoiesis in Shwachman-Diamond Syndrome","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Germline mutation; Biology; Mutation; Genetics; Exome sequencing; Myeloid; Germline; Bone marrow failure; Cancer research; Gene; Haematopoiesis; Stem cell","score_opus":0.015486369202151316,"score_gpt":0.20833045181761733,"score_spread":0.192844082615466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096329976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99628884,0.002021945,0.00015656039,0.00007786788,0.00005923281,0.00022718993,0.00012956213,0.00002123055,0.0010175521],"genre_scores_gemma":[0.99857277,0.00006667609,0.0007149768,0.00010485256,0.00008433979,0.000064234264,0.00034802052,0.000027210579,0.00001690737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892455,0.000039670802,0.00020583626,0.00043466286,0.00013558731,0.00025968696],"domain_scores_gemma":[0.9995761,0.000013288917,0.00006329036,0.00019507458,0.000025782447,0.00012644258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000029652741,0.00020439959,0.00019353374,0.00002770449,0.000056856996,0.000018276822,0.00013711836,0.00014015847,0.00002681752],"category_scores_gemma":[0.000031736738,0.00020514273,0.00009723416,0.00012380118,0.00004731333,0.000005225211,0.000100014266,0.00008406159,0.000030364721],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012830427,0.013838003,0.61529493,0.0008178427,0.0059291404,0.006496034,0.002582077,0.0013260779,0.31849927,0.0020999203,0.005418362,0.014867932],"study_design_scores_gemma":[0.050423674,0.011580515,0.67694026,0.00013482728,0.0011720209,0.0004056926,0.0005538848,0.00086814474,0.2540172,0.0009052336,0.0011278087,0.0018707127],"about_ca_topic_score_codex":0.000042828353,"about_ca_topic_score_gemma":0.00011811455,"teacher_disagreement_score":0.064482056,"about_ca_system_score_codex":0.000020097606,"about_ca_system_score_gemma":0.00008932402,"threshold_uncertainty_score":0.83654773},"labels":[],"label_agreement":null},{"id":"W3096332592","doi":"10.1182/blood-2020-138670","title":"Experiences and Support Needs of Caregivers of Patients with Higher-Risk MDS: Qualitative Insights Via Online Bulletin Board in the US, UK, and Canada","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Focus group; Psychology; Gerontology; Disease; Qualitative research; Medicine; Medical education; Sociology","score_opus":0.013291761844642362,"score_gpt":0.25289507120988336,"score_spread":0.239603309365241,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096332592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963525,0.00039221765,0.0000025601057,0.0026960033,0.00003133885,0.00029291972,0.000106503445,0.0000053165218,0.0001206551],"genre_scores_gemma":[0.99850684,0.000043203574,0.00018727545,0.0011643864,0.000035729165,0.0000091401425,0.00003282588,0.000008754137,0.000011824028],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.9987614,0.00018761441,0.00031451072,0.00016532122,0.00045040436,0.00012072179],"domain_scores_gemma":[0.9992256,0.00021433081,0.00020934269,0.00014627332,0.00009422012,0.00011021152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013389028,0.00012791593,0.000373732,0.00004529835,0.000028611908,0.0000043188147,0.000090471236,0.000036790618,0.000045275418],"category_scores_gemma":[0.000094352676,0.000085066305,0.000020318465,0.00018645704,0.00021303567,0.000027170683,0.000035398672,0.00012908962,1.3024848e-7],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003154566,0.00029088184,0.41890696,0.00018721921,0.00011764539,0.000013821215,0.5791755,8.030396e-7,0.000022438324,0.000022708567,0.00086376903,0.00008286184],"study_design_scores_gemma":[0.007069322,0.0022410282,0.5481728,0.00014587436,0.00021177037,0.0000025623256,0.43770003,0.0000016469454,0.00083712867,0.000012587434,0.0034295802,0.00017570615],"about_ca_topic_score_codex":0.40939912,"about_ca_topic_score_gemma":0.26292837,"teacher_disagreement_score":0.14647076,"about_ca_system_score_codex":0.000013812125,"about_ca_system_score_gemma":0.00021320817,"threshold_uncertainty_score":0.75052124},"labels":[],"label_agreement":null},{"id":"W3096338919","doi":"10.1182/blood-2020-138498","title":"CC-486 Improves Overall Survival (OS) and Relapse-Free Survival (RFS) for Patients with Acute Myeloid Leukemia (AML) in First Remission after Intensive Chemotherapy (IC), Regardless of Amount of Consolidation Received: Results from the Phase III QUAZAR AML-001 Maintenance Trial","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Consolidation (business); Chemotherapy; Surgery","score_opus":0.017199722836313398,"score_gpt":0.26618430315766944,"score_spread":0.24898458032135604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096338919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894239,0.000111678506,0.00012718597,0.005381482,0.00016611494,0.0031950674,0.0014173138,0.00003110871,0.00014619582],"genre_scores_gemma":[0.99593234,0.00065050024,0.001102492,0.0006927708,0.00032804254,0.00013604213,0.0008769864,0.000080005186,0.00020079351],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99667186,0.00020866284,0.0010782903,0.00077529374,0.0007902312,0.00047566852],"domain_scores_gemma":[0.99592346,0.0011765826,0.00069455453,0.0008490194,0.0011167821,0.00023957789],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000772581,0.0003816855,0.0010242364,0.000109243665,0.00008312952,0.000030786705,0.0004117447,0.0002677649,0.000018080791],"category_scores_gemma":[0.003180389,0.00025512688,0.00013566896,0.00032932614,0.00037464415,0.00022899883,0.00020245768,0.00053532363,0.0000015594707],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9388704,0.0034603018,0.00570797,0.00031838144,0.0011321167,0.00008652323,0.007338872,0.000003604938,0.032927036,0.00006053966,0.0069938274,0.0031004495],"study_design_scores_gemma":[0.9357337,0.0067710797,0.023992693,0.00091977365,0.0005577198,0.000007133011,0.0013068998,0.0007893372,0.02691699,0.00014742924,0.002423561,0.00043370106],"about_ca_topic_score_codex":0.0015235086,"about_ca_topic_score_gemma":0.00037276212,"teacher_disagreement_score":0.018284723,"about_ca_system_score_codex":0.00026273108,"about_ca_system_score_gemma":0.00055243284,"threshold_uncertainty_score":0.9999901},"labels":[],"label_agreement":null},{"id":"W3096344781","doi":"10.1182/blood-2020-138667","title":"Reducing Cytogenetic Testing in the Era of Next Generation Sequencing (NGS); Are We Choosing Wisely?","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Medicine; DNA sequencing; Hematologic Neoplasms; Triage; Bone marrow; Oncology; Pathology; Bioinformatics; Internal medicine; Computational biology; Cancer; Biology; DNA; Emergency medicine","score_opus":0.07783649295493959,"score_gpt":0.2548498118513315,"score_spread":0.17701331889639188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096344781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952634,0.0031507632,0.00032932428,0.00086037774,0.000048040223,0.00013569041,0.000010337369,0.0000046107643,0.00019743505],"genre_scores_gemma":[0.9956561,0.00041631778,0.0025797174,0.0006840445,0.0006151369,0.0000102235235,0.000021619066,0.000014996547,0.0000018935443],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992939,0.000038829225,0.00020939267,0.00022755006,0.000086018175,0.00014429535],"domain_scores_gemma":[0.99957967,0.00003165282,0.00011291499,0.00018029734,0.000057477213,0.000038011793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012299753,0.000094148076,0.00010493314,0.000015052502,0.00005593089,0.000037321606,0.0001437712,0.000059420025,0.0000024664223],"category_scores_gemma":[0.00034423353,0.00008544149,0.000038101105,0.00015441458,0.000025761467,0.0000031379038,0.000055401655,0.000100464116,0.000001007393],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000055550186,0.000031008294,0.005471634,0.000026904458,0.000011463932,0.0000059383883,0.0004763083,0.0041733347,0.98738813,0.00000963954,0.0001340929,0.0022659588],"study_design_scores_gemma":[0.0008087853,0.00024025426,0.0027618853,0.00009941314,0.000056363268,0.00002545143,0.000646703,0.004268581,0.99022585,0.00003581732,0.0006436271,0.0001872522],"about_ca_topic_score_codex":0.000077085235,"about_ca_topic_score_gemma":0.00005462513,"teacher_disagreement_score":0.0028377054,"about_ca_system_score_codex":0.000011313425,"about_ca_system_score_gemma":0.0001245963,"threshold_uncertainty_score":0.3484203},"labels":[],"label_agreement":null},{"id":"W3096347403","doi":"10.1182/blood-2020-136588","title":"Outcome Among Adolescents and Young Adults with Mature B-Cell Non Hodgkin Lymphoma at Pediatric Versus Adult Centers: A Population-Based Study Using the IMPACT Cohort","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; Pediatric Oncology Group; University of Toronto; St. Michael's Hospital; Occupational Cancer Research Centre; Hospital for Sick Children","funders":"","keywords":"Medicine; Population; Hazard ratio; Cohort; Young adult; Proportional hazards model; Internal medicine; Pediatrics; Confidence interval; Environmental health","score_opus":0.013732101847511693,"score_gpt":0.27518084212538163,"score_spread":0.26144874027786996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096347403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975392,0.00006841354,0.000044853285,0.00007123306,0.00008288353,0.0020395133,0.0000360771,0.0000655986,0.00005221636],"genre_scores_gemma":[0.99916977,0.0000075742983,0.00017212311,0.00016404866,0.00031597167,0.000029266745,0.000052777992,0.000069126785,0.000019358813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99771345,0.000101830825,0.0003378127,0.0005297714,0.0008476211,0.0004695223],"domain_scores_gemma":[0.99876577,0.00008998472,0.00016833133,0.00040909214,0.00017166176,0.0003951697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001332558,0.00032839432,0.00041395595,0.0001119215,0.00019150779,0.000066164714,0.00018839315,0.00012538,0.000017421278],"category_scores_gemma":[0.00015720191,0.00019952795,0.000100183126,0.0005067251,0.00005091637,0.00009727558,0.00014073859,0.00025107028,0.000011030176],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005838751,0.0010081666,0.9909973,0.00027403104,0.00017802716,0.00033190192,0.0011146514,0.00006525786,0.000094268704,4.875468e-8,0.00006686284,0.00003070306],"study_design_scores_gemma":[0.05568413,0.0015720197,0.9275738,0.00013022119,0.0010682965,0.000039707105,0.0008805593,0.012750065,0.00010206666,7.0398386e-8,3.5074595e-7,0.0001987412],"about_ca_topic_score_codex":0.0024263477,"about_ca_topic_score_gemma":0.00017234733,"teacher_disagreement_score":0.06342356,"about_ca_system_score_codex":0.0005648765,"about_ca_system_score_gemma":0.00027958746,"threshold_uncertainty_score":0.8136513},"labels":[],"label_agreement":null},{"id":"W3096362290","doi":"10.1182/blood-2020-142086","title":"Opposing Evolutionary Pressures Drive Clonal Evolution and Health Outcomes in the Aging Blood System","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; Wilfrid Laurier University; Public Health Ontario; Ontario Institute for Cancer Research","funders":"","keywords":"Biology; Somatic evolution in cancer; Genetics; Disease; Genotyping; Population; Cancer; Gene; Genotype; Medicine; Internal medicine","score_opus":0.01371534882078874,"score_gpt":0.24802150399079345,"score_spread":0.23430615517000472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096362290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817857,0.013709607,0.0004208659,0.0034312368,0.00007259858,0.0002615978,0.00006327482,0.0000126607565,0.00024246941],"genre_scores_gemma":[0.9979811,0.000255798,0.00041171216,0.0010232183,0.00025513978,0.000016725875,0.00003969092,0.000009755961,0.000006908948],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992828,0.000058577578,0.00016328687,0.00023057606,0.000098514225,0.00016625496],"domain_scores_gemma":[0.9996928,0.000025369642,0.000063509906,0.00013207414,0.000022460446,0.0000637889],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014077897,0.0000961393,0.00012187571,0.000018842362,0.000099909674,0.00002800215,0.00011396115,0.00005125084,7.4085256e-7],"category_scores_gemma":[0.000042901105,0.00007978905,0.00003875231,0.00005342229,0.000032917986,0.0000029567032,0.00008732528,0.00007448567,9.094e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000061818144,0.00060308666,0.9253952,0.00042685872,0.0003388789,0.00005139325,0.0017291035,0.0007381045,0.05918214,0.007529624,0.0032397716,0.0007040116],"study_design_scores_gemma":[0.007254754,0.0016818374,0.96310914,0.00020798549,0.00036204397,0.0002937752,0.0030487503,0.0013835003,0.012325683,0.00025805057,0.009365974,0.0007085116],"about_ca_topic_score_codex":0.00014927822,"about_ca_topic_score_gemma":0.00006653839,"teacher_disagreement_score":0.046856456,"about_ca_system_score_codex":0.000013177482,"about_ca_system_score_gemma":0.00011063639,"threshold_uncertainty_score":0.32537034},"labels":[],"label_agreement":null},{"id":"W3096378490","doi":"10.1182/blood-2020-139785","title":"DREAMM-8: A Phase III Study of the Efficacy and Safety of Belantamab Mafodotin with Pomalidomide and Dexamethasone (B-Pd) Vs Pomalidomide Plus Bortezomib and Dexamethasone (PVd) in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pomalidomide; Medicine; Lenalidomide; Dexamethasone; Bortezomib; Internal medicine; Multiple myeloma; Refractory (planetary science); Oncology; Phases of clinical research; Surgery; Clinical trial","score_opus":0.016220613694295595,"score_gpt":0.25784255581232624,"score_spread":0.24162194211803065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096378490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99500996,0.00064531696,0.000016569378,0.00017655834,0.000014431395,0.0039120596,0.00012268391,0.0000309605,0.00007148915],"genre_scores_gemma":[0.99816,0.000108527674,0.0014231123,0.00007380525,0.000030446,0.000068212794,0.0000401348,0.00006607352,0.000029658962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99689466,0.00036160127,0.0007097488,0.0007478152,0.0007843964,0.0005017517],"domain_scores_gemma":[0.9975381,0.0008266702,0.00040387938,0.00055688823,0.00017969537,0.00049479184],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037146758,0.00045000185,0.001203469,0.00019618809,0.0001344621,0.000025274234,0.00017039465,0.00013345672,0.000019574265],"category_scores_gemma":[0.000678764,0.00028066523,0.000055278033,0.0005489753,0.00043686168,0.00015397544,0.0002621683,0.00045139124,7.724567e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.078885466,0.008168006,0.90077776,0.00025453512,0.00095169834,0.00023742767,0.0036438645,0.0000055504966,0.0028371473,0.0000038797025,0.0000074757572,0.004227207],"study_design_scores_gemma":[0.28305608,0.011237146,0.6990346,0.0003350024,0.0006636702,0.000047974496,0.0009440327,0.00012860203,0.0043362384,0.000001561922,0.000013816936,0.00020131383],"about_ca_topic_score_codex":0.0008941816,"about_ca_topic_score_gemma":0.00058097247,"teacher_disagreement_score":0.20417063,"about_ca_system_score_codex":0.000054405147,"about_ca_system_score_gemma":0.00020435987,"threshold_uncertainty_score":0.99996454},"labels":[],"label_agreement":null},{"id":"W3096383113","doi":"10.1182/blood-2020-137572","title":"A Multicenter Phase 1/2 Clinical Trial of Tagraxofusp, a CD123-Targeted Therapy, in Patients with Poor-Risk Primary and Secondary Myelofibrosis","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Myelofibrosis; Internal medicine; Ruxolitinib; Oncology; Phases of clinical research; Clinical trial; Gastroenterology; Bone marrow","score_opus":0.02269525113218795,"score_gpt":0.2888989259235585,"score_spread":0.2662036747913705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096383113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99688876,0.00032952934,0.0000049017162,0.0004536935,0.000047414633,0.001882965,0.00015444921,0.000018553901,0.00021975643],"genre_scores_gemma":[0.9965704,0.00048882555,0.0014382914,0.001138833,0.00010786583,0.00010177844,0.000117380565,0.000025663652,0.000010936312],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983725,0.00016299417,0.0005812692,0.00041319357,0.00027144406,0.00019861548],"domain_scores_gemma":[0.9990704,0.00020046385,0.00022334578,0.00018339016,0.00009429131,0.00022807327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015906939,0.00021664497,0.00068358897,0.000065426706,0.000033239183,0.000012327032,0.000051664127,0.00010113158,0.000119131204],"category_scores_gemma":[0.00013722926,0.00014493923,0.00011347846,0.0001607869,0.00009388088,0.00007001663,0.000040254694,0.00024983377,0.0000063149714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.104800016,0.015325717,0.8501441,0.00006301053,0.0005146817,0.000032160126,0.0003789544,1.09789895e-7,0.0001679908,0.000002352703,0.00015459167,0.028416302],"study_design_scores_gemma":[0.37120265,0.025151303,0.6005174,0.00006677232,0.0002453547,9.349341e-7,0.000016428878,0.00001300658,0.0023719887,0.0000012028631,0.0003153003,0.00009768009],"about_ca_topic_score_codex":0.00004019558,"about_ca_topic_score_gemma":0.000018099465,"teacher_disagreement_score":0.26640263,"about_ca_system_score_codex":0.000014315362,"about_ca_system_score_gemma":0.00012583705,"threshold_uncertainty_score":0.591045},"labels":[],"label_agreement":null},{"id":"W3096384900","doi":"10.1182/blood-2020-133855","title":"Clinical Efficacy and Safety of Oral Decitabine/Cedazuridine in 133 Patients with Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Health Sciences Centre; Sunnybrook Health Science Centre; Hôpital Maisonneuve-Rosemont; University of Alberta; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Decitabine; Medicine; Chronic myelomonocytic leukemia; Myelodysplastic syndromes; Azacitidine; International Prognostic Scoring System; Adverse effect; Internal medicine; Pharmacology; Gastroenterology; Oncology; Bone marrow","score_opus":0.02441159265760262,"score_gpt":0.2943761607689005,"score_spread":0.2699645681112979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096384900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975133,0.00071998715,0.000042344043,0.00054295384,0.000029433782,0.0008719034,0.00002410639,0.00004255614,0.0002134158],"genre_scores_gemma":[0.9979572,0.0006016919,0.0010600945,0.00014036504,0.000093990406,0.000013250494,0.000041896263,0.00005155456,0.000039910738],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976512,0.00012504046,0.00071795215,0.00060258125,0.00044188224,0.0004613321],"domain_scores_gemma":[0.998343,0.00058164116,0.00014542355,0.00031870257,0.0001239047,0.00048733872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003471709,0.00028060548,0.00087416254,0.00016046774,0.00004913737,0.0000166565,0.00015489689,0.00017651897,0.00005370878],"category_scores_gemma":[0.00097570784,0.00021802107,0.00005552281,0.00049686985,0.00040579954,0.00011536971,0.00024169033,0.00061750575,0.000017330407],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00443835,0.00077386195,0.97635853,0.00082038017,0.0004477128,0.0003962366,0.0003461405,0.00003569925,0.0009605653,0.00007401723,0.00015634927,0.015192128],"study_design_scores_gemma":[0.051508,0.0050775083,0.9398183,0.00044287118,0.00039140703,0.0000956378,0.000045808767,0.0013176202,0.0006256058,0.000009080858,0.0004236522,0.00024447448],"about_ca_topic_score_codex":0.000048537644,"about_ca_topic_score_gemma":0.00003191564,"teacher_disagreement_score":0.04706965,"about_ca_system_score_codex":0.00024437162,"about_ca_system_score_gemma":0.00092596404,"threshold_uncertainty_score":0.88906413},"labels":[],"label_agreement":null},{"id":"W3096392740","doi":"10.1182/blood-2020-139736","title":"ATG and Post-Transplant Cyclophosphamide Do Not Abrogate the Inferior Outcome Risk Conferred By HLA-Α and HLA-B Mismatched Unrelated Donors","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Cumulative incidence; Medicine; Internal medicine; Cyclophosphamide; Retrospective cohort study; Proportional hazards model; Log-rank test; Transplantation; Incidence (geometry); Cohort; Oncology; Immunology; Gastroenterology; Chemotherapy","score_opus":0.013055756292346087,"score_gpt":0.2392191001584644,"score_spread":0.2261633438661183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096392740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918329,0.0011534756,0.00022130497,0.0049896087,0.00007794616,0.0008130624,0.00029745448,0.00013979267,0.00047443868],"genre_scores_gemma":[0.99557245,0.0019272894,0.00044596885,0.0017122364,0.000042427524,0.000025766447,0.00012044831,0.000045582943,0.00010783719],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983207,0.000101804995,0.00053607504,0.00043036777,0.00029139017,0.0003196436],"domain_scores_gemma":[0.99886554,0.0003130028,0.00014583289,0.00025204057,0.000069887195,0.00035371122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024971913,0.0002975727,0.00049600564,0.000039250666,0.00013850028,0.000061722574,0.00010650597,0.00019276678,0.000082808736],"category_scores_gemma":[0.00009816927,0.00021193155,0.00007854923,0.00015862654,0.00015465132,0.00007341307,0.000025616644,0.00039134888,0.00004432421],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007814369,0.00019141109,0.8486275,0.00075359107,0.0005439037,0.0002911478,0.01283814,0.0000031770057,0.13493216,0.00009385195,0.00010476181,0.00083888945],"study_design_scores_gemma":[0.024329484,0.0008015518,0.843418,0.00046896248,0.004061752,0.00095517625,0.0015751931,0.00032049732,0.12076774,0.000056711484,0.0025430613,0.00070187025],"about_ca_topic_score_codex":0.00030922669,"about_ca_topic_score_gemma":0.000023436412,"teacher_disagreement_score":0.023548046,"about_ca_system_score_codex":0.0000104252595,"about_ca_system_score_gemma":0.000053990098,"threshold_uncertainty_score":0.86423177},"labels":[],"label_agreement":null},{"id":"W3096394540","doi":"10.1182/blood-2020-143169","title":"Evidence of Educational Bias in Cognitive Screening of Adults with Sickle Cell Disease: Comparison of Available Tools and Possible Strategies for Mitigation","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Centre Hospitalier de l’Université de Montréal; University Health Network","funders":"","keywords":"Montreal Cognitive Assessment; Dementia; Cognition; Population; Gerontology; Medicine; Disease; Inclusion (mineral); Psychology; Cognitive impairment; Pediatrics; Clinical psychology; Family medicine; Psychiatry; Environmental health; Pathology","score_opus":0.07149292074545707,"score_gpt":0.30523156431078596,"score_spread":0.2337386435653289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096394540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924448,0.005897251,0.00025348377,0.00041785085,0.0000050454973,0.00045140044,0.00005468214,0.0000034771801,0.0004719677],"genre_scores_gemma":[0.99823576,0.00012348605,0.0015129609,0.000027568034,0.000009541853,0.000014444609,0.000042490294,0.000005969872,0.000027777036],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99942887,0.000015993626,0.00023398515,0.00012048369,0.00012534336,0.00007534521],"domain_scores_gemma":[0.99928826,0.0002716073,0.00015312505,0.000047841284,0.00017539407,0.00006377556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000058403613,0.00006168771,0.00020938387,0.000039058003,0.000015056784,0.0000052805735,0.000025821715,0.00003413305,0.000037426995],"category_scores_gemma":[0.00019752905,0.00005060067,0.000025307614,0.00015691356,0.000090323156,0.00011687246,0.000007948105,0.000055961267,4.870697e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041945153,0.0016314767,0.9590904,0.006160414,0.000115876814,0.0000023728423,0.007408762,0.00031158965,0.019043064,0.00027364018,0.00023074703,0.0015371515],"study_design_scores_gemma":[0.030288136,0.007884249,0.37124166,0.02830827,0.001702763,0.00000607991,0.08237387,0.01162108,0.46583974,0.00029220048,0.000020646037,0.00042131715],"about_ca_topic_score_codex":0.000054339496,"about_ca_topic_score_gemma":0.0000120139875,"teacher_disagreement_score":0.5878487,"about_ca_system_score_codex":0.0000024034443,"about_ca_system_score_gemma":0.0002952439,"threshold_uncertainty_score":0.20634353},"labels":[],"label_agreement":null},{"id":"W3096400445","doi":"10.1182/blood-2020-136415","title":"Isatuximab Plus Carfilzomib and Dexamethasone Versus Carfilzomib and Dexamethasone in Relapsed Multiple Myeloma Patients with Renal Impairment: Ikema Subgroup Analysis","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Carfilzomib; Medicine; Lenalidomide; Pomalidomide; Dexamethasone; Internal medicine; Renal function; Multiple myeloma; Adverse effect; Interim analysis; Oncology; Urology; Gastroenterology; Randomized controlled trial","score_opus":0.01947837347230705,"score_gpt":0.2509341816604504,"score_spread":0.23145580818814335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096400445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965606,0.0011630997,0.000055204117,0.00041384037,0.000031237323,0.0013305268,0.00016347652,0.00008559008,0.00019647049],"genre_scores_gemma":[0.99323505,0.00013733719,0.005851699,0.00013763101,0.00007686551,0.00011605513,0.00032739053,0.00006244961,0.000055539236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99670535,0.00020857855,0.0004913447,0.0010063533,0.00079337443,0.0007949948],"domain_scores_gemma":[0.99770874,0.0004924753,0.0002049717,0.00047825804,0.0001680974,0.00094746926],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002566602,0.0004858974,0.0010955374,0.00045981893,0.00014835392,0.00007123972,0.00014148284,0.00019833844,0.00008028066],"category_scores_gemma":[0.0007612442,0.00038694605,0.00015412066,0.0014600079,0.00023272142,0.00015918267,0.00019687484,0.00046509987,0.0000138743],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014405179,0.0014130892,0.97362417,0.00016257397,0.0031709066,0.0006509377,0.0014662079,0.000022356064,0.00096959027,0.0000054043626,0.000033746135,0.004075848],"study_design_scores_gemma":[0.13557974,0.003881922,0.8521402,0.000085000735,0.0024162417,0.000018972873,0.00031366435,0.0032650514,0.0018678413,0.000003766969,0.00006446124,0.00036317788],"about_ca_topic_score_codex":0.0011561981,"about_ca_topic_score_gemma":0.0013909631,"teacher_disagreement_score":0.121484,"about_ca_system_score_codex":0.00017369623,"about_ca_system_score_gemma":0.0001702694,"threshold_uncertainty_score":0.99985826},"labels":[],"label_agreement":null},{"id":"W3096417220","doi":"10.1182/blood-2020-140950","title":"Examination and Validation of a Patient-Centric Joint Metric: \"Problem Joint\"; Empirical Evidence from the CHESS US Dataset","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"","keywords":"Haemophilia; Medicine; Hemarthrosis; Synovitis; Haemophilia A; Joint pain; Chronic pain; Arthropathy; Metric (unit); Physical therapy; Intensive care medicine; Pediatrics; Surgery; Arthritis; Internal medicine; Osteoarthritis; Alternative medicine; Operations management","score_opus":0.14294149128351905,"score_gpt":0.3328153064210151,"score_spread":0.18987381513749604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096417220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933702,0.0013983253,0.000038556023,0.0044143354,0.0000144412725,0.00047785527,0.00020396992,0.000014282531,0.000068068715],"genre_scores_gemma":[0.9980932,0.00028492106,0.0005459026,0.00022537909,0.0000824284,0.00001485321,0.00073378335,0.000007924465,0.000011638777],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988327,0.00014320842,0.00023813349,0.00022917196,0.0004258004,0.00013099298],"domain_scores_gemma":[0.9992473,0.00026712407,0.00008321555,0.00019809278,0.000082962455,0.0001212981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002455589,0.00008827127,0.00019357451,0.00006909414,0.000049928713,0.000020807976,0.000062547086,0.000052513507,0.000086941305],"category_scores_gemma":[0.0007819682,0.000052339215,0.00003603966,0.00048219622,0.000052580916,0.00009470563,0.00009351466,0.00012381724,0.000021088363],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015854149,0.0014644865,0.9170276,0.00034069797,0.00036471974,0.000110190726,0.0040815296,0.000004777279,0.041257013,0.000009455852,0.008974838,0.02620618],"study_design_scores_gemma":[0.0036414692,0.001195988,0.631472,0.00027510614,0.00064523774,0.000017959319,0.00029990898,0.0004993658,0.36054048,0.00003927631,0.0012500301,0.00012320065],"about_ca_topic_score_codex":0.00008293212,"about_ca_topic_score_gemma":0.0000018355789,"teacher_disagreement_score":0.31928346,"about_ca_system_score_codex":0.000020401721,"about_ca_system_score_gemma":0.00005991054,"threshold_uncertainty_score":0.21343313},"labels":[],"label_agreement":null},{"id":"W3096432266","doi":"10.1182/blood.v130.suppl_1.2433.2433","title":"Regulation of Lipid Metabolism and Cell Cycle Progression By PU.1 in Myeloid Progenitor Cells","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Cell growth; Cell cycle; Myeloid; Biology; Cell biology; Progenitor cell; Lipogenesis; Lipid metabolism; Cellular differentiation; ATP citrate lyase; Cancer research; Chemistry; Stem cell; Cell; Biochemistry; Citrate synthase","score_opus":0.01039083079978154,"score_gpt":0.2820967414355555,"score_spread":0.271705910635774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096432266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950363,0.00096785754,0.000005464968,0.0004239055,0.000064989144,0.0006838715,0.000012941838,0.000020159801,0.002784491],"genre_scores_gemma":[0.9962629,0.00018651974,0.0021521554,0.000016997166,0.00021583082,0.000038425074,0.000015344318,0.00002445445,0.0010873731],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998884,0.000047947527,0.00023785245,0.00025908518,0.00032600708,0.00024506936],"domain_scores_gemma":[0.9990908,0.000029649289,0.00017268804,0.00049170945,0.00008661242,0.00012852687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003096077,0.00011774162,0.0002783792,0.00010120338,0.00009464206,0.00003404675,0.00015729817,0.0001312145,0.000034719724],"category_scores_gemma":[0.000100638594,0.000096858326,0.000039394938,0.00007454621,0.00013999648,0.00014356757,0.00013508368,0.00019865623,0.000013049755],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012905739,0.00051819277,0.022794588,0.00018673907,0.000021782882,0.0000130461685,0.00019977211,2.8215462e-7,0.96793824,0.000013675576,0.0008589577,0.007325642],"study_design_scores_gemma":[0.005025924,0.00012684005,0.12050482,0.00009344877,0.000066183165,0.000011611676,0.00003241055,0.0001646739,0.8711952,0.00003736339,0.002656016,0.00008553124],"about_ca_topic_score_codex":0.00006819237,"about_ca_topic_score_gemma":0.000004014778,"teacher_disagreement_score":0.09771024,"about_ca_system_score_codex":0.000026850232,"about_ca_system_score_gemma":0.00011413459,"threshold_uncertainty_score":0.3949768},"labels":[],"label_agreement":null},{"id":"W3096442128","doi":"10.1182/blood-2020-142591","title":"Impact of Age, Comorbidity, and Polypharmacy on Treatment and Survival for Aggressive Non-Hodgkin Lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; Research Institute in Oncology and Hematology; University of Manitoba","funders":"","keywords":"Medicine; Comorbidity; Polypharmacy; Proportional hazards model; Cancer registry; Population; Cohort; Internal medicine; Aggressive lymphoma; Cancer; Retrospective cohort study; Oncology; Lymphoma; Pediatrics; Environmental health","score_opus":0.05732195635334823,"score_gpt":0.29528751522203106,"score_spread":0.2379655588686828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096442128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99319285,0.0018698856,0.0001295093,0.00028747533,0.00009921911,0.00029421947,0.00080443756,0.000010974542,0.0033114047],"genre_scores_gemma":[0.9978052,0.0015805569,0.00013563558,0.00016011817,0.00019457714,0.000020663334,0.000012082001,0.000021433047,0.000069739144],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991895,0.0000051781035,0.00030317775,0.00028845776,0.000013391277,0.00020031357],"domain_scores_gemma":[0.99928993,0.000076656295,0.000341664,0.00011805618,0.000015428446,0.00015824343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000802452,0.00016654024,0.0004972796,0.00006326867,0.00005145845,0.000037424994,0.0000775187,0.000058753052,0.000038099875],"category_scores_gemma":[0.00007685474,0.00015871703,0.00012664522,0.00005291604,0.00006655423,0.0001074969,0.00003414464,0.000031073105,0.00001298678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012459642,0.0022161559,0.89653784,0.000207117,0.0015385746,0.00005640785,0.003461242,0.000076300894,0.00079775346,0.025099328,0.0021890108,0.06657431],"study_design_scores_gemma":[0.02164445,0.005917084,0.95335156,0.000045772493,0.00010594387,0.000012939303,0.000049575578,0.0008455931,0.0036532336,0.005420082,0.008354572,0.0005992103],"about_ca_topic_score_codex":0.00058363477,"about_ca_topic_score_gemma":0.000018973938,"teacher_disagreement_score":0.06597511,"about_ca_system_score_codex":0.00005009595,"about_ca_system_score_gemma":0.00003699506,"threshold_uncertainty_score":0.64722925},"labels":[],"label_agreement":null},{"id":"W3096445279","doi":"10.1182/blood-2020-140141","title":"Selinexor, Lenalidomide and Dexamethasone (SRd) for Patients with Relapsed/Refractory and Newly Diagnosed Multiple Myeloma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; CancerCare Manitoba; Vancouver General Hospital; Princess Margaret Cancer Centre; Institute of Cancer Research; University of Calgary; University of Alberta; Queen Elizabeth II Health Sciences Centre; Université de Montréal; Hôpital Maisonneuve-Rosemont; Dalhousie University","funders":"","keywords":"Lenalidomide; Dexamethasone; Multiple myeloma; Medicine; Internal medicine; Oncology; Refractory (planetary science); Carfilzomib; Pomalidomide; Thalidomide; Biology","score_opus":0.021725629664099987,"score_gpt":0.2593842463441836,"score_spread":0.23765861668008362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096445279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965042,0.00083184877,0.00018834976,0.0007451417,0.000018956014,0.0014530679,0.00011048767,0.00006507062,0.00008290788],"genre_scores_gemma":[0.9864653,0.00020337557,0.012336833,0.00045307475,0.0001310304,0.00012661955,0.0001523581,0.000046553945,0.00008485589],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867463,0.000044877223,0.00020555174,0.00043708112,0.00028751636,0.0003503526],"domain_scores_gemma":[0.99843687,0.00057983765,0.00007321608,0.00018674761,0.00014521446,0.00057813077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008719994,0.00021777315,0.00036632858,0.000060746628,0.000108754815,0.000032832184,0.000054013977,0.00008648659,0.000021740518],"category_scores_gemma":[0.0011225608,0.00015707112,0.000048553902,0.000117849275,0.00009495166,0.00011232479,0.000056808483,0.00015946903,0.000008845517],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048335684,0.0013567014,0.9686383,0.00025585337,0.00044854544,0.0001488995,0.00041097158,5.193842e-7,0.0013400865,0.000007351238,0.00040454342,0.022154635],"study_design_scores_gemma":[0.122385815,0.0055576,0.86224866,0.00013380536,0.00047518886,0.00002049024,0.0001290897,0.00058437476,0.0041722157,0.000016943946,0.0040068342,0.00026899524],"about_ca_topic_score_codex":0.00005827097,"about_ca_topic_score_gemma":0.000035347504,"teacher_disagreement_score":0.11755224,"about_ca_system_score_codex":0.000018158646,"about_ca_system_score_gemma":0.0000713254,"threshold_uncertainty_score":0.6405174},"labels":[],"label_agreement":null},{"id":"W3096462006","doi":"10.1182/blood-2020-143139","title":"Genetic Variants That Influence Fetal Hemoglobin Expression from Hydroxyurea Treatment","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Fetal hemoglobin; Medicine; Population; Genome-wide association study; Sickle cell anemia; Single-nucleotide polymorphism; Internal medicine; Oncology; Biology; Disease; Genotype; Fetus; Genetics; Pregnancy; Gene","score_opus":0.012547994505685233,"score_gpt":0.22369206941841688,"score_spread":0.21114407491273166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096462006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99396884,0.0020520717,0.00006186251,0.0013059062,0.00007312474,0.0003606731,0.00003102389,0.00012776231,0.0020187171],"genre_scores_gemma":[0.99647677,0.00052282127,0.0015384682,0.0011413218,0.0001278044,0.000018083305,0.000037777758,0.000027921324,0.00010902387],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988869,0.000032913787,0.00020442475,0.00037498854,0.00023586347,0.00026493266],"domain_scores_gemma":[0.9992705,0.00002689665,0.00006265205,0.00028094498,0.00002262782,0.0003363513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000019384584,0.00021015662,0.00029627112,0.000027738157,0.00007616866,0.00002089433,0.00009576099,0.00017236685,0.00024617952],"category_scores_gemma":[0.000040865296,0.00015250164,0.00011283134,0.00013253726,0.000045856614,0.000059317605,0.00005052698,0.00014524025,0.00026193055],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004313007,0.0024343696,0.29552132,0.00009889061,0.0006082226,0.0020571498,0.003609461,0.00016467938,0.6799389,0.000011599004,0.0009717118,0.014152361],"study_design_scores_gemma":[0.03898581,0.0033867338,0.3969783,0.0006825686,0.0022202907,0.00028131466,0.00117986,0.001777601,0.53940004,0.0002358751,0.013863052,0.0010085636],"about_ca_topic_score_codex":0.00023323693,"about_ca_topic_score_gemma":0.0000033887802,"teacher_disagreement_score":0.14053889,"about_ca_system_score_codex":0.00002594309,"about_ca_system_score_gemma":0.00008482387,"threshold_uncertainty_score":0.6218837},"labels":[],"label_agreement":null},{"id":"W3096469569","doi":"10.1182/blood-2020-136133","title":"Risk of Hypertension in Hemophilia Patients with a History of Inhibitors","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Clotting factor; Population; Pediatrics; Retrospective cohort study; Internal medicine; Family history; Cohort; Haemophilia; Hepatitis C","score_opus":0.022900671547705614,"score_gpt":0.2222006873808337,"score_spread":0.1993000158331281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096469569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99775726,0.00037427133,2.702127e-7,0.00026582277,0.0000195023,0.0002438565,0.000005493687,0.000008297427,0.0013252255],"genre_scores_gemma":[0.9995186,0.00004349763,0.00017419398,0.0000433364,0.000028999566,0.0000032502915,0.00001060645,0.0000085695,0.00016899496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99932164,0.00002607957,0.00016640997,0.00012296393,0.00026390792,0.000098992976],"domain_scores_gemma":[0.9996179,0.000027201915,0.000060540475,0.000115959854,0.00009294052,0.000085459236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004963384,0.000066103865,0.00023290564,0.00007333377,0.0000052984356,3.8390493e-7,0.000032705335,0.0000439233,0.00003460861],"category_scores_gemma":[0.000107177286,0.00004286848,0.000041389027,0.00014202144,0.000066594934,0.000020751268,0.000020813633,0.00010357223,0.000007384964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038806692,0.0014804616,0.98869056,0.0001512027,0.00006631971,0.00004805423,0.00045993034,6.996251e-7,0.0071796738,0.0000025102727,0.00073127315,0.0008012377],"study_design_scores_gemma":[0.018089354,0.0024648851,0.9430671,0.00022872578,0.0003087249,0.0000035181738,0.00006427842,0.000059433052,0.034811,0.000007836681,0.00079941744,0.0000957349],"about_ca_topic_score_codex":0.00006973475,"about_ca_topic_score_gemma":0.0000040430173,"teacher_disagreement_score":0.045623478,"about_ca_system_score_codex":0.000036318277,"about_ca_system_score_gemma":0.000117290976,"threshold_uncertainty_score":0.17481259},"labels":[],"label_agreement":null},{"id":"W3096530647","doi":"10.1182/blood-2020-139502","title":"Maternal Red Blood Cell Alloimmunization Managed with Intrauterine Blood Transfusion: Predictors of Poor Outcome","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Interquartile range; Blood transfusion; Pregnancy; Gestational age; Obstetrics; Anemia; Retrospective cohort study; Pediatrics; Exchange transfusion; Birth weight; Logistic regression; Internal medicine","score_opus":0.009721016187303026,"score_gpt":0.2013094377797661,"score_spread":0.19158842159246306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096530647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944104,0.0002367054,0.0004905379,0.0018418742,0.00010012965,0.0007585403,0.000040513434,0.00019945027,0.0019218437],"genre_scores_gemma":[0.9950307,0.00061391917,0.0033612663,0.0004333688,0.00020125305,0.000020114998,0.0000904862,0.00007818858,0.00017073043],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980083,0.00005552249,0.00064758654,0.00044803324,0.0005200124,0.0003205089],"domain_scores_gemma":[0.9990317,0.000023149929,0.00016044409,0.0003812891,0.0001220219,0.0002813761],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012903487,0.00031931413,0.00061172666,0.00011433727,0.000082865205,0.000022099908,0.00021402664,0.00016205903,0.00031539408],"category_scores_gemma":[0.000015429845,0.00025131204,0.00015360519,0.0004564875,0.000078908684,0.00012243078,0.000048964455,0.00033787126,0.000008963913],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011167199,0.0038224857,0.6465671,0.0015898395,0.0010766332,0.00068002706,0.00095669704,0.000021442123,0.34365994,0.00012394962,0.000035109286,0.00035002077],"study_design_scores_gemma":[0.0426205,0.005592012,0.30750737,0.0003788888,0.008095877,0.00044683478,0.00016095731,0.00013456096,0.6338473,0.000016599657,0.00072539854,0.00047369345],"about_ca_topic_score_codex":0.00012326206,"about_ca_topic_score_gemma":0.00002578042,"teacher_disagreement_score":0.33905977,"about_ca_system_score_codex":0.000004949641,"about_ca_system_score_gemma":0.000046214693,"threshold_uncertainty_score":0.9999939},"labels":[],"label_agreement":null},{"id":"W3096533280","doi":"10.1182/blood-2020-141462","title":"Identification of LAG3+ T Cell Populations in the Tumor Microenvironment of Classical Hodgkin Lymphoma and B-Cell Non-Hodgkin Lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; BC Cancer Agency; University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Cancer research; Lymphoma; Tumor microenvironment; Mantle cell lymphoma; T cell; T-cell lymphoma; CD8; Immune system; Medicine; Biology; Immunology","score_opus":0.017817434885302245,"score_gpt":0.24428899797571577,"score_spread":0.22647156309041352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096533280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99686605,0.0009447576,0.00006268594,0.0014238574,0.000033854896,0.0003706457,0.000026801714,0.0000066234566,0.0002647258],"genre_scores_gemma":[0.9989734,0.00013705864,0.00028877993,0.00044074008,0.000043824453,0.000017926463,0.00001866785,0.000012552881,0.00006701532],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990055,0.000059103848,0.00042370558,0.00019110001,0.00020337965,0.000117195654],"domain_scores_gemma":[0.999487,0.000041313877,0.00018536337,0.00022725752,0.000014987603,0.000044087592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018390878,0.000102636666,0.00021182933,0.000052811527,0.000029120058,0.000008897375,0.00010642499,0.000049533308,0.000024806646],"category_scores_gemma":[0.000014235656,0.00007915621,0.0000788102,0.00019863284,0.00011301257,0.000033455563,0.000027082928,0.000040430157,0.0000045971783],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042665578,0.001687075,0.028722826,0.00018375799,0.000030732495,0.000013427061,0.0015006975,0.0000022673405,0.963736,0.000018400126,0.0003836012,0.003294545],"study_design_scores_gemma":[0.008189077,0.00036660154,0.5463376,0.000044649852,0.00015017121,0.00002108566,0.00057488197,0.0001867062,0.44303918,0.000016498316,0.0009925669,0.00008094825],"about_ca_topic_score_codex":0.000084194406,"about_ca_topic_score_gemma":0.00001782486,"teacher_disagreement_score":0.5206968,"about_ca_system_score_codex":0.000026289137,"about_ca_system_score_gemma":0.000049306826,"threshold_uncertainty_score":0.32278967},"labels":[],"label_agreement":null},{"id":"W3096538903","doi":"10.1182/blood-2020-134847","title":"Updated Analysis of Daratumumab Plus Lenalidomide and Dexamethasone (D-Rd) Versus Lenalidomide and Dexamethasone (Rd) in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma (NDMM): The Phase 3 Maia Study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Alberta; University of Calgary","funders":"","keywords":"Medicine; Lenalidomide; Daratumumab; Internal medicine; Multiple myeloma; Transplantation; Minimal residual disease; Phases of clinical research; Oncology; Surgery; Chemotherapy; Bone marrow","score_opus":0.02812058088858904,"score_gpt":0.2912251193874986,"score_spread":0.2631045384989096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096538903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99563944,0.0007976366,0.00009390205,0.00046427225,0.000027038854,0.002477342,0.0003813536,0.00005219838,0.00006681922],"genre_scores_gemma":[0.99797016,0.00020541609,0.00096530153,0.00011613783,0.000039993894,0.00013269059,0.00050013606,0.000053133823,0.000017033406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99658984,0.00040356696,0.0006885523,0.0008277571,0.00085457903,0.0006357097],"domain_scores_gemma":[0.9973874,0.0010425451,0.000234166,0.0005814187,0.00019662408,0.000557831],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004305332,0.00047897056,0.0013167475,0.00049391825,0.00016491358,0.00006489645,0.00022836974,0.00012362027,0.00007764026],"category_scores_gemma":[0.0005428122,0.00031662025,0.00014742812,0.0018424478,0.00024868167,0.0001823959,0.00011056387,0.00041448363,0.000005010621],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.056454457,0.0052130674,0.9220907,0.00010406061,0.0077297552,0.0007693935,0.0031127324,0.00009629427,0.0011802624,0.0000025493914,0.0000555547,0.0031911728],"study_design_scores_gemma":[0.28297403,0.005017978,0.69638664,0.00009038083,0.006791552,0.000008267863,0.0012168387,0.0032901764,0.0038776665,0.0000018505657,0.000044715198,0.00029990484],"about_ca_topic_score_codex":0.0016545617,"about_ca_topic_score_gemma":0.002386719,"teacher_disagreement_score":0.22651958,"about_ca_system_score_codex":0.00006566113,"about_ca_system_score_gemma":0.0001530091,"threshold_uncertainty_score":0.9999286},"labels":[],"label_agreement":null},{"id":"W3096539584","doi":"10.1182/blood-2020-138840","title":"<i>Pegaspargase Re-Challenge after Grade 2 Hypersensitivity Reaction in Childhood Acute Lymphoblastic Leukemia: Results from DFCI 16-001</i>","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Centre hospitalier de l'Université Laval","funders":"","keywords":"Medicine; Asparaginase; Premedication; Dosing; Hypersensitivity reaction; Gastroenterology; Internal medicine; Neutropenia; Lymphoblastic Leukemia; Pharmacology; Chemotherapy; Surgery; Leukemia","score_opus":0.018146891571717956,"score_gpt":0.2456818225713095,"score_spread":0.22753493099959154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096539584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98410237,0.00036910796,0.00006012443,0.006682154,0.00017052815,0.00082314864,0.0005699186,0.00027694114,0.006945695],"genre_scores_gemma":[0.9943245,0.00046527182,0.00060614233,0.0025505421,0.0010948479,0.000079766214,0.0006027906,0.00011214667,0.0001640121],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9959634,0.00022004683,0.0007591344,0.0012221446,0.00096309715,0.0008721625],"domain_scores_gemma":[0.9975016,0.0006178163,0.0001838519,0.0008078252,0.00012996886,0.00075892155],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003063796,0.0004961963,0.00080834056,0.00021411301,0.00008766139,0.00004731059,0.00022270127,0.0004567267,0.00007654916],"category_scores_gemma":[0.0010863348,0.00046621985,0.00019287736,0.0006078115,0.00015870281,0.0002669594,0.00024958627,0.00095379114,0.00064066774],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09111669,0.05129967,0.021606516,0.001491993,0.010038581,0.18042444,0.044085775,0.00025868355,0.51316154,0.00023136401,0.052858595,0.033426158],"study_design_scores_gemma":[0.47057444,0.008217553,0.36248744,0.0025805484,0.0072518606,0.0036222218,0.0037450118,0.010553568,0.10668029,0.0007317836,0.019352918,0.0042023626],"about_ca_topic_score_codex":0.0018629584,"about_ca_topic_score_gemma":0.000465583,"teacher_disagreement_score":0.40648124,"about_ca_system_score_codex":0.001363958,"about_ca_system_score_gemma":0.0009820118,"threshold_uncertainty_score":0.9997789},"labels":[],"label_agreement":null},{"id":"W3096573094","doi":"10.1182/blood-2020-135872","title":"Robust Overall Survival and Sustained Efficacy Outcomes during Long Term Exposure to Momelotinib in JAK Inhibitor Naïve and Previously JAK Inhibitor Treated Intermediate/High Risk Myelofibrosis Patients","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sierra Wireless (Canada)","funders":"","keywords":"Ruxolitinib; Medicine; Myelofibrosis; Internal medicine; Randomized controlled trial; Clinical endpoint; Dosing; Clinical trial; Phases of clinical research; Oncology; Anemia; Gastroenterology; Bone marrow","score_opus":0.013179630735183334,"score_gpt":0.23065253924799684,"score_spread":0.2174729085128135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096573094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99625015,0.0002701557,0.0000022411937,0.00087017677,0.00012593257,0.0022121603,0.0001240591,0.000108008,0.00003712682],"genre_scores_gemma":[0.9984663,0.00031367797,0.00023005427,0.00020984838,0.00028663664,0.00019831868,0.00013976195,0.000075786156,0.00007959255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99727285,0.00016200989,0.0006971537,0.0008791144,0.0004082641,0.0005806305],"domain_scores_gemma":[0.9984435,0.00026056534,0.00019641628,0.00028433057,0.00014909904,0.00066611794],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013287005,0.0005492638,0.0010139702,0.00022425049,0.00014121334,0.000107470696,0.00009396402,0.00018399859,0.000036681125],"category_scores_gemma":[0.00061605027,0.00043754137,0.00011831285,0.0003070925,0.00007169157,0.00017468205,0.0002470871,0.00030857124,0.000014134301],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009634403,0.0019243954,0.99111044,0.00034078816,0.0003682784,0.0002424804,0.0028699709,0.000010549896,0.00063524925,0.0000073398032,0.000050328716,0.0014767081],"study_design_scores_gemma":[0.03315927,0.0030610624,0.95156705,0.00044637016,0.00043369862,0.0000075962207,0.00021006852,0.000009140831,0.010717345,0.0000020962982,0.000009870938,0.0003763983],"about_ca_topic_score_codex":0.00017739266,"about_ca_topic_score_gemma":0.00020154283,"teacher_disagreement_score":0.03954339,"about_ca_system_score_codex":0.00011327887,"about_ca_system_score_gemma":0.00005885147,"threshold_uncertainty_score":0.99980766},"labels":[],"label_agreement":null},{"id":"W3096590361","doi":"10.1182/blood-2020-142404","title":"Nicotinamide Phosphoribosyltransferase Inhibitors Induce Apoptosis of AML Stem Cells through Dysregulation of Lipid Metabolism","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Nicotinamide phosphoribosyltransferase; CD38; NAD+ kinase; Leukemia; Biology; Stem cell; Cancer research; Myeloid leukemia; CD34; Pharmacology; Chemistry; Biochemistry; Cell biology; Immunology; Enzyme","score_opus":0.02651859232030287,"score_gpt":0.257494335165797,"score_spread":0.23097574284549413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096590361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952375,0.0009528049,0.0006238968,0.0012252505,0.00032726227,0.00051261525,0.00009899193,0.00007433909,0.0009472911],"genre_scores_gemma":[0.99707216,0.00031948552,0.0014110564,0.00055997865,0.00050770456,0.000025230267,0.000020681335,0.000043469805,0.000040236893],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99821997,0.000072007344,0.0006902094,0.00032514718,0.00047802698,0.00021465532],"domain_scores_gemma":[0.99900025,0.00007021217,0.0002600612,0.0003224924,0.00020398699,0.00014302236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013366257,0.00020949113,0.00060870685,0.00006643974,0.00003282463,0.0000062382633,0.00011813683,0.00014739412,0.00018561917],"category_scores_gemma":[0.000020171354,0.00020306732,0.000213836,0.00054506277,0.00011504752,0.00015015037,0.000023854396,0.00019859447,0.0000141784885],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031877094,0.00057258486,0.0018818129,0.00033848456,0.00022684694,0.0000019578822,0.0024393706,0.00004355964,0.9918744,0.00050439755,0.000734996,0.0010628441],"study_design_scores_gemma":[0.005916016,0.0003880922,0.0010639934,0.00020180702,0.00038841582,0.0000043007562,0.00029203712,0.000020848262,0.98867697,0.00006116512,0.0028277803,0.00015859364],"about_ca_topic_score_codex":0.000054152155,"about_ca_topic_score_gemma":0.0000010170278,"teacher_disagreement_score":0.0055972454,"about_ca_system_score_codex":0.000026228126,"about_ca_system_score_gemma":0.0001266743,"threshold_uncertainty_score":0.8280845},"labels":[],"label_agreement":null},{"id":"W3096605023","doi":"10.1182/blood-2020-138953","title":"Impact of COVID19 Pandemic on an International MPN Patient Population: Survey Results from 1560 MPN Patients","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Pandemic; Medicine; Coronavirus disease 2019 (COVID-19); Population; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Virology; Internal medicine; Outbreak; Environmental health; Disease","score_opus":0.04748348636769403,"score_gpt":0.320918894982484,"score_spread":0.27343540861479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096605023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957159,0.000020596264,0.0000028433249,0.00019719986,0.00012733098,0.0004139127,0.0030405654,0.000034804754,0.00044683623],"genre_scores_gemma":[0.9923942,0.00004499957,0.00016202625,0.0003737477,0.0001503107,0.000017964785,0.006830384,0.000018567076,0.000007786599],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99846995,0.00012528384,0.0004490804,0.00037580088,0.000438011,0.0001418669],"domain_scores_gemma":[0.9988655,0.00021762292,0.0002190558,0.0002500633,0.00022044253,0.00022733494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000867682,0.0001818523,0.00032748224,0.000054756572,0.00003606241,0.00001587385,0.00008568842,0.0000762472,0.00017559172],"category_scores_gemma":[0.0005712614,0.00013477894,0.000117301584,0.00011396418,0.000017725126,0.00008825738,0.000034184246,0.0001133427,0.000034993318],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017085862,0.0031699352,0.9910155,0.0000050849712,0.0004125806,0.000013945188,0.000624664,0.000058915222,0.00010576331,0.000009941405,0.0004177387,0.0024573412],"study_design_scores_gemma":[0.010307583,0.0046258583,0.9832579,0.000057430196,0.000102123224,0.000001272473,0.0000126961295,0.00012993343,0.0013115585,0.000010925106,0.000072968476,0.0001097853],"about_ca_topic_score_codex":0.002150303,"about_ca_topic_score_gemma":0.00013926267,"teacher_disagreement_score":0.008598997,"about_ca_system_score_codex":0.000086156215,"about_ca_system_score_gemma":0.0000681037,"threshold_uncertainty_score":0.5496126},"labels":[],"label_agreement":null},{"id":"W3096607082","doi":"10.1182/blood-2020-134449","title":"Interim Analysis of ZUMA-12: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) as First-Line Therapy in Patients (Pts) With High-Risk Large B Cell Lymphoma (LBCL)","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Interim; Medicine; Internal medicine; Lymphoma; Oncology; Political science","score_opus":0.025071458830441692,"score_gpt":0.29942498192249317,"score_spread":0.27435352309205147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096607082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99764335,0.0002569014,0.000035530036,0.00010275056,0.000024800227,0.0013727278,0.00013293151,0.000034422956,0.0003965658],"genre_scores_gemma":[0.9988442,0.00038585323,0.00007613079,0.00015816474,0.000059506685,0.000060796305,0.00012607075,0.00006135812,0.00022790478],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9970645,0.0002213168,0.000758447,0.0005859553,0.0009530771,0.0004167389],"domain_scores_gemma":[0.9982237,0.00011856567,0.0003553008,0.00075471174,0.00028706127,0.00026065667],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00036045304,0.0003116537,0.0011618605,0.000587111,0.000048057285,0.000014064673,0.00032269684,0.00010791923,0.0015644329],"category_scores_gemma":[0.00008934707,0.000245821,0.00023748638,0.0019435113,0.00007791494,0.00006357303,0.00013220117,0.00023711579,0.000012479804],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019662173,0.16709569,0.7367646,0.00019610138,0.0065962095,0.00022659628,0.011822505,0.00008151833,0.040137086,0.000002848115,0.000058146445,0.017356534],"study_design_scores_gemma":[0.37704596,0.09687065,0.29408452,0.0001221626,0.0042601335,0.0000030407164,0.0021366328,0.0012793454,0.22297962,0.0000073410274,0.00070380385,0.0005068064],"about_ca_topic_score_codex":0.0014550276,"about_ca_topic_score_gemma":0.0006128338,"teacher_disagreement_score":0.4426801,"about_ca_system_score_codex":0.000064723965,"about_ca_system_score_gemma":0.0001342082,"threshold_uncertainty_score":0.9999994},"labels":[],"label_agreement":null},{"id":"W3096609892","doi":"10.1182/blood-2020-133355","title":"Preliminary Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Subcutaneously (SC) Administered PF-06863135, a B-Cell Maturation Antigen (BCMA)-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Institute of Cancer Research; University of Alberta; McGill University Health Centre; University of Calgary","funders":"","keywords":"Medicine; Pharmacokinetics; Pharmacodynamics; Refractory (planetary science); Multiple myeloma; Antibody; Pharmacology; Antigen; Internal medicine; Oncology; Immunology","score_opus":0.01532073475445875,"score_gpt":0.26735117926769025,"score_spread":0.2520304445132315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096609892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99609995,0.00075440574,0.000041165895,0.00028092752,0.000069620866,0.0020485758,0.0002766252,0.00007416145,0.00035458483],"genre_scores_gemma":[0.99630654,0.00090693077,0.0013669014,0.00010644873,0.000090156784,0.000021649119,0.0010405603,0.00008251235,0.00007830727],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99737567,0.0001386653,0.0006470811,0.00065263663,0.0006660891,0.0005198682],"domain_scores_gemma":[0.99845093,0.00022084558,0.00027406486,0.0003465939,0.00021489577,0.0004926884],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010808439,0.00040028334,0.000618127,0.00023969599,0.000088988374,0.000031026964,0.00018378586,0.00014663025,0.00007888137],"category_scores_gemma":[0.00012302029,0.0003373576,0.000096871896,0.00041656068,0.00017019021,0.00015808138,0.00014540738,0.00041685754,0.000024794963],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040707547,0.008845648,0.85369396,0.0007133004,0.00045978554,0.0014221884,0.0011837698,0.000026665386,0.08342728,0.0000027228295,0.00010937255,0.009407737],"study_design_scores_gemma":[0.06864115,0.007841688,0.8831824,0.000279393,0.00037899596,0.000071960705,0.00010640572,0.0036562127,0.03493107,0.0000015622579,0.0005304038,0.00037873504],"about_ca_topic_score_codex":0.000044053435,"about_ca_topic_score_gemma":0.000016493199,"teacher_disagreement_score":0.048496213,"about_ca_system_score_codex":0.000061324405,"about_ca_system_score_gemma":0.00017234359,"threshold_uncertainty_score":0.99990785},"labels":[],"label_agreement":null},{"id":"W3096613723","doi":"10.1182/blood-2020-138861","title":"All Cause Mortality and Causes of Death in People with Hemophilia: A Systematic Review and Meta Analysis","year":2020,"lang":"en","type":"review","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics; University of Alberta","funders":"","keywords":"Medicine; Meta-analysis; Cause of death; Population; Standardized mortality ratio; MEDLINE; Cohort study; CINAHL; Pediatrics; Internal medicine; Cohort; Disease; Psychological intervention; Environmental health","score_opus":0.13511135163557833,"score_gpt":0.39247412474140786,"score_spread":0.25736277310582956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096613723","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008660686,0.995106,3.2655439e-7,0.00020872426,0.0000019585623,0.003644673,0.00009250813,0.0000146385255,0.000065124594],"genre_scores_gemma":[0.0007166403,0.99843425,0.00006314889,0.00005850121,0.000011070503,0.0004129163,0.00009352912,0.000030155723,0.00017976521],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99781495,0.00030500404,0.0007857529,0.0004925142,0.00038118075,0.00022057981],"domain_scores_gemma":[0.9986041,0.00022078295,0.00029814386,0.0005781207,0.000073296826,0.0002255354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042776787,0.00040508344,0.00913979,0.00030201938,0.00001952375,0.000014806478,0.00009710611,0.00014199567,0.00003497318],"category_scores_gemma":[0.000178154,0.00020719679,0.0005971637,0.0011325125,0.00006251288,0.00003397896,0.000087617846,0.00026222414,0.000002928781],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000024126268,0.00022013577,0.003282091,0.78519505,0.21076848,0.0004367971,0.000038942722,6.902523e-9,4.930432e-8,0.00000930756,0.0000032826802,0.0000434334],"study_design_scores_gemma":[0.00051064667,0.00016396723,0.0003580913,0.064012036,0.9339156,0.00025743365,0.000009399507,7.0235654e-7,0.0000010405266,0.0000016196427,0.00061015005,0.00015930124],"about_ca_topic_score_codex":0.00025861867,"about_ca_topic_score_gemma":0.00048797115,"teacher_disagreement_score":0.72314715,"about_ca_system_score_codex":0.00003050141,"about_ca_system_score_gemma":0.0002338493,"threshold_uncertainty_score":0.844924},"labels":[],"label_agreement":null},{"id":"W3096616006","doi":"10.1182/blood-2020-141060","title":"Novel Single Panel Method for Minimal Residual Disease Detection for Plasma Cells By Flow Cytometry","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Hospital; Juravinski Cancer Centre; Hamilton Health Sciences","funders":"","keywords":"Minimal residual disease; Bone marrow; Flow cytometry; Lysis; Pathology; Staining; Molecular biology; Bovine serum albumin; Chemistry; Biomedical engineering; Medicine; Chromatography; Biology","score_opus":0.07247607809429459,"score_gpt":0.32188583152384864,"score_spread":0.24940975342955407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096616006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7134156,0.00041904554,0.27401218,0.0028295976,0.00017936008,0.0041291416,0.004578383,0.00021418584,0.00022251958],"genre_scores_gemma":[0.81271476,0.000006619688,0.18537627,0.00027552553,0.00046301747,0.00035344186,0.00033880104,0.00004969352,0.00042187996],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99876785,0.000026245927,0.0001895389,0.0003815747,0.00026147577,0.0003733099],"domain_scores_gemma":[0.9987324,0.00037879907,0.00004984474,0.0001605489,0.00009797288,0.00058047584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011995847,0.00015911124,0.0002471761,0.00007169152,0.00010241255,0.000028123406,0.00007349665,0.00007700831,0.000024189454],"category_scores_gemma":[0.00077384885,0.00013883365,0.0001513184,0.00015709618,0.000023728511,0.000054196953,0.000031684245,0.00008814518,0.00001812661],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005172631,0.002076992,0.00062228733,0.00041900066,0.00035632914,0.00003370683,0.00008463813,0.0000034742945,0.95256037,0.0000038638864,0.0023611009,0.0363056],"study_design_scores_gemma":[0.024501702,0.002832874,0.0016215724,0.00002782384,0.00061245786,0.000014150196,0.00007818294,0.023203727,0.94020945,0.000012261304,0.006721967,0.00016381344],"about_ca_topic_score_codex":0.000012794899,"about_ca_topic_score_gemma":0.0000055906726,"teacher_disagreement_score":0.099299155,"about_ca_system_score_codex":0.000035652127,"about_ca_system_score_gemma":0.00008569522,"threshold_uncertainty_score":0.5661472},"labels":[],"label_agreement":null},{"id":"W3096617937","doi":"10.1182/blood-2020-137700","title":"<i>Nfkbiz</i> 3′ UTR Mutations Confer Selective Growth Advantage and Affect Drug Response in Diffuse Large B-Cell Lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Spinal Cord Injury BC; Simon Fraser University","funders":"","keywords":"Untranslated region; Biology; Diffuse large B-cell lymphoma; Three prime untranslated region; Mutation; Gene; Genetics; CRISPR; Cancer research; Molecular biology; Messenger RNA","score_opus":0.007595140182971929,"score_gpt":0.23904505350470087,"score_spread":0.23144991332172896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096617937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99408287,0.0010103454,0.000009088203,0.0023321467,0.000023138258,0.0005984066,0.00008244074,0.00007344162,0.0017881017],"genre_scores_gemma":[0.9975589,0.00018880221,0.00019371968,0.0016793362,0.00005055026,0.00011571582,0.000044527264,0.00002903124,0.0001394387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988433,0.00015058435,0.00019385901,0.00036507222,0.00016687914,0.00028028377],"domain_scores_gemma":[0.9991339,0.00037553816,0.000052864532,0.00014549636,0.00005222321,0.0002400081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013727146,0.00019567675,0.0003248569,0.0000888582,0.00007045987,0.000025690624,0.000047470116,0.000062789775,0.000018654733],"category_scores_gemma":[0.0001826535,0.00016554425,0.00007346114,0.0002660088,0.00004068921,0.00008351969,0.000049324204,0.000072389106,0.00005375786],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005867852,0.058760855,0.8941554,0.0003328768,0.00044049107,0.004461735,0.01236184,4.988717e-7,0.019530892,0.00090318784,0.0025191414,0.00066523015],"study_design_scores_gemma":[0.15801829,0.0015596264,0.6650367,0.000116854775,0.00066409487,0.00014997003,0.001096521,0.000102439735,0.17097943,0.00007105666,0.0018730981,0.00033195014],"about_ca_topic_score_codex":0.000053389223,"about_ca_topic_score_gemma":0.000029776143,"teacher_disagreement_score":0.22911872,"about_ca_system_score_codex":0.000069491674,"about_ca_system_score_gemma":0.00015326074,"threshold_uncertainty_score":0.6750698},"labels":[],"label_agreement":null},{"id":"W3096623906","doi":"10.1182/blood-2020-141835","title":"Secondary Erythrocytosis Is Phenotypically Distinct from Polycythemia Vera but Associated with Comparable Rates of Thrombosis at Diagnosis","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University; Quebec - Clinical Research Organization in Cancer; Jewish General Hospital; Cégep de Saint-Laurent; Université de Montréal; Hôpital du Sacré-Cœur de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Polycythemia vera; Hematocrit; Internal medicine; Gastroenterology; Erythropoietin; Phlebotomy; Red blood cell distribution width","score_opus":0.036821682752452074,"score_gpt":0.26430781523983243,"score_spread":0.22748613248738037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096623906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99089056,0.0009734497,0.0000146915145,0.004311711,0.000034783567,0.0005540156,0.0010524606,0.000087174405,0.0020811525],"genre_scores_gemma":[0.99597734,0.00025156606,0.0008701335,0.0020354674,0.000118172786,0.00015503948,0.00043471556,0.00005356903,0.00010401213],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980737,0.00007420187,0.00046387254,0.0005787448,0.00045389257,0.00035559587],"domain_scores_gemma":[0.99826455,0.00063077617,0.00026339432,0.00032822782,0.00017207935,0.00034094646],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000056645054,0.0003760414,0.0010267504,0.000041891577,0.00014607627,0.000028898683,0.00013314643,0.00014224774,0.003630437],"category_scores_gemma":[0.00017136165,0.00028064774,0.00019424268,0.00028776444,0.00014675701,0.00008495519,0.00010350886,0.00023052581,0.00012257214],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005426184,0.0027412006,0.98061347,0.00007687644,0.002775389,0.00006156232,0.0011166154,0.0000018012162,0.00541455,0.00002559419,0.0063862004,0.00024411765],"study_design_scores_gemma":[0.007905099,0.001339482,0.5691644,0.0002867664,0.0015198071,0.000004618617,0.00009211156,0.00004310477,0.41885167,0.000028362103,0.0005367739,0.00022779111],"about_ca_topic_score_codex":0.00033236452,"about_ca_topic_score_gemma":0.00017674986,"teacher_disagreement_score":0.4134371,"about_ca_system_score_codex":0.00010553236,"about_ca_system_score_gemma":0.00016733866,"threshold_uncertainty_score":0.9999646},"labels":[],"label_agreement":null},{"id":"W3096624409","doi":"10.1182/blood-2020-136368","title":"Health-Related Quality of Life in the Cartitude-1 Study of Ciltacabtagene Autoleucel for Relapsed/Refractory Multiple Myeloma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Multiple myeloma; Medicine; Pomalidomide; Quality of life (healthcare); Internal medicine; Lenalidomide; Oncology; Gerontology; Family medicine; Nursing","score_opus":0.10097725679551099,"score_gpt":0.36493475699181815,"score_spread":0.26395750019630715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096624409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933336,0.0010666742,0.000012505894,0.0026023386,0.000039310977,0.0025442305,0.000035041736,0.000030515133,0.00033578268],"genre_scores_gemma":[0.9990007,0.00003962583,0.000119966775,0.00047784703,0.000070663446,0.000099419594,0.000018823554,0.00002783166,0.00014510626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973019,0.0004924683,0.0010006012,0.00029578188,0.00062293286,0.00028636816],"domain_scores_gemma":[0.99820274,0.000666099,0.00029644306,0.00050760695,0.00015141355,0.00017568626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016047487,0.00013840827,0.0007542329,0.000088238354,0.000046234425,0.0000054357592,0.00025280015,0.00009541959,0.00013840289],"category_scores_gemma":[0.0012705018,0.000104407896,0.00014388979,0.00045507777,0.00007124554,0.00003477629,0.00006114796,0.00034967464,0.0000042627034],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005035878,0.016058,0.5650678,0.0016695115,0.00083295995,0.000035475532,0.052839622,0.000058953097,0.3512843,0.0000803377,0.0010001666,0.006036954],"study_design_scores_gemma":[0.051087808,0.010394563,0.91385055,0.000102919206,0.00014555706,0.000006098786,0.0088738585,0.00039596698,0.013603798,0.000030918403,0.0013059116,0.00020207248],"about_ca_topic_score_codex":0.0017064909,"about_ca_topic_score_gemma":0.0006850871,"teacher_disagreement_score":0.3487827,"about_ca_system_score_codex":0.000035176217,"about_ca_system_score_gemma":0.00035953618,"threshold_uncertainty_score":0.42576304},"labels":[],"label_agreement":null},{"id":"W3096634367","doi":"10.1182/blood-2020-133289","title":"Pulmonary Embolism in Children with Asymptomatic Proximal Deep Vein Thromboembolism: Single-Center Experience from Sweden","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Medicine; Pulmonary embolism; Asymptomatic; Deep vein; Pediatrics; Protein C deficiency; Thrombosis; Incidence (geometry); Venous thrombosis; Surgery; Internal medicine","score_opus":0.01745576314620898,"score_gpt":0.23565260726451984,"score_spread":0.21819684411831086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096634367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99092287,0.00048600847,0.00011845697,0.0015985628,0.00006746016,0.0015416133,0.00001895729,0.00019328551,0.005052785],"genre_scores_gemma":[0.9945101,0.00007520146,0.0015730095,0.0029583245,0.0004251593,0.00024869174,0.000113918024,0.00007329859,0.000022290671],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976833,0.000060292965,0.00045290362,0.0007204101,0.00052758405,0.0005555037],"domain_scores_gemma":[0.9989968,0.000031091924,0.00013437809,0.00046306776,0.000047247722,0.00032739606],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000070358,0.00036483177,0.00086477166,0.0001110785,0.00007817174,0.0000740229,0.00030627826,0.000119474,0.00033101192],"category_scores_gemma":[0.000049054666,0.00030193263,0.00010190185,0.0003942091,0.00010849778,0.0002392293,0.00019934028,0.00025937156,0.00011941643],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014563408,0.012072666,0.9601248,0.00015105789,0.0008247476,0.00059355295,0.011063554,0.000026030695,0.010150383,0.00022610178,0.0003551332,0.0042663245],"study_design_scores_gemma":[0.0064867395,0.0008493558,0.9838302,0.00035217023,0.00054389786,0.00017780573,0.0009858159,0.00037602446,0.005467241,0.00006944773,0.00038496827,0.00047631568],"about_ca_topic_score_codex":0.00023573785,"about_ca_topic_score_gemma":0.00003556873,"teacher_disagreement_score":0.023705404,"about_ca_system_score_codex":0.000048976322,"about_ca_system_score_gemma":0.000057119447,"threshold_uncertainty_score":0.99994326},"labels":[],"label_agreement":null},{"id":"W3096653635","doi":"10.1182/blood-2020-136613","title":"Development of a Hydrashift 2/4 Isatuximab Assay to Mitigate Interference with Monoclonal Protein Detection on Immunofixation Electrophoresis in Vitro Diagnostic Tests in Multiple Myeloma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Serum protein electrophoresis; Pomalidomide; Daratumumab; Multiple myeloma; Lenalidomide; Carfilzomib; Immunofixation; Medicine; Monoclonal; Monoclonal antibody; Internal medicine; Immunology; Antibody","score_opus":0.020141626482074026,"score_gpt":0.2516306067253915,"score_spread":0.2314889802433175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096653635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99751836,0.000052810068,0.00039030047,0.00036873098,0.000006429138,0.0015619827,0.000009048537,0.00002734945,0.00006496757],"genre_scores_gemma":[0.9911667,0.000005696346,0.008053094,0.00008545186,0.000018640168,0.00060379825,0.000036256664,0.000023314913,0.000007011342],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99845797,0.00009417152,0.0003549204,0.0003678597,0.00037303145,0.00035206095],"domain_scores_gemma":[0.9992721,0.00021567223,0.000081938335,0.00016706789,0.000071002454,0.00019221769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015548311,0.00019019489,0.0003110314,0.00027534657,0.00003640542,0.00001274871,0.00009498697,0.000082988525,0.000009864847],"category_scores_gemma":[0.0013719853,0.00015591815,0.000033162836,0.0005761336,0.000027538003,0.00005760808,0.00004376172,0.00030189124,0.000034691144],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050192056,0.0013267283,0.10468801,0.00009750192,0.00008253176,0.00020144712,0.0008949863,0.000010847927,0.83541405,0.0000010001766,0.0000010468161,0.052262653],"study_design_scores_gemma":[0.005209659,0.0010460315,0.4488418,0.00026808292,0.000012484441,0.000004664829,0.000022666978,0.00035102855,0.54415196,0.0000027813649,0.000008587738,0.00008024272],"about_ca_topic_score_codex":0.00015023435,"about_ca_topic_score_gemma":0.0011615346,"teacher_disagreement_score":0.34415382,"about_ca_system_score_codex":0.0001598083,"about_ca_system_score_gemma":0.00023544305,"threshold_uncertainty_score":0.6358158},"labels":[],"label_agreement":null},{"id":"W3096663275","doi":"10.1182/blood-2020-137225","title":"Measles Reactivity in Windsor Patients Post Autologous Versus Allogeneic Hematopoietic Cell Transplantation: A Retrospective Review","year":2020,"lang":"en","type":"review","venue":"Blood","topic":"Virology and Viral Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Windsor Regional Hospital; Western University","funders":"","keywords":"Medicine; Measles; Transplantation; Hematopoietic stem cell transplantation; Vaccination; Retrospective cohort study; Pediatrics; Immunology; Internal medicine","score_opus":0.027981565444987564,"score_gpt":0.3050328339421383,"score_spread":0.2770512684971507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096663275","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021373502,0.994265,6.4444373e-7,0.00021124634,0.00016446256,0.0018562019,0.0003290148,0.00007677646,0.0009592553],"genre_scores_gemma":[0.004279489,0.99377465,0.000034825734,0.00062773767,0.000096139804,0.00020392086,0.0009048905,0.00005335426,0.000024960904],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99775726,0.0003410304,0.0006254112,0.00066694483,0.0002938155,0.0003155403],"domain_scores_gemma":[0.99884325,0.00014265323,0.00033044582,0.0003798201,0.000110171015,0.0001936504],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012969613,0.00046604028,0.0024157045,0.00012920123,0.000051581217,0.000007057336,0.00018292127,0.0004042708,0.00009824221],"category_scores_gemma":[0.00037985557,0.00039428935,0.000599838,0.00040114406,0.00008384195,0.00006288398,0.000038009028,0.0006486883,0.00021011468],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016102039,0.008814289,0.011569801,0.55846465,0.0018055785,0.0056385747,0.0003320142,6.3148796e-8,0.000014543204,0.000065434884,0.0009347042,0.41075015],"study_design_scores_gemma":[0.031219851,0.008270092,0.14458199,0.25343937,0.1034691,0.0009074646,0.00003817619,3.7443536e-7,0.00008898107,0.00009347853,0.45514923,0.0027418958],"about_ca_topic_score_codex":0.000012505564,"about_ca_topic_score_gemma":0.000016884174,"teacher_disagreement_score":0.4542145,"about_ca_system_score_codex":0.00010269108,"about_ca_system_score_gemma":0.0004280304,"threshold_uncertainty_score":0.9998509},"labels":[],"label_agreement":null},{"id":"W3096663658","doi":"10.1182/blood-2020-137797","title":"The Use of Transthoracic Echocardiograms in Hospitalized Adult Patients with Acute Pulmonary Embolism","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Pulmonary embolism; Thrombolysis; Troponin; Retrospective cohort study; Internal medicine; Emergency medicine; Myocardial infarction","score_opus":0.0147866037304833,"score_gpt":0.22663230710778734,"score_spread":0.21184570337730405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096663658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963462,0.00015291185,0.000060934042,0.0018797639,0.00004519199,0.0009885767,0.000020567617,0.000040763633,0.00046512863],"genre_scores_gemma":[0.9974334,0.0008773871,0.0005761004,0.0009173558,0.000040175113,0.00007260181,0.00003581959,0.000028486113,0.000018678335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988804,0.00004202919,0.00027470998,0.00023314689,0.0003310504,0.00023865055],"domain_scores_gemma":[0.9993854,0.000034092893,0.00008108696,0.00027815372,0.000105984,0.000115256626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005647243,0.00014880535,0.0004397964,0.000046451758,0.000048149752,0.000023199947,0.000116800955,0.00005130319,0.000008585133],"category_scores_gemma":[0.00003469471,0.00009256769,0.00011853563,0.00033161303,0.00006930034,0.0000931199,0.0000364563,0.00012252285,0.0000065394256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016343866,0.0091979755,0.9211182,0.0004424095,0.0029779384,0.0007416593,0.003025062,0.00008338527,0.000355345,0.00088348595,0.0016744781,0.057865687],"study_design_scores_gemma":[0.0057378984,0.0010445808,0.9864243,0.00017204824,0.0011977587,0.000004261192,0.00010671906,0.000092066235,0.00059894595,0.00002299515,0.0044350536,0.00016337572],"about_ca_topic_score_codex":0.00008898347,"about_ca_topic_score_gemma":0.000011754872,"teacher_disagreement_score":0.06530611,"about_ca_system_score_codex":0.000009082977,"about_ca_system_score_gemma":0.00002708569,"threshold_uncertainty_score":0.37748006},"labels":[],"label_agreement":null},{"id":"W3096690841","doi":"10.1182/blood-2020-139182","title":"Dreamm-5 Platform Trial: Belantamab Mafodotin (Belamaf) in Combination with Four Different Novel Agents in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Interim analysis; Multiple myeloma; Lenalidomide; Pomalidomide; Oncology; Dosing; Pharmacology; Refractory (planetary science); Cmax; Internal medicine; Adverse effect; Pharmacokinetics; Clinical trial","score_opus":0.04663736924831915,"score_gpt":0.2639642465014611,"score_spread":0.21732687725314195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096690841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960071,0.000032388194,0.000039863728,0.00030139432,0.0000497584,0.003088461,0.00006529585,0.000072564166,0.00034318565],"genre_scores_gemma":[0.99829584,0.00001846366,0.000530287,0.00015845122,0.00005765821,0.0002039359,0.0005457124,0.00007295835,0.00011671183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972911,0.000065558466,0.00049254316,0.0005888129,0.0009459872,0.00061601034],"domain_scores_gemma":[0.99878436,0.00015920539,0.00018059935,0.00034715745,0.00011148985,0.00041718123],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001256137,0.00038147974,0.0006192821,0.00029436313,0.00007040268,0.000034850014,0.0001684052,0.00015661103,0.00006369988],"category_scores_gemma":[0.0002417246,0.00026434578,0.0000720597,0.00046338598,0.00006099589,0.0002173817,0.00008579553,0.00051767676,0.000038683724],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.057772007,0.012614508,0.92505544,0.00011296794,0.00025864135,0.00040685877,0.00047364767,0.0000052162895,0.0002506948,0.000011344248,0.000037088852,0.0030015605],"study_design_scores_gemma":[0.33742857,0.0061369915,0.65468436,0.00022542953,0.0000861603,0.0000073871047,0.00006536421,0.00031816037,0.0007940977,0.0000040994796,0.000060897022,0.00018847233],"about_ca_topic_score_codex":0.00023538021,"about_ca_topic_score_gemma":0.0006960341,"teacher_disagreement_score":0.2796566,"about_ca_system_score_codex":0.00022071105,"about_ca_system_score_gemma":0.00014561508,"threshold_uncertainty_score":0.99998087},"labels":[],"label_agreement":null},{"id":"W3096697285","doi":"10.1182/blood-2020-136344","title":"A Phase 2 Study of Odronextamab (REGN1979), a CD20 x CD3 Bispecific Antibody, in Patients with Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Tolerability; CD20; Lymphoma; Internal medicine; Refractory (planetary science); Oncology; Follicular lymphoma; Antibody; Phases of clinical research; Gastroenterology; Chemotherapy; Adverse effect; Immunology; Biology","score_opus":0.020780815090792402,"score_gpt":0.2958991003380819,"score_spread":0.27511828524728954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096697285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994577,0.00024169446,0.000011925727,0.00010179223,0.000048571546,0.0021664673,0.00002437267,0.000053638065,0.002774544],"genre_scores_gemma":[0.9989157,0.00005157121,0.00013817925,0.000116116564,0.00011397733,0.00004629715,0.000065673135,0.000091578484,0.00046092132],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9971412,0.00014767697,0.00056163647,0.00063440617,0.0010277986,0.00048731896],"domain_scores_gemma":[0.9984971,0.00009298517,0.00018645028,0.0006923656,0.00019711365,0.0003339815],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023309884,0.0003102344,0.0007243312,0.00031777096,0.0000468446,0.00002133598,0.0002785939,0.0001260708,0.0006873639],"category_scores_gemma":[0.00006141112,0.00025972855,0.00010335937,0.0009902357,0.00010391294,0.000111850335,0.00012189818,0.0003605884,0.00006305688],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015398085,0.15435635,0.62307954,0.0004009921,0.00047722054,0.0010078654,0.00860001,0.000005209932,0.18165821,0.0000024922872,0.00041821864,0.014595795],"study_design_scores_gemma":[0.47764894,0.08494043,0.39183682,0.0003479812,0.00047448793,0.000017456327,0.002595062,0.00017820387,0.0386073,0.0000042481984,0.0027066178,0.00064241275],"about_ca_topic_score_codex":0.00016460233,"about_ca_topic_score_gemma":0.000035086912,"teacher_disagreement_score":0.46225086,"about_ca_system_score_codex":0.000083663195,"about_ca_system_score_gemma":0.00026023426,"threshold_uncertainty_score":0.9999855},"labels":[],"label_agreement":null},{"id":"W3096699547","doi":"10.1182/blood-2020-139008","title":"Decision Making Factors That Influence Treatment Options for an Autologous Stem Cell Transplant for Older Adults (aged 65-75) with Newly Diagnosed Multiple Myeloma: A Mixed Methods Study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; University Health Network; University of Toronto; PROTO Manufacturing (Canada); Ottawa Hospital; Joseph Brant Hospital; University of Ottawa","funders":"","keywords":"Medicine; Thematic analysis; Multiple myeloma; Family medicine; Referral; Cohort; Internal medicine; Qualitative research; Gerontology; Oncology","score_opus":0.05360058509147542,"score_gpt":0.3566460779614236,"score_spread":0.3030454928699482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096699547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9636804,0.0002669725,0.026246132,0.000056520308,0.000049521605,0.00905907,0.00044676434,0.00018417877,0.000010480504],"genre_scores_gemma":[0.8977347,0.00003135904,0.09946875,0.000045974288,0.000037043057,0.0023698881,0.00021144477,0.000073350086,0.000027465398],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99745893,0.00025330458,0.00039250313,0.0008521848,0.00040050322,0.0006425906],"domain_scores_gemma":[0.99662834,0.0020525414,0.000144012,0.00046963786,0.00015139904,0.000554037],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021836492,0.00045391975,0.00071808754,0.00014331244,0.000340165,0.00006459212,0.00019226174,0.00012994166,0.000011091279],"category_scores_gemma":[0.00014076495,0.0002990308,0.00022305682,0.00022550416,0.000048512018,0.00017476399,0.00003009957,0.00014338832,0.0000040762266],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018533953,0.01661995,0.76226205,0.00048192652,0.0015635798,0.0007256517,0.026367303,0.000192886,0.0041925316,0.0000039240285,0.00001953876,0.16903673],"study_design_scores_gemma":[0.09327202,0.019211795,0.83385104,0.0003210776,0.0015253907,0.000032316424,0.008167498,0.0036929948,0.039482586,0.000004505442,0.00006815116,0.00037064086],"about_ca_topic_score_codex":0.00020593728,"about_ca_topic_score_gemma":0.00069954264,"teacher_disagreement_score":0.1686661,"about_ca_system_score_codex":0.000099705925,"about_ca_system_score_gemma":0.00015043002,"threshold_uncertainty_score":0.9999462},"labels":[],"label_agreement":null},{"id":"W3096705707","doi":"10.1182/blood-2020-141910","title":"Nonclinical Efficacy and Toxicity and Selection of a Safe Clinical Starting Dose for an NMT Inhibitor in Development for Hematological Malignancies","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Dasatinib; Cancer research; LYN; Medicine; Pharmacology; Apoptosis; Myristoylation; Toxicity; Leukemia; Ibrutinib; Lymphoma; Myeloid leukemia; Proto-oncogene tyrosine-protein kinase Src; Biology; Internal medicine; Chronic lymphocytic leukemia; Receptor; Phosphorylation","score_opus":0.09150383230867733,"score_gpt":0.36303785247179987,"score_spread":0.27153402016312256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096705707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997877,0.00014347227,0.00023860422,0.0004739489,0.000021452892,0.0011881076,0.00000896404,0.000028368338,0.000020056028],"genre_scores_gemma":[0.9657177,0.00002359153,0.03371117,0.00029523816,0.00013455268,0.000081859915,0.000015014421,0.00001299239,0.000007891284],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99854994,0.00004932865,0.0007106532,0.00037508633,0.000108475106,0.00020651563],"domain_scores_gemma":[0.99889106,0.00065170636,0.00013599233,0.0000671119,0.00006112045,0.00019301803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048093003,0.00012814968,0.0005188028,0.000029976372,0.000046960373,0.000007989317,0.00003343953,0.00015518475,0.000004043659],"category_scores_gemma":[0.0015990445,0.000104987,0.000053792293,0.00008250111,0.00007796287,0.000045665394,0.000046722227,0.00012105356,5.7495123e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007478124,0.008407635,0.88870597,0.0016658818,0.00037854313,0.000035669516,0.0024688789,0.0000028418406,0.062836185,0.00027531703,0.00023656873,0.027508417],"study_design_scores_gemma":[0.12600112,0.016899442,0.6305911,0.00062365935,0.00061893306,0.000102420396,0.00035590716,0.002968475,0.22004767,0.00015947246,0.0011866011,0.00044518075],"about_ca_topic_score_codex":0.0000052345,"about_ca_topic_score_gemma":0.00003395203,"teacher_disagreement_score":0.2581148,"about_ca_system_score_codex":0.00004368224,"about_ca_system_score_gemma":0.0003105754,"threshold_uncertainty_score":0.42812455},"labels":[],"label_agreement":null},{"id":"W3096713005","doi":"10.1182/blood-2020-143408","title":"MRD Xenotransplantation Prospectively Identifies Treatment-Selected Acute Lymphoblastic Leukemia Subpopulations with Relapse-Initiating Potential","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Minimal residual disease; Medicine; Leukemia; Oncology; Acute lymphocytic leukemia; Population; Immunology; Lymphoblastic Leukemia; Transplantation; Internal medicine; Haematopoiesis; Acute leukemia; Cancer research; Stem cell; Biology; Genetics","score_opus":0.015930484651272114,"score_gpt":0.2572236571659911,"score_spread":0.241293172514719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096713005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857225,0.00006196117,0.011016844,0.00084570114,0.000056656314,0.0010138894,0.00012896572,0.00036492312,0.00078856916],"genre_scores_gemma":[0.99519205,0.00006779471,0.0030527234,0.00018920834,0.00031353487,0.0001232221,0.00046541227,0.00008357107,0.00051247736],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9977531,0.00007373451,0.0004040351,0.00058817375,0.0006626305,0.0005183599],"domain_scores_gemma":[0.99875075,0.0001331843,0.00015603231,0.0002446661,0.00036890875,0.0003464594],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000060849805,0.00032636616,0.0004344022,0.00014800737,0.0002947813,0.00009588936,0.00012901059,0.00014615127,0.00009784065],"category_scores_gemma":[0.00018840485,0.000260621,0.00010252409,0.0009051784,0.00012281742,0.00026929696,0.000030434958,0.00022050121,0.00013764211],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010336198,0.0024249307,0.14658657,0.0008919464,0.008471436,0.010869367,0.0136205675,0.0017854798,0.8017565,0.0005942536,0.0011240032,0.0015387817],"study_design_scores_gemma":[0.095711224,0.011721562,0.46586397,0.00074662623,0.013089326,0.006201545,0.0011275971,0.040442787,0.36332354,0.0001911629,0.00013413646,0.0014465332],"about_ca_topic_score_codex":0.00025205957,"about_ca_topic_score_gemma":0.00007227623,"teacher_disagreement_score":0.43843293,"about_ca_system_score_codex":0.0008224487,"about_ca_system_score_gemma":0.00158577,"threshold_uncertainty_score":0.9999846},"labels":[],"label_agreement":null},{"id":"W3096713021","doi":"10.1182/blood-2020-134596","title":"Cost-Effectiveness of a 12-Month Fixed Duration of Venetoclax in Combination with Obinutuzumab Versus Chemoimmunotherapy and Other Novel Combinations in First-Line Chronic Lymphocytic Leukemia in Canada","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Foothills Medical Centre; ABB (Canada); McMaster University","funders":"","keywords":"Obinutuzumab; Venetoclax; Medicine; Chemoimmunotherapy; Chlorambucil; Ofatumumab; Ibrutinib; Bendamustine; Population; Chronic lymphocytic leukemia; Fludarabine; Internal medicine; Rituximab; Oncology; IGHV@; Leukemia; Cyclophosphamide; Chemotherapy; Lymphoma","score_opus":0.03848499139418109,"score_gpt":0.2797604061445555,"score_spread":0.2412754147503744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096713021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99755126,0.00042515248,0.000075621116,0.00006672738,0.00002763599,0.0016820279,0.000020182324,0.000009188043,0.00014222831],"genre_scores_gemma":[0.99954027,0.000083999046,0.00007812735,0.00003377467,0.0000115573985,0.00017239143,0.000042867232,0.000029950186,0.0000070902224],"study_design_codex":"simulation_or_modeling","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9984954,0.00008812609,0.0004795688,0.00028430714,0.00039465126,0.00025795944],"domain_scores_gemma":[0.9990003,0.00044982167,0.00015610876,0.00022389174,0.00009780491,0.000072061084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029836476,0.00016704932,0.00049592304,0.00019520211,0.00001878439,0.000006317408,0.000111444024,0.00009141333,0.000014235234],"category_scores_gemma":[0.00019523116,0.00016085219,0.000025890866,0.0007086814,0.00009749875,0.00008238606,0.000036198315,0.00017923048,4.6544847e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.110602826,0.0065234695,0.23068108,0.023552395,0.0019288207,0.0012152939,0.01966816,0.3537872,0.23761319,0.004122218,0.000058687732,0.010246646],"study_design_scores_gemma":[0.49758735,0.0024334933,0.1014204,0.0015431042,0.00007025887,0.000036407295,0.00032835765,0.32700035,0.06926868,0.000023306622,0.000047632766,0.00024065896],"about_ca_topic_score_codex":0.73819,"about_ca_topic_score_gemma":0.8036136,"teacher_disagreement_score":0.38698453,"about_ca_system_score_codex":0.12847868,"about_ca_system_score_gemma":0.069883086,"threshold_uncertainty_score":0.9353898},"labels":[],"label_agreement":null},{"id":"W3096717600","doi":"10.1182/blood-2020-137233","title":"ZUMA-4: A Phase 1/2 Multicenter Study of KTE-X19 in Pediatric and Adolescent Patients With Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Lymphoma; Mantle cell lymphoma; Internal medicine; Lymphoblastic lymphoma; Refractory (planetary science); Malignancy; Oncology; Gastroenterology; Immunology; T cell","score_opus":0.014890253295505787,"score_gpt":0.2722694317291154,"score_spread":0.2573791784336096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096717600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975306,0.00013958736,0.000011887509,0.000045436987,0.00004860431,0.0019958662,0.000027482483,0.00003228805,0.00016825173],"genre_scores_gemma":[0.9988938,0.00019824137,0.00011597735,0.00023669924,0.00013013158,0.000053367767,0.000020363093,0.00007156967,0.00027987736],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99775356,0.00011348604,0.0004541523,0.00055406126,0.0007027011,0.000422017],"domain_scores_gemma":[0.9987958,0.00013355729,0.00017254897,0.00037910507,0.00015271454,0.00036625427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013562113,0.0002946695,0.0005699873,0.00025752935,0.00004005909,0.000020443758,0.00017083497,0.000106085135,0.00018850922],"category_scores_gemma":[0.000080778664,0.000218153,0.00005760429,0.0006004517,0.000062947234,0.00009411926,0.00014295024,0.00025244075,0.00001898192],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024620652,0.033245485,0.9177795,0.00085458974,0.00028485892,0.0009397341,0.0045710225,0.000008021288,0.012628351,7.853565e-8,0.0004320396,0.004635661],"study_design_scores_gemma":[0.28134972,0.024914179,0.6846296,0.00019023211,0.0011236281,0.000012714441,0.0007509662,0.00058314943,0.005855359,2.7976242e-7,0.00024369161,0.00034644027],"about_ca_topic_score_codex":0.00006109688,"about_ca_topic_score_gemma":0.00003110069,"teacher_disagreement_score":0.25672907,"about_ca_system_score_codex":0.00020146144,"about_ca_system_score_gemma":0.0004462958,"threshold_uncertainty_score":0.8896021},"labels":[],"label_agreement":null},{"id":"W3096717709","doi":"10.1182/blood-2020-140837","title":"CC-486 Prolongs Survival for Patients with Acute Myeloid Leukemia (AML) in Remission after Intensive Chemotherapy (IC) Independent of the Presence of Measurable Residual Disease (MRD) at Study Entry: Results from the QUAZAR AML-001 Maintenance Trial","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Myeloid leukemia; Medicine; Chemotherapy; Chemotherapy regimen; Internal medicine; Minimal residual disease; Oncology; Leukemia; Disease; Complete remission; Myeloid","score_opus":0.01991898408853723,"score_gpt":0.25754255148845406,"score_spread":0.23762356739991683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096717709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858552,0.0000958282,0.000008404049,0.0055025453,0.00011245807,0.0075595123,0.00077851914,0.000023184291,0.000064297354],"genre_scores_gemma":[0.99804497,0.000058429003,0.00011039497,0.00051329896,0.00021992013,0.00037264777,0.00013199568,0.00006098185,0.00048737085],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.995759,0.00047369034,0.0008428359,0.0007781918,0.001621533,0.0005247114],"domain_scores_gemma":[0.99642026,0.00072931295,0.00051209674,0.0010441397,0.001010262,0.00028394413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087031425,0.00033585698,0.0007066137,0.000059765673,0.000103649756,0.000021251932,0.0007035174,0.00014145074,0.000020449272],"category_scores_gemma":[0.004010784,0.00017747693,0.00014938445,0.0004931019,0.00028257663,0.00011966747,0.00041744142,0.00058280834,0.0000032028508],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.68473756,0.0065532755,0.2892172,0.00012691705,0.00086595345,0.00012549479,0.009193017,0.000012383778,0.0043112272,0.0000035731798,0.004447036,0.00040635912],"study_design_scores_gemma":[0.46676692,0.004495201,0.5061611,0.0006211886,0.00069598993,0.000003091423,0.0021054747,0.00018553402,0.018180873,0.000040003615,0.00045939276,0.00028524717],"about_ca_topic_score_codex":0.0008919432,"about_ca_topic_score_gemma":0.00030438506,"teacher_disagreement_score":0.21797064,"about_ca_system_score_codex":0.0003502282,"about_ca_system_score_gemma":0.0011275791,"threshold_uncertainty_score":0.7237299},"labels":[],"label_agreement":null},{"id":"W3096724523","doi":"10.1182/blood-2020-143381","title":"A Novel Anti-Cancer Vaccine Approach for the Treatment of High-Risk Leukemia in Children","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"vaccines and immunoinformatics approaches","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; Calgary Laboratory Services; University of Calgary","funders":"","keywords":"Leukemia; Human leukocyte antigen; Cancer; Biology; Mutation; Epitope; Computational biology; Cancer research; Immunology; Antigen; Genetics; Gene","score_opus":0.01333932306017416,"score_gpt":0.22078247036032764,"score_spread":0.20744314730015348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096724523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916326,0.0024186014,0.0051256404,0.00008933098,0.000013580264,0.0005439714,0.0001381862,0.000004187048,0.000033941535],"genre_scores_gemma":[0.99300706,0.0026315155,0.0037752762,0.00007197314,0.00016456198,0.0001323482,0.00017643538,0.000014467993,0.000026329679],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99945354,0.0000072787184,0.00020270854,0.00015538468,0.000046465502,0.00013461312],"domain_scores_gemma":[0.99963105,0.000008208077,0.000103890976,0.00020623358,0.000024173136,0.000026457768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000048493544,0.000117442294,0.0001758256,0.0000132584955,0.000036957215,0.000009406197,0.00015234745,0.00006548213,0.0000028437191],"category_scores_gemma":[0.000015482874,0.00007434114,0.000091512215,0.00007287868,0.00001029938,0.0000025547354,0.000034369034,0.000034207766,3.7789223e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066191255,0.003451456,0.31229666,0.00019811351,0.0030272014,2.1800862e-7,0.0014957539,0.020764891,0.6336309,0.0002336997,0.0008572756,0.023381935],"study_design_scores_gemma":[0.02064332,0.0021197197,0.17018113,0.000008163642,0.00046330004,0.00000951744,0.00026072472,0.012467197,0.79082936,0.000008806676,0.0026822232,0.0003265649],"about_ca_topic_score_codex":0.00026173604,"about_ca_topic_score_gemma":0.00000911129,"teacher_disagreement_score":0.15719846,"about_ca_system_score_codex":0.000009882465,"about_ca_system_score_gemma":0.00005119229,"threshold_uncertainty_score":0.30315438},"labels":[],"label_agreement":null},{"id":"W3096728088","doi":"10.1182/blood-2020-142638","title":"Integrated Stem Cell Signature and Cytomolecular Risk Determination in Pediatric Acute Myeloid Leukemia","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Medicine; Internal medicine; Myeloid leukemia; Oncology; Leukemia; Bone marrow","score_opus":0.0097375895650086,"score_gpt":0.23910612667912398,"score_spread":0.22936853711411537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096728088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961177,0.0013989008,0.00035077234,0.00048679003,0.000024883875,0.00055324053,0.00003083953,0.00009099163,0.0009458584],"genre_scores_gemma":[0.9957289,0.0015064193,0.0017536028,0.00047570217,0.00019009339,0.000026403897,0.00005167569,0.000044942815,0.0002222741],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984382,0.00013571246,0.00028042682,0.00045231907,0.00035132703,0.00034204795],"domain_scores_gemma":[0.99919415,0.00008935602,0.00009496399,0.00022024053,0.00011070258,0.00029056348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021257297,0.00021333217,0.00033942057,0.0002310357,0.000049994254,0.000034199897,0.00015053312,0.00026219425,0.000026101967],"category_scores_gemma":[0.00011246495,0.00018629472,0.00006288085,0.000847411,0.00004160472,0.000100245226,0.00011280611,0.0010358015,0.00005101754],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015645466,0.000866103,0.35631603,0.0016298422,0.00036817446,0.012418798,0.0061627543,0.000039838982,0.5559335,0.000037998085,0.004042948,0.06061952],"study_design_scores_gemma":[0.054807946,0.0042158086,0.19529134,0.00021403116,0.0040228846,0.00073272013,0.0015123877,0.04082151,0.6921489,0.00010376019,0.00456736,0.0015613026],"about_ca_topic_score_codex":0.000044471974,"about_ca_topic_score_gemma":0.000008879035,"teacher_disagreement_score":0.16102469,"about_ca_system_score_codex":0.00020046496,"about_ca_system_score_gemma":0.00046982747,"threshold_uncertainty_score":0.75968784},"labels":[],"label_agreement":null},{"id":"W3096744447","doi":"10.1182/blood-2020-134787","title":"IPO11 Regulates the Nuclear Import of BZW1/2 and Is Necessary for AML Cells and Stem Cells","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"CD34; Myeloid leukemia; Haematopoiesis; Stem cell; Biology; Cancer research; Myeloid; Progenitor cell; Population; Leukemia; Molecular biology; Immunology; Cell biology; Medicine","score_opus":0.021149983101113077,"score_gpt":0.25166779866802186,"score_spread":0.23051781556690878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096744447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99035066,0.0009903423,0.000005425577,0.007295295,0.000020277581,0.00062963733,0.000059060963,0.000026542863,0.0006227502],"genre_scores_gemma":[0.9960015,0.0005010206,0.00073867483,0.0016698055,0.00015423408,0.00000998937,0.0000039884326,0.000039183276,0.000881627],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99912107,0.00002491081,0.00020373712,0.00024853458,0.00019551678,0.00020624699],"domain_scores_gemma":[0.99931556,0.00014795696,0.00007005575,0.00023567532,0.00006435233,0.00016640838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001923812,0.000114137714,0.00027884872,0.000030852592,0.00006483339,0.000019738076,0.000115230396,0.00008306444,0.000058620823],"category_scores_gemma":[0.000020384088,0.00007606038,0.000052627456,0.0001166626,0.00015898251,0.000046411475,0.00013799021,0.0001610942,0.000008956463],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056036253,0.00021781401,0.0057378383,0.0014699395,0.00043768625,0.00006611662,0.0050293603,8.7163403e-7,0.8981062,0.00016679581,0.082165666,0.0060413415],"study_design_scores_gemma":[0.0057288865,0.0010135775,0.0028787912,0.00007627345,0.00042656035,0.00006142616,0.0017027138,0.0015233768,0.94563615,0.00007422687,0.040723387,0.00015465615],"about_ca_topic_score_codex":0.000025004647,"about_ca_topic_score_gemma":7.122628e-7,"teacher_disagreement_score":0.047529913,"about_ca_system_score_codex":0.000009466087,"about_ca_system_score_gemma":0.00007511698,"threshold_uncertainty_score":0.31016523},"labels":[],"label_agreement":null},{"id":"W3096749218","doi":"10.1182/blood-2020-134741","title":"Practice Patterns and Outcomes of Hemophagocytic Lymphohistiocytosis in Adults: A Two-Decade Provincial Retrospective Review","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Alberta","funders":"","keywords":"Medicine; Interquartile range; Hemophagocytic lymphohistiocytosis; Retrospective cohort study; Pediatrics; Proportional hazards model; Hazard ratio; Cohort; Epidemiology; Survival analysis; Internal medicine; Disease; Intensive care medicine; Confidence interval","score_opus":0.013678274783011044,"score_gpt":0.30210472320829806,"score_spread":0.28842644842528703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096749218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9736302,0.017200273,0.000014081139,0.0063092224,0.000013209965,0.0010116381,0.000022336117,0.00003257531,0.0017664471],"genre_scores_gemma":[0.98966724,0.007382663,0.00017228938,0.002624909,0.000039561877,0.000049799895,0.000008594315,0.000018811692,0.00003615795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867463,0.00008275516,0.00043935172,0.00026597554,0.00034609257,0.00019117919],"domain_scores_gemma":[0.9993198,0.00008274209,0.00015841944,0.00019379062,0.00014263912,0.00010260171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025139507,0.00012576513,0.0005908215,0.000062953855,0.000025871868,0.000006641953,0.000086534514,0.000053766824,0.000063029736],"category_scores_gemma":[0.002524625,0.00011048379,0.00007238943,0.00025999636,0.00006122009,0.00014204197,0.00008525011,0.00021832883,0.000014666937],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005206931,0.00084072497,0.98084325,0.007001832,0.00020534857,0.00027867744,0.001503591,2.2185901e-7,0.00084950775,0.00014552375,0.00018116132,0.0076294662],"study_design_scores_gemma":[0.016834669,0.0010806493,0.9722105,0.0036414468,0.000500429,0.00009392229,0.00081187923,0.00009431089,0.0034417426,0.000017188875,0.0010429291,0.00023031783],"about_ca_topic_score_codex":0.0003288117,"about_ca_topic_score_gemma":0.000027833601,"teacher_disagreement_score":0.016313976,"about_ca_system_score_codex":0.000057037807,"about_ca_system_score_gemma":0.00025333336,"threshold_uncertainty_score":0.4505398},"labels":[],"label_agreement":null},{"id":"W3096766710","doi":"10.1182/blood-2020-142696","title":"Granulocyte Colony-Stimulating Factor Is Safe and Well Tolerated Following Allogeneic Transplantation in Patients with Sickle Cell Disease","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Alemtuzumab; Granulocyte colony-stimulating factor; Transplantation; Internal medicine; Fludarabine; Context (archaeology); Gastroenterology; Surgery; Immunology; Cyclophosphamide; Chemotherapy","score_opus":0.00593672098740242,"score_gpt":0.1987359889057094,"score_spread":0.19279926791830698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096766710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982624,0.00031978605,0.00003540634,0.00039858295,0.000024240886,0.00050275226,0.00002656718,0.00003677169,0.00039346216],"genre_scores_gemma":[0.9987771,0.000059359354,0.0001833666,0.00079650513,0.000013539287,0.000006124477,0.00011031137,0.000021276359,0.000032407435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99918675,0.0000244802,0.00018632856,0.00024376846,0.00017387587,0.0001847935],"domain_scores_gemma":[0.99961597,0.000021045977,0.00004149691,0.000074413954,0.0000256743,0.00022140479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000024063547,0.0001370341,0.00020450301,0.000040035044,0.00005805146,0.000013347392,0.000028967203,0.00006978807,0.000044361725],"category_scores_gemma":[0.000012757443,0.000109329696,0.00004297174,0.00018382077,0.000018789482,0.000059145263,0.000008362962,0.00013304532,0.000010799707],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006938065,0.0003421485,0.99452615,0.00022469477,0.0000511661,0.00015603258,0.0017901286,0.00016333668,0.0017907667,6.0162205e-7,0.000015362093,0.00024578717],"study_design_scores_gemma":[0.024853082,0.0007797653,0.96794045,0.00022809581,0.00060729746,0.0000016616661,0.00014589197,0.0016825029,0.00337366,0.0000029232385,0.00013377037,0.00025087176],"about_ca_topic_score_codex":0.000027646862,"about_ca_topic_score_gemma":0.00000554155,"teacher_disagreement_score":0.02658569,"about_ca_system_score_codex":0.000010155566,"about_ca_system_score_gemma":0.000047289144,"threshold_uncertainty_score":0.44583356},"labels":[],"label_agreement":null},{"id":"W3096790188","doi":"10.1182/blood-2020-138469","title":"Mortality Rate and Functional Outcomes Among Patients Presenting with Anticoagulation- Associated Intracranial Hemorrhage","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Intracerebral and Subarachnoid Hemorrhage Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Stroke (engine); Modified Rankin Scale; Atrial fibrillation; Warfarin; Intracerebral hemorrhage; Incidence (geometry); Retrospective cohort study; Mortality rate; Pediatrics; Emergency medicine; Intensive care medicine; Internal medicine; Ischemic stroke; Subarachnoid hemorrhage","score_opus":0.025173135129651428,"score_gpt":0.2592916011456483,"score_spread":0.2341184660159969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096790188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979815,0.000014104031,0.00014348488,0.0007181823,0.000036481924,0.00040703584,0.000018050663,0.00008654758,0.00059462065],"genre_scores_gemma":[0.9986226,0.0000018019837,0.0005774568,0.00029498685,0.00014235525,0.000011422553,0.00011318464,0.000021244283,0.00021494666],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866015,0.00006442754,0.00023585274,0.00029704778,0.0004552106,0.0002872971],"domain_scores_gemma":[0.9992999,0.00007426619,0.00008275404,0.0001180284,0.00020190154,0.00022316899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018124428,0.00015274924,0.00029788338,0.00004110213,0.00015419498,0.000051581566,0.000043484844,0.000088259105,0.00017912645],"category_scores_gemma":[0.00048696907,0.00011197765,0.00005425206,0.00020339891,0.000090184345,0.00016807133,0.000056791287,0.00029257158,0.00001626786],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007976334,0.000457592,0.9978777,0.00011107432,0.00016685222,0.00021921592,0.00011116008,0.000004703913,0.0004394787,0.000013183631,0.000023370849,0.000495869],"study_design_scores_gemma":[0.0049129697,0.00017024654,0.96862257,0.000011107551,0.000230278,0.000009118841,0.000033457556,0.025129905,0.0007375596,0.000017931641,0.0000011422411,0.00012369479],"about_ca_topic_score_codex":0.00005423855,"about_ca_topic_score_gemma":0.00001892699,"teacher_disagreement_score":0.029255148,"about_ca_system_score_codex":0.000014680958,"about_ca_system_score_gemma":0.000054153825,"threshold_uncertainty_score":0.4566316},"labels":[],"label_agreement":null},{"id":"W3096799668","doi":"10.1182/blood-2020-142871","title":"The Copy Number Landscape of Relapsed and Refractory Diffuse Large B-Cell Lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Princess Margaret Cancer Centre; Canada's Michael Smith Genome Sciences Centre; Spinal Cord Injury BC; Queen's University; Jewish General Hospital","funders":"","keywords":"Diffuse large B-cell lymphoma; Exome sequencing; Exome; Copy-number variation; Medicine; Oncology; Lymphoma; Internal medicine; Cohort; CHOP; Copy number analysis; Biology; Mutation; Genetics; Genome; Gene","score_opus":0.009048029076662474,"score_gpt":0.2285128186527416,"score_spread":0.21946478957607912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096799668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98797214,0.0023779278,0.0000010175632,0.0013703913,0.00003458687,0.00016766264,0.000019648047,0.000027362421,0.008029276],"genre_scores_gemma":[0.99790263,0.0010577333,0.00008434736,0.0005795938,0.00007638145,0.000016455548,0.000012422333,0.000013973404,0.00025644412],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99937,0.000024466157,0.00015525079,0.00015540824,0.00014751503,0.00014738657],"domain_scores_gemma":[0.9994458,0.00013274833,0.00006527753,0.00019203198,0.000031008774,0.00013313117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000055090582,0.00009759507,0.00019256561,0.000008755592,0.000066001296,0.000011927373,0.000046876212,0.00005226846,0.000050405837],"category_scores_gemma":[0.000048938844,0.00005785169,0.000060877403,0.000068791116,0.000034071465,0.000022886514,0.000040832332,0.000034639997,0.00005629533],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030859004,0.012840982,0.9705835,0.00011697713,0.00027511365,0.00018676415,0.0009119474,1.9873445e-8,0.0016535671,0.00051661837,0.010243657,0.0023622909],"study_design_scores_gemma":[0.19238397,0.0016940673,0.5500547,0.0001290189,0.0014325783,0.00013040332,0.00080541725,0.000060552942,0.087556936,0.00007004886,0.16538183,0.0003004633],"about_ca_topic_score_codex":0.000011380549,"about_ca_topic_score_gemma":0.0000031512766,"teacher_disagreement_score":0.42052877,"about_ca_system_score_codex":0.000009247285,"about_ca_system_score_gemma":0.000047957285,"threshold_uncertainty_score":0.23591234},"labels":[],"label_agreement":null},{"id":"W3096812044","doi":"10.1182/blood-2020-134972","title":"Survival Outcomes for Plasmablastic Lymphoma: An International, Multicentre Study By the Australasian Lymphoma Alliance","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Plasmablastic lymphoma; Medicine; Context (archaeology); Lymphoma; Aggressive lymphoma; Diffuse large B-cell lymphoma; Oncology; Internal medicine; Rituximab","score_opus":0.025069105989182966,"score_gpt":0.2920122699026506,"score_spread":0.2669431639134676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096812044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909194,0.0001304589,0.000060913906,0.006685013,0.0003535043,0.0009315261,0.000103729515,0.000094988114,0.00072046934],"genre_scores_gemma":[0.99776435,0.00003262711,0.00008512832,0.0013319803,0.00016983283,0.00008532581,0.00004696611,0.000032824733,0.00045098114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870723,0.000040808638,0.00023597141,0.00033111393,0.00040523638,0.0002796619],"domain_scores_gemma":[0.99932754,0.00007988686,0.000101781494,0.00020756506,0.00010717081,0.00017603516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011714199,0.00018202215,0.00028584615,0.000015188862,0.00011741399,0.000053799828,0.0002608476,0.00006476464,0.000046307185],"category_scores_gemma":[0.0003365934,0.00012999016,0.000112410264,0.000114518036,0.00003837239,0.00011179669,0.000034164786,0.000054491913,0.000024882142],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011236928,0.009287924,0.96030974,0.000078607,0.0019500426,0.00007126981,0.0046443595,0.00004976496,0.00069592113,0.00010441111,0.011810589,0.009873663],"study_design_scores_gemma":[0.12476264,0.0031426172,0.81112754,0.000061173014,0.0018323144,0.0000122847505,0.023877224,0.0033421232,0.00086791196,0.000046195662,0.030326303,0.0006016852],"about_ca_topic_score_codex":0.00011444875,"about_ca_topic_score_gemma":0.00019346846,"teacher_disagreement_score":0.14918223,"about_ca_system_score_codex":0.00008344219,"about_ca_system_score_gemma":0.00011272286,"threshold_uncertainty_score":0.5300845},"labels":[],"label_agreement":null},{"id":"W3096816571","doi":"10.1182/blood-2020-142302","title":"Efficacy and Cost Analysis of Eltrombopag in Thrombocytopenia and Poor Graft Function Post Allogeneic Hematopoietic Cell Transplantation in a Canadian Centre - a Prospective Observational Study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Eltrombopag; Medicine; Internal medicine; Transplantation; Neutropenia; Hematopoietic stem cell transplantation; Platelet transfusion; Thrombopoietin receptor; Platelet; Gastroenterology; Surgery; Thrombopoietin; Haematopoiesis; Stem cell; Chemotherapy; Biology","score_opus":0.023500048564233093,"score_gpt":0.2580726610764234,"score_spread":0.2345726125121903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096816571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981345,0.00023553053,0.0000012550458,0.0004528388,0.000004983408,0.0010323727,0.0000711688,0.0000055652054,0.00006177481],"genre_scores_gemma":[0.99949443,0.00005274575,0.00003408788,0.00015446184,0.0000037632403,0.00002100823,0.00022736246,0.000007079374,0.0000050839203],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999298,0.000030988544,0.00019090153,0.00023105243,0.00010903981,0.00014006946],"domain_scores_gemma":[0.9997108,0.000030404504,0.000042177468,0.00005329895,0.00003550961,0.00012779179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000053305244,0.000099066594,0.00035504898,0.00021240694,0.000024596717,0.00000864376,0.000020316671,0.00003977427,0.000027001746],"category_scores_gemma":[0.000016926346,0.00009133966,0.000025422716,0.00055641955,0.000017839942,0.00005096936,0.0000054503803,0.00006471913,0.0000010028775],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000311939,0.0012120203,0.9913554,0.000056750796,0.0004510163,0.0002768548,0.0037447521,0.00001744384,0.0024700675,0.000011976356,0.0000012967746,0.00009047132],"study_design_scores_gemma":[0.011618086,0.0005167907,0.9842288,0.000023317007,0.0020731513,0.000010074426,0.00087075727,0.0002406894,0.000338692,0.00000883358,0.0000022673441,0.00006856273],"about_ca_topic_score_codex":0.030631637,"about_ca_topic_score_gemma":0.30918643,"teacher_disagreement_score":0.2785548,"about_ca_system_score_codex":0.000032696582,"about_ca_system_score_gemma":0.00009961729,"threshold_uncertainty_score":0.97582346},"labels":[],"label_agreement":null},{"id":"W3096820242","doi":"10.1182/blood-2020-141662","title":"Light Chain Deposition Disease: First Analysis of an International Study in 359 Patients","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Population; Internal medicine; Renal function; Kidney disease; Pediatrics; Surgery","score_opus":0.007808157131735666,"score_gpt":0.2514217200221643,"score_spread":0.24361356289042863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096820242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99917746,0.000091694936,0.000020244956,0.00032064575,0.000027957949,0.00021632171,0.00007537056,0.0000070078304,0.00006329957],"genre_scores_gemma":[0.99901676,0.000044109187,0.0000832198,0.00016533631,0.00004364425,0.000056965175,0.000573648,0.000009591978,0.0000067200517],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99925137,0.000046608453,0.00019097,0.000277576,0.00014285986,0.000090647896],"domain_scores_gemma":[0.99958855,0.000007039886,0.0000818464,0.00019131486,0.0000431721,0.00008809233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003410679,0.000097577074,0.00014744764,0.0000838631,0.000021209727,0.00001070789,0.00015553301,0.00003855377,0.000020380936],"category_scores_gemma":[0.00006606833,0.00009398997,0.000092500675,0.0002122543,0.000009011332,0.000006478419,0.00007372785,0.000026046748,0.0000022824804],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006928687,0.003541343,0.99205935,0.0000053945564,0.0009216284,0.000010233884,0.00019333106,0.00013176851,0.0028470615,0.0000031106408,0.000016867021,0.00020061257],"study_design_scores_gemma":[0.0019666075,0.0004415424,0.97413117,0.0000045233573,0.00070431136,8.2725194e-8,0.0000748533,0.00016121083,0.0223389,9.781226e-7,0.00008435415,0.00009144104],"about_ca_topic_score_codex":0.0000362627,"about_ca_topic_score_gemma":0.00034351388,"teacher_disagreement_score":0.01949184,"about_ca_system_score_codex":0.00001080438,"about_ca_system_score_gemma":0.000013354082,"threshold_uncertainty_score":0.38327998},"labels":[],"label_agreement":null},{"id":"W3096841065","doi":"10.1182/blood-2020-142800","title":"Sequential Use of Carfilzomib and Pomalidomide in Relapsed Multiple Myeloma: A Multi-Institutional Report from the Canadian Myeloma Research Group (CMRG) Database","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University; Hamilton Health Sciences; Princess Margaret Cancer Centre; University of Calgary; Vancouver General Hospital; University of Ottawa; McGill University Health Centre; London Health Sciences Centre; Juravinski Hospital; Hôpital Maisonneuve-Rosemont; University of Toronto; Western University; University of New Brunswick; Université de Montréal; University of Alberta; Saint John Regional Hospital; BC Cancer Agency; University Health Network; Saskatchewan Cancer Agency; CancerCare Manitoba; Ottawa Hospital","funders":"","keywords":"Pomalidomide; Daratumumab; Carfilzomib; Multiple myeloma; Medicine; Internal medicine; Database; Oncology; Lenalidomide; Family medicine","score_opus":0.15810868312927467,"score_gpt":0.3464041833252228,"score_spread":0.18829550019594815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096841065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99415547,0.00057957554,0.000035013465,0.0026042627,0.00004878831,0.0013456845,0.0009781497,0.000028713168,0.00022434992],"genre_scores_gemma":[0.99270684,0.000048286453,0.0053466577,0.00023598105,0.0001986166,0.00010663255,0.0011977378,0.000030644125,0.00012860452],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969047,0.0003530434,0.0005159446,0.0006390341,0.0008815687,0.0007057627],"domain_scores_gemma":[0.9975564,0.0005892913,0.00008972051,0.0006054282,0.00027575754,0.0008833935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007539019,0.00022897018,0.00042159684,0.00024079873,0.00036818284,0.00007776584,0.00020789183,0.00015221692,0.00008771617],"category_scores_gemma":[0.0049473043,0.00016341949,0.00009695269,0.0005669883,0.0005060292,0.00019487053,0.00025925378,0.0006610452,0.000027979795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013701576,0.00079567754,0.92716795,0.000095378986,0.00043433244,0.024923386,0.0009081239,0.0000070625374,0.04252945,0.00025649037,0.00083821063,0.0006737818],"study_design_scores_gemma":[0.02476375,0.00032563813,0.95905006,0.00019939728,0.00014846202,0.000442718,0.00034085914,0.0025832583,0.00786088,0.000020062835,0.0040647215,0.0002001818],"about_ca_topic_score_codex":0.5422581,"about_ca_topic_score_gemma":0.557048,"teacher_disagreement_score":0.03466857,"about_ca_system_score_codex":0.00019916406,"about_ca_system_score_gemma":0.001385058,"threshold_uncertainty_score":0.6664053},"labels":[],"label_agreement":null},{"id":"W3096854524","doi":"10.1182/blood-2020-140949","title":"Rituximab, Methotrexate, Procarbazine and Lomustine (R-MPL) for the Treatment of Primary CNS Lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Procarbazine; Lomustine; Medicine; Rituximab; Primary central nervous system lymphoma; Internal medicine; Methotrexate; Gastroenterology; Performance status; Surgery; Lymphoma; Chemotherapy; Vincristine","score_opus":0.03472658645760045,"score_gpt":0.2667800277470562,"score_spread":0.23205344128945576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096854524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9783713,0.0132111935,0.00011101099,0.0057096784,0.00004014211,0.0017264034,0.00009827022,0.00005401356,0.00067798997],"genre_scores_gemma":[0.99155813,0.0022122401,0.004591439,0.000723299,0.00023720793,0.0004397906,0.00006336478,0.00003352568,0.00014097517],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99915063,0.000017070282,0.00023707244,0.000273168,0.00014026844,0.0001817588],"domain_scores_gemma":[0.99917185,0.00030738954,0.00008448546,0.00023063108,0.000066308676,0.00013930595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000053896514,0.00018534713,0.00049319124,0.000028837767,0.0000658024,0.000011003937,0.00004955977,0.000048813203,0.000020711997],"category_scores_gemma":[0.000055136956,0.00010596538,0.00015207332,0.00013072012,0.00006928612,0.000023421153,0.000022639248,0.000016385758,0.00000567285],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023041184,0.037004016,0.11620388,0.0012289027,0.0044197016,0.00027498577,0.0029535976,0.000004154695,0.018725825,0.0007896261,0.002286959,0.8138042],"study_design_scores_gemma":[0.10543289,0.012970603,0.60693073,0.00014771125,0.008056669,0.0002913735,0.00021580698,0.00041852504,0.14662667,0.00008417479,0.11848652,0.00033833337],"about_ca_topic_score_codex":0.000065041124,"about_ca_topic_score_gemma":0.000008810677,"teacher_disagreement_score":0.8134659,"about_ca_system_score_codex":0.00004053551,"about_ca_system_score_gemma":0.000098198616,"threshold_uncertainty_score":0.43211427},"labels":[],"label_agreement":null},{"id":"W3096860160","doi":"10.1182/blood-2020-142229","title":"Transcriptional Control of HP1a By the RNA Binding Proteins Rbmx/L1 Maintain Chromatin State in Myeloid Leukemia","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"","keywords":"Haematopoiesis; Biology; Myeloid leukemia; Leukemia; RNA-binding protein; Progenitor cell; Small hairpin RNA; Knockout mouse; Myeloid; Chromatin; Stem cell; Molecular biology; Cancer research; RNA; Cell biology; Immunology; Genetics; Gene","score_opus":0.008785540576280993,"score_gpt":0.22456523799833997,"score_spread":0.21577969742205896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096860160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952283,0.000576438,0.0028346397,0.0007349432,0.00000897211,0.0003613182,0.00010979396,0.000005588,0.00014004282],"genre_scores_gemma":[0.99914587,0.000060941304,0.00016877412,0.00026219612,0.000060533857,0.000044096516,0.000049375132,0.000012718399,0.00019550335],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991075,0.000092207796,0.00020089369,0.00018760722,0.00017045389,0.00024133644],"domain_scores_gemma":[0.999699,0.000014972562,0.000052888758,0.00012538237,0.000028248767,0.00007949521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023755577,0.000093672825,0.00013256239,0.000020968057,0.000044109285,0.000016139611,0.00019764589,0.000055928213,0.00002198636],"category_scores_gemma":[0.00007903965,0.00007165994,0.00006175443,0.000096074604,0.000063284155,0.0000034857835,0.000029651705,0.00013230093,0.0000050243234],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010893105,0.00005330075,0.0011318093,0.00003024969,0.00004854733,0.0000056177832,0.00008805017,0.000072339266,0.9976168,0.0000933943,0.00019227107,0.000558644],"study_design_scores_gemma":[0.003237374,0.0004008627,0.0015746763,0.000021338848,0.00001151915,0.0000053983013,0.0001190163,0.000697747,0.9924273,0.00006250289,0.0013344947,0.000107779575],"about_ca_topic_score_codex":0.000112762995,"about_ca_topic_score_gemma":0.000041966163,"teacher_disagreement_score":0.0051895548,"about_ca_system_score_codex":0.000014297527,"about_ca_system_score_gemma":0.00013162363,"threshold_uncertainty_score":0.29222074},"labels":[],"label_agreement":null},{"id":"W3096865169","doi":"10.1182/blood-2020-136682","title":"Dabigatran Etexilate in Children with Venous Thromboembolism: Results of the Open-Label, Phase IIb/III, Randomized Diversity Clinical Trial","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Children's Hospital of Eastern Ontario; Hospital for Sick Children; University of Ottawa","funders":"","keywords":"Medicine; Dosing; Randomized controlled trial; Off-label use; Adverse effect; Data monitoring committee; Clinical endpoint; Dabigatran; Pediatrics; Internal medicine; Warfarin; Surgery","score_opus":0.105850382356078,"score_gpt":0.35868112445817557,"score_spread":0.25283074210209755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096865169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99286,0.00005895842,0.000035924317,0.0018026341,0.0001616155,0.003728105,0.000045640823,0.00004265834,0.0012644444],"genre_scores_gemma":[0.9979116,0.00005080912,0.000506225,0.0012235407,0.00020296166,0.00001977159,0.000034388213,0.000020394164,0.000030338175],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9976107,0.0004650927,0.0008650472,0.00042899975,0.00041134705,0.00021880801],"domain_scores_gemma":[0.9986987,0.00016728991,0.00039781997,0.00046297247,0.00007627258,0.00019691559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001256918,0.0001916997,0.0014891686,0.00004252862,0.00013491264,0.000023538167,0.00048086175,0.00015714586,0.000044328648],"category_scores_gemma":[0.0004355677,0.00011972713,0.00017599849,0.00038589453,0.0002283605,0.000094501054,0.0004645086,0.00039847486,0.0000061969013],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9674419,0.01846712,0.005289003,0.000026533718,0.0016670997,0.000027248132,0.002038579,0.000004232545,0.0027177858,0.00089661736,0.00019115857,0.00123273],"study_design_scores_gemma":[0.97564703,0.0038117524,0.0105141355,0.0000953448,0.0017556064,0.000017109318,0.000044895194,0.00010094268,0.0076536485,0.00018743133,0.000027158007,0.00014491592],"about_ca_topic_score_codex":0.0001902836,"about_ca_topic_score_gemma":0.0000281768,"teacher_disagreement_score":0.014655369,"about_ca_system_score_codex":0.000008689988,"about_ca_system_score_gemma":0.00018847823,"threshold_uncertainty_score":0.48823303},"labels":[],"label_agreement":null},{"id":"W3096900265","doi":"10.1182/blood-2020-141624","title":"Effectiveness of Comprehensive Newborn Screening Program of Sickle Cell Disease on the Childhood Morbidity and Mortality of the Disease: A Systematic Review and Meta-Analysis","year":2020,"lang":"en","type":"review","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pediatrics; Cochrane Library; Newborn screening; Cohort; Disease; Systematic review; Cohort study; MEDLINE; Meta-analysis; Mortality rate; Intensive care medicine; Internal medicine","score_opus":0.047323663281328025,"score_gpt":0.3179964827029211,"score_spread":0.27067281942159305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096900265","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001760326,0.9881867,0.0000070374304,0.0001123049,0.000008475357,0.009323754,0.00055555516,0.000014374441,0.000031451873],"genre_scores_gemma":[0.019473093,0.97991765,0.00003782917,0.00006462232,0.0000062569443,0.00040687376,0.00005603245,0.000028480501,0.000009138438],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99637794,0.0016194552,0.00097408687,0.00040899,0.00046993166,0.0001495773],"domain_scores_gemma":[0.99678344,0.00068144326,0.0011733343,0.0009841297,0.00015922528,0.00021844462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005818081,0.00041503404,0.0065052016,0.00007199955,0.00006133031,0.000008860548,0.00021999552,0.00009136125,0.000015445106],"category_scores_gemma":[0.00039283288,0.00017565997,0.0026518293,0.0008807112,0.00027684757,0.000017616047,0.00016260946,0.00033868855,4.6326727e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013587033,0.0008425611,0.00015665805,0.9111583,0.08709062,0.000013957596,0.000022816273,0.0000018529316,4.0782928e-7,0.000024685038,0.000003909073,0.00067060255],"study_design_scores_gemma":[0.0004127284,0.00011947067,0.0035297833,0.10494555,0.89025205,0.000005656346,0.000030898107,0.000007997173,0.000004597928,0.0000077133145,0.000551551,0.00013197478],"about_ca_topic_score_codex":0.00003547872,"about_ca_topic_score_gemma":0.0000010195324,"teacher_disagreement_score":0.8062128,"about_ca_system_score_codex":0.000007510908,"about_ca_system_score_gemma":0.00019074007,"threshold_uncertainty_score":0.7163205},"labels":[],"label_agreement":null},{"id":"W3096911669","doi":"10.1182/blood-2020-142182","title":"Single Centre, Retrospective Study to Evaluate Treatment Outcomes Following Tyrosine Kinase Inhibitor for Chronic Gvhd Treatment Including Ruxolitinib, Ibrutinib and Imatinib","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Ruxolitinib; Ibrutinib; Internal medicine; Tyrosine-kinase inhibitor; Imatinib; Oncology; Graft-versus-host disease; Hematopoietic stem cell transplantation; Janus kinase inhibitor; Transplantation; Pharmacology; Tofacitinib; Gastroenterology; Cancer; Leukemia; Myelofibrosis; Bone marrow; Chronic lymphocytic leukemia","score_opus":0.07223258988129425,"score_gpt":0.3598346977992248,"score_spread":0.2876021079179305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096911669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99013907,0.000754116,0.000021314156,0.0021020907,0.00016160206,0.0060461126,0.000103554834,0.00017241522,0.0004997567],"genre_scores_gemma":[0.9965136,0.00001984619,0.0015022046,0.00022378268,0.00052926363,0.00046444847,0.00005777457,0.00009906629,0.0005899892],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9967791,0.00011387418,0.0005998706,0.0009868232,0.00066292746,0.00085743534],"domain_scores_gemma":[0.9981955,0.00030312687,0.00012274615,0.0005083136,0.00015409247,0.0007162019],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031430428,0.000514636,0.0010614339,0.00014566076,0.00027493262,0.00009978051,0.00012300866,0.00008590232,0.00008633987],"category_scores_gemma":[0.0008385302,0.000391766,0.00032507445,0.00037156764,0.00005513648,0.00010453984,0.00021599625,0.00011100908,0.000046904606],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049902615,0.06777255,0.6402511,0.001454614,0.014159651,0.004489811,0.08782562,0.00007762231,0.0991018,0.00027604212,0.0010400862,0.07856084],"study_design_scores_gemma":[0.5841162,0.08491466,0.085998945,0.00049277506,0.0071729855,0.000087796885,0.007908384,0.0033622375,0.22071916,0.00008665837,0.003646301,0.0014938746],"about_ca_topic_score_codex":0.00027296296,"about_ca_topic_score_gemma":0.00014103041,"teacher_disagreement_score":0.57912594,"about_ca_system_score_codex":0.015005645,"about_ca_system_score_gemma":0.0021707998,"threshold_uncertainty_score":0.99985343},"labels":[],"label_agreement":null},{"id":"W3096918794","doi":"10.1182/blood-2020-134393","title":"Clinical Characteristics and Follow-up Post-Surgery of Women with Bia-ALCL Operated at a Single Institution","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Seroma; Anaplastic large-cell lymphoma; Surgery; Breast implant; Implant; Radiation therapy; Breast cancer; Cancer; Mastectomy; Lymphoma; Internal medicine; Complication","score_opus":0.03451276076660484,"score_gpt":0.25103533540029277,"score_spread":0.21652257463368793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096918794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991344,0.000042214808,0.000010279933,0.00032204823,0.00018804162,0.0001301958,0.000031764233,0.000034565863,0.00010646659],"genre_scores_gemma":[0.99933195,0.00002637684,0.00015571805,0.00017866962,0.00019286813,0.0000032896867,0.000055671437,0.000008901366,0.000046580306],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993228,0.00002843489,0.00027505748,0.00014881576,0.000091629154,0.00013327543],"domain_scores_gemma":[0.99951583,0.000045213208,0.000098657656,0.0000720145,0.000090614696,0.00017767027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012254057,0.00008089403,0.0003375275,0.00003733532,0.00003680057,0.0000075659673,0.000018043387,0.000085842046,0.000033948705],"category_scores_gemma":[0.0000841609,0.000058482234,0.000033937635,0.0001123919,0.000115638926,0.000048767954,0.000021882535,0.00009059359,0.000008257574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036400433,0.0005372353,0.84535265,0.0002565342,0.00032276465,0.0001230832,0.00069561903,8.736765e-8,0.055105224,0.000019303048,0.00008254592,0.09386491],"study_design_scores_gemma":[0.011486505,0.0026037544,0.94597524,0.00046851946,0.0006729032,0.01946194,0.0003202385,0.00006712622,0.017728202,0.0000031188754,0.0009296387,0.00028282215],"about_ca_topic_score_codex":0.000007557872,"about_ca_topic_score_gemma":0.0000031701509,"teacher_disagreement_score":0.10062258,"about_ca_system_score_codex":0.000017765196,"about_ca_system_score_gemma":0.000108998036,"threshold_uncertainty_score":0.23848362},"labels":[],"label_agreement":null},{"id":"W3096933788","doi":"10.1182/blood-2020-136692","title":"A Prospective Economic Analysis of Canadian Cancer Trials Group Clc.2/Alliance A041202: A Randomized Phase III Comparison of Bendamustine-Rituximab Versus Ibrutinib-Based Regimens in Untreated Older Patients with Chronic Lymphocytic Leukemia","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; University of Ottawa; Hôpital Charles-Le Moyne; Western University; London Health Sciences Centre; McMaster University; Princess Margaret Cancer Centre; Foothills Medical Centre; Ottawa Hospital; University Health Network; Health Sciences Centre; Queen's University; Sunnybrook Hospital; Moncton Hospital; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Ibrutinib; Bendamustine; Medicine; Rituximab; Chronic lymphocytic leukemia; Internal medicine; Population; Quality-adjusted life year; Oncology; Cost effectiveness; Leukemia; Lymphoma; Environmental health","score_opus":0.04013205289859495,"score_gpt":0.34094271097395223,"score_spread":0.3008106580753573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096933788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936006,0.0013733909,0.000032263935,0.00014658243,0.00007155915,0.003988028,0.0005005848,0.000040918898,0.00024604725],"genre_scores_gemma":[0.99850184,0.00012300235,0.00027094362,0.0000667208,0.0000919895,0.00040217678,0.00046079373,0.000057324265,0.000025201844],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9956758,0.00042333963,0.0017600365,0.00080360536,0.0006060173,0.00073116994],"domain_scores_gemma":[0.996384,0.0011434959,0.0010039876,0.0005907313,0.0003166937,0.0005610563],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008643883,0.00043615047,0.004394221,0.0011611641,0.000059372887,0.000021144926,0.00028497627,0.00021787873,0.0005208023],"category_scores_gemma":[0.00089307217,0.00035746666,0.00051872723,0.0029712894,0.00041289348,0.000092072136,0.000048647067,0.00029264347,0.000009087622],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.84038347,0.0039109415,0.06456633,0.0015623242,0.028619649,0.00027258802,0.0047532828,0.05299302,0.0010364475,0.00012540926,0.00045944974,0.0013171176],"study_design_scores_gemma":[0.75688666,0.0012657504,0.0032552406,0.00040622096,0.009108183,9.48256e-7,0.00010904331,0.220994,0.0076899887,9.684924e-7,0.000031025298,0.00025196417],"about_ca_topic_score_codex":0.37306777,"about_ca_topic_score_gemma":0.26677334,"teacher_disagreement_score":0.16800097,"about_ca_system_score_codex":0.04893582,"about_ca_system_score_gemma":0.058086157,"threshold_uncertainty_score":0.9998877},"labels":[],"label_agreement":null},{"id":"W3096948352","doi":"10.1182/blood-2020-136695","title":"Efficacy and Safety of Dabigatran in the Treatment and Secondary Prophylaxis of Children with Venous Thromboembolism and Thrombophilia","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Alberta; University of Ottawa; Hospital for Sick Children","funders":"","keywords":"Medicine; Thrombophilia; Dabigatran; Clinical endpoint; Low molecular weight heparin; Internal medicine; Clinical trial; Pediatrics; Heparin; Surgery; Warfarin; Thrombosis","score_opus":0.011255595053594197,"score_gpt":0.2262790493484613,"score_spread":0.2150234542948671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096948352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943172,0.0029488266,0.0000015241161,0.00082448375,0.000008009781,0.0012826077,0.000028281034,0.000011463877,0.0005776462],"genre_scores_gemma":[0.99632746,0.0031328273,0.00020872889,0.00023623943,0.00004455285,0.000020180885,0.00001188471,0.000015986834,0.0000021145054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914515,0.000043916687,0.00024282117,0.00027266468,0.00014456178,0.00015089205],"domain_scores_gemma":[0.9995515,0.000054137632,0.00008505334,0.0002032363,0.000020308247,0.00008581145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001036271,0.00016588172,0.0006602183,0.000047396617,0.000046163404,0.000010308973,0.00006110341,0.000050666255,0.000011947567],"category_scores_gemma":[0.000013102212,0.0000985868,0.000029637285,0.00014037754,0.00022739975,0.000040143026,0.000038096194,0.00010692701,3.2798508e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017986639,0.0324492,0.6620222,0.0032849049,0.005680861,0.00021310685,0.12452625,0.00001721564,0.024932226,0.0041040704,0.00017602365,0.14079529],"study_design_scores_gemma":[0.008960432,0.009173839,0.97692144,0.00012271338,0.0007571392,0.000061406085,0.00051096827,0.0000028427444,0.0032354402,0.00004574645,0.00010798113,0.000100060766],"about_ca_topic_score_codex":0.00017621143,"about_ca_topic_score_gemma":0.000039345956,"teacher_disagreement_score":0.31489924,"about_ca_system_score_codex":0.0000062634113,"about_ca_system_score_gemma":0.000041132243,"threshold_uncertainty_score":0.4020253},"labels":[],"label_agreement":null},{"id":"W3096953069","doi":"10.1182/blood-2020-142816","title":"Not All Patients Benefit from Switching to Ehl: Results from the Wapps Database","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; McMaster University; Impact","funders":"","keywords":"Haemophilia; Medicine; Database; Population; Haemophilia A; Pharmacokinetics; Trough level; Pediatrics; Internal medicine; Transplantation","score_opus":0.06156573956879387,"score_gpt":0.29865604360571485,"score_spread":0.237090304036921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096953069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9686816,0.00010685415,0.000008611425,0.028224686,0.00006988141,0.00049984845,0.0014435254,0.000056252346,0.0009087712],"genre_scores_gemma":[0.9901202,0.000036148496,0.0010362103,0.005952513,0.0006915125,0.000015436492,0.0019190774,0.000024915234,0.00020398883],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985747,0.000034470704,0.00023366547,0.00040702274,0.00048314236,0.00026701382],"domain_scores_gemma":[0.9987375,0.00030573635,0.000037035374,0.0004952205,0.000056593624,0.00036788356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010053637,0.00014112236,0.00020221768,0.000022688666,0.00008975352,0.000033370467,0.00021424562,0.00005709537,0.00012684456],"category_scores_gemma":[0.0005360834,0.000083601815,0.00006638502,0.00013634149,0.00001375779,0.00005462782,0.00020737149,0.00024371878,0.00066456135],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057858666,0.0046805595,0.63455355,0.000062792686,0.0021613662,0.00086456223,0.023612788,0.000009855569,0.23234135,0.000060897804,0.05543893,0.04042745],"study_design_scores_gemma":[0.04938797,0.002161608,0.7090082,0.00056541146,0.0011594631,0.0000025199101,0.0007065831,0.00041965704,0.1668247,0.0001644267,0.06897878,0.0006206988],"about_ca_topic_score_codex":0.001700508,"about_ca_topic_score_gemma":0.00010035861,"teacher_disagreement_score":0.07445461,"about_ca_system_score_codex":0.000017110196,"about_ca_system_score_gemma":0.00004013003,"threshold_uncertainty_score":0.85418135},"labels":[],"label_agreement":null},{"id":"W3096959229","doi":"10.1182/blood-2020-141168","title":"The Tumor Associated Antigen PRAME Exhibits Dualistic Functions That Are Targetable in Diffuse Large B-Cell Lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; Spinal Cord Injury BC","funders":"Medical Research Council","keywords":"Diffuse large B-cell lymphoma; Biology; Tumor microenvironment; Cancer research; Immune system; Antigen; Context (archaeology); Immunotherapy; Lymphoma; Immunology","score_opus":0.030470672176324858,"score_gpt":0.2646939371310036,"score_spread":0.23422326495467874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096959229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988763,0.0017083767,0.000017328193,0.0028110116,0.00011268805,0.00071405387,0.00009478208,0.00013049241,0.0056483205],"genre_scores_gemma":[0.98706955,0.00021440668,0.00002166013,0.0010947473,0.00019102033,0.00006357242,0.00007708168,0.00005721493,0.011210777],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979846,0.0001806616,0.00026659318,0.00035881478,0.00055616855,0.0006531771],"domain_scores_gemma":[0.99883604,0.00029193153,0.00011722325,0.00037851342,0.00011225093,0.00026403466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044635637,0.00018952819,0.00035303272,0.00007326067,0.00022783,0.0000832103,0.00019270007,0.00009679474,0.0005961549],"category_scores_gemma":[0.00080298836,0.00014234342,0.00012570378,0.0006166648,0.00006186918,0.0000689468,0.00011778786,0.00031471072,0.000255466],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001045581,0.03494074,0.7761661,0.0003121366,0.0007549866,0.0021765444,0.0026165033,0.0000058450355,0.1539282,0.00013501386,0.02701677,0.00090162025],"study_design_scores_gemma":[0.14559735,0.0014018939,0.4878078,0.0003580635,0.00059256615,0.00013480421,0.004049673,0.002258751,0.087883204,0.00016841288,0.26878792,0.00095954165],"about_ca_topic_score_codex":0.000093418435,"about_ca_topic_score_gemma":0.00022266999,"teacher_disagreement_score":0.28835824,"about_ca_system_score_codex":0.000091832924,"about_ca_system_score_gemma":0.0002039605,"threshold_uncertainty_score":0.65274775},"labels":[],"label_agreement":null},{"id":"W3096971678","doi":"10.1182/blood-2020-143392","title":"Platelet Count Trajectory and Mortality in Septic Shock: A Retrospective Cohort Study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Sepsis Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Septic shock; Medicine; Retrospective cohort study; Proportional hazards model; Intensive care unit; Cohort; Shock (circulatory); Hazard ratio; Internal medicine; Logistic regression; Emergency medicine; Sepsis; Confidence interval","score_opus":0.05062821797426285,"score_gpt":0.3123367306310931,"score_spread":0.2617085126568302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096971678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968864,0.00039996265,4.5053233e-7,0.00025538114,0.00002505859,0.0010533936,0.000009638512,0.000039391012,0.0013303381],"genre_scores_gemma":[0.99923223,0.00007949408,0.000026398899,0.00045475527,0.000062692314,0.000111810004,0.000008021972,0.000013442045,0.000011174552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990898,0.000032212516,0.00017437885,0.00033311386,0.00023089154,0.00013960192],"domain_scores_gemma":[0.99962896,0.00003170861,0.0000319327,0.00015581113,0.000026497548,0.0001250995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001255893,0.00012175164,0.00036773522,0.00003138582,0.00002363703,0.000011630629,0.000028294082,0.000040890714,0.00008950154],"category_scores_gemma":[0.000056682657,0.00010006287,0.000039725404,0.00013099931,0.000025541429,0.000027807211,0.000021949838,0.00012221215,0.000013469055],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003269035,0.003091427,0.99425,0.000021923854,0.0004466771,0.00060293206,0.0013021879,6.8837363e-7,0.000085676045,0.000011815869,0.000091512265,0.000062452404],"study_design_scores_gemma":[0.006322888,0.0012452296,0.9906315,0.000023939901,0.00053181255,0.000015864645,0.00042007226,0.000025557347,0.0006550963,0.000011511697,0.000030123436,0.000086370936],"about_ca_topic_score_codex":0.00021636776,"about_ca_topic_score_gemma":0.00028890956,"teacher_disagreement_score":0.006290198,"about_ca_system_score_codex":0.00006432919,"about_ca_system_score_gemma":0.000037912705,"threshold_uncertainty_score":0.40804452},"labels":[],"label_agreement":null},{"id":"W3096985216","doi":"10.1182/blood-2020-138464","title":"Detection of Right Ventricular Dysfunction in Acute Pulmonary Embolism By CT Scan: A Systematic Review and Meta-Analysis","year":2020,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Impact; Queen's University","funders":"","keywords":"Medicine; Pulmonary embolism; Meta-analysis; Radiology; Pre- and post-test probability; Cardiology; Internal medicine","score_opus":0.02207265134446299,"score_gpt":0.2808239951405125,"score_spread":0.25875134379604947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096985216","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008868375,0.9946253,0.000040622992,0.00016438898,0.000034020413,0.004902744,0.00006935335,0.000030549392,0.00012416726],"genre_scores_gemma":[0.00036839288,0.99759686,0.000023083514,0.00024805582,0.000026601869,0.0013193018,0.00020698796,0.000042165055,0.00016857954],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9969789,0.00039215383,0.0014068548,0.00058890926,0.00041482443,0.00021839084],"domain_scores_gemma":[0.9982206,0.00007109563,0.0009241854,0.0005887411,0.00006283489,0.00013250862],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000544037,0.00047305838,0.012316395,0.0005069802,0.000037683687,0.000018920055,0.00014207503,0.0001255234,0.0001256562],"category_scores_gemma":[0.00007960129,0.00031197147,0.0023647132,0.0017074173,0.000026231657,0.000057650446,0.000091491296,0.00026246227,0.000020658206],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000010126946,0.00057546975,7.3540645e-7,0.7665789,0.2294904,0.0005856798,0.000006208328,9.20591e-8,0.0000010567105,0.000011093603,0.000132188,0.0026171796],"study_design_scores_gemma":[0.00023807194,0.00009417834,0.000006002013,0.03209488,0.9054644,0.00034133223,0.0000046626383,0.0000035427,0.000011539071,0.000003276276,0.06152921,0.00020886444],"about_ca_topic_score_codex":0.00008837975,"about_ca_topic_score_gemma":0.000010252127,"teacher_disagreement_score":0.734484,"about_ca_system_score_codex":0.00007460797,"about_ca_system_score_gemma":0.000054268497,"threshold_uncertainty_score":0.99993324},"labels":[],"label_agreement":null},{"id":"W3096997744","doi":"10.1182/blood-2020-133384","title":"Predicting Thrombosis Recurrence in Children: The Role of Thrombophilia Testing","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Thrombophilia; Medicine; Thrombosis; Protein S deficiency; Retrospective cohort study; Internal medicine; Activated protein C resistance; Pediatrics; Venous thrombosis; Surgery; Factor V Leiden","score_opus":0.03601977494061445,"score_gpt":0.26146723440170627,"score_spread":0.22544745946109182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096997744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950106,0.00042841924,0.000019922787,0.00076730823,0.00003430012,0.0004249022,0.0000076576935,0.00007566361,0.0032312323],"genre_scores_gemma":[0.99805516,0.000020709971,0.0012742374,0.00046097022,0.00014847929,0.000013614428,0.0000066908933,0.000018017367,0.000002102259],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988918,0.000053344942,0.000342132,0.00024977326,0.0002682807,0.00019471296],"domain_scores_gemma":[0.9993657,0.00009644939,0.00013875304,0.00023620436,0.00007137154,0.00009152839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019506195,0.00012746717,0.00030143568,0.00004273263,0.00006213868,0.000010983348,0.00015563835,0.00006974401,0.000055261167],"category_scores_gemma":[0.00044895386,0.00009547129,0.000066353095,0.0006021575,0.00005596154,0.00006194387,0.00007803573,0.00024970152,0.000013534327],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006327079,0.0002871312,0.93239707,0.000024740064,0.000074519594,8.413809e-7,0.00075176766,0.000008055656,0.06392099,0.00073164457,0.0000063384564,0.0017905805],"study_design_scores_gemma":[0.001671323,0.00036124073,0.91079944,0.00019134714,0.0002278919,0.000021823616,0.00038725024,0.001450724,0.08397769,0.00078897574,0.000017653021,0.000104612576],"about_ca_topic_score_codex":0.00006411972,"about_ca_topic_score_gemma":0.000004382346,"teacher_disagreement_score":0.021597598,"about_ca_system_score_codex":0.000006789594,"about_ca_system_score_gemma":0.00006346518,"threshold_uncertainty_score":0.3893206},"labels":[],"label_agreement":null},{"id":"W3097008863","doi":"10.1182/blood-2020-134803","title":"Early Initiation of Treatment with Rivipansel for Acute Vaso-Occlusive Crisis in Sickle Cell Disease (SCD) Achieves Earlier Discontinuation of IV Opioids and Shorter Hospital Stay: Reset Clinical Trial Analysis","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Discontinuation; Clinical endpoint; Placebo; Myocardial infarction; Vaso-occlusive crisis; Anesthesia; Internal medicine; Randomized controlled trial; Sickle cell anemia; Disease; Pathology","score_opus":0.018493556869400695,"score_gpt":0.30210589874269095,"score_spread":0.28361234187329026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097008863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99686974,0.00022492217,0.0004421394,0.0008628056,0.00002674913,0.0012429259,0.00027300027,0.000010566681,0.000047144244],"genre_scores_gemma":[0.9985007,0.00040619305,0.000607701,0.00006798223,0.00006868367,0.000056922156,0.00024673386,0.000015805897,0.000029278219],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99874604,0.00007665472,0.0005390454,0.0003029343,0.00018529965,0.00015002606],"domain_scores_gemma":[0.9992343,0.00010253849,0.00021596033,0.00017463851,0.000101967584,0.00017058583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014264384,0.00014386752,0.0005681479,0.00011936165,0.000027901475,0.0000113105,0.000043741973,0.000108452776,0.000011733777],"category_scores_gemma":[0.000069906055,0.00010008433,0.0002227701,0.00032865687,0.00008443772,0.00009455248,0.000022472921,0.00009550178,6.089942e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043981712,0.006905225,0.93233943,0.00013892609,0.0047410903,0.00005514409,0.0092772795,0.000047102356,0.0005289519,0.00002788613,0.00012934992,0.0018278759],"study_design_scores_gemma":[0.21635008,0.055556744,0.6796914,0.0001380388,0.038988862,7.7259415e-7,0.0041916147,0.0024598509,0.0019866738,0.00008571284,0.00012925708,0.00042103327],"about_ca_topic_score_codex":0.00010615244,"about_ca_topic_score_gemma":0.0000347042,"teacher_disagreement_score":0.25264812,"about_ca_system_score_codex":0.000015556616,"about_ca_system_score_gemma":0.00013898933,"threshold_uncertainty_score":0.40813208},"labels":[],"label_agreement":null},{"id":"W3097009020","doi":"10.1182/blood-2020-136801","title":"Overcoming NOTCH1-Driven Chemoresistance in T-Cell Acute Lymphoblastic Leukemia Via Metabolic Intervention with Oxphos Inhibitor","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cancer research; Oxidative phosphorylation; Leukemia; Biology; Stem cell; Downregulation and upregulation; Thymocyte; Cell biology; T cell; Gene; Immunology; Genetics; Biochemistry","score_opus":0.009930602167076863,"score_gpt":0.24203639195699003,"score_spread":0.23210578978991317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097009020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925165,0.00049948314,0.004465172,0.0005844983,0.00005766708,0.0007063603,0.000017886228,0.00013278324,0.0010196194],"genre_scores_gemma":[0.99488205,0.000067891924,0.0034667961,0.0006686959,0.00036425178,0.000089060166,0.000042923497,0.00009284541,0.00032550527],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973202,0.00007678986,0.0005452565,0.0006771234,0.0007413848,0.0006392925],"domain_scores_gemma":[0.9987056,0.00013230137,0.00017225445,0.00041337733,0.00014955437,0.00042690578],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016099795,0.0003584201,0.0006782882,0.00020144197,0.00006414555,0.000047913345,0.00028489885,0.00017613842,0.00011770211],"category_scores_gemma":[0.00018446674,0.00030498178,0.00017093692,0.00083595986,0.00013174549,0.00020897455,0.00014658712,0.00044843144,0.00019041452],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006446279,0.0024357494,0.058597688,0.0017560429,0.0011358666,0.0052969684,0.0026680802,0.00022816927,0.9164569,0.00012078412,0.0021629964,0.0026944857],"study_design_scores_gemma":[0.0928089,0.0023095317,0.03977638,0.0014323232,0.0020055405,0.00066779455,0.00041114018,0.03050334,0.8273181,0.000043357293,0.0017108958,0.0010127204],"about_ca_topic_score_codex":0.00019336017,"about_ca_topic_score_gemma":0.00007185153,"teacher_disagreement_score":0.08913881,"about_ca_system_score_codex":0.00069249497,"about_ca_system_score_gemma":0.0007774192,"threshold_uncertainty_score":0.9999402},"labels":[],"label_agreement":null},{"id":"W3097013104","doi":"10.1182/blood-2020-140185","title":"An Observational Study to Collect and Assess Tissue Samples from Subjects with One of Three Neoplastic Conditions (ANSWer)","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Observational study; Clinical trial; Clinical study design; Informed consent; Oncology; Internal medicine; Medical physics; Pathology; Alternative medicine","score_opus":0.07083631135686538,"score_gpt":0.2900141872606187,"score_spread":0.21917787590375334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097013104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962397,0.00014034977,0.0024728782,0.00012166771,0.00002136695,0.0002884459,0.00067510473,0.000005300562,0.00003514828],"genre_scores_gemma":[0.99646634,0.000016808905,0.0027251597,0.00026111834,0.00015720111,0.000024700577,0.00033240434,0.000012579435,0.00000366843],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9994696,0.000016443382,0.000111741916,0.0002318372,0.00008615852,0.000084226995],"domain_scores_gemma":[0.9995677,0.00006215486,0.00004048321,0.00014530713,0.000077633,0.00010674128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000026157388,0.000081763996,0.00012564915,0.000014075308,0.000046386755,0.000022703623,0.00008375427,0.000029546194,0.0000297795],"category_scores_gemma":[0.00009175839,0.00008200949,0.000010915211,0.0000836799,0.000027677794,0.0000026697155,0.000045923003,0.000028724746,0.0000013899058],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016872586,0.0009728964,0.34597507,0.0000149403795,0.0002053224,0.000006192197,0.00034220246,0.00042319586,0.65144354,0.00012682567,0.00025104763,0.00007002471],"study_design_scores_gemma":[0.0021513808,0.0047714883,0.79916763,0.000013734815,0.00019856641,0.0000022419822,0.0002844902,0.000036207304,0.19271168,0.00012056556,0.0003649547,0.00017705302],"about_ca_topic_score_codex":0.00024415978,"about_ca_topic_score_gemma":0.0030267688,"teacher_disagreement_score":0.45873186,"about_ca_system_score_codex":0.0000026749817,"about_ca_system_score_gemma":0.000121582896,"threshold_uncertainty_score":0.33442497},"labels":[],"label_agreement":null},{"id":"W3097014108","doi":"10.1182/blood-2020-136625","title":"Comparative Efficacy of CC-486 Versus Injectable Azacitidine (AZA) in Patients (Pts) with Acute Myeloid Leukemia (AML) in First Remission after Intensive Induction Chemotherapy: Findings from an Indirect Treatment Comparison (ITC)","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Internal medicine; Chemotherapy; Chemotherapy regimen; Induction chemotherapy; Azacitidine; Oncology; Gastroenterology; Surgery","score_opus":0.03477449543718817,"score_gpt":0.30265461389412934,"score_spread":0.26788011845694115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097014108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99720186,0.00011737953,0.000009470729,0.0008430454,0.00006149193,0.0014428839,0.000074869116,0.000058935235,0.00019006361],"genre_scores_gemma":[0.99794793,0.00008991062,0.00085765764,0.00025077816,0.00010991249,0.000107089676,0.0005412427,0.000059433503,0.000036063753],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973906,0.00014449403,0.0006290388,0.0007612835,0.0005773674,0.00049719727],"domain_scores_gemma":[0.99856454,0.00018581121,0.00022182643,0.00040524645,0.00030039038,0.00032215682],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012371977,0.00043290536,0.0011974361,0.00036740018,0.000062005645,0.000026621306,0.00019404333,0.000255619,0.00008635742],"category_scores_gemma":[0.00014336917,0.00034718015,0.00009111326,0.0010290089,0.00014972943,0.00027631116,0.000089071655,0.00064422336,0.000023213017],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09119873,0.012353594,0.8184762,0.00011497335,0.0014276317,0.0003380486,0.051094145,0.00010786656,0.020760821,0.0000021234466,0.00073178957,0.0033940761],"study_design_scores_gemma":[0.15119646,0.010516055,0.58567655,0.0005157322,0.00035703008,0.000007534297,0.0021861987,0.00094552705,0.24793631,0.0000032446383,0.0002903781,0.00036899882],"about_ca_topic_score_codex":0.0017919109,"about_ca_topic_score_gemma":0.00068106985,"teacher_disagreement_score":0.23279968,"about_ca_system_score_codex":0.0015956172,"about_ca_system_score_gemma":0.0004947761,"threshold_uncertainty_score":0.999898},"labels":[],"label_agreement":null},{"id":"W3097024120","doi":"10.1182/blood-2020-134985","title":"The Burkitt Lymphoma International Prognostic Index (BL-IPI)","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"International Prognostic Index; Medicine; Hazard ratio; Internal medicine; Proportional hazards model; Confidence interval; Oncology; Lactate dehydrogenase; Censoring (clinical trials); Diffuse large B-cell lymphoma; Gastroenterology; Lymphoma; Pathology; Biology","score_opus":0.014450286184508835,"score_gpt":0.24135457275990724,"score_spread":0.2269042865753984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097024120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9631294,0.0009814078,0.000015718535,0.02252035,0.00022700448,0.00036937563,0.000009946587,0.00009022344,0.012656587],"genre_scores_gemma":[0.9972369,0.00014960817,0.00008994657,0.0016956889,0.00044550057,0.0000794244,0.000021394213,0.000013024502,0.00026851756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99923855,0.000015354044,0.00014851103,0.00018020479,0.00026105053,0.00015631109],"domain_scores_gemma":[0.99950176,0.00010762942,0.00004334057,0.00015105624,0.000056368735,0.00013981736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000045582514,0.00010122473,0.00011878926,0.000016605576,0.000083610954,0.00004580774,0.00011774716,0.00003854708,0.00007876628],"category_scores_gemma":[0.00017516607,0.00006110829,0.00008021808,0.00009055884,0.00003894243,0.00003099998,0.000058219535,0.000035763678,0.00022107044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000116831885,0.001544359,0.9576906,0.000017733395,0.00059909374,0.00038801302,0.00028992427,0.0000011245129,0.00016640344,0.0013814628,0.004929038,0.032875396],"study_design_scores_gemma":[0.010145639,0.00039592266,0.8892417,0.000048806785,0.0003164931,0.00014494409,0.00010409032,0.00025683982,0.0041880705,0.00010718499,0.094942756,0.00010754414],"about_ca_topic_score_codex":0.00002011457,"about_ca_topic_score_gemma":0.0000041187177,"teacher_disagreement_score":0.09001372,"about_ca_system_score_codex":0.000036162186,"about_ca_system_score_gemma":0.00009261397,"threshold_uncertainty_score":0.28414872},"labels":[],"label_agreement":null},{"id":"W3097035615","doi":"10.1182/blood-2020-142442","title":"Risk Factors for Iron Deficiency in Very Preterm Infants at 4-6 Months Corrected Age","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Medicine; Pediatrics; Iron deficiency; Micronutrient; Gestational age; Micronutrient deficiency; Anemia; Low birth weight; Population; Birth weight; Iron-deficiency anemia; Pregnancy; Internal medicine; Environmental health","score_opus":0.014376642411761467,"score_gpt":0.2409565079576139,"score_spread":0.2265798655458524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097035615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959069,0.0008648856,0.000040935705,0.00006818706,0.00015609617,0.0006317712,0.00006893452,0.00006867887,0.0021936423],"genre_scores_gemma":[0.9990135,0.00010616591,0.00023434577,0.0002886368,0.000062525374,0.000024336885,0.000081660604,0.000022520984,0.00016630445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999086,0.00002813296,0.00020488411,0.0002606775,0.00015331857,0.00026696388],"domain_scores_gemma":[0.9995251,0.00008250457,0.000066827335,0.00017042975,0.000019076524,0.00013606087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000056724282,0.00013979439,0.00025921917,0.000059023267,0.00005153101,0.000008895824,0.00008048057,0.000090937014,0.00006540944],"category_scores_gemma":[0.0005587926,0.000118697804,0.00008274413,0.00016989635,0.000034361954,0.000052477855,0.000042845168,0.00012171913,0.000020659858],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075900083,0.000541902,0.98285294,0.00027867875,0.000011071315,0.000044624197,0.0055572004,0.000023577648,0.007296207,0.000015032545,0.0012491675,0.0013706122],"study_design_scores_gemma":[0.00915717,0.00043136245,0.9806749,0.000026103951,0.000306514,0.0000030594797,0.000525001,0.000142993,0.007394402,0.000022752667,0.0011073706,0.00020831967],"about_ca_topic_score_codex":0.00013337852,"about_ca_topic_score_gemma":0.00009465977,"teacher_disagreement_score":0.008398169,"about_ca_system_score_codex":0.000013232299,"about_ca_system_score_gemma":0.000039114388,"threshold_uncertainty_score":0.48403558},"labels":[],"label_agreement":null},{"id":"W3097041936","doi":"10.1182/blood-2020-133369","title":"Symptom Burden in Transplant Ineligible Patients with Newly Diagnosed Multiple Myeloma: A Population-Based Study of Patient-Reported Outcomes","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Population; Nausea; Depression (economics); Multiple myeloma; Anxiety; Disease; Disease burden; Pediatrics; Intensive care medicine; Emergency medicine; Internal medicine; Psychiatry","score_opus":0.01746510945567214,"score_gpt":0.26505943704276086,"score_spread":0.24759432758708871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097041936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99727815,0.000025566358,0.000008401644,0.00017065938,0.000017156504,0.002351635,0.000059249796,0.000057517816,0.000031630185],"genre_scores_gemma":[0.99893093,0.000001749787,0.00038550998,0.00008450475,0.000017017112,0.00015939874,0.0003824856,0.00003272809,0.0000056927506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979778,0.0000760743,0.00054351136,0.0003793079,0.00071263785,0.00031069526],"domain_scores_gemma":[0.9989241,0.00019799382,0.00016335535,0.00030305926,0.00013706669,0.00027447368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004769059,0.00022913842,0.00054513715,0.00019112452,0.000042389063,0.000011305113,0.00008932269,0.000059330916,0.00003207171],"category_scores_gemma":[0.000277336,0.00016206026,0.00007298375,0.00043819906,0.00001717443,0.000067828165,0.000021682277,0.00014312369,0.000006059504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018857081,0.008881943,0.98488694,0.00009698207,0.00045658488,0.00065785716,0.0019767876,0.00027724696,0.0000928629,4.680297e-7,0.000003766314,0.0007828675],"study_design_scores_gemma":[0.07945424,0.002922207,0.915695,0.000106017374,0.00026006036,0.0000012908649,0.00028732768,0.0004987944,0.000633964,8.7401025e-7,0.0000042314055,0.00013597932],"about_ca_topic_score_codex":0.0035859842,"about_ca_topic_score_gemma":0.00076795154,"teacher_disagreement_score":0.07756854,"about_ca_system_score_codex":0.000036890084,"about_ca_system_score_gemma":0.000107850115,"threshold_uncertainty_score":0.66086257},"labels":[],"label_agreement":null},{"id":"W3097048703","doi":"10.1182/blood-2020-142637","title":"Acute Myeloid Leukaemia in Elderly: Expression Analysis of DNA Damage Response (DDR) and Anti-Apoptosis Genes Identify Novel Targets for Potential \"Synergistic Lethality\"","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"DNA damage; DNA repair; Cancer research; PARP1; Synthetic lethality; Genome instability; Biology; Cell cycle; Medicine; Cancer; Immunology; Gene; Genetics; Poly ADP ribose polymerase; DNA","score_opus":0.027361336184324275,"score_gpt":0.3149226972238821,"score_spread":0.2875613610395578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097048703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99085015,0.0005029667,0.0056220363,0.0018391171,0.0000473779,0.00069719326,0.0003567945,0.00004979217,0.000034549077],"genre_scores_gemma":[0.9935746,0.00023501534,0.0053403587,0.00022355681,0.00014639983,0.00006309934,0.00022623282,0.00005043882,0.00014030376],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973497,0.00020145735,0.0006724462,0.00070361845,0.0005733662,0.00049944443],"domain_scores_gemma":[0.99833137,0.00039305227,0.0002101275,0.0005044332,0.00022390128,0.00033713484],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00080552464,0.0002840026,0.00097429147,0.00069220585,0.000099354176,0.000044183438,0.00027132788,0.00024970123,0.0000711752],"category_scores_gemma":[0.000831156,0.00026092184,0.00029901884,0.001289094,0.00017704749,0.00015844438,0.0002830911,0.00033435947,0.0000041062326],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029926088,0.00040603764,0.009895668,0.0002915319,0.0015583995,0.00013178078,0.0005151352,0.00010069627,0.9833638,0.000015956306,0.00042239955,0.00030600018],"study_design_scores_gemma":[0.010085298,0.00054704834,0.104360186,0.00010796643,0.0047760434,0.000013657724,0.00030700365,0.0049689603,0.874256,0.000013010622,0.00028395848,0.00028086427],"about_ca_topic_score_codex":0.00012761515,"about_ca_topic_score_gemma":0.000012376352,"teacher_disagreement_score":0.10910778,"about_ca_system_score_codex":0.000079494006,"about_ca_system_score_gemma":0.00029375093,"threshold_uncertainty_score":0.9999843},"labels":[],"label_agreement":null},{"id":"W3097054553","doi":"10.1182/blood-2020-141412","title":"High-Density Domain-Focused CRISPR Screens Reveal Epigenetic Regulators of <i>Hox/Meis</i> Gene Expression in Acute Myeloid Leukemia","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Hox gene; Epigenetics; Chromatin; Biology; Myeloid leukemia; Transcription factor; Cancer research; Genetics; Cell biology; Gene","score_opus":0.005918150406433932,"score_gpt":0.23077046393347936,"score_spread":0.22485231352704543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097054553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887328,0.0011792108,0.00951882,0.00011098486,0.000087028944,0.00022308913,0.00003974488,0.000030910363,0.00007737681],"genre_scores_gemma":[0.978228,0.0002538453,0.02089995,0.00018847441,0.00025118756,0.000012108212,0.00007181698,0.000041336003,0.000053284424],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985426,0.000056764366,0.00038889828,0.0004891789,0.00019533484,0.0003271949],"domain_scores_gemma":[0.99920917,0.000010904555,0.00009453368,0.00045124334,0.000055788492,0.00017836932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012304136,0.00023716135,0.00033356462,0.000049601775,0.000041736188,0.000008843552,0.00024079367,0.00022165882,0.0000096861],"category_scores_gemma":[0.000042361804,0.00024297024,0.00014834462,0.00017807147,0.00005940607,0.0000037176023,0.00020672452,0.00014264978,0.0000044744947],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009434649,0.00006803115,0.004845302,0.00004630171,0.00007783773,0.000025233587,0.000117321266,0.0007588409,0.993042,0.000008913258,0.00062533095,0.00029054322],"study_design_scores_gemma":[0.002020536,0.00027144552,0.026226947,0.000031606873,0.00007538789,0.000012118244,0.00003436915,0.000028262257,0.97024894,0.00003475288,0.0007580699,0.00025758636],"about_ca_topic_score_codex":0.00006190767,"about_ca_topic_score_gemma":0.000033608147,"teacher_disagreement_score":0.02279308,"about_ca_system_score_codex":0.000014585913,"about_ca_system_score_gemma":0.00007777891,"threshold_uncertainty_score":0.9908039},"labels":[],"label_agreement":null},{"id":"W3097057937","doi":"10.1182/blood-2020-138961","title":"Risk Factors for the Development of Skin Cancers in Patients with Chronic Lymphocytic Leukemia: A Retrospective Cohort Study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Chronic lymphocytic leukemia; Skin cancer; Cancer; Retrospective cohort study; Population; Cohort; Internal medicine; Hazard ratio; Basal cell carcinoma; Oncology; Leukemia; Confidence interval; Basal cell","score_opus":0.013772005400500859,"score_gpt":0.26010914150805375,"score_spread":0.2463371361075529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097057937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99522567,0.00012779808,0.00007961306,0.000012981135,0.00003599626,0.004375366,0.000026384252,0.000027284836,0.00008893201],"genre_scores_gemma":[0.9992097,0.000016515683,0.00024145129,0.000023556157,0.00006377192,0.00035497348,0.000019502355,0.000039810042,0.000030696083],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978912,0.00004925973,0.0004173354,0.0004414134,0.00080180756,0.00039902466],"domain_scores_gemma":[0.9988666,0.0002572526,0.00016960425,0.00036304045,0.00020237964,0.00014108338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033348185,0.00020987252,0.00050314364,0.00007582628,0.00010200983,0.000011049455,0.00021958268,0.00007041841,0.0000298463],"category_scores_gemma":[0.00039017646,0.000127889,0.00006592664,0.00049970753,0.00010832543,0.0000445776,0.00009519137,0.00023136742,0.0000046704695],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0008362378,0.00032127733,0.9896422,0.00012662842,0.000918444,0.000008177596,0.0071415724,0.0005378842,0.000011245718,0.00000203434,0.000039411305,0.00041489603],"study_design_scores_gemma":[0.082045905,0.001971846,0.9088143,0.000072428855,0.00042441883,0.0000011021625,0.0010584089,0.003030446,0.0024009445,0.0000016596528,0.000041642725,0.00013685733],"about_ca_topic_score_codex":0.0042224205,"about_ca_topic_score_gemma":0.0023468882,"teacher_disagreement_score":0.08120967,"about_ca_system_score_codex":0.08736045,"about_ca_system_score_gemma":0.04098893,"threshold_uncertainty_score":0.9644478},"labels":[],"label_agreement":null},{"id":"W3097059942","doi":"10.1182/blood-2020-142917","title":"VWF/ADAMTS13 Ratios Are Potential Markers of Immunothrombotic Complications in Patients with COVID-19: A Cross-Sectional Study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; ADAMTS13; Von Willebrand factor; Intensive care unit; Internal medicine; Thrombosis; Platelet activation; Endothelial activation; Coagulopathy; Sepsis; Immunology; Venous thrombosis; Platelet; Gastroenterology; Inflammation","score_opus":0.0513263906465783,"score_gpt":0.3936112398812946,"score_spread":0.3422848492347163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097059942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943732,0.000018529174,0.00043433343,0.0033058089,0.000025990474,0.0016370895,0.00007273653,0.00004135361,0.0000909421],"genre_scores_gemma":[0.998036,0.000006642893,0.0001780351,0.0015529605,0.000044466713,0.00010118197,0.000040452916,0.000016933176,0.000023281882],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979504,0.000112308364,0.00054770824,0.00040200306,0.00076047715,0.00022712494],"domain_scores_gemma":[0.997941,0.0009268938,0.00017328377,0.00032076196,0.00034380978,0.00029421202],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0002882706,0.0001376719,0.00039523057,0.00010125521,0.0001353547,0.000021943648,0.00016756641,0.00005238494,0.00013994188],"category_scores_gemma":[0.011351692,0.000115397655,0.00008478896,0.00046567764,0.00026675544,0.000064062486,0.00016579573,0.00028879757,0.00001791049],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013258592,0.004676779,0.99240565,0.0002541593,0.0003604581,0.000020312671,0.00029239678,0.00045012092,0.00011853663,0.000017203705,0.000059697755,0.000018841223],"study_design_scores_gemma":[0.016641347,0.0024573717,0.980199,0.000033429264,0.00011715222,5.465762e-7,0.00022250118,0.00012288679,0.000013487886,0.000017601622,0.0000763786,0.000098336546],"about_ca_topic_score_codex":0.00023003295,"about_ca_topic_score_gemma":0.00008143934,"teacher_disagreement_score":0.015315487,"about_ca_system_score_codex":0.00008413652,"about_ca_system_score_gemma":0.00060662965,"threshold_uncertainty_score":0.99697614},"labels":[],"label_agreement":null},{"id":"W3097077452","doi":"10.1182/blood-2020-137081","title":"Study Design and Initial Baseline Characteristics in Solace-Kids: Crizanlizumab in Pediatric Patients with Sickle Cell Disease","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto","funders":"","keywords":"Medicine; Sickle cell anemia; Anemia; Internal medicine; Fetal hemoglobin; Disease; Dosing; Acute chest syndrome; Vaso-occlusive crisis; Adverse effect; Placebo; Gastroenterology; Immunology; Pediatrics; Pathology; Pregnancy","score_opus":0.011504361541917023,"score_gpt":0.22364595191283657,"score_spread":0.21214159037091954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097077452","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99802125,0.0003123521,0.000118839205,0.00029521936,0.000030948235,0.0010785884,0.000018572138,0.000030065483,0.00009415248],"genre_scores_gemma":[0.9990856,0.00012807379,0.00020797987,0.0003840237,0.00008768721,0.000024496409,0.000044091892,0.00002732487,0.000010727288],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988738,0.00010900925,0.0002948931,0.0002904333,0.00020564703,0.00022626798],"domain_scores_gemma":[0.99942875,0.000055330725,0.000060857412,0.00012446068,0.000049407805,0.00028117717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012025167,0.0001619318,0.00028066034,0.00010712727,0.000030143723,0.000015999,0.00005036678,0.000061958526,0.000021437381],"category_scores_gemma":[0.00018799171,0.00012820374,0.00001948805,0.00033590093,0.000025849407,0.000058794805,0.0000422566,0.0002575638,0.0000109521425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012586594,0.005636809,0.9898551,0.00017380813,0.000014823206,0.0008496868,0.0016320514,0.000016380009,0.000011318227,6.7170544e-7,0.00005682489,0.0004938392],"study_design_scores_gemma":[0.0329005,0.0027165203,0.9617306,0.00006135692,0.0005631167,0.0000020649702,0.0008011147,0.00088485173,0.000035327434,0.0000040234886,0.000041114745,0.0002593862],"about_ca_topic_score_codex":0.000012475575,"about_ca_topic_score_gemma":0.00000444505,"teacher_disagreement_score":0.03164184,"about_ca_system_score_codex":0.0000126821615,"about_ca_system_score_gemma":0.00016074398,"threshold_uncertainty_score":0.52279973},"labels":[],"label_agreement":null},{"id":"W3097082273","doi":"10.1182/blood-2020-136076","title":"Leukemia Stem Cells Demonstrate Increased DNA Damage Repair and Chemoresistance in Acute Myeloid Leukemia","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Stem cell; DNA repair; Biology; RAD51; Myeloid leukemia; DNA damage; Molecular biology; Cancer research; Cell biology; DNA; Genetics","score_opus":0.015710040178852316,"score_gpt":0.24555456078531307,"score_spread":0.22984452060646077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097082273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99304163,0.0006158127,0.000021539476,0.0010947511,0.00003225054,0.0007832232,0.000048556205,0.00032684658,0.004035397],"genre_scores_gemma":[0.99378,0.0004948972,0.0026723568,0.00175471,0.0002213282,0.000054108,0.000035090707,0.000086543434,0.00090094033],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971169,0.00014856445,0.00057702325,0.0008687565,0.0005482389,0.000740503],"domain_scores_gemma":[0.9982312,0.0001725836,0.0001298871,0.0006146932,0.000105353276,0.000746299],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004527074,0.00039080076,0.0007546825,0.00017205585,0.00009994622,0.000055617,0.00029756443,0.000280596,0.00007085207],"category_scores_gemma":[0.00011297215,0.00037241203,0.00014828402,0.00077879126,0.00025718732,0.00019627337,0.00024938,0.00092876493,0.00011468169],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001446103,0.00020666589,0.049213286,0.00079787936,0.0004843808,0.0066205845,0.00082087744,0.0000069765624,0.9313353,0.000113275244,0.0072934004,0.0016613068],"study_design_scores_gemma":[0.02275882,0.00074645673,0.104021996,0.00037351498,0.0007073937,0.0003340565,0.0006927253,0.0052173464,0.86091137,0.00004354276,0.0034196416,0.0007731459],"about_ca_topic_score_codex":0.00022448666,"about_ca_topic_score_gemma":0.000062702115,"teacher_disagreement_score":0.0704239,"about_ca_system_score_codex":0.00073292863,"about_ca_system_score_gemma":0.0017122438,"threshold_uncertainty_score":0.9998728},"labels":[],"label_agreement":null},{"id":"W3097090129","doi":"10.1182/blood-2020-136645","title":"Risk Profiling of Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients By Measuring Circulating Tumor DNA","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Bendamustine; Internal medicine; Diffuse large B-cell lymphoma; Rituximab; Medicine; Oncology; Lymphoma; Gastroenterology","score_opus":0.007342935661586031,"score_gpt":0.19020223018815732,"score_spread":0.1828592945265713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097090129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99738014,0.0013062531,0.00024633124,0.000009918842,0.0000795547,0.00016859363,0.00033234427,0.000012279511,0.00046459402],"genre_scores_gemma":[0.9987419,0.00017945631,0.00046589976,0.0002261358,0.00016006577,0.000010291949,0.00017103742,0.00003616545,0.000009013683],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990056,0.00003559376,0.0002686123,0.00031838755,0.00014120643,0.00023060839],"domain_scores_gemma":[0.9993217,0.000023523726,0.00022669458,0.00022537385,0.00008253375,0.00012017812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000087130924,0.00014381255,0.00016275952,0.000015627791,0.000069558846,0.000014838785,0.0001510355,0.000080831946,0.0000037093973],"category_scores_gemma":[0.00035009606,0.00015553652,0.00009504393,0.00006114892,0.000021991673,0.0000032780003,0.00014188056,0.000067731686,0.0000047128347],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050784158,0.002512684,0.11884134,0.00009040975,0.00006356272,0.000004412823,0.00014630206,0.000015889493,0.8773976,0.00000828626,0.0003476531,0.0005211001],"study_design_scores_gemma":[0.010985537,0.0003783699,0.0043264455,0.000018881445,0.0000953426,0.0000011865653,0.000072843446,0.0001201256,0.98096526,0.000009575067,0.0027870547,0.000239365],"about_ca_topic_score_codex":0.00001868252,"about_ca_topic_score_gemma":0.00000425835,"teacher_disagreement_score":0.114514895,"about_ca_system_score_codex":0.000011383989,"about_ca_system_score_gemma":0.000072950934,"threshold_uncertainty_score":0.6342595},"labels":[],"label_agreement":null},{"id":"W3097097114","doi":"10.1182/blood-2020-134624","title":"High Doses of Targeted Radiation with Anti-CD45 Iodine (131I) Apamistamab [Iomab-B] Do Not Correlate with Incidence of Mucositis, Febrile Neutropenia or Sepsis in the Prospective, Randomized Phase 3 Sierra Trial for Patients with Relapsed or Refractory Acute Myeloid Leukemia","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Mucositis; Medicine; Neutropenia; Incidence (geometry); Febrile neutropenia; Sepsis; Internal medicine; Randomized controlled trial; Surgery; Radiation therapy; Chemotherapy","score_opus":0.014634953126990315,"score_gpt":0.2826821903523069,"score_spread":0.2680472372253166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097097114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932309,0.000076214776,0.00035143798,0.00042684752,0.000022782979,0.0054908623,0.00031112807,0.000039838633,0.000050025028],"genre_scores_gemma":[0.9965542,0.00009031806,0.0019068848,0.00019558122,0.00010479019,0.00075381197,0.00030641447,0.000038691644,0.000049287424],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980458,0.000115914096,0.00065523916,0.00044876526,0.00048231022,0.00025198076],"domain_scores_gemma":[0.99793136,0.0006841274,0.00059593405,0.00034216716,0.0002950404,0.0001513451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025900087,0.0002891728,0.0010463139,0.000058130125,0.000100742414,0.00002298233,0.00020657144,0.00011250314,0.00006193331],"category_scores_gemma":[0.00041284304,0.00014391239,0.00009691182,0.00074937136,0.00030711718,0.00016007075,0.000019974352,0.00031075114,0.0000010563152],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9368552,0.0024787467,0.0016436354,0.00027777036,0.00067023415,0.000057932873,0.00071769,0.00007071776,0.056868974,0.00003308331,0.00011600208,0.00021004464],"study_design_scores_gemma":[0.8297434,0.0066999937,0.00482523,0.00023196898,0.0023646948,0.00002893334,0.000106406864,0.0005762695,0.1551126,0.0000053011568,0.00008745639,0.00021776598],"about_ca_topic_score_codex":0.000034168443,"about_ca_topic_score_gemma":0.000004963256,"teacher_disagreement_score":0.10711179,"about_ca_system_score_codex":0.00007719392,"about_ca_system_score_gemma":0.0004809953,"threshold_uncertainty_score":0.5868577},"labels":[],"label_agreement":null},{"id":"W3097099568","doi":"10.1182/blood-2020-141635","title":"Fatigue, However Measured, Continues to Refine Prognosis in Higher Risk MDS: An MDS-CAN Study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Dr. Georges-L.-Dumont University Hospital Centre; St. Paul's Hospital; McMaster University; CancerCare Manitoba; University Health Network; Health Sciences Centre; Ottawa Hospital; McGill University Health Centre; McGill University; University of Ottawa; Queen Elizabeth II Health Sciences Centre; University of Alberta; Princess Margaret Cancer Centre; University of Calgary; Hôpital de l'Enfant-Jésus; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; International Prognostic Scoring System; Quality of life (healthcare); Internal medicine; Myelodysplastic syndromes; Rating scale; Disease; Population; Cancer; Physical therapy; Gerontology; Oncology; Psychology; Environmental health","score_opus":0.06734713098575712,"score_gpt":0.28582498727076006,"score_spread":0.21847785628500294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097099568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954721,0.000177917,0.0000014134708,0.0027090455,0.00003514,0.0006991372,0.00007621511,0.000063055355,0.0007660086],"genre_scores_gemma":[0.9979372,0.000008449134,0.00032646966,0.0010398644,0.00021186419,0.00011114408,0.00005426964,0.00002242058,0.00028832894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99889785,0.00006480691,0.00019833994,0.00032128853,0.00035085736,0.00016685332],"domain_scores_gemma":[0.9994642,0.00001764959,0.00004391376,0.00015349496,0.000022190374,0.000298558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008060099,0.00013975042,0.00022854628,0.000044954828,0.000035807294,0.000014875297,0.00008008305,0.00003668396,0.00038756448],"category_scores_gemma":[0.00008143561,0.00011624529,0.000047062833,0.00018722432,0.000023323753,0.00006583258,0.00004662171,0.000105128216,0.00007083661],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033879714,0.0038414972,0.9916956,0.000022503196,0.00009530687,0.000073194184,0.00066179445,0.000007451921,0.0013264316,0.000005587902,0.0007206227,0.0012112459],"study_design_scores_gemma":[0.003621278,0.0015498891,0.99139416,0.000037355803,0.00032366387,0.0000015153917,0.00031892612,0.0000060222646,0.001084393,0.0000098984665,0.0015139144,0.00013896017],"about_ca_topic_score_codex":0.00018915696,"about_ca_topic_score_gemma":0.00012862263,"teacher_disagreement_score":0.003282481,"about_ca_system_score_codex":0.000023257006,"about_ca_system_score_gemma":0.000018947892,"threshold_uncertainty_score":0.47403455},"labels":[],"label_agreement":null},{"id":"W3097113057","doi":"10.1182/blood-2020-138694","title":"Extensive Variability in Platelet Count, Bleeding, and Quality of Life Outcome Measures in Adult and Pediatric Immune Thrombocytopenia: An Appraisal from a Critical Review of the Literature","year":2020,"lang":"en","type":"review","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; MEDLINE; Observational study; Critical appraisal; Systematic review; Immune thrombocytopenia; Pediatrics; Platelet disorder; Quality of life (healthcare); Family medicine; Internal medicine; Alternative medicine; Platelet; Pathology","score_opus":0.06280578565520895,"score_gpt":0.37312541540555916,"score_spread":0.3103196297503502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097113057","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0700899,0.9276953,7.5900573e-7,0.00021171354,0.00007105036,0.0012757858,0.00059784856,0.000008515048,0.0000491699],"genre_scores_gemma":[0.04752786,0.95190024,0.00012652298,0.00017721206,0.00006139509,0.000049036415,0.00013086018,0.000025712025,0.0000011539491],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.9964254,0.0007951423,0.0015871321,0.00058343244,0.00039232217,0.0002165854],"domain_scores_gemma":[0.997337,0.0012860082,0.00048169197,0.00049991463,0.0002438907,0.00015152899],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010005893,0.0004129408,0.004632763,0.00009429971,0.00002497315,0.000017704855,0.00017444452,0.00038382353,0.00001373842],"category_scores_gemma":[0.008769511,0.00025566155,0.00026627784,0.0005492044,0.00015464213,0.000091511516,0.00014654889,0.00073549326,6.3299404e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031372547,0.005143575,0.22479118,0.70318365,0.001233089,0.0006554276,0.0015852081,4.3549452e-8,0.00001719568,0.0005743471,0.00005370851,0.06244884],"study_design_scores_gemma":[0.033929233,0.0016698636,0.4724179,0.42993551,0.030703306,0.0007441003,0.00038398046,0.000011388284,0.000023444969,0.0008481722,0.0270876,0.0022455268],"about_ca_topic_score_codex":0.00038603513,"about_ca_topic_score_gemma":0.000072803894,"teacher_disagreement_score":0.27324814,"about_ca_system_score_codex":0.000027111031,"about_ca_system_score_gemma":0.0003239245,"threshold_uncertainty_score":0.99998957},"labels":[],"label_agreement":null},{"id":"W3097136645","doi":"10.1182/blood-2020-142447","title":"<i>TINF2</i> Mutations Are Associated with Poor Outcome Post Hematopoietic Stem Cell Transplantation for Dyskeratosis Congenita","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; CancerCare Manitoba; University of Calgary; Alberta Children's Hospital; SickKids Foundation; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Dyskeratosis congenita; Medicine; Hematopoietic stem cell transplantation; Bone marrow failure; Internal medicine; Transplantation; Oncology; Stem cell; Telomere; Haematopoiesis; Biology; Genetics","score_opus":0.02425181372060687,"score_gpt":0.24020901638036912,"score_spread":0.21595720265976226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097136645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99384725,0.00020066895,0.000720476,0.003300716,0.000050522947,0.0008793804,0.0005069528,0.00019334248,0.000300667],"genre_scores_gemma":[0.99566305,0.000019782288,0.00054319296,0.0028591899,0.00007102269,0.000080994534,0.00041453209,0.000047499117,0.00030072912],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99872166,0.00003891098,0.00036268312,0.00032216593,0.0002720992,0.00028248518],"domain_scores_gemma":[0.99897146,0.00020073372,0.00016974033,0.00015042166,0.00026821415,0.00023941523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007825881,0.00020707338,0.00039658483,0.00005943636,0.00013799289,0.000034161483,0.00008991823,0.000100515004,0.00003663165],"category_scores_gemma":[0.000063662505,0.00017573568,0.000113131646,0.0002994693,0.000049006132,0.000090909954,0.0000068812487,0.0001457296,0.000032787775],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017641324,0.0036336128,0.7647619,0.0045032166,0.0011977868,0.0010065482,0.020397706,0.00004058222,0.19979389,0.00023334638,0.001292968,0.0013743003],"study_design_scores_gemma":[0.05233134,0.0046983035,0.3339347,0.0009607644,0.009338793,0.0004389165,0.012886387,0.0006132007,0.58181214,0.000034938123,0.0012193994,0.0017311106],"about_ca_topic_score_codex":0.000012936085,"about_ca_topic_score_gemma":0.00005835936,"teacher_disagreement_score":0.4308272,"about_ca_system_score_codex":0.000019794901,"about_ca_system_score_gemma":0.000099473145,"threshold_uncertainty_score":0.7166293},"labels":[],"label_agreement":null},{"id":"W3097137672","doi":"10.1182/blood-2020-133646","title":"Neonates with Asymptomatic Central Venous Catheter-Related Thrombosis - a Systematic Review","year":2020,"lang":"en","type":"review","venue":"Blood","topic":"Central Venous Catheters and Hemodialysis","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Medicine; Asymptomatic; Retrospective cohort study; Thrombosis; Central venous catheter; Prospective cohort study; Cohort study; Venous thrombosis; Pediatrics; Randomized controlled trial; Surgery; Intensive care medicine; Internal medicine; Catheter","score_opus":0.04231661839301324,"score_gpt":0.35111917924376385,"score_spread":0.3088025608507506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097137672","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000016869835,0.9879989,0.000008828577,0.00018270592,0.00025322728,0.010289969,0.000175655,0.00032822933,0.0007456055],"genre_scores_gemma":[0.000032787768,0.9962838,0.00012123441,0.00058238907,0.00017514589,0.001913764,0.00037632015,0.00022498315,0.0002895406],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9929227,0.0017497346,0.002618689,0.0008206159,0.0005803527,0.0013079093],"domain_scores_gemma":[0.99538743,0.0007439877,0.002110087,0.0011371468,0.00012198411,0.00049934135],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00055823894,0.0009321344,0.008410886,0.00016532464,0.000591465,0.000036028094,0.0007710308,0.00061618496,0.00046434248],"category_scores_gemma":[0.00025394242,0.0006065495,0.0014744181,0.00092953746,0.0000710535,0.000082460465,0.00017555097,0.0014587513,0.0019087584],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000016110286,0.0007588403,0.00000756569,0.9868682,0.0029787654,0.00007817007,0.0014658975,5.0871474e-8,6.2370894e-8,0.00005073799,0.00030021532,0.007489866],"study_design_scores_gemma":[0.0006078188,0.00034806042,0.000002558202,0.8346611,0.057130553,0.0000985108,0.000082296625,0.0000032193714,8.300704e-8,0.00001613102,0.106413506,0.0006361071],"about_ca_topic_score_codex":0.00007877107,"about_ca_topic_score_gemma":0.000026781494,"teacher_disagreement_score":0.15220706,"about_ca_system_score_codex":0.00034506436,"about_ca_system_score_gemma":0.0011597812,"threshold_uncertainty_score":0.9996386},"labels":[],"label_agreement":null},{"id":"W3097143196","doi":"10.1182/blood-2020-142175","title":"A Major Knowledge Gap in Women's Health: The Combined Effect of Antifibrinolytics and Estrogen on Risk of Thromboembolism - a Scoping Review","year":2020,"lang":"en","type":"review","venue":"Blood","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; St. Michael's Hospital; University of Toronto","funders":"","keywords":"Medicine; Antifibrinolytic; Thrombosis; Estrogen; Intensive care medicine; Tranexamic acid; Stroke (engine); Gynecology; Surgery; Internal medicine","score_opus":0.03887099140208799,"score_gpt":0.3652155639669611,"score_spread":0.3263445725648731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097143196","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006935208,0.98833567,1.4785783e-7,0.00009086532,0.000042454183,0.0043184836,0.000074824,0.000014158534,0.00018816088],"genre_scores_gemma":[0.0006519349,0.99889904,0.00004491589,0.00005959931,0.000046424535,0.0002103286,0.000031453408,0.000043824017,0.000012484158],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99793625,0.00046679674,0.00083950494,0.00032929977,0.00017031777,0.00025785252],"domain_scores_gemma":[0.99828756,0.00042867954,0.0006731512,0.0004600687,0.000026036027,0.00012452855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004673104,0.0003593394,0.0042326692,0.00010365781,0.000033050026,0.0000058801493,0.00012343774,0.000097658114,0.0000092852515],"category_scores_gemma":[0.00014289332,0.0002067491,0.00029998444,0.0003599178,0.00007105854,0.000012994096,0.0001284272,0.0002870464,0.000009253794],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037348073,0.0005021313,0.00041595404,0.51735914,0.0010407729,0.000044134875,0.00012561753,4.1370516e-9,4.5107376e-7,0.000039583138,0.00002839001,0.48040646],"study_design_scores_gemma":[0.0056604985,0.0048108175,0.00041862176,0.9425843,0.006802287,0.000120390876,0.0000042149513,8.5945015e-7,0.000036937698,0.00000768257,0.03936378,0.00018964017],"about_ca_topic_score_codex":0.000037168586,"about_ca_topic_score_gemma":0.000003271482,"teacher_disagreement_score":0.48021683,"about_ca_system_score_codex":0.000049353985,"about_ca_system_score_gemma":0.00037448033,"threshold_uncertainty_score":0.8430984},"labels":[],"label_agreement":null},{"id":"W3097144186","doi":"10.1182/blood-2020-136039","title":"Efficacy and Safety of Tinzaparin in CAT Patients with Metastatic Disease","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Thornhill Medical (Canada); University of British Columbia","funders":"","keywords":"Medicine; Pulmonary embolism; Internal medicine; Deep vein; Population; Warfarin; Cumulative incidence; Thrombosis; Cancer; Surgery; Cohort; Atrial fibrillation","score_opus":0.012510727189712434,"score_gpt":0.23075110775842578,"score_spread":0.21824038056871334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097144186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99817955,0.0001274944,0.000010241176,0.0006919075,0.0000069720554,0.0005145215,0.00000914474,0.0000106383295,0.0004495094],"genre_scores_gemma":[0.9990013,0.000056022247,0.00040961397,0.00047319,0.000010671377,0.000012087186,0.000019428933,0.000009240899,0.000008391771],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994862,0.000014797574,0.00013848026,0.00013760493,0.00012878553,0.000094140465],"domain_scores_gemma":[0.9996774,0.000022669188,0.000039515326,0.000101435326,0.000019395891,0.0001395629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000034908484,0.00006801269,0.00024251793,0.000029785837,0.0000111482905,0.000003365261,0.00002892909,0.000006476531,0.000029939156],"category_scores_gemma":[0.000055850138,0.000050559804,0.000015688192,0.00010020708,0.000026037236,0.000022420943,0.000036744234,0.00003171381,0.0000041199823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091654924,0.006073389,0.98732996,0.00070360256,0.00027185908,0.000092318995,0.0010642923,0.000027600057,0.00007221198,0.00044838924,0.000269632,0.002730218],"study_design_scores_gemma":[0.010291244,0.00048601857,0.98799574,0.000110585264,0.0005194954,2.9558356e-7,0.00004102524,0.000026222313,0.00011553296,0.000008503123,0.00034995197,0.000055363496],"about_ca_topic_score_codex":0.000028462466,"about_ca_topic_score_gemma":0.0000080443715,"teacher_disagreement_score":0.009374695,"about_ca_system_score_codex":0.0000050065646,"about_ca_system_score_gemma":0.000023056411,"threshold_uncertainty_score":0.20617689},"labels":[],"label_agreement":null},{"id":"W3097146628","doi":"10.1182/blood-2020-139654","title":"Retrospective Review of Treatment Patterns and Outcomes of DLBCL in the Very Elderly: A Single Centre Experience","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Medicine; International Prognostic Index; Chemotherapy regimen; Internal medicine; Diffuse large B-cell lymphoma; Comorbidity; Regimen; Rituximab; Retrospective cohort study; Performance status; Cancer; Single Center; CHOP; Chemotherapy; Surgery; Lymphoma","score_opus":0.025383728692776532,"score_gpt":0.27346081392878546,"score_spread":0.24807708523600894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097146628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888397,0.007533167,4.0954507e-7,0.0028302309,0.000009402771,0.0003829853,0.000021959897,0.000005034533,0.00037713547],"genre_scores_gemma":[0.99365956,0.0055124923,0.000041630497,0.0007270154,0.000012067148,0.00003007933,0.0000055112673,0.0000042648917,0.000007358652],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994556,0.000028638866,0.000181362,0.00013534863,0.00011949477,0.00007956091],"domain_scores_gemma":[0.99967253,0.000045158158,0.00007004029,0.00015045468,0.000023244658,0.000038564565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000030097346,0.00008654835,0.00034440626,0.000013511586,0.000009455933,0.0000027353374,0.000035960125,0.000017974562,0.000031131],"category_scores_gemma":[0.000058777867,0.00004668784,0.00007104401,0.00008494404,0.000027580287,0.000019523246,0.000014960124,0.000019395671,0.0000011064807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012390423,0.0021554367,0.99036974,0.00046556664,0.00009683782,0.000052637995,0.0045187385,1.2829965e-8,0.00015642085,0.000040486128,0.00002885355,0.0021028698],"study_design_scores_gemma":[0.0045093754,0.001706071,0.98029613,0.0014067537,0.0003243251,0.000010799884,0.00092308345,8.021427e-7,0.010545784,0.0000052667956,0.00022703542,0.00004454883],"about_ca_topic_score_codex":0.00015890879,"about_ca_topic_score_gemma":0.00002506222,"teacher_disagreement_score":0.010389362,"about_ca_system_score_codex":0.00004126996,"about_ca_system_score_gemma":0.000025401365,"threshold_uncertainty_score":0.19038749},"labels":[],"label_agreement":null},{"id":"W3097146817","doi":"10.1182/blood-2020-143472","title":"Emergency Department Quality of Care for Sickle Cell Disease in Ontario, Canada: A Population-Based Matched Cohort Study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Joseph's Hospital; McMaster Children's Hospital; McMaster University; Toronto General Hospital; University of Toronto; BC Children's Hospital; University Health Network; St. Joseph’s Healthcare Hamilton; University of British Columbia","funders":"","keywords":"Emergency department; Medicine; Triage; Vaso-occlusive crisis; Population; Emergency medicine; Cohort; Health care; Pediatrics; Disease burden; Disease; Sickle cell anemia; Internal medicine; Environmental health","score_opus":0.013917571836282077,"score_gpt":0.25414692143577083,"score_spread":0.24022934959948875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097146817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969589,0.00037720756,0.000008752958,0.00039290948,0.00006941754,0.0019481373,0.000071298855,0.000014276268,0.00015908608],"genre_scores_gemma":[0.9992931,0.000003916516,0.000065793734,0.00014402987,0.00001473069,0.00010401343,0.00031512658,0.000012481738,0.00004681922],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989754,0.00003614144,0.00039129134,0.00020832612,0.00024022155,0.00014863574],"domain_scores_gemma":[0.9994654,0.00002027699,0.00008528913,0.00016699273,0.00007082312,0.00019123647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007387962,0.00010383558,0.0003161568,0.00002109389,0.00003260262,0.0000016027215,0.000046209265,0.000036741607,0.00013944632],"category_scores_gemma":[0.000061901264,0.000092612994,0.000075504126,0.00010672357,0.000005468248,0.000011123847,0.000012012502,0.000086708045,6.872514e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031080426,0.0013108918,0.99624234,0.00042920987,0.000059400303,0.000022698496,0.0010666414,0.0002927167,0.00008423288,0.0000032664639,0.00016390099,0.000013894498],"study_design_scores_gemma":[0.005459025,0.00031553884,0.99168944,0.000019824456,0.00035028488,5.3366534e-8,0.0015912129,0.00006722961,0.00026068438,0.0000046547416,0.00014378235,0.00009823675],"about_ca_topic_score_codex":0.93332046,"about_ca_topic_score_gemma":0.98167914,"teacher_disagreement_score":0.048358697,"about_ca_system_score_codex":0.00013686265,"about_ca_system_score_gemma":0.0010949873,"threshold_uncertainty_score":0.37766483},"labels":[],"label_agreement":null},{"id":"W3097160786","doi":"10.1182/blood-2020-140577","title":"Real-World Outcomes of Patients Treated with Single-Agent Ibrutinib for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): A Systematic Review and Meta-Analysis","year":2020,"lang":"en","type":"review","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Ibrutinib; Medicine; Internal medicine; Chronic lymphocytic leukemia; Discontinuation; Tolerability; Adverse effect; Oncology; Leukemia","score_opus":0.08689948057481388,"score_gpt":0.33685235446792094,"score_spread":0.24995287389310705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097160786","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00040989878,0.97889376,0.000020929836,0.000034223413,0.000033789234,0.019212421,0.00089630083,0.00020069136,0.00029799677],"genre_scores_gemma":[0.00074453565,0.9889469,0.0005900615,0.00026536232,0.00007830215,0.0047394847,0.0013699475,0.00041557953,0.0028498236],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9895093,0.0008641142,0.0043960614,0.0021553626,0.0017056651,0.0013695264],"domain_scores_gemma":[0.9900694,0.0021195093,0.0031385971,0.0029141859,0.000826179,0.0009321122],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0010745252,0.0021162375,0.027952202,0.0013881408,0.00016407912,0.00011505686,0.0009759651,0.0005724078,0.00015505115],"category_scores_gemma":[0.001155651,0.0012911941,0.0065260967,0.0041030035,0.0003914613,0.000116408475,0.00043605547,0.00029708218,0.000064574444],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00008147648,0.00040228234,0.00001470108,0.7154813,0.28222513,0.00021386298,0.000036140045,0.000003286741,2.3488651e-7,0.000018563336,0.00005932278,0.0014637238],"study_design_scores_gemma":[0.029189806,0.0013075875,0.000010655559,0.06650368,0.892992,0.0003172434,0.00000910997,0.00033285818,0.000022296836,0.0000017669337,0.008314459,0.0009985205],"about_ca_topic_score_codex":0.0015603476,"about_ca_topic_score_gemma":0.00037055148,"teacher_disagreement_score":0.6489776,"about_ca_system_score_codex":0.10934988,"about_ca_system_score_gemma":0.058709405,"threshold_uncertainty_score":0.9991579},"labels":[],"label_agreement":null},{"id":"W3097162507","doi":"10.1182/blood-2020-140234","title":"Retro-Prospective Observational Study on the Risk of Progression in Chronic Phase-Chronic Myeloid Leukemia (CML) Patients Eligible for Tyrosine Kinase Inhibitor Discontinuation (TFR-PRO)","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Discontinuation; Medicine; Observational study; Myeloid leukemia; Tyrosine-kinase inhibitor; Internal medicine; Tyrosine kinase; Oncology; Bosutinib; Imatinib; Dasatinib; Immunology; Cancer","score_opus":0.04972576376106308,"score_gpt":0.3249673287236165,"score_spread":0.2752415649625534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097162507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99154955,0.00061668514,0.000040915475,0.0005514811,0.0001018276,0.0068005533,0.00016790892,0.00006315891,0.00010794338],"genre_scores_gemma":[0.9975101,0.0000511009,0.00027632786,0.00008737602,0.00053758366,0.0010465423,0.00037047037,0.000059267277,0.00006125857],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973606,0.00014283249,0.0007144918,0.0006574683,0.0007304993,0.00039409776],"domain_scores_gemma":[0.998354,0.00028156315,0.00048977474,0.0004738522,0.00027379286,0.00012702007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037031312,0.00034245488,0.0005375828,0.00010936513,0.0001497135,0.000024422088,0.00018703235,0.00012910795,0.00005533884],"category_scores_gemma":[0.00092299236,0.00023530831,0.00016434431,0.00055672956,0.00009086086,0.00016275786,0.000093770206,0.00039835664,0.000019574445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025851538,0.009503332,0.95198786,0.00025759474,0.00054293487,0.000020334182,0.0024146186,0.0001328684,0.024907472,0.00020740519,0.00066010584,0.006780338],"study_design_scores_gemma":[0.089504264,0.02472178,0.7342126,0.0007513629,0.0007765017,0.0000015142992,0.0003779517,0.0031020371,0.1459809,0.000110893096,0.00016152867,0.00029871313],"about_ca_topic_score_codex":0.00009233826,"about_ca_topic_score_gemma":0.000097030825,"teacher_disagreement_score":0.21777529,"about_ca_system_score_codex":0.0032219784,"about_ca_system_score_gemma":0.0014402915,"threshold_uncertainty_score":0.95955944},"labels":[],"label_agreement":null},{"id":"W3097164221","doi":"10.1182/blood-2020-140416","title":"Deep Vein Thrombosis Diagnosis with D-Dimer Adjusted to Clinical Probability","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Dalhousie University; Ottawa Hospital; McGill University; Université de Sherbrooke; London Health Sciences Centre; McMaster University","funders":"","keywords":"Medicine; D-dimer; Deep vein; Ultrasound; Thrombosis; Pre- and post-test probability; Radiology; Vein; Emergency department; Surgery","score_opus":0.07456086426571817,"score_gpt":0.3165270122311704,"score_spread":0.24196614796545224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097164221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9657528,0.00015195573,0.00035998688,0.028783752,0.000111567206,0.0017364386,0.0000063443626,0.00021766702,0.0028795192],"genre_scores_gemma":[0.9774416,0.00013581425,0.0070254714,0.014466776,0.0004172105,0.00041718993,0.000016307444,0.000046545803,0.0000330601],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99801165,0.000090493115,0.00047260977,0.00066047825,0.00038623015,0.00037852724],"domain_scores_gemma":[0.9985166,0.00012547085,0.000086337524,0.00051288423,0.00012827376,0.0006304366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027565585,0.00023305221,0.0007707546,0.00004705003,0.000071447874,0.000030826963,0.00017665088,0.00010913445,0.00059056655],"category_scores_gemma":[0.00040883775,0.00017695155,0.00016910385,0.0004417833,0.000080675025,0.00006587819,0.00015753675,0.00023748845,0.00032557803],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018138225,0.009473618,0.9598623,0.0003512409,0.0011365776,0.00008810383,0.0011424179,0.000052345495,0.00014484761,0.00058971095,0.020812234,0.006165244],"study_design_scores_gemma":[0.004298871,0.004309233,0.9628966,0.00012473375,0.0018457903,0.000004958678,0.00018059909,0.00006172661,0.00188671,0.00003856889,0.024046468,0.00030578062],"about_ca_topic_score_codex":0.00007283209,"about_ca_topic_score_gemma":0.000090801106,"teacher_disagreement_score":0.014316976,"about_ca_system_score_codex":0.000024564388,"about_ca_system_score_gemma":0.000072975534,"threshold_uncertainty_score":0.7215875},"labels":[],"label_agreement":null},{"id":"W3097170436","doi":"10.1182/blood-2020-134825","title":"Intensity of End of Life Care for Hematologic Malignancy Patients in Western Washington, United States and Alberta, Canada","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Cancer registry; Cancer; Emergency department; Population; Intensive care unit; Chemotherapy regimen; Internal medicine; Comorbidity; Emergency medicine; Pediatrics; Environmental health","score_opus":0.041962220775274756,"score_gpt":0.29645148250994846,"score_spread":0.2544892617346737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097170436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998268,0.0009973936,0.000003747101,0.0003154658,0.000021002461,0.00020905932,0.00012300773,0.0000032310309,0.000059075985],"genre_scores_gemma":[0.99895346,0.00018739483,0.00020027433,0.00045480553,0.00000834345,0.0000039572865,0.0001775413,0.000006757402,0.000007439618],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99941266,0.000015090802,0.00026003463,0.00011090809,0.00010540802,0.00009589348],"domain_scores_gemma":[0.9992925,0.00015357812,0.00011992055,0.00007422749,0.00028329255,0.00007651548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000021696533,0.00007759535,0.0003996651,0.00004010635,0.000007486907,0.0000010008133,0.000043305678,0.00003724764,0.000004056024],"category_scores_gemma":[0.0005522021,0.00006483435,0.00002519472,0.00011455569,0.00003844645,0.000017502687,0.000029478335,0.000043977117,8.91835e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000122056845,0.00008649991,0.9908744,0.001235127,0.00005670848,0.0000058552005,0.0072192103,0.000002419294,0.00017790121,0.0000087943,0.00015459524,0.000056420413],"study_design_scores_gemma":[0.012180029,0.0016259525,0.8111493,0.0025498667,0.00036266056,0.0000023990897,0.016801553,0.00009669336,0.1507899,0.000045311946,0.0041465033,0.0002498592],"about_ca_topic_score_codex":0.31235725,"about_ca_topic_score_gemma":0.31241134,"teacher_disagreement_score":0.17972514,"about_ca_system_score_codex":0.000010835894,"about_ca_system_score_gemma":0.00012192399,"threshold_uncertainty_score":0.70013535},"labels":[],"label_agreement":null},{"id":"W3097181424","doi":"10.1182/blood-2020-138834","title":"Incidence of and Risk Factors for Venous Thromboembolism Among Hospitalized Patients with Cancer and COVID-19: Report from the COVID-19 and Cancer Consortium (CCC19) Registry","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer; Internal medicine; Odds ratio; Pulmonary embolism; Incidence (geometry); Intensive care unit; Cancer registry; Confidence interval; Retrospective cohort study; Intensive care medicine","score_opus":0.04616170560242499,"score_gpt":0.35106052553579414,"score_spread":0.30489881993336915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097181424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843752,0.004088969,0.00015708226,0.0083316695,0.000064727195,0.0014324709,0.0014950001,0.000046741006,0.000008175096],"genre_scores_gemma":[0.98868734,0.0029231673,0.00009402472,0.007960268,0.0001313741,0.000088342254,0.00007355333,0.000029753252,0.000012160745],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984459,0.000058402602,0.00038927046,0.00051446864,0.000314817,0.00027709897],"domain_scores_gemma":[0.99719787,0.0007662341,0.0005265298,0.0003239037,0.00015779998,0.0010276895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019589326,0.0002308552,0.00064366654,0.000033144883,0.00024296797,0.00003078971,0.000086568565,0.00013601434,0.000028424707],"category_scores_gemma":[0.0042726765,0.00015163522,0.000042816562,0.00013742487,0.0004932991,0.000097873984,0.00007638362,0.00021607561,7.7961836e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004832247,0.00012040955,0.98956895,0.00077970483,0.00029601235,0.00006128966,0.007147051,0.0000072037124,0.000050548286,0.000005587956,0.0011667256,0.00031330358],"study_design_scores_gemma":[0.007274244,0.0006699648,0.9863893,0.00014897645,0.0010710752,0.000017543773,0.0005557847,0.00003609894,0.00020669695,0.000085576496,0.0033586035,0.00018612907],"about_ca_topic_score_codex":0.11403882,"about_ca_topic_score_gemma":0.0059922705,"teacher_disagreement_score":0.10804655,"about_ca_system_score_codex":0.0000932395,"about_ca_system_score_gemma":0.0018514738,"threshold_uncertainty_score":0.89186084},"labels":[],"label_agreement":null},{"id":"W3097182951","doi":"10.1182/blood-2020-139858","title":"Selinexor in Combination with Pomalidomide and Dexamethasone (SPd) for Treatment of Patients with Relapsed Refractory Multiple Myeloma (RRMM)","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; University of Alberta; Université de Montréal; Hôpital Maisonneuve-Rosemont; Dalhousie University; Royal Victoria Hospital; McGill University Health Centre; Princess Margaret Cancer Centre; University of Calgary; Vancouver General Hospital; CancerCare Manitoba; Institute of Cancer Research","funders":"","keywords":"Pomalidomide; Dexamethasone; Lenalidomide; Multiple myeloma; Carfilzomib; Medicine; Refractory (planetary science); Internal medicine; Oncology; Biology","score_opus":0.009906451867861946,"score_gpt":0.2130256292287946,"score_spread":0.20311917736093266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097182951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985377,0.00020530584,0.0005058239,0.00013004258,0.000009650103,0.0005456087,0.000034303623,0.000005964181,0.000025565434],"genre_scores_gemma":[0.9951556,0.000032139706,0.0043708836,0.00006663299,0.000027687853,0.00005961283,0.0002421579,0.000013584535,0.000031722764],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99950194,0.00002627355,0.00012973443,0.00019162652,0.000067232315,0.00008318438],"domain_scores_gemma":[0.99967676,0.000017963177,0.00008644887,0.000097864286,0.00007410643,0.00004682644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003184872,0.000091713475,0.00012391446,0.000022810927,0.000019333997,0.000005146364,0.000033272612,0.000057070356,0.0000016559687],"category_scores_gemma":[0.00007297921,0.00006777669,0.00001876616,0.000058007943,0.00003158061,0.000004961261,0.0000103595075,0.000016350716,2.3755206e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050797737,0.0032838006,0.6290541,0.00009910956,0.0001960357,0.0000032836642,0.00042702028,0.000017707867,0.3516138,0.000035608533,0.00013313694,0.010056616],"study_design_scores_gemma":[0.033431873,0.009268409,0.08879674,0.000024203651,0.000055212626,0.0000010493247,0.00006694356,0.000099810575,0.86358505,0.000006248103,0.004496357,0.00016810738],"about_ca_topic_score_codex":0.000011155189,"about_ca_topic_score_gemma":0.000041036972,"teacher_disagreement_score":0.5402574,"about_ca_system_score_codex":0.000006562777,"about_ca_system_score_gemma":0.000032560845,"threshold_uncertainty_score":0.2763853},"labels":[],"label_agreement":null},{"id":"W3097183299","doi":"10.1182/blood-2020-140704","title":"Patient Adherence to Medication within a New Multidisciplinary Thrombosis Service","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. John’s Health Sciences Centre; Memorial University of Newfoundland","funders":"","keywords":"Medicine; Thrombosis; Pharmacist; Rivaroxaban; Apixaban; Intensive care medicine; Emergency medicine; Pharmacy; Medical emergency; Family medicine; Warfarin; Surgery; Internal medicine","score_opus":0.0823695494142019,"score_gpt":0.32620981444073394,"score_spread":0.24384026502653205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097183299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9406614,0.00015239358,0.0019664646,0.05283864,0.00012283295,0.00067307276,0.0000048505044,0.00015443687,0.003425912],"genre_scores_gemma":[0.9671404,0.000018492847,0.011361139,0.020704411,0.00023518238,0.00007917779,0.000027135029,0.000015262842,0.00041883363],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99884826,0.000021069509,0.0002811543,0.00031811115,0.00037712307,0.00015427885],"domain_scores_gemma":[0.9988032,0.000023019691,0.00010257707,0.0002980909,0.000103812505,0.00066930713],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000058554975,0.000114503746,0.00019114434,0.000028471883,0.000050302133,0.000009972902,0.0001457563,0.000056051707,0.0011058506],"category_scores_gemma":[0.00017461344,0.00009875696,0.000034569657,0.0004499093,0.000016991316,0.00005823275,0.000078704674,0.00014173143,0.004000413],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007933696,0.0046719834,0.16137569,0.0015275276,0.00064520893,0.00014628163,0.10837935,0.000101487676,0.40246525,0.0013517853,0.24473828,0.07380379],"study_design_scores_gemma":[0.026594285,0.01696578,0.58414274,0.0044589094,0.001778936,0.0002314853,0.016808344,0.010273152,0.2817393,0.0014007016,0.05338117,0.002225185],"about_ca_topic_score_codex":0.00008484931,"about_ca_topic_score_gemma":0.000011087233,"teacher_disagreement_score":0.42276707,"about_ca_system_score_codex":0.00001273957,"about_ca_system_score_gemma":0.00028893078,"threshold_uncertainty_score":0.9998073},"labels":[],"label_agreement":null},{"id":"W3097190573","doi":"10.1182/blood-2020-143427","title":"Developing Transient Gene Therapies to Decrease the Stability of Thrombi for Coagulopathy and Thrombosis","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Hemostasis; Medicine; Fibrinolysis; Thrombosis; Fibrin; Coagulation; Coagulopathy; Pharmacology; Internal medicine; Immunology","score_opus":0.08242551119638084,"score_gpt":0.2978409877788847,"score_spread":0.21541547658250385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097190573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9723001,0.00048224418,0.012298647,0.013676678,0.000040499384,0.0010554789,0.000030373538,0.000045716075,0.00007024853],"genre_scores_gemma":[0.9787484,0.000065568944,0.01576445,0.005275368,0.00005498206,0.00006296859,0.000007642573,0.000019014125,0.0000016121711],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990877,0.000043879078,0.00026525007,0.00025399186,0.00018668672,0.0001625194],"domain_scores_gemma":[0.99923754,0.00010770217,0.000059001635,0.00020821794,0.00013064814,0.00025689875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023013432,0.00013117428,0.00033777213,0.00002546465,0.00009467529,0.000013101803,0.00008251682,0.00005094747,0.000063979904],"category_scores_gemma":[0.0001838848,0.00009057794,0.00008702528,0.00018444944,0.00006137397,0.000025658479,0.000033826826,0.000059030932,0.0000019765228],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022790107,0.0006369791,0.009363592,0.0004028254,0.00044989266,0.0000015265009,0.016604686,0.000002025346,0.9598891,0.008529052,0.000077574616,0.0038148363],"study_design_scores_gemma":[0.0039930376,0.00100501,0.11148623,0.00007242419,0.0005834158,0.000008118012,0.0017341932,0.00012416586,0.8789227,0.00097074604,0.0009200548,0.00017993854],"about_ca_topic_score_codex":0.000014577256,"about_ca_topic_score_gemma":0.000012297558,"teacher_disagreement_score":0.102122635,"about_ca_system_score_codex":0.000008862548,"about_ca_system_score_gemma":0.00013643387,"threshold_uncertainty_score":0.3693661},"labels":[],"label_agreement":null},{"id":"W3097206381","doi":"10.1182/blood-2020-137245","title":"Analyzing Efficacy Outcomes from the Phase 2 Study of Single-Agent Tazemetostat As Third-Line Therapy in Patients with Relapsed or Refractory Follicular Lymphoma to Identify Predictors of Response","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Follicular lymphoma; Refractory (planetary science); Internal medicine; Oncology; Phases of clinical research; Lymphoma; Pharmacology; Clinical trial","score_opus":0.03580417620057491,"score_gpt":0.31022156095091213,"score_spread":0.2744173847503372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097206381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967749,0.00029681172,0.0000037028885,0.00068115635,0.000056446144,0.0020651056,0.00008231197,0.000031290554,0.0000082730885],"genre_scores_gemma":[0.9992186,0.000029552852,0.000115984585,0.0004404041,0.0000335075,0.0000648573,0.000048651433,0.000035038087,0.000013409574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977814,0.00031716176,0.0006466698,0.00040517867,0.00064563984,0.0002039569],"domain_scores_gemma":[0.9980951,0.0007208707,0.00028779331,0.0005734407,0.0001402639,0.00018251638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025367254,0.00025780746,0.0006929582,0.00012495245,0.00004653929,0.000016100646,0.00018322794,0.00006035025,0.00004751653],"category_scores_gemma":[0.00072139024,0.00013349146,0.00013160984,0.00056717,0.00003986727,0.00006142242,0.00006752243,0.00006546987,0.0000065250006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032563232,0.0510277,0.8984267,0.000012186825,0.0018107473,0.00023288142,0.008445306,0.000014310667,0.004007522,4.076844e-7,0.00006737487,0.0033916442],"study_design_scores_gemma":[0.1093922,0.030797228,0.84132147,0.00014924997,0.00076984963,7.9429066e-7,0.0010618579,0.0000025554823,0.01624492,5.8128387e-7,0.00014730326,0.000111969835],"about_ca_topic_score_codex":0.00040510023,"about_ca_topic_score_gemma":0.000041554096,"teacher_disagreement_score":0.076828964,"about_ca_system_score_codex":0.00009031752,"about_ca_system_score_gemma":0.00015089424,"threshold_uncertainty_score":0.54436237},"labels":[],"label_agreement":null},{"id":"W3097208588","doi":"10.1182/blood-2020-141329","title":"Fiirst-2: Prospective, Randomized Study Comparing Administration of Clotting Factor Concentrates with Standard Massive Hemorrhage Protocol in Severely Bleeding Trauma Patients","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Trauma, Hemostasis, Coagulopathy, Resuscitation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Health Sciences Centre; Toronto General Hospital; University Health Network; University of Toronto; Defence Research and Development Canada; Sunnybrook Health Science Centre; McMaster University","funders":"","keywords":"Medicine; Clinical endpoint; Clotting factor; Interim analysis; Fresh frozen plasma; Packed red blood cells; Coagulopathy; Resuscitation; Adverse effect; Randomized controlled trial; Surgery; Blood transfusion; Internal medicine; Platelet","score_opus":0.024497830628675225,"score_gpt":0.2864130136789199,"score_spread":0.2619151830502447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097208588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9152819,0.0000067102883,0.00021570126,0.00008307855,0.000024878334,0.0836831,0.000030302508,0.00007942501,0.0005949316],"genre_scores_gemma":[0.9853957,3.8486147e-7,0.0022312552,0.00002670426,0.00005216147,0.01222439,0.000027665103,0.00003728379,0.000004443515],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976281,0.00017749211,0.0008078213,0.0004522616,0.0006473747,0.00028698205],"domain_scores_gemma":[0.9986433,0.0001890658,0.00049240206,0.00015304594,0.00037020646,0.00015198547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029238634,0.00026840036,0.00096720795,0.000098562174,0.00006941164,0.00004771326,0.00009570013,0.00006947563,0.000025477848],"category_scores_gemma":[0.00055036735,0.00021797349,0.000081431725,0.0004084798,0.00008769955,0.00022662937,0.000030995066,0.00027627556,0.000002068686],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12738387,0.0019853225,0.8565818,0.0006091501,0.0001823064,0.00009861283,0.011306048,0.000028180926,0.00085981557,0.000017966664,0.0000017759094,0.0009451246],"study_design_scores_gemma":[0.4398329,0.005466537,0.4765892,0.00039701798,0.0002973154,0.0000060125435,0.0041829604,0.0009443389,0.07203545,0.000011932142,0.0000023017421,0.00023405431],"about_ca_topic_score_codex":0.000023443803,"about_ca_topic_score_gemma":0.000054794782,"teacher_disagreement_score":0.37999263,"about_ca_system_score_codex":0.00013088714,"about_ca_system_score_gemma":0.00019964483,"threshold_uncertainty_score":0.88887006},"labels":[],"label_agreement":null},{"id":"W3097211158","doi":"10.1182/blood-2020-136980","title":"Early Pharmacodynamic Changes in T-Cell Activation, Proliferation, and Cytokine Production Confirm the Mode of Action of BFCR4350A, a FcRH5/CD3 T-Cell-Engaging Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Pharmacodynamics; Medicine; Aldesleukin; Cytokine; Refractory (planetary science); Antibody; Bispecific antibody; CD3; Cytokine release syndrome; Immunology; T cell; Interleukin 2; Internal medicine; Cancer research; Pharmacology; Immune system; Biology; Pharmacokinetics; Monoclonal antibody; CD8","score_opus":0.021429841381940394,"score_gpt":0.2758974691287646,"score_spread":0.25446762774682424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097211158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99696904,0.00010838474,0.000026843474,0.0016672749,0.00003457874,0.0010343305,0.000024768804,0.000014671095,0.00012011522],"genre_scores_gemma":[0.99926853,0.00020073146,0.00011451841,0.000065176035,0.000106955995,0.000033879674,0.000096196934,0.00002169031,0.00009232321],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99864155,0.000117955344,0.0003314939,0.00030206065,0.00040843675,0.0001984733],"domain_scores_gemma":[0.99926454,0.00009224765,0.00019662647,0.0001478599,0.00022714889,0.000071584254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001644869,0.00015540716,0.00028357972,0.00020242085,0.000068789835,0.000010267556,0.0000777035,0.0000616404,0.0000145174945],"category_scores_gemma":[0.00008622738,0.00010952167,0.000027406872,0.0004493259,0.00011501017,0.00016038858,0.000037748705,0.00037920987,0.0000013606956],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015625174,0.0008386728,0.50844234,0.0003811238,0.000024184512,0.000002625683,0.0020819078,0.000053244425,0.48593587,0.0000049345376,0.000015177427,0.00065744045],"study_design_scores_gemma":[0.0057532294,0.00078995724,0.5506606,0.00013910206,0.000040255545,0.0000024805752,0.00026972563,0.0013302221,0.44078305,0.000005591444,0.00012860792,0.000097161304],"about_ca_topic_score_codex":0.0003101672,"about_ca_topic_score_gemma":0.00015198228,"teacher_disagreement_score":0.045152813,"about_ca_system_score_codex":0.000026236858,"about_ca_system_score_gemma":0.00008554906,"threshold_uncertainty_score":0.4466164},"labels":[],"label_agreement":null},{"id":"W3097213049","doi":"10.1182/blood-2020-136163","title":"Optimal Duration of Imatinib Treatment / Deep Molecular Response for Treatment-Free Remission after Imatinib Discontinuation from a Canadian Tyrosine Kinase Inhibitor Discontinuation Trial","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; McGill University Health Centre; Queen Elizabeth II Health Sciences Centre; London Health Sciences Centre; Juravinski Cancer Centre; Hôpital de l'Enfant-Jésus; Université de Montréal; Hôpital Maisonneuve-Rosemont; Princess Margaret Cancer Centre; University of Calgary; Vancouver General Hospital; Alberta Hospital Edmonton; University of British Columbia; CancerCare Manitoba; University of Alberta Hospital; Ottawa Hospital; University Health Network; University of Toronto; BC Cancer Agency; Alberta Health Services","funders":"","keywords":"Discontinuation; Imatinib; Medicine; Tyrosine-kinase inhibitor; Tyrosine kinase; Imatinib mesylate; Dasatinib; Internal medicine; Oncology; Drug holiday; Immunology; Cancer; Receptor; Human immunodeficiency virus (HIV)","score_opus":0.016663848680172025,"score_gpt":0.2648742075237999,"score_spread":0.2482103588436279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097213049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894956,0.0005110422,0.0009431073,0.003631089,0.00012199845,0.00427278,0.0008860673,0.00006501521,0.00007329818],"genre_scores_gemma":[0.97745645,0.000027295831,0.018296545,0.00011594823,0.0004760904,0.0011260022,0.002247976,0.000070379305,0.00018328322],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99763334,0.00018361254,0.00083877187,0.0006073143,0.00035291395,0.00038407877],"domain_scores_gemma":[0.9981143,0.00022205152,0.00037947434,0.0006477212,0.00015520379,0.00048125858],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017253088,0.00041326374,0.00068249163,0.00015723544,0.00009655473,0.000048475536,0.00010981051,0.00019457516,0.00016258552],"category_scores_gemma":[0.00105931,0.00033370274,0.00031934312,0.0002107772,0.00005109657,0.00020326342,0.00003112692,0.000061854706,0.000015494703],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32509276,0.00712762,0.004865032,0.00012692092,0.0016209211,0.0005332416,0.010787515,0.00012231937,0.61868906,0.000046337824,0.0003396488,0.03064862],"study_design_scores_gemma":[0.33460245,0.018479982,0.007188037,0.00032879531,0.002870016,0.000013749942,0.00039804645,0.00618101,0.62846434,0.00004122476,0.0009896127,0.00044273006],"about_ca_topic_score_codex":0.007493359,"about_ca_topic_score_gemma":0.0053492924,"teacher_disagreement_score":0.03020589,"about_ca_system_score_codex":0.0012213798,"about_ca_system_score_gemma":0.0011133925,"threshold_uncertainty_score":0.9999115},"labels":[],"label_agreement":null},{"id":"W3097225763","doi":"10.1182/blood-2020-133760","title":"The Mutational Landscape of Cold Agglutinin Disease","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Exome sequencing; Biology; Exome; Mutation; Autoimmune hemolytic anemia; Genetics; Immunology; Molecular biology; Gene; Antibody","score_opus":0.011862878763213366,"score_gpt":0.2243815490124757,"score_spread":0.21251867024926233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097225763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98739994,0.0011299324,0.000038353795,0.008771007,0.000030558054,0.00015585312,0.000021682394,0.000023204353,0.0024294534],"genre_scores_gemma":[0.99906963,0.000045200584,0.000103884464,0.0005366775,0.00012648085,0.0000057734514,0.000014055512,0.0000061748137,0.00009214748],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99958676,0.000010279674,0.000102391314,0.00007962317,0.00015080758,0.00007016481],"domain_scores_gemma":[0.9996925,0.000050563547,0.00002432137,0.00007830929,0.000033939756,0.00012038223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000417247,0.000041781142,0.0000781797,0.0000075945413,0.00004500351,0.0000043840832,0.00003789376,0.0000165272,0.00004967569],"category_scores_gemma":[0.000051695515,0.000026131764,0.00005049953,0.000080978796,0.000027306993,0.000012279155,0.000009851133,0.00005624676,0.0000138765645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021378405,0.0032640272,0.8790573,0.00066370046,0.00077389466,0.0005626241,0.0018778197,0.000026015894,0.04864584,0.048466958,0.007992681,0.00653133],"study_design_scores_gemma":[0.015501166,0.0008714452,0.9133433,0.00012623542,0.001339254,0.000029308236,0.00028891081,0.00081979897,0.034971822,0.0003353866,0.03218877,0.00018460306],"about_ca_topic_score_codex":0.0000024039755,"about_ca_topic_score_gemma":0.000001457678,"teacher_disagreement_score":0.048131574,"about_ca_system_score_codex":7.15693e-7,"about_ca_system_score_gemma":0.00005230157,"threshold_uncertainty_score":0.10656224},"labels":[],"label_agreement":null},{"id":"W3097226354","doi":"10.1182/blood-2020-138917","title":"Preparing for Platelet Shortages: Which Surgeries Should be Cancelled?","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Blood donation and transfusion practices","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto General Hospital; University Health Network; University of Toronto","funders":"","keywords":"Economic shortage; Medicine; Blood product; Platelet transfusion; Cardiopulmonary bypass; Platelet; Emergency medicine; Surgery; Medical emergency; Intensive care medicine; Anesthesia; Internal medicine","score_opus":0.05381465238998296,"score_gpt":0.26551802724515183,"score_spread":0.21170337485516888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097226354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8052367,0.00048697297,0.0013206293,0.049940344,0.00081325014,0.0011959787,0.00003469191,0.00087212096,0.14009932],"genre_scores_gemma":[0.9893351,0.00004678227,0.00033809262,0.009071416,0.000882977,0.00007594201,0.000053051455,0.000031351745,0.00016525284],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99901867,0.0000057874277,0.00024081144,0.0003034101,0.00021236313,0.0002189755],"domain_scores_gemma":[0.99945176,0.00011064474,0.00012885735,0.00012636161,0.00015880285,0.00002357417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002104446,0.00014671148,0.0001914892,0.000068180816,0.0002096788,0.00031097373,0.0001718476,0.000068976005,0.00045838804],"category_scores_gemma":[0.00029782258,0.00014069592,0.00007477183,0.0003683335,0.000017784289,0.0010634444,0.00006193549,0.00011681026,0.000048340396],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023485213,0.0046080966,0.2876335,0.0073306677,0.0027384788,0.00015692755,0.004966073,0.0012494697,0.021441532,0.23131026,0.3725917,0.063624755],"study_design_scores_gemma":[0.0017944006,0.000017698805,0.0008074462,0.000018866283,0.00021292387,0.0000017217176,0.00035330962,0.001297909,0.004233691,0.00023626893,0.9907589,0.0002668463],"about_ca_topic_score_codex":0.00018273534,"about_ca_topic_score_gemma":0.00073779846,"teacher_disagreement_score":0.6181672,"about_ca_system_score_codex":0.0000027990213,"about_ca_system_score_gemma":0.000031381573,"threshold_uncertainty_score":0.5737413},"labels":[],"label_agreement":null},{"id":"W3097237398","doi":"10.1182/blood-2020-141790","title":"Role of Allogeneic Hematopoietic Cell Transplant in Patients with Myelofibrosis in the JAK Inhibitor Era","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Jewish General Hospital; University Health Network; University of Toronto; Dalhousie University; University of Calgary; St. Paul's Hospital; Alberta Health Services; University of British Columbia; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Myelofibrosis; Ruxolitinib; Transplantation; Internal medicine; Hematopoietic cell; Hematopoietic stem cell transplantation; Pediatrics; Haematopoiesis; Bone marrow; Stem cell","score_opus":0.00635036303415021,"score_gpt":0.1918222657558316,"score_spread":0.1854719027216814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097237398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99754304,0.00034541843,0.0000011781776,0.00081799855,0.000007400388,0.0006829755,0.00002983392,0.000008252445,0.00056392385],"genre_scores_gemma":[0.9990866,0.00004609481,0.00023337062,0.00045534052,0.000025957117,0.00009674465,0.00003807302,0.000014277745,0.0000035337735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99904644,0.000053875425,0.000252432,0.000212322,0.0002662348,0.00016871441],"domain_scores_gemma":[0.9996352,0.000060667546,0.000055421104,0.00014890303,0.000030138212,0.00006967969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000056102006,0.00014353379,0.00030353732,0.00004788289,0.000017618086,0.000006599247,0.00007100831,0.000049395145,0.000045939265],"category_scores_gemma":[0.0000081931075,0.00008300884,0.000050084946,0.00020785512,0.0000272203,0.000027604356,0.000010531532,0.00012382431,0.000013691834],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002827966,0.003304417,0.9876416,0.00012016647,0.000040779592,0.00003909737,0.005486413,0.000006255911,0.0028240473,0.0000364169,0.000022688931,0.00019534324],"study_design_scores_gemma":[0.009614409,0.0016896074,0.87460685,0.00020443845,0.00016003348,0.000004274585,0.00030503882,0.000005945568,0.113245055,0.000010434162,0.00006240626,0.00009148552],"about_ca_topic_score_codex":0.000028990857,"about_ca_topic_score_gemma":0.00004168477,"teacher_disagreement_score":0.11303471,"about_ca_system_score_codex":0.000012166728,"about_ca_system_score_gemma":0.00004622571,"threshold_uncertainty_score":0.33850023},"labels":[],"label_agreement":null},{"id":"W3097304857","doi":"10.1182/blood-2020-134819","title":"Increased Health Resource Utilization with the Introduction of Matrix for First-Line Treatment of Primary Central Nervous System Lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Juravinski Cancer Centre; McMaster University","funders":"","keywords":"Medicine; Regimen; Cytarabine; ThioTEPA; Primary central nervous system lymphoma; Internal medicine; Chemotherapy regimen; Rituximab; Surgery; Chemotherapy; Lymphoma; Cyclophosphamide","score_opus":0.025175214702854744,"score_gpt":0.25252900200356004,"score_spread":0.2273537873007053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097304857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98424435,0.00247864,0.00040376032,0.011010655,0.000024028906,0.0016354643,0.00010059141,0.00004710431,0.000055398406],"genre_scores_gemma":[0.9982514,0.00018212732,0.00053033576,0.00014147276,0.0003773016,0.00011150528,0.00036424695,0.000022066735,0.000019548304],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991012,0.00004298299,0.00029678558,0.00021029006,0.00018356956,0.0001651544],"domain_scores_gemma":[0.99926126,0.000069403155,0.00024225075,0.00023842737,0.00007574342,0.00011289957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006566088,0.00013367223,0.00042299295,0.000034228586,0.00006741246,0.000005042538,0.000039653987,0.00003473576,0.0000049636537],"category_scores_gemma":[0.000017719056,0.000077289325,0.000102444814,0.00017779076,0.000037155787,0.000018986248,0.000009327687,0.000011749894,7.5084654e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024146628,0.046732165,0.23737554,0.017401092,0.0063388096,0.00015089121,0.013713303,0.0020686814,0.0053534755,0.0041029383,0.014457384,0.6281591],"study_design_scores_gemma":[0.06005836,0.029177727,0.7759019,0.0005177982,0.0037792884,0.00033019594,0.0017862057,0.00184666,0.08602874,0.000004374313,0.040302955,0.00026578203],"about_ca_topic_score_codex":0.0003106418,"about_ca_topic_score_gemma":0.000034611527,"teacher_disagreement_score":0.6278933,"about_ca_system_score_codex":0.00024438844,"about_ca_system_score_gemma":0.00020618874,"threshold_uncertainty_score":0.3151767},"labels":[],"label_agreement":null},{"id":"W3097357948","doi":"10.1182/blood-2020-140165","title":"RBC-Enhance: A Randomized Pilot Feasibility Trial of Red Cell Transfusion Thresholds in Myelodysplastic Syndromes","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; University Health Network; McMaster University; Princess Margaret Cancer Centre; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Myelodysplastic syndromes; Anemia; Hemoglobin; Randomized controlled trial; Blood transfusion; Randomization; Erythropoietin; Quality of life (healthcare); Red blood cell; Life expectancy; Internal medicine; Pediatrics; Surgery; Population; Bone marrow","score_opus":0.040621411507746646,"score_gpt":0.30675477093107995,"score_spread":0.26613335942333327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097357948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896557,0.00029851028,0.00021047033,0.0020096027,0.00009030263,0.0040227002,0.000014391609,0.000066621236,0.0036317182],"genre_scores_gemma":[0.99837404,0.00039508753,0.00055912463,0.00012872265,0.0001640771,0.00013695363,0.00002009414,0.00003448535,0.00018739907],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972437,0.00040142777,0.00080398365,0.00051574066,0.00065452704,0.0003806393],"domain_scores_gemma":[0.99839413,0.00068934454,0.0001252215,0.00041517516,0.000111646055,0.00026445865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011837928,0.00022340352,0.0013159856,0.00015897395,0.00003439337,0.000011043276,0.00021445262,0.00015137627,0.00031478482],"category_scores_gemma":[0.0016580124,0.00017788034,0.00025875718,0.00062026794,0.00021049741,0.000072295275,0.000072444134,0.0005533074,0.000030511703],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8394995,0.0025731828,0.002529089,0.0006485436,0.00010549286,0.00019420485,0.0006374707,0.0000061592546,0.15345928,0.000019723544,0.0002005514,0.00012684365],"study_design_scores_gemma":[0.92830783,0.0042946725,0.0015711194,0.00014795715,0.00036212456,0.000026657759,0.000091133385,0.00047510647,0.06443455,0.0001055416,0.00002847706,0.00015481932],"about_ca_topic_score_codex":0.00009454607,"about_ca_topic_score_gemma":0.00001803017,"teacher_disagreement_score":0.08902473,"about_ca_system_score_codex":0.00008938662,"about_ca_system_score_gemma":0.0005186325,"threshold_uncertainty_score":0.725375},"labels":[],"label_agreement":null},{"id":"W3097361536","doi":"10.1182/blood-2020-141309","title":"Allogeneic Hematopoietic Stem Cell Transplant Versus Gene Therapy in Sickle Cell Disease: Updated Results from a Systematic Review","year":2020,"lang":"en","type":"review","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Hematopoietic stem cell transplantation; Internal medicine; Transplantation; Graft-versus-host disease; Oncology","score_opus":0.024922669315254477,"score_gpt":0.2619832247174348,"score_spread":0.23706055540218032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097361536","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023222789,0.99102795,0.0000022263432,0.0002167945,0.00023440771,0.0065908763,0.0010388474,0.0001396229,0.0005170694],"genre_scores_gemma":[0.0004025685,0.99488086,0.000035576384,0.0003280323,0.000088281166,0.00038578623,0.003422712,0.00016025145,0.00029595292],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9950288,0.0006174326,0.0022257804,0.0010187041,0.00056738,0.0005419176],"domain_scores_gemma":[0.99716705,0.00028187528,0.00073962787,0.0012031904,0.000054411415,0.00055386446],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000352663,0.0008713333,0.0051276237,0.00016037481,0.00005594984,0.000029148616,0.00046743572,0.000537999,0.000095571675],"category_scores_gemma":[0.00003680025,0.00061582436,0.0010919416,0.000787952,0.000048959977,0.000033560245,0.00005104793,0.0008306069,0.00046292352],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032807654,0.0012155753,0.0000015160361,0.9876327,0.00093556644,0.0025658072,0.0003351928,5.819199e-7,0.000014178665,0.0000015956424,0.000503603,0.0064655915],"study_design_scores_gemma":[0.014550292,0.00040054545,8.762066e-7,0.7921471,0.03220639,0.00009488697,0.000078456185,0.0000059531294,0.000063035055,0.0000017973482,0.15958886,0.0008617872],"about_ca_topic_score_codex":0.000038519865,"about_ca_topic_score_gemma":0.000004021648,"teacher_disagreement_score":0.19548559,"about_ca_system_score_codex":0.00009665687,"about_ca_system_score_gemma":0.0007562013,"threshold_uncertainty_score":0.9996293},"labels":[],"label_agreement":null},{"id":"W3097378247","doi":"10.1182/blood-2020-136922","title":"Molecular Characterization of Clinical Response and Relapse in Patients with <i>IDH1</i>-Mutant Newly Diagnosed Acute Myeloid Leukemia Treated with Ivosidenib and Azacitidine","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Myeloid leukemia; Internal medicine; IDH1; Azacitidine; Gastroenterology; Isocitrate dehydrogenase; Myeloid; Refractory (planetary science); Oncology; Biology; Mutant","score_opus":0.012473492353877574,"score_gpt":0.26311456876836514,"score_spread":0.2506410764144876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097378247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976269,0.000046561134,0.000045772933,0.0011534914,0.0000068496315,0.0009804516,0.00006893361,0.000042107768,0.00002891837],"genre_scores_gemma":[0.9982634,0.0002322233,0.0006125854,0.0005878957,0.000034537366,0.000031252268,0.00016637894,0.000053637777,0.000018085815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794,0.00027006693,0.0005552617,0.000514106,0.00043359702,0.00028696],"domain_scores_gemma":[0.99873513,0.0002221197,0.00019766846,0.0002839674,0.00019173202,0.000369399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034710474,0.00023658921,0.00066243863,0.00014684936,0.000033409597,0.00002065647,0.000086187574,0.00016479353,0.000009685912],"category_scores_gemma":[0.0004673907,0.00017176254,0.00003652589,0.0005435379,0.00022517181,0.00014653758,0.00008667945,0.0004098058,0.0000024682647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027267542,0.0003470633,0.6620405,0.00008217726,0.00025476387,0.0013522874,0.0003088592,0.0000012083448,0.30760273,0.000005077149,0.000011448471,0.00072638027],"study_design_scores_gemma":[0.042553153,0.005850353,0.8686884,0.00024911689,0.00041710652,0.000054265685,0.00003896839,0.00019988233,0.081700884,0.0000011442465,0.00006240321,0.00018430944],"about_ca_topic_score_codex":0.000047597692,"about_ca_topic_score_gemma":0.00000683985,"teacher_disagreement_score":0.22590186,"about_ca_system_score_codex":0.00006190422,"about_ca_system_score_gemma":0.00043738363,"threshold_uncertainty_score":0.70042735},"labels":[],"label_agreement":null},{"id":"W3097385183","doi":"10.1182/blood-2020-136677","title":"Health State Utility Valuation in Patients with Triple-Class-Exposed Relapsed and Refractory Multiple Myeloma Treated with the Bcma-Directed CAR T Cell Therapy, Idecabtagene Vicleucel (ide-cel, bb2121): Results from the Karmma Trial","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Population; Multiple myeloma; Internal medicine; Quality of life (healthcare); Chimeric antigen receptor; Oncology; Cancer; Immunotherapy","score_opus":0.1646569257118793,"score_gpt":0.3122895376363006,"score_spread":0.1476326119244213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097385183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97278994,0.0011468532,0.00011224794,0.019572087,0.0001287287,0.004186826,0.0017692625,0.00011653569,0.00017752186],"genre_scores_gemma":[0.9926727,0.00018779133,0.00048603438,0.0056439303,0.00018093885,0.00017515918,0.00051587337,0.0000647066,0.000072903415],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99312824,0.0018514179,0.0031621344,0.0010456953,0.0002879923,0.00052450463],"domain_scores_gemma":[0.99360996,0.0022533655,0.0028792648,0.0008339285,0.00015064684,0.0002728482],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008098143,0.0003839056,0.0011262941,0.00012629002,0.00040367778,0.00014013724,0.00037753533,0.00015339271,0.000040017545],"category_scores_gemma":[0.0019666036,0.0002772507,0.000083588806,0.0005393155,0.00013768321,0.00037491653,0.00005360779,0.00042941456,0.00006731196],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.069663726,0.0033574163,0.8692354,0.00017479336,0.0007068974,0.000006180568,0.042136442,0.0003165136,0.00011051818,0.000065762986,0.010485829,0.0037405228],"study_design_scores_gemma":[0.17210256,0.0024489088,0.81341755,0.000065039945,0.000034461817,3.9569838e-7,0.0008783499,0.0043485174,0.0001669308,0.000114364135,0.005967792,0.00045513042],"about_ca_topic_score_codex":0.0056662974,"about_ca_topic_score_gemma":0.0023647298,"teacher_disagreement_score":0.10243883,"about_ca_system_score_codex":0.0002598717,"about_ca_system_score_gemma":0.0004276963,"threshold_uncertainty_score":0.999968},"labels":[],"label_agreement":null},{"id":"W3097430895","doi":"10.1182/blood-2020-134236","title":"Estimation of the Impact on Treatment Costs of a Switch to Nonacog Beta Pegol (N9-GP) for the Treatment of Adults with Hemophilia B in Canada Based on Real-World Factor IX (FIX) Consumption and Clinical Outcomes Pre- and Post-Switch","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Factor IX; Medicine; Clotting factor; Bleed; Pediatrics; Internal medicine; Surgery","score_opus":0.03611974942240755,"score_gpt":0.35127654493888727,"score_spread":0.31515679551647974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097430895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915503,0.00006109958,0.000004101677,0.004582554,0.00001740736,0.0033867485,0.00036629694,0.0000052304604,0.000026259624],"genre_scores_gemma":[0.999367,0.00017707297,0.00014804878,0.000078077916,0.000018522918,0.00010237619,0.000037361366,0.00001620577,0.000055310593],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873817,0.00007241929,0.00039651658,0.00027262332,0.0003385381,0.00018175451],"domain_scores_gemma":[0.99812835,0.0011549708,0.00014922014,0.000302521,0.00009181131,0.00017312366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000077459175,0.00021819258,0.00057083915,0.00007660733,0.00004059425,0.000005339697,0.000061046376,0.000049871815,0.000010152729],"category_scores_gemma":[0.00009491403,0.000089316185,0.000120389836,0.0001531633,0.000073164076,0.000018945362,0.00001287424,0.000068132125,3.7068452e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069992547,0.0021022642,0.9642776,0.00013326561,0.00045275068,0.000011267029,0.0006921442,0.00012902293,0.00038423727,0.0000061158735,0.000008820492,0.024803204],"study_design_scores_gemma":[0.015562934,0.016086834,0.9483722,0.0002889669,0.00041845007,0.0000024348362,0.00009870912,0.005161152,0.01393048,0.0000012050424,0.000004293957,0.00007236035],"about_ca_topic_score_codex":0.17520313,"about_ca_topic_score_gemma":0.23043582,"teacher_disagreement_score":0.055232696,"about_ca_system_score_codex":0.00031015876,"about_ca_system_score_gemma":0.00066965405,"threshold_uncertainty_score":0.83028924},"labels":[],"label_agreement":null},{"id":"W3097433875","doi":"10.1182/blood-2020-141801","title":"Terminal Half-Life of Factor VIII/IX According to Age and Blood Group Based on 8550 Assessments","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; McMaster University; Impact","funders":"","keywords":"Haemophilia; Medicine; Interquartile range; Population; Pharmacokinetics; Informed consent; Surgery; Pediatrics; Internal medicine; Pathology","score_opus":0.06225399557579481,"score_gpt":0.35155160869182595,"score_spread":0.28929761311603114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097433875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955768,0.00005185297,0.000040367217,0.0019737135,0.000029386709,0.0004630421,0.000024627352,0.00003732447,0.0018028951],"genre_scores_gemma":[0.9973948,0.0000134617185,0.0013915641,0.0008209727,0.00016610986,0.00001978482,0.000025032276,0.000023060416,0.00014523022],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877524,0.000041660427,0.00019815973,0.00030430223,0.00042377718,0.00025683656],"domain_scores_gemma":[0.9991447,0.000098881836,0.000041065723,0.0001979122,0.000035745692,0.00048169866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008451479,0.00015500534,0.00033146518,0.00011311941,0.000053197502,0.000023295066,0.00008945896,0.000072397896,0.000113777875],"category_scores_gemma":[0.00016406411,0.000117304575,0.000073376454,0.00019372154,0.000037116577,0.00004267962,0.00006438709,0.00016596442,0.000024815152],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087482756,0.0044826055,0.6392767,0.00079372904,0.00061356806,0.0036354417,0.00082400325,0.0000021318886,0.33684254,0.000053603067,0.00028658647,0.012314277],"study_design_scores_gemma":[0.04457278,0.020832859,0.6451085,0.0011155043,0.0017132586,0.00007964508,0.0011492221,0.0010432266,0.28123313,0.000021458905,0.00240553,0.00072487886],"about_ca_topic_score_codex":0.000023428796,"about_ca_topic_score_gemma":0.000002148868,"teacher_disagreement_score":0.055609405,"about_ca_system_score_codex":0.000012322986,"about_ca_system_score_gemma":0.00009758152,"threshold_uncertainty_score":0.47835416},"labels":[],"label_agreement":null},{"id":"W3097439692","doi":"10.1182/blood-2020-133372","title":"Efficacy of Daratumumab Containing Regimens Post Lenalidomide Maintenance in Transplant Eligible Patients: Real-World Experience from the Canadian Myeloma Research Group Database","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Saint John Regional Hospital; Université de Montréal; University of New Brunswick; Nova Scotia Health Authority; Hôpital Maisonneuve-Rosemont; University of Calgary; Vancouver General Hospital; Princess Margaret Cancer Centre; CancerCare Manitoba; Ottawa Hospital; McGill University Health Centre; University of Alberta; McMaster University","funders":"","keywords":"Lenalidomide; Daratumumab; Multiple myeloma; Medicine; Tolerability; Bortezomib; Pomalidomide; Internal medicine; Oncology; Maintenance therapy; Autologous stem-cell transplantation; Database; Adverse effect; Chemotherapy","score_opus":0.06544335901939595,"score_gpt":0.3406583747330585,"score_spread":0.2752150157136625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097439692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917297,0.0002575822,0.0000038002142,0.003029005,0.000029999303,0.0010922131,0.0006927527,0.000020839738,0.0031441483],"genre_scores_gemma":[0.998001,0.00015810606,0.00032651497,0.0004481387,0.00008735735,0.000095509036,0.00079945184,0.000028008973,0.000055904544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972151,0.0002786426,0.00041583672,0.0005050332,0.00079224864,0.0007931612],"domain_scores_gemma":[0.99786377,0.00056668377,0.0000718174,0.0005847397,0.00025588175,0.0006570812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043269305,0.00018748362,0.00037721824,0.00020887279,0.00024612766,0.00003918644,0.00037205243,0.00006184129,0.000098471835],"category_scores_gemma":[0.000912014,0.00013077972,0.00007464165,0.00075652514,0.00026051176,0.00012534045,0.00008210517,0.0005480937,0.00003553362],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064332457,0.0012013775,0.9623055,0.00008336644,0.000251624,0.0023732553,0.0129938135,0.0000019134518,0.011311009,0.00078851497,0.00084948185,0.0014068902],"study_design_scores_gemma":[0.026326755,0.0011065346,0.9554859,0.00086530944,0.00007090713,0.00000915427,0.0017317892,0.00013008986,0.012460549,0.000018108502,0.0016108874,0.00018406013],"about_ca_topic_score_codex":0.5082864,"about_ca_topic_score_gemma":0.62004006,"teacher_disagreement_score":0.11175362,"about_ca_system_score_codex":0.00020597823,"about_ca_system_score_gemma":0.0005887124,"threshold_uncertainty_score":0.5333042},"labels":[],"label_agreement":null},{"id":"W3097465577","doi":"10.1182/blood-2020-139598","title":"UM171-Expanded Cord Blood Transplants Support Robust T-Cell Reconstitution with Low Rates of Severe Infections","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Hôpital Maisonneuve-Rosemont; Université de Montréal; Centre intégré universitaire de santé et de services sociaux de l'Est-de-l'Île-de-Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Medicine; Cohort; Cumulative incidence; Transplantation; Cord blood; Hematopoietic stem cell transplantation; Internal medicine; Immunology; ELISPOT; Graft-versus-host disease; Stem cell; T cell; Immune system; Gastroenterology; Biology","score_opus":0.02437055385266671,"score_gpt":0.24590056890089,"score_spread":0.22153001504822328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097465577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843707,0.000051290805,0.002555109,0.00024731836,0.000066449036,0.00060186035,0.00010110829,0.00011472587,0.011891445],"genre_scores_gemma":[0.99716693,0.0001590756,0.002024207,0.00016438762,0.0000708034,0.00002525658,0.00020703123,0.00002577608,0.00015652488],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988066,0.00003840097,0.00038152336,0.0002955586,0.00025982494,0.00021807861],"domain_scores_gemma":[0.9992923,0.00007504457,0.00012264689,0.00018868002,0.00011517401,0.0002061148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009129737,0.00018992003,0.0003777086,0.000079468075,0.00006280077,0.000010880649,0.00006587676,0.00012207674,0.0003809493],"category_scores_gemma":[0.000019585726,0.00016297419,0.00008376818,0.00030422484,0.00009593421,0.00010033934,0.0000051686925,0.00018179887,0.0000560402],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018647873,0.0059601846,0.59413517,0.0068632606,0.0009964098,0.0009729793,0.003711182,0.00051975297,0.38401982,0.0001992814,0.00036995413,0.00038720595],"study_design_scores_gemma":[0.022357803,0.003959298,0.02010043,0.00090716884,0.0034112583,0.0033498793,0.0003683653,0.00009734819,0.94487274,0.000011867342,0.0001671954,0.00039662202],"about_ca_topic_score_codex":0.000030379842,"about_ca_topic_score_gemma":0.00003110165,"teacher_disagreement_score":0.57403475,"about_ca_system_score_codex":0.000008876734,"about_ca_system_score_gemma":0.0002794125,"threshold_uncertainty_score":0.6645894},"labels":[],"label_agreement":null},{"id":"W3097472105","doi":"10.1182/blood-2020-136422","title":"SWOG S1826: A Phase III, Randomized Study of Nivolumab Plus AVD or Brentuximab Vedotin Plus AVD in Patients with Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children; University Health Network; McGill University","funders":"","keywords":"Brentuximab vedotin; Medicine; ABVD; Dacarbazine; Internal medicine; Chemotherapy regimen; Oncology; Regimen; Procarbazine; Vincristine; Nivolumab; Surgery; Chemotherapy; Cyclophosphamide; Lymphoma; Cancer; Hodgkin lymphoma","score_opus":0.014650634502101146,"score_gpt":0.2650438985331142,"score_spread":0.2503932640310131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097472105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99269336,0.00030523379,0.00005749948,0.00029564992,0.00009522119,0.0061317,0.00009251462,0.00010550338,0.00022330409],"genre_scores_gemma":[0.9976522,0.00005234836,0.0005890036,0.00036123552,0.00007391385,0.00088495505,0.00013649049,0.00007538503,0.00017451443],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9962913,0.00030953094,0.0011006457,0.00083200843,0.0009068966,0.0005596256],"domain_scores_gemma":[0.99764466,0.00068643596,0.00046870657,0.00057726534,0.00017382218,0.00044909213],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020752843,0.0005432609,0.0023810184,0.00018228873,0.00007970893,0.000036398378,0.00022294685,0.00013628487,0.00021692357],"category_scores_gemma":[0.0005704755,0.00036365053,0.00024841822,0.00062018994,0.00015008071,0.00015205146,0.00013248711,0.0001602509,0.000022731363],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7335052,0.12858005,0.10359016,0.00026213133,0.0022151335,0.0036023045,0.0089000845,0.00017752993,0.0001017393,0.000051950225,0.0004369595,0.018576749],"study_design_scores_gemma":[0.9408189,0.014126621,0.039763715,0.000300171,0.0015442871,0.000008306443,0.0011748909,0.00082847325,0.00092508394,0.000004589722,0.00013590854,0.00036901937],"about_ca_topic_score_codex":0.00050926756,"about_ca_topic_score_gemma":0.00036797032,"teacher_disagreement_score":0.20731373,"about_ca_system_score_codex":0.00036389814,"about_ca_system_score_gemma":0.00070533674,"threshold_uncertainty_score":0.99988157},"labels":[],"label_agreement":null},{"id":"W3097472578","doi":"10.1182/blood-2020-133813","title":"The Current Practice of Management of Asymptomatic Central Venous Catheters Associated Venous Thromboembolism in Children: A Result of Saudi Arabian Pediatric Hematology/Oncology Society Survey","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Central Venous Catheters and Hemodialysis","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Medicine; Asymptomatic; Thrombophilia; Hematology; Thrombosis; Clinical trial; Guideline; Intensive care medicine; Pediatrics; Venous thromboembolism; Internal medicine; Pathology","score_opus":0.030348366266334262,"score_gpt":0.33811670917883513,"score_spread":0.3077683429125009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097472578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994482,0.0026145962,0.000021226542,0.0007790722,0.00025013572,0.00128507,0.00019880258,0.000027597745,0.00034149006],"genre_scores_gemma":[0.9947468,0.004632303,0.00023458998,0.00016410364,0.000070589784,0.00004436661,0.0000748342,0.000027155887,0.000005257964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99565715,0.0014730953,0.0013999622,0.00033223894,0.00039114623,0.0007464066],"domain_scores_gemma":[0.9962443,0.0013237495,0.0016907236,0.00037512815,0.00022827744,0.00013780914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016801634,0.00021215499,0.0010596452,0.000064783286,0.00024831624,0.0000042976862,0.00042719799,0.00021808402,0.0000107961005],"category_scores_gemma":[0.000561058,0.00017289618,0.0003085914,0.0006999414,0.00013920119,0.00005891247,0.0001953846,0.00065228087,0.000007882639],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043497997,0.019023035,0.90560776,0.0021069434,0.0030186495,0.000017682743,0.06120013,0.00009198343,0.00012274072,0.0005496144,0.0016432576,0.006183202],"study_design_scores_gemma":[0.0049091186,0.00095680554,0.9889987,0.00022114524,0.001568268,0.000003897797,0.002596601,0.000115540184,0.0001154048,0.000100094534,0.00019985669,0.00021457669],"about_ca_topic_score_codex":0.00057756685,"about_ca_topic_score_gemma":0.00020451566,"teacher_disagreement_score":0.08339091,"about_ca_system_score_codex":0.00014850766,"about_ca_system_score_gemma":0.00041278408,"threshold_uncertainty_score":0.7050502},"labels":[],"label_agreement":null},{"id":"W3097480389","doi":"10.1182/blood-2020-140065","title":"High Transfusion Dependence and Serum Ferritin but Not Transferrin Saturation Predict Inferior Clinical Outcomes in Patients with MDS","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; McGill University Health Centre; Sunnybrook Health Science Centre; Jewish General Hospital; St. Paul's Hospital; Dr. Georges-L.-Dumont University Hospital Centre; McMaster University; Hôpital de l'Enfant-Jésus; Juravinski Cancer Centre; Vancouver General Hospital; University of Calgary; Princess Margaret Cancer Centre; Health Sciences Centre; CancerCare Manitoba; University Health Network; Ottawa Hospital; Queen Elizabeth II Health Sciences Centre; University of Alberta; University of Toronto","funders":"","keywords":"Transferrin saturation; Medicine; Ferritin; Internal medicine; Myelodysplastic syndromes; Gastroenterology; Anemia; Immunology; Serum ferritin; Bone marrow","score_opus":0.011455271862057364,"score_gpt":0.23983684700469368,"score_spread":0.22838157514263632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097480389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99575174,0.00005751721,0.000078188925,0.003227287,0.000065507214,0.00063810294,0.00004001643,0.00006100183,0.00008066764],"genre_scores_gemma":[0.9982062,0.0002865394,0.00030939074,0.0010789492,0.000037619153,0.000010293718,0.000033576336,0.000019279049,0.00001815986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987455,0.000059685393,0.0004059189,0.0003164043,0.0002768558,0.00019566438],"domain_scores_gemma":[0.99955493,0.00004832875,0.000035211822,0.00011598427,0.000043031065,0.00020252372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011123971,0.00015880681,0.00037034613,0.000043987482,0.00004652791,0.00001524351,0.000051255796,0.00021295849,0.000033174038],"category_scores_gemma":[0.00009185175,0.00011233341,0.000059755672,0.00013872873,0.00006530647,0.0000986553,0.000013954397,0.00040520524,0.0000047665826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007674343,0.000644931,0.9915529,0.00006685952,0.00006198166,0.000043084423,0.00037748978,0.000005484015,0.00030197122,0.000016749065,0.000006054261,0.0061550764],"study_design_scores_gemma":[0.018316634,0.001881645,0.97822994,0.00012208855,0.00019414167,0.000006452755,0.00013531002,0.000081103615,0.0008569513,0.0000042528336,0.000035655972,0.00013583346],"about_ca_topic_score_codex":0.00014020907,"about_ca_topic_score_gemma":0.00014775425,"teacher_disagreement_score":0.0175492,"about_ca_system_score_codex":0.00000880354,"about_ca_system_score_gemma":0.000067202665,"threshold_uncertainty_score":0.45808235},"labels":[],"label_agreement":null},{"id":"W3097486607","doi":"10.1182/blood-2020-137658","title":"<i>TET2</i> and <i>DNMT3A</i> Mutations Exert Divergent Effects on DNA Repair and Sensitivity of Leukemia Cells to PARP Inhibitors","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Biology; DNA repair; Epigenetics; DNA methylation; Mutation; DNA damage; Ku80; Cancer research; Homologous recombination; Haematopoiesis; Genetics; DNA; Molecular biology; Cell biology; Gene; Stem cell; DNA-binding protein; Gene expression; Transcription factor","score_opus":0.006196082563575432,"score_gpt":0.20831752683633628,"score_spread":0.20212144427276085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097486607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99839354,0.00065962784,0.00028362795,0.00016346507,0.00005929176,0.00021368709,0.000026541453,0.000012735193,0.00018751572],"genre_scores_gemma":[0.99856865,0.00024317982,0.0006515174,0.00034422099,0.00012567932,0.0000074611735,0.000023889297,0.000012288642,0.000023096178],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992998,0.000075685224,0.00013552373,0.0002852533,0.00009268354,0.0001110553],"domain_scores_gemma":[0.9995859,0.000049864102,0.000049812537,0.00013199353,0.000038426682,0.00014396988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012459274,0.00010904448,0.00012851271,0.000019023948,0.000048483576,0.000008940106,0.000022325215,0.000077176854,8.102412e-7],"category_scores_gemma":[0.00011282908,0.00010790397,0.000045531426,0.00006597055,0.00003172243,0.0000021340059,0.00008807628,0.000044924123,0.0000021207475],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027956567,0.000045581804,0.0051129325,0.000056764693,0.000029332188,0.000007034672,0.00014396844,0.00008958688,0.9931685,0.0000072511543,0.00015662961,0.0011545127],"study_design_scores_gemma":[0.00056409085,0.00057181943,0.0059221084,0.000018105182,0.00005390085,0.000001322648,0.000018612407,0.000059084017,0.99053097,0.00001676356,0.0021246846,0.000118547636],"about_ca_topic_score_codex":0.000015480771,"about_ca_topic_score_gemma":0.000012808809,"teacher_disagreement_score":0.0026374883,"about_ca_system_score_codex":0.0000038708686,"about_ca_system_score_gemma":0.00002457814,"threshold_uncertainty_score":0.44001964},"labels":[],"label_agreement":null},{"id":"W3097493469","doi":"10.1182/blood-2020-139948","title":"Safety and Efficacy of the Contact Activation Inhibitor AB023 in Patients with End-Stage Renal Disease on Chronic Hemodialysis: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Trial","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Medicine; Tolerability; Hemodialysis; Hemostasis; Placebo; End stage renal disease; Internal medicine; Adverse effect; Surgery; Urology; Pathology","score_opus":0.015133535987578843,"score_gpt":0.2586536295797788,"score_spread":0.24352009359219992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097493469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99211264,0.00019252203,0.000036973004,0.0006718622,0.000067197536,0.006762523,0.00003120479,0.000027114416,0.00009799043],"genre_scores_gemma":[0.9990923,0.000019553056,0.000010883562,0.0001487204,0.00036275582,0.00016253984,0.00011211215,0.000022492039,0.00006868232],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982527,0.00018705193,0.0006151348,0.00031782285,0.00043836838,0.00018892501],"domain_scores_gemma":[0.99862933,0.0004959762,0.0003768216,0.00023882992,0.0000703857,0.00018864604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032994774,0.00021666003,0.0009109554,0.0000971533,0.00007602099,0.000020146852,0.000072184084,0.000061825325,0.00007187289],"category_scores_gemma":[0.00046912592,0.00012989467,0.00025406343,0.00026123878,0.00008530818,0.00009811917,0.000027791284,0.00016038778,0.0000017695692],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99183446,0.0023886769,0.0035748964,0.000061083265,0.00040882794,0.000005323157,0.00045465524,0.0000855172,0.00027754175,0.000099694465,0.00000807971,0.0008012453],"study_design_scores_gemma":[0.98239017,0.0019770043,0.009416463,0.000297536,0.0011473177,2.9307895e-7,0.000019288454,0.0005691018,0.004001983,0.000003875116,0.000042298037,0.00013467886],"about_ca_topic_score_codex":0.000034078013,"about_ca_topic_score_gemma":0.0000144286605,"teacher_disagreement_score":0.009444298,"about_ca_system_score_codex":0.000048985763,"about_ca_system_score_gemma":0.00030079368,"threshold_uncertainty_score":0.52969515},"labels":[],"label_agreement":null},{"id":"W3097496208","doi":"10.1182/blood-2020-137690","title":"Painting the Clinical Picture of Congenital Plasminogen Deficiency (C-PLGD) through a Comprehensive Case Study Review","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Vascular Malformations and Hemangiomas","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Liminal BioSciences (Canada)","funders":"","keywords":"Medicine; Genitourinary system; MEDLINE; Conjunctiva; Disease; Dermatology; Pathology; Pediatrics; Internal medicine","score_opus":0.10563803116982083,"score_gpt":0.3588027047131609,"score_spread":0.25316467354334005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097496208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98026425,0.016543686,0.00009714195,0.0011966822,0.00003382057,0.0011457874,0.000007598177,0.000029745168,0.0006813063],"genre_scores_gemma":[0.99606514,0.00048421364,0.00073865947,0.0025491067,0.000120880046,0.000017789018,0.0000065251807,0.000010918895,0.000006761622],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9988065,0.00012745212,0.00054060953,0.00017297386,0.00021789441,0.00013458866],"domain_scores_gemma":[0.99916047,0.0001388944,0.00014893507,0.00030735417,0.00017267754,0.00007167473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027814825,0.00010758321,0.00040440974,0.0000130305825,0.00010213122,0.000007906433,0.0000985658,0.000045590503,0.000051324234],"category_scores_gemma":[0.00028220535,0.00006752973,0.0002563509,0.0002296214,0.00007173175,0.000047011745,0.00008434006,0.00020284126,0.000025472627],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003693485,0.0270446,0.7051918,0.022761168,0.010950807,0.039065763,0.13004725,0.000030310253,0.0020455318,0.0022252991,0.020402139,0.039865974],"study_design_scores_gemma":[0.08017994,0.025758034,0.2330769,0.006170368,0.061208174,0.098787315,0.38421038,0.0017792217,0.0032308146,0.00016065444,0.10281851,0.0026196842],"about_ca_topic_score_codex":0.000028165297,"about_ca_topic_score_gemma":0.000008669042,"teacher_disagreement_score":0.47211492,"about_ca_system_score_codex":0.0000031482577,"about_ca_system_score_gemma":0.000061173734,"threshold_uncertainty_score":0.27537823},"labels":[],"label_agreement":null},{"id":"W3097496716","doi":"10.1182/blood-2020-137303","title":"Once Weekly Selinexor, Bortezomib, and Dexamethasone Versus Twice Weekly Bortezomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma: Age and Frailty Subgroup Analyses from the Phase 3 Boston Study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary; University of Alberta","funders":"","keywords":"Bortezomib; Dexamethasone; Multiple myeloma; Medicine; Internal medicine; Oncology; Refractory (planetary science); Biology","score_opus":0.15432705662022184,"score_gpt":0.3934805609807746,"score_spread":0.23915350436055277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097496716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887594,0.0072036763,0.000048620102,0.0014766508,0.00006658804,0.0019768523,0.00026169178,0.000106746986,0.00009976655],"genre_scores_gemma":[0.99433756,0.0010848575,0.003453092,0.00038258475,0.00025365013,0.00012044971,0.00017175908,0.000075359356,0.00012070305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99616355,0.0005793576,0.00068165665,0.0011880747,0.00071146723,0.00067587855],"domain_scores_gemma":[0.99495965,0.003223041,0.00022387669,0.00067818735,0.00011478108,0.00080046395],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006188807,0.0005565203,0.0010556665,0.00017045064,0.00027140518,0.00013504767,0.00022995753,0.00022048257,0.00007439702],"category_scores_gemma":[0.0035227519,0.0003802253,0.00009391615,0.0006767432,0.0003396771,0.00023919345,0.0003058935,0.0008459781,0.000011181914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044109438,0.01084174,0.7483249,0.00019912944,0.0033280817,0.010169836,0.009013978,0.000002364589,0.12266771,0.0000039455244,0.0006104557,0.050728448],"study_design_scores_gemma":[0.16367792,0.011059969,0.807162,0.00017445203,0.001887508,0.000056858076,0.007450085,0.001987674,0.0046924725,0.000011145148,0.0013030757,0.00053682696],"about_ca_topic_score_codex":0.0059163175,"about_ca_topic_score_gemma":0.0051691895,"teacher_disagreement_score":0.11956848,"about_ca_system_score_codex":0.000074597134,"about_ca_system_score_gemma":0.0001960457,"threshold_uncertainty_score":0.999865},"labels":[],"label_agreement":null},{"id":"W3097502162","doi":"10.1182/blood-2020-134929","title":"Single Cell Profiling Reveals Unique CXCL13 Positive T Cell Subsets in the Tumor Microenvironment of Lymphocyte Rich Classic Hodgkin Lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; Terry Fox Research Institute; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Tumor microenvironment; Immune system; Tissue microarray; Immunophenotyping; Pathology; Reed–Sternberg cell; T cell; Lymphoma; Lymph node; Biology; Lymphocyte; B cell; Immunohistochemistry; Cancer research; Flow cytometry; Antibody; Medicine; Immunology","score_opus":0.01502497760786854,"score_gpt":0.21730260625462144,"score_spread":0.20227762864675292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097502162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99128515,0.0023303544,0.0000070974393,0.0012063986,0.000030897612,0.0011122092,0.000060045735,0.000025801868,0.0039420505],"genre_scores_gemma":[0.9959193,0.00020831954,0.0013942126,0.0021160604,0.0000803523,0.000115683484,0.000063207764,0.000035840898,0.000067009816],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99820054,0.00019291001,0.00046934382,0.00043150687,0.00034694257,0.00035874988],"domain_scores_gemma":[0.99904454,0.00018348153,0.00022238251,0.00036456305,0.000034941277,0.00015009576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001854789,0.00027413398,0.00047384255,0.00006804293,0.000055491142,0.000020626863,0.0001847661,0.00008439569,0.000028877294],"category_scores_gemma":[0.000030172498,0.00019489316,0.0001488262,0.00029665785,0.00006483157,0.000049545546,0.00007655798,0.000080509555,0.00006132453],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044267153,0.01719183,0.24963666,0.0005236901,0.00018468744,0.0021379162,0.004444246,0.00001430653,0.723168,0.00010140468,0.0006855031,0.0014690481],"study_design_scores_gemma":[0.011095168,0.0011068907,0.11094199,0.00015519428,0.0003881889,0.00009212309,0.000609219,0.000026917047,0.87505484,0.000017750339,0.0003448783,0.0001668109],"about_ca_topic_score_codex":0.00007835777,"about_ca_topic_score_gemma":0.0000054760126,"teacher_disagreement_score":0.15188682,"about_ca_system_score_codex":0.00027967832,"about_ca_system_score_gemma":0.00017331266,"threshold_uncertainty_score":0.7947512},"labels":[],"label_agreement":null},{"id":"W3097505417","doi":"10.1182/blood-2020-134398","title":"The Echelon-2 Trial: 5-Year Results of a Randomized, Double-Blind, Phase 3 Study of Brentuximab Vedotin and CHP (A+CHP) Versus CHOP in Frontline Treatment of Patients with CD30-Positive Peripheral T-Cell Lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; Health Sciences Centre","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Brentuximab vedotin; CHOP; Vincristine; Prednisone; Population; Surgery; Chemotherapy regimen; Randomization; Gastroenterology; Phases of clinical research; Cyclophosphamide; Randomized controlled trial; Confidence interval; Chemotherapy; Lymphoma; CD30","score_opus":0.025551533868815746,"score_gpt":0.28361959669868864,"score_spread":0.2580680628298729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097505417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99289846,0.0007981492,6.864485e-7,0.00021139775,0.00006403505,0.005517889,0.0001628841,0.000011278843,0.00033522345],"genre_scores_gemma":[0.99907994,0.00030374838,0.00010569751,0.000009873909,0.00005260241,0.00030720254,0.00009341033,0.00002355087,0.000023959945],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99804777,0.00018640028,0.0007847502,0.00036998448,0.00040753238,0.00020356968],"domain_scores_gemma":[0.9984161,0.00046311974,0.00050296733,0.00031400006,0.00017583721,0.00012793239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020575667,0.00027157186,0.0012697552,0.00007352465,0.000043263924,0.000011567358,0.00008114659,0.00006680288,0.000005561762],"category_scores_gemma":[0.000089308836,0.0001517818,0.00017215205,0.00022005592,0.00013959652,0.00004320536,0.000038011312,0.0000394526,8.454779e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87822825,0.08500958,0.027652524,0.000038555492,0.0015085598,0.000043263466,0.0049668513,0.0000036941585,0.000052685722,0.000006142368,0.000009533863,0.0024803893],"study_design_scores_gemma":[0.9177506,0.04465412,0.02382314,0.000079820216,0.0022230078,0.0000010749192,0.0013319582,0.000037282945,0.009961211,7.0647604e-7,0.000027311538,0.00010977976],"about_ca_topic_score_codex":0.00085064274,"about_ca_topic_score_gemma":0.00015434274,"teacher_disagreement_score":0.040355463,"about_ca_system_score_codex":0.00009973358,"about_ca_system_score_gemma":0.00015355767,"threshold_uncertainty_score":0.6189482},"labels":[],"label_agreement":null},{"id":"W3097507376","doi":"10.1182/blood-2020-138796","title":"Survival Varies By Age and Histology in Classical Hodgkin Lymphoma: A Report from the Children's Oncology Group","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Cog; Internal medicine; Histology; Proportional hazards model; Cumulative incidence; Radiation therapy; Cohort; Clinical trial; Oncology","score_opus":0.016250080824054308,"score_gpt":0.24903988358186813,"score_spread":0.23278980275781383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097507376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9761597,0.002591338,0.000011483533,0.019402571,0.00009617784,0.00027991735,0.00003837018,0.000038351813,0.0013820933],"genre_scores_gemma":[0.9967704,0.00017141053,0.00030945407,0.0022123565,0.00020907352,0.00005653137,0.00021595375,0.000014036072,0.000040796152],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989036,0.00011977892,0.00026424002,0.00037424796,0.00013618422,0.00020198483],"domain_scores_gemma":[0.9991982,0.0003642013,0.00007960737,0.00020970112,0.000010689479,0.00013762618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000098566314,0.00014606034,0.00044178404,0.000016918651,0.00005191253,0.000014470279,0.00007148269,0.00014203474,0.000038057962],"category_scores_gemma":[0.00018246975,0.0000956291,0.00005848623,0.00009059239,0.00018631255,0.000023545674,0.00008354042,0.0000919338,0.000011193041],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019973906,0.0028047224,0.9622857,0.0000062142367,0.00032623167,0.011796808,0.0007358219,4.090659e-8,0.00046910648,0.0006430446,0.0113646565,0.009367936],"study_design_scores_gemma":[0.011909065,0.0006761081,0.9420019,0.000012800297,0.0003778845,0.0007679844,0.00007818387,0.000005129967,0.00028736214,0.00012890565,0.043656852,0.00009786991],"about_ca_topic_score_codex":0.0013588088,"about_ca_topic_score_gemma":0.0004462273,"teacher_disagreement_score":0.0322922,"about_ca_system_score_codex":0.00008084287,"about_ca_system_score_gemma":0.000110501605,"threshold_uncertainty_score":0.38996413},"labels":[],"label_agreement":null},{"id":"W3097520009","doi":"10.1182/blood-2020-134645","title":"Geographical Distance from Quaternary Treatment Center Does Not Impact Choice of Upfront Therapy, Clinical Trial Participation and Outcomes in Patients with Newly Diagnosed AML","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Chemotherapy regimen; Internal medicine; Clinical trial; Chemotherapy; Pediatrics","score_opus":0.048409241041222434,"score_gpt":0.36861543943966874,"score_spread":0.32020619839844633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097520009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971462,0.00006664793,0.000019086208,0.0013311327,0.00004575761,0.0011719218,0.0001906892,0.00002037421,0.000008211062],"genre_scores_gemma":[0.9989227,0.00019763884,0.0002098753,0.00029363867,0.00015492596,0.000069052134,0.00012299411,0.000020898884,0.00000824483],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835455,0.0001768564,0.00050429505,0.00036084434,0.00035691148,0.0002465426],"domain_scores_gemma":[0.9988241,0.0004845265,0.00013259434,0.0002466305,0.000053800406,0.00025834344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010826827,0.00018316871,0.0005947833,0.000052596646,0.000020404339,0.000015750396,0.00008167374,0.00009651183,0.000040068495],"category_scores_gemma":[0.00025141638,0.0000941012,0.00013025466,0.00011238083,0.00011705528,0.00007665892,0.000035872807,0.00018862502,0.0000025664583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051456995,0.0048698187,0.9375008,0.000009358496,0.00045220912,0.00003413078,0.00039141515,8.920928e-7,0.000070403454,9.283419e-7,0.000014072014,0.0051990235],"study_design_scores_gemma":[0.21843557,0.0075103575,0.7732819,0.000028951305,0.00010341341,1.0097503e-7,0.000016516515,0.000103227714,0.0003691065,0.0000032320388,0.00006885644,0.00007879972],"about_ca_topic_score_codex":0.0017629702,"about_ca_topic_score_gemma":0.00034214687,"teacher_disagreement_score":0.16697858,"about_ca_system_score_codex":0.000056485893,"about_ca_system_score_gemma":0.0000991158,"threshold_uncertainty_score":0.38373354},"labels":[],"label_agreement":null},{"id":"W3097533843","doi":"10.1182/blood-2020-134948","title":"Personalized Targeted Radioimmunotherapy with Anti-CD45 Iodine (131I) Apamistamab [Iomab-B] in Patients with Active Relapsed or Refractory Acute Myeloid Leukemia Results in Successful Donor Hematopoietic Cells Engraftment with the Timing of Engraftment Not Related to the Radiation Dose Delivered","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Radioimmunotherapy; Medicine; Haematopoiesis; Myeloid leukemia; Refractory (planetary science); Myeloid; Cancer research; Leukemia; Internal medicine; Stem cell; Oncology; Immunology; Antibody; Monoclonal antibody; Biology","score_opus":0.011751975683458435,"score_gpt":0.2494148558218979,"score_spread":0.23766288013843948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097533843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992193,0.00017227992,0.000037456535,0.004744476,0.00001186038,0.0025582504,0.0001466968,0.00004572133,0.000090250534],"genre_scores_gemma":[0.9978734,0.00015938998,0.0006131719,0.000676075,0.000026621707,0.00029202664,0.00022043126,0.000047439808,0.00009140064],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978183,0.00013904065,0.0005671432,0.0005496495,0.0005676004,0.00035827633],"domain_scores_gemma":[0.9985842,0.0002481448,0.0003446513,0.00048569418,0.00015260701,0.00018470282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022940383,0.00034974157,0.00055138266,0.00007831277,0.00014600129,0.000026653648,0.00025474938,0.00011696922,0.000051147737],"category_scores_gemma":[0.00004525487,0.0001788353,0.000063827174,0.0010526511,0.00018179564,0.000100139,0.000030172734,0.00052951253,0.0000052403348],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20157346,0.006913263,0.008027961,0.00051231234,0.003694181,0.00041708408,0.052295916,0.0035360483,0.71866375,0.00004460429,0.00049039215,0.0038310215],"study_design_scores_gemma":[0.11370443,0.00396102,0.08778234,0.000546342,0.00114721,0.000037475802,0.0019216185,0.0013789873,0.78699476,0.0000019336196,0.0019551667,0.000568709],"about_ca_topic_score_codex":0.000064293425,"about_ca_topic_score_gemma":0.000016315775,"teacher_disagreement_score":0.08786903,"about_ca_system_score_codex":0.00032468885,"about_ca_system_score_gemma":0.0003171909,"threshold_uncertainty_score":0.7292692},"labels":[],"label_agreement":null},{"id":"W3097539251","doi":"10.1182/blood-2020-137161","title":"Dose- and Schedule-Dependent Immunomodulatory Effects of the Novel Celmod Agent CC-92480 in Patients with Relapsed/Refractory Multiple Myeloma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Institute of Cancer Research; University of Calgary","funders":"","keywords":"Refractory (planetary science); Multiple myeloma; Pomalidomide; Lenalidomide; Medicine; Carfilzomib; Oncology; Internal medicine; Thalidomide; Biology","score_opus":0.011925850762924567,"score_gpt":0.22431197460194663,"score_spread":0.21238612383902206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097539251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976825,0.00057974714,0.000012693217,0.00013468432,0.00005571987,0.0013686902,0.000025854117,0.000026247517,0.00011383525],"genre_scores_gemma":[0.9991908,0.00002301261,0.00047667607,0.00012884247,0.000033514476,0.000054074444,0.000019051584,0.000036703732,0.000037297606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984085,0.000073051786,0.0002613228,0.00035998598,0.00057529233,0.00032183234],"domain_scores_gemma":[0.9990212,0.00013031563,0.00011494364,0.00040218746,0.00008336752,0.00024799106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008212713,0.00021538386,0.0003484827,0.00007521195,0.0000650185,0.000012303006,0.00014213908,0.000090744965,0.00000846998],"category_scores_gemma":[0.00029551343,0.00013418782,0.00007337712,0.00019816148,0.00010989461,0.000083157385,0.00015753502,0.00031414963,0.000011443947],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014167903,0.00981425,0.9646928,0.0003965062,0.00037584547,0.00008164586,0.00046717795,0.0000027699002,0.019997979,0.000010179719,0.000008528508,0.0027355743],"study_design_scores_gemma":[0.08161479,0.0015684131,0.89117926,0.0002312417,0.00012989908,0.0000047615044,0.00003680743,0.00012375764,0.024944166,0.0000017121997,0.00005095425,0.0001142164],"about_ca_topic_score_codex":0.00008148036,"about_ca_topic_score_gemma":0.000024238328,"teacher_disagreement_score":0.080198005,"about_ca_system_score_codex":0.000057611494,"about_ca_system_score_gemma":0.00011850686,"threshold_uncertainty_score":0.5472021},"labels":[],"label_agreement":null},{"id":"W3097541653","doi":"10.1182/blood-2020-136609","title":"Sex-Based Disparities in Outcome in Childhood Acute Lymphoblastic Leukemia (ALL): A Children's Oncology Group (COG) Report","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Cumulative incidence; Cog; Minimal residual disease; Internal medicine; Proportional hazards model; Cohort; Acute lymphocytic leukemia; Pediatrics; Leukemia; Incidence (geometry); Oncology; Lymphoblastic Leukemia","score_opus":0.01995288946394544,"score_gpt":0.2925703513803391,"score_spread":0.2726174619163937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097541653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99107796,0.00016849254,0.00035412548,0.00483404,0.00010359477,0.0014901806,0.000055428638,0.00020637506,0.0017098003],"genre_scores_gemma":[0.99168736,0.00003730488,0.0017116356,0.0053971014,0.00034176887,0.000261015,0.00030019647,0.000103166254,0.0001604432],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956505,0.00019748107,0.0012402708,0.0009962535,0.0008281894,0.001087361],"domain_scores_gemma":[0.997961,0.00047951896,0.00022414388,0.0006555561,0.00006944031,0.0006103752],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005368369,0.00047112917,0.0012313722,0.000454318,0.00005807397,0.000042868865,0.00042517224,0.0004463079,0.00011467676],"category_scores_gemma":[0.001317937,0.000435529,0.00021334711,0.00090912404,0.00023696505,0.00014708219,0.00027032953,0.00093699276,0.00011830476],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073112256,0.0023688285,0.9650135,0.00020835314,0.00052018155,0.02691194,0.0006530256,0.0001530681,0.0018402215,0.00011735924,0.00066649617,0.0008158904],"study_design_scores_gemma":[0.051091533,0.0023037253,0.933795,0.00023023647,0.00076649996,0.0043018907,0.00012092415,0.004044991,0.002069922,0.000084544845,0.0005581363,0.0006325915],"about_ca_topic_score_codex":0.0011407319,"about_ca_topic_score_gemma":0.00023006905,"teacher_disagreement_score":0.05036041,"about_ca_system_score_codex":0.001828544,"about_ca_system_score_gemma":0.0029340447,"threshold_uncertainty_score":0.9998096},"labels":[],"label_agreement":null},{"id":"W3097547337","doi":"10.1182/blood-2020-140667","title":"Single Cell Immune Profiling Reveals Distinct T Cell Clones and Functional States in <i>in-Vitro</i> Expanded Cord Blood Derived Gamma Delta T Cells","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"T-cell receptor; Biology; Antigen; Major histocompatibility complex; T cell; Antigen-presenting cell; Cord blood; Context (archaeology); Molecular biology; Cell biology; Immune system; Immunology","score_opus":0.014737411146285968,"score_gpt":0.2038848202571365,"score_spread":0.18914740911085054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097547337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930862,0.004219847,0.000115202885,0.00016587907,0.0008896554,0.00039394377,0.000026044107,0.000082824095,0.0010203593],"genre_scores_gemma":[0.99696887,0.00024045448,0.000186519,0.00031458365,0.000054050026,0.00004149203,0.0005500968,0.00003390866,0.0016100485],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998168,0.00022915265,0.00061626564,0.0005021259,0.000054370346,0.0004300866],"domain_scores_gemma":[0.99929297,0.00019116735,0.0002140621,0.0001887035,0.00006780097,0.000045276214],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017448678,0.0002857749,0.000418134,0.00013067707,0.00013107815,0.00003822729,0.00011899809,0.00022349329,0.00034874023],"category_scores_gemma":[0.000050830844,0.00028439204,0.00009315575,0.00021709893,0.000082104016,0.00016479402,0.000106516934,0.00048365415,0.00015701396],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012907311,0.0011983663,0.0046741706,0.000097253745,0.00005898875,0.000025826961,0.00050407025,0.000012286728,0.991585,0.000004844653,0.00036251292,0.00018593794],"study_design_scores_gemma":[0.006930866,0.000546815,0.003575822,0.00003745693,0.00009170665,0.000049373157,0.0008531645,0.000023206987,0.9857861,0.000018647996,0.0017885104,0.00029832075],"about_ca_topic_score_codex":0.000111366644,"about_ca_topic_score_gemma":0.000017131993,"teacher_disagreement_score":0.0057989005,"about_ca_system_score_codex":0.00002355604,"about_ca_system_score_gemma":0.000041875683,"threshold_uncertainty_score":0.99996084},"labels":[],"label_agreement":null},{"id":"W3097549198","doi":"10.1182/blood-2020-136190","title":"Frequency and Prognostic Significance of Recurrent Gene Mutations in Pediatric B-ALL: Report from the DFCI ALL Consortium","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Centre Hospitalier Universitaire Sainte-Justine; McMaster University; Centre hospitalier universitaire de Québec; McMaster Children's Hospital","funders":"","keywords":"KRAS; Neuroblastoma RAS viral oncogene homolog; Medicine; Oncology; CDKN2A; Cancer research; PTEN; Internal medicine; Cancer; Biology; Genetics; PI3K/AKT/mTOR pathway","score_opus":0.03462631082380529,"score_gpt":0.29219463056538864,"score_spread":0.25756831974158334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097549198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926693,0.0020721934,0.00016822536,0.0038436167,0.00004457622,0.00079558365,0.00006196569,0.000028561815,0.00031597863],"genre_scores_gemma":[0.99654794,0.00033528,0.0023210642,0.00035090678,0.00023383049,0.00007896585,0.00009833057,0.000017336844,0.000016363634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985957,0.00007485192,0.0004371484,0.00031745093,0.00036033583,0.00021448953],"domain_scores_gemma":[0.9986664,0.0006622378,0.0001438159,0.00025143658,0.000112373746,0.00016373412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018890618,0.00011066005,0.00023820791,0.00004654217,0.000022358701,0.000010746114,0.00012068408,0.00006284874,0.00003932019],"category_scores_gemma":[0.0022654433,0.00008054478,0.00003847054,0.00032263284,0.00011620471,0.000036162983,0.00006319131,0.0002274933,0.000012638265],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008074737,0.00054913154,0.9697209,0.00018392171,0.00016158934,0.001897043,0.0018978897,0.0000054716847,0.023740787,0.000040600655,0.0012821694,0.00043971918],"study_design_scores_gemma":[0.008728022,0.0006468649,0.97289044,0.00009799684,0.0014474312,0.00039746755,0.00032562917,0.0008299293,0.013444436,0.0005762357,0.00036758228,0.0002479961],"about_ca_topic_score_codex":0.00032177402,"about_ca_topic_score_gemma":0.000037128902,"teacher_disagreement_score":0.01029635,"about_ca_system_score_codex":0.000048409613,"about_ca_system_score_gemma":0.0006965577,"threshold_uncertainty_score":0.32845205},"labels":[],"label_agreement":null},{"id":"W3097577984","doi":"10.1182/blood-2020-137582","title":"Reduction in Absolute Involved Free Light Chain and Difference between Involved and Uninvolved Free Light Chain Is Associated with Prolonged Major Organ Deterioration Progression-Free Survival in Patients with Newly Diagnosed AL Amyloidosis Receiving Bortezomib, Cyclophosphamide, and Dexamethasone with or without Daratumumab: Results from Andromeda","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"AL amyloidosis; Immunoglobulin light chain; Progression-free survival; Medicine; Internal medicine; Multiple myeloma; Amyloidosis; Cyclophosphamide; Gastroenterology; Bortezomib; Dexamethasone; Immunology; Chemotherapy; Antibody","score_opus":0.011571571942733713,"score_gpt":0.22217434073725684,"score_spread":0.2106027687945231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097577984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944053,0.00080800476,0.000016830543,0.0022020761,0.0000387655,0.001953474,0.00049648585,0.00007049186,0.0000085594065],"genre_scores_gemma":[0.9951477,0.0004558285,0.002783885,0.00020618495,0.00007756871,0.0003220452,0.0008725574,0.00011308662,0.00002111866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99638826,0.00028949024,0.0006952175,0.0015031364,0.00053215853,0.00059176865],"domain_scores_gemma":[0.99777436,0.00019510134,0.0006392689,0.00084751693,0.00018288342,0.00036083904],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037369388,0.00070773717,0.0009660301,0.00017005012,0.00021050795,0.0001611737,0.00039504838,0.000417039,0.0000035634212],"category_scores_gemma":[0.0010220816,0.0005144786,0.000036028418,0.0006686415,0.00025668734,0.000087237466,0.00044110263,0.00036615625,2.7863413e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004659726,0.00062507,0.9789733,0.00004911472,0.0005093382,0.000053550044,0.0021435306,9.3384295e-7,0.011900636,5.4671955e-7,0.000088992565,0.0009952593],"study_design_scores_gemma":[0.049370542,0.0038326776,0.91255116,0.0007186153,0.00035732452,0.0000024529782,0.0005149002,0.000046171685,0.031872135,0.00002019236,0.000015067184,0.00069872977],"about_ca_topic_score_codex":0.00081897853,"about_ca_topic_score_gemma":0.024558343,"teacher_disagreement_score":0.06642211,"about_ca_system_score_codex":0.000079399644,"about_ca_system_score_gemma":0.00017267012,"threshold_uncertainty_score":0.9997307},"labels":[],"label_agreement":null},{"id":"W3097583629","doi":"10.1182/blood-2020-141996","title":"Thrombotic Complications in a Canadian Population of Critically Ill Patients with COVID-19","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Medicine; Intensive care unit; Thrombosis; Population; Pulmonary embolism; Venous thrombosis; Retrospective cohort study; Intensive care; Internal medicine; Emergency medicine; Intensive care medicine","score_opus":0.06235507988132449,"score_gpt":0.4007030499938392,"score_spread":0.3383479701125147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097583629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8917438,0.000024238763,0.00024967527,0.106443554,0.000008701059,0.0007852382,0.00008128777,0.00002843712,0.0006350601],"genre_scores_gemma":[0.97429454,0.000007110029,0.0005880862,0.024999468,0.000017130465,0.000021575424,0.000057503392,0.000008722504,0.0000058663427],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990158,0.000038400416,0.00024464965,0.00019655567,0.00027307766,0.00023152887],"domain_scores_gemma":[0.997644,0.00087055186,0.000032801152,0.00017931426,0.0005141785,0.0007591587],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00011174762,0.000068659836,0.00023134594,0.000088580244,0.00004615242,0.000004439866,0.000075620526,0.00003724069,0.000058061134],"category_scores_gemma":[0.056996305,0.000056375113,0.000030687374,0.00033736313,0.00009999036,0.00002867915,0.000034002085,0.00013427428,0.000012682483],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042352553,0.0004077184,0.99817884,0.00028852074,0.000036880923,0.000012330322,0.00022736368,0.00003184956,0.000027682036,0.0005072465,0.000105585015,0.00013361263],"study_design_scores_gemma":[0.002855451,0.00045029144,0.99518985,0.0000515467,0.00006495311,2.0170219e-7,0.00003056887,0.00021293471,0.0000073434667,0.00015473188,0.0009266321,0.00005548568],"about_ca_topic_score_codex":0.120817676,"about_ca_topic_score_gemma":0.09028849,"teacher_disagreement_score":0.082550734,"about_ca_system_score_codex":0.00012700337,"about_ca_system_score_gemma":0.0007416706,"threshold_uncertainty_score":0.950947},"labels":[],"label_agreement":null},{"id":"W3097588851","doi":"10.1182/blood-2020-136730","title":"A Matching-Adjusted Indirect Comparison of Efficacy Outcomes for Idecabtagene Vicleucel (ide-cel, bb2121), a Bcma-Directed CAR T Cell Therapy Versus Conventional Care in Triple-Class-Exposed Relapsed and Refractory Multiple Myeloma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Medicine; Internal medicine; Population; Progression-free survival; Oncology; Immunology; Chemotherapy","score_opus":0.06832235787039867,"score_gpt":0.3291427218745771,"score_spread":0.2608203640041784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097588851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99269426,0.0032833861,0.00001772442,0.00035685732,0.00019000334,0.002650125,0.00014612812,0.00019435523,0.00046716427],"genre_scores_gemma":[0.9973251,0.00018072367,0.0012479845,0.00016195186,0.000115930634,0.00015175805,0.00033156495,0.0001042337,0.0003807417],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969928,0.00027416492,0.00086491543,0.00066857034,0.00068337354,0.000516166],"domain_scores_gemma":[0.99739295,0.0012270984,0.0003126217,0.00041831812,0.00031051497,0.00033848867],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033487153,0.00039098292,0.0012397702,0.00033109632,0.000103762424,0.00003206803,0.00023942397,0.00028446218,0.00029280674],"category_scores_gemma":[0.00048907154,0.00036760105,0.00033410254,0.00059566286,0.00013204069,0.00008951724,0.00008317593,0.0005456489,0.000009206936],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023391947,0.0025815507,0.120466776,0.0005909297,0.0006686778,0.000055782144,0.011022259,0.000014350194,0.83417326,0.0000063643606,0.00027110468,0.006757012],"study_design_scores_gemma":[0.2150449,0.0061839023,0.23738015,0.00018937168,0.00037356175,0.000007809994,0.0037880384,0.0012043781,0.53095627,0.000010048328,0.004297981,0.00056358555],"about_ca_topic_score_codex":0.00016302978,"about_ca_topic_score_gemma":0.00021282467,"teacher_disagreement_score":0.30321696,"about_ca_system_score_codex":0.00013229967,"about_ca_system_score_gemma":0.0003379445,"threshold_uncertainty_score":0.9998776},"labels":[],"label_agreement":null},{"id":"W3097593597","doi":"10.1182/blood-2020-140651","title":"Plasmablastic Lymphoma: Synergism between<i>Wnt/B-Catenin</i>and the<i>RAS S</i>ignalling Molecules May Identify Potential Targets for Therapy","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Wnt signaling pathway; Cancer research; Lymphoma; Diffuse large B-cell lymphoma; Biology; Catenin; Carcinogenesis; B-cell lymphoma; Cancer; Gene; Immunology; Genetics","score_opus":0.016295401170209476,"score_gpt":0.23624756558936147,"score_spread":0.219952164419152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097593597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9787642,0.0054769404,0.013539791,0.0011534797,0.000115993804,0.00063382636,0.000099961886,0.0000388718,0.00017697866],"genre_scores_gemma":[0.9961451,0.0006112118,0.001072563,0.0008446525,0.0009029633,0.00013035824,0.00014457425,0.000050669558,0.00009785453],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99863863,0.000101230136,0.00027539802,0.00047381298,0.0001601396,0.00035077572],"domain_scores_gemma":[0.9994194,0.00006421906,0.000121739286,0.00016919737,0.00007326828,0.00015219982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023375511,0.00024968822,0.00026746205,0.000022286575,0.00022453646,0.00008610191,0.00028835534,0.0001674403,0.00001070247],"category_scores_gemma":[0.0001139586,0.00019189945,0.00019528718,0.000066991284,0.00017052959,0.0000058658457,0.00013345985,0.00008445172,0.000012642586],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000631077,0.00010680363,0.00038340598,0.00007270003,0.00044203724,0.000013592038,0.00022900337,0.00008291053,0.9952124,0.00049247936,0.0003619935,0.0019716206],"study_design_scores_gemma":[0.01003285,0.00036432056,0.0004308891,0.000016663822,0.00017282424,0.00002407356,0.00004475388,0.00025950943,0.9805811,0.0006849554,0.0070832106,0.00030483483],"about_ca_topic_score_codex":0.000010745857,"about_ca_topic_score_gemma":0.0000015514104,"teacher_disagreement_score":0.017380996,"about_ca_system_score_codex":0.0000028760933,"about_ca_system_score_gemma":0.000059827977,"threshold_uncertainty_score":0.78254324},"labels":[],"label_agreement":null},{"id":"W3097600052","doi":"10.1182/blood-2020-134730","title":"Cranial Radiation Can be Eliminated in Most Children with T-Cell Acute Lymphoblastic Leukemia (T-ALL) and Bortezomib Potentially Improves Survival in Children with T-Cell Lymphoblastic Lymphoma (T-LL): Results of Children's Oncology Group (COG) Trial AALL1231","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children; Stollery Children's Hospital; University of Alberta","funders":"","keywords":"Medicine; Bortezomib; Cog; Internal medicine; Minimal residual disease; Neutropenia; Phases of clinical research; Dexamethasone; Surgery; Interim analysis; Gastroenterology; Oncology; Leukemia; Clinical trial; Multiple myeloma; Chemotherapy","score_opus":0.007954268509196992,"score_gpt":0.22988041957606498,"score_spread":0.22192615106686797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097600052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927407,0.00022269269,0.00018314617,0.0006394481,0.00010632013,0.0049341936,0.0006390178,0.00014663233,0.00038784996],"genre_scores_gemma":[0.9953258,0.00034332063,0.0012035235,0.0004998477,0.00051898527,0.00017542296,0.0016470387,0.00023119354,0.00005483794],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9928954,0.00050260965,0.0017458152,0.0018519524,0.0015102193,0.0014939638],"domain_scores_gemma":[0.99663126,0.0005216313,0.00087134476,0.00078941777,0.00027821297,0.0009081259],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006970974,0.0010359496,0.0019325651,0.0008121613,0.00014022547,0.000103337,0.00068316836,0.00074067235,0.000019628656],"category_scores_gemma":[0.0004894035,0.000874391,0.00016854571,0.001827392,0.0006426644,0.00030418605,0.00035833876,0.0006607602,0.0000092466],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48455513,0.016266989,0.3125951,0.00053359004,0.006757111,0.0024962944,0.0042800354,0.001134817,0.15443255,0.00005275718,0.000540675,0.01635495],"study_design_scores_gemma":[0.5207919,0.019581256,0.43687916,0.00020023016,0.0025989772,0.0010944968,0.00015076005,0.002467249,0.015306509,0.000005831779,0.000013464309,0.00091019494],"about_ca_topic_score_codex":0.007339006,"about_ca_topic_score_gemma":0.0016317328,"teacher_disagreement_score":0.13912605,"about_ca_system_score_codex":0.0016623347,"about_ca_system_score_gemma":0.006124885,"threshold_uncertainty_score":0.99950945},"labels":[],"label_agreement":null},{"id":"W3097603276","doi":"10.1182/blood-2020-138700","title":"Autologous Stem Cell Transplantation (ASCT) for T-Cell Non Hodgkin Lymphoma (T-NHL) Patients Who Achieve Complete Remission with First-Line Treatment: A Systematic Review and Meta-Analysis","year":2020,"lang":"en","type":"review","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Oncology; Internal medicine; Autologous stem-cell transplantation; Hazard ratio; Transplantation; Meta-analysis; Chemotherapy regimen; Progression-free survival; Surgery; Chemotherapy; Confidence interval","score_opus":0.07641804720976893,"score_gpt":0.3250659612966761,"score_spread":0.24864791408690717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097603276","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006324951,0.9809986,0.00032795296,0.00013764098,0.000013336789,0.016974308,0.001146258,0.00006144044,0.00027726014],"genre_scores_gemma":[0.00016226259,0.98997617,0.0004262957,0.00012174165,0.000040072453,0.0028236757,0.002372889,0.00015645652,0.003920421],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9955326,0.00064475276,0.0015500062,0.0011122591,0.00068495446,0.00047547894],"domain_scores_gemma":[0.99646443,0.0008290607,0.0010864198,0.0009794517,0.00024441385,0.00039625086],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004968626,0.0009895611,0.011707206,0.00038363982,0.00015845914,0.00006035226,0.00027228345,0.00032193217,0.00016898103],"category_scores_gemma":[0.000030284125,0.00056523405,0.0027433382,0.0010496401,0.000054508637,0.000057265515,0.000037770096,0.00021768709,0.000024764775],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021785598,0.0010438827,0.0000051242496,0.9013417,0.07949372,0.00012929893,0.00018927486,7.594153e-7,0.0000035369073,5.875568e-7,0.0000344301,0.017539881],"study_design_scores_gemma":[0.0061168587,0.003994501,0.0000037309348,0.046206877,0.91248435,0.00016426187,0.00000809081,0.00007157295,0.00004271936,9.83799e-7,0.030437117,0.0004689266],"about_ca_topic_score_codex":0.000040877425,"about_ca_topic_score_gemma":0.00004082657,"teacher_disagreement_score":0.8551348,"about_ca_system_score_codex":0.00023688823,"about_ca_system_score_gemma":0.0003341476,"threshold_uncertainty_score":0.9996799},"labels":[],"label_agreement":null},{"id":"W3097608653","doi":"10.1182/blood-2020-134545","title":"Validation Study of the Heavy Menstrual Bleeding Questionnaire in Adolescents","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Menstrual Health and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; CancerCare Manitoba; Hospital for Sick Children; Izaak Walton Killam Health Centre","funders":"","keywords":"Medicine; Quality of life (healthcare); Menstrual bleeding; Menstrual cycle; Informed consent; Pediatrics; Gynecology; Internal medicine; Alternative medicine","score_opus":0.029828196399959,"score_gpt":0.29865209195613385,"score_spread":0.26882389555617486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097608653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982075,0.000088007335,0.000004800473,0.0009041301,0.000077423734,0.00052063295,7.3118593e-7,0.000016081764,0.00018070721],"genre_scores_gemma":[0.9994598,0.0000036433948,0.000015551856,0.00044690818,0.00005637032,0.000007287746,9.541175e-7,0.0000058928754,0.000003617331],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99930304,0.00004830088,0.00021638628,0.00011783775,0.00020323078,0.000111202884],"domain_scores_gemma":[0.999718,0.0000039378324,0.000058108977,0.00010075439,0.000031257383,0.00008794431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009404823,0.00005698817,0.00012931143,0.000027305463,0.000031884516,0.0000027331441,0.0000486946,0.000031112995,0.0000058080927],"category_scores_gemma":[0.00012560541,0.00004164135,0.00002076186,0.00022054093,0.000015292475,0.000026292984,0.000024723144,0.00011323738,0.000004014915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000107082014,0.00105792,0.99388397,0.00029378512,0.0000083615,0.000003747656,0.0030759575,0.0000074802592,0.00059089466,0.0000173461,0.00001769485,0.000935778],"study_design_scores_gemma":[0.0089031495,0.0009495926,0.9831285,0.0006715901,0.00008462821,0.0000061223222,0.0031455846,0.00014390491,0.0028761553,0.000022079337,0.000009713001,0.0000589902],"about_ca_topic_score_codex":0.00017617847,"about_ca_topic_score_gemma":0.000045197965,"teacher_disagreement_score":0.010755463,"about_ca_system_score_codex":0.000010700296,"about_ca_system_score_gemma":0.00006689713,"threshold_uncertainty_score":0.16980849},"labels":[],"label_agreement":null},{"id":"W3097627722","doi":"10.1182/blood-2020-136622","title":"Haploidentical Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide in Patients with Myelofibrosis: A Multi-Institutional Experience","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Myelofibrosis; Internal medicine; Transplantation; Univariate analysis; Fludarabine; Graft-versus-host disease; Cyclophosphamide; Gastroenterology; Surgery; Oncology; Bone marrow; Chemotherapy; Multivariate analysis","score_opus":0.009634928572227752,"score_gpt":0.21735753878847927,"score_spread":0.20772261021625152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097627722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973183,0.00017699882,0.0009280017,0.00047655054,0.00001987817,0.00087645766,0.00007419549,0.000051109248,0.00007846495],"genre_scores_gemma":[0.99345845,0.00010177921,0.0052118464,0.0006839427,0.000023242928,0.00024475262,0.00024112251,0.00002527993,0.000009574292],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848896,0.000030264486,0.00028530217,0.00045883984,0.0004521844,0.00028441966],"domain_scores_gemma":[0.99940383,0.000038260012,0.000058079193,0.00013649098,0.00010787377,0.0002554351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000028771692,0.0002734829,0.0003494199,0.000058924663,0.00008446035,0.00002436792,0.00007203984,0.00007020919,0.00005799719],"category_scores_gemma":[0.000010550856,0.00017625152,0.000056047265,0.000215316,0.00010505047,0.00012646268,0.000008830107,0.00013985447,0.000031741933],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016648904,0.0033941711,0.98774916,0.00024467727,0.000090812035,0.000618015,0.004451596,0.000047003883,0.0016041959,0.000075549666,0.000001498726,0.000058439502],"study_design_scores_gemma":[0.017043915,0.0018335904,0.9353522,0.0004238626,0.00036409352,0.000074591524,0.00015223592,0.000013995112,0.044512853,0.0000010374149,0.000013120133,0.00021450993],"about_ca_topic_score_codex":0.00004380514,"about_ca_topic_score_gemma":0.00008655223,"teacher_disagreement_score":0.052396953,"about_ca_system_score_codex":0.000034617344,"about_ca_system_score_gemma":0.00013640677,"threshold_uncertainty_score":0.71873283},"labels":[],"label_agreement":null},{"id":"W3097634875","doi":"10.1182/blood-2020-139031","title":"Naïve Helper T-Cell and Regulatory T- and NK-Cell Subsets Are Associated with Pediatric Chronic Graft-Versus-Host Disease: Results of the ABLE / PBMTC 1202 Study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Hospital for Sick Children; Alberta Children's Hospital; McGill University; University of Calgary; Centre Hospitalier Universitaire Sainte-Justine; Montreal Children's Hospital; University of Manitoba; BC Children's Hospital; CancerCare Manitoba","funders":"","keywords":"Medicine; Graft-versus-host disease; Hematopoietic stem cell transplantation; Biomarker; Immunology; Immune system; Internal medicine; Disease; Biology","score_opus":0.013768880720987219,"score_gpt":0.2152552996595489,"score_spread":0.20148641893856167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097634875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949073,0.0029785912,0.0000017126024,0.000340987,0.000053216056,0.0010110143,0.000112236776,0.000045158224,0.0005497409],"genre_scores_gemma":[0.99918187,0.0002692055,0.000021235881,0.000058000263,0.000092696064,0.000018280101,0.000028939881,0.00003434152,0.00029544515],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984849,0.000110217734,0.00031705844,0.00039754735,0.00046709608,0.00022315193],"domain_scores_gemma":[0.9989002,0.00018299987,0.00027959837,0.00029599812,0.000094733026,0.000246467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019766827,0.00019721937,0.00033268353,0.000046647663,0.00008896036,0.00001601005,0.00008984822,0.00007772763,0.000015061106],"category_scores_gemma":[0.00011526761,0.00013904968,0.0000461531,0.00034068743,0.00007759687,0.000054015916,0.000041275976,0.00017873135,0.0000052140645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001988853,0.002320254,0.97813815,0.0023086257,0.00025971184,0.00023450844,0.00445437,0.000011152849,0.009681797,0.000004995865,0.0005844364,0.000013158445],"study_design_scores_gemma":[0.041749362,0.0014870084,0.93598014,0.00028369715,0.0031333368,0.000008992813,0.0015613715,0.00006681908,0.015457383,0.0000023852563,0.000032942175,0.00023655045],"about_ca_topic_score_codex":0.000019775413,"about_ca_topic_score_gemma":0.000059993512,"teacher_disagreement_score":0.042157985,"about_ca_system_score_codex":0.00002941216,"about_ca_system_score_gemma":0.00019411762,"threshold_uncertainty_score":0.56702816},"labels":[],"label_agreement":null},{"id":"W3097644161","doi":"10.1182/blood-2020-137183","title":"Selinexor in Combination with Carfilzomib and Dexamethasone, All Once Weekly (SKd), for Patients with Relapsed/Refractory Multiple Myeloma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; Hôpital Maisonneuve-Rosemont; CancerCare Manitoba; Vancouver General Hospital; Princess Margaret Cancer Centre; Dalhousie University; University of Alberta; Université de Montréal; Queen Elizabeth II Health Sciences Centre; Institute of Cancer Research; University of Calgary","funders":"","keywords":"Carfilzomib; Medicine; Bortezomib; Dexamethasone; Internal medicine; Multiple myeloma; Adverse effect; Refractory (planetary science); Neutropenia; Oncology; Lenalidomide; Proteasome inhibitor; Pharmacology; Cancer research; Gastroenterology; Toxicity; Materials science","score_opus":0.022807597408235573,"score_gpt":0.2645409406002516,"score_spread":0.241733343192016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097644161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966731,0.00019402559,0.0002502807,0.0009030792,0.000013812576,0.001737986,0.000065592,0.000049932296,0.000112196656],"genre_scores_gemma":[0.98846847,0.00003418646,0.010599463,0.00027963053,0.000041849722,0.00017848187,0.0002710876,0.000041821346,0.0000850125],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986737,0.0000487267,0.00019944874,0.00040124942,0.00034610069,0.00033082525],"domain_scores_gemma":[0.9989879,0.00025112016,0.000082151935,0.00017873893,0.00018911634,0.00031096887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000088828994,0.00019461234,0.00031184845,0.00008824723,0.000055527704,0.000021839855,0.00006599585,0.00007681083,0.000009390557],"category_scores_gemma":[0.00037110693,0.00013732366,0.0000300842,0.00019631271,0.000062177,0.00014020168,0.000031529067,0.00018706548,0.000006645211],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004577539,0.0025463488,0.98388445,0.00019318286,0.00025124106,0.000093245275,0.00057538063,0.000003157277,0.00075799087,0.000016137068,0.00010923394,0.0069920756],"study_design_scores_gemma":[0.09388413,0.00861072,0.8918624,0.00017289435,0.0002086029,0.00001128622,0.00015292667,0.0014041378,0.0021846239,0.000012927655,0.0012813773,0.00021396262],"about_ca_topic_score_codex":0.00010700431,"about_ca_topic_score_gemma":0.00017934472,"teacher_disagreement_score":0.09202206,"about_ca_system_score_codex":0.00004767514,"about_ca_system_score_gemma":0.00010697593,"threshold_uncertainty_score":0.5599896},"labels":[],"label_agreement":null},{"id":"W3097649246","doi":"10.1182/blood-2020-135935","title":"Prognostication for Advanced Stage Hodgkin Lymphoma (HL) in the Modern Era: A Project from the Hodgkin Lymphoma International Study for Individual Care (HoLISTIC) Consortium","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Hodgkin lymphoma; Lymphoma; Medicine; Stage (stratigraphy); Internal medicine; Oncology; Biology","score_opus":0.06775973462447611,"score_gpt":0.33323942319489197,"score_spread":0.2654796885704159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097649246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98328996,0.0007416192,0.00042325337,0.0041745505,0.00014882052,0.008964252,0.002003177,0.000064156724,0.00019021495],"genre_scores_gemma":[0.9876514,0.000026941885,0.0022754052,0.0016143327,0.00041826544,0.006756708,0.0011953055,0.000039554074,0.000022076287],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99809295,0.00011809246,0.0004352189,0.0005577847,0.0004889862,0.0003069796],"domain_scores_gemma":[0.9981488,0.0009963156,0.00018438861,0.00038416838,0.00021291156,0.000073428964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023189756,0.00026974385,0.00035067258,0.000057980113,0.00015852704,0.000119275486,0.00040220696,0.00008079207,0.000008090883],"category_scores_gemma":[0.0008356984,0.0001631343,0.00015478166,0.00019346813,0.000052632986,0.000093129354,0.000085385254,0.000059628157,0.000005214566],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003398127,0.018133521,0.689067,0.00021916443,0.0022213364,0.00020298164,0.09080316,0.000043539847,0.00040658028,0.001233742,0.0020664968,0.19220433],"study_design_scores_gemma":[0.076407194,0.0036883731,0.87627786,0.00014461664,0.0021613042,0.000023670504,0.029774863,0.0017690639,0.002776802,0.0003322804,0.0062749344,0.00036905694],"about_ca_topic_score_codex":0.00032897436,"about_ca_topic_score_gemma":0.00028767632,"teacher_disagreement_score":0.19183527,"about_ca_system_score_codex":0.00013567884,"about_ca_system_score_gemma":0.00042531002,"threshold_uncertainty_score":0.6652424},"labels":[],"label_agreement":null},{"id":"W3097655634","doi":"10.1182/blood-2020-135868","title":"Safety and Efficacy of Idasanutlin in Patients (pts) with Hydroxyurea (HU)-Resistant/Intolerant Polycythemia Vera (PV): Results of an International Phase II Study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Princess Margaret Cancer Centre","funders":"","keywords":"Polycythemia vera; Medicine; Internal medicine; Maximum tolerated dose; Phases of clinical research; Gastroenterology; Adverse effect; Clinical trial","score_opus":0.012919549952461046,"score_gpt":0.2745294814535199,"score_spread":0.2616099315010589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097655634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977759,0.000049465267,0.0000028431805,0.00042281527,0.000021316097,0.00094339653,0.00021802985,0.000014202945,0.0005519903],"genre_scores_gemma":[0.99934167,0.000026956452,0.00031356307,0.00007606617,0.00004482575,0.00001988628,0.0001483066,0.000016404932,0.000012325521],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848306,0.000058928195,0.0005526946,0.0003583288,0.0004097487,0.00013721157],"domain_scores_gemma":[0.99922305,0.000086165914,0.00019754093,0.00022116843,0.00011937596,0.00015269806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001225147,0.00018142238,0.00047757282,0.000090400354,0.00003754502,0.000007572453,0.00008828463,0.00004435035,0.000029336612],"category_scores_gemma":[0.00013018512,0.00013228947,0.000040166055,0.00016660633,0.000055128072,0.00007814074,0.000056152145,0.000114030394,0.0000010696369],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06712721,0.07943507,0.8288434,0.00008646489,0.0010821694,0.00021471099,0.011800208,0.000035081084,0.0028226094,0.00005884356,0.000030688847,0.008463515],"study_design_scores_gemma":[0.17643349,0.034314245,0.76588994,0.0002278011,0.00034759296,0.000003857155,0.0003012204,0.00019008938,0.022011764,0.0000023888383,0.00014025407,0.00013735091],"about_ca_topic_score_codex":0.00012183221,"about_ca_topic_score_gemma":0.00007166113,"teacher_disagreement_score":0.10930628,"about_ca_system_score_codex":0.000028219854,"about_ca_system_score_gemma":0.000065799635,"threshold_uncertainty_score":0.5394608},"labels":[],"label_agreement":null},{"id":"W3097675294","doi":"10.1182/blood-2020-136019","title":"A Retrospective Review of the Appropriateness of D-Dimer Ordering and Interpretation Using Wells' Clinical Probability Criteria","year":2020,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute of Health Economics; University of Alberta","funders":"","keywords":"Medicine; Pre- and post-test probability; Pulmonary embolism; Deep vein; Venous thromboembolism; D-dimer; Retrospective cohort study; Specialty; Appropriate Use Criteria; Thrombosis; Emergency medicine; Internal medicine; Pediatrics; Surgery; Family medicine","score_opus":0.07883311786483392,"score_gpt":0.3933105388988608,"score_spread":0.31447742103402687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097675294","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016351959,0.9949699,0.000039971314,0.000088133405,0.00019724452,0.0027282613,0.000016683094,0.000012147129,0.0003124496],"genre_scores_gemma":[0.002041618,0.99666566,0.000967644,0.00013660298,0.00009189397,0.0000545831,0.000009107927,0.000029152741,0.0000037669427],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.997772,0.0003371935,0.001155699,0.00039296452,0.00022728853,0.00011487284],"domain_scores_gemma":[0.99841803,0.00006786013,0.00082678196,0.00046982072,0.00016206794,0.00005541341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079243723,0.00022160869,0.0029225233,0.00003798752,0.00002571588,0.000006946499,0.00014722288,0.00013492926,0.00003497643],"category_scores_gemma":[0.00073285616,0.0001392045,0.0005206678,0.000293279,0.00013985767,0.000029749965,0.0002738733,0.0002715017,0.0000011596806],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013210744,0.0012404234,0.0009203476,0.7232948,0.001309963,0.0000050413255,0.0001762338,8.022654e-8,0.00000744321,0.00017052326,0.00008447182,0.27277747],"study_design_scores_gemma":[0.0012910331,0.00062033196,0.00697478,0.79687446,0.03661191,0.00006236196,0.000030211173,0.00006425882,0.00003241353,0.00024283056,0.15679696,0.00039846855],"about_ca_topic_score_codex":0.000036365844,"about_ca_topic_score_gemma":0.0000017615153,"teacher_disagreement_score":0.272379,"about_ca_system_score_codex":0.000037057533,"about_ca_system_score_gemma":0.00022793029,"threshold_uncertainty_score":0.56765944},"labels":[],"label_agreement":null},{"id":"W3097677520","doi":"10.1182/blood-2020-135880","title":"Momelotinib's Spleen, Symptom and Anemia Efficacy Is Maintained in Intermediate/High Risk Myelofibrosis Patients with Thrombocytopenia","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sierra Wireless (Canada)","funders":"","keywords":"Myelofibrosis; Medicine; Anemia; Spleen; Romiplostim; Splenectomy; Internal medicine; Gastroenterology; Thrombopoietin; Bone marrow; Haematopoiesis","score_opus":0.007611426859306224,"score_gpt":0.21804324498162156,"score_spread":0.21043181812231534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097677520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99660003,0.00011259369,0.000007977176,0.0018108343,0.000032733933,0.0010499939,0.0001221919,0.000061103936,0.0002025198],"genre_scores_gemma":[0.99714804,0.00023310335,0.0010086466,0.0012351477,0.00009833785,0.00008357678,0.00012708463,0.000045286426,0.000020785112],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983439,0.00006751367,0.0003468776,0.00057917123,0.000315409,0.00034713544],"domain_scores_gemma":[0.99902415,0.00015685447,0.00013642223,0.00025066675,0.000089171845,0.00034273852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007046022,0.0003227568,0.0006432096,0.00009059642,0.00007646618,0.000044782133,0.000088308065,0.00010339701,0.00023934418],"category_scores_gemma":[0.00012878962,0.00023044898,0.000058748778,0.00029099378,0.000089992405,0.00009589425,0.00009606439,0.00024316079,0.00006325017],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060933275,0.0015275679,0.9935088,0.000088409615,0.0002538093,0.0000976136,0.0017813345,0.0000017933446,0.00009840868,0.000059900383,0.00029274853,0.0016802514],"study_design_scores_gemma":[0.02672047,0.0031639887,0.96158093,0.00020191497,0.0004943286,0.0000079298725,0.00009628939,0.000025332085,0.007269392,0.000019061854,0.00018628074,0.00023410808],"about_ca_topic_score_codex":0.00014694929,"about_ca_topic_score_gemma":0.000050222607,"teacher_disagreement_score":0.031927925,"about_ca_system_score_codex":0.000047763577,"about_ca_system_score_gemma":0.00007159924,"threshold_uncertainty_score":0.93974364},"labels":[],"label_agreement":null},{"id":"W3097681321","doi":"10.1182/blood-2020-136957","title":"Ivosidenib Improves Overall Survival Relative to Standard Therapies in Relapsed or Refractory Mutant <i>IDH1</i> AML: Results from Matched Comparisons to Historical Controls","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Medicine; Regimen; Internal medicine; Refractory (planetary science); Isocitrate dehydrogenase; Oncology; Gastroenterology; Surgery; Biology","score_opus":0.041513464589884565,"score_gpt":0.29874770792655153,"score_spread":0.25723424333666695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097681321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9443031,0.00049924717,0.00055665686,0.050547563,0.00020868628,0.001833166,0.0005667012,0.00020267967,0.0012821958],"genre_scores_gemma":[0.98645455,0.0000755718,0.0071327314,0.00452245,0.00052284484,0.00011615699,0.00007368286,0.0000954472,0.0010065921],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99611706,0.0003540723,0.00093430426,0.000911674,0.0009946068,0.0006882666],"domain_scores_gemma":[0.99662733,0.001409242,0.0001759907,0.0006541834,0.00024127094,0.0008919817],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00051771326,0.00038673755,0.0012631107,0.00018403381,0.000089435496,0.000054949345,0.00037332397,0.0002664307,0.00011831356],"category_scores_gemma":[0.0036520176,0.0003052038,0.00015307606,0.0005887803,0.000067662426,0.00012876705,0.00023366394,0.0011276571,0.00019477132],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09055701,0.0011183565,0.0049527446,0.00006211344,0.00084088865,0.0017939905,0.022072904,0.000033009874,0.81622976,0.00018503697,0.061063804,0.0010903752],"study_design_scores_gemma":[0.21099155,0.02445077,0.09263406,0.0009976325,0.0010339672,0.000051655552,0.0066334377,0.0008732104,0.08690561,0.00046955756,0.5726244,0.0023341717],"about_ca_topic_score_codex":0.0024137408,"about_ca_topic_score_gemma":0.0006086247,"teacher_disagreement_score":0.72932416,"about_ca_system_score_codex":0.0015232522,"about_ca_system_score_gemma":0.0008279318,"threshold_uncertainty_score":0.99994},"labels":[],"label_agreement":null},{"id":"W3097691142","doi":"10.1182/blood-2020-140624","title":"Three-Dimensional Telomere Analysis Using Teloview® Technology Predicts the Response of Classic Hodgkin's Lymphoma Patients to First Line Therapy at Point of Diagnosis","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Ontario Genomics; McGill University; CancerCare Manitoba; Jewish General Hospital","funders":"","keywords":"ABVD; Dacarbazine; Medicine; Brentuximab vedotin; Internal medicine; Oncology; Vinblastine; Chemotherapy regimen; Chlorambucil; Lymphoma; Chemotherapy; Vincristine; Hodgkin lymphoma","score_opus":0.024747470936385484,"score_gpt":0.256083679106671,"score_spread":0.23133620817028552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097691142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900321,0.001762216,0.000020306776,0.007087687,0.00003681771,0.0008626233,0.00013990937,0.000039885494,0.000018487248],"genre_scores_gemma":[0.99774325,0.0002170207,0.0010078772,0.0008179918,0.00004422829,0.00010833789,0.000029136232,0.000026558657,0.000005596956],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982348,0.00007361633,0.0005478238,0.00040424088,0.00048263842,0.00025687122],"domain_scores_gemma":[0.99830455,0.00041734902,0.00028713295,0.0005595124,0.00025311633,0.00017837029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017764831,0.00024447445,0.0007272551,0.00032538196,0.00010173967,0.0000059841536,0.0001853033,0.00014158954,0.00012765407],"category_scores_gemma":[0.00039867047,0.00015262506,0.00032681657,0.0017150945,0.0001464174,0.00003204469,0.00020944749,0.000055392567,0.00001534718],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020581286,0.0039463863,0.9813021,0.000042549345,0.0025325764,0.000051809147,0.00036001345,0.00014278802,0.0021380985,0.000012724823,0.00041218722,0.0070006563],"study_design_scores_gemma":[0.00919459,0.0031092707,0.8528234,0.00016148831,0.002501929,0.000012722286,0.000037074464,0.00034807704,0.13093632,0.000018280154,0.0007191782,0.00013767224],"about_ca_topic_score_codex":0.00010388735,"about_ca_topic_score_gemma":0.00007945418,"teacher_disagreement_score":0.12879823,"about_ca_system_score_codex":0.000121433404,"about_ca_system_score_gemma":0.00013895068,"threshold_uncertainty_score":0.62238693},"labels":[],"label_agreement":null},{"id":"W3097698924","doi":"10.1182/blood-2020-142722","title":"The Incidence and Associated Risk Factors in Central Venous Catheter Associated Infectious Complications within the Autologous Stem Cell Transplant Population of Eastern Health","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Central Venous Catheters and Hemodialysis","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Population; Bacteremia; Central venous catheter; Neutropenia; Risk factor; Febrile neutropenia; Complication; Incidence (geometry); Surgery; Internal medicine; Intensive care medicine; Catheter; Chemotherapy; Antibiotics; Environmental health","score_opus":0.030049250002211602,"score_gpt":0.2910763809653182,"score_spread":0.2610271309631066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097698924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971701,0.00028789704,0.0000553342,0.001211522,0.000107426895,0.00083544356,0.00022222198,0.000059576116,0.00005051493],"genre_scores_gemma":[0.9992613,0.00025117295,0.0000059195727,0.00032000334,0.000022683776,0.000031418847,0.00007248457,0.000018357057,0.00001663216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997334,0.0010843278,0.00067815476,0.00022990006,0.00020519613,0.00046839914],"domain_scores_gemma":[0.9981395,0.000654975,0.00081395544,0.00019803192,0.000058761212,0.00013477707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006209714,0.00015116532,0.0003667994,0.00003692925,0.0010539218,0.00001680207,0.00018308483,0.00014062249,0.000003641402],"category_scores_gemma":[0.00009029409,0.00009530395,0.00008994475,0.00028247177,0.00006105394,0.00004748545,0.000041677853,0.00058667635,0.0000043625078],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017190336,0.0005831054,0.9446031,0.000038179558,0.00007039358,9.916238e-7,0.054218676,0.0001313753,0.00005426522,0.000048421247,0.000017080743,0.00021722727],"study_design_scores_gemma":[0.0010623449,0.0003433974,0.9943577,0.00007962453,0.0001315866,8.1563235e-7,0.0016833686,0.0020941237,0.000038189213,0.00008815685,0.000019071857,0.00010160093],"about_ca_topic_score_codex":0.010887808,"about_ca_topic_score_gemma":0.015050235,"teacher_disagreement_score":0.052535307,"about_ca_system_score_codex":0.00015064955,"about_ca_system_score_gemma":0.00016838979,"threshold_uncertainty_score":0.99569875},"labels":[],"label_agreement":null},{"id":"W3097738396","doi":"10.1182/blood.2020008824","title":"Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients","year":2020,"lang":"en","type":"review","venue":"Blood","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":659,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Malignancy; Relative risk; Hematologic malignancy; Confidence interval; Meta-analysis; Mechanical ventilation; Intensive care unit; Pediatrics","score_opus":0.13626888233971318,"score_gpt":0.4039075555849518,"score_spread":0.2676386732452386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097738396","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002969785,0.99343234,0.000006154261,0.0004978886,0.00000674721,0.004981054,0.00074811024,0.00002065284,0.0000100942125],"genre_scores_gemma":[0.001534814,0.9944769,0.000104971805,0.003393466,0.000002655551,0.0002112142,0.00021211432,0.000030849562,0.000032993503],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99661434,0.00035741724,0.0017497129,0.0004759234,0.00057857984,0.00022401512],"domain_scores_gemma":[0.9958418,0.0007596884,0.0019635104,0.0006323912,0.00031552478,0.0004870716],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00040604864,0.00051129435,0.016826242,0.00041548957,0.000038891845,0.000009813849,0.00014048566,0.0001766649,0.000059649527],"category_scores_gemma":[0.0034626184,0.00025872135,0.0012102146,0.0009762646,0.0001118425,0.000042030046,0.000106705585,0.00017349435,0.0000016434457],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006518031,0.0003016618,0.015708502,0.87457097,0.10915137,0.000013974797,0.00009075238,1.323514e-8,3.5527772e-9,0.000016507178,0.000033406235,0.00010631961],"study_design_scores_gemma":[0.0009218731,0.00047060498,0.0026374399,0.040067054,0.9523021,0.000014291479,0.000010299098,1.4829256e-7,1.3194686e-7,0.0000028272834,0.0033712033,0.00020200708],"about_ca_topic_score_codex":0.00006868676,"about_ca_topic_score_gemma":0.000025255453,"teacher_disagreement_score":0.84315073,"about_ca_system_score_codex":0.000049563423,"about_ca_system_score_gemma":0.00058186887,"threshold_uncertainty_score":0.9999865},"labels":[],"label_agreement":null},{"id":"W3097738629","doi":"10.1182/blood-2020-137754","title":"Targeted Deep Sequencing As a Clinically Effective Approach to Profile the Mutational Landscape in Multiple Myeloma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Nova Scotia Health Authority; Dalhousie University","funders":"","keywords":"KRAS; Multiple myeloma; Cancer research; Malignancy; Somatic evolution in cancer; Neuroblastoma RAS viral oncogene homolog; Exome sequencing; Deep sequencing; Mutation; Medicine; Exome; Indel; Biology; Oncology; Gene; Internal medicine; Genetics; Cancer; Single-nucleotide polymorphism; Genotype; Genome","score_opus":0.03417814561777288,"score_gpt":0.3039738596276435,"score_spread":0.2697957140098706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097738629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98947334,0.00012526564,0.00034638285,0.0012054172,0.000018423943,0.0023752798,0.000024983616,0.000060833027,0.006370065],"genre_scores_gemma":[0.9896888,0.000003175625,0.008185802,0.0010790706,0.00016183125,0.0006466731,0.00015302672,0.000022331371,0.000059303813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847966,0.00015580765,0.00026934576,0.00037203246,0.00039399145,0.0003291533],"domain_scores_gemma":[0.99886674,0.00047374243,0.000046487537,0.00018384437,0.00009515117,0.00033405836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025900928,0.00014566552,0.0002588195,0.00006886298,0.00008360703,0.000023578514,0.00012701678,0.0000715633,0.000092653],"category_scores_gemma":[0.0023313381,0.00009448001,0.00008650471,0.00042068964,0.00004055374,0.00004655079,0.000075501994,0.00029147507,0.00031922228],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037174702,0.0026189222,0.94252455,0.00024570758,0.0007925815,0.0011407277,0.00875075,0.00033716648,0.01747119,0.00012825991,0.00036098014,0.021911705],"study_design_scores_gemma":[0.02082416,0.002136802,0.9182895,0.00007346018,0.00013468061,0.00014253672,0.0014629827,0.04313691,0.013314929,0.00006582865,0.0001898339,0.00022842361],"about_ca_topic_score_codex":0.00007211742,"about_ca_topic_score_gemma":0.000022834147,"teacher_disagreement_score":0.04279974,"about_ca_system_score_codex":0.000048476937,"about_ca_system_score_gemma":0.0002094276,"threshold_uncertainty_score":0.41030627},"labels":[],"label_agreement":null},{"id":"W3097746180","doi":"10.1182/blood-2020-136607","title":"Investigational CD47-Blocker TTI-622 Shows Single-Agent Activity in Patients with Advanced Relapsed or Refractory Lymphoma: Update from the Ongoing First-in-Human Dose Escalation Study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Therapeutics (Canada)","funders":"","keywords":"CD47; Medicine; Pharmacodynamics; Tolerability; Pharmacology; Adverse effect; Internal medicine; Refractory (planetary science); Lymphoma; Pharmacokinetics; Immune system; Immunology; Oncology; Biology","score_opus":0.01970412747875858,"score_gpt":0.22331695551200867,"score_spread":0.2036128280332501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097746180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984036,0.00022270372,0.000012590259,0.00037664728,0.00011618348,0.0007684216,0.00003188733,0.000041128314,0.000026833366],"genre_scores_gemma":[0.9992699,0.000005826429,0.000072122566,0.0001854614,0.000028909537,0.000054978893,0.00033388307,0.000022264456,0.000026659833],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985498,0.00033629994,0.00036352925,0.0004086629,0.0001038367,0.00023786427],"domain_scores_gemma":[0.9992339,0.00018276118,0.00023252783,0.00027324655,0.000049664413,0.000027895552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015984241,0.00020714945,0.00028095793,0.000060921036,0.0002155761,0.000025141848,0.00018130256,0.00013408902,0.00011305726],"category_scores_gemma":[0.00012647285,0.00014402742,0.00004084857,0.00025274206,0.00008511439,0.0003125322,0.000093275914,0.00022568874,0.000028559152],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015722202,0.0056412853,0.86885685,0.000009492862,0.00019355105,0.0000062289214,0.0033353074,0.00018053081,0.11444302,0.000013499454,0.000091251844,0.005656781],"study_design_scores_gemma":[0.017595313,0.00096809765,0.96327424,0.00007518268,0.00006890246,6.637281e-7,0.00020421694,0.00003980007,0.01703431,0.000020237403,0.0005269039,0.00019215197],"about_ca_topic_score_codex":0.00014662577,"about_ca_topic_score_gemma":0.0009407265,"teacher_disagreement_score":0.09740871,"about_ca_system_score_codex":0.00010977471,"about_ca_system_score_gemma":0.00006995176,"threshold_uncertainty_score":0.58732677},"labels":[],"label_agreement":null},{"id":"W3097756286","doi":"10.1182/blood.v130.suppl_1.27.27","title":"Response Kinetics and Factors Predicting Survival Among Patients with Core Binding Factor (CBF) Acute Myeloid Leukemia (AML)","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Core binding factor; Myeloid leukemia; Medicine; Internal medicine; Leukemia; Oncology; Kinetics; Immunology; Cancer research; Biology; Transcription factor; Genetics","score_opus":0.028484602731934382,"score_gpt":0.28423748166622287,"score_spread":0.2557528789342885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097756286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979779,0.000023839024,0.000019145336,0.00012308291,0.0001715408,0.0007637512,0.0002372348,0.00012451349,0.0005589535],"genre_scores_gemma":[0.99792254,0.000036831792,0.00050969503,0.000028589386,0.00014450312,0.00001714241,0.00009959945,0.000099020464,0.0011421043],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974243,0.000100384015,0.0003371662,0.0005851212,0.000851933,0.0007010946],"domain_scores_gemma":[0.9975752,0.00036653472,0.00031341673,0.00097997,0.0002578995,0.0005069607],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035124514,0.0003761228,0.00052371185,0.00022578968,0.0006131744,0.00020539139,0.00038950003,0.00024801987,0.000049451937],"category_scores_gemma":[0.0013110054,0.00028168145,0.00007656069,0.00013883278,0.00046445412,0.00032449787,0.00039339298,0.0006755866,0.000014413552],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00160311,0.00016806588,0.9747644,0.00005414656,0.0004094872,0.00019497551,0.000790703,6.936833e-7,0.021515016,0.0000029604998,0.0000796171,0.00041681353],"study_design_scores_gemma":[0.010050701,0.0012942542,0.9710069,0.00021630045,0.00036157624,0.000025937983,0.00023308981,0.00009811073,0.016218899,0.0000025584714,0.00019764778,0.0002940564],"about_ca_topic_score_codex":0.0002579045,"about_ca_topic_score_gemma":0.00007137926,"teacher_disagreement_score":0.008447591,"about_ca_system_score_codex":0.00034680628,"about_ca_system_score_gemma":0.00035813736,"threshold_uncertainty_score":0.9999635},"labels":[],"label_agreement":null},{"id":"W3097766015","doi":"10.1182/blood-2020-134557","title":"Characterizing Frailty in Myeloproliferative Neoplasms: Baseline Results from the Orchid Study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University; Population Health Research Institute; Queen's University","funders":"","keywords":"Medicine; Internal medicine; Stroke (engine); Weight loss; Depression (economics); Physical therapy; Obesity","score_opus":0.05270650216916771,"score_gpt":0.3051623174984077,"score_spread":0.25245581532924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097766015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96524876,0.000120035016,0.000023345357,0.032065064,0.000043393582,0.0012482592,0.00019820424,0.00007914858,0.00097377005],"genre_scores_gemma":[0.99213415,0.000050852195,0.0005881132,0.005766226,0.0010235728,0.00006692945,0.00019872864,0.00003488825,0.00013654851],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99777263,0.0003640674,0.00048083212,0.0005383842,0.00048641127,0.0003576955],"domain_scores_gemma":[0.99832124,0.0007836937,0.00008694799,0.00049138436,0.000096058044,0.0002206553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006982251,0.00020261337,0.000392227,0.00005481037,0.000095982105,0.000043649023,0.00028994668,0.000082919076,0.000120669734],"category_scores_gemma":[0.0027939554,0.00013325574,0.000060158403,0.0005196268,0.00006094499,0.00009064066,0.00021805732,0.0008866913,0.00021153105],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01610408,0.007363327,0.5586104,0.00009941648,0.0016886799,0.0062517007,0.18746883,0.00002410244,0.19309457,0.00007963551,0.01447773,0.014737558],"study_design_scores_gemma":[0.068485126,0.0029992466,0.84705883,0.00027123175,0.0004307132,0.000051724266,0.016664604,0.005272692,0.044167895,0.000044022454,0.013977412,0.00057650317],"about_ca_topic_score_codex":0.00059968675,"about_ca_topic_score_gemma":0.00022680529,"teacher_disagreement_score":0.28844845,"about_ca_system_score_codex":0.000063476975,"about_ca_system_score_gemma":0.00035723258,"threshold_uncertainty_score":0.5434011},"labels":[],"label_agreement":null},{"id":"W3097778032","doi":"10.1182/blood-2020-137258","title":"Double-Hit Signature with <i>TP53</i> Abnormalities Predicts Poor Survival in Patients with Germinal Center Type Diffuse Large B-Cell Lymphoma Treated with R-CHOP","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; CancerCare Manitoba","funders":"","keywords":"Diffuse large B-cell lymphoma; BCL6; Germinal center; Lymphoma; Fluorescence in situ hybridization; Biology; Cancer research; Comparative genomic hybridization; Immunophenotyping; Oncology; Internal medicine; Pathology; Medicine; B cell; Immunology; Genetics; Gene; Flow cytometry","score_opus":0.007823083668783001,"score_gpt":0.1955919838357955,"score_spread":0.1877689001670125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097778032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99518245,0.00023322518,0.0000021326543,0.00032073818,0.000035604073,0.0009436263,0.00019198288,0.00011562701,0.0029746233],"genre_scores_gemma":[0.9978529,0.00002720124,0.00013594476,0.00091551204,0.00010537254,0.00007687973,0.00046926946,0.00007404141,0.00034287362],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99798065,0.00004848743,0.00026899469,0.0005286297,0.00061877613,0.0005544831],"domain_scores_gemma":[0.99897933,0.00004045072,0.00012929819,0.0003036075,0.00018990245,0.00035740715],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00004767044,0.00043216263,0.0005618452,0.00008606034,0.00007569981,0.000048442012,0.00011636768,0.00014069819,0.000055646724],"category_scores_gemma":[0.0000068267527,0.0002525724,0.000057361052,0.00043990053,0.00006884657,0.00016031603,0.000047343594,0.0001451123,0.000027788046],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012822627,0.02514342,0.958537,0.0001603384,0.00040398372,0.0017252349,0.0007368329,0.000002226535,0.000018594466,0.00002128849,0.00028551315,0.00014298393],"study_design_scores_gemma":[0.2934577,0.007961514,0.6915153,0.00037394118,0.0008803669,0.00006997201,0.0002292373,0.000013852831,0.003668294,4.636589e-7,0.0014537844,0.00037555947],"about_ca_topic_score_codex":0.0001530904,"about_ca_topic_score_gemma":0.00016116802,"teacher_disagreement_score":0.28063506,"about_ca_system_score_codex":0.000090677,"about_ca_system_score_gemma":0.0002065249,"threshold_uncertainty_score":0.99999267},"labels":[],"label_agreement":null},{"id":"W3097781129","doi":"10.1182/blood-2020-141952","title":"Overcoming Multidrug Resistance in B Cell Malignancies By Antagonism of Stromal Mediated TGF-β Signalling","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Stromal cell; Cancer research; Tumor microenvironment; Stroma; Biology; Cancer cell; Leukemia; Drug resistance; Medicine; Cancer; Immunology; Internal medicine","score_opus":0.008032498384552668,"score_gpt":0.20949968335917885,"score_spread":0.20146718497462618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097781129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99409384,0.0050741164,0.00023991175,0.00005834801,0.000026228257,0.00011578268,0.00015492352,0.000018108012,0.00021874331],"genre_scores_gemma":[0.99780566,0.00006276791,0.0016281813,0.00014303731,0.00008226128,0.000009718255,0.00017687745,0.00002582815,0.00006566296],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989246,0.000054989414,0.0003047804,0.0003267424,0.0001580945,0.0002307577],"domain_scores_gemma":[0.9995279,0.000036680605,0.00012847954,0.00016576576,0.000041696574,0.00009950089],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008603669,0.00015051838,0.00018703945,0.00002400261,0.000033191853,0.000012054836,0.00022683451,0.00010485537,0.000012649949],"category_scores_gemma":[0.00014383826,0.00016386375,0.000067848894,0.00009709183,0.000058067144,0.0000046113146,0.00008328006,0.00008306846,0.0000039338393],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008842739,0.00022815923,0.00829966,0.00010041819,0.000026048174,0.00001430359,0.0001992242,0.000074519216,0.99054474,0.000004849057,0.00041057545,0.00000908376],"study_design_scores_gemma":[0.0015770555,0.00008904246,0.0010659099,0.00004185886,0.000026945603,4.8076464e-7,0.00009718506,0.000048957652,0.9950167,0.0000065122276,0.0018528444,0.00017650792],"about_ca_topic_score_codex":0.000014588382,"about_ca_topic_score_gemma":0.00001805644,"teacher_disagreement_score":0.00723375,"about_ca_system_score_codex":0.0000052623755,"about_ca_system_score_gemma":0.00007977537,"threshold_uncertainty_score":0.66821694},"labels":[],"label_agreement":null},{"id":"W3097786185","doi":"10.1182/blood-2020-140563","title":"Prevalence of Gaucher Disease in Patients of Unknown Cause of Splenomegaly and/or Thrombocytopenia in Saudi Arabia","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"","keywords":"Medicine; Hematology; Dried blood spot; Disease; Thalassemia; Incidence (geometry); Internal medicine; Pediatrics; Enzyme replacement therapy; Anemia","score_opus":0.03211763613808399,"score_gpt":0.2911509799252413,"score_spread":0.2590333437871573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097786185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99801314,0.0009516404,9.135395e-7,0.00019067671,0.0000068418103,0.0005533753,0.000045870336,0.0000043942077,0.00023316217],"genre_scores_gemma":[0.99948597,0.0002724959,0.0000887079,0.000038100916,0.000008124153,0.000010657044,0.00000587677,0.000012721794,0.00007735495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886054,0.00006010632,0.0003714118,0.00021132664,0.0003340936,0.00016249421],"domain_scores_gemma":[0.99940205,0.000051150506,0.00009693143,0.00020345552,0.000102269114,0.00014414755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010504296,0.00009286033,0.00038750743,0.00009928979,0.0000054093643,0.0000018996639,0.000118811586,0.000044930202,0.00017673102],"category_scores_gemma":[0.0006487983,0.00007679639,0.000038273793,0.00038092647,0.00012046884,0.000065036955,0.000105498846,0.00012091022,0.000002398065],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011652714,0.001810785,0.98956096,0.0028854012,0.000036628517,0.000044015997,0.0009219635,0.0000035476992,0.003237722,0.000014790909,0.000021160487,0.00029777197],"study_design_scores_gemma":[0.0069574835,0.0007974425,0.986453,0.00036294363,0.00008515029,4.251152e-7,0.00004157141,0.00005142042,0.005158341,0.000014805033,0.000012489352,0.00006491055],"about_ca_topic_score_codex":0.00018797623,"about_ca_topic_score_gemma":0.000058161724,"teacher_disagreement_score":0.005792212,"about_ca_system_score_codex":0.000017573026,"about_ca_system_score_gemma":0.00015150227,"threshold_uncertainty_score":0.3131666},"labels":[],"label_agreement":null},{"id":"W3097787544","doi":"10.1182/blood-2020-133912","title":"Delays in Time to Deterioration of Health-Related Quality of Life Were Observed in Patients with Acute Myeloid Leukemia Receiving Venetoclax in Combination with Azacitidine or in Combination with Low-Dose Cytarabine","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Venetoclax; Azacitidine; Cytarabine; Myeloid leukemia; Medicine; Leukemia; Myeloid; Oncology; Internal medicine; Clofarabine; Quality of life (healthcare); Biology; DNA methylation","score_opus":0.02896554083932576,"score_gpt":0.2730905731527798,"score_spread":0.24412503231345403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097787544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957417,0.000035795998,0.000064180495,0.0013458013,0.000007992729,0.002717873,0.000025389982,0.00002875264,0.000032516018],"genre_scores_gemma":[0.9978602,0.000020850128,0.001288955,0.000210664,0.000006548186,0.00010668839,0.00042745678,0.000050500606,0.000028144183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963224,0.00053767394,0.0014135812,0.0004885676,0.00082693266,0.0004108449],"domain_scores_gemma":[0.9984285,0.00016154799,0.00056346087,0.00031078077,0.00033543125,0.0002002475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012134527,0.00026873912,0.0010440063,0.0005996798,0.000025597199,0.000013935765,0.00019355855,0.00016910097,0.000036785506],"category_scores_gemma":[0.0004889927,0.00021388884,0.00002720754,0.0025103597,0.000079784426,0.00031184408,0.0000759344,0.0005339525,0.000006710527],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023305316,0.0018460293,0.95701355,0.00067826814,0.00010038599,0.00008178529,0.0029036982,0.0017683179,0.011164581,0.000013303116,0.000015386984,0.0011093671],"study_design_scores_gemma":[0.059147988,0.008431555,0.9235348,0.0016983326,0.000027336646,0.0000042735105,0.00017950454,0.003857055,0.0028916476,0.000010155298,0.0000016532416,0.00021567619],"about_ca_topic_score_codex":0.0026167794,"about_ca_topic_score_gemma":0.0036615569,"teacher_disagreement_score":0.035842672,"about_ca_system_score_codex":0.0015821065,"about_ca_system_score_gemma":0.0020890292,"threshold_uncertainty_score":0.87221336},"labels":[],"label_agreement":null},{"id":"W3097795751","doi":"10.1182/blood-2020-138822","title":"Preliminary Results from a Phase 1 Study of Cfi-400495, a PLK4 Inhibitor, in Patients with Acute Myeloid Leukemia and High Risk MDS","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Princess Margaret Cancer Centre; McMaster University; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Tolerability; Internal medicine; Myeloid leukemia; Pharmacodynamics; Induction chemotherapy; Oncology; Chemotherapy regimen; Leukemia; Phases of clinical research; Chemotherapy; Gastroenterology; Adverse effect; Pharmacokinetics","score_opus":0.012716654860611078,"score_gpt":0.2596851803734144,"score_spread":0.24696852551280335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097795751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968164,0.00010420611,0.0000071554587,0.00033069594,0.000033363805,0.0017789224,0.0007549468,0.000058476817,0.000115844436],"genre_scores_gemma":[0.9981969,0.00006932967,0.0009691452,0.00013386454,0.00018528655,0.000055215714,0.00029320372,0.000054025226,0.000043058546],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973742,0.00017331156,0.0006068936,0.00071217713,0.00075896183,0.00037449444],"domain_scores_gemma":[0.99849737,0.00021259875,0.00023640397,0.0005308876,0.00016988805,0.0003528775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021931308,0.00028512243,0.0006525363,0.00018151342,0.000059488004,0.000019479292,0.00019349519,0.0001456816,0.000021578993],"category_scores_gemma":[0.00040723124,0.00022472157,0.000042511787,0.00057557493,0.00011787938,0.00013887692,0.00028026482,0.0006938209,0.000011951527],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13144182,0.018368734,0.80207276,0.000180374,0.0022380978,0.0025667013,0.027117006,0.000025946349,0.004036714,0.0000030892074,0.002768036,0.009180703],"study_design_scores_gemma":[0.25531605,0.04978697,0.6832093,0.00023952,0.0013124011,0.000010009476,0.0015244297,0.00044143273,0.0076980046,0.000012795415,0.00013227272,0.00031679956],"about_ca_topic_score_codex":0.0028974111,"about_ca_topic_score_gemma":0.000081550534,"teacher_disagreement_score":0.123874225,"about_ca_system_score_codex":0.00015186609,"about_ca_system_score_gemma":0.00047761627,"threshold_uncertainty_score":0.91638803},"labels":[],"label_agreement":null},{"id":"W3097818908","doi":"10.1182/blood-2020-137154","title":"Once Weekly Selinexor, Bortezomib, and Dexamethasone (SVd) Versus Twice Weekly Bortezomib and Dexamethasone (Vd) in Relapsed or Refractory Multiple Myeloma: High-Risk Cytogenetic Risk Planned Subgroup Analyses from the Phase 3 Boston Study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary; University of Alberta","funders":"","keywords":"Bortezomib; Dexamethasone; Multiple myeloma; Medicine; Oncology; Internal medicine; Refractory (planetary science); Biology","score_opus":0.08415400050837109,"score_gpt":0.356338819197198,"score_spread":0.27218481868882693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097818908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873526,0.007624484,0.00010177932,0.0008378611,0.0001212056,0.0026928633,0.0010660605,0.00015635336,0.000046802033],"genre_scores_gemma":[0.9909604,0.0028337191,0.0048831776,0.00021086221,0.0003947514,0.00019815602,0.00033146268,0.000117654854,0.000069778216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942542,0.0013196914,0.00097406184,0.0015296843,0.0009887023,0.00093367544],"domain_scores_gemma":[0.992336,0.005017236,0.0004980582,0.0010254694,0.00017220613,0.00095105503],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009232667,0.00075256196,0.001341209,0.00024818952,0.00042472256,0.00013554654,0.00038072493,0.00029328399,0.00010597895],"category_scores_gemma":[0.005515448,0.0005213767,0.00015926486,0.00096836616,0.00031569842,0.00020579319,0.00032353625,0.0012455367,0.000035880486],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.052639358,0.0077853734,0.8782706,0.00007900692,0.0033943355,0.002614034,0.0036313005,0.000019496807,0.02521379,0.0000011214291,0.00032749114,0.026024044],"study_design_scores_gemma":[0.18114296,0.019875597,0.7751572,0.00014862689,0.00408832,0.000039287614,0.0066022114,0.003550847,0.008336186,0.0000145897775,0.0004227355,0.0006214076],"about_ca_topic_score_codex":0.017506098,"about_ca_topic_score_gemma":0.009831154,"teacher_disagreement_score":0.1285036,"about_ca_system_score_codex":0.000119746546,"about_ca_system_score_gemma":0.0003005292,"threshold_uncertainty_score":0.9997238},"labels":[],"label_agreement":null},{"id":"W3097824528","doi":"10.1182/blood-2020-142723","title":"Totality of Scientific Evidence in the Development of ABP 798, a Biosimilar to Rituximab","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Regional Hospital","funders":"","keywords":"Medicine; Rituximab; Oncology; Pharmacology; Clinical trial; In vivo; Pharmacodynamics; Internal medicine; Biosimilar; Lymphoma; Pharmacokinetics; Biology","score_opus":0.11105793542711007,"score_gpt":0.32541391752517074,"score_spread":0.21435598209806067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097824528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939722,0.0012880071,0.0002534126,0.0037956177,0.00009794842,0.00026926727,0.0000204653,0.000008683876,0.00029438618],"genre_scores_gemma":[0.99209034,0.0000054583143,0.0072537665,0.0005937756,0.000007162763,0.000008900688,0.000002149404,0.0000029889054,0.000035457924],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998911,0.0002285447,0.00038441314,0.00023495484,0.00006337123,0.0001776671],"domain_scores_gemma":[0.9994216,0.00019609867,0.00007452182,0.00022262524,0.000062814,0.000022352982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010858281,0.00008557347,0.00024644853,0.000050810984,0.00005733496,0.000008644877,0.0003698536,0.00009591501,0.00012351711],"category_scores_gemma":[0.0005048529,0.000055023138,0.000060279777,0.00050078455,0.00022412224,0.000028622462,0.00012210003,0.0001282388,0.000029050168],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009757059,0.00090766343,0.0067416052,0.00010444869,0.00007553676,0.0000024015646,0.0035996013,3.102218e-7,0.9829963,0.00028924888,0.0007330825,0.004452217],"study_design_scores_gemma":[0.0008382592,0.00018362183,0.02982809,0.00010012532,0.00005374408,0.0000033098001,0.00031091334,0.0000016490848,0.96111196,0.000068051326,0.007408727,0.00009152649],"about_ca_topic_score_codex":0.0000071207446,"about_ca_topic_score_gemma":0.000023246881,"teacher_disagreement_score":0.023086485,"about_ca_system_score_codex":0.0000052460664,"about_ca_system_score_gemma":0.00008941478,"threshold_uncertainty_score":0.22437786},"labels":[],"label_agreement":null},{"id":"W3097833703","doi":"10.1182/blood-2020-140684","title":"The Importance of Hematology Working Groups for Rare Genetic Diseases","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"","keywords":"Medicine; Intensive care medicine; Rare disease; Etiology; Pediatrics; Disease; Pathology","score_opus":0.01010493776149686,"score_gpt":0.2196901555059117,"score_spread":0.20958521774441485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097833703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791135,0.019723088,0.0004203384,0.00036480412,0.00005048217,0.00018219312,0.00006725628,0.0000060142975,0.00007230646],"genre_scores_gemma":[0.9986413,0.0003094859,0.00034087093,0.00036740885,0.0002118439,0.000036762038,0.000060033406,0.0000143880225,0.000017878512],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99944395,0.0000143314855,0.00015158427,0.00018595252,0.000042813,0.0001613495],"domain_scores_gemma":[0.999602,0.000023558108,0.00008005649,0.0001838164,0.000036753627,0.000073787574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000230276,0.00007839661,0.00010209876,0.00000517177,0.00008701754,0.000010454995,0.00017721634,0.000043471355,0.00000321259],"category_scores_gemma":[0.00009876314,0.000058498314,0.00010900809,0.000034035616,0.00005380142,5.832159e-7,0.00007671436,0.000019672434,8.8574757e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066569116,0.0005901904,0.8314011,0.0003789985,0.00071589346,0.00006059646,0.00022905487,0.00009827553,0.14775176,0.004233372,0.008893526,0.00498154],"study_design_scores_gemma":[0.012833754,0.0030911495,0.25251257,0.00011621812,0.0015185784,0.00022656666,0.0021693334,0.0005775805,0.5320218,0.0068591572,0.18630353,0.0017697222],"about_ca_topic_score_codex":5.060288e-7,"about_ca_topic_score_gemma":0.000006285425,"teacher_disagreement_score":0.57888854,"about_ca_system_score_codex":9.1437386e-7,"about_ca_system_score_gemma":0.000044265875,"threshold_uncertainty_score":0.2385492},"labels":[],"label_agreement":null},{"id":"W3097838507","doi":"10.1182/blood-2020-141925","title":"Tonic Signaling Leads to Off-Target Activation of T Cells Engineered with Chimeric Antigen Receptors That Is Not Seen in T Cells Engineered with T Cell Antigen Coupler (TAC) Receptors","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"T-cell receptor; Chimeric antigen receptor; Cell biology; T cell; Antigen; Cytotoxic T cell; Receptor; Antigen-presenting cell; Molecular biology; Biology; Chemistry; Immunology; Immune system; Biochemistry; In vitro","score_opus":0.020323630542912162,"score_gpt":0.24080840056362807,"score_spread":0.2204847700207159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097838507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958493,0.00022823093,0.0005995025,0.000703045,0.00010659474,0.0017046113,0.000036117694,0.00011637943,0.00065622246],"genre_scores_gemma":[0.99116164,0.00028446698,0.0066188383,0.00038434297,0.00018801619,0.000048408852,0.00008696487,0.00017787519,0.0010494482],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968524,0.00009116616,0.0005227198,0.00075160194,0.0010345825,0.0007475505],"domain_scores_gemma":[0.9984329,0.00016508832,0.00019138143,0.0005419179,0.00021112617,0.00045760663],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033937133,0.00049007067,0.0008829436,0.00044165307,0.00005400309,0.000036700676,0.0003250494,0.00021532406,0.0023856203],"category_scores_gemma":[0.000033806606,0.0004179301,0.00013936455,0.0016902221,0.000076269454,0.00017566266,0.000072317416,0.0005724059,0.00006445448],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013230814,0.00048170623,0.030963188,0.00028437935,0.00029544125,0.000020254061,0.00366939,0.004289852,0.9576081,6.341098e-7,0.0005110962,0.00055286917],"study_design_scores_gemma":[0.005431304,0.0021339015,0.0038170354,0.00028927068,0.00011761581,0.0000053009144,0.00041045833,0.0010302289,0.98305374,5.40554e-7,0.0032362214,0.00047439785],"about_ca_topic_score_codex":0.00012474459,"about_ca_topic_score_gemma":0.000009119254,"teacher_disagreement_score":0.027146153,"about_ca_system_score_codex":0.00011354752,"about_ca_system_score_gemma":0.00031233372,"threshold_uncertainty_score":0.99982727},"labels":[],"label_agreement":null},{"id":"W3097857176","doi":"10.1182/blood-2020-138837","title":"Administration of Neuraxial Anesthesia in Adults with Pre-Existing Bleeding Disorders and Tendencies: Methodology for Delphi Consensus Recommendations","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Neonatal Respiratory Health Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Calgary; St. Michael's Hospital; University of Toronto","funders":"","keywords":"Medicine; Context (archaeology); Anesthesiology; Delphi method; Platelet disorder; Delphi; Von Willebrand disease; Intensive care medicine; Anesthesia; Platelet; Internal medicine; Von Willebrand factor","score_opus":0.1600880757981837,"score_gpt":0.4149082150214852,"score_spread":0.2548201392233015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097857176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844075,0.00032067992,0.00052116095,0.013647218,0.000010233797,0.00094748044,0.0000107294545,0.000020295933,0.00011469516],"genre_scores_gemma":[0.9748984,0.0000904001,0.024524143,0.0003279616,0.000050791874,0.00007128045,0.000014944281,0.0000144806945,0.000007611489],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990592,0.00010880411,0.0002836205,0.0002195422,0.00013931653,0.00018953215],"domain_scores_gemma":[0.99860835,0.0009690724,0.000099676654,0.00007920169,0.00010390374,0.00013978392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004384036,0.00008016913,0.00021735359,0.0000826313,0.000050325776,0.0000051867905,0.000042348092,0.000059159018,0.0000075629505],"category_scores_gemma":[0.0019121333,0.000070293616,0.000018646302,0.0001977858,0.000092508184,0.00003249713,0.000014754277,0.0001535983,2.9849116e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09286686,0.0031615666,0.32092392,0.034740996,0.000493924,0.0011980638,0.034749743,0.000058594833,0.08643103,0.0066740606,0.0004540138,0.41824722],"study_design_scores_gemma":[0.17612588,0.11964387,0.4594789,0.007050227,0.0015518382,0.0061978227,0.05388116,0.0222253,0.10565866,0.0020555565,0.043801334,0.0023294238],"about_ca_topic_score_codex":0.00006060907,"about_ca_topic_score_gemma":0.0002395843,"teacher_disagreement_score":0.4159178,"about_ca_system_score_codex":0.000011632887,"about_ca_system_score_gemma":0.00034871182,"threshold_uncertainty_score":0.28664905},"labels":[],"label_agreement":null},{"id":"W3097857700","doi":"10.1182/blood-2020-142565","title":"Effect of Pembrolizumab (Pembro) Monotherapy Versus Brentuximab Vedotin (BV) on Patients (Pts) with Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL): Exploratory Analysis of the Randomized, Phase 3 Keynote-204 Study By Prior Lines of Therapy","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Brentuximab vedotin; Pembrolizumab; Medicine; Internal medicine; Classical Hodgkin lymphoma; Refractory (planetary science); Oncology; Phases of clinical research; Lymphoma; Hodgkin lymphoma; Clinical trial; Cancer; Materials science; Immunotherapy","score_opus":0.014271756820089344,"score_gpt":0.2743418253335899,"score_spread":0.26007006851350056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097857700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995009,0.0013700065,0.000008075811,0.00018493347,0.0001096956,0.0030708194,0.0001420907,0.000036579364,0.000068812195],"genre_scores_gemma":[0.9988817,0.0004109939,0.000029498417,0.00014969561,0.000059537782,0.00032445136,0.000073735995,0.00005827889,0.000012104765],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9963572,0.00093049224,0.0009082556,0.0005646899,0.0009688236,0.00027054624],"domain_scores_gemma":[0.99663275,0.0013494538,0.0008456744,0.00077319425,0.00022090548,0.00017802214],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038460604,0.0004820273,0.0022583583,0.00021102653,0.00006914724,0.000011518786,0.00027701326,0.0001371946,0.000047686866],"category_scores_gemma":[0.00027554735,0.00025763863,0.0008397346,0.0009184221,0.00027278316,0.0000708221,0.000050205515,0.00012874062,0.0000032098235],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.73110014,0.073906705,0.13114119,0.00013971447,0.020445867,0.000027583945,0.0026555897,0.000034142104,0.0037487552,0.000007507628,0.0002426478,0.036550194],"study_design_scores_gemma":[0.7832849,0.040546287,0.026907206,0.00012371053,0.009681668,7.152018e-7,0.00013375843,0.00017826892,0.13883795,5.66036e-7,0.0001130561,0.00019193675],"about_ca_topic_score_codex":0.00009074151,"about_ca_topic_score_gemma":0.000011370188,"teacher_disagreement_score":0.1350892,"about_ca_system_score_codex":0.000098281096,"about_ca_system_score_gemma":0.00019022387,"threshold_uncertainty_score":0.9999876},"labels":[],"label_agreement":null},{"id":"W3097858251","doi":"10.1182/blood-2020-136991","title":"Clonally Expanded Bone Marrow T Cells Show Effector Differentiation and Rarely Recognize Disease-Associated Antigens in Multiple Myeloma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Biology; Bone marrow; Cytotoxic T cell; Antigen; Multiple myeloma; Immunology; CD8; T cell; Immune system; Cancer research; In vitro","score_opus":0.027021206205120756,"score_gpt":0.25292436395849077,"score_spread":0.22590315775337003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097858251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99704546,0.0006439875,0.000015411919,0.00082872226,0.000045989582,0.0010599521,0.00019148529,0.00009470121,0.00007431985],"genre_scores_gemma":[0.9984444,0.00020572031,0.0002847265,0.00020404824,0.00008488762,0.000075366734,0.00050587335,0.000037179034,0.000157793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832946,0.00015182976,0.00027159834,0.0004409582,0.00039066593,0.0004154606],"domain_scores_gemma":[0.9988153,0.00022161425,0.000080327314,0.00017037946,0.00007268614,0.0006397191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001131605,0.0002224231,0.0004105745,0.00010825002,0.00007825593,0.000040965617,0.000062406856,0.00010026735,0.00011345499],"category_scores_gemma":[0.0007704273,0.00019346717,0.00010145456,0.00024301313,0.00004326522,0.00008360857,0.00006677796,0.00020207764,0.000062855885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001156427,0.0012349687,0.84902453,0.00017553034,0.00023221645,0.00070253573,0.00019903702,4.970878e-7,0.14449807,0.000001082446,0.00019043127,0.002584673],"study_design_scores_gemma":[0.021342417,0.00042411804,0.94250625,0.00014361666,0.00019536588,0.000006813643,0.000022246388,0.0018196427,0.03331228,0.000012594934,0.00004480583,0.00016987199],"about_ca_topic_score_codex":0.000051777723,"about_ca_topic_score_gemma":0.00012538605,"teacher_disagreement_score":0.11118578,"about_ca_system_score_codex":0.00004638176,"about_ca_system_score_gemma":0.00008711536,"threshold_uncertainty_score":0.78893626},"labels":[],"label_agreement":null},{"id":"W3097912792","doi":"10.1182/blood-2020-136307","title":"CARTITUDE-1: Phase 1b/2 Study of Ciltacabtagene Autoleucel, a B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy, in Relapsed/Refractory Multiple Myeloma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Chimeric antigen receptor; Internal medicine; Antigen; Population; Fludarabine; Immunology; Oncology; Gastroenterology; Cyclophosphamide; Immunotherapy; Chemotherapy; Cancer","score_opus":0.032698462280976295,"score_gpt":0.29832936063552745,"score_spread":0.26563089835455117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097912792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99316293,0.0022362971,0.00000888341,0.00017976464,0.0001375905,0.0027063468,0.00003397964,0.0002391128,0.001295098],"genre_scores_gemma":[0.99698174,0.0011209471,0.00047294513,0.00016371072,0.0002596361,0.000095870186,0.00010582459,0.0001068976,0.00069240906],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99673,0.00037726614,0.00078758347,0.0007281649,0.00083942607,0.0005375297],"domain_scores_gemma":[0.99836403,0.00014569369,0.00027756393,0.0006577326,0.00022997241,0.0003250119],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00036491916,0.00038108393,0.000794951,0.00031391115,0.0000924948,0.000033891036,0.00030722783,0.00020721777,0.001413949],"category_scores_gemma":[0.00013163859,0.00035644096,0.00017082618,0.0012466504,0.00007790593,0.00011948982,0.00009658145,0.0006167015,0.000089677465],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031414647,0.026784249,0.04050491,0.00013098364,0.00020084153,0.00015427844,0.007837698,0.000012128761,0.91431123,2.0699268e-7,0.00044034168,0.006481645],"study_design_scores_gemma":[0.073134616,0.009745675,0.06187971,0.000061156876,0.00008912748,0.000008947557,0.0013087734,0.0010804407,0.84803176,9.955986e-7,0.004269604,0.0003892159],"about_ca_topic_score_codex":0.00034246073,"about_ca_topic_score_gemma":0.00007163969,"teacher_disagreement_score":0.06999315,"about_ca_system_score_codex":0.00007290005,"about_ca_system_score_gemma":0.00025701904,"threshold_uncertainty_score":0.9998888},"labels":[],"label_agreement":null},{"id":"W3097923020","doi":"10.1182/blood-2020-135839","title":"Mosunetuzumab Shows Promising Efficacy in Patients with Multiply Relapsed Follicular Lymphoma: Updated Clinical Experience from a Phase I Dose-Escalation Trial","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); BC Cancer Agency; Jewish General Hospital","funders":"","keywords":"Medicine; Follicular lymphoma; Internal medicine; Refractory (planetary science); Clinical trial; Oncology; Progressive disease; Lymphoma; Phases of clinical research; Gastroenterology; Chemotherapy","score_opus":0.033216889916838646,"score_gpt":0.3106191460288156,"score_spread":0.27740225611197694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097923020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970439,0.00008607142,0.000019063524,0.00025811925,0.00011124185,0.0022883455,0.000039109054,0.000097390126,0.000056731787],"genre_scores_gemma":[0.9971858,0.0000073004594,0.0014280111,0.00035981217,0.0002168336,0.00014478904,0.0006181446,0.000033160202,0.0000061442647],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99785095,0.00012384968,0.0006884518,0.00063675386,0.0004299889,0.00027002027],"domain_scores_gemma":[0.9989512,0.00014543046,0.00019257735,0.00033723543,0.00007421933,0.00029936255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009562278,0.00025068125,0.00057525956,0.0000478074,0.00006179695,0.000039116178,0.00009591099,0.00015775199,0.00007401553],"category_scores_gemma":[0.00030876644,0.00018509121,0.0001445218,0.00029501776,0.00005891048,0.00013193866,0.00004194626,0.00010137508,0.000029355204],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.067802526,0.052788798,0.85574275,0.000011849959,0.0004086682,0.00042338244,0.0021653262,0.000009672619,0.00032510553,0.0000043701575,0.000108240194,0.020209324],"study_design_scores_gemma":[0.50767195,0.0035861023,0.48534617,0.00008625074,0.00034357925,0.0000014440524,0.00005020784,0.0005567671,0.001999428,0.0000011917795,0.0002082247,0.00014870633],"about_ca_topic_score_codex":0.00012364327,"about_ca_topic_score_gemma":0.000009715186,"teacher_disagreement_score":0.4398694,"about_ca_system_score_codex":0.00010481694,"about_ca_system_score_gemma":0.00017266792,"threshold_uncertainty_score":0.75478},"labels":[],"label_agreement":null},{"id":"W3097943171","doi":"10.1182/blood-2020-137747","title":"Peripheral Venous Access for Collection of Immune Effector Cells and Hematopoietic Stem Cells Is Feasible and Safe in Older Children and Young Adult Patients","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Medicine; Population; Apheresis; Transplantation; Surgery; Internal medicine","score_opus":0.007613335785646083,"score_gpt":0.22264286061184202,"score_spread":0.21502952482619594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097943171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99720657,0.0005377356,0.000043194508,0.00028498223,0.00006159453,0.0017451185,0.00003192965,0.000014258415,0.000074598895],"genre_scores_gemma":[0.9989487,0.0004281823,0.00014018695,0.00030559188,0.000018991823,0.00003739676,0.0000100766565,0.000016502603,0.00009436476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99930763,0.0000206524,0.00020595371,0.00023009512,0.00010829558,0.0001273799],"domain_scores_gemma":[0.99971914,0.00001758643,0.000054135257,0.00008061052,0.00004119997,0.00008734344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000052118103,0.00011358864,0.00028850252,0.000055568533,0.000045669483,0.000022046539,0.000035892015,0.000053596446,0.000016105505],"category_scores_gemma":[0.000004257796,0.00010289699,0.000032677413,0.00011926454,0.000029075802,0.000053990825,0.00004554695,0.000063397965,5.128364e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001405651,0.004824322,0.87149245,0.006180207,0.00056096906,0.000015656919,0.015576471,0.0000021936798,0.091382354,0.0000328941,0.0014935577,0.0070332834],"study_design_scores_gemma":[0.026451597,0.0017393177,0.7858362,0.0002523179,0.00045947407,0.000011521159,0.00019331182,0.00012481422,0.18471788,0.000005831013,0.000047265956,0.00016043172],"about_ca_topic_score_codex":0.00016540167,"about_ca_topic_score_gemma":0.000025666119,"teacher_disagreement_score":0.093335524,"about_ca_system_score_codex":0.000007187288,"about_ca_system_score_gemma":0.0000117243035,"threshold_uncertainty_score":0.41960177},"labels":[],"label_agreement":null},{"id":"W3097954755","doi":"10.1182/blood-2020-137215","title":"CRISPR Mediated <i>ELANE</i> Single-Allele Knock-out Restores Proliferation and Myeloid Differentiation of Neutropenia Patient Derived BM HSCs","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biology; Myeloid; Population; Genetics; Allele; Cancer research; Medicine; Gene","score_opus":0.011038918425545696,"score_gpt":0.20216569371744453,"score_spread":0.19112677529189884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097954755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99793637,0.001144224,0.0001433111,0.00023229599,0.000032123287,0.00026180784,0.000035265308,0.000013515288,0.00020107727],"genre_scores_gemma":[0.99864215,0.00019911797,0.00021648893,0.00025189068,0.000059991697,0.000022322776,0.0005801513,0.000016829617,0.000011088954],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992751,0.000046747486,0.00019238963,0.0002564194,0.0001050958,0.00012424406],"domain_scores_gemma":[0.99960953,0.000006611418,0.0001114207,0.00013037899,0.00006203801,0.00008004183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00001679904,0.00012974557,0.00014324248,0.00001579668,0.000050240076,0.000019497043,0.00005889734,0.00009440175,0.0000072027874],"category_scores_gemma":[0.00004522653,0.000115180716,0.000038687285,0.000041294817,0.000031696403,0.0000056570193,0.000062725296,0.000040091916,0.0000034645525],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011572614,0.0005957391,0.047938596,0.000030362526,0.00013362398,0.0000027328792,0.00035474938,0.000007448181,0.94955915,0.000007879393,0.00029867174,0.00095533364],"study_design_scores_gemma":[0.0028988104,0.0013057409,0.013800445,0.000008797202,0.00013726039,0.0000032755804,0.000096386044,0.00003227369,0.9807551,0.000012765924,0.0008017197,0.00014742649],"about_ca_topic_score_codex":0.0000116963865,"about_ca_topic_score_gemma":0.000064985594,"teacher_disagreement_score":0.03413815,"about_ca_system_score_codex":0.0000025789693,"about_ca_system_score_gemma":0.000023429455,"threshold_uncertainty_score":0.46969333},"labels":[],"label_agreement":null},{"id":"W3097957926","doi":"10.1182/blood-2020-139575","title":"Safety and Efficacy of CTX001 in Patients with Transfusion-Dependent β-Thalassemia and Sickle Cell Disease: Early Results from the Climb THAL-111 and Climb SCD-121 Studies of Autologous CRISPR-CAS9-Modified CD34+ Hematopoietic Stem and Progenitor Cells","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; BC Children's Hospital","funders":"","keywords":"Climb; Thalassemia; Medicine; CRISPR; Disease; Sickle cell anemia; Blood transfusion; Internal medicine; Biology; Genetics; Gene","score_opus":0.011390601197811028,"score_gpt":0.22491722567613265,"score_spread":0.21352662447832163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097957926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98788965,0.009770162,0.000003366199,0.0007215677,0.000035436828,0.0012580127,0.00022918316,0.000021508475,0.000071105],"genre_scores_gemma":[0.9958021,0.0039793584,0.00006526988,0.00006364064,0.000020261286,0.000009676046,0.000016612748,0.00002489981,0.000018180783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983018,0.00011694036,0.00055522367,0.00047717732,0.00031281353,0.0002360301],"domain_scores_gemma":[0.998844,0.00039902757,0.000190546,0.00023952709,0.0000912232,0.0002356493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017459232,0.00024853752,0.000620836,0.000044926306,0.00009697971,0.000015808444,0.000070288166,0.0001327155,0.0000018596685],"category_scores_gemma":[0.00007015274,0.00015376961,0.000042442385,0.00015237958,0.0003501553,0.000051699506,0.00010412896,0.00024899226,4.2039574e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016004808,0.0026902515,0.93840295,0.0018302215,0.00068382686,0.00017386921,0.03233522,0.000016699429,0.0048127836,0.000018187877,0.00005406883,0.002977093],"study_design_scores_gemma":[0.04526289,0.002903603,0.9335447,0.0008887635,0.0015201649,0.000010862681,0.0073318477,0.000081300845,0.008111464,0.000021397496,0.000027840937,0.00029513767],"about_ca_topic_score_codex":0.00011144958,"about_ca_topic_score_gemma":0.000022647553,"teacher_disagreement_score":0.029258085,"about_ca_system_score_codex":0.0000089770065,"about_ca_system_score_gemma":0.000060100887,"threshold_uncertainty_score":0.6270543},"labels":[],"label_agreement":null},{"id":"W3097964787","doi":"10.1182/blood-2020-137681","title":"Depth of Response and Response Kinetics of Isatuximab Plus Carfilzomib and Dexamethasone in Relapsed Multiple Myeloma: Ikema Interim Analysis","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Multiple myeloma; Carfilzomib; Oncology; Hazard ratio; Progression-free survival; Clinical endpoint; Minimal residual disease; Interim analysis; Dexamethasone; Bone marrow; Bortezomib; Gastroenterology; Randomized controlled trial; Confidence interval; Chemotherapy","score_opus":0.03920528921607046,"score_gpt":0.3076559750043929,"score_spread":0.26845068578832243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097964787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99725324,0.0012946134,0.000069744725,0.00076985394,0.000008081713,0.00045022875,0.000082224135,0.000017972206,0.00005405313],"genre_scores_gemma":[0.9946387,0.00010021918,0.005078818,0.00005443331,0.000012751914,0.000018024055,0.000018956516,0.000021971511,0.00005616402],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980753,0.0004922727,0.00047106316,0.0003729593,0.0003232586,0.0002651379],"domain_scores_gemma":[0.9979671,0.0011421109,0.00013938904,0.000327468,0.00011446872,0.0003094265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005126103,0.00018593167,0.00078399596,0.00046183408,0.00001922242,0.00000909275,0.00008566298,0.000113532624,0.000023202329],"category_scores_gemma":[0.003865474,0.00016113014,0.00010997591,0.0008842009,0.0002140111,0.00003564874,0.00014351493,0.00018219335,0.0000016910963],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07806461,0.0009985409,0.4434802,0.00022669914,0.0011779116,0.000478964,0.0029629052,0.000010274871,0.4706061,0.000002971385,0.000011877037,0.0019789464],"study_design_scores_gemma":[0.028812137,0.0026895308,0.8013816,0.000086002205,0.0008525316,0.000030664494,0.000554031,0.0021701525,0.16327167,0.0000035803794,0.00003875564,0.000109382585],"about_ca_topic_score_codex":0.00032023754,"about_ca_topic_score_gemma":0.00029307834,"teacher_disagreement_score":0.35790136,"about_ca_system_score_codex":0.00004475063,"about_ca_system_score_gemma":0.00011812277,"threshold_uncertainty_score":0.6570697},"labels":[],"label_agreement":null},{"id":"W3098497307","doi":"10.1182/blood.v130.suppl_1.4041.4041","title":"Significant Adverse Consequences of Initial Watchful Waiting for Follicular Lymphoma Patients: A Retrospective Analysis of Patients Diagnosed in Alberta from 1994-2011","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of Calgary","funders":"","keywords":"Watchful waiting; Medicine; Follicular lymphoma; Retrospective cohort study; Lymphoma; Adverse effect; Pediatrics; Internal medicine; Cancer; Prostate cancer","score_opus":0.015029638595004332,"score_gpt":0.2744969535572582,"score_spread":0.2594673149622539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3098497307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976188,0.000042387564,0.0000023107548,0.000060168994,0.00007371932,0.0008647491,0.00096208125,0.000006969457,0.000368792],"genre_scores_gemma":[0.9988468,0.000034804787,0.00027598147,0.00003678013,0.000031314623,0.0001802017,0.0005695102,0.000015837044,0.000008768266],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983941,0.000045368673,0.0005917849,0.00039475536,0.00033364716,0.00024040115],"domain_scores_gemma":[0.99803746,0.0003983097,0.0006860645,0.00053926365,0.0002426509,0.00009627858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010276384,0.00019951662,0.00085996086,0.00020402375,0.00009184567,0.000012442506,0.0001658981,0.00010502404,0.00005750773],"category_scores_gemma":[0.0007127339,0.000161247,0.00038335763,0.00014184038,0.00019185925,0.00010978582,0.000059659065,0.000031425418,0.000002633568],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002779174,0.0064499113,0.9882509,0.000033348253,0.0027493867,0.000043374414,0.00073606597,0.0000022235338,0.00022274778,0.00011853445,0.000016151826,0.0010994346],"study_design_scores_gemma":[0.02402243,0.00080679014,0.93499494,0.00016729983,0.0048034526,1.709344e-7,0.00015696285,0.0000766273,0.03470803,0.00010497294,0.000018328914,0.00013999411],"about_ca_topic_score_codex":0.02875838,"about_ca_topic_score_gemma":0.0022278337,"teacher_disagreement_score":0.053255964,"about_ca_system_score_codex":0.000101789,"about_ca_system_score_gemma":0.000112671296,"threshold_uncertainty_score":0.9777092},"labels":[],"label_agreement":null},{"id":"W3098899061","doi":"10.1182/blood.v130.suppl_1.2372.2372","title":"Beyond ABR: High FIX Activity Levels Translate into Clinical Benefits over Standard Prophylaxis","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Pre-exposure prophylaxis; Intensive care medicine; Human immunodeficiency virus (HIV); Immunology","score_opus":0.1890371746978146,"score_gpt":0.49417082250704175,"score_spread":0.30513364780922714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3098899061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989663,0.00009512471,0.0003563129,0.0074484916,0.0006797136,0.0006871584,0.00016518038,0.000075866585,0.000829132],"genre_scores_gemma":[0.9918068,0.00011122252,0.006037038,0.00076389516,0.00094480265,0.000020112977,0.000028289067,0.000042985095,0.00024487855],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9973177,0.0001463392,0.0010468108,0.00055258954,0.0006128269,0.00032377263],"domain_scores_gemma":[0.9969444,0.00077727914,0.00059935753,0.0011268075,0.0002680504,0.00028405822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018955673,0.00022436475,0.0005883804,0.000056024815,0.00033336994,0.00011150949,0.00025785272,0.0002623652,0.00058708526],"category_scores_gemma":[0.005361896,0.00019482037,0.00024925524,0.00006676129,0.00019444597,0.0005381671,0.00012378517,0.0006351851,0.00009552461],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019186483,0.002351632,0.3202571,0.00014934111,0.0005262182,0.00013633417,0.00021251202,0.0000024627916,0.0047763055,0.00035433483,0.0013174368,0.66799766],"study_design_scores_gemma":[0.016001943,0.002088112,0.96594113,0.00008423322,0.0007400925,0.000024622508,0.000020530844,0.0000285511,0.007710683,0.0019375527,0.005162577,0.00025997584],"about_ca_topic_score_codex":0.0006464294,"about_ca_topic_score_gemma":0.0006296886,"teacher_disagreement_score":0.6677377,"about_ca_system_score_codex":0.00004204826,"about_ca_system_score_gemma":0.0003160268,"threshold_uncertainty_score":0.79445446},"labels":[],"label_agreement":null},{"id":"W3099093202","doi":"10.1182/blood-2020-136598","title":"Early-Onset Osteopenia and Osteoporosis in Patients with Pyruvate Kinase Deficiency","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Osteopenia; Osteoporosis; Pyruvate kinase deficiency; Bone mineral; Internal medicine; Pyruvate kinase; Placebo; Anemia; Bone density; Pediatrics; Pathology","score_opus":0.010164899814988382,"score_gpt":0.20673235907655427,"score_spread":0.19656745926156588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3099093202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984694,0.0000860588,0.0000025584393,0.00042462032,0.000032344244,0.00026702855,0.0000134849315,0.000034450164,0.00067003845],"genre_scores_gemma":[0.99808407,0.000013406047,0.00026498138,0.0015041856,0.000029510213,0.000009569515,0.000032393018,0.00001306224,0.000048852235],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99932927,0.00002742713,0.00013565765,0.00023711046,0.00011242934,0.00015811356],"domain_scores_gemma":[0.999642,0.000020056363,0.00003920143,0.000119637916,0.000040717077,0.00013835919],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000032689717,0.00010305057,0.00019771987,0.000045162582,0.000033370292,0.00000813035,0.00003355409,0.000053840387,0.00008420372],"category_scores_gemma":[0.000045303426,0.0000784393,0.000019450164,0.00020346387,0.000050314517,0.00004737293,0.000032811804,0.00012530434,0.000054412285],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055939396,0.0003255719,0.99562407,0.000050828254,0.0000102420745,0.000034512137,0.00073911314,5.908244e-7,0.0020018856,0.0000061454684,0.00009859255,0.0005490686],"study_design_scores_gemma":[0.008767449,0.0026480805,0.98673695,0.000035022695,0.00006808282,0.000004781984,0.00010512853,0.000004974649,0.0012859758,0.0000068035947,0.00023741485,0.00009930613],"about_ca_topic_score_codex":0.000029143197,"about_ca_topic_score_gemma":0.00001008287,"teacher_disagreement_score":0.008887077,"about_ca_system_score_codex":0.000005666511,"about_ca_system_score_gemma":0.000031339285,"threshold_uncertainty_score":0.31986618},"labels":[],"label_agreement":null},{"id":"W3099980423","doi":"10.1182/blood-2020-143816","title":"Efficacy and Safety Results from ASCEMBL, a Multicenter, Open-Label, Phase 3 Study of Asciminib, a First-in-Class STAMP Inhibitor, vs Bosutinib (BOS) in Patients (Pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Previously Treated with ≥2 Tyrosine Kinase Inhibitors (TKIs","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Bosutinib; Medicine; Open label; Myeloid leukemia; Internal medicine; Phases of clinical research; Oncology; Adverse effect; Clinical trial; Imatinib; Nilotinib","score_opus":0.02238647833757712,"score_gpt":0.28372661809334515,"score_spread":0.26134013975576803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3099980423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868635,0.0012003033,0.0000019644242,0.00023957156,0.00005469781,0.010916351,0.0005450238,0.00009556004,0.00008300769],"genre_scores_gemma":[0.9973628,0.00038960623,0.00026219303,0.000103349834,0.00016951197,0.00042845734,0.0010748191,0.0001751851,0.00003410702],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99329627,0.0003792522,0.0021483088,0.002044822,0.0009850009,0.0011463613],"domain_scores_gemma":[0.9967332,0.00040432636,0.00083636324,0.0011732389,0.00019261145,0.000660282],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004387968,0.0010498957,0.0020777984,0.0005031164,0.0001250415,0.00009337699,0.000506466,0.00030823844,0.000057837675],"category_scores_gemma":[0.00041406773,0.00086021266,0.00006672027,0.0018067531,0.00022885614,0.0004961139,0.00046581458,0.00092695485,0.000013984529],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3437257,0.175163,0.4184027,0.001504242,0.0020114705,0.0057859756,0.022716798,0.0008439578,0.012401751,0.0000023783261,0.00032458338,0.01711744],"study_design_scores_gemma":[0.8190449,0.083676904,0.071897216,0.00509887,0.0010754097,0.000015973736,0.0005578357,0.0027203818,0.014690274,4.3806534e-7,0.00042064273,0.0008011854],"about_ca_topic_score_codex":0.011720628,"about_ca_topic_score_gemma":0.022245025,"teacher_disagreement_score":0.47531915,"about_ca_system_score_codex":0.006540463,"about_ca_system_score_gemma":0.0028447395,"threshold_uncertainty_score":0.9993849},"labels":[],"label_agreement":null},{"id":"W3100462444","doi":"10.1182/blood.v130.suppl_1.4934.4934","title":"Comparative Assessment of the Performance of Pharmacokinetic Tools for Prophylactic Dosing of Antihemophilic Factor Recombinant Plasma/Albumin-Free Method (rAHF-PFM) Concentrate in Patients with Hemophilia A","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; University of Waterloo; Impact; Ottawa Hospital","funders":"","keywords":"Medicine; Dosing; Pharmacokinetics; Recombinant DNA; Albumin; Pharmacology; Internal medicine; Chemistry","score_opus":0.05514829457088596,"score_gpt":0.3674697330272108,"score_spread":0.3123214384563249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3100462444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99652714,0.000043661665,0.000008250994,0.00022339936,0.000098617325,0.0026991346,0.00007825719,0.0000055346663,0.00031601824],"genre_scores_gemma":[0.99642855,0.000027952177,0.003317338,0.000007681489,0.000020009487,0.00006279863,0.000012102479,0.000019323861,0.00010424162],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825567,0.00010522533,0.0005067751,0.0002792575,0.00052970095,0.00032339327],"domain_scores_gemma":[0.9979032,0.00025515852,0.0006109601,0.00076555746,0.0003699881,0.00009508913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028329313,0.00021197833,0.0007604556,0.00009913038,0.00012670989,0.00002023884,0.0004073453,0.00006956497,0.000015792308],"category_scores_gemma":[0.0002061069,0.00012171482,0.00012450559,0.0001632468,0.000316369,0.00019016961,0.00012796979,0.00020598467,4.1198462e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013948935,0.003448301,0.9262838,0.0014511759,0.00035401707,0.000004410803,0.0005136954,0.000017544404,0.06370227,0.00003181703,0.000007933687,0.0027901598],"study_design_scores_gemma":[0.016429564,0.0020342974,0.5881933,0.0005381285,0.00023164607,0.0000026378248,0.00003869364,0.0011555196,0.39127198,0.000011378656,0.0000072334315,0.00008560434],"about_ca_topic_score_codex":0.000024286715,"about_ca_topic_score_gemma":0.000005063776,"teacher_disagreement_score":0.33809045,"about_ca_system_score_codex":0.000056751243,"about_ca_system_score_gemma":0.0003919201,"threshold_uncertainty_score":0.49633864},"labels":[],"label_agreement":null},{"id":"W3100496148","doi":"10.1182/blood.2020008250","title":"Hodgkin lymphoma: outsmarting HRS cells","year":2020,"lang":"en","type":"letter","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Lymphoma; Medicine; Hodgkin lymphoma; Internal medicine; Immunology; Cancer research","score_opus":0.018606444995281222,"score_gpt":0.23401402565069632,"score_spread":0.2154075806554151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3100496148","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.039940592,0.001630025,0.0000020007087,0.9317826,0.0005802873,0.0008437851,0.000121770994,0.00032532096,0.024773626],"genre_scores_gemma":[0.018293142,0.0002082165,0.00094277324,0.9625357,0.0077820765,0.0001491181,0.00056975434,0.0001382418,0.009380974],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99801683,0.000050956827,0.00038585134,0.00061063195,0.000463338,0.00047236658],"domain_scores_gemma":[0.9990014,0.000118476455,0.00015591676,0.0005086132,0.00005183933,0.00016378834],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000045801586,0.0004287227,0.00073743105,0.00006760997,0.000074164585,0.000052904972,0.00014335157,0.00047603948,0.0006087034],"category_scores_gemma":[0.00003749121,0.00034998418,0.00038177465,0.00013800878,0.00004476875,0.000027263552,0.00006491713,0.00035531455,0.0022248575],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013312124,0.00071224547,0.0027753399,0.00030516443,0.0006821217,0.01659816,0.000104669634,1.0545044e-7,0.00014713529,0.0000019978647,0.9700474,0.008612306],"study_design_scores_gemma":[0.007564506,0.0003376478,0.0018855307,0.00028450985,0.0022584854,0.0002320882,0.000010262751,0.0000045840347,0.0108065065,0.000016872815,0.97626156,0.0003374252],"about_ca_topic_score_codex":0.00009715753,"about_ca_topic_score_gemma":0.0000016528903,"teacher_disagreement_score":0.03075311,"about_ca_system_score_codex":0.00012527288,"about_ca_system_score_gemma":0.00020049392,"threshold_uncertainty_score":0.9998952},"labels":[],"label_agreement":null},{"id":"W3100577837","doi":"10.1182/blood.2020008676","title":"CC-90009, a novel cereblon E3 ligase modulator, targets acute myeloid leukemia blasts and leukemia stem cells","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":221,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"National Institute of General Medical Sciences; Canadian Institutes of Health Research; National Institutes of Health; U.S. Department of Energy; International Development Research Centre; Office of Science; Government of Ontario; Bristol-Myers Squibb","keywords":"Cereblon; Ubiquitin ligase; Cancer research; Cell biology; Integrated stress response; Stem cell; Chemistry; Biology; Myeloid leukemia; Leukemia; Ubiquitin; Immunology; Biochemistry; Translation (biology)","score_opus":0.009025599242421198,"score_gpt":0.20269255849027798,"score_spread":0.1936669592478568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3100577837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99657214,0.0009799611,0.0010995218,0.00030138157,0.00012239127,0.00029391126,0.0000911957,0.00005088627,0.00048858946],"genre_scores_gemma":[0.9960488,0.0002804268,0.001117043,0.0012185858,0.00045104345,0.000023679408,0.0000808787,0.000043678847,0.00073583634],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99864686,0.00003179415,0.00026906407,0.0005667032,0.00017846756,0.00030710342],"domain_scores_gemma":[0.9992079,0.000006864863,0.00011355019,0.0003079661,0.00006193533,0.00030174694],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00007679405,0.00026043283,0.00021735411,0.00003271076,0.000097609634,0.000055473254,0.00020246272,0.0002347342,0.000013329369],"category_scores_gemma":[0.000022316164,0.00025562177,0.00009823206,0.00011152588,0.000084666775,0.00001160361,0.00020692108,0.00015965036,0.000037918446],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054705168,0.00016151633,0.0001413364,0.000034014414,0.000120977056,0.000012560415,0.00008354142,0.000015943457,0.99466217,0.000041482766,0.0035215295,0.0011502515],"study_design_scores_gemma":[0.004799777,0.00031752296,0.00016139315,0.00001581875,0.00007467296,0.00002797915,0.00003250409,0.0003619447,0.966111,0.000007885667,0.027787693,0.0003018179],"about_ca_topic_score_codex":0.000014534039,"about_ca_topic_score_gemma":0.0000040586046,"teacher_disagreement_score":0.028551152,"about_ca_system_score_codex":0.000031250507,"about_ca_system_score_gemma":0.00019522833,"threshold_uncertainty_score":0.9999896},"labels":[],"label_agreement":null},{"id":"W310066127","doi":"10.1182/blood.v96.1.145","title":"The elusive factor Xa receptor: failure to detect transcripts that correspond to the published sequence of EPR-1","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Incyte","keywords":"Complementary DNA; Survivin; Electron paramagnetic resonance; Biology; Molecular biology; Gene; Genetics","score_opus":0.03150495725205605,"score_gpt":0.2701051410277075,"score_spread":0.23860018377565145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W310066127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9701084,0.0002028152,0.0003871699,0.02461423,0.00049243215,0.0014278664,0.000105157815,0.00009449733,0.0025674498],"genre_scores_gemma":[0.9939334,0.000037480975,0.0008892903,0.0024514003,0.00017246902,0.00006867121,0.000011222793,0.000028262431,0.002407846],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984596,0.000119933764,0.00028118803,0.0003126566,0.0005046047,0.00032203732],"domain_scores_gemma":[0.9987134,0.000145411,0.00006773089,0.00069786655,0.00014345188,0.00023213797],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030325897,0.00018693422,0.00028826884,0.00007595267,0.0002044949,0.00008231481,0.00038746715,0.000104857514,0.001957393],"category_scores_gemma":[0.00018264343,0.00010580493,0.00013772072,0.00047120158,0.000054287604,0.00010942656,0.00003233277,0.00021131412,0.00025449385],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078552833,0.0003976741,0.0009429454,0.00004810823,0.00040982268,0.000011005378,0.007736403,0.000025985353,0.89407265,0.0014379198,0.019444516,0.07468745],"study_design_scores_gemma":[0.0029240586,0.0010882192,0.013276835,0.00016034153,0.00028905342,0.000053853026,0.0008611457,0.000019370545,0.594934,0.00039706627,0.38570258,0.00029347744],"about_ca_topic_score_codex":0.00004543329,"about_ca_topic_score_gemma":0.00023357688,"teacher_disagreement_score":0.36625805,"about_ca_system_score_codex":0.000024258305,"about_ca_system_score_gemma":0.00010819801,"threshold_uncertainty_score":0.99895495},"labels":[],"label_agreement":null},{"id":"W3101364852","doi":"10.1182/blood.2020009342","title":"A validated pediatric disease risk index for allogeneic hematopoietic cell transplantation","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"National Cancer Institute","keywords":"Transplantation; Medicine; Minimal residual disease; Hematopoietic stem cell transplantation; Internal medicine; Disease; Leukemia; Myeloid leukemia; Oncology; Gastroenterology","score_opus":0.016191053001084147,"score_gpt":0.2584309863950892,"score_spread":0.24223993339400507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3101364852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9785573,0.00045342272,0.018466081,0.0009772616,0.000034631183,0.0009881239,0.00022152082,0.00012211448,0.00017953373],"genre_scores_gemma":[0.99706864,0.00044123322,0.001135321,0.00048243382,0.00040650353,0.00010747707,0.00020352879,0.000043242344,0.000111634865],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99872273,0.000047677742,0.00023193317,0.00033863133,0.00035336445,0.0003056479],"domain_scores_gemma":[0.9989337,0.00016859091,0.000070680326,0.0001961546,0.000093489776,0.0005373886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010692425,0.00014623994,0.00021342424,0.00007995284,0.0000669652,0.00001837651,0.00011836615,0.000082203944,0.000077743076],"category_scores_gemma":[0.00021601279,0.00012821237,0.000122001846,0.00031479305,0.000026199565,0.000044572447,0.000021818827,0.00014607834,0.000097621574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063410546,0.0028131625,0.9425014,0.009515757,0.00042586648,0.0018139156,0.0027912266,0.0002792476,0.025197182,0.00007131667,0.0075150784,0.0007347889],"study_design_scores_gemma":[0.20559576,0.0050885277,0.5316523,0.00024237535,0.02727975,0.00043971845,0.0005218561,0.029453762,0.1927833,0.0010253781,0.003783698,0.002133601],"about_ca_topic_score_codex":0.000011854823,"about_ca_topic_score_gemma":8.093566e-7,"teacher_disagreement_score":0.41084912,"about_ca_system_score_codex":0.000041763535,"about_ca_system_score_gemma":0.00051632954,"threshold_uncertainty_score":0.52283484},"labels":[],"label_agreement":null},{"id":"W3102505760","doi":"10.1182/blood-2020-138752","title":"The BET Inhibitor, CPI-0610, Promotes Myeloid Differentiation in Myelofibrosis Patient Bone Marrow and Peripheral CD34+ Hematopoietic Stem Cells","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Myelofibrosis; CD34; Haematopoiesis; Bone marrow; Stem cell; Medicine; Myeloid; Cancer research; Immunology; Biology; Cell biology","score_opus":0.011218679323022007,"score_gpt":0.20972733454213277,"score_spread":0.19850865521911076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3102505760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99104935,0.0019727456,0.000009106632,0.0056053377,0.0000915343,0.0010395987,0.000021259488,0.00004780181,0.00016324001],"genre_scores_gemma":[0.9984517,0.00039334092,0.00025650015,0.00040707114,0.000121272446,0.00022905754,0.000022968243,0.000030326692,0.0000877498],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99844164,0.00009722391,0.00041158154,0.0004107249,0.00033454254,0.00030427062],"domain_scores_gemma":[0.9992797,0.0001211725,0.000120476536,0.00020749502,0.00006111883,0.0002100635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000087302156,0.0002572257,0.00039759418,0.000040324918,0.00016199418,0.00009082843,0.00005445724,0.00008959935,0.000046145997],"category_scores_gemma":[0.000027610835,0.00016895344,0.00008598943,0.00016072397,0.000063500185,0.00007186227,0.00007751414,0.00017277965,0.000018577332],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067355455,0.0044734,0.8141515,0.00086775626,0.0005902436,0.0002849402,0.021510132,0.000009080633,0.12849133,0.00061312335,0.0017257697,0.026609125],"study_design_scores_gemma":[0.012787071,0.004197691,0.20521154,0.0006006472,0.0005819536,0.00008913167,0.0018534876,0.0006664219,0.7709751,0.00014595494,0.0023111054,0.00057987846],"about_ca_topic_score_codex":0.000017757744,"about_ca_topic_score_gemma":0.000034791454,"teacher_disagreement_score":0.6424838,"about_ca_system_score_codex":0.00004925739,"about_ca_system_score_gemma":0.00004898767,"threshold_uncertainty_score":0.6889721},"labels":[],"label_agreement":null},{"id":"W3102608389","doi":"10.1182/blood.v130.suppl_1.4236.4236","title":"Serially Transplantable Patient-Derived Xenograft Model of Chronic Myelomonocytic Leukemia (CMML)","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Chronic myelomonocytic leukemia; Medicine; Leukemia; Cancer research; Immunology; Bone marrow; Myelodysplastic syndromes","score_opus":0.02241161785346447,"score_gpt":0.2548835494229029,"score_spread":0.23247193156943846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3102608389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900994,0.0005947226,0.0001563011,0.00008401082,0.00014846362,0.00064106047,0.00008821679,0.00008159409,0.008106289],"genre_scores_gemma":[0.9967054,0.00043653426,0.0018439593,0.00004309525,0.00014999711,0.000050953022,0.00006845697,0.00005740552,0.00064420555],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982883,0.000023887538,0.00044596582,0.00040713375,0.00034911506,0.00048560297],"domain_scores_gemma":[0.9980717,0.000028105276,0.00032089738,0.0012856603,0.00008719707,0.0002064858],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009252619,0.00029041767,0.0005845795,0.0000820315,0.0002323503,0.000037485755,0.0003218245,0.000179822,0.00014557788],"category_scores_gemma":[0.000051247385,0.00026148802,0.0001969662,0.00005195934,0.00016945401,0.0001964667,0.000086598106,0.00019809589,0.000059823633],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007137962,0.0014981715,0.005922821,0.00095475756,0.0012026462,0.00030911443,0.0012592304,0.0012129191,0.97347736,0.00016355442,0.00023523951,0.013050413],"study_design_scores_gemma":[0.03431411,0.0016413073,0.005157251,0.0007157683,0.0019156887,0.0002366836,0.000050856106,0.015203974,0.9397477,0.00018956845,0.00038749448,0.00043959616],"about_ca_topic_score_codex":0.00045891822,"about_ca_topic_score_gemma":0.00015112074,"teacher_disagreement_score":0.033729635,"about_ca_system_score_codex":0.0008130576,"about_ca_system_score_gemma":0.0020940998,"threshold_uncertainty_score":0.9999837},"labels":[],"label_agreement":null},{"id":"W3102826017","doi":"10.1182/blood.v130.suppl_1.3953.3953","title":"Single Cell Transcriptome Analysis Reveals Changing Levels and Distributions of Stemness across Disease States in Pediatric AML","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Transcriptome; Stem cell; Disease; Biology; Medicine; Computational biology; Genetics; Internal medicine; Gene expression; Gene","score_opus":0.03130108368714987,"score_gpt":0.31734054518670046,"score_spread":0.2860394614995506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3102826017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99694777,0.00082400074,0.0003796465,0.00040960842,0.000020848202,0.0003005478,0.0009985085,0.00001772334,0.00010135966],"genre_scores_gemma":[0.99894816,0.00018613506,0.00016908531,0.000015584847,0.00007609741,0.000024542429,0.00010595772,0.000015617497,0.00045879793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986447,0.00005205103,0.00029251352,0.00028445947,0.00027481862,0.00045147183],"domain_scores_gemma":[0.99884486,0.00008484605,0.00013895589,0.0005573569,0.00011971645,0.000254246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004575511,0.00013059405,0.00042187647,0.0003331619,0.00022133187,0.000061625906,0.00018926252,0.00006202909,0.000024415838],"category_scores_gemma":[0.00020628147,0.000118165444,0.000118268,0.00063622865,0.0001386783,0.00014447588,0.00011091434,0.00016503462,0.0000029308449],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008030545,0.0007713746,0.9754579,0.00062865065,0.00017161759,0.00015205044,0.0012435885,0.0000075499943,0.021172242,0.000016371529,0.000022746743,0.00027558688],"study_design_scores_gemma":[0.003655687,0.00008157224,0.98369664,0.000050238967,0.0014650238,0.0000036021372,0.00038557782,0.00026575133,0.010185266,0.000055732045,0.000026687392,0.00012822798],"about_ca_topic_score_codex":0.000114434944,"about_ca_topic_score_gemma":0.000049860457,"teacher_disagreement_score":0.010986975,"about_ca_system_score_codex":0.000064025604,"about_ca_system_score_gemma":0.00010345074,"threshold_uncertainty_score":0.4818647},"labels":[],"label_agreement":null},{"id":"W3103885896","doi":"10.1182/blood.v130.suppl_1.3917.3917","title":"Prognosis and Application of Day 14 Bone Marrow Results in Acute Myeloid Leukemia Induction","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Hematological disorders and diagnostics","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Leukemia & Lymphoma Society of Canada; University of Alberta; University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Bone marrow; Gastroenterology; Univariate analysis; Etoposide; Myeloid; Myeloid leukemia; Mitoxantrone; Leukemia; Oncology; Chemotherapy; Multivariate analysis","score_opus":0.01791701793412753,"score_gpt":0.2739681661585998,"score_spread":0.2560511482244723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3103885896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954119,0.00018837754,0.00006587688,0.0014759874,0.000021889085,0.0003328229,0.0000115107405,0.000014928504,0.0024767113],"genre_scores_gemma":[0.9987067,0.00034120306,0.00074517325,0.00005094983,0.000027664528,0.000041779793,0.000024412,0.0000053930753,0.000056710433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994322,0.000012404886,0.00020151403,0.00016237874,0.0000943932,0.000097118515],"domain_scores_gemma":[0.99948543,0.000048305177,0.00012713562,0.00024352413,0.00004366597,0.00005195507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001573145,0.0000626406,0.00018695583,0.000040269515,0.000049694594,0.000011444608,0.00004695739,0.00010559876,0.0000026825735],"category_scores_gemma":[0.0007823486,0.000050576873,0.000020109776,0.00004749449,0.00008006599,0.000050555194,0.00003613043,0.00008940855,0.0000045316287],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043049915,0.0016873893,0.88913065,0.0002894944,0.00009549319,0.00009113101,0.00045495795,0.0000016067255,0.044362176,0.0015905611,0.0012833126,0.060582735],"study_design_scores_gemma":[0.0048640626,0.00028382574,0.9652515,0.000113769034,0.00015214966,0.000034685556,0.00004689428,0.000100604426,0.02763867,0.0007249196,0.0007062132,0.0000827278],"about_ca_topic_score_codex":0.00009710791,"about_ca_topic_score_gemma":0.000039283925,"teacher_disagreement_score":0.07612083,"about_ca_system_score_codex":0.000009455515,"about_ca_system_score_gemma":0.000028318727,"threshold_uncertainty_score":0.20624651},"labels":[],"label_agreement":null},{"id":"W3108287138","doi":"10.1182/blood.2020007667","title":"Making a bet on RET for hematopoietic stem cell expansion","year":2020,"lang":"en","type":"letter","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Stem cell; Hematopoietic stem cell; Haematopoiesis; Medicine; Cancer research; Biology; Genetics","score_opus":0.04982892904963825,"score_gpt":0.2822119462205718,"score_spread":0.23238301717093351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108287138","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027480198,0.000899766,0.0040352517,0.935401,0.0014857401,0.007488542,0.0006774942,0.00089100644,0.021640992],"genre_scores_gemma":[0.099478886,0.00007861435,0.0039115646,0.8840093,0.005416385,0.0005243641,0.0019864922,0.00043621496,0.0041581523],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974685,0.000073456,0.00057044765,0.00074608973,0.0006622996,0.00047923398],"domain_scores_gemma":[0.9985614,0.0004036879,0.00024570987,0.00059703353,0.00008240148,0.00010980066],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000120038756,0.0004671565,0.0008421678,0.00016749681,0.00008435459,0.000037938433,0.00018592142,0.00074824505,0.00009039659],"category_scores_gemma":[0.000015316906,0.0004294142,0.00033587587,0.00015392285,0.00003453888,0.000029205969,0.000023388926,0.0010799845,0.00027438765],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002517263,0.00037759217,0.000106722306,0.022876387,0.0002519816,0.004666379,0.0025119428,9.565475e-7,0.0059155277,0.000043535598,0.9625856,0.0004116409],"study_design_scores_gemma":[0.015998334,0.0028888471,0.000048489976,0.01146813,0.005809228,0.0013637545,0.00043469822,0.000103234794,0.18596967,0.00035082732,0.77406186,0.0015029188],"about_ca_topic_score_codex":0.0000016798552,"about_ca_topic_score_gemma":3.318357e-7,"teacher_disagreement_score":0.18852374,"about_ca_system_score_codex":0.000050710463,"about_ca_system_score_gemma":0.0001550463,"threshold_uncertainty_score":0.99981576},"labels":[],"label_agreement":null},{"id":"W3108606285","doi":"10.1182/blood-2020-142888","title":"Efficacy of Oral Ribavirin in Respiratory Syncytial Virus Infection in Hematopoietic Stem Cell Transplant Patients: A Single-Centre Experience","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Respiratory viral infections research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Ribavirin; Medicine; Hematopoietic stem cell transplantation; Internal medicine; Transplantation; Retrospective cohort study; Immunology; Virus; Hepatitis C virus","score_opus":0.052433651597259184,"score_gpt":0.30599642322223736,"score_spread":0.2535627716249782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108606285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983671,0.00012683816,0.000031148393,0.00004206829,0.000051149655,0.0008223719,0.000009393099,0.000046424822,0.0005035471],"genre_scores_gemma":[0.9996699,0.000016390968,0.00001842702,0.0001721916,0.00003588334,0.000044667795,0.0000054965353,0.000025447254,0.000011586403],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980691,0.00022386982,0.00061192166,0.0003680815,0.0004079176,0.00031912234],"domain_scores_gemma":[0.9993413,0.00006720668,0.00009590047,0.00023947001,0.000082098246,0.00017401038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016890457,0.0001739577,0.00039134253,0.0002930632,0.00003071162,0.000015357655,0.00010104399,0.00013440238,0.00008391944],"category_scores_gemma":[0.000095688745,0.00016870823,0.00008868836,0.0008969446,0.00009547997,0.00015296956,0.000043204807,0.0003741885,0.00004218622],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005638964,0.0053782235,0.83905125,0.00032357516,0.000015377618,0.00014659975,0.004599779,0.00006466909,0.14870447,0.000008791626,0.000020238527,0.0011231137],"study_design_scores_gemma":[0.020148648,0.0026137035,0.3980994,0.00039590598,0.000060871636,0.000005275464,0.00023724281,0.0000953706,0.5772907,0.0000023131424,0.0007911065,0.0002594581],"about_ca_topic_score_codex":0.00023503699,"about_ca_topic_score_gemma":0.00028172895,"teacher_disagreement_score":0.44095188,"about_ca_system_score_codex":0.00011564961,"about_ca_system_score_gemma":0.00013037145,"threshold_uncertainty_score":0.6879722},"labels":[],"label_agreement":null},{"id":"W3110545125","doi":"10.1182/blood.2019004108","title":"CRISPR screen identifies genes that sensitize AML cells to double-negative T-cell therapy","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto General Hospital; University Health Network; Princess Margaret Cancer Centre","funders":"Canadian Institutes of Health Research; Princess Margaret Cancer Foundation","keywords":"CRISPR; Cancer research; Biology; Leukemia; Myeloid leukemia; Immunology; Medicine; Gene; Genetics","score_opus":0.018115423116292533,"score_gpt":0.2713269304883873,"score_spread":0.25321150737209475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110545125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98919404,0.0019925048,0.0067305206,0.00044693457,0.00013543598,0.00029293797,0.000034945173,0.000038783743,0.0011339],"genre_scores_gemma":[0.99560946,0.0005342582,0.0018576123,0.00096678146,0.00042554963,0.000015443213,0.000029715999,0.000035877583,0.00052528945],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991011,0.00002167312,0.00013300266,0.00037380733,0.00012896955,0.00024143935],"domain_scores_gemma":[0.99947864,0.000010420512,0.00003221074,0.00025540683,0.00005438588,0.00016892469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000056020737,0.00018429713,0.00015127628,0.00002494635,0.00005534976,0.000046492423,0.0001767916,0.00009348088,0.000028676557],"category_scores_gemma":[0.000009149902,0.00017900187,0.000095659365,0.00008996565,0.000024877432,0.0000029010787,0.000114657516,0.00006664186,0.000057920453],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008370122,0.000053101256,0.00031367794,0.000015706999,0.00006556153,0.000009763579,0.0003171045,0.0004296414,0.99542916,0.0000023750317,0.0028104503,0.00046972992],"study_design_scores_gemma":[0.0016692595,0.00021678355,0.000487854,0.0000054186658,0.000027042159,0.000004430882,0.00022335218,0.000020729092,0.9856844,0.000005071238,0.011421367,0.00023428086],"about_ca_topic_score_codex":0.0000412186,"about_ca_topic_score_gemma":0.000016710072,"teacher_disagreement_score":0.009744775,"about_ca_system_score_codex":0.0000023317534,"about_ca_system_score_gemma":0.00002198196,"threshold_uncertainty_score":0.72994846},"labels":[],"label_agreement":null},{"id":"W3110635148","doi":"10.1182/blood.2020007075","title":"<i>IDH1</i> mutation contributes to myeloid dysplasia in mice by disturbing heme biosynthesis and erythropoiesis","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Erythropoiesis; Biology; Myeloid; Isocitrate dehydrogenase; Haematopoiesis; Ineffective erythropoiesis; Myeloid leukemia; Cancer research; Cell biology; Stem cell; Biochemistry; Internal medicine; Enzyme; Anemia; Medicine","score_opus":0.01146840320203328,"score_gpt":0.2503119315040346,"score_spread":0.2388435283020013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110635148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96015555,0.0012179547,0.0002663074,0.0370211,0.00002261586,0.0005900799,0.0000587993,0.0000735121,0.00059410435],"genre_scores_gemma":[0.99477273,0.00015089731,0.0013005987,0.003470673,0.000085352935,0.0000464548,0.00004444917,0.000033639313,0.000095173644],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99863166,0.000062863226,0.00027808608,0.00040777863,0.000257704,0.00036188273],"domain_scores_gemma":[0.99918026,0.00027532,0.00004462455,0.00013869784,0.000074382115,0.0002867422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001997573,0.00017103668,0.0003613862,0.00012598824,0.000069460286,0.000045241417,0.00011006688,0.0001047279,0.00003614552],"category_scores_gemma":[0.0010248595,0.00015987507,0.000040188574,0.00058165047,0.0000810659,0.00008973419,0.00010863435,0.00023264933,0.00007202717],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000435737,0.00029673058,0.03227947,0.0002703993,0.00019495103,0.0002969638,0.0013525586,0.0000018201408,0.9452879,0.00006815542,0.014788567,0.0047267694],"study_design_scores_gemma":[0.009090375,0.00055622763,0.022328004,0.00025600215,0.00030275894,0.000099389596,0.0015771121,0.0004320856,0.9529337,0.00004862626,0.012017059,0.00035862433],"about_ca_topic_score_codex":0.00018808356,"about_ca_topic_score_gemma":0.000034447174,"teacher_disagreement_score":0.034617234,"about_ca_system_score_codex":0.00011117659,"about_ca_system_score_gemma":0.000100685415,"threshold_uncertainty_score":0.6519516},"labels":[],"label_agreement":null},{"id":"W3110644227","doi":"10.1182/blood.2020005985","title":"Platelet extracellular vesicles mediate transfusion-related acute lung injury by imbalancing the sphingolipid rheostat","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Metropolitan University; SickKids Foundation; University of Toronto; St. Michael's Hospital","funders":"Canadian Institutes of Health Research","keywords":"Ceramide; Sphingolipid; Platelet; Sphingomyelin; Sphingosine; Acid sphingomyelinase; Lipid signaling; Platelet activation; Platelet transfusion; Endothelial stem cell; Cell biology; Pharmacology; Biology; Chemistry; Immunology; Biochemistry; In vitro; Inflammation; Cholesterol; Apoptosis","score_opus":0.008446737422278682,"score_gpt":0.22793646797227807,"score_spread":0.21948973054999937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110644227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883461,0.0026547483,0.00024146248,0.007248905,0.00036365577,0.0003995997,0.000056644785,0.00021144563,0.0004774224],"genre_scores_gemma":[0.993007,0.0016835637,0.00012409649,0.004117571,0.00043020636,0.000018452383,0.00017143582,0.000046295616,0.00040139921],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99864596,0.00009965828,0.00035711317,0.0003492181,0.00022732298,0.0003207326],"domain_scores_gemma":[0.99927485,0.00010335157,0.000094857736,0.00024936278,0.000043108994,0.00023446976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016435176,0.00021158558,0.00035194805,0.00003533298,0.00017155385,0.000017088303,0.0001315771,0.00017234881,0.00045623732],"category_scores_gemma":[0.000065834705,0.00014611568,0.00014364679,0.000271196,0.00009171029,0.00006802222,0.00003725224,0.0004958479,0.00015998149],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035758165,0.0001820357,0.0010782649,0.00007143055,0.00033721328,0.00015218671,0.0018739047,0.0000044305084,0.98109245,0.000065316715,0.013172041,0.0016131524],"study_design_scores_gemma":[0.022483513,0.0029441514,0.00870178,0.00027609692,0.0027482917,0.0007621172,0.0012701204,0.0050130878,0.8533646,0.00023856238,0.10111798,0.001079688],"about_ca_topic_score_codex":0.000016680313,"about_ca_topic_score_gemma":0.0000016173502,"teacher_disagreement_score":0.12772784,"about_ca_system_score_codex":0.000013849049,"about_ca_system_score_gemma":0.0000621335,"threshold_uncertainty_score":0.5958425},"labels":[],"label_agreement":null},{"id":"W3111405919","doi":"10.1182/blood-2020-140585","title":"Frailty Is Associated with Increased One-Year Mortality in Patients with Newly Diagnosed Diffuse Large-B-Cell Lymphoma: A Population-Based Study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Frailty in Older Adults","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Population; Proportional hazards model; Internal medicine; Retrospective cohort study; Emergency department; Lymphoma","score_opus":0.018294577639944444,"score_gpt":0.24311586310910027,"score_spread":0.22482128546915583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111405919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969992,0.000013023245,0.000021269441,0.00025970154,0.000020570433,0.002111574,0.00024149011,0.00018894084,0.00014421585],"genre_scores_gemma":[0.99702996,5.255766e-7,0.00032043896,0.0016848625,0.00004752477,0.00009893725,0.00071270927,0.00007861721,0.00002640116],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972813,0.00018351646,0.00045317982,0.0006293603,0.0009970169,0.0004556396],"domain_scores_gemma":[0.9984387,0.00018716256,0.00023318193,0.00055755465,0.00021361886,0.00036974027],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016421356,0.00034654187,0.00066079415,0.000110978646,0.000078440775,0.00003556834,0.00016915542,0.00014041412,0.00009772035],"category_scores_gemma":[0.0005771204,0.00028630177,0.00006903104,0.00076169125,0.00003022847,0.00011961577,0.000046357072,0.00023515492,0.000025608206],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074212905,0.06415251,0.9332271,0.000066208384,0.00031377425,0.00017568689,0.0011774591,0.000009638532,0.000015099283,9.1702685e-7,0.00008713011,0.00003234685],"study_design_scores_gemma":[0.20398405,0.0023846105,0.7919873,0.00017331995,0.0006154993,2.1128047e-7,0.00019189647,0.00018950073,0.00018731032,0.0000018782798,0.000007292968,0.0002771314],"about_ca_topic_score_codex":0.0025750536,"about_ca_topic_score_gemma":0.0029206364,"teacher_disagreement_score":0.20324193,"about_ca_system_score_codex":0.00014246978,"about_ca_system_score_gemma":0.00024966436,"threshold_uncertainty_score":0.99995893},"labels":[],"label_agreement":null},{"id":"W3112014241","doi":"10.1182/blood.v130.suppl_1.5530.5530","title":"Chemosensitive Disease Better Predicts Outcome Than Age Following Autologous Heamatopoietic Stem Cell Transplantation in Elderly Patients with Multiple Myeloma","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôpital de l'Enfant-Jésus","funders":"","keywords":"Medicine; Multiple myeloma; Hematopoietic stem cell transplantation; Transplantation; Internal medicine; Surgery; Pediatrics","score_opus":0.01620754916367078,"score_gpt":0.26184550030829207,"score_spread":0.24563795114462128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112014241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978238,0.00004185378,0.000026654849,0.00021910373,0.000065499684,0.0011938807,0.00010158976,0.00006153381,0.0004661069],"genre_scores_gemma":[0.99884206,0.000006810092,0.00045417738,0.0000724251,0.000035286877,0.00008247968,0.0002679059,0.00003871838,0.00020016215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982899,0.00006262496,0.00026589687,0.00040801344,0.0004983744,0.00047520403],"domain_scores_gemma":[0.9988503,0.00008294606,0.00011292313,0.0005319858,0.000054807657,0.00036704697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008929562,0.00024232481,0.00037470742,0.00011304838,0.0002201183,0.00006844115,0.00013373715,0.000083894665,0.0000066473453],"category_scores_gemma":[0.000051644383,0.00018466418,0.00012089099,0.000059463502,0.00007504386,0.00019768131,0.000033530887,0.0002007591,0.00003105996],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010412873,0.0013965637,0.98487955,0.00024445445,0.00014817817,0.007953634,0.0005796457,0.000001146108,0.00032766943,8.065095e-7,0.0000039745955,0.0034231115],"study_design_scores_gemma":[0.029145375,0.0005705873,0.96502686,0.00028219505,0.00034773626,0.000013018857,0.000049191174,0.00008895763,0.0042915945,0.000007195669,0.0000051122533,0.00017218021],"about_ca_topic_score_codex":0.00016294414,"about_ca_topic_score_gemma":0.00021465903,"teacher_disagreement_score":0.028104087,"about_ca_system_score_codex":0.000053592805,"about_ca_system_score_gemma":0.00007199597,"threshold_uncertainty_score":0.7530387},"labels":[],"label_agreement":null},{"id":"W3112054388","doi":"10.1182/blood.v130.suppl_1.898.898","title":"Response to Front-Line Imatinib Treatment in Children and Adolescents with CML - Data from a Large Pediatric Cohort","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Shriners Hospitals for Children - Canada","funders":"","keywords":"Medicine; Imatinib; Internal medicine; Neutropenia; Adverse effect; Imatinib mesylate; Transplantation; Cohort; Gastroenterology; Myeloid leukemia; Surgery; Toxicity","score_opus":0.017945412882390877,"score_gpt":0.2875594664409274,"score_spread":0.2696140535585365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112054388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99635684,0.0006242847,0.000011397026,0.00034496665,0.00003164169,0.0014564847,0.0010299857,0.000038738846,0.000105628096],"genre_scores_gemma":[0.99678904,0.00020290754,0.0016872126,0.00011634789,0.00022089516,0.00006191635,0.0005985192,0.00003786785,0.0002852808],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984179,0.00006484764,0.00023786869,0.0006650889,0.00026370236,0.00035060494],"domain_scores_gemma":[0.9975199,0.00003792049,0.00012508668,0.0020378996,0.00002369408,0.0002554909],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024369558,0.00025193,0.00043409792,0.00010935019,0.00012425106,0.00005177423,0.00029962388,0.00008234197,0.000069406626],"category_scores_gemma":[0.00021380492,0.00018581879,0.000025520618,0.000054371143,0.00003120063,0.00013173698,0.00030469062,0.00011557926,0.000109466564],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021789833,0.0019913581,0.9942684,0.000013425774,0.00024816155,0.00027219826,0.00018345329,3.2667683e-7,0.00010511564,3.0127555e-7,0.00024346702,0.0004948092],"study_design_scores_gemma":[0.041302685,0.0008244314,0.9559667,0.00020250074,0.000996415,0.00007028585,0.000016256252,0.00005522005,0.00026065533,0.0000027265396,0.00013753935,0.00016454596],"about_ca_topic_score_codex":0.002947004,"about_ca_topic_score_gemma":0.0010758789,"teacher_disagreement_score":0.039123703,"about_ca_system_score_codex":0.00024413555,"about_ca_system_score_gemma":0.00034278812,"threshold_uncertainty_score":0.75774705},"labels":[],"label_agreement":null},{"id":"W3112059656","doi":"10.1182/blood.2020009499","title":"T-cell activation profiles distinguish hemophagocytic lymphohistiocytosis and early sepsis","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Heart, Lung, and Blood Institute","keywords":"Hemophagocytic lymphohistiocytosis; Cytokine storm; Macrophage activation syndrome; Immunology; Sepsis; CD8; T cell; Cytokine; Cytotoxic T cell; Biology; Immune system; Medicine; Internal medicine; Genetics; In vitro; Disease","score_opus":0.020686406320622127,"score_gpt":0.2554883829735847,"score_spread":0.2348019766529626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112059656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904734,0.0007502249,0.000052541,0.001149293,0.00001257019,0.00031175432,0.0000034437353,0.000088805165,0.0071579507],"genre_scores_gemma":[0.9984865,0.000063113774,0.00029837276,0.00041492836,0.00010864854,0.000027270979,0.000013018408,0.00002257007,0.0005655521],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99914145,0.000024740983,0.00019313638,0.00022830284,0.00022440038,0.00018797994],"domain_scores_gemma":[0.9995452,0.000036866448,0.00005912242,0.00013975643,0.00007486001,0.00014419497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006731408,0.000109684435,0.00021933798,0.000045909008,0.00009763885,0.000032660486,0.000059361202,0.00006524565,0.0000875924],"category_scores_gemma":[0.00031571908,0.000100331905,0.000048377427,0.00018034295,0.000061334744,0.00008294919,0.00005709936,0.00012446613,0.00005585104],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048537183,0.0011064652,0.62774384,0.0020267724,0.00026826607,0.00016223671,0.004198079,0.000002667663,0.34445924,0.00022671181,0.006158004,0.013162358],"study_design_scores_gemma":[0.013316534,0.0012621256,0.46524796,0.00020812162,0.00036207458,0.00003185761,0.0008601135,0.0007156615,0.50537205,0.000066424196,0.012105951,0.0004510957],"about_ca_topic_score_codex":0.000039633618,"about_ca_topic_score_gemma":1.7659238e-7,"teacher_disagreement_score":0.16249587,"about_ca_system_score_codex":0.000020269215,"about_ca_system_score_gemma":0.00012391483,"threshold_uncertainty_score":0.40914163},"labels":[],"label_agreement":null},{"id":"W3112890012","doi":"10.1182/blood-2020-136335","title":"Patient Preferences for Maintenance Treatment of Acute Myeloid Leukemia: Results of a Discrete Choice Experiment","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Maintenance therapy; Azacitidine; Internal medicine; Myeloid leukemia; Placebo; Oncology; Chemotherapy; Alternative medicine","score_opus":0.03536047990813374,"score_gpt":0.30758159564510723,"score_spread":0.2722211157369735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112890012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932116,0.00061852287,0.00019191239,0.0016801857,0.00004040572,0.0017024905,0.0006169263,0.00003700507,0.0019009226],"genre_scores_gemma":[0.9940755,0.00045957314,0.004407391,0.00012147748,0.00013045811,0.00028403726,0.00011070947,0.000026902502,0.0003839879],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99827653,0.000039324706,0.0005593717,0.00040267286,0.00038393182,0.00033817158],"domain_scores_gemma":[0.9987578,0.00017655552,0.00024225141,0.00038394803,0.00021323681,0.00022620645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007466978,0.00020359563,0.0005702217,0.000059816717,0.00003367895,0.000006228719,0.00014355753,0.000092184404,0.00002003241],"category_scores_gemma":[0.00021997033,0.00014155752,0.0001975028,0.00019799544,0.00012253212,0.000049549235,0.000072065435,0.00009310246,0.0000053837475],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021493496,0.0041198465,0.0075033465,0.0013192529,0.0053474475,0.00018387409,0.025936289,0.000051203508,0.8954083,0.0003497571,0.010917105,0.02737009],"study_design_scores_gemma":[0.023336202,0.015434409,0.0025032957,0.00017297488,0.0006179087,0.000014901088,0.0007256956,0.00039359348,0.9466583,0.000024302299,0.009958446,0.0001599692],"about_ca_topic_score_codex":0.00023719863,"about_ca_topic_score_gemma":0.000007924856,"teacher_disagreement_score":0.05125001,"about_ca_system_score_codex":0.00023553113,"about_ca_system_score_gemma":0.00049050414,"threshold_uncertainty_score":0.57725483},"labels":[],"label_agreement":null},{"id":"W3113309259","doi":"10.1182/blood-2021-147101","title":"Part 1 Results of a Dose-Finding Study of Belantamab Mafodotin in Combination with Pomalidomide and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma (RRMM)","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Juravinski Cancer Centre; Queen Elizabeth II Health Sciences Centre; University of Alberta; London Health Sciences Centre; Western University; CancerCare Manitoba; Vancouver General Hospital; Ottawa Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Pomalidomide; Lenalidomide; Medicine; Multiple myeloma; Dosing; Dexamethasone; Internal medicine; Refractory (planetary science); Pharmacology; Adverse effect; Oncology; Gastroenterology","score_opus":0.05008346032906371,"score_gpt":0.31301101659526115,"score_spread":0.26292755626619746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113309259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968415,0.000980842,0.000009982709,0.000104588835,0.000020123041,0.0018496359,0.0001034346,0.0000070281967,0.00008285843],"genre_scores_gemma":[0.99814886,0.00032731344,0.0010971229,0.000003166392,0.000016775532,0.00016357454,0.000067974324,0.000017769926,0.00015745302],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99862885,0.00013699026,0.00045180603,0.00026515225,0.00031720434,0.00020000893],"domain_scores_gemma":[0.9979065,0.0012526468,0.00023519811,0.0003505382,0.00018630797,0.000068784066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028891783,0.00014331247,0.0004853229,0.00013546998,0.000046399015,0.0000053703907,0.000051824965,0.000054426902,0.0000060509133],"category_scores_gemma":[0.00042648794,0.0000892095,0.00006111537,0.0002564047,0.000092016315,0.00003975666,0.000025140649,0.00006832682,2.8727726e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013062018,0.033300225,0.9084042,0.00024267673,0.0014043042,0.00023283972,0.0048230644,0.000010018409,0.021878768,0.000024313353,0.0000096643535,0.016607955],"study_design_scores_gemma":[0.14095911,0.013003657,0.69320625,0.00023679662,0.0005033187,0.000031676627,0.0030921528,0.00017843345,0.14863831,0.0000100657135,0.00006995642,0.00007029803],"about_ca_topic_score_codex":0.00065654854,"about_ca_topic_score_gemma":0.0014282637,"teacher_disagreement_score":0.21519794,"about_ca_system_score_codex":0.00004695028,"about_ca_system_score_gemma":0.00012354147,"threshold_uncertainty_score":0.36378577},"labels":[],"label_agreement":null},{"id":"W3113542088","doi":"10.1182/blood.v130.suppl_1.203.203","title":"SETBP1 and NRAS Mutations Are Frequent Events in Post-Myeloproliferative Neoplasm Acute Myeloid Leukemia (post-MPN AML) Lacking JAK-STAT Activating Mutations","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Essential thrombocythemia; Myelofibrosis; Polycythemia vera; Neuroblastoma RAS viral oncogene homolog; Medicine; Myeloproliferative neoplasm; Ruxolitinib; Myeloid; Cancer research; Oncology; Mutation; Cancer; Myeloid leukemia; Internal medicine; KRAS; Immunology; Gene; Biology; Genetics; Bone marrow","score_opus":0.019077214798341294,"score_gpt":0.2934034473382868,"score_spread":0.27432623253994554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113542088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925811,0.00022357353,0.000051571795,0.0037392667,0.00015699105,0.0015170862,0.00032787552,0.000085405176,0.0013170857],"genre_scores_gemma":[0.9943241,0.00022458304,0.0032035855,0.0006581253,0.00016837288,0.0005747614,0.00043592296,0.00006973491,0.00034081252],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974255,0.00012969864,0.00061455905,0.0007632513,0.0004768297,0.0005901588],"domain_scores_gemma":[0.99765384,0.0003753247,0.0005473641,0.000621254,0.0004740958,0.00032814324],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023023882,0.0004993165,0.00070897234,0.00029838365,0.0011304618,0.00018151884,0.0001926277,0.00020291586,0.0000750657],"category_scores_gemma":[0.00084795227,0.00044100801,0.00014364594,0.00018699825,0.00018334875,0.0006028927,0.00016321869,0.0004996597,0.000050236566],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018401572,0.0013311454,0.97029155,0.00013178588,0.0013761749,0.0008463941,0.007923023,0.00006258408,0.010251448,0.00064229977,0.000046155634,0.006913426],"study_design_scores_gemma":[0.009368316,0.0005438535,0.95423496,0.00067624403,0.0006367368,0.00032185751,0.002201731,0.00020313745,0.030786375,0.00048729448,0.000108584,0.00043090736],"about_ca_topic_score_codex":0.0006530487,"about_ca_topic_score_gemma":0.0024184762,"teacher_disagreement_score":0.020534927,"about_ca_system_score_codex":0.00037391478,"about_ca_system_score_gemma":0.0005817292,"threshold_uncertainty_score":0.9998042},"labels":[],"label_agreement":null},{"id":"W3113752789","doi":"10.1182/blood.2020006322","title":"Natural history of monoclonal B-cell lymphocytosis among relatives in CLL families","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"National Center for Advancing Translational Sciences; National Institute on Aging; Centers for Disease Control and Prevention; National Cancer Institute; CancerCare Manitoba Foundation; National Institutes of Health; Huntsman Cancer Foundation; University of Utah; U.S. Department of Veterans Affairs","keywords":"Cumulative incidence; Lymphocytosis; Incidence (geometry); Population; Medicine; Internal medicine; Immunology; Chronic lymphocytic leukemia; Cohort; Leukemia","score_opus":0.02188533929062256,"score_gpt":0.24356327027944077,"score_spread":0.22167793098881822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113752789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97654295,0.006765517,0.00000335346,0.00017536011,0.000082222374,0.0002632603,0.0000044193835,0.00004131615,0.01612159],"genre_scores_gemma":[0.9969775,0.00023438911,0.0005479088,0.0001857139,0.00009850526,0.00001639519,0.000011764878,0.00002630075,0.001901522],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9985723,0.00006256148,0.00034159407,0.0003042406,0.00043174997,0.0002875804],"domain_scores_gemma":[0.9992804,0.00016283384,0.000086250664,0.0002333922,0.00006953363,0.00016761437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001274388,0.00014803011,0.0003781918,0.0001371007,0.000012882603,0.0000033896185,0.00015607687,0.00011130542,0.00010400622],"category_scores_gemma":[0.00027005453,0.00013401022,0.00011790521,0.0002570312,0.00027100742,0.000094384646,0.00010983285,0.00028637308,0.000040201256],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049585328,0.0073519195,0.36125118,0.0049909772,0.0010729427,0.0037262414,0.066665925,0.00016139634,0.5233496,0.00054798945,0.02120448,0.0047188117],"study_design_scores_gemma":[0.3201069,0.0020354725,0.29621372,0.0010020193,0.00072101614,0.00024047488,0.0044458224,0.046398498,0.3158899,0.00012769633,0.011638276,0.0011801802],"about_ca_topic_score_codex":0.0009311954,"about_ca_topic_score_gemma":0.00003458162,"teacher_disagreement_score":0.31514838,"about_ca_system_score_codex":0.006025688,"about_ca_system_score_gemma":0.0051514264,"threshold_uncertainty_score":0.99779},"labels":[],"label_agreement":null},{"id":"W3115183047","doi":"10.1182/blood.2020009217","title":"Long-term outcomes with emicizumab prophylaxis for hemophilia A with or without FVIII inhibitors from the HAVEN 1-4 studies","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":289,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"Chugai Pharmaceutical; F. Hoffmann-La Roche","keywords":"Medicine; Adverse effect; Confidence interval; Internal medicine; Interquartile range; Hemostasis; Bleed; Surgery; Gastroenterology","score_opus":0.07264896458015811,"score_gpt":0.3371038152387838,"score_spread":0.2644548506586257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3115183047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98203737,0.0009608134,0.000019507013,0.014213497,0.000039068218,0.0024730966,0.000048500846,0.00010512826,0.000103015846],"genre_scores_gemma":[0.9947235,0.00008023657,0.0014842112,0.0006750108,0.00050979474,0.00032723675,0.00004638291,0.00006454107,0.002089081],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831873,0.00004230627,0.0002434974,0.0004756473,0.000525842,0.00039397477],"domain_scores_gemma":[0.99883103,0.00026538974,0.00008341739,0.00040037106,0.00020304244,0.00021673931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009678786,0.00031320183,0.000649955,0.000041081184,0.0002129566,0.00003992783,0.00017899742,0.000084362364,0.000036971083],"category_scores_gemma":[0.00020847369,0.00011912986,0.000112509515,0.00026257432,0.00026455923,0.0000694553,0.000084354164,0.0002551774,0.000025387622],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036947725,0.0005734354,0.9865683,0.00028764285,0.0022642051,0.0004169902,0.0035661731,4.4551732e-7,0.0006398238,0.000006655771,0.00052579807,0.0014557671],"study_design_scores_gemma":[0.115763955,0.05417424,0.7084422,0.0028811623,0.007430921,0.00042510976,0.010123189,0.00010318813,0.09692009,0.000098001765,0.0020313223,0.0016066034],"about_ca_topic_score_codex":0.000031330037,"about_ca_topic_score_gemma":0.00019556361,"teacher_disagreement_score":0.2781261,"about_ca_system_score_codex":0.000040789022,"about_ca_system_score_gemma":0.00025630256,"threshold_uncertainty_score":0.48579746},"labels":[],"label_agreement":null},{"id":"W3118472773","doi":"10.1182/blood.2020008801","title":"Ciraparantag: the next anticoagulant airbag?","year":2021,"lang":"en","type":"letter","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Anticoagulant; Intensive care medicine; Medical emergency; Internal medicine","score_opus":0.11281863629311584,"score_gpt":0.31534633581096727,"score_spread":0.20252769951785143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118472773","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0059762495,0.0023599318,0.000024426598,0.9761014,0.0009031124,0.0006060717,0.00000979956,0.000106369655,0.013912662],"genre_scores_gemma":[0.006597203,0.0006027718,0.00022383653,0.8824218,0.03149058,0.0000047879735,0.0007245444,0.00008308083,0.07785139],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985813,0.00007060373,0.00029557952,0.0003103416,0.00045681623,0.0002853815],"domain_scores_gemma":[0.99897903,0.0001655056,0.00012776605,0.0006318971,0.00006117818,0.000034598303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012554282,0.00023896889,0.0005063304,0.000088470326,0.00008562983,0.000091041,0.00015500617,0.00033244354,0.0006911815],"category_scores_gemma":[0.00007583741,0.00014982035,0.00039035952,0.00019388602,0.000054980716,0.000040836705,0.00009305969,0.0007083811,0.0004318632],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009698267,0.000010353569,0.009589513,0.00020811117,0.0005569569,0.0013387643,0.00004260765,3.373812e-7,0.00016631774,0.000078695535,0.98756665,0.00043199275],"study_design_scores_gemma":[0.0014690482,0.000042030446,0.00582405,0.00012555873,0.0016512485,0.00012810275,0.000028019125,0.000007335316,0.00025412315,0.00004353336,0.9902465,0.00018048742],"about_ca_topic_score_codex":0.000012622006,"about_ca_topic_score_gemma":0.0000014671476,"teacher_disagreement_score":0.09367957,"about_ca_system_score_codex":0.000012490363,"about_ca_system_score_gemma":0.00007652046,"threshold_uncertainty_score":0.7567953},"labels":[],"label_agreement":null},{"id":"W3119945178","doi":"10.1182/blood.2020007789","title":"Cerebrospinal fluid with unusual natural killer cell population","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Cerebrospinal fluid; Population; Medicine; Immunology; Pathology","score_opus":0.0052955419163070215,"score_gpt":0.20116668558873824,"score_spread":0.19587114367243122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119945178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859218,0.0020325691,0.00006679694,0.0001324227,0.00429947,0.00007035467,9.882395e-7,0.000073907686,0.007401679],"genre_scores_gemma":[0.93567324,0.000021348425,0.000084389496,0.00020419636,0.000049971164,0.0000051749,0.0004112831,0.000011342023,0.06353906],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994026,0.00007004077,0.00013736707,0.00019336735,0.000027594122,0.00016907278],"domain_scores_gemma":[0.99969095,0.000018464165,0.00005356989,0.00015513322,0.00007195422,0.000009951613],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000034719054,0.00010404062,0.00011364888,0.00004114896,0.00013580825,0.000018069275,0.00004707891,0.00010386494,0.001801321],"category_scores_gemma":[0.000013479736,0.00008592795,0.00005177221,0.000099808436,0.000025606838,0.000109050416,0.000024416604,0.00021851317,0.0007024617],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021192925,0.0005040184,0.0078978175,0.000014564166,0.0001592662,0.000014689774,0.000111566434,0.0000055216606,0.98170215,0.00036714043,0.008292076,0.00071928615],"study_design_scores_gemma":[0.0034463399,0.0002931952,0.06852769,0.000025694308,0.00012075073,0.0004932397,0.00019790343,0.0000046511163,0.8531197,0.000011533026,0.073553056,0.0002062977],"about_ca_topic_score_codex":0.000055393615,"about_ca_topic_score_gemma":0.00001892883,"teacher_disagreement_score":0.12858248,"about_ca_system_score_codex":0.000016297934,"about_ca_system_score_gemma":0.00002996223,"threshold_uncertainty_score":0.9991112},"labels":[],"label_agreement":null},{"id":"W3120493183","doi":"10.1182/blood.v130.suppl_1.2404.2404","title":"Population Pharmacokinetics Profiling to Tailor Prophylaxis in Hemophilia a Patients: A Pilot Feasibility Study","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Waterloo","funders":"","keywords":"Medicine; Pharmacokinetics; Population pharmacokinetics; Profiling (computer programming); Population; Internal medicine; Intensive care medicine","score_opus":0.06745029152345304,"score_gpt":0.373199669122983,"score_spread":0.30574937759952997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120493183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943337,0.00002014758,9.641723e-7,0.00041977692,0.00009577483,0.0045099375,0.000011250675,0.000038530976,0.0005699312],"genre_scores_gemma":[0.99878615,0.0000032808207,0.00043013,0.00003534466,0.00013912367,0.00016943159,0.000030211162,0.000022957813,0.00038338857],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984049,0.00007535182,0.00030032278,0.0004216814,0.00047381007,0.00032389624],"domain_scores_gemma":[0.99885017,0.000022751516,0.00007319763,0.00068688544,0.00016410304,0.00020288661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036189915,0.0001621311,0.00029607487,0.00016408037,0.00019764555,0.00005843558,0.00017942759,0.000048796395,0.000039505027],"category_scores_gemma":[0.00060296204,0.00012490693,0.000047606198,0.00016174506,0.000034204313,0.00010482557,0.00014321746,0.00021545467,0.000074641786],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062309566,0.014265298,0.97861767,0.000089504756,0.0000476612,0.00008358408,0.00027533813,0.0000010280834,0.0031878585,0.0000035898156,0.000014221945,0.002791155],"study_design_scores_gemma":[0.013250007,0.005039024,0.97511685,0.000058821686,0.000085317704,0.0000021246271,0.000066091685,0.000029704353,0.0061739534,0.00004241613,0.00001425532,0.00012142604],"about_ca_topic_score_codex":0.00027259064,"about_ca_topic_score_gemma":0.00010559108,"teacher_disagreement_score":0.0126269115,"about_ca_system_score_codex":0.00010522766,"about_ca_system_score_gemma":0.000054586835,"threshold_uncertainty_score":0.5093557},"labels":[],"label_agreement":null},{"id":"W3120517312","doi":"10.1182/blood.v130.suppl_1.269.269","title":"Inhibition of the Epigenetic Modifier EZH2 By Mir-138 Upregulates Tumor Suppressor Gene Rbpms and Contributes to Drug Susceptibility in Preclinical Model of Multiple Myeloma","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Epigenetics; Cancer research; EZH2; Multiple myeloma; microRNA; Gene; Suppressor; Tumor suppressor gene; Biology; Genetics; Molecular biology; Medicine; Immunology; Carcinogenesis","score_opus":0.01874335898611425,"score_gpt":0.2881021923290323,"score_spread":0.26935883334291805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120517312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979431,0.00064357155,0.0001035599,0.0002452462,0.000037552487,0.00060256623,0.00038083718,0.0000035120172,0.00004008074],"genre_scores_gemma":[0.9992134,0.000026117541,0.00041051378,0.000026811302,0.000030995438,0.000047859437,0.000037880753,0.000018060191,0.0001883854],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99854237,0.0001390203,0.00043280833,0.00042810274,0.00020109779,0.00025663173],"domain_scores_gemma":[0.998604,0.00006461051,0.00017561442,0.00090691843,0.00016037867,0.00008845455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004851484,0.00014565141,0.0002782434,0.00003648845,0.000108105996,0.00002070469,0.00033332992,0.00014146663,0.000003588415],"category_scores_gemma":[0.0011325234,0.00012087658,0.000097760065,0.000048517435,0.0003952493,0.000007132766,0.0004447721,0.00012226505,0.0000010148972],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001634368,0.00044879588,0.036034252,0.00005045312,0.00002909191,7.6618386e-7,0.00010141947,0.00022428039,0.9624515,0.000004025484,0.0003906645,0.000101298385],"study_design_scores_gemma":[0.0021420491,0.0001206905,0.040710982,0.000052320334,0.00002230278,0.0000016546265,0.000019047127,0.0016592926,0.95500445,0.00011146448,0.000040797586,0.000114953706],"about_ca_topic_score_codex":0.00017892884,"about_ca_topic_score_gemma":0.0005374914,"teacher_disagreement_score":0.00744707,"about_ca_system_score_codex":0.000012694421,"about_ca_system_score_gemma":0.000087267035,"threshold_uncertainty_score":0.4929204},"labels":[],"label_agreement":null},{"id":"W3120759933","doi":"10.1182/blood-2020-139793","title":"Elucidating Barriers to Advance Care Planning in Malignant Hematology Clinics: A Single Centre Experience in Ontario, Canada","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Juravinski Cancer Centre; McMaster University","funders":"","keywords":"Hematology; Medicine; Advance care planning; Population; Internal medicine; Hematologic Neoplasms; Family medicine; Cancer; Intensive care medicine; Palliative care; Nursing","score_opus":0.07178592319066178,"score_gpt":0.35851940019437706,"score_spread":0.28673347700371526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120759933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99680996,0.001721487,0.000031602325,0.00039396208,0.00007032362,0.00017283646,0.0000061449164,0.000011434639,0.0007822575],"genre_scores_gemma":[0.99609655,0.000007753405,0.0023134612,0.0015041305,0.00002523124,0.000011324362,0.000011583263,0.0000100703755,0.000019882584],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.99897623,0.00002824447,0.00033163402,0.0002610618,0.00014538692,0.00025745385],"domain_scores_gemma":[0.9994318,0.000085441,0.00006742791,0.00012162674,0.000047997648,0.00024572565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000036962516,0.00010838684,0.00035728095,0.00004402575,0.00001838037,0.0000031455886,0.00008718321,0.000047222482,0.00006568313],"category_scores_gemma":[0.00086075615,0.00010835969,0.000024886132,0.0001845791,0.000019039104,0.000036611462,0.000044448254,0.00016527531,0.0000013504672],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007614122,0.000027790498,0.8960311,0.00006946554,0.000009009072,0.0007378514,0.101465985,0.00012491431,0.0012394903,0.000010326611,0.000054587817,0.0001533786],"study_design_scores_gemma":[0.0098061375,0.0010301858,0.09714678,0.008827499,0.00008777113,0.00003969112,0.5829454,0.00016573007,0.2458139,0.000013105043,0.053381357,0.00074242655],"about_ca_topic_score_codex":0.45097062,"about_ca_topic_score_gemma":0.94560313,"teacher_disagreement_score":0.7988843,"about_ca_system_score_codex":0.00016531964,"about_ca_system_score_gemma":0.00075205375,"threshold_uncertainty_score":0.5526854},"labels":[],"label_agreement":null},{"id":"W3121321861","doi":"10.1182/blood.2020009103","title":"Modeling and targeting of erythroleukemia by hematopoietic genome editing","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Institute of General Medical Sciences; National Cancer Institute; National Heart, Lung, and Blood Institute; European Hematology Association","keywords":"Biology; GATA1; Epigenetics; Decitabine; Genetics; Somatic evolution in cancer; Leukemia; Transcription factor; Cancer research; DNA methylation; Gene; Gene expression","score_opus":0.011969102595614995,"score_gpt":0.2564444647818105,"score_spread":0.2444753621861955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3121321861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899942,0.0062853103,0.0012476533,0.0004970105,0.000027183552,0.00011521102,0.000011974737,0.000036425212,0.0017849919],"genre_scores_gemma":[0.9919738,0.00028882257,0.0069767,0.00014005016,0.00024944593,0.0000074078066,0.00005492712,0.000031074705,0.00027774228],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988016,0.000035935027,0.00029646026,0.00027293168,0.00029296605,0.00030014061],"domain_scores_gemma":[0.9993461,0.000059513844,0.00004769224,0.00021752708,0.0001866716,0.00014248947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028264234,0.00011196532,0.00030544243,0.000053687403,0.00006453489,0.000015714919,0.00006173535,0.00009058811,0.00008242281],"category_scores_gemma":[0.00034679816,0.000108838874,0.00005489891,0.00018180696,0.000054864788,0.00005463959,0.00014336008,0.0002784006,0.000007934604],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022143126,0.00022449103,0.0039076773,0.00067493325,0.00017216522,0.0002876747,0.0007233962,0.0001252381,0.992498,0.00010030314,0.00069783395,0.0005661797],"study_design_scores_gemma":[0.01655483,0.0003976548,0.0008001142,0.0008666553,0.000823337,0.0024117683,0.0068960413,0.116767734,0.8509306,0.0005347756,0.0023556675,0.0006608425],"about_ca_topic_score_codex":0.000033133983,"about_ca_topic_score_gemma":0.000001207765,"teacher_disagreement_score":0.14156738,"about_ca_system_score_codex":0.000054864162,"about_ca_system_score_gemma":0.00026300002,"threshold_uncertainty_score":0.44383204},"labels":[],"label_agreement":null},{"id":"W3123787238","doi":"10.1182/blood.2020009166","title":"Targeting the AnxA1/Fpr2/ALX pathway regulates neutrophil function, promoting thromboinflammation resolution in sickle cell disease","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"S100 Proteins and Annexins","field":"Biochemistry, Genetics and Molecular Biology","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institute of General Medical Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; National Institutes of Health; American Heart Association","keywords":"Annexin A1; Inflammation; Kinase; Receptor; Protein kinase B; Signal transduction; Immunology; Phenotype; Biology; Cancer research; Cell biology; Medicine; Annexin; Biochemistry; Flow cytometry; Gene","score_opus":0.005265096565886793,"score_gpt":0.18821642434240524,"score_spread":0.18295132777651846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3123787238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959805,0.0026346052,0.00025968466,0.00044053936,0.00008210933,0.00020875075,0.000008474004,0.000019732663,0.00036558352],"genre_scores_gemma":[0.99847513,0.00009424256,0.00027306034,0.000103185535,0.00046085528,0.000037419668,0.0002280029,0.000019343854,0.0003087714],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990383,0.0001125052,0.00020982005,0.00031113933,0.00010976212,0.00021850644],"domain_scores_gemma":[0.9994686,0.000009116055,0.0000890473,0.0002865475,0.00009390134,0.000052760966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022615229,0.000118199365,0.000086674554,0.000020645151,0.00016880638,0.00004543201,0.000091514514,0.000078263874,0.000021276168],"category_scores_gemma":[0.00012041021,0.00009653721,0.00006536855,0.00013794201,0.000033472148,0.000009227458,0.00009230892,0.00009604107,0.000007704857],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002723524,0.00023615059,0.0036840732,0.000038879087,0.000013884862,0.000014234792,0.00007996111,0.00043188603,0.99479276,0.00015350964,0.00014909852,0.00037831368],"study_design_scores_gemma":[0.0010247169,0.00012826822,0.023126073,0.000049991475,0.00004141645,0.000006356576,0.00022820279,0.000780908,0.96812826,0.0006817234,0.0055888477,0.0002152205],"about_ca_topic_score_codex":0.000011983303,"about_ca_topic_score_gemma":0.000026484378,"teacher_disagreement_score":0.0266645,"about_ca_system_score_codex":0.000007918262,"about_ca_system_score_gemma":0.00010376144,"threshold_uncertainty_score":0.3936673},"labels":[],"label_agreement":null},{"id":"W3125485851","doi":"10.1182/blood.v130.suppl_1.979.979","title":"Burden and Risk of Neurological and Cognitive Impairment in Pediatric Sickle Cell Anemia in Uganda (BRAIN SAFE): Interim Overall Results","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Stroke (engine); Pediatrics; Sickle cell anemia; Interim; Anemia; Transcranial Doppler; Interim analysis; Incidence (geometry); Guideline; Physical therapy; Psychological intervention; Randomized controlled trial; Internal medicine; Psychiatry; Disease; Pathology","score_opus":0.00736169791394044,"score_gpt":0.24169728944820285,"score_spread":0.2343355915342624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3125485851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99550766,0.0011812178,6.978983e-7,0.00080798275,0.000030346731,0.00033695035,0.00003474795,0.000008047977,0.0020923596],"genre_scores_gemma":[0.99563956,0.0040711625,0.0000445013,0.00008045151,0.000054267326,0.0000051656725,0.0000065458057,0.000008290574,0.000090037225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991095,0.00006840631,0.00027584168,0.00025769256,0.00009863097,0.00018992466],"domain_scores_gemma":[0.99941665,0.00015940476,0.00015246782,0.00016041358,0.000023327282,0.000087743036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027638787,0.000117486554,0.00026542737,0.00009717532,0.00004744496,0.000015104698,0.00005719772,0.00015124962,0.000009971972],"category_scores_gemma":[0.0005317416,0.00008992461,0.000029037787,0.000049061364,0.00011449445,0.000043912874,0.00011512849,0.00031261062,0.0000020169684],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017281319,0.0006019633,0.99215204,0.00016322604,0.00002051982,0.0003853932,0.0017239501,0.0000040614273,0.0004861926,0.0000035652824,0.0001110262,0.0026199627],"study_design_scores_gemma":[0.018556466,0.0018450371,0.97825235,0.000114521594,0.00019384413,0.000036564696,0.00028920366,0.00012478298,0.0003639161,0.00006034499,0.000058649875,0.00010433667],"about_ca_topic_score_codex":0.0004535631,"about_ca_topic_score_gemma":0.00008398076,"teacher_disagreement_score":0.016828334,"about_ca_system_score_codex":0.000005136933,"about_ca_system_score_gemma":0.000034527962,"threshold_uncertainty_score":0.36670193},"labels":[],"label_agreement":null},{"id":"W3125941142","doi":"10.1182/blood.2020009234","title":"A case of lymphocytic variant hypereosinophilic syndrome in an elderly patient","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fraser Health","funders":"","keywords":"Hypereosinophilic syndrome; Medicine; Internal medicine; Immunology; Eosinophilia","score_opus":0.015457379423500495,"score_gpt":0.24428885606943815,"score_spread":0.22883147664593764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3125941142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964318,0.0014828814,0.000003068564,0.00016243715,0.00006986945,0.0002183105,0.000014925923,0.000024955301,0.0015917311],"genre_scores_gemma":[0.9989619,0.00004514731,0.0006224893,0.00017666219,0.000014058078,0.000017001019,0.000022004702,0.000022648968,0.00011803595],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99881,0.000063508334,0.0003847244,0.0003098934,0.00018619277,0.0002456802],"domain_scores_gemma":[0.99916416,0.000037634472,0.0000655745,0.00048692344,0.000098771794,0.00014691726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008974756,0.00014377847,0.00042744906,0.00013452531,0.00003046859,0.0000132241585,0.000056935056,0.00009629627,0.00018497353],"category_scores_gemma":[0.0000706764,0.00013248886,0.00008778016,0.00035983356,0.00004892893,0.00007322109,0.000039429335,0.00010400849,0.000012535982],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013833957,0.014440131,0.041837078,0.0008600357,0.00037367936,0.88424844,0.0044920477,0.000028407814,0.022898123,0.0022042217,0.00005323074,0.028426297],"study_design_scores_gemma":[0.022203537,0.008118593,0.06587044,0.00080032274,0.00081917515,0.8841118,0.0037349218,0.0004578698,0.011206767,0.001706866,0.00030596904,0.00066371413],"about_ca_topic_score_codex":0.00024574896,"about_ca_topic_score_gemma":0.0001535687,"teacher_disagreement_score":0.027762583,"about_ca_system_score_codex":0.000044978395,"about_ca_system_score_gemma":0.0003978632,"threshold_uncertainty_score":0.54027385},"labels":[],"label_agreement":null},{"id":"W3127180090","doi":"10.1182/blood.v130.suppl_1.3832.3832","title":"Inhibition of FAO in AML Co-Cultured with BM Adipocytes: Mechanisms of Survival and Chemosensitization to Cytarabine","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph; University of Waterloo","funders":"","keywords":"Cytarabine; Internal medicine; Medicine; Cancer research; Chemotherapy","score_opus":0.010972093255159856,"score_gpt":0.23260745036820077,"score_spread":0.22163535711304092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127180090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987971,0.000012754753,0.0005824663,0.00009107305,0.00003705625,0.00021946152,0.000033698216,0.0000133348,0.00021300741],"genre_scores_gemma":[0.99766785,0.0000021350602,0.0022507878,0.000023056005,0.000017230283,0.000005850766,0.000008229641,0.000008883674,0.000016002496],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99925166,0.00003334006,0.00019781104,0.00018584219,0.00020071432,0.00013061194],"domain_scores_gemma":[0.9993751,0.000022729773,0.00017781006,0.00025963795,0.00012176289,0.000042959542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028291382,0.00008482126,0.00020254136,0.000044477652,0.00005087263,0.000033767996,0.00008247027,0.00004215932,0.000018871124],"category_scores_gemma":[0.000089341636,0.000072440576,0.000012704391,0.00007570476,0.00008527888,0.00020569572,0.00004310118,0.000028172264,0.000013444087],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012220757,0.0001797608,0.0016357813,0.00004806453,0.0000041052667,0.000011293036,0.00025551696,0.0000591474,0.9969557,0.0006906681,0.0000066051534,0.000031153308],"study_design_scores_gemma":[0.0020301146,0.00019627386,0.0050167385,0.00011836412,0.000028198392,0.000005660091,0.000100391175,0.00004771354,0.9920757,0.0002903199,0.0000022648037,0.00008830124],"about_ca_topic_score_codex":0.00017609856,"about_ca_topic_score_gemma":0.00018542682,"teacher_disagreement_score":0.0048800367,"about_ca_system_score_codex":0.000011730366,"about_ca_system_score_gemma":0.000032737513,"threshold_uncertainty_score":0.2954041},"labels":[],"label_agreement":null},{"id":"W3127449404","doi":"10.1182/blood.v130.suppl_1.702.702","title":"Aspirin Thromboprophylaxis in Joint Replacement Surgery","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Aspirin; Orthopedic surgery; Knee replacement; Surgery; Joint replacement; Arthroplasty; Anticoagulant; Asymptomatic; Population; Internal medicine","score_opus":0.04038926149058536,"score_gpt":0.2856883620251702,"score_spread":0.2452991005345848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127449404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97268534,0.00021288652,0.0000049478685,0.001957666,0.00026917452,0.00045421804,0.0000020439395,0.000042964508,0.024370763],"genre_scores_gemma":[0.99816746,0.00023845394,0.00024073863,0.00052016275,0.00016752792,0.00007297192,0.00000734322,0.000022066251,0.00056329905],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987815,0.00002063602,0.00031422757,0.00031839925,0.00025927514,0.00030593504],"domain_scores_gemma":[0.99867743,0.000024114594,0.00014866718,0.0010147166,0.000034393724,0.00010068436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047189227,0.00013835247,0.0005195286,0.0001351725,0.00014722698,0.00006118442,0.00011953559,0.000058043195,0.00027449863],"category_scores_gemma":[0.0001870791,0.00012116391,0.0001272035,0.00005090315,0.00005830674,0.000058856338,0.00015881762,0.00011988371,0.00014920374],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000094690135,0.010305567,0.9406362,0.00073133584,0.00054519525,0.0010879507,0.00047818408,0.000003992568,0.0060842196,0.0020804803,0.018199362,0.019752827],"study_design_scores_gemma":[0.0018655595,0.00027419144,0.9822648,0.00028550517,0.000115201736,0.000014119012,0.00005138461,0.0000070203632,0.0098570045,0.00018666698,0.004934421,0.00014413563],"about_ca_topic_score_codex":0.0005436075,"about_ca_topic_score_gemma":0.00012913726,"teacher_disagreement_score":0.04162859,"about_ca_system_score_codex":0.000041703006,"about_ca_system_score_gemma":0.00006021385,"threshold_uncertainty_score":0.4940921},"labels":[],"label_agreement":null},{"id":"W3127510669","doi":"10.1182/blood.v130.suppl_1.5646.5646","title":"Usage of Patient-Centered Outcomes in the Management of Anemia: A Systematic Review","year":2017,"lang":"en","type":"review","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Anemia; Intensive care medicine; Internal medicine","score_opus":0.054787319606068835,"score_gpt":0.3459461757756448,"score_spread":0.29115885616957593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127510669","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000046531743,0.9916178,4.688358e-7,0.000024762825,0.00006633941,0.0050110626,0.000029605135,0.0000048766838,0.0031985445],"genre_scores_gemma":[0.000088518194,0.9991995,0.00007984877,0.00010153174,0.00000777374,0.00026302785,0.000037736507,0.000018705225,0.00020333772],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9977982,0.0002496937,0.0012190498,0.00018788068,0.00039122606,0.00015396287],"domain_scores_gemma":[0.9973906,0.00006977526,0.0011723648,0.0013067881,0.000031216867,0.000029248322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058245484,0.00024347982,0.003667554,0.00011134449,0.000017731882,0.0000058598553,0.00043990774,0.00009462929,0.000018706658],"category_scores_gemma":[0.00013570982,0.00012608843,0.00057466695,0.00012965454,0.000046420366,0.000021310512,0.00007986801,0.00015751229,0.00001452729],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000013018998,0.00057729596,0.00003967062,0.96474355,0.00018176236,0.000050659248,0.000061980594,1.4286118e-9,1.3501203e-8,0.00010199647,0.000054315966,0.034187436],"study_design_scores_gemma":[0.0011521577,0.00006124059,0.000079417456,0.93661225,0.028696395,0.000035080906,0.00010586503,7.543923e-9,2.228042e-7,0.0000044588696,0.033143308,0.00010961132],"about_ca_topic_score_codex":0.000010834241,"about_ca_topic_score_gemma":0.0000015947122,"teacher_disagreement_score":0.034077827,"about_ca_system_score_codex":0.0000075723456,"about_ca_system_score_gemma":0.000050056602,"threshold_uncertainty_score":0.5141737},"labels":[],"label_agreement":null},{"id":"W3128829816","doi":"10.1182/blood.2020009150","title":"Redefining outcomes in immune TTP: an international working group consensus report","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":211,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"ADAMTS13; Discontinuation; Medicine; Thrombotic thrombocytopenic purpura; Thrombotic microangiopathy; Von Willebrand factor; Exacerbation; Internal medicine; Platelet; Immunology; Disease","score_opus":0.032304628311464384,"score_gpt":0.28759124556267146,"score_spread":0.25528661725120705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128829816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99028707,0.0014656065,0.000006593933,0.00025279546,0.0013085118,0.000093030845,0.000018273879,0.00007115962,0.006496981],"genre_scores_gemma":[0.9980993,0.000008192325,0.000311844,0.000062970685,0.00003385903,0.000022910164,0.00043348852,0.0000117628615,0.0010156527],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987979,0.00017006567,0.0004693086,0.00030415764,0.00004441802,0.00021416023],"domain_scores_gemma":[0.9992602,0.00015291297,0.00014539868,0.00038112732,0.000045510318,0.000014837942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026291682,0.00011081517,0.00023727311,0.00008470963,0.00006902182,0.000024106268,0.0001777373,0.00007676371,0.0007572156],"category_scores_gemma":[0.00031365224,0.000114073664,0.00007633113,0.00008835375,0.000043247994,0.000038682498,0.00015012703,0.00013222148,0.00006856252],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002191166,0.0006270504,0.90765136,0.0000058329683,0.0002560666,0.0011163327,0.00013186315,0.000002068651,0.08799417,0.0016195201,0.00009663621,0.0004771896],"study_design_scores_gemma":[0.0042375783,0.000049729326,0.95884365,0.0001605,0.00007841314,0.0020335778,0.0009869564,0.0000022840447,0.018118927,0.00021639407,0.0150151765,0.00025682934],"about_ca_topic_score_codex":0.00009043707,"about_ca_topic_score_gemma":0.00018755448,"teacher_disagreement_score":0.06987525,"about_ca_system_score_codex":0.00002445015,"about_ca_system_score_gemma":0.000054431577,"threshold_uncertainty_score":0.829098},"labels":[],"label_agreement":null},{"id":"W3132032553","doi":"10.1182/blood.v130.suppl_1.549.549","title":"Multimerin-1 Binds to Specific Motifs in Vessel Wall Collagens and Contributes to Thrombosis: Novel Insights Regarding the Mechanisms That Support Human and Mouse Platelet Adhesion","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; Thrombosis and Atherosclerosis Research Institute; Canadian Blood Services; University of Toronto; McMaster University","funders":"","keywords":"Platelet; Thrombosis; Cell biology; Platelet adhesion; Integrin; Biology; Medicine; Chemistry; Immunology; Biochemistry; Surgery; Cell","score_opus":0.052076037474492284,"score_gpt":0.31096912033721213,"score_spread":0.25889308286271984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132032553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954423,0.00018017017,0.00014370013,0.0022205056,0.00005050033,0.001316495,0.000017362365,0.000033978187,0.0005949976],"genre_scores_gemma":[0.9969625,0.00021451378,0.0011015967,0.00041711357,0.000043037104,0.00006354966,0.000013062334,0.000045679935,0.0011389571],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982693,0.00004857856,0.00027275324,0.00054761907,0.00042639067,0.00043532084],"domain_scores_gemma":[0.99856174,0.00011373674,0.0000854147,0.0008083888,0.000103724655,0.00032699786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004461425,0.00023462698,0.0004462601,0.00028135287,0.0005096658,0.00024370033,0.0003037185,0.0001368287,0.000038805374],"category_scores_gemma":[0.00022386543,0.00016963367,0.000047006888,0.00014570347,0.00010900913,0.00009689939,0.0005098352,0.00024843903,0.000035613935],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000111487956,0.0003210115,0.006621932,0.000045328896,0.00006752396,0.00013739312,0.000998625,0.0000014490381,0.99026227,0.00036892312,0.00075531,0.00030875797],"study_design_scores_gemma":[0.0065128207,0.0006219008,0.16300464,0.00020233584,0.000060256734,0.00004291954,0.0005141004,0.0000590634,0.8230332,0.00009367104,0.005633698,0.00022137843],"about_ca_topic_score_codex":0.00015168196,"about_ca_topic_score_gemma":0.00017013747,"teacher_disagreement_score":0.16722903,"about_ca_system_score_codex":0.000053173353,"about_ca_system_score_gemma":0.000047518508,"threshold_uncertainty_score":0.691746},"labels":[],"label_agreement":null},{"id":"W3132194946","doi":"10.1182/blood.2020010150","title":"Clonal hematopoiesis and therapy-related myeloid neoplasms following neuroblastoma treatment","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institute for Health and Care Research; Cancer Research UK; Wellcome Trust","keywords":"Myeloid; Medicine; Haematopoiesis; Neuroblastoma; Hematologic Neoplasms; Oncology; Immunology; Cancer research; Biology; Internal medicine; Stem cell; Transplantation; Genetics","score_opus":0.01568089701656968,"score_gpt":0.26487280630535887,"score_spread":0.24919190928878918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132194946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994373,0.002158679,0.0000013841142,0.0008323974,0.00008109142,0.0002950397,0.0000097988395,0.00009934068,0.0021492436],"genre_scores_gemma":[0.996056,0.0007707461,0.00035842333,0.00019847737,0.000043207947,0.000042958793,0.00002917251,0.00003903932,0.00246194],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998659,0.00007032283,0.00019608926,0.0004085183,0.00030206775,0.0003640132],"domain_scores_gemma":[0.99921376,0.00011562146,0.00003452442,0.00029276364,0.000046850455,0.00029645744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004255654,0.00021702742,0.00033162438,0.00008384054,0.00013097312,0.00004418368,0.00004001398,0.00007008354,0.0001897677],"category_scores_gemma":[0.00004903215,0.00016831026,0.00019923819,0.00024257113,0.000044753575,0.00006728965,0.00004900261,0.00011991134,0.00006723266],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095604116,0.01315123,0.114791304,0.00013090337,0.0062839957,0.055306233,0.0008895063,0.0000025046259,0.7633341,0.0002952619,0.00040183406,0.04445711],"study_design_scores_gemma":[0.031665407,0.003972724,0.06658626,0.00013907549,0.00056504394,0.005416407,0.00010844355,0.00003738723,0.88721484,0.00020497777,0.0038035214,0.00028592575],"about_ca_topic_score_codex":0.000021735339,"about_ca_topic_score_gemma":0.000014178563,"teacher_disagreement_score":0.123880744,"about_ca_system_score_codex":0.000028109393,"about_ca_system_score_gemma":0.00016943325,"threshold_uncertainty_score":0.68634933},"labels":[],"label_agreement":null},{"id":"W3134147891","doi":"10.1182/blood.v130.suppl_1.281.281","title":"Days Spent at Home in the Last 6 Months of Life. a Potential Patient-Determined Quality Indicator for Patients with Hematologic Malignancies at the End of Life","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Ontario Institute for Cancer Research; University of Toronto; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Hematologic malignancy; Quality of life (healthcare); Cohort; Population; Emergency medicine; Palliative care; Hematologic Neoplasms; Logistic regression; Psychological intervention; Cancer; Internal medicine","score_opus":0.05870510393590293,"score_gpt":0.3331621048455485,"score_spread":0.27445700090964553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134147891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99755585,0.0007383909,0.0000068831323,0.0002875438,0.00006460403,0.0008828475,0.00025660102,0.000006136665,0.00020115603],"genre_scores_gemma":[0.9994303,0.000069288595,0.00019529233,0.000118286,0.000035108493,0.00006585204,0.000046776466,0.00001194173,0.000027133503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985455,0.0000967006,0.00050849817,0.00019863465,0.00044182525,0.00020883209],"domain_scores_gemma":[0.9980425,0.00028145374,0.00082472735,0.0006377726,0.00014172979,0.00007178545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002691607,0.00015521876,0.0005519662,0.000051182888,0.00011713857,0.000008384942,0.00030341686,0.00007434844,0.00003121248],"category_scores_gemma":[0.0008525549,0.000077794146,0.0001332484,0.0000559689,0.00039102772,0.000051703402,0.00016124317,0.00007043524,0.0000025650288],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010130791,0.0010260128,0.99204016,0.000345071,0.00015995912,0.0000069301454,0.0034771303,0.0000010570143,0.0014649983,0.000051861647,0.00025874496,0.00015501771],"study_design_scores_gemma":[0.00786988,0.0013390888,0.9638183,0.00038144088,0.00023737992,0.000002836867,0.001151168,0.000004359923,0.024591666,0.00004276341,0.00044166675,0.000119424956],"about_ca_topic_score_codex":0.00013521976,"about_ca_topic_score_gemma":0.0003228435,"teacher_disagreement_score":0.028221814,"about_ca_system_score_codex":0.000021128855,"about_ca_system_score_gemma":0.00008524149,"threshold_uncertainty_score":0.31723532},"labels":[],"label_agreement":null},{"id":"W3134569209","doi":"10.1182/blood.2020009806","title":"Brentuximab vedotin in combination with chemotherapy for pediatric patients with ALK+ ALCL: results of COG trial ANHL12P1","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute","keywords":"Brentuximab vedotin; Medicine; Internal medicine; Oncology; Anaplastic large-cell lymphoma; Chemotherapy; Chemotherapy regimen; Anaplastic lymphoma kinase; Lymphoma; Hodgkin lymphoma; Lung cancer","score_opus":0.008790326467041958,"score_gpt":0.23731495414156306,"score_spread":0.2285246276745211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134569209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977116,0.00017670618,0.000010580414,0.0003503662,0.00005013773,0.0012173015,0.000060549413,0.000013697987,0.00040907765],"genre_scores_gemma":[0.9980814,0.000053448304,0.0011321931,0.00007836108,0.000071973416,0.00012992667,0.00037097232,0.00001898501,0.00006277806],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990819,0.000023937106,0.00026244114,0.00023773046,0.00024638267,0.00014760777],"domain_scores_gemma":[0.9992954,0.00010159525,0.00014630886,0.00019214157,0.00021463692,0.00004990173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007969706,0.00011764352,0.00029705738,0.00007493461,0.000020708132,0.0000086435,0.00003190813,0.000050953928,0.000007644106],"category_scores_gemma":[0.0000559648,0.000081687394,0.00004951829,0.0002511578,0.000017198307,0.000036797952,0.000008225108,0.00003429825,0.0000013184103],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.053763542,0.03837487,0.90076345,0.0001254031,0.000260172,0.000047670528,0.0003036604,0.0000022094614,0.000042654185,0.00009111699,0.0004281311,0.005797098],"study_design_scores_gemma":[0.54677576,0.0058186194,0.43805245,0.00007948628,0.0003977137,0.000003371104,0.00002271611,0.000007647913,0.008551328,0.000017663313,0.00019387138,0.000079403886],"about_ca_topic_score_codex":0.00003233715,"about_ca_topic_score_gemma":0.00003913232,"teacher_disagreement_score":0.4930122,"about_ca_system_score_codex":0.000035329507,"about_ca_system_score_gemma":0.00017512876,"threshold_uncertainty_score":0.33311152},"labels":[],"label_agreement":null},{"id":"W3134855792","doi":"10.1182/blood.2020008654","title":"AID overexpression leads to aggressive murine CLL and nonimmunoglobulin mutations that mirror human neoplasms","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"","keywords":"Chronic lymphocytic leukemia; Cancer research; Biology; Mutation; Gene; Somatic hypermutation; Leukemia; Cytidine deaminase; Activation-induced (cytidine) deaminase; Cancer; Lymphoma; Point mutation; Immunology; B cell; Genetics; Antibody","score_opus":0.02698113262165302,"score_gpt":0.32126205110735323,"score_spread":0.2942809184857002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134855792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942727,0.0012540234,0.000013615008,0.0007262513,0.0000648238,0.00041269136,0.000026714128,0.00006768773,0.00316149],"genre_scores_gemma":[0.9904444,0.00009783236,0.0029389195,0.00037292726,0.00010716573,0.00005922294,0.00012368022,0.000040468367,0.005815356],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99832994,0.000064292544,0.00023949881,0.00045786012,0.00049747236,0.00041094478],"domain_scores_gemma":[0.99870855,0.00014756159,0.00008754689,0.0005582479,0.00017455271,0.0003235396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011820128,0.00018765217,0.00031367945,0.00011218513,0.00019235314,0.00005962815,0.000116866126,0.000126278,0.000525649],"category_scores_gemma":[0.00035609608,0.00016704774,0.00007894121,0.0002708968,0.00010241213,0.00008647825,0.0002986064,0.00024579596,0.00017508077],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004407567,0.0023225292,0.012978483,0.000655394,0.00035842665,0.0068153,0.0024508117,0.000011139918,0.9676155,0.0003452282,0.0034909653,0.0025154958],"study_design_scores_gemma":[0.057746142,0.0006072858,0.024390344,0.001771351,0.0002966709,0.0038237218,0.00056364253,0.0001686752,0.90403926,0.00018485126,0.0060229404,0.00038511062],"about_ca_topic_score_codex":0.00032395002,"about_ca_topic_score_gemma":0.00011823734,"teacher_disagreement_score":0.06357621,"about_ca_system_score_codex":0.0008157186,"about_ca_system_score_gemma":0.0017867357,"threshold_uncertainty_score":0.6812009},"labels":[],"label_agreement":null},{"id":"W3135007625","doi":"10.1182/blood.2020009023","title":"A JAK/STAT-mediated inflammatory signaling cascade drives oncogenesis in AF10-rearranged AML","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Cancer research; stat; JAK-STAT signaling pathway; PIM1; Fusion protein; Carcinogenesis; Transcriptome; Myeloid leukemia; Biology; Leukemia; Signal transduction; Computational biology; Gene; STAT3; Genetics; Tyrosine kinase; Gene expression; Phosphorylation","score_opus":0.016919866997526355,"score_gpt":0.2743598381551708,"score_spread":0.25743997115764444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135007625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942363,0.0018791169,0.000016678221,0.0010913474,0.00006291923,0.00037235455,0.000020775871,0.0001167313,0.0022037802],"genre_scores_gemma":[0.99638677,0.00034684432,0.0012745451,0.00048819982,0.00029387505,0.00007286039,0.00011141874,0.00006665775,0.00095885043],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99772745,0.00022052902,0.0004325099,0.00045825547,0.0005565519,0.00060471083],"domain_scores_gemma":[0.99861044,0.0003359158,0.00007332448,0.00046362472,0.00020662417,0.00031005804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041702244,0.00022098023,0.00046141096,0.00030849726,0.00006007304,0.00003323941,0.0001594647,0.00022864284,0.00035954316],"category_scores_gemma":[0.0009138499,0.00021462783,0.00013161088,0.0007858323,0.00010100809,0.00010151873,0.00013463588,0.0005754036,0.0002377909],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001545298,0.00056083297,0.08477402,0.00021665847,0.0002607857,0.008472311,0.0020987524,0.000011638604,0.9012791,0.000021542872,0.000524926,0.0016249317],"study_design_scores_gemma":[0.016686922,0.00020873245,0.10046019,0.00048724073,0.0003039062,0.0007768326,0.0022114466,0.00028712314,0.86750007,0.00004105469,0.010562401,0.00047409657],"about_ca_topic_score_codex":0.0001372455,"about_ca_topic_score_gemma":0.00024635068,"teacher_disagreement_score":0.033779014,"about_ca_system_score_codex":0.00022307815,"about_ca_system_score_gemma":0.0012476133,"threshold_uncertainty_score":0.87522686},"labels":[],"label_agreement":null},{"id":"W3135013756","doi":"10.1182/blood.v130.suppl_1.999.999","title":"The Role of Soluble Interleukin-2 Receptor (sIL-2r) in Diagnosis of Adult Hemophagocytic Lymphohistiocytosis (HLH): A Single Center Retrospective Study","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Hemophagocytic lymphohistiocytosis; Medicine; Macrophage activation syndrome; Immunology; Internal medicine; Gastroenterology; Sepsis; Retrospective cohort study; Disease","score_opus":0.01331176503629323,"score_gpt":0.27457235860541257,"score_spread":0.26126059356911935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135013756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99285966,0.00096625264,8.0604997e-7,0.00021161753,0.00009775409,0.0007801684,0.000012403817,0.000015317319,0.0050560012],"genre_scores_gemma":[0.9989406,0.00031267697,0.000034836725,0.000017537794,0.000039456732,0.00015597524,0.000004291772,0.000026698697,0.00046795674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982983,0.00008481894,0.00056682265,0.00027495073,0.0004494056,0.00032568572],"domain_scores_gemma":[0.9982116,0.00007750027,0.00035714588,0.00094733806,0.00034311917,0.00006328051],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003554876,0.00016020256,0.0005229995,0.00012424376,0.00022275648,0.000041059764,0.0004502485,0.0000820035,0.000085201966],"category_scores_gemma":[0.0010550978,0.00011950723,0.00014413585,0.00013630032,0.0002984161,0.00013312566,0.00024811624,0.00020017046,0.000022888264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040617338,0.005157035,0.97851264,0.00006599908,0.00023130924,0.000014718899,0.0018904002,2.8035691e-7,0.008065714,0.00007976049,0.00018498882,0.0053909817],"study_design_scores_gemma":[0.018102413,0.0033376077,0.7012664,0.00059642975,0.00019771667,0.000012622515,0.00891782,0.00008034333,0.26529592,0.0001917132,0.0017701606,0.0002308621],"about_ca_topic_score_codex":0.0009081749,"about_ca_topic_score_gemma":0.0004726351,"teacher_disagreement_score":0.27724624,"about_ca_system_score_codex":0.0001501133,"about_ca_system_score_gemma":0.00016238022,"threshold_uncertainty_score":0.48733637},"labels":[],"label_agreement":null},{"id":"W3135457122","doi":"10.1182/blood.2020009735","title":"Bone marrow infiltration by plasmablastic neoplasm: plasmablastic myeloma or plasmablastic lymphoma?","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hematological disorders and diagnostics","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Plasmablastic lymphoma; Medicine; Bone marrow; Lymphoma; Multiple myeloma; Pathology; Plasma Cell Myeloma; Internal medicine","score_opus":0.013027254806729562,"score_gpt":0.23733089869563034,"score_spread":0.22430364388890078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135457122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866997,0.00092994835,0.0021610854,0.0010009571,0.00049052,0.00053610984,0.00016184876,0.00034067367,0.0076791574],"genre_scores_gemma":[0.9911056,0.0003606957,0.0024781115,0.0013053059,0.00019075233,0.00010371296,0.00040402502,0.00009232264,0.003959476],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966289,0.00011027815,0.0008441874,0.0008284527,0.0006972411,0.00089098234],"domain_scores_gemma":[0.9964363,0.001882476,0.00020690801,0.0005638725,0.00028016095,0.00063027634],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00013749374,0.00054327154,0.00093974516,0.00015504124,0.00024056855,0.00013401142,0.00016569655,0.00043025508,0.0012331147],"category_scores_gemma":[0.005516814,0.00044437687,0.00021331657,0.00077354343,0.00019103756,0.00017993076,0.00012782589,0.00031876634,0.00094576244],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01396062,0.06253343,0.10481284,0.008645698,0.004990846,0.07688083,0.0019457123,0.0019079059,0.34476036,0.014773985,0.340482,0.024305766],"study_design_scores_gemma":[0.14086567,0.014295179,0.08678322,0.0052959183,0.010740271,0.04716154,0.0026000256,0.02874848,0.5120401,0.0038384874,0.14075862,0.0068725385],"about_ca_topic_score_codex":0.000014001683,"about_ca_topic_score_gemma":0.00011532607,"teacher_disagreement_score":0.19972338,"about_ca_system_score_codex":0.00007151065,"about_ca_system_score_gemma":0.00075243507,"threshold_uncertainty_score":0.9998321},"labels":[],"label_agreement":null},{"id":"W3135525877","doi":"10.1182/blood.2020009690","title":"Sickle cell disease, interleukin-18, and arrhythmias","year":2021,"lang":"en","type":"letter","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Disease; Internal medicine; Immunology; Cardiology","score_opus":0.010702178548927438,"score_gpt":0.2176924213894874,"score_spread":0.20699024284055997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135525877","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.085586846,0.05628802,0.000014382417,0.80178636,0.001033873,0.0008035783,0.0001371215,0.00021634485,0.054133452],"genre_scores_gemma":[0.020068046,0.005129607,0.00030791425,0.89338017,0.005855799,0.00005082484,0.0014761407,0.0002122449,0.07351926],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998497,0.000048145066,0.0002692134,0.00051128166,0.00029225493,0.0003821249],"domain_scores_gemma":[0.9990732,0.00005298546,0.00009059956,0.00049599214,0.00007165359,0.00021553662],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000049364244,0.00032631427,0.00049848016,0.00010790839,0.0000611925,0.00004699221,0.00007902734,0.0006920469,0.00066995295],"category_scores_gemma":[0.000052657295,0.00027141016,0.00020364184,0.00012851197,0.000103561986,0.000027633687,0.000103283724,0.0016019661,0.00010898985],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023273467,0.00021124032,0.000637652,0.0014057572,0.00021162647,0.017707158,0.000108044966,2.4462744e-7,0.00013324746,0.0000031102763,0.978884,0.0006746396],"study_design_scores_gemma":[0.0028053774,0.00012846694,0.00032939023,0.00079564966,0.0014746271,0.00047466296,0.00009442845,0.0000067035503,0.00037545382,0.000053126194,0.9931197,0.00034242493],"about_ca_topic_score_codex":0.000017716911,"about_ca_topic_score_gemma":0.000001525737,"teacher_disagreement_score":0.09159378,"about_ca_system_score_codex":0.000020997808,"about_ca_system_score_gemma":0.00024612606,"threshold_uncertainty_score":0.99997383},"labels":[],"label_agreement":null},{"id":"W3135559489","doi":"10.1182/blood.2020009497","title":"Anti-inflammatory activity of CD44 antibodies in murine immune thrombocytopenia is mediated by Fcγ receptor inhibition","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Antibody; Immunology; Phagocytosis; Immune system; CD44; Receptor; Monoclonal antibody; Subclass; Blockade; Medicine; Fc receptor; Biology; In vitro; Internal medicine; Biochemistry","score_opus":0.016421430445821672,"score_gpt":0.2824051467517951,"score_spread":0.26598371630597345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135559489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99195313,0.0025685772,0.0000019230108,0.0024708887,0.00007322899,0.0002491459,0.0001846937,0.000027829245,0.0024705736],"genre_scores_gemma":[0.99431616,0.002714956,0.00017874848,0.00014100452,0.00009146378,0.0000116013,0.00028952985,0.000023029133,0.0022335225],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998274,0.00011473552,0.00042740922,0.0003347766,0.00050009403,0.00034897294],"domain_scores_gemma":[0.99911356,0.00012903968,0.0001194722,0.00029971063,0.00021538312,0.00012284736],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002680743,0.00019167816,0.0006837576,0.00013253698,0.00005910115,0.0000135358805,0.00008372888,0.00014140698,0.001673378],"category_scores_gemma":[0.00017132176,0.00016872332,0.00013891574,0.00038970046,0.00017049488,0.00012759064,0.00015864344,0.0003450945,0.0001079803],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019297293,0.0012165842,0.12630904,0.00038565893,0.00013618391,0.00026775966,0.00021303458,2.0009763e-7,0.86847055,0.00003482059,0.0022881047,0.00048511644],"study_design_scores_gemma":[0.002712284,0.00015160539,0.18210067,0.00027932148,0.000044177617,0.000088450994,0.00006726082,0.000012632202,0.81100017,0.000018383691,0.003386638,0.00013843074],"about_ca_topic_score_codex":0.00029560077,"about_ca_topic_score_gemma":0.00005000978,"teacher_disagreement_score":0.057470385,"about_ca_system_score_codex":0.000029826515,"about_ca_system_score_gemma":0.00021069159,"threshold_uncertainty_score":0.9992392},"labels":[],"label_agreement":null},{"id":"W3135826314","doi":"10.1182/blood.2020007683","title":"Characterization of DLBCL with a PMBL gene expression signature","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Simon Fraser University; Spinal Cord Injury BC; University of British Columbia","funders":"Terry Fox Research Institute; Genome British Columbia; Michael Smith Health Research BC; BC Cancer Foundation; Canadian Institutes of Health Research; Genome Canada","keywords":"Lymphoma; Germinal center; Diffuse large B-cell lymphoma; Pathology; Bone marrow; Biology; Large-cell lymphoma; Reed–Sternberg cell; Gene signature; BCL6; Cancer research; B cell; Medicine; Gene; Gene expression; Immunology; Genetics; Antibody; Hodgkin lymphoma","score_opus":0.0070007974373664785,"score_gpt":0.2135871744456708,"score_spread":0.20658637700830432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135826314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985206,0.00037541482,0.000040050098,0.00023448799,0.000023231056,0.00011232148,0.000015175779,0.000016177904,0.0006625391],"genre_scores_gemma":[0.99774104,0.00009338433,0.0014534218,0.00013989156,0.000059448375,0.000018724551,0.0002166316,0.000008821809,0.00026862088],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99958336,0.0000116320225,0.00008382559,0.00012355662,0.00012875997,0.00006887907],"domain_scores_gemma":[0.99965984,0.000009681597,0.00004610535,0.00015970808,0.00008065158,0.000044014254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000014466739,0.000062462306,0.00013647086,0.000019342213,0.000017090022,0.0000046888604,0.000015646994,0.00004648167,0.000081020844],"category_scores_gemma":[0.000009372151,0.000040970346,0.00003197726,0.00008950438,0.000009409932,0.000026740565,0.000013092352,0.000026971236,0.000005187038],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041673335,0.002163846,0.076640084,0.000038462884,0.00007622544,0.0002536958,0.00009935643,1.487993e-7,0.91998035,0.000028164386,0.000025731686,0.0006522712],"study_design_scores_gemma":[0.004009371,0.00015070794,0.22201094,0.00015658411,0.00016415374,0.00008432278,0.000012167376,0.0000011665837,0.7729964,0.000002596565,0.0003781003,0.000033479824],"about_ca_topic_score_codex":0.0000024455255,"about_ca_topic_score_gemma":0.0000010055556,"teacher_disagreement_score":0.14698394,"about_ca_system_score_codex":0.00000931578,"about_ca_system_score_gemma":0.00007125979,"threshold_uncertainty_score":0.16707222},"labels":[],"label_agreement":null},{"id":"W3136017577","doi":"10.1182/blood.2020008551","title":"Very long chain fatty acid metabolism is required in acute myeloid leukemia","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Western University; Population Health Research Institute; Ontario Institute for Cancer Research; University of Waterloo; University of Guelph","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Citric acid cycle; Biology; Beta oxidation; Glycolysis; Oxidative phosphorylation; Myeloid leukemia; Myeloid; Leukemia; Haematopoiesis; Fatty acid metabolism; Metabolism; Biochemistry; Cancer research; Cell biology; Stem cell; Immunology","score_opus":0.019494416410620233,"score_gpt":0.2833962493196377,"score_spread":0.2639018329090175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3136017577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98489726,0.004684013,0.00016876576,0.003502689,0.0002090856,0.00045391152,0.000045958095,0.00012558866,0.005912757],"genre_scores_gemma":[0.9811087,0.0020048935,0.0046980027,0.0034954166,0.0006737742,0.00010274401,0.00018005178,0.00011097948,0.0076254234],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99700755,0.00016443097,0.0005018007,0.00072574965,0.00073789526,0.000862577],"domain_scores_gemma":[0.9982499,0.00009217525,0.00008463153,0.0009902428,0.00023051759,0.00035251697],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005112311,0.000315197,0.0007540711,0.0003092303,0.00008835638,0.000056575755,0.0002961036,0.00031398062,0.00059605186],"category_scores_gemma":[0.00037988235,0.00030082767,0.00022396714,0.0011055009,0.00012588926,0.000217081,0.00035209744,0.0008554644,0.0004143709],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055824674,0.0010134503,0.03727495,0.0003187115,0.001510046,0.021073407,0.0021422727,0.0000036899821,0.9139457,0.00045839942,0.008851739,0.012849442],"study_design_scores_gemma":[0.012923732,0.000112909875,0.12717219,0.00018508095,0.0005573196,0.0011274355,0.00027361565,0.00017874273,0.84954226,0.0001583802,0.007384196,0.0003841318],"about_ca_topic_score_codex":0.00014265275,"about_ca_topic_score_gemma":0.000069734015,"teacher_disagreement_score":0.08989724,"about_ca_system_score_codex":0.0005172079,"about_ca_system_score_gemma":0.0018950084,"threshold_uncertainty_score":0.9999444},"labels":[],"label_agreement":null},{"id":"W3136388199","doi":"10.1182/blood.2020008787","title":"Oral ixazomib, lenalidomide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University; University of Calgary; University of Alberta","funders":"","keywords":"Ixazomib; Medicine; Lenalidomide; Hazard ratio; Placebo; Internal medicine; Multiple myeloma; Adverse effect; Clinical endpoint; Surgery; Randomized controlled trial; Confidence interval; Carfilzomib","score_opus":0.021123076286984066,"score_gpt":0.27062624192890355,"score_spread":0.2495031656419195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3136388199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970469,0.0006334715,0.0004647876,0.00024051667,0.000035774006,0.001066404,0.0002520036,0.000055078977,0.00020506038],"genre_scores_gemma":[0.9789285,0.00016395886,0.019473778,0.00015167215,0.00007090304,0.00019757789,0.00059082167,0.000044107623,0.00037868344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985001,0.000050995422,0.0002128745,0.00043160457,0.00033169298,0.0004727094],"domain_scores_gemma":[0.9986538,0.00040664192,0.00004855136,0.00028214327,0.00024882847,0.0003599802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009970992,0.00022026949,0.00041411145,0.000086606575,0.000118725366,0.000042241514,0.000057913618,0.000086190164,0.000057772882],"category_scores_gemma":[0.000308391,0.00016284845,0.00008783885,0.00018460504,0.000064344145,0.00009704436,0.000027620295,0.00012057627,0.000012313244],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033140334,0.00232666,0.97936463,0.0002143165,0.00062268676,0.00062907825,0.0001527171,0.0000013574146,0.0023202705,0.000018175191,0.00019140243,0.010844654],"study_design_scores_gemma":[0.13989183,0.0012787242,0.78780675,0.00022609126,0.00065310835,0.000100721634,0.00006892713,0.00019707554,0.06816222,0.00003203751,0.0013202298,0.00026229175],"about_ca_topic_score_codex":0.00012245025,"about_ca_topic_score_gemma":0.0003249873,"teacher_disagreement_score":0.19155791,"about_ca_system_score_codex":0.000023164373,"about_ca_system_score_gemma":0.00015905398,"threshold_uncertainty_score":0.6640767},"labels":[],"label_agreement":null},{"id":"W3136648532","doi":"10.1182/blood.2020009165","title":"MARCKS affects cell motility and response to BTK inhibitors in CLL","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Institutes of Health; Ministry of Science and Higher Education of the Russian Federation; Genome Canada; Skolkovo Institute of Science and Technology; Deutsche Forschungsgemeinschaft; Megagrants; José Carreras Leukämie-Stiftung; National Heart, Lung, and Blood Institute; Gilead Sciences","keywords":"Bruton's tyrosine kinase; IGHV@; MARCKS; Chronic lymphocytic leukemia; Phosphorylation; Ibrutinib; Biology; Tyrosine phosphorylation; Cancer research; Protein kinase B; Idelalisib; breakpoint cluster region; Signal transduction; B-cell receptor; Tyrosine kinase; Cell biology; Protein kinase C; Immunology; Biochemistry; B cell; Leukemia; Antibody; Receptor","score_opus":0.010416831276222404,"score_gpt":0.2761495664808537,"score_spread":0.2657327352046313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3136648532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99485254,0.0008697972,0.0000020035611,0.0009997862,0.000056824694,0.00038990282,0.000005244138,0.000030229712,0.0027936413],"genre_scores_gemma":[0.99686855,0.00002977394,0.00041441736,0.0003117878,0.00008790689,0.000022103966,0.00000438763,0.000020154164,0.0022409],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985031,0.00021751394,0.00016648829,0.00038959403,0.00036127513,0.00036204557],"domain_scores_gemma":[0.99879956,0.0003838957,0.000017696662,0.00043998254,0.00005915368,0.00029973505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007578972,0.0001164731,0.00024204399,0.00013274422,0.000028120077,0.000023029108,0.0000679815,0.00010690315,0.000085865344],"category_scores_gemma":[0.0010572523,0.000110551424,0.000042527423,0.00042189562,0.000053423268,0.000025176747,0.00022526951,0.00021931017,0.00006288906],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008035756,0.0075490074,0.1865741,0.0023962501,0.00015900769,0.027801149,0.0058142478,0.00002112904,0.7417042,0.000035302237,0.008784486,0.011125306],"study_design_scores_gemma":[0.060184672,0.0006026166,0.22966723,0.00034666283,0.00007624415,0.00063833536,0.00043779882,0.00035724352,0.7034521,0.000052852145,0.0039694323,0.00021478707],"about_ca_topic_score_codex":0.00015133416,"about_ca_topic_score_gemma":0.00013657348,"teacher_disagreement_score":0.052148916,"about_ca_system_score_codex":0.0016164439,"about_ca_system_score_gemma":0.0037121607,"threshold_uncertainty_score":0.65852135},"labels":[],"label_agreement":null},{"id":"W3136957643","doi":"10.1182/blood.2020010470","title":"Multiple Auer rods in a mixed-phenotype acute leukemia","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Leukemia; Phenotype; Pathology; Immunology; Biology; Genetics","score_opus":0.016861192859688602,"score_gpt":0.2860804658041077,"score_spread":0.26921927294441905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3136957643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860989,0.00078698684,0.00006819165,0.0011782916,0.00012499101,0.00027429682,0.000015923131,0.00008334507,0.0113691045],"genre_scores_gemma":[0.98566264,0.00016295994,0.005678248,0.00065376016,0.00022035048,0.000045091794,0.00009021237,0.000051094386,0.0074356506],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983096,0.00008628673,0.0002743355,0.0004287974,0.00038443727,0.0005165553],"domain_scores_gemma":[0.9988549,0.00013716538,0.00003552682,0.0005954683,0.00016242328,0.00021454596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023322857,0.0001705166,0.00037403914,0.00015327989,0.00004749543,0.000025515425,0.00014953515,0.00017673144,0.00039552455],"category_scores_gemma":[0.0005392233,0.00015808917,0.0001033672,0.00066013256,0.00006184928,0.00007754725,0.00019418677,0.00056802185,0.0004329873],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005509441,0.0022932787,0.36959484,0.00033685492,0.0011464952,0.019583102,0.0012718774,0.00003037821,0.57312286,0.0008763121,0.0141803995,0.017012674],"study_design_scores_gemma":[0.0356869,0.0004679775,0.55373275,0.0003588897,0.0006488904,0.0010407204,0.00053467514,0.00201176,0.3666373,0.00035898987,0.037885774,0.00063537294],"about_ca_topic_score_codex":0.00021887825,"about_ca_topic_score_gemma":0.00031983608,"teacher_disagreement_score":0.20648555,"about_ca_system_score_codex":0.00036975017,"about_ca_system_score_gemma":0.0015404564,"threshold_uncertainty_score":0.6446689},"labels":[],"label_agreement":null},{"id":"W3137158297","doi":"10.1182/blood.2020009744","title":"Cabot rings in acute myeloid leukemia","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Myeloid leukemia; Medicine; Leukemia; Acute leukemia; Myeloid; Internal medicine","score_opus":0.015272653279523705,"score_gpt":0.28295162710815386,"score_spread":0.26767897382863015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137158297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97362703,0.0007002091,0.000020514786,0.00230168,0.000069252936,0.00020737281,0.000008743942,0.000077192206,0.022988006],"genre_scores_gemma":[0.98063827,0.0004694451,0.003015528,0.0011017771,0.00025964342,0.00003957894,0.00005369376,0.00004771548,0.014374382],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984206,0.000054131277,0.00025687928,0.0003927384,0.00038128323,0.0004943807],"domain_scores_gemma":[0.99904984,0.000068551075,0.000033210366,0.0005035155,0.00013478467,0.00021007983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002242635,0.00015321425,0.00034780783,0.00015624381,0.00004350879,0.000027286089,0.00014326283,0.00014823963,0.00042822244],"category_scores_gemma":[0.0002334487,0.00014614809,0.00008984127,0.00063209556,0.000061229235,0.00008131833,0.00017807246,0.0005870553,0.0003736293],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003528773,0.0013443724,0.20054641,0.00035051283,0.00087680074,0.036597535,0.0013779233,0.0000115193,0.7317823,0.001496808,0.011327222,0.013935703],"study_design_scores_gemma":[0.02107168,0.00031223425,0.31300598,0.00029827657,0.00044442652,0.0036369117,0.0004334973,0.00025715545,0.61080027,0.0002774026,0.04898872,0.00047342162],"about_ca_topic_score_codex":0.00024576686,"about_ca_topic_score_gemma":0.00010570133,"teacher_disagreement_score":0.12098203,"about_ca_system_score_codex":0.0004276155,"about_ca_system_score_gemma":0.0013980934,"threshold_uncertainty_score":0.5959746},"labels":[],"label_agreement":null},{"id":"W3138046343","doi":"10.1182/blood.v130.suppl_1.3914.3914","title":"N-Myristoyltransferase 2 (NMT2) Protein Levels Predict Survival in Acute Myeloid Leukemia (AML): A Novel Prognostic Biomarker","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Alberta; University of British Columbia","funders":"","keywords":"Myeloid leukemia; Biomarker; Myeloid; Leukemia; Medicine; Cancer research; Oncology; Internal medicine; Biology; Genetics","score_opus":0.03884656240479668,"score_gpt":0.3047226401332673,"score_spread":0.2658760777284706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3138046343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848307,0.00016978905,0.0007094649,0.0018985383,0.00018373817,0.003204624,0.00027885893,0.00018892447,0.008535401],"genre_scores_gemma":[0.99308574,0.000041571584,0.0024940274,0.00013354892,0.00031712383,0.0005293009,0.00008186214,0.00012882543,0.0031880192],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99600965,0.00012738965,0.0006897519,0.0009397411,0.0010600667,0.0011733874],"domain_scores_gemma":[0.997094,0.0001657097,0.00018277913,0.0017685163,0.00024472,0.0005443171],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011166215,0.00050889654,0.00082206,0.00040165498,0.00040176205,0.00019438959,0.00090557686,0.00041078005,0.00019206994],"category_scores_gemma":[0.001452759,0.00045147946,0.00023045973,0.00034472154,0.0005039864,0.00038993135,0.00031357037,0.0010637182,0.00018697568],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015746744,0.0022343162,0.204035,0.000566028,0.001081143,0.00436089,0.00042216663,0.0000020974983,0.779052,0.00030540882,0.0006133972,0.0057528457],"study_design_scores_gemma":[0.033597354,0.0008950879,0.87718636,0.00092509564,0.00067046616,0.0006575242,0.00008254558,0.00078922353,0.08216839,0.0001133769,0.002194723,0.00071983394],"about_ca_topic_score_codex":0.00090469175,"about_ca_topic_score_gemma":0.00026201425,"teacher_disagreement_score":0.6968836,"about_ca_system_score_codex":0.00059584674,"about_ca_system_score_gemma":0.002147615,"threshold_uncertainty_score":0.9997937},"labels":[],"label_agreement":null},{"id":"W3138563371","doi":"10.1182/blood.v130.suppl_1.5523.5523","title":"Early Relapse in Transplant-Eligible MM Patients Undergoing Auto-SCT Followed By Maintenance Therapy","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Medicine; Family medicine; Internal medicine","score_opus":0.014521101104872808,"score_gpt":0.2539827828767559,"score_spread":0.2394616817718831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3138563371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905726,0.00020654123,0.00019922049,0.00041773083,0.00017907652,0.0005651708,0.000031278927,0.00006594072,0.0077624596],"genre_scores_gemma":[0.99739164,0.0007980386,0.00040878955,0.00015690619,0.000033435994,0.000033964723,0.00005606303,0.000039103765,0.0010820741],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99862075,0.000039895123,0.00033644377,0.000325629,0.00031364858,0.00036363356],"domain_scores_gemma":[0.99910426,0.00008906182,0.00013289101,0.0005094717,0.000046006397,0.00011832015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019088811,0.00018735061,0.00031431217,0.00007941714,0.00014379757,0.00005111311,0.00019718058,0.00013771829,0.000042821594],"category_scores_gemma":[0.000050704133,0.00016359753,0.00009026767,0.00006923585,0.000051451167,0.0001670538,0.000008821168,0.00018851378,0.00007156216],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033712617,0.0009077081,0.9728028,0.00016844833,0.000086824635,0.00018960645,0.0015971237,5.9130133e-7,0.02268403,0.00009960195,0.0005532378,0.00057288684],"study_design_scores_gemma":[0.042766437,0.00076476065,0.88469595,0.001613708,0.00016959611,0.00005413186,0.000059420425,0.000031713065,0.068473704,0.00016321006,0.0008430061,0.00036437332],"about_ca_topic_score_codex":0.00019526988,"about_ca_topic_score_gemma":0.000070412876,"teacher_disagreement_score":0.08810688,"about_ca_system_score_codex":0.00003260124,"about_ca_system_score_gemma":0.00008061336,"threshold_uncertainty_score":0.66713136},"labels":[],"label_agreement":null},{"id":"W3138818958","doi":"10.1182/blood.2020009081","title":"Venetoclax enhances T cell–mediated antileukemic activity by increasing ROS production","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":145,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Toronto General Hospital; University Health Network","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Venetoclax; Cancer research; Medicine; Leukemia; Immunology; Chronic lymphocytic leukemia","score_opus":0.01551792651846018,"score_gpt":0.28204364045300373,"score_spread":0.26652571393454355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3138818958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939055,0.0015153448,0.000011316573,0.00030668793,0.0001760173,0.00032755962,0.000010877709,0.000094510964,0.0036521812],"genre_scores_gemma":[0.9923854,0.0005905797,0.00014400699,0.00006533805,0.0004138796,0.000025434465,0.00008349768,0.0000331209,0.0062587834],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99857736,0.0001629379,0.00014556541,0.00040110678,0.0003993208,0.00031372134],"domain_scores_gemma":[0.9991822,0.00010250533,0.00005770314,0.000380119,0.00014668817,0.00013077621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003167936,0.0001311331,0.00024268561,0.0000639181,0.000082632454,0.000031490516,0.00006729738,0.00010214825,0.0008616227],"category_scores_gemma":[0.00034479168,0.00012905209,0.00007103768,0.00039631253,0.00006361955,0.000093465394,0.000045683355,0.0003162379,0.000059256177],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021812877,0.000518095,0.008052908,0.000101794896,0.000065397944,0.00007529918,0.00010219352,0.0000010377104,0.98544407,4.0358506e-7,0.0009066521,0.004514021],"study_design_scores_gemma":[0.0017825995,0.00012142276,0.008762174,0.000069531656,0.00008024582,0.0001856664,0.00004671388,0.000046585148,0.9840407,0.0000083166615,0.0047378857,0.000118178985],"about_ca_topic_score_codex":0.00021846376,"about_ca_topic_score_gemma":0.000016971624,"teacher_disagreement_score":0.004395842,"about_ca_system_score_codex":0.00016304434,"about_ca_system_score_gemma":0.0005651066,"threshold_uncertainty_score":0.9434164},"labels":[],"label_agreement":null},{"id":"W3140298617","doi":"10.1182/blood.v130.suppl_1.80.80","title":"Overlap of SEC23A and SEC23B Function Suggests a Novel Therapeutic Approach for Congenital Dyserythropoietic Anemia Type II","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Biology; Zebrafish; Morpholino; Genetics; Immunology; Gene","score_opus":0.03276445941891173,"score_gpt":0.27840138467420733,"score_spread":0.2456369252552956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3140298617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99434364,0.0005713751,0.0011729265,0.00012985578,0.00038031072,0.00048526903,0.000025503246,0.000035994988,0.0028551333],"genre_scores_gemma":[0.99694574,0.000060303242,0.0013977269,0.00023710882,0.0002681412,0.000023023602,0.00006239507,0.000023467488,0.0009820822],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99927026,0.000013074483,0.00017396903,0.00025974654,0.00010707207,0.00017588759],"domain_scores_gemma":[0.99917626,0.000042050033,0.00014594613,0.00039901346,0.00015767649,0.000079032216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000102196915,0.00013838717,0.00029466316,0.000049297203,0.00024986026,0.0000143360385,0.00006649323,0.0001571715,0.00006078543],"category_scores_gemma":[0.00007803226,0.000115926334,0.00007384768,0.00004317757,0.00019245598,0.0000694482,0.000051391195,0.000119876575,0.000004038691],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00304405,0.0025839976,0.047004823,0.0008338552,0.0006793754,0.000005727141,0.0006123853,0.0000042703386,0.9381165,0.0024461995,0.00052075664,0.0041480768],"study_design_scores_gemma":[0.044018712,0.018116828,0.8759363,0.00014598804,0.0037446858,0.0009129452,0.0010571077,0.0015135573,0.04437866,0.0006731291,0.008711195,0.0007908713],"about_ca_topic_score_codex":0.000019858227,"about_ca_topic_score_gemma":0.000005566636,"teacher_disagreement_score":0.8937378,"about_ca_system_score_codex":0.000008744748,"about_ca_system_score_gemma":0.00007004304,"threshold_uncertainty_score":0.47273389},"labels":[],"label_agreement":null},{"id":"W3140744447","doi":"10.1182/blood.v130.suppl_1.3869.3869","title":"Characteristics of Venous Thromboembolism in Patients with Acute Leukemia","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Venous thromboembolism; Medicine; Acute leukemia; Leukemia; Leukostasis; Pulmonary embolism; Intensive care medicine; Internal medicine; Thrombosis","score_opus":0.010894430492074742,"score_gpt":0.2658471762923168,"score_spread":0.2549527458002421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3140744447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961702,0.000014150432,0.000004416122,0.00010243105,0.000047998616,0.00036743967,0.000042097883,0.00001558296,0.0032356633],"genre_scores_gemma":[0.99898213,0.000042525335,0.000542826,0.000057855505,0.00008102509,0.000011048584,0.000044867553,0.000028543987,0.0002091768],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989416,0.000016675656,0.00021292016,0.00019774176,0.00034861307,0.00028245797],"domain_scores_gemma":[0.99877286,0.000021094784,0.00017244853,0.00077286694,0.00015815286,0.00010257899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011190614,0.00012163887,0.0004815438,0.00009505012,0.00007896414,0.000021809457,0.00026224737,0.00009507995,0.000034049302],"category_scores_gemma":[0.00013407148,0.00009401288,0.00003639678,0.00006433515,0.00016433069,0.000096544565,0.00011961783,0.0002777976,0.000028561142],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004328488,0.0012025337,0.99206793,0.00009874706,0.0002748062,0.0003162129,0.0002779391,1.1130683e-7,0.0014297598,0.00007054771,0.00011429863,0.0037142606],"study_design_scores_gemma":[0.008887365,0.0007880046,0.9861721,0.00013602866,0.00021296948,0.000017298287,0.0000083339055,0.000009925182,0.0035198976,0.000019290948,0.00013514873,0.000093680355],"about_ca_topic_score_codex":0.0001576044,"about_ca_topic_score_gemma":0.0000104848805,"teacher_disagreement_score":0.0084545165,"about_ca_system_score_codex":0.0001286557,"about_ca_system_score_gemma":0.00044151855,"threshold_uncertainty_score":0.3833734},"labels":[],"label_agreement":null},{"id":"W3143852803","doi":"10.1182/blood.v130.suppl_1.749.749","title":"A Protective Role of DNA Repair Genes Against Acute Graft Versus Host Disease in Children","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Graft-versus-host disease; Busulfan; Methotrexate; Medicine; Cyclophosphamide; Immunology; Transplantation; Total body irradiation; Hematopoietic stem cell transplantation; Tacrolimus; Human leukocyte antigen; Cord blood; Internal medicine; Gastroenterology; Chemotherapy; Antigen","score_opus":0.005523331389701806,"score_gpt":0.22924377188660025,"score_spread":0.22372044049689843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3143852803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983327,0.00059012417,0.00001016174,0.000025725425,0.000055614375,0.00045433777,0.00008068274,0.000023608647,0.0004270618],"genre_scores_gemma":[0.9991837,0.0000773768,0.0004028913,0.00001594132,0.00009709495,0.00008448137,0.000048539336,0.000021660564,0.00006830683],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99918777,0.000035517878,0.0001387563,0.0003412042,0.00010654745,0.0001902008],"domain_scores_gemma":[0.998939,0.0000025462332,0.00012959894,0.0007986526,0.00004441764,0.00008580666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008934652,0.00013326255,0.00013642498,0.000033379732,0.00008103383,0.000016400501,0.00030287442,0.000097629374,0.0000026460652],"category_scores_gemma":[0.000121564655,0.00013246962,0.00013499257,0.000027459791,0.000072084236,0.000005697326,0.00023778398,0.000058283844,0.0000043716022],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033999438,0.00035312818,0.04844908,0.00000897379,0.00030255222,0.000014803623,0.000024922192,0.0000029687103,0.94989794,0.0000445302,0.000011209975,0.0005499067],"study_design_scores_gemma":[0.0027770791,0.00029646684,0.13879535,0.000018541632,0.00010331661,0.0000028304166,0.000015897427,0.000021589029,0.85753417,0.00010607339,0.0001646945,0.00016398834],"about_ca_topic_score_codex":0.00006348779,"about_ca_topic_score_gemma":0.00006054588,"teacher_disagreement_score":0.09236376,"about_ca_system_score_codex":0.000006642831,"about_ca_system_score_gemma":0.00007440393,"threshold_uncertainty_score":0.5401954},"labels":[],"label_agreement":null},{"id":"W3144005575","doi":"10.1182/blood.2020009409","title":"Has MRD graduated from its adolescence in ALL?","year":2021,"lang":"en","type":"letter","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine","score_opus":0.06892092539122815,"score_gpt":0.2945466930764583,"score_spread":0.22562576768523016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3144005575","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.068365656,0.0028031727,0.000039991017,0.92501354,0.00046405074,0.0009815049,0.0002581377,0.00017102573,0.0019028893],"genre_scores_gemma":[0.041626807,0.0005933572,0.0013461269,0.93086225,0.007938633,0.00014186672,0.005452544,0.0002722578,0.011766181],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964851,0.0001852415,0.00049053936,0.00088765135,0.0011492624,0.0008021635],"domain_scores_gemma":[0.9982784,0.0003332707,0.000119064876,0.0008702479,0.00022186719,0.00017716616],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00014523159,0.00042001245,0.00084378396,0.0002924809,0.000037590216,0.000083319945,0.00042373064,0.0011786628,0.00060338306],"category_scores_gemma":[0.0005970162,0.00037644163,0.00017547337,0.0004903984,0.00012739001,0.000055126886,0.0002583669,0.0032541754,0.00069467205],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005000863,0.00037310022,0.0015166433,0.00041218742,0.00036440516,0.047843877,0.00014628179,3.0806333e-7,0.0038614045,0.0000011929561,0.9451257,0.0003048699],"study_design_scores_gemma":[0.0213451,0.00029557213,0.008100524,0.0048905113,0.0011988595,0.0009224744,0.000047112342,0.0004318197,0.017801987,0.00009228417,0.94388986,0.000983891],"about_ca_topic_score_codex":0.0006748631,"about_ca_topic_score_gemma":0.000053268333,"teacher_disagreement_score":0.046921402,"about_ca_system_score_codex":0.00048000916,"about_ca_system_score_gemma":0.0021079683,"threshold_uncertainty_score":0.99986875},"labels":[],"label_agreement":null},{"id":"W3146282831","doi":"10.1182/blood.v130.suppl_1.sci-2.sci-2","title":"Mediators of Disseminated Intravascular Coagulation: Molecular Mechanisms","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Neutrophil extracellular traps; Disseminated intravascular coagulation; Sepsis; HMGB1; Coagulation; Platelet; Immunology; Medicine; Hemostasis; Platelet activation; Inflammation; Pathology; Internal medicine","score_opus":0.007691386799362124,"score_gpt":0.23184632715507794,"score_spread":0.22415494035571581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3146282831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947747,0.0007273113,0.0026533229,0.0001288955,0.0003959423,0.00020885444,0.000027931972,0.000048243994,0.0010348235],"genre_scores_gemma":[0.99899656,0.0000364559,0.00051170896,0.000037621758,0.000018664387,0.000017283735,0.00006732786,0.000021218151,0.0002931685],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990648,0.00009405049,0.00025464004,0.00027504485,0.0000612523,0.00025018022],"domain_scores_gemma":[0.99885786,0.00003239318,0.00024339472,0.0007336807,0.00010264029,0.000030041563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019109472,0.0001758683,0.00031707188,0.00007477832,0.00027118955,0.000020302916,0.00045942137,0.00020597495,0.00042924215],"category_scores_gemma":[0.00011446224,0.00015519507,0.000119672884,0.000051807503,0.000198675,0.000107181186,0.00014041607,0.0001513489,0.00015005565],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018810111,0.0002424023,0.00025152223,0.000014680379,0.00028758665,0.000036106663,0.00008492896,8.45503e-7,0.9654056,0.032792922,0.000045544566,0.0008190808],"study_design_scores_gemma":[0.0019409147,0.00016189952,0.004226694,0.000037884132,0.00017935553,0.00002857141,0.00006129492,9.86571e-7,0.9886355,0.0041080504,0.0004483968,0.00017045655],"about_ca_topic_score_codex":0.00003123724,"about_ca_topic_score_gemma":0.00000424554,"teacher_disagreement_score":0.02868487,"about_ca_system_score_codex":0.0000066807042,"about_ca_system_score_gemma":0.000029700954,"threshold_uncertainty_score":0.63286716},"labels":[],"label_agreement":null},{"id":"W3146459321","doi":"10.1182/blood.v130.suppl_1.766.766","title":"Gastrointestinal Flora Dictates the Biological Response in Murine Transfusion Related Acute Lung Injury (TRALI)","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Transfusion-related acute lung injury; Medicine; Pulmonary edema; Immunology; Sepsis; Lung; ARDS; Diffuse alveolar damage; Antibody; Pathogenesis; Internal medicine; Acute respiratory distress","score_opus":0.016790471043795115,"score_gpt":0.2831332134457882,"score_spread":0.26634274240199307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3146459321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823088,0.00008163078,0.000057130324,0.014385339,0.00010741394,0.0007000658,0.000010900829,0.000098610166,0.0022501147],"genre_scores_gemma":[0.9977383,0.00044389383,0.0005869727,0.00038936894,0.000049504662,0.000041450767,0.0000141159935,0.000017891602,0.00071848853],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986952,0.00014561559,0.00031869003,0.00031783935,0.0002031172,0.00031955843],"domain_scores_gemma":[0.99906415,0.000084301224,0.00007496242,0.00062392006,0.000035993875,0.000116685216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006949052,0.00018227022,0.0002672481,0.000104616076,0.00028096343,0.00004545193,0.0002819456,0.00006559557,0.0001974118],"category_scores_gemma":[0.00018855216,0.0001100013,0.00012197701,0.000115205585,0.00019285707,0.00007357013,0.00008939724,0.00040125492,0.000034050034],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024292205,0.005580938,0.5174011,0.0001519652,0.0006430587,0.006743937,0.0015040868,0.0000056915305,0.43218067,0.0015371405,0.002065683,0.007893492],"study_design_scores_gemma":[0.009730516,0.0018076053,0.9743221,0.0003954038,0.0004638681,0.00079525774,0.00012749303,0.00012352131,0.010521363,0.00019052677,0.0013351914,0.00018720291],"about_ca_topic_score_codex":0.00008015253,"about_ca_topic_score_gemma":0.000029891555,"teacher_disagreement_score":0.45692092,"about_ca_system_score_codex":0.000016129105,"about_ca_system_score_gemma":0.00003718785,"threshold_uncertainty_score":0.44857228},"labels":[],"label_agreement":null},{"id":"W3147605822","doi":"10.1182/blood.v130.suppl_1.881.881","title":"Inhibiting the Mitochondrial Sulfhydryl Oxidase Alr Reduces Cox17 and Alters Mitochondrial Cristae Structure Leading to the Differentiation of AML and Stem Cells","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Gene knockdown; Haematopoiesis; Stem cell; Biology; Clonogenic assay; Mitochondrion; Molecular biology; Bone marrow; Myeloid leukemia; Cell biology; Apoptosis; Chemistry; Cancer research; Biochemistry; Immunology","score_opus":0.018105695605676788,"score_gpt":0.27776445624343377,"score_spread":0.259658760637757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3147605822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946239,0.00022001228,0.000056258436,0.0035061752,0.00044771703,0.00095866,0.00006213669,0.000017298036,0.000107844506],"genre_scores_gemma":[0.9975136,0.000044213353,0.00057429494,0.00012859139,0.0012611612,0.000019611974,0.000008214929,0.000027760225,0.00042258078],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99847966,0.00011926357,0.00029993578,0.00036100452,0.00041692218,0.0003232217],"domain_scores_gemma":[0.99865276,0.00023699577,0.00024607024,0.00058703794,0.00011818062,0.00015896559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019473214,0.00019279821,0.0003243826,0.00008028258,0.0006263491,0.00024530262,0.00030058174,0.00011130959,0.000013719918],"category_scores_gemma":[0.00031773746,0.000111128764,0.00006070022,0.0000745277,0.00028996283,0.00013054871,0.00028879393,0.00037887113,0.0000029612618],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028374876,0.000041201158,0.0016477598,0.000089375506,0.00011479682,0.000014352103,0.0023603195,0.0000026068785,0.9905604,0.000034656812,0.0018148522,0.0030359377],"study_design_scores_gemma":[0.0052564824,0.00026004162,0.0072115697,0.00021687159,0.0003399721,0.00006335327,0.0012368595,0.00018756374,0.9843825,0.00005180185,0.0006317226,0.00016125961],"about_ca_topic_score_codex":0.00016421483,"about_ca_topic_score_gemma":0.00010211938,"teacher_disagreement_score":0.006177891,"about_ca_system_score_codex":0.00004037374,"about_ca_system_score_gemma":0.00009257819,"threshold_uncertainty_score":0.48174343},"labels":[],"label_agreement":null},{"id":"W3148352923","doi":"10.1182/blood.2020007651","title":"Targeting AXL kinase sensitizes leukemic stem and progenitor cells to venetoclax treatment in acute myeloid leukemia","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SignalChem (Canada); Canada's Michael Smith Genome Sciences Centre; University of British Columbia; Terry Fox Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Venetoclax; Myeloid leukemia; Progenitor cell; Cancer research; Stem cell; Leukemia; Biology; Myeloid; Immunology; Cell biology; Chronic lymphocytic leukemia","score_opus":0.009616529857277527,"score_gpt":0.2207454706866285,"score_spread":0.21112894082935096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3148352923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99215865,0.0070857177,0.000011089149,0.00006145834,0.00024293535,0.00030784353,0.000027533784,0.00003690654,0.00006787229],"genre_scores_gemma":[0.9976386,0.00030258205,0.00024046308,0.00005988639,0.00004436094,0.000045967372,0.00010294592,0.000017799082,0.0015474189],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989432,0.00014654819,0.00025159845,0.00032931787,0.000026228683,0.00030311896],"domain_scores_gemma":[0.999627,0.000050488718,0.00005954645,0.00019066266,0.000042094834,0.000030200234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000087928864,0.00017288102,0.00029075117,0.00007088736,0.00010098373,0.00002263736,0.000054241395,0.00015299686,0.000026224952],"category_scores_gemma":[0.0000094604675,0.00015946377,0.000055459826,0.00013404865,0.00003447394,0.00005920377,0.00007378835,0.00009933787,0.00009325578],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057676727,0.000100425736,0.0015997646,0.000012046895,0.00018529831,0.000075721684,0.0005220872,0.000044088865,0.9922338,0.000017107695,0.00012377292,0.005028168],"study_design_scores_gemma":[0.0027420823,0.00019692915,0.006472542,0.000043574175,0.00011846494,0.0001287098,0.00025943626,0.000020398244,0.9861604,0.000008235763,0.0036772713,0.0001719881],"about_ca_topic_score_codex":0.00010515682,"about_ca_topic_score_gemma":0.000025287907,"teacher_disagreement_score":0.0067831357,"about_ca_system_score_codex":0.00030612142,"about_ca_system_score_gemma":0.00026969178,"threshold_uncertainty_score":0.6502744},"labels":[],"label_agreement":null},{"id":"W3148446124","doi":"10.1182/blood.v130.suppl_1.419.419","title":"A Simulation Analysis to Evaluate the Effect of Prospective Biomarker Testing on Progression-Free Survival (PFS) in DLBCL","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Randomization; Population; Internal medicine; Oncology; Prospective cohort study; Biomarker; Clinical trial; Surgery","score_opus":0.036270301535498546,"score_gpt":0.3683797931621523,"score_spread":0.33210949162665376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3148446124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963076,0.000059939077,0.000005520767,0.00039476706,0.000036951475,0.0011164165,0.000007351528,0.000015101452,0.0020563656],"genre_scores_gemma":[0.99956435,0.000001017143,0.00016837346,0.000016351953,0.00003813655,0.00018136912,0.000004807963,0.000009235835,0.00001637496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896014,0.000108430555,0.00018052063,0.00023315114,0.00037553074,0.00014225881],"domain_scores_gemma":[0.9980517,0.0009371661,0.00011494667,0.00074751757,0.000094749055,0.000053945994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066857255,0.000121728415,0.0003243409,0.00013023282,0.0001288009,0.000029296792,0.00013316129,0.000039137558,0.0000085971515],"category_scores_gemma":[0.0034591935,0.00006283728,0.00011318279,0.00032055052,0.000036658792,0.000033231197,0.000082514474,0.000042951317,0.000009593238],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003388524,0.0009209522,0.9816974,0.000020082183,0.0008134984,0.000035336183,0.000106111496,0.00052014587,0.000323822,0.000010954397,0.000005075437,0.01520776],"study_design_scores_gemma":[0.009754261,0.0014017596,0.9706113,0.00019598771,0.0018530245,0.0000011356163,0.000007993543,0.005378259,0.010705799,0.000028241917,0.0000030662507,0.00005919711],"about_ca_topic_score_codex":0.00020473692,"about_ca_topic_score_gemma":0.00012440504,"teacher_disagreement_score":0.015148563,"about_ca_system_score_codex":0.000058235662,"about_ca_system_score_gemma":0.00002675224,"threshold_uncertainty_score":0.41412276},"labels":[],"label_agreement":null},{"id":"W3149092134","doi":"10.1182/blood.2020007507","title":"Mutational landscape of gray zone lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"Canadian Institutes of Health Research; BC Cancer Foundation; Institut Carnot Santé Animale; Terry Fox Research Institute; Michael Smith Health Research BC","keywords":"Lymphoma; Biology; RELB; Mutation; Gene; Cancer research; Genetics; Immunology; P50","score_opus":0.014370583573348812,"score_gpt":0.2361975682613343,"score_spread":0.2218269846879855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3149092134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930091,0.00059336965,0.000018548695,0.0015913133,0.000020879288,0.00010474582,0.000019184414,0.000026082987,0.0046168026],"genre_scores_gemma":[0.9983713,0.000023669363,0.0007668245,0.0006113754,0.00010428136,0.000013444893,0.000048417613,0.0000068504114,0.000053823936],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995457,0.000007019994,0.00011710786,0.00010736984,0.00014839837,0.00007438396],"domain_scores_gemma":[0.9997253,0.00003110291,0.000035886223,0.00007657102,0.00003738301,0.00009378471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00001756906,0.000060227023,0.00014954162,0.000019373634,0.0000140716975,0.0000032455127,0.000025985082,0.000026299076,0.00020816532],"category_scores_gemma":[0.000027382277,0.00004548782,0.00006271188,0.000089569585,0.000015706337,0.000016648379,0.00001231457,0.000011415063,0.00007210948],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015933889,0.0041674366,0.97363245,0.0001316366,0.0005638298,0.00053145346,0.0007021549,0.000004452138,0.0036715302,0.0016430733,0.0033760571,0.011416597],"study_design_scores_gemma":[0.01823201,0.0007485473,0.8974649,0.000043711818,0.00048983213,0.00013509986,0.000096219585,0.000072281975,0.07882227,0.000040656338,0.003769077,0.00008542615],"about_ca_topic_score_codex":0.0000150836795,"about_ca_topic_score_gemma":0.000001350758,"teacher_disagreement_score":0.07616757,"about_ca_system_score_codex":0.0000066468656,"about_ca_system_score_gemma":0.00006603007,"threshold_uncertainty_score":0.22792643},"labels":[],"label_agreement":null},{"id":"W3149483318","doi":"10.1182/blood.2021012452","title":"Great Games, Local Rules: The New Great Power Contest in Central Asia","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Politics and Conflicts in Afghanistan, Pakistan, and Middle East","field":"Social Sciences","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CONTEST; Central asia; China; Great power; Sovereignty; Political science; Politics; Quarter (Canadian coin); Power (physics); Economy; Competition (biology); Political economy; Geography; Sociology; Law; International trade; Economics","score_opus":0.01905952356041381,"score_gpt":0.2708991341350736,"score_spread":0.2518396105746598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3149483318","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.039473463,0.0035855635,0.00028037175,0.00029213182,0.0009159522,0.0003067999,0.00004196687,0.00007189917,0.9550319],"genre_scores_gemma":[0.88990855,0.00011217847,0.000045085013,0.00041450668,0.0005675782,0.0000072303696,0.0000046068876,0.0000133500425,0.10892694],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982705,0.00012081745,0.00020327618,0.00016997675,0.00030899842,0.00092641334],"domain_scores_gemma":[0.99920624,0.00007576911,0.000054510714,0.00023067638,0.00003353137,0.0003992612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003733725,0.000147121,0.00016592628,0.00003491881,0.00028882766,0.00011009905,0.00032795637,0.00011363633,0.00045934276],"category_scores_gemma":[0.00007770791,0.000109939334,0.00008663038,0.00014186646,0.00038536926,0.00014927436,0.000039901468,0.00017022238,0.00010575964],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009305673,0.00019103814,0.025851946,0.000003921671,0.000023091558,0.000012340218,0.0045404052,2.736295e-7,0.000016585946,0.96746767,0.00025513425,0.0016283062],"study_design_scores_gemma":[0.0007507905,0.000030781634,0.019855754,0.00003078696,0.000034807552,0.000007827977,0.0025342696,0.000001807144,0.0000980288,0.001625189,0.9748584,0.00017155678],"about_ca_topic_score_codex":0.005042628,"about_ca_topic_score_gemma":0.0054583536,"teacher_disagreement_score":0.97460324,"about_ca_system_score_codex":0.00008397052,"about_ca_system_score_gemma":0.0002927722,"threshold_uncertainty_score":0.76229787},"labels":[],"label_agreement":null},{"id":"W3153382454","doi":"10.1182/blood.v130.suppl_1.3941.3941","title":"Utility of Leukemic Stem Cells Markers in Determining Minimal Residual Disease in Patients with AML","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Alberta Hospital; Alberta Hospital Edmonton","funders":"","keywords":"Minimal residual disease; Interleukin-3 receptor; Medicine; CD34; Myeloid leukemia; Leukemia; Population; Bone marrow; Oncology; CD33; Immunology; Internal medicine; Stem cell; Biology","score_opus":0.01884192932014905,"score_gpt":0.26721718309099074,"score_spread":0.2483752537708417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3153382454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99830204,0.00003239457,8.52342e-7,0.000059693328,0.000024977131,0.0005353485,0.000038745053,0.000011023591,0.0009949397],"genre_scores_gemma":[0.99935955,0.0000069389503,0.00031444608,0.000022613294,0.000027862128,0.000015955995,0.000010668292,0.000023210176,0.00021873401],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998439,0.000084502084,0.00032612318,0.00033581184,0.0004426744,0.00037188933],"domain_scores_gemma":[0.99869853,0.00008970789,0.00015443034,0.0007769806,0.00007751478,0.00020284827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033810313,0.00014531711,0.00033518835,0.00017384645,0.000051651707,0.000018764995,0.00027845986,0.00007635429,0.000033534667],"category_scores_gemma":[0.00017386205,0.000121871126,0.000039260216,0.000097779535,0.00020877503,0.00013311717,0.00017053967,0.0003006063,0.0000074965337],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031671396,0.0005857017,0.99219066,0.0001827705,0.000030121379,0.0002943593,0.00017164634,0.0000010630625,0.000606565,9.956557e-7,0.000087001696,0.002681952],"study_design_scores_gemma":[0.015073935,0.00037638165,0.9776689,0.00036272182,0.000061759216,0.000001399225,0.00009531482,0.0002310761,0.0060011996,0.0000028384782,0.000015615438,0.00010885504],"about_ca_topic_score_codex":0.00027423204,"about_ca_topic_score_gemma":0.00012629086,"teacher_disagreement_score":0.01452178,"about_ca_system_score_codex":0.00009992647,"about_ca_system_score_gemma":0.00063047494,"threshold_uncertainty_score":0.49697605},"labels":[],"label_agreement":null},{"id":"W3153787254","doi":"10.1182/blood.2021010835","title":"Iron, FRDA, and intermediary metabolism","year":2021,"lang":"en","type":"letter","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Metabolism; Ferroportin; Medicine; Internal medicine; Iron homeostasis","score_opus":0.009497325164695642,"score_gpt":0.22734752835834107,"score_spread":0.21785020319364543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3153787254","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.077990726,0.13223816,0.000035213314,0.75748074,0.0025035879,0.0007702347,0.00017242784,0.00020755,0.028601348],"genre_scores_gemma":[0.0018970097,0.0033682599,0.0010193707,0.96666986,0.010475682,0.000047877962,0.0012029163,0.00012784715,0.015191153],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983729,0.0000816367,0.00027956328,0.0005220145,0.0003546779,0.0003891677],"domain_scores_gemma":[0.9991226,0.00006614483,0.00009296848,0.0005277335,0.00007018955,0.00012036786],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009459835,0.00034903997,0.0007470487,0.00017035186,0.000046478504,0.000039528535,0.000114382055,0.00069561164,0.00062181667],"category_scores_gemma":[0.00012872824,0.00030270955,0.00017586154,0.00011416317,0.00015826595,0.000053319665,0.00012853897,0.0013907638,0.00007975],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010866552,0.00015136172,0.00059291685,0.00081314007,0.000108482294,0.0021756385,0.00019334443,8.138185e-9,0.00031333393,0.00003258212,0.99349725,0.0021110785],"study_design_scores_gemma":[0.0033608046,0.00003402284,0.006382933,0.00013965773,0.0022366904,0.0003923666,0.000081787824,2.965692e-7,0.0005182767,0.0001015493,0.9864284,0.00032326183],"about_ca_topic_score_codex":0.00003304989,"about_ca_topic_score_gemma":0.000003177049,"teacher_disagreement_score":0.20918913,"about_ca_system_score_codex":0.0000054921575,"about_ca_system_score_gemma":0.0001503612,"threshold_uncertainty_score":0.9999425},"labels":[],"label_agreement":null},{"id":"W3153841548","doi":"10.1182/blood.v130.suppl_1.5653.5653","title":"Side Effects and Supportive Care in Relapsed or Refractory Classical Hodgkin Lymphoma Patients Treated in Later Lines of Therapy: A Pilot Analysis Conducted in 4 Countries","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Brentuximab vedotin; Medicine; Nivolumab; Internal medicine; Refractory (planetary science); Pembrolizumab; Chemotherapy regimen; Oncology; Lymphoma; Chemotherapy; Hodgkin lymphoma; Cancer; Immunotherapy","score_opus":0.017258968994376397,"score_gpt":0.2799360110748409,"score_spread":0.2626770420804645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3153841548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982912,0.0007505591,2.3578353e-8,0.00011875626,0.00002508656,0.00063829916,0.00004513489,0.000011669105,0.00011929055],"genre_scores_gemma":[0.99924266,0.00038746136,0.000024200697,0.000061892286,0.000013280987,0.00010589616,0.00011356075,0.000015469705,0.000035602185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987868,0.00011257949,0.0003901175,0.00031540412,0.00018179392,0.00021327335],"domain_scores_gemma":[0.9990552,0.00022766308,0.0002035902,0.00034092765,0.00010140582,0.00007120689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008528192,0.00019570912,0.0007149017,0.00036558186,0.000035705754,0.000021610305,0.00006760803,0.00011965544,0.000014154972],"category_scores_gemma":[0.00020678095,0.00012944627,0.00006533222,0.00024594602,0.00012090781,0.00007859954,0.000035592868,0.00006015908,0.0000018136371],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00244056,0.004699449,0.98599577,0.00009448252,0.00048320947,0.0006898403,0.0013105673,4.5079997e-7,0.0005084758,0.0000028137722,0.000007679531,0.0037666727],"study_design_scores_gemma":[0.048661314,0.0029877056,0.92457205,0.00026487137,0.00051139185,0.0000026561354,0.0000968676,0.000013057625,0.022733288,0.000005152671,0.000035678648,0.00011597077],"about_ca_topic_score_codex":0.0015237882,"about_ca_topic_score_gemma":0.0080401,"teacher_disagreement_score":0.061423756,"about_ca_system_score_codex":0.00013633404,"about_ca_system_score_gemma":0.00011879347,"threshold_uncertainty_score":0.52786654},"labels":[],"label_agreement":null},{"id":"W3155027991","doi":"10.1182/blood.2021011281","title":"HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":164,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Cyclophosphamide; Medicine; Human leukocyte antigen; Histocompatibility Testing; Immunology; Internal medicine; Chemotherapy; Antigen","score_opus":0.01050875958882247,"score_gpt":0.23011963441999134,"score_spread":0.21961087483116887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155027991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99256337,0.00036377902,0.0034541872,0.0007696542,0.00013266444,0.000736672,0.00011136016,0.00027152454,0.0015967952],"genre_scores_gemma":[0.9929836,0.00014341257,0.0052732998,0.00043543585,0.000061152554,0.000058801925,0.00052652886,0.000084870044,0.00043291808],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99747276,0.00010287193,0.0005500424,0.0006230638,0.00070913247,0.0005421448],"domain_scores_gemma":[0.9986338,0.00018465413,0.00008184737,0.0005008907,0.0002322896,0.0003664902],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001832782,0.00036321217,0.00062258024,0.000121292556,0.00010044092,0.00004666498,0.00012118286,0.00028206516,0.0005021298],"category_scores_gemma":[0.00002802573,0.0002972065,0.00016476498,0.00054299564,0.000112797905,0.00008440533,0.000006598098,0.0004177462,0.00019285298],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006477134,0.006310029,0.51099384,0.006220261,0.0015491075,0.039813392,0.0021053231,0.000114414564,0.425522,0.00038013686,0.000050479357,0.0004639078],"study_design_scores_gemma":[0.019866701,0.0012504084,0.13316217,0.0019633414,0.0022958356,0.005143148,0.00012020184,0.00009594194,0.83540916,0.000037560654,0.00013446753,0.0005210889],"about_ca_topic_score_codex":0.000053030653,"about_ca_topic_score_gemma":0.000040423853,"teacher_disagreement_score":0.40988714,"about_ca_system_score_codex":0.000038206057,"about_ca_system_score_gemma":0.0005237856,"threshold_uncertainty_score":0.999948},"labels":[],"label_agreement":null},{"id":"W3155027998","doi":"10.1182/blood.v130.suppl_1.24.24","title":"The LSC17 Leukemic Stem Cell Signature Predicts Outcome in Pediatric Acute Myeloid Leukemia","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"NPM1; Oncology; Myeloid leukemia; Internal medicine; Medicine; Gene signature; Multivariate analysis; Myeloid; Leukemia; Cancer; Bioinformatics; Biology; Gene; Gene expression; Genetics; Karyotype","score_opus":0.019261430068779065,"score_gpt":0.2845178960960196,"score_spread":0.2652564660272405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155027998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9774918,0.0024340348,0.000010007166,0.0017642751,0.00039353344,0.0010606798,0.000034558074,0.00013313943,0.01667798],"genre_scores_gemma":[0.9749927,0.0026517792,0.0001944853,0.00030822807,0.0010461439,0.00010283232,0.000021631933,0.00009114821,0.020591041],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965768,0.00012181893,0.0006448458,0.0006603687,0.0009164438,0.0010797608],"domain_scores_gemma":[0.9965857,0.00033930142,0.00034715873,0.0021706934,0.0001683923,0.00038875124],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009836685,0.00039911352,0.0006037373,0.00024880568,0.00078268576,0.0002480828,0.0014785281,0.00048068474,0.000032443906],"category_scores_gemma":[0.0002855809,0.00027254503,0.00021911119,0.00029829773,0.00024378412,0.00026733422,0.00059479446,0.0019777287,0.0003455329],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062729,0.00048216226,0.95220995,0.0004759263,0.0003226194,0.0028841712,0.0006824729,0.00001671921,0.01692276,0.00018339927,0.01911915,0.00607335],"study_design_scores_gemma":[0.024521152,0.0006604125,0.94026715,0.00011670676,0.0012050899,0.0003950147,0.00029210397,0.00061741064,0.020071713,0.00015605988,0.0109969545,0.00070023426],"about_ca_topic_score_codex":0.00014630426,"about_ca_topic_score_gemma":0.00006700194,"teacher_disagreement_score":0.023893861,"about_ca_system_score_codex":0.0008608834,"about_ca_system_score_gemma":0.0015878655,"threshold_uncertainty_score":0.9999727},"labels":[],"label_agreement":null},{"id":"W3155589128","doi":"10.1182/blood.v130.suppl_1.3403.3403","title":"Incremental Financial and Health-Related Burden of Novel Drugs Used in the Treatment of Relapsed and/or Refractory Multiple Myeloma (RRMM): A Meta-Analysis of Phase III Randomized Controlled Trials (RCTs)","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Pomalidomide; Medicine; Randomized controlled trial; Internal medicine; Meta-analysis; Refractory (planetary science); Oncology; Multiple myeloma; Lenalidomide","score_opus":0.1858870700279212,"score_gpt":0.37302470508607205,"score_spread":0.18713763505815084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155589128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869835,0.008303694,0.00002118794,0.0012146496,0.000050824972,0.0019286138,0.0010847445,0.0000034914203,0.0004093329],"genre_scores_gemma":[0.9965993,0.0028484464,0.00015204333,0.00010895039,0.00003054392,0.00017221888,0.000020294061,0.000011384503,0.00005681057],"study_design_codex":"meta_analysis","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9959098,0.00027764842,0.0032241591,0.0003176402,0.00005850541,0.00021224041],"domain_scores_gemma":[0.99304736,0.0023104667,0.004051011,0.00047776234,0.000029608274,0.00008378884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0077899364,0.00022635954,0.008067688,0.0004599971,0.00010149904,0.000035808465,0.00023099167,0.00011772641,0.00014944153],"category_scores_gemma":[0.0016548027,0.00014413233,0.0015468335,0.00015379307,0.00022554706,0.000105163446,0.00004115804,0.00008880488,8.659787e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32795477,0.02857186,0.007666612,0.00034563505,0.5086902,0.000017866947,0.045790914,0.00024227425,0.004808488,0.070337154,0.00009767726,0.005476538],"study_design_scores_gemma":[0.9469375,0.0007259589,0.0016606648,0.000010761037,0.034985915,0.0000013533648,0.00015064859,0.013266088,0.00090927916,0.0008060961,0.0003417311,0.00020400246],"about_ca_topic_score_codex":0.0053997063,"about_ca_topic_score_gemma":0.0003645577,"teacher_disagreement_score":0.61898273,"about_ca_system_score_codex":0.00003562632,"about_ca_system_score_gemma":0.00007913743,"threshold_uncertainty_score":0.8162777},"labels":[],"label_agreement":null},{"id":"W3157387440","doi":"10.1182/blood.2020008812","title":"Multisite 11-year experience of less-intensive vs intensive therapies in acute myeloid leukemia","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Intensive care; Comorbidity; Prospective cohort study; Internal medicine; Cohort; Retrospective cohort study; Quality of life (healthcare); Myeloid leukemia; Adverse effect; Intensive care unit; Cohort study; Intensive care medicine; Pediatrics","score_opus":0.022897661682954998,"score_gpt":0.2992772939892336,"score_spread":0.2763796323062786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157387440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99590266,0.001032874,0.00005393363,0.0016822919,0.00011195284,0.0004030581,0.000027265445,0.000050598577,0.0007353493],"genre_scores_gemma":[0.9926619,0.0009890737,0.002504429,0.0018859409,0.0001078149,0.000055331006,0.000047354297,0.000051214043,0.0016969449],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977912,0.000113343405,0.00047734473,0.0005523475,0.0005309672,0.00053482415],"domain_scores_gemma":[0.99648225,0.00020193755,0.00012473244,0.0007070776,0.0023024124,0.00018160857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017438918,0.000257359,0.00073859445,0.00024197737,0.000055295706,0.000023437993,0.00025044053,0.00019050077,0.00018235098],"category_scores_gemma":[0.0012630654,0.00022860525,0.00016704739,0.00068773446,0.00036932912,0.00014420532,0.00029465542,0.00054465723,0.00006144442],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009266419,0.00038900864,0.29594105,0.00018204436,0.0006910682,0.0064361156,0.02766651,0.0000059522304,0.6636019,0.00040709134,0.0018823084,0.0018703474],"study_design_scores_gemma":[0.011479421,0.00039723655,0.18330823,0.0005282315,0.0002063761,0.0009761246,0.06590912,0.00015150021,0.73515296,0.00007650258,0.001476965,0.00033736072],"about_ca_topic_score_codex":0.0009087339,"about_ca_topic_score_gemma":0.00029275398,"teacher_disagreement_score":0.11263281,"about_ca_system_score_codex":0.00028715073,"about_ca_system_score_gemma":0.000651561,"threshold_uncertainty_score":0.93222517},"labels":[],"label_agreement":null},{"id":"W3157658077","doi":"10.1182/blood.v130.suppl_1.40.40","title":"Genetic Characterization and Clinical Impact of Loss of MHC Class I and II Expression in De Novo Diffuse Large B-Cell Lymphoma","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Princess Margaret Cancer Centre; University Health Network; BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Biology; MHC class II; Cancer research; Genetics; Medicine; Immunology; Major histocompatibility complex; Gene","score_opus":0.014528656818758744,"score_gpt":0.3066935214741197,"score_spread":0.29216486465536096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157658077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99936765,0.00028110427,0.000007013144,0.000045022804,0.000019307708,0.0001765446,0.00003874992,0.000003932326,0.000060643746],"genre_scores_gemma":[0.9985403,0.0011769105,0.00017311824,0.000018587516,0.00003653236,0.0000069257644,0.000012923309,0.000008758004,0.000025946469],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99936575,0.000029759522,0.00025269674,0.00014950409,0.00007999428,0.00012231],"domain_scores_gemma":[0.99938256,0.00004225584,0.00019110205,0.00026530935,0.000026526357,0.000092236245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010268422,0.0000857055,0.00027822366,0.00003959006,0.00004809573,0.000009366253,0.000042426826,0.000089756606,0.000006149038],"category_scores_gemma":[0.00006670026,0.00006184799,0.00005732957,0.000018863364,0.000067612906,0.00004578375,0.00008253622,0.000023815952,4.795795e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011599194,0.011608514,0.9330256,0.000060725422,0.000042486543,0.000059588267,0.00016761373,2.6682434e-8,0.051552635,0.0000036258893,0.0000032422618,0.0033599716],"study_design_scores_gemma":[0.03660602,0.0007418272,0.9235213,0.00017956147,0.0001424003,0.000038115108,0.000007656407,0.00005876735,0.03862812,0.0000061444625,0.000022833054,0.000047300706],"about_ca_topic_score_codex":0.00006193047,"about_ca_topic_score_gemma":0.000012060963,"teacher_disagreement_score":0.036490027,"about_ca_system_score_codex":0.000019731187,"about_ca_system_score_gemma":0.00006571937,"threshold_uncertainty_score":0.2522088},"labels":[],"label_agreement":null},{"id":"W3157860815","doi":"10.1182/blood.v130.suppl_1.3612.3612","title":"Brain-Derived Neurotrophic Factor Induces Platelet Aggregation","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Platelet; Chemistry; Thrombin; Neurotrophic factors; Brain-derived neurotrophic factor; Stimulation; Internal medicine; Thromboxane A2; Confocal microscopy; Endocrinology; Blot; Adenosine diphosphate; Platelet activation; Receptor; Platelet factor 4; Biochemistry; Cell biology; Biology; Medicine; Platelet aggregation","score_opus":0.024678365355506642,"score_gpt":0.26648240062222184,"score_spread":0.2418040352667152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157860815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962772,0.00093703484,0.000033921075,0.0008521287,0.00013609686,0.00025340967,0.000011071207,0.00008447781,0.0014146612],"genre_scores_gemma":[0.998347,0.0002884321,0.0000606538,0.0007008922,0.00036238434,0.0000124257995,0.000017870758,0.000023854534,0.00018647936],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99920315,0.00003532138,0.00012313499,0.0002234948,0.00023406735,0.00018082882],"domain_scores_gemma":[0.99908036,0.000022145476,0.00009847727,0.00062654685,0.000049872215,0.00012260779],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000060876602,0.00013038103,0.00024036814,0.000041970674,0.00029220662,0.0000778439,0.00014848595,0.000087718894,0.00013539942],"category_scores_gemma":[0.00018516956,0.00011054946,0.00023206275,0.000029138591,0.00008808825,0.00014781831,0.000035940742,0.00012865143,0.000077474375],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090997503,0.0018669803,0.09681666,0.0003204546,0.0037740266,0.0034053382,0.00068133365,0.00000564465,0.60612804,0.00035409498,0.0008304533,0.284907],"study_design_scores_gemma":[0.008940794,0.00029914716,0.69127077,0.00012598913,0.00032343573,0.00033198614,0.000027205258,0.0000092267155,0.29176167,0.00013250535,0.0065331236,0.0002441597],"about_ca_topic_score_codex":0.000014926434,"about_ca_topic_score_gemma":0.0000014336961,"teacher_disagreement_score":0.5944541,"about_ca_system_score_codex":0.0000061068476,"about_ca_system_score_gemma":0.00005484361,"threshold_uncertainty_score":0.45080763},"labels":[],"label_agreement":null},{"id":"W3157953135","doi":"10.1182/blood.v130.suppl_1.2596.2596","title":"Patients Who Are Refractory to Ida-FLAG As Initial Induction Chemotherapy for AML Have Persistence of the Dominant Genetic Mutations and a Poor Clinical Outcome","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Foundation; University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Flag (linear algebra); Persistence (discontinuity); Chemotherapy regimen; Refractory (planetary science); Chemotherapy; Medicine; Induction chemotherapy; Internal medicine; Oncology; Mutation; Pediatrics; Biology; Genetics; Gene","score_opus":0.04738016962087138,"score_gpt":0.34905688058938683,"score_spread":0.30167671096851545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157953135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99845123,0.00008548029,0.00026205624,0.00041058057,0.00026805504,0.00040104814,0.000056755118,0.0000015863142,0.00006322614],"genre_scores_gemma":[0.99836546,0.000082724255,0.00047843123,0.00059520575,0.00018198171,0.000042560147,0.000007783536,0.000014366955,0.00023150344],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99935746,0.000023056191,0.00020446996,0.00022151429,0.00008119178,0.00011230467],"domain_scores_gemma":[0.99924856,0.0000086403725,0.00022156027,0.00034949827,0.000117793956,0.000053937125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000102295984,0.00008727632,0.0001388819,0.000014619015,0.00017584872,0.0000248339,0.00017840153,0.00010657045,0.000002848981],"category_scores_gemma":[0.0001223694,0.00006826664,0.000103735314,0.000012428909,0.000091380854,0.0000034619898,0.00007311456,0.00005074942,5.76498e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009211093,0.0013458127,0.1797106,0.0000954776,0.00042306364,0.0000017718015,0.0008475799,0.0000051784605,0.75114655,0.000111306355,0.00025569828,0.06513587],"study_design_scores_gemma":[0.0053247553,0.0016125755,0.39432713,0.000049633003,0.00016267116,0.0000062833933,0.00023807214,0.00001369563,0.5874862,0.00028094664,0.010293504,0.00020449038],"about_ca_topic_score_codex":0.000022786786,"about_ca_topic_score_gemma":0.00006735249,"teacher_disagreement_score":0.21461655,"about_ca_system_score_codex":0.000005562521,"about_ca_system_score_gemma":0.000045715926,"threshold_uncertainty_score":0.27838328},"labels":[],"label_agreement":null},{"id":"W3158347976","doi":"10.1182/blood.v130.suppl_1.4253.4253","title":"Predictive Factors of Overall Survival and the Completion of Four Cycles of Azacitidine: An MDS-CAN Study","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Statistics Canada; Centre hospitalier de l'Université Laval; McGill University; Royal Victoria Hospital; Royal Victoria Regional Health Centre; Dr. Georges-L.-Dumont University Hospital Centre; St. Paul's Hospital; Juravinski Hospital; Queen Elizabeth II Health Sciences Centre; University of Alberta; Saskatchewan Cancer Agency; CancerCare Manitoba; Health Sciences Centre; Ottawa Hospital; University Health Network; Dalhousie University; Vancouver General Hospital; Princess Margaret Cancer Centre; Jewish General Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Azacitidine; Medicine; Oncology; Internal medicine; Biology; DNA methylation; Genetics","score_opus":0.03766719118776251,"score_gpt":0.28532502152743017,"score_spread":0.24765783033966765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3158347976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99809515,0.000034191828,0.0000071891786,0.00018293542,0.000032154374,0.00050479214,0.000049667804,0.0000070698197,0.0010868172],"genre_scores_gemma":[0.99966043,0.000025089977,0.00010181247,0.0000020073053,0.000022068336,0.00000778541,0.000018116547,0.0000073221263,0.000155371],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992848,0.0000639267,0.0002150114,0.00011835178,0.00023890445,0.000078976016],"domain_scores_gemma":[0.99926746,0.00008091252,0.0002241318,0.00029296384,0.00009283653,0.00004169484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021165343,0.000093925104,0.0003692591,0.000042050408,0.00007301815,0.0000060433026,0.00008490566,0.000025996773,0.000011860032],"category_scores_gemma":[0.0000779904,0.000055571643,0.000047070138,0.000021918351,0.000200765,0.000046112178,0.000048186423,0.000043812393,2.1985572e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029087614,0.0014974801,0.9915792,0.00004203127,0.0005535837,0.0000047106796,0.0044251443,4.163498e-7,0.0010882857,0.00035596054,0.000009292406,0.00015302206],"study_design_scores_gemma":[0.011568193,0.00059984723,0.9750452,0.000056663397,0.00050112547,0.0000024630804,0.0020031957,0.00002068857,0.01002552,0.00012580818,0.0000072698604,0.000044024353],"about_ca_topic_score_codex":0.00030727233,"about_ca_topic_score_gemma":0.0001366939,"teacher_disagreement_score":0.016533995,"about_ca_system_score_codex":0.000006461609,"about_ca_system_score_gemma":0.00003370606,"threshold_uncertainty_score":0.2266146},"labels":[],"label_agreement":null},{"id":"W3158352351","doi":"","title":"Cultured dendritic cells can prime potent cytotoxic t lymphocyte responses to chronic myelogenous leukemia","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Chronic myelogenous leukemia; Cytotoxic T cell; Leukemia; Immunology; Medicine; Cancer research; Biology; In vitro; Genetics","score_opus":0.007440846163806784,"score_gpt":0.21536754410855719,"score_spread":0.2079266979447504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3158352351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9693377,0.028282529,0.000014231735,0.00022086692,0.00044767561,0.00059606315,0.00009298475,0.00020226969,0.0008056617],"genre_scores_gemma":[0.9425639,0.0017796995,0.00013336018,0.0008523694,0.00008726289,0.00009667226,0.000062833446,0.00005883517,0.054365072],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99751896,0.0005445704,0.00045235245,0.0005101514,0.00008084042,0.00089315214],"domain_scores_gemma":[0.9989313,0.0001515802,0.00007964102,0.0007116373,0.00006252097,0.000063337335],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00026077987,0.00038848975,0.0004737929,0.00017498882,0.00047536258,0.0000514695,0.0005833456,0.00038421885,0.0025369],"category_scores_gemma":[0.000049776307,0.00035034757,0.000208276,0.00027459714,0.00019926947,0.00007380619,0.00007329974,0.00029142277,0.004267325],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017317451,0.00031672366,0.00005288286,0.000013921594,0.0003504247,0.0000726884,0.0010423838,0.000023438244,0.9775374,0.000016267693,0.0006024907,0.018239617],"study_design_scores_gemma":[0.0045492738,0.00092699757,0.0029215373,0.000070094895,0.00011641277,0.0007287982,0.00006786951,5.434923e-7,0.8691887,0.000010561871,0.1210042,0.0004149534],"about_ca_topic_score_codex":0.00033207357,"about_ca_topic_score_gemma":0.00005842927,"teacher_disagreement_score":0.12040171,"about_ca_system_score_codex":0.0004739203,"about_ca_system_score_gemma":0.0008869348,"threshold_uncertainty_score":0.99989486},"labels":[],"label_agreement":null},{"id":"W3158536935","doi":"10.1182/blood.v130.suppl_1.2482.2482","title":"Somatic Mutations Associated with Myeloid Transformation of RUNX1 -Mutated Familial Platelet Disorders with Propensity to Myeloid Malignancies Using Targeted Next-Generation Sequencing","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"RUNX1; Platelet disorder; CEBPA; Myeloid leukemia; Myelodysplastic syndromes; Myeloid; Medicine; Leukemia; Biology; Oncology; Cancer research; Genetics; Bone marrow; Internal medicine; Mutation; Haematopoiesis; Gene; Stem cell","score_opus":0.06287888414082493,"score_gpt":0.2767635651384534,"score_spread":0.21388468099762847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3158536935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99370724,0.000022723227,0.0032872928,0.00046539694,0.000038683753,0.0019294685,0.000057139114,0.000100210964,0.0003918735],"genre_scores_gemma":[0.9942626,0.000011747849,0.005038768,0.00006588445,0.000061802384,0.00006459551,0.00036430222,0.000055808167,0.0000745378],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978976,0.00010601654,0.00047374377,0.00034505167,0.0007067505,0.00047078397],"domain_scores_gemma":[0.99837106,0.000052328694,0.0003747838,0.00049205375,0.0005193223,0.00019047115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042006606,0.0002789619,0.0005188495,0.00025457342,0.0006888103,0.0001363791,0.0002097864,0.00014443934,0.00002087295],"category_scores_gemma":[0.00040974584,0.00021404687,0.00006437588,0.00036534606,0.00022782582,0.0007598138,0.000041257263,0.00027756704,0.000008982986],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042705465,0.00029659373,0.0131404055,0.00021567267,0.00041535948,0.000069095935,0.0050037173,0.003483439,0.97603506,0.000025805139,0.000013200157,0.00087462185],"study_design_scores_gemma":[0.013203513,0.001762368,0.11968955,0.0008248054,0.0008597126,0.00018428148,0.0020970283,0.053085428,0.8076731,0.00004012848,0.000012782265,0.00056732417],"about_ca_topic_score_codex":0.0011150097,"about_ca_topic_score_gemma":0.0017397555,"teacher_disagreement_score":0.16836195,"about_ca_system_score_codex":0.00040139092,"about_ca_system_score_gemma":0.0010929343,"threshold_uncertainty_score":0.8728578},"labels":[],"label_agreement":null},{"id":"W3158959319","doi":"10.1182/blood.v130.suppl_1.293.293","title":"The Identification of the Amino Acids on Platelet Factor 4 That Bind Pathogenic Antibodies in Heparin-Induced Thrombocytopenia","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Blood Services; McMaster University","funders":"","keywords":"Platelet factor 4; Heparin; Alanine; Alanine scanning; Amino acid; Chemistry; Antibody; Heparin-induced thrombocytopenia; Molecular biology; Biochemistry; Mutant; Biology; Mutagenesis; Immunology; Gene","score_opus":0.05739589062322333,"score_gpt":0.31183164495505533,"score_spread":0.254435754331832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3158959319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99400014,0.000089341615,0.0000010326746,0.0011472529,0.0005765496,0.0009634418,0.000038591686,0.00003332893,0.0031503208],"genre_scores_gemma":[0.9990201,0.00027266654,0.000020042453,0.00007762997,0.00010253642,0.000042869062,0.00000915665,0.00004142802,0.0004135495],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99771565,0.00014306893,0.0006583881,0.00047901768,0.0005348811,0.00046897086],"domain_scores_gemma":[0.99672264,0.00017651707,0.0006284665,0.0022655325,0.000103087325,0.0001037309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054778013,0.0003093677,0.0006649306,0.00010072341,0.0008501215,0.00019277328,0.000980475,0.00022692759,0.00003479219],"category_scores_gemma":[0.0005298949,0.00018012765,0.00024969553,0.00016283758,0.00030873058,0.0002224014,0.0003192639,0.00047527783,0.0000917785],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007003981,0.000451704,0.3437584,0.000040496405,0.0001888432,0.000016310636,0.0005092419,3.2363494e-7,0.65153784,0.00055456633,0.00002258946,0.0028496475],"study_design_scores_gemma":[0.001590696,0.000109177454,0.55870885,0.00010403393,0.000097848715,0.000017455037,0.000102698956,0.000008204484,0.4388469,0.00011208292,0.00018809158,0.000113971735],"about_ca_topic_score_codex":0.00023924443,"about_ca_topic_score_gemma":0.00048883684,"teacher_disagreement_score":0.21495044,"about_ca_system_score_codex":0.000071974995,"about_ca_system_score_gemma":0.00018078944,"threshold_uncertainty_score":0.7345393},"labels":[],"label_agreement":null},{"id":"W315932131","doi":"10.1182/blood.v122.21.838.838","title":"Results Of The DFCI ALL Consortium Protocol 05-001 For Children and Adolescents With Newly Diagnosed ALL","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Hamilton Health Sciences; Centre hospitalier universitaire de Québec; Université de Montréal; McMaster Children's Hospital","funders":"","keywords":"Medicine; Internal medicine; Minimal residual disease; Asparaginase; Regimen; Gastroenterology; Adverse effect; Vincristine; Imatinib mesylate; Pediatrics; Surgery; Chemotherapy; Imatinib; Leukemia; Lymphoblastic Leukemia; Cyclophosphamide","score_opus":0.01327390975821762,"score_gpt":0.2761563615139058,"score_spread":0.2628824517556882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W315932131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88600564,0.0000124390845,0.000026343165,0.0012659343,0.00001896403,0.1121948,0.00008326437,0.000035766403,0.0003568412],"genre_scores_gemma":[0.9631238,0.000004209169,0.0010125897,0.0007299371,0.0001242357,0.034300964,0.000032532687,0.000040141735,0.0006315736],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99860793,0.000047637164,0.0002991931,0.00029794622,0.00038905954,0.00035824624],"domain_scores_gemma":[0.998866,0.0001241817,0.0001464148,0.00046927275,0.00021204175,0.00018209433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016215091,0.00015875469,0.00026076892,0.000046647623,0.00004159428,0.000022098755,0.00019199967,0.000095967036,0.00001777445],"category_scores_gemma":[0.000379191,0.000087676985,0.000048052487,0.00010482697,0.00020851218,0.000059665996,0.00011028153,0.00015368378,0.000012997302],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015072367,0.014052476,0.6202253,0.00321881,0.002654564,0.00015063604,0.0018971481,0.000012964977,0.03596588,0.00012382319,0.2931511,0.013474944],"study_design_scores_gemma":[0.17100562,0.0023449692,0.79718035,0.00096625165,0.0004694819,0.00027111155,0.000046492234,0.00025367865,0.023383886,0.000051813666,0.0037838572,0.00024246609],"about_ca_topic_score_codex":0.0005973606,"about_ca_topic_score_gemma":0.00003830899,"teacher_disagreement_score":0.28936723,"about_ca_system_score_codex":0.000044451463,"about_ca_system_score_gemma":0.00030733732,"threshold_uncertainty_score":0.35753638},"labels":[],"label_agreement":null},{"id":"W3159572149","doi":"10.1182/blood.2020010463","title":"TLR8 gain of function: a tall surprise","year":2021,"lang":"en","type":"letter","venue":"Blood","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Gain of function; Function (biology); Medicine; Biology; Cell biology; Genetics; Phenotype","score_opus":0.010696019344260486,"score_gpt":0.1997835176172399,"score_spread":0.1890874982729794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3159572149","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34999612,0.14100257,0.0006750233,0.44085923,0.013123483,0.0018661111,0.0003433692,0.0005653528,0.051568758],"genre_scores_gemma":[0.1269466,0.002291577,0.0002168943,0.47131494,0.0054496154,0.00026227342,0.024630897,0.00032168697,0.36856553],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986909,0.0003643142,0.00038391186,0.00025374515,0.000045678342,0.0002614682],"domain_scores_gemma":[0.9990101,0.00015156322,0.00024352546,0.00046133462,0.00012834684,0.0000051147313],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017630881,0.00020462534,0.00041338394,0.00013853308,0.000061262916,0.000010322595,0.00017428836,0.0012012353,0.0020555363],"category_scores_gemma":[0.000080479105,0.00019562643,0.00021848115,0.000112913454,0.0000917192,0.00004703191,0.000074495234,0.00093244377,0.0006194474],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007491531,0.000105698695,0.000039095285,0.00013238293,0.0007024916,0.00012378099,0.000096749776,4.7645915e-7,0.17632256,0.000023720027,0.82178354,0.00059457315],"study_design_scores_gemma":[0.00111238,0.00012677973,0.00013209866,0.0000990969,0.0002987736,0.0001390215,0.00002521966,7.897008e-8,0.17536977,0.000034509503,0.8224917,0.00017058828],"about_ca_topic_score_codex":0.000029379056,"about_ca_topic_score_gemma":0.0000025055394,"teacher_disagreement_score":0.31699678,"about_ca_system_score_codex":0.000011689304,"about_ca_system_score_gemma":0.00015657465,"threshold_uncertainty_score":0.9988567},"labels":[],"label_agreement":null},{"id":"W3159953554","doi":"10.1182/blood.v130.suppl_1.1107.1107","title":"The Effect of Rivaroxaban Exposure and Clinical Risk Factors on Efficacy and Safety Outcomes in Patients with Nonvalvular Atrial Fibrillation","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Rivaroxaban; Atrial fibrillation; Medicine; Internal medicine; Cardiology; Warfarin","score_opus":0.021291948003712136,"score_gpt":0.31894590773652237,"score_spread":0.2976539597328102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3159953554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986671,0.000053376756,0.0000021854948,0.00016523109,0.00013598993,0.00085513334,0.000007525352,0.000011797455,0.00010161181],"genre_scores_gemma":[0.9995676,0.0001143553,0.000030562354,0.000002954043,0.00021137488,2.2790962e-7,0.000010013802,0.0000105683075,0.00005231442],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990137,0.00014027607,0.00032953284,0.00018447814,0.00022176116,0.0001102238],"domain_scores_gemma":[0.998022,0.0012473126,0.00031159862,0.0003414213,0.00002339916,0.00005423605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000523167,0.00012915095,0.0004005947,0.000045551616,0.00022071955,0.00003592236,0.00005468514,0.00007456509,0.0000024766634],"category_scores_gemma":[0.0014944123,0.00006548212,0.00010737875,0.000031452524,0.00011577879,0.000067965615,0.000057818153,0.000101872814,0.0000011191468],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026764346,0.000010621805,0.99001724,0.00001641619,0.00025703353,8.401161e-7,0.000035208344,0.000009116212,0.0000010383193,0.000023173072,0.000002010859,0.0069508776],"study_design_scores_gemma":[0.027657045,0.003038564,0.96844083,0.00004218593,0.0004963217,1.375501e-7,0.0000066178027,0.000015370924,0.00004151574,0.000006939982,0.0001844159,0.00007004956],"about_ca_topic_score_codex":0.000035983325,"about_ca_topic_score_gemma":0.000014152233,"teacher_disagreement_score":0.02498061,"about_ca_system_score_codex":0.0000062120166,"about_ca_system_score_gemma":0.000007755745,"threshold_uncertainty_score":0.26702833},"labels":[],"label_agreement":null},{"id":"W3160085875","doi":"10.1182/blood.v130.suppl_1.4241.4241","title":"Evidence of Targetable Immune Dysfunction in the Bone Marrow of Patients with Intermediate/High-Risk Myelodysplastic Syndrome Refractory to Hypomethylating Agents","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Bone marrow; FOXP3; Immunology; Myelodysplastic syndromes; CD8; Internal medicine; Immune system; Cancer research","score_opus":0.020106891657820827,"score_gpt":0.2691771713093096,"score_spread":0.2490702796514888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160085875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984026,0.0003597834,0.00006166873,0.00012610838,0.000106555126,0.0007726894,0.000022368451,0.000010651078,0.00013755308],"genre_scores_gemma":[0.9987283,0.00011138773,0.00086358446,0.000034604658,0.000037730584,0.00004751312,0.000017017943,0.000028048591,0.00013181163],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979294,0.00016200588,0.00049536495,0.0002897613,0.00078483886,0.00033861297],"domain_scores_gemma":[0.99768,0.0004361193,0.0005317783,0.0009897016,0.00026230657,0.00010011296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010431667,0.000168604,0.0004812968,0.0002672788,0.00012780388,0.000024810397,0.00044308676,0.00008884497,0.000074173106],"category_scores_gemma":[0.00365373,0.00011034492,0.000057868874,0.00028735833,0.00016539164,0.00028847562,0.00021256116,0.00045043678,0.000023742095],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014662304,0.0010868999,0.97310036,0.00048190737,0.00019138296,0.0001397255,0.0009243406,0.000036398204,0.019621441,0.000004264069,0.0000967191,0.0028503563],"study_design_scores_gemma":[0.0052743405,0.0025897285,0.98421043,0.001498742,0.0002072799,0.000016561993,0.00013721442,0.000054617823,0.0058733346,0.000013918404,0.000019720215,0.000104105224],"about_ca_topic_score_codex":0.00089624437,"about_ca_topic_score_gemma":0.000051827203,"teacher_disagreement_score":0.013748106,"about_ca_system_score_codex":0.00010298393,"about_ca_system_score_gemma":0.00016716536,"threshold_uncertainty_score":0.44997352},"labels":[],"label_agreement":null},{"id":"W3160102879","doi":"10.1182/blood.v130.suppl_1.3249.3249","title":"Prediction of Severe Acute Graft-Versus-Host Disease (aGVHD) Based on Whole Transcriptome Sequencing of Donor CD4 T Cells","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Research in Immunology and Cancer; University of Calgary; Hôpital Maisonneuve-Rosemont; Université de Montréal","funders":"","keywords":"Immunology; Hematopoietic stem cell transplantation; Medicine; Transplantation; Myeloid leukemia; Graft-versus-host disease; Leukemia; Stem cell; Acute leukemia; Calcineurin; Myeloid; Internal medicine; Biology","score_opus":0.03160705933585361,"score_gpt":0.2602615663380162,"score_spread":0.2286545070021626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160102879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933963,0.00004464696,0.00055586104,0.00029237257,0.0003457012,0.00055297586,0.00082909904,0.000050671435,0.003932364],"genre_scores_gemma":[0.9986523,0.000039071616,0.00079104776,0.000052247222,0.00007917796,0.00001921836,0.000114733244,0.000029053617,0.000223179],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99868375,0.0000380369,0.00037562853,0.00026632735,0.0004395879,0.0001966597],"domain_scores_gemma":[0.9986931,0.000080629936,0.00023071542,0.00069424,0.00011054114,0.00019074332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016952482,0.00016857206,0.00033954185,0.00011687141,0.0000949401,0.000014323513,0.00015605945,0.000098872464,0.00007882564],"category_scores_gemma":[0.00004244296,0.00015587953,0.00016686037,0.000072044284,0.00010750242,0.00012018798,0.000008024066,0.00012386001,0.000017228658],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021300872,0.00074210786,0.021749169,0.0017093358,0.00028550264,0.0001466958,0.0006573616,0.00008896954,0.9722263,0.0000468757,0.00011393145,0.000103666585],"study_design_scores_gemma":[0.021882093,0.001084004,0.14262776,0.0017066486,0.0032839912,0.000019341183,0.00013659902,0.0013960071,0.8274596,0.000023396944,0.00017140966,0.00020917627],"about_ca_topic_score_codex":0.000053741933,"about_ca_topic_score_gemma":0.000006752355,"teacher_disagreement_score":0.14476673,"about_ca_system_score_codex":0.000039821767,"about_ca_system_score_gemma":0.00021037392,"threshold_uncertainty_score":0.6356583},"labels":[],"label_agreement":null},{"id":"W3160242308","doi":"10.1182/blood.v130.suppl_1.5632.5632","title":"Treatment Patterns and Health/Economic Outcomes in Relapsed/Refractory Follicular Lymphoma: A Real-World Study","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Gilead Sciences (Canada); Université de Montréal; Hôpital Maisonneuve-Rosemont; Windsor Regional Hospital; Ottawa Hospital","funders":"","keywords":"Medicine; Rituximab; Follicular lymphoma; Refractory (planetary science); Health care; Lymphoma; Internal medicine; Pediatrics","score_opus":0.03490968824506855,"score_gpt":0.3279803172315923,"score_spread":0.29307062898652375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160242308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948061,0.0004226663,9.108248e-8,0.0022020657,0.00011927478,0.0011528237,0.000027746386,0.000035147248,0.0012340653],"genre_scores_gemma":[0.997722,0.00088514085,0.000043032913,0.0001423056,0.0000724413,0.00029349525,0.000013517037,0.00002585731,0.00080219173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876744,0.000043200704,0.00034446976,0.00042902867,0.00012128713,0.00029455798],"domain_scores_gemma":[0.99872667,0.000049736518,0.00019350967,0.00081733684,0.000010149943,0.00020258664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012724119,0.00024790777,0.0006702849,0.00012919487,0.00019935066,0.000063120744,0.00008771871,0.000047850408,0.000026025433],"category_scores_gemma":[0.000011205918,0.0001798249,0.00011024036,0.000019875246,0.000032559197,0.00006651624,0.000064927604,0.000034933902,0.000044054916],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041259907,0.012285012,0.971886,0.000020854588,0.00046809114,0.00078343455,0.00060099276,2.1924504e-7,0.000002296442,0.000057545483,0.000036598674,0.013817698],"study_design_scores_gemma":[0.042900253,0.0020927312,0.9535495,0.0000636784,0.0002932687,0.000032575626,0.00019228287,0.0000050902386,0.0001340515,0.000012990535,0.0005905311,0.00013301834],"about_ca_topic_score_codex":0.042813953,"about_ca_topic_score_gemma":0.029014112,"teacher_disagreement_score":0.04285899,"about_ca_system_score_codex":0.0006580162,"about_ca_system_score_gemma":0.00019139657,"threshold_uncertainty_score":0.98870385},"labels":[],"label_agreement":null},{"id":"W3160561535","doi":"10.1182/blood.2021011517","title":"Coexistence of <i>BCR-ABL1</i> and <i>RUNX1-RUNX1T1</i> in a de novo AML","year":2021,"lang":"yi","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"breakpoint cluster region; Medicine; Internal medicine; Receptor","score_opus":0.018695602804601058,"score_gpt":0.2851669732813565,"score_spread":0.2664713704767554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160561535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9622921,0.019656982,0.000028422603,0.0022338922,0.00013546937,0.00050069386,0.000094818795,0.000031343778,0.015026319],"genre_scores_gemma":[0.9850247,0.0063841445,0.002519306,0.0013696837,0.00031223125,0.00003675406,0.00003087984,0.00006940387,0.004252878],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964921,0.00031859917,0.00073972857,0.00073640293,0.00066991703,0.0010432546],"domain_scores_gemma":[0.9976326,0.0005231821,0.00016527485,0.00086434867,0.0003428005,0.000471766],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000967112,0.00034491072,0.00089296326,0.00023097859,0.000073549265,0.00004747966,0.0003190975,0.00037233485,0.00027755497],"category_scores_gemma":[0.0012592856,0.00035842712,0.00013532527,0.0008970376,0.00046435482,0.00012356619,0.0004823122,0.0010027981,0.00007418557],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008429689,0.0057709496,0.3983504,0.004456099,0.0008438125,0.020666752,0.008128896,0.00001155017,0.54850805,0.0013959575,0.0039937985,0.0070308],"study_design_scores_gemma":[0.06155035,0.0020191127,0.12684807,0.0051968102,0.0017450824,0.007818512,0.007343362,0.00087919534,0.7590886,0.00065068254,0.025503824,0.0013564422],"about_ca_topic_score_codex":0.0006007215,"about_ca_topic_score_gemma":0.0004217967,"teacher_disagreement_score":0.27150232,"about_ca_system_score_codex":0.00023207869,"about_ca_system_score_gemma":0.002461893,"threshold_uncertainty_score":0.99988675},"labels":[],"label_agreement":null},{"id":"W3160734451","doi":"10.1182/blood.2021012217","title":"Frequency of positive anti-PF4/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":150,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Vaccination; Platelet factor 4; Antibody; Medicine; Titer; Immunology; Virology; Platelet; Platelet activation","score_opus":0.01729853111923075,"score_gpt":0.30867362753847843,"score_spread":0.2913750964192477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160734451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944901,0.0006608557,0.000217228,0.0015557805,0.00006906975,0.00044717165,0.000050207604,0.0000578435,0.00245175],"genre_scores_gemma":[0.9973533,0.0001740164,0.0012653767,0.0008222689,0.00009406418,0.000022139184,0.00013613985,0.000035727113,0.000096929696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985741,0.00008013357,0.0003097538,0.0004677721,0.00028829416,0.00027996974],"domain_scores_gemma":[0.99880826,0.00009664605,0.0001362616,0.00037772188,0.00024402293,0.00033710594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016602447,0.00022692217,0.00054654427,0.00015077846,0.00009255078,0.000028011478,0.00006596038,0.00015717016,0.0002533607],"category_scores_gemma":[0.00022874365,0.00019369765,0.000069751666,0.00043132238,0.000067513865,0.00018271462,0.00007075082,0.00018996821,0.000014592019],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053906653,0.0008133337,0.6166318,0.00031754217,0.00024467736,0.00059039646,0.0006766491,3.1633616e-7,0.37980494,0.0006102496,0.000019279021,0.00023689082],"study_design_scores_gemma":[0.004494975,0.00046575113,0.8176708,0.00018295596,0.0004396035,0.00066980993,0.00017514681,0.000006238005,0.17540264,0.00022182755,0.000066653854,0.00020359895],"about_ca_topic_score_codex":0.00041659296,"about_ca_topic_score_gemma":0.00018905467,"teacher_disagreement_score":0.2044023,"about_ca_system_score_codex":0.00006583357,"about_ca_system_score_gemma":0.00047414823,"threshold_uncertainty_score":0.7898761},"labels":[],"label_agreement":null},{"id":"W3161845972","doi":"10.1182/blood.v130.suppl_1.4724.4724","title":"Post-Thrombotic Syndrome and Recurrent Thromboembolism in Patients with Upper Extremity Deep Vein Thrombosis: A Systematic Review and Meta-Analysis of Proportions","year":2017,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Interquartile range; Post-thrombotic syndrome; Meta-analysis; Thrombosis; Confidence interval; Randomized controlled trial; Internal medicine; Venography; MEDLINE; Observational study; Cohort study; Deep vein; Surgery","score_opus":0.061770941918147686,"score_gpt":0.33551542866815653,"score_spread":0.27374448675000884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3161845972","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00090243114,0.98778594,0.0000019267873,0.00009850001,0.00003082558,0.010311708,0.0006775395,0.0000324577,0.00015867382],"genre_scores_gemma":[0.0016778451,0.9951477,0.00022629168,0.00016071835,0.00000841398,0.0018768307,0.00073805306,0.00008500712,0.00007913459],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9952549,0.00041133026,0.0020764878,0.001049576,0.00073225604,0.00047544972],"domain_scores_gemma":[0.9952374,0.00017627074,0.0021596185,0.0018381106,0.00033114722,0.00025741974],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00083705806,0.00089786464,0.021273296,0.0009207219,0.00014325601,0.00007539268,0.00035008372,0.00027787482,0.0004712169],"category_scores_gemma":[0.00040838955,0.0005430775,0.0016108322,0.0007768734,0.00024770206,0.0001835389,0.00029147934,0.00043736177,0.000010282213],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000019183437,0.0030427577,0.00034302752,0.76475525,0.23044625,0.00002895738,0.000104182516,7.5382125e-8,1.2844891e-8,0.000065058746,0.000044290544,0.0011682055],"study_design_scores_gemma":[0.00065062905,0.00046705303,0.028352594,0.121392116,0.84764355,0.000041548104,0.000022967333,8.242151e-7,3.0718567e-8,0.000005699745,0.000980802,0.00044217278],"about_ca_topic_score_codex":0.00011579855,"about_ca_topic_score_gemma":0.000165773,"teacher_disagreement_score":0.6433632,"about_ca_system_score_codex":0.00007717076,"about_ca_system_score_gemma":0.00018040983,"threshold_uncertainty_score":0.9997021},"labels":[],"label_agreement":null},{"id":"W3161976706","doi":"10.1182/blood.2020009417","title":"Upregulated PD-L1 delays human neutrophil apoptosis and promotes lung injury in an experimental mouse model of sepsis","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Sepsis Diagnosis and Treatment","field":"Medicine","cited_by":209,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Natural Science Foundation of China","keywords":"Sepsis; Tumor necrosis factor alpha; Protein kinase B; Downregulation and upregulation; Immunology; Apoptosis; Lung; PI3K/AKT/mTOR pathway; Medicine; Cancer research; Fas ligand; Biology; Programmed cell death; Internal medicine","score_opus":0.047527093934308,"score_gpt":0.3257743458852947,"score_spread":0.2782472519509867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3161976706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983016,0.0009942797,0.0000010931019,0.00015739132,0.0000129642885,0.00029458207,0.00002821283,0.000033991786,0.00017586829],"genre_scores_gemma":[0.9985514,0.000075699754,0.0010027599,0.00010309088,0.00002325699,0.00007521402,0.00007374583,0.000029692088,0.00006511242],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989982,0.000039796,0.00027673302,0.0003324314,0.00016484139,0.0001879758],"domain_scores_gemma":[0.99941945,0.000014721043,0.000059432557,0.00031700128,0.00006463265,0.00012477465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004961606,0.00016519387,0.00035024394,0.00009511115,0.000047527577,0.000017377028,0.00004505149,0.00009334504,0.00006204043],"category_scores_gemma":[0.000009745411,0.0001510347,0.000072213996,0.000137629,0.00004588123,0.0000892046,0.00006079091,0.000080854465,0.0000010166756],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005115647,0.0069172895,0.10910027,0.000057310615,0.00017135478,0.000027180407,0.00092103856,0.000032921984,0.8824522,0.00010609306,0.00003686011,0.00012632646],"study_design_scores_gemma":[0.0038037614,0.00059588894,0.01948223,0.00010327012,0.0002992972,0.000012040629,0.00021435929,0.001651509,0.9736674,0.00004208806,9.770648e-7,0.00012718064],"about_ca_topic_score_codex":0.0000767098,"about_ca_topic_score_gemma":0.000012257284,"teacher_disagreement_score":0.0912152,"about_ca_system_score_codex":0.000039504626,"about_ca_system_score_gemma":0.000045085915,"threshold_uncertainty_score":0.6159017},"labels":[],"label_agreement":null},{"id":"W3162424751","doi":"10.1182/blood.v130.suppl_1.3518.3518","title":"Erythroferrone (ERFE) and Hepcidin Levels in Sickle Cell Disease with and without Transfusional Iron Overload","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hepcidin; Ineffective erythropoiesis; Internal medicine; Medicine; Erythropoiesis; Volume overload; Anemia; Thalassemia; Beta thalassemia; Endocrinology; Heart failure","score_opus":0.010834863003008713,"score_gpt":0.23821961352300172,"score_spread":0.22738475051999302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3162424751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99327004,0.0023270973,0.000010002583,0.0015624781,0.000030137517,0.0003079547,0.000018041088,0.00001913084,0.0024551314],"genre_scores_gemma":[0.9981271,0.00074495975,0.00017784706,0.00014397707,0.000034090794,0.000008471142,0.0000058679148,0.000019037128,0.0007386243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99923366,0.000016033719,0.00012354288,0.00026407666,0.00015796143,0.00020472755],"domain_scores_gemma":[0.99943846,0.0000122337315,0.00004535397,0.00025403086,0.00001692478,0.0002329799],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007997596,0.00014186089,0.00021795178,0.00004403144,0.00017234226,0.0000301742,0.000047956302,0.00008563587,0.0000459348],"category_scores_gemma":[0.000019497698,0.00010255729,0.000023101073,0.00002999995,0.00019841222,0.00009469903,0.000031846386,0.0001806046,0.0000041669364],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065785885,0.0010206554,0.98359305,0.0003126819,0.00004216628,0.0002659601,0.000842169,0.0000037141622,0.011190009,0.00008319327,0.000063280415,0.0019252894],"study_design_scores_gemma":[0.01681891,0.0003987502,0.9791179,0.00032556604,0.00030507054,0.000085005835,0.00028166434,0.00010149467,0.0018321361,0.00008860763,0.0004357217,0.00020919084],"about_ca_topic_score_codex":0.00017973201,"about_ca_topic_score_gemma":0.00013409765,"teacher_disagreement_score":0.016161053,"about_ca_system_score_codex":0.000007854717,"about_ca_system_score_gemma":0.00008217772,"threshold_uncertainty_score":0.4182165},"labels":[],"label_agreement":null},{"id":"W3163826074","doi":"10.1182/blood.2021011269","title":"Rethinking platelet transfusion practices","year":2021,"lang":"en","type":"letter","venue":"Blood","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Platelet transfusion; Medicine; Platelet; Blood transfusion; Intensive care medicine; Internal medicine","score_opus":0.03446276849065698,"score_gpt":0.27299417477640325,"score_spread":0.23853140628574626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163826074","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027131082,0.002379408,0.000047347003,0.85891455,0.00057984167,0.0006419647,0.000020375785,0.00019869093,0.11008676],"genre_scores_gemma":[0.00098479,0.0022484148,0.0059737917,0.9598689,0.00958012,0.00005669398,0.0014678832,0.00014011623,0.019679276],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979419,0.000066857196,0.0003212745,0.0005958043,0.0007181005,0.00035607375],"domain_scores_gemma":[0.99858093,0.00016351859,0.00042596573,0.00068921974,0.00008780947,0.00005256366],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0002011861,0.0003083837,0.0005233091,0.00013574745,0.000062438885,0.00005243158,0.00018761057,0.0008338455,0.00077551964],"category_scores_gemma":[0.0002636851,0.0002817893,0.00021146964,0.00016266448,0.000036227033,0.000065940636,0.00011367369,0.002579174,0.000087816625],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001680214,0.00012955077,0.00015109201,0.0008189721,0.0007479712,0.016687164,0.00038141006,5.0040857e-8,0.002307796,0.000002006191,0.97774714,0.0010100488],"study_design_scores_gemma":[0.0019164319,0.00009604275,0.00004512594,0.0007120974,0.0019180357,0.0009702164,0.00005930936,0.0000023502428,0.007952671,0.000012084128,0.9860666,0.00024904168],"about_ca_topic_score_codex":0.000049665887,"about_ca_topic_score_gemma":0.0000031248373,"teacher_disagreement_score":0.10095439,"about_ca_system_score_codex":0.000046158864,"about_ca_system_score_gemma":0.00013117373,"threshold_uncertainty_score":0.9999634},"labels":[],"label_agreement":null},{"id":"W3164016517","doi":"10.1182/blood.v130.suppl_1.3994.3994","title":"Deciphering Discordance between MYC mRNA and MYC IHC in DLBCL: The Role of MYC Exon 2 Mutations and N11S Polymorphism","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Canada's Michael Smith Genome Sciences Centre; Simon Fraser University; BC Cancer Agency","funders":"","keywords":"Exon; Biology; Cancer research; Immunohistochemistry; Molecular biology; Medicine; Gene; Genetics; Immunology","score_opus":0.018150772771551898,"score_gpt":0.2958433537674796,"score_spread":0.2776925809959277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164016517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99389213,0.0026304764,0.00001384782,0.00060875807,0.000025858453,0.00033795167,0.000013877442,0.000013657843,0.0024634497],"genre_scores_gemma":[0.99891263,0.00021974677,0.00033841986,0.000021806547,0.00018259398,0.000027661501,0.0000053761623,0.000021967537,0.00026979827],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890447,0.000036175217,0.0002426267,0.00025075706,0.00027923257,0.00028675952],"domain_scores_gemma":[0.9988861,0.00023582646,0.00011569227,0.00060169736,0.000037575624,0.00012307533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002841294,0.00012340109,0.0002761441,0.00006437708,0.00019547886,0.000055034903,0.00020959933,0.000068123256,0.000013709128],"category_scores_gemma":[0.00029305302,0.00009047912,0.000035227433,0.00008079093,0.0003765107,0.00012727607,0.0002291865,0.00019319112,0.00000469835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018618898,0.0007071318,0.87627006,0.0003521055,0.00038707492,0.00028297436,0.006002321,0.000006225088,0.036244653,0.00069814525,0.00005974982,0.07880336],"study_design_scores_gemma":[0.027320504,0.00017692478,0.93669987,0.00041382547,0.00023880608,0.00021228829,0.00095243985,0.0009842957,0.031095602,0.0011226443,0.0006016434,0.00018117315],"about_ca_topic_score_codex":0.0022269774,"about_ca_topic_score_gemma":0.00030193682,"teacher_disagreement_score":0.078622185,"about_ca_system_score_codex":0.00028033834,"about_ca_system_score_gemma":0.0006517612,"threshold_uncertainty_score":0.36896315},"labels":[],"label_agreement":null},{"id":"W3164707004","doi":"10.1182/blood.2021011131","title":"Successful prenatal therapy for anti-CD36-mediated severe FNAIT by deglycosylated antibodies in a novel murine model","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Fetus; Antibody; Placenta; Monoclonal antibody; Neonatal alloimmune thrombocytopenia; CD36; Immunology; Polyclonal antibodies; Medicine; Monoclonal; Andrology; Pregnancy; Biology; Internal medicine; Receptor","score_opus":0.014303056129926954,"score_gpt":0.2584341689189961,"score_spread":0.24413111278906915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164707004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942258,0.0033086378,0.00012797919,0.0004527676,0.000041460728,0.0006043958,0.00060287106,0.00007160226,0.0005644804],"genre_scores_gemma":[0.9947551,0.0011459365,0.0011589203,0.00029661204,0.00002275878,0.00006530352,0.0017679741,0.000040761162,0.0007466302],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987961,0.000010760941,0.00026273035,0.0003841235,0.00017991726,0.0003663489],"domain_scores_gemma":[0.99943006,0.000062497944,0.000063124506,0.00022864001,0.00011858679,0.000097089374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000055669465,0.00022575518,0.00047002823,0.00008532598,0.000055539,0.000023306106,0.00007580821,0.00013708467,0.00005029473],"category_scores_gemma":[0.00006902464,0.00019120655,0.00010362283,0.00025334253,0.000031202555,0.000107270396,0.000035073677,0.0001270301,0.000010260572],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024735145,0.046572078,0.48712268,0.00090824364,0.0038687824,0.004700083,0.0018247295,0.00044583643,0.44227087,0.00014285273,0.0044702087,0.005200106],"study_design_scores_gemma":[0.27248576,0.0018190797,0.079497136,0.0010459805,0.0010039806,0.0018582675,0.00049838354,0.053610098,0.5825064,0.0008689958,0.0031007526,0.0017051379],"about_ca_topic_score_codex":0.00007113514,"about_ca_topic_score_gemma":0.000089082474,"teacher_disagreement_score":0.40762556,"about_ca_system_score_codex":0.0000263356,"about_ca_system_score_gemma":0.00022230338,"threshold_uncertainty_score":0.7797177},"labels":[],"label_agreement":null},{"id":"W3164883358","doi":"10.1182/blood.2021011725","title":"The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trial","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"National Center for Research Resources; National Heart, Lung, and Blood Institute","keywords":"Hemodialysis; Medicine; Heparin; Dialysis; Placebo; Internal medicine; Activated clotting time; Adverse effect; Urology; Surgery; Anesthesia; Pathology","score_opus":0.03941692321463643,"score_gpt":0.3465976888030942,"score_spread":0.3071807655884578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164883358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944922,0.0008665908,0.00003918192,0.0019364513,0.00041072041,0.0009880427,0.00001752034,0.000031269206,0.0012180671],"genre_scores_gemma":[0.99763095,0.00035293296,0.00019208394,0.00013848585,0.0009372091,0.00006207896,0.00010250478,0.000015454876,0.0005682892],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9971369,0.00048793587,0.001514758,0.0003016862,0.0003582139,0.00020051897],"domain_scores_gemma":[0.9957932,0.0028685408,0.00044494375,0.0005928401,0.00020653493,0.000093901974],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0025779938,0.00014016581,0.0009852061,0.000078580735,0.000068502886,0.000027901495,0.000112183545,0.00014660879,0.00002481693],"category_scores_gemma":[0.011958346,0.00009770395,0.0005342651,0.00032911863,0.000107631444,0.00007605165,0.000057251935,0.00018719296,0.0000047405224],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97364557,0.004840971,0.002147755,0.000033629636,0.0007104379,0.000051685554,0.0005740502,0.0000020109746,0.0048015425,0.0006403065,0.0014012969,0.0111507755],"study_design_scores_gemma":[0.9384565,0.0004852733,0.0045271274,0.00016011327,0.00062637887,0.0000073442275,0.000117821044,0.0002543518,0.053711437,0.00049698685,0.0010572701,0.00009943172],"about_ca_topic_score_codex":0.00015853731,"about_ca_topic_score_gemma":0.00016881013,"teacher_disagreement_score":0.048909895,"about_ca_system_score_codex":0.00001935404,"about_ca_system_score_gemma":0.00035634567,"threshold_uncertainty_score":0.99636436},"labels":[],"label_agreement":null},{"id":"W3165001243","doi":"10.1182/blood.v130.suppl_1.1494.1494","title":"Impact of PET Staging of Follicular Lymphoma on Treatment Outcomes and Prognosis","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Follicular lymphoma; Medicine; Oncology; Internal medicine; Lymphoma; Rituximab","score_opus":0.02310662063401812,"score_gpt":0.3164304827836925,"score_spread":0.2933238621496744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165001243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981244,0.00025720726,2.1848075e-7,0.00019794893,0.000018467641,0.00035151027,0.000042348547,0.000010929598,0.0009969542],"genre_scores_gemma":[0.9993888,0.00021252249,0.00022802388,0.000012107496,0.000016077869,0.000043505835,0.0000075333096,0.000011565914,0.00007987552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99936146,0.000011322097,0.00017198542,0.00016812136,0.00015218467,0.00013494048],"domain_scores_gemma":[0.9992056,0.00005124038,0.00017429527,0.00044075033,0.00003940173,0.000088736204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000041424497,0.00015250732,0.0004646345,0.000056074827,0.000067236906,0.000015597594,0.00004973577,0.000026112184,0.000015911308],"category_scores_gemma":[0.00004501977,0.00008633457,0.0002326907,0.000019946914,0.000058203812,0.00003669365,0.000026846785,0.000009874518,0.0000025515149],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006331094,0.0058882004,0.9779776,0.000039049635,0.001374586,0.00015178385,0.0001528576,3.6528e-7,0.00050466525,0.00007025575,0.000013883908,0.013763452],"study_design_scores_gemma":[0.013339591,0.002904853,0.9371667,0.00013396233,0.00081288244,0.000032150234,0.000021697091,0.000005500561,0.04548394,0.000014257254,0.00002294602,0.00006151744],"about_ca_topic_score_codex":0.00093295233,"about_ca_topic_score_gemma":0.0000073681717,"teacher_disagreement_score":0.044979274,"about_ca_system_score_codex":0.000076309036,"about_ca_system_score_gemma":0.00007528494,"threshold_uncertainty_score":0.35206217},"labels":[],"label_agreement":null},{"id":"W3166032256","doi":"10.1182/blood.v130.suppl_1.2386.2386","title":"A Pooled Analysis of the Xalia and Xalia-Lea Non-Interventional Studies of Rivaroxaban Versus Standard Anticoagulation in Venous Thromboembolism","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Rivaroxaban; Medicine; Venous thromboembolism; Venous thrombosis; Apixaban; Surgery; Internal medicine; Warfarin; Thrombosis; Atrial fibrillation","score_opus":0.04233569392807829,"score_gpt":0.3499606893817576,"score_spread":0.30762499545367933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166032256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99749994,0.000693139,0.000015923195,0.0005257641,0.00024111179,0.00038855526,0.000039846615,0.000006974356,0.0005887547],"genre_scores_gemma":[0.9994302,0.00027420087,0.00015285665,0.000022541812,0.000042465606,0.0000145765325,0.000009555201,0.000010454796,0.000043179596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880666,0.000043812728,0.000415947,0.00021975164,0.00035388023,0.00015997203],"domain_scores_gemma":[0.99877787,0.000059605874,0.00040080753,0.00056998414,0.00015379096,0.000037915375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036361103,0.00013002721,0.000957776,0.00021919937,0.0001363439,0.000020026613,0.00017143971,0.00005463753,0.000035414985],"category_scores_gemma":[0.00024311646,0.000096386895,0.0002508614,0.00021786429,0.0002393289,0.00007774009,0.00020974701,0.000081929305,6.71498e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008685959,0.008974513,0.9181347,0.0014377318,0.041573692,0.000046319685,0.0068411957,0.00020405697,0.010327808,0.007896566,0.0006040409,0.0030907886],"study_design_scores_gemma":[0.004881706,0.00064683537,0.9776981,0.00037730567,0.011095586,0.0000011049058,0.00046277503,0.00013417628,0.004270641,0.00031372788,0.000033843993,0.00008418143],"about_ca_topic_score_codex":0.0003849276,"about_ca_topic_score_gemma":0.00068965496,"teacher_disagreement_score":0.059563424,"about_ca_system_score_codex":0.000031005326,"about_ca_system_score_gemma":0.000038102004,"threshold_uncertainty_score":0.39305434},"labels":[],"label_agreement":null},{"id":"W3167228241","doi":"10.1182/blood.v130.suppl_1.2870.2870","title":"Imatinib Suspension and Validation Study: Results from the Isav Study at 62 Months","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Discontinuation; Imatinib; Medicine; Internal medicine; Imatinib mesylate; Oncology; Myeloid leukemia; Minimal residual disease; Surgery; Gastroenterology; Leukemia","score_opus":0.03645360255583744,"score_gpt":0.3078223878722005,"score_spread":0.27136878531636305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167228241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949507,0.00014323606,2.1713213e-7,0.0007076295,0.00011524742,0.0018228646,0.000039753868,0.00004169086,0.0021786238],"genre_scores_gemma":[0.99857557,0.000026604577,0.00009382592,0.000044216016,0.00019461534,0.000037008005,0.00006901573,0.000019914862,0.00093921047],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987381,0.000098495926,0.00026430783,0.00039649545,0.00034162775,0.00016094868],"domain_scores_gemma":[0.99810284,0.00023429263,0.00020750875,0.0013261648,0.000052208135,0.0000770059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035277437,0.00015542837,0.000250512,0.000019265492,0.0005211895,0.00007962302,0.0001574045,0.000047774512,0.000051168638],"category_scores_gemma":[0.0005926664,0.00009750965,0.0000341534,0.000027920165,0.000053008887,0.00009019768,0.00027331864,0.00011760506,0.000081945866],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005390883,0.0030279479,0.9836334,0.000005410094,0.00043553772,0.00023617642,0.0075235213,5.95308e-7,0.0013066608,0.0000026568512,0.0010665063,0.0022225298],"study_design_scores_gemma":[0.038195495,0.00091081613,0.9544331,0.00005464279,0.00093076896,0.000017444367,0.0017343073,0.000036278216,0.0034156472,0.000029060173,0.00015077545,0.00009168155],"about_ca_topic_score_codex":0.0031948483,"about_ca_topic_score_gemma":0.0014878929,"teacher_disagreement_score":0.037656404,"about_ca_system_score_codex":0.00012113152,"about_ca_system_score_gemma":0.000062465195,"threshold_uncertainty_score":0.48296762},"labels":[],"label_agreement":null},{"id":"W3167588435","doi":"10.1182/blood.v130.suppl_1.3497.3497","title":"Efficacy of Iron Therapy on Fatigue and Work Capacity in Non-Anemic Iron Deficient Adults: A Systematic Review of Randomized Controlled Trials","year":2017,"lang":"en","type":"review","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"George & Fay Yee Centre for Healthcare Innovation; Centre hospitalier de l'Université Laval; University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Placebo; Randomized controlled trial; Adverse effect; Anemia; Internal medicine; Iron-deficiency anemia; Physical therapy; Iron deficiency; Meta-analysis; Ferritin; Alternative medicine","score_opus":0.0881202238291925,"score_gpt":0.3597991749250917,"score_spread":0.27167895109589923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167588435","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038318657,0.9616468,0.0000045389884,0.00002308346,0.00013765504,0.03390984,0.00003635591,0.000011019658,0.00039885283],"genre_scores_gemma":[0.0015867967,0.9963684,0.000066907756,0.0000739275,0.000061563376,0.0016876361,0.000058353966,0.00004515618,0.000051278945],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98970425,0.0038143122,0.0051687537,0.00045302528,0.00059293595,0.00026674423],"domain_scores_gemma":[0.98572767,0.006685467,0.006195884,0.0011557847,0.00013038656,0.000104792634],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.012637934,0.00064234587,0.03768502,0.0004043994,0.000035263078,0.0000149719635,0.00028171643,0.00034606387,0.00003192371],"category_scores_gemma":[0.030193886,0.00032950798,0.0030446323,0.00021475788,0.00021019045,0.000024772631,0.000030426245,0.00034837885,0.00000560685],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026061863,0.0010993804,0.0000028334014,0.9560965,0.0005556295,0.0000050181316,0.00019749229,1.3926957e-7,0.0000011698719,0.000029978639,0.000022594035,0.015927425],"study_design_scores_gemma":[0.35996693,0.00012924043,0.000005222325,0.61702543,0.022437425,0.000007688473,0.000009670754,3.2457774e-7,0.0000025751756,0.0000019374597,0.0002540131,0.00015954347],"about_ca_topic_score_codex":0.00005643574,"about_ca_topic_score_gemma":0.0000018518183,"teacher_disagreement_score":0.33907104,"about_ca_system_score_codex":0.000023405606,"about_ca_system_score_gemma":0.00021678553,"threshold_uncertainty_score":0.9999157},"labels":[],"label_agreement":null},{"id":"W3169767623","doi":"10.1182/blood.v130.suppl_1.312.312","title":"Exportin-1 Connects Dynamic Transcription and Translation of Genotoxic Stress Genes in Diffuse Large B-Cell Lymphoma Patients","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Biology; Etoposide; DNA damage; Diffuse large B-cell lymphoma; Cancer research; DNA repair; Gene expression; Gene; Gene dosage; Lymphoma; Molecular biology; DNA; Chemotherapy; Immunology; Genetics","score_opus":0.009300973375794462,"score_gpt":0.24716582740083431,"score_spread":0.23786485402503985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169767623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985754,0.000950649,0.00010265003,0.000012706413,0.000022853525,0.0001795508,0.000050827814,0.000002612019,0.000102764796],"genre_scores_gemma":[0.999201,0.00051009044,0.00008893774,0.000007339813,0.000014635031,0.00001039659,0.00008834016,0.000010173104,0.00006907716],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99937624,0.000028587703,0.00015361201,0.0001787238,0.000092539696,0.00017032778],"domain_scores_gemma":[0.9996074,0.000004411651,0.00008677749,0.00022153361,0.000032181873,0.000047721238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009093209,0.000077535056,0.00009873746,0.000035575187,0.00008024044,0.000020449412,0.00010823392,0.00008029,0.0000015869157],"category_scores_gemma":[0.00002410218,0.000075682256,0.000033476572,0.000015670752,0.000038410326,0.000007982872,0.000023722598,0.000025973299,4.3368118e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004997247,0.0014564929,0.10653857,0.00005588208,0.000011031564,0.0000025274526,0.0000704666,8.674324e-7,0.88565296,0.0000029697014,9.4584215e-7,0.0061573233],"study_design_scores_gemma":[0.014262728,0.00022092609,0.23542687,0.000022992257,0.00001410574,9.806934e-7,0.00004414894,0.00032964203,0.74951833,0.000011218711,0.000051357583,0.000096719625],"about_ca_topic_score_codex":0.00004530174,"about_ca_topic_score_gemma":0.00040431326,"teacher_disagreement_score":0.13613464,"about_ca_system_score_codex":0.0000033933998,"about_ca_system_score_gemma":0.000020053358,"threshold_uncertainty_score":0.30862328},"labels":[],"label_agreement":null},{"id":"W3169901146","doi":"10.1182/blood.v130.suppl_1.2072.2072","title":"Inhibition of WHSC1 As a Promising Therapeutic Strategy in Childhood ALL","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Biology; Gene knockdown; Exome sequencing; Exome; Mutation; Transcriptome; Leukemia; Genetics; Cancer; Cancer research; Gene; Bioinformatics; Gene expression","score_opus":0.029089729480770328,"score_gpt":0.3194891598492402,"score_spread":0.2903994303684699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169901146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98086077,0.00015440579,0.0000166447,0.0004996708,0.000017541866,0.00041842347,0.0000031639404,0.000018772062,0.018010616],"genre_scores_gemma":[0.9993355,0.000037768095,0.00014967541,0.00012791998,0.00008560958,0.000016209731,0.000008884978,0.000020207852,0.00021821803],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99899703,0.0000323489,0.00021715031,0.00019575439,0.00030851905,0.00024919573],"domain_scores_gemma":[0.99923515,0.000041564417,0.00011353016,0.0004618298,0.000064671025,0.00008324828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022148392,0.00010005132,0.00022505406,0.000103875056,0.000056119112,0.000035395264,0.00012314036,0.00009849748,0.00006794734],"category_scores_gemma":[0.0002054681,0.00008384527,0.000049244285,0.00006097005,0.00010098988,0.00011211989,0.000064148066,0.00018635027,0.000038130896],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000968167,0.009468731,0.083826765,0.0008136774,0.00089090166,0.0018816789,0.0050268983,0.000017510472,0.8411318,0.0027440153,0.00027344289,0.052956417],"study_design_scores_gemma":[0.03590522,0.0017298529,0.59244794,0.0010770323,0.00032444156,0.0005833666,0.0004317598,0.00053865794,0.3622838,0.0042562927,0.00014565125,0.00027596368],"about_ca_topic_score_codex":0.00029951357,"about_ca_topic_score_gemma":0.000031539872,"teacher_disagreement_score":0.50862116,"about_ca_system_score_codex":0.000081093414,"about_ca_system_score_gemma":0.00052895397,"threshold_uncertainty_score":0.34191108},"labels":[],"label_agreement":null},{"id":"W3170774988","doi":"10.1182/blood.2021010942","title":"Unraveling von Willebrand factor deficiency","year":2021,"lang":"en","type":"letter","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Von Willebrand factor; Medicine; Factor IX; Immunology; Internal medicine; Platelet","score_opus":0.01935492461153137,"score_gpt":0.24425978158367764,"score_spread":0.22490485697214627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170774988","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73178214,0.014536458,0.000032263135,0.22983271,0.0007262815,0.0007313264,0.00024781836,0.00017215693,0.021938879],"genre_scores_gemma":[0.18582782,0.0016311257,0.0010533265,0.78164715,0.0037862891,0.00006625211,0.004336641,0.00025168504,0.02139974],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998611,0.000022748502,0.00022025112,0.00042977365,0.00034453004,0.00037172166],"domain_scores_gemma":[0.9993833,0.000045926347,0.0000814732,0.00035983077,0.00006449867,0.0000649732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000023758053,0.00029061432,0.0005691764,0.00010547982,0.000069071655,0.000035769965,0.00008049469,0.00054215564,0.00048282612],"category_scores_gemma":[0.00004381514,0.0002362067,0.00020746447,0.00013187189,0.000027355294,0.000027987388,0.000034555782,0.00077225355,0.00013412717],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003458668,0.0020498543,0.017646395,0.0014030684,0.0017282387,0.102289565,0.00040347327,4.5913796e-7,0.0014191701,0.000007842015,0.8677423,0.00527506],"study_design_scores_gemma":[0.0103540765,0.000417198,0.0029353492,0.0008699272,0.0024376786,0.0024287524,0.00004852611,0.00000550548,0.0038296853,0.000113893606,0.9758306,0.0007287986],"about_ca_topic_score_codex":0.000029157542,"about_ca_topic_score_gemma":0.0000035549108,"teacher_disagreement_score":0.55181444,"about_ca_system_score_codex":0.000025834115,"about_ca_system_score_gemma":0.00016072777,"threshold_uncertainty_score":0.963223},"labels":[],"label_agreement":null},{"id":"W3170873716","doi":"10.1182/blood.v130.suppl_1.1138.1138","title":"Gene-Specific Lineage Involvement of Age-Related Clonal Hematopoiesis","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Biology; Haematopoiesis; Lineage (genetic); Gene; Genetics; Immunology; Stem cell","score_opus":0.035200292817024754,"score_gpt":0.279304779419367,"score_spread":0.24410448660234224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170873716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906121,0.0011409821,0.000008303476,0.0006823998,0.00013944446,0.00041901442,0.0000296359,0.000029711538,0.0069384216],"genre_scores_gemma":[0.9959308,0.0005937755,0.0022605371,0.000098883036,0.00014608086,0.00006873914,0.00005813029,0.00002126939,0.0008218024],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988585,0.000021533127,0.00035911426,0.0002711467,0.00029312234,0.00019659224],"domain_scores_gemma":[0.9988063,0.000047648526,0.00022326487,0.00068803877,0.00010629012,0.0001284445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001312112,0.00017213997,0.00041712425,0.00006163827,0.00018657606,0.000033645105,0.00013286347,0.0000899327,0.00041313912],"category_scores_gemma":[0.00005114629,0.00013329943,0.00016122361,0.000043355863,0.00013344525,0.0000510528,0.000077308796,0.00010349628,0.00007948103],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025795092,0.012472643,0.89713514,0.00036965345,0.0028882914,0.002229324,0.0015241777,0.00000456813,0.06407608,0.010194102,0.005450963,0.003397093],"study_design_scores_gemma":[0.0070931404,0.00046869356,0.3034447,0.0001839086,0.0003526978,0.00005414475,0.00004247762,0.0000078036655,0.6844673,0.00015569775,0.0035915663,0.00013784457],"about_ca_topic_score_codex":0.000039880335,"about_ca_topic_score_gemma":0.000021291917,"teacher_disagreement_score":0.6203912,"about_ca_system_score_codex":0.000025474277,"about_ca_system_score_gemma":0.000054424007,"threshold_uncertainty_score":0.54357934},"labels":[],"label_agreement":null},{"id":"W3171496624","doi":"10.1182/blood.v130.suppl_1.1859.1859","title":"The Evolving Impact on Survival Outcomes in Multiple Myeloma with Greater Access to Novel Treatment Regimens: Experience in a Real-World Cohort","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Alberta; University of Calgary","funders":"","keywords":"Multiple myeloma; Cohort; Medicine; Bortezomib; Oncology; Hematologic Neoplasms; Expanded access; Lenalidomide; Daratumumab; Internal medicine; Intensive care medicine; Cancer","score_opus":0.10446215210696526,"score_gpt":0.4018126330277292,"score_spread":0.29735048092076394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171496624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99405164,0.000021761361,0.0000024371116,0.0007299052,0.000050442086,0.001724627,0.000023977427,0.000028796025,0.0033664475],"genre_scores_gemma":[0.9974289,0.000046164238,0.00023436699,0.000044208722,0.00004355434,0.0006960311,0.000010368407,0.000033099503,0.0014632993],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998045,0.000054755496,0.00026327214,0.0004913664,0.00048871886,0.0006568415],"domain_scores_gemma":[0.99808717,0.00029383003,0.00009903653,0.0011709797,0.00006389469,0.0002850832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022257656,0.00030885075,0.0005283118,0.00023569331,0.0003223193,0.0002562314,0.00037982294,0.00004794188,0.0000323036],"category_scores_gemma":[0.0003585641,0.0001491088,0.00009062003,0.00017838742,0.00011009008,0.00022113977,0.00013506527,0.0001452312,0.00003064643],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017095373,0.0016748073,0.9926752,0.0000074682193,0.00028035263,0.0007251606,0.0006563321,0.000008574696,0.0003340361,0.000007925649,0.000012013735,0.0019086276],"study_design_scores_gemma":[0.017846009,0.0011029523,0.97614795,0.00019515354,0.000043573094,0.000014467261,0.000118085314,0.00015799451,0.0041745813,0.0000026179243,0.00004262565,0.00015397227],"about_ca_topic_score_codex":0.020242833,"about_ca_topic_score_gemma":0.035865635,"teacher_disagreement_score":0.016527195,"about_ca_system_score_codex":0.0004322593,"about_ca_system_score_gemma":0.00014356569,"threshold_uncertainty_score":0.98628145},"labels":[],"label_agreement":null},{"id":"W3172177734","doi":"10.1182/blood.v130.suppl_1.3410.3410","title":"A Canadian Cost-Effectiveness Analysis for the Treatment of Immune Thrombocytopenia: Assessing the Relative Value of with Eltrombopag Versus Romiplostim","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Eltrombopag; Romiplostim; Immune thrombocytopenia; Medicine; Value (mathematics); Internal medicine; Thrombopoietin; Platelet; Statistics; Mathematics; Biology; Haematopoiesis","score_opus":0.04218612097967162,"score_gpt":0.3415789927438512,"score_spread":0.29939287176417956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172177734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953857,0.00085194345,0.00020697695,0.0004936335,0.000043844717,0.0016726671,0.000089315574,0.000005139819,0.0012507489],"genre_scores_gemma":[0.99924517,0.000110652356,0.00031619446,0.000006083143,0.00001504581,0.00019145521,0.000036821868,0.000015362817,0.00006323641],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992465,0.000055554636,0.00017451672,0.00017907372,0.00014387238,0.00020049706],"domain_scores_gemma":[0.99822515,0.0006590591,0.0002598372,0.00066804246,0.0001224229,0.00006550406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016751206,0.00015326547,0.00064206414,0.00007453681,0.0004629735,0.000032765758,0.00014884117,0.00005346968,0.000011153659],"category_scores_gemma":[0.00008840394,0.000071110706,0.00025499743,0.00015176008,0.00016799617,0.000092606344,0.000012689401,0.000053572952,0.0000010173097],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003584588,0.0057486887,0.86744213,0.00014156196,0.10207503,0.00034418728,0.0028945385,0.0006035202,0.0036060144,0.0023502351,0.000007930764,0.011201595],"study_design_scores_gemma":[0.017723644,0.002342542,0.9422911,0.000085699045,0.020744419,0.000012094657,0.00028831515,0.00035345374,0.01589527,0.00007600907,0.00010260631,0.00008487901],"about_ca_topic_score_codex":0.07429485,"about_ca_topic_score_gemma":0.035890263,"teacher_disagreement_score":0.08133061,"about_ca_system_score_codex":0.00013711471,"about_ca_system_score_gemma":0.00031021005,"threshold_uncertainty_score":0.9817022},"labels":[],"label_agreement":null},{"id":"W3172426892","doi":"10.1182/blood.v130.suppl_1.3955.3955","title":"Clinical and Genetic Relevance of Somatic Mutations in Core Binding Factor (CBF) Acute Myeloid Leukemia (AML) Patients Using Serial Sequencing","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Neuroblastoma RAS viral oncogene homolog; KRAS; Core binding factor; Myeloid leukemia; Internal medicine; Medicine; Oncology; Hazard ratio; Myeloid; Cancer; Gastroenterology; Biology; Genetics; Gene; Confidence interval","score_opus":0.07426302301770765,"score_gpt":0.36639767474909113,"score_spread":0.2921346517313835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172426892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99891603,0.000056516852,0.000048282727,0.000037211306,0.00016943213,0.0005905664,0.000056303634,0.000021251266,0.00010439147],"genre_scores_gemma":[0.98713857,0.00015317206,0.012398574,0.000024974912,0.00015856535,0.000010955507,0.000021146265,0.000037022684,0.0000570358],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99815756,0.000074024276,0.00067810935,0.00036430557,0.00036219863,0.00036377326],"domain_scores_gemma":[0.99852103,0.00022066795,0.00036459955,0.000581257,0.00013167136,0.00018075656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023152716,0.00017372199,0.00050499506,0.00017631835,0.00021264578,0.0000464152,0.00022760658,0.00018316899,0.000021244074],"category_scores_gemma":[0.0014048042,0.00016186407,0.00007833615,0.000111257534,0.0003412146,0.0001993995,0.00020236579,0.00040907177,0.000010667787],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009978822,0.00011518232,0.8687537,0.0001772901,0.00012923486,0.00016917991,0.00043758514,0.000014775009,0.12779872,0.0000056498143,0.0000062852896,0.0022926615],"study_design_scores_gemma":[0.01097738,0.00034181436,0.9690341,0.0005460999,0.0002997498,0.00009746705,0.000116721785,0.0040590568,0.014243905,0.00009075463,0.000008128112,0.00018482101],"about_ca_topic_score_codex":0.00023552316,"about_ca_topic_score_gemma":0.000053769665,"teacher_disagreement_score":0.11355481,"about_ca_system_score_codex":0.00033464885,"about_ca_system_score_gemma":0.0008647055,"threshold_uncertainty_score":0.66006255},"labels":[],"label_agreement":null},{"id":"W3172755753","doi":"10.1182/blood.v130.suppl_1.2344.2344","title":"A Factor VIII Fusion with an Inactivated FIX Generates a Biologically Active Molecule with Delayed Clearance in a FVIII/VWF Knockout Mouse Model","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Von Willebrand factor; Biological activity; Knockout mouse; Immunology; Factor IX; Chemistry; Fusion protein; Molecular biology; Virology; Biology; Recombinant DNA; Medicine; Receptor; Platelet; Biochemistry; In vitro","score_opus":0.03592234244257146,"score_gpt":0.30428410234803543,"score_spread":0.26836175990546396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172755753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99749357,0.000046939578,0.00006861082,0.00034683783,0.0000051633247,0.00073838345,0.000040230727,0.00006948164,0.0011908073],"genre_scores_gemma":[0.9970538,0.00008613881,0.0017491517,0.00007425979,0.00003935858,0.00008921921,0.000048092606,0.000036321446,0.00082368474],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998617,0.000061526924,0.00015261084,0.00046964988,0.00028496332,0.0004142735],"domain_scores_gemma":[0.99892265,0.00002376982,0.00009867926,0.0005748316,0.0001576643,0.00022243822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006971961,0.00023950454,0.00036532624,0.000113574046,0.00026266166,0.000061261766,0.00020124447,0.00016390994,0.00002977551],"category_scores_gemma":[0.00006204096,0.0001349364,0.00004029867,0.00012414691,0.00017253803,0.00020336274,0.00007341171,0.00031904975,0.0000129690825],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01877601,0.0047143265,0.057371207,0.00004581782,0.00043993728,0.0008444509,0.0009853322,0.00012572427,0.9138795,0.000052930904,0.000009322128,0.0027554329],"study_design_scores_gemma":[0.02141172,0.009667938,0.13347986,0.0002754773,0.00014782778,0.00006861224,0.00022395448,0.011949088,0.82226336,0.000044726992,0.000018637085,0.00044880988],"about_ca_topic_score_codex":0.0002949176,"about_ca_topic_score_gemma":0.0004493006,"teacher_disagreement_score":0.09161617,"about_ca_system_score_codex":0.00005346025,"about_ca_system_score_gemma":0.00026648297,"threshold_uncertainty_score":0.5502547},"labels":[],"label_agreement":null},{"id":"W3173250272","doi":"10.1182/blood.v130.suppl_1.233.233","title":"Maternal Anti-αIIb Antibodies Target Fetal Hematopoietic Stem Cells and May Lead to Pancytopenia and Miscarriage in Fnait","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Canadian Blood Services; University of Toronto","funders":"","keywords":"Neonatal alloimmune thrombocytopenia; Fetus; Haematopoiesis; Stem cell; Immunology; Biology; Miscarriage; Andrology; Medicine; Pregnancy; Genetics","score_opus":0.014213695944545423,"score_gpt":0.2595646033508989,"score_spread":0.2453509074063535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173250272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99631023,0.0010996965,0.0000029216178,0.00047801767,0.00007410557,0.00033896,0.000037379552,0.000017652945,0.0016410154],"genre_scores_gemma":[0.9977253,0.00026122417,0.0005419515,0.00007644479,0.000028481038,0.000009272195,0.0000040912414,0.000018333152,0.0013349063],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99917066,0.000013882425,0.00016303106,0.00027989436,0.00012093234,0.0002516062],"domain_scores_gemma":[0.9995201,0.000012808591,0.00006001512,0.00026603515,0.000015199593,0.00012583814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007173862,0.00016652507,0.00041906702,0.000063054424,0.00012916831,0.000098336,0.00007962703,0.000064420885,0.000022872255],"category_scores_gemma":[0.0000074282575,0.00013406854,0.00003130754,0.000023486966,0.00006770475,0.00009657663,0.00009548017,0.00007874584,0.00004217992],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006587697,0.0003425095,0.9722633,0.00019948221,0.00011536365,0.002787286,0.00047812963,2.061889e-7,0.022309935,0.000023409386,0.00014540419,0.0012690998],"study_design_scores_gemma":[0.007582468,0.00023286372,0.8716778,0.00034059118,0.00016287605,0.00059755234,0.00017029022,0.000016750975,0.118423864,0.00010657874,0.0004791844,0.00020916437],"about_ca_topic_score_codex":0.00018311915,"about_ca_topic_score_gemma":0.000073580595,"teacher_disagreement_score":0.10058548,"about_ca_system_score_codex":0.0000065743134,"about_ca_system_score_gemma":0.000015480131,"threshold_uncertainty_score":0.5467156},"labels":[],"label_agreement":null},{"id":"W3173484049","doi":"10.1182/blood.v130.suppl_1.2986.2986","title":"Iron Overload in Lower International Prognostic Scoring System Risk Myelodysplastic Syndromes Patients Receiving Red Blood Cell Transfusions: Relation to Infection and Possible Benefit of Iron Chelation Therapy","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital","funders":"","keywords":"Myelodysplastic syndromes; Medicine; Deferasirox; Internal medicine; Chelation therapy; Deferoxamine; Anemia; Blood transfusion; Intensive care medicine; Gastroenterology; Thalassemia; Bone marrow","score_opus":0.007403692288995238,"score_gpt":0.22232513227746886,"score_spread":0.21492143998847363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173484049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969591,0.00026140624,0.000046354828,0.00008640339,0.00042625592,0.00084030407,0.000009608196,0.000040727922,0.0013298306],"genre_scores_gemma":[0.9983611,0.0012351673,0.00021530557,0.0000057452457,0.00004050033,0.000029989416,0.000022324775,0.000023076593,0.00006678304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988245,0.000037008158,0.0003973705,0.0002947284,0.000271599,0.00017481632],"domain_scores_gemma":[0.99922657,0.00006503335,0.00028238425,0.00023741843,0.00010565024,0.00008296072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021083678,0.00015551361,0.00023256052,0.0002482909,0.00019875925,0.000041216794,0.00006954585,0.00018276386,0.000012617973],"category_scores_gemma":[0.00029049828,0.00014100649,0.000054635002,0.00012709398,0.000030523588,0.00024324337,0.000033088694,0.00021767498,0.0000046052846],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018480462,0.00086412474,0.9855183,0.00022755167,0.00005329332,0.0000091135025,0.00061582244,0.00046355708,0.0071932846,0.000017319067,0.0000014228007,0.004851433],"study_design_scores_gemma":[0.007747646,0.0007122236,0.9871293,0.0016949241,0.0002450421,0.000018487357,0.00007543475,0.0007523187,0.0014610032,0.000020946682,0.0000075082175,0.00013521951],"about_ca_topic_score_codex":0.0004675694,"about_ca_topic_score_gemma":0.00007901188,"teacher_disagreement_score":0.0075628413,"about_ca_system_score_codex":0.000057251895,"about_ca_system_score_gemma":0.000029763216,"threshold_uncertainty_score":0.5750078},"labels":[],"label_agreement":null},{"id":"W3174731055","doi":"10.1182/blood.v130.suppl_1.5511.5511","title":"Rabbit Anti-Thymocyte Globulin Kills Leukemic Stem Cells to a Greater Degree Than Healthy Hematopoietic Stem Cells","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Alberta; University of Calgary","funders":"","keywords":"Stem cell; Immunology; Haematopoiesis; Leukemia; Medicine; Bone marrow; Anti-thymocyte globulin; Myeloid leukemia; Hematopoietic stem cell transplantation; Transplantation; Biology; Internal medicine","score_opus":0.06725667893017398,"score_gpt":0.3108618785776113,"score_spread":0.2436051996474373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174731055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840975,0.00089245196,0.00008054366,0.001551207,0.0005575109,0.0022351618,0.000043578024,0.00015475377,0.010387327],"genre_scores_gemma":[0.9725371,0.00025319145,0.0004803572,0.0006170794,0.00045143254,0.00009520389,0.0000052515115,0.00012612072,0.025434265],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9950796,0.00021289801,0.00079141615,0.0011038099,0.0013284474,0.0014838404],"domain_scores_gemma":[0.9951381,0.00016666728,0.00031166646,0.0027178025,0.00026981035,0.0013959411],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010312052,0.00054583134,0.0011135782,0.0002739655,0.000551417,0.00028322966,0.0010767712,0.00033911254,0.00036303487],"category_scores_gemma":[0.000041054394,0.00045403466,0.00030197547,0.00025492776,0.00018337136,0.00016683056,0.0006177297,0.0006232502,0.004783322],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019031984,0.0026525687,0.13488732,0.0045747007,0.0008674451,0.006453182,0.0035997878,0.000028890421,0.8106456,0.0001597037,0.014280009,0.019947628],"study_design_scores_gemma":[0.00877864,0.0015979909,0.029226782,0.00095495215,0.00029037782,0.00036203722,0.00030169456,0.00007307019,0.94938886,0.000013843945,0.008362689,0.00064904825],"about_ca_topic_score_codex":0.0004475934,"about_ca_topic_score_gemma":0.000062928055,"teacher_disagreement_score":0.13874331,"about_ca_system_score_codex":0.00026526782,"about_ca_system_score_gemma":0.00053756795,"threshold_uncertainty_score":0.99979115},"labels":[],"label_agreement":null},{"id":"W3175821495","doi":"10.1182/blood.v130.suppl_1.3739.3739","title":"Live Immunization Practices for Chronically Transfused Pediatric Patients","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Stollery Children's Hospital; University of Alberta","funders":"","keywords":"Medicine; Vaccination; Immunization; Population; Measles; Packed red blood cells; Immunology; Blood transfusion; Pediatrics; Intensive care medicine; Immune system; Environmental health","score_opus":0.0233734776686625,"score_gpt":0.297582642846849,"score_spread":0.2742091651781865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3175821495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958511,0.0002763691,0.00037417156,0.00074981444,0.00017729418,0.00081227126,0.000017414426,0.000043498858,0.0016980673],"genre_scores_gemma":[0.99736995,0.00048670397,0.0013474098,0.00008695762,0.00039716458,0.000041435243,0.00007134905,0.00002452511,0.00017451796],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992651,0.000015250108,0.00017983177,0.00020563664,0.00016693043,0.00016730608],"domain_scores_gemma":[0.9989918,0.000067302615,0.00026565275,0.0004106598,0.00018666327,0.00007791525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012858941,0.00010093376,0.0001710433,0.00003892291,0.00035042476,0.000056166795,0.0001345929,0.00010225253,0.000045608504],"category_scores_gemma":[0.00040697615,0.000085271095,0.000091601454,0.000035650046,0.00002679456,0.00021731536,0.000015454105,0.00011253749,0.000020206453],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005035744,0.0054043536,0.97938585,0.0004772344,0.00020748918,0.000010710887,0.0005880941,6.327566e-7,0.002325112,0.00023767086,0.00019365968,0.010665601],"study_design_scores_gemma":[0.023436276,0.0016843538,0.9669513,0.00005326877,0.0019561138,0.0000061069723,0.000029112296,0.00005170344,0.0028114018,0.000078932506,0.0027714341,0.00016997529],"about_ca_topic_score_codex":0.00008618521,"about_ca_topic_score_gemma":0.000051475246,"teacher_disagreement_score":0.0229327,"about_ca_system_score_codex":0.000008442137,"about_ca_system_score_gemma":0.00007947272,"threshold_uncertainty_score":0.34772545},"labels":[],"label_agreement":null},{"id":"W3175941007","doi":"10.1182/blood.v130.suppl_1.3412.3412","title":"Quality Improvement in the Care of Patients with Asplenia: Focus on Diminishing Risk of Infection","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Abdominal Trauma and Injuries","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Asplenia; Medicine; Splenectomy; Pediatrics; Observational study; Vaccination; Intensive care medicine; Internal medicine; Spleen; Immunology","score_opus":0.017591255245682787,"score_gpt":0.2965906712546684,"score_spread":0.27899941600898565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3175941007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99647903,0.000020367846,0.000004907221,0.000058109854,0.00002747423,0.00025924257,0.000024538247,0.0000031971456,0.0031230988],"genre_scores_gemma":[0.9998672,0.000011108338,0.000059800703,0.000013427702,0.000024920153,0.000009880198,0.000004575018,0.0000043075347,0.000004771464],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999442,0.00003690725,0.00016706486,0.00008285078,0.00020476757,0.00006642434],"domain_scores_gemma":[0.9992874,0.00004433583,0.00025322623,0.0003231806,0.00007784745,0.000013999291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001790851,0.00005688636,0.0001569589,0.000024377025,0.00006563452,0.0000072607454,0.000057940488,0.000030785646,0.0000035882813],"category_scores_gemma":[0.00016777213,0.00003169782,0.00003828713,0.0000228694,0.00006187934,0.000052933217,0.00001721756,0.00010127826,4.760282e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036187787,0.0006148954,0.98319167,0.00010077729,0.000040392555,8.987907e-7,0.0020498072,3.3070845e-7,0.00020153979,0.00009934504,0.000004013967,0.013334478],"study_design_scores_gemma":[0.0031164056,0.0025184408,0.9606171,0.00010407896,0.00013435664,1.8522223e-7,0.0005015496,3.217705e-7,0.032882728,0.00006979507,0.000021368647,0.00003363934],"about_ca_topic_score_codex":0.001300207,"about_ca_topic_score_gemma":0.00038125538,"teacher_disagreement_score":0.032681186,"about_ca_system_score_codex":0.00000901637,"about_ca_system_score_gemma":0.000018002955,"threshold_uncertainty_score":0.19655327},"labels":[],"label_agreement":null},{"id":"W3176321244","doi":"10.1182/blood.v130.suppl_1.3718.3718","title":"The Effects of Rivaroxaban Exposure and Clinical Risk Factors on Efficacy and Safety Outcomes in the Prevention of Venous Thromboembolism after Elective Hip or Knee Replacement Surgery","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Rivaroxaban; Medicine; Knee replacement; Population; Clinical trial; Partial thromboplastin time; Regimen; Surgery; Internal medicine; Orthopedic surgery; Coagulation; Warfarin","score_opus":0.020208819498894377,"score_gpt":0.31266077553303045,"score_spread":0.2924519560341361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176321244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99729806,0.0005460122,0.0000027430638,0.00026115586,0.0002080269,0.0015201144,0.000007715897,0.000008659979,0.00014751854],"genre_scores_gemma":[0.99648255,0.0032464722,0.000019286254,0.00006779136,0.000053462627,0.00006548024,0.0000029628115,0.000015249373,0.000046742032],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983454,0.00034924838,0.0005292836,0.0002809612,0.000282887,0.00021222468],"domain_scores_gemma":[0.995735,0.002984031,0.00047543528,0.0007113699,0.00003972624,0.000054450175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001342934,0.00017616546,0.00081588567,0.00006445994,0.00021964088,0.000032326992,0.00012653344,0.00009235363,0.0000056877107],"category_scores_gemma":[0.00194933,0.00008687974,0.00014777688,0.00005046541,0.00022323751,0.000052126652,0.00010465316,0.00021581186,6.5272144e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010222265,0.006027059,0.9777056,0.00026018338,0.0009861306,0.000023034043,0.0017911777,2.7424812e-7,0.000042816835,0.00014898602,0.00010907598,0.011883464],"study_design_scores_gemma":[0.0043631964,0.004385946,0.98837036,0.00039511063,0.001031712,0.0000030104152,0.00026163066,0.0000012184234,0.0008466685,0.00015465506,0.00009770862,0.00008880926],"about_ca_topic_score_codex":0.00019685658,"about_ca_topic_score_gemma":0.00014590898,"teacher_disagreement_score":0.011794655,"about_ca_system_score_codex":0.00001455584,"about_ca_system_score_gemma":0.000044568744,"threshold_uncertainty_score":0.3542853},"labels":[],"label_agreement":null},{"id":"W3176497490","doi":"10.1182/blood.v130.suppl_1.28.28","title":"Simultaneous Identification and Stratification of Low Molecular Risk AML Patients Using a Single LSC17-Based Nanostring Assay at Diagnosis","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Oncology; NPM1; Myeloid leukemia; Induction chemotherapy; Clinical trial; Chemotherapy; Framingham Risk Score; Chemotherapy regimen; Disease; Gene; Karyotype","score_opus":0.019189947427503885,"score_gpt":0.28407650297006254,"score_spread":0.26488655554255863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176497490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99815416,0.0001192643,0.00081786147,0.00009039634,0.000041375464,0.0005855667,0.000053668347,0.000022534601,0.000115145354],"genre_scores_gemma":[0.9983541,0.00003775446,0.0013875387,0.000015889627,0.000029653413,0.000020571475,0.000073703086,0.000027794642,0.000053011005],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99864376,0.000094530464,0.00031858904,0.00032726707,0.0004084809,0.00020735984],"domain_scores_gemma":[0.99816364,0.00022959565,0.000447176,0.0007292209,0.00031551553,0.00011485002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030910358,0.00013010307,0.00021509951,0.00011276118,0.00027336628,0.00007666498,0.00015596014,0.000112580376,0.000014730325],"category_scores_gemma":[0.0026914987,0.00012880123,0.000057102217,0.000084665044,0.00014642756,0.00011045978,0.00008289046,0.00014020555,0.000010580982],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000821472,0.0008230704,0.38347447,0.00017709457,0.00007349057,0.000035552534,0.00008820661,0.00015705462,0.60861987,0.0000055185956,0.000010655317,0.00645289],"study_design_scores_gemma":[0.0032941676,0.00020137963,0.13994768,0.00018066597,0.00027852983,0.0000061731766,0.000017881179,0.012738097,0.8431824,0.000017080036,0.000020589378,0.000115348994],"about_ca_topic_score_codex":0.00019059314,"about_ca_topic_score_gemma":0.000021792548,"teacher_disagreement_score":0.24352679,"about_ca_system_score_codex":0.0001685349,"about_ca_system_score_gemma":0.00010498269,"threshold_uncertainty_score":0.5252362},"labels":[],"label_agreement":null},{"id":"W3176781225","doi":"10.1182/blood.v130.suppl_1.4207.4207","title":"Platelet Function Tests and Inflammatory Markers for the Differentiation of Primary Thrombocytosis and Secondary Thrombocytosis","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Thrombocytosis; Medicine; Platelet; Internal medicine; Erythrocyte sedimentation rate; Gastroenterology; C-reactive protein; Von Willebrand factor; Immunology; Inflammation","score_opus":0.01891405940328669,"score_gpt":0.2511722046933629,"score_spread":0.23225814529007618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176781225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963982,0.0010549846,0.00004335686,0.0005766603,0.00008924999,0.00088769034,0.000043787917,0.000016537319,0.0008895166],"genre_scores_gemma":[0.9981358,0.0010681131,0.00031131733,0.00013165029,0.000084363084,0.00016993114,0.000033461107,0.000016583379,0.000048774196],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992928,0.000021040487,0.00019731416,0.00022217682,0.00013629,0.00013039],"domain_scores_gemma":[0.99905396,0.00029528572,0.00019976863,0.0003159247,0.00007307891,0.00006200709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001466574,0.00014633284,0.0003221108,0.00004041174,0.00037543912,0.00005322891,0.000051031842,0.00007956764,0.000036058398],"category_scores_gemma":[0.00008811649,0.00009445997,0.00006233551,0.000018381563,0.00014427934,0.00013158147,0.000059163773,0.0000818913,0.00000104392],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041822103,0.000478541,0.9499277,0.0005137018,0.001201551,0.0000040661453,0.0002623094,2.2889084e-7,0.014037194,0.00047134073,0.0004071797,0.032277964],"study_design_scores_gemma":[0.005803075,0.00062204665,0.9630421,0.00011546367,0.00091144355,0.000019415378,0.000056356366,0.000034765217,0.028804483,0.00017843593,0.00032700272,0.00008541413],"about_ca_topic_score_codex":0.000025640482,"about_ca_topic_score_gemma":0.00004651935,"teacher_disagreement_score":0.032192547,"about_ca_system_score_codex":0.000019258576,"about_ca_system_score_gemma":0.000055145192,"threshold_uncertainty_score":0.38519657},"labels":[],"label_agreement":null},{"id":"W3176931337","doi":"10.1182/blood.v130.suppl_1.4935.4935","title":"Variations in Red Blood Cell and Frozen Plasma Transfusion Rates Across 60 Ontario Community Hospitals","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Blood donation and transfusion practices","field":"Business, Management and Accounting","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; Ontario Stroke Network; University of Toronto","funders":"","keywords":"Medicine; Fresh frozen plasma; Emergency medicine; Blood transfusion; Audit; Christian ministry; Observational study; Blood management; Retrospective cohort study; Intensive care medicine; Surgery; Internal medicine","score_opus":0.0217796357578753,"score_gpt":0.2545347468871235,"score_spread":0.2327551111292482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176931337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9621271,0.000044866032,0.000016799566,0.0016993737,0.00020213593,0.00030966033,0.000010044254,0.00006747342,0.03552255],"genre_scores_gemma":[0.99854827,0.00008052033,0.00030219927,0.00030963944,0.00011943543,0.000027045622,0.000035642308,0.00002104662,0.00055617746],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893814,0.000044525124,0.00030696034,0.00025216056,0.00019895019,0.00025925948],"domain_scores_gemma":[0.99896723,0.00012833938,0.00028304415,0.0004933325,0.000104486695,0.000023585386],"candidate_categories":["sts","scholarly_communication"],"consensus_categories":[],"category_scores_codex":[0.0007422077,0.00018845969,0.00022944176,0.000116601834,0.0016393677,0.0010891657,0.0004097034,0.00012896865,0.00031164294],"category_scores_gemma":[0.0001570556,0.00018559028,0.000056723948,0.00012404933,0.00007795183,0.0022483112,0.00018046431,0.00046915552,0.000047963433],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007072792,0.0027121855,0.98637265,0.00013827941,0.00008963105,0.00004349132,0.0031373838,0.0000057801094,0.0036988517,0.0017177254,0.00012552446,0.0018877544],"study_design_scores_gemma":[0.00851345,0.000032938184,0.9795749,0.000057373003,0.00028017405,0.000004788574,0.0006665054,0.00013843781,0.002575185,0.0016973526,0.0061552348,0.00030362682],"about_ca_topic_score_codex":0.087686755,"about_ca_topic_score_gemma":0.28191546,"teacher_disagreement_score":0.1942287,"about_ca_system_score_codex":0.000008712709,"about_ca_system_score_gemma":0.000033341894,"threshold_uncertainty_score":0.9999478},"labels":[],"label_agreement":null},{"id":"W3177050893","doi":"10.1182/blood.v130.suppl_1.1706.1706","title":"A Simple Tool for the Prediction of Azacytidine Treatment Failure in Patients with Myelodysplastic Syndrome","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre; University of Toronto","funders":"","keywords":"Medicine; Myelodysplastic syndromes; International Prognostic Scoring System; Internal medicine; Bone marrow; Erythropoiesis; Ruxolitinib; Oncology; Cohort; Dosing; Myelofibrosis; Anemia; Surgery","score_opus":0.014997319765032548,"score_gpt":0.26048513888174607,"score_spread":0.24548781911671352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3177050893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976873,0.000015361622,0.00009828117,0.0003517802,0.00002334922,0.001594211,0.00014272235,0.000013940959,0.00007309255],"genre_scores_gemma":[0.999034,0.000011537787,0.00034897664,0.000012174234,0.0000490902,0.00022230431,0.000069593145,0.000019780353,0.00023256849],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99918133,0.000013512137,0.00017155155,0.00017671648,0.00024146483,0.0002154497],"domain_scores_gemma":[0.9990249,0.00015330753,0.000099747886,0.00056142453,0.000111843576,0.000048747374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000099323064,0.00011058308,0.00023031975,0.000066485205,0.00013419305,0.0000183892,0.00013888197,0.00005538779,0.000024279285],"category_scores_gemma":[0.0002402432,0.000059950784,0.00004798264,0.00006167438,0.0000860275,0.000079146346,0.00004020682,0.0000895625,0.000004689559],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010239978,0.0010160151,0.99529326,0.000096845724,0.00031738356,0.00003020453,0.00012293088,0.000013431123,0.00037164928,0.000029276678,0.00024578904,0.0014391913],"study_design_scores_gemma":[0.02220278,0.0038492437,0.97111106,0.00008725631,0.00031871226,0.000024480512,0.000031861488,0.00037560653,0.001296353,0.00001550623,0.00063487986,0.000052258867],"about_ca_topic_score_codex":0.000115143295,"about_ca_topic_score_gemma":0.000104538136,"teacher_disagreement_score":0.024182225,"about_ca_system_score_codex":0.00012622942,"about_ca_system_score_gemma":0.00017089798,"threshold_uncertainty_score":0.2444722},"labels":[],"label_agreement":null},{"id":"W3177151213","doi":"10.1182/blood.v130.suppl_1.4735.4735","title":"Inferior Vena Cava Filter Utilization at Kingston Health Sciences Centre: A Comparison of Practice with Guidelines","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Kingston General Hospital; Queen's University","funders":"","keywords":"Medicine; Inferior vena cava; Pulmonary embolism; Inferior vena cava filter; Guideline; Venous thrombosis; Deep vein; Interventional radiology; Radiology; Surgery; Thrombosis","score_opus":0.11932600938521408,"score_gpt":0.41857125540184287,"score_spread":0.2992452460166288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3177151213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96615815,0.0013605733,0.00014084046,0.022892194,0.00015279921,0.00064695865,0.0000075162625,0.000033662785,0.008607285],"genre_scores_gemma":[0.9937492,0.0003627415,0.004370865,0.0012156052,0.00008815368,0.00000836992,0.000012611812,0.000011230467,0.00018121862],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891675,0.000030588875,0.00029518484,0.00021366334,0.00034575412,0.00019807891],"domain_scores_gemma":[0.9987461,0.000036240108,0.0005528109,0.00036984964,0.00021727425,0.00007772924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036923663,0.00009964249,0.0003629937,0.000056402507,0.00038389643,0.000044884728,0.00013435975,0.00002895859,0.000051155967],"category_scores_gemma":[0.00045672446,0.000073045725,0.000032381402,0.00006933298,0.00014144788,0.0001606211,0.000102205995,0.00005082692,0.000010763589],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026219414,0.008188286,0.8948025,0.000994363,0.0005450465,0.000047306086,0.00810686,0.00013861248,0.0017258064,0.0029767903,0.05511375,0.027098447],"study_design_scores_gemma":[0.006389957,0.0033716005,0.7751438,0.0018185565,0.0011169213,0.000055948185,0.0022027104,0.0007047366,0.021955535,0.000029544872,0.18688896,0.00032171735],"about_ca_topic_score_codex":0.0011116209,"about_ca_topic_score_gemma":0.00046957616,"teacher_disagreement_score":0.13177522,"about_ca_system_score_codex":0.000030071587,"about_ca_system_score_gemma":0.00013391493,"threshold_uncertainty_score":0.2978718},"labels":[],"label_agreement":null},{"id":"W3178200071","doi":"10.1182/blood.v130.suppl_1.4366.4366","title":"Evolution of Monoclonal Gammopathy of Undetermined Significance in Kidney Transplant Recipients at the CHUM (Centre Hospitalier de l'Université de Montréal) — a Single-Institution Retrospective Study","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Monoclonal gammopathy of undetermined significance; Medicine; Multiple myeloma; Transplantation; Immunosuppression; Internal medicine; Retrospective cohort study; Kidney transplantation; Monoclonal; Immunology; Monoclonal antibody; Antibody","score_opus":0.006719686251840298,"score_gpt":0.2115667240247641,"score_spread":0.2048470377729238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178200071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99860996,0.0004429204,0.000043848428,0.00011692921,0.00005140209,0.00040834237,0.00015067952,0.000004935575,0.00017099673],"genre_scores_gemma":[0.9994976,0.00018946834,0.00007892458,0.00001389984,0.000023751463,0.000022483582,0.000025805317,0.000010618581,0.0001374806],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991354,0.000077109566,0.00018370459,0.00026927865,0.0001365059,0.00019803172],"domain_scores_gemma":[0.99918187,0.000009834073,0.00025474431,0.00043722676,0.000052130712,0.00006422015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013088394,0.00013566231,0.00018051508,0.000033438584,0.00016384108,0.0000073915867,0.00023515378,0.00009328465,0.000007642884],"category_scores_gemma":[0.000099986864,0.00011481178,0.0000956031,0.000042488406,0.000136655,0.000008487057,0.00010339005,0.000047806378,0.0000013678601],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002512278,0.0012157891,0.8107767,0.000008767518,0.00011967795,0.000022498944,0.00074353867,0.000026336713,0.1867122,0.000010600713,0.000056299923,0.00005633975],"study_design_scores_gemma":[0.002493668,0.00040493545,0.71205527,0.000044991117,0.00014457069,0.0000065175877,0.00020041871,0.000013540094,0.28452143,0.000013730803,0.0000191941,0.00008175621],"about_ca_topic_score_codex":0.0013278374,"about_ca_topic_score_gemma":0.005050303,"teacher_disagreement_score":0.098721474,"about_ca_system_score_codex":0.00041844702,"about_ca_system_score_gemma":0.00009532418,"threshold_uncertainty_score":0.46818888},"labels":[],"label_agreement":null},{"id":"W3178268161","doi":"10.1182/blood.v130.suppl_1.1075.1075","title":"Contribution of Select ISTH-BAT Subscores to the Total Score in Type 1 VWD","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Cardiac Imaging and Diagnostics","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Biology; Internal medicine; Statistics; Mathematics","score_opus":0.013970398182631585,"score_gpt":0.2787722097715863,"score_spread":0.2648018115889547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178268161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958248,0.0007082938,0.000018050772,0.0015436463,0.00020333154,0.00019833879,0.000011099437,0.000012645969,0.0014797683],"genre_scores_gemma":[0.999467,0.000023187798,0.0000418206,0.00012769394,0.00018261319,0.000005625838,0.00001169731,0.0000064648584,0.00013387052],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995455,0.000015132458,0.00010121237,0.00009291452,0.00011753199,0.00012768507],"domain_scores_gemma":[0.99935675,0.00007785013,0.0000454333,0.00034164262,0.00013437762,0.00004392141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015533081,0.000055992125,0.00015636218,0.000032599077,0.00005855537,0.000019513243,0.000068204004,0.000030922914,0.000009314303],"category_scores_gemma":[0.0022215946,0.000039424216,0.00004464766,0.00006584979,0.000043880074,0.00002270704,0.00003538009,0.000084721956,0.000031660882],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001139941,0.000192408,0.98873127,0.000017857266,0.000037230184,0.00004044466,0.00016463902,0.000012150368,0.0061280066,0.00027595425,0.0034728919,0.0008131613],"study_design_scores_gemma":[0.0015950204,0.00015610704,0.9619688,0.00011645134,0.000110341134,0.000042268042,0.000017203445,0.00001699433,0.035234652,0.00003370397,0.000661386,0.000047108326],"about_ca_topic_score_codex":0.00024111393,"about_ca_topic_score_gemma":0.00007083405,"teacher_disagreement_score":0.029106645,"about_ca_system_score_codex":0.000012506039,"about_ca_system_score_gemma":0.00006260349,"threshold_uncertainty_score":0.26596168},"labels":[],"label_agreement":null},{"id":"W3178455046","doi":"10.1182/blood.2020009346","title":"Multimodal single-cell analysis of cutaneous T-cell lymphoma reveals distinct subclonal tissue-dependent signatures","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; National Cancer Institute; National Institutes of Health; LEO Fondet; National Human Genome Research Institute; Danmarks Frie Forskningsfond; York University; Chan Zuckerberg Initiative; Novo Nordisk Fonden; Kræftens Bekæmpelse; Howard Hughes Medical Institute","keywords":"Mycosis fungoides; Cutaneous T-cell lymphoma; Biology; Lymphoma; Cell; Cancer research; Lymph; Disease; Cancer; Pathology; Immunology; Medicine; Genetics","score_opus":0.015363751017479233,"score_gpt":0.2761645072407377,"score_spread":0.2608007562232585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178455046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838222,0.0035683196,0.00015600225,0.00016776871,0.000062629704,0.00044382832,0.00022867709,0.00006637161,0.011484184],"genre_scores_gemma":[0.9885834,0.000084041254,0.0012382463,0.00013869097,0.0000992815,0.000022123424,0.0004037145,0.00006164317,0.009368851],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966417,0.00021967276,0.0006208539,0.00073470984,0.0012028815,0.00058018905],"domain_scores_gemma":[0.99757844,0.00042937632,0.00019714281,0.0007456314,0.0007347388,0.000314691],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019273863,0.0003385948,0.0009779788,0.00043648394,0.000111239184,0.000049342256,0.00023797095,0.00023814295,0.0014141287],"category_scores_gemma":[0.00048556292,0.0003204944,0.0004362634,0.0013094775,0.00016157825,0.00004146396,0.00017637988,0.0002189639,0.00006000111],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044775932,0.012195392,0.09353732,0.00035256904,0.0018244791,0.008344635,0.00044943392,0.00015431945,0.880439,0.000018960494,0.0002776633,0.0019584524],"study_design_scores_gemma":[0.0093172975,0.0010365514,0.012643335,0.00007386842,0.0053925076,0.0023199415,0.00044121832,0.0012770084,0.9664293,0.000056832065,0.00053387875,0.00047826234],"about_ca_topic_score_codex":0.00019834736,"about_ca_topic_score_gemma":0.0002710327,"teacher_disagreement_score":0.08599029,"about_ca_system_score_codex":0.00013965231,"about_ca_system_score_gemma":0.00047433545,"threshold_uncertainty_score":0.9999247},"labels":[],"label_agreement":null},{"id":"W3179410427","doi":"10.1182/blood.v130.suppl_1.4557.4557","title":"Comparison of Outcomes of Elderly Patients with Acute Myeloid Leukemia (AML) in CR1 Receiving Reduced Intensity Allogeneic Stem Cell Transplantation (RICT) from Matched Sibling (MSD) or Unrelated Donors (URD)","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Université Laval; Hôpital de l'Enfant-Jésus; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Cumulative incidence; Internal medicine; NPM1; Transplantation; Incidence (geometry); Proportional hazards model; Hematopoietic stem cell transplantation; Gastroenterology; Oncology; Surgery; Biology","score_opus":0.029762727557884516,"score_gpt":0.3046170071623095,"score_spread":0.274854279604425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3179410427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99830437,0.000065859596,0.00011659816,0.000117543255,0.000100911246,0.0009032283,0.00009164352,0.000047807895,0.0002520416],"genre_scores_gemma":[0.9966878,0.0001914509,0.0025820388,0.000027725939,0.000024772102,0.000020275924,0.0002155809,0.0000585253,0.0001917888],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99731225,0.00012208564,0.0009374342,0.00050809793,0.00067226804,0.00044784506],"domain_scores_gemma":[0.99743736,0.00029609253,0.00080262846,0.00085328415,0.0004390033,0.00017160589],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034428536,0.00033082222,0.0012527999,0.00038105177,0.0001380938,0.000036081296,0.00046801483,0.00030573536,0.00003310064],"category_scores_gemma":[0.000115141745,0.00024870934,0.00012152777,0.0003442322,0.00018208683,0.00024876266,0.00009869291,0.0006240051,0.000007580228],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033754588,0.0007973277,0.87936825,0.00025993265,0.00063154224,0.00012336845,0.003428024,0.00005963256,0.11051424,0.0000011437801,0.000021776592,0.0014192777],"study_design_scores_gemma":[0.01299902,0.000784184,0.7049811,0.0004809285,0.0007294964,0.000008058149,0.00066348247,0.00022555786,0.27893072,0.0000067831206,0.0000018410515,0.00018883897],"about_ca_topic_score_codex":0.0031720737,"about_ca_topic_score_gemma":0.0007667688,"teacher_disagreement_score":0.17438719,"about_ca_system_score_codex":0.00029650686,"about_ca_system_score_gemma":0.0005742394,"threshold_uncertainty_score":0.99999654},"labels":[],"label_agreement":null},{"id":"W318007764","doi":"10.1182/blood.v122.21.2501.2501","title":"Identification and Characterization By ChIP-Seq Of Genomic Sites Bound By E2A-PBX1 In Acute Lymphoblastic Leukemia Demonstrates Associations With p300 Recruitment, Transcriptionally Active Chromatin and Abundant Transcription","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Chromatin immunoprecipitation; Chromatin; CTCF; Biology; ChIP-sequencing; Molecular biology; Transcription factor; RNA polymerase II; Promoter; Transcription (linguistics); Gene; H3K4me3; Enhancer; Genetics; ChIP-on-chip; Gene expression; Chromatin remodeling","score_opus":0.014335939224557372,"score_gpt":0.2474288338219285,"score_spread":0.23309289459737115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W318007764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99552023,0.0002795722,0.0012481699,0.00055391854,0.000021647622,0.0016762913,0.00060869067,0.00003838178,0.000053070133],"genre_scores_gemma":[0.996506,0.000579764,0.00039679214,0.00006741194,0.000026863301,0.000333477,0.0017512501,0.000038819137,0.0002996388],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99821293,0.00010353768,0.0005504989,0.0004282533,0.00039228203,0.00031247927],"domain_scores_gemma":[0.9990847,0.00013503454,0.0002718384,0.00017126078,0.0001837567,0.00015337455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020184884,0.00024101137,0.00039670803,0.00021739955,0.00012533105,0.00010686279,0.00008669265,0.00016893743,0.00006821792],"category_scores_gemma":[0.000044457454,0.00021652055,0.000039593695,0.00028402277,0.00022562809,0.0005210432,0.000015392303,0.00016542625,0.00001008453],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015063792,0.0003927265,0.016935725,0.00012669023,0.00031667083,0.000003895252,0.0009957538,0.0000011992496,0.9797324,0.0000315157,0.000111977475,0.0012008249],"study_design_scores_gemma":[0.007811149,0.0004914591,0.7841735,0.000165839,0.00053175265,0.00009368192,0.00023895579,0.0025039064,0.20362481,0.000113135655,0.000023761875,0.00022805063],"about_ca_topic_score_codex":0.00025576644,"about_ca_topic_score_gemma":0.00006839507,"teacher_disagreement_score":0.77610755,"about_ca_system_score_codex":0.0006196997,"about_ca_system_score_gemma":0.00044061278,"threshold_uncertainty_score":0.88294524},"labels":[],"label_agreement":null},{"id":"W3180549397","doi":"10.1182/blood.2020010439","title":"Sustained minimal residual disease negativity in newly diagnosed multiple myeloma and the impact of daratumumab in MAIA and ALCYONE","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"National Cancer Institute","keywords":"Daratumumab; Medicine; Internal medicine; Lenalidomide; Bortezomib; Minimal residual disease; Multiple myeloma; Oncology; Melphalan; Prednisone; Population; Gastroenterology; Surgery; Leukemia","score_opus":0.014807023198906767,"score_gpt":0.2988162049552055,"score_spread":0.28400918175629875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180549397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99605256,0.002288159,0.0000011937707,0.0007002026,0.0000066831412,0.0006469514,0.00007296672,0.000008362184,0.00022293458],"genre_scores_gemma":[0.9992536,0.000258973,0.00021712367,0.000018430334,0.000030803178,0.0000525497,0.000048666632,0.000013367997,0.00010651464],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867946,0.0002493257,0.00024022783,0.00027888533,0.00022764795,0.00032445087],"domain_scores_gemma":[0.99863356,0.0007154205,0.000050122573,0.0002792266,0.00006940143,0.00025228193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002490391,0.00015115397,0.00038590207,0.00012247497,0.000045745048,0.000023933735,0.000048107326,0.00005045557,0.000027027152],"category_scores_gemma":[0.002163854,0.0000975403,0.00006671547,0.00029492495,0.00023082067,0.000080496095,0.0001498808,0.00017392018,0.0000010221352],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062750145,0.0016332885,0.98212874,0.00011073133,0.00015673849,0.004044597,0.0006361705,0.00000242538,0.0017601342,0.00004491631,0.000035965128,0.003171296],"study_design_scores_gemma":[0.06550181,0.00026596815,0.9304801,0.0001059388,0.00007184108,0.000036981055,0.0004097093,0.0006434949,0.0022270887,0.00017846002,0.000002701795,0.00007589754],"about_ca_topic_score_codex":0.0018365269,"about_ca_topic_score_gemma":0.0016748643,"teacher_disagreement_score":0.059226792,"about_ca_system_score_codex":0.00004308676,"about_ca_system_score_gemma":0.00035140506,"threshold_uncertainty_score":0.39775783},"labels":[],"label_agreement":null},{"id":"W3182324170","doi":"10.1182/blood.v130.suppl_1.2584.2584","title":"A Strategy of Day 14 Bone Marrows and Early Intervention Is Associated with Similar Outcomes Compared to a Strategy of No Day 14 Bone Marrows and Delayed Intervention in Patients with Acute Myeloid Leukemia","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Induction chemotherapy; Internal medicine; Chemotherapy; Retrospective cohort study; Chemotherapy regimen; Leukemia; Cohort; Bone marrow; Surgery","score_opus":0.01542028637652406,"score_gpt":0.2788541444685726,"score_spread":0.26343385809204856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182324170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99742955,0.00015551518,0.00006387285,0.0001929308,0.00003551976,0.001524512,0.00026313853,0.000030822677,0.00030412097],"genre_scores_gemma":[0.99820477,0.00003244021,0.00042567667,0.000040324427,0.00001813296,0.000062155246,0.00017378503,0.00006198574,0.0009807434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969342,0.00024431784,0.00094827334,0.00059815927,0.00076783,0.0005072477],"domain_scores_gemma":[0.99736094,0.000112312846,0.0008454061,0.0007140118,0.0006866329,0.0002806843],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010014086,0.00040181744,0.0012265084,0.0004127093,0.00011340451,0.00010602935,0.00026376077,0.00023574915,0.000065521206],"category_scores_gemma":[0.0003446158,0.00031582857,0.00013858831,0.00026444724,0.000293896,0.0004218736,0.000253087,0.00047219382,0.000004501874],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053476393,0.0020458875,0.977927,0.00045674594,0.0020956846,0.0002461845,0.0011347288,0.0000107195365,0.006143242,0.000015799616,0.00036617057,0.004210165],"study_design_scores_gemma":[0.03567814,0.005756811,0.9521538,0.0014050765,0.00069396495,0.000020047155,0.00024236107,0.0002593522,0.0034440903,0.00003252047,0.000013683243,0.00030016195],"about_ca_topic_score_codex":0.0019230695,"about_ca_topic_score_gemma":0.002072196,"teacher_disagreement_score":0.0303305,"about_ca_system_score_codex":0.00025570102,"about_ca_system_score_gemma":0.0002049354,"threshold_uncertainty_score":0.99992937},"labels":[],"label_agreement":null},{"id":"W3183575767","doi":"10.1182/blood.2020008238","title":"Immune cells surveil aberrantly sialylated <i>O</i>-glycans on megakaryocytes to regulate platelet count","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Institute of Allergy and Infectious Diseases; National Heart, Lung, and Blood Institute","keywords":"Thrombopoiesis; Immune system; Antigen; Immunology; Biology; Antibody; Molecular biology; Megakaryocyte; Cell biology; Stem cell; Progenitor cell","score_opus":0.010610744054344671,"score_gpt":0.2343741000045405,"score_spread":0.22376335595019584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3183575767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871697,0.0011913723,0.0000054868574,0.0011347738,0.00028108922,0.00043230082,0.00010720775,0.00013535611,0.009542733],"genre_scores_gemma":[0.99303,0.00032705883,0.00032687094,0.001205673,0.00007835537,0.00002544743,0.00030798893,0.000060232604,0.004638388],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99817073,0.000056574627,0.00037853912,0.000514948,0.0003922368,0.0004869891],"domain_scores_gemma":[0.99881214,0.00009101452,0.00007602816,0.00060419476,0.00015140534,0.0002652],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014019474,0.00031025166,0.0006460859,0.00010755233,0.000116523566,0.00004331465,0.00010478756,0.00015662276,0.00032328157],"category_scores_gemma":[0.000056495242,0.00027128533,0.0001797845,0.00045665406,0.000037967588,0.00005488675,0.00005338149,0.00020454725,0.0005460039],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020181388,0.012594697,0.005874027,0.00021540916,0.003653882,0.038632974,0.0011785872,0.00022540062,0.91740215,0.00030107083,0.009704972,0.008198693],"study_design_scores_gemma":[0.013787599,0.0010098725,0.020004557,0.00024314498,0.00043466894,0.0006622758,0.00008111512,0.00003625604,0.9393855,0.0000807956,0.023856098,0.00041811788],"about_ca_topic_score_codex":0.00022720639,"about_ca_topic_score_gemma":0.000104301296,"teacher_disagreement_score":0.0379707,"about_ca_system_score_codex":0.000051980627,"about_ca_system_score_gemma":0.00018292296,"threshold_uncertainty_score":0.99997395},"labels":[],"label_agreement":null},{"id":"W3183590901","doi":"10.1182/blood.2021012938","title":"Anti–platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":127,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Universität Greifswald; Deutsche Forschungsgemeinschaft; Wilhelm Sander-Stiftung; European Commission; Deutsches Zentrum für Infektionsforschung; Bundesministerium für Bildung und Forschung","keywords":"Platelet factor 4; Antibody; Immunology; Epitope; Platelet activation; Platelet; Virology; Medicine","score_opus":0.04972978789613579,"score_gpt":0.32515024444825036,"score_spread":0.27542045655211456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3183590901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943006,0.00014903948,0.000020380045,0.00052863767,0.000137188,0.0006270119,0.000053223346,0.00017487573,0.0040090657],"genre_scores_gemma":[0.997159,0.000042669708,0.0016091298,0.0004545864,0.00023892325,0.000022247264,0.000048934948,0.000084888416,0.0003396404],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99776,0.000062033105,0.00040706244,0.00068311056,0.00046161198,0.00062616816],"domain_scores_gemma":[0.9986546,0.000040353403,0.00014446971,0.0007132288,0.00028652317,0.00016081834],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013639012,0.000395618,0.000899709,0.00011670949,0.00023074314,0.00022911406,0.00011320368,0.00022389779,0.00015565183],"category_scores_gemma":[0.0001396486,0.00031684426,0.00016044058,0.00039405894,0.00016486492,0.00027868687,0.00012752198,0.0004363321,0.00015350248],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000078033634,0.0007452706,0.07310787,0.00019813355,0.00044472748,0.0021785365,0.00032698663,4.0688516e-7,0.9222509,0.00009594645,0.000026951759,0.00054620137],"study_design_scores_gemma":[0.0038440593,0.0002533102,0.18353549,0.00044462498,0.00022747026,0.00086182635,0.000056489844,0.0000038815697,0.80823165,0.000015992513,0.0021830702,0.00034213727],"about_ca_topic_score_codex":0.00022085311,"about_ca_topic_score_gemma":0.000078315854,"teacher_disagreement_score":0.11401929,"about_ca_system_score_codex":0.000053882766,"about_ca_system_score_gemma":0.00041705833,"threshold_uncertainty_score":0.99992836},"labels":[],"label_agreement":null},{"id":"W3183608863","doi":"10.1182/blood.v130.suppl_1.3298.3298","title":"Autologous Transplantation Improves Survival Rates for Follicular Lymphoma Patients Who Relapse within 2-Years of Chemoimmunotherapy: A Multi-Centre Retrospective Analysis of Consecutively Treated Patients in the Real World","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Follicular lymphoma; Chemoimmunotherapy; Melphalan; Rituximab; Internal medicine; Surgery; Salvage therapy; Retrospective cohort study; Transplantation; International Prognostic Index; Alemtuzumab; Univariate analysis; Etoposide; Oncology; Lymphoma; Chemotherapy; Multivariate analysis","score_opus":0.013172906686767101,"score_gpt":0.27705856654892785,"score_spread":0.2638856598621607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3183608863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99815315,0.000052062864,0.0000029597738,0.000045799992,0.00004329878,0.0011701476,0.00043404932,0.000010781047,0.000087770386],"genre_scores_gemma":[0.9990143,0.00017624439,0.00023832559,0.000022688377,0.0000064596425,0.00008740641,0.00039240316,0.00001689182,0.000045272544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998709,0.00009097663,0.00045806632,0.00028976754,0.00026725666,0.00018490695],"domain_scores_gemma":[0.9985333,0.000169088,0.00058175623,0.00041411133,0.00026521875,0.00003650466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018479051,0.00018054832,0.0006788604,0.0002224062,0.000090535315,0.00001999386,0.00014895001,0.00008635791,0.0000032239186],"category_scores_gemma":[0.00012859785,0.00012866026,0.00027645341,0.0003084951,0.00012852394,0.00007159085,0.000011946707,0.00003854892,4.0447287e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013153285,0.0071252896,0.98297447,0.000048126924,0.0028667902,0.000025265614,0.0036693828,0.0000016190862,0.00040564762,0.00007316615,0.0000046118334,0.001490286],"study_design_scores_gemma":[0.03836145,0.00074704044,0.9368327,0.000121105935,0.0037281516,6.2397226e-7,0.0001621092,0.00016673909,0.019760538,0.000012108253,0.000002436525,0.00010498745],"about_ca_topic_score_codex":0.0034449329,"about_ca_topic_score_gemma":0.0027250582,"teacher_disagreement_score":0.046141773,"about_ca_system_score_codex":0.000097282216,"about_ca_system_score_gemma":0.000069950955,"threshold_uncertainty_score":0.52466136},"labels":[],"label_agreement":null},{"id":"W3184241470","doi":"10.1182/blood.v130.suppl_1.2255.2255","title":"Lack of an Alberta Newborn Screening Program Is Associated with Delayed Diagnosis of Sickle Cell Disease","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Medicine; Newborn screening; Pediatrics; Retrospective cohort study; Disease; Anemia; Cohort; Sickle cell anemia; Acute chest syndrome; Hemoglobinopathy; Internal medicine","score_opus":0.0194203689554193,"score_gpt":0.2794612011875819,"score_spread":0.26004083223216257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3184241470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99470586,0.0003114555,0.000010634326,0.00055056356,0.000018548088,0.00050034164,0.00004870014,0.00003408503,0.003819831],"genre_scores_gemma":[0.9973847,0.00009261108,0.0015827552,0.0001048092,0.00002178126,0.000031671687,0.00005820511,0.000030242887,0.00069317676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990436,0.000027638429,0.00023832034,0.00021154364,0.00024674894,0.00023215624],"domain_scores_gemma":[0.9986649,0.000051162715,0.00031929865,0.0005734866,0.00014074706,0.00025038762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009216568,0.0001406762,0.00033519996,0.000043214142,0.000116177536,0.00001838483,0.00016143257,0.00011625205,0.000076130025],"category_scores_gemma":[0.00021039095,0.000105352745,0.000101939324,0.00009486079,0.00016489037,0.00009169033,0.000044342298,0.00013302083,0.0000036846516],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000636935,0.009271033,0.9624242,0.00026267848,0.0007368981,0.000133376,0.0008387078,0.000018226603,0.00059350324,0.0000136034705,0.00055955077,0.024511266],"study_design_scores_gemma":[0.036426354,0.008005116,0.88398796,0.002116079,0.006253798,0.00001578384,0.00096398534,0.0023988553,0.052982938,0.000080088044,0.006052503,0.0007165219],"about_ca_topic_score_codex":0.001348659,"about_ca_topic_score_gemma":0.00023383297,"teacher_disagreement_score":0.07843624,"about_ca_system_score_codex":0.0000060588814,"about_ca_system_score_gemma":0.00009911106,"threshold_uncertainty_score":0.42961603},"labels":[],"label_agreement":null},{"id":"W3184766220","doi":"10.1182/blood.v130.suppl_1.5075.5075","title":"Morphological Subtype According to the FAB Classification Correlates with Molecular Subtype Using Genomic Risk Classification Based on Somatic Mutation Profiles in Normal Karyotype AML","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Agriculture, Soil, Plant Science","field":"Agricultural and Biological Sciences","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Karyotype; Somatic cell; Mutation; Biology; Genetics; Oncology; Medicine; Gene; Chromosome","score_opus":0.030049624051281032,"score_gpt":0.23303499950541545,"score_spread":0.20298537545413442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3184766220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99777293,0.000021784525,0.00017389462,0.0009304619,0.00008632494,0.00063336454,0.000026691894,0.000052284642,0.00030224983],"genre_scores_gemma":[0.99890465,0.0000066915973,0.00071053376,0.00013021134,0.00008954544,0.000050396942,0.00009213725,0.0000024047836,0.000013435257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842113,0.0001749942,0.00025688732,0.0004812448,0.00034182234,0.00032393922],"domain_scores_gemma":[0.9989509,0.00020215768,0.00042669178,0.00023091827,0.00010344664,0.00008585752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004938435,0.00019627826,0.00017258737,0.000031564843,0.0007926097,0.00026087408,0.00064616674,0.0001349028,0.000008267205],"category_scores_gemma":[0.00036175357,0.000067623085,0.000044356046,0.00040371346,0.00010759507,0.0002424111,0.00006506403,0.00024103899,0.00008137835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000091397684,0.00021232448,0.774991,0.0000051140423,0.000008349836,0.00002952334,0.00008750739,0.0029694939,0.21884096,0.0001758177,0.000013934501,0.0025746091],"study_design_scores_gemma":[0.0002756542,0.00028508698,0.9607326,0.000048503574,0.00004255635,0.000027615019,0.00043549927,0.03154453,0.0063081523,0.000083303246,0.0000143690395,0.00020217129],"about_ca_topic_score_codex":0.00034005698,"about_ca_topic_score_gemma":0.0004729711,"teacher_disagreement_score":0.2125328,"about_ca_system_score_codex":0.000057856592,"about_ca_system_score_gemma":0.000032774497,"threshold_uncertainty_score":0.6096193},"labels":[],"label_agreement":null},{"id":"W3184863509","doi":"10.1182/blood.2021012206","title":"High-dose AraC is essential for the treatment of ML-DS independent of postinduction MRD: results of the COG AAML1531 trial","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Internal medicine","score_opus":0.022666973621216068,"score_gpt":0.2818213398882308,"score_spread":0.25915436626701477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3184863509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99454546,0.0010594198,0.0000044380927,0.0019694704,0.0006154647,0.0012976438,0.0003638143,0.0000064779438,0.0001377886],"genre_scores_gemma":[0.9983364,0.00048447453,0.00016741006,0.00003890958,0.0003218944,0.00011653957,0.00006353101,0.000011980867,0.00045889977],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987584,0.00005553847,0.0004914761,0.00022036466,0.0003431026,0.00013116185],"domain_scores_gemma":[0.9985641,0.00029189052,0.00034337788,0.00052621064,0.00023539593,0.00003900316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012303809,0.00013442256,0.00039167982,0.00003230546,0.00005863271,0.000005941867,0.00007427772,0.00008596143,0.000037776226],"category_scores_gemma":[0.0001273907,0.000068128924,0.0003450104,0.00014811163,0.00007383669,0.00002068295,0.00002723036,0.00003364273,0.00000146894],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23340216,0.25200787,0.04501777,0.0009962195,0.027218394,0.00026386324,0.017150763,0.00012645284,0.2604562,0.0041605476,0.008277431,0.1509223],"study_design_scores_gemma":[0.1507717,0.002924774,0.04139309,0.00008008487,0.0029013834,0.000026782449,0.0002347898,0.000006745854,0.8005178,0.000053636755,0.0010392466,0.000049978138],"about_ca_topic_score_codex":0.0006288489,"about_ca_topic_score_gemma":0.00006563288,"teacher_disagreement_score":0.5400616,"about_ca_system_score_codex":0.000048210422,"about_ca_system_score_gemma":0.0002570011,"threshold_uncertainty_score":0.2778217},"labels":[],"label_agreement":null},{"id":"W3185171385","doi":"10.1182/blood.2021011101","title":"Prognostic value of minimal residual disease negativity in myeloma: combined analysis of POLLUX, CASTOR, ALCYONE, and MAIA","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"National Cancer Institute","keywords":"Internal medicine; Medicine; Hazard ratio; Oncology; Multiple myeloma; Daratumumab; Proportional hazards model; Progression-free survival; Minimal residual disease; Confidence interval; Overall survival; Lenalidomide; Bone marrow","score_opus":0.01710911962369718,"score_gpt":0.28758062782116406,"score_spread":0.2704715081974669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185171385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980157,0.0009749745,0.0000036715346,0.00025592663,0.000009890909,0.00030620367,0.00018694204,0.000008323685,0.00023836433],"genre_scores_gemma":[0.99880433,0.000049456252,0.0007955035,0.000013938798,0.000014226355,0.00001992733,0.00013952352,0.000010175378,0.00015292123],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987135,0.00014164842,0.0002910135,0.0002640973,0.00036197787,0.0002277781],"domain_scores_gemma":[0.999009,0.0002423502,0.00008077678,0.00028838948,0.00012364514,0.00025581603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013527882,0.00011807803,0.00051277527,0.00031589903,0.000023254284,0.0000064293727,0.000044974364,0.000045145298,0.00006529909],"category_scores_gemma":[0.0008820281,0.00010398996,0.00011008368,0.0008721659,0.00011812404,0.000042011983,0.000077409684,0.00008944741,0.0000013445024],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076528423,0.003312694,0.9852631,0.00024035224,0.0017307496,0.0014609663,0.00018749235,0.0000045725633,0.0062344833,0.00009315185,0.00001070733,0.00069642055],"study_design_scores_gemma":[0.008033663,0.00038040947,0.9760093,0.00010062483,0.002903684,0.0000108338345,0.00009656452,0.0006250362,0.011729736,0.000037840095,0.000003312263,0.00006897511],"about_ca_topic_score_codex":0.00031831703,"about_ca_topic_score_gemma":0.00030917098,"teacher_disagreement_score":0.009253805,"about_ca_system_score_codex":0.000019647603,"about_ca_system_score_gemma":0.00029481988,"threshold_uncertainty_score":0.42405874},"labels":[],"label_agreement":null},{"id":"W3185361406","doi":"10.1182/blood.v130.suppl_1.1280.1280","title":"CTL019 Therapy Appears Safe and Effective in Pediatric Patients with Down Syndrome with Relapsed/ Refractory (r/r) Acute Lymphoblastic Leukemia","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Lymphoblastic Leukemia; Refractory (planetary science); Acute lymphocytic leukemia; Leukemia; Internal medicine; Pediatrics; Chemotherapy regimen; Chemotherapy; Intensive care medicine; Oncology","score_opus":0.005470402394775921,"score_gpt":0.23415136384342258,"score_spread":0.22868096144864666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185361406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962814,0.00027181764,0.000032921816,0.00009011413,0.000060517814,0.001667183,0.000025051928,0.000057580855,0.0015134517],"genre_scores_gemma":[0.9982303,0.00045927198,0.0004987653,0.00009072336,0.00010044275,0.00015354267,0.000028118557,0.00009293994,0.0003459012],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99734616,0.00010031865,0.00029688654,0.00072484976,0.00085183413,0.00067991856],"domain_scores_gemma":[0.9978955,0.0003220209,0.00025465773,0.0009855053,0.00018957585,0.00035276375],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026875894,0.0004038773,0.0006536425,0.0003472133,0.00027704885,0.00009939771,0.00033085857,0.00022198456,0.000027951623],"category_scores_gemma":[0.00021526736,0.00026819174,0.0000522404,0.00027721148,0.0003755925,0.00033367155,0.00016925219,0.0005090887,0.000060809525],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046975305,0.0010875664,0.9859964,0.00019578748,0.00053278747,0.003053193,0.00037182393,0.0000049676955,0.00019676426,0.000012007179,0.00012188134,0.003729263],"study_design_scores_gemma":[0.05761712,0.0057172347,0.9345743,0.00030448593,0.00043503148,0.00059653394,0.000023572595,0.00004554872,0.00024548586,0.000017177837,0.00009226793,0.0003312492],"about_ca_topic_score_codex":0.0002010773,"about_ca_topic_score_gemma":0.000036965084,"teacher_disagreement_score":0.05291959,"about_ca_system_score_codex":0.0007506635,"about_ca_system_score_gemma":0.0010800102,"threshold_uncertainty_score":0.99997705},"labels":[],"label_agreement":null},{"id":"W3185696431","doi":"10.1182/blood.2020009957","title":"Platelet EVs contain an active proteasome involved in protein processing for antigen presentation via MHC-I molecules","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre Hospitalier de l’Université de Montréal; Université de Montréal; Université Laval; Translational Research in Oncology; Centre hospitalier universitaire de Québec","funders":"Mitacs; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Institut National de la Santé et de la Recherche Médicale; Fonds de Recherche du Québec - Santé; Arthritis Society; Canadian Blood Services; Agence Nationale de la Recherche; Vetenskapsrådet; National Science Foundation","keywords":"Platelet; Antigen presentation; Antigen processing; Antigen; MHC class I; Biology; Immune system; Immunology; CD8; Major histocompatibility complex; Cross-presentation; Cell biology; T cell","score_opus":0.019416299648704578,"score_gpt":0.28996764495864713,"score_spread":0.27055134530994257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185696431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954967,0.00050651043,0.0004979918,0.00033419486,0.000013283236,0.0026254072,0.000023715354,0.000044709188,0.00045747389],"genre_scores_gemma":[0.99535,0.000012655457,0.0031675105,0.00009930375,0.00003959445,0.0007498239,0.00042269114,0.000028806664,0.00012962974],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990122,0.000046461595,0.00020052098,0.00032303765,0.00016359024,0.00025421393],"domain_scores_gemma":[0.99952966,0.000014816901,0.00008338718,0.00014839992,0.00013781864,0.000085929605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007214996,0.0001487986,0.0002855438,0.00007949677,0.00007538217,0.000032221065,0.00004568243,0.00009597633,0.00001391305],"category_scores_gemma":[0.00008376814,0.00013692478,0.000050517992,0.00018880185,0.000023883784,0.00022020793,0.000017332915,0.0001053891,0.0000038216526],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028510634,0.014169862,0.054548234,0.0014223871,0.0007655603,0.005482615,0.004194352,0.000023189052,0.8287427,0.00018563186,0.000029526607,0.08758489],"study_design_scores_gemma":[0.017408054,0.00068819954,0.025655963,0.0003953352,0.00011156594,0.00011639731,0.001102358,0.0012110566,0.9512145,0.0017102353,0.00016604169,0.0002203097],"about_ca_topic_score_codex":0.00007599322,"about_ca_topic_score_gemma":0.00027052703,"teacher_disagreement_score":0.122471794,"about_ca_system_score_codex":0.000037528414,"about_ca_system_score_gemma":0.00018478755,"threshold_uncertainty_score":0.558363},"labels":[],"label_agreement":null},{"id":"W3186993723","doi":"10.1182/blood.2021011787","title":"BTK inhibition sensitizes acute lymphoblastic leukemia to asparaginase by suppressing the amino acid response pathway","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"Radboud Universitair Medisch Centrum; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"Ibrutinib; Bruton's tyrosine kinase; Asparaginase; Cancer research; Pharmacology; Medicine; Tyrosine kinase; Leukemia; Lymphoblastic Leukemia; Immunology; Internal medicine; Chronic lymphocytic leukemia; Receptor","score_opus":0.011995025791761545,"score_gpt":0.26634365839987123,"score_spread":0.2543486326081097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186993723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941949,0.00086469157,0.00023111833,0.0029932444,0.00013674705,0.00045827034,0.000093128205,0.00013001768,0.00089788577],"genre_scores_gemma":[0.9931174,0.000049472346,0.0005995529,0.0019964012,0.00026608663,0.000066808614,0.00012646095,0.00006482549,0.00371299],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99706906,0.00042773748,0.00036650806,0.0006049944,0.000825449,0.000706244],"domain_scores_gemma":[0.9976174,0.0006684963,0.000071498245,0.0009468504,0.00029062727,0.00040507957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065247883,0.00028026235,0.00038542136,0.000119000826,0.00025631438,0.00014697012,0.00014770127,0.0001683845,0.00013771316],"category_scores_gemma":[0.0012842102,0.00021390493,0.00014235254,0.0005966546,0.0001790013,0.000113540766,0.00028935677,0.00032068713,0.0003614722],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0016226921,0.000343568,0.00003661466,0.000071195995,0.00022025766,0.008783124,0.00071828085,0.000015934324,0.9744316,0.000023744175,0.012406161,0.0013268421],"study_design_scores_gemma":[0.021250611,0.00028962432,0.00062900904,0.00032956473,0.00034054226,0.006308245,0.00033307413,0.0007497148,0.96376395,0.000034337423,0.005731256,0.00024008253],"about_ca_topic_score_codex":0.00007249892,"about_ca_topic_score_gemma":0.000018745208,"teacher_disagreement_score":0.019627918,"about_ca_system_score_codex":0.005125126,"about_ca_system_score_gemma":0.010267198,"threshold_uncertainty_score":0.998694},"labels":[],"label_agreement":null},{"id":"W3187033897","doi":"10.1182/blood.v130.suppl_1.36.36","title":"Identification of Recurrent Non-Coding Driver Mutations in Non-Hodgkin Lymphomas through Integrative Genomic Analysis of 777 Patients","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency; Simon Fraser University","funders":"","keywords":"Identification (biology); Lymphoma; Coding (social sciences); Hodgkin lymphoma; Medicine; Cancer research; Biology; Computational biology; Genetics; Oncology; Internal medicine","score_opus":0.009149074227139923,"score_gpt":0.2724213416361612,"score_spread":0.2632722674090213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3187033897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975298,0.00010299419,0.0014740634,0.000012179181,0.00010974672,0.00015679054,0.00020040103,9.447978e-7,0.00041307986],"genre_scores_gemma":[0.99895877,0.00034116028,0.00034236498,0.000010477429,0.000027734039,0.000018255007,0.00027155346,0.000008099293,0.000021618293],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99925774,0.00001602691,0.00033609316,0.00021561177,0.0000762597,0.000098268574],"domain_scores_gemma":[0.9989632,0.000018505587,0.00042159812,0.00041523922,0.00015552426,0.000025932684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000087758155,0.00009086247,0.00020088781,0.00009597811,0.0000609525,0.000019267285,0.00021235923,0.000066681474,0.000006539212],"category_scores_gemma":[0.00020260841,0.00009194061,0.00011806342,0.00010936924,0.00008217785,0.0000071399345,0.000097073804,0.000032835327,0.0000012894212],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052043415,0.00082889595,0.3152848,0.000031276453,0.00073270634,0.0000010139318,0.0015161644,0.00053029787,0.67863023,0.00018681923,0.00008026318,0.002125517],"study_design_scores_gemma":[0.0011001488,0.00010668443,0.59684783,0.000021218,0.0004089162,1.2902503e-7,0.000108601096,0.00048790773,0.40068084,0.00009678099,0.00004647737,0.00009444237],"about_ca_topic_score_codex":0.00026336082,"about_ca_topic_score_gemma":0.0006330932,"teacher_disagreement_score":0.28156304,"about_ca_system_score_codex":0.000025170659,"about_ca_system_score_gemma":0.00007559655,"threshold_uncertainty_score":0.3749229},"labels":[],"label_agreement":null},{"id":"W3187457379","doi":"10.1182/blood.v130.suppl_1.3679.3679","title":"Immune Tolerance Induction in Hemophilia A Patients Using Wilate® —a Canadian 10 Year Study (PREVAIL)","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; Children's Hospital of Eastern Ontario; Centre Hospitalier Universitaire Sainte-Justine; Queen's University; University of Alberta; Janeway Children's Health and Rehabilitation Centre","funders":"","keywords":"Medicine; Factor IX; Von Willebrand factor; Internal medicine; Immune tolerance; Hemarthrosis; Pediatrics; Immunology; Surgery; Immune system; Platelet","score_opus":0.037900328845881535,"score_gpt":0.31144873832803444,"score_spread":0.2735484094821529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3187457379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99586606,0.00007914688,5.0088214e-8,0.00024164031,0.00013105402,0.00077261217,0.000005424363,0.000012194818,0.002891845],"genre_scores_gemma":[0.99799114,0.000012802929,0.000065163724,0.000013243543,0.00012431419,0.000016471176,0.000012469801,0.000018129213,0.0017462677],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899507,0.00003497678,0.0001802597,0.00023156771,0.0002418567,0.0003163009],"domain_scores_gemma":[0.999155,0.000006782566,0.000054353102,0.0005154922,0.0000844236,0.00018394488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017549518,0.00011215175,0.00021565553,0.00017946363,0.00025655242,0.00004713124,0.00013299812,0.00008425997,0.00013972912],"category_scores_gemma":[0.00011068969,0.000095683725,0.00004120166,0.00010171952,0.00004704711,0.00012905391,0.000045039098,0.00018622128,0.00013939377],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060474587,0.001349978,0.9961383,0.000019580479,0.00005423198,0.00016798236,0.00038070467,0.0000013628783,0.00072650024,0.0000017526985,0.000036446992,0.0010627393],"study_design_scores_gemma":[0.0071981675,0.00032508044,0.9900028,0.00010654391,0.00006951037,0.00000765234,0.00013184275,0.000038045637,0.0018175473,0.000009539944,0.0001960861,0.00009717025],"about_ca_topic_score_codex":0.044683214,"about_ca_topic_score_gemma":0.017822564,"teacher_disagreement_score":0.026860649,"about_ca_system_score_codex":0.00013552982,"about_ca_system_score_gemma":0.00021542079,"threshold_uncertainty_score":0.9945409},"labels":[],"label_agreement":null},{"id":"W3187864884","doi":"10.1182/blood.2021011619","title":"MICA/B antibody induces macrophage-mediated immunity against acute myeloid leukemia","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Population and Public Health","funders":"National Cancer Institute","keywords":"Myeloid leukemia; Cancer research; Leukemia; Stem cell; Romidepsin; Biology; Haematopoiesis; Immunology; Myeloid; Histone deacetylase; Cell biology","score_opus":0.009000512000262102,"score_gpt":0.23958956801075026,"score_spread":0.23058905601048815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3187864884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98135495,0.0041000624,0.000028047552,0.00013474698,0.0033342664,0.000100860045,0.000020283422,0.00015604627,0.010770764],"genre_scores_gemma":[0.9752666,0.0012204293,0.00004732896,0.0007234757,0.000063574524,0.000010909957,0.0024290415,0.000024220097,0.020214422],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987416,0.00026881503,0.00031562708,0.0002958649,0.00003858492,0.00033946626],"domain_scores_gemma":[0.9991953,0.00009776631,0.00012471052,0.0003957235,0.00015965276,0.00002688167],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00010508498,0.00019813853,0.00027142692,0.00009367534,0.0002885946,0.0000378966,0.00018683446,0.00033148073,0.0024584497],"category_scores_gemma":[0.0001342167,0.00019136378,0.00013727558,0.00024582562,0.000102120655,0.00016419214,0.00012731882,0.0006712301,0.0035069222],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000668737,0.00035813017,0.00035467927,0.000009024253,0.0006979057,0.00006601592,0.00018268646,8.175236e-7,0.9936816,0.000035423833,0.00359896,0.00094786007],"study_design_scores_gemma":[0.0022574647,0.00009025949,0.0077773915,0.00002710383,0.00015369289,0.00026095132,0.0003544721,0.000001842199,0.90882725,0.000007266553,0.08004021,0.00020208002],"about_ca_topic_score_codex":0.00007055623,"about_ca_topic_score_gemma":0.000006837735,"teacher_disagreement_score":0.08485436,"about_ca_system_score_codex":0.0000543559,"about_ca_system_score_gemma":0.00017776604,"threshold_uncertainty_score":0.99845344},"labels":[],"label_agreement":null},{"id":"W3190635421","doi":"10.1182/blood.v130.suppl_1.3505.3505","title":"Isolation and Chelation Activity of Plant Phenolic Root Exudates As Potential Clinical Iron Chelators","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Plant Micronutrient Interactions and Effects","field":"Agricultural and Biological Sciences","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"","keywords":"Deferasirox; Deferiprone; Chemistry; Chelation; Deferoxamine; Biochemistry; Pharmacology; Thalassemia; Medicine; Internal medicine","score_opus":0.019628307284779118,"score_gpt":0.26146912840162273,"score_spread":0.2418408211168436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3190635421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990724,0.000043382013,0.0000047132366,0.00018996348,0.00014411748,0.00010016129,0.00006387314,0.000014786297,0.00036660949],"genre_scores_gemma":[0.99962354,0.000059590384,0.000020177959,0.000008329301,0.00017966665,0.000002385867,0.000056583547,4.7067218e-7,0.000049250935],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99950266,0.000040308467,0.00013126325,0.00015561396,0.00007181716,0.00009835497],"domain_scores_gemma":[0.99958247,0.00009924043,0.00019780251,0.00005647674,0.000019245319,0.000044746754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016116683,0.00006840847,0.000117513024,0.0000073630868,0.00025141574,0.000060548256,0.00009143285,0.00011915119,0.00004637164],"category_scores_gemma":[0.00006966975,0.000029357305,0.00004737038,0.00002211176,0.000047325746,0.00022561224,0.000051258172,0.00011205566,0.000014579882],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000083245905,0.0003315028,0.15167075,0.0000071596123,0.000020569432,0.0000025156162,0.000020023743,9.742047e-7,0.82896334,0.00005476228,0.000059991635,0.018785164],"study_design_scores_gemma":[0.00035771405,0.0002514624,0.95377195,0.000022265105,0.00003925404,0.000020682943,0.000014023841,0.00020423619,0.04444009,0.00010490311,0.0006956408,0.000077766],"about_ca_topic_score_codex":0.00030052138,"about_ca_topic_score_gemma":0.00014468601,"teacher_disagreement_score":0.8021012,"about_ca_system_score_codex":0.0000032784194,"about_ca_system_score_gemma":0.0000035034034,"threshold_uncertainty_score":0.1933712},"labels":[],"label_agreement":null},{"id":"W3191071188","doi":"10.1182/blood.v130.suppl_1.1691.1691","title":"Rates of Severe Bleeding Are Low in Patients with MDS and Severe Thrombocytopenia and May be Mitigated By Tranexamic Acid","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Tranexamic acid; Platelet; Platelet transfusion; Internal medicine; Blood transfusion; Surgery; Demographics; Blood loss","score_opus":0.010034648417403338,"score_gpt":0.23063746020051995,"score_spread":0.2206028117831166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3191071188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984288,0.00039928197,8.2448884e-7,0.00032429217,0.000019395957,0.0003774532,0.00006567438,0.000012054532,0.00037221165],"genre_scores_gemma":[0.99953884,0.00014800431,0.00012281448,0.00006727213,0.000013307659,0.000004923069,0.000036514935,0.000019439527,0.000048887683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992527,0.000015162492,0.00016120437,0.00024052766,0.0001606493,0.00016980841],"domain_scores_gemma":[0.9995292,0.000017525996,0.00010074879,0.0002078273,0.000053835578,0.00009089761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007269769,0.00014765085,0.00037544404,0.000043616277,0.000106411826,0.000030859606,0.000065394626,0.00010030843,0.000020732534],"category_scores_gemma":[0.000016433421,0.000111128786,0.000019144998,0.000049796825,0.00012653171,0.00015947946,0.000026572952,0.00014496811,4.5376316e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024138617,0.0004898842,0.9811772,0.00030420738,0.00009730794,0.000022965107,0.0003876165,1.3273306e-7,0.016578754,0.000005124015,0.000034323017,0.00066108396],"study_design_scores_gemma":[0.018764645,0.0005724053,0.93758637,0.0007878327,0.00025575567,0.00003601524,0.0001730596,0.0000072095504,0.041646443,0.000010840047,0.000016645969,0.00014276715],"about_ca_topic_score_codex":0.00011792002,"about_ca_topic_score_gemma":0.00011420876,"teacher_disagreement_score":0.043590836,"about_ca_system_score_codex":0.0000052416976,"about_ca_system_score_gemma":0.00001931902,"threshold_uncertainty_score":0.45317006},"labels":[],"label_agreement":null},{"id":"W3191708669","doi":"10.1182/blood.2019004247","title":"Myelodysplastic pure red cell aplasia","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Parvovirus B19 Infection Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Island Health; Royal Jubilee Hospital","funders":"","keywords":"Myelodysplastic syndromes; Medicine; Pure red cell aplasia; Bone marrow; Internal medicine","score_opus":0.01453104030463721,"score_gpt":0.25201979753423864,"score_spread":0.23748875722960144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3191708669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8176662,0.0015480838,0.00010391018,0.0007865242,0.0003366379,0.0001172669,0.000006884312,0.00015407898,0.17928044],"genre_scores_gemma":[0.9904444,0.00012290712,0.00056703924,0.00036270657,0.00024883216,0.000017694167,0.000011569741,0.000017424078,0.008207432],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99928534,0.000024014129,0.00014447384,0.00019934497,0.00016932252,0.00017751857],"domain_scores_gemma":[0.99946845,0.00006630061,0.00003643831,0.00022227105,0.00011904816,0.00008751406],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000046782632,0.000102036596,0.0002077077,0.000045906705,0.000071828465,0.000011158948,0.00002794005,0.00006299944,0.0004963392],"category_scores_gemma":[0.00020203833,0.00009344496,0.00007177559,0.00022557551,0.000030686533,0.000028053897,0.000046723635,0.00014350741,0.0013096523],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014183042,0.003799694,0.31011745,0.0005298954,0.0009029688,0.00306394,0.0005546514,0.000010748167,0.5576815,0.000527109,0.1209458,0.0017244124],"study_design_scores_gemma":[0.009453893,0.00015983958,0.14286865,0.000118458185,0.0011801576,0.0013905801,0.00019370967,0.000016001499,0.62690836,0.00021022621,0.21718085,0.00031926174],"about_ca_topic_score_codex":0.0000018318269,"about_ca_topic_score_gemma":0.0000075046623,"teacher_disagreement_score":0.17277822,"about_ca_system_score_codex":0.000015851481,"about_ca_system_score_gemma":0.00009117608,"threshold_uncertainty_score":0.99946797},"labels":[],"label_agreement":null},{"id":"W3193676805","doi":"10.1182/blood.2020007209","title":"Biomaterial and cellular implants: foreign surfaces where immunity and coagulation meet","year":2021,"lang":"en","type":"review","venue":"Blood","topic":"Hemostasis and retained surgical items","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Innate immune system; Context (archaeology); Biocompatibility; Biomaterial; Immunology; Cell biology; Coagulation; Immunity; Biology; Immune system; Medicine; Chemistry; Biomedical engineering","score_opus":0.044035753237626304,"score_gpt":0.310945007727126,"score_spread":0.2669092544894997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193676805","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03742771,0.96103424,0.0000023308496,0.000020146706,0.00009736813,0.0004848979,0.0001422543,0.000031984662,0.0007590592],"genre_scores_gemma":[0.0029829908,0.99585605,0.000106289066,0.000009320968,0.00017304804,0.000012405616,0.00069953484,0.000034818742,0.00012556977],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99869806,0.0001936493,0.0004317306,0.00030737827,0.00016131488,0.00020787517],"domain_scores_gemma":[0.9992647,0.000117481446,0.00014924588,0.0002554966,0.00005375174,0.00015933649],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000291531,0.0002885199,0.0015440573,0.000066510875,0.00009401923,0.00007619941,0.000048636724,0.00039414203,0.00009550182],"category_scores_gemma":[0.00004216768,0.00019075346,0.00015612907,0.00013074774,0.00007793285,0.000039909195,0.00009153862,0.00014777314,0.00000400638],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038602524,0.0006659625,0.00065960817,0.06486997,0.0019062374,0.0012041772,0.00012353325,4.162521e-8,0.0015877681,0.0007964652,0.00060649007,0.92754114],"study_design_scores_gemma":[0.0014397245,0.00012702995,0.00003208737,0.011527745,0.0025228641,0.0011267674,0.00007169474,0.000003984792,0.0003669622,0.000022432185,0.98246866,0.00029006082],"about_ca_topic_score_codex":0.000055981574,"about_ca_topic_score_gemma":0.0000057693956,"teacher_disagreement_score":0.9818621,"about_ca_system_score_codex":0.000012040947,"about_ca_system_score_gemma":0.00010265046,"threshold_uncertainty_score":0.77787006},"labels":[],"label_agreement":null},{"id":"W3194203975","doi":"10.1182/blood.2021012082","title":"Ponatinib dose-ranging study in chronic-phase chronic myeloid leukemia: a randomized, open-label phase 2 clinical trial","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":193,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Takeda Oncology; National Cancer Institute; National Institute for Health and Care Research","keywords":"Ponatinib; Medicine; Internal medicine; Clinical endpoint; Adverse effect; Myeloid leukemia; Cohort; Confidence interval; Oncology; Nilotinib; Clinical trial; Imatinib","score_opus":0.08930478020376911,"score_gpt":0.43065048697855457,"score_spread":0.3413457067747855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194203975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97830427,0.0065289303,0.000043310414,0.00037435803,0.0008433384,0.010176218,0.00004474366,0.00015453431,0.0035302716],"genre_scores_gemma":[0.99080956,0.000917343,0.0011478591,0.00035323016,0.00224001,0.0014984659,0.00031305,0.00014205376,0.0025784576],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9926581,0.0013696576,0.0025039874,0.0015429683,0.00085904414,0.0010662914],"domain_scores_gemma":[0.9957597,0.001479406,0.0005168704,0.0015439003,0.0002040813,0.00049599004],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0038229222,0.00067379395,0.0030290056,0.00029588086,0.00019339022,0.00017040677,0.00060832023,0.0004147318,0.0010981567],"category_scores_gemma":[0.0024653906,0.0005961304,0.0004942097,0.00093887857,0.00024377958,0.00030271223,0.00065834075,0.0013026907,0.00022609142],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.7782721,0.12105625,0.0008118137,0.0002831655,0.0041626752,0.01800925,0.0011290073,0.000019670231,0.0044355495,0.00016412108,0.00077726424,0.07087912],"study_design_scores_gemma":[0.97734797,0.012127294,0.00014359172,0.00046868052,0.0026870312,0.00035630897,0.00029937012,0.0019731214,0.002153189,0.000042451396,0.001889998,0.00051099586],"about_ca_topic_score_codex":0.00041177744,"about_ca_topic_score_gemma":0.00070400554,"teacher_disagreement_score":0.19907585,"about_ca_system_score_codex":0.004784893,"about_ca_system_score_gemma":0.015262726,"threshold_uncertainty_score":0.999815},"labels":[],"label_agreement":null},{"id":"W3194588255","doi":"10.1182/blood.v130.suppl_1.2441.2441","title":"An Enhanced Zebrafish Xenograft Model to Study the Behavior of Human Hematopoietic Stem Cells and Patient Derived Leukemia In Vivo","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Zebrafish Biomedical Research Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Haematopoiesis; Stem cell; Leukemia; Zebrafish; In vivo; Cancer research; Hematopoietic stem cell; Medicine; Immunology; Biology; Cell biology; Genetics; Gene","score_opus":0.020164101709068735,"score_gpt":0.3098448439565268,"score_spread":0.28968074224745805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194588255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985099,0.00003171833,0.00018548215,0.00004810061,0.000008605358,0.0010863728,0.000031469288,0.000005353893,0.00009298563],"genre_scores_gemma":[0.9990429,0.000010250308,0.0002203938,0.00005833162,0.000016064556,0.0006096322,0.000004523635,0.000014900185,0.000022976654],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99899864,0.00005326153,0.00021299926,0.00032034444,0.00020420669,0.00021052187],"domain_scores_gemma":[0.9987678,0.000009275219,0.000088853245,0.00091203646,0.000064990796,0.00015705208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016278937,0.00010662697,0.00013489086,0.000033600838,0.00019740008,0.0000482204,0.00051074085,0.00007395596,0.000006658157],"category_scores_gemma":[0.00002569525,0.00008449269,0.000030235802,0.00004714234,0.00016322384,0.00000521391,0.0003007859,0.00008407498,0.0000013176293],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012992748,0.0007973386,0.0011551459,0.0000062726226,0.000019997413,0.0000023421,0.00053289393,0.000009298098,0.9960267,0.0000102493195,0.000039700706,0.0013870893],"study_design_scores_gemma":[0.0009683171,0.0007955687,0.0079865055,0.000007977611,0.000028083108,0.0000011642246,0.0005530397,0.00004688419,0.9894528,0.000032781285,0.000030169325,0.00009673803],"about_ca_topic_score_codex":0.000083912564,"about_ca_topic_score_gemma":0.00033247378,"teacher_disagreement_score":0.006831359,"about_ca_system_score_codex":0.00001177597,"about_ca_system_score_gemma":0.000072954914,"threshold_uncertainty_score":0.3445512},"labels":[],"label_agreement":null},{"id":"W3195243079","doi":"10.1182/blood.2020009984","title":"A phase 3, open-label, randomized study of asciminib, a STAMP inhibitor, vs bosutinib in CML after 2 or more prior TKIs","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":336,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute; National Institute for Health and Care Research; Novartis Pharmaceuticals Corporation","keywords":"Bosutinib; Medicine; Open label; Randomized controlled trial; Internal medicine; Oncology; Imatinib; Nilotinib; Myeloid leukemia","score_opus":0.0352400247850263,"score_gpt":0.35368915112360194,"score_spread":0.31844912633857564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195243079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936412,0.0009515165,0.000002708528,0.0003723119,0.00012298411,0.0042719906,0.000048521008,0.000037943086,0.00055084313],"genre_scores_gemma":[0.99451005,0.00008954946,0.0015604715,0.00031243273,0.000103818995,0.0009514364,0.00004950981,0.000054610024,0.0023681272],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99717647,0.00033763854,0.0009255653,0.00062851823,0.00052858144,0.00040324972],"domain_scores_gemma":[0.9982042,0.00036647051,0.00022024426,0.00084530277,0.00017221709,0.00019156504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060709345,0.00032035584,0.0015973708,0.00016944692,0.00004064462,0.000042842366,0.00021210745,0.00013114256,0.0008554183],"category_scores_gemma":[0.0009251711,0.00023711014,0.00010863395,0.00058659585,0.000100340745,0.00012724541,0.00036234237,0.00026840667,0.000026569684],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.621223,0.29007292,0.022740208,0.00068492297,0.003478668,0.022246154,0.022068692,0.0000014016757,0.008388957,0.000014358341,0.0009599354,0.0081208],"study_design_scores_gemma":[0.97198117,0.0041614855,0.0018293583,0.00056975055,0.0016104162,0.00018038023,0.0019209269,0.000051984684,0.01696981,0.000009289644,0.0004890031,0.00022644427],"about_ca_topic_score_codex":0.00035019108,"about_ca_topic_score_gemma":0.0005977339,"teacher_disagreement_score":0.35075817,"about_ca_system_score_codex":0.00023626586,"about_ca_system_score_gemma":0.001501084,"threshold_uncertainty_score":0.96690714},"labels":[],"label_agreement":null},{"id":"W3195611250","doi":"10.1182/blood.v130.suppl_1.2496.2496","title":"The Origin and Functional Impact of Mitochondrial DNA Mutations in Acute Myeloid Leukemia","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Biology; Mitochondrial DNA; Genetics; COLD-PCR; Myeloid leukemia; Gene; Mutation; Myeloid; Genome; Point mutation; Cancer research","score_opus":0.024591861126764494,"score_gpt":0.32432944947917747,"score_spread":0.299737588352413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195611250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99630135,0.00013363782,0.000022973125,0.00076877116,0.00012083647,0.00032550056,0.00002972802,0.000012629405,0.0022845746],"genre_scores_gemma":[0.99740237,0.00015934407,0.00046986403,0.000019519091,0.00031036642,0.000033148684,0.00002351062,0.000015931488,0.0015659707],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99903816,0.00003522308,0.00020852422,0.00018480592,0.00027958135,0.00025373232],"domain_scores_gemma":[0.9989847,0.00019207694,0.00010581551,0.0004967746,0.00010602976,0.00011458792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019637591,0.000108165805,0.00021169017,0.00009456467,0.0002980495,0.00006153164,0.00015817939,0.00008484805,0.00005465356],"category_scores_gemma":[0.00045892378,0.00006890328,0.00009177523,0.00008805779,0.00031777186,0.000120004115,0.00009426216,0.00029085277,0.000019403733],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025689865,0.00054510124,0.45443898,0.00007951764,0.0018717655,0.00039351647,0.0007979164,0.000031889867,0.5167685,0.0017199907,0.011231204,0.009552636],"study_design_scores_gemma":[0.010470261,0.0003739634,0.97607076,0.000047268728,0.00020878942,0.00022582019,0.000067313726,0.0003227694,0.01062019,0.0004420132,0.0010499129,0.0001009219],"about_ca_topic_score_codex":0.0005967787,"about_ca_topic_score_gemma":0.00013745224,"teacher_disagreement_score":0.5216318,"about_ca_system_score_codex":0.00021614444,"about_ca_system_score_gemma":0.0010891815,"threshold_uncertainty_score":0.28097942},"labels":[],"label_agreement":null},{"id":"W3197199162","doi":"10.1182/blood.2021010745","title":"<i>HLF</i> expression defines the human hematopoietic stem cell state","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Stem cell; Biology; Haematopoiesis; Progenitor cell; Cord blood; Transplantation; Bone marrow; Cell biology; Population; Hematopoietic stem cell; Immunology; Cancer research; Medicine; Internal medicine","score_opus":0.017574783148244778,"score_gpt":0.24792585563323177,"score_spread":0.23035107248498699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197199162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98265046,0.0011496748,0.0003543576,0.00045834412,0.000092927476,0.0002843509,0.000010844937,0.00009821761,0.014900815],"genre_scores_gemma":[0.9942733,0.00011709616,0.0005761247,0.000425739,0.00007896368,0.000034455057,0.000040937037,0.00003648524,0.004416874],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99869853,0.000091122165,0.00031844436,0.0002844451,0.00035479994,0.0002526512],"domain_scores_gemma":[0.9990769,0.00012360282,0.00007823382,0.0005115055,0.00009939552,0.00011033926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016055109,0.00016138631,0.00024761027,0.00003250742,0.00015272165,0.000034978268,0.00010055195,0.0000691608,0.00018718773],"category_scores_gemma":[0.0000068384975,0.00011011589,0.00010375746,0.0001804158,0.00004541336,0.000043038457,0.00003515685,0.00017062855,0.00014984478],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018270388,0.00079443183,0.011961479,0.0009773321,0.00005060075,0.0006439661,0.0026024526,0.000004634524,0.98138607,0.00027408946,0.0010499816,0.00023669448],"study_design_scores_gemma":[0.0025880903,0.00005820208,0.0025323455,0.0003487204,0.00026602173,0.00061818556,0.0006894953,0.000004483118,0.9910455,0.00021447435,0.0015016091,0.00013290887],"about_ca_topic_score_codex":0.000006928676,"about_ca_topic_score_gemma":0.0000047539556,"teacher_disagreement_score":0.011622857,"about_ca_system_score_codex":0.00001074637,"about_ca_system_score_gemma":0.00008780316,"threshold_uncertainty_score":0.44903958},"labels":[],"label_agreement":null},{"id":"W3197211115","doi":"10.1182/blood.2020008376","title":"Primary mediastinal large B-cell lymphoma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Rituximab; Lymphoma; Medicine; Phenotype; Cancer research; Disease; Oncology; Bioinformatics; Immunology; Pathology; Biology; Gene; Genetics","score_opus":0.00868751703938859,"score_gpt":0.22523528684941518,"score_spread":0.2165477698100266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197211115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9336437,0.0039288104,0.000008278791,0.0006027658,0.00011860039,0.00010683662,0.00002125159,0.00005795565,0.061511803],"genre_scores_gemma":[0.9938499,0.0002494813,0.001560119,0.0015979309,0.00024765154,0.00003346178,0.00014411208,0.000017614264,0.0022997705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913156,0.00002070318,0.00014292117,0.00023358513,0.00022854384,0.0002426833],"domain_scores_gemma":[0.9994187,0.000053438875,0.000032499418,0.0002684851,0.00006938028,0.00015749846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000053239153,0.00011477122,0.00021606863,0.00002839396,0.000050247923,0.000014609691,0.00003698341,0.000056793997,0.0003375769],"category_scores_gemma":[0.00003442016,0.00009431788,0.000111150526,0.00011717589,0.000015758656,0.000028859278,0.000055415043,0.000031142063,0.0003072474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014949085,0.11234393,0.78161037,0.00053229084,0.0007946532,0.025789067,0.0005649373,1.8147767e-7,0.023751158,0.0014213384,0.017050292,0.035992317],"study_design_scores_gemma":[0.04844866,0.0003008241,0.6850539,0.000103642975,0.0007882787,0.00133169,0.000094641546,0.000004192392,0.21058764,0.000043769927,0.053070627,0.00017214795],"about_ca_topic_score_codex":0.0000074582204,"about_ca_topic_score_gemma":0.0000049918367,"teacher_disagreement_score":0.18683648,"about_ca_system_score_codex":0.00005637765,"about_ca_system_score_gemma":0.00031782693,"threshold_uncertainty_score":0.3949146},"labels":[],"label_agreement":null},{"id":"W3197359830","doi":"10.1182/blood.2019003689","title":"How I treat and prevent venous thrombotic complications in patients with lymphoma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Lymphoma; Venous thrombosis; Intensive care medicine; Internal medicine; Surgery; Thrombosis","score_opus":0.008305790595472276,"score_gpt":0.21243366108004558,"score_spread":0.20412787048457331,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197359830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950028,0.00045697924,0.000017098055,0.0015023071,0.000015911895,0.0004121811,0.0000058638893,0.000022262082,0.0025645823],"genre_scores_gemma":[0.9986699,0.00012481508,0.00050169963,0.00030171536,0.000019027568,0.00005128098,0.00005105391,0.000014588198,0.00026590488],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99938476,0.000018798473,0.00009232661,0.00021763491,0.00013473621,0.00015174622],"domain_scores_gemma":[0.9995762,0.00001662822,0.000031801785,0.00025229147,0.000053741,0.00006934301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000026321337,0.0000925765,0.00025108326,0.000044737706,0.000044966466,0.000030105713,0.000031376927,0.000027547449,0.000013642851],"category_scores_gemma":[0.000015470308,0.000075483586,0.000022419714,0.00013142491,0.000029052051,0.000042056243,0.000040436185,0.00003242658,0.0000050960507],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031757932,0.04987453,0.92117345,0.0003649622,0.00045031158,0.00019633425,0.00091662037,0.000006117342,0.00029433842,0.0022000135,0.0007866346,0.023704944],"study_design_scores_gemma":[0.004977178,0.0005018404,0.9924162,0.00013130855,0.00033053427,0.000015178302,0.00011269076,0.000004964765,0.0006465041,0.0000666195,0.0007125654,0.00008443209],"about_ca_topic_score_codex":0.000027831997,"about_ca_topic_score_gemma":0.000063954365,"teacher_disagreement_score":0.07124275,"about_ca_system_score_codex":0.000029013752,"about_ca_system_score_gemma":0.00004277888,"threshold_uncertainty_score":0.30781314},"labels":[],"label_agreement":null},{"id":"W3197918893","doi":"10.1182/blood.2021012304","title":"The journey of a thousand miles begins with 1 step","year":2021,"lang":"en","type":"letter","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Combinatorics; Mathematics","score_opus":0.022881523067450612,"score_gpt":0.27429878945023306,"score_spread":0.25141726638278244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197918893","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04264921,0.0083535435,0.00004878616,0.93052906,0.00015746009,0.00096008606,0.000113467766,0.000058052963,0.017130313],"genre_scores_gemma":[0.013736059,0.009443495,0.009123206,0.792972,0.02403745,0.0003633747,0.0011808504,0.00076845713,0.14837506],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978793,0.00014477606,0.0002807392,0.0003231192,0.0008991057,0.00047294563],"domain_scores_gemma":[0.99807775,0.00043281945,0.0001677385,0.0009000181,0.0003324249,0.00008922944],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0002680241,0.00025020164,0.00056440703,0.00011346092,0.00011345231,0.00004995538,0.00033029664,0.00043362819,0.0001290954],"category_scores_gemma":[0.0001728449,0.00013359556,0.00015999224,0.00026143182,0.0002933729,0.000022488584,0.0001251393,0.002438324,0.000020063535],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000072759794,0.00010538935,0.0011236129,0.0004161754,0.0010004145,0.0042855996,0.00012216988,1.2676745e-7,0.00046098954,0.000009933988,0.99179167,0.0006111768],"study_design_scores_gemma":[0.0034700788,0.00041685675,0.00059777265,0.0006977764,0.0008241958,0.0013692528,0.00018915487,0.000005229273,0.0032374177,0.000008991099,0.98901916,0.00016409857],"about_ca_topic_score_codex":0.000083675164,"about_ca_topic_score_gemma":0.00004805043,"teacher_disagreement_score":0.13755704,"about_ca_system_score_codex":0.00007293825,"about_ca_system_score_gemma":0.0013842889,"threshold_uncertainty_score":0.9998631},"labels":[],"label_agreement":null},{"id":"W3199502236","doi":"10.1182/blood.2021011121","title":"Clonal hematopoiesis in sickle cell disease","year":2021,"lang":"en","type":"letter","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; Montreal Heart Institute","funders":"National Cancer Institute; Canadian Institutes of Health Research; Institut National de la Santé et de la Recherche Médicale; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Gilead Foundation; Gilead Sciences; Agence Nationale de la Recherche; Pfizer","keywords":"Disease; Immunology; Medicine; Haematopoiesis; Sickle cell anemia; Biology; Genetics; Internal medicine; Stem cell","score_opus":0.008298040455545483,"score_gpt":0.21287953447537455,"score_spread":0.20458149401982906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199502236","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09659751,0.020435227,0.0000037789825,0.8542207,0.00051548023,0.00062490354,0.00010443667,0.00011913537,0.027378866],"genre_scores_gemma":[0.021889014,0.0014441445,0.00031326214,0.941741,0.002765631,0.00008365688,0.002014935,0.00017278906,0.029575597],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99839175,0.000054702505,0.00031772308,0.00043691398,0.00037953272,0.0004193806],"domain_scores_gemma":[0.99920046,0.00005397028,0.00007459809,0.00046203134,0.000050286584,0.00015866151],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00006121872,0.00028090566,0.00051437656,0.00015184628,0.000036458692,0.000021703545,0.00010788865,0.0007210747,0.0008290572],"category_scores_gemma":[0.00005639225,0.00024600315,0.00027032773,0.00024036028,0.000059188198,0.000022533655,0.00006756321,0.0016381552,0.0001774055],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024857984,0.00090087554,0.004132854,0.0017093668,0.000115620125,0.02939417,0.0000971254,0.0000014057134,0.000117601776,0.0000067829315,0.9634133,0.000086060005],"study_design_scores_gemma":[0.004782348,0.000072859344,0.0014737624,0.0010274679,0.0010971088,0.00017616336,0.00012269686,0.000009727114,0.00066554773,0.000112229485,0.9899902,0.0004699396],"about_ca_topic_score_codex":0.000039415307,"about_ca_topic_score_gemma":0.0000037226491,"teacher_disagreement_score":0.08752031,"about_ca_system_score_codex":0.000033585446,"about_ca_system_score_gemma":0.00042920248,"threshold_uncertainty_score":0.9999992},"labels":[],"label_agreement":null},{"id":"W3199917877","doi":"10.1182/blood.2021013244","title":"Metabolomic identification of α-ketoglutaric acid elevation in pediatric chronic graft-versus-host disease","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba; Centre Hospitalier Universitaire Sainte-Justine; Alberta Children's Hospital; University of Calgary; SickKids Foundation; University of Toronto; BC Children's Hospital; Hospital for Sick Children; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Internal medicine; Medicine; Graft-versus-host disease; Hematopoietic stem cell transplantation; Biomarker; Metabolomics; Disease; Immunology; Gastroenterology; Oncology; Biology; Bioinformatics","score_opus":0.01437286469196142,"score_gpt":0.2603566810486302,"score_spread":0.24598381635666877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199917877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950627,0.0033715693,0.00059309497,0.00022260332,0.00020036829,0.0003069766,0.000021626885,0.00003195437,0.000189069],"genre_scores_gemma":[0.99827546,0.00092448946,0.00026889425,0.000014870542,0.00013170017,0.000035455752,0.00022798176,0.00001812677,0.000103020466],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99869645,0.000067922905,0.0004932369,0.00027058081,0.00030610006,0.00016571813],"domain_scores_gemma":[0.99925166,0.00007875296,0.00014620057,0.00031233573,0.000120300436,0.000090734626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022591872,0.000109041015,0.00023053428,0.00020105416,0.00002212768,0.000009798047,0.0000591461,0.0000682955,0.00010185274],"category_scores_gemma":[0.00016516275,0.00011570922,0.00008029403,0.00066846807,0.000021095937,0.00009837253,0.00001196888,0.00010438338,0.000056328747],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028507996,0.0011986695,0.2682928,0.0017309085,0.000095423675,0.00014872328,0.0005361526,0.000025560304,0.7265658,0.0007820403,0.000015821804,0.00032298997],"study_design_scores_gemma":[0.0053729955,0.000052333937,0.67510927,0.000059074384,0.0010604542,0.000015075403,0.00006346033,0.00013869193,0.31794465,0.000062446765,0.0000236975,0.00009787245],"about_ca_topic_score_codex":0.0000096742315,"about_ca_topic_score_gemma":0.00003472071,"teacher_disagreement_score":0.40862116,"about_ca_system_score_codex":0.00006127658,"about_ca_system_score_gemma":0.00042684187,"threshold_uncertainty_score":0.4718485},"labels":[],"label_agreement":null},{"id":"W3200434719","doi":"10.1182/blood.v130.suppl_1.4377.4377","title":"Targeting of Marcks By MiR-34a Overcomes Drug Resistance in Multiple Myeloma","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"MARCKS; Bortezomib; Cancer research; Drug resistance; Carfilzomib; microRNA; Multiple myeloma; Cell culture; Downregulation and upregulation; Lenalidomide; Biology; Medicine; Chemistry; Protein kinase C; Immunology; Kinase; Cell biology; Genetics; Gene","score_opus":0.019584759188848597,"score_gpt":0.2907585840408525,"score_spread":0.27117382485200386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200434719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919578,0.001822054,0.0000050827334,0.0005948619,0.000038293132,0.00040149209,0.000061018778,0.000021459862,0.0050979597],"genre_scores_gemma":[0.9931653,0.0001040617,0.0027896794,0.000024163952,0.00004402105,0.000034128403,0.000050626262,0.000021130514,0.0037668792],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987153,0.00004529227,0.00026393106,0.0002644315,0.0003471867,0.00036389177],"domain_scores_gemma":[0.99893004,0.0001345498,0.00014448195,0.00057575,0.00006506327,0.00015009435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022197088,0.00013795636,0.00032617647,0.000080060025,0.00014883057,0.00002674014,0.00021412806,0.000059169153,0.000077972836],"category_scores_gemma":[0.0009041314,0.0001171973,0.000073787356,0.00005886882,0.00012037979,0.00010910331,0.000101259255,0.00016088902,0.00002457558],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042927434,0.0011053585,0.9338768,0.00021111719,0.00013096395,0.00029467358,0.00022282447,1.3863973e-7,0.058685165,0.00002964626,0.0041273627,0.000886642],"study_design_scores_gemma":[0.014933726,0.00007706285,0.88576746,0.00030715094,0.000047637375,0.0000052803202,0.00008338486,0.00006660582,0.09423204,0.00009072574,0.0042473986,0.00014152903],"about_ca_topic_score_codex":0.00059865817,"about_ca_topic_score_gemma":0.00054277433,"teacher_disagreement_score":0.048109375,"about_ca_system_score_codex":0.000035354864,"about_ca_system_score_gemma":0.000062148,"threshold_uncertainty_score":0.47791672},"labels":[],"label_agreement":null},{"id":"W3201609934","doi":"10.1182/blood.2022019117","title":"Outcomes of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute; Agence Nationale de la Recherche","keywords":"Wiskott–Aldrich syndrome protein; Autoimmunity; Immunology; Wiskott–Aldrich syndrome; Genetic enhancement; Stem cell; Transplantation; Fludarabine; Hematopoietic stem cell transplantation; Biology; Medicine; Immune system; Cyclophosphamide; Internal medicine; Cell; Gene; Actin cytoskeleton; Cell biology; Genetics","score_opus":0.0410312759080021,"score_gpt":0.3152371416997443,"score_spread":0.2742058657917422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201609934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957948,0.0007728857,0.000027409676,0.00055894034,0.00010261279,0.0011484177,0.00003012031,0.00013431582,0.0014304989],"genre_scores_gemma":[0.96999604,0.0004353816,0.00032726873,0.00011899137,0.000058566155,0.00015056125,0.000028704708,0.00007051914,0.02881397],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99852264,0.000036908623,0.00030884496,0.000276811,0.00045628267,0.0003985364],"domain_scores_gemma":[0.9988715,0.00027095093,0.00007159467,0.00053994276,0.00011897443,0.00012705794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038752245,0.00016163394,0.00051219075,0.00021347038,0.00004575735,0.000011403968,0.00017965531,0.000098907316,0.0004871836],"category_scores_gemma":[0.000016888293,0.00012839712,0.00024017974,0.0004898805,0.000056861023,0.000028297713,0.000049375532,0.00012314072,0.00011977401],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044316193,0.0020453196,0.095012926,0.0008242035,0.00087242073,0.00029383186,0.0012730749,0.0000052929945,0.8905676,0.00011233069,0.0018366921,0.0067131617],"study_design_scores_gemma":[0.015632745,0.0019825639,0.10286403,0.000059989452,0.00018247348,0.00023008532,0.00035337755,0.000059333586,0.8736824,0.0003495455,0.0043444885,0.00025897007],"about_ca_topic_score_codex":0.000014336508,"about_ca_topic_score_gemma":0.0000014284582,"teacher_disagreement_score":0.02738347,"about_ca_system_score_codex":0.000019712685,"about_ca_system_score_gemma":0.00009721788,"threshold_uncertainty_score":0.5334319},"labels":[],"label_agreement":null},{"id":"W3201657639","doi":"10.1182/blood.2021013201","title":"The STAT3-MYC axis promotes survival of leukemia stem cells by regulating SLC1A5 and oxidative phosphorylation","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"STAT3; Biology; Oxidative phosphorylation; Haematopoiesis; Cancer research; Stem cell; Leukemia; Myeloid leukemia; Citric acid cycle; Population; STAT protein; Cell biology; Signal transduction; Biochemistry; Immunology; Metabolism; Medicine","score_opus":0.016525582536743137,"score_gpt":0.26270489846628364,"score_spread":0.2461793159295405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201657639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99546707,0.0019774772,0.00008520562,0.00044358821,0.00004877892,0.00037117174,0.000048517173,0.00002829188,0.0015299245],"genre_scores_gemma":[0.99384826,0.00032310528,0.0010401981,0.000027902517,0.00006471162,0.000016014343,0.00004712508,0.000030173678,0.0046025035],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984972,0.00016812203,0.00030659698,0.00029092724,0.00045469016,0.00028250244],"domain_scores_gemma":[0.9985207,0.00057020056,0.00013058732,0.00035521755,0.00031612438,0.000107180414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005780605,0.00013478234,0.0002715481,0.000032314252,0.00015360197,0.000038219085,0.00009033929,0.00008911673,0.000045366654],"category_scores_gemma":[0.00021107605,0.00009822488,0.000050059545,0.00026910251,0.00016099791,0.00007515856,0.00012787017,0.0002648693,0.000009033017],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014097673,0.00015832811,0.010661595,0.00017715617,0.00027196924,0.000038684448,0.0010715849,0.0000029580651,0.9723644,0.00022751864,0.001827548,0.013057242],"study_design_scores_gemma":[0.002627542,0.00021255853,0.005033949,0.000089925765,0.000103889215,0.000029327535,0.0016833942,0.0005351501,0.9875067,0.00008394671,0.0019928133,0.000100815174],"about_ca_topic_score_codex":0.00009003322,"about_ca_topic_score_gemma":0.000022111244,"teacher_disagreement_score":0.01514225,"about_ca_system_score_codex":0.00013560633,"about_ca_system_score_gemma":0.00051418965,"threshold_uncertainty_score":0.40054944},"labels":[],"label_agreement":null},{"id":"W3203248391","doi":"10.1182/blood.2021013231","title":"Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":311,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Heart, Lung, and Blood Institute; Leibniz-Gemeinschaft; National Institutes of Health; Deutsche Herzstiftung; Deutsche Forschungsgemeinschaft; European Commission; U.S. Department of Veterans Affairs","keywords":"Platelet factor 4; Neutrophil extracellular traps; Proinflammatory cytokine; Immunology; Immune system; Antibody; Platelet activation; Immunogenicity; Platelet; Biology; Medicine; Inflammation","score_opus":0.03264382994585779,"score_gpt":0.29018072697121233,"score_spread":0.25753689702535454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203248391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9749109,0.0015073592,0.000015107895,0.0017357076,0.00055138394,0.00079343456,0.000006302048,0.00021824118,0.020261576],"genre_scores_gemma":[0.9963544,0.00038900506,0.0010239618,0.0010171471,0.0003124111,0.00007853337,0.00009481193,0.0001187989,0.00061093655],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99622536,0.00023110317,0.0010409704,0.0010717062,0.00055471994,0.0008761184],"domain_scores_gemma":[0.9974271,0.00016827679,0.00018897153,0.0014608665,0.00025371302,0.0005010374],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002683434,0.0005773686,0.0018062457,0.00036044847,0.00020148532,0.00009429307,0.0003648187,0.00045229716,0.0008750592],"category_scores_gemma":[0.00041586338,0.0005421156,0.00035448957,0.0014764536,0.000054609376,0.0003445966,0.00034721295,0.00087211153,0.00074281765],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008135022,0.0035913552,0.049504343,0.00023676388,0.00055868615,0.0024673035,0.0012186688,0.0000027750416,0.938364,0.0033178688,0.00016938729,0.0004874716],"study_design_scores_gemma":[0.012074405,0.00042794185,0.5735174,0.00039013766,0.00055397564,0.00070224033,0.00047065422,0.000034063913,0.40915397,0.0009779888,0.0010895376,0.0006077044],"about_ca_topic_score_codex":0.0004915901,"about_ca_topic_score_gemma":0.0008248506,"teacher_disagreement_score":0.52921003,"about_ca_system_score_codex":0.00021226764,"about_ca_system_score_gemma":0.0009458976,"threshold_uncertainty_score":0.99970305},"labels":[],"label_agreement":null},{"id":"W3204212764","doi":"10.1182/blood.2021012302","title":"A long-half-life, high-affinity P-selectin inhibitor","year":2021,"lang":"en","type":"letter","venue":"Blood","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Internal medicine","score_opus":0.027483851575347558,"score_gpt":0.28182674444184314,"score_spread":0.2543428928664956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3204212764","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19663318,0.0034011106,0.000040583756,0.7858907,0.00079436845,0.0015483571,0.00008043166,0.000378599,0.011232677],"genre_scores_gemma":[0.027120925,0.00052785414,0.0019353426,0.84886885,0.026688902,0.000248983,0.0035858115,0.0005113324,0.090512],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99571216,0.00029448984,0.0005398625,0.0010002119,0.0015455291,0.0009077678],"domain_scores_gemma":[0.9974503,0.00033167572,0.00016612736,0.0012136025,0.00046687407,0.00037142102],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.00024230962,0.0005092267,0.00097130093,0.00039739537,0.00011308159,0.000107359905,0.0003374928,0.0013551444,0.003684075],"category_scores_gemma":[0.001254336,0.00047959806,0.000400665,0.00071176287,0.00011210108,0.000036823432,0.00035748686,0.0048911753,0.0012477081],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057531422,0.00073344307,0.0010755452,0.0009556112,0.00041760074,0.02316293,0.000025896139,1.8410053e-7,0.0057958085,0.000003866432,0.96742404,0.00034751956],"study_design_scores_gemma":[0.0060052327,0.0005934335,0.002928256,0.0006203121,0.000864719,0.0010415197,0.000015000315,0.000004257871,0.050593495,0.000025182495,0.93663186,0.00067672384],"about_ca_topic_score_codex":0.00019629426,"about_ca_topic_score_gemma":0.000041886226,"teacher_disagreement_score":0.16951224,"about_ca_system_score_codex":0.00012227276,"about_ca_system_score_gemma":0.001458034,"threshold_uncertainty_score":0.9999413},"labels":[],"label_agreement":null},{"id":"W3205235877","doi":"10.1182/blood.2021013996","title":"<i>JAK2</i> wild-type erythrocytosis associated with sodium-glucose cotransporter 2 inhibitor therapy","year":2021,"lang":"en","type":"letter","venue":"Blood","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Internal medicine; Medicine; Cotransporter; Sodium; Chemistry; Pharmacology; Endocrinology","score_opus":0.016707203998869272,"score_gpt":0.21686241698928493,"score_spread":0.20015521299041567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3205235877","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6221408,0.008404892,0.0000068525073,0.3489126,0.0012893383,0.0031940357,0.00021109014,0.0008452326,0.014995122],"genre_scores_gemma":[0.045322455,0.0035373291,0.00048321718,0.89445305,0.0046055173,0.0002981124,0.014203645,0.0004155886,0.03668109],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973361,0.00006661745,0.00038826675,0.00076058455,0.00077188364,0.0006765822],"domain_scores_gemma":[0.9985884,0.00007099148,0.00023204887,0.0007474497,0.00024169065,0.00011946505],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010087147,0.000654981,0.0010453482,0.00018201837,0.00008945335,0.00008015058,0.00016623185,0.00071114843,0.0005225079],"category_scores_gemma":[0.000016625778,0.0004933378,0.00031863188,0.00043334303,0.000096712225,0.00008605996,0.00003950232,0.00095403753,0.00008714281],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014821439,0.0024610232,0.012408665,0.00025124292,0.007901645,0.0067631616,0.00013277918,1.2530637e-7,0.0008021528,0.000002696387,0.96795094,0.0011773378],"study_design_scores_gemma":[0.015083709,0.0020259393,0.0033310421,0.0012183688,0.0060272533,0.00002903864,0.00002445891,6.700177e-7,0.020913143,0.000010285544,0.95061654,0.0007195408],"about_ca_topic_score_codex":0.00002330784,"about_ca_topic_score_gemma":0.000024279341,"teacher_disagreement_score":0.5768184,"about_ca_system_score_codex":0.00010152068,"about_ca_system_score_gemma":0.00020702745,"threshold_uncertainty_score":0.9997518},"labels":[],"label_agreement":null},{"id":"W3206296081","doi":"10.1182/blood.2021011941","title":"A gene expression–based model predicts outcome in children with intermediate-risk classical Hodgkin lymphoma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Spinal Cord Injury BC","funders":"National Cancer Institute; National Institutes of Health; BC Cancer Foundation; Michael Smith Health Research BC; Genome British Columbia; Children’s Oncology Group; Paul G. Allen Frontiers Group; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Genome Canada; St. Baldrick's Foundation","keywords":"Oncology; Internal medicine; Medicine; Cohort; Gene expression profiling; Lymphoma; Biology; Gene expression; Gene","score_opus":0.0138069628895325,"score_gpt":0.24511071673448184,"score_spread":0.23130375384494933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206296081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99807096,0.00042176485,0.00020086182,0.00036947938,0.00003458555,0.0003842304,0.00008432976,0.00006611427,0.0003676794],"genre_scores_gemma":[0.992849,0.000061698105,0.005876965,0.00057963585,0.0000994436,0.00018994272,0.00015379976,0.00003662071,0.00015291512],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984311,0.00006512242,0.00032378078,0.00048212832,0.00036300052,0.00033488625],"domain_scores_gemma":[0.9990505,0.000063375046,0.00009096944,0.00049361814,0.000058034806,0.00024347659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007840341,0.00024113905,0.0004357137,0.00010135755,0.000047978898,0.000025687672,0.00008741708,0.00013031201,0.000052936004],"category_scores_gemma":[0.00009119213,0.00016644438,0.00012128533,0.00019693913,0.000059023158,0.00005525984,0.000071728195,0.00010934896,0.000033223685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015162354,0.0061009265,0.98954594,0.000018170109,0.00019912854,0.0007443055,0.00008930942,0.00019967063,0.0008712657,0.000011164866,0.00018543316,0.0018830836],"study_design_scores_gemma":[0.029471718,0.00039371182,0.87277555,0.00019673412,0.0005032887,0.00020369244,0.00001742917,0.0027575959,0.09346355,0.000023539946,0.000022200402,0.00017099998],"about_ca_topic_score_codex":0.000030998628,"about_ca_topic_score_gemma":0.000055857814,"teacher_disagreement_score":0.11677038,"about_ca_system_score_codex":0.000110811496,"about_ca_system_score_gemma":0.000443144,"threshold_uncertainty_score":0.6787405},"labels":[],"label_agreement":null},{"id":"W3207994228","doi":"10.1182/blood-2021-148813","title":"Phase 1b Results for Subcutaneous Talquetamab Plus Daratumumab in Patients with Relapsed/Refractory Multiple Myeloma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Institute of Cancer Research; University of Calgary","funders":"","keywords":"Daratumumab; Medicine; Internal medicine; CD38; Pomalidomide; Refractory (planetary science); Multiple myeloma; Oncology; Tumor lysis syndrome; Immunology; Gastroenterology; Lenalidomide; Chemotherapy; Stem cell; Biology","score_opus":0.018257228312412603,"score_gpt":0.2827512217054763,"score_spread":0.2644939933930637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207994228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99530125,0.00038931242,0.000031646643,0.00016128777,0.00008909092,0.001517201,0.00058461906,0.00007138457,0.0018542088],"genre_scores_gemma":[0.99336827,0.00003101457,0.0026109135,0.0000764017,0.00008918376,0.00017126331,0.002065565,0.000059205006,0.0015281689],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99764603,0.00007878225,0.00043199165,0.00064307655,0.0005552321,0.00064487895],"domain_scores_gemma":[0.9982329,0.0003005201,0.000115336356,0.00063665636,0.0003687042,0.00034588337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012812152,0.00028532688,0.00049369456,0.00016807002,0.00012817417,0.000037729675,0.00011097518,0.00014964203,0.00003272809],"category_scores_gemma":[0.00087574695,0.00022852562,0.00012065857,0.00033551984,0.00007236052,0.00012229891,0.00006044539,0.0003005945,0.000043373337],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22783764,0.20520785,0.42178017,0.0011043431,0.0032028188,0.04124743,0.002113993,0.000027832875,0.009380238,0.000094690666,0.003402464,0.08460053],"study_design_scores_gemma":[0.78034925,0.017906496,0.16787803,0.00047526127,0.0004409889,0.00037730212,0.00017906615,0.0006322814,0.023882259,0.000027517126,0.0072832513,0.0005683149],"about_ca_topic_score_codex":0.00006319197,"about_ca_topic_score_gemma":0.0003543056,"teacher_disagreement_score":0.5525116,"about_ca_system_score_codex":0.00019171748,"about_ca_system_score_gemma":0.00047040067,"threshold_uncertainty_score":0.93190044},"labels":[],"label_agreement":null},{"id":"W3208128184","doi":"10.1182/blood-2021-146820","title":"Subcutaneous Daratumumab with Bortezomib, Cyclophosphamide, and Dexamethasone in Patients with Newly Diagnosed Light Chain (AL) Amyloidosis: 18-Month Analysis of the Phase 3 ANDROMEDA Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Daratumumab; Bortezomib; AL amyloidosis; Medicine; Amyloidosis; Dexamethasone; Cyclophosphamide; Internal medicine; Melphalan; Andromeda; Immunoglobulin light chain; Phases of clinical research; Oncology; Multiple myeloma; Dermatology; Antibody; Immunology; Chemotherapy","score_opus":0.0046167787621430485,"score_gpt":0.22903573774211505,"score_spread":0.224418958979972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208128184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99658036,0.0021213097,0.000008127705,0.00013972913,0.000037739017,0.00084343087,0.000131235,0.00001314828,0.00012492083],"genre_scores_gemma":[0.998714,0.00031989053,0.00026017902,0.00019860947,0.000014518983,0.00017476555,0.00017284688,0.000045566816,0.00009961806],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978703,0.00017097054,0.0004216701,0.0007828261,0.0003859892,0.00036821503],"domain_scores_gemma":[0.99839234,0.00008935655,0.00029052366,0.00092743867,0.0001712688,0.00012904283],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015819877,0.0003827818,0.000683162,0.00015063322,0.0001264044,0.00004209963,0.00024739,0.00012112151,0.000024766503],"category_scores_gemma":[0.0001340825,0.00025551044,0.00014010002,0.0011900987,0.00012291656,0.000011790108,0.00017662554,0.00015634243,5.931028e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006910536,0.009330783,0.9821284,0.000014807366,0.0038085033,0.0002848682,0.00039642528,0.000070638096,0.0022427281,0.0000021254746,0.000055816814,0.00097388774],"study_design_scores_gemma":[0.026814917,0.0036991735,0.923558,0.000053900927,0.0036198879,0.000018666244,0.00076542475,0.000009248816,0.040893525,0.0000015721813,0.00018408729,0.00038159074],"about_ca_topic_score_codex":0.00022226035,"about_ca_topic_score_gemma":0.004418793,"teacher_disagreement_score":0.058570355,"about_ca_system_score_codex":0.000029774994,"about_ca_system_score_gemma":0.0001264632,"threshold_uncertainty_score":0.9999897},"labels":[],"label_agreement":null},{"id":"W3208468707","doi":"10.1182/blood-2021-146200","title":"Ciltacabtagene Autoleucel for Triple-Class Exposed Multiple Myeloma: Adjusted Comparisons of CARTITUDE-1 Patient Outcomes Versus Therapies from Real-World Clinical Practice from the LocoMMotion Prospective Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Multiple myeloma; Internal medicine; Clinical trial; Clinical endpoint; Oncology; Lenalidomide","score_opus":0.11321306732251128,"score_gpt":0.3950350964076225,"score_spread":0.2818220290851112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208468707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99037194,0.0008109085,0.00013651681,0.0021352111,0.0007003354,0.004294099,0.00036291717,0.00009765533,0.001090437],"genre_scores_gemma":[0.99405366,0.000106631924,0.0038396283,0.00022321526,0.00031744043,0.0004417109,0.00028546163,0.00006219505,0.00067004864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99599904,0.0009536492,0.0010508709,0.0006928721,0.00092257507,0.00038098544],"domain_scores_gemma":[0.98831505,0.008943069,0.00045805128,0.0011662786,0.00095441897,0.00016312503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008022668,0.00030465313,0.0010137326,0.000077992176,0.00019336236,0.0000553969,0.00026955284,0.00014380249,0.00038130203],"category_scores_gemma":[0.003052885,0.00022118892,0.00040638496,0.0004506317,0.00016773523,0.00011638271,0.00018935103,0.0005648651,0.000012355364],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011189193,0.018229129,0.91517526,0.000024395613,0.0062877648,0.00010056857,0.007565045,0.0000096096055,0.032357763,0.00005523624,0.0016120417,0.007394005],"study_design_scores_gemma":[0.051917247,0.003050129,0.8804463,0.00006010917,0.0017563498,0.0000022819793,0.016967015,0.00031706254,0.038525607,0.000028963053,0.0067116152,0.0002172777],"about_ca_topic_score_codex":0.003008413,"about_ca_topic_score_gemma":0.0093678655,"teacher_disagreement_score":0.040728055,"about_ca_system_score_codex":0.00014110486,"about_ca_system_score_gemma":0.0004148798,"threshold_uncertainty_score":0.90198225},"labels":[],"label_agreement":null},{"id":"W3208720801","doi":"10.1182/blood.v130.suppl_1.271.271","title":"Next Generation Sequencing (NGS)-Based Post-Transplant Monitoring in Acute Myeloid Leukemia Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation (HCT)","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Transplantation; Myeloid leukemia; Stem cell; Hematopoietic stem cell transplantation; Medicine; Haematopoiesis; Hematologic Neoplasms; Leukemia; Hematopoietic cell; Myeloid; Cancer research; Oncology; Immunology; Internal medicine; Biology; Genetics","score_opus":0.03809514935073274,"score_gpt":0.27424933861959705,"score_spread":0.2361541892688643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208720801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99752593,0.00019577741,0.00031500467,0.00018904121,0.0002746489,0.00088254194,0.00004361171,0.000090338486,0.0004831228],"genre_scores_gemma":[0.9965985,0.0005729583,0.0017687037,0.00011240458,0.00029570312,0.000098816105,0.00029905626,0.0000811028,0.0001727507],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972934,0.00013000055,0.0005881768,0.00062333257,0.00069499045,0.00067008415],"domain_scores_gemma":[0.9983846,0.00009340763,0.00025568422,0.0007786303,0.00024178697,0.00024591014],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004654699,0.0003498415,0.0004556808,0.00031435041,0.00043813224,0.0001999144,0.00039363911,0.00027787776,0.00001837648],"category_scores_gemma":[0.000039220373,0.00034094043,0.00013499569,0.00016237173,0.00007493606,0.0005041611,0.000041505984,0.00055957533,0.000049880753],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021226317,0.00017948738,0.32936117,0.00045779688,0.00007464262,0.0006461322,0.0018179982,0.00018015181,0.6644633,0.0000031340342,0.000009761593,0.0025941392],"study_design_scores_gemma":[0.009249716,0.00034909774,0.2859504,0.00071341806,0.00043648283,0.00010985284,0.00020298785,0.0018688941,0.70074964,0.0000032246273,0.000010923313,0.0003553515],"about_ca_topic_score_codex":0.0006733403,"about_ca_topic_score_gemma":0.0001942054,"teacher_disagreement_score":0.043410793,"about_ca_system_score_codex":0.0010920728,"about_ca_system_score_gemma":0.00096305966,"threshold_uncertainty_score":0.9999043},"labels":[],"label_agreement":null},{"id":"W3208814858","doi":"10.1182/blood-2021-148039","title":"Primary Analysis of ZUMA-7: A Phase 3 Randomized Trial of Axicabtagene Ciloleucel (Axi-Cel) Versus Standard-of-Care Therapy in Patients with Relapsed/Refractory Large B-Cell Lymphoma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Medicine; Refractory (planetary science); Internal medicine; Oncology; Lymphoma; Biology","score_opus":0.015746695104493107,"score_gpt":0.293887349007926,"score_spread":0.2781406539034329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208814858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99194777,0.0030300056,0.000028000568,0.000017318753,0.000106957385,0.0016462326,0.00034768812,0.000015449452,0.0028606022],"genre_scores_gemma":[0.99754226,0.0010964322,0.00034072067,0.000026896068,0.00004554066,0.00006131666,0.00054595416,0.000046424295,0.00029448266],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9964548,0.000544812,0.00093281653,0.00042497125,0.0012948192,0.00034780137],"domain_scores_gemma":[0.9970913,0.0006221112,0.00045880498,0.00083467545,0.00085913937,0.00013400333],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008832052,0.00025447796,0.0022484777,0.00064623426,0.000029175755,0.000008435667,0.00017564674,0.00017136773,0.0010380979],"category_scores_gemma":[0.00026340567,0.00020030436,0.0007166506,0.0015560773,0.00018555281,0.00006292709,0.000066895234,0.00019466547,0.0000010717482],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9223468,0.027783189,0.004142367,0.000244383,0.0048539834,0.00006534527,0.0012048855,0.0000036171864,0.029363127,0.0000069515168,0.000012986067,0.009972388],"study_design_scores_gemma":[0.851414,0.012311822,0.0016050375,0.00009703243,0.0024511677,4.6508177e-7,0.00026334793,0.000013539349,0.13136865,0.0000026146479,0.0003262276,0.00014606773],"about_ca_topic_score_codex":0.000050170867,"about_ca_topic_score_gemma":0.00004672341,"teacher_disagreement_score":0.10200553,"about_ca_system_score_codex":0.00015279517,"about_ca_system_score_gemma":0.0010228031,"threshold_uncertainty_score":0.99987507},"labels":[],"label_agreement":null},{"id":"W3209530143","doi":"10.1182/blood-2021-145872","title":"Mosunetuzumab Monotherapy Is an Effective and Well-Tolerated Treatment Option for Patients with Relapsed/Refractory (R/R) Follicular Lymphoma (FL) Who Have Received ≥2 Prior Lines of Therapy: Pivotal Results from a Phase I/II Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada); Princess Margaret Cancer Centre; Jewish General Hospital; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Refractory (planetary science); Follicular lymphoma; Internal medicine; Salvage therapy; Oncology; Bendamustine; Lymphoma; Rituximab; Chemotherapy","score_opus":0.013910371336629356,"score_gpt":0.2705252749562076,"score_spread":0.2566149036195782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209530143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929906,0.0016486382,0.000008818645,0.000092688526,0.00004985759,0.004446856,0.0006882354,0.00004462051,0.000029663122],"genre_scores_gemma":[0.99588555,0.0008469426,0.00073815644,0.00008885736,0.00009175802,0.0008193425,0.0013281313,0.000058349615,0.00014290049],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980912,0.0001572129,0.00045349853,0.00076180097,0.00029825888,0.00023800983],"domain_scores_gemma":[0.998385,0.00020369634,0.0002785418,0.0005356926,0.0004289045,0.00016817209],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000082155246,0.000397395,0.0007508311,0.000084135456,0.00018247744,0.00003578269,0.000050391704,0.00013598091,0.000018834551],"category_scores_gemma":[0.000032078788,0.00027038032,0.00013142628,0.00014100737,0.00005013889,0.00013047174,0.000019225557,0.000038984665,0.0000012844423],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.061340697,0.2890964,0.29659107,0.000045982346,0.009644677,0.0003823079,0.027878368,0.000012064093,0.0071889735,0.000003641547,0.00008659804,0.3077292],"study_design_scores_gemma":[0.36507365,0.08479723,0.4327379,0.00020006335,0.00141432,0.000008727095,0.0008193694,0.00032739423,0.1137184,0.0000120821,0.0006206717,0.00027019254],"about_ca_topic_score_codex":0.0007781099,"about_ca_topic_score_gemma":0.00013275967,"teacher_disagreement_score":0.30745903,"about_ca_system_score_codex":0.00018552317,"about_ca_system_score_gemma":0.00016759297,"threshold_uncertainty_score":0.99997485},"labels":[],"label_agreement":null},{"id":"W3209533924","doi":"10.1182/blood-2021-154182","title":"Perioperative Anemia Management in Women Undergoing Gynecologic Procedures: A 10 Year Multisite Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Blood Services; McMaster University","funders":"","keywords":"Medicine; Perioperative; Anemia; Blood transfusion; Retrospective cohort study; Intensive care unit; Blood management; Emergency medicine; Pediatrics; Surgery; Intensive care medicine; Internal medicine","score_opus":0.011228699096478076,"score_gpt":0.2617920243931804,"score_spread":0.25056332529670233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209533924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96581817,0.00016139087,0.0000142741965,0.0004625257,0.00005088298,0.0013166138,0.0000013686202,0.00007122454,0.032103542],"genre_scores_gemma":[0.98476094,0.0002892314,0.0012877058,0.00094711507,0.00002973564,0.0003188654,0.0000070773294,0.000019016366,0.012340288],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987658,0.000066112,0.00022781533,0.00040768457,0.00023304304,0.000299513],"domain_scores_gemma":[0.99951863,0.00003303472,0.000027146954,0.00027187142,0.00005143514,0.00009787632],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001800329,0.00014896745,0.00025824155,0.00012431358,0.00006510256,0.00003422711,0.00007329513,0.000047497364,0.0012573809],"category_scores_gemma":[0.00007350924,0.00013232812,0.00004141926,0.00036027294,0.000018812603,0.000046607318,0.00011331885,0.00014284604,0.000118598786],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025387781,0.135732,0.5912672,0.0074305157,0.0067371456,0.06249179,0.13067771,0.00018274282,0.013940184,0.005910091,0.004055233,0.03903655],"study_design_scores_gemma":[0.061454628,0.0024180207,0.7720427,0.0004150475,0.0007877734,0.000077852645,0.15163936,0.000026238162,0.0021241931,0.00007585156,0.008403816,0.0005345504],"about_ca_topic_score_codex":0.000011490414,"about_ca_topic_score_gemma":0.0007063968,"teacher_disagreement_score":0.18077542,"about_ca_system_score_codex":0.00007936385,"about_ca_system_score_gemma":0.000092752955,"threshold_uncertainty_score":0.9996556},"labels":[],"label_agreement":null},{"id":"W3209573575","doi":"10.1182/blood.2021013338","title":"ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":155,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto; Children's Hospital of Eastern Ontario; University of Saskatchewan","funders":"Servier; Leids Universitair Medisch Centrum; National Cancer Institute; National Institutes of Health; Cincinnati Children's Hospital Medical Center; Universiteit Leiden; Cancer Research UK; Applebaum Foundation","keywords":"Anaplastic lymphoma kinase; Histiocyte; Histiocytosis; Pathology; Langerhans cell histiocytosis; Medicine; Disease","score_opus":0.024349832704361606,"score_gpt":0.2731335024151223,"score_spread":0.24878366971076069,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209573575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98505104,0.0015702443,0.00012974827,0.009064169,0.00010718011,0.00038846512,0.000018802846,0.000086256325,0.0035841265],"genre_scores_gemma":[0.990198,0.0001962481,0.0023171077,0.0046680733,0.00012402626,0.000036057358,0.000056869754,0.000019012556,0.0023846028],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865377,0.00010393443,0.00028721822,0.00049637485,0.00018796137,0.00027076996],"domain_scores_gemma":[0.99929017,0.000100961806,0.0000770303,0.00023868597,0.00005786991,0.00023526952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014474579,0.00018352356,0.0003116717,0.00010142529,0.00012575944,0.000034417764,0.000031974683,0.000086463624,0.00008075872],"category_scores_gemma":[0.000337099,0.00015946757,0.000072162584,0.00022207997,0.00004206175,0.00004499568,0.0000889679,0.00012419545,0.00007287011],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00677733,0.023723166,0.6759748,0.0006596388,0.0015676919,0.067135364,0.00982962,0.000020399902,0.14642814,0.0068986765,0.013082187,0.04790298],"study_design_scores_gemma":[0.042717744,0.016325459,0.6888979,0.0010691074,0.0040620873,0.003669289,0.0013988075,0.000055321685,0.21118176,0.005935929,0.023458764,0.0012278532],"about_ca_topic_score_codex":0.00007355159,"about_ca_topic_score_gemma":0.00004851563,"teacher_disagreement_score":0.06475362,"about_ca_system_score_codex":0.0000532456,"about_ca_system_score_gemma":0.00019716186,"threshold_uncertainty_score":0.6502899},"labels":[],"label_agreement":null},{"id":"W3210549609","doi":"10.1182/blood-2021-146060","title":"Updated Results from CARTITUDE-1: Phase 1b/2Study of Ciltacabtagene Autoleucel, a B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy, in Patients With Relapsed/Refractory Multiple Myeloma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Chimeric antigen receptor; Antigen; Medicine; Multiple myeloma; Immunology; Refractory (planetary science); Immunotherapy; Cancer research; Biology; Immune system","score_opus":0.014589790550367214,"score_gpt":0.25885141836574355,"score_spread":0.24426162781537633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3210549609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951598,0.0012398261,0.0000074516174,0.00006794328,0.00016832603,0.0015662317,0.00046284057,0.00015306043,0.0011745398],"genre_scores_gemma":[0.99185264,0.0008199868,0.0017372356,0.00007245917,0.00011799161,0.000042060226,0.004002135,0.00010428524,0.0012511915],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99635535,0.000400749,0.0008654362,0.0008688383,0.00096441427,0.00054521003],"domain_scores_gemma":[0.9975428,0.00018486188,0.0003834548,0.0010061137,0.00065167464,0.0002310917],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003093533,0.00040071816,0.00076867425,0.00029957754,0.00009695485,0.000042094664,0.0002267849,0.00024831147,0.0011874613],"category_scores_gemma":[0.0001474936,0.00034955816,0.00013622342,0.0012638603,0.000100041594,0.0001767967,0.000088071305,0.0005338151,0.000048438425],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0114879925,0.024460651,0.13505508,0.000040591083,0.00033032332,0.0001349313,0.0018026995,0.000007864643,0.8222407,1.2824258e-7,0.00052797113,0.0039110663],"study_design_scores_gemma":[0.087663524,0.002183835,0.31882977,0.00010464759,0.00006922202,0.000002230066,0.00015672867,0.0001356892,0.5882228,9.688538e-7,0.0023590706,0.00027147832],"about_ca_topic_score_codex":0.0006267193,"about_ca_topic_score_gemma":0.00017592454,"teacher_disagreement_score":0.23401786,"about_ca_system_score_codex":0.000104790786,"about_ca_system_score_gemma":0.000492756,"threshold_uncertainty_score":0.99989563},"labels":[],"label_agreement":null},{"id":"W3210578782","doi":"10.1182/blood.2020006477","title":"Hemostatic and thrombotic disorders in the pediatric patient","year":2021,"lang":"en","type":"review","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; American Heart Association","keywords":"Medicine; Intensive care medicine","score_opus":0.038093201232652446,"score_gpt":0.31307139290207986,"score_spread":0.2749781916694274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3210578782","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010383601,0.9968996,0.000006935782,0.00016498813,0.000111979396,0.0010151507,0.000004890617,0.00002033498,0.0007377332],"genre_scores_gemma":[0.0019624128,0.9972604,0.0002201819,0.0002617614,0.000068253416,0.00009680299,0.0000689413,0.000034378052,0.000026880714],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99860173,0.00021060597,0.00041314797,0.00031032434,0.00026709284,0.00019709904],"domain_scores_gemma":[0.9992263,0.00019434057,0.00014259528,0.00035177747,0.000020371574,0.00006461928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016477943,0.00025244284,0.0010567206,0.00013812339,0.00004664346,0.00003186727,0.00008857708,0.00015637511,0.00004319192],"category_scores_gemma":[0.000075293865,0.00015849851,0.00019632487,0.00051361637,0.00002360753,0.0000226327,0.000053187894,0.00033309718,0.000017888508],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000014108132,0.0024108698,0.00084321096,0.01646192,0.00032711137,0.00011866752,0.0009980458,1.6880706e-7,3.66652e-7,0.0024481227,0.00030503506,0.97608507],"study_design_scores_gemma":[0.0040761363,0.00085118023,0.001233886,0.010148045,0.01924982,0.0011316629,0.0009580836,0.000008138437,0.0000023617977,0.0008075389,0.960677,0.0008560962],"about_ca_topic_score_codex":0.000006044288,"about_ca_topic_score_gemma":0.000012811511,"teacher_disagreement_score":0.97522897,"about_ca_system_score_codex":0.000012937671,"about_ca_system_score_gemma":0.00016984942,"threshold_uncertainty_score":0.64633816},"labels":[],"label_agreement":null},{"id":"W3210721043","doi":"10.1182/blood-2021-148723","title":"Subcutaneous Teclistamab in Combination with Daratumumab for the Treatment of Patients with Relapsed/Refractory Multiple Myeloma: Results from a Phase 1b Multicohort Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Daratumumab; Internal medicine; Oncology; Phases of clinical research; Gastroenterology; Lenalidomide; Multiple myeloma; Clinical trial","score_opus":0.02074947527204619,"score_gpt":0.2892408066175379,"score_spread":0.26849133134549175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3210721043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938685,0.0003660919,0.000038783444,0.00008065574,0.000040435498,0.0044029406,0.0010944394,0.00002971264,0.00007838631],"genre_scores_gemma":[0.9961232,0.000058738988,0.0011532567,0.000009185178,0.00003110018,0.0005226559,0.001858338,0.000041868596,0.00020167933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979928,0.00010977428,0.00043665376,0.0005318698,0.00059040554,0.0003384962],"domain_scores_gemma":[0.9976244,0.00092570996,0.00017912907,0.0007003288,0.00043372973,0.00013671695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000103320745,0.00026793475,0.000494991,0.0001109105,0.0001367389,0.00002559407,0.0000924775,0.00007117535,0.0000142117215],"category_scores_gemma":[0.00029465804,0.00015047195,0.00007954482,0.00029488426,0.00008696126,0.00007271906,0.000021973485,0.00012872461,0.0000032487974],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.053675175,0.22522143,0.69415474,0.000037894377,0.001876526,0.0021098587,0.0029977309,0.000009666199,0.00048708363,0.0000025980344,0.000014139261,0.019413171],"study_design_scores_gemma":[0.38194686,0.03328628,0.57596433,0.000096690106,0.0008538632,0.000016520265,0.001059219,0.00048662728,0.0057569803,0.000003789598,0.00037724373,0.0001516135],"about_ca_topic_score_codex":0.00088285335,"about_ca_topic_score_gemma":0.0032184813,"teacher_disagreement_score":0.3282717,"about_ca_system_score_codex":0.00017574622,"about_ca_system_score_gemma":0.00022998455,"threshold_uncertainty_score":0.6136068},"labels":[],"label_agreement":null},{"id":"W3210991186","doi":"10.1182/blood-2021-148949","title":"Glofitamab Step-up Dosing Induces High Response Rates in Patients (pts) with Relapsed or Refractory (R/R) Mantle Cell Lymphoma (MCL), Most of Whom Had Failed Prior Bruton's Tyrosine Kinase Inhibitor (BTKi) Therapy","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Obinutuzumab; Medicine; Mantle cell lymphoma; Tolerability; Internal medicine; Dosing; Gastroenterology; Cytokine release syndrome; Pharmacology; Rituximab; Lymphoma; Oncology; Adverse effect; Cancer; Immunotherapy; Chimeric antigen receptor","score_opus":0.011081378863928492,"score_gpt":0.2364690204649568,"score_spread":0.2253876416010283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3210991186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99561054,0.0026570684,0.0000012923804,0.00035698444,0.00022732126,0.0009081621,0.000094148745,0.000058430865,0.00008604509],"genre_scores_gemma":[0.99721265,0.00036468543,0.00094017613,0.00027341506,0.00007158246,0.000108742366,0.00018095992,0.00008209871,0.0007656741],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99729943,0.00030971732,0.0006572925,0.0006711224,0.0006021503,0.00046030586],"domain_scores_gemma":[0.9979938,0.00040820014,0.00035101303,0.00070457225,0.00036398755,0.00017841377],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002497781,0.00043927322,0.0008061753,0.0002403431,0.00014044641,0.000073976844,0.00013401889,0.00023248022,0.00013907877],"category_scores_gemma":[0.00019636325,0.00030456667,0.00011424618,0.00073098304,0.00013371701,0.00021024184,0.000083536106,0.000136812,0.00002252067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04517918,0.05091752,0.68292236,0.0003513245,0.00068208243,0.0028292167,0.0019710031,0.0000019943816,0.16853721,0.000019134312,0.000700474,0.04588846],"study_design_scores_gemma":[0.06737831,0.0029237464,0.4942478,0.0006542162,0.00018816149,0.000018043504,0.00029041705,0.0000032165626,0.4331805,0.0000021000972,0.00089255726,0.00022091136],"about_ca_topic_score_codex":0.00043669128,"about_ca_topic_score_gemma":0.00009514468,"teacher_disagreement_score":0.2646433,"about_ca_system_score_codex":0.00031835094,"about_ca_system_score_gemma":0.001189814,"threshold_uncertainty_score":0.99994063},"labels":[],"label_agreement":null},{"id":"W3211342731","doi":"10.1182/blood-2021-148759","title":"Once Weekly Oral Selinexor, Pomalidomide, and Dexamethasone in Relapsed Refractory Multiple Myeloma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; University of Calgary; Vancouver General Hospital; CancerCare Manitoba; Université de Montréal; University of Alberta; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; Royal Victoria Hospital; Dalhousie University","funders":"","keywords":"Pomalidomide; Dexamethasone; Medicine; Refractory (planetary science); Lenalidomide; Multiple myeloma; Regimen; Bortezomib; Internal medicine; Pharmacology; Phases of clinical research; Oncology; Cancer research; Toxicity; Biology","score_opus":0.008436314806170152,"score_gpt":0.22305830336241225,"score_spread":0.2146219885562421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211342731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99735516,0.0015924467,0.000067653054,0.00011190225,0.000121091354,0.00005819048,0.0000067294823,0.0000111085465,0.00067570235],"genre_scores_gemma":[0.9946041,0.0001697935,0.004087402,0.0002779807,0.00016357141,0.0000040524633,0.000055708897,0.000017935623,0.0006194304],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992951,0.00006525454,0.0001355464,0.00029045818,0.000065678796,0.0001479486],"domain_scores_gemma":[0.99963945,0.000017989207,0.00003868636,0.00020957785,0.000044703986,0.000049601345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009540804,0.00009907678,0.00011757287,0.00002473313,0.000036417416,0.000016453816,0.000048934122,0.00014942019,0.000023675912],"category_scores_gemma":[0.0002015818,0.00009930388,0.000034830442,0.000086845306,0.00003114461,0.0000033532647,0.000067168745,0.000108834225,0.000005233387],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010179736,0.00011425578,0.03313898,0.000011331761,0.000033210294,0.000044869696,0.000036076646,0.0000045699485,0.96052253,0.000022418224,0.0003819528,0.0055879834],"study_design_scores_gemma":[0.008645087,0.00049411383,0.21899785,0.000035822388,0.00007493148,0.00023434637,0.00026569847,0.00010162077,0.6958098,0.00014610126,0.07477957,0.00041509324],"about_ca_topic_score_codex":0.000027522365,"about_ca_topic_score_gemma":0.0002387266,"teacher_disagreement_score":0.26471278,"about_ca_system_score_codex":0.0000050250164,"about_ca_system_score_gemma":0.00004121628,"threshold_uncertainty_score":0.4049495},"labels":[],"label_agreement":null},{"id":"W3211352653","doi":"10.1182/blood-2021-145854","title":"Transcriptomic Features of Immune Exhaustion and Senescence Predict Outcomes and Define Checkpoint Blockade-Unresponsive Microenvironments in Acute Myeloid Leukemia","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Immune checkpoint; Myeloid leukemia; Medicine; Oncology; Internal medicine; Immunology; Immune system; Immunotherapy","score_opus":0.00876558264766543,"score_gpt":0.24904633955645578,"score_spread":0.24028075690879036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211352653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99268854,0.0053892983,0.000023778945,0.0012160992,0.000039742798,0.00044490478,0.00005597731,0.000022854394,0.00011878436],"genre_scores_gemma":[0.9924421,0.0043156315,0.0018547042,0.00013141215,0.00002814901,0.000025973644,0.000057371675,0.000032625692,0.001112082],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998251,0.00010950524,0.00046613356,0.00046834187,0.00033994453,0.00036503252],"domain_scores_gemma":[0.99919057,0.00011695673,0.00009857211,0.00036912455,0.00006505614,0.00015971003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029647385,0.00024411749,0.000611984,0.00020308746,0.00005161371,0.000018158173,0.000095993586,0.00018462416,0.000036084566],"category_scores_gemma":[0.00020651297,0.0002187654,0.00009119982,0.00024228594,0.00024988642,0.00009217438,0.00014958138,0.00044342855,0.0000036701],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052871415,0.00023015318,0.1648936,0.00018942813,0.00027055366,0.00053188746,0.00049061707,0.0000014795863,0.8316075,0.000010437854,0.000031927353,0.0012136865],"study_design_scores_gemma":[0.0067333723,0.00015385413,0.58063895,0.00015756152,0.00027441565,0.0007502939,0.00021050265,0.000022182421,0.410886,0.000019084142,0.000050597988,0.00010321246],"about_ca_topic_score_codex":0.0001512018,"about_ca_topic_score_gemma":0.000036684287,"teacher_disagreement_score":0.4207215,"about_ca_system_score_codex":0.00018819478,"about_ca_system_score_gemma":0.0003364198,"threshold_uncertainty_score":0.89209944},"labels":[],"label_agreement":null},{"id":"W3211353714","doi":"10.1182/blood-2021-146001","title":"Tumor Lysis Syndrome: Incidence, Mitigation and Management in Patients with Chronic Lymphocytic Leukemia Initiating Venetoclax in Routine Clinical Practice (DEVOTE) across Canada","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Foothills Medical Centre; Ottawa Hospital; Moncton Hospital; Jewish General Hospital; ABB (Canada); Thunder Bay Regional Health Sciences Centre; CancerCare Manitoba","funders":"","keywords":"Medicine; Tumor lysis syndrome; Venetoclax; Interim analysis; Internal medicine; Ibrutinib; Chronic lymphocytic leukemia; Fludarabine; Chemoimmunotherapy; Incidence (geometry); Clinical trial; Leukemia; Chemotherapy; Cyclophosphamide","score_opus":0.00951893093795496,"score_gpt":0.3000948973313526,"score_spread":0.2905759663933976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211353714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979908,0.00061417033,0.0000073475117,0.000101065896,0.000068534064,0.000759743,0.000010907847,0.0000214895,0.00042592923],"genre_scores_gemma":[0.99725705,0.0001934019,0.0016630848,0.00053115305,0.00006139312,0.00008094314,0.000091644804,0.00003754723,0.000083796476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966711,0.00024765718,0.0008084292,0.00065396854,0.00095847563,0.00066039944],"domain_scores_gemma":[0.99828786,0.0005327459,0.00021590645,0.00048665697,0.0002506036,0.0002262256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009176444,0.00022668343,0.0005217656,0.00009115797,0.00008151668,0.000054572356,0.00013336138,0.00010499582,0.000023363062],"category_scores_gemma":[0.0013067551,0.0002163487,0.000039855346,0.0009837241,0.00011529541,0.00023919274,0.00027783215,0.00040643176,0.00000703074],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0010506217,0.00071831787,0.92680216,0.0019838875,0.0008366299,0.05364706,0.0006526454,0.0020958434,0.000018573352,0.00005843059,0.000121843295,0.012014004],"study_design_scores_gemma":[0.08903979,0.00039883758,0.8969861,0.0013677864,0.00027846472,0.0013261752,0.0005816445,0.0091775,0.0002857653,0.0000102118365,0.0002574184,0.00029029502],"about_ca_topic_score_codex":0.21268559,"about_ca_topic_score_gemma":0.37124628,"teacher_disagreement_score":0.15856071,"about_ca_system_score_codex":0.07994645,"about_ca_system_score_gemma":0.050354768,"threshold_uncertainty_score":0.95502883},"labels":[],"label_agreement":null},{"id":"W3211360047","doi":"10.1182/blood-2021-153166","title":"Preliminary Safety and Efficacy of PBCAR0191, an Allogeneic 'Off-the-Shelf' CD19-Directed CAR-T for Patients with Relapsed/Refractory (R/R) CD19+ B-ALL","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Fludarabine; Population; Internal medicine; Cyclophosphamide; Refractory (planetary science); CAR T-cell therapy; Immunology; Gastroenterology; T cell; Chemotherapy; Chimeric antigen receptor; Biology; Immune system","score_opus":0.017393008910047605,"score_gpt":0.2749539471231319,"score_spread":0.25756093821308434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211360047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951488,0.0021155642,0.000016213295,0.0002561744,0.00009103043,0.0014814893,0.00009799806,0.00008405418,0.00070868596],"genre_scores_gemma":[0.99416363,0.00063613255,0.0014502362,0.00021568904,0.00017720823,0.000077264376,0.0005282989,0.000103826926,0.0026477128],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9978689,0.00019166677,0.00039867844,0.00053992704,0.0005579769,0.000442826],"domain_scores_gemma":[0.9977774,0.0004789271,0.00013644285,0.0008441038,0.000507357,0.0002557755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003278831,0.0002539186,0.00050331815,0.000102744896,0.00012039731,0.000021412405,0.00017766011,0.00017056536,0.00022101859],"category_scores_gemma":[0.00032133807,0.00018522814,0.0001348852,0.00029325634,0.00018975988,0.00008690973,0.000108947876,0.00030566467,0.0000029083142],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040893633,0.021603929,0.25300968,0.0011984269,0.0040045474,0.0003326063,0.0049776575,0.000023768134,0.5404658,0.00010563389,0.0011642092,0.1322201],"study_design_scores_gemma":[0.05631778,0.015238303,0.8129189,0.0003288173,0.0018135834,0.00016570018,0.0003282237,0.00014918504,0.07317662,0.000043516273,0.038949095,0.0005702767],"about_ca_topic_score_codex":0.000037163885,"about_ca_topic_score_gemma":0.000044699824,"teacher_disagreement_score":0.5599092,"about_ca_system_score_codex":0.000052577758,"about_ca_system_score_gemma":0.00030929776,"threshold_uncertainty_score":0.75533843},"labels":[],"label_agreement":null},{"id":"W3211368441","doi":"10.1182/blood-2021-147837","title":"Comparative Analysis of Mature T-Cell and NK/T-Cell Lymphomas in Patients with and without HIV: Results from the NA-Accord and Complete Cohorts","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Lymphoma; Cohort; Population; Internal medicine; Diffuse large B-cell lymphoma; Oncology; Pediatrics","score_opus":0.012257262357492325,"score_gpt":0.22809761018699198,"score_spread":0.21584034782949965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211368441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954634,0.0026693447,0.000001014969,0.00014709758,0.000010387609,0.00031227508,0.00051405706,0.000006619026,0.0008758236],"genre_scores_gemma":[0.99854547,0.00022047307,0.00056063157,0.00014538364,0.000010001837,0.000012432611,0.00044573625,0.0000077152135,0.000052170624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990093,0.00006675641,0.00024293704,0.00035790258,0.00019543737,0.00012768348],"domain_scores_gemma":[0.9992253,0.00018831328,0.00013529554,0.00027715872,0.0000882364,0.0000856613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000058047564,0.00016558937,0.0006116168,0.00006350587,0.000049882336,0.000027944592,0.000031390926,0.000054440552,0.000009849778],"category_scores_gemma":[0.000013479174,0.00009898989,0.000036956415,0.0002965827,0.000105198196,0.00003572839,0.000058911228,0.00005698359,6.948576e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005389224,0.0015031555,0.99476486,0.000025655805,0.0010056567,0.00004290526,0.0015594254,0.0000028174197,0.0003349761,0.000008479375,0.0000768186,0.00013633653],"study_design_scores_gemma":[0.024351276,0.00026851415,0.96700615,0.000111410336,0.003469591,0.000005753362,0.00045832468,0.00009667439,0.004011085,0.0000068331037,0.00011234184,0.000102058446],"about_ca_topic_score_codex":0.00047021775,"about_ca_topic_score_gemma":0.00048207294,"teacher_disagreement_score":0.027758714,"about_ca_system_score_codex":0.000017430788,"about_ca_system_score_gemma":0.000048781734,"threshold_uncertainty_score":0.40366906},"labels":[],"label_agreement":null},{"id":"W3211377756","doi":"10.1182/blood-2021-152662","title":"DREAMM-5 Study: Investigating the Synergetic Effects of Belantamab Mafodotin Plus Inducible T-Cell Co-Stimulator Agonist (aICOS) Combination Therapy in Patients with Relapsed/Refractory Multiple Myeloma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Vancouver General Hospital","funders":"","keywords":"Tolerability; Medicine; Multiple myeloma; Oncology; Refractory (planetary science); Interim analysis; Lenalidomide; Phases of clinical research; Internal medicine; Pharmacology; Clinical trial; Adverse effect","score_opus":0.014788209068084217,"score_gpt":0.2600192719463961,"score_spread":0.2452310628783119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211377756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968034,0.0003814697,0.0000033998078,0.00006460855,0.00006244647,0.002337773,0.000018695322,0.000040178977,0.00028802562],"genre_scores_gemma":[0.9989854,0.00003641921,0.00027276267,0.00007031999,0.000028419698,0.0001595343,0.00022155906,0.00005507264,0.00017053005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99748766,0.00040703962,0.0004178079,0.00046307617,0.00080924545,0.00041517123],"domain_scores_gemma":[0.9980313,0.00068838877,0.000211824,0.0006150502,0.00025703662,0.00019635334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027507835,0.00027671093,0.0004956125,0.00016273539,0.00017342308,0.000037925638,0.00015984161,0.00010942578,0.000024427072],"category_scores_gemma":[0.00057558174,0.00018505834,0.000074870215,0.0005186693,0.00013317833,0.0001067674,0.00007443291,0.00041708694,0.000016106931],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005753497,0.014191268,0.97072506,0.00021999048,0.0003292296,0.00028488852,0.0012855345,0.000018051029,0.010292517,0.000008275158,0.00002359624,0.0020462328],"study_design_scores_gemma":[0.06791941,0.0037496744,0.8130503,0.0002664508,0.00013270268,0.00000597792,0.00033279927,0.00017521533,0.11419514,0.0000094483885,0.000016474216,0.00014639401],"about_ca_topic_score_codex":0.00032957364,"about_ca_topic_score_gemma":0.000112585214,"teacher_disagreement_score":0.15767476,"about_ca_system_score_codex":0.00012102508,"about_ca_system_score_gemma":0.00041570063,"threshold_uncertainty_score":0.754646},"labels":[],"label_agreement":null},{"id":"W3211430792","doi":"10.1182/blood-2021-154143","title":"Hypomethylating Agent (HMA) Therapy and Venetoclax (VEN) with FLT3 Inhibitor \"Triplet\" Therapy Is Highly Active in Older/Unfit Patients with FLT3 Mutated AML","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Venetoclax; Internal medicine; Regimen; Oncology; Chemotherapy regimen; Salvage therapy; Gastroenterology; Chemotherapy; Leukemia; Chronic lymphocytic leukemia","score_opus":0.017150608256754806,"score_gpt":0.2574034655527049,"score_spread":0.24025285729595008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211430792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99576265,0.0014972968,0.000014625955,0.0006124711,0.000059414084,0.0014322718,0.00004554059,0.000070253416,0.00050549646],"genre_scores_gemma":[0.99600345,0.0006728327,0.0016234497,0.00070147077,0.0001868461,0.00014243816,0.00014817675,0.000109160224,0.00041216897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99721956,0.00019034886,0.00037333646,0.0007379779,0.00083295867,0.00064578746],"domain_scores_gemma":[0.9983001,0.00019054873,0.00016495978,0.00050530524,0.0005628763,0.00027624858],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022811169,0.00038641118,0.0005916795,0.00028256528,0.0001320939,0.00006894709,0.0001373629,0.00018553475,0.00016407187],"category_scores_gemma":[0.000111951646,0.0002766191,0.00006490693,0.001104416,0.00015598658,0.00018952752,0.000084013845,0.00066778343,0.000019438143],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012276906,0.0057435026,0.6873661,0.0003078095,0.0029023034,0.003079147,0.017098136,0.000038168622,0.10375025,0.000033328004,0.0012463556,0.16615798],"study_design_scores_gemma":[0.059304483,0.0029974994,0.60697085,0.00048888684,0.00009681175,0.000076941535,0.00083027594,0.000112284186,0.32629788,0.000029512637,0.0022918368,0.0005027511],"about_ca_topic_score_codex":0.0002190091,"about_ca_topic_score_gemma":0.000058750436,"teacher_disagreement_score":0.22254762,"about_ca_system_score_codex":0.0003771802,"about_ca_system_score_gemma":0.00094140554,"threshold_uncertainty_score":0.9999686},"labels":[],"label_agreement":null},{"id":"W3211442768","doi":"10.1182/blood-2021-147593","title":"Outcomes for Patients with Late-Stage Mutant-<i>IDH2</i> (m <i>IDH2</i>) Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) Treated with Enasidenib Vs Other Lower-Intensity Therapies in the Randomized, Phase 3 IDHentify Trial","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"IDH2; Myeloid leukemia; Refractory (planetary science); Medicine; Stage (stratigraphy); Internal medicine; Oncology; Leukemia; Mutant; Cancer research; IDH1; Biology; Genetics; Gene","score_opus":0.00856959204541249,"score_gpt":0.24006863027496794,"score_spread":0.23149903822955545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211442768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964069,0.00024072787,0.00029863842,0.000244663,0.0001854054,0.0021267398,0.00021962688,0.000031508822,0.00024575586],"genre_scores_gemma":[0.9952441,0.00013172824,0.0003944784,0.0013987455,0.00014935495,0.00037065166,0.0005793416,0.000061629275,0.0016700011],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980046,0.00029900155,0.0004512667,0.0005645296,0.0003158258,0.00036474952],"domain_scores_gemma":[0.99863666,0.00011695969,0.00027628674,0.0006200536,0.00027352152,0.000076501296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040392668,0.0003732022,0.0006172715,0.000059983406,0.00014679061,0.000092309456,0.00025375668,0.00021480114,0.000035389974],"category_scores_gemma":[0.00019505495,0.00021469156,0.00026924186,0.00018074174,0.00019348248,0.000023721268,0.000051230538,0.00020799207,0.0000045074307],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8537127,0.005367518,0.016266178,0.00005077543,0.0025930188,0.00015095393,0.00060912385,0.000013948013,0.11945703,0.000074895106,0.000998071,0.00070583675],"study_design_scores_gemma":[0.68600607,0.0022615422,0.00056370464,0.000043076045,0.00039564355,0.000008061128,0.0001359732,0.000009622141,0.29881173,0.000021381642,0.01133902,0.00040416335],"about_ca_topic_score_codex":0.000061450344,"about_ca_topic_score_gemma":0.00017350423,"teacher_disagreement_score":0.1793547,"about_ca_system_score_codex":0.00002851143,"about_ca_system_score_gemma":0.00020456179,"threshold_uncertainty_score":0.8754868},"labels":[],"label_agreement":null},{"id":"W3211445741","doi":"10.1182/blood-2021-145491","title":"KDM6 Demethylases Integrate DNA Repair Gene Regulation: Loss of KDM6A Sensitizes AML to PARP Inhibition and Potentiates with BCL2 Blockade","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Cancer research; Myeloid leukemia; DNA repair; Synthetic lethality; Biology; Carcinogenesis; Leukemia; Small hairpin RNA; DNA damage; PARP inhibitor; Gene knockdown; Poly ADP ribose polymerase; Cancer; Genetics; Gene; DNA; Polymerase","score_opus":0.011444731214741787,"score_gpt":0.24903668557681397,"score_spread":0.23759195436207217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211445741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99578834,0.0007174283,0.00032774245,0.0022864428,0.000025558345,0.00033030793,0.000030563053,0.00009865877,0.0003949528],"genre_scores_gemma":[0.98318815,0.00017325861,0.015216011,0.00025413863,0.0001933224,0.000018671553,0.00011511022,0.000034982615,0.0008063807],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984563,0.00012082149,0.00031523017,0.0004212863,0.00039770806,0.00028867132],"domain_scores_gemma":[0.998621,0.00012499033,0.000085625856,0.00040020034,0.00055501907,0.00021319446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002535626,0.00017894286,0.0003876077,0.0001643905,0.00007375299,0.000022362796,0.000038652634,0.00010817089,0.000080742],"category_scores_gemma":[0.00030962322,0.00014474112,0.0000767206,0.000518732,0.00015069127,0.00007737764,0.00010943852,0.00019348439,0.000012258714],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047539335,0.00038053407,0.017255988,0.00026222665,0.00041867347,0.0017253339,0.00040073408,0.000023059243,0.97729254,0.00013381569,0.000694074,0.00093765504],"study_design_scores_gemma":[0.0034321928,0.00056320394,0.037983526,0.00030971848,0.00036667177,0.001683583,0.00042771845,0.00015820119,0.9544109,0.00012575336,0.00038242262,0.00015610969],"about_ca_topic_score_codex":0.000069666916,"about_ca_topic_score_gemma":0.00007716546,"teacher_disagreement_score":0.022881614,"about_ca_system_score_codex":0.000051382183,"about_ca_system_score_gemma":0.00030608886,"threshold_uncertainty_score":0.59023714},"labels":[],"label_agreement":null},{"id":"W3211450144","doi":"10.1182/blood-2021-148254","title":"Characteristics of High-Risk Polycythemia Vera Patients with Suboptimal Response to First-Line Therapy Who Switched to Ruxolitinib Vs Those Who Did Not Switch: Findings from PV-Switch, a Multinational, Retrospective Chart Review Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Polycythemia vera; Internal medicine; Ruxolitinib; Pediatrics; Myelofibrosis; Bone marrow","score_opus":0.01568797078002976,"score_gpt":0.27255795313385495,"score_spread":0.2568699823538252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211450144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893769,0.0005372364,0.000033015458,0.00458724,0.00009660205,0.0036139155,0.0016770702,0.00005311944,0.000024892113],"genre_scores_gemma":[0.99133444,0.0025944407,0.0018324547,0.0024962872,0.00018604627,0.000771254,0.00044041913,0.00008788861,0.00025674695],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963452,0.00025976103,0.000871095,0.0010116453,0.0010514898,0.00046078354],"domain_scores_gemma":[0.99638087,0.0006493095,0.0003993757,0.00084556756,0.0013143804,0.0004105048],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004999012,0.0005565879,0.0015496823,0.00017325176,0.00020165282,0.000049891434,0.00018559623,0.000104674684,0.00037800334],"category_scores_gemma":[0.0016661301,0.00042685185,0.00018215114,0.00064608606,0.000041228486,0.00010266177,0.00014433626,0.00033118736,0.000054253782],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013918406,0.01106336,0.9664405,0.00012588104,0.0011266824,0.00022396739,0.004522583,0.0000014900768,0.0011402828,0.000023363425,0.00035223382,0.0010612794],"study_design_scores_gemma":[0.018813934,0.009587029,0.9314897,0.002943119,0.00083314034,0.00000832908,0.000122024394,0.000005843974,0.035122544,0.000008649589,0.0006777284,0.00038793692],"about_ca_topic_score_codex":0.00024128504,"about_ca_topic_score_gemma":0.00008379068,"teacher_disagreement_score":0.034950748,"about_ca_system_score_codex":0.00020619012,"about_ca_system_score_gemma":0.00028799038,"threshold_uncertainty_score":0.9998183},"labels":[],"label_agreement":null},{"id":"W3211456396","doi":"10.1182/blood-2021-147813","title":"Pharmacist Integration into the Hemophilia Treatment Centre: A Canadian Pilot Project to Optimize Treatment and Improve Cost-Savings Using Pharmacokinetic Assessments of Hemophilia Patients","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Blood Services; University of Ottawa; Children's Hospital of Eastern Ontario","funders":"","keywords":"Medicine; Pharmacist; Formulary; Context (archaeology); Health care; Intensive care medicine; Pharmacy; Family medicine","score_opus":0.05875020322709027,"score_gpt":0.36703644830505944,"score_spread":0.30828624507796915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211456396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99350446,0.00034920944,0.000010007086,0.001706234,0.00017908453,0.0033837145,0.00014090454,0.00002588094,0.00070047297],"genre_scores_gemma":[0.99364185,0.00060026813,0.0024112172,0.00026727523,0.00013726832,0.00021705253,0.00024550187,0.00004707417,0.0024324644],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99792236,0.00014660081,0.00041405926,0.00057352183,0.0003892911,0.0005541954],"domain_scores_gemma":[0.99849135,0.000086209344,0.00010143828,0.000418973,0.00037432928,0.0005276938],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001331728,0.00038862787,0.00049666455,0.0002467164,0.00024300847,0.00006870036,0.00010681374,0.00007391472,0.00009655783],"category_scores_gemma":[0.00007191033,0.00024623386,0.00013489401,0.0004951375,0.00009789866,0.000093912546,0.000070088965,0.0001352633,0.000013323758],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022057486,0.019368771,0.23556502,0.00037652426,0.0036020975,0.0009821713,0.011238365,0.000040246625,0.44720125,0.000036053654,0.00046744724,0.2789163],"study_design_scores_gemma":[0.04867273,0.0098601505,0.012580393,0.00040715295,0.0037525727,0.00015840531,0.0010328552,0.0038747184,0.91139543,0.000037025413,0.0075634685,0.0006650822],"about_ca_topic_score_codex":0.028544499,"about_ca_topic_score_gemma":0.0059219846,"teacher_disagreement_score":0.4641942,"about_ca_system_score_codex":0.0010214237,"about_ca_system_score_gemma":0.0011983362,"threshold_uncertainty_score":0.999999},"labels":[],"label_agreement":null},{"id":"W3211480515","doi":"10.1182/blood-2021-148709","title":"<i>In Vivo</i> Delivery of a CD20 CAR Using a CD8-Targeted Fusosome in Southern Pig-Tail Macaques (<i>M. nemestrina</i>) Results in B Cell Depletion","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biology; CD8; Ex vivo; In vivo; Chimeric antigen receptor; Gene delivery; T cell; Immunology; Transduction (biophysics); B cell; Cell biology; Genetic enhancement; Molecular biology; Antigen; Immune system; Antibody; Biochemistry","score_opus":0.02224595986032634,"score_gpt":0.27137122919723045,"score_spread":0.2491252693369041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211480515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947587,0.0018539145,0.0000038419776,0.00027764126,0.000054135948,0.0004935456,0.00006700845,0.0000253119,0.0024658802],"genre_scores_gemma":[0.99676555,0.0004284846,0.0006660163,0.00017376067,0.00010841046,0.000021501353,0.00003566617,0.00004983497,0.0017507952],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997534,0.00028854387,0.0006909228,0.0004895722,0.00048524162,0.00051176734],"domain_scores_gemma":[0.9989882,0.00014694704,0.00011964752,0.0004675733,0.0001608364,0.00011675957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005226695,0.00020927905,0.00053545006,0.00048667268,0.000021546386,0.000017203103,0.00013603066,0.00020034098,0.00034253713],"category_scores_gemma":[0.0001522118,0.00022439974,0.00012140655,0.0011836062,0.000064207685,0.000093442875,0.00010166613,0.0004829036,0.000014269923],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010446194,0.0013282349,0.07790306,0.00021204352,0.000028606493,0.0016406203,0.0021735206,0.00006074212,0.91527057,0.0000038934436,0.000050025308,0.00028409017],"study_design_scores_gemma":[0.025867142,0.00041153526,0.009407092,0.0007022154,0.00008452427,0.00013643755,0.0025912295,0.00067032996,0.9587189,0.00009901687,0.0009822107,0.00032939634],"about_ca_topic_score_codex":0.006455986,"about_ca_topic_score_gemma":0.0036871487,"teacher_disagreement_score":0.06849597,"about_ca_system_score_codex":0.00016611899,"about_ca_system_score_gemma":0.00050815346,"threshold_uncertainty_score":0.97595626},"labels":[],"label_agreement":null},{"id":"W3211499988","doi":"10.1182/blood-2021-153560","title":"Long-Term Survival Benefit of Eculizumab Treatment in Patients with Paroxysmal Nocturnal Hemoglobinuria: Data from the International PNH Registry","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Eculizumab; Medicine; Paroxysmal nocturnal hemoglobinuria; Internal medicine; Population; Hemoglobinuria; Proportional hazards model; Cohort; Disease registry; Pediatrics; Anemia; Disease; Immunology","score_opus":0.02453686445795158,"score_gpt":0.25211920045868375,"score_spread":0.22758233600073216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211499988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947711,0.001426543,0.000005587077,0.0001592106,0.00049738865,0.00020317125,0.0026513436,0.000011754989,0.0002738872],"genre_scores_gemma":[0.9930619,0.00002109362,0.000036669222,0.000025415784,0.000059870352,0.000014009228,0.0065111835,0.000009585414,0.00026030143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899757,0.00010854948,0.00029588485,0.00033690696,0.000090828005,0.0001702344],"domain_scores_gemma":[0.9987437,0.00015188864,0.0001651359,0.0008414745,0.00008205901,0.00001573123],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00006355688,0.00014278258,0.0002287419,0.000021804362,0.000050355662,0.000020321744,0.00063390005,0.00006354841,0.0011754683],"category_scores_gemma":[0.00004396913,0.000095109164,0.000047447764,0.00006458654,0.000072143695,0.00006750955,0.0003274165,0.000086565706,0.00003098814],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003051672,0.0016363619,0.99527574,0.000008217956,0.0008403362,0.000036726364,0.000082699444,0.0000030843878,0.0010228214,0.00003941256,0.00031530397,0.0004341222],"study_design_scores_gemma":[0.009534175,0.00012286851,0.9831653,0.000095766874,0.0001920259,0.00001496962,0.00010657547,6.447484e-7,0.005924413,0.000019803692,0.0007203371,0.00010309819],"about_ca_topic_score_codex":0.00041100002,"about_ca_topic_score_gemma":0.0025869736,"teacher_disagreement_score":0.012110424,"about_ca_system_score_codex":0.000050404953,"about_ca_system_score_gemma":0.0001355241,"threshold_uncertainty_score":0.9997376},"labels":[],"label_agreement":null},{"id":"W3211507089","doi":"10.1182/blood-2021-154105","title":"Prognostic Value of Measurable Residual Disease Assessed By Multiparameter Flowcytometry in Patients with NPM1-Mutated Acute Myeloid Leukemia","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"NPM1; Medicine; Cytarabine; Minimal residual disease; Internal medicine; Myeloid leukemia; Oncology; Induction chemotherapy; Leukemia; Chemotherapy; Myeloid; Chemotherapy regimen; Hematopoietic stem cell transplantation; Gastroenterology; Transplantation; Immunology; Biology","score_opus":0.009517854523805356,"score_gpt":0.25448540588338026,"score_spread":0.2449675513595749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211507089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976318,0.0003540428,0.00006733243,0.00021912467,0.00004305679,0.0010605075,0.00022266568,0.000070234426,0.000331262],"genre_scores_gemma":[0.99387556,0.000038274782,0.0043182042,0.00017787852,0.000039526196,0.00009674244,0.0008140915,0.00008485101,0.00055487145],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965838,0.00027298572,0.0005434889,0.00066290906,0.0012559775,0.00068084284],"domain_scores_gemma":[0.99758947,0.00034708853,0.00014275563,0.0007304203,0.00071766484,0.00047262618],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035208548,0.0003207594,0.00068887323,0.00033737184,0.00005950811,0.00004028121,0.0002255756,0.00016973118,0.00010245509],"category_scores_gemma":[0.001638098,0.00026513624,0.00009788221,0.0015293236,0.00015478108,0.00019843194,0.00014400519,0.0006048484,0.00003169226],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021490117,0.0032293715,0.9557936,0.0003752891,0.0007984721,0.0011784635,0.00011475034,0.00006203797,0.034677643,0.0000067865294,0.0012670404,0.00034754045],"study_design_scores_gemma":[0.026107274,0.0007278051,0.84689766,0.0004820824,0.0009752716,0.000028384808,0.00006641902,0.0006617295,0.12362301,0.000017271457,0.00008096705,0.00033210602],"about_ca_topic_score_codex":0.00011898255,"about_ca_topic_score_gemma":0.00001198651,"teacher_disagreement_score":0.10889591,"about_ca_system_score_codex":0.00043472715,"about_ca_system_score_gemma":0.0023517287,"threshold_uncertainty_score":0.9999801},"labels":[],"label_agreement":null},{"id":"W3211510829","doi":"10.1182/blood-2021-150573","title":"A Phase II Study of 5-Azacytidine (AZA) and Venetoclax As Maintenance Therapy in Patients with Acute Myeloid Leukemia (AML) in Remission","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Venetoclax; Myeloid leukemia; Complete remission; Medicine; Azacitidine; Internal medicine; Leukemia; Maintenance therapy; Cytarabine; Oncology; Chemotherapy; Chemistry; Chronic lymphocytic leukemia","score_opus":0.012592767777018697,"score_gpt":0.2914724844513646,"score_spread":0.2788797166743459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211510829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978939,0.0003265429,0.000002317038,0.0001811565,0.000017908578,0.0011970877,0.0000103793855,0.000017943881,0.000352752],"genre_scores_gemma":[0.9984279,0.0004625886,0.00034059514,0.00012947118,0.000029455865,0.000060088543,0.000040069863,0.00003747998,0.0004723248],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981025,0.00011760266,0.00039080152,0.00048064004,0.0005278974,0.00038056308],"domain_scores_gemma":[0.9989673,0.000059521615,0.00010361524,0.0004839804,0.00022447313,0.00016113206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002781733,0.00020563496,0.0005170618,0.00022582812,0.000049868708,0.000010616036,0.00012546586,0.00010309045,0.000046581135],"category_scores_gemma":[0.00016692623,0.00015574224,0.00003140692,0.0007556794,0.000072520816,0.00009460229,0.00016530216,0.00043956135,0.0000025214342],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016113821,0.023498222,0.80557775,0.00014988898,0.0005755829,0.0047673695,0.005829443,0.000017466893,0.109292105,0.000021010706,0.0003240766,0.033833236],"study_design_scores_gemma":[0.29796562,0.038507804,0.5589878,0.0009237032,0.00017196557,0.00017475574,0.0016212949,0.0002022052,0.10041659,0.00005054461,0.00060192525,0.0003758014],"about_ca_topic_score_codex":0.0003618202,"about_ca_topic_score_gemma":0.00012517878,"teacher_disagreement_score":0.2818518,"about_ca_system_score_codex":0.000470231,"about_ca_system_score_gemma":0.0012624358,"threshold_uncertainty_score":0.6350984},"labels":[],"label_agreement":null},{"id":"W3211521877","doi":"10.1182/blood-2021-148062","title":"Rivaroxaban for Improvement in Thromboembolism Outcomes in Patients with Multiple Myeloma on Lenalidomide-Based Therapy: The Rithmm Feasibility Pilot Trial","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Victoria Hospital; Health Sciences Centre; Ottawa Hospital; PROTO Manufacturing (Canada); Dalhousie University; University of Ottawa; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Rivaroxaban; Lenalidomide; Internal medicine; Surgery; Randomized controlled trial; Randomization; Adverse effect; Multiple myeloma; Warfarin; Atrial fibrillation","score_opus":0.04579526784693528,"score_gpt":0.3123710177476709,"score_spread":0.2665757499007356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211521877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926375,0.00005234563,0.000011035154,0.0010361301,0.00009100475,0.005945788,0.00011809002,0.00002640319,0.00008168021],"genre_scores_gemma":[0.9976913,0.000007808586,0.0005249656,0.000591604,0.00006594328,0.0008506482,0.00016921057,0.000034664674,0.00006390212],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978393,0.00017447161,0.00039567117,0.00051085214,0.00058474287,0.00049499475],"domain_scores_gemma":[0.99834687,0.0005789314,0.000088708126,0.000649667,0.0002020439,0.00013376142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003916985,0.00026096366,0.0005723304,0.000121803845,0.000092204034,0.000036162095,0.00013444824,0.00006538362,0.00004188912],"category_scores_gemma":[0.0006898971,0.00014502114,0.00013995614,0.00024607955,0.00007169167,0.000054101336,0.000038018396,0.00023678015,0.000006103742],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06579451,0.022240631,0.9052373,0.00004020077,0.0002538146,0.000050405022,0.00008919825,0.000004716029,0.0005422865,0.000014461275,0.000015109096,0.005717359],"study_design_scores_gemma":[0.34175438,0.0054563535,0.6398189,0.000053327436,0.00003731042,4.0698131e-7,0.000029951489,0.000039665912,0.012629096,0.000049902163,0.000031981122,0.000098748096],"about_ca_topic_score_codex":0.000360188,"about_ca_topic_score_gemma":0.0010910921,"teacher_disagreement_score":0.27595985,"about_ca_system_score_codex":0.00015818863,"about_ca_system_score_gemma":0.00031689662,"threshold_uncertainty_score":0.59137905},"labels":[],"label_agreement":null},{"id":"W3211527733","doi":"10.1182/blood-2021-154279","title":"Venetoclax, Obinutuzumab and Atezolizumab (PD-L1 Checkpoint Inhibitor) for Treatment for Patients with Richter Transformation","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Atezolizumab; Venetoclax; Obinutuzumab; Medicine; Internal medicine; Oncology; Pembrolizumab; Rituximab; Cancer; Immunotherapy; Lymphoma; Leukemia; Chronic lymphocytic leukemia","score_opus":0.015558274020095164,"score_gpt":0.2694863837476252,"score_spread":0.25392810972753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211527733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962096,0.00037434502,0.00042709272,0.00017783305,0.00005712655,0.002226921,0.0000877049,0.000035733818,0.00040359728],"genre_scores_gemma":[0.995398,0.00008178636,0.0027548692,0.00006718572,0.00017193778,0.00053901516,0.00046341564,0.00004072177,0.00048308496],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9988112,0.000016667866,0.00026064002,0.00030680178,0.00025743502,0.00034728993],"domain_scores_gemma":[0.9991813,0.00010106642,0.000051346848,0.00024642205,0.00027117252,0.00014873239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007667668,0.00017613432,0.00030457057,0.000058639707,0.000092926646,0.00003366004,0.00003637813,0.00009515515,0.000019207657],"category_scores_gemma":[0.00005663399,0.000128906,0.000100622856,0.000108123146,0.000044491404,0.00009581552,0.000016022705,0.000042299835,0.0000053697886],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1310782,0.04707099,0.027500883,0.032476258,0.019679392,0.0014890251,0.079659484,0.00052493287,0.05821583,0.005726093,0.008315388,0.5882635],"study_design_scores_gemma":[0.60388225,0.013500769,0.0074174744,0.00061208714,0.0018192229,0.00041855004,0.00052116776,0.007127447,0.33356667,0.0003104172,0.030222982,0.00060096546],"about_ca_topic_score_codex":0.000046950216,"about_ca_topic_score_gemma":0.00003979104,"teacher_disagreement_score":0.5876626,"about_ca_system_score_codex":0.006466165,"about_ca_system_score_gemma":0.004443644,"threshold_uncertainty_score":0.99734783},"labels":[],"label_agreement":null},{"id":"W3211544433","doi":"10.1182/blood-2021-151313","title":"Impact of Age, Body Surface Area, and Body Mass Index on Pegaspargase Toxicity and Pharmacokinetics: A Report from the DFCI ALL Consortium","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; McMaster University","funders":"","keywords":"Medicine; Body surface area; Body mass index; Toxicity; Asparaginase; Internal medicine; Gastroenterology; Pharmacokinetics; Leukemia","score_opus":0.03065556108493981,"score_gpt":0.3327119917516591,"score_spread":0.3020564306667193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211544433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99431276,0.0020422535,0.000031562442,0.0019293657,0.0001054427,0.0003649296,0.0002170398,0.000043060976,0.00095359236],"genre_scores_gemma":[0.9975419,0.00038942395,0.00026022294,0.0012421659,0.0002123152,0.0000055878354,0.00009800053,0.000030047331,0.00022030674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980409,0.00018674393,0.00052423956,0.00049716135,0.00047421976,0.000276742],"domain_scores_gemma":[0.9981236,0.0005233937,0.00027024696,0.0006708718,0.00013953746,0.00027236858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004731143,0.0002500227,0.0005732316,0.00003120867,0.000060379785,0.000041027233,0.0000956637,0.000104718405,0.0002001481],"category_scores_gemma":[0.0005882622,0.00018826977,0.00013579678,0.00013614442,0.00019419841,0.000050799365,0.000102594626,0.00034001193,0.000002530366],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038635771,0.001487905,0.87116504,0.000090503265,0.0012745396,0.0024244343,0.0009918016,0.000011692068,0.11804382,0.000011024341,0.004022908,0.000089952875],"study_design_scores_gemma":[0.007590831,0.00048528909,0.9207674,0.00023142793,0.0008861104,0.0006238693,0.00030452677,0.00011569813,0.06775355,0.00016358147,0.0008387387,0.00023896748],"about_ca_topic_score_codex":0.0022187366,"about_ca_topic_score_gemma":0.0002208386,"teacher_disagreement_score":0.050290264,"about_ca_system_score_codex":0.000028110308,"about_ca_system_score_gemma":0.00025911443,"threshold_uncertainty_score":0.76774186},"labels":[],"label_agreement":null},{"id":"W3211546201","doi":"10.1182/blood-2021-148049","title":"Matching Adjusted Indirect Comparison (MAIC) of Oral Azacitidine (Oral-AZA) Versus Injectable AZA in Patients (pts) with Acute Myeloid Leukemia (AML) in First Remission after Intensive Induction Chemotherapy","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Tolerability; Internal medicine; Azacitidine; Adverse effect; Placebo; Oncology; Chemotherapy regimen; Chemotherapy; Induction chemotherapy; Gastroenterology; Pathology","score_opus":0.023330634514462,"score_gpt":0.2813407140878673,"score_spread":0.2580100795734053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211546201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99778134,0.00020993725,0.00002691305,0.0005538121,0.00015293121,0.00079353567,0.00002344176,0.00005757341,0.0004004898],"genre_scores_gemma":[0.99643457,0.00017628001,0.0024221386,0.00022199037,0.000064199914,0.000076514996,0.0002777803,0.00008431446,0.00024219732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99702156,0.00018279123,0.0007175811,0.0006753606,0.00075520785,0.00064747524],"domain_scores_gemma":[0.99821377,0.00010881234,0.0002495004,0.00054049405,0.00068578124,0.00020167058],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036314066,0.00037698096,0.0010293276,0.000587085,0.00006540818,0.000031065567,0.00018100567,0.00034506276,0.00016650384],"category_scores_gemma":[0.00025147884,0.00033189973,0.00009676721,0.0016579252,0.000120402656,0.00030240588,0.00017401508,0.0010977613,0.000015087008],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0364716,0.0031018662,0.8757926,0.0006124906,0.0010840851,0.0015273632,0.009809698,0.00020905853,0.056279644,0.0000090235435,0.001451958,0.013650593],"study_design_scores_gemma":[0.07171632,0.002647862,0.5677042,0.002001724,0.00038840555,0.00013997196,0.003884415,0.00042276064,0.34986708,0.000028825763,0.00061627285,0.00058216345],"about_ca_topic_score_codex":0.0015883909,"about_ca_topic_score_gemma":0.0018550213,"teacher_disagreement_score":0.30808842,"about_ca_system_score_codex":0.0013045839,"about_ca_system_score_gemma":0.00086769793,"threshold_uncertainty_score":0.9999133},"labels":[],"label_agreement":null},{"id":"W3211546461","doi":"10.1182/blood-2021-147711","title":"Durability of Hemoglobin Response and Reduction in Transfusion Burden Is Maintained over Time in Patients with Pyruvate Kinase Deficiency Treated with Mitapivat in a Long-Term Extension Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Pyruvate kinase; Pyruvate kinase deficiency; Medicine; Hemoglobin; Reduction (mathematics); Internal medicine; Glycolysis; Metabolism; Mathematics","score_opus":0.006517483601372284,"score_gpt":0.2251161484014277,"score_spread":0.21859866480005544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211546461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99883235,0.000060905473,0.0000016590897,0.00013518454,0.000015245956,0.0009197585,0.0000067868873,0.000015061754,0.000013070053],"genre_scores_gemma":[0.9997342,0.000021801103,0.000060547627,0.000032607877,0.000007729892,0.00001893618,0.0000367333,0.000014097992,0.00007332143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851984,0.00032855838,0.0003278223,0.0004531913,0.00019151556,0.00017906513],"domain_scores_gemma":[0.99941355,0.00005253991,0.000067837376,0.00028722046,0.00012382006,0.000055010227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027396082,0.00015472838,0.00038344847,0.00023913357,0.000023030969,0.000004184398,0.000026061054,0.00008773282,0.00007951413],"category_scores_gemma":[0.00007540941,0.00011621098,0.00002393143,0.00070003746,0.000075321914,0.00006827845,0.000021042673,0.00016110932,0.0000015250783],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024075033,0.0047088596,0.7823823,0.00006695448,0.0000131029165,0.00031201428,0.0014626372,0.00000951931,0.18667398,3.1587092e-7,0.000001335467,0.00029391702],"study_design_scores_gemma":[0.026990645,0.0046668635,0.9545656,0.000328561,0.000072443305,0.000033558696,0.00044555176,0.000026848918,0.01275232,0.000004938335,3.3271021e-7,0.00011238032],"about_ca_topic_score_codex":0.00027723226,"about_ca_topic_score_gemma":0.0003084739,"teacher_disagreement_score":0.17392167,"about_ca_system_score_codex":0.00007159698,"about_ca_system_score_gemma":0.000093164665,"threshold_uncertainty_score":0.4738946},"labels":[],"label_agreement":null},{"id":"W3211551470","doi":"10.1182/blood-2021-146160","title":"A Novel Methodology for Building Longitudinal, Patient-Centric Real World Datasets in Hemophilia A","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Haemophilia; Medicine; Outreach; Population; Health care; Family medicine; Pediatrics","score_opus":0.1328388665052531,"score_gpt":0.3910315950003591,"score_spread":0.258192728495106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211551470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952371,0.0008905594,0.0003718435,0.001718357,0.00012459669,0.0006843055,0.00022655899,0.00003376987,0.00071289676],"genre_scores_gemma":[0.8958857,0.00028851305,0.10081025,0.0002309603,0.0002751941,0.00016935526,0.0010573125,0.0000423523,0.001240323],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99848855,0.0000890528,0.00028445083,0.0004377852,0.00022559291,0.0004745434],"domain_scores_gemma":[0.9988332,0.0005017126,0.00004657643,0.0003643802,0.000094459814,0.00015969982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003533839,0.00014609347,0.00038837854,0.00031354197,0.00006318521,0.000016812752,0.00008204438,0.00008574399,0.000107510175],"category_scores_gemma":[0.00062994816,0.00012302464,0.00010676117,0.0007551135,0.00004287992,0.000050864222,0.00011264026,0.00018891023,0.000016760481],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001235942,0.013685313,0.64022136,0.0009044282,0.0009755708,0.006398465,0.0005328539,0.00000772653,0.29834,0.0031604732,0.0066648237,0.027873073],"study_design_scores_gemma":[0.0690607,0.0019373304,0.21845768,0.0009504341,0.0017974362,0.002082874,0.00047372672,0.00052307977,0.66056496,0.0017369298,0.041409746,0.0010050875],"about_ca_topic_score_codex":0.00011810124,"about_ca_topic_score_gemma":0.000273991,"teacher_disagreement_score":0.42176366,"about_ca_system_score_codex":0.00006846307,"about_ca_system_score_gemma":0.00022994478,"threshold_uncertainty_score":0.50167996},"labels":[],"label_agreement":null},{"id":"W3211568627","doi":"10.1182/blood-2021-146570","title":"Three-Year Follow-up of the Ascend Trial: Acalabrutinib Vs Rituximab Plus Idelalisib or Bendamustine in Relapsed/Refractory Chronic Lymphocytic Leukemia","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saint John Regional Hospital; University of New Brunswick","funders":"","keywords":"Bendamustine; Medicine; Idelalisib; Rituximab; Internal medicine; Chronic lymphocytic leukemia; Gastroenterology; Fludarabine; Progression-free survival; Neutropenia; Oncology; Ibrutinib; Toxicity; Chemotherapy; Leukemia; Lymphoma","score_opus":0.032711779869195344,"score_gpt":0.3020224346088241,"score_spread":0.2693106547396288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211568627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917097,0.003163396,0.00001777764,0.0003593944,0.00089433487,0.0015779199,0.000048202164,0.000100518766,0.0021287343],"genre_scores_gemma":[0.99259293,0.00043073893,0.00033967927,0.00024246996,0.000760708,0.000111316665,0.000047317,0.00012567919,0.0053491374],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9950754,0.00026563802,0.0012285543,0.0008838694,0.0015009949,0.0010455509],"domain_scores_gemma":[0.9962826,0.00077316683,0.00033294395,0.0019379434,0.00035875136,0.00031463124],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009810036,0.0004546497,0.0013452609,0.00023826331,0.00013115013,0.000044033037,0.0006769461,0.0004996049,0.0010739925],"category_scores_gemma":[0.003059707,0.00032036143,0.00047789686,0.0015779979,0.00039094387,0.00011678411,0.00061379216,0.0009472474,0.00014743026],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.64449203,0.027176972,0.010707217,0.023106838,0.0103245815,0.039508995,0.010769118,0.003301082,0.11766433,0.008174362,0.07317964,0.031594828],"study_design_scores_gemma":[0.9454523,0.0015570879,0.0016482136,0.001440117,0.0007891716,0.0010083851,0.0002802179,0.0066049783,0.034528084,0.00015931403,0.0060817185,0.00045044004],"about_ca_topic_score_codex":0.002312965,"about_ca_topic_score_gemma":0.0035518764,"teacher_disagreement_score":0.30096024,"about_ca_system_score_codex":0.051137112,"about_ca_system_score_gemma":0.12941019,"threshold_uncertainty_score":0.99992484},"labels":[],"label_agreement":null},{"id":"W3211572770","doi":"10.1182/blood-2021-145362","title":"Impact of <i>FLT3</i> Mutation Clearance after Front-Line Treatment with Gilteritinib Plus Azacitidine, or Gilteritinib or Azacitidine Alone in Patients with Newly Diagnosed AML: Results from the Phase 2/3 Lacewing Trial","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Azacitidine; Internal medicine; Surgery; Gastroenterology; Chemotherapy; Biology","score_opus":0.029041214357268787,"score_gpt":0.31476356714797715,"score_spread":0.28572235279070834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211572770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937043,0.000228756,0.00010262293,0.00053705915,0.000061025876,0.002579611,0.0025819784,0.000059321414,0.00014529104],"genre_scores_gemma":[0.9921554,0.00018320467,0.0040972563,0.00021618574,0.0004966203,0.0004179624,0.0019565676,0.00010393769,0.00037290744],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99643344,0.00032155187,0.00094354706,0.00080022804,0.000829174,0.00067207805],"domain_scores_gemma":[0.99722904,0.0008343451,0.00032913164,0.0008843538,0.0004472255,0.00027591764],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029574233,0.0004956277,0.0010796429,0.00014163295,0.00009186969,0.00007239946,0.00019247433,0.0001571027,0.00035864982],"category_scores_gemma":[0.0006885353,0.00025779262,0.00018438052,0.00069014734,0.00019907755,0.00026453423,0.000075816155,0.00038881492,0.000013953047],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94151074,0.009682084,0.024143435,0.0000849837,0.0011118173,0.009920009,0.0025082517,0.00008291444,0.0023234684,8.1442397e-7,0.00024654367,0.008384913],"study_design_scores_gemma":[0.83224255,0.036226816,0.11467747,0.0013301794,0.0007325342,0.00015975618,0.00054604776,0.0002978485,0.01310484,0.000003496193,0.00024977446,0.0004286851],"about_ca_topic_score_codex":0.0020363047,"about_ca_topic_score_gemma":0.0024133504,"teacher_disagreement_score":0.10926821,"about_ca_system_score_codex":0.00049245066,"about_ca_system_score_gemma":0.0016453504,"threshold_uncertainty_score":0.9999874},"labels":[],"label_agreement":null},{"id":"W3211576181","doi":"10.1182/blood-2021-151084","title":"Impact of Compliance on Elastic Compression Stockings Efficacy to Prevent Post-Thrombotic Syndrome: A Prespecified Analysis of the Celest Double-Blind Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Post-thrombotic syndrome; Double blind; Placebo; Deep vein; Thrombosis; Compression stockings; Venous thrombosis; Internal medicine; Venous thromboembolism; Clinical trial; Intention-to-treat analysis; Surgery","score_opus":0.060707397071139764,"score_gpt":0.358018045102582,"score_spread":0.29731064803144225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211576181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99703366,0.00011670931,0.000025502026,0.00017009932,0.000088341556,0.0022102995,0.000032255593,0.00001990567,0.0003032534],"genre_scores_gemma":[0.99958485,0.00001542334,0.000071090515,0.000077069875,0.000022099275,0.000057422843,0.000022879167,0.000023527336,0.00012563296],"study_design_codex":"nonrandomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9980193,0.00012326162,0.00053107954,0.00042975877,0.00063628145,0.00026034185],"domain_scores_gemma":[0.9980673,0.00020908819,0.00027301675,0.0010180121,0.0002900714,0.00014249103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018276068,0.00022134675,0.0010744592,0.0002668405,0.00007952254,0.000020148946,0.00026905214,0.00005123505,0.00022893053],"category_scores_gemma":[0.000126162,0.00014713369,0.0004753165,0.0013870443,0.00004574358,0.000029137414,0.00026591468,0.00015955903,0.000010993604],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007045852,0.3850286,0.33690333,0.001454762,0.06106362,0.00058612326,0.013673338,0.07301666,0.1177836,0.0004898207,0.0013081937,0.0016460785],"study_design_scores_gemma":[0.010231989,0.003363982,0.9701408,0.00083795155,0.008919235,0.000010884089,0.00032037633,0.0000681842,0.0059614126,0.0000028381166,0.000012337201,0.00013000146],"about_ca_topic_score_codex":0.00024161239,"about_ca_topic_score_gemma":0.00008677268,"teacher_disagreement_score":0.6332375,"about_ca_system_score_codex":0.00006195068,"about_ca_system_score_gemma":0.000116531366,"threshold_uncertainty_score":0.59999377},"labels":[],"label_agreement":null},{"id":"W3211615499","doi":"10.1182/blood-2021-154302","title":"Prognostic Value of Elafin in Acute Graft-Versus-Host Disease","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Elafin; Medicine; Biomarker; Graft-versus-host disease; Hematopoietic stem cell transplantation; Population; Internal medicine; Immunology; Gastrointestinal tract; Oncology; Transplantation; Gastroenterology; Biology","score_opus":0.014261398814251161,"score_gpt":0.26782913280269866,"score_spread":0.2535677339884475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211615499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965706,0.0004413612,0.00009258593,0.00038298772,0.0001051829,0.00027466594,0.000028459677,0.000025180474,0.0020789972],"genre_scores_gemma":[0.9982698,0.00010845941,0.0012036787,0.00006250678,0.000030503736,0.000022334641,0.00007886552,0.000015496513,0.00020834527],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99916357,0.000042346142,0.00023561892,0.00018411063,0.00021891296,0.00015544036],"domain_scores_gemma":[0.9994183,0.00013602758,0.000038798928,0.000218484,0.000058952948,0.00012941187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000079488294,0.00008696791,0.00020173726,0.000064297055,0.00001152891,0.000004557136,0.000041439296,0.000046518588,0.00010108431],"category_scores_gemma":[0.00014730936,0.000084439765,0.00006380429,0.00025184584,0.000029324914,0.000030979805,0.000012057384,0.0000851067,0.00003292242],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008126402,0.0028672544,0.89494514,0.0016466739,0.00042711897,0.0063778674,0.0011020399,0.000009267355,0.08838735,0.0031347924,0.0000613653,0.00022849005],"study_design_scores_gemma":[0.012913221,0.00020651484,0.84343326,0.00088690576,0.0019762684,0.00013691673,0.00015753733,0.00010943338,0.13978355,0.00012963422,0.000113536815,0.00015322068],"about_ca_topic_score_codex":0.000011069344,"about_ca_topic_score_gemma":0.000012776332,"teacher_disagreement_score":0.051511876,"about_ca_system_score_codex":0.0000126145505,"about_ca_system_score_gemma":0.00022291813,"threshold_uncertainty_score":0.34433538},"labels":[],"label_agreement":null},{"id":"W3211621704","doi":"10.1182/blood-2021-146393","title":"Real-World Outcomes for Pediatric and Young Adult Patients with Relapsed or Refractory (R/R) B-Cell Acute Lymphoblastic Leukemia (ALL) Treated with Tisagenlecleucel: Update from the Center for International Blood and Marrow Transplant Research (CIBMTR) Registry","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Cytokine release syndrome; Single Center; Clinical trial; Refractory (planetary science); Hematopoietic stem cell transplantation; Oncology; Pediatrics; Immunotherapy; Transplantation; Chimeric antigen receptor","score_opus":0.0201699544481447,"score_gpt":0.2896246359916098,"score_spread":0.26945468154346514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211621704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950242,0.00017571542,0.00003153255,0.0005543951,0.00012293374,0.0016152684,0.0018661615,0.000047990987,0.0005617964],"genre_scores_gemma":[0.9797805,0.002682773,0.0017837115,0.00026796083,0.00039451072,0.00037422494,0.002214779,0.00013635764,0.0123652],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997374,0.00013920254,0.00037023667,0.00073962647,0.00081071915,0.00056620344],"domain_scores_gemma":[0.9968675,0.0010463198,0.00013348674,0.00054743415,0.0011602014,0.000245063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003194261,0.00030862784,0.0004399505,0.00018283086,0.00021342357,0.00012708559,0.00023262975,0.00013727654,0.00015848296],"category_scores_gemma":[0.0002456113,0.00018095257,0.000086779444,0.0003302635,0.00017598426,0.00012130034,0.00007387865,0.00038841192,0.0000026547689],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014308786,0.0014293247,0.97181463,0.00024278075,0.00173592,0.00035036303,0.0005042157,4.4340055e-7,0.007248244,0.000014699813,0.001800767,0.0005498097],"study_design_scores_gemma":[0.18357106,0.0054750443,0.7735795,0.0006282557,0.00588995,0.0002247313,0.0004035908,0.00021056789,0.023811923,0.00006304908,0.0053312015,0.00081113575],"about_ca_topic_score_codex":0.0004492428,"about_ca_topic_score_gemma":0.0018342269,"teacher_disagreement_score":0.19823515,"about_ca_system_score_codex":0.00015233258,"about_ca_system_score_gemma":0.0005124752,"threshold_uncertainty_score":0.7379032},"labels":[],"label_agreement":null},{"id":"W3211633668","doi":"10.1182/blood-2021-149969","title":"Antiphospholipid Antibody Profiles and Thrombotic Outcomes in the Starlet Cohort of Patients with Systemic Lupus Erythematosus","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; University of Calgary","funders":"","keywords":"Medicine; Antiphospholipid syndrome; Lupus anticoagulant; Cohort; Internal medicine; Systemic lupus erythematosus; Thrombosis; Autoantibody; Immunology; Antibody; Disease","score_opus":0.011262657769570077,"score_gpt":0.2696386112068883,"score_spread":0.25837595343731823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211633668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958189,0.0017062026,0.000008152599,0.00014318376,0.0001013075,0.0015341453,0.000039208877,0.000025337375,0.00062356493],"genre_scores_gemma":[0.9991587,0.00015761377,0.00020741393,0.000047553505,0.00002586346,0.000058232876,0.000063069616,0.000034724817,0.0002468309],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977533,0.0001842404,0.00048378573,0.00036627174,0.0008624591,0.00034990438],"domain_scores_gemma":[0.99851304,0.00027914872,0.00015237274,0.0006806214,0.00029278776,0.00008203015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004935594,0.00020954544,0.0007800956,0.00011973132,0.000047873884,0.000029935363,0.00016317882,0.00009057572,0.000023250483],"category_scores_gemma":[0.00023693015,0.00011738377,0.0000660448,0.00041907007,0.00015096288,0.00007020462,0.00008820831,0.00021098107,0.00000813894],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008404024,0.001149983,0.9927335,0.0016976948,0.00029696277,0.00022745303,0.0014805726,4.3752175e-7,0.002099783,0.00014437584,0.00007322477,0.000011992317],"study_design_scores_gemma":[0.009968187,0.00032684105,0.9688062,0.0014721267,0.0003001561,0.011714355,0.0035923223,0.000010654043,0.0036078626,0.00001879061,0.000021324267,0.00016115769],"about_ca_topic_score_codex":0.00004827003,"about_ca_topic_score_gemma":0.000015527383,"teacher_disagreement_score":0.023927258,"about_ca_system_score_codex":0.000029943008,"about_ca_system_score_gemma":0.00020751878,"threshold_uncertainty_score":0.47867712},"labels":[],"label_agreement":null},{"id":"W3211648211","doi":"10.1182/blood-2021-150092","title":"Definition and Clinical Significance of the MGUS-like Phenotype: A Study in 5,114 Patients (Pts) with Monoclonal Gammopathies","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Monoclonal gammopathy of undetermined significance; Multiple myeloma; Medicine; Monoclonal; AL amyloidosis; Pathology; Flow cytometry; Phenotype; Internal medicine; Gastroenterology; Immunology; Monoclonal antibody; Immunoglobulin light chain; Biology; Antibody; Genetics","score_opus":0.04212614470195446,"score_gpt":0.3117220646237578,"score_spread":0.2695959199218033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211648211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986306,0.00018643631,0.000002039899,0.000072416085,0.00002722792,0.00057060167,0.000017379285,0.000006356237,0.00048697044],"genre_scores_gemma":[0.9991575,0.00005246487,0.0006119586,0.000042855165,0.000020410342,0.000040071154,0.000015287784,0.000008787024,0.000050698687],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998941,0.00016222039,0.00023034458,0.00021551803,0.00030904662,0.00014187029],"domain_scores_gemma":[0.999384,0.00013864563,0.00006046363,0.00021863611,0.00012509462,0.00007320175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015482807,0.00008260299,0.00021249775,0.0000318337,0.000035866433,0.000007983961,0.000044730547,0.000035425837,0.00001753434],"category_scores_gemma":[0.00023654534,0.000049895905,0.00003664664,0.00018424587,0.000092188915,0.000029127446,0.000058204936,0.00015225164,0.0000036690146],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044447667,0.0072997776,0.9890457,0.000037627655,0.00014373423,0.00013756055,0.00019975181,2.1169052e-7,0.0000918682,0.000025676409,0.000008913482,0.0025647306],"study_design_scores_gemma":[0.014514232,0.0013755758,0.9828593,0.000088588364,0.0001424775,0.00000912587,0.00026911253,0.000012811916,0.0006118516,0.00005881857,0.000011700499,0.00004636373],"about_ca_topic_score_codex":0.00009008415,"about_ca_topic_score_gemma":0.0005354768,"teacher_disagreement_score":0.014069756,"about_ca_system_score_codex":0.000014092829,"about_ca_system_score_gemma":0.00015382581,"threshold_uncertainty_score":0.20346959},"labels":[],"label_agreement":null},{"id":"W3211674543","doi":"10.1182/blood-2021-151808","title":"Brentuximab Vedotin As Consolidation Therapy Following Autologous Stem Cell Transplantation in Children and Adolescents with Relapsed/Refractory Hodgkin Lymphoma: A Multi-Center Retrospective Analysis","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto; University of British Columbia","funders":"","keywords":"Brentuximab vedotin; Medicine; Internal medicine; Autologous stem-cell transplantation; Oncology; Salvage therapy; Transplantation; Clinical endpoint; Retrospective cohort study; Surgery; Clinical trial; Lymphoma; Chemotherapy; CD30","score_opus":0.007169298363502249,"score_gpt":0.23236415373453026,"score_spread":0.225194855371028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211674543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977236,0.0014985033,0.000051919877,0.000054290722,0.000033844284,0.00046671185,0.00003472907,0.000040788418,0.00009565459],"genre_scores_gemma":[0.99814844,0.0010274281,0.00029859776,0.00012563176,0.000018522349,0.0000462471,0.00027715685,0.000021846277,0.00003610193],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871093,0.00010962386,0.0002475176,0.00047395861,0.00024133854,0.00021660479],"domain_scores_gemma":[0.9995064,0.000023481805,0.00010833601,0.0002123539,0.00005913057,0.00009028724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000078522375,0.00020716936,0.00043416745,0.00018886081,0.000063731255,0.000036705424,0.000036360452,0.00010176009,0.000009724396],"category_scores_gemma":[0.0000054288425,0.00016837085,0.0001402484,0.00042268238,0.000028339915,0.00009727842,0.000011349591,0.0000762714,0.0000069167113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027721073,0.009631191,0.98272264,0.000026006906,0.0012319431,0.00072817475,0.000829316,0.0000028668626,0.00074562087,0.0000032556497,0.0000021962612,0.0037995744],"study_design_scores_gemma":[0.065301985,0.00043326788,0.91231674,0.000216824,0.0019183183,0.00024444508,0.00012104158,0.00003095999,0.019261023,0.0000018497869,0.000003605773,0.00014991271],"about_ca_topic_score_codex":0.0001963673,"about_ca_topic_score_gemma":0.00015597847,"teacher_disagreement_score":0.07040588,"about_ca_system_score_codex":0.00014801131,"about_ca_system_score_gemma":0.00012893102,"threshold_uncertainty_score":0.6865964},"labels":[],"label_agreement":null},{"id":"W3211684717","doi":"10.1182/blood-2021-144648","title":"Oral Decitabine/Cedazuridine in Patients with Lower Risk Myelodysplastic Syndrome: A Longer-Term Follow-up of from the Ascertain Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Health Sciences Centre; Sunnybrook Health Science Centre; Hôpital Maisonneuve-Rosemont; University of Alberta; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Decitabine; Medicine; Azacitidine; Myelodysplastic syndromes; Internal medicine; Oncology; Intensive care medicine; Bone marrow; Biology; DNA methylation","score_opus":0.010361926829314454,"score_gpt":0.24925738470902611,"score_spread":0.23889545787971167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211684717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99817705,0.00019276045,0.000016430951,0.0001428418,0.00013077034,0.0010842846,0.00010204222,0.000027292139,0.00012654392],"genre_scores_gemma":[0.9989908,0.000019508638,0.00028611996,0.000062711355,0.00005601083,0.00006479478,0.00012409066,0.000055720724,0.0003402727],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974031,0.00031048091,0.00041086596,0.00051584136,0.00090922,0.00045049985],"domain_scores_gemma":[0.9978416,0.00052947766,0.00014229877,0.00089695246,0.00042897472,0.000160716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038101798,0.00026292037,0.0006267711,0.00013030574,0.00007085053,0.000025722416,0.00028369634,0.000099290446,0.0003788054],"category_scores_gemma":[0.0012217613,0.00016599243,0.000091655646,0.000991745,0.00010986899,0.000082448736,0.00022813445,0.00058921165,0.00004477864],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015758842,0.004694371,0.989125,0.00003046839,0.0007530512,0.0018246908,0.00097131793,0.0000061647847,0.00021093585,0.0000024996114,0.0002599168,0.0005456595],"study_design_scores_gemma":[0.041506834,0.0024785162,0.95339316,0.00022987883,0.0007707148,0.000041510884,0.00075282506,0.000041637042,0.0005709738,0.000011554424,0.000029589319,0.0001727756],"about_ca_topic_score_codex":0.00043771177,"about_ca_topic_score_gemma":0.00090198504,"teacher_disagreement_score":0.03993095,"about_ca_system_score_codex":0.00012044482,"about_ca_system_score_gemma":0.00057045143,"threshold_uncertainty_score":0.67689747},"labels":[],"label_agreement":null},{"id":"W3211699349","doi":"10.1182/blood.2021012589","title":"Neutrophil and platelet increases with luspatercept in lower-risk MDS: secondary endpoints from the MEDALIST trial","year":2021,"lang":"en","type":"letter","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Center for Advancing Translational Sciences","keywords":"Medicine; Internal medicine; Clinical endpoint; Romiplostim; Platelet; Clinical trial; Thrombopoietin; Biology","score_opus":0.01509013717606393,"score_gpt":0.2427511755753923,"score_spread":0.22766103839932839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211699349","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8436882,0.0019591993,0.0000013815046,0.15074696,0.00020101319,0.0013092663,0.0010948819,0.000052912215,0.0009461901],"genre_scores_gemma":[0.19509089,0.0058002686,0.0011748384,0.74312496,0.036139082,0.00074680016,0.012401781,0.00069084164,0.0048305257],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99629986,0.0006857514,0.0004870222,0.000971196,0.000871238,0.00068494154],"domain_scores_gemma":[0.99709606,0.0012271787,0.00023273106,0.0011509332,0.000115646784,0.00017742525],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043596723,0.000562708,0.0011196486,0.00020234157,0.00012670107,0.000150947,0.0004166928,0.0009076772,0.0012392374],"category_scores_gemma":[0.0004321873,0.00035259232,0.00016150082,0.00030180434,0.00039123857,0.000092012255,0.00036249676,0.0055815745,0.000044382967],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020014899,0.00067439326,0.0058743716,0.0003073212,0.0015542406,0.064739235,0.00057600794,4.2945499e-7,0.0002937153,0.0000013051102,0.90293926,0.0030248428],"study_design_scores_gemma":[0.290454,0.0030488425,0.020025097,0.0018108035,0.002232625,0.0023434155,0.00041729992,0.000017490856,0.0015645431,0.00009931762,0.67682964,0.0011569229],"about_ca_topic_score_codex":0.009141754,"about_ca_topic_score_gemma":0.001277895,"teacher_disagreement_score":0.6485973,"about_ca_system_score_codex":0.00017095641,"about_ca_system_score_gemma":0.0013165232,"threshold_uncertainty_score":0.9998926},"labels":[],"label_agreement":null},{"id":"W3211702719","doi":"10.1182/blood-2021-150013","title":"Impact of COVID-19 Pandemic on Global Unrelated Stem Cell Donations in 2020 - Report from World Marrow Donor Association","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services","funders":"","keywords":"Stem cell; Pandemic; Medicine; Population; Coronavirus disease 2019 (COVID-19); Cord blood; Haematopoiesis; Hematopoietic stem cell transplantation; Bone marrow; Transplantation; Immunology; Internal medicine; Demography; Biology; Environmental health; Disease; Infectious disease (medical specialty); Genetics","score_opus":0.02858895723609532,"score_gpt":0.3292038226987494,"score_spread":0.3006148654626541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211702719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899044,0.00040276648,0.00008320705,0.0067608096,0.0001429098,0.0001689061,0.00013025932,0.000035056397,0.0023717058],"genre_scores_gemma":[0.99721247,0.000088994806,0.00012646776,0.00028892612,0.00008973508,0.0000046284654,0.00060170586,0.0000073284814,0.0015797486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987086,0.00009982531,0.0004092874,0.00022412553,0.00042285107,0.00013530873],"domain_scores_gemma":[0.9989995,0.00023246607,0.00025909577,0.00019254554,0.00014188579,0.00017450364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000424457,0.000089515175,0.00023874472,0.000067063695,0.00002990779,0.000009020091,0.00003810704,0.0002850813,0.000259713],"category_scores_gemma":[0.00031535435,0.00007359317,0.000119668264,0.0007226082,0.000042908203,0.000027458758,0.000021467398,0.0002849236,0.000008812755],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000064912274,0.0009048541,0.9869456,0.000042248907,0.00018661104,0.000324362,0.00014578455,0.00006365479,0.0090719,0.00010849089,0.0015005742,0.0006409686],"study_design_scores_gemma":[0.004836904,0.00010787096,0.99039054,0.00010997774,0.00022399328,0.00005106648,0.00004816482,0.00023614122,0.0010289048,0.0016508562,0.0012209469,0.00009462834],"about_ca_topic_score_codex":0.0008616595,"about_ca_topic_score_gemma":0.0012496533,"teacher_disagreement_score":0.008042995,"about_ca_system_score_codex":0.00062263175,"about_ca_system_score_gemma":0.0009842755,"threshold_uncertainty_score":0.30010423},"labels":[],"label_agreement":null},{"id":"W3211708440","doi":"10.1182/blood-2021-154082","title":"Immune Profiling of Diagnostic DLBCL Biopsies Dramatically Improves upon Cell-of-Origin Risk Stratification","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; Terry Fox Research Institute","funders":"","keywords":"Mass cytometry; Biology; Immune system; Diffuse large B-cell lymphoma; Germinal center; Tumor microenvironment; Gene expression profiling; Phenotype; Cell of origin; B cell; Lymphoma; Cancer research; Immunology; Pathology; Cell; Medicine; Antibody; Genetics; Gene expression; Gene","score_opus":0.008431144477234455,"score_gpt":0.22006711662225822,"score_spread":0.21163597214502378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211708440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99510264,0.0020815164,0.0020584168,0.000020711246,0.00010777434,0.00013415665,0.000042907224,0.000007843782,0.00044405012],"genre_scores_gemma":[0.9917597,0.00058781303,0.007322117,0.0000074479362,0.00006460137,0.0000103955,0.00016222944,0.0000148983445,0.00007076916],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99915355,0.000057120982,0.0003492188,0.00021076482,0.00009823702,0.00013109812],"domain_scores_gemma":[0.9992633,0.000079719146,0.00016315772,0.00030543705,0.000153828,0.00003458664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012358505,0.00010820175,0.00016961635,0.000021343816,0.000037228154,0.000014226707,0.000114863535,0.00011707509,0.00000687617],"category_scores_gemma":[0.000398712,0.00010458698,0.00009865976,0.00008537515,0.00005797734,0.0000033697704,0.000028505281,0.000072369985,0.0000016975109],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019568353,0.00073024235,0.010371559,0.00015898203,0.00005846611,0.0000018534516,0.000062331776,0.000022455612,0.98749405,0.0001542979,0.0000033504698,0.0009228562],"study_design_scores_gemma":[0.00083209464,0.00019532806,0.0052336818,0.000030144627,0.00011806031,0.0000032789894,0.0001063273,0.00009602758,0.9930702,0.00013747152,0.00006574627,0.00011165184],"about_ca_topic_score_codex":0.000035274403,"about_ca_topic_score_gemma":0.000014316036,"teacher_disagreement_score":0.005576151,"about_ca_system_score_codex":0.0000024257301,"about_ca_system_score_gemma":0.00011588353,"threshold_uncertainty_score":0.42649335},"labels":[],"label_agreement":null},{"id":"W3211710841","doi":"10.1182/blood-2021-151586","title":"Real-World Management of Patients with Newly Diagnosed Acute Myeloid Leukemia Treated with Venetoclax-Based Regimens: Results from the AML Real World Evidence (ARC) Initiative","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Ven; Venetoclax; Medicine; Cytarabine; Decitabine; Internal medicine; Azacitidine; Chemotherapy regimen; Oncology; Myeloid leukemia; Leukemia; Chemotherapy; Chronic lymphocytic leukemia; Humanities","score_opus":0.029243344570952314,"score_gpt":0.2841597342596075,"score_spread":0.2549163896886552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211710841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98484534,0.00017170083,0.000035123026,0.0015613561,0.00003587971,0.0019618887,0.0005533185,0.00012589872,0.010709523],"genre_scores_gemma":[0.9828216,0.0011334537,0.009416056,0.00071589823,0.00015755784,0.00027970047,0.0016996864,0.000118353135,0.0036577133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956737,0.00041777198,0.00071432843,0.0010034026,0.0014408538,0.0007499416],"domain_scores_gemma":[0.995053,0.001606771,0.0004858061,0.0017376665,0.0008254742,0.00029126857],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000430012,0.0004803567,0.00078106887,0.00024874115,0.00019310121,0.000059745485,0.00047843863,0.0001069516,0.000099877674],"category_scores_gemma":[0.00019502488,0.0003044377,0.00012786163,0.002221518,0.00039427914,0.00020783301,0.00023953087,0.0006487801,0.000030446783],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07306432,0.0029378345,0.8596261,0.0006497695,0.012223378,0.019080713,0.0030515385,0.0007046876,0.0026732306,0.00042826956,0.020082664,0.005477509],"study_design_scores_gemma":[0.04811854,0.002021945,0.90360266,0.004719665,0.0029323364,0.000006993413,0.00051864976,0.00021094458,0.03647372,0.000024452143,0.0009163727,0.00045369752],"about_ca_topic_score_codex":0.0061904336,"about_ca_topic_score_gemma":0.004385553,"teacher_disagreement_score":0.043976597,"about_ca_system_score_codex":0.0013497561,"about_ca_system_score_gemma":0.0023972762,"threshold_uncertainty_score":0.99994075},"labels":[],"label_agreement":null},{"id":"W3211716756","doi":"10.1182/blood-2021-153928","title":"Shared and Distinct Genetic Features in Human and Canine B-Cell Lymphomas","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Veterinary Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Simon Fraser University","funders":"","keywords":"Lymphoma; Biology; CBCL; Comparative genomic hybridization; CDKN2A; Immunophenotyping; Mutation; B-cell lymphoma; Cancer research; Genetics; Molecular biology; Pathology; Cancer; Gene; Medicine; Immunology; Flow cytometry; Chromosome","score_opus":0.020801104723612577,"score_gpt":0.30898645437782135,"score_spread":0.2881853496542088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211716756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909641,0.0042052343,6.1704765e-7,0.0004609384,0.000013791255,0.00013062923,0.000007246278,0.0000136725785,0.0042037754],"genre_scores_gemma":[0.99627656,0.00007165803,0.0009794086,0.00008976986,0.000056368306,0.000013934606,0.000022123695,0.000012320527,0.0024778717],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993659,0.000047494166,0.000096583,0.00022688252,0.00009530572,0.00016778093],"domain_scores_gemma":[0.999661,0.000037356924,0.0000142436975,0.00015115514,0.000030692732,0.00010555109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006561944,0.00007628829,0.00017717278,0.000055075725,0.000044640943,0.000015777741,0.000032496704,0.00006789887,0.00012459946],"category_scores_gemma":[0.000059561393,0.00007047076,0.000013387549,0.00009659264,0.00007516033,0.000016848695,0.00011487041,0.000118488955,0.000002669737],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049018996,0.00068211573,0.76680124,0.00018664903,0.00002904866,0.0067899525,0.00021903972,9.918903e-8,0.22416411,0.000013768063,0.00034071223,0.0007242632],"study_design_scores_gemma":[0.006123453,0.00063742563,0.98317844,0.000044654582,0.000052564814,0.0054899836,0.00006433527,0.00000938799,0.003961019,0.000041811567,0.00032866298,0.00006829214],"about_ca_topic_score_codex":0.000099572084,"about_ca_topic_score_gemma":0.0003758441,"teacher_disagreement_score":0.22020309,"about_ca_system_score_codex":0.000017645687,"about_ca_system_score_gemma":0.000090112815,"threshold_uncertainty_score":0.28737143},"labels":[],"label_agreement":null},{"id":"W3211725527","doi":"10.1182/blood-2021-147379","title":"Venetoclax for Acute Myeloid Leukemia in Pediatric Patients: A Texas Medical Center Collaboration","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Venetoclax; Medicine; Common Terminology Criteria for Adverse Events; Adverse effect; Internal medicine; Oncology; Myeloid leukemia; Population; Chemotherapy regimen; Cancer; Pediatrics; Leukemia","score_opus":0.01037928400971649,"score_gpt":0.2959992125211594,"score_spread":0.2856199285114429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211725527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99525267,0.00033301112,0.00009178621,0.0014275702,0.00018865225,0.0008888369,0.000086259904,0.00004673599,0.0016844693],"genre_scores_gemma":[0.9889199,0.0010976205,0.002976315,0.0019637947,0.0012559303,0.00027108347,0.0013318893,0.000083304556,0.002100133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99787736,0.00008291874,0.0004058313,0.00042269714,0.0007426207,0.00046856108],"domain_scores_gemma":[0.9986204,0.00015157959,0.00006885521,0.0003362606,0.000530626,0.00029230866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002951272,0.00016589937,0.0003423832,0.00020283452,0.000050050774,0.000033719938,0.00015225695,0.00026635546,0.00023486275],"category_scores_gemma":[0.0011765567,0.00015499492,0.00009028817,0.00089257525,0.000039655108,0.00011026771,0.00011921684,0.00037734568,0.00009200316],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075936754,0.0015016851,0.9571819,0.00043913577,0.0003608006,0.0012501504,0.00042817538,0.000008763101,0.0013622452,0.00021122658,0.03337155,0.003125],"study_design_scores_gemma":[0.15401247,0.0027420458,0.731476,0.00046137077,0.0016035521,0.00042118112,0.00037801111,0.0032348302,0.03387332,0.00034316306,0.07033586,0.0011181795],"about_ca_topic_score_codex":0.000020241625,"about_ca_topic_score_gemma":0.00012406509,"teacher_disagreement_score":0.22570588,"about_ca_system_score_codex":0.0012607245,"about_ca_system_score_gemma":0.0063775326,"threshold_uncertainty_score":0.99925536},"labels":[],"label_agreement":null},{"id":"W3211737035","doi":"10.1182/blood-2021-152697","title":"A Phase 3, Randomized, Double-Blinded Study of Four-Factor Prothrombin Complex Concentrate in Patients with Acute Major Bleeding on Direct Oral Anticoagulant Therapy with Factor Xa Inhibitor: The Lex-210 Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Medicine; Prothrombin complex concentrate; Randomized controlled trial; Adverse effect; Surgery; Internal medicine; Warfarin; Atrial fibrillation","score_opus":0.11594587575053204,"score_gpt":0.35438977881996975,"score_spread":0.2384439030694377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211737035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98746246,0.000028024058,0.000007345225,0.00021422855,0.00009657177,0.011969188,0.000019919195,0.0000513925,0.00015087184],"genre_scores_gemma":[0.99949574,0.000012391769,0.00007178732,0.000057561672,0.000111096044,0.00007225884,0.000030322175,0.000040928622,0.0001079044],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99752843,0.00034892565,0.000592371,0.00042691935,0.0008005645,0.0003027829],"domain_scores_gemma":[0.99875957,0.00020876864,0.00033853375,0.00040134773,0.00021160752,0.00008020023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003209292,0.00032669678,0.0012528378,0.00014218809,0.000110474735,0.00007406922,0.000118501266,0.000046183777,0.00008715226],"category_scores_gemma":[0.000035868015,0.00016721727,0.00011698245,0.0005036253,0.00008862526,0.00012000073,0.000053951182,0.00018226274,0.0000027242984],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23934087,0.008310428,0.74406904,0.000026582695,0.0033080354,0.00012984265,0.0033184348,0.000007665787,0.0011988907,0.000017935863,0.00000777523,0.00026449162],"study_design_scores_gemma":[0.7146593,0.008044246,0.26950026,0.00008975645,0.001002127,0.0000022980414,0.0014979966,0.00002745011,0.0049723564,0.0000019868323,0.000018489423,0.00018375709],"about_ca_topic_score_codex":0.00009674981,"about_ca_topic_score_gemma":0.00012717933,"teacher_disagreement_score":0.4753184,"about_ca_system_score_codex":0.000032626842,"about_ca_system_score_gemma":0.000097189484,"threshold_uncertainty_score":0.6818922},"labels":[],"label_agreement":null},{"id":"W3211741334","doi":"10.1182/blood-2021-153760","title":"Degradation of Red Blood Cell Deformability during Cold Storage in Blood Bags","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital; Canadian Blood Services; University of British Columbia","funders":"","keywords":"Red blood cell; Biomedical engineering; Erythrocyte deformability; Lesion; Transfusion medicine; Chemistry; Medicine; Pathology; Surgery; Immunology; Blood transfusion","score_opus":0.00997211039045319,"score_gpt":0.21682322412546062,"score_spread":0.20685111373500742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211741334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928389,0.00048381317,0.000027320884,0.00037053804,0.00008275071,0.0005148797,0.000009965485,0.00005960841,0.0056121964],"genre_scores_gemma":[0.99673647,0.00030593807,0.0012997498,0.000112018664,0.000037773,0.000030971063,0.000034446024,0.00002170056,0.0014209386],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998502,0.00007170578,0.00047983095,0.00035012598,0.00033296342,0.00026335727],"domain_scores_gemma":[0.9991408,0.000030357593,0.0000937829,0.00050295674,0.00011459158,0.00011754181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002601545,0.0001593994,0.00036334823,0.00014219558,0.000045662062,0.000011163661,0.0000877011,0.00010554941,0.00023487915],"category_scores_gemma":[0.0000627126,0.00015852269,0.00012622021,0.00041841881,0.00003479882,0.00008985945,0.000071776965,0.00021211618,0.000007349979],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009424145,0.010386615,0.16655537,0.0013414917,0.0002122464,0.00054415315,0.0002541893,0.000012431997,0.8201868,0.0002110842,0.000029741637,0.0001716349],"study_design_scores_gemma":[0.014203893,0.00017322872,0.20450239,0.00013124298,0.00090600876,0.000053539003,0.00020029489,0.000010051436,0.7794575,0.000017348606,0.00021687227,0.00012765122],"about_ca_topic_score_codex":0.00009999687,"about_ca_topic_score_gemma":0.00019827239,"teacher_disagreement_score":0.04072931,"about_ca_system_score_codex":0.000019310693,"about_ca_system_score_gemma":0.000109413966,"threshold_uncertainty_score":0.64643675},"labels":[],"label_agreement":null},{"id":"W3211753107","doi":"10.1182/blood-2021-147377","title":"Dabrafenib, Alone or in Combination with Trametinib, in Pediatric Patients with <i>BRAF</i> V600 Mutation-Positive Langerhans Cell Histiocytosis","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Dabrafenib; Trametinib; Medicine; Internal medicine; Oncology; Rash; MEK inhibitor; Adverse effect; Gastroenterology; Surgery; Vemurafenib; Cancer","score_opus":0.005219649416107726,"score_gpt":0.2055850398381201,"score_spread":0.20036539042201237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211753107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953856,0.00019869213,0.00005720924,0.00018037112,0.000026629816,0.0005609648,0.000039140174,0.000026533262,0.003524893],"genre_scores_gemma":[0.9969594,0.000037977192,0.0014578549,0.00016514525,0.000017951776,0.0000825247,0.0006007182,0.000030014102,0.00064841326],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998832,0.00005746995,0.0002472593,0.00032777997,0.00031521963,0.00022028213],"domain_scores_gemma":[0.9994076,0.00009679702,0.000094628485,0.00016790372,0.00014950828,0.00008359776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005563425,0.00017199204,0.00030357993,0.00018571265,0.000039766535,0.000017267048,0.00003996074,0.000069716676,0.00007116226],"category_scores_gemma":[0.00004951577,0.00012726255,0.000027867723,0.00075513247,0.00002955522,0.000090133646,0.000011236045,0.00013047979,0.0000194973],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066442165,0.016827954,0.97800404,0.00013631418,0.00007080594,0.0016274163,0.0012740646,0.000018154766,0.000028777138,0.000017330001,0.00006739146,0.0012633273],"study_design_scores_gemma":[0.06320165,0.0019476938,0.93091404,0.00017366369,0.000624377,0.000034265715,0.00032154025,0.000020550655,0.002469579,0.000018161316,0.00004545258,0.00022904166],"about_ca_topic_score_codex":0.00012544957,"about_ca_topic_score_gemma":0.0010763826,"teacher_disagreement_score":0.06253723,"about_ca_system_score_codex":0.000110047586,"about_ca_system_score_gemma":0.00025665775,"threshold_uncertainty_score":0.51896167},"labels":[],"label_agreement":null},{"id":"W3211760408","doi":"10.1182/blood-2021-150541","title":"Follow-up of More Than 5 Years in a Cohort of Patients with Hemophilia B Treated with Fidanacogene Elaparvovec Adeno-Associated Virus Gene Therapy","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Adverse effect; Internal medicine; Cohort; Pediatrics; Surgery","score_opus":0.01297443137248601,"score_gpt":0.250546902525979,"score_spread":0.23757247115349298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211760408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99827,0.0005515812,3.475905e-7,0.00008079927,0.00001376898,0.00068327587,0.000107491855,0.000020211282,0.00027257545],"genre_scores_gemma":[0.99798566,0.00029574925,0.0001406697,0.000026248326,0.000016030055,0.000032901928,0.000392265,0.00004058409,0.001069875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837047,0.000073367984,0.00029921986,0.00031203908,0.0006380476,0.000306848],"domain_scores_gemma":[0.998999,0.000042719068,0.00012339694,0.00036766526,0.00034727284,0.000119951794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001113739,0.00019062929,0.0005847483,0.00015762393,0.000022848952,0.000005227106,0.0000876053,0.00012706994,0.00010657482],"category_scores_gemma":[0.000044393004,0.0001289172,0.00009337476,0.00078803464,0.000108724234,0.00003886636,0.000027612254,0.00014186495,0.000003729249],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015562535,0.004362137,0.9612815,0.000035957593,0.0013465608,0.00046491175,0.00036945337,0.0000027347166,0.030037295,0.0000013824636,0.00002457542,0.0005172741],"study_design_scores_gemma":[0.020778868,0.0012757247,0.7165485,0.00014797715,0.00024349995,0.000007345195,0.000053733012,0.0000047494154,0.260829,0.0000024363026,0.00001169796,0.00009648379],"about_ca_topic_score_codex":0.0004047975,"about_ca_topic_score_gemma":0.00032661622,"teacher_disagreement_score":0.24473296,"about_ca_system_score_codex":0.000054273492,"about_ca_system_score_gemma":0.00027663138,"threshold_uncertainty_score":0.5257091},"labels":[],"label_agreement":null},{"id":"W3211760722","doi":"10.1182/blood-2021-151361","title":"COVID-19 and Sickle Cell Disease in the Province of Quebec: Morbidity and Mortality Rates Derived from the Provincial Registry","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital de l'Enfant-Jésus; Montreal Children's Hospital; Centre Hospitalier Universitaire de Sherbrooke; Centre Hospitalier de l’Université de Montréal; McGill University; Centre Hospitalier Universitaire Sainte-Justine; Hôpital Maisonneuve-Rosemont; Université Laval; Université de Montréal","funders":"","keywords":"Medicine; Epidemiology; Population; Public health; Disease; Mortality rate; Pediatrics; Internal medicine; Environmental health; Pathology","score_opus":0.013709422618948391,"score_gpt":0.26049355619612086,"score_spread":0.24678413357717247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211760722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989663,0.005067133,0.000011185682,0.004482789,0.000025226083,0.0004026136,0.00008403992,0.000011903898,0.00025207546],"genre_scores_gemma":[0.99806315,0.00044084017,0.000034588043,0.0012186477,0.000052122206,0.000012406547,0.000039478236,0.000006711707,0.00013203117],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991826,0.00014366099,0.00017196537,0.00021944375,0.00015862125,0.00012371782],"domain_scores_gemma":[0.99925023,0.00017582055,0.00007164857,0.00032319443,0.000030326337,0.00014877612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018668154,0.00009797664,0.00016903538,0.000009508129,0.0000840401,0.000022923272,0.00007481971,0.00006966982,0.00001805896],"category_scores_gemma":[0.0005753691,0.0000551299,0.000037220823,0.00009217163,0.00025190503,0.00003464218,0.00006394472,0.00018577179,6.2631057e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013670957,0.0009907333,0.98704726,0.00053081923,0.00006187273,0.00077694794,0.0018886504,0.0000061391843,0.007417338,0.00009743138,0.0007469337,0.0002991923],"study_design_scores_gemma":[0.0038475194,0.0000574619,0.98435754,0.00007866337,0.00047360742,0.000017736618,0.0031552159,0.00008961067,0.0063625905,0.0005084893,0.00093387853,0.00011769685],"about_ca_topic_score_codex":0.01858909,"about_ca_topic_score_gemma":0.017504456,"teacher_disagreement_score":0.00840014,"about_ca_system_score_codex":0.00001313516,"about_ca_system_score_gemma":0.0010764239,"threshold_uncertainty_score":0.9879462},"labels":[],"label_agreement":null},{"id":"W3211765601","doi":"10.1182/blood-2021-151271","title":"Cost of Care of Rare Hematologic Disorders in the United States: Call to Action for Policy Supporting Pharmacologic Innovation","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Porphyrin Metabolism and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Indirect costs; Disease; Thalassemia; Specialty; Health care; Pediatrics; Intensive care medicine; Family medicine; Internal medicine","score_opus":0.025174456961258734,"score_gpt":0.34461149925584034,"score_spread":0.3194370422945816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211765601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973768,0.0002728245,0.0012293073,0.0004731849,0.000031530675,0.00036901212,0.000083002815,0.000003531069,0.00016082857],"genre_scores_gemma":[0.99749357,0.00020825311,0.00048044912,0.0005654757,0.0000283952,0.00006956964,0.0011344851,0.0000062076624,0.000013614304],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99935013,0.000060275594,0.0002413213,0.00014322683,0.00006550892,0.00013955099],"domain_scores_gemma":[0.99946874,0.00002341496,0.00012873622,0.0001337996,0.00023065356,0.000014623143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001370372,0.000072606425,0.00012026103,0.00010735192,0.000025987512,0.000004425719,0.00010715863,0.000063457075,0.0000038600483],"category_scores_gemma":[0.00037009234,0.00005878454,0.00003828454,0.000663015,0.000028311175,0.0000025808731,0.000037107402,0.00003750167,2.5074408e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020718732,0.00066818146,0.022996956,0.00040508248,0.00006460573,0.0000023807881,0.0015495892,0.001771888,0.9662193,0.0010426891,0.00074572104,0.00432644],"study_design_scores_gemma":[0.0026504728,0.00032929447,0.0058906833,0.00001534018,0.00005796632,0.000005709313,0.009856541,0.000042619413,0.96896464,0.00046134338,0.011581072,0.0001443089],"about_ca_topic_score_codex":0.00010377632,"about_ca_topic_score_gemma":0.00021549236,"teacher_disagreement_score":0.017106272,"about_ca_system_score_codex":0.0000039689294,"about_ca_system_score_gemma":0.000112191185,"threshold_uncertainty_score":0.2397164},"labels":[],"label_agreement":null},{"id":"W3211771177","doi":"10.1182/blood-2021-152383","title":"Mobility and Muscle Strength in Recipients of Hematopoietic Cell Transplantation for Sickle Cell Disease: A Preliminary Report from Sickle Transplant Evaluation of Longterm and Late Effects Registry (STELLaR)","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"","keywords":"Medicine; Transplantation; Hematopoietic stem cell transplantation; Disease; Anemia; Sickle cell anemia; Pediatrics; Internal medicine; Physical therapy","score_opus":0.00844721959636436,"score_gpt":0.2417383532173826,"score_spread":0.23329113362101825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211771177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99242115,0.0061705434,0.000056337714,0.000044555098,0.0000561938,0.0009047923,0.00014064477,0.000010063828,0.0001957085],"genre_scores_gemma":[0.9981138,0.0010614111,0.0002984682,0.0000090691165,0.000011001814,0.0000379861,0.00041038066,0.00001436254,0.000043492488],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987452,0.0000971012,0.00041519266,0.00033290088,0.00027582567,0.00013380228],"domain_scores_gemma":[0.999169,0.00018998745,0.00016272825,0.00026155708,0.00011634872,0.00010039861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034832617,0.00012594325,0.0003133287,0.000045086006,0.0000252705,0.000004896582,0.000029335662,0.000121569086,0.000011618407],"category_scores_gemma":[0.00007498028,0.00011762386,0.00006633246,0.00010146481,0.00006399805,0.00004405485,0.000010266833,0.00009553218,1.7402598e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035260883,0.011776163,0.577129,0.029912913,0.00026099643,0.0018586055,0.013176266,0.0003389074,0.3516029,0.0000071410846,0.000034388137,0.010376584],"study_design_scores_gemma":[0.012885118,0.00040730948,0.7049252,0.0013715471,0.0025764317,0.00006084582,0.00039038793,0.0014761329,0.2755292,0.00022463732,0.000006371055,0.00014683661],"about_ca_topic_score_codex":0.00006655947,"about_ca_topic_score_gemma":0.000019732304,"teacher_disagreement_score":0.12779613,"about_ca_system_score_codex":0.000012627278,"about_ca_system_score_gemma":0.00014949185,"threshold_uncertainty_score":0.4796562},"labels":[],"label_agreement":null},{"id":"W3211778366","doi":"10.1182/blood-2021-149049","title":"Diffuse Large B-Cell Lymphoma (DLBCL) Patients with Late Relapses Who Are Transplant-Eligible Have Excellent Outcomes and May Represent Unique Biology","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Medicine; Internal medicine; Salvage therapy; Oncology; Lymphoma; Population; Diffuse large B-cell lymphoma; Transplantation; Cancer; Chemotherapy","score_opus":0.014850131788839791,"score_gpt":0.2707231962552273,"score_spread":0.25587306446638747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211778366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99296814,0.0013956232,0.000028127932,0.0008758775,0.00006349477,0.0005677225,0.00013379403,0.000065932705,0.003901259],"genre_scores_gemma":[0.9739213,0.0026108548,0.00017495119,0.00038886647,0.000049777926,0.000046801873,0.00017861222,0.00006013657,0.022568682],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980887,0.00017455316,0.00029782124,0.00059377693,0.00030574013,0.00053937244],"domain_scores_gemma":[0.99863476,0.000169041,0.000089760135,0.00064788124,0.00018994007,0.0002686063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001706816,0.00026710855,0.00059058715,0.00013084878,0.000104419654,0.000034367262,0.0001133515,0.00017990258,0.00029912102],"category_scores_gemma":[0.000040073075,0.00019546156,0.00011324369,0.00016250872,0.000105851366,0.000048785787,0.000108368105,0.00021611828,0.000017518421],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005045853,0.010153548,0.9797643,0.00021173041,0.00033104123,0.00068836927,0.0006280982,2.9159946e-7,0.006564247,0.000051945273,0.00024349157,0.00085836445],"study_design_scores_gemma":[0.1531808,0.0015647782,0.58904773,0.00062630884,0.0006480442,0.0001844255,0.000485393,0.000046937002,0.22673553,0.00020268504,0.026590312,0.0006870782],"about_ca_topic_score_codex":0.0001315153,"about_ca_topic_score_gemma":0.00019558672,"teacher_disagreement_score":0.39071658,"about_ca_system_score_codex":0.000040066552,"about_ca_system_score_gemma":0.0001272679,"threshold_uncertainty_score":0.7970691},"labels":[],"label_agreement":null},{"id":"W3211783573","doi":"10.1182/blood-2021-148636","title":"Association between Bariatric Surgery and Outcomes in Patients with Chronic Myeloid Leukemia Treated with Oral Tyrosine Kinase Inhibitors","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Myeloid leukemia; Tyrosine kinase; Internal medicine; Surgery; Tyrosine-kinase inhibitor; Gastroenterology; Cancer","score_opus":0.00798914801371739,"score_gpt":0.21606377838258492,"score_spread":0.20807463036886753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211783573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99857724,0.00048803358,0.0000015669993,0.00020051058,0.000039267565,0.0004730249,0.000042558186,0.00007092913,0.00010684799],"genre_scores_gemma":[0.9981795,0.000067591616,0.00021968236,0.000050823586,0.00011593011,0.000034050434,0.0005718988,0.00005176046,0.0007087672],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981273,0.00009037169,0.00037660342,0.00046681316,0.0004981221,0.0004408268],"domain_scores_gemma":[0.9988944,0.00025420298,0.00020463398,0.00030871952,0.00016634208,0.0001717342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016310568,0.00030330964,0.00074098917,0.00021866526,0.000063948886,0.00003445129,0.000038218815,0.00017880117,0.00004910209],"category_scores_gemma":[0.00017171583,0.00022210357,0.00006603556,0.00071639783,0.000034774257,0.00014737625,0.00004372409,0.0002492924,0.000012055876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001313823,0.00060618564,0.99603164,0.000083665065,0.0007230453,0.00022689301,0.000044473785,0.0000033347271,0.000067377405,0.0000011704813,0.000113827344,0.0019669964],"study_design_scores_gemma":[0.026487688,0.0005741683,0.96612686,0.00023319104,0.001311115,0.000011598955,0.0000122299425,0.0000047925814,0.0049102237,0.0000020108903,0.00009277961,0.00023332967],"about_ca_topic_score_codex":0.00057636993,"about_ca_topic_score_gemma":0.00056012935,"teacher_disagreement_score":0.029904775,"about_ca_system_score_codex":0.0029910966,"about_ca_system_score_gemma":0.0013165197,"threshold_uncertainty_score":0.90571207},"labels":[],"label_agreement":null},{"id":"W3211790423","doi":"10.1182/blood-2021-144905","title":"Olutasidenib (FT-2102) in Combination with Azacitidine Induces Durable Complete Remissions in Patients with mIDH1 Acute Myeloid Leukemia","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Myeloid leukemia; Azacitidine; Gastroenterology; Hypomethylating agent; Refractory (planetary science); Myeloid; Venetoclax; Leukemia; Acute leukemia; Oncology; Biology","score_opus":0.016045889082207093,"score_gpt":0.2547655137594515,"score_spread":0.23871962467724442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211790423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946136,0.00012234341,0.00001733046,0.0015316943,0.00002801773,0.0007939801,0.000046073656,0.00006183683,0.0027851118],"genre_scores_gemma":[0.99548304,0.000084928426,0.0022629034,0.00031254094,0.000042341722,0.00008344135,0.00052794284,0.00006490433,0.0011379576],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99723154,0.00015626344,0.00045325182,0.0006056179,0.0009009793,0.0006523349],"domain_scores_gemma":[0.998475,0.00014207298,0.00012583862,0.0005586766,0.0004273907,0.0002710046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028829047,0.00029587108,0.00059725693,0.00041983722,0.00011134972,0.000051050713,0.00021220975,0.0001809625,0.00015675582],"category_scores_gemma":[0.00022101372,0.00023221092,0.000045964916,0.0015211513,0.00012853488,0.0002743684,0.00014122613,0.00085394963,0.00003516301],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018278582,0.0032039122,0.9268576,0.00023845091,0.00043151845,0.003415797,0.0008627618,0.0000849922,0.0609255,0.00019890559,0.001000659,0.0009520733],"study_design_scores_gemma":[0.042340558,0.0012793423,0.9038902,0.0010245257,0.00019378198,0.0002504994,0.00036841258,0.00015712336,0.049354974,0.00009425223,0.00065364793,0.00039269586],"about_ca_topic_score_codex":0.0003268714,"about_ca_topic_score_gemma":0.00036487848,"teacher_disagreement_score":0.040512703,"about_ca_system_score_codex":0.00077101996,"about_ca_system_score_gemma":0.0014913233,"threshold_uncertainty_score":0.9469286},"labels":[],"label_agreement":null},{"id":"W3211808513","doi":"10.1182/blood-2021-154074","title":"Updated Results from a Phase II Study of Mini-Hyper-CVD Plus Inotuzumab Ozogamicin, with or without Blinatumomab, in Older Adults with Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Blinatumomab; Rituximab; Internal medicine; Gastroenterology; Cytarabine; Chemotherapy; Surgery; Leukemia; Lymphoblastic Leukemia; Lymphoma","score_opus":0.012817446921125932,"score_gpt":0.2746609611731929,"score_spread":0.261843514252067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211808513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943828,0.0001738548,0.0000726013,0.00032937172,0.00008637344,0.0035243256,0.00088748813,0.00015702446,0.00038617593],"genre_scores_gemma":[0.99433094,0.000069682166,0.0027311866,0.00023610325,0.00020480786,0.0002958369,0.0010828057,0.00020896806,0.00083968864],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9933012,0.00035277812,0.0014452419,0.0018834601,0.0018758726,0.0011414391],"domain_scores_gemma":[0.99479383,0.0011469519,0.0006608967,0.0016410092,0.001154079,0.0006032367],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002679527,0.0009302727,0.0021056526,0.0006350344,0.00019697954,0.00006214712,0.0005732634,0.00039615674,0.00026178587],"category_scores_gemma":[0.00068578974,0.00065176917,0.00012324983,0.0028916034,0.00044085138,0.0003252756,0.0004683802,0.0008997483,0.000034103683],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.46954727,0.15611352,0.018906888,0.0012589162,0.009478743,0.14331262,0.1297821,0.0015636167,0.06342817,0.000007866189,0.0046824464,0.0019178573],"study_design_scores_gemma":[0.7988343,0.038263127,0.010463415,0.0035842815,0.0036382673,0.0013655451,0.023006674,0.010094529,0.10958206,0.0000049471737,0.00005614406,0.0011067069],"about_ca_topic_score_codex":0.004130882,"about_ca_topic_score_gemma":0.004695297,"teacher_disagreement_score":0.32928702,"about_ca_system_score_codex":0.0017823956,"about_ca_system_score_gemma":0.010570918,"threshold_uncertainty_score":0.9995934},"labels":[],"label_agreement":null},{"id":"W3211809470","doi":"10.1182/blood-2021-147294","title":"Characterizing Iron Overload By Age in Patients Diagnosed with Pyruvate Kinase Deficiency - a Descriptive Analysis from the Peak Registry","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Cohort; Pediatrics; Ferritin; Phlebotomy; Deferasirox; Internal medicine; Anemia; Thalassemia","score_opus":0.011243574540931214,"score_gpt":0.21465400870179024,"score_spread":0.20341043416085902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211809470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984799,0.0003821047,0.000021127591,0.0001904705,0.0000760222,0.0001556789,0.00008939156,0.000025745268,0.0005795553],"genre_scores_gemma":[0.9973872,0.00010259169,0.00010957908,0.0011147278,0.000058330672,0.000023289076,0.0009119148,0.000013318388,0.00027910038],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989401,0.000109916116,0.00019673718,0.00035598475,0.000186486,0.00021075847],"domain_scores_gemma":[0.99926096,0.000092447815,0.00010798425,0.00040441105,0.0000642283,0.00006997566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000060691455,0.00014183998,0.00031140106,0.00005552922,0.00007128319,0.00002159287,0.00007224663,0.00007777188,0.0001363702],"category_scores_gemma":[0.00012292145,0.000096177195,0.00009348705,0.00060628954,0.000065792265,0.00005431343,0.00003971557,0.00022046384,0.0000150296855],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036097542,0.001900138,0.8575016,0.000021876243,0.00027602052,0.0007461838,0.002554385,0.0000029695664,0.1357935,0.000008288755,0.000424255,0.000409774],"study_design_scores_gemma":[0.0045854608,0.0003218764,0.9867208,0.00007774746,0.00087638263,0.000002670518,0.0011571015,0.000009987856,0.005370413,0.00000601716,0.00074352074,0.0001279976],"about_ca_topic_score_codex":0.00050926907,"about_ca_topic_score_gemma":0.00063935557,"teacher_disagreement_score":0.13042308,"about_ca_system_score_codex":0.0000360917,"about_ca_system_score_gemma":0.000062965126,"threshold_uncertainty_score":0.39219922},"labels":[],"label_agreement":null},{"id":"W3211838148","doi":"10.1182/blood-2021-146737","title":"High-Dose Methotrexate Is Not Associated with Reduction in CNS Relapse in Patients with Aggressive B-Cell Lymphoma: An International Retrospective Study of 2300 High-Risk Patients","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Calgary; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Methotrexate; Retrospective cohort study; Lymphoma; Internal medicine; Oncology; Reduction (mathematics); Rituximab; Gastroenterology","score_opus":0.007138644328554607,"score_gpt":0.230745298865182,"score_spread":0.2236066545366274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211838148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985656,0.000030408486,4.808909e-7,0.000043315842,0.00015599905,0.000893632,0.00021277927,0.00002196146,0.00007580937],"genre_scores_gemma":[0.9988213,0.000047118927,0.0003602793,0.000029202694,0.000028537774,0.00011191371,0.000499864,0.00004009889,0.000061680206],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977848,0.00023053205,0.00044381132,0.00060391705,0.00070498226,0.00023197933],"domain_scores_gemma":[0.99819946,0.000051645686,0.00064565527,0.0003755955,0.000630881,0.00009675726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001361688,0.00025274354,0.00054401247,0.000256965,0.00004804691,0.000019279272,0.00008785746,0.00009998601,0.000038556245],"category_scores_gemma":[0.00019493491,0.00019686084,0.00004813461,0.0006137192,0.000042965672,0.00019366147,0.000055397908,0.00013945748,0.0000033142999],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014705523,0.09358203,0.8993704,0.000007929312,0.0006585458,0.00031494402,0.0026959204,0.000023213459,0.000037439237,0.000009095193,0.000012461336,0.0018174847],"study_design_scores_gemma":[0.109366745,0.0057424484,0.87506545,0.00030694943,0.0005981675,0.0000042904885,0.00063940894,0.0000076859615,0.008083749,0.000016822469,0.0000010606535,0.00016724644],"about_ca_topic_score_codex":0.0024561996,"about_ca_topic_score_gemma":0.0012809805,"teacher_disagreement_score":0.107896194,"about_ca_system_score_codex":0.0005971112,"about_ca_system_score_gemma":0.00014428137,"threshold_uncertainty_score":0.80277526},"labels":[],"label_agreement":null},{"id":"W3211862217","doi":"10.1182/blood-2021-153240","title":"Inhibition of the DOT1L/MPL/JAK2 Signaling Axis Selectively Targets <i>TET2</i> Mutation-Driven Clonal Hematopoiesis","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Haematopoiesis; Biology; Cancer research; Progenitor cell; Myeloid; Epigenetics; Leukemia; Stem cell; Immunology; Genetics; Gene","score_opus":0.013500876726300903,"score_gpt":0.2600462198651964,"score_spread":0.24654534313889548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211862217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941534,0.00056421256,0.0004738142,0.001510807,0.00006156716,0.00036394713,0.00004404857,0.00004399423,0.0027842238],"genre_scores_gemma":[0.9941752,0.00002470775,0.0045938515,0.00040426376,0.00017761198,0.00003682207,0.00006469619,0.000031414194,0.00049144507],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982766,0.00014609894,0.0003356533,0.0003125449,0.0006290523,0.00030006992],"domain_scores_gemma":[0.9986269,0.0002226872,0.00012727834,0.00031868438,0.00060061546,0.00010386977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022732397,0.00014941263,0.00030403206,0.000086960674,0.0001485088,0.000019254516,0.000108347216,0.0001146394,0.0002973679],"category_scores_gemma":[0.00051021494,0.00011689645,0.00018304738,0.00069719297,0.000120597746,0.00009045403,0.0001234073,0.00035415945,0.00003491237],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009418934,0.00062549644,0.010336622,0.00024252944,0.00035889394,0.00033208646,0.0010248697,0.000058329337,0.9850932,0.00043395557,0.0011764634,0.00022340828],"study_design_scores_gemma":[0.0029138695,0.0001266158,0.009427929,0.00018560218,0.00024375913,0.00051594264,0.0003888603,0.00014156113,0.9849063,0.0006019968,0.00042906104,0.00011849837],"about_ca_topic_score_codex":0.000052927273,"about_ca_topic_score_gemma":0.000023940558,"teacher_disagreement_score":0.0041200374,"about_ca_system_score_codex":0.000101130696,"about_ca_system_score_gemma":0.00081479136,"threshold_uncertainty_score":0.4766899},"labels":[],"label_agreement":null},{"id":"W3211864651","doi":"10.1182/blood-2021-151711","title":"Long-Term Outcome of Treatment-Naïve and Relapsed/Refractory Patients with CLL and <i>TP53</i> Aberrations Treated with Ibrutinib, with or without Rituximab","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ibrutinib; Medicine; Rituximab; Internal medicine; Neutropenia; Progression-free survival; Oncology; Chronic lymphocytic leukemia; Lymphocytosis; Refractory (planetary science); Median follow-up; Leukemia; Chemotherapy; Lymphoma","score_opus":0.02149044637896687,"score_gpt":0.2866232311997149,"score_spread":0.26513278482074804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211864651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975624,0.00040643534,0.000016850894,0.000068465066,0.000011264916,0.00086916116,0.000064890235,0.000052803327,0.00094771985],"genre_scores_gemma":[0.995402,0.00014273028,0.0012364882,0.00006576983,0.0000349584,0.00006361441,0.00016953677,0.00006492976,0.0028199735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822646,0.00006325261,0.0003319281,0.0005449964,0.0004548273,0.00037850466],"domain_scores_gemma":[0.9984833,0.00015168621,0.00015563471,0.00057305396,0.00034814267,0.00028817673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006595996,0.00032543243,0.00071064377,0.000110813315,0.00011021295,0.000041429223,0.00006026379,0.00011820792,0.000070202856],"category_scores_gemma":[0.000054012056,0.00017857781,0.000035598518,0.00035481964,0.00037590327,0.00015753509,0.000050041184,0.00017437394,0.0000047438257],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032447916,0.003935632,0.9892584,0.00029584736,0.00077080034,0.00071990263,0.00051233824,8.666432e-7,0.0002718498,0.000008272071,0.000016585156,0.0009647289],"study_design_scores_gemma":[0.35049337,0.015061022,0.61855215,0.00083601056,0.002749502,0.0019788353,0.0003081689,0.00009023235,0.009254667,0.0000020862344,0.0001989706,0.000475001],"about_ca_topic_score_codex":0.00034251958,"about_ca_topic_score_gemma":0.001318453,"teacher_disagreement_score":0.37070626,"about_ca_system_score_codex":0.0008075463,"about_ca_system_score_gemma":0.0029580207,"threshold_uncertainty_score":0.72821915},"labels":[],"label_agreement":null},{"id":"W3211871096","doi":"10.1182/blood-2021-147614","title":"A Randomized, Phase 3 Trial of Fedratinib Versus Best Available Therapy in Patients with Intermediate-2 or High-Risk Myelofibrosis Previously Treated with Ruxolitinib (FREEDOM2)","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Ruxolitinib; Myelofibrosis; Internal medicine; Adverse effect; Population; Clinical trial; Phases of clinical research; Surgery; Pediatrics; Bone marrow","score_opus":0.02224321597315307,"score_gpt":0.2714861247213994,"score_spread":0.2492429087482463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211871096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99414873,0.00036663224,0.00000498037,0.000075484255,0.00010248775,0.004146278,0.00017217967,0.00003927217,0.000943955],"genre_scores_gemma":[0.99489164,0.001444162,0.0012151175,0.00006253539,0.00012219297,0.0011754221,0.00047315625,0.00006132053,0.0005544252],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99731344,0.0003952482,0.0007416706,0.00059137936,0.0005354903,0.0004227425],"domain_scores_gemma":[0.9976186,0.0007764554,0.00042485917,0.0005217317,0.0004502028,0.00020816232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027492,0.00043325618,0.0016217798,0.00015949982,0.000074991534,0.00004237246,0.000091786664,0.00012913754,0.0008387648],"category_scores_gemma":[0.00042664734,0.0002386779,0.0001732056,0.0005038531,0.00021791682,0.00011558743,0.000031816824,0.00021270046,0.00003199731],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8187262,0.023392437,0.15312453,0.00006306403,0.0018302317,0.00021784232,0.0004190532,0.0000019212773,0.000036313468,0.00002379388,0.00009496218,0.0020696868],"study_design_scores_gemma":[0.9226359,0.04542717,0.0067878426,0.0006006011,0.001752214,0.000009422188,0.000115212686,0.000008728799,0.022300826,0.0000034034824,0.00011108795,0.00024757234],"about_ca_topic_score_codex":0.00060204725,"about_ca_topic_score_gemma":0.00053405756,"teacher_disagreement_score":0.14633667,"about_ca_system_score_codex":0.00006596734,"about_ca_system_score_gemma":0.0005278706,"threshold_uncertainty_score":0.9733002},"labels":[],"label_agreement":null},{"id":"W3211878598","doi":"10.1182/blood-2021-148967","title":"Blinatumomab Associated Seizure Risk in Patients with Down Syndrome and B-Lymphoblastic Leukemia: An Interim Report from Children's Oncology Group (COG) Study AALL1731","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; University of Toronto; BC Children's Hospital; University of British Columbia","funders":"","keywords":"Blinatumomab; Medicine; Internal medicine; Incidence (geometry); Pediatrics; Interim analysis; Acute lymphocytic leukemia; Oncology; Leukemia; Lymphoblastic Leukemia; Clinical trial","score_opus":0.007919790803210716,"score_gpt":0.2582305017382727,"score_spread":0.250310710935062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211878598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99773586,0.00018853904,0.00002860572,0.000058619247,0.00011663651,0.0013510197,0.00016597948,0.00011977726,0.00023495893],"genre_scores_gemma":[0.9977161,0.000022555654,0.00060342427,0.00011540577,0.00008451403,0.00009239499,0.0011385158,0.00008888944,0.00013819047],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959378,0.0005543089,0.0007367831,0.0011770136,0.00091632264,0.0006777348],"domain_scores_gemma":[0.99756503,0.00039772713,0.00035691072,0.0008639495,0.00038364853,0.00043274614],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005335892,0.00042090472,0.0010154666,0.00028263286,0.0001289214,0.00007181115,0.00022833253,0.00041169737,0.00010969453],"category_scores_gemma":[0.0013644086,0.00035142587,0.000071011775,0.0007649813,0.00017372463,0.00021573703,0.00038242838,0.00094510044,0.000020017833],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084173586,0.011647983,0.9539844,0.00002113088,0.0014239656,0.030428298,0.0006738342,0.000005335518,0.00012702246,0.0000015960894,0.00010425386,0.00074047607],"study_design_scores_gemma":[0.05347313,0.008038981,0.93293554,0.00022708593,0.0015448413,0.0026446525,0.00050417613,0.000158223,0.000086097876,0.00003236517,0.000018569703,0.00033636705],"about_ca_topic_score_codex":0.0027522717,"about_ca_topic_score_gemma":0.0023316904,"teacher_disagreement_score":0.052631393,"about_ca_system_score_codex":0.001427797,"about_ca_system_score_gemma":0.0018700246,"threshold_uncertainty_score":0.9998938},"labels":[],"label_agreement":null},{"id":"W3211879125","doi":"10.1182/blood-2021-146036","title":"Outcomes in Relapsed/Refractory Burkitt Lymphoma: A Multi-Centre Canadian Experience","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Juravinski Cancer Centre; Ottawa Hospital; Princess Margaret Cancer Centre; BC Cancer Agency; University of Manitoba; University of Calgary; Queen Elizabeth II Health Sciences Centre; University of Alberta","funders":"","keywords":"Medicine; Internal medicine; Refractory (planetary science); Lymphoma; Burkitt's lymphoma; Chemotherapy regimen; Regimen; Immunophenotyping; Chemotherapy; Stage (stratigraphy); Gastroenterology; Surgery; Immunology","score_opus":0.017873112375156115,"score_gpt":0.2620726234395241,"score_spread":0.24419951106436796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211879125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943651,0.0016773124,4.2418853e-7,0.0013053517,0.00015547249,0.00019063038,0.000018081548,0.000031550542,0.0022560924],"genre_scores_gemma":[0.99617195,0.00011056466,0.0006436782,0.0009853697,0.000036373676,0.000054868327,0.000028998707,0.000018084978,0.001950096],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888366,0.000031352633,0.0002124294,0.00032896994,0.00017226333,0.00037134014],"domain_scores_gemma":[0.99914277,0.00004188981,0.00003313188,0.00036391232,0.000058014215,0.00036027012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000037660695,0.00016111454,0.00030249602,0.00010479597,0.0000552636,0.000019431434,0.000062057275,0.00009839269,0.00024234087],"category_scores_gemma":[0.00014625417,0.00013607141,0.000098182725,0.0001942871,0.000030770443,0.0000416131,0.000028705657,0.0000527116,0.00012872637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006343811,0.0049315738,0.98394185,0.000014037566,0.000087881825,0.0061296546,0.0015070345,3.642106e-7,0.00028678344,0.000070291986,0.00016870139,0.0028554725],"study_design_scores_gemma":[0.017404305,0.000054300886,0.964795,0.000090196074,0.000097235665,0.00014202716,0.0009876299,0.000011436315,0.007954032,0.000004800549,0.008312193,0.00014682446],"about_ca_topic_score_codex":0.04404918,"about_ca_topic_score_gemma":0.13061346,"teacher_disagreement_score":0.08656427,"about_ca_system_score_codex":0.0003349424,"about_ca_system_score_gemma":0.00075944,"threshold_uncertainty_score":0.9623166},"labels":[],"label_agreement":null},{"id":"W3211885324","doi":"10.1182/blood-2021-148866","title":"Deleterious Germline Variants Are Present in Patients with Myelodysplastic Syndrome of All Ages Treated with Related Allogeneic Stem Cell Transplantation","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Germline; Transplantation; Hematopoietic stem cell transplantation; Medicine; Medical genetics; Myelodysplastic syndromes; Genetics; Germline mutation; Biology; Internal medicine; Bone marrow; Mutation; Gene","score_opus":0.008765423723606959,"score_gpt":0.21869479566049857,"score_spread":0.20992937193689162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211885324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986738,0.00018989963,0.000028321623,0.000094265735,0.0000144278465,0.00069640955,0.00009075136,0.00003996993,0.00017213983],"genre_scores_gemma":[0.997995,0.0001220182,0.0005596478,0.000030429275,0.000009548832,0.00003585463,0.0006479664,0.000053476153,0.0005460412],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981382,0.00014376585,0.00040183176,0.00042017744,0.000529284,0.0003667733],"domain_scores_gemma":[0.9989667,0.00009845786,0.0001640482,0.00035461466,0.00026693402,0.00014925915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010029215,0.00022439414,0.0004845777,0.00020471863,0.000026452657,0.000012018788,0.00010156902,0.00014187898,0.000066389715],"category_scores_gemma":[0.000012947773,0.00016528185,0.000041814597,0.0005508703,0.00006386282,0.00007713401,0.000026268817,0.0002750905,0.000010574478],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040066894,0.004273113,0.9337526,0.0013768511,0.0010077232,0.021191064,0.0008128999,0.0005138126,0.032311283,0.0000026401715,0.000025517538,0.0007257962],"study_design_scores_gemma":[0.025159188,0.002755196,0.94510025,0.00065470353,0.0007183112,0.0008350236,0.00006512824,0.00013745662,0.024376795,0.0000011286646,0.000007747523,0.00018906427],"about_ca_topic_score_codex":0.00009763701,"about_ca_topic_score_gemma":0.000058513437,"teacher_disagreement_score":0.021152498,"about_ca_system_score_codex":0.00009285402,"about_ca_system_score_gemma":0.0002256288,"threshold_uncertainty_score":0.6739998},"labels":[],"label_agreement":null},{"id":"W3211914517","doi":"10.1182/blood-2021-146012","title":"Rapid and Sustained Reduction of Immunosuppressive T-Cells and Focusing of the T-Cell Repertoire in t(11;14) Relapsed/Refractory Multiple Myeloma Patients Treated with Venetoclax in Combination with Daratumumab and Dexamethasone","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Daratumumab; Venetoclax; Multiple myeloma; Medicine; Refractory (planetary science); Lenalidomide; Immunology; Cancer research; Oncology; Biology; Leukemia; Chronic lymphocytic leukemia","score_opus":0.008048729171041265,"score_gpt":0.21969716987758914,"score_spread":0.21164844070654787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211914517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975905,0.0014533611,0.0000015461244,0.00004330948,0.000012473342,0.0007693216,0.000015058929,0.0000058848495,0.00010859185],"genre_scores_gemma":[0.9990497,0.00028468197,0.00048375945,0.0000031303991,0.000005027961,0.000024330267,0.000044435204,0.000018600613,0.00008633871],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886376,0.0001721098,0.0002500406,0.00028833892,0.0002432171,0.0001825537],"domain_scores_gemma":[0.9991673,0.00012467061,0.00016842372,0.00024158545,0.0002337499,0.00006426331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000108831715,0.00014610526,0.0003207541,0.00014685017,0.000059486178,0.000011292295,0.000032289397,0.000082747014,0.0000028878815],"category_scores_gemma":[0.0001451143,0.000096468146,0.000018327504,0.00033318918,0.0002025464,0.0001113132,0.000054274817,0.00015770977,4.8485113e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00219871,0.0019548752,0.8164322,0.00029123452,0.000105815736,0.00011950783,0.0011001909,0.00000407583,0.17221758,0.0000033165456,0.0000027535698,0.0055697686],"study_design_scores_gemma":[0.033983994,0.0012239836,0.5583424,0.0004941959,0.00009480129,0.000047434492,0.0006882889,0.000118109994,0.40492254,0.000005572279,0.0000065148993,0.00007217081],"about_ca_topic_score_codex":0.0005035888,"about_ca_topic_score_gemma":0.00021735551,"teacher_disagreement_score":0.2580898,"about_ca_system_score_codex":0.000074662246,"about_ca_system_score_gemma":0.00017917271,"threshold_uncertainty_score":0.39338568},"labels":[],"label_agreement":null},{"id":"W3211916615","doi":"10.1182/blood-2021-148731","title":"Impact of Polypharmacy and Potentially Inappropriate Medications Among Older Adults with Blood Cancers","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Polypharmacy; Medicine; Population; Comorbidity; Geriatric oncology; Geriatrics; Adverse effect; Deprescribing; Montreal Cognitive Assessment; Gerontology; Cancer; Internal medicine; Cognition; Psychiatry; Cognitive impairment","score_opus":0.025342846951717568,"score_gpt":0.3453685108656461,"score_spread":0.3200256639139285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211916615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996463,0.0012598739,0.00003934364,0.0004732377,0.000045305518,0.00030641316,0.000022407834,0.000023437025,0.0013669892],"genre_scores_gemma":[0.99805266,0.0005864861,0.0009192763,0.00017551905,0.00006179742,0.000013264196,0.00003016168,0.000016116288,0.00014469445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990692,0.00004315983,0.0002104797,0.00021493436,0.0002721676,0.00019006558],"domain_scores_gemma":[0.9991777,0.000075540185,0.00013601853,0.00020345731,0.00015223505,0.0002550784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008469835,0.00012100918,0.00023836979,0.000050963237,0.000046577657,0.000012265584,0.00004921966,0.00004510442,0.0003499389],"category_scores_gemma":[0.00008238135,0.00008449044,0.00007608308,0.00021373686,0.00010728899,0.00012805784,0.000038411363,0.00019464412,0.0000023976893],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030952122,0.0012640101,0.988381,0.00023472407,0.0014715424,0.00017976252,0.0006452516,0.0000042016572,0.00454317,0.000024100984,0.000037475336,0.002905236],"study_design_scores_gemma":[0.017356081,0.0005388028,0.962508,0.00037230656,0.003414056,0.00030810235,0.0002167895,0.00029753093,0.0147235105,0.000008217946,0.00010033989,0.00015622562],"about_ca_topic_score_codex":0.00047412905,"about_ca_topic_score_gemma":0.000042554148,"teacher_disagreement_score":0.025872968,"about_ca_system_score_codex":0.00001482412,"about_ca_system_score_gemma":0.00039130895,"threshold_uncertainty_score":0.38315856},"labels":[],"label_agreement":null},{"id":"W3211924837","doi":"10.1182/blood-2021-146078","title":"The International Hemoglobinopathy Research Network (INHERENT): An International Initiative to Study the Role of Genetic Modifiers in Hemoglobinopathies","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Hemoglobinopathy; Thalassemia; Medicine; Disease; Ethnic group; Genotyping; Intensive care medicine; Genetics; Biology; Genotype; Pathology; Political science; Gene; Internal medicine","score_opus":0.033952324102535784,"score_gpt":0.3198960594190098,"score_spread":0.285943735316474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211924837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825929,0.0018656803,0.000010332778,0.002970226,0.00050863303,0.00095753645,0.000015207532,0.000024743003,0.011054751],"genre_scores_gemma":[0.99798155,0.0005753234,0.00035005895,0.00042720197,0.0002957893,0.00015143919,0.000020885853,0.00002751837,0.00017026108],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996955,0.00047776732,0.00057210715,0.00043843198,0.0010281423,0.0005285484],"domain_scores_gemma":[0.9981492,0.00028899562,0.000103125,0.0006272566,0.00067930203,0.00015213121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014042328,0.00018422617,0.00026429963,0.00015152823,0.00032722115,0.00010178864,0.00069421093,0.0001116275,0.00007620667],"category_scores_gemma":[0.0005941347,0.00011872261,0.00009699215,0.0009104799,0.0002033023,0.000095719064,0.000463864,0.0006477962,0.000024365208],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011271622,0.0093312,0.89723843,0.000023679997,0.0014370071,0.0009281779,0.021710522,0.0021144992,0.008306617,0.0034001293,0.0010143949,0.05336815],"study_design_scores_gemma":[0.011827291,0.0025152485,0.7745162,0.0003455002,0.000317259,0.00043396233,0.16653809,0.0020863952,0.018263994,0.006805998,0.015835388,0.0005146283],"about_ca_topic_score_codex":0.0001523175,"about_ca_topic_score_gemma":0.00031256204,"teacher_disagreement_score":0.14482756,"about_ca_system_score_codex":0.00009368772,"about_ca_system_score_gemma":0.000349569,"threshold_uncertainty_score":0.48413676},"labels":[],"label_agreement":null},{"id":"W3211931509","doi":"10.1182/blood-2021-147551","title":"Disrupting Ectopic Super-Enhancers to Treat Multiple Myeloma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Enhancer; BRD4; Bromodomain; Cancer research; Bortezomib; Biology; Ixazomib; Transcription factor; Multiple myeloma; Chromatin; Acetylation; Carfilzomib; Genetics; Immunology; Gene","score_opus":0.0265716416777689,"score_gpt":0.30919431805025294,"score_spread":0.28262267637248406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211931509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98874134,0.00047799115,0.000060842616,0.00083127676,0.00006705147,0.00034721603,0.00002158942,0.00008573776,0.009366941],"genre_scores_gemma":[0.98967916,0.00004898353,0.003642297,0.00024342042,0.00021773661,0.00007332737,0.000078606165,0.00002824785,0.0059882044],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99861836,0.00004302274,0.00017673367,0.00038287838,0.00031665564,0.00046235],"domain_scores_gemma":[0.9989189,0.00011423811,0.000018483683,0.00040642405,0.00011461963,0.00042732846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000059917504,0.00015890454,0.00026820792,0.00008105108,0.000109448985,0.000035979865,0.000069903144,0.00006106171,0.0004971387],"category_scores_gemma":[0.00052626117,0.00013326416,0.00011657652,0.00029238174,0.000024399904,0.00005411043,0.00008400996,0.00012657876,0.00042767107],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020460448,0.0016356151,0.6746509,0.00018848827,0.00031293157,0.004091407,0.00061825337,0.000002845724,0.26318425,0.000037774076,0.00043041806,0.054642476],"study_design_scores_gemma":[0.010657884,0.00044002046,0.35100338,0.00014083312,0.00018325435,0.00029801,0.00033458628,0.00007851774,0.63357276,0.00001549329,0.003080058,0.00019523092],"about_ca_topic_score_codex":0.00012220789,"about_ca_topic_score_gemma":0.0001295854,"teacher_disagreement_score":0.37038848,"about_ca_system_score_codex":0.00007034781,"about_ca_system_score_gemma":0.00015562733,"threshold_uncertainty_score":0.5496989},"labels":[],"label_agreement":null},{"id":"W3211966340","doi":"10.1182/blood-2021-145694","title":"Mosunetuzumab in Combination with Lenalidomide Has a Manageable Safety Profile and Encouraging Activity in Patients with Relapsed/Refractory Follicular Lymphoma: Initial Results from a Phase Ib Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Lenalidomide; Follicular lymphoma; Internal medicine; Refractory (planetary science); Population; Cytokine release syndrome; Oncology; Gastroenterology; Lymphoma; Cancer; Multiple myeloma; Immunotherapy","score_opus":0.013166044199786413,"score_gpt":0.24545393056901374,"score_spread":0.23228788636922731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211966340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976628,0.00016740843,0.000009098735,0.00019089745,0.000028014862,0.0013698604,0.0001105637,0.000028202456,0.00043315676],"genre_scores_gemma":[0.9988985,0.00002047794,0.0003903746,0.00004461174,0.000019820787,0.00016543744,0.00039948215,0.000025466123,0.00003584522],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829745,0.00016613216,0.00031858403,0.0005630276,0.00040202859,0.00025279817],"domain_scores_gemma":[0.9991589,0.00015092162,0.00014668376,0.0003465366,0.00009822369,0.00009872101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001819046,0.00022948727,0.0004568909,0.00013812051,0.00009107367,0.000055391916,0.000043582255,0.00006978213,0.000014605603],"category_scores_gemma":[0.00007854819,0.00017467489,0.000030379382,0.00035060983,0.00004553508,0.00023995245,0.000054571145,0.00010952075,0.000002591594],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012837648,0.07737999,0.89009815,0.00004280749,0.00048565093,0.004852741,0.0026205059,0.000013041277,0.00010561218,0.000007481214,0.000020331354,0.011536049],"study_design_scores_gemma":[0.2728468,0.002654309,0.7193481,0.00034947094,0.00034441444,0.000013768494,0.0005557284,0.00009465396,0.0035720647,0.000010278424,0.000053929343,0.00015650614],"about_ca_topic_score_codex":0.0023781136,"about_ca_topic_score_gemma":0.0015562502,"teacher_disagreement_score":0.26000914,"about_ca_system_score_codex":0.00030246872,"about_ca_system_score_gemma":0.00030335656,"threshold_uncertainty_score":0.7123035},"labels":[],"label_agreement":null},{"id":"W3211973494","doi":"10.1182/blood-2021-149784","title":"Sarcopenia Is a Clinically Relevant and Independent Predictor of Health Outcomes after Chimeric Antigen Receptor T-Cell Therapy for Lymphoma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Chimeric antigen receptor; Sarcopenia; Internal medicine; Cytokine release syndrome; Oncology; Lymphoma; Population; Aggressive lymphoma; Cancer; Rituximab; Immunotherapy","score_opus":0.0333452428984363,"score_gpt":0.34050106791555657,"score_spread":0.30715582501712024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211973494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9782252,0.01062466,0.00007449976,0.009774878,0.00018511,0.0008381365,0.000099856086,0.00003266944,0.00014500899],"genre_scores_gemma":[0.95970213,0.011062836,0.01475915,0.013476977,0.00013309944,0.00009100975,0.000037869282,0.00003434808,0.00070258084],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984339,0.00008031839,0.0006904491,0.00030716162,0.00022850555,0.00025969645],"domain_scores_gemma":[0.999057,0.00012607287,0.0002105989,0.0002633676,0.00014027512,0.00020266527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046225317,0.00012761589,0.00055124116,0.00006177957,0.000063803054,0.000010665466,0.000051459698,0.00008795852,0.00024780043],"category_scores_gemma":[0.00007257199,0.00010477024,0.0001215589,0.00010515703,0.00004391936,0.000030910494,0.000033833858,0.00009000701,0.000008813664],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008364853,0.0030984937,0.9662563,0.0011375208,0.00016044264,0.000017310425,0.0011681113,1.0801143e-8,0.0051139956,0.000019952855,0.0023774593,0.019813912],"study_design_scores_gemma":[0.030200725,0.0015698774,0.9121014,0.00046803156,0.00006975319,0.00004552642,0.00023401342,0.000009848583,0.013889334,0.00015106976,0.041093986,0.00016645479],"about_ca_topic_score_codex":0.000020394444,"about_ca_topic_score_gemma":0.0000037606453,"teacher_disagreement_score":0.05415493,"about_ca_system_score_codex":0.000020985539,"about_ca_system_score_gemma":0.00049544405,"threshold_uncertainty_score":0.42724064},"labels":[],"label_agreement":null},{"id":"W3211979408","doi":"10.1182/blood-2021-154457","title":"Clinical and Pathological Characteristics of Hypocellular Myelodysplastic Syndrome : A Single-Center Retrospective Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Myelodysplastic syndromes; Single Center; Retrospective cohort study; International Prognostic Scoring System; Multivariate analysis; Oncology; Pathology; Gastroenterology","score_opus":0.036707680814483265,"score_gpt":0.3031005321545125,"score_spread":0.2663928513400292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211979408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985531,0.00013036237,0.00004683058,0.00014873211,0.000092955015,0.00044520252,0.000035702706,0.000032990036,0.00051413773],"genre_scores_gemma":[0.99847674,0.00006005964,0.0008876546,0.000085586275,0.00011274426,0.000014601815,0.000023415385,0.000023510142,0.00031570994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99810773,0.00023422381,0.0005329546,0.000471594,0.00038249439,0.00027099444],"domain_scores_gemma":[0.9988128,0.00019528695,0.00010293245,0.00039272034,0.00029447136,0.0002017906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048368837,0.0001526889,0.00070143153,0.00006878051,0.000042075364,0.000017791242,0.00008474332,0.00015292696,0.00012559287],"category_scores_gemma":[0.0017538558,0.00012607539,0.00009942404,0.00023068325,0.0002483727,0.0000321251,0.0002515276,0.0005100819,0.000024095954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001625546,0.008185079,0.9663856,0.0000723556,0.00025512456,0.013696716,0.00017109468,8.5215826e-9,0.010439634,0.000033962155,0.00002760662,0.00057024416],"study_design_scores_gemma":[0.00820932,0.0038849572,0.9824161,0.000087112596,0.00039108735,0.0037898787,0.00026713134,0.00001768552,0.0007072974,0.000036849044,0.00008077314,0.000111824746],"about_ca_topic_score_codex":0.000001844744,"about_ca_topic_score_gemma":0.0000013094974,"teacher_disagreement_score":0.016030464,"about_ca_system_score_codex":0.000043203698,"about_ca_system_score_gemma":0.00016794214,"threshold_uncertainty_score":0.5141205},"labels":[],"label_agreement":null},{"id":"W3211983706","doi":"10.1182/blood-2021-147390","title":"Optimizing Cancer Associated Thrombosis (CAT) Risk Assessment Model at a Safety-Net Healthcare System","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Deep vein; Pulmonary embolism; Thrombosis; Cancer; Internal medicine; Medical record; Diagnosis code; Cohort; Emergency medicine; Intensive care medicine; Population","score_opus":0.026265198901224456,"score_gpt":0.3103451572103137,"score_spread":0.2840799583090892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211983706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9742347,0.003261273,0.00075586763,0.0064701014,0.0004617803,0.0010991622,0.00038394416,0.0003881756,0.012944975],"genre_scores_gemma":[0.9849123,0.0058312356,0.0064944937,0.0013270847,0.00015884051,0.00026166366,0.00020299303,0.00006880298,0.00074263354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976833,0.00016872524,0.0004882388,0.00056716666,0.00054429605,0.0005482721],"domain_scores_gemma":[0.99855244,0.00006123094,0.0002651075,0.00056064775,0.00029856243,0.00026202048],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038103008,0.00026752971,0.00086982583,0.0000775712,0.00037680112,0.000048697228,0.00011541212,0.0001608571,0.00018048137],"category_scores_gemma":[0.000053675696,0.00025375673,0.00022008292,0.00029917882,0.000026249161,0.00007233559,0.00024507768,0.00023243605,0.000028683335],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032057284,0.039550856,0.6611161,0.013705218,0.03417691,0.0024152,0.016262833,0.07977927,0.029992199,0.0314412,0.081121415,0.010118201],"study_design_scores_gemma":[0.026339747,0.0011540484,0.74523026,0.0072255987,0.017511891,0.00010339291,0.006483739,0.17659634,0.012166156,0.00020229712,0.0050266203,0.0019598894],"about_ca_topic_score_codex":0.0013543272,"about_ca_topic_score_gemma":0.0013570643,"teacher_disagreement_score":0.09681707,"about_ca_system_score_codex":0.0011713027,"about_ca_system_score_gemma":0.00050417637,"threshold_uncertainty_score":0.9999915},"labels":[],"label_agreement":null},{"id":"W3211995673","doi":"10.1182/blood-2021-151458","title":"Dynamic Stromal Changes in Myelofibrosis Patients Pre/Post JAK Inhibition Is Revealed in Clinically Archived Bone Marrow Biopsies By Smooth Muscle Actin (SMA)-CD34 Dual Immunohistochemistry","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Queen's University; University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Myelofibrosis; Pathology; Stromal cell; CD34; Bone marrow; Pulmonary fibrosis; Fibrosis; Cancer research; Internal medicine; Oncology; Stem cell; Biology","score_opus":0.007572596675188288,"score_gpt":0.258740802648175,"score_spread":0.2511682059729867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211995673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958313,0.0005776148,0.0000015460528,0.0018505121,0.00007131353,0.00069330464,0.0005367592,0.00004022144,0.0003974433],"genre_scores_gemma":[0.99512523,0.00053055363,0.0012088376,0.00049125624,0.000045217024,0.0003338683,0.0017131659,0.0000439323,0.0005079101],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.997644,0.00014335451,0.00070901436,0.00068529724,0.0003739853,0.0004443361],"domain_scores_gemma":[0.9988322,0.00022001176,0.00023350134,0.0004037941,0.00015454885,0.00015589123],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018179904,0.00033745618,0.00064062135,0.0001397705,0.00007602892,0.000036489004,0.00006308598,0.00021067288,0.00022938747],"category_scores_gemma":[0.00033527784,0.00032826496,0.00014176437,0.00024533444,0.000095357915,0.00008262002,0.000115147806,0.00037189436,0.0000173149],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053442724,0.0067528253,0.431268,0.00021553617,0.00010535591,0.00030873853,0.0012859805,4.848462e-7,0.55593944,0.0000024555993,0.0002830572,0.0033037062],"study_design_scores_gemma":[0.012391313,0.0011266011,0.84682584,0.00082135224,0.00015694641,0.000023760285,0.00032406815,0.000023519131,0.1378775,0.000019964384,0.00012880372,0.0002803381],"about_ca_topic_score_codex":0.00015420953,"about_ca_topic_score_gemma":0.00050399394,"teacher_disagreement_score":0.41806194,"about_ca_system_score_codex":0.00018085787,"about_ca_system_score_gemma":0.00018271967,"threshold_uncertainty_score":0.9999169},"labels":[],"label_agreement":null},{"id":"W3211997738","doi":"10.1182/blood-2021-147937","title":"Subcutaneous (SC) Administration of Mosunetuzumab with Cycle 1 Step-up Dosing Is Tolerable and Active in Patients with Relapsed/Refractory B-Cell Non-Hodgkin Lymphomas (R/R B-NHL): Initial Results from a Phase I/II Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada); BC Cancer Agency; Jewish General Hospital","funders":"","keywords":"Tolerability; Dosing; Medicine; Pharmacokinetics; Refractory (planetary science); Internal medicine; Neutropenia; Cytokine release syndrome; Gastroenterology; Toxicity; Adverse effect; Pharmacology; Immunotherapy; Cancer","score_opus":0.013300032276117554,"score_gpt":0.2837511359260015,"score_spread":0.27045110364988395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211997738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958874,0.00009816197,0.0000104352775,0.0000420094,0.000048392376,0.0011927796,0.0002895372,0.00002313156,0.002408176],"genre_scores_gemma":[0.9983506,0.000022469614,0.0004324139,0.000047422815,0.000064583044,0.000031770636,0.0002914294,0.00005370117,0.0007055878],"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975939,0.00016182294,0.0004889387,0.00064802566,0.0007646196,0.00034269827],"domain_scores_gemma":[0.998519,0.00021045584,0.00022473725,0.0005460715,0.00032650382,0.00017325596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017562055,0.0002652371,0.0005404584,0.0001570693,0.00010790545,0.000042059568,0.000092260874,0.0001299678,0.00024477055],"category_scores_gemma":[0.000060618866,0.00022634197,0.000043269614,0.00043599305,0.0001070668,0.0001722464,0.0000775674,0.0003448541,0.0000023959346],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.46395814,0.13627651,0.09669828,0.00030825892,0.0019841194,0.011334039,0.05734,0.0000239586,0.15167756,0.0000029243345,0.00014420206,0.080251984],"study_design_scores_gemma":[0.40025333,0.10357579,0.07485079,0.0007924411,0.00086355495,0.00024686658,0.007324278,0.00043548504,0.41070315,0.000017400054,0.00024761556,0.0006893016],"about_ca_topic_score_codex":0.0008866912,"about_ca_topic_score_gemma":0.0007271631,"teacher_disagreement_score":0.25902557,"about_ca_system_score_codex":0.00013243312,"about_ca_system_score_gemma":0.00078084244,"threshold_uncertainty_score":0.9229958},"labels":[],"label_agreement":null},{"id":"W3212004376","doi":"10.1182/blood-2021-149728","title":"A Large Multicenter Real-World Evidence (RWE) Analysis of Autoimmune (AI) Diseases and Lymphoma: Histologic Associations, Disease Characteristics, Survival, and Prognostication","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Lymphoma; Univariate analysis; Diffuse large B-cell lymphoma; Proportional hazards model; Disease; Rituximab; Rheumatoid arthritis; Survival analysis; Oncology; Multivariate analysis","score_opus":0.021407496171548072,"score_gpt":0.2953472159676918,"score_spread":0.27393971979614373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212004376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870252,0.010472596,0.000015211968,0.0015583573,0.000050628587,0.00028985273,0.0004998542,0.000035496156,0.000052791795],"genre_scores_gemma":[0.9943606,0.004355186,0.00017896772,0.00014216905,0.000028747201,0.000071666436,0.0006727115,0.000009549622,0.00018040367],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988485,0.00010691231,0.0003315526,0.0003295972,0.00021514244,0.00016830495],"domain_scores_gemma":[0.9986762,0.00041244415,0.00019296946,0.00030250908,0.00023837379,0.00017754793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000117835014,0.00013757583,0.0004938212,0.00014634315,0.000087844004,0.000033286193,0.000034352546,0.000038008067,0.000051613926],"category_scores_gemma":[0.0011291446,0.0001175547,0.00011751991,0.0003964206,0.00006171949,0.000087692155,0.00006937723,0.0000272577,0.0000023450705],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006771289,0.004520144,0.99169624,0.00013984121,0.0014105089,0.0001516382,0.00011424553,1.2343602e-7,0.00018534315,0.00066047,0.000044274995,0.0010094313],"study_design_scores_gemma":[0.0029708466,0.00005432255,0.9796734,0.0001869847,0.016240222,0.0000021165667,0.000047002522,0.0003905862,0.0001619658,0.000021953269,0.00015037134,0.00010022959],"about_ca_topic_score_codex":0.00016276723,"about_ca_topic_score_gemma":0.0001248028,"teacher_disagreement_score":0.014829714,"about_ca_system_score_codex":0.00009654865,"about_ca_system_score_gemma":0.00020117604,"threshold_uncertainty_score":0.47937417},"labels":[],"label_agreement":null},{"id":"W3212033375","doi":"10.1182/blood-2021-147195","title":"Emicizumab Outcomes in Hemophilia A Using Real-World Data from the Canadian Hemophilia Bleeding Disorder Registry","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Impact; Roche (Canada); University of Calgary","funders":"","keywords":"Medicine; Pediatrics; Population; Environmental health","score_opus":0.08611013211458522,"score_gpt":0.35184657715546624,"score_spread":0.265736445040881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212033375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97660685,0.0008116442,0.0000010824122,0.01590004,0.00014613272,0.00038236982,0.00026806712,0.000038050337,0.0058457726],"genre_scores_gemma":[0.99172527,0.00024123349,0.0008795167,0.0005302435,0.0003731179,0.0000118955195,0.00074642967,0.000048760787,0.0054435357],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976803,0.00009900619,0.00037221133,0.0006643311,0.0005087259,0.0006754407],"domain_scores_gemma":[0.9974366,0.00027590554,0.00007077137,0.0017654145,0.00010286328,0.00034843318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034302776,0.00025326695,0.0005050067,0.00018827118,0.00030569424,0.00010831911,0.0005146462,0.00012574455,0.0003064289],"category_scores_gemma":[0.00046327212,0.00017691361,0.00009882675,0.00084871054,0.00016868244,0.00012827304,0.00034184064,0.00056282873,0.000072835486],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030836985,0.00040604259,0.994012,0.00003101297,0.0002698757,0.00197296,0.00021610958,0.0000024604399,0.0014048088,0.00008915959,0.0009332884,0.0006314487],"study_design_scores_gemma":[0.008726809,0.000063316445,0.9735671,0.00060690683,0.00079285406,0.00021899496,0.0012392239,0.0015950658,0.0033520926,0.0005936906,0.008717602,0.0005263018],"about_ca_topic_score_codex":0.42474356,"about_ca_topic_score_gemma":0.85600615,"teacher_disagreement_score":0.43126258,"about_ca_system_score_codex":0.0003005835,"about_ca_system_score_gemma":0.0016330343,"threshold_uncertainty_score":0.7214328},"labels":[],"label_agreement":null},{"id":"W3212033605","doi":"10.1182/blood-2021-153165","title":"Development and Evaluation of a Library of TikToks to Support Recruitment of Committed Hematopoietic Stem Cell Donors from Needed Demographic Groups","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Social Media in Health Education","field":"Social Sciences","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; The Scarborough Hospital; University of British Columbia; Western University; University of Toronto; Toronto Metropolitan University; Brock University; McMaster University; University of Alberta; Simon Fraser University; Stem Cell Network; University of Regina","funders":"","keywords":"Donation; Stakeholder; Social media; Medicine; Public relations; Political science; World Wide Web; Computer science; Law","score_opus":0.16287251388208482,"score_gpt":0.3620652015594348,"score_spread":0.19919268767734996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212033605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963509,0.00052317325,0.000004735491,0.0005547751,0.0004153051,0.0012555524,0.000011434445,0.000014886363,0.00086925586],"genre_scores_gemma":[0.9951154,0.0000941381,0.0042945254,0.00005889855,0.000055795575,0.00032899165,0.000029649847,0.000009065137,0.000013510639],"study_design_codex":"qualitative","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99819505,0.00040994785,0.0004744391,0.00016564033,0.0006064889,0.00014840906],"domain_scores_gemma":[0.9986701,0.0005402716,0.00026995124,0.00015398308,0.00023540533,0.00013027039],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089350017,0.000072575196,0.00023746694,0.00010692132,0.00008011551,0.0000095585765,0.00011326961,0.00009232171,0.00011641375],"category_scores_gemma":[0.00016620404,0.00008121802,0.00003475047,0.0006110428,0.00008545519,0.00008066162,0.000047647325,0.00005274178,0.0000017584493],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030532985,0.0014815712,0.43646115,0.00043208807,0.00011884378,0.0000015967981,0.5061573,0.0000021485544,0.0063221618,0.0014254028,0.00021446412,0.04735274],"study_design_scores_gemma":[0.0023159683,0.00020550746,0.34882608,0.0003554677,0.0004305246,6.7203786e-7,0.16292793,0.000008363109,0.48037064,0.0017204166,0.002580769,0.00025767522],"about_ca_topic_score_codex":0.0010459287,"about_ca_topic_score_gemma":0.0007300751,"teacher_disagreement_score":0.47404847,"about_ca_system_score_codex":0.00003471257,"about_ca_system_score_gemma":0.0014009712,"threshold_uncertainty_score":0.3311975},"labels":[],"label_agreement":null},{"id":"W3212046099","doi":"10.1182/blood-2021-148806","title":"Integrating Touchscreen-Based Geriatric Assessment and Frailty Screening for Adults with Acute Myelogenous Leukemia to Drive Personalized Treatment Decisions","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Frailty in Older Adults","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Quality of life (healthcare); Activities of daily living; Geriatric oncology; Myeloid leukemia; Physical therapy; Cancer; Internal medicine","score_opus":0.03087929328161957,"score_gpt":0.3159009970430943,"score_spread":0.28502170376147473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212046099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9071432,0.00038914403,0.08812826,0.0016263287,0.00005393019,0.0017592487,0.00024565696,0.00011178365,0.0005424719],"genre_scores_gemma":[0.55421394,0.00005655604,0.44341666,0.00061703596,0.00014828485,0.00040740523,0.00030753846,0.000054144755,0.0007784235],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980463,0.000059398393,0.00035120896,0.0006925298,0.0003909593,0.00045964107],"domain_scores_gemma":[0.997985,0.0006238814,0.00011377423,0.00047017325,0.00040463204,0.0004025277],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011817391,0.00035166962,0.0005840896,0.00015278123,0.00025860994,0.00007163045,0.00009464976,0.00012261055,0.00006561805],"category_scores_gemma":[0.00028652762,0.00026500205,0.00016192907,0.00039931582,0.0000565603,0.00006096164,0.0000558578,0.00017487828,0.0000042960914],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011911822,0.00720452,0.10026741,0.0006092744,0.009969714,0.008363215,0.020120407,0.0006487506,0.089798346,0.0009095016,0.0028628388,0.7473342],"study_design_scores_gemma":[0.3574279,0.0569209,0.28085303,0.01009085,0.021226225,0.0062241224,0.029004507,0.030321972,0.18191554,0.00021853865,0.02162608,0.004170345],"about_ca_topic_score_codex":0.00022878406,"about_ca_topic_score_gemma":0.000658706,"teacher_disagreement_score":0.7431639,"about_ca_system_score_codex":0.00033399355,"about_ca_system_score_gemma":0.00118392,"threshold_uncertainty_score":0.9999802},"labels":[],"label_agreement":null},{"id":"W3212046139","doi":"10.1182/blood-2021-152750","title":"Safety and Efficacy of Lower Intensity Induction Therapy with Intravenous Prexigebersen (BP1001) in Patients with High-Risk and Relapsed/Refractory Acute Myeloid Leukemia (AML)","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Refractory (planetary science); Medicine; Myeloid leukemia; Internal medicine; Leukemia; Oncology; Induction therapy; Chemotherapy","score_opus":0.007087328058147671,"score_gpt":0.22210113527182812,"score_spread":0.21501380721368046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212046139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99851036,0.00030449405,0.0000281146,0.0001546667,0.000052233358,0.0007060138,0.000029039742,0.000033289463,0.00018179836],"genre_scores_gemma":[0.9963829,0.001873896,0.001267498,0.00010254342,0.00006545864,0.000009459782,0.000086985136,0.0000485295,0.00016270945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982352,0.000123204,0.0003277533,0.0005256479,0.00045055425,0.00033763977],"domain_scores_gemma":[0.9986476,0.000120606666,0.00017078375,0.0004666519,0.00041050377,0.00018390678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024220021,0.00025119534,0.00056742795,0.00017420364,0.00008214196,0.000019727795,0.00007354849,0.00019991297,0.000028828485],"category_scores_gemma":[0.00012237218,0.00018050766,0.000031147414,0.0004275519,0.0003071858,0.00016396114,0.00009749227,0.0007863056,0.0000024630835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039891765,0.0036453267,0.8883709,0.00014987473,0.0017104245,0.0008686511,0.003056615,0.000016931797,0.011246269,0.000037256563,0.00008214281,0.05092385],"study_design_scores_gemma":[0.036109082,0.0051020863,0.94490016,0.00022397838,0.0003203639,0.00021057461,0.00024690913,0.000009024436,0.012392541,0.000014616082,0.00026222557,0.00020842603],"about_ca_topic_score_codex":0.00061287475,"about_ca_topic_score_gemma":0.0001196886,"teacher_disagreement_score":0.056529276,"about_ca_system_score_codex":0.00028010574,"about_ca_system_score_gemma":0.0006327207,"threshold_uncertainty_score":0.7360889},"labels":[],"label_agreement":null},{"id":"W3212070088","doi":"10.1182/blood-2021-152762","title":"The Monocyte Monolayer Assay to Build a Personalized Pipeline of Transfusion Support in Highly Sensitized Sickle Cell Disease","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Canadian Blood Services; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Antigen; Seroconversion; Immunology; Antibody; Internal medicine","score_opus":0.009303353242544351,"score_gpt":0.23915145978351757,"score_spread":0.2298481065409732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212070088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99116117,0.0011959259,0.00041650597,0.004983524,0.00010281422,0.000582669,0.000033776352,0.000040359664,0.0014832341],"genre_scores_gemma":[0.9954953,0.0007748517,0.0009664059,0.0006452207,0.00009947552,0.000029541397,0.000042978863,0.000035289464,0.0019109261],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983484,0.00012320612,0.00043018252,0.00038109286,0.00039464387,0.00032248188],"domain_scores_gemma":[0.99889165,0.00012983326,0.000050367747,0.00045615836,0.00016926986,0.00030270292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041275757,0.00019334766,0.00042072692,0.00008498253,0.000085238345,0.000017339831,0.000087379696,0.000088543304,0.000119741344],"category_scores_gemma":[0.00007236276,0.0001411998,0.00022721964,0.0004011104,0.000034847617,0.00004103007,0.000037282192,0.00022222525,0.000022163069],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035555093,0.004250135,0.02474685,0.0003205716,0.00012108576,0.0018142689,0.0018923604,0.000020145324,0.95733756,0.00023289824,0.00068759965,0.005021028],"study_design_scores_gemma":[0.036171246,0.00058040523,0.057655804,0.00036114978,0.0014640907,0.00011576888,0.00080053706,0.0006907818,0.8842563,0.00014362538,0.01731852,0.00044176148],"about_ca_topic_score_codex":0.00014247713,"about_ca_topic_score_gemma":0.00019315531,"teacher_disagreement_score":0.07308124,"about_ca_system_score_codex":0.000018190447,"about_ca_system_score_gemma":0.00024903266,"threshold_uncertainty_score":0.57579607},"labels":[],"label_agreement":null},{"id":"W3212076589","doi":"10.1182/blood-2021-147307","title":"Clinical Outcomes of Solid Organ Transplant Patients with Epstein-Barr Virus-Driven (EBV +) Post-Transplant Lymphoproliferative Disorder (PTLD) Who Fail Rituximab Plus Chemotherapy: A Multinational, Retrospective Chart Review Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rituximab; Medicine; Post-transplant lymphoproliferative disorder; Immunosuppression; Internal medicine; Transplantation; Diffuse large B-cell lymphoma; Salvage therapy; Oncology; Chemotherapy; Gastroenterology; Lymphoma","score_opus":0.010131639561006198,"score_gpt":0.2851847260573234,"score_spread":0.2750530864963172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212076589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99185306,0.0028810434,0.00006078756,0.0015928193,0.00009482357,0.0021298742,0.0011128192,0.00006479268,0.00020996771],"genre_scores_gemma":[0.98964036,0.006443176,0.0001481069,0.0027956888,0.000056448258,0.00012947862,0.00046297474,0.000073503805,0.0002502833],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99678016,0.00023569906,0.0009528699,0.00071964547,0.0009041161,0.00040753031],"domain_scores_gemma":[0.9977916,0.00011217252,0.00040177457,0.00045751032,0.0010445241,0.00019242428],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029598904,0.00043264276,0.001741208,0.0000856401,0.00014506171,0.000017795048,0.00017064129,0.00016965091,0.000315528],"category_scores_gemma":[0.0001790091,0.00032444875,0.0003593676,0.00042793076,0.00014241283,0.00012854862,0.000027042906,0.00035126545,0.000015096245],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009582295,0.01158119,0.97921544,0.0003947852,0.0022928033,0.000094810726,0.004749703,0.0000026874422,0.00010443609,0.000019163788,0.00013615526,0.0004505654],"study_design_scores_gemma":[0.07213733,0.0030950473,0.91885144,0.0016538621,0.0019693759,0.000013755909,0.0011762991,0.000022071805,0.00050719193,0.00001077198,0.00015600689,0.00040686573],"about_ca_topic_score_codex":0.00020345667,"about_ca_topic_score_gemma":0.0010626953,"teacher_disagreement_score":0.07117911,"about_ca_system_score_codex":0.00013755875,"about_ca_system_score_gemma":0.00069283845,"threshold_uncertainty_score":0.9999208},"labels":[],"label_agreement":null},{"id":"W3212096586","doi":"10.1182/blood-2021-147723","title":"Risk of Recurrence after Stopping Anticoagulants in Women with Combined Oral Contraceptive-Associated Venous Thromboembolism: A Systematic Review and Meta-Analysis","year":2021,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; Thrombosis and Atherosclerosis Research Institute; University of Ottawa; Princess Margaret Cancer Centre; Ottawa Hospital; University of Calgary; Impact; McGill University; University Health Network","funders":"","keywords":"Medicine; Discontinuation; Systematic review; Meta-analysis; Prospective cohort study; Cohort study; MEDLINE; Randomized controlled trial; Relative risk; Pediatrics; Incidence (geometry); Internal medicine; Surgery; Confidence interval","score_opus":0.04159331805374656,"score_gpt":0.3137450464240003,"score_spread":0.27215172837025375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212096586","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026332445,0.9916158,0.0000060581133,0.000035718032,0.000019695006,0.005365076,0.0002517838,0.000027182166,0.00004544663],"genre_scores_gemma":[0.008150735,0.9891956,0.000110612375,0.00023448965,0.000007729762,0.0020974432,0.000092729555,0.000059536957,0.000051134164],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9951957,0.0012644287,0.0016890068,0.0007677884,0.00055018143,0.00053293636],"domain_scores_gemma":[0.99663454,0.0003212563,0.001702329,0.0009067853,0.00025843835,0.00017664125],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0016781981,0.000691261,0.027010828,0.00049116166,0.000049793663,0.00004328658,0.00021505904,0.00022423257,0.00021017651],"category_scores_gemma":[0.0004845902,0.00044493133,0.0012602056,0.0017774756,0.00010223305,0.00006938989,0.00014862356,0.00046290134,0.0000058960322],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009067162,0.0030091915,0.00008981303,0.6101335,0.38543037,0.00025720676,0.00035442555,3.3071404e-7,4.323148e-8,0.000013130892,0.000017934366,0.0006849534],"study_design_scores_gemma":[0.0009856287,0.00047796158,0.0017539053,0.16780517,0.8282446,0.000028029042,0.00009305278,0.0000010486618,2.0384452e-7,0.0000038978765,0.00025534633,0.0003511633],"about_ca_topic_score_codex":0.0001527044,"about_ca_topic_score_gemma":0.00014055522,"teacher_disagreement_score":0.44281423,"about_ca_system_score_codex":0.00012598358,"about_ca_system_score_gemma":0.00022348724,"threshold_uncertainty_score":0.99980026},"labels":[],"label_agreement":null},{"id":"W3212097861","doi":"10.1182/blood-2021-146543","title":"Characterizing Mild and Moderate Hemophilia A Patients in the Real World: A Patient-Centric Approach","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Cohort; Disease; Health care; Family medicine; Internal medicine","score_opus":0.027696480162016493,"score_gpt":0.27046893271162886,"score_spread":0.24277245254961238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212097861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895674,0.00032727083,6.424775e-7,0.00085800904,0.000027704553,0.0004720292,0.000008446454,0.000015704658,0.008722807],"genre_scores_gemma":[0.9981092,0.0003895736,0.00028046657,0.00035218074,0.000067979716,0.000051379797,0.00012912629,0.0000143929,0.0006056532],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987985,0.00010833271,0.00018637681,0.00028089908,0.00032307746,0.00030283572],"domain_scores_gemma":[0.99951994,0.000048989135,0.000031275275,0.00023827922,0.00006556215,0.000095924916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011956004,0.00012394399,0.00021392452,0.00014413166,0.00008523093,0.0000434803,0.000055137883,0.000050398725,0.000017678249],"category_scores_gemma":[0.000043788612,0.00007851984,0.00004757062,0.0005339583,0.000035450434,0.000055075576,0.00006245395,0.0002117111,0.0000088405795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019842236,0.00577868,0.9788212,0.00017078256,0.0001148268,0.0005816514,0.003360732,3.8121098e-7,0.0014555804,0.00012121955,0.00011116197,0.009285365],"study_design_scores_gemma":[0.012571148,0.00040029964,0.9756837,0.00017959777,0.00019211155,0.00008067727,0.0006005181,0.00045448236,0.008514148,0.00009061651,0.0010066899,0.00022600565],"about_ca_topic_score_codex":0.000039394352,"about_ca_topic_score_gemma":0.000017089365,"teacher_disagreement_score":0.012372725,"about_ca_system_score_codex":0.000024940397,"about_ca_system_score_gemma":0.00007290929,"threshold_uncertainty_score":0.32019463},"labels":[],"label_agreement":null},{"id":"W3212101598","doi":"10.1182/blood-2021-149745","title":"Genomic and Transcriptional Characterization of Primary Mediastinal Large B Cell Lymphoma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Lymphoma; Diffuse large B-cell lymphoma; Transcriptome; Exome sequencing; Exome; Population; Cancer; Medicine; Biology; Cancer research; Gene; Genetics; Pathology; Gene expression; Mutation","score_opus":0.009339733984790783,"score_gpt":0.2005546087269797,"score_spread":0.1912148747421889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212101598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967748,0.0014118244,0.000028444589,0.00019802368,0.000048398448,0.00009347391,0.000108602115,0.00001111905,0.0013253293],"genre_scores_gemma":[0.9979877,0.00047992528,0.00046394783,0.00024520568,0.00008085841,0.000011400768,0.000534953,0.000008412987,0.00018761038],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99949336,0.000014744616,0.00013780985,0.00013760405,0.00011997939,0.00009649965],"domain_scores_gemma":[0.9997428,0.000015550275,0.000039953153,0.000088486835,0.000050203584,0.00006301173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000036027504,0.00006962675,0.00016582766,0.00002764172,0.00002447603,0.00000573155,0.000015167892,0.00003717956,0.000101106205],"category_scores_gemma":[0.000005328504,0.00006201168,0.00004614661,0.000051150866,0.000017839977,0.000029137622,0.000013738474,0.000014952305,0.0000071047575],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003794771,0.0045866035,0.15968895,0.0001245323,0.00007104063,0.00010440029,0.00019742246,1.7111871e-8,0.83229494,0.00031401074,0.000009761469,0.0025703802],"study_design_scores_gemma":[0.010413433,0.00009656813,0.82843316,0.000035450248,0.00023971255,0.00017148578,0.000015587075,0.0000036795818,0.15945911,0.000007950336,0.0010812739,0.000042609478],"about_ca_topic_score_codex":0.0000036009108,"about_ca_topic_score_gemma":0.000001535939,"teacher_disagreement_score":0.6728358,"about_ca_system_score_codex":0.000024970443,"about_ca_system_score_gemma":0.00015587159,"threshold_uncertainty_score":0.25287628},"labels":[],"label_agreement":null},{"id":"W3212121153","doi":"10.1182/blood-2021-145949","title":"Myelodysplastic Syndromes: A More Global 5-Hydroxymethylcytosine Deficiency Disorder Than Suggested By the Presence of TET2 Mutations","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Myelodysplastic syndromes; Biology; Missense mutation; Genetics; Cancer research; Mutation; Myeloid; Myeloid leukemia; Population; Deep sequencing; Gene; Medicine; Immunology; Genome; Bone marrow","score_opus":0.013312526206543458,"score_gpt":0.2900261979436438,"score_spread":0.2767136717371004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212121153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98744226,0.005743705,0.00078067713,0.002986535,0.00006035338,0.0004833214,0.0002175329,0.00006060266,0.0022250141],"genre_scores_gemma":[0.9974924,0.00015275556,0.0006903664,0.00008931627,0.000037528618,0.000060880924,0.00014181428,0.000024570112,0.001310383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979194,0.00014080046,0.0003471153,0.00039755844,0.0007574251,0.0004376997],"domain_scores_gemma":[0.99817,0.00050524104,0.00008704084,0.00073728844,0.00034240575,0.00015798147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022632886,0.00019127846,0.00035496807,0.00005990643,0.0001467664,0.000028972452,0.00031090996,0.00010804578,0.00016648445],"category_scores_gemma":[0.0017168763,0.00013352749,0.00014096634,0.0014378598,0.0004060341,0.00008043095,0.0001890753,0.00031163692,0.000040131625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061315764,0.018907085,0.5796614,0.0029150124,0.0038124954,0.003962965,0.006239213,0.001168159,0.34879148,0.004044399,0.014058519,0.015826073],"study_design_scores_gemma":[0.04004916,0.0035282706,0.6824836,0.0016629192,0.0064206235,0.016045278,0.01603777,0.011469635,0.2071268,0.0018124385,0.011556244,0.001807256],"about_ca_topic_score_codex":0.00028791776,"about_ca_topic_score_gemma":0.00005416302,"teacher_disagreement_score":0.14166468,"about_ca_system_score_codex":0.00008279851,"about_ca_system_score_gemma":0.0008243567,"threshold_uncertainty_score":0.5445093},"labels":[],"label_agreement":null},{"id":"W3212123828","doi":"10.1182/blood-2021-149967","title":"Efficacy, Toxicity and Cost of Venetoclax-Based Combinations for the Treatment of Acute Myeloid Leukemia: Real-World Evidence from a Canadian Academic Center","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Ven; Venetoclax; Medicine; Cytarabine; Internal medicine; Chemotherapy regimen; Myeloid leukemia; Azacitidine; Tumor lysis syndrome; Posaconazole; Chemotherapy; Oncology; Leukemia; Surgery; Chronic lymphocytic leukemia; Voriconazole","score_opus":0.044092088180513,"score_gpt":0.33585577871312666,"score_spread":0.29176369053261364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212123828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924167,0.0012684712,0.00007305475,0.0037314,0.00004689545,0.0014077714,0.00082163664,0.000013267575,0.00022082274],"genre_scores_gemma":[0.99474055,0.0032359948,0.00067949423,0.00023934794,0.00008003969,0.00016412092,0.00021249626,0.000022772427,0.00062518654],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987817,0.00007291547,0.0003099755,0.00028075106,0.00025212456,0.00030258036],"domain_scores_gemma":[0.99759495,0.0013329592,0.000103037804,0.00046781785,0.00025420793,0.0002470057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016357834,0.00014504809,0.00036974536,0.00013556523,0.00010530954,0.000010155954,0.00015226548,0.00012401694,0.000049800612],"category_scores_gemma":[0.00021510432,0.00010738374,0.00012204755,0.00032932984,0.00017626162,0.000041299005,0.000030546984,0.00020977847,0.0000026386135],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00345771,0.0059291855,0.51953864,0.000741895,0.00797342,0.00065152487,0.005616122,0.00027790244,0.40872717,0.0011676669,0.01076346,0.035155285],"study_design_scores_gemma":[0.031200903,0.0012877479,0.36658353,0.00070039503,0.0023650548,0.000031377327,0.00016462604,0.003780915,0.58697945,0.00006682681,0.006637736,0.00020145874],"about_ca_topic_score_codex":0.07921218,"about_ca_topic_score_gemma":0.08677241,"teacher_disagreement_score":0.17825228,"about_ca_system_score_codex":0.0011761382,"about_ca_system_score_gemma":0.004161663,"threshold_uncertainty_score":0.9298916},"labels":[],"label_agreement":null},{"id":"W3212141300","doi":"10.1182/blood-2021-152681","title":"Can Patient-Reported Ocular Symptoms Guide Dose Modifications in Patients with Relapsed/Refractory Multiple Myeloma Receiving Belantamab Mafodotin?","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Multiple myeloma; Refractory (planetary science); Lenalidomide; Carfilzomib; Internal medicine; Surgery","score_opus":0.01438412536529552,"score_gpt":0.2536311524582137,"score_spread":0.2392470270929182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212141300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966953,0.0002696565,0.000011308355,0.00023718868,0.00006590642,0.0009920346,0.000086083666,0.00009314794,0.0015493722],"genre_scores_gemma":[0.99619323,0.000042747866,0.0017184115,0.000099650795,0.000038587055,0.0001597455,0.0009940731,0.000063208696,0.00069037103],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99726146,0.00014538075,0.0005855063,0.0006460316,0.0007614862,0.0006001219],"domain_scores_gemma":[0.99792135,0.00014558173,0.00018966314,0.00089675485,0.00044958974,0.00039703635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012506825,0.00028736697,0.0004173365,0.0002357777,0.00015582073,0.000040054118,0.000113768794,0.00013572178,0.00011418513],"category_scores_gemma":[0.00081368425,0.00024073872,0.00010274277,0.00057589164,0.00006949015,0.00012714652,0.00009296163,0.00034585063,0.000038403556],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035420162,0.0055455663,0.9797015,0.000052782372,0.00057096715,0.0016483532,0.00036151736,0.000011139405,0.0017491303,0.000008035473,0.00010460476,0.009892194],"study_design_scores_gemma":[0.025466066,0.0006732952,0.9656538,0.00029707173,0.00024469945,0.000083637446,0.00014531735,0.0001123636,0.006459698,0.000008514666,0.0006140124,0.0002415466],"about_ca_topic_score_codex":0.000557137,"about_ca_topic_score_gemma":0.00065329164,"teacher_disagreement_score":0.025111863,"about_ca_system_score_codex":0.00021444049,"about_ca_system_score_gemma":0.00047327075,"threshold_uncertainty_score":0.981704},"labels":[],"label_agreement":null},{"id":"W3212160629","doi":"10.1182/blood-2021-150172","title":"Pelabresib (CPI-0610) Monotherapy in Patients with Myelofibrosis - Update of Clinical and Translational Data from the Ongoing Manifest Trial","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Myelofibrosis; Clinical trial; Internal medicine; Pediatrics","score_opus":0.054030964309501016,"score_gpt":0.3240995657734011,"score_spread":0.2700686014639001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212160629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99696153,0.0004877085,0.000014984695,0.0014104415,0.00005585963,0.00052935054,0.00040017694,0.0000070268607,0.00013290011],"genre_scores_gemma":[0.99549055,0.0003629371,0.0027198454,0.0003155381,0.00017220466,0.000021966462,0.000886863,0.000015165172,0.000014954886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866986,0.00013597753,0.00044183934,0.0003627893,0.00027750112,0.00011202342],"domain_scores_gemma":[0.99883825,0.00048147075,0.00010476473,0.00044294388,0.00007194399,0.000060638195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020917381,0.00012274842,0.00037391778,0.000022272869,0.000043133787,0.000019475414,0.000088100685,0.000064887485,0.00017870513],"category_scores_gemma":[0.00007961356,0.00007458564,0.000045370318,0.00010373946,0.00007091326,0.0000793722,0.00003978725,0.00012835488,0.0000042591437],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0080233915,0.002792713,0.9842324,0.0000096518725,0.00036008656,0.000021735901,0.0001591817,7.243244e-7,0.000016752781,0.00009268308,0.00011215785,0.004178523],"study_design_scores_gemma":[0.114817254,0.00058593025,0.882983,0.0001240223,0.00027993735,0.0000024585793,0.000029075636,0.00003619772,0.00052501925,0.00004740221,0.0005014272,0.000068250454],"about_ca_topic_score_codex":0.00008699122,"about_ca_topic_score_gemma":0.00045212737,"teacher_disagreement_score":0.10679386,"about_ca_system_score_codex":0.0000031714242,"about_ca_system_score_gemma":0.00015217056,"threshold_uncertainty_score":0.30415142},"labels":[],"label_agreement":null},{"id":"W3212160764","doi":"10.1182/blood-2021-152369","title":"Performance of Next Generation Sequencing for Minimal Residual Disease Detection for Pediatric Patients with Acute Lymphoblastic Leukemia: Results from the Prospective Clinical Trial DFCI 16-001","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal; Centre hospitalier universitaire de Québec","funders":"","keywords":"Minimal residual disease; Medicine; Immunophenotyping; Internal medicine; Oncology; Leukemia; Acute lymphocytic leukemia; Pediatrics; Immunology; Lymphoblastic Leukemia; Flow cytometry","score_opus":0.05097793872791398,"score_gpt":0.2995989036764302,"score_spread":0.24862096494851624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212160764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99411416,0.00007829275,0.0012031442,0.000097860706,0.00035802263,0.0031362884,0.0009442082,0.00003603952,0.000031968706],"genre_scores_gemma":[0.9915896,0.00006877939,0.0027629158,0.000086220614,0.0036335506,0.00049030397,0.0011527871,0.000050519036,0.00016534663],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99730283,0.00013472584,0.00084245,0.0006689532,0.00065626577,0.0003948026],"domain_scores_gemma":[0.9959928,0.0018638239,0.00036099186,0.0004963076,0.0010748702,0.00021124372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055884226,0.00022816595,0.0004373379,0.000072636976,0.00024269464,0.000047287213,0.00014968717,0.00018374558,0.000007650493],"category_scores_gemma":[0.0041035987,0.00015528235,0.0001690114,0.00032730712,0.00012181037,0.00018872731,0.00007736951,0.00022152861,0.0000042752135],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8275129,0.0050745443,0.1446848,0.00054476946,0.0020856846,0.00011342779,0.00073152996,0.00021324705,0.00895647,0.00002119869,0.0029692517,0.0070921336],"study_design_scores_gemma":[0.73022896,0.016593397,0.16964312,0.00019016255,0.007349659,0.000025791413,0.00020713653,0.04100714,0.034155175,0.00004475804,0.00009229624,0.00046240693],"about_ca_topic_score_codex":0.00005619252,"about_ca_topic_score_gemma":0.00008218178,"teacher_disagreement_score":0.097283974,"about_ca_system_score_codex":0.00092595787,"about_ca_system_score_gemma":0.0046915608,"threshold_uncertainty_score":0.83226275},"labels":[],"label_agreement":null},{"id":"W3212166614","doi":"10.1182/blood-2021-153045","title":"Propensity Score Matching Analysis Comparing Extracorporeal Photopheresis (ECP) Vs Best Available Therapy in Third Line or Later Treatment of Chronic Graft-Versus-Host Disease (cGVHD)","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Prednisone; Extracorporeal Photopheresis; Propensity score matching; Rituximab; Photopheresis; Internal medicine; Graft-versus-host disease; Randomized controlled trial; Maintenance therapy; Cohort; Retrospective cohort study; Surgery; Transplantation; Chemotherapy; Disease; Lymphoma","score_opus":0.08091759889445783,"score_gpt":0.29071814912617633,"score_spread":0.2098005502317185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212166614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967826,0.0012376976,0.00006255574,0.00009921951,0.0000671699,0.00062053854,0.000039197796,0.000039540904,0.0010514527],"genre_scores_gemma":[0.9959587,0.0018163322,0.0006113875,0.00002848155,0.00008196982,0.00005130053,0.00028167406,0.000030397352,0.0011397976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982999,0.00009628437,0.0005284857,0.00045278462,0.00032543554,0.00029713634],"domain_scores_gemma":[0.9989157,0.00014998902,0.00014640577,0.000493055,0.00011008788,0.000184781],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014019993,0.0002464511,0.00080157735,0.00017156634,0.000058642567,0.000026904883,0.00007948448,0.00008439269,0.0009777403],"category_scores_gemma":[0.00002014117,0.00018386082,0.00022686216,0.000669583,0.000049633036,0.000083384904,0.000020003306,0.00010853313,0.000044629716],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052369214,0.0064146994,0.9349502,0.0006290993,0.0020430589,0.0026311632,0.001093727,0.00021845926,0.046377026,0.0000100054285,0.000021580112,0.00037407575],"study_design_scores_gemma":[0.030618295,0.0020499565,0.6327954,0.0011225988,0.0068061985,0.0000723954,0.00021998363,0.0012728723,0.32452,0.000014081052,0.000112401336,0.0003958707],"about_ca_topic_score_codex":0.00091305416,"about_ca_topic_score_gemma":0.0041414034,"teacher_disagreement_score":0.3021548,"about_ca_system_score_codex":0.0001242296,"about_ca_system_score_gemma":0.00040122907,"threshold_uncertainty_score":0.9999355},"labels":[],"label_agreement":null},{"id":"W3212171289","doi":"10.1182/blood-2021-147881","title":"Five-Year Follow-up of Keynote-087: Pembrolizumab Monotherapy in Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL)","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Classical Hodgkin lymphoma; Pembrolizumab; Medicine; Refractory (planetary science); Internal medicine; Oncology; Lymphoma; Gastroenterology; Hodgkin lymphoma; Cancer; Immunotherapy","score_opus":0.01331762239791026,"score_gpt":0.2520312517522002,"score_spread":0.23871362935428994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212171289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914856,0.0026210104,0.000003985198,0.0008494997,0.00020824002,0.00030822138,0.000028330809,0.0000505048,0.0044446406],"genre_scores_gemma":[0.9958724,0.0007577856,0.0005115876,0.00036926134,0.00015473632,0.00007649194,0.000052241263,0.000047869697,0.0021576232],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981803,0.00010080356,0.0004680653,0.0004782545,0.00040554308,0.00036699817],"domain_scores_gemma":[0.9988076,0.00017133255,0.0001281901,0.00059706194,0.00011478921,0.00018102795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010793182,0.000261962,0.00065657485,0.00014135354,0.00004166237,0.000017097496,0.00011095776,0.00022854823,0.00031372075],"category_scores_gemma":[0.00012457643,0.00022702807,0.00029403027,0.00032973848,0.00007710614,0.00005512627,0.000056537596,0.00011881091,0.000081228136],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056819967,0.037712954,0.85026693,0.00031738757,0.0018331499,0.0055678636,0.0024586339,0.0000095121695,0.027427383,0.0032266404,0.00563946,0.05985806],"study_design_scores_gemma":[0.14304277,0.0014954344,0.72831815,0.0003993392,0.00047000393,0.00022814231,0.00025988667,0.000044247005,0.1151337,0.00022897805,0.010047719,0.0003316223],"about_ca_topic_score_codex":0.00018786661,"about_ca_topic_score_gemma":0.00012157354,"teacher_disagreement_score":0.13736078,"about_ca_system_score_codex":0.00019697454,"about_ca_system_score_gemma":0.00052253495,"threshold_uncertainty_score":0.9257936},"labels":[],"label_agreement":null},{"id":"W3212185798","doi":"10.1182/blood-2021-145385","title":"Patient and Physician Preferences for Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML) in Patients Not Candidates for Intensive Chemotherapy","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; University of Calgary","funders":"","keywords":"Medicine; Myeloid leukemia; Internal medicine; Chemotherapy regimen; Chemotherapy; Disease; Intensive care medicine; Family medicine","score_opus":0.01889015608637003,"score_gpt":0.28579214759028865,"score_spread":0.26690199150391863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212185798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99773866,0.00036732823,0.000008692266,0.00036733877,0.000050361057,0.0012338754,0.00017296335,0.0000090959265,0.00005169283],"genre_scores_gemma":[0.997112,0.0006840681,0.0003875401,0.0013570654,0.000042295032,0.00030881973,0.000067077155,0.000008832519,0.000032310145],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993718,0.00001579384,0.00016838795,0.00020620787,0.00007538611,0.00016238971],"domain_scores_gemma":[0.99935216,0.00025736535,0.00007371295,0.00006965876,0.00019767352,0.000049423295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000020443422,0.0001268889,0.00041453508,0.000028309514,0.000035547124,0.0000056877943,0.000020052557,0.000041220108,0.000003319184],"category_scores_gemma":[0.00009526708,0.000085150416,0.000074629854,0.00006104567,0.000044787572,0.000023792927,0.000016891703,0.000023221703,2.333704e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007857505,0.013403075,0.33035663,0.00075430196,0.0043566483,0.00008367082,0.012097686,0.0000073577007,0.24179663,0.00006233742,0.0013491345,0.38787502],"study_design_scores_gemma":[0.030297041,0.009233957,0.21401265,0.00010345122,0.00048802217,9.1185825e-7,0.00040797394,0.000061902225,0.74447846,0.00012346165,0.0006708045,0.000121329955],"about_ca_topic_score_codex":0.000047672787,"about_ca_topic_score_gemma":0.00004771091,"teacher_disagreement_score":0.50268185,"about_ca_system_score_codex":0.000051356757,"about_ca_system_score_gemma":0.00005497429,"threshold_uncertainty_score":0.34723333},"labels":[],"label_agreement":null},{"id":"W3212201454","doi":"10.1182/blood-2021-154492","title":"Autologous Stem Cell Transplant Outcome in Classic Hodgkin Lymphoma Patients in the Era of Post-Transplant Brentuximab Vedotin Consolidation","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Brentuximab vedotin; Medicine; ABVD; Dacarbazine; Internal medicine; Autologous stem-cell transplantation; Oncology; Transplantation; Salvage therapy; Surgery; Lymphoma; Chemotherapy; Vincristine; Hodgkin lymphoma; Cyclophosphamide","score_opus":0.013241617105003286,"score_gpt":0.23633808770450832,"score_spread":0.22309647059950502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212201454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973833,0.00055715226,0.0000034484256,0.0006631582,0.00010070672,0.0004900478,0.00017940633,0.000016722068,0.0006060655],"genre_scores_gemma":[0.99882054,0.0002346816,0.00007961231,0.00039336385,0.00001548309,0.00006391747,0.00035553492,0.000014610183,0.00002227742],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983942,0.00017792516,0.0005632559,0.0002864515,0.0003109105,0.00026724674],"domain_scores_gemma":[0.99926907,0.00019277203,0.00011523531,0.000296432,0.00007111495,0.00005539145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014913335,0.0001857841,0.00043664765,0.00009168284,0.000029003202,0.000014103789,0.00010208332,0.00011105295,0.000027411792],"category_scores_gemma":[0.000009983314,0.00012952929,0.000120026976,0.00024511965,0.00003907532,0.000045314908,0.000012478122,0.00011172153,0.000016893335],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001562666,0.011157611,0.9759432,0.00017437119,0.0000615081,0.0012392316,0.0027614983,0.000003873005,0.00093857927,0.00008575013,0.000013860341,0.0074642356],"study_design_scores_gemma":[0.02118832,0.00044824858,0.94111955,0.0002894536,0.0003083502,0.00015408163,0.0003326932,0.00002396506,0.03595027,0.0000074676204,0.00006117247,0.00011640583],"about_ca_topic_score_codex":0.00035732763,"about_ca_topic_score_gemma":0.00047677002,"teacher_disagreement_score":0.03501169,"about_ca_system_score_codex":0.00008463514,"about_ca_system_score_gemma":0.00020164002,"threshold_uncertainty_score":0.52820516},"labels":[],"label_agreement":null},{"id":"W3212209742","doi":"10.1182/blood-2021-147434","title":"Eptacog Beta Efficacy in Children and Adolescents with Hemophilia A or B and Inhibitors: Subset Analysis Suggests Improved Caregiver Capacity to Assess Bleeding Episode Resolution with Subject Age","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Haemophilia; Pediatrics; Bleed; Population; Confidence interval; Internal medicine; Clinical trial; Surgery","score_opus":0.02254172190660885,"score_gpt":0.2754118856375905,"score_spread":0.25287016373098165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212209742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983999,0.0002734575,0.000012887948,0.00039988043,0.000010356688,0.00078272243,0.000032526088,0.000034909957,0.000053346186],"genre_scores_gemma":[0.9987655,0.00007888478,0.0007010702,0.00004125526,0.000093558236,0.000027946186,0.00009002862,0.000028794677,0.00017290472],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816823,0.00010585381,0.00022090976,0.0006575853,0.0003944751,0.00045294786],"domain_scores_gemma":[0.99907756,0.000050322036,0.00005496695,0.00032701142,0.00014340374,0.00034676242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000233543,0.0002577428,0.00055569655,0.00039368655,0.00011116599,0.000076083124,0.000063120606,0.00012570473,0.000009115145],"category_scores_gemma":[0.00008126076,0.00016911948,0.00005884213,0.0014311258,0.00012731049,0.000112778434,0.00009240316,0.0002967639,0.0000015916567],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007149506,0.0009707288,0.988107,0.00012474557,0.00088027277,0.001006625,0.00071425864,0.0000045578126,0.0070922654,0.0000023715495,0.000011801049,0.00037041487],"study_design_scores_gemma":[0.010313403,0.0008045488,0.9675581,0.00064808666,0.0017067718,0.00026863665,0.00015270061,0.00006154044,0.018257916,0.0000014737382,0.0000040495415,0.00022281005],"about_ca_topic_score_codex":0.00081712776,"about_ca_topic_score_gemma":0.005073983,"teacher_disagreement_score":0.020548945,"about_ca_system_score_codex":0.000079358,"about_ca_system_score_gemma":0.0001248912,"threshold_uncertainty_score":0.6896492},"labels":[],"label_agreement":null},{"id":"W3212214614","doi":"10.1182/blood-2021-154227","title":"Impact of the COVID-19 Pandemic on Primary Care Access for Patients with Hematologic Malignancies","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; Pandemic; Cancer; Cohort; Population; Retrospective cohort study; Emergency department; Health care; Cohort study; Pediatrics; Emergency medicine; Family medicine; Internal medicine; Coronavirus disease 2019 (COVID-19); Disease; Nursing","score_opus":0.08244260685130558,"score_gpt":0.3963178090588706,"score_spread":0.31387520220756504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212214614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973976,0.00041584103,0.000022512035,0.00087469013,0.000054915443,0.00081546296,0.00017040609,0.000036269397,0.00021232781],"genre_scores_gemma":[0.9943761,0.000036058882,0.00007269997,0.0052747093,0.00004047437,0.000034483444,0.00009879387,0.000016376254,0.000050304872],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99904126,0.000043969663,0.00019142931,0.00021385228,0.00026313998,0.00024633223],"domain_scores_gemma":[0.9986906,0.0002811712,0.00012926968,0.00039526145,0.0003063802,0.00019733797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007163378,0.0001338732,0.0003305124,0.000047186546,0.00009562605,0.000013039564,0.00012628084,0.00008716898,0.0000270256],"category_scores_gemma":[0.0007466576,0.000070708986,0.00015711003,0.00021427688,0.00005296803,0.000044334556,0.000061913335,0.00011467472,0.0000011440793],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040273138,0.0005342525,0.99551135,0.0018661572,0.000084786065,0.000016822738,0.00051922165,0.000007647718,0.00035080768,0.000027422222,0.00037609428,0.00030270548],"study_design_scores_gemma":[0.006231252,0.0014091219,0.9896128,0.00029305654,0.00019114758,0.00005407594,0.00009217871,4.5307058e-7,0.0013903343,0.00006601611,0.00056911324,0.000090440044],"about_ca_topic_score_codex":0.00016380161,"about_ca_topic_score_gemma":0.00014745566,"teacher_disagreement_score":0.005898541,"about_ca_system_score_codex":0.00026703245,"about_ca_system_score_gemma":0.0026494109,"threshold_uncertainty_score":0.4699941},"labels":[],"label_agreement":null},{"id":"W3212235981","doi":"10.1182/blood-2021-148839","title":"Long-Term Safety and Efficacy of Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura (aTTP): The Post-HERCULES Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Population; Medicine; Internal medicine; Placebo; Immunosuppression; Gastroenterology; Surgery; Pathology","score_opus":0.022845054002827467,"score_gpt":0.2831727147314503,"score_spread":0.2603276607286228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212235981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897667,0.0076393015,0.000025104082,0.00025852624,0.0002885103,0.0016639293,0.00018965275,0.0000375883,0.00013069225],"genre_scores_gemma":[0.99918216,0.000056000532,0.000024095347,0.00006178973,0.000030965173,0.00007406805,0.0001999434,0.000021201231,0.0003497835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984263,0.00036564542,0.00046707486,0.00038209668,0.00005855281,0.00030031297],"domain_scores_gemma":[0.99832654,0.00068855035,0.00017007874,0.00062455406,0.00017044051,0.000019810755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002446057,0.00020211184,0.00049402594,0.0000385017,0.00028245637,0.000029441931,0.00031991367,0.000086209846,0.00065412675],"category_scores_gemma":[0.00020458657,0.00014678236,0.00014426328,0.00010823275,0.00019893656,0.00006424906,0.00026615817,0.00007234466,0.00003930086],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001555626,0.010866323,0.4912082,0.0005730569,0.0065596798,0.00006988498,0.0052191075,0.0000068078384,0.47796172,0.00138161,0.0009881012,0.003609889],"study_design_scores_gemma":[0.012312765,0.00069978816,0.955879,0.000084428335,0.0010659295,0.00015624957,0.0019489446,4.9783193e-7,0.027403079,0.000027652233,0.00022462322,0.00019706237],"about_ca_topic_score_codex":0.000037162932,"about_ca_topic_score_gemma":0.00023133044,"teacher_disagreement_score":0.46467078,"about_ca_system_score_codex":0.000018018243,"about_ca_system_score_gemma":0.00011922214,"threshold_uncertainty_score":0.71622294},"labels":[],"label_agreement":null},{"id":"W3212241519","doi":"10.1182/blood-2021-150641","title":"Super-Enhancer Driven Regulation of CKS1B in Multiple Myeloma: Implications in Mediating Response to BET Inhibitor and Celmod Agent Combination","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Bromodomain; BRD4; Multiple myeloma; Cancer research; BET inhibitor; Enhancer; Biology; Medicine; Molecular biology; Internal medicine; Gene; Gene expression; Genetics; Epigenetics","score_opus":0.02636046732419182,"score_gpt":0.3021907183115276,"score_spread":0.27583025098733577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212241519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974653,0.00015422027,0.000026103342,0.0015982132,0.000021401123,0.0005850542,0.000031553103,0.000012499805,0.00010564069],"genre_scores_gemma":[0.9975479,0.000031587806,0.001976495,0.000026495783,0.00002673213,0.00013663381,0.00013656623,0.000012307392,0.00010528268],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989077,0.00014379846,0.0002936838,0.00024692246,0.0002194731,0.00018845999],"domain_scores_gemma":[0.9991618,0.0003143472,0.000046884492,0.00021341395,0.00014223221,0.00012132908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026067818,0.000087278975,0.00020271781,0.00024627385,0.00003720515,0.00000951257,0.00003465102,0.00006349514,0.000018583081],"category_scores_gemma":[0.0012360614,0.000087018125,0.000027453172,0.0004329046,0.000026367446,0.00007329813,0.0000612377,0.00009380848,0.0000057411717],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030194916,0.0008685266,0.46792975,0.000040735697,0.0000195765,0.000028920715,0.0009397426,0.00000857688,0.52678216,0.000034776174,0.000009495279,0.0030357821],"study_design_scores_gemma":[0.0071184775,0.00017014431,0.79128575,0.00011194111,0.000017255725,0.000008826321,0.00018296542,0.00043943102,0.20052902,0.000052626765,0.000030848438,0.00005271181],"about_ca_topic_score_codex":0.00010204969,"about_ca_topic_score_gemma":0.0005357967,"teacher_disagreement_score":0.32625315,"about_ca_system_score_codex":0.00009970056,"about_ca_system_score_gemma":0.00013773234,"threshold_uncertainty_score":0.35484964},"labels":[],"label_agreement":null},{"id":"W3212241914","doi":"10.1182/blood-2021-150965","title":"Newly Developed Oncolytic Herpes Simplex Viruses Expressing Multiple Immunomodulatory Transgenes Effectively Target AML Cells","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Biotech (Canada); Terry Fox Research Institute; University of British Columbia","funders":"","keywords":"Oncolytic virus; Herpes simplex virus; Myeloid leukemia; Multiplicity of infection; Biology; Leukemia; Virology; Cancer research; Immune system; Immunology; Medicine; Virus","score_opus":0.025474312770169764,"score_gpt":0.29266910285791925,"score_spread":0.2671947900877495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212241914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99171144,0.0061041764,0.0013676443,0.000034373938,0.00012964377,0.0003128191,0.000061191364,0.000042571628,0.00023614596],"genre_scores_gemma":[0.9937113,0.00022486353,0.004852544,0.00036994077,0.0002684015,0.00007182127,0.000092379785,0.000085395026,0.00032337688],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979276,0.00034072562,0.00029551296,0.0006368211,0.00026631696,0.000533018],"domain_scores_gemma":[0.99892807,0.000078235986,0.00007677441,0.0005719534,0.00019464605,0.00015033454],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002694596,0.0002977532,0.00029101365,0.000059943668,0.00021443934,0.00008226904,0.0003224194,0.00021074837,0.00010166899],"category_scores_gemma":[0.00010675579,0.00030718817,0.00018681341,0.0001931865,0.000112766036,0.00001074591,0.0001397654,0.00013643793,0.000040471827],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058538705,0.0005087185,0.001207036,0.00004761471,0.00029295887,0.000048385235,0.00014855224,0.00023335552,0.98390347,0.0000010489679,0.00016336098,0.012860122],"study_design_scores_gemma":[0.0034219746,0.0006064764,0.0017538816,0.000029187071,0.00004090154,0.000015457474,0.00008492036,0.00007234404,0.96571106,0.00002475459,0.027864587,0.00037447264],"about_ca_topic_score_codex":0.000028918763,"about_ca_topic_score_gemma":0.00018552567,"teacher_disagreement_score":0.027701225,"about_ca_system_score_codex":0.000026708987,"about_ca_system_score_gemma":0.00059007364,"threshold_uncertainty_score":0.999938},"labels":[],"label_agreement":null},{"id":"W3212249039","doi":"10.1182/blood-2021-146623","title":"Baseline Serum Ferritin Differentially Predicts W24 Transfusion Independence Response for Momelotinib and Ruxolitinib in Patients with Myelofibrosis","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Ferritin; Internal medicine; Serum ferritin; Bone marrow","score_opus":0.00922556990859842,"score_gpt":0.2329814678827612,"score_spread":0.2237558979741628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212249039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965457,0.0001682171,0.00013465581,0.0013375569,0.00004738956,0.0012209791,0.00043566103,0.000030782547,0.00007911357],"genre_scores_gemma":[0.9965303,0.00014160694,0.002091798,0.0003155971,0.000057115907,0.00027935344,0.00027539834,0.00003667632,0.00027216855],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982042,0.00017009751,0.0003444842,0.00053879956,0.00040221057,0.00034025067],"domain_scores_gemma":[0.9988201,0.00038377848,0.000064581815,0.00024488007,0.0002799489,0.00020667762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027841577,0.0002502689,0.000440351,0.00011548952,0.00009594482,0.000036525318,0.000045686254,0.00013503165,0.00013674574],"category_scores_gemma":[0.000295105,0.00019493891,0.00006607188,0.0001913701,0.000044929115,0.000082039114,0.00003669964,0.00016153489,0.000003633686],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005546098,0.0039151595,0.98407507,0.00018498533,0.000127921,0.00011599206,0.00034077564,0.0000015875277,0.0024967818,0.000073586445,0.000025286146,0.003096762],"study_design_scores_gemma":[0.028113127,0.0023733259,0.9010906,0.0005377174,0.0002876987,0.000029352861,0.00006769805,0.0000418051,0.06714944,0.000030361427,0.00010311853,0.00017573535],"about_ca_topic_score_codex":0.000027070797,"about_ca_topic_score_gemma":0.00031600724,"teacher_disagreement_score":0.08298444,"about_ca_system_score_codex":0.000035945926,"about_ca_system_score_gemma":0.000219577,"threshold_uncertainty_score":0.7949378},"labels":[],"label_agreement":null},{"id":"W3212256991","doi":"10.1182/blood-2018-99-117045","title":"Two-Year Follow-up of Keynote-087 Study: Pembrolizumab Monotherapy in Relapsed/Refractory Classic Hodgkin Lymphoma","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Pembrolizumab; Medicine; Brentuximab vedotin; Internal medicine; Oncology; Cohort; Population; Salvage therapy; Refractory (planetary science); Clinical endpoint; Autologous stem-cell transplantation; Chemotherapy regimen; Transplantation; Surgery; Lymphoma; Chemotherapy; Clinical trial; Cancer; Hodgkin lymphoma; Immunotherapy","score_opus":0.017963725474459166,"score_gpt":0.27775886340980166,"score_spread":0.2597951379353425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212256991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913649,0.0006338848,0.0000019213637,0.00016824939,0.00027717717,0.000872757,0.000012922628,0.000065649874,0.006602533],"genre_scores_gemma":[0.9984049,0.00011660093,0.00026914736,0.00020862148,0.0002842581,0.0001306584,0.000011222215,0.00005635372,0.00051819487],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981068,0.00011344211,0.00049822783,0.00047463382,0.00042753093,0.0003794106],"domain_scores_gemma":[0.9987368,0.00010866138,0.00017712922,0.00070682593,0.00011905414,0.00015154971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002041729,0.0002866468,0.00063020113,0.00024164928,0.000061662824,0.000016894479,0.00015840818,0.0001335562,0.0002144601],"category_scores_gemma":[0.000059870847,0.00023481635,0.00018163452,0.00034393911,0.00012370509,0.0000653044,0.000053568776,0.00008545879,0.00015023888],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031444929,0.021305244,0.95165396,0.000039869294,0.0007387003,0.00035049464,0.002459812,6.1355667e-7,0.002926667,0.000354648,0.0006995052,0.016326],"study_design_scores_gemma":[0.17430879,0.006903141,0.79488856,0.0001786957,0.00046983798,0.000044654636,0.00071490736,0.000014409972,0.020572128,0.00011546332,0.001541029,0.00024841315],"about_ca_topic_score_codex":0.0007635066,"about_ca_topic_score_gemma":0.0005040636,"teacher_disagreement_score":0.17116429,"about_ca_system_score_codex":0.00019755053,"about_ca_system_score_gemma":0.00027711302,"threshold_uncertainty_score":0.9575533},"labels":[],"label_agreement":null},{"id":"W3212267000","doi":"10.1182/blood-2021-148922","title":"Patterns of Care and Outcomes in Adolescents and Young Adults with Myeloproliferative Neoplasms: A Multicenter Population-Based Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Quebec - Clinical Research Organization in Cancer; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Population; Myelofibrosis; Essential thrombocythemia; Polycythemia vera; Pediatrics; Young adult; Myeloproliferative neoplasm; Internal medicine; Bone marrow","score_opus":0.0074473887807283284,"score_gpt":0.25330578447427543,"score_spread":0.24585839569354712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212267000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981781,0.0004911311,0.000003874334,0.0001023865,0.000025959054,0.0011179829,0.000049691655,0.000012358447,0.000018479299],"genre_scores_gemma":[0.99916524,0.000039892664,0.00044747838,0.00011001434,0.000013685996,0.00013472368,0.000056906065,0.000018195384,0.000013864625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890023,0.00007529925,0.00026758437,0.00036622878,0.00023327963,0.00015739199],"domain_scores_gemma":[0.99941415,0.00005134494,0.00008002443,0.00017906974,0.00017999789,0.00009539999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000036060417,0.00020036317,0.00047165668,0.0000901347,0.000044016626,0.000019603935,0.000021846357,0.000046887726,0.000011247636],"category_scores_gemma":[0.000054199107,0.00014306372,0.00003290312,0.00009441526,0.000014014637,0.00005031562,0.000030246014,0.000100243364,5.812856e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044424197,0.0039218217,0.98765457,0.00044147673,0.00020368755,0.00031299744,0.00649692,0.0000032813198,0.000022531513,0.000005974944,2.706909e-7,0.0004922353],"study_design_scores_gemma":[0.026355436,0.0014940827,0.96140605,0.0012925846,0.00030014926,0.000018296923,0.006196683,0.00004712137,0.002765394,8.1179167e-7,6.3080194e-7,0.00012277126],"about_ca_topic_score_codex":0.000516327,"about_ca_topic_score_gemma":0.01115387,"teacher_disagreement_score":0.026248522,"about_ca_system_score_codex":0.00002978808,"about_ca_system_score_gemma":0.000065938024,"threshold_uncertainty_score":0.62241215},"labels":[],"label_agreement":null},{"id":"W3212269438","doi":"10.1182/blood-2021-149652","title":"COVID-19 Vaccine Response in Patients with Hematologic Malignancy: A Systematic Review and Meta-Analysis","year":2021,"lang":"en","type":"review","venue":"Blood","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Health Sciences Centre; Sunnybrook Health Science Centre; St. Michael's Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Hematologic malignancy; Malignancy; Internal medicine; Meta-analysis; Cancer; Vaccination; Population; Immunology","score_opus":0.10298082559527809,"score_gpt":0.3973474890243992,"score_spread":0.2943666634291211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212269438","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001953612,0.99314106,0.000007529699,0.00025306107,0.0000065768045,0.0062337024,0.00008218104,0.000044799857,0.000035756686],"genre_scores_gemma":[0.00005620307,0.97227126,0.00011503992,0.025164474,0.000008905032,0.0021300048,0.00008485681,0.00006821642,0.00010103398],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.993675,0.002421095,0.0015996885,0.0010069924,0.00083074125,0.00046647765],"domain_scores_gemma":[0.9959933,0.0012662122,0.00068978575,0.0015814959,0.00026216856,0.00020704587],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0025431204,0.00069655885,0.015457705,0.0010105347,0.000060044567,0.000051197676,0.0003290654,0.00030998688,0.00013979856],"category_scores_gemma":[0.0052627237,0.0003805066,0.0018834381,0.003514816,0.00004525859,0.00004975333,0.00019324385,0.0005235895,0.000040417435],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000086179694,0.00062427495,0.0007343618,0.88833934,0.108910106,0.0011651232,0.000023640585,9.390957e-9,6.401053e-8,0.000009995161,0.00005607223,0.000050845174],"study_design_scores_gemma":[0.0018104569,0.00033738193,0.000024830293,0.08146422,0.872246,0.00033027932,0.000008883523,1.8877692e-7,0.0000012868616,0.0000026576831,0.043419614,0.00035419283],"about_ca_topic_score_codex":0.00003672222,"about_ca_topic_score_gemma":0.000035604124,"teacher_disagreement_score":0.8068751,"about_ca_system_score_codex":0.00018942855,"about_ca_system_score_gemma":0.0017513204,"threshold_uncertainty_score":0.9998647},"labels":[],"label_agreement":null},{"id":"W3212299214","doi":"10.1182/blood-2021-152561","title":"Efficacy and Safety Results from Ascembl, a Multicenter, Open-Label, Phase 3 Study of Asciminib, a First-in-Class STAMP Inhibitor, Vs Bosutinib in Patients with Chronic Myeloid Leukemia in Chronic Phase after ≥2 Prior Tyrosine Kinase Inhibitors: Update after 48 Weeks","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Bosutinib; Medicine; Discontinuation; Tolerability; Internal medicine; Adverse effect; Nilotinib; Imatinib mesylate; Imatinib; Myeloid leukemia; Gastroenterology; Oncology","score_opus":0.01260281943940314,"score_gpt":0.278387262362273,"score_spread":0.26578444292286985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212299214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895521,0.0031034108,0.0000014454563,0.00020403096,0.00019813055,0.0060438327,0.00081429514,0.000046607933,0.000036169757],"genre_scores_gemma":[0.9970999,0.0003673098,0.00043064696,0.00013114688,0.00021705909,0.0006983834,0.00083724235,0.00014165309,0.0000766608],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9936332,0.00037937125,0.0021180466,0.0018905995,0.0008960123,0.0010827739],"domain_scores_gemma":[0.996997,0.00029920213,0.00054668036,0.0015094643,0.00022614108,0.00042149663],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00050521747,0.00087833195,0.0016692756,0.00051973766,0.00008526721,0.00011376297,0.00035393573,0.00033499912,0.00018424504],"category_scores_gemma":[0.00034124494,0.00079251424,0.00007948272,0.0011436492,0.00017935739,0.00054102065,0.00078330643,0.00089138804,0.00002906156],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3248995,0.22714126,0.38879144,0.0012340539,0.0014562069,0.014767596,0.011696191,0.000117181495,0.0068560415,0.0000015572351,0.0002587915,0.02278017],"study_design_scores_gemma":[0.66073096,0.012438544,0.30941263,0.004730678,0.00062606676,0.0000137755005,0.00025200236,0.00056359416,0.009830209,0.0000014393844,0.00076894683,0.00063119107],"about_ca_topic_score_codex":0.0027236952,"about_ca_topic_score_gemma":0.024042826,"teacher_disagreement_score":0.33583143,"about_ca_system_score_codex":0.0062250723,"about_ca_system_score_gemma":0.0033504802,"threshold_uncertainty_score":0.9994526},"labels":[],"label_agreement":null},{"id":"W3212303742","doi":"10.1182/blood-2021-147915","title":"Updated Results from MajesTEC-1: Phase 1/2 Study of Teclistamab, a B-Cell Maturation Antigen x CD3 Bispecific Antibody, in Relapsed/Refractory Multiple Myeloma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Multiple myeloma; Antibody; Medicine; Antigen; Refractory (planetary science); Immunology; Cancer research; Biology","score_opus":0.029544945508862545,"score_gpt":0.3206302640846435,"score_spread":0.29108531857578096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212303742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996113,0.00074882247,0.000008042829,0.00009511943,0.00010321732,0.0012215957,0.00053436594,0.00007061695,0.0011052351],"genre_scores_gemma":[0.994771,0.00017265497,0.0009014893,0.000019712603,0.00009649407,0.00003363093,0.00342106,0.000043939734,0.0005400109],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9971511,0.000261263,0.00081038603,0.0007047147,0.0006495962,0.00042293489],"domain_scores_gemma":[0.99810994,0.00024584265,0.00023577503,0.00089991937,0.00028539484,0.00022315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000236333,0.00027397132,0.0005858411,0.00031305625,0.000081814476,0.000039561164,0.00014968673,0.00016776989,0.00016482733],"category_scores_gemma":[0.00046076084,0.00024490632,0.00010454314,0.00073292083,0.00005718199,0.000121531164,0.00010607151,0.0003711099,0.00007146078],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077177836,0.061554685,0.3038848,0.00007246125,0.00046429213,0.0070072063,0.0019231638,0.000005597519,0.6137159,0.0000020666532,0.000286415,0.0033656291],"study_design_scores_gemma":[0.1519756,0.0020570313,0.64296037,0.0001796753,0.00018623372,0.000030983312,0.0022072522,0.00039208366,0.19905126,0.000009737687,0.0007233645,0.00022640412],"about_ca_topic_score_codex":0.0013053243,"about_ca_topic_score_gemma":0.0008968497,"teacher_disagreement_score":0.41466463,"about_ca_system_score_codex":0.00007223009,"about_ca_system_score_gemma":0.00025364975,"threshold_uncertainty_score":0.99869895},"labels":[],"label_agreement":null},{"id":"W3212313924","doi":"10.1182/blood-2021-146228","title":"Characterization of Bruton Tyrosine Kinase Inhibitor (BTKi)-Related Adverse Events in a Head-to-Head Trial of Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia (CLL)","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Medicine; Ibrutinib; Tolerability; Adverse effect; Internal medicine; Incidence (geometry); Cumulative incidence; Chronic lymphocytic leukemia; Gastroenterology; Surgery; Cohort; Leukemia","score_opus":0.02485270191560354,"score_gpt":0.3096979181604436,"score_spread":0.2848452162448401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212313924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960934,0.00041839885,0.000003024587,0.000082927276,0.0003651461,0.0025962798,0.000046976467,0.00006224209,0.00033162814],"genre_scores_gemma":[0.99811816,0.00030320662,0.00007534112,0.000035562596,0.0001894858,0.00013904048,0.00053172844,0.000079016514,0.00052848354],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9953407,0.00037141857,0.0017245408,0.0007843688,0.00095060776,0.00082833075],"domain_scores_gemma":[0.99779856,0.00027961083,0.00039928645,0.00088089966,0.0003210585,0.00032060902],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007322854,0.000403843,0.0012256068,0.0006912185,0.000034449648,0.0000067685114,0.0002650213,0.000466597,0.00021278707],"category_scores_gemma":[0.0013788064,0.00041080124,0.000252204,0.0026497399,0.00013626991,0.00016291287,0.00023404502,0.00041734442,0.00005837435],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.09617039,0.004367338,0.005278324,0.0017614637,0.0004105225,0.0013280564,0.001352752,0.00045279838,0.88606113,0.000040124054,0.000018831524,0.0027582508],"study_design_scores_gemma":[0.5735823,0.0027562785,0.017237088,0.0025227503,0.00029280316,0.00008411267,0.000058189664,0.0033189263,0.3997477,0.0000054614834,0.00011051814,0.00028385958],"about_ca_topic_score_codex":0.0024991941,"about_ca_topic_score_gemma":0.0010705988,"teacher_disagreement_score":0.48631343,"about_ca_system_score_codex":0.030808305,"about_ca_system_score_gemma":0.033236958,"threshold_uncertainty_score":0.99983436},"labels":[],"label_agreement":null},{"id":"W3212315446","doi":"10.1182/blood-2021-151532","title":"Early Findings on the Use of Motion Capture during Simulated Sports Activities to Better Understand Hemophilic Arthropathy","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Physical therapy; Ankle; Barefoot; Jumping; Physical medicine and rehabilitation; Arthropathy; Squatting position; Haemophilia; Range of motion; Hemarthrosis; Osteoarthritis; Surgery","score_opus":0.04346240136996556,"score_gpt":0.26193180989393633,"score_spread":0.21846940852397076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212315446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99518687,0.000055476063,0.000004470858,0.0041604303,0.00003739955,0.00030755938,0.000010211347,0.000025014544,0.0002125812],"genre_scores_gemma":[0.9977787,0.000023711222,0.000045795172,0.00025769198,0.00007141682,0.0000034663901,0.000012530605,0.000018805473,0.0017878913],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990299,0.000039870727,0.00013375648,0.00020101664,0.00038652268,0.00020894296],"domain_scores_gemma":[0.9994237,0.00010943436,0.00002541564,0.0002884161,0.00006629271,0.000086736836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006875265,0.00011404461,0.00018562452,0.00009342665,0.000092101865,0.000027333012,0.000034551605,0.00007939433,0.00016427744],"category_scores_gemma":[0.0000898528,0.000073251795,0.0000804725,0.00023627748,0.000049965718,0.00006533285,0.000034331788,0.0001789332,0.000011615402],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007036854,0.0026328363,0.5117428,0.00032380523,0.0006604622,0.0030527622,0.008668133,0.00024169806,0.47005528,0.00015897024,0.00040426443,0.0013553288],"study_design_scores_gemma":[0.002646458,0.00028213972,0.37988463,0.00038163157,0.0001670781,0.000073674564,0.0007207014,0.000027659855,0.6154094,0.000073212716,0.0001992793,0.00013415096],"about_ca_topic_score_codex":0.000019216079,"about_ca_topic_score_gemma":0.0000064554574,"teacher_disagreement_score":0.1453541,"about_ca_system_score_codex":0.00003637637,"about_ca_system_score_gemma":0.00004516649,"threshold_uncertainty_score":0.29871213},"labels":[],"label_agreement":null},{"id":"W3212362631","doi":"10.1182/blood-2021-151701","title":"Are Novel Therapies Worth the Cost for Young Patients?: A Cost-Effectiveness Analysis of Frontline Therapies with or without Radiation for Early-Stage Unfavourable Hodgkin Lymphoma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Population; Radiation therapy; Cost-effectiveness analysis; Breast cancer; Cost effectiveness; Oncology; Cancer; Intensive care medicine; Internal medicine; Risk analysis (engineering); Environmental health","score_opus":0.20216192218752607,"score_gpt":0.38339458964770917,"score_spread":0.1812326674601831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212362631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92561895,0.001675861,0.06377753,0.0013137774,0.00018171544,0.0036392868,0.0036999055,0.000027959022,0.00006499336],"genre_scores_gemma":[0.99242276,0.00011423983,0.003417688,0.00093034277,0.000116957795,0.002167542,0.00031900508,0.00005246951,0.000458978],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99716496,0.00024128974,0.0016149472,0.0005238236,0.00011154791,0.00034343312],"domain_scores_gemma":[0.9942673,0.0020833288,0.0026498013,0.00054019,0.00038696185,0.0000724339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047710943,0.00022911932,0.001258839,0.0002805836,0.00029054,0.00011754384,0.00021803119,0.00011177453,0.00007276346],"category_scores_gemma":[0.0014176063,0.00018766256,0.00025361814,0.0005789401,0.00007503701,0.00029790128,0.000022903383,0.000059479295,0.000006732346],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034886273,0.0007599527,0.98774046,0.0002961346,0.0031205746,2.5465894e-7,0.002962063,0.0009936473,0.000009321712,0.0030684427,0.00013126471,0.0005690255],"study_design_scores_gemma":[0.01073149,0.00028848747,0.9637222,0.0000920798,0.00050297286,0.0000010442672,0.0028599408,0.008948017,0.00020273255,0.00027303287,0.012059552,0.0003184274],"about_ca_topic_score_codex":0.00070732425,"about_ca_topic_score_gemma":0.0032215114,"teacher_disagreement_score":0.066803806,"about_ca_system_score_codex":0.00020158381,"about_ca_system_score_gemma":0.00019029222,"threshold_uncertainty_score":0.7652657},"labels":[],"label_agreement":null},{"id":"W3212384018","doi":"10.1182/blood-2021-151264","title":"Risk of Recurrent Venous Thromboembolism and Hemorrhage Following Interruption of Anticoagulation at Delivery","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Low molecular weight heparin; Anesthesia; Discontinuation; Retrospective cohort study; Surgery; Thrombosis","score_opus":0.018648320331589634,"score_gpt":0.2699307560872741,"score_spread":0.2512824357556845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212384018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955343,0.0030786104,0.000092235234,0.00006516913,0.0002113083,0.00022622095,0.000011989314,0.000018571529,0.0007615965],"genre_scores_gemma":[0.99727416,0.0013592528,0.0011775318,0.000041116615,0.000051821964,0.000006078115,0.000038198614,0.000014536334,0.000037315578],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99908584,0.00005008249,0.00030997285,0.00020983451,0.00021096285,0.0001333261],"domain_scores_gemma":[0.99939877,0.0000428958,0.00017417235,0.0002395159,0.000090542315,0.00005408202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016749717,0.00010464879,0.00052775996,0.00007400764,0.00004898124,0.0000062543795,0.000034965742,0.00005735379,0.00005278037],"category_scores_gemma":[0.000083746236,0.000100959594,0.00013954856,0.00012330117,0.000034490386,0.00005575989,0.000118461445,0.0000703245,0.0000037810933],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002151547,0.01927518,0.36972293,0.0037260219,0.0039019529,0.0005582939,0.00712816,0.000066854496,0.47342098,0.0012600506,0.00050836214,0.12021607],"study_design_scores_gemma":[0.0028149686,0.00060081494,0.8632026,0.00044489768,0.002970215,0.000049464004,0.00033981533,0.00027544828,0.12889336,0.00016687224,0.000113792834,0.0001277802],"about_ca_topic_score_codex":0.00007314865,"about_ca_topic_score_gemma":0.00002891825,"teacher_disagreement_score":0.49347964,"about_ca_system_score_codex":0.000023382252,"about_ca_system_score_gemma":0.000029948598,"threshold_uncertainty_score":0.41170126},"labels":[],"label_agreement":null},{"id":"W3212400736","doi":"10.1182/blood-2021-150481","title":"Zebrafish Models Provide Novel Insights into the Disease Biology of Parn-Mutant Dyskeratosis Congenita and DNAJC21-Mutant Shwachman-Diamond Syndrome","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; AGADA Biosciences; Hospital for Sick Children; Agricultural Research Institute of Ontario","funders":"","keywords":"Dyskeratosis congenita; Biology; Zebrafish; Genetics; Cancer research; Gene; Telomere","score_opus":0.009089426180147289,"score_gpt":0.21727889823259325,"score_spread":0.20818947205244595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212400736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9784391,0.020333385,0.00024285243,0.0002722671,0.00006232116,0.0002937695,0.00011295811,0.000010574579,0.00023275506],"genre_scores_gemma":[0.9979265,0.0011482754,0.0002448264,0.0002643263,0.000035207573,0.00007415801,0.00021300292,0.000026595362,0.00006714833],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987855,0.00007394446,0.00027327327,0.0005117196,0.00010834702,0.00024720552],"domain_scores_gemma":[0.9990909,0.00002639742,0.00010259051,0.0005158634,0.00011131844,0.00015290198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000057190082,0.00023057971,0.00026546442,0.000032022843,0.00013206816,0.00003303931,0.0001742514,0.00014415936,0.00000891354],"category_scores_gemma":[0.000057336765,0.00016655664,0.000110173125,0.0001220948,0.00019639729,0.000010089387,0.00023589592,0.00008008864,0.0000018742446],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013640498,0.0027762307,0.017363962,0.000106020794,0.0014608417,0.00019298987,0.000522053,0.000034801848,0.9730764,0.0027044183,0.000049762533,0.0015761344],"study_design_scores_gemma":[0.006752274,0.000758127,0.0050222604,0.0000580541,0.0010520993,0.00019268673,0.0003898133,0.00039153986,0.97383624,0.007873127,0.0031010017,0.000572792],"about_ca_topic_score_codex":0.00006507213,"about_ca_topic_score_gemma":0.00020810125,"teacher_disagreement_score":0.019487342,"about_ca_system_score_codex":0.0000047653366,"about_ca_system_score_gemma":0.00018207612,"threshold_uncertainty_score":0.67919827},"labels":[],"label_agreement":null},{"id":"W3212419124","doi":"10.1182/blood-2021-152614","title":"Low-Dose Dasatinib 50 Mg/Day Versus Standard-Dose Dasatinib 100 Mg/Day As Frontline Therapy in Chronic Myeloid Leukemia in Chronic Phase: A Propensity Score Analysis","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dasatinib; Medicine; Myeloid leukemia; Internal medicine; Propensity score matching; Oncology; Imatinib","score_opus":0.03958019677847365,"score_gpt":0.3183442552377831,"score_spread":0.27876405845930946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212419124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809473,0.0135915475,0.000054731747,0.00035164566,0.00037751574,0.0024809144,0.00024646628,0.00021711712,0.0017327315],"genre_scores_gemma":[0.99042314,0.004177336,0.0005324682,0.0002709914,0.00078159914,0.000362684,0.0017170366,0.00018652219,0.0015481914],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9924968,0.0007313104,0.0016545695,0.0020236166,0.001480091,0.0016136413],"domain_scores_gemma":[0.9956957,0.00047114975,0.00054048485,0.002358243,0.00036675425,0.00056763],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013868627,0.0010853088,0.0024528932,0.0009163261,0.00021301824,0.00013246734,0.00055545924,0.00057969615,0.0033228216],"category_scores_gemma":[0.00072795857,0.0010004281,0.0006846245,0.0033749866,0.00030269177,0.00037656302,0.00033598937,0.0014427822,0.00025088992],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.04437463,0.020455161,0.20349136,0.0021572374,0.027888516,0.03368692,0.011193569,0.00673567,0.41444063,0.0002625971,0.0019163908,0.2333973],"study_design_scores_gemma":[0.5480171,0.013637776,0.21899696,0.0023466547,0.0059492197,0.0002910846,0.00055292615,0.0066326708,0.19080476,0.00009419834,0.0102333445,0.002443309],"about_ca_topic_score_codex":0.0026325919,"about_ca_topic_score_gemma":0.018210668,"teacher_disagreement_score":0.5036425,"about_ca_system_score_codex":0.024265252,"about_ca_system_score_gemma":0.023773832,"threshold_uncertainty_score":0.9997044},"labels":[],"label_agreement":null},{"id":"W3212444048","doi":"10.1182/blood-2021-153710","title":"Frailty Scale for Outcome Predictions in Hematopoietic Cell Transplanted Adults","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Frailty in Older Adults","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cohort; Hematopoietic cell; Transplantation; Activities of daily living; Hematopoietic stem cell transplantation; Gerontology; Cohort study; Prospective cohort study; Physical therapy; Internal medicine; Stem cell; Haematopoiesis","score_opus":0.02145385034068422,"score_gpt":0.2750160320401284,"score_spread":0.2535621816994442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212444048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897361,0.00035145547,0.0011480858,0.0018634435,0.0002502739,0.00074125023,0.00025172016,0.00014176744,0.0055159475],"genre_scores_gemma":[0.9923786,0.000050163293,0.0038811115,0.00030197547,0.000116516225,0.00013679756,0.00021285379,0.00003290365,0.0028890846],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99875784,0.000023995393,0.00038598783,0.00033057953,0.00019701807,0.0003045667],"domain_scores_gemma":[0.99923044,0.00011774779,0.00004087831,0.00036033778,0.00011132004,0.0001392737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008088788,0.0001467619,0.00031915167,0.00008428693,0.000046270707,0.000010901116,0.00007696528,0.00013790093,0.00019424595],"category_scores_gemma":[0.00010636016,0.00014498766,0.00014418966,0.00025939805,0.00003473344,0.000050416136,0.000016551658,0.00020944928,0.000042123356],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006273806,0.012042953,0.9186122,0.006767491,0.0002154438,0.0011256074,0.0072950944,0.000047537294,0.048445437,0.00011576617,0.003393848,0.0013112525],"study_design_scores_gemma":[0.092852734,0.0015088792,0.39453542,0.0037975782,0.0016795942,0.0019936706,0.002404088,0.0016413014,0.4911759,0.00043239607,0.0070384024,0.0009400288],"about_ca_topic_score_codex":0.000034638462,"about_ca_topic_score_gemma":0.00042730608,"teacher_disagreement_score":0.52407676,"about_ca_system_score_codex":0.000026365096,"about_ca_system_score_gemma":0.00010259008,"threshold_uncertainty_score":0.59124255},"labels":[],"label_agreement":null},{"id":"W3212456862","doi":"10.1182/blood-2021-146352","title":"Outcome of Relapsed and Refractory Peripheral T-Cell Lymphoma (PTCL) with Intention for Curative Therapy Incorporating High Dose Chemotherapy and Hematopoietic Stem Cell Transplant (HDC/SCT)","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency; University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Medicine; Internal medicine; Chemotherapy; Oncology; Hematopoietic stem cell transplantation; Refractory (planetary science); Progression-free survival; Lymphoma; Peripheral T-cell lymphoma; Gastroenterology; Transplantation; Chemotherapy regimen; Salvage therapy; Anthracycline; Cancer; T cell; Immunology; Breast cancer; Immune system","score_opus":0.015376599245650819,"score_gpt":0.23868589176268584,"score_spread":0.22330929251703502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212456862","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953139,0.0033080105,0.0001105032,0.00031577397,0.00003696662,0.00065700006,0.000030827974,0.000026024527,0.00020103146],"genre_scores_gemma":[0.99609756,0.0010024102,0.0021900926,0.00020574543,0.000026179765,0.00010326043,0.000050591534,0.000034430188,0.0002897107],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989432,0.000045962635,0.0003400213,0.00033823322,0.00016841547,0.00016413796],"domain_scores_gemma":[0.99927205,0.00010824385,0.00019593976,0.00019964174,0.00012575138,0.00009835491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009161928,0.00022376586,0.0004749904,0.00004308186,0.00007416414,0.000025541038,0.0000322507,0.00009138818,0.000014415074],"category_scores_gemma":[0.0000029179819,0.00015602293,0.00008270795,0.00009225448,0.00007956029,0.00008286752,0.000009928804,0.000049585953,5.1010545e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035674456,0.015110012,0.7605254,0.0016699241,0.0009923609,0.0005153134,0.011997206,0.0000016625966,0.18027233,0.0006017246,0.000043937787,0.024702676],"study_design_scores_gemma":[0.107591026,0.004989329,0.14168964,0.0005527248,0.0006446883,0.00035520346,0.002784944,0.000066955254,0.7405673,0.00014787624,0.00024513653,0.00036515488],"about_ca_topic_score_codex":0.000054257285,"about_ca_topic_score_gemma":0.000017979319,"teacher_disagreement_score":0.61883575,"about_ca_system_score_codex":0.000047792262,"about_ca_system_score_gemma":0.000106592386,"threshold_uncertainty_score":0.63624305},"labels":[],"label_agreement":null},{"id":"W3212459009","doi":"10.1182/blood-2021-150763","title":"\"Building a More Inclusive Blood System in Canada\": A Mixed-Methods Evaluation of a Workshop to Guide Medical Students to Develop as Health Advocates Through Advancing Health Equity in Blood Product Donation for Gay, Bisexual, and Queer Men","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Blood donation and transfusion practices","field":"Business, Management and Accounting","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; University of Manitoba; Western University; Dalhousie University; University of Toronto; University of Saskatchewan; Stem Cell Network; University of Ottawa","funders":"","keywords":"Donation; Context (archaeology); Equity (law); Health care; Medicine; Public relations; Medical education; Nursing; Political science","score_opus":0.0668070005764825,"score_gpt":0.4593164958175214,"score_spread":0.39250949524103884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212459009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9579701,0.0027489571,0.003735055,0.032060992,0.00032758462,0.002688591,0.00001202514,0.000045731074,0.00041099812],"genre_scores_gemma":[0.95629996,0.00011698131,0.03726463,0.00563538,0.00015488124,0.00042809226,0.000047069192,0.000036967478,0.000016048925],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9952357,0.00038708688,0.0011878369,0.00073616335,0.0019279569,0.00052529084],"domain_scores_gemma":[0.9973643,0.00045579995,0.0005428566,0.00026246003,0.0012793285,0.00009526498],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.011439515,0.00025225233,0.00059305434,0.00044336743,0.00022133434,0.00016099057,0.00033658344,0.000076205746,0.000023824196],"category_scores_gemma":[0.0073020244,0.00026055492,0.000030342222,0.0021951643,0.000017544457,0.0007344748,0.0006596805,0.00020516077,0.0000011102669],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059870846,0.009178314,0.15520452,0.014249389,0.0014859727,0.0002049423,0.025404995,0.005062628,0.005510727,0.018859012,0.004095829,0.76014495],"study_design_scores_gemma":[0.10556506,0.0009223034,0.50183356,0.025231926,0.0047557172,0.0004800496,0.23104836,0.023237383,0.04783695,0.0065866453,0.047520198,0.0049818386],"about_ca_topic_score_codex":0.36693433,"about_ca_topic_score_gemma":0.75337976,"teacher_disagreement_score":0.75516313,"about_ca_system_score_codex":0.0005016578,"about_ca_system_score_gemma":0.0067327865,"threshold_uncertainty_score":0.9999847},"labels":[],"label_agreement":null},{"id":"W3212466623","doi":"10.1182/blood-2021-146675","title":"A Retrospective Head-to-Head Comparison between Pacritinib and Ruxolitinib in Patients with Myelofibrosis and Moderate to Severe Thrombocytopenia","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Ruxolitinib; Medicine; Myelofibrosis; Dosing; Internal medicine; Surgery; Gastroenterology; Bone marrow","score_opus":0.021375848778062534,"score_gpt":0.29120746873472725,"score_spread":0.2698316199566647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212466623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961619,0.00016966535,0.00001622546,0.0015446795,0.000017717239,0.0010224455,0.00019187482,0.000027350588,0.0008481858],"genre_scores_gemma":[0.9948862,0.000025469773,0.004084033,0.00062309095,0.00005804679,0.00012838178,0.000094405885,0.00003156844,0.00006879355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998357,0.00007299685,0.00029982868,0.0006252283,0.0002933563,0.0003516026],"domain_scores_gemma":[0.99902695,0.00008345422,0.000049290524,0.00024365273,0.00021980375,0.00037684102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008029369,0.00026657834,0.0008459139,0.00009921319,0.00010758153,0.000073821626,0.000035150875,0.00008295572,0.000037403905],"category_scores_gemma":[0.00008288031,0.00021569648,0.000031163243,0.00030278706,0.000039102273,0.000082778446,0.00009802294,0.00017429757,0.000013009923],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004101467,0.0011478914,0.9947885,0.00005522686,0.00017742894,0.000066257286,0.0013581571,0.0000021459484,0.00010064502,0.000113572656,0.000071063034,0.0017089634],"study_design_scores_gemma":[0.012083798,0.002466667,0.9769159,0.00050379825,0.00024527733,0.000021804568,0.00019643772,0.000008003699,0.007135773,0.00006753055,0.000117083735,0.00023790098],"about_ca_topic_score_codex":0.000112860806,"about_ca_topic_score_gemma":0.00057234167,"teacher_disagreement_score":0.017872576,"about_ca_system_score_codex":0.000075451295,"about_ca_system_score_gemma":0.00008143332,"threshold_uncertainty_score":0.8795847},"labels":[],"label_agreement":null},{"id":"W3212486006","doi":"10.1182/blood-2021-151597","title":"Prediction of Early Mortality with Non-Intensive Acute Myeloid Leukemia (AML) Therapies: Analysis of 1336 Patients from MRC/NCRI and SWOG","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Oncology; Internal medicine; Midostaurin; Myeloid leukemia; Logistic regression","score_opus":0.017591307162793075,"score_gpt":0.26244641263683094,"score_spread":0.24485510547403785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212486006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978242,0.00029114567,0.00021451201,0.000088391476,0.000036068537,0.00033830595,0.00081781717,0.0000243037,0.0003652582],"genre_scores_gemma":[0.9979819,0.00031745492,0.00073032733,0.00013656678,0.000056058612,0.000018830578,0.0005808443,0.00002792355,0.00015011356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980251,0.00008798095,0.00045736457,0.0004643365,0.0007078572,0.00025735394],"domain_scores_gemma":[0.9972003,0.00012256167,0.00023361694,0.000660239,0.0016198809,0.00016336852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015886463,0.0002017407,0.00080375094,0.00026142312,0.00004554993,0.000015387524,0.00011837617,0.0001483189,0.00010612966],"category_scores_gemma":[0.00015119578,0.00015864761,0.0001711372,0.001034995,0.00022393033,0.000121018806,0.00011207304,0.00027580082,0.0000024161607],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000445889,0.0003441478,0.9137668,0.00007173727,0.016768046,0.00008633591,0.0023406132,0.0000072917337,0.065574065,0.0000068928834,0.00012464219,0.00046351398],"study_design_scores_gemma":[0.0064799893,0.0007860549,0.8994517,0.000120050274,0.009755248,0.0000057744196,0.00090096507,0.00044882877,0.081899725,0.000019621446,0.000025416668,0.00010664869],"about_ca_topic_score_codex":0.0021468066,"about_ca_topic_score_gemma":0.00016169538,"teacher_disagreement_score":0.016325656,"about_ca_system_score_codex":0.00012377722,"about_ca_system_score_gemma":0.000503662,"threshold_uncertainty_score":0.6469462},"labels":[],"label_agreement":null},{"id":"W3212498888","doi":"10.1182/blood-2021-144730","title":"Initial Safety and Efficacy Results from the Phase II, Multicenter, Open-Label Solace-Kids Trial of Crizanlizumab in Adolescents with Sickle Cell Disease (SCD)","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto","funders":"","keywords":"Medicine; Dosing; Pharmacokinetics; Clinical trial; Placebo; Internal medicine; Clinical endpoint; Pharmacodynamics; Adverse effect; Gastroenterology; Pharmacology; Pathology","score_opus":0.020478839345782325,"score_gpt":0.29530869868981996,"score_spread":0.27482985934403764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212498888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944248,0.0014269378,0.000014136845,0.0012237943,0.00015504274,0.0012197392,0.00028612648,0.000018020957,0.0012313799],"genre_scores_gemma":[0.9985215,0.0005140186,0.00014620546,0.00036692887,0.00010891953,0.000010088278,0.00017894158,0.000025329997,0.00012805258],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9984153,0.00015069798,0.00050102925,0.000402679,0.00027009964,0.00026022666],"domain_scores_gemma":[0.9989805,0.000098782875,0.00014023023,0.0004697092,0.000085605294,0.00022513226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017847352,0.00019057404,0.00039471782,0.00003611454,0.00012587408,0.00003368644,0.00016840608,0.00010581631,0.000022477414],"category_scores_gemma":[0.0003809488,0.00012391273,0.000047481903,0.00022024661,0.00014154516,0.000078136116,0.00024146198,0.00032562838,0.0000034626496],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.85747194,0.10922331,0.004000223,0.00028371427,0.00031955945,0.0018263648,0.004581393,0.000017380176,0.0050767646,0.000018812369,0.0003747762,0.016805733],"study_design_scores_gemma":[0.98308414,0.002963682,0.0050066127,0.0016588152,0.00082897564,0.0000097575785,0.0009942529,0.0003588676,0.0040883822,0.000010954502,0.0007807505,0.00021479435],"about_ca_topic_score_codex":0.00029139756,"about_ca_topic_score_gemma":0.000084490144,"teacher_disagreement_score":0.12561218,"about_ca_system_score_codex":0.000016231628,"about_ca_system_score_gemma":0.00037756303,"threshold_uncertainty_score":0.5053015},"labels":[],"label_agreement":null},{"id":"W3212509541","doi":"10.1182/blood-2021-153237","title":"Single-Cell Profiling Reveals Clinically Relevant Evolutionary Trajectories and Alternate Biologies in Human Follicular Lymphoma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Spinal Cord Injury BC; Terry Fox Research Institute","funders":"","keywords":"Follicular lymphoma; Biology; Germinal center; CD8; Lymphoma; Immunology; Mass cytometry; B cell; Immune system; Diffuse large B-cell lymphoma; Cytotoxic T cell; Immunophenotyping; Cluster of differentiation; Phenotype; Cell of origin; Flow cytometry; Cell; Antibody; Genetics; Gene","score_opus":0.027154530611760035,"score_gpt":0.28096618479846747,"score_spread":0.2538116541867074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212509541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988253,0.009783757,0.0000016204731,0.0003398529,0.00010581673,0.0002635869,0.000014353852,0.00005667305,0.0011813205],"genre_scores_gemma":[0.99467504,0.0010334391,0.003628468,0.00016652649,0.00010593006,0.00003618023,0.000068739944,0.000016299726,0.00026935473],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987161,0.0000783706,0.00042345191,0.0003934017,0.00014899793,0.00023966757],"domain_scores_gemma":[0.9993167,0.00017286526,0.000088761866,0.00025876446,0.00007637435,0.00008652914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015438671,0.00015912476,0.00036894277,0.000056687106,0.00007065122,0.000023402392,0.000047976744,0.00011009208,0.00001216879],"category_scores_gemma":[0.00021027609,0.00012717713,0.00009858067,0.00012745016,0.000059050377,0.000048265058,0.00007481858,0.00005625608,0.000006476159],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050859595,0.003730674,0.88946456,0.00010247271,0.00012361725,0.00181147,0.00009938103,0.000001004029,0.10278151,0.00045611238,0.000054437216,0.001323927],"study_design_scores_gemma":[0.0151170725,0.0012326527,0.7044817,0.0004428584,0.00037629213,0.0005142283,0.00030254573,0.000012797161,0.27509332,0.0016173662,0.00055145123,0.00025768488],"about_ca_topic_score_codex":0.000052072588,"about_ca_topic_score_gemma":0.000010916276,"teacher_disagreement_score":0.18498282,"about_ca_system_score_codex":0.00008010984,"about_ca_system_score_gemma":0.000118267824,"threshold_uncertainty_score":0.5186133},"labels":[],"label_agreement":null},{"id":"W3212509840","doi":"10.1182/blood-2021-149478","title":"A Phase 3 Randomized Trial of Inotuzumab Ozogamicin for Newly Diagnosed High-Risk B-ALL: Safety Phase Results from Children's Oncology Group Protocol AALL1732","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Internal medicine; CD22; Calicheamicin; Interim analysis; Minimal residual disease; Surgery; Hematopoietic stem cell transplantation; Chemotherapy; Gastroenterology; Transplantation; Oncology; Bone marrow; Randomized controlled trial; Lymphoma; CD20","score_opus":0.01948813220071422,"score_gpt":0.3483837757388616,"score_spread":0.3288956435381474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212509840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81547266,0.00004899528,0.0045595868,0.00097131875,0.0002668177,0.17458324,0.0034189546,0.00012927629,0.00054913544],"genre_scores_gemma":[0.8000063,0.00020578255,0.031126916,0.00066452427,0.0033193878,0.15744485,0.0065168007,0.00020455148,0.0005109067],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99429435,0.0011477174,0.0019684457,0.0010040129,0.0008456063,0.00073984725],"domain_scores_gemma":[0.9891955,0.007898258,0.00089510815,0.001080881,0.0005032409,0.0004270132],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019834512,0.00045382776,0.002407236,0.00023857965,0.00012437353,0.000033598084,0.00035460579,0.00049647165,0.00021554707],"category_scores_gemma":[0.013319479,0.0003672898,0.0006910271,0.00044411392,0.00035337606,0.00010983522,0.00020907974,0.0005714159,0.00002248125],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9309739,0.032084595,0.00002131996,0.00009964695,0.0024040726,0.000656266,0.0005196821,0.000004441303,0.010007755,0.00014320623,0.0024573775,0.02062773],"study_design_scores_gemma":[0.93364525,0.014963607,0.00004698901,0.00020273954,0.0028319568,0.00006381135,0.00007042009,0.0008569045,0.041296333,0.0003551715,0.0053646322,0.0003021761],"about_ca_topic_score_codex":0.0021886153,"about_ca_topic_score_gemma":0.00015353425,"teacher_disagreement_score":0.03128858,"about_ca_system_score_codex":0.0005562584,"about_ca_system_score_gemma":0.0031459546,"threshold_uncertainty_score":0.9998779},"labels":[],"label_agreement":null},{"id":"W3212524403","doi":"10.1182/blood-2021-150142","title":"How Important Are in-Person Clinic Visits during Maintenance Therapy for Pediatric Acute Lymphoblastic Leukemia?","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Maintenance therapy; Pediatrics; Acute lymphocytic leukemia; Medical record; Chemotherapy regimen; Lymphoblastic Leukemia; Physical therapy; Chemotherapy; Surgery; Internal medicine; Leukemia","score_opus":0.019590930427396642,"score_gpt":0.2776712345371473,"score_spread":0.2580803041097507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212524403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936653,0.0031138984,0.0002345476,0.0014913037,0.00022055498,0.0008826178,0.00006921868,0.00009659721,0.00022601067],"genre_scores_gemma":[0.9870484,0.003521485,0.0013412553,0.0004539053,0.0008816806,0.00021533201,0.00005012098,0.000107053595,0.006380797],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99708664,0.00006463139,0.00049692794,0.0008036597,0.0005840449,0.0009641114],"domain_scores_gemma":[0.99805856,0.00040865174,0.0002414018,0.0006264453,0.00035293726,0.0003120291],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032166232,0.0003413292,0.0007114911,0.00026041153,0.000117444004,0.00008507851,0.00023470788,0.00024574943,0.00007792055],"category_scores_gemma":[0.0009860115,0.00029241832,0.00027898,0.0007837629,0.000052891595,0.00014646097,0.000088848305,0.00034868403,0.00003485332],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051743663,0.003591056,0.82211983,0.0023606864,0.0020687317,0.030315481,0.0010950466,0.000012565117,0.12363155,0.00009958265,0.0073085036,0.0022226102],"study_design_scores_gemma":[0.1652115,0.0023051305,0.6735752,0.0010484859,0.0019464921,0.005698538,0.0021089849,0.0026083207,0.14180079,0.00021338293,0.001961237,0.0015219257],"about_ca_topic_score_codex":0.00001351395,"about_ca_topic_score_gemma":0.000025668918,"teacher_disagreement_score":0.16003713,"about_ca_system_score_codex":0.00096128683,"about_ca_system_score_gemma":0.0023626252,"threshold_uncertainty_score":0.9999528},"labels":[],"label_agreement":null},{"id":"W3212525057","doi":"10.1182/blood-2021-154380","title":"Treatment-Free Remission in Patients with Chronic Myeloid Leukemia Following the Discontinuation of Tyrosine Kinase Inhibitors","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Discontinuation; Medicine; Internal medicine; Univariate analysis; Myeloid leukemia; Imatinib mesylate; Imatinib; Multivariate analysis; Oncology","score_opus":0.007465383064755747,"score_gpt":0.22651198705685585,"score_spread":0.2190466039921001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212525057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99681765,0.0015304419,0.000004275159,0.00027524916,0.00009693115,0.00064364745,0.000016725015,0.000028887878,0.0005862074],"genre_scores_gemma":[0.99847054,0.00007137338,0.00031993302,0.000022311524,0.00010890179,0.00004726972,0.00025697847,0.000035144727,0.000667566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853235,0.00006690489,0.00036480476,0.00034591515,0.00041351654,0.0002765334],"domain_scores_gemma":[0.99878144,0.00007466264,0.00015124278,0.0008006533,0.0001070249,0.00008494849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008316912,0.00022572782,0.0003779233,0.00007750011,0.000066335306,0.0000139215645,0.000102980164,0.00009067192,0.000041104566],"category_scores_gemma":[0.00021636275,0.00013500561,0.00010996798,0.000532474,0.00004852422,0.00010809579,0.000074936215,0.00013331475,0.000005388372],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032600338,0.0022167624,0.9610939,0.00007643441,0.0004069076,0.0002933057,0.0006269923,0.000028513738,0.018011833,0.000023848776,0.00012652222,0.016768953],"study_design_scores_gemma":[0.06872897,0.0021487228,0.6443975,0.0011084472,0.00096960855,0.000024591092,0.00015751494,0.00006285527,0.28168634,0.000019733772,0.0004799083,0.00021582107],"about_ca_topic_score_codex":0.00032296032,"about_ca_topic_score_gemma":0.00037294909,"teacher_disagreement_score":0.31669644,"about_ca_system_score_codex":0.0017409355,"about_ca_system_score_gemma":0.0014395223,"threshold_uncertainty_score":0.55053693},"labels":[],"label_agreement":null},{"id":"W3212528433","doi":"10.1182/blood-2021-147326","title":"Rates and Predictors of Visits to Primary Care Physicians during and after Treatment of Childhood Acute Lymphoblastic Leukemia: A Population-Based Cohort Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Kingston General Hospital; Children's Hospital of Eastern Ontario; Institute for Clinical Evaluative Sciences; Hospital for Sick Children; McMaster University; McMaster Children's Hospital; London Health Sciences Centre; University of Toronto","funders":"","keywords":"Medicine; Population; Cohort; Survivorship curve; Socioeconomic status; Pediatrics; Family medicine; Internal medicine","score_opus":0.005246008506388806,"score_gpt":0.24569561533850617,"score_spread":0.24044960683211736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212528433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973366,0.001338154,0.0000039659094,0.00007563436,0.000050862265,0.0009963232,0.00013353224,0.000028566956,0.00003634732],"genre_scores_gemma":[0.9993192,0.000049488648,0.00018015079,0.00012697763,0.000107324944,0.000079887104,0.00008700366,0.000027443548,0.000022551749],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870914,0.000067495355,0.00036578448,0.00037626733,0.00032454092,0.00015674808],"domain_scores_gemma":[0.999245,0.000085009735,0.00011345955,0.00031947132,0.00011990002,0.0001171724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005143047,0.00019227814,0.00062728924,0.00009127951,0.000043170607,0.000010223115,0.000030099007,0.00005212532,0.0000071783816],"category_scores_gemma":[0.000033951146,0.00018006437,0.000072933864,0.0001879174,0.000026874626,0.000041599225,0.0000435989,0.000042947453,4.5090678e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020662062,0.0017412899,0.98568755,0.000487577,0.000884973,0.0000648152,0.008769369,0.000018348523,0.0018220713,4.0085325e-7,0.0000013726155,0.00031558846],"study_design_scores_gemma":[0.008356345,0.0014584746,0.96998674,0.00048419758,0.0018033995,0.000019656754,0.0012648334,0.0000036505087,0.01648929,0.0000014056476,0.0000017619251,0.00013025069],"about_ca_topic_score_codex":0.00038770522,"about_ca_topic_score_gemma":0.00042803976,"teacher_disagreement_score":0.015700838,"about_ca_system_score_codex":0.00015292816,"about_ca_system_score_gemma":0.00026226236,"threshold_uncertainty_score":0.7342812},"labels":[],"label_agreement":null},{"id":"W3212530786","doi":"10.1182/blood-2021-151466","title":"Second Line Treatment Strategies in Multiple Myeloma: A Referral-Center Experience","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Interquartile range; Multiple myeloma; Regimen; Stage (stratigraphy); Internal medicine; Referral; Family medicine","score_opus":0.06384833249801761,"score_gpt":0.33749987252539126,"score_spread":0.2736515400273737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212530786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876257,0.00071386155,0.000009212709,0.00021285411,0.00004803583,0.00035026713,0.000037227383,0.00004512893,0.010957698],"genre_scores_gemma":[0.9954192,0.00023658753,0.001112718,0.0000744481,0.00008435101,0.00017321469,0.00016510632,0.000019931318,0.0027144433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986873,0.000054444245,0.00023388497,0.0003839639,0.00022883025,0.00041152656],"domain_scores_gemma":[0.99924,0.00005855806,0.000030705,0.0003840246,0.00007589453,0.00021085794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000038697828,0.0001854854,0.00030265396,0.00009242546,0.000054513803,0.00004433704,0.000057206595,0.00007299195,0.0009009437],"category_scores_gemma":[0.000078839614,0.00014348989,0.000093957475,0.00020796931,0.000053145246,0.0001264813,0.000048127764,0.000117761396,0.000091556285],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079469144,0.018216237,0.8535497,0.00017248026,0.00047827404,0.016415767,0.0040510856,0.000004938095,0.084952585,0.00014452085,0.00009557973,0.02112414],"study_design_scores_gemma":[0.06241369,0.0018260382,0.5646829,0.00023598842,0.00010081558,0.0008649455,0.0036687683,0.00033196402,0.35424182,0.00008900428,0.0111913225,0.00035273458],"about_ca_topic_score_codex":0.00011484294,"about_ca_topic_score_gemma":0.001733968,"teacher_disagreement_score":0.2888668,"about_ca_system_score_codex":0.00010017081,"about_ca_system_score_gemma":0.00026594766,"threshold_uncertainty_score":0.98647016},"labels":[],"label_agreement":null},{"id":"W3212550404","doi":"10.1182/blood-2021-146171","title":"Guiding the Standardization in Acute Leukemia Service Delivery through the Development of Organizational Requirements","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Health Sciences Centre; Windsor Regional Hospital; Ottawa Hospital; Kingston Health Sciences Centre; University of Ottawa; Juravinski Cancer Centre; Victoria Hospital; Sunnybrook Health Science Centre; Grand River Hospital; London Health Sciences Centre; Cancer Care Ontario","funders":"","keywords":"Service delivery framework; Business; Government (linguistics); Medicine; Best practice; Health care; Population; Service (business); Public relations; Economic growth; Political science; Marketing; Environmental health","score_opus":0.2986464168123819,"score_gpt":0.38869784910638416,"score_spread":0.09005143229400225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212550404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96277153,0.0013541732,0.013931564,0.017850438,0.0002999193,0.00041860007,0.00012261787,0.000018662971,0.0032324689],"genre_scores_gemma":[0.98135585,0.0001438231,0.011136097,0.006877993,0.00012139793,0.00004396225,0.00011329309,0.000024488794,0.00018311302],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970056,0.00018626922,0.0022352028,0.0002599208,0.00012793974,0.000185089],"domain_scores_gemma":[0.99819356,0.000327184,0.0009055568,0.00033284153,0.0002149615,0.000025889782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048349844,0.000098370336,0.0003210205,0.00005651937,0.00023895563,0.000046896337,0.00025340656,0.00006359076,0.0002395224],"category_scores_gemma":[0.00088480895,0.000089792455,0.00003376755,0.000505589,0.000024655374,0.00026745597,0.000104421844,0.000067297995,0.00014143398],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004293391,0.0008477361,0.49498156,0.0009731096,0.0018089437,0.000009100406,0.11214358,0.008594015,0.0013037513,0.36644107,0.012451619,0.00040258595],"study_design_scores_gemma":[0.017251613,0.00013705729,0.5332551,0.0013701547,0.00031803825,0.00008025886,0.047848288,0.011592148,0.033406522,0.091476195,0.26088572,0.0023789203],"about_ca_topic_score_codex":0.00012476946,"about_ca_topic_score_gemma":0.00054030505,"teacher_disagreement_score":0.27496487,"about_ca_system_score_codex":0.0004078686,"about_ca_system_score_gemma":0.00083568855,"threshold_uncertainty_score":0.36616302},"labels":[],"label_agreement":null},{"id":"W3212566661","doi":"10.1182/blood-2021-153098","title":"PLAGL2 Independently Drives Aberrant Erythropoiesis and Initiation of Preleukemic State","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; McMaster University; Population Health Research Institute","funders":"","keywords":"Haematopoiesis; Erythropoiesis; Biology; Cancer research; Progenitor cell; CD34; Stem cell; Bone marrow; Leukemia; Malignancy; Myeloid; Immunology; Anemia; Medicine; Internal medicine; Cell biology; Genetics","score_opus":0.014838370857839157,"score_gpt":0.2714841318293106,"score_spread":0.2566457609714714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212566661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955523,0.0010510271,0.000079213496,0.00044004672,0.00003369463,0.00019603907,0.000027165399,0.000030066836,0.002590473],"genre_scores_gemma":[0.9965683,0.0011866912,0.0011081003,0.00011414143,0.0000530437,0.000011409348,0.00004423349,0.000021199015,0.00089285057],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99888575,0.00006483762,0.00024816638,0.0002379815,0.0003511939,0.00021209208],"domain_scores_gemma":[0.99924284,0.00011071463,0.000075044845,0.00025482153,0.0002050483,0.00011155218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015635202,0.00010406625,0.00025988187,0.00010894658,0.00004218834,0.000015331414,0.00005627321,0.00008432948,0.00014946795],"category_scores_gemma":[0.00024136985,0.000095925076,0.00004628874,0.00021403021,0.00011278682,0.00009392598,0.0001038168,0.00022720326,0.000015239358],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044460798,0.0013850132,0.2245443,0.0011596554,0.0010529605,0.0014344078,0.005253817,0.000009910075,0.75190926,0.00041752393,0.0017537351,0.010634836],"study_design_scores_gemma":[0.01033917,0.00041184374,0.2573177,0.00024256113,0.0003355122,0.00071417965,0.00097525417,0.00018510525,0.7281857,0.0005256637,0.00057989714,0.00018741783],"about_ca_topic_score_codex":0.000063740335,"about_ca_topic_score_gemma":0.000035715868,"teacher_disagreement_score":0.0327734,"about_ca_system_score_codex":0.00006213822,"about_ca_system_score_gemma":0.00054713833,"threshold_uncertainty_score":0.3911711},"labels":[],"label_agreement":null},{"id":"W3212572680","doi":"10.1182/blood-2021-146003","title":"Clinical Outcomes in Patients (Pts) with Dose Reduction of Selinexor in Combination with Bortezomib, and Dexamethasone (XVd) in Previously Treated Multiple Myeloma from the Boston Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Bortezomib; Dexamethasone; Tolerability; Internal medicine; Multiple myeloma; Adverse effect; Population; Discontinuation; Oncology; Neutropenia; Gastroenterology; Pharmacology; Chemotherapy","score_opus":0.008855952597589074,"score_gpt":0.24508042139328068,"score_spread":0.23622446879569162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212572680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99938077,0.00010005412,0.000005343769,0.000037081798,0.000033442004,0.00042188202,0.0000068769755,0.0000032348516,0.000011307821],"genre_scores_gemma":[0.9994239,0.00004148157,0.00034072896,0.00002276434,0.000020049534,0.000014666548,0.000111047586,0.000010972286,0.00001434594],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99912256,0.00018102147,0.00025314375,0.00026675375,0.000088649766,0.00008789597],"domain_scores_gemma":[0.99959177,0.000034585217,0.00009100275,0.00019792566,0.00006570074,0.0000190134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015962444,0.00009308296,0.00018438508,0.00003098735,0.000015684569,0.000008170401,0.000043788023,0.00008525832,0.0000020722475],"category_scores_gemma":[0.00010654945,0.00006089143,0.00001809158,0.00014618937,0.00003780369,0.0000064537935,0.000030171213,0.00010327673,1.7948828e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006833641,0.0019238788,0.98819804,0.0000041429294,0.00006153299,0.0000051400775,0.0002885555,0.000008790078,0.0045733834,6.441253e-7,0.0000044450467,0.0042480784],"study_design_scores_gemma":[0.01346058,0.0016655629,0.9790683,0.000024661138,0.000052946736,0.0000024914716,0.0005438528,0.000016613523,0.005064896,0.0000062852255,0.000018250277,0.000075553915],"about_ca_topic_score_codex":0.00050794816,"about_ca_topic_score_gemma":0.0054728584,"teacher_disagreement_score":0.012777217,"about_ca_system_score_codex":0.000007489291,"about_ca_system_score_gemma":0.000030391988,"threshold_uncertainty_score":0.30539834},"labels":[],"label_agreement":null},{"id":"W3212573488","doi":"10.1182/blood-2021-149920","title":"Functional Immune Tolerance Induced By Sequential Hematopoietic Stem Cell-Solid Organ Transplantation","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Immunosuppression; Medicine; Transplantation; Fludarabine; Hematopoietic stem cell transplantation; Immunology; Internal medicine; Cyclophosphamide; Chemotherapy","score_opus":0.009132929800263269,"score_gpt":0.2060811489522511,"score_spread":0.19694821915198785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212573488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.962647,0.034024723,0.0005431074,0.00015231571,0.0009772574,0.00011815926,0.000048244878,0.00009288815,0.0013962834],"genre_scores_gemma":[0.99533314,0.00024014518,0.000007797227,0.00013586687,0.000007266172,0.000021511783,0.00077274337,0.000021648444,0.0034598876],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987012,0.00015074397,0.00036520435,0.0003315895,0.000061053586,0.00039020125],"domain_scores_gemma":[0.9994942,0.0000429775,0.0001050503,0.00026874183,0.00008139455,0.000007661573],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012295092,0.00019355763,0.00025681555,0.000043702246,0.00034811883,0.0000271995,0.00015725615,0.00022975644,0.0011164516],"category_scores_gemma":[0.0000049827404,0.0002021146,0.0001233914,0.0002111678,0.00007777643,0.00011346269,0.000034396417,0.00030286037,0.0005621959],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000529907,0.0007358432,0.000059642523,0.00005208412,0.00009882685,0.000016101383,0.0010094824,0.000012740056,0.9967851,0.00019029854,0.00014791942,0.0008389825],"study_design_scores_gemma":[0.003939944,0.00006650028,0.0019786148,0.00003792658,0.00013123815,0.0002585646,0.0008031487,0.0000015073903,0.9903841,0.000037103277,0.0021161917,0.00024517183],"about_ca_topic_score_codex":0.000030684812,"about_ca_topic_score_gemma":0.0000016428398,"teacher_disagreement_score":0.03378458,"about_ca_system_score_codex":0.00001318723,"about_ca_system_score_gemma":0.00013052243,"threshold_uncertainty_score":0.9997967},"labels":[],"label_agreement":null},{"id":"W3212592260","doi":"10.1182/blood-2021-152993","title":"Integrated Epigenetic and Transcriptional Single Cell Analysis of t(11;14) Myeloma and Its BCL2 Dependency","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Biology; Cancer research; Gene expression profiling; Multiple myeloma; Epigenomics; Epigenetics; Chromatin; Venetoclax; Epigenetic therapy; Chromosomal translocation; Molecular biology; Gene; Genetics; Gene expression; DNA methylation; Leukemia; Immunology","score_opus":0.02714428134344178,"score_gpt":0.2679746298240504,"score_spread":0.24083034848060864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212592260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902779,0.008412225,0.000060380982,0.00014599698,0.000014320023,0.00013983516,0.00010799592,0.000012477472,0.0008289103],"genre_scores_gemma":[0.9973598,0.0004947079,0.0010205619,0.000023371551,0.000014748661,0.000008256567,0.0002034602,0.000009975981,0.0008651163],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990593,0.000055146917,0.00019006191,0.00025612905,0.00025743336,0.00018190373],"domain_scores_gemma":[0.9993865,0.000056114375,0.000034483073,0.00014073636,0.00019196587,0.00019021964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006550114,0.00011034921,0.00031020105,0.00019600838,0.000041302723,0.000014812055,0.000031033775,0.000064079446,0.00033821558],"category_scores_gemma":[0.000079662794,0.00009236393,0.000087010536,0.00048593112,0.000042043834,0.00003565799,0.000022139082,0.00007858183,0.0000039431047],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010565657,0.0022406874,0.3625466,0.0001673465,0.0017386915,0.00039120845,0.0003154747,0.0000022683193,0.6269579,0.000101144025,0.000007348625,0.0054256674],"study_design_scores_gemma":[0.0047011613,0.00029223942,0.7071154,0.000040915027,0.0026511012,0.0000641715,0.00013546935,0.0005377638,0.28424305,0.000039227853,0.00009533273,0.000084168016],"about_ca_topic_score_codex":0.00006933364,"about_ca_topic_score_gemma":0.00036428004,"teacher_disagreement_score":0.3445688,"about_ca_system_score_codex":0.000012625033,"about_ca_system_score_gemma":0.00009871884,"threshold_uncertainty_score":0.37664917},"labels":[],"label_agreement":null},{"id":"W3212599750","doi":"10.1182/blood-2021-149245","title":"TIRAP Drives Marrow Failure through an Ifnγ-Hmgb1 Axis That Disrupts the Endothelial Niche","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"","keywords":"Bone marrow; Proinflammatory cytokine; Myeloid leukemia; Haematopoiesis; Myeloid; Immunology; Progenitor cell; Cytopenia; Biology; Innate immune system; Cancer research; Bone marrow failure; Stem cell; Medicine; Immune system; Inflammation; Cell biology","score_opus":0.01669036395431634,"score_gpt":0.24178418907407467,"score_spread":0.22509382511975834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212599750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96108395,0.0059320214,0.00025084178,0.0036003913,0.007489523,0.00030178885,0.00003306242,0.00022376918,0.02108467],"genre_scores_gemma":[0.960006,0.00034377255,0.00008884844,0.0010431168,0.00017208212,0.000027368047,0.00023957025,0.000024094297,0.038055155],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988144,0.00034078292,0.00019190955,0.0003180777,0.000044549284,0.00029030113],"domain_scores_gemma":[0.9992099,0.00011178092,0.00008981652,0.00049961236,0.0000734433,0.000015467385],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00010686819,0.00017863403,0.00018383606,0.000027043237,0.0003519726,0.000052676507,0.00021276105,0.00021337504,0.0051005175],"category_scores_gemma":[0.00006848939,0.00012595583,0.00015040257,0.00010501605,0.00013822375,0.0003187144,0.000081901715,0.0004162405,0.0011711478],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000085639804,0.0005514355,0.0018432556,0.000008857294,0.00036893412,0.00001639863,0.0020208992,0.0000010204336,0.9689783,0.0015780176,0.023607979,0.0009392558],"study_design_scores_gemma":[0.0012145824,0.00012247854,0.0016849652,0.000012541562,0.00009965197,0.00036918645,0.0020612404,7.851123e-7,0.56017137,0.0001168368,0.43401772,0.00012864609],"about_ca_topic_score_codex":0.0000655471,"about_ca_topic_score_gemma":0.00012111834,"teacher_disagreement_score":0.41040975,"about_ca_system_score_codex":0.000013020816,"about_ca_system_score_gemma":0.00005333945,"threshold_uncertainty_score":0.99960655},"labels":[],"label_agreement":null},{"id":"W3212602214","doi":"10.1182/blood-2021-153086","title":"A Phase I/II Study of Venetoclax in Combination with 5-Azacytidine in Treatment-Naïve and Relapsed/Refractory High-Risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chronic myelomonocytic leukemia; Venetoclax; Myelodysplastic syndromes; Azacitidine; Medicine; Refractory (planetary science); Internal medicine; Phases of clinical research; Leukemia; Oncology; Gastroenterology; Chemotherapy; Chronic lymphocytic leukemia; Bone marrow; Biology; Genetics","score_opus":0.017438468941269835,"score_gpt":0.2871701145387691,"score_spread":0.2697316455974993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212602214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99706906,0.000918121,0.0000093591925,0.000068639354,0.00004253698,0.0017398744,0.000027394783,0.000041650404,0.000083360545],"genre_scores_gemma":[0.9977714,0.0007851629,0.00022285535,0.000012611506,0.00004445343,0.00025092484,0.00008788298,0.00006801665,0.00075670535],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99734503,0.00029090076,0.00063922844,0.0006963457,0.000506069,0.0005224053],"domain_scores_gemma":[0.99837184,0.00043499627,0.0002185454,0.000622966,0.00014703772,0.00020463155],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003217561,0.00035882153,0.0009197754,0.00059482636,0.00009247925,0.000021529646,0.00013200473,0.00018046176,0.000093742834],"category_scores_gemma":[0.00034500723,0.00027970906,0.000047397156,0.0011957376,0.00013556151,0.00017815962,0.00014367365,0.000591921,0.000010802853],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037391637,0.18167938,0.40942845,0.0034614576,0.0063127354,0.13381957,0.02675623,0.0026647593,0.09153137,0.0003380374,0.00015482007,0.10646157],"study_design_scores_gemma":[0.47208256,0.18853551,0.30479982,0.001445552,0.0018448171,0.0025774892,0.0035572632,0.0057829777,0.018483583,0.000070777576,0.00013375987,0.0006858899],"about_ca_topic_score_codex":0.0028175062,"about_ca_topic_score_gemma":0.005568778,"teacher_disagreement_score":0.43469092,"about_ca_system_score_codex":0.0043170354,"about_ca_system_score_gemma":0.0042408733,"threshold_uncertainty_score":0.9999655},"labels":[],"label_agreement":null},{"id":"W3212606852","doi":"10.1182/blood-2021-145409","title":"Experiences of Sickle Cell Disease (SCD) Reported By Healthcare Professionals (HCPs) across Different Regions: International Sickle Cell World Assessment Survey (SWAY)","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Quality of life (healthcare); Family medicine; Disease; Life expectancy; Specialty; Physical therapy; Internal medicine; Nursing; Population; Environmental health","score_opus":0.019944793370640382,"score_gpt":0.33073847836103737,"score_spread":0.310793684990397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212606852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98911333,0.004670232,0.0000405003,0.0031303263,0.00065290916,0.00047475935,0.00020114452,0.00005596725,0.0016608583],"genre_scores_gemma":[0.9850591,0.00062343886,0.00015660364,0.0005615544,0.000068522546,0.00011585492,0.0009988627,0.000030525367,0.012385548],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973732,0.0002476573,0.0007259622,0.0005280672,0.0007328859,0.0003922219],"domain_scores_gemma":[0.99814224,0.00014962057,0.00037581965,0.00052159396,0.00041399425,0.00039675887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032213487,0.00024228703,0.00045017086,0.00007124412,0.0001653118,0.00003125821,0.00017699835,0.00012414223,0.0004948494],"category_scores_gemma":[0.00015622455,0.00018766084,0.00017635268,0.0003715186,0.00012751155,0.000077369376,0.0001611179,0.00034633323,0.000007511629],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006836206,0.03148634,0.88367283,0.001668079,0.0006315244,0.0013711008,0.017426804,0.00001378084,0.020566223,0.0001987123,0.04122989,0.0010511208],"study_design_scores_gemma":[0.023198789,0.0009923045,0.5758792,0.0026716206,0.00077659055,0.00010322142,0.13941717,0.00040033786,0.23576723,0.00034669452,0.018912695,0.0015341194],"about_ca_topic_score_codex":0.00021636806,"about_ca_topic_score_gemma":0.0001390211,"teacher_disagreement_score":0.3077936,"about_ca_system_score_codex":0.000059190417,"about_ca_system_score_gemma":0.000615634,"threshold_uncertainty_score":0.7652587},"labels":[],"label_agreement":null},{"id":"W3212614000","doi":"10.1182/blood-2021-146031","title":"Evaluating the Impact of Thrombopoietin Receptor Agonists Medications on Patient Outcomes and Quality of Life in Pediatric Immune Thrombocytopenia","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; University of Toronto; Children's Hospital of Eastern Ontario; University of Ottawa; Hospital for Sick Children","funders":"","keywords":"Medicine; Quality of life (healthcare); Thrombopoietin; Clinical trial; Pediatrics; Immune thrombocytopenia; Thrombopoietin receptor; Romiplostim; Intensive care medicine; Internal medicine; Platelet","score_opus":0.05940015533020936,"score_gpt":0.38978394363556224,"score_spread":0.33038378830535287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212614000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964844,0.0019541963,5.1928606e-7,0.0006839166,0.000028720422,0.00029174058,0.000034692508,0.000005961985,0.0005158544],"genre_scores_gemma":[0.99907035,0.0004988579,0.000283553,0.00005114591,0.000009865395,0.000016427604,0.00004132505,0.00000820325,0.000020300926],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998809,0.0001524337,0.00047790815,0.00015817746,0.000281264,0.00012123379],"domain_scores_gemma":[0.9990017,0.0003146371,0.00024083468,0.00029577131,0.000092136645,0.000054933487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003437598,0.00010339049,0.0005360661,0.000046631496,0.00004076518,0.0000047375524,0.000050887924,0.000048953167,0.00011737048],"category_scores_gemma":[0.000795876,0.000061358616,0.00011099156,0.00022358316,0.000052708445,0.000022625445,0.000043732547,0.00010331356,0.0000039470574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079937636,0.0026181573,0.9867094,0.0000714545,0.0003387419,0.0000057019124,0.0010840559,0.000007176322,0.007894363,0.000055832796,0.000030430654,0.0011047417],"study_design_scores_gemma":[0.0046603177,0.0006997652,0.9903513,0.000045250657,0.00018515594,0.0000040126097,0.00026736443,0.000010647362,0.003646933,0.000075976444,0.0000011989941,0.00005205618],"about_ca_topic_score_codex":0.00058023346,"about_ca_topic_score_gemma":0.000046703797,"teacher_disagreement_score":0.00458038,"about_ca_system_score_codex":0.00002096103,"about_ca_system_score_gemma":0.00029219233,"threshold_uncertainty_score":0.25021318},"labels":[],"label_agreement":null},{"id":"W3212627357","doi":"10.1182/blood-2021-152021","title":"The Use of Virtual Care in Patients with Hematologic Malignancies - a Scoping Review","year":2021,"lang":"en","type":"review","venue":"Blood","topic":"Telemedicine and Telehealth Implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; MEDLINE; CINAHL; Population; Health care; Intensive care medicine; Nursing; Psychological intervention","score_opus":0.08811888549666871,"score_gpt":0.38055280220667376,"score_spread":0.29243391671000507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212627357","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00096857455,0.9956492,0.0000017824848,0.000044568034,0.00004625759,0.0032392088,0.00002673889,0.000012047252,0.000011592511],"genre_scores_gemma":[0.00003395006,0.99863064,0.0002267399,0.00028438956,0.000029293027,0.00022817389,0.00053044996,0.00002341156,0.000012934557],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99813557,0.00016824258,0.0009145409,0.00022731844,0.00032728625,0.00022704489],"domain_scores_gemma":[0.9985529,0.00029380427,0.0005249015,0.00036826858,0.00020365382,0.000056451383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016055531,0.00020460584,0.0017113003,0.000081989514,0.00004550205,0.000008343216,0.00007884065,0.00007942272,0.000022582775],"category_scores_gemma":[0.00037866135,0.000110365036,0.00013040932,0.00041562252,0.000045841,0.000038938975,0.000044586795,0.00020030039,0.000002360661],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008611624,0.00015666042,0.005076493,0.36955392,0.00010747154,0.000043832093,0.000079693236,1.2547231e-8,1.0494957e-8,0.000035059787,0.00027946907,0.62465876],"study_design_scores_gemma":[0.0014729139,0.0006771735,0.00044619502,0.7471825,0.0017435693,0.00003840042,0.00007741623,9.734259e-9,0.0000010743016,1.5640931e-7,0.24826136,0.00009921496],"about_ca_topic_score_codex":0.00002080934,"about_ca_topic_score_gemma":0.00008922166,"teacher_disagreement_score":0.6245595,"about_ca_system_score_codex":0.000038791364,"about_ca_system_score_gemma":0.00080126466,"threshold_uncertainty_score":0.45005554},"labels":[],"label_agreement":null},{"id":"W3212627496","doi":"10.1182/blood-2021-151757","title":"Functional Connectivity in Pediatric Sickle Cell Disease","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Resting state fMRI; Neuroimaging; Medicine; Functional magnetic resonance imaging; Neuropsychology; Stroke (engine); Neurocognitive; Magnetic resonance imaging; Blood-oxygen-level dependent; Physical medicine and rehabilitation; Neuroscience; Cognition; Psychology; Psychiatry; Radiology","score_opus":0.007877688887311246,"score_gpt":0.20748416196610522,"score_spread":0.19960647307879398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212627496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98515075,0.0035030327,0.000022403421,0.00095893565,0.00014237029,0.00009164544,0.0000054712377,0.000032797885,0.010092592],"genre_scores_gemma":[0.99752945,0.00040479153,0.000047825684,0.00031753976,0.00015150708,0.0000074639547,0.000031693122,0.00000975894,0.001499949],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99940175,0.000026830383,0.000107258915,0.00018126663,0.0001319558,0.00015095623],"domain_scores_gemma":[0.99961686,0.00003855039,0.000019098068,0.00013948296,0.00004298842,0.00014301534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000056781104,0.0000700339,0.00011497501,0.000050641203,0.000031653155,0.000006159679,0.000017838523,0.000060618084,0.00038345577],"category_scores_gemma":[0.00010406893,0.00006332327,0.00006466142,0.00026781022,0.000014614545,0.000027704502,0.00002309902,0.00016488056,0.00011085205],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008548537,0.0036799712,0.99025875,0.0002019281,0.000022143042,0.001286541,0.00007461522,0.000051244355,0.0016190712,0.00016117221,0.0021849328,0.000374115],"study_design_scores_gemma":[0.0066337595,0.00006246287,0.98806036,0.00002158778,0.0003234846,0.000042552525,0.0001475726,0.00006667664,0.0025533843,0.0002379254,0.0017197584,0.00013049807],"about_ca_topic_score_codex":0.00001032346,"about_ca_topic_score_gemma":0.00000927456,"teacher_disagreement_score":0.01237872,"about_ca_system_score_codex":0.0000130182725,"about_ca_system_score_gemma":0.00027382717,"threshold_uncertainty_score":0.4198572},"labels":[],"label_agreement":null},{"id":"W3212627725","doi":"10.1182/blood-2021-153657","title":"A Phase I/II Study of Venetoclax in Combination with ASTX727 (cedazuridine/decitabine) in Treatment-Naïve High-Risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Decitabine; Chronic myelomonocytic leukemia; Venetoclax; Myelodysplastic syndromes; Medicine; Azacitidine; Internal medicine; Leukemia; Oncology; Bone marrow; Chronic lymphocytic leukemia; Biology; Genetics; DNA methylation","score_opus":0.01998827595166818,"score_gpt":0.2953549840939761,"score_spread":0.2753667081423079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212627725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99669987,0.0005172954,0.00002987711,0.00010233674,0.00007238763,0.0022988005,0.000044277534,0.00006194363,0.00017321335],"genre_scores_gemma":[0.9975521,0.00032766376,0.00038462292,0.00001542691,0.00007592265,0.00042196433,0.00014706173,0.0000966338,0.0009786204],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9964351,0.00034860134,0.00085718214,0.0008486066,0.0007598395,0.00075066753],"domain_scores_gemma":[0.99792033,0.00044974184,0.00026666853,0.00087306206,0.00025045985,0.00023975324],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037408122,0.00047099905,0.0011692764,0.0007849024,0.000106158564,0.000029823621,0.00023965146,0.00019888234,0.00021215998],"category_scores_gemma":[0.0004355561,0.00036824413,0.000090495836,0.0020714873,0.00012216622,0.00019497602,0.00017591288,0.00063833245,0.000036847992],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.041570526,0.26190352,0.25452307,0.0036345012,0.009179,0.19446695,0.02586204,0.013797969,0.088067256,0.0007108117,0.0002920209,0.10599234],"study_design_scores_gemma":[0.53414667,0.19830807,0.20267038,0.0017656418,0.0023377477,0.003424922,0.00458663,0.011572518,0.039901026,0.000097398224,0.00016920627,0.0010198232],"about_ca_topic_score_codex":0.004101783,"about_ca_topic_score_gemma":0.007637944,"teacher_disagreement_score":0.49257612,"about_ca_system_score_codex":0.0059645413,"about_ca_system_score_gemma":0.0062144874,"threshold_uncertainty_score":0.999877},"labels":[],"label_agreement":null},{"id":"W3212628307","doi":"10.1182/blood-2021-147455","title":"DUSP6 Mediates Resistance to JAK2 Inhibition and Drives Myeloproliferative Neoplasm Disease Progression","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Biology; Cancer research; Myeloproliferative neoplasm; Myeloid; Myelofibrosis; Gene expression profiling; Transcriptome; Progenitor cell; Bone marrow; Stem cell; Immunology; Gene expression; Gene; Cell biology; Genetics","score_opus":0.010122875962954695,"score_gpt":0.2705913397530173,"score_spread":0.2604684637900626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212628307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98313314,0.0034118153,0.000024027808,0.010195358,0.0000744799,0.00077816396,0.000059720118,0.00006293013,0.002260379],"genre_scores_gemma":[0.9908152,0.0007285222,0.0051429947,0.0010804805,0.00022873317,0.0004745117,0.00016230324,0.000029258968,0.0013379578],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99846506,0.00008558938,0.00026175164,0.00056199677,0.00034413158,0.00028149135],"domain_scores_gemma":[0.99870354,0.00015980254,0.00006819402,0.0002659732,0.0002407896,0.00056170044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008033835,0.00024647693,0.00035055354,0.000083297215,0.00018696362,0.000066002205,0.000028407138,0.000073875366,0.00011570754],"category_scores_gemma":[0.00043825625,0.00019392693,0.00006878844,0.00024944573,0.00006917344,0.000108787615,0.00007780839,0.00012786877,0.00005513645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095510605,0.0051667616,0.9473617,0.00061371515,0.0005155049,0.003787976,0.0033703793,0.00000311581,0.023126215,0.0054595293,0.0035981142,0.0060419017],"study_design_scores_gemma":[0.006320764,0.0004567367,0.6132578,0.0013458685,0.0006131732,0.00009297271,0.00026234318,0.00001176478,0.37111777,0.0006475993,0.0055318545,0.0003413015],"about_ca_topic_score_codex":0.0000018560756,"about_ca_topic_score_gemma":0.000091930626,"teacher_disagreement_score":0.34799156,"about_ca_system_score_codex":0.000037631962,"about_ca_system_score_gemma":0.00021650572,"threshold_uncertainty_score":0.79081106},"labels":[],"label_agreement":null},{"id":"W3212668607","doi":"10.1182/blood-2021-151249","title":"Prognostic Factors for Early (&amp;lt;2 years) and Late (&amp;gt;5 years) Relapse in Multiple Myeloma- Pivotal Role of Cytogenetic Changes","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Internal medicine; Cohort; Multivariate analysis; Odds ratio; Multiple myeloma; Oncology","score_opus":0.039429567468611794,"score_gpt":0.285232250251891,"score_spread":0.24580268278327919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212668607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963904,0.0023903616,0.000007663701,0.000052392938,0.00003578822,0.00084264914,0.00014995062,0.000029361494,0.0001014014],"genre_scores_gemma":[0.9959451,0.00017312227,0.0027109883,0.000013706798,0.000056351008,0.00010601643,0.00018360406,0.00004042335,0.00077069266],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865896,0.00005578508,0.00022558607,0.00035938868,0.00028794928,0.00041230902],"domain_scores_gemma":[0.99903965,0.0002792693,0.00006520062,0.000301547,0.000098487726,0.00021583811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000109150074,0.00016951202,0.00036439495,0.00016839273,0.00003475476,0.000021918702,0.00006944601,0.00011894389,0.000058778194],"category_scores_gemma":[0.0007136713,0.00015990142,0.00008463249,0.00022574503,0.0000755108,0.000042286956,0.000085623666,0.00013254791,0.00002287059],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018587125,0.0008571799,0.86212677,0.00013038274,0.00020366142,0.00013878843,0.001091046,9.965389e-7,0.12914304,0.000009563835,0.000009490285,0.0061032115],"study_design_scores_gemma":[0.007850732,0.0004500307,0.96611893,0.00016298008,0.00017236696,0.000033134347,0.00009222799,0.000031786938,0.023954622,0.00006689731,0.0009312253,0.00013504976],"about_ca_topic_score_codex":0.00012464137,"about_ca_topic_score_gemma":0.0010032115,"teacher_disagreement_score":0.10518842,"about_ca_system_score_codex":0.000023738266,"about_ca_system_score_gemma":0.0001022491,"threshold_uncertainty_score":0.6520591},"labels":[],"label_agreement":null},{"id":"W3212668755","doi":"10.1182/blood-2021-152379","title":"Proteomics and Phospho-Proteomics Reveal Predictive Signatures of Response and Mechanisms of Resistance to Midostaurin Plus Chemotherapy in FLT3 Mutant Positive Acute Myeloid Leukemia","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Midostaurin; Cancer research; Myeloid leukemia; Oncology; Medicine; Internal medicine; Chemotherapy; Bone marrow; Biology","score_opus":0.006599343522056687,"score_gpt":0.24978639197708885,"score_spread":0.24318704845503217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212668755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933411,0.0010110639,0.0015087518,0.0015769578,0.000023446471,0.0020308308,0.0003500966,0.00002229294,0.00013545105],"genre_scores_gemma":[0.9522582,0.00048047604,0.046063766,0.00033469172,0.000034603523,0.00010576522,0.00002261648,0.000057136498,0.0006427088],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99774736,0.00023733711,0.0005227502,0.0006072321,0.00047929856,0.00040603138],"domain_scores_gemma":[0.9984432,0.00028602706,0.0001839656,0.00045731245,0.00039548337,0.00023401466],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007784325,0.0002747034,0.0007770052,0.00025383715,0.000052016378,0.000017462226,0.00015431436,0.00028403822,0.000011718242],"category_scores_gemma":[0.00058996945,0.00026369418,0.00007046263,0.0006033139,0.00022183183,0.00008376469,0.00021676286,0.00054148235,7.278438e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031589452,0.00021269382,0.0005970032,0.0002567775,0.00037144322,0.0006526727,0.0028394137,0.00001048862,0.96285546,0.0003874421,0.0000679513,0.00015921814],"study_design_scores_gemma":[0.011290959,0.001212116,0.041968845,0.00070485595,0.00017168591,0.00015525761,0.0008175439,0.00014266232,0.94239247,0.00092573604,0.000016744732,0.00020115488],"about_ca_topic_score_codex":0.00009398876,"about_ca_topic_score_gemma":0.00006264857,"teacher_disagreement_score":0.044555016,"about_ca_system_score_codex":0.0005074917,"about_ca_system_score_gemma":0.0016593016,"threshold_uncertainty_score":0.9999815},"labels":[],"label_agreement":null},{"id":"W3212675168","doi":"10.1182/blood-2021-144820","title":"Early Integration of High Dose Methotrexate to Frontline DLBCL Therapy Does Not Impact CNS Relapse Compared to End of Treatment Delivery: A Multicentre International Analysis of 1384 Patients","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Methotrexate; Internal medicine; Primary central nervous system lymphoma; Oncology; Diffuse large B-cell lymphoma; Proportional hazards model; Lymphoma; Surgery","score_opus":0.019984033264034275,"score_gpt":0.3005542960512361,"score_spread":0.2805702627872019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212675168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976388,0.0001343561,0.00007655161,0.00027613118,0.00008495031,0.0005175818,0.0012208176,0.000010090571,0.000040694827],"genre_scores_gemma":[0.9939507,0.00021481665,0.00485146,0.000064911525,0.000024138328,0.000044103188,0.00074489985,0.000014730354,0.000090222755],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986273,0.000077435376,0.00053139636,0.0002889841,0.0003357794,0.00013910625],"domain_scores_gemma":[0.9985133,0.00014807463,0.00024454595,0.00035275854,0.00059322646,0.00014813223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007030951,0.00019277254,0.0007478711,0.00037778495,0.00001735488,0.000009776772,0.00007762065,0.000049737264,0.00029806164],"category_scores_gemma":[0.00009655879,0.000121461315,0.0004014119,0.0005119457,0.000021837239,0.000047190817,0.000038276346,0.000029773133,0.000004192018],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030139396,0.024814708,0.8008015,0.000017179502,0.01752052,0.000040532745,0.006006322,0.0006571099,0.08370068,0.00003830226,0.000041848427,0.06334737],"study_design_scores_gemma":[0.011497644,0.0012908401,0.69230205,0.00007978623,0.0026760143,7.6219965e-7,0.00016396967,0.00034108237,0.29153186,0.0000027790036,0.00004246281,0.000070723734],"about_ca_topic_score_codex":0.009003867,"about_ca_topic_score_gemma":0.0014275585,"teacher_disagreement_score":0.20783119,"about_ca_system_score_codex":0.00023531869,"about_ca_system_score_gemma":0.00010926525,"threshold_uncertainty_score":0.99759525},"labels":[],"label_agreement":null},{"id":"W3212689194","doi":"10.1182/blood-2021-150634","title":"Germline-Somatic Interactions in Myelofibrosis Susceptibility","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Biology; Myelofibrosis; Genome-wide association study; Genetics; Loss of heterozygosity; Genotyping; SNP array; Myeloid; Bone marrow; Single-nucleotide polymorphism; Cancer research; Immunology; Genotype; Allele; Gene","score_opus":0.025621913766289816,"score_gpt":0.3042765106407568,"score_spread":0.278654596874467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212689194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99211586,0.00031557752,0.00001563988,0.0018888401,0.000094816896,0.00025484513,0.000012259157,0.00003982715,0.005262319],"genre_scores_gemma":[0.9959831,0.00009083061,0.0025494867,0.00028523649,0.00008684364,0.00010570845,0.000056136872,0.000013269083,0.00082939165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99903494,0.00006063483,0.00028185532,0.0002927061,0.00014683454,0.00018301852],"domain_scores_gemma":[0.9992767,0.0001500904,0.000041030704,0.00032840113,0.00010106014,0.0001027058],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007692682,0.00012648676,0.00029032526,0.00006937888,0.000044306158,0.00002044284,0.000029769892,0.00003611711,0.0010751977],"category_scores_gemma":[0.00020541374,0.000107302556,0.00010834536,0.00024980473,0.000023416862,0.000060982893,0.000034447345,0.00013755859,0.0001417621],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024315324,0.004566851,0.9794136,0.00009258261,0.00013299331,0.00034635921,0.00031323638,0.0000022052561,0.01355262,0.00020622782,0.00020434831,0.0011446265],"study_design_scores_gemma":[0.0035316958,0.00014099757,0.875788,0.0002238955,0.00020263018,0.00018579187,0.00019241744,0.00005208823,0.11840271,0.00017261587,0.0009999991,0.00010716908],"about_ca_topic_score_codex":0.000056224995,"about_ca_topic_score_gemma":0.00094905496,"teacher_disagreement_score":0.10485009,"about_ca_system_score_codex":0.000067353,"about_ca_system_score_gemma":0.00012939524,"threshold_uncertainty_score":0.99983793},"labels":[],"label_agreement":null},{"id":"W3212702091","doi":"10.1182/blood-2021-153228","title":"Diagnostic Accuracy of D-Dimer for Pulmonary Embolism and Lower Limb Deep Vein Thrombosis Testing in People with Cancer: A Meta-Analysis","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; McMaster University; Impact; Queen's University","funders":"","keywords":"Medicine; Meta-analysis; Pulmonary embolism; Deep vein; Pre- and post-test probability; Thrombosis; D-dimer; Venous thrombosis; Cancer; Publication bias; MEDLINE; Radiology; Surgery; Internal medicine","score_opus":0.04724798272237566,"score_gpt":0.3010282353805554,"score_spread":0.2537802526581797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212702091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838997,0.012656369,0.00017694492,0.0016310294,0.00004219776,0.00087166706,0.000045643632,0.00002751893,0.0006489153],"genre_scores_gemma":[0.9938487,0.0012878407,0.0034525471,0.0004926886,0.000068857546,0.0006903276,0.00003734718,0.000034493438,0.00008724389],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849945,0.00005002371,0.00040034045,0.00046993874,0.00026238832,0.00031785888],"domain_scores_gemma":[0.9976587,0.0013985381,0.00018708938,0.0004022514,0.0002445761,0.00010883177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002180363,0.00022065554,0.0015556058,0.00021920718,0.00006174603,0.000026521824,0.000083314706,0.000068235146,0.00026582193],"category_scores_gemma":[0.0009084032,0.00017136497,0.00036132184,0.0010937365,0.00004657264,0.00009348606,0.000097817836,0.00010580684,0.0000014018781],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016435186,0.016527785,0.7439239,0.0021272565,0.22154754,0.0005495324,0.0022476683,0.0015778908,0.0054848995,0.0006271483,0.0004460319,0.0047759884],"study_design_scores_gemma":[0.0018541723,0.0005086698,0.68760794,0.00009733225,0.30545005,0.000017826636,0.00038824257,0.0005485619,0.0029140522,0.00007855775,0.00028497956,0.0002495895],"about_ca_topic_score_codex":0.0014415084,"about_ca_topic_score_gemma":0.0030221194,"teacher_disagreement_score":0.08390252,"about_ca_system_score_codex":0.000021001744,"about_ca_system_score_gemma":0.0001232089,"threshold_uncertainty_score":0.6988061},"labels":[],"label_agreement":null},{"id":"W3212704623","doi":"10.1182/blood-2021-148982","title":"Outcomes of Patients with Indolent Lymphoma Treated with Bendamustine Plus Rituximab Compared to Rituximab Plus CVP or CHOP Chemoimmunotherapy in Ontario","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; University of Toronto","funders":"","keywords":"Medicine; Rituximab; Chemoimmunotherapy; Bendamustine; CHOP; Internal medicine; Vincristine; Population; Diffuse large B-cell lymphoma; Cyclophosphamide; Surgery; Oncology; Lymphoma; Chemotherapy","score_opus":0.015450881672926174,"score_gpt":0.23752959049002828,"score_spread":0.2220787088171021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212704623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976271,0.00022087866,0.0000045930565,0.00024556377,0.00003953244,0.0011430542,0.000070768765,0.000050130195,0.00059838936],"genre_scores_gemma":[0.99613905,0.000020919566,0.0020179916,0.00046223224,0.000015525911,0.00020685382,0.00030814644,0.00005350531,0.0007758033],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979015,0.000040644827,0.00052798033,0.0005377918,0.00056175253,0.00043035304],"domain_scores_gemma":[0.9986329,0.00007960327,0.00017283246,0.00061803986,0.0002976943,0.00019893811],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00005839757,0.00041943017,0.0013650336,0.00018200811,0.000056039327,0.000028083237,0.00012240958,0.00009843479,0.00030086303],"category_scores_gemma":[0.000027048716,0.00025895805,0.00010720897,0.000500574,0.000060795224,0.000073246774,0.000059948947,0.00009833693,0.00002075443],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069735614,0.028301334,0.95931727,0.00006539595,0.0010690691,0.0008295844,0.0016044736,0.000021549338,0.00007984993,0.000008072675,0.000034754015,0.0016950744],"study_design_scores_gemma":[0.21351095,0.0016841379,0.7742373,0.00042553173,0.00048274494,0.000055227945,0.00014916934,0.000008025737,0.008741639,7.190877e-7,0.00045878673,0.00024580315],"about_ca_topic_score_codex":0.025969183,"about_ca_topic_score_gemma":0.08552337,"teacher_disagreement_score":0.20653738,"about_ca_system_score_codex":0.00101865,"about_ca_system_score_gemma":0.0013158151,"threshold_uncertainty_score":0.9999863},"labels":[],"label_agreement":null},{"id":"W3212708861","doi":"10.1182/blood-2021-149673","title":"Impact of Inherited Bleeding Disorders on Maternal Bleeding and Other Pregnancy Outcomes: A Population-Based Cohort Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Maternal and fetal healthcare","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Pregnancy; Cohort; Population; Obstetrics; Von Willebrand disease; Retrospective cohort study; Diagnosis code; Odds ratio; Pediatrics; Cohort study; Internal medicine; Von Willebrand factor; Platelet","score_opus":0.024330236701790502,"score_gpt":0.32892830058906286,"score_spread":0.30459806388727234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212708861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99867755,0.0001822886,0.0000046075943,0.000071866365,0.000052920263,0.00047984067,0.00002550362,0.000032570566,0.00047284103],"genre_scores_gemma":[0.9995983,0.000008742149,0.000067409,0.00008782229,0.000027728367,0.000013117525,0.000009961966,0.000022607772,0.00016429642],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908495,0.000031449836,0.00026364016,0.0002086926,0.00024609372,0.00016517549],"domain_scores_gemma":[0.9995607,0.000036616286,0.00008986591,0.00015453447,0.000057080022,0.000101212674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007914563,0.00013343763,0.00031933057,0.000082591556,0.00004427985,0.000014723551,0.000033932756,0.00004861605,0.00013459986],"category_scores_gemma":[0.000034846904,0.00009711089,0.00008182685,0.00012973667,0.000012086047,0.00003133092,0.000019709432,0.0000994005,0.0000023650025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006685406,0.000922797,0.9970408,0.00028210034,0.00022341053,0.000040484843,0.00021828932,0.000006218996,0.0005565679,0.0000119648785,8.698826e-7,0.00062960904],"study_design_scores_gemma":[0.0031287502,0.00076367415,0.9945739,0.0006510039,0.0001737678,0.000012994746,0.00014819184,0.000110066394,0.00032416702,0.000026652988,0.0000016565278,0.000085210915],"about_ca_topic_score_codex":0.0025997425,"about_ca_topic_score_gemma":0.00012958082,"teacher_disagreement_score":0.0030618962,"about_ca_system_score_codex":0.000026669039,"about_ca_system_score_gemma":0.000041982938,"threshold_uncertainty_score":0.3960067},"labels":[],"label_agreement":null},{"id":"W3212730017","doi":"10.1182/blood-2021-149327","title":"Efficacy Comparison of Tisagenlecleucel Versus Standard of Care in Patients with Relapsed or Refractory Follicular Lymphoma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Retrospective cohort study; Follicular lymphoma; Refractory (planetary science); Cohort; Clinical trial; Lymphoma","score_opus":0.02377851177416539,"score_gpt":0.3142376873177308,"score_spread":0.2904591755435654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212730017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964527,0.0011714336,0.0000026810715,0.0000198764,0.000057673493,0.00042612533,0.000033696822,0.000013410986,0.0018223904],"genre_scores_gemma":[0.9990148,0.000041201936,0.00049726415,0.00000852717,0.000021502512,0.000007760962,0.00008712895,0.000030570438,0.00029122902],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841624,0.000092146474,0.00032867756,0.0002331303,0.0007208447,0.00020892714],"domain_scores_gemma":[0.9987667,0.00015048639,0.00010827146,0.00047062477,0.0004142445,0.00008966023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009541221,0.00012021727,0.00054389244,0.0001103581,0.000019428002,0.000004972237,0.000088816894,0.00009417736,0.00054780586],"category_scores_gemma":[0.00018485765,0.000094770774,0.00008106728,0.00043466102,0.000072269206,0.000029213821,0.000048168884,0.00013345528,0.0000032426144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17901388,0.011410053,0.6864812,0.000987423,0.0010626656,0.0004872081,0.0055537955,0.000023398532,0.046829544,0.000020333118,0.00020135257,0.06792915],"study_design_scores_gemma":[0.15857323,0.01994964,0.4089593,0.00058219425,0.00034897373,0.000004338863,0.0014694245,0.0000071410327,0.40586302,0.0000014583828,0.0040544206,0.00018686416],"about_ca_topic_score_codex":0.000034851626,"about_ca_topic_score_gemma":0.00020686537,"teacher_disagreement_score":0.35903347,"about_ca_system_score_codex":0.00012321242,"about_ca_system_score_gemma":0.00052447204,"threshold_uncertainty_score":0.599809},"labels":[],"label_agreement":null},{"id":"W3212761655","doi":"10.1182/blood-2021-146483","title":"The Compass-COVID19-ICU Study: Identification of Factors to Predict the Risk of Intubation and Mortality in Patients with Severe COVID-19","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Lawson Health Research Institute","funders":"","keywords":"Medicine; Intensive care unit; Context (archaeology); Partial thromboplastin time; Internal medicine; Intubation; Fibrinogen; Anesthesia; Platelet","score_opus":0.040994517927857445,"score_gpt":0.3881871347264393,"score_spread":0.3471926167985818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212761655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99758404,0.000041004827,0.000086937776,0.000950895,0.000025961386,0.0011936675,0.00009226769,0.000009175127,0.00001604767],"genre_scores_gemma":[0.9996935,0.000096491436,0.000010019792,0.00009014593,0.000012403249,0.000045679644,0.000018567276,0.0000062891672,0.000026870854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99817246,0.0003244906,0.00047895373,0.00023899137,0.0006552208,0.00012986873],"domain_scores_gemma":[0.99518806,0.0036223023,0.00021947715,0.00048270827,0.00038469472,0.000102755606],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.001264558,0.00008930853,0.0002702337,0.00005024977,0.000120057804,0.000014975715,0.000117442716,0.00003138553,0.0000069898874],"category_scores_gemma":[0.030308751,0.00004577358,0.000038581893,0.0004113743,0.00018337513,0.000040948,0.00016594499,0.00017278353,6.2515045e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002101344,0.001300825,0.99548614,0.00015178902,0.00031447012,0.0000017036305,0.0018772332,0.00007935328,0.00007081513,0.00001488518,0.000037571917,0.0004550845],"study_design_scores_gemma":[0.003488521,0.0008749522,0.9930483,0.000038261234,0.0002859317,9.14685e-8,0.0015105691,0.000041979416,0.00049680145,0.00009266624,0.00007831232,0.000043579512],"about_ca_topic_score_codex":0.0007379329,"about_ca_topic_score_gemma":0.0012718594,"teacher_disagreement_score":0.029044194,"about_ca_system_score_codex":0.000051718485,"about_ca_system_score_gemma":0.00028866797,"threshold_uncertainty_score":0.9778594},"labels":[],"label_agreement":null},{"id":"W3212782606","doi":"10.1182/blood-2021-150998","title":"Selinexor-Based Regimens in Patients with Multiple Myeloma after Prior Anti-B-Cell Maturation Antigen Treatment","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of Alberta; Université de Montréal; Hôpital Maisonneuve-Rosemont; Princess Margaret Cancer Centre; Dalhousie University; University of Calgary; Institute of Cancer Research; Vancouver General Hospital; CancerCare Manitoba","funders":"","keywords":"Medicine; Multiple myeloma; Internal medicine; Bortezomib; Pomalidomide; Oncology; Chimeric antigen receptor; Pharmacology; Immunotherapy; Cancer","score_opus":0.009864349185879324,"score_gpt":0.24097564005758013,"score_spread":0.2311112908717008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212782606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99813116,0.0002864086,0.000021109287,0.00020580483,0.000029699282,0.00095469627,0.00006187834,0.00004578345,0.0002634655],"genre_scores_gemma":[0.9938487,0.000036495254,0.0045975097,0.00009633037,0.00004984524,0.00013120571,0.00066233246,0.000035835325,0.0005417667],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849623,0.00007471723,0.00023186018,0.00041891675,0.00039092012,0.00038732513],"domain_scores_gemma":[0.9990688,0.00005827986,0.00006006558,0.00042212056,0.00019594989,0.00019480879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000474413,0.00022630523,0.00031773373,0.00013117188,0.000056867346,0.00003198164,0.00004163111,0.0000851348,0.00011780203],"category_scores_gemma":[0.000052259737,0.00015959021,0.000078227604,0.00027126382,0.00003093801,0.00007961457,0.000021570584,0.00010223684,0.000076774726],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014857583,0.007972372,0.9843405,0.00006401716,0.00014248122,0.0016695706,0.00011322746,0.000009522475,0.0024921596,4.4938253e-7,0.000020669611,0.001689264],"study_design_scores_gemma":[0.040740557,0.0010206955,0.87534946,0.00011170966,0.00011284648,0.000011431125,0.000027007238,0.0002618924,0.08193168,6.725468e-7,0.00029251585,0.0001395556],"about_ca_topic_score_codex":0.000072107476,"about_ca_topic_score_gemma":0.00019928139,"teacher_disagreement_score":0.10899107,"about_ca_system_score_codex":0.0001172992,"about_ca_system_score_gemma":0.00030069303,"threshold_uncertainty_score":0.65079004},"labels":[],"label_agreement":null},{"id":"W3212789567","doi":"10.1182/blood-2021-150649","title":"Long-Term Subgroup Analyses from Azacitidine Vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the Pethema Registry","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Decitabine; Azacitidine; Medicine; Internal medicine; Myeloid leukemia; Hypomethylating agent; Oncology; Subgroup analysis; Leukemia; Cytarabine; Confidence interval; DNA methylation","score_opus":0.029208762009357014,"score_gpt":0.3070496838151518,"score_spread":0.2778409218057948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212789567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908396,0.0016187739,0.000100849495,0.003548901,0.00018630362,0.00067264587,0.0016811391,0.00011801803,0.0012337464],"genre_scores_gemma":[0.98460025,0.0015993055,0.0019039499,0.0015105972,0.0009546659,0.000091221016,0.00755545,0.000107233405,0.0016773583],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99526995,0.00037133557,0.0010832633,0.0012440655,0.0011630285,0.00086835294],"domain_scores_gemma":[0.9942352,0.0023491445,0.00031526576,0.0022038415,0.0004884676,0.0004080505],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004340574,0.00052403926,0.0009772946,0.00018478112,0.00017192248,0.00015949289,0.0007531126,0.00037526997,0.00053935725],"category_scores_gemma":[0.0034678816,0.00039216166,0.000320739,0.0012628745,0.00026443705,0.00025656138,0.00050878065,0.0012196362,0.00018183474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036507198,0.002366351,0.8935404,0.00006749127,0.0023333083,0.014461792,0.0018514651,0.000016845059,0.060484927,0.000024287347,0.016556468,0.004645978],"study_design_scores_gemma":[0.038248643,0.00027648572,0.9042843,0.0005858407,0.0010820528,0.000064682754,0.00034569885,0.00007999638,0.053589452,0.00017585886,0.00084249675,0.00042450457],"about_ca_topic_score_codex":0.006153786,"about_ca_topic_score_gemma":0.0033211438,"teacher_disagreement_score":0.034597922,"about_ca_system_score_codex":0.0007316896,"about_ca_system_score_gemma":0.0011966029,"threshold_uncertainty_score":0.999853},"labels":[],"label_agreement":null},{"id":"W3212806462","doi":"10.1182/blood-2021-146049","title":"ALKBH5 Modulates Hematopoietic Stem and Progenitor Cell Energy Metabolism through m 6a Modification-Mediated RNA Stability","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Haematopoiesis; Biology; Progenitor cell; Demethylase; Cell biology; Stem cell; Hematopoietic stem cell; Molecular biology; Biochemistry; Gene","score_opus":0.014733569707032108,"score_gpt":0.2259111084963457,"score_spread":0.21117753878931358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212806462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9796143,0.017876765,0.0012629844,0.00017802928,0.000083116145,0.000114469796,0.00006261757,0.00002084516,0.0007868652],"genre_scores_gemma":[0.9964308,0.0016208695,0.00086529745,0.00010550454,0.00014532296,0.000101156,0.00019609534,0.000022962586,0.0005120017],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989232,0.0000736823,0.00022297767,0.00046573975,0.00011975477,0.00019466407],"domain_scores_gemma":[0.99909836,0.000014051789,0.000080920414,0.0005437127,0.00018243038,0.00008051144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000071671435,0.00015064518,0.0001605753,0.0000138096175,0.000098389304,0.000042803524,0.000116528965,0.00013247792,0.000032137505],"category_scores_gemma":[0.000019998572,0.00014495534,0.00006890259,0.000120825214,0.000072491355,0.000008152504,0.00007208069,0.00005425508,0.0000051896227],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009920924,0.00039847393,0.00065325596,0.00003781595,0.000071150505,0.0000025946968,0.00012960577,0.000008219146,0.99718946,0.0005690358,0.00013920414,0.0007912387],"study_design_scores_gemma":[0.00072985096,0.00002740825,0.0013230699,0.00000474821,0.000076213735,0.000013973362,0.00023135258,0.00006536138,0.98332477,0.00025171577,0.013770968,0.0001805883],"about_ca_topic_score_codex":0.00003725332,"about_ca_topic_score_gemma":0.000015418926,"teacher_disagreement_score":0.016816482,"about_ca_system_score_codex":0.000006526678,"about_ca_system_score_gemma":0.0001248974,"threshold_uncertainty_score":0.5911107},"labels":[],"label_agreement":null},{"id":"W3212812892","doi":"10.1182/blood-2021-153724","title":"Integrative Genomic Analysis Uncovers Unique Diffuse Large B Cell Lymphoma (DLBCL) Immune Environments and Identifies Associations with Specific Oncogenic Alterations","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Diffuse large B-cell lymphoma; Immune system; Biology; Immune checkpoint; CD8; Cancer research; Lymphoma; Large-cell lymphoma; Chemoimmunotherapy; T cell; Immunology; Immunotherapy","score_opus":0.006890774325263639,"score_gpt":0.21712832006145005,"score_spread":0.21023754573618642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212812892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957038,0.0022990268,0.0002871946,0.00023951179,0.000036506855,0.00025713528,0.0002557015,0.000022253394,0.0008988615],"genre_scores_gemma":[0.9938599,0.0019695328,0.0007025687,0.00012968725,0.000036561014,0.000070556714,0.000850162,0.000019942578,0.0023611267],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884033,0.000081420796,0.0002669459,0.00037368436,0.00021556363,0.00022204743],"domain_scores_gemma":[0.99922186,0.00010777878,0.0001327229,0.0003638001,0.00005322487,0.000120584766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006689225,0.00020240605,0.00040892453,0.00013682239,0.000215299,0.000088069464,0.00004743688,0.00007038354,0.00009435783],"category_scores_gemma":[0.000018120028,0.00015819319,0.0001901216,0.00039742576,0.00004909296,0.000099186844,0.00005732379,0.000059068345,0.000035770714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006507512,0.036482047,0.90103006,0.000025299349,0.01088748,0.00078912446,0.0032564076,0.000019259413,0.045981817,0.00073465495,0.00026759962,0.00046117618],"study_design_scores_gemma":[0.023973137,0.0001974355,0.7996341,0.00003505697,0.0064410465,0.000044999513,0.00128014,0.000029174085,0.16614345,0.000040622737,0.0019679633,0.0002128717],"about_ca_topic_score_codex":0.00009853107,"about_ca_topic_score_gemma":0.0004066045,"teacher_disagreement_score":0.12016163,"about_ca_system_score_codex":0.0003048983,"about_ca_system_score_gemma":0.00015065844,"threshold_uncertainty_score":0.64509314},"labels":[],"label_agreement":null},{"id":"W3212892660","doi":"10.1182/blood-2021-153960","title":"Impact of Frontline Treatment Approach in Patients with Secondary AML and Prior Hypomethylating Agent Exposure: A Retrospective Analysis of 562 Patients with Treated Secondary AML","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Hypomethylating agent; Decitabine; Venetoclax; Chemotherapy regimen; Chemotherapy; Azacitidine; Cytarabine; Oncology; Retrospective cohort study; Leukemia; Surgery; Chronic lymphocytic leukemia","score_opus":0.009273470443319116,"score_gpt":0.24900919414552905,"score_spread":0.23973572370220994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212892660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997318,0.00033851844,0.00001699205,0.000009020069,0.000006168367,0.000999631,0.0005925943,0.000016200464,0.0007028336],"genre_scores_gemma":[0.99517256,0.00003101682,0.0034028457,0.000010595782,0.000015292353,0.00004686304,0.0011585344,0.000046454832,0.00011586391],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976197,0.00016534443,0.0005749986,0.0006169002,0.0006273634,0.00039569562],"domain_scores_gemma":[0.9981541,0.000094867784,0.0003473292,0.00055849634,0.0006337565,0.0002114282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017267892,0.00034248398,0.0012771932,0.0006782252,0.00004933195,0.000015563532,0.00008136814,0.0001281308,0.00019311413],"category_scores_gemma":[0.00009914759,0.00022358724,0.00019748944,0.0019501667,0.00014129627,0.00012434556,0.00007969818,0.0003261382,6.4124663e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018488007,0.0069532054,0.97345424,0.0001081713,0.00843389,0.00006190553,0.0014719588,0.000042024185,0.00054205087,8.738739e-7,0.000007194571,0.0070756925],"study_design_scores_gemma":[0.037480474,0.008903367,0.9468515,0.000091833084,0.002909984,0.0000044944363,0.00023233003,0.00019948013,0.003135547,0.0000016181267,0.0000014122262,0.00018795033],"about_ca_topic_score_codex":0.00058154284,"about_ca_topic_score_gemma":0.00017717914,"teacher_disagreement_score":0.035631675,"about_ca_system_score_codex":0.00070023927,"about_ca_system_score_gemma":0.0007573924,"threshold_uncertainty_score":0.9117623},"labels":[],"label_agreement":null},{"id":"W3212899144","doi":"10.1182/blood-2021-147376","title":"Decision Analysis of Allogeneic Stem Cell Transplantation for Primary Myelofibrosis","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Myelofibrosis; Medicine; Cohort; Transplantation; Ruxolitinib; Natural history; Internal medicine; Pediatrics; Oncology; Bone marrow","score_opus":0.014712208037197852,"score_gpt":0.2605849413601725,"score_spread":0.24587273332297466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212899144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948002,0.0010408963,0.0026927725,0.000088461,0.000037071924,0.0003086081,0.00017572695,0.000010526091,0.00084572844],"genre_scores_gemma":[0.98644185,0.0010640016,0.011341426,0.00015087679,0.000026932457,0.000095750336,0.00052896846,0.000012694886,0.00033750295],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99911284,0.000026684922,0.00027921167,0.0002544056,0.00020419752,0.00012267428],"domain_scores_gemma":[0.9991809,0.0002801488,0.00007981704,0.00020563052,0.00018350124,0.0000699943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000077209166,0.000110590445,0.000428212,0.00013681506,0.000040115385,0.000008362451,0.000030935273,0.00006453782,0.00015643881],"category_scores_gemma":[0.0000085447155,0.000090576235,0.00029992402,0.00037618788,0.0000125912375,0.000028239678,0.00000833611,0.000030408875,0.000008045106],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000475759,0.0036495037,0.8196643,0.0005948229,0.004291139,0.00011095612,0.0004885317,0.00012670201,0.14738439,0.00015685185,0.000115804796,0.022941232],"study_design_scores_gemma":[0.0028003207,0.00026122015,0.49286732,0.00005106944,0.009082159,0.000009938499,0.000028329277,0.000028595186,0.49463525,0.0000117072705,0.00016512415,0.000058970578],"about_ca_topic_score_codex":0.0000068732843,"about_ca_topic_score_gemma":0.000053165233,"teacher_disagreement_score":0.34725088,"about_ca_system_score_codex":0.00002301623,"about_ca_system_score_gemma":0.00009611365,"threshold_uncertainty_score":0.36935917},"labels":[],"label_agreement":null},{"id":"W3212904758","doi":"10.1182/blood-2021-148701","title":"Gene Expression Analysis of CML Patients across the Age Spectrum","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Myeloid; Biology; CD34; Young adult; White blood cell; Medicine; Oncology; Immunology; Internal medicine; Genetics; Stem cell","score_opus":0.012250775473735123,"score_gpt":0.27023088864152833,"score_spread":0.25798011316779323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212904758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998253,0.00044632624,0.00001385871,0.00012332188,0.000056701716,0.00013394603,0.000068771675,0.000017687164,0.00088641664],"genre_scores_gemma":[0.99812937,0.000068055466,0.00044394165,0.00012381507,0.00006522921,0.000009711432,0.00028622767,0.000012166671,0.0008614616],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99903595,0.000040542287,0.0002101998,0.00021940985,0.0002957113,0.00019816188],"domain_scores_gemma":[0.99915326,0.00005022023,0.0000855047,0.00059788127,0.0000608901,0.000052271185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006916771,0.00010056867,0.0003014139,0.000041700958,0.000060159182,0.000009345937,0.00008117627,0.000053790332,0.00030089854],"category_scores_gemma":[0.000076226235,0.000064358064,0.00019929527,0.00054881215,0.000041556923,0.00002238239,0.000098970195,0.0000878637,0.000016463628],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006400212,0.0027319088,0.91384304,0.000048658232,0.0039414163,0.0004595955,0.0015827864,0.000023754425,0.075300224,0.000009106998,0.0005142515,0.0014812631],"study_design_scores_gemma":[0.00409051,0.000074465344,0.47003272,0.00003221524,0.0024749262,0.0000069535495,0.00007968707,0.000019545287,0.52272666,0.000010511728,0.00039975197,0.0000520418],"about_ca_topic_score_codex":0.000056109708,"about_ca_topic_score_gemma":0.00007313738,"teacher_disagreement_score":0.44742644,"about_ca_system_score_codex":0.00008471623,"about_ca_system_score_gemma":0.00009621225,"threshold_uncertainty_score":0.3294628},"labels":[],"label_agreement":null},{"id":"W3212910936","doi":"10.1182/blood-2021-152149","title":"Mapping the Multiple Myeloma T Cell Landscape By Immunotherapeutic Perturbation Reveals Mechanism and Determinants of Response to Bispecific T Cell Engagers","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Immune system; Chimeric antigen receptor; Bone marrow; Immunotherapy; T cell; Medicine; Multiple myeloma; Antigen; Cancer research; Immunology","score_opus":0.028813889938514223,"score_gpt":0.2679662286620868,"score_spread":0.23915233872357258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212910936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99467963,0.0032957643,0.000068774076,0.00051057764,0.000058955942,0.0005473531,0.000021849777,0.0000229624,0.0007941504],"genre_scores_gemma":[0.9839211,0.00045035314,0.00047445847,0.00030345688,0.00004699153,0.00003337019,0.000010037778,0.000039577684,0.014720668],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99835294,0.00043478952,0.00028753513,0.00030403087,0.0003416161,0.0002790971],"domain_scores_gemma":[0.9984068,0.0007671661,0.00008198449,0.00050342845,0.00013429919,0.00010627836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009792581,0.00014775169,0.00028323784,0.00012861528,0.00013600936,0.000034800985,0.00012379838,0.00009339834,0.0004436603],"category_scores_gemma":[0.00019337611,0.000114184695,0.0000797014,0.00035053818,0.000044166478,0.000034855348,0.000073734605,0.0002297315,0.000017397617],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074108626,0.00026049215,0.0048685954,0.000103450715,0.0000373352,0.000046881032,0.003705245,3.6610732e-7,0.98697853,0.0000023134778,0.00018417752,0.00307152],"study_design_scores_gemma":[0.0040053884,0.00033711156,0.01351695,0.00009483404,0.00005384025,0.000068122776,0.0020280967,0.00014352333,0.9752695,0.00005800166,0.004294087,0.0001305251],"about_ca_topic_score_codex":0.000012060368,"about_ca_topic_score_gemma":0.0000039362594,"teacher_disagreement_score":0.013926518,"about_ca_system_score_codex":0.00002544041,"about_ca_system_score_gemma":0.000097202916,"threshold_uncertainty_score":0.4857769},"labels":[],"label_agreement":null},{"id":"W3212917465","doi":"10.1182/blood-2021-153011","title":"Myeloma Patients with Deletion of 17p: Impact of Tandem Transplant and Clone Size","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Fluorescence in situ hybridization; Multiple myeloma; Transplantation; Medicine; Oncology; Monosomy; Internal medicine; Autologous stem-cell transplantation; Chromosome abnormality; Biology; Karyotype; Genetics; Chromosome","score_opus":0.00946990536767246,"score_gpt":0.26121099036784434,"score_spread":0.2517410850001719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212917465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990053,0.00030634343,0.000013967254,0.000024360981,0.0000051190623,0.00019577227,0.000088100365,0.000006382773,0.00035461513],"genre_scores_gemma":[0.99904716,0.0001621591,0.00063740055,0.0000056186095,0.000010730373,0.0000048712745,0.000084462474,0.000008643574,0.00003897559],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99934036,0.000026290136,0.00013476606,0.0001212369,0.00024378828,0.00013357011],"domain_scores_gemma":[0.9994894,0.00006331319,0.00004743271,0.00013014923,0.00015851398,0.000111191104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000038183003,0.000077997654,0.0002254866,0.00003142884,0.000016683663,0.0000027748004,0.000018666122,0.000036501417,0.00008220199],"category_scores_gemma":[0.00005679565,0.00005070324,0.000053654072,0.00010704434,0.000043912463,0.000027390312,0.000008854656,0.00005094771,0.0000010437922],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054940826,0.0015175453,0.9758673,0.000106251966,0.0005012574,0.0001156529,0.000109798384,4.0049778e-7,0.01899834,0.0000067734095,0.000007183994,0.0022201468],"study_design_scores_gemma":[0.012950798,0.0015467274,0.9340412,0.00014358827,0.0002069154,0.00004162682,0.000011424337,0.000008746647,0.050994307,0.000011485189,0.0000027291148,0.000040461302],"about_ca_topic_score_codex":0.00008303213,"about_ca_topic_score_gemma":0.000019691908,"teacher_disagreement_score":0.04182605,"about_ca_system_score_codex":0.0000122433285,"about_ca_system_score_gemma":0.000104673156,"threshold_uncertainty_score":0.2067618},"labels":[],"label_agreement":null},{"id":"W3212938097","doi":"10.1182/blood-2021-152151","title":"Differential Activation of V γ4V δ1 and V γ9V δ2 Cord Blood Derived Gamma Delta T Cells upon Exposure to EBV-Lcl and K562 Cells","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; BC Cancer Agency","funders":"","keywords":"Biology; T-cell receptor; K562 cells; T cell; Leukemia; Molecular biology; Cell biology; Immunology; Immune system","score_opus":0.008654517836229163,"score_gpt":0.2059826099417118,"score_spread":0.19732809210548263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212938097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99679554,0.0006576011,0.00043997058,0.000095574695,0.0013950863,0.00018621943,0.000014800325,0.00003484293,0.0003803671],"genre_scores_gemma":[0.9949823,0.0002629305,0.00015567835,0.00013459925,0.00004850812,0.000011932802,0.00012923106,0.00001821731,0.0042566145],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998954,0.00015216797,0.00030452484,0.00033043532,0.00004141825,0.00021745935],"domain_scores_gemma":[0.9993749,0.000097585355,0.00013490689,0.0002253449,0.00013239385,0.000034814402],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0000594253,0.00018046041,0.00027516775,0.000098415825,0.0001269543,0.000028498564,0.000069375776,0.00023705485,0.0009416746],"category_scores_gemma":[0.000044266242,0.00017726715,0.00006279447,0.0001045237,0.000054009986,0.00010727205,0.00010375927,0.00021768865,0.00005342989],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027374213,0.0006120701,0.0005913048,0.0000408651,0.0002788766,0.000004236873,0.00044018883,0.0000017934548,0.9948414,0.00003632648,0.0007952116,0.002083958],"study_design_scores_gemma":[0.0032467784,0.00065285247,0.0059732036,0.000056063604,0.00024649964,0.00008081469,0.00040396472,0.0000022979293,0.9827354,0.000009927287,0.0064174025,0.00017479909],"about_ca_topic_score_codex":0.000056230125,"about_ca_topic_score_gemma":0.000026250957,"teacher_disagreement_score":0.01210603,"about_ca_system_score_codex":0.000008221741,"about_ca_system_score_gemma":0.000032558422,"threshold_uncertainty_score":0.9999716},"labels":[],"label_agreement":null},{"id":"W3212940473","doi":"10.1182/blood-2021-144912","title":"Molecular Characteristics of Response to Olutasidenib (FT-2102) in Patients with Relapsed/Refractory mIDH1 Acute Myeloid Leukemia","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Interim analysis; Clinical endpoint; Population; Refractory (planetary science); Phases of clinical research; Gastroenterology; Myeloid leukemia; Surrogate endpoint; Clinical trial; Biology","score_opus":0.0075747479113264645,"score_gpt":0.24857881542706195,"score_spread":0.2410040675157355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212940473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979362,0.0001288918,0.000050015693,0.00063265854,0.000056645342,0.00064256386,0.00012094159,0.000041675954,0.0003904315],"genre_scores_gemma":[0.99564236,0.000045989433,0.002427761,0.00072112744,0.00005402771,0.00004518438,0.00015917438,0.00008570146,0.00081866496],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9970854,0.00027683302,0.0005633779,0.00055456674,0.0009467349,0.0005730752],"domain_scores_gemma":[0.997734,0.0002030733,0.00015006283,0.0009455652,0.0005943063,0.00037300293],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046762993,0.00028120223,0.0006857339,0.00038316104,0.00004192159,0.000023152055,0.00026088496,0.00021373497,0.000082614286],"category_scores_gemma":[0.0011213013,0.0002560469,0.000100564386,0.00090711616,0.00010290251,0.00010149749,0.00024400553,0.0006349295,0.00008245507],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020401796,0.0026457647,0.32402495,0.00027839883,0.0008448388,0.008918833,0.0010872454,0.00002189503,0.6384389,0.000034458546,0.00082989206,0.0024730535],"study_design_scores_gemma":[0.014001787,0.0017018189,0.777107,0.00035324745,0.00029645505,0.000086557506,0.000075528704,0.000008755389,0.20438452,0.000007985416,0.0017086904,0.00026764744],"about_ca_topic_score_codex":0.00004990702,"about_ca_topic_score_gemma":0.000012610691,"teacher_disagreement_score":0.45308205,"about_ca_system_score_codex":0.000610449,"about_ca_system_score_gemma":0.0020459613,"threshold_uncertainty_score":0.99998915},"labels":[],"label_agreement":null},{"id":"W3212941834","doi":"10.1182/blood-2021-150875","title":"Management of Edoxaban Therapy in Patients Undergoing Major Surgery: A Sub-Analysis of the Prospective, Observational, Multinational Emit-AF/VTE Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Edoxaban; Perioperative; Dosing; Incidence (geometry); Observational study; Thrombosis; Surgery; Dabigatran; Internal medicine; Atrial fibrillation; Warfarin","score_opus":0.06204479983852596,"score_gpt":0.31193224387232055,"score_spread":0.2498874440337946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212941834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982799,0.00007453524,0.00001385883,0.00039645733,0.000067548506,0.0007897392,0.000009536275,0.000009450198,0.00035891717],"genre_scores_gemma":[0.9990373,0.000041766783,0.00024744918,0.00004268862,0.000030322626,0.000010529945,0.00007139119,0.000009324744,0.00050920004],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985603,0.00009154754,0.00047836607,0.00020558877,0.00056174584,0.00010243947],"domain_scores_gemma":[0.9989722,0.00024085319,0.00024588915,0.00026021077,0.0002618034,0.000019060497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030401078,0.000098596705,0.00038522377,0.00024006622,0.000041624764,0.000008314763,0.00006861986,0.000026287695,0.00007705662],"category_scores_gemma":[0.00013941765,0.00007454499,0.00027379117,0.0016291655,0.0000220235,0.000060393955,0.000080309495,0.000046928697,0.0000010082803],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008468031,0.00078861805,0.9938191,0.000055539975,0.003714246,0.0000051371726,0.00019197426,0.00009270949,0.00010678769,0.000769783,0.000021322896,0.0003501061],"study_design_scores_gemma":[0.005308594,0.00006284787,0.99111724,0.00005181357,0.0015041629,9.818836e-8,0.00035908906,0.00006374673,0.0013647703,0.00007100564,0.000032104977,0.00006450316],"about_ca_topic_score_codex":0.000017169183,"about_ca_topic_score_gemma":0.000085313375,"teacher_disagreement_score":0.005223914,"about_ca_system_score_codex":0.000034919456,"about_ca_system_score_gemma":0.00006333561,"threshold_uncertainty_score":0.30398563},"labels":[],"label_agreement":null},{"id":"W3212959964","doi":"10.1182/blood-2021-146838","title":"A Validated Risk Prediction Model for Bone Fragility in Children with Acute Lymphoblastic Leukemia","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; McMaster University; Brock University; University of Alberta; Université de Montréal; University of Toronto; Dalhousie University; University of Ottawa; McGill University; University of Calgary; Children's Hospital of Eastern Ontario; Impact","funders":"","keywords":"Medicine; Bone mineral; Osteoporosis; Cohort; Pediatrics; Osteopenia; Logistic regression; Bone density; Population; Standard score; Internal medicine; Physical therapy; Surgery","score_opus":0.011072012919704692,"score_gpt":0.25434990295539134,"score_spread":0.24327789003568664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212959964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95330757,0.00011396447,0.044531025,0.00010690208,0.00002850396,0.0010211717,0.0005280701,0.00012983101,0.00023295796],"genre_scores_gemma":[0.98525596,0.00012258971,0.012789878,0.00013281817,0.00013309218,0.00024218897,0.0005566218,0.000063593696,0.00070327485],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9977462,0.000078120516,0.00041684398,0.0006560307,0.0005399086,0.0005628888],"domain_scores_gemma":[0.9985791,0.0001499346,0.00010542903,0.0006007016,0.0003196624,0.00024518828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032814135,0.00024886033,0.00048231194,0.00016436714,0.00010225425,0.0000336154,0.00011740429,0.0002181745,0.000034197463],"category_scores_gemma":[0.00048072636,0.0002080319,0.000108313616,0.0005802174,0.00010357814,0.00012343118,0.00009645197,0.00033247442,0.000017357772],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005488848,0.0047869924,0.9156701,0.00040646683,0.00477571,0.0013457406,0.0011206487,0.014199698,0.04761384,0.00017567952,0.0021828527,0.0022334175],"study_design_scores_gemma":[0.05490078,0.0008755438,0.20081201,0.00025188483,0.0026019134,0.0030626596,0.0000586224,0.6915406,0.045116793,0.0003737198,0.000041547326,0.00036393633],"about_ca_topic_score_codex":0.00017329957,"about_ca_topic_score_gemma":0.00006875323,"teacher_disagreement_score":0.7148581,"about_ca_system_score_codex":0.00091828906,"about_ca_system_score_gemma":0.0033465966,"threshold_uncertainty_score":0.8483295},"labels":[],"label_agreement":null},{"id":"W3212965014","doi":"10.1182/blood-2021-151431","title":"Pragmatic Evaluation of an Algorithm Using D-Dimer Adjusted to Clinical Probability in the Diagnosis of Pulmonary Embolism","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Pulmonary embolism; D-dimer; Emergency department; Algorithm; Cohort; Pediatrics; Retrospective cohort study; Clinical Practice; Demographics; Internal medicine; Physical therapy; Mathematics","score_opus":0.11197468596740093,"score_gpt":0.3895091169683315,"score_spread":0.27753443100093056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212965014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99668133,0.00045873437,0.00005753393,0.00063883484,0.000112372356,0.0015458866,0.000011040307,0.00000946389,0.0004848279],"genre_scores_gemma":[0.9906376,0.000079163954,0.008553443,0.00037889436,0.00011182693,0.0001913268,0.00003108851,0.000012880494,0.0000037516318],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9973543,0.0008020766,0.0007041917,0.0002915693,0.0006821845,0.00016561977],"domain_scores_gemma":[0.9985237,0.00021683659,0.00016581001,0.0006002011,0.00042139678,0.000072059745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034008767,0.00010786067,0.0005352003,0.000083870655,0.000025951469,0.0000075706043,0.000121677476,0.00008047616,0.00011694396],"category_scores_gemma":[0.00091204786,0.0000818811,0.000113744885,0.0004635818,0.000052312127,0.00006562311,0.00007781833,0.00012455315,0.0000026714963],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000829628,0.09488043,0.3282695,0.001661938,0.0008965449,0.00019445829,0.0069425125,0.0017467579,0.003312721,0.00061747327,0.00030142846,0.5610933],"study_design_scores_gemma":[0.0024535696,0.00037008297,0.9747568,0.0004073068,0.0023053007,0.000026691241,0.0010942442,0.013207581,0.0044790404,0.0006917991,0.00009808917,0.000109508765],"about_ca_topic_score_codex":0.00023863718,"about_ca_topic_score_gemma":0.00008624398,"teacher_disagreement_score":0.6464873,"about_ca_system_score_codex":0.000029014456,"about_ca_system_score_gemma":0.00022405245,"threshold_uncertainty_score":0.33390146},"labels":[],"label_agreement":null},{"id":"W3212985656","doi":"10.1182/blood-2021-146947","title":"IL-4 Mediated Upregulation of AMPK/SIRT1/PGC-1α Signalling Pathway Is Bypassed By Mitochondrial Complex I Downregulation By NAMPT Inhibition in Venetoclax and Ibrutinib Treated CLL Cells","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Ibrutinib; Venetoclax; Chronic lymphocytic leukemia; Biology; Cancer research; AMPK; Downregulation and upregulation; Leukemia; Pharmacology; Cell biology; Immunology; Biochemistry; Kinase; Protein kinase A","score_opus":0.016498775524927834,"score_gpt":0.25325367415602945,"score_spread":0.2367548986311016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212985656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99752134,0.00059687987,0.00021003507,0.00019795196,0.00005669165,0.0007977409,0.00030985984,0.000057070705,0.00025240862],"genre_scores_gemma":[0.9952807,0.00011181826,0.0006147825,0.00009271205,0.0001300649,0.000037656635,0.003359546,0.000044861747,0.000327882],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99740565,0.00020912972,0.0007132949,0.0005602595,0.0007006021,0.00041106393],"domain_scores_gemma":[0.9986572,0.00031614982,0.00022513818,0.00033192127,0.00027659256,0.0001929631],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002493964,0.00025298147,0.0005332698,0.00017600085,0.0000653543,0.00004050334,0.000059905302,0.00032557343,0.0002988702],"category_scores_gemma":[0.00016334622,0.00025868684,0.00009017862,0.00064404646,0.00013375288,0.00013839689,0.00006484107,0.00021912518,0.000013397572],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044150278,0.00056571944,0.00038014122,0.0002076632,0.00009430821,0.000070127986,0.0006186986,0.00009792185,0.99454737,0.00001218907,0.002498649,0.0004656982],"study_design_scores_gemma":[0.044252105,0.00026048862,0.0016714354,0.0003094676,0.00012380337,0.000054798787,0.00012310114,0.027594687,0.9245068,0.00006758939,0.00081552425,0.00022018641],"about_ca_topic_score_codex":0.0005533553,"about_ca_topic_score_gemma":0.0000693778,"teacher_disagreement_score":0.07004057,"about_ca_system_score_codex":0.00140246,"about_ca_system_score_gemma":0.0016999056,"threshold_uncertainty_score":0.9999865},"labels":[],"label_agreement":null},{"id":"W3212989706","doi":"10.1182/blood-2021-150231","title":"Venetoclax Therapy in a Heavily Treated Cohort of Patients with Relapsed or Refractory Acute Myeloid Leukemia: Update of the Pethema Registry Experience","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Venetoclax; Medicine; Internal medicine; Cytarabine; Decitabine; Azacitidine; Retrospective cohort study; Myeloid leukemia; Cohort; Oncology; Leukemia; Surgery; Pediatrics; Chronic lymphocytic leukemia","score_opus":0.013524814090618176,"score_gpt":0.2709590697692928,"score_spread":0.2574342556786746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212989706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979848,0.00026928564,0.000004301076,0.00015829664,0.00003360466,0.00077171205,0.000049911272,0.000022362921,0.00070570497],"genre_scores_gemma":[0.99712473,0.0006604685,0.00047840018,0.00018585954,0.000028159942,0.00008979487,0.00006842622,0.000044271732,0.0013198968],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99786615,0.00016597952,0.00048430916,0.00041852557,0.00072165625,0.0003433706],"domain_scores_gemma":[0.99797636,0.00011088135,0.0002642533,0.0011283171,0.00041245154,0.000107720974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019596999,0.0002150442,0.0005618716,0.000095936455,0.000047589958,0.000008972778,0.0003218381,0.00018213726,0.00014821648],"category_scores_gemma":[0.00022171905,0.00012474289,0.00010134001,0.0009227862,0.00032621645,0.00009353071,0.00011787756,0.0005070359,0.0000034602901],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046702004,0.001150183,0.9271322,0.00011558811,0.00054387737,0.00050468504,0.0014144415,0.0000074347954,0.063312806,0.000014114967,0.00035532913,0.0007791681],"study_design_scores_gemma":[0.015556218,0.0010485913,0.6915065,0.000376397,0.00015988451,0.00008528584,0.00035005805,0.000021803211,0.289877,0.0000076279753,0.000854343,0.00015626133],"about_ca_topic_score_codex":0.00024991547,"about_ca_topic_score_gemma":0.000063534324,"teacher_disagreement_score":0.23562564,"about_ca_system_score_codex":0.00046187217,"about_ca_system_score_gemma":0.0025443656,"threshold_uncertainty_score":0.5086868},"labels":[],"label_agreement":null},{"id":"W3212999994","doi":"10.1182/blood-2021-147601","title":"Health-Related Quality of Life (HRQoL) during Treatment with Enasidenib (ENA) Plus Azacitidine (AZA) in Patients with Newly Diagnosed Mutant <i>IDH2</i> (m <i>IDH2</i>) Acute Myeloid Leukemia (AML) Not Eligible for Intensive Chemotherapy (IC)","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Azacitidine; IDH2; Myeloid leukemia; Medicine; Quality of life (healthcare); Internal medicine; Myeloid; Oncology; Mutant; Biology; IDH1; DNA methylation; Genetics; Gene","score_opus":0.017589774981762136,"score_gpt":0.2627484715674916,"score_spread":0.24515869658572945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212999994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99253255,0.0012233686,0.00005031536,0.0017137324,0.00011286836,0.0036703437,0.00043761084,0.00014969453,0.00010952009],"genre_scores_gemma":[0.992325,0.0010472342,0.0028114333,0.0014204482,0.00008518704,0.00053026504,0.0010578784,0.00019268408,0.0005298369],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99506426,0.00018724438,0.0015916419,0.0012306178,0.000823764,0.0011024899],"domain_scores_gemma":[0.996089,0.00037181386,0.0009414815,0.0011416951,0.0009375776,0.00051847607],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002702006,0.00084050605,0.0024072863,0.0002695445,0.00016958019,0.000036217898,0.00020059453,0.00028171227,0.000054964923],"category_scores_gemma":[0.0002391547,0.0006422826,0.0003242562,0.00085546396,0.00019083952,0.00020266933,0.00008048422,0.00038015953,0.00001205438],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07774817,0.017501736,0.7110838,0.003365871,0.019615835,0.0032582604,0.014199721,0.00072245253,0.1432888,0.00011494533,0.0005329642,0.008567429],"study_design_scores_gemma":[0.3082778,0.008194574,0.21178497,0.0015226976,0.0011158211,0.00022231282,0.0008463975,0.00004776836,0.46693417,0.000017400029,0.00023452318,0.0008015811],"about_ca_topic_score_codex":0.002909468,"about_ca_topic_score_gemma":0.0014616757,"teacher_disagreement_score":0.49929884,"about_ca_system_score_codex":0.0040562544,"about_ca_system_score_gemma":0.005276866,"threshold_uncertainty_score":0.999767},"labels":[],"label_agreement":null},{"id":"W3213000652","doi":"10.1182/blood-2021-147317","title":"Mitapivat Improves Ineffective Erythropoiesis and Reduces Iron Overload in Patients with Pyruvate Kinase Deficiency","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Pyruvate kinase deficiency; Transferrin saturation; Anemia; Ineffective erythropoiesis; Soluble transferrin receptor; Internal medicine; Ferritin; Erythropoiesis; Hepcidin; Gastroenterology; Iron deficiency; Pyruvate kinase","score_opus":0.004927552389723942,"score_gpt":0.20891659490178072,"score_spread":0.20398904251205677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213000652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977374,0.0007566971,0.0000027237188,0.00016764904,0.00011347795,0.00023755174,0.000007990541,0.000030424279,0.00094610604],"genre_scores_gemma":[0.9989636,0.00011139491,0.00033892388,0.00027877477,0.000048396167,0.000017345306,0.00003855246,0.000015076718,0.00018794232],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991334,0.00005553133,0.00014627732,0.00033537202,0.00013064152,0.00019876796],"domain_scores_gemma":[0.9995288,0.00005991988,0.00005269588,0.00017826114,0.00010388857,0.00007642431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000048041456,0.00013982458,0.00025431757,0.00008157699,0.000055018216,0.000010896982,0.000025131521,0.0000785199,0.00004697567],"category_scores_gemma":[0.000116504125,0.000107201835,0.00003160395,0.00025418363,0.00010647614,0.00007551474,0.000041998614,0.00014327675,0.000009783947],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095240376,0.003250657,0.6160244,0.00027771696,0.00007708585,0.00018684787,0.00083767483,0.00000203055,0.37083554,0.00008883523,0.00015571868,0.007311112],"study_design_scores_gemma":[0.0074044694,0.0017066768,0.9295585,0.00011619628,0.00011591109,0.000015790705,0.00035539086,0.0000036338306,0.060431134,0.000043790238,0.00010420628,0.00014428332],"about_ca_topic_score_codex":0.00003838528,"about_ca_topic_score_gemma":0.000025663714,"teacher_disagreement_score":0.31353414,"about_ca_system_score_codex":0.000022455204,"about_ca_system_score_gemma":0.00007103823,"threshold_uncertainty_score":0.43715638},"labels":[],"label_agreement":null},{"id":"W3213014119","doi":"10.1182/blood-2021-145287","title":"Umbilical Cord Blood Transplantation after Graft Failure from a Previous Hematopoietic Stem Cell Transplantation","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Transplantation; Umbilical cord; Umbilical Cord Blood Transplantation; Pancytopenia; Hematopoietic stem cell transplantation; Stem cell; Leukemia; Cord blood; Surgery; Internal medicine; Acute leukemia; Gastroenterology; Bone marrow; Immunology; Biology","score_opus":0.010348116008856564,"score_gpt":0.2315600318686308,"score_spread":0.22121191585977423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213014119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908184,0.0015355326,0.0041543483,0.000473913,0.00017187819,0.00085299875,0.00034602432,0.00024630327,0.0014006287],"genre_scores_gemma":[0.9912656,0.001318358,0.0048402776,0.0003577589,0.0001817583,0.00020954912,0.0012623881,0.00009004627,0.00047426604],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969371,0.000207958,0.00080382364,0.0008403415,0.0007231705,0.00048758526],"domain_scores_gemma":[0.9984809,0.00027947378,0.00014132854,0.0005787079,0.00018809884,0.00033146812],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016081665,0.0004247834,0.00064567156,0.0001241523,0.00009459816,0.00007323938,0.00013078995,0.00036499015,0.0007456935],"category_scores_gemma":[0.000008193815,0.00042641722,0.0002980941,0.0003928848,0.00007172943,0.00017940656,0.000010875258,0.00038303208,0.00022487775],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004216442,0.010195575,0.13299267,0.017791452,0.0015568538,0.038179163,0.030459503,0.000019729549,0.76092213,0.00035897671,0.00023558205,0.0030719282],"study_design_scores_gemma":[0.017115124,0.00053844356,0.052941307,0.0015001048,0.009214512,0.008260421,0.00078517495,0.00003177667,0.9084663,0.00020612414,0.0002608488,0.00067985564],"about_ca_topic_score_codex":0.000047390455,"about_ca_topic_score_gemma":0.00016027899,"teacher_disagreement_score":0.14754418,"about_ca_system_score_codex":0.000028697847,"about_ca_system_score_gemma":0.00022988686,"threshold_uncertainty_score":0.99981874},"labels":[],"label_agreement":null},{"id":"W3213015981","doi":"10.1182/blood-2021-146738","title":"Frontline Therapy with Bendamustine-Rituximab (BR) in Patients with Treatment-Naïve Waldenstrom's Macroglobulinemia Confers Similar Long-Term Outcomes to R-CVP in a Real-World Setting: A Population-Based Analysis","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Rituximab; Medicine; Bendamustine; Waldenstrom macroglobulinemia; Internal medicine; Population; Macroglobulinemia; Prednisone; Oncology; Lymphoplasmacytic Lymphoma; Vincristine; Cyclophosphamide; Lymphoma; Immunology; Chemotherapy; Multiple myeloma","score_opus":0.018608643665092593,"score_gpt":0.30814377243699803,"score_spread":0.28953512877190546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213015981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970387,0.00008748385,0.00003447764,0.0010902737,0.000021192607,0.001379252,0.00010690627,0.000070598784,0.00017106965],"genre_scores_gemma":[0.99329466,0.00002260886,0.0038315423,0.00047232088,0.000049025315,0.00014880463,0.0016474377,0.00007309186,0.0004604852],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967365,0.00013968935,0.0006463375,0.00086323346,0.0008740701,0.0007401297],"domain_scores_gemma":[0.99808216,0.00023503212,0.0001571871,0.0008664732,0.00032476583,0.00033438284],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017606629,0.00046797688,0.0011941058,0.000901059,0.000063002786,0.000061341736,0.00015898833,0.00012498142,0.00023106323],"category_scores_gemma":[0.00011581576,0.00033330588,0.0001883741,0.0023361319,0.000060369268,0.00007794399,0.000047838686,0.00025532418,0.000010846254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00221908,0.0054158443,0.9860988,0.000070540096,0.0013659522,0.0018582478,0.00026551198,0.001244816,0.00004603303,0.0000037734687,0.000012454801,0.0013989283],"study_design_scores_gemma":[0.1493095,0.00096717634,0.8457442,0.00023812987,0.00088679575,0.000011298464,0.00005974061,0.0015701868,0.000896914,0.0000013315163,0.000016228165,0.0002984954],"about_ca_topic_score_codex":0.008227889,"about_ca_topic_score_gemma":0.061004598,"teacher_disagreement_score":0.14709042,"about_ca_system_score_codex":0.0054387585,"about_ca_system_score_gemma":0.003814586,"threshold_uncertainty_score":0.9999119},"labels":[],"label_agreement":null},{"id":"W3213022568","doi":"10.1182/blood-2021-149018","title":"Characteristics and Outcomes of Adolescent and Young Adult (AYA) Patients with Myelodysplastic Syndrome (MDS) and Chronic Myelomonocytic Leukemia (CMML): A Single-Center Retrospective Analysis","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Chronic myelomonocytic leukemia; Myelodysplastic syndromes; Internal medicine; Retrospective cohort study; International Prognostic Scoring System; Cancer; Pediatrics; Bone marrow","score_opus":0.007393911002242059,"score_gpt":0.22771382055345166,"score_spread":0.2203199095512096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213022568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987028,0.00033629755,0.00009013033,0.00010774254,0.00003856679,0.00045519666,0.00013929176,0.000027467531,0.000102487036],"genre_scores_gemma":[0.99855834,0.0004118969,0.00054794474,0.00007481229,0.000034631452,0.000019141022,0.00012038022,0.000041795596,0.00019104479],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979913,0.000069521455,0.00040842543,0.00060754444,0.0005120683,0.0004111212],"domain_scores_gemma":[0.9985347,0.000093122886,0.0001874917,0.0003952123,0.0005071107,0.000282379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000104585495,0.00030172977,0.0009438005,0.00029374778,0.00009017605,0.00005880061,0.00007176516,0.0001325369,0.00003140926],"category_scores_gemma":[0.00032136703,0.00024299919,0.00007990427,0.00058574864,0.0002974344,0.000111543304,0.00020889378,0.00035720272,0.000002820704],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018478496,0.0006232011,0.99415845,0.00049652846,0.0020378176,0.00039232746,0.00024282117,3.8426415e-7,0.001099215,0.000019043438,0.000010117767,0.0007353302],"study_design_scores_gemma":[0.010816101,0.000988364,0.9825843,0.00035523248,0.0032822492,0.0004439352,0.00008757273,0.00041938512,0.00078034814,0.0000047562453,0.000007814575,0.00022996296],"about_ca_topic_score_codex":0.00004881121,"about_ca_topic_score_gemma":0.00013491834,"teacher_disagreement_score":0.01157415,"about_ca_system_score_codex":0.0006273826,"about_ca_system_score_gemma":0.00036359805,"threshold_uncertainty_score":0.9909219},"labels":[],"label_agreement":null},{"id":"W3213024712","doi":"10.1182/blood-2021-149312","title":"CXCR4 Drives Lympho-Myeloid Fate of Hematopoietic Progenitors <i>Via</i> mTOR and Mitochondrial Metabolic Pathways","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Biology; Myeloid; Haematopoiesis; Progenitor cell; Cell biology; Stem cell; Bone marrow; PI3K/AKT/mTOR pathway; Immunology; Signal transduction","score_opus":0.013556429593460215,"score_gpt":0.24897907201009073,"score_spread":0.23542264241663052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213024712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99098015,0.005974985,0.000096700205,0.00062350684,0.00029255802,0.0005859315,0.000053305615,0.00008134748,0.0013115236],"genre_scores_gemma":[0.9879256,0.0009481456,0.009065372,0.00036947356,0.0008038385,0.00010966678,0.00006948853,0.000069784284,0.00063864875],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99791616,0.00012882079,0.00045091205,0.0004392265,0.00059172796,0.00047315206],"domain_scores_gemma":[0.99850154,0.00011872921,0.000118410004,0.0005790948,0.00034578863,0.00033641202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015504546,0.00025059542,0.00066447794,0.0001562009,0.00008147417,0.000037101025,0.0001596847,0.00017902901,0.000123215],"category_scores_gemma":[0.0003639908,0.00021852896,0.00018501187,0.00046183448,0.00022988018,0.00013935017,0.00022852817,0.00025286974,0.00006042655],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019203265,0.0008141926,0.011117418,0.00041062414,0.00058104005,0.000520445,0.0010807036,3.5283654e-7,0.97948337,0.0006410218,0.00090175803,0.0042570494],"study_design_scores_gemma":[0.0097483555,0.00021200231,0.0039188676,0.00011219137,0.0006218915,0.0012764522,0.0004318353,0.00002275334,0.9697083,0.00023216225,0.013474737,0.00024044488],"about_ca_topic_score_codex":0.000045578283,"about_ca_topic_score_gemma":0.000005156867,"teacher_disagreement_score":0.012572979,"about_ca_system_score_codex":0.00003919705,"about_ca_system_score_gemma":0.00083672133,"threshold_uncertainty_score":0.8911352},"labels":[],"label_agreement":null},{"id":"W3213111836","doi":"10.1182/blood-2021-149469","title":"Incidence of Mental Health Events and Its Association with Survival Among Patients with Diffuse Large B-Cell Lymphoma: A Population-Based Cohort Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Family Support in Illness","field":"Social Sciences","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Queen's University; Cancer Care Ontario; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Population; Rituximab; Mental health; Comorbidity; Internal medicine; Proportional hazards model; Cumulative incidence; Cohort; Psychiatry; Lymphoma; Environmental health","score_opus":0.007003272306158746,"score_gpt":0.24591896742431954,"score_spread":0.2389156951181608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213111836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998599,0.000034853867,0.0000052990617,0.000063236956,0.00011774809,0.0008795016,0.00008631952,0.000026643385,0.00018740237],"genre_scores_gemma":[0.99955946,0.000006917091,0.000060753922,0.00004885245,0.00001737161,0.000029579187,0.00011643353,0.000014548745,0.0001461042],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99763024,0.00041332707,0.00024587536,0.00028664304,0.0011372968,0.00028659438],"domain_scores_gemma":[0.9989901,0.00012073501,0.00037133542,0.00014131349,0.00026028158,0.0001162233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007978783,0.0001154443,0.00025815083,0.000043667198,0.00038151914,0.00002931261,0.000101237696,0.000056523735,0.000015296311],"category_scores_gemma":[0.00014707824,0.0001031972,0.00002138386,0.00036131585,0.000024775967,0.00021487365,0.000039992756,0.000053520052,0.0000012809704],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024208968,0.008470586,0.9880008,0.00001873533,0.000055358898,0.0000038777207,0.0033705565,0.0000017334435,0.0000018050324,0.000020278692,0.0000094852485,0.00002256274],"study_design_scores_gemma":[0.0107044745,0.00019581211,0.9859033,0.00004577132,0.000060242022,9.3439105e-8,0.0028757134,0.000013108331,0.0000620394,0.000004295075,0.000009593839,0.00012553266],"about_ca_topic_score_codex":0.0059573967,"about_ca_topic_score_gemma":0.027319325,"teacher_disagreement_score":0.021361928,"about_ca_system_score_codex":0.00022852836,"about_ca_system_score_gemma":0.00043539246,"threshold_uncertainty_score":0.9904296},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"agree"},{"id":"W3213131678","doi":"10.1182/blood-2021-148370","title":"A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of Mitapivat in Patients with Sickle Cell Disease","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Hemolysis; Pyruvate kinase deficiency; Placebo; Sickle cell anemia; Anemia; Internal medicine; Hemolytic anemia; Pyruvate kinase; Gastroenterology; Disease; Glycolysis; Pathology","score_opus":0.008237923920311481,"score_gpt":0.2439470165751577,"score_spread":0.23570909265484621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213131678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924642,0.0009673126,0.0000058332876,0.000112568465,0.00005660146,0.0043776077,0.000007761271,0.00002389772,0.0019842365],"genre_scores_gemma":[0.9990557,0.00004274055,0.000049931703,0.00007363591,0.000019922045,0.00020680281,0.000051684834,0.000026004393,0.0004736159],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99840707,0.00015970509,0.00050965487,0.00030161696,0.00038191452,0.00024005222],"domain_scores_gemma":[0.99898666,0.0001240174,0.00015031203,0.00035747656,0.00018041652,0.00020108726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023174232,0.00019288297,0.0009939537,0.0001324129,0.00003686943,0.000011682937,0.000063462554,0.000073995136,0.00009662131],"category_scores_gemma":[0.00012430745,0.00012689269,0.00016505149,0.00034635112,0.00006045365,0.000046735535,0.00003627548,0.00020001603,0.000009337965],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87920153,0.07211257,0.04644821,0.000114295464,0.00055887876,0.00035928414,0.00093796296,0.000036160454,0.000085779284,0.000008089449,0.000029747913,0.00010750561],"study_design_scores_gemma":[0.992864,0.0015189033,0.00095389836,0.00012759912,0.0023562983,0.0000018941728,0.0013460988,0.00006182178,0.000600187,0.000008239508,0.000017249171,0.0001437695],"about_ca_topic_score_codex":0.000044410725,"about_ca_topic_score_gemma":0.000024864627,"teacher_disagreement_score":0.11366252,"about_ca_system_score_codex":0.000014144386,"about_ca_system_score_gemma":0.00020792366,"threshold_uncertainty_score":0.5174534},"labels":[],"label_agreement":null},{"id":"W3213136165","doi":"10.1182/blood-2021-152612","title":"Fitness Assessment of Elderly Patients with AML and Outcomes","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Hospital; Juravinski Cancer Centre; McMaster University","funders":"","keywords":"Medicine; Proportional hazards model; Cohort; Retrospective cohort study; Performance status; Internal medicine; Cancer; Physical therapy","score_opus":0.011549093824666568,"score_gpt":0.29926196083058804,"score_spread":0.28771286700592147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213136165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966403,0.00007084318,0.0000533499,0.00047315613,0.00001669795,0.00017468199,0.000012214873,0.000012351342,0.0025463882],"genre_scores_gemma":[0.99459076,0.000018254692,0.00442255,0.00010484261,0.000015007151,0.000009736923,0.000031830365,0.000012692521,0.00079431356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99922955,0.00002627267,0.000121325254,0.00015830535,0.00032396984,0.00014058362],"domain_scores_gemma":[0.99936837,0.00006181559,0.000036111047,0.0002310986,0.00021827819,0.000084298845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000067277586,0.000074581505,0.00022829062,0.00004187598,0.000022945314,0.000008671615,0.000039513,0.000038590966,0.000082945764],"category_scores_gemma":[0.00006304411,0.000051432686,0.000024902467,0.0001241504,0.000053165295,0.00003535288,0.000058712296,0.00012388814,0.0000020176183],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020249832,0.00062927004,0.9957675,0.000107727996,0.00017209817,0.000078202866,0.000054062068,2.836077e-7,0.0007121818,0.000102779064,0.00009551482,0.0022601534],"study_design_scores_gemma":[0.0077676354,0.0004941499,0.9862051,0.000054985692,0.00013257582,0.000017244998,0.000078213896,0.000011581124,0.0049138935,0.000012766277,0.00025526143,0.00005659921],"about_ca_topic_score_codex":0.000019706662,"about_ca_topic_score_gemma":0.000008170066,"teacher_disagreement_score":0.009562384,"about_ca_system_score_codex":0.000023978424,"about_ca_system_score_gemma":0.000283745,"threshold_uncertainty_score":0.2097364},"labels":[],"label_agreement":null},{"id":"W3213141384","doi":"10.1182/blood-2021-148881","title":"SCRI-CAR19x22v2 T Cell Product Demonstrates Bispecific Activity in B-ALL","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"CD22; CD19; Antigen; Population; Medicine; Immunology; Chimeric antigen receptor; T cell; Biology; Immune system","score_opus":0.05609788024173643,"score_gpt":0.3150073002991131,"score_spread":0.25890942005737666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213141384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9512587,0.0018369728,0.0000037034501,0.0013558799,0.00010032629,0.00037248718,0.0000060524044,0.000054141463,0.045011688],"genre_scores_gemma":[0.9846529,0.00043122,0.00044957318,0.00011106229,0.00027355648,0.00002613373,0.000017262559,0.000035521676,0.014002782],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984002,0.00011858057,0.00018273188,0.0004836079,0.00038326837,0.00043158108],"domain_scores_gemma":[0.9990327,0.000079684825,0.000033703513,0.00057440886,0.00012518799,0.00015433146],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031516058,0.00015392281,0.00030037592,0.00014213375,0.000034792694,0.000041248317,0.00010527946,0.00008333989,0.0019510294],"category_scores_gemma":[0.00010333766,0.00014626585,0.00009965543,0.0005668568,0.00007459573,0.00007357269,0.00007271054,0.00045837517,0.00013840302],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001179884,0.002102424,0.040689673,0.00011749392,0.00005797548,0.00077759183,0.00015093086,8.8919757e-7,0.9437738,0.000019528454,0.0005542516,0.011637459],"study_design_scores_gemma":[0.0032868758,0.00014362323,0.03722485,0.000051702285,0.00005633214,0.00016047612,0.00010586049,0.000019193387,0.9449946,0.000068829875,0.01374475,0.00014289412],"about_ca_topic_score_codex":0.00008465322,"about_ca_topic_score_gemma":0.0001262684,"teacher_disagreement_score":0.03339414,"about_ca_system_score_codex":0.000059357128,"about_ca_system_score_gemma":0.0003650344,"threshold_uncertainty_score":0.9989613},"labels":[],"label_agreement":null},{"id":"W3213145999","doi":"10.1182/blood-2021-147575","title":"RNA Binding Protein Syncrip Is Required for the Low-Output HSC By Sustaining Proteome Quality","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; BC Cancer Agency","funders":"","keywords":"Haematopoiesis; Stem cell; Biology; Transplantation; Bone marrow; Progenitor cell; Hematopoietic stem cell; Molecular biology; Leukemia; Myeloid leukemia; RNA-binding protein; Myeloid; Conditional gene knockout; RNA; Immunology; Cell biology; Cancer research; Genetics; Gene; Internal medicine; Medicine","score_opus":0.025294815969072678,"score_gpt":0.3052958475071119,"score_spread":0.28000103153803924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213145999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944958,0.00090804877,0.0019221057,0.0014504547,0.000032880154,0.0008055118,0.00006545744,0.000013822448,0.00030592957],"genre_scores_gemma":[0.9802365,0.000052667252,0.00064986805,0.00025509248,0.00020269073,0.0003421419,0.000101197846,0.000027952821,0.018131936],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99865884,0.000103349405,0.00021837771,0.00037367136,0.0002018063,0.00044395617],"domain_scores_gemma":[0.99917996,0.000038542785,0.00007542577,0.00043851975,0.00017416723,0.000093414834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006143382,0.00013012151,0.00014114968,0.000019425746,0.00026035702,0.000092455644,0.0002369801,0.00011442999,0.000016776554],"category_scores_gemma":[0.000713034,0.000101270016,0.00012231883,0.00011460152,0.000055925313,0.0000054873153,0.00015988837,0.00011824116,0.0000056998097],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056971607,0.0000892742,0.00021107771,0.0000960145,0.000106862644,0.0000068039835,0.000046679426,8.203871e-7,0.9961517,0.000039422564,0.00185363,0.0013407742],"study_design_scores_gemma":[0.0011620153,0.0001646402,0.000067683235,0.00003742293,0.000018919844,0.0000069385933,0.00038650673,0.000041425457,0.98877704,0.000037285532,0.009151585,0.00014853221],"about_ca_topic_score_codex":0.0000376582,"about_ca_topic_score_gemma":0.000010043524,"teacher_disagreement_score":0.017826008,"about_ca_system_score_codex":0.000012821543,"about_ca_system_score_gemma":0.00019167621,"threshold_uncertainty_score":0.41296715},"labels":[],"label_agreement":null},{"id":"W3213162785","doi":"10.1182/blood-2021-149788","title":"Virtual Care during the COVID-19 Pandemic Among Patients with Hematologic Malignancies - a Princess Margaret Cancer Centre Experience","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Pandemic; Population; Cancer; Hematologic malignancy; Coronavirus disease 2019 (COVID-19); Family medicine; Emergency medicine; Internal medicine; Disease","score_opus":0.032841830140654574,"score_gpt":0.32368052213644266,"score_spread":0.2908386919957881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213162785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99615985,0.0014038597,0.000013931912,0.0015764283,0.00010074737,0.0005165253,0.000050137296,0.000111587775,0.00006691576],"genre_scores_gemma":[0.99589086,0.0001872607,0.00002830124,0.0033934198,0.00008005085,0.00008466085,0.000031044383,0.000021523652,0.00028285352],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984259,0.000077685436,0.00022766656,0.00039118624,0.00043091495,0.00044666973],"domain_scores_gemma":[0.9987403,0.000117277465,0.00011454666,0.00040735342,0.00024204158,0.00037844712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000059411566,0.00019480835,0.00030447522,0.000042071828,0.00029678922,0.00003540379,0.00014031935,0.00009895606,0.00022072268],"category_scores_gemma":[0.0004074496,0.00011919177,0.000058114514,0.0002824647,0.00016074156,0.000091213304,0.000108216576,0.00022452332,0.0000043002924],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011158584,0.00015520638,0.98276967,0.0005941739,0.00004557324,0.00032870148,0.015583073,0.000013885397,0.00020985973,0.000023684332,0.00004565532,0.00011893942],"study_design_scores_gemma":[0.003950179,0.00013086508,0.97991663,0.00035195018,0.00011188833,0.00011887759,0.010211499,0.0000016413892,0.0031283274,0.0000048046377,0.00189255,0.00018080913],"about_ca_topic_score_codex":0.001074253,"about_ca_topic_score_gemma":0.0041870694,"teacher_disagreement_score":0.0053715734,"about_ca_system_score_codex":0.00028200567,"about_ca_system_score_gemma":0.0011758539,"threshold_uncertainty_score":0.48604992},"labels":[],"label_agreement":null},{"id":"W3213172814","doi":"10.1182/blood-2021-144421","title":"Sustained Improvement in Health-Related Quality of Life in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma Treated with Daratumumab, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexamethasone: Update of the Phase 3 MAIA Trial","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Alberta; University of Calgary","funders":"","keywords":"Lenalidomide; Dexamethasone; Daratumumab; Multiple myeloma; Medicine; Internal medicine; Oncology","score_opus":0.02593192923513089,"score_gpt":0.2995565192646997,"score_spread":0.27362459002956885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213172814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952647,0.0010951967,0.000016359558,0.0003459345,0.000032514265,0.0029241315,0.00026808365,0.000018433093,0.000034664492],"genre_scores_gemma":[0.9981577,0.00039269996,0.0009236453,0.00004634532,0.00001431174,0.00013260712,0.00026576195,0.00003816919,0.000028765644],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99626935,0.00068663,0.0012073418,0.0005907758,0.0006612038,0.00058471883],"domain_scores_gemma":[0.99745584,0.0009146331,0.0005036565,0.00050075573,0.00026397425,0.0003611396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080192555,0.00035884744,0.0012498309,0.00025257916,0.000082729144,0.00002225117,0.00011276101,0.00013658618,0.000026269798],"category_scores_gemma":[0.0009775985,0.00023020283,0.00008797729,0.000882601,0.00025883777,0.00012489127,0.000083632876,0.00033880374,3.9893806e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.30237272,0.00609792,0.68332106,0.0005839685,0.00074455957,0.00022993213,0.0005148988,0.000014683623,0.0027611514,0.000018785571,0.0000049272135,0.0033353928],"study_design_scores_gemma":[0.6125498,0.0044004177,0.36108133,0.00050072744,0.0002088451,0.000007917443,0.00045986183,0.0001247632,0.02047491,0.000010272399,0.000004291721,0.00017689826],"about_ca_topic_score_codex":0.007712873,"about_ca_topic_score_gemma":0.007823517,"teacher_disagreement_score":0.32223973,"about_ca_system_score_codex":0.00011407259,"about_ca_system_score_gemma":0.00072436355,"threshold_uncertainty_score":0.9988949},"labels":[],"label_agreement":null},{"id":"W3213192832","doi":"10.1182/blood-2021-146397","title":"Real-World Efficacy and Safety Outcomes for Patients with Relapsed or Refractory (R/R) Aggressive B-Cell Non-Hodgkin's Lymphoma (aBNHL) Treated with Commercial Tisagenlecleucel: Update from the Center for International Blood and Marrow Transplant Research (CIBMTR) Registry","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada); McMaster University; Juravinski Hospital","funders":"","keywords":"Medicine; Internal medicine; Cytokine release syndrome; Diffuse large B-cell lymphoma; Single Center; Oncology; Adverse effect; Aggressive lymphoma; Lymphoma; Surgery; Immunotherapy; Rituximab; Cancer; Chimeric antigen receptor","score_opus":0.02530467328569276,"score_gpt":0.31217945976276346,"score_spread":0.2868747864770707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213192832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99268174,0.0001713343,0.000028768147,0.0014455118,0.00011876987,0.0023973878,0.0021698407,0.000040124178,0.0009465174],"genre_scores_gemma":[0.98773986,0.0012624727,0.001705484,0.00033031055,0.00035948073,0.0002988794,0.0026336461,0.00013207416,0.0055377823],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99724555,0.00021852819,0.00040766897,0.0007569796,0.00079784606,0.0005734026],"domain_scores_gemma":[0.9959101,0.0019574391,0.00021273745,0.0006514236,0.0010130751,0.00025523026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044004095,0.00033656298,0.00055717834,0.00014751361,0.0003615587,0.00012121838,0.00027339513,0.0001544046,0.00022860219],"category_scores_gemma":[0.00033159443,0.00019835957,0.00009782434,0.00028497953,0.00035317082,0.00010618491,0.00010132036,0.0003705478,0.000002263307],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06504146,0.006222637,0.9019559,0.0002363487,0.0023533772,0.0006080646,0.001173105,4.273945e-7,0.0068355547,0.00001845335,0.0023866063,0.013168061],"study_design_scores_gemma":[0.1561356,0.003773668,0.799766,0.0009827989,0.0010796624,0.00007345251,0.00022654343,0.00003110308,0.017828304,0.000020527577,0.019667892,0.0004144296],"about_ca_topic_score_codex":0.00036075138,"about_ca_topic_score_gemma":0.0014673008,"teacher_disagreement_score":0.10218988,"about_ca_system_score_codex":0.00008668568,"about_ca_system_score_gemma":0.00035353674,"threshold_uncertainty_score":0.8088869},"labels":[],"label_agreement":null},{"id":"W3213194096","doi":"10.1182/blood-2021-145883","title":"Event-Free and Overall Survival in over 6,000 Patients Treated with Frontline Immunochemotherapy for Follicular Lymphoma between 2002-2018: First Report from the International FLIPI24 Consortium","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Follicular lymphoma; Medicine; Event (particle physics); Internal medicine; Oncology; Lymphoma","score_opus":0.011083558379022748,"score_gpt":0.2369471744649472,"score_spread":0.22586361608592445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213194096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957201,0.001193738,0.000017262997,0.0015255258,0.00012944033,0.000581289,0.0005390818,0.000021924829,0.00027165335],"genre_scores_gemma":[0.9963957,0.00023264726,0.0005436113,0.00038531848,0.0002486879,0.00013250024,0.00148669,0.00003275361,0.0005420798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869317,0.000029603643,0.00035987407,0.00039313987,0.0003240773,0.0002001099],"domain_scores_gemma":[0.9988954,0.0002331403,0.0001392636,0.00052100123,0.00013571818,0.00007545942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000100532794,0.00020388626,0.0003721663,0.000032866672,0.00006515403,0.000046432375,0.00011604825,0.00008518833,0.00015633134],"category_scores_gemma":[0.00011505178,0.00013163718,0.00010297506,0.00007741893,0.000042189058,0.00006247424,0.00006511711,0.000041978412,0.000002740161],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034442337,0.0020810852,0.9921074,0.000008875956,0.0012953473,0.00035400988,0.0001088325,7.998806e-7,0.00010865503,0.000012154046,0.002672374,0.00090606755],"study_design_scores_gemma":[0.046558253,0.0002647152,0.9355075,0.00014426617,0.00046228527,0.000043134805,0.000026845257,0.000024387018,0.005395729,0.000053217685,0.0113791805,0.0001405342],"about_ca_topic_score_codex":0.0017149083,"about_ca_topic_score_gemma":0.0007177556,"teacher_disagreement_score":0.056599922,"about_ca_system_score_codex":0.00012143553,"about_ca_system_score_gemma":0.000115014875,"threshold_uncertainty_score":0.5368008},"labels":[],"label_agreement":null},{"id":"W3213195131","doi":"10.1182/blood-2021-154193","title":"Blinatumomab Is Cost-Effective Compared to Standard Chemotherapy for Children with High Risk Relapses of Acute Lymphoblastic Leukemia: A Cost-Effectiveness Analysis Using Population-Based Healthcare Data","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Hospital; Kingston General Hospital; Institute for Clinical Evaluative Sciences; Children's Hospital of Eastern Ontario; London Health Sciences Centre; McMaster University; McMaster Children's Hospital; Hospital for Sick Children","funders":"","keywords":"Blinatumomab; Medicine; Population; Oncology; Internal medicine; Health care; Intensive care medicine; Pediatrics; Leukemia; Lymphoblastic Leukemia; Environmental health","score_opus":0.028454982815256713,"score_gpt":0.3439341205967869,"score_spread":0.3154791377815302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213195131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8956214,0.00018442578,0.08588633,0.000310434,0.000053454645,0.0073393774,0.010525996,0.00007415109,0.000004435918],"genre_scores_gemma":[0.97418106,0.000035293102,0.019728689,0.00039013635,0.000112712,0.000663129,0.00476532,0.00010834607,0.000015332149],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996087,0.00042156165,0.0005946223,0.0012142948,0.0010219724,0.00066055177],"domain_scores_gemma":[0.9945966,0.0014196133,0.00039444005,0.0016965956,0.0014744358,0.00041830537],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00067277445,0.00044673373,0.0015496004,0.00059212366,0.0002607519,0.000057940633,0.00040795133,0.00023402555,0.00004376083],"category_scores_gemma":[0.0006239371,0.00038480436,0.0002605918,0.002816738,0.00012078726,0.00014923819,0.00018844506,0.0003107148,0.000002835428],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016624046,0.0013429461,0.9377058,0.000805845,0.023122435,0.00017267103,0.00035551653,0.0113722915,0.0028929333,0.000039738934,0.00025895692,0.0053068134],"study_design_scores_gemma":[0.0569635,0.002208725,0.7960701,0.0007951733,0.018772997,0.0001659566,0.00009882986,0.043425735,0.08086604,0.00004460141,0.00005149396,0.0005368566],"about_ca_topic_score_codex":0.0049038995,"about_ca_topic_score_gemma":0.00059714494,"teacher_disagreement_score":0.14163572,"about_ca_system_score_codex":0.002392169,"about_ca_system_score_gemma":0.0039779004,"threshold_uncertainty_score":0.9998604},"labels":[],"label_agreement":null},{"id":"W3213196162","doi":"10.1182/blood-2021-144554","title":"Predictors for Improvement in Patient-Reported Outcomes: <i>Post-Hoc</i> Analysis of a Phase 3 Randomized, Open-Label Study of Eculizumab and Ravulizumab in Complement Inhibitor-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Eculizumab; Internal medicine; Quality of life (healthcare); Post-hoc analysis; Physical therapy; Immunology; Complement system","score_opus":0.015862318298956454,"score_gpt":0.2840489322060092,"score_spread":0.26818661390705273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213196162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918804,0.00055519707,0.000023279901,0.000022598657,0.00016118851,0.006343257,0.0009813205,0.000012563205,0.00002015844],"genre_scores_gemma":[0.9978465,0.0000075826906,0.00015586308,0.000039624603,0.000004370699,0.0008029673,0.0011062862,0.000021623151,0.000015181945],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9960573,0.00057027215,0.0021236683,0.0006394849,0.00020531395,0.0004039789],"domain_scores_gemma":[0.99743915,0.00042788952,0.0010816966,0.00053474423,0.00046287657,0.00005367129],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00055450364,0.00035670598,0.0019601188,0.00046721453,0.000075243646,0.000027075232,0.0002849759,0.00009148524,0.00013586644],"category_scores_gemma":[0.0002222553,0.00028144132,0.00016348297,0.00065978867,0.00013437236,0.000120461315,0.00040841135,0.00012974683,4.5936685e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09721109,0.06684947,0.8070592,0.00021342952,0.015628234,0.00005304233,0.004157618,0.00003243898,0.00752525,0.000028596285,0.000057865684,0.0011837521],"study_design_scores_gemma":[0.893658,0.008984169,0.07862627,0.00016343205,0.0056179482,0.0000053771982,0.005061315,0.0000335933,0.007471154,0.000013197108,0.00003613665,0.000329399],"about_ca_topic_score_codex":0.00082228205,"about_ca_topic_score_gemma":0.0030287441,"teacher_disagreement_score":0.7964469,"about_ca_system_score_codex":0.0000835933,"about_ca_system_score_gemma":0.00021352609,"threshold_uncertainty_score":0.99996376},"labels":[],"label_agreement":null},{"id":"W3213205338","doi":"10.1182/blood-2021-153426","title":"Quizartinib (Quiz) with Decitabine (DAC) and Venetoclax (VEN) Is Highly Active in Patients (pts) with FLT3-ITD Mutated Acute Myeloid Leukemia (AML) - RAS/MAPK Mutations Continue to Drive Primary and Secondary Resistance","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Decitabine; Venetoclax; Medicine; Ven; Myeloid leukemia; Bristol-Myers; Oncology; Leukemia; Internal medicine; Cancer research; Chronic lymphocytic leukemia; Biology; Gene; Genetics","score_opus":0.005387130484892558,"score_gpt":0.23303281225113728,"score_spread":0.22764568176624472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213205338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99443465,0.00048126135,0.000059987113,0.0012600723,0.00004137338,0.001450489,0.00035768363,0.000070722155,0.0018437495],"genre_scores_gemma":[0.98834884,0.00013840066,0.0060971677,0.0015666896,0.00008328794,0.00022630376,0.0006465624,0.00011085502,0.0027819092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970705,0.0001507578,0.00048591354,0.00096263335,0.0006425657,0.00068765803],"domain_scores_gemma":[0.99769044,0.00028070153,0.00017732344,0.00054572924,0.00081659755,0.00048920285],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019657346,0.0004156303,0.00075260305,0.00031549245,0.00018406268,0.000084131214,0.00015091574,0.00018553312,0.00006677764],"category_scores_gemma":[0.00025290894,0.00035501333,0.000045618064,0.0010722823,0.00031736033,0.00034756731,0.0002076838,0.0007035822,0.000018406281],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.054575946,0.0043908344,0.5938744,0.0025038517,0.008966661,0.019549573,0.049326003,0.000102348815,0.20751435,0.00035425075,0.020984082,0.03785769],"study_design_scores_gemma":[0.045160763,0.0024559016,0.83068234,0.0010632867,0.00079501467,0.00027488408,0.0012278968,0.000044367822,0.112448916,0.00005908155,0.0050846613,0.0007028719],"about_ca_topic_score_codex":0.00014993823,"about_ca_topic_score_gemma":0.00092694967,"teacher_disagreement_score":0.23680794,"about_ca_system_score_codex":0.00094187824,"about_ca_system_score_gemma":0.0027337454,"threshold_uncertainty_score":0.9998902},"labels":[],"label_agreement":null},{"id":"W3213207497","doi":"10.1182/blood-2021-148683","title":"Efficacy and Safety of Apixaban for Primary Prevention of Thromboembolism in Cancer Patients with a Newly Inserted Central Venous Catheter: A Post-Hoc Analysis of the Avert Trial","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Apixaban; Ambulatory; Internal medicine; Surgery; Population; Hazard ratio; Placebo; Confidence interval; Warfarin; Atrial fibrillation","score_opus":0.009776237565555936,"score_gpt":0.2520800148401733,"score_spread":0.24230377727461735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213207497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99741876,0.00043897567,0.000016801961,0.000109977125,0.000070096095,0.0017509056,0.00012186032,0.000005023606,0.000067580746],"genre_scores_gemma":[0.9991741,0.0002790078,0.00021957862,0.0000895233,0.00002573074,0.00006125376,0.00011805211,0.000014478995,0.000018284165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988181,0.00006647358,0.00045773605,0.00021862958,0.00026030806,0.00017877138],"domain_scores_gemma":[0.999106,0.000060641098,0.00030111935,0.00028284133,0.00020587652,0.00004355344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011482506,0.00011884456,0.00086312415,0.00013902693,0.00002771303,0.0000039845527,0.00007743981,0.00005734758,0.000021582264],"category_scores_gemma":[0.000051745432,0.000083144594,0.00020546681,0.0005330311,0.000061500396,0.000036759735,0.00006119563,0.00006087611,4.0239048e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11013817,0.20892987,0.54086006,0.0048653316,0.03914095,0.000019518155,0.025812231,0.001130414,0.021360809,0.0007160005,0.00017967068,0.046847012],"study_design_scores_gemma":[0.06891959,0.003418871,0.9173014,0.00035483896,0.007304132,4.43838e-7,0.00008987966,0.000022689212,0.0024554792,0.0000152285875,0.000040432136,0.00007700062],"about_ca_topic_score_codex":0.0004952479,"about_ca_topic_score_gemma":0.00078226195,"teacher_disagreement_score":0.3764414,"about_ca_system_score_codex":0.000038164846,"about_ca_system_score_gemma":0.00022535714,"threshold_uncertainty_score":0.3390538},"labels":[],"label_agreement":null},{"id":"W3213209173","doi":"10.1182/blood-2021-154364","title":"Comparing Exercise-Induced Musculoskeletal Bleeding in Murine Models of Hemophilia A and B","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Medicine; Hemarthrosis; Complication; Coagulopathy; Treadmill; Surgery; Haemophilia; Internal medicine; Physical therapy","score_opus":0.049678834558889294,"score_gpt":0.31069525431885203,"score_spread":0.26101641975996276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213209173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932357,0.0010552082,0.0000031565091,0.0002868182,0.000021334994,0.00019678989,0.0000011107248,0.000017354876,0.005182509],"genre_scores_gemma":[0.9987087,0.00032093085,0.00053285237,0.000007446071,0.000045726905,0.000011441453,0.000009804862,0.000013373352,0.00034971474],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991236,0.000018752822,0.0002025197,0.00021664072,0.00022140829,0.00021709355],"domain_scores_gemma":[0.99958783,0.0000326813,0.000024635194,0.00017340474,0.000070742586,0.000110696485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013111251,0.000099183206,0.00035514208,0.00012804971,0.0000265963,0.0000080029395,0.000037532303,0.00006359777,0.000033331347],"category_scores_gemma":[0.00003548131,0.00008446884,0.00006187115,0.00025049862,0.000033442033,0.000063602376,0.0000903896,0.00015055531,0.0000032934731],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017470065,0.0032414384,0.5893505,0.0016191457,0.0002690619,0.0015993208,0.001142497,0.00002790415,0.39505643,0.00055289565,0.000018705547,0.0069473544],"study_design_scores_gemma":[0.02682553,0.0006704657,0.22791618,0.0024624185,0.00067549304,0.00043674724,0.0010350517,0.011064695,0.72697693,0.0015061748,0.000028472432,0.00040181397],"about_ca_topic_score_codex":0.000050729785,"about_ca_topic_score_gemma":0.0000179154,"teacher_disagreement_score":0.36143437,"about_ca_system_score_codex":0.000015979169,"about_ca_system_score_gemma":0.00007649753,"threshold_uncertainty_score":0.34445393},"labels":[],"label_agreement":null},{"id":"W3213227101","doi":"10.1182/blood-2021-145379","title":"Phase 3, Open-Label, Randomized Study of Gilteritinib and Azacitidine Vs Azacitidine for Newly Diagnosed <i>FLT3</i>-Mutated Acute Myeloid Leukemia in Patients Ineligible for Intensive Induction Chemotherapy","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Azacitidine; Myeloid leukemia; Medicine; Chemotherapy; Chemotherapy regimen; Induction chemotherapy; Internal medicine; Acute leukemia; Leukemia; Oncology; Biology; DNA methylation","score_opus":0.03491268422275007,"score_gpt":0.34731182308565184,"score_spread":0.31239913886290177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213227101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860031,0.0001927934,0.00031130484,0.0009382216,0.00013373153,0.011997735,0.00030430124,0.000048855512,0.00006992868],"genre_scores_gemma":[0.9897819,0.0006019459,0.0043917415,0.00094643375,0.00016355557,0.002458029,0.0011945188,0.00011394076,0.00034791423],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9968365,0.00024651288,0.0011072605,0.00081612344,0.00040684448,0.00058675476],"domain_scores_gemma":[0.99607086,0.00071467436,0.0003466987,0.00050014205,0.0021337909,0.00023385839],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000918283,0.00040901397,0.0018932078,0.00038399687,0.00011837794,0.00008099472,0.0002607358,0.00020993293,0.00003116293],"category_scores_gemma":[0.0022700801,0.00036633405,0.0001284204,0.0007771075,0.00018047422,0.00030885905,0.00023558682,0.00034883094,0.0000015802733],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.628468,0.0345191,0.006327803,0.0009337059,0.0042984257,0.00044039023,0.005369193,0.000009383303,0.29796255,0.000081821585,0.005736644,0.015853029],"study_design_scores_gemma":[0.8208747,0.009124111,0.0009868135,0.00025872613,0.00082447723,0.000054766228,0.0014132187,0.0006849595,0.1650456,0.00013112366,0.00029997728,0.0003015357],"about_ca_topic_score_codex":0.000280593,"about_ca_topic_score_gemma":0.000061757,"teacher_disagreement_score":0.19240674,"about_ca_system_score_codex":0.00030377827,"about_ca_system_score_gemma":0.00075440976,"threshold_uncertainty_score":0.9998789},"labels":[],"label_agreement":null},{"id":"W3213230758","doi":"10.1182/blood-2021-149145","title":"Comparative Study of Haiti and Miami Cohorts of Sickle Cell Disease (CSHSCD): Methods, Accomplishments, and Implementation","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Miami; Ethnic group; Medicine; Pediatrics; Newborn screening; Sickle cell anemia; Family medicine; Disease; Internal medicine","score_opus":0.019201763080452888,"score_gpt":0.3469883763088228,"score_spread":0.3277866132283699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213230758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945519,0.004043041,0.00004074629,0.00006895134,0.00002867239,0.00050770387,0.000028597311,0.000007969307,0.0007223941],"genre_scores_gemma":[0.9978756,0.0002753734,0.0016574935,0.00003810882,0.00000821115,0.000009889143,0.00003722299,0.0000068280574,0.000091305876],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992363,0.00010336739,0.00025129787,0.00018150774,0.0001307239,0.00009679152],"domain_scores_gemma":[0.99951595,0.000055976663,0.00010002238,0.00013841278,0.000084525214,0.000105095205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011181058,0.0000883495,0.00032202897,0.00004083288,0.00003761533,0.0000067477627,0.000020671681,0.000028696863,0.000055370743],"category_scores_gemma":[0.000014673783,0.000076142365,0.000027332082,0.000111216505,0.00005373428,0.000038259583,0.000055298733,0.00006440136,3.5928485e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022129534,0.008147644,0.9154642,0.0009141489,0.00074124156,0.00011501682,0.01089818,0.0000065467684,0.058011062,0.00009381652,0.0005117685,0.004875056],"study_design_scores_gemma":[0.017236523,0.0010744637,0.78935724,0.00011694845,0.0020278231,0.000023531467,0.0695266,0.00006722722,0.11974531,0.00016300108,0.0004884072,0.00017292648],"about_ca_topic_score_codex":0.00010111555,"about_ca_topic_score_gemma":0.000025082609,"teacher_disagreement_score":0.12610698,"about_ca_system_score_codex":0.000004302136,"about_ca_system_score_gemma":0.00005489273,"threshold_uncertainty_score":0.31049958},"labels":[],"label_agreement":null},{"id":"W3213240658","doi":"10.1182/blood-2021-154403","title":"Epor Stimulates Rapid Cycling and Larger Red Cells during Mouse and Human Erythropoiesis","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"World Anti-Doping Agency; National Institutes of Health; Partnership for Clean Competition; Gentofte Hospital; University of Massachusetts","keywords":"Erythropoietin receptor; Biology; Cell biology; Cell cycle; Erythropoiesis; Erythropoietin; Flow cytometry; Signal transduction; Cell; Molecular biology; Genetics; Internal medicine; Medicine","score_opus":0.013900532667450824,"score_gpt":0.24799465226519837,"score_spread":0.23409411959774756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213240658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997733,0.0011234668,0.0000044421154,0.0003070122,0.000092337876,0.00009163094,0.000005173218,0.00006319274,0.00057974807],"genre_scores_gemma":[0.9955827,0.00059482094,0.0006683744,0.0002902846,0.00019407277,0.0000042672823,0.000022756209,0.00002080722,0.002621897],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99926585,0.000039871065,0.0001733719,0.00027625303,0.00007419618,0.00017043816],"domain_scores_gemma":[0.9995614,0.00005059756,0.00004435104,0.00018556109,0.000052859818,0.000105218554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006332652,0.0001120483,0.00025331348,0.00005160397,0.00015669095,0.000017350743,0.000016266284,0.000090467445,0.00036107478],"category_scores_gemma":[0.00004910801,0.00010182991,0.00004261238,0.00007311376,0.000066425884,0.00003943464,0.00005451141,0.0001283335,0.000009685168],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039205544,0.0002025803,0.013213081,0.00015374747,0.00008563985,0.00020482771,0.00016967516,0.0000019854645,0.9856435,0.000016044994,0.00016099135,0.00010871138],"study_design_scores_gemma":[0.0053707776,0.00021467572,0.08316538,0.000080925725,0.00025688077,0.0003462074,0.0003048455,0.000022325798,0.9086782,0.00005512771,0.001330328,0.00017438445],"about_ca_topic_score_codex":0.000009634653,"about_ca_topic_score_gemma":0.0000062954105,"teacher_disagreement_score":0.07696536,"about_ca_system_score_codex":0.000005591699,"about_ca_system_score_gemma":0.000019127461,"threshold_uncertainty_score":0.41525033},"labels":[],"label_agreement":null},{"id":"W3213249616","doi":"10.1182/blood-2021-153374","title":"Thrombotic Events in COVID-19 Patients Undergoing Convalescent Plasma Therapy: A Systematic Review","year":2021,"lang":"en","type":"review","venue":"Blood","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; University of Ottawa; St. Joseph's Hospital; McMaster University","funders":"","keywords":"Medicine; Randomized controlled trial; Meta-analysis; Internal medicine; Relative risk; Subgroup analysis; MEDLINE; Cohort study; Confidence interval","score_opus":0.13844677470132385,"score_gpt":0.4663850649493397,"score_spread":0.3279382902480158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213249616","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000031122738,0.9879342,0.000006870049,0.00051076734,0.00015372035,0.01120978,0.000031700114,0.00006722089,0.000054675726],"genre_scores_gemma":[0.00009292877,0.99468076,0.000032727054,0.0032795533,0.00007919828,0.0013142109,0.0002061855,0.0000997814,0.00021465024],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9925045,0.0018968931,0.0025086731,0.0010022738,0.0013836719,0.0007039995],"domain_scores_gemma":[0.9807873,0.015923236,0.0009318429,0.001405822,0.00027737184,0.0006744313],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021196362,0.0006989886,0.008256882,0.00030591746,0.00010009856,0.000025163396,0.0004816355,0.00033221385,0.00014502612],"category_scores_gemma":[0.1263387,0.0004990611,0.0013391137,0.0010303237,0.000103587314,0.000057513254,0.00047234967,0.0010317216,0.0002300183],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007419132,0.002092772,0.00067788723,0.9851087,0.0016037629,0.00026271355,0.000037049405,1.7846871e-7,1.7318001e-8,0.000009860981,0.00018489982,0.010014781],"study_design_scores_gemma":[0.0051055094,0.00036649164,0.000059604212,0.93400514,0.0068745986,0.000018453211,0.00001242114,0.0000013109374,9.1297544e-8,0.000013468712,0.0531679,0.00037498682],"about_ca_topic_score_codex":0.00002165369,"about_ca_topic_score_gemma":0.000024063476,"teacher_disagreement_score":0.124219075,"about_ca_system_score_codex":0.0010191521,"about_ca_system_score_gemma":0.004980627,"threshold_uncertainty_score":0.9997461},"labels":[],"label_agreement":null},{"id":"W3213254497","doi":"10.1182/blood-2021-147386","title":"Racial, Ethnic, and Socioeconomic Factors Result in Disparities in Outcome Among Children with Acute Lymphoblastic Leukemia Not Fully Attenuated By Disease Prognosticators: A Children's Oncology Group (COG) Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Cohort; Ethnic group; Socioeconomic status; Demography; Hazard ratio; Health equity; Gerontology; Cohort study; Public health; Internal medicine; Population; Environmental health; Confidence interval; Pathology","score_opus":0.01536204820666812,"score_gpt":0.2889741822858602,"score_spread":0.27361213407919205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213254497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99578536,0.0004631583,0.000014635642,0.0004927844,0.000048204143,0.0027132586,0.00034086374,0.00010172297,0.000039991824],"genre_scores_gemma":[0.99810123,0.00014259914,0.00010773229,0.00028775012,0.0000979849,0.00040335985,0.0006294801,0.00010417124,0.00012570056],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959203,0.00040146054,0.00094532274,0.0011960049,0.000547745,0.000989176],"domain_scores_gemma":[0.9976771,0.0007090732,0.00022608305,0.0006203823,0.00011303819,0.0006543638],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043704142,0.0005559295,0.001162518,0.00039050812,0.00012778754,0.00009160066,0.0002930828,0.00031888537,0.00004517763],"category_scores_gemma":[0.00080999563,0.00047092527,0.00010317,0.00054232555,0.0006048343,0.00026080807,0.00037974212,0.00081612816,0.000022161537],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014325841,0.0032388973,0.9905006,0.000060637696,0.0010999928,0.0018016796,0.0011377468,0.000010193202,0.00031101936,0.000014448563,0.00011732432,0.00027487386],"study_design_scores_gemma":[0.034370326,0.0016264685,0.9605782,0.00015088785,0.0014656839,0.00018446421,0.0006703504,0.00018947161,0.00027870125,0.000012389577,0.0000039303086,0.00046914897],"about_ca_topic_score_codex":0.0024065021,"about_ca_topic_score_gemma":0.0034122118,"teacher_disagreement_score":0.032937743,"about_ca_system_score_codex":0.0014175035,"about_ca_system_score_gemma":0.0023460616,"threshold_uncertainty_score":0.9997742},"labels":[],"label_agreement":null},{"id":"W3213271038","doi":"10.1182/blood-2021-149696","title":"Safety and Efficacy of JAK Inhibitor Therapy in <i>BCR-ABL</i> Negative MPN Patients with Underlying Portal Hypertension","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Myelofibrosis; Internal medicine; Gastroenterology; Esophageal varices; Population; Esophagogastroduodenoscopy; Polycythemia vera; Portal hypertension; Portal hypertensive gastropathy; Clinical endpoint; Surgery; Clinical trial; Cirrhosis","score_opus":0.01884720862864479,"score_gpt":0.24555464846014396,"score_spread":0.22670743983149919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213271038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978412,0.0005713109,0.000003361743,0.00032475806,0.00003235735,0.000476371,0.000016701619,0.000011410552,0.0007225214],"genre_scores_gemma":[0.99839514,0.0005086912,0.00067840004,0.00026654164,0.000025031037,0.000016812684,0.00005962054,0.000017448097,0.00003233009],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990602,0.00004683106,0.00024330625,0.00027559182,0.00022334167,0.00015069595],"domain_scores_gemma":[0.9993295,0.0001738622,0.000082620325,0.00015644966,0.00017639021,0.00008114216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000050875267,0.00015155654,0.00037368463,0.000052418378,0.00004646521,0.000008861054,0.000018590164,0.00005745616,0.00004185437],"category_scores_gemma":[0.00007127757,0.00010282888,0.000039956416,0.00018201064,0.00004984134,0.00005350049,0.000022716526,0.0001033626,0.0000017777933],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008220155,0.00557127,0.9815865,0.00003492479,0.00028973416,0.00036478665,0.0006736123,0.0000031354562,0.002586127,0.00008186169,0.00003413649,0.007951862],"study_design_scores_gemma":[0.030540908,0.0014795617,0.9080931,0.00034669478,0.00012267628,0.000046991376,0.00018911039,0.0000059692775,0.058945846,0.00001578048,0.000106426654,0.00010696445],"about_ca_topic_score_codex":0.000044090993,"about_ca_topic_score_gemma":0.000080180485,"teacher_disagreement_score":0.073493466,"about_ca_system_score_codex":0.000017134413,"about_ca_system_score_gemma":0.00010289832,"threshold_uncertainty_score":0.419324},"labels":[],"label_agreement":null},{"id":"W3213271278","doi":"10.1182/blood-2021-154022","title":"Updated Results from a Phase II Study of Hyper-CVAD with Sequential Blinatumomab in Adults with Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Blinatumomab; Medicine; Minimal residual disease; Internal medicine; Rituximab; Cytarabine; Oncology; Chemotherapy; Acute lymphocytic leukemia; Maintenance therapy; Gastroenterology; Leukemia; Immunology; Pediatrics; Lymphoblastic Leukemia; Lymphoma","score_opus":0.01257834677322908,"score_gpt":0.2672741256543651,"score_spread":0.25469577888113604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213271278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957099,0.00013958826,0.00006490361,0.0003396667,0.000075494085,0.0019745824,0.0009498079,0.00011840521,0.0006276586],"genre_scores_gemma":[0.99583924,0.000053693282,0.0019894582,0.00011888236,0.00021178006,0.0001745664,0.0011982467,0.00013222624,0.0002819043],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99476117,0.00030596743,0.0010719454,0.0014214994,0.0015635468,0.0008758707],"domain_scores_gemma":[0.9962819,0.00068389636,0.0004523275,0.0012259398,0.0008851432,0.0004707914],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023395251,0.0006399015,0.0013068635,0.0004458581,0.00015826187,0.00004717564,0.00041599415,0.00027806958,0.00016937642],"category_scores_gemma":[0.00048056332,0.00049358176,0.00011020535,0.0021783323,0.0003330036,0.00025668327,0.00036828755,0.00071188033,0.00002906405],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.25396463,0.18773149,0.012930972,0.0008755205,0.010397971,0.19946074,0.056700345,0.002025824,0.270524,0.000023504681,0.0033282603,0.0020367655],"study_design_scores_gemma":[0.7102143,0.035066936,0.0063886154,0.0020448565,0.003079722,0.0009877369,0.007871908,0.004059222,0.22937113,0.000017646978,0.000066819455,0.00083107507],"about_ca_topic_score_codex":0.0034829408,"about_ca_topic_score_gemma":0.002229356,"teacher_disagreement_score":0.4562497,"about_ca_system_score_codex":0.0009684065,"about_ca_system_score_gemma":0.0059876214,"threshold_uncertainty_score":0.99975157},"labels":[],"label_agreement":null},{"id":"W3213274702","doi":"10.1182/blood-2021-145639","title":"Outcomes in Patients with Poor-Risk Cytogenetics with or without <i>TP53</i> Mutations Treated with Venetoclax Combined with Hypomethylating Agents","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Venetoclax; Hypomethylating agent; Medicine; Decitabine; Oncology; Cytogenetics; Internal medicine; Leukemia; Genetics; DNA methylation; Biology; Chronic lymphocytic leukemia; Gene; Chromosome","score_opus":0.017512239752694735,"score_gpt":0.27379925292779855,"score_spread":0.25628701317510383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213274702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969762,0.00003792242,0.00014750281,0.0001761571,0.000011262055,0.0016157416,0.00008170542,0.00011207231,0.0008414198],"genre_scores_gemma":[0.97834307,0.000019115952,0.019239832,0.00025536786,0.00002827613,0.0001701694,0.00036861363,0.00015839454,0.0014171324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968438,0.00018947174,0.00042314548,0.0007076026,0.0011122416,0.00072374963],"domain_scores_gemma":[0.9977576,0.0002210088,0.00025345501,0.00072325167,0.0006937912,0.00035089487],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016302035,0.00048000386,0.0008586676,0.00029415725,0.00018729572,0.00007075746,0.00017885573,0.00013559536,0.000075967284],"category_scores_gemma":[0.00017317689,0.0002687259,0.000046711153,0.0017211854,0.00022733698,0.00013809407,0.000080113066,0.0006113173,0.000016195143],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055025006,0.0014763355,0.98911035,0.00008893414,0.0010058737,0.0012010748,0.00047026615,0.0004583723,0.00021362324,0.0000035850894,0.000022486614,0.0004465941],"study_design_scores_gemma":[0.06693345,0.0105113685,0.90800685,0.0005053096,0.0012377227,0.0001750333,0.000617089,0.00035852008,0.011092031,0.0000038324147,0.00006896212,0.00048980745],"about_ca_topic_score_codex":0.00034893613,"about_ca_topic_score_gemma":0.0015133872,"teacher_disagreement_score":0.08110348,"about_ca_system_score_codex":0.0003413391,"about_ca_system_score_gemma":0.0016915257,"threshold_uncertainty_score":0.9999765},"labels":[],"label_agreement":null},{"id":"W3213296385","doi":"10.1182/blood-2021-152549","title":"Cytogenetics in Essential Thrombocythemia: Phenotype and Molecular Correlates and Prognostic Relevance in 818 Informative Cases","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Essential thrombocythemia; Medicine; Trisomy 8; Anagrelide; Cytogenetics; Internal medicine; Trisomy; Clinical significance; Polycythemia vera; Cohort; Myelofibrosis; Anemia; Gastroenterology; Karyotype; Pathology; Pediatrics; Biology; Bone marrow; Chromosome; Genetics","score_opus":0.009637452859286466,"score_gpt":0.2554097320558072,"score_spread":0.24577227919652073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213296385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926942,0.006224333,0.000016488566,0.00025635673,0.00002389175,0.00033682422,0.000009534142,0.000010048298,0.00042830224],"genre_scores_gemma":[0.99641204,0.0021525687,0.0011589663,0.000156087,0.000016020222,0.000052715048,0.000024272294,0.0000108847025,0.000016455257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992837,0.000032457803,0.00020695696,0.00020237884,0.00011121615,0.00016330706],"domain_scores_gemma":[0.9994508,0.0002755255,0.000041349394,0.00010686552,0.00005976451,0.00006568871],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000046107132,0.00013188628,0.00026802026,0.00005565859,0.000026556045,0.000020082642,0.00001697865,0.000071912524,0.000015529324],"category_scores_gemma":[0.0003857248,0.000114338785,0.000018397195,0.00015903136,0.0000628622,0.000050078223,0.000050772545,0.00013682686,0.000003988659],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060763905,0.00081012165,0.9900347,0.00013757592,0.000094733914,0.0029767933,0.001405965,0.0000138227415,0.0024616586,0.0005235974,0.000009793455,0.0014704951],"study_design_scores_gemma":[0.010581108,0.0009055483,0.72950244,0.00081786345,0.00039108057,0.0012826254,0.000699222,0.0003716636,0.25449473,0.00058637676,0.000100659134,0.00026664816],"about_ca_topic_score_codex":0.000022287415,"about_ca_topic_score_gemma":0.00018987797,"teacher_disagreement_score":0.2605322,"about_ca_system_score_codex":0.000019058407,"about_ca_system_score_gemma":0.00008819162,"threshold_uncertainty_score":0.46626002},"labels":[],"label_agreement":null},{"id":"W3213306989","doi":"10.1182/blood-2021-145276","title":"A Phase 1/2 Study of Single Agent Tagraxofusp, a First-in-Class CD123-Targeted Therapy, in Patients with Myelofibrosis That Is Relapsed/Refractory Following JAK Inhibitor Therapy","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Myelofibrosis; Internal medicine; Constitutional symptoms; Refractory (planetary science); Ruxolitinib; Gastroenterology; Myeloid; Myeloproliferative neoplasm; Oncology; Bone marrow; Disease","score_opus":0.02370567160200735,"score_gpt":0.2601668068438865,"score_spread":0.23646113524187914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213306989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953718,0.0018895076,0.0000011413438,0.00028902723,0.00013571033,0.0020799858,0.00003605545,0.0000330245,0.00016375798],"genre_scores_gemma":[0.99847347,0.0003425528,0.000195292,0.00034301085,0.000044736575,0.00038168847,0.00008119135,0.00006304434,0.00007503409],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974706,0.00017479947,0.00055635744,0.00066680793,0.00071987807,0.00041152202],"domain_scores_gemma":[0.99876404,0.0001691169,0.00021245428,0.00053983484,0.00016290904,0.000151625],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001508649,0.0004053306,0.00084555167,0.00025412228,0.00008562787,0.000032922893,0.00009465212,0.00012853612,0.00016919382],"category_scores_gemma":[0.000048760212,0.00029766117,0.00019102998,0.00064653927,0.00003535358,0.00014549073,0.000045814788,0.00022494739,0.0000060871453],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015393979,0.12522952,0.8550024,0.000032973894,0.00091011985,0.00044424902,0.0069429115,0.0000023155799,0.0046197004,0.000001316591,0.00009222093,0.005182886],"study_design_scores_gemma":[0.1399269,0.02353268,0.67188185,0.0005563847,0.0002416837,0.0000035601079,0.0014430092,0.0000054927095,0.1615347,0.0000046752925,0.00056680857,0.00030229436],"about_ca_topic_score_codex":0.00018996242,"about_ca_topic_score_gemma":0.0004727335,"teacher_disagreement_score":0.18312055,"about_ca_system_score_codex":0.00014773026,"about_ca_system_score_gemma":0.00015283453,"threshold_uncertainty_score":0.99994755},"labels":[],"label_agreement":null},{"id":"W3213308040","doi":"10.1182/blood-2021-149223","title":"The 1.5 Million Platelet Count Threshold in Essential Thrombocythemia: Phenotype and Genotype Correlates and Relevance to Vascular Events","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Essential thrombocythemia; Leukocytosis; Thrombocytosis; Internal medicine; Gastroenterology; Context (archaeology); Anemia; Platelet","score_opus":0.008706644511585376,"score_gpt":0.2457494269999107,"score_spread":0.23704278248832533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213308040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98263925,0.015250717,0.000016559688,0.0013185015,0.00010287638,0.00041647087,0.000007170077,0.000014550925,0.00023389143],"genre_scores_gemma":[0.98874795,0.010314276,0.00030292379,0.0003562787,0.0000678565,0.00005767044,0.000017406996,0.000018285595,0.00011735792],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990175,0.000032438827,0.00019096426,0.00033007475,0.00020998785,0.00021904193],"domain_scores_gemma":[0.999369,0.00017763891,0.00003638622,0.0002293292,0.00008056426,0.00010707807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013451179,0.000153192,0.00026859975,0.000030736566,0.00013312744,0.000031266198,0.000037196547,0.00008256311,0.00002428741],"category_scores_gemma":[0.00012240998,0.00010448167,0.000035495155,0.00014912596,0.0000407829,0.00004281919,0.000071511364,0.00015528302,0.000018527413],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057797914,0.0022059674,0.96276385,0.00020576951,0.0011169002,0.0011837722,0.002133207,0.00005184062,0.015074172,0.004239882,0.0006655405,0.009781119],"study_design_scores_gemma":[0.014909798,0.0010403779,0.8729005,0.00071311306,0.00073479157,0.00043453576,0.00034503487,0.00033096064,0.094655134,0.0019425931,0.011522867,0.00047029532],"about_ca_topic_score_codex":0.000023697723,"about_ca_topic_score_gemma":0.00024283095,"teacher_disagreement_score":0.08986335,"about_ca_system_score_codex":0.000029142982,"about_ca_system_score_gemma":0.00006530459,"threshold_uncertainty_score":0.42606387},"labels":[],"label_agreement":null},{"id":"W3213312927","doi":"10.1182/blood-2021-150232","title":"Efficacy and Safety of Selinexor-Containing Regimens in Patients with Multiple Myeloma Previously Treated with Anti-CD38 Monoclonal Antibodies (αCD38 mAb)","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Princess Margaret Cancer Centre; University of Alberta; Queen Elizabeth II Health Sciences Centre; Dalhousie University; CancerCare Manitoba; Vancouver General Hospital; McGill University Health Centre","funders":"","keywords":"Pomalidomide; Medicine; Carfilzomib; Internal medicine; Regimen; Population; Oncology; Refractory (planetary science); Multiple myeloma; Adverse effect; Dexamethasone; Daratumumab; Pharmacology; Gastroenterology; Bortezomib; Biology","score_opus":0.012462478136754619,"score_gpt":0.25182255970764145,"score_spread":0.23936008157088684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213312927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979626,0.0005521036,0.0000068215213,0.00008483118,0.0000070328347,0.00094016345,0.000054438347,0.000039034152,0.00035298397],"genre_scores_gemma":[0.994965,0.00015600477,0.0043182382,0.000024561936,0.000019090267,0.000023162269,0.0003299226,0.000038215196,0.00012580925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822503,0.00009140242,0.0003468141,0.00046178818,0.00042449575,0.00045044927],"domain_scores_gemma":[0.9988268,0.00018106599,0.00012343115,0.00035194893,0.00030071137,0.00021603318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011485624,0.00026306827,0.00062650733,0.00015272517,0.00007606721,0.000019339932,0.000059880902,0.00007813478,0.000034515233],"category_scores_gemma":[0.00019487948,0.0001804098,0.00004543295,0.000346179,0.00012919065,0.00009691502,0.000066752655,0.00018509034,0.0000034229795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00609724,0.0027460144,0.98563457,0.00015848603,0.00070583785,0.0008775119,0.00035016882,0.000010658652,0.0012101162,0.000008802689,0.0000070587084,0.002193517],"study_design_scores_gemma":[0.06469554,0.002301884,0.92146426,0.00075195497,0.0002630893,0.00008467884,0.00012827161,0.00010777848,0.010007951,0.0000015108548,0.000024159088,0.00016889414],"about_ca_topic_score_codex":0.00017163488,"about_ca_topic_score_gemma":0.00018745603,"teacher_disagreement_score":0.0641703,"about_ca_system_score_codex":0.00003896124,"about_ca_system_score_gemma":0.00019470979,"threshold_uncertainty_score":0.7356898},"labels":[],"label_agreement":null},{"id":"W3213323850","doi":"10.1182/blood-2021-153879","title":"Toll-like Receptor-3 Ligation Induces Pro-Survival Signaling in Pediatric Acute Lymphoblastic Leukemia","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Neonatal Respiratory Health Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Children's Hospital","funders":"","keywords":"Leukemia; Immunology; TLR3; Toll-like receptor; Cancer research; TLR9; Receptor; Biology; In utero; Medicine; Immune system; Internal medicine; Innate immune system; DNA methylation; Pregnancy; Fetus; Gene; Genetics","score_opus":0.03786919844271704,"score_gpt":0.3297007291723289,"score_spread":0.2918315307296119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213323850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947831,0.0031430142,0.00001731887,0.0003483242,0.0002898813,0.00043750994,0.000008361336,0.000061850194,0.000910626],"genre_scores_gemma":[0.9968013,0.00066845154,0.0007247267,0.0003699121,0.00068104366,0.00007980455,0.000043074582,0.0000410188,0.00059066305],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976959,0.00016496472,0.00044071444,0.0004398779,0.00076015375,0.00049837487],"domain_scores_gemma":[0.9987993,0.00027511007,0.00008777346,0.0003016238,0.00023470561,0.00030146504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054473884,0.00016426189,0.000339158,0.0002572821,0.00008085198,0.000034281566,0.000120502984,0.00018130496,0.0001675429],"category_scores_gemma":[0.00075680483,0.00016099983,0.00006421876,0.0009914954,0.000032740198,0.00012584416,0.00009726262,0.00044946972,0.0002084391],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080972846,0.0017210307,0.15177469,0.00365549,0.00028068395,0.004523893,0.00093867595,0.000050872586,0.8027581,0.0002489817,0.00042365782,0.03281419],"study_design_scores_gemma":[0.023026522,0.0015600241,0.11860223,0.00089767604,0.00081514125,0.00039986803,0.00054889865,0.00023967847,0.84192044,0.00027102296,0.010845563,0.00087292795],"about_ca_topic_score_codex":0.000034269568,"about_ca_topic_score_gemma":0.000031621883,"teacher_disagreement_score":0.03916235,"about_ca_system_score_codex":0.00034860996,"about_ca_system_score_gemma":0.003104574,"threshold_uncertainty_score":0.65653825},"labels":[],"label_agreement":null},{"id":"W3213371026","doi":"10.1182/blood-2021-148481","title":"Late vs Early Response and Depth of Response Are Associated with Improved Outcomes in Newly Diagnosed Multiple Myeloma (NDMM) Patients (pts) Treated with Ixazomib-Lenalidomide-Dexamethasone (IRd) or Placebo-Lenalidomide-Dexamethasone (pbo-Rd) in the Phase 3 TOURMALINE-MM2 Trial","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Queen Elizabeth II Health Sciences Centre; Institute of Cancer Research; University of Calgary; University of Alberta","funders":"","keywords":"Lenalidomide; Ixazomib; Dexamethasone; Multiple myeloma; Medicine; Internal medicine; Oncology; Placebo; Carfilzomib; Pathology","score_opus":0.02882644790991139,"score_gpt":0.30070417148720346,"score_spread":0.27187772357729206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213371026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99295574,0.00021560662,0.000012550785,0.0009802933,0.000046509384,0.005164556,0.0005031154,0.00009472994,0.000026866132],"genre_scores_gemma":[0.9965182,0.00008097919,0.0012432601,0.00022234351,0.000058292557,0.0007804013,0.00024492628,0.00014413612,0.0007074774],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99005646,0.004887244,0.0013685641,0.0011483534,0.001339367,0.0012000266],"domain_scores_gemma":[0.9844116,0.012506636,0.00078752,0.0011117688,0.00065618154,0.0005262745],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0035526203,0.0008421966,0.002069815,0.00076533284,0.00017535427,0.00013554073,0.0003567727,0.00039360547,0.00007395315],"category_scores_gemma":[0.021931907,0.0004993214,0.00024155606,0.0017940195,0.0003610202,0.0003116948,0.00015433051,0.0008608738,0.0000075475423],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5018038,0.009988661,0.47404832,0.000055128017,0.00094546535,0.0051873713,0.001188835,0.0000073905867,0.005880845,2.8697428e-7,0.000016757927,0.00087714306],"study_design_scores_gemma":[0.42503142,0.011066663,0.545157,0.0005688977,0.00049646123,0.000048260616,0.0006992069,0.00022148012,0.016356854,0.0000022027707,0.000014987139,0.0003365605],"about_ca_topic_score_codex":0.0017528164,"about_ca_topic_score_gemma":0.008991157,"teacher_disagreement_score":0.07677237,"about_ca_system_score_codex":0.00028694826,"about_ca_system_score_gemma":0.0009953439,"threshold_uncertainty_score":0.99974585},"labels":[],"label_agreement":null},{"id":"W3213373125","doi":"10.1182/blood-2021-147941","title":"Intravenous Immunoglobulin in the Management of Severe Early Onset Red Blood Cell Alloimmunization","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Gestation; Pregnancy; Fetus; Anemia; Obstetrics; Gestational age; Blood transfusion; Pediatrics; Surgery; Internal medicine","score_opus":0.007004405129520927,"score_gpt":0.20713294690373324,"score_spread":0.2001285417742123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213373125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895995,0.0014545879,0.000025308673,0.0005270844,0.00004682124,0.00036116698,0.000009698009,0.000018684035,0.0079571195],"genre_scores_gemma":[0.99659,0.0010716069,0.0016977182,0.00014998628,0.00002522722,0.00001376108,0.00008936302,0.000016570566,0.00034572414],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901015,0.00007869853,0.00029080315,0.00018894745,0.00025843995,0.00017295605],"domain_scores_gemma":[0.99935234,0.000026509304,0.000057499015,0.0004626069,0.000072183575,0.000028857316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020592917,0.00011256173,0.00020838017,0.000049899372,0.00004629634,0.000014782182,0.0001317696,0.00008011483,0.00008975977],"category_scores_gemma":[0.0000057249144,0.000088233064,0.00007368574,0.00041891442,0.000024207657,0.000035030695,0.000043044012,0.0001875842,0.000009532363],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014249204,0.08405412,0.5583523,0.006204852,0.004845143,0.01529674,0.027034111,0.00012340845,0.27201247,0.0045412206,0.00050821045,0.025602508],"study_design_scores_gemma":[0.013466637,0.0006293816,0.9100974,0.0005086012,0.0017234023,0.00052698917,0.0014695786,0.0000060567063,0.070605285,0.00023956237,0.0005504707,0.00017662792],"about_ca_topic_score_codex":0.000108674896,"about_ca_topic_score_gemma":0.000026038306,"teacher_disagreement_score":0.35174513,"about_ca_system_score_codex":0.0000066141206,"about_ca_system_score_gemma":0.00004149374,"threshold_uncertainty_score":0.35980397},"labels":[],"label_agreement":null},{"id":"W3213387284","doi":"10.1182/blood-2021-144454","title":"Nonmyeloablative HLA-Identical Sibling Donor Transplantation for Children and Young Adults with Sickle Cell Disease: Interim Results of the SUN Multicenter Phase II Trial","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Children's Hospital; Hospital for Sick Children","funders":"","keywords":"Medicine; Alemtuzumab; Hematopoietic stem cell transplantation; Total body irradiation; Transplantation; Regimen; Internal medicine; Pediatrics; Chemotherapy; Cyclophosphamide","score_opus":0.006959898951671165,"score_gpt":0.2504574193770873,"score_spread":0.24349752042541617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213387284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971164,0.00041239892,0.00021428187,0.00046697253,0.00012361993,0.0011446706,0.00031051243,0.000014667878,0.00019646177],"genre_scores_gemma":[0.99870175,0.00020502099,0.00042938016,0.00005511682,0.000081458544,0.000022326565,0.0002441921,0.000016065998,0.00024468414],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99908423,0.000041381758,0.0003097408,0.00024672953,0.00015927176,0.00015867123],"domain_scores_gemma":[0.9994529,0.000062757135,0.000106747495,0.00016273186,0.00011256082,0.00010230761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010004859,0.0001181699,0.000198878,0.000037270598,0.000107075844,0.000014341363,0.000046140725,0.0000658724,0.0000102819895],"category_scores_gemma":[0.000117968746,0.000074096955,0.00009520727,0.00012979431,0.00008438935,0.000057736288,0.000023263578,0.00012484114,5.3574746e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8651598,0.028142406,0.029347055,0.0022803496,0.0016094968,0.0002946685,0.02755358,0.000045829853,0.037146088,0.00010580558,0.0005568262,0.0077581033],"study_design_scores_gemma":[0.84640914,0.0060326783,0.037449494,0.0016634171,0.003948523,0.00009487011,0.0018582277,0.0009320687,0.10116902,0.000022190276,0.00011484618,0.00030555332],"about_ca_topic_score_codex":0.000040356015,"about_ca_topic_score_gemma":0.000050809413,"teacher_disagreement_score":0.06402293,"about_ca_system_score_codex":0.000006999069,"about_ca_system_score_gemma":0.00008723554,"threshold_uncertainty_score":0.3021586},"labels":[],"label_agreement":null},{"id":"W3213388135","doi":"10.1182/blood-2021-147678","title":"The Evolution of Children's Oncology Group Hodgkin Lymphoma Trials: Predicted Impact on Late Cardiac Toxicity","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hôtel-Dieu de Québec; University of Alberta; University of British Columbia; Public Health Ontario; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Radiation therapy; Internal medicine; Clinical trial; Coronary artery disease; Oncology; Cog; Disease; Toxicity; Surgery; Cardiology","score_opus":0.015777825713958193,"score_gpt":0.2942446136437423,"score_spread":0.27846678792978413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213388135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950335,0.0011081039,0.00010047244,0.00041995125,0.00027374286,0.0005838355,0.00012354215,0.00006243619,0.0022943835],"genre_scores_gemma":[0.9984476,0.00044722675,0.00010658297,0.00011971844,0.0005874973,0.000026590791,0.00012608929,0.000021096348,0.000117612166],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980516,0.0006483415,0.0004521694,0.00026291827,0.00033791162,0.00024709888],"domain_scores_gemma":[0.9985093,0.0005493528,0.00024035259,0.00043426018,0.00015694556,0.00010981864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012147188,0.00016823219,0.000695646,0.00006429556,0.0001190389,0.000015933689,0.00007982703,0.0002487172,0.000030637602],"category_scores_gemma":[0.0008277038,0.00011300534,0.0005674951,0.000317499,0.00009038334,0.000046309724,0.00002743611,0.00016775285,0.0000055744604],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093986903,0.0014356564,0.011310609,0.000026791584,0.0019260058,0.000022337346,0.000266799,0.000017287448,0.9443975,0.00047999294,0.000555204,0.038621936],"study_design_scores_gemma":[0.006887835,0.0011121588,0.3071319,0.00008300348,0.0005973816,0.0000769031,0.00010820896,0.000025206626,0.6832302,0.00022356615,0.00042449645,0.00009911684],"about_ca_topic_score_codex":0.0001246261,"about_ca_topic_score_gemma":0.000016979455,"teacher_disagreement_score":0.29582125,"about_ca_system_score_codex":0.00036671318,"about_ca_system_score_gemma":0.0005336686,"threshold_uncertainty_score":0.4608224},"labels":[],"label_agreement":null},{"id":"W3213408194","doi":"10.1182/blood-2021-151294","title":"<i>Thiol Isomerase Activity of</i> <i>β</i> <i>3 Integrin Psi Domain and L33P Polymorphism: Implications in Blood Coagulation and Anti-Thrombotic Therapy</i>","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Axon Guidance and Neuronal Signaling","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Integrin; Platelet; CD47; Platelet activation; Coagulation; Fibrinogen; Hemostasis; Chemistry; Molecular biology; Biology; Cell biology; Biochemistry; Receptor; Immunology; Medicine; Internal medicine","score_opus":0.03316675975626466,"score_gpt":0.2642181039868545,"score_spread":0.23105134423058987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213408194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99730855,0.0011168043,0.0001640203,0.0007864829,0.000045622295,0.00024494747,0.00004089039,0.000034386932,0.00025828002],"genre_scores_gemma":[0.9965916,0.0022012559,0.00019635206,0.00090789597,0.00003592137,0.000022694583,0.0000030336996,0.000020643509,0.000020549885],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998533,0.00020652074,0.000294926,0.000530364,0.0001828001,0.00025235658],"domain_scores_gemma":[0.9991156,0.00033393546,0.00014284057,0.00028233617,0.000036433154,0.000088872395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017374191,0.00017825923,0.0002990296,0.00009130634,0.00013182164,0.000041460145,0.00011488875,0.000082775165,0.0000179214],"category_scores_gemma":[0.00011873844,0.00017563207,0.00004865738,0.0004912443,0.00016472573,0.00030424705,0.00009632649,0.00021671302,0.0000021985202],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018663402,0.0006540374,0.038560253,0.000020793794,0.000009015454,0.00003375451,0.00015743813,0.000007100912,0.9577183,0.0012406793,0.0000057386055,0.0015742122],"study_design_scores_gemma":[0.0020363259,0.000081268314,0.08529088,0.000051649684,0.00003182403,0.00017594414,0.00002692264,0.000021619913,0.9109385,0.0010778737,0.00010042517,0.0001667928],"about_ca_topic_score_codex":0.00005946587,"about_ca_topic_score_gemma":0.000024351782,"teacher_disagreement_score":0.046779837,"about_ca_system_score_codex":0.000007185111,"about_ca_system_score_gemma":0.00007970296,"threshold_uncertainty_score":0.71620685},"labels":[],"label_agreement":null},{"id":"W3213442100","doi":"10.1182/blood-2021-148942","title":"Risk Stratification for Relapsed/Refractory Classical Hodgkin Lymphoma Integrating Pretransplant Deauville Score and Residual Metabolic Tumor Volume","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Women's College Hospital; Dalhousie University; University Health Network; University of Toronto; Mount Sinai Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; ABVD; Internal medicine; Dacarbazine; Autologous stem-cell transplantation; Oncology; Vinblastine; Standardized uptake value; Salvage therapy; Nuclear medicine; Positron emission tomography; Transplantation; Vincristine; Chemotherapy; Cyclophosphamide","score_opus":0.015066095320018794,"score_gpt":0.24699186625536168,"score_spread":0.2319257709353429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213442100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99249536,0.005357357,0.00016819272,0.0005122801,0.00010107602,0.0005293757,0.00020420371,0.0000622779,0.0005698794],"genre_scores_gemma":[0.99124503,0.00065197865,0.0068030558,0.00012964367,0.00023801682,0.00022091909,0.0003431229,0.00003004788,0.00033818782],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986525,0.00008749329,0.00033315088,0.0004533891,0.00022005675,0.0002534183],"domain_scores_gemma":[0.9990368,0.00021410728,0.00013053593,0.00031123,0.00013897495,0.0001683595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017194175,0.00020125195,0.00037115152,0.000056697056,0.00016442499,0.000058832764,0.000049320388,0.00010783683,0.000028508366],"category_scores_gemma":[0.0002953549,0.000159545,0.00011508298,0.00012172912,0.00006388131,0.000085961394,0.000019487472,0.00009726676,0.000013017989],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006025208,0.008593483,0.85005534,0.00041953463,0.0014823552,0.0008185721,0.0013789545,0.0000016122274,0.033918202,0.009954127,0.0026248887,0.090150416],"study_design_scores_gemma":[0.014941434,0.00091099023,0.8737293,0.00028620384,0.0024738023,0.0005354263,0.00041740751,0.00031040836,0.097104274,0.00029236235,0.008728409,0.0002699754],"about_ca_topic_score_codex":0.00006520162,"about_ca_topic_score_gemma":0.00013985121,"teacher_disagreement_score":0.08988044,"about_ca_system_score_codex":0.00004656385,"about_ca_system_score_gemma":0.00031893427,"threshold_uncertainty_score":0.6506056},"labels":[],"label_agreement":null},{"id":"W3213453147","doi":"10.1182/blood-2021-153587","title":"Thrombin Generation to Predict the Risk of Venous Thromboembolism Recurrence, Major Bleeding and Death in the Elderly: A Prospective Multicenter Cohort Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pulmonary embolism; Prospective cohort study; Thrombosis; Cohort; Cohort study; Internal medicine; Population; Incidence (geometry); Intensive care medicine; Surgery","score_opus":0.01670872741360228,"score_gpt":0.2705066046499654,"score_spread":0.2537978772363631,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213453147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935937,0.0007160984,0.00003860525,0.00052546937,0.0001613103,0.0036172268,0.000014682753,0.00001891395,0.0013139833],"genre_scores_gemma":[0.9982932,0.0005218413,0.00023035133,0.0002607904,0.00018784234,0.00045484272,0.0000105551835,0.000017801969,0.000022745848],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837023,0.00022873172,0.0003337866,0.00040699134,0.00041532845,0.0002449124],"domain_scores_gemma":[0.9991262,0.0001090233,0.00011322361,0.00045277656,0.0001419156,0.000056839104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008925647,0.00016904532,0.00050003704,0.00007984164,0.0001729907,0.000059391892,0.00014091014,0.0000481394,0.000024784133],"category_scores_gemma":[0.00022302032,0.00010169222,0.0000615252,0.00035352548,0.000040023224,0.00006659302,0.00012669242,0.00023266544,0.0000043986433],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023055589,0.008879657,0.9723695,0.000050111787,0.00076958456,0.00006383669,0.014632847,0.00001797214,0.0012789433,0.00056258717,0.0004423799,0.00090950506],"study_design_scores_gemma":[0.0028360074,0.0017245051,0.9861557,0.0000943007,0.0019595495,0.00002531553,0.004502547,0.00011099709,0.0022580894,0.00014876507,0.000080875834,0.00010335586],"about_ca_topic_score_codex":0.00045196808,"about_ca_topic_score_gemma":0.00062864553,"teacher_disagreement_score":0.013786172,"about_ca_system_score_codex":0.000031962656,"about_ca_system_score_gemma":0.00006072305,"threshold_uncertainty_score":0.41468883},"labels":[],"label_agreement":null},{"id":"W3213475946","doi":"10.1182/blood-2021-150689","title":"Cognitive Profile of Adults with Sickle Cell Disease - Cluster Analysis","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; University Health Network","funders":"","keywords":"Neuropsychology; Montreal Cognitive Assessment; Anxiety; Cognition; Medicine; Hospital Anxiety and Depression Scale; Neuropsychological assessment; Depression (economics); Executive functions; Effects of sleep deprivation on cognitive performance; Clinical psychology; Psychiatry; Pediatrics; Psychology; Cognitive impairment","score_opus":0.004084132329953132,"score_gpt":0.21178228590280748,"score_spread":0.20769815357285434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213475946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872571,0.0012906728,0.0001156916,0.00030596607,0.00001368347,0.00022329002,0.000060767226,0.000020708554,0.010712091],"genre_scores_gemma":[0.9973206,0.00008419071,0.00033433366,0.00027168423,0.000020155232,0.00001292048,0.00020654175,0.000012148304,0.0017374617],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99931973,0.00002685343,0.0001401142,0.00019858898,0.00017639567,0.00013833016],"domain_scores_gemma":[0.9993778,0.000029877163,0.0000555478,0.00017620683,0.00020952775,0.00015106336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003184282,0.0000884735,0.00023319392,0.00006777383,0.000026868089,0.0000047072463,0.000024510286,0.000050532904,0.00043296147],"category_scores_gemma":[0.000044647324,0.00006272073,0.00012649475,0.00056237343,0.000054195552,0.000023367635,0.00002296205,0.000095769006,0.000024310993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052674254,0.01738784,0.9474538,0.002671884,0.009279083,0.0032116366,0.0050116703,0.00013722954,0.004542883,0.00005368532,0.0014901183,0.003492727],"study_design_scores_gemma":[0.094947435,0.0028141001,0.44788155,0.0029195147,0.10302687,0.00013159437,0.024381751,0.0032971797,0.31813028,0.00005531927,0.0012073487,0.0012070615],"about_ca_topic_score_codex":0.000021398899,"about_ca_topic_score_gemma":0.000016194937,"teacher_disagreement_score":0.49957228,"about_ca_system_score_codex":0.0000040013274,"about_ca_system_score_gemma":0.00015606178,"threshold_uncertainty_score":0.47406244},"labels":[],"label_agreement":null},{"id":"W3213484399","doi":"10.1182/blood-2021-152922","title":"Molecular Characterization Using Oncoscan Chromosome Microarray in an International Cohort of 51 Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Hematopathology; Pathology; Tissue microarray; Cancer; Hematologic malignancy; Malignancy; Internal medicine; Oncology; Cytogenetics; Chromosome; Biology","score_opus":0.008523603842332797,"score_gpt":0.25603465460969815,"score_spread":0.24751105076736535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213484399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988349,0.00004402554,0.00015366773,0.000029641425,0.00006747955,0.0004905494,0.000070310605,0.0000148587405,0.00029454814],"genre_scores_gemma":[0.99827874,0.000035038112,0.0006099202,0.000073431795,0.000033457552,0.00001888861,0.0008607198,0.000040926985,0.000048861883],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998456,0.00008649499,0.0003034058,0.00036129978,0.0005417319,0.00025106393],"domain_scores_gemma":[0.998952,0.0000332565,0.00009480845,0.00025165628,0.00055036525,0.00011794299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000061648825,0.0001601209,0.00029461662,0.00021166533,0.000033403547,0.000031395135,0.00011018087,0.000074153955,0.00013287162],"category_scores_gemma":[0.00010720055,0.00015862338,0.000043118984,0.000335216,0.000073791525,0.00014082917,0.000051164257,0.00014728835,0.0000060913667],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013166167,0.0017798019,0.5185864,0.000050949184,0.00005738339,0.0003001086,0.00014049,0.000060289552,0.47879884,0.0000029843427,2.216512e-7,0.000090858855],"study_design_scores_gemma":[0.0073795235,0.00048117692,0.39937207,0.00018618628,0.00008185476,0.00029380762,0.0000742878,0.0016696001,0.59027916,0.0000029291245,0.00002115347,0.0001582702],"about_ca_topic_score_codex":0.000034136032,"about_ca_topic_score_gemma":0.000064586406,"teacher_disagreement_score":0.11921434,"about_ca_system_score_codex":0.00012739727,"about_ca_system_score_gemma":0.0004824724,"threshold_uncertainty_score":0.6468474},"labels":[],"label_agreement":null},{"id":"W3213505659","doi":"10.1182/blood-2021-146009","title":"Emicizumab Prophylaxis in Persons with Mild or Moderate Hemophilia A: Results from the Interim Analysis of the HAVEN 6 Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Interim analysis; Adverse effect; Internal medicine; Interim; Clinical trial; Pediatrics","score_opus":0.04782236675874249,"score_gpt":0.31172896652864024,"score_spread":0.2639065997698977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213505659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951211,0.00020771302,9.550898e-7,0.0033046266,0.000020348205,0.0006586344,0.00013285001,0.000010401931,0.00054337905],"genre_scores_gemma":[0.9963859,0.000021341311,0.00009311402,0.00006622219,0.00004402781,0.00003464073,0.000045592762,0.000013912493,0.0032952486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985156,0.00021630699,0.00028096387,0.0003471366,0.00043661543,0.00020335188],"domain_scores_gemma":[0.99876225,0.00020702464,0.00006701315,0.0007834858,0.00012521009,0.000054997585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021740119,0.00013802972,0.0004141841,0.00010216706,0.000089974135,0.000021993772,0.00018649823,0.00005705757,0.00007764627],"category_scores_gemma":[0.00021218637,0.0000547173,0.00014094468,0.0014406502,0.00009834954,0.000025776493,0.00012129809,0.00028366927,0.0000034774282],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077880877,0.011945521,0.918229,0.00005219942,0.012000137,0.0017731094,0.03774609,0.000110631714,0.008809511,0.00000765916,0.00027748506,0.0012605627],"study_design_scores_gemma":[0.02524998,0.0027848214,0.8922189,0.00038791247,0.0068039475,0.00003359548,0.023060568,0.0014061263,0.04772053,0.000021749902,0.00008989015,0.00022196877],"about_ca_topic_score_codex":0.0009515544,"about_ca_topic_score_gemma":0.00643529,"teacher_disagreement_score":0.03891102,"about_ca_system_score_codex":0.000039155562,"about_ca_system_score_gemma":0.00029019135,"threshold_uncertainty_score":0.3591043},"labels":[],"label_agreement":null},{"id":"W3213513316","doi":"10.1182/blood-2021-147156","title":"Bone Mineral Density Remains Stable in Pyruvate Kinase Deficiency Patients Receiving Long-Term Treatment with Mitapivat","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Pyruvate kinase deficiency; Pyruvate kinase; Internal medicine; Anemia; Hemolysis; Bone mineral; Gastroenterology; Population; Osteoporosis; Glycolysis","score_opus":0.01578986110846964,"score_gpt":0.23520496004121044,"score_spread":0.2194150989327408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213513316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978974,0.00037878967,0.000015435164,0.00012006461,0.00013289493,0.00023999791,0.0000068737977,0.00004122428,0.0011673354],"genre_scores_gemma":[0.9967583,0.0001757549,0.00067192485,0.0002884703,0.000076618846,0.000017669432,0.00015764007,0.000019223879,0.0018343901],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99889153,0.000066736946,0.0002144075,0.00036184056,0.00015675736,0.0003087032],"domain_scores_gemma":[0.99933845,0.000037392198,0.000063830346,0.000312272,0.00013348799,0.00011456463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005619639,0.00016752542,0.00033241656,0.000082836785,0.00006722202,0.000011096801,0.000027863804,0.00007784253,0.000103433726],"category_scores_gemma":[0.000058851838,0.0001291274,0.00006049309,0.00028710128,0.0000400393,0.00005636262,0.000030968302,0.000114706876,0.000029205],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025233044,0.0032714703,0.9092246,0.000068492795,0.00003683492,0.0015187135,0.000270088,0.0000036783806,0.08421436,0.000010406768,0.000046210116,0.0010828011],"study_design_scores_gemma":[0.00924426,0.0016091848,0.9612979,0.00015334027,0.00014618253,0.00012751449,0.00005826458,0.000007700266,0.027092211,0.0000072580788,0.00010538534,0.00015077047],"about_ca_topic_score_codex":0.000049806153,"about_ca_topic_score_gemma":0.0011250402,"teacher_disagreement_score":0.057122152,"about_ca_system_score_codex":0.00010200191,"about_ca_system_score_gemma":0.00014353704,"threshold_uncertainty_score":0.5265662},"labels":[],"label_agreement":null},{"id":"W3213514829","doi":"10.1182/blood-2021-145131","title":"Very Elderly Patients with Myeloproliferative Neoplasms: Phenotypic Distinctions and Prognostic Determinants of Complications and Mortality","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; Hôpital de l'Enfant-Jésus; Centre Hospitalier de l’Université de Montréal; McGill University; Quebec - Clinical Research Organization in Cancer; McGill University Health Centre; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Thrombocytosis; Leukocytosis; Myelofibrosis; Internal medicine; Polycythemia vera; Incidence (geometry); Population; Gastroenterology; Surgery; Pediatrics; Bone marrow; Platelet","score_opus":0.014934982506050255,"score_gpt":0.2589592871307675,"score_spread":0.24402430462471725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213514829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998071,0.00041080007,0.000043287495,0.00012961017,0.000022951988,0.0006339471,0.00012463146,0.000021422567,0.0005423408],"genre_scores_gemma":[0.9979157,0.00009389401,0.0015621755,0.00007740048,0.000018718505,0.0001810772,0.000108809014,0.0000146852835,0.000027571297],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990324,0.000043945904,0.0002493365,0.00033681432,0.00018175654,0.00015575191],"domain_scores_gemma":[0.99901843,0.000169199,0.000104699604,0.00023219104,0.00033578498,0.00013967733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000037446924,0.00016865616,0.000338262,0.000042647283,0.00015114014,0.000023480685,0.000023598239,0.00004907533,0.00002141996],"category_scores_gemma":[0.00013031726,0.00012729222,0.000030395197,0.00014496536,0.00015292787,0.00007193168,0.0000391936,0.000085573636,0.0000025438592],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038346647,0.0021865778,0.9943731,0.000113499395,0.00027739073,0.000027401133,0.0002791639,4.2685338e-7,0.00007521625,0.00039468103,0.000009456324,0.0022247701],"study_design_scores_gemma":[0.0041101417,0.0009238135,0.9894667,0.00020146609,0.00076515554,0.00007171569,0.000088038854,0.000029860228,0.004055301,0.00013183177,0.000038837363,0.00011712357],"about_ca_topic_score_codex":0.000024694054,"about_ca_topic_score_gemma":0.00027789857,"teacher_disagreement_score":0.004906355,"about_ca_system_score_codex":0.0000133824915,"about_ca_system_score_gemma":0.00013289538,"threshold_uncertainty_score":0.51908267},"labels":[],"label_agreement":null},{"id":"W3213532983","doi":"10.1182/blood-2021-151683","title":"Propensity Score Matching Analysis Comparing Ruxolitinib Vs Historical Controls in 2 nd Line or Beyond Treatment for Chronic Gvhd after Therapy Failure","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; London Health Sciences Centre; Western University; Vancouver General Hospital; Saskatchewan Cancer Agency; University of Saskatchewan; BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Prednisone; Ruxolitinib; Internal medicine; Rituximab; Salvage therapy; Retrospective cohort study; Propensity score matching; Corticosteroid; Surgery; Gastroenterology; Chemotherapy; Myelofibrosis; Lymphoma","score_opus":0.07654796442627441,"score_gpt":0.32601916825522376,"score_spread":0.24947120382894933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213532983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99248886,0.0039016842,0.00019796484,0.0015345156,0.000056001238,0.0013742299,0.000022286493,0.000041454332,0.00038300265],"genre_scores_gemma":[0.9907196,0.00027554954,0.00086271786,0.00021641585,0.00045298526,0.00042334246,0.00013680794,0.00004309089,0.006869475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99809426,0.000120696815,0.0004084405,0.000521373,0.00034794377,0.0005072855],"domain_scores_gemma":[0.99879724,0.00024737912,0.00007381991,0.00051468384,0.00018164793,0.00018523162],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002967929,0.00024563423,0.0010398662,0.0002257911,0.00007493986,0.000056071836,0.00009790991,0.00012239588,0.0023740595],"category_scores_gemma":[0.000072145056,0.00017658768,0.00038443442,0.00056111446,0.000035777917,0.00005864913,0.000047842885,0.0002545653,0.000008907049],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01686248,0.00864499,0.7377282,0.0003884971,0.007989038,0.0028187954,0.0023789709,0.00018528094,0.1896837,0.000062493,0.00022955521,0.03302802],"study_design_scores_gemma":[0.1478088,0.0103699835,0.6151176,0.00045319888,0.00608227,0.00039924454,0.0003247083,0.0017950931,0.1493544,0.00032612807,0.06669411,0.0012744302],"about_ca_topic_score_codex":0.00039524736,"about_ca_topic_score_gemma":0.004245752,"teacher_disagreement_score":0.13094632,"about_ca_system_score_codex":0.0011592988,"about_ca_system_score_gemma":0.0004976107,"threshold_uncertainty_score":0.9985379},"labels":[],"label_agreement":null},{"id":"W3213536518","doi":"10.1182/blood-2021-148859","title":"Update of Multicenter, Retrospective Evaluation of Overall Response and Failure Free Survival Following Ruxolitinib Therapy for Heavily Pre-Treated Chronic Gvhd Patients with Steroid-Failure: A Proposal of Risk Score Model for Failure-Free Survival","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; BC Cancer Agency; Princess Margaret Cancer Centre; University of Toronto; University Health Network; University of Saskatchewan; Vancouver General Hospital","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Ruxolitinib; Proportional hazards model; Refractory (planetary science); Retrospective cohort study; Surgery; Myelofibrosis; Bone marrow; Confidence interval","score_opus":0.014976947645831813,"score_gpt":0.2692817938590268,"score_spread":0.254304846213195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213536518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895828,0.0011187115,0.00086751214,0.00025997087,0.0000888815,0.0048555536,0.0031705056,0.000048385144,0.000007722979],"genre_scores_gemma":[0.9892069,0.000034964218,0.009631687,0.000014280687,0.000048690174,0.00030733086,0.0006220546,0.000104618324,0.000029455528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963192,0.00051415997,0.0008166489,0.00066817575,0.0012349273,0.00044688498],"domain_scores_gemma":[0.99521464,0.00047532676,0.00078625727,0.0011463376,0.002250179,0.00012728588],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012724303,0.00040677688,0.0010682055,0.00015997759,0.00010675864,0.000022271277,0.00027536493,0.00016947876,0.000028205422],"category_scores_gemma":[0.00272258,0.00034296588,0.00035546342,0.00024949384,0.00017740707,0.00020420115,0.000157218,0.00017465673,1.8084836e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.046135508,0.0070855785,0.9052976,0.0011387027,0.0034736877,0.000013047869,0.0021369357,0.00048458975,0.033050623,0.00020114532,0.00026443222,0.00071818335],"study_design_scores_gemma":[0.12425448,0.0042169597,0.80682105,0.0007901285,0.0035757143,0.0000037674208,0.00038685085,0.008309071,0.050046515,0.0011995534,0.00001454169,0.00038139697],"about_ca_topic_score_codex":0.00014120062,"about_ca_topic_score_gemma":0.00080795836,"teacher_disagreement_score":0.098476544,"about_ca_system_score_codex":0.00017646664,"about_ca_system_score_gemma":0.0013858469,"threshold_uncertainty_score":0.99990225},"labels":[],"label_agreement":null},{"id":"W3213547762","doi":"10.1182/blood-2021-151105","title":"Brentuximab Vedotin Plus Cyclophosphamide, Doxorubicin, Etoposide, and Prednisone (CHEP-BV) Followed By BV Consolidation in Patients with CD30-Expressing Peripheral T-Cell Lymphomas","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Brentuximab vedotin; Medicine; Etoposide; Internal medicine; Anaplastic large-cell lymphoma; Vincristine; CHOP; CD30; Oncology; Cyclophosphamide; Chemotherapy regimen; Chemotherapy; Prednisone; Autologous stem-cell transplantation; Lymphoma; Gastroenterology","score_opus":0.004026462495773129,"score_gpt":0.200203021382474,"score_spread":0.19617655888670088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213547762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99283355,0.004153161,0.000012904406,0.0002213128,0.000101296566,0.0006431829,0.000053981876,0.000057410853,0.0019232114],"genre_scores_gemma":[0.9969277,0.00023862315,0.0013212129,0.0003125475,0.00004153284,0.00009505229,0.00049587287,0.00004824917,0.0005192314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981021,0.00007574222,0.00040492197,0.00060056086,0.0004033479,0.00041328595],"domain_scores_gemma":[0.99906397,0.00007560437,0.0001554052,0.00035579363,0.00014493972,0.00020430562],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00007681119,0.00032612198,0.00054219627,0.0000715464,0.0001176812,0.00009854756,0.000061321,0.00013930183,0.000083658866],"category_scores_gemma":[0.000045158507,0.00027439496,0.000072472474,0.00025278528,0.000079087935,0.00016951762,0.000074876305,0.00010459201,0.000009168131],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052052643,0.006446195,0.97780687,0.0001175999,0.00018372084,0.00029850905,0.00053334225,0.000007563406,0.011637028,0.00002116685,0.0007476543,0.0016798176],"study_design_scores_gemma":[0.0917233,0.0008455356,0.6851389,0.0005070841,0.0005906807,0.00006546184,0.00021362418,0.00007814231,0.21959238,0.000015532065,0.000840398,0.00038901417],"about_ca_topic_score_codex":0.00023374778,"about_ca_topic_score_gemma":0.000053452313,"teacher_disagreement_score":0.292668,"about_ca_system_score_codex":0.00025657137,"about_ca_system_score_gemma":0.0003062915,"threshold_uncertainty_score":0.9999708},"labels":[],"label_agreement":null},{"id":"W3213549898","doi":"10.1182/blood-2021-145369","title":"High-Throughput Chemical Screen on Acute Myeloid Leukemia Stem Cells Identifies Novel Anti-LSC Compounds","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal; Université Laval; Hôpital de l'Enfant-Jésus; McGill University; McGill University Health Centre","funders":"","keywords":"Haematopoiesis; CD34; Leukemia; Stem cell; Bone marrow; Myeloid leukemia; Immunology; Cytotoxic T cell; Cord blood; Cancer research; Myeloid; Medicine; Biology; In vitro; Cell biology; Biochemistry","score_opus":0.02420899417155728,"score_gpt":0.2773976597964566,"score_spread":0.2531886656248993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213549898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991901,0.0003740843,0.00021090235,0.0015613,0.00036630602,0.00044820883,0.0002271443,0.0002383729,0.0046726908],"genre_scores_gemma":[0.98001784,0.00034146273,0.0050723646,0.0015872458,0.0009885237,0.00003556391,0.00039876692,0.00012992944,0.011428273],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99639595,0.000081357575,0.0005735466,0.00095261564,0.0011362596,0.00086025597],"domain_scores_gemma":[0.9976225,0.00025049373,0.00012974461,0.0011927414,0.00038811268,0.00041639112],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003188554,0.00043004056,0.00085148413,0.00017980699,0.00017071808,0.00014922213,0.00043752958,0.00036713076,0.00028277904],"category_scores_gemma":[0.000057585017,0.00039923674,0.0002754795,0.00065592374,0.00026340003,0.00017236176,0.00048497246,0.0010218347,0.0008485825],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018124856,0.00091665384,0.00064437627,0.0001390971,0.0008836765,0.0016632449,0.00013432019,0.000007427863,0.9742045,0.00047153878,0.020034296,0.00071964605],"study_design_scores_gemma":[0.009732012,0.00023079048,0.0029057786,0.00022639634,0.00059555995,0.00075870997,0.00018581504,0.00012819971,0.978776,0.000034773242,0.0060333805,0.00039259373],"about_ca_topic_score_codex":0.00016981525,"about_ca_topic_score_gemma":0.000009720702,"teacher_disagreement_score":0.014000917,"about_ca_system_score_codex":0.0005946074,"about_ca_system_score_gemma":0.0011590442,"threshold_uncertainty_score":0.99992937},"labels":[],"label_agreement":null},{"id":"W3213564228","doi":"10.1182/blood-2021-146016","title":"Clinical Predictors of Outcome in Adult Patients with Acute Leukemias and Myelodysplastic Syndrome and COVID-19 Infection: Report from the American Society of Hematology Research Collaborative (ASH RC) Data Hub","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; BC Cancer Agency","funders":"","keywords":"Hematology; Medicine; Internal medicine; Myelodysplastic syndromes; Coronavirus disease 2019 (COVID-19); Hematologic Neoplasms; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Oncology; Intensive care medicine; Immunology; Cancer; Disease; Bone marrow","score_opus":0.06874796974461896,"score_gpt":0.40694446466256085,"score_spread":0.3381964949179419,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213564228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965936,0.00017247674,0.000060460305,0.0018445035,0.000041010277,0.0006780022,0.0005289156,0.000016048652,0.00006501319],"genre_scores_gemma":[0.9965504,0.0008165397,0.00164156,0.0003466675,0.000049465827,0.000031736767,0.00046655993,0.000024576044,0.00007248714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99664026,0.00066434406,0.0008694718,0.0007095983,0.0007859167,0.00033039102],"domain_scores_gemma":[0.99406666,0.003178588,0.00039699633,0.0010735028,0.001002773,0.0002814591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015250907,0.00016993063,0.00091106154,0.00009921214,0.00009935881,0.000016718719,0.00022748756,0.00015385389,0.000021871982],"category_scores_gemma":[0.0057738195,0.000115144816,0.000047842103,0.0013159679,0.0020750791,0.00011801857,0.00083195267,0.00085591886,0.000001326596],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005364438,0.0005630185,0.992325,0.00018853982,0.0009978774,0.0013689322,0.0005643001,0.0000010186628,0.00007734751,0.000022067006,0.003255582,0.00009983849],"study_design_scores_gemma":[0.009014001,0.0012011044,0.98624855,0.00015141304,0.00038683324,0.0010573086,0.001071575,0.000103695085,0.00020230464,0.000029445027,0.00043257987,0.00010116868],"about_ca_topic_score_codex":0.0018731069,"about_ca_topic_score_gemma":0.0008781814,"teacher_disagreement_score":0.008477557,"about_ca_system_score_codex":0.00014795002,"about_ca_system_score_gemma":0.0029724075,"threshold_uncertainty_score":0.76457155},"labels":[],"label_agreement":null},{"id":"W3213571777","doi":"10.1182/blood-2021-147598","title":"Patient-Reported Outcomes in a Phase 3, Randomized, Open-Label Study Evaluating the Efficacy of Axicabtagene Ciloleucel (Axi-Cel) Versus Standard of Care Therapy in Patients with Relapsed/Refractory Large B-Cell Lymphoma (ZUMA-7)","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; McGill University Health Centre; Hôpital de l'Enfant-Jésus; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Quality of life (healthcare); Internal medicine; Refractory (planetary science); Randomization; Randomized controlled trial; Oncology","score_opus":0.04728086257192918,"score_gpt":0.3732617414523252,"score_spread":0.32598087888039606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213571777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908326,0.0015515517,0.0000021334838,0.000039959497,0.00012530932,0.0065120542,0.000077469886,0.000017103304,0.00084176345],"genre_scores_gemma":[0.9989923,0.00012676365,0.0002017556,0.000045671244,0.000016537768,0.00026782285,0.0000965937,0.00006926243,0.00018328968],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9946901,0.0012666878,0.001309453,0.0005916377,0.0016639072,0.000478168],"domain_scores_gemma":[0.99584925,0.0013273469,0.00060000946,0.0011511298,0.00095370447,0.00011853799],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019653216,0.00034342488,0.0017203197,0.00026334904,0.00008154891,0.0000343355,0.00034899815,0.000116107956,0.00029045285],"category_scores_gemma":[0.001240352,0.00022238663,0.00017333825,0.0008501026,0.00014834663,0.00010690851,0.00026178136,0.00035045017,0.000001659447],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.63299453,0.12286335,0.19195089,0.00010850824,0.0013060179,0.0002881224,0.012161138,0.0000062491363,0.010238739,0.0000033040344,0.0000062527547,0.02807287],"study_design_scores_gemma":[0.91228867,0.0332069,0.026784182,0.00020470511,0.00041390065,0.0000026890168,0.004906,0.0000254045,0.0219238,0.0000033307138,0.00003443279,0.0002060006],"about_ca_topic_score_codex":0.00024656134,"about_ca_topic_score_gemma":0.00029441327,"teacher_disagreement_score":0.2792941,"about_ca_system_score_codex":0.00020478261,"about_ca_system_score_gemma":0.001086524,"threshold_uncertainty_score":0.9068664},"labels":[],"label_agreement":null},{"id":"W3213586012","doi":"10.1182/blood-2021-149588","title":"A Real-World Canadian Experience of Asciminib Use in Chronic Myeloid Leukemia (CML) Patients Who Failed Multiple Lines of Tyrosine Kinase Inhibitor (TKI) Therapy","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; Juravinski Cancer Centre; McGill University; University of Calgary; Brampton Civic Hospital; Alberta Health Services; Hôpital Maisonneuve-Rosemont; Western University; Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Bosutinib; Dasatinib; Medicine; Nilotinib; Discontinuation; Internal medicine; Imatinib mesylate; Imatinib; Adverse effect; Oncology; Myeloid leukemia","score_opus":0.023282543078454003,"score_gpt":0.26629955650069187,"score_spread":0.24301701342223786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213586012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99746895,0.0010106053,6.202337e-7,0.000072206945,0.000145667,0.00074781984,0.0001436984,0.000026839416,0.00038360228],"genre_scores_gemma":[0.99698305,0.0008085738,0.0006921765,0.0000964109,0.00013904709,0.00009948781,0.0002391878,0.000056117304,0.0008859502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99763,0.00008788569,0.0007623886,0.0005428351,0.00043977678,0.0005371401],"domain_scores_gemma":[0.9980785,0.0001709789,0.0002447534,0.00081017567,0.00036025,0.00033528736],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010237241,0.00032077997,0.0007472622,0.00039083976,0.000051213105,0.000016935528,0.00016802299,0.00016198494,0.0002235641],"category_scores_gemma":[0.00042772735,0.00029812404,0.0001532861,0.00089759013,0.00014951099,0.00018560763,0.00007243466,0.00022099988,0.00000841522],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002455627,0.00118137,0.92219275,0.000180096,0.0001656443,0.0003048524,0.0019004683,0.000029002167,0.07125847,0.000021280734,0.00020903215,0.0023114684],"study_design_scores_gemma":[0.021114457,0.0004395871,0.55399126,0.0006908343,0.00008239263,0.000006683582,0.00015513132,0.00017529512,0.42208508,0.0000034531506,0.0010579668,0.00019786322],"about_ca_topic_score_codex":0.21415728,"about_ca_topic_score_gemma":0.46329272,"teacher_disagreement_score":0.3682015,"about_ca_system_score_codex":0.0022962273,"about_ca_system_score_gemma":0.0050714016,"threshold_uncertainty_score":0.9999471},"labels":[],"label_agreement":null},{"id":"W3213587144","doi":"10.1182/blood-2021-145985","title":"Novel Mechanisms of Thrombopoietin Generation: The Essential Role of Kupffer Cells","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Thrombopoietin; Kupffer cell; Megakaryocyte; Platelet; Haematopoiesis; Internal medicine; Thrombopoiesis; Endocrinology; Cell biology; Biology; Chemistry; Immunology; Stem cell; Medicine","score_opus":0.011313917967282483,"score_gpt":0.23162146498985853,"score_spread":0.22030754702257604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213587144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953812,0.00053787924,0.00085199985,0.00027901144,0.00007778887,0.00011867044,0.000023724933,0.000006403019,0.00272333],"genre_scores_gemma":[0.9969344,0.000043286716,0.00246922,0.00008585575,0.0000498464,0.000004734632,0.000035883095,0.000007951081,0.00036881794],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995159,0.0000124547905,0.0001387452,0.0001032828,0.00015093488,0.00007871829],"domain_scores_gemma":[0.9996414,0.000014856194,0.00005396106,0.0001894408,0.00007742088,0.000022898555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000040221978,0.00006178643,0.00018089561,0.000013275994,0.000025930614,0.0000037764999,0.00003725995,0.00004124974,0.00024165676],"category_scores_gemma":[0.0000094071165,0.000041334875,0.000070681264,0.00008025439,0.00002433805,0.000014242796,0.000024421879,0.000039630668,0.000007716863],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008578412,0.0013641005,0.00015578105,0.000016881464,0.00020909056,0.000028930266,0.00014081041,0.0000034995853,0.99608034,0.0016982879,0.0001094337,0.0001842767],"study_design_scores_gemma":[0.0023698115,0.00009064234,0.0008149127,0.000016040847,0.0003242547,0.000060680228,0.00016194272,0.00006826459,0.99530184,0.0006238095,0.00013346063,0.00003436213],"about_ca_topic_score_codex":0.000033787757,"about_ca_topic_score_gemma":0.000019118193,"teacher_disagreement_score":0.002361233,"about_ca_system_score_codex":0.0000025370864,"about_ca_system_score_gemma":0.000060478425,"threshold_uncertainty_score":0.2645972},"labels":[],"label_agreement":null},{"id":"W3213598721","doi":"10.1182/blood-2021-148528","title":"Characterizing Safety in Patients with Hematologic Malignancies Receiving Allogeneic Stem Cell Transplant (Allo-SCT) Following Pembrolizumab Therapy","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cumulative incidence; Pembrolizumab; Internal medicine; Incidence (geometry); Transplantation; Oncology; Lymphoma; Graft-versus-host disease; Gastroenterology; Surgery; Cancer; Immunotherapy","score_opus":0.010974602034954747,"score_gpt":0.21045519621638298,"score_spread":0.19948059418142822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213598721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949111,0.0037529713,0.000018294022,0.00025215087,0.00014176543,0.00039655648,0.000017203796,0.000060781662,0.00044919126],"genre_scores_gemma":[0.9973777,0.0013863879,0.00018340547,0.0006928214,0.000030629802,0.000029819055,0.00008118236,0.000038024416,0.00018006255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845713,0.00008813515,0.00038677733,0.00038492223,0.00029492847,0.00038810226],"domain_scores_gemma":[0.99942005,0.00004908537,0.000105349885,0.00029980912,0.000056540488,0.00006915939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018112765,0.00023996283,0.00046910226,0.00008652553,0.00009113838,0.000028552604,0.000099427365,0.000115824325,0.00006927392],"category_scores_gemma":[0.0000034545542,0.00018314831,0.00017777231,0.00026789683,0.000029826042,0.000103311155,0.000016535363,0.00016560235,0.0000041722983],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035100745,0.0012203793,0.65592784,0.00016143368,0.00035705706,0.0006455056,0.0018417693,9.564429e-7,0.33268532,0.0000052753803,0.000004615292,0.003639747],"study_design_scores_gemma":[0.025370274,0.0005181313,0.7766988,0.0008461136,0.00012981672,0.00010697608,0.00024221712,0.000001946797,0.1950968,0.0000019695779,0.0006889913,0.0002979164],"about_ca_topic_score_codex":0.000025406542,"about_ca_topic_score_gemma":0.000029975025,"teacher_disagreement_score":0.13758852,"about_ca_system_score_codex":0.000071247436,"about_ca_system_score_gemma":0.00016662978,"threshold_uncertainty_score":0.74685717},"labels":[],"label_agreement":null},{"id":"W3213612154","doi":"10.1182/blood-2021-147465","title":"Prognostic Impact of <i>NPM1</i> and <i>FLT3</i> Mutations at Diagnosis and Presence of Measurable Residual Disease (MRD) after Intensive Chemotherapy (IC) for Patients with Acute Myeloid Leukemia (AML) in Remission: Outcomes from the QUAZAR AML-001 Trial of Oral Azacitidine (Oral-AZA) Maintenance","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"NPM1; Myeloid leukemia; Medicine; Chemotherapy regimen; Cytarabine; Internal medicine; Oncology; Chemotherapy; Minimal residual disease; Leukemia; Disease; Residual; Biology; Gene; Genetics","score_opus":0.01993687099546896,"score_gpt":0.28515399052427687,"score_spread":0.2652171195288079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213612154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993676,0.00073690974,0.000019705196,0.0016917475,0.00003111792,0.0024753127,0.0013404854,0.000011947481,0.000016790027],"genre_scores_gemma":[0.9968245,0.0007250909,0.001335489,0.00020341437,0.000034507997,0.00042450396,0.0002811433,0.00004542376,0.0001259169],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977145,0.00017644295,0.00061640394,0.00049167813,0.0006119721,0.0003889908],"domain_scores_gemma":[0.9961605,0.0015129229,0.00031906788,0.00053082604,0.0012272742,0.0002494145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032507986,0.00028567167,0.0008321155,0.000097246695,0.00006597144,0.000019581405,0.00016155613,0.000105949104,0.00004494538],"category_scores_gemma":[0.003057869,0.00017491209,0.00014669192,0.00038958597,0.00047335582,0.00016488458,0.00015355302,0.00022955408,4.2523385e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048801944,0.001138729,0.9415843,0.00021177506,0.000775645,0.00010836998,0.0008077943,0.0000063027924,0.0042030765,0.000004009035,0.001355365,0.0010026869],"study_design_scores_gemma":[0.105173886,0.0020839756,0.86532104,0.0008923589,0.0009446358,0.000014773588,0.00030557765,0.00010235434,0.024765957,0.00013329822,0.000054461558,0.00020770883],"about_ca_topic_score_codex":0.0006736313,"about_ca_topic_score_gemma":0.00021050511,"teacher_disagreement_score":0.07626329,"about_ca_system_score_codex":0.00016814108,"about_ca_system_score_gemma":0.00095535023,"threshold_uncertainty_score":0.7132708},"labels":[],"label_agreement":null},{"id":"W3213616525","doi":"10.1182/blood-2021-148044","title":"Impact of Post-Remission Maintenance Therapy (MT) on Outcomes in Patients (pts) with Newly Diagnosed Acute Myeloid Leukemia (AML) in Real-World Practice","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Venetoclax; Internal medicine; Oncology; Induction chemotherapy; Cohort; Myeloid leukemia; Maintenance therapy; Azacitidine; Minimal residual disease; Chemotherapy; Leukemia; Chronic lymphocytic leukemia","score_opus":0.015318017967176125,"score_gpt":0.3228791073365389,"score_spread":0.3075610893693628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213616525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99283576,0.00009017002,0.000003881119,0.0015237802,0.000041748364,0.00093603606,0.00004628798,0.00003820261,0.0044841073],"genre_scores_gemma":[0.9945678,0.0012169991,0.00137156,0.00090872386,0.00004592472,0.000056131532,0.0001264951,0.000074453616,0.0016318926],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970129,0.0002804263,0.0005848833,0.0005909638,0.0008686521,0.00066217827],"domain_scores_gemma":[0.9972477,0.00079291133,0.00026879756,0.000817911,0.0006163818,0.0002562948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044178846,0.00035442386,0.0007971282,0.00047891744,0.000040155814,0.000025420552,0.00023847538,0.00016324988,0.00011882357],"category_scores_gemma":[0.001547989,0.00023680899,0.00016758312,0.0012450244,0.0000850226,0.00026403682,0.00010164308,0.00085244334,0.000024366276],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007446598,0.004506628,0.95927,0.000049741262,0.0005081407,0.002625575,0.0007005863,0.000048434966,0.016864289,0.00002831043,0.00069059146,0.0072611338],"study_design_scores_gemma":[0.04296037,0.0033276572,0.9398668,0.0005706497,0.00009629626,0.000044747758,0.00020816024,0.00003821844,0.012286672,0.000010035697,0.00035233927,0.00023804854],"about_ca_topic_score_codex":0.004883419,"about_ca_topic_score_gemma":0.00084483885,"teacher_disagreement_score":0.035513774,"about_ca_system_score_codex":0.0015794641,"about_ca_system_score_gemma":0.0023586794,"threshold_uncertainty_score":0.96567905},"labels":[],"label_agreement":null},{"id":"W3213619768","doi":"10.1182/blood-2021-151744","title":"ATG and Post-Transplant Cyclophosphamide Predisposes to Inferior Outcome When Using Cryopreserved Stem Cell Grafts","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Cumulative incidence; Medicine; Cyclophosphamide; Hematopoietic stem cell transplantation; Internal medicine; Surgery; Transplantation; Proportional hazards model; Incidence (geometry); Oncology; Gastroenterology; Chemotherapy","score_opus":0.02603224949610817,"score_gpt":0.26551421582900714,"score_spread":0.23948196633289898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213619768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962992,0.0009267991,0.0006470646,0.00041753368,0.00015785459,0.0005520613,0.00010804565,0.0000933339,0.0007980743],"genre_scores_gemma":[0.9911325,0.000094312694,0.0071512833,0.00056496816,0.00007444033,0.000020143392,0.00006795799,0.000046468267,0.000847924],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837637,0.00006160944,0.0004637493,0.00041609272,0.00034137728,0.00034077305],"domain_scores_gemma":[0.99895525,0.00012799511,0.000062086576,0.0003663191,0.00016061576,0.00032774048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014874955,0.00022710278,0.0004296151,0.00008800654,0.000077989374,0.000048234608,0.00008420202,0.00012692253,0.00011258349],"category_scores_gemma":[0.000026422642,0.00021348141,0.00008884251,0.00016399428,0.00002931498,0.00009768637,0.00004198955,0.00014750003,0.000031147552],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012976838,0.00032353753,0.6276935,0.0012005115,0.00009066644,0.0010147339,0.002716381,0.000009435447,0.3666469,0.000020686528,0.0000130481585,0.00014086187],"study_design_scores_gemma":[0.0044751395,0.00021728533,0.4965128,0.0006518961,0.00095921924,0.0009929967,0.0004645617,0.000033559652,0.49511302,0.000022531154,0.00025166565,0.00030532983],"about_ca_topic_score_codex":0.00012745746,"about_ca_topic_score_gemma":0.00006840838,"teacher_disagreement_score":0.1311807,"about_ca_system_score_codex":0.00002401412,"about_ca_system_score_gemma":0.00014256618,"threshold_uncertainty_score":0.8705519},"labels":[],"label_agreement":null},{"id":"W3213621180","doi":"10.1182/blood-2021-153315","title":"DREAMM-9: Phase I Study of Belantamab Mafodotin Plus Standard of Care in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Lenalidomide; Medicine; Multiple myeloma; Tolerability; Cohort; Bortezomib; Regimen; Internal medicine; Oncology; Adverse effect; Surgery","score_opus":0.012040937761254046,"score_gpt":0.2802904466225992,"score_spread":0.2682495088613452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213621180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99713784,0.0004067904,0.000009319237,0.000017741226,0.000023193448,0.0014820604,0.00069080695,0.000021381422,0.00021085393],"genre_scores_gemma":[0.9986928,0.000051909257,0.00054640585,0.000008114898,0.00001780997,0.00006377363,0.00055145286,0.000032344364,0.000035401186],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797314,0.00010618762,0.0004413355,0.00036306967,0.0007580451,0.0003582476],"domain_scores_gemma":[0.9987321,0.00014065982,0.00011234954,0.00042870542,0.0003940539,0.00019212277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007842982,0.00021354725,0.00073933374,0.00019719201,0.000039060033,0.0000083769,0.00010140814,0.0000684799,0.00006836274],"category_scores_gemma":[0.00010535349,0.00016601382,0.000077588884,0.000416336,0.000047308866,0.00005959937,0.000038797963,0.00016088922,0.0000030879853],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016773773,0.017309327,0.95345074,0.00041288242,0.00050562725,0.0019730723,0.0048151626,0.000015400281,0.0006864861,0.0000015488802,0.000009679333,0.004046274],"study_design_scores_gemma":[0.23624381,0.012855011,0.68460906,0.00041484038,0.00037281826,0.000011392654,0.0032230609,0.000018599658,0.062103596,9.4499035e-7,0.000016431502,0.00013040818],"about_ca_topic_score_codex":0.0006735928,"about_ca_topic_score_gemma":0.0033324638,"teacher_disagreement_score":0.26884168,"about_ca_system_score_codex":0.000071192,"about_ca_system_score_gemma":0.00038241316,"threshold_uncertainty_score":0.6769847},"labels":[],"label_agreement":null},{"id":"W3213621509","doi":"10.1182/blood-2021-153170","title":"A Phase I Study of the Combination of Venetoclax and Azacitidine in Relapse/Refractory Higher Risk Myelodysplastic Syndrome (MDS)","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Venetoclax; Azacitidine; Medicine; Internal medicine; Regimen; Concomitant; Myelodysplastic syndromes; Oncology; Refractory (planetary science); Cohort; Gastroenterology; Leukemia; Bone marrow","score_opus":0.015823490518004458,"score_gpt":0.28517564193859457,"score_spread":0.2693521514205901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213621509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985164,0.000454496,0.0000024014337,0.00010284922,0.00006388375,0.0005303813,0.000018459103,0.000007980428,0.00030316986],"genre_scores_gemma":[0.9993203,0.000089062734,0.000045517627,0.000016798656,0.000017636858,0.000024602621,0.0000075056923,0.000017884324,0.0004606559],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986882,0.00022393261,0.0003275812,0.00021632595,0.00038618143,0.00015777572],"domain_scores_gemma":[0.99902475,0.00024355343,0.00013978856,0.0003801352,0.00014980754,0.00006198836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029166302,0.00010261039,0.00033276665,0.00012940781,0.000033095974,0.00000484986,0.00009354407,0.000076417746,0.000072439885],"category_scores_gemma":[0.00041587432,0.00007747586,0.000039856328,0.00050031894,0.00009405511,0.00003767649,0.00012467819,0.0003575052,0.000002772973],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011744464,0.045298647,0.6666779,0.0010531765,0.001159184,0.0024696596,0.0050036493,0.000054806664,0.2731848,0.0005137213,0.0002687632,0.0031412435],"study_design_scores_gemma":[0.05204956,0.0043761833,0.9212238,0.00029898458,0.00047436953,0.00023539952,0.0008445646,0.00025724704,0.019882685,0.00012923028,0.00011886323,0.000109123095],"about_ca_topic_score_codex":0.00021095642,"about_ca_topic_score_gemma":0.000049273396,"teacher_disagreement_score":0.2545459,"about_ca_system_score_codex":0.00010687202,"about_ca_system_score_gemma":0.00032357775,"threshold_uncertainty_score":0.3159374},"labels":[],"label_agreement":null},{"id":"W3213640376","doi":"10.1182/blood-2021-153959","title":"Proteomic Profiles in Patients with Thrombosis Due to COVID-19 Are Distinct from Non-COVID-19 Thrombosis","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Coronavirus disease 2019 (COVID-19); Thrombosis; Venous thrombosis; Internal medicine; Cardiology; Gastroenterology; Disease; Infectious disease (medical specialty)","score_opus":0.051557400569357474,"score_gpt":0.38180700674035034,"score_spread":0.33024960617099286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213640376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97361666,0.000060883176,0.0007657599,0.021443745,0.00007906271,0.0031360516,0.00059506233,0.00013901897,0.00016378176],"genre_scores_gemma":[0.98360324,0.00006243719,0.0026960687,0.01208969,0.0002049507,0.0008846093,0.00024513365,0.00007033729,0.00014351156],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99575263,0.00026519687,0.0006946331,0.0012820117,0.0012073398,0.0007982054],"domain_scores_gemma":[0.9938426,0.0029957725,0.00020818265,0.0010856611,0.00037301285,0.0014947718],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00053755153,0.00043938126,0.0012294326,0.00023232053,0.00025752376,0.00006725176,0.0003521548,0.00019770344,0.0006914257],"category_scores_gemma":[0.05324184,0.00034121843,0.00018910352,0.0011089997,0.00026570543,0.00011475554,0.0006792865,0.0005957298,0.00015935846],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050530006,0.0034910191,0.98989826,0.0010703753,0.00047965732,0.0004193217,0.00096102565,0.00003356508,0.0010905906,0.000007936767,0.0018421304,0.00020079133],"study_design_scores_gemma":[0.012850626,0.0009585557,0.9800343,0.0005240834,0.00033923396,0.0000012507986,0.0002625584,0.00002105152,0.0024010371,0.0002061582,0.0019953665,0.00040576264],"about_ca_topic_score_codex":0.0027910846,"about_ca_topic_score_gemma":0.0015102013,"teacher_disagreement_score":0.05270429,"about_ca_system_score_codex":0.0006893235,"about_ca_system_score_gemma":0.0026991728,"threshold_uncertainty_score":0.999904},"labels":[],"label_agreement":null},{"id":"W3213641350","doi":"10.1182/blood-2021-154195","title":"Venetoclax, Obinutuzumab and Atezolizumab (PD-L1 Checkpoint Inhibitor) for First-Line Treatment for Patients with Chronic Lymphocytic Leukemia (CLL)","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Venetoclax; Atezolizumab; Obinutuzumab; Chronic lymphocytic leukemia; Medicine; Ibrutinib; Rituximab; Internal medicine; Oncology; Bendamustine; Alemtuzumab; Leukemia; Pembrolizumab; Cancer; Immunotherapy; Lymphoma; Transplantation","score_opus":0.01772876279167776,"score_gpt":0.2684535897771648,"score_spread":0.25072482698548704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213641350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926806,0.002938631,0.00018996159,0.000118132426,0.00015449565,0.0034396197,0.00017406468,0.00010623571,0.00019825183],"genre_scores_gemma":[0.99269617,0.000628784,0.002156383,0.00009904639,0.0007241244,0.0011500319,0.0006749137,0.00014006413,0.0017304668],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99712646,0.00003126776,0.0005296152,0.00088289694,0.00052966067,0.00090009253],"domain_scores_gemma":[0.99784946,0.00035702044,0.0001462015,0.00075499533,0.0004923735,0.00039995954],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014973915,0.00045636878,0.00074520044,0.00011901259,0.0002476365,0.00007619825,0.00013547819,0.00023073408,0.00005454994],"category_scores_gemma":[0.00026286862,0.00035756337,0.00023693024,0.0002688292,0.00016191232,0.00010363471,0.00012546379,0.000120038,0.000019173815],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.21346438,0.035363313,0.034779772,0.10415478,0.05085934,0.012427297,0.021849256,0.029679166,0.045752864,0.005842297,0.024567267,0.42126027],"study_design_scores_gemma":[0.71666694,0.022941887,0.0028004702,0.0016230219,0.0026258114,0.0010619956,0.00013757715,0.052450027,0.16181244,0.0003386718,0.036440246,0.0011009403],"about_ca_topic_score_codex":0.00046242104,"about_ca_topic_score_gemma":0.0005760095,"teacher_disagreement_score":0.50320256,"about_ca_system_score_codex":0.1559443,"about_ca_system_score_gemma":0.06446832,"threshold_uncertainty_score":0.99988765},"labels":[],"label_agreement":null},{"id":"W3213645881","doi":"10.1182/blood-2021-152141","title":"COVID Vaccination Rates in Children and Adults with Sickle Cell Disease in British Columbia, Canada","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Vaccine Coverage and Hesitancy","field":"Social Sciences","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Children's Hospital; Provincial Health Services Authority; St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Vaccination; Population; Pediatrics; Immunization; Disease; Pandemic; Family medicine; Coronavirus disease 2019 (COVID-19); Immunology; Internal medicine; Environmental health; Infectious disease (medical specialty)","score_opus":0.002956992520874208,"score_gpt":0.19907026953731943,"score_spread":0.19611327701644524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213645881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974569,0.0012929583,4.5299748e-7,0.00036789547,0.000016441905,0.00016750017,0.000023911009,0.00000811741,0.00066583726],"genre_scores_gemma":[0.9988103,0.00025978044,0.000017273383,0.00020005764,0.000040799412,0.000009715649,0.000024385847,0.0000048178,0.0006328672],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99938387,0.000065349726,0.000087487264,0.00017466838,0.00013321244,0.00015544205],"domain_scores_gemma":[0.9997146,0.000032260472,0.000025244615,0.000059607297,0.000042035932,0.00012625405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000074965705,0.00003613972,0.000081704886,0.000013334479,0.00010813899,0.00013063241,0.000052355834,0.000023311113,0.00020501245],"category_scores_gemma":[0.00010457479,0.000057878337,0.000007621089,0.00022035881,0.0000039178967,0.000121574565,0.000016410244,0.000055219276,5.901761e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000038707185,0.0001328798,0.9979879,0.000012565336,0.0000026999512,0.00021179816,0.00049721426,0.0000026930963,0.0000021469525,0.000007411428,0.0005011087,0.0006377069],"study_design_scores_gemma":[0.0017650927,0.0000120531895,0.9971677,0.000038970637,0.000010460196,0.000002308195,0.0006291741,0.0000029412224,0.000025853566,0.00009713298,0.00016244779,0.00008584068],"about_ca_topic_score_codex":0.9735347,"about_ca_topic_score_gemma":0.9998575,"teacher_disagreement_score":0.026322821,"about_ca_system_score_codex":0.000056320485,"about_ca_system_score_gemma":0.0013967787,"threshold_uncertainty_score":0.24778254},"labels":[],"label_agreement":null},{"id":"W3213659569","doi":"10.1182/blood-2021-147769","title":"Results from a Global Randomized Phase 3 Study of Guadecitabine (G) Vs Treatment Choice (TC) in 302 Patients with Relapsed or Refractory (r/r) Acute Myeloid Leukemia after Intensive Chemotherapy (ASTRAL-2 Study)","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Decitabine; Internal medicine; Medicine; Cytarabine; Clinical endpoint; Anthracycline; Chemotherapy regimen; Chemotherapy; Surrogate endpoint; Gastroenterology; Oncology; Azacitidine; Refractory (planetary science); Randomized controlled trial; Biology; Cancer; Breast cancer","score_opus":0.016189166860232987,"score_gpt":0.30773893768878774,"score_spread":0.29154977082855477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213659569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99238694,0.0002352772,0.000006700352,0.00030753683,0.00009344249,0.0061760005,0.0005711883,0.00006223852,0.00016068394],"genre_scores_gemma":[0.9966929,0.00020956925,0.00078993564,0.00031602653,0.00014762707,0.00062298065,0.0004340871,0.00007952189,0.0007073372],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9949845,0.0007162508,0.0013552626,0.0011658937,0.0011436867,0.0006344232],"domain_scores_gemma":[0.9959114,0.0008420858,0.00042703186,0.001325574,0.0011738985,0.00031999464],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004391305,0.0006102647,0.002223038,0.0002257627,0.000057200417,0.00003755575,0.0002599002,0.00020459857,0.00021817394],"category_scores_gemma":[0.0014789386,0.00039303917,0.00022310077,0.0010731173,0.00017742568,0.00017552839,0.00014787665,0.0005160607,0.000018072444],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7944696,0.0562224,0.12197377,0.000027190097,0.0063145705,0.0055748452,0.010800279,0.0000037805105,0.0009976536,2.5994186e-7,0.00021012728,0.003405519],"study_design_scores_gemma":[0.76685274,0.02128447,0.20163019,0.00021985917,0.0020464463,0.000018962868,0.0050035245,0.00003152745,0.0024837188,0.000003454047,0.00012953847,0.00029553872],"about_ca_topic_score_codex":0.0032173907,"about_ca_topic_score_gemma":0.0023771496,"teacher_disagreement_score":0.07965643,"about_ca_system_score_codex":0.0015001972,"about_ca_system_score_gemma":0.0014925345,"threshold_uncertainty_score":0.9998521},"labels":[],"label_agreement":null},{"id":"W3213660215","doi":"10.1182/blood-2021-148497","title":"Clinical Experience in the Randomized Phase 3 Sierra Trial: Anti-CD45 Iodine (131I) Apamistamab [Iomab-B] Conditioning Enables Hematopoietic Cell Transplantation with Successful Engraftment and Acceptable Safety in Patients with Active, Relapsed/Refractory AML Not Responding to Targeted Therapies","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ottawa Hospital; Princess Margaret Cancer Centre; University of Ottawa","funders":"","keywords":"Medicine; Internal medicine; Fludarabine; Tolerability; Transplantation; Oncology; Hematopoietic stem cell transplantation; Refractory (planetary science); Clinical trial; Adverse effect; Chemotherapy; Cyclophosphamide","score_opus":0.019088134888986346,"score_gpt":0.31811780428681447,"score_spread":0.2990296693978281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213660215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955292,0.00025095884,0.0003149658,0.00041651848,0.00004654496,0.0030775405,0.00005535646,0.000033486762,0.00027545608],"genre_scores_gemma":[0.9968495,0.0005471827,0.0013470408,0.00032636579,0.000045721703,0.00045195266,0.0002872815,0.000040526564,0.0001044381],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9961795,0.0011742502,0.0008080365,0.0006365972,0.0007297082,0.00047187606],"domain_scores_gemma":[0.9973025,0.0017107155,0.00022463128,0.00039848097,0.0002001247,0.00016355293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001545556,0.00029746332,0.0009556401,0.00043764865,0.000262833,0.0000889799,0.00017894797,0.0001386044,0.00012451157],"category_scores_gemma":[0.00047104328,0.0001882985,0.00008270066,0.0011350423,0.00026999443,0.00033886815,0.000048287817,0.0005745256,0.000002260402],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90882367,0.005937184,0.03905979,0.0002380212,0.00027648162,0.0008982246,0.03248047,0.00002469461,0.0113628665,0.00004970678,0.000015716787,0.0008331821],"study_design_scores_gemma":[0.892373,0.00217347,0.0573579,0.0004540138,0.000292035,0.00004662899,0.008243885,0.00004604868,0.038531035,0.000007943168,0.00019078694,0.00028320213],"about_ca_topic_score_codex":0.000068609166,"about_ca_topic_score_gemma":0.000051145045,"teacher_disagreement_score":0.02716817,"about_ca_system_score_codex":0.00015036683,"about_ca_system_score_gemma":0.00044648623,"threshold_uncertainty_score":0.767859},"labels":[],"label_agreement":null},{"id":"W3213661499","doi":"10.1182/blood-2021-149855","title":"The Impact of Oral Hypoglycemics and Statins on Outcomes in Myelodysplastic Syndromes","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Princess Margaret Cancer Centre; Ottawa Hospital; Sunnybrook Health Science Centre; Juravinski Cancer Centre; Institute for Clinical Evaluative Sciences; University of Toronto","funders":"","keywords":"Medicine; Proportional hazards model; Hazard ratio; Disease registry; Internal medicine; Population; Observational study; Disease; Confidence interval; Environmental health","score_opus":0.03844971627023123,"score_gpt":0.36201192757563233,"score_spread":0.3235622113054011,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213661499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99772775,0.00030616685,0.0000027136684,0.0012190549,0.0000377419,0.000089195135,0.000012155248,0.000008651433,0.0005965764],"genre_scores_gemma":[0.99884516,0.00032025075,0.00044402346,0.0001753585,0.000009754106,0.000003854021,0.0000046517875,0.000006284247,0.00019066638],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99950844,0.00002638513,0.00016263794,0.000081210244,0.00009330438,0.00012802452],"domain_scores_gemma":[0.99950993,0.00025416538,0.000034925983,0.0001057519,0.00003458207,0.000060636405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009247634,0.000055706583,0.00018086271,0.00004407068,0.000035576104,0.0000074574305,0.000020061343,0.00002556102,0.000022018536],"category_scores_gemma":[0.00020459811,0.000034332003,0.000033750443,0.00009532917,0.00003273291,0.0000133337435,0.000013415765,0.00011370965,0.0000029769926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000109917986,0.0006262788,0.99548215,0.00013730227,0.00006855029,0.00014220476,0.00022060185,0.0000031784407,0.0010204434,0.00065468927,0.00016259278,0.0013720992],"study_design_scores_gemma":[0.0048545515,0.0004665869,0.9923205,0.00018610655,0.000036421297,0.00015502992,0.00025625856,0.000073639,0.000933933,0.00051101245,0.00015918091,0.000046790206],"about_ca_topic_score_codex":0.000037640068,"about_ca_topic_score_gemma":0.00003192215,"teacher_disagreement_score":0.0047446336,"about_ca_system_score_codex":0.000017752256,"about_ca_system_score_gemma":0.0001074183,"threshold_uncertainty_score":0.14000185},"labels":[],"label_agreement":null},{"id":"W3213661800","doi":"10.1182/blood-2021-147780","title":"Glofitamab Plus R-CHOP Induces High Response Rates with Minimal Cytokine Release Syndrome (CRS) in Patients (pts) with Relapsed/Refractory (R/R) Non-Hodgkin Lymphoma (NHL) and Previously Untreated (1L) Diffuse Large B-Cell Lymphoma (DLBCL): Preliminary Results from a Dose-Escalation and Safety Run-in Phase Ib Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cytokine release syndrome; Rituximab; CHOP; Obinutuzumab; Internal medicine; Vincristine; Prednisone; Lymphoma; Gastroenterology; Cyclophosphamide; Diffuse large B-cell lymphoma; Oncology; Chemotherapy; Cancer; Immunotherapy","score_opus":0.007138151283826661,"score_gpt":0.23236526270599306,"score_spread":0.2252271114221664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213661800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944822,0.0012397956,0.0000011943147,0.0001884302,0.000048953316,0.0031957843,0.00071458565,0.000082807186,0.00004625475],"genre_scores_gemma":[0.99739194,0.00037345392,0.00040180245,0.00009645735,0.000036015408,0.00040547262,0.0010699136,0.00010551144,0.000119417804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954233,0.0006280779,0.0010638759,0.0014971349,0.0006854918,0.0007021245],"domain_scores_gemma":[0.9971489,0.00089010794,0.00044490446,0.00085314177,0.00021238383,0.00045059936],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004614524,0.0007472211,0.001229919,0.00041014134,0.00018690155,0.00010586015,0.0001283944,0.00030261895,0.000014644007],"category_scores_gemma":[0.00030837697,0.00057046226,0.00007064335,0.0008027955,0.00013100603,0.00039049715,0.00018354104,0.00018727742,0.000009081403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22137523,0.16908397,0.5781606,0.00012659092,0.00059599185,0.02010313,0.0047251023,0.0000054190973,0.00079844426,0.000001625217,0.000025571591,0.004998363],"study_design_scores_gemma":[0.38074207,0.019608334,0.594298,0.0008927102,0.00083606277,0.00022088522,0.00087255123,0.000100340774,0.0020226862,0.0000020860623,0.00002903053,0.00037520844],"about_ca_topic_score_codex":0.0019262828,"about_ca_topic_score_gemma":0.0007995241,"teacher_disagreement_score":0.15936686,"about_ca_system_score_codex":0.000634113,"about_ca_system_score_gemma":0.00072784966,"threshold_uncertainty_score":0.9996747},"labels":[],"label_agreement":null},{"id":"W3213664447","doi":"10.1182/blood-2021-148064","title":"Randomized Controlled Trial of the Efficacy and Safety of Deferiprone: Subgroup Analysis of Pediatric Patients in Iron-Overloaded Patients with Sickle Cell Disease and Other Anemias","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Deferiprone; Medicine; Deferoxamine; Clinical endpoint; Anemia; Deferasirox; Thalassemia; Randomized controlled trial; Adverse effect; Subgroup analysis; Internal medicine; Sickle cell anemia; Clinical trial; Pediatrics; Disease; Confidence interval","score_opus":0.003420389220406561,"score_gpt":0.1968013522225035,"score_spread":0.19338096300209695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213664447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960846,0.0013163685,0.000001748622,0.000025029622,0.000031415948,0.0022400962,0.00005047737,0.0000032349178,0.00024707097],"genre_scores_gemma":[0.99947613,0.00036743635,0.00002500957,0.00003163062,0.000010127134,0.00002122588,0.00002595357,0.000011119734,0.000031335167],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9985334,0.00023878065,0.0006192188,0.00018927909,0.0002988806,0.00012038944],"domain_scores_gemma":[0.99888575,0.00030965483,0.0003722092,0.00022722506,0.00012410806,0.00008105914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022611501,0.00013172586,0.001242661,0.00013449747,0.000021688385,0.0000030540048,0.000041787505,0.00007990931,0.000028854036],"category_scores_gemma":[0.00042688128,0.000071882176,0.00022255555,0.00061339635,0.00013785597,0.000019149256,0.000037087957,0.00009314903,1.0253306e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.518823,0.0033712904,0.47654352,0.00014149687,0.00067122426,0.0000015708757,0.0003102367,0.000029136074,0.00006126444,0.0000049306464,0.0000024304757,0.00003987136],"study_design_scores_gemma":[0.71451455,0.00023836171,0.2744372,0.000037738268,0.0104708215,6.694466e-8,0.0000546208,0.000045898676,0.00014144885,0.0000025731115,0.0000011859762,0.000055561162],"about_ca_topic_score_codex":0.000054888496,"about_ca_topic_score_gemma":0.0000129299715,"teacher_disagreement_score":0.20210633,"about_ca_system_score_codex":0.00000675717,"about_ca_system_score_gemma":0.00009515744,"threshold_uncertainty_score":0.293127},"labels":[],"label_agreement":null},{"id":"W3213668598","doi":"10.1182/blood-2021-154379","title":"Geographic Remoteness Is Associated with Increased Blood Product Utilization and Higher Rates of Hospitalization and Deaths in Adults with Immune Thrombocytopenia","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of Alberta Hospital; Alberta Hospital Edmonton","funders":"","keywords":"Medicine; Rituximab; Splenectomy; Internal medicine; Immune thrombocytopenia; Blood product; Antibody; Immunology; Pediatrics; Surgery","score_opus":0.010371034725441708,"score_gpt":0.2327557500608501,"score_spread":0.22238471533540838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213668598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940936,0.005171979,0.0000030031208,0.00011097072,0.000008057153,0.00041191402,0.000014954582,0.000018807063,0.00016671309],"genre_scores_gemma":[0.9982703,0.0011076321,0.00021047979,0.000038594913,0.0000054218517,0.000011321753,0.00029379374,0.000020232845,0.00004222919],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991992,0.000041192674,0.00017597532,0.0002939895,0.000154465,0.00013515347],"domain_scores_gemma":[0.99947196,0.000021964554,0.00010823295,0.00015873511,0.00019363727,0.00004546807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006557565,0.00014301001,0.00039208285,0.000084467385,0.000040114224,0.000015782622,0.000021033029,0.000062604304,0.00001484049],"category_scores_gemma":[0.00004643124,0.00010484575,0.000015478787,0.0004725947,0.000064786815,0.00009685414,0.00001780646,0.00005392555,1.6660081e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025191612,0.0016402253,0.99390477,0.00015921355,0.0004718393,0.00041185188,0.00032310322,4.464681e-7,0.0023578967,0.000024550336,0.0000014557603,0.00045271852],"study_design_scores_gemma":[0.016805893,0.00061780744,0.9360791,0.0008990625,0.00069969177,0.00013068417,0.00009051743,0.000027379252,0.044484675,0.000046171506,0.0000030999458,0.000115956784],"about_ca_topic_score_codex":0.00035942942,"about_ca_topic_score_gemma":0.000269093,"teacher_disagreement_score":0.05782572,"about_ca_system_score_codex":0.000006140255,"about_ca_system_score_gemma":0.000068976544,"threshold_uncertainty_score":0.42754856},"labels":[],"label_agreement":null},{"id":"W3213670395","doi":"10.1182/blood-2021-148904","title":"Saving Lives with Pride: Development and Evaluation of Multimedia Resources to Engage Gay, Bisexual, and Queer Men in Canada As Stem Cell Donors","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"LGBTQ Health, Identity, and Policy","field":"Psychology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; University of Ottawa; Stem Cell Network; Hospital for Sick Children; Queen's University; McMaster University; University of Toronto","funders":"","keywords":"Men who have sex with men; Social media; Medicine; Family medicine; Human immunodeficiency virus (HIV); World Wide Web; Computer science","score_opus":0.05793053342378043,"score_gpt":0.3369137688867634,"score_spread":0.278983235462983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213670395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99062717,0.0024210163,6.157822e-7,0.00020973769,0.000064430555,0.00027643386,0.0000067206215,0.0000057812495,0.006388106],"genre_scores_gemma":[0.9980205,0.00007371949,0.00055298675,0.00010375626,0.000032928234,0.000033369783,0.0000039258016,0.000011823525,0.0011669444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987807,0.0003010051,0.00022512767,0.00023910959,0.0002599696,0.00019407472],"domain_scores_gemma":[0.9994246,0.00014794561,0.00007475832,0.00014537078,0.00008589768,0.00012142319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005481435,0.00009414126,0.00015484709,0.00009030047,0.00006917192,0.000018618612,0.000054455257,0.0000387262,0.000073765565],"category_scores_gemma":[0.000038359667,0.000088262364,0.000005267733,0.00013870228,0.000021198039,0.00003687803,0.00004514434,0.0001034701,0.00000430696],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036761678,0.00018722964,0.9077324,0.00038047932,0.00007076205,0.000056543107,0.07409624,0.000014511505,0.00074543594,0.000013447012,0.0005303624,0.016135808],"study_design_scores_gemma":[0.0019521078,0.00006923249,0.9862273,0.00004286771,0.0000930636,0.000018367471,0.008581951,0.000013725156,0.002043268,0.000009105214,0.0008178759,0.00013115164],"about_ca_topic_score_codex":0.7201598,"about_ca_topic_score_gemma":0.9133752,"teacher_disagreement_score":0.19321539,"about_ca_system_score_codex":0.00008439314,"about_ca_system_score_gemma":0.0011901775,"threshold_uncertainty_score":0.35992348},"labels":[],"label_agreement":null},{"id":"W3213674163","doi":"10.1182/blood-2021-147731","title":"Assessment of the Clonal Dynamics of Acquired Mutations in Patients (Pts) with Relapsed/Refractory Chronic Lymphocytic Leukemia (R/R CLL) Treated in the Randomized Phase 3 Murano Trial Supports Venetoclax-Rituximab (VenR) Fixed-Duration Combination Treatment (Tx)","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Venetoclax; Medicine; Bendamustine; Chronic lymphocytic leukemia; Internal medicine; Oncology; Ven; Minimal residual disease; Tumor lysis syndrome; Rituximab; KRAS; Lenalidomide; Leukemia; Gastroenterology; Lymphoma; Cancer; Multiple myeloma; Chemotherapy","score_opus":0.011383762729242167,"score_gpt":0.2960673765236078,"score_spread":0.28468361379436563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213674163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99485713,0.0001904857,0.000037349677,0.00009935015,0.00011343786,0.004293846,0.00006497689,0.000016120097,0.00032727342],"genre_scores_gemma":[0.9976839,0.00010622554,0.00009954998,0.000022168962,0.000042791653,0.00053048716,0.0013575709,0.000032564123,0.00012476783],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9960232,0.001005618,0.0011584407,0.00039933616,0.0010622992,0.0003511437],"domain_scores_gemma":[0.997498,0.00086233177,0.00054083194,0.0006963509,0.0003343224,0.00006820509],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086457876,0.00027599256,0.0009224663,0.00023434097,0.00008276428,0.000024090745,0.0001963102,0.00017790834,0.00007184952],"category_scores_gemma":[0.00036037236,0.00016646573,0.0002556164,0.0008564875,0.00031084567,0.00013264945,0.00004797834,0.00015915175,0.0000017453593],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.81463534,0.09174953,0.035791177,0.0019222664,0.0041234135,0.0016612153,0.010419221,0.013026126,0.0076121907,0.0033755312,0.00009672162,0.015587258],"study_design_scores_gemma":[0.89507073,0.0032323354,0.011078914,0.0003385232,0.0007715249,0.000054947628,0.0002800523,0.083503395,0.0054512112,0.0000769792,0.000007341772,0.00013401367],"about_ca_topic_score_codex":0.0016592195,"about_ca_topic_score_gemma":0.001503406,"teacher_disagreement_score":0.08851719,"about_ca_system_score_codex":0.060024362,"about_ca_system_score_gemma":0.03684149,"threshold_uncertainty_score":0.96861875},"labels":[],"label_agreement":null},{"id":"W3213674796","doi":"10.1182/blood-2021-148706","title":"Clinical Features and Long-Term Outcomes in a Molecularly-Annotated Cohort of Adolescents and Young Adults with Myeloproliferative Neoplasms","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Royal Victoria Regional Health Centre; Princess Margaret Cancer Centre; Health Sciences Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Essential thrombocythemia; Internal medicine; Myelofibrosis; Polycythemia vera; Population; Oncology; Cohort; Hazard ratio; Bone marrow; Confidence interval","score_opus":0.01201167451677876,"score_gpt":0.2898668418790969,"score_spread":0.27785516736231813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213674796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967618,0.0018675259,0.000009918994,0.00028265404,0.000045481826,0.00085138914,0.000027742513,0.000018855146,0.00013465942],"genre_scores_gemma":[0.9972611,0.0011938614,0.00097250345,0.00025268187,0.000026016518,0.000087116394,0.000060249957,0.000024326322,0.00012213548],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836236,0.00012673618,0.0004482012,0.0005362803,0.00029061458,0.00023581774],"domain_scores_gemma":[0.99911445,0.000099785684,0.00012512326,0.00024044253,0.00023054304,0.00018966624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013185522,0.0002634855,0.00080576603,0.00008684669,0.000043463275,0.000030444944,0.000037188816,0.0001342216,0.000012140015],"category_scores_gemma":[0.00016285376,0.00018495067,0.000070607704,0.00018240332,0.0001475725,0.00006542637,0.00006360413,0.00025471882,0.0000014526946],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006482847,0.002745576,0.9918997,0.00021651828,0.00076748437,0.0018813444,0.00062654045,2.3956628e-7,0.00025800453,0.000048043534,0.000008726452,0.0008995277],"study_design_scores_gemma":[0.01683668,0.0010204376,0.96723825,0.0011063674,0.00052639877,0.00067820854,0.000112905116,0.0000082519755,0.012296012,0.000008122017,0.0000014620068,0.00016688739],"about_ca_topic_score_codex":0.000049676557,"about_ca_topic_score_gemma":0.00085260835,"teacher_disagreement_score":0.024661444,"about_ca_system_score_codex":0.00001637046,"about_ca_system_score_gemma":0.0001406868,"threshold_uncertainty_score":0.75420696},"labels":[],"label_agreement":null},{"id":"W3213689430","doi":"10.1182/blood-2021-148029","title":"Loss of <i>iqgap1</i> (IQ Motif Containing GTPase Activating Protein 1) in Zebrafish Leads to Intracerebellar Hemorrhage, Morphological Abnormalities and Activates Hematopoietic Response","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Intracerebral and Subarachnoid Hemorrhage Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Genetics; Dalhousie University; Agricultural Research Institute of Ontario","funders":"","keywords":"Biology; IQGAP1; Zebrafish; Cell biology; Signal transducing adaptor protein; Genetic screen; Mutant; Signal transduction; Genetics; Scaffold protein; Gene","score_opus":0.01651402387149127,"score_gpt":0.27014400235946934,"score_spread":0.2536299784879781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213689430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949812,0.00047677997,0.00006084233,0.0030751405,0.000024236766,0.0007280602,0.00001792435,0.00006203768,0.00057374773],"genre_scores_gemma":[0.9891572,0.000013355484,0.009460323,0.00039483278,0.00008403187,0.000088017456,0.000013881404,0.0000399147,0.000748449],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972874,0.00038630658,0.0006123907,0.00054524286,0.0005033518,0.0006653448],"domain_scores_gemma":[0.9983789,0.00053097744,0.00011476619,0.00041388243,0.000266505,0.00029497495],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011646133,0.00028560893,0.00073354546,0.00023477909,0.000118741256,0.00005587824,0.00014653048,0.00024008406,0.00025827248],"category_scores_gemma":[0.002616969,0.00025243472,0.000100485035,0.0006314106,0.00020092593,0.00017011359,0.00027270484,0.0007183133,0.000014494035],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029463398,0.0011020649,0.053636745,0.0010953225,0.000048572543,0.009081545,0.0018651033,0.00000715579,0.92672163,0.0002693329,0.00001988953,0.0032063234],"study_design_scores_gemma":[0.0038639875,0.0009128737,0.013463376,0.0005274409,0.000043385327,0.0025727563,0.003317634,0.0003655028,0.97446793,0.00016020646,0.000026224243,0.0002786511],"about_ca_topic_score_codex":0.000060627488,"about_ca_topic_score_gemma":0.000015702268,"teacher_disagreement_score":0.047746357,"about_ca_system_score_codex":0.000065209744,"about_ca_system_score_gemma":0.00029222004,"threshold_uncertainty_score":0.9999928},"labels":[],"label_agreement":null},{"id":"W3213695821","doi":"10.1182/blood-2021-153914","title":"A Pharmacist-Managed Hydroxyurea Prescribing Protocol Improves Uptake and Optimization Among Patients with Sickle Cell Disease within the Southern Alberta Rare Blood and Bleeding Disorders (SARBBD) Comprehensive Care Program","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Foothills Medical Centre","funders":"","keywords":"Medicine; Pharmacist; Disease; Protocol (science); Intensive care medicine; Pharmacy; Internal medicine; Family medicine; Alternative medicine; Pathology","score_opus":0.0059825738023550285,"score_gpt":0.21883369397516808,"score_spread":0.21285112017281305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213695821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9631233,0.00071817933,0.000028699042,0.00017862239,0.000034970803,0.03501661,0.00002717242,0.00010280334,0.0007695994],"genre_scores_gemma":[0.98902804,0.000045196033,0.0012421312,0.0001338967,0.00003720868,0.008988122,0.0001741453,0.00007524774,0.0002760063],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99843735,0.00007880001,0.00030501996,0.00053184363,0.00031128284,0.00033569752],"domain_scores_gemma":[0.99896234,0.000051396455,0.00018508222,0.00030016812,0.00022352707,0.00027747563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000050206025,0.0003276843,0.00029391993,0.000056146015,0.0003873366,0.00014468802,0.00008453565,0.00010726301,0.000012770714],"category_scores_gemma":[0.00006123148,0.00021437512,0.00006866297,0.0002605866,0.00022877776,0.00015354498,0.00012211633,0.00033434934,0.0000011696504],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002239524,0.007020483,0.92644745,0.005847776,0.0017496124,0.0002491828,0.037118178,0.004784936,0.0023287856,0.00002321996,0.000057217218,0.012133629],"study_design_scores_gemma":[0.3453374,0.009975295,0.2252889,0.008264523,0.03462656,0.00021243189,0.22482969,0.12514117,0.01227526,0.00015218457,0.007727148,0.0061694514],"about_ca_topic_score_codex":0.00014247779,"about_ca_topic_score_gemma":0.00011320333,"teacher_disagreement_score":0.7011586,"about_ca_system_score_codex":0.000011118966,"about_ca_system_score_gemma":0.00010478196,"threshold_uncertainty_score":0.87419635},"labels":[],"label_agreement":null},{"id":"W3213696764","doi":"10.1182/blood-2021-147607","title":"Safety and Tolerability of Fedratinib (FEDR), an Oral Inhibitor of Janus Kinase 2 (JAK2), in Patients with Intermediate- or High-Risk Myelofibrosis (MF) Previously Treated with Ruxolitinib (RUX): Results from the Phase 3b FREEDOM Trial","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; St. Paul's Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Ruxolitinib; Myelofibrosis; Janus kinase inhibitor; Medicine; Tolerability; Internal medicine; Janus kinase 2; Extramedullary hematopoiesis; Phases of clinical research; Janus kinase; Adverse effect; Clinical trial; Bone marrow; Haematopoiesis","score_opus":0.013457521453542209,"score_gpt":0.2540983390556299,"score_spread":0.2406408176020877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213696764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934708,0.00012998328,0.0000057836614,0.00018552787,0.00007210369,0.002447709,0.00360984,0.00002632097,0.00005194367],"genre_scores_gemma":[0.99613905,0.00012313551,0.0017214016,0.000058029233,0.00014278904,0.00014411531,0.0016085658,0.000036571942,0.000026346712],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99669075,0.0005533999,0.0011323997,0.00077019783,0.00051619305,0.00033707346],"domain_scores_gemma":[0.9970805,0.0008394175,0.0005842477,0.00079738314,0.00045671474,0.00024174052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038358304,0.00040265717,0.0011974297,0.00007351882,0.00009946327,0.00003624629,0.000113071386,0.00014853336,0.00009530695],"category_scores_gemma":[0.0007776008,0.00021242682,0.000091232665,0.0003949898,0.00031843164,0.00015088209,0.00007459654,0.00026113752,0.0000011482135],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.25162646,0.017264755,0.7236097,0.00007413539,0.0005495147,0.0001203604,0.0018606208,0.000006272999,0.00016701543,0.000009917984,0.000038646853,0.004672586],"study_design_scores_gemma":[0.32665864,0.022524795,0.61785585,0.0006359123,0.0010014551,0.0000052407154,0.00029873705,0.000023667879,0.03074688,0.000008369662,0.000047151367,0.00019332727],"about_ca_topic_score_codex":0.0030303919,"about_ca_topic_score_gemma":0.0052800295,"teacher_disagreement_score":0.105753876,"about_ca_system_score_codex":0.000063444844,"about_ca_system_score_gemma":0.0004085535,"threshold_uncertainty_score":0.86625147},"labels":[],"label_agreement":null},{"id":"W3213704960","doi":"10.1182/blood-2021-153994","title":"Pre-Clinical and Clinical Immunomodulatory Effects of Pomalidomide or CC-92480 in Combination with Bortezomib in Multiple Myeloma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Pomalidomide; Bortezomib; Panobinostat; Multiple myeloma; Dexamethasone; Ixazomib; Proteasome inhibitor; Carfilzomib; Pharmacology; Medicine; Chemistry; Immunology; Cancer research; Internal medicine; Biochemistry","score_opus":0.030104273116348328,"score_gpt":0.34843880240225616,"score_spread":0.31833452928590783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213704960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99799424,0.00082209456,0.000011911617,0.00009493989,0.000060725382,0.0008395306,0.000005591257,0.000016967833,0.00015399157],"genre_scores_gemma":[0.9975653,0.00038052088,0.0016375753,0.000052438358,0.000041045558,0.00004863635,0.000038336668,0.000022176822,0.00021393615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99795204,0.00038828404,0.00069210975,0.00040129496,0.00028748022,0.0002787686],"domain_scores_gemma":[0.997834,0.0013993249,0.00011067652,0.00035630417,0.00011010052,0.00018956837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005651803,0.0001531117,0.0006369161,0.00013340598,0.000025029016,0.000011487241,0.00006433516,0.00016651743,0.00001561922],"category_scores_gemma":[0.0021885172,0.00011249857,0.00008484419,0.00027444417,0.00019881861,0.00007758985,0.00007960821,0.00034621096,0.000005641306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031193728,0.017735992,0.9644657,0.0002552535,0.00029551555,0.0027549306,0.00009323286,2.2484033e-7,0.00075685297,0.000017914732,0.000009547282,0.010495495],"study_design_scores_gemma":[0.12999749,0.0022017325,0.86012137,0.00045087782,0.00011262849,0.00008600572,0.000038804013,0.0003534887,0.006499219,0.000023012286,0.000023736531,0.0000916442],"about_ca_topic_score_codex":0.00019913334,"about_ca_topic_score_gemma":0.000987944,"teacher_disagreement_score":0.12687811,"about_ca_system_score_codex":0.000027842496,"about_ca_system_score_gemma":0.00035709675,"threshold_uncertainty_score":0.45875585},"labels":[],"label_agreement":null},{"id":"W3213746728","doi":"10.1182/blood-2021-147568","title":"Novel Agents May be Preferable to Chemotherapy for Large B-Cell Lymphoma Progressing after CD19-CAR-T: A Multicenter Observational Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stem Cell Network","funders":"","keywords":"Medicine; Interquartile range; Internal medicine; CAR T-cell therapy; Cumulative incidence; Population; Cohort; Oncology; Cytokine release syndrome; Minimal residual disease; Lymphoma; Cancer; Chimeric antigen receptor; Immunotherapy; Leukemia","score_opus":0.09814892694299518,"score_gpt":0.3666650623625426,"score_spread":0.26851613541954744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213746728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938518,0.00021842976,0.00031925508,0.0016785006,0.00012621147,0.0029096392,0.000094132345,0.000058685833,0.0007433472],"genre_scores_gemma":[0.9488683,0.000013527582,0.014313709,0.004304891,0.00038152494,0.0011808402,0.00012636761,0.00010447097,0.030706381],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9977901,0.000055340202,0.0003294067,0.0005725706,0.00066012377,0.00059246755],"domain_scores_gemma":[0.9986548,0.000093497576,0.00005678136,0.0005260057,0.0004311703,0.0002377688],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038709765,0.00023012985,0.0003476079,0.00009703714,0.000119297416,0.00010769902,0.00014557077,0.00009711419,0.0018456295],"category_scores_gemma":[0.0000904507,0.00021383015,0.00016749011,0.0003089617,0.000018814957,0.000099140816,0.000115669754,0.000119882585,0.000030084364],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035584231,0.07194648,0.36241686,0.00042159375,0.0009348683,0.0002693471,0.0046856212,0.0000016212681,0.54801226,0.00001540149,0.0020109338,0.0057266243],"study_design_scores_gemma":[0.14377166,0.0016687725,0.39521402,0.00028095712,0.00042465393,0.00006865181,0.0010287656,0.00058437034,0.30512744,0.000012426103,0.15126386,0.00055442925],"about_ca_topic_score_codex":0.000017190026,"about_ca_topic_score_gemma":0.00004572941,"teacher_disagreement_score":0.2428848,"about_ca_system_score_codex":0.000104177685,"about_ca_system_score_gemma":0.00028751252,"threshold_uncertainty_score":0.9990668},"labels":[],"label_agreement":null},{"id":"W3213759191","doi":"10.1182/blood-2021-149339","title":"Outcomes Following Biochemical or Clinical Progression in Patients with Multiple Myeloma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Multiple myeloma; Plasma cell leukemia; Internal medicine; Creatinine; Lenalidomide; Gastroenterology; Surgery; Oncology","score_opus":0.03303626481738194,"score_gpt":0.3652707919915378,"score_spread":0.33223452717415586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213759191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99886394,0.00012053258,0.000003699526,0.00018989679,0.000059531787,0.000508552,0.0000088691095,0.000041093776,0.00020391827],"genre_scores_gemma":[0.9933036,0.000007337766,0.0060529183,0.0000921774,0.00003453965,0.000047903653,0.00015133491,0.000023279154,0.00028693693],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984105,0.00007709676,0.00031532062,0.00037056103,0.00047750588,0.00034897312],"domain_scores_gemma":[0.9990742,0.00021974008,0.000043630578,0.00031590762,0.00008738298,0.000259106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012716587,0.000149041,0.00039137996,0.00006324928,0.0000418378,0.000016967728,0.00006236506,0.0001096906,0.00006586629],"category_scores_gemma":[0.0011360539,0.00008566886,0.00013268279,0.0002385848,0.000042072683,0.000054736254,0.00008487794,0.0002223855,0.000034076387],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088002475,0.0063548815,0.9809606,0.00003437716,0.00029762083,0.0018597597,0.00002409209,3.26698e-8,0.0002167545,8.764813e-7,0.0000448234,0.009326179],"study_design_scores_gemma":[0.03984331,0.00072389585,0.9524542,0.00024116109,0.000102932914,0.0000086570735,0.0000241663,0.000013106041,0.0063956752,0.0000021059084,0.00009104481,0.000099719546],"about_ca_topic_score_codex":0.00000986586,"about_ca_topic_score_gemma":0.000034576915,"teacher_disagreement_score":0.038963284,"about_ca_system_score_codex":0.000029231498,"about_ca_system_score_gemma":0.00019934657,"threshold_uncertainty_score":0.34934744},"labels":[],"label_agreement":null},{"id":"W3213759856","doi":"10.1182/blood-2021-147809","title":"Haploidentical Allogeneic Stem Cell Transplantation in Sickle Cell Disease: A Systematic Review and Meta-Analysis","year":2021,"lang":"en","type":"review","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Transplantation; Internal medicine; Hematopoietic stem cell transplantation; Disease; Stem cell; Cumulative incidence; Sibling; Meta-analysis; Oncology","score_opus":0.03518822136616573,"score_gpt":0.29526921353847096,"score_spread":0.26008099217230524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213759856","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000018364215,0.9965759,0.000019972684,0.00009699165,0.000016950427,0.0029373723,0.00011538985,0.00002685385,0.0001921833],"genre_scores_gemma":[0.00010332603,0.99682546,0.00004449312,0.00022306397,0.000009812953,0.00044802076,0.0004753344,0.000049079918,0.0018214247],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9967683,0.0006368448,0.0013345353,0.00060572656,0.0003742927,0.00028032187],"domain_scores_gemma":[0.998545,0.0001609678,0.0003544797,0.0005936387,0.00006219301,0.00028374032],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047558246,0.00048018768,0.0080759665,0.00030845628,0.000037882626,0.000036153746,0.0001266621,0.00029011216,0.00021568414],"category_scores_gemma":[0.000027125128,0.00030857112,0.0028615207,0.0010770982,0.000035913457,0.000034912766,0.0000317581,0.0003970987,0.00004572702],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000001359403,0.00045881755,0.0000052711816,0.9531313,0.045352347,0.00079532695,0.00003513993,5.122502e-7,2.6357253e-7,0.000006650496,0.000019501464,0.00019350495],"study_design_scores_gemma":[0.00045022654,0.000024655794,0.0000018538635,0.07778755,0.91817445,0.0001131647,0.000029920353,0.0000018061029,0.0000013231053,8.194445e-7,0.0031556345,0.0002586106],"about_ca_topic_score_codex":0.00001034415,"about_ca_topic_score_gemma":0.000010189659,"teacher_disagreement_score":0.87534374,"about_ca_system_score_codex":0.000030245115,"about_ca_system_score_gemma":0.00024087596,"threshold_uncertainty_score":0.99993664},"labels":[],"label_agreement":null},{"id":"W3213761918","doi":"10.1182/blood-2021-153826","title":"A Phase II Study of Mini-Hyper-CVD Plus Venetoclax in Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Venetoclax; Lymphoblastic Leukemia; Medicine; Philadelphia chromosome; Acute lymphocytic leukemia; Internal medicine; Leukemia; Oncology; Cancer research; Immunology; Chromosomal translocation; Biology; Genetics; Chronic lymphocytic leukemia; Gene","score_opus":0.013372712386807093,"score_gpt":0.27751988986173093,"score_spread":0.26414717747492383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213761918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976398,0.00008937758,0.00002061649,0.00010913233,0.00007526934,0.001513277,0.00009840713,0.000047056015,0.0004070989],"genre_scores_gemma":[0.9986306,0.00001501804,0.0005206359,0.000111273264,0.00011159672,0.00014894376,0.00011241347,0.00007919281,0.00027035922],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99655485,0.00014971371,0.0006692607,0.0007427802,0.0012336096,0.0006497601],"domain_scores_gemma":[0.99780893,0.0002771711,0.0002125703,0.0007969976,0.0005892565,0.0003150531],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015034567,0.00038735286,0.0009872308,0.00032480116,0.000111119705,0.000020181114,0.0002679141,0.00017314167,0.0001645481],"category_scores_gemma":[0.00038891038,0.0003195899,0.00009342007,0.0013043451,0.00020059872,0.00014315784,0.00034451514,0.0003656205,0.000029244105],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06683068,0.3188724,0.38595906,0.0026743696,0.020999124,0.035161585,0.07275543,0.0023370225,0.082724854,0.00013783484,0.0043364833,0.0072111664],"study_design_scores_gemma":[0.7040829,0.07878909,0.14406794,0.0015214607,0.0037490642,0.0005302078,0.0048468527,0.0032276213,0.05789051,0.000042621847,0.00017425367,0.0010774884],"about_ca_topic_score_codex":0.00023363662,"about_ca_topic_score_gemma":0.00012145067,"teacher_disagreement_score":0.6372522,"about_ca_system_score_codex":0.0022763961,"about_ca_system_score_gemma":0.006399619,"threshold_uncertainty_score":0.9999256},"labels":[],"label_agreement":null},{"id":"W3213772215","doi":"10.1182/blood-2021-145890","title":"Surgical Experience from the Phase III STASEY Trial of Emicizumab Prophylaxis in Persons with Hemophilia A with FVIII Inhibitors: Final Analysis","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Haemophilia A; Bleed; Surgery; Pediatrics; Internal medicine; Haemophilia","score_opus":0.03010807187877028,"score_gpt":0.3155033294459192,"score_spread":0.2853952575671489,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213772215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977573,0.0004364211,0.000006005056,0.0007470735,0.00001769323,0.00064379815,0.000077873556,0.000015156611,0.00029867206],"genre_scores_gemma":[0.99879897,0.000036490266,0.0002535179,0.000018356775,0.00019983859,0.000100262194,0.00014299419,0.000014582171,0.0004350039],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99808145,0.00014506116,0.00031643338,0.00042742974,0.00072237424,0.0003072828],"domain_scores_gemma":[0.99891204,0.00021237189,0.000080599835,0.0005111836,0.00013786912,0.00014596371],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017353221,0.00018470394,0.00057584455,0.00014395834,0.00008234744,0.000024358724,0.00011770631,0.000090179296,0.00030538495],"category_scores_gemma":[0.00007507017,0.00009343116,0.00016624745,0.0015880796,0.00027850195,0.00005684712,0.000049130736,0.0003020485,0.000002981443],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.35747275,0.04715519,0.49182308,0.00017524765,0.008800709,0.035358813,0.033099752,0.00003749611,0.017910497,0.000078244906,0.0002558121,0.007832423],"study_design_scores_gemma":[0.80505425,0.017429383,0.008472171,0.0005942218,0.0043547265,0.00037738713,0.01217028,0.00026351726,0.1499926,0.000018433835,0.0007739051,0.00049910345],"about_ca_topic_score_codex":0.0005143273,"about_ca_topic_score_gemma":0.0003978488,"teacher_disagreement_score":0.4833509,"about_ca_system_score_codex":0.000041665622,"about_ca_system_score_gemma":0.0005439658,"threshold_uncertainty_score":0.3810012},"labels":[],"label_agreement":null},{"id":"W3213788905","doi":"10.1182/blood-2021-147391","title":"Outcomes and Health Resource Utilization Among Second-Line Therapies for Immune Thrombocytopenia: A Provincial Retrospective Cohort Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of Alberta Hospital; Alberta Hospital Edmonton","funders":"","keywords":"Medicine; Rituximab; Splenectomy; Retrospective cohort study; Cumulative incidence; Azathioprine; Internal medicine; Romiplostim; Cohort; Incidence (geometry); Pediatrics; Thrombopoietin; Lymphoma","score_opus":0.03055335470108172,"score_gpt":0.31486981789324237,"score_spread":0.28431646319216064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213788905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948494,0.0016884626,0.000030337314,0.0006088247,0.000036273577,0.0021379236,0.000043464293,0.00004448398,0.0005608717],"genre_scores_gemma":[0.9978166,0.00006149354,0.00019915123,0.00021967401,0.000035740653,0.00012887245,0.0001394452,0.00002289118,0.0013761222],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908316,0.00003935283,0.00022891788,0.00031074352,0.0001578705,0.00017995776],"domain_scores_gemma":[0.9995224,0.00002782253,0.000093713184,0.00019971389,0.0000945205,0.000061851686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002060326,0.00013879118,0.0006152732,0.000036495177,0.00015856136,0.000026930798,0.000029543293,0.00004845468,0.000052164352],"category_scores_gemma":[0.000055937748,0.00010933011,0.00006046614,0.00009738443,0.00003456574,0.000048014706,0.000034056975,0.00008031313,0.0000011520887],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000065355445,0.0022521804,0.99462223,0.000045290635,0.0007854306,0.00008642849,0.0011774744,1.11270595e-7,0.00006455718,0.000041754458,0.00007819182,0.00078099204],"study_design_scores_gemma":[0.010452241,0.0012585858,0.9856735,0.000026618729,0.00030686954,0.000028345692,0.0011374943,0.000013215372,0.00074161263,0.00011503828,0.00015963044,0.00008684666],"about_ca_topic_score_codex":0.00018209807,"about_ca_topic_score_gemma":0.0017130935,"teacher_disagreement_score":0.010386885,"about_ca_system_score_codex":0.000046909016,"about_ca_system_score_gemma":0.000119326636,"threshold_uncertainty_score":0.44583526},"labels":[],"label_agreement":null},{"id":"W3213815301","doi":"10.1182/blood-2021-154267","title":"Clinical Features Associated with Long-Term Ruxolitinib Exposure in Myelofibrosis and Predictive Role of Neutrophils","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ruxolitinib; Myelofibrosis; Term (time); Medicine; Immunology; Internal medicine; Bone marrow","score_opus":0.012904061510805705,"score_gpt":0.27611957133891113,"score_spread":0.26321550982810543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213815301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99526775,0.0030105042,0.0000012173407,0.00028734503,0.00002531623,0.00035493224,0.00009131269,0.000019047147,0.0009425477],"genre_scores_gemma":[0.99858683,0.00061211345,0.00025825534,0.00012796443,0.00007967104,0.00006342766,0.00013459673,0.000018966679,0.00011816704],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998728,0.00013979827,0.0003477658,0.00035450753,0.00022143495,0.00020848698],"domain_scores_gemma":[0.99904495,0.00029897882,0.000125436,0.00020797043,0.00018434737,0.00013834158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013218213,0.00016757517,0.00055929297,0.0000567935,0.000032855674,0.000014493608,0.000034331846,0.0001527563,0.00004013466],"category_scores_gemma":[0.00021847965,0.00012372492,0.00008293873,0.0001829061,0.00009899264,0.000045339704,0.000040549516,0.00020849096,0.0000012939734],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002869227,0.0034610901,0.99243176,0.00004525874,0.00064466393,0.00041715245,0.00033348484,0.00000118074,0.0010841785,0.00011046549,0.000021586939,0.0011622797],"study_design_scores_gemma":[0.009128003,0.0022615355,0.95916814,0.0005918873,0.0005578267,0.0000899565,0.00013765434,0.000002787546,0.027910113,0.00004332038,0.00001012848,0.00009865778],"about_ca_topic_score_codex":0.000012646175,"about_ca_topic_score_gemma":0.0001452611,"teacher_disagreement_score":0.03326361,"about_ca_system_score_codex":0.000022429684,"about_ca_system_score_gemma":0.00014848914,"threshold_uncertainty_score":0.5045356},"labels":[],"label_agreement":null},{"id":"W3213817406","doi":"10.1182/blood-2021-148652","title":"Impact of Allogeneic Hematopoietic Cell Transplantation (HCT) As Consolidation Following CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy for Treatment of Relapsed Acute Lymphoblastic Leukemia (ALL)","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Chimeric antigen receptor; Hematopoietic cell; Medicine; Hematopoietic stem cell transplantation; Transplantation; Hematologic Neoplasms; Acute lymphocytic leukemia; CD19; Immunology; Cancer research; Antigen; Lymphoblastic Leukemia; Leukemia; Oncology; Haematopoiesis; Stem cell; Internal medicine; T cell; Biology; Immune system","score_opus":0.01989192779643441,"score_gpt":0.3112064418056722,"score_spread":0.2913145140092378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213817406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99565387,0.0019166694,0.00022737929,0.00003306372,0.000104804116,0.0013121364,0.00011283756,0.000032920525,0.00060632586],"genre_scores_gemma":[0.9898275,0.006901568,0.0012537917,0.000026043945,0.00006603149,0.00009940978,0.00071204157,0.00006951953,0.0010440821],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982008,0.00012229428,0.0005173116,0.0003935333,0.0003996432,0.00036642814],"domain_scores_gemma":[0.99872893,0.0002806827,0.00021504087,0.00042620255,0.00019823918,0.00015088954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015557124,0.00027342947,0.00068696664,0.00016414172,0.000054228927,0.000015370633,0.00009903962,0.00015775,0.00083643716],"category_scores_gemma":[0.000021564196,0.00023081237,0.0007118564,0.00032452284,0.000053723732,0.0000652455,0.000009139954,0.00005774288,0.000020011516],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017743232,0.0018892037,0.01116278,0.00024051621,0.0015930322,0.00007661029,0.0017128757,0.000046927045,0.9795054,0.0000031752077,0.000028096363,0.0019670266],"study_design_scores_gemma":[0.023236541,0.0051322235,0.0071388534,0.00009445249,0.0010559406,0.00010174821,0.00016673729,0.00005726791,0.9626997,0.000025164798,0.00011369438,0.0001776626],"about_ca_topic_score_codex":0.00019398237,"about_ca_topic_score_gemma":0.000005898539,"teacher_disagreement_score":0.021462217,"about_ca_system_score_codex":0.00028788584,"about_ca_system_score_gemma":0.0011633243,"threshold_uncertainty_score":0.9412255},"labels":[],"label_agreement":null},{"id":"W3213855053","doi":"10.1182/blood-2021-153613","title":"An Open-Label, First-in-Human, Phase I Trial of Daily Pclx-001","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Spinal Cord Injury BC; University of Alberta","funders":"","keywords":"Tolerability; Medicine; Pharmacokinetics; In vivo; Lymphoma; Cancer; Internal medicine; Oncology; Pharmacology; Cancer research; Adverse effect; Biology","score_opus":0.0352055203736284,"score_gpt":0.32358763230811494,"score_spread":0.28838211193448654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213855053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932261,0.0005170074,0.000016690616,0.000050978968,0.00008931967,0.00031936265,0.0000770568,0.0000066233783,0.0056968243],"genre_scores_gemma":[0.99782443,0.00008333954,0.00060408155,0.00011593734,0.00024935603,0.000053207455,0.00045131517,0.000018251343,0.0006000543],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990722,0.00008947774,0.00023933372,0.00031971058,0.00009393604,0.00018531819],"domain_scores_gemma":[0.99929696,0.000008387328,0.00007505274,0.00047436173,0.00007004167,0.00007521898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002123331,0.000109755674,0.00018292908,0.000023626031,0.000053519376,0.00003448397,0.00033101108,0.00012607162,0.00015135929],"category_scores_gemma":[0.00006935133,0.00011415691,0.000028791475,0.000088102955,0.000035830977,0.000005578681,0.00017554169,0.00007190204,0.0000063189286],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015075787,0.009842412,0.00013774811,0.000026310398,0.000038679,0.00003922706,0.00003893266,7.9199594e-7,0.9866431,0.00019150277,0.00039083668,0.0011429252],"study_design_scores_gemma":[0.14021851,0.002811145,0.0000362438,0.00001716107,0.000025415284,0.000011827053,0.0000259063,0.000005068804,0.8405656,0.00011339493,0.016032325,0.00013737509],"about_ca_topic_score_codex":0.000038843056,"about_ca_topic_score_gemma":0.00016819852,"teacher_disagreement_score":0.14607742,"about_ca_system_score_codex":0.00000308572,"about_ca_system_score_gemma":0.000105559346,"threshold_uncertainty_score":0.46551836},"labels":[],"label_agreement":null},{"id":"W3213874179","doi":"10.1182/blood-2021-149921","title":"<i>BTG1</i> Mutation Promotes Aggressive Lymphoma Development By Lowering the Threshold to MYC Activation and Generating \"Super-Competitor\" B Cells","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Biology; Germinal center; Mutation; Germline; Phenotype; Diffuse large B-cell lymphoma; Somatic hypermutation; B cell; Genetics; Missense mutation; Lymphoma; Cancer research; Gene; Immunology; Antibody","score_opus":0.004725535511844357,"score_gpt":0.2048363059420003,"score_spread":0.20011077043015596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213874179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99585134,0.0012263322,0.0022534244,0.00022591148,0.000120080615,0.00020019647,0.0000051323254,0.000012113411,0.000105446015],"genre_scores_gemma":[0.9970994,0.000053751784,0.0020031338,0.00016532652,0.00024671198,0.00004390427,0.00015803515,0.00001941985,0.00021029642],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992544,0.00002499781,0.00015635834,0.00029574343,0.00012537747,0.00014312839],"domain_scores_gemma":[0.9995951,0.000010837591,0.00008611994,0.0001687665,0.000093405964,0.000045752833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007686393,0.0001161749,0.000075673226,0.000016965858,0.0001664853,0.00006206743,0.00006158341,0.000089954636,0.0000054159705],"category_scores_gemma":[0.000042315813,0.00010404881,0.000023547698,0.000095001225,0.000018546634,0.0000067492574,0.000082419865,0.000036162444,0.0000028785169],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000908685,0.00005603955,0.00021429898,0.000011536009,0.00004746167,0.0000025519207,0.00031489393,0.0004437419,0.987703,0.0000036075767,0.00028726814,0.01090647],"study_design_scores_gemma":[0.00056090864,0.000051381983,0.00081838155,0.000047188187,0.000019526804,0.000029339511,0.000085236534,0.00015417898,0.99388874,0.0000065564436,0.0041987128,0.00013984661],"about_ca_topic_score_codex":0.0000056155914,"about_ca_topic_score_gemma":0.000024404046,"teacher_disagreement_score":0.010766623,"about_ca_system_score_codex":0.00002293377,"about_ca_system_score_gemma":0.000115672905,"threshold_uncertainty_score":0.42429873},"labels":[],"label_agreement":null},{"id":"W3213879987","doi":"10.1182/blood-2021-148302","title":"Tafasitamab Plus Lenalidomide Versus Pola-BR, R2, and CAR T: Comparing Outcomes from RE-MIND2, an Observational, Retrospective Cohort Study in Relapsed/Refractory Diffuse Large B-Cell Lymphoma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Internal medicine; Propensity score matching; Lenalidomide; Cohort; Population; Diffuse large B-cell lymphoma; Chemotherapy regimen; Retrospective cohort study; Regimen; Oncology; Surgery; Cancer; Lymphoma; Multiple myeloma","score_opus":0.0768311610291272,"score_gpt":0.3310662052840418,"score_spread":0.2542350442549146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213879987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946759,0.0010226028,0.0000028349132,0.00016481962,0.00026501418,0.001028456,0.00008278749,0.00007440808,0.0026831836],"genre_scores_gemma":[0.9971748,0.00011630869,0.00021197705,0.00016054898,0.00021379524,0.00007660725,0.0002418895,0.00007356519,0.0017305161],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99673146,0.00033688228,0.0005266904,0.00088561047,0.0009813827,0.00053796184],"domain_scores_gemma":[0.99790084,0.0005032336,0.00013293736,0.00090582075,0.00026396176,0.00029323177],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000650905,0.0003350183,0.0009843129,0.0001946093,0.00015840887,0.00009180749,0.00020246238,0.0001843963,0.0005662581],"category_scores_gemma":[0.00043902893,0.00033120374,0.00012728744,0.00042386763,0.00008054078,0.00018919731,0.000242543,0.0004975722,0.000021367166],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016828834,0.015304762,0.96069074,0.000026266262,0.0006112261,0.0009393666,0.002370149,0.0000016649841,0.018177744,0.000029500132,0.00007432234,0.00009134989],"study_design_scores_gemma":[0.12651148,0.0006648643,0.8645998,0.000048455855,0.0003426039,0.000012232992,0.0033947688,0.00015814485,0.003748627,0.00003333743,0.00021560819,0.0002700457],"about_ca_topic_score_codex":0.0019375217,"about_ca_topic_score_gemma":0.0040266314,"teacher_disagreement_score":0.12482859,"about_ca_system_score_codex":0.0006689234,"about_ca_system_score_gemma":0.00043062886,"threshold_uncertainty_score":0.999914},"labels":[],"label_agreement":null},{"id":"W3213903705","doi":"10.1182/blood-2021-149681","title":"Safety and Efficacy of Apixaban Thromboprophylaxis in Ambulatory Cancer Patients By Renal Function: A Subgroup Analysis of the Avert Trial","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Apixaban; Renal function; Randomization; Placebo; Ambulatory; Internal medicine; Subgroup analysis; Surgery; Randomized controlled trial; Warfarin; Meta-analysis; Rivaroxaban; Atrial fibrillation","score_opus":0.007835092970374984,"score_gpt":0.23930815130522556,"score_spread":0.23147305833485057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213903705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979018,0.0010130642,0.000010117744,0.00010722124,0.00014484368,0.00041696153,0.00004058784,0.0000054978236,0.00035988574],"genre_scores_gemma":[0.9991593,0.00046630763,0.00002664042,0.00014809326,0.000044070515,0.000017563381,0.000038339924,0.000008844807,0.00009085056],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989201,0.00005658103,0.0003736678,0.00022802963,0.00029863344,0.00012303305],"domain_scores_gemma":[0.9993759,0.000045102297,0.00014789528,0.00029641337,0.00009163067,0.000043071905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013100033,0.00009838873,0.00056768605,0.00008913553,0.000034639255,0.0000049050823,0.00005566897,0.000055442662,0.00019290533],"category_scores_gemma":[0.000051333296,0.00007146972,0.0002038287,0.00075717835,0.00006519354,0.00002675021,0.00008071357,0.000085186584,3.8638794e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006075724,0.021166638,0.93127555,0.00041965686,0.012503537,0.00000793536,0.0016850975,0.000112196525,0.013287207,0.00029341422,0.0020318355,0.011141184],"study_design_scores_gemma":[0.032459214,0.00050168746,0.9570233,0.00009517316,0.0042408947,2.2427608e-7,0.00004923593,0.000026899563,0.0044620708,0.0000059388453,0.0010686419,0.0000667187],"about_ca_topic_score_codex":0.00042501805,"about_ca_topic_score_gemma":0.00036685396,"teacher_disagreement_score":0.026383491,"about_ca_system_score_codex":0.000028400667,"about_ca_system_score_gemma":0.00006447731,"threshold_uncertainty_score":0.29144508},"labels":[],"label_agreement":null},{"id":"W3213933946","doi":"10.1182/blood-2021-153146","title":"Long-Term Results of Alliance A041202 Show Continued Advantage of Ibrutinib-Based Regimens Compared with Bendamustine Plus Rituximab (BR) Chemoimmunotherapy","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Chemoimmunotherapy; Bendamustine; Ibrutinib; Rituximab; Medicine; Internal medicine; Oncology; Lymphoma; Chronic lymphocytic leukemia; Leukemia","score_opus":0.022792972030502113,"score_gpt":0.2977375818499089,"score_spread":0.27494460981940677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213933946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99271685,0.0028695578,0.0001304296,0.00046423887,0.000059962724,0.00073877454,0.00018690997,0.000068879854,0.0027644183],"genre_scores_gemma":[0.99231297,0.00022288902,0.0042199665,0.00014041192,0.00009134968,0.000028146738,0.00036626693,0.00006742893,0.0025505803],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99708426,0.00009941921,0.0007961542,0.0005822361,0.0008977106,0.0005402388],"domain_scores_gemma":[0.997041,0.00035221956,0.00042865015,0.0012985405,0.0007020948,0.0001775372],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035600417,0.00030420354,0.0011114033,0.00009537022,0.000048203045,0.000016912729,0.00028730088,0.00014893706,0.0002041656],"category_scores_gemma":[0.00029902364,0.00026132067,0.00018054659,0.00057134056,0.00041485735,0.00006436739,0.00008465465,0.0003023548,0.000012197056],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05412696,0.01988646,0.019944165,0.00683043,0.0033521603,0.007957981,0.0023453936,0.00026246277,0.879672,0.0001588576,0.0022579955,0.0032051217],"study_design_scores_gemma":[0.30549303,0.0007980664,0.0114583615,0.0017905458,0.00036002984,0.00035190248,0.00017488515,0.0011285569,0.6774325,0.0000027505812,0.00074646395,0.00026291655],"about_ca_topic_score_codex":0.00016871422,"about_ca_topic_score_gemma":0.00012880386,"teacher_disagreement_score":0.25136608,"about_ca_system_score_codex":0.00092845986,"about_ca_system_score_gemma":0.0069640777,"threshold_uncertainty_score":0.9999839},"labels":[],"label_agreement":null},{"id":"W3213943548","doi":"10.1182/blood-2021-148227","title":"First Year Comparison of Sickle Cell Pediatric Cohorts from Haiti and Miami (CSHSCD Multicenter Study): Baseline Data","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Medicine; Miami; Interquartile range; Sickle cell anemia; Pediatrics; Cohort; Demography; Internal medicine; Disease","score_opus":0.018845860954145213,"score_gpt":0.2661452895322131,"score_spread":0.24729942857806791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213943548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99032813,0.008125596,0.000039299022,0.00024779135,0.00013221511,0.0003203451,0.0002131818,0.000028852972,0.00056460284],"genre_scores_gemma":[0.99692804,0.0009075887,0.001266682,0.000070008144,0.0001448901,0.0000028647592,0.00037191735,0.00002101631,0.0002870218],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988429,0.000052626867,0.0003400931,0.0003702017,0.00022650664,0.00016769944],"domain_scores_gemma":[0.9989634,0.00011715393,0.00008998903,0.0006376719,0.000073192496,0.00011855337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013610038,0.00012882326,0.00038600023,0.00004549198,0.000053125696,0.000013303629,0.00010788003,0.0000999445,0.000251015],"category_scores_gemma":[0.00012392124,0.000111441135,0.000037788548,0.00015944599,0.00003600621,0.000046080706,0.00022390665,0.00019631827,0.000027553713],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055484572,0.005901907,0.9877251,0.00019223857,0.00012975658,0.0001622484,0.0007890315,0.000006920196,0.00050801306,8.8277005e-7,0.004309537,0.00021890928],"study_design_scores_gemma":[0.066230215,0.0016254073,0.82954925,0.00040667437,0.010401132,0.000034935892,0.031731393,0.012154158,0.017325183,0.00002248852,0.029576154,0.0009429811],"about_ca_topic_score_codex":0.00030521856,"about_ca_topic_score_gemma":0.00020604504,"teacher_disagreement_score":0.1581758,"about_ca_system_score_codex":0.0000052678956,"about_ca_system_score_gemma":0.00006215294,"threshold_uncertainty_score":0.45444375},"labels":[],"label_agreement":null},{"id":"W3213958873","doi":"10.1182/blood-2021-153189","title":"Initial Results of Phase I/II Study of Azacitidine in Combination with Quizartinib for Patients with Myelodysplastic Syndrome and Myelodysplastic/Myeloproliferative Neoplasm with <i>FLT3</i> or <i>CBL</i> Mutations","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Azacitidine; Medicine; Tolerability; Hypomethylating agent; Myelodysplastic syndromes; Internal medicine; Phases of clinical research; Decitabine; Oncology; Clinical trial; Adverse effect; Bone marrow; Biology; Genetics","score_opus":0.016054618808344186,"score_gpt":0.29324784245792823,"score_spread":0.27719322364958404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213958873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956361,0.000017197255,0.000416415,0.00016084765,0.000025557996,0.0030372315,0.00047468705,0.00002908673,0.00020288474],"genre_scores_gemma":[0.99522686,0.0000071890304,0.0036138617,0.0000351235,0.000023872803,0.000355389,0.00052808656,0.00006158473,0.00014804103],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972891,0.00014004209,0.0007666177,0.00060145365,0.00079071557,0.0004120405],"domain_scores_gemma":[0.99668354,0.0009164834,0.00037558627,0.00036159236,0.0014682818,0.00019452555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002550696,0.00033057464,0.0008283996,0.00036586024,0.00014892695,0.000022408325,0.00010341406,0.00010015891,0.000012851992],"category_scores_gemma":[0.0007644443,0.00022406096,0.000029764054,0.0011795933,0.00030144735,0.00023332477,0.00008639064,0.00030952107,8.3847993e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.31466976,0.2079675,0.39963245,0.0041628308,0.0057936697,0.007602647,0.04044829,0.0009142081,0.013084348,0.0004928932,0.00022724726,0.005004164],"study_design_scores_gemma":[0.56310296,0.23298328,0.15364835,0.002025024,0.00228399,0.0012437921,0.007314048,0.0009921906,0.03562632,0.000040207397,0.000048059865,0.00069177226],"about_ca_topic_score_codex":0.000057709076,"about_ca_topic_score_gemma":0.00080971734,"teacher_disagreement_score":0.24843323,"about_ca_system_score_codex":0.00007036445,"about_ca_system_score_gemma":0.0011460317,"threshold_uncertainty_score":0.9136941},"labels":[],"label_agreement":null},{"id":"W3213958976","doi":"10.1182/blood-2021-147548","title":"An Open-Source Toolkit That Powers the Genome-Wide Analysis of Mature B-Cell Lymphomas (GAMBL) Project","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Spinal Cord Injury BC; Simon Fraser University","funders":"","keywords":"Exome; Genome; Computational biology; Biology; Lymphoma; Genomics; Exome sequencing; Bioinformatics; Gene; Genetics; Mutation","score_opus":0.01033080460477089,"score_gpt":0.24586185344611797,"score_spread":0.23553104884134707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213958976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906999,0.0036791998,0.00026613253,0.00013598836,0.00006624559,0.00020258254,0.00016794643,0.000006333844,0.004775694],"genre_scores_gemma":[0.9959466,0.00092704204,0.000557649,0.00089689734,0.00009286119,0.000019190677,0.00056412787,0.000025964735,0.0009696854],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99905246,0.00006523145,0.00017652464,0.0003788577,0.00012609264,0.00020082807],"domain_scores_gemma":[0.99882925,0.000039142713,0.00012020514,0.0008466907,0.00010585141,0.000058893344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015518752,0.00014275174,0.00022831446,0.000048731086,0.000078306715,0.00010909706,0.00054722436,0.00012347229,0.000046950405],"category_scores_gemma":[0.00006435114,0.00011578426,0.00015949576,0.00037189535,0.00005284233,0.0000042111938,0.0003297099,0.00006291805,0.0000021093417],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014506432,0.0017164472,0.07396043,0.00004604281,0.0026412301,0.000044697947,0.0006554471,0.0015068554,0.9149995,0.00014713666,0.0032763153,0.0008608433],"study_design_scores_gemma":[0.002276223,0.00039102868,0.041857876,0.000009038474,0.0023164048,0.000020990852,0.0011781593,0.00008116867,0.72845435,0.00003108082,0.22297268,0.00041101183],"about_ca_topic_score_codex":0.00014893568,"about_ca_topic_score_gemma":0.0003595045,"teacher_disagreement_score":0.21969636,"about_ca_system_score_codex":0.000011153842,"about_ca_system_score_gemma":0.00029465696,"threshold_uncertainty_score":0.47215453},"labels":[],"label_agreement":null},{"id":"W3213971798","doi":"10.1182/blood-2021-149875","title":"Recurrent VTE in Pregnant Woman with Previous Personal History of VTE: A Systematic Review and Meta-Analysis","year":2021,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Pregnancy; Pulmonary embolism; Meta-analysis; Low molecular weight heparin; MEDLINE; Thrombosis; Deep vein; Venous thromboembolism; Venous thrombosis; Funnel plot; Thrombophilia; Obstetrics; Intensive care medicine; Pediatrics; Publication bias; Surgery; Internal medicine","score_opus":0.07138066384836407,"score_gpt":0.3151809352081974,"score_spread":0.24380027135983334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213971798","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000033248102,0.9940291,0.0000026709686,0.0000722044,0.000027374293,0.005439589,0.000034316974,0.000016031185,0.00037540236],"genre_scores_gemma":[0.000010577619,0.9956978,0.00014697896,0.0002464004,0.000015662996,0.0021548527,0.00010560383,0.000047530877,0.0015745815],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9966032,0.00052475976,0.0013987985,0.0006766676,0.0005281711,0.00026843758],"domain_scores_gemma":[0.99770755,0.00013228542,0.0010566764,0.0008426713,0.00012283165,0.00013800412],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0007946067,0.00052058295,0.016685475,0.00043341628,0.000016352475,0.000011547341,0.00016920497,0.00012335644,0.0003288384],"category_scores_gemma":[0.00014266599,0.00031539655,0.0022044892,0.0006953785,0.000065218774,0.00003264664,0.00011525113,0.00028809934,0.000005395282],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[8.5617586e-7,0.0012122662,0.000001478347,0.8076109,0.1880873,0.00015058747,0.00020108963,2.9054734e-8,1.0084416e-8,0.000028370969,0.00057035347,0.0021366996],"study_design_scores_gemma":[0.00023683075,0.00017928604,0.0000038906387,0.29178518,0.6500639,0.00008365364,0.000017628736,4.0060058e-7,4.0239346e-8,2.3278443e-7,0.05744452,0.00018443796],"about_ca_topic_score_codex":0.000047748905,"about_ca_topic_score_gemma":0.00007624399,"teacher_disagreement_score":0.51582575,"about_ca_system_score_codex":0.00024652103,"about_ca_system_score_gemma":0.00045055905,"threshold_uncertainty_score":0.9999298},"labels":[],"label_agreement":null},{"id":"W3213974098","doi":"10.1182/blood-2021-145723","title":"Analysis of Duration of Response, Exposure-Adjusted Safety and Progression to Acute Myeloid Leukemia (AML) for Patients with Lower-Risk Myelodysplastic Syndromes (LR-MDS) Receiving Luspatercept in the MEDALIST Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Myelodysplastic syndromes; Medicine; Myeloid leukemia; Internal medicine; Oncology; Leukemia; Cytarabine; Bone marrow","score_opus":0.01253221888091933,"score_gpt":0.286206911600602,"score_spread":0.2736746927196827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213974098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968442,0.000074708005,0.0003716497,0.00025938184,0.00003253505,0.00222751,0.00014850081,0.000017643582,0.000023870183],"genre_scores_gemma":[0.9980347,0.000069827176,0.0013581697,0.00003152986,0.000018906634,0.00015640589,0.0001856134,0.0000318808,0.000112923124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99689436,0.00069924636,0.00071290554,0.0005125341,0.00085310644,0.0003278191],"domain_scores_gemma":[0.9972892,0.00095826393,0.0003305224,0.0006383667,0.00066013326,0.00012353303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014995756,0.00023272568,0.00078801555,0.00061023905,0.00011784647,0.000029982408,0.00019754957,0.000116420786,0.000026220696],"category_scores_gemma":[0.0017367837,0.00015179026,0.00010412729,0.0022694624,0.000098338656,0.00011241959,0.00013665887,0.00026068065,8.461466e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017458837,0.0020032183,0.95816946,0.00020004882,0.0025813952,0.00015807888,0.00707299,0.00016666875,0.008929912,0.0000025030188,0.000030024492,0.003226891],"study_design_scores_gemma":[0.011465958,0.005378944,0.9720732,0.00031217816,0.0045859884,0.000022187962,0.0025726021,0.0006119203,0.0027948746,0.000001415664,0.000027122065,0.00015359276],"about_ca_topic_score_codex":0.00012590211,"about_ca_topic_score_gemma":0.0007343645,"teacher_disagreement_score":0.013903785,"about_ca_system_score_codex":0.00020642996,"about_ca_system_score_gemma":0.00047650872,"threshold_uncertainty_score":0.6189827},"labels":[],"label_agreement":null},{"id":"W3213981466","doi":"10.1182/blood-2021-148155","title":"Majic: A Phase 3 Prospective, Multicenter, Randomized, Open-Label Trial of Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Venetoclax; Obinutuzumab; Ibrutinib; Medicine; Chronic lymphocytic leukemia; IGHV@; Internal medicine; Neutropenia; Tumor lysis syndrome; Oncology; Regimen; Leukemia; Chemotherapy","score_opus":0.06305773727376265,"score_gpt":0.3625124696844897,"score_spread":0.29945473241072706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213981466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9760193,0.005385364,0.000046870606,0.000029120796,0.0008945775,0.014635589,0.000088710876,0.0002198712,0.0026805655],"genre_scores_gemma":[0.987175,0.0026429747,0.0014709231,0.00012724866,0.0006483425,0.0027580727,0.0003642518,0.0002879516,0.00452523],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99054617,0.0011524434,0.0024870127,0.002078515,0.0015518339,0.0021840446],"domain_scores_gemma":[0.99281555,0.0023273425,0.0008532887,0.0023475636,0.00080053374,0.00085570343],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018260994,0.0011467133,0.0042155124,0.0006010158,0.00021296048,0.00024789933,0.0014113195,0.0008018745,0.0005000113],"category_scores_gemma":[0.004720504,0.0009858609,0.0005862594,0.0023492025,0.00088763883,0.0003441828,0.0013280404,0.0005696492,0.00018618656],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.9752084,0.0014547111,0.000008007287,0.0017709144,0.0022592177,0.008436423,0.0010856407,0.0037340426,0.0021329802,0.00015798828,0.00016215976,0.003589533],"study_design_scores_gemma":[0.7254347,0.0048979395,0.00000902457,0.0018099512,0.0018743287,0.0011472158,0.00020050745,0.24200611,0.021432422,0.000031473213,0.00048618382,0.00067012134],"about_ca_topic_score_codex":0.014371092,"about_ca_topic_score_gemma":0.0025695332,"teacher_disagreement_score":0.24977367,"about_ca_system_score_codex":0.6458672,"about_ca_system_score_gemma":0.5878464,"threshold_uncertainty_score":0.9992592},"labels":[],"label_agreement":null},{"id":"W3213986007","doi":"10.1182/blood-2021-153691","title":"A Phase Ib Pilot Study of Itacitinib Combined with Alemtuzumab in Patients with T-Cell Prolymphocytic Leukemia (T-PLL)","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Prolymphocytic leukemia; Alemtuzumab; Medicine; Leukemia; Internal medicine; Oncology; Cancer research; Chronic lymphocytic leukemia; Transplantation","score_opus":0.01614263831618313,"score_gpt":0.26476546369620696,"score_spread":0.24862282538002384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213986007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954469,0.00012965882,0.0000050372837,0.000021691567,0.000025636222,0.0023306275,0.000017964549,0.000050489343,0.0019719454],"genre_scores_gemma":[0.9986397,0.00000785535,0.00030752283,0.0000646902,0.000033006465,0.00017453273,0.00009221066,0.00007729688,0.0006031868],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.996849,0.00014310583,0.00055831624,0.00064452447,0.0012070894,0.00059794605],"domain_scores_gemma":[0.9979984,0.00014946162,0.00017437142,0.0009302176,0.00049396016,0.00025356538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021467927,0.00032051592,0.0007524072,0.00022419433,0.00005434477,0.000026762826,0.0002036734,0.000067211855,0.0001022831],"category_scores_gemma":[0.00012357518,0.00023908057,0.000042142954,0.00097428664,0.00014161585,0.000108851316,0.00012960457,0.0003092198,0.000021387777],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.103551835,0.53989625,0.31912306,0.0032518622,0.0021869896,0.014015687,0.0063336315,0.00019465276,0.008628374,0.00006879348,0.00028304305,0.0024658213],"study_design_scores_gemma":[0.8480769,0.100001685,0.018041063,0.0005273998,0.0005919921,0.00017062621,0.0011820362,0.00049227796,0.03052886,0.000007335568,0.000028989545,0.00035082456],"about_ca_topic_score_codex":0.0006517372,"about_ca_topic_score_gemma":0.00051230984,"teacher_disagreement_score":0.7445251,"about_ca_system_score_codex":0.0056186183,"about_ca_system_score_gemma":0.016479064,"threshold_uncertainty_score":0.9981986},"labels":[],"label_agreement":null},{"id":"W3213989749","doi":"10.1182/blood-2021-153449","title":"Thrombocytopenia with and without Thrombosis Following COVID-19 Vaccination","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Vaccination; Adverse effect; Internal medicine; Population; Cohort; Pediatrics; Immunology","score_opus":0.04333638065389387,"score_gpt":0.3275895423251213,"score_spread":0.2842531616712274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213989749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98383594,0.00041090968,0.00034261617,0.0028803363,0.00011767142,0.00050583284,0.000008013888,0.00020017783,0.011698486],"genre_scores_gemma":[0.9924893,0.00019118223,0.004694729,0.0018950576,0.00011369453,0.000047681602,0.000059970276,0.00006583484,0.00044260107],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980045,0.00010363674,0.00033136836,0.0007050585,0.00041550325,0.0004399606],"domain_scores_gemma":[0.9984862,0.00009331083,0.000103057675,0.00057937886,0.00014271156,0.0005952998],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026702843,0.0003219126,0.0008439941,0.00012132775,0.00031403467,0.00011527132,0.00010713114,0.00018358993,0.0004936514],"category_scores_gemma":[0.00031396185,0.00026932312,0.00014027454,0.0005144132,0.00005645231,0.0002868706,0.00013188974,0.0002864705,0.000051205687],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000075937336,0.0010386951,0.86325705,0.00030196665,0.0014103666,0.00037200097,0.0011321388,0.0000017755323,0.1299618,0.0014216474,0.00021640405,0.0008101845],"study_design_scores_gemma":[0.01767151,0.0006875204,0.86077213,0.00023539488,0.0029910502,0.0014017068,0.00094665395,0.000033481752,0.11016916,0.00046351054,0.0039736717,0.00065418],"about_ca_topic_score_codex":0.00013094668,"about_ca_topic_score_gemma":0.00023652909,"teacher_disagreement_score":0.019792648,"about_ca_system_score_codex":0.000108672764,"about_ca_system_score_gemma":0.0007549961,"threshold_uncertainty_score":0.9999759},"labels":[],"label_agreement":null},{"id":"W3213995973","doi":"10.1182/blood-2021-146608","title":"Maternal Outcomes in Women with Bleeding Disorders According to Mode of Delivery: A Single-Center Retrospective Cohort Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Obstetrics; Retrospective cohort study; Vaginal delivery; Pregnancy; Surgery","score_opus":0.01594769139407011,"score_gpt":0.28625605750439237,"score_spread":0.2703083661103223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213995973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975945,0.000015310723,0.0000046033056,0.00029535545,0.000027365666,0.0007541002,0.0000077604045,0.000018546194,0.0012824609],"genre_scores_gemma":[0.99920297,0.000012917891,0.0002497003,0.000035639998,0.000023075103,0.000092591334,0.0000027354843,0.000019893769,0.00036049268],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880105,0.00003229429,0.00018105617,0.0002740107,0.00040880535,0.00030275868],"domain_scores_gemma":[0.9995416,0.000028838022,0.000031356387,0.00018448052,0.00010351179,0.00011024664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012547764,0.00011998488,0.0004073762,0.000163301,0.000032073323,0.000018223134,0.000060994204,0.000032020056,0.00004688673],"category_scores_gemma":[0.000050848972,0.00008554831,0.00003392369,0.0003258145,0.000022637092,0.000056820107,0.0000850659,0.0001191517,0.000005225692],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003851458,0.004563885,0.98547584,0.000030524843,0.00057758327,0.00029354932,0.0018064603,0.00000405572,0.006561801,0.000002856277,0.0000028399786,0.00029546462],"study_design_scores_gemma":[0.0071857106,0.00148942,0.9787697,0.00014370131,0.00009283974,0.00001787863,0.0045311195,0.000010723571,0.007659503,0.000012480606,0.0000031597601,0.00008377196],"about_ca_topic_score_codex":0.0002622289,"about_ca_topic_score_gemma":0.00034168136,"teacher_disagreement_score":0.006800565,"about_ca_system_score_codex":0.00019980168,"about_ca_system_score_gemma":0.00006835553,"threshold_uncertainty_score":0.34885588},"labels":[],"label_agreement":null},{"id":"W3214030030","doi":"10.1182/blood-2021-153380","title":"Fibrinolytic Dysregulation Contributes to the Hypercoagulable State in Pulmonary Embolism Patients","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pulmonary embolism; Fibrinolysis; Cardiology; Thrombus; Internal medicine; Platelet activation; Endothelial activation; Platelet; Endothelium","score_opus":0.008253126140063944,"score_gpt":0.226898904485085,"score_spread":0.21864577834502108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214030030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919546,0.00066714606,0.000045829645,0.0035430593,0.0001642291,0.00064677035,0.000011178779,0.00003025697,0.002936934],"genre_scores_gemma":[0.99628884,0.00014038879,0.000114950315,0.0020552785,0.000066955225,0.00006974206,0.00006298895,0.000017297114,0.0011835705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899477,0.000041752144,0.00022898777,0.0002446513,0.00021506872,0.00027479112],"domain_scores_gemma":[0.9993977,0.0000419393,0.00003429805,0.00033516056,0.000121372446,0.00006952905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013144709,0.00010888991,0.00028243774,0.000084937805,0.000063867046,0.000033871693,0.00007408468,0.000036319307,0.00006576025],"category_scores_gemma":[0.00009587992,0.000083762345,0.00005063442,0.00034970205,0.000015594542,0.000054850865,0.000117031814,0.000078724785,0.00010639681],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013018966,0.013935581,0.8965692,0.00040223473,0.0006931555,0.00071203767,0.0020022271,0.0013874535,0.009854905,0.004201499,0.016883506,0.05322804],"study_design_scores_gemma":[0.0018803319,0.00007921012,0.97558796,0.00012894964,0.00016322342,0.0000074067657,0.00008952036,0.00010167826,0.006452726,0.0004909982,0.014922366,0.000095649106],"about_ca_topic_score_codex":0.00016588448,"about_ca_topic_score_gemma":0.00012361998,"teacher_disagreement_score":0.079018764,"about_ca_system_score_codex":0.00004362679,"about_ca_system_score_gemma":0.00005337297,"threshold_uncertainty_score":0.34157294},"labels":[],"label_agreement":null},{"id":"W3214030476","doi":"10.1182/blood-2021-146275","title":"Impact of Age on Hospitalization and Readmission on Post Allogeneic Stem Cell Transplantation Outcome, Single Center Experience","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Transplantation; Single Center; Internal medicine; Cumulative incidence; Graft-versus-host disease; Proportional hazards model; Hematopoietic stem cell transplantation; Retrospective cohort study; Regimen; Surgery; Gastroenterology","score_opus":0.024228058093226458,"score_gpt":0.28986776519662016,"score_spread":0.2656397071033937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214030476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99686116,0.00006638594,0.0002548379,0.000047548423,0.000060013077,0.00024465463,0.000048081572,0.00002761949,0.0023896727],"genre_scores_gemma":[0.99899834,0.00013322117,0.0002660478,0.000096659525,0.000019727468,0.0000071284653,0.0002703724,0.00002084875,0.00018766154],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99899495,0.00005139861,0.0003026119,0.00025548358,0.00025675024,0.00013881951],"domain_scores_gemma":[0.9994566,0.00006175066,0.00008917625,0.0001955823,0.00008495044,0.00011192686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005609054,0.00013939677,0.00021978811,0.00008076206,0.00003308805,0.000013112402,0.000032489363,0.00008674463,0.000058313446],"category_scores_gemma":[0.000013803265,0.00011432657,0.00008042153,0.0001238622,0.00002406921,0.000052223055,0.0000044007884,0.000063569445,0.0000069696703],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002504261,0.0015677736,0.33908504,0.0005164733,0.000034398643,0.00034440323,0.0037292666,0.000013736986,0.6538627,0.000032948155,0.000006517629,0.0005562747],"study_design_scores_gemma":[0.003058487,0.00125317,0.35728967,0.0004182424,0.00013457931,0.0001956079,0.00025687538,0.000009011015,0.63727003,0.000002968061,0.000008822824,0.00010253719],"about_ca_topic_score_codex":0.000012555922,"about_ca_topic_score_gemma":0.0000035808202,"teacher_disagreement_score":0.018204609,"about_ca_system_score_codex":0.00002868388,"about_ca_system_score_gemma":0.000042127176,"threshold_uncertainty_score":0.46621022},"labels":[],"label_agreement":null},{"id":"W3214034632","doi":"10.1182/blood-2021-152693","title":"Trial in Progress: Phase 1b Bridging Study of the Pharmacokinetics (PK), Safety, and Efficacy of Orally Administered Olverembatinib (HQP1351) in Patients with Refractory Chronic Myeloid Leukemia (CML) and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph⁺ ALL)","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Adverse effect; Ponatinib; Dasatinib; Oncology; Myeloid leukemia; Imatinib; Pharmacology","score_opus":0.01288316360663517,"score_gpt":0.28068947466523486,"score_spread":0.2678063110585997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214034632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947075,0.0012134241,0.0000017291082,0.00010480686,0.00010729409,0.0036510408,0.00013156224,0.000024735538,0.000057908153],"genre_scores_gemma":[0.9990277,0.00036479114,0.000124522,0.000052541178,0.00011065705,0.00007984712,0.00013966556,0.000071768336,0.000028479562],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.996522,0.0002967737,0.0011350842,0.0007861291,0.0007508629,0.0005091193],"domain_scores_gemma":[0.9980105,0.0002930171,0.0006378327,0.00065008266,0.00021468864,0.00019386265],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022782397,0.0004944193,0.0011119964,0.00022324872,0.00007017965,0.000027036194,0.00021440256,0.00016730577,0.000029741113],"category_scores_gemma":[0.0001638061,0.000379278,0.00009142032,0.0006585798,0.0003309076,0.00014981524,0.00032189878,0.00044601999,8.6525756e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28707618,0.11645685,0.46896473,0.0026165822,0.010526235,0.0037060298,0.018139593,0.0003876415,0.037884872,0.000015647776,0.00008556782,0.054140072],"study_design_scores_gemma":[0.64269227,0.014330365,0.32212785,0.0016087821,0.0023408781,0.00010400044,0.0002560837,0.00038810706,0.015773732,0.000001962704,0.000034638924,0.00034133263],"about_ca_topic_score_codex":0.00011127169,"about_ca_topic_score_gemma":0.00025044917,"teacher_disagreement_score":0.3556161,"about_ca_system_score_codex":0.0019500642,"about_ca_system_score_gemma":0.0029722557,"threshold_uncertainty_score":0.9998659},"labels":[],"label_agreement":null},{"id":"W3214037196","doi":"10.1182/blood-2021-146043","title":"Safety and Preliminary Efficacy from the Expansion Cohort of a Phase 1/2 Study of Venetoclax Plus Daratumumab and Dexamethasone Vs Daratumumab Plus Bortezomib and Dexamethasone in Patients with t(11;14) Relapsed/Refractory Multiple Myeloma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Daratumumab; Medicine; Internal medicine; Dexamethasone; Venetoclax; Oncology; Multiple myeloma; Bortezomib; Lenalidomide; Proteasome inhibitor; Phases of clinical research; Gastroenterology; Clinical trial; Surgery; Leukemia; Chronic lymphocytic leukemia","score_opus":0.015627071897642265,"score_gpt":0.27519022754206174,"score_spread":0.25956315564441945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214037196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99303013,0.0037734872,0.000018420787,0.00003855419,0.00003869148,0.0028226052,0.00021529432,0.000021505522,0.000041332285],"genre_scores_gemma":[0.9979449,0.00044726822,0.0010954635,0.000021685995,0.000029929208,0.000081276456,0.0002908325,0.00005016793,0.000038470385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99694073,0.0004385578,0.0006586008,0.0007876411,0.0007677328,0.0004067531],"domain_scores_gemma":[0.99704075,0.0013113994,0.00027997504,0.0007952367,0.00027336486,0.00029928007],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003851453,0.00037756367,0.0010593014,0.00015475924,0.00017410557,0.000027578883,0.0001242112,0.00016609795,0.00002055906],"category_scores_gemma":[0.000810874,0.00026460362,0.000052608622,0.000403931,0.00033463884,0.00015730837,0.00029073394,0.0004238464,6.690453e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031504884,0.008031583,0.94229746,0.00014139937,0.00094352616,0.0005133662,0.003812664,0.000015172586,0.001795299,0.0000017923342,0.000014052038,0.010928788],"study_design_scores_gemma":[0.15979885,0.009073777,0.8249985,0.0004595233,0.00076330674,0.00003582446,0.00128483,0.000671547,0.0026907194,0.0000028346042,0.00002859294,0.00019169901],"about_ca_topic_score_codex":0.0017183597,"about_ca_topic_score_gemma":0.0010165923,"teacher_disagreement_score":0.12829396,"about_ca_system_score_codex":0.00015931403,"about_ca_system_score_gemma":0.00047150688,"threshold_uncertainty_score":0.9999806},"labels":[],"label_agreement":null},{"id":"W3214043801","doi":"10.1182/blood-2021-146572","title":"Single-Cell Proteogenomic Sequencing Allows Early Detection of Relapse Clone with CN-LOH at <i>FLT3</i>-ITD Locus from Initial Diagnosis in AML","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"NPM1; Oncology; Medicine; Internal medicine; Midostaurin; CDKN2A; Myeloid leukemia; Biology; Karyotype; Gene; Genetics","score_opus":0.021957124140736906,"score_gpt":0.2407634925257403,"score_spread":0.2188063683850034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214043801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99659956,0.0008969728,0.00007763842,0.0001847613,0.00006505972,0.0008679201,0.00004294346,0.00005716808,0.0012079878],"genre_scores_gemma":[0.9964239,0.0001327271,0.0024575994,0.000104622035,0.0002315494,0.0001996592,0.00006225174,0.00007685268,0.00031081098],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977701,0.00018711886,0.00047934693,0.0005642277,0.0005313512,0.0004678755],"domain_scores_gemma":[0.99864346,0.00022722814,0.0001662955,0.00055770576,0.00021216038,0.00019314994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002442424,0.00024015861,0.0005071515,0.0002031459,0.00007143829,0.000025781672,0.00014218454,0.00022623308,0.00015388502],"category_scores_gemma":[0.00024125003,0.00022361783,0.00010187434,0.00056554016,0.00012601358,0.00012892506,0.00017711801,0.0005969045,0.00006818018],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007697615,0.0007984858,0.045988943,0.00013108218,0.0001402116,0.0024466482,0.0009045123,0.000019064295,0.9474189,0.0000010940188,0.0000291723,0.0013521033],"study_design_scores_gemma":[0.012244232,0.0012272667,0.008099063,0.00034025114,0.00026173802,0.00023132091,0.00025417248,0.000056290643,0.97680736,0.000021979504,0.00023458456,0.00022175802],"about_ca_topic_score_codex":0.0034227655,"about_ca_topic_score_gemma":0.002030335,"teacher_disagreement_score":0.03788988,"about_ca_system_score_codex":0.0010874589,"about_ca_system_score_gemma":0.00084052334,"threshold_uncertainty_score":0.91188705},"labels":[],"label_agreement":null},{"id":"W3214055114","doi":"10.1182/blood-2021-147296","title":"Clinical Outcomes of Patients with Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disease Following Hematopoietic Stem Cell Transplantation Who Fail Rituximab: A Multinational, Retrospective Chart Review Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; University of Calgary","funders":"","keywords":"Rituximab; Medicine; Transplantation; Internal medicine; Hematopoietic stem cell transplantation; Immunosuppression; Population; Oncology; Post-transplant lymphoproliferative disorder; Immunology; Lymphoma","score_opus":0.010990760192473375,"score_gpt":0.2767548225470477,"score_spread":0.26576406235457434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214055114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99413097,0.0029837172,0.000038567796,0.00037716137,0.00008487805,0.0016330995,0.00054645975,0.000041008694,0.00016414281],"genre_scores_gemma":[0.9964113,0.0019586424,0.00008457705,0.00082975207,0.000022812048,0.000119764554,0.00040775829,0.000037021688,0.00012833234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99749285,0.00023494022,0.0007202125,0.0005144795,0.0007898782,0.00024764842],"domain_scores_gemma":[0.99853,0.00011488103,0.00029715456,0.00029754097,0.00055571564,0.00020472145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023451637,0.0002731219,0.0009985429,0.00006335858,0.00011057306,0.000016604805,0.00009077517,0.00007824982,0.000055757835],"category_scores_gemma":[0.00007163331,0.00021593522,0.00038762926,0.00027753031,0.00005069157,0.00013326204,0.000015762478,0.00018711334,0.000009486781],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005821983,0.00764176,0.98662424,0.0010429054,0.00083184947,0.0002812731,0.002804371,0.0000026040036,0.000045066332,0.00001535071,0.00003087394,0.00009751236],"study_design_scores_gemma":[0.033761486,0.0011619998,0.9574665,0.0018935459,0.0039016737,0.0000030720198,0.0011997357,0.000009202946,0.00033795743,0.000008030681,0.000011087684,0.00024570804],"about_ca_topic_score_codex":0.000039269027,"about_ca_topic_score_gemma":0.00011595711,"teacher_disagreement_score":0.033179287,"about_ca_system_score_codex":0.00007924956,"about_ca_system_score_gemma":0.00041253638,"threshold_uncertainty_score":0.88055825},"labels":[],"label_agreement":null},{"id":"W3214062012","doi":"10.1182/blood-2021-146862","title":"Is Symptom Burden Associated with Health Care Utilization: A Longitudinal Population-Based Cohort Study of Transplant Ineligible Patients with Newly Diagnosed Multiple Myeloma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Population; Emergency department; Nausea; Depression (economics); Health care; Emergency medicine; Family medicine; Psychiatry; Internal medicine; Environmental health","score_opus":0.02539162776975244,"score_gpt":0.29463116859813493,"score_spread":0.2692395408283825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214062012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970284,0.00022186578,0.000051641404,0.000113748225,0.000018190583,0.0021410747,0.00031299164,0.00005886592,0.00005323809],"genre_scores_gemma":[0.9953329,0.000012683702,0.0003678481,0.00006876298,0.00002666688,0.00015089393,0.0039610686,0.00004056779,0.000038595772],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976373,0.00013847057,0.00037341402,0.00047702354,0.0010031934,0.00037062756],"domain_scores_gemma":[0.99822295,0.0001594282,0.00018719034,0.00040936522,0.000756126,0.00026496916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000814625,0.00024150312,0.00056867476,0.00014058479,0.00016137061,0.000023397297,0.000074723175,0.00006697346,0.000073361916],"category_scores_gemma":[0.00011952543,0.00017784182,0.00006142797,0.0006170354,0.000029781198,0.00006463779,0.00001627174,0.00013010087,0.0000027252056],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008967343,0.006653625,0.9882754,0.00017361974,0.0011956297,0.00029569745,0.0019190962,0.00010566367,0.000005410501,7.291434e-7,0.000019105131,0.00045926718],"study_design_scores_gemma":[0.050740533,0.0033002575,0.9432206,0.0004974349,0.00054094795,0.0000048339602,0.00064112793,0.00022704684,0.000670088,2.7055543e-7,0.0000047460917,0.00015210846],"about_ca_topic_score_codex":0.0033495945,"about_ca_topic_score_gemma":0.0053992346,"teacher_disagreement_score":0.0498438,"about_ca_system_score_codex":0.00014921789,"about_ca_system_score_gemma":0.00061038154,"threshold_uncertainty_score":0.72521794},"labels":[],"label_agreement":null},{"id":"W3214072263","doi":"10.1182/blood-2021-153660","title":"Enasidenib in Combination with Venetoclax in <i>IDH2</i>-Mutated Myeloid Malignancies: Preliminary Results of the Phase Ib/II Enaven-AML Trial","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Venetoclax; IDH2; Medicine; Internal medicine; Ven; Myeloid leukemia; Myeloid; Oncology; IDH1; Leukemia; Biology; Mutation; Chronic lymphocytic leukemia","score_opus":0.01857005648884793,"score_gpt":0.2886640578184658,"score_spread":0.2700940013296179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214072263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949389,0.00034957493,0.000005931418,0.0015794862,0.000089752706,0.0015760196,0.00004602788,0.000028207674,0.0013861189],"genre_scores_gemma":[0.997877,0.00008306108,0.00029390753,0.00014870756,0.00008660637,0.00012840732,0.00014280093,0.000035315865,0.0012041678],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99747485,0.00032981506,0.00067502947,0.00043189197,0.0006749593,0.00041348173],"domain_scores_gemma":[0.99849766,0.00027501993,0.00019817307,0.0006597698,0.00027180708,0.000097588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007260369,0.00019602593,0.00046962762,0.000225681,0.000065117536,0.000014506585,0.00023336535,0.00017188049,0.000028205575],"category_scores_gemma":[0.0011057518,0.00014217559,0.000090149806,0.0013701641,0.00015138328,0.00010315698,0.0001978725,0.0005551466,0.0000059056533],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44348714,0.0239164,0.011940779,0.00094621937,0.0005535679,0.0094225565,0.013622309,0.000532067,0.48633224,0.00043826978,0.0035621522,0.0052463],"study_design_scores_gemma":[0.4747956,0.007657597,0.0146113355,0.0010974058,0.00015615337,0.00031193954,0.0007958669,0.0005630138,0.4988208,0.00010567678,0.00087368995,0.0002108955],"about_ca_topic_score_codex":0.0003404803,"about_ca_topic_score_gemma":0.00026309022,"teacher_disagreement_score":0.031308483,"about_ca_system_score_codex":0.00032016909,"about_ca_system_score_gemma":0.0022886614,"threshold_uncertainty_score":0.5797752},"labels":[],"label_agreement":null},{"id":"W3214073113","doi":"10.1182/blood-2021-147293","title":"OMNIVERSE: A Phase 1b/2 Study of Oral Azacitidine Plus Venetoclax in Patients with Relapsed/Refractory (R/R) or Newly Diagnosed (ND) Acute Myeloid Leukemia (AML)","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Venetoclax; Azacitidine; Medicine; Refractory (planetary science); Myeloid leukemia; Internal medicine; Leukemia; Oncology; Myeloid; Phases of clinical research; Gastroenterology; Clinical trial; Biology","score_opus":0.01874568387630128,"score_gpt":0.29085800065010825,"score_spread":0.272112316773807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214073113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99701965,0.00015074277,0.00001766166,0.00007788952,0.000089963236,0.001915813,0.000102046695,0.00007408343,0.00055217353],"genre_scores_gemma":[0.9962966,0.000103576036,0.0009864031,0.00016768655,0.000090170404,0.000115374685,0.00026882722,0.000098718716,0.0018726604],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9964521,0.00024683468,0.00066225673,0.00077864365,0.0011202601,0.00073991495],"domain_scores_gemma":[0.997645,0.00022881078,0.0002362359,0.0009757047,0.00053227274,0.00038193178],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029519803,0.00040988866,0.0009995095,0.0004044493,0.0000860772,0.000027653568,0.0003164818,0.00022199313,0.00041186484],"category_scores_gemma":[0.0003873744,0.000325034,0.00011159441,0.0013378646,0.00015578537,0.00025471914,0.00024672115,0.00086094835,0.000041748095],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08030373,0.11388529,0.62271214,0.0011003758,0.007833913,0.08961708,0.019633325,0.00035568365,0.02955051,0.00005408552,0.00973098,0.025222903],"study_design_scores_gemma":[0.707072,0.033536606,0.2282886,0.00073533115,0.0024026225,0.00022133523,0.006944165,0.00036507752,0.01637011,0.00001349451,0.0030885322,0.00096209865],"about_ca_topic_score_codex":0.00083781854,"about_ca_topic_score_gemma":0.00074209255,"teacher_disagreement_score":0.6267683,"about_ca_system_score_codex":0.0017338785,"about_ca_system_score_gemma":0.0048301057,"threshold_uncertainty_score":0.9999202},"labels":[],"label_agreement":null},{"id":"W3214084938","doi":"10.1182/blood-2021-154283","title":"Risks for Hospitalization and Death Among Patients with Blood Disorders from the ASH RC COVID-19 Registry for Hematology","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; St. Michael's Hospital","funders":"","keywords":"Medicine; Comorbidity; Internal medicine; Logistic regression; Cancer; Hematology; Cancer registry","score_opus":0.04061433728254365,"score_gpt":0.3443789378059111,"score_spread":0.30376460052336746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214084938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98321205,0.0010187033,0.005643052,0.008306993,0.00007775437,0.001398578,0.00025185273,0.00004586592,0.000045119174],"genre_scores_gemma":[0.993756,0.00014125339,0.0010724993,0.0040860116,0.000108249595,0.00014909108,0.0005932675,0.000029645164,0.00006396963],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99902797,0.00003796451,0.00019711957,0.00033032504,0.00014920016,0.0002574185],"domain_scores_gemma":[0.9985164,0.00062115927,0.00012969141,0.00032756914,0.0001674362,0.00023773861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000109535,0.00013984548,0.00026779776,0.000027360034,0.00020958582,0.0000279631,0.00006161873,0.00013168027,0.000014392251],"category_scores_gemma":[0.0017704095,0.00009753035,0.000057989302,0.00010048381,0.000063570835,0.00005109255,0.000030467709,0.000092030634,4.6904364e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018222658,0.0004794794,0.9963973,0.0003955071,0.0001753934,0.000009239785,0.0005818173,0.0000020530651,0.0000120531595,0.0004716291,0.0007856893,0.0005076084],"study_design_scores_gemma":[0.017335715,0.0009787445,0.9710699,0.00014306474,0.001057531,0.000016603735,0.00038899892,0.000042933618,0.00052541133,0.0021136354,0.0061572636,0.00017020044],"about_ca_topic_score_codex":0.0010150558,"about_ca_topic_score_gemma":0.0024578967,"teacher_disagreement_score":0.025327407,"about_ca_system_score_codex":0.000026580925,"about_ca_system_score_gemma":0.0005246515,"threshold_uncertainty_score":0.39771724},"labels":[],"label_agreement":null},{"id":"W3214093530","doi":"10.1182/blood-2021-153571","title":"A Triplet Combination of Azacitidine, Venetoclax and Gilteritinib for Patients with <i>FLT3</i>-Mutated Acute Myeloid Leukemia: Results from a Phase I/II Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Venetoclax; Azacitidine; Medicine; Internal medicine; Decitabine; Chemotherapy regimen; Regimen; Gastroenterology; Myeloid leukemia; Myeloid; Chemotherapy; Leukemia; Oncology; Chemistry","score_opus":0.015928170738365263,"score_gpt":0.28881110676484634,"score_spread":0.27288293602648106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214093530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99436605,0.00010152105,0.00006900985,0.00026081572,0.00004558192,0.002325746,0.0025794667,0.00005368217,0.00019811302],"genre_scores_gemma":[0.9930397,0.000052494415,0.0022934638,0.00010163497,0.0000752831,0.0001921161,0.00390904,0.000051551913,0.00028467932],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9978325,0.00011122669,0.00056867365,0.00059407495,0.0005415162,0.00035200408],"domain_scores_gemma":[0.9979867,0.00028047143,0.00021669392,0.0004859767,0.0008351261,0.00019505723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026252307,0.00024133101,0.00060884876,0.00014526752,0.00013770511,0.00002991574,0.00011889924,0.00012308855,0.00002079076],"category_scores_gemma":[0.0004975561,0.00020725043,0.00007048167,0.00045794048,0.00008888073,0.00012481229,0.00014213673,0.00026153467,0.0000018962289],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17200617,0.10575008,0.15495552,0.001421807,0.016595418,0.0049193227,0.020047374,0.000021142145,0.46972284,0.00021113949,0.012356857,0.041992333],"study_design_scores_gemma":[0.67105013,0.048860937,0.08575512,0.00053373916,0.0032955538,0.00010845913,0.0014936032,0.0009919174,0.18506844,0.00013949513,0.0020884916,0.00061413343],"about_ca_topic_score_codex":0.00016483662,"about_ca_topic_score_gemma":0.000041762898,"teacher_disagreement_score":0.4990439,"about_ca_system_score_codex":0.00021827365,"about_ca_system_score_gemma":0.000882763,"threshold_uncertainty_score":0.8451427},"labels":[],"label_agreement":null},{"id":"W3214114333","doi":"10.1182/blood-2021-151837","title":"Intensification of Chemotherapy Using a Modified BFM Backbone for Children, Adolescents and Young Adults with T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL) Identifies Highly Chemorefractory Patients Who Benefit from Allogeneic Hematopoietic Stem Cell Transplantation","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Minimal residual disease; Internal medicine; Cog; Chemotherapy; Gastroenterology; Bone marrow; Oncology; Surgery","score_opus":0.00858315532911089,"score_gpt":0.2192099718548367,"score_spread":0.21062681652572582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214114333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928428,0.0013136343,0.0036358323,0.000024195277,0.00011090903,0.0015328618,0.00043727297,0.00006434113,0.000038135102],"genre_scores_gemma":[0.99488515,0.0012881935,0.0022822977,0.00015776778,0.00008942886,0.00008100387,0.0008775776,0.0001689334,0.00016967765],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963292,0.000084180145,0.0008947039,0.001170752,0.0008520327,0.0006691483],"domain_scores_gemma":[0.99733853,0.00025299567,0.0005433653,0.0006400621,0.00083815836,0.0003868659],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015320751,0.00063263334,0.000983024,0.00027610405,0.00016537355,0.000100244,0.00022023857,0.00036531754,0.000010960543],"category_scores_gemma":[0.000030641284,0.0005862449,0.00015342896,0.0003700047,0.00026792198,0.00025776064,0.00009648021,0.00015406487,0.00000454956],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010099587,0.004332891,0.107426226,0.006393259,0.0012708838,0.00021002076,0.0071623554,0.000115939154,0.8596401,0.000011774931,0.00006380087,0.0032731511],"study_design_scores_gemma":[0.07884721,0.0008216837,0.22426705,0.002039653,0.0030516253,0.0004480961,0.00079236994,0.006044758,0.6829714,0.00004090185,0.0000016368873,0.00067358196],"about_ca_topic_score_codex":0.00032356544,"about_ca_topic_score_gemma":0.000040933934,"teacher_disagreement_score":0.17666867,"about_ca_system_score_codex":0.000548726,"about_ca_system_score_gemma":0.00082055415,"threshold_uncertainty_score":0.9996589},"labels":[],"label_agreement":null},{"id":"W3214146106","doi":"10.1182/blood-2021-154278","title":"STAT5 Signaling Promotes Resistance to Ivosidenib in <i>IDH1</i>-Mutated AML","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"IDH1; Isocitrate dehydrogenase; Cancer research; Syk; Myeloid leukemia; Myeloid; Mutant; Biology; Cell biology; Signal transduction; Tyrosine kinase; Genetics; Gene; Biochemistry","score_opus":0.01875031370733994,"score_gpt":0.2922035889889574,"score_spread":0.27345327528161745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214146106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895283,0.0009356557,0.000095421354,0.004590707,0.000037605623,0.00051886286,0.000016499422,0.000088846245,0.004188076],"genre_scores_gemma":[0.9834766,0.000046760313,0.00984441,0.000992003,0.00014035217,0.000066389955,0.000048362712,0.00004870829,0.005336424],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99810016,0.00011297227,0.0003340415,0.0004629725,0.00046432717,0.0005255073],"domain_scores_gemma":[0.9988315,0.00016213633,0.000039362207,0.0004403815,0.00026130793,0.0002652894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035816876,0.00015881479,0.00033846032,0.00017654158,0.00005298178,0.00004295037,0.00014033623,0.000094811076,0.00021515772],"category_scores_gemma":[0.0008775322,0.00015371862,0.000060075603,0.0010574196,0.0000385573,0.0000722224,0.00011960226,0.0004097589,0.00016748343],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027486918,0.0006465929,0.014408399,0.00024248488,0.000105581756,0.0065731714,0.001000971,0.000013911943,0.97238946,0.00012127814,0.0037016016,0.0005216558],"study_design_scores_gemma":[0.0053989096,0.00016721824,0.007856708,0.00052924524,0.00007527648,0.0001380589,0.0003943303,0.000033153337,0.979306,0.00025380915,0.0056297723,0.00021752332],"about_ca_topic_score_codex":0.00007412588,"about_ca_topic_score_gemma":0.0003890008,"teacher_disagreement_score":0.009748989,"about_ca_system_score_codex":0.00017513616,"about_ca_system_score_gemma":0.0007593263,"threshold_uncertainty_score":0.6268463},"labels":[],"label_agreement":null},{"id":"W3214159399","doi":"10.1182/blood-2021-149140","title":"A Globally Applicable \"Triple AAA\" Risk Model for Essential Thrombocythemia Based on Age, Absolute Neutrophil Count, and Absolute Lymphocyte Count","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Leukocytosis; Myelofibrosis; Essential thrombocythemia; Medicine; Internal medicine; Absolute neutrophil count; Polycythemia vera; Gastroenterology; Thrombocytosis; Complete blood count; Interquartile range; White blood cell; Immunology; Neutropenia; Bone marrow; Platelet; Chemotherapy","score_opus":0.015004159258327989,"score_gpt":0.26343599843894383,"score_spread":0.24843183918061584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214159399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827638,0.0020038646,0.006198453,0.0011728628,0.00019045183,0.0020510675,0.0011550926,0.0001474029,0.0043169674],"genre_scores_gemma":[0.9825812,0.001612349,0.011021658,0.0021450773,0.00034733137,0.0007868498,0.00035700898,0.00008318039,0.0010653445],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99779934,0.000039432503,0.0003825952,0.0007751018,0.00048621115,0.0005173297],"domain_scores_gemma":[0.9985558,0.00016564359,0.0001636919,0.0005744718,0.0002647472,0.00027565713],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020109814,0.0003867409,0.00068288884,0.00006333478,0.0002788826,0.000109836416,0.00010230509,0.000176839,0.000071940965],"category_scores_gemma":[0.00007329947,0.00033399055,0.00021501238,0.0001794254,0.00009145228,0.00006344878,0.00006530679,0.00015960819,0.00002964149],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03634663,0.13864346,0.16709167,0.009756203,0.028612211,0.017612966,0.0055358433,0.100904904,0.16809553,0.07225595,0.22773992,0.02740473],"study_design_scores_gemma":[0.10929128,0.0030874042,0.05553959,0.00080496306,0.00678157,0.00043924362,0.000090914094,0.70447516,0.08692753,0.002689307,0.028338555,0.0015344566],"about_ca_topic_score_codex":0.00013025229,"about_ca_topic_score_gemma":0.00020002293,"teacher_disagreement_score":0.6035703,"about_ca_system_score_codex":0.00020435204,"about_ca_system_score_gemma":0.0006737251,"threshold_uncertainty_score":0.9999112},"labels":[],"label_agreement":null},{"id":"W3214159644","doi":"10.1182/blood-2021-148708","title":"Inhibiting Mitochondrial Complex II Exposes a Novel Metabolic Vulnerability in Acute Myeloid Leukemia","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; Princess Margaret Cancer Centre; University Health Network; University of Guelph","funders":"","keywords":"Myeloid leukemia; Leukemia; Clonogenic assay; Cancer research; Haematopoiesis; Biology; Oxidative phosphorylation; Small hairpin RNA; Cell growth; Cell culture; Gene knockdown; Chemistry; Cell biology; In vitro; Stem cell; Biochemistry; Immunology; Genetics","score_opus":0.022348291674684943,"score_gpt":0.2876432056239809,"score_spread":0.26529491394929594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214159644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99699736,0.000944331,0.0001684384,0.00015287488,0.0001554722,0.00022404111,0.00009156685,0.000022163336,0.0012437548],"genre_scores_gemma":[0.99331754,0.00008755307,0.0045272,0.00015350153,0.00065266265,0.00006989585,0.00033335344,0.000037387443,0.00082090765],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979659,0.0001635963,0.00040051198,0.00068104937,0.00029759735,0.00049134775],"domain_scores_gemma":[0.99903977,0.000030440318,0.00007200202,0.00053841376,0.00018197912,0.00013737362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023813953,0.00021724793,0.00032169285,0.000079876896,0.00018730285,0.000041341264,0.00022380489,0.00021173418,0.000070718845],"category_scores_gemma":[0.0005183375,0.00023537286,0.0001570686,0.00032701594,0.00013134947,0.000007935376,0.0004906198,0.00030324736,0.000016953245],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067628636,0.00054203026,0.0005072279,0.00001795632,0.000085380096,0.00006399497,0.0001402364,0.000022850516,0.9973911,0.000049138333,0.00064763526,0.0004648245],"study_design_scores_gemma":[0.0033756874,0.00014080651,0.0016738978,0.000020377007,0.000038844115,0.00012446701,0.00007773011,0.000032386903,0.976892,0.000015620453,0.017353345,0.0002548298],"about_ca_topic_score_codex":0.000105808824,"about_ca_topic_score_gemma":0.0004654129,"teacher_disagreement_score":0.02049909,"about_ca_system_score_codex":0.00005137196,"about_ca_system_score_gemma":0.00057855865,"threshold_uncertainty_score":0.95982265},"labels":[],"label_agreement":null},{"id":"W3214164674","doi":"10.1182/blood-2021-151208","title":"PIK-001 a Novel Small Molecule Inhibitor of Pikfyve for Treatment of Multiple Myeloma (MM)","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Synthesis and Biological Evaluation","field":"Chemistry","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Ex vivo; In vivo; Pharmacology; Viability assay; Multiple myeloma; Cell culture; Biology; Immunology; Genetics","score_opus":0.05673721515622571,"score_gpt":0.2632742377658461,"score_spread":0.20653702260962037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214164674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99768925,0.00036298056,0.00009858468,0.00005084461,0.000021592914,0.000099912155,0.00017844631,0.000013458109,0.0014849518],"genre_scores_gemma":[0.9958196,0.000025319263,0.0034505967,0.000013016163,0.00010185422,0.00006272128,0.000108042994,0.0000082981815,0.0004104965],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99935657,0.000010690226,0.00023937851,0.00018588052,0.00009219704,0.000115261915],"domain_scores_gemma":[0.99931496,0.00021524983,0.00011977697,0.00017920844,0.00013867271,0.0000321246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000543323,0.000093957104,0.00022517852,0.000012270841,0.000019636593,0.000004630919,0.000054465254,0.00010002571,0.00020208847],"category_scores_gemma":[0.00029623558,0.00007019093,0.0001386861,0.000049968996,0.000025454228,0.000009618462,0.000020526475,0.000013849638,0.000002297331],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048372924,0.0033496772,0.002285147,0.00007609121,0.00009097441,0.0000017489689,0.00005178834,0.0000017420917,0.98848665,0.000037118956,0.00001400476,0.005556712],"study_design_scores_gemma":[0.0037756807,0.00021970345,0.0013958877,0.000036340185,0.00012869315,0.0000034360967,0.00008736703,0.00020932504,0.99323004,0.000037243553,0.000797162,0.00007913489],"about_ca_topic_score_codex":0.000022787739,"about_ca_topic_score_gemma":0.000023295788,"teacher_disagreement_score":0.005477577,"about_ca_system_score_codex":0.000015929647,"about_ca_system_score_gemma":0.000046488833,"threshold_uncertainty_score":0.2862303},"labels":[],"label_agreement":null},{"id":"W3214165942","doi":"10.1182/blood-2021-147805","title":"AGILE: A Global, Randomized, Double-Blind, Phase 3 Study of Ivosidenib + Azacitidine Versus Placebo + Azacitidine in Patients with Newly Diagnosed Acute Myeloid Leukemia with an <i>IDH1</i> Mutation","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; IDH1; Interquartile range; Clinical endpoint; Myeloid leukemia; Placebo; Gastroenterology; Phases of clinical research; Randomized controlled trial; Oncology; Surgery; Clinical trial; Pathology; Biology","score_opus":0.021167656536138023,"score_gpt":0.30955397527476297,"score_spread":0.28838631873862497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214165942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921904,0.00014725329,0.00012966341,0.0001594392,0.00009451946,0.0063538733,0.00016379326,0.00011016448,0.00065085513],"genre_scores_gemma":[0.99551475,0.000079835554,0.0019196734,0.00012560181,0.00013781502,0.00077249826,0.0012685057,0.00009847656,0.00008283764],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9950245,0.000523726,0.0009967764,0.0010279235,0.0016478617,0.00077919423],"domain_scores_gemma":[0.99639016,0.0005233304,0.00041839966,0.0010303557,0.0011440072,0.0004937522],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007090342,0.0005925464,0.0016767059,0.00035925594,0.00012281451,0.00008520833,0.0003172557,0.0002159824,0.000113946655],"category_scores_gemma":[0.00034893496,0.0004565791,0.00014251917,0.0020148382,0.00029372936,0.00052174606,0.00014872946,0.00063462363,0.000016602722],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9399816,0.014982628,0.0335171,0.00013899825,0.0024312506,0.005349374,0.001402182,0.00022565843,0.00083340844,0.000041065985,0.00012918662,0.0009675711],"study_design_scores_gemma":[0.961736,0.0146265915,0.004013482,0.0002897509,0.002833116,0.00013814619,0.0029967814,0.00025208946,0.01261541,0.000009769869,0.00002047277,0.00046839193],"about_ca_topic_score_codex":0.001230125,"about_ca_topic_score_gemma":0.002327476,"teacher_disagreement_score":0.02950362,"about_ca_system_score_codex":0.000739945,"about_ca_system_score_gemma":0.0019275089,"threshold_uncertainty_score":0.9997886},"labels":[],"label_agreement":null},{"id":"W3214174124","doi":"10.1182/blood-2021-146147","title":"Evaluation of the Safety of Emicizumab Prophylaxis in Persons with Hemophilia A: An Updated Summary of Thrombotic Events and Thrombotic Microangiopathies","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Thrombotic microangiopathy; Medicine; Microangiopathic hemolytic anemia; Thrombotic thrombocytopenic purpura; Clinical trial; Atypical hemolytic uremic syndrome; MedDRA; Schistocyte; Internal medicine; Pediatrics; Adverse effect; Immunology; Pharmacovigilance; Platelet","score_opus":0.02715124707715822,"score_gpt":0.29143519258901734,"score_spread":0.26428394551185913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214174124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971189,0.001653745,9.484743e-7,0.0002509286,0.000019487381,0.0006307441,0.000027778251,0.0000048854836,0.00029257493],"genre_scores_gemma":[0.99947685,0.00008654861,0.00025164927,0.0000059470185,0.000012036753,0.000010573386,0.00004374508,0.000013257478,0.00009936723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983636,0.00029779322,0.0002835736,0.00020680773,0.0006961379,0.00015208064],"domain_scores_gemma":[0.99901515,0.000037480273,0.000104829065,0.00036121017,0.00043477045,0.00004656398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006009279,0.000111714726,0.0003752994,0.00009590759,0.000035156943,0.0000023434427,0.00007644162,0.00007753843,0.000052396146],"category_scores_gemma":[0.00010615773,0.000067342255,0.00006103218,0.00048412758,0.0002127168,0.000054716947,0.000056761146,0.00013188248,4.2595028e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030281616,0.0031574834,0.71344715,0.00043842854,0.0005295204,0.000029459674,0.0024993985,0.000028741628,0.27811074,0.00003862928,0.000016885455,0.0014007405],"study_design_scores_gemma":[0.007203872,0.0010915966,0.7375414,0.0005894745,0.0010177845,0.000075969605,0.0011547675,0.00026520796,0.25082156,0.00016083437,0.0000015407934,0.00007604669],"about_ca_topic_score_codex":0.00006489664,"about_ca_topic_score_gemma":0.00011396421,"teacher_disagreement_score":0.02728918,"about_ca_system_score_codex":0.000042219388,"about_ca_system_score_gemma":0.00057347945,"threshold_uncertainty_score":0.27461374},"labels":[],"label_agreement":null},{"id":"W3214176281","doi":"10.1182/blood-2021-146027","title":"Serine and Threonine Phosphorylation Marks Proteins for Degradation By Clpxp","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Phosphorylation; Biology; Biochemistry; Serine; Threonine; Protease; Amino acid; Arginine; Serine protease; Protein degradation; Molecular biology; Enzyme","score_opus":0.0073893702282228375,"score_gpt":0.22283733945481735,"score_spread":0.2154479692265945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214176281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9749828,0.0024332826,0.019109795,0.0015457405,0.00008491143,0.0007006638,0.000039710765,0.000056490233,0.0010466033],"genre_scores_gemma":[0.96545744,0.00027888335,0.022806127,0.00016177715,0.000100518315,0.000096277305,0.00076319504,0.000024090721,0.010311721],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994852,0.0000053105077,0.00012289592,0.00017096597,0.0001024082,0.00011322191],"domain_scores_gemma":[0.99971414,0.0000100106845,0.00003238473,0.00010919708,0.000077409124,0.00005688489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007511831,0.00007696149,0.00013302355,0.000017477521,0.000052755662,0.0000109985585,0.000016312248,0.000057879683,0.000054841355],"category_scores_gemma":[0.000017100514,0.00006658586,0.000035659716,0.000076554876,0.000013306312,0.00003381907,0.0000051509082,0.000051785737,0.0000013763415],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003478427,0.0010397284,0.014811939,0.0005897518,0.00016124791,0.00005781524,0.00014456367,7.864823e-7,0.9597375,0.0023317179,0.00079198205,0.019985138],"study_design_scores_gemma":[0.0054129795,0.00023176901,0.021997893,0.000107142565,0.0002953846,0.000043284865,0.0000782347,0.000098202836,0.9544678,0.000559618,0.0165736,0.0001341411],"about_ca_topic_score_codex":0.000006706308,"about_ca_topic_score_gemma":0.000058326295,"teacher_disagreement_score":0.019850997,"about_ca_system_score_codex":0.000007338853,"about_ca_system_score_gemma":0.000043664433,"threshold_uncertainty_score":0.27152926},"labels":[],"label_agreement":null},{"id":"W3214193024","doi":"10.1182/blood-2021-153916","title":"Management of Severe Iron Deficiency Anemia in the Pediatric Emergency Department: A Comparison of IV Iron Vs Transfusions","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"","keywords":"Medicine; Mean corpuscular volume; Asymptomatic; Pediatrics; Anemia; Iron-deficiency anemia; Emergency department; Iron sucrose; Parenteral nutrition; Packed red blood cells; Retrospective cohort study; Iron deficiency; Blood transfusion; Hemoglobin; Intravenous iron; Surgery; Internal medicine","score_opus":0.01303264990196768,"score_gpt":0.27097535341043427,"score_spread":0.2579427035084666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214193024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9772002,0.01024362,0.000031590294,0.0002113982,0.00008955186,0.00035784926,0.000016986172,0.000009128432,0.011839649],"genre_scores_gemma":[0.995174,0.004097553,0.00046239173,0.000031340864,0.00002921315,0.000018722907,0.000030520783,0.000009155922,0.0001470919],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998807,0.000067281166,0.0004082055,0.00018973762,0.00033678603,0.00019098185],"domain_scores_gemma":[0.99949443,0.000021628946,0.00008483235,0.0003234846,0.000036379835,0.000039260827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001446386,0.00010946686,0.00026052503,0.00008243124,0.000039582774,0.0000022030283,0.00011919994,0.00005270458,0.00030712606],"category_scores_gemma":[0.000014298509,0.000083168445,0.00009604891,0.00054867036,0.000024285659,0.000026985474,0.000029691693,0.00010883458,0.000006521197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012452324,0.008598516,0.9760471,0.0036840024,0.000012474105,0.000103609425,0.0043732403,0.00010908797,0.0015863371,0.0021709155,0.0007768831,0.0024133092],"study_design_scores_gemma":[0.0051181233,0.00026122236,0.98458254,0.000038337417,0.001538759,0.000023250872,0.006775672,0.0000073247056,0.0011144398,0.000105763196,0.00029262135,0.0001419691],"about_ca_topic_score_codex":0.00003366193,"about_ca_topic_score_gemma":0.000044988836,"teacher_disagreement_score":0.017973782,"about_ca_system_score_codex":0.0000052454457,"about_ca_system_score_gemma":0.00004587941,"threshold_uncertainty_score":0.33915105},"labels":[],"label_agreement":null},{"id":"W3214205179","doi":"10.1182/blood-2021-145124","title":"The Echelon-2 Trial: 5-Year Exploratory Subgroup Analyses of a Randomized, Double-Blind, Phase 3 Study of Brentuximab Vedotin and CHP (A+CHP) Vs CHOP in Frontline Treatment of Pts with CD30-Positive Peripheral T-Cell Lymphoma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Brentuximab vedotin; Subgroup analysis; Medicine; Internal medicine; Oncology; Exploratory analysis; Randomized controlled trial; Phases of clinical research; Clinical trial; Hodgkin lymphoma; Lymphoma; Confidence interval","score_opus":0.04121522537111414,"score_gpt":0.3278261193347301,"score_spread":0.28661089396361594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214205179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892801,0.00715468,0.000003406182,0.00011465399,0.000051656054,0.0031683117,0.000045570574,0.0000121062585,0.00016949237],"genre_scores_gemma":[0.99731064,0.0016565365,0.00017926059,0.000011404857,0.00005832547,0.00062069984,0.000054452725,0.000029926521,0.00007873297],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99772525,0.00037316553,0.0008179905,0.00042181878,0.00042196343,0.00023981297],"domain_scores_gemma":[0.9981874,0.00046515238,0.000474485,0.00049034186,0.00026800472,0.000114610935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034571454,0.0003224904,0.001772297,0.000143907,0.00005882645,0.000019968284,0.00007732241,0.000079916084,0.000017237326],"category_scores_gemma":[0.00004790169,0.00018442026,0.0002736944,0.0003617482,0.00019084332,0.00006776372,0.000042722088,0.00004479602,7.3287424e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8107749,0.13425069,0.040654622,0.00008248585,0.0035850233,0.00039940103,0.0049256347,0.0000068948625,0.0031114307,0.000014790318,0.000007154514,0.0021869612],"study_design_scores_gemma":[0.8032528,0.012227208,0.0090207765,0.00015403732,0.003756145,0.000021035585,0.0045880983,0.00002439438,0.16682106,0.0000029461912,0.00001036134,0.00012112678],"about_ca_topic_score_codex":0.0010742182,"about_ca_topic_score_gemma":0.00066632195,"teacher_disagreement_score":0.16370963,"about_ca_system_score_codex":0.0001321777,"about_ca_system_score_gemma":0.0003644649,"threshold_uncertainty_score":0.752044},"labels":[],"label_agreement":null},{"id":"W3214210779","doi":"10.1182/blood-2021-148218","title":"Six-Year Results from the Phase 3 Randomized Study Relevance Show Similar Outcomes for Previously Untreated Follicular Lymphoma Patients Receiving Lenalidomide Plus Rituximab (R 2) Versus Rituximab-Chemotherapy Followed By Rituximab Maintenance","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; Centre hospitalier universitaire de Québec","funders":"","keywords":"Rituximab; Medicine; Internal medicine; Lenalidomide; Follicular lymphoma; Vincristine; Interim analysis; Oncology; CHOP; Bendamustine; Chemotherapy; Gastroenterology; Randomized controlled trial; Cyclophosphamide; Surgery; Lymphoma; Multiple myeloma","score_opus":0.015711766455278255,"score_gpt":0.27915610990993456,"score_spread":0.2634443434546563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214210779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819522,0.0042053806,0.00012484498,0.0036735863,0.0006268375,0.0074396497,0.0014594233,0.00022382897,0.00029428574],"genre_scores_gemma":[0.99011534,0.00162314,0.0024745502,0.0013354723,0.00021018558,0.0016205742,0.0017724519,0.00016167715,0.0006866167],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9943293,0.0006829135,0.0014683522,0.0015402175,0.0009844934,0.0009947639],"domain_scores_gemma":[0.9915625,0.0051290193,0.0006377302,0.001670841,0.0006738717,0.0003260568],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009832846,0.00089382014,0.0028875675,0.00007948802,0.00046053802,0.00019246261,0.00043014195,0.00025853212,0.00006396231],"category_scores_gemma":[0.0055568814,0.0005934095,0.0011766662,0.00044795408,0.00018301244,0.00020405572,0.00013603123,0.0001928844,0.000056704124],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.64814764,0.19173095,0.07868182,0.00015291007,0.019254483,0.0015720207,0.0043641375,0.000011243606,0.0006225862,0.00007870524,0.036742885,0.018640626],"study_design_scores_gemma":[0.97042894,0.0015624497,0.0059460625,0.0004438189,0.0053659156,0.000013126043,0.00062551344,0.00025531847,0.008126274,0.00006734721,0.006556,0.0006092559],"about_ca_topic_score_codex":0.00075886154,"about_ca_topic_score_gemma":0.00032125358,"teacher_disagreement_score":0.32228127,"about_ca_system_score_codex":0.0005638756,"about_ca_system_score_gemma":0.00043334093,"threshold_uncertainty_score":0.99965173},"labels":[],"label_agreement":null},{"id":"W3214221676","doi":"10.1182/blood-2021-146904","title":"Efficacy and Safety of Primary Thromboprophylaxis for the Prevention of Venous Thromboembolism in Patients with Cancer and Central Venous Catheter: A Systematic Review and Meta-Analysis","year":2021,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Odds ratio; Cancer; Central venous catheter; Meta-analysis; Randomized controlled trial; Placebo; Venous thromboembolism; Surgery; Internal medicine; Catheter; Thrombosis","score_opus":0.03496174388175924,"score_gpt":0.3035386700021017,"score_spread":0.26857692612034245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214221676","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024481576,0.986116,0.000011797354,0.000045621822,0.000020353593,0.0110887,0.0002486312,0.0000064967635,0.000014257985],"genre_scores_gemma":[0.0036947546,0.99474734,0.00015996552,0.00007434928,0.000014279928,0.0010885936,0.00015393672,0.000044396445,0.000022364473],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9974628,0.00022499946,0.0011851828,0.0005139244,0.00034492105,0.00026815993],"domain_scores_gemma":[0.9977947,0.00030509106,0.0010334159,0.00062830845,0.00015858187,0.00007990142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047245412,0.0004216042,0.011294482,0.00018736914,0.00006261627,0.000018465505,0.00012806765,0.00012519128,0.00002148956],"category_scores_gemma":[0.00008004465,0.00022740357,0.0008379295,0.00051604665,0.00012508729,0.000044232584,0.0001244461,0.00016024566,1.0725672e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016369744,0.0039781216,0.00005191372,0.82213306,0.16359586,0.0000031794682,0.00027868286,7.968627e-7,1.2799535e-7,0.000041963496,0.000007687914,0.009892214],"study_design_scores_gemma":[0.0017741454,0.0012170466,0.009840825,0.070193164,0.91607594,0.000008573306,0.000018836516,4.569024e-7,8.643637e-7,0.000004329915,0.00066339783,0.00020242987],"about_ca_topic_score_codex":0.00015209518,"about_ca_topic_score_gemma":0.000060855422,"teacher_disagreement_score":0.7524801,"about_ca_system_score_codex":0.00005226923,"about_ca_system_score_gemma":0.00017374409,"threshold_uncertainty_score":0.92732483},"labels":[],"label_agreement":null},{"id":"W3214236472","doi":"10.1182/blood-2021-146172","title":"Targeted Next Generation Sequencing Reveals a Third Breakpoint Cluster Region and New Partner Genes in the <i>KMT2A</i> Recombinome","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Breakpoint; breakpoint cluster region; Biology; Genetics; Gene; Gene rearrangement; Chromosomal translocation","score_opus":0.10079042494012913,"score_gpt":0.2965271475511858,"score_spread":0.19573672261105668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214236472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9760313,0.004042482,0.00016030976,0.017336994,0.0000711762,0.0005145331,0.000001766647,0.00003560822,0.0018058361],"genre_scores_gemma":[0.9831479,0.0015304559,0.0028682298,0.007389646,0.00084298605,0.000054804288,0.000091205984,0.0000355505,0.004039175],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99833685,0.00031372003,0.00032596113,0.00038195023,0.0003058585,0.00033566347],"domain_scores_gemma":[0.9990876,0.00012448392,0.00006546321,0.00046729264,0.00011552246,0.00013967036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058868714,0.00015518734,0.00027321317,0.00009570764,0.00008984123,0.000097423035,0.000104181214,0.00013773548,0.00003849709],"category_scores_gemma":[0.00025258015,0.00011106513,0.000061780906,0.00039339962,0.000044361266,0.00016189388,0.00009169371,0.0003693252,0.000023150453],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013482806,0.00030638045,0.018029192,0.00018448991,0.00014237786,0.001910325,0.004067618,0.000018569812,0.9090382,0.0004327952,0.055934064,0.0098011885],"study_design_scores_gemma":[0.06542683,0.002151614,0.092657596,0.0017030868,0.0016235379,0.03598531,0.008250005,0.015884671,0.69800353,0.0062439027,0.06980962,0.0022602824],"about_ca_topic_score_codex":0.00032761815,"about_ca_topic_score_gemma":0.00023028582,"teacher_disagreement_score":0.21103463,"about_ca_system_score_codex":0.00014094514,"about_ca_system_score_gemma":0.0005674391,"threshold_uncertainty_score":0.45291042},"labels":[],"label_agreement":null},{"id":"W3214248259","doi":"10.1182/blood-2021-145995","title":"Post Hoc Analysis of Responses to Ponatinib in Patients with Chronic-Phase Chronic Myeloid Leukemia (CP-CML) By Baseline <i>BCR-ABL1</i> Level and Baseline Mutation Status in the Optic Trial","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ponatinib; Medicine; Myeloid leukemia; Internal medicine; Imatinib; Oncology; Dasatinib","score_opus":0.01470383091207388,"score_gpt":0.28042550153440937,"score_spread":0.2657216706223355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214248259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939403,0.002199507,0.00009248322,0.0004930868,0.000046539815,0.001619447,0.0015433674,0.000022126549,0.000043159245],"genre_scores_gemma":[0.9941649,0.00021651461,0.0013457756,0.00040250452,0.000096202144,0.00014817282,0.0033785286,0.000045080993,0.00020231759],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.996463,0.00057903497,0.0009057984,0.0007026752,0.0007882829,0.00056118716],"domain_scores_gemma":[0.9975599,0.000917552,0.00026454692,0.00071147847,0.00033753767,0.00020898409],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010169412,0.00036940174,0.000871084,0.0006489627,0.000064728905,0.000034671742,0.00015059876,0.00014514868,0.00017001595],"category_scores_gemma":[0.0012648074,0.00027819705,0.00012795164,0.0022514134,0.00009295981,0.00013767305,0.00007621727,0.00032597018,0.0000059170065],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4470614,0.051195752,0.26982033,0.0016436991,0.012338166,0.0055136816,0.011068048,0.0064690285,0.063127495,0.00010968908,0.0017048827,0.12994781],"study_design_scores_gemma":[0.69414866,0.022538524,0.25361365,0.00067710597,0.007139294,0.00007699467,0.00080143544,0.004785492,0.014411731,0.000005476985,0.0010616302,0.0007400067],"about_ca_topic_score_codex":0.0010437908,"about_ca_topic_score_gemma":0.0043925117,"teacher_disagreement_score":0.24708727,"about_ca_system_score_codex":0.0018721864,"about_ca_system_score_gemma":0.0034670897,"threshold_uncertainty_score":0.99996704},"labels":[],"label_agreement":null},{"id":"W3214290048","doi":"10.1182/blood-2021-151605","title":"A Phase I/II Study of Sapacitabine and Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Venetoclax; Ven; Medicine; Decitabine; Internal medicine; Gastroenterology; Regimen; Concomitant; Cytarabine; Oncology; Myeloid leukemia; Mucositis; Leukemia; Chemotherapy; Chemistry; Chronic lymphocytic leukemia","score_opus":0.019874684448830796,"score_gpt":0.3076351623868574,"score_spread":0.2877604779380266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214290048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964094,0.0013114375,0.0000032044004,0.00019590057,0.000045738157,0.00065238925,0.00002169031,0.000035221852,0.0013250046],"genre_scores_gemma":[0.99752694,0.0002958376,0.00043276456,0.00011197729,0.000099859244,0.00005176416,0.000030875333,0.00004003482,0.0014099159],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998129,0.00013483204,0.0004448384,0.00046154985,0.0004521394,0.00037765218],"domain_scores_gemma":[0.9988185,0.00011679217,0.000091052374,0.0005913631,0.00017184477,0.00021040135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034267173,0.00019835195,0.0005941533,0.00025400595,0.00006773133,0.000011649645,0.00012102736,0.00014313041,0.000113051625],"category_scores_gemma":[0.00028755635,0.00018554807,0.000060976232,0.00063396676,0.00010330278,0.00007495995,0.00025449722,0.00060642976,0.000010574472],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023641472,0.026455907,0.04747181,0.00041258225,0.0015501078,0.0103977155,0.010292268,0.000013239622,0.87913054,0.000082431456,0.0012341749,0.020595092],"study_design_scores_gemma":[0.4675071,0.06230994,0.14750063,0.0008971941,0.0029999425,0.0027548103,0.013331586,0.0011526949,0.29089436,0.00020682438,0.0092583895,0.0011865133],"about_ca_topic_score_codex":0.00020832174,"about_ca_topic_score_gemma":0.00013540301,"teacher_disagreement_score":0.58823615,"about_ca_system_score_codex":0.00041196344,"about_ca_system_score_gemma":0.001368961,"threshold_uncertainty_score":0.75664306},"labels":[],"label_agreement":null},{"id":"W3214297432","doi":"10.1182/blood-2021-154494","title":"DNA Mediated Blood Coagulation: Extracellular DNA Accelerates Fibrinogen Polymerization By Thrombin Independent of Contact Pathway","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Extracellular; DNA; Chemistry; Coagulation; Thrombin; Biochemistry; Activator (genetics); Fibrinogen; Biophysics; Cell biology; Molecular biology; Biology; Platelet; Immunology; Medicine; Receptor","score_opus":0.014508326899427527,"score_gpt":0.23522403920320462,"score_spread":0.2207157123037771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214297432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99004805,0.007743182,0.00004520518,0.00019500982,0.0001124708,0.00047285526,0.00015344906,0.00009367374,0.0011361317],"genre_scores_gemma":[0.99581414,0.00026729616,0.00018794803,0.000072787356,0.00010998476,0.000028528102,0.002406952,0.00005243749,0.0010599346],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99796695,0.00010034996,0.0005744071,0.00046253705,0.00056845776,0.0003273276],"domain_scores_gemma":[0.99872315,0.00011305,0.00026223256,0.0005191204,0.00019411521,0.00018835436],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011371566,0.0002731153,0.0005395165,0.00007913043,0.00006911284,0.0000280705,0.00010750366,0.00022770888,0.0013520684],"category_scores_gemma":[0.0001322425,0.00026603416,0.00013606907,0.0003640735,0.000047019545,0.0001327707,0.000068952155,0.00015788557,0.000044279746],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045955105,0.0018585111,0.038835563,0.0001065433,0.00075716776,0.00032039583,0.00023038185,0.0000020981922,0.9572578,0.00012268423,0.00012378293,0.00033913268],"study_design_scores_gemma":[0.013471562,0.00036284994,0.030644411,0.00014495278,0.0007625314,0.00029768105,0.00010767303,0.000059217295,0.9536008,0.000022489938,0.0003213817,0.00020440895],"about_ca_topic_score_codex":0.000096574135,"about_ca_topic_score_gemma":0.000016325217,"teacher_disagreement_score":0.013425607,"about_ca_system_score_codex":0.00011641641,"about_ca_system_score_gemma":0.00072274066,"threshold_uncertainty_score":0.9999792},"labels":[],"label_agreement":null},{"id":"W3214305505","doi":"10.1182/blood-2021-147095","title":"Impact of Tet2 Deficiency, and of <i>TET2</i> Mutations in Clonal Hematopoiesis, on Neutrophil/Granulocyte Immune Function","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Molecular biology; Haematopoiesis; Biology; Immune system; Granulocyte; Immunology; Bone marrow; Genetics; Stem cell","score_opus":0.013321235152191897,"score_gpt":0.28816659256660543,"score_spread":0.2748453574144135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214305505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960597,0.0017944615,0.000029803106,0.00025629578,0.000026785418,0.00021764939,0.000040392155,0.000012429446,0.0015624587],"genre_scores_gemma":[0.9992361,0.00019903606,0.0003118117,0.000027821143,0.000030161427,0.000012136682,0.00005776236,0.000016397062,0.00010877228],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988107,0.0000668298,0.00035772892,0.00022154617,0.00032329466,0.00021989111],"domain_scores_gemma":[0.99918115,0.00016301539,0.00009153571,0.00029889302,0.00018541176,0.00008000975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020089698,0.00011916501,0.0003591341,0.00022451597,0.00003600996,0.0000068971567,0.000060023638,0.00008216417,0.00008710723],"category_scores_gemma":[0.00019554717,0.000101049416,0.00012480286,0.0005749106,0.0001328087,0.000053836196,0.000053600314,0.00024232715,0.000006578398],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006838816,0.0021731975,0.091220014,0.00032454217,0.00017208404,0.0001892999,0.00041087833,0.000097690594,0.9029672,0.000587328,0.000090951944,0.0010829159],"study_design_scores_gemma":[0.00728633,0.0013812219,0.72150254,0.00019564993,0.00020048763,0.00032479505,0.00028376168,0.00010273099,0.26828203,0.0002939879,0.000038221708,0.00010823133],"about_ca_topic_score_codex":0.00031065758,"about_ca_topic_score_gemma":0.000025564797,"teacher_disagreement_score":0.63468516,"about_ca_system_score_codex":0.00007980515,"about_ca_system_score_gemma":0.00054600864,"threshold_uncertainty_score":0.41206756},"labels":[],"label_agreement":null},{"id":"W3214311634","doi":"10.1182/blood-2021-152640","title":"Single Centre, Retrospective Analysis of Extracorporeal Photopheresis (ECP) Therapy in the Patients Who Are Heavily Pre-Treated for Steroid Resistant Chronic Graft-Versus-Host Disease (GVHD)","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Extracorporeal Photopheresis; Azathioprine; Graft-versus-host disease; Rituximab; Prednisone; Internal medicine; Gastroenterology; Tacrolimus; Adverse effect; Surgery; Transplantation; Lymphoma; Disease","score_opus":0.018022802604581698,"score_gpt":0.25736240257594306,"score_spread":0.23933959997136137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214311634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965394,0.00082003465,0.00003308274,0.0001806254,0.00005819136,0.0011369025,0.0007063288,0.000024548317,0.0005008728],"genre_scores_gemma":[0.9985608,0.00021724601,0.00016027884,0.000062747866,0.000040294442,0.000083879466,0.0007202962,0.000029890376,0.0001246058],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981,0.00016740905,0.00050112687,0.0004408899,0.00049667933,0.0002938977],"domain_scores_gemma":[0.9983513,0.0002910918,0.00025143597,0.0006556043,0.00033356287,0.00011702538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016686953,0.0002124564,0.0005820632,0.00016748876,0.000061989405,0.000024675743,0.00015111956,0.00008859512,0.00016614546],"category_scores_gemma":[0.00014793596,0.00016189888,0.0003098029,0.0010674549,0.000060082482,0.00005960661,0.000015137943,0.00010656003,0.0000012911672],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004291119,0.004627204,0.9705951,0.00039352206,0.0018348107,0.00018216937,0.0016281793,0.000009179585,0.015964184,0.000043233904,0.00008707062,0.00034422235],"study_design_scores_gemma":[0.013552619,0.00077503,0.9369621,0.00027179267,0.0032787712,9.418262e-7,0.00047281623,0.00007049644,0.04440562,0.000025222547,0.000041632837,0.00014293792],"about_ca_topic_score_codex":0.00009149868,"about_ca_topic_score_gemma":0.0013233041,"teacher_disagreement_score":0.033632986,"about_ca_system_score_codex":0.00015709709,"about_ca_system_score_gemma":0.00014666711,"threshold_uncertainty_score":0.66020447},"labels":[],"label_agreement":null},{"id":"W3214319350","doi":"10.1182/blood-2021-149221","title":"Impact of Race/Ethnicity on Cancer Associated Thrombosis Among Underserved Patients with Cancer","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Cancer; Pulmonary embolism; Deep vein; Thrombosis; Incidence (geometry); Internal medicine; Cumulative incidence; Retrospective cohort study; Malignancy; Cohort","score_opus":0.025638817222176015,"score_gpt":0.3048171628157968,"score_spread":0.27917834559362076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214319350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99731153,0.00022356001,0.0000021344624,0.00025664933,0.00009492558,0.00041493683,0.00009785229,0.000038228958,0.0015601714],"genre_scores_gemma":[0.99867743,0.00055697764,0.000026419622,0.00029508353,0.000044978042,0.00006926691,0.0000691827,0.000033241402,0.00022739125],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987546,0.000054015916,0.0002193634,0.00028835205,0.0003985358,0.0002851029],"domain_scores_gemma":[0.99901825,0.00004110059,0.0001910442,0.00030747062,0.00032418693,0.00011792061],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000076659264,0.00018112923,0.0005872789,0.0000575746,0.0000570752,0.0000124709095,0.0000676065,0.000084359126,0.0009814987],"category_scores_gemma":[0.0000639572,0.00013164377,0.00017071143,0.000333405,0.000054442513,0.000058931368,0.000047051013,0.00014094776,0.000004380065],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046855366,0.007220716,0.98624665,0.00007311828,0.0026606936,0.0000124472,0.00026335454,0.00016485028,0.00051072356,0.000020778562,0.0024789737,0.00030086603],"study_design_scores_gemma":[0.0056285923,0.00081524166,0.986764,0.00057287235,0.0013700566,1.4381492e-7,0.000063097614,0.000012465476,0.004591423,0.000008881452,0.000026492655,0.00014673725],"about_ca_topic_score_codex":0.006454271,"about_ca_topic_score_gemma":0.0034596012,"teacher_disagreement_score":0.006405474,"about_ca_system_score_codex":0.00020742533,"about_ca_system_score_gemma":0.0002384921,"threshold_uncertainty_score":0.99993175},"labels":[],"label_agreement":null},{"id":"W3214324911","doi":"10.1182/blood-2021-146324","title":"Effects of Cytogenetic Risk on Outcomes in Multiple Myeloma Treated with Selinexor, Bortezomib, and Dexamethasone (XVd)","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Princess Margaret Cancer Centre; Royal Victoria Hospital; Dalhousie University; University of Alberta; Queen Elizabeth II Health Sciences Centre; Institute of Cancer Research; University of Calgary","funders":"","keywords":"Multiple myeloma; Bortezomib; Dexamethasone; Internal medicine; Medicine; Oncology; Cytogenetics; Progression-free survival; Chemotherapy; Biology; Chromosome","score_opus":0.014842797403253912,"score_gpt":0.2671911534404253,"score_spread":0.25234835603717143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214324911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99780285,0.0011907718,0.000012264154,0.0000671946,0.000010026288,0.0006414595,0.000032939166,0.00002786382,0.00021459737],"genre_scores_gemma":[0.99622744,0.00043416666,0.0029057467,0.000038316684,0.000017900406,0.00006427699,0.000035459085,0.000028738294,0.0002479594],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866855,0.00014839445,0.0002211723,0.00035327443,0.00030645198,0.00030217014],"domain_scores_gemma":[0.99864465,0.0006885723,0.000070626695,0.00030303904,0.00009349582,0.0001996145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009753786,0.00019929738,0.0005160163,0.00015183022,0.00003825238,0.000010005581,0.000042996493,0.00008105906,0.000019037963],"category_scores_gemma":[0.00072768325,0.00013670752,0.00006134886,0.00028755883,0.0000704749,0.000025472831,0.00003688525,0.00017162955,0.000009563966],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070139364,0.0028883568,0.9631732,0.00019698584,0.0005640006,0.0020167523,0.00008472498,0.0000036059353,0.022114431,0.0000039268766,0.0000036937831,0.008248906],"study_design_scores_gemma":[0.024104236,0.0011278058,0.6796918,0.00016370529,0.00028580625,0.000053380303,0.00003370677,0.000101653284,0.29434052,0.0000063716943,0.000009183674,0.00008186812],"about_ca_topic_score_codex":0.00037796004,"about_ca_topic_score_gemma":0.00035363558,"teacher_disagreement_score":0.28348145,"about_ca_system_score_codex":0.000024566252,"about_ca_system_score_gemma":0.00009386428,"threshold_uncertainty_score":0.5574771},"labels":[],"label_agreement":null},{"id":"W3214338991","doi":"10.1182/blood-2021-147812","title":"CC-92480, a Potent, Novel Cereblon E3 Ligase Modulator (CELMoD) Agent, in Combination with Dexamethasone (DEX) and Bortezomib (BORT) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Preliminary Results from the Phase 1/2 Study CC-92480-MM-002","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute of Cancer Research; University of Calgary; Princess Margaret Cancer Centre; Hôpital Maisonneuve-Rosemont; Queen Elizabeth II Health Sciences Centre; University of Alberta; University of Toronto; Dalhousie University","funders":"","keywords":"Bortezomib; Cereblon; Dexamethasone; Medicine; Lenalidomide; Multiple myeloma; Refractory (planetary science); Internal medicine; Pharmacology; Oncology; Ubiquitin ligase; Chemistry; Biology; Ubiquitin","score_opus":0.023712702083550627,"score_gpt":0.2703067045698111,"score_spread":0.24659400248626046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214338991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944698,0.0005903112,0.000038775892,0.00033411724,0.00006264417,0.0037313243,0.0005675172,0.000075916985,0.00012959719],"genre_scores_gemma":[0.9964216,0.0001048161,0.0013285964,0.00012490254,0.00007065949,0.0003247876,0.0013022325,0.000110391615,0.00021204689],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955766,0.0003472218,0.00082790415,0.0012996675,0.0011751,0.0007734604],"domain_scores_gemma":[0.99692285,0.00070928334,0.0003474444,0.0011843434,0.00037051432,0.00046558172],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00049329264,0.00058814534,0.0008111961,0.00031996347,0.00021405594,0.00009772792,0.0002403095,0.00020959131,0.00001340668],"category_scores_gemma":[0.00092061615,0.00040671366,0.00008687798,0.0008687071,0.00015316645,0.00036013348,0.00022564322,0.0007814026,0.00001323216],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023932353,0.22525088,0.73107076,0.000068903224,0.0008128268,0.003089254,0.0027741313,0.000011483701,0.001363835,0.0000034991647,0.000077603196,0.011544498],"study_design_scores_gemma":[0.36096483,0.009996623,0.6218192,0.00042357857,0.0003756635,0.00004632153,0.0011146137,0.0014038477,0.0034943246,0.0000065927766,0.00005821668,0.0002961775],"about_ca_topic_score_codex":0.0027338893,"about_ca_topic_score_gemma":0.0032691383,"teacher_disagreement_score":0.33703247,"about_ca_system_score_codex":0.00025771974,"about_ca_system_score_gemma":0.00037984253,"threshold_uncertainty_score":0.9998385},"labels":[],"label_agreement":null},{"id":"W3214344627","doi":"10.1182/blood-2021-154311","title":"Bleeding Outcomes in Patients with Gastrointestinal Malignancies Treated with Distally Absorbed Versus Proximally Absorbed Direct Oral Anticoagulants","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Rivaroxaban; Edoxaban; Apixaban; Dabigatran; Internal medicine; Cancer; Gastroenterology; Malignancy; Warfarin; Atrial fibrillation","score_opus":0.01688496194765079,"score_gpt":0.26532386837195676,"score_spread":0.24843890642430597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214344627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99681056,0.000060534105,0.0000037331279,0.00014318383,0.000051100997,0.0004921806,0.000042122767,0.00009116734,0.0023053994],"genre_scores_gemma":[0.99707854,0.0000068718296,0.0017316414,0.00006285864,0.000033596152,0.00004732397,0.00018253598,0.000038258182,0.00081838673],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863935,0.000038703496,0.00022888987,0.00038000025,0.00029128787,0.00042176974],"domain_scores_gemma":[0.99933404,0.00007669611,0.00009234342,0.00018448292,0.00018311568,0.000129308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000053539687,0.00027026804,0.00058593444,0.00010157632,0.000052998734,0.00002861359,0.00006155414,0.00004015906,0.000120109085],"category_scores_gemma":[0.000039415223,0.00018404046,0.00005766994,0.00031246478,0.00008030417,0.00008704574,0.000032138167,0.00013904131,0.000008541149],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059973607,0.0033888444,0.98502344,0.000059863134,0.0005069186,0.001588287,0.00010074745,0.000004596952,0.003175207,0.0000067707674,0.000028004244,0.00011994459],"study_design_scores_gemma":[0.04692067,0.004103724,0.9388038,0.000318312,0.00091988617,0.00010016099,0.00007436915,0.000007629406,0.008523939,0.0000013126934,0.00002534722,0.00020083862],"about_ca_topic_score_codex":0.00011659136,"about_ca_topic_score_gemma":0.00054739736,"teacher_disagreement_score":0.046219643,"about_ca_system_score_codex":0.00008260007,"about_ca_system_score_gemma":0.00021919918,"threshold_uncertainty_score":0.75049525},"labels":[],"label_agreement":null},{"id":"W3214376594","doi":"10.1182/blood-2021-152987","title":"Immune Repertoire Analysis of Multiple Myeloma Research Samples Using NGS Characterization of Multiple B Cell Receptors in a Single Reaction","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Biology; Immunoglobulin heavy chain; Chronic lymphocytic leukemia; Immunoglobulin light chain; breakpoint cluster region; B-cell receptor; Molecular biology; Multiplex ligation-dependent probe amplification; B cell; IGHV@; Gene rearrangement; Genetics; Plasma cell neoplasm; Computational biology; Antibody; Gene; Multiple myeloma; Leukemia; Immunology","score_opus":0.0800012272170901,"score_gpt":0.33169516697377804,"score_spread":0.25169393975668797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214376594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998689,0.00040909005,0.000033563923,0.00020586772,0.000049955037,0.00022511162,0.00006557884,0.000011185794,0.00031066503],"genre_scores_gemma":[0.99687743,0.00027554686,0.0013809438,0.000010627535,0.0000618911,0.000008857945,0.0006135114,0.000019135021,0.0007520444],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978748,0.00025817746,0.00059232995,0.0003281388,0.0006354881,0.00031105414],"domain_scores_gemma":[0.99837255,0.0003542348,0.00017245136,0.00035732996,0.0006575107,0.000085903805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005943136,0.00011971973,0.0005485228,0.0007894228,0.000081026905,0.000011452648,0.0000933164,0.0001232802,0.00013744493],"category_scores_gemma":[0.00077734847,0.00011133782,0.00020903091,0.0024542972,0.00013152833,0.0000953297,0.00011199625,0.0002671097,0.0000030579263],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029961366,0.0013677884,0.25601965,0.00020551837,0.00025353712,0.000043069656,0.0005582352,0.000009921396,0.7396303,0.0000064323676,0.0000026496834,0.0016033177],"study_design_scores_gemma":[0.0010976196,0.00014156805,0.31446403,0.00016541805,0.00021530433,0.000014637956,0.00041466506,0.0018513198,0.6811024,0.000004350972,0.0004579972,0.00007067684],"about_ca_topic_score_codex":0.0029765435,"about_ca_topic_score_gemma":0.0005801949,"teacher_disagreement_score":0.058527857,"about_ca_system_score_codex":0.000070919334,"about_ca_system_score_gemma":0.00018659221,"threshold_uncertainty_score":0.45402244},"labels":[],"label_agreement":null},{"id":"W3214381411","doi":"10.1182/blood-2021-151731","title":"Multispectral Imaging for Microchip Electrophoresis Enables Point-of-Care Newborn Hemoglobin Variant Screening","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Newborn screening; Medicine; Context (archaeology); Population; Pediatrics; Hemoglobin variants; Hemoglobin; Biology; Internal medicine; Environmental health","score_opus":0.006139262410362929,"score_gpt":0.23151033699879842,"score_spread":0.2253710745884355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214381411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92833525,0.044526517,0.017339112,0.0030780516,0.0002442575,0.0010448107,0.000095056006,0.0001837139,0.0051532527],"genre_scores_gemma":[0.88533825,0.00064030424,0.11269684,0.00048413608,0.00019383829,0.000028009117,0.00016131316,0.00006962013,0.00038767065],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99857455,0.000034974597,0.00034246233,0.00037532888,0.00017447282,0.0004982209],"domain_scores_gemma":[0.9991276,0.000076940334,0.0000930859,0.00030236694,0.00025810752,0.00014186489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010190961,0.00020105613,0.00040121246,0.000097454336,0.00013065344,0.000026690323,0.00009231209,0.00012103692,0.00007572996],"category_scores_gemma":[0.00019085885,0.00018335239,0.00028208087,0.0002936713,0.00005574235,0.00005461371,0.000048085305,0.00021121732,0.0000048443667],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057279784,0.0010532272,0.010969233,0.0010794187,0.000711443,0.0014841217,0.0015822438,0.000027434791,0.9356262,0.00076835096,0.0017403711,0.044385146],"study_design_scores_gemma":[0.015946604,0.00048541158,0.0035747497,0.0007872793,0.0014044454,0.0017620651,0.0063154898,0.0006240451,0.95649546,0.00031985558,0.011833225,0.00045136816],"about_ca_topic_score_codex":0.0000786231,"about_ca_topic_score_gemma":0.000020862286,"teacher_disagreement_score":0.09535772,"about_ca_system_score_codex":0.000029286684,"about_ca_system_score_gemma":0.0002520863,"threshold_uncertainty_score":0.7476893},"labels":[],"label_agreement":null},{"id":"W3214381809","doi":"10.1182/blood-2021-149185","title":"Identification of a Highly Deregulated eIF4F Translation Initiation Complex in Drug-Resistant BCR-ABL + Cells By a Phospho-Proteomic Antibody Microarray","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; Kinexus Bioinformatics Corporation (Canada); University of British Columbia","funders":"","keywords":"Biology; Phosphorylation; Antibody microarray; Microarray analysis techniques; Cancer research; Myeloid leukemia; ABL; Imatinib mesylate; breakpoint cluster region; Tyrosine kinase; Progenitor cell; Imatinib; Stem cell; Antibody; Cell biology; Molecular biology; Signal transduction; Immunology; Gene expression; Genetics; Receptor; Gene","score_opus":0.01393623118559776,"score_gpt":0.2615298038477432,"score_spread":0.24759357266214546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214381809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968292,0.0013300237,0.00018525735,0.0003783194,0.00006254989,0.00078128214,0.00012679007,0.00004907362,0.0002574651],"genre_scores_gemma":[0.9962229,0.00016607552,0.0014676386,0.000051274044,0.000026971229,0.00003635727,0.0016954945,0.000034042434,0.00029923455],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99818665,0.00011771281,0.0007359444,0.00040778602,0.00030951988,0.00024238742],"domain_scores_gemma":[0.9990272,0.000057539415,0.00027501525,0.0004063483,0.00016161283,0.000072319795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002038664,0.00019180884,0.00039093907,0.0001420064,0.000045765537,0.000021330581,0.000078796256,0.00012762233,0.000144835],"category_scores_gemma":[0.000037044218,0.00020422401,0.00009910936,0.00051792606,0.000052142415,0.00010952428,0.000015165957,0.00013509204,0.000031103318],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017168911,0.0013406031,0.0033557834,0.00024226,0.00013421608,0.00005257006,0.00071389414,0.00001221353,0.9932834,0.000017372999,0.00024836443,0.00042763175],"study_design_scores_gemma":[0.011617441,0.000070984526,0.051003035,0.00022620545,0.0003174316,0.00002433401,0.00011264947,0.0004632112,0.93575597,0.000039835995,0.00021945235,0.00014947458],"about_ca_topic_score_codex":0.00043328674,"about_ca_topic_score_gemma":0.000120964745,"teacher_disagreement_score":0.057527456,"about_ca_system_score_codex":0.00029174294,"about_ca_system_score_gemma":0.00038695868,"threshold_uncertainty_score":0.8328013},"labels":[],"label_agreement":null},{"id":"W3214389996","doi":"10.1182/blood-2021-147916","title":"Novel Genetic Subgroups Inform on Shared Pathobiology within Adult and Pediatric Burkitt Lymphoma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; Spinal Cord Injury BC; Simon Fraser University","funders":"","keywords":"Somatic hypermutation; Biology; Lymphoma; Burkitt's lymphoma; Genome; Genetics; Cancer research; Oncology; Immunology; Medicine; Gene; B cell","score_opus":0.011476197009913026,"score_gpt":0.22637604249415644,"score_spread":0.2148998454842434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214389996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961818,0.001746032,0.0000052707414,0.00032614893,0.0001290608,0.00021452898,0.000049538747,0.000045504406,0.0013021432],"genre_scores_gemma":[0.99522585,0.00072415976,0.0021772154,0.0012342844,0.00025839132,0.00006523199,0.00010705454,0.000019221116,0.00018857022],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990169,0.000014608305,0.00025055624,0.00033051975,0.00015344383,0.00023397327],"domain_scores_gemma":[0.9992796,0.00007497539,0.000074310454,0.0002918227,0.00011684065,0.00016242747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000041633768,0.00017862434,0.00028103273,0.000071776805,0.00005952303,0.000025652966,0.00004398674,0.00012598159,0.00008207897],"category_scores_gemma":[0.00011718497,0.00013967659,0.00007083334,0.00016624446,0.000028258173,0.000031242325,0.000057208727,0.000046994242,0.00006380727],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012109025,0.0050531244,0.9734932,0.00014837428,0.0002573592,0.0014968948,0.00058312464,0.00000168132,0.003017069,0.000853282,0.000319977,0.014654779],"study_design_scores_gemma":[0.015257996,0.0008101491,0.9688721,0.00004998695,0.00055476074,0.0013700033,0.000085482796,0.000024077543,0.012392515,0.000042661613,0.00037625167,0.00016402015],"about_ca_topic_score_codex":0.000075937634,"about_ca_topic_score_gemma":0.000041906053,"teacher_disagreement_score":0.015136906,"about_ca_system_score_codex":0.000045898207,"about_ca_system_score_gemma":0.00018379268,"threshold_uncertainty_score":0.5695846},"labels":[],"label_agreement":null},{"id":"W3214392141","doi":"10.1182/blood-2021-152984","title":"Magnetismm-3: An Open-Label, Multicenter, Non-Randomized Phase 2 Study of Elranatamab (PF-06863135) in Patients with Relapsed or Refractory Multiple Myeloma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Carfilzomib; Multiple myeloma; Internal medicine; Refractory (planetary science); Bortezomib; Population; Clinical endpoint; Oncology; Proteasome inhibitor; Phases of clinical research; Lenalidomide; Clinical trial","score_opus":0.031146593383131953,"score_gpt":0.3333311392751745,"score_spread":0.3021845458920425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214392141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931392,0.00019410762,0.000009726312,0.00004540465,0.000071168884,0.0060631996,0.00011312105,0.000035011893,0.000329081],"genre_scores_gemma":[0.9947298,0.00006001678,0.0035224834,0.000062730374,0.000032375912,0.00043959075,0.0005046574,0.00007051909,0.00057782966],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99644655,0.0005905516,0.00079398975,0.00075918186,0.0008530077,0.0005566955],"domain_scores_gemma":[0.99735725,0.00043252524,0.00025449638,0.0010305527,0.00049628154,0.00042891013],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043986947,0.0003679268,0.0013331833,0.00026170208,0.00009872074,0.0000565541,0.0003505582,0.0001198284,0.0003649103],"category_scores_gemma":[0.0010711778,0.00025150733,0.00005828713,0.0005301825,0.00014202303,0.00038526498,0.00025012047,0.00034894716,0.000020384166],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42394158,0.24980548,0.30478355,0.00016830512,0.0012521148,0.0034591407,0.0018005654,0.0000012392288,0.0029231668,0.000001356425,0.000049544124,0.011813966],"study_design_scores_gemma":[0.76807076,0.018424151,0.20800488,0.0002660356,0.000513362,0.000011437606,0.0009144933,0.0004563252,0.003084079,0.0000013881229,0.000041531337,0.00021155468],"about_ca_topic_score_codex":0.0011548373,"about_ca_topic_score_gemma":0.0022857503,"teacher_disagreement_score":0.3441292,"about_ca_system_score_codex":0.0000785723,"about_ca_system_score_gemma":0.00036317777,"threshold_uncertainty_score":0.99999374},"labels":[],"label_agreement":null},{"id":"W3214400070","doi":"10.1182/blood-2021-146987","title":"Phase 1 Study of JNJ-64619178, a Protein Arginine Methyltransferase 5 Inhibitor, in Patients with Lower-Risk Myelodysplastic Syndromes","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Tolerability; Medicine; Myelodysplastic syndromes; Splicing factor; Internal medicine; Pharmacodynamics; Protein arginine methyltransferase 5; International Prognostic Scoring System; Pharmacology; Oncology; Methyltransferase; Cancer research; Gastroenterology; Adverse effect; Pharmacokinetics; RNA splicing; Biology; Methylation; Gene; Bone marrow; Genetics","score_opus":0.004577758031000481,"score_gpt":0.22229395563255877,"score_spread":0.2177161976015583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214400070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986455,0.00032425523,0.00014506614,0.000013927611,0.00006944532,0.0007157795,0.000048351663,0.000009004316,0.000028709828],"genre_scores_gemma":[0.99939495,0.000015502463,0.00020942095,0.000004563782,0.000052725944,0.000069201895,0.00014668723,0.000028145456,0.00007881945],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99879587,0.00012053872,0.0002728452,0.0003977225,0.00022635434,0.00018669905],"domain_scores_gemma":[0.99931455,0.000009933675,0.00010465153,0.00035405418,0.00015774323,0.000059085345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009617036,0.00017100712,0.00023001576,0.00007623357,0.000031713844,0.000010038385,0.00008004727,0.000110004745,0.000021720603],"category_scores_gemma":[0.00007512598,0.00016019239,0.000047306894,0.0003028232,0.000036270507,0.000005644279,0.0000401692,0.00011608471,0.0000016716378],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026948126,0.04016978,0.20883828,0.0001335422,0.0009439844,0.000110396904,0.0005037626,0.0013192341,0.74123025,0.0000054240477,0.000050275372,0.0040002414],"study_design_scores_gemma":[0.05141252,0.013817806,0.06376834,0.00014761584,0.00035064563,0.000011169468,0.00016990915,0.000039971485,0.8697152,0.000008977387,0.00017442428,0.00038340007],"about_ca_topic_score_codex":0.000029467205,"about_ca_topic_score_gemma":0.0002643359,"teacher_disagreement_score":0.14506994,"about_ca_system_score_codex":0.0000131134975,"about_ca_system_score_gemma":0.00014709453,"threshold_uncertainty_score":0.6532456},"labels":[],"label_agreement":null},{"id":"W3214401861","doi":"10.1182/blood-2021-151242","title":"Selective Cell State in the Clonally Expanded T-Cell Compartment of Vκ*MYC Mice Responding to Treatment with Checkpoint Inhibitors","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto; University Health Network","funders":"","keywords":"Blockade; Cancer research; Immune checkpoint; Bone marrow; Immune system; T cell; Immunology; Medicine; Biology; Receptor; Internal medicine","score_opus":0.020697118025805348,"score_gpt":0.28825409320888573,"score_spread":0.26755697518308036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214401861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993799,0.00042683794,0.000013984614,0.00035651863,0.000016586095,0.0010816498,0.00003475566,0.000013837926,0.004256887],"genre_scores_gemma":[0.99635684,0.00007804841,0.0015057501,0.000089931185,0.00003247268,0.00017636648,0.000054545148,0.000019740324,0.001686301],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983567,0.00018343078,0.000286659,0.0003323057,0.00047089037,0.00036999257],"domain_scores_gemma":[0.99912894,0.0001718443,0.000076269185,0.0003034358,0.00014059701,0.00017890467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020179313,0.00019254832,0.00034432704,0.00023059215,0.000053971384,0.00001961463,0.000077305966,0.00003345002,0.000028141185],"category_scores_gemma":[0.000028456885,0.000114839095,0.00008537079,0.0007350388,0.000033489894,0.00003245925,0.000038686063,0.00012767705,0.000023978168],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006082646,0.0236891,0.28316846,0.0002876135,0.00082383724,0.0035855246,0.016708786,0.0000737775,0.66332215,0.000024789064,0.00020465361,0.002028662],"study_design_scores_gemma":[0.01695625,0.0038948983,0.05120818,0.000142371,0.00014503679,0.00006114774,0.0012270976,0.000017126571,0.9257636,0.00001699691,0.00045846563,0.00010885205],"about_ca_topic_score_codex":0.00029777896,"about_ca_topic_score_gemma":0.0004745714,"teacher_disagreement_score":0.26244143,"about_ca_system_score_codex":0.00019256104,"about_ca_system_score_gemma":0.00039854628,"threshold_uncertainty_score":0.46830022},"labels":[],"label_agreement":null},{"id":"W3214405719","doi":"10.1182/blood-2021-153970","title":"Integrated Transcriptomics and Proteomics Identifies Therapeutic Targets in Pediatric Acute Myeloid Leukemia","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Transcriptome; Proteomics; Myeloid leukemia; Bone marrow; Haematopoiesis; Myeloid; Biology; CD34; Leukemia; Proteome; Cancer research; Stem cell; Bioinformatics; Immunology; Computational biology; Medicine; Gene; Genetics; Gene expression","score_opus":0.016017235536676357,"score_gpt":0.2657290045148789,"score_spread":0.24971176897820255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214405719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916598,0.005698026,0.00026112335,0.0008487502,0.00010434663,0.00063324126,0.00002543857,0.00007773987,0.0006915336],"genre_scores_gemma":[0.9855664,0.007761612,0.0039033396,0.00050180446,0.00019939928,0.00008748034,0.00012156912,0.00006397085,0.0017944656],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998249,0.000108343374,0.00037630313,0.00047605133,0.0003109037,0.00047939332],"domain_scores_gemma":[0.9991427,0.00007115184,0.000053901902,0.0003600533,0.00019274588,0.00017946278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003039374,0.00023608972,0.00044930892,0.0002765912,0.00006907941,0.00007507743,0.00014295364,0.00021962402,0.000079946454],"category_scores_gemma":[0.0001283568,0.0002118183,0.00008899335,0.00077919936,0.00009645177,0.00014249896,0.000078455865,0.0007535093,0.000029841165],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004935049,0.0007235454,0.087196544,0.00055942935,0.00059680635,0.0029873217,0.002302276,0.0000035916833,0.90013754,0.00025620262,0.00077085523,0.0039723986],"study_design_scores_gemma":[0.027985899,0.0005734122,0.18537478,0.00020853139,0.0021412056,0.002409606,0.0017457556,0.0018901791,0.772187,0.0015497252,0.0030003968,0.00093348714],"about_ca_topic_score_codex":0.00006754987,"about_ca_topic_score_gemma":0.000107459695,"teacher_disagreement_score":0.1279505,"about_ca_system_score_codex":0.0002757962,"about_ca_system_score_gemma":0.0014161902,"threshold_uncertainty_score":0.86376995},"labels":[],"label_agreement":null},{"id":"W3214406140","doi":"10.1182/blood-2021-154106","title":"Sex Differences in Anemia and Red Blood Cell Transfusions Among General Internal Medicine Inpatients","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Anemia; Hemoglobin; Retrospective cohort study; Cohort study; Cohort; Blood transfusion; Population; Sickle cell anemia; Epidemiology; Pediatrics; Internal medicine; Disease","score_opus":0.012358387119852933,"score_gpt":0.22776149544653923,"score_spread":0.2154031083266863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214406140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981227,0.0005753108,0.00004444152,0.0014081593,0.00014989992,0.0003236255,0.0000061734772,0.000043573225,0.016221862],"genre_scores_gemma":[0.993356,0.0014658463,0.00045266084,0.00058643974,0.00011578814,0.000024888019,0.000025557587,0.00001819172,0.0039546276],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986208,0.00006947099,0.0003557133,0.00039237613,0.00030736427,0.00025424865],"domain_scores_gemma":[0.9994294,0.000036053385,0.0000430597,0.00023723269,0.000046784327,0.00020744927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012181024,0.00018361659,0.00039757477,0.00015983138,0.000057097015,0.000014449765,0.000081614715,0.00009655835,0.00049630407],"category_scores_gemma":[0.000029323359,0.00014839675,0.00005394156,0.0002534313,0.000104079314,0.000048996786,0.00005903285,0.00026749715,0.000002772446],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055206718,0.0025201796,0.93925613,0.00024125648,0.0001253944,0.0010383119,0.0020967606,3.8920635e-7,0.051945195,0.00008516699,0.0003895803,0.0022464292],"study_design_scores_gemma":[0.020811714,0.0006465467,0.93499863,0.00046289194,0.0008831605,0.0001221713,0.00084589096,0.00005513509,0.040259723,0.00008376327,0.0006157046,0.00021466595],"about_ca_topic_score_codex":0.0005212645,"about_ca_topic_score_gemma":0.0007134752,"teacher_disagreement_score":0.02075651,"about_ca_system_score_codex":0.000007911379,"about_ca_system_score_gemma":0.000039522743,"threshold_uncertainty_score":0.6051444},"labels":[],"label_agreement":null},{"id":"W3214408062","doi":"10.1182/blood-2021-144939","title":"Tisagenlecleucel Leukapheresis and Manufacturing Outcomes in Patients Less Than 3 Years of Age with Relapsed/Refractory Acute Lymphoblastic Leukemia","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Leukapheresis; Medicine; Blinatumomab; Internal medicine; Leukemia; Lymphoblastic Leukemia; Stem cell; Biology","score_opus":0.014969082656810635,"score_gpt":0.2531213890440729,"score_spread":0.23815230638726226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214408062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99799603,0.00018023097,0.0000032958937,0.000022711776,0.0000371672,0.00023830644,0.000014682651,0.00002059435,0.0014869538],"genre_scores_gemma":[0.99559164,0.0001530056,0.00025641342,0.000051146606,0.000020946287,0.000011137978,0.000021793308,0.000042672444,0.003851223],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986706,0.000061813844,0.00023806172,0.00030805683,0.00043512817,0.00028634048],"domain_scores_gemma":[0.99925715,0.00013707759,0.00006758623,0.00036448045,0.000050437025,0.00012326815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000096681986,0.00015204979,0.00043290737,0.00013956905,0.000024828978,0.000018633478,0.00008689467,0.00009813274,0.00021996979],"category_scores_gemma":[0.000046451936,0.00013491955,0.00006293998,0.00014456807,0.000092181996,0.000064997985,0.00009405412,0.00021276789,0.0000068546706],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006771887,0.0009902118,0.93087304,0.00021114995,0.00065098284,0.0018950629,0.00064309133,0.0000063037337,0.0457479,0.0000054117745,0.00003275389,0.018266909],"study_design_scores_gemma":[0.011038722,0.00044227895,0.88810605,0.00017023357,0.00017283368,0.00003153922,0.00014548641,0.0000034196578,0.099641785,0.000016811468,0.00010314411,0.00012768096],"about_ca_topic_score_codex":0.00022440366,"about_ca_topic_score_gemma":0.0003249582,"teacher_disagreement_score":0.053893887,"about_ca_system_score_codex":0.00013364124,"about_ca_system_score_gemma":0.0002216195,"threshold_uncertainty_score":0.550186},"labels":[],"label_agreement":null},{"id":"W3214408187","doi":"10.1182/blood-2021-151797","title":"A Population Cohort Study to Evaluate the Risk of Ischemic Stroke Among Individuals with a New Diagnosis of Cancer Compared to Matched Cancer-Free Controls: Impact of Prior Stroke History","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; University of Toronto; University Health Network; University of Ottawa; Thrombosis and Atherosclerosis Research Institute; Ottawa Hospital","funders":"","keywords":"Medicine; Stroke (engine); Cohort; Cancer; Population; Internal medicine; Hazard ratio; Cohort study; Thrombosis; Confidence interval","score_opus":0.018773463859506102,"score_gpt":0.30173057801147,"score_spread":0.2829571141519639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214408187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926728,0.0018976623,0.00005254002,0.00029486083,0.00007224074,0.0039243484,0.0006949056,0.000024640438,0.00036601996],"genre_scores_gemma":[0.9971662,0.00009782697,0.00097568054,0.00008652456,0.00008696757,0.00076001626,0.00002676588,0.000042134892,0.0007578756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973153,0.00014100294,0.00074718246,0.00044045347,0.0010530989,0.00030295274],"domain_scores_gemma":[0.99744266,0.00018448535,0.00061119156,0.0011044556,0.00044355102,0.00021362558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058307726,0.00028657223,0.0011530863,0.00017899873,0.000030589294,0.00000766978,0.00035266698,0.000056201607,0.0003380177],"category_scores_gemma":[0.00046462874,0.00019835285,0.0002196851,0.00035767574,0.00006667092,0.000057880206,0.00025387623,0.0001912011,0.0000011395339],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057296164,0.0012163977,0.95331514,0.00009790697,0.0065753893,0.0000069857983,0.0030756416,0.00087982864,0.0155104315,4.4827294e-7,0.018277202,0.00047165318],"study_design_scores_gemma":[0.0110224085,0.00092681014,0.9422341,0.00037994972,0.008252625,0.0000019016045,0.0013181729,0.000039401275,0.035449278,5.9950656e-7,0.0002123319,0.00016243309],"about_ca_topic_score_codex":0.056426547,"about_ca_topic_score_gemma":0.0070202085,"teacher_disagreement_score":0.049406342,"about_ca_system_score_codex":0.0004905238,"about_ca_system_score_gemma":0.0006336686,"threshold_uncertainty_score":0.94985676},"labels":[],"label_agreement":null},{"id":"W3214412162","doi":"10.1182/blood-2021-153441","title":"The Genomic Landscape of Plasmablastic Lymphoma (PBL) - an L.L.M.P.P. Project","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Canada's Michael Smith Genome Sciences Centre; University Health Network; Spinal Cord Injury BC","funders":"","keywords":"Exome sequencing; Biology; Lymphoma; HRAS; Exome; Indel; Plasmablastic lymphoma; Comparative genomic hybridization; Genome; Whole genome sequencing; Gene duplication; Fluorescence in situ hybridization; Genetics; Mutation; Gene; KRAS; Immunology; Single-nucleotide polymorphism","score_opus":0.010871982027634949,"score_gpt":0.24400729682291086,"score_spread":0.2331353147952759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214412162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869743,0.0025102822,0.0000052191654,0.00023617753,0.00010257425,0.00013919224,0.000014469961,0.000030776595,0.009987034],"genre_scores_gemma":[0.99818575,0.00042163677,0.00010527773,0.00015946614,0.00008563356,0.000014156415,0.000026157088,0.000018024906,0.0009838939],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992769,0.000037298323,0.00016670614,0.00015968832,0.00015877713,0.00020067669],"domain_scores_gemma":[0.99949425,0.000052085918,0.00007078722,0.00025342294,0.0000763202,0.00005311151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009615958,0.00008636534,0.000179518,0.000028683993,0.000089271954,0.000018543979,0.00007328736,0.00006011906,0.000044909128],"category_scores_gemma":[0.00009995532,0.00005982121,0.00007695249,0.00018320947,0.00004080232,0.000030139188,0.000026456559,0.0000556446,0.0000122275615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004022303,0.016055053,0.5445901,0.0011941595,0.005716934,0.0015518019,0.00942189,0.00022860384,0.25237885,0.0054414393,0.043190803,0.11620802],"study_design_scores_gemma":[0.11431597,0.006363928,0.60406405,0.0005962394,0.0047756974,0.00096355303,0.020375354,0.0027019784,0.1387828,0.0019340486,0.10371292,0.0014134536],"about_ca_topic_score_codex":0.00006896705,"about_ca_topic_score_gemma":0.00014980468,"teacher_disagreement_score":0.11479456,"about_ca_system_score_codex":0.000022327025,"about_ca_system_score_gemma":0.00053265865,"threshold_uncertainty_score":0.24394381},"labels":[],"label_agreement":null},{"id":"W3214431912","doi":"10.1182/blood-2021-154280","title":"<i>Long-Term Quality of Life after Hematopoietic Cell Transplantation for Sickle Cell Disease: A Preliminary Report from the Sickle Cell Transplant Evaluation of Long Term and Late Effects Registry (STELLAR)</i>","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"","keywords":"Medicine; Quality of life (healthcare); Transplantation; Disease; Pediatrics; Univariate analysis; Young adult; Hematopoietic stem cell transplantation; Marital status; Hematopoietic cell; Internal medicine; Multivariate analysis; Stem cell; Haematopoiesis; Population","score_opus":0.01233304590926283,"score_gpt":0.26029836030959114,"score_spread":0.24796531440032832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214431912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.976406,0.020941703,0.00039746528,0.0002117909,0.000115795345,0.0013575158,0.00022560998,0.000022981196,0.0003211572],"genre_scores_gemma":[0.9971387,0.0015012923,0.00011106475,0.00011371154,0.000057247416,0.00009575484,0.00075466273,0.000033709406,0.00019385567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978731,0.00025007408,0.00069201645,0.0004157594,0.00054679404,0.00022224168],"domain_scores_gemma":[0.9982709,0.00042995848,0.00036897286,0.0005444016,0.00021112956,0.00017458266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059554627,0.00022226071,0.00046543413,0.000031097436,0.0000664323,0.00001496852,0.000082272985,0.00018509704,0.00003899358],"category_scores_gemma":[0.00007149225,0.00017044209,0.00022377804,0.0001163529,0.00010926987,0.000059618607,0.000018591787,0.00017138757,0.0000015686093],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041567185,0.0041464567,0.7451179,0.03038715,0.00034594382,0.0016145284,0.006741007,0.0000842772,0.20627274,0.0000023556697,0.000090152054,0.0010407892],"study_design_scores_gemma":[0.009743447,0.00025101722,0.66991,0.001115249,0.0053591384,0.00007730823,0.00017323226,0.00007709686,0.31305042,0.000040091407,0.0000041999065,0.00019877481],"about_ca_topic_score_codex":0.000045140863,"about_ca_topic_score_gemma":0.000022689832,"teacher_disagreement_score":0.10677769,"about_ca_system_score_codex":0.000013380918,"about_ca_system_score_gemma":0.0003483107,"threshold_uncertainty_score":0.69504267},"labels":[],"label_agreement":null},{"id":"W3214432495","doi":"10.1182/blood-2021-145773","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Entospletinib in Combination with Intensive Induction and Consolidation Chemotherapy in Adults with Newly Diagnosed <i>N</i> <i>ucleophosmin 1-</i>mutated Acute Myeloid Leukemia","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cytarabine; Idarubicin; Medicine; Internal medicine; Myeloid leukemia; Oncology; Induction chemotherapy; Myeloid; Daunorubicin; Mitoxantrone; Gastroenterology; Immunology; Chemotherapy","score_opus":0.017673283038204854,"score_gpt":0.3028552899997753,"score_spread":0.2851820069615704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214432495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853955,0.00014452417,0.0001586368,0.0021063047,0.00002513273,0.012037584,0.0000108368495,0.000026443284,0.00009502492],"genre_scores_gemma":[0.9975084,0.0005565499,0.00041450208,0.00046291813,0.00003000838,0.0008380798,0.000102179445,0.00004131444,0.000046040237],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972678,0.0006283569,0.0007063558,0.00056673447,0.00051556417,0.00031520965],"domain_scores_gemma":[0.9970678,0.0013395377,0.0002867525,0.00034929518,0.0008113628,0.00014525552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014101538,0.0003017111,0.0012650681,0.00036170112,0.000072793366,0.000059201087,0.00010123641,0.00010719623,0.000011465474],"category_scores_gemma":[0.0006683646,0.00019258205,0.000045121713,0.0010988003,0.00023934801,0.00015730537,0.0000696908,0.0005164272,0.0000010865031],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9646156,0.0043349387,0.005960346,0.00007246446,0.0008819803,0.00044622773,0.012128574,0.00004547037,0.0095778145,0.000025684976,0.000021100355,0.0018898064],"study_design_scores_gemma":[0.95348257,0.0035865584,0.0077627185,0.0005781328,0.00065255107,0.00023238629,0.009555849,0.0005294235,0.023406116,0.0000063739376,0.000009751044,0.00019756364],"about_ca_topic_score_codex":0.0005347306,"about_ca_topic_score_gemma":0.0007089677,"teacher_disagreement_score":0.013828303,"about_ca_system_score_codex":0.00019200715,"about_ca_system_score_gemma":0.00067538244,"threshold_uncertainty_score":0.78532684},"labels":[],"label_agreement":null},{"id":"W3214440901","doi":"10.1182/blood-2021-150102","title":"Clinical Significance of Clonal Hematopoiesis in the Setting of Autologous Stem Cell Transplantation for Lymphoma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Transplantation; Minimal residual disease; Biology; Hematopoietic stem cell transplantation; Lymphoma; Stem cell; Myeloid; Autologous stem-cell transplantation; Oncology; Immunology; Leukemia; Cancer research; Internal medicine; Genetics; Medicine","score_opus":0.03010330333754787,"score_gpt":0.3269630076835547,"score_spread":0.29685970434600684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214440901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974901,0.0002894672,0.0004562292,0.00063489925,0.000026672422,0.0004043991,0.00004738494,0.000007788035,0.0006430424],"genre_scores_gemma":[0.9952767,0.00009910058,0.004290188,0.00011403169,0.000051372637,0.000041386862,0.000029659468,0.000010080427,0.00008750867],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99876714,0.00017879625,0.00047693614,0.00017214069,0.00024580586,0.00015918296],"domain_scores_gemma":[0.99821866,0.0012816949,0.00011882043,0.00021041822,0.00013896983,0.00003144353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008685527,0.00006624165,0.0003076356,0.00004401135,0.00002050154,0.0000032825792,0.00011208355,0.00009186147,0.000010465575],"category_scores_gemma":[0.00010663049,0.000049607097,0.00011925122,0.00022148028,0.00006800393,0.000020978507,0.000012948658,0.000104102335,0.0000014608298],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025690345,0.007953765,0.5971222,0.012475434,0.00052724115,0.0013438464,0.012610611,0.00004301658,0.2874816,0.0020842752,0.0013900051,0.07439898],"study_design_scores_gemma":[0.010471547,0.00045054685,0.41647428,0.000215466,0.0003259078,0.00029559454,0.0023459313,0.00041199036,0.56863207,0.0001093638,0.00017738981,0.00008990559],"about_ca_topic_score_codex":0.000022810746,"about_ca_topic_score_gemma":0.000021293066,"teacher_disagreement_score":0.28115046,"about_ca_system_score_codex":0.000020608937,"about_ca_system_score_gemma":0.00050857494,"threshold_uncertainty_score":0.20229186},"labels":[],"label_agreement":null},{"id":"W3214473897","doi":"10.1182/blood-2021-150371","title":"Safety and Efficacy of Cusatuzumab in Combination with Venetoclax and Azacitidine (CVA) in Patients with Previously Untreated Acute Myeloid Leukemia (AML) Who Are Not Eligible for Intensive Chemotherapy; An Open-Label, Multicenter, Phase 1b Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Alberta","funders":"","keywords":"Venetoclax; Azacitidine; Medicine; Myeloid leukemia; Chemotherapy regimen; Internal medicine; Oncology; Leukemia; Chemotherapy; Cytarabine; Myeloid; Chronic lymphocytic leukemia","score_opus":0.020015693072060543,"score_gpt":0.31708747151549754,"score_spread":0.297071778443437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214473897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99394065,0.00016997241,0.000027073063,0.00019024384,0.000011158296,0.0055202935,0.00009893859,0.000020784797,0.000020868805],"genre_scores_gemma":[0.99779904,0.0002636772,0.0009733632,0.00019951485,0.000011598574,0.000144344,0.00043761384,0.000065247346,0.00010561715],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980171,0.0001461808,0.0004616077,0.0006537038,0.00033147106,0.000389989],"domain_scores_gemma":[0.99809164,0.00015612757,0.00021416735,0.00042940717,0.00095121533,0.00015746897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029311737,0.00029223697,0.0008494981,0.00024583435,0.00006830904,0.00005592728,0.0001632594,0.00010657223,0.000005812496],"category_scores_gemma":[0.00020608195,0.00023041673,0.000014894774,0.0005688361,0.00012937044,0.00027305487,0.00015202383,0.0002955532,4.6485684e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18459007,0.052641086,0.700721,0.00082483474,0.002149161,0.00078152,0.010217333,0.000034785484,0.025141472,0.000026038464,0.0000854105,0.022787265],"study_design_scores_gemma":[0.55534345,0.02684559,0.37710497,0.0012199233,0.00048534828,0.0000373622,0.0017548753,0.0012194952,0.03565808,0.0000034248703,0.000037882095,0.00028959048],"about_ca_topic_score_codex":0.00039112745,"about_ca_topic_score_gemma":0.0005918752,"teacher_disagreement_score":0.3707534,"about_ca_system_score_codex":0.0005538532,"about_ca_system_score_gemma":0.00065473234,"threshold_uncertainty_score":0.93961215},"labels":[],"label_agreement":null},{"id":"W3214477505","doi":"10.1182/blood-2021-152225","title":"TAK-981, a First-in-Class SUMO-Activating Enzyme Inhibitor, Combined with Rituximab in Adult Patients (Pts) with CD20-Positive Relapsed/Refractory (R/R) Non-Hodgkin Lymphoma (NHL): Phase 1 Data","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Jewish General Hospital","funders":"","keywords":"Rituximab; CD20; Refractory (planetary science); Lymphoma; Medicine; Hodgkin lymphoma; Internal medicine; Cancer research; Oncology; Biology","score_opus":0.00996564159610825,"score_gpt":0.23156265987685942,"score_spread":0.22159701828075118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214477505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970504,0.0002838526,0.00010529706,0.00012263379,0.00007926231,0.00061020174,0.00041747352,0.000022873059,0.001307999],"genre_scores_gemma":[0.99517834,0.00007733806,0.0014049875,0.00028274904,0.00013847862,0.00011992309,0.0026250754,0.000074205804,0.00009891866],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975297,0.00016610483,0.00042259283,0.0010074528,0.00032717723,0.0005470143],"domain_scores_gemma":[0.9983217,0.00006301422,0.00023039982,0.00097006775,0.00026488083,0.00014992224],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019918519,0.00039230307,0.00042041694,0.000096690674,0.00012393187,0.00006358941,0.00040385174,0.00025527886,0.000021846761],"category_scores_gemma":[0.00022239661,0.0003550483,0.00005084068,0.0003839462,0.00010811738,0.0000410426,0.00037820084,0.00025713845,0.000009989306],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016101897,0.08320785,0.20724225,0.00081094104,0.0011236881,0.0031580643,0.0032490424,0.00006658495,0.6610022,0.00013081299,0.0024019554,0.021504682],"study_design_scores_gemma":[0.08402069,0.0046489416,0.0072135003,0.00074106926,0.000073561874,0.00006710757,0.0004070745,0.000246482,0.8984897,0.00000896224,0.0032973923,0.00078552944],"about_ca_topic_score_codex":0.00016243465,"about_ca_topic_score_gemma":0.0016241816,"teacher_disagreement_score":0.23748747,"about_ca_system_score_codex":0.00005702385,"about_ca_system_score_gemma":0.00040378267,"threshold_uncertainty_score":0.99989015},"labels":[],"label_agreement":null},{"id":"W3214494474","doi":"10.1182/blood-2021-145294","title":"The Impact of Revised Definitions for TACO and TRALI on Hemovigilance Reporting","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Transfusion-related acute lung injury; Exact test; Demographics; Blood transfusion; Intensive care medicine; Pediatrics; Emergency medicine; Internal medicine; Lung; Pulmonary edema","score_opus":0.0703792468134859,"score_gpt":0.34047083402279593,"score_spread":0.27009158720931004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214494474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98445225,0.000751031,0.00011517823,0.0026095216,0.000034627017,0.00041022064,0.000015157567,0.000021075857,0.011590956],"genre_scores_gemma":[0.9973804,0.0006630016,0.001178215,0.00025414434,0.000034750185,0.00002795309,0.000012596601,0.0000074797154,0.00044149783],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9994509,0.000011307592,0.00026640555,0.00010595525,0.00007132946,0.000094089446],"domain_scores_gemma":[0.99950945,0.00008663915,0.00012927767,0.00017523603,0.000058850663,0.000040537932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018056796,0.000050761228,0.00014183782,0.000014604309,0.000075045165,0.000009343833,0.000017692491,0.000018925062,0.00001603507],"category_scores_gemma":[0.00032795023,0.000031739182,0.000109565735,0.00007000169,0.00002107088,0.000010020911,0.000007812165,0.000045939225,6.981061e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025423963,0.01861785,0.17016268,0.006782071,0.007654833,0.0017479167,0.0032751549,0.00006902842,0.4174006,0.18756777,0.049895965,0.13428375],"study_design_scores_gemma":[0.037152663,0.003986357,0.6331063,0.0024368889,0.0032805956,0.0009540421,0.0013542671,0.00031981218,0.27910182,0.0062109623,0.03153426,0.00056202343],"about_ca_topic_score_codex":0.000008582582,"about_ca_topic_score_gemma":0.00000652794,"teacher_disagreement_score":0.46294364,"about_ca_system_score_codex":0.0000037948294,"about_ca_system_score_gemma":0.00004248631,"threshold_uncertainty_score":0.12942864},"labels":[],"label_agreement":null},{"id":"W3214512886","doi":"10.1182/blood-2021-153876","title":"Outcomes of Maintenance Treatment Post Autologous Stem Cell Transplantation in Newly Diagnosed Multiple Myeloma Patients: A Canadian Single Center Experience","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; London Health Sciences Centre; Sunnybrook Hospital; University of Toronto","funders":"","keywords":"Medicine; Multiple myeloma; Lenalidomide; Internal medicine; Autologous stem-cell transplantation; Cohort; Maintenance therapy; Oncology; Transplantation; Proportional hazards model; Single Center; Retrospective cohort study; Univariate analysis; Surgery; Multivariate analysis; Chemotherapy","score_opus":0.017718298065217963,"score_gpt":0.25433554100460515,"score_spread":0.23661724293938718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214512886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978886,0.00013735205,0.000008134302,0.00021631298,0.00006100317,0.0005854732,0.00037605446,0.0000181283,0.000708904],"genre_scores_gemma":[0.998427,0.0001081585,0.00046617133,0.00014111039,0.0000089782825,0.0001073756,0.00037825477,0.000018296569,0.00034470763],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986524,0.000067017434,0.0002988705,0.00030878372,0.00022895042,0.00044399334],"domain_scores_gemma":[0.9990966,0.000120306955,0.00006137896,0.00026191503,0.0001655985,0.00029421676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000027774508,0.00017578047,0.00034252138,0.00015618026,0.000045608336,0.000012442382,0.00006592581,0.00007157424,0.000057646248],"category_scores_gemma":[0.00006691494,0.00013981156,0.0000980445,0.00018473092,0.00004426964,0.000074299365,0.000011276144,0.00006628648,0.000016470798],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022551572,0.004700026,0.976708,0.00006939268,0.000084901665,0.0029247918,0.0030592172,0.0000025157158,0.002914129,0.000002803654,0.0000077401355,0.009300988],"study_design_scores_gemma":[0.023229932,0.0007445257,0.91212267,0.00009895268,0.000056147863,0.000034131455,0.00072141807,0.00003088305,0.06275365,0.0000012668075,0.00010361327,0.00010282974],"about_ca_topic_score_codex":0.037527114,"about_ca_topic_score_gemma":0.17373371,"teacher_disagreement_score":0.1362066,"about_ca_system_score_codex":0.0002652939,"about_ca_system_score_gemma":0.00030585047,"threshold_uncertainty_score":0.9688821},"labels":[],"label_agreement":null},{"id":"W3214517671","doi":"10.1182/blood-2021-145278","title":"A Novel CD34-Specific T-Cell Engager Efficiently Depletes Stem Cells and Acute Myeloid Leukemia Cells <i>in Vitro</i> and <i>In Vivo</i>","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"CD34; Myeloid leukemia; Cancer research; Stem cell; Leukemia; Haematopoiesis; Antigen; T cell; Biology; Immunology; Molecular biology; Chemistry; Cell biology; Immune system","score_opus":0.01639355764875683,"score_gpt":0.23852785130132656,"score_spread":0.22213429365256973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214517671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98822725,0.0053870794,0.000033542852,0.00015859556,0.00014038639,0.0006836388,0.00011079137,0.000047265457,0.0052114334],"genre_scores_gemma":[0.9784903,0.0049815397,0.0018770035,0.000647025,0.00018049186,0.000055122906,0.000017932745,0.000113164984,0.0136374505],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972482,0.00016267558,0.00046660926,0.0008578793,0.00052302604,0.000741657],"domain_scores_gemma":[0.9985049,0.0004453346,0.00007357551,0.00057291874,0.00009550176,0.00030776844],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00062533974,0.00034279673,0.0006395166,0.00026915254,0.00008674167,0.00010931478,0.00014701423,0.00021212197,0.00026538287],"category_scores_gemma":[0.000012115606,0.00033677206,0.00010926089,0.00064234657,0.00015295563,0.00008292144,0.00020828462,0.00078323396,0.000032665248],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043310307,0.0009698208,0.0009972698,0.00016820943,0.0000673848,0.0010952038,0.00064004754,0.000009238064,0.9932852,0.000008280131,0.00048084607,0.0018454366],"study_design_scores_gemma":[0.0130250305,0.00016922932,0.00045967358,0.000116777606,0.00009763655,0.00025992308,0.00038594098,0.00014296085,0.9642633,0.0000052012992,0.020773113,0.00030120983],"about_ca_topic_score_codex":0.000054875076,"about_ca_topic_score_gemma":0.00004589181,"teacher_disagreement_score":0.029021855,"about_ca_system_score_codex":0.00014008506,"about_ca_system_score_gemma":0.00027440555,"threshold_uncertainty_score":0.99990845},"labels":[],"label_agreement":null},{"id":"W3214525102","doi":"10.1182/blood-2021-145870","title":"A Retrospective Cohort Study of Treatment Outcomes of Adult Patients with Relapsed or Refractory Low-Grade Follicular Lymphoma (ReCORD-FL)","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Follicular lymphoma; Retrospective cohort study; Cohort; Salvage therapy; Population; Oncology; Progression-free survival; Rituximab; Chemotherapy regimen; Hazard ratio; Clinical trial; Surgery; Lymphoma; Chemotherapy; Confidence interval","score_opus":0.00844342573270342,"score_gpt":0.23980056453208995,"score_spread":0.23135713879938652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214525102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99773014,0.00012057767,6.118196e-7,0.00003970205,0.00007825694,0.0015713539,0.00006786887,0.000031587624,0.00035992102],"genre_scores_gemma":[0.9986812,0.00013267156,0.000366071,0.000048613107,0.000021279433,0.00026715,0.000077027464,0.000035993842,0.00036999662],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820507,0.00007508987,0.00047644618,0.00047381414,0.00054847595,0.00022110288],"domain_scores_gemma":[0.9982859,0.00008485585,0.0002958903,0.0006979564,0.0005072377,0.00012815007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000041093936,0.00029168517,0.0010405304,0.000087718596,0.000047154786,0.0000068694344,0.00006179624,0.00008344794,0.00007601941],"category_scores_gemma":[0.00011671221,0.0001705107,0.00019372324,0.00029339927,0.000045095185,0.000050006187,0.000035857705,0.000037070393,0.000005609976],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005362827,0.08196687,0.9102157,0.000045073793,0.0048002196,0.00053113594,0.00074767135,5.7243244e-7,0.00007794097,0.000016587355,0.000025236515,0.001036732],"study_design_scores_gemma":[0.063239604,0.015446205,0.90692323,0.00015996837,0.0031283642,0.000014521892,0.00059444044,0.0000014304488,0.010300671,0.00000385287,0.00004041856,0.00014731483],"about_ca_topic_score_codex":0.0009914973,"about_ca_topic_score_gemma":0.00052264734,"teacher_disagreement_score":0.06652067,"about_ca_system_score_codex":0.00047950415,"about_ca_system_score_gemma":0.00032470093,"threshold_uncertainty_score":0.69532245},"labels":[],"label_agreement":null},{"id":"W3214530473","doi":"10.1182/blood-2021-153616","title":"Randomized, Multi-Center, Double-Blinded, Placebo Controlled Safety and Early Efficacy Trial of Cryopreserved Cord Blood Derived T-Regulatory Cell Infusions (CK0802) in the Treatment of COVID-19 Induced ARDS. (RESOLVE Trial)","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Long-Term Effects of COVID-19","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; ARDS; Randomized controlled trial; Clinical endpoint; Placebo; Regimen; Internal medicine; Surgery; Lung; Pathology","score_opus":0.049332495292921864,"score_gpt":0.3294199207338161,"score_spread":0.2800874254408942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214530473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9738152,0.0023019519,0.000059132635,0.0011129444,0.00034518776,0.02198761,0.000059937367,0.00006167424,0.00025636287],"genre_scores_gemma":[0.996561,0.0010902501,0.0005105007,0.00032257728,0.00024290229,0.0010054143,0.0000709493,0.000058614067,0.00013778744],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9934975,0.002376294,0.0019832244,0.00072951993,0.00088438205,0.0005290661],"domain_scores_gemma":[0.98699874,0.009944563,0.00096717,0.0013262847,0.00027174418,0.0004915258],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025239657,0.00058247696,0.0034270745,0.00040863294,0.0001518978,0.000051332292,0.0003649103,0.0004187603,0.000061835046],"category_scores_gemma":[0.0050048176,0.00038951938,0.0010738624,0.00047097917,0.00037183455,0.000105012834,0.00014939833,0.00036348784,0.0000027054673],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93067753,0.036772262,0.0013818219,0.0003552049,0.00174282,0.00036752614,0.003072109,0.000020266527,0.025370456,0.000055992732,0.000015018962,0.00016900648],"study_design_scores_gemma":[0.9557663,0.0071280138,0.0022579022,0.00020366821,0.004378863,0.000042289113,0.00025746392,0.000057966787,0.029409256,0.000019993535,0.00018012973,0.00029811173],"about_ca_topic_score_codex":0.0009576276,"about_ca_topic_score_gemma":0.00036690797,"teacher_disagreement_score":0.02964425,"about_ca_system_score_codex":0.000115281175,"about_ca_system_score_gemma":0.0015838031,"threshold_uncertainty_score":0.9998557},"labels":[],"label_agreement":null},{"id":"W3214543320","doi":"10.1182/blood-2021-152071","title":"Upregulation of CD47 Expression in <i>De Novo</i> Diffuse Large B-Cell Lymphoma Is More Frequent in Activated B-Cell Type","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Diffuse large B-cell lymphoma; Germinal center; CD47; BCL6; Cancer research; Biology; Immunohistochemistry; Lymphoma; B cell; Pathology; Immunology; Medicine; Immune system; Antibody","score_opus":0.00851275811266036,"score_gpt":0.2269901550706564,"score_spread":0.21847739695799603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214543320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952588,0.0038579297,0.000021976735,0.000060886217,0.00012631045,0.00013814498,0.000022282968,0.000018852254,0.0004948048],"genre_scores_gemma":[0.9986676,0.00018939572,0.00011395933,0.000078789955,0.000010105722,0.000009747734,0.00022412831,0.000016700686,0.00068957085],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99889094,0.00017971956,0.00035410788,0.00025259334,0.000044436565,0.0002781855],"domain_scores_gemma":[0.9994309,0.00004940912,0.00014256852,0.00029423553,0.00006820499,0.000014696161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013957835,0.00013809597,0.00026143022,0.0001133916,0.00003867831,0.000006917758,0.00010920278,0.0002782944,0.00015688194],"category_scores_gemma":[0.000031681026,0.00013583348,0.000062811785,0.00032355174,0.000033175333,0.00011158039,0.00007860936,0.00011963017,0.000025339785],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010215356,0.007242347,0.020962438,0.00004096466,0.00001670246,0.00000995237,0.0011535897,0.000010603771,0.9699915,0.000020713014,0.00013465954,0.00031438933],"study_design_scores_gemma":[0.016271379,0.00005053266,0.08057652,0.00010697822,0.000021780286,0.000013929885,0.0002191009,0.000019158548,0.9015343,0.000039914303,0.0010245632,0.00012182157],"about_ca_topic_score_codex":0.0000578528,"about_ca_topic_score_gemma":0.000023298073,"teacher_disagreement_score":0.068457164,"about_ca_system_score_codex":0.000055160162,"about_ca_system_score_gemma":0.00010713346,"threshold_uncertainty_score":0.5539129},"labels":[],"label_agreement":null},{"id":"W3214579091","doi":"10.1182/blood-2021-147417","title":"Surpass-ET Trial: A Phase 3, Open-Label, Multicenter, Randomized, Active-Controlled Study to Assess Pharmacokinetics and Compare the Efficacy, Safety, and Tolerability of P1101 Vs Anagrelide As Second Line Therapy for Essential Thrombocythemia","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Tolerability; Anagrelide; Internal medicine; Clinical endpoint; Essential thrombocythemia; Randomized controlled trial; Hydroxycarbamide; Clinical trial; Surgery; Adverse effect; Polycythemia vera; Oncology; Chemotherapy","score_opus":0.06692123825267011,"score_gpt":0.41784009619556883,"score_spread":0.35091885794289873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214579091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97530293,0.001039212,0.00016177191,0.002259342,0.00016291553,0.020648057,0.00023690573,0.000018986815,0.00016987661],"genre_scores_gemma":[0.9954924,0.0010853861,0.0009931842,0.0008227267,0.0001389996,0.0012371655,0.000086878026,0.00003489914,0.00010837247],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99705255,0.0009058895,0.00086656114,0.0006125108,0.00030198795,0.00026049066],"domain_scores_gemma":[0.99454904,0.0040428583,0.00030993024,0.00043384815,0.0004606765,0.00020364109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014118642,0.00035734786,0.0023021006,0.000057162346,0.00017040367,0.00013183818,0.00015600181,0.00005055172,0.00020157437],"category_scores_gemma":[0.0009010318,0.00021667207,0.00016510472,0.0001550785,0.00013186142,0.00008429692,0.00020162783,0.00017925004,0.0000010570886],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91937894,0.061011147,0.003039707,0.00008819625,0.004311381,0.000050557686,0.0020122633,0.0000057542175,0.0073690605,0.00006862919,0.00014342257,0.0025209754],"study_design_scores_gemma":[0.90852934,0.006633385,0.004876882,0.00009255374,0.0023927276,0.000022195953,0.000525707,0.00041645672,0.075842574,0.000029767521,0.0004599446,0.00017844244],"about_ca_topic_score_codex":0.000065363885,"about_ca_topic_score_gemma":0.00019627146,"teacher_disagreement_score":0.06847352,"about_ca_system_score_codex":0.000026070022,"about_ca_system_score_gemma":0.00022224172,"threshold_uncertainty_score":0.88356304},"labels":[],"label_agreement":null},{"id":"W3214582472","doi":"10.1182/blood-2021-148673","title":"Disrupting Mitohormesis As a Novel Therapeutic Strategy for Multiple Myeloma (MM) Including Those with High Risk Disease and Proteosome Inhibitor Resistance","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Unfolded protein response; XBP1; Downregulation and upregulation; Mitochondrion; Biology; Cancer research; Apoptosis; Gene signature; Molecular biology; Gene; Cell biology; Gene expression; Endoplasmic reticulum; Genetics; RNA","score_opus":0.044417988746988955,"score_gpt":0.3174616241647744,"score_spread":0.2730436354177855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214582472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937247,0.002987324,0.0004436232,0.00050984527,0.00002450742,0.0018214153,0.00026483653,0.00007126187,0.0001524952],"genre_scores_gemma":[0.98610383,0.0001913861,0.011767998,0.00006836431,0.00021717855,0.0006751533,0.000100571386,0.00005927462,0.0008162242],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981643,0.000067316614,0.00025050036,0.0005869546,0.00041159548,0.00051934057],"domain_scores_gemma":[0.99843884,0.0003522085,0.00012031198,0.00038750982,0.0002185524,0.00048258548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015719596,0.00026624196,0.00035591642,0.000082099825,0.00036219694,0.00009676888,0.0000698305,0.00007269267,0.000019856096],"category_scores_gemma":[0.00067171984,0.0001980339,0.0000927009,0.0002445068,0.00009432432,0.00013981813,0.00008077635,0.0001952959,0.0000056157946],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011698232,0.006253389,0.8166516,0.002307452,0.0031364637,0.003185138,0.00079138455,0.00001235379,0.13385111,0.0006990848,0.000048125665,0.021365708],"study_design_scores_gemma":[0.04788559,0.0015459094,0.8309837,0.0013850218,0.0018185854,0.00017448403,0.0009567577,0.00072698924,0.11262777,0.00083516847,0.0004698268,0.00059022126],"about_ca_topic_score_codex":0.00011553115,"about_ca_topic_score_gemma":0.00023405587,"teacher_disagreement_score":0.03618736,"about_ca_system_score_codex":0.00005337206,"about_ca_system_score_gemma":0.0004051,"threshold_uncertainty_score":0.8075588},"labels":[],"label_agreement":null},{"id":"W3214589663","doi":"10.1182/blood-2021-154148","title":"A Phase II Study of CPX-351 Plus Venetoclax in Patients with Relapsed/Refractory (R/R) or Newly Diagnosed Acute Myeloid Leukemia (AML)","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Venetoclax; Medicine; Myeloid leukemia; Refractory (planetary science); Internal medicine; Leukemia; Chemotherapy regimen; Oncology; Azacitidine; Chemotherapy; Biology; Chronic lymphocytic leukemia","score_opus":0.01673062602691864,"score_gpt":0.29051826080820903,"score_spread":0.27378763478129037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214589663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969183,0.0002261388,0.000008900217,0.000088558314,0.00009042591,0.0019251073,0.00006281652,0.00006828848,0.0006114186],"genre_scores_gemma":[0.9965056,0.00011287093,0.0006778231,0.00021438678,0.00012471595,0.00019184065,0.00018380789,0.000098481396,0.0018904714],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99653476,0.00021997395,0.0007033052,0.0007429957,0.0011249384,0.0006739974],"domain_scores_gemma":[0.997603,0.00025122726,0.00022790674,0.0010978777,0.00047243084,0.00034754077],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002893043,0.00037743204,0.00093091576,0.00035212238,0.00011983709,0.000022785593,0.00031861383,0.00021939547,0.0002885374],"category_scores_gemma":[0.000485375,0.0002892476,0.00010026265,0.0012141897,0.00012267033,0.00018905316,0.00034666224,0.0008761985,0.000030059531],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0660976,0.1548098,0.6129226,0.0010467769,0.0070774173,0.047108565,0.030011332,0.00030124825,0.037926316,0.000033783148,0.008069867,0.034594662],"study_design_scores_gemma":[0.61472213,0.07862166,0.27501106,0.0008487462,0.0020137588,0.00016312816,0.0042021465,0.00023569862,0.020107042,0.00001094697,0.0031862475,0.0008774036],"about_ca_topic_score_codex":0.00050271174,"about_ca_topic_score_gemma":0.000541995,"teacher_disagreement_score":0.5486245,"about_ca_system_score_codex":0.0014845217,"about_ca_system_score_gemma":0.005279423,"threshold_uncertainty_score":0.99995595},"labels":[],"label_agreement":null},{"id":"W3214596074","doi":"10.1182/blood-2021-151346","title":"The Atlas of Blood Cancer Genomes (ABCG) Project: A Comprehensive Molecular Characterization of Leukemias and Lymphomas","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Genomics; Computational biology; Exome sequencing; Biology; CDKN2A; Molecular diagnostics; Cancer; Bioinformatics; Genome; Genetics; Gene; Mutation","score_opus":0.007885654580957633,"score_gpt":0.2315646027730055,"score_spread":0.22367894819204787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214596074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807451,0.018639795,0.00003055092,0.00006618291,0.00006249357,0.0001426849,0.0001343359,0.0000023558537,0.00017654497],"genre_scores_gemma":[0.97904754,0.020366432,0.00016770848,0.0000905102,0.0000779124,0.000026099682,0.00011845048,0.000015577074,0.000089795896],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993767,0.000028993747,0.00019330122,0.00019667372,0.00008150877,0.00012280163],"domain_scores_gemma":[0.9993455,0.000024212291,0.00013562886,0.00024392709,0.00022180092,0.00002894203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000034878576,0.00009732843,0.00014461555,0.000016896578,0.000045750265,0.0000154588,0.00008625476,0.00007171974,0.0000034833713],"category_scores_gemma":[0.00003991689,0.00008435457,0.000056321114,0.000083580795,0.00009165383,0.0000017157059,0.00012439182,0.00002954479,1.8700298e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024824392,0.00010577277,0.004108002,0.00004907472,0.00021856598,0.000007650972,0.000085918895,0.0000090607155,0.99392986,0.0002661369,0.000019448593,0.0011756766],"study_design_scores_gemma":[0.0011905157,0.000116265845,0.006695112,0.000022537026,0.00014958109,0.00002599278,0.000062163526,0.000012084323,0.98044264,0.0000334182,0.011152766,0.000096937],"about_ca_topic_score_codex":0.000073798685,"about_ca_topic_score_gemma":0.00005286233,"teacher_disagreement_score":0.01348724,"about_ca_system_score_codex":0.0000048415263,"about_ca_system_score_gemma":0.00034705154,"threshold_uncertainty_score":0.34398797},"labels":[],"label_agreement":null},{"id":"W3214599575","doi":"10.1182/blood-2021-150496","title":"Risk of Progression in Chronic Phase - Chronic Myeloid Leukemia (CML) Patients Eligible for Tyrosine Kinase Inhibitor Discontinuation (TFR-PRO study): Preliminary Results","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Quebec - Clinical Research Organization in Cancer; Jewish General Hospital","funders":"","keywords":"Discontinuation; Medicine; Internal medicine; Imatinib mesylate; Drug holiday; Myeloid leukemia; Tyrosine-kinase inhibitor; Oncology; Clinical trial; Imatinib; Immunology; Cancer; Human immunodeficiency virus (HIV)","score_opus":0.015651943631827047,"score_gpt":0.3103818157024025,"score_spread":0.29472987207057544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214599575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99002296,0.0042596096,0.00002667071,0.000093764866,0.00022247272,0.0047850725,0.00035129528,0.000076558405,0.00016157329],"genre_scores_gemma":[0.9951296,0.00038944613,0.0009703269,0.0000132348205,0.0004632369,0.0007720584,0.0016877169,0.000080944184,0.0004934372],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99644464,0.00019260842,0.0011770064,0.00092286925,0.00065642997,0.00060643797],"domain_scores_gemma":[0.9976775,0.00020562513,0.00061977585,0.0009169027,0.0003933255,0.00018684645],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004927879,0.0004201803,0.00076240115,0.00024696588,0.00012722822,0.00002814982,0.0001587452,0.00021833688,0.000035151617],"category_scores_gemma":[0.0008897789,0.00036776662,0.00020814479,0.00061132613,0.00008904889,0.00023242076,0.00018327031,0.00035022033,0.000015354597],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03595399,0.12158148,0.32088682,0.0038075254,0.0024193926,0.001309901,0.0063416595,0.0005238413,0.20061754,0.00003749658,0.0034733273,0.30304703],"study_design_scores_gemma":[0.26634464,0.039206002,0.12892385,0.002636062,0.0018986162,0.000024896666,0.00033143553,0.0018499915,0.5574154,0.000035400426,0.0008239072,0.00050976645],"about_ca_topic_score_codex":0.00021410009,"about_ca_topic_score_gemma":0.0004135175,"teacher_disagreement_score":0.3567979,"about_ca_system_score_codex":0.0035343524,"about_ca_system_score_gemma":0.00316442,"threshold_uncertainty_score":0.99987745},"labels":[],"label_agreement":null},{"id":"W3214600827","doi":"10.1182/blood-2021-148903","title":"Management Strategies in Persons with Inherited Hemophilia Requiring Antithrombotic Therapy: A Scoping Review","year":2021,"lang":"en","type":"review","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; MEDLINE; Antithrombotic; Psychological intervention; Population; Venous thromboembolism; Family medicine; Intensive care medicine; Thrombosis; Psychiatry","score_opus":0.10461760722823235,"score_gpt":0.40111825187563055,"score_spread":0.2965006446473982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214600827","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025668638,0.99105334,0.000001933358,0.00017295506,0.000034603334,0.004592583,0.0000047529725,0.000065387896,0.00381775],"genre_scores_gemma":[0.000027894423,0.99763024,0.0007033159,0.0000655495,0.000096264455,0.0004642693,0.00015967725,0.000092529575,0.0007602724],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99744874,0.0002178999,0.0006029499,0.0006880407,0.0005135749,0.00052877254],"domain_scores_gemma":[0.99888223,0.000071145485,0.00015320534,0.000686186,0.00006481201,0.00014243655],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003546702,0.0004932959,0.0026810984,0.00035047348,0.00007349908,0.000083559244,0.0001867892,0.00018340845,0.00018809472],"category_scores_gemma":[0.000023474311,0.00032939465,0.00037317394,0.00123934,0.00009536048,0.000097186276,0.000103749866,0.00054538634,0.000041023377],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000964387,0.0010112684,0.00013568974,0.57370347,0.0016417295,0.0089322645,0.000066024026,1.1754987e-7,0.0000015886764,0.00007220872,0.000050042294,0.414376],"study_design_scores_gemma":[0.002093235,0.00028827522,0.000043264485,0.9549706,0.0024432708,0.00051381433,0.00011612609,3.3476357e-7,0.0000029635212,0.0000024830435,0.039186627,0.0003390304],"about_ca_topic_score_codex":0.000012213283,"about_ca_topic_score_gemma":0.000016634334,"teacher_disagreement_score":0.41403696,"about_ca_system_score_codex":0.00010364984,"about_ca_system_score_gemma":0.0009664394,"threshold_uncertainty_score":0.99991584},"labels":[],"label_agreement":null},{"id":"W3214605197","doi":"10.1182/blood-2021-147595","title":"Safety and Efficacy of Early-Start Deferiprone in Infants and Young Children with Beta-Thalassemia (START study)","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Deferiprone; Medicine; Chelation therapy; Deferoxamine; Thalassemia; Regimen; Beta thalassemia; Deferasirox; Pediatrics; Blood transfusion; Internal medicine","score_opus":0.006630251700912386,"score_gpt":0.22397055090408055,"score_spread":0.21734029920316816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214605197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99584293,0.0025550735,0.0000026094258,0.00013302403,0.000020743864,0.00051324227,0.000008830006,0.00001806624,0.0009054647],"genre_scores_gemma":[0.99898016,0.00060457335,0.00021313423,0.00003421651,0.000016868145,0.0000047629674,0.000017175325,0.000018280229,0.00011079997],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990217,0.000044087312,0.00026284857,0.00028014617,0.00018413305,0.00020705577],"domain_scores_gemma":[0.9995387,0.000027664171,0.000054295087,0.00022234688,0.000050578004,0.00010639199],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013750009,0.00013947477,0.00037209308,0.00006896772,0.00004303247,0.0000120191,0.000031798703,0.000093561786,0.000019360978],"category_scores_gemma":[0.00004405753,0.00010663399,0.000024923002,0.00027484016,0.000083773535,0.00004749457,0.00006151012,0.0002149267,0.0000013838411],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032156616,0.0012155178,0.99405676,0.00003529007,0.00031588093,0.00013496637,0.0015404727,0.0000020880595,0.0009192534,0.000009996723,0.000009202069,0.0014390135],"study_design_scores_gemma":[0.01601724,0.0008570266,0.9799481,0.00016945593,0.00042361196,0.0002402756,0.0008535609,0.0000039153556,0.0013201496,0.0000033325898,0.000044888307,0.00011845229],"about_ca_topic_score_codex":0.00024284956,"about_ca_topic_score_gemma":0.0002382085,"teacher_disagreement_score":0.015695672,"about_ca_system_score_codex":0.000007882419,"about_ca_system_score_gemma":0.00008298894,"threshold_uncertainty_score":0.43484077},"labels":[],"label_agreement":null},{"id":"W3214617383","doi":"10.1182/blood-2021-150386","title":"Long-Term Efficacy and Safety of the Oral Pyruvate Kinase Activator Mitapivat in Adults with Non-Transfusion-Dependent Alpha- or Beta-Thalassemia","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Ineffective erythropoiesis; Hemolysis; Thalassemia; Internal medicine; Pyruvate kinase deficiency; Erythropoiesis; Pyruvate kinase; Anemia; Hemoglobin; Beta thalassemia; Gastroenterology; Glycolysis; Metabolism","score_opus":0.006658763767903331,"score_gpt":0.23019239589246965,"score_spread":0.2235336321245663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214617383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969998,0.000719453,0.000009427156,0.0010136605,0.000081376435,0.00062952423,0.00001597812,0.000018989329,0.0005117994],"genre_scores_gemma":[0.9980439,0.0012689565,0.00011644394,0.00014347366,0.000027191985,0.000011942853,0.000016563012,0.000029118331,0.00034243238],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987115,0.00005785081,0.00031918724,0.00033769873,0.00030173836,0.0002720128],"domain_scores_gemma":[0.99923307,0.00007945571,0.000082795144,0.0003862403,0.00008507883,0.00013335075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010717889,0.0001989099,0.00038779597,0.000054314653,0.00007505745,0.000011611738,0.00009647972,0.00016897383,0.000113134345],"category_scores_gemma":[0.00006621253,0.00010878433,0.00007564152,0.00038462534,0.000117641954,0.000057450252,0.000075513315,0.00035678802,0.0000029560808],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052460134,0.0037478728,0.87934166,0.0009845068,0.0005109906,0.002182652,0.0022713963,0.000013285711,0.09681658,0.00002296246,0.00006412039,0.00879798],"study_design_scores_gemma":[0.029324783,0.0005164249,0.8102489,0.0024829323,0.00045056187,0.0002804752,0.00064213085,0.000011276151,0.15576519,0.0000032029639,0.000079378304,0.00019471844],"about_ca_topic_score_codex":0.00009747108,"about_ca_topic_score_gemma":0.0004196019,"teacher_disagreement_score":0.06909271,"about_ca_system_score_codex":0.000024090854,"about_ca_system_score_gemma":0.00025685155,"threshold_uncertainty_score":0.4436096},"labels":[],"label_agreement":null},{"id":"W3214624665","doi":"10.1182/blood-2021-145750","title":"A Pilot Study of the Anti-SLAMF7 Monoclonal Antibody, Elotuzumab, in Myelofibrosis","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Myelofibrosis; Medicine; Bone marrow; Cancer research; Internal medicine; Immunology; Oncology","score_opus":0.027626342156516416,"score_gpt":0.29195359031333695,"score_spread":0.2643272481568205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214624665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99583346,0.00042076097,0.0000012054927,0.00053473294,0.000085885906,0.00064757245,0.000014294054,0.0000123916725,0.0024496908],"genre_scores_gemma":[0.9989997,0.0001117074,0.0002610147,0.00014258875,0.000049260674,0.000076176846,0.000012595305,0.00001790857,0.00032900664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986715,0.000116659656,0.0003409016,0.00031859748,0.00034469977,0.00020766712],"domain_scores_gemma":[0.9991912,0.0001064044,0.00008649224,0.00043529205,0.000117932905,0.000062648665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010449444,0.00016587714,0.00042758934,0.000066349516,0.00006377955,0.000014008849,0.00008892366,0.000028466671,0.00018924549],"category_scores_gemma":[0.00009472291,0.00010905619,0.00008571088,0.00042663934,0.000040532286,0.00003505119,0.00010898605,0.0001461092,0.000018172286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007130498,0.02073747,0.94544196,0.000042852844,0.00028192915,0.00023382976,0.00046296764,0.0000067983387,0.03228576,0.000199728,0.000067117806,0.0001682877],"study_design_scores_gemma":[0.008251486,0.0024214752,0.89041144,0.00017305334,0.00027916837,0.000072014554,0.000311284,0.000008573537,0.0978666,0.000025867685,0.00009173881,0.000087305816],"about_ca_topic_score_codex":0.00038018991,"about_ca_topic_score_gemma":0.0011272014,"teacher_disagreement_score":0.06558084,"about_ca_system_score_codex":0.000031451265,"about_ca_system_score_gemma":0.00021107396,"threshold_uncertainty_score":0.44471824},"labels":[],"label_agreement":null},{"id":"W3214643294","doi":"10.1182/blood-2021-153037","title":"Development and Testing of a Lymphoma Clinical Trials Specific Frailty Index: A Secondary Analysis of the LY.12 Clinical Trial","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Frailty in Older Adults","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Hospital; Queen's University; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Clinical trial; Oncology; Aggressive lymphoma; Lymphoma; Rituximab","score_opus":0.2753137514997397,"score_gpt":0.42445638250693185,"score_spread":0.14914263100719216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214643294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99659896,0.0006285199,0.000052011022,0.0003078553,0.00041892458,0.00055395055,0.000036973124,0.000020426683,0.0013823588],"genre_scores_gemma":[0.98582006,0.00008495678,0.013007177,0.00023812546,0.00048595664,0.000015568781,0.000026017698,0.000019251283,0.00030287],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942772,0.0011208529,0.0033687877,0.000492105,0.00052310544,0.00021795677],"domain_scores_gemma":[0.9918992,0.005770199,0.0010653673,0.00076304417,0.00031534996,0.00018684291],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.006550793,0.00018202073,0.0019410664,0.00014304348,0.0000566329,0.000015767853,0.00017684701,0.00028689747,0.0001947706],"category_scores_gemma":[0.022236304,0.00012725074,0.00074303994,0.0009751376,0.00028712215,0.00003506561,0.00023978436,0.0003194358,0.000002949299],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004660626,0.0042817798,0.7035902,0.00012597423,0.0066642403,0.00008850155,0.00052488944,0.000001782946,0.0009949061,0.000030325162,0.00054256496,0.27849418],"study_design_scores_gemma":[0.105366684,0.00044223826,0.87566185,0.00023940646,0.004479339,0.000042977477,0.00022990686,0.00009326452,0.0069574215,0.00003105219,0.00631846,0.00013736941],"about_ca_topic_score_codex":0.000018161369,"about_ca_topic_score_gemma":0.000107017375,"teacher_disagreement_score":0.27835682,"about_ca_system_score_codex":0.000021167289,"about_ca_system_score_gemma":0.0014563621,"threshold_uncertainty_score":0.9859998},"labels":[],"label_agreement":null},{"id":"W3214653528","doi":"10.1182/blood-2021-151090","title":"Single Cell Analysis Elucidates the Maturation of Human Stem and Progenitor Cell Function from Fetal through Adult Hematopoiesis","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Haematopoiesis; Biology; Progenitor cell; Stem cell; Bone marrow; Myeloid; Immunology; Population; Blood cell; Lymphopoiesis; Embryonic stem cell; Hematopoietic stem cell; Cell biology; Genetics; Gene; Medicine","score_opus":0.010017909507666293,"score_gpt":0.19924394722575814,"score_spread":0.18922603771809185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214653528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99652785,0.0018458469,0.0010033869,0.000032884906,0.00006864773,0.00008289952,0.00004404807,0.000008032447,0.00038638143],"genre_scores_gemma":[0.99853426,0.00006770407,0.0006314558,0.000059564212,0.00013316091,0.000006956914,0.00035717696,0.000011830324,0.00019789506],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99933356,0.0000428508,0.00018513468,0.00024540295,0.00009455561,0.00009848406],"domain_scores_gemma":[0.99950933,0.000012326203,0.00009253013,0.00024429717,0.00011836777,0.000023119454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000036088702,0.00010615793,0.0001463417,0.000015444712,0.00009632542,0.00003541955,0.00007078569,0.00010280613,0.0000151373315],"category_scores_gemma":[0.0000055288815,0.000084302235,0.00011776982,0.00012935969,0.00004371413,0.0000059030926,0.000034026594,0.000047471414,0.0000011577833],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032823544,0.00035930757,0.0068186806,0.000032396274,0.000262518,0.0000013037992,0.0001629203,0.000005975825,0.99218,0.000015697631,0.000033140343,0.00009526687],"study_design_scores_gemma":[0.0006205526,0.00014828163,0.0017263058,0.0000054850275,0.0008975028,0.000001793074,0.0004520282,0.000027358637,0.9957636,0.00006875776,0.00018838602,0.00009992322],"about_ca_topic_score_codex":0.00008740077,"about_ca_topic_score_gemma":0.00017716907,"teacher_disagreement_score":0.005092375,"about_ca_system_score_codex":0.0000028037125,"about_ca_system_score_gemma":0.000018657964,"threshold_uncertainty_score":0.34377456},"labels":[],"label_agreement":null},{"id":"W3214665300","doi":"10.1182/blood-2021-151245","title":"A Novel FBXO45-Gef-H1 Axis Controls Oncogenic Signaling in B-Cell Lymphoma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Germinal center; Biology; Lymphoma; Follicular lymphoma; Cancer research; B cell; Diffuse large B-cell lymphoma; B-cell lymphoma; Molecular biology; Genetics; Immunology; Antibody","score_opus":0.012363726708004443,"score_gpt":0.2249483726121388,"score_spread":0.21258464590413434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214665300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98936933,0.0042282715,0.0004749492,0.00007216504,0.00008378327,0.00016661697,0.000051224913,0.000014389012,0.005539253],"genre_scores_gemma":[0.99619764,0.00011030438,0.002134145,0.00049106724,0.00024608691,0.000047233494,0.00010074405,0.000026633148,0.0006461371],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998893,0.00006074764,0.00023172142,0.00038786666,0.0001172367,0.00030940978],"domain_scores_gemma":[0.9994393,0.000021723748,0.00006347599,0.00031561323,0.00007232507,0.000087548106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017958393,0.00015670648,0.00018753875,0.00003201351,0.000047256777,0.000035093784,0.00015291519,0.00017700372,0.000059298458],"category_scores_gemma":[0.00009224927,0.00016600423,0.00013035121,0.000121883255,0.000028270651,0.0000028971542,0.000110652145,0.00007239755,0.000030407224],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003371056,0.00090926205,0.00094403065,0.000024751236,0.000044445285,0.000056609624,0.000046649988,0.00001017459,0.99666375,0.00007157618,0.000053803393,0.0011412223],"study_design_scores_gemma":[0.0067403666,0.00014888673,0.00033305382,0.000023882765,0.000032202493,0.000085727566,0.00006499494,0.000017402714,0.9777313,0.000057834455,0.0145509085,0.00021342431],"about_ca_topic_score_codex":0.00003527175,"about_ca_topic_score_gemma":0.00006081367,"teacher_disagreement_score":0.018932449,"about_ca_system_score_codex":0.000010455078,"about_ca_system_score_gemma":0.0002223363,"threshold_uncertainty_score":0.6769456},"labels":[],"label_agreement":null},{"id":"W3214689435","doi":"10.1182/blood-2021-147360","title":"Phase II Study of Venetoclax Added to Cladribine (CLAD) and Low Dose AraC (LDAC) Alternating with 5-Azacytidine (AZA) in Older and Unfit Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Venetoclax; Cladribine; Medicine; Internal medicine; Concomitant; Cytarabine; Gastroenterology; Myeloid leukemia; Leukemia; Chronic lymphocytic leukemia","score_opus":0.011253979336483009,"score_gpt":0.27869610009412255,"score_spread":0.2674421207576395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214689435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969081,0.00024294875,0.000022921802,0.00021260697,0.00002889987,0.0023665696,0.00005934105,0.000042077892,0.000116507064],"genre_scores_gemma":[0.996938,0.00009330783,0.0019573176,0.00026989574,0.000101286685,0.00016486253,0.00012105852,0.00008581393,0.00026845324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99704486,0.00012040792,0.00055228284,0.0008486994,0.00083160325,0.00060215837],"domain_scores_gemma":[0.99808735,0.00018689275,0.00019278224,0.00064827455,0.00042908548,0.00045560402],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024887745,0.00040091702,0.0008328746,0.00034474378,0.00012395167,0.000046598387,0.00017395875,0.00011743551,0.000044520883],"category_scores_gemma":[0.00022395838,0.0003146103,0.000035728677,0.00093003345,0.000117294774,0.00019083482,0.00038842144,0.00053513923,0.0000028337595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01263603,0.025446955,0.82531136,0.0007447295,0.0026370767,0.010933281,0.013896802,0.00042198543,0.07984913,0.000025909456,0.0005026869,0.027594073],"study_design_scores_gemma":[0.34243798,0.03706089,0.56040037,0.0017096899,0.0011976565,0.00028445228,0.0026762253,0.0011904635,0.052137446,0.000010023151,0.000110746325,0.0007840711],"about_ca_topic_score_codex":0.0006974986,"about_ca_topic_score_gemma":0.0008920191,"teacher_disagreement_score":0.32980195,"about_ca_system_score_codex":0.00039958366,"about_ca_system_score_gemma":0.00091299537,"threshold_uncertainty_score":0.9999306},"labels":[],"label_agreement":null},{"id":"W3214698439","doi":"10.1182/blood-2021-150638","title":"DNMT3A R882 Mutation in Human Haematopoietic Stem Cells Alters Differentiation Towards Neutrophils and Monocytes","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Biology; Haematopoiesis; Stem cell; Progenitor cell; Mutation; Myeloid; Flow cytometry; Cellular differentiation; Leukemia; CD34; Immunology; Phenotype; Cancer research; Genetics; Gene","score_opus":0.022481807033848868,"score_gpt":0.2826747966274937,"score_spread":0.2601929895936448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214698439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99773294,0.0005244902,0.0000951302,0.0008365027,0.000045251967,0.00031026508,0.0000047942062,0.000037916176,0.00041271248],"genre_scores_gemma":[0.9988245,0.00015422367,0.00030018127,0.00012730199,0.00007690417,0.000029550882,0.000047396934,0.000023989249,0.00041597604],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988375,0.00009323744,0.00025072508,0.00030737653,0.00026367474,0.0002474969],"domain_scores_gemma":[0.999449,0.000049969985,0.00005285143,0.00024420657,0.00009040064,0.0001135786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001306327,0.0001265741,0.00026270226,0.00015410683,0.000056479526,0.000047490084,0.000057273464,0.0000895114,0.00004578605],"category_scores_gemma":[0.00002475948,0.000120660574,0.00004569069,0.00023081404,0.000044506698,0.000090330315,0.00007405703,0.00021666996,0.000014651243],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000072860006,0.00097286067,0.028367983,0.0006863666,0.00017732717,0.0019205972,0.0022490472,0.000024729687,0.95660037,0.0005549354,0.00021409274,0.008158812],"study_design_scores_gemma":[0.00655922,0.0002602967,0.13246307,0.00016355875,0.00017264269,0.0002537071,0.00066565454,0.00081290386,0.85814804,0.00027844557,0.000058164904,0.00016428044],"about_ca_topic_score_codex":0.000077927485,"about_ca_topic_score_gemma":0.000028871693,"teacher_disagreement_score":0.10409508,"about_ca_system_score_codex":0.00010699087,"about_ca_system_score_gemma":0.00013868483,"threshold_uncertainty_score":0.49203956},"labels":[],"label_agreement":null},{"id":"W3214705636","doi":"10.1182/blood-2021-151972","title":"Machine Learning of Genomic Factors in 1,961 Patients with Acute Myeloid Leukemia Identifies Patients with Very Good or Very Poor Prognosis Who Do Not Benefit from Allogeneic Hematopoietic Cell Transplant in First Remission","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cohort; Oncology; Internal medicine; Transplantation; Myeloid leukemia; Myeloid; Hematopoietic cell; Haematopoiesis; Stem cell; Biology; Genetics","score_opus":0.004536426845935931,"score_gpt":0.18233632732821986,"score_spread":0.17779990048228392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214705636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981269,0.0006769389,0.000014745528,0.000012290433,0.00005828698,0.00033214726,0.00074139476,0.0000063408716,0.00003091619],"genre_scores_gemma":[0.99614215,0.0014122336,0.00021767835,0.000035947774,0.000024832918,0.00003006709,0.002035947,0.000050185696,0.000050972794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985161,0.000036666555,0.00038933443,0.0005380721,0.0002217828,0.0002980658],"domain_scores_gemma":[0.99930227,0.000055475586,0.000189692,0.00026457236,0.0000965564,0.000091429174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000050378927,0.00028209685,0.0003705883,0.00008680072,0.00006168976,0.000038076698,0.00018204114,0.00017098412,0.000027269798],"category_scores_gemma":[0.000024537481,0.0002246835,0.00007244378,0.00015713213,0.000043021413,0.000010718556,0.00011381089,0.00016461633,0.0000013508251],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008946758,0.0007349618,0.9380003,0.00010044479,0.00014797394,0.00004479804,0.00044029657,0.00068361114,0.058849,0.0000011792201,0.0000065309246,0.000096186544],"study_design_scores_gemma":[0.0058258357,0.0005902135,0.5419799,0.00025454292,0.00017826447,0.0000021292294,0.00006645646,0.000014129031,0.450579,0.0000045543784,0.00020861428,0.00029638075],"about_ca_topic_score_codex":0.00049830595,"about_ca_topic_score_gemma":0.002588898,"teacher_disagreement_score":0.39602044,"about_ca_system_score_codex":0.00006883866,"about_ca_system_score_gemma":0.00023641107,"threshold_uncertainty_score":0.9162327},"labels":[],"label_agreement":null},{"id":"W3214708416","doi":"10.1182/blood-2021-151275","title":"Clinical Validation of MCL35 in Mantle Cell Lymphoma Patients ≥65 Years Receiving Bendamustine-Rituximab","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Mantle cell lymphoma; Medicine; Bendamustine; Rituximab; Internal medicine; Hazard ratio; International Prognostic Index; Oncology; Cohort; Lymphoma; Confidence interval","score_opus":0.01761964910597387,"score_gpt":0.2833849990435385,"score_spread":0.2657653499375646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214708416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99679214,0.0002948743,0.000001710674,0.00008241801,0.00015432417,0.00016413668,0.0000157672,0.00001513636,0.00247952],"genre_scores_gemma":[0.9981779,0.00017072787,0.0011970715,0.00009170377,0.00006565148,0.000013595942,0.00012311185,0.000014606533,0.00014564606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888736,0.000065451786,0.00043077092,0.00024812014,0.00021125302,0.00015703641],"domain_scores_gemma":[0.9993517,0.00011709637,0.00010606152,0.00024922096,0.00010082422,0.00007514521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014309977,0.00009391514,0.0003130644,0.00006060987,0.000015427047,0.0000102980675,0.000042903182,0.000088232635,0.00010481034],"category_scores_gemma":[0.00016792535,0.00008949355,0.000110865905,0.00017490075,0.000022386288,0.000051197567,0.000048813792,0.000044380868,0.000054386728],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029642168,0.016806938,0.9639644,0.000062905114,0.00005016742,0.00020934848,0.00010747911,8.599601e-7,0.00026893217,0.0000135261935,0.00018893281,0.018296866],"study_design_scores_gemma":[0.024606496,0.0002452806,0.9058315,0.00016582214,0.00019732218,0.0000113738115,0.000057221165,0.0000075416588,0.06827827,0.000017955375,0.00050732115,0.00007387381],"about_ca_topic_score_codex":0.000057247984,"about_ca_topic_score_gemma":0.000013858516,"teacher_disagreement_score":0.06800934,"about_ca_system_score_codex":0.000047111225,"about_ca_system_score_gemma":0.00013882463,"threshold_uncertainty_score":0.3649441},"labels":[],"label_agreement":null},{"id":"W3214721421","doi":"10.1182/blood-2021-146432","title":"Retrospective Single-Institution Analysis of Patients with Chronic Lymphocytic Leukemia with <i>TP53</i> alterations Treated First-Line with Bruton's Tyrosine Kinase Inhibitor-Based Therapy","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Tyrosine-kinase inhibitor; Chronic lymphocytic leukemia; Bruton's tyrosine kinase; Tyrosine kinase; Leukemia; Oncology; Internal medicine; Cancer research; Cancer","score_opus":0.012037388453728903,"score_gpt":0.2399911795046364,"score_spread":0.2279537910509075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214721421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99665415,0.00059051695,0.001095786,0.000089443456,0.000025333127,0.0009315143,0.00013999223,0.00011753905,0.00035571578],"genre_scores_gemma":[0.99715525,0.00007954465,0.00078519195,0.00011984592,0.000117782234,0.00010120556,0.0013789745,0.00006952268,0.00019270022],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970111,0.00008622025,0.00046502645,0.00077226496,0.0011431922,0.00052218145],"domain_scores_gemma":[0.99695086,0.000098231736,0.0002693608,0.00097295793,0.0014606587,0.00024792476],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012351302,0.00041716447,0.000885382,0.00047864934,0.00021097698,0.000057732064,0.00012902524,0.00014934392,0.00013439456],"category_scores_gemma":[0.000085003936,0.00028191024,0.00016497477,0.0037936885,0.00042702098,0.00018759274,0.000035609864,0.00022549658,0.0000056754575],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.023588115,0.016132984,0.7439876,0.0011755428,0.021756545,0.0039672125,0.001018551,0.15119895,0.03467072,0.0002793973,0.00015508689,0.0020692935],"study_design_scores_gemma":[0.25975516,0.0127906585,0.1448021,0.0013684521,0.009346701,0.00013269356,0.000045206198,0.037001148,0.5336928,0.000003998741,0.00030541926,0.000755708],"about_ca_topic_score_codex":0.001389862,"about_ca_topic_score_gemma":0.0037997998,"teacher_disagreement_score":0.59918547,"about_ca_system_score_codex":0.033798676,"about_ca_system_score_gemma":0.027714357,"threshold_uncertainty_score":0.9999633},"labels":[],"label_agreement":null},{"id":"W3214724472","doi":"10.1182/blood-2021-154005","title":"High-Throughput Characterization of Cytogenomic Heterogeneity of MDS Using High-Resolution Optical Genome Mapping","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Copy number analysis; Biology; Computational biology; DNA sequencing; Genetics; Genome; Molecular Inversion Probe; Copy-number variation; Gene; Single-nucleotide polymorphism; Genotype","score_opus":0.01688870221070112,"score_gpt":0.23425336310767197,"score_spread":0.21736466089697085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214724472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851427,0.0005496251,0.013784777,0.00002393465,0.00015514698,0.0000919161,0.00022150263,0.0000039723236,0.000026416585],"genre_scores_gemma":[0.9914413,0.00046891032,0.007119897,0.000048490238,0.000263326,0.0000035969008,0.00062533177,0.000019046662,0.000010085798],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99914026,0.00003085395,0.00031441686,0.000261397,0.00009011314,0.00016293002],"domain_scores_gemma":[0.99932706,0.000009446141,0.00016307336,0.0003051081,0.00014823291,0.000047078585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008212216,0.00010984916,0.00020635933,0.000032794916,0.000037626643,0.000010605265,0.000092675225,0.0001244173,0.00001205885],"category_scores_gemma":[0.00004866558,0.00012952044,0.00008630573,0.00009242453,0.00005776243,0.0000035821674,0.00015255099,0.000040680043,0.0000013213612],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022423445,0.00020128992,0.0019731089,0.0000476604,0.00009799659,0.0000042584743,0.000019853156,0.00061047124,0.99658126,0.00030467898,0.0000014880068,0.00013553283],"study_design_scores_gemma":[0.00080116524,0.000105122825,0.030442186,0.000017703689,0.00008064938,0.000020449907,0.000010689635,0.00007323689,0.96792346,0.000034182278,0.00036630224,0.00012484184],"about_ca_topic_score_codex":0.000053705728,"about_ca_topic_score_gemma":0.000017640652,"teacher_disagreement_score":0.028657768,"about_ca_system_score_codex":0.000019601635,"about_ca_system_score_gemma":0.00015416127,"threshold_uncertainty_score":0.52816904},"labels":[],"label_agreement":null},{"id":"W3214768513","doi":"10.1182/blood-2021-154000","title":"Validation of <i>NMT1</i> and <i>NMT2</i> As Novel Drug Targets in Adult Acute Myeloid Leukemia: Rationale for N-Myristoyltransferase Inhibition with Pclx-001 for Clinical Trials","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Myristoylation; Biology; Myeloid leukemia; Cancer research; Kinase; Leukemia; Pharmacology; Phosphorylation; Cell biology; Immunology","score_opus":0.02564804802804132,"score_gpt":0.3131186902226401,"score_spread":0.2874706421945988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214768513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98448026,0.0017360697,0.010337699,0.00038703202,0.00086684874,0.0010773733,0.000988149,0.000007689502,0.00011885915],"genre_scores_gemma":[0.9512523,0.009577813,0.016471498,0.002180562,0.009838908,0.0010650493,0.008284395,0.00008638626,0.0012430933],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986053,0.00010868242,0.0006086944,0.00039451977,0.00011510572,0.00016765899],"domain_scores_gemma":[0.9990554,0.0001753125,0.00017638064,0.00017542327,0.0003477468,0.00006975267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089441246,0.00014360966,0.00040810773,0.000034455446,0.000051225343,0.000018751321,0.000048394748,0.00016638376,0.0000054345396],"category_scores_gemma":[0.0005368695,0.00013358323,0.00015057596,0.000074048265,0.00006295685,0.000012175153,0.00001949815,0.00007384614,3.5989535e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012642485,0.00062650355,0.00033978903,0.000121802346,0.00019105534,3.6173537e-7,0.00009039871,0.00001980414,0.9868139,0.00044027335,0.008890275,0.0012015753],"study_design_scores_gemma":[0.020250257,0.00034716303,0.00019351918,0.000045429733,0.00035503763,0.000023105544,0.00008269908,0.000014882681,0.91640216,0.0001968193,0.06190552,0.0001833871],"about_ca_topic_score_codex":0.000027056738,"about_ca_topic_score_gemma":0.00019373027,"teacher_disagreement_score":0.070411734,"about_ca_system_score_codex":0.000009740562,"about_ca_system_score_gemma":0.00042490597,"threshold_uncertainty_score":0.54473656},"labels":[],"label_agreement":null},{"id":"W3214826832","doi":"10.1182/blood-2021-153632","title":"A Phase 2 Multi-Center, Open Label Study of Isatuximab Added to Standard Cybord Induction and Lenalidomide Maintenance Treatments in Newly Diagnosed, Transplant Eligible Multiple Myeloma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; CancerCare Manitoba","funders":"","keywords":"Lenalidomide; Autologous stem-cell transplantation; Multiple myeloma; Melphalan; Medicine; Internal medicine; Maintenance therapy; Transplantation; Oncology; Bortezomib; Surgery; Chemotherapy","score_opus":0.06499604698242274,"score_gpt":0.3708422051237642,"score_spread":0.3058461581413415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214826832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955017,0.00041279505,0.00005563594,0.00020784678,0.000054286873,0.003125276,0.00051294774,0.000025999127,0.00010353668],"genre_scores_gemma":[0.9939552,0.00045227268,0.0045012813,0.00007684902,0.0000285573,0.00046897313,0.00016988508,0.000036650923,0.00031032707],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99776626,0.00018185878,0.00049379887,0.0006386545,0.00042788993,0.00049151876],"domain_scores_gemma":[0.9987816,0.00011686295,0.00009393003,0.00044601553,0.00019464247,0.00036694366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002162399,0.00028117406,0.00072443334,0.00022723427,0.00008548702,0.000058055248,0.00016042787,0.000081204416,0.000026456322],"category_scores_gemma":[0.00028169111,0.00023319258,0.00005273211,0.00046677195,0.00004203218,0.00018450644,0.00015301294,0.00018306117,0.00000948482],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017880937,0.27707458,0.58068377,0.0001918219,0.0015779866,0.008915512,0.0056077745,0.0000026558575,0.053015497,0.00000641004,0.00015860584,0.05488443],"study_design_scores_gemma":[0.7534544,0.009617736,0.15262759,0.0006816875,0.00039679295,0.0002241053,0.0025092755,0.00014399405,0.0798116,0.000008423883,0.00026264746,0.00026174402],"about_ca_topic_score_codex":0.0023208533,"about_ca_topic_score_gemma":0.005508215,"teacher_disagreement_score":0.7355735,"about_ca_system_score_codex":0.00012426054,"about_ca_system_score_gemma":0.00022461703,"threshold_uncertainty_score":0.9509317},"labels":[],"label_agreement":null},{"id":"W3214885106","doi":"10.1182/blood-2021-152895","title":"Progressive Multifocal Leukoencephalopathy in Multiple Myeloma: A Single Institution Case Series","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lenalidomide; Progressive multifocal leukoencephalopathy; Pomalidomide; Thalidomide; Autologous stem-cell transplantation; Multiple myeloma; Melphalan; Transplantation; Bortezomib; Surgery; Internal medicine; Hematopoietic stem cell transplantation; Immunology; Virus","score_opus":0.020031152485136497,"score_gpt":0.2534592636142219,"score_spread":0.2334281111290854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214885106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99187756,0.0064638746,0.000012906121,0.00016958808,0.0001274983,0.00023235737,0.000023482422,0.00007611977,0.0010165911],"genre_scores_gemma":[0.998555,0.0000447077,0.00091885607,0.00007926524,0.00010905145,0.000040475956,0.00004074767,0.000013077925,0.00019882903],"study_design_codex":"case_report","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991265,0.00003982653,0.00020547668,0.00025231237,0.0001401534,0.00023576524],"domain_scores_gemma":[0.9995095,0.000026650185,0.000044276807,0.0001860168,0.00008103172,0.00015251256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000040089715,0.00012394984,0.00019751072,0.00007109117,0.000092684044,0.000020813955,0.000028900176,0.00011596507,0.000050586066],"category_scores_gemma":[0.00030728552,0.00010480145,0.00007212435,0.00026980348,0.00012893279,0.00013681021,0.000042542168,0.0001602954,0.000029492649],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004944843,0.011282972,0.19804277,0.00026334208,0.00018807585,0.6913506,0.0015541329,0.00003826543,0.08198933,0.00028902045,0.00008309889,0.014423889],"study_design_scores_gemma":[0.03712685,0.0013188636,0.1166679,0.001809728,0.0011604466,0.29694223,0.0045164176,0.0010192789,0.5347453,0.0001746515,0.0036368815,0.0008814457],"about_ca_topic_score_codex":0.00007250117,"about_ca_topic_score_gemma":0.00020655054,"teacher_disagreement_score":0.45275596,"about_ca_system_score_codex":0.00004108472,"about_ca_system_score_gemma":0.0002736301,"threshold_uncertainty_score":0.42736793},"labels":[],"label_agreement":null},{"id":"W3214923683","doi":"10.1182/blood-2021-153569","title":"Myelodysplastic Syndromes: Have You Seen Your Patient Beyond His Hemoglobin?","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Myelodysplastic syndromes; Population; Quality of life (healthcare); Palliative care; Disease; Psychosocial; Delirium; Hematologic disease; Pediatrics; Asymptomatic; Advance care planning; Intensive care medicine; Internal medicine; Psychiatry; Bone marrow","score_opus":0.02051867763771643,"score_gpt":0.274874113350438,"score_spread":0.25435543571272157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214923683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9735421,0.00127453,0.000060634546,0.002002005,0.0002003336,0.00042189346,0.000068439585,0.00012617385,0.022303872],"genre_scores_gemma":[0.9820808,0.00013398583,0.0025568684,0.001000452,0.0002866662,0.00005882084,0.00018816262,0.00007835096,0.013615903],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975646,0.00008630244,0.00037781583,0.00057155004,0.00075115176,0.0006485403],"domain_scores_gemma":[0.99829626,0.00012929703,0.00007522086,0.00074422796,0.00032431708,0.00043065817],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015086816,0.00026184245,0.00047000832,0.0001560289,0.0001142325,0.000047219975,0.0001727051,0.00018425006,0.001130307],"category_scores_gemma":[0.0005468341,0.00023576026,0.00016598347,0.0004013206,0.00009366206,0.00008687684,0.00027594928,0.0005217342,0.00073305256],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014328458,0.01783264,0.23197834,0.003463254,0.0077161714,0.169059,0.0114688035,0.00008295435,0.34470323,0.0015384716,0.13395324,0.07677104],"study_design_scores_gemma":[0.060073383,0.007969563,0.119190566,0.0016523529,0.0048279664,0.051312756,0.010488966,0.0016945624,0.5301365,0.0011924251,0.20849834,0.0029626174],"about_ca_topic_score_codex":0.000054906057,"about_ca_topic_score_gemma":0.000013224328,"teacher_disagreement_score":0.18543327,"about_ca_system_score_codex":0.000274877,"about_ca_system_score_gemma":0.0008717198,"threshold_uncertainty_score":0.9997828},"labels":[],"label_agreement":null},{"id":"W3214925166","doi":"10.1182/blood-2021-153162","title":"Complex Structural Variation Associated with Enhancer Hijacking and Loss of Tumor Suppressors in Mantle Cell Lymphoma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; Simon Fraser University","funders":"","keywords":"Chromothripsis; Biology; Mantle cell lymphoma; Chromosomal translocation; Breakpoint; Lymphoma; Gene; Cancer research; Genetics; Molecular biology; DNA; Genome instability; DNA damage","score_opus":0.011366768799382268,"score_gpt":0.23473530571873757,"score_spread":0.22336853691935532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214925166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99871117,0.00035605143,0.000001984882,0.00008387344,0.000021508395,0.0001279001,0.000024359604,0.000010741695,0.0006624196],"genre_scores_gemma":[0.999352,0.000023122624,0.00040740005,0.00005136443,0.000017605675,0.000010709526,0.000072547125,0.000009916252,0.000055383254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99937975,0.00003169023,0.00015135478,0.0001656198,0.00014330617,0.00012825048],"domain_scores_gemma":[0.9996358,0.000063191765,0.00008371615,0.00010942917,0.00006806356,0.00003976058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000039127208,0.00008891438,0.00022947515,0.00003538256,0.000023386376,0.000010685713,0.000020434773,0.000032794553,0.00008662203],"category_scores_gemma":[0.000028707225,0.00006882246,0.000024583187,0.00012423626,0.000026095768,0.00003773868,0.000022142702,0.000022597438,0.0000012418006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006793442,0.0015150661,0.9759696,0.00008632406,0.00017844349,0.00061718625,0.0007505325,0.0000056502913,0.02030373,0.00009010117,0.000017378905,0.0003980151],"study_design_scores_gemma":[0.011474754,0.00012589445,0.8213473,0.00013039952,0.0001871965,0.00006553608,0.000070152,0.000104062354,0.1663883,0.00003395663,0.000011873933,0.00006054374],"about_ca_topic_score_codex":0.00014369156,"about_ca_topic_score_gemma":0.00013044414,"teacher_disagreement_score":0.15462232,"about_ca_system_score_codex":0.000057047902,"about_ca_system_score_gemma":0.00007704331,"threshold_uncertainty_score":0.28064984},"labels":[],"label_agreement":null},{"id":"W3214959760","doi":"10.1182/blood-2021-151670","title":"Clinical Outcomes of Patients with Newly Diagnosed Myelodysplastic Syndrome with <i>MLL</i> Aberrations","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Myelodysplastic syndromes; Decitabine; Oncology; Population; Cytarabine; Hypomethylating agent; Cancer; Chemotherapy; Pediatrics; Bone marrow; DNA methylation; Biology","score_opus":0.016196650347414365,"score_gpt":0.2894902193334967,"score_spread":0.27329356898608237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214959760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973517,0.000049812064,0.00024632894,0.00048292615,0.00006003252,0.0004388428,0.000040066447,0.000044739973,0.0012855743],"genre_scores_gemma":[0.99229795,0.00002805022,0.0057222247,0.00037425777,0.000041906544,0.00003952389,0.00015362739,0.000041339077,0.0013011501],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998206,0.00008969654,0.00043587186,0.00036588954,0.00059489394,0.0003076023],"domain_scores_gemma":[0.9979175,0.00062113744,0.00012405908,0.00056708313,0.0005227284,0.00024750023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014949267,0.0001757629,0.0005786219,0.00008020943,0.00005992972,0.000016814452,0.00011930151,0.00010839377,0.00015984374],"category_scores_gemma":[0.0006796576,0.00011548537,0.000097185286,0.0004451215,0.00019675883,0.000088056964,0.00007205989,0.0003716762,0.00004255008],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019705883,0.0025274626,0.9937628,0.00007255875,0.0006875873,0.0018304028,0.00006873767,0.000010285898,0.00004423875,0.00007593236,0.00043916272,0.00028378336],"study_design_scores_gemma":[0.019385174,0.001642645,0.97710764,0.00013392571,0.0006390103,0.00016255685,0.00006896704,0.00001778356,0.0002515927,0.000009741032,0.00044305573,0.00013792382],"about_ca_topic_score_codex":0.000028651542,"about_ca_topic_score_gemma":0.00011063921,"teacher_disagreement_score":0.019188115,"about_ca_system_score_codex":0.000036228044,"about_ca_system_score_gemma":0.00089502736,"threshold_uncertainty_score":0.47093567},"labels":[],"label_agreement":null},{"id":"W3215020056","doi":"10.1182/blood-2021-151340","title":"Single-Cell RNA Sequencing Analysis Reveals Mechanisms of Initiation and Progression in Chronic Myelomonocytic Leukemia","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chronic myelomonocytic leukemia; Biology; Haematopoiesis; Transcriptome; Progenitor cell; Cancer research; Myeloid; Stem cell; CD34; Bone marrow; Myeloid leukemia; Leukemia; Immunology; Cell biology; Genetics; Gene expression; Gene; Myelodysplastic syndromes","score_opus":0.03073158341712162,"score_gpt":0.29858406225657763,"score_spread":0.267852478839456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215020056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950116,0.0015360542,0.0009847959,0.000117977565,0.000014521986,0.0002908791,0.00000512302,0.000025807096,0.0020131862],"genre_scores_gemma":[0.992926,0.00020875756,0.0064347507,0.000063037434,0.000050328537,0.000020765003,0.00006193429,0.000020925549,0.00021347168],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984709,0.0001333162,0.0003978753,0.00034462678,0.0003673639,0.00028593387],"domain_scores_gemma":[0.99912524,0.00011343649,0.00014339545,0.0003302683,0.00017481903,0.00011283386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045199148,0.00013157354,0.0004624004,0.00041809253,0.000037219732,0.00001899576,0.00006892471,0.00014264909,0.00007120509],"category_scores_gemma":[0.00023711764,0.00012283113,0.000087756154,0.0012977273,0.00004776746,0.000097119155,0.000106010644,0.00026866305,0.0000051252678],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033819117,0.00013931416,0.005627845,0.000402536,0.0001923026,0.0003974709,0.00028687008,0.00005257417,0.99013096,0.00011734644,0.000009247455,0.0026097428],"study_design_scores_gemma":[0.0042115166,0.0003691333,0.008392898,0.0003879126,0.0009581986,0.00007450761,0.0003022556,0.0041044615,0.9805526,0.0005127034,0.00000921464,0.0001246076],"about_ca_topic_score_codex":0.000066460794,"about_ca_topic_score_gemma":0.000068394176,"teacher_disagreement_score":0.009578342,"about_ca_system_score_codex":0.0016018397,"about_ca_system_score_gemma":0.0015954658,"threshold_uncertainty_score":0.50089085},"labels":[],"label_agreement":null},{"id":"W3215031611","doi":"10.1182/blood-2021-145344","title":"Integrated Safety Analysis of Tagraxofusp, a CD123-Directed Targeted Therapy, in Patients with Hematologic Malignancies","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton; Princess Margaret Cancer Centre","funders":"","keywords":"Hematologic Neoplasms; Medicine; Hematologic disease; Hematologic malignancy; Interleukin-3 receptor; Targeted therapy; Hematologic disorders; Intensive care medicine; Leukemia; Oncology; Immunology; Internal medicine; Cancer; Disease","score_opus":0.011378290762788786,"score_gpt":0.24324819223877106,"score_spread":0.23186990147598227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215031611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981447,0.00049169257,0.00003346009,0.00015903814,0.000013450472,0.00039555796,0.00011003749,0.00008277747,0.00056928955],"genre_scores_gemma":[0.9961672,0.00012851683,0.002246502,0.00012991742,0.000007220525,0.000026907064,0.0010088279,0.000022306911,0.00026258928],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821806,0.00018074915,0.00042417148,0.00036775685,0.0004653738,0.00034390262],"domain_scores_gemma":[0.9984395,0.000118214484,0.000117512274,0.00047028196,0.00075193145,0.00010257998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019492891,0.00019230033,0.00082331436,0.00055821467,0.000032686366,0.000010672102,0.00012619697,0.00013216215,0.00060952693],"category_scores_gemma":[0.00035255807,0.00013060584,0.00014411098,0.0048507205,0.00010834659,0.00004977911,0.00005670387,0.0002800366,0.000005693232],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010119058,0.002134735,0.97853273,0.00004822144,0.0027358446,0.00028028662,0.0003241236,0.000014273629,0.014160033,0.000035860623,0.000112408,0.0006095505],"study_design_scores_gemma":[0.010499907,0.00049518043,0.934317,0.000107771964,0.0007900972,0.000011346575,0.00025849894,0.00031240835,0.052822948,0.000008336776,0.00022732967,0.00014921276],"about_ca_topic_score_codex":0.0002485322,"about_ca_topic_score_gemma":0.0002848308,"teacher_disagreement_score":0.044215795,"about_ca_system_score_codex":0.00010861974,"about_ca_system_score_gemma":0.0004908364,"threshold_uncertainty_score":0.6673893},"labels":[],"label_agreement":null},{"id":"W3215055844","doi":"10.1182/blood-2021-144892","title":"Transformation of Follicular Lymphoma into Primary Mediastinal B-Cell Lymphoma-like Large B-Cell Lymphoma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"BCL6; CD30; Pathology; Lymphoma; Follicular lymphoma; Immunophenotyping; Reed–Sternberg cell; Biology; Diffuse large B-cell lymphoma; Anaplastic large-cell lymphoma; Germinal center; B cell; Medicine; Immunology; Antibody; Flow cytometry","score_opus":0.0073122393817467565,"score_gpt":0.22025579322521646,"score_spread":0.21294355384346972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215055844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9725054,0.0075085512,0.00021449591,0.00036813956,0.0002751623,0.00056549563,0.000082042796,0.000113195056,0.018367544],"genre_scores_gemma":[0.9934993,0.0009851576,0.0029821917,0.0009033291,0.00016555579,0.00012826423,0.000702416,0.00006517737,0.00056863757],"study_design_codex":"nonrandomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970626,0.00011251625,0.00080733607,0.00057348906,0.00085027295,0.0005937456],"domain_scores_gemma":[0.9982625,0.00013755173,0.0002530902,0.00070036104,0.00028081817,0.0003656602],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025817982,0.00044172074,0.000817704,0.00018237774,0.00015648917,0.00003846897,0.00017670674,0.00026151564,0.0001481336],"category_scores_gemma":[0.00003939498,0.00039537606,0.00051609735,0.0005105313,0.00008033534,0.00021472714,0.000093476374,0.000045628985,0.00014183891],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017229308,0.3766581,0.13514453,0.008859339,0.0032247752,0.011279766,0.01378869,0.000010532583,0.13055475,0.0020493392,0.0051367744,0.31157047],"study_design_scores_gemma":[0.15471628,0.00096848345,0.114295326,0.00042146596,0.0023813813,0.0010703374,0.00084489165,0.00012885072,0.6986886,0.000111805035,0.025784668,0.00058787],"about_ca_topic_score_codex":0.00012618431,"about_ca_topic_score_gemma":0.0000264494,"teacher_disagreement_score":0.5681339,"about_ca_system_score_codex":0.00034322048,"about_ca_system_score_gemma":0.001059464,"threshold_uncertainty_score":0.9998498},"labels":[],"label_agreement":null},{"id":"W3215189460","doi":"10.1182/blood-2021-151023","title":"Clinical Characteristics and Outcomes of Patients Diagnosed with Acute Myeloid Leukemia with Expression of CD71","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Transferrin receptor; Myeloid leukemia; Medicine; Bone marrow; Myeloid; Leukemia; Induction chemotherapy; Internal medicine; Immunology; Chemotherapy; Transferrin","score_opus":0.015686041771244122,"score_gpt":0.29972915512028003,"score_spread":0.2840431133490359,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215189460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990736,0.000062871724,0.00004708762,0.00008699191,0.000028043556,0.00031069384,0.000083393614,0.000016981201,0.0002903091],"genre_scores_gemma":[0.9934023,0.00036041235,0.0056006806,0.00012307425,0.000044775377,0.000014999672,0.00011517788,0.000031928234,0.00030666738],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984158,0.000082766164,0.00047362113,0.00030982366,0.0004970141,0.00022094736],"domain_scores_gemma":[0.9983383,0.00032381,0.00023573363,0.00045677816,0.00046137066,0.00018400593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017165841,0.00016256899,0.0007082328,0.00006769011,0.00003010698,0.000007780205,0.00009358194,0.00012524532,0.00004239284],"category_scores_gemma":[0.00035445645,0.00010194567,0.00006236762,0.00018458688,0.00024368944,0.00006123389,0.00013577577,0.0002967052,0.000002536546],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008053343,0.0009642852,0.9865166,0.00017770096,0.0004013811,0.000481604,0.00018312554,1.0212971e-7,0.008320865,0.000008815501,0.000112470334,0.0020277123],"study_design_scores_gemma":[0.013059118,0.001362672,0.9234536,0.00029629545,0.0005119082,0.00004159442,0.00010012131,0.00000731255,0.060900632,0.000002763116,0.00015722672,0.00010670264],"about_ca_topic_score_codex":0.00001925558,"about_ca_topic_score_gemma":0.000007332301,"teacher_disagreement_score":0.06306295,"about_ca_system_score_codex":0.000037389927,"about_ca_system_score_gemma":0.00065932283,"threshold_uncertainty_score":0.41572237},"labels":[],"label_agreement":null},{"id":"W3215248009","doi":"10.1182/blood-2021-145384","title":"Elucidating the Mechanisms of Leukemogenesis Driven By <i>FBXO11</i> Depletion","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Biology; CD34; Molecular biology; Progenitor cell; Cancer research; Cell biology; Stem cell","score_opus":0.013940754134227547,"score_gpt":0.25840122818205524,"score_spread":0.2444604740478277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215248009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9811508,0.00086103514,0.009672921,0.003449638,0.00006811267,0.0003653528,0.00003658542,0.000064147076,0.0043313955],"genre_scores_gemma":[0.99251163,0.00013794216,0.005275721,0.00069514284,0.0000998492,0.000025945483,0.00008215161,0.000031258718,0.0011403341],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99876034,0.00010539056,0.00023381494,0.00023234294,0.00042441516,0.00024368807],"domain_scores_gemma":[0.9990327,0.00013209971,0.000079436424,0.00046069588,0.00021201187,0.00008309423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028216979,0.00010401947,0.00022219382,0.00003791697,0.000090384754,0.000014637768,0.00014577211,0.000082197694,0.00019111708],"category_scores_gemma":[0.00030417967,0.00007568617,0.0000979204,0.0003418394,0.000055922046,0.000038892595,0.000126483,0.00019840412,0.000039293493],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022136559,0.00021049933,0.0020208284,0.000064596454,0.00013941353,0.00007070937,0.00010060515,0.0000029965295,0.99168724,0.00061287684,0.003369218,0.0016988852],"study_design_scores_gemma":[0.0020799222,0.00011333115,0.0013104958,0.000053269054,0.00021044267,0.00019173835,0.00037826796,0.00021605042,0.99330336,0.00022395693,0.0018420252,0.00007711287],"about_ca_topic_score_codex":0.00006115895,"about_ca_topic_score_gemma":0.000011523477,"teacher_disagreement_score":0.011360843,"about_ca_system_score_codex":0.00006240268,"about_ca_system_score_gemma":0.00035496042,"threshold_uncertainty_score":0.30863926},"labels":[],"label_agreement":null},{"id":"W3215404402","doi":"10.1182/blood-2021-147946","title":"A Randomized Phase 3 Trial of Blinatumomab Vs. Chemotherapy As Post-Reinduction Therapy in Low Risk (LR) First Relapse of B-Acute Lymphoblastic Leukemia (B-ALL) in Children and Adolescents/Young Adults (AYAs): A Report from Children's Oncology Group Study AALL1331","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Chemotherapy; Blinatumomab; Mitoxantrone; Acute lymphocytic leukemia; Internal medicine; Leukemia; Maintenance therapy; Minimal residual disease; Surgery; Oncology; Lymphoblastic Leukemia","score_opus":0.007673334348850686,"score_gpt":0.28522793010807385,"score_spread":0.27755459575922314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215404402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921595,0.00062812056,0.000027273909,0.00019467194,0.00022660855,0.0065445704,0.00013404113,0.00004796683,0.000037254486],"genre_scores_gemma":[0.99479806,0.0035208908,0.00038211152,0.00010575918,0.00028829047,0.00028819975,0.00048793363,0.00009609037,0.00003265534],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99406695,0.0010750229,0.0020558804,0.0011805815,0.001015226,0.0006063512],"domain_scores_gemma":[0.99668384,0.00064245146,0.0010683103,0.0009532311,0.00039289315,0.0002592704],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017109378,0.00053767307,0.0024710218,0.0006673879,0.00006560722,0.000028076658,0.00029131674,0.0005071653,0.00008521439],"category_scores_gemma":[0.0018184682,0.00047007867,0.00036440778,0.000932565,0.0003829248,0.00017749438,0.00017448059,0.00079316413,0.000004356552],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8137353,0.027055366,0.14157657,0.000071406364,0.0032763656,0.002750491,0.002965174,0.000009063329,0.0053295386,0.0000026999487,0.000025061096,0.00320297],"study_design_scores_gemma":[0.7286234,0.007510304,0.25373966,0.0006868787,0.0010040781,0.0018186835,0.0002466374,0.00031058711,0.005755968,0.000032935404,0.0000018209769,0.00026909125],"about_ca_topic_score_codex":0.012583384,"about_ca_topic_score_gemma":0.0007689286,"teacher_disagreement_score":0.112163074,"about_ca_system_score_codex":0.0008838743,"about_ca_system_score_gemma":0.0022503443,"threshold_uncertainty_score":0.9997751},"labels":[],"label_agreement":null},{"id":"W3215439278","doi":"10.1182/blood-2021-147739","title":"<i>Patient and Physician Perspectives of Unmet Needs in CML - Designing the CML SUN Survey</i>","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Family medicine; Referral; Quality of life (healthcare); Qualitative research; Inclusion (mineral); Nursing; Psychology","score_opus":0.01520937901663872,"score_gpt":0.24867288394776552,"score_spread":0.2334635049311268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215439278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99289364,0.004381392,0.000009660088,0.0001938175,0.000028464889,0.00020792017,0.00001373541,0.000011847664,0.0022595248],"genre_scores_gemma":[0.9990991,0.00017126993,0.00036592188,0.00014919283,0.000038291273,0.000012236451,0.000018048413,0.000015703807,0.00013026051],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913746,0.00015522605,0.00017261185,0.00018444798,0.00017871223,0.00017152536],"domain_scores_gemma":[0.99932134,0.00022367999,0.0000637807,0.00026840714,0.00007711843,0.000045699027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001787143,0.000112171234,0.00025377862,0.000060697548,0.000036260386,0.000009088554,0.000041300405,0.00004097984,0.00002159746],"category_scores_gemma":[0.00015639239,0.000082386396,0.000045804376,0.00040066516,0.00007895401,0.00003612697,0.00005573119,0.00013024449,0.00000321841],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021725913,0.0043350304,0.84248036,0.00019704213,0.00094465615,0.0004114243,0.048202086,0.000024080013,0.09035891,0.0005855607,0.00038210762,0.011861489],"study_design_scores_gemma":[0.010907775,0.0005892778,0.6858428,0.00035058215,0.00041497525,0.000114873794,0.026462227,0.00005660841,0.27467826,0.000109177796,0.00026318736,0.00021025224],"about_ca_topic_score_codex":0.00046421424,"about_ca_topic_score_gemma":0.00019668996,"teacher_disagreement_score":0.18431935,"about_ca_system_score_codex":0.0001039717,"about_ca_system_score_gemma":0.00024367301,"threshold_uncertainty_score":0.33596197},"labels":[],"label_agreement":null},{"id":"W3215514790","doi":"10.1182/blood-2021-149241","title":"A Prediction Rule to Guide <i>JAK2</i> Testing in Patients with Suspected Polycythemia Vera","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Medicine; Polycythemia vera; Mean corpuscular volume; Hematocrit; Internal medicine; Logistic regression; Cohort; Complete blood count; Mean corpuscular hemoglobin; Hemoglobin; Phlebotomy; Gastroenterology","score_opus":0.012007550937879492,"score_gpt":0.22649583093170797,"score_spread":0.21448827999382847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215514790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931901,0.00006729006,0.000011507467,0.00045519302,0.0000440694,0.00044173945,0.000031642412,0.000061695995,0.005696758],"genre_scores_gemma":[0.99169034,0.000005249524,0.0071623023,0.00047124783,0.000087532644,0.00010855778,0.000117649404,0.00002252502,0.00033457362],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898934,0.000024745901,0.00021201542,0.00030707786,0.0002499682,0.0002168654],"domain_scores_gemma":[0.99932265,0.00006693834,0.000039038252,0.00021802924,0.00022262729,0.00013070411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000047432564,0.00013732904,0.0002217609,0.000070911134,0.00004969017,0.000018824205,0.000028898618,0.000045628156,0.00007194372],"category_scores_gemma":[0.0002603306,0.00010790046,0.000026210857,0.00044218646,0.000010899597,0.000042667256,0.000031430074,0.00010223933,0.000029578361],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011255032,0.0021771397,0.9942102,0.000018166127,0.00008875365,0.00019588498,0.00016828737,0.000007508716,0.0015957905,0.000020869335,0.00044694814,0.0009579363],"study_design_scores_gemma":[0.009071615,0.0008876587,0.94186354,0.00030248557,0.0001405943,0.000034416757,0.000036789315,0.000012545502,0.046881687,0.000009145129,0.0006629802,0.000096517135],"about_ca_topic_score_codex":0.00006380488,"about_ca_topic_score_gemma":0.000079341036,"teacher_disagreement_score":0.052346602,"about_ca_system_score_codex":0.000098442935,"about_ca_system_score_gemma":0.00016711147,"threshold_uncertainty_score":0.4400053},"labels":[],"label_agreement":null},{"id":"W3215615180","doi":"10.1182/blood-2021-154506","title":"Normalization of the Immune Microenvironment during Lenalidomide Maintenance Is Associated with Sustained MRD Negativity in Patients with Multiple Myeloma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Lenalidomide; Multiple myeloma; Medicine; Bone marrow; Minimal residual disease; Maintenance therapy; Immune system; Oncology; Internal medicine; Hematology; Immunology; Chemotherapy","score_opus":0.005425268742964134,"score_gpt":0.2016910275470722,"score_spread":0.19626575880410804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215615180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998873,0.00008020358,0.000016943843,0.0002102978,0.000009330739,0.00066270045,0.000044829365,0.0000109096545,0.000091768256],"genre_scores_gemma":[0.9990387,0.00001784848,0.0002094154,0.00003560335,0.000006714867,0.000032354852,0.00009111925,0.000021819595,0.0005464089],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986582,0.00010918682,0.00023236763,0.00023690163,0.0004399821,0.00032336454],"domain_scores_gemma":[0.9992046,0.000056914596,0.00015276979,0.00034471697,0.00017130213,0.00006973139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008823238,0.00014646922,0.00027924732,0.000051133127,0.000078590834,0.000009987436,0.00007212614,0.000046181045,0.00003834186],"category_scores_gemma":[0.0002785599,0.000087943954,0.000054332268,0.00035480483,0.000088163644,0.00007544272,0.000081730934,0.00013410034,0.000001948092],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011138425,0.0023161967,0.9860864,0.00007816363,0.00032345878,0.00014550997,0.00025688423,0.000022651877,0.009524251,0.0000027266449,0.0000035860155,0.00012628919],"study_design_scores_gemma":[0.026529921,0.00019887423,0.7496247,0.00035390182,0.0000772171,0.000007711089,0.00010217284,0.000049987015,0.22297984,0.0000019813472,0.0000045416723,0.00006910906],"about_ca_topic_score_codex":0.00013183174,"about_ca_topic_score_gemma":0.0003472193,"teacher_disagreement_score":0.2364617,"about_ca_system_score_codex":0.00016835143,"about_ca_system_score_gemma":0.00011678019,"threshold_uncertainty_score":0.35862502},"labels":[],"label_agreement":null},{"id":"W3215637673","doi":"10.1182/blood-2021-153795","title":"Updated Results of a Phase II Study of Ponatinib and Blinatumomab for Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Blinatumomab; Medicine; Ponatinib; Internal medicine; Acute lymphocytic leukemia; Philadelphia chromosome; Oncology; Hematopoietic stem cell transplantation; Chemotherapy; Chemotherapy regimen; Clinical endpoint; Gastroenterology; Leukemia; Myeloid leukemia; Transplantation; Lymphoblastic Leukemia; Nilotinib; Clinical trial; Imatinib","score_opus":0.01112127825041482,"score_gpt":0.28296997029274257,"score_spread":0.27184869204232776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215637673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99649775,0.00009127246,0.00006220573,0.00016613274,0.000038164573,0.0017250897,0.0011951883,0.000029790297,0.00019438118],"genre_scores_gemma":[0.99777555,0.000018358223,0.0011003464,0.00004497427,0.000051500832,0.00007584746,0.00072240585,0.00005164074,0.00015938947],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99754167,0.00007901069,0.00066283863,0.0005769947,0.0007589434,0.00038054123],"domain_scores_gemma":[0.99712116,0.00039535604,0.00032362487,0.0004913047,0.0014574481,0.00021113541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017989536,0.00026912842,0.00075529347,0.00022345257,0.00011000195,0.000011973476,0.00014312439,0.00012571645,0.00002154562],"category_scores_gemma":[0.0005489309,0.0002144559,0.00007173068,0.00068630074,0.00019247165,0.0001017466,0.00022295506,0.00015962092,0.000001174229],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22613205,0.34010285,0.034866955,0.0034314378,0.032377463,0.006401379,0.027766211,0.000093997915,0.30887452,0.0003614573,0.009306071,0.010285603],"study_design_scores_gemma":[0.6751296,0.10353387,0.0390996,0.00092984637,0.005851042,0.00043635172,0.0015979795,0.002234277,0.17045416,0.00004386671,0.0001344107,0.00055501075],"about_ca_topic_score_codex":0.000044866858,"about_ca_topic_score_gemma":0.000014909182,"teacher_disagreement_score":0.44899756,"about_ca_system_score_codex":0.00022484748,"about_ca_system_score_gemma":0.00151515,"threshold_uncertainty_score":0.8745257},"labels":[],"label_agreement":null},{"id":"W3215641558","doi":"10.1182/blood-2021-153262","title":"Tisagenlecleucel Therapy Is Safe and Effective for Children with Down Syndrome with ALL in First Relapse","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario; Centre Hospitalier Universitaire Sainte-Justine; London Health Sciences Centre; Montreal Children's Hospital; Izaak Walton Killam Health Centre; Hospital for Sick Children","funders":"","keywords":"Medicine; Population; Blinatumomab; Hematopoietic stem cell transplantation; Pediatrics; Cumulative incidence; Chimeric antigen receptor; Transplantation; Cytokine release syndrome; Incidence (geometry); Internal medicine; Oncology; Leukemia; Lymphoblastic Leukemia; Immunotherapy; Cancer","score_opus":0.015171049975039468,"score_gpt":0.2743083153968002,"score_spread":0.2591372654217607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215641558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99407923,0.0018631772,0.000022822927,0.0010720659,0.000011489146,0.001808414,0.00002435979,0.000026717735,0.0010917241],"genre_scores_gemma":[0.99437547,0.0007491727,0.0009792314,0.0005593898,0.000053897667,0.00028888675,0.000045349312,0.000059671154,0.0028889116],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882495,0.00004874015,0.00012531554,0.00041705588,0.00026362084,0.00032028655],"domain_scores_gemma":[0.9992459,0.00016180973,0.00003307256,0.0003415006,0.000087975,0.00012976304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018433372,0.00017334678,0.00033808124,0.000093109426,0.00005668794,0.000029677316,0.00006300834,0.00008629838,0.00046187916],"category_scores_gemma":[0.000025436932,0.00012258544,0.00004627193,0.0002770363,0.00008567703,0.000052945372,0.00002915676,0.00023016974,0.000008264675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006918103,0.003825772,0.8889666,0.00035116158,0.004081392,0.0030372515,0.0050512915,0.0000059864346,0.05210482,0.00006243297,0.0009901143,0.034605067],"study_design_scores_gemma":[0.039474443,0.005797186,0.87902737,0.0003032708,0.00020380657,0.004534003,0.000080460035,0.000011945904,0.06665224,0.00007200908,0.0035665338,0.0002767352],"about_ca_topic_score_codex":0.000114869974,"about_ca_topic_score_gemma":0.00030683156,"teacher_disagreement_score":0.03432833,"about_ca_system_score_codex":0.000038216975,"about_ca_system_score_gemma":0.00011477201,"threshold_uncertainty_score":0.50572526},"labels":[],"label_agreement":null},{"id":"W3215668940","doi":"10.1182/blood-2021-146021","title":"Health-Related Quality of Life Following Valoctocogene Roxaparvovec Gene Therapy for Severe Hemophilia A in the Phase 3 Trial GENEr8-1","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Haemophilia; Quality of life (healthcare); Worry; Haemophilia A; Internal medicine; Physical therapy; Pediatrics; Anxiety; Psychiatry","score_opus":0.10572524543807113,"score_gpt":0.40214721162834594,"score_spread":0.29642196619027483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215668940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830465,0.0067841304,0.000015196728,0.006612203,0.0001445807,0.0030767634,0.000054981196,0.000023512666,0.00024218873],"genre_scores_gemma":[0.99682486,0.0004097755,0.0007146748,0.00067514967,0.0002968919,0.00028792108,0.00022550955,0.000028450368,0.00053677394],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9973839,0.00048516603,0.0008247766,0.000359305,0.00052871264,0.00041813173],"domain_scores_gemma":[0.9986327,0.0003993578,0.00015177285,0.0005226927,0.000120160395,0.0001732789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017555436,0.00018189948,0.0007678292,0.00009201963,0.00011125172,0.000016266677,0.0001485733,0.00014511445,0.000072978924],"category_scores_gemma":[0.0005068199,0.000118937984,0.00046512342,0.000495462,0.000044255492,0.000039353763,0.000029550682,0.00020262075,0.000005626281],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16991778,0.09741328,0.073912136,0.0016858239,0.008375717,0.001595168,0.011505722,0.000031453594,0.5391738,0.00091383664,0.0033547613,0.092120536],"study_design_scores_gemma":[0.8509863,0.0056956834,0.011171639,0.00016824483,0.00027797557,0.00010610228,0.00060433627,0.000096388205,0.1280362,0.00066294806,0.0018380929,0.00035610332],"about_ca_topic_score_codex":0.00015781344,"about_ca_topic_score_gemma":0.000051589665,"teacher_disagreement_score":0.68106854,"about_ca_system_score_codex":0.000044149478,"about_ca_system_score_gemma":0.0010478108,"threshold_uncertainty_score":0.485015},"labels":[],"label_agreement":null},{"id":"W3215728887","doi":"10.1182/blood-2021-153887","title":"Pregnancy Management and Outcomes in Patients with Myeloproliferative Neoplasms","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Mount Sinai Hospital; Princess Margaret Cancer Centre; Sinai Health System; University of Toronto","funders":"","keywords":"Medicine; Pregnancy; Essential thrombocythemia; Obstetrics; Retrospective cohort study; Preeclampsia; Pediatrics; Polycythemia vera; Internal medicine","score_opus":0.006603631693702869,"score_gpt":0.22401754236660204,"score_spread":0.21741391067289917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215728887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993956,0.0007157452,0.0000069781104,0.0004869392,0.000033156735,0.00079972314,0.000014754261,0.000025544545,0.003961103],"genre_scores_gemma":[0.99394494,0.00027795305,0.0037631518,0.00031327887,0.0000123179825,0.00023559522,0.00005764359,0.000020793803,0.0013743417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888813,0.00003544162,0.0002012363,0.000386247,0.00026044337,0.00022851452],"domain_scores_gemma":[0.9994668,0.000047187124,0.000045265864,0.00022858409,0.00010169577,0.000110466506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00002867865,0.00020294356,0.00037453463,0.00008019926,0.00005401556,0.000027825523,0.000027998321,0.00004754217,0.0000707573],"category_scores_gemma":[0.000022078313,0.00013885085,0.00003625907,0.00017391711,0.000033493314,0.00006922356,0.00005513607,0.0000987749,0.000014921148],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007924632,0.0035969247,0.9909933,0.00008756152,0.00048774361,0.00061860005,0.00030429784,8.7942163e-7,0.0000038921175,0.0012692919,0.000023341152,0.0025348722],"study_design_scores_gemma":[0.016748562,0.00062962377,0.9786633,0.00045933854,0.00027150102,0.000018626493,0.000094314775,0.000002586099,0.002749519,0.00007542563,0.0001412191,0.00014597728],"about_ca_topic_score_codex":0.0000057639954,"about_ca_topic_score_gemma":0.00006996914,"teacher_disagreement_score":0.016669316,"about_ca_system_score_codex":0.00003130192,"about_ca_system_score_gemma":0.0000464459,"threshold_uncertainty_score":0.56621736},"labels":[],"label_agreement":null},{"id":"W3215731520","doi":"10.1182/blood-2021-152314","title":"Snake Venom Botrocetin Induces GPIb-Independent Platelet Aggregation","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Von Willebrand factor; Glycoprotein Ib; Platelet; Bernard–Soulier syndrome; Platelet membrane glycoprotein; Platelet Glycoprotein GPIb-IX Complex; Von Willebrand disease; Molecular biology; Chemistry; Biochemistry; Cell biology; Biology; Immunology","score_opus":0.014348794141471147,"score_gpt":0.24814561195033202,"score_spread":0.23379681780886089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215731520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98967505,0.001667968,0.000009865776,0.00067021325,0.00010462061,0.00015070196,0.000012517763,0.000054818527,0.0076542525],"genre_scores_gemma":[0.99751896,0.00020366129,0.00046296287,0.00030906737,0.000099749835,0.000015703466,0.00018394456,0.000018760325,0.0011871995],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99912685,0.00002033526,0.00016373581,0.00024871252,0.00023190945,0.00020846762],"domain_scores_gemma":[0.99955076,0.000021453561,0.00005566815,0.00020379163,0.000066835884,0.0001015103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000051293395,0.0001248795,0.00023659463,0.0000465067,0.00006760266,0.000026187112,0.000042038493,0.00009882372,0.00028087985],"category_scores_gemma":[0.000051705614,0.00011172352,0.00007369817,0.00014017033,0.000015834079,0.000054805965,0.000028895489,0.0001318022,0.00018773647],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075102516,0.03145658,0.32423648,0.00070053316,0.005726657,0.090530045,0.0033979085,0.000026205067,0.21177123,0.0017606448,0.006232836,0.32340986],"study_design_scores_gemma":[0.024496408,0.00072089286,0.113108695,0.00032789918,0.0008948578,0.0042819544,0.000589879,0.00003644381,0.8348214,0.0013271574,0.018911406,0.00048299116],"about_ca_topic_score_codex":0.000027924827,"about_ca_topic_score_gemma":0.00003599332,"teacher_disagreement_score":0.6230502,"about_ca_system_score_codex":0.000023063103,"about_ca_system_score_gemma":0.00012261533,"threshold_uncertainty_score":0.4555953},"labels":[],"label_agreement":null},{"id":"W3215756016","doi":"10.1182/blood-2021-153813","title":"Treatment of Portal, Mesenteric, and Splenic Vein Thrombosis with Rivaroxaban: A Pilot, Prospective Cohort Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Rivaroxaban; Thrombosis; Surgery; Concomitant; Vitamin K antagonist; Apixaban; Anticoagulant; Cohort; Prospective cohort study; Portal vein thrombosis; Warfarin; Internal medicine; Atrial fibrillation","score_opus":0.015281433104596214,"score_gpt":0.2639186599306419,"score_spread":0.2486372268260457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215756016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99730414,0.00026824712,0.0000036035574,0.000039618066,0.000011950212,0.0008702522,0.000031743573,0.000019044186,0.0014513817],"genre_scores_gemma":[0.9993545,0.00027170702,0.00009001227,0.000010396388,0.000025714282,0.000070430004,0.00007308882,0.000010752255,0.00009343467],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99941164,0.000021651862,0.00011026052,0.00021124189,0.00016351747,0.00008168014],"domain_scores_gemma":[0.99964964,0.000014157984,0.000037376376,0.0001505125,0.00008647332,0.00006183357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00001708887,0.00009530527,0.0002411647,0.000027781953,0.000025799576,0.000007039294,0.000013066289,0.000013281693,0.000055000306],"category_scores_gemma":[0.0000015674934,0.00006734562,0.000030085728,0.00009880392,0.000029170018,0.000043764918,0.000005542666,0.000021581933,0.0000024168241],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022328156,0.010643786,0.98403376,0.000057032346,0.0025184785,0.00035296535,0.0010944258,5.666923e-8,0.0010299458,0.000022287915,0.0000029339403,0.000021036096],"study_design_scores_gemma":[0.012311739,0.006138357,0.9618307,0.000037964463,0.0059444257,0.00006597778,0.00052373053,9.0525174e-7,0.013072354,0.000008797225,0.0000024290994,0.000062637686],"about_ca_topic_score_codex":0.00011676878,"about_ca_topic_score_gemma":0.000082193765,"teacher_disagreement_score":0.022203088,"about_ca_system_score_codex":0.000012343682,"about_ca_system_score_gemma":0.00007244183,"threshold_uncertainty_score":0.27462748},"labels":[],"label_agreement":null},{"id":"W3215813916","doi":"10.1182/blood-2021-147963","title":"A Patient-Centered Approach to Gathering Information on Social Determinants of Health from Patients with Sickle Cell Disease in Preparation for Their Transition to Adult Care","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Focus group; Disease; Health care; Acknowledgement; Social work; Family medicine; Gerontology; Nursing; Political science; Business; Internal medicine","score_opus":0.03429625339874354,"score_gpt":0.33125684236860026,"score_spread":0.2969605889698567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215813916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99454737,0.000028871458,0.0010502847,0.00020116556,0.00008858871,0.002744155,0.0012468921,0.00002011891,0.00007254237],"genre_scores_gemma":[0.99641794,0.000004227272,0.00074755546,0.0010692482,0.00008625987,0.0003039247,0.0013535261,0.000014641005,0.0000026530172],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857605,0.00023071659,0.0005311058,0.00019000845,0.00019025762,0.00028187194],"domain_scores_gemma":[0.99910533,0.000046823803,0.00022050043,0.00013689627,0.00033952444,0.00015093175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000083966195,0.000116804804,0.000227773,0.000082774364,0.0002289135,0.000005870856,0.000048899296,0.00007745126,0.0000036036286],"category_scores_gemma":[0.000041342533,0.00010291771,0.00003885152,0.00018041258,0.000004025012,0.00013199009,0.000019699555,0.000116127645,0.0000062085624],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026227,0.0018009419,0.5587048,0.0037797086,0.000010027672,6.018423e-7,0.40854046,0.00019948688,0.000020359608,0.000013274804,0.00028236926,0.02402527],"study_design_scores_gemma":[0.012645961,0.0014230015,0.9338103,0.0014639816,0.000049173355,4.068865e-8,0.048447594,0.00050445966,0.00072309247,0.000024343788,0.00054148136,0.00036654898],"about_ca_topic_score_codex":0.00024467296,"about_ca_topic_score_gemma":0.0004517801,"teacher_disagreement_score":0.3751055,"about_ca_system_score_codex":0.00011142486,"about_ca_system_score_gemma":0.00040883097,"threshold_uncertainty_score":0.41968623},"labels":[],"label_agreement":null},{"id":"W3215825228","doi":"10.1182/blood-2021-154368","title":"Comparison of the Efficacy of Simple, Partial Manual and Automated Exchange Transfusions in the Management of Sickle Cell Disease in Pediatric Patients","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Exchange transfusion; Blood transfusion; Interquartile range; Pediatrics; Intensive care medicine; Internal medicine","score_opus":0.010066791622843324,"score_gpt":0.2705682408977273,"score_spread":0.26050144927488394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215825228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976237,0.001296559,0.0000011495704,0.00016571522,0.000030496996,0.00044659374,0.000023862842,0.000006989554,0.00040498085],"genre_scores_gemma":[0.9993883,0.00052232033,0.000017742328,0.000022025388,0.0000070796923,0.000007787642,0.000014978854,0.0000054121674,0.000014388883],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991919,0.00008228686,0.00030770455,0.00010756187,0.00019956946,0.00011102351],"domain_scores_gemma":[0.9996305,0.000047591417,0.0000758357,0.0001829239,0.000027686361,0.000035454592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000087641856,0.00006737265,0.00019187933,0.00004991071,0.000019462805,0.0000015934191,0.00006623848,0.0000408835,0.00002072213],"category_scores_gemma":[0.000016419715,0.000040901836,0.000054644413,0.00040159575,0.00004344495,0.000011125063,0.00004467101,0.00009436353,3.643782e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011075485,0.007107167,0.9870558,0.0011567918,0.000030637693,0.0000239575,0.003366348,0.00010287653,0.00020903314,0.000024817798,0.000098158,0.00071369816],"study_design_scores_gemma":[0.0069304006,0.00011179935,0.9891736,0.00009757319,0.00044449218,3.28758e-7,0.0012649426,0.000442813,0.0014239997,0.0000075298503,0.000061021612,0.00004148872],"about_ca_topic_score_codex":0.000044323082,"about_ca_topic_score_gemma":0.000028066224,"teacher_disagreement_score":0.006995368,"about_ca_system_score_codex":0.0000037826576,"about_ca_system_score_gemma":0.00003131482,"threshold_uncertainty_score":0.16679284},"labels":[],"label_agreement":null},{"id":"W3215828780","doi":"10.1182/blood-2021-153062","title":"Characterization of a Novel Missense <i>CXCR4</i> Mutation in a Patient with WHIM-like Syndrome","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Missense mutation; Primary immunodeficiency; Hypogammaglobulinemia; Medicine; Immunology; Population; Immunodeficiency; Context (archaeology); Biology; Mutation; Pathology; Genetics; Disease; Antibody","score_opus":0.00855900897908599,"score_gpt":0.2100146014640285,"score_spread":0.20145559248494252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215828780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99918514,0.00004770092,0.00028767902,0.00012571683,0.000031724336,0.00014490938,0.000008681959,0.000012194255,0.00015623236],"genre_scores_gemma":[0.99855226,0.000007606666,0.001070082,0.00012109809,0.00001812001,0.000007852627,0.00014190243,0.000012413723,0.00006867743],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994062,0.000010883418,0.0001913743,0.00013895359,0.00016092462,0.000091645365],"domain_scores_gemma":[0.9996499,0.000014397788,0.00007611879,0.00010616372,0.000112683774,0.00004073421],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000042141204,0.00006925532,0.00018123149,0.00005631124,0.000010804462,0.000005788453,0.000013783496,0.000039168113,0.000044928645],"category_scores_gemma":[0.000025420384,0.000059215516,0.000028916473,0.00027809432,0.000011047652,0.00003793852,0.0000098760265,0.00006126704,0.0000012591365],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000064225336,0.001248758,0.0047977245,0.000116859,0.000035239827,0.00091065746,0.00080680655,0.00000811274,0.9913794,0.00000958669,0.0000019466272,0.0006206742],"study_design_scores_gemma":[0.006053196,0.0005646989,0.022774767,0.0006676645,0.00014182815,0.005507179,0.0002763584,0.0002712041,0.9634122,0.0000028884772,0.00020319797,0.00012476451],"about_ca_topic_score_codex":0.000017188788,"about_ca_topic_score_gemma":0.000012807678,"teacher_disagreement_score":0.027967155,"about_ca_system_score_codex":0.000015958105,"about_ca_system_score_gemma":0.000087012886,"threshold_uncertainty_score":0.24147387},"labels":[],"label_agreement":null},{"id":"W3215874969","doi":"10.1182/blood-2021-146610","title":"New Acalabrutinib Formulation Enables Co-Administration with Proton Pump Inhibitors and Dosing in Patients Unable to Swallow Capsules (ELEVATE-PLUS)","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Pharmacology; Medicine; Pharmacokinetics; Tolerability; Adverse effect","score_opus":0.013132787101375125,"score_gpt":0.2782734632806179,"score_spread":0.2651406761792428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215874969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971657,0.000075382006,0.00007410364,0.00029384837,0.000025267098,0.0015261112,0.000003972176,0.00003373279,0.00080191554],"genre_scores_gemma":[0.9970671,0.000017304163,0.001761263,0.00008856597,0.00010572957,0.00007204753,0.00012598242,0.000028118082,0.00073388166],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984007,0.000041715997,0.00029667115,0.00037964125,0.00051443407,0.00036687587],"domain_scores_gemma":[0.9992432,0.00005013211,0.000061317674,0.00024253107,0.0001620185,0.0002408194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019762288,0.0001561573,0.0002472692,0.00013472572,0.00007176717,0.000080431455,0.000048949772,0.00011441112,0.0000434533],"category_scores_gemma":[0.00021459397,0.00013370288,0.000023336052,0.0004162476,0.00002477945,0.00019728637,0.00005198589,0.00015151799,0.000013857689],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0072770594,0.005152711,0.8605593,0.0041411323,0.00044878694,0.0015566242,0.008055981,0.00035947558,0.08174469,0.00082708435,0.0012871107,0.028590078],"study_design_scores_gemma":[0.07093212,0.0014885399,0.06663177,0.0009669788,0.000108381246,0.00012657068,0.00031702616,0.00096005586,0.8562542,0.00009119336,0.0018129455,0.0003101746],"about_ca_topic_score_codex":0.00054596085,"about_ca_topic_score_gemma":0.00033655207,"teacher_disagreement_score":0.7939275,"about_ca_system_score_codex":0.0016322208,"about_ca_system_score_gemma":0.005364014,"threshold_uncertainty_score":0.951553},"labels":[],"label_agreement":null},{"id":"W3215933821","doi":"10.1182/blood-2021-154497","title":"The Prognostic Implication of Adult Comorbidity Evaluation 27 Score in CML Patients on Tyrosine-Kinase Inhibitors","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dasatinib; Medicine; Nilotinib; Internal medicine; Imatinib mesylate; Imatinib; Population; Oncology; Philadelphia chromosome; Ponatinib; Tyrosine-kinase inhibitor; Cancer; Myeloid leukemia","score_opus":0.02204189603364523,"score_gpt":0.2844263008851013,"score_spread":0.2623844048514561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215933821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99750274,0.00035446786,8.671161e-7,0.00034923287,0.00015564707,0.0009782205,0.000015844988,0.000015768253,0.0006272143],"genre_scores_gemma":[0.99925315,0.0000926448,0.000060103208,0.000059632213,0.00006415289,0.00011129276,0.0002930541,0.000014295856,0.000051645293],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987096,0.00010608633,0.00030549447,0.00023500514,0.00048241921,0.00016135826],"domain_scores_gemma":[0.9987433,0.00015824933,0.00013611869,0.0004122668,0.0004977695,0.0000522754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018562422,0.000110736866,0.00016050212,0.000048598424,0.00005021327,0.000009516745,0.000055495584,0.00006580032,0.00002284578],"category_scores_gemma":[0.0013523687,0.00008174165,0.000051743682,0.00028013985,0.00004069924,0.000036432702,0.000032816275,0.00012360692,0.000023354272],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007970454,0.0025313413,0.9782675,0.00007006731,0.000050734772,0.000013413062,0.00015131194,0.0000075963226,0.0036260833,0.00011688857,0.0002976075,0.014787731],"study_design_scores_gemma":[0.009319784,0.00035893338,0.8687322,0.0003560884,0.0002365583,0.0000071942845,0.000043940912,0.00014728817,0.1205448,0.0001063137,0.00008185717,0.0000650351],"about_ca_topic_score_codex":0.0001117778,"about_ca_topic_score_gemma":0.00019555862,"teacher_disagreement_score":0.11691871,"about_ca_system_score_codex":0.00034721076,"about_ca_system_score_gemma":0.0004523088,"threshold_uncertainty_score":0.33333278},"labels":[],"label_agreement":null},{"id":"W3215939429","doi":"10.1182/blood-2021-151119","title":"Searching for Service and Accessibility Excellence in Paroxysmal Nocturnal Hemoglobinuria in Canada: The Epic Program","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; University Health Network","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Medicine; Eculizumab; Pediatrics; Hemoglobinuria; Coroner; Intensive care medicine; Anemia; Internal medicine; Emergency medicine; Immunology","score_opus":0.02150176385369945,"score_gpt":0.27481101190996354,"score_spread":0.2533092480562641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215939429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952175,0.0030265418,0.0000020505634,0.0008454686,0.000138289,0.0006044185,0.000037576723,0.000010783575,0.00011736486],"genre_scores_gemma":[0.99950564,0.000009595782,0.00008073068,0.00015351392,0.000015913618,0.00016199527,0.000028192058,0.0000051121915,0.00003932906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891925,0.00026743647,0.00024026785,0.0002494012,0.00003316859,0.00029047014],"domain_scores_gemma":[0.9993592,0.00031601352,0.00004932828,0.0002127597,0.000044501485,0.000018233937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029312595,0.00008926384,0.00015909014,0.000021440685,0.000090414585,0.000021379561,0.00019606386,0.0000377947,0.00009649612],"category_scores_gemma":[0.00010810327,0.000068741785,0.00002156345,0.00014784926,0.00003307093,0.000042815962,0.0001477919,0.00015648759,0.000002024307],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000719909,0.00042067101,0.9810012,0.00022838582,0.000055669847,0.000036251047,0.00043075075,0.000010961533,0.010730197,0.00013065999,0.000133729,0.00674954],"study_design_scores_gemma":[0.0029405677,0.000034738016,0.9843708,0.00010606834,0.000028633849,0.000060991108,0.0012766216,0.000040437702,0.00912705,0.0004972575,0.0013989038,0.00011791938],"about_ca_topic_score_codex":0.2989423,"about_ca_topic_score_gemma":0.91803,"teacher_disagreement_score":0.6190877,"about_ca_system_score_codex":0.00007212931,"about_ca_system_score_gemma":0.00082078564,"threshold_uncertainty_score":0.7057261},"labels":[],"label_agreement":null},{"id":"W3215940921","doi":"10.1182/blood-2021-145690","title":"Protein Profiling Identify Distinct Tumor-Tissue Protein Expression Pattern Specific for Relapsing Diffuse Large B-Cell Lymphoma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Diffuse large B-cell lymphoma; CHOP; Lymphoma; Rituximab; Medicine; Oncology; Gene expression profiling; Internal medicine; Etoposide; Clinical trial; Cancer research; Biology; Gene expression; Gene; Chemotherapy","score_opus":0.01677689605969993,"score_gpt":0.26594995224675083,"score_spread":0.2491730561870509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215940921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920393,0.0025434063,0.0011628072,0.00021054802,0.00015800222,0.0030264403,0.00010860849,0.00013457339,0.00061629707],"genre_scores_gemma":[0.98924136,0.00002060301,0.006504058,0.00008184728,0.0004011075,0.0015649273,0.00031307308,0.000083016566,0.0017900303],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978004,0.00008067802,0.00046275122,0.0007123145,0.0003947965,0.0005490679],"domain_scores_gemma":[0.99874324,0.00006357471,0.00018807381,0.0006278646,0.00015941243,0.00021783424],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018112373,0.00032349527,0.00046250626,0.00007175156,0.0002511933,0.00011697861,0.00010873762,0.00011784194,0.000098661854],"category_scores_gemma":[0.00012048448,0.00026859893,0.00020386702,0.0001686567,0.000028977543,0.00011245026,0.00013291156,0.00009065819,0.00008450761],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001511143,0.026040833,0.030230818,0.0009836304,0.000105501735,0.0028724375,0.00022601036,1.02490404e-7,0.9294238,0.00010301169,0.00034929835,0.009513456],"study_design_scores_gemma":[0.038604617,0.0003224084,0.010505332,0.0015608998,0.00021408201,0.00014818537,0.00016468999,0.000024127827,0.94204867,0.000097356555,0.0060308976,0.00027871144],"about_ca_topic_score_codex":0.000018863688,"about_ca_topic_score_gemma":0.00000930384,"teacher_disagreement_score":0.0384535,"about_ca_system_score_codex":0.00017173964,"about_ca_system_score_gemma":0.00021019905,"threshold_uncertainty_score":0.99997663},"labels":[],"label_agreement":null},{"id":"W3215954853","doi":"10.1182/blood-2021-153688","title":"Physician and Patient Beliefs and Preferences in Pulmonary Embolism and Deep Vein Thrombosis Testing in People with Cancer","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Queen's University","funders":"","keywords":"Medicine; Cancer; Family medicine; Test (biology); Thrombosis; Pulmonary embolism; Deep vein; Qualitative research; Nonprobability sampling; Grounded theory; Surgery; Internal medicine; Population","score_opus":0.014689625991699382,"score_gpt":0.24223260083349477,"score_spread":0.2275429748417954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215954853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99052227,0.0066087344,9.207559e-7,0.0006631549,0.000021466927,0.0002949468,0.000004277002,0.000013914264,0.0018703187],"genre_scores_gemma":[0.99577165,0.0030621989,0.00046510386,0.0005304158,0.00004311142,0.00009787172,0.000005395776,0.000013897756,0.000010359845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99916375,0.000028514876,0.0001538187,0.0003213758,0.00012828835,0.00020424632],"domain_scores_gemma":[0.9996802,0.000056432047,0.000045470286,0.000111133435,0.000036163798,0.00007056876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000052786923,0.0001292354,0.00036053167,0.00007251446,0.000047634774,0.000029992547,0.000023066123,0.000038830498,0.000009604452],"category_scores_gemma":[0.00002676656,0.000107099,0.000009026905,0.00025252142,0.00004507222,0.000078580015,0.0000965165,0.00010238769,3.414204e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010408369,0.0013884397,0.92392755,0.00029671672,0.00007206748,0.000115589384,0.004432083,0.000009603026,0.0014897982,0.00011126277,0.000016359956,0.06813011],"study_design_scores_gemma":[0.0013229252,0.0002590579,0.99435556,0.00068439223,0.00013659272,0.000017390652,0.0019372983,0.00011785742,0.0007857791,0.00014747537,0.00010321932,0.0001324334],"about_ca_topic_score_codex":0.0017332486,"about_ca_topic_score_gemma":0.0061457665,"teacher_disagreement_score":0.07042802,"about_ca_system_score_codex":0.000015083679,"about_ca_system_score_gemma":0.00004862385,"threshold_uncertainty_score":0.43673703},"labels":[],"label_agreement":null},{"id":"W3216000032","doi":"10.1182/blood-2021-151555","title":"Quantitative Trait of Neutrophil Count Is Influenced By Variants in the Region of <i>Gsdma</i> and <i>PSMD3-CSF3, a</i>ging, Cardiometabolic Comorbidities but Not By Chip","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal Heart Institute; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Genome-wide association study; Imputation (statistics); Biology; Genotyping; Cohort; Linkage disequilibrium; Minor allele frequency; Single-nucleotide polymorphism; Oncology; Quantitative trait locus; Immunology; Internal medicine; Genetics; Medicine; Genotype; Gene","score_opus":0.013476580581164863,"score_gpt":0.24187645092654708,"score_spread":0.22839987034538223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216000032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9806706,0.015766058,0.00001391205,0.001693257,0.00005688727,0.00025519487,0.00024150651,0.000011522091,0.0012910698],"genre_scores_gemma":[0.99205375,0.0063086846,0.00007832104,0.0013440545,0.000017858989,0.00001235159,0.000042040447,0.000017519396,0.00012545011],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998656,0.00013928881,0.00040249006,0.00024457223,0.0003335794,0.00022406837],"domain_scores_gemma":[0.99923533,0.00012196319,0.00016524615,0.0002855155,0.00013144226,0.000060493614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019968803,0.00016741341,0.00054155185,0.000085528845,0.000051307266,0.000013510599,0.00010688168,0.00013849273,0.000011226911],"category_scores_gemma":[0.0001062335,0.00012316545,0.00009871303,0.0004588487,0.00026595668,0.000067417815,0.000033574594,0.00025385822,0.000001240046],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006062376,0.0031805784,0.026773695,0.0011866526,0.0011975211,0.00041010586,0.026100645,0.00002136199,0.9191218,0.0033842393,0.015042262,0.002974906],"study_design_scores_gemma":[0.044212583,0.0032961438,0.15124235,0.002402235,0.0035973266,0.0018671945,0.0551727,0.00025949272,0.70899355,0.0009165688,0.026776027,0.0012638129],"about_ca_topic_score_codex":0.0008107434,"about_ca_topic_score_gemma":0.000012968529,"teacher_disagreement_score":0.21012822,"about_ca_system_score_codex":0.000007852613,"about_ca_system_score_gemma":0.00011970361,"threshold_uncertainty_score":0.5022541},"labels":[],"label_agreement":null},{"id":"W3216009163","doi":"10.1182/blood-2021-154124","title":"A Phase II Study of Inotuzumab Ozogamicin for the Treatment of Measurable Residual Disease-Positive B-Cell Acute Lymphoblastic Leukemia","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Minimal residual disease; Medicine; Lymphoblastic Leukemia; Acute lymphocytic leukemia; Leukemia; Internal medicine; Immunology","score_opus":0.023426078948289235,"score_gpt":0.30245612963471996,"score_spread":0.2790300506864307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216009163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952181,0.0012836161,0.00026784834,0.00019731924,0.00007477417,0.002183267,0.0004265146,0.000028209812,0.00032033987],"genre_scores_gemma":[0.9966679,0.00023568502,0.000348257,0.000043685643,0.00014211544,0.00027121828,0.000091007605,0.000051090494,0.0021489991],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976743,0.00013442448,0.0005324685,0.0004696115,0.00075758784,0.00043161566],"domain_scores_gemma":[0.99706167,0.0010667407,0.00019239305,0.0008213118,0.0006276915,0.00023020993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018740077,0.00027642265,0.0006903794,0.0001229782,0.0002033309,0.000014110936,0.00019856254,0.00008227441,0.000045240628],"category_scores_gemma":[0.00027870075,0.00018445603,0.00022725263,0.000421518,0.00016054815,0.000051793646,0.00010167624,0.00009154342,0.0000056757785],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044605736,0.38904053,0.0071468656,0.0015150597,0.020424249,0.0056202523,0.028353622,0.0006530742,0.48246193,0.0002510952,0.0040791766,0.015848419],"study_design_scores_gemma":[0.2324317,0.060803104,0.0037328538,0.0002723084,0.013209309,0.00016228847,0.004123044,0.0031216666,0.6814479,0.000049767466,0.0003504223,0.00029562757],"about_ca_topic_score_codex":0.00027850107,"about_ca_topic_score_gemma":0.00004485294,"teacher_disagreement_score":0.3282374,"about_ca_system_score_codex":0.0009595537,"about_ca_system_score_gemma":0.003698777,"threshold_uncertainty_score":0.7521899},"labels":[],"label_agreement":null},{"id":"W3216096981","doi":"10.1182/blood-2021-153595","title":"Efficacy and Safety of Chimeric Antigen Receptor T Cell Therapy in Chronic Lymphocytic Leukemia: A Systematic Review","year":2021,"lang":"en","type":"review","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fraser Health","funders":"","keywords":"Medicine; Chronic lymphocytic leukemia; Chimeric antigen receptor; Internal medicine; Cytokine release syndrome; Ibrutinib; Oncology; Adverse effect; Immunotherapy; Leukemia; Idelalisib; Immunology; Cancer","score_opus":0.03877698807722168,"score_gpt":0.34124428812178104,"score_spread":0.30246730004455935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216096981","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035317367,0.99023026,7.5964726e-7,0.000009835734,0.00005900088,0.008539591,0.000020688201,0.000031593365,0.0007551097],"genre_scores_gemma":[0.000018210041,0.9975423,0.00006097652,0.0000596293,0.00014437355,0.00041662453,0.00015356981,0.00013021899,0.0014740535],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9955913,0.0009287451,0.0017153414,0.000677252,0.00060575496,0.0004816335],"domain_scores_gemma":[0.99720544,0.0006055407,0.00063445594,0.0012478267,0.00011962422,0.00018709028],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001218547,0.0005587824,0.0067675263,0.0003274915,0.000035328067,0.000020044681,0.00033400257,0.00036650256,0.0011425251],"category_scores_gemma":[0.0002715725,0.00042098312,0.0007040789,0.0013105032,0.00011231812,0.00003164353,0.00012812893,0.0006418616,0.00007089765],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026632062,0.00016621062,0.0000016447659,0.8674332,0.0007229327,0.000082906554,0.000042867377,1.3618764e-7,0.00023865445,0.0000020835275,0.00006167351,0.13122109],"study_design_scores_gemma":[0.006188942,0.00051965145,0.000003916011,0.83758205,0.003010624,0.00038873285,0.0000068491436,0.0000026638568,0.00014246478,3.4914083e-7,0.15183519,0.00031853435],"about_ca_topic_score_codex":0.000065563545,"about_ca_topic_score_gemma":0.0000035032278,"teacher_disagreement_score":0.15177351,"about_ca_system_score_codex":0.0028525607,"about_ca_system_score_gemma":0.009000612,"threshold_uncertainty_score":0.9998242},"labels":[],"label_agreement":null},{"id":"W3216115561","doi":"10.1182/blood-2021-146642","title":"The Impact of Marginalization on Diffuse Large B-Cell Lymphoma Overall Survival: A Retrospective Cohort Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and Retrovirus Studies","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Diffuse large B-cell lymphoma; Rituximab; Medicine; Demography; Retrospective cohort study; Population; Proportional hazards model; International Prognostic Index; Cohort; Gerontology; Survival analysis; Internal medicine; Oncology; Lymphoma; Environmental health; Sociology","score_opus":0.007893188828113337,"score_gpt":0.2410193369437543,"score_spread":0.23312614811564097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216115561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99082303,0.00249546,0.000006952097,0.00002383556,0.00035384562,0.00030358476,0.000067779045,0.00003375007,0.0058917445],"genre_scores_gemma":[0.9941837,0.00048331651,0.0000017318793,0.000014693908,0.000028611807,0.000020669526,0.000039053568,0.000015696669,0.0052125063],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885994,0.00029955962,0.00021439303,0.00026923657,0.00006741171,0.00028943887],"domain_scores_gemma":[0.99919707,0.00014235926,0.00013093583,0.0003557571,0.00016042223,0.000013472303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025068753,0.00016476624,0.0003281888,0.000033887125,0.00033648306,0.000014893884,0.0001325112,0.00010004224,0.00008270463],"category_scores_gemma":[0.00010242684,0.000098963355,0.00016256796,0.00014536337,0.00008684777,0.000024914503,0.00011724914,0.000112525915,0.000070545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001640675,0.016472701,0.93653744,0.0000066676844,0.0013153143,0.00001872843,0.00068965333,0.0000010495626,0.04308063,0.00064981927,0.0010096609,0.000054288827],"study_design_scores_gemma":[0.01335068,0.00087317935,0.9560555,0.000009969163,0.00018437109,0.0000093265935,0.00062930177,7.395148e-7,0.027919406,0.00010062168,0.0007405722,0.00012633622],"about_ca_topic_score_codex":0.00032217288,"about_ca_topic_score_gemma":0.00017230165,"teacher_disagreement_score":0.019518077,"about_ca_system_score_codex":0.00005469805,"about_ca_system_score_gemma":0.00006864698,"threshold_uncertainty_score":0.40356088},"labels":[],"label_agreement":null},{"id":"W3216268272","doi":"10.1182/blood-2021-152407","title":"Real-World Data on the Occurrence of Vaso-Occlusive Crises (VOCs) in Patients with Sickle Cell Disease (SCD) and a High Baseline Disease Burden Treated with Crizanlizumab: Results from a Managed Access Program (MAP)","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Vaso-occlusive crisis; Disease; Clinical trial; Disease burden; Disease registry; Internal medicine; Pediatrics; Sickle cell anemia","score_opus":0.018288822292588745,"score_gpt":0.26812123786985015,"score_spread":0.2498324155772614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216268272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99035776,0.00037875274,0.0000043409136,0.0019518526,0.00002540979,0.0014203012,0.0055207675,0.00006631246,0.00027449348],"genre_scores_gemma":[0.991682,0.0003650086,0.00023576197,0.00018857236,0.000042278378,0.000057772675,0.0072763925,0.000030901698,0.000121314086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99785256,0.00018838486,0.00038271496,0.0007784896,0.00048295016,0.00031488767],"domain_scores_gemma":[0.99761313,0.0002808736,0.00022083773,0.001318104,0.00021313266,0.00035391038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000130663,0.0002955242,0.00041663382,0.00012055064,0.00010280085,0.000062920575,0.00032578773,0.000046227316,0.00003575404],"category_scores_gemma":[0.0003149317,0.0001687802,0.000038214668,0.00074006326,0.0002362716,0.00015219934,0.00029829555,0.00030397845,0.0000031304667],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032907464,0.01728088,0.9304973,0.00081692927,0.00063615397,0.0033713344,0.0008496895,0.00022311453,0.00003237619,0.00004247006,0.0034712423,0.009871074],"study_design_scores_gemma":[0.042672496,0.0015965349,0.9448234,0.0027449531,0.0034194214,0.0000014165439,0.00093379145,0.0016805164,0.0005997828,0.000064676795,0.0009027083,0.00056030776],"about_ca_topic_score_codex":0.0028084428,"about_ca_topic_score_gemma":0.0007941983,"teacher_disagreement_score":0.015684344,"about_ca_system_score_codex":0.000020608655,"about_ca_system_score_gemma":0.00032488452,"threshold_uncertainty_score":0.6882657},"labels":[],"label_agreement":null},{"id":"W3216359699","doi":"10.1182/blood-2021-151885","title":"Effect of Levofloxacin Prophylaxis on Rates of Febrile Neutropenia in Patients Receiving DA-EPOCH-R Chemotherapy for Aggressive Lymphomas","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Febrile neutropenia; Levofloxacin; Vincristine; Epoch (astronomy); Internal medicine; Neutropenia; Regimen; Surgery; Chemotherapy; Cyclophosphamide; Antibiotics","score_opus":0.010488135838967795,"score_gpt":0.28968346990763694,"score_spread":0.27919533406866914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216359699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997085,0.0002676837,0.000004096249,0.00006947716,0.00015270492,0.00090465165,0.000025376414,0.000013593333,0.0014774338],"genre_scores_gemma":[0.9992498,0.000058462905,0.00012136363,0.000086631175,0.0000710517,0.00012621307,0.00003135064,0.000030451383,0.00022468758],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99897337,0.000095802905,0.0003124671,0.00025978213,0.00017602972,0.00018252325],"domain_scores_gemma":[0.9990305,0.00019597763,0.00023404924,0.00028905965,0.000198398,0.000052053423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001372981,0.0001489038,0.00048719984,0.000108684726,0.000034547375,0.000008584479,0.000063446394,0.00007596922,0.00007672252],"category_scores_gemma":[0.00024642705,0.00012155852,0.00014255807,0.00033141722,0.00004476963,0.00004477089,0.00002363296,0.00009345999,0.0000035928745],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026578084,0.002733742,0.7697502,0.0010797904,0.00024937862,0.00003196938,0.0003241777,0.000018402805,0.19295006,0.000083990686,0.00039385064,0.029726634],"study_design_scores_gemma":[0.014854034,0.005243625,0.2185062,0.00054822164,0.00008429776,0.00000802792,0.000013030319,0.0000028451882,0.7604398,0.000021428705,0.00019409202,0.000084397536],"about_ca_topic_score_codex":0.00005268712,"about_ca_topic_score_gemma":0.000026635316,"teacher_disagreement_score":0.56748974,"about_ca_system_score_codex":0.0000456691,"about_ca_system_score_gemma":0.0001341899,"threshold_uncertainty_score":0.49570125},"labels":[],"label_agreement":null},{"id":"W3216382063","doi":"10.1182/blood-2021-153897","title":"Pembrolizumab Added to First-Line Cyclophosphamide, Bortezomib and Dexamethasone in Newly Diagnosed Transplant Non-Eligible Myeloma Patients: A Phase 2A Open Label, Multi Centre Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hôpital Fleurimont; University Health Network; Moncton Hospital; CancerCare Manitoba","funders":"","keywords":"Bortezomib; Medicine; Multiple myeloma; Oncology; Dexamethasone; Proteasome inhibitor; Minimal residual disease; Cyclophosphamide; Immunology; Melphalan; Internal medicine; Population; Cancer research; Chemotherapy; Leukemia","score_opus":0.035969974717345116,"score_gpt":0.34137627923060127,"score_spread":0.3054063045132561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216382063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935661,0.0007057579,0.000037562037,0.00048637105,0.000063808744,0.004516602,0.0003468139,0.000045531917,0.00023144751],"genre_scores_gemma":[0.99426436,0.0005556987,0.0034286946,0.0002754436,0.000045618814,0.0004096676,0.00045364414,0.00006032262,0.00050655083],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99711007,0.0001490004,0.00056093506,0.00088740775,0.0005326245,0.00075999234],"domain_scores_gemma":[0.99804026,0.0002306929,0.000081418395,0.0006107216,0.00025053916,0.00078634155],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022177832,0.00039490798,0.00081577216,0.00021252452,0.00015084425,0.00011853738,0.00026129518,0.00011507627,0.00022620117],"category_scores_gemma":[0.00048440462,0.00034445742,0.000062802595,0.0006763717,0.000039627826,0.0001867842,0.00028308237,0.00027943187,0.00006437155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044616633,0.06437721,0.890186,0.00014930985,0.00060600805,0.008948866,0.003026092,0.000004670858,0.001423781,0.0000019692004,0.00019553935,0.02661888],"study_design_scores_gemma":[0.31729668,0.003667019,0.668075,0.00044520348,0.00039805044,0.000046634883,0.00056898827,0.00029965807,0.00847708,0.000004546385,0.00037235208,0.0003487432],"about_ca_topic_score_codex":0.0022364159,"about_ca_topic_score_gemma":0.00621513,"teacher_disagreement_score":0.312835,"about_ca_system_score_codex":0.00009920028,"about_ca_system_score_gemma":0.00028095065,"threshold_uncertainty_score":0.99990076},"labels":[],"label_agreement":null},{"id":"W3216439638","doi":"10.1182/blood-2021-145096","title":"Patient, Caregiver, and Healthcare Provider Priorities for Future Multiple Myeloma Research: Results of a James Lind Alliance Priority Setting Partnership","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital; Université de Moncton; Horizon Health Network; Princess Margaret Cancer Centre; Saint John Regional Hospital","funders":"","keywords":"General partnership; Multiple myeloma; Medicine; Alliance; Health care; Family medicine; Nursing; Political science; Internal medicine","score_opus":0.07891637162729005,"score_gpt":0.36732426042606214,"score_spread":0.2884078887987721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216439638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9755025,0.015731407,0.0000029408586,0.0061650155,0.00009667461,0.0017616313,0.0004502358,0.00004129521,0.00024833187],"genre_scores_gemma":[0.99203175,0.0008121336,0.0054412833,0.0000866476,0.00044959268,0.00018428797,0.00017197683,0.000031055082,0.0007912587],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974133,0.00028319948,0.0004052363,0.00057606597,0.00066186796,0.0006603403],"domain_scores_gemma":[0.9967462,0.0007263029,0.0001271067,0.00047374438,0.0015653817,0.00036125994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005150279,0.0001902617,0.0004097018,0.000089389665,0.00027160588,0.00004431089,0.000074772644,0.0001682167,0.0000046008354],"category_scores_gemma":[0.0036190103,0.00016463784,0.000108522894,0.0002764746,0.00018483275,0.00010753331,0.00013433774,0.0003822465,0.000002164038],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007748736,0.0024783385,0.7228158,0.009632291,0.0010438048,0.0013102784,0.03456279,7.23955e-7,0.0057351007,0.00040374874,0.006086075,0.2081823],"study_design_scores_gemma":[0.08320334,0.0072509027,0.47730216,0.003495056,0.00040549936,0.0003195278,0.06579724,0.00029485903,0.26363808,0.00081802683,0.09666849,0.0008068349],"about_ca_topic_score_codex":0.0003180882,"about_ca_topic_score_gemma":0.00081168156,"teacher_disagreement_score":0.25790298,"about_ca_system_score_codex":0.0000667408,"about_ca_system_score_gemma":0.0009303278,"threshold_uncertainty_score":0.6713736},"labels":[],"label_agreement":null},{"id":"W3216453369","doi":"10.1182/blood-2021-153321","title":"Outcomes of Tandem Hematopoietic Stem Cell Autologous Transplant in High-Risk Myeloma Patients: A Single-Center Experience","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Multiple myeloma; Single Center; Internal medicine; Autologous stem-cell transplantation; Oncology; Hematopoietic stem cell transplantation; Transplantation; Progression-free survival; Stem cell; Melphalan; Surgery; Overall survival","score_opus":0.018170437707012013,"score_gpt":0.25553659653085803,"score_spread":0.237366158823846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216453369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99851555,0.00030319847,0.000018358274,0.000059681817,0.00006347514,0.00037096493,0.00007885765,0.000028317809,0.00056161283],"genre_scores_gemma":[0.9990908,0.00006552359,0.00046325513,0.000045902198,0.000009653522,0.000054190234,0.00005587976,0.00001773364,0.00019706151],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984932,0.00009596723,0.00036937193,0.00030477124,0.00038821032,0.0003484592],"domain_scores_gemma":[0.99923515,0.000106769025,0.00008881596,0.00031835318,0.00009646842,0.00015443069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000056715628,0.0001631097,0.00045635074,0.00009386778,0.00003484707,0.0000099760855,0.00008631103,0.000082375,0.000095508934],"category_scores_gemma":[0.00004127793,0.00012678906,0.00010567496,0.00019950488,0.0000596741,0.00005019046,0.000038613256,0.00014087823,0.00001919203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009021958,0.007285254,0.98513466,0.0001299202,0.000115642826,0.0010768588,0.0019463362,4.6743722e-7,0.0020925186,0.000010811932,0.0000071565714,0.0021101376],"study_design_scores_gemma":[0.016698817,0.00051069056,0.8854802,0.00015479304,0.00010015666,0.00006277318,0.00032503792,0.0000118087755,0.09651632,0.000013247903,0.00002283623,0.00010330605],"about_ca_topic_score_codex":0.00008862587,"about_ca_topic_score_gemma":0.00009639075,"teacher_disagreement_score":0.099654466,"about_ca_system_score_codex":0.0000469629,"about_ca_system_score_gemma":0.00007999158,"threshold_uncertainty_score":0.5170308},"labels":[],"label_agreement":null},{"id":"W3216487577","doi":"10.1182/blood-2021-144888","title":"First Line B+R in Elderly Patients with Indolent Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma: A Real-World Experience","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Royal Victoria Regional Health Centre; Western University; University of Toronto","funders":"","keywords":"Medicine; Bendamustine; Mantle cell lymphoma; Rituximab; Internal medicine; Lymphoma; Cytopenia; Gastroenterology; Surgery; Bone marrow","score_opus":0.007790462150406807,"score_gpt":0.22960905797552136,"score_spread":0.22181859582511457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216487577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944056,0.00061733526,0.0000038504427,0.0002031262,0.00006491393,0.00043203236,0.000017070377,0.000031121675,0.004224934],"genre_scores_gemma":[0.9976628,0.0006008344,0.00071829575,0.0002273687,0.000057860463,0.00017828314,0.000058521622,0.00003123282,0.00046480514],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851745,0.000024767924,0.0002877603,0.0005064705,0.00031707415,0.00034646603],"domain_scores_gemma":[0.99914426,0.000069622285,0.00008691083,0.00039813452,0.00009901933,0.00020208608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004434966,0.00024990214,0.0003937364,0.00012150604,0.000081704995,0.00004022268,0.0000651638,0.000073227464,0.000064114356],"category_scores_gemma":[0.000017096347,0.0001931047,0.00005499256,0.0003745679,0.00006059612,0.000087423265,0.00008606975,0.0000377925,0.000020008067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019366379,0.012483775,0.96905535,0.000110938265,0.000070800386,0.0014929958,0.0013143439,0.0000016456347,0.00005482591,0.000020400794,0.00007420038,0.015127044],"study_design_scores_gemma":[0.044358764,0.000983684,0.931301,0.00031701438,0.00016576507,0.00005426711,0.00020504424,0.000018891855,0.021124722,0.000008859019,0.0012534023,0.00020857024],"about_ca_topic_score_codex":0.00070825254,"about_ca_topic_score_gemma":0.001928799,"teacher_disagreement_score":0.044165097,"about_ca_system_score_codex":0.00014161228,"about_ca_system_score_gemma":0.00018939612,"threshold_uncertainty_score":0.7874581},"labels":[],"label_agreement":null},{"id":"W3216578292","doi":"10.1182/blood-2021-148144","title":"Chimerism of Blood T-Cells and Leukemia Lineage Cells Following Myeloablative Hematopoietic Cell Transplantation Is a Risk Factor for Relapse and Chronic Graft-Versus-Host Disease","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Calgary","funders":"","keywords":"Fludarabine; Internal medicine; Myeloid; Immunology; Medicine; Busulfan; Transplantation; Leukemia; Hematopoietic stem cell transplantation; Haematopoiesis; Myeloid leukemia; Gastroenterology; Biology; Stem cell; Cyclophosphamide; Chemotherapy","score_opus":0.0109498323110444,"score_gpt":0.2428852437637877,"score_spread":0.2319354114527433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216578292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921864,0.0037309462,0.0012768636,0.000059881804,0.00020644747,0.0010126011,0.0013291956,0.000049736274,0.00014787297],"genre_scores_gemma":[0.9917671,0.0038756717,0.0037395875,0.000050485774,0.00008721049,0.000049561313,0.00010325021,0.00006351039,0.00026360914],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99810416,0.00009138736,0.00055101485,0.0005868442,0.0003286836,0.00033788616],"domain_scores_gemma":[0.99847025,0.0005461301,0.00023042312,0.00032230475,0.00010495725,0.00032593618],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016032685,0.00032434412,0.0005721377,0.00011093457,0.00012859343,0.00003020957,0.00006337045,0.00017515346,0.000079616075],"category_scores_gemma":[0.000040628205,0.0003222781,0.00023757687,0.00020242087,0.000090490714,0.00013073195,0.000018775778,0.00021473697,0.000005023105],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006647038,0.0005492618,0.006496293,0.00615425,0.0007004353,0.0004089981,0.008238674,0.000007693257,0.97652674,0.000022367196,0.000014919555,0.00021565761],"study_design_scores_gemma":[0.020969678,0.00052960863,0.011154778,0.00071518135,0.007514231,0.000057369787,0.00043755825,0.00022277926,0.95802116,0.00002255661,0.000047055793,0.00030805936],"about_ca_topic_score_codex":0.000020356512,"about_ca_topic_score_gemma":0.000012357633,"teacher_disagreement_score":0.020304974,"about_ca_system_score_codex":0.000034348206,"about_ca_system_score_gemma":0.0003770016,"threshold_uncertainty_score":0.99992293},"labels":[],"label_agreement":null},{"id":"W3216581958","doi":"10.1182/blood-2021-145954","title":"Population-Wide Introduction of Dose-Adjusted EPOCH-R Is Associated with Improved Outcome of High Grade B-Cell Lymphoma with MYC and BCL2 Rearrangements with Diffuse Large B-Cell Lymphoma Morphology","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Diffuse large B-cell lymphoma; Vincristine; Medicine; Rituximab; Population; Internal medicine; Epoch (astronomy); BCL6; Lymphoma; Prednisone; Oncology; Cyclophosphamide; Chemotherapy; Immunology; B cell","score_opus":0.010717542123750031,"score_gpt":0.22245726122753812,"score_spread":0.21173971910378808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216581958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978477,0.00046955468,0.0000176225,0.00065569114,0.00006130104,0.00064680167,0.00013512903,0.000051801955,0.00011443584],"genre_scores_gemma":[0.996751,0.00009759316,0.0014021224,0.00026128505,0.00006148448,0.00006910478,0.0006599128,0.00006393771,0.0006335326],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99785995,0.00010274119,0.0005566572,0.00062881946,0.00045554247,0.0003963049],"domain_scores_gemma":[0.99819344,0.000110695124,0.000568287,0.000601619,0.0003621123,0.00016384311],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013202007,0.0003649611,0.00092552823,0.00015626107,0.00007824746,0.000018659799,0.00007515094,0.0001716902,0.00005995743],"category_scores_gemma":[0.00006913405,0.00025156964,0.00008404224,0.00048976945,0.00011213618,0.000106781445,0.000056956225,0.000061970066,0.0000034192644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009917585,0.03757275,0.9485365,0.0002696671,0.0012467048,0.00045241072,0.00040477514,0.0000019791,0.009954268,0.000057163103,0.000175493,0.0003365312],"study_design_scores_gemma":[0.12569077,0.0020607999,0.7408022,0.00013140663,0.0022113828,0.00024611602,0.00023751677,0.000020868563,0.12829334,0.000014079197,0.00006414479,0.00022734214],"about_ca_topic_score_codex":0.0012641818,"about_ca_topic_score_gemma":0.00039640494,"teacher_disagreement_score":0.20773426,"about_ca_system_score_codex":0.00014740576,"about_ca_system_score_gemma":0.00014881557,"threshold_uncertainty_score":0.9999937},"labels":[],"label_agreement":null},{"id":"W3216583281","doi":"10.1182/blood-2021-152316","title":"Variant Allele Frequency Status in Elderly Patients with Acute Myeloid Leukemia Can be Early Predictors of Responsiveness to Decitabine Treatment","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Occupational Cancer Research Centre; University of Toronto","funders":"","keywords":"Decitabine; Medicine; Internal medicine; Myeloid leukemia; Oncology; Bone marrow; Azacitidine; Cytarabine; Biopsy; DNA methylation; Biology; Gene","score_opus":0.011089224717956436,"score_gpt":0.2550478201262814,"score_spread":0.24395859540832499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216583281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99679583,0.00016063028,0.000035375484,0.000673876,0.000057443915,0.0011305343,0.00040709294,0.000039865026,0.00069937704],"genre_scores_gemma":[0.99291146,0.00013380898,0.0051557566,0.00017601231,0.000068281275,0.00016880031,0.00040419083,0.000069180016,0.0009125229],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972088,0.00017863892,0.0004917735,0.00059928175,0.0007728814,0.0007486316],"domain_scores_gemma":[0.99782264,0.0001615251,0.00010467794,0.0007685293,0.00062276353,0.00051987846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016791685,0.00031022078,0.00065218244,0.0003572825,0.00005575521,0.000022977836,0.00017033867,0.00015362405,0.00011437378],"category_scores_gemma":[0.00030085136,0.0002437798,0.00008808748,0.001003977,0.00008315946,0.00009602396,0.00010438627,0.00027080064,0.000010338417],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037603644,0.002871579,0.9374531,0.000099048375,0.0016827151,0.006976022,0.0046231197,0.00003086304,0.039217375,0.00014038873,0.00024473848,0.0029007173],"study_design_scores_gemma":[0.024564458,0.008582381,0.91255534,0.00020393549,0.00051847805,0.000104157494,0.00031121224,0.000005551099,0.051906187,0.000033539938,0.0009378081,0.00027693654],"about_ca_topic_score_codex":0.0041711167,"about_ca_topic_score_gemma":0.0022449507,"teacher_disagreement_score":0.024897711,"about_ca_system_score_codex":0.0014867052,"about_ca_system_score_gemma":0.0047907727,"threshold_uncertainty_score":0.99410516},"labels":[],"label_agreement":null},{"id":"W3216624362","doi":"10.1182/blood-2021-147333","title":"Clinical Activity of CC-99282, a Novel, Oral Small Molecule Cereblon E3 Ligase Modulator (CELMoD) Agent, in Patients (Pts) with Relapsed or Refractory Non-Hodgkin Lymphoma (R/R NHL) - First Results from a Phase 1, Open-Label Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lenalidomide; Tolerability; Internal medicine; Lymphoma; Follicular lymphoma; Cereblon; Oncology; Pharmacology; Adverse effect; Multiple myeloma; Biology; Ubiquitin ligase","score_opus":0.0472277822596604,"score_gpt":0.3196736704764509,"score_spread":0.2724458882167905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216624362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977669,0.000057215664,0.00013989022,0.000050376806,0.00014207626,0.0010935228,0.0005425206,0.000014815647,0.00019268141],"genre_scores_gemma":[0.99634886,0.000038040947,0.0022831212,0.00013901209,0.00009485552,0.00007982422,0.00067091687,0.00005236285,0.00029298328],"study_design_codex":"nonrandomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972839,0.00028015889,0.0007962813,0.0010202917,0.00029811126,0.0003212864],"domain_scores_gemma":[0.998,0.0000624622,0.0004755274,0.0010264921,0.0002345468,0.00020093737],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004214789,0.00032598033,0.0005353388,0.000067985384,0.000087720946,0.00006022285,0.00045742912,0.00029572836,0.000013489776],"category_scores_gemma":[0.0006801897,0.00028063278,0.00008871761,0.00030951775,0.00008727658,0.000027699321,0.00051357975,0.0001941759,0.000005308277],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02875565,0.52255315,0.030407857,0.00006373217,0.0009290899,0.00033708685,0.00042413204,0.000008683762,0.40105522,0.000003379034,0.0012087673,0.014253284],"study_design_scores_gemma":[0.30976206,0.010001707,0.026905408,0.00014307839,0.00015839229,0.000004905498,0.00010703484,0.00023742116,0.6505143,0.0000023834343,0.0016662076,0.00049711904],"about_ca_topic_score_codex":0.0007094273,"about_ca_topic_score_gemma":0.0021564036,"teacher_disagreement_score":0.5125514,"about_ca_system_score_codex":0.00003819758,"about_ca_system_score_gemma":0.00044682182,"threshold_uncertainty_score":0.9999646},"labels":[],"label_agreement":null},{"id":"W3216627495","doi":"10.1182/blood-2021-147626","title":"Investigating Erythrocytosis: Changing Practice Patterns in the Era of Molecular Diagnostics","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Medicine; Molecular diagnostics; Polycythemia vera; Clinical Practice; Internal medicine; Diagnostic test; Retrospective cohort study; Pediatrics; Family medicine; Bioinformatics; Biology","score_opus":0.0172013780386173,"score_gpt":0.2815299753066155,"score_spread":0.2643285972679982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216627495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893037,0.0024434784,0.00010722395,0.0067021903,0.000036130026,0.00028846684,0.000011699834,0.000011778929,0.0010953206],"genre_scores_gemma":[0.9914963,0.0009115841,0.0033627353,0.0039900374,0.00007071248,0.000117594915,0.000029977571,0.000014610353,0.0000063977827],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989162,0.0001515898,0.00024539293,0.00019640394,0.0002891051,0.00020131808],"domain_scores_gemma":[0.9986813,0.0007502705,0.00010427188,0.00026566433,0.00014512421,0.000053367756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002397726,0.00011921866,0.00023426033,0.000048577556,0.000047509195,0.00002046672,0.00005542309,0.00004801104,0.000027969485],"category_scores_gemma":[0.0018281944,0.00008611941,0.0000639699,0.00033457062,0.000026741804,0.000055438533,0.000046828674,0.00022418775,0.000005558101],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013346369,0.00482586,0.9628958,0.00031447873,0.00049749255,0.0036593047,0.00980003,0.000027717151,0.010541957,0.0040360983,0.00011347198,0.0032744303],"study_design_scores_gemma":[0.0056271125,0.00054338935,0.17514691,0.001858724,0.0013031793,0.0008162723,0.008122124,0.00006163841,0.8053751,0.00024394233,0.0006818337,0.00021980886],"about_ca_topic_score_codex":0.000048618524,"about_ca_topic_score_gemma":0.00003400418,"teacher_disagreement_score":0.7948331,"about_ca_system_score_codex":0.00001794292,"about_ca_system_score_gemma":0.00011731249,"threshold_uncertainty_score":0.35118476},"labels":[],"label_agreement":null},{"id":"W3216633465","doi":"10.1182/blood-2021-151862","title":"Supermobilizers with High CD34 + Cell Collection for Autologous Transplant and Impact on Survival Outcomes in Multiple Myeloma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Multiple myeloma; Bortezomib; CD34; Autologous stem-cell transplantation; Lenalidomide; Cyclophosphamide; Transplantation; Internal medicine; Vincristine; Leukapheresis; Oncology; Urology; Stem cell; Dexamethasone; Surgery; Chemotherapy; Biology","score_opus":0.020934222514732197,"score_gpt":0.2829169357886185,"score_spread":0.2619827132738863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216633465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983875,0.00012012657,0.000020085692,0.00022252205,0.000042271295,0.00079722895,0.00014459944,0.00003475038,0.00023092037],"genre_scores_gemma":[0.9982478,0.000062539155,0.00088055804,0.00003086519,0.000020011174,0.00013020127,0.00015575797,0.000023690272,0.0004485648],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893594,0.000058602487,0.00014866261,0.00031273847,0.00020814396,0.00033588862],"domain_scores_gemma":[0.9991994,0.00037240624,0.000022872959,0.000176096,0.00006140797,0.00016783086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008883084,0.00017340561,0.0003894861,0.00011758361,0.00007786352,0.000017598759,0.000030338482,0.00007819465,0.000034636978],"category_scores_gemma":[0.000074407246,0.000112624795,0.00007984756,0.00017141247,0.000041304294,0.000035177574,0.000008777888,0.00011878715,0.0000038946782],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023194118,0.0020411287,0.984174,0.000115606395,0.00027489298,0.0009257696,0.00020786023,0.000010398518,0.009193376,0.000008355949,0.000017475895,0.0007117293],"study_design_scores_gemma":[0.02998788,0.0023606115,0.90877205,0.000056693945,0.00013657717,0.00013539569,0.00014550041,0.00024405473,0.05802634,0.000010823942,0.000013330428,0.00011075658],"about_ca_topic_score_codex":0.0005445339,"about_ca_topic_score_gemma":0.0012411688,"teacher_disagreement_score":0.07540196,"about_ca_system_score_codex":0.00006642724,"about_ca_system_score_gemma":0.00018981431,"threshold_uncertainty_score":0.4592706},"labels":[],"label_agreement":null},{"id":"W3216682708","doi":"10.1182/blood-2021-151151","title":"Numb Chin Syndrome in Sickle Cell Disease: A Systematic Review","year":2021,"lang":"en","type":"review","venue":"Blood","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal; McGill University","funders":"","keywords":"Medicine; Chin; Hypoesthesia; MEDLINE; Cochrane Library; Systematic review; CINAHL; Disease; Dysgeusia; Inclusion and exclusion criteria; Pediatrics; Family medicine; Alternative medicine; Internal medicine; Surgery; Meta-analysis; Pathology; Psychiatry; Adverse effect; Psychological intervention","score_opus":0.02475321999903026,"score_gpt":0.32095395509789315,"score_spread":0.2962007350988629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216682708","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008081031,0.99422127,1.5871734e-7,0.000106248866,0.00008677996,0.004965359,0.000093071154,0.000031324245,0.00048771722],"genre_scores_gemma":[0.000027170436,0.9959028,0.000022641421,0.00021213133,0.000059048605,0.0022788574,0.00042872917,0.00006616784,0.0010024635],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9977938,0.00020880398,0.00092909846,0.000491615,0.00032271174,0.00025395802],"domain_scores_gemma":[0.9983404,0.00014317641,0.00032270385,0.000919137,0.000032413773,0.00024213477],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020806165,0.00040807837,0.004959683,0.00010807118,0.000019875155,0.000021838268,0.0001285405,0.00010765125,0.0003085271],"category_scores_gemma":[0.00012037519,0.00029215682,0.0009979123,0.00044791782,0.000013213055,0.000020384901,0.000062433115,0.00025052117,0.000339598],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[4.7784795e-7,0.0017842343,0.000028677474,0.98714495,0.0004509944,0.004946126,0.0000056178624,7.832338e-9,3.7693026e-9,0.00001693807,0.00039006636,0.0052319374],"study_design_scores_gemma":[0.0007185931,0.00005621862,0.000030508387,0.82866615,0.034704328,0.00066852086,0.0000018072128,5.2297217e-8,1.5242462e-7,0.0000012425021,0.13495646,0.00019597988],"about_ca_topic_score_codex":0.000021389777,"about_ca_topic_score_gemma":0.000009708493,"teacher_disagreement_score":0.15847878,"about_ca_system_score_codex":0.0001864688,"about_ca_system_score_gemma":0.0006044058,"threshold_uncertainty_score":0.99995303},"labels":[],"label_agreement":null},{"id":"W3216683318","doi":"10.1182/blood-2021-154405","title":"Von Willebrand Factor Expression in Endothelium in a Co-Culturing System of Acute Lymphoblastic Leukemia","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Clinical Laboratory Practices and Quality Control","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre; McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Von Willebrand factor; Medicine; Umbilical vein; Acute leukemia; Platelet; Lymphoblast; Endothelium; Immunology; Leukemia; Cancer; Acute lymphocytic leukemia; Thrombosis; Cell culture; Andrology; Cancer research; Lymphoblastic Leukemia; Internal medicine; Biology; In vitro; Biochemistry","score_opus":0.021706311877661987,"score_gpt":0.31162210768739673,"score_spread":0.28991579580973476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216683318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99809223,0.00048465966,0.000020699938,0.00013217557,0.000078173274,0.00021033602,0.000060742288,0.000021603615,0.00089939253],"genre_scores_gemma":[0.99935323,0.00008683676,0.00019713736,0.000119428776,0.00008206695,0.000014242145,0.0000127219955,0.000012996746,0.00012134603],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99862003,0.00018195961,0.0005562974,0.00024550004,0.0002160282,0.00018018446],"domain_scores_gemma":[0.9989607,0.00045131627,0.0001670561,0.00024962856,0.0000803094,0.00009100462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000262068,0.00011278785,0.00050067186,0.00006555669,0.000018117878,0.00001373262,0.000056767316,0.00012277313,0.00006328749],"category_scores_gemma":[0.0005027468,0.00009026933,0.00007747563,0.00019516062,0.000022045084,0.00010309979,0.000032555814,0.00019660206,0.000011599539],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007026496,0.0008689682,0.12008858,0.0008120096,0.0001458962,0.00096167764,0.0007742144,0.00001068483,0.8751485,0.00013877159,0.000019388162,0.00032868172],"study_design_scores_gemma":[0.044130567,0.0003880894,0.13295238,0.0043313014,0.00056635373,0.0001643778,0.0017146595,0.0004818963,0.8127746,0.000013933308,0.0021661583,0.00031566908],"about_ca_topic_score_codex":0.00003995081,"about_ca_topic_score_gemma":0.000054006545,"teacher_disagreement_score":0.06237386,"about_ca_system_score_codex":0.00010125247,"about_ca_system_score_gemma":0.00027084386,"threshold_uncertainty_score":0.36810765},"labels":[],"label_agreement":null},{"id":"W3216754191","doi":"10.1182/blood-2021-148143","title":"Sirtuin 3 Inhibition Targets AML Stem Cells through Perturbation of Fatty Acid Oxidation","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Sirtuin; SIRT3; Stem cell; Cancer research; Biology; Oxidative phosphorylation; Myeloid; NAD+ kinase; Cancer cell; Cancer stem cell; Viability assay; Cancer; Biochemistry; Cell; Cell biology; Genetics","score_opus":0.013166223429150454,"score_gpt":0.24940648566894374,"score_spread":0.2362402622397933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216754191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99383605,0.001104743,0.0033428487,0.00010176589,0.00010339553,0.00014574367,0.000043207812,0.000012108325,0.0013101205],"genre_scores_gemma":[0.9958685,0.00017339583,0.0016558915,0.000063511,0.00016927777,0.000018520988,0.00043790645,0.000020162286,0.0015928225],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99893093,0.00011606477,0.00023207745,0.0003107771,0.0002346454,0.00017552507],"domain_scores_gemma":[0.9992699,0.000010992881,0.00009224415,0.00030820575,0.0002732329,0.00004540497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012664314,0.00010935912,0.00012454284,0.000030427724,0.000059019098,0.000015386191,0.00006827647,0.00015964427,0.00005283832],"category_scores_gemma":[0.00005906725,0.00011745103,0.000084171515,0.00014145601,0.00005447121,0.000010217451,0.00007791055,0.000085503365,0.000028176597],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020892849,0.00028895642,0.000089599365,0.00005290307,0.000031124357,0.000010248286,0.00011357636,0.000014156868,0.99788225,0.00007382633,0.0009920931,0.0004303699],"study_design_scores_gemma":[0.00082479964,0.00014572077,0.00011124456,0.000022165677,0.000018128932,0.000014799525,0.000099343786,0.000012738798,0.9940804,0.000046357174,0.0045051915,0.000119056895],"about_ca_topic_score_codex":0.000008197856,"about_ca_topic_score_gemma":0.000016400569,"teacher_disagreement_score":0.0038018,"about_ca_system_score_codex":0.000018406663,"about_ca_system_score_gemma":0.00011891049,"threshold_uncertainty_score":0.4789514},"labels":[],"label_agreement":null},{"id":"W3216809265","doi":"10.1182/blood-2021-149264","title":"The Impact of Artificial Intelligence on Health Equity in Oncology: A Scoping Review","year":2021,"lang":"en","type":"review","venue":"Blood","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute; London Health Sciences Centre; University of Toronto; Western University","funders":"","keywords":"Equity (law); MEDLINE; Medicine; Health equity; Health care; Family medicine; Oncology; Internal medicine; Political science; Public health; Pathology","score_opus":0.5824635557701325,"score_gpt":0.6497007598681908,"score_spread":0.06723720409805822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216809265","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000026782323,0.99519813,0.00001827014,0.0011652495,0.00030813925,0.0028360717,0.000008778102,0.000013456034,0.00042512422],"genre_scores_gemma":[0.00006377892,0.9989391,0.00007736468,0.00028190104,0.00032934232,0.00020898452,0.00006178151,0.00002535255,0.000012406655],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99619997,0.00062667386,0.0020755422,0.00037567457,0.00027825905,0.00044388205],"domain_scores_gemma":[0.9967481,0.0014102678,0.0008538371,0.0006290908,0.00018428049,0.00017441886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002489308,0.00025670612,0.0023343617,0.00015173163,0.000114624054,0.000016747825,0.00022347445,0.0002426965,0.00007514963],"category_scores_gemma":[0.0021116377,0.00016360015,0.00062149786,0.00085061614,0.00010008998,0.00002455057,0.00008284066,0.00077022874,0.000058090933],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007680187,0.0006096675,0.000006444685,0.08315655,0.000056789842,0.000013275333,0.00011376879,5.157043e-7,7.95558e-8,0.00018718427,0.00018921503,0.91565883],"study_design_scores_gemma":[0.0000145409995,0.0013853669,0.0000035891171,0.9709837,0.00035739504,0.00009817654,0.00014351611,0.000003314496,0.000024651315,0.00031589533,0.026517494,0.00015236533],"about_ca_topic_score_codex":0.0010854086,"about_ca_topic_score_gemma":0.0006778031,"teacher_disagreement_score":0.9155065,"about_ca_system_score_codex":0.00073804223,"about_ca_system_score_gemma":0.014229685,"threshold_uncertainty_score":0.9913587},"labels":[],"label_agreement":null},{"id":"W3216815214","doi":"10.1182/blood-2021-149270","title":"Real-World Effectiveness of Bortezomib Plus Dexamethasone in Patients with t(11;14) Positive Multiple Myeloma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Bortezomib; Medicine; Regimen; Internal medicine; Multiple myeloma; Dexamethasone; Oncology; Salvage therapy; Retrospective cohort study; Cohort; Surrogate endpoint; Venetoclax; Progression-free survival; Refractory (planetary science); Surgery; Chemotherapy; Leukemia","score_opus":0.011944329175700243,"score_gpt":0.27463708178375534,"score_spread":0.2626927526080551,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216815214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99679667,0.00010641366,0.00002397089,0.000027248585,0.000031839932,0.0009980579,0.00009684631,0.000026738086,0.0018921976],"genre_scores_gemma":[0.997366,0.000020623922,0.001860919,0.0000150605565,0.000023746668,0.00008113404,0.000374346,0.00003570831,0.00022242541],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99813324,0.0002886114,0.00025890442,0.00041297896,0.0005102314,0.000396046],"domain_scores_gemma":[0.9983233,0.0005771301,0.000083932835,0.00039999388,0.0004070174,0.00020862829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021848956,0.00020514622,0.0005715333,0.00021816882,0.000041523243,0.000011071109,0.000072649236,0.00007372654,0.000047758844],"category_scores_gemma":[0.00035602154,0.0001624432,0.0000845164,0.00065928017,0.000086574095,0.00008155251,0.0000746608,0.0001814305,0.000011569737],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033633893,0.0039166072,0.9856574,0.00026358754,0.00046750632,0.00089300325,0.00011366621,0.000006065203,0.003837191,0.000039525217,0.000004954525,0.0014371303],"study_design_scores_gemma":[0.041371126,0.000775299,0.8285725,0.00059514935,0.00016004703,0.000010955152,0.00003255835,0.000034149783,0.12830894,0.000010574134,0.000008410225,0.00012027179],"about_ca_topic_score_codex":0.0013026786,"about_ca_topic_score_gemma":0.0019064917,"teacher_disagreement_score":0.15708484,"about_ca_system_score_codex":0.0001664534,"about_ca_system_score_gemma":0.00034293838,"threshold_uncertainty_score":0.66242415},"labels":[],"label_agreement":null},{"id":"W3216889628","doi":"10.1182/blood-2021-153585","title":"Outcomes of High Grade B- Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements: An Atlantic Canadian Centre Perspective","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Nova Scotia Health Authority; Dalhousie University","funders":"","keywords":"Medicine; BCL6; Oncology; Internal medicine; Lymphoma; Diffuse large B-cell lymphoma; Regimen; Burkitt's lymphoma; Chemoimmunotherapy; Aggressive lymphoma; Rituximab; Immunology; B cell","score_opus":0.009925915419526676,"score_gpt":0.23014141537095995,"score_spread":0.22021549995143327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216889628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954956,0.0010297498,2.8367586e-7,0.0018706658,0.000025730273,0.00023491224,0.00004706806,0.0000149605075,0.0012810417],"genre_scores_gemma":[0.9980907,0.0003614629,0.00061157474,0.00030614212,0.000027424308,0.0000109114735,0.00004416169,0.00001731147,0.00053035095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999185,0.000029060491,0.00012097856,0.00029421624,0.00015233528,0.00021838376],"domain_scores_gemma":[0.99927574,0.000038019043,0.000044268854,0.00022901669,0.000102459955,0.0003105005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000029281524,0.00014944105,0.0003194439,0.00007018528,0.000060999886,0.000020361662,0.000029714329,0.000049123693,0.00008028532],"category_scores_gemma":[0.000020328322,0.00009853616,0.000031299187,0.00010942194,0.000055027576,0.000050984097,0.00001980531,0.000025775982,0.0000033040028],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062163446,0.002446,0.9925774,0.000069756825,0.00046983955,0.0014759789,0.0013851499,9.583777e-8,0.00014008311,0.0006235765,0.000107535634,0.00064241816],"study_design_scores_gemma":[0.016247384,0.0005677142,0.970535,0.00009732693,0.00090414734,0.00024746134,0.0038989217,0.000002379291,0.006955862,0.000043669857,0.00037550423,0.00012465302],"about_ca_topic_score_codex":0.13637279,"about_ca_topic_score_gemma":0.13452019,"teacher_disagreement_score":0.022042427,"about_ca_system_score_codex":0.00009998264,"about_ca_system_score_gemma":0.00030568536,"threshold_uncertainty_score":0.88127255},"labels":[],"label_agreement":null},{"id":"W3216956782","doi":"10.1182/blood-2021-154729","title":"The POLARIX Study: Polatuzumab Vedotin with Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (pola-R-CHP) Versus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP) Therapy in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Sunnybrook Health Science Centre; Health Sciences Centre; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Rituximab; Vincristine; Internal medicine; Prednisone; International Prognostic Index; Cyclophosphamide; Diffuse large B-cell lymphoma; Clinical endpoint; Gastroenterology; Placebo; Bendamustine; Surgery; Oncology; Chemotherapy; Lymphoma; Clinical trial; Pathology","score_opus":0.004783608112453132,"score_gpt":0.20937665576874326,"score_spread":0.20459304765629013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216956782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96270925,0.032083057,0.0000052450687,0.00040838978,0.00017488224,0.0037907509,0.00017492959,0.00019144347,0.00046206315],"genre_scores_gemma":[0.99199194,0.005718099,0.0006594976,0.0003264823,0.000103198756,0.00037954055,0.00025352245,0.00019526089,0.00037246893],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99434286,0.000340721,0.0010168698,0.0017027626,0.0011517698,0.0014449884],"domain_scores_gemma":[0.9962757,0.00062852976,0.00046854035,0.0014511176,0.0005335517,0.00064255233],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003906177,0.0011630373,0.0016220361,0.0002221757,0.000764842,0.00033672558,0.00029576354,0.00030743153,0.00003567239],"category_scores_gemma":[0.00018202278,0.0007446616,0.00014417365,0.0010988542,0.0003804979,0.00032498332,0.0003287179,0.00040212646,0.00001905107],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015436342,0.09594912,0.8778172,0.00013325276,0.0014500212,0.0013692009,0.0015104633,0.000001179994,0.00023028896,0.000066146815,0.0001324435,0.0059043146],"study_design_scores_gemma":[0.35845917,0.008424229,0.6253378,0.00033715717,0.0011441319,0.00010695484,0.0007711698,0.000023704386,0.0036496469,0.00001584176,0.001130228,0.00060000346],"about_ca_topic_score_codex":0.0020147625,"about_ca_topic_score_gemma":0.002132564,"teacher_disagreement_score":0.34302282,"about_ca_system_score_codex":0.00040465387,"about_ca_system_score_gemma":0.00062423054,"threshold_uncertainty_score":0.99950045},"labels":[],"label_agreement":null},{"id":"W3216969145","doi":"10.1182/blood-2021-149602","title":"Outcomes of Single Versus Tandem Hematopoietic Stem Cell Autologous Transplant in High-Risk Myeloma Patients: A Single-Center Experience","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; London Health Sciences Centre; Sunnybrook Hospital; University of Toronto","funders":"","keywords":"Medicine; Multiple myeloma; Internal medicine; Oncology; Autologous stem-cell transplantation; Proportional hazards model; Hematopoietic stem cell transplantation; Univariate analysis; Single Center; Transplantation; Surgery; Multivariate analysis","score_opus":0.026690148592107228,"score_gpt":0.26347976866733197,"score_spread":0.23678962007522475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216969145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982412,0.0003190592,0.000014264318,0.00005457092,0.00014906818,0.0003769542,0.00008268648,0.000035666195,0.0007265212],"genre_scores_gemma":[0.9991886,0.00004394128,0.00046535843,0.00002787091,0.000013738552,0.00004716936,0.00007047489,0.000022063303,0.000120755285],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982997,0.00010465309,0.0003949438,0.0003511819,0.0004424038,0.00040707836],"domain_scores_gemma":[0.99909693,0.00018376001,0.00008080518,0.00035330452,0.000111552894,0.00017365151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000056399072,0.0001921654,0.0004881748,0.0001050097,0.00004357224,0.000014118927,0.00009965612,0.000097477365,0.00009098474],"category_scores_gemma":[0.00006850792,0.0001564743,0.00012054371,0.00023319185,0.000075194795,0.00006350522,0.00004672332,0.0001450861,0.000020274894],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039676038,0.010739115,0.97665524,0.00012231195,0.00017046068,0.0010668834,0.0020917985,8.235988e-7,0.006609433,0.000008676812,0.00000763129,0.0021308546],"study_design_scores_gemma":[0.041727755,0.0016499608,0.743643,0.00019591476,0.00018463277,0.000047924306,0.00072471733,0.000012675468,0.21159472,0.000006940233,0.000047337293,0.00016444083],"about_ca_topic_score_codex":0.00008904478,"about_ca_topic_score_gemma":0.00015695782,"teacher_disagreement_score":0.23301226,"about_ca_system_score_codex":0.00008578299,"about_ca_system_score_gemma":0.00008481119,"threshold_uncertainty_score":0.63808364},"labels":[],"label_agreement":null},{"id":"W3216998789","doi":"10.1182/blood-2021-148715","title":"Generating Large Numbers of Human Megakaryocytes from Pluripotent Stem Cells","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Stemcell Technologies","funders":"","keywords":"Haematopoiesis; Biology; Induced pluripotent stem cell; Progenitor cell; Stem cell; Thrombopoiesis; Cell biology; Immunology; Thrombopoietin; Platelet; Megakaryocyte; Genetics; Embryonic stem cell; Gene","score_opus":0.014177623172948982,"score_gpt":0.24557899675348638,"score_spread":0.2314013735805374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216998789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955454,0.0020353475,0.000015049658,0.000057804937,0.000065070155,0.00009825521,0.00007241729,0.000024975714,0.0020857055],"genre_scores_gemma":[0.9971758,0.00006080917,0.0012708891,0.00014575555,0.00006309495,0.0000053944586,0.00012119301,0.000015767619,0.0011412789],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992733,0.00002175168,0.00019147317,0.00019189708,0.00015791673,0.00016368457],"domain_scores_gemma":[0.99958915,0.00002250809,0.000061817176,0.0002064288,0.00005121394,0.00006888735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003470933,0.00009999942,0.00027894616,0.000020676855,0.000059337784,0.000009570311,0.000034801535,0.000052663705,0.00023046554],"category_scores_gemma":[0.000005122072,0.00008801307,0.00009172803,0.000071604256,0.000012710847,0.000026244586,0.00003435995,0.000065491644,0.000023363235],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018537172,0.003280207,0.059438158,0.000076960394,0.0009770719,0.0029271825,0.0007058229,0.000008002457,0.9308987,0.000114330585,0.00047481325,0.0010801691],"study_design_scores_gemma":[0.0067261443,0.00012210263,0.0033822092,0.00009700529,0.00047043496,0.000041754072,0.000431875,0.000073087394,0.98789835,0.000066955705,0.000588843,0.000101263126],"about_ca_topic_score_codex":0.00014108793,"about_ca_topic_score_gemma":0.00008709437,"teacher_disagreement_score":0.05699958,"about_ca_system_score_codex":0.000011216845,"about_ca_system_score_gemma":0.00004592726,"threshold_uncertainty_score":0.35890687},"labels":[],"label_agreement":null},{"id":"W3217080490","doi":"10.1182/blood-2021-153072","title":"Incidence of Thrombotic Microangiopathies in Quebec: An 8-Year Overview from a Laboratory Centralizing Adamts-13 Testing","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Incidence (geometry); ADAMTS; Population; Internal medicine; Pediatrics; Environmental health","score_opus":0.03103891498130681,"score_gpt":0.26461412591585964,"score_spread":0.23357521093455283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217080490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96359044,0.035747327,0.000004194169,0.00002811611,0.00017885045,0.00013549482,0.00018939622,0.00004544459,0.00008070772],"genre_scores_gemma":[0.9991091,0.00007107869,0.00054350443,0.00006451561,0.000028265295,0.000012292084,0.0001107378,0.000014717966,0.00004578787],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985304,0.00043611205,0.00040368314,0.0003075987,0.00004906072,0.00027318523],"domain_scores_gemma":[0.9990317,0.0002657384,0.00015497248,0.00038820275,0.00013549623,0.000023881277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017020233,0.0001405337,0.00034153304,0.00006173741,0.000056445828,0.000019101051,0.00021217113,0.00008923527,0.00048821082],"category_scores_gemma":[0.00037378207,0.00014990785,0.0000547491,0.0003178077,0.00008071791,0.00015421984,0.00014352589,0.00011962987,0.00005680355],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000780756,0.0004049412,0.43192196,0.00009329857,0.00007069756,0.00004661034,0.00060437084,0.0000042305674,0.5664211,0.00016911642,0.00008936875,0.00016652825],"study_design_scores_gemma":[0.0019079457,0.00006641895,0.7161733,0.0012023455,0.00015814297,0.000017040116,0.002423856,0.000002687786,0.27724534,0.00018191956,0.00038189156,0.00023911765],"about_ca_topic_score_codex":0.01363309,"about_ca_topic_score_gemma":0.01960343,"teacher_disagreement_score":0.28917572,"about_ca_system_score_codex":0.000030151521,"about_ca_system_score_gemma":0.0002726905,"threshold_uncertainty_score":0.99828625},"labels":[],"label_agreement":null},{"id":"W3217096783","doi":"10.1182/blood-2021-151648","title":"Phase II Study of Cladribine, Idarubicin, Cytarabine (CLIA) Plus Gilteritinib in Patients with FLT3 Mutated Acute Myeloid Leukemia (AML)","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Idarubicin; Cytarabine; Cladribine; Medicine; Internal medicine; Concomitant; Gastroenterology; Fludarabine; Chemotherapy; Regimen; Surgery; Cyclophosphamide","score_opus":0.01629800285645637,"score_gpt":0.29204286724317335,"score_spread":0.27574486438671697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217096783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964936,0.00011529718,0.000018756537,0.00023713462,0.0000737956,0.0018012382,0.0001374879,0.000092200826,0.001030517],"genre_scores_gemma":[0.996978,0.00004434737,0.00083393755,0.00021058299,0.000103591265,0.000103491555,0.0006191021,0.000099306846,0.0010076718],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9962042,0.00020590721,0.00088453037,0.0008210914,0.0011373033,0.00074694265],"domain_scores_gemma":[0.9975266,0.000090890666,0.00022083786,0.0010177365,0.0008128533,0.0003310883],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031230898,0.0004176404,0.0010879678,0.00040413058,0.00012325772,0.000025788704,0.00030191205,0.00018972815,0.0002731589],"category_scores_gemma":[0.00023795833,0.0003566252,0.0001047777,0.0015322769,0.00015529283,0.00017999207,0.00036405196,0.00080843735,0.000026513746],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029916797,0.14107445,0.52387094,0.00092068745,0.0059113177,0.020239431,0.010321981,0.00018440794,0.2524857,0.000044912093,0.0026485552,0.0123807965],"study_design_scores_gemma":[0.48456863,0.053179286,0.28672406,0.00072983146,0.001894051,0.0002992381,0.002790493,0.00049899326,0.16783747,0.000015125842,0.000571743,0.00089107687],"about_ca_topic_score_codex":0.00033877196,"about_ca_topic_score_gemma":0.00023114748,"teacher_disagreement_score":0.45465183,"about_ca_system_score_codex":0.0005673355,"about_ca_system_score_gemma":0.00160599,"threshold_uncertainty_score":0.9998886},"labels":[],"label_agreement":null},{"id":"W3217194789","doi":"10.1182/blood-2021-151761","title":"Real-Life Use of Nilotinib for Chronic Phase CML Demonstrates Similar Efficacy and Rate of Cardiovascular Events As Enestnd","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; Hôpital Maisonneuve-Rosemont; Quebec - Clinical Research Organization in Cancer; Centre Hospitalier de l’Université de Montréal; McGill University","funders":"","keywords":"Nilotinib; Medicine; Internal medicine; Imatinib; Myeloid leukemia; Dasatinib; Imatinib mesylate","score_opus":0.036006044511524796,"score_gpt":0.3029920284002244,"score_spread":0.2669859838886996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217194789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98999417,0.008737479,0.00007901984,0.0000821676,0.00005762009,0.0008275586,0.0001001342,0.000027193864,0.000094679366],"genre_scores_gemma":[0.9946493,0.003255864,0.0015345712,0.00003684808,0.00010837873,0.000042783486,0.00014347598,0.000043196353,0.00018559105],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985403,0.0000983504,0.00045085006,0.00039730564,0.00023622387,0.0002769853],"domain_scores_gemma":[0.9984767,0.000332929,0.00015700232,0.0006251229,0.0002124702,0.00019576798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023426043,0.00021717034,0.0007712617,0.000067027424,0.00004284881,0.000007834534,0.000063013395,0.000119753655,0.0000517459],"category_scores_gemma":[0.0006619669,0.00020087068,0.00032277266,0.00017713965,0.000091443486,0.00007482986,0.00005241215,0.00008970487,0.000003818832],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040593287,0.025654284,0.08248744,0.008991557,0.051299673,0.0021228555,0.0011811416,0.0010161663,0.78276986,0.00090052944,0.00083344866,0.03868374],"study_design_scores_gemma":[0.10934125,0.0026719626,0.025020016,0.0008323562,0.008962063,0.0003158927,0.0000819245,0.0003569798,0.84754443,0.00007949049,0.004479684,0.00031396846],"about_ca_topic_score_codex":0.00019743135,"about_ca_topic_score_gemma":0.000011303937,"teacher_disagreement_score":0.10528192,"about_ca_system_score_codex":0.00010015363,"about_ca_system_score_gemma":0.0013879205,"threshold_uncertainty_score":0.81912684},"labels":[],"label_agreement":null},{"id":"W3217205918","doi":"10.1182/blood-2021-146175","title":"Dose Modification Dynamics of Ponatinib in Patients with Chronic-Phase Chronic Myeloid Leukemia (CP-CML) from the PACE and Optic Trials","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ponatinib; Medicine; Adverse effect; Internal medicine; Dosing; Clinical trial; Myeloid leukemia; Oncology; Nilotinib; Imatinib","score_opus":0.021214651857451392,"score_gpt":0.28550244644087175,"score_spread":0.26428779458342033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217205918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936086,0.00423495,0.000051839586,0.0004566958,0.00006445618,0.0011258338,0.00023867044,0.000027694954,0.0001912794],"genre_scores_gemma":[0.99706924,0.0003870424,0.0009762937,0.00004541368,0.00013723715,0.000075981436,0.0011279236,0.000041156756,0.00013969225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99793035,0.00021952941,0.0006459122,0.00047612854,0.00043079036,0.00029730034],"domain_scores_gemma":[0.9980949,0.00052942964,0.00035886816,0.00074471516,0.00016151648,0.00011054328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038353197,0.00025993394,0.0006975614,0.000070045615,0.00006112456,0.000025288702,0.0001265044,0.0001449172,0.0001231279],"category_scores_gemma":[0.00048785695,0.00017673125,0.00008732459,0.00033324028,0.00012535306,0.00009755734,0.00007725008,0.00026427483,0.000008554975],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008549371,0.021322478,0.69917023,0.0017803984,0.006775113,0.0009702626,0.0064131287,0.001235897,0.045956463,0.003169282,0.00062105164,0.2040363],"study_design_scores_gemma":[0.22520937,0.0032548723,0.7347982,0.0013952769,0.0025814709,0.000061572464,0.00044142312,0.0091050435,0.022147529,0.00020242849,0.0002811998,0.0005216312],"about_ca_topic_score_codex":0.00059815275,"about_ca_topic_score_gemma":0.00092014193,"teacher_disagreement_score":0.21666,"about_ca_system_score_codex":0.002174883,"about_ca_system_score_gemma":0.0023083643,"threshold_uncertainty_score":0.7206891},"labels":[],"label_agreement":null},{"id":"W3217243785","doi":"10.1182/blood-2021-148909","title":"The Benefits Trial of PB-04 to Evaluate Safety, PK, and Preliminary Efficacy in Inducing Fetal Globin Expression in Beta Thalassemia Intermedia and Sickle Cell Disease","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network","funders":"","keywords":"Fetal hemoglobin; Thalassemia; Globin; Hemoglobinopathy; Medicine; Sickle cell anemia; Fetus; Pharmacology; Immunology; Biology; Internal medicine; Disease; Hemoglobin; Hemolytic anemia; Genetics; Pregnancy","score_opus":0.010421571709677266,"score_gpt":0.25564127244455614,"score_spread":0.24521970073487886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217243785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99123776,0.0060496395,0.0000014571708,0.0011677758,0.00013486194,0.0007555177,0.000010557722,0.000009173201,0.00063328294],"genre_scores_gemma":[0.9980656,0.0015670576,0.00008866204,0.00006105906,0.000050410257,0.00002171673,0.000018215369,0.000017534217,0.00010974902],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986565,0.00013580227,0.0004006456,0.00032424214,0.00023274627,0.00025004227],"domain_scores_gemma":[0.99909467,0.0003115363,0.00007462051,0.00027023884,0.000041044616,0.00020787556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037036478,0.0001524761,0.00030720962,0.00008661037,0.00006054334,0.000018618,0.000074040254,0.00012381916,0.000010699929],"category_scores_gemma":[0.00045184433,0.00010798136,0.000051534334,0.00024553548,0.00007075824,0.000050642575,0.00024209921,0.0002740738,0.0000021187273],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15774073,0.021540549,0.22624333,0.002255279,0.00036761267,0.0023444619,0.026929954,0.0012320299,0.29291007,0.00018097604,0.0009070419,0.26734796],"study_design_scores_gemma":[0.22161411,0.002641992,0.68288696,0.0047507766,0.00066168833,0.00006939815,0.0035681087,0.00067264173,0.08211353,0.00010391741,0.00043287652,0.00048401378],"about_ca_topic_score_codex":0.000041087853,"about_ca_topic_score_gemma":0.00006695233,"teacher_disagreement_score":0.45664364,"about_ca_system_score_codex":0.000022330823,"about_ca_system_score_gemma":0.00016968201,"threshold_uncertainty_score":0.4403352},"labels":[],"label_agreement":null},{"id":"W3217295000","doi":"10.1182/blood-2021-148191","title":"Lenalidomide Dosing and Outcomes in Transplant-Ineligible Patients with Newly-Diagnosed Multiple Myeloma: A Multi-Institutional Report from the Canadian Myeloma Research Group (CMRG) Database","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Saint John Regional Hospital; BC Cancer Agency; Queen Elizabeth II Health Sciences Centre; Dalhousie University; McGill University Health Centre; Princess Margaret Cancer Centre; University of Calgary; CancerCare Manitoba; Ottawa Hospital; Hôpital Maisonneuve-Rosemont; Western University; University of Alberta; Université de Montréal; London Health Sciences Centre; McMaster University","funders":"","keywords":"Lenalidomide; Tolerability; Medicine; Multiple myeloma; Dosing; Ixazomib; Internal medicine; Hazard ratio; Oncology; Surgery; Adverse effect; Carfilzomib; Confidence interval","score_opus":0.04791665323441076,"score_gpt":0.31545289136587984,"score_spread":0.2675362381314691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217295000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953153,0.0007444171,0.000053073203,0.0013945677,0.00006442846,0.0011437123,0.0009910464,0.00003185533,0.00026159832],"genre_scores_gemma":[0.9900253,0.00010173473,0.0058788816,0.00019948739,0.0000879162,0.00016175292,0.003371707,0.000036007725,0.00013724774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966865,0.00026685352,0.00042253925,0.000730993,0.0010442656,0.00084886025],"domain_scores_gemma":[0.99741167,0.0008173966,0.0000622123,0.0006881624,0.00034407506,0.00067647285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059148716,0.00029084223,0.0004585485,0.00028522327,0.0006322252,0.00013226707,0.00016824684,0.00012585394,0.00006789003],"category_scores_gemma":[0.0013414572,0.00018199057,0.00007662648,0.0005411609,0.0002889577,0.00021779563,0.000096397234,0.0005983066,0.00002279738],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058158865,0.0016477202,0.97084415,0.000045413213,0.00035904473,0.023908282,0.00038390496,0.000003607218,0.0009009832,0.000028888337,0.000105154584,0.0011912419],"study_design_scores_gemma":[0.038787,0.00012509465,0.9569894,0.0004121196,0.00012890226,0.00028773223,0.0001860547,0.0001919105,0.002031964,0.000013860599,0.00065474916,0.0001912182],"about_ca_topic_score_codex":0.31743425,"about_ca_topic_score_gemma":0.83500886,"teacher_disagreement_score":0.5175746,"about_ca_system_score_codex":0.00025390062,"about_ca_system_score_gemma":0.0015749261,"threshold_uncertainty_score":0.74213606},"labels":[],"label_agreement":null},{"id":"W3217304519","doi":"10.1182/blood-2021-149261","title":"A Phase II Study of Blinatumomab for the Treatment of Measurable Residual Disease-Positive B-Cell Acute Lymphoblastic Leukemia","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Blinatumomab; Minimal residual disease; Medicine; Internal medicine; Oncology; Salvage therapy; Hematopoietic stem cell transplantation; Philadelphia chromosome; Transplantation; Maintenance therapy; Donor lymphocyte infusion; Lymphoblastic Leukemia; Leukemia; Immunology; Gastroenterology; Chemotherapy; Chromosomal translocation; Biology","score_opus":0.031048777727325987,"score_gpt":0.32337302358971287,"score_spread":0.29232424586238687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217304519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943078,0.002845466,0.000023223216,0.00016709525,0.000052024072,0.0018080834,0.00019633326,0.000016138703,0.0005838418],"genre_scores_gemma":[0.99111825,0.00033931053,0.00009016144,0.00001895211,0.00010632248,0.00023010629,0.00004487538,0.000032998367,0.0080189975],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985326,0.00010335441,0.0002935943,0.00029744665,0.0005116059,0.00026141855],"domain_scores_gemma":[0.9982407,0.00051127543,0.00009512692,0.0005834808,0.00042838263,0.00014102254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017027486,0.0001615567,0.00043292236,0.0000783795,0.00012792303,0.000010357117,0.00011163356,0.000041926593,0.00017249378],"category_scores_gemma":[0.00009292277,0.00010848567,0.00019108813,0.00028906533,0.00008224972,0.000025982054,0.00004409028,0.00006700092,0.0000023169412],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015642362,0.16373737,0.0018416193,0.0002830528,0.005346893,0.0011245722,0.006398993,0.00004026842,0.7931477,0.000036001107,0.0005192852,0.011881889],"study_design_scores_gemma":[0.11119109,0.045710694,0.002398117,0.000097045915,0.0054928283,0.000047448444,0.001596599,0.00032561447,0.83242595,0.000040314277,0.0005449508,0.00012932526],"about_ca_topic_score_codex":0.00009132804,"about_ca_topic_score_gemma":0.00003471503,"teacher_disagreement_score":0.118026674,"about_ca_system_score_codex":0.00017474063,"about_ca_system_score_gemma":0.0009446017,"threshold_uncertainty_score":0.44239172},"labels":[],"label_agreement":null},{"id":"W3217314293","doi":"10.1182/blood-2021-147550","title":"Perioperative Outcomes Associated with Inhibitor Status in Patients with Hemophilia - a Retrospective Cohort Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"","keywords":"Medicine; Perioperative; Retrospective cohort study; Hemostasis; Clotting factor; Surgery; Thrombosis; Internal medicine","score_opus":0.010216998126163633,"score_gpt":0.26650817495451096,"score_spread":0.25629117682834734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217314293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99594706,0.00003513507,2.0725001e-7,0.0001875706,0.000026693198,0.0017998994,0.000034912726,0.000040747123,0.0019277813],"genre_scores_gemma":[0.99663454,0.0000052662713,0.00007605453,0.00004831868,0.000025184938,0.00012464459,0.00014761854,0.000032875872,0.0029054875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997973,0.00012622237,0.00020118077,0.00046207604,0.00082214084,0.00041532947],"domain_scores_gemma":[0.9988941,0.00005421026,0.000049829217,0.00029414403,0.00054150895,0.00016621618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000148081,0.00021623424,0.00057119975,0.000109507404,0.00009333705,0.000034871297,0.000041908585,0.00007005996,0.00012005099],"category_scores_gemma":[0.00029459782,0.00012811497,0.000042286578,0.000604494,0.000077783676,0.00008580812,0.000046829442,0.00030512025,0.000012826612],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035223205,0.013003373,0.9828915,0.000008693467,0.001158326,0.0010104253,0.0014780379,4.5467505e-7,0.00004308764,0.0000055307705,0.000012100393,0.000036226073],"study_design_scores_gemma":[0.030422604,0.004256921,0.96301997,0.000105567065,0.0003102298,0.0000035376456,0.0008677001,0.0000017532673,0.0008473093,0.00000225842,0.0000070988717,0.00015502605],"about_ca_topic_score_codex":0.000082398736,"about_ca_topic_score_gemma":0.0006592053,"teacher_disagreement_score":0.030070372,"about_ca_system_score_codex":0.00030674879,"about_ca_system_score_gemma":0.00038576708,"threshold_uncertainty_score":0.5224377},"labels":[],"label_agreement":null},{"id":"W3217349842","doi":"10.1182/blood-2021-153674","title":"Iron Chelation Therapy in Low- to Intermediate- Risk Myelodysplastic Syndrome Patients: A Systematic Review and Meta-Analysis","year":2021,"lang":"en","type":"review","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Joseph’s Healthcare Hamilton; St. Joseph's Hospital; McMaster University; University of Ottawa","funders":"","keywords":"Medicine; Hazard ratio; Randomized controlled trial; Meta-analysis; Internal medicine; Relative risk; Cochrane Library; Number needed to treat; Observational study; Lower risk; MEDLINE; Confidence interval","score_opus":0.04098586254030382,"score_gpt":0.33558522641567046,"score_spread":0.2945993638753666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217349842","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006416624,0.9913949,0.00001659042,0.000057405876,0.000024660172,0.0076442496,0.00016245001,0.0000285727,0.000029506025],"genre_scores_gemma":[0.00032772054,0.99593085,0.00011926477,0.00027769146,0.000022536506,0.0022032822,0.00064258656,0.000084487016,0.0003915759],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9947845,0.0014061902,0.0017927173,0.000876733,0.0007128649,0.0004270193],"domain_scores_gemma":[0.99685764,0.00074291247,0.0007298006,0.0011151123,0.0002507815,0.00030375883],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013704828,0.00065065257,0.011928613,0.001133109,0.000042710315,0.000055684264,0.00029328972,0.0003281703,0.00042342846],"category_scores_gemma":[0.0023156502,0.0004127165,0.0019125293,0.0027889046,0.00004258946,0.000077785866,0.00019477955,0.00086944783,0.000182408],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004619506,0.00040874202,0.00005940348,0.8753012,0.12152456,0.00022970248,0.00006349474,6.622671e-7,2.904135e-8,0.0000014442124,0.000039190647,0.0023669836],"study_design_scores_gemma":[0.00095792767,0.00031441948,0.00016497036,0.13297091,0.863708,0.00012774447,0.000008050777,0.0000052791447,1.4447278e-7,7.175405e-7,0.001418391,0.00032345348],"about_ca_topic_score_codex":0.00003526284,"about_ca_topic_score_gemma":0.000021870364,"teacher_disagreement_score":0.74233025,"about_ca_system_score_codex":0.00034000017,"about_ca_system_score_gemma":0.00037066275,"threshold_uncertainty_score":0.99983245},"labels":[],"label_agreement":null},{"id":"W3217363670","doi":"10.1182/blood-2021-146237","title":"Cost per Responder Analysis to Assess the Value of CAR-T Therapy for Relapsed or Refractory Multiple Myeloma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Multiple myeloma; Oncology; Clinical trial; Internal medicine; Chimeric antigen receptor; Cost effectiveness; Immunotherapy; Cancer","score_opus":0.09148170366789479,"score_gpt":0.378496741030424,"score_spread":0.2870150373625292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217363670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942809,0.00070050627,0.0007305455,0.0017838554,0.000084813146,0.0013451257,0.000067830246,0.00003197887,0.00097448676],"genre_scores_gemma":[0.9650378,0.00029133528,0.0030732418,0.0011516123,0.0002539532,0.0002925954,0.00007784096,0.00006432985,0.02975725],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99802685,0.00028880936,0.00033645378,0.00039678023,0.0006050943,0.00034604222],"domain_scores_gemma":[0.9966567,0.0014682339,0.000081197366,0.0010210407,0.0006086249,0.00016419095],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00085440854,0.00016498142,0.0005032678,0.00023724722,0.00010573458,0.000031869957,0.00022399634,0.00012575062,0.002785035],"category_scores_gemma":[0.00093015813,0.00010271498,0.00040099787,0.0011820932,0.00007128023,0.00004112462,0.00006627757,0.0002436921,0.0000142582585],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005629522,0.0012395402,0.02369866,0.000048640963,0.0039788065,0.00007551035,0.0016015174,0.000040308954,0.95095515,0.00005656794,0.001196364,0.011479394],"study_design_scores_gemma":[0.015038091,0.0015749257,0.17127368,0.000051920884,0.0017885389,0.000047323516,0.0017453965,0.00043362647,0.65069836,0.000032360796,0.15704632,0.00026943898],"about_ca_topic_score_codex":0.00008190657,"about_ca_topic_score_gemma":0.00022560118,"teacher_disagreement_score":0.3002568,"about_ca_system_score_codex":0.000062968575,"about_ca_system_score_gemma":0.00051415025,"threshold_uncertainty_score":0.99812657},"labels":[],"label_agreement":null},{"id":"W3217436200","doi":"10.1182/blood-2021-150519","title":"Elranatamab (PF-06863135), a B-Cell Maturation Antigen (BCMA) Targeted CD3-Engaging Bispecific Molecule, for Patients with Relapsed or Refractory Multiple Myeloma: Results from Magnetismm-1","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Institute of Cancer Research; University of Calgary; McGill University Health Centre","funders":"","keywords":"Medicine; Multiple myeloma; Cytokine release syndrome; Lenalidomide; Adverse effect; Common Terminology Criteria for Adverse Events; Neutropenia; Internal medicine; Pomalidomide; Oncology; Febrile neutropenia; Toxicity; Pharmacology; Gastroenterology; Immunotherapy; Cancer; Chimeric antigen receptor","score_opus":0.016623479650106996,"score_gpt":0.24550516732316358,"score_spread":0.22888168767305658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217436200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99320936,0.00110987,0.00030700854,0.00032187512,0.00017072436,0.0019516159,0.0018676581,0.00015845086,0.0009034101],"genre_scores_gemma":[0.96212745,0.0002354204,0.024410442,0.000113559596,0.0001960486,0.00017529126,0.010730627,0.0001058429,0.0019053302],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99677336,0.00019174698,0.0005799361,0.00096563535,0.00079517014,0.0006941513],"domain_scores_gemma":[0.99724054,0.00061679195,0.00023882174,0.0008552275,0.0006570287,0.0003915685],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017477405,0.00040431265,0.0005353927,0.0002010567,0.0003221769,0.00010227864,0.00016644895,0.0002076494,0.00020452403],"category_scores_gemma":[0.0012203179,0.00030722131,0.00015452951,0.00048110023,0.00007006651,0.00024238738,0.000081836806,0.00040835247,0.00007867114],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14032814,0.045759894,0.31997746,0.0012507866,0.00463257,0.010843493,0.003851858,0.000028747296,0.40852427,0.000030010737,0.01779716,0.04697561],"study_design_scores_gemma":[0.17264958,0.003647199,0.60860133,0.00049032026,0.00062763446,0.000036624497,0.00057775964,0.0011804076,0.20311259,0.000024766165,0.008330801,0.0007210064],"about_ca_topic_score_codex":0.00022444232,"about_ca_topic_score_gemma":0.00020953269,"teacher_disagreement_score":0.28862384,"about_ca_system_score_codex":0.00011107754,"about_ca_system_score_gemma":0.00041152368,"threshold_uncertainty_score":0.999938},"labels":[],"label_agreement":null},{"id":"W3217458626","doi":"10.1182/blood-2021-150369","title":"Meaningful Changes in Patient-Reported Outcomes in Relation to Best Clinical Response and Disease Progression: <i>Post Hoc</i> Analyses from MAIA","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Alberta; University of Calgary","funders":"","keywords":"Post-hoc analysis; Post hoc; Medicine; Disease; Internal medicine","score_opus":0.3642509410995547,"score_gpt":0.4836283883829353,"score_spread":0.11937744728338062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217458626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9568281,0.002734631,0.00002827599,0.039227158,0.00025503326,0.0005167525,0.00026604795,0.000023351931,0.0001206531],"genre_scores_gemma":[0.99012136,0.00015390544,0.0029954475,0.006267718,0.00010410228,0.0001249566,0.000097406584,0.000024396411,0.0001106892],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949248,0.00084842584,0.0031268585,0.00071850285,0.00010485231,0.0002765646],"domain_scores_gemma":[0.99631685,0.0017175175,0.0010451007,0.0004934915,0.00006905613,0.0003579576],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0062723462,0.00016706224,0.0008586656,0.0003726103,0.00006992567,0.00007217074,0.0001022832,0.00014093568,0.00011465503],"category_scores_gemma":[0.018875886,0.00019923931,0.000077881494,0.00033809524,0.000036795594,0.00022648321,0.0001029705,0.00017760911,0.000177276],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029682324,0.0006355608,0.9965699,0.0000358898,0.000056771565,0.00009334441,0.0014784123,0.000021055172,0.00002685777,0.00022154646,0.00022458822,0.00033930014],"study_design_scores_gemma":[0.0022467894,0.0002135355,0.99226934,0.00021890579,0.000026792444,0.0000030498384,0.0010334171,0.00020660255,0.000028069013,0.0011619347,0.0023484908,0.00024308568],"about_ca_topic_score_codex":0.00042722197,"about_ca_topic_score_gemma":0.0019894654,"teacher_disagreement_score":0.033293284,"about_ca_system_score_codex":0.00011863465,"about_ca_system_score_gemma":0.00024241449,"threshold_uncertainty_score":0.9893885},"labels":[],"label_agreement":null},{"id":"W3217461843","doi":"10.1182/blood-2021-151467","title":"Elucidating the Importance and Regulation of Key Enhancers for Human MEIS1 Expression","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Enhancer; Biology; CRISPR; Cas9; Genetics; Intron; Enhancer trap; Gene; Molecular biology; Transcription factor","score_opus":0.0230980652139318,"score_gpt":0.3156076905347915,"score_spread":0.29250962532085967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217461843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962742,0.0005358718,0.000625144,0.00059258495,0.000015026732,0.00028283757,0.000004467044,0.00001250176,0.0016574106],"genre_scores_gemma":[0.99419576,0.000037001424,0.0044949916,0.00008229253,0.00011898341,0.000031342348,0.0000340438,0.00001184843,0.0009937228],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99937826,0.000027217231,0.00016212654,0.00015191193,0.0001626026,0.00011789016],"domain_scores_gemma":[0.9994079,0.00010858813,0.000076258984,0.00024062452,0.00012988206,0.00003676237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002394211,0.000053299074,0.00012470031,0.000021684587,0.000093574534,0.0000082517645,0.000044574845,0.000043226333,0.00005666352],"category_scores_gemma":[0.00026325684,0.00003686863,0.00003327446,0.000091842936,0.000049384165,0.000039471375,0.000048010585,0.00008674035,6.3836524e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028484252,0.00004535293,0.0067098383,0.00011258238,0.000027324837,0.0000038795524,0.0002862507,8.627849e-7,0.9907996,0.00045066752,0.00053049735,0.0010046596],"study_design_scores_gemma":[0.001955906,0.00008098535,0.02166211,0.00012365206,0.00006009429,0.000021020744,0.0002703882,0.00011063973,0.97445995,0.00043222704,0.00078406994,0.000038957976],"about_ca_topic_score_codex":0.000008148652,"about_ca_topic_score_gemma":0.000010498225,"teacher_disagreement_score":0.01633965,"about_ca_system_score_codex":0.000019926194,"about_ca_system_score_gemma":0.00011350954,"threshold_uncertainty_score":0.1503459},"labels":[],"label_agreement":null},{"id":"W3217476733","doi":"10.1182/blood-2021-151696","title":"Rate of Clonal Hematopoiesis in Patients with Venous Thromboembolism","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Internal medicine; Venous thrombosis; Incidence (geometry); Thrombosis; Oncology","score_opus":0.006218967977257774,"score_gpt":0.21679264152922237,"score_spread":0.2105736735519646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217476733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977305,0.00026141218,0.0000018816851,0.00024503068,0.000028188011,0.00021781934,0.000020017655,0.000009213093,0.001485953],"genre_scores_gemma":[0.9988279,0.000036561338,0.0007649577,0.00019073437,0.000023520017,0.000031025134,0.00005531326,0.000012625981,0.00005736186],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99931586,0.000034047123,0.00017596367,0.00017954307,0.00015583308,0.00013876127],"domain_scores_gemma":[0.999518,0.00005171326,0.000053488144,0.0001757334,0.00014419512,0.00005687514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000044623433,0.0001032044,0.00039070306,0.000043813943,0.000020718984,0.0000052260007,0.000024266474,0.000039509225,0.00016864628],"category_scores_gemma":[0.000037936155,0.00007482871,0.000042624983,0.00016062894,0.000028674407,0.000027574377,0.000019934987,0.00006469987,0.000012184779],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009392034,0.009049258,0.9886583,0.00008013632,0.00028553916,0.00020851055,0.00031738917,0.0000018035255,0.00028964417,0.000678129,0.000064966596,0.00027236983],"study_design_scores_gemma":[0.007854268,0.0006372452,0.9164788,0.00017480901,0.00019504002,0.000015373142,0.000038889488,9.358865e-7,0.07435808,0.0000853558,0.00009447704,0.00006672368],"about_ca_topic_score_codex":0.00002371625,"about_ca_topic_score_gemma":0.000040476025,"teacher_disagreement_score":0.07406844,"about_ca_system_score_codex":0.00001749133,"about_ca_system_score_gemma":0.00012568479,"threshold_uncertainty_score":0.30514264},"labels":[],"label_agreement":null},{"id":"W3217481197","doi":"10.1182/blood-2021-153445","title":"Constrained FL: A Genetically Distinct Subgroup of Follicular Lymphoma with Low Rates of Somatic Hypermutation and a Reduced Propensity for Histologic Transformation","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Simon Fraser University; University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Somatic hypermutation; BCL6; Biology; Follicular lymphoma; Germinal center; Somatic cell; Genetics; Lymphoma; Cell of origin; Diffuse large B-cell lymphoma; Fluorescence in situ hybridization; Cancer research; Gene; B cell; Chromosome; Immunology","score_opus":0.01613062665789393,"score_gpt":0.2415695368399892,"score_spread":0.22543891018209528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217481197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99777913,0.0004734889,0.0005434048,0.00023614783,0.000009081163,0.0007849097,0.000023892842,0.000011406632,0.00013854941],"genre_scores_gemma":[0.9945425,0.000029252098,0.005187703,0.000022508639,0.0000069723933,0.00009242416,0.00010364114,0.0000073607284,0.000007673131],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993678,0.000027280239,0.00025172814,0.0001411772,0.0001183355,0.000093692404],"domain_scores_gemma":[0.99946594,0.0000771458,0.00010650605,0.00011070328,0.0001911075,0.000048577513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000063665604,0.00009492843,0.0003287649,0.000029029534,0.000030169842,0.0000061028786,0.000017124265,0.00004341409,0.0000063532348],"category_scores_gemma":[0.0000789082,0.00006505641,0.00005848574,0.00008217274,0.00008889947,0.000032837743,0.000005158778,0.000010851056,3.146002e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016936589,0.012445042,0.26099625,0.0057173893,0.0016457657,0.00036406913,0.0030683444,0.000010534791,0.6623786,0.0029551627,0.000010575371,0.048714597],"study_design_scores_gemma":[0.013544853,0.0011190466,0.4602265,0.0002470242,0.0009808985,0.00037954698,0.00013260187,0.00037698343,0.52278185,0.00013297651,0.000005294358,0.00007239957],"about_ca_topic_score_codex":0.000015486807,"about_ca_topic_score_gemma":0.000015774898,"teacher_disagreement_score":0.19923025,"about_ca_system_score_codex":0.000022421305,"about_ca_system_score_gemma":0.00018267697,"threshold_uncertainty_score":0.26529235},"labels":[],"label_agreement":null},{"id":"W3217566107","doi":"10.1182/blood-2021-149585","title":"Environmental, Lifestyle Risk Factors and Host Characteristics Associated with Philadelphia Negative Myeloproliferative Neoplasm: A Systematic Review","year":2021,"lang":"en","type":"review","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Essential thrombocythemia; Systematic review; Myelofibrosis; Epidemiology; Etiology; MEDLINE; Polycythemia vera; Internal medicine","score_opus":0.02055970374362189,"score_gpt":0.26819965749094193,"score_spread":0.24763995374732004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217566107","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032247105,0.9864706,0.0000028468742,0.00010424988,0.00006774645,0.007928718,0.0020402074,0.00007980851,0.00008111326],"genre_scores_gemma":[0.0027250713,0.9923556,0.00010894369,0.0002573788,0.00011640639,0.002143479,0.0019376505,0.0001817913,0.00017369486],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99485534,0.0011264429,0.0015580124,0.001156869,0.0007421306,0.0005612025],"domain_scores_gemma":[0.99481004,0.0017306693,0.0020277968,0.0007889976,0.00015304926,0.0004894181],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00038431952,0.0014136336,0.00850036,0.00018202227,0.00030746084,0.00012016157,0.00016211497,0.00047615127,0.00013360189],"category_scores_gemma":[0.0017933347,0.0008738085,0.0006752056,0.00045799263,0.00020648244,0.00011223988,0.00014481257,0.00095388456,0.000063100066],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017310407,0.004497981,0.019747812,0.9464167,0.024039267,0.0015143189,0.0008181728,2.281557e-8,4.860698e-7,0.000032688957,0.00020126227,0.002713974],"study_design_scores_gemma":[0.0024185216,0.0010775406,0.004593166,0.88662386,0.09688557,0.00090441096,0.00013438004,0.0000017094607,0.000021623111,0.0000012788188,0.006336646,0.0010012882],"about_ca_topic_score_codex":0.000014870026,"about_ca_topic_score_gemma":0.000016140279,"teacher_disagreement_score":0.0728463,"about_ca_system_score_codex":0.00031736383,"about_ca_system_score_gemma":0.00054239045,"threshold_uncertainty_score":0.99986136},"labels":[],"label_agreement":null},{"id":"W3217592658","doi":"10.1182/blood-2021-154190","title":"Outcomes after First Rescue Treatment in Patients with Relapsed or Refractory Multiple Myeloma in Colombia","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University; University of Toronto","funders":"","keywords":"Lenalidomide; Carfilzomib; Medicine; Multiple myeloma; Internal medicine; Bortezomib; Clinical endpoint; Refractory (planetary science); Propensity score matching; Pomalidomide; Oncology; Gastroenterology; Surgery; Clinical trial","score_opus":0.01632419019254333,"score_gpt":0.26656195274061373,"score_spread":0.2502377625480704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217592658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99805117,0.00018187922,3.3228022e-7,0.00028135692,0.000038552756,0.0010243772,0.00005733469,0.000031226402,0.0003337684],"genre_scores_gemma":[0.9958002,0.000061757615,0.00082540896,0.00009509002,0.00001957056,0.0004238699,0.00017608475,0.00003737008,0.0025606363],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982648,0.000093473296,0.00031454486,0.00045269667,0.00039682508,0.00047764668],"domain_scores_gemma":[0.99894583,0.00021100162,0.00004069067,0.0004889867,0.000095706055,0.00021776168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006681258,0.00024497646,0.00048571645,0.00018720947,0.000044450604,0.000019740473,0.000059639202,0.00011537841,0.00030570565],"category_scores_gemma":[0.00033862886,0.00015431688,0.00007494921,0.00035604328,0.000045284825,0.00009155976,0.000050374823,0.0001790058,0.00006358557],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005490351,0.011108935,0.9743257,0.00005471508,0.00020653986,0.0060937153,0.00035239442,0.0000014378008,0.000032319003,5.036318e-7,0.000040183695,0.0022931693],"study_design_scores_gemma":[0.07007924,0.0019847364,0.92536104,0.00020836575,0.00007940754,0.00001219932,0.00007457776,0.000014760832,0.0010363554,0.000001194981,0.0009990023,0.00014914818],"about_ca_topic_score_codex":0.0006600513,"about_ca_topic_score_gemma":0.036846876,"teacher_disagreement_score":0.06458888,"about_ca_system_score_codex":0.00033129382,"about_ca_system_score_gemma":0.0002975193,"threshold_uncertainty_score":0.98072815},"labels":[],"label_agreement":null},{"id":"W3217612228","doi":"10.1182/blood-2021-151285","title":"Comparative Effectiveness of Venetoclax Combinations Vs Other Therapies Among Patients with Newly Diagnosed Acute Myeloid Leukemia: Results from the AML Real World Evidence (ARC) Initiative","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Venetoclax; Myeloid leukemia; Medicine; Internal medicine; Oncology; Leukemia; Intensive care medicine; Chronic lymphocytic leukemia","score_opus":0.03277429001177048,"score_gpt":0.3032070922019721,"score_spread":0.27043280219020166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217612228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99440515,0.00035043445,0.000061649764,0.0004776146,0.000064184205,0.0015460509,0.0005947123,0.000054535103,0.002445646],"genre_scores_gemma":[0.99765474,0.00023140476,0.000773876,0.00024409665,0.00009097001,0.00023444083,0.00042647828,0.00004821222,0.00029577216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99661523,0.0011501851,0.00045895972,0.000576011,0.0008140549,0.0003855392],"domain_scores_gemma":[0.99040884,0.007241163,0.00031546637,0.0007984468,0.0010910252,0.00014508165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054069964,0.0003121571,0.00077352335,0.00012920587,0.00020872323,0.00005167972,0.0003411875,0.000118873984,0.00006054446],"category_scores_gemma":[0.00064450817,0.000205369,0.00012419777,0.0010429887,0.00063823856,0.00028751203,0.00017460497,0.000658025,0.000020900403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011687532,0.0018514622,0.9556185,0.00013799578,0.004782055,0.00037331844,0.016821291,0.00016152326,0.0062782643,0.0005469136,0.0013539032,0.0003872598],"study_design_scores_gemma":[0.023360599,0.0010284279,0.92273206,0.001691031,0.00061807793,0.0000033238025,0.0008381311,0.00008869316,0.049164344,0.00016115591,0.00010566523,0.00020850204],"about_ca_topic_score_codex":0.0036492944,"about_ca_topic_score_gemma":0.0022064464,"teacher_disagreement_score":0.04288608,"about_ca_system_score_codex":0.0006441583,"about_ca_system_score_gemma":0.0018070644,"threshold_uncertainty_score":0.8374704},"labels":[],"label_agreement":null},{"id":"W3217639770","doi":"10.1182/blood-2021-153490","title":"Initial Clinical Presentation and Predictors of Thrombotic Thrombocytopenic Purpura in Quebec","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Thrombotic thrombocytopenic purpura; Medicine; Thrombotic microangiopathy; Internal medicine; Schistocyte; ADAMTS13; Microangiopathic hemolytic anemia; Pediatrics; Surgery; Disease; Platelet","score_opus":0.03672744363361246,"score_gpt":0.3360813318256413,"score_spread":0.29935388819202885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217639770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966002,0.002064154,0.0000063261987,0.00007399323,0.00043697318,0.0002191184,0.00003420604,0.00001856486,0.00054643716],"genre_scores_gemma":[0.9994639,0.000060744747,0.000026856622,0.000024052944,0.000038212598,0.000014654142,0.000107428976,0.0000067568503,0.00025735667],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987509,0.00038658717,0.00046859143,0.0002173487,0.000033833698,0.00014272064],"domain_scores_gemma":[0.9993679,0.00026549344,0.00010537567,0.00019821414,0.000047150534,0.00001589453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016302796,0.000081440565,0.00029057037,0.000046085643,0.000028472019,0.000009404034,0.00008956032,0.000098218814,0.00054068037],"category_scores_gemma":[0.00020253897,0.000079334684,0.00005632796,0.00009561606,0.0001511526,0.00008134389,0.0001189967,0.000102748614,0.000027624099],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039490842,0.00093235396,0.9582435,0.00007075895,0.00025868195,0.000022789944,0.00032155617,0.0000011078217,0.03847621,0.00047855513,0.0006127473,0.00054225617],"study_design_scores_gemma":[0.00394408,0.000114137605,0.95603025,0.00007611631,0.00014189289,0.000029338744,0.00052123255,8.7795536e-7,0.038593534,0.00011783844,0.00034784607,0.000082845516],"about_ca_topic_score_codex":0.0009302978,"about_ca_topic_score_gemma":0.0040514763,"teacher_disagreement_score":0.003904589,"about_ca_system_score_codex":0.000008765939,"about_ca_system_score_gemma":0.00013774798,"threshold_uncertainty_score":0.5920071},"labels":[],"label_agreement":null},{"id":"W3217659172","doi":"10.1182/blood-2021-147827","title":"Tagraxofusp (SL-401) in Patients with Chronic Myelomonocytic Leukemia (CMML): Updated Results of an Ongoing Phase 1/2 Trial","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Chronic myelomonocytic leukemia; Medicine; Internal medicine; Oncology; Bone marrow; Myelodysplastic syndromes","score_opus":0.015545395059151097,"score_gpt":0.293888911158437,"score_spread":0.2783435160992859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217659172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996617,0.00013263694,0.000011493228,0.00011950963,0.00007938995,0.0011600972,0.0000969251,0.000060352504,0.0017225636],"genre_scores_gemma":[0.99686337,0.000030682382,0.001009856,0.00006711988,0.0002579664,0.00004003975,0.0011882936,0.000060204933,0.00048245836],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99707055,0.00021604888,0.0007285652,0.00063326105,0.0007558599,0.00059568806],"domain_scores_gemma":[0.9981117,0.0001170751,0.0002050505,0.00091868336,0.00036130426,0.00028615296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048224456,0.00026162504,0.00064190273,0.0002964242,0.00005738936,0.00002953209,0.00022337255,0.00019389216,0.00013514994],"category_scores_gemma":[0.0005043474,0.0002216484,0.00008952114,0.0010349989,0.00012752824,0.00019938867,0.0001235142,0.00059231935,0.00002739085],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7041906,0.044070665,0.043255802,0.0012784348,0.0024239111,0.008558969,0.0028960751,0.00032790666,0.08446931,0.00019322422,0.003698293,0.10463681],"study_design_scores_gemma":[0.85154945,0.0113207325,0.020897087,0.00042067186,0.00036721287,0.000052646195,0.00013786572,0.0010653373,0.11253588,0.000014545023,0.0012805044,0.000358095],"about_ca_topic_score_codex":0.00032694486,"about_ca_topic_score_gemma":0.00038384338,"teacher_disagreement_score":0.14735883,"about_ca_system_score_codex":0.0010349739,"about_ca_system_score_gemma":0.003943538,"threshold_uncertainty_score":0.903856},"labels":[],"label_agreement":null},{"id":"W3217673531","doi":"10.1182/blood-2021-153594","title":"Clinical Utility of Hematopathologist-Triaged NGS Testing When Investigating Patients with Suspected MDS","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; Queen's University","funders":"","keywords":"Medicine; Internal medicine; Myelodysplastic syndromes; Cytopenia; Hematology; Dysplasia; Myeloid; Retrospective cohort study; Clofarabine; Bone marrow; Oncology; Leukemia; Cytarabine","score_opus":0.06582940178956316,"score_gpt":0.330629738939636,"score_spread":0.26480033715007284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217673531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995168,0.000096479154,0.00006105308,0.00023866986,0.000037500497,0.0003926882,0.000017034998,0.00009912282,0.0038894832],"genre_scores_gemma":[0.94616604,0.0000040052373,0.053276062,0.00018459352,0.00010406676,0.000011859365,0.00006906357,0.000028640656,0.00015564241],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99757314,0.000352085,0.00068576157,0.00046961554,0.0005629808,0.00035643385],"domain_scores_gemma":[0.9968661,0.0009375246,0.0002430908,0.00063183974,0.0010702205,0.0002511951],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0010577809,0.00016346463,0.00057676283,0.00006369956,0.0000798068,0.000016281216,0.00014559977,0.00015726849,0.0001299192],"category_scores_gemma":[0.018242655,0.00012837953,0.000087595276,0.000570497,0.00038144883,0.00006451801,0.000210316,0.0007032505,0.000011851504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008542929,0.0010795364,0.9917809,0.00019090403,0.00009230629,0.0003303243,0.00017535654,1.6239304e-7,0.004301888,0.000021578619,0.00025953818,0.0016821281],"study_design_scores_gemma":[0.009621891,0.0005902497,0.9664084,0.00032996252,0.00021689165,0.00010723685,0.0001559001,0.00014481142,0.022068994,0.00017922315,0.000045758286,0.00013071284],"about_ca_topic_score_codex":0.00006436879,"about_ca_topic_score_gemma":0.000015709482,"teacher_disagreement_score":0.05321501,"about_ca_system_score_codex":0.00003719311,"about_ca_system_score_gemma":0.00092580763,"threshold_uncertainty_score":0.9900271},"labels":[],"label_agreement":null},{"id":"W3217685862","doi":"10.1182/blood-2021-145886","title":"Efficacy and Safety of Tinzaparin in CAT Patients with Hematological Malignancy","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Warfarin; Pulmonary embolism; Thrombosis; Deep vein; Surgery; Randomized controlled trial; Gastroenterology; Atrial fibrillation","score_opus":0.00887742591940551,"score_gpt":0.22843962865032622,"score_spread":0.2195622027309207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217685862","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960331,0.000276265,0.0000051255265,0.00019147313,0.000014608319,0.00026583564,0.0000025246682,0.000009947812,0.003201148],"genre_scores_gemma":[0.99885505,0.00014729713,0.0007739049,0.00013511912,0.000008504618,0.00001069694,0.000016693979,0.0000067859132,0.000045918416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994104,0.000018580713,0.00016635591,0.00016506034,0.00011974998,0.00011986665],"domain_scores_gemma":[0.9996931,0.000030365767,0.000039178856,0.00014875391,0.000041815467,0.0000467737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000047447556,0.0000698221,0.00031409564,0.00003114312,0.000014241047,0.000003646522,0.000025142566,0.000034888817,0.00006493785],"category_scores_gemma":[0.000044162305,0.000050791245,0.000017996015,0.000110488196,0.000030375806,0.000016002325,0.0000556631,0.000040995663,0.0000033527158],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011442818,0.0069156936,0.9884257,0.00021673944,0.00009988765,0.00018339923,0.00023406965,0.0000016248467,0.00021648293,0.0019701675,0.000110533525,0.0015113229],"study_design_scores_gemma":[0.008146642,0.00031421703,0.98782146,0.00027688305,0.00014154204,0.000013206721,0.000051122763,0.0000013635295,0.0028526448,0.000026614503,0.00029533717,0.000058967755],"about_ca_topic_score_codex":0.00002016411,"about_ca_topic_score_gemma":0.00002734784,"teacher_disagreement_score":0.008032214,"about_ca_system_score_codex":0.000006377894,"about_ca_system_score_gemma":0.000024752864,"threshold_uncertainty_score":0.20712067},"labels":[],"label_agreement":null},{"id":"W3217726622","doi":"10.1182/blood-2021-153719","title":"Risk of Major Bleeding with Ibrutinib in Patients with Thrombocytopenia - a Retrospective Single-Center Canadian Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Victoria Hospital; Western University; London Health Sciences Centre; Sunnybrook Hospital; University of Toronto","funders":"","keywords":"Medicine; Common Terminology Criteria for Adverse Events; Ibrutinib; Single Center; Retrospective cohort study; Univariate analysis; Internal medicine; Adverse effect; Population; Surgery; Multivariate analysis; Chronic lymphocytic leukemia; Leukemia","score_opus":0.010821093530594674,"score_gpt":0.23892522704136193,"score_spread":0.22810413351076725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217726622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99484867,0.000038039943,0.000001348916,0.000045911413,0.000025890065,0.0010455509,0.00004692155,0.00001410621,0.0039335615],"genre_scores_gemma":[0.99929684,0.0000029453781,0.0003869458,0.000036258363,0.000035993493,0.00002666943,0.00002587502,0.000037085338,0.00015138743],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981585,0.00007914782,0.0002518874,0.00041343144,0.0006365843,0.00046042353],"domain_scores_gemma":[0.99877274,0.000050662748,0.00009414634,0.0004433557,0.00039340043,0.00024570266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020027168,0.00016427414,0.0004706731,0.00019117662,0.000058773712,0.000024921897,0.00010740586,0.00006367638,0.00014766163],"category_scores_gemma":[0.00018459157,0.00012132903,0.00003374113,0.00069031765,0.000088892535,0.00008021575,0.00006810596,0.00028129658,0.000009340953],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052041654,0.0046250722,0.99198496,0.000047491336,0.00048252364,0.0008170929,0.001319143,0.0000016359893,0.00009179666,0.000008163708,0.000028035904,0.00007365785],"study_design_scores_gemma":[0.11564433,0.0028451697,0.8769513,0.00031514792,0.000334268,0.000074213014,0.0010564023,0.000018877774,0.0025906945,0.000004858264,0.000021993685,0.00014277412],"about_ca_topic_score_codex":0.0671389,"about_ca_topic_score_gemma":0.29855353,"teacher_disagreement_score":0.23141463,"about_ca_system_score_codex":0.004740118,"about_ca_system_score_gemma":0.005442405,"threshold_uncertainty_score":0.9990805},"labels":[],"label_agreement":null},{"id":"W3217731474","doi":"10.1182/blood-2021-146103","title":"Favorable Outcomes with Thiotepa/Busulfan-Based Conditioning and Autotransplant for Patients with Aggressive B-Cell Lymphoma and Secondary CNS Involvement","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Foothills Medical Centre; University of Alberta; University of Calgary","funders":"","keywords":"ThioTEPA; Medicine; Busulfan; Diffuse large B-cell lymphoma; Internal medicine; Lymphoma; Oncology; Transplantation; Regimen; Surgery; Chemotherapy; Hematopoietic stem cell transplantation; Cyclophosphamide","score_opus":0.006023137289638694,"score_gpt":0.2056863356318183,"score_spread":0.1996631983421796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217731474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971251,0.001127199,0.00006988879,0.00032668453,0.000025929186,0.00070530985,0.000322567,0.000034973727,0.00026235232],"genre_scores_gemma":[0.9945095,0.00008658202,0.0036950575,0.0006877505,0.000015444319,0.0001972818,0.0006695533,0.000030153766,0.000108683016],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990261,0.000017872237,0.00016378328,0.00036105473,0.00020187492,0.00022926574],"domain_scores_gemma":[0.9992433,0.00015064156,0.00012313778,0.00018654285,0.00014461493,0.00015174646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000039630384,0.00021283746,0.0003451319,0.00005445215,0.00016842943,0.000050882572,0.00002383628,0.000056080935,0.00003187244],"category_scores_gemma":[0.000013046302,0.00014247371,0.000044360015,0.00007175107,0.00006862368,0.000061473474,0.000014274569,0.000041799663,0.0000011941935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000281982,0.004634503,0.9872358,0.00042577754,0.00056983414,0.0004806216,0.00029289367,0.000004765226,0.0001446122,0.0000683134,0.00008218126,0.0057787113],"study_design_scores_gemma":[0.051033232,0.0018150924,0.91765374,0.00059684593,0.0011454673,0.000063180174,0.00017602145,0.000035905112,0.026937459,0.000021627717,0.00031842233,0.0002030097],"about_ca_topic_score_codex":0.000048013175,"about_ca_topic_score_gemma":0.00011555333,"teacher_disagreement_score":0.06958207,"about_ca_system_score_codex":0.00004089652,"about_ca_system_score_gemma":0.00031252872,"threshold_uncertainty_score":0.5809909},"labels":[],"label_agreement":null},{"id":"W3217731526","doi":"10.1182/blood-2021-149785","title":"M-Protein Sequencing and Monitoring in Serum of LC-Only Multiple Myeloma Patients","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Waterloo","funders":"","keywords":"Medicine; Multiple myeloma; Melphalan; Serum protein electrophoresis; Internal medicine; Thalidomide; Lenalidomide; Bone marrow; Bortezomib; Antibody; Immunofixation; Gastroenterology; Immunology; Monoclonal; Monoclonal antibody","score_opus":0.026081212424968744,"score_gpt":0.27765190012104674,"score_spread":0.251570687696078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217731526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99863076,0.00048968074,0.0000022147744,0.00004667071,0.000029559647,0.00030644095,0.000019509309,0.000015416637,0.0004597484],"genre_scores_gemma":[0.9973723,0.000040500785,0.0022842106,0.0000074442983,0.00004158922,0.00001927841,0.000017746372,0.000014806389,0.00020212364],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990205,0.000044200307,0.00020257238,0.00021911843,0.00026096802,0.00025259668],"domain_scores_gemma":[0.99945897,0.000052049858,0.00004127648,0.00019547985,0.00011691229,0.00013532884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007684191,0.000101442216,0.0002232126,0.00009080092,0.000032136897,0.000009834502,0.00003600822,0.000056463872,0.000020849731],"category_scores_gemma":[0.0003744528,0.00009210069,0.000037423113,0.00018430264,0.000029027027,0.00006340739,0.00007359266,0.00012272738,0.0000059293484],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056765566,0.0004967926,0.9194033,0.0001483985,0.00006722464,0.00038795717,0.00017131033,4.6487352e-7,0.0669575,0.0000061452483,9.207801e-7,0.012303217],"study_design_scores_gemma":[0.0068500587,0.00014215184,0.6849056,0.00025941804,0.000021789307,0.00002074929,0.00014095184,0.00003707265,0.30754796,0.000013150358,0.0000116770725,0.000049471124],"about_ca_topic_score_codex":0.00019025353,"about_ca_topic_score_gemma":0.00008049837,"teacher_disagreement_score":0.24059045,"about_ca_system_score_codex":0.00005262807,"about_ca_system_score_gemma":0.00016188351,"threshold_uncertainty_score":0.3755757},"labels":[],"label_agreement":null},{"id":"W3217750548","doi":"10.1182/blood-2021-148935","title":"Single-Cell Analysis of Human B Lymphoid and Neutrophil/Monocyte Lineage Restriction","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Biology; Haematopoiesis; Progenitor cell; CD34; Immunology; Population; Lineage (genetic); Stromal cell; Stem cell; Cord blood; Cell biology; Lineage markers; Bone marrow; Myeloid; Molecular biology; Genetics; Cancer research; Gene; Medicine","score_opus":0.027557297300122706,"score_gpt":0.28468396479078306,"score_spread":0.2571266674906604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217750548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933382,0.00092394016,0.00004390392,0.0001900954,0.000019334226,0.00010375092,0.000012882586,0.000030548155,0.0053373324],"genre_scores_gemma":[0.9970697,0.00044023024,0.0007619626,0.000088828514,0.000118545475,0.0000050389076,0.00011060383,0.000017821636,0.0013872595],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989647,0.00006388937,0.00025751675,0.0002808067,0.00024506918,0.00018797404],"domain_scores_gemma":[0.99915063,0.00007210814,0.00007996621,0.00038909545,0.00018179086,0.00012643157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013288332,0.00010134673,0.00036354084,0.0003681847,0.00006019096,0.00001725137,0.000057704587,0.00009603606,0.00007870879],"category_scores_gemma":[0.00008759403,0.000096706186,0.00012831601,0.0012271694,0.00006294296,0.000041917323,0.00008541965,0.00015050838,0.000005473174],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004852952,0.0008646269,0.062512845,0.000088530745,0.00082401297,0.00031467748,0.00010276016,0.0000090573685,0.9346265,0.00006897819,0.00016028831,0.00037915786],"study_design_scores_gemma":[0.0055411947,0.0005057302,0.08903093,0.00003243428,0.004686526,0.000094839925,0.0001546142,0.000564171,0.8983929,0.000014492446,0.0008571398,0.00012501505],"about_ca_topic_score_codex":0.000120268254,"about_ca_topic_score_gemma":0.000024821702,"teacher_disagreement_score":0.036233623,"about_ca_system_score_codex":0.000078123856,"about_ca_system_score_gemma":0.00015495402,"threshold_uncertainty_score":0.3943564},"labels":[],"label_agreement":null},{"id":"W3217766765","doi":"10.1182/blood-2021-148718","title":"Identification of Previously Unrecognized Multiple Myeloma Risk Subgroups with a Novel Biological Disease Stratifier","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency; Simon Fraser University; Canada's Michael Smith Genome Sciences Centre; University of British Columbia; Terry Fox Research Institute","funders":"","keywords":"Oncology; Internal medicine; Hazard ratio; Multiple myeloma; Disease; Framingham Risk Score; Proportional hazards model; Medicine; Cytogenetics; Survival analysis; Bioinformatics; Biology; Confidence interval; Genetics; Gene","score_opus":0.030892080059636375,"score_gpt":0.28432168439028077,"score_spread":0.2534296043306444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217766765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99731153,0.00062241685,0.0007896754,0.00010579815,0.00002289754,0.00067085394,0.00029663846,0.00004464543,0.00013552108],"genre_scores_gemma":[0.99659646,0.0001969384,0.002302009,0.00002061525,0.00005072784,0.00010440017,0.00037028518,0.000017471208,0.0003411185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985907,0.0000943383,0.00032082392,0.00038590212,0.00033418328,0.00027406806],"domain_scores_gemma":[0.9986271,0.00016404087,0.0001438656,0.00043786623,0.0002973765,0.0003297464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017183702,0.00014923606,0.00029247784,0.000060032668,0.00006967059,0.000023747278,0.0000724001,0.00006548543,0.00012954614],"category_scores_gemma":[0.0010039296,0.000101491416,0.00011041066,0.00025477272,0.000102807004,0.0000606217,0.000038716877,0.00013796113,0.000025308387],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013990902,0.004986592,0.8552704,0.00013712521,0.00056154456,0.00040378052,0.00011657633,0.0000019967597,0.13269703,0.0000399147,0.000014244211,0.0043717134],"study_design_scores_gemma":[0.013643042,0.00037960976,0.8824568,0.00009200929,0.00043737373,0.00005721564,0.000079536454,0.0003369061,0.102316566,0.00004033826,0.000051242503,0.0001093685],"about_ca_topic_score_codex":0.000045197987,"about_ca_topic_score_gemma":0.000070196154,"teacher_disagreement_score":0.030380458,"about_ca_system_score_codex":0.000019740086,"about_ca_system_score_gemma":0.00026034465,"threshold_uncertainty_score":0.41386998},"labels":[],"label_agreement":null},{"id":"W3217767137","doi":"10.1182/blood-2021-152442","title":"The Prevalence of May Thurner Syndrome in Children with Ileo-Femoral Deep Vein Thrombosis- Does It Take 2 to Tango?","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre","funders":"","keywords":"Medicine; May–Thurner syndrome; Surgery; Deep vein; Thrombosis; Venous thrombosis; Groin; Thrombolysis; Compression stockings; Pediatrics; Internal medicine","score_opus":0.00964944641475411,"score_gpt":0.2502621649076072,"score_spread":0.24061271849285312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217767137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918529,0.0007555351,0.000014237404,0.004398271,0.000074091724,0.0007534227,0.00001752091,0.000026822685,0.0021072323],"genre_scores_gemma":[0.9962353,0.00072032947,0.00066620356,0.000864477,0.000060139122,0.000107494016,0.00000990419,0.000027695323,0.0013084377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985616,0.000058859863,0.00029914145,0.0003546638,0.0003800165,0.00034572193],"domain_scores_gemma":[0.99906063,0.000051933373,0.000084191364,0.0006047334,0.00008968112,0.00010881875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023769951,0.00017269356,0.00042864808,0.00007092601,0.00007910751,0.000032281045,0.0002129106,0.000054601616,0.0002656244],"category_scores_gemma":[0.00007282042,0.000097413445,0.00007516488,0.0003723511,0.00008751516,0.00005928463,0.00013846508,0.00014037333,0.000030002751],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033942746,0.0035409445,0.98760724,0.00046528954,0.000843748,0.00019889214,0.0013344863,0.000036821515,0.0012038852,0.0018744061,0.0013920261,0.0014683214],"study_design_scores_gemma":[0.0016288799,0.00048952585,0.9901249,0.00039612563,0.0005452245,0.00010999022,0.00038038605,0.0000039297056,0.0051612584,0.000058065954,0.0009539739,0.00014775942],"about_ca_topic_score_codex":0.00010862435,"about_ca_topic_score_gemma":0.00066472735,"teacher_disagreement_score":0.004382454,"about_ca_system_score_codex":0.000024862786,"about_ca_system_score_gemma":0.000079466576,"threshold_uncertainty_score":0.3972405},"labels":[],"label_agreement":null},{"id":"W322754315","doi":"10.1182/blood.v96.5.1836.h8001836_1836_1843","title":"Activation of macrophage cytostatic effector mechanisms during acute graft-versus-host disease: release of intracellular iron and nitric oxide–mediated cytostasis","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Cytostasis; Lipopolysaccharide; Nitric oxide; Immunology; Graft-versus-host disease; Intracellular; Macrophage; Medicine; Biology; Chemistry; Cancer research; Transplantation; Internal medicine; Cell biology; Cytotoxicity; In vitro; Biochemistry","score_opus":0.006318000434322129,"score_gpt":0.22119860834638477,"score_spread":0.21488060791206265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W322754315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99824166,0.00027379638,0.0003786254,0.000050213443,0.000022631039,0.0007394965,0.00016353463,0.000055030945,0.00007503179],"genre_scores_gemma":[0.9977786,0.0005156798,0.0013087572,0.000016024736,0.000019310079,0.000028683211,0.00020488664,0.000040287334,0.000087800414],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99855494,0.00009017769,0.00044355838,0.00028435068,0.000398244,0.00022873985],"domain_scores_gemma":[0.99898297,0.00026537696,0.00016733319,0.00028465563,0.000068897374,0.00023078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013280853,0.00020246266,0.00039408897,0.00019567084,0.000048378693,0.000007664624,0.000063548076,0.00010085227,0.0002686538],"category_scores_gemma":[0.00010527444,0.00019338095,0.00008073325,0.00037010974,0.000068276335,0.000103810715,0.000012230613,0.00012749629,0.00002273728],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024066623,0.0005065556,0.0023538764,0.0022983006,0.0002264706,0.00024061251,0.00023986484,0.000006151253,0.99130046,0.000031181837,0.000002434011,0.00038744038],"study_design_scores_gemma":[0.010022324,0.00025609822,0.104370184,0.00048193175,0.0015858586,0.000039810137,0.00006839748,0.0001299615,0.8828748,0.00001908943,0.0000033149581,0.00014824796],"about_ca_topic_score_codex":0.00003642684,"about_ca_topic_score_gemma":8.6709383e-7,"teacher_disagreement_score":0.10842567,"about_ca_system_score_codex":0.000030513074,"about_ca_system_score_gemma":0.00006065826,"threshold_uncertainty_score":0.78858465},"labels":[],"label_agreement":null},{"id":"W324951808","doi":"10.1182/blood.v122.21.90.90","title":"Preliminary Evidence Of Anti Tumor Activity Of Selinexor (KPT-330) In a Phase I Trial Ofa First-In-Class Oral Selective Inhibitor Of Nuclear Export (SINE) In Patients (pts) With Relapsed / Refractory Non Hodgkin’s Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ozmosis Research (Canada); Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Neutropenia; Tolerability; Medicine; Internal medicine; Pharmacodynamics; Gastroenterology; Febrile neutropenia; Adverse effect; Pharmacokinetics; Refractory (planetary science); Pharmacology; Toxicity; Biology","score_opus":0.006923298756439553,"score_gpt":0.222188814725335,"score_spread":0.21526551596889545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W324951808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99881935,0.00018646207,0.0000039126394,0.0000058126707,0.000070208705,0.0008727479,0.000010952017,0.0000048684956,0.00002566448],"genre_scores_gemma":[0.9996209,0.00007839129,0.00013977215,0.0000142057215,0.00005930767,0.000036235077,0.000013115907,0.000029676377,0.00000837833],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99864584,0.0000922595,0.00045483685,0.00039601335,0.00019431586,0.00021673815],"domain_scores_gemma":[0.9991117,0.000034210236,0.00038079554,0.0002856573,0.00013672821,0.000050884653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017032333,0.00019941865,0.0004342075,0.00014934657,0.000019662531,0.0000066998487,0.00012056323,0.00018946014,0.000009680309],"category_scores_gemma":[0.00012631304,0.00017892751,0.000056063116,0.00024024575,0.0001268454,0.00004266047,0.00008372819,0.000107394815,7.599863e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.046747345,0.0018575651,0.028365232,0.00039748035,0.00008370859,0.0000140283655,0.000365374,0.00009518418,0.9182791,9.433373e-7,0.00009832808,0.003695694],"study_design_scores_gemma":[0.12744637,0.027512107,0.36698937,0.0007012725,0.00010756687,0.000016808608,0.00011452205,0.0012752824,0.47541493,0.0000067569053,0.000068568916,0.00034644545],"about_ca_topic_score_codex":0.0007898237,"about_ca_topic_score_gemma":0.00027615106,"teacher_disagreement_score":0.44286418,"about_ca_system_score_codex":0.00032393937,"about_ca_system_score_gemma":0.0006461904,"threshold_uncertainty_score":0.72964525},"labels":[],"label_agreement":null},{"id":"W338936873","doi":"10.1182/blood.v126.23.908.908","title":"Additional Analyses of a Randomized Phase II Study of Azacitidine Combined with Lenalidomide or with Vorinostat Vs. Azacitidine Monotherapy in Higher-Risk Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML): North American Intergroup Study SWOG S1117","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Lenalidomide; Azacitidine; International Prognostic Scoring System; Internal medicine; Myelodysplastic syndromes; Chronic myelomonocytic leukemia; Oncology; Decitabine; Adverse effect; Clinical endpoint; Phases of clinical research; Gastroenterology; Randomized controlled trial; Multiple myeloma; Clinical trial; Bone marrow","score_opus":0.0458846168319952,"score_gpt":0.32696466333407215,"score_spread":0.28108004650207696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W338936873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99393415,0.00022298444,0.00009900223,0.0000865958,0.000026110594,0.0046617524,0.00084241503,0.0000710989,0.000055868357],"genre_scores_gemma":[0.99687064,0.00020980631,0.0008351182,0.000031968644,0.00010686406,0.0010598437,0.00046998088,0.00011186396,0.00030390423],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99477285,0.0008792152,0.0014334023,0.0009026151,0.0013488717,0.000663045],"domain_scores_gemma":[0.995167,0.0019492548,0.0010053687,0.00079632964,0.0006077447,0.0004742825],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008620099,0.00069438474,0.0034229963,0.0010775813,0.00011594548,0.000035614004,0.00035448524,0.00007500653,0.000657066],"category_scores_gemma":[0.0006584477,0.0004383075,0.00015121751,0.002006454,0.0011058545,0.0002458211,0.00020446182,0.0006558419,0.0000037929804],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.84118754,0.026982926,0.10719194,0.00037346355,0.01163555,0.0027311018,0.0051100757,0.000696628,0.00091947545,0.00000830899,0.0006988121,0.002464184],"study_design_scores_gemma":[0.78813684,0.15380153,0.044820387,0.0005845467,0.0036853938,0.00030434754,0.0041628783,0.0023813453,0.0015436149,0.000008025769,0.00003324121,0.0005378356],"about_ca_topic_score_codex":0.0025199242,"about_ca_topic_score_gemma":0.0058702994,"teacher_disagreement_score":0.1268186,"about_ca_system_score_codex":0.00063679746,"about_ca_system_score_gemma":0.001967925,"threshold_uncertainty_score":0.9998069},"labels":[],"label_agreement":null},{"id":"W34295218","doi":"10.1182/blood.v122.21.355.355","title":"Gemtuzumab Ozogamicin (GO) In Children With De Novo Acute Myeloid Leukemia (AML) Improves Event-Free Survival (EFS) By Reducing Relapse Risk – Results From The Randomized Phase III Children’s Oncology Group (COG) Trial, AAML0531","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Hospital for Sick Children","funders":"","keywords":"Medicine; Gemtuzumab ozogamicin; Induction chemotherapy; Internal medicine; Oncology; Chemotherapy regimen; Chemotherapy; Randomized controlled trial; Myeloid leukemia; Leukemia; Surgery; Stem cell","score_opus":0.009068426536026344,"score_gpt":0.2710262027850045,"score_spread":0.26195777624897815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W34295218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824319,0.001192687,0.00024962713,0.00241219,0.0002468772,0.011394682,0.0010215468,0.00022831387,0.00082216173],"genre_scores_gemma":[0.9878473,0.0023628417,0.003224748,0.00060285564,0.0014163384,0.0013538189,0.0019034115,0.00022006902,0.0010686056],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99115604,0.0024337322,0.0019569464,0.0016226767,0.0011940558,0.0016365334],"domain_scores_gemma":[0.99244493,0.0030713195,0.0010150671,0.0026200332,0.00024612749,0.00060251117],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0049778214,0.0008781492,0.0024527148,0.00036016598,0.00041514845,0.00016806104,0.0015429996,0.00074006803,0.0001642872],"category_scores_gemma":[0.0044648126,0.0005722193,0.0004827072,0.00082444114,0.0007960704,0.00042155042,0.00063583785,0.0028670253,0.0001147159],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8965947,0.003603967,0.004329939,0.000015771895,0.0071586855,0.00021768949,0.0022819778,0.000027473678,0.05253005,0.000039456798,0.02043328,0.012767019],"study_design_scores_gemma":[0.9674126,0.0043800627,0.013192989,0.0001978891,0.003678427,0.00049896777,0.0003346756,0.0006182945,0.008584712,0.00021449337,0.00022015785,0.00066675426],"about_ca_topic_score_codex":0.06640956,"about_ca_topic_score_gemma":0.001262222,"teacher_disagreement_score":0.07081789,"about_ca_system_score_codex":0.0017069395,"about_ca_system_score_gemma":0.002433915,"threshold_uncertainty_score":0.99967295},"labels":[],"label_agreement":null},{"id":"W343231960","doi":"10.1182/blood.v122.21.1365.1365","title":"Defining Functional Heterogeneity In Acute Lymphoblastic Leukemia","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Acute lymphocytic leukemia; Transplantation; clone (Java method); Leukemia; Medicine; Somatic evolution in cancer; Oncology; Immunophenotyping; Disease; Minimal residual disease; Cytogenetics; Acute leukemia; Immunology; Cancer; Biology; Internal medicine; Lymphoblastic Leukemia; Genetics; Antigen; Chromosome; Gene","score_opus":0.014424069967158377,"score_gpt":0.25910928982061987,"score_spread":0.2446852198534615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W343231960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99411285,0.00021951257,0.00043081955,0.0002548489,0.00011309454,0.00039437664,0.00000829254,0.00009482567,0.0043714046],"genre_scores_gemma":[0.9964937,0.000029344475,0.0018114942,0.00056062354,0.00013966813,0.00015169106,0.000048614875,0.00004058231,0.0007242857],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99809057,0.000048262693,0.0003409283,0.00040598479,0.0005367813,0.0005774541],"domain_scores_gemma":[0.9989448,0.000223881,0.000054284697,0.0003682059,0.00012987328,0.0002789129],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016628802,0.00020325748,0.000335844,0.00023606687,0.000067402354,0.000040936102,0.0001346562,0.00016378361,0.0007482382],"category_scores_gemma":[0.0002486791,0.00017636851,0.00010097914,0.00038534158,0.00010116568,0.00015640414,0.00013518415,0.00027013285,0.002374525],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008003019,0.0024270532,0.8293827,0.0003701141,0.0016362466,0.0023393636,0.00041923742,0.0003527636,0.13264409,0.0019969253,0.018265322,0.009365847],"study_design_scores_gemma":[0.024376702,0.00057104585,0.93011165,0.0002225976,0.0003805422,0.0023904485,0.00008936204,0.00809108,0.032357812,0.00038310236,0.00059003965,0.00043560806],"about_ca_topic_score_codex":0.00033069443,"about_ca_topic_score_gemma":0.000028546136,"teacher_disagreement_score":0.10072892,"about_ca_system_score_codex":0.00086507486,"about_ca_system_score_gemma":0.0011351937,"threshold_uncertainty_score":0.99840224},"labels":[],"label_agreement":null},{"id":"W345840093","doi":"10.1182/blood.v96.13.4118","title":"Evidence that ceramide mediates the ability of tumor necrosis factor to modulate primitive human hematopoietic cell fates","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Ceramide; CD38; Cell biology; Stem cell factor; Haematopoiesis; Biology; Tumor necrosis factor alpha; Stromal cell; CD34; Intracellular; Stem cell; Apoptosis; Cancer research; Immunology; Biochemistry","score_opus":0.021435897389745287,"score_gpt":0.2513492747550544,"score_spread":0.22991337736530915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W345840093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975502,0.0016951414,0.000047466663,0.00008815386,0.00005039439,0.0002869738,0.00003375849,0.000013826425,0.0002340687],"genre_scores_gemma":[0.999033,0.00020072331,0.00022400965,0.00023407915,0.00013199203,0.000030650757,0.000011214201,0.000019308942,0.00011502386],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99887866,0.00008478932,0.00024233652,0.00035419234,0.00018447047,0.00025554825],"domain_scores_gemma":[0.9991861,0.000065045984,0.0001065012,0.00047834794,0.000071227085,0.00009276799],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021554941,0.0001717704,0.00021804003,0.0000216882,0.00011035153,0.000030807332,0.0003359797,0.000070950206,0.00016364372],"category_scores_gemma":[0.00013226313,0.00012406446,0.00012748857,0.00008987525,0.00010468562,0.0000073333617,0.00008831065,0.00008197653,0.000012946875],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002572095,0.00012985399,0.011040052,0.00004224898,0.000028417115,9.633718e-7,0.00058486406,0.000056814886,0.98766863,0.000009456838,0.000030310173,0.0003826518],"study_design_scores_gemma":[0.00036837067,0.00010113394,0.07278455,0.000044748555,0.000058101927,0.0000033897006,0.00008543002,0.0000062220574,0.9260692,0.000094480136,0.00023948793,0.00014488024],"about_ca_topic_score_codex":0.00010691079,"about_ca_topic_score_gemma":0.000010645821,"teacher_disagreement_score":0.061744496,"about_ca_system_score_codex":0.000004340454,"about_ca_system_score_gemma":0.000034419743,"threshold_uncertainty_score":0.5059202},"labels":[],"label_agreement":null},{"id":"W348899769","doi":"10.1182/blood.v122.21.5078.5078","title":"Indolent Non-Hodgkin Lymphoma: Skeletal Muscle Density Predicts Overall Survival With Rituximab Based Chemotherapy","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Sarcopenia; Internal medicine; Diffuse large B-cell lymphoma; Lymphoma; Oncology; Chemotherapy regimen; Skeletal muscle; Rituximab; Chemotherapy; International Prognostic Index","score_opus":0.01353792291167666,"score_gpt":0.2531683195751018,"score_spread":0.23963039666342512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W348899769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930785,0.000088884044,0.0005504422,0.0029921837,0.00014200395,0.00080419274,0.0000070248816,0.00015045993,0.0021863102],"genre_scores_gemma":[0.9892533,0.00003684012,0.00506353,0.004961596,0.00035557785,0.000066366265,0.0000349477,0.0000405515,0.00018732049],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985795,0.000044254903,0.0002520488,0.0003144162,0.00040792787,0.0004018775],"domain_scores_gemma":[0.9990593,0.000046473993,0.000086010274,0.00033646284,0.00016027223,0.00031146107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001803572,0.00019332209,0.0003735598,0.000093910276,0.00011118621,0.000031738287,0.000081750004,0.00010812527,0.0004172202],"category_scores_gemma":[0.00001794062,0.00015851924,0.00007785457,0.00013420792,0.00006888458,0.00009191192,0.000019790554,0.00016434013,0.0001459306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020830852,0.05755948,0.7647162,0.0045592394,0.00092958997,0.0010526167,0.0023916091,0.000010866147,0.05635403,0.00056000735,0.02552512,0.08425816],"study_design_scores_gemma":[0.06416068,0.00077227055,0.9196487,0.00034763507,0.00009588909,0.00007069338,0.0000583834,0.0007145155,0.009318255,0.000070978,0.004499782,0.000242238],"about_ca_topic_score_codex":0.00027951377,"about_ca_topic_score_gemma":0.00002644811,"teacher_disagreement_score":0.15493248,"about_ca_system_score_codex":0.00006106964,"about_ca_system_score_gemma":0.00020605467,"threshold_uncertainty_score":0.6464227},"labels":[],"label_agreement":null},{"id":"W379374868","doi":"10.1182/blood.v124.21.5527.5527","title":"Impact of Transition to Generic Imatinib in the Molecular Response Among Patients with Chronic Myeloid Leukemia","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Imatinib; Imatinib mesylate; Medicine; Myeloid leukemia; Internal medicine; Tyrosine-kinase inhibitor; Oncology; Pharmacology; Cancer","score_opus":0.00601177962925511,"score_gpt":0.23820856781201355,"score_spread":0.23219678818275843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W379374868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984533,0.00007429722,0.00019800485,0.00008685465,0.000013092858,0.0008890083,0.000015486752,0.00002175528,0.0002481653],"genre_scores_gemma":[0.99914604,0.000004145035,0.0004997054,0.00013669276,0.00003593569,0.00007534239,0.000056767385,0.000030638505,0.000014699335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985991,0.0002194009,0.00026475536,0.0002491849,0.00038177395,0.000285762],"domain_scores_gemma":[0.9991202,0.00009599912,0.00009142729,0.0005226984,0.00006737331,0.00010231654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032325642,0.00019042668,0.00030605902,0.00014534297,0.000028675106,0.000009166881,0.00012778351,0.00007133664,0.000042692158],"category_scores_gemma":[0.00009579922,0.000116021605,0.000107525055,0.0004022693,0.000054606717,0.0000556379,0.000015426765,0.00014255293,0.000016339583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008561622,0.0039728717,0.8399544,0.0003227087,0.0009240067,0.00026251512,0.0076945927,0.00612623,0.121891126,0.000038802125,0.00024928994,0.010001866],"study_design_scores_gemma":[0.014895415,0.004282795,0.9715575,0.00018974663,0.00023026094,0.00002253912,0.000023310253,0.00032137148,0.008319244,0.0000067315923,0.000027641108,0.0001234446],"about_ca_topic_score_codex":0.00039927624,"about_ca_topic_score_gemma":0.00006059075,"teacher_disagreement_score":0.13160314,"about_ca_system_score_codex":0.0009239522,"about_ca_system_score_gemma":0.0005510549,"threshold_uncertainty_score":0.47312236},"labels":[],"label_agreement":null},{"id":"W394742526","doi":"10.1182/blood.v122.21.3185.3185","title":"Efficacy and Safety Of Pomalidomide Plus Low-Dose Dexamethasone In Advanced Multiple Myeloma: Results Of Randomized Phase 2 and 3 Trials (MM-002/MM-003)","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Vancouver General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Pomalidomide; Dexamethasone; Multiple myeloma; Medicine; Randomized controlled trial; Internal medicine; Oncology; Nuclear medicine; Lenalidomide","score_opus":0.03229036244339042,"score_gpt":0.33606534210989253,"score_spread":0.30377497966650213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W394742526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907331,0.0029865012,0.00004107862,0.00021189779,0.000037570295,0.0053325766,0.00024376942,0.00002560674,0.00038789818],"genre_scores_gemma":[0.9918555,0.0013030367,0.006201087,0.000020527606,0.000046192978,0.00023234358,0.00013099468,0.000030188065,0.00018014737],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99627674,0.0008152549,0.0015819375,0.00046937575,0.00043044094,0.0004262795],"domain_scores_gemma":[0.9929197,0.005536377,0.0005327511,0.00045781187,0.00019239704,0.00036096445],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0024230897,0.000293939,0.0024999166,0.00031911823,0.00004599535,0.000016884173,0.00009667044,0.0001444992,0.00008287022],"category_scores_gemma":[0.017911674,0.00021196505,0.0001973171,0.00029107594,0.00035768998,0.00014793093,0.00009940491,0.00019551069,0.000006454696],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7428012,0.005461927,0.006049109,0.0004995804,0.0012765531,0.00017100635,0.00091876806,0.000011648658,0.18053952,0.00002328028,0.0000469481,0.062200487],"study_design_scores_gemma":[0.8584936,0.0008717014,0.03946551,0.00047384828,0.00043256805,0.000031859636,0.0001190461,0.00083071063,0.09903938,0.000049462393,0.000041474337,0.00015078773],"about_ca_topic_score_codex":0.0010223213,"about_ca_topic_score_gemma":0.00006542104,"teacher_disagreement_score":0.115692474,"about_ca_system_score_codex":0.00003884347,"about_ca_system_score_gemma":0.00015042257,"threshold_uncertainty_score":0.99036086},"labels":[],"label_agreement":null},{"id":"W398314045","doi":"10.1182/blood.v124.21.3585.3585","title":"Timing of the Loss of Pten Is Critical in Determining the Disease Phenotype in Mice- a Mouse Model for Pediatric Mixed MDS/MPN","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"","keywords":"PTEN; Biology; Myeloid; Phenotype; Cancer research; Epigenetics; Myeloid leukemia; Somatic cell; Germline mutation; Germline; Immunology; Mutation; Genetics; PI3K/AKT/mTOR pathway; Gene","score_opus":0.032716894905506416,"score_gpt":0.30989997042903367,"score_spread":0.2771830755235273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W398314045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99740565,0.000104045495,0.0004862016,0.0012929044,0.000018693168,0.00050130073,0.00003730086,0.000006992601,0.00014694144],"genre_scores_gemma":[0.99818367,0.000015788633,0.0012347223,0.00026301874,0.00009815013,0.00005077714,0.0000031506117,0.000025008398,0.00012571516],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99880594,0.00008803182,0.00032632193,0.00019260983,0.0002939943,0.00029310718],"domain_scores_gemma":[0.99864185,0.00069769967,0.000063268555,0.00037897666,0.00012903473,0.000089156994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050546246,0.00010361952,0.0002559529,0.0001231622,0.00003456103,0.000005928371,0.00027453736,0.00006822506,0.000007500052],"category_scores_gemma":[0.0024693755,0.00006414955,0.00009669294,0.00024920853,0.00012381682,0.00004167473,0.0001371589,0.00023264113,0.0000019724218],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001261209,0.0026711707,0.9665791,0.0025096769,0.00007998985,0.000022821538,0.0052991807,0.0005986217,0.015886102,0.0011476679,0.00096759683,0.0029769123],"study_design_scores_gemma":[0.014050417,0.00023085607,0.1796937,0.00022987042,0.00065165357,0.000004922308,0.0002989997,0.78499526,0.01846358,0.0011246947,0.000025937821,0.00023008285],"about_ca_topic_score_codex":0.000044734923,"about_ca_topic_score_gemma":0.000027527654,"teacher_disagreement_score":0.7868853,"about_ca_system_score_codex":0.000042806267,"about_ca_system_score_gemma":0.00029769915,"threshold_uncertainty_score":0.29562515},"labels":[],"label_agreement":null},{"id":"W401489608","doi":"10.1182/blood-2010-09-295212","title":"Pseudothrombocytopenia","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; Complete blood count; Internal medicine; Gastroenterology; Physical examination; Bone marrow examination; Platelet; Aspirin; Anticoagulant; White blood cell; Bone marrow; Surgery","score_opus":0.03310605239312965,"score_gpt":0.2518932366897211,"score_spread":0.21878718429659144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W401489608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8595421,0.00014402738,0.0000048463016,0.000035013007,0.000025746263,0.00008656668,0.0000015412562,0.0000375917,0.14012258],"genre_scores_gemma":[0.9970015,0.000027000977,0.0016545043,0.00018047537,0.000017375225,0.000006362667,0.0000052664436,0.000008329784,0.0010991826],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996921,0.000003338899,0.000057003792,0.00008990489,0.00005562094,0.00010205505],"domain_scores_gemma":[0.9997888,0.000002803149,0.000012587997,0.00012645416,0.000011926021,0.00005739141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000015465419,0.0000527015,0.00011878537,0.000020629,0.000020159443,0.0000023594407,0.00002592806,0.0000280195,0.00065651885],"category_scores_gemma":[0.0000057464536,0.000040163082,0.000034118068,0.000042120602,0.000014791374,0.000024626786,0.000010080701,0.00003361443,0.00042896162],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003253128,0.015927657,0.9265512,0.00009580474,0.00158645,0.012970339,0.00232669,2.5654673e-8,0.018015685,0.0035517348,0.0042575966,0.014391472],"study_design_scores_gemma":[0.017988002,0.001188424,0.8398134,0.000059530852,0.0009523282,0.0020606553,0.000113037706,0.000004026639,0.13011692,0.0021529612,0.005296482,0.00025421852],"about_ca_topic_score_codex":0.00004011509,"about_ca_topic_score_gemma":0.0000044852095,"teacher_disagreement_score":0.1390234,"about_ca_system_score_codex":0.0000032628532,"about_ca_system_score_gemma":0.000016462041,"threshold_uncertainty_score":0.7188421},"labels":[],"label_agreement":null},{"id":"W4200051856","doi":"10.1182/blood-2021-154179","title":"Efficacy of Oral Decitabine/Cedazuridine (ASTX727) in the CMML Subgroup from the Ascertain Phase 3 Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Health Sciences Centre; Sunnybrook Health Science Centre; Hôpital Maisonneuve-Rosemont; University of Alberta; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Decitabine; Medicine; Internal medicine; Oncology; Biology; Genetics","score_opus":0.035805484142917565,"score_gpt":0.3477579079077924,"score_spread":0.3119524237648748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200051856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927042,0.00078554096,0.000017867325,0.004452496,0.000054712134,0.001014436,0.000036384856,0.000022585871,0.0009117786],"genre_scores_gemma":[0.99845994,0.00004614965,0.0002961435,0.00056628446,0.0002460673,0.00006169676,0.000096732285,0.000029548633,0.00019745748],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99755704,0.0005615196,0.00041797792,0.00036405845,0.0007321285,0.00036726933],"domain_scores_gemma":[0.9972106,0.0013664762,0.00007524202,0.0010614448,0.00019596894,0.00009023409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010883008,0.00018278121,0.00041544292,0.00007310143,0.00007893758,0.000033358672,0.00048002435,0.00007317748,0.0003580951],"category_scores_gemma":[0.0017787603,0.00010063689,0.00011516462,0.0010472827,0.00011201009,0.000049364022,0.0001879897,0.0005866441,0.000044233493],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005708463,0.09437678,0.64411396,0.00014007688,0.0029283543,0.011754465,0.032705385,0.000028222536,0.148326,0.00079838024,0.025192076,0.033927813],"study_design_scores_gemma":[0.13436887,0.0029533547,0.7873049,0.00018869796,0.0012528563,0.0002558038,0.02086902,0.00033724803,0.043990143,0.0001671624,0.007953721,0.00035825252],"about_ca_topic_score_codex":0.0013482111,"about_ca_topic_score_gemma":0.0005755466,"teacher_disagreement_score":0.14319089,"about_ca_system_score_codex":0.000056413974,"about_ca_system_score_gemma":0.00048816096,"threshold_uncertainty_score":0.41038534},"labels":[],"label_agreement":null},{"id":"W4200100973","doi":"10.1182/blood-2021-148009","title":"Primary Analysis of ZUMA-12: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) As First-Line Therapy in Patients with High-Risk Large B-Cell Lymphoma (LBCL)","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Internal medicine; B-cell lymphoma; Oncology; Lymphoma","score_opus":0.013679287038108634,"score_gpt":0.27678842652890645,"score_spread":0.26310913949079784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200100973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969382,0.0008066711,0.000014789687,0.000041130323,0.00003088259,0.0011433265,0.00017592996,0.000025825888,0.0008232094],"genre_scores_gemma":[0.99740326,0.00076552987,0.00015960087,0.000098538956,0.000045493412,0.000060781174,0.00035998595,0.000059503767,0.0010472832],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99670666,0.00028181873,0.0007420079,0.00060873624,0.0012080552,0.00045272856],"domain_scores_gemma":[0.9976636,0.00018393132,0.00032803268,0.0011322306,0.0005080194,0.0001841947],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005099908,0.0002991794,0.0012126438,0.00069678936,0.000062188104,0.000014328411,0.00023290757,0.00012500012,0.0015347445],"category_scores_gemma":[0.00007863709,0.00024367373,0.00025618655,0.0022917453,0.000073901814,0.00006562243,0.00012743643,0.00022665701,0.000006561786],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066745393,0.21127781,0.7391284,0.00013720892,0.0053929375,0.00032780934,0.0020605256,0.00003500336,0.02229116,0.0000028443947,0.000023196924,0.012648551],"study_design_scores_gemma":[0.2391563,0.016342085,0.6418924,0.00007507315,0.002853234,0.0000037342927,0.0005101446,0.00008690343,0.098501444,0.000008356065,0.0003045764,0.00026574288],"about_ca_topic_score_codex":0.00096054014,"about_ca_topic_score_gemma":0.00082725537,"teacher_disagreement_score":0.23248176,"about_ca_system_score_codex":0.00009868094,"about_ca_system_score_gemma":0.00035146018,"threshold_uncertainty_score":0.99937797},"labels":[],"label_agreement":null},{"id":"W4200108738","doi":"10.1182/blood-2021-147983","title":"Cevostamab Monotherapy Continues to Show Clinically Meaningful Activity and Manageable Safety in Patients with Heavily Pre-Treated Relapsed/Refractory Multiple Myeloma (RRMM): Updated Results from an Ongoing Phase I Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":161,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Jewish General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Multiple myeloma; Cytokine release syndrome; Internal medicine; Lenalidomide; Adverse effect; Refractory (planetary science); Cohort; Oncology; Cancer; Immunotherapy; Chimeric antigen receptor","score_opus":0.017965553631843066,"score_gpt":0.3122577428817261,"score_spread":0.29429218924988304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200108738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962528,0.00007216958,0.00002169809,0.0001696907,0.00003611124,0.0024708877,0.0005772583,0.00012840335,0.00027103137],"genre_scores_gemma":[0.99627215,0.000044333727,0.001749263,0.00013336577,0.000054413085,0.00007359966,0.0012595035,0.00007221553,0.00034114558],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99653995,0.0004198769,0.0006638351,0.001148455,0.0006407333,0.00058714754],"domain_scores_gemma":[0.9975415,0.00045254876,0.00019263169,0.0009087772,0.0003229264,0.0005816542],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043590984,0.0003932346,0.0007857021,0.00019938116,0.00016295566,0.00010013552,0.0001462918,0.00015460757,0.000057607147],"category_scores_gemma":[0.000649726,0.00032226523,0.00006320516,0.00047976425,0.00006117364,0.00034996623,0.00012841877,0.00042469412,0.000011600257],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.063705415,0.03008841,0.86541176,0.000016762304,0.0008368787,0.0012355659,0.0017880191,0.0000050754497,0.0043860083,3.099906e-7,0.000036392466,0.032489378],"study_design_scores_gemma":[0.15905684,0.008520484,0.82524437,0.000204257,0.00019216214,0.000003074061,0.0003982301,0.00020184412,0.005730233,0.000002419813,0.00018301193,0.00026306833],"about_ca_topic_score_codex":0.0025825123,"about_ca_topic_score_gemma":0.0045171296,"teacher_disagreement_score":0.09535142,"about_ca_system_score_codex":0.00012176931,"about_ca_system_score_gemma":0.00017846658,"threshold_uncertainty_score":0.99992293},"labels":[],"label_agreement":null},{"id":"W4200115086","doi":"10.1182/blood-2021-149046","title":"Impact of Disease Extent and Distribution on Outcomes in Stage II Follicular Lymphoma Treated with Curative-Intent Radiation Therapy","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Follicular lymphoma; Stage (stratigraphy); Internal medicine; Disease; Radiation therapy; Lymphoma; Oncology; Cancer; B symptoms; Progression-free survival; Surgery; Chemotherapy","score_opus":0.013263577872438736,"score_gpt":0.2795579557964124,"score_spread":0.26629437792397365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200115086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99775314,0.0012623298,0.000005198465,0.0003655118,0.0000082306315,0.00037921048,0.00018253949,0.00001334675,0.000030460704],"genre_scores_gemma":[0.9986398,0.0007269291,0.000013061476,0.000042829877,0.000008085537,0.000060605722,0.00041592086,0.000008802024,0.00008392608],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99930966,0.00004156146,0.00015577192,0.00020213003,0.00016868426,0.00012218501],"domain_scores_gemma":[0.99952817,0.00003518297,0.00006801,0.00018475404,0.00006654348,0.000117317526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000032476222,0.00013963225,0.00027107474,0.000040189712,0.00003566597,0.000009643047,0.00001543084,0.00002849779,0.000024408275],"category_scores_gemma":[0.000033729248,0.00008129686,0.00010350287,0.00013034046,0.000023558501,0.000043348482,0.000010646727,0.000019162659,9.468864e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007007508,0.008671001,0.98289454,0.000012963687,0.00045941645,0.00037282315,0.00011458549,0.000011060697,0.00055431115,0.00011917956,0.000010529746,0.006078812],"study_design_scores_gemma":[0.020518575,0.002237751,0.95551866,0.00010413871,0.00017460326,0.000010061027,0.00003789324,0.00004322359,0.021231672,0.0000062095824,0.000041177118,0.00007603007],"about_ca_topic_score_codex":0.00025827077,"about_ca_topic_score_gemma":0.000013227415,"teacher_disagreement_score":0.027375901,"about_ca_system_score_codex":0.00017402945,"about_ca_system_score_gemma":0.00013129051,"threshold_uncertainty_score":0.33151895},"labels":[],"label_agreement":null},{"id":"W4200116858","doi":"10.1182/blood-2021-147618","title":"Spleen and Symptom Responses with Fedratinib (FEDR) in Patients with Myelofibrosis (MF) and Substantial Splenomegaly","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Myelofibrosis; Ruxolitinib; Internal medicine; Gastroenterology; Placebo; Clinical trial; Spleen; Phases of clinical research; Surgery; Bone marrow; Pathology","score_opus":0.0063409982194134774,"score_gpt":0.21234891591118035,"score_spread":0.20600791769176688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200116858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99763024,0.000630041,0.000003122305,0.00051088515,0.000015436204,0.0004549282,0.000077794684,0.00002216808,0.00065535755],"genre_scores_gemma":[0.9974385,0.0001833206,0.001858184,0.00016258028,0.00003175523,0.000057908266,0.00009066515,0.000022511693,0.0001546064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987862,0.00006793129,0.00020135035,0.00045115955,0.000257449,0.0002358714],"domain_scores_gemma":[0.99929214,0.00014204324,0.00006296571,0.0002191026,0.000129488,0.00015424419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007221098,0.00021741525,0.00039400285,0.0000930259,0.00008708973,0.00006290639,0.000024934943,0.00006264238,0.00006695295],"category_scores_gemma":[0.000043975386,0.00014732874,0.000021184413,0.00019546584,0.000088539215,0.00009288265,0.0000364931,0.000108882836,0.000004486488],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015933058,0.0012607853,0.9947455,0.00006112945,0.00022475922,0.0003108519,0.00047439913,3.069922e-7,0.00030094569,0.00013183133,0.000027831995,0.0008683313],"study_design_scores_gemma":[0.017478894,0.002374387,0.9660774,0.00028454707,0.00032266096,0.000086225606,0.0001222029,0.0000024015803,0.012790309,0.0000075012795,0.00027481915,0.00017867328],"about_ca_topic_score_codex":0.00003779319,"about_ca_topic_score_gemma":0.00033591146,"teacher_disagreement_score":0.028668145,"about_ca_system_score_codex":0.000022485998,"about_ca_system_score_gemma":0.0001439361,"threshold_uncertainty_score":0.6007892},"labels":[],"label_agreement":null},{"id":"W4200137491","doi":"10.1182/blood.2021014559","title":"Suppression of fibrin(ogen)-driven pathologies in disease models through controlled knockdown by lipid nanoparticle delivery of siRNA","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Dental and Craniofacial Research; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Fibrinogen; Fibrin; Platelet; Coagulation; Immunology; Ex vivo; In vivo; Hemostasis; Chemistry; Proinflammatory cytokine; Immune system; Gene knockdown; Medicine; Inflammation; Pharmacology; Cancer research; Internal medicine; Biology; Apoptosis; In vitro; Biochemistry","score_opus":0.01641546061555888,"score_gpt":0.2488801387148349,"score_spread":0.232464678099276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200137491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936675,0.0051404163,0.000015642341,0.00020032923,0.000031480773,0.000307624,0.00013209297,0.000016385373,0.0004885566],"genre_scores_gemma":[0.9984474,0.000813071,0.0004192448,0.000056751353,0.000009501181,0.00002663337,0.00007448178,0.000011245926,0.00014166256],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990447,0.00006003975,0.00032360456,0.0002074443,0.00018075322,0.00018344935],"domain_scores_gemma":[0.9994076,0.00007684575,0.000099025114,0.0002615693,0.000084441075,0.000070505484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004143317,0.000118866665,0.00054246146,0.000031169864,0.000019811308,0.0000041727117,0.00005431439,0.000058349604,0.000055385663],"category_scores_gemma":[0.00009045758,0.00009285912,0.00012836172,0.00012246906,0.0000523827,0.000108682616,0.00006319242,0.000055230266,0.00000351183],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029248612,0.011187557,0.10821073,0.00027484482,0.00043042345,0.0024324094,0.00081362505,0.00049675367,0.87163305,0.00012304347,0.0005574964,0.0009151816],"study_design_scores_gemma":[0.06595909,0.0007099683,0.020021176,0.0005271128,0.00092417,0.000062059924,0.0003531474,0.0026960399,0.9067746,0.0016320458,0.00011943553,0.00022117743],"about_ca_topic_score_codex":0.000042961932,"about_ca_topic_score_gemma":0.0000064062183,"teacher_disagreement_score":0.08818955,"about_ca_system_score_codex":0.00000987832,"about_ca_system_score_gemma":0.00009598363,"threshold_uncertainty_score":0.3786685},"labels":[],"label_agreement":null},{"id":"W4200139163","doi":"10.1182/blood.2021013998","title":"Limited-stage diffuse large B-cell lymphoma","year":2021,"lang":"en","type":"review","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Diffuse large B-cell lymphoma; Rituximab; Medicine; Vincristine; Oncology; Radiation therapy; Lymphoma; Clinical trial; Internal medicine; Population; Stage (stratigraphy); Cyclophosphamide; Chemotherapy; Biology","score_opus":0.036066013690203194,"score_gpt":0.30855543925608303,"score_spread":0.27248942556587985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200139163","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005010047,0.9861629,9.275273e-7,0.000027959244,0.00021663611,0.0008786675,0.00033267954,0.000115289746,0.011763937],"genre_scores_gemma":[0.00008430327,0.98499113,0.00017808848,0.00023040216,0.00038264197,0.00034292752,0.0013647127,0.00011785159,0.012307937],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977681,0.00011084797,0.00057261845,0.0006815371,0.00035501196,0.0005118892],"domain_scores_gemma":[0.9981525,0.00018592559,0.00025317247,0.0010247779,0.00006925261,0.00031439663],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00010238225,0.0006069764,0.0024714407,0.00016212517,0.00008237485,0.000060082904,0.00016048661,0.0004414201,0.0003438377],"category_scores_gemma":[0.00006268124,0.000435273,0.0012577075,0.00034859375,0.000024945695,0.000031485055,0.00016716326,0.00014324073,0.00079811894],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000050850217,0.09111425,0.0003835956,0.026085,0.0020834887,0.009465124,0.00005229147,2.9725222e-9,4.7416682e-7,0.00043429213,0.005588849,0.8647875],"study_design_scores_gemma":[0.020680357,0.00017431629,0.0000543555,0.011905955,0.010722459,0.0004787509,0.000015361147,2.439366e-7,0.000044012148,7.250106e-7,0.9555707,0.00035273976],"about_ca_topic_score_codex":0.000017535063,"about_ca_topic_score_gemma":0.000004833213,"teacher_disagreement_score":0.94998187,"about_ca_system_score_codex":0.00019292593,"about_ca_system_score_gemma":0.00073877577,"threshold_uncertainty_score":0.99997985},"labels":[],"label_agreement":null},{"id":"W4200196470","doi":"10.1182/blood-2021-152223","title":"Cardiac Arrhythmias and Mortality after Hematopoietic Stem Cell Transplant (HSCT): A Systematic Review and Meta-Analysis","year":2021,"lang":"en","type":"review","venue":"Blood","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Incidence (geometry); Atrial fibrillation; Meta-analysis; Hematopoietic stem cell transplantation; Transplantation","score_opus":0.04831602080406193,"score_gpt":0.3043785486126757,"score_spread":0.25606252780861377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200196470","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003887939,0.9953814,0.000021226926,0.000050791514,0.000023322436,0.0036187128,0.000332972,0.000036079084,0.0001467031],"genre_scores_gemma":[0.0018793521,0.99575466,0.00004527195,0.0003246092,0.00005942791,0.0011870444,0.00018384263,0.000055801665,0.00050997303],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99672574,0.00067702075,0.0011644426,0.00074186665,0.0004393345,0.00025162566],"domain_scores_gemma":[0.99807686,0.00017334419,0.00043886784,0.0009885563,0.00008819309,0.00023420478],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008624971,0.00061964634,0.013484631,0.00016115261,0.000047107373,0.000057243724,0.000071558236,0.00035081097,0.000080664635],"category_scores_gemma":[0.000014475659,0.00042106723,0.0046419674,0.00058318936,0.0000547726,0.000048320497,0.000031607968,0.00037183875,0.000007669898],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[7.86921e-7,0.000063857784,0.000003190426,0.809579,0.18973608,0.0002126878,0.00013739173,9.778902e-9,0.0000032449684,0.0000067743686,0.0000063348457,0.00025064935],"study_design_scores_gemma":[0.0002457021,0.000025416986,0.000002665317,0.0720825,0.92338955,0.0007684544,0.000026758655,1.40481e-7,0.0001396807,0.000001750599,0.0029795833,0.00033778689],"about_ca_topic_score_codex":0.000008682997,"about_ca_topic_score_gemma":0.000004193999,"teacher_disagreement_score":0.7374965,"about_ca_system_score_codex":0.00003402499,"about_ca_system_score_gemma":0.00014093533,"threshold_uncertainty_score":0.9998241},"labels":[],"label_agreement":null},{"id":"W4200275091","doi":"10.1182/blood-2021-148230","title":"Spectrum of Myeloid Mutations in Patients with Elevated Hemoglobin","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Medicine; Internal medicine; Genetic testing; Population; Hemoglobin; Incidence (geometry); Oncology; Genetics; Biology","score_opus":0.006602397248185671,"score_gpt":0.22132343824818843,"score_spread":0.21472104100000275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200275091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975186,0.0000846439,0.000005384536,0.00048471126,0.0000182937,0.00027314946,0.000025432644,0.000012685249,0.0015770892],"genre_scores_gemma":[0.9985031,0.000015895559,0.0010142992,0.00009196708,0.00001429714,0.000031567084,0.00017285871,0.000010696515,0.00014533092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99933237,0.00002351854,0.00017541123,0.00016694846,0.00017335181,0.00012839962],"domain_scores_gemma":[0.99958575,0.00003671937,0.000048586535,0.00015861575,0.000116130774,0.00005421178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000026497817,0.00008985012,0.00021963498,0.000060064645,0.000019133204,0.0000049491655,0.000020079642,0.000031910913,0.00020459245],"category_scores_gemma":[0.000044355023,0.000068069996,0.000031720392,0.00029403338,0.000023127242,0.000027172924,0.000012452726,0.00006363261,0.000014666904],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006972972,0.004180284,0.9942069,0.000028082508,0.0001445758,0.000107857886,0.00013821763,0.000005044525,0.0006175219,0.00029608922,0.000026663298,0.00017902696],"study_design_scores_gemma":[0.009181234,0.0004960128,0.825781,0.00009945073,0.00012985201,0.000009972031,0.000039333743,0.0000036462393,0.16409464,0.00005361013,0.000056099343,0.000055183707],"about_ca_topic_score_codex":0.000020783367,"about_ca_topic_score_gemma":0.00013432764,"teacher_disagreement_score":0.16842595,"about_ca_system_score_codex":0.000026993781,"about_ca_system_score_gemma":0.00012741386,"threshold_uncertainty_score":0.2775814},"labels":[],"label_agreement":null},{"id":"W4200312704","doi":"10.1182/blood-2021-146940","title":"Efficacy of Daratumumab, Lenalidomide, and Dexamethasone in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma and Impaired Renal Function from the Phase 3 Maia Study Based on Lenalidomide Starting Dose","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Alberta; University of Calgary","funders":"","keywords":"Lenalidomide; Medicine; Multiple myeloma; Daratumumab; Dexamethasone; Internal medicine; Carfilzomib; Oncology; Phases of clinical research; Renal function; Bortezomib; Urology; Toxicity","score_opus":0.020433083204420964,"score_gpt":0.2753407263694819,"score_spread":0.254907643165061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200312704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975758,0.00038439306,0.00007863599,0.0001375406,0.00002321521,0.0015506615,0.00019314462,0.000025753183,0.00003086244],"genre_scores_gemma":[0.99854064,0.000034962286,0.0008026973,0.00010602596,0.000046017067,0.000085732296,0.00034184323,0.000030901152,0.000011191027],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99782586,0.0003440748,0.0004231692,0.0005108129,0.0005413571,0.0003547004],"domain_scores_gemma":[0.9976202,0.0014957027,0.0001340216,0.0004048431,0.00013080265,0.00021441383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003217496,0.00026349552,0.0004964313,0.00013133186,0.00013559652,0.00004461119,0.000066114226,0.00006649544,0.000029747907],"category_scores_gemma":[0.00055574364,0.0001684833,0.00006033659,0.00034106002,0.000088983266,0.0000956619,0.000033200853,0.00024981587,0.0000017612509],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036018573,0.01176266,0.93423384,0.000052081086,0.0004740708,0.0007266877,0.0008425527,0.000047771326,0.007153678,0.0000011587908,0.00001548246,0.008671467],"study_design_scores_gemma":[0.22319175,0.0030052683,0.7589551,0.00038181792,0.00045592876,0.0000045385004,0.00031523342,0.0010979053,0.012454671,0.0000055676164,0.000007651869,0.00012453126],"about_ca_topic_score_codex":0.0010835232,"about_ca_topic_score_gemma":0.0016517158,"teacher_disagreement_score":0.18717317,"about_ca_system_score_codex":0.000032788226,"about_ca_system_score_gemma":0.00014638064,"threshold_uncertainty_score":0.68705493},"labels":[],"label_agreement":null},{"id":"W4200335416","doi":"10.1182/blood-2021-153871","title":"A BCL2L1 Armoured BCMA Targeting CAR T Cell to Overcome Exhaustion and Enhance Persistence in Multiple Myeloma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Chimeric antigen receptor; CD28; TIGIT; CD19; T cell; Antigen; Immunology; Cancer research; Biology; Medicine; Immune system","score_opus":0.025327477432969377,"score_gpt":0.2788545808456693,"score_spread":0.2535271034126999,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200335416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99556136,0.0018350808,0.00004229578,0.0005472713,0.00005346594,0.00033735283,0.00000543514,0.000029596822,0.0015881279],"genre_scores_gemma":[0.99190074,0.00016802293,0.0024682544,0.00020765801,0.0001303667,0.00003075597,0.000014918852,0.000023288363,0.005055989],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987309,0.000065939006,0.0001892608,0.00038540352,0.0002964291,0.00033206816],"domain_scores_gemma":[0.9992989,0.00012322247,0.000029367586,0.00024928022,0.00011512245,0.00018410696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025952296,0.00012057186,0.00023503127,0.000105722655,0.00005516686,0.000027394293,0.00006575627,0.00008002767,0.00041863322],"category_scores_gemma":[0.00038728656,0.00012551433,0.000055546403,0.0003714789,0.0000330908,0.00005216477,0.00008936677,0.00024247452,0.000033597964],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012470239,0.0003042435,0.05037184,0.00012722227,0.000019130795,0.00032565842,0.0016224819,0.000007442447,0.9446571,0.0000018519036,0.00008872679,0.0023496156],"study_design_scores_gemma":[0.0036767705,0.00023584209,0.09471081,0.00016767147,0.00004308581,0.00008688998,0.001329736,0.0002870429,0.89713883,0.000010613101,0.0021393374,0.00017339064],"about_ca_topic_score_codex":0.00008142122,"about_ca_topic_score_gemma":0.00008981612,"teacher_disagreement_score":0.047518276,"about_ca_system_score_codex":0.00006458909,"about_ca_system_score_gemma":0.000097657015,"threshold_uncertainty_score":0.5118326},"labels":[],"label_agreement":null},{"id":"W4200358412","doi":"10.1182/blood.2021013172","title":"B-lymphoblastic lymphoma presenting as a primary breast mass with periductal invasion","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Lymphoma; Primary (astronomy); Lymphoblastic lymphoma; Pathology; Oncology; Internal medicine; Immunology","score_opus":0.007800158083805725,"score_gpt":0.21390528073572543,"score_spread":0.20610512265191971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200358412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826989,0.00078274426,0.00000899531,0.0005918008,0.00008049666,0.00023894856,0.000014871759,0.00008714694,0.015496057],"genre_scores_gemma":[0.99624807,0.00007231064,0.0016949719,0.0004155876,0.0002510425,0.000064656786,0.00010958623,0.00003768762,0.0011061127],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986085,0.000035160898,0.00019505729,0.00042522815,0.00041661263,0.0003194099],"domain_scores_gemma":[0.99914294,0.00007422104,0.000066373315,0.00037913243,0.00013107907,0.00020623705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000047850088,0.00020857519,0.00031566806,0.000054360968,0.00010911586,0.000059454665,0.00005900498,0.000070440714,0.00021788543],"category_scores_gemma":[0.00004647455,0.00015407865,0.00011012249,0.0002247221,0.00005172986,0.000092491355,0.00007814006,0.000042070333,0.00014592703],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046270312,0.010541182,0.89856917,0.00050361716,0.0012795103,0.025076143,0.0005899476,0.000004400592,0.05041709,0.000469814,0.00041960226,0.011666793],"study_design_scores_gemma":[0.02315124,0.00057079794,0.8166073,0.0006199548,0.0011687605,0.034411203,0.00040489555,0.000026165912,0.12155103,0.00006192711,0.0011150446,0.00031170298],"about_ca_topic_score_codex":0.000049494352,"about_ca_topic_score_gemma":0.0000066633547,"teacher_disagreement_score":0.081961915,"about_ca_system_score_codex":0.00013314249,"about_ca_system_score_gemma":0.0006868974,"threshold_uncertainty_score":0.6283145},"labels":[],"label_agreement":null},{"id":"W4200362686","doi":"10.1182/blood-2021-146245","title":"Post-Transplant Cyclophosphamide Versus Tacrolimus and Methotrexate to Prevent Graft-Versus-Host Disease in Recipients of Matched Donor Transplantation: Comparison of Sequential Cohorts in a Prospective Trial","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Busulfan; Regimen; Transplantation; Tacrolimus; Internal medicine; Fludarabine; Surgery; Cyclophosphamide; Graft-versus-host disease; Gastroenterology; Hematopoietic stem cell transplantation; Chemotherapy","score_opus":0.023368870023481057,"score_gpt":0.31477907823399043,"score_spread":0.2914102082105094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200362686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964722,0.00039570505,0.00012234754,0.00013933162,0.00040170268,0.0019356089,0.00031816136,0.000017739147,0.00019721688],"genre_scores_gemma":[0.997746,0.00033048738,0.0014771057,0.000015885096,0.00003485796,0.00013082163,0.00021853407,0.000024690607,0.000021649603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99775136,0.00019350843,0.0008821885,0.00045571677,0.0004440165,0.0002732286],"domain_scores_gemma":[0.99891335,0.00030442947,0.00017142278,0.00024470425,0.00014791549,0.0002181673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031699913,0.000220059,0.0007744698,0.00020993252,0.000021902713,0.000009416345,0.000073305404,0.000110876026,0.000043771866],"category_scores_gemma":[0.000093854025,0.00022612556,0.00010839065,0.00046288336,0.000060673425,0.000076099976,0.000015289193,0.00017194763,0.0000022835002],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29758576,0.0052289055,0.5986406,0.001970784,0.00041899778,0.0015007016,0.017861001,0.0001266967,0.07638075,0.000111438705,0.0000015021328,0.00017283662],"study_design_scores_gemma":[0.14037596,0.0013597886,0.54761064,0.0012629665,0.0012740268,0.000031015188,0.0004956463,0.000028613136,0.30732608,0.000022647208,0.0000033874633,0.00020925113],"about_ca_topic_score_codex":0.00035868312,"about_ca_topic_score_gemma":0.0012182028,"teacher_disagreement_score":0.23094533,"about_ca_system_score_codex":0.00006567831,"about_ca_system_score_gemma":0.00027210516,"threshold_uncertainty_score":0.92211324},"labels":[],"label_agreement":null},{"id":"W4200397657","doi":"10.1182/blood-2021-155156","title":"Efficacy of rFVIIIFc for First-Time Immune Tolerance Induction (ITI) Therapy: Final Results from the Global, Prospective VerITI-8 Study","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; McMaster Children's Hospital","funders":"","keywords":"Haemophilia; Interquartile range; Medicine; Haemophilia A; Factor IX; Internal medicine; Titer; Prospective cohort study; Pediatrics; Immunology; Antibody","score_opus":0.043793151820011755,"score_gpt":0.3188160811657789,"score_spread":0.27502292934576716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200397657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918621,0.0019247454,0.0000026560917,0.0034614725,0.00008868743,0.0017446824,0.00020440044,0.000029278379,0.0006819493],"genre_scores_gemma":[0.9983512,0.00016429811,0.00021402792,0.000049366023,0.00032130687,0.000110472436,0.00012806385,0.0000132180485,0.00064800284],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988211,0.00007021514,0.00027433678,0.000324108,0.00031020917,0.00020002463],"domain_scores_gemma":[0.9988208,0.00029482186,0.00006890626,0.00043760304,0.00032855963,0.000049352464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002060103,0.000126966,0.00029506595,0.000016809821,0.00015476832,0.000020617725,0.00010427628,0.000067958295,0.00006566307],"category_scores_gemma":[0.00043939656,0.00008092812,0.0001270551,0.00028281764,0.00007539457,0.00004360895,0.00004160607,0.00013074427,0.000017792916],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050656635,0.098186195,0.69869334,0.00019797233,0.009147088,0.00094511436,0.020991491,0.000042869506,0.08020594,0.0002788789,0.0056538666,0.03500063],"study_design_scores_gemma":[0.051100563,0.002304492,0.87001646,0.00017274798,0.00026757646,0.000024426352,0.0008317534,0.000020927055,0.07383536,0.00030797793,0.0010059269,0.000111810295],"about_ca_topic_score_codex":0.00016132978,"about_ca_topic_score_gemma":0.000034537064,"teacher_disagreement_score":0.17132312,"about_ca_system_score_codex":0.000049022427,"about_ca_system_score_gemma":0.0001728855,"threshold_uncertainty_score":0.3300153},"labels":[],"label_agreement":null},{"id":"W4200407778","doi":"10.1182/blood-2021-151493","title":"Updated Results of a Phase 1/2 Study of Lower Dose CPX-351 for Patients with Int-2 or High Risk IPSS Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia after Failure to Hypomethylating Agents","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cytarabine; Chronic myelomonocytic leukemia; Daunorubicin; Internal medicine; Azacitidine; Myelodysplastic syndromes; Hypomethylating agent; Gastroenterology; Leukemia; Oncology; Surgery; Bone marrow","score_opus":0.016715334186357175,"score_gpt":0.29344233401011716,"score_spread":0.27672699982376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200407778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99639463,0.00013289088,0.00006335133,0.00006766702,0.00006528002,0.0026539243,0.00056751893,0.000035596368,0.000019118896],"genre_scores_gemma":[0.99538165,0.000039652903,0.0036735886,0.000034376033,0.00007043247,0.0002329869,0.00019000923,0.00008036358,0.00029693628],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969593,0.00016781902,0.00082542107,0.00075660605,0.00073122245,0.00055962335],"domain_scores_gemma":[0.99723965,0.00052570074,0.00034620005,0.00075762626,0.00079543394,0.0003353631],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003638985,0.0003573855,0.0008859403,0.0003660572,0.0000890901,0.00003074757,0.0001868504,0.00015402153,0.00010323171],"category_scores_gemma":[0.0016715135,0.00026081534,0.000076381046,0.0010245123,0.000112607064,0.00014193081,0.0002968676,0.00037626168,0.0000069587945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3220735,0.08492725,0.3766701,0.00954165,0.022095706,0.011277693,0.03370293,0.0009481593,0.043289088,0.00001525881,0.0048073903,0.0906513],"study_design_scores_gemma":[0.4124487,0.096388936,0.45099103,0.002193863,0.005389935,0.00021316289,0.00309716,0.0013909513,0.025945684,0.000020065194,0.00086407136,0.0010564396],"about_ca_topic_score_codex":0.00021168585,"about_ca_topic_score_gemma":0.00037079921,"teacher_disagreement_score":0.09037524,"about_ca_system_score_codex":0.00042729697,"about_ca_system_score_gemma":0.0011796289,"threshold_uncertainty_score":0.9999844},"labels":[],"label_agreement":null},{"id":"W4200440558","doi":"10.1182/blood-2021-153847","title":"Inhibition of PINK1-Dependent Mitochondrial Quality Control Pathways Induces Senescence of Acute Myeloid Leukemia Stem Cells","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"PINK1; Mitophagy; Mitochondrion; Stem cell; Biology; Cell biology; Myeloid leukemia; Haematopoiesis; Cancer research; Apoptosis; Biochemistry; Autophagy","score_opus":0.02732148597733019,"score_gpt":0.28197719616800626,"score_spread":0.25465571019067607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200440558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99640334,0.00030828718,0.0006924816,0.000243181,0.0002769214,0.0006194314,0.00036864055,0.00004901865,0.0010386923],"genre_scores_gemma":[0.9975231,0.00021428021,0.0011745264,0.00013637607,0.00032131316,0.000032348675,0.000058339756,0.000033904464,0.0005058104],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968166,0.00035467505,0.00088054367,0.0004990334,0.0010391216,0.00041007847],"domain_scores_gemma":[0.9976671,0.00028255492,0.0003855451,0.0007030247,0.0007440395,0.00021773459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052456924,0.00023569608,0.00081858336,0.00014282633,0.00005563912,0.000017452217,0.00017702818,0.00028561655,0.00010481989],"category_scores_gemma":[0.00014297158,0.0002176959,0.00024321921,0.0004052878,0.00017216506,0.00012296783,0.00015243249,0.00048617818,0.000030630123],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053840294,0.0006412378,0.0013627869,0.00042782893,0.00048300062,0.0003815185,0.00048406146,0.0000057996413,0.9942488,0.00026780833,0.00019201911,0.00096671993],"study_design_scores_gemma":[0.013574211,0.00037730474,0.0029247375,0.0002738269,0.000516563,0.00011934097,0.0005570844,0.00003160757,0.98132074,0.00006353653,0.00006451138,0.00017651862],"about_ca_topic_score_codex":0.00015760236,"about_ca_topic_score_gemma":0.000020700802,"teacher_disagreement_score":0.013035809,"about_ca_system_score_codex":0.0002588175,"about_ca_system_score_gemma":0.0019791732,"threshold_uncertainty_score":0.8877381},"labels":[],"label_agreement":null},{"id":"W4200443315","doi":"10.1182/blood-2021-154155","title":"Long-Term Follow-up of the Combination of Low-Intensity Chemotherapy Plus Inotuzumab Ozogamicin with or without Blinatumomab in Patients with Relapsed-Refractory Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Blinatumomab; Medicine; Vincristine; Internal medicine; Rituximab; Chemotherapy; Acute lymphocytic leukemia; Gastroenterology; Chemotherapy regimen; Chills; Cyclophosphamide; Surgery; Oncology; Leukemia; Lymphoblastic Leukemia; Lymphoma","score_opus":0.008599248401804548,"score_gpt":0.23940779477789245,"score_spread":0.23080854637608791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200443315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977436,0.000055549604,0.00012722044,0.00017773848,0.00013239917,0.0014449036,0.000057441564,0.000039113744,0.00022203641],"genre_scores_gemma":[0.9984612,0.000039732764,0.00032875084,0.00019043668,0.000040364303,0.00003741418,0.00009497048,0.00010361007,0.00070351735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964747,0.00016718177,0.00071390363,0.0006659149,0.0014318504,0.0005464748],"domain_scores_gemma":[0.99643093,0.00031649473,0.0006175777,0.0009781222,0.0014817552,0.00017512684],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019417639,0.0004609089,0.00117252,0.0002865056,0.00008845512,0.000019425152,0.00039065274,0.00027361105,0.00007588351],"category_scores_gemma":[0.0002815813,0.00028086326,0.00014955444,0.0014115913,0.0005769078,0.00020917355,0.00020216178,0.0005839918,0.0000067285437],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0413894,0.009343722,0.9069577,0.0016582693,0.0017568468,0.0007959822,0.0035252841,0.000078249235,0.034021813,0.000026026288,0.00015801765,0.00028873348],"study_design_scores_gemma":[0.15385823,0.0038002064,0.55229,0.0019693684,0.00070990785,0.00017428363,0.00022982876,0.0005977159,0.2860434,0.000012755312,0.0000018457338,0.0003124247],"about_ca_topic_score_codex":0.00014973566,"about_ca_topic_score_gemma":0.00024330088,"teacher_disagreement_score":0.35466763,"about_ca_system_score_codex":0.0019863907,"about_ca_system_score_gemma":0.005843157,"threshold_uncertainty_score":0.99996436},"labels":[],"label_agreement":null},{"id":"W4200449197","doi":"10.1182/blood-2021-146177","title":"Meta-Analysis of Ciltacabtagene Autoleucel Versus Physician's Choice in the Treatment of Patients with Relapsed or Refractory Multiple Myeloma","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Pomalidomide; Multiple myeloma; Medicine; Refractory (planetary science); Lenalidomide; Internal medicine; Thalidomide; Oncology; Surgery","score_opus":0.08879304162732031,"score_gpt":0.3271464727081697,"score_spread":0.2383534310808494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200449197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997392,0.00095795636,0.0000025514532,0.00010022541,0.000020658304,0.00046403686,0.000087301094,0.000009180819,0.00096610724],"genre_scores_gemma":[0.99733603,0.00009934707,0.0002861576,0.0000654937,0.000031963868,0.000071839764,0.00015569902,0.000021811438,0.0019316586],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.9982467,0.00021486504,0.00033376744,0.00029115376,0.0007047553,0.00020874868],"domain_scores_gemma":[0.99790734,0.0007981667,0.00016289977,0.0008162793,0.000260613,0.00005472939],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015632689,0.00016684769,0.000987758,0.0002010652,0.000026553245,0.000006763641,0.00012495677,0.000062456624,0.0009572888],"category_scores_gemma":[0.000106584645,0.00008802786,0.00056763564,0.0014044907,0.000070664835,0.0000377773,0.000019584457,0.00011017729,0.0000028717109],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014460938,0.052129086,0.21796551,0.00019898755,0.5668073,0.0004764821,0.006171191,0.00019337378,0.12416388,0.000014353614,0.00007843701,0.017340453],"study_design_scores_gemma":[0.036930088,0.0063759373,0.5690952,0.0000151457725,0.24395192,0.0000012784644,0.00050433597,0.00013502804,0.13779028,0.0000016027329,0.005015757,0.00018344165],"about_ca_topic_score_codex":0.00029911753,"about_ca_topic_score_gemma":0.0011116123,"teacher_disagreement_score":0.35112968,"about_ca_system_score_codex":0.00006741086,"about_ca_system_score_gemma":0.0001711217,"threshold_uncertainty_score":0.99995595},"labels":[],"label_agreement":null},{"id":"W4200510398","doi":"10.1182/blood.2021013480","title":"Atypical CML with mutated SRSF2, ASXL1, CSF3R, and MPL","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surrey Memorial Hospital; University of British Columbia","funders":"","keywords":"Medicine; Cancer research; Genetics; Biology","score_opus":0.009673645310568203,"score_gpt":0.23843839772295145,"score_spread":0.22876475241238325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200510398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920482,0.0012625019,0.000022212387,0.00074340444,0.000034538112,0.00017221701,0.000007452066,0.00007670673,0.0056327623],"genre_scores_gemma":[0.99349797,0.00009575125,0.0032979953,0.00039398152,0.000101839585,0.000015442925,0.000069264075,0.00002630288,0.002501439],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991363,0.000024814923,0.00013266993,0.0002951893,0.00018969877,0.00022129716],"domain_scores_gemma":[0.9993994,0.000044432174,0.000030218094,0.0002877824,0.000067317014,0.00017085235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000038282426,0.0001337249,0.00023902536,0.000029314431,0.000043929227,0.000015874124,0.000030210296,0.00007653675,0.0003587002],"category_scores_gemma":[0.00006299134,0.0001007959,0.000033364995,0.00015735798,0.00006201838,0.00003314978,0.000042045267,0.00014539741,0.00007226995],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021644637,0.008267051,0.86531425,0.00073162816,0.00435422,0.037002925,0.0016563055,0.0000056221047,0.04967089,0.0013523186,0.006350416,0.023129899],"study_design_scores_gemma":[0.08261637,0.0020518168,0.68410397,0.00066721364,0.0030914373,0.014782812,0.00043207797,0.00016053776,0.18200696,0.00022597337,0.029227292,0.00063355855],"about_ca_topic_score_codex":0.000028006762,"about_ca_topic_score_gemma":0.000046528265,"teacher_disagreement_score":0.1812103,"about_ca_system_score_codex":0.000057776317,"about_ca_system_score_gemma":0.0003596517,"threshold_uncertainty_score":0.41103375},"labels":[],"label_agreement":null},{"id":"W4200520522","doi":"10.1182/blood-2021-149365","title":"Vincristine Sulfate Liposome Injection (VSLI, Marqibo®) in Combination with UK ALL-R3 Induction Chemotherapy for Children, Adolescents and Young Adults with Relapsed Acute Lymphoblastic Leukemia (ALL): A Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) Consortium Trial","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Vincristine; Tolerability; Regimen; Pharmacology; Chemotherapy regimen; Chemotherapy; Oncology; Internal medicine; Adverse effect; Cyclophosphamide","score_opus":0.0066562497593469095,"score_gpt":0.24544850874567,"score_spread":0.23879225898632309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200520522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99421704,0.0013518882,0.00038519676,0.00032068012,0.000159798,0.003392206,0.0000352147,0.00008896607,0.000048989285],"genre_scores_gemma":[0.9953817,0.0024064046,0.00070186774,0.00032042502,0.00020397088,0.00042465818,0.00036583014,0.00011679549,0.00007831076],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99661756,0.00018380342,0.00071503205,0.0010733771,0.0006767735,0.000733446],"domain_scores_gemma":[0.9985649,0.00015747831,0.0003248803,0.0004082707,0.00029686734,0.000247614],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038753435,0.00054190046,0.000819313,0.0005018579,0.00013526845,0.00009908165,0.00013347606,0.0003537889,0.000009311447],"category_scores_gemma":[0.0001810578,0.00045281244,0.00006840055,0.0008495495,0.00025953568,0.000510233,0.00007203922,0.0003875847,0.0000017253647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4028086,0.009059347,0.48804262,0.0018001156,0.0031681112,0.0010821358,0.006120739,0.00021335603,0.015388613,0.00026016223,0.000095475196,0.071960725],"study_design_scores_gemma":[0.45363498,0.0062319757,0.52546585,0.0015807574,0.00073061005,0.0036038507,0.00038668787,0.0018209022,0.0058093737,0.00013220892,0.000046743673,0.0005560821],"about_ca_topic_score_codex":0.00038163425,"about_ca_topic_score_gemma":0.00073617947,"teacher_disagreement_score":0.07140464,"about_ca_system_score_codex":0.0017686782,"about_ca_system_score_gemma":0.0017759182,"threshold_uncertainty_score":0.99979234},"labels":[],"label_agreement":null},{"id":"W4200541567","doi":"10.1182/blood.2021012537","title":"Hypofibrinogenemia with preserved hemostasis and protection from thrombosis in mice with an <i>Fga</i> truncation mutation","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Blood properties and coagulation","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Fibrinogen; Hypofibrinogenemia; Platelet; Fibrin; Hemostasis; Nonsense mutation; Biology; Molecular biology; Internal medicine; Immunology; Endocrinology; Andrology; Medicine; Mutation; Biochemistry; Gene; Missense mutation","score_opus":0.028706186832033517,"score_gpt":0.23250944579547358,"score_spread":0.20380325896344006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200541567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978389,0.0005742867,0.00027744766,0.0006170893,0.00001187108,0.0004542457,0.000007331899,0.00004297664,0.00017581024],"genre_scores_gemma":[0.9941259,0.000045480312,0.00533946,0.00012358278,0.00006338959,0.000073357165,0.00016225035,0.000021147533,0.00004544169],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991986,0.00005867924,0.00014555374,0.00030020173,0.00018063975,0.000116287556],"domain_scores_gemma":[0.9995491,0.000013072119,0.000062433595,0.00018566333,0.00012952901,0.000060220198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000059078022,0.00010850475,0.0001662337,0.000040745228,0.000055583358,0.000037563146,0.000023254435,0.00007012565,0.00002094631],"category_scores_gemma":[0.00001665744,0.00008292512,0.000013470212,0.0002435657,0.000024387327,0.00023744658,0.000013353241,0.00008963127,0.0000016103128],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018259624,0.0016132572,0.38469204,0.00027652833,0.00035093844,0.00009753604,0.0023351866,0.00016718409,0.57784855,0.000028640903,0.000012195745,0.030751958],"study_design_scores_gemma":[0.004390141,0.0008147352,0.55629474,0.0002065812,0.00032766513,0.00010492297,0.00059878186,0.00073664344,0.43630433,0.000060623257,0.000037285754,0.00012356417],"about_ca_topic_score_codex":0.0012127277,"about_ca_topic_score_gemma":0.0014886055,"teacher_disagreement_score":0.17160268,"about_ca_system_score_codex":0.00002006902,"about_ca_system_score_gemma":0.00009329471,"threshold_uncertainty_score":0.33815885},"labels":[],"label_agreement":null},{"id":"W4200542010","doi":"10.1182/blood-2021-149840","title":"Liposomal Cytarabine and Daunorubicin (CPX-351) in Combination with Gemtuzumab Ozogamicin (GO) in Relapsed Refractory (R/R) Acute Myeloid Leukemia (AML) and Post-Hypomethylating Agent (Post-HMA) Failure High-Risk Myelodysplastic Syndrome (HR-MDS)","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Gemtuzumab ozogamicin; Calicheamicin; Cytarabine; Internal medicine; Daunorubicin; Gastroenterology; Refractory (planetary science); Myeloid leukemia; Population; Oncology; CD33; Leukemia; Pharmacology; Stem cell","score_opus":0.0068502452173089135,"score_gpt":0.22922753284286135,"score_spread":0.22237728762555242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200542010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994924,0.0014392822,0.00005444416,0.001757936,0.0001020346,0.0012954379,0.00011475616,0.00012446834,0.00018762406],"genre_scores_gemma":[0.9926467,0.0009892354,0.004530101,0.0003048503,0.00009329383,0.000096883894,0.00043820645,0.00015265109,0.0007481043],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9949954,0.0005451808,0.000995058,0.0013652224,0.0010234546,0.0010756422],"domain_scores_gemma":[0.9970228,0.00085617666,0.00035755982,0.000796974,0.00049838,0.00046809707],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00091940025,0.00067947846,0.0012409874,0.0011098053,0.00022246025,0.00012173809,0.00024866493,0.00053770107,0.00009418374],"category_scores_gemma":[0.001236877,0.00062147016,0.0000887244,0.001554938,0.00031265782,0.00042337482,0.00042335625,0.0021719895,0.000034885754],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004466289,0.0026048445,0.28908125,0.0013829375,0.00139477,0.028415937,0.004319678,0.00029152763,0.65540123,0.00034189175,0.00013657118,0.012163113],"study_design_scores_gemma":[0.052671473,0.006806722,0.90923285,0.0014813979,0.00096841727,0.005934553,0.0018571666,0.0018263,0.018034039,0.00013003954,0.00014285353,0.0009141699],"about_ca_topic_score_codex":0.0021056735,"about_ca_topic_score_gemma":0.0021790839,"teacher_disagreement_score":0.6373672,"about_ca_system_score_codex":0.001361359,"about_ca_system_score_gemma":0.0015043346,"threshold_uncertainty_score":0.99962366},"labels":[],"label_agreement":null},{"id":"W4200555722","doi":"10.1182/blood-2021-153144","title":"An Observational Study of Fostamatinib As Second Line Therapy in Adult Patients with Immune Thrombocytopenia (ITP) in Real-World Clinical Practice","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Syk; Medicine; Immune thrombocytopenia; Adverse effect; Internal medicine; Placebo; Immunology; Platelet; Gastroenterology; Tyrosine kinase; Receptor; Pathology","score_opus":0.08418083220155705,"score_gpt":0.3958991442104127,"score_spread":0.3117183120088557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200555722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99708265,0.00008676865,2.8821177e-7,0.00019972296,0.000036970832,0.0008433864,0.000018845622,0.00001116344,0.0017202313],"genre_scores_gemma":[0.9975937,0.0001363495,0.0013125159,0.00044966475,0.00002104051,0.00003823585,0.00028476852,0.000019903744,0.0001437996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983334,0.00018841239,0.0006685049,0.00030754658,0.00032911068,0.00017300999],"domain_scores_gemma":[0.99874467,0.00024626005,0.0002223012,0.00035010595,0.00037414834,0.000062512074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002730181,0.00014059755,0.00057816546,0.00010292252,0.000025047026,0.00001182323,0.00007175907,0.000062311614,0.00017532674],"category_scores_gemma":[0.00024151188,0.00010925573,0.000037100497,0.00051581993,0.000025304893,0.00021525192,0.000028080789,0.00021945908,0.0000058570836],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014516909,0.056144126,0.9382819,0.000016672644,0.00028592456,0.00070553174,0.0011820616,0.0000026600696,0.00008945896,0.00004277403,0.000007295625,0.0017899266],"study_design_scores_gemma":[0.04920285,0.0058322996,0.94245654,0.00009182972,0.00010815907,0.000012085657,0.00151614,0.000013209345,0.00057483814,0.000044130946,0.000051759303,0.000096126845],"about_ca_topic_score_codex":0.00059155084,"about_ca_topic_score_gemma":0.005796486,"teacher_disagreement_score":0.050311826,"about_ca_system_score_codex":0.00002024315,"about_ca_system_score_gemma":0.00023767956,"threshold_uncertainty_score":0.44553193},"labels":[],"label_agreement":null},{"id":"W4200569817","doi":"10.1182/blood-2021-146632","title":"Hydroxyurea Reduces the Transfusion Burden in Children with Sickle Cell Anemia: The Reach Experience","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"Medicine; Hazard ratio; Anemia; Sickle cell anemia; Blood transfusion; Confidence interval; Malaria; Pediatrics; Thalassemia; Incidence (geometry); Internal medicine; Immunology; Disease","score_opus":0.004940548329145268,"score_gpt":0.20899253299614137,"score_spread":0.20405198466699612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200569817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814933,0.0033864945,0.0000034692773,0.004545178,0.000032114967,0.00034263553,0.0000017598568,0.000027877755,0.010167184],"genre_scores_gemma":[0.9974386,0.0012762533,0.00005192604,0.000313469,0.0000847956,0.000026877797,0.000013174125,0.000015106996,0.00077977293],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99914086,0.000055878827,0.00014584712,0.00022590703,0.00021996206,0.00021157063],"domain_scores_gemma":[0.9995168,0.000031278738,0.000030701736,0.0003389469,0.000031163647,0.00005112501],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011118516,0.00011535091,0.00014123911,0.000021306232,0.0001382753,0.000019612295,0.00012830863,0.00009930689,0.000073250005],"category_scores_gemma":[0.000020198184,0.0000527078,0.000047394133,0.00034093572,0.00012791895,0.00003372306,0.000025924048,0.00037295924,0.000010008346],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000427751,0.0046435595,0.3203201,0.0001555233,0.00041516352,0.0010641025,0.12494046,0.00058349414,0.5241714,0.00021731487,0.0020206077,0.02104054],"study_design_scores_gemma":[0.017203392,0.000917676,0.14842644,0.0005510496,0.0010418168,0.0031796987,0.059846256,0.00015455724,0.7613032,0.000102753314,0.006623305,0.000649884],"about_ca_topic_score_codex":0.00037355308,"about_ca_topic_score_gemma":0.000042507017,"teacher_disagreement_score":0.23713179,"about_ca_system_score_codex":0.000009221114,"about_ca_system_score_gemma":0.00011123197,"threshold_uncertainty_score":0.21493618},"labels":[],"label_agreement":null},{"id":"W4200614870","doi":"10.1182/blood-2021-145889","title":"Use of Thromboprophylaxis for Central Venous Access Devices in Patients with Sickle Cell Disease: A Survey of Canadian Providers","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Centre Hospitalier de l’Université de Montréal; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Population; Incidence (geometry); Thrombosis; Venous access; Intensive care medicine; Internal medicine; Pediatrics; Catheter; Surgery","score_opus":0.02089691718522175,"score_gpt":0.22991808133052943,"score_spread":0.2090211641453077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200614870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99829626,0.00046573105,0.0000022620466,0.000093411465,0.00003899733,0.0006257287,0.0003839422,0.000005034373,0.00008862167],"genre_scores_gemma":[0.9993523,0.000045149493,0.00015307586,0.0000738446,0.000004941164,0.000009771732,0.0003093557,0.000017532875,0.000034079272],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991624,0.00003628515,0.00020790412,0.00017399967,0.00015314356,0.000266305],"domain_scores_gemma":[0.99920017,0.000047293794,0.000082528335,0.0001890031,0.00026740882,0.00021358696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000051784304,0.00009365502,0.00026114847,0.00014868302,0.000024575535,0.0000124994285,0.00006401891,0.00006114014,0.000021437449],"category_scores_gemma":[0.00014459727,0.00007444179,0.000042315136,0.0005438945,0.000049185852,0.000089130685,0.000016810014,0.00007089605,4.80661e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026274577,0.0020928283,0.9961042,0.0006179465,0.000081920145,0.000030075696,0.00023768934,0.000050560255,0.00007215652,0.0000024582741,0.00007470742,0.0003727453],"study_design_scores_gemma":[0.003787715,0.0004996338,0.993008,0.0001762839,0.00015058616,5.0584157e-7,0.00008498692,0.000019288402,0.001970835,0.0000025548004,0.00021353058,0.00008608863],"about_ca_topic_score_codex":0.14883271,"about_ca_topic_score_gemma":0.2355428,"teacher_disagreement_score":0.08671009,"about_ca_system_score_codex":0.000024704172,"about_ca_system_score_gemma":0.0010887726,"threshold_uncertainty_score":0.8568353},"labels":[],"label_agreement":null},{"id":"W4205136684","doi":"10.1182/blood.v124.21.594.594","title":"Influence of Age and Renal Function on Efficacy and Safety of Dabigatran Versus Warfarin for the Treatment of Acute Venous Thromboembolism: A Pooled Analysis of RE-COVER™ and RE-COVER™ II","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Dabigatran; Warfarin; Renal function; Venous thromboembolism; Atrial fibrillation; Internal medicine; Randomization; Randomized controlled trial; Surgery; Thrombosis","score_opus":0.016319599226289897,"score_gpt":0.26816169816452856,"score_spread":0.25184209893823867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205136684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99778813,0.0007016688,0.000062526706,0.00012834423,0.0000345321,0.0008620231,0.00009087621,0.000008792796,0.00032309906],"genre_scores_gemma":[0.99636334,0.003291853,0.00015967381,0.00005071201,0.00003171758,0.000027534219,0.00003247411,0.000014305472,0.000028377632],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988045,0.00004514777,0.00045874467,0.00028997794,0.00023751083,0.00016412186],"domain_scores_gemma":[0.99867266,0.00041947616,0.00033389343,0.00042276684,0.00008669372,0.000064488406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002514316,0.0001834054,0.0011120891,0.00017812701,0.000083529114,0.000005912658,0.00006773089,0.000079382844,0.000011975575],"category_scores_gemma":[0.000062549414,0.00012669199,0.00015011415,0.00026070818,0.00020310204,0.000042534324,0.00004807449,0.000049550472,1.9403682e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.053993996,0.060808342,0.037963398,0.0046090344,0.22538808,0.00004941107,0.04230596,0.022559838,0.44429752,0.011019607,0.00060254685,0.09640226],"study_design_scores_gemma":[0.016849048,0.020111814,0.88403314,0.00019942728,0.054192945,0.0000017143062,0.0001423299,0.0004391083,0.023143152,0.00006680443,0.000691345,0.00012914455],"about_ca_topic_score_codex":0.00037486426,"about_ca_topic_score_gemma":0.00006588982,"teacher_disagreement_score":0.84606975,"about_ca_system_score_codex":0.000017668666,"about_ca_system_score_gemma":0.000024713898,"threshold_uncertainty_score":0.5166349},"labels":[],"label_agreement":null},{"id":"W4205155690","doi":"10.1182/blood.2021013404","title":"Oral azacitidine prolongs survival of patients with AML in remission independently of measurable residual disease status","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Celgene; Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; Minimal residual disease; Azacitidine; Placebo; Oncology; Chemotherapy; Hematopoietic stem cell transplantation; Transplantation; Gastroenterology; Leukemia; Pathology","score_opus":0.016671621693273783,"score_gpt":0.2585591832911514,"score_spread":0.2418875615978776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205155690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99819344,0.00012501486,0.0000027327817,0.00014994474,0.000027373777,0.0007219697,0.0002224963,0.000017522516,0.00053948705],"genre_scores_gemma":[0.99900186,0.000011896658,0.0002577812,0.000021717806,0.000018062563,0.000052257543,0.00022979396,0.00003041892,0.00037623916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973232,0.00021970221,0.00034998613,0.00028173966,0.0014472728,0.00037807893],"domain_scores_gemma":[0.9989317,0.000060538947,0.00014799861,0.00036584606,0.0002430627,0.0002508294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056831026,0.00012961245,0.00036731074,0.00024292627,0.000052531133,0.0000040615114,0.00015729827,0.000041054318,0.0002705743],"category_scores_gemma":[0.0003167271,0.00010576622,0.000042756306,0.0005365195,0.00008714169,0.000076299126,0.00021509397,0.000422758,0.0000014816513],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006021633,0.002476526,0.9867343,0.0002239137,0.000078777724,0.00017164725,0.00025970404,0.000041643958,0.0033329874,0.000025979356,0.00021148834,0.0004214247],"study_design_scores_gemma":[0.019180099,0.0016535341,0.9699626,0.000099849094,0.0001376506,0.0000049276455,0.00027001114,0.000041692456,0.008205169,0.000048649134,0.00027320563,0.00012262195],"about_ca_topic_score_codex":0.00039235767,"about_ca_topic_score_gemma":0.000047031914,"teacher_disagreement_score":0.016771683,"about_ca_system_score_codex":0.00018155726,"about_ca_system_score_gemma":0.0009634219,"threshold_uncertainty_score":0.43130213},"labels":[],"label_agreement":null},{"id":"W4205275534","doi":"10.1182/blood-2018-99-115160","title":"Disease Burden Subgroup Analysis of Health-Related Quality of Life of Blinatumomab Versus Standard-of-Care Chemotherapy in Patients with Relapsed or Refractory Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia in a Randomized, Open-Label Phase 3 Study (TOWER)","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Blinatumomab; Medicine; Internal medicine; Chemotherapy; Quality of life (healthcare); Leukemia; Oncology; Gastroenterology; Lymphoblastic Leukemia","score_opus":0.030097742039561778,"score_gpt":0.3495460298688065,"score_spread":0.3194482878292447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205275534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922945,0.0005408131,0.000045577726,0.00009113124,0.000063880354,0.006012935,0.0008404014,0.00002027361,0.00009048846],"genre_scores_gemma":[0.9988336,0.00010826436,0.00052180584,0.000023906494,0.000022129452,0.00016468255,0.00021720568,0.00007135948,0.00003705209],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99233896,0.0014604471,0.0030977288,0.000811482,0.0017352115,0.0005561532],"domain_scores_gemma":[0.9923983,0.0021088868,0.0024514035,0.001111265,0.0015321824,0.00039793592],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022590295,0.00047970578,0.004625886,0.001358535,0.000054044238,0.000012835165,0.00065544306,0.00021455543,0.00017674615],"category_scores_gemma":[0.0031111683,0.00035465966,0.00025611088,0.003940268,0.0009767041,0.00022622896,0.0002438038,0.00036518346,0.0000014558761],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9292636,0.022715693,0.025708437,0.001012321,0.00793158,0.000055972283,0.012315984,0.000054104177,0.000580477,0.000008149934,0.000024384732,0.000329306],"study_design_scores_gemma":[0.913827,0.03841416,0.03576354,0.00096907275,0.004514825,5.1516e-7,0.0023183674,0.0014562065,0.002419297,0.000010690934,0.0000014866622,0.00030485174],"about_ca_topic_score_codex":0.0025353099,"about_ca_topic_score_gemma":0.00056383526,"teacher_disagreement_score":0.015698468,"about_ca_system_score_codex":0.0018246617,"about_ca_system_score_gemma":0.0088551305,"threshold_uncertainty_score":0.99989057},"labels":[],"label_agreement":null},{"id":"W4205402413","doi":"10.1182/blood-2020-141327","title":"Outcomes of Patients with Hematologic Malignancies and COVID-19 Infection: A Report from the ASH Research Collaborative Data Hub","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; BC Cancer Agency","funders":"","keywords":"Medicine; Disease; Hematology; Cancer; Internal medicine; Intensive care medicine; Hematologic disease; Comorbidity; Hematologic Neoplasms","score_opus":0.23814650995889708,"score_gpt":0.4524691789114215,"score_spread":0.21432266895252444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205402413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9498954,0.00039500915,0.00004429676,0.048395663,0.000023313265,0.00073682005,0.00032620275,0.00003525203,0.00014806523],"genre_scores_gemma":[0.99301153,0.000086158005,0.00022996131,0.006358641,0.000060240178,0.000016164795,0.00019894989,0.000009572346,0.000028754352],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857855,0.00015048495,0.00026071025,0.0003306662,0.0004948409,0.00018473488],"domain_scores_gemma":[0.99767685,0.00085811975,0.00013891715,0.00061318703,0.00042004563,0.0002928661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048571272,0.0001007388,0.0003363806,0.00004019084,0.00015182003,0.000021518501,0.00012773738,0.00006424349,0.00004456519],"category_scores_gemma":[0.007469088,0.000055622648,0.000016273336,0.00050152984,0.00020876272,0.000083968655,0.00023540735,0.00020922293,0.0000039380166],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002197328,0.000208393,0.98966265,0.00021050613,0.00012645572,0.00019242414,0.0020223227,3.0648926e-7,0.000038829192,0.000037144237,0.0072268834,0.000054378637],"study_design_scores_gemma":[0.0029633928,0.00069421553,0.9818965,0.000058658108,0.00012578286,0.000031621297,0.00060322526,0.0000038583917,0.0002483112,0.0000867069,0.01322477,0.00006291685],"about_ca_topic_score_codex":0.0017930965,"about_ca_topic_score_gemma":0.0008689206,"teacher_disagreement_score":0.043116182,"about_ca_system_score_codex":0.000028957587,"about_ca_system_score_gemma":0.0013589232,"threshold_uncertainty_score":0.8941735},"labels":[],"label_agreement":null},{"id":"W4205450923","doi":"10.1182/blood.v130.suppl_1.821.821","title":"A Phase Ib/IIa Trial of the Combination of Romidepsin, Lenalidomide and Carfilzomib in Patients with Relapsed/Refractory Lymphoma Shows Complete Responses in Relapsed and Refractory B- and T-Cell Lymphomas","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Carfilzomib; Lenalidomide; Refractory (planetary science); Medicine; Romidepsin; Lymphoma; Internal medicine; Oncology; Multiple myeloma; Materials science; Chemistry","score_opus":0.011050302612879995,"score_gpt":0.23461188556539733,"score_spread":0.22356158295251732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205450923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986818,0.00045761466,0.0000013712897,0.00004328477,0.000060676764,0.0005203576,0.000052077994,0.0000024045014,0.00018041009],"genre_scores_gemma":[0.99963164,0.000109568515,0.000078316676,0.000029180906,0.000017072412,0.000016479098,0.000024218813,0.0000135764685,0.00007993246],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99896353,0.00018885446,0.00032112413,0.0002585495,0.0001482746,0.00011965947],"domain_scores_gemma":[0.9990616,0.00004349187,0.00039117032,0.00039080708,0.000068720954,0.000044246117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030214235,0.00013607062,0.0002324389,0.00007847491,0.00008626788,0.00002228251,0.00013186433,0.0001333828,0.00000154661],"category_scores_gemma":[0.00033920677,0.00010468652,0.000029301396,0.000043481035,0.00028137764,0.000018450548,0.00012588385,0.00006254004,7.712192e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.046352636,0.0047063692,0.3145786,0.00010786991,0.00005995784,0.000004632458,0.00029725887,5.925038e-7,0.6301733,0.00006330852,0.00007231502,0.0035831311],"study_design_scores_gemma":[0.28768188,0.0029850807,0.4348472,0.00011808676,0.000045083565,0.0000034101893,0.00005549075,0.000013727947,0.27355552,0.00005795086,0.00045402432,0.00018253703],"about_ca_topic_score_codex":0.00012829875,"about_ca_topic_score_gemma":0.0001331788,"teacher_disagreement_score":0.3566178,"about_ca_system_score_codex":0.000013500004,"about_ca_system_score_gemma":0.000093767834,"threshold_uncertainty_score":0.42689922},"labels":[],"label_agreement":null},{"id":"W4205527069","doi":"10.1182/blood.2021012743","title":"A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; NYU Grossman School of Medicine; Genentech; National Institutes of Health; Italfarmaco; Astellas Pharma; Rosetrees Trust; Cancer Research UK; Sierra Oncology; CTI Biopharma; Incyte; Tizona Therapeutics; Constellation Pharmaceuticals; Jazz Pharmaceuticals; Memorial Sloan-Kettering Cancer Center; Medical Research Council; Celgene; Gilead Sciences; Amgen","keywords":"Essential thrombocythemia; Polycythemia vera; Hydroxycarbamide; Adverse effect; Clinical endpoint; Phases of clinical research; Myelofibrosis; Randomized controlled trial","score_opus":0.013426965618761739,"score_gpt":0.29497064113746935,"score_spread":0.2815436755187076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205527069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958895,0.00049818953,0.0000086127375,0.00063385826,0.00013383768,0.0015566448,0.000033752458,0.000018867675,0.0012267544],"genre_scores_gemma":[0.9987274,0.00014432344,0.00012349336,0.00012566865,0.000108438144,0.0006018399,0.000047892732,0.000018742225,0.000102192185],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9986203,0.00018680678,0.00044927123,0.00027547445,0.0002816419,0.00018655388],"domain_scores_gemma":[0.99927247,0.0002722324,0.0001379239,0.00021003243,0.00002376471,0.00008358103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040576473,0.0001727409,0.0009187681,0.00014142646,0.00006237647,0.000009875399,0.0000613619,0.000046562236,0.0005158972],"category_scores_gemma":[0.000109197244,0.00013768305,0.0001618406,0.00014278175,0.00010476817,0.000034705306,0.00010155923,0.00020451436,0.0000025606294],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9751378,0.009914804,0.0022293606,0.000060043323,0.00064237666,0.00018367196,0.0014905343,0.0000028297352,0.009227145,0.00044111404,0.00021088921,0.00045942722],"study_design_scores_gemma":[0.93316823,0.0035022476,0.000120115285,0.0000563582,0.0005770213,0.000080220976,0.000119518845,0.00011973892,0.061855383,0.0001266769,0.00016965334,0.00010483467],"about_ca_topic_score_codex":0.00007967601,"about_ca_topic_score_gemma":0.000010655406,"teacher_disagreement_score":0.052628238,"about_ca_system_score_codex":0.00004727572,"about_ca_system_score_gemma":0.000115450566,"threshold_uncertainty_score":0.56487125},"labels":[],"label_agreement":null},{"id":"W4205723666","doi":"10.1182/blood.v126.23.3561.3561","title":"C-Reactive Protein (CRP) Enhances Murine Antibody-Mediated Transfusion Related Acute Lung Injury (TRALI)","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Transfusion-related acute lung injury; Immunology; Medicine; Pulmonary edema; Antibody; Isotype; Lung; Lipopolysaccharide; Antigen; Diffuse alveolar damage; Monoclonal antibody; Internal medicine","score_opus":0.010915388054459902,"score_gpt":0.2794967102329367,"score_spread":0.2685813221784768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205723666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9764663,0.000352339,0.00022793759,0.002567346,0.0002549286,0.0020232499,0.000028776283,0.00038387813,0.017695233],"genre_scores_gemma":[0.9946461,0.00028550279,0.0006796336,0.00039059346,0.000113562266,0.000113544775,0.00023981351,0.000052423395,0.0034788705],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99803853,0.00008357125,0.0004379552,0.00048358538,0.0005469232,0.00040941697],"domain_scores_gemma":[0.9989274,0.000020675245,0.000099375626,0.00039442413,0.00016248078,0.00039560016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032021358,0.00029406356,0.00045705683,0.0002180443,0.000083228915,0.000023756791,0.00014442357,0.00019664691,0.00026042998],"category_scores_gemma":[0.000054290012,0.00024275556,0.00014846283,0.0005304052,0.00008420448,0.00018493886,0.000045332057,0.00039078726,0.00019918299],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001115916,0.0037602265,0.0034896706,0.00021396269,0.0013829421,0.0006088813,0.0016690767,7.440263e-7,0.98311555,0.00045815535,0.0018605569,0.002324325],"study_design_scores_gemma":[0.0241446,0.002295919,0.00989038,0.0005935082,0.0026563045,0.00015372793,0.00054508663,0.00012369308,0.9433191,0.00021434727,0.015440998,0.0006223285],"about_ca_topic_score_codex":0.00018506298,"about_ca_topic_score_gemma":0.000027726235,"teacher_disagreement_score":0.039796434,"about_ca_system_score_codex":0.000039019582,"about_ca_system_score_gemma":0.00012702592,"threshold_uncertainty_score":0.9899284},"labels":[],"label_agreement":null},{"id":"W4205735812","doi":"10.1182/blood-2018-99-114502","title":"Nivolumab Treatment Beyond Investigator-Assessed Progression: Extended Follow-up in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma from the Phase 2 CheckMate 205 Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Nivolumab; Brentuximab vedotin; Refractory (planetary science); Oncology; Phases of clinical research; Clinical trial; Lymphoma; Surgery; Cancer; Hodgkin lymphoma; Immunotherapy","score_opus":0.016509765708378265,"score_gpt":0.2847018162377192,"score_spread":0.2681920505293409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205735812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99543124,0.0005119068,8.5124464e-7,0.00056134484,0.00026510702,0.002534235,0.00007430321,0.00010379515,0.0005171855],"genre_scores_gemma":[0.99774253,0.000031842064,0.00039561928,0.00036953465,0.00031400804,0.0007056298,0.00021277709,0.00006351017,0.00016451594],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972831,0.00022506613,0.00049516564,0.0007710906,0.00072754663,0.000498033],"domain_scores_gemma":[0.99804586,0.00017399582,0.0002313738,0.0009602926,0.00015765232,0.0004308475],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014872036,0.00048589119,0.00066548144,0.00009419304,0.00023558874,0.00007441365,0.0001939677,0.00015516496,0.00012455402],"category_scores_gemma":[0.00011014442,0.0002587827,0.00013260287,0.00035235574,0.00027050063,0.00015115549,0.00008319929,0.00010891027,0.000075345466],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026777745,0.09161808,0.85241276,0.000008069815,0.00092794484,0.00045678983,0.0017784281,4.3001688e-8,0.00012725503,0.00001753811,0.00095554243,0.049019776],"study_design_scores_gemma":[0.18792346,0.02338442,0.778821,0.0002075202,0.0012087328,0.000006723427,0.0003886325,0.000011722232,0.005074094,0.00004061361,0.0026780185,0.0002550699],"about_ca_topic_score_codex":0.0004702712,"about_ca_topic_score_gemma":0.00052864273,"teacher_disagreement_score":0.18524568,"about_ca_system_score_codex":0.00044572164,"about_ca_system_score_gemma":0.000603104,"threshold_uncertainty_score":0.9999864},"labels":[],"label_agreement":null},{"id":"W4205779867","doi":"10.1182/blood.v126.23.4455.4455","title":"Patterns of Venous Thromboembolism Prophylaxis during Inpatient Treatment of Acute Leukemia: Results of a North American Web-Based Survey","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Venous thromboembolism; Family medicine; Population; Emergency medicine; Internal medicine; Thrombosis","score_opus":0.023487751261898695,"score_gpt":0.26122211030257886,"score_spread":0.23773435904068016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205779867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978505,0.00008394846,0.000007532664,0.00003830357,0.00009119992,0.00090290816,0.0007918757,0.000031607855,0.00020212257],"genre_scores_gemma":[0.99901694,0.0002938241,0.00028776823,0.000024668472,0.000048438087,0.000059991944,0.00020575852,0.000035390418,0.000027230204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99795914,0.00011794487,0.00074920664,0.0003411047,0.0005305711,0.00030200797],"domain_scores_gemma":[0.99806285,0.000065128675,0.00065682514,0.00067785615,0.00034958767,0.00018775178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002074674,0.00024648773,0.0013536911,0.00022594117,0.000026464493,0.000004263179,0.000141072,0.000049926966,0.000005247288],"category_scores_gemma":[0.00007452919,0.00019885474,0.00017665313,0.00041142487,0.000118581665,0.000034189976,0.00006443254,0.000075424905,0.0000032831529],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010883843,0.02126809,0.9647195,0.0005859778,0.0020257025,0.000104475876,0.0024992952,0.00020713011,0.0024639927,0.0000059316535,0.00011205393,0.0049194843],"study_design_scores_gemma":[0.01252115,0.0145664485,0.903743,0.0001399761,0.0010104746,0.00000444441,0.00009263177,0.00002140902,0.06770712,0.0000012807554,0.00005135677,0.00014067374],"about_ca_topic_score_codex":0.0087052435,"about_ca_topic_score_gemma":0.0017840777,"teacher_disagreement_score":0.06524313,"about_ca_system_score_codex":0.0001773019,"about_ca_system_score_gemma":0.00043550035,"threshold_uncertainty_score":0.9978959},"labels":[],"label_agreement":null},{"id":"W4205842243","doi":"10.1182/blood.2021010791","title":"Inherited human Apollo deficiency causes severe bone marrow failure and developmental defects","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Agence Nationale de la Recherche","keywords":"Dyskeratosis congenita; Biology; Bone marrow failure; Telomere; Microcephaly; Progeria; Genetics; Missense mutation; Premature aging; Cancer research; Immunology; Phenotype; Gene; Stem cell; Haematopoiesis","score_opus":0.015460022724972091,"score_gpt":0.23462547123227592,"score_spread":0.21916544850730382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205842243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99606746,0.0017562126,0.0000015370475,0.00030959703,0.00006801709,0.00029970787,0.000029665025,0.00013476973,0.0013330005],"genre_scores_gemma":[0.9971245,0.000032984146,0.00085758325,0.0006754592,0.000057703266,0.00004564419,0.000065184635,0.00003156303,0.0011093664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986216,0.00005529749,0.0002343884,0.0003686554,0.0003765921,0.00034346236],"domain_scores_gemma":[0.9995039,0.000036236994,0.000062808955,0.00019139776,0.000035607485,0.00017004326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013216642,0.00019148311,0.00027658173,0.00015479652,0.0005022683,0.000026378548,0.000098410754,0.000057018788,0.0005260724],"category_scores_gemma":[0.000059857484,0.00018889197,0.000054127693,0.00038177567,0.00008501682,0.00006762643,0.0001763995,0.0002708322,0.000018802035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011223973,0.001849431,0.5288629,0.00035665176,0.00014016546,0.0018028768,0.005289241,0.0000019504814,0.45406988,0.00042242845,0.005555479,0.0015367643],"study_design_scores_gemma":[0.021660218,0.0022547354,0.80891144,0.00027387447,0.00087166706,0.018332137,0.023822544,0.000014048514,0.058252435,0.00034438318,0.06335629,0.0019062072],"about_ca_topic_score_codex":0.0001064243,"about_ca_topic_score_gemma":0.0001751462,"teacher_disagreement_score":0.39581743,"about_ca_system_score_codex":0.000058410365,"about_ca_system_score_gemma":0.00014062872,"threshold_uncertainty_score":0.77027905},"labels":[],"label_agreement":null},{"id":"W4205918029","doi":"10.1182/blood.2021014027","title":"Sirolimus plus prednisolone vs sirolimus monotherapy for kaposiform hemangioendothelioma: a randomized clinical trial","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Vascular Malformations and Hemangiomas","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"West China Hospital, Sichuan University; Sichuan University; National Natural Science Foundation of China","keywords":"Medicine; Sirolimus; Prednisolone; Surgery; Combination therapy; Adverse effect; Internal medicine; Gastroenterology","score_opus":0.041668099245715275,"score_gpt":0.3345935149485713,"score_spread":0.292925415702856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205918029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816487,0.0021295028,0.0035068695,0.002029289,0.0007004516,0.007990846,0.00009869605,0.000246767,0.0016489214],"genre_scores_gemma":[0.98651814,0.00023727056,0.004268371,0.0015019391,0.0012709281,0.004373493,0.0002333142,0.00009875592,0.0014977929],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99725264,0.0002805723,0.0011074231,0.00041060406,0.00048182884,0.00046691153],"domain_scores_gemma":[0.99812645,0.00063967274,0.00031448517,0.000620478,0.00010178441,0.0001971385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024063655,0.00026397072,0.0013271851,0.0002695178,0.00041516504,0.000036595804,0.00022331627,0.00012750807,0.00033771907],"category_scores_gemma":[0.00034985895,0.00022154773,0.0016868409,0.0002828053,0.00011641651,0.00008952093,0.000112252834,0.00028182924,0.000028208142],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9859613,0.0044424096,0.00011006091,0.00016400425,0.0020667457,0.00007680663,0.0009710803,0.000048663183,0.0003246895,0.0022744257,0.0017485518,0.0018112295],"study_design_scores_gemma":[0.96379066,0.0037241683,0.00008671613,0.00001716797,0.0016763425,0.0003606009,0.00014788278,0.0035372775,0.0004628175,0.0008149944,0.025126437,0.0002549523],"about_ca_topic_score_codex":0.000018890138,"about_ca_topic_score_gemma":0.0000030073788,"teacher_disagreement_score":0.023377884,"about_ca_system_score_codex":0.000073917945,"about_ca_system_score_gemma":0.00025880188,"threshold_uncertainty_score":0.90344536},"labels":[],"label_agreement":null},{"id":"W4206174687","doi":"10.1182/blood.v124.21.lba-5.lba-5","title":"A Randomized Phase II Study of Azacitidine Combined with Lenalidomide or with Vorinostat Vs. Azacitidine Monotherapy in Higher-Risk Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML): North American Intergroup Study SWOG S1117","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Lenalidomide; Azacitidine; Internal medicine; Chronic myelomonocytic leukemia; International Prognostic Scoring System; Decitabine; Oncology; Myelodysplastic syndromes; Hypomethylating agent; Phases of clinical research; Clinical endpoint; Adverse effect; Gastroenterology; Randomized controlled trial; Clinical trial; Bone marrow; Multiple myeloma; DNA methylation","score_opus":0.01897090738087662,"score_gpt":0.2835828388358142,"score_spread":0.26461193145493755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206174687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99158,0.00017453305,0.00030866766,0.00019327791,0.000049711787,0.0074313213,0.000033012475,0.00015093686,0.00007855883],"genre_scores_gemma":[0.997051,0.00041002908,0.0005122493,0.00008060778,0.0001588377,0.001054931,0.000046627873,0.00019363523,0.00049208145],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99398637,0.001227389,0.0013840589,0.0012660535,0.0011182983,0.0010178393],"domain_scores_gemma":[0.99553555,0.0016683487,0.00080041523,0.0011932187,0.00030304008,0.0004994258],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013363175,0.000924379,0.0036174639,0.00094484753,0.00023215708,0.00007106944,0.0004695561,0.00009761925,0.000093525145],"category_scores_gemma":[0.00040646008,0.0005817462,0.00013950505,0.0017804047,0.0010198564,0.00024798745,0.0002700801,0.0010063939,0.000007142909],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.742421,0.018313624,0.2166767,0.0004284438,0.005084583,0.0019770553,0.0057390817,0.00029896028,0.0008217908,0.00001865944,0.000040668227,0.008179489],"study_design_scores_gemma":[0.76404643,0.16298375,0.062376853,0.0004295537,0.0024175958,0.00030035572,0.0018936543,0.0039739744,0.0009037783,0.0000062665895,0.000034276327,0.00063351874],"about_ca_topic_score_codex":0.0027448698,"about_ca_topic_score_gemma":0.009638529,"teacher_disagreement_score":0.15429984,"about_ca_system_score_codex":0.0006603199,"about_ca_system_score_gemma":0.00092545315,"threshold_uncertainty_score":0.9996634},"labels":[],"label_agreement":null},{"id":"W4206364523","doi":"10.1182/blood.v126.23.5492.5492","title":"Cyclophosphamide, Bortezomib, and Dexamethasone (CyBorD) Induction Followed By ASCT with HDM or Bor-HDM Conditioning Regimens: A Single Center Experience","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Calgary","funders":"","keywords":"Medicine; Bortezomib; Cyclophosphamide; Melphalan; Internal medicine; Single Center; Lenalidomide; Median follow-up; Dexamethasone; Transplantation; Urology; Oncology; Multiple myeloma; Chemotherapy","score_opus":0.043573851624621004,"score_gpt":0.3019730353361254,"score_spread":0.2583991837115044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206364523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961463,0.0009889835,0.00012946647,0.00026841147,0.00006651504,0.000603738,0.00003305132,0.00008871172,0.0016747946],"genre_scores_gemma":[0.9941238,0.00007995606,0.003879183,0.00014697888,0.000075408745,0.00014301973,0.00015649007,0.000035665616,0.0013594712],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984165,0.000062591724,0.00020754614,0.00042705092,0.00047414014,0.00041216964],"domain_scores_gemma":[0.99890137,0.00006429158,0.000094504896,0.00030213376,0.00015579785,0.0004819218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001417057,0.00021269322,0.00030747382,0.00008967196,0.00012000399,0.00006368667,0.000063899475,0.00009193678,0.000071628085],"category_scores_gemma":[0.00029783385,0.00014891452,0.000035099067,0.00026226,0.00016118269,0.00026398184,0.00004579884,0.00017055249,0.000018810593],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006007529,0.006067872,0.9069163,0.000118785814,0.001107523,0.001940982,0.003397681,0.0000012838548,0.057744894,0.000037044323,0.008231028,0.008429061],"study_design_scores_gemma":[0.23707362,0.024978861,0.2021718,0.002004675,0.0015378857,0.007015968,0.011089034,0.00025519895,0.48173574,0.00018217682,0.029983124,0.001971917],"about_ca_topic_score_codex":0.00030040933,"about_ca_topic_score_gemma":0.000047240268,"teacher_disagreement_score":0.7047445,"about_ca_system_score_codex":0.00008867912,"about_ca_system_score_gemma":0.00014999139,"threshold_uncertainty_score":0.6072558},"labels":[],"label_agreement":null},{"id":"W4206373994","doi":"10.1182/blood-2019-122254","title":"Β-Catenin-Tcf/Lef Signaling Promotes Steady State and Emergency Granulopoiesis through G-CSF Receptor Upregulation","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Wnt signaling pathway; Biology; Cell biology; Haematopoiesis; Granulopoiesis; Progenitor cell; Myelopoiesis; LRP5; Beta-catenin; Transcription factor; WNT3A; Signal transduction; Stem cell; Molecular biology; Gene; Genetics","score_opus":0.007425204733685332,"score_gpt":0.2253741179732812,"score_spread":0.21794891323959587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206373994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960973,0.0020089867,0.00049973617,0.00012786733,0.00029118027,0.00042876235,0.000025759511,0.000025692936,0.00049467065],"genre_scores_gemma":[0.99518913,0.00046558253,0.0013435016,0.000016265796,0.00020805359,0.000021389322,0.00023329562,0.000037791815,0.002485001],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99884075,0.000056699984,0.00027480858,0.0004371406,0.00015482638,0.00023579234],"domain_scores_gemma":[0.9994031,0.000007831569,0.00014415856,0.0002783853,0.000113610375,0.000052883915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012766059,0.0001826698,0.00015596036,0.00003514807,0.00007982093,0.00002507483,0.0000930737,0.00016268234,0.000203903],"category_scores_gemma":[0.000024791625,0.00018590357,0.00006796996,0.00012542726,0.000034872195,0.000017893712,0.00006741124,0.000070067355,0.00005400076],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056220964,0.000077044126,0.009723554,0.00004950981,0.000117976444,2.84798e-7,0.00029305383,0.0002434169,0.98705316,0.000024975448,0.00031632025,0.0020445166],"study_design_scores_gemma":[0.0014125208,0.0003114682,0.008665783,0.000037369573,0.00008958419,0.000009428707,0.00007211729,0.00014554568,0.9835094,0.00058417814,0.00482381,0.00033878378],"about_ca_topic_score_codex":0.00003148507,"about_ca_topic_score_gemma":0.000024231285,"teacher_disagreement_score":0.0045074895,"about_ca_system_score_codex":0.000012517672,"about_ca_system_score_gemma":0.000039500617,"threshold_uncertainty_score":0.75809276},"labels":[],"label_agreement":null},{"id":"W4206398617","doi":"10.1182/blood-2018-99-112174","title":"Integrated Safety Results from the Phase II and Phase III Studies with Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Tolerability; Internal medicine; Medicine; Population; Adverse effect; Gastroenterology; Surgery","score_opus":0.023320051912410503,"score_gpt":0.2789718015367453,"score_spread":0.2556517496243348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206398617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99529546,0.001752264,0.000008786197,0.00019941547,0.00018081414,0.0011476836,0.0011985616,0.000067161374,0.0001498716],"genre_scores_gemma":[0.9986133,0.00003565943,0.000055916797,0.00009630925,0.000037104885,0.000053384392,0.00097205513,0.00002250578,0.000113764094],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9981795,0.00029778833,0.0005118331,0.0005366682,0.00008725706,0.0003869833],"domain_scores_gemma":[0.99859726,0.000333484,0.00023923538,0.0005914624,0.00020699446,0.00003157893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020873336,0.00031332488,0.0005631851,0.000064563115,0.00050740625,0.000026995083,0.00030187634,0.0000859697,0.0002372895],"category_scores_gemma":[0.000137094,0.00017016254,0.000032367017,0.00025228798,0.0008116498,0.00015350766,0.0002209262,0.00013659074,0.00004034237],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.287342,0.08829241,0.33805937,0.00023618432,0.032756004,0.00025974927,0.107216656,0.0000098080245,0.074151844,0.00094963604,0.038244367,0.032481965],"study_design_scores_gemma":[0.65450394,0.021162815,0.28148314,0.0015030891,0.0020287256,0.00004635647,0.011777525,0.000009069901,0.020462163,0.00015251627,0.005724179,0.0011464619],"about_ca_topic_score_codex":0.00043297524,"about_ca_topic_score_gemma":0.0017405293,"teacher_disagreement_score":0.36716196,"about_ca_system_score_codex":0.000052400144,"about_ca_system_score_gemma":0.00010004623,"threshold_uncertainty_score":0.69390273},"labels":[],"label_agreement":null},{"id":"W4206433678","doi":"10.1182/blood.2021012077","title":"Tcf1 is essential for initiation of oncogenic Notch1-driven chromatin topology in T-ALL","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Université de Lausanne; École Polytechnique Fédérale de Lausanne; National Cancer Institute; National Science Foundation; National Institutes of Health; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"Enhancer; Chromatin; Biology; Transcription factor; Epigenetics; Leukemia; Genetics; Cell biology; Cancer research; Gene","score_opus":0.011373792405371792,"score_gpt":0.26987160549739164,"score_spread":0.25849781309201986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206433678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998314,0.00038330816,0.00042093618,0.00023896022,0.00014940205,0.00026145583,0.00007816471,0.0000050950607,0.0001486606],"genre_scores_gemma":[0.99858063,0.000031316715,0.00053321157,0.000114221904,0.00014451118,0.000097396754,0.00039132105,0.000013412834,0.00009397886],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993579,0.000044205786,0.00020355626,0.00018949229,0.000081872684,0.00012300174],"domain_scores_gemma":[0.999666,0.000009346677,0.000116546,0.00015666422,0.000034611057,0.000016872045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008908228,0.00006668092,0.00010342993,0.000055986085,0.000036221783,0.0000026154025,0.00009324748,0.00008335218,0.00008628938],"category_scores_gemma":[0.000021254806,0.00008265439,0.0000704938,0.00008441974,0.000023578325,0.0000020462921,0.0000795564,0.000048964983,0.0000010636684],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008192332,0.00017554636,0.0008970214,0.000019845827,0.00006240819,7.218304e-7,0.00017205742,0.00095822365,0.99615395,0.00006795251,0.00058252783,0.0008278181],"study_design_scores_gemma":[0.0027423115,0.00051992066,0.0027084816,0.0000045638963,0.00006440427,0.000017210317,0.00006211164,0.0006997556,0.9848173,0.0001973153,0.008046991,0.000119628974],"about_ca_topic_score_codex":0.000031463656,"about_ca_topic_score_gemma":0.00007237922,"teacher_disagreement_score":0.011336649,"about_ca_system_score_codex":0.000022752209,"about_ca_system_score_gemma":0.00009047893,"threshold_uncertainty_score":0.33705485},"labels":[],"label_agreement":null},{"id":"W4206502760","doi":"10.1182/blood.2021014506","title":"Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Pharmacyclics; Genentech; Assistance publique-Hôpitaux de Paris; University of Cambridge; Cambridge University Hospitals; BeiGene; Gilead Sciences; Atara Biotherapeutics; Brown University; Incyte; Bristol-Myers Squibb; AstraZeneca; University Hospitals Bristol NHS Foundation Trust; Celgene; Amgen; University of Texas MD Anderson Cancer Center; Pfizer","keywords":"Methotrexate; Central nervous system; Cohort; Chemotherapy; Cohort study; Lymphoma; Primary central nervous system lymphoma; Clinical trial","score_opus":0.01564028191000926,"score_gpt":0.2740507937589462,"score_spread":0.25841051184893693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206502760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991218,0.00007401193,0.000004491979,0.000077838406,0.00007546822,0.0002457301,0.00014508826,0.000006336095,0.00024926485],"genre_scores_gemma":[0.99868447,0.000013797215,0.0009230139,0.00003801393,0.000009624455,0.000081691454,0.00018769858,0.000009377462,0.00005234395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989959,0.00005566492,0.00032778695,0.00017969502,0.00033940206,0.00010152308],"domain_scores_gemma":[0.99946755,0.000067746485,0.00016212693,0.0001863352,0.00007982709,0.000036429756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011430184,0.00008223144,0.0003351306,0.0004921586,0.000019063384,0.0000027494705,0.00007953224,0.000019883535,0.00046723676],"category_scores_gemma":[0.000060456146,0.000071691684,0.00016701482,0.00054085476,0.000019050069,0.000024243362,0.00010711883,0.000057367364,0.0000016925331],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001884332,0.013402309,0.97378004,0.000026359015,0.0022998338,0.00004341887,0.00074906,0.0002742255,0.0007008236,0.000025506526,0.00001776191,0.008492215],"study_design_scores_gemma":[0.0102442885,0.00048019434,0.97916675,0.000028894434,0.0017042196,0.0000013867742,0.00011457545,0.0011576278,0.006936518,0.0000058719015,0.000103952865,0.00005574541],"about_ca_topic_score_codex":0.0010738249,"about_ca_topic_score_gemma":0.00006119979,"teacher_disagreement_score":0.012922115,"about_ca_system_score_codex":0.0000861739,"about_ca_system_score_gemma":0.000030300333,"threshold_uncertainty_score":0.5115915},"labels":[],"label_agreement":null},{"id":"W4206949196","doi":"10.1182/blood-2019-131217","title":"Results from a Phase 1/2 Clinical Trial of Tagraxofusp (SL-401) in Patients with Intermediate, or High Risk, Relapsed/Refractory Myelofibrosis","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Monocytosis; Myelofibrosis; Refractory (planetary science); Internal medicine; Ruxolitinib; Phases of clinical research; Myeloid; Oncology; Regimen; Gastroenterology; Clinical trial; Bone marrow","score_opus":0.021539292520514345,"score_gpt":0.3020193437126692,"score_spread":0.28048005119215486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206949196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958882,0.000037917533,0.000001913279,0.000078983045,0.00045167483,0.0020469625,0.0011302237,0.000026298487,0.00033783377],"genre_scores_gemma":[0.9974808,0.0002284132,0.00087020115,0.00011874782,0.00023892007,0.00010831167,0.0006638851,0.000038685983,0.0002520104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970932,0.0002705941,0.0011767907,0.00065857964,0.0005041676,0.00029667458],"domain_scores_gemma":[0.997106,0.0012348031,0.00061284046,0.000673032,0.00015983095,0.00021349551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038248274,0.00030306805,0.0010122036,0.0001513095,0.000030185487,0.000014833165,0.00012504234,0.00023067146,0.00043596886],"category_scores_gemma":[0.00076646055,0.00018695075,0.00016926302,0.00023822898,0.000100166806,0.00010807891,0.00006164417,0.00042080204,0.00013071882],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22816496,0.027661419,0.7375626,0.000023964676,0.00049460155,0.00005089478,0.00023446893,6.792856e-7,0.000029053104,0.0000054004017,0.0003827367,0.0053892285],"study_design_scores_gemma":[0.41723725,0.02754056,0.55255723,0.00029999125,0.00042942676,5.8026336e-7,0.000027380043,0.0000044492763,0.0013814126,0.000009517396,0.00037752764,0.00013469024],"about_ca_topic_score_codex":0.0006633217,"about_ca_topic_score_gemma":0.00038193978,"teacher_disagreement_score":0.1890723,"about_ca_system_score_codex":0.000055422188,"about_ca_system_score_gemma":0.00023312849,"threshold_uncertainty_score":0.7623631},"labels":[],"label_agreement":null},{"id":"W4207082494","doi":"10.1182/blood.v128.22.2595.2595","title":"The Risk of Venous Thromboembolism in Pregnant Women with Essential Thrombocythemia: A Systematic Review and Meta-Analysis","year":2016,"lang":"en","type":"review","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Pregnancy; Essential thrombocythemia; Absolute risk reduction; Obstetrics; Thrombophilia; Aspirin; Low molecular weight heparin; Meta-analysis; Relative risk; Venous thromboembolism; Cohort study; Confidence interval; Thrombosis; Surgery; Internal medicine; Polycythemia vera","score_opus":0.026959144689271436,"score_gpt":0.3053683838241388,"score_spread":0.27840923913486737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4207082494","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015141843,0.99372745,0.0000032397918,0.000081378086,0.000010211323,0.00568412,0.00020079498,0.000012900328,0.00012847959],"genre_scores_gemma":[0.00042006906,0.9944327,0.000057034962,0.00003553498,0.000021847429,0.00479742,0.000018153347,0.000046045858,0.00017122518],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99664515,0.0007177487,0.0012813945,0.00054581894,0.00044601734,0.00036385065],"domain_scores_gemma":[0.99646395,0.0008925757,0.0013393029,0.0010440414,0.00012912544,0.0001309941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091904536,0.00059157156,0.014074948,0.00018442639,0.00009286988,0.0000279287,0.00018944971,0.00016714384,0.00011574014],"category_scores_gemma":[0.00020025334,0.00020238424,0.0012520392,0.00061151304,0.00014675509,0.000034203007,0.000076022094,0.00027611616,0.000014043307],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005877187,0.0009051414,0.000023979037,0.5656124,0.4317924,0.000057396177,0.00014620203,3.1314144e-8,6.1649295e-8,0.00007351028,0.000008309342,0.0013747247],"study_design_scores_gemma":[0.0007098728,0.0004291368,0.00003754966,0.13812928,0.8590019,0.0001342722,0.000018217743,8.352667e-8,0.0000048661313,0.000017887829,0.0013379406,0.00017903536],"about_ca_topic_score_codex":0.000029459832,"about_ca_topic_score_gemma":0.00006221316,"teacher_disagreement_score":0.42748308,"about_ca_system_score_codex":0.00008830217,"about_ca_system_score_gemma":0.00027874942,"threshold_uncertainty_score":0.9621353},"labels":[],"label_agreement":null},{"id":"W4210445533","doi":"10.1182/blood.2021014237","title":"Proton export takes charge of proliferation","year":2022,"lang":"en","type":"letter","venue":"Blood","topic":"Radiation Therapy and Dosimetry","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Proton; Charge (physics); Physics; Nuclear physics; Particle physics","score_opus":0.018585741105966943,"score_gpt":0.2566914619533721,"score_spread":0.23810572084740517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210445533","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15566544,0.0042002164,0.000058870985,0.78368413,0.0013891757,0.013007186,0.00037542824,0.00044320102,0.041176353],"genre_scores_gemma":[0.027240677,0.00019747115,0.00040774967,0.92321813,0.010203454,0.002340312,0.0043761013,0.00016226433,0.031853843],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988604,0.00005123455,0.00030770182,0.00021395448,0.00042730992,0.00013937194],"domain_scores_gemma":[0.99933934,0.00002939247,0.00023537697,0.00031333766,0.000054648106,0.000027910211],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014604235,0.00014228761,0.00032703648,0.00016410423,0.00004471823,0.0000073270435,0.00007524542,0.00027324926,0.0035501863],"category_scores_gemma":[0.000048258476,0.0001279589,0.00011987427,0.0001376149,0.000020547082,0.000038414208,0.000008386076,0.00066344644,0.000024438947],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012568914,0.00065240386,0.017668065,0.0012923363,0.00036683094,0.00022908075,0.00037359408,2.465504e-7,0.0028767462,0.00002610398,0.9759372,0.0004517394],"study_design_scores_gemma":[0.0017525925,0.00063498993,0.00072399806,0.000053622825,0.00022667416,0.0000720864,0.000009122776,0.000004940914,0.056046918,0.000016053767,0.9403293,0.00012970416],"about_ca_topic_score_codex":0.0000035253165,"about_ca_topic_score_gemma":6.043876e-8,"teacher_disagreement_score":0.139534,"about_ca_system_score_codex":0.000021126601,"about_ca_system_score_gemma":0.00015561332,"threshold_uncertainty_score":0.9973607},"labels":[],"label_agreement":null},{"id":"W4210485820","doi":"10.1182/blood.2021014251","title":"Megakaryocytic emperipolesis as a dyshematopoietic feature in acute myeloid leukemia with inv(16)","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Emperipolesis; Myeloid leukemia; Feature (linguistics); Myeloid; Medicine; Cancer research; Pathology; Philosophy; Disease","score_opus":0.008839263724598652,"score_gpt":0.2547337429939986,"score_spread":0.24589447926939995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210485820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859085,0.00091561314,0.00000658782,0.004093826,0.000058084832,0.00093737757,0.000028179471,0.00015330943,0.007898503],"genre_scores_gemma":[0.98650867,0.00012650042,0.0009494499,0.001993368,0.00011774098,0.0004930428,0.00012886502,0.00011071347,0.0095716715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99694395,0.00016998124,0.0003166005,0.000667725,0.0011049702,0.0007967913],"domain_scores_gemma":[0.99854344,0.00010634608,0.00009390499,0.00083584676,0.00008611877,0.00033433503],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003931337,0.00034827561,0.0006261885,0.0005025472,0.00024474825,0.000042851323,0.0004380816,0.00015412447,0.0006824426],"category_scores_gemma":[0.000108372355,0.00029330127,0.00013032684,0.0014892829,0.00015489843,0.00011583559,0.0004415317,0.0015995393,0.00013689221],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018490588,0.009446697,0.4108017,0.0028535628,0.008280686,0.1506546,0.023024095,0.00043698732,0.20328407,0.0051406324,0.15920654,0.008379824],"study_design_scores_gemma":[0.194981,0.023011625,0.2736002,0.0018778738,0.0076699215,0.11621227,0.023517644,0.001824113,0.17455193,0.0025391572,0.17450073,0.0057135546],"about_ca_topic_score_codex":0.00068952533,"about_ca_topic_score_gemma":0.00014335597,"teacher_disagreement_score":0.17649041,"about_ca_system_score_codex":0.002276717,"about_ca_system_score_gemma":0.0020701687,"threshold_uncertainty_score":0.9999519},"labels":[],"label_agreement":null},{"id":"W4210768673","doi":"10.1182/blood.2021014618","title":"A Micro-lyse goes a long way","year":2022,"lang":"sv","type":"letter","venue":"Blood","topic":"Hemoglobin structure and function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Biology; Medicine","score_opus":0.005864149340609524,"score_gpt":0.2089678840006158,"score_spread":0.20310373466000628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210768673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9419529,0.016301261,0.00021924327,0.02383563,0.0046915915,0.0010507744,0.0009994636,0.00008137356,0.010867763],"genre_scores_gemma":[0.51687765,0.003450301,0.0016455882,0.3394339,0.040250555,0.000508396,0.025659004,0.0006357532,0.071538836],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971993,0.00021071821,0.00045465174,0.0011040304,0.0003402461,0.00069108047],"domain_scores_gemma":[0.99851656,0.000023381344,0.0002583335,0.0009963049,0.00008764389,0.00011775842],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016823114,0.00060889014,0.00048277233,0.0001078012,0.00029244288,0.000092542316,0.00052781263,0.0012460556,0.002125366],"category_scores_gemma":[0.000056358254,0.00060653186,0.00048802482,0.00018433794,0.000117029216,0.0000039397705,0.0004592277,0.0011768754,0.00012799303],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012158738,0.0002621755,0.0015717322,0.00026901544,0.0010383482,0.0006352341,0.00009616457,0.000003658597,0.5282855,0.0000037136144,0.46564558,0.0020672805],"study_design_scores_gemma":[0.00147311,0.0006009503,0.0005254264,0.000028844546,0.00062165747,0.00049852213,0.00003981086,6.263762e-7,0.14049308,0.000017734119,0.85504746,0.00065275514],"about_ca_topic_score_codex":0.00005074403,"about_ca_topic_score_gemma":0.000021363943,"teacher_disagreement_score":0.42507523,"about_ca_system_score_codex":0.000039462073,"about_ca_system_score_gemma":0.00020029201,"threshold_uncertainty_score":0.9996386},"labels":[],"label_agreement":null},{"id":"W4210950866","doi":"10.1182/blood.2021014299","title":"Telomeres, aging, and cancer: the big picture","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research; Terry Fox Research Institute","keywords":"Telomere; Biology; Context (archaeology); Genetics; Cancer; Senescence; Disease; Telomerase; Evolutionary biology; DNA; Medicine; Gene; Pathology","score_opus":0.01532761594304906,"score_gpt":0.2490442419186859,"score_spread":0.23371662597563683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210950866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9745004,0.018067583,0.000003783625,0.005258042,0.00032631907,0.0002672968,0.000037558435,0.00008701024,0.0014519669],"genre_scores_gemma":[0.9924213,0.0010677362,0.00006104918,0.0030619928,0.00041745955,0.00007919937,0.00001225351,0.00002229575,0.0028566942],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990051,0.000053622563,0.00013998523,0.00024949995,0.00030325458,0.00024857622],"domain_scores_gemma":[0.99944216,0.000049463273,0.000052114716,0.00032464476,0.000027903587,0.00010369669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014523759,0.00012858142,0.00018514536,0.000065454864,0.00038165774,0.000020763327,0.00014311446,0.00003139494,0.00042250106],"category_scores_gemma":[0.00003067014,0.00008688799,0.00005026022,0.0002570602,0.00009116889,0.00002148791,0.00013852835,0.0003538222,0.000005916618],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021080839,0.0012448534,0.6232602,0.00031850516,0.0005801927,0.00070606195,0.008647439,0.000020281304,0.028439973,0.00094524975,0.028024783,0.30760163],"study_design_scores_gemma":[0.003561437,0.00031146317,0.17671184,0.000051720017,0.00040428442,0.000785926,0.0018221495,0.000032606265,0.006679671,0.00015084793,0.8092039,0.00028412047],"about_ca_topic_score_codex":0.00034234606,"about_ca_topic_score_gemma":0.0000674116,"teacher_disagreement_score":0.78117913,"about_ca_system_score_codex":0.000023247007,"about_ca_system_score_gemma":0.00012833161,"threshold_uncertainty_score":0.46260902},"labels":[],"label_agreement":null},{"id":"W4211188108","doi":"10.1182/blood-2003-12-4195","title":"New anticoagulants","year":2004,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":147,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"","keywords":"Ximelagatran; Medicine; Discovery and development of direct thrombin inhibitors; Direct thrombin inhibitor; Warfarin; Atrial fibrillation; Coagulation; Thrombin; Vitamin K antagonist; Anticoagulant; Thrombosis; Tissue factor; Thrombomodulin; Dabigatran; Pharmacology; Internal medicine; Platelet","score_opus":0.04837935815607195,"score_gpt":0.3422306693773152,"score_spread":0.29385131122124325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211188108","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000035209712,0.98957175,0.000027343283,0.00004604402,0.00024078542,0.0009976585,0.000007147433,0.00009545443,0.009010302],"genre_scores_gemma":[0.0000034454363,0.9958573,0.0011401868,0.00011232365,0.0005841637,0.000035878824,0.00008018256,0.000069003916,0.002117543],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99874884,0.000018594004,0.00036114498,0.00034663352,0.00023580024,0.0002890083],"domain_scores_gemma":[0.9991064,0.00001975751,0.00013929114,0.0005022004,0.000017481547,0.0002148525],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007083281,0.0003139675,0.0022302151,0.00015148266,0.000033641452,0.000026024736,0.00014902714,0.00020077168,0.00041004634],"category_scores_gemma":[0.000023730776,0.00023477645,0.00048272626,0.00018741401,0.000014009459,0.000020845036,0.00008596459,0.00021212253,0.001041108],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[6.0791496e-7,0.0009603603,0.0000050508525,0.036803707,0.0010230546,0.00034262784,0.000018073126,3.7358166e-8,1.1434643e-7,0.00080365775,0.007281894,0.9527608],"study_design_scores_gemma":[0.0010021653,0.00012775678,0.00006624445,0.039502766,0.012029995,0.00018710554,0.0000020488685,1.3730018e-8,0.0000025037614,0.000056854882,0.94681394,0.00020861987],"about_ca_topic_score_codex":0.000081133396,"about_ca_topic_score_gemma":0.000002725816,"teacher_disagreement_score":0.9525522,"about_ca_system_score_codex":0.000050114784,"about_ca_system_score_gemma":0.0006057628,"threshold_uncertainty_score":0.9997367},"labels":[],"label_agreement":null},{"id":"W4211195961","doi":"10.1182/blood.v96.9.2951.h8002951_2951_2964","title":"Mechanisms of HIV-associated lymphocyte apoptosis","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Immune system; Apoptosis; Cytotoxic T cell; Immunology; Biology; CD8; T cell; Viral replication; Lymphocyte; Virology; Virus; In vitro","score_opus":0.00874553566597122,"score_gpt":0.22195374780474517,"score_spread":0.21320821213877394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211195961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876032,0.0007982559,0.000016911446,0.00007121519,0.00004246009,0.00012343258,0.0001948397,0.00004859028,0.011101088],"genre_scores_gemma":[0.98906463,0.00015411174,0.000080805585,0.000027488124,0.000003263403,0.000018733626,0.00023393208,0.000008093676,0.010408936],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993393,0.00008994814,0.00013481836,0.00013742779,0.000032868535,0.00026565764],"domain_scores_gemma":[0.99971014,0.000043178763,0.000032639025,0.00016433276,0.000028260198,0.000021445816],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000081912855,0.00008465203,0.00016615177,0.000041690222,0.000070064016,0.000003495544,0.000112809474,0.00011507014,0.0063126725],"category_scores_gemma":[0.000020924695,0.00007009738,0.00007184917,0.00009401424,0.00005780339,0.000023202174,0.000019067355,0.000063514264,0.0047638975],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022163587,0.0038311284,0.0025308395,0.000015065196,0.001835039,0.00001731071,0.00030481923,0.000002187222,0.9612085,0.0009727099,0.0034566342,0.025604099],"study_design_scores_gemma":[0.0064957268,0.00034672988,0.0040255655,0.000016938322,0.00010118968,0.00001404672,0.000030291203,3.7497426e-7,0.98344165,0.00037294423,0.0050657666,0.00008876611],"about_ca_topic_score_codex":0.000099130804,"about_ca_topic_score_gemma":0.000008694515,"teacher_disagreement_score":0.025515333,"about_ca_system_score_codex":0.000021347787,"about_ca_system_score_gemma":0.00005137116,"threshold_uncertainty_score":0.996011},"labels":[],"label_agreement":null},{"id":"W4213274632","doi":"10.1182/blood.2021014309","title":"Guiding the global evolution of cytogenetic testing for hematologic malignancies","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"National Cancer Institute; Mayo Clinic","keywords":"Hematologic Neoplasms; Cytogenetics; Biology; Genomics; Computational biology; Chromosome; Bioinformatics; Genome; Genetics; Cancer; Gene","score_opus":0.025454859222298353,"score_gpt":0.24487108218807072,"score_spread":0.21941622296577237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213274632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937587,0.003805527,0.001485132,0.00007522965,0.00010594044,0.00018840621,0.0001505418,0.00000491722,0.00042561494],"genre_scores_gemma":[0.9979492,0.000016671884,0.0017303914,0.000084729516,0.000084838226,0.000090027825,0.000020150132,0.00000632764,0.000017655642],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99952483,0.00001963997,0.00012808185,0.00013636955,0.00006465967,0.00012642628],"domain_scores_gemma":[0.9996363,0.000040324645,0.00008096075,0.00016911028,0.000057343892,0.00001595791],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013593594,0.0000586945,0.000070604576,0.000007914828,0.00016435803,0.000006659344,0.00015834713,0.00002409427,0.0000035391727],"category_scores_gemma":[0.00026818144,0.00005067625,0.000055044457,0.000085931126,0.00003268655,4.7594375e-7,0.00017990527,0.000015692789,2.8427573e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003654408,0.00015989615,0.09620049,0.000034702432,0.000061112536,0.0000017437602,0.000025810874,0.0020217455,0.8934532,0.006793572,0.00085712294,0.00035409268],"study_design_scores_gemma":[0.0035191546,0.0029112028,0.031058399,0.00002746667,0.0003841212,0.00040740045,0.0011937937,0.0006101257,0.9177372,0.015036973,0.02657091,0.0005432574],"about_ca_topic_score_codex":0.000030940228,"about_ca_topic_score_gemma":0.000014940837,"teacher_disagreement_score":0.06514209,"about_ca_system_score_codex":0.000024304572,"about_ca_system_score_gemma":0.00010339118,"threshold_uncertainty_score":0.20665175},"labels":[],"label_agreement":null},{"id":"W4213412735","doi":"10.1182/blood.2021014936","title":"Clearing NETs with T-series resolvins","year":2021,"lang":"en","type":"letter","venue":"Blood","topic":"Optimization and Search Problems","field":"Computer Science","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Clearing; Series (stratigraphy); Computer science; Biology; Business","score_opus":0.020455928698242663,"score_gpt":0.21445348321539798,"score_spread":0.1939975545171553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213412735","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007183798,0.0004365003,0.07036546,0.9008452,0.0003497605,0.00029044304,0.000006571027,0.00047203523,0.027162163],"genre_scores_gemma":[0.00017503748,0.00023216844,0.2429738,0.72341377,0.0013826299,0.000053796422,0.00013431063,0.00008170359,0.031552788],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99850625,0.00008862151,0.0001521926,0.0004745936,0.0004203875,0.000357948],"domain_scores_gemma":[0.9989644,0.000039301347,0.000073219286,0.00073801883,0.000129504,0.00005554204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009115196,0.00017784633,0.00020084578,0.00009708091,0.00012191817,0.0005577795,0.0007858654,0.00022942097,0.00006862756],"category_scores_gemma":[0.000020545509,0.00015167537,0.000050417257,0.0003207005,0.000044454562,0.0003311438,0.00035007772,0.00084890384,0.00005010669],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000020886735,0.000083146326,0.00013607304,0.00011269054,0.000110043016,0.0025110608,0.0004344006,0.00011803152,0.000028103861,0.0028598644,0.9927964,0.000808074],"study_design_scores_gemma":[0.00044056633,0.00012132443,0.000041811945,0.00012267477,0.00001546596,0.00017366037,0.0000066435123,0.00060081587,0.00030758642,0.0001408622,0.99774176,0.00028685544],"about_ca_topic_score_codex":0.00001532819,"about_ca_topic_score_gemma":0.00001591142,"teacher_disagreement_score":0.17743146,"about_ca_system_score_codex":0.000011899193,"about_ca_system_score_gemma":0.00019759848,"threshold_uncertainty_score":0.6185142},"labels":[],"label_agreement":null},{"id":"W4213455234","doi":"10.1182/blood.2021014393","title":"TEMPI syndrome associated with IgM monoclonal gammopathy","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Vascular Malformations and Hemangiomas","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Monoclonal gammopathy; Medicine; Immunoglobulin M; Paraproteinemias; Monoclonal gammopathy of undetermined significance; Immunology; Waldenstrom macroglobulinemia; Monoclonal; Monoclonal antibody; Antibody; Immunoglobulin G; Lymphoma","score_opus":0.010519415688082102,"score_gpt":0.20735906064052584,"score_spread":0.19683964495244374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213455234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947035,0.00026847035,0.000025530207,0.00037161607,0.000028800328,0.00020433553,0.00002337908,0.000086644446,0.004287739],"genre_scores_gemma":[0.99792784,0.0000028397044,0.00032840663,0.00022168348,0.000022494069,0.00007410792,0.0001404576,0.000017632354,0.0012645457],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992313,0.000027801576,0.00012642886,0.00012088383,0.00032611113,0.00016749765],"domain_scores_gemma":[0.99963826,0.000014455632,0.000051026724,0.00018934731,0.000037508034,0.00006938172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001706628,0.000079261226,0.00016293002,0.000090178,0.00019260662,0.000009946319,0.00005947597,0.000024599176,0.0005996527],"category_scores_gemma":[0.00002039865,0.000066240245,0.00008181894,0.00026470615,0.00001688332,0.000044890767,0.000051121424,0.00014936221,0.000033337634],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004328895,0.017668052,0.9313957,0.00032764208,0.0060997545,0.013225095,0.004827642,0.0003725875,0.0053074183,0.006102903,0.012686306,0.0015540138],"study_design_scores_gemma":[0.016229257,0.0032692167,0.9446998,0.00012502514,0.0015688228,0.013727132,0.0009953937,0.0004901588,0.0011731457,0.00020236644,0.017027406,0.0004922681],"about_ca_topic_score_codex":0.000013977993,"about_ca_topic_score_gemma":0.0000060767466,"teacher_disagreement_score":0.015796367,"about_ca_system_score_codex":0.00004071699,"about_ca_system_score_gemma":0.00008100172,"threshold_uncertainty_score":0.65657765},"labels":[],"label_agreement":null},{"id":"W4214590475","doi":"10.1182/blood.2021013674","title":"A randomized, placebo-controlled, double-blind trial of canakinumab in children and young adults with sickle cell anemia","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Canakinumab; Medicine; Placebo; Internal medicine; Adverse effect; Sickle cell anemia; Randomized controlled trial; Anemia; Clinical endpoint; Gastroenterology; Anakinra; Pediatrics; Disease; Pathology","score_opus":0.004913476142165777,"score_gpt":0.21235085630878422,"score_spread":0.20743738016661845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214590475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98782516,0.0017506799,0.0000017397181,0.00015521946,0.00007664034,0.004889123,0.000015313859,0.00002071817,0.0052654054],"genre_scores_gemma":[0.9987926,0.0001909048,0.000051841096,0.00004748206,0.00004934948,0.0003495787,0.00004038701,0.000022899034,0.00045498618],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998623,0.00013396222,0.00042289178,0.0002631726,0.0003175506,0.0002394367],"domain_scores_gemma":[0.99941665,0.00007982006,0.00017905627,0.00019682491,0.00003354353,0.000094083116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005390244,0.00016501689,0.0008579284,0.00017461754,0.00007796259,0.000008542413,0.00007461134,0.00008499034,0.00010215786],"category_scores_gemma":[0.000036556226,0.000116929914,0.000114019356,0.0002512938,0.000097231234,0.000028600356,0.000053321866,0.00036075595,0.0000011426898],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9935068,0.0012119937,0.0033892393,0.00004826999,0.00023525293,0.00006136239,0.0011854522,0.00007682366,0.00004769526,0.000024791332,0.000058875466,0.00015345874],"study_design_scores_gemma":[0.9959695,0.001236892,0.00019438077,0.000055106262,0.00082856766,0.00024648217,0.00096700015,0.00008563973,0.00025217826,0.000008172137,0.00001942084,0.00013668613],"about_ca_topic_score_codex":0.0039497344,"about_ca_topic_score_gemma":0.00035533516,"teacher_disagreement_score":0.010967412,"about_ca_system_score_codex":0.000026052587,"about_ca_system_score_gemma":0.00022885815,"threshold_uncertainty_score":0.5970843},"labels":[],"label_agreement":null},{"id":"W4214663833","doi":"10.1182/blood.v126.23.4163.4163","title":"An Phase 2 Study of Lenalidomide in Combination with Oral Dexamethasone in Previously Untreated, Symptomatic Patients with Chronic Lymphocytic Leukemia (CLL)","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Institute in Oncology and Hematology; CancerCare Manitoba; Princess Margaret Cancer Centre","funders":"","keywords":"Lenalidomide; Medicine; Dexamethasone; Internal medicine; Multiple myeloma; Regimen; Gastroenterology; Tumor lysis syndrome; Thalidomide; Surgery; Oncology; Chemotherapy","score_opus":0.021142130278443975,"score_gpt":0.3059574708397,"score_spread":0.284815340561256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214663833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963865,0.00021052508,0.000018199242,0.000007575459,0.00001912016,0.003177994,0.0000043293894,0.000059478698,0.00011627055],"genre_scores_gemma":[0.9992515,0.00001054161,0.00031989635,0.000018150162,0.000022827853,0.00019227286,0.000080231555,0.00006492738,0.000039689006],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9967104,0.0003435225,0.000643561,0.0005236947,0.0011964078,0.0005823754],"domain_scores_gemma":[0.9982044,0.00013967982,0.00022351992,0.00076054555,0.00034874046,0.0003231296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079711253,0.0003118509,0.00079370814,0.0005345393,0.000027020824,0.000029802475,0.00026197723,0.00011752783,0.000019631576],"category_scores_gemma":[0.00020191535,0.00022845261,0.000029572988,0.0011771102,0.00014770924,0.00029030212,0.00006267809,0.00024002093,0.0000118321],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.015460961,0.047615286,0.9071306,0.0012458464,0.00069323747,0.0018799149,0.0125773195,0.006379873,0.00037500256,0.00002561698,0.00003099229,0.006585372],"study_design_scores_gemma":[0.85172796,0.040614724,0.064161725,0.0012713242,0.0005592403,0.00016815629,0.001391825,0.03718581,0.0025255245,0.000023787039,0.000004184106,0.00036575057],"about_ca_topic_score_codex":0.011628598,"about_ca_topic_score_gemma":0.006667647,"teacher_disagreement_score":0.8429688,"about_ca_system_score_codex":0.043654926,"about_ca_system_score_gemma":0.021422734,"threshold_uncertainty_score":0.99495304},"labels":[],"label_agreement":null},{"id":"W4214859401","doi":"10.1182/blood.2022015789","title":"CAR T cells as a second-line therapy for large B-cell lymphoma: a paradigm shift?","year":2022,"lang":"en","type":"review","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":164,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Chimeric antigen receptor; Oncology; Lymphoma; Internal medicine; Chemotherapy; Autologous stem-cell transplantation; Transplantation; Refractory (planetary science); Cell therapy; Surgery; Stem cell; Immunotherapy; Cancer; Biology","score_opus":0.058664802153939176,"score_gpt":0.3534623504236394,"score_spread":0.2947975482697002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214859401","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042435672,0.98400337,0.000010371023,0.00008381525,0.0004028777,0.0064791576,0.0009336459,0.00014182307,0.0075205998],"genre_scores_gemma":[0.00003331796,0.95835775,0.00009668014,0.00046506175,0.0011244584,0.002702152,0.0011765374,0.00038396678,0.035660073],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958397,0.00033126812,0.0008663148,0.0010551126,0.0008116149,0.0010959718],"domain_scores_gemma":[0.99697024,0.0007959298,0.0003464485,0.0014231879,0.000045931905,0.0004182692],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010266071,0.0007968589,0.0028841714,0.00043136918,0.00021497456,0.000069276604,0.00065355754,0.0005133056,0.031500578],"category_scores_gemma":[0.000045197205,0.00065912306,0.001909081,0.0006406135,0.000056204448,0.000045823177,0.0001962345,0.00075692736,0.00038544548],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072136626,0.016288154,0.0000033528263,0.041671894,0.0032338346,0.0010380972,0.0005535907,5.4130773e-8,0.00039919882,0.0004898656,0.0061606513,0.92943996],"study_design_scores_gemma":[0.022308202,0.0020718046,5.779756e-7,0.0009869192,0.0016077897,0.000316934,0.00001976028,0.0000018663719,0.0007758333,0.0001634729,0.9711833,0.0005635425],"about_ca_topic_score_codex":0.000031817537,"about_ca_topic_score_gemma":0.000013480241,"teacher_disagreement_score":0.9650226,"about_ca_system_score_codex":0.0002870576,"about_ca_system_score_gemma":0.0021293252,"threshold_uncertainty_score":0.999586},"labels":[],"label_agreement":null},{"id":"W4220904165","doi":"10.1182/blood.2021015365","title":"Macrophage NOX2 NADPH oxidase maintains alveolar homeostasis in mice","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Hospital for Sick Children","funders":"National Institute of Dental and Craniofacial Research; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of General Medical Sciences; National Heart, Lung, and Blood Institute","keywords":"Proinflammatory cytokine; NADPH oxidase; Inflammation; TLR4; Immunology; TLR2; Chronic granulomatous disease; Macrophage; Alveolar macrophage; Biology; Chemistry; Cell biology; Reactive oxygen species; Biochemistry","score_opus":0.009239000233799506,"score_gpt":0.21379825290609342,"score_spread":0.2045592526722939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220904165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993719,0.0037533406,0.00005509114,0.0003671324,0.00043334847,0.00035192954,0.00030107962,0.00009283652,0.0009262467],"genre_scores_gemma":[0.99641025,0.00008798101,0.00019666171,0.0010284303,0.000033667406,0.00015607776,0.00022165812,0.00004069483,0.0018245976],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99790096,0.00053969986,0.00034204384,0.0005136595,0.000076425626,0.0006271905],"domain_scores_gemma":[0.9993567,0.00009399919,0.000104702434,0.00036834533,0.000033361313,0.000042925472],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041210648,0.0002595576,0.00034683733,0.0002781072,0.0004272646,0.000017151535,0.00045847145,0.00012804328,0.0040493053],"category_scores_gemma":[0.000039997714,0.00026739607,0.00013095562,0.00045795715,0.00009892179,0.00009493615,0.00044387503,0.00071081537,0.0006935956],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012649239,0.0010375166,0.00074951764,0.00001385673,0.00014800509,0.0006098985,0.0004722962,0.00000886986,0.9911948,0.0029086438,0.0007062459,0.002023899],"study_design_scores_gemma":[0.0051470543,0.000467154,0.0023195192,0.000012885564,0.0000776101,0.00032425343,0.0011787367,8.1739825e-7,0.9479943,0.0005166197,0.04158729,0.00037376335],"about_ca_topic_score_codex":0.00021569013,"about_ca_topic_score_gemma":0.00007169065,"teacher_disagreement_score":0.04320046,"about_ca_system_score_codex":0.00008837544,"about_ca_system_score_gemma":0.00008013221,"threshold_uncertainty_score":0.9999778},"labels":[],"label_agreement":null},{"id":"W4220939421","doi":"10.1182/blood.2021013950","title":"Activation of the zinc-sensing receptor GPR39 promotes T-cell reconstitution after hematopoietic cell transplant in mice","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Trace Elements in Health","field":"Nursing","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; University of Washington; National Institute on Aging; National Cancer Institute; National Institutes of Health; University of Toronto; National Heart, Lung, and Blood Institute","keywords":"T cell; Immunology; Cancer research; Stem cell; Regeneration (biology); Hematopoietic stem cell transplantation; Hematopoietic stem cell; Biology; Haematopoiesis; Immune system; Medicine; Cell biology","score_opus":0.011319718029122757,"score_gpt":0.22936976447791413,"score_spread":0.21805004644879136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220939421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970394,0.00013461473,0.00003927456,0.0008300843,0.00067552476,0.000643306,0.000033575245,0.000030733616,0.0005735201],"genre_scores_gemma":[0.9984897,0.0000042508887,0.0012273524,0.00013433197,0.000042093,0.000029144874,0.000010871006,0.000018658133,0.00004362066],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986427,0.0002774064,0.000358367,0.00022622054,0.00026505004,0.00023028106],"domain_scores_gemma":[0.9994485,0.00010073006,0.00018181527,0.00022004382,0.000022096545,0.000026833437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036101555,0.000109706605,0.00014234973,0.00008837468,0.00016295457,0.000010086918,0.0001343795,0.000048575675,0.00010685159],"category_scores_gemma":[0.00002031174,0.0001001864,0.000051605155,0.00028033875,0.000047496706,0.00008873315,0.00003426426,0.00030722914,0.0000050879266],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053283584,0.0025741872,0.051350277,0.00093726953,0.000016702868,0.000008725425,0.014682393,0.0002737985,0.92692447,0.000058103662,0.0002023247,0.0024389338],"study_design_scores_gemma":[0.001597755,0.0001529999,0.0044143926,0.00020652394,0.000052070507,0.000021548847,0.00054984656,0.00007248755,0.9920008,0.00013447246,0.0006571135,0.00013994418],"about_ca_topic_score_codex":0.00015379343,"about_ca_topic_score_gemma":0.0000668756,"teacher_disagreement_score":0.065076396,"about_ca_system_score_codex":0.00013457616,"about_ca_system_score_gemma":0.00007076978,"threshold_uncertainty_score":0.4085483},"labels":[],"label_agreement":null},{"id":"W4221017287","doi":"10.1182/blood.2021013113","title":"CRLF3 plays a key role in the final stage of platelet genesis and is a potential therapeutic target for thrombocythemia","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute","funders":"Medical Research Council; Deutsche Forschungsgemeinschaft; UK Research and Innovation; British Heart Foundation; Wellcome Trust","keywords":"Platelet; Megakaryocyte; Thrombopoietin; Haematopoiesis; Cell biology; Biology; Stem cell; Thrombopoiesis; Essential thrombocythemia; Immunology","score_opus":0.02347596223597036,"score_gpt":0.268012092046979,"score_spread":0.24453612981100864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221017287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954316,0.0022729612,0.00003593715,0.00085252814,0.000021779193,0.00083354744,0.000311009,0.000008008505,0.0002326217],"genre_scores_gemma":[0.9976561,0.000109436645,0.00073007465,0.00067385467,0.000041734635,0.00055622484,0.000039382303,0.0000152699,0.0001778865],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991324,0.000060596994,0.00018888673,0.00020951289,0.0002301945,0.00017842864],"domain_scores_gemma":[0.9995808,0.00011546023,0.00006984671,0.00017271392,0.000027055767,0.00003410829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001942776,0.00012380122,0.00028237505,0.000059133752,0.00012541543,0.000011360515,0.0000765378,0.000034135588,0.00038517136],"category_scores_gemma":[0.000010943971,0.00008389147,0.00008225923,0.00010238385,0.000033531807,0.00002194462,0.000042481486,0.00010435224,0.0000011893156],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050359247,0.02365763,0.77708656,0.0009903013,0.0037928158,0.000956641,0.057110976,0.00041782527,0.10651049,0.006736789,0.0031113438,0.014592731],"study_design_scores_gemma":[0.06878733,0.015254951,0.4086595,0.00012674942,0.0020860964,0.0010004333,0.0148960985,0.003186874,0.43908563,0.0030342469,0.04309583,0.0007862846],"about_ca_topic_score_codex":0.00007457607,"about_ca_topic_score_gemma":0.000012439981,"teacher_disagreement_score":0.36842704,"about_ca_system_score_codex":0.00002067635,"about_ca_system_score_gemma":0.00007605752,"threshold_uncertainty_score":0.4217356},"labels":[],"label_agreement":null},{"id":"W4223525031","doi":"10.1182/blood.2021014735","title":"Long-term follow-up of liver-directed, adeno-associated vector-mediated gene therapy in the canine model of hemophilia A","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Southeastern Ontario Academic Medical Organization; Canadian Institutes of Health Research; BioMarin Pharmaceutical","keywords":"Genetic enhancement; Capsid; Titer; Medicine; Adeno-associated virus; Spleen; Gastroenterology; Virology; Immunology; Internal medicine; Antibody; Biology; Molecular biology; Vector (molecular biology); Virus; Gene; Recombinant DNA; Genetics","score_opus":0.02307641239934956,"score_gpt":0.2646365220195952,"score_spread":0.24156010962024563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223525031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99567443,0.0034640667,0.0000054558636,0.000076682336,0.00003593529,0.00041356502,0.0002605041,0.000013024461,0.000056357167],"genre_scores_gemma":[0.9981976,0.00089280546,0.00002359352,0.00013704857,0.000037292877,0.000105498744,0.0003810383,0.000032951368,0.00019214896],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998333,0.00037046074,0.00029031414,0.0002873098,0.0004226478,0.0002963154],"domain_scores_gemma":[0.9991651,0.000038710845,0.00015047679,0.00048026076,0.00012133504,0.0000440937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005405794,0.00015741878,0.00023919145,0.00009203622,0.00007473913,0.0000061654664,0.00057670346,0.000098546196,0.00008759129],"category_scores_gemma":[0.00007265541,0.00013538235,0.00013052257,0.00039984874,0.00007654335,0.0000024628116,0.00014810759,0.00019699745,0.0000011090142],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014755726,0.0010709453,0.0099822115,0.000012996725,0.00023030324,0.00001590549,0.00047712313,0.00056661473,0.985724,0.000002540201,0.00011882751,0.00032296995],"study_design_scores_gemma":[0.007290649,0.0043732817,0.017913705,0.000009391188,0.000035922276,0.000011032041,0.000052372525,0.0010132361,0.96906257,0.000019358376,0.000020136495,0.00019837174],"about_ca_topic_score_codex":0.00019228959,"about_ca_topic_score_gemma":0.0010058084,"teacher_disagreement_score":0.016661447,"about_ca_system_score_codex":0.000025257626,"about_ca_system_score_gemma":0.0002644618,"threshold_uncertainty_score":0.5520732},"labels":[],"label_agreement":null},{"id":"W4223545595","doi":"10.1182/blood.2021013541","title":"Low von Willebrand factor phenotype: the enigma continues","year":2022,"lang":"en","type":"letter","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Von Willebrand factor; Von Willebrand disease; Phenotype; Medicine; Genetics; Biology; Immunology; Platelet; Gene","score_opus":0.010117904019699859,"score_gpt":0.22566273135855877,"score_spread":0.2155448273388589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223545595","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38145006,0.0073346957,0.0000036373813,0.57833445,0.0010609019,0.0017984324,0.00080621423,0.00021616204,0.02899544],"genre_scores_gemma":[0.1127334,0.0007348766,0.00007138478,0.82576054,0.003858037,0.0002848683,0.003080026,0.00021822806,0.053258613],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99864423,0.00006312027,0.00019827067,0.00033937418,0.00041822574,0.00033675565],"domain_scores_gemma":[0.99921155,0.00011730309,0.000115602,0.00047866523,0.000032096006,0.000044785073],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000044061868,0.00029751632,0.0005280468,0.000064187996,0.00016294401,0.000036232894,0.00018158148,0.00028794803,0.0032778503],"category_scores_gemma":[0.00003592048,0.00018438618,0.00021762167,0.00009557645,0.00005931518,0.000027959355,0.00006672652,0.0011007059,0.00012979576],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062961924,0.0004468029,0.0012959085,0.00013232816,0.0010845717,0.00568956,0.00027831036,6.266883e-8,0.00009733482,0.0000029419991,0.9885861,0.0023230747],"study_design_scores_gemma":[0.0041904207,0.00030767496,0.0010295317,0.00006158618,0.00087383867,0.0002191971,0.000026987249,7.176346e-7,0.00043851498,0.000063669504,0.9925879,0.00019996613],"about_ca_topic_score_codex":0.000043961194,"about_ca_topic_score_gemma":0.0000072324806,"teacher_disagreement_score":0.26871666,"about_ca_system_score_codex":0.000028688872,"about_ca_system_score_gemma":0.00008145711,"threshold_uncertainty_score":0.9976333},"labels":[],"label_agreement":null},{"id":"W4224094923","doi":"10.1182/blood.2021013563","title":"First study of extended half-life rFVIIIFc in previously untreated patients with hemophilia A: PUPs A-LONG final results","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Swedish Orphan Biovitrum; Sanofi","keywords":"Interquartile range; Medicine; Regimen; Dosing; Internal medicine; Clinical endpoint; Incidence (geometry); Adverse effect; Titer; Confidence interval; Pediatrics; Clinical trial; Immunology; Antibody","score_opus":0.026490873916922977,"score_gpt":0.2750097518228457,"score_spread":0.24851887790592272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224094923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962427,0.00016465093,1.9026277e-7,0.00048219017,0.000035021305,0.0021787966,0.00003930236,0.00004112024,0.0008160446],"genre_scores_gemma":[0.9981388,0.000017140786,0.000046008794,0.000028007255,0.000034266734,0.00020494593,0.000164188,0.00003093142,0.0013356977],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975687,0.00015803378,0.00047863118,0.00045699676,0.0009220495,0.00041557613],"domain_scores_gemma":[0.99894506,0.00009852781,0.00012742715,0.00051054766,0.00012840267,0.00019005463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003191916,0.00020820458,0.0004684458,0.00028775746,0.00017912715,0.000010278475,0.0001720739,0.00005000338,0.00016433987],"category_scores_gemma":[0.00018327829,0.00015234786,0.000059628,0.00076370576,0.000060580995,0.00005424194,0.00016569177,0.00033912447,0.000010049572],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046335775,0.02837251,0.96255565,0.000112520705,0.00033854094,0.00095841096,0.0022008673,0.000056577013,0.000023283414,0.0000041965213,0.00016667604,0.00057719595],"study_design_scores_gemma":[0.061134804,0.011948846,0.92503047,0.00012160368,0.00029435093,0.000022867112,0.00079075765,0.000039017174,0.00033262064,0.000006634794,0.00012467145,0.00015337241],"about_ca_topic_score_codex":0.0005033016,"about_ca_topic_score_gemma":0.00059402105,"teacher_disagreement_score":0.056501225,"about_ca_system_score_codex":0.000102241254,"about_ca_system_score_gemma":0.00022018357,"threshold_uncertainty_score":0.62125653},"labels":[],"label_agreement":null},{"id":"W4224242533","doi":"10.1182/blood.2022015508","title":"Determinants of long-term outcomes of splenectomy in pediatric autoimmune cytopenias","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Splenectomy; Medicine; Hazard ratio; Autoimmune hemolytic anemia; Cytopenia; Internal medicine; Cohort; Evans syndrome; Confidence interval; Anemia; Pediatrics; Spleen","score_opus":0.01771542928988208,"score_gpt":0.28278785319973015,"score_spread":0.2650724239098481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224242533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998259,0.0009723325,3.0675318e-7,0.000026169475,0.00005108012,0.00026271178,0.000025504836,0.000010235833,0.00039267176],"genre_scores_gemma":[0.999467,0.000112751506,0.000067639696,0.00002134386,0.000006325977,0.000028935894,0.000017745735,0.000012365652,0.00026585133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99917746,0.00002568513,0.00031072673,0.00013397785,0.00020311645,0.0001490326],"domain_scores_gemma":[0.9995721,0.000038212173,0.00013173418,0.00021193732,0.000017613842,0.000028424965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008471554,0.00009375907,0.00047435227,0.00017141762,0.00002461046,0.0000014203555,0.00009305003,0.00002720819,0.0001895644],"category_scores_gemma":[0.000024973822,0.00008082768,0.00008718598,0.00023589101,0.000016434557,0.000027086433,0.00009356985,0.00008444896,0.0000042394922],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057787158,0.0024534145,0.9938872,0.00010583564,0.000057387067,0.0011778004,0.00014232704,0.0000011692906,0.00039270075,0.0000025701054,0.0000049587657,0.0017168751],"study_design_scores_gemma":[0.0075836903,0.00038996423,0.9877832,0.000014545291,0.00025368237,0.00011849943,0.000025257592,0.0000046332475,0.0037440115,0.000012227036,0.0000080561385,0.00006225317],"about_ca_topic_score_codex":0.00010877169,"about_ca_topic_score_gemma":0.00004966536,"teacher_disagreement_score":0.007525903,"about_ca_system_score_codex":0.000015843125,"about_ca_system_score_gemma":0.000072183,"threshold_uncertainty_score":0.32960573},"labels":[],"label_agreement":null},{"id":"W4224311738","doi":"10.1182/blood.2021015162","title":"Inflammation and myeloid malignancy: quenching the flame","year":2022,"lang":"en","type":"review","venue":"Blood","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Canada's Michael Smith Genome Sciences Centre","funders":"Canadian Cancer Society Research Institute; Leukemia and Lymphoma Society; Genome Canada; Canadian Institutes of Health Research; Genome British Columbia; BC Cancer Foundation","keywords":"Inflammation; Medicine; Malignancy; Myeloid; Cancer research; Immunology; Chemistry; Pathology","score_opus":0.02495730697613132,"score_gpt":0.2650570926678667,"score_spread":0.24009978569173537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224311738","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010685484,0.9952079,0.0000019975112,0.000034492514,0.001141036,0.0005088799,0.00002586603,0.000052927946,0.00292004],"genre_scores_gemma":[0.00001732879,0.99559,0.000017981016,0.000028308095,0.00010708451,0.00042693134,0.00020920564,0.000039875944,0.0035633305],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984908,0.0005171362,0.00040005604,0.00030262818,0.000035551668,0.000253812],"domain_scores_gemma":[0.99885815,0.00034603814,0.0003142017,0.00046282096,0.0000118733105,0.0000069070584],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041818738,0.00027017333,0.00065580406,0.000082380604,0.00036729395,0.000026534042,0.00039322607,0.00030474778,0.0016076536],"category_scores_gemma":[0.000068106994,0.0001821761,0.00017978033,0.0001347412,0.00013796291,0.000044932367,0.00031561483,0.0008335912,0.00025584732],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000018224165,0.000021573536,0.000001969814,0.0019239052,0.00041391587,0.0000073827046,0.00026642883,1.16742854e-7,0.0002264281,0.000498248,0.00044821991,0.99619],"study_design_scores_gemma":[0.00030917482,0.000030238434,0.0000024430428,0.0011208929,0.00091353606,0.00039455274,0.000031631436,2.168122e-8,0.00029959617,0.00006803331,0.9966218,0.00020808056],"about_ca_topic_score_codex":0.000028611967,"about_ca_topic_score_gemma":0.0000049368446,"teacher_disagreement_score":0.99617356,"about_ca_system_score_codex":0.000046365756,"about_ca_system_score_gemma":0.00017153929,"threshold_uncertainty_score":0.999305},"labels":[],"label_agreement":null},{"id":"W4225984984","doi":"10.1182/blood.2021014240","title":"<i>ABO</i> O blood group as a risk factor for platelet reactivity in heparin-induced thrombocytopenia","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Environmental Health Sciences; National Institute of Neurological Disorders and Stroke; National Institute of General Medical Sciences; National Center for Advancing Translational Sciences; National Human Genome Research Institute; National Heart, Lung, and Blood Institute; National Institutes of Health; Vanderbilt University; Université François-Rabelais; Deutsche Forschungsgemeinschaft; National Center for Research Resources; Georgia Clinical and Translational Science Alliance; RIKEN; Vanderbilt University Medical Center","keywords":"ABO blood group system; Odds ratio; Internal medicine; Antibody; Medicine; Immunology; Platelet; Gastroenterology; Heparin-induced thrombocytopenia; Cohort; Confidence interval","score_opus":0.03190472578880337,"score_gpt":0.28756250688993246,"score_spread":0.2556577811011291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225984984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905799,0.00013459918,0.000013500714,0.00043058058,0.0004439695,0.002747109,0.0005202515,0.00024893772,0.0048811357],"genre_scores_gemma":[0.9968256,0.00010750045,0.00075452717,0.00057687814,0.00025679512,0.00092911214,0.00012500316,0.00014881925,0.00027576546],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99592304,0.00033537595,0.00079108303,0.0011789056,0.0007020164,0.0010696014],"domain_scores_gemma":[0.9976337,0.00043054356,0.00035875218,0.0010700683,0.000091728114,0.000415218],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008130245,0.0005776225,0.0014942414,0.00036730207,0.0005862005,0.00007188682,0.00048742996,0.0002774004,0.0010065996],"category_scores_gemma":[0.00039984312,0.0005899507,0.00042978028,0.0008248965,0.000071259485,0.00029987626,0.00048234154,0.0013555905,0.000104030885],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011249731,0.010902274,0.11836995,0.00019117119,0.001261332,0.0006227453,0.0020073657,0.0000050769236,0.8555738,0.0011935972,0.00018113512,0.008566584],"study_design_scores_gemma":[0.044657264,0.006977265,0.4539902,0.00012656291,0.0020123478,0.001303788,0.000812042,0.000087804496,0.4668942,0.0015414548,0.020063493,0.0015335841],"about_ca_topic_score_codex":0.0020527935,"about_ca_topic_score_gemma":0.00069991767,"teacher_disagreement_score":0.3886796,"about_ca_system_score_codex":0.00024698078,"about_ca_system_score_gemma":0.00045968697,"threshold_uncertainty_score":0.9999066},"labels":[],"label_agreement":null},{"id":"W4226051064","doi":"10.1182/blood-2021-147088","title":"Maintenance with Hypomethylating Agents after Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Systematic Meta-Analysis","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada","funders":"","keywords":"Medicine; Internal medicine; Myeloid leukemia; Oncology; Transplantation; Hematopoietic stem cell transplantation; Decitabine; Myelodysplastic syndromes; Odds ratio; Leukemia; Acute leukemia; Randomized controlled trial; Bone marrow; DNA methylation","score_opus":0.023290163144045077,"score_gpt":0.25775297802973546,"score_spread":0.23446281488569037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226051064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993377,0.0039493227,0.001266688,0.0001443858,0.000015757856,0.0009011173,0.000059989674,0.00004132217,0.00024443486],"genre_scores_gemma":[0.99271125,0.00044778973,0.003816977,0.00019657094,0.000012217835,0.00043515724,0.00006470628,0.0000539569,0.002261368],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99692225,0.0003708438,0.0006978477,0.00072779873,0.0007133119,0.0005679583],"domain_scores_gemma":[0.9984145,0.0003911091,0.00019293018,0.00056049856,0.00019484582,0.0002460926],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00061903737,0.00036109483,0.0017373846,0.0005648988,0.00006744113,0.00007346788,0.00013576979,0.00015352156,0.00013302348],"category_scores_gemma":[0.00004825341,0.00025763793,0.00038164406,0.0018561892,0.00007589557,0.00015046049,0.00006296973,0.00041455313,0.000028961094],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020441127,0.0016132608,0.1495839,0.0937682,0.5030401,0.17700762,0.008130617,0.0020183516,0.062479723,0.00005503843,0.000041264553,0.00021784772],"study_design_scores_gemma":[0.0125738075,0.0006714902,0.18884447,0.0017605552,0.75846934,0.0108804405,0.0012891394,0.0029741542,0.021697115,0.000017738148,0.000006201334,0.0008155488],"about_ca_topic_score_codex":0.000056133424,"about_ca_topic_score_gemma":0.00019670962,"teacher_disagreement_score":0.25542927,"about_ca_system_score_codex":0.00027268194,"about_ca_system_score_gemma":0.00042407605,"threshold_uncertainty_score":0.9999876},"labels":[],"label_agreement":null},{"id":"W4226092325","doi":"10.1182/blood-2021-153120","title":"Quality of Life and Caregiver Burden in Patients and Their Caregivers Undergoing Outpatient Autologous Stem Cell Transplantation Compared to Inpatient Transplantation","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Family Support in Illness","field":"Social Sciences","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Transplantation; Quality of life (healthcare); Caregiver burden; Autologous stem-cell transplantation; Emergency medicine; Cohort; Family medicine; Physical therapy; Gerontology; Internal medicine; Disease; Nursing","score_opus":0.02280830412748976,"score_gpt":0.25479224577491777,"score_spread":0.231983941647428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226092325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99779004,0.00014523117,0.0001378287,0.00011551443,0.00015517126,0.00038187986,0.0001340444,0.000020882757,0.0011194343],"genre_scores_gemma":[0.99952024,0.0002063676,0.0001051726,0.000050453633,0.00001160122,0.000012591714,0.00006485176,0.000008445982,0.00002026433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984734,0.00038194619,0.00035054394,0.00028710547,0.00030286258,0.00020416536],"domain_scores_gemma":[0.9992507,0.00023959152,0.00013211014,0.00010242849,0.00014409822,0.00013108991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023777586,0.0001209908,0.00026156733,0.00009134504,0.00013296149,0.00002651145,0.00008308374,0.00009409905,0.000006451987],"category_scores_gemma":[0.000033203356,0.00012534483,0.00003148893,0.00022158766,0.00009560691,0.0001414632,0.00002018244,0.00007539938,8.4356395e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011249611,0.0002639652,0.5042131,0.00041763115,0.000026183136,0.000010265178,0.49174282,0.00023945967,0.0003659825,0.00019900028,0.0000109142975,0.0023981782],"study_design_scores_gemma":[0.004418134,0.00015686781,0.8529751,0.000116100215,0.000050791885,7.4081476e-7,0.13809212,0.00001649097,0.0038008194,0.00005642789,0.000055123353,0.00026132574],"about_ca_topic_score_codex":0.0035636486,"about_ca_topic_score_gemma":0.0100796,"teacher_disagreement_score":0.3536507,"about_ca_system_score_codex":0.000057654306,"about_ca_system_score_gemma":0.00022215051,"threshold_uncertainty_score":0.5624653},"labels":[],"label_agreement":null},{"id":"W4226227402","doi":"10.1182/blood-2021-152740","title":"Modulating Endothelial Cells with EGFL7 to Diminish aGVHD after Allogeneic Bone Marrow Transplantation in Mice","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Hematopoietic stem cell transplantation; Immunology; Bone marrow; Transplantation; Leukemia; Inflammation; Haematopoiesis; Stem cell; Cancer research; Internal medicine; Biology","score_opus":0.010692134018533802,"score_gpt":0.2489640674452903,"score_spread":0.23827193342675648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226227402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968637,0.00018246695,0.00027657195,0.0008128001,0.000045755216,0.0004010532,0.00005369761,0.000032754284,0.0013311668],"genre_scores_gemma":[0.98381233,0.000083922976,0.013646816,0.00076413015,0.00017720058,0.00009240568,0.000051662482,0.00004242004,0.0013290807],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99857223,0.00007486025,0.00023977975,0.00037502893,0.00036196486,0.00037612743],"domain_scores_gemma":[0.99938905,0.00007872809,0.000031180887,0.00023695733,0.00009427084,0.00016978139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015568166,0.00014916014,0.0002567236,0.00013550268,0.000030036523,0.000024525714,0.000070247195,0.000089327725,0.00015002288],"category_scores_gemma":[0.00004381683,0.00013315449,0.000048490834,0.00035853984,0.000027528575,0.00006173288,0.00003233104,0.0002465116,0.000067498986],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007785706,0.0003288657,0.016318083,0.0002017588,0.000062912026,0.0059288535,0.0012646136,0.000096488126,0.9735461,0.0000054869242,0.00007649499,0.0013917945],"study_design_scores_gemma":[0.008559657,0.00033686415,0.052368887,0.000317299,0.00020012337,0.0010036399,0.00022069717,0.00013878975,0.9360473,0.000010459745,0.0005684336,0.00022781872],"about_ca_topic_score_codex":0.0001002003,"about_ca_topic_score_gemma":0.00047993823,"teacher_disagreement_score":0.037498746,"about_ca_system_score_codex":0.000080863654,"about_ca_system_score_gemma":0.00023064672,"threshold_uncertainty_score":0.54298824},"labels":[],"label_agreement":null},{"id":"W4226457448","doi":"10.1182/blood-2021-154490","title":"Updates from Ongoing, First-in-Human Phase 1 Dose Escalation and Expansion Study of TTI-621, a Novel Biologic Targeting CD47, in Patients with Relapsed or Refractory Hematologic Malignancies","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"CD47; Medicine; Lymphoma; Immune system; Immunology; Internal medicine; Oncology; Pharmacology; Cancer research","score_opus":0.013607978120069433,"score_gpt":0.23819297056662356,"score_spread":0.2245849924465541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226457448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987532,0.0005514281,0.000012718268,0.000014500728,0.0002652438,0.0003245742,0.000008564808,0.00002893978,0.0000408195],"genre_scores_gemma":[0.9991606,0.000034712542,0.00009300433,0.000029550389,0.000006560423,0.000024410818,0.00046959764,0.000010622284,0.00017096785],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988075,0.00017719631,0.00045088667,0.00034487923,0.000038985287,0.00018053656],"domain_scores_gemma":[0.999324,0.00014837766,0.00024371485,0.00018188704,0.000091025395,0.0000109467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013772388,0.00016026784,0.0003307684,0.0001364806,0.00010949024,0.000011312949,0.00006327532,0.0001723492,0.00035710042],"category_scores_gemma":[0.00017146538,0.000117412106,0.00002607612,0.00017843892,0.000054149932,0.00015449896,0.00006380252,0.00022629595,0.000007870902],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010659416,0.01004227,0.37712073,0.000022215896,0.0000944006,0.000018553272,0.0015535773,0.000007153031,0.60986,0.000008865983,0.0000623875,0.00014387764],"study_design_scores_gemma":[0.043864425,0.004916158,0.7582878,0.00032422156,0.000120115656,0.000017145707,0.0067986334,0.0000140524935,0.18482423,0.000016764247,0.00049743825,0.00031904556],"about_ca_topic_score_codex":0.0002702041,"about_ca_topic_score_gemma":0.00044409808,"teacher_disagreement_score":0.4250358,"about_ca_system_score_codex":0.000025589343,"about_ca_system_score_gemma":0.000025802956,"threshold_uncertainty_score":0.4787927},"labels":[],"label_agreement":null},{"id":"W4229013347","doi":"10.1182/blood.2021014956","title":"Lenalidomide promotes the development of <i>TP53</i>-mutated therapy-related myeloid neoplasms","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":139,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Health Sciences Centre; University Health Network; Sunnybrook Health Science Centre","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center; National Heart, Lung, and Blood Institute; National Institutes of Health; Andrew Sabin Family Foundation; Edward P. Evans Foundation; Howard Hughes Medical Institute; Cancer Prevention and Research Institute of Texas; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Welch Foundation; University of Texas System; Leukemia and Lymphoma Society","keywords":"Lenalidomide; Progenitor cell; Haematopoiesis; Thalidomide; Myeloid; Cancer research; Biology; Pomalidomide; Stem cell; Immunology; Multiple myeloma; Genetics","score_opus":0.02093353391674051,"score_gpt":0.2662075918491015,"score_spread":0.24527405793236096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229013347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99304444,0.0007949395,0.000017164755,0.0017747186,0.00007927256,0.0010409087,0.000012905881,0.00009790375,0.0031377485],"genre_scores_gemma":[0.99571395,0.00005215208,0.0015318264,0.0003039268,0.000042788703,0.00024090413,0.00007577169,0.00005072553,0.0019879588],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997721,0.00021983951,0.0005406745,0.00030568973,0.0007993096,0.00041344762],"domain_scores_gemma":[0.9989082,0.00020419034,0.00016168492,0.00047612604,0.00013950499,0.0001102543],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001016092,0.00019062925,0.00033973853,0.00014875853,0.00038294977,0.000014422465,0.00038745446,0.00006453268,0.0009446484],"category_scores_gemma":[0.0001221422,0.00012591349,0.00011509078,0.0007549677,0.0001323511,0.000040661682,0.00030196825,0.00065220444,0.00004896167],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018298982,0.003930989,0.015648084,0.00018138418,0.0028753255,0.00036119312,0.02317215,0.00009985591,0.9092743,0.0003121431,0.00410565,0.038209025],"study_design_scores_gemma":[0.018617954,0.0010244397,0.013272021,0.00006845811,0.0002152543,0.00070979027,0.0021069024,0.00028421296,0.9284759,0.00022402842,0.034661468,0.00033952866],"about_ca_topic_score_codex":0.000043925633,"about_ca_topic_score_gemma":0.000008722117,"teacher_disagreement_score":0.037869498,"about_ca_system_score_codex":0.0001479423,"about_ca_system_score_gemma":0.0012848423,"threshold_uncertainty_score":0.99996865},"labels":[],"label_agreement":null},{"id":"W4229018428","doi":"10.1182/blood.2022015832","title":"Prospective comparison of outcomes with azacitidine and decitabine in patients with AML ineligible for intensive chemotherapy","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Alberta Hospital; Alberta Hospital Edmonton","funders":"National Cancer Institute; National Institutes of Health; Astex Pharmaceuticals; National Center for Advancing Translational Sciences; Leukemia and Lymphoma Society","keywords":"Azacitidine; Decitabine; Medicine; Chemotherapy regimen; Chemotherapy; Oncology; Internal medicine; Intensive care medicine; Chemistry; DNA methylation","score_opus":0.012528109539386288,"score_gpt":0.2889779682851103,"score_spread":0.27644985874572403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229018428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99729604,0.00007603595,0.00006721454,0.0006205594,0.000009484296,0.0017148061,0.000046833386,0.000016529464,0.00015251672],"genre_scores_gemma":[0.9968968,0.000004514302,0.0023519658,0.00026052428,0.000012102698,0.00025326412,0.000052368065,0.000031862197,0.0001366122],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896795,0.000020542511,0.00020530341,0.00024660953,0.0003418394,0.0002177742],"domain_scores_gemma":[0.9991414,0.00009954741,0.00009317982,0.00018173279,0.0004207515,0.000063371655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000114361974,0.00013150233,0.00047978846,0.00018332437,0.000052377207,0.0000053301173,0.00007091217,0.000026117157,0.000025760424],"category_scores_gemma":[0.00007947296,0.00008932617,0.000025342977,0.00033641604,0.00009757818,0.00004320054,0.000065701446,0.00021931139,3.3722978e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042753797,0.0012052143,0.9918952,0.00007020098,0.00021354051,0.0000073306505,0.0013020954,0.000007675117,0.00035615443,0.000053150423,0.00020804524,0.0004060133],"study_design_scores_gemma":[0.046958856,0.0062926165,0.9357398,0.000050177645,0.00008854871,0.000011447045,0.0017085982,0.00011836963,0.008739203,0.000045335706,0.00012952012,0.00011748392],"about_ca_topic_score_codex":0.000072398965,"about_ca_topic_score_gemma":0.000033630437,"teacher_disagreement_score":0.056155358,"about_ca_system_score_codex":0.00011697918,"about_ca_system_score_gemma":0.00012957769,"threshold_uncertainty_score":0.36426154},"labels":[],"label_agreement":null},{"id":"W4229560303","doi":"10.1182/blood.v116.21.20.20","title":"Recombinant Factor XIII, Safe and Novel Treatment for Congenital Factor XIII Deficiency","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Blood properties and coagulation","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Factor XIII deficiency; Factor XIII; Pediatrics; Internal medicine; Gastroenterology; Surgery; Fibrinogen","score_opus":0.03653067932731232,"score_gpt":0.26518403698650844,"score_spread":0.22865335765919612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229560303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970863,0.000420502,0.00013881888,0.00038766043,0.00037443815,0.00073858054,0.00008539564,0.00004432025,0.0007239922],"genre_scores_gemma":[0.99647087,0.000035683184,0.0016316636,0.00007828269,0.0001523081,0.00006166049,0.000028287683,0.000022834321,0.0015183991],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9992005,0.0000051123493,0.00019224828,0.00025426835,0.00011488038,0.00023296275],"domain_scores_gemma":[0.9994865,0.000040232037,0.00005523586,0.00021198194,0.00007497524,0.00013105861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003691814,0.00016161668,0.00023493357,0.00004300917,0.0001145852,0.00002903364,0.00004326037,0.00011352258,0.00013983155],"category_scores_gemma":[0.000049302824,0.00011035264,0.00008390067,0.000046984977,0.000043274733,0.000066395216,0.000020090114,0.00009131706,0.000011474498],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005945815,0.0058581876,0.08991566,0.00017290581,0.0004351943,0.000013619494,0.0016436442,3.0008727e-7,0.7717187,0.0018523864,0.00014062539,0.1276542],"study_design_scores_gemma":[0.050094973,0.010475347,0.60321254,0.000096869335,0.0017947227,0.0004753057,0.00043175925,0.00055617106,0.27598184,0.00033818817,0.055597626,0.00094463484],"about_ca_topic_score_codex":0.00008692157,"about_ca_topic_score_gemma":0.000079570615,"teacher_disagreement_score":0.5132969,"about_ca_system_score_codex":0.000015146964,"about_ca_system_score_gemma":0.00007246761,"threshold_uncertainty_score":0.450005},"labels":[],"label_agreement":null},{"id":"W4229684014","doi":"10.1182/blood.v114.22.8.8","title":"Acute T-Cell Leukemias Remain Dependent On Notch Signaling Despite PTEN and INK4A/ARF Loss.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Children's Hospital; BC Cancer Agency","funders":"","keywords":"PTEN; Notch signaling pathway; Cancer research; Protein kinase B; Biology; PI3K/AKT/mTOR pathway; Signal transduction; Cyclin-dependent kinase 8; Cell biology","score_opus":0.011961060170759211,"score_gpt":0.24417860237509956,"score_spread":0.23221754220434035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229684014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851314,0.003141516,0.000031979474,0.0014140802,0.00006846559,0.00025651502,0.000008261014,0.00007495111,0.009872827],"genre_scores_gemma":[0.9954268,0.00036236923,0.0004930548,0.0024896823,0.00029744284,0.000009883325,0.000010238355,0.000020077518,0.0008904704],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988135,0.000022236396,0.00021068672,0.00036227095,0.00028287125,0.0003084263],"domain_scores_gemma":[0.9994168,0.00004838074,0.000060862876,0.0002699895,0.00005361017,0.0001503141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001296081,0.00020605406,0.00032679064,0.00009428424,0.00011229278,0.000030623298,0.00007555261,0.000090364316,0.000020058436],"category_scores_gemma":[0.000025311934,0.00017298908,0.00008675106,0.00011931154,0.000040723455,0.00004981231,0.00004251669,0.00023682188,0.000031639353],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023453475,0.003926908,0.24758577,0.00049603055,0.0021980123,0.009689625,0.00945992,0.000033031247,0.67262346,0.0006254912,0.011006485,0.040009934],"study_design_scores_gemma":[0.030256726,0.004439905,0.32466865,0.00066111755,0.0032784767,0.0011970862,0.0005675525,0.00005701541,0.6287199,0.0007787304,0.0043196026,0.0010552324],"about_ca_topic_score_codex":0.000023282719,"about_ca_topic_score_gemma":0.000012963133,"teacher_disagreement_score":0.077082865,"about_ca_system_score_codex":0.000058080357,"about_ca_system_score_gemma":0.00006004991,"threshold_uncertainty_score":0.705429},"labels":[],"label_agreement":null},{"id":"W4229742526","doi":"10.1182/blood.v96.10.3630.h8003630_3630_3636","title":"o-Raffinose cross-linked hemoglobin improves the hemostatic defect associated with anemia and thrombocytopenia in rabbits","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobin structure and function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Queen's University","funders":"","keywords":"Vasoconstriction; Medicine; Platelet; Bleeding time; Thrombosis; Hemostasis; Internal medicine; Anesthesia; Pharmacology","score_opus":0.005550846795797855,"score_gpt":0.22646879847654194,"score_spread":0.2209179516807441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229742526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975815,0.0005938843,0.000007190291,0.00009922539,0.00003477018,0.00027773328,0.000013845206,0.000017521697,0.001374354],"genre_scores_gemma":[0.9985422,0.000098386525,0.00009676607,0.00047895944,0.00006590463,0.00001936229,0.000091192014,0.000019875037,0.0005873941],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99905914,0.0000712616,0.00017144928,0.0003290951,0.000106782085,0.00026228387],"domain_scores_gemma":[0.9995661,0.000031623676,0.00005389672,0.00025736124,0.00003768277,0.000053383406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016738934,0.00017287812,0.00017071221,0.000018380617,0.00011102745,0.000063419895,0.00012172956,0.0001623207,0.000042205218],"category_scores_gemma":[0.00007849757,0.000114819035,0.00004460766,0.00014530195,0.0001258562,0.000007892795,0.000035645593,0.00013576481,0.0000063256343],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000601121,0.00040838722,0.13012055,0.00004492771,0.0002850505,0.000058066707,0.00045018806,0.0001150529,0.846999,0.000030292955,0.0009164139,0.019970953],"study_design_scores_gemma":[0.010047185,0.0012279678,0.7625937,0.00006252356,0.00019662839,0.00022635069,0.00008954342,0.000067127745,0.22025962,0.0002258232,0.0043894537,0.00061408343],"about_ca_topic_score_codex":0.00003885305,"about_ca_topic_score_gemma":0.00022783557,"teacher_disagreement_score":0.6324731,"about_ca_system_score_codex":0.000011354689,"about_ca_system_score_gemma":0.00006407256,"threshold_uncertainty_score":0.46821845},"labels":[],"label_agreement":null},{"id":"W4230111288","doi":"10.1182/blood.v95.1.102.001k25_102_110","title":"Expansion of human cord blood CD34+CD38−cells in ex vivo culture during retroviral transduction without a corresponding increase in SCID repopulating cell (SRC) frequency: dissociation of SRC phenotype and function","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"CD38; Stem cell; Biology; Haematopoiesis; CD34; Cord blood; Molecular biology; Ex vivo; Population; Cell biology; Immunology; Medicine; In vitro; Biochemistry","score_opus":0.009587674266420888,"score_gpt":0.24348748602836945,"score_spread":0.23389981176194857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230111288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99781156,0.00018164216,0.000035655212,0.000009934479,0.000067837216,0.00058755215,0.00001417571,0.000038199596,0.0012534444],"genre_scores_gemma":[0.99858046,0.0000854307,0.0009380442,0.000009289014,0.00006526891,0.000011636456,0.00006592238,0.000031257667,0.00021270553],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99801886,0.0001622558,0.0008348178,0.000375753,0.0003721452,0.000236162],"domain_scores_gemma":[0.9992825,0.00004444857,0.000319933,0.00020790212,0.0000699946,0.00007522801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044764119,0.00020083942,0.0004710236,0.0003196735,0.00007065138,0.000010977474,0.000048738424,0.00020976878,0.00008979867],"category_scores_gemma":[0.00004266532,0.00020451313,0.00006805798,0.0004996109,0.000049115475,0.000215567,0.0000068766453,0.00025195535,0.0000015353979],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006514143,0.00040125713,0.26935035,0.00074720755,0.000021171845,0.000028693561,0.004011569,0.000026292484,0.72449434,0.000013790729,6.5681115e-7,0.0002532512],"study_design_scores_gemma":[0.008548891,0.000766428,0.28630963,0.0013924224,0.00048819528,0.0000518729,0.0009981475,0.000118128126,0.7010279,0.00010965079,9.076686e-7,0.00018779204],"about_ca_topic_score_codex":0.00079267984,"about_ca_topic_score_gemma":0.00019036327,"teacher_disagreement_score":0.02346639,"about_ca_system_score_codex":0.00006502185,"about_ca_system_score_gemma":0.00005357269,"threshold_uncertainty_score":0.8339803},"labels":[],"label_agreement":null},{"id":"W4230270945","doi":"10.1182/blood-2019-124116","title":"Brentuximab Vedotin with Chemotherapy for Stage 3/4 Classical Hodgkin Lymphoma (cHL): 4-Year Update of the Echelon-1 Study","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"ABVD; Brentuximab vedotin; Medicine; Dacarbazine; Internal medicine; Vinblastine; Progression-free survival; Chemotherapy regimen; Clinical endpoint; Population; Oncology; Surgery; Procarbazine; Chemotherapy; Vincristine; Lymphoma; Randomized controlled trial; Hodgkin lymphoma; Cyclophosphamide","score_opus":0.008803946367613627,"score_gpt":0.24582186709172427,"score_spread":0.23701792072411065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230270945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99578667,0.00009313627,0.000008539403,0.0009841777,0.000079909136,0.0021701804,0.000046663194,0.000032822383,0.0007979287],"genre_scores_gemma":[0.99770576,0.000019376634,0.0006191904,0.0003166072,0.000066806984,0.00013584166,0.00001388545,0.000038317583,0.0010842193],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886495,0.000037889607,0.00022596435,0.0003124837,0.0003226109,0.00023612283],"domain_scores_gemma":[0.9990476,0.00007543998,0.0001292521,0.0006001337,0.0000752398,0.00007235121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012605038,0.00018733856,0.00039898412,0.000037675105,0.000045482124,0.000016198355,0.00014492284,0.00006269949,0.000106961634],"category_scores_gemma":[0.000014454678,0.00010198852,0.00014811661,0.00014398627,0.000052866988,0.00003333207,0.000042340256,0.000044815944,0.000037247257],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010152254,0.018457595,0.97171885,0.00009284229,0.00090596854,0.000019186678,0.00040147017,0.0000015120497,0.0014298509,0.000507393,0.00049902545,0.0049510994],"study_design_scores_gemma":[0.08720129,0.004455752,0.82341075,0.00012124195,0.00068546465,0.000026709618,0.00053232716,0.000030748968,0.077080145,0.000025952708,0.006249673,0.00017995795],"about_ca_topic_score_codex":0.0000430886,"about_ca_topic_score_gemma":0.000025638685,"teacher_disagreement_score":0.1483081,"about_ca_system_score_codex":0.000058300287,"about_ca_system_score_gemma":0.00017204383,"threshold_uncertainty_score":0.4158971},"labels":[],"label_agreement":null},{"id":"W4230574050","doi":"10.1182/blood.v124.21.888.888","title":"Evidence of an Oncogenic Role for Aberrant Tox Activation in Cutaneous T Cell Lymphoma","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Mycosis fungoides; Biology; Cancer research; Pathogenesis; Lymphoma; Cutaneous T-cell lymphoma; Small hairpin RNA; Apoptosis; Immunology; Genetics; Gene knockdown","score_opus":0.02739141516510657,"score_gpt":0.30827310796755686,"score_spread":0.2808816928024503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230574050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99706334,0.00032003352,0.00028697422,0.00017079384,0.00001968642,0.00085705804,0.0000042612237,0.00002483137,0.0012530521],"genre_scores_gemma":[0.9981967,0.000046325775,0.0011133504,0.00011519846,0.00007553898,0.000077850986,0.000017112334,0.000028769986,0.00032915204],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99871534,0.00008647898,0.0002844153,0.00029564838,0.00033468375,0.0002834341],"domain_scores_gemma":[0.99891394,0.00035118347,0.00008352018,0.0003474282,0.00019831907,0.00010559851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028041415,0.00012683147,0.00029851473,0.00015758193,0.000039109465,0.000011962558,0.00013402592,0.000096679505,0.000043901637],"category_scores_gemma":[0.00063033664,0.0001183379,0.00008046117,0.00020456,0.00005191754,0.00009591365,0.00002854788,0.000065415676,0.0000112522475],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001517546,0.0029879184,0.011529432,0.00037107087,0.000036683214,0.000025531457,0.0009477568,0.00003283862,0.95224375,0.000051317526,0.000027366668,0.030228797],"study_design_scores_gemma":[0.008773232,0.0036191854,0.0037092292,0.00035878498,0.000085181615,0.00048284067,0.0003820527,0.0076673385,0.97393644,0.0005268494,0.000275768,0.00018308],"about_ca_topic_score_codex":0.00021142013,"about_ca_topic_score_gemma":0.0001444184,"teacher_disagreement_score":0.030045716,"about_ca_system_score_codex":0.00008247078,"about_ca_system_score_gemma":0.00025089426,"threshold_uncertainty_score":0.48256797},"labels":[],"label_agreement":null},{"id":"W4230576967","doi":"10.1182/blood.v116.21.2006.2006","title":"Prediction of Survival In Diffuse Large B-Cell Lymphoma Based On the Expression of Two Genes Reflecting Tumor and Microenvironment","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; International Prognostic Index; Stromal cell; Germinal center; Biology; Survival analysis; Tumor microenvironment; Oncology; Lymphoma; Cancer research; Medicine; Immune system; Computational biology; Internal medicine; B cell; Immunology; Antibody","score_opus":0.01764671600249155,"score_gpt":0.2466483515204561,"score_spread":0.22900163551796457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230576967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99895334,0.00016193092,0.0000034284728,0.000112135494,0.00005430336,0.00024552536,0.00002716466,0.000007094879,0.00043507136],"genre_scores_gemma":[0.9994548,0.00004223965,0.00034708253,0.000057315876,0.000034353194,0.000030466683,0.000008272823,0.000009864284,0.000015607728],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993562,0.000043058437,0.00018433116,0.00014893213,0.00015723678,0.000110259454],"domain_scores_gemma":[0.99949783,0.00013503569,0.000095017094,0.0002226807,0.000011249164,0.000038156944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017349546,0.00008818002,0.00016863964,0.000046677993,0.000033026685,0.0000033833642,0.000033888005,0.000031532654,0.000022345248],"category_scores_gemma":[0.00002818427,0.00005415056,0.00003993152,0.000045410103,0.00003315586,0.000012353663,0.000027019605,0.000044018543,0.0000012870701],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000682284,0.012184697,0.46446073,0.00003897473,0.000009770868,0.000012844495,0.00010630067,9.045652e-7,0.5226173,0.000016972901,0.000009985626,0.0004733505],"study_design_scores_gemma":[0.020985976,0.00023554818,0.3062351,0.00010143497,0.000066437664,0.000005685226,0.000059626207,0.00009682896,0.6720742,0.0000049292075,0.00010640709,0.000027819167],"about_ca_topic_score_codex":0.00006305779,"about_ca_topic_score_gemma":0.00002479559,"teacher_disagreement_score":0.15822563,"about_ca_system_score_codex":0.000017594104,"about_ca_system_score_gemma":0.000020295467,"threshold_uncertainty_score":0.22081958},"labels":[],"label_agreement":null},{"id":"W4230678902","doi":"10.1182/blood.v108.11.1998.1998","title":"Long Term Follow-Up of a Randomized Trial Comparing Response Adapted (RA), Non-Cross Resistant Induction and Consolidation with Idarubicin/Cytarabine (IDAC) Followed by Mitoxantone/Etoposide (NOVE) Compared with Consolidation with High Dose Cytarabine (HDAC) in Adult Patients with AML. A Study by the Canadian Leukemia Studies Group (CLSG).","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Quebec - Clinical Research Organization in Cancer; University of Saskatchewan; Saskatchewan Hospital; Dalhousie University; Ottawa Hospital","funders":"","keywords":"Idarubicin; Etoposide; Cytarabine; Internal medicine; Mitoxantrone; Medicine; Bilirubin; Gastroenterology; Chemotherapy","score_opus":0.013677306426728292,"score_gpt":0.26572269535538634,"score_spread":0.252045388928658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230678902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98718596,0.00026382276,0.00007286202,0.00038665722,0.00006329535,0.011768194,0.00014398117,0.000063876054,0.000051349973],"genre_scores_gemma":[0.9972651,0.000028442915,0.00045217975,0.00007189604,0.00006982464,0.0008930827,0.00092282443,0.00010929785,0.0001873232],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9943597,0.00096716965,0.0013697151,0.0009947742,0.0014583851,0.00085030287],"domain_scores_gemma":[0.99576133,0.00086086465,0.0009203751,0.0007667903,0.001381212,0.00030940794],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019523085,0.0007337281,0.0022721335,0.0006536162,0.0005269803,0.00017240671,0.00026968264,0.00020141157,0.0000069927546],"category_scores_gemma":[0.00043750723,0.00043249677,0.00008514794,0.0012312846,0.0012367041,0.00040498146,0.000079170626,0.0007498616,0.0000012323578],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.71030456,0.0014554862,0.27567548,0.000106556596,0.0015104269,0.0001579438,0.0016899179,0.00008052552,0.008733126,0.000010466625,0.00024552,0.00003001153],"study_design_scores_gemma":[0.6786518,0.0068009594,0.30352992,0.000777532,0.0014746948,0.00006215241,0.0015586109,0.00019320576,0.00650591,0.0000029227303,0.0000062433187,0.00043603114],"about_ca_topic_score_codex":0.14544359,"about_ca_topic_score_gemma":0.5006497,"teacher_disagreement_score":0.35520607,"about_ca_system_score_codex":0.0015336457,"about_ca_system_score_gemma":0.0017606053,"threshold_uncertainty_score":0.99981266},"labels":[],"label_agreement":null},{"id":"W4230721068","doi":"10.1182/blood.v96.13.4185.h8004185_4185_4193","title":"Human hematopoietic stem cells stimulated to proliferate in vitro lose engraftment potential during their S/G2/M transit and do not reenter G0","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":212,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Stem cell; Haematopoiesis; Biology; Stem cell factor; Cell biology; Cord blood; Population; CD34; Interleukin 3; Homing (biology); Progenitor cell; Molecular biology; Cell cycle; Immunology; Cell; T cell; Antigen-presenting cell; Medicine; Biochemistry; Immune system","score_opus":0.010435913374374824,"score_gpt":0.22987683555431213,"score_spread":0.2194409221799373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230721068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997713,0.00011429154,0.0000641321,0.00030610274,0.00003777259,0.0013335195,0.000032485197,0.00008576288,0.0003129263],"genre_scores_gemma":[0.9987016,0.00003395939,0.00025104554,0.00020606628,0.00006280626,0.000059936385,0.000019291781,0.00004904614,0.0006162896],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982428,0.000082117185,0.0005046899,0.00046888745,0.0002994483,0.00040203842],"domain_scores_gemma":[0.99935615,0.000021891252,0.00004205107,0.00030277733,0.000036770038,0.0002403461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017795661,0.0002744622,0.00044174516,0.00016985956,0.00008418993,0.000045293276,0.00008224623,0.00012542687,0.00024297478],"category_scores_gemma":[0.000001107286,0.00024072861,0.000081028214,0.0001831383,0.00003260391,0.000064403044,0.000013386904,0.00019753288,0.00007279176],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089385046,0.0007936716,0.00084878126,0.0006233679,0.000108175154,0.00065907766,0.004837729,0.00017768351,0.99032825,0.0000042203033,0.0000051541892,0.0007200593],"study_design_scores_gemma":[0.01077113,0.00025566816,0.010822847,0.00052577205,0.0002434822,0.00038200096,0.00018227161,0.00013197376,0.97640157,0.000010695075,0.000027673166,0.00024489415],"about_ca_topic_score_codex":0.000019344137,"about_ca_topic_score_gemma":0.000005969992,"teacher_disagreement_score":0.013926637,"about_ca_system_score_codex":0.0000374947,"about_ca_system_score_gemma":0.000026359756,"threshold_uncertainty_score":0.9816628},"labels":[],"label_agreement":null},{"id":"W4230787579","doi":"10.1182/blood.v122.21.3505.3505","title":"Platelet-Derived ERp57 Mediates Platelet Incorporation Into a Growing Thrombus By Regulation Of The αIIbβ3 Integrin","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Blood properties and coagulation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor","funders":"","keywords":"Platelet; Chemistry; Thrombus; Platelet activation; Thrombin; Cell biology; Integrin; Platelet adhesiveness; Hemostasis; Receptor; Biochemistry; Internal medicine; Biology; Immunology; Medicine; Platelet aggregation","score_opus":0.009784187179859963,"score_gpt":0.20608436154220672,"score_spread":0.19630017436234676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230787579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99621594,0.0004506518,0.00011972338,0.001984763,0.00013466661,0.00064901373,0.000002842855,0.00006103499,0.0003813635],"genre_scores_gemma":[0.9985179,0.000031788222,0.00073593616,0.00027788986,0.00012865907,0.00003846588,0.00007637714,0.000025814363,0.00016720142],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988568,0.000062299114,0.00039563832,0.00020623117,0.00031285934,0.00016617458],"domain_scores_gemma":[0.99918854,0.000042533084,0.00022403731,0.00031305372,0.00016882009,0.000062986495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015107935,0.00015360177,0.0002623772,0.000055253124,0.00010145773,0.00002818059,0.00011572888,0.00015329494,0.0001719791],"category_scores_gemma":[0.00009620542,0.00009904334,0.00008453068,0.00022504952,0.00008481224,0.00035044664,0.00006489527,0.00017952267,0.00003151974],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048015925,0.00023759744,0.0104297735,0.00008831441,0.00011432077,9.847802e-7,0.001074313,0.00002305611,0.97403306,0.00018030523,0.001167311,0.012602969],"study_design_scores_gemma":[0.002384679,0.00024700823,0.09850244,0.00017819827,0.00013366879,0.000025939496,0.00037286864,0.0011971897,0.8942339,0.0021649753,0.0004133383,0.00014582645],"about_ca_topic_score_codex":0.0006936376,"about_ca_topic_score_gemma":0.00003159473,"teacher_disagreement_score":0.08807267,"about_ca_system_score_codex":0.000028203496,"about_ca_system_score_gemma":0.000059640333,"threshold_uncertainty_score":0.40388703},"labels":[],"label_agreement":null},{"id":"W4231010457","doi":"10.1182/blood.v122.21.2275.2275","title":"Engage: A Phase 3, Randomized, Double-blind, Placebo-controlled, Multi-center Study To Investigate The Efficacy and Safety Of Eliglustat In Adults With Gaucher Disease Type 1: 9 Month Results","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Mount Sinai Hospital","funders":"","keywords":"Enzyme replacement therapy; Medicine; Clinical endpoint; Placebo; Adverse effect; Internal medicine; Randomized controlled trial; Anemia; Bone marrow; Gastroenterology; Surgery; Disease; Pathology","score_opus":0.029961365802304168,"score_gpt":0.3169617012495453,"score_spread":0.28700033544724113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231010457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9777092,0.0007008294,0.00001392658,0.0015810252,0.000027126982,0.01958398,0.000022706226,0.00003009745,0.00033116384],"genre_scores_gemma":[0.9979466,0.000100006444,0.00021791921,0.00018006019,0.00004338447,0.00094028295,0.000027947526,0.000041861003,0.0005018941],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9971848,0.0006619703,0.0006664628,0.00049823505,0.000568416,0.00042009653],"domain_scores_gemma":[0.9977035,0.00069402327,0.00014385532,0.0005952841,0.00035031146,0.00051303406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013980503,0.00028446104,0.00090671243,0.00021214361,0.00009519613,0.000045614805,0.00020230435,0.00005477928,0.000047141304],"category_scores_gemma":[0.0024534592,0.00015375,0.000085852516,0.000492492,0.00025055444,0.00010972614,0.00014092111,0.00042834037,0.000035661706],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9643567,0.01490618,0.011097777,0.000103898186,0.00047445262,0.00015384947,0.008240714,0.000035224504,0.000116091964,0.0000038891803,0.00014254816,0.0003686308],"study_design_scores_gemma":[0.9849518,0.0016614031,0.009410336,0.00033039256,0.0004362536,0.000007237649,0.0020878927,0.0008012729,0.00010847605,0.0000034906946,0.000029759649,0.00017168722],"about_ca_topic_score_codex":0.0014095441,"about_ca_topic_score_gemma":0.00056315,"teacher_disagreement_score":0.020595053,"about_ca_system_score_codex":0.00003282122,"about_ca_system_score_gemma":0.00019286598,"threshold_uncertainty_score":0.62697434},"labels":[],"label_agreement":null},{"id":"W4231085890","doi":"10.1182/blood.v110.11.360.360","title":"Follicular Lymphomas with and without Translocation t(14;18) Differ in Gene Expression Profiles and Genetic Alterations.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Chromosomal translocation; Follicular lymphoma; Fluorescence in situ hybridization; Biology; Comparative genomic hybridization; Molecular biology; Lymphoma; clone (Java method); In situ hybridization; Immunohistochemistry; Gene; Gene expression; Genetics; Chromosome; Immunology","score_opus":0.010667655400651685,"score_gpt":0.2430981211410825,"score_spread":0.23243046574043083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231085890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951367,0.0036544318,0.00036807085,0.00015494543,0.000011256352,0.0005197321,0.000003070217,0.00001971919,0.00013212346],"genre_scores_gemma":[0.9913016,0.00043264285,0.007976363,0.00008351612,0.000042964835,0.00008729784,0.000024059062,0.000013942277,0.00003759476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99932486,0.000016609141,0.00015551831,0.0002276249,0.0001340623,0.00014131409],"domain_scores_gemma":[0.9996924,0.000020526802,0.000031483825,0.0001338763,0.000027836999,0.00009390322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000058299185,0.00011932875,0.00016870418,0.000075814874,0.000050831008,0.000019236175,0.000015716876,0.000054051667,0.000009345413],"category_scores_gemma":[0.0000065728827,0.00008027167,0.00001539716,0.00007597088,0.00003698434,0.00004561051,0.000008023724,0.000026921862,0.0000012126134],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010409177,0.00080855243,0.9339536,0.000041378258,0.000046223737,0.00011351592,0.00041226746,0.0000015118753,0.05912257,0.00002234531,0.0000102354625,0.0053637307],"study_design_scores_gemma":[0.007715412,0.00020441241,0.64016014,0.00013639287,0.000113299546,0.00023445139,0.000028907187,0.00002995569,0.3512595,0.000014988599,0.00003528732,0.000067239416],"about_ca_topic_score_codex":0.00003688507,"about_ca_topic_score_gemma":0.000040561292,"teacher_disagreement_score":0.29379344,"about_ca_system_score_codex":0.000023483592,"about_ca_system_score_gemma":0.000032666074,"threshold_uncertainty_score":0.32733834},"labels":[],"label_agreement":null},{"id":"W4231329669","doi":"10.1182/blood.v116.21.789.789","title":"Bortezomib Induced BRCAness Sensitizes Multiple Myeloma Cells to PARP Inhibitors","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Poly ADP ribose polymerase; PARP1; Bortezomib; DNA damage; Proteasome; DNA repair; Biology; Proteasome inhibitor; PARP inhibitor; Ubiquitin; Molecular biology; Synthetic lethality; Cancer research; Genome instability; Apoptosis; Cell culture; Cell biology; Polymerase; DNA; Multiple myeloma; Biochemistry; Genetics; Immunology; Gene","score_opus":0.014639103231341108,"score_gpt":0.26892369678760053,"score_spread":0.25428459355625943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231329669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938415,0.000030704385,0.000032863325,0.0014082578,0.0013764756,0.0006201751,0.000033340955,0.00022766537,0.0024289857],"genre_scores_gemma":[0.9933578,0.000007369037,0.002405297,0.0021752408,0.0014864269,0.00007767879,0.000020366637,0.00006042287,0.00040942273],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99843246,0.00003699636,0.0003398946,0.00042102757,0.00036765114,0.00040194555],"domain_scores_gemma":[0.99863815,0.00011041258,0.000089556335,0.00058304536,0.00017273893,0.00040608173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020276998,0.00023419865,0.0003540487,0.00016165464,0.00009894209,0.000032400232,0.00010949197,0.00020828439,0.00025030275],"category_scores_gemma":[0.000110868925,0.00022324367,0.000113565315,0.00031747395,0.000062821535,0.00007281881,0.00004678077,0.0004426901,0.0003706123],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012932192,0.0003686237,0.008522317,0.000028384315,0.000066293294,0.00012130012,0.00044745905,0.0000020642904,0.9847443,0.00003191587,0.0032859514,0.0022520812],"study_design_scores_gemma":[0.0056488817,0.0002284988,0.017604966,0.00008132537,0.00008096148,0.00016759333,0.00012627123,0.000014414812,0.96094805,0.000034513898,0.014798814,0.00026569157],"about_ca_topic_score_codex":0.00010936916,"about_ca_topic_score_gemma":0.00013596933,"teacher_disagreement_score":0.02379622,"about_ca_system_score_codex":0.000033458844,"about_ca_system_score_gemma":0.0001638654,"threshold_uncertainty_score":0.91036123},"labels":[],"label_agreement":null},{"id":"W4231342473","doi":"10.1182/blood.v112.11.3679.3679","title":"Identification of a Potent Natural Triterpenoid Inhibitor of Proteosome Chymotrypsin-Like Activity and NF-κB with Specific Anti-Myeloma Activity in Vitro and in Vivo","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Natural Compounds in Disease Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Proteasome; Chemistry; Cancer research; Cyclin D1; Transactivation; Biochemistry; Biology; Molecular biology; Transcription factor; Cell cycle; Apoptosis","score_opus":0.01115432808960634,"score_gpt":0.23764292785704552,"score_spread":0.22648859976743918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231342473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975502,0.0012190775,0.0000034974826,0.00014932174,0.000055544853,0.0009513363,0.000025952168,0.000017264227,0.000027806049],"genre_scores_gemma":[0.9992221,0.00010898642,0.000501207,0.0000071922327,0.0000321614,0.000036404632,0.0000059926924,0.00001671878,0.00006921238],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987382,0.000079504636,0.00029580717,0.0003671596,0.00032934052,0.00018998663],"domain_scores_gemma":[0.9992943,0.000050859617,0.00021124221,0.00028816253,0.00007298093,0.00008245341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012544941,0.00019246094,0.0004892691,0.0003306822,0.00003576118,0.000009044835,0.00005581721,0.00008226551,0.0000029424218],"category_scores_gemma":[0.000028600765,0.00015339455,0.000045696648,0.00041028945,0.00020383568,0.00019634097,0.00005321733,0.00023286416,3.5469162e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028961285,0.0022414443,0.060790718,0.00021542441,0.00005736718,0.00017583506,0.00020459028,4.952974e-7,0.93080544,0.0000015369855,0.0000057466473,0.0026052482],"study_design_scores_gemma":[0.0045254976,0.00017905545,0.4737207,0.000112501846,0.00004288963,0.0001271652,0.000013964174,0.000029357314,0.5211644,0.0000065008344,0.0000029934276,0.00007495666],"about_ca_topic_score_codex":0.000084776184,"about_ca_topic_score_gemma":0.000031272528,"teacher_disagreement_score":0.41292998,"about_ca_system_score_codex":0.00007663012,"about_ca_system_score_gemma":0.00006909239,"threshold_uncertainty_score":0.6255248},"labels":[],"label_agreement":null},{"id":"W4231569554","doi":"10.1182/blood.v96.9.3029.h8003029_3029_3039","title":"Generation of murine dendritic cells from flt3-ligand–supplemented bone marrow cultures","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research & Development Corporation","funders":"","keywords":"Biology; CD40; Bone marrow; CD11c; CD86; Dendritic cell; CD80; Immunology; CD8; MHC class II; Population; Follicular dendritic cells; Major histocompatibility complex; Antigen; Myeloid; Cytotoxic T cell; Antigen-presenting cell; Cell biology; T cell; Immune system; In vitro; Phenotype; Medicine","score_opus":0.01248712909344847,"score_gpt":0.23355049083647103,"score_spread":0.22106336174302255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231569554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826996,0.016049111,0.000013352039,0.000104047176,0.00027708,0.00017260613,0.00024077043,0.00004318398,0.00040029045],"genre_scores_gemma":[0.9901485,0.0011856948,0.00019873239,0.00013657984,0.000066187386,0.000018096283,0.0010078931,0.000017721353,0.00722062],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99897856,0.00018246088,0.000350946,0.00020525142,0.00004118528,0.00024162342],"domain_scores_gemma":[0.99953216,0.00006175043,0.000080085665,0.0002801301,0.000034736066,0.000011140974],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000102276295,0.00016012223,0.00026340713,0.000056871784,0.00012761122,0.000013458183,0.00016108007,0.00016650742,0.0110807065],"category_scores_gemma":[0.000011602393,0.00013978909,0.00008227323,0.00007777342,0.00010524926,0.000072543844,0.000021867803,0.00013400525,0.0004333054],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029644073,0.0005269007,0.00017827541,0.000007470531,0.0003145618,0.000006282879,0.00032472206,0.0000036649574,0.9907747,0.000031732976,0.004199575,0.003335685],"study_design_scores_gemma":[0.003818589,0.00020022644,0.0012194391,0.000022072367,0.000106673804,0.00003068182,0.000059533308,0.0000018882376,0.9124429,0.000021131369,0.08193425,0.0001426081],"about_ca_topic_score_codex":0.00037794802,"about_ca_topic_score_gemma":0.000039265364,"teacher_disagreement_score":0.07833178,"about_ca_system_score_codex":0.0000074795785,"about_ca_system_score_gemma":0.000028648015,"threshold_uncertainty_score":0.9898233},"labels":[],"label_agreement":null},{"id":"W4231663067","doi":"10.1182/blood.v95.1.256.001k29_256_262","title":"Nuclear factor-κB activation by the photochemotherapeutic agent verteporfin","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital","funders":"","keywords":"Verteporfin; Apoptosis; Molecular biology; Biology; Survivin; Transfection; Programmed cell death; IκBα; NF-κB; Caspase 3; Cancer research; Biochemistry; Gene","score_opus":0.019143233487684572,"score_gpt":0.28473971249412944,"score_spread":0.26559647900644484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231663067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916882,0.00031681723,0.0000038938892,0.0020941435,0.000019278616,0.0005956224,0.000012296456,0.0000831993,0.0051865526],"genre_scores_gemma":[0.99335366,0.00045788818,0.00002478249,0.0017732293,0.00006158154,0.000037264876,0.000011521609,0.000030805862,0.0042492794],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990414,0.000044100423,0.00013645542,0.00018928219,0.00033266903,0.0002561397],"domain_scores_gemma":[0.9994815,0.00005924268,0.00003082349,0.00032446274,0.000032854252,0.00007110443],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000088651825,0.00012708131,0.00016275865,0.000027664099,0.00014252175,0.000021923002,0.00012798853,0.00005171739,0.0026810258],"category_scores_gemma":[0.000026775293,0.00008124487,0.00007200544,0.0001418633,0.00008989011,0.00004661797,0.000018525017,0.00019977237,0.00015489104],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027831428,0.00082921056,0.0005428227,0.000026881873,0.0005427522,0.000010948237,0.0015389316,4.6702525e-7,0.9446679,0.000011632031,0.0057311715,0.045819003],"study_design_scores_gemma":[0.009596773,0.000947787,0.047397308,0.00013117204,0.00021025629,0.00010827438,0.0005342538,0.00028823456,0.6436243,0.000188605,0.29658732,0.00038570957],"about_ca_topic_score_codex":0.000077656456,"about_ca_topic_score_gemma":0.000002909891,"teacher_disagreement_score":0.30104357,"about_ca_system_score_codex":0.000053757954,"about_ca_system_score_gemma":0.00003532503,"threshold_uncertainty_score":0.99823064},"labels":[],"label_agreement":null},{"id":"W4231713150","doi":"10.1182/blood.v124.21.3095.3095","title":"Four-Year Survival Data from an Ongoing Pivotal Phase 2 Study of Brentuximab Vedotin in Patients with Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Brentuximab vedotin; Medicine; Internal medicine; Anaplastic large-cell lymphoma; Population; Refractory (planetary science); Oncology; Phases of clinical research; Chemotherapy regimen; CD30; Lymphoma; Surgery; Clinical trial; Cancer","score_opus":0.021746382804301072,"score_gpt":0.26774050288155915,"score_spread":0.24599412007725807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231713150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99839973,0.000066180866,0.0000096266895,0.000004831777,0.0001377472,0.0008343226,0.00038387446,0.000038424067,0.0001252316],"genre_scores_gemma":[0.9987924,0.0000064738965,0.00014250929,0.000017996143,0.00008786465,0.000029284203,0.00086215656,0.000044253014,0.0000170786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978947,0.00022047514,0.00046635274,0.0005939725,0.00051872944,0.0003057932],"domain_scores_gemma":[0.998098,0.00026651454,0.0002428208,0.0011445677,0.00007893767,0.00016914168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024865443,0.00024846668,0.000614971,0.00012613309,0.00005273546,0.000020849036,0.0002399236,0.00007806705,0.000041566378],"category_scores_gemma":[0.00012095165,0.00017353383,0.000032425723,0.00018769475,0.000022602684,0.00016892467,0.00012946488,0.000077210374,0.000022519915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028055615,0.12112636,0.87396014,0.00008681204,0.00023914271,0.00017864688,0.00053197384,0.0000014733757,0.00009342612,0.0000022545369,0.00003079464,0.00094341236],"study_design_scores_gemma":[0.24576642,0.015297512,0.7362332,0.0003721214,0.00077675306,0.0000064552805,0.0008489545,0.00025527755,0.00023228597,6.489125e-7,0.000035856887,0.00017455009],"about_ca_topic_score_codex":0.00070142874,"about_ca_topic_score_gemma":0.001179953,"teacher_disagreement_score":0.24296086,"about_ca_system_score_codex":0.00009537389,"about_ca_system_score_gemma":0.00015248859,"threshold_uncertainty_score":0.7076504},"labels":[],"label_agreement":null},{"id":"W4231838548","doi":"10.1182/blood-2005-05-1845","title":"Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":239,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Xenon Pharmaceuticals (Canada)","funders":"National Institutes of Health","keywords":"Hepcidin; Ferroportin; Biology; Endocrinology; Cell biology; Internal medicine; Immunology; Inflammation; Medicine","score_opus":0.006019353162603078,"score_gpt":0.2162007441430671,"score_spread":0.210181390980464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231838548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98042476,0.0024329105,0.000026898366,0.0005727228,0.000033645254,0.00014691491,0.00001424024,0.000026010164,0.016321909],"genre_scores_gemma":[0.9963673,0.0001809888,0.0007299709,0.00020240524,0.000050341332,0.0000025941551,0.000064511754,0.000010336025,0.002391574],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99944586,0.000022655213,0.00015749192,0.00011756358,0.00013480287,0.00012162035],"domain_scores_gemma":[0.99969774,0.000024224875,0.00007431179,0.00009288922,0.0000546462,0.000056208857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010547717,0.00007298883,0.00018130409,0.000035965153,0.000031053907,0.0000048984007,0.000024756755,0.00006423068,0.00012803596],"category_scores_gemma":[0.0000399378,0.00006877159,0.000030101002,0.00007566223,0.000042573498,0.000052479103,0.000014610614,0.00005752625,0.000011971437],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023805877,0.005470382,0.07477453,0.0002839428,0.00010655118,0.000005150569,0.002176833,0.000013621003,0.8694889,0.0044937977,0.036898762,0.006049488],"study_design_scores_gemma":[0.022062108,0.0003345063,0.18813622,0.00009105276,0.00059601484,0.000011610009,0.00084636774,0.00019553992,0.761322,0.00022497661,0.025901483,0.00027810497],"about_ca_topic_score_codex":0.00005048364,"about_ca_topic_score_gemma":0.000022452843,"teacher_disagreement_score":0.113361694,"about_ca_system_score_codex":0.0000069539415,"about_ca_system_score_gemma":0.000026649843,"threshold_uncertainty_score":0.2804424},"labels":[],"label_agreement":null},{"id":"W4232135396","doi":"10.1182/blood.v96.12.3734","title":"Differential stimulation of c-Kit mutants by membrane-bound and soluble Steel Factor correlates with leukemic potential","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Stimulation; Receptor; Biology; Molecular biology; Mutant; Cell culture; Cell biology; Endocrinology; Internal medicine; Biochemistry; Medicine; Gene","score_opus":0.004750098800799955,"score_gpt":0.18087529569265418,"score_spread":0.1761251968918542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232135396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99797577,0.00096261944,0.000041729225,0.000009374564,0.00013705167,0.00014074451,0.000094455696,0.000026126952,0.00061211665],"genre_scores_gemma":[0.98917276,0.00010296737,0.000017570364,0.0000081826365,0.000015570744,0.0000028059499,0.00016769102,0.00001342019,0.010499029],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993539,0.00003454704,0.00018449099,0.00019875629,0.00003627726,0.00019204237],"domain_scores_gemma":[0.99972975,0.000026723383,0.00007474467,0.00012295405,0.000025778581,0.000020037956],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000019823065,0.00013301945,0.00021821374,0.00003564203,0.00010551532,0.000013524898,0.00007088731,0.00014987559,0.0060545104],"category_scores_gemma":[0.0000024864635,0.00010708873,0.000030177956,0.000041292402,0.000158903,0.000058570302,0.000018451452,0.00011933385,0.000044732747],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003260924,0.00032510422,0.0039156596,0.000030968054,0.00017140555,0.0000034685704,0.00019426197,0.000018875111,0.99300516,0.000021332353,0.00015075451,0.0018369477],"study_design_scores_gemma":[0.023301205,0.0013803516,0.075205885,0.000095796546,0.0007085886,0.00024775288,0.00010829998,0.00024215276,0.89331967,0.000042385782,0.0047524134,0.000595512],"about_ca_topic_score_codex":0.00012662787,"about_ca_topic_score_gemma":0.000020806816,"teacher_disagreement_score":0.099685475,"about_ca_system_score_codex":0.000006346462,"about_ca_system_score_gemma":0.000023621522,"threshold_uncertainty_score":0.9948541},"labels":[],"label_agreement":null},{"id":"W4232139787","doi":"10.1182/blood.v114.22.1872.1872","title":"Arterial and Venous Thrombosis in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma: A Population-Based Study.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Monoclonal gammopathy of undetermined significance; Hazard ratio; Venous thrombosis; Thrombosis; Internal medicine; Multiple myeloma; Population; Confidence interval; Gastroenterology; Proportional hazards model; Monoclonal; Immunology; Monoclonal antibody; Antibody","score_opus":0.025100910829319766,"score_gpt":0.29583229384803705,"score_spread":0.2707313830187173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232139787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99893814,0.00011964296,0.0000045412116,0.00008934835,0.000014239162,0.0007611834,0.000025056623,0.000015741263,0.000032127027],"genre_scores_gemma":[0.9991489,0.000008699686,0.0007172676,0.000024219147,0.000034968663,0.000020534317,0.000031125815,0.000008364274,0.000005904535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999117,0.00005017244,0.00021568249,0.00023472113,0.00019724488,0.00018517663],"domain_scores_gemma":[0.99954814,0.00010021918,0.000053761403,0.00015438462,0.00003113068,0.00011234879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009191554,0.00011601861,0.0003081857,0.00011803379,0.000037099577,0.000012212294,0.00003251415,0.000042843327,0.000008745917],"category_scores_gemma":[0.00010047888,0.000100270896,0.000026279022,0.00011268512,0.00002890517,0.000040463732,0.000012035203,0.00006644164,6.935326e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005944097,0.0042291363,0.97179306,0.00003872433,0.000049043658,0.00012899762,0.00024082782,0.000002600514,0.019413935,0.0000028807976,9.846544e-7,0.0035054188],"study_design_scores_gemma":[0.016845357,0.0023679414,0.9763127,0.00005179008,0.00007604495,0.000009009588,0.000060540646,0.0006775909,0.0034859763,0.000036336354,0.0000011760827,0.00007551995],"about_ca_topic_score_codex":0.00042405937,"about_ca_topic_score_gemma":0.00021416105,"teacher_disagreement_score":0.016250947,"about_ca_system_score_codex":0.000021944239,"about_ca_system_score_gemma":0.000054346063,"threshold_uncertainty_score":0.40889284},"labels":[],"label_agreement":null},{"id":"W4232494473","doi":"10.1182/blood-2019-123486","title":"Randomized Phase 2 Study of Subcutaneous Daratumumab Plus Carfilzomib/Dexamethasone Versus Carfilzomib/Dexamethasone Alone in Patients with Multiple Myeloma Who Have Been Previously Treated with Intravenous Daratumumab to Evaluate Retreatment (LYNX)","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Daratumumab; Medicine; Carfilzomib; Dexamethasone; Internal medicine; Multiple myeloma; Oncology; Adverse effect; Surgery; Proteasome inhibitor; Bortezomib","score_opus":0.01949929881675953,"score_gpt":0.2947767710423797,"score_spread":0.27527747222562016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232494473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9745331,0.00050847785,0.000016396354,0.000048019443,0.00009581352,0.02340521,0.0002885876,0.00013780926,0.0009666113],"genre_scores_gemma":[0.99509317,0.00006253172,0.0016412863,0.000025869394,0.00006192833,0.0013880497,0.0007133156,0.00022864933,0.00078517414],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9913419,0.0013703721,0.0014410949,0.0018112316,0.0024326083,0.0016028103],"domain_scores_gemma":[0.9942243,0.0011887323,0.0006351713,0.0019892275,0.0009906366,0.000971907],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001110621,0.001232797,0.0041326312,0.0009157853,0.00023110691,0.000085755724,0.00045764164,0.00029415963,0.00017693164],"category_scores_gemma":[0.00080314884,0.0008474671,0.0002963539,0.0013419623,0.0002954292,0.00022700634,0.00021793284,0.00077078934,0.00008816875],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.68312174,0.027629625,0.26895112,0.00020070079,0.0062652514,0.002882044,0.005498656,0.0003033338,0.00038228737,0.0000016132647,0.000015946618,0.004747695],"study_design_scores_gemma":[0.8153775,0.078510925,0.093327366,0.00063724665,0.0036057157,0.00012484605,0.0012403807,0.001052104,0.0053715534,0.0000014718635,0.0000140067095,0.0007369197],"about_ca_topic_score_codex":0.006182041,"about_ca_topic_score_gemma":0.0031986271,"teacher_disagreement_score":0.17562376,"about_ca_system_score_codex":0.0009997616,"about_ca_system_score_gemma":0.0005931224,"threshold_uncertainty_score":0.99939764},"labels":[],"label_agreement":null},{"id":"W4232774961","doi":"10.1182/blood-2019-124457","title":"A Randomized Phase II, Open Label, Study of Daratumumab, Weekly Low-Dose Oral Dexamethasone and Cyclophosphamide with or without Pomalidomide in Patients with Relapsed and Refractory Multiple Myeloma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Calgary; Thunder Bay Regional Health Sciences Centre; Ottawa Hospital; CancerCare Manitoba; Queen Elizabeth II Health Sciences Centre; University of New Brunswick; Dalhousie University; University of Ottawa; McGill University Health Centre; Juravinski Cancer Centre; Saint John Regional Hospital; BC Cancer Agency","funders":"","keywords":"Pomalidomide; Daratumumab; Medicine; Dexamethasone; Lenalidomide; Internal medicine; Cyclophosphamide; Oncology; Multiple myeloma; Regimen; Pharmacology; Surgery; Chemotherapy","score_opus":0.024975060637187456,"score_gpt":0.31624395299566677,"score_spread":0.2912688923584793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232774961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989546,0.00026204964,0.0000021845628,0.000031943207,0.000021759508,0.00985498,0.0000370145,0.000028188158,0.00021587721],"genre_scores_gemma":[0.9957566,0.000049014827,0.002974819,0.00003642411,0.000010444354,0.0003394208,0.000061421415,0.00006275243,0.00070908834],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9973315,0.00037147125,0.00054397946,0.0006812264,0.0006160106,0.00045578546],"domain_scores_gemma":[0.9980898,0.0004817639,0.00028601012,0.00059599895,0.00020278918,0.00034362622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006313726,0.00038757827,0.0016415906,0.0002399396,0.00011165502,0.00005441564,0.00017873352,0.00009997804,0.000050500985],"category_scores_gemma":[0.00044772105,0.00022430351,0.00002871069,0.00038396486,0.00023341956,0.00032821068,0.00027190865,0.00030477438,0.000003972956],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42259437,0.02227667,0.55106616,0.0000926739,0.0007146995,0.00022451562,0.00087561,3.7399053e-7,0.00042285118,0.0000011014118,0.0000046642735,0.0017262908],"study_design_scores_gemma":[0.6619869,0.023746831,0.31205252,0.00039077326,0.00040102427,0.000021259199,0.00047941878,0.00013229901,0.0005838235,0.0000021720825,0.00001034832,0.0001926695],"about_ca_topic_score_codex":0.0014732714,"about_ca_topic_score_gemma":0.0012998428,"teacher_disagreement_score":0.23939249,"about_ca_system_score_codex":0.000045375557,"about_ca_system_score_gemma":0.000206607,"threshold_uncertainty_score":0.9146832},"labels":[],"label_agreement":null},{"id":"W4233173587","doi":"10.1182/blood-2019-131818","title":"Obinutuzumab Plus Gemcitabine, Dexamethasone and Cisplatin (O-GDP) As Salvage Chemotherapy Prior to Autologous Stem Cell Transplant in Aggressive B Cell Lymphoma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre; BC Cancer Agency; Simon Fraser University; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Obinutuzumab; Salvage therapy; Internal medicine; Rituximab; Gemcitabine; Oncology; Chemotherapy regimen; Regimen; Autologous stem-cell transplantation; Transplantation; Chemotherapy; Surgery; Lymphoma","score_opus":0.010714106517421475,"score_gpt":0.2580992509205724,"score_spread":0.24738514440315093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233173587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98372465,0.0020786214,0.000030877018,0.00034675802,0.00011688768,0.002266318,0.000036600846,0.000096584874,0.011302673],"genre_scores_gemma":[0.97959757,0.0006348223,0.0011883334,0.00067900773,0.00009842292,0.00009464933,0.000021199872,0.000113555965,0.017572448],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99716896,0.00014409449,0.0004791141,0.00079847476,0.00061252184,0.0007968242],"domain_scores_gemma":[0.9983146,0.0003336248,0.0001626972,0.00070301647,0.000082971215,0.00040306867],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042397212,0.00040746504,0.0008382906,0.00037889654,0.00005919232,0.000052288724,0.00026933683,0.00029798373,0.0011919289],"category_scores_gemma":[0.000021042737,0.00036879818,0.00013369267,0.0005037423,0.00008270612,0.00008035655,0.00007375188,0.0003675549,0.00035955335],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005015551,0.0015823344,0.018626614,0.0008588495,0.00018687939,0.0024569558,0.010496644,0.000038756698,0.8807478,0.00003532146,0.0002571973,0.07969709],"study_design_scores_gemma":[0.09234868,0.0046125436,0.062389642,0.00079180894,0.0002502107,0.001331608,0.0009764565,0.0007509241,0.8300143,0.0000536824,0.005469305,0.0010108646],"about_ca_topic_score_codex":0.00041268018,"about_ca_topic_score_gemma":0.00008139217,"teacher_disagreement_score":0.08733313,"about_ca_system_score_codex":0.00036966498,"about_ca_system_score_gemma":0.0006058515,"threshold_uncertainty_score":0.9998764},"labels":[],"label_agreement":null},{"id":"W4233433583","doi":"10.1182/blood.v96.5.1836","title":"Activation of macrophage cytostatic effector mechanisms during acute graft-versus-host disease: release of intracellular iron and nitric oxide–mediated cytostasis","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Cytostasis; Lipopolysaccharide; Nitric oxide; Intracellular; Immunology; Graft-versus-host disease; Macrophage; Medicine; Biology; Cancer research; Chemistry; Transplantation; Internal medicine; Cell biology; Cytotoxicity; In vitro; Biochemistry","score_opus":0.006318000434322129,"score_gpt":0.22119860834638477,"score_spread":0.21488060791206265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233433583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99824166,0.00027379638,0.0003786254,0.000050213443,0.000022631039,0.0007394965,0.00016353463,0.000055030945,0.00007503179],"genre_scores_gemma":[0.9977786,0.0005156798,0.0013087572,0.000016024736,0.000019310079,0.000028683211,0.00020488664,0.000040287334,0.000087800414],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99855494,0.00009017769,0.00044355838,0.00028435068,0.000398244,0.00022873985],"domain_scores_gemma":[0.99898297,0.00026537696,0.00016733319,0.00028465563,0.000068897374,0.00023078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013280853,0.00020246266,0.00039408897,0.00019567084,0.000048378693,0.000007664624,0.000063548076,0.00010085227,0.0002686538],"category_scores_gemma":[0.00010527444,0.00019338095,0.00008073325,0.00037010974,0.000068276335,0.000103810715,0.000012230613,0.00012749629,0.00002273728],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024066623,0.0005065556,0.0023538764,0.0022983006,0.0002264706,0.00024061251,0.00023986484,0.000006151253,0.99130046,0.000031181837,0.000002434011,0.00038744038],"study_design_scores_gemma":[0.010022324,0.00025609822,0.104370184,0.00048193175,0.0015858586,0.000039810137,0.00006839748,0.0001299615,0.8828748,0.00001908943,0.0000033149581,0.00014824796],"about_ca_topic_score_codex":0.00003642684,"about_ca_topic_score_gemma":8.6709383e-7,"teacher_disagreement_score":0.10842567,"about_ca_system_score_codex":0.000030513074,"about_ca_system_score_gemma":0.00006065826,"threshold_uncertainty_score":0.78858465},"labels":[],"label_agreement":null},{"id":"W4233476122","doi":"10.1182/blood.v112.11.4223.4223","title":"Genetic Variants in the Candidate Genes of the Apoptosis Pathway and Susceptibility to Chronic Myeloid Leukemia","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Biology; Myeloid leukemia; Cancer research; Single-nucleotide polymorphism; Imatinib mesylate; Immunology; Leukemia; Haplotype; Genetics; Allele; Imatinib; Gene; Genotype","score_opus":0.013840683967377908,"score_gpt":0.23330502280869672,"score_spread":0.2194643388413188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233476122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99658585,0.0015019114,0.0000066808598,0.0003496461,0.00006344171,0.0008653382,0.00002358255,0.000015092017,0.00058845023],"genre_scores_gemma":[0.9985668,0.00046849134,0.00035164002,0.000259902,0.000111412555,0.00005948435,0.0000045170036,0.000018325618,0.00015944519],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985729,0.00012511028,0.00031378362,0.00033820193,0.00034203436,0.00030795808],"domain_scores_gemma":[0.99888194,0.00008595968,0.000079273814,0.00082229165,0.000039903207,0.00009062855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022717712,0.00018030545,0.00031010163,0.00005740542,0.0001072525,0.000007765678,0.00024818844,0.00008360154,0.000054211137],"category_scores_gemma":[0.00008897742,0.00010207633,0.00007682385,0.0003374547,0.00015445995,0.00002930893,0.00012266905,0.00016637998,0.000013262397],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000100482386,0.0006874643,0.8922403,0.00021360803,0.00019686585,0.00009747063,0.003866147,0.000056279743,0.09276591,0.00003238835,0.0002784611,0.009464633],"study_design_scores_gemma":[0.0048572137,0.00034243887,0.9316441,0.00009554929,0.00015726787,0.00025654782,0.000099814075,0.00003994031,0.06181996,0.000025405952,0.000551787,0.00011000613],"about_ca_topic_score_codex":0.0015563346,"about_ca_topic_score_gemma":0.0012228288,"teacher_disagreement_score":0.039403785,"about_ca_system_score_codex":0.00051146187,"about_ca_system_score_gemma":0.0010665482,"threshold_uncertainty_score":0.4162552},"labels":[],"label_agreement":null},{"id":"W4233614159","doi":"10.1182/blood.v95.7.2337.007k22_2337_2345","title":"Transgenic expression of granulocyte-macrophage colony-stimulating factor induces the differentiation and activation of a novel dendritic cell population in the lung","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Biology; Granulocyte macrophage colony-stimulating factor; Population; Immunology; CD8; Immune system; Cytokine; Medicine","score_opus":0.013134549137735107,"score_gpt":0.24045664234879804,"score_spread":0.22732209321106295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233614159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973904,0.002054809,0.00009956988,0.000030631985,0.000037390902,0.00033256534,0.000014436659,0.000007179088,0.000033020955],"genre_scores_gemma":[0.9997153,0.00011616803,0.000023899205,0.000016815662,0.000005781731,0.000016125012,0.00003731225,0.0000072128914,0.000061374354],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99911875,0.0003135025,0.0002931225,0.00011041155,0.00004543475,0.00011875386],"domain_scores_gemma":[0.9993147,0.00038190302,0.00013310094,0.00014702929,0.000020127098,0.0000031295979],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001743659,0.000096078926,0.00015917535,0.00006195593,0.00012948422,0.000008349917,0.00011982237,0.0001232586,0.00011104501],"category_scores_gemma":[0.000029856477,0.00005905103,0.000047499117,0.00011987069,0.00007230148,0.00009965166,0.0000085632055,0.00015341402,8.0446796e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002928739,0.00038491085,0.008462766,0.000036193105,0.00002360657,8.7453515e-8,0.003828375,0.00003755728,0.98518604,0.000014714534,0.0000014917455,0.0017313956],"study_design_scores_gemma":[0.00203787,0.00008773206,0.36919782,0.000061886814,0.000029668137,0.0000033281215,0.0001898482,0.000027044642,0.6283005,0.000009395629,0.000009392579,0.000045548422],"about_ca_topic_score_codex":0.00018880045,"about_ca_topic_score_gemma":0.0000072254606,"teacher_disagreement_score":0.36073506,"about_ca_system_score_codex":0.0000067870274,"about_ca_system_score_gemma":0.000011928623,"threshold_uncertainty_score":0.24080312},"labels":[],"label_agreement":null},{"id":"W4234160198","doi":"10.1182/blood.v122.21.582.582","title":"Influence Of Active Cancer On The Efficacy and Safety Of Dabigatran Versus Warfarin For The Treatment Of Acute Venous Thromboembolism: A Pooled Analysis From RE-Cover and RE-Cover II","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Warfarin; Dabigatran; Discontinuation; Placebo; Cancer; Internal medicine; Surgery; Randomization; Randomized controlled trial; Atrial fibrillation","score_opus":0.018837492710004438,"score_gpt":0.28099696474051433,"score_spread":0.2621594720305099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234160198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99538606,0.0011847102,0.000009035262,0.0010045184,0.000041869112,0.0018189067,0.0002577034,0.000008562241,0.00028864061],"genre_scores_gemma":[0.9935678,0.0058208792,0.000082968276,0.00017322235,0.000050699196,0.00021562676,0.000021244861,0.00001769438,0.00004981334],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.9988516,0.000043941345,0.0003540293,0.00030165364,0.00024868027,0.00020011801],"domain_scores_gemma":[0.9982462,0.000757563,0.00027910693,0.0005336561,0.0001221098,0.000061399376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010045301,0.00020615515,0.00092502485,0.00008124473,0.00012040604,0.000010366456,0.00012771145,0.0000741403,0.00017752028],"category_scores_gemma":[0.00004451546,0.00011262728,0.0001847162,0.00024229259,0.00020313113,0.000060391816,0.00006149095,0.00006849184,0.0000017142994],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024853827,0.06226789,0.044119757,0.0010414768,0.4505298,0.000030881452,0.1483239,0.019451838,0.14985688,0.0032705949,0.0026772672,0.09357587],"study_design_scores_gemma":[0.010722557,0.0040295157,0.91039926,0.000121040684,0.0366044,4.0655772e-7,0.0005510835,0.00028429637,0.036579255,0.00008100049,0.00049841614,0.00012876191],"about_ca_topic_score_codex":0.006397362,"about_ca_topic_score_gemma":0.000235373,"teacher_disagreement_score":0.8662795,"about_ca_system_score_codex":0.000038789374,"about_ca_system_score_gemma":0.000046598445,"threshold_uncertainty_score":0.967094},"labels":[],"label_agreement":null},{"id":"W4234319046","doi":"10.1182/blood.v104.11.3195.3195","title":"Overexpression of Mitochondrial Ferritin Causes Cytosolic Iron Starvation and Changes Cellular Iron Homeostatis.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Ferritin; Cytosol; Transferrin receptor; Aconitase; Mitochondrion; Intracellular; Biochemistry; Deferoxamine; Chemistry; Cell biology; Transferrin; Iron deficiency; Biology; Internal medicine; Enzyme; Anemia","score_opus":0.009605549329487602,"score_gpt":0.23031054283383934,"score_spread":0.22070499350435174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234319046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99746305,0.0015760825,0.00048462165,0.00012873633,0.000047133413,0.00013330215,0.000057477955,0.0000061320734,0.00010349586],"genre_scores_gemma":[0.99727356,0.00079122506,0.0014160246,0.00004317642,0.00019491864,0.000024353036,0.00014563024,0.000012549642,0.00009856852],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999481,0.000018476003,0.00011084775,0.00019496368,0.00008746491,0.00010724116],"domain_scores_gemma":[0.9996578,0.0000034635063,0.00007495173,0.00018780013,0.00003873207,0.000037272323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000029151806,0.00008525691,0.00008494296,0.000027432598,0.000048169615,0.000011820584,0.000058152757,0.000086679065,0.000010264874],"category_scores_gemma":[0.00001674795,0.00008126791,0.000021677262,0.00003873131,0.000047078036,0.000004158003,0.000034902943,0.000033669294,0.000001123879],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028028564,0.00011233626,0.00041217424,0.000033986104,0.000009339734,5.7462216e-7,0.00007557479,0.000028239732,0.9985345,0.00013288106,0.00010406866,0.0005282944],"study_design_scores_gemma":[0.0015082529,0.00024894887,0.003882048,0.000037635127,0.000025920774,0.0000032437208,0.00006233949,0.000001739551,0.9920634,0.00011808409,0.0019457968,0.0001026034],"about_ca_topic_score_codex":0.000096672295,"about_ca_topic_score_gemma":0.00007674384,"teacher_disagreement_score":0.0064711147,"about_ca_system_score_codex":0.0000059505032,"about_ca_system_score_gemma":0.000034675155,"threshold_uncertainty_score":0.33140093},"labels":[],"label_agreement":null},{"id":"W4234777867","doi":"10.1182/blood.v114.22.641.641","title":"Recipient T and B Lymphocytes Dictate the Severity of Antibody-Mediated Transfusion-Related Acute Lung Injury (TRALI).","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Transfusion-related acute lung injury; Medicine; Granulocyte; Immunology; Antibody; Lung; Internal medicine; Pulmonary edema","score_opus":0.0055502456484314054,"score_gpt":0.25508330573442767,"score_spread":0.24953306008599627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234777867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913923,0.00089612516,0.000043320983,0.0041246326,0.000118214055,0.0007654462,0.00003380442,0.00010103092,0.0025251026],"genre_scores_gemma":[0.99206424,0.006315062,0.0001450672,0.0011098828,0.00002132002,0.000008779143,0.00005184655,0.00001478125,0.00026901357],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99873924,0.00005761038,0.00037980085,0.00027217585,0.00030287393,0.0002482971],"domain_scores_gemma":[0.99935555,0.000046327896,0.00007574948,0.00032090588,0.000062876636,0.00013856348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025002673,0.00018442086,0.00034127838,0.00010271135,0.000106660504,0.0000134821175,0.00010911026,0.00010378099,0.00010438505],"category_scores_gemma":[0.000021739908,0.000122055695,0.0001146166,0.0003511501,0.00011315507,0.000061730454,0.00002604531,0.00017621185,0.000008067016],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003229325,0.0115116425,0.08385989,0.00075783493,0.005303599,0.0007122482,0.01115923,0.000006555079,0.7315618,0.004097591,0.005218641,0.14258166],"study_design_scores_gemma":[0.023306137,0.0019505176,0.8466183,0.00055058725,0.0049802,0.00035298435,0.00032510998,0.00053407764,0.11638146,0.0005050427,0.003994936,0.0005006766],"about_ca_topic_score_codex":0.00006424345,"about_ca_topic_score_gemma":0.000007311121,"teacher_disagreement_score":0.7627584,"about_ca_system_score_codex":0.000013748095,"about_ca_system_score_gemma":0.00004908592,"threshold_uncertainty_score":0.4977287},"labels":[],"label_agreement":null},{"id":"W4234928752","doi":"10.1182/blood-2020-135858","title":"The Metabolic Enzyme Hexokinase 2 Localizes to the Nucleus in AML and Normal Hematopoietic Stem/Progenitor Cells to Maintain Stemness","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Stem cell; Biology; Mitochondrion; Haematopoiesis; Cell biology","score_opus":0.015942526401816766,"score_gpt":0.25721996609109116,"score_spread":0.2412774396892744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234928752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9678488,0.0025546388,0.0001410961,0.02735396,0.00008237183,0.0017083007,0.00003385705,0.000055073295,0.00022190635],"genre_scores_gemma":[0.9938148,0.00018624563,0.00036297325,0.004527103,0.00042352837,0.00021443571,0.0000027857748,0.000053542943,0.0004145378],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978468,0.0002239753,0.000358418,0.0004124603,0.0005257378,0.0006326296],"domain_scores_gemma":[0.9984672,0.00025423593,0.000044173503,0.0005465368,0.000090764326,0.0005970538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065859023,0.00022777915,0.00039259408,0.00008660401,0.00019545858,0.00011232756,0.00046174185,0.000084191786,0.000047594192],"category_scores_gemma":[0.00017276124,0.00013229961,0.00007364972,0.0006957401,0.00009058822,0.000054082913,0.0004627353,0.00041348295,0.00038218917],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015101546,0.005402372,0.05654425,0.003904997,0.0038691617,0.013325581,0.096009895,0.00096056465,0.47072637,0.036275145,0.11460424,0.18327586],"study_design_scores_gemma":[0.010545911,0.0014026994,0.0063698497,0.00019033784,0.00048109007,0.00046011547,0.009435266,0.001241884,0.5268884,0.00006148045,0.4422788,0.00064416527],"about_ca_topic_score_codex":0.00016682094,"about_ca_topic_score_gemma":0.00008975241,"teacher_disagreement_score":0.32767457,"about_ca_system_score_codex":0.00006052907,"about_ca_system_score_gemma":0.00021152956,"threshold_uncertainty_score":0.53950214},"labels":[],"label_agreement":null},{"id":"W4235159110","doi":"10.1182/blood.v126.23.1842.1842","title":"Addition of Cyclophosphamide, on Demand, to Lenalidomide and Corticosteroids in Patients with Relapsed/Refractory Multiple Myeloma, a Retrospective Review of a Single Centre Experience","year":2015,"lang":"en","type":"review","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Lenalidomide; Medicine; Regimen; Multiple myeloma; Internal medicine; Cyclophosphamide; Dexamethasone; Gastroenterology; Progression-free survival; Bortezomib; Progressive disease; Surgery; Median follow-up; Oncology; Chemotherapy","score_opus":0.027547759311993568,"score_gpt":0.3001757576348941,"score_spread":0.2726279983229006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235159110","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12441259,0.87139285,0.000001198271,0.000008483192,0.000029630113,0.0035086626,0.000421646,0.000012316272,0.00021263419],"genre_scores_gemma":[0.036358822,0.96237904,0.00034223782,0.000042391912,0.00002460712,0.00024731713,0.00048490553,0.000053644257,0.0000670564],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9973255,0.0001890608,0.000826981,0.00054165255,0.0007871168,0.0003297292],"domain_scores_gemma":[0.997995,0.00018372164,0.0005592126,0.00052500004,0.00040139342,0.0003356421],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020649929,0.00039512035,0.002162524,0.00027575565,0.000023006416,0.000006858261,0.000115844,0.00015258705,0.00004644587],"category_scores_gemma":[0.0010847892,0.00027068824,0.00015701981,0.00046174784,0.00010584554,0.000078915145,0.000082404185,0.00026567042,0.000011462869],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032514136,0.012103329,0.2585778,0.12615061,0.0010436509,0.0003198665,0.00073355355,1.5545744e-7,0.000021878206,0.0000067246883,0.00042538406,0.5973656],"study_design_scores_gemma":[0.033466753,0.012231437,0.17451955,0.7060346,0.002364433,0.000040008188,0.000084739535,8.58005e-7,0.00030608193,0.0000053033714,0.0702541,0.0006921199],"about_ca_topic_score_codex":0.000045292232,"about_ca_topic_score_gemma":0.00003468999,"teacher_disagreement_score":0.5966735,"about_ca_system_score_codex":0.00028518194,"about_ca_system_score_gemma":0.00023634102,"threshold_uncertainty_score":0.99997455},"labels":[],"label_agreement":null},{"id":"W4235369297","doi":"10.1182/blood.v114.22.1315.1315","title":"Bleeding Manifestations and Management of Children with Persistent and Chronic Immune Thrombocytopenia (ITP): Data From the Intercontinental Cooperative ITP Study Group.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Immune thrombocytopenia; Pediatrics; Gastrointestinal bleeding; Platelet; Internal medicine; Surgery","score_opus":0.021198975721016856,"score_gpt":0.2652663873083992,"score_spread":0.24406741158738232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235369297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951036,0.0031388584,0.000008649989,0.00032332327,0.000010282207,0.0010015368,0.00008291348,0.000011210876,0.0003196202],"genre_scores_gemma":[0.9986225,0.00068859453,0.00027189672,0.000038816834,0.000017227494,0.000010388076,0.00030262256,0.000007792532,0.000040186485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99935424,0.000019115321,0.00014252821,0.00025588128,0.00012016749,0.000108067885],"domain_scores_gemma":[0.99958545,0.000017554932,0.0000535199,0.00029105126,0.000017789107,0.00003460599],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006144172,0.00012060221,0.00023797213,0.000020033276,0.00010696033,0.000029822208,0.00010472136,0.000016010883,0.000017888175],"category_scores_gemma":[0.000002359565,0.00007207111,0.00001779516,0.000061309904,0.00005663571,0.00010970642,0.00012211535,0.00006708742,0.0000015157966],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005070115,0.011557099,0.94973695,0.0000702098,0.015320839,0.0009850973,0.008023174,0.0000035260657,0.0039801653,0.00023832313,0.00017611464,0.009401459],"study_design_scores_gemma":[0.01124269,0.0022761587,0.9775013,0.00018674898,0.002304191,0.00018218273,0.005987261,0.00005859542,0.00016567924,0.0000063420375,0.000006876199,0.000081973805],"about_ca_topic_score_codex":0.00025471277,"about_ca_topic_score_gemma":0.0002805978,"teacher_disagreement_score":0.02776432,"about_ca_system_score_codex":0.000013064276,"about_ca_system_score_gemma":0.000010551843,"threshold_uncertainty_score":0.29389745},"labels":[],"label_agreement":null},{"id":"W4235426531","doi":"10.1182/blood.v106.11.355.355","title":"CD28-Mediated Regulation of Multiple Myeloma Cell Proliferation and Survival.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Stromal cell; Multiple myeloma; Bone marrow; CD28; Cancer research; Plasma cell; CD86; Biology; Monoclonal gammopathy of undetermined significance; CD80; T cell; Immunology; Medicine; CD40; Monoclonal; Antibody; In vitro; Cytotoxic T cell; Monoclonal antibody; Immune system","score_opus":0.018141114981176713,"score_gpt":0.265237578060888,"score_spread":0.24709646307971128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235426531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99681216,0.0002845836,0.000050980496,0.00027053268,0.00001683399,0.0004700993,0.000015543576,0.00003470028,0.0020445548],"genre_scores_gemma":[0.996896,0.00006066759,0.002017686,0.000021656047,0.00011134041,0.00002246316,0.00015262424,0.000012738523,0.00070481264],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992054,0.00003861541,0.00018214573,0.00015949075,0.00025792167,0.00015644287],"domain_scores_gemma":[0.9994659,0.00008401372,0.000057579233,0.0001603166,0.00010729993,0.0001249267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001180419,0.000086946566,0.00016430859,0.00009053564,0.000040013263,0.000008665239,0.000025756493,0.0000622693,0.000070098125],"category_scores_gemma":[0.00016953427,0.00007179603,0.00003053838,0.000111097055,0.000036081015,0.00007933135,0.000018818439,0.00006295326,0.00003252663],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029175964,0.0013015515,0.8252137,0.00013096642,0.00008987326,0.000010728585,0.00022560102,0.0000046902674,0.16027664,0.000024030047,0.00010172889,0.012328773],"study_design_scores_gemma":[0.009126138,0.00025663665,0.7494239,0.000026749345,0.00006411939,0.000011758962,0.00002435119,0.0027612657,0.2377971,0.000010584777,0.00043958533,0.000057791298],"about_ca_topic_score_codex":0.000030484347,"about_ca_topic_score_gemma":0.00005902869,"teacher_disagreement_score":0.07752045,"about_ca_system_score_codex":0.000016148491,"about_ca_system_score_gemma":0.000047606944,"threshold_uncertainty_score":0.2927757},"labels":[],"label_agreement":null},{"id":"W4236199686","doi":"10.1182/blood.v126.23.29.29","title":"Clinical Efficacy of Daratumumab Monotherapy in Patients with Heavily Pretreated Relapsed or Refractory Multiple Myeloma","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Daratumumab; Medicine; Internal medicine; Refractory (planetary science); Gastroenterology; Multiple myeloma; Surgery; Lenalidomide","score_opus":0.04897654935328532,"score_gpt":0.3399102040956416,"score_spread":0.2909336547423563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236199686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99778897,0.000171981,0.00000582926,0.00004004892,0.000050799754,0.0011849094,0.000030109404,0.000051113675,0.0006762363],"genre_scores_gemma":[0.99733526,0.000038094713,0.0019812253,0.000038933347,0.00004711816,0.00003042829,0.00013741729,0.000043056833,0.00034845292],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979554,0.000185811,0.00054334325,0.00038596182,0.0005738113,0.00035571874],"domain_scores_gemma":[0.9982973,0.00030361905,0.00015401856,0.0005636663,0.00026428042,0.00041713478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027518952,0.00020868264,0.00056546816,0.0001747901,0.000029000152,0.000009071362,0.000120135504,0.00015780525,0.000043712003],"category_scores_gemma":[0.00088496617,0.00013046074,0.00008476452,0.00036306508,0.00012671214,0.000092639435,0.00003366587,0.0002944822,0.000033244396],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03270309,0.012504809,0.94181645,0.00003023905,0.00035750592,0.00021176609,0.00020326408,0.0000014516241,0.00008204334,0.000001233363,0.00013278819,0.011955381],"study_design_scores_gemma":[0.1419888,0.008922378,0.8471423,0.00018433364,0.000084114145,0.0000055991604,0.000030114707,0.0000545769,0.0011564788,0.000002224694,0.00031446866,0.00011461923],"about_ca_topic_score_codex":0.0001763469,"about_ca_topic_score_gemma":0.0001216683,"teacher_disagreement_score":0.10928571,"about_ca_system_score_codex":0.00007601104,"about_ca_system_score_gemma":0.0003612371,"threshold_uncertainty_score":0.53200346},"labels":[],"label_agreement":null},{"id":"W4236340533","doi":"10.1182/blood.v112.11.524.524","title":"Validation of a Predictive Model for Indentifying An Increased Risk for Thromboembolism in Children with Acute Lymphoblastic Leukemia: Results of a Multicenter Cohort Study","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stollery Children's Hospital","funders":"","keywords":"Medicine; Asparaginase; Internal medicine; Cohort; Pediatrics; Prednisone; Leukemia; Lymphoblastic Leukemia","score_opus":0.018881313559223813,"score_gpt":0.28635866582637326,"score_spread":0.26747735226714947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236340533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97360104,0.000012021892,0.018086758,0.0000042209003,0.000016289274,0.0071826144,0.001027068,0.00003440961,0.000035546764],"genre_scores_gemma":[0.9917005,0.000025146295,0.007014843,0.000011726615,0.00006214693,0.00073883514,0.00036462792,0.000058793466,0.000023399307],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99755657,0.00011281478,0.00071805576,0.00056307396,0.00066880794,0.00038068465],"domain_scores_gemma":[0.99797124,0.00036784643,0.00041708103,0.0005164966,0.00057519926,0.00015215403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007001046,0.00024041302,0.00075822335,0.00034642077,0.00009151732,0.000008078969,0.00020036192,0.00015753301,0.0000015702617],"category_scores_gemma":[0.0006812507,0.00019568783,0.00010036815,0.0003178425,0.00017213993,0.00020341908,0.00007018335,0.00017100992,5.092508e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0131474575,0.0050345,0.96720624,0.00012093162,0.002310757,0.000018827632,0.0043925005,0.003287612,0.0044027017,0.0000035937844,0.000029832376,0.00004506341],"study_design_scores_gemma":[0.08118653,0.0031797339,0.6654607,0.00013669503,0.0022251543,0.00007610221,0.000243222,0.23047312,0.01686244,0.000025013836,9.3262216e-8,0.00013118259],"about_ca_topic_score_codex":0.0013316409,"about_ca_topic_score_gemma":0.00007073057,"teacher_disagreement_score":0.3017455,"about_ca_system_score_codex":0.00041816794,"about_ca_system_score_gemma":0.0014955604,"threshold_uncertainty_score":0.79799175},"labels":[],"label_agreement":null},{"id":"W4236433348","doi":"10.1182/blood.v108.11.268.268","title":"Direct Interorganellar Transfer of Iron from Endosome to Mitochondrion.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Endosome; Endocytosis; Ferrochelatase; Transferrin receptor; Internalization; Cell biology; Mitochondrion; Chemistry; Biochemistry; Transferrin; Vesicle; Biophysics; Cytoplasm; Heme; Receptor; Biology; Membrane; Enzyme","score_opus":0.005594577614371514,"score_gpt":0.2084455846862467,"score_spread":0.20285100707187517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236433348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878762,0.001552749,0.00039013772,0.00024906345,0.000148034,0.00021799238,0.00004441392,0.000040257797,0.009481169],"genre_scores_gemma":[0.99752235,0.000035176552,0.0010301821,0.00026651585,0.0002207696,0.0000075392095,0.000042956326,0.000020060092,0.0008544334],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99928516,0.00001827086,0.00019819797,0.00018080809,0.00016612693,0.00015142783],"domain_scores_gemma":[0.99962854,0.000024900268,0.0000142111385,0.00023143544,0.000027332117,0.000073559975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000030893014,0.00010497639,0.00025453608,0.00007315529,0.000015245685,0.0000046799446,0.00006679792,0.000058211113,0.0002812264],"category_scores_gemma":[0.000021905127,0.00008970063,0.00008170742,0.00011620137,0.000021175796,0.000026218839,0.00001206699,0.000057552093,0.00008481872],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017420397,0.0013228094,0.026385298,0.000079229314,0.000032566164,0.00003272876,0.0006252708,0.000012061747,0.96794236,0.00027866615,0.0024563256,0.00065847056],"study_design_scores_gemma":[0.0065216627,0.00024193594,0.120726444,0.00006695766,0.00053758733,0.000007350401,0.00014428962,0.0000015542653,0.854754,0.00010831949,0.016713435,0.00017651262],"about_ca_topic_score_codex":0.000572309,"about_ca_topic_score_gemma":0.000056712684,"teacher_disagreement_score":0.11318842,"about_ca_system_score_codex":0.000004220345,"about_ca_system_score_gemma":0.000020536994,"threshold_uncertainty_score":0.36578855},"labels":[],"label_agreement":null},{"id":"W4237113827","doi":"10.1182/blood.v96.5.1703.h8001703_1703_1708","title":"Impact of the patient population on the risk for heparin-induced thrombocytopenia","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":313,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Medicine; Heparin-induced thrombocytopenia; Heparin; Orthopedic surgery; Internal medicine; Odds ratio; Platelet factor 4; Population; Immunology; Antigen; Gastroenterology; Surgery","score_opus":0.02958309133572942,"score_gpt":0.29524573535032167,"score_spread":0.2656626440145923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237113827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99189925,0.000020131309,0.0000015640587,0.00046521332,0.00011777528,0.0017350734,0.000059529255,0.0000400114,0.0056614564],"genre_scores_gemma":[0.99927,0.000030595176,0.00008644807,0.00020902338,0.00011657587,0.00008777249,0.000020012896,0.000040305637,0.00013926366],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984385,0.00014587703,0.00042463889,0.0003148663,0.000334129,0.0003419947],"domain_scores_gemma":[0.9984555,0.00022248532,0.00021385933,0.0009111502,0.000091319765,0.000105673425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024922515,0.00024614861,0.000508354,0.000048284805,0.00029496106,0.000025116815,0.00024408809,0.00013778222,0.000659113],"category_scores_gemma":[0.00020775168,0.000120792545,0.00053806155,0.00029269015,0.000054687298,0.00006735019,0.000045946214,0.00028540657,0.000063293846],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008212387,0.003920348,0.8600919,0.00006974426,0.0018099194,0.000004377899,0.0015142304,0.00010401422,0.09423605,0.0018217942,0.0010217027,0.034584645],"study_design_scores_gemma":[0.0024296604,0.0015887308,0.9436866,0.00009340931,0.00058668264,0.000018016082,0.000033922635,0.00008405905,0.05057079,0.00048307073,0.0002756296,0.0001494006],"about_ca_topic_score_codex":0.0013632522,"about_ca_topic_score_gemma":0.00007829112,"teacher_disagreement_score":0.083594695,"about_ca_system_score_codex":0.000089906214,"about_ca_system_score_gemma":0.0001250568,"threshold_uncertainty_score":0.7216825},"labels":[],"label_agreement":null},{"id":"W4237487229","doi":"10.1182/blood.v104.11.1051.1051","title":"Inhibition of Factor Xa in Prothrombinase Is Enhanced by Covalent Linkage of Antithrombin to Heparin.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Prothrombinase; Chemistry; Antithrombin; Covalent bond; Thrombin; Stereochemistry; Conjugate; Heparin; Biochemistry; Organic chemistry; Immunology; Platelet; Biology","score_opus":0.018176196869993045,"score_gpt":0.27524838629550646,"score_spread":0.2570721894255134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237487229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996968,0.00007150661,0.00089994166,0.00037302368,0.00005539484,0.0010088971,0.00004600532,0.00003113968,0.000546133],"genre_scores_gemma":[0.9979452,0.000033809498,0.001530569,0.00032679844,0.000015347117,0.000037555546,0.000026056372,0.000020268268,0.00006439411],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987937,0.000023813394,0.00044960354,0.00024866514,0.0003040413,0.00018015504],"domain_scores_gemma":[0.9993617,0.000011542068,0.00014102727,0.00027331297,0.00010452921,0.000107872525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010337021,0.00013796076,0.00043211118,0.00016196303,0.000016689788,0.0000044843882,0.00005472175,0.00011501763,0.00018502602],"category_scores_gemma":[0.000042850403,0.00013560647,0.0000814756,0.00035372097,0.000036906586,0.00006270749,0.000035554105,0.00010700951,0.00002576735],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041920022,0.0032739164,0.0019112577,0.00022180464,0.000051766492,0.000004392192,0.0011749597,0.0000034920258,0.99237883,0.000669765,0.00004495363,0.00022295078],"study_design_scores_gemma":[0.007843608,0.0011096444,0.01996062,0.0005497646,0.000076705284,0.00000344308,0.000096006515,0.0000024888882,0.9695946,0.0006226414,0.000024147988,0.00011630632],"about_ca_topic_score_codex":0.00016482103,"about_ca_topic_score_gemma":0.00002780138,"teacher_disagreement_score":0.022784198,"about_ca_system_score_codex":0.000033593067,"about_ca_system_score_gemma":0.00010382059,"threshold_uncertainty_score":0.55298716},"labels":[],"label_agreement":null},{"id":"W4237642525","doi":"10.1182/blood.v96.9.3200.h8003200_3200_3208","title":"Altered ligand binding and transcriptional regulation by mutations in the PML/RARα ligand-binding domain arising in retinoic acid–resistant patients with acute promyelocytic leukemia","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Corepressor; Acute promyelocytic leukemia; Transcription factor; Biology; Cancer research; Retinoic acid; Coactivator; Promyelocytic leukemia protein; Leukemia; Nuclear receptor; Tretinoin; Cell biology; Genetics; Cell culture; Gene","score_opus":0.004281676916367981,"score_gpt":0.20056655372629376,"score_spread":0.19628487680992576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237642525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99841934,0.0005919991,0.00009467962,0.00006265771,0.000021236241,0.00036692643,0.000042240856,0.000009109312,0.00039182452],"genre_scores_gemma":[0.99835324,0.00012189783,0.0005519636,0.00004341144,0.000053891003,0.00004896826,0.0006492601,0.000022041146,0.00015534797],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987451,0.00008882897,0.0002958643,0.0003801369,0.00022143203,0.0002686412],"domain_scores_gemma":[0.99964,0.00001802714,0.00008519658,0.00018055766,0.000032776225,0.000043463257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023848684,0.00018507394,0.00015538034,0.00007692005,0.00016287014,0.000087359986,0.00014744831,0.00014542235,0.000008323401],"category_scores_gemma":[0.00001802749,0.00014500204,0.000033575496,0.000243421,0.00009964233,0.000022747821,0.00001493863,0.0001657085,0.000001960501],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025533853,0.00015877893,0.018614119,0.000039829665,0.00005058177,0.00001236216,0.0010203309,0.00004301557,0.9790452,0.000035671324,0.00003470821,0.0006900647],"study_design_scores_gemma":[0.00826498,0.00058982836,0.05605667,0.00026481433,0.00015756828,0.00007582205,0.000494725,0.00006565068,0.9322103,0.0004403647,0.00086765684,0.0005115988],"about_ca_topic_score_codex":0.0000162909,"about_ca_topic_score_gemma":0.00003455655,"teacher_disagreement_score":0.04683488,"about_ca_system_score_codex":0.000052757543,"about_ca_system_score_gemma":0.00012675319,"threshold_uncertainty_score":0.59130114},"labels":[],"label_agreement":null},{"id":"W4237720275","doi":"10.1182/blood.v95.1.314.001k32_314_319","title":"Resistance of ICAM-1–deficient mice to metastasis overcome by increased aggressiveness of lymphoma cells","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Armand Frappier Museum; Institut National de la Recherche Scientifique","funders":"","keywords":"Lymphoma; Homing (biology); BCL10; Metastasis; Cancer research; Cell adhesion molecule; Biology; Immunology; Cell adhesion; Neural cell adhesion molecule; Medicine; Pathology; Cancer; Cell; Internal medicine","score_opus":0.009835746044694064,"score_gpt":0.2622170535836297,"score_spread":0.2523813075389356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237720275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929688,0.0020669138,0.000023413984,0.00015646355,0.000016564994,0.00041575325,0.00018848103,0.000017964067,0.0041456725],"genre_scores_gemma":[0.9936874,0.0002067401,0.0016162319,0.00016105056,0.000016967519,0.000021675489,0.000023565877,0.00002989202,0.0042364956],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980342,0.0001236469,0.00042378783,0.0003329458,0.0007770068,0.00030845465],"domain_scores_gemma":[0.99867153,0.00016016667,0.0001210085,0.00058500556,0.00020388018,0.00025840147],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002708966,0.00015457378,0.00047854602,0.00016532726,0.000033281045,0.0000072196563,0.0002425765,0.00007217635,0.0010834169],"category_scores_gemma":[0.00013119158,0.0001391931,0.00013927199,0.00060754095,0.000102123726,0.00002560766,0.00006830633,0.00007278112,0.000088074936],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083208317,0.0021021818,0.0006842883,0.0003305719,0.000103705686,0.00008489329,0.000110657296,0.0000061817436,0.9890702,0.000015549893,0.002752593,0.00390713],"study_design_scores_gemma":[0.0036255554,0.00028100255,0.0058831684,0.00029141703,0.00017682306,0.000012282126,0.000046825076,0.0000068490513,0.97247815,0.00000755685,0.017072208,0.00011813442],"about_ca_topic_score_codex":0.00023239948,"about_ca_topic_score_gemma":0.000012428038,"teacher_disagreement_score":0.016591987,"about_ca_system_score_codex":0.000043435222,"about_ca_system_score_gemma":0.00015091867,"threshold_uncertainty_score":0.9998297},"labels":[],"label_agreement":null},{"id":"W4237747876","doi":"10.1182/blood.v128.22.4263.4263","title":"Impact of Genomic Alterations on Outcomes in Myelofibrosis Patients Undergoing JAK1/2 Inhibitor Therapy","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Myelofibrosis; Ruxolitinib; Medicine; International Prognostic Scoring System; Oncology; Internal medicine; Population; Myeloid; Bone marrow; Myelodysplastic syndromes","score_opus":0.01812504723493484,"score_gpt":0.28604574830719215,"score_spread":0.2679207010722573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237747876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99845177,0.00006405041,0.000004161955,0.00044595535,0.00004923417,0.00050162734,0.000062021434,0.00001556961,0.00040563318],"genre_scores_gemma":[0.9992199,0.00023274121,0.00017964885,0.00009919127,0.000045263158,0.00007482835,0.000016371958,0.000019390924,0.00011268368],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99912274,0.000038587346,0.00028253175,0.0002084495,0.00016832682,0.00017937146],"domain_scores_gemma":[0.99929655,0.00025837737,0.00008796808,0.00021704944,0.000062347026,0.000077688586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000046064633,0.0001618087,0.00032132326,0.00014509812,0.000035604236,0.000008911916,0.0000390692,0.000051186194,0.00016915839],"category_scores_gemma":[0.000068966816,0.000085570035,0.0001518783,0.00007753616,0.00002368737,0.000059084352,0.000014825803,0.00004468543,0.000052254563],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012995466,0.0039692977,0.979401,0.0000078457215,0.0002731802,0.000004517566,0.00017191337,0.0000026937605,0.012926273,0.00008768604,0.00008024269,0.0029454075],"study_design_scores_gemma":[0.013466055,0.003111432,0.94146484,0.00017311447,0.0000397174,0.0000012735167,0.000005900038,0.0000010594923,0.04159084,0.000040191273,0.000021298014,0.00008427704],"about_ca_topic_score_codex":0.00005188263,"about_ca_topic_score_gemma":0.00004990519,"teacher_disagreement_score":0.037936144,"about_ca_system_score_codex":0.00012744512,"about_ca_system_score_gemma":0.00011260644,"threshold_uncertainty_score":0.34894446},"labels":[],"label_agreement":null},{"id":"W4237955961","doi":"10.1182/blood.v122.21.635.635","title":"Genomic Rearrangements Involving Programmed Death Ligands Are Recurrent In Primary Mediastinal Large B-Cell Lymphoma","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Fluorescence in situ hybridization; Biology; Lymphoma; Cancer research; Comparative genomic hybridization; Diffuse large B-cell lymphoma; Follicular lymphoma; Gene; Genetics; Chromosome; Immunology","score_opus":0.015670916103664292,"score_gpt":0.23278064174697613,"score_spread":0.21710972564331182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237955961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913831,0.0045466856,0.0000011997832,0.00029955374,0.00013278768,0.0011748524,0.000012993262,0.00007337829,0.0023754996],"genre_scores_gemma":[0.9970693,0.0005345728,0.0008204462,0.00040357801,0.00016878404,0.0006552532,0.00012758082,0.000035082867,0.0001853925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833566,0.000030175283,0.0003644207,0.000399797,0.000322151,0.00054782524],"domain_scores_gemma":[0.9991706,0.000047868733,0.00013602624,0.00032027898,0.000074562864,0.00025069134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016020208,0.0002453433,0.0003946468,0.00014693386,0.000064303575,0.000047496145,0.00010961459,0.00009934594,0.0001033962],"category_scores_gemma":[0.000040417464,0.00019949207,0.00010941905,0.00017497558,0.000022439295,0.000091785616,0.00010503353,0.00008173504,0.0002480201],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005588603,0.015924275,0.9628702,0.00019656259,0.00010775988,0.0003294689,0.00035300205,6.9200404e-8,0.002399757,0.000014260957,0.00071574963,0.017033003],"study_design_scores_gemma":[0.030289123,0.0004690905,0.9609555,0.00038183355,0.00022848503,0.000051565807,0.00016302145,0.000026629212,0.0060643884,0.000027154847,0.0011547682,0.00018841369],"about_ca_topic_score_codex":0.00018198209,"about_ca_topic_score_gemma":0.0000587285,"teacher_disagreement_score":0.030233236,"about_ca_system_score_codex":0.00031552007,"about_ca_system_score_gemma":0.00015209228,"threshold_uncertainty_score":0.8135051},"labels":[],"label_agreement":null},{"id":"W4238273633","doi":"10.1182/blood.v96.1.139.013k15_139_144","title":"Sphingosine-1-phosphate and lysophosphatidic acid trigger invasion of primitive hematopoietic cells into stromal cell layers","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"","keywords":"Lysophosphatidic acid; Stromal cell; Haematopoiesis; Sphingosine; Biology; Cell biology; Sphingosine-1-phosphate; Receptor; Cell culture; Cell; Stem cell; Cancer research; Biochemistry","score_opus":0.004454798118171216,"score_gpt":0.19770126341477826,"score_spread":0.19324646529660705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238273633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889467,0.00989173,0.00007564314,0.000027307418,0.00008072745,0.00018490941,0.000012390343,0.000013502908,0.0007671213],"genre_scores_gemma":[0.99612,0.0017873129,0.0014047913,0.00013358571,0.00013141498,0.0000107153555,0.000029631645,0.000029346995,0.00035319966],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988544,0.000045711506,0.00029884223,0.00038341078,0.00016262458,0.00025500736],"domain_scores_gemma":[0.999411,0.00001538309,0.00011272077,0.00028634796,0.000053949392,0.00012060399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017321057,0.00020478538,0.00027051623,0.00004061192,0.000080331076,0.000023028982,0.00015831995,0.00015173735,0.000113978895],"category_scores_gemma":[0.00002085791,0.000192455,0.00009901535,0.00010768611,0.000099789344,0.0000095262485,0.00007132645,0.000087180924,0.000011350452],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009137958,0.00021390124,0.00095480104,0.00008062605,0.00004337094,0.000006174643,0.00035132872,0.000018336106,0.9969597,0.000025217394,0.0001037309,0.0011514315],"study_design_scores_gemma":[0.002349965,0.00022239558,0.0009745262,0.000035798097,0.000114539485,0.000012778447,0.000103228114,0.0000103382245,0.99398154,0.00004963523,0.0019396979,0.00020555951],"about_ca_topic_score_codex":0.000051881634,"about_ca_topic_score_gemma":0.000003157183,"teacher_disagreement_score":0.008104417,"about_ca_system_score_codex":0.000003570807,"about_ca_system_score_gemma":0.00006026546,"threshold_uncertainty_score":0.78480875},"labels":[],"label_agreement":null},{"id":"W4238316183","doi":"10.1182/blood.v96.10.3310","title":"Hypersensitivity of circulating progenitor cells to megakaryocyte growth and development factor (PEG-rHu MGDF) in essential thrombocythemia","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Thrombopoietin; Megakaryocyte; Progenitor cell; Biology; Immunology; Haematopoiesis; Myeloid; Interleukin 3; Stem cell factor; Thrombopoietin receptor; Cancer research; Stem cell; Cell biology; T cell","score_opus":0.012061819164593382,"score_gpt":0.23761648777615924,"score_spread":0.22555466861156587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238316183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982205,0.00013891743,0.000006217425,0.00003804204,0.00002568528,0.00042025952,0.000012600287,0.000021833222,0.0011159171],"genre_scores_gemma":[0.99763805,0.000028197925,0.0021761162,0.00004679668,0.000023404007,0.000012321118,0.000012404431,0.000016598378,0.000046119],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99910456,0.000019886109,0.00022497453,0.00024583942,0.00018091452,0.00022383993],"domain_scores_gemma":[0.9997027,0.00002662742,0.00003895426,0.00011031789,0.000026296751,0.00009511412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000046114685,0.00014571384,0.00034799895,0.000073355935,0.000040369498,0.0000083318255,0.00002947346,0.0000662435,0.000057787154],"category_scores_gemma":[0.00001451873,0.00012813116,0.000035267338,0.00012484912,0.000027057857,0.000047330588,0.00002327904,0.000076513505,0.000019619732],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030028838,0.0030435782,0.14509775,0.00036351016,0.0005114018,0.001645267,0.0043712878,0.0000052936502,0.80611473,0.0000076250676,0.0000098191795,0.038529478],"study_design_scores_gemma":[0.00506223,0.00014002094,0.17510983,0.00013720118,0.000096601165,0.00016852384,0.00011215674,0.00001556482,0.8188997,0.000008722651,0.0000829478,0.00016651006],"about_ca_topic_score_codex":0.00011005213,"about_ca_topic_score_gemma":0.000025166952,"teacher_disagreement_score":0.038362965,"about_ca_system_score_codex":0.000024360399,"about_ca_system_score_gemma":0.000087215994,"threshold_uncertainty_score":0.52250373},"labels":[],"label_agreement":null},{"id":"W4238442067","doi":"10.1182/blood.v112.11.3057.3057","title":"Long Term Responses to Fludarabine and Rituximab in Waldenstrom’s Macroglobulinemia","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Waldenstrom macroglobulinemia; Fludarabine; Rituximab; Gastroenterology; Macroglobulinemia; Internal medicine; Neutropenia; Regimen; Surgery; Chemotherapy; Lymphoma; Cyclophosphamide; Multiple myeloma","score_opus":0.0239040858792998,"score_gpt":0.3029738346164581,"score_spread":0.2790697487371583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238442067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966482,0.0009906401,0.000009992001,0.00090314756,0.000036571193,0.00047832064,0.000009550761,0.00005834395,0.00086524454],"genre_scores_gemma":[0.99472445,0.00023223179,0.0014689242,0.00032633965,0.00015545367,0.000034935892,0.000009974206,0.000028825956,0.003018876],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984403,0.000050474453,0.0002762351,0.00038096102,0.00038729332,0.00046472778],"domain_scores_gemma":[0.99906725,0.00012852174,0.000025517167,0.0004059569,0.00006571891,0.0003070442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022033283,0.00016078718,0.00035201368,0.00023830649,0.000064289416,0.000014923548,0.000115218405,0.000103490114,0.0000790205],"category_scores_gemma":[0.0004237484,0.00014373954,0.000044876448,0.00033067074,0.00014409411,0.000052007756,0.00015124635,0.0002265439,0.00015016545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005906333,0.008991049,0.8570289,0.0007600147,0.00024920396,0.05419839,0.0027242308,0.0000029126393,0.049493466,0.000074417345,0.00460511,0.015965955],"study_design_scores_gemma":[0.16192693,0.00069514976,0.7890956,0.000381043,0.00008874831,0.016611284,0.000051361472,0.0001436776,0.029724795,0.000017084574,0.0009528702,0.00031150933],"about_ca_topic_score_codex":0.00027674445,"about_ca_topic_score_gemma":0.00010141262,"teacher_disagreement_score":0.1560206,"about_ca_system_score_codex":0.0012439804,"about_ca_system_score_gemma":0.0020073068,"threshold_uncertainty_score":0.5861528},"labels":[],"label_agreement":null},{"id":"W4238817388","doi":"10.1182/blood.v118.21.436.436","title":"Whole Transcriptome Sequencing Reveals Recurrent NOTCH1 Mutations in Mantle Cell Lymphoma","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Mantle cell lymphoma; Sanger sequencing; Transcriptome; Biology; Cancer research; Cyclin D1; Lymphoma; Molecular biology; Genetics; Exon; DNA sequencing; Gene; Cell cycle; Immunology; Gene expression","score_opus":0.03791925599566054,"score_gpt":0.25330303484173555,"score_spread":0.215383778846075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238817388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803346,0.0010780257,0.000008354876,0.00015744464,0.00011264335,0.0003671418,0.000027252256,0.00004922362,0.017865362],"genre_scores_gemma":[0.9975098,0.00008866695,0.0015107244,0.0001873837,0.000047332444,0.00011566846,0.00004140427,0.000019810273,0.00047922597],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99902725,0.00003100734,0.0002733307,0.00025159222,0.00015897423,0.00025784023],"domain_scores_gemma":[0.9995137,0.000028631754,0.000052549265,0.00024293942,0.0000372832,0.00012491636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000935871,0.00014360248,0.0002421002,0.00012408533,0.000043994103,0.0000100751595,0.000062160325,0.00006677469,0.00014126729],"category_scores_gemma":[0.000014872793,0.00012265024,0.00009789836,0.00018747663,0.000027519805,0.00006904498,0.000012333077,0.000046539586,0.00021999533],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003074352,0.038637772,0.72518414,0.0007216564,0.0004864442,0.004734502,0.030321823,0.000003629134,0.16716233,0.0012015516,0.0018215072,0.029417207],"study_design_scores_gemma":[0.022261124,0.00079859456,0.7818498,0.000447693,0.00065981824,0.00020180039,0.0009378713,0.000025725214,0.19026278,0.00054856826,0.0016992412,0.00030699314],"about_ca_topic_score_codex":0.00027063707,"about_ca_topic_score_gemma":0.00005938622,"teacher_disagreement_score":0.056665644,"about_ca_system_score_codex":0.00016106939,"about_ca_system_score_gemma":0.00012186173,"threshold_uncertainty_score":0.5001532},"labels":[],"label_agreement":null},{"id":"W4238879625","doi":"10.1182/blood.v96.12.3991.h8003991_3991_3994","title":"Polyclonal hematopoiesis with variable telomere shortening in human long-term allogeneic marrow graft recipients","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute","funders":"","keywords":"Biology; Fluorescence in situ hybridization; Haematopoiesis; Variable number tandem repeat; Polyclonal antibodies; Molecular biology; Immunology; Transplantation; Telomere; Hematopoietic stem cell transplantation; Granulocyte; Bone marrow; Stem cell; Andrology; Pathology; Internal medicine; Genetics; Chromosome; Antibody; Medicine; DNA; Genotype; Gene","score_opus":0.011656022124765372,"score_gpt":0.245932902442782,"score_spread":0.2342768803180166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238879625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99319303,0.0007050551,0.000022602382,0.00010226368,0.000061989245,0.00040091752,0.000012522721,0.0001288131,0.0053727846],"genre_scores_gemma":[0.9933573,0.00007616645,0.0024635743,0.0003498562,0.00017686034,0.000048487094,0.00008265469,0.00006490629,0.003380214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976807,0.00005633814,0.00046198105,0.00060499733,0.00051406934,0.0006819006],"domain_scores_gemma":[0.9989821,0.000041551946,0.000081024424,0.0005489821,0.00006324379,0.00028311927],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020010196,0.0003404089,0.0005548419,0.00025568844,0.00016862675,0.000041970772,0.00022715717,0.00016979591,0.002295768],"category_scores_gemma":[0.00001503873,0.00028986094,0.00008992244,0.00063738116,0.00012926623,0.00015167128,0.000039053186,0.00032960417,0.000068732035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002549413,0.0012942217,0.96526664,0.00012096508,0.00017349703,0.0011076337,0.00028280608,0.0000073308915,0.02675045,0.000082767154,0.000088047644,0.0045707207],"study_design_scores_gemma":[0.0060955933,0.00054006657,0.97063756,0.00074042485,0.00034655258,0.0012759471,0.00006854396,0.000013705904,0.01921456,0.00005937104,0.00046206103,0.0005456188],"about_ca_topic_score_codex":0.00024138423,"about_ca_topic_score_gemma":0.00024492372,"teacher_disagreement_score":0.0075358893,"about_ca_system_score_codex":0.000057746944,"about_ca_system_score_gemma":0.00011876547,"threshold_uncertainty_score":0.99995536},"labels":[],"label_agreement":null},{"id":"W4239172580","doi":"10.1182/blood.v120.21.798.798","title":"Frontline Therapy with Brentuximab Vedotin Combined with ABVD or AVD in Patients with Newly Diagnosed Advanced Stage Hodgkin Lymphoma","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Brentuximab vedotin; ABVD; Medicine; Dacarbazine; Vinblastine; Internal medicine; Oncology; Regimen; Bleomycin; Hodgkin's lymphoma; Lymphoma; Chemotherapy; Vincristine; CD30","score_opus":0.009071070798672023,"score_gpt":0.22776056938644199,"score_spread":0.21868949858776995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239172580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99681157,0.00066850544,0.000032653763,0.00015827247,0.00006158097,0.0018271381,0.000048175956,0.00009779806,0.00029430992],"genre_scores_gemma":[0.9947956,0.00011579303,0.0034634415,0.0004472029,0.00006127769,0.00040950504,0.00020791932,0.0000925898,0.0004066345],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979255,0.00006431983,0.0003219066,0.0004530556,0.000563428,0.0006717813],"domain_scores_gemma":[0.99867773,0.00013617377,0.00019843948,0.00055654213,0.00012642286,0.00030469912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009510749,0.00045971895,0.0006800469,0.0001371834,0.00007488112,0.00003869973,0.00011626288,0.00009136017,0.00010780421],"category_scores_gemma":[0.000026995467,0.00023974804,0.000053104624,0.00037218962,0.00007445501,0.00033587744,0.000028410115,0.00009015199,0.000024093717],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019340586,0.032127768,0.93417597,0.000041137617,0.00048332164,0.00036332448,0.00056911964,0.000011706483,0.000028511384,0.00004617588,0.000082431034,0.012729944],"study_design_scores_gemma":[0.22181256,0.012444622,0.7616195,0.00032946074,0.00022714696,0.000020950569,0.00014619023,0.000005035345,0.0026263325,0.0000022555619,0.0004614856,0.00030445482],"about_ca_topic_score_codex":0.0002488016,"about_ca_topic_score_gemma":0.0004039327,"teacher_disagreement_score":0.20247199,"about_ca_system_score_codex":0.00017301054,"about_ca_system_score_gemma":0.00023804964,"threshold_uncertainty_score":0.9776641},"labels":[],"label_agreement":null},{"id":"W4239220545","doi":"10.1182/blood.v124.21.111.111","title":"Prostaglandin E Synthase Is Upregulated By Gas6 during Cancer-Induced Venous Thromboembolism","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"GAS6; Thrombus; Cancer; Pathology; Cancer cell; Medicine; Lung cancer; Cancer research; Biology; Internal medicine; Receptor; Receptor tyrosine kinase","score_opus":0.008890866435485131,"score_gpt":0.2277490231641797,"score_spread":0.21885815672869458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239220545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957822,0.0027010771,0.000012896835,0.0003865325,0.00038253283,0.0002521119,0.00006000523,0.000122003905,0.00030066946],"genre_scores_gemma":[0.99843,0.00007194478,0.0000079634765,0.0000802806,0.00006541251,0.00004589113,0.00011961378,0.000029189241,0.0011496948],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988874,0.00012206407,0.00021026189,0.0003302063,0.000044704433,0.0004053521],"domain_scores_gemma":[0.99941564,0.00003063823,0.00013806664,0.00033896253,0.000047463815,0.000029234832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000113046386,0.00020244216,0.00036825906,0.0000611213,0.00026679496,0.00003217629,0.0001709135,0.00025997547,0.0002967614],"category_scores_gemma":[0.000030774638,0.00018313581,0.00008275237,0.000114732284,0.00006269728,0.000120543235,0.000057615296,0.00018327287,0.000112525755],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035370547,0.00044566704,0.0016508767,0.000025915188,0.00023336858,9.768388e-7,0.0002956582,7.496618e-7,0.99401623,0.000048426886,0.0014266284,0.0018201498],"study_design_scores_gemma":[0.0033650561,0.00016593044,0.042458437,0.000060729737,0.00013490418,0.000038838458,0.000017913031,0.000009956441,0.94880563,0.000040281702,0.0046748808,0.00022744556],"about_ca_topic_score_codex":0.00020584858,"about_ca_topic_score_gemma":0.0000071003215,"teacher_disagreement_score":0.045210585,"about_ca_system_score_codex":0.000030361154,"about_ca_system_score_gemma":0.0000310851,"threshold_uncertainty_score":0.74680614},"labels":[],"label_agreement":null},{"id":"W4239274327","doi":"10.1182/blood.v124.21.5715.5715","title":"MiR-137 Contributes to Drug Susceptibility and Chromosomal Instability of Multiple Myeloma through Targeting AURKA","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Bisulfite sequencing; CpG site; Cancer research; DNA methylation; microRNA; Molecular biology; Biology; Methylation; Clonogenic assay; Epigenetics; Pathogenesis; In vivo; Gene expression; Immunology; Gene; Genetics","score_opus":0.005840828810670223,"score_gpt":0.22404651414696627,"score_spread":0.21820568533629606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239274327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979489,0.00059464603,0.0007838122,0.00008993272,0.000045988854,0.00030739827,0.000050840572,0.000014425409,0.00016404524],"genre_scores_gemma":[0.99716276,0.000006280396,0.0025338295,0.000064428445,0.00009487269,0.000014041621,0.00009897217,0.000012526062,0.00001230504],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989954,0.00010938945,0.0002553007,0.0003690571,0.00008649246,0.00018430853],"domain_scores_gemma":[0.999313,0.00004330862,0.00008579571,0.00035763026,0.00012932462,0.00007092085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030378392,0.00012466083,0.00017568473,0.000015305432,0.000059460388,0.000012096358,0.00010717599,0.00009284488,0.000011974634],"category_scores_gemma":[0.0007505658,0.00012292975,0.0000615228,0.00006769695,0.00011133479,0.0000054279108,0.00015113017,0.00004163265,0.0000022785089],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054700067,0.00019543747,0.117652714,0.0000720252,0.00003492711,2.0110001e-7,0.000099628385,0.000009961511,0.88143426,0.00005268933,0.00017684225,0.0002166157],"study_design_scores_gemma":[0.00114031,0.00008776652,0.17423677,0.00001496584,0.000030923293,0.0000012396019,0.00004720842,0.00006322569,0.8218934,0.00017488589,0.002192148,0.00011717005],"about_ca_topic_score_codex":0.000040489012,"about_ca_topic_score_gemma":0.00009018339,"teacher_disagreement_score":0.059540883,"about_ca_system_score_codex":0.000009403413,"about_ca_system_score_gemma":0.000033541884,"threshold_uncertainty_score":0.50129294},"labels":[],"label_agreement":null},{"id":"W4239376504","doi":"10.1182/blood-2019-122506","title":"Dynamic and Time-to-Event Analyses Demonstrate Marked Reduction in Transfusion Requirements for Janus Kinase Inhibitor-Naïve Myelofibrosis Patients Treated with Momelotinib Compared Head to Head with Ruxolitinib","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sierra Wireless (Canada)","funders":"","keywords":"Ruxolitinib; Anemia; Myelofibrosis; Medicine; Hepcidin; Internal medicine; Gastroenterology; Bone marrow","score_opus":0.022464254339492215,"score_gpt":0.30306630699863457,"score_spread":0.28060205265914234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239376504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937907,0.000053939144,0.000034054,0.00045174157,0.000033560602,0.0050949617,0.0001465002,0.000051423125,0.00034311364],"genre_scores_gemma":[0.99564224,0.000023651806,0.0026667546,0.00009439564,0.00002390779,0.00066293986,0.0004473454,0.00005133701,0.00038741893],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978613,0.00008724912,0.00047629754,0.0007405192,0.00038338357,0.00045124625],"domain_scores_gemma":[0.9989381,0.00006747107,0.000121818266,0.00029653707,0.00022713175,0.00034894628],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001341798,0.0003977392,0.0007148176,0.00034668497,0.000101406054,0.000041220803,0.000054671505,0.000089333895,0.00005983351],"category_scores_gemma":[0.000020733407,0.00028758653,0.000073929565,0.00051202124,0.000042213418,0.00012018386,0.000022291728,0.00009975748,0.00004113842],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011250871,0.00524652,0.9253787,0.00023909817,0.00056852505,0.000036356323,0.00061848434,0.00014500131,0.05200816,0.000004089072,0.00007336888,0.0044308244],"study_design_scores_gemma":[0.032645963,0.013173289,0.8790168,0.0017309673,0.0007175668,0.000036545658,0.00019774369,0.0004400452,0.07153517,0.000004647646,0.00009288758,0.0004083372],"about_ca_topic_score_codex":0.00028692553,"about_ca_topic_score_gemma":0.00038042726,"teacher_disagreement_score":0.046361867,"about_ca_system_score_codex":0.00017784578,"about_ca_system_score_gemma":0.00009306447,"threshold_uncertainty_score":0.9999576},"labels":[],"label_agreement":null},{"id":"W4239443215","doi":"10.1182/blood.v122.21.212.212","title":"Influence Of Renal Function On The Efficacy and Safety Of Dabigatran Versus Warfarin For The Treatment Of Acute Venous Thromboembolism: A Pooled Analysis From RE-Cover and RE-Cover II","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Warfarin; Medicine; Dabigatran; Discontinuation; Placebo; Randomization; Internal medicine; Randomized controlled trial; Anesthesia; Surgery; Atrial fibrillation","score_opus":0.016937663772613264,"score_gpt":0.25627447571414597,"score_spread":0.2393368119415327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239443215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965663,0.00074947684,0.000042830314,0.0006907216,0.000046889483,0.0014968249,0.00010555669,0.000010794683,0.000290605],"genre_scores_gemma":[0.9973868,0.002092402,0.00009949346,0.00014900732,0.000059416405,0.00010381677,0.00003580088,0.000015606027,0.000057620222],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.9988304,0.000046800713,0.0003980101,0.0002860357,0.0002593529,0.00017941176],"domain_scores_gemma":[0.9983998,0.000628403,0.00026225043,0.00054671516,0.00010614965,0.00005668868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015566433,0.00018963095,0.00079265883,0.00009226793,0.0001284465,0.000012272854,0.00010124593,0.00007615797,0.00013516004],"category_scores_gemma":[0.000048200724,0.00010439252,0.00018784501,0.00024161831,0.0001653912,0.0000593914,0.0000509188,0.00006414232,0.0000028417871],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03545416,0.07242968,0.04463636,0.0011018539,0.3965544,0.000030523213,0.05745765,0.02482026,0.29990354,0.0065650376,0.0062427362,0.054803792],"study_design_scores_gemma":[0.01174359,0.008160157,0.9163223,0.00011088604,0.04409816,7.695104e-7,0.00026986538,0.00036877577,0.017780755,0.00014653661,0.00087404606,0.00012415908],"about_ca_topic_score_codex":0.0016838087,"about_ca_topic_score_gemma":0.00006332063,"teacher_disagreement_score":0.8716859,"about_ca_system_score_codex":0.000023430248,"about_ca_system_score_gemma":0.00003073745,"threshold_uncertainty_score":0.42570034},"labels":[],"label_agreement":null},{"id":"W4239547194","doi":"10.1182/blood.v96.6.2163","title":"Interleukin-9 enhances interleukin-5 receptor expression, differentiation, and survival of human eosinophils","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Christie (Canada)","funders":"","keywords":"Eosinophil; Interleukin 5; Biology; Interleukin 9; Molecular biology; Interleukin; Immunology; Interleukin 19; Eosinophil cationic protein; Interleukin 3; Cellular differentiation; Allergic inflammation; IL-2 receptor; Cytokine; Inflammation; T cell; Immune system","score_opus":0.010195059666253715,"score_gpt":0.2592663720029962,"score_spread":0.24907131233674246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239547194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969403,0.0007828471,0.000010461497,0.00006336245,0.00008481934,0.00015336038,0.000016182652,0.00004347194,0.0019051785],"genre_scores_gemma":[0.9983515,0.00008600251,0.00007126132,0.00007109029,0.00021719729,0.000012010425,0.000029347644,0.000016763448,0.0011448199],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990703,0.000056374884,0.0003040447,0.00022640903,0.00019563541,0.00014725138],"domain_scores_gemma":[0.9994608,0.000031019757,0.00008738006,0.00021579968,0.00006877082,0.00013621082],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00006088826,0.00013825776,0.00028939996,0.00007107196,0.00007210109,0.000014662104,0.0000797271,0.00006852837,0.002114585],"category_scores_gemma":[0.000027788656,0.000103886865,0.00007658344,0.00007544253,0.0001274201,0.00007322438,0.000029133309,0.0000864299,0.000024010002],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018688566,0.0013047156,0.09525898,0.00022094035,0.00009669795,0.000012860089,0.00076680223,1.591532e-7,0.8896094,0.000054231445,0.001089745,0.011398559],"study_design_scores_gemma":[0.003480157,0.00084400317,0.25582516,0.00063988846,0.0002057772,0.000012851949,0.0003097929,0.000001974954,0.7335094,0.00011551019,0.0048537203,0.00020173154],"about_ca_topic_score_codex":0.000007586333,"about_ca_topic_score_gemma":0.000004957005,"teacher_disagreement_score":0.16056618,"about_ca_system_score_codex":0.000007334654,"about_ca_system_score_gemma":0.0000296233,"threshold_uncertainty_score":0.9987976},"labels":[],"label_agreement":null},{"id":"W4239876213","doi":"10.1182/blood.v108.11.3187.3187","title":"A GMCSF &amp; IL15 Fusokine Leads to Paradoxical Immunosuppression In Vivo Via Asymmetrical JAK/STAT Signalling through the IL15 Receptor Complex.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; McGill University; Jewish General Hospital","funders":"","keywords":"Biology; Immune system; Immunology; Cell biology; Cytokine; Cancer research","score_opus":0.02019708383476388,"score_gpt":0.25611776778629897,"score_spread":0.2359206839515351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239876213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97241336,0.0028354167,0.00836643,0.0023390192,0.0034355382,0.0007691483,0.000023320707,0.00019950421,0.009618268],"genre_scores_gemma":[0.9876234,0.00006493569,0.0005893026,0.0008012011,0.00017690119,0.000060118065,0.00026972682,0.000030990715,0.010383419],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99795115,0.00038967084,0.00060930266,0.00042603997,0.000098131546,0.0005257289],"domain_scores_gemma":[0.99900544,0.0003489142,0.00014073876,0.0003754314,0.00010449074,0.000024976096],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00023890506,0.00027514566,0.0003662905,0.0001858228,0.0003112296,0.000045017703,0.000317004,0.0003120767,0.0047313822],"category_scores_gemma":[0.00014825918,0.00020053545,0.00014649006,0.00065154576,0.00012416411,0.00015955973,0.00013226304,0.0006655193,0.0024223633],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045135972,0.0009748498,0.00082068756,0.000007468263,0.00006553967,0.000003407171,0.00030604846,0.00010175956,0.9215052,0.00035128777,0.07487052,0.0005418818],"study_design_scores_gemma":[0.0024407269,0.00029387273,0.002366841,0.000052203613,0.000056397508,0.00009401204,0.00013925228,0.000015275862,0.43795198,0.00012404994,0.55619466,0.00027073378],"about_ca_topic_score_codex":0.0007642041,"about_ca_topic_score_gemma":0.00011025433,"teacher_disagreement_score":0.48355323,"about_ca_system_score_codex":0.00007078249,"about_ca_system_score_gemma":0.000021657206,"threshold_uncertainty_score":0.9983544},"labels":[],"label_agreement":null},{"id":"W4240353569","doi":"10.1182/blood.v120.21.2202.2202","title":"The International Prospective Glanzmann's Thrombasthenia Registry (GTR). Special Issues in Women.","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Thrombasthenia; Glanzmann's thrombasthenia; Pediatrics; Prospective cohort study; Cohort; Platelet transfusion; Observational study; Internal medicine; Platelet; Gynecology; Surgery; Platelet aggregation","score_opus":0.008170296185510136,"score_gpt":0.2611789085970852,"score_spread":0.2530086124115751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240353569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.958934,0.00075014157,5.2711835e-7,0.001599133,0.00031616748,0.00020083033,0.000006697761,0.000020453783,0.038172048],"genre_scores_gemma":[0.9945388,0.00021052292,0.0000875412,0.00016098896,0.0012705012,0.000050695275,0.000010391719,0.000010993013,0.0036595627],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99929285,0.000011600656,0.00011731392,0.000117946474,0.00019183171,0.00026847766],"domain_scores_gemma":[0.9996868,0.000025147772,0.000040974646,0.00015649151,0.000025517616,0.000065103966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011738444,0.00009160862,0.00014365347,0.000030970077,0.00005810886,0.000022708427,0.00009115503,0.000043501386,0.00016830377],"category_scores_gemma":[0.00005416141,0.00005922701,0.000033661592,0.00006814789,0.000047601046,0.00008032025,0.00003374923,0.00011078161,0.0001069682],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000478568,0.0034591837,0.97404146,0.000012551728,0.0004940303,0.00033347023,0.0036646998,1.7781997e-7,0.00034416482,0.004763395,0.007618602,0.0047897245],"study_design_scores_gemma":[0.0072185625,0.00019220386,0.88073516,0.000047879283,0.00005683269,0.00022743184,0.0011381651,0.0000026203575,0.0023076832,0.0032591491,0.10468397,0.00013034353],"about_ca_topic_score_codex":0.00002871381,"about_ca_topic_score_gemma":0.00003148943,"teacher_disagreement_score":0.097065374,"about_ca_system_score_codex":0.00008063911,"about_ca_system_score_gemma":0.000029234363,"threshold_uncertainty_score":0.24152075},"labels":[],"label_agreement":null},{"id":"W4240765124","doi":"10.1182/blood.v122.21.2375.2375","title":"Influence Of Age On The Efficacy and Safety Of Dabigatran Versus Warfarin For The Treatment Of Acute Venous Thromboembolism: A Pooled Analysis Of RE-Cover and RE-Cover II","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Warfarin; Dabigatran; Discontinuation; Placebo; Randomization; Randomized controlled trial; Internal medicine; Surgery; Atrial fibrillation","score_opus":0.03929776275397517,"score_gpt":0.3079289871027534,"score_spread":0.26863122434877823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240765124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976432,0.00028510505,0.000007950658,0.00060255436,0.00002065175,0.0010504827,0.000042662217,0.0000051272855,0.0003423155],"genre_scores_gemma":[0.99894583,0.0006565469,0.00009378158,0.000034928726,0.00003476081,0.0000065055747,0.0000134284,0.000007802292,0.00020640902],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992043,0.000030490506,0.00034600755,0.00013879301,0.00018171476,0.00009868971],"domain_scores_gemma":[0.99856466,0.00075358513,0.00024519305,0.0003399677,0.00006959256,0.000027000315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001336583,0.00011279134,0.00060061336,0.000090414855,0.000052861746,0.00000461154,0.00006758007,0.000045681554,0.000056581],"category_scores_gemma":[0.00007803495,0.00005919205,0.00017755867,0.00025434006,0.00013861337,0.000038782608,0.000032909575,0.000027813383,7.31349e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031522788,0.0047165323,0.4434225,0.0013354442,0.20083964,0.000016076649,0.045799688,0.016809484,0.22631878,0.00847591,0.0007316721,0.020011492],"study_design_scores_gemma":[0.010461662,0.0027591903,0.9494816,0.00004471472,0.023036389,3.19363e-7,0.00016578409,0.00031681842,0.013100592,0.000046400233,0.0005192968,0.00006724707],"about_ca_topic_score_codex":0.00023448588,"about_ca_topic_score_gemma":0.000012763209,"teacher_disagreement_score":0.5060591,"about_ca_system_score_codex":0.000008994868,"about_ca_system_score_gemma":0.00001617398,"threshold_uncertainty_score":0.24137817},"labels":[],"label_agreement":null},{"id":"W4240810606","doi":"10.1182/blood.v120.21.679.679","title":"Gene Expression Signatures That Delineate Biologic and Prognostic Subgroups in Peripheral T-Cell Lymphoma","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lymphoma; Anaplastic large-cell lymphoma; Peripheral T-cell lymphoma; Anaplastic lymphoma kinase; Medicine; T-cell lymphoma; Not Otherwise Specified; Pathology; Leukemia; Oncology; Cancer research; Internal medicine; T cell; Immunology; Lung cancer","score_opus":0.017754767901032247,"score_gpt":0.24122807573663735,"score_spread":0.2234733078356051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240810606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97722423,0.021793762,0.00000455371,0.000089911926,0.00007520616,0.00037336885,0.000006792275,0.000040722574,0.0003914327],"genre_scores_gemma":[0.9972148,0.0005967247,0.0015923457,0.00021616738,0.00015252826,0.00009944736,0.000045515746,0.000015733483,0.000066750144],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914646,0.00004454187,0.00014502597,0.00022013333,0.00011978513,0.00032402348],"domain_scores_gemma":[0.9995532,0.00006729847,0.00004497272,0.00015914222,0.000018437131,0.00015692247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009592092,0.00016937003,0.00022971851,0.00005863686,0.000044506305,0.00001538838,0.00003999209,0.0001250195,0.00003652525],"category_scores_gemma":[0.00003060512,0.000110297755,0.000049083155,0.00007234307,0.000034825935,0.00007264069,0.00004855281,0.000046145095,0.000012164767],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006101081,0.0036286514,0.94578165,0.000036792408,0.00002516612,0.00011238537,0.00022009149,7.1774394e-7,0.047278658,0.000008105889,0.00006501781,0.0027817464],"study_design_scores_gemma":[0.007971995,0.00025701197,0.6910276,0.000073595635,0.00012019046,0.00009481587,0.00006369698,0.00001484158,0.30001688,0.0000116577985,0.00023512529,0.00011259667],"about_ca_topic_score_codex":0.000039361923,"about_ca_topic_score_gemma":0.0000052498426,"teacher_disagreement_score":0.25475407,"about_ca_system_score_codex":0.000041243795,"about_ca_system_score_gemma":0.000026106234,"threshold_uncertainty_score":0.4497812},"labels":[],"label_agreement":null},{"id":"W4240828665","doi":"10.1182/blood.v108.11.1868.1868","title":"In Vivo Control of Acute Lymphoblastic Leukemia by Immunostimulatory CpG Oligonucleotides.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Immunology; Medicine; CpG Oligodeoxynucleotide; Immune system; Transplantation; Severe combined immunodeficiency; Immunotherapy; Bone marrow; Cancer research; In vivo; Cancer; Leukemia; CpG site; Biology; Internal medicine; DNA methylation","score_opus":0.0025702471179553767,"score_gpt":0.19727815699634257,"score_spread":0.1947079098783872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240828665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99707276,0.0010947844,0.0003541464,0.000015438485,0.000074968906,0.00009209103,0.00010918855,0.000006010196,0.001180606],"genre_scores_gemma":[0.9988551,0.00009071134,0.00004132125,0.00018537552,0.00008455612,0.00001384512,0.00003394706,0.0000152570965,0.00067984324],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99923,0.000023697592,0.0002516034,0.00021536491,0.00008052913,0.0001987525],"domain_scores_gemma":[0.9995991,0.000011825308,0.00007576034,0.00023750094,0.00004724807,0.000028566772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000059864957,0.00012790976,0.00016899558,0.00004087395,0.000018799848,0.000008240743,0.00016791257,0.00012146036,0.000052173073],"category_scores_gemma":[0.000011855878,0.00012804015,0.00008233195,0.000056143705,0.00005995314,0.0000045061875,0.00003965007,0.000045508856,0.000014013242],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000772967,0.00015322659,0.0041640652,0.000007561378,0.000097970806,0.0000106801235,0.0000054673383,0.00017385522,0.9882747,0.000026497719,0.00697463,0.000034034445],"study_design_scores_gemma":[0.0030150595,0.00026362736,0.00395671,0.000018419652,0.00008140462,0.000015057588,0.00000718828,0.00008780317,0.9901144,0.000055844313,0.0022297488,0.00015471608],"about_ca_topic_score_codex":0.00024153409,"about_ca_topic_score_gemma":0.000022790886,"teacher_disagreement_score":0.0047448813,"about_ca_system_score_codex":0.000015775127,"about_ca_system_score_gemma":0.00008068663,"threshold_uncertainty_score":0.5221326},"labels":[],"label_agreement":null},{"id":"W4240960183","doi":"10.1182/blood.v112.11.44.44","title":"A Phase II Study of Lenalidomide in Previously Untreated, Symptomatic Chronic Lymphocytic Leukemia (CLL)","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lenalidomide; Tumor lysis syndrome; Internal medicine; Multiple myeloma; Gastroenterology; Sepsis; Chronic lymphocytic leukemia; Immunology; Leukemia; Chemotherapy","score_opus":0.026420939464282662,"score_gpt":0.30825182400103057,"score_spread":0.2818308845367479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240960183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941467,0.0021549836,0.0000040920127,0.000019385072,0.000047907863,0.002387012,0.0000054517645,0.00012476752,0.0011097037],"genre_scores_gemma":[0.9979739,0.00038491932,0.000086958134,0.00004542894,0.00014395533,0.00020952334,0.000017610271,0.00007049701,0.0010672179],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99639976,0.00018006406,0.0009847926,0.00059509656,0.0010168909,0.0008233877],"domain_scores_gemma":[0.9980425,0.00022979233,0.00020618727,0.0010735763,0.00014891279,0.00029898642],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048985437,0.00035780302,0.0010096204,0.00048710764,0.00013804082,0.000011847009,0.0003752619,0.00016890143,0.00018209226],"category_scores_gemma":[0.00034890638,0.00030966298,0.0001600358,0.00099644,0.0002310081,0.00012175402,0.00025262567,0.00029838763,0.00009350057],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.028266456,0.34232888,0.07521929,0.024406923,0.015325496,0.13384858,0.16717395,0.010410032,0.14804932,0.00038369125,0.007864731,0.04672267],"study_design_scores_gemma":[0.89484733,0.02840888,0.0021805621,0.0015577421,0.0011366871,0.0070424164,0.0010140819,0.029984346,0.03304413,0.000033871598,0.00016306645,0.0005868645],"about_ca_topic_score_codex":0.005789558,"about_ca_topic_score_gemma":0.0005684093,"teacher_disagreement_score":0.8665809,"about_ca_system_score_codex":0.04771151,"about_ca_system_score_gemma":0.037045486,"threshold_uncertainty_score":0.99993557},"labels":[],"label_agreement":null},{"id":"W4241027748","doi":"10.1182/blood.v118.21.lba-6.bld0076_p3_lba-6","title":"Results of Eastern Cooperative Oncology Group Protocol E4402 (RESORT): A Randomized Phase III Study Comparing Two Different Rituximab Dosing Strategies for Low Tumor Burden Follicular Lymphoma","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Rituximab; Follicular lymphoma; Interim analysis; Hazard ratio; Internal medicine; Clinical endpoint; Randomized controlled trial; Oncology; Chemotherapy; Progression-free survival; Surgery; Gastroenterology; Lymphoma; Confidence interval","score_opus":0.043929145144591966,"score_gpt":0.33856769130066294,"score_spread":0.294638546156071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241027748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88346416,0.00009452567,0.0002519327,0.000023832728,0.000058853668,0.114573106,0.000029292387,0.00006284918,0.0014414238],"genre_scores_gemma":[0.8829209,0.000002808902,0.00081266573,0.000031659172,0.00012763194,0.11599534,0.000039771174,0.000035543413,0.000033637567],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972117,0.00034273206,0.0011212406,0.00057341816,0.00033670707,0.00041418523],"domain_scores_gemma":[0.99822354,0.0003559423,0.0005266183,0.0004639949,0.00024497014,0.00018494195],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004946891,0.00042620144,0.0021498594,0.00014176169,0.00012569758,0.000047394686,0.00016235492,0.000075948876,0.000024990606],"category_scores_gemma":[0.000105182895,0.00028496914,0.00037160245,0.00012431202,0.00016876466,0.00011948652,0.00009814675,0.00007364306,0.0000064323144],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.71074593,0.23568496,0.010112623,0.0005233127,0.006688223,0.0015170556,0.022054868,0.000017837701,0.0025820762,0.0008980828,0.000065684304,0.009109318],"study_design_scores_gemma":[0.9585574,0.011580756,0.0016611434,0.0004618854,0.0025445397,0.000077046796,0.0037910182,0.001600176,0.019286603,0.00008488329,0.00009111241,0.00026342206],"about_ca_topic_score_codex":0.001566608,"about_ca_topic_score_gemma":0.00040516947,"teacher_disagreement_score":0.24781147,"about_ca_system_score_codex":0.00013897404,"about_ca_system_score_gemma":0.0003033743,"threshold_uncertainty_score":0.99996024},"labels":[],"label_agreement":null},{"id":"W4241186020","doi":"10.1182/blood.v108.11.1858.1858","title":"A Multicenter Phase II Study Using a Dose Intensified Pediatric Regimen in Adults with Untreated Acute Lymphoblastic Leukemia.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Vincristine; Regimen; Asparaginase; Mercaptopurine; Acute lymphocytic leukemia; Internal medicine; Prednisone; Chemotherapy regimen; Pediatrics; Dexamethasone; Methotrexate; Chemotherapy; Surgery; Leukemia; Cyclophosphamide; Lymphoblastic Leukemia","score_opus":0.013033521791229812,"score_gpt":0.27919209156134944,"score_spread":0.26615856977011965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241186020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99675715,0.00012028126,0.00009589197,0.0000671832,0.00005486891,0.0022475552,0.000024809777,0.00015144506,0.0004807871],"genre_scores_gemma":[0.99748653,0.00001847321,0.0012171721,0.00010219992,0.00034078243,0.0001086844,0.00006396569,0.00009984986,0.0005623463],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99674535,0.00012303864,0.0006483505,0.0008077524,0.00079471275,0.0008807839],"domain_scores_gemma":[0.9983479,0.00016703502,0.00018481736,0.0006681262,0.00035675315,0.00027539858],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023443044,0.00044859416,0.0007165272,0.00069889234,0.00014588531,0.000042684605,0.0002246095,0.00017316685,0.000045938228],"category_scores_gemma":[0.0001605318,0.00034192603,0.0000868959,0.0013764123,0.00011743991,0.00016194153,0.00021904692,0.00037384845,0.000042924883],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.123819016,0.10572395,0.63546276,0.0011196974,0.0031939028,0.07649123,0.0121741695,0.00062346057,0.037346706,0.000031566105,0.0019776665,0.002035902],"study_design_scores_gemma":[0.78111583,0.03410663,0.09964596,0.0014526672,0.00782363,0.0031069345,0.0036861806,0.060688958,0.0068528075,0.000018066286,0.000057662,0.0014446839],"about_ca_topic_score_codex":0.0033113007,"about_ca_topic_score_gemma":0.00035215865,"teacher_disagreement_score":0.65729684,"about_ca_system_score_codex":0.0014357686,"about_ca_system_score_gemma":0.0013943528,"threshold_uncertainty_score":0.99990326},"labels":[],"label_agreement":null},{"id":"W4241239208","doi":"10.1182/blood.v112.11.5067.5067","title":"Five New Pedigrees with Inherited RUNX1 Mutations Causing Familial Platelet Disorder with Propensity to Myeloid Malignancy (FPD/AML)","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; University of Calgary; Leukemia & Lymphoma Society of Canada","funders":"","keywords":"Platelet disorder; Transplantation; RUNX1; Medicine; Trisomy 8; Hematopoietic stem cell transplantation; Myeloid leukemia; Myeloid; Internal medicine; Immunology; Oncology; Biology; Genetics; Haematopoiesis; Cytogenetics; Stem cell; Platelet; Gene","score_opus":0.02485628954828486,"score_gpt":0.25992894214957984,"score_spread":0.23507265260129498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241239208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937326,0.00013855922,0.0007043968,0.0015729317,0.000032809196,0.0015702152,0.00002753085,0.00017239564,0.0020486186],"genre_scores_gemma":[0.97898984,0.00004733204,0.012702801,0.0005482327,0.000352849,0.000073631374,0.00010637876,0.000090839836,0.0070881117],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977767,0.000054188182,0.0002788293,0.00055362756,0.00071335153,0.000623322],"domain_scores_gemma":[0.9984912,0.00006212058,0.000082495746,0.00049775874,0.00036455182,0.0005018264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010008256,0.00031771624,0.00047959312,0.00022715368,0.0003398639,0.000036711273,0.00014415386,0.00012522413,0.00008906914],"category_scores_gemma":[0.00013398174,0.0002261672,0.00005306726,0.0009286848,0.00021198054,0.00019164992,0.00011157902,0.00045628386,0.00010618266],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010940713,0.0051506325,0.805304,0.00070743414,0.0025311373,0.041010913,0.03901947,0.0011033318,0.058167774,0.00025716558,0.019582266,0.01622518],"study_design_scores_gemma":[0.03415298,0.005562337,0.90780574,0.0008815867,0.0007111904,0.014294663,0.0019604194,0.0001935712,0.024786392,0.00003058595,0.008404936,0.0012155785],"about_ca_topic_score_codex":0.0028916071,"about_ca_topic_score_gemma":0.0016788901,"teacher_disagreement_score":0.10250177,"about_ca_system_score_codex":0.00013053979,"about_ca_system_score_gemma":0.001536229,"threshold_uncertainty_score":0.9222831},"labels":[],"label_agreement":null},{"id":"W4241322874","doi":"10.1182/blood-2019-130534","title":"Cellular and Molecular Architecture of Hematopoietic Stem Cells and Progenitors in Genetic Models of Bone Marrow Failure","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster Children's Hospital; Children's Hospital of Eastern Ontario; Princess Margaret Cancer Centre; Montreal Children's Hospital; University Health Network; BC Children's Hospital; University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Bone marrow failure; Progenitor cell; Bone marrow; Haematopoiesis; Myeloid leukemia; Cancer research; Myeloid; Biology; Fanconi anemia; Stem cell; Myelodysplastic syndromes; Leukemia; Molecular biology; Immunology; Genetics; Gene; DNA repair","score_opus":0.0030860464076539755,"score_gpt":0.1736209400998564,"score_spread":0.17053489369220243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241322874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98846096,0.010938141,0.00015106116,0.000018377916,0.00001308336,0.00032829097,0.000017594542,0.0000025488616,0.000069935646],"genre_scores_gemma":[0.9985229,0.00012632806,0.0012591681,0.000012636547,0.000006128889,0.00001119413,0.000008554721,0.000018201556,0.000034905162],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992762,0.00003226115,0.00019470506,0.00026321405,0.000090739406,0.00014285484],"domain_scores_gemma":[0.99961126,0.000004616017,0.000080125625,0.00023283169,0.000023814488,0.000047338468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000039989678,0.00013658538,0.00022721321,0.00004960547,0.00000899135,0.0000051348384,0.000058690675,0.000121518606,0.0000024488943],"category_scores_gemma":[0.000001320822,0.00012466473,0.00004912274,0.0000598184,0.000055708606,0.0000022123024,0.000075123986,0.000046791523,4.7846686e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024394938,0.00031310998,0.020877445,0.0002453305,0.000095407835,0.000011126841,0.00013946574,0.00018308313,0.9775678,0.000043101005,0.0000031660231,0.0004965993],"study_design_scores_gemma":[0.0021820795,0.0003314437,0.00034531296,0.00003867488,0.00008138217,0.00002339318,0.00011297777,0.000042968215,0.99625134,0.0004303671,0.00003628644,0.00012378718],"about_ca_topic_score_codex":0.000017359565,"about_ca_topic_score_gemma":0.000012570571,"teacher_disagreement_score":0.020532133,"about_ca_system_score_codex":0.0000011634663,"about_ca_system_score_gemma":0.00002238666,"threshold_uncertainty_score":0.508368},"labels":[],"label_agreement":null},{"id":"W4241746508","doi":"10.1182/blood.v96.8.2803.h8002803_2803_2807","title":"A partial deficiency of interleukin-7Rα is sufficient to abrogate T-cell development and cause severe combined immunodeficiency","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Severe combined immunodeficiency; Biology; Missense mutation; T cell; Immunology; Lymphopoiesis; Mutation; Cell biology; Progenitor cell; Immune system; Stem cell; Genetics; In vivo; Gene","score_opus":0.007364937601120065,"score_gpt":0.20652808685563065,"score_spread":0.1991631492545106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241746508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9795826,0.014440605,0.00003619322,0.0000904958,0.00024761143,0.00041007844,0.000032115826,0.00007969731,0.005080606],"genre_scores_gemma":[0.9963192,0.0001228546,0.0001021993,0.00024990996,0.0000018137739,0.000038808077,0.000031294298,0.00002580507,0.0031081638],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977812,0.00010474486,0.0007439763,0.00055533386,0.00009819333,0.00071654184],"domain_scores_gemma":[0.99917245,0.00006011342,0.00015064362,0.0005061458,0.00008556818,0.000025102201],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00032148167,0.00034832733,0.00046036782,0.00018540803,0.00039356996,0.000030409563,0.0004698271,0.00020091783,0.00137889],"category_scores_gemma":[0.000027420425,0.00032390337,0.00011409816,0.00041545113,0.00028115013,0.00009524933,0.00017064059,0.00026538048,0.00079258275],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014055497,0.016287496,0.009887207,0.0003408605,0.0005578246,0.000035996003,0.09000373,0.00020406925,0.8032138,0.0013615886,0.0006049792,0.07609695],"study_design_scores_gemma":[0.012296723,0.0018575741,0.026317302,0.00024286288,0.0003127461,0.0002184099,0.0042971675,0.000019697482,0.88743275,0.000050831557,0.065617315,0.00133661],"about_ca_topic_score_codex":0.00013443174,"about_ca_topic_score_gemma":0.0000036168876,"teacher_disagreement_score":0.08570656,"about_ca_system_score_codex":0.000026279784,"about_ca_system_score_gemma":0.00016393761,"threshold_uncertainty_score":0.9999854},"labels":[],"label_agreement":null},{"id":"W4241778779","doi":"10.1182/blood.v116.21.2528.2528","title":"Amelioration of Murine Immune Thrombocytopenia by CD44 Antibodies: a Potential Therapy for ITP?","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services","funders":"","keywords":"Medicine; Antibody; Immunology; Monoclonal antibody; Autoimmunity; Autoimmune disease; Rituximab; Experimental autoimmune encephalomyelitis; Immune system; CD44; Cell; Biology","score_opus":0.007665491616162226,"score_gpt":0.27600612537501956,"score_spread":0.26834063375885736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241778779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974836,0.00049225613,0.0009499974,0.00014906657,0.000084011466,0.00045933845,0.000062743544,0.000007580243,0.00031137714],"genre_scores_gemma":[0.9972715,0.00025494446,0.0013926177,0.000037406193,0.00014300046,0.000044363554,0.0003327973,0.000015715203,0.0005076822],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993406,0.000021312773,0.00017258967,0.00019008937,0.00012164323,0.00015377728],"domain_scores_gemma":[0.99945116,0.0000059708364,0.000070910464,0.00026594516,0.00016727437,0.000038767073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015732729,0.00008969923,0.00013098611,0.000032597505,0.00006459537,0.000020066502,0.00014906442,0.0001183471,0.00008873406],"category_scores_gemma":[0.00006179815,0.000079316946,0.00008188987,0.000058813155,0.000063748375,0.0000044885014,0.0000425054,0.00007548966,0.0000050919966],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014387698,0.0002936795,0.00041617648,0.00001380257,0.000046395715,4.3531034e-7,0.000016882674,0.0000021753165,0.9964677,0.000064876265,0.0007730497,0.0017609155],"study_design_scores_gemma":[0.0026166716,0.0004858355,0.0019462662,0.0000031374232,0.000008769653,0.000005103143,0.000015460802,0.0000412836,0.9743047,0.000049772676,0.02043098,0.00009202917],"about_ca_topic_score_codex":0.000036411115,"about_ca_topic_score_gemma":0.0000251274,"teacher_disagreement_score":0.022163045,"about_ca_system_score_codex":0.000001202762,"about_ca_system_score_gemma":0.000050716648,"threshold_uncertainty_score":0.32344514},"labels":[],"label_agreement":null},{"id":"W4242161580","doi":"10.1182/blood-2020-141850","title":"Frequency of Venous Thromboembolism in 6513 Patients with COVID-19: A Retrospective Study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Mechanical ventilation; Emergency department; Retrospective cohort study; Cohort; Emergency medicine; Venous thrombosis; Venous thromboembolism; Pulmonary embolism; Cohort study; Thrombosis; Internal medicine; Pediatrics; Intensive care medicine","score_opus":0.039025494390758295,"score_gpt":0.3337400061843322,"score_spread":0.2947145117935739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242161580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951994,0.00011850274,0.000015531894,0.0028386496,0.00003213141,0.0013295652,0.000034913533,0.00005210947,0.0003792433],"genre_scores_gemma":[0.99510014,0.000008363204,0.00012416393,0.004627338,0.000081982915,0.00002021203,0.000011440301,0.000022103048,0.000004256325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986883,0.000060660263,0.00029248814,0.00030576086,0.00040223304,0.00025057734],"domain_scores_gemma":[0.9989613,0.000052923286,0.00011645544,0.00025373255,0.0001403596,0.00047518633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012434901,0.00014056673,0.00055931107,0.00010313449,0.00004050278,0.000005639409,0.000086450185,0.00006515024,0.00007602888],"category_scores_gemma":[0.0010530686,0.000112293405,0.00003806108,0.00048957963,0.000047067962,0.00005587938,0.000033816483,0.00024763,0.000009146993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001854883,0.004893839,0.97748214,0.00027897942,0.000100153346,0.0001798238,0.016464131,0.0000015226209,0.0001624907,0.000065982975,0.00005225584,0.00013317616],"study_design_scores_gemma":[0.012098992,0.0067957332,0.9796714,0.00006840175,0.00017101484,0.000003749909,0.00078076584,0.0000019008195,0.000106365085,0.0001596299,0.000037897193,0.00010415918],"about_ca_topic_score_codex":0.0027326355,"about_ca_topic_score_gemma":0.000775411,"teacher_disagreement_score":0.015683364,"about_ca_system_score_codex":0.00016141329,"about_ca_system_score_gemma":0.00096975005,"threshold_uncertainty_score":0.4579192},"labels":[],"label_agreement":null},{"id":"W4242302319","doi":"10.1182/blood.v116.21.4188.4188","title":"Post-Transcriptional Deregulation of MYC Via PTEN Constitutes a Major Alternative Pathway of MYC Activation In T-Cell Acute Lymphoblastic Leukemia","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"PTEN; Biology; Carcinogenesis; Cancer research; Context (archaeology); Oncogene; Cancer; Molecular biology; Cell cycle; Genetics; Signal transduction; PI3K/AKT/mTOR pathway","score_opus":0.008176589608773828,"score_gpt":0.2429818965111823,"score_spread":0.23480530690240847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242302319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991957,0.000031610136,0.0049970625,0.00016612446,0.00014050376,0.00062686525,0.00012751517,0.000029534362,0.0019237831],"genre_scores_gemma":[0.9955165,0.000010154115,0.0037588188,0.00008008883,0.00013450722,0.00004131101,0.00019817147,0.000031176533,0.0002293127],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979671,0.00005973725,0.00059770176,0.00034750358,0.0007066318,0.00032127468],"domain_scores_gemma":[0.99832916,0.0003618628,0.00027206045,0.00033283446,0.00056452036,0.00013954964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025911946,0.00022114295,0.0004563939,0.00042530187,0.00004222286,0.000010668672,0.00019376606,0.0002312752,0.0002040164],"category_scores_gemma":[0.00031406502,0.00020018315,0.0001207388,0.00037025168,0.00034297822,0.00023231497,0.000056643636,0.00031817218,0.000020204743],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006815713,0.0008172768,0.005868533,0.00021771899,0.00022048765,0.000039558374,0.0005730842,0.00005378193,0.98916036,0.0013505874,0.00002640385,0.0009906375],"study_design_scores_gemma":[0.015396681,0.00044335512,0.046307776,0.00022769562,0.0002544716,0.00013964165,0.00009095233,0.005036184,0.931295,0.00058470847,0.000044329383,0.00017923658],"about_ca_topic_score_codex":0.00067562226,"about_ca_topic_score_gemma":0.00009477187,"teacher_disagreement_score":0.05786539,"about_ca_system_score_codex":0.0003189426,"about_ca_system_score_gemma":0.0018564735,"threshold_uncertainty_score":0.81632316},"labels":[],"label_agreement":null},{"id":"W4242549471","doi":"10.1182/blood.v128.22.3153.3153","title":"Architectural and Functional Heterogeneity of Hematopoietic Stem/Progenitor Cells in Non-Del(5q) Myelodysplastic Syndromes","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CD34; Progenitor cell; Haematopoiesis; Bone marrow; Myelodysplastic syndromes; CD38; Biology; Stem cell; Cancer research; Immunology; Myeloid; Stromal cell; Genetics","score_opus":0.018071614087886986,"score_gpt":0.2520539705413163,"score_spread":0.2339823564534293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242549471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985947,0.00027027127,0.00019368395,0.00028378554,0.00008875799,0.00040731864,0.000031145297,0.00002515454,0.0001051756],"genre_scores_gemma":[0.9989507,0.000033743127,0.00043983525,0.00003217142,0.00010113683,0.000039578765,0.0000039117594,0.000027438147,0.00037144922],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99852526,0.000056743887,0.0003329829,0.00033728135,0.0003867918,0.00036096093],"domain_scores_gemma":[0.9990719,0.00028912444,0.00006920813,0.00029691798,0.00007892717,0.00019392611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020005525,0.0001773282,0.00038689503,0.00022896833,0.000033227785,0.000008203366,0.00009423746,0.00010559888,0.00008180373],"category_scores_gemma":[0.000059606024,0.000116232564,0.00008047791,0.00019496222,0.00019628501,0.00005522579,0.0001196354,0.00018118843,0.000058564125],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046664523,0.00055296166,0.17112927,0.0006477132,0.00026431866,0.00029458213,0.00023017291,0.000005053212,0.8229756,0.00004519638,0.00013682747,0.003251682],"study_design_scores_gemma":[0.012153963,0.00078728737,0.3681103,0.0005445445,0.00019244137,0.0018533298,0.000090815476,0.000115273804,0.6157292,0.000098856384,0.0000633755,0.00026059567],"about_ca_topic_score_codex":0.000024543555,"about_ca_topic_score_gemma":0.000015338008,"teacher_disagreement_score":0.20724636,"about_ca_system_score_codex":0.00007241346,"about_ca_system_score_gemma":0.0001894623,"threshold_uncertainty_score":0.47398266},"labels":[],"label_agreement":null},{"id":"W4242599543","doi":"10.1182/blood.v118.21.2089.2089","title":"Preoperative Hemoglobin Levels, Characteristics, and Resource Utilization in Total Knee Replacement Patients with An Anemia Diagnosis Versus without An Anemia Diagnosis: An Electronic Medical Record Analysis","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Anemia; Medical record; Hemoglobin; Surgery; Population; Retrospective cohort study; Pediatrics; Internal medicine","score_opus":0.02491476665038834,"score_gpt":0.26348913278571845,"score_spread":0.23857436613533012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242599543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979446,0.00009540229,0.00011510823,0.00013205453,0.000059402722,0.0012002841,0.000039806524,0.00009652597,0.0003168386],"genre_scores_gemma":[0.9974039,0.0002854027,0.0007202012,0.00035039432,0.00007121074,0.00039190004,0.00067741127,0.00004537954,0.00005415756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99720216,0.00031459454,0.00051099586,0.0008422759,0.0006409871,0.000489011],"domain_scores_gemma":[0.9985365,0.000050290295,0.00014999844,0.000612008,0.00013766906,0.0005135075],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005069477,0.0003392649,0.0005653718,0.0003346967,0.00013113781,0.000045762026,0.00013754966,0.00019234038,0.0007368784],"category_scores_gemma":[0.00012993603,0.00028783243,0.000054521894,0.00058801105,0.00010212139,0.0003272526,0.00006347865,0.00038258167,0.000003396618],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002790538,0.006264895,0.9742611,0.00007076406,0.00050586014,0.000056018092,0.0026875555,0.0000013409276,0.000008063383,0.00006896233,0.000031445365,0.013253452],"study_design_scores_gemma":[0.016003681,0.011259694,0.967052,0.00013918855,0.0029708247,0.000007402336,0.000935901,0.0003839269,0.0006073933,0.0000052573755,0.00028682005,0.00034790442],"about_ca_topic_score_codex":0.00057811936,"about_ca_topic_score_gemma":0.0048923213,"teacher_disagreement_score":0.013213145,"about_ca_system_score_codex":0.00010193232,"about_ca_system_score_gemma":0.00014061293,"threshold_uncertainty_score":0.9999574},"labels":[],"label_agreement":null},{"id":"W4242622327","doi":"10.1182/blood.v122.21.2328.2328","title":"Spontaneous Heparin-Induced Thrombocytopenia Syndrome: Two New Cases and a Proposal For Defining This Disorder","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Argatroban; Heparin-induced thrombocytopenia; Heparin; Fondaparinux; Thrombosis; Internal medicine; Platelet activation; Stroke (engine); Surgery; Aspirin; Cardiology; Platelet; Anesthesia","score_opus":0.025653370591774388,"score_gpt":0.2855841220789945,"score_spread":0.2599307514872201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242622327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909367,0.00038646878,0.000028923125,0.0017121122,0.00020298529,0.0026748048,0.000019432326,0.00023320936,0.003805385],"genre_scores_gemma":[0.988135,0.000063592415,0.009194348,0.0004178648,0.00016132099,0.00028833115,0.000053992397,0.00011727719,0.0015682989],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975046,0.000060885006,0.00053703226,0.0007786004,0.0003175117,0.00080139196],"domain_scores_gemma":[0.99807507,0.0003900652,0.00014809176,0.00061264774,0.00015740801,0.00061674597],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019193655,0.0004848229,0.0010971067,0.00016481517,0.00031142426,0.0001754497,0.00020638148,0.0002353257,0.0010173303],"category_scores_gemma":[0.0004154934,0.0004140763,0.00019164747,0.00026948494,0.000099433215,0.00032272542,0.00018539061,0.00035011067,0.0004792234],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011206045,0.00800705,0.2939558,0.0019485411,0.0054494725,0.016927935,0.004970421,0.0000032008502,0.54133564,0.029531427,0.009089534,0.08766034],"study_design_scores_gemma":[0.069595434,0.01484976,0.5404438,0.0015330189,0.0074477526,0.269127,0.001534507,0.00039862315,0.0727486,0.0089363465,0.009252709,0.004132463],"about_ca_topic_score_codex":0.003979427,"about_ca_topic_score_gemma":0.00076266273,"teacher_disagreement_score":0.46858707,"about_ca_system_score_codex":0.00006437736,"about_ca_system_score_gemma":0.0007045044,"threshold_uncertainty_score":0.9998959},"labels":[],"label_agreement":null},{"id":"W4243058622","doi":"10.1182/blood.v124.21.3580.3580","title":"IDH2 R172 Mutations Define a Unique Subgroup of Patients in Angioimmunoblastic T-Cell Lymphoma","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Angioimmunoblastic T-cell lymphoma; Epigenetics; Biology; IDH2; Cancer research; DNA methylation; Molecular biology; Lymphoma; Mutation; Genetics; T cell; Immunology; Gene; Gene expression; IDH1","score_opus":0.002684100064832114,"score_gpt":0.18651970868000925,"score_spread":0.18383560861517714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243058622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980707,0.0002514561,0.0008897302,0.000011506889,0.000058742386,0.00013353559,0.000015154006,0.0000067541773,0.0005624261],"genre_scores_gemma":[0.999124,0.00003218366,0.00038167232,0.000017069524,0.000038177088,0.000016253905,0.00030185652,0.000016077815,0.00007270454],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993741,0.000046789395,0.00020246436,0.00017121283,0.00007908995,0.00012638053],"domain_scores_gemma":[0.9995823,0.000014080522,0.00009215238,0.00021285555,0.000071142706,0.000027504686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007151904,0.000088335546,0.00010026155,0.00006368803,0.000020304644,0.0000047062904,0.00008188425,0.00011385878,0.0000062598883],"category_scores_gemma":[0.00005641103,0.00009606156,0.000050837116,0.00013685692,0.00003431519,0.0000024861527,0.000036358048,0.000026634176,0.0000051604793],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011939735,0.0019259413,0.0807931,0.000070308946,0.000070857546,8.286135e-7,0.00017253307,0.0011281671,0.90925777,0.00019238748,0.00015306361,0.0061156237],"study_design_scores_gemma":[0.0061217984,0.0004782294,0.32539907,0.000031701165,0.0000608775,0.0000029288308,0.000013198281,0.00026911328,0.6658823,0.00019370469,0.0013588689,0.00018818911],"about_ca_topic_score_codex":0.00006381342,"about_ca_topic_score_gemma":0.00014684143,"teacher_disagreement_score":0.24460599,"about_ca_system_score_codex":0.000013478095,"about_ca_system_score_gemma":0.000049703962,"threshold_uncertainty_score":0.39172766},"labels":[],"label_agreement":null},{"id":"W4243344667","doi":"10.1182/blood.v110.11.709.709","title":"Novel VWF Sequence Variations Identified in Normal Controls and Index Cases Enrolled in the TS Zimmerman Program for the Molecular and Clinical Biology of VWD (ZPMCB-VWD).","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Von Willebrand disease; Missense mutation; Genetics; Nonsense mutation; Mutation; Von Willebrand factor; Biology; Point mutation; Exon; Penetrance; Gene; Medicine; Phenotype; Immunology","score_opus":0.03747667242296088,"score_gpt":0.3747064638350483,"score_spread":0.3372297914120874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243344667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966041,0.0007641603,0.00054232916,0.0004715057,0.000025805004,0.0014317769,0.000024571595,0.0000060118637,0.00012975845],"genre_scores_gemma":[0.99906373,0.00009478879,0.00040251788,0.00027867418,0.00001653275,0.000107804444,0.000024153358,0.0000057163325,0.0000060782922],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99922556,0.00004474964,0.0003293603,0.00015516758,0.00006929856,0.00017585032],"domain_scores_gemma":[0.9989072,0.00080361933,0.00008555115,0.00013578322,0.000034320816,0.00003351548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052520377,0.00008162089,0.00025944505,0.00006275723,0.000042936917,0.000011143367,0.000060032267,0.00009151168,0.0000015112726],"category_scores_gemma":[0.00026586547,0.00004920977,0.000045591674,0.000116556716,0.00013228098,0.000028409253,0.000021664233,0.0001114692,2.5259368e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000999476,0.0057325996,0.94723135,0.000055023433,0.00061442406,0.00067622605,0.00065902283,0.0000031918635,0.013030387,0.004526512,0.000006053738,0.02646571],"study_design_scores_gemma":[0.030431716,0.0010296683,0.9654268,0.000037439193,0.00041457193,0.0003780791,0.00024978037,0.00053348305,0.000756057,0.0005021544,0.00015222283,0.00008803723],"about_ca_topic_score_codex":0.0003942638,"about_ca_topic_score_gemma":0.001177529,"teacher_disagreement_score":0.029432239,"about_ca_system_score_codex":0.0000042929437,"about_ca_system_score_gemma":0.00005351649,"threshold_uncertainty_score":0.20067163},"labels":[],"label_agreement":null},{"id":"W4243387969","doi":"10.1182/blood-2020-137089","title":"Brentuximab Vedotin with Chemotherapy for Patients with Previously Untreated, Stage III/IV Classical Hodgkin Lymphoma: 5-Year Update of the ECHELON-1 Study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Brentuximab vedotin; Chemotherapy; Medicine; Internal medicine; Chemotherapy regimen; Oncology; Lymphoma; Classical Hodgkin lymphoma; Stage (stratigraphy); Hodgkin lymphoma; Biology","score_opus":0.008877696365832067,"score_gpt":0.22346718816336134,"score_spread":0.21458949179752926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243387969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949886,0.00008319029,0.000020507156,0.0013772186,0.0000234509,0.0031859404,0.00008358756,0.00005287635,0.00018459963],"genre_scores_gemma":[0.9983018,0.00002352097,0.0006345437,0.0005328318,0.00006250487,0.00022135426,0.000052130174,0.000054350476,0.000116939744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848956,0.000050382587,0.0002853468,0.00042374487,0.00043283697,0.00031812416],"domain_scores_gemma":[0.9989952,0.000059920927,0.00019573199,0.00043766765,0.0001480601,0.00016344439],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006978751,0.00027479534,0.0005163827,0.00002890172,0.00008536221,0.00002218305,0.00015933892,0.0000616896,0.000040712708],"category_scores_gemma":[0.00002429111,0.0001398849,0.00011595262,0.00025291825,0.000083848594,0.00004650481,0.000052216175,0.00005810503,0.000008130078],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037943483,0.02207512,0.9678473,0.00010084799,0.0012259716,0.00003376969,0.0011055089,0.000002326284,0.00004026104,0.00006209794,0.00042414424,0.0032883028],"study_design_scores_gemma":[0.19660698,0.014763306,0.7729291,0.00018514294,0.0018738789,0.000008703186,0.00048013477,0.000033251697,0.0109109795,0.0000045539277,0.0019460103,0.00025796934],"about_ca_topic_score_codex":0.000054511864,"about_ca_topic_score_gemma":0.000034132125,"teacher_disagreement_score":0.1949182,"about_ca_system_score_codex":0.000066316315,"about_ca_system_score_gemma":0.0002075289,"threshold_uncertainty_score":0.57043403},"labels":[],"label_agreement":null},{"id":"W4244181156","doi":"10.1182/blood.v108.11.1664.1664","title":"Identification and Characterization of Zebrafish Mast Cells.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Zebrafish Biomedical Research Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Zebrafish; Biology; Molecular biology; Degranulation; Haematopoiesis; Myeloperoxidase; Population; GATA1; Cell biology; Immunology; Biochemistry; Stem cell; Inflammation; Gene","score_opus":0.00490199442694905,"score_gpt":0.22776929249461822,"score_spread":0.22286729806766917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244181156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996817,0.000053236727,0.0023479022,0.00017098278,0.000014646989,0.00012718566,0.000049694416,0.000006667407,0.0004126975],"genre_scores_gemma":[0.9986932,0.000064684806,0.00016048171,0.000025401385,0.00010143096,0.000025350522,0.00041374337,0.000007635271,0.0005080287],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99949497,0.000016315093,0.00013931353,0.00015517313,0.000103203696,0.000091027956],"domain_scores_gemma":[0.9996684,0.0000046066675,0.000058921672,0.0001681257,0.000060718365,0.00003919163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008938444,0.000045995534,0.000049356717,0.000029358558,0.000028794206,0.000014056185,0.00007863915,0.000060066646,0.000011060441],"category_scores_gemma":[0.000023177077,0.000046787525,0.000017864257,0.00008286761,0.00008334637,0.0000027357823,0.00004429695,0.000026144691,0.00000590261],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000037672385,0.00014196648,0.0010853648,0.000013596783,0.0000074719333,1.8670329e-7,0.000002787083,9.272557e-8,0.9976708,0.00020337809,0.0002733254,0.0005972627],"study_design_scores_gemma":[0.00029029988,0.00003376938,0.06706497,0.0000029349226,0.00000916621,0.000001962463,0.0000027614572,0.000011409986,0.9262366,0.00010639426,0.006196267,0.000043414133],"about_ca_topic_score_codex":0.000011251331,"about_ca_topic_score_gemma":0.0000067876035,"teacher_disagreement_score":0.071434155,"about_ca_system_score_codex":0.0000017098502,"about_ca_system_score_gemma":0.000020220285,"threshold_uncertainty_score":0.19079399},"labels":[],"label_agreement":null},{"id":"W4244211311","doi":"10.1182/blood-2019-125378","title":"Expanding the Indications for Ibrutinib: Complete Remission Obtained By Induction with Ibrutinib Followed By Consolidative Ahsct in Refractory Primary CNS Lymphoma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Ibrutinib; Salvage therapy; Medicine; Primary central nervous system lymphoma; Ptosis; Surgery; Oncology; Internal medicine; Chemotherapy; Leukemia","score_opus":0.016171452915244095,"score_gpt":0.2652064102916479,"score_spread":0.24903495737640377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244211311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99226785,0.0007072013,0.00005142412,0.0017671273,0.00008469165,0.0019976886,0.00017975683,0.000063922234,0.0028803225],"genre_scores_gemma":[0.99681246,0.00011633897,0.00045480087,0.00043508038,0.0000588649,0.0004551275,0.001052687,0.00004149064,0.00057314127],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985466,0.00008083113,0.00034670156,0.00042923316,0.0002787592,0.00031788944],"domain_scores_gemma":[0.99867886,0.00045203418,0.0002490265,0.00042667627,0.0000729019,0.000120477554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023496702,0.00023326415,0.0003947605,0.000114034774,0.00018729127,0.000033351604,0.00011165541,0.00012440326,0.000055190634],"category_scores_gemma":[0.00008857262,0.00015101874,0.0000931503,0.0002884456,0.00008695255,0.000116940486,0.000038264225,0.00010719151,0.000023000655],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026332021,0.013683595,0.5185299,0.0002954963,0.0013414207,0.00004567049,0.0041153627,0.0000032100952,0.37425816,0.00038957852,0.04992376,0.03478066],"study_design_scores_gemma":[0.09447596,0.004684447,0.6168023,0.0014343759,0.0015410436,0.00027855806,0.0037577378,0.00006897415,0.14902365,0.00014948062,0.1267973,0.0009862083],"about_ca_topic_score_codex":0.00009481102,"about_ca_topic_score_gemma":0.000009195001,"teacher_disagreement_score":0.22523452,"about_ca_system_score_codex":0.00027441946,"about_ca_system_score_gemma":0.00026491447,"threshold_uncertainty_score":0.61583656},"labels":[],"label_agreement":null},{"id":"W4244305556","doi":"10.1182/blood.v128.22.692.692","title":"Are We Choosing Wisely in Lymphoma? Excessive Use of Surveillance CT Imaging in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) in Long-Term Remission","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Radiation Dose and Imaging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Institute for Clinical Evaluative Sciences; Cancer Care Ontario; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Population; Cohort; Asymptomatic; Diagnosis code; Incidence (geometry); Lymphoma; Cumulative incidence; Pediatrics; Internal medicine","score_opus":0.010239296199089106,"score_gpt":0.2326529580847067,"score_spread":0.2224136618856176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244305556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986149,0.000556185,0.000033362587,0.00029730055,0.00004620324,0.00033459035,0.000018525407,0.000023810397,0.00007512094],"genre_scores_gemma":[0.99943775,0.00017716312,0.0000730171,0.00014346564,0.00003007145,0.00001063654,0.000017810338,0.000036464215,0.00007361281],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984103,0.00009724093,0.00045253147,0.00036132633,0.0002989243,0.00037966316],"domain_scores_gemma":[0.99902654,0.000113257534,0.00035213344,0.00032585274,0.00007709043,0.00010515077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017839634,0.00019613553,0.00039407838,0.00039763426,0.000025749097,0.000022390372,0.000100657635,0.000040352144,0.000011548893],"category_scores_gemma":[0.00020435368,0.00013969712,0.000040826973,0.00041449536,0.000041641473,0.0004545295,0.000049531052,0.000063661275,0.0000041108624],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002245471,0.0058368184,0.9746698,0.00010314014,0.000008859857,0.00030358284,0.0002596083,0.0000012513384,0.0016948372,6.537618e-7,0.000025328402,0.01687153],"study_design_scores_gemma":[0.06955007,0.000042276937,0.92007357,0.0027528394,0.000015713935,0.000011776744,0.00004730776,0.00007296037,0.00719948,0.0000037495658,0.000056387165,0.0001738855],"about_ca_topic_score_codex":0.000094961775,"about_ca_topic_score_gemma":0.00013677934,"teacher_disagreement_score":0.06932552,"about_ca_system_score_codex":0.0001702501,"about_ca_system_score_gemma":0.000102729115,"threshold_uncertainty_score":0.56966835},"labels":[],"label_agreement":null},{"id":"W4244305813","doi":"10.1182/blood-2019-123121","title":"The Metabolic Enzyme Hexokinase 2 Localizes to the Nucleus in AML and Normal Hematopoietic Stem/Progenitor Cells to Maintain Stemness","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Stem cell; Biology; CD34; Haematopoiesis; Progenitor cell; Cell biology","score_opus":0.009091929553654435,"score_gpt":0.2506405552877589,"score_spread":0.2415486257341045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244305813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899448,0.0021063627,0.000039068902,0.005008526,0.00016452042,0.0022189042,0.000024198594,0.000039479743,0.00045414298],"genre_scores_gemma":[0.9952732,0.00015612955,0.00025036884,0.0013228552,0.00023885477,0.00020506824,0.000002684086,0.000053661042,0.002497208],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977795,0.00021638107,0.0003483388,0.0004077319,0.0005486568,0.00069941697],"domain_scores_gemma":[0.9983213,0.0003088007,0.000048298556,0.00085502747,0.000101752,0.00036481902],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010117862,0.00023050258,0.00040292012,0.00014446564,0.00015402284,0.000109434324,0.00045769004,0.00009786586,0.0000816563],"category_scores_gemma":[0.000080613194,0.00013064577,0.0000742376,0.0005509525,0.000075401105,0.00006320152,0.0004182148,0.00038661857,0.00095658883],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011226764,0.0067086406,0.19097558,0.0034762141,0.0034666762,0.0051518776,0.04077507,0.0008392358,0.49550223,0.050525207,0.04666787,0.14468464],"study_design_scores_gemma":[0.014709708,0.0014999713,0.022160525,0.00037456737,0.0004556567,0.00082016387,0.009164875,0.0007831459,0.5343064,0.00011761761,0.41478708,0.00082030986],"about_ca_topic_score_codex":0.00026691402,"about_ca_topic_score_gemma":0.00013505752,"teacher_disagreement_score":0.3681192,"about_ca_system_score_codex":0.00008673864,"about_ca_system_score_gemma":0.00021278123,"threshold_uncertainty_score":0.9998213},"labels":[],"label_agreement":null},{"id":"W4244612689","doi":"10.1182/blood.v96.1.145.013k34_145_148","title":"The elusive factor Xa receptor: failure to detect transcripts that correspond to the published sequence of EPR-1","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Complementary DNA; Electron paramagnetic resonance; Survivin; Biology; Molecular biology; Gene; Genetics; Physics","score_opus":0.03150495725205605,"score_gpt":0.2701051410277075,"score_spread":0.23860018377565145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244612689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9701084,0.0002028152,0.0003871699,0.02461423,0.00049243215,0.0014278664,0.000105157815,0.00009449733,0.0025674498],"genre_scores_gemma":[0.9939334,0.000037480975,0.0008892903,0.0024514003,0.00017246902,0.00006867121,0.000011222793,0.000028262431,0.002407846],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984596,0.000119933764,0.00028118803,0.0003126566,0.0005046047,0.00032203732],"domain_scores_gemma":[0.9987134,0.000145411,0.00006773089,0.00069786655,0.00014345188,0.00023213797],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030325897,0.00018693422,0.00028826884,0.00007595267,0.0002044949,0.00008231481,0.00038746715,0.000104857514,0.001957393],"category_scores_gemma":[0.00018264343,0.00010580493,0.00013772072,0.00047120158,0.000054287604,0.00010942656,0.00003233277,0.00021131412,0.00025449385],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078552833,0.0003976741,0.0009429454,0.00004810823,0.00040982268,0.000011005378,0.007736403,0.000025985353,0.89407265,0.0014379198,0.019444516,0.07468745],"study_design_scores_gemma":[0.0029240586,0.0010882192,0.013276835,0.00016034153,0.00028905342,0.000053853026,0.0008611457,0.000019370545,0.594934,0.00039706627,0.38570258,0.00029347744],"about_ca_topic_score_codex":0.00004543329,"about_ca_topic_score_gemma":0.00023357688,"teacher_disagreement_score":0.36625805,"about_ca_system_score_codex":0.000024258305,"about_ca_system_score_gemma":0.00010819801,"threshold_uncertainty_score":0.99895495},"labels":[],"label_agreement":null},{"id":"W4244698584","doi":"10.1182/blood.v96.13.4118.h8004118_4118_4123","title":"Evidence that ceramide mediates the ability of tumor necrosis factor to modulate primitive human hematopoietic cell fates","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Ceramide; CD38; Stem cell factor; Cell biology; Haematopoiesis; Biology; Tumor necrosis factor alpha; Stromal cell; CD34; Intracellular; Stem cell; Apoptosis; Immunology; Cancer research; Biochemistry","score_opus":0.021435897389745287,"score_gpt":0.2513492747550544,"score_spread":0.22991337736530915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244698584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975502,0.0016951414,0.000047466663,0.00008815386,0.00005039439,0.0002869738,0.00003375849,0.000013826425,0.0002340687],"genre_scores_gemma":[0.999033,0.00020072331,0.00022400965,0.00023407915,0.00013199203,0.000030650757,0.000011214201,0.000019308942,0.00011502386],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99887866,0.00008478932,0.00024233652,0.00035419234,0.00018447047,0.00025554825],"domain_scores_gemma":[0.9991861,0.000065045984,0.0001065012,0.00047834794,0.000071227085,0.00009276799],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021554941,0.0001717704,0.00021804003,0.0000216882,0.00011035153,0.000030807332,0.0003359797,0.000070950206,0.00016364372],"category_scores_gemma":[0.00013226313,0.00012406446,0.00012748857,0.00008987525,0.00010468562,0.0000073333617,0.00008831065,0.00008197653,0.000012946875],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002572095,0.00012985399,0.011040052,0.00004224898,0.000028417115,9.633718e-7,0.00058486406,0.000056814886,0.98766863,0.000009456838,0.000030310173,0.0003826518],"study_design_scores_gemma":[0.00036837067,0.00010113394,0.07278455,0.000044748555,0.000058101927,0.0000033897006,0.00008543002,0.0000062220574,0.9260692,0.000094480136,0.00023948793,0.00014488024],"about_ca_topic_score_codex":0.00010691079,"about_ca_topic_score_gemma":0.000010645821,"teacher_disagreement_score":0.061744496,"about_ca_system_score_codex":0.000004340454,"about_ca_system_score_gemma":0.000034419743,"threshold_uncertainty_score":0.5059202},"labels":[],"label_agreement":null},{"id":"W4244878561","doi":"10.1182/blood.v116.21.5028.5028","title":"Lenalidomide (Revlimid), Bortezomib (Velcade) and Dexamethasone (RVD) for Heavily Pretreated Relapsed or Refractory Multiple Myeloma","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Lenalidomide; Bortezomib; Medicine; Dexamethasone; Multiple myeloma; Refractory (planetary science); Internal medicine; Concomitant; Gastroenterology; Thalidomide; Toxicity; Pharmacology; Oncology; Surgery","score_opus":0.032615279134119865,"score_gpt":0.3107651264905731,"score_spread":0.2781498473564532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244878561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954043,0.0007247439,0.0000711225,0.0005072416,0.00015060716,0.0020883842,0.00015443878,0.00018938837,0.0007097747],"genre_scores_gemma":[0.9775634,0.0002877863,0.018204667,0.00017957407,0.0003059558,0.0003718869,0.00019439665,0.00009231184,0.0028000532],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99771976,0.00007658917,0.0004268121,0.00065093004,0.00040669023,0.0007192431],"domain_scores_gemma":[0.99740726,0.0009283907,0.00013364929,0.0006402952,0.00022244852,0.00066798483],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039171474,0.00035849446,0.0006045515,0.00020995091,0.00021206817,0.00004830021,0.00014510218,0.00032170507,0.00024787168],"category_scores_gemma":[0.002557799,0.00025934045,0.0001619998,0.00023681502,0.00018749973,0.00015888899,0.000076644355,0.0005544307,0.000042712072],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014480059,0.004722615,0.38776577,0.00059677305,0.0016975624,0.0009297542,0.00041909143,3.180826e-7,0.519355,0.00009268679,0.0023811883,0.067559175],"study_design_scores_gemma":[0.1026903,0.004557763,0.57972497,0.00030173117,0.0011998047,0.00084939605,0.00015313714,0.0007919515,0.29108524,0.00012574026,0.01784633,0.0006736297],"about_ca_topic_score_codex":0.0001963568,"about_ca_topic_score_gemma":0.00041797553,"teacher_disagreement_score":0.22826979,"about_ca_system_score_codex":0.000042953165,"about_ca_system_score_gemma":0.00026509142,"threshold_uncertainty_score":0.9999859},"labels":[],"label_agreement":null},{"id":"W4245008980","doi":"10.1182/blood.v108.11.3484.3484","title":"Targeting Aurora Kinases as Therapy in Multiple Myeloma.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Aurora inhibitor; Mitosis; Kinase; Aurora kinase; Cytokinesis; Cancer research; Cell biology; Cell cycle; Aurora B kinase; Apoptosis; Biology; Bortezomib; Multiple myeloma; Cell; Immunology; Cell division; Genetics","score_opus":0.024780395922784103,"score_gpt":0.29110681245467035,"score_spread":0.26632641653188627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245008980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99189454,0.001490359,0.000004347852,0.00022697405,0.000029030378,0.00048704608,0.0000081151165,0.00007400219,0.005785561],"genre_scores_gemma":[0.9974038,0.00013712015,0.001066594,0.000097678116,0.00018124127,0.00006601823,0.000104660525,0.000025846932,0.0009170631],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988164,0.000047787576,0.00020310444,0.00025270498,0.00028085947,0.0003991483],"domain_scores_gemma":[0.9994846,0.0001099311,0.000036317568,0.00020793326,0.000049619655,0.00011158739],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011148915,0.00014185737,0.00020987345,0.00013754077,0.000065875414,0.000020565369,0.000069167036,0.00006230756,0.00020530591],"category_scores_gemma":[0.00020033849,0.00011212675,0.000065967535,0.0002109643,0.00004154033,0.000059049453,0.000026906897,0.0001366333,0.00019830087],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029736702,0.0024530275,0.93726003,0.000023392786,0.000065299355,0.0013308433,0.000055685818,0.0000067649007,0.048646916,0.00004925471,0.00042416604,0.009387271],"study_design_scores_gemma":[0.020526266,0.0006374891,0.8818869,0.000068276,0.000024177265,0.00006124721,0.0000724548,0.00021162507,0.09198676,0.00018884016,0.004176177,0.0001597767],"about_ca_topic_score_codex":0.0022296624,"about_ca_topic_score_gemma":0.00013879982,"teacher_disagreement_score":0.0553731,"about_ca_system_score_codex":0.000033379314,"about_ca_system_score_gemma":0.00007617164,"threshold_uncertainty_score":0.4572396},"labels":[],"label_agreement":null},{"id":"W4245041214","doi":"10.1182/blood.v96.1.132.013k13_132_138","title":"The Shc adaptor protein forms interdependent phosphotyrosine-mediated protein complexes in mast cells stimulated with interleukin 3","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Ontario Institute for Cancer Research","funders":"","keywords":"GRB2; Signal transducing adaptor protein; SH2 domain; Phosphotyrosine-binding domain; Phosphorylation; Cell biology; Tyrosine phosphorylation; Chemistry; Signal transduction; Proto-oncogene tyrosine-protein kinase Src; Protein tyrosine phosphatase; LYN; Phosphopeptide; Pleckstrin homology domain; Biology; Biochemistry","score_opus":0.010740936855062784,"score_gpt":0.24631045480683667,"score_spread":0.2355695179517739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245041214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914974,0.00037463187,0.00000678151,0.0013086364,0.000018928995,0.0020867968,0.000055943365,0.00007431542,0.00457655],"genre_scores_gemma":[0.9846746,0.000049978036,0.00036444387,0.00012789528,0.00008094154,0.00020604781,0.000075320684,0.00004431533,0.014376466],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99785405,0.000103609666,0.00044654642,0.00036971428,0.00060112175,0.00062494393],"domain_scores_gemma":[0.9991806,0.000081249294,0.000072906616,0.00035214762,0.00009682394,0.00021624284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033889318,0.00028331726,0.00035732304,0.00009917599,0.00015835243,0.000077460005,0.0003053696,0.00008773578,0.00082149066],"category_scores_gemma":[0.000029770687,0.00015310795,0.00009259774,0.00033544764,0.00023198819,0.0000844761,0.00009058674,0.0005563254,0.00028641915],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017608752,0.004473829,0.011354066,0.00048233988,0.00065660424,0.0020047666,0.0012901233,0.00003973992,0.9371317,0.0004184025,0.0008729065,0.023666741],"study_design_scores_gemma":[0.01626215,0.0043237004,0.03017615,0.0020487234,0.00009144301,0.00024859648,0.00043837944,0.0015758796,0.90960735,0.00018580367,0.0343725,0.0006693148],"about_ca_topic_score_codex":0.00076740334,"about_ca_topic_score_gemma":0.0007741586,"teacher_disagreement_score":0.033499595,"about_ca_system_score_codex":0.000061295905,"about_ca_system_score_gemma":0.00012847228,"threshold_uncertainty_score":0.8994747},"labels":[],"label_agreement":null},{"id":"W4245051263","doi":"10.1182/blood-2020-134622","title":"Does Upfront Autologous Stem Cell Transplant at First Relapse Improve Outcome in Transplant Eligible Follicular Lymphoma Patients Who Relapse within 24 Months","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Follicular lymphoma; Internal medicine; Rituximab; Chemoimmunotherapy; Oncology; Hematopoietic stem cell transplantation; Transplantation; Lymphoma","score_opus":0.01020112181199483,"score_gpt":0.20894424549641993,"score_spread":0.1987431236844251,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245051263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937196,0.0013122583,0.000005598367,0.001736197,0.0004830341,0.0015237088,0.0004314945,0.00016660539,0.0006215484],"genre_scores_gemma":[0.99698424,0.000623666,0.00021591218,0.00082354946,0.00007802809,0.00027136618,0.00019882405,0.00007651053,0.0007278819],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99685204,0.00007980487,0.0009794032,0.00089185755,0.0005573594,0.0006395209],"domain_scores_gemma":[0.99857825,0.00010442464,0.00021985215,0.0005261361,0.000053483614,0.00051784975],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013072097,0.00054856867,0.0010083466,0.000115477764,0.00014989659,0.000033716773,0.00021247244,0.00031244234,0.000042717198],"category_scores_gemma":[0.0000134217635,0.0003394037,0.00035611558,0.00023151435,0.0000574866,0.00011834009,0.00005392542,0.00017587605,0.00014686288],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010637493,0.0048703733,0.9790736,0.00057507976,0.00033740888,0.0040516597,0.008224312,0.000039354883,0.0006358551,0.000043450884,0.0004302089,0.000654962],"study_design_scores_gemma":[0.0871564,0.004115111,0.7364018,0.00095673365,0.0029788015,0.00014941691,0.00038020167,0.00078221265,0.16223665,0.000030261283,0.0036596262,0.0011528098],"about_ca_topic_score_codex":0.00058016623,"about_ca_topic_score_gemma":0.00058066344,"teacher_disagreement_score":0.2426718,"about_ca_system_score_codex":0.0003583672,"about_ca_system_score_gemma":0.00012457545,"threshold_uncertainty_score":0.9999058},"labels":[],"label_agreement":null},{"id":"W4245216304","doi":"10.1182/blood.v96.12.4001.h8004000b_4001_4002","title":"Signaling mechanism in the induction of apoptosis by thrombin in human tumor cells","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Apoptosis; Thrombin; Mechanism (biology); Signal transduction; Cancer research; Cell biology; Thrombin generation; Chemistry; Biology; Medicine; Immunology; Biochemistry; Platelet; Physics","score_opus":0.019989512833154095,"score_gpt":0.25695151628832724,"score_spread":0.23696200345517315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245216304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99758226,0.000040476818,0.000021385431,0.00022528127,0.000043503485,0.00034805734,0.0000042252213,0.000021641936,0.0017131967],"genre_scores_gemma":[0.9991793,0.000015361382,0.00024432203,0.00036938037,0.0000381871,0.000024627949,0.000016535658,0.000015011763,0.00009725273],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99896246,0.000099143705,0.0003305546,0.00018623454,0.00025174927,0.00016986937],"domain_scores_gemma":[0.99963415,0.000026382448,0.00006991466,0.00021557116,0.000020177995,0.000033818644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000380541,0.000109284556,0.00025172535,0.00011211456,0.00003927212,0.000009855667,0.00010149513,0.000079211044,0.0006350043],"category_scores_gemma":[0.000007787859,0.00008724725,0.0000551106,0.0003438868,0.00002361906,0.00005593095,0.000009544297,0.00019122647,0.000015868718],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010157417,0.0012497208,0.0002814193,0.00002143213,0.000018643621,0.0000035646724,0.00082147226,0.0000059307476,0.99421656,0.0030437694,0.00006864287,0.00025866766],"study_design_scores_gemma":[0.0028374759,0.00025893643,0.0016106636,0.00010366724,0.0000823628,0.00001277477,0.00052413647,0.000028806022,0.9909799,0.003430568,0.000043547647,0.00008715186],"about_ca_topic_score_codex":0.00017667773,"about_ca_topic_score_gemma":0.000016443591,"teacher_disagreement_score":0.0032366698,"about_ca_system_score_codex":0.00001456115,"about_ca_system_score_gemma":0.000021094727,"threshold_uncertainty_score":0.6952852},"labels":[],"label_agreement":null},{"id":"W4245246241","doi":"10.1182/blood.v110.11.13.13","title":"A Variant Allele of the Gene Growth Factor Independence 1 (GFI1) Is Associated with Acute Myeloid Leukemia.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"","keywords":"Myeloid leukemia; Biology; Chromosomal translocation; Haematopoiesis; Bone marrow; Cancer research; Allele; Leukemia; Myeloid; Immunology; Stem cell; Progenitor cell; Genetics; Gene","score_opus":0.014895523765063114,"score_gpt":0.2587939775509301,"score_spread":0.24389845378586697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245246241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942871,0.00013125571,0.0004126873,0.0005725576,0.000044850767,0.0006512862,0.00013450372,0.000067699766,0.0036980885],"genre_scores_gemma":[0.9955687,0.00008413387,0.0011625197,0.00076648063,0.00011487682,0.000015469594,0.000031455,0.000053593365,0.0022027863],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997188,0.00007932099,0.00039490155,0.00040488894,0.0012809559,0.0006519434],"domain_scores_gemma":[0.99816716,0.00020732344,0.00021595134,0.00067777146,0.00049180794,0.000240002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069117313,0.00024940266,0.00048097374,0.00013851491,0.00012220492,0.000019028548,0.00048400933,0.00028956242,0.00024216267],"category_scores_gemma":[0.0004525298,0.00015312505,0.00014508926,0.00079856743,0.00020413466,0.000096022835,0.00021439114,0.0007889508,0.00003113827],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020407306,0.0025609112,0.2375477,0.00022280647,0.008181559,0.0065900795,0.0048470567,0.000004118823,0.72792476,0.0006745852,0.007616684,0.0017890041],"study_design_scores_gemma":[0.009591446,0.00073023397,0.3159403,0.0001592218,0.00073219585,0.0011829815,0.00014418091,0.0000677699,0.6706292,0.000088486646,0.0004477849,0.00028619758],"about_ca_topic_score_codex":0.00043981615,"about_ca_topic_score_gemma":0.0001217437,"teacher_disagreement_score":0.078392595,"about_ca_system_score_codex":0.00046253944,"about_ca_system_score_gemma":0.0015171112,"threshold_uncertainty_score":0.62442577},"labels":[],"label_agreement":null},{"id":"W4245475931","doi":"10.1182/blood.v96.13.4142.h8004142_4142_4151","title":"Stromal-derived factor 1 and thrombopoietin regulate distinct aspects of human megakaryopoiesis","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services","funders":"","keywords":"Cell biology; Biology; MAPK/ERK pathway; Thrombopoietin; Protein kinase B; Matrigel; Angiogenesis; Signal transduction; Chemistry; Cancer research; Internal medicine; Endocrinology; Haematopoiesis; Stem cell; Medicine","score_opus":0.013051069098412218,"score_gpt":0.24986517615116782,"score_spread":0.2368141070527556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245475931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810219,0.00036628236,4.729791e-7,0.00012102031,0.000011521556,0.00020563339,0.00004224937,0.00004497979,0.018185968],"genre_scores_gemma":[0.99888057,0.00007135446,0.00016793383,0.000024002084,0.000024127761,0.0000056291387,0.00004173644,0.000018778774,0.0007658988],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99925303,0.00001758334,0.00018418553,0.00021419898,0.0001482027,0.00018280518],"domain_scores_gemma":[0.9995911,0.00002142172,0.00005387973,0.00021280306,0.000023400033,0.00009736405],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000025317211,0.00014531995,0.0003664928,0.000038360035,0.00007102138,0.000009102073,0.00004309734,0.00006266217,0.0011303347],"category_scores_gemma":[0.000011837865,0.000116834926,0.00006469434,0.00007400378,0.00008981028,0.00004300139,0.000016519078,0.00006266682,0.000017639157],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055659324,0.0088453395,0.4139604,0.00055212405,0.0029518495,0.0022250884,0.0023897395,7.612897e-7,0.5444461,0.00077247125,0.0005220858,0.022777421],"study_design_scores_gemma":[0.0065016425,0.00076156843,0.9261041,0.00008746422,0.00039460915,0.00011452091,0.00004958157,0.000003305617,0.06498038,0.00075029174,0.0001206261,0.00013188651],"about_ca_topic_score_codex":0.00010285141,"about_ca_topic_score_gemma":0.000034525234,"teacher_disagreement_score":0.51214373,"about_ca_system_score_codex":0.000008115321,"about_ca_system_score_gemma":0.000019896679,"threshold_uncertainty_score":0.99978274},"labels":[],"label_agreement":null},{"id":"W4245729482","doi":"10.1182/blood.v96.5.1827","title":"LSP1 modulates leukocyte populations in resting and inflamed peritoneum","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Peritoneum; Ovalbumin; Chemokine; Chemotaxis; Biology; Macrophage; Immunology; Antigen; Inflammation; Peritoneal cavity; In vitro; Receptor; Biochemistry","score_opus":0.04065337034305626,"score_gpt":0.3192088803125665,"score_spread":0.27855550996951023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245729482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99352276,0.00042688224,0.0000012897209,0.0005405862,0.000009257323,0.00020204538,8.9181714e-7,0.000036913254,0.005259394],"genre_scores_gemma":[0.99610907,0.00009941812,0.001462923,0.0000690057,0.000052328494,0.000013455222,0.0000109711655,0.000015895726,0.0021669115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99920917,0.00003448473,0.00017457792,0.00018801894,0.00018752058,0.00020625112],"domain_scores_gemma":[0.99962986,0.000041176452,0.000014707577,0.00018044306,0.000026850495,0.00010695775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010797791,0.000075532065,0.00013673246,0.0001231472,0.000052828702,0.00001886937,0.000040926494,0.000055405853,0.00031084364],"category_scores_gemma":[0.0001587544,0.00007116379,0.00002290009,0.00021127143,0.000044345914,0.000042775227,0.000030792,0.000180057,0.000042758165],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014791338,0.0005487923,0.680731,0.00012698247,0.000027489785,0.00062553503,0.00068897073,0.0001689959,0.27804106,0.00010875171,0.00011605835,0.038668476],"study_design_scores_gemma":[0.0030989908,0.00014025619,0.96886224,0.00013978218,0.000034619836,0.00017660607,0.00006170727,0.0032767672,0.022536207,0.00022308825,0.0013223622,0.00012740529],"about_ca_topic_score_codex":0.0001990574,"about_ca_topic_score_gemma":0.000073099975,"teacher_disagreement_score":0.28813124,"about_ca_system_score_codex":0.000017873417,"about_ca_system_score_gemma":0.000041231393,"threshold_uncertainty_score":0.34035197},"labels":[],"label_agreement":null},{"id":"W4245847300","doi":"10.1182/blood.v96.12.3979.h8003979_3979_3981","title":"High marrow seeding efficiency of human lymphomyeloid repopulating cells in irradiated NOD/SCID mice","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Haematopoiesis; Nod; Stem cell; Biology; Bone marrow; Severe combined immunodeficiency; Myeloid; Immunology; Cord blood; Transplantation; Andrology; Molecular biology; In vivo; Internal medicine; Medicine; Cell biology","score_opus":0.012207588025855757,"score_gpt":0.24422168806997252,"score_spread":0.23201410004411677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245847300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99284536,0.000075412376,0.000008864073,0.000040705494,0.000064242246,0.0003104619,0.0000071948243,0.00005972495,0.006588067],"genre_scores_gemma":[0.99784946,0.000017809236,0.0015854972,0.000041320305,0.0000621698,0.000008237306,0.000044950208,0.000026757532,0.00036379969],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985261,0.00004373811,0.00060251774,0.00027642213,0.00028175887,0.0002694933],"domain_scores_gemma":[0.9994687,0.00006780298,0.00012177231,0.00021993609,0.000039326296,0.000082493476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028710693,0.00014249996,0.00034275584,0.0001603933,0.00005197858,0.000008670518,0.000085125044,0.00010685242,0.0005153522],"category_scores_gemma":[0.000023488394,0.00014310936,0.00006136482,0.0004007864,0.00003796367,0.000047687325,0.000007091222,0.00011221137,0.000059212052],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036826146,0.0004494126,0.053337995,0.00039159725,0.000023451135,0.00013829966,0.001406827,0.00008278093,0.9436881,0.00004292608,0.000009327326,0.00039247467],"study_design_scores_gemma":[0.0076995,0.00025129342,0.12332565,0.0010149826,0.0002343189,0.00024345596,0.00026096162,0.00042338006,0.8662476,0.00004276779,0.000021179607,0.00023492648],"about_ca_topic_score_codex":0.000557341,"about_ca_topic_score_gemma":0.000022955192,"teacher_disagreement_score":0.0774405,"about_ca_system_score_codex":0.000040064744,"about_ca_system_score_gemma":0.00004778267,"threshold_uncertainty_score":0.583583},"labels":[],"label_agreement":null},{"id":"W4245855097","doi":"10.1182/blood.v108.11.811.811","title":"Structural Profiles of p53 Gene Mutations Predict Clinical Outcome in Diffuse Large B-Cell Lymphoma: An International Collaborative Study.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Missense mutation; Mutation; Diffuse large B-cell lymphoma; Cancer research; Biology; Nonsense mutation; Lymphoma; Gene mutation; Gene; Molecular biology; Genetics; Internal medicine; Medicine; Immunology","score_opus":0.02295707299003613,"score_gpt":0.33455964198884625,"score_spread":0.3116025689988101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245855097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99763286,0.0001243994,0.0000019505965,0.00009035618,0.00016740753,0.0008438071,0.0003695476,0.000030625262,0.000739066],"genre_scores_gemma":[0.9982239,0.000013674461,0.0009156339,0.000039406557,0.00017852982,0.00011425022,0.00038306435,0.000014889375,0.000116677846],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848413,0.00010095301,0.00066210167,0.00028657806,0.00029783207,0.00016838076],"domain_scores_gemma":[0.99923366,0.000104133964,0.0001731441,0.00024063203,0.00016981902,0.00007860738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016526607,0.00014604254,0.0003642896,0.00011548652,0.00003993204,0.000016846754,0.00010051121,0.00007179475,0.000033510503],"category_scores_gemma":[0.00007171465,0.00011249566,0.00008266213,0.00019582719,0.00005490942,0.00011039282,0.000043247124,0.00005022007,0.00000714681],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000965622,0.06844634,0.9302057,0.000011322393,0.00014692708,0.00019141086,0.0003496183,0.0000036237295,0.00012232641,0.00017114404,0.000030891526,0.00022414782],"study_design_scores_gemma":[0.07473999,0.0009418151,0.91991615,0.000015092524,0.00027084225,0.000014284919,0.0005756442,0.00014019471,0.0032179893,0.000038418817,0.000043290132,0.000086293905],"about_ca_topic_score_codex":0.00022801833,"about_ca_topic_score_gemma":0.00027739382,"teacher_disagreement_score":0.07464343,"about_ca_system_score_codex":0.000070588365,"about_ca_system_score_gemma":0.00015790475,"threshold_uncertainty_score":0.458744},"labels":[],"label_agreement":null},{"id":"W4246009384","doi":"10.1182/blood.v96.5.1740.h8001740_1740_1747","title":"Identification of novel circulating human embryonic blood stem cells","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Stem cell; Biology; Embryonic stem cell; Haematopoiesis; Bone marrow; Induced pluripotent stem cell; Fetus; Immunology; Adult stem cell; Amniotic epithelial cells; Amniotic stem cells; Cord blood; Cell biology","score_opus":0.008607086137076274,"score_gpt":0.2258863002920711,"score_spread":0.21727921415499482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246009384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99694836,0.00066312344,0.00005107343,0.000012161272,0.00004690656,0.00008379688,0.00001138702,0.000009043232,0.0021741306],"genre_scores_gemma":[0.996583,0.00014446815,0.000042128024,0.000020749922,0.00009497149,0.0000060932603,0.000021295491,0.000012929356,0.0030743699],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99935013,0.000014953355,0.00021437157,0.0002041622,0.00009006929,0.00012630904],"domain_scores_gemma":[0.9996059,0.0000024988851,0.00009776108,0.00022485286,0.00003443329,0.00003455917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007733012,0.00008198281,0.000088887704,0.000019380679,0.000058613914,0.000010178343,0.00011728726,0.00011531426,0.00002803704],"category_scores_gemma":[0.0000017210858,0.0000764644,0.00007851946,0.000070065296,0.000038032373,0.0000021226645,0.00001638735,0.000057199897,0.000008916205],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004788873,0.00022403576,0.0002113208,0.000026535037,0.00010969386,0.0000013661094,0.000029041134,0.00044191105,0.99790955,0.000030718984,0.000030628857,0.0009804151],"study_design_scores_gemma":[0.001101478,0.00008545346,0.00044999487,0.000022067301,0.000104686056,0.000018821449,0.000019848261,0.000033409488,0.99756473,0.000008358568,0.00049124093,0.00009992088],"about_ca_topic_score_codex":0.000011987467,"about_ca_topic_score_gemma":0.0000024209266,"teacher_disagreement_score":0.0010966891,"about_ca_system_score_codex":0.000002898388,"about_ca_system_score_gemma":0.00002611918,"threshold_uncertainty_score":0.31181276},"labels":[],"label_agreement":null},{"id":"W4246121003","doi":"10.1182/blood.v128.22.3738.3738","title":"Safety and Efficacy of Long-Term Open-Label Dosing of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Romiplostim; Medicine; Dosing; Adverse effect; Clinical endpoint; Splenectomy; Placebo; Incidence (geometry); Intention-to-treat analysis; Pediatrics; Discontinuation; Internal medicine; Open label; Surgery; Thrombopoietin; Clinical trial","score_opus":0.013761170789821447,"score_gpt":0.26518521739449724,"score_spread":0.25142404660467577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246121003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976642,0.0009259638,0.0000084653075,0.00009682416,0.000009054166,0.0007260774,0.000030313819,0.000010415051,0.0005286605],"genre_scores_gemma":[0.99901456,0.00039625,0.00042450288,0.000013295664,0.0000071750574,0.0000040371465,0.00002241521,0.000021827445,0.00009595836],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991296,0.000022053373,0.0003024781,0.00022815059,0.00013299119,0.00018475646],"domain_scores_gemma":[0.999429,0.00006750815,0.00013741403,0.00027221392,0.00003361905,0.00006023826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000073014584,0.00014826116,0.0006270295,0.00006876792,0.000028017312,0.00000842043,0.00011837747,0.00006160025,0.000035796224],"category_scores_gemma":[0.000025861864,0.00008816245,0.000022561286,0.00012199649,0.00010976346,0.000085090775,0.00009842762,0.00005950887,0.0000039233046],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022545897,0.0042714654,0.9367708,0.000040483807,0.0006510439,0.00059431704,0.00013654836,2.687713e-7,0.04141172,0.000027815558,0.0000013711619,0.013839548],"study_design_scores_gemma":[0.05153449,0.00163204,0.91100144,0.0007353807,0.00038592296,0.0014206779,0.0000050766253,9.5138296e-7,0.033161063,0.000014992939,8.384976e-7,0.00010713539],"about_ca_topic_score_codex":0.00017935193,"about_ca_topic_score_gemma":0.00006051922,"teacher_disagreement_score":0.0492799,"about_ca_system_score_codex":0.000017184348,"about_ca_system_score_gemma":0.000059349495,"threshold_uncertainty_score":0.35951602},"labels":[],"label_agreement":null},{"id":"W4246230746","doi":"10.1182/blood.v104.11.4884.4884","title":"P53 Gene Deletion Detected by Fluorescence In Situ Hybridization Is an Adverse Prognostic Factor for Patients with Multiple Myeloma Following Autologous Stem Cell Transplantation.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Fluorescence in situ hybridization; Multiple myeloma; Autologous stem-cell transplantation; Transplantation; Biology; Internal medicine; Cancer research; Oncology; Pathology; Immunology; Medicine; Chromosome; Gene; Genetics","score_opus":0.011556524683610868,"score_gpt":0.23739732105117745,"score_spread":0.22584079636756657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246230746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942933,0.000054662913,0.0028835698,0.000023073255,0.00002908181,0.002316062,0.0003079914,0.00008489,0.0000074162713],"genre_scores_gemma":[0.9902693,0.000019314572,0.008088981,0.000019757888,0.00001614471,0.00021620773,0.0013175434,0.000035765734,0.000016985268],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986038,0.000042383806,0.00024367288,0.00038443485,0.00035364242,0.0003720517],"domain_scores_gemma":[0.9993487,0.000072443516,0.000075419804,0.00017630268,0.0001378432,0.00018926548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000045368743,0.00019298538,0.00021650874,0.00013308466,0.00010379307,0.00001648047,0.00006983743,0.00008496071,0.0000053715767],"category_scores_gemma":[0.00004714137,0.00016196595,0.0000611952,0.00021424064,0.000023593779,0.00020528847,0.0000070393326,0.00009334569,0.000008376259],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010745822,0.0029663297,0.8745719,0.00019653459,0.00010746971,0.00019364263,0.00096137746,0.000039320963,0.11353188,4.365973e-7,0.0000024717542,0.006354035],"study_design_scores_gemma":[0.02509787,0.0014656171,0.66313535,0.0001055028,0.0001564518,0.000009508122,0.00003867402,0.00024942757,0.30960238,0.0000019811457,0.000003187202,0.00013403498],"about_ca_topic_score_codex":0.00008123772,"about_ca_topic_score_gemma":0.0001328032,"teacher_disagreement_score":0.21143657,"about_ca_system_score_codex":0.00010689339,"about_ca_system_score_gemma":0.00012321357,"threshold_uncertainty_score":0.66047794},"labels":[],"label_agreement":null},{"id":"W4246720540","doi":"10.1182/blood.v96.9.3231.h8003231_3231_3240","title":"Nonopsonic monocyte/macrophage phagocytosis of Plasmodium falciparum–parasitized erythrocytes: a role for CD36 in malarial clearance","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Malaria Research and Control","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"CD36; Biology; Phagocytosis; Monocyte; MAPK/ERK pathway; Scavenger receptor; Tyrosine phosphorylation; Intercellular Adhesion Molecule-1; Cell biology; Immunology; Kinase; Intracellular; Receptor; Biochemistry","score_opus":0.01303257456739245,"score_gpt":0.27681636229146384,"score_spread":0.2637837877240714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246720540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914076,0.0015888041,0.00012575374,0.0008152934,0.00005229698,0.00167729,0.00009739024,0.00005748171,0.0041781114],"genre_scores_gemma":[0.9959475,0.00023971051,0.0013712987,0.00016995636,0.0002586329,0.00041651903,0.000025569745,0.000042541946,0.0015282977],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979072,0.000083288396,0.0005102719,0.00042890033,0.00036915226,0.0007011748],"domain_scores_gemma":[0.99897593,0.00016981515,0.0000893738,0.00043393893,0.00010064524,0.00023027697],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003654037,0.00023002441,0.0007010412,0.00017146526,0.000064637534,0.000026185096,0.00023293498,0.00019163171,0.0010034279],"category_scores_gemma":[0.00016585641,0.00021676048,0.0002552275,0.00030008363,0.00009262733,0.000111411515,0.000030263747,0.00028946245,0.00008953587],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18453641,0.019103816,0.025026636,0.0022944696,0.0028870478,0.00097473717,0.002621848,0.0005946804,0.6196972,0.004249817,0.0016237216,0.13638957],"study_design_scores_gemma":[0.26466084,0.0065543107,0.1557737,0.00080024975,0.0012453123,0.0002384823,0.00041319962,0.020221,0.5360142,0.0011011905,0.011877055,0.0011004852],"about_ca_topic_score_codex":0.00022630907,"about_ca_topic_score_gemma":0.00008258462,"teacher_disagreement_score":0.13528909,"about_ca_system_score_codex":0.00005511094,"about_ca_system_score_gemma":0.0002918678,"threshold_uncertainty_score":0.9999098},"labels":[],"label_agreement":null},{"id":"W4246883272","doi":"10.1182/blood.v110.11.2560.2560","title":"Results from a Phase II Study of Lenalidomide Oral Monotherapy in Relapsed/Refractory Indolent Non-Hodgkin’s Lymphoma.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency","funders":"","keywords":"Lenalidomide; Medicine; Internal medicine; Gastroenterology; Lymphoma; Follicular lymphoma; Regimen; Refractory (planetary science); Multiple myeloma; Oncology; Surgery","score_opus":0.030568181730450127,"score_gpt":0.3437606413345285,"score_spread":0.3131924596040784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246883272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967032,0.00047769822,0.000022529635,0.00006581638,0.00012329913,0.0013055915,0.000051343086,0.000047133446,0.0012033529],"genre_scores_gemma":[0.99863595,0.00008350286,0.0004360018,0.00013165062,0.00022951409,0.000037015947,0.000047522215,0.000057998706,0.00034086945],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99664795,0.0001290108,0.0010845872,0.0006095778,0.0009250686,0.0006038167],"domain_scores_gemma":[0.9979091,0.00047533563,0.00024907384,0.0009691029,0.00013711113,0.00026022556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015023063,0.00027533324,0.0007110951,0.00043509947,0.00006236034,0.000012030717,0.00028838275,0.00020998946,0.00008900042],"category_scores_gemma":[0.00036298844,0.0002401948,0.00011937017,0.00053958857,0.00010731665,0.00007490439,0.00015129843,0.0003017396,0.000025918134],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16296054,0.32921693,0.016919695,0.000257307,0.0027302296,0.013184173,0.087791175,0.000079806356,0.15824018,0.000020406947,0.0026261865,0.22597337],"study_design_scores_gemma":[0.880936,0.011750295,0.024418326,0.00035063757,0.000219006,0.00006531796,0.0035358511,0.00059992424,0.07656784,0.000035975987,0.0012056447,0.0003151317],"about_ca_topic_score_codex":0.014033747,"about_ca_topic_score_gemma":0.0019806747,"teacher_disagreement_score":0.7179755,"about_ca_system_score_codex":0.0026832025,"about_ca_system_score_gemma":0.002781734,"threshold_uncertainty_score":0.9925319},"labels":[],"label_agreement":null},{"id":"W4247035353","doi":"10.1182/blood.v96.6.2233.h8002233_2233_2239","title":"Ligand-inducible interaction of the DRIP/TRAP coactivator complex with retinoid receptors in retinoic acid–sensitive and –resistant acute promyelocytic leukemia cells","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Retinoid X receptor; Promyelocytic leukemia protein; Transcription factor; Biology; Nuclear receptor; Retinoic acid; Acute promyelocytic leukemia; Coactivator; Cell biology; Retinoid; Fusion protein; Retinoic acid receptor; Biochemistry; Molecular biology; Gene; Recombinant DNA","score_opus":0.006812133623443235,"score_gpt":0.21323546549415942,"score_spread":0.20642333187071618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247035353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967961,0.00019382707,0.000011973133,0.00005841008,0.00006170066,0.00032812188,0.000014020631,0.000011309345,0.0025245708],"genre_scores_gemma":[0.99843407,0.00033893285,0.00035797467,0.00007075201,0.00007465104,0.000022362723,0.00003201046,0.00002856995,0.0006406732],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987298,0.00011273586,0.0002868453,0.0004409667,0.00017874302,0.00025086533],"domain_scores_gemma":[0.999308,0.000019621113,0.00016160072,0.0003701553,0.00008050279,0.00006010274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015342711,0.00021624113,0.00023635518,0.000041002295,0.000090190675,0.000027095846,0.00018321833,0.00017154332,0.000028760773],"category_scores_gemma":[0.000027549355,0.00015569785,0.000061885316,0.00021343376,0.0002224569,0.000010966538,0.000061809784,0.00021622075,0.0000029164448],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047543374,0.00009983745,0.0016569657,0.00006585642,0.00009548048,0.000010863896,0.00025015924,0.000018239998,0.9965629,0.000007304607,0.00014302462,0.0006139622],"study_design_scores_gemma":[0.0014390595,0.00046585084,0.0026355262,0.00013724752,0.000099017816,0.00007755355,0.0002828966,0.000017904737,0.9925398,0.000015402868,0.0020816054,0.00020813965],"about_ca_topic_score_codex":0.00005040159,"about_ca_topic_score_gemma":0.000034674515,"teacher_disagreement_score":0.0040230765,"about_ca_system_score_codex":0.00004665664,"about_ca_system_score_gemma":0.00022919795,"threshold_uncertainty_score":0.6349174},"labels":[],"label_agreement":null},{"id":"W4247038564","doi":"10.1182/blood.v114.22.1017.1017","title":"The Antihelmintic Flubendazole Inhibits Microtubules through a Mechanism Distinct From Vinca Alkaloids and Displays Preclinical Activity in Leukemia and Myeloma.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Leukemia; Clonogenic assay; Pharmacology; Multiple myeloma; Biology; Cancer research; Immunology; Cell; Biochemistry","score_opus":0.010696915141212888,"score_gpt":0.2589214021998887,"score_spread":0.2482244870586758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247038564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99555653,0.0030998092,0.0005581517,0.0002677914,0.000077186116,0.00021262473,0.000052077954,0.000009942528,0.00016587398],"genre_scores_gemma":[0.99662375,0.0024110628,0.00044042524,0.00025955713,0.00014415862,0.000014356789,0.00002526762,0.000015809006,0.00006558465],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989783,0.00005783996,0.00018844732,0.00042285884,0.00009290494,0.00025962907],"domain_scores_gemma":[0.99951947,0.000046792728,0.00006854632,0.000278121,0.000020001158,0.000067098576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016566475,0.00018154066,0.00018923993,0.000014306819,0.000146336,0.00006592313,0.00012752341,0.00016876767,0.0000030807635],"category_scores_gemma":[0.00003129176,0.0001426645,0.00004964834,0.00004967061,0.00008852276,0.000007653298,0.00013131273,0.00014478626,0.00000113345],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013851152,0.00012665706,0.00066856697,0.0000078261055,0.000046848145,0.000005792669,0.00009716879,2.8019053e-7,0.98314434,0.0008932966,0.00001844972,0.014852282],"study_design_scores_gemma":[0.0021134254,0.0004723575,0.02503023,0.000042931704,0.00007078386,0.000024931092,0.00004244564,0.000075799,0.95807207,0.0106012905,0.0032142363,0.00023950364],"about_ca_topic_score_codex":0.00010516209,"about_ca_topic_score_gemma":0.00050308893,"teacher_disagreement_score":0.025072254,"about_ca_system_score_codex":0.000013012382,"about_ca_system_score_gemma":0.000063851854,"threshold_uncertainty_score":0.58176893},"labels":[],"label_agreement":null},{"id":"W4247088831","doi":"10.1182/blood.v116.21.4209.4209","title":"Validation of A Clinical Prediction Rule for Risk Stratification of Recurrent Venous Thromboembolism In Patients with Cancer-Associated Venous Thromboembolism","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of British Columbia; Victoria Hospital; University of Ottawa; CancerCare Manitoba; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Internal medicine; Pulmonary embolism; Cancer; Retrospective cohort study; Clinical prediction rule; Stage (stratigraphy); Venous thrombosis; Venous thromboembolism; Thrombosis; Cohort; Disease; Surgery; Low molecular weight heparin","score_opus":0.018579963841701023,"score_gpt":0.3046580801457559,"score_spread":0.2860781163040549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247088831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958756,0.00008642809,0.00005387493,0.000069271824,0.000756724,0.0023484612,0.00047858502,0.000047445606,0.00028359954],"genre_scores_gemma":[0.9977826,0.0003065801,0.0008512744,0.000024496845,0.00018995297,0.00025851498,0.0005367667,0.000042125284,0.0000076863635],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99751186,0.00010966837,0.0011379169,0.00044078883,0.0004929333,0.00030684852],"domain_scores_gemma":[0.99763274,0.00014569997,0.0010778955,0.00047030617,0.0005645919,0.00010876576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008662885,0.00021951103,0.0012437236,0.00018764836,0.000078893245,0.0000131046745,0.00014669383,0.00025332067,0.000044898978],"category_scores_gemma":[0.00043458957,0.00019224535,0.00016427497,0.00031872917,0.00012214431,0.00013225402,0.000032879285,0.00036775568,0.0000020788782],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005347738,0.06283488,0.90140843,0.0005376027,0.0012526342,0.0000015546318,0.0016765917,0.00009612073,0.003454832,0.00069780386,0.00034964207,0.027155135],"study_design_scores_gemma":[0.009524006,0.004156975,0.97394216,0.00032385593,0.0017092428,5.121965e-7,0.00007877929,0.00011768496,0.0094554145,0.000460267,0.0000726931,0.00015841844],"about_ca_topic_score_codex":0.00060106063,"about_ca_topic_score_gemma":0.00033088058,"teacher_disagreement_score":0.07253372,"about_ca_system_score_codex":0.000045352717,"about_ca_system_score_gemma":0.00025228024,"threshold_uncertainty_score":0.7839538},"labels":[],"label_agreement":null},{"id":"W4247217619","doi":"10.1182/blood.v96.7.2432.h8002432_2432_2439","title":"Efficient retrovirus-mediated gene transfer to transplantable human bone marrow cells in the absence of fibronectin","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Stem cell; Biology; Haematopoiesis; CD34; Interleukin 3; Bone marrow; Progenitor cell; Stem cell factor; Immunology; CD38; Myeloid; Molecular biology; Virology; Cell biology; Antigen-presenting cell; T cell; Immune system","score_opus":0.010081145027794823,"score_gpt":0.2485484326109615,"score_spread":0.23846728758316665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247217619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99828494,0.0005070527,0.000019880683,0.00010144926,0.000014422701,0.0003647406,0.00010650913,0.000007106106,0.0005938977],"genre_scores_gemma":[0.99916637,0.00018479333,0.00005435071,0.00019842366,0.00005283695,0.00003359577,0.000057878933,0.000020826523,0.0002309388],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987228,0.0001454075,0.00023750067,0.00030281174,0.00025560762,0.00033587634],"domain_scores_gemma":[0.9994554,0.000020759748,0.000011292629,0.00041585858,0.000027753103,0.000068925845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042346475,0.00013565666,0.00015533344,0.00006155272,0.000058347527,0.000011353861,0.00032207379,0.00010080209,0.0002549623],"category_scores_gemma":[0.000005920716,0.00011066275,0.0000726175,0.00025685766,0.000058766273,0.0000011835599,0.000011710227,0.00012156066,0.00003713703],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007322781,0.00042472547,0.00022556451,0.00001971054,0.000023184768,0.000014146306,0.00033668496,0.0014241291,0.99635243,0.0000013925335,0.00012639147,0.00031935395],"study_design_scores_gemma":[0.0014999516,0.001832885,0.0008998841,0.000015668847,0.000011339664,0.000009798152,0.000031208794,0.000026870763,0.99455804,0.0000023632376,0.0009777754,0.00013420472],"about_ca_topic_score_codex":0.00013010726,"about_ca_topic_score_gemma":0.00053056114,"teacher_disagreement_score":0.0017943885,"about_ca_system_score_codex":0.0000064518545,"about_ca_system_score_gemma":0.00004589777,"threshold_uncertainty_score":0.45126963},"labels":[],"label_agreement":null},{"id":"W4247288199","doi":"10.1182/blood.v118.21.767.767","title":"Results of the OPAL Study: A Phase II Study to Evaluate the Efficacy, Safety and Tolerability of Tosedostat (CHR-2797) in Elderly Subjects with Treatment Refractory or Relapsed Acute Myeloid Leukemia","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Tolerability; Internal medicine; Refractory (planetary science); Cytarabine; Gastroenterology; Adverse effect; Hypomethylating agent; Neutropenia; Febrile neutropenia; Nausea; Phases of clinical research; Randomized controlled trial; Myeloid leukemia; Surgery; Chemotherapy","score_opus":0.03373182040978893,"score_gpt":0.3099555019742059,"score_spread":0.27622368156441696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247288199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967779,0.000023610166,0.0000016477345,0.00024327527,0.000011991673,0.0024410428,0.00007851806,0.000017647246,0.0004043698],"genre_scores_gemma":[0.9994381,0.000014119591,0.00005860101,0.00006776146,0.00001946507,0.000052014006,0.00000915004,0.000015006738,0.00032574584],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.9978209,0.0004336502,0.0006800706,0.0004087273,0.0004543814,0.00020226478],"domain_scores_gemma":[0.99852455,0.00018581608,0.00016323844,0.00085658074,0.00015171498,0.00011807447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087879837,0.00022158392,0.00064120116,0.000113539616,0.00012192112,0.000006758419,0.00013925435,0.000042248626,0.00003860761],"category_scores_gemma":[0.0002320987,0.00009886569,0.000100403384,0.00056010677,0.00013652064,0.000047090216,0.000092054324,0.00017097373,0.000001370072],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19741555,0.23569477,0.15066445,0.00013948303,0.005784724,0.00081438123,0.30234194,0.000046987232,0.082762696,0.000010114143,0.00011156918,0.024213353],"study_design_scores_gemma":[0.16264908,0.110820115,0.6541025,0.000489802,0.003784665,0.00004000123,0.01575619,0.000036883994,0.051992163,0.0000055307128,0.00007608693,0.00024698515],"about_ca_topic_score_codex":0.0015227159,"about_ca_topic_score_gemma":0.0048733335,"teacher_disagreement_score":0.50343806,"about_ca_system_score_codex":0.00011396267,"about_ca_system_score_gemma":0.0003472609,"threshold_uncertainty_score":0.40316257},"labels":[],"label_agreement":null},{"id":"W4247341573","doi":"10.1182/blood.v96.13.4160.h8004160_4160_4168","title":"During ontogeny primitive (CD34+CD38−) hematopoietic cells show altered expression of a subset of genes associated with early cytokine and differentiation responses of their adult counterparts","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biology; Haematopoiesis; CD38; CD34; Bone marrow; Stem cell factor; Hematopoietic growth factor; Cord blood; Stem cell; Growth factor; Cytokine; Cell biology; Immunology; Molecular biology; Receptor; Genetics","score_opus":0.010924146603458511,"score_gpt":0.21865961801003742,"score_spread":0.20773547140657891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247341573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988438,0.0001824639,0.000042656106,0.000015271404,0.000016654709,0.0005135147,0.00024127025,0.00002405146,0.000120334815],"genre_scores_gemma":[0.9993288,0.00022144415,0.00022886273,0.000007230148,0.000015868709,0.000018483917,0.000063141364,0.00002712673,0.000089047084],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985865,0.00012701527,0.0005067072,0.00023682846,0.00036688618,0.00017610872],"domain_scores_gemma":[0.9988643,0.00024698093,0.0003303954,0.00024069933,0.0002464629,0.00007116219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013162252,0.00018539424,0.00053553184,0.00011548578,0.00003192762,0.0000061636956,0.000061445644,0.000108658365,0.00008012696],"category_scores_gemma":[0.000036477173,0.0001414656,0.000068191424,0.00013898016,0.00010755217,0.0000742823,0.000011215812,0.00007500443,7.8786223e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016497,0.00065680273,0.1449845,0.0007870988,0.00016717402,0.000011166918,0.004766336,0.0000025241006,0.8469134,0.0000049331275,0.0000016300578,0.000054739307],"study_design_scores_gemma":[0.003853812,0.0003799219,0.375531,0.0018596945,0.00028363272,0.000032874326,0.0001841312,0.000015699614,0.61777854,0.000005473093,3.5197255e-7,0.00007488758],"about_ca_topic_score_codex":0.000042944263,"about_ca_topic_score_gemma":0.000030317766,"teacher_disagreement_score":0.23054647,"about_ca_system_score_codex":0.000015825677,"about_ca_system_score_gemma":0.00005098496,"threshold_uncertainty_score":0.57688},"labels":[],"label_agreement":null},{"id":"W4247395387","doi":"10.1182/blood.v98.10.3143.h8003143_3143_3149","title":"Platelet-derived microparticles bind to hematopoietic stem/progenitor cells and enhance their engraftment","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services","funders":"","keywords":"Homing (biology); CD34; Progenitor cell; Stem cell; Haematopoiesis; Bone marrow; Immunology; Transplantation; Stem cell factor; Biology; Cell biology; Molecular biology; Chemistry; Cancer research; Medicine; Internal medicine","score_opus":0.011659770713467098,"score_gpt":0.23590703688360973,"score_spread":0.22424726617014262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247395387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968307,0.0017401266,0.000017466606,0.00048390045,0.000054112275,0.0006027589,0.000015222032,0.00005658104,0.00019914906],"genre_scores_gemma":[0.9982929,0.000340072,0.00058185065,0.00031398714,0.000043526426,0.000056668432,0.0000062787303,0.000024586947,0.00034011347],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990576,0.000017639424,0.00018520065,0.00029859523,0.00012366608,0.00031729456],"domain_scores_gemma":[0.99943763,0.000029584391,0.000038195685,0.00022688333,0.000030956413,0.00023674699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004775526,0.00018776738,0.00029910463,0.000054561926,0.00007881254,0.000028234494,0.00005365037,0.000058177862,0.00004900853],"category_scores_gemma":[0.000004591299,0.00014235819,0.000053442895,0.00012656032,0.00003241667,0.00003708309,0.000042376134,0.00006560413,0.00016421292],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015119623,0.0016252374,0.008375172,0.00005283014,0.00029325325,0.0011975026,0.0011227684,4.917456e-7,0.97583926,0.0000064626056,0.00016367683,0.011172149],"study_design_scores_gemma":[0.0034056744,0.00043311925,0.0027318492,0.000063162784,0.00012930649,0.0005706223,0.0003220276,0.0000051136863,0.9894438,0.000039593302,0.0027069848,0.0001487566],"about_ca_topic_score_codex":0.00001547493,"about_ca_topic_score_gemma":0.000011690784,"teacher_disagreement_score":0.013604529,"about_ca_system_score_codex":0.000016726006,"about_ca_system_score_gemma":0.00002466869,"threshold_uncertainty_score":0.5805198},"labels":[],"label_agreement":null},{"id":"W4247555289","doi":"10.1182/blood-2009-05-202820","title":"Cutaneous adult T-cell lymphoma leukemia","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and Retrovirus Studies","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Leukemia; Medicine; Lymphoma; Cancer research; Immunology","score_opus":0.00394551466458207,"score_gpt":0.18545249456741308,"score_spread":0.18150697990283102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247555289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95651984,0.0013260042,0.000002538834,0.00007296197,0.0014040835,0.0000846775,0.000019004012,0.00012698548,0.040443882],"genre_scores_gemma":[0.9806715,0.00012787261,0.00007995681,0.00019645966,0.00010544147,0.000010445708,0.000017599039,0.000016235921,0.018774444],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992551,0.000027674743,0.00015599112,0.0001987794,0.000024237124,0.00033819518],"domain_scores_gemma":[0.99954015,0.00005928157,0.00005692645,0.00026400207,0.00005783863,0.000021776186],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000036934576,0.00015572614,0.00019917947,0.000041691033,0.00023220728,0.000009793264,0.0001950688,0.00027382563,0.0003528904],"category_scores_gemma":[0.000042507232,0.000120357596,0.00008654309,0.000060301536,0.00019913646,0.000023808192,0.00009064861,0.00024181452,0.0030204065],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027181752,0.00043541618,0.00459962,0.000012453123,0.00011102943,0.000036973193,0.0003005802,1.11238464e-7,0.9863539,0.00053865195,0.0046182214,0.0029659148],"study_design_scores_gemma":[0.004316576,0.00017398983,0.0012314031,0.000007151249,0.00012758217,0.0010097168,0.0002129243,3.3978168e-7,0.8645856,0.00014129574,0.12793379,0.00025968387],"about_ca_topic_score_codex":0.00019296478,"about_ca_topic_score_gemma":0.00015415266,"teacher_disagreement_score":0.12331556,"about_ca_system_score_codex":0.0000110647725,"about_ca_system_score_gemma":0.000065332366,"threshold_uncertainty_score":0.9977559},"labels":[],"label_agreement":null},{"id":"W4247836910","doi":"10.1182/blood-2020-138542","title":"Successful Treatment of Mature T-Cell Lymphoma with Allogeneic Stem Cell Transplantation: The Largest Multicenter Retrospective Analysis","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and Retrovirus Studies","field":"Immunology and Microbiology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Transplantation; Stem cell; Medicine; Lymphoma; Retrospective cohort study; Oncology; Hematopoietic stem cell transplantation; Internal medicine; Biology","score_opus":0.0072417629165289895,"score_gpt":0.19193556989036464,"score_spread":0.18469380697383567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247836910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895263,0.008238738,0.000049342616,0.00033705225,0.00006795111,0.00023822591,0.00022913642,0.000033454962,0.0012798365],"genre_scores_gemma":[0.9974566,0.0012845115,0.00003695471,0.00009596989,0.000029381017,0.000022069318,0.000076504606,0.000012091998,0.000985905],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991675,0.00010319252,0.00018895885,0.00028376016,0.000046710004,0.00020984867],"domain_scores_gemma":[0.9995399,0.000054906715,0.00013488607,0.00019001772,0.000059306243,0.000020957104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000030176554,0.00019256026,0.00037632303,0.000044138484,0.0001669621,0.0000086365535,0.00014671087,0.00011870504,0.000087874134],"category_scores_gemma":[8.831334e-7,0.00010056806,0.00018150522,0.00030589825,0.00013972099,0.000026355949,0.000017892875,0.000068720576,0.000049673],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006604153,0.0023549292,0.76674914,0.00010208867,0.005646458,0.000057733556,0.009453652,0.00003433717,0.2145262,0.000027421054,0.00010635095,0.00028125895],"study_design_scores_gemma":[0.010570869,0.0013373347,0.17899658,0.000010350257,0.0065203803,0.000015213145,0.0019543911,0.0000026996709,0.7982453,0.0000012751664,0.0021423972,0.0002032009],"about_ca_topic_score_codex":0.00011714979,"about_ca_topic_score_gemma":0.00022853995,"teacher_disagreement_score":0.5877526,"about_ca_system_score_codex":0.000017789775,"about_ca_system_score_gemma":0.000024606892,"threshold_uncertainty_score":0.41010466},"labels":[],"label_agreement":null},{"id":"W4247934501","doi":"10.1182/blood.v110.11.1183.1183","title":"Preliminary Results of CNTO 328, an Anti-Interleukin (IL)-6 Monoclonal Antibody (mAb), in Combination with Bortezomib in the Treatment of Relapsed or Refractory Multiple Myeloma.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Bortezomib; Multiple myeloma; Medicine; Dexamethasone; Internal medicine; Pharmacology; Oncology; Cancer research; Immunology","score_opus":0.029475049843357706,"score_gpt":0.3257205409892322,"score_spread":0.2962454911458745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247934501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997566,0.0002363843,0.000017277942,0.000113092145,0.000025150865,0.0014399949,0.0000807571,0.000020605037,0.00050077116],"genre_scores_gemma":[0.99760854,0.00020278625,0.001530616,0.000015018989,0.000033562508,0.000049204005,0.00042350258,0.000027209355,0.00010954162],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99776167,0.00018189885,0.0007279025,0.0003757367,0.00055617717,0.00039659417],"domain_scores_gemma":[0.99837863,0.0005402686,0.00025069088,0.00057171664,0.00013031156,0.00012837071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006584591,0.0002332666,0.00050308526,0.00041974138,0.000037434605,0.000008787854,0.000161499,0.00012226804,0.000014787678],"category_scores_gemma":[0.00020991809,0.00013499426,0.00007857027,0.0004733877,0.00013306769,0.00013935704,0.000019753423,0.00016695373,0.00000253529],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05584644,0.045015506,0.84052265,0.00014590904,0.00029267158,0.0029775898,0.0058648693,0.000011764112,0.032881424,0.000025210644,0.000017609977,0.016398365],"study_design_scores_gemma":[0.056425635,0.029827096,0.8539813,0.0002752647,0.00010640543,0.00010432609,0.0009784289,0.00040552343,0.05766362,0.000009791892,0.00010905412,0.00011356069],"about_ca_topic_score_codex":0.0017414829,"about_ca_topic_score_gemma":0.0028330765,"teacher_disagreement_score":0.024782196,"about_ca_system_score_codex":0.0001518773,"about_ca_system_score_gemma":0.0001872412,"threshold_uncertainty_score":0.5504906},"labels":[],"label_agreement":null},{"id":"W4248279213","doi":"10.1182/blood.v120.21.3604.3604","title":"AAML0523: A Report From the Children's Oncology Group On the Efficacy of Clofarabine in Combination with Cytarabine in Pediatric Patients with Relapsed Acute Myeloid Leukemia","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Clofarabine; Medicine; Internal medicine; Cytarabine; Gastroenterology; Neutropenia; Ribonucleotide reductase; Oncology; Surgery; Myeloid leukemia; Toxicity; Biology","score_opus":0.009263073661050652,"score_gpt":0.24944095031283453,"score_spread":0.2401778766517839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248279213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950068,0.00015267431,0.000012615446,0.0018233856,0.00005927633,0.0020868941,0.000022173603,0.0000312321,0.00080494286],"genre_scores_gemma":[0.99826366,0.00009914976,0.0004110112,0.00033969287,0.000225603,0.00013280034,0.00040364295,0.000052717623,0.00007174743],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972911,0.00033064187,0.00059765525,0.00040935018,0.0008219695,0.0005493232],"domain_scores_gemma":[0.99747705,0.0010136935,0.00038525852,0.0008358558,0.00015732303,0.00013080866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010524926,0.00027759082,0.000552022,0.00026381426,0.000074009266,0.000010972265,0.00032391428,0.00019503427,0.000038928527],"category_scores_gemma":[0.00053744385,0.00013760176,0.000063207466,0.0011483543,0.00019255027,0.00013431863,0.00010787618,0.0010392836,0.000019359019],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029074845,0.004026403,0.9903017,0.000014076842,0.0002151098,0.00015609496,0.0007566786,0.000011186636,0.00021756056,0.00013604765,0.00040498035,0.00085261976],"study_design_scores_gemma":[0.03346088,0.0026502595,0.96228224,0.000097177675,0.0004347194,0.00008642419,0.0000656131,0.000019019823,0.0005880016,0.000020728174,0.00013764373,0.00015731638],"about_ca_topic_score_codex":0.000832052,"about_ca_topic_score_gemma":0.0002079519,"teacher_disagreement_score":0.030553399,"about_ca_system_score_codex":0.0006126118,"about_ca_system_score_gemma":0.00055974594,"threshold_uncertainty_score":0.5611237},"labels":[],"label_agreement":null},{"id":"W4248979306","doi":"10.1182/blood.v112.11.2449.2449","title":"Probing the Mitotic History and Developmental Stage of Hematopoietic Cells Using Single Telomere Length Analysis (STELA)","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; BC Cancer Agency","funders":"","keywords":"Telomere; Telomerase; Biology; Stem cell; Haematopoiesis; Mitosis; Cell division; CD34; Cell biology; Genetics; Cell; Gene","score_opus":0.03817844792178264,"score_gpt":0.22698458478983635,"score_spread":0.1888061368680537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248979306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99574316,0.0029452245,0.0000774941,0.000038123093,0.00007605231,0.0002766041,0.0000058382016,0.000039034785,0.000798447],"genre_scores_gemma":[0.99450696,0.00012228197,0.0038331621,0.00009499303,0.000042895652,0.0000044910016,0.000004804666,0.000024031076,0.0013663991],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998654,0.00005323971,0.00038201653,0.00030061376,0.00033722803,0.00027289294],"domain_scores_gemma":[0.9992638,0.0001011432,0.00016082631,0.0002835966,0.000072766445,0.00011785883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015135312,0.00018938638,0.00046592098,0.00023519859,0.00015128015,0.000007428863,0.00010920435,0.0000747503,0.00013379092],"category_scores_gemma":[0.000047787627,0.00014375089,0.00013054573,0.00045781358,0.00030811955,0.00007498886,0.000059329926,0.00015895655,0.0000058395512],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000675061,0.0014701652,0.16727987,0.000699002,0.0014239982,0.00038446212,0.01422794,0.00004248617,0.81350535,0.000046693083,0.00019678228,0.00065574393],"study_design_scores_gemma":[0.006015734,0.0005124194,0.08639417,0.00050591264,0.005939993,0.0021137637,0.00931923,0.00094856933,0.88172466,0.000012182005,0.0055176206,0.0009957508],"about_ca_topic_score_codex":0.00011375096,"about_ca_topic_score_gemma":0.000024857314,"teacher_disagreement_score":0.0808857,"about_ca_system_score_codex":0.0001307756,"about_ca_system_score_gemma":0.00023763832,"threshold_uncertainty_score":0.5861991},"labels":[],"label_agreement":null},{"id":"W4249236223","doi":"10.1182/blood.v106.11.360.360","title":"Analysis of Clonotypic Switch Junctions Reveals Multiple Myeloma Originates from a Single Class Switch Event with Ongoing Mutation in the Isotype Switched Progeny.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Isotype; Immunoglobulin class switching; Immunoglobulin D; Immunology; Antibody; Biology; Bone marrow; Immunoglobulin gene; Multiple myeloma; B cell; Monoclonal antibody","score_opus":0.021040794752231962,"score_gpt":0.2858491353832564,"score_spread":0.26480834063102443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249236223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99694073,0.0004756918,0.00035529898,0.0007909188,0.000020827216,0.00097538176,0.000039200302,0.00004336228,0.00035857104],"genre_scores_gemma":[0.99557555,0.000023544284,0.003547729,0.00009073028,0.00009192255,0.00018659257,0.00031495554,0.00002525026,0.00014370518],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980876,0.00012784412,0.00045054333,0.00039264586,0.00056723144,0.00037416967],"domain_scores_gemma":[0.99863243,0.00034859363,0.00018510046,0.000507862,0.00020236938,0.00012364148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030986778,0.00021465785,0.0004909525,0.00045056493,0.000098420176,0.00003231633,0.0001475478,0.000095976844,0.00008207932],"category_scores_gemma":[0.00024370856,0.00013726002,0.00016868216,0.0015922163,0.000053836666,0.00012721494,0.000027357986,0.00022214293,0.00003072328],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007043189,0.0042035063,0.9520971,0.00004716519,0.003084988,0.00012938808,0.0016066243,0.00032981395,0.026952893,0.000025033138,0.000023879227,0.010795248],"study_design_scores_gemma":[0.008588606,0.0007937466,0.95174533,0.0001326646,0.0030074336,0.00002951065,0.00066844415,0.007921306,0.026556782,0.000048709295,0.0003375478,0.00016990051],"about_ca_topic_score_codex":0.0010289631,"about_ca_topic_score_gemma":0.0058596386,"teacher_disagreement_score":0.0106253475,"about_ca_system_score_codex":0.00013219289,"about_ca_system_score_gemma":0.00014739376,"threshold_uncertainty_score":0.5597301},"labels":[],"label_agreement":null},{"id":"W4249401145","doi":"10.1182/blood.v126.23.3352.3352","title":"Transcriptional Induction of Transferrin Receptors By Heme in Erythroid Cells","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Transferrin receptor; Transferrin; Endosome; Endocytic cycle; Endocytosis; Biology; Cell biology; Receptor; Asialoglycoprotein receptor; Molecular biology; Biochemistry; Intracellular; In vitro; Hepatocyte","score_opus":0.021024710804407,"score_gpt":0.24017914887183364,"score_spread":0.21915443806742663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249401145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946246,0.0013621432,0.00013474039,0.00036270195,0.00027609034,0.0001720882,0.000015749416,0.00001751473,0.0030343474],"genre_scores_gemma":[0.9986277,0.00012104125,0.0005521826,0.00010123415,0.00007071945,0.000008091339,0.000045318386,0.000011537736,0.0004621611],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993108,0.00002863197,0.0001994582,0.00012703706,0.00021001647,0.00012405403],"domain_scores_gemma":[0.99975246,0.0000058325522,0.000020599744,0.00009515164,0.00003709707,0.00008888337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014579712,0.0000774435,0.00017624145,0.00008630345,0.000008265015,0.0000021922053,0.000037334932,0.000077775374,0.00014571463],"category_scores_gemma":[0.000014317902,0.00007241136,0.00004787644,0.00015784922,0.000047856895,0.00006304227,0.0000024279764,0.000102641025,0.000015529553],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030367833,0.0027055219,0.012995026,0.00015192416,0.00002507902,0.0000052403443,0.0029583636,0.000012340895,0.96944946,0.0005346912,0.008319786,0.002538915],"study_design_scores_gemma":[0.029849486,0.00070964417,0.025644237,0.00007289065,0.00030080692,0.00003316794,0.0029948158,0.000007309051,0.89340705,0.0005400303,0.046128556,0.00031201995],"about_ca_topic_score_codex":0.00012731155,"about_ca_topic_score_gemma":0.000020502812,"teacher_disagreement_score":0.0760424,"about_ca_system_score_codex":0.0000095802625,"about_ca_system_score_gemma":0.00007588246,"threshold_uncertainty_score":0.29528496},"labels":[],"label_agreement":null},{"id":"W4249539749","doi":"10.1182/blood.v114.22.1874.1874","title":"Phase I-II Trial of Oral Cyclophosphamide, Prednisone and Lenalidomide (Revlimid®) (CPR) for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Lenalidomide; Medicine; Regimen; Thalidomide; Internal medicine; Prednisone; Multiple myeloma; Cyclophosphamide; Gastroenterology; Bortezomib; Surgery; Dexamethasone; Chemotherapy","score_opus":0.023131485574558845,"score_gpt":0.29655952899943766,"score_spread":0.2734280434248788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249539749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99436855,0.0019798852,0.000016108064,0.000146105,0.000029910647,0.0032226641,0.00016669853,0.000016229273,0.00005387072],"genre_scores_gemma":[0.9967862,0.0011485487,0.001578881,0.000019790514,0.00004487511,0.00012599361,0.00009675427,0.000018482358,0.0001805031],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99879956,0.000040759187,0.0003346218,0.00026942085,0.0002973431,0.0002582973],"domain_scores_gemma":[0.9988639,0.00032397642,0.0001791584,0.0003204385,0.00014682896,0.00016572124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000114943665,0.00020175429,0.00049268216,0.00007308417,0.00012128387,0.00000760464,0.000052214924,0.0000704384,0.000008739578],"category_scores_gemma":[0.0001702728,0.000110262365,0.00008918615,0.00009814765,0.00015013063,0.00006494861,0.0000133813555,0.000056177545,3.136492e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.47500697,0.08437022,0.15003377,0.00019856394,0.0021356328,0.00004331358,0.0012050751,0.000001975375,0.0045203664,0.000023879811,0.00011240962,0.28234783],"study_design_scores_gemma":[0.65663064,0.10001162,0.22124,0.00008265265,0.00086710294,0.000005119871,0.000046548805,0.00009856763,0.019791445,0.000025270312,0.001090512,0.00011052138],"about_ca_topic_score_codex":0.00009709848,"about_ca_topic_score_gemma":0.000026424583,"teacher_disagreement_score":0.2822373,"about_ca_system_score_codex":0.000028761167,"about_ca_system_score_gemma":0.00007418667,"threshold_uncertainty_score":0.44963688},"labels":[],"label_agreement":null},{"id":"W4249609113","doi":"10.1182/blood.v124.21.88.88","title":"A Multi-Center Randomized Controlled Trial of Intravenous Magnesium for Sickle Cell Pain Crisis in Children","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Emergency department; Sickle cell anemia; Vaso-occlusive crisis; Randomized controlled trial; Placebo; Pediatrics; Anesthesia; Emergency medicine; Internal medicine; Disease; Psychiatry","score_opus":0.0040679661032565284,"score_gpt":0.21424153881739189,"score_spread":0.21017357271413536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249609113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887987,0.0004580333,0.0015425272,0.00054166163,0.00016347204,0.0077429716,0.000009243713,0.000030141857,0.00071326044],"genre_scores_gemma":[0.9976376,0.000060659582,0.0011547233,0.00033559103,0.00013665871,0.0003864888,0.00002755742,0.000024766121,0.00023593685],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99840444,0.00036926867,0.00063094014,0.00020461334,0.00013885855,0.00025187002],"domain_scores_gemma":[0.99910927,0.00036799448,0.00017717601,0.00020357624,0.000064631306,0.000077372104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019034725,0.00015745325,0.001363504,0.00012655754,0.000025574143,0.000006712648,0.000071764785,0.00017050275,0.000030360829],"category_scores_gemma":[0.0007970105,0.00010677403,0.00045159008,0.00008767093,0.000055477038,0.00001664299,0.000014423449,0.00013208165,0.000005106201],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98322946,0.012126678,0.00084217906,0.00017792746,0.00026304083,0.0000031277405,0.00055823004,0.0000056081003,0.0018065941,0.000021630975,0.00019494779,0.000770593],"study_design_scores_gemma":[0.99492055,0.0012007453,0.000081037615,0.00003076657,0.0008706146,0.0000058798305,0.00014002789,0.0012143949,0.0013162143,0.00004088277,0.0000687548,0.000110150555],"about_ca_topic_score_codex":0.000097881035,"about_ca_topic_score_gemma":0.000007267604,"teacher_disagreement_score":0.011691087,"about_ca_system_score_codex":0.000008155482,"about_ca_system_score_gemma":0.00005108082,"threshold_uncertainty_score":0.43541184},"labels":[],"label_agreement":null},{"id":"W4249725914","doi":"10.1182/blood.v95.8.2645.008k18_2645_2650","title":"Abundance of cyclin B1 regulates γ-radiation–induced apoptosis","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Hamilton Regional Laboratory Medicine Program; McMaster University Medical Centre","funders":"","keywords":"Cyclin A; Cyclin A2; Cyclin B1; Cyclin B; Cyclin D; Cell biology; Biology; Cyclin; Cyclin E; Cell cycle; Apoptosis; DNA damage; Cyclin-dependent kinase; Molecular biology; Cyclin-dependent kinase 1; Cancer research; Biochemistry; DNA","score_opus":0.009681910381166746,"score_gpt":0.23823523375574007,"score_spread":0.22855332337457332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249725914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877706,0.0010434804,0.00001171458,0.00036546707,0.000083585364,0.00025066227,0.000010769502,0.00007519486,0.010388525],"genre_scores_gemma":[0.99771345,0.00023492334,0.0006988328,0.00016507681,0.0001346168,0.000016380076,0.00002295899,0.000029120982,0.00098462],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99906117,0.000024034156,0.0002776383,0.0002221571,0.0002268534,0.0001881593],"domain_scores_gemma":[0.99934536,0.000026562362,0.000080930426,0.0003974068,0.000054678803,0.000095087715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008420505,0.00011644954,0.00024921243,0.0000745078,0.00003461901,0.0000062639774,0.00007697396,0.00011782174,0.0007300678],"category_scores_gemma":[0.000056638793,0.000116446085,0.000112077505,0.0002684243,0.000040080784,0.000040555773,0.000010055912,0.00013624581,0.000114442075],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015249955,0.00094042777,0.0024846797,0.000104676736,0.00031296024,0.000019229214,0.00045327473,0.00006535682,0.93060124,0.00018068256,0.0009474573,0.06373753],"study_design_scores_gemma":[0.003545148,0.00027515157,0.020810654,0.00014553692,0.00028282581,0.000038833092,0.000014304771,0.00006737173,0.9702752,0.000093865005,0.004321614,0.00012948817],"about_ca_topic_score_codex":0.00005955765,"about_ca_topic_score_gemma":0.000004765607,"teacher_disagreement_score":0.063608035,"about_ca_system_score_codex":0.000029050934,"about_ca_system_score_gemma":0.00009315241,"threshold_uncertainty_score":0.79937303},"labels":[],"label_agreement":null},{"id":"W4250055850","doi":"10.1182/blood.v126.23.625.625","title":"Risk Factors Predictive of Occult Cancer Detection in Patients with Unprovoked Venous Thromboembolism","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Université de Montréal; Hôpital du Sacré-Cœur de Montréal; University of Ottawa; McGill University; Ottawa Hospital; CancerCare Manitoba; Queen Elizabeth II Health Sciences Centre; St Mary's Hospital Centre; Western University; St. Joseph’s Healthcare Hamilton; Montreal General Hospital; University of Manitoba; Dalhousie University; Jewish General Hospital","funders":"","keywords":"Medicine; Occult; Cancer; Cancer screening; Hazard ratio; Internal medicine; Proportional hazards model; Pathology; Confidence interval","score_opus":0.011327311767948264,"score_gpt":0.23583488256637292,"score_spread":0.22450757079842465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250055850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978156,0.00013156464,0.00003905958,0.000018658351,0.00016891527,0.00089545053,0.000050322105,0.000044475084,0.00083595864],"genre_scores_gemma":[0.9996111,0.00007761006,0.00007660598,0.0000381673,0.000058769325,0.00007213553,0.000023453824,0.000025659348,0.000016502463],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988445,0.000044002543,0.0002397294,0.00025267602,0.00038654727,0.00023254787],"domain_scores_gemma":[0.99922353,0.000019494373,0.0001800877,0.00023619016,0.00021032766,0.0001303475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011877225,0.00016134018,0.00052661076,0.0001399215,0.000033730168,0.0000068984746,0.00006870774,0.00007861038,0.000018346225],"category_scores_gemma":[0.00007108074,0.00011912139,0.00004797172,0.00026130906,0.000056056128,0.00008924772,0.000037908256,0.00015264521,0.0000043728273],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023570503,0.006457852,0.98730683,0.00006753546,0.00048345825,0.0000056678655,0.003105721,0.00019259249,0.00008996917,0.000012828742,0.00010785147,0.001933964],"study_design_scores_gemma":[0.0076373545,0.0027964816,0.98018557,0.00012498515,0.0008086054,4.865494e-7,0.00053011265,0.000028222415,0.00759836,0.000039986593,0.0001258574,0.00012395575],"about_ca_topic_score_codex":0.0033494136,"about_ca_topic_score_gemma":0.00049009745,"teacher_disagreement_score":0.0075083906,"about_ca_system_score_codex":0.000101024205,"about_ca_system_score_gemma":0.00009508498,"threshold_uncertainty_score":0.5063334},"labels":[],"label_agreement":null},{"id":"W4250195231","doi":"10.1182/blood.v96.3.966.015k12_966_972","title":"Induction of monocyte tissue factor expression by homocysteine: a possible mechanism for thrombosis","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Homocysteine; Tissue factor; Monocyte; Methionine; Internal medicine; Cysteine; Chemistry; Endocrinology; Biochemistry; Biology; Immunology; Medicine; Enzyme; Amino acid; Coagulation","score_opus":0.03315290073987471,"score_gpt":0.31976667652455465,"score_spread":0.28661377578467995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250195231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976253,0.00037344245,0.00016234304,0.00014654729,0.000037802554,0.0005515262,0.00006912146,0.0000378386,0.0009961103],"genre_scores_gemma":[0.99283785,0.00031004226,0.001376612,0.000032656648,0.000097742835,0.00005549095,0.00004685939,0.000022850882,0.005219909],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99914855,0.00001939141,0.00018641041,0.00019784128,0.00023848175,0.00020932977],"domain_scores_gemma":[0.9995112,0.000025164618,0.000039432503,0.00023171927,0.00010066411,0.00009186351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000064506195,0.000101557336,0.00022838298,0.00007810487,0.00005706293,0.000010771798,0.00007401327,0.00012874855,0.00058241637],"category_scores_gemma":[0.000025073949,0.00008005244,0.00006404343,0.00014503414,0.000024348254,0.000092969654,0.000016367017,0.00009845635,0.000035991787],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000101496924,0.0005654247,0.00022319233,0.00012646415,0.000060324182,0.0000024450535,0.00016226165,1.4739466e-7,0.9852644,0.000031046053,0.0011452954,0.012317476],"study_design_scores_gemma":[0.0032359336,0.0011980404,0.0010071142,0.0001056725,0.00008322085,0.000015223235,0.00006760768,0.000038468806,0.9924656,0.00013402,0.0015671615,0.00008190765],"about_ca_topic_score_codex":0.000114726536,"about_ca_topic_score_gemma":0.0000029209527,"teacher_disagreement_score":0.012235568,"about_ca_system_score_codex":0.000015884756,"about_ca_system_score_gemma":0.0000411063,"threshold_uncertainty_score":0.6377051},"labels":[],"label_agreement":null},{"id":"W4250653753","doi":"10.1182/blood.v116.21.1937.1937","title":"Lenalidomide, Bortezomib, Pegylated Liposomal Doxorubicin, and Dexamethasone In Newly Diagnosed Multiple Myeloma (MM): Final Results of Phase I/II MMRC Trial","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Lenalidomide; Thalidomide; Medicine; Bortezomib; Dexamethasone; Regimen; Multiple myeloma; Internal medicine; Melphalan; Phases of clinical research; Urology; Gastroenterology; Surgery; Pharmacology; Chemotherapy","score_opus":0.03389884462609319,"score_gpt":0.32003217873439055,"score_spread":0.28613333410829733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250653753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99650824,0.00032822453,0.0000061765104,0.00037770483,0.00017184563,0.0018374741,0.0002238087,0.000060707265,0.00048579552],"genre_scores_gemma":[0.9954135,0.000112682785,0.0033971977,0.000043291064,0.00032006504,0.000115798364,0.0002209114,0.000042263688,0.00033432475],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9971887,0.0001407179,0.0008418122,0.0006102053,0.00057410327,0.00064444455],"domain_scores_gemma":[0.99771816,0.0007768003,0.00023369852,0.00059491926,0.0001872586,0.0004891889],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006164332,0.0003358576,0.00079265516,0.0003894223,0.0001193052,0.0000280281,0.00016463314,0.0002810416,0.00010172587],"category_scores_gemma":[0.0035444496,0.0002791268,0.00015663431,0.0004421234,0.00023334428,0.00014713721,0.0001348242,0.0006470368,0.0000147189985],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.35037988,0.031001873,0.08103216,0.00017183041,0.0007299582,0.0033762483,0.0010961768,0.0000018577708,0.45719245,0.000028142718,0.00043882476,0.0745506],"study_design_scores_gemma":[0.7246669,0.007547994,0.10070963,0.00014408138,0.000261677,0.0001502214,0.00007225135,0.00051878026,0.16501337,0.000026544461,0.00065244944,0.00023609166],"about_ca_topic_score_codex":0.0016232113,"about_ca_topic_score_gemma":0.0016315021,"teacher_disagreement_score":0.37428704,"about_ca_system_score_codex":0.000027898152,"about_ca_system_score_gemma":0.0002924726,"threshold_uncertainty_score":0.9999661},"labels":[],"label_agreement":null},{"id":"W4250695549","doi":"10.1182/blood.v106.11.117.117","title":"X-Linked Clonality Analysis and Quantitative JAK2V617F Assessment Reveals a Strong Association between Clonality and JAK2V617F in PV but Not in ET/MMM, and Identifies a Subset of JAK2V617F Negative ET and MMM Patients with Clonal Hematopoiesis.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Biology; Myelofibrosis; Essential thrombocythemia; Allele; Polycythemia vera; Myeloid; Immunology; Genetics; Gene; Bone marrow","score_opus":0.02157559065515803,"score_gpt":0.32370485578322117,"score_spread":0.30212926512806315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250695549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99568325,0.00045044994,0.000055863926,0.0017940389,0.000010556633,0.0010848049,0.00079896895,0.000014690342,0.000107371925],"genre_scores_gemma":[0.9937209,0.00047045437,0.005055132,0.00021900624,0.000023992328,0.00014124544,0.0003105409,0.000021354954,0.000037404512],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966169,0.0006576938,0.00089697633,0.0007505688,0.0007163926,0.0003614933],"domain_scores_gemma":[0.9968351,0.0018092892,0.00060596655,0.00021933259,0.0003304624,0.00019985925],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015115226,0.00039891814,0.0013525286,0.0003999421,0.0001041077,0.00009015807,0.00005551058,0.00018752775,0.000019783372],"category_scores_gemma":[0.0004373859,0.00032993435,0.00008692266,0.000547905,0.00021954958,0.00038966295,0.00011780331,0.00037432314,5.2557476e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035403288,0.0014671956,0.99168533,0.00021864744,0.002179266,0.000015974494,0.0024646309,0.000008211142,0.00021911289,0.0011416905,0.000012311199,0.0002336027],"study_design_scores_gemma":[0.010882367,0.00071279623,0.9826659,0.0003133925,0.0019866584,0.0000045936854,0.0006781035,0.0001087043,0.0019768449,0.0003884603,0.000006424207,0.00027576348],"about_ca_topic_score_codex":0.0013711314,"about_ca_topic_score_gemma":0.007763957,"teacher_disagreement_score":0.010528334,"about_ca_system_score_codex":0.00019329894,"about_ca_system_score_gemma":0.00014533995,"threshold_uncertainty_score":0.99991524},"labels":[],"label_agreement":null},{"id":"W4250754662","doi":"10.1182/blood.v120.21.962.962","title":"Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: 2-Year Follow-up Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Multiple sclerosis; Transplantation; Internal medicine; Adverse effect; Prednisone; Surgery; Hematopoietic stem cell transplantation; Clinical endpoint; Busulfan; Clinical trial; Immunology","score_opus":0.03852223527307915,"score_gpt":0.26700609129446257,"score_spread":0.2284838560213834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250754662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98164725,0.01638494,0.00000418375,0.00011153869,0.00052212155,0.0009310331,0.00008195661,0.000029558434,0.00028740478],"genre_scores_gemma":[0.9934475,0.0053952252,0.00059974106,0.000023910316,0.0002509583,0.000031128275,0.000031948963,0.000027526157,0.00019206363],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824214,0.00019355312,0.0007554851,0.00024746184,0.00024333352,0.0003180127],"domain_scores_gemma":[0.9983976,0.00045233153,0.0005062095,0.00043599497,0.00008398449,0.00012390854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021651176,0.00021624447,0.00062377634,0.000027321885,0.00013808637,0.00000842432,0.000096083524,0.00019606644,0.000011813127],"category_scores_gemma":[0.000065029315,0.00012133477,0.00022495321,0.00017809149,0.00022514591,0.000068817564,0.000018610672,0.00015992548,0.0000015424797],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4421089,0.019493936,0.4881978,0.00058487686,0.0028144633,0.00008905325,0.012163121,0.00040284428,0.023041012,0.00010851776,0.0002890194,0.0107064545],"study_design_scores_gemma":[0.396742,0.0039290264,0.5476522,0.0012358289,0.0020117124,0.0001413786,0.0002220228,0.000038982584,0.04768932,0.000010522448,0.000100523925,0.00022652722],"about_ca_topic_score_codex":0.00022414004,"about_ca_topic_score_gemma":0.000007072007,"teacher_disagreement_score":0.05945438,"about_ca_system_score_codex":0.000012923228,"about_ca_system_score_gemma":0.00011897286,"threshold_uncertainty_score":0.49478883},"labels":[],"label_agreement":null},{"id":"W4250896187","doi":"10.1182/blood-2011-07-365544","title":"Dapsone hemolysis","year":2012,"lang":"sv","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Hemolysis; Dapsone; Medicine; Internal medicine; Immunology","score_opus":0.007199401056621526,"score_gpt":0.22643465468761909,"score_spread":0.21923525363099755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250896187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9299511,0.05784716,0.000049682705,0.00016180729,0.00036896818,0.00017426006,0.000066691086,0.000014686663,0.0113657005],"genre_scores_gemma":[0.993865,0.0013138119,0.0004480161,0.00028727407,0.00080395496,0.000023809353,0.00023120227,0.000043330107,0.0029835873],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99862397,0.000057189172,0.00020909836,0.0003435096,0.00014745597,0.0006188066],"domain_scores_gemma":[0.99907166,0.000007066399,0.00009075698,0.000537754,0.000040806546,0.00025196528],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010291247,0.000278743,0.00023061632,0.000035087793,0.00012115051,0.000031478332,0.00016945547,0.00028437024,0.00018617624],"category_scores_gemma":[0.000028283255,0.00026837114,0.00020947945,0.00011854648,0.00006510595,0.000006783292,0.00014769688,0.000088243156,0.00032962186],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016752408,0.033597924,0.64259446,0.00020728353,0.0073362277,0.00005790667,0.0006541169,0.0000046872187,0.260885,0.00058653747,0.014621477,0.039286844],"study_design_scores_gemma":[0.009640722,0.00082513475,0.019803677,0.000038653983,0.0027380271,0.00012808188,0.0003024655,0.00000432164,0.8231027,0.00005916713,0.14241062,0.00094641343],"about_ca_topic_score_codex":0.000039136474,"about_ca_topic_score_gemma":0.000012236913,"teacher_disagreement_score":0.6227908,"about_ca_system_score_codex":0.0000062233385,"about_ca_system_score_gemma":0.00004702484,"threshold_uncertainty_score":0.9999769},"labels":[],"label_agreement":null},{"id":"W4251042006","doi":"10.1182/blood.v116.21.533.533","title":"Analysis of Risk Factors Influencing Outcomes After Unrelated Cord Blood Transplantation In Children with Juvenile Myelomonocytic Leukemia. An Eurocord, EBMT, EWOG-MDS, CIBMTR Study","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Busulfan; Medicine; Juvenile myelomonocytic leukemia; Transplantation; Total body irradiation; Cyclophosphamide; Hematopoietic stem cell transplantation; Internal medicine; ThioTEPA; Surgery; Gastroenterology; Leukemia; Oncology; Chemotherapy; Stem cell; Haematopoiesis; Biology","score_opus":0.010284241721715605,"score_gpt":0.2735640216326619,"score_spread":0.2632797799109463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251042006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982454,0.000034433244,0.000023807444,0.00001119145,0.00003182216,0.0013195715,0.0001586703,0.00010097954,0.00007412927],"genre_scores_gemma":[0.9989023,0.000048280075,0.00049915415,0.000036427442,0.000036334273,0.00007854696,0.0002829421,0.000073325966,0.00004265995],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99691683,0.00025531603,0.00080934644,0.00071299996,0.0007641548,0.00054137356],"domain_scores_gemma":[0.99803656,0.00025281508,0.00030796466,0.0009072856,0.00020278337,0.000292603],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00057217747,0.0004167867,0.0010675439,0.0014120773,0.00008860596,0.000037672282,0.0003230982,0.00024553653,0.00014406514],"category_scores_gemma":[0.00019781762,0.00031866648,0.00019904134,0.0022460935,0.00013838061,0.00027926333,0.000054617623,0.0012945572,0.000009316565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008286545,0.0017811764,0.98365843,0.00003445556,0.0045064217,0.00023799005,0.004961824,0.0002302003,0.0033793026,0.0000019570175,8.5991866e-7,0.00037870943],"study_design_scores_gemma":[0.015020716,0.0013737637,0.9617227,0.00004169309,0.015711168,0.00006511476,0.0010433902,0.00040376635,0.004299363,0.000003935119,0.000001077311,0.0003133627],"about_ca_topic_score_codex":0.008078982,"about_ca_topic_score_gemma":0.008536373,"teacher_disagreement_score":0.021935798,"about_ca_system_score_codex":0.00014169722,"about_ca_system_score_gemma":0.00052454433,"threshold_uncertainty_score":0.99992657},"labels":[],"label_agreement":null},{"id":"W4251085304","doi":"10.1182/blood.v96.3.878.015k15_878_884","title":"In vivo generation of human dendritic cell subsets by Flt3 ligand","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research & Development Corporation","funders":"","keywords":"CD11c; Dendritic cell; In vivo; Immunology; Immune system; In vitro; Immunotherapy; Biology; Cell biology; Phenotype; Gene","score_opus":0.01019832240241072,"score_gpt":0.22767075361093053,"score_spread":0.2174724312085198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251085304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98352176,0.014427445,0.0000017243232,0.000038719292,0.00010790571,0.000106763364,0.000022593074,0.000014658348,0.0017584303],"genre_scores_gemma":[0.9818196,0.00038861952,0.000009873046,0.00008868729,0.000016437862,0.000010590198,0.000043321455,0.000011702483,0.017611155],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992308,0.0001495955,0.00025800135,0.0001426485,0.000022060105,0.0001968974],"domain_scores_gemma":[0.99971336,0.000037037364,0.000046146757,0.00018107466,0.000016221873,0.0000061554706],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012154577,0.000103949766,0.00018161119,0.00006754348,0.00008230017,0.000007409992,0.00013071815,0.00015742265,0.0033190523],"category_scores_gemma":[0.0000062642207,0.00010211647,0.00004924082,0.000083283434,0.00008307688,0.000077866396,0.000009641183,0.00011574676,0.00017592487],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007411995,0.00062322745,0.0005553061,0.000008984099,0.00003677178,0.0000033812546,0.0003671093,7.281884e-7,0.99473786,0.000025541582,0.0030634583,0.0005034841],"study_design_scores_gemma":[0.0029988033,0.00021573501,0.0006900625,0.000015108328,0.000022165319,0.000024425577,0.000028161941,4.1533573e-7,0.975153,0.000017637532,0.02072728,0.00010717064],"about_ca_topic_score_codex":0.00014183336,"about_ca_topic_score_gemma":0.000024319386,"teacher_disagreement_score":0.019584853,"about_ca_system_score_codex":0.000007084733,"about_ca_system_score_gemma":0.00002120203,"threshold_uncertainty_score":0.99759203},"labels":[],"label_agreement":null},{"id":"W4251184633","doi":"10.1182/blood.v114.22.2520.2520","title":"SCL regulates the Quiescence and the Long-Term Competence of Hematopoietic Stem Cells.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research; Université de Montréal","funders":"","keywords":"Stem cell; Biology; Haematopoiesis; Transplantation; Progenitor cell; Bone marrow; Population; Immunology; Cell biology; Cancer research; Internal medicine; Medicine","score_opus":0.011892085469453917,"score_gpt":0.2330152253650096,"score_spread":0.22112313989555568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251184633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99451804,0.0018053113,0.00018647789,0.0016639442,0.00004600952,0.00051447126,0.0000025436475,0.000030615985,0.0012325845],"genre_scores_gemma":[0.99892586,0.00035049857,0.0001915284,0.00025253752,0.000030940766,0.0000068169606,0.0000017563023,0.000008257729,0.00023181645],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99905777,0.00006979874,0.00028016348,0.00016748265,0.00026574903,0.00015903237],"domain_scores_gemma":[0.99912834,0.000274587,0.000102621634,0.0003846779,0.00005742899,0.00005231453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003087149,0.00011736236,0.00026627092,0.000026369371,0.00007876256,0.000017794688,0.00014572841,0.000048260077,0.000018705912],"category_scores_gemma":[0.000009598542,0.00006058353,0.00006062216,0.00013380355,0.00034828048,0.000033304743,0.0000150507,0.000111928195,0.000009573792],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016543576,0.002663112,0.20272802,0.0058829384,0.0006927612,0.00048129092,0.048200585,0.000021751066,0.6711486,0.050808135,0.00024082861,0.015477614],"study_design_scores_gemma":[0.0074370224,0.0002687722,0.21593487,0.0012196538,0.00075969525,0.0011474853,0.00062604854,0.0001240204,0.7718474,0.00046241956,0.00001265161,0.00015993681],"about_ca_topic_score_codex":0.000005558691,"about_ca_topic_score_gemma":0.0000025878621,"teacher_disagreement_score":0.100698814,"about_ca_system_score_codex":0.0000046051914,"about_ca_system_score_gemma":0.000032073865,"threshold_uncertainty_score":0.24705246},"labels":[],"label_agreement":null},{"id":"W4251469366","doi":"10.1182/blood.v97.7.1960.h8001960_1960_1967","title":"Human homologues of Delta-1 and Delta-4 function as mitogenic regulators of primitive human hematopoietic cells","year":2001,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Biology; Haematopoiesis; Cell biology; Stromal cell; Delta; Induced pluripotent stem cell; Progenitor cell; Stem cell; Immunology; Cancer research; Embryonic stem cell; Genetics","score_opus":0.010548643163577665,"score_gpt":0.24811424916511868,"score_spread":0.237565606001541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251469366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99618953,0.0025058726,0.0002109441,0.000007969558,0.00004049777,0.00014298467,0.000013109662,0.000006526167,0.0008825859],"genre_scores_gemma":[0.9990864,0.00025278635,0.00025803418,0.000011435336,0.00006832412,0.0000071466898,0.00009486567,0.000017211993,0.00020381784],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991574,0.00005393507,0.00028733152,0.0002468702,0.00011328814,0.00014113242],"domain_scores_gemma":[0.9993779,0.000009006641,0.00018243969,0.00025595137,0.000121970974,0.00005272506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014277313,0.0001238183,0.00018153251,0.000057280155,0.00006949753,0.0000065022336,0.0000804183,0.00015755478,0.000016375883],"category_scores_gemma":[0.000020477768,0.00012417694,0.00008084001,0.00007697681,0.00012586679,0.0000031418035,0.00006258991,0.00004578986,0.000001158739],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017878616,0.00019594641,0.014537898,0.000034500743,0.00008873116,0.0000015741178,0.000068971116,0.000011693577,0.9845007,0.00027639495,0.000017062865,0.00024861345],"study_design_scores_gemma":[0.0007684299,0.00084113894,0.027973138,0.00001729298,0.00014114795,0.000008021678,0.00007451776,0.0000016631892,0.9685071,0.0011693013,0.0003756406,0.00012262275],"about_ca_topic_score_codex":0.00006636581,"about_ca_topic_score_gemma":0.000050136194,"teacher_disagreement_score":0.015993651,"about_ca_system_score_codex":0.0000032843068,"about_ca_system_score_gemma":0.000023119905,"threshold_uncertainty_score":0.5063788},"labels":[],"label_agreement":null},{"id":"W4251592126","doi":"10.1182/blood-2009-04-217299","title":"Priming reloaded?","year":2009,"lang":"en","type":"letter","venue":"Blood","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine","score_opus":0.018303440088422225,"score_gpt":0.24665888789734097,"score_spread":0.22835544780891875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251592126","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.032197006,0.0024507414,0.000030324987,0.9243364,0.00036233352,0.0004410292,0.00000806778,0.00026435766,0.03990976],"genre_scores_gemma":[0.0028436438,0.00013194053,0.0019016397,0.95756465,0.020735458,0.000010030846,0.00041050118,0.000091782626,0.016310353],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988118,0.000014930781,0.0002363189,0.0003072494,0.00032657592,0.00030315167],"domain_scores_gemma":[0.9994312,0.000038789844,0.00009259544,0.00032896915,0.000049149327,0.000059294678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007121144,0.00022522156,0.00044663638,0.00010384289,0.00003864822,0.000020508394,0.00008965069,0.0006595978,0.00036482525],"category_scores_gemma":[0.000047782345,0.0001932721,0.00021051137,0.000090968075,0.000018559576,0.000017399736,0.000022450762,0.0014702647,0.00009219336],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004776135,0.00009250944,0.0001889048,0.00022862667,0.00010517138,0.0011867721,0.00004346252,5.0981164e-8,0.0038886575,0.000001790701,0.991418,0.0028412875],"study_design_scores_gemma":[0.0012230832,0.000110929795,0.000082812,0.00050664734,0.00064255076,0.0004165766,0.0000034742593,0.0000014857827,0.023783628,0.00004150658,0.9729717,0.00021562731],"about_ca_topic_score_codex":0.000007791295,"about_ca_topic_score_gemma":1.5221961e-7,"teacher_disagreement_score":0.03322827,"about_ca_system_score_codex":0.00003120862,"about_ca_system_score_gemma":0.00009426303,"threshold_uncertainty_score":0.7881408},"labels":[],"label_agreement":null},{"id":"W4251689495","doi":"10.1182/blood.v95.11.3489.011k45_3489_3497","title":"Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research & Development Corporation","funders":"","keywords":"Haematopoiesis; Biology; Progenitor cell; Myeloid; Bone marrow; Spleen; CD8; Immunology; CD11c; Lymphopoiesis; Stem cell; Cell biology; Antigen","score_opus":0.006408495738670238,"score_gpt":0.2070385583558723,"score_spread":0.20063006261720204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251689495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856593,0.006603136,0.000018222227,0.00005656585,0.005661621,0.00039588145,0.0000033197766,0.00015021901,0.0014517109],"genre_scores_gemma":[0.97480345,0.00023748486,0.00012818379,0.00017292827,0.00009134599,0.000025254833,0.000030567204,0.000043180808,0.024467606],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982644,0.00020288584,0.00040756277,0.0005015854,0.00007750947,0.00054608507],"domain_scores_gemma":[0.9992868,0.0001895579,0.00012839212,0.00027616753,0.00007341447,0.00004569523],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0002332749,0.00032682545,0.0003582892,0.00012567922,0.0004692724,0.000100812395,0.00016577274,0.00026937723,0.0011556208],"category_scores_gemma":[0.000021999078,0.0003065073,0.00015420742,0.00012677988,0.00012940266,0.00016189355,0.000074136195,0.00049644517,0.0013375268],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006471812,0.00046899045,0.00019234378,0.00011364238,0.00018337579,0.000016971164,0.0012993417,0.000009224388,0.99330395,0.000012391591,0.0036162557,0.00071881467],"study_design_scores_gemma":[0.0017890595,0.0001343777,0.0001617253,0.00011937425,0.00021037727,0.0005580177,0.0014411309,0.000026173944,0.9746739,0.0000074804198,0.020523945,0.00035440281],"about_ca_topic_score_codex":0.000065395754,"about_ca_topic_score_gemma":0.000015501613,"teacher_disagreement_score":0.023015894,"about_ca_system_score_codex":0.00003816904,"about_ca_system_score_gemma":0.000028729259,"threshold_uncertainty_score":0.9999387},"labels":[],"label_agreement":null},{"id":"W4252188521","doi":"10.1182/blood.v126.23.1845.1845","title":"Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to Lenalidomide and Dexamethasone (LD) for the Treatment of Non-Transplant Eligible Multiple Myeloma","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Calgary Laboratory Services; University of Alberta; University of Calgary","funders":"","keywords":"Dexamethasone; Bortezomib; Lenalidomide; Medicine; Regimen; Multiple myeloma; Cyclophosphamide; Internal medicine; Gastroenterology; Oncology; Chemotherapy; Surgery","score_opus":0.04759866484761019,"score_gpt":0.3205993776655472,"score_spread":0.27300071281793703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252188521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874771,0.007314674,0.0012674563,0.00055769866,0.000065391105,0.0028734263,0.00023933803,0.000037663005,0.00016723991],"genre_scores_gemma":[0.980319,0.0020408619,0.016597629,0.00008616106,0.00009796933,0.00047777928,0.00007237705,0.000042827727,0.00026538476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981853,0.000057575257,0.00038805295,0.00046614776,0.00038122004,0.00052172143],"domain_scores_gemma":[0.9974986,0.0010307768,0.000096406875,0.00047397966,0.00019980677,0.0007004684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003389395,0.00031910214,0.00072076713,0.00013933185,0.00013232228,0.000036552494,0.00011054639,0.000095146155,0.000009936813],"category_scores_gemma":[0.00025350053,0.00020168305,0.0001187793,0.00020870283,0.00016313855,0.000063515705,0.000041416377,0.000083825405,0.000008046454],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012418394,0.0049009137,0.8732375,0.00033599386,0.0028371885,0.00026539396,0.0038223872,0.000039904,0.033905905,0.000037968246,0.000572469,0.06762602],"study_design_scores_gemma":[0.109480366,0.008463508,0.61589384,0.00030864167,0.0020743092,0.00030075843,0.00093720964,0.004172158,0.2502522,0.00011156444,0.007525189,0.00048028017],"about_ca_topic_score_codex":0.0015906711,"about_ca_topic_score_gemma":0.0004349561,"teacher_disagreement_score":0.25734365,"about_ca_system_score_codex":0.00006307881,"about_ca_system_score_gemma":0.00015782261,"threshold_uncertainty_score":0.8224397},"labels":[],"label_agreement":null},{"id":"W4252341638","doi":"10.1182/blood-2019-123483","title":"Four-Year Follow-up of the Phase 3 Pollux Study of Daratumumab Plus Lenalidomide and Dexamethasone (D-Rd) Versus Lenalidomide and Dexamethasone (Rd) Alone in Relapsed or Refractory Multiple Myeloma (RRMM)","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Queen Elizabeth II Health Sciences Centre; Institute of Cancer Research; University of Calgary","funders":"","keywords":"Lenalidomide; Daratumumab; Medicine; Internal medicine; Dexamethasone; Multiple myeloma; Oncology; Surgery; Gastroenterology","score_opus":0.05240809702567301,"score_gpt":0.3185706646804925,"score_spread":0.2661625676548195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252341638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99461114,0.0014469125,0.000005105305,0.00016849142,0.00023091669,0.0030507054,0.00010318909,0.00003292764,0.0003505997],"genre_scores_gemma":[0.9975173,0.00022835603,0.0011462927,0.00003005297,0.00006635707,0.00008946538,0.000021120819,0.00007370367,0.0008273414],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9962082,0.00055353093,0.00086093077,0.0007596103,0.0009640249,0.0006537234],"domain_scores_gemma":[0.99621,0.0016932734,0.0004192838,0.0011163936,0.00020728656,0.000353782],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008965972,0.00045416062,0.001337815,0.00039696856,0.000121458565,0.000027589129,0.00028938503,0.00022664378,0.00013429842],"category_scores_gemma":[0.0023721883,0.00030743645,0.00017367322,0.00067395193,0.0003038381,0.00016136434,0.00032747717,0.0005729333,0.000013284951],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1559577,0.013412484,0.6605051,0.00076579984,0.0033043881,0.00085219456,0.0051568816,0.000013087554,0.14663677,0.00001899046,0.00016604153,0.013210578],"study_design_scores_gemma":[0.63302904,0.011936267,0.29245844,0.0006326541,0.0011311892,0.00013384997,0.005166612,0.00046898067,0.054393474,0.000020963966,0.00019328058,0.00043523608],"about_ca_topic_score_codex":0.0019510086,"about_ca_topic_score_gemma":0.0026820179,"teacher_disagreement_score":0.47707134,"about_ca_system_score_codex":0.0001381416,"about_ca_system_score_gemma":0.00038152045,"threshold_uncertainty_score":0.9999378},"labels":[],"label_agreement":null},{"id":"W4252496106","doi":"10.1182/blood.v96.1.188.013k12_188_194","title":"Morphological analysis of microparticle generation in heparin-induced thrombocytopenia","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services","funders":"","keywords":"Platelet; Microparticle; Population; Chemistry; Heparin; Biophysics; Platelet activation; Vesicle; Flow cytometry; Neonatal alloimmune thrombocytopenia; Endocytosis; Cell biology; Immunology; Molecular biology; Biology; Biochemistry; Membrane; Medicine; Receptor","score_opus":0.05309423063431226,"score_gpt":0.30387122631090424,"score_spread":0.25077699567659195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252496106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938369,0.00006363667,0.000005452281,0.00024537547,0.00003059238,0.0003419059,0.000009258388,0.000044642413,0.005422236],"genre_scores_gemma":[0.998611,0.000070852,0.000753934,0.00022663403,0.00006676381,0.000025652611,0.00007044221,0.000019432138,0.00015532704],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982204,0.000108553715,0.0006049022,0.0004497048,0.00024893723,0.0003674897],"domain_scores_gemma":[0.99912393,0.000038456776,0.00008396043,0.0005272716,0.00006754729,0.0001588347],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028145194,0.00019944635,0.00097185146,0.00031913092,0.000052594532,0.000020432042,0.00014415382,0.00018239008,0.0034298794],"category_scores_gemma":[0.00005013877,0.00017484372,0.00024517087,0.0015649105,0.00006776339,0.000110152556,0.000040389714,0.00020843623,0.00014907529],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005894022,0.0015687097,0.17582695,0.000010620167,0.00070737,0.000095817435,0.00022642633,0.000060594077,0.81944907,0.00009969638,0.000026410096,0.0018693887],"study_design_scores_gemma":[0.0024104107,0.0002802786,0.59541535,0.000012995689,0.0018516427,0.000040992047,0.000027190816,0.0011839294,0.39852455,0.000016833244,0.00008869288,0.00014713767],"about_ca_topic_score_codex":0.00056892453,"about_ca_topic_score_gemma":0.00040796027,"teacher_disagreement_score":0.4209245,"about_ca_system_score_codex":0.000050602408,"about_ca_system_score_gemma":0.000079726946,"threshold_uncertainty_score":0.9974811},"labels":[],"label_agreement":null},{"id":"W4252571225","doi":"10.1182/blood.v110.11.49.49","title":"Paraffin-Based 6-Gene Model Predicts Outcome of Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Internal medicine; Vincristine; Medicine; Prednisone; CHOP; Oncology; Lymphoma; Rituximab; Anthracycline; Cyclophosphamide; International Prognostic Index; Gastroenterology; Cancer; Chemotherapy; Breast cancer","score_opus":0.011909332328848167,"score_gpt":0.2339422522528658,"score_spread":0.22203291992401764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252571225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99692297,0.00021175553,0.00014456705,0.000031196716,0.000025420679,0.0006050939,0.00014780492,0.00007640186,0.0018348125],"genre_scores_gemma":[0.99772954,0.00001759231,0.0013610628,0.0002871603,0.00002829516,0.00004429052,0.00017763599,0.00004294829,0.00031148596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836135,0.00001681065,0.00042690727,0.00032762752,0.000444572,0.00042270464],"domain_scores_gemma":[0.9988737,0.00007443272,0.00017614076,0.0004609646,0.0001561432,0.00025860203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010859308,0.00026654382,0.0004582262,0.0001324789,0.000053311123,0.000008182238,0.000084108615,0.0001177749,0.000015456013],"category_scores_gemma":[0.000025336336,0.00018260034,0.00013513018,0.0001685549,0.000043942193,0.000039978695,0.000024075869,0.000040155697,0.000024253695],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060219434,0.071236834,0.9263298,0.00007880838,0.00018841348,0.00022807397,0.00007821627,0.000029281131,0.00051660906,0.000012813269,0.000055366672,0.0006436192],"study_design_scores_gemma":[0.1430062,0.0013976534,0.6589347,0.00008335494,0.0009476864,0.0000076118654,0.000011955844,0.0009243916,0.19441983,0.000002346584,0.00008399346,0.00018028758],"about_ca_topic_score_codex":0.00006595056,"about_ca_topic_score_gemma":0.00003594623,"teacher_disagreement_score":0.26739508,"about_ca_system_score_codex":0.00009436188,"about_ca_system_score_gemma":0.000108270695,"threshold_uncertainty_score":0.7446226},"labels":[],"label_agreement":null},{"id":"W4252862210","doi":"10.1182/blood-2019-124217","title":"Bendamustine and Rituximab As Induction Therapy in Both Transplant Eligible and Ineligible Patients with Mantle Cell Lymphoma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada; University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Bendamustine; Medicine; Rituximab; Mantle cell lymphoma; Internal medicine; Regimen; Oncology; Transplantation; Chemotherapy regimen; Maintenance therapy; Surgery; Cancer; Lymphoma; Chemotherapy","score_opus":0.004943166813335075,"score_gpt":0.20229945854946726,"score_spread":0.1973562917361322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252862210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99640447,0.0012410788,4.0026524e-7,0.0001208427,0.000033610722,0.0005503566,0.000013498382,0.000021884023,0.0016138862],"genre_scores_gemma":[0.9978777,0.0015292757,0.00017653267,0.00015156556,0.000023321252,0.000031376298,0.000048701426,0.000017982791,0.00014353394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992485,0.000013340541,0.00013697287,0.00026882233,0.00015547348,0.00017689283],"domain_scores_gemma":[0.9996874,0.000021048867,0.000040515704,0.00014244435,0.000025170415,0.000083456194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004294079,0.00014968979,0.00024711748,0.00010173289,0.00003012773,0.000019342866,0.00002316245,0.00006403597,0.000032318774],"category_scores_gemma":[0.0000017447614,0.00010160387,0.000018631627,0.000109423854,0.000024076686,0.00007956059,0.000010564028,0.00003883114,0.000021601605],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041471224,0.0062451023,0.98652184,0.00006956468,0.00005709958,0.000046069094,0.00034084666,4.4420275e-7,0.00083049823,0.000028763428,0.000027063006,0.0054180096],"study_design_scores_gemma":[0.07891661,0.001783999,0.89778715,0.00014451718,0.00010329088,0.00007411153,0.000053599437,0.0000061161754,0.020415237,0.00002724604,0.0005593827,0.0001287219],"about_ca_topic_score_codex":0.00041888587,"about_ca_topic_score_gemma":0.000025439671,"teacher_disagreement_score":0.08873466,"about_ca_system_score_codex":0.000025210766,"about_ca_system_score_gemma":0.000047203248,"threshold_uncertainty_score":0.41432858},"labels":[],"label_agreement":null},{"id":"W4253122809","doi":"10.1182/blood.v100.6.2216.h81802002216_2216_2224","title":"Aberrant regulation of superantigen responses during T-cell reconstitution and graft-versus-host disease in immunodeficient mice","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research; National Cancer Institute; Cancer Care Ontario","keywords":"Superantigen; Adoptive cell transfer; Immunology; Biology; T cell; Clonal deletion; Graft-versus-host disease; T-cell receptor; Severe combined immunodeficiency; Transplantation; Immune system; In vivo; Stem cell; Cell biology; Medicine; Internal medicine","score_opus":0.020716751892494983,"score_gpt":0.23318331493976702,"score_spread":0.21246656304727204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253122809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99656516,0.0017856511,0.000031608095,0.00013087624,0.000073724346,0.0003416597,0.000016326669,0.000023865432,0.0010311385],"genre_scores_gemma":[0.99887437,0.0005308013,0.0003299435,0.000007547077,0.000014474275,0.000009838286,0.000016625921,0.000010108229,0.00020630915],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999135,0.00005658439,0.0002991908,0.00019417357,0.00017529452,0.00013975662],"domain_scores_gemma":[0.9995815,0.00008322221,0.0000567187,0.00017063801,0.00003927925,0.000068642425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014898143,0.00009686917,0.00017194966,0.00016338624,0.000044491087,0.000007127594,0.000030013569,0.000051624393,0.00008170228],"category_scores_gemma":[0.00004951873,0.00009580105,0.00003827185,0.00015479134,0.00007059951,0.00007501379,0.000007934748,0.00006706892,0.000012678567],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014943324,0.0007100957,0.12723738,0.00075519,0.000025738043,0.00007188679,0.001903636,0.000021287055,0.86760736,0.00008777217,0.0000033811161,0.0000819327],"study_design_scores_gemma":[0.010808946,0.00010975222,0.73435014,0.0005498198,0.00025967494,0.00006495809,0.00019667992,0.00048048774,0.2530144,0.000007709575,0.000028676332,0.00012880868],"about_ca_topic_score_codex":0.000052816584,"about_ca_topic_score_gemma":0.000011706027,"teacher_disagreement_score":0.61459297,"about_ca_system_score_codex":0.000023176075,"about_ca_system_score_gemma":0.000029038029,"threshold_uncertainty_score":0.39066535},"labels":[],"label_agreement":null},{"id":"W4253348189","doi":"10.1182/blood-2019-126814","title":"Genetic Ancestry and Skeletal Toxicities Among Childhood Acute Lymphoblastic Leukemia Patients in the DFCI 05-001 Cohort","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Centre Hospitalier Universitaire Sainte-Justine; McMaster University; McMaster Children's Hospital","funders":"","keywords":"Medicine; Cumulative incidence; Proportional hazards model; Cohort; Ethnic group; Internal medicine; Incidence (geometry); Hazard ratio; Genetic genealogy; Demography; Oncology; Population; Confidence interval","score_opus":0.006058566957878855,"score_gpt":0.23090369553437506,"score_spread":0.22484512857649622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253348189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953857,0.00022095251,0.000007586391,0.000065763554,0.0001345337,0.0012306352,0.00003327639,0.000046883808,0.0028746903],"genre_scores_gemma":[0.99822456,0.00021259158,0.0001826839,0.0004637579,0.00018187516,0.00008874481,0.000060809623,0.000047264697,0.0005377341],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975662,0.000100778605,0.00038737862,0.0005070065,0.00081118144,0.0006274302],"domain_scores_gemma":[0.9988082,0.00027027508,0.00009653749,0.00055886025,0.000086659915,0.00017947555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022365968,0.00029133895,0.00043291398,0.00016664197,0.00008516942,0.00006571607,0.00031030414,0.00019003231,0.00010722013],"category_scores_gemma":[0.00014030325,0.00020407022,0.000072852774,0.0003350578,0.00027108396,0.00014103469,0.00016629843,0.0003729919,0.00013406073],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058683305,0.0006601645,0.996302,0.000105438696,0.00023261258,0.0002514602,0.00056446664,0.000010423614,0.00030649416,0.000022049351,0.0005676397,0.00091854937],"study_design_scores_gemma":[0.013816874,0.0007477765,0.9831141,0.0001629584,0.00032081164,0.0003778469,0.00022381748,0.00050130096,0.0003508438,0.0000484043,0.00011441729,0.00022084452],"about_ca_topic_score_codex":0.00029198834,"about_ca_topic_score_gemma":0.000037186015,"teacher_disagreement_score":0.01375819,"about_ca_system_score_codex":0.00033557753,"about_ca_system_score_gemma":0.00056672265,"threshold_uncertainty_score":0.83217424},"labels":[],"label_agreement":null},{"id":"W4253373098","doi":"10.1182/blood-2013-09-525865","title":"MYC fireworks","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"","field":"","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Fireworks; Medicine; Chemistry","score_opus":0.0069937504359527235,"score_gpt":0.21104828590765146,"score_spread":0.20405453547169874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253373098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92130566,0.00012281048,0.000095651994,0.00007324753,0.000077928446,0.000053899334,0.000005138273,0.00027387147,0.07799179],"genre_scores_gemma":[0.9981916,0.0000010591468,0.0007404266,0.00012692784,0.00021459359,0.0000059432514,0.0000042374472,0.000038367954,0.0006768247],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995084,0.000033436227,0.00006662658,0.000118049415,0.00011016774,0.00016334823],"domain_scores_gemma":[0.99959826,0.000036688267,0.000025210004,0.0002675983,0.000016886466,0.000055380777],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014938523,0.00005954439,0.000068927875,0.000024940884,0.000034802088,0.00001819542,0.00011322296,0.000044513603,0.00021289723],"category_scores_gemma":[0.00010613479,0.00005549361,0.000029755394,0.000100024336,0.000019916562,0.00003827867,0.000029137726,0.00007469446,0.02084529],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000864041,0.0062461873,0.33126262,0.00010596516,0.00055091525,0.00008518688,0.0019848282,0.0001210568,0.2096692,0.050360236,0.33873826,0.060789134],"study_design_scores_gemma":[0.007059121,0.00024149595,0.17212152,0.000081962535,0.00029788382,0.00006920991,0.000030171346,0.0012928226,0.07790693,0.0067840964,0.7333628,0.0007519656],"about_ca_topic_score_codex":0.000008783693,"about_ca_topic_score_gemma":0.000009550973,"teacher_disagreement_score":0.39462453,"about_ca_system_score_codex":0.000004366295,"about_ca_system_score_gemma":0.000006669631,"threshold_uncertainty_score":0.9799171},"labels":[],"label_agreement":null},{"id":"W4253587619","doi":"10.1182/blood.v114.22.3851.3851","title":"A Phase I Clinical Trial Testing the Combination of Bortezomib and Tipifarnib in Relapsed/Refractory Multiple Myeloma.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Bortezomib; Medicine; Proteasome inhibitor; Multiple myeloma; Internal medicine; Pharmacology; Refractory (planetary science); Lenalidomide; Oncology; Biology","score_opus":0.0980473417023826,"score_gpt":0.3940497644056899,"score_spread":0.2960024227033073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253587619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971488,0.00032240094,0.0000045165543,0.00031262432,0.000047418795,0.00097210787,0.000007290561,0.000022961785,0.0011618697],"genre_scores_gemma":[0.99907917,0.000051324183,0.0005804757,0.00007475232,0.00011076269,0.000022566292,0.000021010095,0.0000076058213,0.00005231861],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869204,0.00016197824,0.00046232803,0.00021485462,0.00026090821,0.00020789405],"domain_scores_gemma":[0.99851567,0.00090016186,0.00013267795,0.0002434807,0.00008480683,0.00012321059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006953325,0.00010504256,0.00029770637,0.00009463276,0.000054993558,0.000010835313,0.00006777535,0.00009012511,0.000009801663],"category_scores_gemma":[0.0034727415,0.00006999552,0.00006491074,0.0002008475,0.000093565584,0.00004452783,0.000023516632,0.00028138465,0.0000049770283],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029421804,0.037396837,0.5073126,0.00004821188,0.00018011441,0.0003018124,0.00029508193,5.182943e-7,0.01114439,0.00009298013,0.00011037157,0.41369528],"study_design_scores_gemma":[0.37879324,0.009216456,0.60925275,0.000080948565,0.00009696203,0.00002506696,0.0000438851,0.00094475405,0.0012072925,0.000109209046,0.00016712061,0.000062317726],"about_ca_topic_score_codex":0.000056405708,"about_ca_topic_score_gemma":0.000016843333,"teacher_disagreement_score":0.41363296,"about_ca_system_score_codex":0.000017606037,"about_ca_system_score_gemma":0.00010817252,"threshold_uncertainty_score":0.41574466},"labels":[],"label_agreement":null},{"id":"W4253607854","doi":"10.1182/blood.v116.21.3055.3055","title":"Phase I-II Trial of Oral Cyclophosphamide, Prednisone and Lenalidomide (Revlimid®) (CPR) for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Southlake Regional Health Center; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Lenalidomide; Medicine; Internal medicine; Regimen; Thalidomide; Gastroenterology; Cyclophosphamide; Prednisone; Multiple myeloma; Dexamethasone; Bortezomib; Surgery; Chemotherapy","score_opus":0.02025790824414703,"score_gpt":0.29203620686852483,"score_spread":0.2717782986243778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253607854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995658,0.000682666,0.000009145874,0.00008760235,0.000072992974,0.003204707,0.00022675094,0.000015014196,0.000043160697],"genre_scores_gemma":[0.9967702,0.00050556834,0.0021013436,0.000009170239,0.00006137231,0.00024629376,0.00009287829,0.00002669273,0.00018648038],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99884284,0.000033153992,0.00031766258,0.00026926183,0.00028734977,0.0002497222],"domain_scores_gemma":[0.9986442,0.00045204788,0.00018285468,0.00037023734,0.0001704767,0.00018019971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001351644,0.00019646338,0.0004579285,0.00006999521,0.00012984857,0.000008161756,0.00005843705,0.00008864251,0.000017736558],"category_scores_gemma":[0.00025933745,0.000106137515,0.00008583133,0.00008326733,0.0002483961,0.0000631581,0.000023726523,0.00009291355,4.2213287e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36478195,0.06619918,0.39223465,0.00027980856,0.0024367608,0.000032491327,0.001114137,5.4107403e-7,0.018335931,0.000026423848,0.00007857947,0.15447956],"study_design_scores_gemma":[0.69013,0.057268623,0.20754941,0.000053636362,0.0008837602,0.000007216835,0.00004726085,0.00010563769,0.041669473,0.000015957869,0.0021517144,0.00011730159],"about_ca_topic_score_codex":0.00019366089,"about_ca_topic_score_gemma":0.00014010668,"teacher_disagreement_score":0.32534808,"about_ca_system_score_codex":0.000015497682,"about_ca_system_score_gemma":0.00008742043,"threshold_uncertainty_score":0.43281624},"labels":[],"label_agreement":null},{"id":"W4253648635","doi":"10.1182/blood.v104.11.641.641","title":"CHIR258, a Novel Multi-Targeted Tyrosine Kinase Inhibitor, for the Treatment of t(4;14) Multiple Myeloma.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Fibroblast growth factor receptor 3; Tyrosine kinase; Cancer research; Biology; Tyrosine-kinase inhibitor; Receptor tyrosine kinase; Chromosomal translocation; Fibroblast growth factor receptor; Multiple myeloma; Fibroblast growth factor; Cell culture; Molecular biology; Receptor; Kinase; Signal transduction; Cell biology; Immunology; Cancer; Biochemistry; Genetics","score_opus":0.04047147652059239,"score_gpt":0.3035838897335806,"score_spread":0.26311241321298817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253648635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98965263,0.004313178,0.0015968253,0.00068927475,0.00014468329,0.0030512174,0.0003999151,0.00007859801,0.000073682684],"genre_scores_gemma":[0.9791322,0.00033454507,0.018890016,0.000056308774,0.00024162621,0.00054918503,0.00018283006,0.0000475917,0.00056572753],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99847794,0.000016164422,0.00034506485,0.00035132008,0.00033193175,0.00047760233],"domain_scores_gemma":[0.99868125,0.00023403703,0.00010227411,0.0005385451,0.00020150229,0.00024238358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009707617,0.00027202713,0.00041753938,0.00011467385,0.0001705783,0.0000164455,0.00011380021,0.00009931123,0.000026330492],"category_scores_gemma":[0.00028654587,0.00016171033,0.00029932827,0.00022732027,0.0001302867,0.000050948376,0.00002671807,0.00008238737,0.000023992143],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005266793,0.08822895,0.12224101,0.00042614347,0.004230313,0.00033244182,0.0024432053,0.000152816,0.7238896,0.00024961843,0.00017293937,0.052366186],"study_design_scores_gemma":[0.11613083,0.0045528295,0.17594443,0.00012584962,0.0006979649,0.0000565852,0.00012205142,0.00072366185,0.69633573,0.000019715062,0.0050915848,0.00019876462],"about_ca_topic_score_codex":0.00045820937,"about_ca_topic_score_gemma":0.00024945577,"teacher_disagreement_score":0.110864036,"about_ca_system_score_codex":0.00012615444,"about_ca_system_score_gemma":0.00019127282,"threshold_uncertainty_score":0.6594356},"labels":[],"label_agreement":null},{"id":"W4254091309","doi":"10.1182/blood.v110.11.439.439","title":"A Randomized Phase 3 Study of Tipifarnib Compared to Best Supportive Care (Including Hydroxyurea) in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML) in Patients 70 Years or Older.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Clinical endpoint; Neutropenia; Myeloid leukemia; Cytarabine; Chemotherapy; Randomized controlled trial; Surgery; Oncology; Confidence interval","score_opus":0.033266856408351496,"score_gpt":0.3524969342320459,"score_spread":0.31923007782369445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254091309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915582,0.00015179777,0.000011899849,0.000056147503,0.00004654851,0.007734622,0.00006488675,0.000017388318,0.00035850788],"genre_scores_gemma":[0.9988883,0.000107214066,0.00024671535,0.00007560404,0.000055979042,0.00038038963,0.00012056952,0.00004130624,0.00008390138],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99662554,0.0004017553,0.0010856916,0.00045235959,0.0008675431,0.0005671064],"domain_scores_gemma":[0.99771106,0.0009934488,0.00028126582,0.00059670646,0.00022574437,0.00019179568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094262697,0.0003107467,0.0014592651,0.0006363652,0.000047101777,0.000012734797,0.0003132418,0.0001202073,0.000043361153],"category_scores_gemma":[0.00040730636,0.00020298648,0.00018828458,0.0010479235,0.00012356738,0.00006396524,0.000087966975,0.00026170735,0.000010981917],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27286455,0.055855315,0.36780575,0.0001817731,0.0016415239,0.0040765475,0.279965,0.000057468707,0.0031774684,0.000003020738,0.00019313075,0.014178429],"study_design_scores_gemma":[0.81163114,0.010999831,0.13454437,0.00024381356,0.00090209325,0.000009858822,0.032214146,0.0000425345,0.009136828,0.0000017505657,0.000078230696,0.00019539852],"about_ca_topic_score_codex":0.0028842138,"about_ca_topic_score_gemma":0.002271343,"teacher_disagreement_score":0.53876656,"about_ca_system_score_codex":0.0009370041,"about_ca_system_score_gemma":0.0004962743,"threshold_uncertainty_score":0.82775486},"labels":[],"label_agreement":null},{"id":"W4254177981","doi":"10.1182/blood.v96.4.1215.h8001215_1215_1222","title":"A ligand-receptor signaling threshold model of stem cell differentiation control: a biologically conserved mechanism applicable to hematopoiesis","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Stem cell; Biology; Cell biology; Haematopoiesis; Stem cell factor; Receptor; Cytokine receptor; Cellular differentiation; Hematopoietic stem cell; Signal transduction; Biochemistry","score_opus":0.022822231727038473,"score_gpt":0.2298372486206451,"score_spread":0.20701501689360663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254177981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98708683,0.000073485215,0.01051772,0.00024138672,0.00002875745,0.0005905721,0.000090644826,0.00009353342,0.0012770831],"genre_scores_gemma":[0.99657255,0.000017286793,0.0020696355,0.00046550462,0.00006269617,0.00010111005,0.000023474959,0.000022432412,0.0006653241],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988846,0.000021578382,0.0004072141,0.0002792635,0.00018464899,0.00022269278],"domain_scores_gemma":[0.99931896,0.00006920387,0.00010408874,0.0002465361,0.000119904355,0.00014130784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001272106,0.00016690679,0.00043476114,0.0000824727,0.00007238182,0.00001957667,0.000094763695,0.000108940636,0.0006654276],"category_scores_gemma":[0.000008371903,0.00013332262,0.00017375978,0.0001400565,0.000019321309,0.000039730872,0.000018914561,0.00012547414,0.000077921555],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024155452,0.0008987631,0.00030137214,0.00006358123,0.00009021896,0.000001997365,0.00020129242,0.0008279893,0.99647146,0.0006319677,0.00011783982,0.00015196452],"study_design_scores_gemma":[0.0031298138,0.0005291233,0.00005287376,0.00013728115,0.00026343678,0.000009240468,0.00008810907,0.010002506,0.98516583,0.00036856713,0.00011036761,0.00014282379],"about_ca_topic_score_codex":0.000025684663,"about_ca_topic_score_gemma":0.0000023093764,"teacher_disagreement_score":0.011305602,"about_ca_system_score_codex":0.000016669755,"about_ca_system_score_gemma":0.000050321258,"threshold_uncertainty_score":0.72859657},"labels":[],"label_agreement":null},{"id":"W4254559332","doi":"10.1182/blood.v112.11.268.268","title":"Confirmation of the Efficacy and Safety of Lenalidomide Oral Monotherapy in Patients with Relapsed or Refractory Diffuse Large-B-Cell Lymphoma: Results of An International Study (NHL-003)","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Lenalidomide; Medicine; Internal medicine; Diffuse large B-cell lymphoma; Progressive disease; Oncology; Refractory (planetary science); Lymphoma; Surgery; Phases of clinical research; Febrile neutropenia; Chemotherapy regimen; Gastroenterology; Neutropenia; Chemotherapy; Multiple myeloma","score_opus":0.01276798037817791,"score_gpt":0.24683295234209737,"score_spread":0.23406497196391945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254559332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99887085,0.000039713683,0.0000010020416,0.00003231414,0.000033180022,0.0007720966,0.00008070774,0.000005667568,0.00016448335],"genre_scores_gemma":[0.99963343,0.00007659053,0.00015171086,0.000024447641,0.000009571737,0.000012759542,0.000045420013,0.000010603039,0.000035472836],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891305,0.00009080006,0.0004407648,0.00015732516,0.0003146124,0.00008342236],"domain_scores_gemma":[0.999139,0.0001107423,0.0003151136,0.0002792233,0.0001196936,0.000036213285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013732641,0.00010432874,0.00028742192,0.00007587866,0.00002606891,0.0000022712552,0.00007779237,0.000041443236,0.0000070067904],"category_scores_gemma":[0.00007048329,0.000058069632,0.000030818283,0.00012109674,0.00006257802,0.00008045699,0.000022498081,0.00003137713,2.7310836e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0149980765,0.08410133,0.896644,0.00002165014,0.00019733679,0.000014143951,0.0028617838,0.0000035432329,0.0002499267,0.000007774949,0.000013592085,0.00088687334],"study_design_scores_gemma":[0.24996665,0.002257429,0.73958296,0.000080329606,0.00009678154,0.0000035300864,0.00016807168,0.000012786508,0.007744202,7.9045424e-7,0.000044688062,0.000041798634],"about_ca_topic_score_codex":0.00023359095,"about_ca_topic_score_gemma":0.00008759987,"teacher_disagreement_score":0.23496857,"about_ca_system_score_codex":0.00003478528,"about_ca_system_score_gemma":0.00009547984,"threshold_uncertainty_score":0.23680109},"labels":[],"label_agreement":null},{"id":"W4254922035","doi":"10.1182/blood.v104.11.1023.1023","title":"Identification and Functional Characterization of a Novel 27bp Deletion in the Macroglycopeptide-Coding Region of the GPIbα Gene Resulting in Platelet-Type Von Willebrand Disease.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Von Willebrand disease; Platelet; Von Willebrand factor; Ristocetin; Platelet membrane glycoprotein; Bleeding time; Platelet disorder; Immunology; Molecular biology; Chemistry; Internal medicine; Medicine; Biology; Platelet aggregation","score_opus":0.01880371306141006,"score_gpt":0.23163882538584551,"score_spread":0.21283511232443544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254922035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987302,0.0001249738,0.00017467256,0.00048510224,0.00004196643,0.00040480975,0.0000116183355,0.0000049086234,0.000021791735],"genre_scores_gemma":[0.9995744,0.00015979963,0.00004360194,0.000052493022,0.000020087402,0.000013128019,0.00011190877,0.000007065377,0.000017498898],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9993091,0.00002725594,0.00027238092,0.00014121518,0.00016361992,0.00008638139],"domain_scores_gemma":[0.99960953,0.000023803796,0.00016172389,0.00013910086,0.000047368318,0.000018469906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016021356,0.00007275954,0.00013058365,0.00008096321,0.000044103857,0.000007765526,0.000038109923,0.00004208781,0.0000013755731],"category_scores_gemma":[0.00008306578,0.00004807845,0.000028947119,0.00028250922,0.00003776656,0.00008508441,0.0000137957495,0.000070686125,4.5877553e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006023748,0.0013010224,0.19601536,0.00011195732,0.00004075001,0.000043111224,0.00091418374,0.000113611735,0.79955876,0.00024031645,0.000002321407,0.0010562225],"study_design_scores_gemma":[0.0066113523,0.000053899013,0.94754845,0.00028745027,0.00007024113,0.00008296446,0.00007352599,0.00019864354,0.044903804,0.000114334005,0.000008682432,0.00004664005],"about_ca_topic_score_codex":0.000051616986,"about_ca_topic_score_gemma":0.000030051235,"teacher_disagreement_score":0.75465494,"about_ca_system_score_codex":0.000022278302,"about_ca_system_score_gemma":0.000042374606,"threshold_uncertainty_score":0.19605824},"labels":[],"label_agreement":null},{"id":"W4255006273","doi":"10.1182/blood.v122.21.5315.5315","title":"Outcome Of t(4;14) In Multiple Myeloma - Princess Margaret Cancer Centre Experience Over The Last 10 Years","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lenalidomide; Melphalan; Bortezomib; Multiple myeloma; Thalidomide; Internal medicine; Autologous stem-cell transplantation; Oncology; Chemotherapy; Surgery; Chemotherapy regimen; Cancer","score_opus":0.02963862632873042,"score_gpt":0.3127204609648486,"score_spread":0.2830818346361182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255006273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980167,0.00028226763,9.22669e-7,0.00024751615,0.0000498825,0.00067272456,0.000022215718,0.000017598151,0.00069014117],"genre_scores_gemma":[0.99823606,0.000055970522,0.00015952658,0.00007976354,0.000046105066,0.0001625607,0.00001000033,0.00001600339,0.0012340036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988049,0.0000436436,0.00024152297,0.0002110127,0.0003646472,0.00033426133],"domain_scores_gemma":[0.9992989,0.0000984954,0.000060562346,0.00033876408,0.00007322009,0.00013011195],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00006830566,0.000118535856,0.00022693822,0.000067424386,0.00003321983,0.000016351105,0.00016433412,0.00005443753,0.0021692805],"category_scores_gemma":[0.0001704499,0.000075458265,0.000062470805,0.00019580997,0.00011336048,0.000087758286,0.00009126312,0.0001348032,0.0001125618],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049830225,0.0004926047,0.9921436,0.000040835817,0.00006328491,0.000059107086,0.0008243996,0.0000015569575,0.0014498322,0.000009875477,0.000249425,0.00461567],"study_design_scores_gemma":[0.004838915,0.000057743273,0.98788714,0.00007183616,0.000022141368,0.000005345318,0.0003100673,0.000119577635,0.0052649495,0.000006734688,0.0013442663,0.00007128765],"about_ca_topic_score_codex":0.0032309708,"about_ca_topic_score_gemma":0.001421743,"teacher_disagreement_score":0.0047890847,"about_ca_system_score_codex":0.000041829935,"about_ca_system_score_gemma":0.000055434124,"threshold_uncertainty_score":0.9987429},"labels":[],"label_agreement":null},{"id":"W4255247183","doi":"10.1182/blood.v124.21.lba-1.lba-1","title":"Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Medicine; Venography; Venous thrombosis; Thrombosis; Incidence (geometry); Surgery; Risk factor; Internal medicine","score_opus":0.029507095677442967,"score_gpt":0.2917168301873745,"score_spread":0.2622097345099315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255247183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971065,0.00040947495,0.0009466261,0.00013680792,0.00014082913,0.000397779,0.000022147951,0.000059329253,0.0007804988],"genre_scores_gemma":[0.99704504,0.000059227823,0.0020103487,0.00007873773,0.0002446541,0.000011850203,0.000036860376,0.00002503665,0.00048822036],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99924254,0.000021125003,0.0002525453,0.00017171148,0.00013850938,0.00017356555],"domain_scores_gemma":[0.9994023,0.00008721422,0.0001238489,0.00022368433,0.000089680296,0.00007327231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000100703444,0.000104649305,0.0003019788,0.000060119128,0.00005271107,0.000007708002,0.000047949936,0.00006753041,0.00007480792],"category_scores_gemma":[0.000115894705,0.00009640299,0.00017623886,0.00008240967,0.000036807305,0.000051708477,0.00001413411,0.000036683785,0.000013349191],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003840115,0.008788904,0.32933506,0.0019099681,0.0012783696,0.000008765692,0.002909535,0.000015613652,0.4976509,0.0073844893,0.0025510993,0.14778328],"study_design_scores_gemma":[0.005049869,0.0015331666,0.67875475,0.0002468129,0.00062144466,0.000021157352,0.00004575133,0.00026483324,0.30818537,0.001155622,0.0039462536,0.00017495234],"about_ca_topic_score_codex":0.000034705867,"about_ca_topic_score_gemma":0.000011250571,"teacher_disagreement_score":0.34941968,"about_ca_system_score_codex":0.0000078692065,"about_ca_system_score_gemma":0.000032210228,"threshold_uncertainty_score":0.39312},"labels":[],"label_agreement":null},{"id":"W4255531630","doi":"10.1182/blood-2016-09-729434","title":"von Willebrand disease type 2B","year":2017,"lang":"de","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Von Willebrand disease; Medicine; Von Willebrand factor; Internal medicine; Platelet","score_opus":0.014696358482094976,"score_gpt":0.2673714186304004,"score_spread":0.25267506014830543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255531630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93571377,0.051462736,9.608488e-7,0.0014137382,0.0012466852,0.00032868795,0.000074801384,0.000032722084,0.00972592],"genre_scores_gemma":[0.9883975,0.005139948,0.00003420575,0.00022005191,0.00063683704,0.0000077258055,0.000099516576,0.00003401122,0.005430196],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893874,0.000019476594,0.00016088248,0.00031733877,0.00021711798,0.00034641524],"domain_scores_gemma":[0.99846214,0.00002121023,0.00012924604,0.00092192285,0.00005510195,0.00041039582],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000059152917,0.00021569137,0.0003408479,0.00003931946,0.00043180294,0.00011548157,0.00019310132,0.00009768183,0.0003893756],"category_scores_gemma":[0.00023993058,0.00017967435,0.000111152425,0.000035146637,0.000112764996,0.00010922582,0.00008140093,0.00013082872,0.0027980038],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091841404,0.005503086,0.9564456,0.00027177233,0.002748699,0.013768862,0.00022265702,5.02061e-7,0.00016730574,0.00023189753,0.007903845,0.011817397],"study_design_scores_gemma":[0.03657493,0.0009833104,0.7951297,0.000838791,0.012348121,0.000032319444,0.000040330462,0.00008723619,0.0011536817,0.0012885577,0.15089835,0.00062462525],"about_ca_topic_score_codex":0.000068847105,"about_ca_topic_score_gemma":0.00001096243,"teacher_disagreement_score":0.16131581,"about_ca_system_score_codex":0.000013630185,"about_ca_system_score_gemma":0.00014548628,"threshold_uncertainty_score":0.99797845},"labels":[],"label_agreement":null},{"id":"W4256036818","doi":"10.1182/blood-2019-130627","title":"The Neurotransmitter Receptor Gabbr1 Regulates Proliferation and Function of Hematopoietic Stem and Progenitor Cells","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Progenitor cell; Biology; Haematopoiesis; Bone marrow; Cell biology; Stem cell; Hematopoietic stem cell; Stromal cell; Immunology; Cancer research","score_opus":0.004902276731131629,"score_gpt":0.20369756075504966,"score_spread":0.19879528402391802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256036818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99715114,0.0016465188,0.00037091604,0.00012038497,0.000098732344,0.0005410273,0.0000045131874,0.0000060815933,0.000060687787],"genre_scores_gemma":[0.9987868,0.00034867087,0.00008664344,0.000037098933,0.000065272594,0.00003697794,0.000009198663,0.000018077968,0.0006112719],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99932456,0.00006073589,0.00012852829,0.00022612569,0.00012472662,0.00013534016],"domain_scores_gemma":[0.9996222,0.000011482239,0.000046548987,0.00021193232,0.00006678658,0.000041049472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001308373,0.00008617032,0.00008003748,0.00001974235,0.00005863231,0.000031637326,0.0000596322,0.0000972965,0.0000072873618],"category_scores_gemma":[0.000006737082,0.00006605883,0.000029800503,0.000046421806,0.000051537125,0.0000035183814,0.00004761451,0.00006901795,0.0000045185757],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000102983155,0.000033098408,0.00025870907,0.00006529893,0.000047306738,2.907799e-7,0.000034387023,0.0000033705514,0.99765325,0.000057800367,0.00008377659,0.0016597455],"study_design_scores_gemma":[0.0007654498,0.00048490346,0.00036137283,0.00001560263,0.000030690306,0.000013380017,0.00003673456,0.000046798097,0.99457914,0.00003484544,0.0035575563,0.00007355042],"about_ca_topic_score_codex":0.0000015594269,"about_ca_topic_score_gemma":0.0000021391008,"teacher_disagreement_score":0.00347378,"about_ca_system_score_codex":0.0000024996464,"about_ca_system_score_gemma":0.000032478772,"threshold_uncertainty_score":0.2693801},"labels":[],"label_agreement":null},{"id":"W4256185211","doi":"10.1182/blood.v112.11.3328.3328","title":"Outcome of Patients with IgD and IgM Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplants: A Retrospective CIBMTR Study.","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Melphalan; Immunoglobulin D; Medicine; Hematopoietic stem cell transplantation; Multiple myeloma; Internal medicine; Transplantation; Gastroenterology; Median follow-up; Regimen; Surgery; Chemotherapy; Oncology; Immunology; Antibody; B cell","score_opus":0.019329556537412567,"score_gpt":0.24809924023309732,"score_spread":0.22876968369568476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256185211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978002,0.00018711241,0.000032212607,0.000018753592,0.000021290047,0.0013246351,0.000078271194,0.00005954325,0.00047799034],"genre_scores_gemma":[0.9990718,0.00003935563,0.0005232586,0.000013103085,0.000013988611,0.000046759676,0.000024598947,0.000034075558,0.0002330801],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982692,0.000068794136,0.00034239166,0.0004011489,0.00055363175,0.00036480968],"domain_scores_gemma":[0.99903506,0.00015854393,0.00011295398,0.00033753936,0.00013330605,0.00022260948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007839954,0.00023421178,0.00056699006,0.00013710881,0.00014157775,0.0000081543185,0.00008093401,0.00007252944,0.000020768548],"category_scores_gemma":[0.000036028883,0.0001674701,0.00006538549,0.00019253985,0.00013457901,0.00007413773,0.000037844795,0.00017896325,0.000009937601],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007505248,0.006190298,0.9889666,0.0002802475,0.00041443674,0.000858974,0.0022086592,6.899607e-7,0.0001491033,0.00000408372,0.000005406149,0.00017102173],"study_design_scores_gemma":[0.031917177,0.0041156,0.959414,0.00009828463,0.00030159607,0.00013052303,0.00058259163,0.00002039191,0.0032662381,0.000004865806,0.0000025698087,0.0001461634],"about_ca_topic_score_codex":0.00010140468,"about_ca_topic_score_gemma":0.00014893635,"teacher_disagreement_score":0.031166654,"about_ca_system_score_codex":0.000050713832,"about_ca_system_score_gemma":0.00008415642,"threshold_uncertainty_score":0.68292326},"labels":[],"label_agreement":null},{"id":"W4256191981","doi":"10.1182/blood.v116.21.3437.3437","title":"Comparison of Adherence Between Nilotinib and Dasatinib as Second-Line Therapies In Chronic Myeloid Leukemia.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Nilotinib; Dasatinib; Medicine; Myeloid leukemia; Imatinib; Internal medicine; Tyrosine-kinase inhibitor; Medical prescription; Imatinib mesylate; Tyrosine kinase; Oncology; Pharmacology; Cancer","score_opus":0.03324211498638943,"score_gpt":0.3303353564827807,"score_spread":0.29709324149639127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256191981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99431217,0.0019275679,0.0000027223691,0.000106867636,0.00008147939,0.00053399184,0.000028041546,0.000051396626,0.0029557373],"genre_scores_gemma":[0.99789846,0.00009828892,0.0009718572,0.000045946796,0.0002589808,0.000034497967,0.00005956375,0.0000340013,0.00059839175],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998428,0.000041831776,0.0005559739,0.00037710444,0.00026563104,0.00033148305],"domain_scores_gemma":[0.9988796,0.00022714646,0.00021206327,0.0004745767,0.000058116613,0.00014851388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022250313,0.0002447589,0.00072334043,0.00013216725,0.000041844578,0.00001298179,0.0001485853,0.00020602532,0.0008402066],"category_scores_gemma":[0.00011816581,0.00021277656,0.00006500384,0.00019962444,0.00020248673,0.000080510064,0.000079285805,0.000589132,0.000047876994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007886101,0.00043111123,0.82818997,0.0002672571,0.00023361553,0.000025444913,0.0015497312,0.0000016000929,0.15205453,0.00012911117,0.0000709354,0.016967801],"study_design_scores_gemma":[0.019337073,0.002321548,0.66421235,0.00029329504,0.00030343977,0.000073205614,0.0002839315,0.00010503754,0.31032455,0.00022818206,0.0022456578,0.00027173734],"about_ca_topic_score_codex":0.0004236777,"about_ca_topic_score_gemma":0.0011509792,"teacher_disagreement_score":0.16397767,"about_ca_system_score_codex":0.00023583036,"about_ca_system_score_gemma":0.0010329012,"threshold_uncertainty_score":0.9199673},"labels":[],"label_agreement":null},{"id":"W4256240343","doi":"10.1182/blood.v118.21.3612.3612","title":"High Dose (HD-AraC) Vs Standard Dose Cytosine Arabinoside (SD-AraC) During Induction and IL-2 Vs Observation After Consolidation/Autologous Stem Cell Transplantation in Patients with Acute Myelogenous Leukemia (AML): Final Report of the AML-12 Trial of EORTC and GIMEMA Leukemia Groups on the Value of Low Dose IL-2 Maintenance,","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Randomization; Etoposide; Transplantation; Daunorubicin; Leukemia; Internal medicine; Hazard ratio; Cytarabine; Surgery; Gastroenterology; Busulfan; Minimal residual disease; Chemotherapy; Hematopoietic stem cell transplantation; Randomized controlled trial; Confidence interval","score_opus":0.016753933631717365,"score_gpt":0.22298008808980913,"score_spread":0.20622615445809175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256240343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965279,0.000032669923,0.000048640628,0.00014410297,0.00012881533,0.0027426635,0.00024979215,0.000025015515,0.00010038247],"genre_scores_gemma":[0.9986015,0.00022658288,0.0006428922,0.000057845056,0.00007043506,0.00014440915,0.000107856824,0.000048366514,0.00010013485],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99655646,0.00032454875,0.0012191307,0.00056465244,0.0009185775,0.00041661164],"domain_scores_gemma":[0.99748796,0.00020109906,0.0010318306,0.0007074122,0.00046313985,0.00010856128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086633704,0.00036921934,0.00081174844,0.0002935545,0.00013164608,0.000019303889,0.0002038917,0.00028022897,0.000015009836],"category_scores_gemma":[0.00011223989,0.00023497175,0.00010242829,0.0004963136,0.0005320023,0.00028714124,0.00008196971,0.00057527266,8.348307e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48514375,0.0022574253,0.43651643,0.0022564963,0.0008549516,0.00096014375,0.008470696,0.0001823781,0.060663912,0.00041820374,0.0000461657,0.0022294323],"study_design_scores_gemma":[0.057939943,0.0031268394,0.7761238,0.0005814245,0.00053272146,0.0003149367,0.00016700344,0.000045386565,0.16089404,0.000082497165,0.0000035468315,0.00018784727],"about_ca_topic_score_codex":0.0005461615,"about_ca_topic_score_gemma":0.00011203596,"teacher_disagreement_score":0.4272038,"about_ca_system_score_codex":0.0004780245,"about_ca_system_score_gemma":0.00088997546,"threshold_uncertainty_score":0.958187},"labels":[],"label_agreement":null},{"id":"W4256282437","doi":"10.1182/blood.v112.11.5245.5245","title":"Enhancment of SCA1 Positive Hematopoietic Progenitors in Polycythemic Mice Inhibits Leukemogenesis","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Women's College Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Haematopoiesis; Biology; Progenitor cell; Erythropoietin; Cancer research; Immunology; Cell culture; Leukemia; Molecular biology; Stem cell; Cell biology; Endocrinology; Genetics","score_opus":0.013014085090796634,"score_gpt":0.2402509545131229,"score_spread":0.22723686942232627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256282437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99631107,0.001415832,0.0000046701625,0.00024936863,0.000045879664,0.00075594586,0.00001684392,0.000023815119,0.001176598],"genre_scores_gemma":[0.9983354,0.00028306062,0.0008014319,0.00011408689,0.00007291211,0.00015977788,0.00001997728,0.000024441968,0.00018891384],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987377,0.000043559754,0.0003755119,0.00029936957,0.0002866159,0.00025724413],"domain_scores_gemma":[0.99940705,0.00007664737,0.00010447775,0.00020183787,0.00009000125,0.000119977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007020273,0.00020025125,0.00043804076,0.00015358187,0.000050686303,0.000003382858,0.000053408403,0.0000819537,0.000056906494],"category_scores_gemma":[0.00003540727,0.00016648142,0.000119480625,0.00026257092,0.00007874698,0.000039975228,0.000034797802,0.00008964308,0.00003982918],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027627827,0.0071520363,0.77051914,0.00017910526,0.00045292024,0.00065268326,0.0033419381,0.0000024189767,0.21658368,0.00013221486,0.00012682355,0.0005807922],"study_design_scores_gemma":[0.0044225133,0.0005234773,0.113313064,0.0002908306,0.00018468797,0.0006173748,0.00011196536,0.0000022684671,0.88037694,0.0000146948005,0.000023585493,0.000118627504],"about_ca_topic_score_codex":0.00009007603,"about_ca_topic_score_gemma":0.000023329414,"teacher_disagreement_score":0.6637932,"about_ca_system_score_codex":0.00009482166,"about_ca_system_score_gemma":0.00019324839,"threshold_uncertainty_score":0.6788915},"labels":[],"label_agreement":null},{"id":"W4280543391","doi":"10.1182/blood.2022016192","title":"NOX2: is the best defense a good offense?","year":2022,"lang":"en","type":"letter","venue":"Blood","topic":"High Altitude and Hypoxia","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Biology; Immunology","score_opus":0.012613804767999063,"score_gpt":0.2250112425093994,"score_spread":0.21239743774140035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280543391","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13466631,0.01767079,0.000022551116,0.7824559,0.001697158,0.001396927,0.0014643072,0.00008710794,0.06053892],"genre_scores_gemma":[0.01795397,0.0006814408,0.00010816562,0.9399436,0.0072335433,0.00019592047,0.0017190423,0.00013248151,0.032031823],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99841,0.00011753937,0.00021395565,0.0005499747,0.00030017085,0.00040837165],"domain_scores_gemma":[0.99876267,0.00002566975,0.00012013895,0.0009963505,0.000049690196,0.000045510867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011848109,0.0003087097,0.00023325422,0.000039968767,0.00023902894,0.00005194871,0.0006203606,0.0005615823,0.0005719243],"category_scores_gemma":[0.00003077992,0.00023872801,0.00029465015,0.000085222724,0.000084559135,0.0000011579684,0.00035710158,0.000938162,0.00022277734],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012110346,0.00012274685,0.00022727325,0.000036606452,0.00037142826,0.0002399116,0.000054280034,3.5627795e-7,0.006533507,0.000017076976,0.99232274,0.00006197642],"study_design_scores_gemma":[0.0005642692,0.00034679793,0.00003621543,0.000009550548,0.00032843938,0.00017247419,0.000024565683,2.3483004e-7,0.0086356215,0.000021659751,0.9895402,0.00031997287],"about_ca_topic_score_codex":0.000048550257,"about_ca_topic_score_gemma":0.000025324347,"teacher_disagreement_score":0.15748768,"about_ca_system_score_codex":0.000005804298,"about_ca_system_score_gemma":0.0001373887,"threshold_uncertainty_score":0.97350454},"labels":[],"label_agreement":null},{"id":"W4281385697","doi":"10.1182/blood.2021015014","title":"Enduring undetectable MRD and updated outcomes in relapsed/refractory CLL after fixed-duration venetoclax-rituximab","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; University of Calgary","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center; National Institutes of Health; Servier; BeiGene; Adaptive Biotechnologies; TG Therapeutics; Incyte; F. Hoffmann-La Roche; Amsterdam University Medical Centers; Gilead Sciences; Universiteit van Amsterdam; Leukemia and Lymphoma Society; GlaxoSmithKline; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb; Amgen; Breast Cancer Research Foundation; Celgene; Pharmacyclics; Genentech; California Institute for Regenerative Medicine","keywords":"Rituximab; Medicine; Venetoclax; Bendamustine; Internal medicine; Regimen; Population; Progression-free survival; Oncology; Chemotherapy regimen; Gastroenterology; Chemotherapy; Surgery; Chronic lymphocytic leukemia; Leukemia; Lymphoma","score_opus":0.011650595634157547,"score_gpt":0.260368235767024,"score_spread":0.24871764013286646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281385697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99712193,0.0010200819,0.000003157488,0.00020816966,0.00009506032,0.00048246776,0.00001493806,0.00006592569,0.0009882393],"genre_scores_gemma":[0.9971553,0.000038540933,0.00015801494,0.0002000986,0.00005862866,0.00020871675,0.000037969912,0.000036187368,0.0021065262],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99834293,0.0001073782,0.0003192991,0.00035896007,0.0004763233,0.00039508767],"domain_scores_gemma":[0.9993273,0.00010032568,0.000059013597,0.00036542938,0.00003147225,0.000116443814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003496589,0.00015084872,0.00031149853,0.00022832064,0.00010933295,0.000026074582,0.00010327567,0.00008100756,0.00068399834],"category_scores_gemma":[0.00011224137,0.00014611581,0.00005073591,0.0003124973,0.00005011896,0.000091872134,0.00025835124,0.00045960763,0.00003453734],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010550329,0.018528903,0.7814404,0.0023903667,0.0019842556,0.018403126,0.010799272,0.0008401895,0.13122551,0.0004906111,0.0036214688,0.019725576],"study_design_scores_gemma":[0.46491006,0.0033812546,0.4127929,0.00037350206,0.0007562676,0.0028158897,0.0026878626,0.015825473,0.06270841,0.00059875514,0.031549357,0.0016002785],"about_ca_topic_score_codex":0.0004923367,"about_ca_topic_score_gemma":0.00014899585,"teacher_disagreement_score":0.45435974,"about_ca_system_score_codex":0.005076632,"about_ca_system_score_gemma":0.0019846174,"threshold_uncertainty_score":0.9987427},"labels":[],"label_agreement":null},{"id":"W4281625438","doi":"10.1182/blood.2022015851","title":"The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1506,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Institutes of Health; Barts Charity","keywords":"Terminology; Medicine; Consensus conference; Internal medicine","score_opus":0.03787384926230386,"score_gpt":0.30971631521710863,"score_spread":0.27184246595480477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281625438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9694252,0.0012453593,0.0000019195534,0.024190163,0.00065015536,0.0002955876,0.000118888776,0.000024141598,0.004048593],"genre_scores_gemma":[0.99762326,0.00015861425,0.00026038624,0.00087601476,0.00022214123,0.000121728204,0.00018644516,0.000009836552,0.00054154673],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987471,0.00013032318,0.00044215177,0.00019349717,0.00039305747,0.00009387946],"domain_scores_gemma":[0.9978274,0.0012427296,0.00027766876,0.0005310866,0.000080396574,0.000040711937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048656823,0.00008067619,0.00016347501,0.000014542954,0.0002056719,0.000016091786,0.00019825644,0.000042579348,0.00012547034],"category_scores_gemma":[0.00031989787,0.000044110162,0.00014951747,0.000072839284,0.00011629425,0.000008774732,0.000120304845,0.0001427574,0.000011478435],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026725174,0.0020110293,0.90396744,0.0000028432778,0.00059764774,0.0002939389,0.00017517954,0.000001478034,0.00043563257,0.00077188323,0.08438229,0.007093381],"study_design_scores_gemma":[0.0047442773,0.000151692,0.7878614,0.000017604401,0.00037383402,0.0009014523,0.00093296333,0.00008238467,0.0006302422,0.00026880633,0.2039843,0.00005104071],"about_ca_topic_score_codex":0.00016001347,"about_ca_topic_score_gemma":0.000041583768,"teacher_disagreement_score":0.119602025,"about_ca_system_score_codex":0.00006282339,"about_ca_system_score_gemma":0.00025158952,"threshold_uncertainty_score":0.17987603},"labels":[],"label_agreement":null},{"id":"W4281632638","doi":"10.1182/blood.2021014698","title":"PLAG1 dampens protein synthesis to promote human hematopoietic stem cell self-renewal","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; McMaster University","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Canadian Blood Services; Ontario Institute for Cancer Research","keywords":"Stem cell; Biology; Cell biology; Protein biosynthesis; Haematopoiesis; Hematopoietic stem cell; Transcription factor; Translation (biology); Chromatin; Activator (genetics); Genetics; Messenger RNA; Gene","score_opus":0.014596173580390231,"score_gpt":0.23899551518812406,"score_spread":0.22439934160773384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281632638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98740345,0.00006380863,0.00006231912,0.00036703478,0.000073802694,0.0021184906,0.000044911492,0.00032110256,0.009545077],"genre_scores_gemma":[0.9936498,0.0000020456907,0.0027837553,0.00015214643,0.00008397584,0.0010857163,0.00002507954,0.000076877004,0.0021406102],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977713,0.00013479362,0.00044294956,0.0005035486,0.0007150321,0.00043232582],"domain_scores_gemma":[0.9989213,0.000078597855,0.00010600174,0.0005580538,0.000050117425,0.00028593445],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038516024,0.00024924587,0.00041735492,0.00018168538,0.0003106433,0.000027645807,0.00022675261,0.000077046854,0.00088394235],"category_scores_gemma":[0.000013372472,0.00025151722,0.00012361445,0.00035337562,0.000019347273,0.000038124075,0.00009698604,0.00026005617,0.00022220258],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014790703,0.0044849566,0.0033542113,0.002414533,0.00026972382,0.0010900684,0.015751466,0.000015634696,0.9710944,0.00068642985,0.00034536625,0.0003452534],"study_design_scores_gemma":[0.002462719,0.00089546107,0.00042273066,0.00035296206,0.00074789417,0.00073074806,0.0015424077,0.000012015659,0.9899774,0.000067068875,0.0023929898,0.0003955778],"about_ca_topic_score_codex":0.000031068743,"about_ca_topic_score_gemma":0.0000070851165,"teacher_disagreement_score":0.018882975,"about_ca_system_score_codex":0.000094524905,"about_ca_system_score_gemma":0.00014148765,"threshold_uncertainty_score":0.9999937},"labels":[],"label_agreement":null},{"id":"W4281703781","doi":"10.1182/blood.2021014853","title":"p57Kip2 regulates embryonic blood stem cells by controlling sympathoadrenal progenitor expansion","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Zebrafish Biomedical Research Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Health and Medical Research Council; Cambridge Institute for Medical Research, University of Cambridge; Blood Cancer UK; Medical Research Council; Wellcome Trust; Kay Kendall Leukaemia Fund; UK Research and Innovation","keywords":"Biology; Progenitor cell; Cell biology; Embryonic stem cell; Stem cell; Haematopoiesis; Neural crest; Mesenchymal stem cell; Dorsal aorta; Immunology; Cellular differentiation; Embryo; Genetics","score_opus":0.006866920499221385,"score_gpt":0.2332897136900592,"score_spread":0.2264227931908378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281703781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951432,0.0032143807,0.00024615144,0.00034623378,0.00007553693,0.000557199,0.00025433663,0.000042521344,0.00012048261],"genre_scores_gemma":[0.9966324,0.00013056741,0.0003559416,0.00017741357,0.00024713392,0.00060962525,0.00031900493,0.000040032235,0.0014878807],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981467,0.00015253796,0.00024049394,0.00051747967,0.00048562564,0.000457157],"domain_scores_gemma":[0.9990631,0.00003517487,0.00009438016,0.0004868839,0.0000776683,0.00024280944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036250515,0.00016722566,0.00016713729,0.00005071594,0.00033381773,0.00003631546,0.00045480143,0.00010914631,0.000079575104],"category_scores_gemma":[0.000035402336,0.00016629693,0.0001200474,0.00020875287,0.00012322885,0.000003669862,0.00038004652,0.0002246524,0.000021557873],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041105683,0.0007659212,0.00020104229,0.0000145330205,0.00012247638,0.000010948391,0.000021683667,0.000010714369,0.9919518,0.000026282385,0.0054380586,0.0013954401],"study_design_scores_gemma":[0.002397033,0.00055147917,0.00005048821,0.0000062240706,0.00007946085,0.00004313437,0.000089867564,0.000074918695,0.9576563,0.000041184554,0.03881507,0.0001947862],"about_ca_topic_score_codex":0.000009804014,"about_ca_topic_score_gemma":0.0000018661904,"teacher_disagreement_score":0.03429544,"about_ca_system_score_codex":0.000017718281,"about_ca_system_score_gemma":0.00019089687,"threshold_uncertainty_score":0.6781392},"labels":[],"label_agreement":null},{"id":"W4281750080","doi":"10.1182/blood.2022016196","title":"Outcomes following treatment for ADA-deficient severe combined immunodeficiency: a report from the PIDTC","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; University of Manitoba; BC Children's Hospital; CancerCare Manitoba","funders":"NHLBI Division of Intramural Research; National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; National Institute of Allergy and Infectious Diseases; Office of Naval Research; Health Resources and Services Administration; National Cancer Institute; National Institutes of Health; Rare Diseases Clinical Research Network; National Heart, Lung, and Blood Institute; St. Baldrick's Foundation","keywords":"Medicine; Enzyme replacement therapy; Internal medicine; Adenosine deaminase deficiency; Hematopoietic cell; Hematopoietic stem cell transplantation; Severe combined immunodeficiency; Gastroenterology; Adenosine deaminase; Transplantation; Disease; Haematopoiesis; Stem cell; Biology; Adenosine","score_opus":0.02227283479849256,"score_gpt":0.29543794964241504,"score_spread":0.2731651148439225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281750080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99506617,0.0027091189,0.00006366932,0.0006774451,0.00022663575,0.0007159748,0.00021129548,0.00002113993,0.00030855075],"genre_scores_gemma":[0.9964607,0.000024740682,0.00014696052,0.00035526475,0.000055047025,0.00063650386,0.00056668866,0.000034576577,0.0017195473],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986073,0.00012043294,0.00023613396,0.00042939596,0.00027149115,0.0003352934],"domain_scores_gemma":[0.99895686,0.00007300733,0.000084754545,0.0008047155,0.00003691547,0.000043756758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004112405,0.00017207033,0.00018589353,0.000024013954,0.0005354501,0.00003237099,0.0003885399,0.00004518918,0.000063423046],"category_scores_gemma":[0.000073072675,0.000123588,0.00033348473,0.00010339243,0.00003302384,0.0000018267372,0.00022576893,0.00008226722,0.0000044243875],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023116826,0.0033877606,0.0711419,0.0000074842737,0.0018651837,0.00013425385,0.0006794091,0.00078511983,0.91275644,0.000045252553,0.0023162314,0.0045692506],"study_design_scores_gemma":[0.034464203,0.029752987,0.0241766,0.000017549715,0.00084244506,0.00020162456,0.0027028397,0.00022481986,0.7146478,0.00074061815,0.1907793,0.0014492124],"about_ca_topic_score_codex":0.00015081833,"about_ca_topic_score_gemma":0.00009448457,"teacher_disagreement_score":0.19810866,"about_ca_system_score_codex":0.000048085938,"about_ca_system_score_gemma":0.00022817792,"threshold_uncertainty_score":0.5039773},"labels":[],"label_agreement":null},{"id":"W4281886986","doi":"10.1182/blood.2021014527","title":"Anticoagulation in hospitalized patients with COVID-19","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Coronavirus disease 2019 (COVID-19); Intensive care medicine; Heparin; Guideline; Incidence (geometry); Randomized controlled trial; 2019-20 coronavirus outbreak; Thrombosis; Venous thrombosis; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Internal medicine; Disease; Infectious disease (medical specialty); Outbreak; Virology; Pathology","score_opus":0.011479418275154916,"score_gpt":0.25418118503675874,"score_spread":0.24270176676160382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281886986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99697834,0.000047027283,0.000030444531,0.00085875526,0.000051670653,0.0006283335,0.000006430312,0.00003762479,0.0013613795],"genre_scores_gemma":[0.99774826,0.000009359951,0.00019584653,0.0017480253,0.000016690832,0.00011085232,0.00008385542,0.000012210143,0.0000748868],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999306,0.000029482202,0.000116139265,0.00015626477,0.0002626468,0.00012944237],"domain_scores_gemma":[0.9996994,0.000013482407,0.000043620224,0.00015352764,0.00001604961,0.000073929674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010236259,0.00006431689,0.00017725551,0.000100262725,0.000079602585,0.000006836072,0.000044014392,0.000012427304,0.0004106227],"category_scores_gemma":[0.000034765766,0.00005586424,0.00002320731,0.00019590801,0.000012884225,0.00003014605,0.000059522114,0.00006548189,0.000006119129],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006257456,0.0041775825,0.9930713,0.0000486392,0.000057121844,0.00005250856,0.000475131,0.00015999988,0.00001908867,0.00051770033,0.0011195657,0.00023879707],"study_design_scores_gemma":[0.00935535,0.00068302016,0.98309517,0.000010493923,0.0001351055,0.0000023571504,0.000107451066,0.000020499176,0.000028355687,0.00008271914,0.006402614,0.000076855235],"about_ca_topic_score_codex":0.00015990142,"about_ca_topic_score_gemma":0.000016403948,"teacher_disagreement_score":0.009976112,"about_ca_system_score_codex":0.00006983266,"about_ca_system_score_gemma":0.000054406275,"threshold_uncertainty_score":0.44960308},"labels":[],"label_agreement":null},{"id":"W4283073514","doi":"10.1182/blood.2021014901","title":"Enasidenib vs conventional care in older patients with late-stage mutant-<i>IDH2</i> relapsed/refractory AML: a randomized phase 3 trial","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Medical Research Council; National Institute for Health and Care Research; Celgene; Bristol-Myers Squibb","keywords":"Medicine; Hazard ratio; Internal medicine; Gastroenterology; Randomized controlled trial; Clinical endpoint; Cytarabine; Refractory (planetary science); Surgery; Confidence interval; Myeloid leukemia; Biology","score_opus":0.01125520532681904,"score_gpt":0.2783481008911824,"score_spread":0.26709289556436333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283073514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931387,0.0003547265,0.000014311575,0.00023129872,0.00023576496,0.0042612855,0.00027040302,0.00007575509,0.0014178015],"genre_scores_gemma":[0.99500066,0.000027653154,0.00016509449,0.00039121474,0.00016819777,0.0009792594,0.00094775116,0.00007134009,0.0022488055],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9964998,0.00063596165,0.00059702154,0.0005159637,0.0012529726,0.0004982891],"domain_scores_gemma":[0.9985091,0.0004169491,0.00020991644,0.0004400932,0.00020738589,0.00021653327],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00079864805,0.00026066377,0.00084623287,0.00035663598,0.00018008488,0.000026124973,0.00021617448,0.000108199485,0.002466129],"category_scores_gemma":[0.0004166172,0.00021276102,0.0002451596,0.00045579913,0.00016891795,0.00012107778,0.00018311244,0.0009976582,0.00003525637],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.982169,0.0066749486,0.006076227,0.00012680801,0.00040316753,0.001211817,0.0016331915,0.000025456027,0.0005800157,0.00005708555,0.0006901303,0.00035220454],"study_design_scores_gemma":[0.9874678,0.0034657745,0.0009465615,0.000072806026,0.00033825214,0.000018120503,0.0005678014,0.000090935144,0.000899946,0.000011058596,0.0058832983,0.00023763787],"about_ca_topic_score_codex":0.00013712722,"about_ca_topic_score_gemma":0.000032398817,"teacher_disagreement_score":0.00529886,"about_ca_system_score_codex":0.00046082237,"about_ca_system_score_gemma":0.0010197184,"threshold_uncertainty_score":0.99844575},"labels":[],"label_agreement":null},{"id":"W4283078101","doi":"10.1182/blood.2021014875","title":"A macaque clonal hematopoiesis model demonstrates expansion of TET2-disrupted clones and utility for testing interventions","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"National Institutes of Health; Wellcome Trust","keywords":"Biology; Rhesus macaque; Myeloid; Haematopoiesis; Progenitor cell; Transplantation; Cancer research; Immunology; CRISPR; Gene; Genetics; Stem cell; Internal medicine; Medicine","score_opus":0.08343526588746084,"score_gpt":0.3426128571762473,"score_spread":0.2591775912887865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283078101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949631,0.00045142445,0.0027356476,0.00047411196,0.000016343249,0.00063805666,0.0002012363,0.000050505907,0.00046956126],"genre_scores_gemma":[0.9695845,0.0000103285,0.029816369,0.000036969323,0.000024021332,0.00022575272,0.0000540827,0.000019283652,0.000228663],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9988817,0.00005536024,0.00033825162,0.00025256025,0.00025114286,0.00022099292],"domain_scores_gemma":[0.9991128,0.00032687036,0.00009336316,0.00020689113,0.00016444674,0.00009563865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003757096,0.000107208405,0.0002762392,0.00012879855,0.00021388337,0.000008943841,0.00009456741,0.00004625547,0.00006923246],"category_scores_gemma":[0.00055424933,0.00010115929,0.00013550172,0.00025249177,0.00010914216,0.000049887556,0.00022057525,0.0001975738,4.899632e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022016233,0.00674198,0.2921204,0.009336204,0.0011866059,0.00019571879,0.0022703644,0.00045443143,0.65266675,0.00329018,0.0033126345,0.026223127],"study_design_scores_gemma":[0.025089147,0.003669156,0.04170597,0.0011562546,0.0019151522,0.0019795962,0.006306523,0.674028,0.23146276,0.011643243,0.00031484582,0.0007293745],"about_ca_topic_score_codex":0.000064536056,"about_ca_topic_score_gemma":0.000009035049,"teacher_disagreement_score":0.67357355,"about_ca_system_score_codex":0.00004171528,"about_ca_system_score_gemma":0.00029687592,"threshold_uncertainty_score":0.4125156},"labels":[],"label_agreement":null},{"id":"W4283701656","doi":"10.1182/blood.2022016098","title":"Targeted radiotherapy for early-stage, low-risk pediatric Hodgkin lymphoma slow early responders: a COG AHOD0431 analysis","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institutes of Health; Children’s Oncology Group; National Cancer Institute; Princess Margaret Cancer Foundation; St. Baldrick's Foundation","keywords":"Cog; Medicine; Oncology; Hodgkin lymphoma; Internal medicine; Stage (stratigraphy); Radiation therapy; Lymphoma; Biology","score_opus":0.010960613258775238,"score_gpt":0.25436897807985154,"score_spread":0.2434083648210763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283701656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99167114,0.0052869082,0.00027638188,0.00031268367,0.00016556367,0.0012989771,0.0006230289,0.00016230559,0.000203013],"genre_scores_gemma":[0.9919893,0.00065189967,0.0028733138,0.00045093437,0.0003687178,0.0010515495,0.00024041493,0.00007785192,0.0022959805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973685,0.00023738458,0.0004770998,0.00070076296,0.0006400131,0.00057623617],"domain_scores_gemma":[0.9982026,0.00038555852,0.00029099238,0.0007190639,0.00012255188,0.00027920047],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004622232,0.00034647758,0.00075229094,0.0007694419,0.00043702516,0.000076622724,0.00022079819,0.000111392816,0.0006781284],"category_scores_gemma":[0.000117430835,0.0003136286,0.00078968593,0.001864965,0.00004226403,0.00009650844,0.0000728464,0.00012332837,0.000023173428],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015962662,0.005873745,0.977511,0.00005919399,0.007222968,0.0004230422,0.0012424567,0.0001303503,0.00030367676,0.00007484883,0.0023400409,0.0032224117],"study_design_scores_gemma":[0.035376597,0.003414909,0.936101,0.000008855565,0.013655294,0.000033290533,0.00022773964,0.00050013623,0.0022444658,0.000047784506,0.007960423,0.00042946465],"about_ca_topic_score_codex":0.0008579284,"about_ca_topic_score_gemma":0.000027338669,"teacher_disagreement_score":0.041409962,"about_ca_system_score_codex":0.00030415106,"about_ca_system_score_gemma":0.00031006936,"threshold_uncertainty_score":0.9999316},"labels":[],"label_agreement":null},{"id":"W4283832293","doi":"10.1182/blood.2022015674","title":"Human complete NFAT1 deficiency causes a triad of joint contractures, osteochondromas, and B-cell malignancy","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Signaling Pathways in Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; BC Children's Hospital; University of British Columbia","funders":"","keywords":"NFAT; Calcineurin; Cancer research; Germline; Biology; CD8; HEK 293 cells; Cell biology; Immunology; Transcription factor; Medicine; Gene; Genetics; Transplantation; Immune system; Internal medicine","score_opus":0.01794821607786281,"score_gpt":0.2319464877928284,"score_spread":0.21399827171496558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283832293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917494,0.006888775,0.000016535556,0.000025099489,0.00007258401,0.00021806353,0.00030973396,0.000013279916,0.0007065357],"genre_scores_gemma":[0.9993113,0.000017965343,0.00014976203,0.00013934156,0.000050168168,0.000043545944,0.00011379037,0.000020820777,0.00015327655],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998974,0.00010051729,0.00024856735,0.00031086578,0.00017407064,0.0001919445],"domain_scores_gemma":[0.9993923,0.00001211832,0.00014688182,0.0003375684,0.00003726238,0.00007388464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015446269,0.00013364347,0.00018043777,0.000036214507,0.00016415522,0.000011699645,0.00017579632,0.000050659615,0.00007877367],"category_scores_gemma":[0.000048825757,0.00013793424,0.00008722305,0.000063215346,0.00007983898,0.0000015858326,0.00022040971,0.000089338355,0.0000011035223],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000304294,0.0005561812,0.0017565053,0.00004671487,0.00002815907,0.000028646491,0.00006096208,0.000020645137,0.9967427,0.000120226956,0.00056913367,0.000039682527],"study_design_scores_gemma":[0.0038478398,0.0008117756,0.0030808211,0.000012651539,0.00012428142,0.00007108864,0.00010282088,0.000002562329,0.98885137,0.00018458815,0.0026925437,0.00021768773],"about_ca_topic_score_codex":0.000033924785,"about_ca_topic_score_gemma":0.0000068645822,"teacher_disagreement_score":0.007891374,"about_ca_system_score_codex":0.0000053148847,"about_ca_system_score_gemma":0.000065292865,"threshold_uncertainty_score":0.5624795},"labels":[],"label_agreement":null},{"id":"W4284686524","doi":"10.1182/blood.2022016772","title":"Avoiding fratricide: a T-ALL order","year":2022,"lang":"en","type":"letter","venue":"Blood","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine","score_opus":0.03769830451440033,"score_gpt":0.30195906309535075,"score_spread":0.26426075858095044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4284686524","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010422875,0.005085772,0.000052328585,0.96689427,0.0015095981,0.0009100566,0.00015602668,0.0004612803,0.014507803],"genre_scores_gemma":[0.0013782016,0.00019957034,0.0008450759,0.97240466,0.013085471,0.00013387721,0.0011361956,0.00022305624,0.010593923],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959738,0.00048160323,0.0006564656,0.0008233684,0.0013911022,0.0006736506],"domain_scores_gemma":[0.99785507,0.0005447475,0.00032427633,0.0010037229,0.00012386763,0.00014829243],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008473046,0.00049607706,0.0009703002,0.00034066883,0.00025007877,0.000051408082,0.00039694834,0.0006798204,0.0056213643],"category_scores_gemma":[0.00079180254,0.00051437935,0.0003741906,0.00055711844,0.00005694191,0.000056129895,0.00027727627,0.0069538145,0.00029839762],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028901186,0.00027800744,0.00048173772,0.00082767254,0.00068869075,0.003058012,0.0008855011,6.6800226e-7,0.000036945567,0.000010018701,0.99354035,0.00016348473],"study_design_scores_gemma":[0.0027609474,0.00034407992,0.00018292913,0.0002215354,0.0017653272,0.0007536983,0.00016978386,0.0000018231274,0.00015592642,0.00009816479,0.9930144,0.00053141697],"about_ca_topic_score_codex":0.0005113951,"about_ca_topic_score_gemma":0.000022176959,"teacher_disagreement_score":0.011575873,"about_ca_system_score_codex":0.00014382825,"about_ca_system_score_gemma":0.0005270562,"threshold_uncertainty_score":0.99973077},"labels":[],"label_agreement":null},{"id":"W4284887577","doi":"10.1182/blood.2022016171","title":"Longer-term benefit of luspatercept in transfusion-dependent lower-risk myelodysplastic syndromes with ring sideroblasts","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Blood Cancer UK","keywords":"Medicine; Myelodysplastic syndromes; Placebo; Blood transfusion; Anemia; Internal medicine; Surgery; Bone marrow","score_opus":0.011280704140333204,"score_gpt":0.24128972764348222,"score_spread":0.23000902350314903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4284887577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99782985,0.00015461398,0.000089188,0.00014156148,0.00007406635,0.000637794,0.000054112093,0.000052355663,0.00096643786],"genre_scores_gemma":[0.9983358,0.00014663333,0.00039391508,0.000036159487,0.000041226922,0.00012436823,0.000020995421,0.00006110468,0.00083981187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976861,0.000099146324,0.00037185723,0.00046579007,0.0008952254,0.00048191988],"domain_scores_gemma":[0.9989819,0.0001918642,0.000112469585,0.00047860653,0.000067496185,0.00016766462],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038471568,0.00022219308,0.00049335504,0.00042068763,0.00012759364,0.00001400131,0.0002528853,0.00007102597,0.0016766099],"category_scores_gemma":[0.000059490896,0.00019240493,0.00008990144,0.00048891775,0.0000855437,0.00007721794,0.00022265749,0.00075841445,0.000037075755],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004460437,0.0063642026,0.84054935,0.0013864164,0.0010509728,0.013052008,0.009967573,0.005863488,0.1062404,0.00009711073,0.0001316579,0.010836363],"study_design_scores_gemma":[0.050960284,0.009283451,0.86800367,0.0013912717,0.0013097548,0.007552203,0.0043082046,0.0019752944,0.053849228,0.00014509073,0.00013593324,0.0010856327],"about_ca_topic_score_codex":0.0003054087,"about_ca_topic_score_gemma":0.00039770248,"teacher_disagreement_score":0.05239117,"about_ca_system_score_codex":0.00024425422,"about_ca_system_score_gemma":0.00026056642,"threshold_uncertainty_score":0.999236},"labels":[],"label_agreement":null},{"id":"W4284899212","doi":"10.1182/blood.2022016530","title":"Immune complications and their management in inherited and acquired bleeding disorders","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Institute of Allergy and Infectious Diseases; National Heart, Lung, and Blood Institute; Spark Therapeutics; National Institutes of Health; Riley Children's Foundation; Canadian Institutes of Health Research; Regeneron Pharmaceuticals; Lilly Endowment; Eli Lilly and Company","keywords":"Medicine; Bleeding diathesis; Immune system; Immunology; Intensive care medicine; Platelet","score_opus":0.025338999788280706,"score_gpt":0.28344115902285016,"score_spread":0.2581021592345695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4284899212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98794883,0.0016451293,0.0000029773892,0.003928469,0.000009674222,0.0003879406,0.000004241695,0.00001965651,0.0060531027],"genre_scores_gemma":[0.99869317,0.00057233236,0.00014406926,0.0000599904,0.0000060936927,0.00011689035,0.000023902126,0.000007269022,0.00037625863],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995788,0.000020232494,0.00008118115,0.00012882682,0.00007654271,0.00011446683],"domain_scores_gemma":[0.99981695,0.000023121409,0.000011107605,0.00010434588,0.0000056144086,0.000038841798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009331342,0.000052740743,0.000087261826,0.00010722485,0.00012630792,0.000008386341,0.000032365344,0.000011643638,0.000032661872],"category_scores_gemma":[0.0000039765846,0.00004215916,0.000013444692,0.0001747295,0.000039946524,0.000017828255,0.00013789335,0.000057383557,0.000001177612],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017966119,0.004308586,0.81252193,0.00031063746,0.00080049335,0.00012834797,0.005199523,0.0000052245473,0.053707868,0.0022659518,0.00022656683,0.1203452],"study_design_scores_gemma":[0.0064385924,0.00023735831,0.9835659,0.00003467545,0.00006127801,0.000042350137,0.0035551395,0.00036155028,0.00052779383,0.0005496017,0.00453741,0.0000883245],"about_ca_topic_score_codex":0.000026335452,"about_ca_topic_score_gemma":0.000006394171,"teacher_disagreement_score":0.17104399,"about_ca_system_score_codex":0.000015004103,"about_ca_system_score_gemma":0.000006756907,"threshold_uncertainty_score":0.17192008},"labels":[],"label_agreement":null},{"id":"W4285395827","doi":"10.1182/blood.2022015849","title":"Developing a classification of hematologic neoplasms in the era of precision medicine","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Context (archaeology); Hematopathology; Mechanism (biology); Precision medicine; Disease; Computer science; Bioinformatics; Medicine; Pathology; Biology; Genetics","score_opus":0.02213687710880138,"score_gpt":0.26910452598312856,"score_spread":0.24696764887432718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285395827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975593,0.0010172507,0.00034722436,0.00053728477,0.000044989527,0.00010744622,0.0000101265305,9.1867753e-7,0.000375448],"genre_scores_gemma":[0.99906504,0.00023629742,0.00047509882,0.0001250358,0.00002360682,0.00002672562,0.000039780945,0.000003299031,0.000005128437],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99954385,0.00004218505,0.0001728852,0.00009555563,0.0000902829,0.000055264078],"domain_scores_gemma":[0.9996541,0.000053799977,0.00009467555,0.00016432023,0.000026144804,0.0000069324537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022692209,0.00003888456,0.000082292885,0.000020395995,0.000025733198,0.0000012032449,0.00014862558,0.000024090867,0.000009965596],"category_scores_gemma":[0.00012647985,0.000029075674,0.000019896024,0.00010313023,0.00003211572,4.880352e-7,0.000072428455,0.00005247839,1.6224918e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010137627,0.0004240971,0.032203652,0.000055611104,0.00003417232,0.0000044339545,0.0009161858,0.00026759916,0.95240325,0.008916599,0.0009453667,0.0037276365],"study_design_scores_gemma":[0.005456404,0.002270623,0.19941132,0.00010906776,0.00010845851,0.00014796558,0.0043346463,0.00021939965,0.75661457,0.005288696,0.025718477,0.0003203654],"about_ca_topic_score_codex":0.000032924498,"about_ca_topic_score_gemma":0.000038679318,"teacher_disagreement_score":0.1957887,"about_ca_system_score_codex":0.0000057812395,"about_ca_system_score_gemma":0.00006543786,"threshold_uncertainty_score":0.11856716},"labels":[],"label_agreement":null},{"id":"W4285491152","doi":"10.1182/blood.2022016146","title":"Moderate-intensity aerobic exercise vs desmopressin in adolescent males with mild hemophilia A: a randomized trial","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; Queen's University; Hospital for Sick Children; University of Toronto","funders":"Canadian Hemophilia Society","keywords":"Desmopressin; Medicine; Randomized controlled trial; Aerobic exercise; Regimen; Randomization; Internal medicine; Pediatrics","score_opus":0.033838099309822824,"score_gpt":0.2844895870338652,"score_spread":0.25065148772404233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285491152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99339765,0.00095393346,0.000008072718,0.0015734363,0.00009830999,0.0033294887,0.0000063571465,0.00006482344,0.0005679118],"genre_scores_gemma":[0.99558085,0.00015934552,0.00040909788,0.00019274792,0.000113196256,0.0007266149,0.000055984525,0.000035638343,0.0027265335],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9978852,0.00026360233,0.00035987576,0.0004288723,0.000614411,0.0004479924],"domain_scores_gemma":[0.9991883,0.000092775255,0.00007056053,0.00037933697,0.000084585896,0.00018441121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007061615,0.00023461788,0.0010596098,0.0002292914,0.00020061439,0.000026300768,0.00013346557,0.00007466144,0.0002699885],"category_scores_gemma":[0.00007263341,0.000159999,0.00020045039,0.0003319722,0.00015817069,0.000050303668,0.00014423407,0.000533136,0.000019247156],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98361796,0.004791324,0.008324505,0.00009736676,0.00018328824,0.0014015727,0.00030961816,0.00003906049,0.0006220205,0.000017875056,0.00040843713,0.000186989],"study_design_scores_gemma":[0.9836739,0.0010117058,0.0019069479,0.0002976792,0.00049395836,0.00015398632,0.00016318371,0.0005691108,0.011392459,0.000064746615,0.000076762066,0.00019557127],"about_ca_topic_score_codex":0.0001335812,"about_ca_topic_score_gemma":0.000023812478,"teacher_disagreement_score":0.010770439,"about_ca_system_score_codex":0.00010444108,"about_ca_system_score_gemma":0.0002705814,"threshold_uncertainty_score":0.65245706},"labels":[],"label_agreement":null},{"id":"W4285492548","doi":"10.1182/blood.2022015478","title":"Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; McGill University Health Centre; Queen Elizabeth II Health Sciences Centre; Royal Victoria Regional Health Centre; Hôpital de l'Enfant-Jésus; Royal Victoria Hospital; Dalhousie University","funders":"Gilead Sciences","keywords":"Medicine; Quality of life (healthcare); Confidence interval; Visual analogue scale; Internal medicine; Phases of clinical research; Oncology; Clinical trial; Physical therapy","score_opus":0.029688413766771723,"score_gpt":0.32612921224861646,"score_spread":0.29644079848184474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285492548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99586535,0.00030970934,8.5795705e-7,0.00007446122,0.00008434694,0.001556772,0.00006736505,0.000031575346,0.0020095608],"genre_scores_gemma":[0.9955928,0.000011162067,0.000026419511,0.00016298925,0.00002254376,0.00025166772,0.000052687872,0.00004272818,0.0038370583],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972984,0.0002482295,0.0008024348,0.0004174174,0.00078981195,0.0004436606],"domain_scores_gemma":[0.9988844,0.000105220046,0.00017841005,0.00064179953,0.00006954733,0.00012064751],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007030301,0.00019036743,0.0006408431,0.000567282,0.000053762928,0.000007332146,0.00016909899,0.000053549633,0.005626909],"category_scores_gemma":[0.000092183596,0.00018417134,0.00011463791,0.00081596995,0.000025950329,0.000040300547,0.00026836607,0.00031933692,0.0000071478426],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002152205,0.2336287,0.5464619,0.0001152204,0.00033244296,0.0040552476,0.007383882,0.000014224706,0.19857126,0.0000037109623,0.00010606402,0.007175147],"study_design_scores_gemma":[0.5549692,0.025180155,0.23320395,0.00005774343,0.00032168985,0.00022926158,0.01743789,0.00044277086,0.16181682,0.000044890505,0.0056655356,0.000630132],"about_ca_topic_score_codex":0.00042014918,"about_ca_topic_score_gemma":0.00057021534,"teacher_disagreement_score":0.552817,"about_ca_system_score_codex":0.00014973588,"about_ca_system_score_gemma":0.00023264695,"threshold_uncertainty_score":0.99528205},"labels":[],"label_agreement":null},{"id":"W4289522686","doi":"10.1182/blood.2021014586","title":"Phase 3 trial of gilteritinib plus azacitidine vs azacitidine for newly diagnosed <i>FLT3</i>mut+ AML ineligible for intensive chemotherapy","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Astellas Pharma","keywords":"Medicine; Internal medicine; Hazard ratio; Gastroenterology; Azacitidine; Chemotherapy; Interim analysis; Neutropenia; Adverse effect; Surgery; Chemotherapy regimen; Randomized controlled trial; Confidence interval","score_opus":0.037985044924683235,"score_gpt":0.34285779015501583,"score_spread":0.3048727452303326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289522686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803906,0.00034788257,0.0021646747,0.0059591504,0.00042857806,0.008133632,0.0018978559,0.00013878061,0.00053883425],"genre_scores_gemma":[0.97595114,0.000310918,0.0072388654,0.0045045936,0.0019576584,0.0059360424,0.0016001002,0.00021885349,0.0022818092],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9969769,0.00009624271,0.0008385019,0.0006477336,0.00065622886,0.0007844012],"domain_scores_gemma":[0.996902,0.00088645465,0.00030401934,0.00066941726,0.00095137936,0.0002867511],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008120744,0.00036423997,0.0011273214,0.00037588004,0.00024803545,0.000027241216,0.0004054024,0.00013422716,0.00039195467],"category_scores_gemma":[0.0015220263,0.00035435252,0.0005156519,0.0005596445,0.00017471888,0.00010259718,0.00019537994,0.00042544224,0.000005926116],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5037586,0.011852854,0.00016081525,0.0011997718,0.0014821376,0.00034574646,0.0018128055,0.000032063046,0.34303483,0.00083271787,0.122845605,0.012642047],"study_design_scores_gemma":[0.6669283,0.024299169,0.000019202513,0.00008226876,0.00044015306,0.00016684603,0.0009913273,0.0009159675,0.21229875,0.00031139146,0.09319701,0.00034959093],"about_ca_topic_score_codex":0.00008616703,"about_ca_topic_score_gemma":0.000006573217,"teacher_disagreement_score":0.16316971,"about_ca_system_score_codex":0.00028905284,"about_ca_system_score_gemma":0.0009263146,"threshold_uncertainty_score":0.99989086},"labels":[],"label_agreement":null},{"id":"W4290879107","doi":"10.1182/blood.2022016293","title":"Prognostic impact of <i>NPM1</i> and <i>FLT3</i> mutations in patients with AML in first remission treated with oral azacitidine","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Celgene; Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; NPM1; Hazard ratio; Placebo; Myeloid leukemia; Gastroenterology; Transplantation; Hematopoietic stem cell transplantation; Minimal residual disease; Oncology; Confidence interval; Leukemia; Surgery; Pathology; Biology","score_opus":0.009097038633836789,"score_gpt":0.2539137939120548,"score_spread":0.24481675527821803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290879107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99847245,0.00005800606,0.0000021105266,0.0001336861,0.0000030641963,0.0009128967,0.00006545354,0.000019691175,0.00033262032],"genre_scores_gemma":[0.999211,0.000008906949,0.0003212322,0.000022794013,0.0000064412925,0.000098242745,0.00023322912,0.000027608108,0.0000705198],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882406,0.00007072685,0.00021634575,0.00024225825,0.00038187197,0.0002647286],"domain_scores_gemma":[0.9994407,0.000094200164,0.00007199809,0.00018755879,0.00008677828,0.000118762146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014427744,0.00013645699,0.00028835048,0.00027789842,0.000063104395,0.0000070639753,0.00006671175,0.00003461967,0.00006966544],"category_scores_gemma":[0.00009513618,0.000092923285,0.000024461071,0.0009173506,0.00008183683,0.00007083162,0.00006814549,0.00030949444,8.548486e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016216704,0.0015796929,0.99493766,0.00006462059,0.00006242971,0.00019170414,0.0003419866,0.00014728228,0.00062724564,0.000001734145,0.00009457444,0.00032942797],"study_design_scores_gemma":[0.021980498,0.0049904645,0.9712943,0.00019687362,0.000102794904,0.00006539368,0.00013190393,0.00023971745,0.0008511024,0.000004725136,0.00003367951,0.0001085519],"about_ca_topic_score_codex":0.00084179925,"about_ca_topic_score_gemma":0.00019373548,"teacher_disagreement_score":0.023643337,"about_ca_system_score_codex":0.00021380262,"about_ca_system_score_gemma":0.0003099339,"threshold_uncertainty_score":0.37893015},"labels":[],"label_agreement":null},{"id":"W4291820501","doi":"10.1182/blood.2022015790","title":"Germ line predisposition variants occur in myelodysplastic syndrome patients of all ages","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; Pharmacyclics; Kite Pharma; Sanofi Genzyme; Takeda Oncology; Health Resources and Services Administration; National Institutes of Health; MorphoSys; Omeros Corporation; Astellas Pharma; Adaptive Biotechnologies; Kiadis Pharma; TG Therapeutics; bluebird bio; Actinium Pharmaceuticals; CareDx; QEII Foundation; StemCyte; Medac; Jazz Pharmaceuticals; Health Sciences Centre Foundation; Damon Runyon Cancer Research Foundation; Karyopharm Therapeutics; HistoGenetics; Amgen; Accenture; U.S. Department of Defense; Sanofi; Astellas Pharma US; CSL Behring; Bristol-Myers Squibb; Seagen; Be The Match Foundation; National Heart, Lung, and Blood Institute; Edward P. Evans Foundation; Novartis Pharmaceuticals Corporation; Incyte; Pfizer; Daiichi Sankyo Europe; National Cancer Institute; Gilead Sciences","keywords":"Germline; Biology; Genetics; Exome sequencing; Internal medicine; Medicine; Gene; Oncology; Immunology; Mutation","score_opus":0.013613113551851313,"score_gpt":0.2653413020340312,"score_spread":0.2517281884821799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291820501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983531,0.000088673594,0.000010632682,0.00017312414,0.00009420024,0.00052590703,0.0001499721,0.000029217495,0.0005751467],"genre_scores_gemma":[0.9987492,0.000020186804,0.00022027543,0.00013824318,0.000036593723,0.000083238265,0.00040759947,0.000024418325,0.0003202403],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984629,0.00010804088,0.00032253968,0.00025115898,0.0005639831,0.00029137934],"domain_scores_gemma":[0.9993603,0.00010595695,0.00009266797,0.00026668643,0.00007356639,0.00010081445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002648912,0.00011398763,0.0002792719,0.00028383825,0.00004547361,0.0000052670425,0.00015441945,0.00005643634,0.00045410884],"category_scores_gemma":[0.00019293238,0.00011206978,0.00005189797,0.00039229824,0.000040466206,0.00006237642,0.00021771489,0.00038192663,0.000022834713],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034017009,0.027351456,0.8567127,0.0017059256,0.0012569054,0.008432511,0.003594762,0.0008652129,0.08756255,0.00025491512,0.004098026,0.004763333],"study_design_scores_gemma":[0.011442238,0.0025975462,0.98235744,0.00010699759,0.0001955651,0.00035546193,0.00007807456,0.0007541116,0.0016506366,0.000044329416,0.0002763533,0.00014127162],"about_ca_topic_score_codex":0.000074942574,"about_ca_topic_score_gemma":0.0000040695368,"teacher_disagreement_score":0.12564471,"about_ca_system_score_codex":0.00017587647,"about_ca_system_score_gemma":0.00015015181,"threshold_uncertainty_score":0.49721733},"labels":[],"label_agreement":null},{"id":"W4292977925","doi":"10.1182/blood.2022015854","title":"Genomic profiling for clinical decision making in lymphoid neoplasms","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":161,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Spinal Cord Injury BC; Simon Fraser University","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute; Cancer Research UK; Barts Charity","keywords":"Computational biology; Disease; Genomics; Immunophenotyping; Epigenetics; Biology; Genome; Bioinformatics; Medicine; Pathology; Genetics; Gene","score_opus":0.041210583576327633,"score_gpt":0.3566992800359085,"score_spread":0.3154886964595809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292977925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973667,0.0010107078,0.00006350918,0.00013392002,0.00024832643,0.0007068346,0.00001954524,0.000028471311,0.0004219872],"genre_scores_gemma":[0.98567295,0.00008068656,0.013156738,0.00044265756,0.00013196366,0.0004247362,0.000026743292,0.000018915453,0.000044607874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990018,0.00003433149,0.00034527178,0.00027221968,0.00015372118,0.00019262536],"domain_scores_gemma":[0.9992551,0.0004167883,0.00006482095,0.00019433483,0.000016739517,0.0000521925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037848676,0.00008808574,0.00024276962,0.00007725527,0.000096012496,0.000009811501,0.00006621679,0.000038414717,0.0000654881],"category_scores_gemma":[0.000115121366,0.000077217774,0.0001374222,0.00010060123,0.000011562084,0.000017475995,0.000095877374,0.000067644796,0.000013863113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037086193,0.0024242296,0.9572601,0.000016939815,0.00005162772,0.00015965172,0.0000636543,0.00002697594,0.0002199112,0.00016135091,0.0002557791,0.03898895],"study_design_scores_gemma":[0.052994177,0.002460264,0.92204267,0.00017424341,0.0005287062,0.00072395435,0.00031363982,0.0014806608,0.0045361356,0.0008828542,0.013586401,0.0002762701],"about_ca_topic_score_codex":0.000009731548,"about_ca_topic_score_gemma":0.0000075536145,"teacher_disagreement_score":0.052623317,"about_ca_system_score_codex":0.0001629988,"about_ca_system_score_gemma":0.00016706518,"threshold_uncertainty_score":0.31488496},"labels":[],"label_agreement":null},{"id":"W4293572277","doi":"10.1182/blood.2022016410","title":"Hypoxia and low temperature upregulate transferrin to induce hypercoagulability at high altitude","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"High Altitude and Hypoxia","field":"Biochemistry, Genetics and Molecular Biology","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Transferrin; Hypoxia (environmental); Thrombin; Downregulation and upregulation; Thrombomodulin; Transferrin receptor; Internal medicine; Immunology; Endocrinology; Chemistry; Pharmacology; Biology; Medicine; Biochemistry; Platelet; Gene","score_opus":0.006368878211548705,"score_gpt":0.2110415449489088,"score_spread":0.2046726667373601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293572277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981802,0.00064744125,0.0000040763966,0.0004170686,0.00010710305,0.0003074509,0.00012417875,0.000023270775,0.00018918101],"genre_scores_gemma":[0.99747795,0.00004171616,0.00027723337,0.00084145344,0.00015075169,0.000090861104,0.00012669463,0.000027435735,0.00096588983],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987344,0.00009060337,0.00017008778,0.000536262,0.00018374638,0.00028488197],"domain_scores_gemma":[0.99932396,0.00000758762,0.000021530823,0.00043907118,0.000033663317,0.00017418347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016658226,0.00018180597,0.00018012428,0.0000358969,0.00030388066,0.000024861485,0.00021850276,0.00011484557,0.00014495074],"category_scores_gemma":[0.000019625404,0.00018471507,0.00006609336,0.000113824026,0.000047177567,0.000003705728,0.0003538754,0.0001616543,0.000012860697],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008333808,0.0002775258,0.0055015874,0.000020477046,0.0000676632,0.000015029157,0.00009979393,0.000063704996,0.992845,0.00007184263,0.0007906431,0.00016339036],"study_design_scores_gemma":[0.001914633,0.0006713963,0.11340113,0.0000066566054,0.00007542251,0.000111715424,0.000043375687,0.0000017803302,0.85366374,0.000056670542,0.029648859,0.00040461426],"about_ca_topic_score_codex":0.000057351543,"about_ca_topic_score_gemma":0.00017836076,"teacher_disagreement_score":0.13918126,"about_ca_system_score_codex":0.000019099061,"about_ca_system_score_gemma":0.000048556587,"threshold_uncertainty_score":0.7532462},"labels":[],"label_agreement":null},{"id":"W4293794171","doi":"10.1182/blood.2022015797","title":"A randomized clinical trial of the efficacy and safety of rivipansel for sickle cell vaso-occlusive crisis","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Placebo; Discontinuation; Clinical endpoint; Population; Anesthesia; Randomized controlled trial; Hazard ratio; Subgroup analysis; Quartile; Internal medicine; Confidence interval","score_opus":0.016819256478985054,"score_gpt":0.2947300401887747,"score_spread":0.2779107837097896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293794171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937429,0.00087179994,0.00005802842,0.001091779,0.00035122674,0.0027463718,0.00005185396,0.000010968431,0.001075082],"genre_scores_gemma":[0.99876726,0.00040382837,0.00019290857,0.00023726268,0.000079256126,0.00006953713,0.000008196154,0.000014080735,0.00022764764],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99847126,0.00036096977,0.0006520983,0.00017167178,0.00021245217,0.00013154544],"domain_scores_gemma":[0.9979739,0.0013735513,0.00027525367,0.00025765208,0.00006316035,0.000056463676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015214189,0.00009080491,0.0007054172,0.00003459471,0.00011487442,0.0000019842535,0.00009951255,0.00008312919,0.00005862917],"category_scores_gemma":[0.0008353388,0.000055889715,0.00045342225,0.000135942,0.00017843157,0.00000917604,0.000121540725,0.00021805498,4.072278e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98737144,0.005216335,0.00036422763,0.00019450733,0.00063595775,0.000004097828,0.0016865542,0.00002974794,0.001314727,0.0003059483,0.0018506233,0.0010258373],"study_design_scores_gemma":[0.9901622,0.0014112727,0.00018072668,0.000026405942,0.0019093887,0.000008874529,0.0009997993,0.000092678114,0.0022436567,0.00015779394,0.002741301,0.000065880755],"about_ca_topic_score_codex":0.00003277908,"about_ca_topic_score_gemma":0.0000011141119,"teacher_disagreement_score":0.005024393,"about_ca_system_score_codex":0.0000059687336,"about_ca_system_score_gemma":0.00014497919,"threshold_uncertainty_score":0.22791165},"labels":[],"label_agreement":null},{"id":"W4296035094","doi":"10.1182/blood.2022016571","title":"The von Willebrand factor–binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia A","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"","keywords":"Pharmacokinetics; Medicine; Pharmacodynamics; Von Willebrand factor; Factor IX; Pharmacology; Tolerability; Coagulopathy; Internal medicine; Gastroenterology; Adverse effect; Platelet","score_opus":0.02967570965230623,"score_gpt":0.298548953806393,"score_spread":0.26887324415408675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296035094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991222,0.00137846,0.0000016497914,0.0036228837,0.000086482505,0.0016840986,0.00011526919,0.000045718534,0.001843404],"genre_scores_gemma":[0.9696676,0.00035255656,0.000102897015,0.00006161757,0.00012859284,0.00058670965,0.000057757068,0.000036545058,0.02900571],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99864435,0.00007072816,0.0001691306,0.00034298486,0.00035487887,0.00041794992],"domain_scores_gemma":[0.99914956,0.00030105741,0.000047994898,0.00028400903,0.00004090848,0.00017648889],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012866383,0.00020466998,0.00027079319,0.00008298129,0.001003836,0.000046889298,0.00008810679,0.000056199686,0.00028137583],"category_scores_gemma":[0.000059032347,0.00012363463,0.00015282042,0.00014011035,0.00008094704,0.000046232504,0.00009451281,0.00017105736,0.000022835093],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017661208,0.015094063,0.53105956,0.00087953924,0.009907457,0.0032234401,0.020492168,0.00001384313,0.08904727,0.002556648,0.009178469,0.30088636],"study_design_scores_gemma":[0.15037812,0.044542063,0.040802456,0.00034317328,0.0041647186,0.010564831,0.013787195,0.00093909114,0.066174805,0.002022807,0.66421086,0.0020698486],"about_ca_topic_score_codex":0.000043324675,"about_ca_topic_score_gemma":0.0000177516,"teacher_disagreement_score":0.6550324,"about_ca_system_score_codex":0.00015188103,"about_ca_system_score_gemma":0.00019605529,"threshold_uncertainty_score":0.7720797},"labels":[],"label_agreement":null},{"id":"W4296164616","doi":"10.1182/blood.2022016963","title":"Long-term follow-up of VIALE-C in patients with untreated AML ineligible for intensive chemotherapy","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Collège de Maisonneuve; Centres Intégré Universitaires de Santé et de Services Sociaux","funders":"","keywords":"Chemotherapy regimen; Medicine; Term (time); Internal medicine; Oncology; Chemotherapy","score_opus":0.013653420316964135,"score_gpt":0.2692680455346338,"score_spread":0.25561462521766964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296164616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99783105,0.00006178782,0.000029535635,0.00034630252,0.000048224396,0.0013983143,0.000064487955,0.000025917552,0.00019439255],"genre_scores_gemma":[0.99782306,0.000012565721,0.00026633273,0.000492954,0.00003535578,0.00018310151,0.00026044375,0.00004489294,0.0008813201],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881816,0.00003611994,0.00023424502,0.0002527234,0.00036605718,0.00029270325],"domain_scores_gemma":[0.9990434,0.00007055399,0.00008906524,0.0002932308,0.00042802515,0.00007574479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013200332,0.00013231247,0.00035502954,0.00024256438,0.00007127092,0.0000041712146,0.0001393282,0.00004710109,0.00017843355],"category_scores_gemma":[0.00011354853,0.00010759129,0.00006666936,0.00047473976,0.00005773704,0.000037510945,0.000113622904,0.0002172667,0.0000031318302],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060626506,0.0010915934,0.98664033,0.00011381198,0.00026567464,0.000046662113,0.00092302164,0.0000042906613,0.0028152154,0.000011758376,0.0009752735,0.0010497334],"study_design_scores_gemma":[0.1253661,0.0054326346,0.8263897,0.00013166397,0.00020966095,0.00002689743,0.00031569263,0.00006332357,0.041366376,0.000029176155,0.00044093913,0.00022784129],"about_ca_topic_score_codex":0.00010858967,"about_ca_topic_score_gemma":0.000031362466,"teacher_disagreement_score":0.16025063,"about_ca_system_score_codex":0.00017387618,"about_ca_system_score_gemma":0.0002540367,"threshold_uncertainty_score":0.43874454},"labels":[],"label_agreement":null},{"id":"W4297997099","doi":"10.1182/blood.2022017560","title":"Lost in translation: cytoplasmic UBA1 and VEXAS syndrome","year":2022,"lang":"en","type":"letter","venue":"Blood","topic":"Otitis Media and Relapsing Polychondritis","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Translation (biology); Medicine; Genetics; Biology; Gene","score_opus":0.01460980513551392,"score_gpt":0.23156321948288422,"score_spread":0.2169534143473703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297997099","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1920495,0.01672719,0.0000026859323,0.7660353,0.0107590575,0.0009987246,0.00020070086,0.00012015147,0.0131066935],"genre_scores_gemma":[0.03867542,0.0055348165,0.0017245582,0.73782825,0.0065160873,0.00020147642,0.0031291635,0.0004660171,0.20592421],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99856824,0.00006510919,0.00028957395,0.00039467006,0.0003666587,0.0003157383],"domain_scores_gemma":[0.99947333,0.00010710952,0.00006595896,0.00026777133,0.000011695286,0.00007413087],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000072622635,0.00023183237,0.0005093085,0.0003085865,0.00005028765,0.000020364647,0.000084031446,0.0005404995,0.0014404415],"category_scores_gemma":[0.000019190933,0.00023127944,0.00009488196,0.00019839674,0.00008962737,0.000036282432,0.00002807443,0.0019963898,0.00008733051],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033345594,0.0002629087,0.0073227435,0.00089406327,0.00017951425,0.05547527,0.00046928748,2.6424644e-7,0.00012115075,0.000004549895,0.93424743,0.0009894622],"study_design_scores_gemma":[0.0042430335,0.00044687494,0.0023720032,0.00051041617,0.0004179177,0.014926085,0.000018591903,0.0000023643852,0.000053812226,0.000042918058,0.9767066,0.00025935948],"about_ca_topic_score_codex":0.000035945854,"about_ca_topic_score_gemma":0.000023084734,"teacher_disagreement_score":0.19281752,"about_ca_system_score_codex":0.00003707297,"about_ca_system_score_gemma":0.000116680676,"threshold_uncertainty_score":0.9994724},"labels":[],"label_agreement":null},{"id":"W4300713440","doi":"10.1182/blood-2008-09-179630","title":"FAS-L, IL-10, and double-negative CD4−CD8− TCR α/β+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Agence Nationale de la Recherche; Fondation pour la Recherche Médicale; Institut National de la Santé et de la Recherche Médicale; E-Rare","keywords":"Autoimmune lymphoproliferative syndrome; Hypergammaglobulinemia; CD8; Fas receptor; Immunology; Apoptosis; Lymphoproliferative disorders; Autoimmunity; T cell; Biology; Cytotoxic T cell; Molecular biology; In vitro; Antigen; Immune system; Programmed cell death; Antibody; Genetics","score_opus":0.007031756609719515,"score_gpt":0.19612445454344132,"score_spread":0.1890926979337218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4300713440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99397945,0.0007561051,0.00006947179,0.000093801886,0.0006324139,0.00045707187,0.000035473287,0.00007591301,0.0039002711],"genre_scores_gemma":[0.98197925,0.000102697944,0.000034441862,0.000083313455,0.000008774163,0.000018705106,0.00013366857,0.000019598569,0.01761955],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99860084,0.00016508077,0.0004989443,0.00034762573,0.00008357982,0.00030393281],"domain_scores_gemma":[0.99855536,0.000120929355,0.0006588781,0.000269574,0.00037141505,0.000023824992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025516565,0.00026867713,0.0005558242,0.00018058486,0.00017196024,0.000015631907,0.00011077792,0.00032271066,0.0007699507],"category_scores_gemma":[0.00006262713,0.0002280208,0.00009946107,0.00030067062,0.00024219361,0.0002617493,0.000034138735,0.00027775345,0.000068334404],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009560356,0.0022171584,0.005249731,0.000069900656,0.0024407175,0.000020978854,0.0009874029,0.000061409984,0.9746219,0.00022134472,0.0041391845,0.00040992253],"study_design_scores_gemma":[0.014858517,0.0054855747,0.0960747,0.00044558448,0.00061272667,0.0002063996,0.001495418,0.000016619362,0.87876403,0.00007566889,0.00158019,0.0003845809],"about_ca_topic_score_codex":0.00013080852,"about_ca_topic_score_gemma":0.00001299506,"teacher_disagreement_score":0.09585787,"about_ca_system_score_codex":0.0000583841,"about_ca_system_score_gemma":0.00007830048,"threshold_uncertainty_score":0.9298418},"labels":[],"label_agreement":null},{"id":"W4302306840","doi":"10.1182/blood.2022017308","title":"Blastic plasmacytoid dendritic cell neoplasm in ocular adnexa","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Neoplasm; Medicine; Pathology; Immunology","score_opus":0.010590475981391565,"score_gpt":0.25274597474870236,"score_spread":0.2421554987673108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4302306840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98872584,0.0010034202,0.000016755324,0.000330078,0.000082934166,0.00058789086,0.000022895027,0.000054437784,0.009175751],"genre_scores_gemma":[0.99625146,0.000037264126,0.00016969396,0.00035032805,0.00005012529,0.00019403503,0.00003945934,0.00004453469,0.0028631066],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980785,0.0001461798,0.0002540176,0.00037311294,0.00065991987,0.00048823503],"domain_scores_gemma":[0.9992656,0.00016047135,0.000033664328,0.0003197075,0.000057001398,0.00016354413],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001961824,0.00016134793,0.00028926344,0.00030160657,0.00015966588,0.000020293257,0.00017421752,0.000047025176,0.0015401494],"category_scores_gemma":[0.00020217328,0.00017288477,0.00009222544,0.0005152779,0.000062387546,0.00003301423,0.00020564644,0.0004760947,0.00019628352],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014666006,0.017594315,0.7296589,0.000953605,0.00036302782,0.03230554,0.0044470346,0.0017731261,0.20523682,0.00042122355,0.003922339,0.0018574574],"study_design_scores_gemma":[0.20197977,0.01776767,0.0944896,0.0006378387,0.0019220659,0.08310539,0.023594644,0.034881998,0.44193545,0.003144128,0.09189043,0.004651023],"about_ca_topic_score_codex":0.00009329083,"about_ca_topic_score_gemma":0.0000806115,"teacher_disagreement_score":0.6351693,"about_ca_system_score_codex":0.00016600914,"about_ca_system_score_gemma":0.0003998032,"threshold_uncertainty_score":0.9993726},"labels":[],"label_agreement":null},{"id":"W4302532828","doi":"10.1182/blood-2006-05-021105.","title":"The mutational spectrum of type 1 von Willebrand disease: results from a Canadian cohort study","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Von Willebrand disease; Medicine; Cohort; Disease; Von Willebrand factor; Genetics; Internal medicine; Biology; Platelet","score_opus":0.007343378497822107,"score_gpt":0.24417570862319146,"score_spread":0.23683233012536936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4302532828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99432707,0.00043494892,6.767949e-7,0.0004930566,0.000068497415,0.00043336424,0.0001414678,0.000008197443,0.004092735],"genre_scores_gemma":[0.99924505,0.000022277425,0.00002165137,0.000051295538,0.000046499026,0.0000037961552,0.00019785843,0.000007187412,0.00040439176],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99936736,0.000011302084,0.00015412747,0.00012984201,0.00018629534,0.00015108145],"domain_scores_gemma":[0.9994689,0.000092210146,0.000050195522,0.00017543585,0.0000368876,0.00017633285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001420036,0.000063924876,0.00011913753,0.00003978742,0.00008196775,0.000006714402,0.000040912502,0.000020916947,0.00003485675],"category_scores_gemma":[0.00012589969,0.000042333282,0.00002690712,0.000104479725,0.00002703136,0.0000144941305,0.0000060702414,0.00004634351,0.000018190174],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006149424,0.00071949704,0.9962903,0.000001770811,0.00041999327,0.0011089594,0.00018862892,9.738394e-7,0.0000143184125,0.000028541379,0.00029835134,0.0003136887],"study_design_scores_gemma":[0.005268223,0.00018623071,0.99290127,0.000011849744,0.0003287418,0.000008239723,0.0001446997,0.0000074027807,0.00011388262,0.0002469774,0.00074204593,0.000040426865],"about_ca_topic_score_codex":0.039053645,"about_ca_topic_score_gemma":0.15087454,"teacher_disagreement_score":0.1118209,"about_ca_system_score_codex":0.000022387734,"about_ca_system_score_gemma":0.0001987654,"threshold_uncertainty_score":0.96734536},"labels":[],"label_agreement":null},{"id":"W4302742543","doi":"10.1182/blood.2022016534","title":"Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; Spinal Cord Injury BC; Simon Fraser University","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Lymphoma; Somatic hypermutation; Burkitt's lymphoma; Biology; Cancer research; Immunology; Genetics; Medicine; B cell; Antibody","score_opus":0.00705122267271078,"score_gpt":0.2161619672365638,"score_spread":0.20911074456385303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4302742543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968839,0.0011420571,1.710299e-7,0.0002418091,0.00007829465,0.00027913653,0.000017538403,0.000024563911,0.0013324749],"genre_scores_gemma":[0.9980092,0.0006147185,0.000102907296,0.0008527328,0.00010242011,0.00021834133,0.000025538648,0.000011232087,0.00006293252],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99924,0.000029175764,0.0001793553,0.00021338895,0.00013699103,0.00020112206],"domain_scores_gemma":[0.99962634,0.000060826445,0.00004359625,0.0001749491,0.000017039982,0.00007724045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005938751,0.00011242401,0.00019232249,0.00014470452,0.00006539965,0.0000062023632,0.000045193374,0.000043311877,0.000072266295],"category_scores_gemma":[0.000027876247,0.0000937604,0.000040135477,0.00017401858,0.00001680556,0.000014424486,0.00007696552,0.00005391948,0.000022284861],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079689504,0.0019971994,0.9846041,0.00002486676,0.000027724558,0.000611376,0.00023317507,0.0000027059093,0.00004558683,0.00028611644,0.00015064483,0.011936785],"study_design_scores_gemma":[0.011679172,0.0015638998,0.98461235,0.0000068170475,0.00014310308,0.00039832172,0.00010439941,0.000014884022,0.0002718889,0.00005565632,0.001054141,0.00009534835],"about_ca_topic_score_codex":0.00014823921,"about_ca_topic_score_gemma":0.000024304929,"teacher_disagreement_score":0.011841437,"about_ca_system_score_codex":0.00008882624,"about_ca_system_score_gemma":0.00007307794,"threshold_uncertainty_score":0.38234383},"labels":[],"label_agreement":null},{"id":"W4304588764","doi":"10.1182/blood.2022016095","title":"Minimal information for reporting a genomics experiment","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"National Cancer Institute; European Bioinformatics Institute","keywords":"Exome; Genomics; Exome sequencing; Biology; Computational biology; Identification (biology); Genome; Data quality; Genetics; Bioinformatics; Gene; Mutation","score_opus":0.012413227300262826,"score_gpt":0.25131453707616647,"score_spread":0.23890130977590365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304588764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971403,0.00040381556,0.00090475526,0.000068208916,0.00017115455,0.00022170554,0.00009226612,0.000005989326,0.0009918192],"genre_scores_gemma":[0.9958749,0.000027811158,0.0027774097,0.00037884034,0.00019399967,0.00027441644,0.00036604865,0.000009520207,0.000097054006],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994319,0.000005768954,0.00029342624,0.00010195237,0.00005416696,0.00011277339],"domain_scores_gemma":[0.9995301,0.000006932469,0.00026143345,0.0001435698,0.000030078385,0.00002789038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016028355,0.000053222455,0.000058831745,0.000017396107,0.00012469149,0.000018368886,0.00007340478,0.000022047529,0.000013131425],"category_scores_gemma":[0.00013463818,0.00006315322,0.000057269375,0.000021675209,0.0000075965345,0.0000018302885,0.00013545518,0.000026855998,0.0000011157074],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018404264,0.00030210236,0.0018970288,0.000027389657,0.00009941928,0.0000037486977,0.0006247784,0.0011908292,0.9806895,0.0006196408,0.01066377,0.0036976947],"study_design_scores_gemma":[0.0012258942,0.00047601992,0.0002633193,9.0431416e-7,0.000024743866,0.000033625056,0.00046601583,0.00011014758,0.4062278,0.00007093265,0.5909692,0.00013141388],"about_ca_topic_score_codex":0.000008929267,"about_ca_topic_score_gemma":0.0000024338162,"teacher_disagreement_score":0.58030546,"about_ca_system_score_codex":0.000018857812,"about_ca_system_score_gemma":0.00009937845,"threshold_uncertainty_score":0.25753134},"labels":[],"label_agreement":null},{"id":"W4306940023","doi":"10.1182/blood.2022016362","title":"Venetoclax and idasanutlin in relapsed/refractory AML: a nonrandomized, open-label phase 1b trial","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Jewish General Hospital; Princess Margaret Cancer Centre","funders":"Foundation Medicine; Genentech","keywords":"Venetoclax; Medicine; Internal medicine; Gastroenterology; Neutropenia; Febrile neutropenia; Oncology; Leukemia; Chemotherapy; Chronic lymphocytic leukemia","score_opus":0.04777988147615729,"score_gpt":0.35964469803717614,"score_spread":0.31186481656101883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306940023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915249,0.0012168536,0.000006467215,0.0005875053,0.00016522696,0.0031535786,0.000042713174,0.000043623277,0.0032591596],"genre_scores_gemma":[0.99408686,0.00017303361,0.0007549077,0.00068574055,0.00032651695,0.001115747,0.000078447854,0.000061843835,0.0027168882],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9976927,0.00043531499,0.00044948846,0.0004800247,0.0005092821,0.00043319864],"domain_scores_gemma":[0.99878114,0.000373486,0.00010532327,0.0004662803,0.000042857846,0.00023088035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016558636,0.00018638065,0.00063149654,0.00027110608,0.00017257864,0.000052238265,0.0003602421,0.00009671515,0.00055226556],"category_scores_gemma":[0.0005530044,0.00017626733,0.000055463257,0.00043187133,0.00008946281,0.000092021306,0.0007197538,0.0009888381,0.000030904655],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8875256,0.037526023,0.00078724587,0.00013372538,0.00048188257,0.0039708703,0.0013965571,0.00000710799,0.040905442,0.0001883222,0.012641004,0.014436188],"study_design_scores_gemma":[0.96745664,0.0064305663,0.00008093751,0.00003716773,0.00016460425,0.0002084341,0.0002155859,0.000577618,0.0011249944,0.00008511677,0.023430225,0.00018809758],"about_ca_topic_score_codex":0.00032990935,"about_ca_topic_score_gemma":0.000029141413,"teacher_disagreement_score":0.07993102,"about_ca_system_score_codex":0.00038408302,"about_ca_system_score_gemma":0.0011739554,"threshold_uncertainty_score":0.7187973},"labels":[],"label_agreement":null},{"id":"W4307440076","doi":"10.1182/blood.2022018248","title":"Molecular Determinants of Clinical Outcomes In a Real-World Diffuse Large B-cell Lymphoma Population","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Simon Fraser University; BC Cancer Agency; Kelowna General Hospital; Spinal Cord Injury BC; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Population; Germinal center; Oncology; Internal medicine; Fluorescence in situ hybridization; Biology; Cancer research; Medicine; B cell; Immunology; Antibody; Gene; Genetics","score_opus":0.02772950040507347,"score_gpt":0.3427468016348526,"score_spread":0.3150173012297791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307440076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983889,0.000121085155,3.5115545e-7,0.000068971596,0.00009732658,0.0003270894,0.00003670616,0.000021241503,0.0009383623],"genre_scores_gemma":[0.99917436,0.000043439006,0.00015412863,0.00021117565,0.000018534356,0.00009503799,0.0000452419,0.000017430728,0.00024067273],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861085,0.00010987988,0.00057509635,0.00023391366,0.00028080784,0.00018942545],"domain_scores_gemma":[0.9993142,0.000106331485,0.00017060946,0.00031333332,0.000017480319,0.000078077246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024994568,0.00011277177,0.00050350546,0.00013733751,0.00003930273,0.0000038067953,0.000068877576,0.0000386964,0.000045405923],"category_scores_gemma":[0.00005865043,0.00009538561,0.00020123237,0.00018953395,0.000012613055,0.000023248498,0.000101731915,0.00005328563,0.0000060706257],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007638186,0.03941488,0.9571873,0.000028783998,0.000055274475,0.00072346383,0.000059350637,0.0000010347117,0.000055701774,0.000107549145,0.000020682048,0.0022696306],"study_design_scores_gemma":[0.04283171,0.00039069695,0.95362,0.000023196439,0.00022217637,0.000014586958,0.00003483772,0.00007107844,0.0024718018,0.000034924033,0.00020524075,0.000079714],"about_ca_topic_score_codex":0.0012136857,"about_ca_topic_score_gemma":0.00046445185,"teacher_disagreement_score":0.04275533,"about_ca_system_score_codex":0.00007042632,"about_ca_system_score_gemma":0.00006883176,"threshold_uncertainty_score":0.3889712},"labels":[],"label_agreement":null},{"id":"W4307502338","doi":"10.1182/blood.2022016505","title":"Concerning data inconsistencies in Burkitt lymphoma genome study","year":2022,"lang":"en","type":"letter","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"","keywords":"Burkitt's lymphoma; Lymphoma; Medicine; Genome; Virology; Computational biology; Biology; Genetics; Immunology; Gene","score_opus":0.03238338119134524,"score_gpt":0.2550765384674281,"score_spread":0.22269315727608288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307502338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9581028,0.013419054,0.000011162453,0.020131567,0.0009622775,0.0011852757,0.003108042,0.000031126536,0.0030486498],"genre_scores_gemma":[0.5717519,0.002526687,0.00043103794,0.37576577,0.011335703,0.00047794345,0.034364305,0.00032972646,0.0030169005],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99804413,0.0001140709,0.00035442537,0.0008860335,0.00023830053,0.00036306022],"domain_scores_gemma":[0.9980843,0.000057810816,0.00016788291,0.001612401,0.000037624242,0.000039991886],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002546925,0.0002896399,0.00034173985,0.00009711134,0.000098801705,0.00006362097,0.0011389931,0.0003117443,0.0001114118],"category_scores_gemma":[0.00015153456,0.00033178105,0.00006997092,0.000110724446,0.00006295076,0.0000025949325,0.0021033844,0.00041470263,0.000009808268],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012226093,0.0020630532,0.03233653,0.00019655387,0.0012735567,0.005238259,0.0006920324,0.00012860478,0.011669162,0.000006648469,0.9447669,0.0015064769],"study_design_scores_gemma":[0.0020945491,0.000488566,0.0019227837,0.000009794986,0.00016978162,0.000057860438,0.0003319041,0.0000042731517,0.00019898213,0.000009982246,0.9942818,0.00042968747],"about_ca_topic_score_codex":0.00045554552,"about_ca_topic_score_gemma":0.00044949414,"teacher_disagreement_score":0.38635093,"about_ca_system_score_codex":0.000050668456,"about_ca_system_score_gemma":0.0004356951,"threshold_uncertainty_score":0.9999134},"labels":[],"label_agreement":null},{"id":"W4307743190","doi":"10.1182/blood.2022017079","title":"Noncanonical β-catenin interactions promote leukemia-initiating activity in early T-cell acute lymphoblastic leukemia","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; Terry Fox Research Institute","funders":"","keywords":"Cancer research; Leukemia; Biology; Minimal residual disease; Stem cell; Cell cycle; Cell; Cell biology; Immunology; Genetics","score_opus":0.017065523789394146,"score_gpt":0.2796340491265029,"score_spread":0.2625685253371088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307743190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98918176,0.00006314445,0.0002941043,0.00035868626,0.00025924324,0.00086194556,0.000075048185,0.0001782766,0.008727792],"genre_scores_gemma":[0.99518067,0.000021480593,0.0012596782,0.00026051947,0.00025496288,0.00046836815,0.000058826816,0.000107008964,0.0023884918],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99621797,0.00031546797,0.00059407076,0.0008074252,0.0010679172,0.0009971246],"domain_scores_gemma":[0.9980581,0.00059637026,0.00021830731,0.0006201082,0.00012055194,0.00038657652],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00058339565,0.00037396152,0.0006433478,0.0004959993,0.00039007035,0.000067830246,0.00044506762,0.00014554303,0.00051294005],"category_scores_gemma":[0.0003252236,0.0003850065,0.00022157126,0.0010944906,0.00013968653,0.0002759539,0.00076264073,0.0016388989,0.000211552],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.003887464,0.006794445,0.050721467,0.00048848585,0.0011970523,0.012822964,0.0041274983,0.0012864108,0.9070044,0.00017627102,0.0031414249,0.008352098],"study_design_scores_gemma":[0.14392519,0.0108056795,0.19311088,0.0009603139,0.003617771,0.014652244,0.0015341779,0.12080008,0.49711713,0.00040287714,0.009598174,0.0034754982],"about_ca_topic_score_codex":0.0011433648,"about_ca_topic_score_gemma":0.000075652555,"teacher_disagreement_score":0.4098873,"about_ca_system_score_codex":0.0075996704,"about_ca_system_score_gemma":0.006312601,"threshold_uncertainty_score":0.99986017},"labels":[],"label_agreement":null},{"id":"W4308256825","doi":"10.1182/blood.2022016975","title":"EBV-driven lymphoid neoplasms associated with pediatric ALL maintenance therapy","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Western Ontario; Western University","funders":"Tel Aviv University; Novo Nordisk; Jazz Pharmaceuticals; Israel Cancer Association; Servier; Amgen","keywords":"Medicine; Immunology; Hematologic Neoplasms; Maintenance therapy; Cancer; Internal medicine; Chemotherapy","score_opus":0.01579448630697483,"score_gpt":0.24762921075754235,"score_spread":0.23183472445056752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308256825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940418,0.00039198506,0.00007791973,0.0007972996,0.000097705684,0.00058445864,0.000055244247,0.00017848818,0.003775081],"genre_scores_gemma":[0.99266565,0.00025887124,0.00049836317,0.0014808984,0.00022987946,0.00020730036,0.000108102584,0.000075543474,0.004475411],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9975986,0.0001295179,0.00023080956,0.00041112385,0.0010005285,0.0006294369],"domain_scores_gemma":[0.9988541,0.0002467311,0.0001242914,0.0004152597,0.0001391027,0.00022049715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029258544,0.00020727894,0.00033003755,0.00016886924,0.00019355868,0.000021024514,0.00028805019,0.00007319045,0.00060433854],"category_scores_gemma":[0.00018312888,0.00015961037,0.00009249336,0.0006942814,0.00006843197,0.00005320451,0.00017133253,0.0003692153,0.00006230181],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003798188,0.009596404,0.8908169,0.000108919136,0.0022171552,0.00739817,0.0031983806,0.0004966372,0.012302068,0.0002733256,0.06711047,0.002683354],"study_design_scores_gemma":[0.44001818,0.033143062,0.35727185,0.00028728167,0.004052833,0.017207978,0.003189725,0.01582705,0.017841542,0.0004973347,0.10682749,0.0038356765],"about_ca_topic_score_codex":0.000090218484,"about_ca_topic_score_gemma":0.000010938698,"teacher_disagreement_score":0.5335451,"about_ca_system_score_codex":0.00071304146,"about_ca_system_score_gemma":0.0011783928,"threshold_uncertainty_score":0.6617083},"labels":[],"label_agreement":null},{"id":"W4308683890","doi":"10.1182/blood.2022016987","title":"Liver sinusoidal endothelial cells induce BMP6 expression in response to non–transferrin-bound iron","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; McGill University; Jewish General Hospital","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Hepcidin; Bone morphogenetic protein 6; HAMP; Transferrin; Biology; Internal medicine; Endocrinology; Transferrin receptor; Cell biology; Bone morphogenetic protein; Medicine; Immunology; Biochemistry; Bone morphogenetic protein 7; Gene; Inflammation","score_opus":0.010624823205174735,"score_gpt":0.24074270580739063,"score_spread":0.23011788260221588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308683890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967648,0.0002886362,0.000035746925,0.0003456802,0.000252781,0.0005767076,0.00006664383,0.000037796173,0.0016312039],"genre_scores_gemma":[0.995868,0.00002209702,0.00048037598,0.001035274,0.00014305399,0.00009179648,0.000012094158,0.000034240038,0.0023130171],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99846685,0.00021244377,0.00023064732,0.0003382267,0.0004150346,0.00033677503],"domain_scores_gemma":[0.9993878,0.000076965116,0.000027206699,0.00032354236,0.000018503019,0.00016599912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004100943,0.00016064025,0.00024242714,0.00025017824,0.0001262031,0.000015023875,0.00015346285,0.00006748398,0.00084558956],"category_scores_gemma":[0.00006077431,0.00015722708,0.000072641764,0.00026956073,0.00003043576,0.000055931643,0.000115116105,0.0003296911,0.000109972294],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037828365,0.0012268353,0.001504922,0.000047735793,0.0000041266103,0.00035480782,0.0040673623,0.000072437375,0.987269,0.000009765137,0.00087295723,0.00078724325],"study_design_scores_gemma":[0.023315366,0.0015463195,0.09128223,0.000091778806,0.00016792631,0.00010832983,0.0020882278,0.000017001015,0.82069194,0.000030333706,0.06013743,0.00052309973],"about_ca_topic_score_codex":0.0001634565,"about_ca_topic_score_gemma":0.000029467166,"teacher_disagreement_score":0.16657703,"about_ca_system_score_codex":0.000039430706,"about_ca_system_score_gemma":0.00017219342,"threshold_uncertainty_score":0.92586124},"labels":[],"label_agreement":null},{"id":"W4309028432","doi":"10.1182/blood.2022017051","title":"Hydroxyurea treatment is associated with lower malaria incidence in children with sickle cell anemia in sub-Saharan Africa","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"National Heart, Lung, and Blood Institute; Medical Research Council; Wellcome Trust","keywords":"Malaria; Medicine; Incidence (geometry); Anemia; Hazard ratio; Internal medicine; Fetal hemoglobin; Confidence interval; Gastroenterology; Plasmodium falciparum; Immunology; Biology; Pregnancy; Fetus","score_opus":0.004862537560545084,"score_gpt":0.18896148633622084,"score_spread":0.18409894877567576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309028432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99303854,0.0017878411,7.789833e-7,0.0004515576,0.00002029009,0.000776369,0.000032243588,0.000049173526,0.0038432279],"genre_scores_gemma":[0.99846655,0.00026957862,0.000036757407,0.000194172,0.000012290868,0.00010827683,0.00008751118,0.000036387082,0.000788504],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985884,0.00007296441,0.0002269098,0.00036164347,0.00034895632,0.00040116772],"domain_scores_gemma":[0.99948657,0.000024683279,0.00009057508,0.0002707683,0.000023519562,0.00010386504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014450708,0.0002187353,0.00034730128,0.00016456893,0.000089782116,0.000011533549,0.00010040009,0.000107200845,0.00026464683],"category_scores_gemma":[0.000013450789,0.00015759692,0.00004812872,0.0007554003,0.000051020583,0.000048803315,0.00004447801,0.00040869598,0.000016106012],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005391039,0.0067430018,0.9861236,0.000015405145,0.00023733506,0.0014989701,0.0018916856,0.00050571613,0.0014569468,0.0000039330967,0.0007678503,0.00021640841],"study_design_scores_gemma":[0.056835692,0.010229497,0.9210771,0.00037618287,0.0010397022,0.0005685682,0.00071596995,0.00038419184,0.0063251415,0.00003051067,0.0015996168,0.0008178536],"about_ca_topic_score_codex":0.00067697087,"about_ca_topic_score_gemma":0.00028593163,"teacher_disagreement_score":0.06504657,"about_ca_system_score_codex":0.00023189587,"about_ca_system_score_gemma":0.00023408026,"threshold_uncertainty_score":0.6426616},"labels":[],"label_agreement":null},{"id":"W4309413183","doi":"10.1182/blood.2022017865","title":"North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Interleukin-3 receptor; Hematologic malignancy; Transplantation; Hematopoietic cell; Hematologic Neoplasms; Plasmacytoid dendritic cell; Stem cell; Internal medicine; Oncology; Intensive care medicine; Haematopoiesis; Myeloid; Immunology; Dendritic cell; Immune system","score_opus":0.0064188035435533706,"score_gpt":0.25934672256621283,"score_spread":0.25292791902265943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309413183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99621284,0.00040247088,0.000011436921,0.00007024377,0.000023584333,0.00045066554,0.00067449675,0.00001793708,0.002136333],"genre_scores_gemma":[0.999548,0.00007245212,0.00008055233,0.000068237125,0.0000145820795,0.000035939494,0.00009122886,0.000024384855,0.00006462722],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99842674,0.00010496594,0.0002494011,0.0002312062,0.00077495485,0.00021270926],"domain_scores_gemma":[0.99904186,0.0001823594,0.00011867404,0.0002071602,0.00033454862,0.000115417424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000075109405,0.0001289504,0.00037831863,0.00020971228,0.00010335563,0.0000064748388,0.000070953356,0.000018726763,0.00009847364],"category_scores_gemma":[0.00014313456,0.00013005637,0.000065926004,0.00034965167,0.00025785045,0.000016126045,0.00007795208,0.00018510617,0.0000014796074],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036252253,0.0023614103,0.9508696,0.0012590706,0.00026420638,0.00052555103,0.004324685,0.00038769544,0.034070365,0.00006241185,0.00020998085,0.0020397785],"study_design_scores_gemma":[0.037654378,0.056996066,0.31989068,0.00047566436,0.0016552567,0.0046419557,0.045231935,0.0012073572,0.5304772,0.000057417765,0.00079638546,0.0009156904],"about_ca_topic_score_codex":0.00016121958,"about_ca_topic_score_gemma":0.00031453258,"teacher_disagreement_score":0.63097894,"about_ca_system_score_codex":0.000117043346,"about_ca_system_score_gemma":0.0004591344,"threshold_uncertainty_score":0.5303545},"labels":[],"label_agreement":null},{"id":"W4310089851","doi":"10.1182/blood-2022-164874","title":"Real-World Experience with Ruxolitinib Therapy for Steroid Refractory Acute Graft Versus Host Disease","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Université Laval; Princess Margaret Cancer Centre; University of Saskatchewan; University of Calgary","funders":"","keywords":"Ruxolitinib; Medicine; Discontinuation; Internal medicine; Population; Retrospective cohort study; Salvage therapy; Clinical trial; Hematopoietic stem cell transplantation; Transplantation; Myelofibrosis; Bone marrow; Chemotherapy","score_opus":0.029077446136282634,"score_gpt":0.3066607279424573,"score_spread":0.27758328180617464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310089851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955975,0.00015557132,0.00010196563,0.000344428,0.00019957793,0.0009903677,0.00017268673,0.00010228678,0.0023356113],"genre_scores_gemma":[0.99619395,0.00015353301,0.00082400494,0.00028935756,0.00011117308,0.0009036987,0.00020612676,0.0000445649,0.0012736035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988115,0.00004315835,0.00019439765,0.00031252502,0.00037755843,0.00026090312],"domain_scores_gemma":[0.9991601,0.00015013444,0.00007633467,0.00036265238,0.00004894249,0.00020182773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009712656,0.00014811866,0.00020210235,0.00008465689,0.00016888308,0.000013966752,0.00010946888,0.00001953421,0.000265505],"category_scores_gemma":[0.000009602831,0.00012533707,0.00007132505,0.00017664686,0.000052544285,0.00006286491,0.000016560794,0.000121288984,0.0000064912406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17643149,0.017058639,0.408644,0.0021224266,0.004193884,0.0063491846,0.05441341,0.000029264496,0.3171108,0.006551988,0.0029969397,0.0040979716],"study_design_scores_gemma":[0.19624199,0.018448845,0.50293124,0.0005737624,0.0044004363,0.00047399208,0.009474743,0.00013685206,0.16659169,0.00014887334,0.09862821,0.0019493599],"about_ca_topic_score_codex":0.000030676933,"about_ca_topic_score_gemma":0.000012230464,"teacher_disagreement_score":0.15051912,"about_ca_system_score_codex":0.000047574344,"about_ca_system_score_gemma":0.00016658405,"threshold_uncertainty_score":0.51110977},"labels":[],"label_agreement":null},{"id":"W4310089938","doi":"10.1182/blood-2022-165775","title":"Phase I Study Evaluating Outcomes of Autologous HIV-Specific T Cells Targeting Non-Escaped Epitopes (HST-NEET) Therapy in HIV+ Individuals on ART (NCT03485963)","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AIDS Vancouver; Simon Fraser University","funders":"","keywords":"Epitope; Medicine; Immunology; Adverse effect; Virology; Antibody; Immune system; Viral load; CD8; Internal medicine; Human immunodeficiency virus (HIV)","score_opus":0.032001243666104476,"score_gpt":0.32334165159981076,"score_spread":0.2913404079337063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310089938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99559814,0.0015693001,0.000003849912,0.0001653115,0.00023290358,0.0014320075,0.00033922167,0.000051196595,0.000608077],"genre_scores_gemma":[0.99760365,0.00008735871,0.0001817165,0.000057472855,0.000019820523,0.00041417617,0.00038944167,0.000028827959,0.0012175551],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99693024,0.0011286441,0.0005993171,0.00051466003,0.00021769332,0.000609421],"domain_scores_gemma":[0.9986613,0.00059644156,0.00022318476,0.00042827975,0.000051769053,0.0000390554],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001264732,0.0002827479,0.0006234889,0.00034657167,0.00035939377,0.000018028788,0.00040721358,0.00009343765,0.0020112148],"category_scores_gemma":[0.00008880639,0.00023271392,0.00013923846,0.00029421717,0.000092657334,0.000051759765,0.00022235644,0.00054318237,0.0008183156],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010214563,0.055749577,0.42256898,0.000019271229,0.0019307496,0.00028772888,0.010774498,0.0002450223,0.47960803,0.000026899872,0.0084101055,0.019357687],"study_design_scores_gemma":[0.18088551,0.04831342,0.21555871,0.000062890125,0.0002947559,0.00005383883,0.016527703,0.000033711916,0.5172058,0.000107256725,0.019798828,0.0011575718],"about_ca_topic_score_codex":0.00004801287,"about_ca_topic_score_gemma":0.0000072723687,"teacher_disagreement_score":0.20701027,"about_ca_system_score_codex":0.00006356565,"about_ca_system_score_gemma":0.00012056169,"threshold_uncertainty_score":0.99995965},"labels":[],"label_agreement":null},{"id":"W4310090075","doi":"10.1182/blood-2022-165440","title":"Treatment Patterns and Outcomes in Adolescent and Young Adults with Nodular Lymphocyte Predominant Hodgkin Lymphoma: An Impact Cohort Population-Based Study","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Institute for Clinical Evaluative Sciences; Princess Margaret Cancer Centre; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Lymphoma; Cohort; Young adult; Hodgkin lymphoma; Lymphocyte; Population; Cohort study; Immunology; Internal medicine; Oncology; Gerontology; Environmental health","score_opus":0.011001187158341735,"score_gpt":0.26756732155693325,"score_spread":0.2565661343985915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310090075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969535,0.0004055217,0.0000013343422,0.00007550465,0.000037132704,0.002351215,0.00012826554,0.000039112707,0.000008429019],"genre_scores_gemma":[0.9987183,0.000057844707,0.0000729012,0.00006832669,0.000021237272,0.00081225025,0.00019507052,0.00003515531,0.000018898421],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99838364,0.0001254313,0.00028753967,0.000552039,0.00036594676,0.0002854153],"domain_scores_gemma":[0.9992425,0.000039915933,0.00009961889,0.00039087134,0.000025975814,0.00020114741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000112756104,0.00031837702,0.0005613221,0.00016178412,0.00016051841,0.000036668258,0.00004830217,0.000034457298,0.00003292689],"category_scores_gemma":[0.000008053349,0.00020867547,0.000065148946,0.00012217903,0.00001718043,0.000061835686,0.000048516475,0.000037316328,7.9253385e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011207677,0.0239648,0.96624345,0.000033995864,0.00044579033,0.0013106479,0.0009913935,0.000041309704,0.000007783795,0.0000013370383,9.99501e-7,0.005837729],"study_design_scores_gemma":[0.07041763,0.008711673,0.9180143,0.00007214805,0.00082881923,0.00025387167,0.0009269389,0.00039894116,0.00016723413,7.787521e-7,0.000005568963,0.0002021189],"about_ca_topic_score_codex":0.018717257,"about_ca_topic_score_gemma":0.0029663076,"teacher_disagreement_score":0.06929686,"about_ca_system_score_codex":0.0008654418,"about_ca_system_score_gemma":0.00017287127,"threshold_uncertainty_score":0.98781717},"labels":[],"label_agreement":null},{"id":"W4310092952","doi":"10.1182/blood-2022-157256","title":"Analysis of Immune Pharmacodynamic and Baseline Biomarkers in Patients with Relapsed or Refractory Follicular Lymphoma Treated with Mosunetuzumab in Combination with Lenalidomide","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Lenalidomide; Follicular lymphoma; Internal medicine; Lymphoma; Gastroenterology; Pharmacodynamics; CD20; Rituximab; Oncology; Immunology; Pharmacokinetics; Multiple myeloma","score_opus":0.005207669908985609,"score_gpt":0.21806182011278613,"score_spread":0.21285415020380052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310092952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99862653,0.0003973636,0.000004539126,0.00006806675,0.000006574544,0.0007666389,0.000061630926,0.000019241359,0.000049439495],"genre_scores_gemma":[0.99869394,0.00005887207,0.00020282113,0.000041928182,0.0000020630284,0.00020186203,0.00073930493,0.000026573507,0.00003260336],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984938,0.00015473283,0.00038270053,0.00035114423,0.00042291515,0.00019471323],"domain_scores_gemma":[0.9992562,0.000098330034,0.00023192294,0.00026047468,0.00008402529,0.0000690567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022087958,0.0002092773,0.0005932387,0.0007214716,0.00005393988,0.000007504056,0.00005509496,0.000035905472,0.00006631202],"category_scores_gemma":[0.000015666532,0.00013010348,0.000055231412,0.001895874,0.000060108527,0.0000779756,0.000030283696,0.00006304762,2.537055e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014288136,0.011438432,0.96551853,0.00004171325,0.004731571,0.00053453824,0.00019292887,0.00035746142,0.00029044342,0.0000032828627,0.0000030332023,0.0025999288],"study_design_scores_gemma":[0.11679718,0.0046163737,0.86986196,0.00012321312,0.0046151225,0.000020077941,0.00018755015,0.0023133832,0.0012947473,4.764799e-7,0.000016350356,0.00015357225],"about_ca_topic_score_codex":0.0016946528,"about_ca_topic_score_gemma":0.00057261885,"teacher_disagreement_score":0.102509044,"about_ca_system_score_codex":0.00034926724,"about_ca_system_score_gemma":0.0001544824,"threshold_uncertainty_score":0.5305466},"labels":[],"label_agreement":null},{"id":"W4310093222","doi":"10.1182/blood-2022-157679","title":"Polatuzumab Vedotin Plus Bendamustine and Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL): Final Results of a Phase Ib/II Randomized Study and Single-Arm Extension (Ext) Study","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Bendamustine; Rituximab; Medicine; Diffuse large B-cell lymphoma; Internal medicine; Refractory (planetary science); Phases of clinical research; Oncology; Lymphoma; Chemotherapy; Materials science","score_opus":0.021954608644807205,"score_gpt":0.2717345479628102,"score_spread":0.24977993931800302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310093222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99087423,0.0048787156,7.5507774e-7,0.000131365,0.00011188899,0.0035942362,0.00016570224,0.000053044103,0.00019005101],"genre_scores_gemma":[0.9989193,0.00012681501,0.00011238215,0.000084675834,0.000051123876,0.00037180292,0.00008277402,0.000047098823,0.00020404122],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9965283,0.0005975611,0.0010021621,0.0008172567,0.00063915754,0.00041553297],"domain_scores_gemma":[0.998119,0.00060881936,0.00039243896,0.000580352,0.00008859714,0.00021076968],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011273581,0.00040061187,0.0015143774,0.0003804773,0.00032847348,0.000024669962,0.000111191825,0.000077487595,0.000026789536],"category_scores_gemma":[0.00042641786,0.00033014888,0.00014361138,0.00035001276,0.000101859936,0.000069130634,0.00049620686,0.0002148664,0.0000018784704],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14596207,0.82184,0.011979582,0.00007991358,0.0004416288,0.0027411547,0.011690248,0.0000011452877,0.0013435583,0.000008862989,0.00009297149,0.0038188573],"study_design_scores_gemma":[0.9377586,0.024920229,0.027259413,0.0000988967,0.0018953452,0.00018280806,0.0063059493,0.0003799569,0.00069086935,0.000012324896,0.00023004104,0.00026555208],"about_ca_topic_score_codex":0.00072584784,"about_ca_topic_score_gemma":0.00016515798,"teacher_disagreement_score":0.79691976,"about_ca_system_score_codex":0.0002481987,"about_ca_system_score_gemma":0.00021589526,"threshold_uncertainty_score":0.99991506},"labels":[],"label_agreement":null},{"id":"W4310093492","doi":"10.1182/blood-2022-168675","title":"The Empower Study - Design of a Randomized Clinical Trial to Assess the Efficacy and Safety of a Plasma-Derived Von Willebrand Factor / Factor VIII Concentrate for Heavy Menstrual Bleeding in Women with Von Willebrand Disease","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; Queen Elizabeth II Health Sciences Centre; University of Alberta; Queen's University; St. Paul's Hospital; Health Sciences Centre; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Von Willebrand disease; Von Willebrand factor; Randomized controlled trial; Placebo; Crossover study; Menstruation; Clinical trial; Pediatrics; Internal medicine; Obstetrics","score_opus":0.0504650170704808,"score_gpt":0.331584281593129,"score_spread":0.28111926452264824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310093492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834502,0.00021942335,0.00014881162,0.0005562133,0.00016359847,0.015241804,0.00019576398,0.000013419457,0.000010812275],"genre_scores_gemma":[0.9963855,0.00016281684,0.00016773194,0.000084312014,0.00007424868,0.0030667945,0.00000871374,0.000030176672,0.00001967403],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99615794,0.0014085424,0.0010731682,0.00045608266,0.000537543,0.00036673938],"domain_scores_gemma":[0.99058205,0.008329643,0.00039964815,0.00030862016,0.00012434222,0.00025570428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002231739,0.00029270552,0.0014577878,0.00007432488,0.00031895397,0.000040863557,0.00014732666,0.00004602173,0.00005228323],"category_scores_gemma":[0.0012871447,0.00014550783,0.00015579871,0.00020059219,0.00024723055,0.000052676114,0.00009873272,0.00022581436,2.2341284e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9097616,0.005727325,0.07389743,0.00004008081,0.0020468829,0.000024609073,0.0070434394,0.000083141866,0.00044741464,0.000036525824,0.000019931575,0.0008716024],"study_design_scores_gemma":[0.91437966,0.015024581,0.06417157,0.00012219317,0.0010321344,0.0000053732456,0.003143339,0.00023276819,0.0015813246,0.000014137937,0.00010846067,0.00018446552],"about_ca_topic_score_codex":0.000013913526,"about_ca_topic_score_gemma":0.000016044798,"teacher_disagreement_score":0.012935378,"about_ca_system_score_codex":0.000067521294,"about_ca_system_score_gemma":0.00036095307,"threshold_uncertainty_score":0.59336376},"labels":[],"label_agreement":null},{"id":"W4310093515","doi":"10.1182/blood-2022-157343","title":"Eptacog Beta (rFVIIa) Has a Low Incidence of Spontaneous Rebleeding through 24 and 48 Hours in Adult and Adolescent Patients with Hemophilia A or B with Inhibitors","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Dosing; Regimen; Incidence (geometry); Hemostasis; PROTHROMBIN COMPLEX; Recombinant factor VIIa; Internal medicine; Crossover study; Randomized controlled trial; Gastroenterology; Anesthesia; Coagulation; Placebo","score_opus":0.01746998828157639,"score_gpt":0.24781538305891535,"score_spread":0.23034539477733895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310093515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978055,0.00034441068,0.0000010015895,0.0008046501,0.000032726733,0.0008528931,0.000021332116,0.000019711584,0.00011778549],"genre_scores_gemma":[0.99883825,0.00010770145,0.0005358867,0.00013024473,0.00003712244,0.0000484307,0.000017527296,0.000028978853,0.00025585882],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983553,0.000051770232,0.00022958941,0.00036660655,0.0006599611,0.0003367392],"domain_scores_gemma":[0.9993722,0.000055323744,0.000086718195,0.00019598997,0.00011293325,0.00017686546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014300895,0.00018497492,0.0003590672,0.0001468671,0.0001368843,0.000018841722,0.00007222405,0.0000498493,0.000032727126],"category_scores_gemma":[0.00007465895,0.000117901945,0.000024146173,0.00040800998,0.00021649493,0.00009234147,0.00013700585,0.00031576192,9.006652e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030439328,0.0019180122,0.98796844,0.00036705335,0.00010810623,0.0031684956,0.0018186694,0.0000032994767,0.0004830181,0.000006831932,0.00018767526,0.00092644215],"study_design_scores_gemma":[0.053505033,0.016663985,0.90129036,0.0049297647,0.000783753,0.004214213,0.0041711396,0.000095647745,0.013400338,0.000042055846,0.00020617958,0.00069754675],"about_ca_topic_score_codex":0.00013228084,"about_ca_topic_score_gemma":0.00017384609,"teacher_disagreement_score":0.08667812,"about_ca_system_score_codex":0.00007610807,"about_ca_system_score_gemma":0.00025827327,"threshold_uncertainty_score":0.48079017},"labels":[],"label_agreement":null},{"id":"W4310093519","doi":"10.1182/blood-2022-157011","title":"CD19 4-1BBL (RO7227166) a Novel Costimulatory Bispecific Antibody Can be Safely Combined with the T-Cell-Engaging Bispecific Antibody Glofitamab in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Cytokine release syndrome; Medicine; Lymphoma; T cell; Pharmacology; CD8; Antibody; Immune system; Immunology; Cancer research; Chimeric antigen receptor","score_opus":0.025508483590454527,"score_gpt":0.2883838006253497,"score_spread":0.26287531703489514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310093519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982642,0.0013762949,0.000036948506,0.0046070055,0.0003448471,0.001821927,0.0004076929,0.00014042355,0.008622849],"genre_scores_gemma":[0.98479503,0.0003505657,0.00047789444,0.0014959868,0.00031322756,0.00016782637,0.0006509399,0.0001862662,0.011562288],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.994086,0.0004800838,0.0008849167,0.0011939707,0.0019623393,0.0013926468],"domain_scores_gemma":[0.9967023,0.00095972134,0.00035253473,0.0012749904,0.00023020695,0.0004802137],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013534165,0.0007440592,0.0010672774,0.00071387045,0.0012077803,0.00011911164,0.00094142236,0.00019432271,0.00086231204],"category_scores_gemma":[0.00008146357,0.00050511444,0.00029310773,0.0018495161,0.00047863688,0.00012004822,0.0006128163,0.0017733972,0.00006988804],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017148325,0.016775183,0.08343654,0.0006587135,0.00050380337,0.005637877,0.003429656,0.0003316136,0.8638696,0.00027448867,0.0067641097,0.0011700819],"study_design_scores_gemma":[0.19064082,0.028647529,0.314341,0.0011762995,0.0013832992,0.0027212084,0.021804063,0.006110556,0.10577274,0.000054767585,0.3230163,0.0043314197],"about_ca_topic_score_codex":0.0010291104,"about_ca_topic_score_gemma":0.0003736159,"teacher_disagreement_score":0.7580969,"about_ca_system_score_codex":0.00042047995,"about_ca_system_score_gemma":0.0013388427,"threshold_uncertainty_score":0.99974006},"labels":[],"label_agreement":null},{"id":"W4310096202","doi":"10.1182/blood-2022-170828","title":"High Fatality CBFA2T3-GLIS2 Pediatric Acute Megakaryoblastic Leukemia Is Sensitive to BCL-XL Inhibition","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Université de Montréal; Institute for Research in Immunology and Cancer; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Acute megakaryoblastic leukemia; Medicine; Leukemia; Internal medicine; Oncology; Cancer research","score_opus":0.005281950481739907,"score_gpt":0.2132746515933681,"score_spread":0.20799270111162818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310096202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99703366,0.00007713563,0.0008555074,0.00044441884,0.00029295453,0.00033688062,0.0004500027,0.00003932283,0.00047010675],"genre_scores_gemma":[0.9951951,0.00004598501,0.00052400125,0.0018714506,0.00059005246,0.00009875328,0.00068513845,0.000026442252,0.0009630611],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986285,0.00011203171,0.00023887788,0.00047502472,0.00028257596,0.0002629894],"domain_scores_gemma":[0.99932855,0.000010606211,0.00009741139,0.00034140554,0.00008817221,0.00013387078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017332665,0.00017904871,0.00015036526,0.00008978855,0.00024406872,0.000029508361,0.00013219866,0.0000907198,0.00012939627],"category_scores_gemma":[0.00006933895,0.00019515966,0.00010212836,0.00028554516,0.000026916548,0.000007976363,0.00036884015,0.00016526411,0.000057745514],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019003043,0.00038987224,0.0010720455,0.00002670268,0.00016893748,0.00007467497,0.00022826706,0.00014334166,0.94993836,0.00027235074,0.04701233,0.0004831136],"study_design_scores_gemma":[0.0014804499,0.0006263941,0.0021526446,0.000004085198,0.00014604571,0.00006352045,0.00010020007,0.00001531836,0.98238826,0.00007143258,0.012608841,0.00034283867],"about_ca_topic_score_codex":0.000059827962,"about_ca_topic_score_gemma":0.0000085789,"teacher_disagreement_score":0.034403488,"about_ca_system_score_codex":0.000059593323,"about_ca_system_score_gemma":0.00014829928,"threshold_uncertainty_score":0.79583806},"labels":[],"label_agreement":null},{"id":"W4310096221","doi":"10.1182/blood-2022-171028","title":"Incidence of Inhibitors in Previously Untreated Patients with Severe Hemophilia a Treated with Plasma-Derived Vs. Recombinant Factor VIII Concentrates: A Systematic Review and Meta-Analyses","year":2022,"lang":"en","type":"review","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cochrane Library; Incidence (geometry); Meta-analysis; MEDLINE; Observational study; Internal medicine; Cohort; Pediatrics","score_opus":0.07537295812488308,"score_gpt":0.3348156137135221,"score_spread":0.259442655588639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310096221","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.036430743,0.9501536,6.0213296e-8,0.000033423315,0.000010588076,0.013075301,0.00019304389,0.00004460544,0.00005865237],"genre_scores_gemma":[0.008381989,0.98852926,0.000048948856,0.00003058958,0.0000068274,0.001812624,0.00058213156,0.00010442694,0.0005032243],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99483085,0.0010080932,0.00171798,0.00089788175,0.0009813586,0.0005638315],"domain_scores_gemma":[0.99685323,0.00052616146,0.0012018092,0.00084203266,0.00027259343,0.00030415025],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003878214,0.0009765595,0.009817244,0.00044376298,0.00009125876,0.000032188073,0.00027057785,0.00022706197,0.00039176145],"category_scores_gemma":[0.00038185425,0.0004591136,0.0006011634,0.0015990419,0.00018840584,0.000115558796,0.00012630815,0.0005834222,0.0000083767645],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001853251,0.0019549234,0.0062363893,0.96462876,0.024873976,0.0006826147,0.00016710379,1.654106e-7,0.0000012136752,8.7807166e-7,0.00001947075,0.0012491593],"study_design_scores_gemma":[0.009124142,0.0052460344,0.00023632997,0.49969625,0.48291013,0.00063416985,0.00006055158,0.0000017784287,0.000080010344,8.7832666e-7,0.0011771896,0.0008325499],"about_ca_topic_score_codex":0.00017273409,"about_ca_topic_score_gemma":0.000050801358,"teacher_disagreement_score":0.46493253,"about_ca_system_score_codex":0.00026502504,"about_ca_system_score_gemma":0.0007713637,"threshold_uncertainty_score":0.9997861},"labels":[],"label_agreement":null},{"id":"W4310096327","doi":"10.1182/blood-2022-169920","title":"IMiDs Synergize with EP300 Inhibition to Disrupt the Ikzf/MYC/IRF4 Axis in Multiple Myeloma","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Cancer research; Multiple myeloma; Downregulation and upregulation; IRF4; Biology; Transcription factor; Coactivator; Pomalidomide; Lenalidomide; Immunology; Genetics","score_opus":0.018763215678207542,"score_gpt":0.2670754296227389,"score_spread":0.24831221394453135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310096327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99428684,0.00018681097,0.000027575137,0.002539602,0.000041409494,0.0012006768,0.00007656648,0.000059400343,0.0015811373],"genre_scores_gemma":[0.9969972,0.000012717762,0.00052352983,0.00042125612,0.000083217434,0.0008789997,0.00011275469,0.00003535989,0.0009349915],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99815434,0.00014292212,0.00021652848,0.0003642067,0.00065576326,0.0004662583],"domain_scores_gemma":[0.9990572,0.00015547087,0.000042744647,0.0004630106,0.00005175384,0.00022986843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025748753,0.00017813192,0.00024920012,0.00018380833,0.00028752818,0.00002656214,0.00012866026,0.00003513893,0.00041516533],"category_scores_gemma":[0.0001661509,0.00011336879,0.00007095503,0.00062353566,0.00006472311,0.00006061233,0.00019685013,0.00033304884,0.00008383268],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037116192,0.006082892,0.94246155,0.00012985861,0.00050487195,0.004813776,0.0027732581,0.00026001167,0.020800106,0.00022645047,0.0016225406,0.016613076],"study_design_scores_gemma":[0.023870513,0.0032116638,0.9415669,0.00014321087,0.00016736935,0.0006060081,0.0017603753,0.000500245,0.021856338,0.0000749406,0.0059206523,0.00032179814],"about_ca_topic_score_codex":0.000619129,"about_ca_topic_score_gemma":0.0006322074,"teacher_disagreement_score":0.020158894,"about_ca_system_score_codex":0.00014404165,"about_ca_system_score_gemma":0.00012475782,"threshold_uncertainty_score":0.46230453},"labels":[],"label_agreement":null},{"id":"W4310096357","doi":"10.1182/blood-2022-168260","title":"Multiparameter Flow Cytometry-Based Residual Disease Analysis Identifies Intermediate-Risk AML Patients Who May Benefit from Allogeneic Hematopoietic Stem Cell Transplantation","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Cumulative incidence; Medicine; NPM1; Minimal residual disease; Internal medicine; Transplantation; Oncology; Hematopoietic stem cell transplantation; Stem cell; Myeloid leukemia; Leukemia; Biology","score_opus":0.01122539570736487,"score_gpt":0.24897952837618975,"score_spread":0.2377541326688249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310096357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941821,0.00037842142,0.0006292113,0.0001300393,0.00013005389,0.00070820714,0.0037154998,0.000092360664,0.0000341167],"genre_scores_gemma":[0.99330086,0.00009713933,0.00078139425,0.00023921227,0.00009054166,0.00026881546,0.0046236073,0.00006599383,0.00053241674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965039,0.00034631827,0.00058106205,0.0007545759,0.001311142,0.0005030356],"domain_scores_gemma":[0.9980243,0.0004016931,0.00022075175,0.000775512,0.00015387508,0.00042389613],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034583532,0.00031267985,0.000590687,0.0009635816,0.0002775321,0.000074715,0.0003779788,0.00009533884,0.0008645039],"category_scores_gemma":[0.00006103907,0.00029925822,0.00041000656,0.0012590669,0.0000944171,0.00010693923,0.00015292053,0.0005468935,0.00007966692],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016038178,0.0017263292,0.9861868,0.00027617882,0.0015060497,0.0005321827,0.001563476,0.003321835,0.0019138455,8.597235e-7,0.0003651701,0.0010034784],"study_design_scores_gemma":[0.011424131,0.00041787754,0.9430299,0.000050942745,0.00914836,0.0000029662049,0.0004182497,0.006932839,0.028115626,0.000024936788,0.000062518644,0.0003716547],"about_ca_topic_score_codex":0.00034275337,"about_ca_topic_score_gemma":0.00009362212,"teacher_disagreement_score":0.043156877,"about_ca_system_score_codex":0.00024404224,"about_ca_system_score_gemma":0.00021593977,"threshold_uncertainty_score":0.99994594},"labels":[],"label_agreement":null},{"id":"W4310096378","doi":"10.1182/blood-2022-157194","title":"FLIPI24: An Improved International Prognostic Model Developed on Early Events in Follicular Lymphoma","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of British Columbia; University Health Network; Spinal Cord Injury BC","funders":"","keywords":"Medicine; Follicular lymphoma; Bendamustine; Oncology; Internal medicine; Proportional hazards model; Cohort; Rituximab; Lymphoma","score_opus":0.01932055398222882,"score_gpt":0.2626529377360294,"score_spread":0.24333238375380056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310096378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99779946,0.000059542737,0.000012603782,0.0004034259,0.00016259645,0.00055511534,0.000025472851,0.000044499204,0.00093731505],"genre_scores_gemma":[0.99758846,0.000009836287,0.0007484225,0.00041599968,0.000057125726,0.00065954356,0.00013446511,0.000023465362,0.00036268754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988639,0.000040910174,0.00020721919,0.00031062934,0.00037333343,0.00020400867],"domain_scores_gemma":[0.9995606,0.00002810391,0.000052883162,0.00022016447,0.000037929047,0.00010030145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011349401,0.00013777746,0.00018282914,0.00013102654,0.00007492456,0.000010455809,0.00013164945,0.000035367102,0.00006317483],"category_scores_gemma":[0.00004381022,0.00012294375,0.0000679823,0.00014237556,0.000008492535,0.00006252449,0.000090237496,0.00006144411,0.000021122916],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038198888,0.017232655,0.9710703,0.0000142127055,0.0003531902,0.00048293418,0.00066848675,0.00032598432,0.0011972735,0.00059372233,0.000047966165,0.0076313037],"study_design_scores_gemma":[0.022520285,0.0012590152,0.96235245,0.00004851569,0.00017257727,0.00007407631,0.00007143089,0.010579823,0.0020709096,0.00021258647,0.00044542016,0.00019292525],"about_ca_topic_score_codex":0.0001331263,"about_ca_topic_score_gemma":0.000027962999,"teacher_disagreement_score":0.022138296,"about_ca_system_score_codex":0.0002659772,"about_ca_system_score_gemma":0.00021371494,"threshold_uncertainty_score":0.50135005},"labels":[],"label_agreement":null},{"id":"W4310096545","doi":"10.1182/blood-2022-166857","title":"Identification of Novel Antigens for Normal Karyotype Triple Mutated Acute Myeloid Leukemia","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Hôpital Maisonneuve-Rosemont; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"NPM1; Myeloid leukemia; Proteome; Cancer research; Leukemia; Myeloid; Mass cytometry; Antigen; Biology; Flow cytometry; Karyotype; Immunology; Gene; Bioinformatics; Genetics; Phenotype; Chromosome","score_opus":0.02191346774358169,"score_gpt":0.29460420038208146,"score_spread":0.27269073263849974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310096545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949236,0.0001534746,0.0018584218,0.00045807636,0.00020462762,0.0011917556,0.00051021576,0.000077911536,0.0006219498],"genre_scores_gemma":[0.9907375,0.00004199377,0.0019898147,0.00016300868,0.00013711158,0.00024911275,0.0005896797,0.000050521907,0.006041261],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99825567,0.00004080931,0.00048770118,0.00032995403,0.0005157525,0.00037011981],"domain_scores_gemma":[0.9988806,0.00008459118,0.00019711751,0.0004579065,0.00026312185,0.0001166648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059141085,0.00013942829,0.0003347275,0.00024976875,0.0002174184,0.00001317093,0.00026195997,0.00007184166,0.0002069624],"category_scores_gemma":[0.00017700663,0.00014234567,0.00015524415,0.00059772434,0.00007469758,0.00008510255,0.00016854005,0.0003129403,0.000017844452],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008378491,0.0008439175,0.0022683223,0.00012976122,0.00049463275,0.000042157622,0.0003837428,0.00007719388,0.9895674,0.00025379835,0.004336726,0.000764503],"study_design_scores_gemma":[0.029847132,0.0017872836,0.030611433,0.000026558595,0.0011859236,0.00060564245,0.00057046395,0.012361637,0.91130626,0.00007015006,0.011273851,0.00035368287],"about_ca_topic_score_codex":0.000076927296,"about_ca_topic_score_gemma":0.000004249579,"teacher_disagreement_score":0.07826115,"about_ca_system_score_codex":0.0002958101,"about_ca_system_score_gemma":0.0008800215,"threshold_uncertainty_score":0.5804688},"labels":[],"label_agreement":null},{"id":"W4310096555","doi":"10.1182/blood-2022-167804","title":"High Metabolic Tumor Volume Is Associated with Higher Toxicity and Decreased Efficacy of BCMA CAR-T Cell Therapy in Multiple Myeloma","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Multiple myeloma; Bone marrow; Chimeric antigen receptor; Internal medicine; Oncology; Lenalidomide; Cohort; Chemotherapy; Cancer; Immunotherapy","score_opus":0.018692912816314654,"score_gpt":0.25275916974395557,"score_spread":0.2340662569276409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310096555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99700177,0.0012585776,8.5850684e-7,0.0002499609,0.0000400533,0.00085584656,0.00008575539,0.000049356866,0.00045780864],"genre_scores_gemma":[0.9956166,0.00008980127,0.00014116397,0.00041003345,0.00005599486,0.000102162994,0.000047340265,0.000058440583,0.00347842],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99796927,0.00026596765,0.0003000641,0.00038769117,0.00068099,0.00039601038],"domain_scores_gemma":[0.99892634,0.00025586906,0.00013222203,0.00040444118,0.00010569189,0.00017546126],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043806658,0.00020665351,0.00060348946,0.00021502546,0.00009618758,0.000014340682,0.00016230199,0.00006046371,0.0041741137],"category_scores_gemma":[0.00008490994,0.00017674007,0.00009538604,0.0006869475,0.00011353068,0.00003992874,0.00009558397,0.0003939495,0.0000041986696],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022197806,0.006369147,0.4581431,0.000034222423,0.0004652847,0.000220986,0.0009304714,0.000009157034,0.52905035,0.000012236084,0.00026520016,0.0022800472],"study_design_scores_gemma":[0.03457656,0.0014308649,0.7327719,0.0000239791,0.00011850897,0.000021213738,0.00008642768,0.00008653499,0.22821404,0.000011728842,0.0024807556,0.00017751192],"about_ca_topic_score_codex":0.0011908711,"about_ca_topic_score_gemma":0.000079612524,"teacher_disagreement_score":0.30083632,"about_ca_system_score_codex":0.00006912133,"about_ca_system_score_gemma":0.00019373115,"threshold_uncertainty_score":0.9967362},"labels":[],"label_agreement":null},{"id":"W4310096568","doi":"10.1182/blood-2022-166949","title":"Comparison of Rivaroxaban and Low Molecular Weight Heparin in the Treatment of Cancer-Associated Venous Thromboembolism","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital; University of British Columbia","funders":"","keywords":"Rivaroxaban; Venous thromboembolism; Medicine; Heparin; Low molecular weight heparin; Fondaparinux; Cancer; Venous thrombosis; Internal medicine; Warfarin; Thrombosis; Atrial fibrillation","score_opus":0.0167518474079926,"score_gpt":0.30606637150617455,"score_spread":0.2893145240981819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310096568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99199814,0.0057778684,0.0000010325654,0.0004445085,0.00007166984,0.00069864985,0.000035118344,0.000012338556,0.0009607018],"genre_scores_gemma":[0.9984029,0.0011323346,0.000032131073,0.00014032265,0.000021965987,0.00020782829,0.000028179838,0.000015538539,0.000018823568],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998842,0.00011320333,0.00032657257,0.00019139655,0.00032954058,0.00019730988],"domain_scores_gemma":[0.9994343,0.00005144474,0.00017528841,0.00027393454,0.000027640855,0.000037407648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015875786,0.00013029063,0.00075239444,0.000099370605,0.00007273991,0.0000050620174,0.00011685575,0.00003390212,0.00007709205],"category_scores_gemma":[0.000010711181,0.00009867372,0.000089244735,0.00025800552,0.000057722358,0.000014463489,0.00005704053,0.00009275798,5.4756504e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012761766,0.14515692,0.7707624,0.00042375663,0.0025986938,0.0002771406,0.038285267,0.0005115169,0.025109349,0.0039961096,0.0010697624,0.011681493],"study_design_scores_gemma":[0.007008492,0.0052165794,0.94075024,0.00010257408,0.0016417854,0.000008379486,0.0019264796,0.00020666068,0.04045079,0.00023358676,0.0022900468,0.00016439786],"about_ca_topic_score_codex":0.002387835,"about_ca_topic_score_gemma":0.0002846094,"teacher_disagreement_score":0.16998786,"about_ca_system_score_codex":0.00007733614,"about_ca_system_score_gemma":0.000055192526,"threshold_uncertainty_score":0.40237975},"labels":[],"label_agreement":null},{"id":"W4310096775","doi":"10.1182/blood-2022-168374","title":"Proteomic Profiles of Cytokine Release Syndromes Following Lisocabtagene Maraleucel and Idecabtagene Vicleucel","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cytokine; Immunology; Medicine","score_opus":0.022189981912104303,"score_gpt":0.28224858206499914,"score_spread":0.26005860015289484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310096775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99504447,0.0014128007,0.0000101933965,0.0004158963,0.00007630369,0.0013460533,0.00005913411,0.00007624977,0.0015588872],"genre_scores_gemma":[0.9916156,0.0001467402,0.0010607382,0.00012728214,0.000094381794,0.00033162578,0.00004247113,0.00006788286,0.0065132887],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99795324,0.00014456223,0.00037668305,0.0004193931,0.00071271835,0.00039338382],"domain_scores_gemma":[0.9990726,0.000066529545,0.000105789186,0.0004990025,0.00005725609,0.00019881869],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00057004625,0.00019831306,0.0004878795,0.00025499656,0.00018777863,0.000018649882,0.00018469618,0.00006188096,0.002013844],"category_scores_gemma":[0.000107626794,0.00019353391,0.0001945835,0.0004372343,0.00008768244,0.00007066216,0.0003380284,0.00036745312,0.000009534802],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040080058,0.0007919887,0.050622046,0.00027338296,0.00034451904,0.00059891504,0.00024929133,0.000005619574,0.94357175,0.00003931685,0.00020819355,0.0028942064],"study_design_scores_gemma":[0.012991661,0.0022802283,0.07255426,0.00013905007,0.0004968835,0.0011074239,0.0003594707,0.00015499388,0.90603215,0.0002087955,0.0032941597,0.00038091204],"about_ca_topic_score_codex":0.00010132615,"about_ca_topic_score_gemma":0.0000021668684,"teacher_disagreement_score":0.03753956,"about_ca_system_score_codex":0.00006896882,"about_ca_system_score_gemma":0.0002066918,"threshold_uncertainty_score":0.99889845},"labels":[],"label_agreement":null},{"id":"W4310098617","doi":"10.1182/blood-2022-158520","title":"Clinician and Patient Perspectives on Treatment Decision-Making in Multiple Myeloma: A Qualitative Survey","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Multiple myeloma; Medicine; Qualitative research; Pomalidomide; Intensive care medicine; Lenalidomide; Family medicine; Oncology; Internal medicine; Sociology","score_opus":0.07068498751265276,"score_gpt":0.3975614782808181,"score_spread":0.3268764907681654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310098617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973251,0.0010252227,0.000005955744,0.00013632754,0.000037259644,0.0007870662,0.00019623735,0.000023094088,0.00046368543],"genre_scores_gemma":[0.99849147,0.000099977806,0.00094770326,0.00007552113,0.000018526758,0.0002549274,0.00004154845,0.000020812742,0.00004951659],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980015,0.0005855883,0.00026354686,0.00043894767,0.0004147367,0.00029564605],"domain_scores_gemma":[0.99713606,0.0023593926,0.00006826096,0.00024580234,0.00005574296,0.00013474462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041351444,0.00017133681,0.00032755092,0.00024564128,0.00020273004,0.000015501812,0.00005156059,0.000031719057,0.0001144668],"category_scores_gemma":[0.0011987038,0.00013136162,0.000073513984,0.00026506186,0.000057219415,0.000032585187,0.00009693058,0.00018444723,0.00001459679],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005356321,0.012888536,0.7554437,0.000013214123,0.00046326075,0.0013004029,0.09111024,0.00002117348,0.000086965956,0.00006446516,0.00006146417,0.13319026],"study_design_scores_gemma":[0.015155101,0.0073938617,0.9241223,0.00008083769,0.000042631287,0.000039634586,0.05231199,0.00021126184,0.00015792319,0.00013119822,0.00021022087,0.0001430939],"about_ca_topic_score_codex":0.00078573776,"about_ca_topic_score_gemma":0.0010363241,"teacher_disagreement_score":0.16867854,"about_ca_system_score_codex":0.0003344241,"about_ca_system_score_gemma":0.00010910498,"threshold_uncertainty_score":0.5356772},"labels":[],"label_agreement":null},{"id":"W4310103232","doi":"10.1182/blood-2022-169307","title":"Umbrella Trial in Myeloid Malignancies: The Myelomatch National Clinical Trials Network Precision Medicine Initiative","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Clinical trial; Medicine; Precision medicine; Oncology; Internal medicine; Intensive care medicine; Pathology","score_opus":0.20145469015353576,"score_gpt":0.4464099948078948,"score_spread":0.24495530465435902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310103232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9396716,0.0026779661,0.00012710605,0.025570031,0.0021011978,0.006053024,0.000075961434,0.00012332489,0.023599807],"genre_scores_gemma":[0.97976327,0.000842588,0.0006734195,0.0065575065,0.008984446,0.0011346093,0.00016866371,0.000074249976,0.0018012541],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9889135,0.0053599006,0.0021861596,0.0006300687,0.0022945432,0.00061584375],"domain_scores_gemma":[0.984756,0.013613818,0.00053465884,0.0005526007,0.00032860177,0.00021435188],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.03768749,0.00025399428,0.0012046321,0.00024635455,0.00039016816,0.000024003935,0.00054973766,0.00018302102,0.0018891458],"category_scores_gemma":[0.021143185,0.00016226071,0.0003214118,0.0013401103,0.000273792,0.00007380001,0.00052882766,0.0016250451,0.00007126168],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1914287,0.0079300525,0.023396106,0.00016631669,0.0020931216,0.0014059606,0.0058707213,0.001104613,0.002632691,0.0072237686,0.7273634,0.029384552],"study_design_scores_gemma":[0.6843697,0.014632098,0.051396277,0.0006475769,0.0010445922,0.0007342115,0.0046742964,0.0026095815,0.0004939208,0.012736979,0.22586209,0.00079870934],"about_ca_topic_score_codex":0.00006856688,"about_ca_topic_score_gemma":0.000020545725,"teacher_disagreement_score":0.5015013,"about_ca_system_score_codex":0.00038683938,"about_ca_system_score_gemma":0.0019200464,"threshold_uncertainty_score":0.99902326},"labels":[],"label_agreement":null},{"id":"W4310103500","doi":"10.1182/blood-2022-162551","title":"Risk of Venous Thromboembolism or Hemorrhage Among Individuals with Chronic Kidney Disease Taking a Direct Oral Anticoagulant Compared to Low-Molecular-Weight Heparin after a Hip or Knee Arthroplasty","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; Bruyère; University of Ottawa","funders":"","keywords":"Medicine; Venous thromboembolism; Kidney disease; Anticoagulant; Heparin; Low molecular weight heparin; Venous thrombosis; Surgery; Arthroplasty; Hip arthroplasty; Internal medicine; Thrombosis","score_opus":0.010465726658590286,"score_gpt":0.2428386111120025,"score_spread":0.23237288445341223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310103500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949669,0.0006821099,0.00012646668,0.00024159865,0.00025506102,0.002615788,0.00056411076,0.00015966418,0.00038827708],"genre_scores_gemma":[0.9954319,0.00008112815,0.0015090101,0.0011709721,0.0001614403,0.0011709827,0.00014140934,0.00012600006,0.00020715907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99637306,0.00027190248,0.0006284067,0.00083808415,0.0010496917,0.0008388389],"domain_scores_gemma":[0.9975569,0.00008554533,0.0004577602,0.0009780971,0.00009382176,0.0008278227],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004048069,0.00051303266,0.0016057417,0.0003503609,0.00030071713,0.000065950546,0.00026606477,0.000065156215,0.0019298078],"category_scores_gemma":[0.00021678183,0.00037329964,0.00023683331,0.0008057608,0.00016515159,0.000108517626,0.0006171666,0.00037258526,0.00002815441],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066474453,0.03773078,0.90090704,0.0035362362,0.0073619336,0.023569161,0.0048545334,0.0022039437,0.0020216806,0.00013195726,0.004817677,0.0062176012],"study_design_scores_gemma":[0.011518148,0.0042527006,0.96893233,0.0008947631,0.006294702,0.00014264093,0.00022704247,0.00041966047,0.0028156836,0.000019225907,0.0037327325,0.00075035717],"about_ca_topic_score_codex":0.0006178912,"about_ca_topic_score_gemma":0.0003631164,"teacher_disagreement_score":0.06802529,"about_ca_system_score_codex":0.00017375969,"about_ca_system_score_gemma":0.00076794846,"threshold_uncertainty_score":0.9998719},"labels":[],"label_agreement":null},{"id":"W4310103562","doi":"10.1182/blood-2022-163493","title":"Mitapivat Improves Markers of Erythropoietic Activity in Long-Term Study of Adults with Alpha- or Beta-Non-Transfusion-Dependent Thalassemia","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; University Health Network","funders":"","keywords":"Beta thalassemia; Thalassemia; Medicine; BETA (programming language); Term (time); Alpha (finance); Alpha-thalassemia; Internal medicine; Pediatrics; Genetics; Surgery; Biology; Genotype; Physics","score_opus":0.006344133403375308,"score_gpt":0.23569584826637077,"score_spread":0.22935171486299546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310103562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974548,0.00031144632,0.000006248018,0.00015554606,0.000095075244,0.0015987172,0.00001813769,0.00002189572,0.00033808476],"genre_scores_gemma":[0.9993895,0.0002549983,0.000042546864,0.000019557354,0.000012077662,0.000085846965,0.000009078399,0.00003382813,0.00015254572],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982592,0.00010924092,0.00039384988,0.00036807806,0.0005940048,0.0002756549],"domain_scores_gemma":[0.9991752,0.000076755794,0.00017932558,0.00041467007,0.00006106547,0.000092983486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023221648,0.00020575561,0.0005417314,0.00018411377,0.00007882683,0.000004357058,0.00015246947,0.00008608187,0.00026631122],"category_scores_gemma":[0.000021183976,0.00014444074,0.00009175159,0.00046496323,0.000095098745,0.000056552115,0.00011192897,0.00043670693,9.397788e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010356742,0.02354562,0.8930803,0.001053005,0.0008207117,0.00091185555,0.0070809135,0.000045328805,0.05691788,0.0000011721249,0.0000427038,0.0061437753],"study_design_scores_gemma":[0.03099154,0.015327093,0.9082317,0.00042495443,0.0008452507,0.00016926753,0.023014985,0.000035999507,0.02071983,0.0000019720987,0.0000037720831,0.00023366771],"about_ca_topic_score_codex":0.0011121935,"about_ca_topic_score_gemma":0.000855736,"teacher_disagreement_score":0.03619805,"about_ca_system_score_codex":0.000046982128,"about_ca_system_score_gemma":0.00020184834,"threshold_uncertainty_score":0.5890122},"labels":[],"label_agreement":null},{"id":"W4310103737","doi":"10.1182/blood-2022-163685","title":"Targeting PLZF Enhances Glucocorticoid Sensitivity in Acute Myeloid Leukemia","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Myeloid leukemia; Glucocorticoid; Medicine; Immunology; Cancer research","score_opus":0.004846454689153995,"score_gpt":0.21876319771996178,"score_spread":0.2139167430308078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310103737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962151,0.0015123193,0.00033599642,0.000035227153,0.00017805063,0.00016846946,0.0000164741,0.000019337793,0.0015190381],"genre_scores_gemma":[0.99793357,0.0002995069,0.0004055763,0.00023144389,0.00015696534,0.00006697957,0.00015403012,0.00002494511,0.00072699756],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986984,0.00012369822,0.00022967359,0.00043026207,0.0001997092,0.00031822288],"domain_scores_gemma":[0.9995518,0.000017747492,0.00009678334,0.000258054,0.000031449104,0.00004417781],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003545202,0.00015589094,0.00017522636,0.00004403443,0.00014095282,0.000020429257,0.0001810654,0.00008073178,0.00005552698],"category_scores_gemma":[0.0000612569,0.00016836307,0.00007334427,0.00017242033,0.00004475124,0.0000049217656,0.00031586646,0.00023003756,0.000012198048],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004540208,0.00011198691,0.013035116,0.000026256335,0.000051303094,0.00009710363,0.00007504565,0.00086157466,0.9851184,0.00002028283,0.00019740502,0.00036014817],"study_design_scores_gemma":[0.0010235145,0.00021144304,0.0014293393,0.000006554626,0.00003762761,0.00010480854,0.00027228807,0.00016869057,0.98879874,0.000042974196,0.0076444647,0.00025953946],"about_ca_topic_score_codex":0.000031996737,"about_ca_topic_score_gemma":0.000013730846,"teacher_disagreement_score":0.011605777,"about_ca_system_score_codex":0.000049554652,"about_ca_system_score_gemma":0.0002614158,"threshold_uncertainty_score":0.6865647},"labels":[],"label_agreement":null},{"id":"W4310104769","doi":"10.1182/blood-2022-169605","title":"Itacitinib and Corticosteroids As Initial Treatment for Chronic Graft-Versus-Host Disease: Phase 1/2 Results from Gravitas-309","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Gastroenterology; Methylprednisolone; Cohort; Prednisone; Graft-versus-host disease; Tacrolimus; Transplantation","score_opus":0.04047826888902684,"score_gpt":0.3365661468789158,"score_spread":0.29608787798988895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310104769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990742,0.0009929304,0.00008860437,0.00061805896,0.0003174751,0.0013508217,0.0052300184,0.00007596135,0.00058411976],"genre_scores_gemma":[0.9944909,0.00011277097,0.00028859847,0.00012343186,0.00028557944,0.00047280337,0.0039062807,0.000037052854,0.00028253597],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99857503,0.000057934038,0.00036739925,0.00043034172,0.00030095794,0.000268342],"domain_scores_gemma":[0.9988971,0.00038263807,0.000097902,0.00030831044,0.000036781767,0.0002773193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009739258,0.00019388464,0.00028521402,0.00007137582,0.00019503635,0.000024611394,0.000059347134,0.00004145518,0.00021355454],"category_scores_gemma":[0.00007770909,0.00018532285,0.00010250443,0.00009344392,0.00005301246,0.00005165823,0.000025964804,0.00009152995,0.000016712987],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3414507,0.06102307,0.017633954,0.0032865827,0.010226099,0.019088771,0.035142068,0.000065701766,0.42406875,0.003480617,0.003968196,0.0805655],"study_design_scores_gemma":[0.7453366,0.043185648,0.020503711,0.00053429604,0.013432507,0.0006490902,0.0022633695,0.00068810076,0.1380002,0.0008186505,0.033321664,0.001266137],"about_ca_topic_score_codex":0.00010525682,"about_ca_topic_score_gemma":0.000022312453,"teacher_disagreement_score":0.40388593,"about_ca_system_score_codex":0.00012832538,"about_ca_system_score_gemma":0.00026093714,"threshold_uncertainty_score":0.7557246},"labels":[],"label_agreement":null},{"id":"W4310104788","doi":"10.1182/blood-2022-171228","title":"<i>DNMT3A</i> Limits Myeloid Signaling Responses in Committed T Cells during Normal and Leukemic Development","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Biology; Progenitor cell; Epigenetics; Myeloid; Haematopoiesis; Cellular differentiation; Stem cell; Cell biology; T cell; Cancer research; Genetics; Gene; Immune system","score_opus":0.02326314419817613,"score_gpt":0.2615291274510778,"score_spread":0.2382659832529017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310104788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99746776,0.00066874037,0.0000014219388,0.00016952511,0.000048390215,0.00037673808,0.0000059451777,0.000051398194,0.0012101133],"genre_scores_gemma":[0.9940362,0.00007313522,0.00045197387,0.00022319678,0.000060832484,0.00008505454,0.000011988134,0.000034256518,0.00502337],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99841493,0.00016990304,0.00028494507,0.00027790046,0.0004608667,0.00039147038],"domain_scores_gemma":[0.9993961,0.00018985137,0.000044195913,0.00020902192,0.00003246877,0.00012838516],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00063145946,0.0001368287,0.00023750051,0.0002789964,0.00022450395,0.000021454953,0.00012299656,0.000042786825,0.0010080667],"category_scores_gemma":[0.00004336818,0.0001467485,0.000036582438,0.0003553644,0.000041885633,0.0000429587,0.0002233429,0.000512593,0.000011738834],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011532576,0.00032286826,0.067990094,0.00008458275,0.00005668538,0.00040588877,0.0013281408,0.000030514324,0.9269121,0.000001639077,0.000038536156,0.0016756885],"study_design_scores_gemma":[0.006501563,0.00019158171,0.084722206,0.000060491067,0.000026889142,0.00026972298,0.00044299717,0.000022248796,0.9029299,0.0000040247796,0.004658883,0.00016949594],"about_ca_topic_score_codex":0.000054517244,"about_ca_topic_score_gemma":0.000027081149,"teacher_disagreement_score":0.023982208,"about_ca_system_score_codex":0.00018645491,"about_ca_system_score_gemma":0.0002982481,"threshold_uncertainty_score":0.99990517},"labels":[],"label_agreement":null},{"id":"W4310104796","doi":"10.1182/blood-2022-158370","title":"Preliminary Results from a Phase 2 Open-Label, Multicenter, Dose Optimization Clinical Study of the Safety, Tolerability, and Pharmacokinetic (PK) and Pharmacodynamic (PD) Profiles of Cfi-400945 As a Single Agent or in Combination with Azacitidine or Decitabine in Patients with Acute Myeloid Leukemia, Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia (TWT-202)","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Pharmacokinetics; Tolerability; Pharmacodynamics; Pharmacology; Medicine; Clinical trial; Phases of clinical research; Adverse effect; Internal medicine","score_opus":0.03387899499718823,"score_gpt":0.33668694575457664,"score_spread":0.3028079507573884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310104796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98879296,0.00014238109,0.00004964336,0.000160632,0.000091434806,0.009956785,0.00075209234,0.000032403368,0.000021661424],"genre_scores_gemma":[0.996568,0.000281903,0.0015432697,0.000069254296,0.000024342615,0.0006328626,0.0005755118,0.00009332691,0.0002115027],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9942498,0.0010295832,0.0018998012,0.001142892,0.0011294753,0.000548455],"domain_scores_gemma":[0.996647,0.0012349291,0.00082845887,0.00071977143,0.0003198173,0.00025002455],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011186118,0.0005108539,0.0012806462,0.0004576602,0.0001942131,0.000050594892,0.00063187943,0.00012459136,0.0001628274],"category_scores_gemma":[0.00064216886,0.00031865202,0.000036209436,0.0017607886,0.0004248807,0.00036650104,0.0014268744,0.0009331881,8.354499e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7386786,0.09430971,0.11651236,0.0012878078,0.0022476395,0.003796803,0.0055724583,0.019916615,0.004591796,0.000002279426,0.000058661644,0.013025291],"study_design_scores_gemma":[0.502299,0.114232905,0.23454854,0.0013635859,0.0020067892,0.0004532178,0.0012581598,0.14224382,0.0010772661,0.00000474567,0.000012537861,0.000499407],"about_ca_topic_score_codex":0.0011345167,"about_ca_topic_score_gemma":0.0006800661,"teacher_disagreement_score":0.23637955,"about_ca_system_score_codex":0.0021957457,"about_ca_system_score_gemma":0.0030039554,"threshold_uncertainty_score":0.99992657},"labels":[],"label_agreement":null},{"id":"W4310104934","doi":"10.1182/blood-2022-168060","title":"Gonadal Hormone Production after Hematopoietic Cell Transplant (HCT) in Patients with Sickle Cell Disease (SCD): A Stellar Study","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Interquartile range; Medicine; Quartile; Testosterone (patch); Menarche; Internal medicine; Transplantation; Ovarian reserve; Hormone; Follicle-stimulating hormone; Hematopoietic stem cell transplantation; Luteinizing hormone; Endocrinology; Pregnancy; Infertility; Biology; Confidence interval","score_opus":0.002633761148417961,"score_gpt":0.16993291392457296,"score_spread":0.167299152776155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310104934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962988,0.0013632982,0.0000023702978,0.00018063065,0.000093113886,0.001656283,0.000041049432,0.000044348362,0.00032012447],"genre_scores_gemma":[0.999033,0.00003626834,0.000021438273,0.0000937605,0.000027700306,0.00018795578,0.0000752928,0.000037697155,0.00048691357],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847895,0.000082238694,0.00025070822,0.00038961568,0.0005093081,0.00028918256],"domain_scores_gemma":[0.999418,0.000008171498,0.00005627562,0.0003154843,0.00003331427,0.00016874608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000116399664,0.0001835059,0.00023715723,0.00010904474,0.00010741999,0.000009094671,0.00007140543,0.000036748148,0.00011193513],"category_scores_gemma":[0.0000041022095,0.00014451306,0.000053943208,0.00031686368,0.000040542553,0.00004418142,0.000039106184,0.0003321932,0.000014171405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046897777,0.03743706,0.94792145,0.00031725987,0.000084762796,0.0011543237,0.007313567,0.00026324877,0.0004531702,0.0000010189304,0.00023061816,0.00013375022],"study_design_scores_gemma":[0.050929334,0.00850405,0.92732763,0.00012329398,0.001953533,0.00004231583,0.008103453,0.000035035773,0.001101203,0.000018580622,0.0011551994,0.0007063438],"about_ca_topic_score_codex":0.00003968803,"about_ca_topic_score_gemma":0.000011052639,"teacher_disagreement_score":0.046239555,"about_ca_system_score_codex":0.000047010435,"about_ca_system_score_gemma":0.00011363997,"threshold_uncertainty_score":0.5893072},"labels":[],"label_agreement":null},{"id":"W4310104988","doi":"10.1182/blood-2022-166352","title":"Trends in Drug Treatment of Outpatients with Acute Pulmonary Embolism - a 5-Year Retrospective Cohort Study in One Canadian Health Region","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. John’s Health Sciences Centre; Memorial University of Newfoundland","funders":"","keywords":"Medicine; Pulmonary embolism; Retrospective cohort study; Drug; Cohort; Internal medicine; Emergency medicine; Intensive care medicine; Pharmacology","score_opus":0.01657134436791457,"score_gpt":0.2594744328037035,"score_spread":0.24290308843578895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310104988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99321485,0.00017131671,1.9850748e-7,0.0010492958,0.000059123275,0.0019096829,0.000050255,0.000016408578,0.0035288797],"genre_scores_gemma":[0.99832004,0.0002102866,0.000038771024,0.00017416803,0.000025446408,0.00056039426,0.000119271484,0.000027307351,0.0005243267],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99838567,0.0001183965,0.00032942166,0.00039492207,0.0004099312,0.0003616736],"domain_scores_gemma":[0.99929917,0.000007661107,0.00012909505,0.00036418275,0.000028485607,0.00017142073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020156874,0.00016272586,0.0007536125,0.0008029151,0.00008969478,0.0000052671207,0.000082530045,0.000021048772,0.00008102253],"category_scores_gemma":[0.0000031216168,0.00014869648,0.000051262814,0.0007505354,0.00002275035,0.000036572328,0.000045703466,0.00012943562,0.0000015196096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016071052,0.022456048,0.9660608,0.000013689514,0.0004542542,0.0011358861,0.007567254,0.000015255918,0.0000022453137,0.00011530676,0.00028091302,0.0017376179],"study_design_scores_gemma":[0.006980445,0.0065845754,0.98301,0.000051541792,0.0003335051,0.000022073826,0.0026318063,0.0000061849946,0.0000134296015,0.000015898639,0.00023512763,0.00011543246],"about_ca_topic_score_codex":0.47561088,"about_ca_topic_score_gemma":0.37475103,"teacher_disagreement_score":0.10085984,"about_ca_system_score_codex":0.001310257,"about_ca_system_score_gemma":0.00027320738,"threshold_uncertainty_score":0.63665813},"labels":[],"label_agreement":null},{"id":"W4310105145","doi":"10.1182/blood-2022-170223","title":"Activity of Azacitidine and Venetoclax Compared to Other Therapies in Adults with Refractory or Relapsed Acute Myeloid Leukemia, a Retrospective Study","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Venetoclax; Azacitidine; Myeloid leukemia; Medicine; Refractory (planetary science); Internal medicine; Oncology; Leukemia; Myeloid; Retrospective cohort study; Immunology; Biology; Chronic lymphocytic leukemia","score_opus":0.01697384462347137,"score_gpt":0.2813422965255065,"score_spread":0.2643684519020352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310105145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996769,0.00013318879,0.000007072257,0.00023032808,0.000022810242,0.00215395,0.0000927894,0.000048996415,0.0005418578],"genre_scores_gemma":[0.99814165,0.000033025157,0.0004037396,0.00014437152,0.000047526588,0.00040691698,0.00000842625,0.00005721207,0.00075714407],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979339,0.0002447885,0.00026651242,0.0005235488,0.0006800915,0.00035111257],"domain_scores_gemma":[0.9989743,0.00011363836,0.00012705625,0.0005146826,0.00011922934,0.0001510742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046153093,0.00022306132,0.000637344,0.00033193524,0.00011109321,0.00001120619,0.00018484377,0.000055217748,0.00020705581],"category_scores_gemma":[0.00008588248,0.00016904178,0.000040206618,0.000826732,0.00011406458,0.000086080865,0.00024267603,0.00067238254,0.000003275604],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07653806,0.005661121,0.74411213,0.0002324263,0.0022493189,0.001927648,0.044757653,0.000071568546,0.12132755,0.000029929937,0.000562673,0.0025298987],"study_design_scores_gemma":[0.043697264,0.01891529,0.9139392,0.00022516405,0.0002901525,0.00022260175,0.010660659,0.00017544077,0.0107429195,0.000016887752,0.0007624904,0.00035195955],"about_ca_topic_score_codex":0.0016758405,"about_ca_topic_score_gemma":0.0010148595,"teacher_disagreement_score":0.16982703,"about_ca_system_score_codex":0.0012793307,"about_ca_system_score_gemma":0.0008404836,"threshold_uncertainty_score":0.68933237},"labels":[],"label_agreement":null},{"id":"W4310105223","doi":"10.1182/blood-2022-163625","title":"Long-Term Safety and Efficacy of Pegcetacoplan Treatment in Adults with Paroxysmal Nocturnal Hemoglobinuria","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Medicine; Term (time); Internal medicine","score_opus":0.008062017544466098,"score_gpt":0.22628630027287522,"score_spread":0.21822428272840913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310105223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957861,0.0031700789,0.0000019730778,0.00003819223,0.00009592365,0.00046859367,0.00020144382,0.000019691006,0.00021803097],"genre_scores_gemma":[0.99946415,0.000029669407,0.000013684518,0.000011285763,0.000012806242,0.000053441607,0.00018930402,0.000009160836,0.0002164711],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909884,0.00017930707,0.0002561256,0.00022483416,0.000040241317,0.0002006287],"domain_scores_gemma":[0.9995644,0.00009119122,0.00011259487,0.00019880438,0.00001257372,0.00002040871],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007551298,0.00013190007,0.00026114576,0.00007231765,0.00010694676,0.000003984593,0.00011525699,0.00003038898,0.00091864995],"category_scores_gemma":[0.0000070610936,0.000105253726,0.000041426778,0.00008243496,0.00006899444,0.000022274286,0.00009432837,0.00008624429,0.000007658996],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031435823,0.0019552836,0.98770845,0.00007496426,0.0003219622,0.00008503554,0.0009769729,0.00002227688,0.0042833043,0.000050730545,0.00004398952,0.0013334778],"study_design_scores_gemma":[0.025212806,0.0016309359,0.9665436,0.00008727705,0.00015906538,0.00042799013,0.00030671872,7.8570434e-7,0.0049231197,0.0000035554558,0.00055833725,0.0001457732],"about_ca_topic_score_codex":0.00011794471,"about_ca_topic_score_gemma":0.00021820987,"teacher_disagreement_score":0.022069223,"about_ca_system_score_codex":0.000046369234,"about_ca_system_score_gemma":0.000064185384,"threshold_uncertainty_score":0.99999464},"labels":[],"label_agreement":null},{"id":"W4310105226","doi":"10.1182/blood-2022-163257","title":"Initiating First-Line (1L) Ibrutinib (Ibr) in Patients (pts) with Chronic Lymphocytic Leukemia (CLL) Improves Overall Survival (OS) Outcomes to Rates Approximating an Age-Matched Population of ≥65 Years","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Chemoimmunotherapy; Ibrutinib; Population; Fludarabine; Internal medicine; Oncology; Hazard ratio; Clinical trial; Venetoclax; Chronic lymphocytic leukemia; Chemotherapy; Leukemia; Confidence interval; Cyclophosphamide","score_opus":0.021645680935883663,"score_gpt":0.28933510428412695,"score_spread":0.2676894233482433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310105226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979651,0.00006804936,0.0000190525,0.000040380397,0.00011362387,0.0014608811,0.000039362476,0.000100925594,0.0001926187],"genre_scores_gemma":[0.9972529,0.0000065513455,0.0016879551,0.00012546137,0.00010967252,0.00019688939,0.00041592662,0.00010042802,0.00010421368],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962041,0.00021299394,0.00095796585,0.00064755266,0.0012451141,0.0007322768],"domain_scores_gemma":[0.9982413,0.00033275379,0.0003739188,0.00068275025,0.00013073305,0.00023852794],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00083055196,0.0003394847,0.0008602488,0.00039630962,0.00017088478,0.00004815549,0.00034098048,0.00010899132,0.000099286175],"category_scores_gemma":[0.00059725175,0.00031567214,0.000109877394,0.0007437618,0.000069668495,0.00024482352,0.000424757,0.00038761328,0.000009613027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0026909232,0.0026546791,0.9326033,0.002229981,0.00061644835,0.00053054234,0.007240507,0.03702621,0.005436621,0.0001825069,0.000034686298,0.00875357],"study_design_scores_gemma":[0.11823526,0.004139108,0.8157589,0.0004914051,0.00023411734,0.00005352168,0.0006999576,0.05688544,0.0026985314,0.000119086726,0.000036209298,0.0006484643],"about_ca_topic_score_codex":0.010079161,"about_ca_topic_score_gemma":0.0013154106,"teacher_disagreement_score":0.11684442,"about_ca_system_score_codex":0.02634311,"about_ca_system_score_gemma":0.006302563,"threshold_uncertainty_score":0.99992955},"labels":[],"label_agreement":null},{"id":"W4310106177","doi":"10.1182/blood-2022-163487","title":"Longitudinal Assessment of Body Composition in Children with Lymphoma","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Body surface area; Body mass index; Lymphoma; Cancer; Internal medicine; Nuclear medicine; Radiology","score_opus":0.018460570371928813,"score_gpt":0.3175673884414544,"score_spread":0.29910681806952555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310106177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976235,0.00008929514,0.000040451167,0.0005330269,0.000017944412,0.0002421304,0.0000092945975,0.000016284443,0.0014280484],"genre_scores_gemma":[0.9979375,0.000009443886,0.0016477869,0.00025047045,0.00003128124,0.00003726003,0.00006242044,0.000006210097,0.000017649816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99944997,0.0000306331,0.00013331484,0.0000962234,0.0001962433,0.00009361079],"domain_scores_gemma":[0.9997989,0.000007922398,0.00004779682,0.00008789269,0.000019097366,0.000038402493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011647955,0.000041759027,0.00012631713,0.00009623956,0.000055387856,0.0000021961437,0.00002810513,0.000010509051,0.00013705189],"category_scores_gemma":[9.862421e-7,0.000038991668,0.00001685545,0.00014430503,0.000015108953,0.000016345231,0.00002167537,0.00008164576,7.652259e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000513863,0.0018837695,0.9957822,0.000045752022,0.000028956792,0.000023829229,0.000031800886,0.0000069985467,0.0014022104,0.0005286975,0.000048212467,0.00016619511],"study_design_scores_gemma":[0.0078215245,0.00057768397,0.9897119,0.000060163977,0.000050772393,0.00043014853,0.000042372852,0.000077402605,0.001089938,0.000023942213,0.000075183685,0.0000389602],"about_ca_topic_score_codex":0.000049816852,"about_ca_topic_score_gemma":0.0000029535504,"teacher_disagreement_score":0.0077701383,"about_ca_system_score_codex":0.00005685835,"about_ca_system_score_gemma":0.00008749174,"threshold_uncertainty_score":0.1590034},"labels":[],"label_agreement":null},{"id":"W4310106202","doi":"10.1182/blood-2022-159620","title":"Integrative Genomics Identifies a High-Risk Metabolic and TME Depleted Signature That Predicts Early Clinical Failure in DLBCL","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"","keywords":"Oncology; Diffuse large B-cell lymphoma; Lymphoma; Internal medicine; Cancer; Disease; Biology; Medicine; Bioinformatics","score_opus":0.014591015969556604,"score_gpt":0.25844537089205044,"score_spread":0.24385435492249383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310106202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926085,0.0055926912,0.000003237737,0.00063554203,0.00017998017,0.00061915384,0.00020519365,0.00005133947,0.00010438128],"genre_scores_gemma":[0.9976856,0.0009509914,0.0004582208,0.00030317635,0.00011972279,0.00022556407,0.00009262515,0.000025629442,0.00013846158],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984974,0.00023257533,0.00032838422,0.00042206713,0.00027429883,0.0002452183],"domain_scores_gemma":[0.99916226,0.00023288134,0.00014196392,0.00027851664,0.000039169354,0.00014523185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030649148,0.00020495337,0.00052178535,0.00013511801,0.00013015901,0.000040759496,0.000101026635,0.00012081421,0.00006259344],"category_scores_gemma":[0.00014143184,0.0001536164,0.00013158505,0.00021550315,0.00007891898,0.00007805031,0.00017507748,0.00046462248,0.0000085516385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017816786,0.002693873,0.9900021,0.000015204892,0.00074313674,0.00049843075,0.0019007055,0.000001947364,0.0002668106,0.00034159116,0.00096325437,0.002394787],"study_design_scores_gemma":[0.014837364,0.0007562936,0.9758032,0.000039530958,0.0010272397,0.00008469324,0.0010111342,0.000023229579,0.0026013704,0.0004112231,0.0032618064,0.00014290086],"about_ca_topic_score_codex":0.00054072286,"about_ca_topic_score_gemma":0.00050445565,"teacher_disagreement_score":0.014659196,"about_ca_system_score_codex":0.00006093904,"about_ca_system_score_gemma":0.00012578574,"threshold_uncertainty_score":0.6264295},"labels":[],"label_agreement":null},{"id":"W4310106214","doi":"10.1182/blood-2022-164610","title":"Identification of Genetic Subtypes in Follicular Lymphoma","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; BC Cancer Agency; Princess Margaret Cancer Centre; Kingston General Hospital; Jewish General Hospital; Spinal Cord Injury BC; Queen's University; University Health Network","funders":"","keywords":"Follicular lymphoma; Identification (biology); Lymphoma; Biology; Medicine; Computational biology; Genetics; Pathology; Immunology","score_opus":0.008740443350802804,"score_gpt":0.23381972092916037,"score_spread":0.22507927757835755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310106214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99763745,0.001685143,0.0000024646931,0.00014249227,0.0000396733,0.00018914994,0.000007929338,0.00000999571,0.0002856788],"genre_scores_gemma":[0.9995306,0.000052650175,0.00009296438,0.00004925928,0.00001452097,0.00012395174,0.000014499094,0.0000064136552,0.000115129005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99943906,0.000024751627,0.00018450737,0.00011674105,0.00015984708,0.00007511035],"domain_scores_gemma":[0.9997142,0.000015248186,0.00005490596,0.00017605706,0.000015786032,0.000023789531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000070297,0.000045725992,0.00011485435,0.00007107852,0.000026635487,0.0000027788126,0.000039313007,0.000013741249,0.000080814134],"category_scores_gemma":[0.000013330179,0.000042285,0.000047940543,0.00015552527,0.000010422985,0.000010610249,0.000028166973,0.000014058377,0.000010272955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031058273,0.0040628705,0.9764713,0.000030639774,0.00008577512,0.00019511185,0.00020806241,0.00002947548,0.013417183,0.00025246316,0.00008658136,0.0051294756],"study_design_scores_gemma":[0.004363051,0.00016672819,0.93139285,0.000008718033,0.00013844244,0.00006646247,0.00007135983,0.000038851715,0.06301053,0.000081319005,0.00062482845,0.00003688765],"about_ca_topic_score_codex":0.00009779445,"about_ca_topic_score_gemma":0.0000070237215,"teacher_disagreement_score":0.049593344,"about_ca_system_score_codex":0.00005465775,"about_ca_system_score_gemma":0.000052476167,"threshold_uncertainty_score":0.17243321},"labels":[],"label_agreement":null},{"id":"W4310106224","doi":"10.1182/blood-2022-170689","title":"Loss of FBXO11 Function Establishes a Stem Cell Program in Acute Myeloid Leukemia through Dysregulation of the Mitochondrial Protease LONP1","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Progenitor cell; Myeloid leukemia; Biology; CD34; Stem cell; Cancer research; Haematopoiesis; Cord blood; Myeloid; Hematopoietic stem cell; Molecular biology; Immunology; Cell biology","score_opus":0.014644653346449304,"score_gpt":0.25969250084260603,"score_spread":0.24504784749615674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310106224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99455166,0.00015405442,0.00008786428,0.00032438507,0.00023493648,0.0034897616,0.000050418006,0.000053983906,0.0010529257],"genre_scores_gemma":[0.9961779,0.00001687725,0.001475862,0.000055181114,0.00015625788,0.00073070225,0.000058785507,0.00004058242,0.0012878284],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974844,0.0002809151,0.00055038894,0.0003664442,0.0009674011,0.00035048273],"domain_scores_gemma":[0.9987056,0.00007689219,0.00031302517,0.00066052703,0.00017502287,0.00006891796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034081616,0.00018393487,0.0003961831,0.0001647452,0.0001161767,0.000014941006,0.00031389022,0.000115462535,0.00013144567],"category_scores_gemma":[0.000055300785,0.00014307149,0.00017303457,0.0011703669,0.00017735694,0.00018278789,0.00032865698,0.00061402883,0.0000041990475],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013417621,0.011780006,0.24828985,0.0027094013,0.0010624658,0.0003720712,0.008502969,0.0018227134,0.6710922,0.00064435555,0.005549728,0.034756623],"study_design_scores_gemma":[0.044530693,0.007172849,0.17157017,0.000398824,0.0017100746,0.00029390887,0.0034512028,0.0019265343,0.75407755,0.0007544447,0.013487405,0.0006263444],"about_ca_topic_score_codex":0.00042881252,"about_ca_topic_score_gemma":0.000029628403,"teacher_disagreement_score":0.082985364,"about_ca_system_score_codex":0.00047742616,"about_ca_system_score_gemma":0.0011459028,"threshold_uncertainty_score":0.5834286},"labels":[],"label_agreement":null},{"id":"W4310106230","doi":"10.1182/blood-2022-164744","title":"Distinct Molecular Subtypes of Classic Hodgkin Lymphoma Identified By Comprehensive Noninvasive Profiling","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Profiling (computer programming); Lymphoma; Medicine; Hodgkin lymphoma; Computational biology; Pathology; Biology; Computer science","score_opus":0.007830092935507174,"score_gpt":0.22269915666324583,"score_spread":0.21486906372773865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310106230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946892,0.0035903759,0.0002940876,0.00003983692,0.00017244066,0.00020605378,0.00041314965,0.000008195367,0.000586661],"genre_scores_gemma":[0.99853665,0.0000962286,0.0003287409,0.0001757617,0.00006479849,0.00006252402,0.00056986185,0.00002802596,0.00013742724],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99905676,0.0000568225,0.00021205668,0.0003176145,0.00016305146,0.00019370641],"domain_scores_gemma":[0.9993659,0.000031321004,0.0001412241,0.00031629408,0.00008913842,0.000056076253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006542996,0.00013380629,0.00016804526,0.00003237823,0.00010585827,0.000016029224,0.00022228676,0.00005341068,0.000026659654],"category_scores_gemma":[0.00005416855,0.00015435774,0.000107141714,0.00009717704,0.00006803323,0.0000014782205,0.00031464026,0.00005717334,0.0000027438691],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000631641,0.00033042827,0.003344345,0.000026768437,0.00012721009,0.000029718365,0.000029747305,0.000101791746,0.9936493,0.00020248748,0.0017109341,0.0003841133],"study_design_scores_gemma":[0.0016254414,0.0003693838,0.0012303138,0.0000052179435,0.00008541564,0.000033572283,0.00016165628,0.000020096233,0.9835317,0.00011423785,0.012631425,0.00019153503],"about_ca_topic_score_codex":0.00004465234,"about_ca_topic_score_gemma":0.000010643715,"teacher_disagreement_score":0.010920491,"about_ca_system_score_codex":0.000017983612,"about_ca_system_score_gemma":0.00014379613,"threshold_uncertainty_score":0.6294526},"labels":[],"label_agreement":null},{"id":"W4310106406","doi":"10.1182/blood-2022-168958","title":"The Effects of Dietary Asparagine on Pegaspargase Therapy and Blood and Stool Metabolites. a Pilot Study in Mice","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Asparaginase; Medicine; PEG ratio; Glutamine; Internal medicine; Pharmacology; Gastroenterology; Physiology; Immunology; Lymphoblastic Leukemia; Biology; Leukemia; Biochemistry; Amino acid","score_opus":0.02072738457701787,"score_gpt":0.273988463891956,"score_spread":0.25326107931493813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310106406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851303,0.012735147,4.3875912e-7,0.00035519307,0.000047964833,0.0015385601,0.000010580405,0.000019361427,0.00016245771],"genre_scores_gemma":[0.99812984,0.0010411454,0.000051587183,0.00023872404,0.000049813978,0.0002736457,0.000004277183,0.00002749661,0.00018349498],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99827665,0.00032561485,0.00024020894,0.00032399932,0.00053633173,0.0002972087],"domain_scores_gemma":[0.99818325,0.0012625543,0.00006589835,0.00033822382,0.000038622155,0.00011146614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000607208,0.00016786944,0.00036439532,0.00014905079,0.00015675204,0.000016816906,0.00014623936,0.000019072295,0.000014078987],"category_scores_gemma":[0.00031741717,0.00011217482,0.000026401944,0.0003236517,0.000121374615,0.000032682932,0.00021464331,0.00035749696,0.0000011778773],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017004602,0.071506396,0.38450205,0.00088871364,0.0042305794,0.0052017905,0.008856619,0.000018795485,0.48634934,0.00069057033,0.0008892302,0.019861305],"study_design_scores_gemma":[0.08507115,0.054044932,0.8264987,0.00009151431,0.00092162756,0.00048395665,0.0011798659,0.00017502594,0.030507397,0.00011220238,0.00064373575,0.00026991105],"about_ca_topic_score_codex":0.00039018434,"about_ca_topic_score_gemma":0.000041904364,"teacher_disagreement_score":0.45584193,"about_ca_system_score_codex":0.000038854232,"about_ca_system_score_gemma":0.00016686057,"threshold_uncertainty_score":0.45743564},"labels":[],"label_agreement":null},{"id":"W4310106458","doi":"10.1182/blood-2022-163734","title":"<i>JAK2 V617F</i> Mutation and Associated Chromosomal Alterations Involving <i>JAK2</i> in Pre-HCT Blood Samples and Transplant Outcomes in Myelofibrosis Subtypes","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Myelofibrosis; Essential thrombocythemia; Medicine; Polycythemia vera; Internal medicine; Hazard ratio; Oncology; Myeloproliferative neoplasm; Cumulative incidence; Transplantation; Proportional hazards model; Immunology; Bone marrow; Gastroenterology; Confidence interval","score_opus":0.015120145523409054,"score_gpt":0.24247031211100306,"score_spread":0.227350166587594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310106458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961104,0.0016802844,0.0000037270995,0.0009198553,0.000046377343,0.0008086809,0.00029183552,0.000047756545,0.00009111682],"genre_scores_gemma":[0.9975664,0.0005898774,0.00050753687,0.00035206994,0.000025102629,0.00053225615,0.00034844567,0.000026982727,0.000051323907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983666,0.00017547503,0.0004309898,0.0004368066,0.00029094866,0.00029916147],"domain_scores_gemma":[0.99924725,0.0003633388,0.00010370113,0.00014724367,0.000035311285,0.000103152444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025120034,0.00023985383,0.00050063356,0.00022762807,0.00022896298,0.00005269761,0.0000506344,0.00007440834,0.00005997187],"category_scores_gemma":[0.000105235005,0.00022036258,0.00005697709,0.00030081204,0.000048675534,0.00013880977,0.000053783566,0.00024017876,0.0000010288745],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007295313,0.002563734,0.9856729,0.000069543625,0.00023398797,0.00030087927,0.0040645455,0.000037032547,0.0064706667,0.00028073732,0.000017129989,0.00021591097],"study_design_scores_gemma":[0.010144327,0.0008943822,0.9734407,0.00016926392,0.00047008984,0.00018492572,0.000299363,0.0002006913,0.013793407,0.00013050121,0.000049547936,0.00022280328],"about_ca_topic_score_codex":0.0007118454,"about_ca_topic_score_gemma":0.0033395882,"teacher_disagreement_score":0.012232181,"about_ca_system_score_codex":0.000072419636,"about_ca_system_score_gemma":0.00009271499,"threshold_uncertainty_score":0.8986125},"labels":[],"label_agreement":null},{"id":"W4310106485","doi":"10.1182/blood-2022-170366","title":"Metformin Treatment Abrogates the Competitive Advantage of <i>Dnmt3a</i> R878H HSPCs By Enhancing DNA Methylation Activity","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Occupational Cancer Research Centre; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Biology; Haematopoiesis; Progenitor cell; DNA methylation; Gene knockdown; Metformin; Methylation; Cancer research; Stem cell; Molecular biology; Cell biology; DNA; Genetics; Gene; Gene expression","score_opus":0.006986251023224363,"score_gpt":0.2443040589881549,"score_spread":0.23731780796493054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310106485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928802,0.0036746983,0.0011047733,0.000064220425,0.00007264363,0.0002564577,0.00014756431,0.000007647711,0.0017917692],"genre_scores_gemma":[0.9984248,0.00059087353,0.00029741993,0.00002660138,0.000055173405,0.00007196768,0.00020977201,0.00001577308,0.00030761943],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991134,0.00016624235,0.00017546493,0.00022787621,0.00016657633,0.00015046474],"domain_scores_gemma":[0.99943936,0.00006355546,0.00016512751,0.0002554201,0.000043695167,0.000032838776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028717457,0.00012606353,0.00014175156,0.000024515854,0.00018654607,0.000009676679,0.00012149374,0.00004622818,0.000033040644],"category_scores_gemma":[0.000035353,0.0001000755,0.000096733755,0.00009632855,0.00004196638,0.0000042871848,0.000108155386,0.00006649673,0.0000011722591],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003585385,0.0003334084,0.00080387405,0.0000061961914,0.000091092945,7.7271073e-7,0.00014081378,0.00006442439,0.9935709,0.000089359644,0.0000151365775,0.0048481245],"study_design_scores_gemma":[0.00075805315,0.00070247665,0.0003893142,0.00000241029,0.00008345553,0.000002242894,0.00040550076,0.00002842935,0.97726446,0.00008926812,0.02016788,0.00010649535],"about_ca_topic_score_codex":0.00004450295,"about_ca_topic_score_gemma":0.00005804267,"teacher_disagreement_score":0.020152742,"about_ca_system_score_codex":0.000023279783,"about_ca_system_score_gemma":0.00004634874,"threshold_uncertainty_score":0.40809605},"labels":[],"label_agreement":null},{"id":"W4310106561","doi":"10.1182/blood-2022-157559","title":"Risk Profiling of Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL) By Measuring Circulating Tumor DNA (ctDNA): Results from the POLARIX Study","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Hazard ratio; Internal medicine; Medicine; Confidence interval; Oncology; Proportional hazards model; Univariate analysis; Diffuse large B-cell lymphoma; Gastroenterology; Lymphoma; Multivariate analysis","score_opus":0.005116078041516927,"score_gpt":0.18320386198774907,"score_spread":0.17808778394623215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310106561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947487,0.00083359034,0.000027372069,0.000008561118,0.00006143959,0.0007346935,0.0034892515,0.000012427232,0.00008397519],"genre_scores_gemma":[0.99857134,0.000026043548,0.00013167445,0.0000683247,0.00007080123,0.00005769203,0.0010170267,0.000040701005,0.000016404067],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99848396,0.00017076073,0.00033929007,0.00044484093,0.00028095173,0.00028018316],"domain_scores_gemma":[0.99885064,0.00008351137,0.00035873897,0.00055136706,0.000093884024,0.000061831895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030237416,0.00018360221,0.00019007003,0.000020131109,0.0003226771,0.000030511765,0.0002890398,0.00003694076,0.0000040220293],"category_scores_gemma":[0.00021547056,0.00014675094,0.00006656548,0.00012282433,0.000027400216,0.0000031256986,0.00034091275,0.000107971835,7.0629284e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072813197,0.015821522,0.92593104,0.000014074718,0.00037402392,0.00001410426,0.0011884533,0.00015723846,0.05528617,0.0000024153653,0.00016459034,0.00031824052],"study_design_scores_gemma":[0.17460044,0.0049013337,0.37820685,0.000058898117,0.0015715961,0.000008520816,0.00468266,0.00028819774,0.4318094,0.000029517627,0.0026715493,0.001171028],"about_ca_topic_score_codex":0.0010073058,"about_ca_topic_score_gemma":0.00020000724,"teacher_disagreement_score":0.5477242,"about_ca_system_score_codex":0.000029952234,"about_ca_system_score_gemma":0.000116763935,"threshold_uncertainty_score":0.59843296},"labels":[],"label_agreement":null},{"id":"W4310106622","doi":"10.1182/blood-2022-168662","title":"Outcome of ALL in Adult Patient with Down Syndrome, Single Center Experience","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Single Center; Pediatrics; Surgery","score_opus":0.023205331680946954,"score_gpt":0.2778523553225024,"score_spread":0.25464702364155545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310106622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973712,0.000026817122,0.0000124306725,0.00019773163,0.00003907024,0.00032621733,0.000021906106,0.00001870824,0.0019858992],"genre_scores_gemma":[0.99862224,0.000002138227,0.0005847078,0.0004372602,0.000007982877,0.0001129824,0.000015510866,0.000017940798,0.00019924428],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855024,0.000042684092,0.00028195823,0.00021991748,0.00063215144,0.00027305778],"domain_scores_gemma":[0.9994403,0.00004697929,0.00006325558,0.0002927363,0.00006430151,0.00009242017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000070358816,0.00009583992,0.0002308653,0.00012804697,0.00002858304,0.0000044757303,0.00013315713,0.000025381221,0.0003221537],"category_scores_gemma":[0.000076121294,0.00007434583,0.00003579044,0.0002801946,0.00006989194,0.000038115766,0.00018760074,0.0001821852,0.000008699301],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056093495,0.006273076,0.9706018,0.00015257313,0.00011304785,0.0052555986,0.0067507527,0.00004254391,0.009314779,0.00006179144,0.00032127634,0.00055181276],"study_design_scores_gemma":[0.19895889,0.057155214,0.46597314,0.0014497336,0.00072322227,0.0653193,0.037018068,0.0020142533,0.14829814,0.00007405608,0.020753711,0.0022622864],"about_ca_topic_score_codex":0.00020968233,"about_ca_topic_score_gemma":0.000023029917,"teacher_disagreement_score":0.50462866,"about_ca_system_score_codex":0.00026024994,"about_ca_system_score_gemma":0.00011655472,"threshold_uncertainty_score":0.3527357},"labels":[],"label_agreement":null},{"id":"W4310107076","doi":"10.1182/blood-2022-163555","title":"Daratumumab Plus Lenalidomide and Dexamethasone in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Maia Age Subgroup Analysis","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Alberta; University of Calgary","funders":"","keywords":"Daratumumab; Lenalidomide; Multiple myeloma; Medicine; Dexamethasone; Subgroup analysis; Internal medicine; Oncology; Pomalidomide; Pediatrics; Confidence interval","score_opus":0.01224282486809824,"score_gpt":0.24186484019343388,"score_spread":0.22962201532533563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310107076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99777067,0.00047878435,0.00006854575,0.00008140369,0.00002293025,0.0009942751,0.00025170002,0.000051639116,0.00028006276],"genre_scores_gemma":[0.9969773,0.000070130875,0.0013425932,0.00007695935,0.000024571515,0.00028233283,0.0009892544,0.000037933336,0.00019887922],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99763685,0.00017742651,0.00032300316,0.00055656803,0.00073640095,0.0005697272],"domain_scores_gemma":[0.9988898,0.00025112665,0.000082213395,0.00040608054,0.00005275108,0.00031803318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023438799,0.00026931698,0.00065639557,0.0006176472,0.00022168609,0.000037504447,0.00013587456,0.000058264057,0.00018313447],"category_scores_gemma":[0.00007835679,0.00021834891,0.00012242868,0.0012356,0.00007858682,0.00009949313,0.00009083025,0.0003554949,0.000007356393],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005111634,0.0024286048,0.985772,0.000062712395,0.0015260739,0.0030512933,0.00058671634,0.00013013094,0.00024049166,0.0000061927058,0.00003340209,0.0010507432],"study_design_scores_gemma":[0.07922591,0.0009762256,0.9166861,0.000035051653,0.0013374827,0.000026731597,0.0001408377,0.0005975667,0.0006406026,0.000006865492,0.00011110757,0.00021548865],"about_ca_topic_score_codex":0.0017775021,"about_ca_topic_score_gemma":0.002420732,"teacher_disagreement_score":0.07411428,"about_ca_system_score_codex":0.00014670003,"about_ca_system_score_gemma":0.00010676678,"threshold_uncertainty_score":0.890401},"labels":[],"label_agreement":null},{"id":"W4310107128","doi":"10.1182/blood-2022-167913","title":"Leading-Digit Bias Influences the Decision to Transfuse Hospitalized Patients","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Benford’s Law and Fraud Detection","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Numerical digit; Regression discontinuity design; Statistics; Mathematics; Arithmetic; Pathology","score_opus":0.040286300428853734,"score_gpt":0.2813883518016714,"score_spread":0.24110205137281765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310107128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99666744,0.00002224486,0.00049385376,0.0001384668,0.00031066837,0.00044154213,0.000022404945,0.00009614222,0.0018072525],"genre_scores_gemma":[0.9984433,0.0000037466941,0.0007898973,0.00024195967,0.000051588548,0.00012498465,0.0000030201113,0.000020519043,0.00032098495],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988686,0.000060499646,0.00025199115,0.00019005462,0.00043981167,0.00018904358],"domain_scores_gemma":[0.99926203,0.00025495238,0.00007071467,0.000305962,0.000048379912,0.000057981495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024408124,0.000112476526,0.00014594174,0.00006192234,0.00039541928,0.000060331873,0.0002755461,0.000034408014,0.00019586488],"category_scores_gemma":[0.00022291671,0.00008012589,0.000093777984,0.00029768053,0.000021610282,0.00010111268,0.00008470866,0.00014723405,0.00005601909],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017511076,0.016398707,0.41236544,0.00029226777,0.0012084716,0.000080902006,0.040558293,0.0009575296,0.002933588,0.058249116,0.069834344,0.39537022],"study_design_scores_gemma":[0.022135362,0.007839431,0.122982614,0.00019187974,0.0011332612,0.00006871283,0.0021269654,0.00018087572,0.04354322,0.3308348,0.46671098,0.0022519047],"about_ca_topic_score_codex":0.000035448993,"about_ca_topic_score_gemma":0.00002674485,"teacher_disagreement_score":0.39687663,"about_ca_system_score_codex":0.000025547686,"about_ca_system_score_gemma":0.000018460833,"threshold_uncertainty_score":0.3267439},"labels":[],"label_agreement":null},{"id":"W4310107622","doi":"10.1182/blood-2022-169665","title":"Epidemiology and Disease Burden of Mucormycosis in Canada: Canmus Registry","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Saint John Regional Hospital; Dalhousie University; Western University; University of Toronto; CancerCare Manitoba; University Health Network; University of Saskatchewan; Université de Montréal; Institut National de Santé Publique du Québec; Toronto General Hospital; McMaster University; Concordia University; McGill University; McGill University Health Centre; University of Ottawa; Juravinski Hospital; Queen's University; University of British Columbia","funders":"","keywords":"Epidemiology; Mucormycosis; Medicine; Disease registry; Disease; Gerontology; Family medicine; Intensive care medicine; Surgery; Pathology","score_opus":0.020061324100381698,"score_gpt":0.260050943015241,"score_spread":0.23998961891485932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310107622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99464387,0.0030968105,0.0000018001417,0.0016445412,0.00003167207,0.00011507693,0.00006677807,0.000004112818,0.00039537088],"genre_scores_gemma":[0.9991565,0.00007179259,0.00005133611,0.0004056719,0.000023304932,0.000016078919,0.000014089284,0.0000046771174,0.00025656604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99924845,0.00008558322,0.00022644472,0.00017094144,0.0001142351,0.00015437034],"domain_scores_gemma":[0.9993839,0.0001487139,0.00006081853,0.00022581765,0.000017724089,0.00016298363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027495518,0.000054953263,0.00025465977,0.00002742098,0.000034799108,3.1819008e-7,0.000049478713,0.000014883053,0.00011656235],"category_scores_gemma":[0.0008612725,0.00005143866,0.000027684098,0.000089689944,0.000048027006,0.000009622406,0.000056394187,0.0001359813,2.2722914e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014843527,0.000083268606,0.9979732,0.000096190815,0.000016389538,0.00016724369,0.00005164733,0.0000102653685,0.0002706465,0.00013832492,0.0007453237,0.00029907236],"study_design_scores_gemma":[0.0008885288,0.00006079221,0.9971578,0.000020458574,0.000063295454,0.000012914516,0.000672387,0.000054453183,0.00006190332,0.00020780659,0.00075156573,0.00004809673],"about_ca_topic_score_codex":0.836587,"about_ca_topic_score_gemma":0.6703057,"teacher_disagreement_score":0.16628131,"about_ca_system_score_codex":0.00012869453,"about_ca_system_score_gemma":0.0017063079,"threshold_uncertainty_score":0.33571035},"labels":[],"label_agreement":null},{"id":"W4310107696","doi":"10.1182/blood-2022-157949","title":"The Combination of Navitoclax and Ruxolitinib in JAK Inhibitor-Naïve Patients with Myelofibrosis Mediates Responses Suggestive of Disease Modification","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University; University Health Network","funders":"","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Disease; Polycythemia vera; Internal medicine; Cancer research; Bone marrow","score_opus":0.009447585481964296,"score_gpt":0.2412132125914176,"score_spread":0.2317656271094533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310107696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981059,0.0003816353,6.4792397e-7,0.00046992188,0.000024527204,0.00076086755,0.00018994907,0.000006995234,0.000059552276],"genre_scores_gemma":[0.9992495,0.000079526304,0.00007101175,0.000019400015,0.000009970167,0.0003861604,0.00014832181,0.000010020904,0.000026092304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990008,0.00014564859,0.00024286605,0.00016678528,0.0003403056,0.00010363045],"domain_scores_gemma":[0.99897516,0.00047638264,0.00017005269,0.00015440001,0.00015995913,0.00006405883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016340284,0.0000949893,0.00018744382,0.00008933544,0.00010637481,0.0000061108394,0.00003929562,0.000018455848,0.000009324159],"category_scores_gemma":[0.00020728089,0.00006302181,0.000026265274,0.00018399942,0.00010788881,0.000041767744,0.00004152257,0.00007439328,3.3455052e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020400737,0.002470922,0.992143,0.000053246007,0.000061790124,0.00000380706,0.000729255,0.0000056135823,0.00043276377,0.0010692704,0.000029844558,0.0009604515],"study_design_scores_gemma":[0.006112384,0.0016844645,0.9712929,0.00009949381,0.00014660394,9.952207e-7,0.0003704994,0.00002636188,0.01999721,0.00018083623,0.000031225984,0.00005702877],"about_ca_topic_score_codex":0.000048908718,"about_ca_topic_score_gemma":0.000012938401,"teacher_disagreement_score":0.020850066,"about_ca_system_score_codex":0.000045149212,"about_ca_system_score_gemma":0.00010278974,"threshold_uncertainty_score":0.2569955},"labels":[],"label_agreement":null},{"id":"W4310107771","doi":"10.1182/blood-2022-167581","title":"Risk Factor Analysis for Second Treatment-Free Remission Failure from the Canadian TKI Discontinuation (TRAD) Trial in CML Patients: Treatment-Free Remission Accomplished By Dasatinib","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; McGill University; London Health Sciences Centre; University of Manitoba; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Hôpital de l'Enfant-Jésus; Hôpital Maisonneuve-Rosemont; Nova Scotia Health Authority; Princess Margaret Cancer Centre; University of Calgary; Alberta Health Services; University of Alberta Hospital; Ottawa Hospital; University Health Network; University of Toronto; Alberta Hospital Edmonton; University of British Columbia","funders":"","keywords":"Discontinuation; Dasatinib; Medicine; Internal medicine; Complete remission; Oncology; Surgery; Imatinib; Chemotherapy; Myeloid leukemia","score_opus":0.018545649203503014,"score_gpt":0.2556965387667733,"score_spread":0.23715088956327027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310107771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9770531,0.00041312756,0.000009385846,0.0016122843,0.00021685589,0.0042283377,0.015956568,0.00006511507,0.00044524754],"genre_scores_gemma":[0.98301506,0.0000471462,0.00070223503,0.00012557537,0.00028615555,0.0011392278,0.012772768,0.000073736584,0.0018380969],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9966314,0.00038288298,0.00077940285,0.0009465643,0.00062239746,0.00063737994],"domain_scores_gemma":[0.99636734,0.000640154,0.00049159856,0.0019759096,0.00008531911,0.00043969176],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023832597,0.00053137913,0.00088734756,0.000281384,0.0008085721,0.00009737305,0.0005660993,0.0002176927,0.002587562],"category_scores_gemma":[0.0008430225,0.00036240387,0.000536859,0.00074373255,0.00004783638,0.00017620756,0.00014326922,0.00031552024,0.0000063534176],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010781464,0.0072605517,0.92065996,0.000016996239,0.00587008,0.00005534256,0.0045356294,0.000039805076,0.0014352499,0.000008459301,0.022456395,0.026880085],"study_design_scores_gemma":[0.5631223,0.007364798,0.3506524,0.00007955132,0.010218379,0.0000060859293,0.0013249941,0.00060169125,0.005060306,0.0003846477,0.06042886,0.00075600337],"about_ca_topic_score_codex":0.19377638,"about_ca_topic_score_gemma":0.51211095,"teacher_disagreement_score":0.57000756,"about_ca_system_score_codex":0.005541607,"about_ca_system_score_gemma":0.0011714513,"threshold_uncertainty_score":0.9998828},"labels":[],"label_agreement":null},{"id":"W4310107852","doi":"10.1182/blood-2022-170230","title":"<i>IL1R1</i> Expression Predicts the Benefit from Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia and Intermediate-Risk Cytogenetics","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Hôpital Maisonneuve-Rosemont; Université de Montréal; Princess Margaret Cancer Centre; University Health Network; University of Toronto; Institute for Research in Immunology and Cancer","funders":"","keywords":"CEBPA; Oncology; NPM1; Hematopoietic stem cell transplantation; Internal medicine; Medicine; Transplantation; Induction chemotherapy; Myeloid leukemia; Hazard ratio; Proportional hazards model; Leukemia; Chemotherapy; Immunology; Biology; Confidence interval; Karyotype; Gene","score_opus":0.006474025734208399,"score_gpt":0.20817614256753011,"score_spread":0.2017021168333217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310107852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974813,0.0005921684,0.000060816506,0.000078508856,0.00006591609,0.0010283103,0.0005157584,0.000044448894,0.00013280234],"genre_scores_gemma":[0.9976128,0.0009222904,0.00036697203,0.00021464066,0.00005921456,0.00020370836,0.00044741016,0.00005847442,0.00011452832],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99781275,0.00017913339,0.00035323398,0.00048331296,0.000778472,0.0003931045],"domain_scores_gemma":[0.99897647,0.00017419348,0.00015299006,0.0004688772,0.000060116625,0.00016733985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023297107,0.00024655674,0.0003170802,0.00013763142,0.00022937967,0.000029936724,0.00028153817,0.00009775465,0.00005882463],"category_scores_gemma":[0.0000065325053,0.00017021273,0.000050188522,0.0002847312,0.00010523768,0.000072695104,0.00021806337,0.0006888692,0.000007203664],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021170028,0.000602287,0.97059894,0.00012872093,0.0001971628,0.00032394542,0.005704195,0.00030999104,0.017564166,0.0000032962344,0.00017850052,0.0022717656],"study_design_scores_gemma":[0.02433586,0.0018688226,0.8625389,0.00017419689,0.0009885868,0.000093622686,0.0011257622,0.00021644912,0.10805467,0.000063043335,0.00021141143,0.0003287329],"about_ca_topic_score_codex":0.00013906496,"about_ca_topic_score_gemma":0.00005406259,"teacher_disagreement_score":0.108060114,"about_ca_system_score_codex":0.00023168208,"about_ca_system_score_gemma":0.000261059,"threshold_uncertainty_score":0.69410735},"labels":[],"label_agreement":null},{"id":"W4310107925","doi":"10.1182/blood-2022-168586","title":"Long-Term Outcomes of Patients Aged 65 Years or Older with Peripheral T-Cell Lymphoma, Not Otherwise Specified (PTCL-NOS) and T-Follicular Helper T-Cell Lymphoma (TFHTCL) Treated with Curative Intent CHOP(like) Chemotherapy","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Medicine; Lymphoma; Follicular lymphoma; Internal medicine; Not Otherwise Specified; Oncology; Gastroenterology","score_opus":0.012141398437224277,"score_gpt":0.22782259915125588,"score_spread":0.2156812007140316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310107925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967959,0.00063887466,0.0000061006435,0.0001868223,0.00006169493,0.0017641125,0.00012529512,0.000074804084,0.00034637633],"genre_scores_gemma":[0.99475205,0.00027248616,0.00040669026,0.00093655975,0.000037645448,0.00040472476,0.00014933755,0.00012822101,0.00291229],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974022,0.00012341127,0.00047135164,0.00073760515,0.0007849549,0.00048046568],"domain_scores_gemma":[0.9985777,0.000072976785,0.00032561834,0.00061765825,0.0001500654,0.00025593844],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009155995,0.0005746488,0.0009456314,0.00016778403,0.00017732289,0.00004930319,0.00018107508,0.00009998422,0.000621942],"category_scores_gemma":[0.000007018959,0.00036247596,0.00019471964,0.00037299737,0.00018151905,0.00011603809,0.00009622914,0.00009252018,0.000009079413],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056855776,0.025180938,0.95839995,0.000110775,0.0013027798,0.0009896723,0.003139735,0.000004535781,0.0012197328,0.0000045857378,0.00019094998,0.0037707896],"study_design_scores_gemma":[0.11251079,0.004303677,0.8515114,0.000097070486,0.00074416783,0.00009780293,0.0006179924,0.000008365053,0.029332323,6.5079263e-7,0.0003676412,0.00040810806],"about_ca_topic_score_codex":0.00034740925,"about_ca_topic_score_gemma":0.00010498204,"teacher_disagreement_score":0.106888525,"about_ca_system_score_codex":0.00036497123,"about_ca_system_score_gemma":0.00021860377,"threshold_uncertainty_score":0.9998827},"labels":[],"label_agreement":null},{"id":"W4310107990","doi":"10.1182/blood-2022-160274","title":"Mirages - REDS Explorer: An Online Portal for Longitudinal Metabolomics Data from the REDS-III RBC Omics Study","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Neonatal Health and Biochemistry","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; University of British Columbia","funders":"","keywords":"Metabolomics; Omics; Biology; Medicine; Bioinformatics","score_opus":0.14067516755279927,"score_gpt":0.35656092115749816,"score_spread":0.2158857536046989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310107990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877173,0.00278676,0.000017614573,0.0010724458,0.00029263,0.00096679566,0.0070463815,0.00006231613,0.000037811566],"genre_scores_gemma":[0.9809292,0.0001080396,0.0018533559,0.0006947104,0.0010980295,0.000108907065,0.014939242,0.00003671964,0.000231811],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982634,0.000053864787,0.00038919027,0.000600024,0.00037615726,0.00031732526],"domain_scores_gemma":[0.9979945,0.0001252662,0.0001378513,0.001491068,0.000057892135,0.00019345572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005273691,0.00018178794,0.00034194585,0.000025844223,0.00033826116,0.000020194906,0.0006856359,0.000056906454,0.0001486735],"category_scores_gemma":[0.00011589736,0.00013484676,0.00007034721,0.00014527523,0.00005501856,0.00008780784,0.000541364,0.0003957955,0.000002359087],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02292743,0.105224006,0.60132056,0.0009222806,0.0056207203,0.003886443,0.010597657,0.000017410906,0.06933428,0.00023368363,0.115034625,0.06488089],"study_design_scores_gemma":[0.11607681,0.019824581,0.4008947,0.00018437092,0.014982706,0.0023590664,0.15173535,0.002943733,0.05494427,0.0012273599,0.23204853,0.0027785224],"about_ca_topic_score_codex":0.0003275878,"about_ca_topic_score_gemma":0.00018133568,"teacher_disagreement_score":0.20042586,"about_ca_system_score_codex":0.000023709072,"about_ca_system_score_gemma":0.0002636843,"threshold_uncertainty_score":0.54988915},"labels":[],"label_agreement":null},{"id":"W4310108176","doi":"10.1182/blood-2022-162789","title":"High-Plex Imaging and Cellular Neighborhood Spatial Analysis Reveals Multiple Immune Escape and Suppression Patterns in DLBCL","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Tumor microenvironment; Immune system; Cohort; Context (archaeology); Oncology; Diffuse large B-cell lymphoma; Medicine; Biology; Internal medicine; Cancer research; Immunology; Lymphoma","score_opus":0.006078191677673482,"score_gpt":0.22029740884258056,"score_spread":0.21421921716490708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310108176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934708,0.005303733,0.00015197416,0.00057554763,0.00009826001,0.0002664568,0.00006717774,0.000026095497,0.000039942606],"genre_scores_gemma":[0.999084,0.00023726928,0.000120272976,0.00020579669,0.00006466565,0.00003804508,0.00015157694,0.000019592884,0.000078762416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882805,0.00010358685,0.0003049779,0.00032563118,0.00021761438,0.00022012743],"domain_scores_gemma":[0.9995001,0.000058489873,0.000096843985,0.00026180007,0.000017067594,0.00006568887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028250157,0.000143796,0.00035924325,0.00026477457,0.00013256437,0.00002547381,0.00006891517,0.000034674886,0.0005442489],"category_scores_gemma":[0.0000196611,0.00013285055,0.00009299895,0.00035564468,0.00003723939,0.000056640703,0.0001424071,0.000184645,5.391605e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041401578,0.00037927754,0.71961224,0.00004193969,0.00031089748,0.000100426274,0.0003719231,0.0000039288598,0.2723386,0.0000023281998,0.000025933225,0.006398472],"study_design_scores_gemma":[0.013334321,0.00017927532,0.95556307,0.000057674035,0.00080992904,0.000045834775,0.0005141794,0.0016390145,0.02742061,0.000024654484,0.00021950848,0.00019194187],"about_ca_topic_score_codex":0.003095844,"about_ca_topic_score_gemma":0.00013429171,"teacher_disagreement_score":0.24491797,"about_ca_system_score_codex":0.000033158198,"about_ca_system_score_gemma":0.000023172635,"threshold_uncertainty_score":0.5959144},"labels":[],"label_agreement":null},{"id":"W4310108249","doi":"10.1182/blood-2022-160070","title":"Assessing the Epidemiology, Treatment Patterns, and Economic Impact of Marginal Zone Lymphoma: A Review of the Literature","year":2022,"lang":"en","type":"review","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Splenic marginal zone lymphoma; Epidemiology; Marginal zone; Medicine; Incidence (geometry); Checklist; Lymphoma; Systematic review; MEDLINE; Internal medicine; Biology; Immunology; Splenectomy","score_opus":0.0659910679463812,"score_gpt":0.394142646086409,"score_spread":0.32815157814002777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310108249","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0063733314,0.9911777,1.3609595e-7,0.00022557502,0.000089800196,0.0014597786,0.00050815806,0.0000067435362,0.00015878248],"genre_scores_gemma":[0.0012168231,0.99778855,0.000039497594,0.00013385092,0.000112306014,0.00036951466,0.00025209895,0.000030047366,0.00005729077],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99774075,0.00072235323,0.0008535785,0.0003554474,0.000100117744,0.00022772874],"domain_scores_gemma":[0.997046,0.0010299439,0.0010100178,0.0008177427,0.00002210018,0.00007422145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005961878,0.00042097908,0.0027260566,0.000063231695,0.000084818756,0.000014459535,0.00018257818,0.00013611921,0.00020263427],"category_scores_gemma":[0.000113015754,0.00016271241,0.0015264193,0.00014527315,0.00009835476,0.00003588126,0.00013887898,0.00012385526,0.000002235814],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000063719945,0.0009699865,0.022648277,0.060129046,0.0029493533,0.000041370295,0.000050203784,1.3243945e-7,6.5378266e-8,0.000040841267,0.00034199943,0.91282237],"study_design_scores_gemma":[0.0035692342,0.00097673,0.052458797,0.22931212,0.021139871,0.0028324088,0.000019825598,0.0000011077611,0.000003047865,0.000008774619,0.68945754,0.00022052671],"about_ca_topic_score_codex":0.00053122785,"about_ca_topic_score_gemma":0.0000069766866,"teacher_disagreement_score":0.9126018,"about_ca_system_score_codex":0.00070137816,"about_ca_system_score_gemma":0.0010412688,"threshold_uncertainty_score":0.663522},"labels":[],"label_agreement":null},{"id":"W4310108893","doi":"10.1182/blood-2022-168534","title":"Identification of Key microRNAs As Predictive Biomarkers of Nilotinib Response in Chronic Myeloid Leukemia: A Sub-Analysis of the Enestxtnd Clinical Trial","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Occupational Cancer Research Centre; Canada's Michael Smith Genome Sciences Centre; University of British Columbia; BC Cancer Agency; Terry Fox Research Institute","funders":"","keywords":"Nilotinib; Myeloid leukemia; Medicine; Oncology; microRNA; Identification (biology); Clinical trial; Internal medicine; Cancer research; Immunology; Bioinformatics; Biology; Imatinib; Genetics","score_opus":0.02463151413993247,"score_gpt":0.3176401550821788,"score_spread":0.2930086409422463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310108893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971859,0.0007486107,0.0000058950177,0.00019071746,0.00020489728,0.0013361134,0.0002120704,0.000013891214,0.00010194524],"genre_scores_gemma":[0.999365,0.00010773776,0.000033414715,0.000022788512,0.00005238181,0.00012986701,0.000063207386,0.000023593939,0.0002020332],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99559504,0.0012104909,0.0017914643,0.0004540424,0.00072137895,0.00022757973],"domain_scores_gemma":[0.9965988,0.0009359292,0.0012467179,0.0010022243,0.00014488191,0.000071469694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029980764,0.00018027108,0.00092284696,0.0005556314,0.000058203852,0.0000035867454,0.00035391832,0.00014266264,0.00014935966],"category_scores_gemma":[0.0015410632,0.00014872877,0.00070335175,0.00204933,0.00040390436,0.000041377683,0.00022120062,0.0003446289,0.0000030328176],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20903586,0.0050262115,0.11339753,0.00018436287,0.012679373,0.000049227503,0.0015887169,0.00095077587,0.65593755,0.000043658634,0.00017731772,0.0009294305],"study_design_scores_gemma":[0.12359577,0.0056409854,0.5590546,0.00010567868,0.012384079,0.00003325174,0.0006269497,0.00093974295,0.29727867,0.00003119269,0.00015999525,0.00014906075],"about_ca_topic_score_codex":0.0007212179,"about_ca_topic_score_gemma":0.00016212606,"teacher_disagreement_score":0.4456571,"about_ca_system_score_codex":0.0017054722,"about_ca_system_score_gemma":0.0043046526,"threshold_uncertainty_score":0.76362693},"labels":[],"label_agreement":null},{"id":"W4310108940","doi":"10.1182/blood-2022-163661","title":"Impact of Maintenance Therapy after Salvage Autologous Stem Cell Transplantation in Relapsed Multiple Myeloma","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Memorial University of Newfoundland; Regina Qu'Appelle Health Region; Spinal Cord Injury BC; Queen Elizabeth II Health Sciences Centre; Dalhousie University; Saint John Regional Hospital; London Health Sciences Centre; McMaster University; University of Calgary; Princess Margaret Cancer Centre; Vancouver General Hospital; University of British Columbia; Hôpital Maisonneuve-Rosemont; University Health Network; CancerCare Manitoba; Ottawa Hospital; McGill University Health Centre; McGill University; Western University; University of Toronto; Terry Fox Research Institute; Jewish General Hospital","funders":"","keywords":"Medicine; Salvage therapy; Multiple myeloma; Transplantation; Oncology; Maintenance therapy; Surgery; Autologous stem-cell transplantation; Stem cell; Internal medicine; Chemotherapy","score_opus":0.016496195716723453,"score_gpt":0.27702304449750464,"score_spread":0.2605268487807812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310108940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979412,0.00067737716,0.000011252713,0.000045264787,0.000027283691,0.00066044397,0.00017167104,0.000029847044,0.00043566254],"genre_scores_gemma":[0.99891126,0.00017195087,0.00021969723,0.000030248233,0.000012973565,0.00023380002,0.00007061324,0.000022366337,0.00032711157],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988022,0.00013026364,0.00023431788,0.00022220793,0.0003023409,0.0003087058],"domain_scores_gemma":[0.9994794,0.000093660485,0.000065971515,0.00023337838,0.00003339238,0.00009417666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014310726,0.00012945195,0.00025575244,0.00016554426,0.000043756165,0.000004435294,0.000081622995,0.000041751442,0.0002632969],"category_scores_gemma":[0.000009722645,0.00010027662,0.00014406334,0.00023499908,0.000032591055,0.000031875465,0.000020333695,0.00020571947,0.00001029385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005447323,0.0026244195,0.94305056,0.00008039229,0.00015243421,0.0020875006,0.0012636324,0.000047498197,0.035478294,0.0000019596303,0.000032443768,0.009733527],"study_design_scores_gemma":[0.021792099,0.0018451768,0.95842224,0.000029360028,0.000035153054,0.00012294363,0.00010020099,0.00023335173,0.01729917,0.000007486331,0.000029889365,0.00008290728],"about_ca_topic_score_codex":0.00035128588,"about_ca_topic_score_gemma":0.00004801203,"teacher_disagreement_score":0.018179124,"about_ca_system_score_codex":0.00010187223,"about_ca_system_score_gemma":0.00012670363,"threshold_uncertainty_score":0.40891618},"labels":[],"label_agreement":null},{"id":"W4310109030","doi":"10.1182/blood-2022-170869","title":"Post Autologous Stem Cell Transplant Maintenance in Patients with Newly Diagnosed Multiple Myeloma: A Network Meta-Analysis","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Multiple myeloma; Medicine; Stem cell; Meta-analysis; Oncology; Internal medicine; Lenalidomide; Autologous stem-cell transplantation; Transplantation; Biology; Genetics","score_opus":0.022916815207145575,"score_gpt":0.24100253934347954,"score_spread":0.21808572413633395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310109030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966723,0.0008960527,0.000058621557,0.00024924762,0.000027286751,0.0012186663,0.0005476407,0.00005912329,0.00027110724],"genre_scores_gemma":[0.99690545,0.000015184046,0.00094970246,0.00027913353,0.000019691048,0.0005683559,0.0005318012,0.000035028606,0.0006956613],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974008,0.0002615904,0.00036440959,0.00053471664,0.0007351146,0.00070336444],"domain_scores_gemma":[0.9987693,0.00024747846,0.00012380058,0.00050755724,0.000100982776,0.000250917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023947337,0.0002721363,0.0010315898,0.0002707291,0.00018947381,0.000018384382,0.00019001825,0.000051116334,0.00042137754],"category_scores_gemma":[0.000017338505,0.00018725084,0.00050661026,0.0010460753,0.000045731766,0.0000539478,0.000074606316,0.00034713806,0.000019948322],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023889402,0.0046363706,0.94724596,0.00004078592,0.039738372,0.002875581,0.00042885347,0.0019178648,0.000025500469,0.0000058355913,0.000101381265,0.0005945701],"study_design_scores_gemma":[0.027539348,0.001793872,0.90731347,0.0000073930482,0.06193005,0.000016858752,0.00014009522,0.0006599199,0.00018814705,0.000003933383,0.00017558591,0.0002313122],"about_ca_topic_score_codex":0.00069324847,"about_ca_topic_score_gemma":0.0010194721,"teacher_disagreement_score":0.039932463,"about_ca_system_score_codex":0.00009675654,"about_ca_system_score_gemma":0.00011909504,"threshold_uncertainty_score":0.7635868},"labels":[],"label_agreement":null},{"id":"W4310109034","doi":"10.1182/blood-2022-169909","title":"Thrombotic and Bleeding Complications in Patients with Chronic Lymphocytic Leukemia and Severe COVID-19: A Study of Eric, the European Research Initiative on CLL","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Thrombosis; Chronic lymphocytic leukemia; Internal medicine; Retrospective cohort study; Coronavirus disease 2019 (COVID-19); Pediatrics; Disease; Leukemia; Infectious disease (medical specialty)","score_opus":0.07382600572879541,"score_gpt":0.3406315379864103,"score_spread":0.26680553225761494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310109034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994745,0.00022369083,0.000001725261,0.00019687646,0.000011760034,0.0020191283,0.000019175854,0.000022672564,0.0027599703],"genre_scores_gemma":[0.9994284,0.000037278496,0.000021981234,0.00021818792,0.000029655896,0.00016763479,0.000016445809,0.000034898658,0.00004554486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969358,0.00092728186,0.00028621094,0.00044001898,0.0010348724,0.00037580586],"domain_scores_gemma":[0.9981453,0.00092472415,0.00009227091,0.0005037497,0.00014042086,0.00019354733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015917653,0.00014483549,0.00028036602,0.0002879343,0.000496139,0.000029739203,0.00024942128,0.000024088875,0.000038279075],"category_scores_gemma":[0.00038854257,0.00010267968,0.00001771866,0.00086309074,0.00037783192,0.00005278016,0.00061498024,0.0005308894,0.0000048428838],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.005680207,0.016687514,0.83794296,0.0029039257,0.0021700815,0.0014291235,0.11376451,0.011177538,0.00065438496,0.0017250082,0.0018678922,0.0039968803],"study_design_scores_gemma":[0.13561763,0.009868135,0.8372966,0.00022816923,0.00019575411,0.00021840724,0.012729744,0.003285605,0.000038544393,0.00010434485,0.00020052049,0.00021656117],"about_ca_topic_score_codex":0.001507682,"about_ca_topic_score_gemma":0.00024146776,"teacher_disagreement_score":0.12993743,"about_ca_system_score_codex":0.023036292,"about_ca_system_score_gemma":0.010857946,"threshold_uncertainty_score":0.99474955},"labels":[],"label_agreement":null},{"id":"W4310109045","doi":"10.1182/blood-2022-166429","title":"Exposure-Response Analysis Supports a Lower Dose of Venetoclax in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma Patients When Combined with Daratumumab and Dexamethasone","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Venetoclax; Daratumumab; Medicine; Internal medicine; Oncology; Multiple myeloma; Dexamethasone; Population; Proportional hazards model; Bortezomib; Gastroenterology; Leukemia; Chronic lymphocytic leukemia","score_opus":0.00957636951548764,"score_gpt":0.24524580708338173,"score_spread":0.2356694375678941,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310109045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998013,0.00026703725,0.000007830451,0.00006902752,0.000035620593,0.0011935979,0.00026597513,0.000026313108,0.000121585246],"genre_scores_gemma":[0.99803275,0.0000133837775,0.0008161516,0.000047549765,0.00001042507,0.0002506607,0.00042195417,0.000038182767,0.0003689395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972409,0.00054187933,0.00042899314,0.00052700087,0.00081703387,0.00044418022],"domain_scores_gemma":[0.9982775,0.00051959127,0.00020412718,0.00052689546,0.00017964852,0.00029223747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004952346,0.00026499465,0.0006952569,0.00068659446,0.00014731874,0.000016460324,0.00012512364,0.0000794157,0.0002765506],"category_scores_gemma":[0.0003483058,0.00022381062,0.0001378008,0.0008471974,0.00014284273,0.00011057832,0.00019243744,0.00033260346,0.0000030216347],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03897159,0.0062030028,0.94661796,0.00004188202,0.001746247,0.0016044952,0.0015434643,0.000037930156,0.0020959764,0.0000028586494,0.000042015738,0.0010925691],"study_design_scores_gemma":[0.045018606,0.011015272,0.93897057,0.000048563004,0.0009968108,0.000032242962,0.00027274562,0.00024344682,0.0030930906,0.0000079463025,0.00010525945,0.00019544244],"about_ca_topic_score_codex":0.0006937385,"about_ca_topic_score_gemma":0.00068954483,"teacher_disagreement_score":0.0076473895,"about_ca_system_score_codex":0.0002446312,"about_ca_system_score_gemma":0.00032096184,"threshold_uncertainty_score":0.91267323},"labels":[],"label_agreement":null},{"id":"W4310109065","doi":"10.1182/blood-2022-166416","title":"Single Centre, Retrospective Analysis of Treatment Outcomes and Prognostic Factors in Blastic Phase Chronic Myeloid Leukemia (CML-BP) Following Systemic Therapy","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Myeloid leukemia; Dasatinib; Imatinib mesylate; Oncology; Transplantation; Myeloid; Imatinib; Gastroenterology","score_opus":0.017898624782840496,"score_gpt":0.27159618912413536,"score_spread":0.25369756434129487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310109065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99538255,0.0028760664,0.0000057684956,0.000030653195,0.00011152896,0.0012845641,0.00012535232,0.000069055735,0.00011447613],"genre_scores_gemma":[0.99909014,0.00014767796,0.00004400114,0.000017973025,0.000027960474,0.00014551902,0.00020954225,0.000046051042,0.00027112348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99777085,0.00014283136,0.0005743796,0.0006044304,0.0004543554,0.00045315674],"domain_scores_gemma":[0.9987999,0.0002954484,0.00025303976,0.00046707678,0.000038988703,0.00014552815],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014346265,0.0003835961,0.001240037,0.0006559733,0.00012565443,0.000016229322,0.00010936936,0.000075576565,0.0001975002],"category_scores_gemma":[0.000107603824,0.00030747097,0.0004374772,0.001186641,0.000055711993,0.000067121655,0.00007528071,0.0001939008,0.0000021990013],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012156123,0.0029881399,0.9695338,0.000055682365,0.0074568903,0.000253342,0.0019932117,0.00028469495,0.016420865,0.000009947387,0.0000032590299,0.00087857695],"study_design_scores_gemma":[0.062371094,0.0076334053,0.9015201,0.00020011657,0.012515977,0.000060132774,0.0016215685,0.0016707008,0.011910691,0.000013179526,0.0000620417,0.0004209928],"about_ca_topic_score_codex":0.0007186635,"about_ca_topic_score_gemma":0.0002988509,"teacher_disagreement_score":0.06801373,"about_ca_system_score_codex":0.009762612,"about_ca_system_score_gemma":0.00079345313,"threshold_uncertainty_score":0.9999377},"labels":[],"label_agreement":null},{"id":"W4310109066","doi":"10.1182/blood-2022-169640","title":"Arterial Thromboembolism Is Prevalent and Often Suboptimally Managed in Immune Thrombocytopenia","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton; University of Alberta","funders":"","keywords":"Immune thrombocytopenia; Medicine; Venous thromboembolism; Immunology; Thrombosis; Platelet; Intensive care medicine; Internal medicine","score_opus":0.011515487519010008,"score_gpt":0.2432622128097053,"score_spread":0.2317467252906953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310109066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994434,0.0014937132,9.159369e-7,0.0008533956,0.00009635161,0.00051153306,0.000034240216,0.000030461735,0.0025453954],"genre_scores_gemma":[0.9981514,0.00023978368,0.0003161943,0.0005870289,0.000029306364,0.000078870726,0.0000472996,0.000020506322,0.0005295654],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990601,0.000041048264,0.0002038172,0.00026824744,0.00020180263,0.00022498358],"domain_scores_gemma":[0.9996431,0.000013850291,0.00004895239,0.00022479855,0.000010766632,0.000058525617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011142547,0.00013443174,0.00043948373,0.00008196008,0.000105293075,0.00001743606,0.000076007265,0.00003604945,0.0007186929],"category_scores_gemma":[0.000006909005,0.00012467461,0.000054216587,0.00012043628,0.000032493528,0.00005542724,0.00015088091,0.00015568732,0.00001830304],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071447166,0.063081324,0.40935567,0.0018406913,0.00857946,0.039708328,0.03297162,0.00007345569,0.3813515,0.002262163,0.013882071,0.039749015],"study_design_scores_gemma":[0.034250244,0.0011903777,0.9542231,0.000063364685,0.00074551045,0.00088208355,0.000508056,0.00011894954,0.0030192253,0.00074661634,0.0039117513,0.00034072128],"about_ca_topic_score_codex":0.0001038195,"about_ca_topic_score_gemma":0.000011954957,"teacher_disagreement_score":0.5448674,"about_ca_system_score_codex":0.000030371286,"about_ca_system_score_gemma":0.000038143975,"threshold_uncertainty_score":0.78691834},"labels":[],"label_agreement":null},{"id":"W4310109617","doi":"10.1182/blood-2022-169849","title":"Identification of Global miRNA Targetomes within Human Hematopoietic Progenitors and Acute Myeloid Leukemia Uncovers Unique Molecular Networks Centered on Mitochondria Function in Leukemic Stem Cells","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Myeloid leukemia; Haematopoiesis; Stem cell; Biology; Progenitor cell; microRNA; Function (biology); Identification (biology); Myeloid; Cancer research; Leukemia; Cell biology; Immunology; Genetics; Gene","score_opus":0.004788476040597099,"score_gpt":0.21649468101187322,"score_spread":0.21170620497127612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310109617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99780846,0.0006228149,0.0007041988,0.000010488213,0.00023596318,0.00051622186,0.00006469122,0.0000158814,0.000021275566],"genre_scores_gemma":[0.9994441,0.000020768413,0.00008472626,0.00003776098,0.00004380688,0.00008196599,0.00021382049,0.000023830933,0.00004921961],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99862766,0.00016927667,0.000399142,0.00041630722,0.00020249732,0.00018511493],"domain_scores_gemma":[0.9992725,0.000004942445,0.00028318583,0.0003303637,0.000046477802,0.000062520434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016400115,0.0001742848,0.00016398208,0.000058290818,0.00009125035,0.000021671278,0.00015686208,0.00011863753,0.0000058248434],"category_scores_gemma":[0.000004939118,0.00020147143,0.000081388076,0.00021252932,0.0000529841,0.000007821341,0.00012151916,0.0001130699,8.0649073e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016222247,0.00016555248,0.010209053,0.00004075195,0.00014192169,0.000009190808,0.000043415544,0.005938632,0.98286337,0.00027939724,0.0000906995,0.00005577975],"study_design_scores_gemma":[0.0018780809,0.000338896,0.008601487,0.000027614182,0.00015768266,0.000025572757,0.00014212285,0.0003440838,0.987966,0.00022321142,0.000071784954,0.00022347162],"about_ca_topic_score_codex":0.000025321211,"about_ca_topic_score_gemma":0.000017277864,"teacher_disagreement_score":0.005594548,"about_ca_system_score_codex":0.00020116227,"about_ca_system_score_gemma":0.0001259089,"threshold_uncertainty_score":0.8215766},"labels":[],"label_agreement":null},{"id":"W4310109630","doi":"10.1182/blood-2022-165887","title":"Alberta Cellular and Immunotherapy (ACIT) 001, Results of Decentralized Production of Second Generation, Anti-CD19/41BB/CD3z Chimeric Antigen Receptor (CAR) T-Cells in Relapsed/Refractory (R/R) Acute Lymphoblastic Leukemia (ALL) and Aggressive Non-Hodgkin Lymphoma (NHL)","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Stollery Children's Hospital; Alberta Children's Hospital; University of Alberta; University of Calgary","funders":"","keywords":"Medicine; Fludarabine; Chimeric antigen receptor; Blinatumomab; Internal medicine; Immunotherapy; Oncology; Cyclophosphamide; Clinical trial; CD19; Immunology; Antigen; Chemotherapy; Cancer","score_opus":0.010782009342702245,"score_gpt":0.24570286404493302,"score_spread":0.23492085470223079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310109630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940232,0.0037897092,0.0000045409593,0.000117754804,0.00041966853,0.0013390185,0.00014309686,0.000021955837,0.00014105909],"genre_scores_gemma":[0.9884622,0.0073137707,0.00053836097,0.00007259022,0.00014924257,0.00008903187,0.00035742903,0.000091795926,0.0029255685],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99671495,0.00038439292,0.00096718525,0.00079300615,0.0006472999,0.00049317826],"domain_scores_gemma":[0.9980267,0.00019820257,0.00070890714,0.00069117866,0.00020643567,0.0001685444],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007180323,0.0003595754,0.0008495051,0.0004792976,0.00015088748,0.000025376941,0.00021267161,0.00016859092,0.0008634701],"category_scores_gemma":[0.00015754726,0.00035884386,0.00012151701,0.0006643915,0.00029532786,0.00013452744,0.00015002082,0.0002850876,0.0000040417817],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032310893,0.0013127133,0.0032960013,0.00015963525,0.0007133447,0.00008223609,0.0024952157,0.000047792993,0.9830187,0.0000037428335,0.0010354382,0.004604101],"study_design_scores_gemma":[0.033562467,0.0016564054,0.011132455,0.000157464,0.00021491076,0.00026493773,0.00026419098,0.000452689,0.944615,0.000011634266,0.0073160683,0.00035175294],"about_ca_topic_score_codex":0.0013846379,"about_ca_topic_score_gemma":0.00017709924,"teacher_disagreement_score":0.038403664,"about_ca_system_score_codex":0.00029668654,"about_ca_system_score_gemma":0.000541358,"threshold_uncertainty_score":0.99988633},"labels":[],"label_agreement":null},{"id":"W4310112231","doi":"10.1182/blood-2022-165616","title":"Extranodal Marginal Zone Lymphomas Show Recurrent Mutations in DNA Repair Genes, Cancer-Associated Proliferative Signaling and NOTCH1 Signaling Pathways, Regardless of Anatomic Site","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Exome; Biology; Transcriptome; Population; Hematopathology; Genetics; Gene; Exome sequencing; Cancer research; Medicine; Mutation; Gene expression; Chromosome; Cytogenetics","score_opus":0.0188363791763551,"score_gpt":0.25124439853159547,"score_spread":0.23240801935524036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310112231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899796,0.008430905,0.000006402472,0.00022155326,0.00008604654,0.00074578275,0.00038086527,0.00006600524,0.00008283022],"genre_scores_gemma":[0.9982973,0.00027584407,0.00040234692,0.00007727789,0.000055953926,0.00054727774,0.0002499774,0.000030038953,0.00006402265],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998148,0.00019402477,0.00048612745,0.00043935952,0.00041993352,0.0003125097],"domain_scores_gemma":[0.99919903,0.00014736304,0.0002310978,0.0001822768,0.00011786665,0.0001223521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003271859,0.00022726828,0.00051322166,0.000259279,0.000203987,0.000017182505,0.00006440922,0.00006682231,0.00009809136],"category_scores_gemma":[0.000041852185,0.00022007816,0.00013949811,0.00049764686,0.000060119182,0.000065274886,0.00007170506,0.00014277143,0.0000010077417],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006505212,0.007343011,0.8906646,0.00023877161,0.0009459284,0.00093943975,0.0059182565,0.0007149396,0.08585403,0.000398963,0.000067703026,0.0062638344],"study_design_scores_gemma":[0.057897694,0.0034982208,0.524708,0.0015553386,0.0032011096,0.0004437416,0.0039863153,0.0057320353,0.3970696,0.00022122766,0.0006476906,0.0010390829],"about_ca_topic_score_codex":0.00050245866,"about_ca_topic_score_gemma":0.00031914224,"teacher_disagreement_score":0.36595666,"about_ca_system_score_codex":0.0005113786,"about_ca_system_score_gemma":0.00052472594,"threshold_uncertainty_score":0.89745265},"labels":[],"label_agreement":null},{"id":"W4310112251","doi":"10.1182/blood-2022-163517","title":"Younger Matched Unrelated Donors Confer a Decreased Relapse Risk As Compared to Older Sibling Donors for Adult B-Cell ALL Patients Undergoing Allogeneic Hematopoietic Cell Transplantation","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Transplantation; Internal medicine; Graft-versus-host disease; Cohort; Population; Hematopoietic stem cell transplantation; Sibling; Incidence (geometry); Cord blood; Immunology; Oncology","score_opus":0.01141091225402796,"score_gpt":0.2550049209053376,"score_spread":0.24359400865130965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310112251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99260587,0.00011392596,0.0025451232,0.0004350823,0.00019423135,0.0029514553,0.00022309707,0.00016406947,0.0007671556],"genre_scores_gemma":[0.9913323,0.00016678781,0.0035999282,0.0020141946,0.000055827404,0.0006483035,0.0012349958,0.00014094087,0.0008067097],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99658114,0.0002496181,0.0007072549,0.00075559114,0.00091003,0.0007963942],"domain_scores_gemma":[0.9973432,0.0007559311,0.00025115037,0.00049362675,0.0004887205,0.00066741696],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041375306,0.00039198136,0.00056205696,0.000444804,0.00036396983,0.000056262106,0.00030341733,0.0001806217,0.000410157],"category_scores_gemma":[0.0003694076,0.00039047928,0.00023635589,0.0006120417,0.000049705643,0.00011508629,0.00011427443,0.00047392785,0.00012843242],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040112477,0.040844873,0.5091861,0.008831355,0.005638208,0.002413869,0.06880554,0.019655716,0.27978066,0.00043113958,0.023637783,0.00066226505],"study_design_scores_gemma":[0.510529,0.011612264,0.043648947,0.0016140162,0.017066661,0.0010138691,0.015755167,0.014106564,0.37706435,0.00080594356,0.0025564332,0.0042268373],"about_ca_topic_score_codex":0.00080880517,"about_ca_topic_score_gemma":0.00010955843,"teacher_disagreement_score":0.4704165,"about_ca_system_score_codex":0.0005739382,"about_ca_system_score_gemma":0.0010123593,"threshold_uncertainty_score":0.9998547},"labels":[],"label_agreement":null},{"id":"W4310112286","doi":"10.1182/blood-2022-157583","title":"Exploratory Analysis of Factors Influencing Efficacy and Safety of Camidanlumab Tesirine: Data from the Open-Label, Multicenter, Phase 2 Study of Patients with Relapsed or Refractory Classical Hodgkin Lymphoma (R/R cHL)","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Ottawa Hospital","funders":"","keywords":"Medicine; Brentuximab vedotin; Internal medicine; Adverse effect; Rash; Phases of clinical research; Clinical trial; Oncology; Mucositis; Surgery; Toxicity; Lymphoma; Hodgkin lymphoma","score_opus":0.07230352578196757,"score_gpt":0.3474594734599858,"score_spread":0.2751559476780182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310112286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996786,0.00023727551,0.000004003495,0.000013745329,0.000031806554,0.0017047813,0.0011900886,0.00001535776,0.000016915395],"genre_scores_gemma":[0.9989946,0.000032944852,0.00012597877,0.000028907332,0.000017019385,0.000040965435,0.0006998251,0.00003806147,0.000021716198],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964702,0.0004908974,0.0008624791,0.00063084834,0.0012690385,0.0002765404],"domain_scores_gemma":[0.99550647,0.0014893652,0.0005845237,0.0020237507,0.00024260166,0.00015331684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006400221,0.00023919353,0.000981984,0.0002544577,0.0001552204,0.000017029415,0.0011037509,0.000059435428,0.00015800005],"category_scores_gemma":[0.00088687806,0.00014742804,0.000044008535,0.0012835385,0.0002698089,0.00021110279,0.0021557328,0.0002602195,4.2966778e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07748362,0.16320302,0.70429075,0.00030593615,0.019351244,0.00023948532,0.020116778,0.00008940633,0.0072812326,0.0000043696105,0.00029652796,0.0073376535],"study_design_scores_gemma":[0.4515507,0.010088804,0.5132811,0.00014448032,0.00758131,0.0000025775832,0.011829786,0.0035642965,0.0015457362,4.1324904e-7,0.000195155,0.00021562986],"about_ca_topic_score_codex":0.002807317,"about_ca_topic_score_gemma":0.000458713,"teacher_disagreement_score":0.37406707,"about_ca_system_score_codex":0.0010886731,"about_ca_system_score_gemma":0.002616847,"threshold_uncertainty_score":0.60119414},"labels":[],"label_agreement":null},{"id":"W4310112801","doi":"10.1182/blood-2022-160405","title":"Integrated Single Cell Analysis Reveals Co-Evolution of Malignant B Cells and the Tumor Microenvironment in Transformed Follicular Lymphoma","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Follicular lymphoma; Biology; Somatic evolution in cancer; clone (Java method); Phenotype; Diffuse large B-cell lymphoma; Lymphoma; Genetics; Genetic heterogeneity; Transcriptome; Cancer research; Computational biology; Immunology; Cancer; Gene","score_opus":0.00631071562594156,"score_gpt":0.19596600671591646,"score_spread":0.1896552910899749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310112801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99579346,0.0028447085,0.000023647372,0.00024649862,0.000017035965,0.00062758767,0.000094463394,0.00000850496,0.0003440638],"genre_scores_gemma":[0.9991857,0.00019446094,0.00015819371,0.000110928806,0.0000066809616,0.00017327712,0.000058635786,0.000010529228,0.00010161023],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99886215,0.00014702363,0.0003353496,0.00023128829,0.00024613432,0.00017803378],"domain_scores_gemma":[0.9995203,0.000070447524,0.00011119898,0.00023057914,0.000012209387,0.000055245542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027892066,0.00013250837,0.00043597602,0.00016629236,0.00007571347,0.00000714084,0.00006372599,0.00002404925,0.000112977184],"category_scores_gemma":[0.000005752163,0.000085340806,0.00019574308,0.00043787787,0.00008765374,0.000018484334,0.000028731243,0.000042798307,0.0000025272666],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011443153,0.018888421,0.37687045,0.00017071997,0.002389466,0.0005780972,0.0023127927,0.00024789185,0.59518105,0.00018921895,0.00023497669,0.0017925922],"study_design_scores_gemma":[0.037824713,0.0008710017,0.29475275,0.000054179596,0.0057311216,0.00008865296,0.0019121555,0.0002654353,0.6570246,0.000050974613,0.0012511403,0.0001732521],"about_ca_topic_score_codex":0.00061552203,"about_ca_topic_score_gemma":0.000033307842,"teacher_disagreement_score":0.0821177,"about_ca_system_score_codex":0.00030899516,"about_ca_system_score_gemma":0.000054866578,"threshold_uncertainty_score":0.3480097},"labels":[],"label_agreement":null},{"id":"W4310112860","doi":"10.1182/blood-2022-166592","title":"Predictors of 90-Day Mortality in Patients with Acute Pulmonary Embolism- a 5-Year Retrospective Cohort Study of Patients in One Canadian Health Region","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. John’s Health Sciences Centre; Memorial University of Newfoundland","funders":"","keywords":"Medicine; Pulmonary embolism; Concomitant; Retrospective cohort study; Incidence (geometry); Cohort; Internal medicine; Cause of death; Cohort study; Proportional hazards model; Pediatrics; Disease","score_opus":0.009780561108033334,"score_gpt":0.22969748424253042,"score_spread":0.2199169231344971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310112860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99561906,0.000026166057,3.2135907e-7,0.00006883666,0.00009376606,0.003499306,0.00017312804,0.000011325653,0.0005081036],"genre_scores_gemma":[0.9993749,0.000046922847,0.000009923518,0.00010912402,0.00001435212,0.0001947564,0.00021134393,0.00002515099,0.000013519217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978203,0.00018658086,0.00052519824,0.00036987435,0.0007724991,0.00032555673],"domain_scores_gemma":[0.9990074,0.000011415434,0.00028356604,0.00041927194,0.000115889154,0.00016246286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042308963,0.0001498119,0.00078878086,0.00043132264,0.000064447566,0.000002939087,0.00012903681,0.000035518904,0.00003416165],"category_scores_gemma":[0.000026992551,0.00014638965,0.000039309805,0.0006494594,0.000037114747,0.000055881417,0.00010927137,0.00022516704,3.951565e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000121034376,0.027232667,0.9689116,0.000059368063,0.00054355036,0.000059171223,0.0027906923,0.00002317217,4.3562665e-7,0.0000337846,0.00013980446,0.00008470778],"study_design_scores_gemma":[0.006808346,0.0050147474,0.9867656,0.000083116545,0.00035859222,3.628006e-7,0.0008284208,0.000004402009,0.000005001776,0.000010149461,0.000014465443,0.0001067556],"about_ca_topic_score_codex":0.20224997,"about_ca_topic_score_gemma":0.10751223,"teacher_disagreement_score":0.09473775,"about_ca_system_score_codex":0.0005126489,"about_ca_system_score_gemma":0.00029018015,"threshold_uncertainty_score":0.90877336},"labels":[],"label_agreement":null},{"id":"W4310112891","doi":"10.1182/blood-2022-167696","title":"Pediatric Sickle Cell Disease: A Potential Role for the Complement System","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; University Health Network; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Acute chest syndrome; Complement system; Disease; Eculizumab; Sickle cell anemia; Vaso-occlusive crisis; Immune system; Organ dysfunction; Internal medicine; Immunology; Pediatrics; Sepsis","score_opus":0.005762012056404568,"score_gpt":0.20764029356179375,"score_spread":0.2018782815053892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310112891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9576893,0.02959551,0.00090965413,0.003431249,0.0009033512,0.0032107842,0.0003849415,0.00022337609,0.003651871],"genre_scores_gemma":[0.99831575,0.00007859579,0.00006736803,0.00021265197,0.0002756179,0.00028037955,0.000060362418,0.000019418334,0.000689839],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99918175,0.000030672458,0.00015764995,0.00015642794,0.00025778785,0.00021573174],"domain_scores_gemma":[0.9995626,0.00003505718,0.0000528994,0.00021775767,0.00002790858,0.000103759245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014534446,0.00008436601,0.00011874865,0.00003646454,0.00043431416,0.000011343123,0.00010594968,0.000018915709,0.00018404976],"category_scores_gemma":[0.0000073045812,0.00005742539,0.00013728239,0.00012957228,0.00001332443,0.000009864309,0.000090751266,0.00013029062,0.000016553728],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009758742,0.06409029,0.26679045,0.02312411,0.0058530825,0.0042375335,0.01358963,0.03979676,0.022211757,0.026114618,0.498771,0.025662012],"study_design_scores_gemma":[0.07973738,0.004379061,0.04184472,0.00010230545,0.025040654,0.0005581967,0.06534202,0.061665837,0.0011692977,0.00041115002,0.7183036,0.0014457866],"about_ca_topic_score_codex":0.000025002291,"about_ca_topic_score_gemma":6.153611e-7,"teacher_disagreement_score":0.22494572,"about_ca_system_score_codex":0.000029835233,"about_ca_system_score_gemma":0.000103950115,"threshold_uncertainty_score":0.33404374},"labels":[],"label_agreement":null},{"id":"W4310112932","doi":"10.1182/blood-2022-156749","title":"Quality of Life in Patients with Chronic Lymphocytic Leukemia Initiating Venetoclax in Routine Clinical Practice across Canada: Results from the Devote Study","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Alberta; ABB (Canada); CancerCare Manitoba; Alberta Health Services; Ottawa Hospital","funders":"","keywords":"Venetoclax; Chronic lymphocytic leukemia; Medicine; Leukemia; Quality of life (healthcare); Family medicine; Gerontology; Internal medicine; Intensive care medicine; Oncology; Immunology; Nursing","score_opus":0.04395929401260058,"score_gpt":0.3616856000968255,"score_spread":0.3177263060842249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310112932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973311,0.0003504218,9.713673e-7,0.0001537605,0.000113474576,0.001586283,0.0002679031,0.000017540635,0.00017854365],"genre_scores_gemma":[0.9988934,0.00001173912,0.00010866939,0.00052325294,0.00015660695,0.00010873531,0.00014146327,0.000037106834,0.000019061945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99333614,0.0017031991,0.0018322065,0.0006391738,0.0018561733,0.0006330839],"domain_scores_gemma":[0.9929195,0.004985963,0.0006755712,0.0010093763,0.00023118201,0.00017841518],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0053176447,0.00021708434,0.00074450724,0.000042656615,0.00016258904,0.00001840397,0.00045809813,0.0000797521,0.00002479767],"category_scores_gemma":[0.011845895,0.00016436147,0.000060276805,0.0008337141,0.00013372995,0.00010070528,0.0006199061,0.00096573686,0.0000024320839],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.010524846,0.0022448353,0.976882,0.00006821954,0.000365184,0.0004895058,0.0038445857,0.004408093,0.0000043508016,0.0000039590977,0.00013807676,0.0010263722],"study_design_scores_gemma":[0.21700321,0.001224475,0.77439016,0.00010028559,0.00008179797,0.000009519467,0.004310925,0.0025367036,0.000018457464,0.0000021959195,0.00017169502,0.00015059195],"about_ca_topic_score_codex":0.9399049,"about_ca_topic_score_gemma":0.83750933,"teacher_disagreement_score":0.20647837,"about_ca_system_score_codex":0.09863749,"about_ca_system_score_gemma":0.15300873,"threshold_uncertainty_score":0.9964777},"labels":[],"label_agreement":null},{"id":"W4310117556","doi":"10.1182/blood-2022-158327","title":"Ethical Prioritization of Patients to CAR T-Cell Therapies: Tool Development and Process","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Accountability; Transparency (behavior); Health care; Medicine; Process management; Business; Political science","score_opus":0.010573485154248463,"score_gpt":0.2612408947946012,"score_spread":0.2506674096403528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310117556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973891,0.00010046362,0.00015534887,0.0019099204,0.00003991205,0.0002541731,0.0000043523587,0.000010263262,0.00013645917],"genre_scores_gemma":[0.9980286,0.000006286691,0.0010926543,0.00070378336,0.00001892204,0.000023664717,0.000038062004,0.000006104421,0.00008196197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993109,0.000022541779,0.00014373717,0.00010320599,0.00035518556,0.000064396416],"domain_scores_gemma":[0.99974865,0.000017266599,0.00003489387,0.00005452624,0.000093269504,0.00005142425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019144083,0.000041586423,0.00008649521,0.00004247512,0.00006982069,0.0000028715099,0.000026697991,0.00007975338,0.000034987937],"category_scores_gemma":[0.000029832245,0.000034013607,0.000010475869,0.00013380006,0.00004652156,0.00000834988,0.000036854555,0.0001833076,6.207372e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001148178,0.015187503,0.35536063,0.0060340497,0.00054908026,0.000036776484,0.18187878,0.000076470336,0.08720115,0.008751506,0.00093704107,0.34283885],"study_design_scores_gemma":[0.01573881,0.0027383973,0.8210754,0.00024101527,0.00024654425,0.000014429328,0.0024417024,0.00023966534,0.09176933,0.0017778212,0.063247174,0.00046975457],"about_ca_topic_score_codex":0.0000022048105,"about_ca_topic_score_gemma":8.327676e-7,"teacher_disagreement_score":0.46571472,"about_ca_system_score_codex":0.000012712685,"about_ca_system_score_gemma":0.00012911065,"threshold_uncertainty_score":0.13870347},"labels":[],"label_agreement":null},{"id":"W4310117676","doi":"10.1182/blood-2022-166809","title":"A First-in-Human Phase 1 Study of Abbv-319, an Antibody-Drug Conjugate Composed of a CD19 Antibody Linked to a Potent Proprietary Glucocorticoid Receptor Modulator, in Patients with Relapsed or Refractory B-Cell Malignancies","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Antibody; Follicular lymphoma; Chronic lymphocytic leukemia; B cell; Internal medicine; Antibody-drug conjugate; Lymphoma; Oncology; Cancer research; Immunology; Pharmacology; Leukemia; Monoclonal antibody","score_opus":0.01815749915306182,"score_gpt":0.30731094766167855,"score_spread":0.28915344850861674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310117676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950622,0.00012869088,0.0000019421811,0.00013468557,0.00007416811,0.0042991405,0.00020108825,0.000029348583,0.00006878613],"genre_scores_gemma":[0.9983644,0.000025434096,0.00040634576,0.00010250658,0.000031148727,0.00013411268,0.00042648576,0.00005854762,0.00045102419],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99606496,0.00032433245,0.001050474,0.0006656876,0.0013449206,0.00054961105],"domain_scores_gemma":[0.99832916,0.000095665426,0.00034560877,0.00067852496,0.00028459818,0.0002664406],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005058813,0.00034859582,0.0010428816,0.00057223067,0.00014728773,0.000012494572,0.00036499227,0.000068199486,0.00022489573],"category_scores_gemma":[0.000048069393,0.00026518316,0.00010574271,0.0008779283,0.00012018031,0.0001240004,0.00030368284,0.00057299045,0.000006083954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017570654,0.06680368,0.6525368,0.0007028305,0.00017982123,0.00039020268,0.0049489667,0.0003016718,0.25640213,0.000006892455,0.000029638857,0.00012668596],"study_design_scores_gemma":[0.06860274,0.054934263,0.8607779,0.0005255864,0.00018026549,0.0000129473165,0.0026410013,0.00044982697,0.011097598,0.000005580288,0.00033266455,0.00043963103],"about_ca_topic_score_codex":0.0020905915,"about_ca_topic_score_gemma":0.0003227813,"teacher_disagreement_score":0.24530455,"about_ca_system_score_codex":0.00009287151,"about_ca_system_score_gemma":0.00030024163,"threshold_uncertainty_score":0.99998003},"labels":[],"label_agreement":null},{"id":"W4310118179","doi":"10.1182/blood-2022-167088","title":"Targeting a Highly Deregulated eIF4F Translation Initiation Complex Sensitises IM-Resistant Cells to Tyrosine Kinase Inhibitors and Effectively Suppresses BCR-ABL1 Protein Expression","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; Kinexus Bioinformatics Corporation (Canada); University of British Columbia","funders":"","keywords":"Biology; Imatinib mesylate; Molecular biology; Nilotinib; Tyrosine kinase; Myeloid leukemia; Cancer research; Signal transduction; Cell biology; Imatinib","score_opus":0.015438433996950824,"score_gpt":0.2403064383283562,"score_spread":0.22486800433140536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310118179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959803,0.0007993429,0.00014203115,0.00035880948,0.00007876084,0.0022257522,0.00015203605,0.00015977639,0.000103184524],"genre_scores_gemma":[0.99501145,0.000011733055,0.0039136396,0.00010220019,0.00012047998,0.00027434842,0.00045743745,0.00005342201,0.000055299744],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998109,0.00026049555,0.0003668454,0.0004879532,0.00045627562,0.0003194676],"domain_scores_gemma":[0.9992524,0.000118327975,0.00014743797,0.0002203797,0.00008497729,0.00017651817],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020802637,0.00026081578,0.00035180105,0.00019182512,0.00042520772,0.00003634839,0.00005412198,0.00007488674,0.00013705694],"category_scores_gemma":[0.00008695043,0.0002524912,0.00006105422,0.00033519365,0.000042348882,0.00012429824,0.000098422,0.00019284553,0.0000074574073],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071242865,0.0006334159,0.00091152935,0.0002528818,0.000074801384,0.00021438039,0.00093727146,0.00024965656,0.9943922,0.0000058342393,0.00042760326,0.0011879749],"study_design_scores_gemma":[0.009763761,0.0010524036,0.014946514,0.0003696483,0.00027249035,0.000056168712,0.00026324068,0.0007099998,0.97158384,0.00002126092,0.00070023653,0.00026043883],"about_ca_topic_score_codex":0.00020997229,"about_ca_topic_score_gemma":0.000013276329,"teacher_disagreement_score":0.022808386,"about_ca_system_score_codex":0.00029893758,"about_ca_system_score_gemma":0.00012793826,"threshold_uncertainty_score":0.9999927},"labels":[],"label_agreement":null},{"id":"W4310119285","doi":"10.1182/blood-2022-169406","title":"Real-World Outcomes and Adverse Events of Elderly Patients with Ph-Negative Acute Lymphoblastic Leukemia Treated with a Pediatric-Inspired Protocol","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Adverse effect; Regimen; Induction chemotherapy; Confidence interval; Asparaginase; Proportional hazards model; Chemotherapy regimen; Internal medicine; Pediatrics; Chemotherapy; Lymphoblastic Leukemia; Leukemia","score_opus":0.008539344969711676,"score_gpt":0.2618764949051716,"score_spread":0.25333714993545997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310119285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.964253,0.0000019274446,0.000015636935,0.00003934736,0.000014955326,0.034473058,0.00017793472,0.00009102231,0.00093310705],"genre_scores_gemma":[0.96523124,0.0000034073314,0.0012655201,0.000059962982,0.00004013007,0.031757407,0.00007193302,0.000087083354,0.0014833352],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996931,0.00014490633,0.0004776091,0.0005794421,0.0013396818,0.0005273557],"domain_scores_gemma":[0.9982338,0.00027869866,0.00037104278,0.0004871011,0.00032674515,0.00030261817],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015229767,0.0003835683,0.0007005657,0.00044000012,0.0002086798,0.000007940344,0.00021208484,0.00006607658,0.00013668218],"category_scores_gemma":[0.00009888206,0.00025999616,0.000081021644,0.0010765243,0.00015808991,0.00013938906,0.00023297548,0.00029164978,0.0000071206537],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006717458,0.0017280547,0.98903143,0.0002777879,0.0009709076,0.00035031218,0.0004014189,0.000032348908,0.00014497638,0.000011761629,0.00014143309,0.00019210132],"study_design_scores_gemma":[0.094643235,0.010562199,0.89040464,0.00011922178,0.0018561654,0.000081430364,0.000177845,0.00019461848,0.0015256269,0.000014841774,0.000066277906,0.00035391314],"about_ca_topic_score_codex":0.00072746165,"about_ca_topic_score_gemma":0.00007987231,"teacher_disagreement_score":0.098626815,"about_ca_system_score_codex":0.00095745816,"about_ca_system_score_gemma":0.001826631,"threshold_uncertainty_score":0.9999852},"labels":[],"label_agreement":null},{"id":"W4310119420","doi":"10.1182/blood-2022-159389","title":"Improvement in Individual Symptoms and Total Symptom Score (TSS) and Matching-Adjusted Indirect Comparison (MAIC) Analysis to Compare TSS As a Continuous Endpoint in Patients with Myelofibrosis Treated with Pelabresib in Combination with Ruxolitinib Versus Janus Kinase Inhibitor Monotherapy","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Clinical endpoint; Ruxolitinib; Internal medicine; Clinical trial; Phases of clinical research; Myelofibrosis; Surrogate endpoint; Surgery","score_opus":0.011811782464268646,"score_gpt":0.23882372616238914,"score_spread":0.2270119436981205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310119420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964486,0.00013281633,0.0000037504853,0.00014506963,0.000019303177,0.002926291,0.00022044021,0.00004087951,0.00006288505],"genre_scores_gemma":[0.99769115,0.000009447164,0.00029195118,0.0001066994,0.000011539109,0.0010493544,0.0007777794,0.000047266287,0.000014792746],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972453,0.00020626272,0.0005627676,0.00078367506,0.00073546625,0.00046650303],"domain_scores_gemma":[0.9989803,0.00016016747,0.00025039713,0.0002686707,0.000108501816,0.00023198954],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002157969,0.0004677691,0.0011352956,0.0010743524,0.00014066315,0.000074159245,0.00008197018,0.000061295235,0.00004125493],"category_scores_gemma":[0.000012465419,0.00035935963,0.00004613481,0.0015327493,0.00007671298,0.00012392944,0.00010364169,0.00033297617,9.008341e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0140408715,0.007141197,0.96791595,0.000052140018,0.001393137,0.00019059853,0.0062691728,0.0003796118,0.00006806237,0.000033600038,0.0000032774444,0.0025123917],"study_design_scores_gemma":[0.07379985,0.017952261,0.9012813,0.00029434683,0.0010745171,0.000013345079,0.0024957876,0.0001687649,0.0025344202,0.0000028682325,0.000005744941,0.00037680953],"about_ca_topic_score_codex":0.0025892754,"about_ca_topic_score_gemma":0.006161011,"teacher_disagreement_score":0.066634655,"about_ca_system_score_codex":0.00034773236,"about_ca_system_score_gemma":0.000113842594,"threshold_uncertainty_score":0.99988586},"labels":[],"label_agreement":null},{"id":"W4310119424","doi":"10.1182/blood-2022-170814","title":"Efficacy and Safety of Fostamatinib in Elderly Patients with Immune Thrombocytopenia: A Single-Center, Real-World Case Series","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Syk; Immune thrombocytopenia; Internal medicine; Platelet; Tyrosine kinase","score_opus":0.013019735365582298,"score_gpt":0.2386607293102121,"score_spread":0.2256409939446298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310119424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99701303,0.00017809,4.4207667e-7,0.000087112814,0.000022487196,0.0007284084,0.000096146585,0.000016985257,0.0018573246],"genre_scores_gemma":[0.999319,0.00003227905,0.00027219072,0.000024918108,0.000003734423,0.000036356625,0.00011706352,0.000017662289,0.00017676286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991735,0.0000401975,0.00025369955,0.00018236425,0.00016967603,0.00018055087],"domain_scores_gemma":[0.9996037,0.000037967628,0.00009838641,0.00018165632,0.00002962088,0.000048675094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006288977,0.00012248567,0.00040360945,0.0001264325,0.00010126691,0.0000070485216,0.00003693773,0.000019372172,0.00006972055],"category_scores_gemma":[0.000012465965,0.00009955711,0.000026580095,0.00028634552,0.000047166817,0.00006808578,0.000087192464,0.00011175479,7.9176004e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053044525,0.019785212,0.95262474,0.00016561933,0.00047542722,0.010468935,0.0026530288,0.0000042129827,0.0005433316,0.000081650345,0.000028035598,0.007865332],"study_design_scores_gemma":[0.18551998,0.01580723,0.784669,0.00042213933,0.00071858667,0.0074269404,0.0019261251,0.0000065155473,0.002079819,0.00006613917,0.0009475614,0.00040996802],"about_ca_topic_score_codex":0.00026402983,"about_ca_topic_score_gemma":0.00062947976,"teacher_disagreement_score":0.18021552,"about_ca_system_score_codex":0.000032556745,"about_ca_system_score_gemma":0.000036858244,"threshold_uncertainty_score":0.4059821},"labels":[],"label_agreement":null},{"id":"W4310119465","doi":"10.1182/blood-2022-169710","title":"CCUS and Low-Risk MDS Are Inherently Similar, Sharing Clonal and Clinical Features","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; Queen's University","funders":"","keywords":"Cytopenia; Myelodysplastic syndromes; Medicine; Myeloproliferative neoplasm; Internal medicine; Myeloid; Dysplasia; Incidence (geometry); Clinical significance; Oncology; Bone marrow; Myelofibrosis","score_opus":0.025898994057126874,"score_gpt":0.3224210220553147,"score_spread":0.29652202799818783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310119465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945611,0.0025331958,0.0000025929553,0.0012466665,0.00008100133,0.00031625037,0.00006288166,0.00005230296,0.0011440398],"genre_scores_gemma":[0.99631,0.0007246578,0.00039520048,0.00071067986,0.0003504192,0.00003726977,0.0000292273,0.00003178378,0.0014107587],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847525,0.000118258875,0.0002486499,0.00044906157,0.00040850925,0.00030027813],"domain_scores_gemma":[0.9991008,0.00021152328,0.00008441299,0.0003005926,0.00004495328,0.0002577379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063881546,0.00013744646,0.00030914092,0.000093149305,0.00024892815,0.00003765035,0.00013931925,0.00009699682,0.00022015766],"category_scores_gemma":[0.00037911223,0.000120980025,0.00007110561,0.00015236712,0.0001333509,0.000043442808,0.000742171,0.0011901823,0.0000068913346],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031270887,0.00052817946,0.9838303,0.00008788684,0.0002531387,0.00059880235,0.00016649012,0.0000018450542,0.0003958832,0.00005926733,0.007813016,0.005952536],"study_design_scores_gemma":[0.010214849,0.0007790479,0.9788606,0.000057285946,0.00033757903,0.00065723335,0.00048700822,0.00040295513,0.00036778505,0.00021722235,0.0074308477,0.00018757688],"about_ca_topic_score_codex":0.00007410123,"about_ca_topic_score_gemma":0.00002989577,"teacher_disagreement_score":0.009902141,"about_ca_system_score_codex":0.00005364995,"about_ca_system_score_gemma":0.00013285052,"threshold_uncertainty_score":0.5170816},"labels":[],"label_agreement":null},{"id":"W4310119573","doi":"10.1182/blood-2022-157060","title":"Assessing the Burden of Adverse Events in a Head-to-Head Trial of Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia (CLL)","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Medicine; Ibrutinib; Adverse effect; Internal medicine; Chronic lymphocytic leukemia; Incidence (geometry); Post-hoc analysis; Oncology; Leukemia","score_opus":0.049784226107076286,"score_gpt":0.36965476884858345,"score_spread":0.31987054274150717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310119573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99489164,0.0005024585,0.0000017885209,0.00015057354,0.00023108258,0.00292036,0.00001564092,0.000037486338,0.0012489466],"genre_scores_gemma":[0.99883753,0.00005339185,0.00007943015,0.000035833586,0.00023292778,0.00035916586,0.00003786655,0.000056646124,0.00030722975],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99545944,0.0006361758,0.0011609356,0.0005747105,0.0013476943,0.00082103297],"domain_scores_gemma":[0.997611,0.000834628,0.00031662403,0.00095408387,0.00009779859,0.0001858523],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018345425,0.00029651844,0.0009067186,0.00054286775,0.00009708396,0.000006483138,0.0006335548,0.00015376582,0.0002495237],"category_scores_gemma":[0.0009846983,0.0002460562,0.00023692897,0.0019416041,0.00016389892,0.000113516035,0.0005579879,0.00060708844,0.000019598478],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.6030307,0.015633876,0.02651372,0.0068529835,0.003655724,0.005251096,0.039877973,0.1746646,0.09159327,0.0003048154,0.00083914056,0.031782143],"study_design_scores_gemma":[0.9485171,0.0055117835,0.0060703363,0.0010340397,0.00045149532,0.00017471009,0.0022197259,0.026497653,0.008499185,0.000025264935,0.0006541171,0.00034462503],"about_ca_topic_score_codex":0.016739024,"about_ca_topic_score_gemma":0.0005608516,"teacher_disagreement_score":0.3454864,"about_ca_system_score_codex":0.053490978,"about_ca_system_score_gemma":0.04112964,"threshold_uncertainty_score":0.99999917},"labels":[],"label_agreement":null},{"id":"W4310120105","doi":"10.1182/blood-2022-159053","title":"Investigating the Role of Von Willebrand Factor (VWF) in Modulating <i>In Vivo</i> angiogenesis in VWF-Deficient Mice","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Von Willebrand factor; Angiogenesis; In vivo; Von Willebrand disease; Immunology; Medicine; Biology; Molecular biology; Platelet; Cancer research; Genetics","score_opus":0.010236590062428204,"score_gpt":0.22194202529125157,"score_spread":0.21170543522882337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310120105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99626297,0.0014448374,3.3457633e-7,0.00015772587,0.000021569567,0.0003473091,0.0000318914,0.000009629564,0.0017237405],"genre_scores_gemma":[0.9996153,0.000014072317,0.000118736374,0.00014412728,0.000007855574,0.00005552928,0.000010478668,0.000014840291,0.000019056944],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99902016,0.00007112161,0.0002879131,0.00019270736,0.00021501814,0.00021306914],"domain_scores_gemma":[0.9996452,0.000077687444,0.000086294174,0.00014736188,0.0000103464545,0.000033160683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001580076,0.0001023461,0.00025505605,0.0001454191,0.000059688013,0.000005094594,0.0000792107,0.00003096348,0.00003467418],"category_scores_gemma":[0.000056366986,0.00008452515,0.000054374428,0.00048719198,0.00002481141,0.000031183146,0.00007154665,0.00013172094,9.654731e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002420604,0.00092253654,0.90992814,0.00002664492,0.00003157657,0.000082942264,0.0025554188,0.0010530886,0.08421214,0.0000707075,0.0000038475105,0.0010887277],"study_design_scores_gemma":[0.024061099,0.00068133924,0.7828758,0.00044747506,0.00021948684,0.00015927007,0.011435692,0.008142712,0.1694157,0.001285682,0.00078489183,0.00049086905],"about_ca_topic_score_codex":0.0013163547,"about_ca_topic_score_gemma":0.0008644604,"teacher_disagreement_score":0.12705237,"about_ca_system_score_codex":0.000036276055,"about_ca_system_score_gemma":0.00006836139,"threshold_uncertainty_score":0.34468356},"labels":[],"label_agreement":null},{"id":"W4310120142","doi":"10.1182/blood-2022-157691","title":"Mosunetuzumab Monotherapy Demonstrates Durable Efficacy with a Manageable Safety Profile in Patients with Relapsed/Refractory Follicular Lymphoma Who Received ≥2 Prior Therapies: Updated Results from a Pivotal Phase II Study","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Princess Margaret Cancer Centre; Jewish General Hospital; McGill University; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Follicular lymphoma; Medicine; Refractory (planetary science); Safety profile; Oncology; Internal medicine; Rituximab; Lymphoma; Phases of clinical research; Follicular phase; Clinical trial; Adverse effect","score_opus":0.01069748530457965,"score_gpt":0.2509131653512022,"score_spread":0.24021568004662258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310120142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908718,0.00038409,0.00000679511,0.0002086429,0.000045949553,0.0063875197,0.00047701853,0.00018146879,0.0014367469],"genre_scores_gemma":[0.991339,0.00007802617,0.00063504884,0.00012362223,0.00005452605,0.00062911876,0.0011374803,0.000171577,0.005831591],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9952576,0.0005702003,0.00077842467,0.0011758275,0.0014136657,0.0008042759],"domain_scores_gemma":[0.99775434,0.0002228858,0.00032204966,0.0012414363,0.00020914654,0.0002501709],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000669276,0.0005357335,0.00090312294,0.00038383852,0.0006345869,0.00007659404,0.0004279413,0.00011948723,0.0022211059],"category_scores_gemma":[0.000053201955,0.00041441715,0.00011647187,0.0013975521,0.00014394603,0.00024029033,0.00016679423,0.00065139076,0.000013066651],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48169887,0.18706985,0.21324275,0.000076057455,0.007877487,0.0029230125,0.029926667,0.00062238215,0.024418138,0.000007279891,0.0011155286,0.051021975],"study_design_scores_gemma":[0.58849186,0.06744541,0.32310987,0.0002878327,0.0005698654,0.000040132494,0.005796387,0.00066973653,0.0049397824,0.000015333397,0.007660824,0.0009729739],"about_ca_topic_score_codex":0.0017830553,"about_ca_topic_score_gemma":0.0002947648,"teacher_disagreement_score":0.119624436,"about_ca_system_score_codex":0.00045385782,"about_ca_system_score_gemma":0.00057272206,"threshold_uncertainty_score":0.9998308},"labels":[],"label_agreement":null},{"id":"W4310120207","doi":"10.1182/blood-2022-156411","title":"Treatment Patterns and Outcomes in Lower-Risk, Non-Del(5q) Myelodysplastic Syndromes: Findings from a Global Real-World Medical Record Review Study","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Myelodysplastic syndromes; Medical record; Anemia; International Prognostic Scoring System; Hematologist; Internal medicine; Pediatrics; Disease; Bone marrow","score_opus":0.02122256794205495,"score_gpt":0.3259199848047975,"score_spread":0.30469741686274254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310120207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929794,0.0012599806,0.0000063452526,0.0026035658,0.00019421731,0.0020880469,0.0003446086,0.00006611003,0.00045770468],"genre_scores_gemma":[0.9885645,0.0089437645,0.00016386603,0.0005778182,0.000084219646,0.0006845368,0.00010198585,0.00004417959,0.00083512184],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963428,0.0004043655,0.0006338905,0.00078171026,0.0012694052,0.00056783174],"domain_scores_gemma":[0.99813324,0.0005891796,0.00012687367,0.0006565308,0.00003955084,0.00045463417],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007155036,0.0003684708,0.0011641221,0.00021480808,0.00016865638,0.000024246474,0.0003227955,0.000080213664,0.0019271384],"category_scores_gemma":[0.00056310993,0.0002888317,0.0001467597,0.0006942021,0.000065146116,0.0000592234,0.0005133011,0.00073998177,0.00006395722],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019473012,0.0036535421,0.9806225,0.00020272353,0.0005638204,0.007169537,0.00030597838,2.712055e-7,0.000004284701,0.0000032232895,0.0008860549,0.0063933353],"study_design_scores_gemma":[0.015961027,0.0042102565,0.9753816,0.00084099773,0.001052023,0.0003184099,0.0005311561,0.00010018905,0.000004715232,0.000021257592,0.0013158135,0.000262552],"about_ca_topic_score_codex":0.024967099,"about_ca_topic_score_gemma":0.00973088,"teacher_disagreement_score":0.015766297,"about_ca_system_score_codex":0.001153769,"about_ca_system_score_gemma":0.00064814463,"threshold_uncertainty_score":0.99995637},"labels":[],"label_agreement":null},{"id":"W4310120320","doi":"10.1182/blood-2022-159694","title":"Correlation of Minimal Residual Disease (MRD) at the End of Induction (EOI) and Event Free Survival (EFS) in T-Cell Lymphoblastic Lymphoma (T-LL), a Report from the Children's Oncology Group (COG) Trial AALL1231","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Hospital for Sick Children; Stollery Children's Hospital; University of Alberta","funders":"","keywords":"Medicine; Minimal residual disease; Internal medicine; Bortezomib; Oncology; Bone marrow; Lymphoma; Immunophenotyping; Gastroenterology; Immunology; Multiple myeloma; Flow cytometry","score_opus":0.01417306984300151,"score_gpt":0.2605950613855359,"score_spread":0.24642199154253439,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310120320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953336,0.00077406404,0.000044283275,0.001077336,0.00044644062,0.0016578081,0.00031743135,0.000017903576,0.0003310985],"genre_scores_gemma":[0.99844015,0.00004946912,0.00007997788,0.00006369861,0.00045518216,0.00020829837,0.00040116685,0.00003605765,0.00026602793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99620485,0.0007942349,0.00090902013,0.0005210918,0.001231063,0.0003397132],"domain_scores_gemma":[0.9964516,0.0018907709,0.00056976476,0.00083866034,0.00009239035,0.00015678334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001471886,0.00022025408,0.00051371736,0.00015195979,0.00020753556,0.000011007387,0.00035134176,0.00013694845,0.00025871088],"category_scores_gemma":[0.001539743,0.00015204457,0.00013598577,0.00042602816,0.0004910158,0.00006529941,0.00081183476,0.0002966627,0.0000032476687],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27780268,0.020362446,0.64013404,0.00025735557,0.0018760188,0.0030839904,0.0065323026,0.0009158689,0.029214045,0.00043378022,0.009309359,0.010078097],"study_design_scores_gemma":[0.16121851,0.0031003563,0.8287912,0.000073864794,0.0013136987,0.0007170161,0.0010157598,0.0010253105,0.0017408843,0.00034653777,0.0004393731,0.00021750925],"about_ca_topic_score_codex":0.0028428321,"about_ca_topic_score_gemma":0.00052111445,"teacher_disagreement_score":0.18865712,"about_ca_system_score_codex":0.0007289884,"about_ca_system_score_gemma":0.0017736811,"threshold_uncertainty_score":0.62001973},"labels":[],"label_agreement":null},{"id":"W4310125400","doi":"10.1182/blood-2022-170013","title":"A Primed Neutrophil Subset Predicts the Risk of Bloodstream Infections in Allogenic Bone Marrow Transplant Patients: A Prospective Study","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Neutropenia; Bone marrow; Prospective cohort study; Immunology; Hematopoietic stem cell transplantation; Absolute neutrophil count; Internal medicine; Haematopoiesis; Biomarker; Stem cell; Transplantation; Chemotherapy; Biology","score_opus":0.006984079729334171,"score_gpt":0.22466901022936622,"score_spread":0.21768493050003204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310125400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958305,0.00017574358,0.000001983356,0.00015886119,0.00016221988,0.0026930184,0.00030923687,0.000059606922,0.00060884585],"genre_scores_gemma":[0.9980857,0.00008435403,0.000010081819,0.00005653834,0.000060406084,0.0015546326,0.000039720784,0.000026517617,0.000082065264],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983612,0.00029082102,0.00039362017,0.00032056883,0.00038539735,0.00024843472],"domain_scores_gemma":[0.9991636,0.00008269176,0.0001697936,0.00041926425,0.000090600726,0.000073995674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027236165,0.00016808978,0.00034059354,0.00018375868,0.00028453677,0.000008607966,0.00012220275,0.00003555723,0.00014900714],"category_scores_gemma":[0.0000455454,0.00012658373,0.00015289123,0.00077274133,0.000076166405,0.000050339127,0.000073554824,0.00055896695,0.0000034387351],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027239296,0.018529609,0.97668856,0.000021473938,0.00052329566,0.000045256686,0.002454656,0.00010594076,0.0011695487,0.000029076822,0.00007845619,0.00008171117],"study_design_scores_gemma":[0.015392396,0.0055057784,0.9743873,0.000023956949,0.0018217196,0.00014805468,0.00079950003,0.0000069107728,0.0014845019,0.000053030573,0.00025654252,0.00012030123],"about_ca_topic_score_codex":0.0009610699,"about_ca_topic_score_gemma":0.0012960451,"teacher_disagreement_score":0.015120003,"about_ca_system_score_codex":0.000095030264,"about_ca_system_score_gemma":0.00018789724,"threshold_uncertainty_score":0.5161935},"labels":[],"label_agreement":null},{"id":"W4310125603","doi":"10.1182/blood-2022-168228","title":"The Prognostic Impact of <i>HMGCLL1</i> Gene Variant on Treatment Outcomes in Chronic Myeloid Leukemia (CML) Patients: Adverse Impact on the Response, Failure, and Progression with Imatinib Which Can be Abrogated By the Use of 2nd Generation Tyrosine Kinase Inhibitor (TKI) Upfront Therapy","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto; University Health Network","funders":"","keywords":"Imatinib; Myeloid leukemia; Medicine; Adverse effect; Internal medicine; Oncology; Imatinib mesylate; Immunology; Cancer research","score_opus":0.02146055768878582,"score_gpt":0.27370140194382564,"score_spread":0.25224084425503984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310125603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99300843,0.0007172731,9.30252e-7,0.0011811532,0.000046050336,0.004288251,0.0007219288,0.000028023223,0.0000079814645],"genre_scores_gemma":[0.9979865,0.0002944857,0.00009010629,0.00011348965,0.000042019972,0.00078681344,0.00052947627,0.0000656204,0.00009148997],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99684364,0.00081639533,0.0006125243,0.00046955273,0.0007955567,0.0004623191],"domain_scores_gemma":[0.9972916,0.0009701481,0.0005397094,0.00089609827,0.0001772724,0.00012513573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005247054,0.00051786203,0.0005748051,0.00013404462,0.00041311764,0.000041074072,0.00018755601,0.000088201734,0.000051895335],"category_scores_gemma":[0.0002818754,0.00019845626,0.00017577104,0.0005522394,0.0001805932,0.00009087182,0.00007845844,0.00035043628,6.9666885e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048757344,0.017921086,0.6578191,0.000093879135,0.0055627194,0.00026421834,0.0064216717,0.01200963,0.233444,0.000046739242,0.003763601,0.013896016],"study_design_scores_gemma":[0.06596223,0.06935438,0.7125359,0.00048392516,0.0008896868,0.00012746232,0.00040664128,0.003422777,0.14560463,0.0000060415223,0.00069652364,0.0005097808],"about_ca_topic_score_codex":0.0024438952,"about_ca_topic_score_gemma":0.0009917106,"teacher_disagreement_score":0.08783938,"about_ca_system_score_codex":0.00456441,"about_ca_system_score_gemma":0.0022117211,"threshold_uncertainty_score":0.9992569},"labels":[],"label_agreement":null},{"id":"W4310125627","doi":"10.1182/blood-2022-163538","title":"The Bacterial Chaperone High-Temperature Protein G (HtpG) Decreases in Abundance with Induction Therapy in Children with Acute Lymphoblastic Leukemia","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Metabolomics and Mass Spectrometry Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University; University of Waterloo","funders":"","keywords":"Hsp90; Biology; Heat shock protein; Cellular adaptation; Carcinogenesis; Chaperone (clinical); Gene; Cancer cell; Protein quality; Leukemia; Cancer; Cell biology; Genetics; Biochemistry; Medicine","score_opus":0.003078194087091683,"score_gpt":0.18349126334371327,"score_spread":0.1804130692566216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310125627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99805045,0.0011903339,0.0000024241929,0.000116648436,0.000053839798,0.00052714004,0.00002723976,0.000008001126,0.00002390158],"genre_scores_gemma":[0.998106,0.0008093354,0.00019953524,0.000051491646,0.00015731537,0.0004216878,0.000102817365,0.000023455883,0.00012834342],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99902326,0.0000882438,0.00014184738,0.0003418088,0.000151316,0.00025349925],"domain_scores_gemma":[0.99961114,0.000006920773,0.000080501646,0.00024495795,0.000025299361,0.000031210024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013190338,0.00017132895,0.00017325672,0.000054876637,0.00022595176,0.000036837002,0.00018034935,0.000053937296,0.0000156847],"category_scores_gemma":[0.000014481879,0.00010879235,0.00002361296,0.00026260727,0.00007685591,0.000005571067,0.00009471892,0.00016058999,4.359743e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001141055,0.000261857,0.015834996,0.0000021289961,0.00029531072,0.000010794345,0.00004387631,0.000057348756,0.9816666,0.00016216982,0.000027661898,0.00049620366],"study_design_scores_gemma":[0.010500733,0.0035419667,0.3031135,0.000020939242,0.00006214339,0.00025313155,0.00017602963,0.0000025877393,0.6793145,0.00007822944,0.0025026172,0.00043361192],"about_ca_topic_score_codex":0.00017147903,"about_ca_topic_score_gemma":0.00049588614,"teacher_disagreement_score":0.30235207,"about_ca_system_score_codex":0.00004235127,"about_ca_system_score_gemma":0.00018859879,"threshold_uncertainty_score":0.44364232},"labels":[],"label_agreement":null},{"id":"W4310126134","doi":"10.1182/blood-2022-163841","title":"Prolonged Survival in Bi-Allelic <i>TP53</i>-Mutated (<i>TP53</i>mut) MDS Subjects Treated with Oral Decitabine/Cedazuridine in the Ascertain Trial (ASTX727-02)","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Health Sciences Centre; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Hôpital Maisonneuve-Rosemont; University of Alberta; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Decitabine; Medicine; Chronic myelomonocytic leukemia; Internal medicine; International Prognostic Scoring System; Population; Azacitidine; Oncology; Regimen; Myelodysplastic syndromes; Gastroenterology; Biology; Bone marrow; Genetics; DNA methylation","score_opus":0.02431869810751564,"score_gpt":0.28252565881789526,"score_spread":0.25820696071037963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310126134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989152,0.0002980612,0.000005106074,0.003142543,0.00012882189,0.0044468804,0.000055087807,0.00017465102,0.0025968403],"genre_scores_gemma":[0.99590635,0.000053323987,0.00017165071,0.0007121523,0.00030172186,0.0016026949,0.00043461195,0.00013316135,0.0006843431],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9932111,0.0018639594,0.0008682564,0.00095875876,0.0017623972,0.0013355328],"domain_scores_gemma":[0.99758965,0.00069191854,0.00020115163,0.0010377222,0.00021282418,0.0002667544],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0032686861,0.0005681574,0.0010686406,0.0008672775,0.00028141547,0.00007249105,0.0008326633,0.00020052685,0.0003542439],"category_scores_gemma":[0.0007461722,0.00039417038,0.00016758041,0.0046994416,0.00020050535,0.0001574515,0.00031903974,0.0020638816,0.00003699596],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34591317,0.025578484,0.5331851,0.0004155383,0.0015615199,0.03396275,0.009337826,0.0009763692,0.03771586,0.0004129472,0.007579507,0.00336089],"study_design_scores_gemma":[0.7901039,0.02451721,0.15031272,0.00025936693,0.0010151281,0.0025493747,0.0057531632,0.0017331467,0.012991153,0.0001333231,0.008898101,0.0017334134],"about_ca_topic_score_codex":0.0032468026,"about_ca_topic_score_gemma":0.004292298,"teacher_disagreement_score":0.44419074,"about_ca_system_score_codex":0.00062059675,"about_ca_system_score_gemma":0.0016099833,"threshold_uncertainty_score":0.99985105},"labels":[],"label_agreement":null},{"id":"W4310126163","doi":"10.1182/blood-2022-162738","title":"Elranatamab in Combination with Daratumumab for Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Results from the Phase 3 Magnetismm-5 Study Safety Lead-in Cohort","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University; Princess Margaret Cancer Centre","funders":"","keywords":"Daratumumab; Medicine; Multiple myeloma; Lenalidomide; Oncology; Internal medicine; Cohort; Refractory (planetary science); Materials science","score_opus":0.016252222328361206,"score_gpt":0.27809086817263956,"score_spread":0.26183864584427835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310126163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911222,0.0001739158,0.000016776143,0.0004037611,0.00008824611,0.0066067614,0.00063174585,0.000045083412,0.0009114957],"genre_scores_gemma":[0.99614346,0.000028054625,0.0001868662,0.0001094894,0.000052775293,0.0009434267,0.001402029,0.00007024188,0.0010636625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968168,0.00041327826,0.00053596095,0.0006730472,0.001126286,0.00043460476],"domain_scores_gemma":[0.9979403,0.0008330216,0.00017048538,0.00079256395,0.00017117783,0.00009247091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010753692,0.00025100165,0.00044179955,0.00021536983,0.00027214718,0.000029704666,0.0003081629,0.000064928354,0.00030271008],"category_scores_gemma":[0.00027187282,0.00017901407,0.000054995897,0.0006697958,0.00009431373,0.00012043351,0.00011735192,0.0007529506,0.0000053691156],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0889956,0.04350357,0.8332185,0.000031628457,0.00038463186,0.00039364913,0.005931898,0.00006829276,0.0019962126,0.000009202409,0.0007647318,0.024702061],"study_design_scores_gemma":[0.29779533,0.023775395,0.6673665,0.000080688515,0.00019697499,0.000012643591,0.002783973,0.0006514437,0.0005312425,0.000015434644,0.006529746,0.00026064223],"about_ca_topic_score_codex":0.001649609,"about_ca_topic_score_gemma":0.004403998,"teacher_disagreement_score":0.20879972,"about_ca_system_score_codex":0.00034688629,"about_ca_system_score_gemma":0.00023546537,"threshold_uncertainty_score":0.7299982},"labels":[],"label_agreement":null},{"id":"W4310126180","doi":"10.1182/blood-2022-170502","title":"Impact of Thrombotic Events Occurring during Active Treatment of Leukemia on the Overall Survival and Event-Free Survival: A Systematic Review","year":2022,"lang":"en","type":"review","venue":"Blood","topic":"Central Venous Catheters and Hemodialysis","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; CINAHL; MEDLINE; Population; Inclusion and exclusion criteria; Pediatrics; Critical appraisal; Systematic review; Internal medicine; Inclusion (mineral); Family medicine; Oncology; Alternative medicine; Psychological intervention; Pathology; Psychology; Psychiatry","score_opus":0.1025091896182843,"score_gpt":0.40961680748997076,"score_spread":0.30710761787168644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310126180","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025616681,0.9667327,4.427481e-7,0.0000110071405,0.00022217969,0.006480682,0.0006459103,0.000022064696,0.0002683265],"genre_scores_gemma":[0.0024338842,0.9964399,0.0000037253417,0.000011807065,0.000074825024,0.0008024372,0.000065066684,0.00007215509,0.000096233576],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9939834,0.0027853472,0.0016878571,0.00044735876,0.00057132257,0.00052475516],"domain_scores_gemma":[0.99401283,0.0022332605,0.0021884735,0.0013763556,0.000063368316,0.00012569928],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00096111465,0.0005535,0.0050488953,0.0001478022,0.00040867415,0.000005247252,0.000528958,0.00018637833,0.00040706134],"category_scores_gemma":[0.00046409442,0.00031321167,0.0017429288,0.000312718,0.000037666905,0.000042346986,0.00030281433,0.0005128188,0.000011806391],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025052808,0.0009670179,0.00036947566,0.9906125,0.0045279427,0.000009751982,0.0010573243,0.0000017678469,0.0000014220323,0.000110077366,0.000018848934,0.0022987917],"study_design_scores_gemma":[0.0031289516,0.0012936288,0.002009779,0.9581797,0.032348476,0.000019271913,0.0004336755,0.0000027797025,0.0000020578248,0.00006715513,0.0019024167,0.00061208976],"about_ca_topic_score_codex":0.0005899052,"about_ca_topic_score_gemma":0.000052893887,"teacher_disagreement_score":0.03243281,"about_ca_system_score_codex":0.0013520143,"about_ca_system_score_gemma":0.0008632237,"threshold_uncertainty_score":0.999932},"labels":[],"label_agreement":null},{"id":"W4310126655","doi":"10.1182/blood-2022-158180","title":"Iberdomide (IBER) in Combination with Dexamethasone (DEX) in Relapsed/Refractory Multiple Myeloma (RRMM): Results from the Anti-B-Cell Maturation Antigen (BCMA)-Exposed Cohort of the CC-220-MM-001 Trial","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Multiple myeloma; Medicine; Dexamethasone; Lenalidomide; Internal medicine; Refractory (planetary science); Oncology; Immunology; Biology","score_opus":0.008596450704891333,"score_gpt":0.2031214575849355,"score_spread":0.19452500688004415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310126655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974142,0.0003168163,0.000015426482,0.00026383688,0.00023775049,0.0012364953,0.00013179611,0.000010047812,0.00037364353],"genre_scores_gemma":[0.9983637,0.000052002775,0.00021148838,0.00013267227,0.000099813864,0.00010544897,0.000782401,0.000021858166,0.00023062936],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980683,0.0005512939,0.0004911348,0.0003728879,0.00033416186,0.00018222701],"domain_scores_gemma":[0.9988823,0.00012936509,0.00036521954,0.00053282286,0.000061754996,0.00002853153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007075523,0.00015872456,0.00020098808,0.000059437,0.00013825759,0.000020433128,0.000334356,0.00012555928,0.000013553501],"category_scores_gemma":[0.0003401679,0.000111186935,0.00007101462,0.00030947576,0.00008292432,0.000011467465,0.00019779673,0.00028514175,0.0000017875875],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01684181,0.008175074,0.06853269,0.000011826594,0.00009609264,0.000009136217,0.000719819,0.00021586429,0.9030846,0.000022165166,0.0011850526,0.0011059097],"study_design_scores_gemma":[0.17157042,0.0007751429,0.12967241,0.000029697207,0.000038130554,0.000004116825,0.00030271374,0.00017886871,0.6941255,0.000046234243,0.0030332243,0.000223565],"about_ca_topic_score_codex":0.00055323,"about_ca_topic_score_gemma":0.0006548199,"teacher_disagreement_score":0.20895909,"about_ca_system_score_codex":0.000040540373,"about_ca_system_score_gemma":0.00018163,"threshold_uncertainty_score":0.45340717},"labels":[],"label_agreement":null},{"id":"W4310127269","doi":"10.1182/blood-2022-169675","title":"Unravelling the Effect of Blood Type on FVIII:C Levels and Response to DDAVP in 20 Males with a Single Genotype (<i>Twillingate</i> Variant) Causing Mild Hemophilia Α","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Genotype; Medicine; Internal medicine; Immunology; Biology; Genetics; Gene","score_opus":0.029821020041587314,"score_gpt":0.2777046380900307,"score_spread":0.2478836180484434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310127269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996241,0.00074542104,0.0000049933183,0.0017145681,0.000045487453,0.0008872419,0.000022778106,0.000022914028,0.00031563715],"genre_scores_gemma":[0.9984575,0.000016233414,0.00039563014,0.00017276288,0.00006279857,0.000038649832,0.000008527943,0.000039416063,0.0008084632],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981893,0.00040965012,0.00023138267,0.00034793565,0.00047185124,0.00034992502],"domain_scores_gemma":[0.9987224,0.0006819587,0.000057993275,0.00035747598,0.00005594374,0.00012423721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011348104,0.0001976968,0.00036205415,0.00023894994,0.00022158684,0.000020062223,0.00010363047,0.00005754432,0.000054264063],"category_scores_gemma":[0.00020956222,0.00012146265,0.000045735906,0.0007161911,0.00008686107,0.000024516237,0.00011328066,0.00035238234,0.000006409962],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035505634,0.0022791037,0.13013266,0.00037036056,0.0007388668,0.00418239,0.0042937747,0.0010647223,0.820391,0.00004572002,0.000055607776,0.00094017544],"study_design_scores_gemma":[0.027573481,0.062479675,0.05383198,0.0011840637,0.0016630482,0.0018185534,0.00060249795,0.00034322578,0.8479103,0.000063855325,0.0018890259,0.0006403367],"about_ca_topic_score_codex":0.0000753855,"about_ca_topic_score_gemma":0.000029644392,"teacher_disagreement_score":0.07630069,"about_ca_system_score_codex":0.00005331939,"about_ca_system_score_gemma":0.00016039777,"threshold_uncertainty_score":0.49531034},"labels":[],"label_agreement":null},{"id":"W4310127277","doi":"10.1182/blood-2022-163026","title":"RNA Deadenylation Subunit CNOT3 Promotes Myeloid Leukemia By Driving Translation of Oncogenic Targets","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; University of British Columbia","funders":"","keywords":"Biology; Gene knockdown; Small hairpin RNA; CRISPR; Cell biology; Molecular biology; Genetics; Cancer research; Gene","score_opus":0.010108710517906055,"score_gpt":0.22707631273060497,"score_spread":0.21696760221269892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310127277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99435276,0.0030055994,0.0016751955,0.00008451136,0.000046607835,0.00015932931,0.000050913324,0.000009941912,0.00061514],"genre_scores_gemma":[0.99833065,0.000118175856,0.00055811886,0.000027853219,0.000061746396,0.00006548309,0.00042763609,0.000015645788,0.00039468377],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99933785,0.00004994771,0.00017359284,0.00019074668,0.00013344252,0.00011442508],"domain_scores_gemma":[0.9996321,0.000005965654,0.00009799993,0.00019325959,0.00004190965,0.000028723964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012692041,0.00007739693,0.00007842422,0.000030298126,0.00012985244,0.000008185332,0.000120899625,0.00005074471,0.00008284598],"category_scores_gemma":[0.000011881513,0.00008633077,0.000059762348,0.000101577905,0.00002261975,0.0000044617295,0.00003254002,0.00006871677,0.0000014898219],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012059571,0.00010385502,0.0013562341,0.000008652547,0.00003830729,2.747628e-7,0.000089228415,0.00018132819,0.9910334,0.000023002325,0.00033299116,0.0068207076],"study_design_scores_gemma":[0.0007147846,0.00019039988,0.0021118252,0.0000035810335,0.000046938192,0.000005895867,0.00006686169,0.00020397332,0.9739394,0.00005447068,0.02253739,0.0001244566],"about_ca_topic_score_codex":0.000025389145,"about_ca_topic_score_gemma":0.000010645578,"teacher_disagreement_score":0.0222044,"about_ca_system_score_codex":0.000022272845,"about_ca_system_score_gemma":0.000100597426,"threshold_uncertainty_score":0.35204667},"labels":[],"label_agreement":null},{"id":"W4310127303","doi":"10.1182/blood-2022-167235","title":"The Economic Impact of Treatment Sequencing in the Management of Chronic Lymphocytic Leukemia in Canada Using Venetoclax Plus Obinutuzumab","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; McMaster University; ABB (Canada); Université de Montréal","funders":"","keywords":"Venetoclax; Obinutuzumab; Medicine; Chronic lymphocytic leukemia; Internal medicine; Oncology; Intensive care medicine; Leukemia","score_opus":0.026732157363686563,"score_gpt":0.2922066515171132,"score_spread":0.26547449415342667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310127303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99683964,0.0015765679,6.6136914e-7,0.0000045642832,0.000063390595,0.00091389276,0.000023546152,0.000004173046,0.0005735892],"genre_scores_gemma":[0.99941725,0.0002897256,0.00002546288,0.000012827896,0.000035597233,0.00012472914,0.000009519658,0.000021008322,0.000063878986],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9982508,0.0001534576,0.00049469125,0.00023440331,0.00039600418,0.00047064418],"domain_scores_gemma":[0.99893296,0.00020991219,0.00015495108,0.0006337659,0.000015177982,0.00005321361],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005124737,0.00016194857,0.00036266135,0.00011305413,0.00010111879,0.000008885463,0.0003602333,0.000025668283,0.00006640016],"category_scores_gemma":[0.000008486491,0.00010314771,0.00012002673,0.00033080028,0.00007182482,0.000027747255,0.00016862676,0.0001559395,0.0000012544451],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0001985214,0.000004364323,0.00022158251,0.00014518396,0.0003287658,0.00054237567,0.00065683224,0.99693954,0.0004223731,0.000064295185,0.000023537463,0.0004526416],"study_design_scores_gemma":[0.031929247,0.0006965367,0.0008343232,0.00015322269,0.00017890446,0.00047918552,0.0032265044,0.96073556,0.0015212114,0.00002899168,0.00010955528,0.00010677924],"about_ca_topic_score_codex":0.9907539,"about_ca_topic_score_gemma":0.70817745,"teacher_disagreement_score":0.28257647,"about_ca_system_score_codex":0.98208684,"about_ca_system_score_gemma":0.7662686,"threshold_uncertainty_score":0.42062414},"labels":[],"label_agreement":null},{"id":"W4310127311","doi":"10.1182/blood-2022-159745","title":"Palmitoylethanolamide Attenuates Pain-like Behavior in Factor VIII Deficient Mice","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Palmitoylethanolamide; Medicine; Internal medicine; Immunology; Receptor; Agonist","score_opus":0.010925611645412394,"score_gpt":0.2323412558957751,"score_spread":0.2214156442503627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310127311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955439,0.001890847,0.000005606285,0.0007358442,0.00027980597,0.00049227785,0.000030372743,0.0000782809,0.00094306946],"genre_scores_gemma":[0.99785876,0.00008817521,0.000087205466,0.0010580684,0.000034577275,0.000158277,0.000047672664,0.000030599283,0.0006366616],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986204,0.000117221636,0.00026970546,0.00029594122,0.00032889054,0.0003678225],"domain_scores_gemma":[0.9995042,0.00006330636,0.00005859905,0.00024014481,0.00002911946,0.000104597544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026647194,0.00015161528,0.0002341042,0.00015837586,0.00014353928,0.000010510843,0.000118558426,0.00008563201,0.00044820528],"category_scores_gemma":[0.00006876364,0.00013728403,0.00010955511,0.0003670109,0.000039663966,0.0000235171,0.00010959208,0.00046356718,0.00004082014],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015616887,0.006757194,0.8584975,0.00013343777,0.00011664403,0.0016801456,0.0025528825,0.000082822415,0.11952192,0.000050427378,0.0015145908,0.008936244],"study_design_scores_gemma":[0.028681438,0.0042317645,0.81396914,0.00026502254,0.0012898456,0.0013519049,0.017260363,0.00050678366,0.026458489,0.000072605064,0.10437014,0.0015424993],"about_ca_topic_score_codex":0.00017285658,"about_ca_topic_score_gemma":0.000024672998,"teacher_disagreement_score":0.10285555,"about_ca_system_score_codex":0.000071308015,"about_ca_system_score_gemma":0.00009245172,"threshold_uncertainty_score":0.55982804},"labels":[],"label_agreement":null},{"id":"W4310127423","doi":"10.1182/blood-2022-156111","title":"Sperm Banking in Post-Pubertal Males with Newly Diagnosed High-Risk ALL","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Oncofertility; Sperm bank; Medicine; Sperm; Fertility; Internal medicine; Family medicine; Fertility preservation; Population","score_opus":0.013919224215208501,"score_gpt":0.2561293156264752,"score_spread":0.24221009141126668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310127423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929401,0.000611097,0.00000781472,0.004242846,0.0001809636,0.00047225683,0.00008709692,0.00010756126,0.0013502075],"genre_scores_gemma":[0.9940487,0.000041403695,0.0011681825,0.003924934,0.000309229,0.00008676477,0.00015347515,0.00005620164,0.00021112025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979797,0.00019351645,0.00034462992,0.00043002653,0.0006619803,0.0003901224],"domain_scores_gemma":[0.9989692,0.00024398536,0.00014144638,0.0004504358,0.000047835507,0.00014711556],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004504979,0.00020704021,0.00040448812,0.00016661524,0.00011888024,0.000023087317,0.00019179711,0.000050637766,0.0009559535],"category_scores_gemma":[0.00017315167,0.00019497467,0.00008641588,0.00031426607,0.00005377697,0.00008341568,0.00014901208,0.0005389559,0.000027193182],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007915931,0.003092107,0.97583085,0.0001294969,0.0005394517,0.002147923,0.012121285,0.00020361728,0.0008430864,0.00051213097,0.0009672984,0.002821128],"study_design_scores_gemma":[0.021650553,0.002039007,0.96436006,0.0001632345,0.0005048858,0.0004565652,0.003935409,0.000033001448,0.0012881934,0.00018112881,0.004915624,0.00047236515],"about_ca_topic_score_codex":0.010135166,"about_ca_topic_score_gemma":0.008259576,"teacher_disagreement_score":0.020858958,"about_ca_system_score_codex":0.000087368586,"about_ca_system_score_gemma":0.00022834688,"threshold_uncertainty_score":0.9999573},"labels":[],"label_agreement":null},{"id":"W4310127434","doi":"10.1182/blood-2022-157547","title":"Enduring Responses after 1-Year, Fixed-Duration Cevostamab Therapy in Patients with Relapsed/Refractory Multiple Myeloma: Early Experience from a Phase I Study","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Calgary; Princess Margaret Cancer Centre; Jewish General Hospital; University of Toronto","funders":"","keywords":"Multiple myeloma; Medicine; Lenalidomide; Refractory (planetary science); Internal medicine; Oncology; Pomalidomide; Bortezomib","score_opus":0.01930820697504737,"score_gpt":0.285848960289887,"score_spread":0.2665407533148396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310127434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975877,0.00019706633,0.0000031215534,0.000025551928,0.00005767581,0.0018403159,0.00019345182,0.0000569716,0.000038153998],"genre_scores_gemma":[0.99797857,0.000010899494,0.00023087507,0.000042023672,0.000038754337,0.0013518401,0.00015740115,0.000041122992,0.00014849189],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99766624,0.00031206294,0.00030701002,0.00049879553,0.0008429815,0.00037293305],"domain_scores_gemma":[0.9990123,0.00017082601,0.00009214771,0.0004818436,0.000078310695,0.00016457387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014758421,0.00021398223,0.0002727851,0.00023802833,0.00018994739,0.000037523478,0.00012886884,0.000040575727,0.0004894407],"category_scores_gemma":[0.00015076382,0.00017210834,0.000049769547,0.0003057387,0.000044927227,0.00021812563,0.000106758176,0.00033724197,0.000017870507],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03346476,0.020226194,0.9322739,0.0000046877108,0.00017124534,0.0008101949,0.008321201,8.5981526e-7,0.0018153607,2.2295735e-7,0.000006027485,0.002905313],"study_design_scores_gemma":[0.09287037,0.009731471,0.8923929,0.000028164428,0.00003586821,0.0000029072833,0.0018982898,0.000014250118,0.0027519239,0.0000016092627,0.0001174327,0.00015485502],"about_ca_topic_score_codex":0.00067991135,"about_ca_topic_score_gemma":0.0001180346,"teacher_disagreement_score":0.05940561,"about_ca_system_score_codex":0.0001446846,"about_ca_system_score_gemma":0.00011817595,"threshold_uncertainty_score":0.7018375},"labels":[],"label_agreement":null},{"id":"W4310127480","doi":"10.1182/blood-2022-157511","title":"Effect of Luspatercept in β-Thalassemia Patients with β0/β0 Genotype: A Subgroup Analysis of the BELIEVE Study","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Thalassemia; Ineffective erythropoiesis; Anemia; Genotype; Internal medicine; Population; Beta thalassemia; Blood transfusion; Pediatrics; Gastroenterology; Erythropoiesis; Biology; Genetics; Gene","score_opus":0.002325736604903199,"score_gpt":0.20966530400311983,"score_spread":0.20733956739821663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310127480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99855363,0.00016087339,8.1748163e-7,0.000027968445,0.000041489093,0.0009049951,0.000021433532,0.000008868828,0.00027989704],"genre_scores_gemma":[0.9998068,0.0000061172404,0.000006482543,0.000028624401,0.0000040418468,0.00004269784,0.000025728052,0.00001437129,0.00006514445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986396,0.00026874192,0.00028279526,0.00019187242,0.0004599249,0.00015710299],"domain_scores_gemma":[0.99934137,0.00005965105,0.00014311966,0.00037150393,0.00004805984,0.00003632205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033933666,0.00011805632,0.00045595877,0.0002197742,0.000056528763,0.0000021809944,0.00013551001,0.00004399358,0.00012657611],"category_scores_gemma":[0.00003996488,0.00006718778,0.00013476577,0.0015624728,0.000045482455,0.0000149036,0.00012356139,0.00023738143,9.5367034e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043607134,0.0031000236,0.9911621,0.00006399475,0.0013828444,0.000014705099,0.0023710886,0.00035984945,0.00054471585,0.0000012361845,0.000012896621,0.0005504281],"study_design_scores_gemma":[0.009249572,0.0046028094,0.9789177,0.000033012642,0.005107306,0.0000017958661,0.00091292907,0.000083552615,0.0010017001,8.926951e-7,0.000015240225,0.0000734639],"about_ca_topic_score_codex":0.00044456671,"about_ca_topic_score_gemma":0.0001642116,"teacher_disagreement_score":0.012244421,"about_ca_system_score_codex":0.000033603716,"about_ca_system_score_gemma":0.000044046985,"threshold_uncertainty_score":0.2739838},"labels":[],"label_agreement":null},{"id":"W4310127708","doi":"10.1182/blood-2022-159594","title":"Mosunetuzumab with Polatuzumab Vedotin Is Effective and Has a Manageable Safety Profile in Patients Aged &amp;lt;65 and ≥65 Years with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) and ≥1 Prior Therapy: Subgroup Analysis of a Phase Ib/II Study","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; Saskatchewan Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Medicine; Internal medicine; Lymphoma; Oncology; Refractory (planetary science); Biology","score_opus":0.007074890573360376,"score_gpt":0.22455263845268628,"score_spread":0.2174777478793259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310127708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946718,0.0020465667,0.000002218061,0.000028760793,0.000013504222,0.002872631,0.00025719055,0.000030012608,0.00007729592],"genre_scores_gemma":[0.998707,0.0001807762,0.0001869996,0.000094618044,0.000008145449,0.00046942462,0.0001488739,0.000048233167,0.00015594115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978891,0.00022754387,0.00035222762,0.0006937177,0.00049451366,0.00034291035],"domain_scores_gemma":[0.9989201,0.00014618531,0.00024988002,0.00046088453,0.00005659696,0.00016634238],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025580113,0.00033854414,0.000853035,0.0004538624,0.00031155362,0.000037501624,0.00007656443,0.00006436465,0.00004924519],"category_scores_gemma":[0.000016283622,0.0002535568,0.000073039984,0.00086112495,0.000112090274,0.000111558795,0.00018166166,0.0001435956,6.845264e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071724253,0.10379732,0.8644929,0.00007893076,0.0035950174,0.00025872525,0.013184648,0.0000014390587,0.00014109729,0.0000034625482,0.000032565436,0.007241452],"study_design_scores_gemma":[0.22612453,0.014216304,0.75456816,0.0000534401,0.0032257647,0.000013219238,0.0009935197,0.000057452202,0.00024332864,0.0000016676332,0.00029199707,0.00021061554],"about_ca_topic_score_codex":0.0007970475,"about_ca_topic_score_gemma":0.00061109796,"teacher_disagreement_score":0.2189521,"about_ca_system_score_codex":0.0002024447,"about_ca_system_score_gemma":0.00011613302,"threshold_uncertainty_score":0.99999166},"labels":[],"label_agreement":null},{"id":"W4310152998","doi":"10.1182/blood-2022-166596","title":"Cognitive Assessment in Brazilian Adults with Sickle Cell Disease (SCD): The Burdens of Sociocultural Background and Correlations with Neuroimaging Findings","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Montreal Cognitive Assessment; Cognition; Neuroimaging; Medicine; Cognitive decline; Disease; Psychology; Internal medicine; Dementia; Psychiatry; Cognitive impairment","score_opus":0.0076486436205155965,"score_gpt":0.24165318201685682,"score_spread":0.23400453839634122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310152998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99532723,0.00038511454,0.000015527079,0.0019172808,0.000020286232,0.00053243805,0.00003466147,0.000015746,0.0017517053],"genre_scores_gemma":[0.9991919,0.000043351596,0.00008346182,0.00023612559,0.000011278443,0.000041027964,0.00005257303,0.000015517451,0.00032478897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992042,0.000055164553,0.0001377723,0.00019527554,0.00024170999,0.00016588738],"domain_scores_gemma":[0.9996094,0.00008339723,0.0000654587,0.000104181636,0.00005367094,0.00008386107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008086102,0.000109732806,0.00014352941,0.000047991172,0.00023002697,0.000014229493,0.000046136203,0.0000192625,0.00006410082],"category_scores_gemma":[0.000010761649,0.000065034175,0.000029125682,0.00023023877,0.00016745982,0.000052634034,0.00004131612,0.00040207303,0.0000010111319],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010202042,0.0017952916,0.9810501,0.00021440363,0.00015873142,0.00041777262,0.013490373,0.0003639719,0.0006889873,0.00015276793,0.00014207985,0.00050532183],"study_design_scores_gemma":[0.016404515,0.0012196288,0.90049136,0.00035836123,0.00087106455,0.00015534343,0.07841421,0.0015615096,0.00012248455,0.000024590341,0.00016549666,0.00021144452],"about_ca_topic_score_codex":0.000117045834,"about_ca_topic_score_gemma":0.00003619262,"teacher_disagreement_score":0.08055874,"about_ca_system_score_codex":0.000022151233,"about_ca_system_score_gemma":0.00015361405,"threshold_uncertainty_score":0.2652017},"labels":[],"label_agreement":null},{"id":"W4310159140","doi":"10.1182/blood-2022-163785","title":"Prognostic Impact of High Calreticulin Variant Allele Frequency in Patients with Myeloproliferative Neoplasms","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Quebec - Clinical Research Organization in Cancer; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Calreticulin; Myelofibrosis; Allele; JAK2 V617F; Allele frequency; Medicine; Hematologic Neoplasms; Immunology; Myeloproliferative neoplasm; Biology; Internal medicine; Cancer research; Genetics; Bone marrow; Cancer; Gene","score_opus":0.005725406112724976,"score_gpt":0.22480384174292192,"score_spread":0.21907843563019694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310159140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99720407,0.00015371972,0.00001458936,0.00020753626,0.000038746686,0.0017062549,0.00020225819,0.000028516652,0.00044433423],"genre_scores_gemma":[0.9969156,0.000012875112,0.0018423181,0.00008192481,0.000031338768,0.0006696475,0.00036709293,0.000035636855,0.00004357739],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980832,0.00014688047,0.00042153857,0.00041855744,0.0005686519,0.00036122557],"domain_scores_gemma":[0.9990311,0.00013131076,0.00018069212,0.00030564095,0.000192085,0.00015913283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000136758,0.000283144,0.0005914472,0.00018249749,0.000113507485,0.0000120940995,0.00009801903,0.000055064065,0.00091197714],"category_scores_gemma":[0.00010852419,0.00019469282,0.00011619386,0.00045737962,0.00006325268,0.000066303415,0.000073988085,0.00029417672,0.000011013246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064566487,0.009226457,0.98639077,0.000036710408,0.00062792754,0.00038477004,0.0008571036,0.00038508684,0.00006382152,0.0011247244,0.000081923994,0.00017504871],"study_design_scores_gemma":[0.015753381,0.010867368,0.97132146,0.00007219602,0.00033843768,0.00007068658,0.00007299286,0.0000518974,0.0009968239,0.00024454255,0.000010235038,0.00019997775],"about_ca_topic_score_codex":0.0007153213,"about_ca_topic_score_gemma":0.000102465616,"teacher_disagreement_score":0.0151077155,"about_ca_system_score_codex":0.00021677265,"about_ca_system_score_gemma":0.00045220283,"threshold_uncertainty_score":0.998551},"labels":[],"label_agreement":null},{"id":"W4310159176","doi":"10.1182/blood-2022-168998","title":"Immunophenotypic Switch in Leukemic Clone Is Very Common at the Time of Post-Transplant Relapse of Acute Myeloid Leukemia While Immunophenotypic Profile at Diagnosis Correlates with Adverse Outcomes after Post-Transplant Relapse","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Myeloid leukemia; clone (Java method); Immunophenotyping; Leukemia; Adverse effect; Myeloid; Oncology; Internal medicine; Immunology; Cancer research; Flow cytometry; Biology; Gene","score_opus":0.006132046537454842,"score_gpt":0.21969185731275048,"score_spread":0.21355981077529565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310159176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878948,0.0037853674,0.0000014070024,0.0013783589,0.00018733472,0.002533422,0.003694437,0.000100965764,0.0004239288],"genre_scores_gemma":[0.9887468,0.0014279672,0.00017788605,0.00089879386,0.00003631891,0.0011969382,0.0015703503,0.00019845269,0.0057464563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943213,0.00050117087,0.001520011,0.00095331337,0.0015759105,0.0011282987],"domain_scores_gemma":[0.9959304,0.0009689189,0.0006006395,0.0019223053,0.0003350656,0.00024270758],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009266657,0.00078617927,0.001635473,0.00056558935,0.00045353154,0.000016098978,0.0009831918,0.00035751064,0.003902132],"category_scores_gemma":[0.000059759655,0.000568506,0.0005188194,0.0011073829,0.00062308647,0.0002500014,0.0008202803,0.0019240078,0.00030237128],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029075319,0.001606034,0.7325002,0.0005690981,0.0026333625,0.0017855747,0.012360713,0.00014515709,0.21809012,0.000020122867,0.0010324607,0.00018182257],"study_design_scores_gemma":[0.026372325,0.0043700957,0.83335483,0.0011055705,0.0040727714,0.0019539127,0.0014338644,0.000167077,0.12565166,0.000024960467,0.0004562791,0.0010366729],"about_ca_topic_score_codex":0.0031784535,"about_ca_topic_score_gemma":0.0004423096,"teacher_disagreement_score":0.100854605,"about_ca_system_score_codex":0.0022410357,"about_ca_system_score_gemma":0.0013088427,"threshold_uncertainty_score":0.99967664},"labels":[],"label_agreement":null},{"id":"W4310159202","doi":"10.1182/blood-2022-158492","title":"Association of Metabolic Tumor Volume (MTV) and Clinical Outcomes in Second-Line (2L) Relapsed/Refractory (R/R) Large B-Cell Lymphoma (LBCL) Following Axicabtagene Ciloleucel (Axi-Cel) Versus Standard-of-Care (SOC) Therapy in ZUMA-7","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Refractory (planetary science); Oncology; Lymphoma; Internal medicine; Physics","score_opus":0.026009783173247546,"score_gpt":0.3245871880200717,"score_spread":0.29857740484682416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310159202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98776615,0.009381357,0.000002118958,0.0001845287,0.00047141156,0.0008718096,0.00027828856,0.00003294283,0.0010113834],"genre_scores_gemma":[0.9950174,0.0013918868,0.00018059,0.00014518201,0.0000939913,0.000077653436,0.00008442718,0.000070436756,0.0029384524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99583423,0.0006989913,0.0011696973,0.0005425171,0.0011788916,0.0005756818],"domain_scores_gemma":[0.99785745,0.00082206697,0.0004425337,0.00054984546,0.00016800268,0.00016010342],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0028638453,0.00028599848,0.0013921453,0.00046901897,0.00009385512,0.000016794704,0.00026483697,0.00019709216,0.0015200649],"category_scores_gemma":[0.00055054534,0.00028643178,0.0004977415,0.0006278887,0.00006290071,0.00010947968,0.00023383182,0.0007042456,0.000005032445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007073175,0.0070751235,0.9584497,0.00013527375,0.00085546455,0.00022575421,0.0016768972,0.000003417423,0.014978563,0.000023447596,0.000116235344,0.009386924],"study_design_scores_gemma":[0.26024416,0.010864707,0.65930694,0.00009785023,0.00055218494,0.000011984081,0.0036509414,0.00009559107,0.025955703,0.000050149923,0.038615014,0.0005547994],"about_ca_topic_score_codex":0.00015817607,"about_ca_topic_score_gemma":0.00059499673,"teacher_disagreement_score":0.2991428,"about_ca_system_score_codex":0.000387485,"about_ca_system_score_gemma":0.00059601123,"threshold_uncertainty_score":0.9999588},"labels":[],"label_agreement":null},{"id":"W4310159356","doi":"10.1182/blood-2022-159069","title":"Deep Multi-Omics Profiling in Cytogenetically Poor-Risk AML","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Princess Margaret Cancer Centre; University Health Network; Institute for Research in Immunology and Cancer; Centre Hospitalier Universitaire Sainte-Justine","funders":"Incyte; Celgene; Pfizer; Astellas Pharma; Bristol-Myers Squibb","keywords":"Gene expression profiling; Profiling (computer programming); Computational biology; Biology; Bioinformatics; Medicine; Genetics; Computer science; Gene; Gene expression","score_opus":0.02306219860393496,"score_gpt":0.2923445585423202,"score_spread":0.2692823599383853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310159356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99653506,0.00044517443,0.0004480787,0.0006326264,0.00005844075,0.0006924088,0.000027373826,0.00006427464,0.0010965678],"genre_scores_gemma":[0.96627676,0.00012164592,0.032185774,0.000573498,0.00011810649,0.00017228468,0.00006210082,0.000049456565,0.00044036694],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983514,0.00015030857,0.00027474097,0.00034191215,0.000433433,0.00044822777],"domain_scores_gemma":[0.9992893,0.00009537702,0.000049930433,0.00034986692,0.000055765056,0.00015980429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005345667,0.000127283,0.00024036082,0.00019914722,0.00012755483,0.000013008633,0.00021685591,0.00006750646,0.00020277315],"category_scores_gemma":[0.00038010307,0.00012657639,0.00007290647,0.0004108069,0.000055790428,0.00002441612,0.00035528108,0.0008727491,0.00006528645],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058549043,0.0029484679,0.8301169,0.00011539524,0.00021633515,0.0018272932,0.0009808074,0.0007869855,0.15391608,0.0003306387,0.0002617011,0.007913877],"study_design_scores_gemma":[0.092293255,0.0035719026,0.2954002,0.00008171243,0.0008889689,0.0019976601,0.0054880646,0.17908117,0.40733448,0.00042885914,0.012041459,0.0013922529],"about_ca_topic_score_codex":0.000120978366,"about_ca_topic_score_gemma":0.00003447856,"teacher_disagreement_score":0.5347167,"about_ca_system_score_codex":0.00026063583,"about_ca_system_score_gemma":0.00038137852,"threshold_uncertainty_score":0.5161635},"labels":[],"label_agreement":null},{"id":"W4310159991","doi":"10.1182/blood-2022-163335","title":"Daratumumab Plus Lenalidomide and Dexamethasone (D-Rd) Versus Lenalidomide and Dexamethasone (Rd) Alone in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma (NDMM): Updated Analysis of the Phase 3 Maia Study","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Alberta; University of Calgary","funders":"","keywords":"Lenalidomide; Daratumumab; Dexamethasone; Medicine; Multiple myeloma; Internal medicine; Oncology; Thalidomide; Ixazomib; Carfilzomib","score_opus":0.02020970116908737,"score_gpt":0.2842972444813167,"score_spread":0.26408754331222933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310159991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952568,0.0008568089,0.000033335575,0.0001806237,0.00006337638,0.0027424837,0.00075710734,0.000043276785,0.00006620757],"genre_scores_gemma":[0.99796635,0.00012474778,0.0007243212,0.000059832786,0.000022963452,0.00035086708,0.0006267216,0.000057822857,0.00006638006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958934,0.0006711142,0.0007045735,0.00085192773,0.0011875001,0.0006914686],"domain_scores_gemma":[0.99749583,0.00089592306,0.00028702494,0.00078593293,0.00016284808,0.00037242624],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006447351,0.00046810287,0.0012830163,0.00081459375,0.0003608049,0.000047528,0.00028656423,0.000090534704,0.00016063606],"category_scores_gemma":[0.00033338892,0.00033254063,0.00017753454,0.0023647244,0.0002322043,0.0001556339,0.00025705487,0.0005404562,0.0000018530591],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042680915,0.010179412,0.933577,0.00006963941,0.0064335554,0.0008176289,0.002020613,0.00028374942,0.0017511363,0.0000025354386,0.00005293132,0.0021308977],"study_design_scores_gemma":[0.2959157,0.0035424212,0.687155,0.000067187255,0.005799994,0.000026929614,0.0013844237,0.0019952997,0.003742445,0.0000034969032,0.00006151812,0.00030558795],"about_ca_topic_score_codex":0.0035405734,"about_ca_topic_score_gemma":0.005329538,"teacher_disagreement_score":0.25323477,"about_ca_system_score_codex":0.00016992896,"about_ca_system_score_gemma":0.00021443063,"threshold_uncertainty_score":0.9999127},"labels":[],"label_agreement":null},{"id":"W4310160018","doi":"10.1182/blood-2022-163594","title":"Clinical Outcomes in Fresh Versus Cryopreserved Hematopoietic Stem Cell Products in British Columbia: A Retrospective Study","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Terry Fox Research Institute; University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Retrospective cohort study; Hematopoietic stem cell transplantation; Transplantation; Surgery; Oncology","score_opus":0.03469716336323226,"score_gpt":0.29299203196387497,"score_spread":0.2582948686006427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310160018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99543536,0.00018485426,0.0000011835311,0.00013294941,0.0004783239,0.002518598,0.000039296436,0.00007837946,0.001131059],"genre_scores_gemma":[0.9980097,0.000021565424,0.00018770112,0.000060682098,0.00005500951,0.00043479842,0.000023343453,0.000045443925,0.0011617882],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967378,0.00049319834,0.0009233481,0.00073185633,0.00072276645,0.000391053],"domain_scores_gemma":[0.998843,0.0002727268,0.0001427515,0.0005492237,0.00007794363,0.00011431219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012327544,0.00015062442,0.00079002447,0.00011671839,0.000095216164,0.000060024344,0.00021892725,0.00009070947,0.00035253714],"category_scores_gemma":[0.00015569566,0.00023353976,0.00011362361,0.0007200842,0.00005016883,0.00007006195,0.00013321871,0.00073038746,0.000018122415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019725907,0.010967448,0.98326236,0.00020550545,0.00009835719,0.0027485813,0.002122722,0.000004055916,0.00011790108,0.0000021910791,0.00022434272,0.00004927566],"study_design_scores_gemma":[0.033260092,0.0018204967,0.9549313,0.00008766941,0.00022706573,0.000113198446,0.009130429,0.000007702387,0.00016383045,0.00002851153,0.000026845402,0.00020284553],"about_ca_topic_score_codex":0.0060866713,"about_ca_topic_score_gemma":0.07597437,"teacher_disagreement_score":0.0698877,"about_ca_system_score_codex":0.00017268861,"about_ca_system_score_gemma":0.00021608443,"threshold_uncertainty_score":0.95234746},"labels":[],"label_agreement":null},{"id":"W4310160987","doi":"10.1182/blood-2022-167038","title":"First-in-Human Detection of Romiplostim Drug Levels in Cord Blood, Breastmilk and Blood in a Woman with ITP and Her Newborn Infant","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of Calgary","funders":"","keywords":"Romiplostim; Medicine; Cord blood; Pediatrics; Thrombopoietin; Umbilical cord; Immunology; Haematopoiesis","score_opus":0.004979651807638494,"score_gpt":0.2065399282996741,"score_spread":0.20156027649203562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310160987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972139,0.0022512064,0.000002438914,0.00004442756,0.00001425465,0.00030453422,0.000028399447,0.0000053544572,0.00013548185],"genre_scores_gemma":[0.99947727,0.00010830876,0.0001779661,0.000044974233,0.000010804025,0.00007332072,0.000024111452,0.00002162521,0.000061626786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99902034,0.000060213475,0.00022109888,0.00037348017,0.00010728975,0.0002176053],"domain_scores_gemma":[0.99964964,0.000010664093,0.00007917126,0.00019195491,0.000018047862,0.00005053975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000108549815,0.00016658942,0.00022051245,0.000121791636,0.00006939707,0.000011869843,0.00007707877,0.0000646726,0.000009499227],"category_scores_gemma":[0.0000108285985,0.00016185289,0.000023205437,0.00020850833,0.000057545916,0.0000067836545,0.0001453869,0.00012221406,1.4227867e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035393116,0.0031375075,0.880847,0.00006811866,0.00020504418,0.00013792611,0.00042938866,0.000094718846,0.11334707,0.000011919446,0.0000050215,0.0013624043],"study_design_scores_gemma":[0.02952345,0.0037569096,0.7878431,0.000093346134,0.00029773216,0.00034555266,0.0005918046,0.00005099628,0.17651866,0.0002071005,0.0003159582,0.00045539855],"about_ca_topic_score_codex":0.0013791502,"about_ca_topic_score_gemma":0.014125808,"teacher_disagreement_score":0.09300387,"about_ca_system_score_codex":0.0000064025753,"about_ca_system_score_gemma":0.000036513098,"threshold_uncertainty_score":0.78825325},"labels":[],"label_agreement":null},{"id":"W4310161009","doi":"10.1182/blood-2022-167113","title":"Chromosome 1q Abnormalities Are Not an Independent Predictor of Survival in Multiple Myeloma","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Multiple myeloma; Chromosome abnormality; Internal medicine; Oncology; Medicine; Biology; Genetics; Chromosome; Karyotype; Gene","score_opus":0.03853193098052319,"score_gpt":0.28129435749673903,"score_spread":0.24276242651621585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310161009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977732,0.00020552157,0.0000016659305,0.00010849978,0.00010867966,0.00056072866,0.0005182944,0.00004739307,0.00067605526],"genre_scores_gemma":[0.99872994,0.000021478016,0.00013583894,0.000042604337,0.000100966165,0.00020012069,0.00020298133,0.000027317012,0.0005387575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978929,0.00019475255,0.00032932445,0.00029873577,0.00089256803,0.00039172982],"domain_scores_gemma":[0.99910194,0.00010969568,0.00010226872,0.00039706432,0.000068279,0.00022074617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032716576,0.00015352227,0.00038911245,0.00022866635,0.0001054195,0.000010488793,0.00017933539,0.00005255429,0.0006521868],"category_scores_gemma":[0.00015263222,0.00014210874,0.00008618916,0.00022652787,0.00006728807,0.00010207824,0.00020145567,0.0002953246,0.000011004696],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007724877,0.0040720147,0.98483896,0.00013837471,0.00018414544,0.0010117892,0.00083807996,0.000018935496,0.0074494667,0.000056064662,0.000022676133,0.0005970017],"study_design_scores_gemma":[0.014578216,0.0011804047,0.9627558,0.0000410853,0.000055805835,0.00009475804,0.001671585,0.00026960226,0.018954363,0.000021664464,0.00025830124,0.00011838593],"about_ca_topic_score_codex":0.00080503896,"about_ca_topic_score_gemma":0.00053455966,"teacher_disagreement_score":0.022083135,"about_ca_system_score_codex":0.00010073901,"about_ca_system_score_gemma":0.00017074386,"threshold_uncertainty_score":0.7140988},"labels":[],"label_agreement":null},{"id":"W4310161034","doi":"10.1182/blood-2022-171047","title":"Evaluation of Bleeding and Thrombocytopenia in Older Adults with Acute Myeloid Leukemia Treated with Hypomethylating Agents: A Systematic Review and Meta-Analysis","year":2022,"lang":"en","type":"review","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University of Toronto; University of British Columbia; University of Manitoba; BC Cancer Agency; Health Sciences Centre; CancerCare Manitoba; Sunnybrook Health Science Centre","funders":"","keywords":"Hypomethylating agent; Medicine; Myeloid leukemia; Meta-analysis; Internal medicine; Oncology","score_opus":0.09200793101125183,"score_gpt":0.3518450314302243,"score_spread":0.25983710041897246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310161034","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005715357,0.9843599,0.0000021603319,0.00002473239,0.0000028766124,0.009601145,0.00008833884,0.000014992561,0.00019047788],"genre_scores_gemma":[0.004224078,0.9892303,0.00047818635,0.000053322645,0.0000065906715,0.005631073,0.0002706062,0.000053609383,0.00005223191],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99579036,0.0009634003,0.0011781274,0.00074174005,0.0010982306,0.00022811086],"domain_scores_gemma":[0.9974791,0.00043270382,0.0011851323,0.00049376674,0.0002939239,0.00011537246],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019922329,0.0006173303,0.009529286,0.0005342528,0.00008055071,0.000032666678,0.00008693707,0.000110638284,0.0004730218],"category_scores_gemma":[0.00021410013,0.00032064362,0.0005314232,0.0016506815,0.000047889353,0.00009094654,0.000069489346,0.00027428864,0.00000114779],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019796531,0.0004254905,0.0003671005,0.5853482,0.40855604,0.00013399565,0.00034014165,0.0000024980966,1.7429862e-7,0.0000045449083,0.000002903915,0.0047991253],"study_design_scores_gemma":[0.00326026,0.00057360297,0.00020210518,0.081325725,0.9138271,0.0003416043,0.00009487946,0.00003234207,0.0000053774997,6.0131555e-7,0.000079211364,0.00025715373],"about_ca_topic_score_codex":0.000107760796,"about_ca_topic_score_gemma":0.00010873535,"teacher_disagreement_score":0.5052711,"about_ca_system_score_codex":0.0003011955,"about_ca_system_score_gemma":0.00042329382,"threshold_uncertainty_score":0.99992454},"labels":[],"label_agreement":null},{"id":"W4310161038","doi":"10.1182/blood-2022-158011","title":"Once Weekly Selinexor, Carfilzomib and Dexamethasone (XKd) in Triple Class Refractory Multiple Myeloma","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; CancerCare Manitoba; Vancouver General Hospital; University of Calgary; Dalhousie University; University of Alberta; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Carfilzomib; Medicine; Bortezomib; Daratumumab; Tolerability; Refractory (planetary science); Regimen; Dexamethasone; Internal medicine; Population; Multiple myeloma; Oncology; Proteasome inhibitor; Pharmacology; Adverse effect; Biology","score_opus":0.027351468814737673,"score_gpt":0.28865458530026,"score_spread":0.26130311648552235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310161038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99405533,0.0025228157,0.000009333407,0.00062526006,0.00009449456,0.0007700266,0.00011246255,0.00007274126,0.001737563],"genre_scores_gemma":[0.9949548,0.00019266395,0.001861119,0.00022217522,0.00010527403,0.00026116899,0.0001257892,0.000040213126,0.0022367563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997919,0.00022038055,0.00031843345,0.0004847385,0.0005455548,0.00051184575],"domain_scores_gemma":[0.99886835,0.00030089653,0.00008031027,0.00039320262,0.00005573473,0.00030152657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042001472,0.00020562886,0.00040504834,0.00025879458,0.00019202226,0.000020777848,0.00013260041,0.000073743475,0.00029162073],"category_scores_gemma":[0.0005249149,0.00019140932,0.000078255245,0.00041775813,0.00007291386,0.00008868548,0.0002347682,0.00055592204,0.000022487944],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019162195,0.0046699694,0.9123683,0.00014653963,0.0003523208,0.0026770346,0.0008091926,0.000015414895,0.04055422,0.000051458697,0.0014006452,0.03503867],"study_design_scores_gemma":[0.067067765,0.0026436185,0.8698538,0.00009653485,0.00022483217,0.0006007832,0.0015724576,0.0030885243,0.010681234,0.000073564166,0.043619268,0.0004776116],"about_ca_topic_score_codex":0.0007724348,"about_ca_topic_score_gemma":0.0003392973,"teacher_disagreement_score":0.06515154,"about_ca_system_score_codex":0.00016952933,"about_ca_system_score_gemma":0.00020639948,"threshold_uncertainty_score":0.7805445},"labels":[],"label_agreement":null},{"id":"W4310161266","doi":"10.1182/blood-2022-166854","title":"Magnetismm-4: An Open Label, Phase 1B/2 Umbrella Study of Elranatamab in Combination with Other Anti-Cancer Treatments for Patients with Multiple Myeloma","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Multiple myeloma; Medicine; Cancer; Internal medicine; Open label; Oncology; Clinical trial","score_opus":0.04226042840478516,"score_gpt":0.35336905738708646,"score_spread":0.3111086289823013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310161266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99222475,0.000072478455,0.0000060332004,0.00004432503,0.000018971385,0.006898784,0.00060191046,0.000019835947,0.00011291517],"genre_scores_gemma":[0.99553794,0.000008590148,0.0010888702,0.00003501882,0.000010361278,0.002351149,0.00050561514,0.00005716435,0.00040531528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982556,0.00013503923,0.00025895986,0.00044767125,0.00058353256,0.0003192154],"domain_scores_gemma":[0.99910784,0.0000595566,0.00014476737,0.0003955083,0.00015489967,0.00013742963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013692306,0.00020540872,0.00041881634,0.00019648849,0.00016097557,0.00002596316,0.00023146218,0.000029462797,0.00016954863],"category_scores_gemma":[0.000020087955,0.00015022107,0.000018332767,0.0003496832,0.000038042315,0.0001733053,0.00011446975,0.00011008876,0.0000016395028],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009009761,0.20513634,0.77296835,0.0000490982,0.00071677,0.00006403363,0.00064727233,0.000011777514,0.00087777455,0.0000054331595,0.000018868155,0.010494548],"study_design_scores_gemma":[0.41931334,0.07102186,0.506275,0.000049634258,0.00039214146,0.000004174851,0.0005569679,0.0003524065,0.0017489804,0.0000045944744,0.00012879902,0.00015210005],"about_ca_topic_score_codex":0.002161132,"about_ca_topic_score_gemma":0.0011156626,"teacher_disagreement_score":0.4103036,"about_ca_system_score_codex":0.00010401931,"about_ca_system_score_gemma":0.00012398775,"threshold_uncertainty_score":0.6125837},"labels":[],"label_agreement":null},{"id":"W4310161323","doi":"10.1182/blood-2022-168140","title":"A First in Class, Open-Label, First-in-Human, Phase I Trial of Daily Oral Pclx-001","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; Princess Margaret Cancer Centre; University Health Network; Centre Hospitalier de l’Université de Montréal; Spinal Cord Injury BC; University of British Columbia; University of Alberta","funders":"","keywords":"Tolerability; Medicine; Pharmacokinetics; Pharmacology; Internal medicine; Toxicity; Oncology; Lymphoma; Adverse effect; Gastroenterology","score_opus":0.03660661734123606,"score_gpt":0.3044627311404808,"score_spread":0.26785611379924473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310161323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950404,0.0004993585,0.0000029773196,0.00016493094,0.00012248525,0.00080396805,0.00016193272,0.0000069923613,0.003196946],"genre_scores_gemma":[0.9982658,0.000054736454,0.00017007928,0.0001382496,0.00011401158,0.0003684238,0.00028775423,0.000022618247,0.00057835196],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99873024,0.00012955985,0.0003530062,0.00035769225,0.00015644435,0.00027305246],"domain_scores_gemma":[0.9994175,0.000014215312,0.00011931692,0.00036798185,0.000024078554,0.00005693703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004672133,0.00014368481,0.00025086582,0.000073438605,0.00012155473,0.000022566488,0.0005191456,0.00009722653,0.0002868763],"category_scores_gemma":[0.00006812694,0.00015702624,0.000044802964,0.00018237966,0.000045416095,0.000005249622,0.00059285946,0.00017998216,0.0000046600903],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03119162,0.062282544,0.0043098507,0.00025466748,0.00019611725,0.00030821748,0.00073636585,0.000121208475,0.884843,0.0011854881,0.011355939,0.0032150021],"study_design_scores_gemma":[0.49704248,0.009649075,0.00018263116,0.00004154178,0.000051555988,0.000028975084,0.00015526976,0.000087108,0.24125576,0.00033554216,0.25067422,0.00049584854],"about_ca_topic_score_codex":0.00028920936,"about_ca_topic_score_gemma":0.0011276067,"teacher_disagreement_score":0.64358723,"about_ca_system_score_codex":0.000017778275,"about_ca_system_score_gemma":0.00010188671,"threshold_uncertainty_score":0.6403344},"labels":[],"label_agreement":null},{"id":"W4310161884","doi":"10.1182/blood-2022-162652","title":"Uncovering Distinct Metabolic Properties of Relapse and Relapse-Fated Clones in B-Cell Acute Lymphoblastic Leukemia","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"clone (Java method); Cancer; Biology; Chemotherapy; Acute lymphocytic leukemia; Somatic evolution in cancer; Cancer research; Oncology; Leukemia; Immunology; Internal medicine; Medicine; Gene; Genetics; Lymphoblastic Leukemia","score_opus":0.012629844737801084,"score_gpt":0.23317604686159868,"score_spread":0.2205462021237976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310161884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99485976,0.0032648905,0.000016236363,0.00011932274,0.00010768434,0.0005544939,0.00004159744,0.00007214017,0.000963896],"genre_scores_gemma":[0.99768937,0.00029302383,0.00033086524,0.000075883785,0.000056108307,0.00014317072,0.000024556914,0.00006484368,0.0013221994],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99759185,0.00016387588,0.000556713,0.0004681185,0.00071885705,0.0005005835],"domain_scores_gemma":[0.99898136,0.00015182322,0.00015329532,0.0004421538,0.00008851436,0.0001828415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004300189,0.00025966082,0.0006543486,0.00036052716,0.0001466229,0.000019093732,0.00022713275,0.00009372668,0.00008449171],"category_scores_gemma":[0.00033558303,0.00022158267,0.00008888174,0.00077564927,0.00020269358,0.000111610985,0.00058695395,0.00043516236,0.000010718715],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003966995,0.002841718,0.11315835,0.001543317,0.00097838,0.002648999,0.003960201,0.0009190858,0.86776316,0.00022962276,0.00068383064,0.001306352],"study_design_scores_gemma":[0.13313168,0.0049535586,0.16843337,0.0013678395,0.00464451,0.0062268395,0.0037393337,0.013890503,0.65387,0.00044819032,0.0073765004,0.0019177137],"about_ca_topic_score_codex":0.00069399015,"about_ca_topic_score_gemma":0.0000282048,"teacher_disagreement_score":0.21389318,"about_ca_system_score_codex":0.0005610847,"about_ca_system_score_gemma":0.0012057947,"threshold_uncertainty_score":0.9035879},"labels":[],"label_agreement":null},{"id":"W4310161917","doi":"10.1182/blood-2022-170026","title":"Higher Rates of Perioperative Thrombosis and Distinct Management Practices in Secondary Erythrocytosis Versus Polycythemia Vera","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Université Laval; Quebec - Clinical Research Organization in Cancer; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Polycythemia vera; Medicine; Thrombosis; Internal medicine; Gastroenterology; Intensive care medicine","score_opus":0.05142106782183492,"score_gpt":0.33286534946577107,"score_spread":0.28144428164393614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310161917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9747973,0.0011232352,4.1190623e-7,0.0015338452,0.00011642288,0.0005161697,0.000055913093,0.000015864272,0.021840835],"genre_scores_gemma":[0.99784803,0.0005034469,0.00059264776,0.00014634684,0.00003624975,0.00040105006,0.000043003583,0.000017929764,0.0004112839],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989133,0.000092518305,0.00023990918,0.00032876368,0.0002498267,0.00017570819],"domain_scores_gemma":[0.99933565,0.00019915,0.000180652,0.00018910367,0.00003121566,0.000064242275],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012871396,0.00016990812,0.00035380005,0.00010421605,0.00014377662,0.000019474583,0.00005838666,0.000029595605,0.0014988341],"category_scores_gemma":[0.000027477203,0.00014328815,0.000053250216,0.00019885482,0.00006580608,0.00009264429,0.00016063631,0.00018376393,0.0000047210824],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019820556,0.007637583,0.9712774,0.0004331244,0.0027083422,0.00035617145,0.0040397937,0.000005972989,0.003137755,0.0042773164,0.00069278566,0.0034516642],"study_design_scores_gemma":[0.018454634,0.0024078877,0.94606215,0.0000811216,0.00082044926,0.000024889936,0.002638924,0.000010927238,0.021403654,0.000023339944,0.007870574,0.0002014508],"about_ca_topic_score_codex":0.00014157787,"about_ca_topic_score_gemma":0.0000661599,"teacher_disagreement_score":0.025215287,"about_ca_system_score_codex":0.000084010375,"about_ca_system_score_gemma":0.00006324829,"threshold_uncertainty_score":0.9994139},"labels":[],"label_agreement":null},{"id":"W4310162531","doi":"10.1182/blood-2022-163653","title":"Myosteatosis As a Predictor of Toxicity Among Older Adults with DLBCL Receiving CHOP-Based Regimens","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Oncology; Internal medicine; Toxicity; Diffuse large B-cell lymphoma; Lymphoma","score_opus":0.005920574001681676,"score_gpt":0.20996509075921468,"score_spread":0.20404451675753302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310162531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99626774,0.00010374344,0.00006338125,0.00034435402,0.00005474146,0.00075993873,0.000032469005,0.00010110029,0.0022725195],"genre_scores_gemma":[0.9984608,0.000010186984,0.00035238845,0.00053136883,0.00010321177,0.00013762481,0.000043188367,0.000037948135,0.00032322618],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998619,0.000079396676,0.00023315764,0.00031169306,0.00053816766,0.0002185566],"domain_scores_gemma":[0.9991724,0.00006267209,0.00016222948,0.0003852368,0.00009247587,0.00012500325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002181898,0.00015488362,0.00032433882,0.00011432106,0.0001288224,0.000008367688,0.00009351848,0.00007656663,0.00028412518],"category_scores_gemma":[0.00006339764,0.00014354338,0.000136951,0.00034110868,0.00007419061,0.00006284448,0.000034714372,0.00027289017,0.0000023165271],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002149527,0.0058034374,0.43841255,0.0007955542,0.0010409231,0.00013277185,0.008000094,0.000118646174,0.53982794,0.000051539108,0.0009914149,0.0026756176],"study_design_scores_gemma":[0.016270455,0.0011669102,0.119275235,0.00058458967,0.000364687,0.00009637946,0.0010250233,0.00010428753,0.8607158,0.000009955967,0.00020111486,0.00018555575],"about_ca_topic_score_codex":0.00010082538,"about_ca_topic_score_gemma":0.000018103516,"teacher_disagreement_score":0.3208879,"about_ca_system_score_codex":0.000078286685,"about_ca_system_score_gemma":0.00018621773,"threshold_uncertainty_score":0.58535296},"labels":[],"label_agreement":null},{"id":"W4310162547","doi":"10.1182/blood-2022-159000","title":"Vitalize Trial: A Phase 2b, Open-Label, Multicenter, Randomized Parallel-Group, Two-Stage, Study of the Novel Immunotherapeutic, Maveropepimut-S, and Pembrolizumab with and without Intermittent Low-Dose Cyclophosphamide, in Subjects with Relapsed/Refractory Diffuse Large B-Cell Lymphoma","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Oncology; Cyclophosphamide; Regimen; Chemotherapy regimen; Phases of clinical research; Interim analysis; Clinical trial; Chemotherapy; Surgery; Immunotherapy; Cancer","score_opus":0.015168957182122461,"score_gpt":0.26405276948709355,"score_spread":0.24888381230497109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310162547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914934,0.0025199312,0.00004788125,0.000027344076,0.00071782735,0.0048798556,0.000027333464,0.000037770056,0.00024865894],"genre_scores_gemma":[0.9951573,0.00026443874,0.000046524034,0.00027060552,0.0000088617035,0.00077720755,0.000046585275,0.000064170534,0.0033642885],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99692863,0.0011998955,0.0007343775,0.00059409876,0.0001375001,0.00040552346],"domain_scores_gemma":[0.99842244,0.000246518,0.0006533745,0.0005768326,0.000065541564,0.000035312238],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00072066404,0.00040872308,0.0009426858,0.00017250367,0.00040995306,0.00007179531,0.0004297842,0.00009544772,0.00013557446],"category_scores_gemma":[0.00004344693,0.00026608986,0.00007159764,0.00024132826,0.00028401753,0.00024446793,0.00056349806,0.00049293117,0.0000039580227],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.78764844,0.10904652,0.0031941968,0.00004421847,0.0011264564,0.000022727574,0.0035976584,0.0000047800304,0.09482149,0.000063827334,0.00002419413,0.00040548752],"study_design_scores_gemma":[0.97802603,0.007837606,0.0021978866,0.00009900217,0.00055389595,0.00014561022,0.0040424624,0.0000768762,0.0048503685,0.0000019680606,0.0018228693,0.00034544626],"about_ca_topic_score_codex":0.0009701242,"about_ca_topic_score_gemma":0.0003624204,"teacher_disagreement_score":0.19037756,"about_ca_system_score_codex":0.00007490903,"about_ca_system_score_gemma":0.0000947316,"threshold_uncertainty_score":0.99997914},"labels":[],"label_agreement":null},{"id":"W4310162558","doi":"10.1182/blood-2022-163123","title":"<i>In silico</i> and Functional Studies for Classification of <i>EPAS1/HIF2A</i> Genetic Variants Identified in Patients with Erythrocytosis","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Agence Nationale de la Recherche","keywords":"In silico; Genetics; Biology; Computational biology; Medicine; Gene","score_opus":0.014005471163640978,"score_gpt":0.2326578188163414,"score_spread":0.21865234765270042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310162558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99585694,0.0033202542,0.0000703069,0.00004301855,0.00027819476,0.00031823706,0.00008514153,0.0000022728073,0.000025629488],"genre_scores_gemma":[0.9987765,0.0003147228,0.00023177278,0.00011786162,0.00012430348,0.00022479519,0.000082094666,0.000011904637,0.0001160424],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9992788,0.000036504054,0.0001866764,0.00025575885,0.00012000177,0.00012229783],"domain_scores_gemma":[0.99967426,0.000013916346,0.000084876025,0.00014048167,0.0000656568,0.000020813182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009552656,0.000083685176,0.00014771143,0.000056185494,0.000052015526,0.000004807384,0.0000528494,0.000033744403,0.000004414077],"category_scores_gemma":[0.000026328835,0.000082560335,0.000028083212,0.00010503043,0.00004278788,0.000004648843,0.00006411989,0.00004169558,1.3281598e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001283089,0.0016694696,0.20713879,0.00015202475,0.00027307984,8.0647504e-7,0.00039877897,0.00015585605,0.783147,0.00013959527,0.0037631358,0.0018783744],"study_design_scores_gemma":[0.008219074,0.00048685411,0.95408124,0.000011274628,0.00009542445,0.000003993192,0.0002898454,0.000012524039,0.028476344,0.00012108639,0.008037689,0.00016462641],"about_ca_topic_score_codex":0.000016285605,"about_ca_topic_score_gemma":0.00011826806,"teacher_disagreement_score":0.7546707,"about_ca_system_score_codex":0.0000098578,"about_ca_system_score_gemma":0.000048207912,"threshold_uncertainty_score":0.33667126},"labels":[],"label_agreement":null},{"id":"W4310163212","doi":"10.1182/blood-2022-158650","title":"A Phase 1-2, Open-Label Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Activity of Tolinapant in Combination with Oral Decitabine/Cedazuridine and Oral Decitabine/Cedazuridine Alone in Subjects with Relapsed/Refractory Peripheral T-Cell Lymphoma","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Decitabine; Pharmacodynamics; Pharmacokinetics; Medicine; Pharmacology; Chemistry","score_opus":0.018552294918837694,"score_gpt":0.28789978770429453,"score_spread":0.26934749278545683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310163212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99507016,0.0010771931,0.0000037427628,0.00036613012,0.000070169284,0.003178461,0.00010868933,0.000017933564,0.00010752261],"genre_scores_gemma":[0.99878085,0.00032346498,0.00031151832,0.000066297,0.000014417061,0.00034743067,0.00004718523,0.000056009634,0.000052811953],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9974741,0.00037553854,0.0005793723,0.0006101203,0.00059472135,0.0003661676],"domain_scores_gemma":[0.99869955,0.0001938282,0.00040595,0.0004191618,0.00013282087,0.00014869735],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004985069,0.00039994472,0.0009121281,0.0002650831,0.00014827191,0.000024223958,0.0002583026,0.0000567938,0.000023784745],"category_scores_gemma":[0.000035828816,0.00028258716,0.00003687236,0.00071935845,0.00018908922,0.00023805787,0.0005375341,0.0002500067,1.4784698e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.046647858,0.3486503,0.55745184,0.000345306,0.00062980474,0.0011089614,0.0035833148,0.00021782647,0.028616302,0.000034317676,0.00005006536,0.01266405],"study_design_scores_gemma":[0.48835617,0.03784264,0.43667415,0.000230385,0.0011800836,0.00039197647,0.001305254,0.0034717347,0.03012509,0.000012580003,0.0000496055,0.00036031412],"about_ca_topic_score_codex":0.001676679,"about_ca_topic_score_gemma":0.00088657514,"teacher_disagreement_score":0.44170833,"about_ca_system_score_codex":0.0002889429,"about_ca_system_score_gemma":0.00034870848,"threshold_uncertainty_score":0.9999626},"labels":[],"label_agreement":null},{"id":"W4310163262","doi":"10.1182/blood-2022-160319","title":"A Phase 3 Study of Tafasitamab Plus Lenalidomide in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (firmMIND)","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lenalidomide; Diffuse large B-cell lymphoma; Refractory (planetary science); Medicine; Internal medicine; Phases of clinical research; Lymphoma; Oncology; Gastroenterology; Multiple myeloma; Clinical trial; Materials science","score_opus":0.018524220612302716,"score_gpt":0.2875345803979591,"score_spread":0.26901035978565635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310163262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969411,0.00011065579,0.0000014773514,0.000026595739,0.00005679283,0.0019466557,0.000071240196,0.000034606852,0.00081087544],"genre_scores_gemma":[0.99512947,0.0000083465575,0.00004051003,0.0000841686,0.000038203245,0.00022176445,0.00006631261,0.000068431764,0.004342796],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972245,0.0003000598,0.00044362235,0.00042704638,0.001158219,0.00044655582],"domain_scores_gemma":[0.9987053,0.00014485721,0.00017070623,0.00070507603,0.0001151611,0.00015886882],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00047409747,0.00021106286,0.000545197,0.0003701497,0.00010812747,0.000010959816,0.00023791184,0.00005603421,0.0016859464],"category_scores_gemma":[0.00008165804,0.0001642989,0.00007343883,0.00069487974,0.000043484575,0.00006707201,0.00021215751,0.00036038537,0.000009581936],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.076134086,0.67102426,0.2232356,0.00017811224,0.0004948952,0.0017546273,0.009685215,0.0000046219234,0.013927913,0.0000031384793,0.0003569609,0.003200573],"study_design_scores_gemma":[0.89042866,0.045143336,0.049000047,0.000057610156,0.0003190839,0.000026173244,0.0052669123,0.000040252653,0.0066300007,0.0000025722197,0.0028043306,0.0002810349],"about_ca_topic_score_codex":0.000201694,"about_ca_topic_score_gemma":0.00014182829,"teacher_disagreement_score":0.8142946,"about_ca_system_score_codex":0.00029392843,"about_ca_system_score_gemma":0.0004119538,"threshold_uncertainty_score":0.9992266},"labels":[],"label_agreement":null},{"id":"W4310163270","doi":"10.1182/blood-2022-158277","title":"Need for Dynamic Frailty Risk Assessment Among Older Adults with Multiple Myeloma: A Population-Based Cohort Study","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Multiple myeloma; Cohort; Population; Gerontology; Cohort study; Oncology; Internal medicine; Environmental health","score_opus":0.00985233204811935,"score_gpt":0.22931240113113643,"score_spread":0.21946006908301707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310163270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913422,0.00016510281,0.003667434,0.00007680042,0.00025838346,0.0024204473,0.0011351987,0.00006284889,0.00087160454],"genre_scores_gemma":[0.9964422,0.000006750326,0.0012425721,0.000119967524,0.000063727115,0.0016403635,0.00019569318,0.0000565933,0.00023212846],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983982,0.000025446772,0.00057140284,0.000587172,0.000067223635,0.000350544],"domain_scores_gemma":[0.99870807,0.00010999776,0.00061596144,0.0004275584,0.000044208184,0.00009419231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005567802,0.00021232256,0.0004973816,0.00018858169,0.0004583564,0.00007191033,0.00023608208,0.00005667899,0.0002868251],"category_scores_gemma":[0.000084125975,0.00024213946,0.00012737539,0.0001902762,0.000027280053,0.00021628445,0.000058351856,0.00022701666,0.000012081072],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010267448,0.001179162,0.99500483,0.000016722151,0.00016723413,0.0000028575876,0.00024854892,0.0023917197,4.1193812e-7,0.00040623112,0.00007220987,0.00040738017],"study_design_scores_gemma":[0.0092767,0.00062694156,0.9667317,0.000009340101,0.00006985099,8.29404e-7,0.0004097468,0.021656139,0.0000025896154,0.000467802,0.00040527983,0.00034307822],"about_ca_topic_score_codex":0.0035268858,"about_ca_topic_score_gemma":0.0019072773,"teacher_disagreement_score":0.028273147,"about_ca_system_score_codex":0.00027801524,"about_ca_system_score_gemma":0.000074297706,"threshold_uncertainty_score":0.987416},"labels":[],"label_agreement":null},{"id":"W4310163385","doi":"10.1182/blood-2022-168328","title":"Red Cell Exchange with a Targeted Ht of 34% in Sickle Cell Disease: A Cohort Study from CHUM","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Hematocrit; Cohort; Retrospective cohort study; Blood transfusion; Anemia; Hemoglobin; Transfusion therapy; Red blood cell; Red Cell; Internal medicine; Pediatrics","score_opus":0.005010576030229502,"score_gpt":0.19834967390904054,"score_spread":0.19333909787881104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310163385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905602,0.0033409395,0.0000018444133,0.00019672514,0.00006148104,0.0013341425,0.000087155444,0.00004338368,0.0043741306],"genre_scores_gemma":[0.9982378,0.00007992622,0.00007207572,0.000110881636,0.000028043298,0.00018039643,0.00013199895,0.00003252908,0.0011263703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986806,0.000099344055,0.00025220975,0.00032198042,0.0004115658,0.00023431492],"domain_scores_gemma":[0.99932766,0.000024148487,0.000097369615,0.00037477296,0.0000332681,0.00014280269],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015844173,0.000146973,0.00034558904,0.00011558338,0.00006564921,0.0000043090436,0.00010701209,0.00004258002,0.00091879524],"category_scores_gemma":[0.00001373773,0.00012066713,0.000059315516,0.00041794876,0.000035243353,0.000022652901,0.00009863691,0.00028635561,0.000007486492],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072550314,0.012789565,0.9763257,0.00013458877,0.00015589567,0.00086100004,0.002776397,0.000065558306,0.0051823654,0.0000010282447,0.0009187442,0.0000636646],"study_design_scores_gemma":[0.030420166,0.00292136,0.94750786,0.000081282626,0.0014662448,0.0000073505703,0.010689831,0.0002135108,0.0031310143,0.000025995969,0.0031891072,0.00034625237],"about_ca_topic_score_codex":0.0008246677,"about_ca_topic_score_gemma":0.000059401584,"teacher_disagreement_score":0.029694663,"about_ca_system_score_codex":0.000038008908,"about_ca_system_score_gemma":0.0001352652,"threshold_uncertainty_score":0.9999945},"labels":[],"label_agreement":null},{"id":"W4310167620","doi":"10.1182/blood-2022-169721","title":"Discovery of Tumor Reactive T Cell Receptors in Newly Diagnosed Multiple Myeloma","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Multiple myeloma; Medicine; Receptor; Cancer research; Lenalidomide; Internal medicine; Oncology; Immunology","score_opus":0.01622887686775603,"score_gpt":0.2632041443761236,"score_spread":0.24697526750836757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310167620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99612105,0.0002874633,0.0000033473304,0.00009778427,0.00008521424,0.0006769634,0.00009952816,0.000023412049,0.0026052373],"genre_scores_gemma":[0.998005,0.000028650604,0.00046872,0.00005248513,0.000041886622,0.00023858859,0.00010837532,0.0000259744,0.0010303365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985762,0.00012330752,0.0002520727,0.0002832788,0.00044666967,0.00031843048],"domain_scores_gemma":[0.9991696,0.00029100876,0.00009465167,0.00029924183,0.000035806897,0.00010972925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015713427,0.00013409593,0.0003082851,0.00020725015,0.000066211935,0.00000814331,0.00011617443,0.000026013913,0.00019904533],"category_scores_gemma":[0.00026881872,0.00012021119,0.00010561929,0.00035595318,0.00004860073,0.00010064415,0.00014636634,0.0002675523,0.000018713936],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014893208,0.0070039704,0.93334883,0.00009208775,0.00013848422,0.0017413138,0.0007535709,0.000012790845,0.052874528,0.000014085665,0.00039617243,0.0021348356],"study_design_scores_gemma":[0.03136158,0.0016099102,0.6142286,0.000060801944,0.00009993245,0.000056752026,0.0017570187,0.000116237454,0.3491779,0.000035046123,0.0013150093,0.00018119275],"about_ca_topic_score_codex":0.001048442,"about_ca_topic_score_gemma":0.00011788059,"teacher_disagreement_score":0.3191202,"about_ca_system_score_codex":0.00011746247,"about_ca_system_score_gemma":0.00018529917,"threshold_uncertainty_score":0.490207},"labels":[],"label_agreement":null},{"id":"W4311165255","doi":"10.1182/blood-2022-171751","title":"Consolidation Therapy with Blinatumomab Improves Overall Survival in Newly Diagnosed Adult Patients with B-Lineage Acute Lymphoblastic Leukemia in Measurable Residual Disease Negative Remission: Results from the ECOG-ACRIN E1910 Randomized Phase III National Cooperative Clinical Trials Network Trial","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Blinatumomab; Minimal residual disease; Internal medicine; Induction chemotherapy; Chemotherapy regimen; Chemotherapy; Rituximab; Oncology; Gastroenterology; Surgery; Leukemia; Lymphoblastic Leukemia; Lymphoma","score_opus":0.042848676650522215,"score_gpt":0.3463355024982483,"score_spread":0.30348682584772607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311165255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98707426,0.00015487001,0.000138665,0.0011178433,0.0004175278,0.00938233,0.0014177958,0.00006386186,0.00023283836],"genre_scores_gemma":[0.992176,0.0002705155,0.0005902735,0.00090462714,0.0011967032,0.001822868,0.0027282464,0.00008722987,0.00022354657],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9833169,0.009307805,0.0027813949,0.0012186539,0.0026169633,0.00075828936],"domain_scores_gemma":[0.95550704,0.040074002,0.0015431383,0.0008408074,0.0014492717,0.0005857164],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.010838524,0.0005917733,0.002324797,0.0002305464,0.0004371955,0.0001344613,0.0004733146,0.00019903095,0.00015793079],"category_scores_gemma":[0.031756807,0.00034692534,0.0002839604,0.0010735459,0.000553323,0.00031464978,0.00021858863,0.0012563269,0.000005186888],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.983695,0.0046397434,0.0025030593,0.0000096021795,0.0012759975,0.0006562375,0.0010471677,0.0032722447,0.00009594195,0.00007984011,0.0022249878,0.00050018815],"study_design_scores_gemma":[0.96866536,0.0048735254,0.009894134,0.0003650044,0.00073019345,0.000008851048,0.00035526228,0.014133162,0.0002904582,0.00017306986,0.0000807576,0.00043020496],"about_ca_topic_score_codex":0.001229649,"about_ca_topic_score_gemma":0.00036592552,"teacher_disagreement_score":0.030766197,"about_ca_system_score_codex":0.0016882777,"about_ca_system_score_gemma":0.011073518,"threshold_uncertainty_score":0.99989825},"labels":[],"label_agreement":null},{"id":"W4312115002","doi":"10.1182/blood.2022017147","title":"Novel insights into Hodgkin lymphoma biology by single-cell analysis","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Tumor microenvironment; Biology; Computational biology; Immunotherapy; Immune system; Single-cell analysis; Systems biology; Lymphoma; Cell; Immunology; Genetics","score_opus":0.009523246311929153,"score_gpt":0.2057959706925294,"score_spread":0.19627272438060023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312115002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888382,0.0025445758,0.006895899,0.00005177922,0.0001825941,0.00009685581,0.00007219281,0.000024172914,0.0012937172],"genre_scores_gemma":[0.996742,0.00006208227,0.0010166873,0.00047065062,0.000114790004,0.0000336952,0.0009356892,0.000027576838,0.00059679407],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99883443,0.00008386965,0.0002294966,0.00048041044,0.00011927576,0.0002525139],"domain_scores_gemma":[0.9994035,0.000013857356,0.000086786145,0.00037238808,0.000038877624,0.000084589126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000090795664,0.00018195104,0.00022194191,0.00011320404,0.00022167752,0.00002098268,0.0003268973,0.00012699299,0.00006771829],"category_scores_gemma":[0.000014462453,0.00018757014,0.00020876138,0.00038382065,0.000067857465,0.0000023444577,0.0001700646,0.00008065176,0.0000050856434],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042700394,0.0018333135,0.005963479,0.0000062793256,0.00037983942,0.000002985781,0.00011129516,0.000068217676,0.99031305,0.000027601862,0.00040509383,0.00084615836],"study_design_scores_gemma":[0.002821858,0.0008106921,0.00037417293,9.753389e-7,0.00046630483,0.000010241256,0.00008236658,0.000118795935,0.8862965,0.00006296188,0.10860755,0.00034755716],"about_ca_topic_score_codex":0.00030966473,"about_ca_topic_score_gemma":0.00015469482,"teacher_disagreement_score":0.108202465,"about_ca_system_score_codex":0.000021668795,"about_ca_system_score_gemma":0.000054355904,"threshold_uncertainty_score":0.7648888},"labels":[],"label_agreement":null},{"id":"W4313313022","doi":"10.1182/blood.2022018428","title":"DNA polymerase theta protects leukemia cells from metabolic-induced DNA damage","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Cancer Institute","keywords":"DNA damage; DNA polymerase; Polymerase; DNA; Leukemia; Molecular biology; Biology; Genetics; Cancer research; Chemistry","score_opus":0.007928936234048983,"score_gpt":0.20773559166963837,"score_spread":0.1998066554355894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313313022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965767,0.0007208201,0.000035023368,0.0000578974,0.00028083377,0.0004392636,0.00018923574,0.000061335326,0.0016388701],"genre_scores_gemma":[0.99684906,0.00001709466,0.0006159776,0.00042185333,0.00029561916,0.00021425626,0.00020384607,0.000059575978,0.0013226987],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984253,0.00019338173,0.00020304135,0.0005686341,0.00026625115,0.00034335747],"domain_scores_gemma":[0.99891514,0.000010211162,0.000109309185,0.00081719144,0.000026063104,0.00012207511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018519546,0.00022541224,0.00020843411,0.000046803,0.00019721262,0.000030903593,0.0004650286,0.0001171125,0.0003017794],"category_scores_gemma":[0.00003110752,0.00023261839,0.0001567044,0.00012717549,0.000023496115,0.0000041139856,0.0005492874,0.00020199962,0.00003776892],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003973987,0.00023067326,0.000024210598,0.0000044342532,0.00014457582,0.000038896753,0.000071162554,0.000008694095,0.9984381,0.00008872355,0.00029586177,0.00061488344],"study_design_scores_gemma":[0.0015455027,0.00027569622,0.00015780532,0.0000028761174,0.00009720238,0.000014291512,0.000101137884,0.000024366167,0.9804802,0.00018038921,0.016837327,0.00028322477],"about_ca_topic_score_codex":0.00017573894,"about_ca_topic_score_gemma":0.000022132108,"teacher_disagreement_score":0.017957963,"about_ca_system_score_codex":0.000018195764,"about_ca_system_score_gemma":0.00019638713,"threshold_uncertainty_score":0.9485902},"labels":[],"label_agreement":null},{"id":"W4315473447","doi":"10.1182/blood.2022017734","title":"Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trial","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Rituximab; Hazard ratio; Prednisone; Vincristine; Population; CHOP; Gastroenterology; Adverse effect; Confidence interval; Cyclophosphamide; Surgery; Oncology; Lymphoma; Chemotherapy","score_opus":0.030816614180201356,"score_gpt":0.3290154114159041,"score_spread":0.29819879723570275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4315473447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976051,0.00044201652,0.0000026958,0.0006903685,0.00007666113,0.0008386252,0.000068537614,0.00012862482,0.00014735771],"genre_scores_gemma":[0.9969907,0.000062829764,0.000050336097,0.00009194464,0.00024709204,0.00008694922,0.0023719028,0.000019499601,0.000078737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99864674,0.0001511158,0.00033805548,0.00034274146,0.00026562714,0.00025570794],"domain_scores_gemma":[0.9991052,0.00015192435,0.000095499796,0.00049432367,0.000034676184,0.000118365766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019304518,0.00016511593,0.00039067998,0.00023307357,0.00008166997,0.000046242618,0.00009331137,0.00010416138,0.00010662442],"category_scores_gemma":[0.00011877766,0.00010853786,0.00019554293,0.0014704528,0.00002124244,0.00007590561,0.000025588199,0.00008834527,0.00008410558],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003718722,0.0065917443,0.98084927,0.0000048610827,0.0015371933,0.00027849563,0.0009216193,0.000019121255,0.00043865736,0.000054022934,0.00015966,0.0054266336],"study_design_scores_gemma":[0.14999957,0.0008363811,0.84230554,0.000029035886,0.0042746314,0.0000035621679,0.00014539197,0.0010002964,0.0010283907,0.000068599424,0.00020679981,0.00010181141],"about_ca_topic_score_codex":0.011328822,"about_ca_topic_score_gemma":0.004162921,"teacher_disagreement_score":0.14628084,"about_ca_system_score_codex":0.00009792207,"about_ca_system_score_gemma":0.0000980174,"threshold_uncertainty_score":0.9952548},"labels":[],"label_agreement":null},{"id":"W4317350983","doi":"10.1182/blood.2022017174","title":"Aging alters the cell cycle control and mitogenic signaling responses of human hematopoietic stem cells","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency; Canadian Institutes of Health Research; Terry Fox Foundation","keywords":"Stem cell; Biology; Cell biology; Haematopoiesis; Population; Growth factor; Bone marrow; Immunology; Medicine; Receptor; Genetics","score_opus":0.018126285987880415,"score_gpt":0.2607044546689858,"score_spread":0.24257816868110538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317350983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99821705,0.0004668663,0.000112742695,0.00030558175,0.00005459961,0.00043098035,0.000013775856,0.000080486665,0.00031790862],"genre_scores_gemma":[0.99927956,0.000042947056,0.00008080449,0.0001277802,0.000046854042,0.000019833944,0.000004436111,0.000027527813,0.00037022794],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99887127,0.00011954787,0.00032692705,0.00020219758,0.00025543213,0.00022465401],"domain_scores_gemma":[0.99896896,0.00056044786,0.00010093377,0.00025411215,0.000039222847,0.00007630195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046759754,0.00012387328,0.00027018035,0.00011190571,0.00010558289,0.000015561844,0.00008296949,0.00005340158,0.000017942226],"category_scores_gemma":[0.000008031338,0.000093751514,0.00007519665,0.00020946459,0.00008114398,0.000026968248,0.00001629415,0.00010516954,0.00003087495],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052500498,0.00008690583,0.006754028,0.0007118237,0.00007066087,0.00007989859,0.0029276798,0.000020622932,0.9891605,0.000056938272,0.00003440057,0.00004408805],"study_design_scores_gemma":[0.0041851853,0.00014855816,0.0030543897,0.00030775677,0.0005761805,0.00008917238,0.0016709997,0.00012420601,0.98963517,0.000085262174,0.0000199347,0.00010317331],"about_ca_topic_score_codex":0.000014009848,"about_ca_topic_score_gemma":0.0000013089184,"teacher_disagreement_score":0.004132685,"about_ca_system_score_codex":0.000007176459,"about_ca_system_score_gemma":0.000036586807,"threshold_uncertainty_score":0.3823076},"labels":[],"label_agreement":null},{"id":"W4317356542","doi":"10.1182/blood.2022018825","title":"A practical approach to curate clonal hematopoiesis of indeterminate potential in human genetic datasets","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton; Impact; Queen's University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; National Institute for Occupational Safety and Health; Medical Research Council; Canadian Institutes of Health Research; National Cancer Institute; Ludwig Center at Harvard; National Institutes of Health; Alexander and Margaret Stewart Trust; Vanderbilt University Medical Center; Vanderbilt University","keywords":"Exome; Biology; Exome sequencing; Population; Genetics; Biobank; Germline; DNA microarray; Computational biology; Medicine; Mutation; Gene","score_opus":0.04406056898626023,"score_gpt":0.36075093180581763,"score_spread":0.3166903628195574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317356542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975104,0.000016943024,0.00016717185,0.0006878321,0.0000216926,0.000517413,0.00011697908,0.00004511695,0.0009165038],"genre_scores_gemma":[0.99129343,0.000011937335,0.0078544505,0.000106334795,0.00009611265,0.00007450197,0.00032283322,0.000029842067,0.00021056816],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998284,0.00009306685,0.0003489666,0.0003496305,0.00050881575,0.00041556355],"domain_scores_gemma":[0.9991687,0.000065126886,0.000057450405,0.00044984158,0.000056475383,0.0002024207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003914623,0.00013096108,0.00032479712,0.00040686774,0.00004021119,0.00001575192,0.00017432147,0.00010877594,0.0000507183],"category_scores_gemma":[0.00026003906,0.00011976188,0.000058353075,0.0007536556,0.00008251478,0.000065304026,0.00029848726,0.000326882,0.00012494244],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015574769,0.011480948,0.063367516,0.0032709814,0.000932597,0.01897938,0.0025577494,0.00022267221,0.80007267,0.00194187,0.09134622,0.0042699035],"study_design_scores_gemma":[0.02582074,0.001965785,0.7666299,0.00047799834,0.00077996793,0.0037130483,0.0012440747,0.009662008,0.18476136,0.00063898956,0.0033627048,0.0009434465],"about_ca_topic_score_codex":0.00012253188,"about_ca_topic_score_gemma":0.000009866763,"teacher_disagreement_score":0.7032624,"about_ca_system_score_codex":0.000047910442,"about_ca_system_score_gemma":0.00023474343,"threshold_uncertainty_score":0.48837477},"labels":[],"label_agreement":null},{"id":"W4318763628","doi":"10.1182/blood.2022018604","title":"Consensus proposal for revised International Working Group response criteria for higher risk myelodysplastic syndromes","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Associazione Italiana per la Ricerca sul Cancro; Cancer Research UK; Yale University; Leukemia and Lymphoma Society","keywords":"Medicine; Myelodysplastic syndromes; Clinical trial; International Prognostic Scoring System; Delphi method; Intensive care medicine; Internal medicine; Statistics","score_opus":0.05115591448008695,"score_gpt":0.3500419484903222,"score_spread":0.2988860340102353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318763628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856236,0.00012835427,0.0006916591,0.009059519,0.00097327866,0.0024937976,0.0002912956,0.00035030927,0.00038820706],"genre_scores_gemma":[0.9608193,0.000058831032,0.026829302,0.00020575839,0.0010927714,0.00087123964,0.0003106968,0.00010864687,0.0097034285],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99821216,0.00014875516,0.00034849698,0.0004304908,0.00035746448,0.0005026121],"domain_scores_gemma":[0.99684894,0.0023472337,0.00010977327,0.00030396035,0.00022976496,0.0001603064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001423676,0.00018576249,0.00033240384,0.00032850032,0.00015810145,0.00006388759,0.0002072542,0.00013570928,0.00014104479],"category_scores_gemma":[0.003348941,0.00016259712,0.00016617822,0.00033487426,0.00010459267,0.000036670204,0.00010431425,0.00022350752,0.00010841581],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11208534,0.0023169708,0.053302996,0.0030457857,0.0055800346,0.0030945032,0.0013861144,0.000025963132,0.3965266,0.00921682,0.39440018,0.019018702],"study_design_scores_gemma":[0.112493865,0.007294154,0.31254527,0.002639486,0.002987723,0.001418265,0.000619939,0.020336803,0.015840916,0.0072315503,0.51497006,0.001621947],"about_ca_topic_score_codex":0.000006585553,"about_ca_topic_score_gemma":0.0000028774164,"teacher_disagreement_score":0.3806857,"about_ca_system_score_codex":0.0001406546,"about_ca_system_score_gemma":0.0004065452,"threshold_uncertainty_score":0.66305184},"labels":[],"label_agreement":null},{"id":"W4318918842","doi":"10.1182/blood.2022018787","title":"DDX41: the poster child for familial MDS/AML grows up","year":2023,"lang":"en","type":"letter","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"Medicine; Hematologic Neoplasms; Pediatrics; Internal medicine; Transplantation","score_opus":0.031524114970605484,"score_gpt":0.2933775588121621,"score_spread":0.2618534438415566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318918842","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0040812134,0.0003776767,0.000023338855,0.97940826,0.0015621559,0.0031472284,0.0005870622,0.00028496748,0.01052807],"genre_scores_gemma":[0.0011004217,0.00020005621,0.00016417907,0.8297521,0.036960382,0.00084656576,0.0023500994,0.00042271297,0.12820351],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99679774,0.00011563338,0.00043147505,0.0007184724,0.0009261733,0.001010525],"domain_scores_gemma":[0.99764204,0.00065338047,0.00012765748,0.0012389862,0.00021323988,0.00012471295],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00046709934,0.00046517595,0.000679803,0.00026271457,0.00024570513,0.00007726425,0.0007242089,0.0010929557,0.0001647693],"category_scores_gemma":[0.00048364198,0.00029811487,0.00052076543,0.00032001568,0.00019327433,0.0000475865,0.00031961428,0.003580549,0.0010939625],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000113120856,0.000057699883,0.0001174316,0.0004741739,0.00058284035,0.0007589325,0.00016413526,6.0359206e-8,0.00017810789,0.0000152053,0.9968631,0.0006751588],"study_design_scores_gemma":[0.005798497,0.00042237533,0.00085963873,0.0002519222,0.0008626342,0.00047090076,0.000045533376,0.000013154974,0.00097872,0.000114964016,0.98985475,0.00032691352],"about_ca_topic_score_codex":0.00014103088,"about_ca_topic_score_gemma":0.000019443256,"teacher_disagreement_score":0.1496562,"about_ca_system_score_codex":0.00015491793,"about_ca_system_score_gemma":0.00047405533,"threshold_uncertainty_score":0.9999471},"labels":[],"label_agreement":null},{"id":"W4319068233","doi":"10.1182/blood.2022017780","title":"Recombinant factor VIII Fc fusion protein for first-time immune tolerance induction: final results of the verITI-8 study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto; McMaster University; McMaster Children's Hospital","funders":"Swedish Orphan Biovitrum; Sanofi","keywords":"Interquartile range; Medicine; Internal medicine; Adverse effect; Titer; Gastroenterology; Clinical endpoint; Prospective cohort study; Surgery; Immunology; Clinical trial; Antibody","score_opus":0.053845302876858785,"score_gpt":0.3075369446677606,"score_spread":0.2536916417909018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319068233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933065,0.00008775901,3.294016e-7,0.0033303825,0.00017181931,0.0028021357,0.00005007996,0.00004875867,0.00020223009],"genre_scores_gemma":[0.98535174,0.000025396477,0.00006246052,0.000005494386,0.00013405955,0.0002421952,0.00003304584,0.000016162889,0.014129441],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99889237,0.000050270817,0.0002808698,0.00022466198,0.0003259201,0.00022590156],"domain_scores_gemma":[0.99931574,0.0000674922,0.00007007391,0.000384575,0.00011287582,0.00004923285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028035036,0.00010674215,0.00024062027,0.00007009552,0.00019291903,0.000008773041,0.00012088384,0.00006888269,0.00005185362],"category_scores_gemma":[0.00022436252,0.00006323578,0.00011210461,0.0003923463,0.0000474846,0.000035835583,0.00008248233,0.00013870161,0.00006551363],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013696569,0.029610926,0.063030645,0.0016136412,0.0012415866,0.0003655855,0.009660589,0.000014473316,0.8404816,0.0000422854,0.009476317,0.03076581],"study_design_scores_gemma":[0.041971147,0.008968148,0.6140969,0.00092357333,0.00021584857,0.00003176487,0.0006119477,0.000137939,0.32712463,0.000092245195,0.005602311,0.00022357205],"about_ca_topic_score_codex":0.000042934294,"about_ca_topic_score_gemma":0.000013497858,"teacher_disagreement_score":0.5510662,"about_ca_system_score_codex":0.000023494113,"about_ca_system_score_gemma":0.00008641065,"threshold_uncertainty_score":0.25786802},"labels":[],"label_agreement":null},{"id":"W4319303771","doi":"10.1182/blood.2022017968","title":"Novel immunodeficiency caused by homozygous mutation in <i>SLC19A1</i> encoding the reduced folate carrier","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Structural Genomics Consortium; SickKids Foundation; Hospital for Sick Children; Oracle (Canada); University of Toronto","funders":"Immunodeficiency Canada; Canadian Allergy, Asthma and Immunology Foundation","keywords":"Mutation; Immunodeficiency; Cancer research; Genetics; Biology; Medicine; Virology; Gene","score_opus":0.010799131548161102,"score_gpt":0.22644852770785,"score_spread":0.21564939615968892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319303771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9775607,0.018572668,0.000052019255,0.00030755406,0.0010002939,0.00034827358,0.00006720647,0.00020278766,0.0018885077],"genre_scores_gemma":[0.9975444,0.00020576193,0.0000034505365,0.00013817084,0.000005084454,0.000084865176,0.0002470647,0.000029724946,0.001741464],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982644,0.00014638738,0.00045397127,0.0003816146,0.00007494198,0.0006787077],"domain_scores_gemma":[0.99918455,0.00018445648,0.00013847015,0.00044222578,0.00004422242,0.0000060964603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006087085,0.0002360762,0.00026184248,0.00017929189,0.00054470217,0.000040903396,0.00047605505,0.000220188,0.000078184],"category_scores_gemma":[0.00014504234,0.00018866383,0.00011709479,0.00096633285,0.00021876293,0.00014212189,0.00011066873,0.00045200263,0.00039930784],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021363836,0.00033455412,0.00015023141,0.000009346555,0.000066285436,0.000016107088,0.0035951056,0.000083229694,0.99254364,0.00027055017,0.00033166382,0.002577913],"study_design_scores_gemma":[0.019581761,0.00057627214,0.03483847,0.00021323141,0.0003356804,0.00055854354,0.014919281,0.00019177617,0.88878757,0.00067626,0.03770289,0.0016182393],"about_ca_topic_score_codex":0.0005172928,"about_ca_topic_score_gemma":0.000013797589,"teacher_disagreement_score":0.103756055,"about_ca_system_score_codex":0.000027451937,"about_ca_system_score_gemma":0.00008763783,"threshold_uncertainty_score":0.7693488},"labels":[],"label_agreement":null},{"id":"W4321606951","doi":"10.1182/blood.2022018899","title":"Impact of Vincristine-Steroid Pulses in Maintenance for B-Cell Pediatric ALL: A Systematic Review and Meta-Analysis","year":2023,"lang":"en","type":"review","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Work & Health; St. Joseph’s Healthcare Hamilton; Hospital for Sick Children; University Health Network; University of Toronto; McMaster University; Institute for Clinical Evaluative Sciences; Ted Rogers Centre for Heart Research; Impact","funders":"McMaster University","keywords":"Vincristine; Medicine; Context (archaeology); Clinical trial; Maintenance therapy; Meta-analysis; Internal medicine; Oncology; Pediatrics; Chemotherapy; Cyclophosphamide","score_opus":0.11001672066704121,"score_gpt":0.4103697045942921,"score_spread":0.3003529839272509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321606951","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000024187519,0.9912472,0.000041422652,0.000036117355,0.0000088889,0.007880164,0.0006898822,0.000031082025,0.000041090076],"genre_scores_gemma":[0.000057356163,0.9952352,0.0002646045,0.00005218949,0.000047820664,0.0022324026,0.00021019859,0.00010966429,0.0017905799],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99568427,0.0003935882,0.0021519526,0.00067259424,0.000546612,0.000550979],"domain_scores_gemma":[0.99543875,0.0019138484,0.0011281512,0.0010160074,0.00027980376,0.00022345419],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017456203,0.0006036482,0.014273185,0.0011127557,0.000020001708,0.000020962281,0.00037817287,0.00025218158,0.00006159637],"category_scores_gemma":[0.0027628688,0.00033764317,0.0047326563,0.0025287992,0.00004904302,0.0000384868,0.00016749756,0.00032646992,0.000035966754],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006170806,0.00026496354,0.000013144366,0.8876135,0.11132844,0.00009154315,0.0000108851345,1.7540296e-7,1.5024085e-7,0.000001571334,0.0006229921,0.000046464615],"study_design_scores_gemma":[0.0013847097,0.00030691942,0.0000059996473,0.040994857,0.9563773,0.00015696055,0.000004264784,0.000020116404,2.388679e-7,0.0000035291853,0.00050604163,0.00023905539],"about_ca_topic_score_codex":0.00015481905,"about_ca_topic_score_gemma":0.000019844052,"teacher_disagreement_score":0.84661865,"about_ca_system_score_codex":0.00034087888,"about_ca_system_score_gemma":0.001094501,"threshold_uncertainty_score":0.99990755},"labels":[],"label_agreement":null},{"id":"W4321612412","doi":"10.1182/blood.2022019104","title":"Breaking the CH inflammation-expansion cycle","year":2023,"lang":"en","type":"letter","venue":"Blood","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Inflammation; Medicine; Immunology","score_opus":0.011373562357286541,"score_gpt":0.22681888176922746,"score_spread":0.21544531941194092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321612412","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.048787776,0.012087531,0.00002715173,0.8992658,0.018830769,0.0012804869,0.0001452209,0.0010342216,0.018540986],"genre_scores_gemma":[0.051210035,0.0013981527,0.00008619691,0.7119476,0.016177071,0.0007232472,0.00578943,0.0006413103,0.21202697],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986404,0.00020281202,0.00031293445,0.0003344413,0.00006525481,0.00044413033],"domain_scores_gemma":[0.9986177,0.00037372243,0.00021062931,0.0007338984,0.00006005156,0.0000040103414],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022990214,0.00025500488,0.00027575577,0.00009963138,0.00029803536,0.000031332544,0.0005855504,0.0011564718,0.000760881],"category_scores_gemma":[0.000066039895,0.00018377493,0.00014600203,0.00015923583,0.00017611032,0.00004320112,0.00021770323,0.0019954327,0.0067841467],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004955024,0.000015917016,0.000040156305,0.00006235198,0.00033219845,0.000056799054,0.00031242074,0.0000049545392,0.028042046,0.00001668103,0.9688527,0.0022588458],"study_design_scores_gemma":[0.00067672593,0.000023821105,0.00028755,0.000114939125,0.0001867956,0.00009078398,0.00002742715,5.8277124e-7,0.04703608,0.00018000191,0.9511469,0.00022840941],"about_ca_topic_score_codex":0.00015205808,"about_ca_topic_score_gemma":0.000015753485,"teacher_disagreement_score":0.19348598,"about_ca_system_score_codex":0.000032141954,"about_ca_system_score_gemma":0.00009056013,"threshold_uncertainty_score":0.99398917},"labels":[],"label_agreement":null},{"id":"W4322489387","doi":"10.1182/blood.2022019343","title":"Romiplostim drug presence in pregnancy and lactation","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Obstetrics and gynaecology; Library science; Family medicine; Pregnancy; Biology; Genetics; Computer science","score_opus":0.007400380969531572,"score_gpt":0.2355114086783861,"score_spread":0.22811102770885452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322489387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972543,0.0018210732,0.000004198999,0.00008344113,0.00002138328,0.000108237815,0.000006083279,0.000011893862,0.00068934733],"genre_scores_gemma":[0.9985148,0.00065467187,0.000076530385,0.00001788097,0.0000142811405,0.00002948933,0.00006300617,0.0000071194668,0.00062226085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999632,0.000014345436,0.00005734125,0.00015566101,0.000038803548,0.00010182602],"domain_scores_gemma":[0.99985474,0.0000061940873,0.00001510793,0.00009253065,0.000008536185,0.000022886672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000024650955,0.000053301912,0.000045783923,0.000024896159,0.000021420441,0.000008726067,0.00003709066,0.000034707035,0.000002257846],"category_scores_gemma":[0.00002538083,0.00005055391,0.000012736101,0.000077833385,0.000014742771,0.0000024080105,0.00004111905,0.000020235146,0.000011628343],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052837262,0.0012420475,0.86079717,0.00009984398,0.00016391568,0.00009210935,0.00081007567,0.000058359943,0.1095155,0.00022221812,0.0019858931,0.024960022],"study_design_scores_gemma":[0.0139673995,0.00055379083,0.5107235,0.0003042703,0.00013360579,0.000023668308,0.00054419774,0.0003033458,0.46789873,0.0026087493,0.002334423,0.00060431246],"about_ca_topic_score_codex":0.000021246544,"about_ca_topic_score_gemma":0.00009938568,"teacher_disagreement_score":0.35838324,"about_ca_system_score_codex":7.9664363e-7,"about_ca_system_score_gemma":0.000011174851,"threshold_uncertainty_score":0.20615286},"labels":[],"label_agreement":null},{"id":"W4323322251","doi":"10.1182/blood.2022018309","title":"Natural killer cell memory precedes HLH in monozygotic twins discordant for chronic active Epstein-Barr virus disease","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Institute of Molecular and Cell Biology; National University of Singapore; Agency for Science, Technology and Research; Duke-NUS Medical School","keywords":"Immunology; Hemophagocytic lymphohistiocytosis; Biology; Perforin; Virus; Cytokine; Immune system; Disease; Medicine; CD8; Internal medicine","score_opus":0.010229405704003958,"score_gpt":0.23615740496340454,"score_spread":0.22592799925940057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323322251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988446,0.002283765,0.000031907428,0.00021798354,0.006942809,0.0006938804,0.000023812408,0.00015883756,0.0012009897],"genre_scores_gemma":[0.95701283,0.00015557573,0.000009179522,0.0000880187,0.000086628424,0.00019664156,0.0004068324,0.000029360292,0.042014915],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99884695,0.00010983739,0.00025630483,0.0003398453,0.000031530013,0.0004155368],"domain_scores_gemma":[0.9994313,0.00016688422,0.00009137654,0.00024602187,0.000034336015,0.000030069295],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009980673,0.00019421619,0.00021817874,0.00019469297,0.00015820986,0.00001787447,0.00014681742,0.00009647531,0.00052957516],"category_scores_gemma":[0.000078878664,0.00017157261,0.00015733093,0.00014420782,0.00006995556,0.00016850783,0.000066781155,0.0003080699,0.0012251718],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010288246,0.0007300442,0.0003516163,0.000100738434,0.00021424492,0.000019156623,0.0005792963,0.00010413242,0.9872297,0.000115262475,0.0078835655,0.0016434394],"study_design_scores_gemma":[0.00802777,0.0005312024,0.027865697,0.00011384816,0.00023805536,0.000021805587,0.0010076008,0.00023239246,0.9255501,0.00012175234,0.0358191,0.0004706432],"about_ca_topic_score_codex":0.000094112314,"about_ca_topic_score_gemma":0.0001397853,"teacher_disagreement_score":0.061679546,"about_ca_system_score_codex":0.00009602759,"about_ca_system_score_gemma":0.000103496444,"threshold_uncertainty_score":0.9995525},"labels":[],"label_agreement":null},{"id":"W4323821448","doi":"10.1182/blood.2022017951","title":"Nivolumab combined with brentuximab vedotin for relapsed/refractory mediastinal gray zone lymphoma","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Spinal Cord Injury BC","funders":"Seagen; Bristol-Myers Squibb","keywords":"Nivolumab; Library science; Web site; Medicine; Art history; Art; World Wide Web; Cancer; Internal medicine; Computer science","score_opus":0.014395435835163306,"score_gpt":0.24272774717149329,"score_spread":0.22833231133632997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323821448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959199,0.0003782312,0.000048045855,0.0009583302,0.00023584752,0.0009179467,0.0000618744,0.0003512536,0.0011285724],"genre_scores_gemma":[0.9955013,0.00010241393,0.0011268066,0.00022187439,0.0002554176,0.00051868067,0.00037274338,0.00006628973,0.0018345166],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983896,0.000027201942,0.00027959148,0.00042821627,0.00039440586,0.00048095992],"domain_scores_gemma":[0.99885964,0.00025801206,0.000112361115,0.00040419103,0.00012386696,0.00024194345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014522608,0.0002667073,0.00045736588,0.00015713878,0.00014216432,0.000026932634,0.00010342212,0.000103723076,0.000063338855],"category_scores_gemma":[0.00008921086,0.00019551555,0.00015575693,0.00036589697,0.000081827326,0.00006645367,0.000043012722,0.00005963044,0.00024756507],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013245443,0.05970708,0.65808016,0.0013669637,0.0051258295,0.0062766424,0.0022465233,0.000013600071,0.0066393255,0.0028513442,0.08007621,0.16437086],"study_design_scores_gemma":[0.20875956,0.017588126,0.71602994,0.0006465187,0.00261011,0.00064319366,0.00041684668,0.00023535466,0.023670632,0.00017236134,0.028562587,0.000664781],"about_ca_topic_score_codex":0.000073849325,"about_ca_topic_score_gemma":0.00005360324,"teacher_disagreement_score":0.19551411,"about_ca_system_score_codex":0.000108459026,"about_ca_system_score_gemma":0.00026625162,"threshold_uncertainty_score":0.79728925},"labels":[],"label_agreement":null},{"id":"W433802874","doi":"10.1182/blood.v124.21.4410.4410","title":"A Phase II Clinical Trial of Rituximab, Cyclophosphamide, Bortezomib, and Dexamethasone (R-CyBor-D) in Relapsed Low Grade and Mantle Cell Lymphoma","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Mantle cell lymphoma; Bortezomib; Rituximab; Internal medicine; Follicular lymphoma; Cyclophosphamide; Gastroenterology; Tolerability; Marginal zone B-cell lymphoma; Multiple myeloma; Oncology; Surgery; Lymphoma; Immunology; Chemotherapy; Adverse effect; B cell","score_opus":0.021446768741428156,"score_gpt":0.3095067927312773,"score_spread":0.28806002398984915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W433802874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99566394,0.0022073248,0.0000057259117,0.00028178786,0.0001402319,0.0007771837,0.000015663543,0.000026403754,0.00088174414],"genre_scores_gemma":[0.9966618,0.0013829892,0.0014286593,0.00019251154,0.00013765779,0.00006111636,0.000016665757,0.000024857936,0.00009374078],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998254,0.00012740017,0.0006840396,0.00044709828,0.00021965512,0.00026778245],"domain_scores_gemma":[0.99871707,0.00045076528,0.00019138413,0.00036277733,0.00003590298,0.00024207114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058423413,0.000215553,0.0008127246,0.00010471521,0.000054524317,0.000012552832,0.000060821334,0.00018875141,0.000019408584],"category_scores_gemma":[0.00027807438,0.00017617302,0.00012187673,0.00015059205,0.00016546689,0.000040861505,0.00008083218,0.00009186147,0.000005789131],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039114647,0.30965662,0.3517255,0.0005132288,0.0005597331,0.0007681794,0.00069085613,3.9682922e-7,0.0024988225,0.00050164683,0.0005974913,0.2933729],"study_design_scores_gemma":[0.8440609,0.012317955,0.12317921,0.00014897312,0.00062047114,0.00006584973,0.000036963298,0.0001435217,0.018107131,0.00018229791,0.000946709,0.00019004277],"about_ca_topic_score_codex":0.00017126848,"about_ca_topic_score_gemma":0.000023657862,"teacher_disagreement_score":0.80494624,"about_ca_system_score_codex":0.000024926756,"about_ca_system_score_gemma":0.000096355965,"threshold_uncertainty_score":0.71841276},"labels":[],"label_agreement":null},{"id":"W4360600421","doi":"10.1182/blood.2022018873","title":"HU for SCA in Africa: associated malaria benefit","year":2023,"lang":"en","type":"letter","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation","funders":"","keywords":"Malaria; Medicine; Immunology","score_opus":0.021248015021069096,"score_gpt":0.23969725334228809,"score_spread":0.21844923832121899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360600421","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019362072,0.0019667172,0.00000460006,0.9586159,0.0012227863,0.0021062237,0.000433373,0.00043369026,0.01585465],"genre_scores_gemma":[0.022331618,0.0016415583,0.00069755944,0.6995706,0.0074407663,0.0008837124,0.009763677,0.0010290395,0.25664148],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99815756,0.000027505635,0.000401002,0.00042985863,0.00030575346,0.0006783205],"domain_scores_gemma":[0.99921864,0.00016946737,0.00013436712,0.00031927112,0.00009214581,0.00006612608],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00023911141,0.0002904973,0.00064395694,0.0002952649,0.00005278128,0.000022546461,0.00014390412,0.0019238142,0.00008401483],"category_scores_gemma":[0.00034183558,0.00025572814,0.0002724253,0.00046478552,0.000035700064,0.000021222259,0.000050294766,0.0015317176,0.00020235438],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023075718,0.00030312143,0.0010791945,0.00035551883,0.00047571317,0.0010790221,0.00015476724,0.000002087486,0.000054510343,0.000030235511,0.9962221,0.00022068962],"study_design_scores_gemma":[0.01069285,0.00045279227,0.0046804263,0.0012698177,0.0015330891,0.000041326068,0.00009941369,0.00006067772,0.00006624161,0.00093752757,0.9796306,0.0005352566],"about_ca_topic_score_codex":0.0000865017,"about_ca_topic_score_gemma":0.00003972209,"teacher_disagreement_score":0.25904527,"about_ca_system_score_codex":0.00007553416,"about_ca_system_score_gemma":0.00012883754,"threshold_uncertainty_score":0.9999895},"labels":[],"label_agreement":null},{"id":"W4361282797","doi":"10.1182/blood.2022016322","title":"STAT5 activation promotes progression and chemotherapy-resistance in early T-cell precursor acute lymphoblastic leukemia","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"STAT5; Cancer research; Leukemia; Biology; Immunology; Medicine; Signal transduction; Cell biology","score_opus":0.010771262543145048,"score_gpt":0.27608297914421476,"score_spread":0.2653117166010697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361282797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963547,0.00013944799,0.00009711362,0.00067761674,0.00003453848,0.0010776528,0.000012828431,0.00020776145,0.0013983274],"genre_scores_gemma":[0.9941626,0.00020007257,0.0019319156,0.00010432672,0.00009584479,0.00017600422,0.000043503984,0.000067506866,0.0032182282],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980384,0.000059106806,0.00029655037,0.00049218326,0.00056803634,0.0005457141],"domain_scores_gemma":[0.99907166,0.00023477539,0.000098348864,0.00031345655,0.000092377435,0.00018939054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002695,0.00022666305,0.00032788306,0.00031256632,0.00007713858,0.000051779603,0.0001288647,0.00017180399,0.000022516188],"category_scores_gemma":[0.00018268544,0.00019085914,0.000043882475,0.00087730144,0.000117751704,0.00017768612,0.000089949695,0.00023013285,0.00008932716],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056791063,0.002946314,0.15430167,0.0029295888,0.0006590151,0.0017809271,0.010721179,0.000012576583,0.79097074,0.00027199753,0.008507432,0.02121943],"study_design_scores_gemma":[0.04573427,0.0016842744,0.46421942,0.002096663,0.00028804404,0.00009647851,0.000204695,0.003310796,0.4790878,0.0008719922,0.0017368753,0.0006686631],"about_ca_topic_score_codex":0.00003115175,"about_ca_topic_score_gemma":0.000014921255,"teacher_disagreement_score":0.31188294,"about_ca_system_score_codex":0.00045970065,"about_ca_system_score_gemma":0.0007235634,"threshold_uncertainty_score":0.77830094},"labels":[],"label_agreement":null},{"id":"W4362459564","doi":"10.1182/blood.2023019765","title":"Genomic landscape of Down syndrome-associated acute lymphoblastic leukemia","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Center for Research Resources; National Institute of Child Health and Human Development; National Institute of General Medical Sciences; National Eye Institute; National Cancer Institute; National Institutes of Health; Cancer Prevention and Research Institute of Texas; National Institute of Environmental Health Sciences; American Lebanese Syrian Associated Charities; NIH Office of the Director; National Heart, Lung, and Blood Institute; McGill University; Eunice Kennedy Shriver National Institute of Child Health and Human Development; U.S. Department of Defense","keywords":"Biology; Genetics; CEBPA; Transcriptome; Enhancer; Copy-number variation; Gene; Cancer research; Genome; Mutation; Gene expression","score_opus":0.011942950693408831,"score_gpt":0.2555919687781071,"score_spread":0.24364901808469824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362459564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953509,0.000116210176,0.000025409521,0.0001759204,0.00011934526,0.00038518215,0.00010198548,0.00031336644,0.003411711],"genre_scores_gemma":[0.9954764,0.00015485082,0.00016769845,0.000098560486,0.000077209734,0.00003908758,0.00019695344,0.00007031676,0.0037188926],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9977344,0.000058475456,0.000452371,0.0003943867,0.000683928,0.0006764057],"domain_scores_gemma":[0.99855703,0.00034291812,0.00014075625,0.0005222314,0.00016703653,0.00027005502],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035064315,0.00023075686,0.0006215539,0.00043064475,0.000077317956,0.000018478651,0.0002779221,0.00022783525,0.00032286224],"category_scores_gemma":[0.0004385189,0.00020120668,0.0001807588,0.0012472091,0.00012681524,0.000056898494,0.00022587922,0.00021691936,0.0012457593],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014153745,0.0028051306,0.33403054,0.0013382634,0.0107874125,0.020988584,0.0017164147,0.00036632016,0.55475736,0.00041195273,0.06952196,0.0018606863],"study_design_scores_gemma":[0.04120675,0.002160416,0.9141436,0.0006121108,0.0027898336,0.0037657123,0.00028296222,0.00997584,0.02346633,0.00024692898,0.0006933744,0.000656098],"about_ca_topic_score_codex":0.00008502757,"about_ca_topic_score_gemma":0.000007661553,"teacher_disagreement_score":0.5801131,"about_ca_system_score_codex":0.0005713389,"about_ca_system_score_gemma":0.0015406015,"threshold_uncertainty_score":0.99953187},"labels":[],"label_agreement":null},{"id":"W4366609228","doi":"10.1182/blood.2022018719","title":"Genetic subdivisions of follicular lymphoma defined by distinct coding and noncoding mutation patterns","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; Canada's Michael Smith Genome Sciences Centre; Simon Fraser University","funders":"Michael Smith Health Research BC; Canadian Institutes of Health Research; Canada's Michael Smith Genome Sciences Centre; National Cancer Institute; Genome Canada","keywords":"Somatic hypermutation; Biology; Follicular lymphoma; Diffuse large B-cell lymphoma; Malignancy; Lymphoma; BCL6; Germinal center; Oncology; Genetics; Computational biology; Cancer research; Medicine; B cell; Immunology","score_opus":0.0138347985585874,"score_gpt":0.2504044069735727,"score_spread":0.23656960841498528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366609228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99875087,0.0004506595,0.000094816794,0.00018714466,0.00003702024,0.00019330169,0.000060120332,0.00005379346,0.00017226028],"genre_scores_gemma":[0.9991878,0.0002522264,0.00028941897,0.000032935062,0.000028549204,0.000038222526,0.00011013713,0.000014517832,0.000046152054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993136,0.00001726356,0.00018125739,0.00017954428,0.00015968073,0.00014868271],"domain_scores_gemma":[0.999563,0.00012764355,0.00005950104,0.00013669707,0.000029384157,0.00008380681],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000059241076,0.000097698714,0.00019301004,0.0000705844,0.000063557396,0.0000126441655,0.000027412016,0.00003946834,0.000016851076],"category_scores_gemma":[0.00006333206,0.000080495236,0.000057193694,0.00015922847,0.000020086853,0.000022620789,0.000034366072,0.000014872727,0.000015195021],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009926392,0.0006777124,0.98044944,0.000103593076,0.00014949337,0.0002976839,0.00019410718,0.000001192714,0.006022452,0.00007606152,0.00028344934,0.011734905],"study_design_scores_gemma":[0.0054052044,0.00021566018,0.96934503,0.00015512783,0.00040682437,0.00008611097,0.00008048663,0.0002954106,0.02378418,0.00003542168,0.00011266076,0.00007788857],"about_ca_topic_score_codex":0.00013984571,"about_ca_topic_score_gemma":0.000012375029,"teacher_disagreement_score":0.017761728,"about_ca_system_score_codex":0.000024266685,"about_ca_system_score_gemma":0.000024545312,"threshold_uncertainty_score":0.32825005},"labels":[],"label_agreement":null},{"id":"W4372250795","doi":"10.1182/blood.2022018651","title":"A non-canonical enzymatic function of PIWIL4 maintains genomic integrity and leukemic growth in AML","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chromosomal and Genetic Variations","field":"Agricultural and Biological Sciences","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"Canadian Institutes of Health Research; Universität Ulm; Deutsche Forschungsgemeinschaft","keywords":"Biology; Myeloid leukemia; Haematopoiesis; Stem cell; Progenitor cell; Gene; RNA; Myeloid; Cell biology; Cancer research; Genetics","score_opus":0.016195151625772907,"score_gpt":0.20849156976633737,"score_spread":0.19229641814056447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4372250795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989786,0.00003795249,0.0000021595542,0.00046013357,0.00003657772,0.00011601029,0.00001751109,0.000023915529,0.00032715002],"genre_scores_gemma":[0.99970186,0.00005301785,0.000041448682,0.000037169546,0.000066436776,0.0000130077715,0.000024339273,5.3805655e-7,0.000062198415],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99944633,0.000027900904,0.0001652779,0.00014891097,0.00007365296,0.00013793109],"domain_scores_gemma":[0.99977577,0.00009693489,0.00003834063,0.000028363576,0.000019119805,0.00004148189],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001446909,0.000063696585,0.000115060415,0.000017818233,0.00004657469,0.000011852575,0.00007697788,0.00006133881,0.00007896028],"category_scores_gemma":[0.000037109316,0.000027233393,0.00003465588,0.00034384386,0.00003343535,0.000028403083,0.00006202744,0.00010002271,0.000028186665],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018685461,0.0002524186,0.22049773,0.000026919593,0.000021861284,0.000005086052,0.00021399728,0.00000511687,0.7732148,0.0016554708,0.000062680185,0.004025214],"study_design_scores_gemma":[0.00034224437,0.00018413842,0.9924847,0.00001810462,0.000018648807,0.000005083317,0.00018749869,0.00018890804,0.0020926388,0.0043508415,0.000061200364,0.000066026216],"about_ca_topic_score_codex":0.0004921408,"about_ca_topic_score_gemma":0.0013520615,"teacher_disagreement_score":0.77198696,"about_ca_system_score_codex":0.000012889003,"about_ca_system_score_gemma":0.000018344632,"threshold_uncertainty_score":0.11105455},"labels":[],"label_agreement":null},{"id":"W4377010769","doi":"10.1182/blood.2023019859","title":"TEMRA: the CD8 subset in chronic ITP?","year":2023,"lang":"en","type":"letter","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services","funders":"","keywords":"Immunology; Medicine; CD8; Virology; Immune system","score_opus":0.02038758304734713,"score_gpt":0.26061783991334686,"score_spread":0.24023025686599972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377010769","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1947782,0.004848799,3.9573462e-7,0.78853464,0.00045962638,0.0011754871,0.00015302257,0.0001741981,0.009875635],"genre_scores_gemma":[0.119782194,0.0026347772,0.00003638321,0.81219107,0.0075596203,0.0005672811,0.0043032244,0.0003500562,0.0525754],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988008,0.000037900772,0.00019899425,0.00030986714,0.0002616782,0.0003907661],"domain_scores_gemma":[0.99932975,0.00010249064,0.00006213923,0.00046000085,0.000016447999,0.000029187353],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008458196,0.00023137686,0.00042587452,0.00012059773,0.000043154872,0.000017786164,0.00014822457,0.00046313697,0.000118423595],"category_scores_gemma":[0.000030062218,0.00014282906,0.00013061255,0.00023626536,0.000044106248,0.000017465518,0.00004568434,0.0011560629,0.00096142804],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007083743,0.00015640665,0.0020261477,0.00017649225,0.00038095418,0.020643804,0.000059551952,3.8345362e-7,0.000027954666,0.0000037298246,0.9759541,0.0005633925],"study_design_scores_gemma":[0.005622105,0.00024468667,0.008032198,0.0003764641,0.0006757228,0.00037333937,0.00001738141,0.0000071507548,0.00011871552,0.00020791701,0.9841032,0.00022109092],"about_ca_topic_score_codex":0.00021054811,"about_ca_topic_score_gemma":0.0002958799,"teacher_disagreement_score":0.07499602,"about_ca_system_score_codex":0.00009741936,"about_ca_system_score_gemma":0.00021445146,"threshold_uncertainty_score":0.9998164},"labels":[],"label_agreement":null},{"id":"W4378953885","doi":"10.1182/blood.2023020396","title":"Targeted therapy in mediastinal gray zone lymphoma","year":2023,"lang":"en","type":"letter","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lymphoma; Ibrutinib; Gray (unit); Internal medicine; Radiology; Surgery; Chronic lymphocytic leukemia; Leukemia","score_opus":0.022466062525544585,"score_gpt":0.25448360834420963,"score_spread":0.23201754581866504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378953885","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4928947,0.005282181,0.000001499663,0.4967926,0.0010760821,0.0013882547,0.00017208532,0.00041770568,0.001974879],"genre_scores_gemma":[0.13530302,0.005586144,0.0006386021,0.8294326,0.012853902,0.0015490869,0.0050348197,0.0004480523,0.009153779],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978391,0.00007188591,0.00039922085,0.0005637635,0.0005679294,0.0005581144],"domain_scores_gemma":[0.99897367,0.00022793746,0.00012572158,0.0005090432,0.00005993731,0.000103674116],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011647214,0.000434547,0.0007614196,0.0003605231,0.000039096823,0.000026191572,0.00015147973,0.0006450498,0.00024380292],"category_scores_gemma":[0.00005721388,0.0003275848,0.00025047798,0.00039402736,0.00005818349,0.000027863829,0.000044090673,0.00037862136,0.0006554072],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007469345,0.0021384351,0.06013787,0.00013863368,0.0007345871,0.032604687,0.00018821952,1.650185e-7,0.000100486446,0.00000451361,0.88903064,0.01484708],"study_design_scores_gemma":[0.030344386,0.0011505284,0.33875674,0.00066964043,0.0005471791,0.00050562265,0.00002338723,0.0000037589773,0.0032193733,0.000058714068,0.6242104,0.000510242],"about_ca_topic_score_codex":0.0005209455,"about_ca_topic_score_gemma":0.000052094645,"teacher_disagreement_score":0.3575917,"about_ca_system_score_codex":0.00015908414,"about_ca_system_score_gemma":0.00029046036,"threshold_uncertainty_score":0.9999176},"labels":[],"label_agreement":null},{"id":"W4379768349","doi":"10.1182/blood.2023020167","title":"Macrophage checkpoint for iron absorption","year":2023,"lang":"en","type":"letter","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institutes of Health; American Society of Hematology","keywords":"Iron Isotopes; Macrophage; Medicine; Cancer research; Immunology; Chemistry; Biochemistry; Physics","score_opus":0.01936737015913262,"score_gpt":0.264442304920831,"score_spread":0.24507493476169837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379768349","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.034042165,0.007752396,0.00046158943,0.92449605,0.004321979,0.0043639936,0.0007707177,0.0011037656,0.022687312],"genre_scores_gemma":[0.0011214851,0.0011901543,0.0022119854,0.8396648,0.022708457,0.00054189214,0.00608498,0.0004231535,0.12605308],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99868375,0.000019949824,0.0002631376,0.00037491313,0.00027301212,0.00038520826],"domain_scores_gemma":[0.9993276,0.000050147693,0.00010326904,0.0004070459,0.000054222663,0.00005769831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013404521,0.00024708197,0.0004065228,0.000093550916,0.00004900521,0.000019674699,0.00010072499,0.0006432301,0.00030777074],"category_scores_gemma":[0.000091771086,0.000219746,0.00027900146,0.000081644845,0.000036487672,0.000032962176,0.000031652602,0.0005293164,0.00059701205],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030563606,0.000109794666,0.000031269687,0.0017006639,0.00003929165,0.00019961262,0.000055877943,1.7768728e-7,0.0014591423,0.00002156487,0.9953009,0.0010511592],"study_design_scores_gemma":[0.0048791287,0.00017782192,0.0010503586,0.00009808002,0.00121615,0.00003726426,0.000038394737,0.0000039646143,0.0014810844,0.00024091787,0.990497,0.0002798156],"about_ca_topic_score_codex":0.00007378126,"about_ca_topic_score_gemma":0.000008333291,"teacher_disagreement_score":0.103365764,"about_ca_system_score_codex":0.00002264724,"about_ca_system_score_gemma":0.00006893715,"threshold_uncertainty_score":0.89609814},"labels":[],"label_agreement":null},{"id":"W4380086369","doi":"10.1182/blood.2022019333","title":"Lipid nanoparticles allow efficient and harmless ex vivo gene editing of human hematopoietic cells","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics; European Hematology Association","keywords":"Electroporation; Ex vivo; Genome editing; Biology; Cell biology; Haematopoiesis; Progenitor cell; Gene delivery; Stem cell; Genetic enhancement; Molecular biology; In vivo; Gene; CRISPR; Genetics","score_opus":0.007610037621833489,"score_gpt":0.2594565427466761,"score_spread":0.25184650512484263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380086369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989023,0.00047922027,0.00024564686,0.000022550506,0.0001085024,0.00008075025,0.000011098066,0.000023198483,0.00012672062],"genre_scores_gemma":[0.999284,0.000052509975,0.00027829234,0.000013310585,0.00020646752,0.000007250504,0.000012811693,0.000017946919,0.0001274033],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993383,0.000012584159,0.00016303251,0.00020153173,0.00008990389,0.00019461292],"domain_scores_gemma":[0.9996887,0.0000084088415,0.000036931844,0.00018028848,0.000026116722,0.00005954891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011881717,0.00009638495,0.000115474264,0.00003408404,0.000046543024,0.0000115306175,0.000081333754,0.000056496443,0.000008312857],"category_scores_gemma":[0.000015475343,0.00009807816,0.000042471114,0.00008233205,0.00004069666,7.900738e-7,0.00010637553,0.000032996122,0.0000050406093],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000002227055,0.00006497466,0.0006312056,0.00006541386,0.000025366671,0.0000039617757,0.00013519346,0.0008336704,0.9979397,0.000013655579,0.00019233277,0.00009228122],"study_design_scores_gemma":[0.00052552496,0.00008951074,0.0010946271,0.000019478743,0.000030965875,0.000009262134,0.00012243916,0.00024234715,0.997398,0.0000067389087,0.00035634974,0.0001047321],"about_ca_topic_score_codex":0.0000045192487,"about_ca_topic_score_gemma":0.0000029152243,"teacher_disagreement_score":0.00059132325,"about_ca_system_score_codex":0.0000013299898,"about_ca_system_score_gemma":0.000008353703,"threshold_uncertainty_score":0.39995113},"labels":[],"label_agreement":null},{"id":"W4380740576","doi":"10.1182/blood.2023020035","title":"Higher abatacept exposure after transplant decreases acute GVHD risk without increasing adverse events","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"National Institute of Allergy and Infectious Diseases; National Heart, Lung, and Blood Institute","keywords":"Medicine; Abatacept; Internal medicine; Hazard ratio; Population; Placebo; Adverse effect; Confidence interval; Rituximab","score_opus":0.013968790582837728,"score_gpt":0.27292670122974955,"score_spread":0.2589579106469118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380740576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997526,0.00020822737,0.000041872878,0.00010123295,0.0001699215,0.00035217212,0.00036204944,0.00022184431,0.0010166735],"genre_scores_gemma":[0.9952803,0.00089560804,0.0009879348,0.0001906014,0.00009001151,0.00007346408,0.0004286826,0.000042367454,0.002010994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987063,0.000080067824,0.00025955896,0.00030299352,0.00033631834,0.00031478077],"domain_scores_gemma":[0.9993109,0.00008606264,0.00007217858,0.00026049677,0.00003556833,0.00023481164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010839022,0.00022828754,0.00031223844,0.00013344741,0.00008907326,0.00000799162,0.00006574387,0.00009244956,0.000531177],"category_scores_gemma":[0.000011646324,0.00017116319,0.0001976113,0.00024233849,0.000026571926,0.00012306156,0.000011799334,0.00013415099,0.0004517339],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084117125,0.0004344111,0.9940008,0.00010893481,0.0011500079,0.0022103412,0.0003058996,0.000004049399,0.00041982668,0.000007128377,0.000012614398,0.0005048159],"study_design_scores_gemma":[0.009918165,0.0002355859,0.98328036,0.0003460837,0.0031800147,0.0002958831,0.00003382949,0.000007757925,0.0022583287,0.000028937608,0.00024144667,0.0001735789],"about_ca_topic_score_codex":0.00014453354,"about_ca_topic_score_gemma":0.000021157106,"teacher_disagreement_score":0.010720411,"about_ca_system_score_codex":0.000019022451,"about_ca_system_score_gemma":0.000042205542,"threshold_uncertainty_score":0.69798326},"labels":[],"label_agreement":null},{"id":"W4380854067","doi":"10.1182/blood.2022019386","title":"Five-year follow-up of KEYNOTE-087: pembrolizumab monotherapy for relapsed/refractory classical Hodgkin lymphoma","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"Genentech","keywords":"Medicine; Pembrolizumab; Internal medicine; Discontinuation; Cohort; Adverse effect; Brentuximab vedotin; Surgery; Salvage therapy; Chemotherapy; Lymphoma; Cancer; Immunotherapy; Hodgkin lymphoma","score_opus":0.02062562091102287,"score_gpt":0.2741899358055085,"score_spread":0.2535643148944856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380854067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99559736,0.0005301003,0.000023242246,0.0009918171,0.00031521093,0.0007863718,0.00010273575,0.00017712744,0.0014760557],"genre_scores_gemma":[0.9935442,0.00046148122,0.00058877404,0.00023666643,0.0002756715,0.00031326388,0.00012801097,0.00006897997,0.004382954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984132,0.000040640924,0.00037942958,0.00041117275,0.00034937952,0.0004061436],"domain_scores_gemma":[0.9987543,0.00032137256,0.0001354747,0.00049714587,0.00010973009,0.00018196713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014016304,0.0002468993,0.00055424555,0.00017292373,0.00008125905,0.000016193488,0.00012838139,0.00019975539,0.00009049182],"category_scores_gemma":[0.00012609901,0.00020050834,0.00040132817,0.00028866218,0.00007592389,0.000060143117,0.000040799863,0.000059987076,0.00016375151],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026924472,0.03734601,0.43102404,0.0014170269,0.008360894,0.0014402461,0.0053030686,0.000023141174,0.044093147,0.013306785,0.20589355,0.22486763],"study_design_scores_gemma":[0.2615455,0.0072669024,0.5611618,0.00041304438,0.0016297362,0.000095221,0.0003513229,0.00030377787,0.08577444,0.0010181693,0.07983315,0.0006068858],"about_ca_topic_score_codex":0.00006669227,"about_ca_topic_score_gemma":0.000015101465,"teacher_disagreement_score":0.23462105,"about_ca_system_score_codex":0.00010882902,"about_ca_system_score_gemma":0.0002452284,"threshold_uncertainty_score":0.8176493},"labels":[],"label_agreement":null},{"id":"W4382752021","doi":"10.1182/blood.2022018818","title":"Detailed safety profile of acalabrutinib vs ibrutinib in previously treated chronic lymphocytic leukemia in the ELEVATE-RR trial","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"National Cancer Institute; BeiGene; AstraZeneca","keywords":"Ibrutinib; Medicine; Internal medicine; Hazard ratio; Adverse effect; Discontinuation; Chronic lymphocytic leukemia; Incidence (geometry); Confidence interval; Leukemia","score_opus":0.02521432312752855,"score_gpt":0.30397325027301203,"score_spread":0.2787589271454835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382752021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99120486,0.0005604736,0.0000012804551,0.00016767523,0.00010142995,0.0044014715,0.000025174142,0.00016045244,0.003377158],"genre_scores_gemma":[0.9968241,0.0005440108,0.000044951244,0.00008510926,0.00030396692,0.00055300066,0.00018320135,0.000069807065,0.0013918392],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9953049,0.00051746954,0.0012608441,0.0006624456,0.0010524543,0.0012019259],"domain_scores_gemma":[0.99736637,0.0010297883,0.00022002429,0.0011021273,0.00011097952,0.00017073276],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025335115,0.00036372826,0.0009701434,0.0005566831,0.00007296337,0.000029617504,0.0006171405,0.00035416833,0.0003198858],"category_scores_gemma":[0.0013476704,0.00025876088,0.00023710779,0.0030438602,0.0002541101,0.00009938959,0.00020528733,0.00057646324,0.00039002637],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.6355197,0.013405977,0.10345973,0.020379804,0.0041054897,0.028458185,0.034900222,0.0062883114,0.08223436,0.0029752809,0.022381768,0.045891188],"study_design_scores_gemma":[0.9018461,0.0032582206,0.03057617,0.0011987324,0.00039065944,0.00035238624,0.00048378063,0.033062816,0.026834011,0.000093488234,0.0014248721,0.00047875772],"about_ca_topic_score_codex":0.0019390978,"about_ca_topic_score_gemma":0.0009295388,"teacher_disagreement_score":0.26632643,"about_ca_system_score_codex":0.035809662,"about_ca_system_score_gemma":0.042394165,"threshold_uncertainty_score":0.99998647},"labels":[],"label_agreement":null},{"id":"W4385295225","doi":"10.1182/blood.2023021129","title":"ZDHHC21: a mitochondrial vulnerability in AML","year":2023,"lang":"en","type":"letter","venue":"Blood","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Vulnerability (computing); Biology; Computer science; Computer security","score_opus":0.018147842145462847,"score_gpt":0.25574458819104295,"score_spread":0.23759674604558012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385295225","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32034603,0.002272705,0.0012249658,0.5905762,0.052342314,0.005111345,0.0017050847,0.0006950399,0.025726307],"genre_scores_gemma":[0.003023972,0.00048987207,0.0024546173,0.7979059,0.10007482,0.00095202256,0.0125017725,0.0005038094,0.082093194],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99772483,0.0003189295,0.00039826517,0.0008888346,0.00019489441,0.00047422142],"domain_scores_gemma":[0.99892,0.000051734267,0.000115040275,0.0007975292,0.000058817513,0.000056854104],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00016230119,0.0003324944,0.00038115308,0.00014647935,0.00005010655,0.000028679584,0.00032715884,0.0017523343,0.00017773324],"category_scores_gemma":[0.00038870433,0.00033572214,0.00023307512,0.0001802148,0.00008771489,0.000001690495,0.00016059136,0.00111358,0.0003572797],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055959237,0.00009603942,0.0005280056,0.00005588829,0.000055860997,0.00031075225,0.000018840015,0.0000033253348,0.073195845,0.0000039508773,0.9255553,0.00012026425],"study_design_scores_gemma":[0.0018231987,0.0002634752,0.00019992233,0.000022537271,0.000054878445,0.000061426195,0.0000059828467,0.0000012910464,0.010109433,0.00014013442,0.98693067,0.0003870231],"about_ca_topic_score_codex":0.00007013934,"about_ca_topic_score_gemma":0.00025633816,"teacher_disagreement_score":0.31732208,"about_ca_system_score_codex":0.000014063604,"about_ca_system_score_gemma":0.00014378424,"threshold_uncertainty_score":0.99990946},"labels":[],"label_agreement":null},{"id":"W4385567458","doi":"10.1182/blood.2023020703","title":"Mitigating inequity: ethically prioritizing patients for CAR T-cell therapy","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Accountability; Equity (law); Psychosocial; Transparency (behavior); Population; Health care; Medicine; Economic Justice; Business; Public relations; Computer science; Political science","score_opus":0.03867946994497546,"score_gpt":0.3120654317574304,"score_spread":0.27338596181245495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385567458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921943,0.0001459424,0.00012098328,0.0059394077,0.00017928128,0.00047503272,0.000011608198,0.00012744998,0.00080599065],"genre_scores_gemma":[0.99613214,0.00011240445,0.0018369602,0.0011119,0.00029767232,0.000028459439,0.00013983989,0.00002237322,0.00031825062],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991048,0.000021067257,0.00019264568,0.000170236,0.000306262,0.00020499846],"domain_scores_gemma":[0.99940956,0.00014811648,0.000051878404,0.00012026487,0.00016185376,0.00010833206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003998533,0.0000770878,0.00014429734,0.000059304482,0.00010534202,0.00001352272,0.000047033773,0.00023955441,0.0000063200287],"category_scores_gemma":[0.00016912418,0.000060207964,0.00007603446,0.00022148786,0.000102781625,0.000021650427,0.000028414617,0.0002399829,0.000013064059],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025198868,0.002814386,0.0704267,0.0021001918,0.00035462345,0.00004323372,0.005466963,0.0000034522077,0.65258306,0.0061499234,0.0047880174,0.25501746],"study_design_scores_gemma":[0.08852047,0.006130548,0.5578179,0.0018597782,0.0007088866,0.00002647504,0.00077901135,0.0055812476,0.19890633,0.029218344,0.1091379,0.0013131482],"about_ca_topic_score_codex":0.000008522174,"about_ca_topic_score_gemma":0.0000015881448,"teacher_disagreement_score":0.48739117,"about_ca_system_score_codex":0.000010202605,"about_ca_system_score_gemma":0.00008848108,"threshold_uncertainty_score":0.24552095},"labels":[],"label_agreement":null},{"id":"W4385716765","doi":"10.1182/blood.2023020982","title":"Resolvin D4 disengages emergency granulopoiesis","year":2023,"lang":"en","type":"letter","venue":"Blood","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Granulopoiesis; Medicine; Internal medicine; Haematopoiesis; Biology; Cell biology; Stem cell","score_opus":0.02418331651972663,"score_gpt":0.23776288445416457,"score_spread":0.21357956793443794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385716765","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08327506,0.020699196,0.0001136279,0.85166997,0.021643473,0.0023176968,0.0037180472,0.0030104518,0.013552455],"genre_scores_gemma":[0.01355888,0.008483653,0.00027352344,0.34589598,0.009507679,0.00087791967,0.015390234,0.0010087136,0.6050034],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969208,0.00062597526,0.0005562732,0.0008848656,0.00010356716,0.0009084991],"domain_scores_gemma":[0.99851656,0.00023559628,0.0002402808,0.0008768401,0.00010229904,0.000028424049],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.00025011395,0.00062502624,0.00074303127,0.0003468013,0.0004298088,0.000024743957,0.0007267531,0.0015646621,0.0037271355],"category_scores_gemma":[0.00013430351,0.0005510992,0.00039386787,0.00035482182,0.00015909878,0.00007338997,0.0002917165,0.0027324655,0.0121047925],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012926072,0.00010627589,0.000065612156,0.00011025534,0.0006695346,0.00067889696,0.00011255351,4.999038e-8,0.11866155,0.00010231972,0.87921137,0.0002686576],"study_design_scores_gemma":[0.0010323664,0.00016714114,0.00030502983,0.00008903448,0.0004953047,0.000053426797,0.00005102481,2.6170474e-8,0.13491787,0.0009925724,0.86126727,0.00062894885],"about_ca_topic_score_codex":0.00007850791,"about_ca_topic_score_gemma":0.000026285235,"teacher_disagreement_score":0.591451,"about_ca_system_score_codex":0.000023415249,"about_ca_system_score_gemma":0.00006612702,"threshold_uncertainty_score":0.99973154},"labels":[],"label_agreement":null},{"id":"W4385719099","doi":"10.1182/blood.2022019586","title":"Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; Alberta Children's Hospital; University of Calgary; CancerCare Manitoba; Montreal Clinical Research Institute; Hospital for Sick Children; University of Toronto","funders":"NHLBI Division of Intramural Research; National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; National Institute of Allergy and Infectious Diseases; Office of Naval Research; Health Resources and Services Administration; National Cancer Institute; U.S. Department of Health and Human Services; National Institutes of Health; National Heart, Lung, and Blood Institute; St. Baldrick's Foundation","keywords":"Medicine; Internal medicine; Chronic granulomatous disease; Transplantation; Melphalan; Hematopoietic stem cell transplantation; Retrospective cohort study; Surgery; Immunology","score_opus":0.027993379442436347,"score_gpt":0.27892818912076256,"score_spread":0.2509348096783262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385719099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99752706,0.00021358205,0.00041759212,0.00014354674,0.0005036732,0.0007463539,0.000069432834,0.00029488117,0.00008388064],"genre_scores_gemma":[0.99661314,0.0003244309,0.00031691912,0.00010230437,0.00006418934,0.00019417719,0.0002664017,0.000035483565,0.0020829672],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99876904,0.00012460383,0.00024828085,0.00037175376,0.000040422787,0.00044591038],"domain_scores_gemma":[0.9992795,0.0003122669,0.000112310445,0.00019418642,0.00006542763,0.000036291385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033617756,0.00021974026,0.00029618607,0.00018712564,0.0004723318,0.00006899687,0.00007717351,0.00020420708,0.00009971311],"category_scores_gemma":[0.00022667724,0.00016893468,0.00008704194,0.00022202992,0.000055110446,0.00015422956,0.00008800801,0.00013596605,0.00025315836],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001793579,0.00008744522,0.014575983,0.000076271455,0.00028996833,0.0000067487144,0.00020750864,0.000006450015,0.97708225,0.0012570064,0.0002810508,0.005949928],"study_design_scores_gemma":[0.003977837,0.00056440354,0.12558869,0.00003747291,0.00019787767,0.00002554527,0.0000552556,0.000007719291,0.8615124,0.0004000947,0.0073613217,0.00027138265],"about_ca_topic_score_codex":0.000047278027,"about_ca_topic_score_gemma":0.000095337215,"teacher_disagreement_score":0.115569875,"about_ca_system_score_codex":0.000023119239,"about_ca_system_score_gemma":0.000047517387,"threshold_uncertainty_score":0.68889564},"labels":[],"label_agreement":null},{"id":"W4386884209","doi":"10.1182/blood.2023020276","title":"Integrated epigenetic and transcriptional single-cell analysis of t(11;14) multiple myeloma and its BCL2 dependency","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Epigenetics; Venetoclax; Biology; Chromatin; Transcriptome; Genetics; Computational biology; Cancer research; Molecular biology; Gene; Gene expression; Leukemia","score_opus":0.03871333577447593,"score_gpt":0.2750702087617518,"score_spread":0.23635687298727587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386884209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969965,0.0019676387,0.000037403286,0.00013355864,0.000020086656,0.00031144757,0.0001928493,0.000050736966,0.00028977878],"genre_scores_gemma":[0.9978971,0.00042133316,0.00047017867,0.000014420336,0.000018125109,0.000022982767,0.00034160013,0.000016848126,0.00079740124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879944,0.000053779782,0.00024202511,0.00030251392,0.00033085106,0.00027139258],"domain_scores_gemma":[0.99929035,0.0001403241,0.000046352645,0.00015939151,0.00013221764,0.00023134462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012661745,0.00014661795,0.0003616618,0.000522104,0.0000613608,0.000014980486,0.00005204772,0.00008204515,0.00012668518],"category_scores_gemma":[0.0001567514,0.00011988195,0.00010321617,0.00093777466,0.00006103307,0.000046221692,0.000031250645,0.000094554205,0.000017215782],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016922901,0.0011453269,0.65623087,0.00015670713,0.0013762063,0.00016309426,0.0003853421,0.000007649625,0.33537295,0.000035723213,0.000015377458,0.0049415366],"study_design_scores_gemma":[0.007126272,0.00041980768,0.9195621,0.00004456676,0.001962979,0.000022314625,0.00015435695,0.0057020597,0.064779714,0.000030250314,0.00008526951,0.0001103213],"about_ca_topic_score_codex":0.00015170168,"about_ca_topic_score_gemma":0.0004512479,"teacher_disagreement_score":0.27059326,"about_ca_system_score_codex":0.000014486364,"about_ca_system_score_gemma":0.000055083554,"threshold_uncertainty_score":0.48886442},"labels":[],"label_agreement":null},{"id":"W4386950576","doi":"10.1182/blood.2023019782","title":"Inhibition of PLK4 remodels histone methylation and activates the immune response via the cGAS-STING pathway in TP53-mutated AML","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Cancer Research UK","keywords":"Biology; Cancer research; Myeloid leukemia; Signal transduction; Cell biology","score_opus":0.016561899801830492,"score_gpt":0.25587915366585706,"score_spread":0.23931725386402658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386950576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99564683,0.0028944183,0.00004781043,0.0008189648,0.00012853894,0.00024898487,0.000012860577,0.000057471796,0.00014414167],"genre_scores_gemma":[0.9988643,0.00008923611,0.000011215165,0.000039642455,0.000007854369,0.000023620247,0.000042365635,0.000014500234,0.00090730184],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981319,0.0010860811,0.00035233513,0.00016867346,0.00003756501,0.00022346961],"domain_scores_gemma":[0.99841523,0.0011140403,0.00016074271,0.00024821257,0.000055344717,0.0000064144224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001440317,0.00012430089,0.00020060124,0.00017335976,0.00019721403,0.000010913986,0.00011812019,0.00013920125,0.000039127404],"category_scores_gemma":[0.0005266166,0.000077088596,0.00005478765,0.0003468804,0.00023841354,0.00008659925,0.00010476696,0.00027943726,0.00004671336],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016999345,0.00007960273,0.000084226886,0.00000984661,0.000063902575,0.000004703522,0.0031593682,0.00001493845,0.991983,0.00012760864,0.000030747735,0.0027421317],"study_design_scores_gemma":[0.0014925849,0.00019684123,0.02366841,0.0000734197,0.000025771169,0.00004737539,0.0010812143,0.000067445864,0.9724345,0.00030843655,0.00051496364,0.00008900391],"about_ca_topic_score_codex":0.00018362931,"about_ca_topic_score_gemma":0.000016265903,"teacher_disagreement_score":0.023584183,"about_ca_system_score_codex":0.000022605962,"about_ca_system_score_gemma":0.00004484783,"threshold_uncertainty_score":0.31435817},"labels":[],"label_agreement":null},{"id":"W4387088874","doi":"10.1182/blood.2022015752","title":"Germ line variant GFI1-36N affects DNA repair and sensitizes AML cells to DNA damage and repair therapy","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Montreal Clinical Research Institute","funders":"National Cancer Institute","keywords":"DNA repair; Cancer research; Biology; Olaparib; DNA damage; Temozolomide; Transplantation; Molecular biology; Homologous recombination; Synthetic lethality; Myeloid leukemia; DNA; Poly ADP ribose polymerase; Genetics; Polymerase; Medicine","score_opus":0.018761235001241442,"score_gpt":0.2819424546381048,"score_spread":0.26318121963686336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387088874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926153,0.00044171506,0.0000093494245,0.0038644974,0.00010527585,0.0010198148,0.000029817797,0.0009558533,0.00095837924],"genre_scores_gemma":[0.9859045,0.0017014007,0.0027838042,0.0024915824,0.0006992987,0.00005758222,0.000049573446,0.000110867535,0.00620135],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99794835,0.00012376264,0.00024617088,0.00066853146,0.00042277842,0.0005904273],"domain_scores_gemma":[0.998255,0.00040364603,0.000051356696,0.0007053967,0.000102547536,0.0004820257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090070924,0.00027020866,0.00047604294,0.00030496586,0.00014277287,0.000052930194,0.00009234808,0.00017525489,0.000049562415],"category_scores_gemma":[0.00028207136,0.00022287983,0.000116124414,0.0006329216,0.00012746495,0.000090476584,0.00025814667,0.00034195295,0.00013057681],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005735589,0.00039266903,0.0024738074,0.00041851756,0.00056369207,0.009007052,0.0017580925,0.0000029480702,0.92881775,0.00011341324,0.052968066,0.0029104096],"study_design_scores_gemma":[0.024351317,0.00515541,0.18461019,0.0005627446,0.0005656761,0.0017509384,0.0010567928,0.0047831074,0.72602254,0.00017082272,0.04989002,0.0010804712],"about_ca_topic_score_codex":0.00009680119,"about_ca_topic_score_gemma":0.00002552757,"teacher_disagreement_score":0.20279525,"about_ca_system_score_codex":0.000051367988,"about_ca_system_score_gemma":0.0001784492,"threshold_uncertainty_score":0.90887755},"labels":[],"label_agreement":null},{"id":"W4387608510","doi":"10.1182/blood.2023021348","title":"The influence of immunodeficiency, disease features, and patient characteristics on survival in plasmablastic lymphoma","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of British Columbia","funders":"Blood Cancer UK; Cancer Research UK","keywords":"Plasmablastic lymphoma; Medicine; Internal medicine; Retrospective cohort study; International Prognostic Index; Univariate analysis; Regimen; Lymphoma; Oncology; Multivariate analysis; Cohort; Rituximab","score_opus":0.0058221470480725014,"score_gpt":0.22086652090658784,"score_spread":0.21504437385851535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387608510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99859345,0.0005366094,1.1825885e-7,0.00029944858,0.00007704104,0.00014343248,0.00003926907,0.000021247419,0.00028937802],"genre_scores_gemma":[0.9991524,0.00063895655,0.0000013689344,0.00010416767,0.000007875209,0.000013732024,0.000011693687,0.000008820422,0.00006094941],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993112,0.0000238808,0.00015704476,0.00012322616,0.00020514827,0.00017946813],"domain_scores_gemma":[0.999578,0.00011985197,0.00006599171,0.00014928063,0.000031191314,0.000055667097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008431832,0.00007869969,0.00013779165,0.000052906456,0.00006512993,0.000011416013,0.00005066396,0.000033812958,0.0000014185887],"category_scores_gemma":[0.0003395067,0.00005462042,0.000027894743,0.00023303002,0.000069379945,0.00001810164,0.000032305852,0.00006436113,0.000005877134],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038952765,0.002783004,0.9317503,0.00039403324,0.00022603179,0.000507008,0.0028912956,0.000922839,0.006627935,0.002373055,0.00084679684,0.046782445],"study_design_scores_gemma":[0.0024728905,0.00026599847,0.9963003,0.0001218844,0.000047053298,0.0000019850886,0.00023954794,0.00008265196,0.0001120669,0.00009317187,0.00020278447,0.000059696238],"about_ca_topic_score_codex":0.00007104043,"about_ca_topic_score_gemma":0.000020675408,"teacher_disagreement_score":0.06454999,"about_ca_system_score_codex":0.000023385515,"about_ca_system_score_gemma":0.000099167206,"threshold_uncertainty_score":0.22273561},"labels":[],"label_agreement":null},{"id":"W4387948811","doi":"10.1182/blood.2023021647","title":"T/myeloid MPAL with biallelic <i>CEBPA</i> mutations","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"CEBPA; Myeloid; Mutation; Biology; Genetics; Cancer research; Medicine; Gene","score_opus":0.014119294307215929,"score_gpt":0.25066561307359575,"score_spread":0.23654631876637983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387948811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867998,0.0000874335,0.000009441017,0.0008988846,0.00003121608,0.00018460758,0.000013540931,0.00017899422,0.011796093],"genre_scores_gemma":[0.99669796,0.00006154075,0.00034988037,0.00023787115,0.000047722184,0.000035037523,0.00015571553,0.000017492892,0.0023967666],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99948394,0.0000062773443,0.00007618673,0.00013513054,0.00012795653,0.000170522],"domain_scores_gemma":[0.99972683,0.000021552893,0.00001893059,0.00013204252,0.000025911666,0.000074735355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000026307089,0.0000784091,0.00013597394,0.00007425293,0.00006323738,0.00000898271,0.000028471592,0.000032530865,0.00006117015],"category_scores_gemma":[0.00001327443,0.000056936926,0.00003396156,0.00031573174,0.000027307939,0.000028722441,0.000010811279,0.000054394124,0.0006290798],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009050603,0.013642228,0.82497036,0.00045725712,0.0058594705,0.044557143,0.005217307,0.00015214249,0.028279914,0.0020988863,0.03433142,0.039528795],"study_design_scores_gemma":[0.08911386,0.0047424072,0.7997918,0.0004193987,0.0039206664,0.0044863964,0.0018923221,0.00033367885,0.029120615,0.0025869948,0.062447958,0.0011439081],"about_ca_topic_score_codex":0.00003517209,"about_ca_topic_score_gemma":0.000045829056,"teacher_disagreement_score":0.0882088,"about_ca_system_score_codex":0.0000056548024,"about_ca_system_score_gemma":0.00005277692,"threshold_uncertainty_score":0.8085758},"labels":[],"label_agreement":null},{"id":"W4387954302","doi":"10.1182/blood.2023022136","title":"Anti-PF4 immunothrombosis without proximate heparin or adenovirus vector vaccine exposure","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Agència per a la Competitivitat de l’Empresa; Universität Innsbruck; Deutsches Zentrum für Neurodegenerative Erkrankungen; Generalitat de Catalunya; European Commission; Fondation Leducq; Deutsche Forschungsgemeinschaft; Medizinische Universität Innsbruck; Bundesministerium für Bildung und Forschung; Corona-Stiftung","keywords":"Platelet factor 4; Heparin; Heparin-induced thrombocytopenia; Medicine; Immunology; Antibody; Platelet; Platelet activation; Antithrombin; Internal medicine","score_opus":0.04024423955676743,"score_gpt":0.3065678489330712,"score_spread":0.2663236093763038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387954302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99196655,0.00024088661,0.000009982976,0.0013020848,0.00044991035,0.001154683,0.0000443252,0.0010846504,0.0037469326],"genre_scores_gemma":[0.9950441,0.0004981966,0.0006764511,0.0003368902,0.00042320296,0.00018079682,0.000113873946,0.00016541123,0.0025610602],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99685365,0.00010023039,0.0007154767,0.0008052798,0.00054861716,0.0009767751],"domain_scores_gemma":[0.9980691,0.000107038,0.00018343449,0.0011004012,0.00015943094,0.00038061457],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00042249606,0.00051784917,0.0013165523,0.00036388522,0.0002772059,0.000094566014,0.0003571455,0.0003245702,0.0010865342],"category_scores_gemma":[0.000259207,0.00040272422,0.00025985597,0.0014517723,0.00007146762,0.00023836718,0.0002749019,0.0004911033,0.0024407562],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000345871,0.0016717528,0.36126924,0.0004360927,0.00132252,0.000505148,0.00074437563,0.0000014576373,0.6302604,0.00023370188,0.0014882415,0.0017212123],"study_design_scores_gemma":[0.009357839,0.001097803,0.795716,0.0003040837,0.0010829011,0.0003027831,0.00021123048,0.000052735297,0.18733698,0.0000513441,0.0039220196,0.000564296],"about_ca_topic_score_codex":0.0002564958,"about_ca_topic_score_gemma":0.00009960984,"teacher_disagreement_score":0.44292343,"about_ca_system_score_codex":0.00007813178,"about_ca_system_score_gemma":0.00028257645,"threshold_uncertainty_score":0.99984246},"labels":[],"label_agreement":null},{"id":"W4388571551","doi":"10.1182/blood.2023020860","title":"Trogocytosis drives red blood cell antigen loss in association with antibody-mediated immune suppression","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Canadian Blood Services; St. Michael's Hospital","funders":"Canadian Blood Services","keywords":"Antigen; Antibody; Immune system; Immunology; Biology; Red blood cell","score_opus":0.006242465052661045,"score_gpt":0.2324448309528675,"score_spread":0.22620236590020645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388571551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99671024,0.00033789725,0.0000074366,0.0010062541,0.00010897232,0.0005113194,0.000030272578,0.00024864235,0.0010389581],"genre_scores_gemma":[0.9969401,0.0015299885,0.00023621516,0.000054499877,0.00010919236,0.000027370112,0.0005819797,0.00005100105,0.00046966775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99817705,0.00008246748,0.0003722935,0.00039548133,0.00049816474,0.00047455318],"domain_scores_gemma":[0.99920547,0.000121476296,0.00014315636,0.00031786825,0.000089879184,0.00012212152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033658423,0.00021813455,0.0004520609,0.00028514254,0.00009924476,0.000024091163,0.000106390195,0.0002462143,0.00006890848],"category_scores_gemma":[0.00006714174,0.00017295005,0.000105554056,0.0010249584,0.000030751646,0.00012233133,0.000041796975,0.0003246773,0.00007983586],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012799489,0.0011739234,0.56901723,0.00007752732,0.000118641685,0.0003762402,0.00036675905,0.0000026281753,0.42858034,0.0000032553094,0.00007417837,0.00008128792],"study_design_scores_gemma":[0.012903492,0.00047420315,0.67009753,0.00027933955,0.00038898835,0.000027560316,0.00010830184,0.00006149471,0.31523395,0.000011674558,0.0002469137,0.00016656029],"about_ca_topic_score_codex":0.00014198283,"about_ca_topic_score_gemma":0.00003790259,"teacher_disagreement_score":0.11334638,"about_ca_system_score_codex":0.00002710296,"about_ca_system_score_gemma":0.00007631063,"threshold_uncertainty_score":0.7052698},"labels":[],"label_agreement":null},{"id":"W4388722018","doi":"10.1182/blood.2023022497","title":"Sphingolipids and HSC fitness: enigma no more","year":2023,"lang":"en","type":"letter","venue":"Blood","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Sphingolipid; Biology; Cell biology","score_opus":0.00999488938906991,"score_gpt":0.23121674823205424,"score_spread":0.22122185884298431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388722018","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84571874,0.0147004975,0.00016865983,0.12606822,0.0063087614,0.0010614365,0.00070332637,0.0004152322,0.0048551606],"genre_scores_gemma":[0.023429459,0.005697734,0.0016969315,0.78353053,0.1306692,0.0002748808,0.006551733,0.000816694,0.047332827],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981513,0.000059222057,0.00029046307,0.0007401986,0.00025779658,0.000501024],"domain_scores_gemma":[0.99902946,0.000032940898,0.00012968529,0.0006203952,0.00010015661,0.00008736782],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018577997,0.00040585198,0.00040730173,0.00009948135,0.00011408954,0.00008494198,0.00035186508,0.0010526944,0.0000349115],"category_scores_gemma":[0.00019488316,0.0003918033,0.00017715499,0.00010544505,0.00011420927,0.000003524959,0.00029066595,0.00064568844,0.000097952085],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014086261,0.000038141396,0.00044476794,0.0003776691,0.0002683396,0.00016161439,0.00007441694,0.0000021429835,0.081204005,0.000008323643,0.91719186,0.00021464794],"study_design_scores_gemma":[0.0010336423,0.00007329886,0.0002706354,0.000066092565,0.000220045,0.00006219225,0.000018204943,0.00000677298,0.019163977,0.00003326606,0.9785414,0.0005104925],"about_ca_topic_score_codex":0.000044641594,"about_ca_topic_score_gemma":0.0000042890665,"teacher_disagreement_score":0.8222892,"about_ca_system_score_codex":0.0000037464354,"about_ca_system_score_gemma":0.00008063705,"threshold_uncertainty_score":0.9998534},"labels":[],"label_agreement":null},{"id":"W4388751802","doi":"10.1182/blood.2023022052","title":"Regulation of kynurenine metabolism by blood donor genetics and biology impacts red cell hemolysis in vitro and in vivo","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; University of British Columbia","funders":"National Institute of General Medical Sciences; National Heart, Lung, and Blood Institute; National Institute on Aging; National Institutes of Health","keywords":"Kynurenine; Biology; Indoleamine 2,3-dioxygenase; Population; Immunology; Biochemistry; Medicine; Tryptophan","score_opus":0.013377968238046389,"score_gpt":0.24747309006241444,"score_spread":0.23409512182436806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388751802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99730265,0.0020100423,0.000003546253,0.00026203613,0.00005203169,0.00016202382,0.000029984005,0.000021041555,0.00015662298],"genre_scores_gemma":[0.9973949,0.0017225823,0.0004476035,0.000092863665,0.000053131087,0.000008622971,0.00008681228,0.000011769596,0.00018171572],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99924403,0.000067565605,0.00025161312,0.00021798845,0.000048123842,0.00017065651],"domain_scores_gemma":[0.9996205,0.000065264765,0.000076833756,0.00014232688,0.000027929544,0.00006714027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013202091,0.00010332299,0.00035207882,0.00025796625,0.0000140960865,0.0000026553344,0.000024599938,0.00014357855,0.000031764277],"category_scores_gemma":[0.00005249394,0.00009224142,0.00002702512,0.00037992233,0.0000621401,0.000020844538,0.000033866967,0.00009531469,0.0000015866619],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002321474,0.00021030511,0.026125826,0.00006507056,0.00002950885,0.0000064369974,0.00015722771,0.0000025391275,0.97268426,0.000006087731,0.00013701222,0.0003435957],"study_design_scores_gemma":[0.006729087,0.00021758728,0.2776297,0.000018099563,0.00017431543,0.000023576453,0.000044910594,0.00018688593,0.7143232,0.00016492239,0.00040732647,0.00008034207],"about_ca_topic_score_codex":0.000060949864,"about_ca_topic_score_gemma":0.000031022955,"teacher_disagreement_score":0.25836098,"about_ca_system_score_codex":0.0000041083063,"about_ca_system_score_gemma":0.000022222684,"threshold_uncertainty_score":0.37614956},"labels":[],"label_agreement":null},{"id":"W4388901146","doi":"10.1182/blood.2023022281","title":"Survival in primary hemophagocytic lymphohistiocytosis, 2016 to 2021: etoposide is better than its reputation","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre","funders":"","keywords":"Hemophagocytic lymphohistiocytosis; Medicine; Etoposide; Internal medicine; Hematopoietic stem cell transplantation; Asymptomatic; Alemtuzumab; Gastroenterology; Transplantation; Chemotherapy; Disease","score_opus":0.019867359754314074,"score_gpt":0.2884018858684621,"score_spread":0.268534526114148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388901146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870605,0.00064550503,0.000015587259,0.00404912,0.000111503614,0.0005046539,0.000011520298,0.00008545228,0.007516157],"genre_scores_gemma":[0.98361397,0.0004214397,0.000133882,0.001851887,0.00017529826,0.00011691794,0.00012158629,0.000049146965,0.013515886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983467,0.00006916264,0.00036820755,0.00034085638,0.00046442944,0.00041067365],"domain_scores_gemma":[0.9993212,0.00007369115,0.000047452322,0.00034579606,0.00008883415,0.00012298043],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043748386,0.00014555626,0.000324898,0.00036750644,0.00006651125,0.000025979576,0.00012393817,0.000105283405,0.00031426802],"category_scores_gemma":[0.00018241488,0.00013724151,0.00008237974,0.00077166257,0.00002786592,0.00012464132,0.000109920424,0.00016213174,0.0026145414],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010423673,0.0018652317,0.5477794,0.0014299317,0.0005210658,0.0025173137,0.0056779943,0.00008052202,0.30467546,0.00017331926,0.0686994,0.06553802],"study_design_scores_gemma":[0.0062457602,0.00029331178,0.92986804,0.00030515803,0.00007445618,0.00003064611,0.0002771296,0.0002462776,0.051729932,0.000087417626,0.010558525,0.00028332244],"about_ca_topic_score_codex":0.00008323692,"about_ca_topic_score_gemma":0.000011898741,"teacher_disagreement_score":0.3820887,"about_ca_system_score_codex":0.00012722117,"about_ca_system_score_gemma":0.0003985505,"threshold_uncertainty_score":0.99816203},"labels":[],"label_agreement":null},{"id":"W4389218798","doi":"10.1182/blood-2023-181406","title":"Lipid Nanoparticle Library Towards Development of Next Generation Genomic Medicines","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Nucleic acid; Genetic enhancement; Transfection; In vivo; Cancer; Computational biology; Chemistry; Biology; Biochemistry; Gene; Biotechnology; Genetics","score_opus":0.03288884195111931,"score_gpt":0.24427855471282514,"score_spread":0.21138971276170582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389218798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988902,0.00034815504,0.00003785121,0.00012711552,0.00013081457,0.00006053283,0.0000043936398,0.000020057842,0.00038088608],"genre_scores_gemma":[0.9977874,0.00022577163,0.00072710856,0.00014862494,0.00034648206,0.000013480647,0.00016170034,0.0000113855995,0.0005780142],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99946535,0.000015516069,0.00017361189,0.00015291554,0.00007078927,0.00012183843],"domain_scores_gemma":[0.9997508,0.000002329246,0.000038851915,0.00014637124,0.000024695732,0.000036964335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006702973,0.00006955028,0.00007777667,0.00003645736,0.000035845573,0.000011301683,0.000109641696,0.000053079246,0.00003951048],"category_scores_gemma":[0.000014103526,0.00006209489,0.000031905838,0.000087631335,0.00002180985,0.000005766448,0.000091882735,0.00002077728,0.000055559816],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009937684,0.000048791324,0.0017812743,0.000010428281,0.000038062008,0.0000016732994,0.00014468726,0.000010458679,0.98884535,0.000004864778,0.0036477947,0.0054567037],"study_design_scores_gemma":[0.00032748593,0.000121891986,0.010304863,0.00000821397,0.000012931063,0.0000029233756,0.000071341754,0.00007583685,0.98195183,0.0000068419804,0.007040567,0.00007525781],"about_ca_topic_score_codex":0.0000023261246,"about_ca_topic_score_gemma":0.0000062493036,"teacher_disagreement_score":0.008523589,"about_ca_system_score_codex":0.0000015548469,"about_ca_system_score_gemma":0.00010986141,"threshold_uncertainty_score":0.2532156},"labels":[],"label_agreement":null},{"id":"W4389218814","doi":"10.1182/blood-2023-181014","title":"Updated Results on a Multicenter Phase II Study of a Dose Intensified Pediatric Regimen in Adults with Acute Lymphoblastic Leukemia: The 06-254 DFCI ALL Consortium Trial","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Centres Intégré Universitaires de Santé et de Services Sociaux; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Vincristine; Regimen; Etoposide; Asparaginase; Cytarabine; Dexamethasone; Internal medicine; Acute lymphocytic leukemia; Chemotherapy; Pediatrics; Surgery; Gastroenterology; Leukemia; Cyclophosphamide; Lymphoblastic Leukemia","score_opus":0.024669212673318078,"score_gpt":0.30707218710151996,"score_spread":0.2824029744282019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389218814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933863,0.000022285627,0.0000031839797,0.00072143925,0.0001584832,0.00499054,0.00012284538,0.00017656901,0.00041832848],"genre_scores_gemma":[0.9976071,0.00007873902,0.000056082958,0.00028839285,0.00032290426,0.00036708533,0.00025267762,0.000083182946,0.00094379525],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9955371,0.00034087384,0.0011208312,0.0008825102,0.0012672861,0.00085139804],"domain_scores_gemma":[0.9967145,0.001011118,0.00039985866,0.0011860188,0.0004044366,0.0002840695],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009278132,0.00043620614,0.00083936553,0.0007472863,0.00012829207,0.000028810304,0.00046791218,0.00021818126,0.000020751697],"category_scores_gemma":[0.0014514013,0.00026733015,0.000120269884,0.0019890468,0.00020043226,0.00009083108,0.0003622445,0.00064230873,0.00012921439],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93402016,0.023400664,0.0015431143,0.00018173405,0.0019109192,0.00847197,0.013749055,0.00012637227,0.0016404272,0.000012689103,0.014522107,0.00042076805],"study_design_scores_gemma":[0.9278769,0.052583266,0.0055518714,0.00036113407,0.0022009676,0.00017965613,0.004435605,0.005070736,0.0011918189,0.000005258623,0.00018477817,0.0003579911],"about_ca_topic_score_codex":0.00052694045,"about_ca_topic_score_gemma":0.00017993936,"teacher_disagreement_score":0.029182602,"about_ca_system_score_codex":0.00052590156,"about_ca_system_score_gemma":0.0014428131,"threshold_uncertainty_score":0.9999779},"labels":[],"label_agreement":null},{"id":"W4389218816","doi":"10.1182/blood-2023-178053","title":"Case Series of Paraspinal Extramedullary Hematopoiesis in Transfusion-Dependent Thalassemia Treated with Luspatercept","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Extramedullary hematopoiesis; Ineffective erythropoiesis; Thalassemia; Blood transfusion; Surgery; Beta thalassemia; Pediatrics; Anemia; Erythropoiesis; Internal medicine; Haematopoiesis","score_opus":0.011171163347663254,"score_gpt":0.2346238639436349,"score_spread":0.22345270059597167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389218816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99758637,0.00028618675,0.000007155688,0.00036853674,0.000028330858,0.00036246923,0.000014131323,0.0001137555,0.0012330347],"genre_scores_gemma":[0.9985636,0.0007110109,0.00011649208,0.000027674176,0.000014746796,0.000031828862,0.000027334214,0.000028749122,0.00047856625],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99892473,0.000036983354,0.00029595854,0.00023390588,0.00022775734,0.00028066742],"domain_scores_gemma":[0.99954647,0.000029063774,0.000048563074,0.00022651581,0.000044223663,0.00010519346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011865008,0.00016597692,0.00035260565,0.0002012648,0.00004892362,0.0000071231475,0.00004979825,0.00016500663,0.00012233469],"category_scores_gemma":[0.000017891782,0.00011845281,0.000070177084,0.0006152716,0.00009287825,0.00005893647,0.000017577298,0.00019506742,0.000020881293],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015860808,0.0026372462,0.7907913,0.0013421247,0.00054517883,0.14385602,0.006227123,0.00016380618,0.049626414,0.00009195623,0.00025064437,0.0028821179],"study_design_scores_gemma":[0.050082833,0.007959418,0.30373904,0.0040934077,0.0028009648,0.2414323,0.050917633,0.0005043024,0.33638853,0.00023909485,0.0003136692,0.0015288345],"about_ca_topic_score_codex":0.00039103322,"about_ca_topic_score_gemma":0.00028323338,"teacher_disagreement_score":0.48705226,"about_ca_system_score_codex":0.000015655589,"about_ca_system_score_gemma":0.00008203115,"threshold_uncertainty_score":0.48303655},"labels":[],"label_agreement":null},{"id":"W4389218826","doi":"10.1182/blood-2023-173873","title":"Improved Overall Survival with Axicabtagene Ciloleucel Vs Standard of Care in Second-Line Large B-Cell Lymphoma Among the Elderly: A Subgroup Analysis of ZUMA-7","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Subgroup analysis; Oncology; Chemoimmunotherapy; Aggressive lymphoma; Intention-to-treat analysis; Lymphoma; Randomized controlled trial; Surgery; Confidence interval; Rituximab","score_opus":0.01250162557583315,"score_gpt":0.2699300756294732,"score_spread":0.25742845005364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389218826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963602,0.0005384959,0.000022784456,0.00009857649,0.00003381468,0.0006344168,0.0003950752,0.000043627213,0.0018729973],"genre_scores_gemma":[0.99673814,0.00016489923,0.000055184482,0.000029639354,0.00005189213,0.000040767445,0.00020567323,0.00004886436,0.0026649383],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976898,0.00015919423,0.00049555756,0.0003827929,0.00077433133,0.000498311],"domain_scores_gemma":[0.99835426,0.00021755903,0.00017912898,0.0008064171,0.00031916462,0.0001234807],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00085357577,0.00021887315,0.0009363102,0.0006004487,0.000049489252,0.0000169756,0.00026219146,0.00012707312,0.0009611241],"category_scores_gemma":[0.000053387954,0.00015094398,0.00030637273,0.0023167096,0.0001462625,0.000049911603,0.00012123621,0.00021977142,0.0000030071576],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013807829,0.003681588,0.47953957,0.0014531012,0.0059918035,0.00046017414,0.007288915,0.00012540176,0.48126072,0.00008986832,0.00012675552,0.006174265],"study_design_scores_gemma":[0.06629869,0.011726376,0.49943408,0.00021872645,0.003531064,0.000010154666,0.0049302126,0.0028120629,0.40933654,0.000024324794,0.0012107677,0.00046701528],"about_ca_topic_score_codex":0.0006467333,"about_ca_topic_score_gemma":0.011392028,"teacher_disagreement_score":0.071924195,"about_ca_system_score_codex":0.000086226355,"about_ca_system_score_gemma":0.00030761262,"threshold_uncertainty_score":0.99995214},"labels":[],"label_agreement":null},{"id":"W4389218846","doi":"10.1182/blood-2023-187455","title":"The Challenge of Treating Relapsed Myeloid Leukemia in Children with Down Syndrome - a Targeted Analysis Using Patient-Derived Xenograft Models","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Decitabine; Cytarabine; Context (archaeology); Myeloid leukemia; Venetoclax; Oncology; Down syndrome; Internal medicine; Transplantation; Leukemia; Hematopoietic stem cell transplantation; Myelopoiesis; Myeloid; GATA1; Immunology; Stem cell; Haematopoiesis; Erythropoiesis; Biology; Anemia; DNA methylation","score_opus":0.01876873671367195,"score_gpt":0.2578453370201008,"score_spread":0.23907660030642885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389218846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99786854,0.0005058983,0.000069200716,0.00018181132,0.000009995476,0.00083461596,0.000030482413,0.00011589256,0.00038359046],"genre_scores_gemma":[0.99816597,0.00029552073,0.0011763325,0.0000193681,0.000025114456,0.000069650414,0.000127365,0.000057166577,0.00006348867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974651,0.00016496138,0.00055401906,0.00046944033,0.00068936445,0.0006571279],"domain_scores_gemma":[0.9985749,0.00018475024,0.00021954041,0.00071510224,0.0001501725,0.00015555025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048769984,0.00025589025,0.00067000766,0.00082606054,0.00019251657,0.000026922875,0.000245066,0.00014985316,0.000023127272],"category_scores_gemma":[0.00013463106,0.00016911187,0.0001964125,0.0037913853,0.0001724561,0.00013135897,0.00015558857,0.0004720696,0.000008710111],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022353975,0.0017856807,0.69188833,0.00043060264,0.030436883,0.00228637,0.020612484,0.097407706,0.1405362,0.00025646517,0.0001185402,0.012005339],"study_design_scores_gemma":[0.031370755,0.003588823,0.542562,0.00074509974,0.0075869393,0.0007006777,0.004521631,0.38120934,0.026180504,0.00044231053,0.000018744086,0.0010731276],"about_ca_topic_score_codex":0.0013180486,"about_ca_topic_score_gemma":0.00019145312,"teacher_disagreement_score":0.28380165,"about_ca_system_score_codex":0.00038567584,"about_ca_system_score_gemma":0.00057284517,"threshold_uncertainty_score":0.6896182},"labels":[],"label_agreement":null},{"id":"W4389218862","doi":"10.1182/blood-2023-182919","title":"EBV Prevalence and Overall Survival in the <i>M</i>ulti <i>e</i>thnic <i>S</i>tudy of <i>H</i>odgkin Lymphoma (MESH)","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC","funders":"Daiichi Sankyo Europe; National Cancer Institute; Pharmacyclics; Genentech; Incyte; BeiGene; Gilead Sciences; Atara Biotherapeutics; Seagen; MorphoSys; Cancer Prevention and Research Institute of Texas; Celgene; AstraZeneca; Bristol-Myers Squibb; TG Therapeutics; Amgen","keywords":"Lymphoma; Population; Medicine; Cancer; Tissue microarray; Oncology; Internal medicine; Pathology","score_opus":0.015201806781029382,"score_gpt":0.25661854327274997,"score_spread":0.24141673649172057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389218862","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990656,0.0023898634,0.0000019975853,0.00078975153,0.00011825082,0.00047088874,0.000035945286,0.000072588984,0.0054647136],"genre_scores_gemma":[0.9952343,0.0031433296,0.000024592973,0.0009818972,0.00006649139,0.000045577868,0.000019645959,0.000024891351,0.00045923502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843013,0.0001164095,0.0003239432,0.00031636533,0.0004448277,0.00036835103],"domain_scores_gemma":[0.9992535,0.00016111198,0.00011010006,0.0003581877,0.000045397162,0.000071713526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006180326,0.00017683362,0.0003560099,0.00009693737,0.000058281734,0.000018046007,0.00018594395,0.00010332789,0.000023902754],"category_scores_gemma":[0.00012849121,0.00013212567,0.00009898636,0.0006213678,0.000101005164,0.00007681343,0.000068292364,0.00013953338,0.000017305929],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003610914,0.0020123092,0.9680435,0.00085031474,0.00022039886,0.00020550248,0.0043911887,0.000012260349,0.009491646,0.00055386714,0.00923674,0.004621196],"study_design_scores_gemma":[0.021097295,0.00070399034,0.9689676,0.00032099057,0.00041959656,0.000045207013,0.0013376226,0.00007411165,0.0023972762,0.00071687216,0.0036190879,0.0003003084],"about_ca_topic_score_codex":0.00038604866,"about_ca_topic_score_gemma":0.00014235562,"teacher_disagreement_score":0.020736203,"about_ca_system_score_codex":0.000024645253,"about_ca_system_score_gemma":0.00010344159,"threshold_uncertainty_score":0.53879285},"labels":[],"label_agreement":null},{"id":"W4389218898","doi":"10.1182/blood-2023-174327","title":"Trial in Progress: Investigating the Prognostic Significance of Malnutrition and Sarcopenia in Older Adults with Acute Myeloid Leukemia","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sarcopenia; Medicine; Malnutrition; Polypharmacy; Geriatric oncology; Myeloid leukemia; Observational study; Internal medicine; Intensive care medicine; Cancer; Physical therapy; Pediatrics","score_opus":0.024367470719266576,"score_gpt":0.2988875986350392,"score_spread":0.2745201279157726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389218898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994116,0.00047537434,0.0000013976669,0.0028666947,0.00002644949,0.0023961745,0.0000059921194,0.00004020784,0.0000716947],"genre_scores_gemma":[0.9972464,0.00017697434,0.0017832369,0.00019346125,0.000081684615,0.00046017955,0.000022570099,0.000013728883,0.00002180089],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99903286,0.00007169961,0.00031042565,0.00019112397,0.00018550552,0.00020840684],"domain_scores_gemma":[0.9995496,0.00013435278,0.00009572781,0.0001126112,0.00004316362,0.00006451818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003768417,0.00008565612,0.00022519127,0.00014978525,0.000039297745,0.000011291346,0.00004789744,0.00005198516,0.0000053030526],"category_scores_gemma":[0.00010546382,0.000059876107,0.000014539504,0.00063131074,0.00013112249,0.000052580635,0.000021215768,0.00022115566,0.0000025605643],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012491865,0.0010762382,0.96577626,0.0038769608,0.000056771532,0.00042687636,0.0056762663,0.0000031947218,0.004487784,0.00018259828,0.000358838,0.005586355],"study_design_scores_gemma":[0.16150872,0.0011131568,0.82166654,0.007882184,0.0001049857,0.0000832565,0.0013378893,0.0004122513,0.0053499443,0.00033524312,0.00006232516,0.00014349009],"about_ca_topic_score_codex":0.00005878416,"about_ca_topic_score_gemma":0.00009075953,"teacher_disagreement_score":0.14901687,"about_ca_system_score_codex":0.000029143348,"about_ca_system_score_gemma":0.00018449278,"threshold_uncertainty_score":0.24416769},"labels":[],"label_agreement":null},{"id":"W4389218920","doi":"10.1182/blood-2023-181296","title":"Indolent Lymphoma Care Delivery and Outcomes during the COVID-19 Pandemic in Ontario, Canada","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Rituximab; Pandemic; Regimen; Cohort; Internal medicine; Pediatrics; Prednisone; Lymphoma; Disease; Coronavirus disease 2019 (COVID-19); Infectious disease (medical specialty)","score_opus":0.04737886847943318,"score_gpt":0.3192876827995117,"score_spread":0.2719088143200785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389218920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99350965,0.0006465049,1.5618932e-7,0.0052423156,0.000103621554,0.00032643523,0.000015856498,0.00006104618,0.00009443491],"genre_scores_gemma":[0.9906524,0.00014623835,0.0000034017576,0.008653622,0.000040203533,0.000020532327,0.000014804892,0.000012325816,0.0004564742],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990151,0.000037167036,0.00018851226,0.00019438432,0.00024593747,0.00031891646],"domain_scores_gemma":[0.99916893,0.00024396436,0.00003596146,0.00022011815,0.00002847512,0.00030256776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014693702,0.00011587688,0.0002221,0.000104462546,0.00013086705,0.000011960113,0.0000679683,0.00006290333,0.000033452452],"category_scores_gemma":[0.0002725597,0.000081271,0.000031608688,0.00014587825,0.00002594189,0.000025698586,0.000074172385,0.00016582225,0.00000398386],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043248998,0.000024666793,0.99271756,0.00028083986,0.000028365763,0.0004996252,0.005253425,0.0000069717203,0.000071794995,0.0000029771038,0.00028451686,0.0007860181],"study_design_scores_gemma":[0.0044303136,0.0000438993,0.98385,0.000053744927,0.000043436627,0.00011322146,0.001813364,0.0000023058872,0.000054065815,0.000008019583,0.009502583,0.00008502414],"about_ca_topic_score_codex":0.99159926,"about_ca_topic_score_gemma":0.9994412,"teacher_disagreement_score":0.009218066,"about_ca_system_score_codex":0.0013940684,"about_ca_system_score_gemma":0.005861515,"threshold_uncertainty_score":0.99977434},"labels":[],"label_agreement":null},{"id":"W4389219072","doi":"10.1182/blood-2023-174301","title":"A Feasibility Study Evaluating Von Willebrand Factor in Patients with Gastrointestinal Angiodysplasia","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University of British Columbia","funders":"","keywords":"Angiodysplasia; Medicine; Von Willebrand factor; Capsule endoscopy; Gastroenterology; Internal medicine; Von Willebrand disease; Gastrointestinal bleeding; Platelet","score_opus":0.029900369300842663,"score_gpt":0.3022202396926872,"score_spread":0.2723198703918445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389219072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984436,0.000010020422,0.000001100388,0.000025992105,0.000015175492,0.0012353486,0.000019293113,0.000072506846,0.00017697497],"genre_scores_gemma":[0.99952704,4.2420152e-7,0.00027818672,0.000012582671,0.000010263385,0.00003425489,0.000059444385,0.00001657937,0.00006121331],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989083,0.000044086428,0.00017290196,0.0002862597,0.00033279834,0.00025566484],"domain_scores_gemma":[0.9995729,0.00004205369,0.00004738016,0.00019746106,0.000060474104,0.00007973907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012482541,0.00013716615,0.00025617765,0.00010726007,0.00004604634,0.000012001108,0.00003977068,0.00001989068,0.000038267794],"category_scores_gemma":[0.00012531852,0.00009830926,0.000033649692,0.00035121862,0.000018171144,0.000053454332,0.000026153923,0.000100391386,0.000041609983],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047106572,0.0055535375,0.992458,0.000019984855,0.00006962829,0.00044458275,0.00032577242,0.0000028084505,0.00006875731,2.3118906e-7,0.000010351979,0.00057528645],"study_design_scores_gemma":[0.02841163,0.0049071605,0.96601945,0.00010983168,0.00012922159,0.000028587043,0.0002286324,0.000048288435,0.000027445922,0.0000107556225,6.2147507e-7,0.00007834408],"about_ca_topic_score_codex":0.000041509487,"about_ca_topic_score_gemma":0.000091452835,"teacher_disagreement_score":0.027940566,"about_ca_system_score_codex":0.00003200637,"about_ca_system_score_gemma":0.000053786214,"threshold_uncertainty_score":0.40089354},"labels":[],"label_agreement":null},{"id":"W4389219486","doi":"10.1182/blood-2023-184995","title":"Allogeneic Hematopoietic Cell Transplantation in the Elderly Results in Similar Survival with Matched Related or Unrelated and Haploidentical Donors: A Report from the Société Francophone De Greffe De Moelle Et De Thérapie Cellulaire (SFGM-TC)","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"Medac; Swedish Orphan Biovitrum; Incyte; Philippe Foundation; Jazz Pharmaceuticals; Astellas Pharma; Alexion Pharmaceuticals; Celgene; Mallinckrodt Pharmaceuticals; Kite Pharma; Gilead Sciences; Servier; Amgen","keywords":"Medicine; Univariate analysis; Internal medicine; Hematopoietic cell; Cumulative incidence; Transplantation; Graft-versus-host disease; Cyclophosphamide; Incidence (geometry); Gastroenterology; Hematopoietic stem cell transplantation; Multivariate analysis; Surgery; Oncology; Immunology; Haematopoiesis; Chemotherapy; Stem cell; Biology","score_opus":0.015385999403385399,"score_gpt":0.26881317667175636,"score_spread":0.25342717726837094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389219486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941373,0.00030317844,0.00052499154,0.0031966001,0.0000702964,0.0009866753,0.000043936147,0.00013132594,0.00060570677],"genre_scores_gemma":[0.9969729,0.0011177002,0.0008852933,0.0002560908,0.00004354217,0.00010639782,0.00038888035,0.00006219822,0.00016698314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99706817,0.0006077978,0.00079508906,0.0004971809,0.00048953574,0.00054220716],"domain_scores_gemma":[0.997475,0.001733369,0.00017024291,0.00044681897,0.00004385131,0.00013066288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024553235,0.0002896842,0.00046122517,0.000135068,0.00010844009,0.000049658287,0.0001946019,0.0003489844,0.00003299204],"category_scores_gemma":[0.00013834426,0.00018049568,0.00008055383,0.0009708158,0.00012518872,0.00007827649,0.000016310441,0.00063782703,0.000019863106],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056026983,0.0022577837,0.6035719,0.0016942372,0.00062140456,0.055144213,0.21482949,0.0011406691,0.11434692,0.00009846265,0.00034273785,0.0003494803],"study_design_scores_gemma":[0.03363918,0.00070663635,0.8958687,0.0017880485,0.0012349214,0.0057341643,0.017669426,0.0013978295,0.039964873,0.0014485742,0.000037097467,0.00051054725],"about_ca_topic_score_codex":0.0015796011,"about_ca_topic_score_gemma":0.0024415068,"teacher_disagreement_score":0.2922968,"about_ca_system_score_codex":0.00006963555,"about_ca_system_score_gemma":0.00048498093,"threshold_uncertainty_score":0.73604},"labels":[],"label_agreement":null},{"id":"W4389219575","doi":"10.1182/blood-2023-182949","title":"<i>UBA1</i> Mutations Identify a Rare but Distinct Subtype of Myelodysplastic Syndromes","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Otitis Media and Relapsing Polychondritis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Cohort; Internal medicine; Myelodysplastic syndromes; Oncology; Population; Genetics; Biology; Bone marrow","score_opus":0.018096051080692087,"score_gpt":0.27781299059782877,"score_spread":0.2597169395171367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389219575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934365,0.00045412118,0.000037047877,0.00042318826,0.0032256853,0.00019233629,0.000077968456,0.00019760005,0.0019555492],"genre_scores_gemma":[0.97814864,0.000112698806,0.00019382504,0.000033325367,0.00014046894,0.000019782174,0.00018164337,0.000030960913,0.021138674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899024,0.000025583327,0.00026577682,0.00019603327,0.00028233347,0.00024004848],"domain_scores_gemma":[0.99930096,0.00018044138,0.00007900644,0.00022987228,0.00007602806,0.00013370623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000706263,0.000114046685,0.00027779638,0.00019036497,0.000070955604,0.00001294499,0.000077872886,0.00009143613,0.00016988024],"category_scores_gemma":[0.00042277703,0.00010142015,0.00010717186,0.00053891074,0.00012895878,0.00004397949,0.00003545679,0.00014547152,0.0005000074],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015811055,0.0027955745,0.7401788,0.0029968675,0.0014147694,0.009958094,0.003453474,0.000016751752,0.15406016,0.0010899887,0.07982492,0.004052453],"study_design_scores_gemma":[0.010556528,0.00094793906,0.9318164,0.0016751196,0.0022719689,0.003369375,0.0009380883,0.00010414851,0.03862218,0.0009934291,0.008199075,0.0005057737],"about_ca_topic_score_codex":0.000031620253,"about_ca_topic_score_gemma":0.000026961648,"teacher_disagreement_score":0.19163753,"about_ca_system_score_codex":0.000009412161,"about_ca_system_score_gemma":0.00010873776,"threshold_uncertainty_score":0.64267504},"labels":[],"label_agreement":null},{"id":"W4389219614","doi":"10.1182/blood-2023-174682","title":"Marstacimab, an Anti-Tissue Factor Pathway Inhibitor, in Participants with Hemophilia Α or B, with and without Inhibitors: An Integrated Analysis of Safety","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Medicine; Factor IX; Tissue factor pathway inhibitor; Hemostasis; Internal medicine; Phases of clinical research; Tissue factor; Gastroenterology; Pharmacology; Coagulation; Toxicity","score_opus":0.04403073692274602,"score_gpt":0.32759789869535105,"score_spread":0.28356716177260505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389219614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99871117,0.0000612664,0.0000072090725,0.00018058298,0.000017635835,0.0006932695,0.00013556783,0.00011390275,0.00007939219],"genre_scores_gemma":[0.9983962,0.000091421985,0.00048728636,0.000018610106,0.00005737782,0.000040521114,0.00032284786,0.00004841442,0.00053729815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976702,0.00015034544,0.00044428353,0.00057806366,0.00057301304,0.0005840947],"domain_scores_gemma":[0.99871755,0.00006999715,0.00010230904,0.0005100208,0.00017911736,0.00042100265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035397813,0.00030346354,0.0008992403,0.00091940135,0.00007591354,0.000036349706,0.00010073234,0.00014955629,0.000104262],"category_scores_gemma":[0.00007515322,0.00016860031,0.000049200895,0.0033533997,0.00023960846,0.00025106143,0.000049370807,0.00025170404,0.0000071229247],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021799009,0.0019276154,0.96054316,0.00013087594,0.0011747129,0.000740509,0.0019070101,0.000026557072,0.027375571,0.0000065891954,0.0000056676995,0.00398183],"study_design_scores_gemma":[0.011862074,0.006590366,0.8533133,0.00046249403,0.0014273357,0.00004752532,0.0020023033,0.001142382,0.122603856,0.0000047482827,0.00019369002,0.0003498926],"about_ca_topic_score_codex":0.0004024901,"about_ca_topic_score_gemma":0.003006508,"teacher_disagreement_score":0.10722983,"about_ca_system_score_codex":0.00004509794,"about_ca_system_score_gemma":0.00039789462,"threshold_uncertainty_score":0.6875321},"labels":[],"label_agreement":null},{"id":"W4389219628","doi":"10.1182/blood-2023-185220","title":"Post Allogeneic Stem Cell Transplant Outcomes Following Response to Hypomethylating Agent Therapy in Myelodysplastic Syndromes Are Predicted By Persistent International Prognostic Scoring System-Molecular Risk","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Genentech; Sierra Oncology; Daiichi Sankyo Europe; Gilead Sciences; Servier; Juno Therapeutics; Astellas Pharma; Syndax Pharmaceuticals; Incyte; CTI Biopharma; bluebird bio; CareDx; Agios Pharmaceuticals; Sarepta Therapeutics; Vertex Pharmaceuticals; Swedish Orphan Biovitrum; Omeros Corporation; Celgene; BioCryst; Astex Pharmaceuticals; Alexion Pharmaceuticals; Jazz Pharmaceuticals; Regeneron Pharmaceuticals; AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Amgen","keywords":"Decitabine; Medicine; International Prognostic Scoring System; Internal medicine; Hypomethylating agent; Myelodysplastic syndromes; Azacitidine; Oncology; Bone marrow","score_opus":0.018569506488095272,"score_gpt":0.26526402742254757,"score_spread":0.2466945209344523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389219628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99577665,0.0005534951,0.00011546372,0.0008140563,0.00032929034,0.0016450214,0.0003726159,0.00031801302,0.00007537612],"genre_scores_gemma":[0.9984235,0.00009041706,0.00027222073,0.00010142542,0.000036918515,0.00030964706,0.00014309627,0.00009554553,0.00052723987],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963632,0.00047060163,0.00062736747,0.00068353163,0.0011117257,0.0007435561],"domain_scores_gemma":[0.998015,0.0009318924,0.00015105354,0.00041283504,0.00013570461,0.00035354972],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013150696,0.00035591147,0.0005964848,0.00093788805,0.00013679385,0.000073595256,0.0003857794,0.00015283636,0.0000127334015],"category_scores_gemma":[0.00058049394,0.0003098584,0.00034909826,0.00096417725,0.00003038501,0.00008160388,0.00013222385,0.00047601,0.00008529666],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008980256,0.0003802066,0.6800588,0.0002705698,0.0010247363,0.0054556895,0.0019353124,0.0006126346,0.3087941,0.0000012477038,0.000035873047,0.0005328006],"study_design_scores_gemma":[0.016530767,0.0021532956,0.9369318,0.0025023445,0.0007484543,0.00029689632,0.0067674867,0.0028989424,0.030411681,0.0000011584999,0.00011365996,0.0006435231],"about_ca_topic_score_codex":0.000087711356,"about_ca_topic_score_gemma":0.000008129213,"teacher_disagreement_score":0.27838245,"about_ca_system_score_codex":0.0005500706,"about_ca_system_score_gemma":0.0002596348,"threshold_uncertainty_score":0.9999353},"labels":[],"label_agreement":null},{"id":"W4389219661","doi":"10.1182/blood-2023-179252","title":"Phase 1/2 First-in-Human Study of the Menin-MLL Inhibitor DSP-5336 in Patients with Relapsed or Refractory Acute Leukemia","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Concomitant; Internal medicine; Refractory (planetary science); Medicine; Leukemia; Cytarabine; Oncology; NPM1; Acute leukemia; Gastroenterology; Cancer research; Biology; Gene; Genetics","score_opus":0.008627195344441329,"score_gpt":0.25212268537557325,"score_spread":0.2434954900311319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389219661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990356,0.000018970783,7.317082e-7,0.000030262801,0.00008595037,0.000658948,0.000033482647,0.000010899449,0.00012514058],"genre_scores_gemma":[0.9989489,0.000010116763,0.0000168165,0.000037516053,0.00005022568,0.000064167434,0.000088032735,0.000020665597,0.00076358166],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99896127,0.00007736761,0.00028510392,0.000280572,0.00021020307,0.00018546642],"domain_scores_gemma":[0.99937683,0.000010129272,0.00012745168,0.00039894923,0.000048388065,0.00003825452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013306666,0.00013478218,0.00015831181,0.00008726402,0.000063344756,0.000009249592,0.00020460528,0.00009805166,0.000011505037],"category_scores_gemma":[0.00006282683,0.0000878194,0.000036207177,0.0003694792,0.000043415712,0.0000073790334,0.00012745734,0.00012837588,0.0000034694153],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025255526,0.019129993,0.576477,0.000076002485,0.00040735258,0.000092344766,0.0017616927,0.00007736178,0.39017296,0.000012033357,0.007997455,0.0012702609],"study_design_scores_gemma":[0.06685256,0.012094844,0.24622595,0.00017295452,0.00011735837,0.0000019347183,0.00080276193,0.000018023322,0.66892076,0.000011932287,0.004308367,0.0004725389],"about_ca_topic_score_codex":0.000089426314,"about_ca_topic_score_gemma":0.0010404235,"teacher_disagreement_score":0.33025104,"about_ca_system_score_codex":0.000028163466,"about_ca_system_score_gemma":0.00008736689,"threshold_uncertainty_score":0.3581171},"labels":[],"label_agreement":null},{"id":"W4389219681","doi":"10.1182/blood-2023-190058","title":"A First-in-Human, Open-Label, Phase I Dose Escalation Trial of Daily Oral Nmt Inhibitor Zelenirstat in Patients with Relapsed/Refractory B-Cell Lymphomas and Advanced Solid Tumors","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre; Spinal Cord Injury BC; University of British Columbia; University Health Network; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Neutropenia; Tolerability; Medicine; Pharmacology; Febrile neutropenia; Pharmacokinetics; Internal medicine; Cancer; Refractory (planetary science); Toxicity; Oncology; Gastroenterology; Adverse effect; Biology","score_opus":0.01822706120611121,"score_gpt":0.29676005661221083,"score_spread":0.2785329954060996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389219681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99854636,0.000022818216,0.0000027921026,0.00010040113,0.000024689065,0.00088809204,0.00003764183,0.00004083583,0.00033639625],"genre_scores_gemma":[0.9989448,0.000021280977,0.00020618954,0.000063336374,0.000041939948,0.000059878734,0.0002839224,0.00002906174,0.0003495418],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9984016,0.00006667344,0.00057401566,0.00036183992,0.00033718607,0.00025869155],"domain_scores_gemma":[0.9992536,0.00005043162,0.0002300167,0.00024398642,0.000087783905,0.00013421946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024812957,0.00018589129,0.00052704447,0.00043207066,0.000063133084,0.000024640656,0.00008126588,0.0000870966,0.000044133423],"category_scores_gemma":[0.00009177855,0.00014778398,0.000040947692,0.00075334485,0.0000739113,0.00027909622,0.000075997385,0.00015153401,0.00001062022],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24355625,0.19306071,0.38093784,0.0017694657,0.00045645246,0.0016158446,0.005741478,0.00026858208,0.15411708,0.00013066552,0.001887673,0.016457964],"study_design_scores_gemma":[0.9214032,0.008037443,0.0558856,0.0013515401,0.00019799254,0.0000032284772,0.00029723017,0.0005257132,0.011767415,0.000060682,0.0001550201,0.00031491581],"about_ca_topic_score_codex":0.000075586126,"about_ca_topic_score_gemma":0.00020284334,"teacher_disagreement_score":0.67784697,"about_ca_system_score_codex":0.000060714316,"about_ca_system_score_gemma":0.000100248355,"threshold_uncertainty_score":0.60264564},"labels":[],"label_agreement":null},{"id":"W4389219695","doi":"10.1182/blood-2023-189515","title":"LSD1 Inhibition Synergizes with Venetoclax in Acute Myeloid Leukemia By Targeting Cellular Metabolism","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Juravinski Cancer Centre; Population Health Research Institute; McMaster University","funders":"","keywords":"Venetoclax; Myeloid leukemia; Azacitidine; Myeloid; Cancer research; Leukemia; Pharmacology; Biology; Medicine; Internal medicine; Chronic lymphocytic leukemia; Biochemistry; DNA methylation","score_opus":0.005019309610893325,"score_gpt":0.22567310532348753,"score_spread":0.2206537957125942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389219695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99752903,0.0014850956,0.000059960727,0.00007408122,0.00006062878,0.00021784886,0.000054968605,0.000049198152,0.00046916868],"genre_scores_gemma":[0.9965697,0.0003713241,0.00026510598,0.000048906524,0.00022958401,0.00009722412,0.0009990588,0.000054473385,0.0013646419],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99847883,0.00009779263,0.00022349952,0.00045263956,0.00028195404,0.00046526527],"domain_scores_gemma":[0.99947417,0.0000133958065,0.00006079743,0.00028726304,0.000062390485,0.00010201509],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030063704,0.00018397241,0.00018628908,0.0001307183,0.000092801274,0.000029946192,0.00014662322,0.00017899924,0.000014216],"category_scores_gemma":[0.00006181313,0.00017517952,0.00006152572,0.0004448213,0.00008858756,0.00000783072,0.00012689267,0.00020185168,0.00008372448],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005615603,0.000044902412,0.00019171655,0.000019189205,0.00006164353,0.00012920776,0.00007463808,0.00016999332,0.989497,0.0000105540585,0.009621149,0.00012383291],"study_design_scores_gemma":[0.0016019894,0.00013326207,0.00018619212,0.000027336708,0.00003248105,0.000013413917,0.00006670963,0.00007414429,0.9780458,0.000012932367,0.019581433,0.00022430395],"about_ca_topic_score_codex":0.00011856727,"about_ca_topic_score_gemma":0.000038250808,"teacher_disagreement_score":0.0114512155,"about_ca_system_score_codex":0.000064074404,"about_ca_system_score_gemma":0.00023488242,"threshold_uncertainty_score":0.71436137},"labels":[],"label_agreement":null},{"id":"W4389219740","doi":"10.1182/blood-2023-182261","title":"Unlocking Global Potential: Education and Funding Opportunities for International Trainees in Hematology","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Global Health and Surgery","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Hematology; Medical education; Higher education; Political science; Medicine; Public relations; Internal medicine","score_opus":0.07141831015440711,"score_gpt":0.35475803456154215,"score_spread":0.28333972440713506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389219740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99172735,0.00037098498,0.000058213343,0.0046641137,0.0009959089,0.00015380932,0.000014149649,0.0000477431,0.0019677025],"genre_scores_gemma":[0.998411,0.00012789441,0.00027838568,0.0005824089,0.00016152143,0.00003111098,0.000095598065,0.000004387734,0.00030768747],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99950266,0.000009613651,0.00014644573,0.00009627173,0.000067261346,0.00017775649],"domain_scores_gemma":[0.9997596,0.00004045628,0.000027339081,0.00004041228,0.00005207785,0.00008009026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017404779,0.0000463308,0.00011177078,0.00010612977,0.000028266588,0.000008082006,0.000022596814,0.00004240065,0.000008148497],"category_scores_gemma":[0.0001709521,0.000046195713,0.000023318744,0.0000965909,0.000016146621,0.000034730543,0.000013841578,0.000030669216,0.00000195637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026759648,0.0009855086,0.8190587,0.0009301172,0.00012209931,0.00034134064,0.0006800613,0.000007790917,0.00045369173,0.053881545,0.024797406,0.09847414],"study_design_scores_gemma":[0.012605274,0.00046445083,0.8498132,0.0013329141,0.00026301268,0.0032194254,0.02805171,0.003300961,0.00068768946,0.022342173,0.077370405,0.00054875336],"about_ca_topic_score_codex":0.000030556606,"about_ca_topic_score_gemma":0.000023549934,"teacher_disagreement_score":0.09792539,"about_ca_system_score_codex":0.000022194114,"about_ca_system_score_gemma":0.00016936327,"threshold_uncertainty_score":0.18838064},"labels":[],"label_agreement":null},{"id":"W4389219761","doi":"10.1182/blood-2023-173949","title":"Dexamethasone is Associated with a Lower Incidence and Severity of Cytokine Release Syndrome Compared with Other Corticosteroid Regimens When Given as Premedication for Glofitamab Monotherapy in Patients with Relapsed/Refractory (R/R) Large B-Cell Lymphoma (LBCL)","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Premedication; Cytokine release syndrome; Prednisolone; Dexamethasone; Corticosteroid; Internal medicine; Methylprednisolone; Prednisone; Follicular lymphoma; Gastroenterology; Surgery; Lymphoma; Cancer","score_opus":0.013440384799756854,"score_gpt":0.2531730764839318,"score_spread":0.23973269168417494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389219761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99693036,0.0001359519,0.000084921994,0.00023276712,0.000015240484,0.0022463566,0.00013876095,0.00007820364,0.00013745115],"genre_scores_gemma":[0.9972227,0.000056740297,0.00060982356,0.0002434366,0.000013255503,0.00018576343,0.00014317036,0.000098944074,0.0014261228],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976188,0.000132481,0.0003805015,0.0005345877,0.0008551834,0.00047844535],"domain_scores_gemma":[0.998248,0.0002548017,0.0003452313,0.0005593569,0.00038787455,0.00020474709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048935524,0.00027388023,0.0006233878,0.00025605754,0.000064153704,0.000019327083,0.00014828176,0.00015330676,0.00016143676],"category_scores_gemma":[0.00013815808,0.00020744666,0.000046997156,0.000637242,0.00018525087,0.00015652613,0.000045954348,0.00019449322,0.000007102488],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023039455,0.010179236,0.9525964,0.00027879095,0.00080250035,0.00020234004,0.0031473022,0.0000034593327,0.008440552,0.000002607521,0.0002703886,0.0010369467],"study_design_scores_gemma":[0.13398916,0.01241472,0.8437309,0.0011506722,0.00035081455,0.00006313766,0.0002344384,0.00042519532,0.0065660006,0.000043494394,0.0006503721,0.00038106466],"about_ca_topic_score_codex":0.00025775057,"about_ca_topic_score_gemma":0.0002486561,"teacher_disagreement_score":0.1109497,"about_ca_system_score_codex":0.00018030239,"about_ca_system_score_gemma":0.00029948395,"threshold_uncertainty_score":0.845943},"labels":[],"label_agreement":null},{"id":"W4389219809","doi":"10.1182/blood-2023-183055","title":"Factor First: An Assessment of Emergency Department Care of Patients with Hemophilia","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"Novo Nordisk; BioCryst","keywords":"Medicine; Emergency department; Clotting factor; Emergency medicine; Bleed; Hemarthrosis; Haemophilia; Pediatrics; Medical emergency; Intensive care medicine; Surgery; Internal medicine","score_opus":0.029740949029433535,"score_gpt":0.3458492745774956,"score_spread":0.31610832554806206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389219809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998266,0.00007075613,0.0000013168068,0.000088349036,0.00006207056,0.00057080126,0.00015669763,0.00003318738,0.0007508295],"genre_scores_gemma":[0.9988197,0.00008364431,0.00030687256,0.0000028739876,0.00003273971,0.000032571847,0.00042297968,0.000018153518,0.00028042632],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884444,0.000021297035,0.00021844625,0.00018402295,0.0005279291,0.00020383859],"domain_scores_gemma":[0.9992542,0.000016932636,0.000064255415,0.00030778145,0.00022849016,0.00012831001],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004298033,0.000109941204,0.00024400417,0.00011436129,0.000040507144,0.0000018738506,0.000072111194,0.00004747268,0.00028610602],"category_scores_gemma":[0.000014213155,0.00007199194,0.00006757847,0.00029698145,0.000029025387,0.00003810083,0.000037981325,0.00006362386,0.000010082159],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058060814,0.0017401552,0.99580467,0.00035497756,0.00019912934,0.000023441631,0.00042793484,0.0000025180568,0.0005089028,0.000016708835,0.000076412194,0.0007870785],"study_design_scores_gemma":[0.0035224291,0.0023791029,0.98339796,0.000060124537,0.00014490301,4.4782539e-7,0.00015723053,0.000013996587,0.010031211,0.000008038286,0.00021621342,0.00006834258],"about_ca_topic_score_codex":0.000016256266,"about_ca_topic_score_gemma":0.00002689595,"teacher_disagreement_score":0.012406721,"about_ca_system_score_codex":0.000027964341,"about_ca_system_score_gemma":0.00010016284,"threshold_uncertainty_score":0.313266},"labels":[],"label_agreement":null},{"id":"W4389219823","doi":"10.1182/blood-2023-187067","title":"Evaluation of Bleeding Self-Assessments By Patients with Immune Thrombocytopenia (ITP): An Agreement Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Cohen's kappa; Kappa; Inter-rater reliability; Gastrointestinal bleeding; Immune thrombocytopenia; Surgery; Pediatrics; Internal medicine; Rating scale; Platelet","score_opus":0.028364021287242924,"score_gpt":0.32736662585110665,"score_spread":0.29900260456386374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389219823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971531,0.00007376803,0.0000014915278,0.00001631241,0.00004851447,0.0016271308,0.000019665933,0.000062991676,0.0009970282],"genre_scores_gemma":[0.9993379,0.000015453194,0.00015310342,0.000010661279,0.000009883648,0.000092992486,0.00030845936,0.000020411231,0.000051112587],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99807537,0.00007484494,0.00024174804,0.00025338022,0.0011570675,0.00019760922],"domain_scores_gemma":[0.99922895,0.000013016526,0.00012156125,0.00027043364,0.0002967233,0.00006928289],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053820416,0.0001419326,0.0003351792,0.00009006666,0.0000715971,0.000013724277,0.00007209471,0.000035005603,0.000078647994],"category_scores_gemma":[0.000012558596,0.00010653152,0.000030158086,0.0003008677,0.000011211886,0.00013034635,0.000038467704,0.000056973542,0.000030568983],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010004851,0.021084622,0.9690499,0.000031056526,0.0018526334,0.000035730147,0.0010120049,0.0000063388034,0.0021417495,0.000001919374,0.00010360323,0.004580397],"study_design_scores_gemma":[0.03327672,0.005256935,0.95359033,0.000060852468,0.0033521329,0.0000024015292,0.0011538526,0.00028714706,0.0028641196,0.000023831237,0.000011848797,0.00011980876],"about_ca_topic_score_codex":0.000095011615,"about_ca_topic_score_gemma":0.000022916276,"teacher_disagreement_score":0.033176675,"about_ca_system_score_codex":0.000064219705,"about_ca_system_score_gemma":0.00009307312,"threshold_uncertainty_score":0.43442297},"labels":[],"label_agreement":null},{"id":"W4389219846","doi":"10.1182/blood-2023-190650","title":"Neurocognitive Outcomes over the First 3 Months after Chimeric Antigen Receptor T-Cell (CAR T) Therapy: Preliminary Findings from a Longitudinal Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Neurocognitive; Neuropsychology; Verbal learning; Verbal memory; Neuropsychological assessment; Medicine; Cognition; Trail Making Test; Psychology; Cohort; Executive functions; Recall; Clinical psychology; Psychiatry; Internal medicine","score_opus":0.021671316307744534,"score_gpt":0.2749528398859974,"score_spread":0.25328152357825284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389219846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99302536,0.0012239697,0.0000022133488,0.0016049932,0.0003931059,0.002811052,0.00015332803,0.00027772097,0.0005082642],"genre_scores_gemma":[0.99583787,0.0008034681,0.000017528948,0.0011590181,0.00028522985,0.0008923166,0.000044288026,0.0000837936,0.0008765105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99783826,0.00009244893,0.00035256543,0.00065633486,0.0005528843,0.00050749147],"domain_scores_gemma":[0.99873304,0.00049726927,0.00011527138,0.00041875552,0.00013145844,0.00010421396],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017320042,0.0004118449,0.0005302223,0.00017782561,0.00033694314,0.00004667667,0.00018405604,0.00008776556,0.0005466053],"category_scores_gemma":[0.00013453199,0.0002752186,0.00025176353,0.00069316325,0.00015500633,0.000113224814,0.0002609219,0.00039585738,0.0005980482],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012686438,0.0023522568,0.98421144,0.000018318116,0.0015444938,0.00031391473,0.005021406,6.1422884e-7,0.00031108502,1.8489973e-7,0.0044457586,0.00051190174],"study_design_scores_gemma":[0.010171614,0.0026121002,0.98114586,0.00011552418,0.0009147261,0.000007436564,0.0023110276,0.000010053122,0.0010382357,0.000012437634,0.0013717555,0.0002892231],"about_ca_topic_score_codex":0.00031681944,"about_ca_topic_score_gemma":0.000067869274,"teacher_disagreement_score":0.00890297,"about_ca_system_score_codex":0.00004438223,"about_ca_system_score_gemma":0.00005791187,"threshold_uncertainty_score":0.99997},"labels":[],"label_agreement":null},{"id":"W4389219865","doi":"10.1182/blood-2023-174993","title":"Prevention of Ocular Toxicity Using Protective Contact Lenses in Multiple Myeloma Patients Receiving Belantamab Mafodotin, Pomalidomide and Dexamethasone: A Sub-Study of the Cmrg-007 Trial","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Western University; Alberta Health; Ottawa Hospital; Alberta Health Services; London Health Sciences Centre; McMaster University; Vancouver General Hospital; Health Sciences Centre; CancerCare Manitoba","funders":"","keywords":"Medicine; Lenalidomide; Dexamethasone; Pomalidomide; Tolerability; Adverse effect; Multiple myeloma; Internal medicine; Contact lens; Refractory (planetary science); Surgery; Ophthalmology","score_opus":0.04989332451591136,"score_gpt":0.31242170032171873,"score_spread":0.26252837580580735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389219865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946577,0.000056194436,0.0000069532634,0.000011365021,0.000049756134,0.0051518157,0.000026321788,0.00002083539,0.000019037116],"genre_scores_gemma":[0.9996308,0.00001408744,0.00015529415,0.0000031927293,0.000026947882,0.00012239527,0.0000118363705,0.000020782663,0.0000146287975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980201,0.00047781147,0.00044267884,0.00029869904,0.00048272,0.0002779674],"domain_scores_gemma":[0.9989441,0.00032707505,0.0002455949,0.0002797195,0.00013102118,0.00007250586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005533245,0.00015759228,0.00046180518,0.00021934109,0.00008948016,0.000009331678,0.0000854148,0.000083003986,0.0000050364993],"category_scores_gemma":[0.0017961346,0.0001138464,0.00010570783,0.00050140236,0.00005711109,0.00008026676,0.0001437785,0.00017735816,0.0000011344658],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011214303,0.004837376,0.9184421,0.00014045446,0.00033617433,0.000040331583,0.00084538426,0.0000040220316,0.060506973,8.602823e-7,0.0000012199116,0.0036308025],"study_design_scores_gemma":[0.11351975,0.002853689,0.7620845,0.00032924747,0.00017340358,0.0000070398173,0.00047522035,0.00021026356,0.120260604,0.00001759687,3.8017515e-7,0.00006828779],"about_ca_topic_score_codex":0.0014447885,"about_ca_topic_score_gemma":0.0008926753,"teacher_disagreement_score":0.15635759,"about_ca_system_score_codex":0.000062073996,"about_ca_system_score_gemma":0.00009626164,"threshold_uncertainty_score":0.46425214},"labels":[],"label_agreement":null},{"id":"W4389220160","doi":"10.1182/blood-2023-182093","title":"Longitudinal Analysis of Circulating Tumor DNA (ctDNA) in Diffuse Large B-Cell Lymphoma (DLBCL) Using KAPA HyperCap Design Share Non-Hodgkin Lymphoma (KAPA HyperCap DS NHL) Next-Generation Sequencing (NGS) Panel","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Lymphoma; Minimal residual disease; Oncology; Medicine; Internal medicine; DNA sequencing; Diffuse large B-cell lymphoma; Liquid biopsy; Cancer; Biology; Gene; Leukemia; Genetics","score_opus":0.08343706829423285,"score_gpt":0.2657425272890398,"score_spread":0.18230545899480693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389220160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964647,0.0006414356,0.0020729778,0.00001300329,0.00013784018,0.00030386,0.00025702856,0.000027635584,0.000081476],"genre_scores_gemma":[0.99576473,0.0001999619,0.0025094836,0.00012077302,0.00033830304,0.00003820393,0.0009239326,0.00007492887,0.000029705909],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99756444,0.00011430903,0.0006408817,0.0007779423,0.0002832255,0.00061921286],"domain_scores_gemma":[0.99872166,0.00008434576,0.0002890311,0.00059985183,0.00015852436,0.0001465768],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047483278,0.00035814822,0.00055353687,0.0004484451,0.0001781483,0.00010251405,0.000304404,0.00022263263,0.000019664616],"category_scores_gemma":[0.00021155938,0.0004074706,0.0003028014,0.0011609443,0.000057049092,0.000021869146,0.00023479185,0.00007296384,0.000009081733],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003971889,0.0011413986,0.025385669,0.00006919495,0.00033871617,0.00012634222,0.00029192533,0.009120458,0.9627015,0.000011848346,0.000066679655,0.00070656737],"study_design_scores_gemma":[0.013822081,0.00030247643,0.043955415,0.000115936666,0.0016398139,0.00008113904,0.0009360574,0.26953098,0.66849685,0.000026414116,0.00013648409,0.0009563542],"about_ca_topic_score_codex":0.0004635961,"about_ca_topic_score_gemma":0.000566513,"teacher_disagreement_score":0.29420465,"about_ca_system_score_codex":0.00017672169,"about_ca_system_score_gemma":0.00044655064,"threshold_uncertainty_score":0.9998377},"labels":[],"label_agreement":null},{"id":"W4389220192","doi":"10.1182/blood-2023-190173","title":"Evaluating Hemoglobin Thresholds on the Basis of Sex: Preliminary Insights from a Systematic Review","year":2023,"lang":"en","type":"review","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University; St. Michael's Hospital; University of British Columbia","funders":"","keywords":"Medicine; CINAHL; MEDLINE; Population; Anemia; Systematic review; Iron deficiency; Iron-deficiency anemia; Hemoglobin; Family medicine; Pediatrics; Internal medicine; Environmental health; Psychiatry; Psychological intervention","score_opus":0.10616413828000813,"score_gpt":0.37437416370391285,"score_spread":0.2682100254239047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389220192","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023093434,0.991681,8.202854e-7,0.00008460867,0.00013684087,0.006135947,0.00007254207,0.000071445655,0.0015858929],"genre_scores_gemma":[0.000025288797,0.9974912,0.00009208493,0.00050070253,0.00015861144,0.0008965469,0.00018495439,0.000096816235,0.0005538146],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9961839,0.00083132513,0.0014424967,0.000469091,0.00083951466,0.00023371069],"domain_scores_gemma":[0.99608284,0.001386541,0.0008711606,0.0014848828,0.000087236294,0.00008731625],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009958168,0.00046712678,0.004250556,0.00015143515,0.000073258314,0.000014011911,0.0004154878,0.00024482564,0.00010051896],"category_scores_gemma":[0.0019534105,0.0002476323,0.00086894986,0.0006149315,0.00005728836,0.00002545259,0.00013221854,0.00041742646,0.00039469404],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005684109,0.000255043,0.0000010010225,0.98016304,0.00045813495,0.000022669581,0.000117078285,7.976588e-8,8.1242126e-7,0.00015762312,0.0005770688,0.018241756],"study_design_scores_gemma":[0.0006461611,0.00026729231,0.0000045392376,0.9479813,0.04498889,0.000035750552,0.0001124012,0.0000030147344,0.000008533115,0.000085637905,0.0056327092,0.00023377326],"about_ca_topic_score_codex":0.000028644063,"about_ca_topic_score_gemma":0.0000017669655,"teacher_disagreement_score":0.044530757,"about_ca_system_score_codex":0.00002291246,"about_ca_system_score_gemma":0.00034370518,"threshold_uncertainty_score":0.9999976},"labels":[],"label_agreement":null},{"id":"W4389220199","doi":"10.1182/blood-2023-173975","title":"Interactions between Iron Overload, Oxidative Stress, and Somatic Mutations in Myelodysplastic Syndromes; Evidence from the Literature","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Oxidative stress; Myelodysplastic syndromes; Medicine; Mutation; Bone marrow; Stem cell; Cancer research; Internal medicine; Immunology; Biology; Genetics","score_opus":0.03212480228918037,"score_gpt":0.32060163983272344,"score_spread":0.2884768375435431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389220199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99456644,0.00086818635,0.000028941513,0.003602313,0.000051160685,0.0004657395,0.00023232555,0.000073870826,0.00011100571],"genre_scores_gemma":[0.9981298,0.0003945022,0.00034446848,0.0000596074,0.00016820691,0.000082478444,0.00032440812,0.00002095913,0.00047557594],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987864,0.00014091967,0.00023376143,0.0002881233,0.00029001443,0.0002607786],"domain_scores_gemma":[0.9962588,0.0032022404,0.00005748895,0.00031671728,0.000059212034,0.00010556738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017961592,0.00014020765,0.00022795447,0.00019511512,0.00012326252,0.00008571745,0.00014526104,0.00007739864,0.00009061409],"category_scores_gemma":[0.0012464115,0.00009859142,0.000040601048,0.0008356054,0.000110591754,0.00026414104,0.0001325309,0.00060620473,0.00019893223],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007479052,0.00025740507,0.9618533,0.00042279542,0.00033877356,0.0008036083,0.017556954,0.00004697352,0.014766699,0.000050914347,0.0014722935,0.002355495],"study_design_scores_gemma":[0.0016847546,0.00012192414,0.9898785,0.0033419477,0.00028322218,0.00006112885,0.002059516,0.00056141726,0.0014196095,0.00039101386,0.00007931384,0.00011767518],"about_ca_topic_score_codex":0.00024970956,"about_ca_topic_score_gemma":0.00019493265,"teacher_disagreement_score":0.028025178,"about_ca_system_score_codex":0.00008705675,"about_ca_system_score_gemma":0.000156978,"threshold_uncertainty_score":0.40204415},"labels":[],"label_agreement":null},{"id":"W4389220209","doi":"10.1182/blood-2023-186880","title":"Blood Biomarkers and Risk of Venous Thromboembolism in Cancer Patients: A Systematic Review and Meta-Analysis","year":2023,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Meta-analysis; MEDLINE; Observational study; Confidence interval; Internal medicine; Odds ratio; Biomarker; Cancer; Systematic review; Risk assessment; Oncology; Intensive care medicine","score_opus":0.05921426797289189,"score_gpt":0.3422545521749589,"score_spread":0.28304028420206706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389220209","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00047420358,0.99225616,3.7227372e-7,0.000041583386,0.000033572385,0.0065733083,0.00049439515,0.000038236052,0.00008818277],"genre_scores_gemma":[0.000094322306,0.99732,0.00005091304,0.00013077192,0.000018139617,0.0021160925,0.000105761595,0.0000832474,0.0000807676],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9961332,0.00050572935,0.0018153982,0.00073970377,0.00044827553,0.0003577109],"domain_scores_gemma":[0.9971802,0.00031037215,0.0014207388,0.0008029084,0.00012366122,0.00016212363],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0010751274,0.0006179802,0.018395144,0.00085545826,0.000051875424,0.000026244923,0.00019485393,0.00022453156,0.00009404578],"category_scores_gemma":[0.00036629866,0.00040656616,0.0017853284,0.0017464918,0.00009156774,0.0000486524,0.00021873311,0.00027396486,0.000009434694],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[5.0920806e-7,0.0013797878,0.000093565584,0.60308945,0.39462483,0.000020862657,0.00006221853,6.6527484e-8,1.2662062e-8,0.000013769254,0.00006716349,0.0006477748],"study_design_scores_gemma":[0.0006617191,0.0002018623,0.0007308904,0.100216165,0.8966767,0.0000086872415,0.00001842969,4.231366e-7,2.4805627e-7,0.0000094641155,0.0011885262,0.00028686313],"about_ca_topic_score_codex":0.0013038224,"about_ca_topic_score_gemma":0.00034933616,"teacher_disagreement_score":0.50287324,"about_ca_system_score_codex":0.000037061538,"about_ca_system_score_gemma":0.000103750266,"threshold_uncertainty_score":0.9998386},"labels":[],"label_agreement":null},{"id":"W4389220244","doi":"10.1182/blood-2023-180737","title":"Venous Thromboembolism in Hematopoietic Stem Cell Transplantation","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Hematopoietic stem cell transplantation; Surgery; Transplantation; Retrospective cohort study; Incidence (geometry); Thrombosis; Internal medicine; Adverse effect; Venous thrombosis; Cohort","score_opus":0.01609064855801104,"score_gpt":0.25068406999277637,"score_spread":0.23459342143476533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389220244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98651254,0.00027313188,0.000017451595,0.0005147518,0.00015330724,0.00050618814,0.000006421624,0.00020376581,0.011812451],"genre_scores_gemma":[0.99768597,0.001227047,0.000066733104,0.00030114065,0.00007888117,0.00008091762,0.00004476735,0.000031445274,0.0004830872],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891233,0.00002699158,0.0002464149,0.00025322437,0.00023772364,0.00032329682],"domain_scores_gemma":[0.9995809,0.00003660698,0.000042600317,0.00023815586,0.000019605239,0.00008213874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017778986,0.00013128915,0.00041394186,0.00022425069,0.000046719266,0.000016408821,0.00007957459,0.00007271373,0.00007140111],"category_scores_gemma":[0.0000028162663,0.00012541925,0.000074253694,0.00045573816,0.000020741221,0.000051799456,0.000023751452,0.00011538836,0.00055898994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000601271,0.11734271,0.20959319,0.03671079,0.0027679456,0.037704404,0.20796824,0.0018965086,0.1927076,0.039849482,0.065312214,0.087545656],"study_design_scores_gemma":[0.0072260327,0.00063294324,0.9485159,0.00044483473,0.00087147614,0.00010732784,0.001786563,0.00007995831,0.03717229,0.00070565677,0.002093513,0.0003635212],"about_ca_topic_score_codex":0.000062563944,"about_ca_topic_score_gemma":0.0000269072,"teacher_disagreement_score":0.73892266,"about_ca_system_score_codex":0.00002134025,"about_ca_system_score_gemma":0.00003732879,"threshold_uncertainty_score":0.7184871},"labels":[],"label_agreement":null},{"id":"W4389220262","doi":"10.1182/blood-2023-178366","title":"Diffuse Large B-Cell Lymphoma Has a Low Frequency of dMMR and High Frequencies of DNA Mismatch Repair Protein High Expression Associated with Lower T-Cell Infiltration","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"PMS2; MSH6; MSH2; MLH1; Diffuse large B-cell lymphoma; Biology; Cancer research; Germinal center; Microsatellite instability; Tissue microarray; DNA mismatch repair; Lymphoma; Cancer; B cell; Immunohistochemistry; Immunology; Antibody; Gene; Genetics; Colorectal cancer","score_opus":0.010992399274226534,"score_gpt":0.20891251863911584,"score_spread":0.1979201193648893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389220262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979286,0.00027497025,0.000016083643,0.00008308421,0.000101609425,0.0008726366,0.00009833234,0.00017815003,0.00044651743],"genre_scores_gemma":[0.9974253,0.000030832274,0.0016057114,0.000028339737,0.00003976701,0.000102395934,0.00008662838,0.00004707202,0.00063391833],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982596,0.00008509063,0.0004406843,0.00036203317,0.000537382,0.0003152232],"domain_scores_gemma":[0.99878925,0.00009664002,0.00033046532,0.00042466988,0.00024970996,0.0001092421],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000242148,0.00023089495,0.00045897462,0.00014401246,0.000067129535,0.000013080811,0.000103152066,0.00022332041,0.00007587725],"category_scores_gemma":[0.00023489926,0.00018351764,0.00008204805,0.00046409052,0.00016321741,0.00007627476,0.00005869071,0.00011591961,0.0000054679267],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016788261,0.003955245,0.033262204,0.0005583993,0.00007828771,0.00005268254,0.00087472156,0.0000021754718,0.96069413,0.000017132892,0.00031038886,0.00002674748],"study_design_scores_gemma":[0.015663303,0.0016056123,0.056629933,0.0007726837,0.00019380763,0.0000066261473,0.00014799404,0.00004341957,0.9245301,0.00019604847,0.000021410997,0.00018906752],"about_ca_topic_score_codex":0.0003322319,"about_ca_topic_score_gemma":0.000117474025,"teacher_disagreement_score":0.036164038,"about_ca_system_score_codex":0.00005855741,"about_ca_system_score_gemma":0.00027339824,"threshold_uncertainty_score":0.74836326},"labels":[],"label_agreement":null},{"id":"W4389220320","doi":"10.1182/blood-2023-182878","title":"A Whole Foods Plant-Based Weight Loss Intervention Improves Quality of Life, Metabolic, Microbiome and Immune Profile in MGUS/SMM As Well As Progression Trajectory in a Subset - the Nutrivention Trial","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Adiponectin; Internal medicine; Microbiome; Body mass index; Immunology; Obesity; Biology; Insulin resistance; Bioinformatics","score_opus":0.010779304716670544,"score_gpt":0.28469394569817696,"score_spread":0.2739146409815064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389220320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922318,0.0063454723,0.000010339008,0.00012645463,0.00012511043,0.00087969564,0.00021643219,0.0000139754875,0.00005070679],"genre_scores_gemma":[0.99787015,0.00043184625,0.000061870254,0.000027593323,0.00011968789,0.00020028207,0.0011738375,0.000016234331,0.00009849698],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985091,0.00033890925,0.0004932774,0.00032086714,0.00013040812,0.00020741018],"domain_scores_gemma":[0.99941057,0.000024853165,0.00019996741,0.00025842732,0.00004327386,0.00006287929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006155172,0.00014736761,0.00023669966,0.00014915022,0.000044089877,0.00002087622,0.00014153919,0.0001516135,0.000019084859],"category_scores_gemma":[0.00011206226,0.00012300578,0.0001614656,0.00023113244,0.00011440652,0.000007706094,0.000071151604,0.00008326906,0.000008726235],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009291537,0.0023319782,0.00739652,0.00032583758,0.000054309334,0.0000053492163,0.00007797595,0.0000018392967,0.9797778,0.000026117837,0.00016007248,0.00055062375],"study_design_scores_gemma":[0.05014424,0.0009750092,0.0901704,0.00014808658,0.000063511354,0.0000029392468,0.00015524801,0.000019128169,0.85669756,0.00034886965,0.0010802809,0.00019470265],"about_ca_topic_score_codex":0.00014018897,"about_ca_topic_score_gemma":0.00012743982,"teacher_disagreement_score":0.12308025,"about_ca_system_score_codex":0.00000582723,"about_ca_system_score_gemma":0.00011059375,"threshold_uncertainty_score":0.501603},"labels":[],"label_agreement":null},{"id":"W4389220343","doi":"10.1182/blood-2023-189200","title":"Intensity of Survivin Expression Correlates with Clinical and Biological Markers of Aggressive R/R DLBCL","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Calgary; London Health Sciences Centre; Queen Elizabeth II Health Sciences Centre; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Survivin; Medicine; Immunohistochemistry; Oncology; Internal medicine; Pathology; Cancer","score_opus":0.05891360144423264,"score_gpt":0.3468215963229426,"score_spread":0.28790799487871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389220343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984769,0.00020831193,0.000004124529,0.00012148088,0.000047376587,0.00023385494,0.00000940177,0.000030962863,0.0008675936],"genre_scores_gemma":[0.99849135,0.00079973345,0.00018254873,0.000022422853,0.000037453832,0.000004772001,0.0000146332695,0.000010978505,0.00043609669],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990109,0.00012733515,0.0002685825,0.00021029811,0.00022319968,0.00015964128],"domain_scores_gemma":[0.99877787,0.00055132696,0.00018238368,0.00022405079,0.00016043059,0.000103938626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067245046,0.00008416354,0.00040553737,0.000081958846,0.0000191966,0.000002607575,0.000064847874,0.00012822909,0.0002180101],"category_scores_gemma":[0.00081994204,0.000051691477,0.000067944486,0.00022730362,0.0005131379,0.000015693116,0.00012310596,0.00022429698,0.0000062620857],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002602311,0.00043099103,0.8766937,0.000057529604,0.00012796237,0.00009090844,0.00008657265,2.2800498e-7,0.117191225,0.0000067885267,0.00034445937,0.002367268],"study_design_scores_gemma":[0.005511547,0.002261742,0.9159748,0.00047006592,0.00007111808,0.00007827379,0.00032299908,0.000055181274,0.075023405,0.00008837655,0.00007084744,0.00007165944],"about_ca_topic_score_codex":0.000027346056,"about_ca_topic_score_gemma":0.0000045799975,"teacher_disagreement_score":0.042167827,"about_ca_system_score_codex":0.0000032620883,"about_ca_system_score_gemma":0.00004780644,"threshold_uncertainty_score":0.23870578},"labels":[],"label_agreement":null},{"id":"W4389220348","doi":"10.1182/blood-2023-191019","title":"Assessment of Gaps in Hematology Education in Canadian Internal Medicine Residency Programs","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; University Health Network; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Family medicine; Curriculum; Likert scale; Competence (human resources); Internal medicine; Respondent; Hematology; Specialty; Medical education; Psychology","score_opus":0.04727374135241389,"score_gpt":0.3965827328142806,"score_spread":0.34930899146186667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389220348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.972107,0.00059502723,0.0000017482739,0.0025341443,0.00011511839,0.00023096698,8.186321e-7,0.000014056632,0.024401147],"genre_scores_gemma":[0.99894565,0.00007838289,0.0004304336,0.00019560903,0.00006222948,0.000034950524,0.00002820383,0.000005784255,0.00021877706],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991203,0.000029744499,0.00028523884,0.00014051309,0.00017620498,0.0002479985],"domain_scores_gemma":[0.9996056,0.000023819772,0.000051176106,0.00013499307,0.000056518988,0.00012790746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003907535,0.00006177882,0.00021845891,0.00042711786,0.00000979087,0.0000024647584,0.00007625961,0.000055947527,0.00006602259],"category_scores_gemma":[0.0001545429,0.000055058517,0.000019327299,0.0005712555,0.00003942437,0.000036705347,0.000015794572,0.00013709445,0.000007310463],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009030244,0.00009968585,0.99093956,0.00007270101,0.000008659219,0.00018926687,0.00023607195,0.0000013615143,0.0002487971,0.002935533,0.0005972325,0.0046621263],"study_design_scores_gemma":[0.00114125,0.00027185516,0.994347,0.0013510747,0.000021884338,0.000104978484,0.0011060034,0.000046835026,0.00024587108,0.0008751623,0.00044268506,0.000045412613],"about_ca_topic_score_codex":0.55280036,"about_ca_topic_score_gemma":0.71336377,"teacher_disagreement_score":0.16056341,"about_ca_system_score_codex":0.00012838314,"about_ca_system_score_gemma":0.0020104642,"threshold_uncertainty_score":0.4501776},"labels":[],"label_agreement":null},{"id":"W4389220356","doi":"10.1182/blood-2023-178738","title":"A Systematic Literature Review (SLR) and Meta-Analysis of Clinical Evidence of Second Line or Later (2L+) Treatments for Follicular Lymphoma (FL) in Adult Patients","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Oncology; Follicular lymphoma; Internal medicine; Pembrolizumab; Population; MEDLINE; Cochrane Library; Meta-analysis; Systematic review; Lymphoma; Immunotherapy; Cancer","score_opus":0.12261468838760457,"score_gpt":0.4252385404789309,"score_spread":0.3026238520913263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389220356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9236398,0.07301316,0.0000014851747,0.00019341418,0.000017686962,0.0029477985,0.00015649525,0.000011464871,0.000018709101],"genre_scores_gemma":[0.9132647,0.07231865,0.00069223525,0.0007081893,0.000046200974,0.0011487697,0.0002831472,0.000060249782,0.011477848],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9973106,0.00033580035,0.0013505024,0.00035027484,0.00045434778,0.00019850054],"domain_scores_gemma":[0.997458,0.0010374881,0.00034500944,0.00056654995,0.0004894259,0.00010357261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014623059,0.00017284091,0.002775165,0.00035871397,0.0000137149345,0.000010739209,0.00011350347,0.00012007302,0.0004229611],"category_scores_gemma":[0.0018535557,0.000097777076,0.0010658614,0.0015644905,0.00003973705,0.00006346845,0.000053347376,0.000076374534,0.0000040191003],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002257764,0.0047022146,0.084876396,0.48168218,0.42131698,0.00032702208,0.0011353098,0.0000020750779,0.0018740678,0.000010675668,0.00037699807,0.0014382962],"study_design_scores_gemma":[0.018940568,0.0040893448,0.055258766,0.048740666,0.8681944,0.000025348078,0.000049248847,0.00059198204,0.0037322703,0.000020752783,0.000084874606,0.00027175466],"about_ca_topic_score_codex":0.000010933217,"about_ca_topic_score_gemma":0.00006989842,"teacher_disagreement_score":0.44687742,"about_ca_system_score_codex":0.000016725166,"about_ca_system_score_gemma":0.00006323378,"threshold_uncertainty_score":0.46311274},"labels":[],"label_agreement":null},{"id":"W4389220360","doi":"10.1182/blood-2023-180207","title":"Functional Deconvolution of the Leukemia Stem Cell Pool Uncovers Co-Existing Alternative Stem Cell Driven Hierarchies","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Stem cell; Biology; Leukemia; Computational biology; Myeloid leukemia; Cancer research; Genetics","score_opus":0.03628485470383753,"score_gpt":0.278726753032844,"score_spread":0.24244189832900648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389220360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820542,0.00011553547,0.00013453877,0.00022937956,0.00024709932,0.0005366326,0.000086555025,0.000106482184,0.016489623],"genre_scores_gemma":[0.9806089,0.00007190377,0.00012554458,0.00009682927,0.0002842302,0.00003669044,0.000060181188,0.000039470375,0.018676246],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99791867,0.00016452621,0.00035646016,0.00035195574,0.00078337296,0.00042501625],"domain_scores_gemma":[0.99862576,0.00042619224,0.00020565976,0.00041784975,0.00019151442,0.00013305509],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003833599,0.00019106841,0.00029532175,0.00022738878,0.0001965165,0.000019526788,0.00026535537,0.000112646296,0.00006151977],"category_scores_gemma":[0.000038745715,0.00014432582,0.00017710819,0.0006277199,0.00020868087,0.0000949236,0.00020966525,0.00050171744,0.00026611146],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012602108,0.0010929467,0.35680193,0.0022681158,0.0013014806,0.00044450548,0.008089771,0.010176026,0.52818173,0.0013908586,0.08154311,0.0074492814],"study_design_scores_gemma":[0.011926276,0.0005860096,0.106114075,0.00029926293,0.0003919944,0.00008131243,0.004638713,0.007350725,0.86381793,0.00017975319,0.004252626,0.00036132493],"about_ca_topic_score_codex":0.00015366325,"about_ca_topic_score_gemma":0.000012655136,"teacher_disagreement_score":0.33563617,"about_ca_system_score_codex":0.00058517954,"about_ca_system_score_gemma":0.000980027,"threshold_uncertainty_score":0.5885436},"labels":[],"label_agreement":null},{"id":"W4389220387","doi":"10.1182/blood-2023-178097","title":"Long-Term Remissions after First-Line Autologous Stem Cell Transplantation for Mantle Cell Lymphoma","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of Calgary","funders":"","keywords":"Medicine; Autologous stem-cell transplantation; Mantle cell lymphoma; Internal medicine; Population; Oncology; Rituximab; Transplantation; Surgery; International Prognostic Index; Progression-free survival; Bendamustine; Hazard ratio; Cytarabine; Median follow-up; Lymphoma; Chemotherapy; Confidence interval","score_opus":0.017305788770932248,"score_gpt":0.258110924069722,"score_spread":0.24080513529878977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389220387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963992,0.0007091519,0.00010556621,0.0005473895,0.00014938081,0.0007137874,0.00015494891,0.00018648691,0.0010340668],"genre_scores_gemma":[0.9934707,0.0009324365,0.0002955413,0.00013730701,0.00011913593,0.00046464964,0.0003499921,0.000035062887,0.004195123],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901336,0.000014154625,0.00022516007,0.00029830486,0.00015607526,0.00029296387],"domain_scores_gemma":[0.99936813,0.00013255716,0.000055063305,0.00025327897,0.000040680905,0.00015030423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006036096,0.00016881626,0.00023635564,0.0000920519,0.00010111667,0.000016629328,0.000057093606,0.00011168711,0.000072961295],"category_scores_gemma":[0.0000036547067,0.00013263205,0.00015453309,0.00014962045,0.000018299823,0.00003688552,0.000015557565,0.000027916576,0.00024054166],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001548033,0.014891182,0.9018154,0.0044050477,0.00037633104,0.008533951,0.002424269,0.00003428264,0.0068355473,0.000038292917,0.005652491,0.053445175],"study_design_scores_gemma":[0.017389055,0.00060581224,0.8259149,0.00022358084,0.0011140527,0.00015703535,0.000034421937,0.000060803995,0.1532124,0.000024389425,0.0010845171,0.00017901247],"about_ca_topic_score_codex":0.000011163705,"about_ca_topic_score_gemma":0.000027469745,"teacher_disagreement_score":0.14637685,"about_ca_system_score_codex":0.000048575253,"about_ca_system_score_gemma":0.00007013204,"threshold_uncertainty_score":0.5408578},"labels":[],"label_agreement":null},{"id":"W4389220396","doi":"10.1182/blood-2023-187014","title":"A Novel Beta Globin Frameshift Mutation Causing Autosomal Dominant Beta Thalassemia","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Ineffective erythropoiesis; Thalassemia; Medicine; Anemia; Beta thalassemia; Diamond–Blackfan anemia; Frameshift mutation; Splenectomy; Gene mutation; Hemolytic anemia; Bone marrow; Internal medicine; Immunology; Mutation; Biology; Erythropoiesis; Genetics; Spleen; Gene","score_opus":0.01328425664951834,"score_gpt":0.2590922787537458,"score_spread":0.24580802210422745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389220396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915753,0.00041943393,0.00031353065,0.0027920105,0.00031873744,0.00038376998,0.000022152071,0.00029815428,0.0038768935],"genre_scores_gemma":[0.9976009,0.00010246192,0.00088049134,0.00026907757,0.000159525,0.000018781153,0.00011870556,0.000044274235,0.0008057911],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99855244,0.000023206134,0.00031066395,0.00033373904,0.00033239412,0.0004475388],"domain_scores_gemma":[0.9993199,0.0000636223,0.000088691864,0.00029833807,0.00006504804,0.00016441505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020199243,0.00019385494,0.00030451405,0.00016702703,0.00015294808,0.00003554219,0.00007063811,0.00027560224,0.000058784753],"category_scores_gemma":[0.00008948794,0.00016118996,0.0001388652,0.0006557526,0.0000689157,0.00007992822,0.0000673086,0.0003189663,0.00026608535],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032080826,0.00406347,0.063107274,0.0010067931,0.0014152174,0.0066152266,0.006892773,0.0004168487,0.8869806,0.003966369,0.008770365,0.016444255],"study_design_scores_gemma":[0.069031425,0.0023919023,0.5375676,0.0033179824,0.0062122266,0.007604929,0.008523031,0.014591145,0.31726193,0.0010371276,0.02984705,0.0026136478],"about_ca_topic_score_codex":0.000122073,"about_ca_topic_score_gemma":0.000016013984,"teacher_disagreement_score":0.56971866,"about_ca_system_score_codex":0.000035407225,"about_ca_system_score_gemma":0.00016676278,"threshold_uncertainty_score":0.65731364},"labels":[],"label_agreement":null},{"id":"W4389220410","doi":"10.1182/blood-2023-189653","title":"Proinflammatory Cytokine Release and Infusional Side-Effects after Anti-Thymocyte Globulin Serotherapy for Graft-Versus-Host Disease Prophylaxis in Allogeneic Hematopoietic Cell Transplantation","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Internal medicine; Cumulative incidence; Transplantation; Graft-versus-host disease; Anti-thymocyte globulin; Hematopoietic stem cell transplantation; Immunology; Gastroenterology; Busulfan","score_opus":0.010411248300024399,"score_gpt":0.2462467807815661,"score_spread":0.23583553248154168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389220410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949423,0.0008202103,0.00022349777,0.0003320367,0.00013655883,0.0031741858,0.00013196265,0.00017400627,0.0000652055],"genre_scores_gemma":[0.9962602,0.0011559476,0.00080905866,0.00012665706,0.00010882138,0.0010495617,0.00030291104,0.00007855342,0.000108279455],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99800134,0.00009171933,0.00049098756,0.00055741315,0.00041576073,0.00044280855],"domain_scores_gemma":[0.99888396,0.0003424148,0.00009176568,0.00028664627,0.00007455014,0.0003206585],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028101535,0.00032099325,0.00041870165,0.0003143294,0.00007633852,0.000027296535,0.000080179074,0.0001650611,0.000021638369],"category_scores_gemma":[0.000049822353,0.00030042886,0.00013026294,0.00043145995,0.00007567052,0.00012289576,0.000015077805,0.00016482979,0.000051701532],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016505642,0.002050328,0.27901155,0.025779918,0.00024797046,0.0067914133,0.0040604784,0.000082908366,0.6634768,0.00016866282,0.000045603396,0.0017787099],"study_design_scores_gemma":[0.030530205,0.0009354559,0.74953264,0.0011777794,0.00062946946,0.00010441641,0.00009514359,0.00020732974,0.21601322,0.00011673778,0.00016187069,0.00049571734],"about_ca_topic_score_codex":0.000013180586,"about_ca_topic_score_gemma":0.000029462804,"teacher_disagreement_score":0.4705211,"about_ca_system_score_codex":0.000037057576,"about_ca_system_score_gemma":0.00020310396,"threshold_uncertainty_score":0.9999448},"labels":[],"label_agreement":null},{"id":"W4389220419","doi":"10.1182/blood-2023-179596","title":"Sodium-Glucose Co-Transporter-2 Inhibitor Use in the Setting of Myeloproliferative Neoplasms: Impact on Hemoglobin/Hematocrit Levels and Thrombosis Risk","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Internal medicine; Polycythemia vera; Essential thrombocythemia; Gastroenterology; Myelofibrosis; Anagrelide; Myeloproliferative neoplasm; Hematocrit; Thrombosis; Diabetes mellitus; Surgery; Endocrinology; Bone marrow","score_opus":0.034838825285021836,"score_gpt":0.31634320086731366,"score_spread":0.2815043755822918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389220419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99658495,0.000165979,0.000003836146,0.0009123915,0.00005464987,0.001414768,0.00054787175,0.00007267883,0.00024287189],"genre_scores_gemma":[0.9983755,0.00047359467,0.00030282693,0.00032471155,0.00010915949,0.0002412725,0.000104946,0.000041464784,0.000026560843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977415,0.00021634829,0.00056584284,0.0005001261,0.00051343034,0.00046272235],"domain_scores_gemma":[0.9980578,0.0010472003,0.00020741214,0.00042727694,0.00010804893,0.0001523021],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057011336,0.0004010483,0.00075369194,0.00025294482,0.00016730004,0.00006412447,0.000107412256,0.00013984201,0.000058924918],"category_scores_gemma":[0.00023022304,0.00024262124,0.00019982728,0.00060779316,0.00011274294,0.00016902864,0.000030531763,0.0003638992,0.00004304198],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002221876,0.0016664156,0.98635095,0.0001344151,0.00048522756,0.0002030102,0.0067517464,0.000018018882,0.0028011224,0.00020350091,0.00067128695,0.000492116],"study_design_scores_gemma":[0.006083392,0.0012788817,0.87961024,0.00043330292,0.00038846274,0.000058126087,0.0009057603,0.00009868257,0.11076487,0.00012460534,0.00005095395,0.00020270905],"about_ca_topic_score_codex":0.0002638449,"about_ca_topic_score_gemma":0.000243825,"teacher_disagreement_score":0.10796374,"about_ca_system_score_codex":0.000054256507,"about_ca_system_score_gemma":0.00013568897,"threshold_uncertainty_score":0.9893807},"labels":[],"label_agreement":null},{"id":"W4389220424","doi":"10.1182/blood-2023-185491","title":"“Advancing a More Inclusive Blood and Transplant System for Marginalized Groups”: Development and Evaluation of a Transfusion Medicine Health Equity and Advocacy Curriculum","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Blood donation and transfusion practices","field":"Business, Management and Accounting","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Carleton University; University of British Columbia; University of Manitoba; Canadian Blood Services; University of Toronto; Stem Cell Network","funders":"","keywords":"Curriculum; Donation; Health equity; Equity (law); Ethnic group; Inclusion (mineral); Health care; Medicine; Public relations; Political science; Medical education; Sociology; Gender studies; Law","score_opus":0.031447888274761256,"score_gpt":0.3202709898345491,"score_spread":0.28882310155978785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389220424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918915,0.0015054818,0.0005445729,0.0041919616,0.00010685346,0.0012008026,0.000007817005,0.000103337356,0.0004476832],"genre_scores_gemma":[0.99793977,0.00077933696,0.0006356891,0.00030358828,0.0001197561,0.00011945721,0.00007782725,0.000018567349,0.0000060073894],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983629,0.000045715875,0.00045568778,0.00033765682,0.00056285836,0.00023520908],"domain_scores_gemma":[0.9991974,0.00013265974,0.0002795393,0.00009119303,0.00025860278,0.000040566232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029446525,0.00017651102,0.00034903738,0.00031696056,0.00038079818,0.000056895584,0.00007361393,0.000057447684,0.000014051846],"category_scores_gemma":[0.00010126891,0.00014750464,0.000026727788,0.0003943986,0.000060822735,0.000494957,0.00009743019,0.000077860146,9.221303e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001463025,0.0038228845,0.15578078,0.061480317,0.0018461286,0.00009575734,0.057282258,0.00009327846,0.032748733,0.059692096,0.0005563203,0.6251384],"study_design_scores_gemma":[0.24930738,0.0014590912,0.45518067,0.015402271,0.020059139,0.0006215173,0.111495234,0.09381369,0.010817425,0.012072691,0.026273081,0.0034978138],"about_ca_topic_score_codex":0.0006467131,"about_ca_topic_score_gemma":0.00053932244,"teacher_disagreement_score":0.6216406,"about_ca_system_score_codex":0.0000158508,"about_ca_system_score_gemma":0.00009945572,"threshold_uncertainty_score":0.60150653},"labels":[],"label_agreement":null},{"id":"W4389220524","doi":"10.1182/blood-2023-178794","title":"Disease-Modifying Therapies for Sickle Cell Disease: Decisional Needs and Supports Among Adolescents and Young Adults","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Thematic analysis; Medicine; Disease; Young adult; Health care; Family medicine; Gerontology; Disease management; Qualitative research; Internal medicine","score_opus":0.007710881785310321,"score_gpt":0.23438846473576394,"score_spread":0.22667758295045362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389220524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99257195,0.006035678,0.000022569142,0.0003813942,0.00013570568,0.0005932043,0.00006495982,0.000103047205,0.000091466805],"genre_scores_gemma":[0.9973508,0.0015881857,0.00006124106,0.00013838074,0.00009222311,0.00004319841,0.00009817995,0.000034112858,0.000593671],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99902034,0.000014471448,0.00017800683,0.00026745652,0.00022120775,0.00029852855],"domain_scores_gemma":[0.9992426,0.00004776979,0.00004389916,0.00016616129,0.000047517082,0.00045202562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010239034,0.00015775484,0.00018572393,0.00013554207,0.00016169435,0.00003387963,0.000043175845,0.00007345936,0.000014741901],"category_scores_gemma":[0.000070263646,0.00012547939,0.00007727845,0.00018243723,0.00009997087,0.0000735711,0.000059182665,0.00010017799,0.000007397285],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000589236,0.00040562588,0.9914263,0.00077118864,0.00006741598,0.00017957408,0.0009334571,0.000003787623,0.0003646207,0.000023604465,0.0012708865,0.003964296],"study_design_scores_gemma":[0.0074247993,0.00011398936,0.9874158,0.00073989347,0.0004004096,0.000012691397,0.001261548,0.001037231,0.000081634455,0.0003282027,0.0009846439,0.000199192],"about_ca_topic_score_codex":0.000014262202,"about_ca_topic_score_gemma":0.0000038589005,"teacher_disagreement_score":0.006835563,"about_ca_system_score_codex":0.00000603857,"about_ca_system_score_gemma":0.00005860775,"threshold_uncertainty_score":0.51169014},"labels":[],"label_agreement":null},{"id":"W4389220704","doi":"10.1182/blood-2023-185951","title":"Real World Experience of FLT3-Inhibitor Post-Transplant Maintenance with Sorafenib Demonstrating Superior Overall- and Relapse Free Survival Following Allogeneic Hematopoietic Stem Cell Transplantation in FLT3-ITD Mutated Acute Myeloid Leukemia","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Sorafenib; Medicine; Oncology; Internal medicine; Tolerability; Transplantation; Clinical endpoint; Maintenance therapy; Hematopoietic stem cell transplantation; Fms-Like Tyrosine Kinase 3; Clinical trial; Adverse effect; Chemotherapy; Hepatocellular carcinoma; Biology","score_opus":0.011523159327589955,"score_gpt":0.2510350328995918,"score_spread":0.23951187357200182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389220704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976728,0.00016523042,0.000077910314,0.00023744792,0.00011803178,0.0009533031,0.00014559885,0.00018276523,0.00044690067],"genre_scores_gemma":[0.9966835,0.0006836515,0.0016095673,0.0000397614,0.00005982312,0.00011951304,0.00017762961,0.00009296997,0.0005335975],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965746,0.00017266421,0.0007988517,0.0007452215,0.0008434917,0.00086519244],"domain_scores_gemma":[0.99858224,0.00032069473,0.00015886499,0.0005212322,0.00013362932,0.00028331327],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005755217,0.00042229376,0.00081042247,0.00047264813,0.00014375076,0.00004620031,0.000305183,0.00019343047,0.00001511294],"category_scores_gemma":[0.000031718304,0.00036102635,0.00014674138,0.001118028,0.00022233438,0.0002901086,0.000073085306,0.0005815302,0.000011153206],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017207738,0.00017758133,0.19332825,0.00082810054,0.00026766447,0.0078685675,0.014418148,0.000066827364,0.781037,0.00006395679,0.000021436397,0.00020172964],"study_design_scores_gemma":[0.03396978,0.0012107282,0.23616526,0.0031099473,0.0012609028,0.0012475142,0.00941625,0.0010892245,0.711459,0.000040628845,0.000011400562,0.0010194073],"about_ca_topic_score_codex":0.0011126179,"about_ca_topic_score_gemma":0.0015676288,"teacher_disagreement_score":0.069578,"about_ca_system_score_codex":0.00024046199,"about_ca_system_score_gemma":0.00075253745,"threshold_uncertainty_score":0.9998842},"labels":[],"label_agreement":null},{"id":"W4389220730","doi":"10.1182/blood-2023-182019","title":"Favezelimab in Combination with Pembrolizumab in Patients with Heavily Pretreated Anti-PD-1-Refractory Classical Hodgkin Lymphoma: Updated Analysis of an Open-Label Phase 1/2 Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Refractory (planetary science); Oncology; Cohort; Salvage therapy; Neutropenia; Chemotherapy regimen; Chemotherapy; Gastroenterology; Cancer; Immunotherapy","score_opus":0.020525088306902833,"score_gpt":0.307566127537709,"score_spread":0.28704103923080615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389220730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99758786,0.000022059317,0.0000010116859,0.00006188729,0.00001623738,0.0019906943,0.00009774795,0.00006948375,0.0001530061],"genre_scores_gemma":[0.9975154,0.000009453745,0.000082453385,0.00003314697,0.0000054369534,0.00020218026,0.002084634,0.000038997252,0.000028340271],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977334,0.00020187063,0.0005225636,0.00060369575,0.0005927264,0.00034570612],"domain_scores_gemma":[0.9988132,0.00006772624,0.00021236908,0.0005554752,0.00019992332,0.00015131451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021053903,0.00029203517,0.0009611271,0.001103107,0.000050085182,0.000043459826,0.00018626326,0.00010039244,0.000025354097],"category_scores_gemma":[0.000030140533,0.00020675112,0.000037423404,0.0039795474,0.00006458934,0.0002738043,0.00008350074,0.00008825163,0.000007309444],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038636895,0.19926758,0.790856,0.000016543325,0.0017320951,0.0005770857,0.0005229185,0.00002317357,0.00009545282,0.000010299221,0.000016564123,0.0030186162],"study_design_scores_gemma":[0.24154447,0.017208906,0.73649424,0.00008789177,0.0025597857,0.0000028363766,0.0002484131,0.0010572696,0.0006252323,0.0000018125187,0.000004581035,0.00016454252],"about_ca_topic_score_codex":0.0009771439,"about_ca_topic_score_gemma":0.0010511378,"teacher_disagreement_score":0.23768078,"about_ca_system_score_codex":0.00024289427,"about_ca_system_score_gemma":0.0002216908,"threshold_uncertainty_score":0.8431066},"labels":[],"label_agreement":null},{"id":"W4389220741","doi":"10.1182/blood-2023-186199","title":"Loss of Platelet 12-Lipoxygenase Aggravates the Severity of Sars-Cov-2 Infection","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Inflammasome and immune disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Inflammation; Knockout mouse; Immunology; Platelet; Platelet activation; Biology; Chemokine; Proinflammatory cytokine; Receptor","score_opus":0.013493715985908724,"score_gpt":0.24931901597286718,"score_spread":0.23582529998695845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389220741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99904263,0.00022757663,0.000011046245,0.000049402057,0.00006910919,0.000096787444,0.000017744518,0.000010395459,0.00047529896],"genre_scores_gemma":[0.9992779,0.00045412686,0.00001106148,0.00003505595,0.000036984315,0.000007957134,0.00008972119,0.000009321321,0.000077862016],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99950296,0.000031523,0.00015812389,0.00011152976,0.00007196723,0.00012388256],"domain_scores_gemma":[0.9995997,0.0000081660155,0.00008536533,0.00024785026,0.000051302053,0.000007629642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001399893,0.000075358264,0.000096491574,0.000030039737,0.0000388228,0.0000039886195,0.000101109465,0.00008004937,0.0000041229546],"category_scores_gemma":[0.000056014782,0.0000584987,0.000087294415,0.00012589915,0.0000827056,0.0000023620494,0.00006829364,0.000045639645,0.000010578245],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032180473,0.000088827794,0.008319785,0.000035742865,0.00010233516,0.0000017138807,0.00009453997,0.0000123544305,0.98952436,0.00001896528,0.000835332,0.00093386596],"study_design_scores_gemma":[0.0005734666,0.00012962511,0.015409793,0.0000086822565,0.000021720603,0.000007085695,0.000035429126,0.000008808713,0.97664154,0.00009055866,0.007004751,0.00006852927],"about_ca_topic_score_codex":0.0001330749,"about_ca_topic_score_gemma":0.00007814481,"teacher_disagreement_score":0.012882806,"about_ca_system_score_codex":0.0000011066302,"about_ca_system_score_gemma":0.00002636906,"threshold_uncertainty_score":0.23855077},"labels":[],"label_agreement":null},{"id":"W4389220744","doi":"10.1182/blood-2023-188076","title":"A Translational Approach to Identifying and Targeting TNF Signaling in Idiopathic Multicentric Castleman Disease","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Cytokine; Medicine; Ionomycin; Tumor necrosis factor alpha; Interleukin 6; Immunology; Inflammation; Cytotoxic T cell; Immune system; Internal medicine; Stimulation; Biology","score_opus":0.027330632107251795,"score_gpt":0.2771036555470527,"score_spread":0.2497730234398009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389220744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962961,0.002251609,0.00020718675,0.00045805852,0.000039184164,0.0003278937,0.000008935004,0.00006899713,0.00034199818],"genre_scores_gemma":[0.99913114,0.000054628163,0.00043555687,0.00016093417,0.00007401752,0.00003603827,0.00004075273,0.000018088955,0.000048831662],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990583,0.000033009936,0.00019439451,0.00023791971,0.0002208901,0.0002554565],"domain_scores_gemma":[0.9996758,0.000024814291,0.000033309087,0.000066340755,0.0000251549,0.00017459961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030615492,0.00009142188,0.00016201292,0.00020805291,0.0000760345,0.00002423975,0.000034142533,0.000042635987,0.000008230666],"category_scores_gemma":[0.00015167617,0.00009213639,0.00004528418,0.0006022435,0.00001286024,0.00005671214,0.000018426941,0.00012279785,0.000013723582],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053208263,0.0016352017,0.9344039,0.0017834303,0.0002130346,0.00064843794,0.017409993,0.005614709,0.029434534,0.0003619295,0.0004242647,0.0075384723],"study_design_scores_gemma":[0.028480858,0.00018637652,0.9203351,0.0011750557,0.0008324455,0.000022054379,0.008741347,0.03701134,0.0011195383,0.0010375533,0.00027386262,0.0007844802],"about_ca_topic_score_codex":0.000056845274,"about_ca_topic_score_gemma":0.000010012472,"teacher_disagreement_score":0.03139663,"about_ca_system_score_codex":0.000021769958,"about_ca_system_score_gemma":0.000071186674,"threshold_uncertainty_score":0.3757213},"labels":[],"label_agreement":null},{"id":"W4389220803","doi":"10.1182/blood-2023-174510","title":"3-Year Analysis of ZUMA-12: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) As First-Line Therapy in Patients with High-Risk Large B-Cell Lymphoma (LBCL)","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Internal medicine; Fludarabine; Chemotherapy regimen; Phases of clinical research; International Prognostic Index; Regimen; Diffuse large B-cell lymphoma; Interim analysis; Surgery; Oncology; Lymphoma; Cyclophosphamide; Chemotherapy; Clinical trial","score_opus":0.01785151884795993,"score_gpt":0.2935026324855429,"score_spread":0.275651113637583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389220803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997653,0.00014099704,0.000005126361,0.000038061702,0.000032706826,0.0014491716,0.00020687739,0.000059369853,0.0004147011],"genre_scores_gemma":[0.9978167,0.00054790714,0.00004809808,0.000033138625,0.00004683184,0.00008051739,0.00024104344,0.00006825123,0.0011175057],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968692,0.00020353608,0.0006711458,0.00054242386,0.0012010313,0.0005126734],"domain_scores_gemma":[0.99803036,0.00018903721,0.00029212565,0.0009948979,0.0003133602,0.00018023797],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006940915,0.00028406217,0.0010302064,0.0012975946,0.00006652448,0.000012497552,0.00027703043,0.00012004016,0.0011585705],"category_scores_gemma":[0.00008807436,0.00022482012,0.00022669716,0.0035972085,0.00007526853,0.000056567547,0.00011069433,0.00020122358,0.000031672775],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071588275,0.10362299,0.86825323,0.000087463835,0.004302098,0.00014629077,0.0028867158,0.00008027854,0.0070632775,0.0000044616154,0.00005935601,0.006335007],"study_design_scores_gemma":[0.24048768,0.023704436,0.6983905,0.00006251624,0.002117923,9.75832e-7,0.0009916833,0.0003251329,0.033367813,0.000012938499,0.0002692268,0.00026921195],"about_ca_topic_score_codex":0.0016361135,"about_ca_topic_score_gemma":0.00079946575,"teacher_disagreement_score":0.23332886,"about_ca_system_score_codex":0.00006154928,"about_ca_system_score_gemma":0.00014255787,"threshold_uncertainty_score":0.9997545},"labels":[],"label_agreement":null},{"id":"W4389220807","doi":"10.1182/blood-2023-190815","title":"Risk of Recurrent Venous Thromboembolism in Patients with Acute Isolated Subsegmental Pulmonary Embolism - a Single Center Chart Review","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Pulmonary embolism; Overdiagnosis; Retrospective cohort study; Incidence (geometry); Concomitant; Deep vein; Single Center; Case fatality rate; Medical record; Surgery; Thrombosis; Internal medicine; Pediatrics; Epidemiology","score_opus":0.009288579212698374,"score_gpt":0.23579283312560836,"score_spread":0.22650425391291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389220807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935416,0.0025313974,0.0000027786173,0.00038714975,0.00023224438,0.0018897797,0.0001619496,0.00012165558,0.0011314601],"genre_scores_gemma":[0.9781002,0.020286247,0.00008908012,0.00056880433,0.000069980764,0.00012907729,0.00063071935,0.000066626024,0.000059271206],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978174,0.0000892095,0.0005785406,0.00046506053,0.0005278433,0.0005219368],"domain_scores_gemma":[0.9989187,0.000026752183,0.00027747653,0.0005130509,0.0001148463,0.0001491863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024837413,0.00028899856,0.0011222648,0.00027288296,0.00006455891,0.000011956616,0.00016856712,0.0000865031,0.000116438096],"category_scores_gemma":[0.00003047043,0.00024098878,0.00015863773,0.0008057438,0.000067393084,0.000112435606,0.0001522787,0.00023813841,0.000112867485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011651898,0.13062403,0.77221024,0.0078521585,0.0062800357,0.001658431,0.0028410517,0.000008884646,0.0020022872,0.00018181976,0.016158974,0.059016902],"study_design_scores_gemma":[0.0063830707,0.0026049903,0.98130685,0.0049924096,0.0021758892,0.000031493324,0.00006521053,0.000022803848,0.00041926786,0.000028338834,0.0016615998,0.00030805657],"about_ca_topic_score_codex":0.00008488417,"about_ca_topic_score_gemma":0.000016958295,"teacher_disagreement_score":0.20909663,"about_ca_system_score_codex":0.00006147293,"about_ca_system_score_gemma":0.000046636633,"threshold_uncertainty_score":0.9827237},"labels":[],"label_agreement":null},{"id":"W4389220819","doi":"10.1182/blood-2023-186260","title":"Circadian Rhythms Metabolically Regulate Bone Marrow Retained Primitive Hematopoietic Stem Cell Size and Function","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Stem cell; Haematopoiesis; GLUT3; Bone marrow; Cell biology; Circadian rhythm; Biology; Hematopoietic stem cell; Circadian clock; Glycolysis; Mitochondrion; Progenitor cell; Chemistry; Glucose uptake; Endocrinology; GLUT1; Immunology; Metabolism","score_opus":0.01610643208132054,"score_gpt":0.24603882943341102,"score_spread":0.22993239735209048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389220819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866935,0.0016536597,0.000036327747,0.0074001425,0.00024299415,0.0006302792,0.000022097112,0.00044284493,0.0028781248],"genre_scores_gemma":[0.9910106,0.00014282978,0.00035237064,0.0014652035,0.00042796208,0.00004134258,0.00003523537,0.000068141446,0.006456302],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9978517,0.00014749262,0.00048369664,0.00055822206,0.0005089465,0.00044990858],"domain_scores_gemma":[0.9985414,0.00027213318,0.00016489459,0.0005393103,0.00011136076,0.00037088516],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00070470665,0.00025830205,0.0006178222,0.00014205356,0.00012073968,0.000040146766,0.00007055184,0.00017293014,0.000096036616],"category_scores_gemma":[0.00013776952,0.00025330271,0.00014856031,0.00055066095,0.0001103898,0.00009943161,0.00008784244,0.00027312842,0.00016987037],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071295267,0.008649777,0.06893604,0.018112686,0.0075245076,0.0070809224,0.11493309,0.00004047567,0.6497242,0.024064714,0.048137117,0.04566693],"study_design_scores_gemma":[0.021269387,0.00140237,0.89195275,0.00073929556,0.0028913547,0.001123049,0.004913722,0.00011799674,0.05721706,0.002195469,0.015050276,0.0011272752],"about_ca_topic_score_codex":0.000063231855,"about_ca_topic_score_gemma":0.000035916342,"teacher_disagreement_score":0.8230167,"about_ca_system_score_codex":0.000029710118,"about_ca_system_score_gemma":0.00014106533,"threshold_uncertainty_score":0.9999919},"labels":[],"label_agreement":null},{"id":"W4389220823","doi":"10.1182/blood-2023-187244","title":"DNMT3A R882H Exhibits Greater Inflammatory Potential Than R882C in Primary Hematopoietic Stem and Progenitor Cell Knock-in Model and Population Data","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Biology; Transcriptome; Progenitor cell; Haematopoiesis; Population; Gene expression profiling; Stem cell; Genetics; Molecular biology; Gene; Gene expression","score_opus":0.029034376282497443,"score_gpt":0.26543246076238547,"score_spread":0.23639808447988803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389220823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981938,0.0003961933,0.0000088532015,0.0002817285,0.00002866551,0.000789464,0.00002739287,0.00007613089,0.00019779257],"genre_scores_gemma":[0.99843216,0.00012064038,0.00033512097,0.000048915328,0.00009944623,0.000045609137,0.00022244474,0.000045005385,0.00065064133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983091,0.00007412793,0.00033939927,0.00052735704,0.00035560853,0.00039441237],"domain_scores_gemma":[0.99916637,0.00003602758,0.000053385018,0.0005637532,0.000032189924,0.00014830408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045086938,0.00017616752,0.0003073952,0.00035798823,0.00004542612,0.0000357468,0.0001616903,0.00015487189,0.0000050255276],"category_scores_gemma":[0.000023713945,0.00016106605,0.00002250209,0.00030781268,0.000052191448,0.00024980208,0.0005440387,0.0002923946,0.000025209052],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027144878,0.0002670875,0.9497325,0.0012697148,0.000048595553,0.0011990399,0.0009365435,0.00008780941,0.043782543,0.000015169129,0.0004907708,0.0018988214],"study_design_scores_gemma":[0.010241953,0.00013201084,0.9307286,0.0002908227,0.00013453666,0.0002467065,0.0002655673,0.050385095,0.007141242,0.00010173579,0.00002865258,0.0003030416],"about_ca_topic_score_codex":0.0001310506,"about_ca_topic_score_gemma":0.000072290415,"teacher_disagreement_score":0.050297286,"about_ca_system_score_codex":0.00008368706,"about_ca_system_score_gemma":0.00018344301,"threshold_uncertainty_score":0.6568083},"labels":[],"label_agreement":null},{"id":"W4389220841","doi":"10.1182/blood-2023-174929","title":"A Phase I/II Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of Glofitamab As Monotherapy and in Combination with R-ICE Chemoimmunotherapy in Children and Young Adults with Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (iMATRIX-GLO)","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Chemoimmunotherapy; Medicine; Tumor lysis syndrome; Neutropenia; Internal medicine; Population; Febrile neutropenia; Rituximab; Cytokine release syndrome; Oncology; Tolerability; Lymphoma; Gastroenterology; Cancer; Adverse effect; Chemotherapy; Immunotherapy; Chimeric antigen receptor","score_opus":0.010659493861115539,"score_gpt":0.30349722035288157,"score_spread":0.29283772649176604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389220841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938626,0.0012820533,0.000006291702,0.00064359664,0.000031382024,0.003902574,0.000016089201,0.00003469914,0.00022071406],"genre_scores_gemma":[0.99504733,0.004108558,0.00013716868,0.00012742137,0.000061000854,0.00011633863,0.00003486599,0.000069531314,0.00029778303],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99801207,0.00017200792,0.0004163113,0.0004838664,0.0005585468,0.0003571778],"domain_scores_gemma":[0.9990566,0.00023909134,0.00011285819,0.0003560864,0.00010962996,0.0001257358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009955072,0.00027680933,0.00049739267,0.00041018732,0.000088604786,0.000037047343,0.00014038186,0.00010095437,0.000050536008],"category_scores_gemma":[0.000048359583,0.00019253635,0.000035571476,0.00085688505,0.0001899638,0.00009318493,0.0000738648,0.0002479587,0.0000025122556],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5295227,0.012491496,0.033685423,0.00015021904,0.0005402173,0.00008850754,0.012402787,0.000017584047,0.2234015,0.000008807708,0.000061702376,0.18762903],"study_design_scores_gemma":[0.7380643,0.02060133,0.2073425,0.0003246835,0.00015339794,0.00012979863,0.00028427024,0.000629009,0.032051794,0.000017521068,0.00014095329,0.0002604398],"about_ca_topic_score_codex":0.0006509731,"about_ca_topic_score_gemma":0.000095147014,"teacher_disagreement_score":0.20854157,"about_ca_system_score_codex":0.000062876315,"about_ca_system_score_gemma":0.00016980573,"threshold_uncertainty_score":0.78514045},"labels":[],"label_agreement":null},{"id":"W4389220971","doi":"10.1182/blood-2023-174209","title":"Mosunetuzumab Plus Polatuzumab Vedotin Demonstrates a Favorable Safety Profile and Efficacy in Patients (Pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL): Primary Analysis of a Phase Ib/II Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Follicular lymphoma; Internal medicine; Cytokine release syndrome; Regimen; Lymphoma; Interim analysis; Clinical endpoint; Refractory (planetary science); Gastroenterology; Diffuse large B-cell lymphoma; Oncology; Clinical trial; Cancer; Immunotherapy; Chimeric antigen receptor","score_opus":0.015396412424737509,"score_gpt":0.28835124940416645,"score_spread":0.27295483697942896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389220971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99536157,0.0003124174,0.0000033566298,0.000027122953,0.000024599929,0.002496994,0.00016081183,0.0001154086,0.0014977138],"genre_scores_gemma":[0.9954981,0.00012646898,0.00016981142,0.000032733624,0.000026279811,0.00010364872,0.0005054843,0.00007543284,0.0034620324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966424,0.00026963901,0.0007394857,0.0007344897,0.00092894566,0.00068505044],"domain_scores_gemma":[0.99817145,0.00035041483,0.00024527984,0.0007642891,0.00021156362,0.00025697995],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007506445,0.00035128102,0.0011490118,0.0011695853,0.00016949754,0.000028912746,0.00020944128,0.00016372114,0.000416089],"category_scores_gemma":[0.00016131863,0.0002698148,0.00014495222,0.0040952424,0.00012858535,0.00013350173,0.00021801841,0.00033697448,0.000014929828],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.063374765,0.20011914,0.65059596,0.0008692059,0.007551575,0.0013653758,0.01261862,0.000074089454,0.03999279,0.0000069295265,0.0003201329,0.023111429],"study_design_scores_gemma":[0.31984973,0.02201111,0.6446526,0.00023341867,0.0033408506,0.0000125790475,0.002470951,0.0025135588,0.0040345783,0.0000023858472,0.00040752048,0.00047070367],"about_ca_topic_score_codex":0.000336682,"about_ca_topic_score_gemma":0.0003017367,"teacher_disagreement_score":0.25647494,"about_ca_system_score_codex":0.00033258423,"about_ca_system_score_gemma":0.00094343914,"threshold_uncertainty_score":0.9999754},"labels":[],"label_agreement":null},{"id":"W4389220987","doi":"10.1182/blood-2023-182013","title":"Impact of Publicly Reported Center Specific Analysis on Patient Selection Practices for Hematopoietic Stem Cell Transplantation","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"","keywords":"Medicine; Transplantation; Population; Hematopoietic cell; Confidence interval; Hematopoietic stem cell transplantation; Multivariate analysis; Internal medicine; Stem cell; Haematopoiesis; Biology; Environmental health","score_opus":0.0922351297299126,"score_gpt":0.3607577900702736,"score_spread":0.268522660340361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389220987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99814177,0.000050228908,0.00031247005,0.00009423141,0.00003877974,0.0003239883,0.000038073882,0.000055433782,0.00094503263],"genre_scores_gemma":[0.99935955,0.000075288444,0.00016365618,0.00002457644,0.000042011234,0.000026536443,0.00018937995,0.00000953411,0.0001094808],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900144,0.000025806525,0.00030537153,0.00021657349,0.00028743345,0.00016339438],"domain_scores_gemma":[0.99910706,0.00007013229,0.00042877748,0.00015648398,0.00017473253,0.000062808256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001935694,0.0000874307,0.00021763236,0.00027334242,0.000040933504,0.000019364526,0.000033541866,0.00004885797,0.000041377945],"category_scores_gemma":[0.000025161817,0.00007056453,0.00024215961,0.0010511689,0.0000087555245,0.000110902394,0.0000037664677,0.00006417691,0.000007852403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017474784,0.001249938,0.96075505,0.00036099658,0.0020498906,0.00011058955,0.0021238194,0.0009548566,0.025042778,0.00003182654,0.0019737547,0.0035990311],"study_design_scores_gemma":[0.0059861825,0.005352818,0.8529033,0.00022208394,0.0056472286,0.00022131199,0.0014949661,0.0011154804,0.12594053,0.000030291625,0.0008189298,0.00026687022],"about_ca_topic_score_codex":0.00020047875,"about_ca_topic_score_gemma":0.00004843209,"teacher_disagreement_score":0.107851736,"about_ca_system_score_codex":0.000042988624,"about_ca_system_score_gemma":0.000057244448,"threshold_uncertainty_score":0.2877538},"labels":[],"label_agreement":null},{"id":"W4389221050","doi":"10.1182/blood-2023-184531","title":"Results from an Intergroup Randomized Phase II Study of the Combinations of Ipilimumab, Nivolumab and Brentuximab Vedotin in Patients with Relapsed/Refractory Classic Hodgkin Lymphoma: A Trial of the ECOG-ACRIN Research Group (E4412)","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC","funders":"","keywords":"Brentuximab vedotin; Nivolumab; Medicine; Ipilimumab; Internal medicine; Refractory (planetary science); Oncology; Phases of clinical research; Lymphoma; Gastroenterology; Clinical trial; CD30; Immunotherapy; Cancer","score_opus":0.02715352419553314,"score_gpt":0.3111144662650398,"score_spread":0.28396094206950667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389221050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99513847,0.000080933736,2.2219876e-7,0.00018360573,0.00017579462,0.004081636,0.0002028964,0.00001692625,0.00011954832],"genre_scores_gemma":[0.99945253,0.00004443801,0.000016482507,0.000009275205,0.000027930884,0.00027994817,0.00009346957,0.000024832234,0.000051108575],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99633646,0.0012450226,0.0008972908,0.0004043328,0.0008712276,0.00024563665],"domain_scores_gemma":[0.99723786,0.0011504763,0.00045015058,0.0008558692,0.0002326007,0.00007303931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012562013,0.00019231389,0.000845967,0.00026494992,0.00014610963,0.0000124958,0.00026626687,0.00008652936,0.000007423792],"category_scores_gemma":[0.00079366216,0.00010371984,0.00014662769,0.0008371238,0.00039497798,0.00008815324,0.0003012203,0.00016490133,9.1250837e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6236203,0.26886147,0.08584488,0.000053637596,0.00095708086,0.000018586295,0.011119719,0.0000020771076,0.00032437642,0.000099736986,0.00016331661,0.00893483],"study_design_scores_gemma":[0.6578576,0.012538294,0.3268446,0.00027181886,0.00041488625,6.4972784e-7,0.0011454484,0.000053656342,0.0007288709,0.000074628195,0.000008996559,0.000060526905],"about_ca_topic_score_codex":0.0020089184,"about_ca_topic_score_gemma":0.0011151166,"teacher_disagreement_score":0.2563232,"about_ca_system_score_codex":0.000103110404,"about_ca_system_score_gemma":0.00018531246,"threshold_uncertainty_score":0.42295724},"labels":[],"label_agreement":null},{"id":"W4389221062","doi":"10.1182/blood-2023-177658","title":"Pre-Operative Coagulation Test Results Do Not Correlate with Self-Bleeding Assessment Tool (Self-BAT) Scores","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; St Joseph's Health Centre; St. Michael's Hospital","funders":"","keywords":"Medicine; Partial thromboplastin time; Von Willebrand disease; Von Willebrand factor; Coagulation testing; Perioperative; Prothrombin time; Bleeding time; Hemostasis; Bleeding diathesis; Surgery; Elective surgery; Coagulation; Antithrombotic; Prospective cohort study; Internal medicine; Platelet","score_opus":0.013096354277451929,"score_gpt":0.2863028573309391,"score_spread":0.27320650305348715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389221062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924604,0.000052329357,0.000021655671,0.00047323215,0.00008874291,0.00083047093,0.0000817988,0.00048371925,0.0055076247],"genre_scores_gemma":[0.9958339,0.00014137718,0.002417767,0.000086361375,0.00007638803,0.00008504516,0.0003083203,0.00003611401,0.0010147804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857444,0.000026496504,0.0002890006,0.0003957058,0.00039595948,0.00031839198],"domain_scores_gemma":[0.9992174,0.00019616124,0.00011649563,0.00025566368,0.00011455858,0.000099756246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018574124,0.00022041552,0.00032260045,0.0001290533,0.00018259027,0.00006841653,0.00006154664,0.00009551764,0.000020652664],"category_scores_gemma":[0.0000737547,0.00016070167,0.00005160749,0.00041193125,0.000026555996,0.00016080777,0.000040173894,0.00017942626,0.00011531415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012383405,0.0069148624,0.96668553,0.00023655544,0.002636056,0.003651916,0.0055965176,0.0005625119,0.0063971477,0.0005050935,0.0025357234,0.0030397144],"study_design_scores_gemma":[0.021944052,0.0022356599,0.9646012,0.00038505052,0.0010636316,0.00019927381,0.0002653399,0.004769207,0.003686677,0.000059232774,0.00048056722,0.00031010894],"about_ca_topic_score_codex":0.000037198082,"about_ca_topic_score_gemma":0.000019557574,"teacher_disagreement_score":0.020705711,"about_ca_system_score_codex":0.00007188126,"about_ca_system_score_gemma":0.00016232235,"threshold_uncertainty_score":0.65532243},"labels":[],"label_agreement":null},{"id":"W4389221065","doi":"10.1182/blood-2023-184933","title":"PET4 Response As an Independent Predictor of Long-Term Outcomes in ECHELON2 (A+CHP Vs. CHOP) in CD30+PTCL","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Brentuximab vedotin; Oncology; Internal medicine; Progression-free survival; Diffuse large B-cell lymphoma; CHOP; Positron emission tomography; Surrogate endpoint; Prospective cohort study; Chemotherapy regimen; Chemotherapy; Nuclear medicine; Lymphoma; CD30","score_opus":0.023539901021196817,"score_gpt":0.3126062720174304,"score_spread":0.2890663709962336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389221065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977954,0.00016790227,1.6236578e-7,0.0009608531,0.00010326041,0.00057757925,0.0000311907,0.000082489336,0.00028113625],"genre_scores_gemma":[0.99880254,0.00014192896,0.00004232332,0.00016342236,0.000041611143,0.00014714642,0.000046854584,0.000027886768,0.0005862873],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998352,0.00013200886,0.0004314667,0.00035333142,0.00040756667,0.0003236218],"domain_scores_gemma":[0.99902815,0.00022807115,0.00008587355,0.00045929686,0.000037480964,0.00016115689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047827317,0.00019215274,0.00049265154,0.0004317107,0.000020148926,0.000013474999,0.00012932427,0.00014134847,0.00011512564],"category_scores_gemma":[0.00027163568,0.0001541436,0.00010590912,0.0003999408,0.00003165337,0.000085311345,0.00008318523,0.00012439089,0.00012425109],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010192841,0.004788721,0.9874771,0.000069537615,0.00012416183,0.0032307385,0.0009171196,0.0000019570923,0.0012732644,0.00003141359,0.000045462733,0.0010211931],"study_design_scores_gemma":[0.0160975,0.0010623425,0.96697485,0.00022646418,0.0001237865,0.00006241313,0.00012358543,0.00000903232,0.015121128,0.000039490456,0.000037975322,0.00012143245],"about_ca_topic_score_codex":0.00040493772,"about_ca_topic_score_gemma":0.0006398622,"teacher_disagreement_score":0.0205023,"about_ca_system_score_codex":0.00014292396,"about_ca_system_score_gemma":0.00022356573,"threshold_uncertainty_score":0.6285794},"labels":[],"label_agreement":null},{"id":"W4389221075","doi":"10.1182/blood-2023-182116","title":"Durable Clinical Benefits of Idasanutlin Therapy in Hydroxyurea-Refractory Polycythemia Vera","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Phlebotomy; Medicine; Discontinuation; Clinical trial; Internal medicine; Polycythemia vera; Refractory (planetary science); Thrombocytosis; Surgery; Platelet","score_opus":0.04865075982292039,"score_gpt":0.33139214301040093,"score_spread":0.28274138318748054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389221075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99516684,0.0012602331,3.5579436e-7,0.0008456269,0.00011833231,0.00043817548,0.000021521952,0.000068351146,0.0020805507],"genre_scores_gemma":[0.9938243,0.0050649075,0.00012881911,0.00027099348,0.00018137084,0.00008607829,0.000049005364,0.000028368362,0.0003661725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985556,0.00007041723,0.00051855354,0.00031615043,0.00026454587,0.00027472514],"domain_scores_gemma":[0.99903065,0.00034480356,0.000109039225,0.00033369003,0.00005746177,0.0001243802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034996815,0.00017247407,0.00051921984,0.0001611346,0.000032475662,0.0000072521543,0.00007862678,0.00014677088,0.00018535698],"category_scores_gemma":[0.0001306549,0.0001315786,0.00015628674,0.0003722781,0.000053525066,0.00004524088,0.00003076802,0.00021406457,0.00015248277],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002729954,0.004166782,0.9822088,0.000032357257,0.00025271243,0.00012590161,0.00026936704,0.000012331503,0.0027612236,0.000211079,0.0009968086,0.008689673],"study_design_scores_gemma":[0.011621886,0.0015261765,0.92494744,0.00018850267,0.000077870434,0.000013386527,0.000045654604,0.000029927778,0.059681337,0.00009283247,0.0016530629,0.00012194892],"about_ca_topic_score_codex":0.00007846756,"about_ca_topic_score_gemma":0.00003600346,"teacher_disagreement_score":0.05726136,"about_ca_system_score_codex":0.000023979594,"about_ca_system_score_gemma":0.000117078875,"threshold_uncertainty_score":0.53656197},"labels":[],"label_agreement":null},{"id":"W4389221098","doi":"10.1182/blood-2023-178623","title":"Deciphering the Clinical Benefit of Pola-R-CHP versus R-CHOP in Different Genetic Subtypes Beyond Cell of Origin in the POLARIX Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; Roche (Canada)","funders":"","keywords":"Internal medicine; Oncology; Rituximab; Prednisone; Medicine; Diffuse large B-cell lymphoma; Vincristine; CHOP; Hazard ratio; Cyclophosphamide; Lymphoma; Chemotherapy; Confidence interval","score_opus":0.04947849914337601,"score_gpt":0.3414480010660991,"score_spread":0.29196950192272314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389221098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99778354,0.0007235075,1.6782903e-7,0.00024931954,0.000142411,0.00063358975,0.00000867639,0.000009689016,0.0004491077],"genre_scores_gemma":[0.999528,0.00023781019,0.00003280191,0.000036162226,0.00006913268,0.000051349412,0.0000043456644,0.000011935534,0.000028467162],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987247,0.00010912385,0.0004778221,0.0001996302,0.00029374863,0.00019499368],"domain_scores_gemma":[0.9986112,0.0008014114,0.000096889155,0.0004259147,0.000025097374,0.000039451774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038259858,0.00012658177,0.00035319896,0.00007887243,0.000025081332,0.000007875317,0.00017902158,0.000055244902,0.00001800261],"category_scores_gemma":[0.000076944896,0.00006382736,0.00011094825,0.00036237066,0.000048717156,0.000013227861,0.000074606316,0.000117224474,0.000009964676],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017573668,0.0060201283,0.9901835,0.000024023628,0.000117682626,0.0000934,0.0013937436,0.0000137758325,0.00023946702,0.000057592282,0.000021726191,0.0016592805],"study_design_scores_gemma":[0.013291527,0.0012837468,0.9820996,0.000043946966,0.00030820887,0.0000026979208,0.0015450025,0.000020349264,0.0012453151,0.000050263636,0.000055325163,0.00005402824],"about_ca_topic_score_codex":0.0008894132,"about_ca_topic_score_gemma":0.0013073405,"teacher_disagreement_score":0.01311579,"about_ca_system_score_codex":0.000028305474,"about_ca_system_score_gemma":0.000054329535,"threshold_uncertainty_score":0.26028043},"labels":[],"label_agreement":null},{"id":"W4389221127","doi":"10.1182/blood-2023-188500","title":"Cryoprecipitate-Poor Plasma Instead of Fresh Frozen Plasma As Replacement Therapy in Thrombotic Thrombocytopenic Purpura: A Systematic Review and Meta-Analysis","year":2023,"lang":"en","type":"review","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Thrombotic thrombocytopenic purpura; Cryoprecipitate; Fresh frozen plasma; Thrombotic microangiopathy; Internal medicine; Meta-analysis; Odds ratio; Randomized controlled trial; Confidence interval; Von Willebrand factor; Surgery; Platelet; Disease","score_opus":0.1162903985998209,"score_gpt":0.3536751256181555,"score_spread":0.2373847270183346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389221127","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011236093,0.9871359,7.162371e-7,0.000053404638,0.00015555078,0.010347798,0.00089888816,0.00010203362,0.00018211582],"genre_scores_gemma":[0.0011785396,0.99233,0.000023863668,0.00007851665,0.000010545841,0.0040257364,0.00073200045,0.000105922154,0.0015148803],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99091977,0.003181664,0.0037998145,0.0012276942,0.0002386199,0.00063244003],"domain_scores_gemma":[0.9939163,0.0016124804,0.0024026423,0.0018706431,0.00012929706,0.00006867541],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0018074955,0.0010632909,0.01726009,0.00093275716,0.00011659283,0.00004848389,0.001126796,0.0004832087,0.0030380408],"category_scores_gemma":[0.0005478434,0.0007268338,0.0032662635,0.0015573847,0.00018477268,0.00010596861,0.0005041708,0.00048423617,0.0009407998],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017147058,0.0005517222,0.000024166775,0.603984,0.39427456,0.00002393911,0.00011198916,7.059657e-7,0.000008136892,0.00009605088,0.00075092725,0.00015665217],"study_design_scores_gemma":[0.0020527039,0.00041265608,0.000013341983,0.06995181,0.9188209,0.00012509912,0.00015540235,4.838007e-7,0.000040810773,0.000033039767,0.007689921,0.0007038116],"about_ca_topic_score_codex":0.00025892962,"about_ca_topic_score_gemma":0.0004460816,"teacher_disagreement_score":0.5340322,"about_ca_system_score_codex":0.00010107191,"about_ca_system_score_gemma":0.00029130114,"threshold_uncertainty_score":0.9998371},"labels":[],"label_agreement":null},{"id":"W4389221151","doi":"10.1182/blood-2023-182166","title":"Clinical Factors Associated with Cytokine Release Syndrome and Dosing Recommendations for Restarting Elranatamab Following an Interruption","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Dosing; Cytokine release syndrome; Pharmacokinetics; Population; Internal medicine; Cytokine; Refractory (planetary science); Multiple myeloma; Pharmacology; Disease; Coronavirus disease 2019 (COVID-19); Biology","score_opus":0.15590576573555845,"score_gpt":0.4188750820112462,"score_spread":0.26296931627568776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389221151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99842757,0.000020968308,0.000096019256,0.0005944023,0.000055573077,0.0005279445,0.00006910593,0.00017217512,0.0000362262],"genre_scores_gemma":[0.9975574,0.000019516267,0.00089295255,0.000037237347,0.00003682697,0.0000437526,0.0012703256,0.00002984783,0.00011212041],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886465,0.00009531189,0.00027625513,0.00028494117,0.00017992803,0.00029889547],"domain_scores_gemma":[0.9990087,0.00044284898,0.000080374586,0.00016902007,0.000060142254,0.00023889683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005185372,0.00011421823,0.00025423043,0.0001476054,0.0002077416,0.000037744903,0.00004018855,0.00007196294,0.000010524121],"category_scores_gemma":[0.0012685844,0.00008831517,0.00008345536,0.00025867898,0.000030702624,0.0001597325,0.000031452702,0.00015424783,0.0000040413142],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023173251,0.0008594565,0.9871219,0.00004524152,0.0007860308,0.00033818695,0.00028450566,0.0000011130916,0.0011179774,0.000010898118,0.00008560346,0.0091173835],"study_design_scores_gemma":[0.017067106,0.0023037824,0.9757251,0.0005737038,0.0005482885,0.000031595668,0.0006850038,0.0021077895,0.0006200047,0.00005746262,0.0001279384,0.00015220011],"about_ca_topic_score_codex":0.000046179593,"about_ca_topic_score_gemma":0.00009738146,"teacher_disagreement_score":0.016835373,"about_ca_system_score_codex":0.000040562303,"about_ca_system_score_gemma":0.00005220262,"threshold_uncertainty_score":0.36013883},"labels":[],"label_agreement":null},{"id":"W4389221188","doi":"10.1182/blood-2023-189631","title":"Assessment of ISTH-BAT Scores in a Primary Care Clinic Population of Menstruating Adolescents","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Population; Medicine; Pediatrics; Environmental health","score_opus":0.018214078873409804,"score_gpt":0.3168852998100964,"score_spread":0.2986712209366866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389221188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99720234,0.000084587045,0.000004079859,0.00003334338,0.00006666389,0.00020843519,0.00001249645,0.000025239498,0.0023628105],"genre_scores_gemma":[0.9992325,0.00003307681,0.00041487155,0.00001581059,0.000022027505,0.000007817247,0.00021807505,0.000008402675,0.000047464826],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99927926,0.00002718871,0.00031997313,0.00010217907,0.00017561909,0.00009578921],"domain_scores_gemma":[0.9996608,0.000027266602,0.000098945246,0.00013142533,0.00005334442,0.000028223643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008023182,0.00005158807,0.00018754629,0.00014699738,0.000017087725,0.0000015990048,0.000030599786,0.000067795554,0.000019654171],"category_scores_gemma":[0.00003386244,0.000045782148,0.000054237174,0.0002876409,0.00002414383,0.000021536121,0.00002312826,0.000113911956,0.0000051565034],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009244064,0.00024385248,0.98460054,0.0002921835,0.00008102423,0.000013170641,0.0002524196,0.00001231819,0.014009172,0.00005712831,0.000008451037,0.00042051944],"study_design_scores_gemma":[0.0024880446,0.00013574229,0.9941555,0.0011128524,0.0003991666,0.0000034227317,0.00026893875,0.00012138319,0.0012203649,0.00005633732,7.90299e-7,0.000037448932],"about_ca_topic_score_codex":0.000057134657,"about_ca_topic_score_gemma":0.000009787322,"teacher_disagreement_score":0.012788807,"about_ca_system_score_codex":0.000029143644,"about_ca_system_score_gemma":0.00008350806,"threshold_uncertainty_score":0.18669418},"labels":[],"label_agreement":null},{"id":"W4389221196","doi":"10.1182/blood-2023-189506","title":"Comparison of the Efficacy in Clinical Trials Versus Effectiveness in the Real-World of Treatments for Multiple Myeloma: A Population-Based Cohort Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; McMaster University Medical Centre; University of British Columbia; Institute for Clinical Evaluative Sciences; Population Health Research Institute; McMaster University; Sunnybrook Health Science Centre; Health Sciences Centre; Eli Lilly (Canada); Ottawa Hospital","funders":"","keywords":"Medicine; Daratumumab; Carfilzomib; Pomalidomide; Regimen; Lenalidomide; Internal medicine; Population; Bortezomib; Multiple myeloma; Adverse effect; Oncology; Cohort; Chemotherapy regimen; Randomized controlled trial; Cancer","score_opus":0.22804327444964337,"score_gpt":0.519525203350662,"score_spread":0.29148192890101865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389221196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99078375,0.000025178295,0.0000017166582,0.000058396927,0.0001150563,0.0088765565,0.000054969132,0.000015743988,0.00006865674],"genre_scores_gemma":[0.9988751,0.00000570447,0.000047300848,0.000003677075,0.000038073733,0.0008652749,0.00013040655,0.000015588135,0.000018868708],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958056,0.0022049628,0.0010067485,0.0002748383,0.00047197778,0.00023584075],"domain_scores_gemma":[0.98214996,0.016960163,0.00027927288,0.00048987154,0.00006864251,0.000052100044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049270666,0.00014118127,0.0009958155,0.00022734852,0.00005187591,0.000006015292,0.00017187861,0.000063606356,0.000004742138],"category_scores_gemma":[0.0064175897,0.000075431555,0.00028852248,0.00086131936,0.000052657284,0.00001875536,0.00003525716,0.00014651951,0.0000028645782],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071524926,0.01664601,0.9726929,0.00008064837,0.0006569521,0.000016721426,0.00023144693,0.00010117468,0.00013127844,0.000007811536,0.000009160613,0.0022734248],"study_design_scores_gemma":[0.09042368,0.0017676818,0.9041624,0.00012914588,0.00059536425,1.396023e-7,0.0002111984,0.001126681,0.0015262933,0.0000069636653,0.0000025275674,0.000047893693],"about_ca_topic_score_codex":0.0030110807,"about_ca_topic_score_gemma":0.004493751,"teacher_disagreement_score":0.08327119,"about_ca_system_score_codex":0.0000700279,"about_ca_system_score_gemma":0.00012943656,"threshold_uncertainty_score":0.7682918},"labels":[],"label_agreement":null},{"id":"W4389221243","doi":"10.1182/blood-2023-174057","title":"Experience with Emicizumab Among People with Hemophilia A in the Canadian Hemophilia Bleeding Disorders Registry","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute; University of British Columbia; Roche (Canada); University of Calgary","funders":"","keywords":"Medicine; Bleed; Cohort; Pediatrics; Internal medicine; Surgery","score_opus":0.016142123175826792,"score_gpt":0.26648813309194874,"score_spread":0.25034600991612194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389221243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834193,0.00007058075,7.6844964e-7,0.005922973,0.000027749804,0.0007950451,0.000006336267,0.000083042556,0.009674204],"genre_scores_gemma":[0.9971806,0.0000712544,0.000069605376,0.0001389797,0.00009324643,0.00023625648,0.00004474169,0.000038089514,0.0021272185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979871,0.000040888863,0.0001785665,0.00041417847,0.00062998966,0.0007492879],"domain_scores_gemma":[0.99896455,0.00008350037,0.000041322757,0.0005539473,0.000055486926,0.00030117895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025983862,0.00022102929,0.00026774316,0.00031182298,0.00031790533,0.00007084137,0.00027482343,0.000110118046,0.00005043948],"category_scores_gemma":[0.00007102588,0.00012381558,0.000049606882,0.0016924288,0.00026851008,0.000107775784,0.000034523437,0.00039995357,0.00004675968],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010583005,0.00020286778,0.98935294,0.00007026417,0.00006629704,0.001272035,0.008084338,0.00001003727,0.00017265114,0.00007328026,0.00032056833,0.00026891002],"study_design_scores_gemma":[0.005626659,0.00075837557,0.9795034,0.00038661406,0.00012681069,0.00038895523,0.010968901,0.00020641625,0.0009018861,0.000084726926,0.0007414647,0.00030579566],"about_ca_topic_score_codex":0.05769901,"about_ca_topic_score_gemma":0.5150151,"teacher_disagreement_score":0.45731613,"about_ca_system_score_codex":0.00011892186,"about_ca_system_score_gemma":0.00053841044,"threshold_uncertainty_score":0.94857585},"labels":[],"label_agreement":null},{"id":"W4389221292","doi":"10.1182/blood-2023-178213","title":"Modern Scurvy and Hematology: A Retrospective Chart Review in Kingston, Ontario","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Vitamin C and Antioxidants Research","field":"Nursing","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Hematology; Pediatrics; Internal medicine; Retrospective cohort study; vitamin D deficiency; Diabetes mellitus; Bleeding diathesis; Vitamin D and neurology; Endocrinology","score_opus":0.024134453680463155,"score_gpt":0.29822464955177896,"score_spread":0.27409019587131583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389221292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881903,0.0064715664,0.0000026988891,0.0026207082,0.00009258118,0.0003180031,0.0000045657225,0.00008751838,0.002212087],"genre_scores_gemma":[0.99682146,0.0016054619,0.00005024668,0.00031273367,0.000034519293,0.00002985579,0.000006802037,0.00001848757,0.0011204492],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998931,0.000058968857,0.00017461722,0.00030143934,0.00019813684,0.00033584682],"domain_scores_gemma":[0.99964803,0.000039351045,0.00003638653,0.00017942477,0.0000377125,0.000059094637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038439085,0.00010367501,0.00028583888,0.00013140388,0.00007380519,0.000023065964,0.000101750826,0.00006539632,0.00006173901],"category_scores_gemma":[0.00014332624,0.00009569564,0.00003989937,0.00040146688,0.00005893542,0.000085630345,0.000076814336,0.00026867032,0.00012300936],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034043278,0.00033729288,0.9790302,0.001380189,0.00004565479,0.00031275896,0.002867784,3.10303e-7,0.0035445928,0.0006064062,0.005855154,0.0059856074],"study_design_scores_gemma":[0.0019516381,0.00017577785,0.983716,0.0037686753,0.000058241756,0.00015071007,0.00008411895,0.000117842865,0.0028225682,0.0033387027,0.0035471565,0.00026858546],"about_ca_topic_score_codex":0.0015372582,"about_ca_topic_score_gemma":0.0089656245,"teacher_disagreement_score":0.008631173,"about_ca_system_score_codex":0.00005247306,"about_ca_system_score_gemma":0.00003301039,"threshold_uncertainty_score":0.5003029},"labels":[],"label_agreement":null},{"id":"W4389221384","doi":"10.1182/blood-2023-178790","title":"Long-Term Results from the Optic Trial: A Dose-Optimization Study of 3 Starting Doses of Ponatinib","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ponatinib; Medicine; Internal medicine; Clinical endpoint; Adverse effect; Oncology; Clinical trial; Dasatinib; Imatinib; Myeloid leukemia","score_opus":0.04659768767780648,"score_gpt":0.3128577532226517,"score_spread":0.2662600655448452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389221384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99769694,0.000105896346,0.000005909544,0.00015792128,0.000103603925,0.0014653957,0.000071023685,0.00007409605,0.0003192231],"genre_scores_gemma":[0.9988847,0.000035310113,0.0005069356,0.000016841404,0.00013245405,0.000042357256,0.00018615478,0.000024031628,0.00017124914],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9984535,0.000105660656,0.00061973976,0.00024764793,0.00040729652,0.00016614654],"domain_scores_gemma":[0.99823725,0.0007353876,0.00034956116,0.00053798256,0.00009578665,0.00004403767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037206867,0.00012474628,0.00034012494,0.00007787148,0.00004738508,0.000008279523,0.00012579061,0.00005268483,0.000052221207],"category_scores_gemma":[0.0009979077,0.000084452964,0.000071912844,0.00043182963,0.000038480925,0.000039607294,0.00007713901,0.00009661742,0.000011492004],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.114986576,0.045821514,0.68801826,0.0006904584,0.009763721,0.0014336539,0.08059232,0.021315712,0.021404324,0.000052483203,0.0015071074,0.01441386],"study_design_scores_gemma":[0.54706925,0.0052461238,0.42833313,0.00058066525,0.0023871895,0.000008697929,0.0037147433,0.0025110827,0.009925589,0.00002379638,0.000007424071,0.00019228987],"about_ca_topic_score_codex":0.0005219732,"about_ca_topic_score_gemma":0.000079825746,"teacher_disagreement_score":0.43208268,"about_ca_system_score_codex":0.000055499302,"about_ca_system_score_gemma":0.00017849392,"threshold_uncertainty_score":0.34438917},"labels":[],"label_agreement":null},{"id":"W4389221394","doi":"10.1182/blood-2023-177611","title":"Examining Postpartum Anticoagulation Practices: An International Survey of Healthcare Providers","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"","keywords":"Medicine; Specialty; Pulmonary embolism; Family medicine; Venous thrombosis; Randomized controlled trial; Emergency medicine; Pediatrics; Thrombosis; Surgery","score_opus":0.13454658856183543,"score_gpt":0.3734096762207762,"score_spread":0.23886308765894076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389221394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99649465,0.000036647896,0.00000788176,0.0020043347,0.00022449504,0.00034956328,0.000013664303,0.00008549539,0.00078323955],"genre_scores_gemma":[0.9986808,0.00020628415,0.00026984798,0.00023409704,0.00008455437,0.000017678987,0.00041525197,0.000015918844,0.000075573305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990579,0.00008461565,0.00022384478,0.00019718596,0.00027777636,0.00015867768],"domain_scores_gemma":[0.99915385,0.00010057956,0.00026223264,0.00022084957,0.00018695778,0.00007553948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006855858,0.00007103646,0.00020397712,0.00014617002,0.00003599922,0.000020548108,0.00008015403,0.00004008244,0.000033886343],"category_scores_gemma":[0.0006678212,0.00006768203,0.000022266522,0.000250198,0.000019890755,0.00021908531,0.00004494833,0.000063131934,0.00002128859],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000489597,0.0010813354,0.99251705,0.00023929334,0.00020178458,0.000029844685,0.00082720275,0.000021108506,0.0015520604,0.00047321036,0.00050549785,0.0025026493],"study_design_scores_gemma":[0.0009320038,0.00047754715,0.99609494,0.000105297426,0.00010564122,0.000005570344,0.00054067094,0.0003426068,0.0009978366,0.00001992164,0.0003172393,0.00006074318],"about_ca_topic_score_codex":0.002634206,"about_ca_topic_score_gemma":0.00047496698,"teacher_disagreement_score":0.0035778685,"about_ca_system_score_codex":0.000015115217,"about_ca_system_score_gemma":0.00008384743,"threshold_uncertainty_score":0.3982149},"labels":[],"label_agreement":null},{"id":"W4389221450","doi":"10.1182/blood-2023-173991","title":"Safety, Pharmacodynamic, and Anti-Tumor Activity of SL-172154 As Monotherapy and in Combination with Azacitidine (AZA) in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Higher-Risk Myelodysplastic Syndromes/Neoplasms (HR-MDS) Patients (pts)","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pharmacodynamics; Azacitidine; Myelodysplastic syndromes; Internal medicine; Lenalidomide; Oncology; Neutropenia; Gemtuzumab ozogamicin; Pharmacology; Pharmacokinetics; Toxicity; CD33; Bone marrow; Stem cell; CD34; Multiple myeloma; Chemistry; Biology","score_opus":0.006290228415833346,"score_gpt":0.22259097750304557,"score_spread":0.21630074908721222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389221450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99811673,0.0009801885,0.000010710506,0.000059535894,0.00015435836,0.000479593,0.00009746434,0.000046317604,0.000055091874],"genre_scores_gemma":[0.9959407,0.0036700543,0.000018931614,0.000018997222,0.000005733671,0.00003087358,0.00014331097,0.000031740074,0.00013970092],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99853957,0.00024392288,0.00038400613,0.00043076696,0.00008033951,0.0003214246],"domain_scores_gemma":[0.99918604,0.00026333844,0.00029494453,0.00017195333,0.0000491129,0.00003459533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027584806,0.00026929963,0.00051847805,0.00039473796,0.000120644254,0.000016527169,0.00009030072,0.00019936169,0.000026264048],"category_scores_gemma":[0.000031319065,0.00024427936,0.000030102188,0.00037451068,0.00022429571,0.000275503,0.00009170857,0.00034295203,0.000009950072],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017852193,0.00092407636,0.3106574,0.00010191945,0.0003961468,0.000028303615,0.0004994122,0.00004444535,0.6706725,0.0000733207,0.000020495854,0.014796778],"study_design_scores_gemma":[0.021902043,0.0009138458,0.9130018,0.00015393291,0.0001436614,0.000060748942,0.000036003818,0.0002661244,0.06305752,0.00009153193,0.000115196475,0.00025761107],"about_ca_topic_score_codex":0.00029642668,"about_ca_topic_score_gemma":0.00008749732,"teacher_disagreement_score":0.60761493,"about_ca_system_score_codex":0.000079892096,"about_ca_system_score_gemma":0.0000650177,"threshold_uncertainty_score":0.9961423},"labels":[],"label_agreement":null},{"id":"W4389221452","doi":"10.1182/blood-2023-184853","title":"TIF1γ Counteracts Ferroptosis to Drive Erythroid Progenitor Differentiation","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Biology; Cell biology; Pyrimidine metabolism; Chromatin immunoprecipitation; Zebrafish; Transcription factor; Molecular biology; Biochemistry; Gene expression; Gene; Enzyme","score_opus":0.010821553660630532,"score_gpt":0.25944861730261054,"score_spread":0.24862706364198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389221452","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983142,0.00016770052,0.0004778473,0.00016255016,0.00021304117,0.0002157225,0.000021968484,0.00003485382,0.00039210415],"genre_scores_gemma":[0.9980567,0.00013352229,0.00038210186,0.00006399819,0.0003490469,0.00005077499,0.00033583803,0.000022110715,0.000605909],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999261,0.000029125438,0.00013408536,0.00025576822,0.00013288717,0.00018711384],"domain_scores_gemma":[0.99956244,0.000008502209,0.000043309854,0.00022005344,0.00008362415,0.0000820632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000083563755,0.00010127279,0.00008041217,0.00005878556,0.00006769915,0.000033540444,0.00009294517,0.00008606371,0.000013886582],"category_scores_gemma":[0.00007378311,0.00010020201,0.00005265145,0.00015794011,0.00001060318,0.0000024545654,0.000077228135,0.000035765504,0.0001616316],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000118734815,0.00008530618,0.012909371,0.000008275506,0.00003978227,0.0000013542577,0.00007471053,0.000046112877,0.9853547,0.000009227878,0.00040796702,0.001051269],"study_design_scores_gemma":[0.00041443325,0.00018942867,0.053495035,0.0000077024415,0.000030090236,8.1154485e-7,0.000026832913,0.0000431239,0.9347887,0.00006007539,0.010807686,0.00013607559],"about_ca_topic_score_codex":0.0000064064475,"about_ca_topic_score_gemma":0.000019966905,"teacher_disagreement_score":0.050566044,"about_ca_system_score_codex":0.0000060766524,"about_ca_system_score_gemma":0.000024717241,"threshold_uncertainty_score":0.40861192},"labels":[],"label_agreement":null},{"id":"W4389221684","doi":"10.1182/blood-2023-182055","title":"Severe Reaction to Rituximab in Children","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Rituximab; Medicine; Serum sickness; Anaphylaxis; Rash; Pediatrics; Disease; Internal medicine; Immunology; Allergy; Antibody","score_opus":0.014744193254392312,"score_gpt":0.2730450329587727,"score_spread":0.2583008397043804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389221684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97039056,0.0000081801245,0.0000015640461,0.001063346,0.00010374635,0.0003182508,0.000007464714,0.0002318811,0.027874999],"genre_scores_gemma":[0.9974614,0.000018634062,0.00016398498,0.00018168551,0.00017606409,0.000030099305,0.000049222217,0.000020008418,0.0018988963],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999336,0.000012023764,0.000118591626,0.0001893068,0.00014847956,0.00019562306],"domain_scores_gemma":[0.9996128,0.000020166493,0.000019325626,0.0002203151,0.000022611619,0.00010477469],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009130465,0.00007603401,0.00013755927,0.0002798025,0.000030147441,0.000006145348,0.000038348822,0.000061147264,0.000007993758],"category_scores_gemma":[0.00010198872,0.0000764795,0.000041654,0.0007072489,0.0000069459816,0.00006647344,0.00002845394,0.00016602244,0.0023958404],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005605091,0.010265794,0.48993632,0.00010128582,0.0005889366,0.0006234793,0.0015434639,0.000058939222,0.33356687,0.0006654809,0.00489187,0.15770152],"study_design_scores_gemma":[0.004769433,0.000022917073,0.98339385,0.00005949784,0.00007658345,0.00038466995,0.00013490289,0.0000071050617,0.003337267,0.000046316163,0.007667448,0.00010002602],"about_ca_topic_score_codex":0.00018023267,"about_ca_topic_score_gemma":0.000042863598,"teacher_disagreement_score":0.49345753,"about_ca_system_score_codex":0.000053381376,"about_ca_system_score_gemma":0.000050538223,"threshold_uncertainty_score":0.9983809},"labels":[],"label_agreement":null},{"id":"W4389221699","doi":"10.1182/blood-2023-182859","title":"Fatal Pulmonary Embolism, Fatal Bleeding and Intracranial Hemorrhage with Systemic and Catheter-Directed Thrombolysis in Intermediate-High and High-Risk Pulmonary Embolism: A Systematic Review with Meta-Analysis","year":2023,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Pulmonary embolism; Surgery; Internal medicine; Thrombolysis; Confidence interval; Meta-analysis; Randomized controlled trial; Myocardial infarction","score_opus":0.0268790623004818,"score_gpt":0.2721927773901662,"score_spread":0.24531371508968436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389221699","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030240962,0.9610922,0.00003086564,0.000079938225,0.000081918384,0.0075876643,0.0005545456,0.00029251562,0.000039425464],"genre_scores_gemma":[0.055979904,0.9396072,0.00036887714,0.000104901424,0.00017780076,0.0026891786,0.00069805246,0.00027568583,0.00009841252],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99279386,0.000848706,0.0024141045,0.0020400472,0.0009941044,0.00090920355],"domain_scores_gemma":[0.9956373,0.000640739,0.0017308278,0.0013270337,0.00016699843,0.0004970814],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0015631247,0.0016767998,0.018630372,0.0016335456,0.0002266751,0.00023956553,0.00041647008,0.00046552095,0.000046367724],"category_scores_gemma":[0.0001885202,0.0010344526,0.0011172435,0.0026164535,0.00030132112,0.0003055392,0.00056955224,0.0009678567,0.000017511273],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036018904,0.0010173836,0.00011727672,0.8450006,0.14016634,0.0065527353,0.0002855459,0.00000173246,0.0000016925594,0.000038483264,0.00000877321,0.006773411],"study_design_scores_gemma":[0.0011643339,0.000477817,0.00059819664,0.16142923,0.8289903,0.0057426263,0.0003541899,0.00014682823,0.0000010450107,0.000009398108,0.00006157179,0.0010245149],"about_ca_topic_score_codex":0.0013854144,"about_ca_topic_score_gemma":0.0003573812,"teacher_disagreement_score":0.68882394,"about_ca_system_score_codex":0.00011816252,"about_ca_system_score_gemma":0.00016643724,"threshold_uncertainty_score":0.9995979},"labels":[],"label_agreement":null},{"id":"W4389221847","doi":"10.1182/blood-2023-185358","title":"Assessing Pre-Operative Bleeding Risk Using INR/aPTT: A Systematic Review","year":2023,"lang":"en","type":"review","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Medicine; Perioperative; Partial thromboplastin time; Vitamin K antagonist; Tranexamic acid; Surgery; Observational study; Coagulation testing; Randomized controlled trial; Otorhinolaryngology; Internal medicine; Warfarin; Coagulation; Blood loss","score_opus":0.20544494392302018,"score_gpt":0.4818408484640108,"score_spread":0.2763959045409906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389221847","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008524922,0.99170464,0.000009861443,0.000029181361,0.00012187765,0.007231822,0.000028046863,0.00016324887,0.0006260639],"genre_scores_gemma":[0.000008755101,0.99669564,0.0003992325,0.000027684226,0.00040856667,0.00057212415,0.000110593166,0.00015638737,0.0016210062],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9959987,0.0007920296,0.001307831,0.0006186471,0.0007401265,0.0005426894],"domain_scores_gemma":[0.9975599,0.0006411431,0.0006454199,0.0007256985,0.00017954386,0.00024826778],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001614143,0.0005719692,0.0050537838,0.00039432605,0.00026271338,0.00017724028,0.00024003572,0.00034757177,0.00006526481],"category_scores_gemma":[0.0017487826,0.00035698817,0.0008875052,0.0011328642,0.000062434636,0.0001621548,0.00018084858,0.0009282978,0.0003514073],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[8.6856176e-7,0.00018651476,0.000019993624,0.9816036,0.0023946755,0.000452511,0.00006415575,4.9620546e-8,0.0000013032801,0.000005738492,0.00003999335,0.015230547],"study_design_scores_gemma":[0.00051781524,0.00009087535,0.0000017278951,0.94304925,0.050245654,0.0005735007,0.000046112968,0.000027047332,0.0000034813143,0.0000040457357,0.0051476243,0.0002928663],"about_ca_topic_score_codex":0.000036094938,"about_ca_topic_score_gemma":0.0000021146802,"teacher_disagreement_score":0.047850978,"about_ca_system_score_codex":0.00024924517,"about_ca_system_score_gemma":0.00093969546,"threshold_uncertainty_score":0.9998882},"labels":[],"label_agreement":null},{"id":"W4389221849","doi":"10.1182/blood-2023-187251","title":"A Randomized Comparison of Liposomal Daunorubicin/Daunorubicin Combined with Low-Dose Cytarabine and Etoposide or High-Dose Cytarabine and Fludarabine in Induction Treatment of Pediatric AML Using MRD-Based Risk Stratification in the NOPHO-DBH AML 2012 Protocol","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Cytarabine; Medicine; Fludarabine; Etoposide; Daunorubicin; Internal medicine; Randomization; Minimal residual disease; Mitoxantrone; Population; Oncology; Transplantation; Induction chemotherapy; Randomized controlled trial; Leukemia; Gastroenterology; Surgery; Chemotherapy; Cyclophosphamide","score_opus":0.037544463563562065,"score_gpt":0.33353726627993924,"score_spread":0.2959928027163772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389221849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94876176,0.00016736977,0.0000499143,0.00055004715,0.000027050595,0.050336204,0.000043713477,0.000048021702,0.000015913456],"genre_scores_gemma":[0.98565596,0.00020632384,0.0016010585,0.000018998322,0.00012570297,0.012133626,0.0001499064,0.000055852463,0.00005257626],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99592113,0.000951066,0.0013149384,0.0006127926,0.00069764786,0.000502421],"domain_scores_gemma":[0.9973221,0.000994347,0.000682887,0.0006268901,0.00022390764,0.00014986287],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015732198,0.00044784602,0.0015977358,0.0010415725,0.000110653215,0.00003447488,0.00016492687,0.00022187278,0.000025568723],"category_scores_gemma":[0.00035033785,0.0002700342,0.000096120566,0.0021499237,0.00039795128,0.00020619559,0.00005197142,0.00047593168,0.0000027970493],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42624,0.0126156565,0.3511795,0.0020557595,0.0005444267,0.00028936064,0.0048472723,0.0025046067,0.19677465,0.00008462051,0.00007561973,0.0027885067],"study_design_scores_gemma":[0.61101884,0.009399137,0.25784212,0.00041768255,0.0013717578,0.000070968046,0.0009230332,0.030920336,0.08759738,0.000068712216,0.000008266143,0.0003617977],"about_ca_topic_score_codex":0.003599449,"about_ca_topic_score_gemma":0.0011722553,"teacher_disagreement_score":0.18477881,"about_ca_system_score_codex":0.00022320868,"about_ca_system_score_gemma":0.00070909364,"threshold_uncertainty_score":0.9999752},"labels":[],"label_agreement":null},{"id":"W4389221881","doi":"10.1182/blood-2023-173727","title":"UM171 Expanded Cord Blood Transplantation Outcomes Compare Favorably to All Different Stem Cell Sources: An EBMT Registry Case-Control Analysis","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôpital de l'Enfant-Jésus; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Transplantation; Hematopoietic stem cell transplantation; Cord blood; Stem cell; Internal medicine; Graft-versus-host disease; Oncology; Biology","score_opus":0.05362784227815947,"score_gpt":0.3271574312095789,"score_spread":0.27352958893141943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389221881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963499,0.0001375522,0.0004511294,0.00041847464,0.00006884751,0.0011388003,0.00025751867,0.00030843366,0.0008693682],"genre_scores_gemma":[0.9939243,0.000062463994,0.00014215003,0.0002836569,0.00010742644,0.00013370762,0.00038633563,0.000057181802,0.004902758],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965388,0.00032819682,0.00062015734,0.00074704876,0.001007049,0.00075872935],"domain_scores_gemma":[0.997538,0.00041062947,0.00014768401,0.0009313677,0.00016273675,0.0008095911],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047623806,0.00037837515,0.0010112673,0.0006557167,0.00017536346,0.00010602868,0.0003014775,0.00014959116,0.0002450141],"category_scores_gemma":[0.00003658197,0.00030148978,0.00036574056,0.0011677534,0.000045690143,0.00008316552,0.00004746427,0.00034117213,0.00016387868],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008801311,0.0023680918,0.9299989,0.0009817916,0.0040710457,0.0151726045,0.0038224258,0.0003567899,0.040632106,0.000015213855,0.00039256937,0.001308366],"study_design_scores_gemma":[0.030921912,0.0029655558,0.8601905,0.00022696517,0.02628661,0.0016105298,0.007826809,0.0037986354,0.064469494,0.000018509565,0.0005439565,0.0011404917],"about_ca_topic_score_codex":0.0005506163,"about_ca_topic_score_gemma":0.0014515484,"teacher_disagreement_score":0.069808334,"about_ca_system_score_codex":0.00004761041,"about_ca_system_score_gemma":0.00006908662,"threshold_uncertainty_score":0.99994373},"labels":[],"label_agreement":null},{"id":"W4389221884","doi":"10.1182/blood-2023-178815","title":"Identification and Clinical Characterization of CNS Relapse in DLBCL Patients across 19 Prospective Phase 2 and 3 Trials - a GLA/ DSHNHL and LYSA Collaboration","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC; Occupational Cancer Research Centre","funders":"","keywords":"Medicine; Internal medicine; Diffuse large B-cell lymphoma; Rituximab; Oncology; Clinical endpoint; Salvage therapy; Clinical trial; Lymphoma; Chemotherapy","score_opus":0.05298456924919344,"score_gpt":0.4428726381681948,"score_spread":0.38988806891900135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389221884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99825984,0.00004764075,0.000027666412,0.0004886612,0.000029383358,0.0008404403,0.0002550296,0.00002798437,0.00002334025],"genre_scores_gemma":[0.9987988,0.000508909,0.000031758915,0.000030754014,0.000066148794,0.00007987374,0.000381205,0.00000784009,0.00009474203],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989363,0.00006980662,0.00054684386,0.00024764444,0.00010578685,0.00009361682],"domain_scores_gemma":[0.99932694,0.00016158102,0.00019637987,0.00010832272,0.00010542634,0.00010134969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073870784,0.00007473535,0.00027406897,0.000040462113,0.000056876448,0.000025838905,0.000021254364,0.00009344956,0.0000037101083],"category_scores_gemma":[0.0010027747,0.00006940684,0.000020586314,0.00038366573,0.00011127125,0.00010408477,0.00002347404,0.000091418864,0.000001655346],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038031634,0.0016625075,0.5051439,0.0001637327,0.000052697116,0.000003278352,0.00072798517,7.401246e-8,0.4880216,0.00013708952,0.000022225273,0.0036846083],"study_design_scores_gemma":[0.016465716,0.00017636947,0.88563615,0.000050685976,0.00019514027,0.0000050622866,0.00015147601,0.00031703385,0.096558735,0.00012445103,0.00024608296,0.00007309941],"about_ca_topic_score_codex":0.0000027724432,"about_ca_topic_score_gemma":0.0000022287732,"teacher_disagreement_score":0.3914629,"about_ca_system_score_codex":0.000012425589,"about_ca_system_score_gemma":0.000034021366,"threshold_uncertainty_score":0.28303286},"labels":[],"label_agreement":null},{"id":"W4389221945","doi":"10.1182/blood-2023-182942","title":"Multicenter Study of Mantle Cell Lymphoma Outcomes Following First-Line Bendamustine-Rituximab and Second-Line Bruton's Tyrosine Kinase Inhibitor Therapy","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Bendamustine; Rituximab; Mantle cell lymphoma; Medicine; Internal medicine; Progression-free survival; Maintenance therapy; Ibrutinib; Secondary hyperparathyroidism; Population; Oncology; Surgery; Chemotherapy; Lymphoma; Chronic lymphocytic leukemia; Leukemia","score_opus":0.020995166741289987,"score_gpt":0.2729382086107077,"score_spread":0.25194304186941774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389221945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99632335,0.0014858808,9.0337744e-7,0.0005258329,0.00025008872,0.0010698291,0.00006913898,0.00012742238,0.0001475324],"genre_scores_gemma":[0.99817413,0.00024523106,0.00018136184,0.00020375133,0.00011592758,0.000112945934,0.00007557094,0.000053717464,0.00083735934],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983527,0.00003658707,0.00047234792,0.0004474982,0.0003477958,0.00034306585],"domain_scores_gemma":[0.99901706,0.00018447191,0.00013071908,0.0004319848,0.00007172578,0.00016401948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015571492,0.00031734008,0.0006959874,0.00019298859,0.00011738075,0.000025421423,0.000087077184,0.00008715909,0.0000951209],"category_scores_gemma":[0.00004661547,0.00023450381,0.00019726629,0.0002889806,0.000035336998,0.00007933117,0.000115342096,0.00005874633,0.00004509223],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021754701,0.03719722,0.9517386,0.00018025356,0.00071698125,0.001079271,0.0012388029,0.000002932135,0.0033975304,0.0000040295317,0.00030403605,0.0039228103],"study_design_scores_gemma":[0.12827286,0.0026374997,0.784932,0.00014547119,0.00074319565,0.000012534477,0.0007043926,0.000079579506,0.0813111,0.000006096887,0.00091695855,0.00023829595],"about_ca_topic_score_codex":0.00022255209,"about_ca_topic_score_gemma":0.00016026974,"teacher_disagreement_score":0.16680658,"about_ca_system_score_codex":0.00003875754,"about_ca_system_score_gemma":0.000044951594,"threshold_uncertainty_score":0.9562788},"labels":[],"label_agreement":null},{"id":"W4389221965","doi":"10.1182/blood-2023-177685","title":"Sickle Cell Health Awareness, Perspectives, and Experiences (SHAPE) Survey: Perspectives of Physicians in Gulf Cooperation Council Countries on Sickle Cell Disease","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Context (archaeology); Family medicine; Disease; Quality of life (healthcare); Pediatrics; Internal medicine; Nursing","score_opus":0.019966486218426477,"score_gpt":0.261544583457071,"score_spread":0.2415780972386445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389221965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864432,0.010750086,0.000008747394,0.0011359716,0.000076227596,0.00048211307,0.00010336387,0.00007582702,0.0009244689],"genre_scores_gemma":[0.99411094,0.00492666,0.000015535179,0.00022060014,0.00005328552,0.000040591953,0.00006668985,0.000026719139,0.0005389733],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9983364,0.00013791912,0.00028269002,0.0004381085,0.00047989,0.00032501025],"domain_scores_gemma":[0.99909127,0.00012655297,0.000119940894,0.00023077763,0.00030746261,0.00012399911],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047296693,0.00020156574,0.00040385104,0.00011582067,0.00017282061,0.00002659953,0.00007526697,0.000079735204,0.00005345524],"category_scores_gemma":[0.0001608673,0.00017355835,0.00005640925,0.0005465966,0.00028115892,0.0001022401,0.000032648128,0.00017622985,0.000020308953],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017937544,0.01160392,0.19854267,0.0017703829,0.00017300237,0.00021405198,0.76858,0.0007867711,0.0039047434,0.0010554981,0.010665988,0.0009091826],"study_design_scores_gemma":[0.010360037,0.0021611927,0.19512548,0.00062453956,0.00015250716,0.000005100592,0.78184587,0.0022846728,0.00505891,0.000055666496,0.0017105421,0.0006155022],"about_ca_topic_score_codex":0.0011420344,"about_ca_topic_score_gemma":0.0004034702,"teacher_disagreement_score":0.013265816,"about_ca_system_score_codex":0.00015285618,"about_ca_system_score_gemma":0.0012167498,"threshold_uncertainty_score":0.7077504},"labels":[],"label_agreement":null},{"id":"W4389221984","doi":"10.1182/blood-2023-174750","title":"Acalabrutinib ± Obinutuzumab Vs Obinutuzumab + Chlorambucil in Treatment-Naive Chronic Lymphocytic Leukemia: 6-Year Follow-up of Elevate-TN","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Chlorambucil; Obinutuzumab; Internal medicine; Medicine; Hazard ratio; Neutropenia; Gastroenterology; Chronic lymphocytic leukemia; Leukemia; Chemotherapy; Confidence interval; Cyclophosphamide","score_opus":0.027542263893110604,"score_gpt":0.2925937077638187,"score_spread":0.2650514438707081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389221984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920332,0.0011107969,0.000003444611,0.00009005285,0.00039123098,0.0016126574,0.00008178532,0.00041596335,0.0042608995],"genre_scores_gemma":[0.9862023,0.0017745891,0.00011710468,0.00006856779,0.00045549194,0.00031303935,0.0002496315,0.0001669757,0.010652325],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9946043,0.00016455712,0.0011309719,0.0011166282,0.0012893715,0.0016941654],"domain_scores_gemma":[0.9969418,0.0005294699,0.00026276943,0.0015241852,0.00026364758,0.00047812663],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00066799717,0.0006488765,0.001440509,0.0008588358,0.00012708241,0.000048006557,0.00054335664,0.00057176687,0.00047873257],"category_scores_gemma":[0.0006281272,0.0005772201,0.00049136585,0.0025719232,0.00038469207,0.00019494777,0.000332024,0.0004983724,0.0016598237],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.09322027,0.011159335,0.06712522,0.03497847,0.028740877,0.08871092,0.056646455,0.03519905,0.39294174,0.015305526,0.07829752,0.0976746],"study_design_scores_gemma":[0.66776174,0.008789432,0.0068494612,0.00219289,0.0016185663,0.0012813567,0.0018823954,0.06229541,0.23455375,0.0005496378,0.01064174,0.0015836285],"about_ca_topic_score_codex":0.0068921824,"about_ca_topic_score_gemma":0.00063178764,"teacher_disagreement_score":0.57454145,"about_ca_system_score_codex":0.2727005,"about_ca_system_score_gemma":0.12124339,"threshold_uncertainty_score":0.999721},"labels":[],"label_agreement":null},{"id":"W4389222015","doi":"10.1182/blood-2023-189835","title":"DNA Methylation-Based Classification of Hairy Cell Leukemia and Splenic B Cell Lymphoma","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"DNA methylation; Splenic marginal zone lymphoma; Biology; Methylation; Hairy cell leukemia; Sanger sequencing; Leukemia; Cancer research; Epigenetics; Lymphoma; Mantle cell lymphoma; Molecular biology; Computational biology; DNA sequencing; Genetics; DNA; B cell; Gene; Immunology; Antibody","score_opus":0.026059454567857177,"score_gpt":0.2818296988702216,"score_spread":0.2557702443023644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389222015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99335414,0.0004922233,0.00006582133,0.00016146469,0.0000519409,0.0003802801,0.000014103556,0.00011849645,0.005361515],"genre_scores_gemma":[0.9974104,0.0001155592,0.0005090326,0.000051192463,0.00008734172,0.000034910598,0.00009769403,0.000035793517,0.001658038],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998512,0.00006287513,0.0003238387,0.00032405098,0.00047662124,0.00030057633],"domain_scores_gemma":[0.9987393,0.00038402693,0.00011371189,0.00048157864,0.00012446531,0.00015693787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039791092,0.00013704492,0.0002630992,0.0002588065,0.00005646989,0.000013755351,0.000110901434,0.00014512586,0.00006354357],"category_scores_gemma":[0.00013980984,0.00012712806,0.000082602266,0.0006082965,0.00012363416,0.000049473703,0.000055458182,0.000090694884,0.00016047894],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041413368,0.0018281005,0.008153971,0.0032181507,0.00014729032,0.00021402213,0.00082522223,0.00012572734,0.9652964,0.00020974701,0.004006578,0.015560654],"study_design_scores_gemma":[0.06376894,0.0002904645,0.065052785,0.00011019293,0.00028820802,0.000028711662,0.00025514897,0.06547248,0.80303836,0.00009609082,0.0013940221,0.00020459967],"about_ca_topic_score_codex":0.00019245483,"about_ca_topic_score_gemma":0.000013371117,"teacher_disagreement_score":0.16225804,"about_ca_system_score_codex":0.0016391368,"about_ca_system_score_gemma":0.005590916,"threshold_uncertainty_score":0.9918045},"labels":[],"label_agreement":null},{"id":"W4389222038","doi":"10.1182/blood-2023-174479","title":"Trends in Outcomes over Three Decades after Upfront Autologous Stem Cell Transplant for Multiple Myeloma at MD Anderson Cancer Center","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Ascentage Pharma; Omeros Corporation; Exelixis; Actinium Pharmaceuticals; Amgen; Takeda Pharmaceuticals U.S.A.; Janssen Biotech; Adaptive Biotechnologies; Karyopharm Therapeutics; Genentech; Celgene; Bristol-Myers Squibb","keywords":"Medicine; Multiple myeloma; Oncology; Internal medicine; Proportional hazards model; Transplantation; Retrospective cohort study; Log-rank test; Incidence (geometry); Hematopoietic stem cell transplantation; Progression-free survival; Survival analysis; Overall survival","score_opus":0.037447988666117725,"score_gpt":0.3160839845619128,"score_spread":0.2786359958957951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389222038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99671984,0.0009373458,0.000016671122,0.0004665932,0.00012088797,0.0007164648,0.0006603578,0.00011830201,0.00024352323],"genre_scores_gemma":[0.99451476,0.00021279311,0.00014269704,0.000112605274,0.00005866954,0.0007931067,0.00026013906,0.00004695975,0.0038582503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99826056,0.000031644962,0.00026393455,0.0004284894,0.0003161947,0.0006991723],"domain_scores_gemma":[0.9992896,0.00015321419,0.000044426502,0.00026614647,0.000028099883,0.00021854343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009576587,0.00025179502,0.00043205614,0.00034534026,0.000070834096,0.000016973217,0.00009417325,0.00013726437,0.00026512067],"category_scores_gemma":[0.000008274727,0.00018355233,0.00021645949,0.00023506786,0.000041936426,0.0000621025,0.000044269716,0.00013166192,0.00005792494],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001476663,0.00075450254,0.9765822,0.00017361532,0.00027731634,0.0007892577,0.00069151056,0.0000032086978,0.0013589006,0.0000012903837,0.0010401182,0.016851394],"study_design_scores_gemma":[0.023233183,0.0002845484,0.9653095,0.00010291069,0.00015622399,0.000018197616,0.00005366939,0.00082173955,0.008823747,0.000005796393,0.0010155048,0.00017500178],"about_ca_topic_score_codex":0.00038599095,"about_ca_topic_score_gemma":0.011552676,"teacher_disagreement_score":0.02175652,"about_ca_system_score_codex":0.00014661814,"about_ca_system_score_gemma":0.00004531321,"threshold_uncertainty_score":0.7485047},"labels":[],"label_agreement":null},{"id":"W4389222042","doi":"10.1182/blood-2023-188164","title":"Anticoagulation Use and Patient Outcomes in Paroxysmal Nocturnal Hemoglobinuria: A Province-Wide Retrospective Review","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Paroxysmal nocturnal hemoglobinuria; Interquartile range; Eculizumab; Retrospective cohort study; Thrombosis; Internal medicine; Cohort; Pediatrics; Anemia; Thrombotic microangiopathy; Surgery; Disease; Immunology","score_opus":0.02261067651714001,"score_gpt":0.25808030951490396,"score_spread":0.23546963299776394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389222042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924408,0.005858868,0.0000017891542,0.00055013824,0.00019250198,0.000756168,0.000065117165,0.0000860778,0.000048536134],"genre_scores_gemma":[0.9990002,0.0004086256,0.000021639169,0.0002643053,0.000007080879,0.00005818256,0.00006704358,0.000010266947,0.00016266486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989299,0.00017426672,0.00034152076,0.00026135886,0.000050259285,0.00024265388],"domain_scores_gemma":[0.9994487,0.00016365737,0.000121955716,0.00020389973,0.000042441126,0.000019350855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000143207,0.0001298528,0.0003269823,0.00009631138,0.00006959437,0.000018710916,0.00007589526,0.00006175159,0.000098068216],"category_scores_gemma":[0.00041730603,0.00011313762,0.000056892037,0.00017620066,0.00004962646,0.000119654185,0.00010591553,0.00010736252,0.00011364479],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017797627,0.00018491936,0.9937304,0.0001378721,0.00008975206,0.000027187609,0.00009798722,9.00822e-7,0.002407675,0.00011108066,0.0027484684,0.00044591655],"study_design_scores_gemma":[0.0015286292,0.000112165,0.99447364,0.0005372732,0.00008533849,0.000024473828,0.000048939262,0.0000017668642,0.0013241154,0.00010285624,0.0016321841,0.00012860625],"about_ca_topic_score_codex":0.000084359875,"about_ca_topic_score_gemma":0.00011037237,"teacher_disagreement_score":0.0065593873,"about_ca_system_score_codex":0.00003600434,"about_ca_system_score_gemma":0.00003985669,"threshold_uncertainty_score":0.46136183},"labels":[],"label_agreement":null},{"id":"W4389222044","doi":"10.1182/blood-2023-174139","title":"Multi-Dimensional Molecular and Tumor-Microenvironment Analysis of Classic Hodgkin Lymphoma","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Victoria; Princess Margaret Cancer Centre; University Health Network; Spinal Cord Injury BC","funders":"","keywords":"Biology; Neuroblastoma RAS viral oncogene homolog; Cancer research; Tumor microenvironment; CDKN2A; Lymphoma; ATRX; Comparative genomic hybridization; Gene expression profiling; Cancer; KRAS; Gene; Immunology; Mutation; Gene expression; Genetics; Chromosome","score_opus":0.012070556515798003,"score_gpt":0.24300556486920458,"score_spread":0.23093500835340658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389222044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984342,0.0009873882,0.0000060429647,0.00024310726,0.00001868316,0.0001612363,0.000034146284,0.00003280942,0.00008237104],"genre_scores_gemma":[0.9981373,0.00010802899,0.0012621572,0.00022017823,0.000009895481,0.00003097019,0.00008945711,0.000012900572,0.00012910011],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913114,0.000023228673,0.0001952994,0.00025829687,0.00022329413,0.00016873101],"domain_scores_gemma":[0.99952155,0.000046592093,0.00006305483,0.00024316076,0.000016531772,0.00010912602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007184285,0.00012268445,0.00034680945,0.00024513598,0.000031062726,0.0000057748057,0.00003289013,0.000036790272,0.000056955192],"category_scores_gemma":[0.000016470152,0.00009888072,0.00016188175,0.00045788765,0.00006173027,0.000015321097,0.00006499332,0.00001917424,0.0000404963],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005999585,0.00469218,0.82390904,0.00005893696,0.0068228156,0.001641036,0.00015118251,0.00013903553,0.15733439,0.00009432189,0.00030100538,0.004796073],"study_design_scores_gemma":[0.0061801025,0.00017121901,0.9028482,0.000032045085,0.0047113686,0.000035300625,0.000032056778,0.001105321,0.08454694,0.000006413308,0.00024860929,0.00008246091],"about_ca_topic_score_codex":0.00004885672,"about_ca_topic_score_gemma":0.0000062271106,"teacher_disagreement_score":0.07893914,"about_ca_system_score_codex":0.00003818998,"about_ca_system_score_gemma":0.000031958145,"threshold_uncertainty_score":0.40322387},"labels":[],"label_agreement":null},{"id":"W4389222046","doi":"10.1182/blood-2023-187284","title":"Functional Ex-Vivo Testing Combined with Machine Learning Predicts Clinical Response to Azacitidine+Venetoclax in AML","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Venetoclax; Azacitidine; Medicine; Ven; Oncology; Ex vivo; Internal medicine; Clinical trial; Leukemia; In vivo; Chronic lymphocytic leukemia; Biology; Computer science","score_opus":0.06249343809896792,"score_gpt":0.32836755752295027,"score_spread":0.26587411942398237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389222046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99448764,0.000031478776,0.00006721383,0.0027474996,0.00008002069,0.000728561,0.000016931657,0.00039100696,0.0014496654],"genre_scores_gemma":[0.98875993,0.000014555184,0.0022695302,0.00042150661,0.00035219282,0.000103230035,0.000088733024,0.00007353397,0.007916786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972353,0.00042377796,0.0005059078,0.00053791935,0.0006894827,0.00060764345],"domain_scores_gemma":[0.99680966,0.0021384638,0.0000765476,0.00036150575,0.00019894534,0.0004148488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026673824,0.00020945244,0.00043510113,0.0005216196,0.00011324234,0.000027844586,0.00015291882,0.00015110726,0.00016463349],"category_scores_gemma":[0.0073887683,0.00017428675,0.000067406436,0.0018740303,0.00010252716,0.00006807495,0.0002099941,0.0010598167,0.0005047762],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01749228,0.00043266517,0.94599706,0.00008882925,0.00016522082,0.0025001487,0.00021157839,0.0015812276,0.024803532,0.000022802034,0.0053683952,0.0013362854],"study_design_scores_gemma":[0.02106886,0.0071942643,0.949653,0.000415782,0.00010167999,0.00032557076,0.00015445446,0.013868479,0.0021386293,0.000023487519,0.004795455,0.00026030175],"about_ca_topic_score_codex":0.00012249766,"about_ca_topic_score_gemma":0.000062583866,"teacher_disagreement_score":0.022664903,"about_ca_system_score_codex":0.00022675582,"about_ca_system_score_gemma":0.0010756656,"threshold_uncertainty_score":0.88455796},"labels":[],"label_agreement":null},{"id":"W4389222107","doi":"10.1182/blood-2023-173955","title":"A Phase 1 Cohort Dose Escalation and Expansion Trial to Determine the Safety, Tolerance, Maximum Tolerated Dose, and Preliminary Antineoplastic Activity of IKS03 in Patients with Advanced B-Cell Non-Hodgkin Lymphomas (NHL)","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Cancer research; Antibody-drug conjugate; Radioimmunotherapy; In vivo; Medicine; Lymphoma; Follicular lymphoma; Chemistry; Pharmacology; Antibody; Internal medicine; Immunology; Biology; Monoclonal antibody","score_opus":0.012010767958892821,"score_gpt":0.275547729114953,"score_spread":0.2635369611560602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389222107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963139,0.00004390986,0.000026872765,0.00008856952,0.000067487344,0.0031739473,0.000026235684,0.000035493886,0.00022354425],"genre_scores_gemma":[0.99930835,0.000087544206,0.00015102826,0.000026566295,0.000049065107,0.0001191037,0.000054871023,0.000035291923,0.0001681798],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99839574,0.0001049062,0.00033032405,0.00040502188,0.00045753882,0.00030644334],"domain_scores_gemma":[0.9990442,0.00025603842,0.00010887256,0.0003261245,0.00012535405,0.00013941413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035821748,0.00020445656,0.000448829,0.000249084,0.0000746152,0.000018814211,0.00007326118,0.00008926111,0.00003455866],"category_scores_gemma":[0.00010304903,0.00014451653,0.000034412067,0.0007998891,0.00008814796,0.00011477189,0.000102577724,0.00016138575,0.0000029558325],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36226776,0.0063331015,0.17988722,0.0002593128,0.00007440191,0.000095998264,0.0008164564,0.00012534519,0.2965385,5.670236e-7,0.000030340065,0.153571],"study_design_scores_gemma":[0.23106134,0.011416141,0.7293579,0.00023102741,0.000106651576,0.000011445469,0.00003121341,0.0032338486,0.02436091,0.0000042565166,0.000036407415,0.00014885305],"about_ca_topic_score_codex":0.00005298739,"about_ca_topic_score_gemma":0.000029769373,"teacher_disagreement_score":0.54947066,"about_ca_system_score_codex":0.000032312924,"about_ca_system_score_gemma":0.00011650245,"threshold_uncertainty_score":0.5893213},"labels":[],"label_agreement":null},{"id":"W4389222152","doi":"10.1182/blood-2023-174378","title":"Canadian Cancer Trials Group SC.26 - Emotion and Symptom-Focused Engagement (EASE): A Multi-Site Randomized Controlled Trial of an Intervention for Individuals with Acute Leukemia","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Ottawa; Princess Margaret Cancer Centre; University of Toronto; University Health Network; Queen's University","funders":"Astellas Pharma; Bristol-Myers Squibb; Agios Pharmaceuticals; Teva Pharmaceutical Industries; Gilead Sciences; Servier; Amgen","keywords":"Randomized controlled trial; Psychosocial; Quality of life (healthcare); Palliative care; Medicine; Psychological intervention; Distress; Referral; Population; Physical therapy; Clinical psychology; Psychiatry; Family medicine; Internal medicine; Nursing","score_opus":0.04039076858629119,"score_gpt":0.3451610199740588,"score_spread":0.3047702513877676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389222152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98133975,0.00037025844,0.0007033335,0.0010722881,0.00043508766,0.0154754985,0.00043419804,0.00014897763,0.000020576232],"genre_scores_gemma":[0.9915789,0.00022946966,0.0026631004,0.00030793468,0.0005786874,0.003841772,0.00046295294,0.00007775415,0.0002594571],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9952835,0.0018428512,0.0014885899,0.0004715256,0.00052045565,0.000393089],"domain_scores_gemma":[0.99681044,0.0013766707,0.00090061367,0.000350669,0.00017824155,0.00038335117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012824257,0.00029820632,0.002897251,0.00052679935,0.00014356038,0.000061686886,0.00011299279,0.00016241989,0.000056457444],"category_scores_gemma":[0.002222872,0.00022313608,0.0005940569,0.00030555445,0.00009634506,0.00016085042,0.00003321328,0.00018063429,0.0000032835785],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9792156,0.0009824102,0.0016218643,0.00041068732,0.007877022,0.000023489552,0.005160398,0.000013450197,0.0009064339,0.00009082445,0.00026503135,0.0034327433],"study_design_scores_gemma":[0.9843582,0.002019054,0.002753113,0.0007192419,0.0074639516,0.0000069111534,0.00040606523,0.00083766977,0.0009795176,0.00007478875,0.00015260601,0.0002288644],"about_ca_topic_score_codex":0.05831754,"about_ca_topic_score_gemma":0.09624543,"teacher_disagreement_score":0.037927892,"about_ca_system_score_codex":0.00020877949,"about_ca_system_score_gemma":0.0007921567,"threshold_uncertainty_score":0.9479532},"labels":[],"label_agreement":null},{"id":"W4389222156","doi":"10.1182/blood-2023-182477","title":"Distance to Care Predicts Clinical Trial Enrollment on COG ALL Clinical Trials: A Report from the Children's Oncology Group","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Clinical trial; Cog; Generalizability theory; Ethnic group; Cohort; Randomized controlled trial; Internal medicine; Psychology","score_opus":0.22000296395251756,"score_gpt":0.5016583994547446,"score_spread":0.281655435502227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389222156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9600276,0.0006367435,0.000094881354,0.026216937,0.0061373925,0.004819135,0.00037294845,0.00041023476,0.0012841721],"genre_scores_gemma":[0.95623374,0.00046512295,0.00064991036,0.019317852,0.021263434,0.00045528356,0.0012562709,0.00009075917,0.0002676504],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9887016,0.004162457,0.0040187323,0.0013070806,0.0012283411,0.0005817883],"domain_scores_gemma":[0.9837178,0.012689682,0.0009951729,0.0017597087,0.00013549226,0.00070216146],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.018769141,0.00036770728,0.0021318465,0.0000787048,0.00015080317,0.000046009394,0.0005074972,0.0005187482,0.000096678705],"category_scores_gemma":[0.03034967,0.00025482316,0.0010485883,0.00038190477,0.00021659446,0.0000403248,0.00027870986,0.0011148325,0.00036223241],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15079898,0.01361261,0.37382028,0.00008303921,0.0065011894,0.0029450152,0.008103073,0.0000063199445,0.0000278156,0.00027040887,0.37000212,0.07382916],"study_design_scores_gemma":[0.1796439,0.013108229,0.52473,0.00039414328,0.002366283,0.000065731954,0.0010419432,0.0000059433387,0.000041306314,0.00019798674,0.27802354,0.00038098008],"about_ca_topic_score_codex":0.00063108763,"about_ca_topic_score_gemma":0.0010606635,"teacher_disagreement_score":0.15090975,"about_ca_system_score_codex":0.00010804395,"about_ca_system_score_gemma":0.0007131359,"threshold_uncertainty_score":0.9999904},"labels":[],"label_agreement":null},{"id":"W4389222186","doi":"10.1182/blood-2023-186810","title":"Genomic, Transcriptional, and Immunological Validation of Distinct Molecular Subtypes of Classic Hodgkin Lymphoma through Tissue-Based and Noninvasive Methods","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Biology; Epigenetics; Gene expression profiling; Genetics; Genotype; Copy number analysis; Genotyping; Cancer research; Copy-number variation; Gene; Oncology; Computational biology; Genome; Medicine; Gene expression","score_opus":0.03157524680023135,"score_gpt":0.313715626803719,"score_spread":0.2821403800034877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389222186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948748,0.0037888607,0.0004666765,0.0003175162,0.00002460246,0.00025241158,0.000033152133,0.000026203712,0.00021577171],"genre_scores_gemma":[0.98884827,0.00048690516,0.010482504,0.0000366492,0.000011800135,0.000024260793,0.00008381121,0.0000109551165,0.0000148694535],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992671,0.00009032358,0.00021326324,0.00019985304,0.000119603246,0.00010985819],"domain_scores_gemma":[0.999479,0.00020547844,0.00008430621,0.00014009404,0.000053690725,0.000037407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001360454,0.000111024354,0.0003051996,0.000059240865,0.000030215473,0.0000065744607,0.000032187865,0.0000756766,0.00002253986],"category_scores_gemma":[0.000060021448,0.00008630457,0.00005901119,0.00013405933,0.00014124806,0.000027071235,0.000020588517,0.000022269152,0.0000028465217],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017868205,0.0012758202,0.1115221,0.00023598295,0.00041944406,0.00013191822,0.00034204934,0.0000068087884,0.8696896,0.0017339922,0.000015475765,0.014448168],"study_design_scores_gemma":[0.0037573448,0.00045726838,0.44635907,0.000046824796,0.00035489912,0.000028001297,0.0000354983,0.000017046916,0.54847085,0.00028331575,0.00014229117,0.00004761973],"about_ca_topic_score_codex":0.000046653677,"about_ca_topic_score_gemma":0.0000013099458,"teacher_disagreement_score":0.33483696,"about_ca_system_score_codex":0.000018680621,"about_ca_system_score_gemma":0.000065307635,"threshold_uncertainty_score":0.35193983},"labels":[],"label_agreement":null},{"id":"W4389222208","doi":"10.1182/blood-2023-174891","title":"The XPO1-FOXC1-HOX Functional Axis Opens New Therapeutic Avenues to Treat DEK-NUP214 AML Patients","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer; Centre Hospitalier Universitaire Sainte-Justine","funders":"Gilead Sciences; Janssen Pharmaceuticals; AstraZeneca; Astellas Pharma; Bristol-Myers Squibb; Amgen","keywords":"Biology; Transcriptome; Karyotype; Fusion protein; Myeloid leukemia; Cancer research; Bioinformatics; Internal medicine; Computational biology; Genetics; Gene; Chromosome; Medicine; Gene expression","score_opus":0.03928453400091457,"score_gpt":0.30050463724737037,"score_spread":0.2612201032464558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389222208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868298,0.00036538855,0.00003075686,0.007060641,0.00026834675,0.0007985464,0.000029347599,0.00017044261,0.004446711],"genre_scores_gemma":[0.9429842,0.00026424383,0.00011940988,0.0016598598,0.0008889358,0.000127129,0.00014548858,0.00007861862,0.053732075],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.998175,0.00007526342,0.00022301752,0.00033692457,0.0006486384,0.0005411019],"domain_scores_gemma":[0.99869245,0.00027792776,0.000039740822,0.0005276993,0.00014582451,0.00031638393],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026407806,0.00017679267,0.00021526794,0.00014252377,0.00028446657,0.00006494142,0.00025073142,0.00009040046,0.0002830965],"category_scores_gemma":[0.0002736528,0.00011773781,0.000101311634,0.0006558538,0.00006580474,0.000060667448,0.00017691564,0.0002793642,0.0027614743],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015325844,0.0011631877,0.22911476,0.000110689485,0.0009038934,0.00026529617,0.0024058665,0.000028345868,0.020045917,0.0006674764,0.5260642,0.21769778],"study_design_scores_gemma":[0.0077041388,0.0009745522,0.8051875,0.00006813,0.00023926164,0.000035727076,0.00022996355,0.000046152327,0.0074236435,0.0004269442,0.17743106,0.00023289149],"about_ca_topic_score_codex":0.00014374986,"about_ca_topic_score_gemma":0.000047083333,"teacher_disagreement_score":0.57607275,"about_ca_system_score_codex":0.00014097481,"about_ca_system_score_gemma":0.00038388435,"threshold_uncertainty_score":0.998015},"labels":[],"label_agreement":null},{"id":"W4389222216","doi":"10.1182/blood-2023-173420","title":"Patient Characteristics, Treatment Patterns, and Health Outcomes in a Real-World Population of Patients with Myelofibrosis Treated with Fedratinib","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Swedish Orphan Biovitrum; Eisai; Gilead Sciences; Bristol-Myers Squibb","keywords":"Medicine; Myelofibrosis; Ruxolitinib; Discontinuation; Myeloproliferative neoplasm; Population; Constitutional symptoms; Internal medicine; Pediatrics; Anemia; International Prognostic Scoring System; Bone marrow; Myelodysplastic syndromes; Disease","score_opus":0.020519365206540977,"score_gpt":0.28103736685163716,"score_spread":0.2605180016450962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389222216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978004,0.000015068107,6.99723e-7,0.00040912477,0.000014497418,0.0013607581,0.00028822524,0.000052646184,0.00005856228],"genre_scores_gemma":[0.99767625,0.00023410455,0.00023339044,0.000076035474,0.000011952723,0.00024889954,0.0014035037,0.000030513758,0.00008533777],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986895,0.000051064028,0.000416631,0.0003281566,0.0002665549,0.00024814397],"domain_scores_gemma":[0.9992801,0.000058291236,0.00023950252,0.00021309908,0.00007621063,0.00013278126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000051943713,0.000249907,0.0006695948,0.0002536096,0.000058494174,0.000014444419,0.000018743953,0.000036232337,0.000016371916],"category_scores_gemma":[0.000008683882,0.0001479473,0.000037072386,0.0003129483,0.000024150997,0.00005048,0.000015602474,0.00004888869,0.0000030537512],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033301068,0.0029673716,0.9871455,0.00010730603,0.00024116732,0.00003651659,0.0005730559,0.0000011292693,0.000004446149,0.000026605661,0.000007860395,0.008556069],"study_design_scores_gemma":[0.00977506,0.0069882,0.98168427,0.00043630585,0.00017317425,0.0000019256072,0.0000615259,0.000011635236,0.0007243732,0.0000019175336,0.0000144865435,0.00012711587],"about_ca_topic_score_codex":0.004737076,"about_ca_topic_score_gemma":0.004857751,"teacher_disagreement_score":0.009442049,"about_ca_system_score_codex":0.00012993084,"about_ca_system_score_gemma":0.0000563107,"threshold_uncertainty_score":0.71610737},"labels":[],"label_agreement":null},{"id":"W4389222230","doi":"10.1182/blood-2023-174443","title":"Mezigdomide (MEZI) Plus Dexamethasone (DEX) and Daratumumab (DARA) or Elotuzumab (ELO) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Results from the CC-92480-MM-002 Trial","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Daratumumab; Internal medicine; Lenalidomide; Multiple myeloma; Regimen; Dexamethasone; Oncology; Gastroenterology","score_opus":0.03654031272279376,"score_gpt":0.2834137563408927,"score_spread":0.24687344361809896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389222230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993594,0.0004467691,0.0000050270573,0.0005898354,0.00023883111,0.0032933897,0.0006523281,0.00022389363,0.00095596036],"genre_scores_gemma":[0.9952554,0.00032761914,0.00081085553,0.00014440154,0.00032730983,0.0003418315,0.0011091374,0.000114424714,0.0015690118],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9952472,0.00045287155,0.00084851054,0.0011130277,0.0012949605,0.0010434487],"domain_scores_gemma":[0.995152,0.002689025,0.00028601201,0.0011847636,0.00018397348,0.00050422596],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00076106936,0.00056306843,0.0009309096,0.00034051048,0.0003617984,0.00011008556,0.0003668446,0.00030302862,0.00006779472],"category_scores_gemma":[0.00354324,0.00033210567,0.00014221028,0.0010534477,0.00029833987,0.00025416273,0.00028148206,0.00084979757,0.00023323034],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6932215,0.015481913,0.22708116,0.00013950735,0.002238206,0.0041292603,0.0037105482,0.000015800437,0.0006122647,0.00001621613,0.0055145468,0.047839087],"study_design_scores_gemma":[0.60651594,0.0044524567,0.38292772,0.000331712,0.00031654516,0.000025061878,0.00038330452,0.0004293427,0.0011027717,0.000023798873,0.0031362495,0.00035508574],"about_ca_topic_score_codex":0.0023838547,"about_ca_topic_score_gemma":0.0035103953,"teacher_disagreement_score":0.15584655,"about_ca_system_score_codex":0.00028908916,"about_ca_system_score_gemma":0.0006209975,"threshold_uncertainty_score":0.9999131},"labels":[],"label_agreement":null},{"id":"W4389222395","doi":"10.1182/blood-2023-179050","title":"The GLAMM1 Study - Global Access to Myeloma Medications: Potential Barriers to Chimeric Antigen Receptors (CART) and T-Cell-Engaging Bispecific Antibodies (TCE) Globally","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Chimeric antigen receptor; Multiple myeloma; Health care; Expanded access; Family medicine; Internal medicine; Cancer; Immunotherapy; Economic growth","score_opus":0.035043998705333854,"score_gpt":0.3037439020210804,"score_spread":0.26869990331574656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389222395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791915,0.0012061537,0.000081890925,0.008353445,0.0009888493,0.0007423989,0.00027070715,0.00010618415,0.009058875],"genre_scores_gemma":[0.99604404,0.001933404,0.00010877276,0.001354049,0.0002818271,0.00006806263,0.000012946704,0.000027374674,0.00016951449],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980602,0.000047522804,0.0006143949,0.00060730235,0.000081316866,0.00058921194],"domain_scores_gemma":[0.99868417,0.00008130631,0.00016178483,0.0004371007,0.00003243293,0.0006032161],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009438868,0.00022518063,0.00035551644,0.00020988638,0.000778707,0.0006130131,0.0008060849,0.00006405986,0.00012613673],"category_scores_gemma":[0.0002607269,0.00022220988,0.00008613658,0.0010111488,0.00007974155,0.00021178249,0.00055222533,0.00014980114,0.0008741529],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000074815645,0.00047191832,0.9182345,0.000037793958,0.0007521887,0.000030465884,0.0027725238,0.00039716723,0.00021177743,0.026477473,0.03828267,0.012256669],"study_design_scores_gemma":[0.0022182863,0.00024469668,0.737602,0.000018800927,0.00007411894,0.0000101775595,0.0026506046,0.00092011184,0.00024149084,0.006813723,0.24848127,0.0007247218],"about_ca_topic_score_codex":0.00019522692,"about_ca_topic_score_gemma":0.000112524736,"teacher_disagreement_score":0.21019861,"about_ca_system_score_codex":0.00006944746,"about_ca_system_score_gemma":0.00007000951,"threshold_uncertainty_score":0.9999038},"labels":[],"label_agreement":null},{"id":"W4389222457","doi":"10.1182/blood-2023-173379","title":"Combination Chemotherapy in Patients with Newly Diagnosed Blastic Plasmacytoid Dendritic Cell Neoplasms (BPDCN): First Results of a Prospective French Trial (LpDessai)","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Chemotherapy; Idarubicin; Population; Induction chemotherapy; Chemotherapy regimen; Oncology; Surgery; Gastroenterology; Cytarabine","score_opus":0.008755853157372564,"score_gpt":0.24594849533641785,"score_spread":0.2371926421790453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389222457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950129,0.000026385642,0.000009756838,0.00023670358,0.00007603347,0.0032727583,0.00007393454,0.00007777889,0.00121375],"genre_scores_gemma":[0.9987503,0.000034617653,0.000120239034,0.000029222638,0.000042823092,0.00026397782,0.0002119153,0.000051971947,0.0004949158],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997643,0.00008996321,0.0004964463,0.0004864954,0.0008372849,0.00044683373],"domain_scores_gemma":[0.9983628,0.0006183992,0.00015627459,0.00033903416,0.00039832768,0.00012520005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023750853,0.0002379103,0.0004947871,0.00044254027,0.00007924431,0.000026495545,0.00014487265,0.0001249798,0.000048398397],"category_scores_gemma":[0.00082252384,0.00020570403,0.0000747901,0.0012204273,0.00014444633,0.00007878481,0.000046129247,0.0002450371,0.000045724715],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06796878,0.014044041,0.91189474,0.00032474185,0.00018521905,0.00028114932,0.0036014018,0.00011250824,0.00059840205,0.000022418233,0.0006274395,0.0003391331],"study_design_scores_gemma":[0.47278064,0.007986884,0.50604045,0.0002492303,0.00007896484,0.000012465691,0.00021351357,0.0005159401,0.011779403,0.00010873769,0.00002632539,0.00020742333],"about_ca_topic_score_codex":0.00030136722,"about_ca_topic_score_gemma":0.00081044255,"teacher_disagreement_score":0.40585428,"about_ca_system_score_codex":0.00014933446,"about_ca_system_score_gemma":0.00032242734,"threshold_uncertainty_score":0.83883667},"labels":[],"label_agreement":null},{"id":"W4389228875","doi":"10.1182/blood-2023-173203","title":"Increased Environmental Temperature Is an Emerging Health Risk That Correlates with Rates of Acute Lymphoblastic Leukemia in Europe","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Energy and Environment Impacts","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"","keywords":"Population; Latitude; Environmental science; Irradiance; Climatology; Demography; Atmospheric sciences; Medicine; Geography; Environmental health","score_opus":0.008995770219741349,"score_gpt":0.2171608434528269,"score_spread":0.20816507323308556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389228875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993026,0.000065896835,0.0000037280772,0.000068799374,0.000030560586,0.00013874125,0.00007916173,0.00004927276,0.00026120848],"genre_scores_gemma":[0.9979678,0.001210973,0.00016450058,0.00026235566,0.000014694199,0.000010179995,0.000103901,0.000037054542,0.00022857665],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845666,0.00014538095,0.0002267458,0.00039191646,0.00034246713,0.0004368306],"domain_scores_gemma":[0.99926704,0.000052566815,0.00016251022,0.00031891325,0.0000010570892,0.000197914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027138126,0.00022619344,0.00023532944,0.000075516815,0.00014619286,0.000018384351,0.00021388079,0.0000807239,0.0005547668],"category_scores_gemma":[0.000012127091,0.0001840177,0.00003241152,0.00048678854,0.00018100256,0.0003001652,0.0001382629,0.00018994315,0.00024407251],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007723126,0.00024157536,0.94830096,0.0000103533575,0.0000616946,0.0000662294,0.0012424499,0.026321493,0.023054466,0.0000031620657,0.00028278763,0.0003375808],"study_design_scores_gemma":[0.0017730094,0.00045913103,0.9733074,0.000051422074,0.000082627725,0.000019552093,0.00030533,0.00093914586,0.022673242,0.00002735856,0.00012008379,0.00024173326],"about_ca_topic_score_codex":0.0009663375,"about_ca_topic_score_gemma":0.0002113598,"teacher_disagreement_score":0.025382347,"about_ca_system_score_codex":0.00019025867,"about_ca_system_score_gemma":0.000037647555,"threshold_uncertainty_score":0.7504024},"labels":[],"label_agreement":null},{"id":"W4389228885","doi":"10.1182/blood-2023-178320","title":"CNS Prophylaxis in Diffuse Large B-Cell Lymphoma: A Common Toxic Clinical Practice Based on Abundant Opinion, Despite Evidence Suggesting Futility","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Hematology; Diffuse large B-cell lymphoma; Internal medicine; Rituximab; Lymphoma; Intensive care medicine; Oncology","score_opus":0.056200644628570676,"score_gpt":0.3696670503644386,"score_spread":0.3134664057358679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389228885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948964,0.00091171043,0.0000094127345,0.0021182238,0.00027599256,0.0009908555,0.000034167257,0.0002160651,0.0005471398],"genre_scores_gemma":[0.99713606,0.00053960126,0.00073023146,0.0010435813,0.00018893942,0.00020782917,0.000058526923,0.00004298025,0.000052225838],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969401,0.00042952783,0.0007871598,0.00070978096,0.00057123514,0.0005622237],"domain_scores_gemma":[0.994725,0.003800388,0.00023218313,0.0008405538,0.00012270341,0.00027918044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018679737,0.00028681892,0.0005710401,0.00021121837,0.00014322935,0.000050703136,0.00015901926,0.00018736743,0.000022089062],"category_scores_gemma":[0.003997184,0.00023819847,0.00022373575,0.0008386151,0.00007173379,0.00014312295,0.000121006226,0.0002466291,0.00028714875],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008488535,0.10436395,0.8640663,0.00033038502,0.00007809481,0.0020846091,0.0002939283,0.000007436184,0.00017426153,0.000038724276,0.0005734257,0.027140027],"study_design_scores_gemma":[0.040106088,0.0030325912,0.947119,0.0012554782,0.00023553669,0.00006206079,0.00016558108,0.0021428994,0.0016565907,0.000016963966,0.0039597,0.0002475058],"about_ca_topic_score_codex":0.00033019955,"about_ca_topic_score_gemma":0.00012193229,"teacher_disagreement_score":0.10133136,"about_ca_system_score_codex":0.00020441481,"about_ca_system_score_gemma":0.00039486773,"threshold_uncertainty_score":0.9713452},"labels":[],"label_agreement":null},{"id":"W4389228902","doi":"10.1182/blood-2023-190863","title":"Single-Cell Revelation of Extensive Heterogeneity in the Human Lymphocyte and Neutrophil/Monocyte Lineage Restriction Process Despite Highly Co-Regulated Changes in Cell Cycle Control","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Immune responses and vaccinations","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Biology; Progenitor cell; Haematopoiesis; CD19; CD14; Monocyte; CD34; Phenotype; Cell biology; Lineage markers; CD15; Stem cell; Immunology; Molecular biology; Genetics; Flow cytometry; Gene","score_opus":0.01830916221720811,"score_gpt":0.2603946293054145,"score_spread":0.2420854670882064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389228902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973615,0.0017641584,0.000007742054,0.00021337751,0.000057536494,0.0004575866,0.000033859887,0.000036228495,0.00006802556],"genre_scores_gemma":[0.99937767,0.00026285028,0.0000048946126,0.000057132136,0.000014314239,0.00004412313,0.000118662756,0.000012708921,0.00010764504],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99887383,0.00036905764,0.0002877957,0.00021143397,0.000035170375,0.00022273013],"domain_scores_gemma":[0.99935263,0.00020181715,0.0001768561,0.00018442578,0.00007548453,0.000008755547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003232977,0.00012569042,0.00021709492,0.00030171778,0.00013476986,0.00001272224,0.00011417286,0.00017744044,0.0000045896236],"category_scores_gemma":[0.00004174016,0.00010501136,0.000033888195,0.0004523693,0.000053517262,0.00006621369,0.000024273488,0.00014533974,0.0000128796],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021065323,0.00042459014,0.0102260355,0.000045754117,0.000022870292,0.000012299397,0.0008562439,0.00017907101,0.98774487,0.000032269723,0.00001931982,0.00022604887],"study_design_scores_gemma":[0.007155487,0.00033008726,0.3879029,0.00003815948,0.00005757737,0.000017777178,0.00029851682,0.000079181315,0.60382414,0.0000551097,0.0001283228,0.00011271892],"about_ca_topic_score_codex":0.00015027288,"about_ca_topic_score_gemma":0.00014500556,"teacher_disagreement_score":0.38392067,"about_ca_system_score_codex":0.000026824764,"about_ca_system_score_gemma":0.0000310115,"threshold_uncertainty_score":0.42822388},"labels":[],"label_agreement":null},{"id":"W4389228919","doi":"10.1182/blood-2023-185440","title":"In Vitro Evidence of Synergistically Enhanced Efficacy of Axitinib When Combined with Asciminib in T315I Mutated Chronic Myeloid Leukemia","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Nilotinib; Bosutinib; Axitinib; Dasatinib; Ponatinib; Myeloid leukemia; Cancer research; Medicine; Tyrosine-kinase inhibitor; Pharmacology; Imatinib; Tyrosine kinase; Sunitinib; Cancer; Internal medicine; Receptor","score_opus":0.019741417157586892,"score_gpt":0.2824718528705756,"score_spread":0.2627304357129887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389228919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99752057,0.00039940714,0.000023965162,0.00025495305,0.000055768214,0.0009884925,0.000017050324,0.0000868597,0.000652926],"genre_scores_gemma":[0.9981451,0.00019660586,0.0009161244,0.00004264909,0.000047544578,0.00010297777,0.000073691306,0.00005209085,0.00042321195],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973869,0.000104038685,0.00085643854,0.000526555,0.00056869484,0.0005574285],"domain_scores_gemma":[0.9979315,0.0008665799,0.00026319438,0.0006584619,0.0001357475,0.00014451359],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038403756,0.00029883356,0.0009582206,0.0004367447,0.000019914916,0.000006464293,0.00024530332,0.00016200948,0.00016088119],"category_scores_gemma":[0.0008821456,0.00025555145,0.00009810659,0.0012133478,0.00024225195,0.00011246308,0.000101650345,0.0003296597,0.00005813797],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071332967,0.0018274983,0.0036641916,0.0013518957,0.0003676446,0.0012708599,0.0014342334,0.00045871196,0.980155,0.00009013532,0.0000964583,0.0021500776],"study_design_scores_gemma":[0.046676055,0.0031079047,0.07514883,0.0032742082,0.00035799626,0.00004739459,0.00011356058,0.0009533089,0.8699599,0.00008040391,0.000017836388,0.00026262025],"about_ca_topic_score_codex":0.0005552943,"about_ca_topic_score_gemma":0.00024467072,"teacher_disagreement_score":0.110195115,"about_ca_system_score_codex":0.0010226999,"about_ca_system_score_gemma":0.0022497335,"threshold_uncertainty_score":0.9999897},"labels":[],"label_agreement":null},{"id":"W4389228953","doi":"10.1182/blood-2023-190443","title":"The Non-Hematopoietic Content in Paediatric Autologous Hematopoietic Stem Cell Grafts Is Skewed Towards Regulatory Myeloid and Exhausted Phenotypes","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"CD34; Haematopoiesis; Myeloid; Stem cell; Apheresis; Medicine; Immunology; Hematopoietic stem cell transplantation; Progenitor cell; Hematopoietic stem cell; Cancer research; Transplantation; Internal medicine; Biology; Platelet; Cell biology","score_opus":0.022817417111075558,"score_gpt":0.2553733797716275,"score_spread":0.23255596266055195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389228953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948187,0.0020787404,0.000001136735,0.0012621806,0.00009870818,0.0008385436,0.000010998415,0.00014467024,0.000746318],"genre_scores_gemma":[0.9951078,0.000699755,0.000029288485,0.00015331004,0.00005152922,0.00012686172,0.000008790538,0.000042909072,0.0037797394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99799275,0.000092728085,0.0003525178,0.000429769,0.0005027568,0.0006294514],"domain_scores_gemma":[0.998864,0.00021271652,0.00008299535,0.00048514592,0.000079222096,0.00027593927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029904934,0.0002433387,0.00039769348,0.00023534171,0.00016682403,0.000047443114,0.00015042609,0.000112623806,0.00002528879],"category_scores_gemma":[0.000043228563,0.00016419843,0.00010244091,0.00063307735,0.00014617352,0.000040547722,0.00016524084,0.00027174942,0.00020703602],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004430036,0.016237035,0.58271074,0.009935154,0.0034813979,0.034608137,0.031462844,0.00001669898,0.16854016,0.0012611715,0.04581879,0.10149784],"study_design_scores_gemma":[0.023220431,0.0018398028,0.80603176,0.00032473338,0.0005807927,0.0007251428,0.0019313518,0.00034393888,0.16277798,0.00070838083,0.0009754276,0.000540244],"about_ca_topic_score_codex":0.000072312774,"about_ca_topic_score_gemma":0.000026819838,"teacher_disagreement_score":0.22332105,"about_ca_system_score_codex":0.000044598444,"about_ca_system_score_gemma":0.00016152562,"threshold_uncertainty_score":0.6695818},"labels":[],"label_agreement":null},{"id":"W4389228984","doi":"10.1182/blood-2023-179664","title":"Phase 3b Study Design for a Comparison of Treatment Preference between Oral Decitabine/Cedazuridine and Azacitidine in Adult Patients with IPSS-R Intermediate Myelodysplastic Syndrome, IPSS Intermediate-2 or High-Risk Myelodysplastic Syndrome, Low-Blast Acute Myeloid Leukaemia, or Chronic Myelomonocytic Leukaemia","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Decitabine; Medicine; International Prognostic Scoring System; Azacitidine; Myelodysplastic syndromes; Internal medicine; Hypomethylating agent; Discontinuation; Chronic myelomonocytic leukemia; Oncology; Population; Dysplasia; Bone marrow; Gastroenterology","score_opus":0.04386852271083277,"score_gpt":0.32260504297767184,"score_spread":0.2787365202668391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389228984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98622906,0.00009062028,0.00153014,0.0000483778,0.0002557411,0.009797692,0.001700984,0.00034033472,0.0000070247424],"genre_scores_gemma":[0.99299705,0.0004752829,0.0016705184,0.000019051258,0.00017537591,0.0025735742,0.0013698224,0.00032595717,0.00039335445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9914641,0.0005490063,0.0024420475,0.0020416505,0.0013369762,0.0021662202],"domain_scores_gemma":[0.99216384,0.0037081009,0.0009980928,0.001265631,0.000842083,0.0010222698],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00085172843,0.0015280634,0.003582843,0.0019542251,0.00030903373,0.00013467575,0.0008650272,0.00049336697,0.00010143497],"category_scores_gemma":[0.0018987223,0.0010639256,0.00021866242,0.0030596415,0.0007143371,0.000552777,0.00059385155,0.0011707944,0.000099534394],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06436581,0.022682576,0.8497062,0.0040329075,0.009942511,0.0072337063,0.0047714803,0.0011065392,0.0022171098,0.0000116630545,0.00052167015,0.033407837],"study_design_scores_gemma":[0.2043681,0.16623615,0.5979362,0.0032285852,0.006814955,0.0004159931,0.0012831929,0.011901524,0.0063153543,0.000025946489,0.000021393436,0.0014525868],"about_ca_topic_score_codex":0.00044163846,"about_ca_topic_score_gemma":0.0014152867,"teacher_disagreement_score":0.25176996,"about_ca_system_score_codex":0.0025998093,"about_ca_system_score_gemma":0.0032798133,"threshold_uncertainty_score":0.9997468},"labels":[],"label_agreement":null},{"id":"W4389229041","doi":"10.1182/blood-2023-180239","title":"Patient, Caregiver, and Provider Perceptions of Quality Care for Inpatient Sickle Cell Disease Care: A Scoping Review of Qualitative Literature","year":2023,"lang":"en","type":"review","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CINAHL; Medicine; PsycINFO; MEDLINE; Inpatient care; Health care; Family medicine; Qualitative research; Scopus; Inclusion (mineral); Emergency department; Disease; Nursing; Psychological intervention; Psychology; Internal medicine","score_opus":0.04556637160078875,"score_gpt":0.400362072701232,"score_spread":0.35479570110044323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389229041","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000410896,0.9893274,0.0000048547668,0.00004258425,0.000100040364,0.007178474,0.0027578326,0.0000331471,0.0001448207],"genre_scores_gemma":[0.00015262362,0.9964795,0.00023706518,0.00007340418,0.00003665566,0.0006124039,0.002276925,0.00006463833,0.000066770095],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99734783,0.00041260847,0.0011780357,0.0004888124,0.00033535663,0.00023735187],"domain_scores_gemma":[0.9974279,0.00031513654,0.00078917976,0.00047999056,0.0007792537,0.00020857691],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020450719,0.000383307,0.0022174835,0.00016133155,0.00008213454,0.0000098756655,0.00008807999,0.00028250396,0.000010984669],"category_scores_gemma":[0.00052122166,0.0002823696,0.0007846268,0.00047136893,0.0001385654,0.000044223067,0.00009403086,0.00030695982,0.0000024557057],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000203383,0.00023976828,0.000011778509,0.8975097,0.00018390245,0.000008714523,0.044511143,1.0769314e-7,6.6012984e-7,0.000020804988,0.00014147717,0.05735159],"study_design_scores_gemma":[0.0014647326,0.0005644325,0.000004942676,0.9362284,0.006481434,0.000004614878,0.027070286,1.4733926e-7,0.0000030699114,0.000008613065,0.027867295,0.00030202247],"about_ca_topic_score_codex":0.00004487323,"about_ca_topic_score_gemma":0.000010584395,"teacher_disagreement_score":0.057049565,"about_ca_system_score_codex":0.000060438553,"about_ca_system_score_gemma":0.0009899046,"threshold_uncertainty_score":0.99996287},"labels":[],"label_agreement":null},{"id":"W4389229081","doi":"10.1182/blood-2023-181118","title":"Outcomes of Allogeneic HSCT in Elderly Patients (70 years old and above) -a Canadian Experience","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Cohort; Internal medicine; Transplantation; Incidence (geometry); Retrospective cohort study; Surgery","score_opus":0.017045128320627222,"score_gpt":0.2864355119830567,"score_spread":0.2693903836624295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389229081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99856156,0.00006135202,1.6381904e-7,0.0003313034,0.00003606468,0.0002540436,0.000020604015,0.0000180786,0.0007168553],"genre_scores_gemma":[0.9985707,0.00007775921,0.00008614772,0.00019946549,0.000014231643,0.00002306015,0.000017950288,0.000015157775,0.0009955702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990871,0.00001998667,0.00016517249,0.00018210753,0.00022848982,0.00031713027],"domain_scores_gemma":[0.9994642,0.000047952282,0.000023934317,0.00021117734,0.000041285315,0.00021143595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011775369,0.00007722179,0.00019883353,0.0002950426,0.000019048477,0.000006351334,0.00009711028,0.000069177586,0.00004972016],"category_scores_gemma":[0.0001916603,0.00007004428,0.000026516302,0.00035184258,0.0000640794,0.000037583668,0.000046840647,0.000120830904,0.000047552454],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000965135,0.00006514991,0.9948003,0.000021328786,0.000025814192,0.00014308201,0.0013051111,3.5440777e-7,0.00094085134,0.000024564913,0.0002728382,0.0023909477],"study_design_scores_gemma":[0.0025625767,0.00016262212,0.99483657,0.000026748074,0.000013724219,0.0000042285697,0.00028168177,0.000013146586,0.0012969823,0.000012544354,0.0007257901,0.000063390275],"about_ca_topic_score_codex":0.04224694,"about_ca_topic_score_gemma":0.019468192,"teacher_disagreement_score":0.02277875,"about_ca_system_score_codex":0.00007071636,"about_ca_system_score_gemma":0.00024095774,"threshold_uncertainty_score":0.99842393},"labels":[],"label_agreement":null},{"id":"W4389229120","doi":"10.1182/blood-2023-191009","title":"Use of Pre-Transplant Minicog Cognitive Impairment Screening and Validation of Frailty and Functionality Assessment Prior to Allogeneic Hematopoietic Stem Cell Transplantation","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Transplantation; Hematopoietic stem cell transplantation; Internal medicine; Cohort; Cognition; Comorbidity; Oncology; Gerontology; Psychiatry","score_opus":0.045967391779825964,"score_gpt":0.31077740161980594,"score_spread":0.26481000983998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389229120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956464,0.00013666242,0.002312689,0.00020761338,0.00004119139,0.001185886,0.0003811906,0.000042997497,0.00004536686],"genre_scores_gemma":[0.99843925,0.00048436213,0.0006400827,0.00005729181,0.000019772,0.000089899804,0.00015400328,0.000015590826,0.00009974292],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987376,0.00007378057,0.00038858835,0.00028872778,0.00034382642,0.00016747888],"domain_scores_gemma":[0.9991369,0.00034404374,0.00014771303,0.00009034754,0.00018324568,0.00009773694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026569434,0.0001536472,0.00032485128,0.00015928267,0.00006737756,0.000009667088,0.000021545353,0.00006377816,0.000015571819],"category_scores_gemma":[0.000015217123,0.00014300393,0.00005739269,0.00024362051,0.00007662934,0.000087809094,0.000028530438,0.00008515619,0.0000013945963],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027005805,0.0014865345,0.8937209,0.003737005,0.0012970811,0.000048586502,0.009946866,0.00008424398,0.08025369,0.00002247702,0.00007263511,0.006629403],"study_design_scores_gemma":[0.004262509,0.0010764293,0.83799213,0.00089227676,0.0014824591,0.000038587725,0.000843223,0.000044560104,0.15323818,0.000009318147,0.0000081313165,0.000112210895],"about_ca_topic_score_codex":0.00004681477,"about_ca_topic_score_gemma":0.000011047703,"teacher_disagreement_score":0.07298448,"about_ca_system_score_codex":0.000019846799,"about_ca_system_score_gemma":0.000061570536,"threshold_uncertainty_score":0.5831531},"labels":[],"label_agreement":null},{"id":"W4389229139","doi":"10.1182/blood-2023-182532","title":"Regimen Intensity and Age Affect Transplant-Related Outcomes after Matched Related Donor Hematopoietic Cell Transplantation for Sickle Cell Disease: A STAR Registry Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Medicine; Alemtuzumab; Internal medicine; Busulfan; Transplantation; Hematopoietic stem cell transplantation; Hematopoietic cell; Regimen; Cumulative incidence; Graft-versus-host disease; Oncology; Immunology; Haematopoiesis; Stem cell","score_opus":0.007491992173597691,"score_gpt":0.23411630639083889,"score_spread":0.2266243142172412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389229139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99489063,0.00084755896,0.000017675724,0.0008608234,0.00016342549,0.0024081862,0.00013497437,0.00037520696,0.0003015082],"genre_scores_gemma":[0.9952923,0.0006134276,0.00007854138,0.00011160183,0.000016514381,0.00017626953,0.00036889027,0.00007120205,0.00327125],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981727,0.00008028824,0.00047969245,0.00054938387,0.00026948762,0.00044842335],"domain_scores_gemma":[0.998976,0.00014056843,0.0001173966,0.00040867866,0.00005771859,0.00029962065],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002998561,0.00033619945,0.0006207111,0.00016210868,0.00013799155,0.000031753803,0.0000928286,0.000252392,0.000038041017],"category_scores_gemma":[0.000025821064,0.00027278883,0.00021711807,0.0003503452,0.00009532692,0.00007521136,0.000021756747,0.00033097557,0.000049158596],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008624561,0.008930407,0.8760012,0.010345025,0.0019686867,0.01681745,0.05461849,0.000052239997,0.020865895,0.000034546985,0.0015187274,0.00022278521],"study_design_scores_gemma":[0.04763182,0.0015347175,0.92587763,0.0008239148,0.00877892,0.00023467674,0.007901966,0.00027911295,0.0053933053,0.00047228037,0.00014438995,0.00092727714],"about_ca_topic_score_codex":0.00005229284,"about_ca_topic_score_gemma":0.000019058547,"teacher_disagreement_score":0.049876437,"about_ca_system_score_codex":0.000020889142,"about_ca_system_score_gemma":0.000065692504,"threshold_uncertainty_score":0.9999724},"labels":[],"label_agreement":null},{"id":"W4389229148","doi":"10.1182/blood-2023-174076","title":"<i>Calr</i> Variant Allele Frequency in Essential Thrombocythemia: Molecular Associations and Impact on Disease Phenotype and Outcome","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Quebec - Clinical Research Organization in Cancer; Université de Montréal; MPB Technologies & Communications (Canada); Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Essential thrombocythemia; Myelofibrosis; Medicine; Internal medicine; Leukocytosis; Gastroenterology; Thrombocytosis; Myeloproliferative neoplasm; Calreticulin; Myeloid; Myeloid leukemia; Allele; Polycythemia vera; Oncology; Genetics; Biology; Gene; Platelet; Bone marrow","score_opus":0.014999724719802302,"score_gpt":0.3041925289978127,"score_spread":0.28919280427801036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389229148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99652696,0.0004374194,0.000009966086,0.0017851492,0.00002814676,0.0003754935,0.000102521495,0.000046764697,0.00068758044],"genre_scores_gemma":[0.9989992,0.00022146311,0.00017013215,0.00030457045,0.000049489903,0.00006513169,0.00012628874,0.00001887156,0.000044888642],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991067,0.000041304545,0.00018413743,0.00026605994,0.00018524528,0.00021653967],"domain_scores_gemma":[0.9994619,0.00010872072,0.00004436437,0.00015963301,0.000029650722,0.0001957216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000109190994,0.00015441544,0.000286887,0.000092176495,0.00006301197,0.00002640884,0.000026199623,0.00006197701,0.00004783678],"category_scores_gemma":[0.00014856453,0.0001146206,0.000059853202,0.0001865695,0.000028494527,0.0000389985,0.000031695523,0.00012179203,0.000029500143],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005774323,0.0011920286,0.9914096,0.000039712482,0.00028258425,0.0012159073,0.00022928177,0.0000152523135,0.0019362386,0.0032347983,0.0001701711,0.00021668647],"study_design_scores_gemma":[0.0044234158,0.00027275793,0.9919887,0.000042595835,0.00032876342,0.000011262535,0.000019728726,0.000086515814,0.0011487511,0.0015496304,0.000016524687,0.000111311165],"about_ca_topic_score_codex":0.000108185166,"about_ca_topic_score_gemma":0.000026970787,"teacher_disagreement_score":0.004365673,"about_ca_system_score_codex":0.00004654147,"about_ca_system_score_gemma":0.00007258265,"threshold_uncertainty_score":0.46740922},"labels":[],"label_agreement":null},{"id":"W4389229191","doi":"10.1182/blood-2023-185149","title":"Presence of Recurrent Somatic Mutations in Mesenchymal Stromal Cell Fractions Isolated from Acute Myeloid Leukemia As an Evidence of Clonality","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Trillium Health Centre; University Health Network","funders":"","keywords":"Mesenchymal stem cell; Myeloid leukemia; Bone marrow; Cancer research; CD90; CD33; Myeloid; Biology; Leukemia; Stem cell; Immunology; Medicine; Pathology; CD34; Genetics","score_opus":0.036917236807214204,"score_gpt":0.3468444441332332,"score_spread":0.30992720732601897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389229191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99790716,0.0002728782,0.00009356857,0.00039428668,0.000081810525,0.00067256804,0.00016220413,0.00008561907,0.00032993176],"genre_scores_gemma":[0.997179,0.00029066886,0.0018717181,0.000018904528,0.00006799596,0.0000706756,0.00021003248,0.000026515332,0.0002645469],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974578,0.00021920432,0.0007216571,0.0004373391,0.0007631616,0.00040080675],"domain_scores_gemma":[0.9975689,0.0010022627,0.00025024975,0.00069196854,0.0002642764,0.00022235334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051510026,0.00018611547,0.00048742312,0.00037574608,0.00006715837,0.000013634745,0.00033303918,0.00016596979,0.00028179155],"category_scores_gemma":[0.00086517073,0.00017948319,0.00012043495,0.0012424582,0.00019558427,0.0003496905,0.00016205206,0.00057573715,0.00011786989],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009633908,0.0020428817,0.09503782,0.0006821919,0.0004562299,0.00046094577,0.0048587075,0.00031136576,0.8933875,0.0001329261,0.00048720534,0.0011788666],"study_design_scores_gemma":[0.0077224597,0.00282027,0.6541741,0.0016169912,0.0010201094,0.00009557634,0.0028225463,0.035097238,0.29164535,0.0025500646,0.000036081332,0.00039926328],"about_ca_topic_score_codex":0.0029733665,"about_ca_topic_score_gemma":0.00020209815,"teacher_disagreement_score":0.60174215,"about_ca_system_score_codex":0.00022272175,"about_ca_system_score_gemma":0.0014915685,"threshold_uncertainty_score":0.73191124},"labels":[],"label_agreement":null},{"id":"W4389229226","doi":"10.1182/blood-2023-178635","title":"The ELEMENT-MDS Trial: A Phase 3 Randomized Study Evaluating Luspatercept Versus Epoetin Alfa in Erythropoiesis-Stimulating Agent-Naive, Non-Transfusion-Dependent, Lower-Risk Myelodysplastic Syndromes","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Myelodysplastic syndromes; Anemia; Internal medicine; Erythropoiesis; Ineffective erythropoiesis; International Prognostic Scoring System; Blood transfusion; Population; Bone marrow","score_opus":0.05504110427915776,"score_gpt":0.38968085099199185,"score_spread":0.3346397467128341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389229226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870434,0.00019438192,0.00016941415,0.0005565945,0.0011318842,0.010126861,0.000038762348,0.00025783252,0.00048087243],"genre_scores_gemma":[0.9956586,0.00082661415,0.00035001998,0.000029161096,0.00038701674,0.0014218758,0.00007650128,0.00013616687,0.0011140897],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9921423,0.0020317025,0.0015109535,0.000986687,0.0020254168,0.0013029019],"domain_scores_gemma":[0.99033713,0.00771243,0.0004025107,0.0009748127,0.00026525036,0.00030787685],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0100311935,0.00055343535,0.0014470216,0.00062350143,0.00081890705,0.00018170058,0.00053002633,0.00019150444,0.00045399196],"category_scores_gemma":[0.009695173,0.00039279924,0.00042348777,0.0015037302,0.00028518733,0.00014672766,0.00040752155,0.001115629,0.00038580078],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9453296,0.0059666103,0.010347771,0.00020446032,0.0029026605,0.0029675162,0.0072283484,0.00092633197,0.0077908454,0.0000064485607,0.0006646864,0.015664693],"study_design_scores_gemma":[0.9448145,0.00830922,0.0017397539,0.00025909214,0.002050724,0.000035989015,0.00707014,0.034835707,0.00042537975,0.000033331416,0.000040479317,0.0003856535],"about_ca_topic_score_codex":0.00079461274,"about_ca_topic_score_gemma":0.00040272952,"teacher_disagreement_score":0.033909377,"about_ca_system_score_codex":0.00037141985,"about_ca_system_score_gemma":0.0006082276,"threshold_uncertainty_score":0.9998524},"labels":[],"label_agreement":null},{"id":"W4389229234","doi":"10.1182/blood-2023-186773","title":"ASC4START and ASC4FIRST: Two Ongoing Phase 3 Trials Investigating Asciminib Monotherapy As First-Line Therapy Versus Tyrosine Kinase Inhibitors in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nilotinib; Bosutinib; Medicine; Dasatinib; Discontinuation; Tolerability; Internal medicine; Adverse effect; Oncology; Myeloid leukemia; Imatinib","score_opus":0.03765564633306478,"score_gpt":0.32515279904201,"score_spread":0.2874971527089452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389229234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887253,0.005122645,0.000006273111,0.00084985356,0.00028601944,0.004487084,0.00016375499,0.00028341566,0.00007562073],"genre_scores_gemma":[0.99286133,0.0036481877,0.00029316137,0.00025593876,0.00090648927,0.0006857888,0.001080784,0.0002290791,0.000039215167],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99433154,0.00040086644,0.0016117332,0.0014114935,0.0009398288,0.0013045443],"domain_scores_gemma":[0.99639755,0.0013995911,0.0006688134,0.0008249564,0.00015180699,0.0005573022],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011697967,0.0009907378,0.0018226425,0.0009742704,0.00026748388,0.00011154663,0.00026215307,0.0003343363,0.00017265246],"category_scores_gemma":[0.00084063876,0.0008586735,0.0002277034,0.002167125,0.0003581287,0.0005116577,0.00012834939,0.0008304204,0.00005953321],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.080082096,0.034423716,0.26769525,0.00211916,0.007874472,0.0121019455,0.02374209,0.012477314,0.17871569,0.00012696124,0.0014110011,0.3792303],"study_design_scores_gemma":[0.8380952,0.027546642,0.039332476,0.0038146677,0.00060486083,0.000036415964,0.00022423638,0.004186754,0.08407699,0.00005664667,0.00079446397,0.0012306671],"about_ca_topic_score_codex":0.0016316783,"about_ca_topic_score_gemma":0.001964052,"teacher_disagreement_score":0.75801307,"about_ca_system_score_codex":0.006946062,"about_ca_system_score_gemma":0.0036875582,"threshold_uncertainty_score":0.9993864},"labels":[],"label_agreement":null},{"id":"W4389229286","doi":"10.1182/blood-2023-189928","title":"CD34+ Megakaryocytes Associate with Myelodysplastic Syndromes and Related Cytogenetic Abnormalities, but Not Other Hematological Disorders","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hematological disorders and diagnostics","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"CD34; Bone marrow; Haematopoiesis; Myelodysplastic syndromes; Pathology; Myeloid; Megakaryocyte; Stem cell; Myeloproliferative Disorders; Medicine; Biology; Immunology","score_opus":0.017328526246970313,"score_gpt":0.24173424270092733,"score_spread":0.22440571645395702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389229286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928336,0.0009237824,0.000020996127,0.0011534494,0.000049704122,0.00036503372,0.00003778421,0.00036364276,0.004252017],"genre_scores_gemma":[0.99730635,0.0006460245,0.00024740104,0.0004131365,0.00001727486,0.000054895685,0.000039096954,0.000039556024,0.0012362886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984198,0.000062327585,0.00032380948,0.00037704513,0.0003117957,0.0005052036],"domain_scores_gemma":[0.9986748,0.0007685575,0.000084260246,0.00020848407,0.00004305199,0.0002208407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015266679,0.00025465435,0.0005472987,0.00010766037,0.00012926318,0.00003387971,0.00008505001,0.00023140231,0.00021102336],"category_scores_gemma":[0.00075129257,0.00017196088,0.00007877236,0.00039365413,0.00024135046,0.00004504359,0.000077021316,0.00021098716,0.00018674847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044725052,0.0018910265,0.97847867,0.000767363,0.0011486291,0.003517594,0.00068407593,0.000043198394,0.00069184817,0.010079011,0.0015012223,0.00075012096],"study_design_scores_gemma":[0.0167876,0.003606177,0.9563005,0.0007641359,0.0017342595,0.0033627776,0.0016547188,0.0005323057,0.004597202,0.0076805186,0.0018320202,0.0011477835],"about_ca_topic_score_codex":0.0000418715,"about_ca_topic_score_gemma":0.000029730501,"teacher_disagreement_score":0.022178158,"about_ca_system_score_codex":0.000011143008,"about_ca_system_score_gemma":0.000058057696,"threshold_uncertainty_score":0.7012361},"labels":[],"label_agreement":null},{"id":"W4389229290","doi":"10.1182/blood-2023-185370","title":"Prospective Assessment of Co-Morbidities and Framingham Risk Score in Newly Diagnosed Chronic Myeloid Leukemia (CML) Patients and Its Impact on Clinical Outcomes Following Frontline TKI Therapy: Toronto CML Genomic Alliance in Greater Toronto Area &amp; Ontario (TCGA-GTA)","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Comorbidity; Internal medicine; Framingham Risk Score; Family medicine; Disease","score_opus":0.03602746253166136,"score_gpt":0.3478674559423691,"score_spread":0.3118399934107078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389229290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99340206,0.0035080852,0.000001136312,0.000024344059,0.00023212942,0.0022377768,0.00012992787,0.00007274959,0.00039178412],"genre_scores_gemma":[0.99428827,0.004258004,0.00023640216,0.000072467024,0.000098835844,0.0002464298,0.00020132173,0.00008086647,0.00051739626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967025,0.00017787097,0.0009979563,0.0009178605,0.0005269773,0.00067682413],"domain_scores_gemma":[0.9982997,0.0004864096,0.00036131806,0.000543385,0.00006682057,0.0002423506],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00058086135,0.0005880004,0.0013669886,0.00010257611,0.00008602203,0.000040288425,0.00016933723,0.00029605572,0.00019402403],"category_scores_gemma":[0.0001863723,0.0004629582,0.0002744542,0.00011987663,0.00009521223,0.00033051366,0.00012775908,0.0005054681,0.000010078759],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000491531,0.0010057056,0.9917043,0.00006738433,0.00088845857,0.00017158058,0.0034735182,0.00005982905,0.00015654379,0.000003924989,0.00007777697,0.0018994462],"study_design_scores_gemma":[0.042698946,0.003168863,0.95230955,0.0005080252,0.00024077177,0.000004177132,0.00025804044,0.00016855264,0.00020085966,0.000024865978,0.000058583882,0.00035875107],"about_ca_topic_score_codex":0.11937733,"about_ca_topic_score_gemma":0.42720792,"teacher_disagreement_score":0.3078306,"about_ca_system_score_codex":0.0122149605,"about_ca_system_score_gemma":0.0014498648,"threshold_uncertainty_score":0.9997822},"labels":[],"label_agreement":null},{"id":"W4389229317","doi":"10.1182/blood-2023-186854","title":"Sustained Efficacy and Safety with Asciminib (ASC) after Almost 4 Years of Median Follow-up from Ascembl, a Phase 3 Study of ASC Vs Bosutinib (BOS) in Patients (Pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) after ≥2 Prior Tyrosine Kinase Inhibitors (TKIs): An End of Study Treatment (EOS Tx) Update, Including Results from Switch Population","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Tolerability; Medicine; Discontinuation; Adverse effect; Internal medicine; Bosutinib; Nilotinib; Imatinib; Myeloid leukemia","score_opus":0.015366112831357356,"score_gpt":0.2878198482473606,"score_spread":0.27245373541600326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389229317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912832,0.00031379334,9.93495e-7,0.000029047593,0.00009154845,0.006982675,0.0012248761,0.00006568378,0.000008179302],"genre_scores_gemma":[0.9959039,0.000090024856,0.00018534694,0.000009489689,0.00013698517,0.00048153714,0.0030312806,0.0001394236,0.000021982114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99438834,0.0003797357,0.0019292207,0.0013834944,0.00117885,0.00074033113],"domain_scores_gemma":[0.9969664,0.00035475392,0.0008592894,0.0012806475,0.00020577802,0.0003330848],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00053176016,0.0007563418,0.0017321714,0.0009147113,0.00007513137,0.00002741021,0.00022238026,0.00024002834,0.00007090536],"category_scores_gemma":[0.0001854528,0.0006285638,0.00010821807,0.0015189728,0.00017521712,0.00037718663,0.0002652117,0.00035612236,0.0000041769363],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12961105,0.043316305,0.75279886,0.00023692993,0.0019397173,0.0022068818,0.031124143,0.0002693736,0.0028417301,3.8520164e-7,0.000007294311,0.035647314],"study_design_scores_gemma":[0.3440332,0.038635116,0.60706943,0.0010211287,0.0013832509,0.0000037231803,0.002538099,0.00029650755,0.0046540676,0.000002412825,0.000008332178,0.00035472133],"about_ca_topic_score_codex":0.025294146,"about_ca_topic_score_gemma":0.046581913,"teacher_disagreement_score":0.21442218,"about_ca_system_score_codex":0.0047760815,"about_ca_system_score_gemma":0.0017634989,"threshold_uncertainty_score":0.99961656},"labels":[],"label_agreement":null},{"id":"W4389229326","doi":"10.1182/blood-2023-173147","title":"Safety and Efficacy of Mitapivat in Adult Patients with Erythrocyte Membranopathies (SATISFY)","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Hereditary spherocytosis; Medicine; Anemia; Hemolytic anemia; Jaundice; Pyruvate kinase deficiency; Splenectomy; Hemolysis; Pediatrics; Context (archaeology); Haemolysis; Sickle cell anemia; Internal medicine; Thalassemia; Immunology; Disease; Biology; Pyruvate kinase; Spleen","score_opus":0.007917574580616883,"score_gpt":0.22052276645930172,"score_spread":0.21260519187868485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389229326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99837697,0.00007272717,0.0000048190886,0.0001590457,0.00006811843,0.00026212973,0.000013850689,0.000058178168,0.000984139],"genre_scores_gemma":[0.9989448,0.00032889683,0.00021277342,0.00018973091,0.000037125123,0.0000072299617,0.00006226287,0.0000160246,0.00020114348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99922997,0.000036102818,0.00022409002,0.00020038948,0.00014715656,0.00016227167],"domain_scores_gemma":[0.99949515,0.00011714976,0.00006328251,0.00017108607,0.000092896305,0.0000604319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006624357,0.000107589025,0.00030061346,0.00016149979,0.000029708448,0.0000025520194,0.000030012883,0.00007207318,0.000033948363],"category_scores_gemma":[0.0001349913,0.00008089767,0.00002940418,0.0003847202,0.000093566414,0.000039340066,0.000031859312,0.000109534216,0.000024604415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003598236,0.0011528786,0.9746943,0.00047321015,0.00014729488,0.00007429449,0.0012863395,0.000015018791,0.012476803,0.0004439015,0.0001897203,0.005447984],"study_design_scores_gemma":[0.016567271,0.0009281663,0.97756743,0.00018144093,0.00007733414,0.000010200404,0.0001163672,0.00001777442,0.0041226465,0.000019269615,0.000302064,0.00009001393],"about_ca_topic_score_codex":0.000025272515,"about_ca_topic_score_gemma":0.00003574927,"teacher_disagreement_score":0.012969035,"about_ca_system_score_codex":0.000007391946,"about_ca_system_score_gemma":0.00003350058,"threshold_uncertainty_score":0.32989112},"labels":[],"label_agreement":null},{"id":"W4389229332","doi":"10.1182/blood-2023-180499","title":"The Co-Occurrence of bZIP in-Frame <i>CEBPA</i>-Mutation with Unfavorable Genetic Abnormalities Is Associated with a Poor Prognosis in Acute Myeloid Leukemia","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"CEBPA; Medicine; Internal medicine; Myeloid leukemia; Acute promyelocytic leukemia; Oncology; Mutation; Genetics; Gene; Biology","score_opus":0.015570693078170014,"score_gpt":0.2744075789829805,"score_spread":0.2588368859048105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389229332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99681926,0.00020810092,0.000008841507,0.0010098156,0.000018493427,0.0010702235,0.00015168657,0.00008785412,0.00062572263],"genre_scores_gemma":[0.9977527,0.00044623617,0.00030293848,0.00018297872,0.00002390204,0.0003359874,0.00018732836,0.000038172977,0.00072970544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975131,0.0001653199,0.000455805,0.00037710532,0.0007901281,0.0006984987],"domain_scores_gemma":[0.9986278,0.00048526636,0.00019647049,0.00031470964,0.00026072314,0.000115054194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007374092,0.00023294489,0.00046729587,0.0003591197,0.00010658707,0.000046374254,0.00026916177,0.00014679105,0.000019705802],"category_scores_gemma":[0.00026344467,0.00015178218,0.000049132443,0.0021523943,0.00031630578,0.00013655634,0.000068690686,0.00054973934,0.000029700288],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013925931,0.0006306503,0.97815067,0.00037330049,0.00095511385,0.002148155,0.005995944,0.0002772404,0.004641589,0.00006729905,0.003572735,0.0017947047],"study_design_scores_gemma":[0.02298429,0.003553193,0.88152236,0.0017591764,0.0006767275,0.0004944756,0.004325085,0.0035774624,0.07981268,0.00018145154,0.0005078918,0.00060518924],"about_ca_topic_score_codex":0.00062083296,"about_ca_topic_score_gemma":0.0006160642,"teacher_disagreement_score":0.0966283,"about_ca_system_score_codex":0.0003798713,"about_ca_system_score_gemma":0.0015235897,"threshold_uncertainty_score":0.6189498},"labels":[],"label_agreement":null},{"id":"W4389229334","doi":"10.1182/blood-2023-189797","title":"Final Report: Somatic Mutations and HMGCLL1 Haplotype Are Not Associated with Molecular Relapse-Free Survival in Patients with Chronic Myeloid Leukemia Who Attempt Treatment-Free Remission","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Myeloid leukemia; Oncology; Internal medicine; Imatinib mesylate; Medicine; Population; Immunology; Imatinib","score_opus":0.015673700188890225,"score_gpt":0.23853922376533915,"score_spread":0.22286552357644893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389229334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971219,0.00020912586,0.000007322271,0.00051880523,0.000057477613,0.0012378447,0.00010076714,0.00028065182,0.00046613524],"genre_scores_gemma":[0.9957831,0.00006333274,0.00038062874,0.00004182967,0.000050582712,0.00015921246,0.0010520674,0.00012304353,0.002346229],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99713093,0.00012160155,0.00054822484,0.00075176003,0.0008404865,0.00060702127],"domain_scores_gemma":[0.99763745,0.00020482184,0.00040990624,0.0013379708,0.00014592883,0.00026392436],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002232898,0.00046566591,0.0007405628,0.00029068638,0.00016726347,0.00003624363,0.00019486771,0.00021407136,0.00004070295],"category_scores_gemma":[0.000772139,0.0003482914,0.0000820299,0.0007901589,0.00014995394,0.00014712379,0.00014057527,0.000290972,0.0000313878],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005726428,0.0012474832,0.98799545,0.00018127813,0.0010108823,0.0065866876,0.00049186556,0.00016221109,0.00065134687,0.000012282266,0.00031143398,0.0007764362],"study_design_scores_gemma":[0.058617555,0.0024944732,0.9331838,0.0015886035,0.0011005587,0.0001611421,0.000110416884,0.00030211208,0.0019406988,0.000077772194,0.000057571047,0.00036533078],"about_ca_topic_score_codex":0.00034438723,"about_ca_topic_score_gemma":0.001359286,"teacher_disagreement_score":0.05804491,"about_ca_system_score_codex":0.0026070515,"about_ca_system_score_gemma":0.0013205798,"threshold_uncertainty_score":0.9998969},"labels":[],"label_agreement":null},{"id":"W4389229364","doi":"10.1182/blood-2023-180759","title":"Incremental Burden Associated with Dose Escalation in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Complement Inhibitors","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Eculizumab; Medicine; Dosing; Discontinuation; Anemia; Hemolysis; Internal medicine; Pediatrics; Immunology; Complement system; Antibody","score_opus":0.00954359298446501,"score_gpt":0.21267869725593783,"score_spread":0.20313510427147283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389229364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982135,0.00003642485,0.0000020698353,0.000050792976,0.000064740954,0.0010443297,0.0002080585,0.00018033801,0.00019969819],"genre_scores_gemma":[0.9969772,9.1011447e-7,0.000022387978,0.000020351532,0.00002530036,0.0001041191,0.0026832065,0.000032954602,0.0001335683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833745,0.0002310005,0.00038246333,0.00037872785,0.00017666844,0.00049370417],"domain_scores_gemma":[0.9993064,0.00007885739,0.00023664387,0.00022912867,0.000105766085,0.000043238688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018040699,0.00027813876,0.00032966977,0.00021267202,0.00016363374,0.000028865112,0.00015591185,0.000090055175,0.00034697636],"category_scores_gemma":[0.00001963402,0.00019448203,0.000035740544,0.00057185226,0.00010359388,0.00011403749,0.000079083635,0.00016080913,0.000097608165],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010022491,0.0009322728,0.9940918,0.000017834267,0.0005792702,0.000022262735,0.00025968495,0.00008108205,0.002233933,0.0000098034025,0.0006389141,0.00013085593],"study_design_scores_gemma":[0.026672784,0.0015644379,0.9660183,0.0003048161,0.00021149286,0.000005601477,0.0003811778,0.0000074786963,0.0043858346,0.000003984532,0.00015171434,0.00029237682],"about_ca_topic_score_codex":0.00035484153,"about_ca_topic_score_gemma":0.0007613518,"teacher_disagreement_score":0.028073536,"about_ca_system_score_codex":0.00014169425,"about_ca_system_score_gemma":0.00007057438,"threshold_uncertainty_score":0.7930747},"labels":[],"label_agreement":null},{"id":"W4389229368","doi":"10.1182/blood-2023-174801","title":"Efficacy of Vitamin C with Iron Supplementation in Iron Deficiency Anemia Patients: A Systematic Review and Meta-Analysis","year":2023,"lang":"en","type":"review","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Anemia; Internal medicine; Ferritin; Gastroenterology; Transferrin saturation; Iron deficiency; Odds ratio; Randomized controlled trial; Iron-deficiency anemia; Nausea; Meta-analysis; Adverse effect","score_opus":0.03914506375276677,"score_gpt":0.32920421786807613,"score_spread":0.29005915411530936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389229368","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00034461438,0.994316,0.0000052061073,0.000020060814,0.000008212224,0.005049962,0.00014848325,0.000018754306,0.00008875008],"genre_scores_gemma":[0.00017254177,0.99778014,0.00017972408,0.000061019266,0.0000055049713,0.00053084467,0.0010134437,0.000043256066,0.00021351737],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99714065,0.0003310514,0.0013806715,0.00045290386,0.00046999537,0.00022470791],"domain_scores_gemma":[0.99825984,0.00019399123,0.00083492394,0.00056383637,0.00007338719,0.00007400047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057074294,0.0003920685,0.0064832405,0.0006015277,0.000022957585,0.000011236128,0.00012599399,0.00011405922,0.000113549904],"category_scores_gemma":[0.00025492997,0.00023118584,0.000791022,0.0016931524,0.000045885474,0.000049424336,0.00004201242,0.00015864521,0.000017236884],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000047181593,0.0005442461,0.00008083082,0.9943495,0.0043436266,0.000007277687,0.00007729863,3.5297504e-7,4.498976e-8,0.000016101892,0.000027584812,0.00054844876],"study_design_scores_gemma":[0.0018758429,0.00016180037,0.00018103658,0.033236545,0.96408576,0.0000063503107,0.000054727683,9.054062e-8,2.6868625e-7,5.8297235e-7,0.00019566083,0.00020133317],"about_ca_topic_score_codex":0.000074433665,"about_ca_topic_score_gemma":0.000057731057,"teacher_disagreement_score":0.9611129,"about_ca_system_score_codex":0.000023379169,"about_ca_system_score_gemma":0.00009369069,"threshold_uncertainty_score":0.9427485},"labels":[],"label_agreement":null},{"id":"W4389229374","doi":"10.1182/blood-2023-178754","title":"Patient Preference Studies in Hematologic Malignancies: A Systematic Review","year":2023,"lang":"en","type":"review","venue":"Blood","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; MEDLINE; Lymphoma; Multiple myeloma; Systematic review; Population; Internal medicine; Data extraction; Oncology; Family medicine","score_opus":0.27252187702814507,"score_gpt":0.42202543931753606,"score_spread":0.149503562289391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389229374","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000040200273,0.9905666,4.7849744e-7,0.0001291613,0.0002682188,0.00856613,0.00004581781,0.00023679153,0.00014657517],"genre_scores_gemma":[0.000006559818,0.99504507,0.000085770334,0.0007550245,0.00007799048,0.0036170543,0.000059816375,0.000090396694,0.00026229772],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99419695,0.00087353186,0.0029219692,0.0007630859,0.0007659042,0.00047854197],"domain_scores_gemma":[0.99606615,0.0011138387,0.0012504687,0.0012623991,0.00016191915,0.00014522727],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014396633,0.0006606154,0.009833076,0.00029393137,0.000042612686,0.000015305495,0.00033338825,0.0002679265,0.000017660894],"category_scores_gemma":[0.005309626,0.00046367623,0.00078617485,0.0011057683,0.00009758513,0.000041878986,0.0002815343,0.00054827495,0.00060629717],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000001256912,0.0003101089,0.0000042435713,0.9954507,0.0010870941,0.00038184458,0.0006285729,7.7587545e-9,1.581091e-8,0.000051375904,0.00083115563,0.0012536702],"study_design_scores_gemma":[0.00041272078,0.00019218207,0.0000016213417,0.96954924,0.011309752,0.00066896813,0.00040699076,5.3163923e-8,4.9044553e-7,0.000045953868,0.017019916,0.00039209137],"about_ca_topic_score_codex":0.00003057065,"about_ca_topic_score_gemma":0.000064698375,"teacher_disagreement_score":0.025901394,"about_ca_system_score_codex":0.00019822828,"about_ca_system_score_gemma":0.0005203636,"threshold_uncertainty_score":0.9997815},"labels":[],"label_agreement":null},{"id":"W4389229390","doi":"10.1182/blood-2023-178660","title":"Real-World Patterns of Targeted Therapy Use in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma in the United States: A Longitudinal Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Ibrutinib; Chronic lymphocytic leukemia; Discontinuation; Medicine; Lymphoma; Oncology; Internal medicine; Leukemia","score_opus":0.06969717517833665,"score_gpt":0.32570680477449615,"score_spread":0.25600962959615947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389229390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970109,0.0004256684,0.0000030732863,0.000046861216,0.00005329605,0.002221179,0.000033688037,0.00013032834,0.00007502451],"genre_scores_gemma":[0.99576354,0.0030520859,0.000030057954,0.00014690761,0.000091915186,0.0002888963,0.00019303418,0.00008882899,0.00034475053],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957907,0.000549888,0.00093730754,0.00077633164,0.00091265084,0.0010331084],"domain_scores_gemma":[0.9970495,0.0013066637,0.00018285975,0.001116781,0.00014708318,0.00019707982],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014893308,0.00044793318,0.0008321908,0.0017525258,0.00008728072,0.0000856963,0.00049560075,0.00015582344,0.00004711761],"category_scores_gemma":[0.00025826666,0.00033178958,0.00011793268,0.004170318,0.00021316478,0.0001391019,0.00024408982,0.00027510643,0.000033046545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0022356987,0.0020595267,0.9614893,0.0009910549,0.0007329414,0.010105797,0.014440399,0.004120276,0.0010132648,0.00009668994,0.00015373014,0.00256133],"study_design_scores_gemma":[0.13735372,0.0015511601,0.80196595,0.0005382155,0.00015775747,0.0002600024,0.0030976012,0.05360607,0.00096762134,0.0000501991,0.00012178103,0.00032990254],"about_ca_topic_score_codex":0.18170232,"about_ca_topic_score_gemma":0.037610166,"teacher_disagreement_score":0.15952332,"about_ca_system_score_codex":0.053220168,"about_ca_system_score_gemma":0.023552032,"threshold_uncertainty_score":0.9999134},"labels":[],"label_agreement":null},{"id":"W4389229400","doi":"10.1182/blood-2023-189096","title":"Safety, Tolerability, and Pharmacokinetics of Nirsevimab for the Prevention of RSV Disease in Immunocompromised Children Aged ≤24 Months: Music, an Open Label, Phase 2 Trial","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Respiratory viral infections research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Tolerability; Adverse effect; Internal medicine; Palivizumab; Lower respiratory tract infection; Respiratory tract infections; Pediatrics; Immunology; Respiratory system","score_opus":0.11138719594863432,"score_gpt":0.43501426455332654,"score_spread":0.3236270686046922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389229400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99138945,0.0004033952,0.000027240882,0.00017965882,0.000067930945,0.007709002,0.00014021722,0.000024395526,0.00005868842],"genre_scores_gemma":[0.998824,0.00016340092,0.00013587221,0.000024913046,0.00010055768,0.00050100137,0.00010280853,0.000022725033,0.00012472292],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99850523,0.00025259246,0.0005453611,0.00025828247,0.00024852995,0.00018998451],"domain_scores_gemma":[0.9989653,0.00021576637,0.00013354114,0.00046594706,0.00011654333,0.000102874874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001248169,0.000115389375,0.00036688984,0.00016722067,0.00009023404,0.00002996986,0.00025954473,0.000048502458,0.00007177208],"category_scores_gemma":[0.00039112606,0.00008778768,0.0000623015,0.0004770575,0.00015228681,0.00014561326,0.0002228414,0.00015997727,0.0000014998528],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21073933,0.04493155,0.044600334,0.0010272365,0.0010647937,0.000023794613,0.0009481594,0.00017571091,0.5878241,0.00011593927,0.0007357436,0.10781328],"study_design_scores_gemma":[0.65724486,0.011692427,0.27550873,0.00025089967,0.0009576965,0.000004243563,0.00010305093,0.0036166427,0.04942839,0.00056389056,0.00040295802,0.0002262249],"about_ca_topic_score_codex":0.00014834519,"about_ca_topic_score_gemma":0.000041518364,"teacher_disagreement_score":0.53839576,"about_ca_system_score_codex":0.00002005469,"about_ca_system_score_gemma":0.000184868,"threshold_uncertainty_score":0.35798776},"labels":[],"label_agreement":null},{"id":"W4389229432","doi":"10.1182/blood-2023-188527","title":"The Lack of Tolerable Treatments Options That Can Induce Durable Responses without Fear of Relapse after Discontinuation Represents a Significant Unmet Need for Patients (Pts) with Immune Thrombocytopenia (ITP): Results from the ITP World Impact Survey (I-WISh) 2.0","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Immune thrombocytopenia; Discontinuation; Rituximab; Quality of life (healthcare); Romiplostim; Eltrombopag; Splenectomy; Internal medicine; Pediatrics; Thrombopoietin; Lymphoma; Platelet","score_opus":0.05254868555544652,"score_gpt":0.3140641447481148,"score_spread":0.2615154591926683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389229432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99288297,0.00021973207,0.0000023932782,0.00059283106,0.00007305466,0.0022809713,0.003722967,0.000034704703,0.0001903498],"genre_scores_gemma":[0.99345404,0.0002343519,0.00016384477,0.000024292342,0.000018119992,0.00027761966,0.0018537332,0.000050543997,0.003923461],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99767166,0.00035765878,0.0006089244,0.00043915317,0.0005041144,0.00041848604],"domain_scores_gemma":[0.9967728,0.0014099583,0.00050838053,0.0009425732,0.00026493534,0.000101303274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073237903,0.00029697435,0.00070848834,0.00012714828,0.0002636836,0.000058959547,0.00022022815,0.00008412362,0.000015419353],"category_scores_gemma":[0.00068852055,0.00015123707,0.00018105686,0.00072628225,0.00015966593,0.0001543227,0.00007322392,0.00014892363,0.000008777911],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015883053,0.0025006516,0.97534937,0.000015658472,0.0019337478,0.000033222423,0.0013360089,0.000031792293,0.0017620755,0.0000052823048,0.0007669883,0.0003821553],"study_design_scores_gemma":[0.019966872,0.0013734415,0.9689223,0.0002971186,0.00080806634,0.0000030073745,0.00052152254,0.00006162726,0.0077504646,0.00008790167,0.00005286071,0.00015479003],"about_ca_topic_score_codex":0.012965003,"about_ca_topic_score_gemma":0.005101621,"teacher_disagreement_score":0.007863382,"about_ca_system_score_codex":0.00007610465,"about_ca_system_score_gemma":0.00020884411,"threshold_uncertainty_score":0.99360776},"labels":[],"label_agreement":null},{"id":"W4389229433","doi":"10.1182/blood-2023-181058","title":"Pharmacokinetic-Guided Hydroxyurea to Reduce Transfusion Requirements in Ugandan Children with Sickle Cell Anemia: Baseline Data from the Alternative Dosing and Prevention of Transfusions (ADAPT) Trial","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Dosing; Population; Anemia; Blood transfusion; Sickle cell anemia; Hydroxycarbamide; Pediatrics; Intensive care medicine; Internal medicine; Disease","score_opus":0.04355201386151078,"score_gpt":0.3173907384408363,"score_spread":0.27383872457932557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389229433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995288,0.00034705058,0.0002607431,0.0017556434,0.00008523504,0.0017758883,0.00017344815,0.00003616541,0.00027782834],"genre_scores_gemma":[0.99708974,0.0016939717,0.00035790796,0.000105364445,0.00013055098,0.000020621124,0.00048513012,0.000024085622,0.00009263866],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9986216,0.00012046441,0.00036594266,0.00038294622,0.0003086855,0.00020038265],"domain_scores_gemma":[0.99933684,0.000085960884,0.0000730229,0.00037245502,0.000035000776,0.00009674409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004676406,0.00015016725,0.00025796876,0.00010151688,0.000082921935,0.000010923319,0.00017431588,0.00007943265,0.000049531023],"category_scores_gemma":[0.000052898944,0.00009844096,0.00003811815,0.00049658545,0.000054924047,0.00008065903,0.00006430402,0.00022511803,0.0000035254964],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02709029,0.005028862,0.02638318,0.00019398742,0.00079106516,0.00014509671,0.011155948,0.0010742528,0.8922722,0.000008611076,0.0047772997,0.031079235],"study_design_scores_gemma":[0.5357822,0.0050978893,0.08316914,0.0028784685,0.0050060786,0.00008220411,0.002874697,0.006238201,0.3568801,0.00018795248,0.000986793,0.0008162256],"about_ca_topic_score_codex":0.0014178132,"about_ca_topic_score_gemma":0.00022990671,"teacher_disagreement_score":0.53539205,"about_ca_system_score_codex":0.000011249514,"about_ca_system_score_gemma":0.00008130057,"threshold_uncertainty_score":0.40143058},"labels":[],"label_agreement":null},{"id":"W4389229454","doi":"10.1182/blood-2023-187689","title":"Retrospective Study to Evaluate Probability of MR4 Maintenance Following Frontline Nilotinib Dose De-Escalation after MR4 Achievement in the Patients with Chronic Myeloid Leukemia in Chronic Phase","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Nilotinib; Discontinuation; Imatinib; Internal medicine; Imatinib mesylate; Myeloid leukemia; Dasatinib; Tyrosine-kinase inhibitor; Hazard ratio; Cancer; Confidence interval","score_opus":0.015430110723707703,"score_gpt":0.29349225437395715,"score_spread":0.27806214365024945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389229454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99287236,0.00012747785,0.000022292023,0.00020723403,0.0000700358,0.006526845,0.00003498888,0.00006181954,0.0000769746],"genre_scores_gemma":[0.998186,0.000012400174,0.00026605336,0.000071347684,0.00009029787,0.0011534722,0.00009103724,0.000048296806,0.00008109307],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966254,0.00031596827,0.0007244126,0.0007187636,0.00092432013,0.0006910833],"domain_scores_gemma":[0.99866325,0.00007924866,0.000186151,0.00082447357,0.00013127348,0.00011563103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001661504,0.000348687,0.00061794027,0.0002654639,0.00005783015,0.000017470851,0.0002279228,0.00008072431,0.00004051622],"category_scores_gemma":[0.00027540707,0.00023924229,0.00011984642,0.001245574,0.000058580274,0.00013239108,0.00012980278,0.00039112358,0.00003239552],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018009257,0.0064152475,0.9822545,0.0001356789,0.00027200274,0.00018936498,0.0056568966,0.0009579383,0.00067314954,0.0000047240183,0.00002671427,0.0016128364],"study_design_scores_gemma":[0.066000715,0.0075070593,0.923438,0.000551948,0.00037655566,0.0000027955496,0.00035354047,0.0009986655,0.0004895492,0.000065612374,0.0000149500875,0.00020058748],"about_ca_topic_score_codex":0.0008067692,"about_ca_topic_score_gemma":0.005045301,"teacher_disagreement_score":0.06419979,"about_ca_system_score_codex":0.013862763,"about_ca_system_score_gemma":0.0018214338,"threshold_uncertainty_score":0.9899228},"labels":[],"label_agreement":null},{"id":"W4389229470","doi":"10.1182/blood-2023-174536","title":"Intracellular IL-23 Receptor (IL-23R) Is a Regulator of Mitotic Spindle and Centrosome Formation and Is Essential for AML Viability","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto General Hospital; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Biology; Cell biology; Centrosome; Mitosis; Cell; Molecular biology; Cell cycle; Genetics","score_opus":0.01769769086050517,"score_gpt":0.28157126807909416,"score_spread":0.263873577218589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389229470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942272,0.0004798599,0.000054343844,0.004004214,0.000079241676,0.0007082436,0.00035650158,0.000029854971,0.00006058814],"genre_scores_gemma":[0.99633497,0.00042513103,0.00093324354,0.00012556279,0.00026074811,0.000031899774,0.00014735619,0.00001797147,0.0017231253],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988204,0.000029956545,0.00030013308,0.00025650373,0.00029845152,0.0002945461],"domain_scores_gemma":[0.99933755,0.00010470764,0.00007633503,0.00018939104,0.00012830786,0.00016371477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002657777,0.00012745432,0.0002987664,0.00010352628,0.00009485991,0.000020606352,0.0000577046,0.00009700761,0.00011670749],"category_scores_gemma":[0.00011227036,0.00010587545,0.000090132075,0.00018748506,0.00015583613,0.00009835854,0.00008290962,0.00010403474,0.000030338688],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001145189,0.0007950358,0.03978362,0.005131796,0.00035181412,0.00001537792,0.0026324166,4.5390536e-7,0.92970556,0.00073765323,0.011418958,0.008282113],"study_design_scores_gemma":[0.004878556,0.00097231567,0.04650605,0.00018504524,0.00024999023,0.000049421895,0.0002813054,0.0029150534,0.91734535,0.0012462706,0.025154436,0.00021619009],"about_ca_topic_score_codex":0.000039554692,"about_ca_topic_score_gemma":0.0000042969987,"teacher_disagreement_score":0.013735478,"about_ca_system_score_codex":0.000012572602,"about_ca_system_score_gemma":0.00004398989,"threshold_uncertainty_score":0.43174756},"labels":[],"label_agreement":null},{"id":"W4389229472","doi":"10.1182/blood-2023-189763","title":"Risk of Developing Post Thrombotic Syndrome after Deep Vein Thrombosis with Different Anticoagulant Regimens, a Systematic Review and Pooled Analysis","year":2023,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Deep vein; Thrombosis; Internal medicine; Incidence (geometry); Anticoagulant; Post-thrombotic syndrome; Low molecular weight heparin; Rivaroxaban; Surgery; Warfarin; Atrial fibrillation","score_opus":0.023449476227914157,"score_gpt":0.2920913566389402,"score_spread":0.26864188041102605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389229472","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0057644392,0.9874494,0.00007162438,0.0001012621,0.000042660802,0.006337928,0.00010109133,0.00010534272,0.000026236456],"genre_scores_gemma":[0.0033256912,0.9945349,0.00033872944,0.00019868107,0.00002306058,0.0011537038,0.00020687557,0.00014844323,0.00006989669],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99561936,0.0004771858,0.0018028716,0.00089043565,0.00068008085,0.00053004303],"domain_scores_gemma":[0.9964395,0.0003333661,0.001482758,0.001335176,0.00019752425,0.00021165097],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00066980906,0.00089306955,0.013445445,0.0008347822,0.000091380534,0.000054888213,0.00028164132,0.00023429011,0.00005513942],"category_scores_gemma":[0.00024259202,0.0005321775,0.0010814945,0.0017251688,0.00010812323,0.00005627465,0.00028235422,0.0003510003,0.0000427441],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000028319591,0.0006588609,0.00035932628,0.9282753,0.069905356,0.00028790237,0.00008335743,2.2961855e-7,1.7097214e-7,0.00005514106,0.000017675975,0.00035385508],"study_design_scores_gemma":[0.00043840538,0.00032909904,0.010605444,0.49613497,0.49175563,0.00018356598,0.000037615693,0.000002499885,5.872587e-7,0.0000047408553,0.0001092628,0.00039816773],"about_ca_topic_score_codex":0.00010518053,"about_ca_topic_score_gemma":0.00011686519,"teacher_disagreement_score":0.43214032,"about_ca_system_score_codex":0.00010680475,"about_ca_system_score_gemma":0.00015529014,"threshold_uncertainty_score":0.999713},"labels":[],"label_agreement":null},{"id":"W4389229518","doi":"10.1182/blood-2023-178724","title":"A Potential Paradigm for the Robust and Systematic Prioritisation of Assets in Academic-Led, Multi-Industry Collaborative Trials in Rare Populations (Glo-BNHL)","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Clinical trial; Relevance (law); Adverse effect; Intensive care medicine; Medical physics; Pathology; Pharmacology","score_opus":0.143860817377604,"score_gpt":0.40989628892360797,"score_spread":0.26603547154600393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389229518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911448,0.0013622616,0.00022378603,0.0014218875,0.0001011412,0.0055970075,0.000102694314,0.000025179717,0.000021260275],"genre_scores_gemma":[0.99805814,0.00024448332,0.00042305913,0.000018095048,0.000114373586,0.00062815606,0.000054493397,0.000020625372,0.00043856414],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797314,0.00053261494,0.0007745865,0.0001982889,0.0003026661,0.00021872002],"domain_scores_gemma":[0.9980877,0.0013362033,0.00021463704,0.00019837497,0.00010558793,0.000057503872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032636144,0.000109287575,0.00065122615,0.00029609055,0.000055354965,0.000022156864,0.00008623429,0.00029034313,0.000034451085],"category_scores_gemma":[0.0033013602,0.00008105936,0.000071732604,0.00092991727,0.00005112633,0.0000759392,0.000033278284,0.00041209845,0.000002128583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034992676,0.0025531321,0.60467833,0.032955583,0.0016259513,0.00035877625,0.020428006,0.0055013085,0.31864208,0.0029441598,0.0011404688,0.0056729224],"study_design_scores_gemma":[0.06223839,0.00069619436,0.8563665,0.010660281,0.0012284582,0.00013149291,0.012167287,0.04380244,0.011101346,0.0010866496,0.00008321439,0.00043772242],"about_ca_topic_score_codex":0.00009293081,"about_ca_topic_score_gemma":0.00028973355,"teacher_disagreement_score":0.30754074,"about_ca_system_score_codex":0.000056990604,"about_ca_system_score_gemma":0.0001922362,"threshold_uncertainty_score":0.3952275},"labels":[],"label_agreement":null},{"id":"W4389229545","doi":"10.1182/blood-2023-180772","title":"Incremental Healthcare Resource Utilization and Costs Associated with Non-Optimal Treatment in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated with Tyrosine Kinase Inhibitors (TKI) in Early Lines of Therapy in the United States (US)","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Discontinuation; Dasatinib; Bosutinib; Nilotinib; Internal medicine; Ponatinib; Cohort; Imatinib mesylate; Drug holiday; Imatinib; Oncology; Pediatrics; Myeloid leukemia; Immunology","score_opus":0.017867027619073838,"score_gpt":0.27037533789041845,"score_spread":0.2525083102713446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389229545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957472,0.000684519,4.122196e-7,0.00013698342,0.0000077481145,0.003239325,0.000112342845,0.000056248875,0.000015239239],"genre_scores_gemma":[0.99524176,0.00079158565,0.00002184305,0.000059630875,0.00002790231,0.00034059418,0.0034184046,0.000078069104,0.000020215406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99730057,0.00030466542,0.000636131,0.0005760795,0.0005486747,0.00063386245],"domain_scores_gemma":[0.9989299,0.00017026704,0.00028769686,0.00037824112,0.00011883926,0.00011505325],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031158942,0.0004818408,0.00069000304,0.00083808135,0.00006312296,0.000026031337,0.0001147971,0.00017236726,0.0000069149633],"category_scores_gemma":[0.000032256878,0.00029954777,0.000033043278,0.0033857578,0.00017648352,0.00014800842,0.00003336447,0.0003289221,0.0000013975407],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004823066,0.0031894683,0.9817488,0.00009759558,0.00020411743,0.00042272132,0.003733971,0.0016963705,0.00059461204,0.0000015333512,0.0000071039494,0.0034806046],"study_design_scores_gemma":[0.13936326,0.021188395,0.82601273,0.0021135847,0.000113070026,0.0000083673785,0.0006910621,0.002672221,0.0075614206,6.481081e-7,0.000022449498,0.00025277422],"about_ca_topic_score_codex":0.029505547,"about_ca_topic_score_gemma":0.047018506,"teacher_disagreement_score":0.15573609,"about_ca_system_score_codex":0.008424299,"about_ca_system_score_gemma":0.0013338096,"threshold_uncertainty_score":0.99994564},"labels":[],"label_agreement":null},{"id":"W4389229550","doi":"10.1182/blood-2023-189667","title":"Assessing Pain Severity in Sickle Cell Disease Using Animations and a Graphical Body Image","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; SickKids Foundation; Institute for Clinical Evaluative Sciences","funders":"","keywords":"Medicine; Population; Disease; Chronic pain; Physical therapy; Clinical trial; Pain assessment; Randomized controlled trial; Pain management; Internal medicine","score_opus":0.013557477477302871,"score_gpt":0.278165069272266,"score_spread":0.2646075917949631,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389229550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978632,0.0003064974,0.00014912798,0.00080958696,0.00002306388,0.00017056083,0.0000057029515,0.00008541368,0.0005868512],"genre_scores_gemma":[0.9988612,0.00010136846,0.0007873221,0.00015120365,0.000023548695,0.0000052172504,0.00002141353,0.000013773148,0.0000349489],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99930793,0.00007401518,0.00014289691,0.0001665394,0.000112726564,0.00019589518],"domain_scores_gemma":[0.99963164,0.00005813049,0.000024843672,0.00011317622,0.000020339578,0.0001518852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030703202,0.0000808931,0.00013094892,0.00013513242,0.000090867405,0.000040305655,0.00002401197,0.00006644988,0.000015412019],"category_scores_gemma":[0.00015578227,0.000072729825,0.000040731105,0.00048580227,0.00006114879,0.00011241393,0.000034085813,0.00017151119,0.0000078029525],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000092612216,0.003130041,0.83077383,0.0012810478,0.0000864157,0.002707836,0.0012252297,0.00004774816,0.15705779,0.00020716348,0.0007339487,0.00265632],"study_design_scores_gemma":[0.0055996673,0.00010327481,0.91629183,0.00042952588,0.0004081375,0.000045794528,0.0022635937,0.07255462,0.0007556359,0.0009406146,0.00030032246,0.0003069773],"about_ca_topic_score_codex":0.000052416995,"about_ca_topic_score_gemma":0.000005076597,"teacher_disagreement_score":0.15630217,"about_ca_system_score_codex":0.000010063902,"about_ca_system_score_gemma":0.000079479396,"threshold_uncertainty_score":0.29658362},"labels":[],"label_agreement":null},{"id":"W4389229577","doi":"10.1182/blood-2023-174751","title":"Tailor: Interventional Study Evaluating Physician's Choice of Ibrutinib Monotherapy or Ibrutinib-Venetoclax Combination Using Dose Modifications and Alternate Dosing Approaches in Patients with Untreated Chronic Lymphocytic Leukemia","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"William Osler Health System","funders":"","keywords":"Ibrutinib; Medicine; Venetoclax; Chronic lymphocytic leukemia; Dosing; Internal medicine; Oncology; Leukemia","score_opus":0.1237754229891403,"score_gpt":0.36975347349213017,"score_spread":0.24597805050298988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389229577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99743843,0.00014879112,0.00004013193,0.000013393144,0.000034298504,0.0021358659,0.000018456345,0.00008507373,0.00008554238],"genre_scores_gemma":[0.99908346,0.000015490681,0.0003656778,0.000010843525,0.00006590981,0.000135314,0.00013816079,0.00006226853,0.00012290188],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99737656,0.00021104756,0.0006229987,0.0005513396,0.00079991686,0.00043812403],"domain_scores_gemma":[0.99864453,0.00028298603,0.00031388507,0.00044026796,0.00021644335,0.000101910264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056969107,0.00026289557,0.00048591723,0.0004663338,0.00013589654,0.00005101492,0.00017157938,0.000088811605,0.000018024228],"category_scores_gemma":[0.00016080415,0.0002158901,0.00006812849,0.0011981425,0.00015917979,0.0002041947,0.00011787713,0.00018852907,0.0000071224467],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.015939428,0.021805525,0.68777287,0.0049266447,0.005757627,0.00031103706,0.013775955,0.16581288,0.02658493,0.00054316287,0.00004594836,0.05672401],"study_design_scores_gemma":[0.14843492,0.003228416,0.21425855,0.0009689513,0.00036870825,0.000015907992,0.0004945509,0.62923783,0.0026823157,0.000054641554,0.0000020484201,0.00025312576],"about_ca_topic_score_codex":0.0018513899,"about_ca_topic_score_gemma":0.00016199403,"teacher_disagreement_score":0.4735143,"about_ca_system_score_codex":0.017585367,"about_ca_system_score_gemma":0.008430746,"threshold_uncertainty_score":0.99719054},"labels":[],"label_agreement":null},{"id":"W4389229579","doi":"10.1182/blood-2023-178698","title":"A Matching-Adjusted Indirect Comparison of Acalabrutinib with and without Obinutuzumab Versus Zanubrutinib in Treatment-Naïve Chronic Lymphocytic Leukemia","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Chronic lymphocytic leukemia; Medicine; Internal medicine; Obinutuzumab; Oncology; Randomized controlled trial; Proportional hazards model; Leukemia","score_opus":0.053797107701676894,"score_gpt":0.34228377334425863,"score_spread":0.28848666564258174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389229579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954695,0.0011237734,0.0000032056985,0.000032571093,0.00008924919,0.0010816008,0.00002015995,0.0002379652,0.001941976],"genre_scores_gemma":[0.998204,0.000338289,0.00025119344,0.000013265711,0.00011850507,0.00012145463,0.00009317933,0.000083656916,0.0007764438],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9970805,0.00011522133,0.0006064981,0.0006567605,0.0006925985,0.00084843306],"domain_scores_gemma":[0.99832773,0.0004521664,0.00020000772,0.0006490681,0.000089813104,0.00028124198],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031331906,0.0003996799,0.001166622,0.0005362109,0.00008580479,0.000030378378,0.00019032118,0.00024525254,0.000054639222],"category_scores_gemma":[0.00012708569,0.00031317744,0.00009909427,0.0013524711,0.00032524703,0.00009474854,0.00014968206,0.0003055777,0.0000879765],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.09722139,0.0067784553,0.58086044,0.014307762,0.015739666,0.0104679195,0.0865069,0.017367957,0.0591358,0.0015319352,0.0018281044,0.108253695],"study_design_scores_gemma":[0.7355831,0.013677374,0.06362923,0.002510454,0.0021473083,0.0012637144,0.0048602843,0.09463472,0.07977201,0.00008153436,0.00073328696,0.0011069761],"about_ca_topic_score_codex":0.006240926,"about_ca_topic_score_gemma":0.0023179587,"teacher_disagreement_score":0.6383617,"about_ca_system_score_codex":0.05216724,"about_ca_system_score_gemma":0.033982743,"threshold_uncertainty_score":0.99993205},"labels":[],"label_agreement":null},{"id":"W4389229583","doi":"10.1182/blood-2023-190293","title":"Propensity Score Matching Comparing Asciminib <i>Versus</i> Ponatinib in Chronic Myeloid Leukemia Patients Who Failed Prior Tyrosine Kinase Inhibitor Therapy","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Foothills Medical Centre; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Bosutinib; Ponatinib; Internal medicine; Discontinuation; Propensity score matching; Oncology; Imatinib; Clinical endpoint; Myeloid leukemia; Adverse effect; Clinical trial; Dasatinib","score_opus":0.0456258352050269,"score_gpt":0.2734143701800048,"score_spread":0.22778853497497792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389229583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99551135,0.00045408006,0.0000019870417,0.00016899723,0.00042068324,0.0020519043,0.00002754396,0.00036266673,0.0010007698],"genre_scores_gemma":[0.9976948,0.00031716187,0.00019931274,0.00015701367,0.00040564363,0.00016185812,0.00040885748,0.00011430777,0.00054102583],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967351,0.00010774726,0.00068638386,0.00083246536,0.00076912093,0.00086917117],"domain_scores_gemma":[0.9984732,0.00015783687,0.0002330668,0.0007297486,0.00014187308,0.00026425594],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037465157,0.0005004253,0.0008788584,0.00035437712,0.00020435454,0.000067345914,0.0002709194,0.00021380496,0.00009194833],"category_scores_gemma":[0.00015681614,0.0004413237,0.0001730743,0.000963107,0.00010220683,0.00026262313,0.000282764,0.0005904819,0.0002959915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028974747,0.0020916068,0.9364483,0.0005774851,0.00053818367,0.00086766377,0.0023870433,0.00022437748,0.028366746,0.00004063879,0.0017161276,0.023844348],"study_design_scores_gemma":[0.079827346,0.0010851742,0.8764224,0.001081748,0.00015165693,0.000013834648,0.00009382691,0.00042535012,0.039561126,0.000019649575,0.0008540768,0.00046382446],"about_ca_topic_score_codex":0.00055048714,"about_ca_topic_score_gemma":0.00045067922,"teacher_disagreement_score":0.07692987,"about_ca_system_score_codex":0.0031479604,"about_ca_system_score_gemma":0.0014338872,"threshold_uncertainty_score":0.99980384},"labels":[],"label_agreement":null},{"id":"W4389229589","doi":"10.1182/blood-2023-181299","title":"Low Rebleed Incidence with Eptacog Beta Treatment through 24 and 48 Hours in Children (&amp;lt;12 years) with Hemophilia a or B with Inhibitors","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Bleed; Medicine; Incidence (geometry); Dosing; Population; Internal medicine; Surgery; Factor IX; Pediatrics; Gastroenterology","score_opus":0.02521873457124193,"score_gpt":0.2840650118249135,"score_spread":0.2588462772536716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389229589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99646324,0.00031637412,0.0000024000976,0.001170201,0.000020108782,0.0013644753,0.000020216461,0.0001412693,0.00050174544],"genre_scores_gemma":[0.9913655,0.00049694243,0.0013732248,0.0000775604,0.00015008249,0.0001534996,0.000103991755,0.000073510026,0.0062056775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99789023,0.00005212322,0.00021535243,0.00059248914,0.00061542337,0.0006343761],"domain_scores_gemma":[0.9990297,0.00007134092,0.00006556227,0.00046236938,0.000057403508,0.00031365696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015673383,0.00033832891,0.0005004627,0.0002460571,0.0000951147,0.000044860313,0.000098872646,0.00011960533,0.00004991087],"category_scores_gemma":[0.000030359362,0.00017660033,0.00004257589,0.0009878895,0.00026589987,0.00016096335,0.00005737969,0.00023249407,0.00008456315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016084396,0.001269606,0.9903294,0.00006436643,0.00059654133,0.0019772514,0.0015518833,0.0000074567056,0.0006977961,0.000008513093,0.00046673778,0.0014220251],"study_design_scores_gemma":[0.03298511,0.009682548,0.9327972,0.0016034273,0.0009656165,0.0015555713,0.0004756087,0.000010298496,0.01884115,0.000026128764,0.0005081385,0.00054919283],"about_ca_topic_score_codex":0.00041947875,"about_ca_topic_score_gemma":0.001760536,"teacher_disagreement_score":0.057532173,"about_ca_system_score_codex":0.00010459114,"about_ca_system_score_gemma":0.0005076959,"threshold_uncertainty_score":0.72015524},"labels":[],"label_agreement":null},{"id":"W4389229591","doi":"10.1182/blood-2023-184727","title":"Chimeric Antigen Receptor-Engineered NK Cells Overcome CD226 Downregulation As an Immune Escape Mechanism in Acute Myeloid Leukemia","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Myeloid leukemia; Immune system; CD38; Innate immune system; Leukemia; Chimeric antigen receptor; Downregulation and upregulation; Cancer research; Receptor; NK-92; Cell biology; Biology; Immunology; Immunotherapy; Interleukin 21; Stem cell; T cell; CD34","score_opus":0.007255613416756462,"score_gpt":0.21525115888583038,"score_spread":0.20799554546907392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389229591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939398,0.00043782222,0.00010669358,0.00007295559,0.0037350706,0.00030490122,0.000009833348,0.00036487277,0.0010280086],"genre_scores_gemma":[0.9808532,0.0008322333,0.00008052376,0.000094825096,0.00006502933,0.000037044672,0.0012048684,0.000043123302,0.016789164],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99852407,0.0001845202,0.00042407788,0.00038221985,0.0000584004,0.00042672703],"domain_scores_gemma":[0.9993498,0.0000495159,0.0001323949,0.00038810767,0.000051774303,0.000028416276],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00027756102,0.00024220867,0.00031629403,0.00040035983,0.00016304255,0.000031936,0.00020644613,0.00034814762,0.002478136],"category_scores_gemma":[0.00002577157,0.00024827095,0.000117582065,0.00055842963,0.000038746886,0.00034533755,0.000071898554,0.00039193034,0.007271637],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117753196,0.00016828252,0.00010062643,0.000009609027,0.0002234591,0.0000070488663,0.00042127658,0.000056486697,0.99650925,0.00048204904,0.0011064791,0.0007976594],"study_design_scores_gemma":[0.002813138,0.00032803844,0.026728738,0.000038813665,0.00007815307,0.00006351305,0.000337088,0.0001480553,0.95729274,0.00019226328,0.01164549,0.0003339829],"about_ca_topic_score_codex":0.00031190467,"about_ca_topic_score_gemma":0.000011204207,"teacher_disagreement_score":0.039216544,"about_ca_system_score_codex":0.00009145777,"about_ca_system_score_gemma":0.00006766845,"threshold_uncertainty_score":0.99999696},"labels":[],"label_agreement":null},{"id":"W4389229669","doi":"10.1182/blood-2023-178401","title":"Trends of Obesity over Time and Its Prognostic Significance in Children and Adolescents with Newly-Diagnosed Acute Lymphoblastic Leukemia in Canada: A Population-Based Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; London Health Sciences Centre; McMaster University; Concordia University; Izaak Walton Killam Health Centre; Stollery Children's Hospital; Alberta Children's Hospital; BC Children's Hospital; Kingston Health Sciences Centre; McGill University; Children's Hospital of Eastern Ontario; Centre Hospitalier Universitaire Sainte-Justine; Université de Sherbrooke; CancerCare Manitoba","funders":"","keywords":"Medicine; Pediatrics; Body mass index; Obesity; Population; Incidence (geometry); Retrospective cohort study; Cancer; Cohort; Childhood obesity; Cancer registry; Internal medicine; Overweight; Environmental health","score_opus":0.008368012300194084,"score_gpt":0.24068893188350346,"score_spread":0.2323209195833094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389229669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99873483,0.00012952235,6.08375e-7,0.00008512659,0.000016919364,0.00091940543,0.000076558325,0.000032762135,0.0000042846546],"genre_scores_gemma":[0.9996832,0.000008607701,0.000022505406,0.000112984526,0.000027310405,0.00003795617,0.00006431165,0.00002500444,0.000018148108],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984086,0.00010842589,0.00037997734,0.0003971457,0.00043843483,0.00026741248],"domain_scores_gemma":[0.9993406,0.00015598719,0.00012937693,0.00019983384,0.000034142195,0.00014004722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021155391,0.00019266095,0.00049411075,0.00028733,0.00002840327,0.000008946913,0.000072389535,0.000048310416,0.00000923761],"category_scores_gemma":[0.0001442039,0.00018077953,0.000019000843,0.00083582936,0.000022541357,0.00005406191,0.000037698795,0.0001334921,0.0000012765182],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020870635,0.00056796975,0.99797404,0.00012604368,0.00008874222,0.0001334038,0.00038383392,0.0002635748,0.00008533183,4.6918052e-7,0.0000189244,0.00014893539],"study_design_scores_gemma":[0.017088164,0.00039872853,0.9799162,0.00086174643,0.000248056,0.000009316568,0.000071767434,0.0011054078,0.00012713353,0.0000017832056,1.5734462e-7,0.00017149808],"about_ca_topic_score_codex":0.61941886,"about_ca_topic_score_gemma":0.80999553,"teacher_disagreement_score":0.19057666,"about_ca_system_score_codex":0.00034620872,"about_ca_system_score_gemma":0.0014011137,"threshold_uncertainty_score":0.7371975},"labels":[],"label_agreement":null},{"id":"W4389229675","doi":"10.1182/blood-2023-180968","title":"XPO2 Is Essential for a Subset of AML Cells and Is a Biomarker for Poor Response and Survival in Pediatric and AYA AML","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children; University of Toronto; University Health Network","funders":"","keywords":"Gene knockdown; Biology; RNA interference; Cancer research; Cell culture; Nuclear transport; Importin; Gene expression; Gene; Internal medicine; Medicine; Genetics; RNA; Cell nucleus","score_opus":0.025005493765770395,"score_gpt":0.3125618700007051,"score_spread":0.28755637623493474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389229675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995404,0.00054956484,0.000030236622,0.0022452264,0.000047596648,0.0010908941,0.0005844448,0.000021957549,0.000026080561],"genre_scores_gemma":[0.9968444,0.0009154669,0.0008263955,0.0001403759,0.0001327111,0.0001036828,0.000034442157,0.00003866729,0.00096386037],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998745,0.0000761347,0.00025741148,0.000358598,0.00020987623,0.00035294582],"domain_scores_gemma":[0.99857104,0.0009439928,0.000059464408,0.00018012735,0.00009766388,0.00014769657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010677032,0.00013823797,0.0003477279,0.00043439737,0.000048658007,0.00002121853,0.000062267485,0.00013201554,0.000016581062],"category_scores_gemma":[0.00041509696,0.00012426141,0.00005358667,0.00045952588,0.000108452616,0.000049954855,0.00011440027,0.000100181984,0.0000029875698],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03011866,0.0008584713,0.32847154,0.004823669,0.00049081666,0.0002519733,0.0049360553,1.7929503e-7,0.5591476,0.00005015172,0.06658629,0.0042645726],"study_design_scores_gemma":[0.057385713,0.0022451908,0.76101524,0.00011712478,0.00092315854,0.000096283475,0.0009557666,0.0028496936,0.16814253,0.0003059015,0.005514659,0.00044876774],"about_ca_topic_score_codex":0.00008737083,"about_ca_topic_score_gemma":0.000033792312,"teacher_disagreement_score":0.43254367,"about_ca_system_score_codex":0.000018230223,"about_ca_system_score_gemma":0.00019607012,"threshold_uncertainty_score":0.50672334},"labels":[],"label_agreement":null},{"id":"W4389229704","doi":"10.1182/blood-2023-186539","title":"Randomized, Active-Control Phase 3 Study of Four-Factor Prothrombin Complex Concentrate Versus Frozen Plasma in Bleeding Adult Cardiac Surgery Patients","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Trauma, Hemostasis, Coagulopathy, Resuscitation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Kingston Health Sciences Centre; University of Toronto; Queen's University; University Health Network","funders":"","keywords":"Medicine; Surgery; Fresh frozen plasma; Coagulopathy; Cardiopulmonary bypass; Prothrombin complex concentrate; Anesthesia; Cardiology; Internal medicine; Warfarin; Platelet","score_opus":0.06268955788335459,"score_gpt":0.31424923964676565,"score_spread":0.25155968176341104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389229704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927211,0.000023699307,0.0000045598067,0.00009055438,0.00073272147,0.0057850913,0.00026767747,0.00012760004,0.00024703352],"genre_scores_gemma":[0.99907947,0.000033412598,0.000042425563,0.000020953512,0.000107474385,0.0004646153,0.00018988937,0.00004929575,0.000012468374],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9970814,0.00051245175,0.000833371,0.00043531987,0.00067100616,0.00046646316],"domain_scores_gemma":[0.997022,0.001802799,0.00036670838,0.00029479657,0.00035818858,0.00015553577],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006328823,0.00027480116,0.0014747904,0.00038222125,0.00006449841,0.00002174897,0.000103538296,0.00010453981,0.00003780804],"category_scores_gemma":[0.0017775078,0.000253264,0.0002548762,0.0006609187,0.00009353845,0.00016644005,0.000036092006,0.00022487176,0.000030528798],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.38166007,0.012367591,0.5622872,0.00041957252,0.0027831297,0.0001987989,0.009130205,0.000025962507,0.012244697,0.000020561709,0.00046827144,0.018393923],"study_design_scores_gemma":[0.73287356,0.0010326215,0.2537708,0.00018346045,0.0007284832,8.637943e-7,0.0023556638,0.0006058609,0.008200646,0.000008617572,0.000014630575,0.00022478818],"about_ca_topic_score_codex":0.00014889226,"about_ca_topic_score_gemma":0.000050745624,"teacher_disagreement_score":0.35121349,"about_ca_system_score_codex":0.00009838181,"about_ca_system_score_gemma":0.00014015932,"threshold_uncertainty_score":0.99999195},"labels":[],"label_agreement":null},{"id":"W4389229716","doi":"10.1182/blood-2023-190921","title":"Associations between the Use of Pain Management Strategies and Self-Reported Emotional and Behavioral Functioning of Adolescent and Young Adults with Sickle Cell Disease","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University","funders":"","keywords":"Medicine; Hydromorphone; Oxycodone; Anxiety; Young adult; Clinical psychology; Mindfulness; Medical prescription; Physical therapy; Psychiatry; Opioid; Internal medicine","score_opus":0.019544743062218203,"score_gpt":0.23481496295754525,"score_spread":0.21527021989532705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389229716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99910283,0.00023596555,0.000046081746,0.00018228377,0.00001304624,0.00029564576,0.000039798884,0.000031385065,0.00005295277],"genre_scores_gemma":[0.99927396,0.00035895593,0.00017676255,0.000013660509,0.00001188424,0.0000056031054,0.00008605982,0.000007659482,0.00006545854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994307,0.00003456198,0.00016563808,0.00011915115,0.00015813705,0.00009180599],"domain_scores_gemma":[0.9996652,0.000036021964,0.00009886352,0.000084247724,0.000053016374,0.000062671555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014840771,0.00006913182,0.000121050245,0.000050132294,0.00008266778,0.000020373716,0.000013223923,0.00003345156,0.0000023940827],"category_scores_gemma":[0.000012757674,0.000046622372,0.000018454693,0.00013903856,0.000067869565,0.000063264604,0.00002779079,0.000069727146,1.7150418e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004015217,0.00042159326,0.9971295,0.00026934096,0.00023732886,0.000024624973,0.0006942265,0.000029449964,0.000044258337,0.000040498588,0.000096715376,0.00097231555],"study_design_scores_gemma":[0.0020047186,0.00018044956,0.9930794,0.00020494634,0.0012904387,0.0000036875135,0.0028821342,0.0002255342,0.000026681335,0.00001742665,0.000032604003,0.000051950305],"about_ca_topic_score_codex":0.000093866096,"about_ca_topic_score_gemma":0.00001646807,"teacher_disagreement_score":0.0040500667,"about_ca_system_score_codex":0.000005460262,"about_ca_system_score_gemma":0.00003424023,"threshold_uncertainty_score":0.19012052},"labels":[],"label_agreement":null},{"id":"W4389229748","doi":"10.1182/blood-2023-187008","title":"Trends in Heparin-Induced Thrombocytopenia in the Pre-Pandemic and Peak-Pandemic Era, and Impact of COVID-19 on Mortality; An Analysis Via the National Inpatient Sample","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brampton Civic Hospital","funders":"","keywords":"Pandemic; Medicine; Coronavirus disease 2019 (COVID-19); Heparin-induced thrombocytopenia; Odds; Emergency medicine; Incidence (geometry); Diagnosis code; Mortality rate; Odds ratio; Intensive care medicine; Demography; Internal medicine; Heparin; Population; Logistic regression; Environmental health; Disease","score_opus":0.1053384998330299,"score_gpt":0.40649244695055153,"score_spread":0.30115394711752164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389229748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984209,0.00004487544,0.000006452138,0.00043198818,0.00002321856,0.00056004315,0.00008214066,0.000051285726,0.0003791235],"genre_scores_gemma":[0.9990444,0.00012125762,0.000021879889,0.00042585007,0.00005214678,0.00008282462,0.00021323207,0.000023058597,0.000015343394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99739325,0.00041598536,0.00060558185,0.0005551393,0.00062461215,0.0004054233],"domain_scores_gemma":[0.9982772,0.0007272395,0.0001818081,0.00052318186,0.00006521487,0.00022537012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016756508,0.00029475192,0.00082368037,0.0009824862,0.00014809277,0.000048783935,0.00027261293,0.00017858489,0.00008972833],"category_scores_gemma":[0.00043270373,0.00017805914,0.00018939821,0.0026571827,0.00015751534,0.00015364766,0.00012269392,0.00048307923,0.0000033833892],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000122039826,0.0006358372,0.9804851,0.000032297383,0.0007111908,0.000012668147,0.0056192237,0.00022159086,0.010863942,0.00017464436,0.000019679836,0.0011018284],"study_design_scores_gemma":[0.0035145013,0.0009809613,0.99086666,0.000025755477,0.00079871167,0.000039433566,0.0005090307,0.0020153075,0.00031954848,0.0007230316,0.000017913377,0.00018911764],"about_ca_topic_score_codex":0.012527938,"about_ca_topic_score_gemma":0.013967179,"teacher_disagreement_score":0.010544394,"about_ca_system_score_codex":0.0002019184,"about_ca_system_score_gemma":0.00032262687,"threshold_uncertainty_score":0.9940477},"labels":[],"label_agreement":null},{"id":"W4389229884","doi":"10.1182/blood-2023-183021","title":"Prognosis of Progressive Follicular Lymphoma within 24 Months of First-Line Therapy Is Not Influenced By the Initial Regimen Intensity","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Incyte; Jazz Pharmaceuticals; BeiGene; Seagen; Gilead Sciences; AstraZeneca","keywords":"Rituximab; Medicine; Follicular lymphoma; Bendamustine; Internal medicine; Progression-free survival; Regimen; Oncology; Vincristine; Prednisone; Chemoimmunotherapy; Cyclophosphamide; Lymphoma; Chemotherapy","score_opus":0.029280450191425174,"score_gpt":0.2885598334666918,"score_spread":0.2592793832752666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389229884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937624,0.0013999263,6.5407244e-7,0.003271335,0.00007619177,0.001199694,0.000088683206,0.00006554418,0.00013558229],"genre_scores_gemma":[0.9983106,0.00040631052,0.0001252769,0.0005864631,0.00006281729,0.00036475007,0.000049279184,0.000024551018,0.00006989774],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99856764,0.000041786054,0.00042549134,0.00028573303,0.00045006868,0.000229253],"domain_scores_gemma":[0.99874073,0.00012438392,0.00030625385,0.00045107264,0.00029383798,0.00008370793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001830759,0.00020354397,0.00048581552,0.000074620235,0.00008074924,0.000011991172,0.00015196837,0.00010743659,0.000027022197],"category_scores_gemma":[0.000112348156,0.000119796474,0.00019855428,0.0004363868,0.00019376482,0.00005017891,0.00007674053,0.00005446602,0.00001250769],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025996983,0.01306777,0.91557175,0.00032638316,0.0047573755,0.0006337891,0.010666344,0.0000097579705,0.014961926,0.00013420964,0.012170368,0.025100628],"study_design_scores_gemma":[0.012256712,0.0015619898,0.14790322,0.00030349224,0.0004799851,0.0000485898,0.0003062713,0.00008813655,0.8361856,0.00006672843,0.0006777823,0.00012150357],"about_ca_topic_score_codex":0.00033059792,"about_ca_topic_score_gemma":0.000009658471,"teacher_disagreement_score":0.8212237,"about_ca_system_score_codex":0.0000320125,"about_ca_system_score_gemma":0.00011346888,"threshold_uncertainty_score":0.48851585},"labels":[],"label_agreement":null},{"id":"W4389229885","doi":"10.1182/blood-2023-180132","title":"High Prevalence of Subjective Minimizing Language in Clinical Trials of Hematologic Malignancies: Natural Language Processing (NLP) Validation Study and Systematic Review of Randomized Controlled Trials Presented at ASH 2009-2021","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Queen's University; University of Toronto; Western University","funders":"","keywords":"Medicine; Randomized controlled trial; Chin; Clinical trial; Natural language processing; Artificial intelligence; Medical physics; Computer science; Internal medicine","score_opus":0.26414139478158677,"score_gpt":0.4866435178447698,"score_spread":0.222502123063183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389229885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81297493,0.17443667,0.00003822904,0.00041245803,0.00016750103,0.011666394,0.00025550844,0.000019104815,0.00002918857],"genre_scores_gemma":[0.99209356,0.006205706,0.00031713018,0.00011040622,0.00006485305,0.0009695784,0.000035910925,0.000019213534,0.00018366419],"study_design_codex":"systematic_review","study_design_gemma":"randomized_trial","domain_scores_codex":[0.94597614,0.023137232,0.029639317,0.0006360123,0.0002997257,0.0003115893],"domain_scores_gemma":[0.935371,0.04128022,0.022566801,0.00048479182,0.00023139184,0.000065828724],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.29554042,0.00023814288,0.01640879,0.0005602615,0.000045042052,0.00002309659,0.00024158068,0.00014751483,0.00008615672],"category_scores_gemma":[0.36486462,0.00019398432,0.0008196226,0.0005106224,0.000118022144,0.00019904939,0.000094251634,0.00013789511,0.000016490163],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0081099225,0.0016957081,0.04113393,0.92608184,0.0028320514,0.00001325732,0.018715119,0.000025761137,0.00040915358,0.0007169445,0.00021489762,0.000051388124],"study_design_scores_gemma":[0.6603529,0.00068219757,0.017884156,0.26835927,0.00621289,0.00002103174,0.03667457,0.0057762507,0.002224998,0.0008765624,0.0000012240546,0.0009339359],"about_ca_topic_score_codex":0.00029011353,"about_ca_topic_score_gemma":0.00003745694,"teacher_disagreement_score":0.6577226,"about_ca_system_score_codex":0.000066670786,"about_ca_system_score_gemma":0.00014346575,"threshold_uncertainty_score":0.9981936},"labels":[],"label_agreement":null},{"id":"W4389229912","doi":"10.1182/blood-2023-187775","title":"Morphologic and Genetic Features of Unclassifiable Chronic Myeloid Neoplasms: Five-Year Experience of a Canadian Provincial Referral Center","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Electricity Association; Vancouver General Hospital; Ottawa Hospital; University of British Columbia","funders":"","keywords":"Medicine; Myeloproliferative neoplasm; Essential thrombocythemia; Myeloid; Myelodysplastic syndromes; Myelofibrosis; Bone marrow; Chronic myelomonocytic leukemia; Internal medicine; Thrombocytosis; Pathology; Oncology; Polycythemia vera","score_opus":0.02088657977640402,"score_gpt":0.2555580365971531,"score_spread":0.23467145682074908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389229912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994642,0.000448333,4.5328468e-7,0.0003917298,0.00006819795,0.00048367248,0.000115355,0.00002663139,0.00382359],"genre_scores_gemma":[0.99754345,0.00067327655,0.0005619307,0.000078092984,0.000079845064,0.000106725995,0.000047299673,0.000017050606,0.0008923136],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890256,0.00003192985,0.00023915473,0.00029317435,0.0002054161,0.0003277899],"domain_scores_gemma":[0.99935716,0.00004378582,0.0000832478,0.00022990657,0.000082604085,0.000203293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000050484963,0.00016067333,0.0003469643,0.0003204544,0.00006532219,0.000009727008,0.00007465864,0.000100458456,0.00013388108],"category_scores_gemma":[0.0000701155,0.0001247794,0.000061763625,0.0004166226,0.00013913361,0.000035353274,0.00004813236,0.00010035355,0.000016606478],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018402265,0.0008823186,0.9629832,0.0004095212,0.00027732833,0.00069484214,0.003141137,0.000018080253,0.023047788,0.00071507547,0.0045695086,0.0030772062],"study_design_scores_gemma":[0.005114598,0.0016507063,0.92913604,0.000214947,0.00016568438,0.00019361767,0.00046304867,0.000048471124,0.061244838,0.000053316304,0.0015515557,0.0001632048],"about_ca_topic_score_codex":0.019628102,"about_ca_topic_score_gemma":0.03653909,"teacher_disagreement_score":0.03819705,"about_ca_system_score_codex":0.0000656503,"about_ca_system_score_gemma":0.0004233803,"threshold_uncertainty_score":0.98690027},"labels":[],"label_agreement":null},{"id":"W4389229953","doi":"10.1182/blood-2023-189318","title":"Impact of Kidney Dysfunction on Overall Survival in Myeloproliferative Neoplasms: A Single-Center Retrospective Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Queen's University; University Health Network","funders":"","keywords":"Medicine; Renal function; Internal medicine; Kidney disease; Gastroenterology; Myelofibrosis; Essential thrombocythemia; Urology; Pathology; Polycythemia vera; Oncology; Bone marrow","score_opus":0.028885551216120568,"score_gpt":0.3005566588834749,"score_spread":0.2716711076673543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389229953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940051,0.000016235857,0.0000020347795,0.00037192923,0.0002080015,0.0017776536,0.000125093,0.00009832893,0.003395634],"genre_scores_gemma":[0.998875,0.000039631872,0.000037500155,0.00014677588,0.0001443791,0.0002715674,0.000121198755,0.000042113148,0.00032181863],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978578,0.00017647704,0.00045973592,0.00055835175,0.00055321655,0.00039443397],"domain_scores_gemma":[0.9988635,0.00014022473,0.00015157243,0.00036048092,0.00020605922,0.00027812336],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027647696,0.0003390641,0.00073108164,0.00043183853,0.00006658315,0.000025295925,0.00006772214,0.00010654444,0.00018654202],"category_scores_gemma":[0.0006248677,0.0002531528,0.00022590667,0.00072217657,0.000044337325,0.000097940625,0.00005227699,0.0002651833,0.00011550409],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012365998,0.019562887,0.9726843,0.000028480075,0.0009785896,0.00029994198,0.0022641993,0.000032259162,0.001587109,0.00018102487,0.0009926434,0.00015196366],"study_design_scores_gemma":[0.022529837,0.015006844,0.95798546,0.00022107456,0.00019051757,0.000023395267,0.00034074442,0.00006279896,0.0033384298,0.00008636582,0.00002927302,0.00018525642],"about_ca_topic_score_codex":0.00022606991,"about_ca_topic_score_gemma":0.00019353649,"teacher_disagreement_score":0.021293238,"about_ca_system_score_codex":0.00039619557,"about_ca_system_score_gemma":0.00028137473,"threshold_uncertainty_score":0.9999921},"labels":[],"label_agreement":null},{"id":"W4389229959","doi":"10.1182/blood-2023-185582","title":"Ruxolitinib Versus Best Available Therapy for Polycythemia Vera: A Systematic Review and Meta-Analysis","year":2023,"lang":"en","type":"review","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Ruxolitinib; Medicine; Internal medicine; Polycythemia vera; Population; Meta-analysis; Myelofibrosis; Myeloproliferative neoplasm; Randomized controlled trial; Anemia; Confidence interval; Bone marrow","score_opus":0.2569226833816552,"score_gpt":0.40872079641507186,"score_spread":0.15179811303341667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389229959","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000015602011,0.9874356,0.0000020314133,0.0002318924,0.00004733097,0.010907008,0.00070971233,0.000069558766,0.00059530884],"genre_scores_gemma":[0.0000011957676,0.9743921,0.0003113002,0.0003124741,0.000091977105,0.015649326,0.0005973145,0.000110826615,0.008533447],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9969451,0.00024386418,0.0012344957,0.0008147757,0.00035911961,0.00040266517],"domain_scores_gemma":[0.9964834,0.001507213,0.0006590478,0.000955865,0.00016816531,0.00022631446],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006251431,0.0007672498,0.012921355,0.00029764438,0.00012224849,0.00004698196,0.00015798214,0.0002389143,0.0006676027],"category_scores_gemma":[0.00037499162,0.00043189595,0.0043067923,0.00080701296,0.000040310933,0.000036139827,0.00005145819,0.00020770617,0.00056007213],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012609663,0.00039050108,0.0000015462012,0.59029406,0.40813398,0.000032690128,0.000009988038,7.1124084e-9,1.4735812e-8,0.00008061506,0.00071929797,0.0003246775],"study_design_scores_gemma":[0.0019663565,0.0005144261,1.766093e-7,0.04260523,0.83245075,0.000051169285,0.0000061888913,3.9124242e-7,0.0000031450302,0.0000036238216,0.12212681,0.0002717189],"about_ca_topic_score_codex":0.000026838927,"about_ca_topic_score_gemma":0.0000143189345,"teacher_disagreement_score":0.54768884,"about_ca_system_score_codex":0.00006862501,"about_ca_system_score_gemma":0.00027147777,"threshold_uncertainty_score":0.99981326},"labels":[],"label_agreement":null},{"id":"W4389229994","doi":"10.1182/blood-2023-174207","title":"Cytokine Release Syndrome: The Patient, Caregiver and Healthcare Professional Experience","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Focus group; Follicular lymphoma; Health care; Lymphoma; Internal medicine; Family medicine; Nursing; Oncology","score_opus":0.01917538901883167,"score_gpt":0.3033913881708316,"score_spread":0.28421599915199997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389229994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920292,0.00029453417,0.0000036865174,0.006777152,0.00011879629,0.00044832402,0.000025580845,0.00009214638,0.00021057244],"genre_scores_gemma":[0.9972757,0.00010094338,0.00004940606,0.00069337734,0.0000681489,0.00012449724,0.000026957627,0.000019787554,0.0016411989],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986984,0.000063264546,0.00014856609,0.00025775298,0.0005036941,0.0003282834],"domain_scores_gemma":[0.9991781,0.00016633284,0.00003612301,0.00031825146,0.00009440554,0.0002067586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010660472,0.00010318984,0.00014903508,0.00007283134,0.00018841735,0.00001288507,0.00010269777,0.00006875169,0.000057169276],"category_scores_gemma":[0.00021881815,0.000061679006,0.00003190363,0.00040894118,0.00016549024,0.00004706322,0.00020133534,0.0002196176,0.0000995168],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002679445,0.0038208354,0.48885086,0.00399957,0.0011166843,0.060938843,0.14599447,0.000011517189,0.035453007,0.003471675,0.17710675,0.07655635],"study_design_scores_gemma":[0.030240249,0.004085803,0.83450574,0.0019752423,0.0004062795,0.019471185,0.03835092,0.0029039828,0.015433149,0.0005569928,0.05110576,0.00096467393],"about_ca_topic_score_codex":0.00012405754,"about_ca_topic_score_gemma":0.0000067334354,"teacher_disagreement_score":0.3456549,"about_ca_system_score_codex":0.00007093967,"about_ca_system_score_gemma":0.00037182381,"threshold_uncertainty_score":0.25151968},"labels":[],"label_agreement":null},{"id":"W4389230190","doi":"10.1182/blood-2023-186456","title":"Integrative Genome and Transcriptome Sequencing Analysis Indicates Genetic and Epigenetic Dysregulation in DS-AML","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Exon; Biology; Genetics; Exome sequencing; GATA1; Single molecule real time sequencing; Whole genome sequencing; Mutation; DNA sequencing; Genome; Gene; Transcription factor","score_opus":0.01114732840584547,"score_gpt":0.2408999438110716,"score_spread":0.22975261540522612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389230190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99541414,0.0032011827,0.0010500515,0.000080179816,0.000011466508,0.00012189314,0.000019295565,0.000010705446,0.0000911061],"genre_scores_gemma":[0.9973532,0.0017533755,0.00048505614,0.00002915197,0.000031810694,0.000043817774,0.000115014576,0.000010274604,0.00017827454],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99929464,0.00004036534,0.0001562694,0.00030135264,0.00006252062,0.00014486432],"domain_scores_gemma":[0.99972886,0.000007805318,0.000041253308,0.00015001622,0.000024635207,0.000047438163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010747758,0.00009899102,0.00012648584,0.00020735589,0.00005308087,0.000025605137,0.0000611569,0.00007800284,0.000008535297],"category_scores_gemma":[0.000013871062,0.00009180135,0.000036384656,0.00050269644,0.00006655116,0.0000036130234,0.000026010537,0.00004536995,0.0000021475273],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000067277338,0.000023985887,0.061944723,0.000013152524,0.0001823359,0.0000031188454,0.0006210456,0.0004836575,0.9348392,0.000030114135,0.0000048168176,0.0018471355],"study_design_scores_gemma":[0.0005638004,0.00008511263,0.950129,0.00000740695,0.00022464225,0.0000054345023,0.00040561944,0.0008376439,0.04712305,0.0002439913,0.0002181132,0.00015621747],"about_ca_topic_score_codex":0.00005372767,"about_ca_topic_score_gemma":0.00020639134,"teacher_disagreement_score":0.88818425,"about_ca_system_score_codex":0.000009732944,"about_ca_system_score_gemma":0.000031757067,"threshold_uncertainty_score":0.37435502},"labels":[],"label_agreement":null},{"id":"W4389230248","doi":"10.1182/blood-2023-181307","title":"Outpatient Management of Sickle Cell Vaso-Occlusive Crisis As a Strategy of Decreasing Emergency Department Visits","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Emergency department; Hemoglobinopathy; Vaso-occlusive crisis; Emergency medicine; Outpatient clinic; Pediatrics; Triage; Disease; Intensive care medicine; Sickle cell anemia; Internal medicine; Psychiatry","score_opus":0.01048280751727624,"score_gpt":0.26180519728727686,"score_spread":0.2513223897700006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389230248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98266554,0.0012775584,0.000014539437,0.0001525358,0.0001244664,0.0005330914,0.000020651834,0.000052347754,0.015159283],"genre_scores_gemma":[0.99652565,0.0022049972,0.00033180497,0.000037952905,0.00001661966,0.000018408915,0.00004749034,0.000022993525,0.0007940732],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986671,0.00003095683,0.0004455619,0.00023138299,0.000358129,0.00026684714],"domain_scores_gemma":[0.9992846,0.000014002269,0.00015962169,0.00028180348,0.00010705205,0.00015292385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012541078,0.00014666456,0.00028938844,0.00013154765,0.00004813927,0.0000029336322,0.00008326284,0.0000910982,0.00032389746],"category_scores_gemma":[0.00001550589,0.0001259425,0.00015395551,0.00047238884,0.000017592305,0.000027210119,0.00009621497,0.00009122018,0.000077596196],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052345754,0.10658893,0.31020585,0.054350596,0.026071858,0.0112617845,0.053345483,0.0082282135,0.18478905,0.018809797,0.08820383,0.13291006],"study_design_scores_gemma":[0.04373142,0.012044013,0.18249542,0.0029193885,0.011686927,0.00014020673,0.1012796,0.0010003049,0.62793374,0.004611413,0.010299765,0.0018577992],"about_ca_topic_score_codex":0.00011029439,"about_ca_topic_score_gemma":0.0000046993487,"teacher_disagreement_score":0.4431447,"about_ca_system_score_codex":0.00001849936,"about_ca_system_score_gemma":0.00006242841,"threshold_uncertainty_score":0.51357865},"labels":[],"label_agreement":null},{"id":"W4389230260","doi":"10.1182/blood-2023-189808","title":"Clonal Hematopoiesis and Inflammation in the Vasculature (CHIVE), a Prospective, Longitudinal Clonal Hematopoiesis Cohort and Biorepository","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Biorepository; Medicine; Population; Malignancy; Disease; Prospective cohort study; Internal medicine; Oncology; Immunology; Bioinformatics; Biology; Biobank","score_opus":0.011179087549262827,"score_gpt":0.2605504618246987,"score_spread":0.24937137427543588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389230260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948699,0.0006975994,0.000008858387,0.002047692,0.000033814857,0.0009533033,0.000014709007,0.000090289606,0.0012838274],"genre_scores_gemma":[0.99853253,0.00022307273,0.00038974642,0.00007928465,0.00028347535,0.00019179097,0.00004461063,0.000026639183,0.00022885039],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981968,0.00010855596,0.00028311656,0.0004393927,0.00061787077,0.0003542595],"domain_scores_gemma":[0.9991401,0.00026020993,0.000063704385,0.0003245304,0.000095645955,0.00011580214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007176262,0.00020284812,0.00034517873,0.00028202301,0.00018972131,0.00008282593,0.00012204432,0.00015866903,0.000019616933],"category_scores_gemma":[0.00021233689,0.00014314783,0.00007670609,0.000659123,0.00025096434,0.00014620936,0.00015380986,0.0004675678,0.000017030596],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014312546,0.00015024378,0.98650146,0.0003316929,0.00029605167,0.0006276526,0.0013596034,0.0000011620891,0.007648387,0.0015684455,0.0011785087,0.00019366457],"study_design_scores_gemma":[0.0028768945,0.000121355144,0.98790246,0.00012330836,0.00022490976,0.0015084683,0.00046271103,0.00019332375,0.0055500334,0.00062104064,0.00026595223,0.00014956371],"about_ca_topic_score_codex":0.00008289395,"about_ca_topic_score_gemma":0.000053832122,"teacher_disagreement_score":0.0036626235,"about_ca_system_score_codex":0.000069716545,"about_ca_system_score_gemma":0.00014884699,"threshold_uncertainty_score":0.58373994},"labels":[],"label_agreement":null},{"id":"W4389230267","doi":"10.1182/blood-2023-188892","title":"Wilms' Tumor 1 Functions As a Tumor Suppressor to Suppress FLT3-STAT Signaling and Epigenetic Remodeling in Acute Myeloid Leukemia (CALGB 8461, 9665 and 20202; Alliance)","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; Terry Fox Research Institute","funders":"","keywords":"Cancer research; Biology; Myeloid leukemia; Epigenetics; NPM1; Oncogene; Transcription factor; Leukemia; Cancer; Immunology; Genetics; Gene; Cell cycle","score_opus":0.019580399701353696,"score_gpt":0.28668368007747064,"score_spread":0.26710328037611697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389230267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940723,0.0011517458,0.00017568054,0.0022992336,0.00014454263,0.0013540346,0.00012512262,0.00023931822,0.00043800124],"genre_scores_gemma":[0.98989826,0.00077893946,0.003903145,0.0011150325,0.00030668447,0.0003200668,0.00012389998,0.00014687696,0.0034070713],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996349,0.00014283761,0.00063880923,0.0010758427,0.0006688181,0.0011247337],"domain_scores_gemma":[0.997965,0.00039647732,0.00008905626,0.00062432233,0.00017714364,0.0007480186],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006696409,0.0004322204,0.00072657864,0.0005113626,0.00025114568,0.00013645543,0.000270445,0.00015430676,0.00015311535],"category_scores_gemma":[0.0006036942,0.0004212113,0.000099780096,0.0012311712,0.00016656089,0.00019732422,0.0005080194,0.0007999563,0.00032592416],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014091347,0.00032059455,0.020517496,0.00076253247,0.0005493039,0.005613576,0.0027756272,0.002027261,0.9541589,0.000043215354,0.008856252,0.0029661194],"study_design_scores_gemma":[0.06558657,0.005923495,0.17018136,0.004979464,0.0040416014,0.008443044,0.01194549,0.14288317,0.5448809,0.0019264204,0.03434508,0.00486337],"about_ca_topic_score_codex":0.00044690692,"about_ca_topic_score_gemma":0.000104677885,"teacher_disagreement_score":0.40927795,"about_ca_system_score_codex":0.0002835522,"about_ca_system_score_gemma":0.00063994795,"threshold_uncertainty_score":0.999824},"labels":[],"label_agreement":null},{"id":"W4389230273","doi":"10.1182/blood-2023-182274","title":"Favorable Outcomes with Low Dose Anti Thymocyte Globulin Based Graft Versus Host Disease Prophylaxis after Mismatched Unrelated Donor Allogenic Hematopoietic Cell Transplantation","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Cumulative incidence; Internal medicine; Anti-thymocyte globulin; Graft-versus-host disease; Proportional hazards model; Hematopoietic stem cell transplantation; Transplantation; Regimen; Incidence (geometry); Immunology; Gastroenterology; Oncology","score_opus":0.010772687220874247,"score_gpt":0.2350647139978332,"score_spread":0.22429202677695897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389230273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995794,0.000284052,0.00043163053,0.00063275674,0.0002255683,0.0016182312,0.00017598583,0.0005358829,0.00030192122],"genre_scores_gemma":[0.99680746,0.00019589026,0.0011437911,0.0001775037,0.000042034444,0.00027420383,0.00072663807,0.00011271666,0.0005197458],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972464,0.00011466569,0.00056433224,0.00069061597,0.0007438552,0.00064012833],"domain_scores_gemma":[0.99835837,0.00026776065,0.00014303911,0.00062210124,0.0001333944,0.00047532108],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024265141,0.00047922443,0.00061289745,0.0002898814,0.00012027524,0.000057386806,0.00016412878,0.00021969032,0.0001993878],"category_scores_gemma":[0.00003256165,0.0003826686,0.00024291717,0.00092359196,0.000104814106,0.00014094083,0.000013347679,0.0002830838,0.0005923983],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02563989,0.0054813502,0.80410695,0.017737335,0.0014476448,0.019198038,0.004798276,0.0010113047,0.12025984,0.000035045618,0.000120111836,0.00016423309],"study_design_scores_gemma":[0.057117388,0.0013904658,0.7685937,0.0013662393,0.0045673796,0.00010928351,0.00035843145,0.0007018114,0.16472605,0.000021171814,0.00006294913,0.0009850911],"about_ca_topic_score_codex":0.000050623556,"about_ca_topic_score_gemma":0.00003070786,"teacher_disagreement_score":0.044466212,"about_ca_system_score_codex":0.000053797598,"about_ca_system_score_gemma":0.0003896817,"threshold_uncertainty_score":0.99986255},"labels":[],"label_agreement":null},{"id":"W4389230298","doi":"10.1182/blood-2023-189447","title":"Oral Chemotherapy Adherence in Pediatric Acute Lymphoblastic Leukemia (ALL): A Report from the Dana-Farber Cancer Institute (DFCI) ALL Consortium Protocol 16-001","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Centre hospitalier de l'Université Laval","funders":"","keywords":"Medicine; Regimen; Cog; Internal medicine; Mercaptopurine; Chemotherapy regimen; Chemotherapy; Cancer; Acute lymphocytic leukemia; Pediatrics; Oncology; Leukemia; Lymphoblastic Leukemia","score_opus":0.036403066044837756,"score_gpt":0.34594359866838087,"score_spread":0.3095405326235431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389230298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9556007,0.00010704177,0.000075652315,0.0021507887,0.00043219567,0.038829125,0.00012968588,0.00041503579,0.0022597907],"genre_scores_gemma":[0.8066767,0.00092453766,0.00096110045,0.005682113,0.0028361573,0.17039777,0.00079617015,0.00032524896,0.011400238],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99551344,0.00014118644,0.00096651603,0.0010123092,0.0012170301,0.0011495275],"domain_scores_gemma":[0.9974005,0.000464145,0.0003309223,0.0011883563,0.00023073214,0.0003853511],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006998028,0.0004998923,0.0007272615,0.0002900798,0.00012185828,0.00009121213,0.00067498424,0.00033877327,0.00067323283],"category_scores_gemma":[0.0005881782,0.00035272315,0.00017212066,0.0016436634,0.0003216773,0.00023803645,0.00032002726,0.0006688742,0.00052873814],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045941984,0.0035883992,0.6331896,0.00078756746,0.0037082192,0.037406255,0.0021251393,0.00022425174,0.01122063,0.00010961262,0.29355744,0.009488696],"study_design_scores_gemma":[0.17883204,0.0016536189,0.5577415,0.0009996948,0.0039911354,0.0033687674,0.00030696474,0.0075034737,0.010816266,0.000823963,0.23164365,0.002318888],"about_ca_topic_score_codex":0.009746352,"about_ca_topic_score_gemma":0.0020370032,"teacher_disagreement_score":0.17423783,"about_ca_system_score_codex":0.0017509455,"about_ca_system_score_gemma":0.0054169185,"threshold_uncertainty_score":0.9998925},"labels":[],"label_agreement":null},{"id":"W4389230307","doi":"10.1182/blood-2023-184627","title":"Initial Results in a Phase 1b Trial of PB-04 in Sickle Cell Disease Demonstrate Fetal Hemoglobin Induction, Additive Activity with Hydroxyurea, and Improved Red Blood Cell Sickling Parameters","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; University Health Network","funders":"","keywords":"Fetal hemoglobin; Medicine; Sickle cell anemia; Fetus; Thalassemia; Hemoglobinopathy; Hydroxycarbamide; Internal medicine; Immunology; Disease; Pharmacology; Pregnancy; Biology","score_opus":0.012412833277700276,"score_gpt":0.25425973149672754,"score_spread":0.24184689821902727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389230307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99658847,0.00010369558,0.0000065156983,0.00033704835,0.000113980335,0.0015518924,0.00023451414,0.000082156716,0.0009817542],"genre_scores_gemma":[0.9990679,0.00020398646,0.00026251384,0.00003150196,0.00007584596,0.00006355938,0.00016331993,0.000041316136,0.00009006618],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99782664,0.00017145043,0.0006104822,0.0006000985,0.0002964925,0.00049484323],"domain_scores_gemma":[0.9988538,0.00018179082,0.00028338077,0.00031302674,0.00006812117,0.0002998522],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043109726,0.00031262307,0.0006036192,0.0003930307,0.00006963389,0.000021540196,0.000083790146,0.00024670386,0.0000066260727],"category_scores_gemma":[0.00025974962,0.0002708275,0.00010565772,0.0010052284,0.00024166367,0.00017084251,0.00005756125,0.00059702137,0.0000035141315],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.39709803,0.06548561,0.00506413,0.001188755,0.00071475544,0.0060793683,0.0066711963,0.0004358528,0.4959289,0.000007709278,0.00023014238,0.021095527],"study_design_scores_gemma":[0.6561583,0.0065571233,0.003506546,0.00057574187,0.001155201,0.000049246857,0.0026216786,0.0025157311,0.3261553,0.000090176385,0.000032069478,0.0005828653],"about_ca_topic_score_codex":0.00040576883,"about_ca_topic_score_gemma":0.000118037366,"teacher_disagreement_score":0.2590603,"about_ca_system_score_codex":0.00003301328,"about_ca_system_score_gemma":0.00042278838,"threshold_uncertainty_score":0.99997437},"labels":[],"label_agreement":null},{"id":"W4389230336","doi":"10.1182/blood-2023-185068","title":"Lipid Nanoparticle-Mediated Gene Editing of Human Primary T Cells and Off-Target Analysis of the CRISPR-Cas9 Indels","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"CRISPR; Cas9; Genome editing; Electroporation; Biology; Computational biology; Molecular biology; Gene; Genetics","score_opus":0.006419948274681695,"score_gpt":0.2510793971740688,"score_spread":0.2446594488993871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389230336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990106,0.0005336104,0.00011517782,0.000024069075,0.00006986181,0.00007860982,0.00006309079,0.000010102412,0.00009483642],"genre_scores_gemma":[0.99945474,0.000102724334,0.00016654607,0.000028240538,0.000098404795,0.000005339708,0.000075774165,0.000011963263,0.00005627256],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993011,0.000026830881,0.00022731659,0.00017296906,0.00011600989,0.0001557845],"domain_scores_gemma":[0.99954844,0.000017812441,0.00008369017,0.00026329467,0.000047269183,0.000039495262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016494007,0.000087875604,0.00017960841,0.0000779379,0.000040524224,0.000005215759,0.00012082062,0.000072179384,0.000006762269],"category_scores_gemma":[0.000039532995,0.000073614734,0.00010100563,0.0004271412,0.00005317725,0.0000016834243,0.0001473628,0.00004470129,6.603496e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000032861556,0.000050781753,0.019848337,0.000034206052,0.00032617155,7.946523e-7,0.00010579817,0.0009032082,0.97848296,0.000002679432,0.00012538745,0.00011637943],"study_design_scores_gemma":[0.0003911178,0.00006434233,0.055715423,0.000007291072,0.0003363852,9.630648e-7,0.000053021893,0.0004311303,0.9427251,0.0000053900194,0.00019776204,0.00007205968],"about_ca_topic_score_codex":0.000011010177,"about_ca_topic_score_gemma":0.000012143123,"teacher_disagreement_score":0.035867084,"about_ca_system_score_codex":0.0000018905954,"about_ca_system_score_gemma":0.000017439934,"threshold_uncertainty_score":0.30019218},"labels":[],"label_agreement":null},{"id":"W4389230397","doi":"10.1182/blood-2023-188513","title":"Assessment of Transduction of CD34+ Human Hematopoietic Stem Cells from Patients with Severe Hemophilia-Α with Lentiviral Vector Carrying a High Expression FVIII Transgene (CD68-ET3-LV)","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CD34; Genetic enhancement; Stem cell; Haematopoiesis; Viral vector; Transduction (biophysics); Cancer research; Transgene; Biology; Immunology; Medicine; Molecular biology; Cell biology; Gene; Genetics; Recombinant DNA","score_opus":0.01241849431413095,"score_gpt":0.25667535741637154,"score_spread":0.2442568631022406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389230397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99885064,0.000107069056,0.0001657451,0.000018075567,0.000047782432,0.00048355447,0.00025898663,0.000023608345,0.000044549946],"genre_scores_gemma":[0.9989965,0.000036725214,0.00033581737,0.0000067522083,0.00006315958,0.00004806539,0.00036101445,0.000055683173,0.000096264346],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99830544,0.00013075996,0.00030289372,0.00046052062,0.0005087778,0.00029160388],"domain_scores_gemma":[0.9991349,0.0000140045695,0.0001525882,0.00047846744,0.00014334907,0.00007670334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013752656,0.00022320148,0.00031469334,0.00008902661,0.00008670453,0.0000119545675,0.0002198044,0.00012817123,0.000040656574],"category_scores_gemma":[0.0000011764683,0.00018107714,0.00009559759,0.00023579113,0.00010068043,0.000010176308,0.000039507882,0.00012097842,0.0000016195696],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008334766,0.0006218345,0.009656369,0.00015420742,0.00023400455,0.000004624489,0.00022201453,0.00032373634,0.9876207,0.0000031088518,0.000015881767,0.0003100334],"study_design_scores_gemma":[0.005070042,0.004138415,0.01857093,0.00014726963,0.00010000309,0.0000013966455,0.00013587064,0.000008620068,0.97158915,0.000011827569,0.000013559609,0.00021290466],"about_ca_topic_score_codex":0.000057218138,"about_ca_topic_score_gemma":0.00009855989,"teacher_disagreement_score":0.016031547,"about_ca_system_score_codex":0.000014776955,"about_ca_system_score_gemma":0.000104703315,"threshold_uncertainty_score":0.7384111},"labels":[],"label_agreement":null},{"id":"W4389230398","doi":"10.1182/blood-2023-182177","title":"131I-Apamistamab-Led Allogeneic Hematopoietic Cell Transplant Significantly Improves Overall Survival in Patients with TP53 Mutated R/R AML","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; Ottawa Hospital","funders":"","keywords":"Medicine; Internal medicine; Transplantation; Fludarabine; Randomized controlled trial; Hematopoietic stem cell transplantation; Surgery; Refractory (planetary science); Hematopoietic cell; Total body irradiation; Gastroenterology; Oncology; Haematopoiesis; Chemotherapy; Cyclophosphamide; Stem cell","score_opus":0.008126196839969714,"score_gpt":0.2253316029013182,"score_spread":0.2172054060613485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389230398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99801624,0.000030260637,0.000002814004,0.000099511475,0.000050916136,0.0008994003,0.00008573345,0.00015617351,0.0006589561],"genre_scores_gemma":[0.998562,0.000040945513,0.000047846886,0.000052145948,0.000022549502,0.000068705835,0.0003279596,0.000060403294,0.00081744173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978935,0.00008813955,0.00028645768,0.000469659,0.00059752684,0.00066471973],"domain_scores_gemma":[0.99914443,0.000092009264,0.000059844206,0.00033482682,0.00007495454,0.00029395553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011293513,0.00026798365,0.0003999239,0.0002413775,0.00006445819,0.000026967396,0.00012556592,0.000078761695,0.00006183093],"category_scores_gemma":[0.000020803256,0.00019971222,0.00008332022,0.0004953666,0.000065211156,0.00006229744,0.000030184183,0.0002282883,0.00015718445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003098766,0.0076942933,0.8092726,0.0005801746,0.000458564,0.0059312265,0.00070607685,0.000012433692,0.1717694,0.000015480491,0.00013730586,0.0003237011],"study_design_scores_gemma":[0.0359837,0.0028844252,0.86282605,0.00016210815,0.00024497887,0.00002303876,0.0000740431,0.000037559,0.09741672,0.000039112954,0.00003158829,0.00027666765],"about_ca_topic_score_codex":0.000106378866,"about_ca_topic_score_gemma":0.000091441725,"teacher_disagreement_score":0.074352674,"about_ca_system_score_codex":0.000038269343,"about_ca_system_score_gemma":0.00013967213,"threshold_uncertainty_score":0.81440276},"labels":[],"label_agreement":null},{"id":"W4389230430","doi":"10.1182/blood-2023-179305","title":"Initial Report of Povetacicept, an Enhanced Dual BAFF/APRIL Antagonist, in Autoimmune Cytopenias: The RUBY-4 Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"B-cell activating factor; Medicine; Autoimmune hemolytic anemia; Immunology; Rituximab; Autoantibody; Antibody; Evans syndrome; Systemic lupus erythematosus; Internal medicine; B cell; Disease","score_opus":0.024895601948536544,"score_gpt":0.3130018678597655,"score_spread":0.288106265911229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389230430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99437153,0.000086629574,0.000009772641,0.00044031607,0.00018462716,0.0009094557,0.000013042397,0.0001128273,0.0038718183],"genre_scores_gemma":[0.9991062,0.000040857543,0.00006057209,0.00007454396,0.00017985908,0.00005630629,0.000083023195,0.000031970878,0.000366646],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981593,0.000114734234,0.0006327985,0.00036267558,0.0004367495,0.00029375445],"domain_scores_gemma":[0.9989531,0.00006594648,0.00012795586,0.00070055533,0.0000795373,0.000072917894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082246034,0.00017501638,0.00047160545,0.00014534025,0.00010198982,0.000019146726,0.00014957304,0.00009313365,0.00010350972],"category_scores_gemma":[0.000078833065,0.00012314724,0.000098776756,0.00067523465,0.000081187034,0.00010562447,0.00008043982,0.0002911141,0.000028612343],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017337683,0.025554718,0.19021748,0.00031009244,0.0010012741,0.022050317,0.02183633,0.000028668843,0.7213955,0.00036875944,0.00021854897,0.0152845485],"study_design_scores_gemma":[0.01274814,0.0022802348,0.90249485,0.00011304996,0.000541624,0.00075617275,0.0052731554,0.000043910142,0.075103536,0.00006932956,0.00036224423,0.00021373939],"about_ca_topic_score_codex":0.0006077563,"about_ca_topic_score_gemma":0.0005051286,"teacher_disagreement_score":0.7122774,"about_ca_system_score_codex":0.000010729058,"about_ca_system_score_gemma":0.0001315651,"threshold_uncertainty_score":0.50217986},"labels":[],"label_agreement":null},{"id":"W4389230555","doi":"10.1182/blood-2023-189296","title":"Mixture Model to Predict the Cumulative Incidence of Relapses in Follicular Lymphoma : Need for Longer Follow-up or Alternative Outcomes","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Concordia University; Health Sciences Centre; McGill University","funders":"","keywords":"Follicular lymphoma; Medicine; Rituximab; Cumulative incidence; Internal medicine; Lymphoma; Lenalidomide; Proportional hazards model; Oncology; Follicular phase; Cohort; Multiple myeloma","score_opus":0.0364898041094287,"score_gpt":0.3124659496955246,"score_spread":0.2759761455860959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389230555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955735,0.0001783312,0.00015263537,0.0020255845,0.000121198755,0.0016248462,0.00011067141,0.000049380007,0.00016384093],"genre_scores_gemma":[0.99588805,0.00006107304,0.0009105583,0.0005136047,0.000046469904,0.0007261886,0.000030073452,0.000026802927,0.001797152],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871886,0.000035728917,0.00032696954,0.00030039568,0.00034679438,0.00027122468],"domain_scores_gemma":[0.99874926,0.000568185,0.00010168688,0.00035568257,0.00013032363,0.00009485597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020065838,0.00019656686,0.00044859014,0.00015498535,0.000055981072,0.000011510115,0.00015505179,0.00008042707,0.000009232208],"category_scores_gemma":[0.0006073326,0.00010534262,0.00019950242,0.0004716361,0.000040213123,0.00006767619,0.00009132097,0.000040656283,0.000015040829],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022797831,0.0036325203,0.9513253,0.0002257094,0.0024492508,0.0006587968,0.019376075,0.005088149,0.0012799988,0.0017279165,0.00616211,0.0057943696],"study_design_scores_gemma":[0.046409886,0.0018122179,0.87633204,0.0007796643,0.0014120957,0.000038581547,0.0016876637,0.024526527,0.044058442,0.0021107912,0.00045859066,0.00037346882],"about_ca_topic_score_codex":0.00025448768,"about_ca_topic_score_gemma":0.00022585104,"teacher_disagreement_score":0.07499325,"about_ca_system_score_codex":0.000088648274,"about_ca_system_score_gemma":0.00016957698,"threshold_uncertainty_score":0.42957473},"labels":[],"label_agreement":null},{"id":"W4389230681","doi":"10.1182/blood-2023-173366","title":"Durable Symptom Improvement for Patients with Non-Transfusion Dependent Thalassemia Treated with Luspatercept: Patient-Reported Outcomes from the BEYOND Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Dosing; Placebo; Anemia; Thalassemia; Internal medicine; Physical therapy; Alternative medicine","score_opus":0.005952660741951309,"score_gpt":0.2170941259203972,"score_spread":0.2111414651784459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389230681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941766,0.000023412962,0.000021751188,0.0003479393,0.000118399264,0.004777017,0.000088474735,0.00017052259,0.00027583964],"genre_scores_gemma":[0.99839205,0.000041463474,0.000059621332,0.00019929625,0.000023822791,0.00041551297,0.00045932946,0.000067586785,0.0003413141],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797875,0.00003223224,0.0004185425,0.0005083355,0.0006203972,0.00044172726],"domain_scores_gemma":[0.9988479,0.000108968525,0.00016457602,0.000539983,0.00019920075,0.00013938431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012307256,0.00032280845,0.00042010614,0.00008144045,0.00027989078,0.000041927546,0.00011973539,0.000120140554,0.000051788335],"category_scores_gemma":[0.00002742609,0.00015420023,0.000096103526,0.00037058757,0.000044379132,0.00006898463,0.000048128724,0.00019798249,0.000017965276],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078013027,0.0035623137,0.98822695,0.000030083218,0.0013673716,0.000101214675,0.0023791671,0.000023014447,0.0014050977,3.9377105e-7,0.00023019084,0.0018940835],"study_design_scores_gemma":[0.033538416,0.0071818517,0.94820386,0.00014223701,0.0020366025,0.0000054257507,0.005732351,0.000059994174,0.0027742207,0.0000069286452,0.000058051686,0.00026007352],"about_ca_topic_score_codex":0.0011404706,"about_ca_topic_score_gemma":0.00031482676,"teacher_disagreement_score":0.040023092,"about_ca_system_score_codex":0.000042937245,"about_ca_system_score_gemma":0.00008413901,"threshold_uncertainty_score":0.6288103},"labels":[],"label_agreement":null},{"id":"W4389230816","doi":"10.1182/blood-2023-188739","title":"Treatment of Bleeding Episodes with Efanesoctocog Alfa in Children with Severe Hemophilia A in the XTEND-Kids Phase 3 Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Von Willebrand factor; Surgery; Gastroenterology; Pediatrics; Platelet","score_opus":0.03127421053550209,"score_gpt":0.33110109039343294,"score_spread":0.29982687985793083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389230816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951439,0.00016418748,2.0895752e-7,0.000762541,0.0000062094623,0.003119959,0.000013723214,0.000039796065,0.00074947975],"genre_scores_gemma":[0.9987409,0.00010754725,0.00005543313,0.000014008767,0.00006603273,0.00042438376,0.000051228537,0.000027213326,0.00051322574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845225,0.00009434374,0.00023964126,0.0003262986,0.00050106196,0.00038640766],"domain_scores_gemma":[0.999358,0.0001056074,0.00004766845,0.0003670089,0.000041423118,0.00008030934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025869595,0.00021562682,0.00042567676,0.00033272067,0.000058552625,0.000015784244,0.00012272241,0.00005279729,0.000023998287],"category_scores_gemma":[0.000018350056,0.00010176759,0.000051453168,0.0011871986,0.000090189984,0.000053973217,0.000024421224,0.0001409585,0.000014696331],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006738293,0.014004564,0.975051,0.000033998276,0.0005071025,0.0013643461,0.004790143,0.000009189599,0.0003091107,0.000011036515,0.000012124562,0.0032335515],"study_design_scores_gemma":[0.061888356,0.018313749,0.9110995,0.00017851318,0.00047029706,0.0005546172,0.004724832,0.00004961757,0.0025097036,0.000022024451,0.000022790025,0.00016601925],"about_ca_topic_score_codex":0.00043348782,"about_ca_topic_score_gemma":0.00025753197,"teacher_disagreement_score":0.06395152,"about_ca_system_score_codex":0.0000559728,"about_ca_system_score_gemma":0.00012331111,"threshold_uncertainty_score":0.41499618},"labels":[],"label_agreement":null},{"id":"W4389230817","doi":"10.1182/blood-2023-189877","title":"Deciphering the Role of RAS Pathway Mutations in the Biology of Human Acute Myeloid Leukemia Using In Vivo Models","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital de l'Enfant-Jésus; Institute for Research in Immunology and Cancer; Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal; Université Laval","funders":"","keywords":"Biology; Leukemia; Cancer research; Myeloid leukemia; Haematopoiesis; CD34; Myeloid; Neuroblastoma RAS viral oncogene homolog; Bone marrow; Stem cell; KRAS; Immunology; Mutation; Gene; Genetics","score_opus":0.014105004079062258,"score_gpt":0.29254426654296817,"score_spread":0.27843926246390593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389230817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99828047,0.0005254085,0.0007112897,0.000010710768,0.000018241546,0.00009955662,0.000014680398,0.000003851595,0.00033579484],"genre_scores_gemma":[0.9996404,0.0000693132,0.00020735395,0.000008840304,0.000027425927,0.000013909817,0.0000150132355,0.000008708878,0.000009034081],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994999,0.000036187324,0.00017748203,0.000110676934,0.00004563438,0.00013008846],"domain_scores_gemma":[0.99972016,0.000021380556,0.000037953494,0.00019462571,0.000016251377,0.000009616928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018052736,0.00006495861,0.000091914495,0.000047110672,0.000026575892,0.0000033898841,0.00016803881,0.00006279485,0.000001994143],"category_scores_gemma":[0.00001531975,0.00004687155,0.00004080548,0.00018956837,0.0000411445,0.0000017011279,0.00006232726,0.000056103574,2.2432796e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000002627343,0.000021662328,0.0019580943,0.00000611559,0.000021744867,0.0000012921606,0.0006366472,0.034035686,0.96278495,0.0002652504,0.0000016269249,0.00026430862],"study_design_scores_gemma":[0.0004107318,0.00005445188,0.0019518282,0.000013824706,0.000019900424,0.000005684035,0.0008888239,0.005940574,0.9894005,0.0011490016,0.00010221789,0.00006246551],"about_ca_topic_score_codex":0.00013331886,"about_ca_topic_score_gemma":0.0001916127,"teacher_disagreement_score":0.028095111,"about_ca_system_score_codex":0.0000048332067,"about_ca_system_score_gemma":0.000035697605,"threshold_uncertainty_score":0.19113664},"labels":[],"label_agreement":null},{"id":"W4389230868","doi":"10.1182/blood-2023-182839","title":"Risk Factors for Thrombosis in Pregnant People with Sickle Cell Disease: A Multinational Study.","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"","keywords":"Medicine; Pregnancy; Obstetrics; Cohort; Gestation; Cohort study; Pediatrics; Internal medicine","score_opus":0.011602752832035476,"score_gpt":0.2532939865090194,"score_spread":0.24169123367698392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389230868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99791276,0.00016701057,0.000020431678,0.00021082189,0.000042757012,0.001299174,0.00007081165,0.00009150839,0.00018470296],"genre_scores_gemma":[0.9990372,0.00012315593,0.00010763386,0.000017283926,0.000020993208,0.0001654863,0.000094061375,0.000025009049,0.0004091928],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99915916,0.000024487459,0.00014742628,0.00022883991,0.00021266211,0.00022744495],"domain_scores_gemma":[0.99951714,0.00012133563,0.000049047223,0.0001537613,0.00004758184,0.00011113265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010146556,0.00011542805,0.00018778713,0.00011166263,0.00008355768,0.000009311317,0.000050360526,0.00004662857,0.000025957437],"category_scores_gemma":[0.000110314024,0.000077417986,0.00005966046,0.000401717,0.000020692834,0.000034406265,0.000024359593,0.00011217876,0.000018998418],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008095874,0.0033223606,0.99250543,0.00010509577,0.000092373324,0.000021018335,0.0032674032,0.00018404268,0.000116625,0.0000083988425,0.00017314022,0.00012316574],"study_design_scores_gemma":[0.009289456,0.0006517429,0.9808485,0.00010473467,0.00041253705,7.350778e-7,0.0071885525,0.0009580932,0.00026013888,0.00002779382,0.00013518364,0.00012256183],"about_ca_topic_score_codex":0.00019013525,"about_ca_topic_score_gemma":0.00018356116,"teacher_disagreement_score":0.0116569465,"about_ca_system_score_codex":0.000015384672,"about_ca_system_score_gemma":0.00009397519,"threshold_uncertainty_score":0.3157014},"labels":[],"label_agreement":null},{"id":"W4389230884","doi":"10.1182/blood-2023-182167","title":"Clinical Characteristics, Treatment, and Outcomes of Provoked Acute Cerebral Sinovenous Thrombosis in Patients &amp;lt;21 Years Old: Findings from the Kids-DOTT Multinational Trial","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Cerebral Venous Sinus Thrombosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal Children's Hospital","funders":"","keywords":"Medicine; Randomized controlled trial; Pediatrics; Exact test; Incidence (geometry); Clinical trial; Surgery; Internal medicine","score_opus":0.03951416826085697,"score_gpt":0.3262238748408753,"score_spread":0.2867097065800183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389230884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99686587,0.000013203762,5.7357056e-7,0.0005811674,0.00036837743,0.0013101866,0.0007447274,0.000068532325,0.00004735127],"genre_scores_gemma":[0.9977895,0.00007793391,0.00045497707,0.00019686052,0.00020788795,0.000047685808,0.00080472504,0.00004268211,0.00037772505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979708,0.000117910575,0.0007751478,0.00043423474,0.0003696779,0.0003322279],"domain_scores_gemma":[0.99842566,0.0007316499,0.00023972723,0.00039581818,0.00009182905,0.000115304785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030872042,0.00023867784,0.0008561869,0.00013887616,0.0000763011,0.00002840969,0.00014770076,0.00018178612,0.00010644908],"category_scores_gemma":[0.0007574701,0.00017337358,0.00021822476,0.00029179,0.00018815216,0.00007777003,0.00012304081,0.00020715593,0.00007110873],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011950814,0.0043954994,0.98925,0.0000134649645,0.00091150624,0.0000073623664,0.0013683444,5.7094994e-8,0.00035196944,0.000026503854,0.00022218689,0.0022580025],"study_design_scores_gemma":[0.06571633,0.0015747899,0.9311766,0.000058696216,0.0008858878,0.0000014539798,0.000041486506,0.000009194428,0.00013140126,0.000045485987,0.00020789844,0.00015079936],"about_ca_topic_score_codex":0.0006028938,"about_ca_topic_score_gemma":0.00021497959,"teacher_disagreement_score":0.064521246,"about_ca_system_score_codex":0.00007866602,"about_ca_system_score_gemma":0.00012302377,"threshold_uncertainty_score":0.706997},"labels":[],"label_agreement":null},{"id":"W4389230997","doi":"10.1182/blood-2023-190545","title":"The Presence of Somatic Mutations on Specific Pathways Such As Chromatin Modifier, Spliceosome, and Myeloid Transcription Factor at Diagnosis Was Found to Have Benefit from Allogeneic Hematopoietic Stem Cell Transplantation (HCT) in 1,228 Patients with Acute Myeloid Leukemia in First Complete Remission (CR1)","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; University of British Columbia; University Health Network","funders":"","keywords":"Medicine; Transplantation; Oncology; Internal medicine; Somatic evolution in cancer; Hematopoietic stem cell transplantation; Stem cell; Cancer; Biology; Genetics","score_opus":0.025860447538435364,"score_gpt":0.24637397228304694,"score_spread":0.22051352474461158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389230997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959832,0.00023519347,0.000046085304,0.0003882687,0.00005190412,0.0025382596,0.00056896004,0.00006397952,0.00012417149],"genre_scores_gemma":[0.99635863,0.0018400301,0.00034847713,0.000044101165,0.00003182056,0.00052551937,0.0006236933,0.00006940914,0.00015833086],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9967979,0.00015143589,0.00079721265,0.0007015605,0.00097421935,0.0005776258],"domain_scores_gemma":[0.99768203,0.001151829,0.00020487212,0.0005805397,0.00011395797,0.00026676545],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026298463,0.0003761277,0.0005742437,0.00046376127,0.00028542068,0.000060752114,0.0002883992,0.00018774423,0.00004241653],"category_scores_gemma":[0.000039829647,0.0002857828,0.0000847194,0.00075105333,0.00014123,0.00017378201,0.000068486304,0.0003641391,0.0000713567],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044440846,0.0015140104,0.4005936,0.0019296897,0.00035418366,0.0006815706,0.047912277,0.0032386153,0.53352547,0.00014124007,0.0001729039,0.0054923557],"study_design_scores_gemma":[0.01185215,0.0011941971,0.8609907,0.001561981,0.00020279479,0.000032004016,0.0017784103,0.0018459297,0.119763285,0.00029733242,0.00008696161,0.00039427422],"about_ca_topic_score_codex":0.00069176254,"about_ca_topic_score_gemma":0.0015867729,"teacher_disagreement_score":0.4603971,"about_ca_system_score_codex":0.00073733524,"about_ca_system_score_gemma":0.00020332022,"threshold_uncertainty_score":0.9999594},"labels":[],"label_agreement":null},{"id":"W4389231005","doi":"10.1182/blood-2023-181119","title":"Identification of Unexpected Responders to Gilteritinib in a Cohort of FLT3-WT AML Patients Using Ex-Vivo Testing","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Ex vivo; Phenotype; Medicine; In vivo; Biology; Oncology; Computational biology; Gene; Genetics","score_opus":0.04696847932394191,"score_gpt":0.33234356107957036,"score_spread":0.2853750817556284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389231005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987379,0.000011254874,0.000024868796,0.00007863263,0.00003971444,0.0007241559,0.000033108692,0.000049533162,0.00030086192],"genre_scores_gemma":[0.9984988,0.000003973113,0.0011750915,0.000022153617,0.000030668605,0.000023314456,0.000039207862,0.000027288163,0.00017952967],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983211,0.00008664098,0.0005656803,0.00026279522,0.00049265596,0.00027112736],"domain_scores_gemma":[0.9988571,0.0001903434,0.00014836162,0.00033990663,0.00037319493,0.00009111976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055083074,0.00009701567,0.00028587086,0.00064568163,0.000026518124,0.0000074259206,0.0001292848,0.00007256543,0.000018413592],"category_scores_gemma":[0.0027756875,0.00010067203,0.000039259437,0.0021680503,0.00005296501,0.000058983594,0.000107332744,0.0001335679,0.000018061346],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011063301,0.00020459297,0.39438173,0.00011163265,0.000031062253,0.000023140066,0.0004354879,0.000025480993,0.60428286,0.000003833158,0.00008035056,0.00030919333],"study_design_scores_gemma":[0.0025930149,0.00018545774,0.737827,0.00029307362,0.00005387214,0.0000058985293,0.00033409314,0.0012802467,0.2573278,0.000012976381,0.000012810415,0.00007376908],"about_ca_topic_score_codex":0.00027076268,"about_ca_topic_score_gemma":0.000015999873,"teacher_disagreement_score":0.34695503,"about_ca_system_score_codex":0.000120876466,"about_ca_system_score_gemma":0.00020698083,"threshold_uncertainty_score":0.41052863},"labels":[],"label_agreement":null},{"id":"W4389231016","doi":"10.1182/blood-2023-172922","title":"Oral Anticoagulant (OAC) Use Among Medicare Patients Newly Diagnosed with Venous Thromboembolism (VTE): Factors Associated with Treatment Status","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Apixaban; Rivaroxaban; Edoxaban; Warfarin; Dabigatran; Internal medicine; Ambulatory; Atrial fibrillation; Venous thromboembolism; Cohort; Emergency medicine; Thrombosis","score_opus":0.031412891051369914,"score_gpt":0.2536691199748411,"score_spread":0.2222562289234712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389231016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99665815,0.00006661528,0.0000062854433,0.000109771914,0.00018973209,0.0018356004,0.00019470113,0.0005523701,0.00038676764],"genre_scores_gemma":[0.9969353,0.00043907418,0.00007974327,0.0002093271,0.00007859856,0.0001918088,0.0016991136,0.00013486469,0.00023213716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996725,0.00010395272,0.00040145757,0.00068186625,0.0009896373,0.0010980697],"domain_scores_gemma":[0.99812865,0.00023734465,0.00025053692,0.00061977166,0.00021881309,0.00054487813],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012726236,0.00054958754,0.0013154274,0.00028936495,0.00022490764,0.00010650912,0.00014944335,0.00017048966,0.00008729044],"category_scores_gemma":[0.00019626957,0.00035087907,0.00014734261,0.00077554636,0.00019021296,0.00022434266,0.00008904465,0.00020226273,0.000042007676],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006521123,0.010553369,0.9787905,0.000060093673,0.0028582313,0.0009759285,0.0037633528,0.000046399833,0.000034933277,0.000032730462,0.0016370444,0.0011821662],"study_design_scores_gemma":[0.016365442,0.0058118696,0.97127706,0.00047611824,0.0030400136,0.0000029195166,0.0011976864,0.000033419103,0.000491931,0.00000695526,0.00086083886,0.00043575835],"about_ca_topic_score_codex":0.00320993,"about_ca_topic_score_gemma":0.0022137708,"teacher_disagreement_score":0.016300231,"about_ca_system_score_codex":0.00024076163,"about_ca_system_score_gemma":0.00021577935,"threshold_uncertainty_score":0.9998943},"labels":[],"label_agreement":null},{"id":"W4389231019","doi":"10.1182/blood-2023-191011","title":"Acute Myeloid Leukemia (AML) Patients with Myelodysplasia (MDS) Related-Gene Mutations in First Complete Remission (CR1) Found to Have Benefit from Allogeneic Hematopoietic Stem Cell Transplant (HCT)","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; University of British Columbia; University Health Network","funders":"","keywords":"Internal medicine; Medicine; Oncology; Myelodysplastic syndromes; Myeloid leukemia; International Prognostic Scoring System; Transplantation; Gene mutation; Myeloid; Leukemia; Hematopoietic stem cell transplantation; Mutation; Gene; Bone marrow; Biology; Genetics","score_opus":0.015216234474562646,"score_gpt":0.24161264134207364,"score_spread":0.226396406867511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389231019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995084,0.00014446,0.000072512594,0.00085106795,0.00010992141,0.001822412,0.0007704168,0.000282888,0.00086234347],"genre_scores_gemma":[0.993112,0.00023005389,0.0013493049,0.00021673358,0.00008353335,0.00022437086,0.002657017,0.00017203743,0.0019549467],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957779,0.00009373476,0.0008679014,0.0010872205,0.0011227147,0.0010505216],"domain_scores_gemma":[0.99761415,0.00034605298,0.00017569907,0.00094815256,0.00021077234,0.00070519344],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002702517,0.00054557755,0.0008088485,0.00067600276,0.00030628016,0.000066650624,0.0004669755,0.00036375134,0.00013914163],"category_scores_gemma":[0.00002666378,0.00046882432,0.00015765415,0.0013550449,0.000117062664,0.00015534642,0.00018057233,0.00074878696,0.0007666071],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004496364,0.0026211555,0.6663916,0.0010242711,0.0023325,0.009401702,0.025385728,0.0052294745,0.27748656,0.00010075032,0.0026212765,0.002908603],"study_design_scores_gemma":[0.049059547,0.0024617314,0.8281702,0.0024323813,0.0021761034,0.00041457135,0.0017524896,0.0023073151,0.10622003,0.0003235934,0.0029478243,0.0017342087],"about_ca_topic_score_codex":0.00058659667,"about_ca_topic_score_gemma":0.0006572644,"teacher_disagreement_score":0.17126654,"about_ca_system_score_codex":0.0008402749,"about_ca_system_score_gemma":0.00053250726,"threshold_uncertainty_score":0.99977636},"labels":[],"label_agreement":null},{"id":"W4389231026","doi":"10.1182/blood-2023-184916","title":"Childhood Autoimmune Hemolytic Anemia: A Scoping Review","year":2023,"lang":"en","type":"review","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; Children's Hospital of Eastern Ontario; University of Ottawa","funders":"","keywords":"Medicine; Autoimmune hemolytic anemia; Observational study; Pediatrics; Population; Incidence (geometry); MEDLINE; Anemia; Intensive care medicine; Internal medicine","score_opus":0.04671207691936569,"score_gpt":0.3428471232597919,"score_spread":0.2961350463404262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389231026","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000004583608,0.99311054,0.0000024421545,0.00015952358,0.0002368993,0.004740519,0.000024401603,0.0004203849,0.0013007366],"genre_scores_gemma":[9.677802e-7,0.99753416,0.000150814,0.0003702116,0.00041478092,0.00035303106,0.00036760583,0.0002034654,0.00060496794],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99715555,0.00009724219,0.0011490092,0.0006832853,0.0004274467,0.00048744722],"domain_scores_gemma":[0.998331,0.00014795577,0.0003086366,0.00096090994,0.00005579907,0.00019571594],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042975147,0.0005728804,0.0038886634,0.00021353614,0.00010637711,0.000024766168,0.00024919581,0.00046726316,0.00019561953],"category_scores_gemma":[0.00016657067,0.00045047645,0.0011253868,0.0009573927,0.000042010655,0.00004174544,0.00011432276,0.00095463643,0.001136654],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[7.745516e-7,0.00041908023,0.000001143539,0.5748514,0.0003202585,0.00035171848,0.000010032498,2.5607447e-9,3.5871898e-7,0.000013503099,0.00017903784,0.42385268],"study_design_scores_gemma":[0.0012714578,0.00013796108,0.00002230481,0.8263942,0.018292204,0.0016570839,0.0000012966641,6.9836716e-8,0.0000014114963,0.0000065004547,0.15187117,0.000344329],"about_ca_topic_score_codex":0.000014855366,"about_ca_topic_score_gemma":0.0000044990734,"teacher_disagreement_score":0.42350835,"about_ca_system_score_codex":0.000033165215,"about_ca_system_score_gemma":0.0008573066,"threshold_uncertainty_score":0.9997947},"labels":[],"label_agreement":null},{"id":"W4389231079","doi":"10.1182/blood-2023-182176","title":"Nearly Half of Extreme Preterm Infants Are Iron Deficient at 4-6 Months of Corrected Age Despite Prophylactic Iron Supplementation","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Medicine; Pediatrics; Gestational age; Population; Iron deficiency; Micronutrient; Ferritin; Cohort; Micronutrient deficiency; Pregnancy; Anemia; Internal medicine","score_opus":0.021830679577825963,"score_gpt":0.2598418508553144,"score_spread":0.23801117127748844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389231079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99768203,0.0004068272,0.000015392508,0.000076222655,0.0001603826,0.0007451221,0.00006594734,0.000061984065,0.0007860884],"genre_scores_gemma":[0.99849886,0.000068930836,0.00030644512,0.000035245124,0.000030576113,0.00003364305,0.00024926127,0.00002712318,0.00074989145],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99865377,0.000053940086,0.00038159417,0.0002400916,0.00041358933,0.00025699296],"domain_scores_gemma":[0.9992018,0.000042330375,0.00026580572,0.0003220463,0.0000888724,0.00007914863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013469583,0.0001467454,0.00031338565,0.00018978975,0.000047047117,0.000008019649,0.00008008279,0.00007408224,0.00017460555],"category_scores_gemma":[0.00014168592,0.00013149361,0.00008483794,0.00038502234,0.00007635403,0.00007236699,0.000063338644,0.00007920234,0.00003274021],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001216235,0.0016358278,0.4757551,0.0025045795,0.000050086,0.00012653739,0.0065983734,0.0000941709,0.50622964,0.00005277178,0.0008319674,0.004904719],"study_design_scores_gemma":[0.0072751665,0.0006195903,0.88502675,0.00013133549,0.00052054063,0.000010080574,0.0010542872,0.00012277105,0.10486365,0.000016683085,0.00019224403,0.00016686675],"about_ca_topic_score_codex":0.00028088974,"about_ca_topic_score_gemma":0.00015328857,"teacher_disagreement_score":0.40927166,"about_ca_system_score_codex":0.000020879706,"about_ca_system_score_gemma":0.000049802165,"threshold_uncertainty_score":0.53621536},"labels":[],"label_agreement":null},{"id":"W4389231087","doi":"10.1182/blood-2023-190789","title":"Quality of Life and Comorbidities of Adult Survivors of Allogeneic Hematopoietic Cell Transplant Versus Their Siblings","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Total body irradiation; Quality of life (healthcare); Survivorship curve; Population; Sibling; Internal medicine; Physical therapy; Transplantation; Hematopoietic stem cell transplantation; Comorbidity; Pediatrics; Chemotherapy; Cancer","score_opus":0.04760224526849441,"score_gpt":0.2980443748601661,"score_spread":0.25044212959167167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389231087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99695206,0.0010875445,0.000015134057,0.00051739684,0.00016441314,0.0002572749,0.00037301518,0.0000598094,0.0005733272],"genre_scores_gemma":[0.9986112,0.0009635789,0.00013087604,0.000099513614,0.000057407444,0.000007787837,0.00005957657,0.00002702956,0.000043041175],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979625,0.00016588895,0.0008959785,0.00025018104,0.0005014149,0.00022406512],"domain_scores_gemma":[0.99799305,0.0008500953,0.0003909054,0.00042191264,0.00019637897,0.000147651],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007408996,0.00018719868,0.00090231304,0.00017680171,0.000027253125,0.0000034699246,0.00014787287,0.000113880335,0.00004156872],"category_scores_gemma":[0.00025193984,0.00016740737,0.0001934659,0.00036397766,0.00028155572,0.000038801314,0.000050032602,0.00012834293,0.0000037424209],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004120537,0.0036897308,0.756605,0.029014144,0.0018364683,0.000026300428,0.07118319,0.000025380823,0.13011338,0.0024627696,0.00065206503,0.00027103143],"study_design_scores_gemma":[0.023010306,0.0017127917,0.31237197,0.0010335925,0.0006061471,0.00001539671,0.020704783,0.000024205834,0.63945776,0.000474287,0.00010390117,0.00048484898],"about_ca_topic_score_codex":0.002467735,"about_ca_topic_score_gemma":0.00083739887,"teacher_disagreement_score":0.5093444,"about_ca_system_score_codex":0.0000061138094,"about_ca_system_score_gemma":0.00016296188,"threshold_uncertainty_score":0.6826675},"labels":[],"label_agreement":null},{"id":"W4389231112","doi":"10.1182/blood-2023-186533","title":"Improvements in Markers of Hemolysis and Liver Iron Concentration in Mitapivat-Treated Adult Patients with a Delayed Hemoglobin Response","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Agios Pharmaceuticals","keywords":"Medicine; Pyruvate kinase deficiency; Anemia; Clinical endpoint; Hemolysis; Internal medicine; Hemoglobin; European union; Placebo; Iron deficiency; Gastroenterology; Randomized controlled trial; Pyruvate kinase; Pathology","score_opus":0.005612435949314256,"score_gpt":0.21135987439085535,"score_spread":0.2057474384415411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389231112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993918,0.000027330922,0.0000013500771,0.00006823892,0.00002106386,0.00038704716,0.000015497137,0.000021210573,0.00006648314],"genre_scores_gemma":[0.99940854,0.00006183898,0.00010110921,0.00015205026,0.0000062765644,0.0000204988,0.000119494274,0.000009555725,0.000120630124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992508,0.00009590493,0.00020289898,0.00018781738,0.00011570017,0.00014685061],"domain_scores_gemma":[0.9996357,0.00006808341,0.00006517313,0.00011401151,0.00007178765,0.000045221466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000109656736,0.00008936111,0.00019197274,0.0001423552,0.000013147104,0.0000024346546,0.00002084133,0.00006969838,0.000024993175],"category_scores_gemma":[0.00009120925,0.0000743636,0.000019060606,0.0004246173,0.000041940442,0.00004186392,0.000016602064,0.00007276562,0.000006451606],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01732303,0.0006631819,0.88386565,0.00007835756,0.000051853567,0.000074531745,0.00043717367,0.0000045614793,0.09630092,0.0000026396713,0.00007345897,0.001124652],"study_design_scores_gemma":[0.016369235,0.0017760079,0.9706703,0.000102028236,0.00006133479,0.0000027768526,0.00019195015,0.0002866146,0.010456861,0.000003131559,0.000008441917,0.000071351],"about_ca_topic_score_codex":0.00026751886,"about_ca_topic_score_gemma":0.00015663369,"teacher_disagreement_score":0.08680463,"about_ca_system_score_codex":0.000029008665,"about_ca_system_score_gemma":0.00003412378,"threshold_uncertainty_score":0.30324596},"labels":[],"label_agreement":null},{"id":"W4389231113","doi":"10.1182/blood-2023-190978","title":"Characterization of Clonal Hematopoietic of Indeterminate Potential (CHIP) Mutations in an Imid-Naïve Multiple Myeloma (MM) Autologous Stem Cell Transplant (ASCT) Population: First Results from a Pre-Transplant Time Point in a Prospective, Longitudinal Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"","keywords":"Population; Medicine; Oncology; Internal medicine; Melphalan; Transplantation; Hematopoietic stem cell transplantation; Multiple myeloma","score_opus":0.01949208219430457,"score_gpt":0.2713037724180636,"score_spread":0.251811690223759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389231113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99572986,0.000016262002,0.000034467143,0.000051516985,0.00003703922,0.0022712247,0.001778968,0.00006504039,0.000015646843],"genre_scores_gemma":[0.99634326,0.0000133863205,0.00015921856,0.0000020237499,0.000029921459,0.0001867043,0.0031959906,0.000031000032,0.000038529426],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99742883,0.00018794478,0.0009165133,0.0005504062,0.00054619944,0.00037009164],"domain_scores_gemma":[0.9990036,0.00016300191,0.00024536118,0.00034448918,0.000102130965,0.00014145681],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026872466,0.00024654993,0.00061082054,0.0005298925,0.00006828473,0.000016338056,0.00013758287,0.00012992728,0.000027704496],"category_scores_gemma":[0.000028715693,0.00022504745,0.00009966947,0.000616029,0.000062785686,0.00018013633,0.000033871103,0.00021437921,0.000012162442],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039665797,0.006413532,0.9047965,0.00023715601,0.00015118059,0.0018968207,0.011123896,0.00014722279,0.07096517,0.0000015509371,2.2564015e-7,0.00030016343],"study_design_scores_gemma":[0.02206641,0.0013865217,0.9343815,0.0004172024,0.00021900733,0.000061847575,0.00027301215,0.009322761,0.03168879,0.000025131672,8.3105135e-8,0.00015774767],"about_ca_topic_score_codex":0.0017116999,"about_ca_topic_score_gemma":0.0023859094,"teacher_disagreement_score":0.039276384,"about_ca_system_score_codex":0.00007022431,"about_ca_system_score_gemma":0.00010226602,"threshold_uncertainty_score":0.91771686},"labels":[],"label_agreement":null},{"id":"W4389231133","doi":"10.1182/blood-2023-180644","title":"FORTITUDE: A Phase 2 Open-Label Study in Progress to Evaluate Etavopivat for the Treatment of Anemia in Patients with Lower-Risk Myelodysplastic Syndromes","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Anemia; Myelodysplastic syndromes; Medicine; Ineffective erythropoiesis; Internal medicine; Lenalidomide; Population; Erythropoiesis; Gastroenterology; Oncology; Bone marrow; Multiple myeloma","score_opus":0.0550999316811912,"score_gpt":0.3916374017796931,"score_spread":0.3365374700985019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389231133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870333,0.00009471333,0.000006923543,0.00033681167,0.00004702197,0.012361612,0.000069115515,0.000027452808,0.00002305604],"genre_scores_gemma":[0.99623793,0.000050569397,0.0004034495,0.000018294664,0.000023365079,0.0028979995,0.000045761433,0.00004356483,0.00027904342],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99807495,0.00009714767,0.00036385178,0.00042303713,0.0005658638,0.0004751697],"domain_scores_gemma":[0.9987132,0.00035232664,0.00010028329,0.00054223294,0.00016785764,0.00012408727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005754963,0.00021310827,0.0005139539,0.00032483644,0.00006751889,0.00003199327,0.00032451397,0.00005308849,0.00001681412],"category_scores_gemma":[0.00024797214,0.00012199458,0.000032604723,0.0011471548,0.00006708436,0.000071356815,0.00014091417,0.0001380432,0.000020188485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007244121,0.042937227,0.9303336,0.0001146874,0.0004761024,0.00029999713,0.002273848,0.00006353969,0.000040437983,0.0000035408887,0.00019543967,0.016017457],"study_design_scores_gemma":[0.22131287,0.060002595,0.7151569,0.00023930639,0.0007179249,0.0000059062454,0.0005940288,0.0012230305,0.00036273088,0.000009706775,0.00019787018,0.0001770914],"about_ca_topic_score_codex":0.00018522535,"about_ca_topic_score_gemma":0.0005555325,"teacher_disagreement_score":0.21517667,"about_ca_system_score_codex":0.00025263388,"about_ca_system_score_gemma":0.00034257743,"threshold_uncertainty_score":0.49747944},"labels":[],"label_agreement":null},{"id":"W4389231136","doi":"10.1182/blood-2023-189154","title":"Frailty Impact on Outcomes of Patients Undergoing Chimeric Antigen Receptor T-Cell (CAR T) Therapy at Princess Margaret Cancer Centre: A Prospective Pilot Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Frailty in Older Adults","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Chimeric antigen receptor; Cohort; Hematopoietic stem cell transplantation; Prospective cohort study; Diffuse large B-cell lymphoma; Follicular lymphoma; Cancer; Oncology; Lymphoma; Transplantation; Immunotherapy","score_opus":0.030536305501273106,"score_gpt":0.3099652461533629,"score_spread":0.2794289406520898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389231136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99585545,0.00014717574,5.420109e-7,0.0002540191,0.00029489922,0.0025046347,0.00017751483,0.00017717705,0.0005885959],"genre_scores_gemma":[0.9974721,0.00037679332,0.000046581987,0.000105140796,0.00008047775,0.000090931266,0.00008128053,0.000075606644,0.001671097],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997881,0.00009771242,0.00037825087,0.000507528,0.00068104576,0.00045448059],"domain_scores_gemma":[0.99872947,0.00019004976,0.00023849087,0.0005197592,0.00016523614,0.00015698388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012789061,0.00033473445,0.0005951954,0.00016575726,0.00010025073,0.0000142568,0.00019469754,0.000055479122,0.0004158335],"category_scores_gemma":[0.000120249584,0.0002387921,0.00013298893,0.0006022854,0.000056657253,0.00007111914,0.00011424875,0.00019660179,0.00012633349],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082884764,0.0083424235,0.9830908,0.00006930211,0.0008479043,0.000014358229,0.0024158575,0.000017150443,0.0026131656,0.000001231765,0.0011382037,0.0006207635],"study_design_scores_gemma":[0.017384414,0.007974438,0.95389926,0.00013308732,0.00011716738,5.9858024e-7,0.00031710276,0.0000067506103,0.019852508,0.000009247849,0.000085164116,0.00022024596],"about_ca_topic_score_codex":0.00060409476,"about_ca_topic_score_gemma":0.00037652993,"teacher_disagreement_score":0.029191516,"about_ca_system_score_codex":0.00024775733,"about_ca_system_score_gemma":0.00017182728,"threshold_uncertainty_score":0.9737659},"labels":[],"label_agreement":null},{"id":"W4389231147","doi":"10.1182/blood-2023-178085","title":"Improving the Utilization and Tolerability of Thiotepa-Based Autologous Stem Cell Transplantation in Primary CNS Lymphoma","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of Calgary","funders":"","keywords":"ThioTEPA; Medicine; Tolerability; Busulfan; Transplantation; Autologous stem-cell transplantation; Internal medicine; Rituximab; Oncology; Primary central nervous system lymphoma; Population; Hematopoietic stem cell transplantation; Adverse effect; Surgery; Cyclophosphamide; Lymphoma; Chemotherapy","score_opus":0.020018237100881867,"score_gpt":0.23984440621677156,"score_spread":0.2198261691158897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389231147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99853325,0.00041588768,0.00004521691,0.00028147709,0.000027089998,0.00040304143,0.000017823586,0.000046516176,0.00022969439],"genre_scores_gemma":[0.9994865,0.0002130753,0.000093695184,0.00007471028,0.000009394805,0.00003999556,0.00005941694,0.00000867848,0.000014539179],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993502,0.000047381087,0.00020342141,0.00016470892,0.0001240113,0.00011026381],"domain_scores_gemma":[0.9995548,0.00016886208,0.000061531864,0.00016157959,0.000024571937,0.00002861524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017793212,0.00007889006,0.00017386807,0.00007027414,0.000036591588,0.000006774753,0.00002992606,0.000054566048,0.000003728071],"category_scores_gemma":[0.000009043006,0.000054946337,0.000038773196,0.00021670194,0.000036879763,0.000026812255,0.000009637962,0.000026085036,0.0000022937922],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017744563,0.0017676118,0.6332698,0.0009396876,0.0000344651,0.000121755635,0.0012127964,0.000055472177,0.010423724,0.000034517336,0.000016519163,0.3519462],"study_design_scores_gemma":[0.0040071495,0.00016427299,0.9253485,0.000062344836,0.00016267288,0.00001667448,0.00010340299,0.0013426119,0.06872618,0.000010886359,0.000011811206,0.00004345188],"about_ca_topic_score_codex":0.00017193017,"about_ca_topic_score_gemma":0.000051290313,"teacher_disagreement_score":0.35190275,"about_ca_system_score_codex":0.000044724,"about_ca_system_score_gemma":0.00011153693,"threshold_uncertainty_score":0.22406465},"labels":[],"label_agreement":null},{"id":"W4389231172","doi":"10.1182/blood-2023-181402","title":"An Approach to Hemequity: Identifying the Barriers and Enablers of Iron Deficiency Reduction Strategies in Low-to-Middle-Income Countries","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Public Health Ontario; University of Toronto; McMaster University","funders":"","keywords":"Medicine; Scopus; Iron-deficiency anemia; Anemia; Low and middle income countries; MEDLINE; Grey literature; Global health; Environmental health; Iron deficiency; Developing country; Pediatrics; Family medicine; Public health; Nursing; Political science; Psychiatry; Economic growth","score_opus":0.022488480398028407,"score_gpt":0.28074563006326,"score_spread":0.25825714966523156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389231172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966766,0.0005373191,0.00008975364,0.00026188913,0.00011359836,0.00041779954,0.0000068975287,0.00005047092,0.0018456286],"genre_scores_gemma":[0.999265,0.00013502837,0.0003301274,0.00008725979,0.000049527174,0.00003278709,0.000009161018,0.000013950375,0.000077126366],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895346,0.000044494864,0.00021745324,0.00024706134,0.0002693503,0.0002681603],"domain_scores_gemma":[0.99950695,0.0000181094,0.000041560183,0.00026116372,0.00003988946,0.00013230105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051550363,0.000108473934,0.00019550174,0.00025166347,0.00010492223,0.000053691358,0.00011157683,0.00005175776,0.000009427693],"category_scores_gemma":[0.00009123321,0.00008314659,0.00002475089,0.0006934097,0.00010707057,0.0001829306,0.000049216007,0.00009248842,0.000008724916],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018691799,0.002793416,0.4078453,0.021825846,0.00013551828,0.000106456035,0.2490931,0.01535242,0.2163284,0.07964,0.00085642794,0.00415396],"study_design_scores_gemma":[0.006008907,0.0006109572,0.6020434,0.00058803137,0.00044586955,0.000070009286,0.37117904,0.00025109417,0.016454162,0.0015263639,0.0002571802,0.0005650013],"about_ca_topic_score_codex":0.00020363319,"about_ca_topic_score_gemma":0.000029536823,"teacher_disagreement_score":0.19987424,"about_ca_system_score_codex":0.000011733009,"about_ca_system_score_gemma":0.000117122436,"threshold_uncertainty_score":0.33906195},"labels":[],"label_agreement":null},{"id":"W4389231298","doi":"10.1182/blood-2023-178658","title":"A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-Cell Non-Hodgkin Lymphoma (Glo-BNHL)","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Population; Refractory (planetary science); Clinical trial; Oncology; Pediatrics; Internal medicine; Environmental health","score_opus":0.023666609501856208,"score_gpt":0.2794719716501671,"score_spread":0.25580536214831084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389231298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975686,0.0010660243,6.192786e-7,0.00008538829,0.00007438074,0.000750189,0.00003011921,0.000033609584,0.00039106945],"genre_scores_gemma":[0.9989183,0.00070837804,0.00007901224,0.00008988311,0.000049192477,0.000052562908,0.00001274249,0.000015303676,0.00007461154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880993,0.000033336848,0.00030564095,0.0003492351,0.0002684393,0.00023338734],"domain_scores_gemma":[0.9994294,0.00005759934,0.00009448828,0.0002416606,0.000031678297,0.00014516698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015175335,0.00017192528,0.00035714512,0.00015089176,0.00003344125,0.000011742488,0.000050385454,0.00008286161,0.000004530563],"category_scores_gemma":[0.000038703784,0.0001440968,0.000042983782,0.00051512814,0.000029924178,0.00003802921,0.00011732366,0.000040050876,0.00000900719],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013589657,0.025626065,0.9668638,0.00015559376,0.000099509445,0.0004367927,0.00054994324,0.0000018311175,0.00026469753,0.0000033648494,0.0007441669,0.005118331],"study_design_scores_gemma":[0.053260863,0.0012777928,0.94371235,0.000110399684,0.00035527337,0.000030497,0.0006454862,0.00008297641,0.00025394495,0.0000046175837,0.00015664355,0.00010913383],"about_ca_topic_score_codex":0.0002416237,"about_ca_topic_score_gemma":0.00008698258,"teacher_disagreement_score":0.053124968,"about_ca_system_score_codex":0.00009186155,"about_ca_system_score_gemma":0.00007834037,"threshold_uncertainty_score":0.5876097},"labels":[],"label_agreement":null},{"id":"W4389231321","doi":"10.1182/blood-2023-189040","title":"High-Dose Targeted Radiation with 131I-Apamistamab Prior to HCT Demonstrated a Dose-Response for Durable Complete Remission in Patients with R/R AML","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Princess Margaret Cancer Centre; University Health Network; Ottawa Hospital","funders":"","keywords":"Medicine; Nuclear medicine; Bone marrow; Clinical endpoint; Total body irradiation; Internal medicine; Fludarabine; Refractory (planetary science); Radiation therapy; Oncology; Gastroenterology; Randomized controlled trial; Surgery; Chemotherapy; Cyclophosphamide","score_opus":0.016823031533494823,"score_gpt":0.2767275954564417,"score_spread":0.25990456392294686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389231321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961043,0.000017142413,0.00014585641,0.0017013481,0.000015101424,0.001666287,0.00012538634,0.00015897084,0.00006560199],"genre_scores_gemma":[0.9958636,0.0000041012313,0.002585857,0.00016327441,0.00004467549,0.00033282983,0.00053560664,0.00003533365,0.00043469406],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987362,0.0000399995,0.0002678528,0.00036688024,0.00024886173,0.0003401781],"domain_scores_gemma":[0.9990672,0.00016248065,0.00007704319,0.00027907532,0.00012802845,0.00028618166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020144541,0.00017812235,0.0002718627,0.00010686206,0.00013439717,0.000020892401,0.00008832919,0.00008349166,0.000034303626],"category_scores_gemma":[0.00017349538,0.0001369735,0.000033448785,0.00094329304,0.000042247146,0.0000587015,0.000014802927,0.00015732285,0.000028010907],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034853257,0.0023783694,0.05112042,0.00033854306,0.0001787923,0.00007059533,0.00029050207,0.0005179245,0.9060177,0.000051328498,0.0014927085,0.0026898608],"study_design_scores_gemma":[0.040432356,0.0014585049,0.7152875,0.00031480865,0.00029455105,0.000016236949,0.00008769191,0.0015389373,0.23539186,0.000031912008,0.004767952,0.00037766955],"about_ca_topic_score_codex":0.00001393748,"about_ca_topic_score_gemma":0.0000026890577,"teacher_disagreement_score":0.67062587,"about_ca_system_score_codex":0.0000730603,"about_ca_system_score_gemma":0.00016837037,"threshold_uncertainty_score":0.5585617},"labels":[],"label_agreement":null},{"id":"W4389231326","doi":"10.1182/blood-2023-178885","title":"Safety and Efficacy of Bezuclastinib (CGT9486), a Novel, Highly Selective, Potent KIT D816V Tyrosine Kinase Inhibitor, in Patients with Advanced Systemic Mastocytosis (AdvSM): Results from Part 1 of the Phase 2 Apex Trial","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Daiichi Sankyo Europe; Astellas Pharma; Genentech; Actuate Therapeutics; Sierra Oncology; Incyte; Gilead Sciences; Actinium Pharmaceuticals; ARUP Laboratories; Ono Pharmaceutical; Mateon Therapeutics; Jazz Pharmaceuticals; Celgene; Karyopharm Therapeutics; Constellation Pharmaceuticals; Agios Pharmaceuticals; Eli Lilly and Company; Bristol-Myers Squibb; Amgen","keywords":"Systemic mastocytosis; Medicine; Internal medicine; Clinical endpoint; Midostaurin; Gastroenterology; Progressive disease; Phases of clinical research; Tyrosine-kinase inhibitor; Randomized controlled trial; Clinical trial; Oncology; Leukemia; Chemotherapy; Bone marrow; Cancer","score_opus":0.008231757814372818,"score_gpt":0.206977026345693,"score_spread":0.19874526853132019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389231326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959392,0.00034956879,0.000006388034,0.00005378096,0.0003897094,0.0010889608,0.0020415524,0.000028950775,0.000101914644],"genre_scores_gemma":[0.9990332,0.00005309438,0.000046238318,0.000010492777,0.000036482114,0.000026703594,0.0005426377,0.000021974229,0.00022918994],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998337,0.00014471979,0.0007260267,0.00041327326,0.0000958231,0.00028318795],"domain_scores_gemma":[0.9987544,0.00029269647,0.00044834908,0.00035962506,0.000116328774,0.000028604827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018378919,0.00021657783,0.000537545,0.00012889363,0.000092546325,0.0000052012174,0.00016841348,0.00016376805,0.000019679517],"category_scores_gemma":[0.00018442018,0.00015086577,0.000072690236,0.00047396758,0.00019921889,0.000047460908,0.0001209184,0.00021515707,0.000007608901],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22770551,0.0089415815,0.007460651,0.00014664496,0.00051959266,0.0000074025634,0.001275327,0.00014538907,0.7493699,0.00006409338,0.00038893934,0.0039749467],"study_design_scores_gemma":[0.65340334,0.005531687,0.10294806,0.0009349582,0.00040855946,0.0000062601184,0.00013602823,0.0000101488795,0.23209982,0.0000041028,0.004152606,0.0003644114],"about_ca_topic_score_codex":0.0002075118,"about_ca_topic_score_gemma":0.000090056514,"teacher_disagreement_score":0.5172701,"about_ca_system_score_codex":0.000026897753,"about_ca_system_score_gemma":0.00008060592,"threshold_uncertainty_score":0.61521274},"labels":[],"label_agreement":null},{"id":"W4389231332","doi":"10.1182/blood-2023-184514","title":"Low-Dose Immune Tolerance Induction Therapy for Severe Hemophilia a Inhibitor Patients: Immunosuppressants Improve Outcomes but Are Generally Not Necessary for Inhibitor-Titer below 200 BU/Ml","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Regimen; Rituximab; Prednisone; Internal medicine; Titer; Gastroenterology; Immunology; Antibody","score_opus":0.02427120421933908,"score_gpt":0.286608232686677,"score_spread":0.2623370284673379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389231332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98948896,0.00060846726,0.000008103158,0.0029951907,0.0013367592,0.0044161514,0.0008200519,0.00028698763,0.00003930362],"genre_scores_gemma":[0.983832,0.00041407556,0.00060612475,0.00051444926,0.0015213985,0.0016465505,0.00094507437,0.00017853611,0.0103418045],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99701667,0.000059557766,0.00067145674,0.00074816303,0.0006309839,0.00087318546],"domain_scores_gemma":[0.99814004,0.00018375578,0.00022098667,0.00067033793,0.00057254115,0.00021232049],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003153365,0.00048262964,0.00076927966,0.0002973789,0.000368051,0.00008325356,0.00024408384,0.00036321714,0.000039349066],"category_scores_gemma":[0.00021497655,0.0003658744,0.00046392673,0.00038098943,0.00010146991,0.0003422964,0.000117316005,0.00032064403,0.00007124155],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007986152,0.009026723,0.29505932,0.0016687247,0.0020081887,0.0001319995,0.0011963324,0.000024566805,0.61470187,0.000012991177,0.014762531,0.053420585],"study_design_scores_gemma":[0.05458523,0.0028068882,0.39852154,0.0005353393,0.00026532414,0.000019713987,0.00023912986,0.00021910883,0.53872585,0.00016536708,0.0031980847,0.0007184187],"about_ca_topic_score_codex":0.000030332134,"about_ca_topic_score_gemma":0.000005164284,"teacher_disagreement_score":0.10346223,"about_ca_system_score_codex":0.0000999262,"about_ca_system_score_gemma":0.00019103415,"threshold_uncertainty_score":0.9998793},"labels":[],"label_agreement":null},{"id":"W4389231370","doi":"10.1182/blood-2023-191307","title":"Effects of Hydroxyurea on Fertility in Sickle Cell Disease; A Systemic Review and Meta-Analysis","year":2023,"lang":"en","type":"review","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Hydroxycarbamide; Infertility; Fertility; Meta-analysis; Disease; Pediatrics; Gynecology; Internal medicine; Pregnancy; Population; Biology","score_opus":0.03689406260824067,"score_gpt":0.3084697725731207,"score_spread":0.27157570996488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389231370","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002066315,0.99640167,4.90866e-7,0.0000643131,0.000018606675,0.0029100112,0.000078311255,0.000040618168,0.00027932724],"genre_scores_gemma":[0.0010311031,0.9976691,0.0000045728343,0.00011807411,0.000008213627,0.00031723425,0.000101414,0.000045805114,0.00070450234],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9976017,0.00037903324,0.00094544207,0.00053507276,0.00029720174,0.00024153708],"domain_scores_gemma":[0.9983726,0.00034821307,0.000379529,0.0006507566,0.000037248603,0.00021160943],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004691004,0.0004251448,0.006930718,0.0003854044,0.000020670692,0.0000059298745,0.00012400826,0.00026803027,0.000040979194],"category_scores_gemma":[0.0002447771,0.00025667323,0.002545407,0.0014686722,0.00004749523,0.000014089389,0.00006213587,0.000416454,0.000054440545],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009831657,0.0007990475,0.000027814158,0.9158713,0.07932284,0.00025423866,0.000017796674,7.68848e-7,4.986654e-7,0.0000046063237,0.000092452836,0.0035988018],"study_design_scores_gemma":[0.0006058563,0.00008446959,0.00006367382,0.023565356,0.96167046,0.0000074549916,0.0000034255377,0.0000016339261,0.0000019918289,0.000005010157,0.013796264,0.00019439647],"about_ca_topic_score_codex":0.000049492384,"about_ca_topic_score_gemma":0.0000048155466,"teacher_disagreement_score":0.89230597,"about_ca_system_score_codex":0.000029747778,"about_ca_system_score_gemma":0.0001665639,"threshold_uncertainty_score":0.99998856},"labels":[],"label_agreement":null},{"id":"W4389231373","doi":"10.1182/blood-2023-179274","title":"4D Intravital Imaging Studies Identify Platelets As the Predominant Cellular Procoagulant Surface in Hemostasis","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Fibrin; Platelet; Hemostasis; Fibrinolysis; Coagulation; Platelet activation; Chemistry; Endothelium; Intravital microscopy; Pathology; Immunology; Medicine; Pharmacology; Internal medicine; Microcirculation","score_opus":0.023682502556210835,"score_gpt":0.3155102648686547,"score_spread":0.29182776231244384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389231373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924149,0.0044229487,0.0000018120811,0.0019966443,0.000106525986,0.0007088866,0.000013762,0.00008993403,0.00024457733],"genre_scores_gemma":[0.99860644,0.000588924,0.000075481796,0.0001129237,0.000036788308,0.000048022608,0.000042542288,0.000026497904,0.00046238964],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987905,0.000035382447,0.00024420518,0.00029095076,0.0002575452,0.0003813944],"domain_scores_gemma":[0.99949807,0.00009151046,0.000056817655,0.00024924276,0.00004461051,0.000059736445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023916161,0.00018018219,0.00035348782,0.00008027203,0.00013698224,0.000038767845,0.00009774251,0.000042332274,0.000019759793],"category_scores_gemma":[0.00009961324,0.00011458667,0.00007439527,0.00036880572,0.0000942122,0.00006739048,0.00009824967,0.00015253924,0.00022289538],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010035167,0.007343166,0.6258227,0.0012106124,0.0049550906,0.15193349,0.027974399,0.00020541181,0.14680038,0.00049556146,0.0056466633,0.026608963],"study_design_scores_gemma":[0.047639478,0.0012802269,0.17188044,0.0019359782,0.0027541562,0.004758625,0.030365909,0.0018213632,0.72555625,0.00636457,0.004199163,0.0014438166],"about_ca_topic_score_codex":0.00015954538,"about_ca_topic_score_gemma":0.00005833746,"teacher_disagreement_score":0.5787559,"about_ca_system_score_codex":0.000033085784,"about_ca_system_score_gemma":0.00006472039,"threshold_uncertainty_score":0.46727088},"labels":[],"label_agreement":null},{"id":"W4389231396","doi":"10.1182/blood-2023-177655","title":"Sickle Cell Health Awareness, Perspectives, and Experiences (SHAPE) Survey: Findings on the Burden of Sickle Cell Disease and Impact on the Quality of Life of Patients and Caregivers in Gulf Cooperation Council Countries","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Context (archaeology); Quality of life (healthcare); Family medicine; Disease; Disease burden; Pediatrics; Internal medicine; Geography; Nursing","score_opus":0.029095210221594243,"score_gpt":0.2783073492496702,"score_spread":0.24921213902807596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389231396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99629724,0.0019993193,3.331698e-7,0.0008989918,0.00002008149,0.00045961418,0.00023189344,0.0000068994445,0.00008560965],"genre_scores_gemma":[0.9980785,0.0017662589,9.312712e-7,0.000072101364,0.000008118565,0.000009312141,0.000024177089,0.0000077405975,0.000032859294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988121,0.0002078212,0.00026602286,0.00018672772,0.00038829306,0.00013907395],"domain_scores_gemma":[0.9989168,0.00046922083,0.00015947674,0.00014795946,0.00021688457,0.000089649315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088934606,0.000117943724,0.0002956655,0.000047761263,0.00010810665,0.000011450887,0.00005273717,0.000049295257,0.000022641927],"category_scores_gemma":[0.00048193044,0.000064040614,0.000029676734,0.00021774722,0.0003496235,0.000040434777,0.000031985055,0.00009671958,4.6346136e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001785151,0.0010519229,0.7359997,0.0009168304,0.00009564357,0.0000025401544,0.25725085,0.0001662046,0.00060935173,0.00021154799,0.0018234968,0.00008677363],"study_design_scores_gemma":[0.004926095,0.0014960989,0.779713,0.00023988962,0.000060367154,2.3721121e-7,0.21139954,0.000474502,0.0014716312,0.000019084033,0.000058297144,0.00014126497],"about_ca_topic_score_codex":0.0058136657,"about_ca_topic_score_gemma":0.00014208483,"teacher_disagreement_score":0.04585131,"about_ca_system_score_codex":0.000043445616,"about_ca_system_score_gemma":0.00056869164,"threshold_uncertainty_score":0.8788562},"labels":[],"label_agreement":null},{"id":"W4389231399","doi":"10.1182/blood-2023-180271","title":"Gain1q in Myeloma Randomized Clinical Trials- How Is It Reported and How Does It Impact Outcomes: A Systematic Review","year":2023,"lang":"en","type":"review","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Randomized controlled trial; Population; Clinical trial; Multiple myeloma; Oncology","score_opus":0.30456954541512404,"score_gpt":0.5285760360045559,"score_spread":0.2240064905894319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389231399","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000071089045,0.9664808,0.0000026752307,0.0046369424,0.00017063641,0.028211422,0.00023285288,0.00009778391,0.00009580927],"genre_scores_gemma":[0.000069442605,0.9876944,0.00010093723,0.00040646648,0.00020323461,0.004146784,0.00044030516,0.00014433493,0.0067941113],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9798421,0.012106234,0.00492187,0.0011721388,0.0011531808,0.0008044306],"domain_scores_gemma":[0.9710481,0.022482764,0.003498486,0.0018851858,0.0002371307,0.000848319],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.031254318,0.0010476662,0.0299386,0.00064872316,0.00006667172,0.00017943697,0.00031435952,0.000688449,0.0001399848],"category_scores_gemma":[0.1629101,0.00046981074,0.00562952,0.0008267906,0.0001842362,0.00009415052,0.00018928769,0.0010261704,0.00015539667],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012481386,0.0005960381,0.0003504704,0.943911,0.019888729,0.004207066,0.000048056005,5.717029e-10,4.9048374e-8,0.0000014549764,0.003001167,0.026747812],"study_design_scores_gemma":[0.15845439,0.00023148097,0.00006714196,0.77378774,0.057309695,0.0006893481,0.000057265137,0.0000076396145,1.9831694e-7,0.000009718551,0.008965744,0.00041966792],"about_ca_topic_score_codex":0.00006177529,"about_ca_topic_score_gemma":0.00004612948,"teacher_disagreement_score":0.1701233,"about_ca_system_score_codex":0.00015853248,"about_ca_system_score_gemma":0.0010291967,"threshold_uncertainty_score":0.99977535},"labels":[],"label_agreement":null},{"id":"W4389231411","doi":"10.1182/blood-2023-182314","title":"Multi-Omic Insights into the Mutational Landscape and Dysregulated Transcriptional Programs of Autoimmune B-Cells in Systemic Lupus Erythematosus","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Spinal Cord Injury BC; University of British Columbia; University Health Network","funders":"","keywords":"Immunology; Biology; Epigenetics; Genetics; B cell; Immune dysregulation; Gene; Immune system; Antibody","score_opus":0.021014591402650315,"score_gpt":0.2699299704112158,"score_spread":0.24891537900856547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389231411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949954,0.0035011843,0.000005424431,0.0007499155,0.000092263246,0.0005018074,0.000009485035,0.000043657026,0.000100837184],"genre_scores_gemma":[0.9975559,0.00036989505,0.00023658833,0.000029040977,0.000042337375,0.000054760847,0.00013412988,0.000014808736,0.0015625214],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988401,0.00006626394,0.00032843364,0.00019428195,0.00035975268,0.0002111682],"domain_scores_gemma":[0.9995469,0.00011893016,0.000053164596,0.00013377694,0.00008217322,0.00006508893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022211105,0.0001221799,0.00026344103,0.00018629478,0.00007248657,0.0000139726135,0.00009793708,0.00007703677,0.00002960198],"category_scores_gemma":[0.000018442059,0.00007663252,0.00007308744,0.0004369483,0.0001623024,0.000041405252,0.00004128772,0.00017567538,0.00003449844],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006982457,0.0017201338,0.18690233,0.0015655681,0.0004793302,0.00043943076,0.0136821205,0.00009938412,0.7890516,0.0016211243,0.00019629857,0.0035444666],"study_design_scores_gemma":[0.023274105,0.00079459907,0.9085418,0.0015604093,0.00026465382,0.00320858,0.0030938967,0.032153845,0.023221904,0.0008823344,0.002574333,0.0004295459],"about_ca_topic_score_codex":0.00013633582,"about_ca_topic_score_gemma":0.00006705154,"teacher_disagreement_score":0.7658297,"about_ca_system_score_codex":0.000011145305,"about_ca_system_score_gemma":0.00009116468,"threshold_uncertainty_score":0.31249833},"labels":[],"label_agreement":null},{"id":"W4389231435","doi":"10.1182/blood-2023-173247","title":"Favorable Outcomes of Splenic Marginal Zone Lymphoma in an International Study of 934 Patients with Long Follow-up","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Medicine; Rituximab; Cumulative incidence; Internal medicine; Population; Splenic marginal zone lymphoma; Splenectomy; Pediatrics; Lymphoma; Cohort","score_opus":0.016339767721603404,"score_gpt":0.27110303631320976,"score_spread":0.25476326859160636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389231435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991005,0.000022430704,8.131791e-7,0.000037908772,0.00009336201,0.0004619934,0.000027152326,0.000021266414,0.00023456929],"genre_scores_gemma":[0.99951994,0.000014260941,0.000069652924,0.000014779439,0.000013312798,0.00005168496,0.00009122511,0.00001425759,0.00021090839],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895984,0.000024965602,0.00026822704,0.00019464036,0.00040837034,0.00014395996],"domain_scores_gemma":[0.99944586,0.00004351118,0.00010481718,0.00024482733,0.000106007654,0.000055007207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008111373,0.00011214424,0.00033095691,0.00019849336,0.000015372874,0.000006010223,0.000092595015,0.000029441368,0.000043516327],"category_scores_gemma":[0.00001939824,0.000079834965,0.000047760663,0.00026023964,0.00002045823,0.00008839947,0.000035513596,0.000022195776,0.000010336071],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002882902,0.018566953,0.97763264,0.000026422316,0.00048560198,0.00012794256,0.0006278839,0.0000063983057,0.000020661651,0.000024800778,0.000014265798,0.0021781544],"study_design_scores_gemma":[0.045381244,0.0023408444,0.95067865,0.00007867749,0.00025357012,0.0000030148506,0.00042278648,0.000014984102,0.0007461744,0.000005369215,0.000009388441,0.00006528602],"about_ca_topic_score_codex":0.0004714762,"about_ca_topic_score_gemma":0.000643676,"teacher_disagreement_score":0.045092955,"about_ca_system_score_codex":0.000046701196,"about_ca_system_score_gemma":0.000058401878,"threshold_uncertainty_score":0.32555753},"labels":[],"label_agreement":null},{"id":"W4389231445","doi":"10.1182/blood-2023-190270","title":"Rates and Predictors of Prophylaxis in Women with Von Willebrand Disease and Heavy Menstrual Bleeding","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Dilation and curettage; Desmopressin; Hysterectomy; Retrospective cohort study; Von Willebrand disease; Gynecology; Blood transfusion; Obstetrics; Internal medicine; Pediatrics; Von Willebrand factor; Surgery; Pregnancy","score_opus":0.008427221471121696,"score_gpt":0.2331476104958599,"score_spread":0.22472038902473823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389231445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99863297,0.00046890217,2.1961013e-7,0.00031510714,0.000016195394,0.00042683442,0.000023241395,0.000024626508,0.000091909205],"genre_scores_gemma":[0.99923545,0.0004377335,0.000059717837,0.000026772215,0.000034917965,0.00013379616,0.000008753582,0.000012486646,0.000050364764],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99931115,0.000018705969,0.00013893333,0.00020896303,0.0001475932,0.00017465492],"domain_scores_gemma":[0.9996084,0.00007000839,0.000035441873,0.00008290251,0.000028102797,0.00017517542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009335227,0.00011415753,0.00024828373,0.00011764092,0.000034660567,0.000011608227,0.000015171729,0.000029696204,0.000011985093],"category_scores_gemma":[0.000040687573,0.000075849486,0.000010550372,0.00020756168,0.00008387877,0.000048602218,0.000026432286,0.000057371682,0.0000010773765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008491234,0.0003432912,0.9952589,0.00022964783,0.0001796775,0.00012924995,0.0015100078,0.0000016141927,0.0006128913,0.000038239934,0.000028310238,0.00081900554],"study_design_scores_gemma":[0.0063938154,0.0019750183,0.9824387,0.00030477424,0.00012538266,0.00001536931,0.00042715616,0.000027813134,0.008119656,0.000050569284,0.000042204065,0.000079562735],"about_ca_topic_score_codex":0.000016877239,"about_ca_topic_score_gemma":0.000012248916,"teacher_disagreement_score":0.012820262,"about_ca_system_score_codex":0.000014776349,"about_ca_system_score_gemma":0.000050042694,"threshold_uncertainty_score":0.30930522},"labels":[],"label_agreement":null},{"id":"W4389231472","doi":"10.1182/blood-2023-187580","title":"Targeting Nucleotide Biosynthesis Ameliorates Neutropenia in a Zebrafish Model of Dnajc21-Mutant Shwachman-Diamond Syndrome","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; National Research Council Canada; AGADA Biosciences; Hospital for Sick Children; SickKids Foundation; Agricultural Research Institute of Ontario","funders":"","keywords":"Zebrafish; Biology; Neutropenia; Diamond–Blackfan anemia; Cancer research; Myeloid; Immunology; Genetics; Gene","score_opus":0.010391339397585115,"score_gpt":0.2209864698697666,"score_spread":0.2105951304721815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389231472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986511,0.0005506833,0.000016759623,0.00008219868,0.000031263695,0.00020265613,0.000086907465,0.000029491286,0.00034896703],"genre_scores_gemma":[0.9988946,0.00026753554,0.0004746571,0.00005439467,0.000019806816,0.000034804383,0.000114742485,0.000039910286,0.00009959193],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99884284,0.00004124051,0.0002889039,0.00037448196,0.00011989898,0.00033266394],"domain_scores_gemma":[0.9995001,0.000015311534,0.000097325676,0.00028598067,0.00003601918,0.00006526459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013032452,0.00018628662,0.00026090458,0.00011939259,0.00004883656,0.000018563678,0.00019755115,0.0001240693,0.000013682071],"category_scores_gemma":[0.000058104222,0.00017708124,0.00009815964,0.0003149392,0.00005282062,0.0000070287915,0.00014260337,0.000064600565,0.000028209806],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042708536,0.0007356783,0.022851536,0.000044576333,0.00017899211,0.0000834644,0.00008009455,0.0018038398,0.97361493,0.000034578923,0.00027241217,0.00025721293],"study_design_scores_gemma":[0.003424326,0.00039316222,0.01017481,0.000069809976,0.00016031867,0.00001769041,0.00028135988,0.0038504,0.9805535,0.00048765415,0.0001544915,0.00043245827],"about_ca_topic_score_codex":0.00006963352,"about_ca_topic_score_gemma":0.0000634216,"teacher_disagreement_score":0.012676726,"about_ca_system_score_codex":0.000004685698,"about_ca_system_score_gemma":0.000050968498,"threshold_uncertainty_score":0.72211635},"labels":[],"label_agreement":null},{"id":"W4389231475","doi":"10.1182/blood-2023-189827","title":"New Pattern of Emerging Somatic Mutations in Optimal Responders Following Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia Patients Evidenced from Mutational Kinetic Analysis Based on Pairwise Comparison","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Myeloid leukemia; Fluorescence in situ hybridization; Tyrosine-kinase inhibitor; Dasatinib; Population; Biology; Imatinib mesylate; Internal medicine; Cancer research; Medicine; Oncology; Immunology; Genetics; Imatinib; Cancer","score_opus":0.021858447190414257,"score_gpt":0.29689866038613794,"score_spread":0.2750402131957237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389231475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980506,0.000306528,0.00043143428,0.00021557954,0.00008589483,0.00077179325,0.000042494354,0.00007550044,0.000020213216],"genre_scores_gemma":[0.9971538,0.000017281358,0.0012335296,0.000076724165,0.000057735622,0.00009847871,0.0012896855,0.000044969274,0.00002776489],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972106,0.0001804534,0.00089598686,0.0005219559,0.00078380894,0.00040714518],"domain_scores_gemma":[0.9984984,0.0006107836,0.0002565466,0.00043090348,0.000055215583,0.00014818688],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023722419,0.0003027114,0.0007247967,0.0014530624,0.00004773699,0.000020805513,0.00014601221,0.000121995414,0.00023069953],"category_scores_gemma":[0.00021674657,0.00029880527,0.0002944481,0.0024261735,0.00003569104,0.00012096556,0.00003517313,0.00025056754,0.000037266836],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035061798,0.000900649,0.80047494,0.00007933745,0.0006568897,0.00025388642,0.002165155,0.17397329,0.012062127,0.0000011945419,0.000043298387,0.009038627],"study_design_scores_gemma":[0.028175507,0.000707154,0.7796901,0.0008741898,0.0007497117,4.18957e-7,0.0003173408,0.1742286,0.015016636,0.000021862761,0.0000026294729,0.00021586835],"about_ca_topic_score_codex":0.0025287953,"about_ca_topic_score_gemma":0.00087182096,"teacher_disagreement_score":0.02782489,"about_ca_system_score_codex":0.0018833112,"about_ca_system_score_gemma":0.0013540341,"threshold_uncertainty_score":0.9999464},"labels":[],"label_agreement":null},{"id":"W4389231477","doi":"10.1182/blood-2023-187233","title":"Comparison of Time to Next Treatment or Death between Front-Line Daratumumab, Lenalidomide, and Dexamethasone (DRd) and Bortezomib, Lenalidomide, and Dexamethasone (VRd) in Transplant Ineligible Patients with Multiple Myeloma","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Lenalidomide; Daratumumab; Medicine; Population; Internal medicine; Dexamethasone; Multiple myeloma; Cohort; Bortezomib; Surgery; Oncology","score_opus":0.06021314301611849,"score_gpt":0.33121567867743484,"score_spread":0.2710025356613164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389231477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958496,0.0011612923,0.000048009137,0.00022814522,0.000013803937,0.002072576,0.00044602566,0.00007248572,0.000108071144],"genre_scores_gemma":[0.99395365,0.00060057396,0.004212721,0.00003441923,0.00005418846,0.00016362632,0.00043091472,0.0000661515,0.00048375074],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971515,0.00016435218,0.0006896059,0.000757347,0.00053698494,0.0007002234],"domain_scores_gemma":[0.9977583,0.00088244723,0.00015626304,0.0004009664,0.00012646746,0.0006755467],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033793628,0.0004936953,0.0014109769,0.0005890147,0.0001280274,0.00005585416,0.000101389705,0.000149794,0.000057905927],"category_scores_gemma":[0.00025278778,0.00033476038,0.00006424441,0.00055087934,0.0001609789,0.00018055129,0.00010414018,0.00021294488,0.00003442661],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007745376,0.0017786548,0.9686507,0.00022517367,0.00073659356,0.00027064234,0.0010594203,0.000011828198,0.002465611,0.0000015511563,0.00006319277,0.016991233],"study_design_scores_gemma":[0.06335505,0.0053971843,0.91235876,0.00052054465,0.0006904571,0.000034610857,0.00015674475,0.0009360187,0.016013378,0.0000102241975,0.00019921981,0.0003277916],"about_ca_topic_score_codex":0.0015077709,"about_ca_topic_score_gemma":0.0010140406,"teacher_disagreement_score":0.056291953,"about_ca_system_score_codex":0.000082059654,"about_ca_system_score_gemma":0.00012941647,"threshold_uncertainty_score":0.9999104},"labels":[],"label_agreement":null},{"id":"W4389231492","doi":"10.1182/blood-2023-187702","title":"Appropriateness of Immunosuppression and Blood Product Utilization in Acquired Hemophilia A: A Multicentre Provincial Practice Audit","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Alberta","funders":"","keywords":"Medicine; Adverse effect; Internal medicine; Comorbidity; Pediatrics; Emergency medicine","score_opus":0.02152700142810902,"score_gpt":0.2854654781333211,"score_spread":0.2639384767052121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389231492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967494,0.0009276128,0.0000026259454,0.00049352983,0.000114303315,0.0013139636,0.000015427091,0.00010134887,0.00028176085],"genre_scores_gemma":[0.9979971,0.00043727778,0.00077881315,0.000024506018,0.00012561794,0.00007253673,0.00012550688,0.00003265684,0.00040596834],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99849,0.00009539651,0.0003735479,0.00042316856,0.0003406053,0.0002773189],"domain_scores_gemma":[0.9990907,0.00011476214,0.00019839496,0.00038429,0.00013904352,0.00007285341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000282634,0.000177221,0.0003372111,0.00017390003,0.00004825323,0.000011377047,0.000076457196,0.000108056774,0.000022245244],"category_scores_gemma":[0.0010629961,0.00015176361,0.000040637085,0.00055282115,0.000060552407,0.00018826537,0.00012246659,0.00010351627,0.00001704165],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031476624,0.013278757,0.26515484,0.0033890202,0.0009824154,0.001486884,0.00757757,0.000049184775,0.6748073,0.00012771832,0.00030014486,0.029698486],"study_design_scores_gemma":[0.059116192,0.0008543662,0.51642615,0.0013220815,0.0023861786,0.00052443455,0.0013961778,0.00160419,0.4149903,0.000090080954,0.0008616316,0.00042824046],"about_ca_topic_score_codex":0.00022714723,"about_ca_topic_score_gemma":0.000035560974,"teacher_disagreement_score":0.25981703,"about_ca_system_score_codex":0.00009729564,"about_ca_system_score_gemma":0.0004320196,"threshold_uncertainty_score":0.6188741},"labels":[],"label_agreement":null},{"id":"W4389231558","doi":"10.1182/blood-2023-187458","title":"Analysis of the Impact of Whole Blood and T-Cell Donor Chimerism after Allogeneic Stem Cell Transplant","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Population Health Research Institute; Juravinski Cancer Centre; Hamilton Health Sciences; Juravinski Hospital; Centre Hospitalier Universitaire Sainte-Justine; McMaster University; Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Medicine; Internal medicine; Stem cell; Transplantation; Myeloid leukemia; Oncology; Hematopoietic stem cell transplantation; Haematopoiesis; Myelodysplastic syndromes; Myeloid; Immunology; Gastroenterology; Bone marrow; Biology","score_opus":0.01153860160121315,"score_gpt":0.26015666904979173,"score_spread":0.2486180674485786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389231558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978888,0.0008270489,0.0000035867088,0.000111425186,0.0000140493,0.00031140447,0.0002862328,0.000022309767,0.00053516496],"genre_scores_gemma":[0.9981053,0.00033344014,0.00003640309,0.000023809953,0.000030327637,0.000020696023,0.00003475722,0.00002466592,0.0013906071],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99872094,0.00008278743,0.00030806006,0.0002526367,0.00033416407,0.00030138166],"domain_scores_gemma":[0.9990788,0.000090770714,0.000102683414,0.0005322282,0.0000635694,0.00013192934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025972715,0.00015629893,0.0004978887,0.00035256642,0.00003177882,0.00000727914,0.00017839414,0.00010491326,0.00008465934],"category_scores_gemma":[0.0000065193,0.00009462271,0.0004152011,0.0013408863,0.00011292305,0.00002677481,0.00007940508,0.00019787166,0.000012287764],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001433441,0.00052796805,0.46184003,0.0001944185,0.0024263607,0.00007920675,0.0013363205,0.00005883197,0.53308934,4.5533704e-7,0.00012217036,0.0001815666],"study_design_scores_gemma":[0.0039984365,0.00039117289,0.6621091,0.00004761375,0.006919117,0.000021782811,0.00017810118,0.00042077474,0.32577524,0.0000024418068,0.00003182481,0.00010441903],"about_ca_topic_score_codex":0.00030433922,"about_ca_topic_score_gemma":0.000026246624,"teacher_disagreement_score":0.20731409,"about_ca_system_score_codex":0.000019882487,"about_ca_system_score_gemma":0.0001871897,"threshold_uncertainty_score":0.3858602},"labels":[],"label_agreement":null},{"id":"W4389231562","doi":"10.1182/blood-2023-187737","title":"Investigation of CD83 As a Novel Human Hematopoietic Stem Cell Inflammatory Activation Marker","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Immune responses and vaccinations","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Celgene","keywords":"Stem cell; Haematopoiesis; Biology; Inflammation; Immunology; Immune system; Hematopoietic stem cell; Myeloid; Cancer research; Cell biology","score_opus":0.019210461307039746,"score_gpt":0.23820553133665684,"score_spread":0.2189950700296171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389231562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982416,0.00014244954,0.000026364916,0.00012691604,0.000101193116,0.00018079331,0.0000083122095,0.00009618576,0.0010761748],"genre_scores_gemma":[0.9936503,0.000011871682,0.000014783851,0.000028858567,0.000010910919,0.000028462624,0.00009945001,0.000014455743,0.0061408775],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993159,0.00008994016,0.00025648985,0.00013990668,0.00003491792,0.00016281835],"domain_scores_gemma":[0.9994417,0.00012216718,0.00014913398,0.00020778342,0.00006746195,0.000011798904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021553872,0.00009432853,0.00013557602,0.00018746786,0.0001435733,0.000007290196,0.00010771518,0.00014982592,0.00015161358],"category_scores_gemma":[0.00002381298,0.00009310582,0.00006061911,0.00025886396,0.000050015897,0.0000815421,0.000056457255,0.00011766563,0.0003988402],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023861568,0.00007809735,0.004410012,0.000057760524,0.000059907685,8.2098313e-7,0.0008180104,0.0000022742154,0.9916194,0.0023295942,0.00048699122,0.00011326773],"study_design_scores_gemma":[0.0017287837,0.00007865355,0.1093871,0.00004525814,0.000043564833,0.00001383953,0.0004907464,0.0000023332257,0.88656807,0.00026091206,0.0012828797,0.00009787609],"about_ca_topic_score_codex":0.000027890152,"about_ca_topic_score_gemma":0.0000024717951,"teacher_disagreement_score":0.10505135,"about_ca_system_score_codex":0.0000114717905,"about_ca_system_score_gemma":0.00006706372,"threshold_uncertainty_score":0.51264167},"labels":[],"label_agreement":null},{"id":"W4389231566","doi":"10.1182/blood-2023-181941","title":"Inherited Thrombophilia Gene Mutations and Risk of Venous Thromboembolism in Cancer: A Systematic Review and Meta-Analysis","year":2023,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Thrombophilia; Odds ratio; Meta-analysis; Internal medicine; Cancer; Pulmonary embolism; Population; Venous thrombosis; Thrombosis; Oncology","score_opus":0.09749671484368339,"score_gpt":0.37082092103327774,"score_spread":0.27332420618959435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389231566","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005233942,0.99249345,0.0000021254345,0.00008506408,0.000027572236,0.0061721476,0.0005969437,0.000053973927,0.000045349363],"genre_scores_gemma":[0.00011571975,0.9966283,0.00015219685,0.000130025,0.000026048092,0.002605164,0.00017578664,0.000085312364,0.000081473816],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9963537,0.0004972243,0.0017620794,0.00068922015,0.00037692476,0.00032087174],"domain_scores_gemma":[0.99736536,0.0003216015,0.0012060633,0.00083787873,0.000119816286,0.00014931246],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0009679169,0.0005704082,0.018968904,0.0008236703,0.00007118353,0.000028565179,0.00017992417,0.00022378938,0.00009949165],"category_scores_gemma":[0.00028287093,0.00039960566,0.0015420337,0.002204172,0.00011130387,0.000049208913,0.0001767571,0.00033655373,0.000012432713],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[3.1981693e-7,0.00065307936,0.0000170885,0.6964187,0.30214882,0.000039930597,0.00013740352,0.0000010220053,1.4560948e-7,0.000040192663,0.000037220627,0.00050607213],"study_design_scores_gemma":[0.00035543693,0.000114882896,0.00063985935,0.06443015,0.93328375,0.000032708085,0.00002915225,0.0000026783257,4.922622e-7,0.000043277414,0.00078730396,0.00028030234],"about_ca_topic_score_codex":0.0014490263,"about_ca_topic_score_gemma":0.00050308125,"teacher_disagreement_score":0.6319886,"about_ca_system_score_codex":0.000048669302,"about_ca_system_score_gemma":0.00015113362,"threshold_uncertainty_score":0.99984556},"labels":[],"label_agreement":null},{"id":"W4389231582","doi":"10.1182/blood-2023-180994","title":"Risk of Anemia and Vitamin B12 Deficiency in Patients with Type 2 Diabetes Mellitus on Metformin Therapy: A Systematic Review and Meta-Analysis","year":2023,"lang":"en","type":"review","venue":"Blood","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto","funders":"","keywords":"Metformin; Medicine; Vitamin B12; Internal medicine; Type 2 diabetes; Anemia; Diabetes mellitus; Randomized controlled trial; Type 2 Diabetes Mellitus; Meta-analysis; Cochrane Library; Gastroenterology; Endocrinology; Insulin","score_opus":0.05750910645305428,"score_gpt":0.33045717142533776,"score_spread":0.27294806497228347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389231582","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008384818,0.9879861,1.345214e-7,0.00000593658,0.000005711906,0.0034488442,0.00011101033,0.000013256482,0.000044223838],"genre_scores_gemma":[0.0006546612,0.9986266,0.000050761435,0.000026955888,0.0000042576507,0.00023872637,0.000104190396,0.00004396387,0.00024988025],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9972954,0.00046340402,0.0009094698,0.000476941,0.00056555984,0.00028924778],"domain_scores_gemma":[0.99803704,0.00052839343,0.0005096151,0.0006641341,0.00015972262,0.00010107912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001326121,0.00039637243,0.00712708,0.00075816107,0.00003149555,0.000018138857,0.0001430703,0.00016273219,0.000032689037],"category_scores_gemma":[0.00040332356,0.0001938965,0.00058204593,0.002346746,0.000071774426,0.00003962395,0.000058707745,0.00034160176,0.00001567556],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010186588,0.0005056503,0.0010070743,0.9157384,0.07614222,0.000016143038,0.000033015607,3.681462e-8,1.0581065e-7,0.0000028873328,0.0000109880575,0.0065332707],"study_design_scores_gemma":[0.0008879604,0.0013520584,0.00056358986,0.05029664,0.9462206,0.000004013654,0.000008401079,0.0000011854618,0.0000027138806,0.0000026376797,0.00042965834,0.00023055599],"about_ca_topic_score_codex":0.000035027813,"about_ca_topic_score_gemma":0.000020245832,"teacher_disagreement_score":0.8700784,"about_ca_system_score_codex":0.00002355656,"about_ca_system_score_gemma":0.00009394767,"threshold_uncertainty_score":0.790687},"labels":[],"label_agreement":null},{"id":"W4389231608","doi":"10.1182/blood-2023-189165","title":"Ravulizumab Effectiveness in the Real World: Evidence from the International PNH Registry","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Paroxysmal nocturnal hemoglobinuria; Eculizumab; Adverse effect; Real world data; Clinical trial; Intensive care medicine; Internal medicine; Pediatrics; Complement system; Immunology; Immune system","score_opus":0.03718810960149796,"score_gpt":0.30796902731459525,"score_spread":0.2707809177130973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389231608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951537,0.0010537903,0.000004486224,0.0013582773,0.000687171,0.00031050417,0.00007900432,0.00006575297,0.0012873049],"genre_scores_gemma":[0.9989496,0.000068920286,0.0000029024784,0.00010028672,0.00010054597,0.00014048556,0.00013888869,0.0000065013546,0.00049188215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998768,0.0006185634,0.00016894907,0.00020995074,0.000066238375,0.00016831612],"domain_scores_gemma":[0.9966738,0.0028086537,0.00006623832,0.00042242528,0.000023055272,0.0000058082946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006340811,0.00008858336,0.0001098125,0.00005448924,0.000108614826,0.00003134828,0.0008406588,0.000040166622,0.0003584066],"category_scores_gemma":[0.0003206928,0.000052630265,0.000058105197,0.00025992506,0.00007991161,0.000049802413,0.0001747382,0.0001504685,0.0006324337],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019876708,0.00022612236,0.9310164,0.000021439193,0.00028462594,0.000059113325,0.0011268416,0.000010952589,0.040634807,0.0011167659,0.024530964,0.00077320286],"study_design_scores_gemma":[0.0012371424,0.00002145371,0.98539346,0.00026238424,0.000048007467,0.000009041277,0.00054611487,0.000002420908,0.004236675,0.00048138443,0.0076882,0.00007371288],"about_ca_topic_score_codex":0.0015734134,"about_ca_topic_score_gemma":0.0012686879,"teacher_disagreement_score":0.054377064,"about_ca_system_score_codex":0.000026051699,"about_ca_system_score_gemma":0.000046608835,"threshold_uncertainty_score":0.81288666},"labels":[],"label_agreement":null},{"id":"W4389231617","doi":"10.1182/blood-2023-178995","title":"AML Drug Tolerant Persister (DTP) Cells Survive Chemotherapy By Transiently Altering Cellular Lipidomics to Increase Plasma Membrane Rigidity, but Also Increases Sensitivity to Immune Cell Killing","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Lipidome; Daunorubicin; Multidrug tolerance; Biology; Cell biology; Pharmacology; Immunology; Biochemistry; Lipidomics; Leukemia","score_opus":0.008697622017538442,"score_gpt":0.20545044494679368,"score_spread":0.19675282292925525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389231617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996258,0.00064781716,0.0003557286,0.0004452609,0.0007272506,0.0007454294,0.0004119326,0.00022748411,0.00018107989],"genre_scores_gemma":[0.9964816,0.00025309803,0.00015553989,0.00036382454,0.00012122281,0.000040821404,0.0005762726,0.00008248964,0.0019251067],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972143,0.00050280336,0.00061211915,0.00072744646,0.00012963456,0.000813695],"domain_scores_gemma":[0.9986517,0.00034998095,0.00016545085,0.0005734118,0.000108872686,0.00015062654],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00085653475,0.00047642094,0.00075433165,0.00027781646,0.00038012333,0.0000742986,0.00029967312,0.00025829006,0.00015446826],"category_scores_gemma":[0.00003547878,0.00048540017,0.0003064063,0.00044112126,0.00008951417,0.00018130534,0.00018782406,0.00029549134,0.00083402946],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004856638,0.00081360195,0.00019674972,0.00006869601,0.00024317691,0.000024212082,0.001740665,0.0006186446,0.993713,0.0000031035963,0.0014407305,0.0006517615],"study_design_scores_gemma":[0.004181817,0.00018791176,0.00094602804,0.00009973638,0.00016490881,0.00003254312,0.00046936425,0.00037579573,0.98505336,0.0000032903974,0.007913676,0.0005715562],"about_ca_topic_score_codex":0.0028624418,"about_ca_topic_score_gemma":0.000101704136,"teacher_disagreement_score":0.008659622,"about_ca_system_score_codex":0.000067705514,"about_ca_system_score_gemma":0.000059859714,"threshold_uncertainty_score":0.9999439},"labels":[],"label_agreement":null},{"id":"W4389231618","doi":"10.1182/blood-2023-181900","title":"Flares of Acute Graft-Versus-Host Disease: Mount Sinai Acute Gvhd International Consortium (MAGIC) Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Discontinuation; Graft-versus-host disease; Immunosuppression; Hematopoietic stem cell transplantation; Internal medicine; Transplantation; Gastroenterology; Surgery; Immunology","score_opus":0.02290601942908478,"score_gpt":0.30984369451745636,"score_spread":0.2869376750883716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389231618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949325,0.000056778885,0.00006556524,0.00089416537,0.0006705249,0.0007012051,0.00030528367,0.0001696538,0.0022043688],"genre_scores_gemma":[0.9980146,0.00014039238,0.0001742336,0.000059817037,0.00010511992,0.000046630903,0.00035328732,0.000030634037,0.0010752458],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983866,0.000048775593,0.00039115894,0.00030961938,0.0006347305,0.00022910623],"domain_scores_gemma":[0.99907506,0.00012957225,0.00010710812,0.00034114288,0.00017620057,0.00017095046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018459954,0.00016910816,0.00029686105,0.00019877694,0.000046086017,0.000021064161,0.00017053464,0.000054105454,0.00038112962],"category_scores_gemma":[0.000059692476,0.00015273901,0.0001170052,0.00032218083,0.00007725032,0.00008954157,0.00005287788,0.00011571659,0.00024217542],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048627113,0.008081794,0.85007685,0.0008477017,0.014229105,0.010173761,0.006946591,0.000016241589,0.0993575,0.0018893454,0.0029674778,0.00055094145],"study_design_scores_gemma":[0.017276468,0.00068985013,0.95052576,0.00013490528,0.005678859,0.000073932424,0.0013077388,0.000119276585,0.023290938,0.00005205448,0.00060390215,0.00024630062],"about_ca_topic_score_codex":0.000030994644,"about_ca_topic_score_gemma":0.000008117659,"teacher_disagreement_score":0.10044894,"about_ca_system_score_codex":0.00003924613,"about_ca_system_score_gemma":0.000111569105,"threshold_uncertainty_score":0.6228516},"labels":[],"label_agreement":null},{"id":"W4389231627","doi":"10.1182/blood-2023-189103","title":"Use and Outcomes of Secondary Anticoagulation in Patients &amp;lt;21 Years Old Following Completion of a Primary Course of Anticoagulation for Treatment of Acute Provoked VTE: Findings from the Multinational Kids-DOTT Trial","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Medicine; Thrombophilia; Pediatrics; Venous thromboembolism; Internal medicine; Surgery; Thrombosis","score_opus":0.03890575416926547,"score_gpt":0.29983364033635546,"score_spread":0.26092788616709,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389231627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974018,0.000032353877,0.00002835087,0.00011309711,0.00009904966,0.002002571,0.00030873256,0.00000922658,0.000004820716],"genre_scores_gemma":[0.99785787,0.000045217483,0.0009805419,0.0000194214,0.000019536124,0.000046911955,0.0010008927,0.000012772346,0.000016856413],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893695,0.00003985104,0.0004974791,0.00015363273,0.00027174255,0.000100343146],"domain_scores_gemma":[0.9990596,0.00037072747,0.00028759,0.00015886725,0.00010341862,0.000019750893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020937012,0.00010013434,0.00059560454,0.00013824401,0.000023950812,0.0000055436194,0.000040119226,0.000051678246,0.000005215368],"category_scores_gemma":[0.00010803382,0.00007738257,0.00013825909,0.00015729073,0.000045601555,0.00009333948,0.000029098268,0.000022422113,2.3911417e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011857678,0.0038050208,0.97603196,0.00013781856,0.00097286643,8.1781025e-7,0.0016897151,0.000020669115,0.013657415,0.000104610954,0.0000620626,0.0023313032],"study_design_scores_gemma":[0.043960568,0.0008579208,0.9499025,0.00013841578,0.0011416336,9.623881e-8,0.0000540552,0.00022092005,0.0035901603,0.000057417332,0.00002037685,0.000055943652],"about_ca_topic_score_codex":0.0002532421,"about_ca_topic_score_gemma":0.0000343628,"teacher_disagreement_score":0.0427748,"about_ca_system_score_codex":0.000026844406,"about_ca_system_score_gemma":0.000046677244,"threshold_uncertainty_score":0.31555694},"labels":[],"label_agreement":null},{"id":"W4389231707","doi":"10.1182/blood-2023-180766","title":"Venetoclax in Combination with Daratumumab and Dexamethasone Elicits Deep, Durable Responses in Patients with t(11;14) Relapsed/Refractory Multiple Myeloma: Updated Analyses of Minimal Residual Disease Negativity in Phase 1/2 Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Daratumumab; Internal medicine; Ven; Minimal residual disease; Lenalidomide; Multiple myeloma; Bortezomib; Dexamethasone; Venetoclax; Gastroenterology; Oncology; Phases of clinical research; Refractory (planetary science); Progressive disease; Bone marrow; Clinical trial; Chemotherapy; Leukemia","score_opus":0.03273877375204344,"score_gpt":0.3312713720477828,"score_spread":0.29853259829573936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389231707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976361,0.00013415157,0.0000022166244,0.000046675337,0.000009925621,0.0020225605,0.00009366021,0.000036360347,0.000018373412],"genre_scores_gemma":[0.99906486,0.000020238165,0.00023527796,0.000006651736,0.0000070423416,0.00017639097,0.00040229218,0.00003378874,0.000053478998],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99735194,0.00054149685,0.00045816883,0.0005162895,0.00069524604,0.00043686814],"domain_scores_gemma":[0.99855417,0.0005159946,0.00015843568,0.0003682093,0.0001687208,0.00023449628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048104752,0.00025423063,0.0005715591,0.0010197804,0.00006273225,0.000019985328,0.00008857975,0.000074096475,0.000011663444],"category_scores_gemma":[0.0010558175,0.00019582047,0.000024725545,0.0016718152,0.00013229383,0.00024298781,0.00007082292,0.00026863258,0.00000289867],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034468945,0.016520748,0.9442577,0.00009006512,0.00017662636,0.001419217,0.00070827635,0.00005659595,0.0012729013,0.0000010691666,0.00000859019,0.0010192838],"study_design_scores_gemma":[0.12515864,0.0057147867,0.8643922,0.00024268226,0.00015277838,0.0000021867281,0.00049181754,0.00094026176,0.002741005,0.0000054059415,0.0000022601077,0.00015595842],"about_ca_topic_score_codex":0.0014863973,"about_ca_topic_score_gemma":0.006919091,"teacher_disagreement_score":0.09068969,"about_ca_system_score_codex":0.00015496017,"about_ca_system_score_gemma":0.00032930556,"threshold_uncertainty_score":0.79853266},"labels":[],"label_agreement":null},{"id":"W4389231745","doi":"10.1182/blood-2023-172919","title":"Hydroxyurea Dose Optimization Is Safe and Improves Outcomes for Children with Sickle Cell Anemia Living in Sub-Saharan Africa: The Reach Experience","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Sickle cell anemia; Medicine; Anemia; Pediatrics; Internal medicine; Disease","score_opus":0.008119846633734239,"score_gpt":0.22422022601849825,"score_spread":0.216100379384764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389231745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963607,0.0013002114,0.00007838914,0.00077130756,0.00002580061,0.0007487763,0.000007396049,0.00006232036,0.0006451025],"genre_scores_gemma":[0.9974116,0.0011539571,0.00055762153,0.00018151886,0.000023837289,0.00008507517,0.000017901559,0.000023752897,0.0005447374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992256,0.000016768045,0.00015963997,0.00022851207,0.00012632874,0.00024315971],"domain_scores_gemma":[0.99957937,0.00009323713,0.000050507515,0.00019350016,0.000024330255,0.00005906304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001380241,0.00012675008,0.00017901491,0.00007234014,0.00011092185,0.00002357562,0.00006844403,0.00008962695,0.000008303851],"category_scores_gemma":[0.00006842418,0.000074070704,0.0000353806,0.00030626848,0.00006969418,0.00006678488,0.000035814544,0.00012508064,0.00000394909],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027427863,0.0015623489,0.906471,0.0004032971,0.00028680646,0.00005409558,0.050658293,0.001980231,0.024212295,0.000025739664,0.0039944598,0.010077135],"study_design_scores_gemma":[0.0133298375,0.0010397903,0.9544295,0.0004839841,0.0005922356,0.00010025523,0.005226615,0.013086921,0.010443701,0.000043608467,0.0006224589,0.00060106],"about_ca_topic_score_codex":0.000067356224,"about_ca_topic_score_gemma":0.000010887913,"teacher_disagreement_score":0.04795851,"about_ca_system_score_codex":0.000009069251,"about_ca_system_score_gemma":0.00003514576,"threshold_uncertainty_score":0.30205154},"labels":[],"label_agreement":null},{"id":"W4389231814","doi":"10.1182/blood-2023-186284","title":"Ibrutinib Dose Adjustment Does Not Impact Time to Next Treatment in First-Line Patients with Chronic Lymphocytic Leukemia: A Real-World Analysis of Electronic Medical Records from Academic and Non-Teaching Hospitals Using Target Trial Emulation","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Ibrutinib; Medicine; Dosing; Internal medicine; Medical record; Tolerability; Chronic lymphocytic leukemia; Adverse effect; Oncology; Pediatrics; Leukemia","score_opus":0.018488278592711196,"score_gpt":0.32877485696167913,"score_spread":0.31028657836896795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389231814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99701804,0.00024072934,0.000028591247,0.00010386554,0.000061645675,0.0023117654,0.00011899702,0.00007539465,0.0000409877],"genre_scores_gemma":[0.99778825,0.00049511605,0.00021159185,0.000040060997,0.0003808494,0.0001373969,0.0006958471,0.00006576615,0.00018510956],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9958224,0.00019166296,0.0009667293,0.0007966279,0.0012773061,0.00094526506],"domain_scores_gemma":[0.9978556,0.0007162058,0.00029215304,0.0005810225,0.00007661484,0.00047839756],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007780656,0.00042627408,0.0013094663,0.0013475802,0.000100097786,0.000028825618,0.00020100288,0.00030250364,0.00034537254],"category_scores_gemma":[0.00042177856,0.0002858413,0.00024210427,0.0021000213,0.00009092771,0.00018082281,0.0001689554,0.00046010173,0.00002750965],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.16613209,0.0059548463,0.53787935,0.0009728249,0.032193955,0.0011485106,0.009369061,0.17251115,0.012991155,0.00002270758,0.00022576413,0.060598563],"study_design_scores_gemma":[0.27232304,0.004940067,0.18997818,0.00060470344,0.0032860765,0.0000056862305,0.000032666157,0.5265977,0.0018443522,0.000017697343,0.000023740531,0.00034612813],"about_ca_topic_score_codex":0.035923425,"about_ca_topic_score_gemma":0.004135861,"teacher_disagreement_score":0.35408652,"about_ca_system_score_codex":0.059882425,"about_ca_system_score_gemma":0.02078177,"threshold_uncertainty_score":0.99995935},"labels":[],"label_agreement":null},{"id":"W4389231824","doi":"10.1182/blood-2023-188341","title":"Final Results of the Phase Ib/II Study Evaluating Enasidenib in Combination with Venetoclax in Patients with <i>IDH2</i>-Mutated Relapsed/Refractory Myeloid Malignancies","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton; University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Venetoclax; Medicine; IDH2; Tolerability; Internal medicine; Phases of clinical research; Refractory (planetary science); Myeloid; Oncology; Myeloid leukemia; Gastroenterology; Adverse effect; Leukemia; Clinical trial; IDH1; Biology; Chronic lymphocytic leukemia","score_opus":0.033417867618704945,"score_gpt":0.31759840406593387,"score_spread":0.2841805364472289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389231824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970101,0.000028594428,8.985188e-7,0.00020223825,0.000035295245,0.002423783,0.000030899235,0.00005164272,0.0002165406],"genre_scores_gemma":[0.99912626,0.00000622491,0.0001129982,0.000037693662,0.000020281124,0.0001412822,0.00011896911,0.000041290892,0.000394979],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99702036,0.0003488551,0.0005728609,0.00041125488,0.0012286333,0.00041800484],"domain_scores_gemma":[0.9985276,0.00023977815,0.0002592138,0.0005300228,0.0003712137,0.00007216884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012986959,0.00020591874,0.00038736893,0.00041019067,0.000107427695,0.000013418727,0.0002280783,0.00008663977,0.000008145516],"category_scores_gemma":[0.0008202533,0.0001313937,0.000035639056,0.0020122884,0.00012575323,0.00013558383,0.0001613556,0.00054108206,0.000008226451],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013371454,0.009570671,0.95077455,0.00015528976,0.00019810462,0.00038114903,0.009815655,0.00072179025,0.012175951,0.000008569669,0.00028287555,0.0025439262],"study_design_scores_gemma":[0.13254526,0.015733015,0.8415551,0.000654455,0.00012571097,0.000008101953,0.0014685286,0.0006649323,0.0070546786,0.000014413978,0.000021398988,0.00015437824],"about_ca_topic_score_codex":0.0004466619,"about_ca_topic_score_gemma":0.00042016897,"teacher_disagreement_score":0.1191738,"about_ca_system_score_codex":0.00038845043,"about_ca_system_score_gemma":0.0009970783,"threshold_uncertainty_score":0.5358079},"labels":[],"label_agreement":null},{"id":"W4389231842","doi":"10.1182/blood-2023-185351","title":"Assessing the Impact of Marginalization on Survival for Patients Undergoing Allogeneic Stem Cell Transplant in Ontario, Canada","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; St. Michael's Hospital; Canadian Blood Services; Health Sciences Centre; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; University of Toronto","funders":"","keywords":"Context (archaeology); Medicine; Population; Ethnic group; Psychological intervention; Demography; Gerontology; Transplantation; Immigration; Internal medicine; Environmental health; Geography; Political science; Sociology","score_opus":0.02818577572099166,"score_gpt":0.2935173907265425,"score_spread":0.2653316150055508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389231842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998643,0.000008930523,0.00011725384,0.000056338613,0.0000675964,0.00044911518,0.000027884786,0.00001053595,0.00061936805],"genre_scores_gemma":[0.9994752,0.000008571169,0.00002429789,0.00002164305,0.000020248237,0.000018729479,0.0001374527,0.000019226762,0.0002746337],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895483,0.00005555509,0.00020068324,0.0001471613,0.00037551075,0.00026625348],"domain_scores_gemma":[0.9990933,0.0005704538,0.000059738337,0.00015113743,0.00006783526,0.000057522004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023118794,0.00009521896,0.00017589363,0.00008893195,0.00004744991,0.000013257414,0.00008654308,0.00004508443,0.000017821849],"category_scores_gemma":[0.00003403564,0.000062321364,0.000055866003,0.00023789317,0.000015312078,0.000036038768,0.000014520618,0.00010274575,0.0000013702811],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019047133,0.00047103022,0.99380964,0.00019575849,0.00011067429,0.000059647347,0.00065450877,0.0018782106,0.0017679585,0.000013813474,0.00059061585,0.0002576443],"study_design_scores_gemma":[0.008526217,0.0006228441,0.9836005,0.00022959252,0.00008585666,0.000004442249,0.00027968164,0.0022856584,0.004228558,0.00001345385,0.000036218473,0.000086950655],"about_ca_topic_score_codex":0.71382546,"about_ca_topic_score_gemma":0.87100697,"teacher_disagreement_score":0.1571815,"about_ca_system_score_codex":0.0011051802,"about_ca_system_score_gemma":0.0045150863,"threshold_uncertainty_score":0.80095696},"labels":[],"label_agreement":null},{"id":"W4389231884","doi":"10.1182/blood-2023-179474","title":"TRANSCEND FL: Phase 2 Study Primary Analysis of Lisocabtagene Maraleucel as Second-Line Therapy in Patients with High-Risk Relapsed or Refractory Follicular Lymphoma","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Follicular lymphoma; Refractory (planetary science); Clinical endpoint; Oncology; Cohort; Phases of clinical research; Lymphoma; Gastroenterology; Surgery; Chemotherapy; Clinical trial; Biology","score_opus":0.020436914417571526,"score_gpt":0.2999379315298334,"score_spread":0.2795010171122619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389231884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99726796,0.00027586505,0.0000039938077,0.000046287205,0.000044211072,0.0018898495,0.00015837546,0.000093953284,0.00021948756],"genre_scores_gemma":[0.9954099,0.00060568145,0.00008535461,0.000110334,0.00005675255,0.00011709905,0.00056811026,0.0000867039,0.0029600344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968985,0.00032739723,0.00063000544,0.0005998941,0.0010819559,0.00046226347],"domain_scores_gemma":[0.9982796,0.0002085475,0.00020066948,0.0009137799,0.00020491552,0.00019251599],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00072725286,0.00030646755,0.0010421784,0.001218461,0.000062857376,0.000017660404,0.00023279044,0.00014629653,0.0028709387],"category_scores_gemma":[0.00005983869,0.0002199733,0.00026199102,0.0037817035,0.00008630033,0.00009902284,0.000037209596,0.00027431513,0.00002142855],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03143327,0.042663533,0.80884093,0.00012763549,0.012867652,0.0010136877,0.0027029107,0.000044375614,0.051558148,0.0000011289366,0.00009334838,0.048653375],"study_design_scores_gemma":[0.11275834,0.017687561,0.8533951,0.000043989985,0.002212219,0.0000024425824,0.00027231386,0.000059723025,0.012938575,0.0000045414927,0.00039000702,0.00023521051],"about_ca_topic_score_codex":0.00046613775,"about_ca_topic_score_gemma":0.0003885845,"teacher_disagreement_score":0.08132508,"about_ca_system_score_codex":0.000115479364,"about_ca_system_score_gemma":0.00028870383,"threshold_uncertainty_score":0.99804056},"labels":[],"label_agreement":null},{"id":"W4389231924","doi":"10.1182/blood-2023-181834","title":"Regional Genetic Heterogeneity Among Patients with Pyruvate Kinase Deficiency","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Pyruvate kinase deficiency; Medicine; Genotype; Cohort; Missense mutation; Pyruvate kinase; Internal medicine; Genetics; Biology; Mutation; Gene; Glycolysis","score_opus":0.018586008566875412,"score_gpt":0.23566234619299753,"score_spread":0.2170763376261221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389231924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988882,0.000053966207,0.00001988412,0.00007503852,0.000109377885,0.00019103009,0.0000071471068,0.00013997566,0.00051540695],"genre_scores_gemma":[0.998774,0.000030599625,0.00022870104,0.0004188275,0.000087950495,0.00002058542,0.00010364829,0.000017604423,0.00031809343],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99921,0.00002575643,0.00012281818,0.00023855187,0.0001864592,0.00021638496],"domain_scores_gemma":[0.99952424,0.000019972922,0.00004488039,0.00022564987,0.00007713341,0.000108140324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000037556674,0.00010299241,0.00014311087,0.000084192936,0.00007497137,0.000005096187,0.00004511582,0.00005903646,0.00006784396],"category_scores_gemma":[0.000020476353,0.000076908356,0.000050582592,0.00029097602,0.00008442548,0.000025464124,0.000026581494,0.0000895863,0.0002559479],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010666212,0.00048300886,0.99403894,0.000037583683,0.000032753887,0.00007794438,0.0000532248,0.000020766594,0.003848901,0.000015139369,0.0008207327,0.0004643191],"study_design_scores_gemma":[0.002953458,0.00064579595,0.9938681,0.000026500722,0.00008006014,0.000009935896,0.000015279456,0.000031786385,0.0015343182,0.000024160057,0.000717945,0.00009261934],"about_ca_topic_score_codex":0.000014615055,"about_ca_topic_score_gemma":0.000014245831,"teacher_disagreement_score":0.0028467958,"about_ca_system_score_codex":0.000008743782,"about_ca_system_score_gemma":0.000037663744,"threshold_uncertainty_score":0.3289778},"labels":[],"label_agreement":null},{"id":"W4389231950","doi":"10.1182/blood-2023-179153","title":"Impact of Age on Outcome in Newly Diagnosed Multiple Myeloma Patients Undergoing Upfront Autologous Hematopoietic Cell Transplantation from the Worldwide Network for Blood and Marrow Transplantation Global Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; McMaster University","funders":"","keywords":"Medicine; Transplantation; Multiple myeloma; Cumulative incidence; Internal medicine; Population; Oncology; Proportional hazards model","score_opus":0.02358846687678407,"score_gpt":0.3044549000679961,"score_spread":0.280866433191212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389231950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964177,0.00010825523,0.000057319474,0.00006721728,0.000060392642,0.0026015237,0.00058656174,0.000055477,0.000045547546],"genre_scores_gemma":[0.998199,0.00015018477,0.00043549502,0.000026617434,0.0000428239,0.00020052835,0.00090038223,0.000025143347,0.00001983278],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99828345,0.00015791679,0.0004373845,0.00035084123,0.00034895388,0.0004214865],"domain_scores_gemma":[0.9980346,0.0014502992,0.00011489295,0.00023123441,0.000042320404,0.00012665648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020576305,0.00022682661,0.00040546065,0.0000880801,0.00010529408,0.000024361794,0.00010022621,0.00007752542,0.000008111083],"category_scores_gemma":[0.00013501308,0.0001573701,0.00013492249,0.00034108586,0.000037325048,0.000058804944,0.000014357789,0.00012180932,0.0000065186823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002251626,0.0027976914,0.9900443,0.00020949105,0.00036678297,0.0007065118,0.0017735172,0.00036572624,0.00022454784,0.0000033904673,0.000034306555,0.0012221364],"study_design_scores_gemma":[0.046935406,0.0021675224,0.9489201,0.00019796424,0.0006502962,0.000008216907,0.00023560035,0.0002696398,0.0004027661,0.00009335791,5.732027e-7,0.00011860917],"about_ca_topic_score_codex":0.0013726329,"about_ca_topic_score_gemma":0.0065957922,"teacher_disagreement_score":0.044683777,"about_ca_system_score_codex":0.00006019554,"about_ca_system_score_gemma":0.000072069124,"threshold_uncertainty_score":0.6417367},"labels":[],"label_agreement":null},{"id":"W4389231975","doi":"10.1182/blood-2023-178868","title":"WU-NK-101 (W-NK), a Memory-like (ML) NK Cell, Naturally Overcomes Tumor Microenvironment (TME) Metabolic Challenges, Retaining Anti-Tumor Potency","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tumor microenvironment; Immune system; Biology; Cancer research; Cancer immunotherapy; Immunotherapy; Immunology; Cell biology","score_opus":0.025281636456025786,"score_gpt":0.26789262133763597,"score_spread":0.24261098488161018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389231975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9337072,0.05012411,0.0000025373445,0.0019646941,0.0004121777,0.0013097438,0.00004313447,0.00043367138,0.012002763],"genre_scores_gemma":[0.93543255,0.033751775,0.0006718825,0.0011755804,0.00087980443,0.00017700171,0.000121054036,0.00027003748,0.027520318],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9950466,0.0002606152,0.000690575,0.0011397853,0.0014202023,0.0014421843],"domain_scores_gemma":[0.9975252,0.00022849851,0.00021563175,0.0013993087,0.0001001819,0.0005311831],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0010861161,0.00060676946,0.00109609,0.0005544146,0.00025212643,0.000077466306,0.000582007,0.00019068371,0.0024031503],"category_scores_gemma":[0.00014567167,0.00054411695,0.0004670496,0.00073008967,0.00020803716,0.00017312815,0.00046534534,0.0010782386,0.0011060392],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003503551,0.0018031023,0.0035323105,0.0010741367,0.0009181828,0.005085667,0.0023482658,0.000018559318,0.9634387,0.00010891564,0.0027204338,0.018601386],"study_design_scores_gemma":[0.029905312,0.0022188274,0.12832198,0.0010283985,0.0018389407,0.0023172125,0.004598334,0.00041698283,0.537078,0.00032647612,0.28970417,0.0022453414],"about_ca_topic_score_codex":0.0001409928,"about_ca_topic_score_gemma":0.000027013013,"teacher_disagreement_score":0.42636067,"about_ca_system_score_codex":0.0001338573,"about_ca_system_score_gemma":0.00026684868,"threshold_uncertainty_score":0.999701},"labels":[],"label_agreement":null},{"id":"W4389232055","doi":"10.1182/blood-2023-178867","title":"Inflammatory Markers in Hemophagocytic Lymphohistiocytosis - a Single Centre Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Paul's Hospital; Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Hemophagocytic lymphohistiocytosis; Cytokine storm; Medicine; Ferritin; Macrophage activation syndrome; Immunology; Cytokine; Inflammation; Internal medicine; Pediatrics; Disease; Coronavirus disease 2019 (COVID-19)","score_opus":0.020407008433554533,"score_gpt":0.2721970658911759,"score_spread":0.2517900574576214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389232055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930987,0.00028933468,5.8379356e-7,0.00024010181,0.000059264083,0.00081229047,0.0000025610314,0.0002173773,0.005279829],"genre_scores_gemma":[0.9962494,0.00003651383,0.000018086354,0.000073452335,0.000043716922,0.000061042556,0.00001874475,0.00003811736,0.0034609535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982923,0.00009781001,0.0003941834,0.0003085548,0.00043694174,0.00047018475],"domain_scores_gemma":[0.99929416,0.00006812397,0.000052349522,0.00040974878,0.00005707533,0.0001185636],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044202252,0.00016012456,0.0003361413,0.00041090022,0.000075681615,0.000024100947,0.0001353056,0.00008383124,0.00030379565],"category_scores_gemma":[0.0002432308,0.0001545427,0.00008584607,0.0007783135,0.00006205412,0.00008979456,0.00011700522,0.00018465113,0.0009359656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029021074,0.003465198,0.9741502,0.00023850064,0.00020524688,0.002425866,0.0021473079,0.000016077276,0.009806961,0.000018750261,0.0021090272,0.0051266598],"study_design_scores_gemma":[0.0175377,0.0005689461,0.9654261,0.00017730506,0.00013298722,0.000031339616,0.008810729,0.00030950253,0.0033140013,0.000023269331,0.0033879934,0.0002801648],"about_ca_topic_score_codex":0.000053796477,"about_ca_topic_score_gemma":0.000045729455,"teacher_disagreement_score":0.017247489,"about_ca_system_score_codex":0.00012796081,"about_ca_system_score_gemma":0.0002694632,"threshold_uncertainty_score":0.9998419},"labels":[],"label_agreement":null},{"id":"W4389232057","doi":"10.1182/blood-2023-187648","title":"Predictors of Diagnostic Delays and Loss to Follow-up in Women with Von Willebrand Disease","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; University of Alberta","funders":"","keywords":"Medicine; Von Willebrand disease; Pediatrics; Retrospective cohort study; Emergency department; Disease; Obstetrics; Von Willebrand factor; Internal medicine","score_opus":0.006584235612034074,"score_gpt":0.22194461260470655,"score_spread":0.21536037699267246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389232057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980716,0.00020031213,0.0000059003623,0.00068721076,0.000071946204,0.0006553506,0.000020466723,0.000048559672,0.00023862813],"genre_scores_gemma":[0.9986987,0.0005298413,0.000028309054,0.0002978431,0.00005002795,0.0002157226,0.00001060729,0.0000216245,0.00014728488],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991172,0.000016734832,0.00016802474,0.00022311884,0.000208827,0.00026611038],"domain_scores_gemma":[0.9993224,0.0001385954,0.00003230773,0.00020572297,0.000025772262,0.0002752025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014326097,0.00011120257,0.00031867294,0.0001854969,0.000024797318,0.000008645101,0.000052593,0.000026441727,0.00002761536],"category_scores_gemma":[0.00025954802,0.00008786605,0.00002139452,0.00037976654,0.00004037743,0.000039061062,0.00007320235,0.00005015949,0.000014866795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035923842,0.0008731357,0.99226755,0.00036092504,0.0002212853,0.00044504192,0.0025454124,0.00005647079,0.00011376129,0.00010597921,0.0016901155,0.00096106174],"study_design_scores_gemma":[0.004867758,0.00078303233,0.9919849,0.00038921772,0.0002899993,0.0000029216949,0.0003509916,0.000009840723,0.0001740223,0.00006965217,0.0009773854,0.00010026995],"about_ca_topic_score_codex":0.000041853607,"about_ca_topic_score_gemma":0.00004634889,"teacher_disagreement_score":0.0045085195,"about_ca_system_score_codex":0.000019355244,"about_ca_system_score_gemma":0.000040368857,"threshold_uncertainty_score":0.35830736},"labels":[],"label_agreement":null},{"id":"W4389232062","doi":"10.1182/blood-2023-190642","title":"Predictors of Immune Thrombocytopenic Purpura in COVID-19 Positive Elderly Admitted in the Pre-Vaccination Era of the Pandemic; An Analysis Via the 2020 National Inpatient Sample","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brampton Civic Hospital","funders":"","keywords":"Medicine; Vaccination; Pandemic; Odds ratio; Logistic regression; Retrospective cohort study; Incidence (geometry); Thrombocytopenic purpura; Pediatrics; Internal medicine; Coronavirus disease 2019 (COVID-19); Immunology; Disease; Platelet; Infectious disease (medical specialty)","score_opus":0.01575444333180214,"score_gpt":0.2979627186747878,"score_spread":0.28220827534298565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389232062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99712926,0.00017521004,0.00003080092,0.0015383811,0.000027032575,0.0008880598,0.0001327462,0.000013139619,0.00006536033],"genre_scores_gemma":[0.99906504,0.00012316373,0.000015617597,0.00022525732,0.000012689311,0.00007840042,0.0004637729,0.0000073600304,0.000008676924],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985753,0.00023655043,0.00039791805,0.00017674438,0.00047209449,0.00014137666],"domain_scores_gemma":[0.998971,0.0004278461,0.00020006302,0.00027273028,0.00009525549,0.000033106742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052024843,0.00010747231,0.0002997874,0.00015433642,0.00006903465,0.000009474065,0.00021514078,0.00006514613,0.000046920497],"category_scores_gemma":[0.00039956832,0.00005552898,0.00012913512,0.001891741,0.000044805893,0.00008745567,0.000047364952,0.00018621789,0.0000011754632],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014349811,0.0012520448,0.98878026,0.000022432081,0.00075783144,0.000012648016,0.0065503353,0.00060043286,0.00084105885,0.00006490857,0.000027233018,0.0009472998],"study_design_scores_gemma":[0.0035114954,0.00037804033,0.9917693,0.000027649614,0.00057889055,0.0000092741275,0.0009013367,0.0013219805,0.000778412,0.0006646878,0.000009897811,0.000049030437],"about_ca_topic_score_codex":0.002199778,"about_ca_topic_score_gemma":0.0034019386,"teacher_disagreement_score":0.0056489985,"about_ca_system_score_codex":0.000078883204,"about_ca_system_score_gemma":0.00020945109,"threshold_uncertainty_score":0.3325421},"labels":[],"label_agreement":null},{"id":"W4389232085","doi":"10.1182/blood-2023-179141","title":"Pelabresib in Combination with Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve Patients with Myelofibrosis: Results of the MANIFEST-2 Randomized, Double-Blind, Phase 3 Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Clinical endpoint; Internal medicine; Phases of clinical research; Placebo; Polycythemia vera; Gastroenterology; Anemia; Essential thrombocythemia; Neutropenia; Janus kinase; Clinical trial; Oncology; Bone marrow; Chemotherapy; Pathology","score_opus":0.028040060228644307,"score_gpt":0.2989658824812911,"score_spread":0.2709258222526468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389232085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853006,0.000050971426,0.000002667294,0.00046865558,0.00007091901,0.013441094,0.00025513128,0.000049147628,0.00036079765],"genre_scores_gemma":[0.9946623,0.00002599219,0.00015897294,0.000030197865,0.00006027934,0.004212949,0.00043673354,0.00004302625,0.00036955616],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99791497,0.00017058446,0.0006104585,0.00047531587,0.0005039557,0.00032469563],"domain_scores_gemma":[0.9982953,0.00049434375,0.0003260643,0.00044685006,0.00033083005,0.00010661721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036189292,0.00033022478,0.00082028436,0.00023099725,0.00012607568,0.000028578239,0.00008814349,0.000073389005,0.0000068336885],"category_scores_gemma":[0.00012380375,0.00016775537,0.00014675138,0.00058240374,0.00010433806,0.00008991622,0.000033227305,0.00009224657,0.0000077555615],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.64941883,0.045365807,0.29947716,0.00010183668,0.0010138635,0.00008390059,0.0029152862,0.00001304033,0.00004629465,0.00020242322,0.00007624085,0.0012853344],"study_design_scores_gemma":[0.85739136,0.015228119,0.10800898,0.0004162326,0.0014894077,0.000005684633,0.00067313306,0.0000270752,0.016527977,0.000025111252,0.000048257683,0.00015868666],"about_ca_topic_score_codex":0.0002467466,"about_ca_topic_score_gemma":0.00040783786,"teacher_disagreement_score":0.20797253,"about_ca_system_score_codex":0.00009259255,"about_ca_system_score_gemma":0.0001587565,"threshold_uncertainty_score":0.6840865},"labels":[],"label_agreement":null},{"id":"W4389232111","doi":"10.1182/blood-2023-182906","title":"Evaluation of a Prognostic 23-Gene Expression Panel in a Set of 390 Multiethnic Hodgkin Lymphoma Patients","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC","funders":"","keywords":"Medicine; Oncology; Internal medicine; Lymphoma; Epidemiology; Diffuse large B-cell lymphoma; Nodular sclerosis; Pathology; Hodgkin lymphoma","score_opus":0.07360362703588208,"score_gpt":0.3180780086692459,"score_spread":0.24447438163336382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389232111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983514,0.00039324243,6.8642214e-7,0.000033987013,0.000057066478,0.0009776378,0.000044076543,0.000025506666,0.000116413394],"genre_scores_gemma":[0.99910355,0.000075020725,0.00022760945,0.000010944061,0.000021872564,0.00027327734,0.0002559253,0.000014515061,0.000017268614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842876,0.00012717507,0.00034546657,0.00020822296,0.000727327,0.00016302512],"domain_scores_gemma":[0.9991676,0.00012420453,0.00014713447,0.00024637041,0.00025981263,0.000054872864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048396143,0.00011105895,0.00027523155,0.00018077999,0.0000144339565,0.0000023459058,0.000050221344,0.00007410502,0.000018901237],"category_scores_gemma":[0.0005210322,0.000087356275,0.00007408127,0.0003789547,0.000024628198,0.000034141605,0.00004546999,0.000021847,0.000021768134],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000803059,0.0045396523,0.93999934,0.00012547054,0.00010454173,0.000020940306,0.0010137515,0.000029845882,0.018003844,0.0000016532744,0.0001029894,0.035977647],"study_design_scores_gemma":[0.019070392,0.00047944556,0.7941792,0.000424198,0.0005081768,0.0000029016628,0.00011485607,0.00045491324,0.18466383,0.000039503055,0.0000057873235,0.00005678525],"about_ca_topic_score_codex":0.00008805225,"about_ca_topic_score_gemma":0.00001898883,"teacher_disagreement_score":0.16665998,"about_ca_system_score_codex":0.00007862272,"about_ca_system_score_gemma":0.00017076444,"threshold_uncertainty_score":0.35622856},"labels":[],"label_agreement":null},{"id":"W4389232113","doi":"10.1182/blood-2023-178881","title":"Preclinical and Translational Biomarker Analyses to Inform Clinical Development of Mezigdomide (CC-92480) in Combination with Dexamethasone and Daratumumab in Multiple Myeloma","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Daratumumab; Medicine; Bone marrow; Multiple myeloma; Dexamethasone; Cereblon; Biomarker; Peripheral blood mononuclear cell; Antibody-dependent cell-mediated cytotoxicity; Oncology; Internal medicine; Immunology; Bortezomib; Antibody; Monoclonal antibody; Biology","score_opus":0.1846643830559381,"score_gpt":0.4401408400866205,"score_spread":0.25547645703068245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389232113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99850446,0.00013562218,0.000085403575,0.00038963632,0.00001297643,0.00068418507,0.000010878688,0.000019054916,0.00015779967],"genre_scores_gemma":[0.98397106,0.000056498084,0.0157337,0.000022706361,0.00000777814,0.00006713896,0.00009110685,0.000011374057,0.00003865718],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840873,0.00008451922,0.000627863,0.0002856928,0.00036369328,0.00022947631],"domain_scores_gemma":[0.9987319,0.00080011017,0.000065758206,0.00013053599,0.00007521288,0.00019645489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082968705,0.00012591714,0.00039444095,0.0004536177,0.000051242798,0.000011312461,0.000044647753,0.000095550735,0.000008192806],"category_scores_gemma":[0.000691053,0.00009606444,0.00003181734,0.0007129433,0.00011930934,0.000084245374,0.000049580405,0.00014576105,0.0000062963572],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017928411,0.0020649242,0.9187104,0.000073632946,0.00019206348,0.000068726884,0.00048196266,0.0000021426242,0.0006161682,0.000012234343,0.000005992069,0.07597892],"study_design_scores_gemma":[0.047318447,0.00047845012,0.9478981,0.0001816751,0.000048596907,0.000012207015,0.00011128825,0.0017091845,0.002060051,0.000028581588,0.000063417625,0.00009003386],"about_ca_topic_score_codex":0.00007252211,"about_ca_topic_score_gemma":0.0014951584,"teacher_disagreement_score":0.07588889,"about_ca_system_score_codex":0.000016647675,"about_ca_system_score_gemma":0.00017270017,"threshold_uncertainty_score":0.3917394},"labels":[],"label_agreement":null},{"id":"W4389232132","doi":"10.1182/blood-2023-173942","title":"Meter: A Multi-Country, Real-World Chart Review Study to Explore Treatment Patterns, Effectiveness and Healthcare Resource Utilization for Patients with Myelofibrosis","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Myelofibrosis; Ruxolitinib; Discontinuation; Extramedullary hematopoiesis; Constitutional symptoms; Internal medicine; Clinical trial; Oncology; Intensive care medicine; Bone marrow; Disease; Haematopoiesis","score_opus":0.08302500608640526,"score_gpt":0.3601961046844037,"score_spread":0.2771710985979985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389232132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878713,0.0009419028,0.00002447256,0.0006371622,0.000035716537,0.010165744,0.00021823672,0.00009065815,0.00001482126],"genre_scores_gemma":[0.98666185,0.0048991046,0.00028128046,0.00043451253,0.00005419833,0.006748261,0.000744535,0.000061068866,0.00011521729],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835026,0.0001717923,0.00028961807,0.0005923964,0.0002921571,0.0003037762],"domain_scores_gemma":[0.9989394,0.00020978255,0.000093410534,0.0003452968,0.0001836431,0.00022850113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020130462,0.0003081459,0.0006543397,0.00016604463,0.00016446145,0.00002484796,0.00004310319,0.000032734242,0.000010568813],"category_scores_gemma":[0.00005440363,0.00020541505,0.00006508932,0.0004556264,0.000013525499,0.000048142192,0.0000394471,0.00004469681,0.000015016911],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046501146,0.005205148,0.9773197,0.0023318527,0.00041119658,0.000023631572,0.0011614421,6.637757e-7,0.0000069805146,0.000005720494,0.00014469404,0.012923966],"study_design_scores_gemma":[0.014119107,0.011734803,0.96623313,0.003796242,0.0010233027,0.000002526532,0.00030183085,0.000008233706,0.0010514078,9.540067e-7,0.001542127,0.00018635708],"about_ca_topic_score_codex":0.0004228259,"about_ca_topic_score_gemma":0.0013503667,"teacher_disagreement_score":0.013654095,"about_ca_system_score_codex":0.0001260155,"about_ca_system_score_gemma":0.000043703472,"threshold_uncertainty_score":0.8376582},"labels":[],"label_agreement":null},{"id":"W4389232148","doi":"10.1182/blood-2023-183001","title":"Improved Survival of R/R Double Hit/Triple Hit Lymphoma in the Era of CD19 Chimeric Antigen T Cell (CART) Therapy","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of New Brunswick","funders":"","keywords":"Medicine; Internal medicine; Cart; Diffuse large B-cell lymphoma; Progression-free survival; Chemoimmunotherapy; BCL6; Oncology; Gastroenterology; Lymphoma; Rituximab; Immunology; Chemotherapy; B cell","score_opus":0.033491921752018955,"score_gpt":0.2998034567588199,"score_spread":0.26631153500680094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389232148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99104685,0.00081723306,0.0000022640943,0.00042802692,0.00013805475,0.00093503454,0.000017373386,0.00004491428,0.0065702605],"genre_scores_gemma":[0.99553853,0.0015735272,0.000054351593,0.000063885,0.0001358442,0.00004695852,0.00003872915,0.000044512548,0.0025036735],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99814814,0.0001474547,0.0004036343,0.000273762,0.0006050021,0.00042201873],"domain_scores_gemma":[0.99882406,0.00018415267,0.00012270843,0.00068651425,0.00011089005,0.000071691786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094370835,0.00016901163,0.00047509803,0.00020253003,0.000039688144,0.00001255691,0.000360571,0.000104628954,0.0005401863],"category_scores_gemma":[0.000029264815,0.00012004001,0.00018693185,0.0013402303,0.00011658866,0.000041390475,0.00007010984,0.00021472322,0.00003050142],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088211993,0.0015194668,0.05933367,0.000104659186,0.00015547863,0.00003990739,0.0018821524,0.0000023755915,0.92345756,0.000028629402,0.00029884282,0.01229513],"study_design_scores_gemma":[0.027694017,0.0011518614,0.22837484,0.000051746112,0.000052219762,0.000017199802,0.00092073344,0.00020840632,0.7382699,0.00006171725,0.0030365419,0.00016081962],"about_ca_topic_score_codex":0.0012701232,"about_ca_topic_score_gemma":0.00007663765,"teacher_disagreement_score":0.18518767,"about_ca_system_score_codex":0.000024495537,"about_ca_system_score_gemma":0.00025456143,"threshold_uncertainty_score":0.5914661},"labels":[],"label_agreement":null},{"id":"W4389232150","doi":"10.1182/blood-2023-181541","title":"Optimizing Immunoglobulin Replacement Therapy for Patients with B-Cell Malignancies and Hypogammaglobulinemia: The Investigator-Initiated, International, Randomized Phase II/III Rational Platform Trial, and the Rationalise (STOP IgRT) Domain","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"","keywords":"Image-guided radiation therapy; Medicine; Hypogammaglobulinemia; Randomized controlled trial; Internal medicine; Radiation therapy; Oncology; Immunology; Antibody","score_opus":0.02778403653257089,"score_gpt":0.2924207048232959,"score_spread":0.264636668290725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389232150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862561,0.0013200864,0.00018524977,0.0052768732,0.00014446847,0.0063224738,0.00007547781,0.00006269926,0.00035652836],"genre_scores_gemma":[0.9853473,0.0033326473,0.0033527864,0.0019936012,0.00046799355,0.0029864209,0.00092314207,0.00006103813,0.0015350952],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99776745,0.00016404536,0.00059045386,0.00038197526,0.00077895913,0.00031710693],"domain_scores_gemma":[0.99671525,0.0021827822,0.00025548265,0.0003508635,0.0003542394,0.0001413764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023683181,0.00025137165,0.00051392696,0.00011544998,0.00055071333,0.00014363971,0.00020096208,0.000094131676,0.00006873787],"category_scores_gemma":[0.0010722119,0.0001270463,0.00012670342,0.00024660726,0.00079380214,0.0001685419,0.00015763464,0.00018947343,0.0000040400823],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9822456,0.0015457317,0.000071176815,0.000065938446,0.0010904808,0.000021841683,0.0031677694,0.00005661691,0.0004717745,0.0028100202,0.008113758,0.00033926032],"study_design_scores_gemma":[0.9867353,0.0011406643,0.000019697969,0.000088445595,0.0002507779,0.00004669116,0.00051571097,0.00524013,0.0014287712,0.00064499053,0.0037316354,0.0001572021],"about_ca_topic_score_codex":0.00005176907,"about_ca_topic_score_gemma":0.000005077824,"teacher_disagreement_score":0.005183513,"about_ca_system_score_codex":0.00037906805,"about_ca_system_score_gemma":0.0020514093,"threshold_uncertainty_score":0.51807976},"labels":[],"label_agreement":null},{"id":"W4389232200","doi":"10.1182/blood-2023-190983","title":"Management and Outcomes for Primary Mediastinal B-Cell Lymphoma Patients with Partial Metabolic Response","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Single Center; Stage (stratigraphy); Refractory (planetary science); Lymphoma; Internal medicine; Retrospective cohort study; Chemotherapy; Medical record; Cancer; Population; Surgery; Gastroenterology","score_opus":0.009196977561909209,"score_gpt":0.23401155205805632,"score_spread":0.2248145744961471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389232200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99784803,0.0002575422,0.000006333091,0.0004269324,0.000065085944,0.00086592877,0.000046764235,0.00008316917,0.0004001857],"genre_scores_gemma":[0.9961173,0.00009605717,0.001828717,0.00032495605,0.0000441108,0.0004594391,0.00011336491,0.00002580777,0.0009902744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905026,0.000026998161,0.0001536585,0.0002594278,0.00025765382,0.00025201673],"domain_scores_gemma":[0.9994111,0.00017324842,0.000048563186,0.00019742835,0.000038608396,0.00013101677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013369613,0.00015207744,0.0002748676,0.000108664004,0.00007072734,0.000017042257,0.000039506962,0.00003282832,0.000007788855],"category_scores_gemma":[0.000027062351,0.000099855766,0.00006225311,0.00013736406,0.00003386211,0.000036823436,0.00005288313,0.000015055889,0.000031588203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019061138,0.0035161588,0.9775901,0.00011553959,0.0004563328,0.00021551189,0.000116648174,3.1533432e-7,0.000023586103,0.00008677627,0.00053110253,0.0154418135],"study_design_scores_gemma":[0.041967154,0.0007143644,0.9453333,0.000035634148,0.0010808904,0.000007272058,0.0000363047,0.0000040023783,0.0015957981,0.000012400182,0.009107,0.00010586588],"about_ca_topic_score_codex":0.0000055142664,"about_ca_topic_score_gemma":0.0000011482914,"teacher_disagreement_score":0.04006104,"about_ca_system_score_codex":0.000024639628,"about_ca_system_score_gemma":0.000044680222,"threshold_uncertainty_score":0.4072},"labels":[],"label_agreement":null},{"id":"W4389232244","doi":"10.1182/blood-2023-180518","title":"Distinct Minor Neoplastic Follicular T-Cell Subsets Dictate Lymphoma Fates through Functional Specialization","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Follicular lymphoma; Biology; Cytotoxic T cell; Follicular phase; Tumor microenvironment; CD8; Immunology; Mass cytometry; Cancer research; Lymphoma; Immune system; In vitro; Phenotype; Genetics; Gene","score_opus":0.020512897902196812,"score_gpt":0.23826838035942524,"score_spread":0.21775548245722842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389232244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99239296,0.0004813341,0.00011518873,0.0003150492,0.0003829154,0.00032724836,0.000045606448,0.000221093,0.005718633],"genre_scores_gemma":[0.99632305,0.00016681384,0.00015410954,0.00015942188,0.00045344746,0.00010394307,0.0008820551,0.000032553355,0.0017245836],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878067,0.00002548219,0.00023182732,0.0003268125,0.00034445064,0.00029076732],"domain_scores_gemma":[0.99940234,0.00012585962,0.00007128654,0.00022222991,0.00006625913,0.000112000154],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0000518103,0.00019495784,0.00024604262,0.00007678687,0.00013594085,0.00003535499,0.000048246864,0.000073439194,0.00030744856],"category_scores_gemma":[0.00006529258,0.00015601287,0.00014144927,0.00040138458,0.000040161092,0.00007484378,0.00003834387,0.00002637226,0.0012643464],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020242829,0.0058096326,0.9589903,0.00022001915,0.0006309547,0.0018573073,0.00052410905,0.000046995425,0.0030628128,0.0011822183,0.024109412,0.0033638394],"study_design_scores_gemma":[0.012009245,0.00027350785,0.95054215,0.000077820725,0.000831507,0.00011833038,0.00006589896,0.00017711287,0.022161698,0.00030574706,0.013237333,0.00019962016],"about_ca_topic_score_codex":0.000075706615,"about_ca_topic_score_gemma":0.000022387709,"teacher_disagreement_score":0.019098885,"about_ca_system_score_codex":0.00007281378,"about_ca_system_score_gemma":0.00009934125,"threshold_uncertainty_score":0.99951327},"labels":[],"label_agreement":null},{"id":"W4389232251","doi":"10.1182/blood-2023-174340","title":"All-Cause Mortality after Major Gastrointestinal Bleeding Among Patients Receiving Direct Oral Anticoagulants: A Systematic Review and Meta-Analysis","year":2023,"lang":"en","type":"review","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of British Columbia","funders":"","keywords":"Medicine; Meta-analysis; Internal medicine; Apixaban; Systematic review; MEDLINE; Study heterogeneity; Gastrointestinal bleeding; Cohort study; Randomized controlled trial; Rivaroxaban; Atrial fibrillation; Warfarin","score_opus":0.23505337138561197,"score_gpt":0.4053135180930529,"score_spread":0.1702601467074409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389232251","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024890638,0.9947726,0.000010150148,0.000052108164,0.000043368982,0.0044700177,0.00009584234,0.00016147111,0.00014550482],"genre_scores_gemma":[0.00033657675,0.99684894,0.00030801978,0.00010504323,0.00011179895,0.00020539174,0.00032099054,0.00008780853,0.0016754041],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99595666,0.0004880721,0.0018187404,0.0007073628,0.00063366746,0.00039549323],"domain_scores_gemma":[0.99738425,0.00040755418,0.0011346812,0.00072971534,0.00014173696,0.00020206584],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014383256,0.0006585818,0.011084158,0.0005322777,0.000066693705,0.000109890716,0.00016243044,0.000114717,0.0001857794],"category_scores_gemma":[0.0013209527,0.00042075998,0.0031804289,0.0012419131,0.000048638572,0.00013867978,0.00022723172,0.0002381941,0.00007761823],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000002040764,0.000023001747,0.03872869,0.62648773,0.33457845,0.000087679575,0.00000686199,5.677934e-8,8.721469e-9,0.0000017634635,0.000040677976,0.000043029624],"study_design_scores_gemma":[0.00032522794,0.000038093895,0.007187005,0.09098689,0.90061307,0.000023674755,0.0000048394622,0.0000032179667,3.212522e-8,0.0000012590161,0.0005115752,0.00030508317],"about_ca_topic_score_codex":0.000048181504,"about_ca_topic_score_gemma":0.00004277925,"teacher_disagreement_score":0.5660346,"about_ca_system_score_codex":0.00004457602,"about_ca_system_score_gemma":0.00003450792,"threshold_uncertainty_score":0.9998244},"labels":[],"label_agreement":null},{"id":"W4389232322","doi":"10.1182/blood-2023-188721","title":"Oligomannose-Type Glycans in the Antigen Binding Site Identify Origin and Prognosis of Diffuse Large B Cell Lymphoma","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Biology; Germinal center; IGHV@; Follicular lymphoma; Lymphoma; Cancer research; Immunology; Antibody; Molecular biology; B cell; Chronic lymphocytic leukemia","score_opus":0.01919402398091923,"score_gpt":0.29713552801721554,"score_spread":0.2779415040362963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389232322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998751,0.00038737373,0.0000050784756,0.00008381695,0.000031170308,0.00026597825,0.00004230366,0.000010889363,0.00042237976],"genre_scores_gemma":[0.9985635,0.00073341734,0.000048511534,0.000036434343,0.000042378164,0.000023107108,0.00013414564,0.000012726476,0.000405768],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99913484,0.00007600849,0.00015924717,0.00020910162,0.00017503324,0.00024576028],"domain_scores_gemma":[0.9996392,0.00001700764,0.000045426594,0.00021317377,0.000046267964,0.00003893111],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035040246,0.00008676433,0.00009424057,0.00011286181,0.00006558317,0.000031954554,0.00016454785,0.0000859733,0.000008365136],"category_scores_gemma":[0.00006072477,0.00006818587,0.00003658177,0.00045323576,0.000040851195,0.0000042002807,0.000115539726,0.000049730912,0.000039840877],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033793676,0.0008038867,0.25324926,0.00005770584,0.000023233868,0.000028377746,0.000322548,0.0000010019588,0.7444899,0.00003724912,0.0005988937,0.00035413666],"study_design_scores_gemma":[0.006080766,0.00027223444,0.3044503,0.000027342072,0.00001989279,0.000013487475,0.0003370658,0.00009560824,0.6569185,0.000021922244,0.03158649,0.00017638053],"about_ca_topic_score_codex":0.000056032502,"about_ca_topic_score_gemma":0.00011378402,"teacher_disagreement_score":0.08757141,"about_ca_system_score_codex":0.0000030622834,"about_ca_system_score_gemma":0.000041123752,"threshold_uncertainty_score":0.2780539},"labels":[],"label_agreement":null},{"id":"W4389232337","doi":"10.1182/blood-2023-187433","title":"131I-Apamistamab Effectively Achieved Durable Responses in Patients with R/R AML Irrespective of the Presence of Multiple High-Risk Factors","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Ottawa Hospital","funders":"","keywords":"Medicine; Fludarabine; Internal medicine; Gastroenterology; Transplantation; Total body irradiation; Hematopoietic stem cell transplantation; Randomization; Surgery; Randomized controlled trial; Oncology; Chemotherapy; Cyclophosphamide","score_opus":0.013784661947980921,"score_gpt":0.26362406264146937,"score_spread":0.24983940069348845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389232337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998929,0.000014183472,0.000007543331,0.00008047005,0.000015410898,0.0006088472,0.00016242971,0.00002920842,0.00015287437],"genre_scores_gemma":[0.99966025,0.000007827528,0.00006151048,0.000004941668,0.000011195776,0.000046440175,0.000013419882,0.00001206268,0.00018234296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991158,0.00009241019,0.00019207688,0.00019749854,0.00024534416,0.00015681791],"domain_scores_gemma":[0.9986603,0.0007574758,0.00012723648,0.00030560486,0.00009240416,0.00005693351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012677573,0.00010455068,0.00022082412,0.000045115812,0.000058571444,0.0000029262544,0.00012831017,0.00005220412,0.000010452743],"category_scores_gemma":[0.0008849973,0.00006509929,0.000051392173,0.0006303628,0.00016605858,0.000033261542,0.00004239679,0.00020166063,0.0000025210863],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009786363,0.0008995017,0.9142836,0.000086451524,0.000079723955,0.0000018738209,0.00028250893,0.000051791107,0.0832407,0.000019612242,0.000018633187,0.000056995643],"study_design_scores_gemma":[0.003332357,0.00012685965,0.59603333,0.00006400508,0.000076506425,3.9047754e-7,0.000076411496,0.00003729499,0.40016955,0.000031443433,0.000012173003,0.000039650164],"about_ca_topic_score_codex":0.00017001017,"about_ca_topic_score_gemma":0.0000096395925,"teacher_disagreement_score":0.31825024,"about_ca_system_score_codex":0.00002273317,"about_ca_system_score_gemma":0.00005708288,"threshold_uncertainty_score":0.2654672},"labels":[],"label_agreement":null},{"id":"W4389232407","doi":"10.1182/blood-2023-188363","title":"Preclinical <i>In Vivo</i> Imaging of Multiple Myeloma with [ 18f]Fluorohomoleucine (FHL) PET/CT","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; Simon Fraser University; Spinal Cord Injury BC; Terry Fox Research Institute; TRIUMF","funders":"","keywords":"In vivo; Multiple myeloma; Medicine; Positron emission tomography; Bone marrow; Flow cytometry; Preclinical imaging; Ex vivo; Cancer; Cancer research; Imaging agent; Pathology; Nuclear medicine; Internal medicine; Immunology; Biology","score_opus":0.012813523833134647,"score_gpt":0.25741024898028636,"score_spread":0.24459672514715172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389232407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951905,0.0002678688,0.000055206387,0.0005021301,0.00010359012,0.00033845808,0.000022045228,0.00015495172,0.0033652473],"genre_scores_gemma":[0.9959843,0.00008737531,0.0019165984,0.000113788425,0.000079035024,0.000026350577,0.000030183764,0.00004114451,0.0017212112],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986062,0.00002161225,0.00039591928,0.00032114048,0.0003230677,0.0003320527],"domain_scores_gemma":[0.9993004,0.00009717973,0.000082497965,0.0003458922,0.00005695056,0.000117059615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029676143,0.00016169474,0.00042300762,0.00015052155,0.000031863554,0.000005355736,0.00010599339,0.000011475422,0.00008865581],"category_scores_gemma":[0.000047780122,0.00012118212,0.00010539597,0.000457163,0.00008547335,0.000048894468,0.000021603482,0.00018437536,0.000027434606],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064378965,0.001332778,0.8931074,0.00049006625,0.00013502278,0.013735877,0.00019024135,0.000022015893,0.08878573,0.00016003537,0.00038831594,0.0010087034],"study_design_scores_gemma":[0.027709404,0.0006827033,0.43478295,0.0017766142,0.00065567874,0.0014612759,0.00079165347,0.0007635893,0.5269042,0.00018597658,0.003781124,0.0005048279],"about_ca_topic_score_codex":0.000046828824,"about_ca_topic_score_gemma":0.00020046535,"teacher_disagreement_score":0.45832446,"about_ca_system_score_codex":0.0000105443105,"about_ca_system_score_gemma":0.00009380139,"threshold_uncertainty_score":0.49416637},"labels":[],"label_agreement":null},{"id":"W4389232433","doi":"10.1182/blood-2023-188285","title":"Targeting Mitochondrial Calcium Uptake to Eradicate Venetoclax-Resistant Acute Myeloid Leukemia Stem Cells","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Ven; Stem cell; Biology; Cancer research; Calcium; Myeloid leukemia; Leukemia; Pharmacology; Cell biology; Immunology; Medicine; Internal medicine","score_opus":0.027062683300059873,"score_gpt":0.2896289170301697,"score_spread":0.2625662337301098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389232433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992585,0.00024037935,0.00029130754,0.0016949952,0.00087422354,0.001696871,0.00015372779,0.0006958316,0.0017676606],"genre_scores_gemma":[0.91544324,0.0005228055,0.013342307,0.002594853,0.0067523196,0.0008128456,0.00048240178,0.00059148244,0.05945777],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958719,0.00012113465,0.00068914046,0.00089400844,0.0010637548,0.0013600512],"domain_scores_gemma":[0.99773073,0.00018145604,0.00012381803,0.0008867931,0.00020185739,0.0008753469],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00054734026,0.0004117407,0.00067506934,0.0004971917,0.00026143447,0.00009306339,0.0005383517,0.00028552653,0.00017356683],"category_scores_gemma":[0.00013163617,0.00037645793,0.00023869681,0.0015181158,0.00010119979,0.00009864658,0.00040416938,0.00075703976,0.004001201],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006774147,0.00008051355,0.00020344203,0.000120340446,0.0004587559,0.001835116,0.00053209893,0.00021178761,0.9135105,0.000045725443,0.08120619,0.0011181041],"study_design_scores_gemma":[0.012847832,0.0012557417,0.003952802,0.00029123574,0.0009061095,0.00015498868,0.0005683124,0.002418406,0.74959743,0.00003672203,0.22710082,0.0008695822],"about_ca_topic_score_codex":0.00013270772,"about_ca_topic_score_gemma":0.000008787047,"teacher_disagreement_score":0.16391306,"about_ca_system_score_codex":0.0011806405,"about_ca_system_score_gemma":0.0017656464,"threshold_uncertainty_score":0.99986875},"labels":[],"label_agreement":null},{"id":"W4389232454","doi":"10.1182/blood-2023-188990","title":"Updated Protocol for the Phase 3, Randomized, Double-Blinded Lex-210 Study of Four-Factor Prothrombin Complex Concentrate in Patients with Acute Major Bleeding on Factor Xa Inhibitor Therapy","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Medicine; Prothrombin complex concentrate; Informed consent; Randomized controlled trial; Recombinant factor VIIa; Adverse effect; Internal medicine; Surgery; Warfarin; Atrial fibrillation","score_opus":0.17072775807477067,"score_gpt":0.4024969005734092,"score_spread":0.23176914249863853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389232454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.71485186,9.540653e-7,0.000016589267,0.00033392882,0.00006288467,0.28458267,0.000033743214,0.000078759,0.00003863523],"genre_scores_gemma":[0.9571239,0.0000017340553,0.00006906025,0.00005811013,0.000186251,0.042201873,0.00008087781,0.000045719684,0.00023248821],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99806184,0.00011176499,0.0006456883,0.00032716914,0.0005344076,0.00031912382],"domain_scores_gemma":[0.998768,0.00031101322,0.00037742316,0.00029463117,0.00018077553,0.00006815899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035434478,0.0002721631,0.00080515904,0.00021554455,0.00011784921,0.00004745661,0.00013971134,0.00006723443,0.0001408484],"category_scores_gemma":[0.000048906735,0.00014804082,0.0001531652,0.0005618699,0.00007270499,0.00011544677,0.00004122577,0.00012985672,0.000008392374],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.76266664,0.0025043879,0.22636499,0.00012966288,0.0027328199,0.000014131588,0.001522338,0.00002391326,0.0026380986,0.00011269044,0.0003262701,0.0009640486],"study_design_scores_gemma":[0.90913194,0.004168695,0.07859696,0.00008872208,0.0003635036,3.0285415e-7,0.0002483794,0.0002449489,0.006426844,0.000014409668,0.00053741346,0.00017790298],"about_ca_topic_score_codex":0.000027278427,"about_ca_topic_score_gemma":0.000011572866,"teacher_disagreement_score":0.2423808,"about_ca_system_score_codex":0.000029160665,"about_ca_system_score_gemma":0.000060868584,"threshold_uncertainty_score":0.60369295},"labels":[],"label_agreement":null},{"id":"W4389232596","doi":"10.1182/blood-2023-181094","title":"Impaired Cognitive Function in Immune-TTP Is Better Predicted By Serum Thrombomodulin Than ADAMTS13 Activity: Results of a Longitudinal Multicenter Pilot Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Montreal Cognitive Assessment; ADAMTS13; Internal medicine; Quality of life (healthcare); Hospital Anxiety and Depression Scale; Mood; Anxiety; Neuropsychology; Prospective cohort study; Physical therapy; Cognition; Psychiatry; Thrombotic thrombocytopenic purpura; Disease; Dementia","score_opus":0.03170516252429503,"score_gpt":0.273671732115693,"score_spread":0.24196656959139798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389232596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943569,0.0002667106,0.000008287154,0.00016208517,0.00037834237,0.0014462704,0.0031463082,0.00016484334,0.00007027422],"genre_scores_gemma":[0.9987181,0.000009081398,0.0000019292709,0.000033552853,0.00003067629,0.00017233177,0.00068730116,0.000028008162,0.0003190659],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977659,0.0005377046,0.00059726735,0.00054324855,0.000111680005,0.00044421921],"domain_scores_gemma":[0.99890137,0.00029543496,0.0002767541,0.00038766363,0.00011154721,0.000027206594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038033645,0.0002572691,0.00047344223,0.00024273926,0.000105602325,0.000014115565,0.0001986448,0.00009494802,0.00030163236],"category_scores_gemma":[0.0001378723,0.00024498615,0.000095041185,0.00042755832,0.000102949074,0.00014020513,0.00023146474,0.00022067512,0.00018508974],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046011545,0.009160509,0.78248554,0.00006529291,0.0015589987,0.000022458902,0.0014921712,8.8644464e-7,0.1961927,5.13213e-7,0.0040220567,0.00039773688],"study_design_scores_gemma":[0.022083744,0.003741347,0.91778314,0.0001904008,0.0004441541,0.0000044382905,0.0015730335,0.000013321027,0.053905547,0.0000068606246,0.00005614731,0.00019787683],"about_ca_topic_score_codex":0.00084836205,"about_ca_topic_score_gemma":0.00051494734,"teacher_disagreement_score":0.14228715,"about_ca_system_score_codex":0.000026206342,"about_ca_system_score_gemma":0.00004154068,"threshold_uncertainty_score":0.99902457},"labels":[],"label_agreement":null},{"id":"W4389232602","doi":"10.1182/blood-2023-174913","title":"Analysis of Ventricular Arrhythmias and Sudden Death with Acalabrutinib from 5 Prospective Clinical Trials","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Obinutuzumab; Ibrutinib; Medicine; Internal medicine; Mantle cell lymphoma; Ofatumumab; Chronic lymphocytic leukemia; Oncology; Chlorambucil; Leukemia; Lymphoma; Chemotherapy; Cyclophosphamide","score_opus":0.0960004294500061,"score_gpt":0.4168035876570206,"score_spread":0.3208031582070145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389232602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980755,0.00057504827,0.00004026815,0.00013508907,0.0000296271,0.00063845364,0.000069099355,0.000063132684,0.00037380532],"genre_scores_gemma":[0.99870616,0.00022036686,0.00036057507,0.000031380245,0.0002631476,0.00003608372,0.0000921836,0.000020487701,0.00026960415],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976694,0.00032431888,0.0006915794,0.00044997386,0.0005821693,0.00028255052],"domain_scores_gemma":[0.9968664,0.0020944793,0.00019800772,0.00046356308,0.0001611409,0.0002163808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025994703,0.0001368665,0.0012169759,0.00032962646,0.000035135952,0.000016456714,0.00008517389,0.00012557156,0.00012851409],"category_scores_gemma":[0.0031199118,0.000091507354,0.00027670214,0.0016256416,0.00014557518,0.000033421413,0.0001008381,0.00020812376,0.000031877073],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013347842,0.0007302844,0.97444415,0.00007846607,0.016022246,0.004084318,0.0003408034,0.000023139655,0.00026644635,0.00011799804,0.00023853709,0.002318826],"study_design_scores_gemma":[0.0669466,0.0007578865,0.9023741,0.00015169692,0.01669404,0.00013997125,0.0002659381,0.0053705997,0.006722977,0.00016412542,0.00023051456,0.00018158426],"about_ca_topic_score_codex":0.0004968573,"about_ca_topic_score_gemma":0.000037565133,"teacher_disagreement_score":0.072070085,"about_ca_system_score_codex":0.0003331625,"about_ca_system_score_gemma":0.0016602181,"threshold_uncertainty_score":0.37350512},"labels":[],"label_agreement":null},{"id":"W4389232625","doi":"10.1182/blood-2023-181765","title":"Efficacy and Safety of Daratumumab (DARA) Monotherapy in Patients with Intermediate-Risk or High-Risk Smoldering Multiple Myeloma (SMM): Final Analysis of the Phase 2 Centaurus Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Internal medicine; Tolerability; Daratumumab; Gastroenterology; Multiple myeloma; Oncology; Lenalidomide; Adverse effect","score_opus":0.01957714151402078,"score_gpt":0.2954745439370473,"score_spread":0.2758974024230265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389232625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99792075,0.00005356704,0.000009249774,0.000014062745,0.000029919624,0.0015884445,0.00035029763,0.000025251726,0.000008432694],"genre_scores_gemma":[0.99950695,0.00014840673,0.00011613365,0.0000054096245,0.000013440405,0.00004830999,0.00010553932,0.000025010257,0.000030828225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99815,0.00019716738,0.00044978206,0.00035274224,0.00053816667,0.00031214982],"domain_scores_gemma":[0.99871397,0.00029972562,0.00025669765,0.0005169776,0.00009096632,0.00012163586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002362536,0.0002041075,0.0006195716,0.0004835316,0.00009972572,0.000010861687,0.00015173291,0.00005129147,0.000035383644],"category_scores_gemma":[0.0002743747,0.00011582407,0.000100294295,0.0016060511,0.00012238884,0.000054373537,0.000109914414,0.0002180662,0.0000019093557],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015581756,0.007963132,0.94629574,0.000036482666,0.0037723028,0.00007274457,0.0013697947,0.000093679526,0.00013265779,3.594491e-7,0.0000040043556,0.02467732],"study_design_scores_gemma":[0.11215796,0.003832716,0.8792159,0.00009152539,0.001666245,7.84597e-7,0.00035454132,0.0009230576,0.0016596596,0.0000010298749,0.0000046115606,0.00009198213],"about_ca_topic_score_codex":0.0012306,"about_ca_topic_score_gemma":0.0016729777,"teacher_disagreement_score":0.096576214,"about_ca_system_score_codex":0.000037985363,"about_ca_system_score_gemma":0.00007269518,"threshold_uncertainty_score":0.47231683},"labels":[],"label_agreement":null},{"id":"W4389232661","doi":"10.1182/blood-2023-174956","title":"Fixed Duration Mosunetuzumab Plus Polatuzumab Vedotin Has Promising Efficacy and a Manageable Safety Profile in Patients with BTKi Relapsed/Refractory Mantle Cell Lymphoma: Initial Results from a Phase Ib/II Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); McGill University; Jewish General Hospital","funders":"","keywords":"Mantle cell lymphoma; Medicine; Internal medicine; Neutropenia; Ibrutinib; Gastroenterology; Population; Adverse effect; Febrile neutropenia; Oncology; Pharmacology; Lymphoma; Chemotherapy; Leukemia; Chronic lymphocytic leukemia","score_opus":0.025440544477267114,"score_gpt":0.2851808303898294,"score_spread":0.25974028591256226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389232661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935476,0.00010388291,0.000006585225,0.00013137405,0.000091049544,0.0039893575,0.00021319489,0.00018032014,0.0017366338],"genre_scores_gemma":[0.99534386,0.000022947243,0.0002573112,0.000025595926,0.00014600657,0.00010983445,0.001313976,0.0000924504,0.0026880323],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99685836,0.00023465717,0.00069469184,0.0008239372,0.00081778463,0.0005705881],"domain_scores_gemma":[0.9985117,0.00027874616,0.00021031631,0.000656816,0.00013419052,0.00020825113],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00050304877,0.000328768,0.0005461342,0.00041866818,0.00032799304,0.00010374578,0.00015925274,0.00016309271,0.00019008835],"category_scores_gemma":[0.0002479544,0.00029001018,0.000051216277,0.00086850935,0.000107976564,0.00023027521,0.00021118221,0.0003775313,0.000054821245],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42519066,0.1580209,0.089308366,0.0010875679,0.0024873244,0.00738483,0.0954884,0.00021952594,0.12384457,0.00001211958,0.004099519,0.09285622],"study_design_scores_gemma":[0.5959631,0.016333142,0.36676842,0.00053400855,0.00045989675,0.00001475309,0.0019875928,0.0025796674,0.013053736,0.000022046432,0.0016254295,0.00065820187],"about_ca_topic_score_codex":0.0009850436,"about_ca_topic_score_gemma":0.00023804985,"teacher_disagreement_score":0.27746007,"about_ca_system_score_codex":0.000340127,"about_ca_system_score_gemma":0.00049165846,"threshold_uncertainty_score":0.9999552},"labels":[],"label_agreement":null},{"id":"W4389232674","doi":"10.1182/blood-2023-181263","title":"Efficacy and Safety of the Anti-Tissue Factor Pathway Inhibitor Marstacimab in Participants with Severe Hemophilia without Inhibitors: Results from the Phase 3 Basis Trial","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Medicine; Factor IX; Clinical endpoint; Adverse effect; Internal medicine; Incidence (geometry); Quality of life (healthcare); Hemostasis; Observational study; Clinical trial; Phases of clinical research; Surgery","score_opus":0.04607185591760321,"score_gpt":0.3201263108774575,"score_spread":0.2740544549598543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389232674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933601,0.00015343603,2.6581984e-7,0.0033290584,0.00013684948,0.0021691849,0.0006254669,0.000050086684,0.00017556762],"genre_scores_gemma":[0.9987339,0.000111617344,0.000036932805,0.000039034814,0.0004083388,0.000048408067,0.0000814342,0.00003288047,0.00050745625],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99771005,0.00023027767,0.0005269486,0.0004331558,0.00063128734,0.00046828963],"domain_scores_gemma":[0.9983627,0.0006540884,0.00013270481,0.0006216112,0.00006878836,0.00016009466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004839644,0.00023478281,0.00049342774,0.000091695845,0.00014463138,0.00002962744,0.0001642516,0.00013561976,0.000032698183],"category_scores_gemma":[0.0006960645,0.00010952826,0.00007590332,0.0007201807,0.00024393025,0.00007332391,0.0001473849,0.00032748297,0.000019116265],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28526992,0.014047987,0.49298546,0.00032261777,0.0016263863,0.0011903056,0.017074618,0.000015622503,0.14440775,0.000024186867,0.0018723763,0.041162793],"study_design_scores_gemma":[0.46836358,0.0026238891,0.2676201,0.001074495,0.00032363558,0.00002499819,0.00067408214,0.000050116636,0.25715676,0.000027199818,0.0017913707,0.00026979749],"about_ca_topic_score_codex":0.00019449135,"about_ca_topic_score_gemma":0.000118633834,"teacher_disagreement_score":0.22536536,"about_ca_system_score_codex":0.000032791333,"about_ca_system_score_gemma":0.00028084283,"threshold_uncertainty_score":0.44664326},"labels":[],"label_agreement":null},{"id":"W4389232778","doi":"10.1182/blood-2023-190310","title":"Selected Frailty Testing Can Predict for Risk of Febrile Neutropenia in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplant","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cégep de Lévis; University Health Network; Windsor Regional Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Multiple myeloma; Internal medicine; Population; Neutropenia; Transplantation; Febrile neutropenia; Surgery; Oncology; Toxicity","score_opus":0.02667805074943483,"score_gpt":0.2413777836218315,"score_spread":0.21469973287239666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389232778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99780357,0.000035344892,0.00004537233,0.000031883417,0.0001349411,0.00094764447,0.00037256698,0.00019583032,0.00043284104],"genre_scores_gemma":[0.9990896,0.00003272986,0.00033137656,0.000022318078,0.000060196144,0.00014910156,0.00012100476,0.000038060523,0.00015562348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987954,0.00005831073,0.00035832525,0.00028108413,0.00015937402,0.00034749662],"domain_scores_gemma":[0.9989487,0.0004698909,0.00014472009,0.00019013371,0.000154299,0.000092233444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011247776,0.00014820842,0.00032818047,0.00016752182,0.000119391516,0.000009034029,0.00008187848,0.00008632498,0.000008316907],"category_scores_gemma":[0.00010997388,0.0001377844,0.000073919335,0.0008207159,0.00002957846,0.00004127632,0.000021913282,0.00018824964,0.000006864769],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014193455,0.0004505731,0.97564805,0.0003001121,0.00007517203,0.000020623911,0.00052821636,0.00027098315,0.020630712,0.000002643553,0.00016749866,0.0017635042],"study_design_scores_gemma":[0.01044883,0.0011041716,0.9357003,0.00022711094,0.00036511713,0.0000148270665,0.00010320728,0.000995356,0.0507965,0.000010934345,0.000098407836,0.00013526074],"about_ca_topic_score_codex":0.00055392727,"about_ca_topic_score_gemma":0.0019044931,"teacher_disagreement_score":0.03994775,"about_ca_system_score_codex":0.000048408783,"about_ca_system_score_gemma":0.0002576617,"threshold_uncertainty_score":0.5618685},"labels":[],"label_agreement":null},{"id":"W4389232890","doi":"10.1182/blood-2023-187443","title":"Enhanced Ferroptosis Induction Susceptibility in Diffuse Large B-Cell Lymphoma through Rocaglate-Mediated Translation Inhibition","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bioinformatics Solutions (Canada)","funders":"","keywords":"Cancer research; Diffuse large B-cell lymphoma; Biology; GPX4; Programmed cell death; Lymphoma; Immunology; Oxidative stress; Apoptosis; Genetics","score_opus":0.027276647806760042,"score_gpt":0.27138071539453584,"score_spread":0.2441040675877758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389232890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964191,0.00019307151,0.00018677229,0.00074796466,0.00017076587,0.0006745674,0.00003491329,0.00033871847,0.001234138],"genre_scores_gemma":[0.99807036,0.000569618,0.00016437542,0.00020946946,0.00014689175,0.00018236408,0.0005155129,0.00004170537,0.00009972221],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99814373,0.000092679016,0.00045805026,0.0005062498,0.00036014852,0.00043913754],"domain_scores_gemma":[0.9993571,0.000052565618,0.00010173499,0.00030590632,0.00008707754,0.00009563178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031057704,0.00021670725,0.0003456317,0.00020894062,0.00009257852,0.000022948097,0.000053973643,0.00025117752,0.00010312854],"category_scores_gemma":[0.00005952575,0.00020824593,0.00013481418,0.0013111925,0.00004133859,0.00027711262,0.000026646547,0.00017785793,0.00017916757],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006623448,0.027745161,0.05744502,0.0006182294,0.00011130409,0.000050804152,0.006609455,0.000013076545,0.89426917,0.000056620607,0.00054666324,0.011872154],"study_design_scores_gemma":[0.051812746,0.00058754405,0.20633689,0.0002485394,0.00023952154,0.000008166289,0.0011849096,0.00049677386,0.7378469,0.00017358718,0.0006834415,0.00038098113],"about_ca_topic_score_codex":0.00015727224,"about_ca_topic_score_gemma":0.0002827635,"teacher_disagreement_score":0.15642227,"about_ca_system_score_codex":0.00011901185,"about_ca_system_score_gemma":0.00008502612,"threshold_uncertainty_score":0.8492022},"labels":[],"label_agreement":null},{"id":"W4389233142","doi":"10.1182/blood-2023-187408","title":"A Longitudinal Single-Cell Atlas of Treatment Response in Pediatric AML","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; BC Children's Hospital; Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Biology; Epigenetics; Oncology; Internal medicine; Cancer research; Genetics; Bioinformatics; Medicine; Gene","score_opus":0.041873040313112286,"score_gpt":0.3019821434894276,"score_spread":0.2601091031763153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389233142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970156,0.00026107047,0.0000018727006,0.0004947405,0.00002855855,0.0003426007,0.000010878675,0.0000631852,0.0017814904],"genre_scores_gemma":[0.9951372,0.00028011895,0.00024015814,0.000012606012,0.00013868138,0.000036803634,0.000017698603,0.000025089079,0.0041116485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988077,0.0001038751,0.0002436867,0.0002453992,0.0002589382,0.00034040218],"domain_scores_gemma":[0.9990993,0.00035958094,0.000048785812,0.00031988323,0.000055041528,0.000117375086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003849498,0.00011937677,0.0002730972,0.00054862833,0.000020773414,0.000005949014,0.000087480534,0.000082057864,0.000059495233],"category_scores_gemma":[0.00026444026,0.00009834551,0.000084906096,0.0011266123,0.00004008287,0.000027990423,0.000064048625,0.00013818502,0.00032941072],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049130307,0.0037624664,0.8393949,0.0002824125,0.00009415651,0.0032355995,0.0011107294,0.000025416037,0.14408064,0.000011721807,0.002265472,0.0008234292],"study_design_scores_gemma":[0.021724064,0.00803041,0.8555276,0.00005944475,0.0003663009,0.00013053212,0.0002559201,0.00018302843,0.11206961,0.000025144835,0.0014352378,0.00019271312],"about_ca_topic_score_codex":0.00011690545,"about_ca_topic_score_gemma":0.000022395532,"teacher_disagreement_score":0.032011036,"about_ca_system_score_codex":0.00029765494,"about_ca_system_score_gemma":0.0005189935,"threshold_uncertainty_score":0.4234018},"labels":[],"label_agreement":null},{"id":"W4389233152","doi":"10.1182/blood-2023-177798","title":"Outcome of Infants Treated on Total Therapy for Infants with Acute Lymphoblastic Leukemia I: Results from a Non-Randomized Multi-Center Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stollery Children's Hospital; McMaster University; Centre Hospitalier Universitaire Sainte-Justine; Centre hospitalier de l'Université Laval; University of Calgary; Montreal Children's Hospital; BC Children's Hospital","funders":"","keywords":"Medicine; Vorinostat; Internal medicine; Tolerability; Adverse effect; Clinical endpoint; Leukopenia; Oncology; Pediatrics; Chemotherapy; Clinical trial; Histone deacetylase","score_opus":0.03527057051335463,"score_gpt":0.32801837939513867,"score_spread":0.29274780888178403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389233152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99392116,0.000026747904,0.00006568434,0.00021277397,0.00019234484,0.004160008,0.0011096259,0.00019589289,0.000115762356],"genre_scores_gemma":[0.99763656,0.00004028825,0.00063528377,0.00036579443,0.00017117771,0.0003226661,0.00035952742,0.00008043277,0.00038829455],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9970572,0.00018759313,0.0010820145,0.0006316004,0.0006370311,0.0004045327],"domain_scores_gemma":[0.9970803,0.0014301025,0.0003919559,0.00075536093,0.00016383719,0.000178414],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00077702245,0.00038616938,0.0015507104,0.00025042176,0.000070104776,0.000020627433,0.00017980713,0.0001256043,0.000014222443],"category_scores_gemma":[0.00068980403,0.00026691638,0.00028708423,0.00042315933,0.00012678215,0.00007074498,0.000056129324,0.00016434074,0.00003644019],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6630329,0.011770365,0.29020005,0.000103219856,0.009012385,0.00029211826,0.022474648,0.00006548987,0.0019197355,0.000002198646,0.00042292857,0.0007039848],"study_design_scores_gemma":[0.6995742,0.0029597278,0.29124492,0.00037412168,0.00085938215,0.000012058403,0.00058907573,0.0006840771,0.0034347645,0.0000051284123,0.0000135247265,0.00024901066],"about_ca_topic_score_codex":0.002376361,"about_ca_topic_score_gemma":0.00040652946,"teacher_disagreement_score":0.036541313,"about_ca_system_score_codex":0.00007358143,"about_ca_system_score_gemma":0.00021578543,"threshold_uncertainty_score":0.9999783},"labels":[],"label_agreement":null},{"id":"W4389233179","doi":"10.1182/blood-2023-174718","title":"Traverse: A Phase 2, Open-Label, Randomized Study of Acalabrutinib in Combination with Venetoclax and Rituximab in Patients with Treatment-Naive Mantle Cell Lymphoma","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Medicine; Mantle cell lymphoma; Rituximab; Internal medicine; Oncology; Venetoclax; Ibrutinib; Chemoimmunotherapy; Lymphoma; Gastroenterology; Chronic lymphocytic leukemia; Leukemia","score_opus":0.02358003933382442,"score_gpt":0.3151918053041063,"score_spread":0.2916117659702819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389233179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99431497,0.000055966175,0.0000011393487,0.000019003475,0.000011546249,0.0051244884,0.000014152164,0.000019812886,0.00043892537],"genre_scores_gemma":[0.99914414,0.000046512585,0.0000895042,0.000009215479,0.0000062368285,0.0003454675,0.000075170115,0.00002984085,0.00025392257],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983728,0.00019309061,0.0003444859,0.00036010487,0.00043082633,0.00029870908],"domain_scores_gemma":[0.9991745,0.0002499645,0.00011278978,0.00028229578,0.00008686709,0.00009357934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038637823,0.00018226117,0.00078549725,0.00031885257,0.000032207376,0.00002193741,0.00011518746,0.00006433067,0.000013031285],"category_scores_gemma":[0.000061024617,0.00012419595,0.000016363982,0.00071838277,0.00012000306,0.00009811111,0.000082218896,0.00007376569,0.000009244486],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.53616667,0.34975713,0.086516745,0.00047158773,0.0008713252,0.0021840888,0.014459984,0.000023881918,0.00023716265,0.00003963344,0.000046326837,0.009225444],"study_design_scores_gemma":[0.9662595,0.010992576,0.017380588,0.00019239349,0.00027720927,0.000011793255,0.0011636163,0.0022768646,0.001304934,0.0000108314025,0.000007965984,0.00012172687],"about_ca_topic_score_codex":0.0022571262,"about_ca_topic_score_gemma":0.00036761744,"teacher_disagreement_score":0.4300928,"about_ca_system_score_codex":0.0019140703,"about_ca_system_score_gemma":0.0018077312,"threshold_uncertainty_score":0.50645643},"labels":[],"label_agreement":null},{"id":"W4389233210","doi":"10.1182/blood-2023-185812","title":"Long-Term Eltrombopag in Children with Chronic Immune Thrombocytopenia: A Single-Center Extended Real-Life Observational Study in China","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Discontinuation; Eltrombopag; Immune thrombocytopenia; Single Center; Observational study; Internal medicine; Pediatrics; Clinical endpoint; Surgery; Gastroenterology; Platelet; Clinical trial","score_opus":0.03904927820696058,"score_gpt":0.29439804327106406,"score_spread":0.2553487650641035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389233210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973844,0.00024013541,8.8191024e-7,0.00023145623,0.000031007625,0.0016706187,0.000017297647,0.0000856983,0.0003385008],"genre_scores_gemma":[0.9989606,0.00011377356,0.0000291947,0.000045681267,0.00004559655,0.00016223405,0.00045142038,0.00003895519,0.00015250419],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984878,0.00004962909,0.00034891238,0.0004000374,0.0003159858,0.00039764988],"domain_scores_gemma":[0.9994674,0.000021014617,0.00007877453,0.000323043,0.000023922215,0.00008585087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013672718,0.00022511033,0.0005701699,0.00022464644,0.000050443054,0.000023725175,0.000116441865,0.000068767244,0.000072851006],"category_scores_gemma":[0.000023281502,0.00017902303,0.000054394266,0.0006649373,0.000035953424,0.00012620483,0.00007013248,0.0002041149,0.000057302936],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016987062,0.0110498555,0.9855624,0.000023436629,0.00044914146,0.0013086011,0.0003170286,0.000007324045,0.0007963895,0.000010869064,0.00001289276,0.0002922238],"study_design_scores_gemma":[0.033398047,0.0016607917,0.96405345,0.00017175147,0.00015636654,0.0001760562,0.00004494476,0.000017188973,0.00014286858,0.000018140321,8.7249043e-7,0.00015951382],"about_ca_topic_score_codex":0.0005165201,"about_ca_topic_score_gemma":0.0024436377,"teacher_disagreement_score":0.033228178,"about_ca_system_score_codex":0.00013511478,"about_ca_system_score_gemma":0.00020186549,"threshold_uncertainty_score":0.7300347},"labels":[],"label_agreement":null},{"id":"W4389233231","doi":"10.1182/blood-2023-181788","title":"The Impact of Age and Genomics on Drug Sensitivity in 1,076 Children and Adults with B-Cell Acute Lymphoblastic Leukemia","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Lymphoblastic Leukemia; Medicine; Acute lymphocytic leukemia; Drug; Childhood leukemia; Oncology; Leukemia; Pediatrics; Internal medicine; Pharmacology","score_opus":0.005521756804807384,"score_gpt":0.24122873511492227,"score_spread":0.2357069783101149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389233231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998828,0.000095733565,0.0000045370703,0.000089844674,0.0000109730145,0.0005395045,0.00006488963,0.00003601091,0.00033052286],"genre_scores_gemma":[0.99899554,0.0005530361,0.00007403684,0.000028467606,0.000050891314,0.000010493121,0.00003265311,0.00003604999,0.00021885282],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987043,0.00007000898,0.00020015781,0.00032534663,0.00029521625,0.00040497203],"domain_scores_gemma":[0.998779,0.0006033494,0.00007263656,0.00032471312,0.000048539077,0.00017177344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003722599,0.00019542834,0.00033935023,0.00016110958,0.000080659556,0.000027482338,0.00007352182,0.000076872384,0.000002006148],"category_scores_gemma":[0.000102673606,0.000114943476,0.000048062546,0.0003663082,0.00026115525,0.000040216994,0.000133136,0.00021407852,0.0000124491235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020601885,0.0025369965,0.79000455,0.0007702181,0.0036737847,0.016277317,0.012426671,0.0013563285,0.12979233,0.00013379513,0.0054854387,0.016940713],"study_design_scores_gemma":[0.020227533,0.0011029661,0.9642331,0.0002276779,0.00018656043,0.00070884044,0.00016420704,0.004991784,0.007963419,0.000029734501,0.000004251857,0.00015993867],"about_ca_topic_score_codex":0.001110874,"about_ca_topic_score_gemma":0.00021657036,"teacher_disagreement_score":0.17422856,"about_ca_system_score_codex":0.00036271685,"about_ca_system_score_gemma":0.0006620415,"threshold_uncertainty_score":0.4687259},"labels":[],"label_agreement":null},{"id":"W4389233276","doi":"10.1182/blood-2023-182099","title":"UM171 Enhances Fitness and Engraftment of Gene Modified Hematopoietic Stem Cells from Sickle Cells Disease Patients","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Haematopoiesis; Stem cell; Genetic enhancement; Ex vivo; CD34; Cancer research; Biology; Hematopoietic stem cell; Viral vector; Immunology; CD90; Myeloid; Cell biology; In vivo; Gene; Genetics","score_opus":0.006413821601569239,"score_gpt":0.23339007174295065,"score_spread":0.2269762501413814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389233276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976971,0.0011295093,0.0006705611,0.000009090392,0.00013170356,0.0001566302,0.00015721485,0.000016703067,0.00003145017],"genre_scores_gemma":[0.9990856,0.0003227499,0.00019992636,0.000013674793,0.000060199513,0.000021957705,0.000108747,0.000017262495,0.0001698576],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99929047,0.000016543561,0.00016051692,0.0002567491,0.00011324391,0.00016249761],"domain_scores_gemma":[0.9995718,0.000013863605,0.00004272377,0.00024024112,0.000030058784,0.00010131082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000040342355,0.00012253186,0.00013108086,0.000026691894,0.0000286183,0.000010307173,0.000095841846,0.00005416782,0.000006031482],"category_scores_gemma":[0.00000407172,0.000118650445,0.00005052835,0.000061102626,0.000029301587,0.0000017273102,0.00008018371,0.000028321114,0.0000072174585],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017917571,0.00015773583,0.0009285827,0.000067538596,0.000053517382,0.0000034510797,0.00012534327,0.000624198,0.9974822,0.0000033228894,0.00010940634,0.00042678503],"study_design_scores_gemma":[0.0008626842,0.000080876955,0.0052253287,0.000017874092,0.00006146107,1.7684309e-7,0.000054527,0.00015379352,0.9931765,0.000023748797,0.00020906558,0.00013394617],"about_ca_topic_score_codex":0.000010943405,"about_ca_topic_score_gemma":0.0000030744648,"teacher_disagreement_score":0.004305684,"about_ca_system_score_codex":0.0000020472535,"about_ca_system_score_gemma":0.000015591484,"threshold_uncertainty_score":0.48384246},"labels":[],"label_agreement":null},{"id":"W4389233282","doi":"10.1182/blood-2023-190037","title":"Trem-Cel, a CRISPR/Cas9 Gene-Edited Allograft Lacking CD33, Shows Rapid Primary Engraftment with CD33-Negative Hematopoiesis in Patients with High-Risk Acute Myeloid Leukemia (AML) and Avoids Hematopoietic Toxicity during Gemtuzumab Ozogamicin (GO) Maintenance Post-Hematopoietic Cell Transplant (HCT)","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"CD33; Plerixafor; Myeloid leukemia; CD34; Medicine; Hematopoietic stem cell transplantation; Haematopoiesis; Leukemia; Stem cell; Myeloid; Immunology; Cancer research; Transplantation; Internal medicine; Oncology; Biology; CXCR4; Immune system","score_opus":0.00656140965244994,"score_gpt":0.21476699234294463,"score_spread":0.2082055826904947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389233282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99461466,0.00036681758,0.00009690761,0.00033585235,0.00008613371,0.003354402,0.0003825612,0.00040199928,0.00036068898],"genre_scores_gemma":[0.99457306,0.0013915249,0.001487621,0.0002737061,0.00011675296,0.00040007726,0.00036057958,0.00026852137,0.0011281484],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99344724,0.0003921776,0.0010302655,0.0016067849,0.0017724073,0.0017511117],"domain_scores_gemma":[0.9969004,0.0005546208,0.00041444876,0.0011268503,0.00041597584,0.00058775354],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00074766646,0.0010505611,0.001664387,0.00094476715,0.00039460938,0.00013184539,0.00044721965,0.00038178617,0.0002551226],"category_scores_gemma":[0.00008074624,0.00081994326,0.0002505429,0.00164632,0.00049089064,0.00031793342,0.00024798815,0.0012820221,0.00003962646],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018659607,0.0052846675,0.35972056,0.004765871,0.0031545009,0.0069560036,0.02200554,0.00020467957,0.57775307,0.000034663957,0.0002880167,0.0011728337],"study_design_scores_gemma":[0.057382558,0.004912684,0.3565523,0.0021143544,0.0017374693,0.0007966269,0.0016920001,0.0001478948,0.5730904,0.00008043837,0.000054218664,0.001439097],"about_ca_topic_score_codex":0.00045833903,"about_ca_topic_score_gemma":0.0005482474,"teacher_disagreement_score":0.03872295,"about_ca_system_score_codex":0.00091656536,"about_ca_system_score_gemma":0.0005254177,"threshold_uncertainty_score":0.9994251},"labels":[],"label_agreement":null},{"id":"W4389233288","doi":"10.1182/blood-2023-173362","title":"Primary or Secondary Plasma Cell Leukemia: Dismal Outcome Despite Modern Treatments","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Jewish General Hospital; McGill University; Hôtel-Dieu de Québec; Hôpital Charles-Le Moyne; Université Laval; Université de Montréal; Concordia University; Hôpital du Sacré-Cœur de Montréal; Hôpital Maisonneuve-Rosemont; Université de Sherbrooke","funders":"","keywords":"Plasma cell leukemia; Medicine; Multiple myeloma; Plasma cell dyscrasia; Internal medicine; Incidence (geometry); Gastroenterology; Bortezomib; Cohort; Retrospective cohort study; Surgery; Immunology; Immunoglobulin light chain; Antibody","score_opus":0.042708375587919865,"score_gpt":0.3053376740174409,"score_spread":0.26262929842952104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389233288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830198,0.00017875334,0.000010103916,0.0001563166,0.00008692281,0.0006989692,0.00015196558,0.00029249018,0.0154046295],"genre_scores_gemma":[0.95486164,0.00015141413,0.0011035565,0.00015956459,0.00012903161,0.00016016774,0.0005403726,0.00006527688,0.04282897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998106,0.000043342796,0.00029930464,0.0004296933,0.00047340847,0.0006482769],"domain_scores_gemma":[0.9989055,0.00013151302,0.000057003723,0.00044771843,0.000042492014,0.00041577037],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000103820035,0.0002645909,0.00041153387,0.00021176634,0.00013676388,0.00003153198,0.00012929577,0.00013405312,0.00031431305],"category_scores_gemma":[0.000058363425,0.00018257156,0.0001638089,0.00031944312,0.00005391291,0.00010792425,0.00013576342,0.00026509946,0.0015404592],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018726229,0.0032511575,0.89609975,0.00081434695,0.0013109378,0.013536864,0.0004994693,0.000008958482,0.016552905,0.0000068681416,0.0020513395,0.06399478],"study_design_scores_gemma":[0.04357845,0.0015260219,0.9302136,0.0000679073,0.0007068826,0.0002647242,0.00007625242,0.0013385942,0.020090275,0.00006384953,0.0017517182,0.00032175667],"about_ca_topic_score_codex":0.00005989207,"about_ca_topic_score_gemma":0.000022718958,"teacher_disagreement_score":0.06367302,"about_ca_system_score_codex":0.00027165338,"about_ca_system_score_gemma":0.00050385174,"threshold_uncertainty_score":0.99923694},"labels":[],"label_agreement":null},{"id":"W4389233329","doi":"10.1182/blood-2023-185956","title":"MRD Directed Treatment Intensification with Either FLAG-Ida or DA-Cladribine Improves Survival in Older AML Patients: Results from the NCRI AML18 Randomised Trial","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Medicine; Cytarabine; Internal medicine; Minimal residual disease; Cladribine; Daunorubicin; Chemotherapy; Gemtuzumab ozogamicin; Chemotherapy regimen; Flag (linear algebra); Randomization; Randomized controlled trial; Oncology; Leukemia; Pediatrics; Surgery; Stem cell","score_opus":0.03474727807158158,"score_gpt":0.29002437810046355,"score_spread":0.255277100028882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389233329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914827,0.00003946098,0.000006585716,0.003077058,0.00022067643,0.004144708,0.00021214181,0.00023354695,0.0005831377],"genre_scores_gemma":[0.9925287,0.00015791957,0.00020602792,0.00017587956,0.00055413024,0.00056797196,0.0016827505,0.00007741084,0.0040492434],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9973984,0.00036262415,0.000585968,0.00060180307,0.00058838737,0.00046282014],"domain_scores_gemma":[0.99724776,0.0013277143,0.00016992225,0.0008189331,0.00029601084,0.0001396564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005886091,0.00029069986,0.000576958,0.00016856642,0.00009328173,0.00005351149,0.0002066386,0.00014283133,0.00008096438],"category_scores_gemma":[0.002004695,0.00014347525,0.00009626977,0.0009202531,0.00012489103,0.0000781645,0.000068457186,0.00029682598,0.00010851396],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9333422,0.003919216,0.01273159,0.000030922238,0.0012865484,0.0003078228,0.0053969477,0.0000042980114,0.0200236,0.000007401414,0.008588776,0.014360676],"study_design_scores_gemma":[0.7694544,0.0024226166,0.21711038,0.00014563573,0.00039242153,0.000003586144,0.0007716489,0.00041291898,0.007728916,0.000008244869,0.0013434244,0.00020580782],"about_ca_topic_score_codex":0.0032965208,"about_ca_topic_score_gemma":0.0013528166,"teacher_disagreement_score":0.2043788,"about_ca_system_score_codex":0.0002599796,"about_ca_system_score_gemma":0.00038927727,"threshold_uncertainty_score":0.5850751},"labels":[],"label_agreement":null},{"id":"W4389233331","doi":"10.1182/blood-2023-185055","title":"Real-World Outcomes of Pfts in Screening for Lung Involvement in Chronic Gvhd Post-Allogeneic Stem Cell Transplant: A Retrospective Study of 387 Patients in British Columbia, Canada","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Occupational Cancer Research Centre; University of British Columbia","funders":"","keywords":"Medicine; Asymptomatic; Internal medicine; Retrospective cohort study; Graft-versus-host disease; Hematopoietic stem cell transplantation; Population; Lung; Transplantation; Surgery","score_opus":0.010601409829301765,"score_gpt":0.23720589488500088,"score_spread":0.2266044850556991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389233331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969815,0.00016333844,9.608615e-7,0.000016057189,0.00008658243,0.0018793499,0.0007767554,0.00001193247,0.000083497405],"genre_scores_gemma":[0.9993523,0.00006238614,0.0000144306605,0.000027049746,0.000018329185,0.00015518193,0.00015951287,0.000025509646,0.0001853204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982775,0.000060683702,0.0006482956,0.00031799258,0.00036290733,0.0003326136],"domain_scores_gemma":[0.9994152,0.000052820596,0.0001694303,0.0001772532,0.00011165241,0.00007360758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020122543,0.000120284465,0.00058280386,0.00021927492,0.000028346618,0.000009570378,0.00011472136,0.00005266983,0.000016724129],"category_scores_gemma":[0.000013661353,0.00016986237,0.00008804939,0.00054618664,0.000021354956,0.000047012094,0.00004106851,0.00013331696,1.2372546e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036711004,0.0021385197,0.9945644,0.0007742296,0.00008538835,0.00027723005,0.0009461901,0.000043888296,0.00044239123,0.0000013101821,0.000037970774,0.00032135032],"study_design_scores_gemma":[0.010582324,0.003597315,0.9822814,0.0008635758,0.00015637792,7.161054e-7,0.0020195458,0.00019572258,0.00016197561,0.00000287688,0.0000023552327,0.00013581246],"about_ca_topic_score_codex":0.9444658,"about_ca_topic_score_gemma":0.9973102,"teacher_disagreement_score":0.05284437,"about_ca_system_score_codex":0.00055912684,"about_ca_system_score_gemma":0.00049972296,"threshold_uncertainty_score":0.69267863},"labels":[],"label_agreement":null},{"id":"W4389233333","doi":"10.1182/blood-2023-172819","title":"A Phase 3 Study of Eltrombopag Vs. Standard First-Line Management for Newly Diagnosed Immune Thrombocytopenia in Children: Trial in Progress Update","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Eltrombopag; Medicine; Internal medicine; Thrombopoietin receptor; Pediatrics; Thrombopoietin; Randomized controlled trial; Romiplostim; Rituximab; Immune thrombocytopenia; Surgery; Platelet; Lymphoma","score_opus":0.017941493518901157,"score_gpt":0.3185488502783134,"score_spread":0.30060735675941225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389233333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990879,0.0003659193,0.0000032435034,0.00032062375,0.00007377091,0.008149512,0.00011058814,0.000052424555,0.00004493557],"genre_scores_gemma":[0.9978659,0.00037637883,0.0002247491,0.000023655664,0.00003540014,0.0010900755,0.0003080616,0.00003186624,0.000043919274],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9984364,0.000037384547,0.00055115425,0.0003495861,0.0002801109,0.00034536014],"domain_scores_gemma":[0.9994198,0.00004402198,0.00012235284,0.00032471324,0.000031771477,0.000057331363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029690462,0.00019779032,0.0008358942,0.00031061578,0.000041619456,0.000014933878,0.0001257908,0.000057346973,0.00002250071],"category_scores_gemma":[0.000034251112,0.00016846147,0.00009256626,0.0005798964,0.000029538816,0.000059636266,0.00007689929,0.0000960252,0.0000093957615],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.176232,0.2272047,0.5307404,0.0006012932,0.0043219016,0.007538442,0.0030877646,0.000060501334,0.00013495941,0.00009340166,0.0006854417,0.049299248],"study_design_scores_gemma":[0.79723203,0.016776433,0.18370996,0.00018234618,0.0005911742,0.000008647118,0.000374161,0.00004515489,0.0006378351,0.00011413107,0.00016504641,0.00016309286],"about_ca_topic_score_codex":0.0001171245,"about_ca_topic_score_gemma":0.0003338796,"teacher_disagreement_score":0.621,"about_ca_system_score_codex":0.000037890768,"about_ca_system_score_gemma":0.00003798449,"threshold_uncertainty_score":0.68696594},"labels":[],"label_agreement":null},{"id":"W4389233361","doi":"10.1182/blood-2023-189163","title":"Chronic TNF in the Aging Microenvironment Exacerbates <i>TET2-</i>loss-of-Function Myeloid Expansion","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Queen's University; Ontario Institute for Cancer Research; McMaster University","funders":"","keywords":"Medicine; Myeloid; Function (biology); Tumor necrosis factor alpha; Cancer research; Internal medicine; Immunology; Biology; Cell biology","score_opus":0.010387092898658523,"score_gpt":0.24915912809689733,"score_spread":0.2387720351982388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389233361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971059,0.0020386653,0.000033640117,0.00028643833,0.000074775744,0.00020058596,0.000007612986,0.000012478614,0.00023991561],"genre_scores_gemma":[0.9983574,0.000701968,0.00003142444,0.00004857048,0.0002480629,0.000051055005,0.000110556764,0.000019306435,0.00043162057],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989668,0.00010442314,0.00018001496,0.0002653303,0.00021767177,0.0002657224],"domain_scores_gemma":[0.9994998,0.000023139917,0.000044987388,0.00038643074,0.000015565724,0.000030063917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036087856,0.000105203035,0.00009495747,0.00007569527,0.00006760526,0.0000117647205,0.00020337783,0.000083660176,0.000017050874],"category_scores_gemma":[0.000037560352,0.00008588165,0.00006358265,0.0002213824,0.000090376,0.0000033712456,0.000121141,0.00012030935,0.000074217416],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015037752,0.00009872573,0.0019487498,0.000031975884,0.000016172926,0.000014587542,0.00014691288,0.00012295826,0.99499595,0.0000049445334,0.00096650934,0.0016375032],"study_design_scores_gemma":[0.00083935267,0.00027219323,0.008260809,0.000031468033,0.000014389197,0.0000141260425,0.00016409294,0.000020947276,0.96718293,0.00001704047,0.023080181,0.00010246783],"about_ca_topic_score_codex":0.000032344193,"about_ca_topic_score_gemma":0.000043895605,"teacher_disagreement_score":0.027812991,"about_ca_system_score_codex":0.000025189007,"about_ca_system_score_gemma":0.000055160635,"threshold_uncertainty_score":0.3502152},"labels":[],"label_agreement":null},{"id":"W4389233388","doi":"10.1182/blood-2023-174955","title":"Janus Kinase (JAK) 1 Inhibition Results in Significant Changes in Serum Proteins and Peripheral T-Cell Populations That Correlated with Clinical Scores in Chronic Graft Versus Host Disease (GVHD) Patients (an Analysis from GRAVITAS-309)","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Cohort; Internal medicine; Prednisone; Gastroenterology; Transplantation; Peripheral blood mononuclear cell; Graft-versus-host disease; Immunology; Biology","score_opus":0.042272066538839526,"score_gpt":0.2990799440660886,"score_spread":0.2568078775272491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389233388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975672,0.00009033435,0.00001618072,0.00025684887,0.00008274881,0.001397622,0.0004942847,0.00006167981,0.000033120305],"genre_scores_gemma":[0.99522305,0.00012722386,0.00015697215,0.00002036355,0.00003858211,0.00015552412,0.0042295572,0.00002953496,0.000019219551],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978491,0.0002547979,0.00058186677,0.00060379325,0.0003738517,0.0003366012],"domain_scores_gemma":[0.99907213,0.00015697109,0.00015700176,0.00032197183,0.00004896187,0.00024298075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003257842,0.00022113355,0.00044228692,0.0006085749,0.000047983758,0.000029037676,0.000056727316,0.00015246937,0.000031545973],"category_scores_gemma":[0.00009817171,0.00019936364,0.000059786427,0.0012760537,0.00008360353,0.00012799038,0.00002256575,0.0002848502,0.0000073098854],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024713126,0.0013024826,0.9926141,0.00013557005,0.00007022966,0.0007577159,0.0012247497,0.0005123307,0.00070178317,0.000003586261,0.0000021459136,0.00020400554],"study_design_scores_gemma":[0.028546188,0.0009283653,0.96345854,0.00055025954,0.0007892419,8.877568e-7,0.00042206055,0.0037878342,0.0012806072,0.000020748983,0.0000010278603,0.00021421854],"about_ca_topic_score_codex":0.0022991693,"about_ca_topic_score_gemma":0.03635975,"teacher_disagreement_score":0.034060583,"about_ca_system_score_codex":0.00014375085,"about_ca_system_score_gemma":0.00014961076,"threshold_uncertainty_score":0.9812242},"labels":[],"label_agreement":null},{"id":"W4389233407","doi":"10.1182/blood-2023-181973","title":"Experiences with Efanesoctocog Alfa: Exit Interviews with Caregivers of Previously Treated Patients with Hemophilia A from the XTEND-Kids Phase 3 Clinical Trial","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Hemarthrosis; Family medicine; Quality of life (healthcare); Pediatrics; Likert scale; Clinical trial; Descriptive statistics; Qualitative research; Surgery; Psychology; Internal medicine; Nursing","score_opus":0.06844473455879814,"score_gpt":0.37240700480259015,"score_spread":0.303962270243792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389233407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955962,0.0001854259,0.0000022363233,0.000410276,0.000060816885,0.003171631,0.00004859079,0.000083067374,0.00044175863],"genre_scores_gemma":[0.9980527,0.00015038322,0.00010805138,0.000046974314,0.00020587053,0.00049523683,0.00026782832,0.000037735063,0.00063518557],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99765,0.00021496652,0.00046865936,0.000504468,0.0007654946,0.00039635506],"domain_scores_gemma":[0.9984196,0.00032890006,0.0001939921,0.000606486,0.00021926958,0.00023177886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003178439,0.00027711992,0.00068226183,0.00013130062,0.000112569505,0.000026494361,0.00025332393,0.00010676241,0.00016636688],"category_scores_gemma":[0.00010498095,0.00011506,0.00014555185,0.0009016064,0.00058800704,0.00008565276,0.00006296341,0.00024801184,0.000027294584],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14624926,0.011290213,0.7950124,0.00013241502,0.0026958464,0.00096087594,0.027061554,7.6968973e-7,0.00005682877,0.000004603215,0.0024530515,0.014082135],"study_design_scores_gemma":[0.78828603,0.09531442,0.07592167,0.0018518264,0.0032962225,0.000040206993,0.026983554,0.00004292313,0.004732416,0.000010278309,0.002883386,0.0006370576],"about_ca_topic_score_codex":0.00028706872,"about_ca_topic_score_gemma":0.00012716187,"teacher_disagreement_score":0.71909076,"about_ca_system_score_codex":0.000020020474,"about_ca_system_score_gemma":0.00022412198,"threshold_uncertainty_score":0.46920106},"labels":[],"label_agreement":null},{"id":"W4389233413","doi":"10.1182/blood-2023-187817","title":"Management of Catheter-Related Upper Extremity Deep Vein Thrombosis in Patients with Cancer: A Systematic Review and Meta-Analysis","year":2023,"lang":"en","type":"review","venue":"Blood","topic":"Central Venous Catheters and Hemodialysis","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Cancer; Prospective cohort study; Surgery; Meta-analysis; Retrospective cohort study; Randomized controlled trial; Thrombosis; Cohort study; Deep vein; Internal medicine","score_opus":0.0928557680823956,"score_gpt":0.38591949686962573,"score_spread":0.29306372878723014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389233413","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018950134,0.99164015,0.0000030851736,0.00003711191,0.000030702176,0.0075310217,0.00040654934,0.00003924411,0.00012263772],"genre_scores_gemma":[0.00014632412,0.9957418,0.00007205605,0.000063392436,0.00000563552,0.0030389936,0.00020605321,0.000075221156,0.0006505482],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9948357,0.0012021543,0.0023151527,0.0006647649,0.00045576438,0.0005265061],"domain_scores_gemma":[0.9966443,0.00033029515,0.0017945886,0.0009734025,0.0001304246,0.00012696638],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010285765,0.00054943626,0.010957971,0.000498484,0.00015270982,0.000009730804,0.00034462276,0.00030242695,0.00058223656],"category_scores_gemma":[0.00003465869,0.00032382092,0.0020530636,0.0021610023,0.000042331234,0.000049626356,0.00021161832,0.00049941643,0.000048977876],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000012117403,0.0004868007,0.0009368519,0.7749876,0.22284715,0.0000045206048,0.0003098756,4.143907e-7,7.287748e-10,0.000015975005,0.000013283681,0.00039636376],"study_design_scores_gemma":[0.00039337453,0.000036653513,0.0004075613,0.14698717,0.8513738,1.912698e-7,0.000053134292,0.0000010744868,5.947107e-9,0.0000049087466,0.0004705565,0.00027155958],"about_ca_topic_score_codex":0.0004779532,"about_ca_topic_score_gemma":0.00053795404,"teacher_disagreement_score":0.6285266,"about_ca_system_score_codex":0.00016538647,"about_ca_system_score_gemma":0.000099110424,"threshold_uncertainty_score":0.9999214},"labels":[],"label_agreement":null},{"id":"W4389233418","doi":"10.1182/blood-2023-182447","title":"Harnessing TCR/CAR Antagonism to Enhance Immunotherapeutic Precision","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"T-cell receptor; Chimeric antigen receptor; Antigen; Adoptive cell transfer; Biology; CD19; Immunology; Immunotherapy; T cell; Cancer research; Leukemia; Cell biology; Immune system","score_opus":0.033525931763121374,"score_gpt":0.35828287330636066,"score_spread":0.3247569415432393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389233418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990906,0.00063781114,0.00015283095,0.001621666,0.00026566675,0.00059387734,0.0000052787445,0.00027027348,0.005546569],"genre_scores_gemma":[0.95909077,0.00041682913,0.00058423035,0.0006869595,0.00043525515,0.00006800231,0.000024416093,0.00007935516,0.03861419],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984285,0.00005821898,0.00021178405,0.000349591,0.00050862785,0.00044324138],"domain_scores_gemma":[0.9990384,0.00012786899,0.000030972795,0.00056136394,0.00008510658,0.00015630417],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00044650625,0.0001404137,0.00024810855,0.00024047834,0.00011253166,0.000054997563,0.00017127463,0.000086755485,0.0010270837],"category_scores_gemma":[0.00008431571,0.00012491751,0.000098725825,0.00078149285,0.000040029667,0.000059355953,0.000099288285,0.00022727768,0.0014974995],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015974064,0.00016459433,0.00080383505,0.000033783657,0.00007722642,0.00007688983,0.0005183407,0.0000022758786,0.87267977,0.000010089405,0.00039465885,0.12507881],"study_design_scores_gemma":[0.0016742753,0.0003965451,0.013290277,0.00017536199,0.000060634695,0.000060607323,0.00008951248,0.00007135234,0.9281571,0.0001496838,0.055710696,0.0001639408],"about_ca_topic_score_codex":0.000033478216,"about_ca_topic_score_gemma":0.0000033820518,"teacher_disagreement_score":0.12491488,"about_ca_system_score_codex":0.000053843472,"about_ca_system_score_gemma":0.00010206814,"threshold_uncertainty_score":0.9998861},"labels":[],"label_agreement":null},{"id":"W4389233430","doi":"10.1182/blood-2023-191113","title":"Is Allogeneic Hematopoietic Stem Cell Transplant (HCT) in First Remission Beneficial to Acute Myeloid Leukemia (AML) Patients with Isocitrate Dehydrogenase(IDH) Mutations?","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; University of British Columbia; University Health Network","funders":"","keywords":"IDH2; Isocitrate dehydrogenase; IDH1; Oncology; Myeloid leukemia; Medicine; Hematopoietic stem cell transplantation; Internal medicine; Transplantation; Stem cell; Leukemia; Myeloid; Mutation; Biology; Genetics; Gene","score_opus":0.013833246048802664,"score_gpt":0.25261754792801494,"score_spread":0.2387843018792123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389233430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99635357,0.00011082715,0.000042838183,0.0010715537,0.000059969105,0.0014263351,0.0002232365,0.00020082798,0.0005108674],"genre_scores_gemma":[0.99693364,0.00019288558,0.00043455156,0.00057356834,0.000092548915,0.0001857814,0.00045828868,0.00011619537,0.0010125632],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99672616,0.000076043776,0.00057958596,0.00076711475,0.0009418912,0.00090922933],"domain_scores_gemma":[0.998497,0.00012867076,0.00010403915,0.00057229045,0.00016996151,0.0005280481],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030348913,0.00039872958,0.0005603123,0.00054685946,0.00022333492,0.000044752254,0.00031449928,0.0002615279,0.00011221609],"category_scores_gemma":[0.000016945913,0.0003332364,0.00014402438,0.0016775841,0.00006752233,0.0001152486,0.00009738604,0.0004934361,0.0005433756],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056577143,0.004219302,0.67822224,0.0028779313,0.0016276524,0.00768851,0.042927388,0.0031034616,0.24017915,0.000064197775,0.009576982,0.0038554503],"study_design_scores_gemma":[0.043615855,0.0032909974,0.2418748,0.0019336692,0.0015980544,0.00031274106,0.001741372,0.001659973,0.69933796,0.00010234484,0.002803454,0.0017288007],"about_ca_topic_score_codex":0.00016193089,"about_ca_topic_score_gemma":0.00016236093,"teacher_disagreement_score":0.45915878,"about_ca_system_score_codex":0.0005734774,"about_ca_system_score_gemma":0.0007612415,"threshold_uncertainty_score":0.99991196},"labels":[],"label_agreement":null},{"id":"W4389233438","doi":"10.1182/blood-2023-178786","title":"Matching-Adjusted Indirect Comparison (MAIC) of Efficacy and Safety of Lisocabtagene Maraleucel (liso-cel) and Mosunetuzumab for the Treatment (Tx) of Third Line or Later (3L+) Relapsed or Refractory (R/R) Follicular Lymphoma (FL)","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Population; Internal medicine; Oncology; Refractory (planetary science); Monoclonal; Monoclonal antibody; Gastroenterology; Immunology; Antibody; Biology","score_opus":0.05250218656409533,"score_gpt":0.32336730339557646,"score_spread":0.2708651168314811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389233438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943416,0.0028742384,0.000024287841,0.0002927638,0.00007110967,0.0020732782,0.00013315957,0.000058295667,0.0001312603],"genre_scores_gemma":[0.9874179,0.0058546257,0.0006083504,0.000034471555,0.00009523073,0.000097593314,0.00010201162,0.00007038398,0.00571946],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978842,0.00014532858,0.00075941655,0.00038634552,0.0004622524,0.00036242165],"domain_scores_gemma":[0.9970827,0.0016746456,0.0003163196,0.00062397536,0.00016926797,0.00013307997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006341969,0.00027846126,0.0010427756,0.00023690893,0.00010256846,0.000013519425,0.0001643388,0.00020511827,0.00016479552],"category_scores_gemma":[0.0001726198,0.00016338348,0.00018195846,0.0005087143,0.00023686534,0.00004564503,0.00010134275,0.00013568073,0.0000025518189],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07871413,0.010313919,0.023332106,0.0031653377,0.0070021497,0.00022190275,0.016735611,0.00014785228,0.6833044,0.000054695865,0.00098103,0.17602687],"study_design_scores_gemma":[0.113442615,0.021521432,0.2054174,0.00094567164,0.0033287094,0.00013271382,0.0019881283,0.0026360955,0.63466394,0.00007836223,0.015326212,0.0005187137],"about_ca_topic_score_codex":0.00029389097,"about_ca_topic_score_gemma":0.00018789568,"teacher_disagreement_score":0.18208529,"about_ca_system_score_codex":0.000073451716,"about_ca_system_score_gemma":0.00021686521,"threshold_uncertainty_score":0.66625845},"labels":[],"label_agreement":null},{"id":"W4389233500","doi":"10.1182/blood-2023-182113","title":"Long-Term Treatment with Fostamatinib in Japanese Patients with Primary Immune Thrombocytopenia: An Open-Label Extension Study Following a Phase 3 Placebo-Controlled, Double-Blind, Parallel-Group Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Placebo; Internal medicine; Danazol; Concomitant; Adverse effect; Clinical endpoint; Platelet; Gastroenterology; Clinical trial","score_opus":0.05052385404561024,"score_gpt":0.3416541682959806,"score_spread":0.2911303142503704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389233500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97439295,0.00024329907,0.0000017395148,0.000037247424,0.00006537843,0.024832627,0.000016991555,0.00015828083,0.0002514624],"genre_scores_gemma":[0.9949827,0.00002441218,0.00018470644,0.000043513264,0.00002212444,0.003431608,0.00087945204,0.000116002266,0.0003154793],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99662066,0.0002077974,0.0007071273,0.0010327277,0.00076252094,0.0006691486],"domain_scores_gemma":[0.99831396,0.000098828066,0.00025053244,0.0009808656,0.00010085261,0.00025494653],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004295027,0.0006552966,0.002112809,0.00034032506,0.0002765773,0.00016643564,0.00030427615,0.00009871276,0.000022771304],"category_scores_gemma":[0.000011896569,0.0004014605,0.00008344696,0.000771902,0.000038457005,0.000558342,0.00019912273,0.00020953729,0.000041520834],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20373212,0.22059458,0.5525936,0.00002897856,0.0030293108,0.012851381,0.0050920704,0.0000066840407,0.0002234277,3.4359e-7,0.0000025193888,0.0018449671],"study_design_scores_gemma":[0.5891229,0.060235396,0.34560564,0.00016141913,0.0021440892,0.000035665384,0.0023696492,0.000018732168,0.000018405135,0.0000013108166,5.996777e-7,0.0002862392],"about_ca_topic_score_codex":0.0007693044,"about_ca_topic_score_gemma":0.0024227616,"teacher_disagreement_score":0.38539073,"about_ca_system_score_codex":0.00017044919,"about_ca_system_score_gemma":0.0001609187,"threshold_uncertainty_score":0.9998437},"labels":[],"label_agreement":null},{"id":"W4389233509","doi":"10.1182/blood-2023-187283","title":"Polyamines Are Required for AML LSC Function through Their Role in Regulating eIF5A Dependent Protein Synthesis","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Polyamine Metabolism and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Biology; Function (biology); Cell biology; Molecular biology; Chemistry; Computational biology; Cancer research","score_opus":0.016863683472133927,"score_gpt":0.24417334640919203,"score_spread":0.2273096629370581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389233509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99698275,0.0008983157,0.00077002565,0.0002566676,0.00004774721,0.00053568056,0.00014784317,0.000048593178,0.0003123512],"genre_scores_gemma":[0.99700093,0.000045495213,0.00054505037,0.000048289912,0.00030000988,0.0010738309,0.00019700159,0.000022844944,0.0007665524],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991318,0.00003242055,0.00019372822,0.0003208874,0.00007351557,0.00024762945],"domain_scores_gemma":[0.99949366,0.000024016386,0.000093667586,0.00032142366,0.000036063117,0.00003118713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014529435,0.00012881853,0.00014002761,0.000045025306,0.00009272192,0.000018757968,0.00013392269,0.000109208304,0.000003992406],"category_scores_gemma":[0.00015534947,0.00011739499,0.000072854695,0.00018469535,0.000024890525,0.0000066953426,0.000073199044,0.000038754642,0.000012024869],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032540625,0.00011546462,0.0011353426,0.000024236215,0.000031373835,4.6042453e-7,0.000045626664,0.000014168127,0.99312574,0.00018897161,0.00018135908,0.005104727],"study_design_scores_gemma":[0.00074111123,0.000053660548,0.011863129,0.00002883175,0.000040485065,0.000003019118,0.00043935777,0.00008185458,0.97823256,0.0011143964,0.0072305556,0.00017101428],"about_ca_topic_score_codex":0.00003399221,"about_ca_topic_score_gemma":0.00008101705,"teacher_disagreement_score":0.014893144,"about_ca_system_score_codex":0.0000041998865,"about_ca_system_score_gemma":0.000025079307,"threshold_uncertainty_score":0.4787229},"labels":[],"label_agreement":null},{"id":"W4389233512","doi":"10.1182/blood-2023-177527","title":"Human iPSC-Derived NK Cells with Knock-in of the BCL2 G101V Mutation Are Resistant to Venetoclax and Demonstrate Improved Anti-AML Activity In Vivo","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Venetoclax; Induced pluripotent stem cell; Cancer research; Biology; Immunotherapy; Leukemia; Immunology; Immune system; Embryonic stem cell; Genetics; Gene; Chronic lymphocytic leukemia","score_opus":0.02075981551833654,"score_gpt":0.2862143710152169,"score_spread":0.26545455549688035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389233512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99813336,0.000039075825,0.0000019439344,0.00029890705,0.000020125297,0.00091688393,0.000015899357,0.000025550004,0.0005482284],"genre_scores_gemma":[0.99917364,0.000030700405,0.000049164253,0.000025266956,0.000025139037,0.000042033073,0.0000020633636,0.000025148609,0.00062686607],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99888897,0.00011452915,0.00018928433,0.0002710128,0.00026185066,0.00027433372],"domain_scores_gemma":[0.99939597,0.0000703252,0.000082487255,0.00031369593,0.000058093945,0.00007944874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003350953,0.00012152217,0.0002786452,0.00019146407,0.00005087498,0.00001667893,0.00009418237,0.000070934206,0.000046702095],"category_scores_gemma":[0.00003748461,0.00008899006,0.000036241658,0.0007086792,0.00008812614,0.00004137773,0.0000623485,0.00021817788,0.000002688452],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003486034,0.0001541945,0.0259823,0.00014471199,0.000030309746,0.000106059815,0.00049303385,0.0000320692,0.97165155,0.000002520903,0.000017326847,0.0010373285],"study_design_scores_gemma":[0.0028069643,0.0003112083,0.3680907,0.00021110482,0.000023252318,0.000006642744,0.00028161524,0.00019096553,0.6279699,0.000020260743,0.00001858811,0.00006878878],"about_ca_topic_score_codex":0.0006341972,"about_ca_topic_score_gemma":0.0029024007,"teacher_disagreement_score":0.3436816,"about_ca_system_score_codex":0.000073770025,"about_ca_system_score_gemma":0.0001567702,"threshold_uncertainty_score":0.36289096},"labels":[],"label_agreement":null},{"id":"W4389233520","doi":"10.1182/blood-2023-181410","title":"Mitophagy As a Novel Cell-Protective Mechanism Against Mitochondrial Ferroptosis in Acute Myeloid Leukemia","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"GPX4; Myeloid leukemia; Gene knockdown; Cancer research; Lipid peroxidation; Leukemia; Apoptosis; Mitophagy; Context (archaeology); Programmed cell death; Biology; Chemistry; Immunology; Glutathione; Autophagy; Oxidative stress; Biochemistry","score_opus":0.015835066920219455,"score_gpt":0.256045041560313,"score_spread":0.24020997464009353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389233520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992598,0.00017091114,0.0001261552,0.0006951664,0.0005846701,0.0011603395,0.000045411714,0.0002859512,0.0043333885],"genre_scores_gemma":[0.9944991,0.00042708375,0.001449806,0.000815548,0.00055080926,0.0007819946,0.00005640872,0.000088106266,0.0013311666],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977269,0.000046396384,0.00041021913,0.00067986,0.00050919456,0.00062739226],"domain_scores_gemma":[0.9990558,0.00005243908,0.00011242671,0.00045370572,0.00010165098,0.0002239565],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015486286,0.00032720022,0.0005641825,0.0003829968,0.000110920075,0.000042066487,0.00021599607,0.0002813374,0.000115222116],"category_scores_gemma":[0.00008262671,0.0003052393,0.00024945993,0.0011146413,0.00005198202,0.00010342158,0.00014913197,0.00045855928,0.00047663838],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003906566,0.0008257585,0.0009801505,0.000103743434,0.0003232393,0.0003227994,0.00092849927,0.000017227567,0.9931824,0.00036860103,0.00095241994,0.001604511],"study_design_scores_gemma":[0.015136511,0.0009974767,0.008289114,0.00026348673,0.00044820583,0.00005454369,0.00069008087,0.00027147544,0.9717168,0.00046228652,0.0011990366,0.0004709848],"about_ca_topic_score_codex":0.0003482643,"about_ca_topic_score_gemma":0.000051017472,"teacher_disagreement_score":0.021465596,"about_ca_system_score_codex":0.00025395417,"about_ca_system_score_gemma":0.00040775476,"threshold_uncertainty_score":0.99994},"labels":[],"label_agreement":null},{"id":"W4389233524","doi":"10.1182/blood-2023-179417","title":"Effect of New or Worsening Anemia on Clinical Outcomes in 2233 Patients with Myelofibrosis Treated with Ruxolitinib in the Expanded-Access Jump Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ruxolitinib; Medicine; Anemia; Myelofibrosis; Discontinuation; Internal medicine; Clinical trial; Pure red cell aplasia; Bone marrow","score_opus":0.04665425392825574,"score_gpt":0.3791412665114085,"score_spread":0.3324870125831528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389233524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970188,0.000008651236,2.2403513e-7,0.0001457881,0.000024879128,0.0025031245,0.0000123708005,0.00004256963,0.00024356126],"genre_scores_gemma":[0.99920547,0.00001598736,0.000038185033,0.00010783321,0.00003589361,0.00036499696,0.00004743131,0.000029466833,0.00015475116],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979288,0.0003867437,0.000501264,0.00040756224,0.00047685285,0.00029880565],"domain_scores_gemma":[0.9977559,0.0015750587,0.00014760783,0.00037208988,0.00004716003,0.000102210564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000500392,0.0002802782,0.00081434724,0.00022366636,0.000043474618,0.000028531254,0.00013650251,0.00007310848,0.00003341724],"category_scores_gemma":[0.00024161123,0.00011778921,0.00007385276,0.0008607333,0.000046431873,0.00006332595,0.000040158386,0.00022253637,0.000012736312],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048157517,0.0062834974,0.9834508,0.000054713008,0.00026351959,0.00039454838,0.0011187706,0.000010041261,0.0000017585769,0.000002818159,0.00006324462,0.003540572],"study_design_scores_gemma":[0.04057423,0.028673327,0.92828363,0.000482379,0.00041458115,0.000004184956,0.00035336395,0.0000031507345,0.0010832838,0.000001161819,0.000007155912,0.00011957776],"about_ca_topic_score_codex":0.00044148866,"about_ca_topic_score_gemma":0.0008494827,"teacher_disagreement_score":0.05516716,"about_ca_system_score_codex":0.000028748605,"about_ca_system_score_gemma":0.00009059063,"threshold_uncertainty_score":0.48033047},"labels":[],"label_agreement":null},{"id":"W4389233533","doi":"10.1182/blood-2023-173509","title":"Transform-1: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, International Phase 3 Study of Navitoclax in Combination with Ruxolitinib Versus Ruxolitinib Plus Placebo in Patients with Untreated Myelofibrosis","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Placebo; Internal medicine; Phases of clinical research; Gastroenterology; Polycythemia vera; Anemia; Clinical trial; Surgery; Oncology; Bone marrow; Pathology","score_opus":0.02273215938856701,"score_gpt":0.3032064606300736,"score_spread":0.28047430124150663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389233533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984101,0.000020474728,0.000010207085,0.00023555063,0.00013476358,0.014080435,0.00008667526,0.00006360886,0.0012673148],"genre_scores_gemma":[0.9942858,0.00003525326,0.00012924362,0.00002174775,0.000036012934,0.004582998,0.000722674,0.000051176525,0.00013507495],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99690187,0.0002577369,0.00096508086,0.00056374003,0.00085524295,0.00045634346],"domain_scores_gemma":[0.99808884,0.0008018544,0.00032121604,0.0002843662,0.00034684307,0.00015689552],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00050994154,0.00043765598,0.0014914487,0.00079836603,0.00006411786,0.000032660024,0.00013966476,0.00012046349,0.000090322545],"category_scores_gemma":[0.00012429859,0.00029970365,0.00014127625,0.0007474894,0.00010308508,0.00019859047,0.000032880256,0.00025563655,0.000020403893],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7525326,0.023468776,0.21863428,0.0000615385,0.0015884809,0.00021904029,0.0028884388,0.00024367635,0.000008343393,0.000095242256,0.0000052477762,0.000254351],"study_design_scores_gemma":[0.9405336,0.008775876,0.045202114,0.00049829116,0.0011035872,0.000006465303,0.0014684265,0.0013919879,0.0007520812,0.000005692011,0.0000076269184,0.00025424545],"about_ca_topic_score_codex":0.0007707814,"about_ca_topic_score_gemma":0.0017623719,"teacher_disagreement_score":0.18800102,"about_ca_system_score_codex":0.00025388887,"about_ca_system_score_gemma":0.00019920836,"threshold_uncertainty_score":0.9999455},"labels":[],"label_agreement":null},{"id":"W4389233600","doi":"10.1182/blood-2023-187632","title":"Disparities in the Enrollment of Racialized, Ethnic Minority, and Older Adults in Randomized Trials of Acute Myeloid Leukemia: A Systematic Review","year":2023,"lang":"en","type":"review","venue":"Blood","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; York University; McMaster University","funders":"","keywords":"Medicine; Pacific islanders; Ethnic group; Population; Randomized controlled trial; Clinical trial; Incidence (geometry); Gerontology; Health equity; Demography; Subgroup analysis; Epidemiology; Family medicine; Internal medicine; Meta-analysis; Public health; Environmental health; Pathology","score_opus":0.3967621188640022,"score_gpt":0.4804591895692652,"score_spread":0.083697070705263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389233600","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00034672613,0.980596,0.000009458461,0.00075387966,0.00020595266,0.016996663,0.00092190254,0.000013013252,0.00015641637],"genre_scores_gemma":[0.00010679571,0.99357903,0.000090210175,0.000596964,0.00009045298,0.005286324,0.00010208647,0.00004141623,0.00010669711],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.96100783,0.0114607075,0.026189681,0.000687462,0.00023779144,0.00041653984],"domain_scores_gemma":[0.9613626,0.022052621,0.015543727,0.00090707274,0.000061369734,0.00007263219],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.15968327,0.00045905833,0.025594842,0.0008682563,0.000037806538,0.000035427445,0.0006421414,0.00041946082,0.000037069833],"category_scores_gemma":[0.03300617,0.00036829544,0.001410337,0.00071569363,0.00014679815,0.00013839123,0.00012501545,0.00040974846,0.00007457878],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011229858,0.00016057838,0.00003008012,0.9923535,0.0009934688,0.00000321479,0.0010146082,2.1851753e-7,3.7287067e-9,0.0044435123,0.00031187257,0.0005766277],"study_design_scores_gemma":[0.05393857,0.000049053528,0.000098539786,0.9367514,0.004930378,0.000023696202,0.00027660868,0.000026032172,9.5985854e-8,0.0017066962,0.0017025893,0.00049630675],"about_ca_topic_score_codex":0.0024380167,"about_ca_topic_score_gemma":0.00036440327,"teacher_disagreement_score":0.12667711,"about_ca_system_score_codex":0.00028120514,"about_ca_system_score_gemma":0.0004545488,"threshold_uncertainty_score":0.9998769},"labels":[],"label_agreement":null},{"id":"W4389233604","doi":"10.1182/blood-2023-186571","title":"<i>SH2B3</i> Mutations in Patients with <i>JAK2</i>-Negative Erythrocytosis","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Medicine; Internal medicine; Population; Cohort; Hematology; Phlebotomy; Ruxolitinib; Gastroenterology; Myelofibrosis; Environmental health","score_opus":0.010408834904551724,"score_gpt":0.23868852320916417,"score_spread":0.22827968830461245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389233604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946776,0.000024994199,0.0000034660764,0.0007650118,0.00003512132,0.00071833964,0.00005661065,0.0001077575,0.0036110713],"genre_scores_gemma":[0.99797255,0.000039102488,0.0007976337,0.00034542402,0.000035697583,0.0003330189,0.00020328535,0.00002655409,0.00024673215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99894804,0.000029063567,0.00019370495,0.000284736,0.00028636653,0.00025807944],"domain_scores_gemma":[0.99939084,0.00014663082,0.000053458047,0.0001918799,0.00011276649,0.000104421444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000054854376,0.00016244949,0.0002690028,0.00017247794,0.00007736043,0.0000156351,0.000040334195,0.000051223455,0.000084748644],"category_scores_gemma":[0.00007228854,0.000118477445,0.000048250273,0.0007021228,0.000049721206,0.00007607722,0.000025963393,0.00011135498,0.00024218422],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010196043,0.0021403898,0.99545723,0.000026295082,0.0001856229,0.00009011931,0.00061036664,0.00001441658,0.00004542217,0.00012305143,0.00065410306,0.0005510462],"study_design_scores_gemma":[0.013195214,0.0009267827,0.9722387,0.00014353322,0.00022349591,0.0000048184374,0.00014694611,0.00001175227,0.012516057,0.000110275534,0.00034495274,0.0001374528],"about_ca_topic_score_codex":0.00004511516,"about_ca_topic_score_gemma":0.000120103796,"teacher_disagreement_score":0.023218486,"about_ca_system_score_codex":0.00004476069,"about_ca_system_score_gemma":0.000074070595,"threshold_uncertainty_score":0.483137},"labels":[],"label_agreement":null},{"id":"W4389233607","doi":"10.1182/blood-2023-178410","title":"Comparison of Alloimmunization in Pregnant People with Sickle Cell Disease Receiving Chronic Versus on-Demand Transfusions: A Multinational Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"","keywords":"Medicine; Disease; Pregnancy; Immunology; Intensive care medicine; Pediatrics; Internal medicine; Biology","score_opus":0.015746614718037077,"score_gpt":0.2847046249070496,"score_spread":0.26895801018901255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389233607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99765944,0.0007234382,0.000019267976,0.00020064451,0.00005479026,0.000826399,0.0000056895065,0.000049813956,0.00046049917],"genre_scores_gemma":[0.9993902,0.00030756544,0.000035180663,0.0000062711447,0.0000143142,0.00004664964,0.00005616361,0.000017714698,0.00012595876],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99910814,0.000051875202,0.0002313522,0.00018025341,0.00027296587,0.00015539641],"domain_scores_gemma":[0.9995396,0.000110767374,0.0000592804,0.00017178348,0.00005173073,0.00006682373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012531612,0.00009939845,0.00021504016,0.00015539164,0.00006625135,0.0000051785332,0.00005483781,0.00004483565,0.00003681423],"category_scores_gemma":[0.00006926398,0.00007688172,0.000034058026,0.00059396756,0.00002496503,0.000034106975,0.000018869321,0.0001492766,0.000012049223],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015566839,0.014965147,0.9506409,0.0004243827,0.00015143887,0.0000686279,0.013149,0.014491588,0.0030599826,0.000032599033,0.00006444716,0.0013951797],"study_design_scores_gemma":[0.031165207,0.003309105,0.94464016,0.00094178313,0.00037467587,0.0000011814545,0.0077687292,0.010542933,0.0010535968,0.0000052905825,0.000044323348,0.00015303223],"about_ca_topic_score_codex":0.000072487426,"about_ca_topic_score_gemma":0.00034325945,"teacher_disagreement_score":0.029608523,"about_ca_system_score_codex":0.00003267035,"about_ca_system_score_gemma":0.00016042279,"threshold_uncertainty_score":0.31351456},"labels":[],"label_agreement":null},{"id":"W4389233640","doi":"10.1182/blood-2023-190722","title":"Cellular and Molecular Analysis of Hematopoietic Stem and Progenitor Cells in Shwachman-Diamond Syndrome","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Children's Hospital of Eastern Ontario; University Health Network; SickKids Foundation; University of Toronto; Centre Hospitalier Universitaire Sainte-Justine; Hospital for Sick Children","funders":"","keywords":"Progenitor cell; Stem cell; Haematopoiesis; Biology; Myeloid; CD34; Bone marrow; Bone marrow failure; Immunology; Cancer research; Cell biology","score_opus":0.005587320670356334,"score_gpt":0.2096723574748098,"score_spread":0.20408503680445347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389233640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99592793,0.0037536912,0.000014784818,0.000017607186,0.00001484727,0.00016652088,0.00003422527,0.000008442598,0.000061962055],"genre_scores_gemma":[0.9994828,0.00023847863,0.000076991724,0.000014723697,0.000004566256,0.000024254818,0.00006838781,0.000014171177,0.000075593234],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992533,0.00003128255,0.00016584148,0.00029475216,0.00008686166,0.00016800045],"domain_scores_gemma":[0.9996579,0.000007528146,0.000048920916,0.00020948777,0.000016748023,0.000059415077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000074034084,0.00012110198,0.00023504098,0.00016402267,0.00002177069,0.000011695675,0.0000621466,0.00009608495,0.0000030206504],"category_scores_gemma":[0.0000037179623,0.00011715335,0.000070750924,0.00041535325,0.000050250168,0.0000023510818,0.00008748176,0.00003213384,0.0000021884662],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020600362,0.00059263443,0.14407833,0.00013031639,0.0019857201,0.00029174547,0.00018445386,0.00004033269,0.8521254,0.00005066953,0.000024384837,0.0004754081],"study_design_scores_gemma":[0.0017971708,0.00026592112,0.017279457,0.000014555606,0.0011859282,0.00001641315,0.00019678325,0.000105084095,0.9788224,0.000066953224,0.00006758139,0.00018173516],"about_ca_topic_score_codex":0.00002214809,"about_ca_topic_score_gemma":0.000024386667,"teacher_disagreement_score":0.12679887,"about_ca_system_score_codex":0.0000015612925,"about_ca_system_score_gemma":0.000013879564,"threshold_uncertainty_score":0.47773752},"labels":[],"label_agreement":null},{"id":"W4389233642","doi":"10.1182/blood-2023-188008","title":"Identification of Novel Transcripts and Potential Therapeutic Targets for Acute Leukemia","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Leukemia; Biology; Myeloid leukemia; Gene; Transcriptome; Acute leukemia; Computational biology; Human genome; Genome; Genetics; Cancer research; Gene expression","score_opus":0.015251986972846014,"score_gpt":0.2726917084927368,"score_spread":0.25743972151989075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389233642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97104365,0.0008500856,0.027611818,0.00010055899,0.00007801489,0.00016590598,0.00011540615,0.0000092203045,0.000025346819],"genre_scores_gemma":[0.99854213,0.00044026814,0.00020320348,0.000030461253,0.000059141545,0.00005889875,0.00014442953,0.000009762814,0.00051172526],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996096,0.0000051848265,0.00011351048,0.00014509725,0.00004402249,0.00008258593],"domain_scores_gemma":[0.99975413,0.0000023443113,0.00004269306,0.00013482114,0.00004776351,0.000018264654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000071548755,0.000048804992,0.00005795555,0.000023118764,0.000041966246,0.000009232318,0.00006200816,0.00005231446,0.0000016017884],"category_scores_gemma":[0.0000047246654,0.00004714824,0.000041858875,0.000052373984,0.00002967808,0.0000021937758,0.000009389246,0.000015063478,8.4964984e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019564504,0.000046614394,0.0000582769,0.000013344146,0.00010116245,1.2086393e-7,0.00003461413,0.000029850431,0.9979245,0.00018350009,0.00018399644,0.0014044712],"study_design_scores_gemma":[0.0013714626,0.00008902365,0.007979738,0.0000027451517,0.00016302773,0.0000046759405,0.000041809595,0.0006293465,0.98674744,0.0001268854,0.0027647186,0.00007911364],"about_ca_topic_score_codex":0.000002189187,"about_ca_topic_score_gemma":0.0000016149795,"teacher_disagreement_score":0.027498465,"about_ca_system_score_codex":0.0000022990855,"about_ca_system_score_gemma":0.000031380023,"threshold_uncertainty_score":0.19226494},"labels":[],"label_agreement":null},{"id":"W4389233717","doi":"10.1182/blood-2023-180872","title":"Spatiotemporal Impact of Sars-Cov-2 Infection on the Transcriptome of Bone Marrow Megakaryocytes","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Transcriptome; Bone marrow; Megakaryocyte; Biology; Inflammation; Platelet; Immunology; S100A8; Haematopoiesis; Platelet activation; Leukocyte extravasation; Cell biology; Gene; Gene expression; Stem cell; Genetics","score_opus":0.038100125115322986,"score_gpt":0.3093632944923099,"score_spread":0.2712631693769869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389233717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976584,0.00010304234,0.0000011993645,0.0002247708,0.000045666016,0.00023616134,0.000032210657,0.00003748374,0.0016610892],"genre_scores_gemma":[0.9997128,0.00008504539,0.000012227221,0.00003579576,0.00002101768,0.000009347009,0.00004101036,0.000011963993,0.00007073953],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9994429,0.000021594575,0.00017002976,0.00009347092,0.00015626782,0.00011578374],"domain_scores_gemma":[0.99966,0.000041751886,0.00007327626,0.00016415646,0.000041744453,0.000019074436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009824477,0.00008965526,0.00024411557,0.00011394049,0.000023752895,0.000002729078,0.00002492542,0.00004707527,0.00002665249],"category_scores_gemma":[0.000055586996,0.000053214277,0.0001733665,0.00029090137,0.000035976125,0.000023660568,0.0000057856882,0.000062848754,0.000023351964],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040152844,0.0023410302,0.38442,0.00014808867,0.0010486938,0.00014309795,0.00044329025,0.000009555241,0.6063363,0.00018198256,0.0032311366,0.0012953172],"study_design_scores_gemma":[0.0035232136,0.0014061279,0.5190761,0.00009493995,0.00023176,0.000021704765,0.00001685702,0.000053997413,0.4751242,0.00027641593,0.00011651233,0.000058132635],"about_ca_topic_score_codex":0.00093060225,"about_ca_topic_score_gemma":0.000039378185,"teacher_disagreement_score":0.13465612,"about_ca_system_score_codex":0.000012270057,"about_ca_system_score_gemma":0.00003903632,"threshold_uncertainty_score":0.21700151},"labels":[],"label_agreement":null},{"id":"W4389233727","doi":"10.1182/blood-2023-189554","title":"The Efficacy and Safely of Anticoagulation for the Management of Gonadal Vein Thrombosis","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Thrombosis; Population; Incidence (geometry); Surgery; Deep vein; Observational study; Cumulative incidence; Confidence interval; Randomized controlled trial; Venous thrombosis; Internal medicine; Cohort","score_opus":0.03104911640930062,"score_gpt":0.3019454045146035,"score_spread":0.27089628810530286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389233727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945246,0.00080144353,0.000119616496,0.0022376233,0.00010541602,0.0011719947,0.000009316647,0.000024064038,0.0010059372],"genre_scores_gemma":[0.9964471,0.0029477116,0.0002634807,0.000047956204,0.000039634902,0.00005766854,0.000008658284,0.000010563762,0.00017724697],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9993945,0.000011395995,0.00019019742,0.000105986815,0.00017030668,0.00012764984],"domain_scores_gemma":[0.9993711,0.00025464728,0.00007813259,0.00023628003,0.000039860763,0.000019938718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031977159,0.00006337827,0.00018314898,0.000033071152,0.000113070084,0.0000089937685,0.000078841054,0.000020189984,0.000005878922],"category_scores_gemma":[0.000019975283,0.000035571855,0.000053459607,0.00016108429,0.00007202842,0.000015926425,0.00007308784,0.000026262745,0.0000023239177],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007041452,0.009409149,0.043992132,0.008552932,0.018771023,0.000027040007,0.006184093,0.0006039975,0.050790463,0.34634912,0.034728628,0.47988728],"study_design_scores_gemma":[0.002465337,0.00027007988,0.98547596,0.00012941494,0.0012749333,7.2822064e-7,0.00058679713,0.00026870964,0.0037892568,0.0003303572,0.0053634522,0.00004500496],"about_ca_topic_score_codex":0.000028085764,"about_ca_topic_score_gemma":0.0000070043216,"teacher_disagreement_score":0.9414838,"about_ca_system_score_codex":0.0000041560024,"about_ca_system_score_gemma":0.00000863688,"threshold_uncertainty_score":0.14505781},"labels":[],"label_agreement":null},{"id":"W4389233774","doi":"10.1182/blood-2023-187446","title":"Infusion of UM171-Expanded Cord Blood Led to Excellent Survival in Patients with High-Risk Leukemias: Results from Two Independent Phase II Studies","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Medicine; Leukemia; Cord blood; Internal medicine; Oncology","score_opus":0.023452139348393335,"score_gpt":0.3058245687017003,"score_spread":0.2823724293533069,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389233774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978357,0.000084754814,0.000003921394,0.00016298497,0.00044853208,0.00086696685,0.00026544958,0.00009762415,0.00023409378],"genre_scores_gemma":[0.99875057,0.00030675443,0.00009880477,0.000053552834,0.00015128215,0.00007868606,0.0001954058,0.000031048672,0.00033390912],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998035,0.00009098602,0.00055137277,0.00045863408,0.0005640769,0.0002999392],"domain_scores_gemma":[0.99879557,0.0001517011,0.00020694574,0.0004612658,0.00023317544,0.00015131442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025875602,0.00022527427,0.00057771266,0.0002786024,0.00012842915,0.000009409257,0.000111639616,0.000068990135,0.00003699022],"category_scores_gemma":[0.00017830248,0.00017485097,0.000070446986,0.00070778525,0.000048891834,0.00006306963,0.0002169481,0.00025403773,0.00003030583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013915292,0.009452306,0.949825,0.00008488281,0.0014564735,0.00018720423,0.004683909,0.0003319256,0.011488298,0.00002446902,0.0009849251,0.0075653237],"study_design_scores_gemma":[0.17092068,0.012727543,0.77385885,0.00056888483,0.0012476018,0.000002970734,0.0010471226,0.0000058785163,0.038841896,0.00007121655,0.00038895645,0.0003183842],"about_ca_topic_score_codex":0.0030874328,"about_ca_topic_score_gemma":0.0024239265,"teacher_disagreement_score":0.17596613,"about_ca_system_score_codex":0.000083450024,"about_ca_system_score_gemma":0.00014075288,"threshold_uncertainty_score":0.7130216},"labels":[],"label_agreement":null},{"id":"W4389233783","doi":"10.1182/blood-2023-173441","title":"Clinical Factors but Not Somatic Mutations Predict for Survival in Patients with Myelofibrosis Undergoing Allogeneic Hematopoietic Cell Transplant: Analysis of the North American Myelofibrosis Transplant Outcome (NAMTO) Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Myelofibrosis; Internal medicine; Univariate analysis; Hazard ratio; Oncology; Hematopoietic stem cell transplantation; Proportional hazards model; Transplantation; Cumulative incidence; Graft-versus-host disease; Survival analysis; Multivariate analysis; Confidence interval; Bone marrow","score_opus":0.02903976474016231,"score_gpt":0.2890969394949203,"score_spread":0.26005717475475804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389233783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958168,0.000009880123,0.000090379195,0.00011565616,0.000077382036,0.0024760729,0.0013343127,0.00006436028,0.000015134996],"genre_scores_gemma":[0.99855477,0.000042138705,0.0002373273,0.000040652423,0.000017980783,0.0003723264,0.00065741147,0.00005010634,0.000027285858],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968187,0.00026061837,0.0011870905,0.00058982335,0.00070136256,0.00044239845],"domain_scores_gemma":[0.99720347,0.0015945442,0.0003905686,0.0005239963,0.00011074615,0.00017667944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029945862,0.00038213772,0.0014061569,0.00044346548,0.00017716365,0.000021624239,0.00020118475,0.00007078463,0.00001437114],"category_scores_gemma":[0.000064966815,0.00023466637,0.0005666787,0.0018797112,0.00015644768,0.000055852957,0.000027813841,0.00017244613,0.000003842364],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035800968,0.006259075,0.98552066,0.00025771628,0.0034994215,0.000013737656,0.003455054,0.00050807616,0.000040133124,0.0000038953863,0.000001447425,0.00008277621],"study_design_scores_gemma":[0.010059195,0.002808606,0.97083366,0.00013116293,0.0132282525,7.627662e-7,0.001301588,0.0001825862,0.0012278097,0.0000017193629,6.375625e-7,0.00022400903],"about_ca_topic_score_codex":0.00023285935,"about_ca_topic_score_gemma":0.0061892364,"teacher_disagreement_score":0.014686987,"about_ca_system_score_codex":0.000050680293,"about_ca_system_score_gemma":0.00014016985,"threshold_uncertainty_score":0.95694166},"labels":[],"label_agreement":null},{"id":"W4389233810","doi":"10.1182/blood-2023-182390","title":"A CD5 Gene Signature Identifies Diffuse Large B-Cell Lymphomas Sensitive to Brutonʼs Tyrosine Kinase Inhibition","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Diffuse large B-cell lymphoma; breakpoint cluster region; Cancer research; Chronic lymphocytic leukemia; Population; Biology; Surrogate endpoint; Internal medicine; Lymphoma; Immunology; Genetics; Medicine; Gene; Leukemia","score_opus":0.0129255657016233,"score_gpt":0.27091212401578585,"score_spread":0.25798655831416256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389233810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995727,0.00034283087,0.00007108409,0.0008690629,0.00018037799,0.0008363374,0.00020178384,0.00039723184,0.0013742952],"genre_scores_gemma":[0.98821646,0.00011924349,0.00023420839,0.0009603047,0.0004934879,0.00007642308,0.000518407,0.00008051572,0.009300932],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99739766,0.00008520678,0.00031646184,0.0006004365,0.0008005424,0.00079969096],"domain_scores_gemma":[0.99848115,0.00016506526,0.000062989304,0.0006086964,0.0002661436,0.00041597875],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041355778,0.00026997324,0.00038960806,0.00040758445,0.00015778746,0.000074306285,0.000112426846,0.00023408506,0.000099234654],"category_scores_gemma":[0.0003821312,0.00024830518,0.00015428997,0.00122308,0.000072268405,0.0001085194,0.00032673564,0.0002628464,0.0018438017],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046053188,0.0050099534,0.00016757406,0.00047832885,0.00017875324,0.012332624,0.0020743618,0.000014031112,0.94768506,0.00014763925,0.031126453,0.00032466653],"study_design_scores_gemma":[0.08008155,0.00028483733,0.0023350513,0.00027369164,0.00020393795,0.00056329864,0.00044627782,0.0010285655,0.9121642,0.00006831949,0.0022394508,0.00031080228],"about_ca_topic_score_codex":0.00018842019,"about_ca_topic_score_gemma":0.000070170725,"teacher_disagreement_score":0.07962102,"about_ca_system_score_codex":0.0018951391,"about_ca_system_score_gemma":0.0016909903,"threshold_uncertainty_score":0.9999969},"labels":[],"label_agreement":null},{"id":"W4389233901","doi":"10.1182/blood-2023-181792","title":"Chip-AML22 Master Protocol: An Open-Label Clinical Trial in Newly Diagnosed Pediatric De Novo Acute Myeloid Leukemia (AML) Patients Including a Linked Phase II Trial with Quizartinib in <i>FLT3</i>-ITD/ <i>NPM1</i>wt Patients - a Study By the NOPHO-DB-SHIP Consortium","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Gemtuzumab ozogamicin; Internal medicine; Oncology; Clinical trial; Phases of clinical research; Induction chemotherapy; Transplantation; Chemotherapy; Surgery; Stem cell; CD34; CD33","score_opus":0.11968569198844832,"score_gpt":0.42131693353384114,"score_spread":0.30163124154539284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389233901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8298069,0.000009516798,0.0000028552001,0.00026720774,0.00030759312,0.16909628,0.00015896805,0.00016974927,0.00018092588],"genre_scores_gemma":[0.8839204,0.00002738058,0.00028791337,0.000860091,0.001117169,0.11282903,0.00045361242,0.00022655628,0.00027789982],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9885779,0.002574608,0.0030706665,0.0018047947,0.0020001025,0.0019718965],"domain_scores_gemma":[0.99475837,0.0015361955,0.0008992546,0.0015599758,0.00038931542,0.00085690344],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.006014876,0.00085799635,0.0017964969,0.0008145437,0.0005059129,0.00031009305,0.0018223936,0.00056711136,0.00006494403],"category_scores_gemma":[0.0033316035,0.00061679166,0.00016979703,0.0035128614,0.00030006314,0.00066330476,0.0019665963,0.0026886575,0.000075463264],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3983422,0.06627085,0.52702534,0.00007445012,0.00030225777,0.0008309134,0.0024875612,0.0000031432514,0.00024804636,0.0000011317645,0.0021916234,0.0022224712],"study_design_scores_gemma":[0.83223486,0.08493755,0.08001755,0.00013126909,0.0006708116,0.0000126801415,0.0003682349,0.00027320476,0.00015519088,0.000013635543,0.0005671081,0.0006179095],"about_ca_topic_score_codex":0.0006906099,"about_ca_topic_score_gemma":0.00070490263,"teacher_disagreement_score":0.4470078,"about_ca_system_score_codex":0.0008327278,"about_ca_system_score_gemma":0.003624489,"threshold_uncertainty_score":0.99962837},"labels":[],"label_agreement":null},{"id":"W4389233907","doi":"10.1182/blood-2023-187125","title":"Longitudinal Differences By Treatment Arm in Health-Related Quality of Life Among High Risk Pediatric Hodgkin's Lymphoma Patients Treated on the Children's Oncology Group Ahod 1331 Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Quality of life (healthcare); Internal medicine; Physical therapy; Pediatrics","score_opus":0.037034852997182656,"score_gpt":0.30808010254029844,"score_spread":0.27104524954311576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389233907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995122,0.0003283887,6.44409e-7,0.0010858851,0.00021869437,0.0026547885,0.0003236407,0.00018727542,0.000078689234],"genre_scores_gemma":[0.99841714,0.0006079102,0.000010418987,0.00016344129,0.00016309063,0.00021422174,0.00031681592,0.00004747959,0.000059482885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9934612,0.0024945638,0.0017483862,0.00078927533,0.00089891534,0.00060764345],"domain_scores_gemma":[0.9960884,0.0015461807,0.001215698,0.0007409002,0.00008944589,0.00031941084],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018263786,0.0004602491,0.0015219689,0.00037005413,0.00020815487,0.000018894203,0.0002841338,0.00021313105,0.000068020054],"category_scores_gemma":[0.00075326744,0.00031525854,0.00021926966,0.0013348431,0.00015645525,0.000059226506,0.000099905345,0.00031564388,0.000035332534],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006443493,0.02877177,0.9634394,0.00006295679,0.0007571229,0.000016100055,0.00403216,0.0000037886807,0.0000015425884,0.000031877415,0.00029597044,0.0019429856],"study_design_scores_gemma":[0.026444005,0.015570436,0.95598805,0.00006858212,0.00044004884,0.0000016760999,0.001142138,0.0000066175844,0.000035346075,0.000052142565,0.0000056314702,0.00024534253],"about_ca_topic_score_codex":0.09532706,"about_ca_topic_score_gemma":0.0078048767,"teacher_disagreement_score":0.08752219,"about_ca_system_score_codex":0.00035622218,"about_ca_system_score_gemma":0.00029279786,"threshold_uncertainty_score":0.99992996},"labels":[],"label_agreement":null},{"id":"W4389233951","doi":"10.1182/blood-2023-177767","title":"Are Medical Learners Adept at Recognizing Heavy Vaginal Bleeding?","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Female Genital Mutilation/Cutting Issues","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Feeling; Family medicine; Medicine; Obstetrics and gynaecology; Descriptive statistics; Psychology; Medical education; Pregnancy","score_opus":0.04317523636987612,"score_gpt":0.3063266140990715,"score_spread":0.2631513777291954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389233951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98346627,0.00041035877,0.000005118433,0.0056859767,0.00029793012,0.00018149352,0.000004601554,0.00062495377,0.009323314],"genre_scores_gemma":[0.9903407,0.000050635987,0.0005639276,0.0006460312,0.0007443773,0.00001767015,0.000044978406,0.000050078375,0.007541603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982174,0.000034373774,0.00027002118,0.00034745428,0.0007209019,0.00040983944],"domain_scores_gemma":[0.9991302,0.00014063457,0.00010701798,0.00023644092,0.00007727648,0.00030843736],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040935163,0.00015635582,0.00027539596,0.00018057262,0.00013635744,0.000020588252,0.000116669136,0.00016924062,0.000734345],"category_scores_gemma":[0.0014410624,0.00014679802,0.00009110759,0.0005262522,0.000087379136,0.00006244363,0.00014241411,0.0003072949,0.00211285],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015926668,0.00036479422,0.96262014,0.00037431312,0.00028355216,0.0021676915,0.0017172237,0.000007708839,0.0049616476,0.000048191618,0.022153629,0.0051418236],"study_design_scores_gemma":[0.0139384335,0.0010180437,0.8443718,0.0028550003,0.0013150935,0.0028550369,0.0064861607,0.0021716112,0.06257988,0.0003723743,0.060873203,0.0011633432],"about_ca_topic_score_codex":0.000016529648,"about_ca_topic_score_gemma":0.000021709866,"teacher_disagreement_score":0.118248336,"about_ca_system_score_codex":0.000046545265,"about_ca_system_score_gemma":0.000074012736,"threshold_uncertainty_score":0.99866414},"labels":[],"label_agreement":null},{"id":"W4389233972","doi":"10.1182/blood-2023-189697","title":"Precise Single-Cell Transcriptomic Mapping of Leukemia Cell States Reveals Unconventional Lineage Priming in Acute Myeloid Leukemia","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Leukemia; Biology; Myeloid leukemia; Haematopoiesis; Transcriptome; CD34; Stem cell; Progenitor cell; Bone marrow; Cancer research; Myeloid; Computational biology; Acute leukemia; Immunology; Genetics; Gene; Gene expression","score_opus":0.029446971191672434,"score_gpt":0.2699031278656334,"score_spread":0.24045615667396097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389233972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99424744,0.00057878706,0.00019490314,0.0002112352,0.00014838309,0.0010221186,0.00011059677,0.0002019943,0.0032845465],"genre_scores_gemma":[0.9852514,0.00074486923,0.0038072607,0.00012701041,0.00019640333,0.00008947174,0.00046003837,0.00011476728,0.009208764],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963533,0.0001599897,0.0010753312,0.00068032165,0.0008177237,0.0009133308],"domain_scores_gemma":[0.9982844,0.00038082723,0.00025635352,0.00059329206,0.00020424485,0.00028090444],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010882278,0.00037237132,0.00082920707,0.00093781704,0.00008484339,0.000035166868,0.0003990692,0.00029268445,0.00017353833],"category_scores_gemma":[0.00013196869,0.00037254783,0.00029570295,0.0014751693,0.0001633832,0.00019902685,0.00017052786,0.0008106349,0.00020954403],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029603174,0.0005351218,0.0131811295,0.0013959488,0.00018638853,0.0006002913,0.0018723118,0.00024385781,0.97826535,0.0000137185025,0.0027029507,0.000706923],"study_design_scores_gemma":[0.018195273,0.000577729,0.023604434,0.0010040625,0.00042991244,0.000099763674,0.0012624931,0.0032769197,0.9491087,0.00020370791,0.0017324821,0.00050451985],"about_ca_topic_score_codex":0.00018293601,"about_ca_topic_score_gemma":0.000025887806,"teacher_disagreement_score":0.029156623,"about_ca_system_score_codex":0.0012586296,"about_ca_system_score_gemma":0.001527564,"threshold_uncertainty_score":0.9998726},"labels":[],"label_agreement":null},{"id":"W4389234009","doi":"10.1182/blood-2023-186530","title":"Integrative Genomic and Transcriptomic Analysis Reveals Targetable Vulnerabilities in Angioimmunoblastic T-Cell Lymphoma","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Biology; DNA methylation; Epigenetics; Cancer research; RHOA; Molecular biology; Genetics; Gene; Signal transduction; Gene expression","score_opus":0.009178195687767161,"score_gpt":0.23238213633178698,"score_spread":0.22320394064401983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389234009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99430364,0.0037641223,0.000008758102,0.00018271068,0.000042110478,0.0003330442,0.00004324535,0.00007363801,0.0012487354],"genre_scores_gemma":[0.99718696,0.0006662135,0.00022027461,0.00008268128,0.000026748736,0.00013537733,0.00008911375,0.000018838691,0.0015738083],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885166,0.00006548003,0.00030048055,0.0003443925,0.00013283592,0.00030518183],"domain_scores_gemma":[0.9994024,0.0001755218,0.000046931204,0.0002481526,0.000033727545,0.000093260816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018576506,0.00019650834,0.0005508052,0.00047798041,0.000061662286,0.000028749719,0.000057021516,0.00007124979,0.00007725891],"category_scores_gemma":[0.000039234237,0.00015075953,0.00018683814,0.00090781134,0.00006345281,0.000060356662,0.000026207454,0.000052646592,0.000067382025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011678824,0.0024465455,0.9631288,0.0001396715,0.0017364797,0.0002833619,0.0036591054,0.000057934732,0.026578601,0.00017853577,0.00036133573,0.0013128484],"study_design_scores_gemma":[0.009505483,0.0003109132,0.9716693,0.00007145894,0.00236977,0.000019317991,0.0011572456,0.00032597687,0.013937573,0.00025826026,0.000207841,0.0001668254],"about_ca_topic_score_codex":0.0004904545,"about_ca_topic_score_gemma":0.00019391283,"teacher_disagreement_score":0.012641029,"about_ca_system_score_codex":0.00012030998,"about_ca_system_score_gemma":0.00008121632,"threshold_uncertainty_score":0.6147795},"labels":[],"label_agreement":null},{"id":"W4389234069","doi":"10.1182/blood-2023-185353","title":"Decoding the Epigenetic Drivers of Menin-MLL Inhibitor Resistance in KMT2A-Rearranged Acute Myeloid Leukemia","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Cancer research; Epigenetics; Chromatin; Biology; Myeloid leukemia; PRC2; EZH2; Decitabine; DNA methylation; Genetics; Gene; Gene expression","score_opus":0.018893559033513144,"score_gpt":0.2817525776908748,"score_spread":0.26285901865736166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389234069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912902,0.00063208985,0.00001306036,0.0019389322,0.000098964425,0.00065623375,0.000028398994,0.0000871593,0.005254925],"genre_scores_gemma":[0.9933493,0.0009954432,0.0010186642,0.00014429176,0.00017560227,0.00007197071,0.000030645122,0.000051235435,0.0041628582],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978082,0.00013662565,0.00043618417,0.00038625245,0.00063453225,0.00059816893],"domain_scores_gemma":[0.99864477,0.00035627888,0.00011149068,0.0006219849,0.00011871051,0.00014676843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007655517,0.00019752716,0.00043100803,0.00035459327,0.00011138603,0.00001821771,0.0003561096,0.00014804621,0.000067307614],"category_scores_gemma":[0.00036373627,0.00014991622,0.0001287318,0.0014531596,0.00022275106,0.000068397145,0.00018615506,0.0005208932,0.00015891179],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009118636,0.00029182836,0.06624246,0.0004375822,0.0008167058,0.0023083563,0.006543441,0.000052499043,0.89541197,0.00033951562,0.02306963,0.0035741564],"study_design_scores_gemma":[0.022663858,0.0006008676,0.30161157,0.0012666001,0.0008561776,0.0000955095,0.0034018306,0.00075120584,0.65504915,0.0007259432,0.012306218,0.0006710431],"about_ca_topic_score_codex":0.00015136428,"about_ca_topic_score_gemma":0.0004408125,"teacher_disagreement_score":0.24036281,"about_ca_system_score_codex":0.0003751618,"about_ca_system_score_gemma":0.00063043385,"threshold_uncertainty_score":0.6113406},"labels":[],"label_agreement":null},{"id":"W4389234076","doi":"10.1182/blood-2023-174816","title":"Considering Older Patients As Candidates for Auto Stem Cell Transplants: A Comprehensive Study on Toxicities and Survival Analysis","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Common Terminology Criteria for Adverse Events; Autologous stem-cell transplantation; Proportional hazards model; Hematopoietic stem cell transplantation; Hazard ratio; Oncology; Transplantation; Progression-free survival; Comorbidity; Adverse effect; Surgery; Chemotherapy; Confidence interval","score_opus":0.026835312235596206,"score_gpt":0.29427605770610016,"score_spread":0.26744074547050395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389234076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980356,0.00004399717,0.000047672296,0.00007514573,0.000056937595,0.0010992058,0.00019008476,0.00010006249,0.0003512657],"genre_scores_gemma":[0.9988346,0.0000257384,0.00004766231,0.00010535184,0.0000380404,0.000100537756,0.00009068387,0.000029227527,0.0007281252],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985619,0.000065543274,0.00023450899,0.00035483393,0.00043637535,0.00034680372],"domain_scores_gemma":[0.998674,0.0007609248,0.000046350273,0.00022399338,0.00014321107,0.00015156897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010675781,0.00017364947,0.00045688445,0.00035272955,0.00011213949,0.00003415424,0.000069450485,0.00006180468,0.000020574795],"category_scores_gemma":[0.000033511074,0.00014392052,0.000087701184,0.0004622541,0.00005754592,0.000036784662,0.000047419413,0.00010101651,0.000025876585],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001384848,0.0035202834,0.9627462,0.00096115505,0.006948305,0.0007660131,0.01584084,0.000088389264,0.005960382,0.000034685352,0.0010923884,0.00065649895],"study_design_scores_gemma":[0.051785834,0.005041674,0.8853857,0.00021507575,0.006256794,0.000019847257,0.023555968,0.0034649097,0.023495225,0.000027695873,0.0002695814,0.00048167628],"about_ca_topic_score_codex":0.00016386867,"about_ca_topic_score_gemma":0.00007019559,"teacher_disagreement_score":0.07736049,"about_ca_system_score_codex":0.00006423445,"about_ca_system_score_gemma":0.00012848241,"threshold_uncertainty_score":0.5868908},"labels":[],"label_agreement":null},{"id":"W4389234172","doi":"10.1182/blood-2023-191191","title":"The Presence of Somatic Mutation in Donor Does Not Affect Long-Term Outcomes in 339 Patients Following Allogeneic Hematopoietic Stem Cell Transplantation Using Uniform Fludarabine/Busulfan Myeloablative Conditioning and Cyclosporine/Methotrexate and ATG Gvhd Prophylaxis","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Fludarabine; Medicine; Busulfan; Transplantation; Context (archaeology); Hematopoietic stem cell transplantation; Internal medicine; Oncology; Stem cell; Surgery; Immunology; Chemotherapy; Cyclophosphamide; Biology","score_opus":0.0197165680889852,"score_gpt":0.2934844320197312,"score_spread":0.273767863930746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389234172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982271,0.00009830867,0.0000714284,0.00006578705,0.000051658637,0.0013952329,0.000031738193,0.00003056309,0.000028170443],"genre_scores_gemma":[0.99915975,0.00016133272,0.00042541965,0.000008507538,0.000010291054,0.000070890135,0.00007449705,0.000027927481,0.00006138999],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99823445,0.00021464066,0.0004979828,0.0003187042,0.0003983601,0.0003358664],"domain_scores_gemma":[0.99858105,0.00090645324,0.00017934892,0.00018738178,0.00007025814,0.00007553375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068142015,0.00019655804,0.0004079979,0.00035674623,0.00012913038,0.000038909624,0.00009194307,0.000092214854,0.000002610202],"category_scores_gemma":[0.00014390213,0.00013194626,0.000058099187,0.0005549008,0.00011504278,0.00022954195,0.000055620174,0.00022389425,0.0000012901612],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011865548,0.0001259125,0.9722568,0.001163715,0.000077507284,0.0002312164,0.005069899,0.000111862755,0.018381532,0.000009136332,1.6153331e-7,0.00245364],"study_design_scores_gemma":[0.0051334905,0.00025852383,0.9323524,0.00041919426,0.0001312528,0.000020147421,0.0009315211,0.0009079424,0.059636377,0.000077662036,6.27116e-8,0.00013138156],"about_ca_topic_score_codex":0.00017500063,"about_ca_topic_score_gemma":0.00021525355,"teacher_disagreement_score":0.041254845,"about_ca_system_score_codex":0.00010057123,"about_ca_system_score_gemma":0.000098929595,"threshold_uncertainty_score":0.5380612},"labels":[],"label_agreement":null},{"id":"W4389234217","doi":"10.1182/blood-2023-180037","title":"Apixaban Is Effective and Safe in Reducing Venous Thromboembolism (VTE) in Obese Patients with Newly Diagnosed Pediatric Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma (ALL/LL) a Sub-Study Analysis of the Prevapix-ALL/Children's Oncology Group ACCL1333 Trial","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Apixaban; Randomized controlled trial; Internal medicine; Induction chemotherapy; Pediatrics; Asparaginase; Chemotherapy; Surgery; Warfarin; Leukemia; Lymphoblastic Leukemia","score_opus":0.008287751611139368,"score_gpt":0.26564882134068535,"score_spread":0.257361069729546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389234217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99214,0.00021094231,0.000014285438,0.00007932769,0.00024249972,0.0069979527,0.0001526165,0.00010203758,0.000060339135],"genre_scores_gemma":[0.99796647,0.00039232124,0.00009963757,0.00017816771,0.00023806404,0.00081866136,0.00015294019,0.00013251457,0.000021226877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99310356,0.0010319562,0.0013827278,0.0015043842,0.0016073624,0.0013699947],"domain_scores_gemma":[0.99443704,0.0030934974,0.00062390225,0.0011744683,0.0002578416,0.0004132547],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011628014,0.000761226,0.0024460917,0.002634984,0.00017066288,0.00006434248,0.0006831869,0.0004852583,0.000027093865],"category_scores_gemma":[0.0015288792,0.00055909046,0.00036058313,0.007836085,0.0003561756,0.0002384197,0.00072738633,0.0005353294,0.00002522124],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020543301,0.016191004,0.93507713,0.00029933188,0.008265153,0.0012444187,0.0118649565,0.00095476926,0.0008034852,0.000008537184,0.00014455912,0.0046033617],"study_design_scores_gemma":[0.19975665,0.007015835,0.77839315,0.00021330162,0.011603352,0.000047165744,0.00035346736,0.001935831,0.00024732135,0.000023590059,0.0000029074338,0.0004074149],"about_ca_topic_score_codex":0.0033084706,"about_ca_topic_score_gemma":0.0014641045,"teacher_disagreement_score":0.17921336,"about_ca_system_score_codex":0.00327463,"about_ca_system_score_gemma":0.002348962,"threshold_uncertainty_score":0.99968606},"labels":[],"label_agreement":null},{"id":"W4389234238","doi":"10.1182/blood-2023-189576","title":"Disparities in Phase 3 Leukemia Trials from the Last Decade: A Long Way to Go","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Clinical trial; Randomized controlled trial; Family medicine; Descriptive statistics; Internal medicine; Statistics","score_opus":0.4056769978191431,"score_gpt":0.4537387917101298,"score_spread":0.04806179389098669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389234238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9662415,0.001520735,0.0004032468,0.02797734,0.00060613063,0.0008965031,0.0010823152,0.00009059141,0.0011816428],"genre_scores_gemma":[0.9868399,0.00022871677,0.0004141035,0.009924807,0.0009961042,0.0004206249,0.0001354849,0.00004465974,0.0009955828],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947422,0.00055402314,0.0036322435,0.0005082725,0.00009287339,0.00047034447],"domain_scores_gemma":[0.9937071,0.0046397042,0.0009042066,0.0005609768,0.000024029901,0.0001639608],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.02272699,0.0001759794,0.0011249696,0.00029977824,0.0001549924,0.00014945272,0.0004191065,0.00013631956,0.00033896885],"category_scores_gemma":[0.011914047,0.00017699743,0.00014315672,0.00050786365,0.00004194735,0.00023809832,0.00010253061,0.00019649211,0.009604405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007854919,0.0005682476,0.6655923,0.00021488534,0.00034808434,0.000023882465,0.008653378,0.00071662053,0.000043498036,0.047239274,0.27467456,0.0018467064],"study_design_scores_gemma":[0.011041673,0.00015210238,0.8555864,0.00028284392,0.00004333626,0.000003978362,0.0016082771,0.0019910703,0.00016518208,0.023691092,0.10471905,0.00071500835],"about_ca_topic_score_codex":0.003999357,"about_ca_topic_score_gemma":0.0039005317,"teacher_disagreement_score":0.18999408,"about_ca_system_score_codex":0.00029023414,"about_ca_system_score_gemma":0.00013169351,"threshold_uncertainty_score":0.996409},"labels":[],"label_agreement":null},{"id":"W4389234266","doi":"10.1182/blood-2023-173241","title":"A Phase 2, Single-Arm, Multicohort, Open Label, Multicenter Trial of Off-the-Shelf Natural Killer Cells (SAR445419) in Patients with High-Risk Myeloid Malignancies Undergoing Allogeneic HSCT","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Transplantation; Internal medicine; Myeloid leukemia; Hematopoietic stem cell transplantation; Oncology; Leukemia; Immunology","score_opus":0.02631994969765771,"score_gpt":0.2939405461620323,"score_spread":0.2676205964643746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389234266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99470365,0.00015807709,0.000005081961,0.0003407228,0.0005034739,0.004007695,0.00006565997,0.00007771199,0.00013792246],"genre_scores_gemma":[0.996063,0.00018008995,0.0015100958,0.00021167951,0.00014727896,0.00017603375,0.0001992237,0.00009775808,0.0014148434],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9966067,0.00030234375,0.00072344975,0.0006269959,0.0009216084,0.00081888365],"domain_scores_gemma":[0.99775666,0.00066264556,0.00031608684,0.0007836076,0.0002920604,0.00018891698],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007891821,0.00037153222,0.0007408415,0.00037051,0.00015162333,0.000080226084,0.0006644798,0.00016593502,0.00005315714],"category_scores_gemma":[0.00064884307,0.00024752074,0.00010162083,0.00096062734,0.00023944878,0.00023095551,0.0005834902,0.0006147507,0.000075123105],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2975514,0.124200575,0.28571278,0.0012530879,0.005297496,0.0016217957,0.006253675,0.0002561495,0.22462828,0.00009553413,0.0079414155,0.0451878],"study_design_scores_gemma":[0.87017864,0.014234607,0.04657993,0.0006450948,0.0008460922,0.0000103195,0.00051782164,0.0011310339,0.06394315,0.000014816269,0.0013071687,0.00059133075],"about_ca_topic_score_codex":0.00054921344,"about_ca_topic_score_gemma":0.00034791455,"teacher_disagreement_score":0.57262725,"about_ca_system_score_codex":0.00022485432,"about_ca_system_score_gemma":0.0004391615,"threshold_uncertainty_score":0.9999977},"labels":[],"label_agreement":null},{"id":"W4389234269","doi":"10.1182/blood-2023-174501","title":"<i>Cooperative Super-Enhancer Inactivation through Loss of Crebbp and KMT2D Skews B Cell Fate Decisions and Yields T Cell-Depleted Lymphomas</i>","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC","funders":"Daiichi Sankyo Europe; Ipsen; DNA Genotek","keywords":"Biology; Enhancer; Chromatin; BCL6; Psychological repression; B cell; Epigenetics; Genetics; Immune system; Germinal center; Cancer research; Transcription factor; Cell biology; Gene; Gene expression","score_opus":0.015547618589675268,"score_gpt":0.2348396834733903,"score_spread":0.21929206488371503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389234269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98884565,0.0021440124,0.00031720096,0.00015938982,0.0007642721,0.00021351027,0.00001623607,0.00007727352,0.007462485],"genre_scores_gemma":[0.99121046,0.001819885,0.00005696196,0.00012614316,0.000022754877,0.000023999735,0.00012761778,0.00001835674,0.0065938323],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99904263,0.000120362565,0.00029517067,0.0002911616,0.000038725906,0.00021195048],"domain_scores_gemma":[0.9993019,0.00027451944,0.00011269402,0.00018782649,0.00010611616,0.000016955531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001150211,0.00016426317,0.0002388982,0.00010775845,0.00022238656,0.000020345962,0.00007139538,0.00023041668,0.0003114171],"category_scores_gemma":[0.000084824984,0.00014364853,0.0000487173,0.0002632762,0.00013488405,0.00025432033,0.0000860714,0.00019268612,0.00019391948],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015294322,0.0002623151,0.0008450888,0.000018366496,0.00008415041,0.0000027479796,0.0017807211,0.0000047673666,0.9902928,0.00022128833,0.005847198,0.00048761928],"study_design_scores_gemma":[0.0028515495,0.00027874572,0.0031549109,0.000035533834,0.000077214754,0.000031554067,0.0014894872,0.00001409322,0.9707894,0.00009868528,0.021019807,0.00015905616],"about_ca_topic_score_codex":0.000107854015,"about_ca_topic_score_gemma":0.000012531425,"teacher_disagreement_score":0.019503431,"about_ca_system_score_codex":0.000015044729,"about_ca_system_score_gemma":0.000035764526,"threshold_uncertainty_score":0.5857817},"labels":[],"label_agreement":null},{"id":"W4389234334","doi":"10.1182/blood-2023-189351","title":"Novel Therapeutics Targeting Acute Myeloid Leukemia (AML) Stem Cells Identified through High-Throughput Screening","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Hôpital de l'Enfant-Jésus; Institute for Research in Immunology and Cancer; McGill University; Université Laval; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Myeloid leukemia; CD34; Leukemia; Stem cell; Haematopoiesis; Cancer research; Cord blood; Medicine; Minimal residual disease; Cytotoxic T cell; Immunology; Acute leukemia; Pharmacology; In vitro; Chemistry; Biology; Cell biology; Biochemistry","score_opus":0.04831357275802787,"score_gpt":0.30684271457074636,"score_spread":0.25852914181271847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389234334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9787939,0.00072109606,0.01311218,0.0016675799,0.00081277883,0.0011673486,0.0001307176,0.0011454634,0.0024489197],"genre_scores_gemma":[0.92483866,0.0014992631,0.039414912,0.0023068232,0.0019047458,0.00018285087,0.00042849066,0.00041708793,0.029007165],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99565905,0.00010654688,0.00073572993,0.00094212237,0.001187928,0.0013686231],"domain_scores_gemma":[0.9978536,0.00035105352,0.00022164593,0.0009973459,0.00029863566,0.00027776553],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00083758496,0.00048617698,0.0007190143,0.00027576069,0.00040601104,0.00015220701,0.00056739675,0.00037849345,0.0001759946],"category_scores_gemma":[0.000044345543,0.00044465187,0.0002796455,0.0015758674,0.00020152904,0.00037008588,0.0005403031,0.001043637,0.001323326],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002557888,0.00031487265,0.0011317537,0.00019207681,0.0022585243,0.0011099513,0.0022864072,0.000116196854,0.973592,0.00065245,0.012762949,0.0053270413],"study_design_scores_gemma":[0.017026562,0.0005169112,0.005898926,0.00035140358,0.0019537532,0.00037305785,0.0033114732,0.002102548,0.9400894,0.00021457401,0.027166983,0.0009944249],"about_ca_topic_score_codex":0.00044692552,"about_ca_topic_score_gemma":0.000008321984,"teacher_disagreement_score":0.053955253,"about_ca_system_score_codex":0.00038409542,"about_ca_system_score_gemma":0.00059366506,"threshold_uncertainty_score":0.9998005},"labels":[],"label_agreement":null},{"id":"W4389234360","doi":"10.1182/blood-2023-188796","title":"Slow and Steady Wins the Race: Optimization of Older Adult Allogeneic Hematopoietic Cell Transplant (Allo-HCT) Candidates","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Frailty in Older Adults","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Intervention (counseling); Physical therapy; Transplantation; Internal medicine","score_opus":0.008534139856408184,"score_gpt":0.2297242531883469,"score_spread":0.22119011333193872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389234360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994998,0.0006481064,0.00032668194,0.0025242814,0.000101626654,0.0006183622,0.00006658076,0.00010863218,0.00060776935],"genre_scores_gemma":[0.996346,0.0009605491,0.0005661926,0.0002545047,0.00006282652,0.000034194134,0.00012844814,0.000034152352,0.0016131452],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989521,0.00004552236,0.00026580418,0.00023245944,0.00026635616,0.0002377501],"domain_scores_gemma":[0.99928904,0.00012876623,0.00007719819,0.00032281128,0.000091005284,0.000091171445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014058777,0.00015334514,0.00026111017,0.000081717466,0.00006667096,0.000014063593,0.00011060623,0.000121030964,0.00006806775],"category_scores_gemma":[0.000045911547,0.00010587346,0.000057258003,0.00027186933,0.00009397413,0.000046071167,0.000030319938,0.00016213632,0.00002481208],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080120465,0.0053860755,0.5956524,0.008952709,0.0020112188,0.0010400644,0.08550477,0.020105798,0.24764447,0.0005303681,0.029866882,0.002504061],"study_design_scores_gemma":[0.048532665,0.0021517153,0.26666158,0.0031504345,0.005205306,0.0015069931,0.0059659644,0.028178241,0.63546115,0.00018449767,0.0015702266,0.0014312052],"about_ca_topic_score_codex":0.0000799417,"about_ca_topic_score_gemma":0.000057380796,"teacher_disagreement_score":0.3878167,"about_ca_system_score_codex":0.000008796691,"about_ca_system_score_gemma":0.000055796587,"threshold_uncertainty_score":0.43173945},"labels":[],"label_agreement":null},{"id":"W4389234373","doi":"10.1182/blood-2023-178024","title":"Development of Oral Azacitidine with Cedazuridine for Myelodysplastic Syndrome (MDS) and Myeloproliferative Neoplasms (MPN) Including CMML (Chronic Myelomonocytic Leukemia) By Targeting Pharmacokinetic AUC Equivalence Vs Subcutaneous Azacitidine","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Azacitidine; Medicine; Decitabine; Myelodysplastic syndromes; Pharmacokinetics; Chronic myelomonocytic leukemia; Hypomethylating agent; Pharmacology; Area under the curve; Internal medicine; Lenalidomide; Adverse effect; Oncology; International Prognostic Scoring System; Myeloid leukemia; Gastroenterology; Bone marrow","score_opus":0.03044335139828663,"score_gpt":0.30152921953870404,"score_spread":0.2710858681404174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389234373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992722,0.0010670972,0.0025366093,0.0005671078,0.0001179607,0.0023093799,0.00016439173,0.00036800755,0.0001474969],"genre_scores_gemma":[0.9743051,0.0007200979,0.0225445,0.00010864703,0.00017009031,0.0005480361,0.0005417132,0.0002087581,0.00085305184],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99483484,0.000115275136,0.001153374,0.0011872667,0.0010779103,0.0016313364],"domain_scores_gemma":[0.9971844,0.000875771,0.00039700704,0.0004518538,0.00047272365,0.00061825383],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00102531,0.00077248766,0.0013328865,0.0006557242,0.0005137446,0.000072972456,0.00041382693,0.00024471467,0.00011192508],"category_scores_gemma":[0.00051576254,0.0006790756,0.00013317523,0.0014978972,0.00045392406,0.000281972,0.000505134,0.00069667475,0.000057452708],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048872535,0.00055768277,0.002888429,0.0057228785,0.0021380312,0.0035214361,0.0020322022,0.0007900026,0.9669999,0.00022829023,0.003814965,0.006418962],"study_design_scores_gemma":[0.04189444,0.010251809,0.0025731274,0.0024843805,0.0021878546,0.0096331965,0.0010819793,0.052616376,0.86887753,0.00010197998,0.006215117,0.002082205],"about_ca_topic_score_codex":0.000039986,"about_ca_topic_score_gemma":0.000025077743,"teacher_disagreement_score":0.098122336,"about_ca_system_score_codex":0.0012368199,"about_ca_system_score_gemma":0.002505426,"threshold_uncertainty_score":0.999566},"labels":[],"label_agreement":null},{"id":"W4389234384","doi":"10.1182/blood-2023-181054","title":"Efficacy and Safety Is Maintained in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria Receiving Pegcetacoplan for up to 3 Years","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Medicine; Adverse effect; Internal medicine; Hemoglobinuria; Eculizumab; Clinical trial; Incidence (geometry); Anemia; Hemolysis; Surgery; Immunology; Complement system; Antibody","score_opus":0.00843493029343439,"score_gpt":0.23569328785924162,"score_spread":0.22725835756580723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389234384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982001,0.000061342136,0.000016178541,0.0001861108,0.00023785656,0.0008976707,0.00028142086,0.00006428922,0.000055021857],"genre_scores_gemma":[0.99889666,0.000005021933,0.00009402711,0.0001477635,0.000025753023,0.00007734405,0.0002329106,0.000018277226,0.0005022169],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990233,0.000068390495,0.00023562473,0.0002845312,0.000040798583,0.0003473097],"domain_scores_gemma":[0.9995066,0.00016394976,0.000061007544,0.00017615384,0.00005255328,0.000039755312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013060206,0.00013146306,0.00020975209,0.00012206965,0.00008635755,0.00001601356,0.00012743684,0.00006670905,0.00017472569],"category_scores_gemma":[0.00011858982,0.000117086136,0.000031821906,0.00018294212,0.000031645082,0.00003631504,0.00008617639,0.000076595556,0.00011474392],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030699659,0.00037385992,0.97388846,0.00012166468,0.00031909606,0.000013885003,0.002556395,0.000013657134,0.0036130387,0.00012004176,0.013163471,0.0027464814],"study_design_scores_gemma":[0.01851276,0.0004058587,0.97569335,0.00016628153,0.00006949796,0.000008588858,0.00031162243,0.000002579624,0.0010400527,0.000025208292,0.003570611,0.0001935903],"about_ca_topic_score_codex":0.00003380995,"about_ca_topic_score_gemma":0.000091377246,"teacher_disagreement_score":0.015442793,"about_ca_system_score_codex":0.000024160961,"about_ca_system_score_gemma":0.00003236495,"threshold_uncertainty_score":0.4774634},"labels":[],"label_agreement":null},{"id":"W4389234406","doi":"10.1182/blood-2023-177591","title":"Molecular Determinants of Response to Mosunetuzumab Plus CHOP in Patients with Previously Untreated (1L) Diffuse Large B Cell Lymphoma (DLBCL)","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"CHOP; Medicine; Rituximab; Oncology; Internal medicine; Lymphoma; Diffuse large B-cell lymphoma; Chemotherapy regimen; Biomarker; Gene signature; Immunology; Chemotherapy; Cancer research; Biology; Gene expression; Gene","score_opus":0.009579933272469627,"score_gpt":0.2652194575617714,"score_spread":0.25563952428930176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389234406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99791133,0.00008230903,0.0000024344288,0.00005156448,0.000028519913,0.0014925463,0.000048680326,0.00008464385,0.00029797523],"genre_scores_gemma":[0.9968434,0.00002682114,0.00007165241,0.000092879534,0.000015491947,0.00008987136,0.000040692932,0.00008370755,0.0027354867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997583,0.00020416561,0.00037825663,0.00043519962,0.00071474264,0.00068466604],"domain_scores_gemma":[0.998604,0.00012824596,0.00008433205,0.0007335104,0.00017219713,0.00027769565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045931578,0.00023424551,0.0005150221,0.000528372,0.00003592264,0.000015557789,0.00021259983,0.00012214635,0.00010864009],"category_scores_gemma":[0.00021985844,0.00019582467,0.00008197093,0.0013488877,0.00004789074,0.00004466687,0.00014847172,0.00012444603,0.00010529753],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03471138,0.015765542,0.8178933,0.00038670935,0.00017706321,0.0026484032,0.0027846626,0.000024872044,0.12022955,0.0000017743297,0.00016190075,0.0052147876],"study_design_scores_gemma":[0.12891684,0.0035859484,0.71582633,0.00036023627,0.00012503359,0.000015453834,0.000092212074,0.00022727487,0.15006787,0.0000039100937,0.00051699684,0.00026187534],"about_ca_topic_score_codex":0.00016061732,"about_ca_topic_score_gemma":0.00010277534,"teacher_disagreement_score":0.10206699,"about_ca_system_score_codex":0.00018348361,"about_ca_system_score_gemma":0.0003261516,"threshold_uncertainty_score":0.79854983},"labels":[],"label_agreement":null},{"id":"W4389234429","doi":"10.1182/blood-2023-174790","title":"Outcomes of Patients with Accelerated/Blast-Phase MPNs That Received Allogeneic Stem-Cell Transplant in the Current Era of Myeloid Therapies","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Cohort; Transplantation; Myeloid; Hematopoietic stem cell transplantation; Oncology; Gastroenterology; Surgery","score_opus":0.03210762976622982,"score_gpt":0.2810069876121128,"score_spread":0.24889935784588296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389234429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974947,0.0008495719,0.0000029777275,0.00019766767,0.000074242445,0.0009772615,0.00021299963,0.000039388953,0.00015120974],"genre_scores_gemma":[0.9984263,0.0010402226,0.000037382408,0.00005068101,0.000015210436,0.00007802972,0.0002522991,0.00003095148,0.00006890678],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998414,0.00010521007,0.00039631003,0.0002676854,0.00051764207,0.00029918813],"domain_scores_gemma":[0.99904394,0.00018128724,0.00019397245,0.0004413293,0.00008008479,0.000059374754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016902664,0.00024395212,0.0005176411,0.00013911811,0.000033610744,0.00000767283,0.00020647123,0.00006165,0.000048540376],"category_scores_gemma":[0.0000073965134,0.00013518837,0.00010825615,0.00043394123,0.00008234737,0.000058169993,0.000021914822,0.00027274125,0.0000124770295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052479777,0.005186587,0.96938205,0.0002715792,0.00047371283,0.000050909406,0.0059995432,0.000015700301,0.0018195694,0.000003734021,0.000052416457,0.016219381],"study_design_scores_gemma":[0.03416934,0.0011736336,0.9369898,0.00031636207,0.0004950171,0.000004326781,0.00046979453,0.000016257216,0.025990164,0.000008015494,0.00021816646,0.00014912544],"about_ca_topic_score_codex":0.000062703795,"about_ca_topic_score_gemma":0.000077453486,"teacher_disagreement_score":0.033644542,"about_ca_system_score_codex":0.00006342431,"about_ca_system_score_gemma":0.00023925671,"threshold_uncertainty_score":0.55128217},"labels":[],"label_agreement":null},{"id":"W4389234459","doi":"10.1182/blood-2023-187626","title":"Epigenetic Scarring Leads to Irreversible NK Cell Dysfunction in Myeloid Malignancies","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Myeloid; Immunology; Myeloid leukemia; Immunotherapy; Cancer research; Immune system; Bone marrow; Biology; Medicine","score_opus":0.012430382023638038,"score_gpt":0.21615684331776847,"score_spread":0.20372646129413044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389234459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906168,0.0006111801,0.000059303624,0.00013825402,0.0032547454,0.00017314749,0.0000018017597,0.00016214277,0.004982621],"genre_scores_gemma":[0.947653,0.00012490277,0.000021034308,0.00018350109,0.000037311518,0.00003332276,0.000057912366,0.000015740268,0.0518733],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991281,0.000072375406,0.00020899397,0.00024312706,0.000029661955,0.00031776147],"domain_scores_gemma":[0.9996755,0.000044415217,0.000043100812,0.00018365287,0.00003584267,0.000017463353],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016947537,0.00011879777,0.00014218006,0.00033837062,0.00011738568,0.000015170461,0.000101218066,0.00013379502,0.0008077996],"category_scores_gemma":[0.00004034641,0.00012373271,0.000060225593,0.00046632925,0.00002334667,0.0000916103,0.00006544457,0.00017995211,0.010880169],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051291518,0.00010707675,0.007231875,0.000021865895,0.00002045306,0.0000050460235,0.0003348576,0.00014027479,0.9820062,0.000018672323,0.009326331,0.0007360815],"study_design_scores_gemma":[0.0015079655,0.00020604914,0.03771757,0.000050104027,0.000031303323,0.000019206464,0.00061483437,0.0000069384937,0.91463137,0.0000100231555,0.045038037,0.00016657838],"about_ca_topic_score_codex":0.00009693609,"about_ca_topic_score_gemma":0.000043045107,"teacher_disagreement_score":0.06737478,"about_ca_system_score_codex":0.000036156638,"about_ca_system_score_gemma":0.000025534995,"threshold_uncertainty_score":0.98989},"labels":[],"label_agreement":null},{"id":"W4389234561","doi":"10.1182/blood-2023-184941","title":"Clocking the Processes and Challenges of Urgent Red Blood Cell Exchange for Acute Complications of Sickle Cell Disease","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; Apheresis; Acute chest syndrome; Disease; Intensive care medicine; Anemia; Internal medicine; Sickle cell anemia","score_opus":0.02846502380890783,"score_gpt":0.264377744295923,"score_spread":0.23591272048701514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389234561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9467019,0.042137843,0.000016073207,0.0082989875,0.000038156755,0.0009687611,0.00012687827,0.00005878513,0.0016526456],"genre_scores_gemma":[0.97307706,0.026329255,0.00010190961,0.000060339844,0.000029357077,0.000100546815,0.000031662606,0.000017845037,0.00025204394],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993813,0.000013307362,0.00018416527,0.0001565514,0.00011608642,0.00014856858],"domain_scores_gemma":[0.9993477,0.0000987108,0.000103492435,0.00022707092,0.000118269556,0.000104769955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009470965,0.00008683801,0.0001787308,0.000056315308,0.00007486815,0.000003339608,0.00007272667,0.000048001068,0.000008594971],"category_scores_gemma":[0.000066717985,0.000058968784,0.000059083864,0.00020028352,0.00007184672,0.00001701633,0.000044678778,0.000054799682,0.0000016765943],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002049463,0.049966466,0.099490635,0.2004879,0.0078664925,0.00028150884,0.07055177,0.00024269252,0.5128348,0.006651397,0.017945783,0.031631105],"study_design_scores_gemma":[0.056676254,0.0048042955,0.12644608,0.0033119603,0.029666273,0.000095322284,0.032534715,0.0016619845,0.6537459,0.0042164586,0.08532517,0.001515606],"about_ca_topic_score_codex":0.0000065405084,"about_ca_topic_score_gemma":0.000003314568,"teacher_disagreement_score":0.19717593,"about_ca_system_score_codex":0.0000018848908,"about_ca_system_score_gemma":0.00008527998,"threshold_uncertainty_score":0.24046773},"labels":[],"label_agreement":null},{"id":"W4389234564","doi":"10.1182/blood-2023-184921","title":"Management of Hyperleukocytosis in Pediatric Acute Myeloid Leukemia Using Immediate Chemotherapy without Leukapheresis, in Protocol NOPHO-DBH AML-2012","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Cytarabine; Etoposide; Mitoxantrone; Leukapheresis; Internal medicine; Chemotherapy; Chemotherapy regimen; Myeloid leukemia; Leukemia; Gastroenterology; Oncology; Stem cell","score_opus":0.02525566120483506,"score_gpt":0.32172651189479484,"score_spread":0.29647085068995976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389234564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96433353,0.00010705614,0.0000150849055,0.00022121277,0.000052354066,0.033211727,0.000013705197,0.00012850082,0.0019168518],"genre_scores_gemma":[0.9477915,0.0022230498,0.0076929783,0.00023583615,0.0004941912,0.03869167,0.00005829991,0.00027477447,0.0025376615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99638903,0.00013407382,0.00089811307,0.0006868487,0.0008792378,0.0010126968],"domain_scores_gemma":[0.9986178,0.00009145147,0.0002262316,0.0007340919,0.00010241391,0.00022796028],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000916659,0.00040036257,0.00082994986,0.0012718989,0.000054551743,0.00002546673,0.00042763603,0.00027162593,0.00014215738],"category_scores_gemma":[0.000039696028,0.00037303718,0.00016587476,0.0034532205,0.00010737609,0.00021382669,0.00028541646,0.000622818,0.00013156007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029684093,0.0018081323,0.8942466,0.004251046,0.0008610624,0.0036669755,0.0011969041,0.00025892426,0.07835291,0.00004937587,0.0018218064,0.010517887],"study_design_scores_gemma":[0.06596718,0.0006844885,0.84540933,0.000929622,0.0007210712,0.00012989913,0.0006992235,0.0033320272,0.07945991,0.0001089298,0.0016659828,0.0008923078],"about_ca_topic_score_codex":0.00037772598,"about_ca_topic_score_gemma":0.00007262401,"teacher_disagreement_score":0.06299877,"about_ca_system_score_codex":0.0009464456,"about_ca_system_score_gemma":0.00081783585,"threshold_uncertainty_score":0.99987215},"labels":[],"label_agreement":null},{"id":"W4389234575","doi":"10.1182/blood-2023-173550","title":"Longitudinal Correlative Profiles of Responders, Nonresponders, and Those with Relapse on Treatment with Teclistamab in the Phase 1/2 MajesTEC-1 Study of Patients with Relapsed/Refractory Multiple Myeloma","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Bone marrow; Internal medicine; CD8; Cytopenia; Oncology; Immune system; Gastroenterology; Multiple myeloma; Flow cytometry; Immunology","score_opus":0.04014223672840837,"score_gpt":0.31468856441477894,"score_spread":0.27454632768637055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389234575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995596,0.000110448884,0.0000041496855,0.00006656188,0.000010310005,0.003858901,0.0001565,0.000037048947,0.00016009505],"genre_scores_gemma":[0.99890655,0.00004370457,0.00021731583,0.000009256273,0.000011995903,0.0003327642,0.0001589515,0.000046273442,0.00027316532],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974308,0.00034201224,0.0003567345,0.00052579027,0.0009555343,0.00038912322],"domain_scores_gemma":[0.9979166,0.00087394053,0.0002491889,0.00062290626,0.00019057601,0.0001468172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003054687,0.0003616253,0.0005844406,0.0004897341,0.000113963266,0.000015844767,0.00012243095,0.000078287434,0.000011882248],"category_scores_gemma":[0.000147648,0.00017025248,0.00004356438,0.0008955184,0.00027631517,0.00011834786,0.00003920097,0.0002712733,0.0000046094647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07020444,0.029824145,0.8865384,0.00008603588,0.00089398597,0.0015636892,0.0086771855,0.000010761379,0.0001698412,0.000009781995,0.000020731308,0.0020009947],"study_design_scores_gemma":[0.110294625,0.089190684,0.78770655,0.0004377842,0.00043434888,0.000023342334,0.010546815,0.000037533937,0.0011572626,0.0000028023915,0.000020993371,0.00014725843],"about_ca_topic_score_codex":0.00029777712,"about_ca_topic_score_gemma":0.0007689611,"teacher_disagreement_score":0.098831855,"about_ca_system_score_codex":0.00009084968,"about_ca_system_score_gemma":0.00022650899,"threshold_uncertainty_score":0.6942694},"labels":[],"label_agreement":null},{"id":"W4389234593","doi":"10.1182/blood-2023-187778","title":"The Impact of Clonal Hematopoiesis on Clinical Outcomes and Clonal Dynamics in Older Lymphoma Patients Receiving Chemotherapy","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Queen's University; University of Ottawa; Sunnybrook Health Science Centre","funders":"","keywords":"Chemotherapy; Oncology; Internal medicine; Population; Lymphoma; Cancer; Medicine; Biology; Immunology","score_opus":0.022939585452327493,"score_gpt":0.36223280923606777,"score_spread":0.33929322378374027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389234593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978688,0.000033658886,0.0000012164982,0.0010532311,0.000051486324,0.00034552373,0.000022851043,0.00003061519,0.00059266237],"genre_scores_gemma":[0.99892926,0.00037148813,0.00009571933,0.00014637483,0.000053507065,0.000015535545,0.000032771262,0.000030472784,0.00032485998],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984528,0.00010008667,0.00044772885,0.00024274425,0.0004178094,0.00033882426],"domain_scores_gemma":[0.998166,0.0012276674,0.00009739879,0.00030775738,0.00008299266,0.0001181677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000809438,0.00014509079,0.00038624954,0.00014482744,0.000063729974,0.000016770156,0.00013949543,0.00012947673,0.000022050765],"category_scores_gemma":[0.0007500052,0.00008693093,0.00018482,0.00036186315,0.00015900443,0.00003382877,0.00009057768,0.00022134068,0.000017682754],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003196353,0.0007916616,0.9818731,0.000024832598,0.00023076448,0.000023519075,0.00012599448,0.0000010860493,0.000023535025,0.000073856834,0.0009114709,0.015600557],"study_design_scores_gemma":[0.010920817,0.00055525824,0.98696035,0.00007552512,0.000022621967,0.000010801232,0.00010736405,0.0010284702,0.00010990712,0.00010686802,0.000024207662,0.000077816105],"about_ca_topic_score_codex":0.00014215066,"about_ca_topic_score_gemma":0.000054681554,"teacher_disagreement_score":0.015522741,"about_ca_system_score_codex":0.00022860373,"about_ca_system_score_gemma":0.00024731175,"threshold_uncertainty_score":0.35449404},"labels":[],"label_agreement":null},{"id":"W4389234604","doi":"10.1182/blood-2023-182330","title":"Clinical Outcomes of Subsequent Therapies in Patients with Relapsed/Refractory Multiple Myeloma Following Talquetamab Treatment: Analyses from the Phase 1/2 MonumenTAL-1 Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Discontinuation; Refractory (planetary science); Internal medicine; Multiple myeloma; Clinical trial; Phases of clinical research; Oncology; Carfilzomib; Lenalidomide; Bortezomib","score_opus":0.0844195497930193,"score_gpt":0.4021215023683741,"score_spread":0.3177019525753548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389234604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99727565,0.0003092122,0.0000012277991,0.00008468292,0.00007549887,0.0019623472,0.00016886937,0.00007131287,0.00005118908],"genre_scores_gemma":[0.9989123,0.000086085565,0.00014890918,0.000032343894,0.000036394875,0.00018534595,0.00041929472,0.00004124689,0.00013812841],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974899,0.00033118343,0.0006248273,0.00045947082,0.0007031186,0.00039145778],"domain_scores_gemma":[0.99791604,0.001011675,0.00016742838,0.0006789998,0.00006224277,0.00016360673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028726796,0.00029768422,0.00077900925,0.0001838044,0.000108109,0.000023632972,0.00017245719,0.00007553818,0.000047893944],"category_scores_gemma":[0.000257536,0.00015231033,0.00033513957,0.00048556615,0.00010163172,0.00011629098,0.00007130245,0.00018438192,0.00003665101],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015985803,0.027783139,0.95420307,0.0000059949552,0.005772359,0.00048196292,0.0014237973,0.000001898346,0.00030514144,4.3138155e-7,0.0000133807025,0.008410244],"study_design_scores_gemma":[0.09930592,0.0058595627,0.8913148,0.00005660722,0.00081880734,4.9568143e-7,0.0016389728,0.000031792228,0.0008139592,0.0000059545846,0.000034119534,0.00011899283],"about_ca_topic_score_codex":0.0020736477,"about_ca_topic_score_gemma":0.0009254428,"teacher_disagreement_score":0.097707346,"about_ca_system_score_codex":0.000091343936,"about_ca_system_score_gemma":0.000100729354,"threshold_uncertainty_score":0.6211035},"labels":[],"label_agreement":null},{"id":"W4389234631","doi":"10.1182/blood-2023-179515","title":"Accuracy of Reticulocyte Hemoglobin for Diagnosing Iron Deficiency in Very Preterm Infants: A Population-Based Cohort Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Medicine; Iron deficiency; Pediatrics; Population; Cohort; Hemoglobin; Ferritin; Anemia; Complete blood count; Soluble transferrin receptor; Internal medicine; Iron status","score_opus":0.013474100753664656,"score_gpt":0.28992098323638915,"score_spread":0.2764468824827245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389234631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972079,0.00035807004,0.000022971644,0.000062936546,0.000103311104,0.0019574899,0.000019317473,0.000059382117,0.00020861295],"genre_scores_gemma":[0.999287,0.000032310076,0.00022689147,0.000080367885,0.000032759683,0.00019408959,0.00010213044,0.000019856347,0.000024576984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885756,0.000042685166,0.00035844964,0.00024975932,0.00025548442,0.0002360366],"domain_scores_gemma":[0.99918294,0.00031485618,0.00010936792,0.00029689047,0.00004840712,0.00004753176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036567147,0.00011711395,0.00030225344,0.00022204172,0.000043339725,0.000009685318,0.00007657173,0.000057138648,0.000015106019],"category_scores_gemma":[0.0010109649,0.00010791907,0.000069506146,0.0004663582,0.000023259883,0.0000689552,0.000024691206,0.00006864349,0.00000516445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013794878,0.0010888663,0.99646467,0.00029823915,0.00000595189,0.000015654403,0.00036781575,0.00012113453,0.0006123181,0.000020344887,0.000055672514,0.00081139436],"study_design_scores_gemma":[0.0076743807,0.00029803705,0.98946524,0.00009980547,0.00024314952,0.0000014523642,0.00036769998,0.00025577596,0.0014296917,0.00003766793,0.000017998671,0.00010909283],"about_ca_topic_score_codex":0.00036597817,"about_ca_topic_score_gemma":0.00009006517,"teacher_disagreement_score":0.007536432,"about_ca_system_score_codex":0.000018306988,"about_ca_system_score_gemma":0.00009023356,"threshold_uncertainty_score":0.4400812},"labels":[],"label_agreement":null},{"id":"W4389234641","doi":"10.1182/blood-2023-187651","title":"Clonal Dynamics of Gene Mutations during Oral Azacitidine Maintenance Therapy in Patients with Acute Myeloid Leukemia (AML): Outcomes from the QUAZAR AML-001 Trial","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Azacitidine; Internal medicine; Myeloid leukemia; Medicine; Oncology; Minimal residual disease; Leukemia; Myeloid; Bone marrow; Gastroenterology; Biology; Gene; DNA methylation; Genetics","score_opus":0.018204964939673364,"score_gpt":0.27544827239026953,"score_spread":0.25724330745059615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389234641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963583,0.000031705684,0.00003063893,0.001281978,0.00011103291,0.0013661272,0.0006109668,0.00008623676,0.00012301892],"genre_scores_gemma":[0.9961639,0.00014765873,0.0009581091,0.00016874303,0.00014576255,0.00013607554,0.0015792821,0.00006546865,0.0006350148],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99763364,0.00012334196,0.00052434456,0.0003957063,0.0007839718,0.0005389909],"domain_scores_gemma":[0.998564,0.00035311928,0.00017613661,0.00055488065,0.00023297333,0.00011886899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033410147,0.00025785062,0.0005459122,0.00022002518,0.00012002087,0.000025233407,0.0003400329,0.00012736791,0.00008753434],"category_scores_gemma":[0.00020283877,0.00016020458,0.00012312333,0.0008770518,0.00020956762,0.00011907377,0.000097958626,0.00048535288,0.000039580635],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03294369,0.001509003,0.95445406,0.000038729868,0.0017484062,0.00042690398,0.0010402123,0.00014325813,0.0043008407,0.00014624487,0.00042783865,0.0028208352],"study_design_scores_gemma":[0.16802312,0.000827286,0.8268943,0.000064472566,0.0001589437,0.000009430015,0.00022439138,0.0006467536,0.0028458603,0.00008720513,0.000041852276,0.00017637883],"about_ca_topic_score_codex":0.00095885183,"about_ca_topic_score_gemma":0.00046025802,"teacher_disagreement_score":0.13507944,"about_ca_system_score_codex":0.00042942664,"about_ca_system_score_gemma":0.0005746097,"threshold_uncertainty_score":0.65329534},"labels":[],"label_agreement":null},{"id":"W4389234664","doi":"10.1182/blood-2023-190426","title":"Treatment Patterns and Healthcare Resource Utilization Among Patients with Triple Class Exposed Multiple Myeloma: A Population-Based Cohort Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Juravinski Cancer Centre; Institute for Clinical Evaluative Sciences; Population Health Research Institute; McMaster University; Ottawa Hospital","funders":"","keywords":"Medicine; Pomalidomide; Daratumumab; Lenalidomide; Population; Regimen; Multiple myeloma; Internal medicine; Health care; Clinical trial; Oncology","score_opus":0.036318336607746644,"score_gpt":0.2969344160111481,"score_spread":0.2606160794034015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389234664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950722,0.000025024372,0.000011675388,0.0001386511,0.000024180108,0.004348325,0.00014405293,0.00019701512,0.000038911134],"genre_scores_gemma":[0.9958893,0.000010934592,0.00006123019,0.000031333013,0.000037851816,0.0005737974,0.0031247209,0.000048841695,0.00022198926],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99807346,0.0001545091,0.00027597707,0.00050351874,0.00059862743,0.0003939023],"domain_scores_gemma":[0.99892163,0.00012912921,0.00009548556,0.0004048498,0.00012776729,0.0003211437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010765552,0.0002412038,0.00036516602,0.00024866324,0.00022271609,0.000036103873,0.000049388545,0.00007327466,0.000018374561],"category_scores_gemma":[0.00010259295,0.00017371736,0.000050555434,0.00040646098,0.000029035233,0.00006679337,0.000028476194,0.00008803642,0.000012103091],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065609446,0.0034368583,0.991245,0.000072049756,0.00032130716,0.00016437074,0.00031557606,0.000009677555,0.000007943064,7.770828e-7,0.000013780521,0.0037566212],"study_design_scores_gemma":[0.036924373,0.0036937762,0.9565179,0.0000714738,0.00024945298,0.0000022773131,0.00033750225,0.0017925529,0.00023353481,9.106486e-7,0.00003838938,0.00013786858],"about_ca_topic_score_codex":0.0032505577,"about_ca_topic_score_gemma":0.0028244255,"teacher_disagreement_score":0.03626828,"about_ca_system_score_codex":0.0001468152,"about_ca_system_score_gemma":0.0000799021,"threshold_uncertainty_score":0.7083988},"labels":[],"label_agreement":null},{"id":"W4389234725","doi":"10.1182/blood-2023-173855","title":"The Composite Health Risk Assessment Model (CHARM) to Predict 1-Year Non-Relapse Mortality (NRM) Among Older Recipients of Allogeneic Transplantation: A Prospective BMT-CTN Study 1704","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Frailty in Older Adults","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Transplantation; Prospective cohort study; Internal medicine; Comorbidity; Hematopoietic cell; Gerontology; Stem cell; Haematopoiesis","score_opus":0.022775993550660695,"score_gpt":0.3339378007972543,"score_spread":0.31116180724659365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389234725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923865,0.00004962996,0.0008358566,0.00058311864,0.00023991734,0.0049001044,0.00037508865,0.00015619199,0.00047357456],"genre_scores_gemma":[0.9974147,0.00028935442,0.00094978156,0.00011788085,0.00009623472,0.0005310624,0.000101164835,0.00005124535,0.0004485747],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970383,0.00021080594,0.00070368004,0.00058962574,0.0009717888,0.0004857732],"domain_scores_gemma":[0.9982764,0.00013018795,0.00027233674,0.0007623695,0.00024892238,0.0003097745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010552851,0.0002720686,0.00052066543,0.00013714631,0.0002952421,0.000031567524,0.00026552897,0.000082630635,0.000014213384],"category_scores_gemma":[0.00005818718,0.00020846656,0.00013888784,0.00059136254,0.00009913002,0.00009438407,0.00008952737,0.00038213623,0.00003738957],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018587636,0.0024687673,0.98344594,0.00016307684,0.0007841964,0.00004842382,0.009626013,0.001633262,0.0005943976,0.000012799,0.0007698193,0.00026743967],"study_design_scores_gemma":[0.009046053,0.0016077,0.9819381,0.00032332214,0.0006852766,0.000009744722,0.0009883253,0.0042086225,0.00095828617,0.000057867303,0.00000571925,0.00017093477],"about_ca_topic_score_codex":0.00066720234,"about_ca_topic_score_gemma":0.0008164652,"teacher_disagreement_score":0.0088601755,"about_ca_system_score_codex":0.00013305253,"about_ca_system_score_gemma":0.00028430676,"threshold_uncertainty_score":0.85010195},"labels":[],"label_agreement":null},{"id":"W4389234736","doi":"10.1182/blood-2023-179156","title":"Epigenetic Profiling and Machine Learning for Enhanced Risk Stratification in Pediatric Acute Lymphoblastic Leukemia","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Oncology; DNA methylation; Medicine; Proportional hazards model; Cohort; Concordance; Internal medicine; Receiver operating characteristic; Framingham Risk Score; Biology","score_opus":0.01737857319009834,"score_gpt":0.28018364602405427,"score_spread":0.26280507283395593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389234736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928545,0.0003753947,0.005243884,0.0000797183,0.000053951728,0.0010129046,0.000023158198,0.00015444463,0.00020207881],"genre_scores_gemma":[0.9942128,0.0018585413,0.0026220763,0.00001684195,0.0002110676,0.00026739933,0.00017385953,0.00005102515,0.000586402],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983166,0.000075619086,0.0003642228,0.00046145808,0.0003030017,0.00047909358],"domain_scores_gemma":[0.99880695,0.000603132,0.00011789483,0.00022171922,0.000096890966,0.00015338551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004997421,0.00017880174,0.0003016327,0.00039600924,0.0001299307,0.00003226231,0.00009771366,0.00013608015,0.000010384798],"category_scores_gemma":[0.0010669063,0.00016502837,0.000053495118,0.0007986753,0.000047654394,0.000062302905,0.000066699824,0.00027674294,0.000055875134],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012767622,0.0005952674,0.524484,0.0020350555,0.00047841575,0.00030101498,0.0018019581,0.0036115514,0.44255006,0.00022859537,0.00016658203,0.022470774],"study_design_scores_gemma":[0.034202985,0.0019389639,0.39102188,0.00018440458,0.0018373282,0.00014265286,0.0003472113,0.30435294,0.26431796,0.00092172023,0.00008757232,0.0006443548],"about_ca_topic_score_codex":0.000051538034,"about_ca_topic_score_gemma":0.000025252473,"teacher_disagreement_score":0.3007414,"about_ca_system_score_codex":0.00026738964,"about_ca_system_score_gemma":0.00067593093,"threshold_uncertainty_score":0.6729662},"labels":[],"label_agreement":null},{"id":"W4389234798","doi":"10.1182/blood-2023-190501","title":"Facilitators and Barriers to Accessing Antifibrinolytic and Iron Therapies for Patients Who Menstruate - a Global Healthcare Provider Survey","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Ovarian function and disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; St. Michael's Hospital","funders":"","keywords":"Antifibrinolytic; Medicine; Medical prescription; Formulary; Health care; Iron supplementation; Family medicine; Anemia; Intensive care medicine; Pediatrics; Internal medicine; Iron deficiency; Tranexamic acid; Surgery; Pharmacology","score_opus":0.025484584211423706,"score_gpt":0.297959261457761,"score_spread":0.27247467724633734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389234798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970532,0.00024400896,0.000023576358,0.0015595133,0.00012048973,0.0006598179,0.00018052553,0.00007083953,0.00008800651],"genre_scores_gemma":[0.99882954,0.000035794306,0.00015149331,0.00070462946,0.000017208673,0.0000251842,0.00004405999,0.000012115398,0.00017999749],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99921,0.000041001622,0.00013873707,0.00026292092,0.00012431791,0.00022301673],"domain_scores_gemma":[0.99944717,0.00005006584,0.000028747034,0.00010843066,0.000074638025,0.00029094797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015555655,0.00010824456,0.00017543291,0.000061471386,0.00014229384,0.00005159926,0.000024196526,0.000049783917,0.000009451767],"category_scores_gemma":[0.0003659487,0.00009331684,0.000022941562,0.00022448073,0.000046700527,0.00007187995,0.000034094606,0.000036319692,0.000005082089],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019357356,0.00002408171,0.9851911,0.00023351744,0.000044941225,0.0000013826525,0.0007406938,3.3409128e-7,0.000032548556,0.00002655117,0.0007910973,0.012720197],"study_design_scores_gemma":[0.0037925753,0.00042912737,0.99356693,0.000057170993,0.000042454827,0.0000026820837,0.0009518445,0.000050063973,0.000030169718,0.00008684687,0.00088867155,0.00010148607],"about_ca_topic_score_codex":0.00021688888,"about_ca_topic_score_gemma":0.00013777666,"teacher_disagreement_score":0.012618711,"about_ca_system_score_codex":0.000015104235,"about_ca_system_score_gemma":0.00008069448,"threshold_uncertainty_score":0.38053504},"labels":[],"label_agreement":null},{"id":"W4389234838","doi":"10.1182/blood-2023-178546","title":"Long-Term Evaluation of Luspatercept in Erythropoiesis-Stimulating Agent (ESA)-Intolerant/Refractory Patients (pts) with Lower-Risk Myelodysplastic Syndromes (LR-MDS) in the Phase 3 MEDALIST Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Cumulative incidence; Myelodysplastic syndromes; Internal medicine; Adverse effect; Anemia; International Prognostic Scoring System; Refractory (planetary science); Phases of clinical research; Clinical trial; Surgery; Gastroenterology; Cohort; Bone marrow","score_opus":0.04973880724398392,"score_gpt":0.3599468793225341,"score_spread":0.31020807207855017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389234838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99636436,0.000079422185,0.000016601713,0.00009979797,0.00011347076,0.0030918168,0.00003687081,0.00005444687,0.00014322839],"genre_scores_gemma":[0.99927753,0.000044729622,0.00003773209,0.000028370006,0.00006782303,0.00026609135,0.00016742617,0.00005741298,0.000052874137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99507415,0.00092415564,0.00069594703,0.0005465481,0.0022034622,0.00055575767],"domain_scores_gemma":[0.9979809,0.0005611445,0.00026542527,0.0006956977,0.0003796436,0.00011720746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028253263,0.00031028898,0.00058869837,0.0006647825,0.00011441596,0.000038459613,0.00032492308,0.00011424063,0.00020654198],"category_scores_gemma":[0.0010832691,0.00021043583,0.00007691735,0.0013804986,0.00016248501,0.00016559844,0.00013939201,0.0006083914,0.000062257546],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081536267,0.009301416,0.9677054,0.00022893767,0.00025193827,0.0008140899,0.009726801,0.0009049916,0.0006419676,7.0490955e-7,0.00006326559,0.009545072],"study_design_scores_gemma":[0.043768153,0.004611858,0.9373054,0.00050466415,0.00075254386,0.000026742104,0.0026273704,0.010010207,0.00017222737,0.0000063219727,0.0000041800745,0.0002103519],"about_ca_topic_score_codex":0.00059319317,"about_ca_topic_score_gemma":0.0012337249,"teacher_disagreement_score":0.042952787,"about_ca_system_score_codex":0.00041547423,"about_ca_system_score_gemma":0.00042118004,"threshold_uncertainty_score":0.8581324},"labels":[],"label_agreement":null},{"id":"W4389234851","doi":"10.1182/blood-2023-191036","title":"Uncovering the Role of CD59 As a Novel Therapeutic Target Against High-Risk Acute Myeloid Leukemia","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"Servier; Agios Pharmaceuticals","keywords":"Myeloid leukemia; CD59; Leukemia; Myeloid; Cytarabine; Cancer research; Biology; Haematopoiesis; Immunology; Medicine; Oncology; Stem cell; Complement system; Immune system; Genetics","score_opus":0.01193553498185994,"score_gpt":0.26290042385715845,"score_spread":0.2509648888752985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389234851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912616,0.000677689,0.000070350376,0.0007515591,0.00011053245,0.0006127609,0.00009673115,0.000218215,0.0062005883],"genre_scores_gemma":[0.9953688,0.001044511,0.00068949297,0.00057571323,0.00030841588,0.00007644517,0.00007860092,0.00008511415,0.0017729029],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99777716,0.00007953017,0.000376749,0.0003937398,0.00074311777,0.0006296896],"domain_scores_gemma":[0.9983879,0.0003038266,0.00015630547,0.00083477533,0.00014759647,0.00016962271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063596846,0.00025315848,0.00045237906,0.00021808165,0.00017614313,0.000031091553,0.00045379778,0.00016690377,0.00008960823],"category_scores_gemma":[0.0002299459,0.00017271805,0.00019278176,0.0010367678,0.00017462911,0.00009034161,0.0002944385,0.0006942164,0.0004765256],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047948427,0.00045305092,0.025772061,0.00013411578,0.002880878,0.00027475596,0.0019878235,0.0007537069,0.94478273,0.0010902373,0.0012193905,0.02017175],"study_design_scores_gemma":[0.019246668,0.001361177,0.08882179,0.0002858283,0.0018677228,0.0003186697,0.003173252,0.0067329807,0.82767326,0.006065142,0.043723203,0.0007303066],"about_ca_topic_score_codex":0.0007420753,"about_ca_topic_score_gemma":0.000015774885,"teacher_disagreement_score":0.117109485,"about_ca_system_score_codex":0.00023709545,"about_ca_system_score_gemma":0.0008844789,"threshold_uncertainty_score":0.70432377},"labels":[],"label_agreement":null},{"id":"W4389234861","doi":"10.1182/blood-2023-175079","title":"Identification of Risk Categories from the Advanced-Stage Hodgkin International Prognostic Index (A-HIPI) Model: A Detailed Analysis from the Hodgkin Lymphoma International Study for Individual Care (HoLISTIC) Consortium","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; International Prognostic Index; Clinical trial; Internal medicine; Oncology; Stage (stratigraphy); Lymphoma; Medical physics; Diffuse large B-cell lymphoma","score_opus":0.029666469429999193,"score_gpt":0.3083927011317674,"score_spread":0.27872623170176825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389234861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98657817,0.00040198956,0.0016546508,0.00054294633,0.00037635455,0.0014916195,0.008839926,0.00007988621,0.00003445475],"genre_scores_gemma":[0.99362063,0.000111294794,0.00030731136,0.000080550555,0.00024376529,0.0010767232,0.0044657364,0.000029233677,0.00006477799],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976949,0.00012896354,0.00065909605,0.00051115593,0.00078937,0.00021652383],"domain_scores_gemma":[0.9968172,0.0015475837,0.0005090142,0.0005963152,0.000464131,0.00006577746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035632803,0.00023959567,0.00040400145,0.00018322798,0.00020281422,0.00013366994,0.0005367113,0.000081427694,0.000049506052],"category_scores_gemma":[0.0011072798,0.00015051717,0.00028964342,0.0005492584,0.00010724982,0.000111425885,0.00018106936,0.000089119276,0.000014373847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027301535,0.0013732117,0.9744462,0.000007726366,0.0075373244,0.00002002414,0.008691281,0.0023210119,0.000103301034,0.00019442591,0.00014396568,0.00488856],"study_design_scores_gemma":[0.008748454,0.00012301166,0.95175725,0.000029867866,0.008485482,0.0000011726294,0.015454359,0.01308321,0.0014304053,0.0006531184,0.00009486968,0.00013878396],"about_ca_topic_score_codex":0.0013537556,"about_ca_topic_score_gemma":0.0027948578,"teacher_disagreement_score":0.022688886,"about_ca_system_score_codex":0.00011559254,"about_ca_system_score_gemma":0.00019273291,"threshold_uncertainty_score":0.61379117},"labels":[],"label_agreement":null},{"id":"W4389234876","doi":"10.1182/blood-2023-180107","title":"Progression-Free Survival (PFS) and Toxicity with Nivolumab-AVD Compared to Brentuximab Vedotin-AVD in Pediatric Advanced Stage (AS) Classic Hodgkin Lymphoma (cHL), Results of SWOG S1826","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Internal medicine; Brentuximab vedotin; Oncology; Clinical endpoint; Chemotherapy regimen; Progression-free survival; Nivolumab; Randomized controlled trial; Chemotherapy; Cancer; Lymphoma; Hodgkin lymphoma; Immunotherapy","score_opus":0.015254296584439435,"score_gpt":0.277822775644979,"score_spread":0.26256847906053954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389234876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99534154,0.00059369794,0.000003259663,0.0008184123,0.0001322529,0.0012810878,0.00023357433,0.00016456148,0.0014316046],"genre_scores_gemma":[0.9976018,0.00039497472,0.0010504453,0.00008169691,0.00012099614,0.0001972685,0.0001220288,0.000051718063,0.00037905335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99719965,0.00010646136,0.00062507135,0.0007189358,0.0007808893,0.0005689871],"domain_scores_gemma":[0.99816716,0.0003216035,0.00025076838,0.0007731524,0.00013646473,0.00035083108],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035510564,0.0003599216,0.00079658587,0.00039310526,0.000089275825,0.000032072367,0.00021923502,0.00012296179,0.000017438202],"category_scores_gemma":[0.00034239743,0.00027884846,0.00009006563,0.0012255135,0.00008845857,0.00010522585,0.00025349995,0.00009968318,0.000046843412],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005055043,0.00884899,0.9608594,0.00048639224,0.0002348744,0.0012930367,0.0010757193,0.00004245042,0.002524982,0.00010010633,0.0014154966,0.018063493],"study_design_scores_gemma":[0.07209186,0.0027272834,0.90584314,0.00048525404,0.00032460492,0.000043902735,0.00041089498,0.00011081122,0.017111551,0.000036651705,0.000483565,0.0003304621],"about_ca_topic_score_codex":0.0003733764,"about_ca_topic_score_gemma":0.0008550507,"teacher_disagreement_score":0.067036815,"about_ca_system_score_codex":0.00013599143,"about_ca_system_score_gemma":0.00032305662,"threshold_uncertainty_score":0.9999664},"labels":[],"label_agreement":null},{"id":"W4389234885","doi":"10.1182/blood-2023-180114","title":"Nivolumab-AVD Is Better Tolerated and Improves Progression-Free Survival Compared to Bv-AVD in Older Patients (Aged ≥60 Years) with Advanced Stage Hodgkin Lymphoma Enrolled on SWOG S1826","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Internal medicine; Clinical endpoint; Neutropenia; Progression-free survival; Regimen; Chemotherapy regimen; Phases of clinical research; Surrogate endpoint; Oncology; Surgery; Clinical trial; Chemotherapy","score_opus":0.009811042039027357,"score_gpt":0.25776014205619513,"score_spread":0.24794910001716777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389234885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99668866,0.00008538471,7.933218e-7,0.00077142654,0.000117129646,0.0017744692,0.00011169996,0.00015088687,0.00029956902],"genre_scores_gemma":[0.997386,0.00003024784,0.0005309282,0.0007782045,0.000052860072,0.00042827232,0.00016668058,0.00006241748,0.000564398],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99783844,0.00009723829,0.00035634986,0.00063246285,0.0005821856,0.0004933038],"domain_scores_gemma":[0.99885446,0.00011491546,0.00011044485,0.0005713359,0.000092053975,0.00025676348],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015532374,0.00033494504,0.00060507463,0.00024954413,0.000088124434,0.00005847151,0.0001361828,0.00010861955,0.000060873743],"category_scores_gemma":[0.000071693656,0.0002502302,0.00006557109,0.0005392281,0.000044004915,0.000076609744,0.00013806923,0.00009164489,0.000077950375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018889926,0.0062936875,0.94578767,0.00011141198,0.0003419426,0.0012666441,0.0018893577,0.000008562624,0.0023311167,0.0000046046016,0.0025568197,0.037519213],"study_design_scores_gemma":[0.063637964,0.0019197385,0.923796,0.0004849442,0.000111649184,0.000003984592,0.0002059817,0.00004718616,0.0091142915,0.0000060153097,0.00040201927,0.00027019644],"about_ca_topic_score_codex":0.00015363753,"about_ca_topic_score_gemma":0.00017559048,"teacher_disagreement_score":0.061748974,"about_ca_system_score_codex":0.000107758286,"about_ca_system_score_gemma":0.00008562521,"threshold_uncertainty_score":0.999995},"labels":[],"label_agreement":null},{"id":"W4389234887","doi":"10.1182/blood-2023-174550","title":"Trial in Progress: A Phase 1 Study of KTX-1001, an Oral, First-in-Class, Selective MMSET Inhibitor in Patients with Relapsed and Refractory Multiple Myeloma","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Tolerability; Medicine; Multiple myeloma; Internal medicine; Oncology; Population; Pharmacodynamics; Pharmacokinetics; Cmax; Adverse effect; Pharmacology; Phases of clinical research; Refractory (planetary science); Clinical trial; Biology","score_opus":0.008988037532944677,"score_gpt":0.25989733269902543,"score_spread":0.25090929516608074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389234887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99841017,0.0001005208,3.6041945e-7,0.000014833373,0.000051245283,0.0013815307,0.00002424938,0.000011114669,0.000006006713],"genre_scores_gemma":[0.9995017,0.00001620775,0.000039662704,0.0000032215485,0.00005165484,0.0001444427,0.0002119033,0.000021841133,0.000009349169],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99889547,0.00011470166,0.00028292878,0.0003738492,0.00014896704,0.00018407126],"domain_scores_gemma":[0.99956316,0.00001656503,0.00011726299,0.00020453597,0.00005852911,0.0000399406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001670926,0.00012974648,0.00019845944,0.0001775514,0.000022582084,0.000008528153,0.0000639112,0.0001456057,0.0000013130862],"category_scores_gemma":[0.00007100222,0.00012389148,0.00001671182,0.00045438696,0.000043169373,0.0000118748185,0.000045792374,0.00010669485,4.6788264e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032892473,0.0126555115,0.93486965,0.000031975324,0.000092807466,0.000015476013,0.0014344868,0.00021297765,0.014014922,3.4543794e-7,0.00011884225,0.0036605329],"study_design_scores_gemma":[0.24407814,0.015017593,0.72202533,0.00006617933,0.0000360032,7.501935e-7,0.0003396547,0.00024595458,0.017818198,0.0000041033336,0.00015615794,0.0002119251],"about_ca_topic_score_codex":0.00013101193,"about_ca_topic_score_gemma":0.007939075,"teacher_disagreement_score":0.21284431,"about_ca_system_score_codex":0.00003170059,"about_ca_system_score_gemma":0.00008262536,"threshold_uncertainty_score":0.5052148},"labels":[],"label_agreement":null},{"id":"W4389234911","doi":"10.1182/blood-2023-177979","title":"Efficacy and Safety Outcomes in Patients with Cancer-Associated Thromboembolism Treated with Tinzaparin According to the Tumor Site: Meta-Analysis of Prospective Studies Involving 1413 Individual Patients' Data","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Prospective cohort study; Cumulative incidence; Confidence interval; Low molecular weight heparin; Surgery; Thrombosis; Oncology; Cohort","score_opus":0.0663079966378825,"score_gpt":0.31963603266577273,"score_spread":0.2533280360278902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389234911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962679,0.0003423175,7.1951825e-7,0.0003657386,0.00002457294,0.0021994202,0.0006926578,0.000063403044,0.000043284694],"genre_scores_gemma":[0.99860424,0.00011807206,0.00007355991,0.00028462792,0.000012019787,0.00023969897,0.0006048839,0.00003535543,0.00002752463],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99769473,0.00011221369,0.0004910286,0.0006330798,0.00068559276,0.00038337396],"domain_scores_gemma":[0.9982778,0.00031286172,0.00032320787,0.0007038206,0.00029502637,0.000087272994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052937114,0.00031105443,0.0021370207,0.00048381818,0.00016417493,0.000039463972,0.0002810411,0.00004024443,0.000017741228],"category_scores_gemma":[0.00040008806,0.00016493449,0.000114280585,0.002486129,0.00008734931,0.00015202288,0.0006370916,0.00015504668,0.0000028114719],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014524008,0.0022453144,0.8554604,0.00004187094,0.13836281,0.000006953369,0.0032370572,0.00018674284,0.000002278432,0.000018095048,0.00016072665,0.00013253269],"study_design_scores_gemma":[0.0062376475,0.0006571003,0.83360344,0.000071835086,0.15789525,7.390165e-8,0.0012928866,0.000023174007,0.00003999109,0.0000023762943,0.00000985785,0.00016636134],"about_ca_topic_score_codex":0.0015190238,"about_ca_topic_score_gemma":0.004924689,"teacher_disagreement_score":0.021856943,"about_ca_system_score_codex":0.00007693368,"about_ca_system_score_gemma":0.000046271736,"threshold_uncertainty_score":0.67258334},"labels":[],"label_agreement":null},{"id":"W4389234913","doi":"10.1182/blood-2023-177740","title":"Somatic TET2 Mutations Prime the Immune System for Response to Immune Checkpoint Blockade","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Immune system; Cancer research; Immune checkpoint; Biology; Bone marrow; CD8; Haematopoiesis; Immunotherapy; Immunology; Stem cell; Genetics","score_opus":0.011929741797777962,"score_gpt":0.26230454405921977,"score_spread":0.2503748022614418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389234913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99437344,0.0014959614,0.002185431,0.0008524964,0.00015948084,0.00069190643,0.000037974325,0.00004967453,0.00015363128],"genre_scores_gemma":[0.9972743,0.000026631089,0.0009929417,0.0000062072736,0.00015338347,0.00028776395,0.00013297504,0.000030548836,0.0010952803],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99901086,0.0001115094,0.00030785645,0.00022651356,0.000112796566,0.00023047697],"domain_scores_gemma":[0.9991902,0.00010083798,0.00008852329,0.00047451525,0.00009054557,0.000055363984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008187502,0.00011775906,0.00012621992,0.000061248276,0.00020111422,0.000035831767,0.00019904117,0.00008906334,0.0000027853137],"category_scores_gemma":[0.0004298668,0.000093174174,0.00012747501,0.00021232791,0.000027663873,0.0000016570186,0.00009771277,0.00004521709,0.000058527],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000882203,0.000048011974,0.00008514748,0.000031535805,0.00006277983,0.000001291,0.00017187305,0.00020707157,0.99891514,0.000009651016,0.0000017801815,0.00037750736],"study_design_scores_gemma":[0.0008284484,0.0002481789,0.008300431,0.000026378857,0.000065754044,0.0000043703562,0.00031235738,0.00017701065,0.9858839,0.000103717815,0.003923474,0.0001260027],"about_ca_topic_score_codex":0.000011513474,"about_ca_topic_score_gemma":0.0000050929534,"teacher_disagreement_score":0.0130312545,"about_ca_system_score_codex":0.000010968352,"about_ca_system_score_gemma":0.00007053954,"threshold_uncertainty_score":0.37995324},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"bench_or_experimental","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"bench_or_experimental","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W4389235010","doi":"10.1182/blood-2023-190081","title":"Transcriptomic Analysis of Clonal Hematopoiesis in Solid Tumors Reveals Driver Mutation-Specific Patterns of Immune Dysregulation","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Biology; Transcriptome; CDKN2A; Cancer research; Cancer; Adenocarcinoma; Exome sequencing; Germline mutation; Lung cancer; Exome; Somatic evolution in cancer; Gene; Genetics; Mutation; Oncology; Medicine; Gene expression","score_opus":0.008595147397561951,"score_gpt":0.24001788461224954,"score_spread":0.2314227372146876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389235010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99879086,0.0004304439,0.00035542913,0.00002910511,0.000041153053,0.00009512298,0.00021461735,0.0000042944594,0.000038987862],"genre_scores_gemma":[0.9987889,0.00042334874,0.000112378875,0.000012476745,0.000030751893,0.000011460185,0.000573219,0.000011109164,0.000036354093],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99916875,0.000023603488,0.00040694058,0.0001791107,0.00010177768,0.00011979857],"domain_scores_gemma":[0.999523,0.00002842249,0.0001439971,0.00021591867,0.000065306245,0.000023371857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001371346,0.00008168542,0.000253093,0.0002342859,0.000015032188,0.000005086417,0.000096315736,0.00006559593,0.000028959848],"category_scores_gemma":[0.0000237824,0.00009084364,0.00016550346,0.00044067626,0.000029571354,0.0000023300706,0.000027599315,0.000028065197,0.0000016686358],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032670396,0.00014455275,0.11101325,0.000042662265,0.00037112297,0.0000058415976,0.00027827432,0.003794607,0.8838455,0.00020867339,0.000053921445,0.00020891124],"study_design_scores_gemma":[0.00065991405,0.00005345393,0.596874,0.000020833546,0.00017913365,0.0000012854132,0.00010981605,0.00019069691,0.40169284,0.00009321496,0.00004429566,0.00008052973],"about_ca_topic_score_codex":0.00008061242,"about_ca_topic_score_gemma":0.00019227849,"teacher_disagreement_score":0.48586074,"about_ca_system_score_codex":0.0000076124006,"about_ca_system_score_gemma":0.000030714287,"threshold_uncertainty_score":0.3704496},"labels":[],"label_agreement":null},{"id":"W4389235020","doi":"10.1182/blood-2023-178696","title":"Inhibiting Mitochondrial RNA Degradosome Complex SUV3 and PNPT1 Increases dsRNA in the Cytoplasm, Triggers Viral Mimicry Response and Sensitizes AML Cells to Immune Mediated Killing","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Biology; RNA Helicase A; Molecular biology; Gene knockdown; Small hairpin RNA; Gene; RNA; Mitochondrial DNA; RNA silencing; RNA interference; Cell biology; Genetics; Helicase","score_opus":0.014632703423219331,"score_gpt":0.23650155125431713,"score_spread":0.22186884783109778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389235020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99677086,0.0014112749,0.0000031516784,0.0008286512,0.00030421233,0.0004232516,0.00009421239,0.00011411168,0.00005027556],"genre_scores_gemma":[0.9986779,0.00030065284,0.00008156892,0.0003965774,0.00005066403,0.00002682268,0.000098220204,0.000029739698,0.00033787396],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974026,0.0010995014,0.0004836212,0.00038279954,0.0000670114,0.00056445866],"domain_scores_gemma":[0.9969897,0.0025727125,0.00010701367,0.00024478242,0.000042967364,0.00004281702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008925675,0.00027900736,0.00044525584,0.0004419227,0.0003014924,0.00006939403,0.00019695492,0.00022034514,0.0000359962],"category_scores_gemma":[0.0006065865,0.00021941439,0.00008344845,0.0003738954,0.00027812266,0.000088761684,0.00020218738,0.00039038816,0.00016681971],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046215896,0.00013081846,0.00022362797,0.00001779452,0.00009673182,0.00012436745,0.002218878,0.0000021965982,0.99153477,0.00001942723,0.00046019143,0.0005495819],"study_design_scores_gemma":[0.007809496,0.0006042488,0.030580975,0.00018751073,0.00009636522,0.0005082755,0.0052574663,0.000023283459,0.9517446,0.000024044404,0.0027561677,0.0004075611],"about_ca_topic_score_codex":0.0003851817,"about_ca_topic_score_gemma":0.00006342702,"teacher_disagreement_score":0.03979019,"about_ca_system_score_codex":0.000020229998,"about_ca_system_score_gemma":0.00006352403,"threshold_uncertainty_score":0.89474595},"labels":[],"label_agreement":null},{"id":"W4389235051","doi":"10.1182/blood-2023-190694","title":"Prognostic Role of Multiparameter Flow Cytometry-Based Measurable Residual Disease Assessment in Acute Myeloid Leukemia Patients with FMS3-like Tyrosine Kinase-3 Internal Tandem Duplication (FLT3-ITD)","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Takeda Canada; Merck Canada; Astellas Pharma; Celgene; Sierra Oncology; CTI Biopharma; Gilead Sciences; Jazz Pharmaceuticals; Teva Pharmaceutical Industries; Leukemia and Lymphoma Society; Agios Pharmaceuticals; Bristol-Myers Squibb; Servier; Amgen","keywords":"NPM1; Oncology; Medicine; Myeloid leukemia; Internal medicine; Minimal residual disease; Cumulative incidence; Hazard ratio; Proportional hazards model; Multivariate analysis; Log-rank test; Survival analysis; Leukemia; Biology; Transplantation; Confidence interval; Genetics; Gene","score_opus":0.012998129630276484,"score_gpt":0.27396050043053766,"score_spread":0.2609623708002612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389235051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99685824,0.00012351811,0.00040516854,0.00031270736,0.000052284988,0.0017634287,0.00017915314,0.00015562975,0.00014984231],"genre_scores_gemma":[0.9924081,0.000040243773,0.0056218053,0.000113231385,0.00007084934,0.0004412218,0.0009655565,0.00008784449,0.00025113492],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99650717,0.0001576742,0.00060387293,0.00066687237,0.0013783615,0.0006860584],"domain_scores_gemma":[0.99778664,0.0003088564,0.00021631668,0.00075105275,0.0005147152,0.00042242935],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00057103595,0.00033925156,0.00055146957,0.0008263739,0.000084515785,0.00004727678,0.00032277664,0.00014700808,0.000059693626],"category_scores_gemma":[0.0005299838,0.00027782918,0.000113457645,0.0017367867,0.00015707752,0.00017713764,0.0001511547,0.0006178555,0.0000629334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013944868,0.0015306448,0.97577935,0.00021163939,0.00028427015,0.0002118257,0.0000913889,0.00048923626,0.018096387,0.00001022287,0.00036821453,0.0015323567],"study_design_scores_gemma":[0.015437437,0.00091188407,0.94132453,0.00056694116,0.0005067957,0.000006079086,0.0000589956,0.024386939,0.016412593,0.000025599027,0.00009175465,0.00027042322],"about_ca_topic_score_codex":0.00020030755,"about_ca_topic_score_gemma":0.000048670514,"teacher_disagreement_score":0.034454767,"about_ca_system_score_codex":0.00077012606,"about_ca_system_score_gemma":0.0016444564,"threshold_uncertainty_score":0.9999674},"labels":[],"label_agreement":null},{"id":"W4389235066","doi":"10.1182/blood-2023-181190","title":"How Much Furosemide Should be Administered to Prevent Transfusion-Associated Circulatory Overload? Results of a Dose-Finding Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; Sunnybrook Health Science Centre; Health Sciences Centre; University Health Network","funders":"","keywords":"Furosemide; Medicine; Dosing; Renal function; Anesthesia; Surgery; Internal medicine","score_opus":0.06355463520179216,"score_gpt":0.32103197353432145,"score_spread":0.2574773383325293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389235066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949383,0.0001944824,5.6563084e-7,0.002113702,0.00013346078,0.0013589174,0.00030873233,0.00020087462,0.0007509711],"genre_scores_gemma":[0.99767125,0.000029640281,0.000012728619,0.00039382014,0.000101406455,0.00008663505,0.0001494925,0.000040698465,0.0015143439],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.997953,0.000089738605,0.00043093835,0.00046761578,0.0006305544,0.00042815483],"domain_scores_gemma":[0.9986588,0.00017138591,0.00011915751,0.00052438636,0.00009172499,0.0004345731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046480086,0.00021227913,0.0004887138,0.00023135217,0.000082320556,0.0000279006,0.00013825367,0.00011747436,0.000034800978],"category_scores_gemma":[0.001039139,0.00019755877,0.00021245035,0.0007274689,0.000027873653,0.000059622504,0.00007859507,0.00016153487,0.000017458118],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017997259,0.033998035,0.24274015,0.0011192815,0.0032705902,0.0010826864,0.0200845,0.0000102542635,0.66058344,0.000047859652,0.032378078,0.0028854252],"study_design_scores_gemma":[0.051686723,0.004906801,0.8032715,0.0012138728,0.0029515729,0.000013447703,0.010171923,0.00007235345,0.12201929,0.000086782435,0.0029105362,0.0006952481],"about_ca_topic_score_codex":0.000060837185,"about_ca_topic_score_gemma":0.00007212465,"teacher_disagreement_score":0.5605313,"about_ca_system_score_codex":0.00008631748,"about_ca_system_score_gemma":0.00039667147,"threshold_uncertainty_score":0.80562127},"labels":[],"label_agreement":null},{"id":"W4389235092","doi":"10.1182/blood-2023-173609","title":"Assessing the Impact of Marginalization on Survival for Patients Undergoing Autologous Stem Cell Transplant in Ontario, Canada","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; St. Michael's Hospital; Canadian Blood Services; Health Sciences Centre; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Population; Ethnic group; Multiple myeloma; Socioeconomic status; Internal medicine; Proportional hazards model; Gerontology; Demography; Oncology; Environmental health","score_opus":0.03194161488123259,"score_gpt":0.23817766723276157,"score_spread":0.20623605235152898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389235092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993166,0.00006386761,0.00017201238,0.00004737147,0.00028642928,0.0002218308,0.000178304,0.000009290691,0.0058548725],"genre_scores_gemma":[0.99957615,0.000034411245,0.0000133669455,0.000027900423,0.000021977343,0.000015076,0.000043738146,0.000015389282,0.00025197185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99915826,0.000010071698,0.00038462944,0.00017769857,0.000026827684,0.00024250954],"domain_scores_gemma":[0.99939436,0.00017339029,0.00024808903,0.00013363817,0.00001871818,0.000031791344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025619683,0.00010163971,0.0002635322,0.000100798316,0.000063044,0.00003481685,0.00012245937,0.000053693093,0.000029896626],"category_scores_gemma":[0.00002069359,0.000092001465,0.00007808697,0.00013345359,0.000013949883,0.00013571221,0.000009983646,0.00008116812,0.0000060816287],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021818147,0.00014827811,0.9919974,0.000030319781,0.00003198891,0.000001966777,0.00046239045,0.004015409,0.0000031794577,0.002653921,0.00032021143,0.0003130786],"study_design_scores_gemma":[0.0014739017,0.00017120305,0.99569774,0.000029853281,0.000007024457,2.4557997e-7,0.000066508364,0.00075770996,0.00007534819,0.0012361614,0.00036277412,0.000121559235],"about_ca_topic_score_codex":0.7218097,"about_ca_topic_score_gemma":0.8605261,"teacher_disagreement_score":0.1387164,"about_ca_system_score_codex":0.00038023753,"about_ca_system_score_gemma":0.00046259907,"threshold_uncertainty_score":0.37517107},"labels":[],"label_agreement":null},{"id":"W4389235109","doi":"10.1182/blood-2023-173796","title":"Mosunetuzumab Monotherapy Demonstrates Activity and a Manageable Safety Profile in Patients with Relapsed or Refractory Richter's Transformation","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Tolerability; Internal medicine; Transplantation; Neutropenia; Gastroenterology; Clinical endpoint; Refractory (planetary science); Phases of clinical research; Cytokine release syndrome; Rituximab; Adverse effect; Lymphoma; Clinical trial; Cancer; Toxicity; Immunotherapy; Chimeric antigen receptor","score_opus":0.011448898622576973,"score_gpt":0.25482436445354434,"score_spread":0.24337546583096736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389235109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970691,0.00004797916,0.00003304116,0.00014273755,0.000016388049,0.0010626263,0.000019468578,0.00009668914,0.0015119261],"genre_scores_gemma":[0.9984679,0.0001957128,0.00028332887,0.00003227346,0.00001867158,0.00007479442,0.00006183729,0.000028656374,0.00083679566],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99881285,0.000054842036,0.00019679581,0.00025343313,0.00035365002,0.00032842008],"domain_scores_gemma":[0.9994697,0.0001065606,0.000049312865,0.00023056263,0.000046915746,0.000096975855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022768018,0.00013942878,0.00024093507,0.00019560657,0.00006365041,0.000022212174,0.000060645823,0.00009995417,0.00006329194],"category_scores_gemma":[0.000036012138,0.00009746863,0.00002323587,0.0005843738,0.00006470958,0.00025070918,0.000019444775,0.00019562278,0.000030242862],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10982518,0.01688786,0.39140666,0.0053687277,0.0023145266,0.0022513107,0.0174745,0.00031716214,0.011943523,0.00025631228,0.0021148087,0.43983942],"study_design_scores_gemma":[0.18680331,0.0025264528,0.78720075,0.00041457487,0.0001307212,0.0000502494,0.00031709654,0.013456663,0.007969372,0.000045594486,0.00075825385,0.00032697045],"about_ca_topic_score_codex":0.00032028003,"about_ca_topic_score_gemma":0.00017653758,"teacher_disagreement_score":0.43951246,"about_ca_system_score_codex":0.0010611074,"about_ca_system_score_gemma":0.0010730627,"threshold_uncertainty_score":0.39746556},"labels":[],"label_agreement":null},{"id":"W4389235115","doi":"10.1182/blood-2023-174089","title":"Efficacy and Safety of Luspatercept in Patients Enrolled in the BELIEVE Trial: Data from the Phase 3b Long-Term Rollover Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Anemia; Surgery; Randomized controlled trial; Intention-to-treat analysis; Internal medicine","score_opus":0.033362615067451945,"score_gpt":0.31718855691223863,"score_spread":0.2838259418447867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389235115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996285,0.0002831766,4.2214404e-7,0.0004604687,0.000103110644,0.0026285686,0.000087797824,0.000016661423,0.0001347501],"genre_scores_gemma":[0.9991208,0.0002665187,0.0000023333005,0.00016557713,0.000044362176,0.000019488467,0.00032458964,0.000014483132,0.000041856878],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985762,0.00023905576,0.0004207044,0.000281235,0.00029559757,0.00018719555],"domain_scores_gemma":[0.9987967,0.0003258877,0.00008173728,0.00073977077,0.00001889654,0.000036992933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068527996,0.00012636518,0.00032309134,0.00006960998,0.00004628987,0.000013784678,0.0003080173,0.00008322376,0.000044726065],"category_scores_gemma":[0.00028068453,0.000064713066,0.000033871132,0.00042102166,0.00005553384,0.000046657286,0.00021375173,0.00024714746,0.000015817237],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023638053,0.014346275,0.942056,0.000022456541,0.00026415728,0.00011451426,0.012718825,0.0000047514454,0.000089509376,8.771827e-7,0.0005211425,0.0062234476],"study_design_scores_gemma":[0.28618348,0.0010346684,0.71064776,0.000080798214,0.00022040209,7.212408e-7,0.0016761745,0.000041539828,0.0000094635625,0.000004620911,0.000043685042,0.00005671423],"about_ca_topic_score_codex":0.0003117907,"about_ca_topic_score_gemma":0.00025779562,"teacher_disagreement_score":0.2625454,"about_ca_system_score_codex":0.000007720704,"about_ca_system_score_gemma":0.000038293456,"threshold_uncertainty_score":0.26389223},"labels":[],"label_agreement":null},{"id":"W4389235150","doi":"10.1182/blood-2023-178753","title":"Retrospective Analysis of the Relationship between Transfusion Independence and Bone Marrow Fibrosis Reduction in Patients with Myelofibrosis Treated with Pacritinib Versus Ruxolitinib","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Myelofibrosis; Ruxolitinib; Medicine; Internal medicine; Anemia; Bone marrow; Gastroenterology; Fibrosis; Surgery","score_opus":0.02016026273135185,"score_gpt":0.2550750532538174,"score_spread":0.23491479052246556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389235150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985401,0.000025678497,0.000002350481,0.0002890516,0.0000150444,0.00071985956,0.00016752942,0.000038114908,0.0002022904],"genre_scores_gemma":[0.999377,0.000034291977,0.00015919082,0.0000052426003,0.000020181727,0.000094897085,0.00023602163,0.000019405144,0.000053762073],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853504,0.00009889511,0.00028278417,0.00038359562,0.00049398135,0.00020569406],"domain_scores_gemma":[0.99910873,0.00023501118,0.00013052484,0.0002740814,0.00017059693,0.00008104892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014761118,0.00018346164,0.00047226145,0.0003841117,0.00012979258,0.000015018341,0.00004149524,0.00010839044,0.000019324225],"category_scores_gemma":[0.000120414414,0.0001127438,0.00008311919,0.002597497,0.00011593666,0.00009786776,0.000020271149,0.00018383397,0.0000015784279],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010426755,0.00043068588,0.99669224,0.000035027504,0.0007416383,0.0000053065296,0.00058169774,0.000010539,0.00013857127,0.00009363571,0.000005581536,0.00022239446],"study_design_scores_gemma":[0.010729927,0.0017220554,0.97813594,0.0002935599,0.003696285,0.0000020856928,0.000237813,0.000008562013,0.0050363205,0.000020375017,0.0000012311549,0.000115834046],"about_ca_topic_score_codex":0.00024489695,"about_ca_topic_score_gemma":0.00026688614,"teacher_disagreement_score":0.018556295,"about_ca_system_score_codex":0.000076892684,"about_ca_system_score_gemma":0.00004819061,"threshold_uncertainty_score":0.4597559},"labels":[],"label_agreement":null},{"id":"W4389235174","doi":"10.1182/blood-2023-190888","title":"FLT3-Ligand Alone Enables the Identification and Maintenance <i>in Vitro</i> of Viable Quiescent Human Fetal Liver Hematopoietic Stem Cells with Maintenance of Their Function","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Haematopoiesis; Stem cell; Biology; Cord blood; Bone marrow; Cell biology; CD34; Immunology; Population; CD90; CD38; Stem cell factor; Cancer research; Medicine","score_opus":0.013144700505388976,"score_gpt":0.2098330620752906,"score_spread":0.1966883615699016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389235174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99856484,0.0003942132,0.00018002413,0.00015689571,0.000100583995,0.00037738346,0.000016803242,0.00003183667,0.00017744568],"genre_scores_gemma":[0.99738413,0.00037074764,0.000032559252,0.0000919546,0.000039232826,0.00002746172,0.000019119976,0.000015959706,0.0020188203],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99903905,0.00005266787,0.00032593295,0.00023372195,0.00015513119,0.00019346543],"domain_scores_gemma":[0.99930537,0.00006487197,0.00019944568,0.0002884324,0.00010546658,0.000036402995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030228484,0.00012128954,0.00030750607,0.00008651984,0.00006282702,0.0000070248884,0.000065823486,0.000060865343,0.0000121931525],"category_scores_gemma":[0.0000073002125,0.00007327005,0.00004777476,0.0003210706,0.00019458796,0.000051118725,0.000036257377,0.00011330184,0.000010807622],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048029452,0.00026109393,0.0019580347,0.0004689468,0.000057685633,0.000012876846,0.0006418106,0.00002185879,0.99523777,0.00017145005,0.00037549983,0.00031269848],"study_design_scores_gemma":[0.0030755287,0.00048083582,0.026457762,0.0003101145,0.00012597797,0.0000634368,0.0023012676,0.00023130274,0.9662571,0.00011704701,0.0004842835,0.00009534996],"about_ca_topic_score_codex":0.000058536963,"about_ca_topic_score_gemma":0.00004642899,"teacher_disagreement_score":0.028980656,"about_ca_system_score_codex":0.000013079758,"about_ca_system_score_gemma":0.00003072427,"threshold_uncertainty_score":0.2987866},"labels":[],"label_agreement":null},{"id":"W4389235188","doi":"10.1182/blood-2023-179924","title":"Assessment of Minimal Clinically Important Difference in Patient-Reported Myelofibrosis-Associated Symptoms Using an Anchor-Based Analysis Based on MANIFEST Arm 3 Data","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Ruxolitinib; Medicine; Clinical endpoint; Myelofibrosis; Clinical trial; Internal medicine; Minimal clinically important difference; Phlebotomy; Surgery; Randomized controlled trial","score_opus":0.06707208395435149,"score_gpt":0.36133022280332344,"score_spread":0.29425813884897195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389235188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99830544,0.000018696319,0.00006388663,0.00013174696,0.00006339972,0.0007223633,0.000470279,0.00008904833,0.00013511702],"genre_scores_gemma":[0.9936492,0.000021544594,0.0021486885,0.00024560795,0.000032472228,0.00008118941,0.0037762763,0.000036783116,0.000008235117],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99594736,0.0002576385,0.0016201156,0.00090950995,0.000827732,0.00043764483],"domain_scores_gemma":[0.99675786,0.00056727976,0.0008439213,0.0013819465,0.00020223207,0.00024673558],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00085634046,0.00034047887,0.0010523759,0.0006264577,0.00007969596,0.000033365282,0.00023215186,0.00017400757,0.000102071375],"category_scores_gemma":[0.00048497177,0.00028076014,0.000226651,0.0017488061,0.00006913052,0.00007045705,0.00009581822,0.00023552268,0.0000026568562],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000190527,0.01616751,0.9765743,0.000048641705,0.0013766353,0.0007791311,0.00005049912,0.0008167737,0.003612943,0.000010566851,0.000009343802,0.00036310198],"study_design_scores_gemma":[0.0059026657,0.0032452983,0.792143,0.00028973524,0.0028616479,0.000002957569,0.00005039481,0.19334991,0.0019513675,0.0000045645575,0.0000025687345,0.00019590053],"about_ca_topic_score_codex":0.00026683195,"about_ca_topic_score_gemma":0.00041474073,"teacher_disagreement_score":0.19253315,"about_ca_system_score_codex":0.00013377397,"about_ca_system_score_gemma":0.00061350723,"threshold_uncertainty_score":0.9999645},"labels":[],"label_agreement":null},{"id":"W4389235194","doi":"10.1182/blood-2023-182466","title":"Improvement in Survival of Patients with FLT3 Mutated Acute Myeloid Leukemia: Results from a Retrospective Canadian Cohort","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Cytarabine; Internal medicine; Gemtuzumab ozogamicin; Midostaurin; Chemotherapy regimen; Myeloid leukemia; Oncology; Anthracycline; Transplantation; Decitabine; Cohort; Induction chemotherapy; Surgery; Pediatrics; Chemotherapy; Stem cell; Cancer; CD34; CD33","score_opus":0.009014258293375639,"score_gpt":0.24121950704282139,"score_spread":0.23220524874944576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389235194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934717,0.000010356845,0.0000015159021,0.000347981,0.0000866989,0.001273402,0.0019512333,0.000074644195,0.0027824754],"genre_scores_gemma":[0.9966631,0.000047162666,0.00016634892,0.000076732016,0.000069556365,0.0000691857,0.0022233475,0.00005267679,0.0006318774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974099,0.000059844442,0.00048017554,0.0005753944,0.0007984376,0.0006762815],"domain_scores_gemma":[0.99843675,0.000105353465,0.0001262366,0.0005728813,0.00037263328,0.00038617148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044974568,0.00022361723,0.00053809106,0.0005254184,0.00005724732,0.000014453782,0.00020142047,0.00017402746,0.000056499135],"category_scores_gemma":[0.00032245985,0.00018695267,0.00005849145,0.0013910012,0.000110325804,0.00007560555,0.00009876539,0.0005201089,0.000070133545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013835381,0.00023418854,0.99105185,0.00002242273,0.0008275539,0.0008007125,0.0006865814,0.000008824571,0.003629144,0.000010601382,0.00092144584,0.00042312074],"study_design_scores_gemma":[0.021324657,0.0009346046,0.9673941,0.00009817383,0.00023166662,0.0000022778636,0.00020904843,0.00015326423,0.009336287,0.00003195343,0.00010580343,0.00017812134],"about_ca_topic_score_codex":0.28376555,"about_ca_topic_score_gemma":0.15598935,"teacher_disagreement_score":0.12777619,"about_ca_system_score_codex":0.0017859067,"about_ca_system_score_gemma":0.0021302442,"threshold_uncertainty_score":0.85941166},"labels":[],"label_agreement":null},{"id":"W4389235230","doi":"10.1182/blood-2023-186347","title":"Indolent Lymphoma: High CR and VGPR Rate with Fixed Duration Bendamustine, Rituximab and Acalabrutinib in Waldenstroms Macroglobulinaemia (BRAWM)","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Spinal Cord Injury BC; Health Research Foundation; Juravinski Cancer Centre; Sunnybrook Health Science Centre; McGill University Health Centre; University of Calgary; Université Laval; Queen Elizabeth II Health Sciences Centre; Health Sciences North","funders":"","keywords":"Medicine; Bendamustine; Rituximab; Internal medicine; Ibrutinib; Clinical trial; Surgery; Lymphoma; Leukemia; Chronic lymphocytic leukemia","score_opus":0.01091186289496117,"score_gpt":0.2550507896457149,"score_spread":0.24413892675075374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389235230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975059,0.0003731597,0.000008152117,0.0010110271,0.00005413516,0.0006528918,0.000023094351,0.00013225751,0.00023940852],"genre_scores_gemma":[0.99793375,0.0004042297,0.00058957626,0.00012116319,0.00014402292,0.00006943431,0.00010356256,0.00004352182,0.00059072376],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998015,0.000083012616,0.00037252967,0.00054580474,0.00042390532,0.0005597903],"domain_scores_gemma":[0.9990572,0.00019630237,0.00008357566,0.0003308141,0.000092449125,0.00023970059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038155625,0.00024104674,0.00043120622,0.00025025653,0.00009604053,0.00006343539,0.00008971275,0.00016994849,0.000034121476],"category_scores_gemma":[0.00025518276,0.00019514836,0.000028462928,0.00065640814,0.00022022074,0.00011484049,0.0001775649,0.00021404211,0.000053898853],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020779917,0.017156392,0.49580038,0.01119827,0.0027777606,0.06883546,0.014444052,0.00017542775,0.15893808,0.0037293881,0.013548031,0.19261685],"study_design_scores_gemma":[0.28820652,0.0011762783,0.66587186,0.00079341093,0.00034232123,0.003331256,0.00071395497,0.0063863755,0.03174332,0.00017762782,0.0007063459,0.00055073877],"about_ca_topic_score_codex":0.00059347245,"about_ca_topic_score_gemma":0.00019792205,"teacher_disagreement_score":0.26742658,"about_ca_system_score_codex":0.00086823915,"about_ca_system_score_gemma":0.0014793212,"threshold_uncertainty_score":0.7957919},"labels":[],"label_agreement":null},{"id":"W4389235299","doi":"10.1182/blood-2023-181138","title":"Second Line Treatment and Outcomes of Patients with Multiple Myeloma: A Real World Multi-Institutional Report from the Canadian Myeloma Research Group (CMRG) Database","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont; London Health Sciences Centre; Jewish General Hospital; Université de Montréal; University of Saskatchewan; Memorial University of Newfoundland; Concordia University; Juravinski Cancer Centre; Princess Margaret Cancer Centre; University of Calgary; Vancouver General Hospital; McGill University; University of Alberta; Queen Elizabeth II Health Sciences Centre; Dalhousie University; Saint John Regional Hospital; BC Cancer Agency; CancerCare Manitoba; Saskatchewan Cancer Agency; Ottawa Hospital; University of British Columbia","funders":"","keywords":"Lenalidomide; Multiple myeloma; Medicine; Bortezomib; Regimen; Internal medicine; Autologous stem-cell transplantation; Oncology; Transplantation; Retrospective cohort study; Database; Surgery","score_opus":0.06968017449943593,"score_gpt":0.3416757621476033,"score_spread":0.2719955876481674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389235299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937818,0.00013198334,0.0000032472637,0.0006475477,0.000055456585,0.0015165415,0.0030172574,0.000052986285,0.00079319556],"genre_scores_gemma":[0.9902235,0.00006144967,0.0015972372,0.00004058164,0.0000975953,0.00022259346,0.005695392,0.000034678076,0.0020269202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973946,0.00014117944,0.00038459612,0.0005670499,0.0008398287,0.00067274726],"domain_scores_gemma":[0.99754107,0.0006241002,0.00009301452,0.00078071584,0.000325111,0.0006360052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004770329,0.00027045293,0.00044738085,0.00043958004,0.0005474256,0.000044200377,0.00015235016,0.00007879739,0.00015613761],"category_scores_gemma":[0.00053489493,0.00014764165,0.00008358905,0.0006944095,0.00041546297,0.0001159224,0.00013204379,0.00027566607,0.00004927957],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044470854,0.0015052176,0.9914499,0.000033429696,0.0009191144,0.0023284375,0.0002575453,7.76013e-7,0.0002316131,0.000044938533,0.0003214702,0.0024628702],"study_design_scores_gemma":[0.017827826,0.000558393,0.97764933,0.00008555796,0.00016742075,0.00002547256,0.000101162885,0.00016309066,0.00080294133,0.0000108677295,0.0024784408,0.00012950339],"about_ca_topic_score_codex":0.29259682,"about_ca_topic_score_gemma":0.89277387,"teacher_disagreement_score":0.60017705,"about_ca_system_score_codex":0.00027859118,"about_ca_system_score_gemma":0.0009066656,"threshold_uncertainty_score":0.71211386},"labels":[],"label_agreement":null},{"id":"W4389235308","doi":"10.1182/blood-2023-187921","title":"CNS Involvement in Pediatric Hodgkin Lymphoma: A Comprehensive Retrospective Analysis from the Staging, Evaluation and Response Criteria Harmonization (SEARCH) for Childhood, Adolescent and Young Adult Hodgkin Lymphoma (CAYAHL) Group","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Lymphoma; Retrospective cohort study; Clinical trial; Cancer; Young adult; Radiology; Pediatrics; Oncology; Internal medicine","score_opus":0.025300831185863404,"score_gpt":0.29353343775171375,"score_spread":0.26823260656585035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389235308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935426,0.002390518,0.00009822303,0.0010306023,0.00009980767,0.0024236008,0.00033002807,0.00007514708,0.000009473405],"genre_scores_gemma":[0.9949463,0.002700854,0.00036116855,0.00032564419,0.00018670672,0.00052235695,0.00090121117,0.000044737477,0.000011035828],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997383,0.00043515547,0.00044177836,0.0007366381,0.00062342145,0.00037998887],"domain_scores_gemma":[0.9984363,0.00043799635,0.00015816942,0.00040948347,0.00040757924,0.00015050912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008487153,0.0002980804,0.00050630886,0.00057049387,0.00024348106,0.00013027678,0.000092661496,0.00010809028,0.000019453588],"category_scores_gemma":[0.00031984938,0.00023850429,0.00014637702,0.001452508,0.00007546159,0.0001091048,0.00014032378,0.000063575026,0.0000057313005],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000797836,0.0018489268,0.9798678,0.000053988606,0.000833781,0.00004593555,0.0049427426,0.000011687665,0.00062427676,0.000045605382,0.00031746126,0.010609961],"study_design_scores_gemma":[0.021496644,0.00053559284,0.96555316,0.0001174967,0.0043082484,0.000009875084,0.0019127973,0.004772024,0.0009312992,0.00012349474,0.000025925225,0.00021345893],"about_ca_topic_score_codex":0.0016840348,"about_ca_topic_score_gemma":0.0009738179,"teacher_disagreement_score":0.02069881,"about_ca_system_score_codex":0.0005013367,"about_ca_system_score_gemma":0.00017902374,"threshold_uncertainty_score":0.9725923},"labels":[],"label_agreement":null},{"id":"W4389235322","doi":"10.1182/blood-2023-185914","title":"Large-Scale Genomic Analysis of Mutational Hotspots in Burkitt Lymphoma and Diffuse Large B-Cell Lymphoma","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Canada's Michael Smith Genome Sciences Centre; Simon Fraser University","funders":"","keywords":"Biology; Diffuse large B-cell lymphoma; Exome sequencing; Exome; Deep sequencing; Computational biology; Genetics; Genome; Lymphoma; Mutation; Gene; Immunology","score_opus":0.005150619577326275,"score_gpt":0.2216764550950434,"score_spread":0.21652583551771715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389235322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99789315,0.0010669334,0.00008320915,0.00002815379,0.00004715741,0.000090736336,0.00053757144,0.000008292938,0.00024478234],"genre_scores_gemma":[0.9980943,0.00085237605,0.0001511807,0.00011611975,0.00006377388,0.000017301281,0.0005260344,0.00001819008,0.00016067734],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99909806,0.000022822062,0.00022708696,0.00030318653,0.00009601131,0.00025284704],"domain_scores_gemma":[0.9995394,0.00003729175,0.00007795349,0.00023697564,0.000039875125,0.000068552465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015236954,0.00011763895,0.00021033842,0.00022560122,0.000040285253,0.000015353353,0.00011080687,0.00010659427,0.000011330234],"category_scores_gemma":[0.00003643927,0.00012977044,0.00010516328,0.00046534574,0.000032987726,0.0000022573904,0.0001520007,0.000019030802,0.000007065997],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022592233,0.008010112,0.4754687,0.0001015806,0.0011731603,0.00009902677,0.0014005998,0.0006157382,0.509997,0.0003711639,0.0008343165,0.0017026844],"study_design_scores_gemma":[0.014130589,0.00014073691,0.9335315,0.000007302519,0.00050552667,0.000006542573,0.00037210487,0.0022404788,0.044769328,0.000102197955,0.0039312653,0.0002624272],"about_ca_topic_score_codex":0.00005125788,"about_ca_topic_score_gemma":0.0007245312,"teacher_disagreement_score":0.46522766,"about_ca_system_score_codex":0.000013073766,"about_ca_system_score_gemma":0.000086578126,"threshold_uncertainty_score":0.5291885},"labels":[],"label_agreement":null},{"id":"W4389235331","doi":"10.1182/blood-2023-190409","title":"<i>Hnrnpu</i> mutations Are Haploinsufficient and Alter the Transcriptome of MYC-Driven Lymphomas","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Canada's Michael Smith Genome Sciences Centre; Simon Fraser University","funders":"","keywords":"Biology; Cancer research; Molecular biology; Exome sequencing; Transcriptome; Lymphoma; Gene expression profiling; Gene; Genetics; Mutation; Gene expression; Immunology","score_opus":0.017293452637522185,"score_gpt":0.2510827985554384,"score_spread":0.23378934591791622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389235331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947166,0.0007124332,0.000003863067,0.0029765684,0.00006480481,0.00031281408,0.00005755642,0.00006279983,0.0010925564],"genre_scores_gemma":[0.99892956,0.0002231943,0.0000776422,0.0003688225,0.000040686646,0.00007757438,0.000029476814,0.000013622203,0.00023940037],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993262,0.0000204463,0.00016944858,0.00016420514,0.00016343482,0.0001562136],"domain_scores_gemma":[0.9995278,0.00008397786,0.00005319901,0.00021602467,0.000046596193,0.00007236273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006372186,0.00009854441,0.00018684652,0.000069460344,0.0000834177,0.000011717793,0.00004882139,0.00003501462,0.000027320819],"category_scores_gemma":[0.000020724026,0.000060293587,0.00008543243,0.00025413494,0.000087930304,0.000024130486,0.000021059666,0.00003060993,0.00004504828],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001143239,0.008872832,0.9249525,0.0004099908,0.0014377905,0.0007135482,0.009835649,0.0000868379,0.03552271,0.0045053074,0.007045894,0.0065026097],"study_design_scores_gemma":[0.008621756,0.00040368488,0.95464605,0.000144802,0.00089549815,0.00014467599,0.0010332653,0.00021604753,0.029997773,0.00014615219,0.003635656,0.00011461597],"about_ca_topic_score_codex":0.000046808374,"about_ca_topic_score_gemma":0.000014625844,"teacher_disagreement_score":0.029693568,"about_ca_system_score_codex":0.000016687723,"about_ca_system_score_gemma":0.000045480127,"threshold_uncertainty_score":0.24587011},"labels":[],"label_agreement":null},{"id":"W4389235353","doi":"10.1182/blood-2023-178816","title":"Clinical Effectiveness and Safety of Momelotinib Compared with Continued Ruxolitinib or Best Available Therapy in Patients with Myelofibrosis Who Required RBC Transfusions: Subgroup Analysis of the Phase 3 Simplify-2 Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Ruxolitinib; Medicine; Myelofibrosis; Anemia; Internal medicine; Clinical trial; Gastroenterology; Bone marrow","score_opus":0.03773473642772903,"score_gpt":0.3299724246593061,"score_spread":0.2922376882315771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389235353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99589384,0.00007652185,0.000005009013,0.000052632935,0.000022021322,0.0035755907,0.0002708435,0.000024253686,0.00007929888],"genre_scores_gemma":[0.9991508,0.00028927135,0.00006935205,0.000028197292,0.00001234717,0.00028375513,0.000083973035,0.000029504476,0.000052772146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973965,0.0005359917,0.000798146,0.00051680737,0.0004816306,0.00027087043],"domain_scores_gemma":[0.99760675,0.0011627191,0.0002971769,0.00051787525,0.00029618028,0.00011930912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000672217,0.0002771245,0.0015207872,0.00027290464,0.0001020642,0.000012908536,0.000113235415,0.000080770515,0.00008051201],"category_scores_gemma":[0.00011726015,0.0001401698,0.00016136674,0.0020819702,0.00022598916,0.0000647829,0.00003989504,0.00014344357,0.0000021334533],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019037548,0.022495927,0.9507693,0.00009145224,0.0043954663,0.000021649646,0.001139904,0.000018008603,0.00023014107,0.000008902457,0.000009381878,0.0017823252],"study_design_scores_gemma":[0.08719953,0.013912961,0.89146847,0.0005466805,0.0032682868,0.0000011470934,0.0005677751,0.000057214518,0.0028191586,0.0000015599616,0.000019396117,0.00013785396],"about_ca_topic_score_codex":0.00027254532,"about_ca_topic_score_gemma":0.00073853927,"teacher_disagreement_score":0.06816198,"about_ca_system_score_codex":0.000023201768,"about_ca_system_score_gemma":0.00012167734,"threshold_uncertainty_score":0.57159585},"labels":[],"label_agreement":null},{"id":"W4389235357","doi":"10.1182/blood-2023-177774","title":"Longitudinal Assessment of Transfusion Intensity in Patients with JAK Inhibitor-Naive or -Experienced Myelofibrosis Treated with Momelotinib in the Phase 3 Simplify-1 and Momentum Trials","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Myelofibrosis; Ruxolitinib; Anemia; Internal medicine; Phases of clinical research; Clinical trial; Clinical endpoint; Gastroenterology; Bone marrow","score_opus":0.04069344640571948,"score_gpt":0.336656887551284,"score_spread":0.2959634411455645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389235357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99724054,0.000019752006,0.0000071718696,0.00038306724,0.000020144449,0.0021723663,0.00005837657,0.00002482196,0.000073742114],"genre_scores_gemma":[0.9990436,0.00011312099,0.00017726632,0.00005702869,0.000021356891,0.00043231182,0.00012116123,0.00001819755,0.000015950687],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981707,0.00015985241,0.00052149815,0.00040356608,0.00047580566,0.00026863272],"domain_scores_gemma":[0.9990638,0.00031363382,0.00016365857,0.00022491314,0.00014476487,0.000089245106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004999056,0.00025324035,0.0008318424,0.00025429227,0.00006859087,0.000022586288,0.000059506685,0.000067818975,0.00003633458],"category_scores_gemma":[0.000080874976,0.000119697535,0.000052131494,0.0008638838,0.0001073687,0.00008948904,0.000025736572,0.00014556562,0.0000010549282],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051398384,0.006101837,0.98357964,0.00006791957,0.00019262951,0.00014534986,0.0027894143,0.0000057548154,0.0012131379,0.000014208906,0.00003309075,0.00071720616],"study_design_scores_gemma":[0.047546845,0.0105729755,0.92019963,0.00043778852,0.0003083425,0.000011990692,0.0017167821,0.000055109354,0.019003602,0.000003649446,0.000011156638,0.00013210572],"about_ca_topic_score_codex":0.00027886935,"about_ca_topic_score_gemma":0.00028361488,"teacher_disagreement_score":0.06337996,"about_ca_system_score_codex":0.000056734287,"about_ca_system_score_gemma":0.000106878404,"threshold_uncertainty_score":0.4881124},"labels":[],"label_agreement":null},{"id":"W4389235359","doi":"10.1182/blood-2023-179375","title":"Rituximab Combined with Chemotherapy and Acalabrutinib Prior to Autologous Stem Cell Transplantation in Mantle Cell Lymphoma: The Rectangle Trial","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; University of Toronto; Queen Elizabeth II Health Sciences Centre; Sunnybrook Health Science Centre; Hôpital de l'Enfant-Jésus; Princess Margaret Cancer Centre; Centre hospitalier universitaire de Québec; Health Sciences Centre; McMaster University; Spinal Cord Injury BC","funders":"","keywords":"Mantle cell lymphoma; Ibrutinib; Medicine; Rituximab; Internal medicine; Transplantation; Oncology; Autologous stem-cell transplantation; Chemotherapy regimen; Diffuse large B-cell lymphoma; Surgery; Chemotherapy; Lymphoma; Leukemia; Chronic lymphocytic leukemia","score_opus":0.011184035330873247,"score_gpt":0.23683911131216084,"score_spread":0.2256550759812876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389235359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954491,0.00019750379,0.000003360896,0.0016633554,0.00006256839,0.0014291821,0.00001581423,0.000085324325,0.001093756],"genre_scores_gemma":[0.99833703,0.00033315513,0.00020572623,0.00030636878,0.00004527857,0.00022414555,0.00002669443,0.000023476096,0.0004981386],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99910223,0.000047127272,0.00018595438,0.00026096407,0.00017517639,0.00022854812],"domain_scores_gemma":[0.99951786,0.00014375728,0.000046574834,0.00019290247,0.000018910669,0.000080011756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014150496,0.00014686816,0.00028537688,0.00008285152,0.00006912531,0.000022643135,0.000058463134,0.00007097669,0.000011531941],"category_scores_gemma":[0.0000031150814,0.00008848664,0.000039181235,0.00031729526,0.000027955663,0.000026173939,0.000011432579,0.000042978845,0.00005417599],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27834556,0.08501907,0.2501197,0.0018174438,0.0010200882,0.008630513,0.040838595,0.0000248428,0.017272562,0.00039587702,0.005415366,0.3111004],"study_design_scores_gemma":[0.56217265,0.005549348,0.31720594,0.00013287221,0.00042995394,0.0001296706,0.0005302412,0.000040486255,0.112340935,0.000019215866,0.0012319593,0.00021675612],"about_ca_topic_score_codex":0.00007400438,"about_ca_topic_score_gemma":0.0000621385,"teacher_disagreement_score":0.31088364,"about_ca_system_score_codex":0.000041689218,"about_ca_system_score_gemma":0.00008091537,"threshold_uncertainty_score":0.36083803},"labels":[],"label_agreement":null},{"id":"W4389235362","doi":"10.1182/blood-2023-178819","title":"Extended Follow-up and Resistance Mutations in CLL Patients Treated with Acalabrutinib","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Bruton's tyrosine kinase; Ibrutinib; Chronic lymphocytic leukemia; Medicine; Progressive disease; Peripheral blood mononuclear cell; Somatic evolution in cancer; Immunology; Internal medicine; Cancer research; Oncology; Leukemia; Tyrosine kinase; Cancer; Chemotherapy; Biology; Genetics","score_opus":0.01767307885723865,"score_gpt":0.2852902259037935,"score_spread":0.2676171470465548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389235362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953279,0.00009191551,0.0000010560318,0.00017407416,0.000017829436,0.0004375717,0.0000143884,0.000091534785,0.0038437413],"genre_scores_gemma":[0.99351186,0.000047112047,0.00019655944,0.00004067531,0.000021452448,0.00006464153,0.00010236381,0.000024181814,0.0059911497],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988897,0.000035220284,0.00017035501,0.00026938252,0.0003263657,0.0003089701],"domain_scores_gemma":[0.9993974,0.00012649664,0.000030883166,0.00023555804,0.00008909957,0.00012056095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012666667,0.000101981655,0.00018549977,0.00017307387,0.000049078506,0.000014413102,0.00005488393,0.000054117576,0.000024075138],"category_scores_gemma":[0.0002408224,0.00008007513,0.000021542746,0.0007803626,0.00008804209,0.00004905841,0.000039158433,0.00012297239,0.00005601684],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053837667,0.004658415,0.95829463,0.0012406016,0.00073763245,0.0061163055,0.0048478064,0.0000073517854,0.00296074,0.0009912658,0.0073586316,0.007402833],"study_design_scores_gemma":[0.1591865,0.00045131656,0.8341568,0.00039136386,0.00017212865,0.000053056767,0.00027600853,0.00040303695,0.0036666256,0.00021909762,0.00082208466,0.00020198853],"about_ca_topic_score_codex":0.00015197627,"about_ca_topic_score_gemma":0.00041048173,"teacher_disagreement_score":0.15380272,"about_ca_system_score_codex":0.0006269285,"about_ca_system_score_gemma":0.0008931886,"threshold_uncertainty_score":0.3265369},"labels":[],"label_agreement":null},{"id":"W4389242900","doi":"10.1182/blood-2023-188514","title":"Donor Hemoglobin Genotype Does Not Impact Outcomes Following Matched Related Donor Hematopoietic Cell Transplantation for Sickle Cell Disease: A STAR Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Medicine; Transplantation; Internal medicine; Hematopoietic stem cell transplantation; Sickle cell anemia; Sickle cell trait; Oncology; Cohort; Gastroenterology; Disease","score_opus":0.009732650262987037,"score_gpt":0.26381040367754716,"score_spread":0.2540777534145601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389242900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99448997,0.00046558492,0.00004098576,0.0008084016,0.0004069723,0.0028643466,0.00020301667,0.00047864366,0.0002420661],"genre_scores_gemma":[0.99594456,0.00017007592,0.0002437079,0.00014266354,0.000042391108,0.00018526257,0.00036014238,0.000108296306,0.0028029103],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976298,0.000077253375,0.0006273903,0.00057036575,0.00042860638,0.0006665399],"domain_scores_gemma":[0.99870783,0.00020058845,0.00014738354,0.0004877051,0.000072148105,0.00038432135],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003770699,0.00040883632,0.00068323105,0.00023087444,0.00023785456,0.000053200736,0.00016645517,0.00020486703,0.000095138],"category_scores_gemma":[0.000060366572,0.0002769226,0.0006169434,0.0005573477,0.0000358556,0.00011854225,0.000035830555,0.00026600767,0.00018303518],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026781915,0.011363727,0.84914434,0.0041560116,0.002693036,0.0027800745,0.021441987,0.00043410994,0.10378373,0.000030899817,0.0009047373,0.000589158],"study_design_scores_gemma":[0.10023124,0.0039569098,0.7899901,0.0005915581,0.016861659,0.00005098551,0.019827563,0.00094776903,0.0641062,0.00081280444,0.0004616529,0.0021615545],"about_ca_topic_score_codex":0.00014707391,"about_ca_topic_score_gemma":0.000023465023,"teacher_disagreement_score":0.09755305,"about_ca_system_score_codex":0.000060293827,"about_ca_system_score_gemma":0.00020749446,"threshold_uncertainty_score":0.9999683},"labels":[],"label_agreement":null},{"id":"W4389242912","doi":"10.1182/blood-2023-174436","title":"The Effect of Allogeneic Hematopoietic Stem Cell Transplantation on Sickle Cell Disease-Related Organ Damage: A Systematic Review and Meta-Analysis","year":2023,"lang":"en","type":"review","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Meta-analysis; Hematopoietic stem cell transplantation; Internal medicine; Transplantation; Confidence interval; Relative risk","score_opus":0.021004695367099223,"score_gpt":0.2794412785521532,"score_spread":0.258436583185054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389242912","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020070453,0.9933614,0.0000016832416,0.000090295136,0.000029228491,0.0059224833,0.00013300667,0.00007043009,0.00019075381],"genre_scores_gemma":[0.00094409933,0.9959145,0.000002470761,0.000041859614,0.0000058637634,0.0004930892,0.00025262963,0.00009423505,0.002251232],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9959716,0.0012315543,0.0015216401,0.00050903636,0.00047585357,0.00029030704],"domain_scores_gemma":[0.996788,0.0010828319,0.0009000724,0.0009519028,0.000059803355,0.00021736308],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011565064,0.0006081015,0.007105428,0.00024413354,0.00012856691,0.000026406176,0.00023717263,0.0002951626,0.000058368987],"category_scores_gemma":[0.00006120276,0.00028275678,0.0030054057,0.0013598973,0.00008184802,0.000019310408,0.000032693104,0.0004368304,0.00015302555],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008240171,0.00011767542,0.0000023987468,0.92099017,0.07850698,0.00013179242,0.00006073916,0.0000024321446,8.047047e-7,0.0000061884375,0.000032393084,0.00014021691],"study_design_scores_gemma":[0.0006773699,0.0002679177,0.000001212074,0.06457858,0.93374383,0.000044859236,0.00002687641,0.000002711017,0.000021875365,0.0000020927687,0.0004041885,0.00022848071],"about_ca_topic_score_codex":0.000006016459,"about_ca_topic_score_gemma":0.0000020049843,"teacher_disagreement_score":0.8564116,"about_ca_system_score_codex":0.00002153425,"about_ca_system_score_gemma":0.00011270055,"threshold_uncertainty_score":0.99996245},"labels":[],"label_agreement":null},{"id":"W4389242918","doi":"10.1182/blood-2023-179387","title":"Durable Efficacy and Manageable Safety in Patients Age ≥ 75 Years with Relapsed/Refractory Large B-Cell Lymphoma Treated with Tisagenlecleucel in the Real-World Setting","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Cytokine release syndrome; Internal medicine; Oncology; Blinatumomab; Clinical trial; Salvage therapy; Refractory (planetary science); Chimeric antigen receptor; CD19; Immunotherapy; Chemotherapy; Cancer","score_opus":0.011834043048669978,"score_gpt":0.25214075025714483,"score_spread":0.24030670720847486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389242918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9728662,0.0000679488,4.404986e-7,0.000105384286,0.000011249889,0.0010032867,0.000013225001,0.00007946957,0.025852835],"genre_scores_gemma":[0.9854195,0.0002449128,0.000074784046,0.00012430541,0.0000290871,0.00004593293,0.00011914728,0.00006509543,0.01387725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980642,0.0001821675,0.00025636633,0.00040243007,0.0005013679,0.0005934275],"domain_scores_gemma":[0.99908566,0.00024405471,0.00006873855,0.00046601053,0.000034816538,0.000100687714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071546214,0.00019294118,0.00031234347,0.00039508,0.00008762369,0.000043426546,0.00014941303,0.00007676922,0.00010996706],"category_scores_gemma":[0.00003249158,0.00013214635,0.000028700291,0.0015482034,0.000069644164,0.00008817047,0.00006648559,0.00030711442,0.000044880348],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026598752,0.0040658186,0.9783619,0.00016432042,0.00011006254,0.003482306,0.0022550165,0.000016563028,0.0027242624,0.000015305042,0.000491577,0.005653017],"study_design_scores_gemma":[0.04740965,0.0008249472,0.94782114,0.00023361066,0.000069472604,0.000011405577,0.00038600678,0.000057131692,0.0006789875,0.0000052790724,0.0023416413,0.00016072062],"about_ca_topic_score_codex":0.00088430336,"about_ca_topic_score_gemma":0.0013947992,"teacher_disagreement_score":0.044749774,"about_ca_system_score_codex":0.00011035119,"about_ca_system_score_gemma":0.000077680335,"threshold_uncertainty_score":0.5388772},"labels":[],"label_agreement":null},{"id":"W4389242944","doi":"10.1182/blood-2023-180920","title":"Bellwave-010: Phase 3, Open-Label, Randomized Study of Nemtabrutinib Plus Venetoclax Versus Venetoclax Plus Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Following at Least One Prior Therapy","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Venetoclax; Ibrutinib; Chronic lymphocytic leukemia; Tumor lysis syndrome; Rituximab; Medicine; Bruton's tyrosine kinase; Internal medicine; Oncology; Neutropenia; Lymphoma; Gastroenterology; Immunology; Leukemia; Chemotherapy; Tyrosine kinase; Receptor","score_opus":0.054291680657758315,"score_gpt":0.3259056005492849,"score_spread":0.2716139198915266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389242944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98240215,0.0027074143,0.000007889992,0.0000151867525,0.00061849493,0.013245374,0.000048397756,0.000323325,0.0006317483],"genre_scores_gemma":[0.9954909,0.0006576727,0.00022205722,0.00007875638,0.0002633426,0.0013940936,0.00038570998,0.00038233868,0.0011251384],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9901664,0.0009470625,0.0021808804,0.0019292047,0.0026243862,0.0021520238],"domain_scores_gemma":[0.99367917,0.0018953166,0.00087523105,0.00242108,0.00040929942,0.0007199085],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022914994,0.0011589464,0.00398446,0.0010725466,0.0004655628,0.0001489275,0.0015275546,0.0005556741,0.00013700675],"category_scores_gemma":[0.0008888099,0.0010181242,0.00042065108,0.0026696157,0.0005541818,0.00041593413,0.0013490719,0.00053984334,0.0003297898],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.9444863,0.014795339,0.000977295,0.0010902712,0.006925363,0.0038545993,0.006312738,0.008619781,0.0017884977,0.0000261691,0.00019293907,0.010930713],"study_design_scores_gemma":[0.9289099,0.013574638,0.0012748899,0.0012606456,0.0015602151,0.00006400971,0.00051836844,0.049546394,0.002176405,0.000010410693,0.00017375822,0.0009303811],"about_ca_topic_score_codex":0.011813039,"about_ca_topic_score_gemma":0.0012948271,"teacher_disagreement_score":0.20861645,"about_ca_system_score_codex":0.35872495,"about_ca_system_score_gemma":0.15010849,"threshold_uncertainty_score":0.9992269},"labels":[],"label_agreement":null},{"id":"W4389242945","doi":"10.1182/blood-2023-179840","title":"DNA Methylation Changes in Nucleated Red Blood Cells from Patients with Sickle Cell Disease: A Potential Marker of Engraftment after Stem Cell Transplantation","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; Alberta Children's Hospital; Centre Hospitalier Universitaire Sainte-Justine; University of Calgary","funders":"","keywords":"Differentially methylated regions; DNA methylation; Biology; Nucleated Red Blood Cell; Transplantation; Molecular biology; Haematopoiesis; CpG site; Hematopoietic stem cell transplantation; Stem cell; Immunology; Genetics; Gene; Medicine; Fetus; Internal medicine; Gene expression","score_opus":0.0036466730484493123,"score_gpt":0.17820371946713312,"score_spread":0.1745570464186838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389242945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981874,0.00031617837,0.000011037167,0.00015945459,0.000077339966,0.0007492225,0.00023659931,0.00006711802,0.00019561678],"genre_scores_gemma":[0.9984176,0.00042062154,0.000120613644,0.000044857912,0.000022812068,0.000047868394,0.0006460843,0.000038173184,0.00024136635],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99878246,0.00007744042,0.0002681717,0.00028998603,0.0003443695,0.00023756735],"domain_scores_gemma":[0.99948514,0.000027555621,0.00010747311,0.00019377393,0.000063657106,0.00012241001],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000080965336,0.00017401017,0.0002453017,0.00018569932,0.000029338866,0.0000092580085,0.00004948921,0.00012173993,0.00012439946],"category_scores_gemma":[0.0000019838235,0.0001394726,0.00006443217,0.00037736396,0.000029097793,0.00005215864,0.000015011812,0.00012161861,0.00002358634],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010929261,0.013246734,0.33671367,0.0024588045,0.0007657308,0.0015660794,0.008270591,0.0006307557,0.6210932,0.0000019067605,0.00026771132,0.0040555405],"study_design_scores_gemma":[0.020849466,0.0006114985,0.6616051,0.0003714278,0.0019758265,8.278906e-7,0.00043286005,0.00028863296,0.3135204,0.000010034193,0.00008858266,0.00024531566],"about_ca_topic_score_codex":0.000057516736,"about_ca_topic_score_gemma":0.000032969187,"teacher_disagreement_score":0.32489145,"about_ca_system_score_codex":0.000015039284,"about_ca_system_score_gemma":0.000039350154,"threshold_uncertainty_score":0.56875277},"labels":[],"label_agreement":null},{"id":"W4389242960","doi":"10.1182/blood-2023-190795","title":"Discriminating Risk of Anticoagulant-Related Bleeding in Ambulatory Cancer Patients on Thromboprophylaxis","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Randomized controlled trial; Apixaban; Bleed; Anticoagulant; Internal medicine; Clinical endpoint; Framingham Risk Score; Ambulatory; Major bleeding; Cohort; Intensive care medicine; Surgery; Warfarin; Rivaroxaban; Disease; Atrial fibrillation","score_opus":0.015386832255021951,"score_gpt":0.27543544596785197,"score_spread":0.26004861371283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389242960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971756,0.00010338304,6.6665217e-7,0.000083224804,0.00021952332,0.00043456876,0.000016986902,0.0000709293,0.0018951555],"genre_scores_gemma":[0.99905163,0.0006514467,0.000047412483,0.000057727797,0.000042761323,0.000036323025,0.000020910775,0.00002812948,0.00006366403],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881405,0.00002751059,0.00033122743,0.00025026262,0.00030992826,0.00026700253],"domain_scores_gemma":[0.99949825,0.0000536227,0.00014674527,0.00019557412,0.000050725273,0.00005506975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021436776,0.00012932072,0.00040585676,0.00023761384,0.000052632375,0.000006924467,0.00007085747,0.00006402752,0.000053971155],"category_scores_gemma":[0.00009589317,0.000109677734,0.00009430341,0.0004956731,0.000036859306,0.000042142005,0.00007289042,0.00015814173,0.000031778694],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015218221,0.0027321035,0.9848987,0.00036503945,0.00036865784,0.000027393975,0.0018343473,0.00016842858,0.0034061717,0.00034836153,0.00046327687,0.0053723194],"study_design_scores_gemma":[0.0027896566,0.0004807054,0.9873408,0.00067593873,0.00035240682,3.2549625e-7,0.00028440417,0.00037571802,0.007454504,0.00010460245,0.000030664567,0.00011026417],"about_ca_topic_score_codex":0.00077855034,"about_ca_topic_score_gemma":0.00004819623,"teacher_disagreement_score":0.005262055,"about_ca_system_score_codex":0.00003691251,"about_ca_system_score_gemma":0.000023231283,"threshold_uncertainty_score":0.4472528},"labels":[],"label_agreement":null},{"id":"W4389242980","doi":"10.1182/blood-2023-186367","title":"Identification of Acute Myeloid Leukemia Cell Surface Therapeutic Targets Using Single Cell RNA Sequencing Supported By Surface Proteomics","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Université de Montréal; Université Laval; Hôpital de l'Enfant-Jésus; Institute for Research in Immunology and Cancer; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Biology; Myeloid leukemia; Myeloid; CD33; NPM1; Cancer research; Leukemia; Computational biology; Immunology; Stem cell; Karyotype; Gene; Genetics; CD34; Chromosome","score_opus":0.019472739455419975,"score_gpt":0.2611407093865156,"score_spread":0.24166796993109566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389242980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96956396,0.00020870932,0.028336417,0.000031573774,0.000023053446,0.00044958544,0.00033100348,0.00038326735,0.00067242456],"genre_scores_gemma":[0.9571103,0.00019613435,0.040619414,0.000014941782,0.00002582109,0.00003682163,0.00028314188,0.000079323014,0.0016341442],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983893,0.000020138747,0.0005529369,0.00043969403,0.00022421799,0.00037370186],"domain_scores_gemma":[0.9986453,0.00004403976,0.0005132168,0.00059289555,0.00012724515,0.00007732452],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020425023,0.00023241356,0.00025063733,0.000037229194,0.00016765975,0.000042958447,0.00034581678,0.0001969558,0.000059135145],"category_scores_gemma":[0.0000075119533,0.00026367058,0.00009844592,0.00040805523,0.000068671085,0.00014589382,0.00009509652,0.00024168017,0.000023226034],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008416135,0.0001386054,0.00022068241,0.00013902476,0.000040709336,0.0000031246263,0.00016752954,0.002230191,0.9968941,0.000016270393,0.000100477686,0.000040843897],"study_design_scores_gemma":[0.0004896388,0.000018831208,0.0000059721015,0.000025209061,0.00015472832,0.000005244188,0.00015514264,0.007614107,0.9904164,0.0006830053,0.00016164366,0.00027005599],"about_ca_topic_score_codex":0.000058947404,"about_ca_topic_score_gemma":0.0000010248227,"teacher_disagreement_score":0.012453707,"about_ca_system_score_codex":0.00023308412,"about_ca_system_score_gemma":0.00017303853,"threshold_uncertainty_score":0.9999815},"labels":[],"label_agreement":null},{"id":"W4389242997","doi":"10.1182/blood-2023-189646","title":"Deciphering the Boundaries of KBTBD4-CoREST1 Axis Modulation to Maximally Expand Human HSCs","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Stem cell; Ubiquitin ligase; Downregulation and upregulation; In vivo; Ex vivo; Biology; Cell biology; Cancer research; Ubiquitin; Molecular biology; Chemistry; Immunology; Genetics","score_opus":0.017614214304433006,"score_gpt":0.27475280668098867,"score_spread":0.2571385923765557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389242997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973194,0.00025991295,0.0013744967,0.000092377464,0.00007751838,0.00013505496,0.000008298404,0.000014397116,0.0007185434],"genre_scores_gemma":[0.9989057,0.00006154287,0.00054059643,0.00002423595,0.00013171903,0.000017665274,0.000063011415,0.000015461676,0.00024005435],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993797,0.000027557986,0.00016441535,0.0001709255,0.000120449964,0.00013696606],"domain_scores_gemma":[0.9995589,0.000011237999,0.000054170847,0.00027415666,0.00006576912,0.000035742734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001944133,0.00007919619,0.00007831285,0.000036479993,0.00016517458,0.000045259294,0.00012579402,0.00006492431,0.000007036138],"category_scores_gemma":[0.00008129562,0.000065415465,0.000046628524,0.0001530507,0.000058584505,0.0000022746538,0.00009830561,0.00003216372,0.000007645429],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010630739,0.000031157968,0.016205676,0.000010008065,0.000027046779,7.6280753e-7,0.00019984646,0.0007580159,0.979968,0.00018215123,0.00005873877,0.002547943],"study_design_scores_gemma":[0.0003622358,0.00021725285,0.152715,0.000009675929,0.000020784093,7.227813e-7,0.000058903628,0.00009029315,0.83331895,0.00085359346,0.012244573,0.000108003274],"about_ca_topic_score_codex":0.00005430009,"about_ca_topic_score_gemma":0.0002075087,"teacher_disagreement_score":0.14664906,"about_ca_system_score_codex":0.0000029399596,"about_ca_system_score_gemma":0.00003183286,"threshold_uncertainty_score":0.26675653},"labels":[],"label_agreement":null},{"id":"W4389242999","doi":"10.1182/blood-2023-182536","title":"Favezelimab (anti-LAG-3) Plus Pembrolizumab in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL): Cohort 3 of a Multicohort Open-Label Phase 1/2 Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba; BC Cancer Agency; Jewish General Hospital","funders":"","keywords":"Medicine; Pembrolizumab; Internal medicine; Cohort; Refractory (planetary science); Lymphoma; Diffuse large B-cell lymphoma; Gastroenterology; Neutropenia; Febrile neutropenia; Oncology; Phases of clinical research; Cancer; Chemotherapy; Immunotherapy","score_opus":0.02301311069555842,"score_gpt":0.3045561159586645,"score_spread":0.28154300526310605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389242999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99517494,0.0001629375,0.000002878802,0.000041619132,0.00012279527,0.0038902047,0.00010713722,0.00010938783,0.00038809952],"genre_scores_gemma":[0.9977819,0.00014416607,0.00011326092,0.00017487501,0.00003373705,0.00024198012,0.00020683199,0.00009244921,0.0012108046],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9971864,0.0001300117,0.0007502927,0.00063502946,0.0007238918,0.0005743639],"domain_scores_gemma":[0.99841166,0.00010641248,0.00029279923,0.0008528531,0.00017836786,0.00015790717],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005325674,0.00036123738,0.00089842983,0.00036905773,0.00010408371,0.00003905458,0.00038426605,0.00015195111,0.000089408284],"category_scores_gemma":[0.00008039049,0.00026356394,0.000075489355,0.0010912548,0.0000961874,0.00018930972,0.0001846121,0.00019233374,0.000031883577],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06121693,0.30003244,0.62674904,0.00022020191,0.0011041419,0.0009836743,0.0020114554,4.0630465e-7,0.0042860545,0.0000014593179,0.0005255243,0.002868701],"study_design_scores_gemma":[0.5115266,0.007317689,0.4777856,0.00019189659,0.00045864104,0.000013830476,0.000673789,0.0000930344,0.001290038,4.772138e-7,0.00039417096,0.00025427926],"about_ca_topic_score_codex":0.0004642779,"about_ca_topic_score_gemma":0.00016542582,"teacher_disagreement_score":0.45030963,"about_ca_system_score_codex":0.00019206159,"about_ca_system_score_gemma":0.00052459084,"threshold_uncertainty_score":0.99998164},"labels":[],"label_agreement":null},{"id":"W4389243001","doi":"10.1182/blood-2023-190720","title":"Multiple Myeloma B Cells and Pre-Plasma Cells Are Important Reservoirs for Myeloma Relapse Following Plasma Cell-Directed Therapy and Prevent Cure with Standard Therapies","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada); Princess Margaret Cancer Centre","funders":"","keywords":"Pomalidomide; Daratumumab; Carfilzomib; Lenalidomide; Bortezomib; Plasma cell; Multiple myeloma; Plasma Cell Myeloma; CD20; Cancer research; clone (Java method); Plasma cell neoplasm; Plasma cell leukemia; CD38; Medicine; Biology; Stem cell; Immunology; Lymphoma; CD34; Plasmacytoma","score_opus":0.019349774552108956,"score_gpt":0.2675097893738075,"score_spread":0.24816001482169853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933336,0.0017658925,0.000009694923,0.00039607886,0.00013110127,0.0033625597,0.00050159666,0.000381666,0.00011784937],"genre_scores_gemma":[0.98684055,0.004840071,0.0051376047,0.000037904927,0.00012391775,0.00059569813,0.0001657656,0.00014029014,0.0021182108],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99707395,0.00011932041,0.0004570837,0.0008135753,0.00069306174,0.0008429964],"domain_scores_gemma":[0.9979707,0.0005798661,0.00021138646,0.0005269578,0.00022275237,0.0004883366],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042250156,0.0004923886,0.0007208999,0.00025316648,0.0003858414,0.000113280745,0.00014488769,0.00020431084,0.000019505422],"category_scores_gemma":[0.00014671244,0.0003460804,0.00017465974,0.0004280744,0.00013029233,0.0001645532,0.00009694659,0.00028237057,0.000008587399],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024666289,0.0033811058,0.5779912,0.0017812934,0.0057185763,0.0035295456,0.013092429,0.000032108426,0.3418832,0.000012598249,0.0056338524,0.022277782],"study_design_scores_gemma":[0.062432557,0.006010021,0.12332111,0.00074893323,0.00056511257,0.00008134676,0.0024668078,0.002708319,0.7861039,0.0000663185,0.014752865,0.00074271084],"about_ca_topic_score_codex":0.000066956345,"about_ca_topic_score_gemma":0.0002210212,"teacher_disagreement_score":0.4546701,"about_ca_system_score_codex":0.00006785148,"about_ca_system_score_gemma":0.00018569457,"threshold_uncertainty_score":0.99989915},"labels":[],"label_agreement":null},{"id":"W4389243021","doi":"10.1182/blood-2023-190428","title":"Assessment of Optical Genome Mapping for Front-Line Diagnostic Evaluation of Acute Leukemia: A Canadian Single-Center Evaluation of Added Yield in 69 Informative Cases","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Myeloid leukemia; Fluorescence in situ hybridization; Acute leukemia; Leukemia; Fusion gene; Population; Oncology; Cancer research; Biology; Medicine; Internal medicine; Gene; Genetics; Chromosome","score_opus":0.0548670250181625,"score_gpt":0.29934803886937955,"score_spread":0.24448101385121707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976966,0.00008678317,0.00022541988,0.000031198244,0.00004599324,0.000645784,0.00047528272,0.0000022214956,0.0007907512],"genre_scores_gemma":[0.9980762,0.000034351542,0.0007514365,0.000014248067,0.000034717636,0.0001691737,0.00089675665,0.0000070071865,0.000016131464],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99903387,0.00006279687,0.00038913955,0.00011733075,0.00024471022,0.0001521761],"domain_scores_gemma":[0.9990335,0.00009010656,0.00016494737,0.00014501804,0.0005279219,0.0000385029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089991343,0.00008101192,0.00015892125,0.0001412255,0.00002525865,0.000005267946,0.00007713434,0.000091044654,0.000035764635],"category_scores_gemma":[0.0005676088,0.000082932,0.00005866355,0.00010345664,0.000029851599,0.0000086102555,0.00003668546,0.00003454438,7.5813443e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010628199,0.0010923957,0.06236811,0.00063912466,0.0014611622,0.000007995095,0.004041576,0.036254093,0.8894501,0.00057041424,0.00019969058,0.003809083],"study_design_scores_gemma":[0.011963438,0.0020499832,0.45208588,0.00030206455,0.0018484212,0.000035523142,0.003722862,0.029841883,0.4972227,0.00037312144,0.00013759748,0.00041654802],"about_ca_topic_score_codex":0.0014379745,"about_ca_topic_score_gemma":0.008040624,"teacher_disagreement_score":0.39222738,"about_ca_system_score_codex":0.000111881316,"about_ca_system_score_gemma":0.0009528084,"threshold_uncertainty_score":0.44868568},"labels":[],"label_agreement":null},{"id":"W4389243031","doi":"10.1182/blood-2023-172955","title":"A Day 14 Endpoint for Acute Gvhd Clinical Trials","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Clinical endpoint; Internal medicine; Clinical trial; Prednisone; Disease; Immunology; Gastroenterology; Oncology","score_opus":0.16487778370400438,"score_gpt":0.4572242230366097,"score_spread":0.2923464393326053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96605307,0.00015093366,0.012191383,0.0045332187,0.0020160754,0.0037852568,0.00035246953,0.00072316243,0.0101944385],"genre_scores_gemma":[0.9788204,0.00063254026,0.00950736,0.0010395721,0.0016619001,0.0004931639,0.0007533463,0.00009599806,0.0069957124],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998341,0.00020799304,0.00077261013,0.0002502035,0.0002014028,0.000226737],"domain_scores_gemma":[0.9972332,0.0021978212,0.00011396817,0.0002521434,0.00005982991,0.00014305073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045011523,0.000103318605,0.0005832942,0.00008133536,0.000036115936,0.000011592108,0.00006246303,0.00013861909,0.00021763414],"category_scores_gemma":[0.0015066066,0.000081550876,0.00030617847,0.00016801957,0.000027889233,0.000023561739,0.000011464734,0.00010722524,0.000405369],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008754104,0.011723802,0.16686545,0.0073600407,0.023713317,0.006792878,0.013031596,0.000011082386,0.2507829,0.015544126,0.26256326,0.2328574],"study_design_scores_gemma":[0.13469818,0.004476487,0.3186903,0.00078635773,0.026764786,0.00070971233,0.00076056476,0.0010274987,0.39877898,0.0042602965,0.10786971,0.0011771311],"about_ca_topic_score_codex":0.000001530749,"about_ca_topic_score_gemma":0.0000012872974,"teacher_disagreement_score":0.23168027,"about_ca_system_score_codex":0.0000067632477,"about_ca_system_score_gemma":0.000093043425,"threshold_uncertainty_score":0.52103335},"labels":[],"label_agreement":null},{"id":"W4389243100","doi":"10.1182/blood-2023-189475","title":"Generation and Screening of Various CD70 CAR NK Cells Identify the Most Effective Construct Against Hematologic Malignancies","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Chimeric antigen receptor; Cancer research; Biology; Immunology; Cytotoxic T cell; Immunotherapy; Natural killer T cell; CD28; Immune system; Antigen; Cancer; Lymphokine-activated killer cell; Interleukin 21; T cell","score_opus":0.015256322523699614,"score_gpt":0.23417026701634283,"score_spread":0.21891394449264323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99641985,0.0011333497,0.00022278645,0.000050401926,0.001357573,0.00025770004,0.000007816717,0.000067775516,0.00048274358],"genre_scores_gemma":[0.99842453,0.00022279569,0.00003062635,0.0001068694,0.000025442756,0.000025730065,0.00009221606,0.000008288426,0.001063478],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992726,0.00018100803,0.00020006344,0.00016696336,0.00002641593,0.0001529603],"domain_scores_gemma":[0.99948895,0.00016522141,0.00012249999,0.00014535394,0.00007069788,0.0000072868806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020166875,0.00010379681,0.0001674434,0.00008020791,0.00023280353,0.000019430627,0.00007128086,0.0001243074,0.00006646226],"category_scores_gemma":[0.00006961435,0.00007568832,0.00004950401,0.00016111172,0.00016742514,0.000070412825,0.00005891941,0.00015387201,0.00012764592],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020373023,0.000032543354,0.0012431404,0.000019752952,0.00017268118,0.0000040171212,0.00038843698,0.000021031727,0.9944776,0.000233299,0.0025190974,0.00086800713],"study_design_scores_gemma":[0.00095211534,0.00010173879,0.00579374,0.000031996675,0.00009225866,0.00011376469,0.000761761,0.000055947225,0.9902224,0.00002246626,0.0017633196,0.00008850344],"about_ca_topic_score_codex":0.00006317314,"about_ca_topic_score_gemma":0.000010301744,"teacher_disagreement_score":0.0045505995,"about_ca_system_score_codex":0.0000063128537,"about_ca_system_score_gemma":0.000014291302,"threshold_uncertainty_score":0.308648},"labels":[],"label_agreement":null},{"id":"W4389243107","doi":"10.1182/blood-2023-181886","title":"Influence of Pre-Treatment Features and Therapy Choice By Physicians on Overall Survival in Older Adults with Acute Myeloid Leukemia: A Report from the Beat AML Master Trial","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Genentech; Sierra Oncology; MorphoSys; Astellas Pharma; Actuate Therapeutics; Karyopharm Therapeutics; Revolution Medicines; Incyte; Syndax Pharmaceuticals; Oregon Health and Science University; BeiGene; Bristol-Myers Squibb; Constellation Pharmaceuticals; Agios Pharmaceuticals; Ascentage Pharma; Actinium Pharmaceuticals; Mateon Therapeutics; Jazz Pharmaceuticals; Astex Pharmaceuticals; Daiichi Sankyo Europe; National Cancer Institute; Servier; Foghorn Therapeutics; Gilead Sciences; Iterion Therapeutics; Celgene; AstraZeneca; Ono Pharmaceutical; Eli Lilly and Company; Amgen","keywords":"Medicine; Venetoclax; Azacitidine; Internal medicine; Oncology; Myeloid leukemia; Clinical trial; Hematology; Chemotherapy; Leukemia; DNA methylation","score_opus":0.0131047628027076,"score_gpt":0.27754463292176756,"score_spread":0.26443987011905995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995947,0.00038269733,7.6972583e-7,0.0013240909,0.000036345904,0.001870097,0.00011154336,0.00005475477,0.00027269262],"genre_scores_gemma":[0.99583656,0.0014209559,0.000043452015,0.00038975605,0.0002482523,0.0002011888,0.00017925684,0.00004628644,0.0016342686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99814487,0.00009708932,0.0003029744,0.0005076407,0.00059320475,0.00035425407],"domain_scores_gemma":[0.9985873,0.00048217006,0.00014498431,0.00062492985,0.000078315985,0.00008231788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018795732,0.00026638014,0.00047542428,0.00008160263,0.000057925845,0.000026461978,0.00016062304,0.00013827212,0.000011374393],"category_scores_gemma":[0.000076262084,0.00014993634,0.00007323576,0.0002910506,0.00013847275,0.000086383756,0.00006346565,0.00035904665,0.000006416203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29740798,0.0060994048,0.47191718,0.00020093654,0.006749628,0.008150717,0.021931522,0.00040292443,0.14162399,0.000044683387,0.015691658,0.029779363],"study_design_scores_gemma":[0.12694316,0.0029910961,0.8390174,0.00037377543,0.00020999322,0.000084413405,0.00020313654,0.000022813721,0.029207062,0.000016260074,0.00074424193,0.0001866754],"about_ca_topic_score_codex":0.0047011203,"about_ca_topic_score_gemma":0.00041173171,"teacher_disagreement_score":0.3671002,"about_ca_system_score_codex":0.0001466356,"about_ca_system_score_gemma":0.0002570473,"threshold_uncertainty_score":0.7106719},"labels":[],"label_agreement":null},{"id":"W4389243111","doi":"10.1182/blood-2023-188546","title":"Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN):Multi-Center Collaboration and Global Registry Program","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa; University of Calgary","funders":"","keywords":"Medicine; Presentation (obstetrics); Surgery","score_opus":0.018578713470391046,"score_gpt":0.3246014180971332,"score_spread":0.3060227046267422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99492806,0.0003417153,0.000034604374,0.00064499927,0.00010533163,0.0011517658,0.00010282571,0.00032973324,0.0023609349],"genre_scores_gemma":[0.9958174,0.00018503034,0.0010841193,0.00011206467,0.000094598596,0.00016189733,0.00017288499,0.000033626508,0.002338343],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983846,0.000060972197,0.00023455356,0.00042188118,0.00042344516,0.00047453886],"domain_scores_gemma":[0.99911183,0.000079484846,0.00004959401,0.00027603822,0.00023439314,0.00024866394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000103311555,0.00019595868,0.00025564583,0.00010398344,0.00013631415,0.000115195144,0.00009206278,0.0001281908,0.000033173405],"category_scores_gemma":[0.00034280546,0.00018715467,0.000052108513,0.0007882467,0.00015322665,0.00006851809,0.000094462535,0.00016107719,0.0002972935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091825874,0.01308386,0.928619,0.0018616249,0.00044167734,0.004723935,0.0012556737,0.000030138155,0.027969906,0.00016267564,0.012050548,0.008882666],"study_design_scores_gemma":[0.28754827,0.01472779,0.3791427,0.0021164773,0.002683662,0.036387518,0.017326467,0.08090666,0.11635595,0.0009451557,0.0575114,0.0043479474],"about_ca_topic_score_codex":0.000024559846,"about_ca_topic_score_gemma":0.00020340746,"teacher_disagreement_score":0.5494763,"about_ca_system_score_codex":0.000085636166,"about_ca_system_score_gemma":0.00033245003,"threshold_uncertainty_score":0.76319456},"labels":[],"label_agreement":null},{"id":"W4389243140","doi":"10.1182/blood-2023-190168","title":"Efficacy and Tolerance of Isatuximab, Cyclophosphamide, Bortezomib, and Dexamethasone (Isa-CBD) Induction Chemotherapy in Newly Diagnosed, Transplant Eligible Multiple Myeloma: Report of the Phase 2 Multi-Centre, Open Label Canadian Myeloma Research Group (CMRG)-008 Prospective Clinical Trial","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Ottawa Hospital; Princess Margaret Cancer Centre; Dalhousie University; University of Saskatchewan; Queen Elizabeth II Health Sciences Centre; CancerCare Manitoba","funders":"","keywords":"Lenalidomide; Medicine; Melphalan; Multiple myeloma; Internal medicine; Autologous stem-cell transplantation; Oncology","score_opus":0.12265492500038555,"score_gpt":0.4250328955985352,"score_spread":0.30237797059814964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915225,0.00071295066,0.0000049221217,0.0008965554,0.00015777406,0.006376328,0.00016145926,0.000029384035,0.00013812013],"genre_scores_gemma":[0.99578893,0.0018804012,0.0014805649,0.00004066673,0.000119762655,0.00027636086,0.00009326268,0.00005132501,0.00026873642],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961481,0.00049412606,0.0010385826,0.000840845,0.0007097626,0.0007685924],"domain_scores_gemma":[0.9974053,0.00084062363,0.00025078413,0.0006877491,0.00027870142,0.0005368588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026308738,0.00028642046,0.000913646,0.00040687236,0.00021066987,0.00004854105,0.0003238173,0.00026960354,0.000017722365],"category_scores_gemma":[0.0021145276,0.00021735879,0.00009782739,0.0013679751,0.00056111073,0.00017972992,0.00015819677,0.00069052796,0.000004187811],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041859746,0.013290364,0.8914714,0.00018040034,0.0005254655,0.0019323517,0.001893661,0.0000015198137,0.0069336393,0.000036254558,0.00023189388,0.041643314],"study_design_scores_gemma":[0.33989263,0.0015471585,0.6494601,0.00030000816,0.000081753955,0.000099683944,0.00021255323,0.00033035397,0.007710368,0.00004415991,0.00018199974,0.0001392429],"about_ca_topic_score_codex":0.065366365,"about_ca_topic_score_gemma":0.06414156,"teacher_disagreement_score":0.29803288,"about_ca_system_score_codex":0.00012398697,"about_ca_system_score_gemma":0.0009444476,"threshold_uncertainty_score":0.9529354},"labels":[],"label_agreement":null},{"id":"W4389243157","doi":"10.1182/blood-2023-180776","title":"Development of a Combined Risk Assessment Model for Venous Thromboembolism and Bleeding in Hematopoietic Stem Cell Transplantation Patients","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Thrombosis; Pulmonary embolism; Population; Surgery; Retrospective cohort study; Transplantation; Venous thrombosis; Internal medicine; Hematopoietic stem cell transplantation; Deep vein","score_opus":0.022859686077006256,"score_gpt":0.27490560665943853,"score_spread":0.25204592058243225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981977,0.00004125623,0.00048415424,0.000042879765,0.000028931243,0.0009697713,0.000046306774,0.000024505096,0.00016453932],"genre_scores_gemma":[0.9926215,0.00024054895,0.00665223,0.000016282705,0.0000064775236,0.0003185816,0.00010879386,0.000016289952,0.000019293628],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913186,0.000016024505,0.00031052515,0.00019567771,0.00017966842,0.00016622215],"domain_scores_gemma":[0.99962175,0.0000847969,0.000097542514,0.00007582657,0.0000630188,0.00005708057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014912292,0.000118775104,0.0003366277,0.000114795184,0.0000656337,0.0000079172305,0.000025394309,0.00004880744,0.000002373942],"category_scores_gemma":[0.0000042152637,0.000101687314,0.000034734003,0.000118483316,0.000012319223,0.00003593448,0.00001309068,0.00005671313,0.000001739745],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026081022,0.010004527,0.9355742,0.0025816816,0.00041924944,0.000028728484,0.03851131,0.00037043402,0.004259396,0.00065028976,0.000036810274,0.007302569],"study_design_scores_gemma":[0.01995853,0.0008426193,0.9120767,0.00040018058,0.00056789507,0.0000032768369,0.00056821894,0.014803082,0.05038094,0.00022744945,0.0000065811837,0.00016449104],"about_ca_topic_score_codex":0.00000560983,"about_ca_topic_score_gemma":0.00001736067,"teacher_disagreement_score":0.046121545,"about_ca_system_score_codex":0.000035636338,"about_ca_system_score_gemma":0.00009949256,"threshold_uncertainty_score":0.41466883},"labels":[],"label_agreement":null},{"id":"W4389243189","doi":"10.1182/blood-2023-190200","title":"Efficacy of Maintenance Therapies By Prognostic Subgroups in Post-Transplant Newly Diagnosed Multiple Myeloma Patients: A Systematic Review and Network Meta-Analysis","year":2023,"lang":"en","type":"review","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"","keywords":"Lenalidomide; Ixazomib; Internal medicine; Daratumumab; Medicine; Multiple myeloma; Oncology; Carfilzomib; Pomalidomide; Hazard ratio; Progression-free survival; Transplantation; Confidence interval; Overall survival","score_opus":0.05455623364378186,"score_gpt":0.32165691286035386,"score_spread":0.267100679216572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243189","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00068271795,0.98546624,0.0000054881752,0.000048289832,0.000016801885,0.012655064,0.0010627237,0.000053729305,0.000008933831],"genre_scores_gemma":[0.0027702574,0.99092144,0.00014988142,0.00007607686,0.000020125737,0.0034417494,0.0023736777,0.00009573403,0.00015106204],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99504,0.00093590206,0.0019102615,0.00075780664,0.00067699834,0.0006790149],"domain_scores_gemma":[0.9944661,0.0033142925,0.00083838287,0.0008697984,0.00023826961,0.00027315598],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008310573,0.0007287746,0.010870611,0.00043828454,0.000056191962,0.000030116536,0.00030016666,0.00022120695,0.000048480364],"category_scores_gemma":[0.0021581617,0.0004220715,0.0023317086,0.0019283795,0.000098443714,0.000055509747,0.00008062305,0.0003779403,0.000034641278],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004871346,0.001520424,0.0048349784,0.74188274,0.24866998,0.00032605376,0.00008069596,2.634006e-7,9.744857e-8,0.0000028576333,0.000071918636,0.0025613],"study_design_scores_gemma":[0.004414177,0.00038475718,0.0041526463,0.20817049,0.7818703,0.000026302869,0.0000106318475,0.000004637431,3.187809e-7,0.0000016188063,0.0006434339,0.0003206791],"about_ca_topic_score_codex":0.0002583334,"about_ca_topic_score_gemma":0.0003074577,"teacher_disagreement_score":0.5337122,"about_ca_system_score_codex":0.000056992092,"about_ca_system_score_gemma":0.00014681887,"threshold_uncertainty_score":0.9998231},"labels":[],"label_agreement":null},{"id":"W4389243191","doi":"10.1182/blood-2023-188259","title":"<i>Perioperative Outcomes and Management in Patients with Myeloproliferative Neoplasms: A Multicentric Retrospective Analysis of 354 Surgical Interventions</i>","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University; Jewish General Hospital; Concordia University; St Mary's Hospital Centre; Université de Montréal","funders":"","keywords":"Medicine; Essential thrombocythemia; Perioperative; Myelofibrosis; Population; Polycythemia vera; Surgery; Thrombosis; Myeloproliferative neoplasm; Venous thrombosis; Internal medicine","score_opus":0.011499135810078186,"score_gpt":0.27667086762581344,"score_spread":0.2651717318157353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972922,0.00013774284,0.0000079387755,0.00023135866,0.000025910163,0.0014084654,0.000098113545,0.00004389896,0.0007543709],"genre_scores_gemma":[0.9979641,0.00045192553,0.00068222167,0.000053982363,0.0000089618125,0.0003372317,0.00018571406,0.00001910918,0.00029674172],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822325,0.00009667741,0.00048272507,0.00049242756,0.0004224502,0.0002824958],"domain_scores_gemma":[0.99913174,0.0001448463,0.00014405345,0.00024194608,0.00021692697,0.00012049069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001675699,0.00026377922,0.0009008031,0.0009212861,0.000074770775,0.000025874393,0.00005479425,0.000064337924,0.00007577078],"category_scores_gemma":[0.000056729757,0.00017998532,0.00021858476,0.002296809,0.000100348494,0.000094779694,0.00008585121,0.0001330079,0.000011428545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000341428,0.0032547617,0.9860798,0.000110914494,0.0072792284,0.00025438034,0.0011287495,0.000044594115,0.0000023483112,0.0011347544,0.000013518902,0.00035552555],"study_design_scores_gemma":[0.018471127,0.0010351854,0.97509784,0.0002057218,0.004006134,0.0000030112485,0.00037970967,0.00023611884,0.00036945855,0.000008927,0.000025245274,0.00016154174],"about_ca_topic_score_codex":0.00003819793,"about_ca_topic_score_gemma":0.00020330389,"teacher_disagreement_score":0.018129699,"about_ca_system_score_codex":0.000087555825,"about_ca_system_score_gemma":0.000028741764,"threshold_uncertainty_score":0.73395884},"labels":[],"label_agreement":null},{"id":"W4389243194","doi":"10.1182/blood-2023-190230","title":"<i>BTG2</i> Super-Enhancer Mutations Disrupt TFAP4 Binding and Deregulate BTG2 Expression in Diffuse Large B-Cell Lymphoma","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Biology; Diffuse large B-cell lymphoma; Somatic hypermutation; Cancer research; Genetics; Enhancer; Gene; Lymphoma; B cell; Transcription factor; Immunology","score_opus":0.005929685323243366,"score_gpt":0.2326254506934015,"score_spread":0.22669576537015812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99792194,0.001119041,0.00015404169,0.000089494824,0.00016111652,0.00021340422,0.000053890482,0.000045884084,0.00024116275],"genre_scores_gemma":[0.9973054,0.0004642869,0.00015961983,0.000028084476,0.00013703201,0.0000552803,0.0004636486,0.00003888467,0.0013477416],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988622,0.000051336814,0.00021749613,0.00040794833,0.00012964719,0.0003313426],"domain_scores_gemma":[0.9995376,0.00001826628,0.00006337208,0.00027059167,0.000030606312,0.00007960484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012552994,0.00016229581,0.00013385084,0.00012235485,0.00012168456,0.00003411661,0.000093506525,0.00019811555,0.0000113949145],"category_scores_gemma":[0.000028326507,0.00016691377,0.00005609219,0.0003037906,0.000041185107,0.000011582894,0.00014010233,0.000057591278,0.000027202572],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025224599,0.0005698581,0.0045506624,0.000028834676,0.000019331948,0.000008397618,0.00021396409,0.00006691141,0.99289495,0.00000647691,0.00048926345,0.0011260984],"study_design_scores_gemma":[0.009478392,0.00006971342,0.01644202,0.00005750721,0.00003985741,0.000015088497,0.00016565813,0.00040208382,0.96926093,0.00006150249,0.0037554547,0.00025177456],"about_ca_topic_score_codex":0.000011750863,"about_ca_topic_score_gemma":0.00009450229,"teacher_disagreement_score":0.02363403,"about_ca_system_score_codex":0.000019815348,"about_ca_system_score_gemma":0.000050988376,"threshold_uncertainty_score":0.6806546},"labels":[],"label_agreement":null},{"id":"W4389243209","doi":"10.1182/blood-2023-186969","title":"Gene Expression Profiling Reveals Two Overarching Types of Anaplastic Large Cell Lymphoma with Distinct Targetable Biology: An L.L.M.P.P. Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Toronto; Spinal Cord Injury BC","funders":"","keywords":"Anaplastic large-cell lymphoma; Biology; Gene expression profiling; Cancer research; Subtyping; Fluorescence in situ hybridization; Lymphoma; Genetics; Gene; Gene expression; Immunology","score_opus":0.016163835044492196,"score_gpt":0.2848491811892356,"score_spread":0.2686853461447434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998183,0.0003836908,0.000038529597,0.000012858285,0.000055373803,0.0006669813,0.000074437135,0.00011014355,0.00047497236],"genre_scores_gemma":[0.99704283,0.000022279199,0.0023510177,0.000019339075,0.000094617884,0.000098727316,0.00020728812,0.000031149342,0.00013272585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873376,0.000094324285,0.00025790636,0.00037567155,0.00020146862,0.00033686293],"domain_scores_gemma":[0.9992043,0.00012297096,0.000120680976,0.00036280125,0.00005931352,0.00012994044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023960478,0.00018350569,0.0003973403,0.00012498436,0.00011874017,0.000013683802,0.00008400828,0.00004375939,0.000027065342],"category_scores_gemma":[0.000049258044,0.00011906439,0.000051135634,0.00029038958,0.00002243556,0.000069700436,0.00007914881,0.000045235254,0.000026680615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023331505,0.010037701,0.9223138,0.00009729748,0.00016669252,0.00025383697,0.00042068414,0.000016921469,0.06604756,0.00004463897,0.000029811394,0.0003377402],"study_design_scores_gemma":[0.030708369,0.004481868,0.5107274,0.00021752942,0.0006786429,0.000030413908,0.00045900137,0.00020435962,0.45213893,0.00008868471,0.00005441309,0.00021036132],"about_ca_topic_score_codex":0.000083314495,"about_ca_topic_score_gemma":0.000025466587,"teacher_disagreement_score":0.41158637,"about_ca_system_score_codex":0.00002875862,"about_ca_system_score_gemma":0.00009675615,"threshold_uncertainty_score":0.48553047},"labels":[],"label_agreement":null},{"id":"W4389243215","doi":"10.1182/blood-2023-182130","title":"Long-Term Efficacy and Safety of Elranatamab Monotherapy in the Phase 2 Magnetismm-3 Trial in Relapsed or Refractory Multiple Myeloma (RRMM)","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Internal medicine; Multiple myeloma; Adverse effect; Clinical endpoint; Pomalidomide; Minimal residual disease; Gastroenterology; Phases of clinical research; Lenalidomide; Oncology; Clinical trial; Surgery; Leukemia","score_opus":0.04387892977143066,"score_gpt":0.3515561858806986,"score_spread":0.30767725610926794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965307,0.0006225085,0.0000022627064,0.000373173,0.000047958147,0.0021630796,0.00004941542,0.00003653459,0.00017435227],"genre_scores_gemma":[0.9980386,0.0011701966,0.00010446814,0.000055036016,0.000086554275,0.00013203504,0.0001058708,0.000026670547,0.00028055254],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99826515,0.00022612177,0.00043782833,0.00031329316,0.00038923923,0.00036835816],"domain_scores_gemma":[0.99852854,0.0008246251,0.00007941237,0.00042493857,0.000028960165,0.00011350304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005357148,0.00017397436,0.0004015831,0.00032533408,0.000047886693,0.000014171573,0.00015073485,0.00011231001,0.000131671],"category_scores_gemma":[0.00052201963,0.00010891446,0.000066235596,0.0005985237,0.00009834417,0.00005202779,0.000040341674,0.00027193702,0.000021046098],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.45879522,0.017085921,0.25750884,0.00029980548,0.0003799202,0.0063854964,0.0031905218,0.0000027718977,0.01641192,0.000016715254,0.00019306925,0.23972978],"study_design_scores_gemma":[0.42693233,0.0031016902,0.5680142,0.0001233624,0.000043807697,0.00002717352,0.00009216834,0.00011456821,0.0012929704,0.0000065956365,0.00017219037,0.000078902565],"about_ca_topic_score_codex":0.00017645948,"about_ca_topic_score_gemma":0.0004537404,"teacher_disagreement_score":0.3105054,"about_ca_system_score_codex":0.00003378441,"about_ca_system_score_gemma":0.00012984542,"threshold_uncertainty_score":0.44414026},"labels":[],"label_agreement":null},{"id":"W4389243235","doi":"10.1182/blood-2023-180829","title":"Systematic Literature Review and Meta-Analysis of Comparative Clinical Evidence Investigating Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Bortezomib, Lenalidomide, and Dexamethasone (VRd) As First-Line Treatment for Transplant-Ineligible Newly Diagnosed Multiple Myeloma","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Lenalidomide; Medicine; Daratumumab; Population; Internal medicine; Multiple myeloma; Bortezomib; Oncology; Clinical trial","score_opus":0.25152029933865633,"score_gpt":0.43487470191905686,"score_spread":0.18335440258040053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72119373,0.27233765,0.00006498829,0.0011522984,0.000030633448,0.0045520933,0.0005819917,0.0000682655,0.000018321693],"genre_scores_gemma":[0.84902126,0.14305782,0.0055871652,0.0002622281,0.00005519963,0.0013471583,0.00041691083,0.000046189354,0.00020607017],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99528134,0.0008048812,0.0016643556,0.0010646979,0.00058738975,0.0005973372],"domain_scores_gemma":[0.98267823,0.014839317,0.0006223846,0.0007160672,0.0004185219,0.0007254982],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020510626,0.0006526624,0.0049994504,0.00054030825,0.000261033,0.00011101149,0.00015661048,0.00020428613,0.000027113641],"category_scores_gemma":[0.005200119,0.00043681415,0.00093539624,0.0016304649,0.00037359446,0.00027048387,0.00009393985,0.0002899889,0.0000066111556],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013155593,0.003821166,0.1376488,0.17462745,0.65843165,0.001997677,0.0062318086,0.00008628236,0.0018608505,0.00015579493,0.0005579339,0.0014249703],"study_design_scores_gemma":[0.067994386,0.0059375605,0.02726994,0.018563347,0.86581135,0.00022782257,0.00043588504,0.007369365,0.005497045,0.00006625732,0.00006805257,0.00075898133],"about_ca_topic_score_codex":0.00033392216,"about_ca_topic_score_gemma":0.00081129174,"teacher_disagreement_score":0.2073797,"about_ca_system_score_codex":0.000050247403,"about_ca_system_score_gemma":0.00015178465,"threshold_uncertainty_score":0.9998084},"labels":[],"label_agreement":null},{"id":"W4389243236","doi":"10.1182/blood-2023-173489","title":"DNA Methylation Instability: A Novel Biomarker for Aging, Clonality, and Cancer","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre; University Health Network; Ontario Institute for Cancer Research","funders":"","keywords":"DNA methylation; Epigenetics; Biology; CpG site; Methylation; Genome instability; Genetics; Differentially methylated regions; Gene; Cancer research; Molecular biology; DNA; DNA damage; Gene expression","score_opus":0.040320586707422515,"score_gpt":0.32356894629791416,"score_spread":0.28324835959049166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941419,0.0020163672,0.002942512,0.0003057857,0.000093692055,0.00022501656,0.00008772712,0.000019404328,0.00016759055],"genre_scores_gemma":[0.99773604,0.00059336884,0.0009416767,0.000053194468,0.00014186645,0.00008503872,0.00020756073,0.000016586466,0.00022466507],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993667,0.000021240307,0.00013198478,0.0002605144,0.00007426158,0.00014527127],"domain_scores_gemma":[0.9996562,0.000026921334,0.00004707472,0.00015344744,0.00007138832,0.000044991913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033838695,0.00008377709,0.000080579484,0.000039557177,0.00006679539,0.000020362262,0.000049786104,0.000091924114,0.0000044491494],"category_scores_gemma":[0.00010435398,0.00008250413,0.000045382272,0.00010859991,0.000033880002,0.0000026438283,0.00006537344,0.000023881896,0.0000012035325],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001364859,0.000055323675,0.021946248,0.00003588273,0.000051163184,1.4731303e-7,0.000036434438,0.0000117518775,0.9669295,0.000084116204,0.000049845654,0.010785949],"study_design_scores_gemma":[0.0013667409,0.00009036599,0.12835069,0.000008547755,0.000059677506,6.749802e-7,0.000019256693,0.00032471385,0.8255866,0.0010218715,0.043012667,0.00015819843],"about_ca_topic_score_codex":0.000035971603,"about_ca_topic_score_gemma":0.00008143832,"teacher_disagreement_score":0.1413429,"about_ca_system_score_codex":0.0000040468817,"about_ca_system_score_gemma":0.000036909594,"threshold_uncertainty_score":0.33644205},"labels":[],"label_agreement":null},{"id":"W4389243238","doi":"10.1182/blood-2023-182004","title":"Long-Term Follow-up of Hypereosinophilic Syndrome Patients Treated with Mepolizumab: A Nationwide Real-Life Study of 59 Patients","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Mepolizumab; Medicine; Hypereosinophilic syndrome; Internal medicine; Adverse effect; Randomized controlled trial; Gastroenterology; Eosinophil; Eosinophilia; Surgery; Pediatrics","score_opus":0.016893530539941894,"score_gpt":0.251764623027311,"score_spread":0.23487109248736912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973111,0.000041707663,2.6733204e-7,0.0000316552,0.00008349093,0.0013920323,0.000058414113,0.000106957465,0.00097435765],"genre_scores_gemma":[0.9989749,0.000045653574,0.000011973914,0.000025503257,0.000012347397,0.00006651903,0.0002712709,0.00005742242,0.0005343834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976993,0.00007077288,0.0006609009,0.0003932761,0.00084956916,0.0003261341],"domain_scores_gemma":[0.9984357,0.00007018364,0.00031856474,0.0005485788,0.00044662648,0.00018035487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010678899,0.0002673143,0.0007700084,0.00043891039,0.00007193246,0.000009863789,0.00016995151,0.00010096233,0.000050840896],"category_scores_gemma":[0.00015472648,0.00020763716,0.00011543687,0.0010040788,0.00008851697,0.000098265555,0.000074870986,0.00010799533,0.000022081955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002846288,0.009548125,0.9876284,0.00024900955,0.0006429734,0.000099351666,0.0010555582,0.0000019407528,0.00010611324,0.000011599166,0.00006144989,0.00031084038],"study_design_scores_gemma":[0.028859572,0.007816604,0.9615806,0.00025481186,0.00073101575,0.00001968762,0.00029949326,0.0000053282974,0.00024069371,0.000008051404,0.0000023027567,0.00018186437],"about_ca_topic_score_codex":0.0004215719,"about_ca_topic_score_gemma":0.00012910592,"teacher_disagreement_score":0.028574944,"about_ca_system_score_codex":0.00002266526,"about_ca_system_score_gemma":0.000105575404,"threshold_uncertainty_score":0.8467198},"labels":[],"label_agreement":null},{"id":"W4389243258","doi":"10.1182/blood-2023-189140","title":"Erythrocyte Disorders Mimicking Congenital Dyserythropoietic Anemia Based on Bone Marrow Pathology Exposed By Genetic Evaluation","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Ineffective erythropoiesis; Medicine; Anemia; Bone marrow; Myelodysplastic syndromes; Erythropoiesis; Hemolysis; Pediatrics; Internal medicine; Pathology","score_opus":0.01920288624748713,"score_gpt":0.26263959037301393,"score_spread":0.24343670412552681,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941838,0.0005115851,0.00018588122,0.0012842951,0.0007461108,0.00080233964,0.00003268725,0.00034996716,0.0019033686],"genre_scores_gemma":[0.99601275,0.00021711733,0.00046378718,0.0016629894,0.0002468456,0.000153157,0.0006932175,0.000069433714,0.00048071073],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9977253,0.0002654993,0.0003940784,0.0006213676,0.0004886357,0.0005051172],"domain_scores_gemma":[0.9988567,0.00018961218,0.00013234715,0.0005184876,0.00013146257,0.00017134137],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034896805,0.00029474893,0.0004159922,0.0002907949,0.00017041028,0.000016864355,0.00009129033,0.00027209282,0.0008531625],"category_scores_gemma":[0.00024316148,0.000285003,0.00016214231,0.000505282,0.00018300627,0.00004495092,0.000037965503,0.00029743125,0.0006628035],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001101032,0.0019648669,0.020780565,0.0002516812,0.00017986516,0.00058823335,0.00054406276,0.00085731293,0.935323,0.000033009244,0.022765161,0.015611207],"study_design_scores_gemma":[0.12738538,0.02361809,0.5509679,0.0006576888,0.0060196607,0.0018324512,0.0026625432,0.09494806,0.16445014,0.0016546381,0.022098608,0.0037048957],"about_ca_topic_score_codex":0.000012884942,"about_ca_topic_score_gemma":0.000025027253,"teacher_disagreement_score":0.7708729,"about_ca_system_score_codex":0.00006805862,"about_ca_system_score_gemma":0.00018015673,"threshold_uncertainty_score":0.9999602},"labels":[],"label_agreement":null},{"id":"W4389243260","doi":"10.1182/blood-2023-180567","title":"Targeting CDK9 in KMT2A-Rearranged Infant Leukemia: Evidence for Activity and Drug Synergy with Enitociclib","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Propidium iodide; Cancer research; Leukemia; Biology; Apoptosis; Programmed cell death; Immunology; Biochemistry","score_opus":0.040844396706024015,"score_gpt":0.35252926437032056,"score_spread":0.31168486766429654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954639,0.0014873578,0.00002001179,0.0018629737,0.000033344437,0.00079947815,0.000008627721,0.00010168065,0.000222629],"genre_scores_gemma":[0.9976391,0.00079767784,0.00038185157,0.000056129287,0.00016682896,0.00040662795,0.0000053067074,0.000024568859,0.00052190287],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881166,0.000051403455,0.00012981801,0.00031432352,0.00030325298,0.00038951097],"domain_scores_gemma":[0.99889,0.0007121675,0.00004376732,0.00017501597,0.000083094004,0.00009598711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005724099,0.00012703333,0.00029153083,0.00013418385,0.000100888356,0.000020459116,0.00006829472,0.000043622254,0.0000049073556],"category_scores_gemma":[0.0012111356,0.00009391716,0.00003204206,0.00040920073,0.000097934775,0.00013665539,0.000109119195,0.00022382494,0.0000049434148],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034246568,0.00034460114,0.7120047,0.0028887994,0.00068393233,0.0006503614,0.0053161383,0.00006642717,0.2581412,0.0000678044,0.008415901,0.007995493],"study_design_scores_gemma":[0.026355289,0.0018178982,0.85723656,0.004122752,0.0005425434,0.00007541701,0.0021742966,0.0017981987,0.101144575,0.00018665254,0.0038487846,0.00069704803],"about_ca_topic_score_codex":0.0011424127,"about_ca_topic_score_gemma":0.00086259004,"teacher_disagreement_score":0.15699661,"about_ca_system_score_codex":0.00011330184,"about_ca_system_score_gemma":0.00024699018,"threshold_uncertainty_score":0.38298306},"labels":[],"label_agreement":null},{"id":"W4389243266","doi":"10.1182/blood-2023-187295","title":"CAR T-Related Toxicities Based on Dynamic Proteomic Profiles Identifies Risk Factors for Cytokine Release Syndrome (CRS) and Immune Effector Cell -Associated Neurotoxicity Syndrome (ICANS)","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cytokine release syndrome; Medicine; Receiver operating characteristic; Oncology; Internal medicine; Immunology; Area under the curve; Immune system; Pharmacology; Immunotherapy; Chimeric antigen receptor","score_opus":0.012366434127539882,"score_gpt":0.255808980568887,"score_spread":0.24344254644134714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910806,0.000117545445,0.00000945667,0.00015459416,0.00018029952,0.006591262,0.0011648214,0.000604896,0.00009654432],"genre_scores_gemma":[0.9930787,0.0001156301,0.000026346806,0.000031548407,0.000020514968,0.0009271895,0.0006360911,0.00017530439,0.004988675],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99663275,0.00039860865,0.0005988163,0.0007859958,0.0007269878,0.0008568298],"domain_scores_gemma":[0.99755174,0.0010589658,0.00026990255,0.000673923,0.0001459191,0.00029957786],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000824897,0.00049880135,0.0009170854,0.00065232074,0.0003474286,0.00009676165,0.0002515142,0.0003212204,0.0003058201],"category_scores_gemma":[0.0010219542,0.00043944168,0.00035110774,0.0008727021,0.00024973683,0.00010805009,0.00010508371,0.0005922254,0.00007574796],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000995974,0.001037757,0.021248449,0.0009775585,0.00044542822,0.0005821561,0.00025330178,0.00010297867,0.97417355,0.0000024854671,0.00006269403,0.000117694224],"study_design_scores_gemma":[0.014615473,0.006424131,0.4973742,0.0005934178,0.00069772557,0.000144841,0.00015623849,0.0113896085,0.4678448,0.00013075321,0.000020977119,0.00060781365],"about_ca_topic_score_codex":0.00036947356,"about_ca_topic_score_gemma":0.000023771305,"teacher_disagreement_score":0.5063287,"about_ca_system_score_codex":0.00019571622,"about_ca_system_score_gemma":0.00018901983,"threshold_uncertainty_score":0.99980575},"labels":[],"label_agreement":null},{"id":"W4389243281","doi":"10.1182/blood-2023-180061","title":"The 3D- Telomere Profiling Assay Identifies High Risk Smoldering Multiple Myeloma Patients with High Precision","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; University of Manitoba; Ontario Genomics","funders":"","keywords":"Telomere; Multiple myeloma; Medicine; Oncology; Internal medicine; Genotyping; Asymptomatic; Bioinformatics; Genotype; Biology; Genetics; Gene","score_opus":0.014425750659531056,"score_gpt":0.2576301301874951,"score_spread":0.24320437952796403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977043,0.00014040506,0.000032082553,0.00011841293,0.0001864391,0.0012750893,0.00008978231,0.00025209557,0.00020139264],"genre_scores_gemma":[0.9963824,0.00017314266,0.001685408,0.00001091018,0.00012782867,0.00021172692,0.00028002914,0.00005957533,0.0010689598],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99753934,0.0001414294,0.0003018309,0.00045045762,0.0009300282,0.0006369043],"domain_scores_gemma":[0.99808156,0.0007389606,0.00013116717,0.00059640827,0.00023269732,0.00021921191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045909043,0.00024427945,0.0002849039,0.00016265322,0.0006369619,0.000120812634,0.00019173186,0.000089611174,0.000031899806],"category_scores_gemma":[0.0010741235,0.00013907805,0.00007920587,0.0005258215,0.00009668604,0.00014157397,0.00018127266,0.00029989937,0.00029202158],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005199429,0.00052374124,0.95827323,0.000067536355,0.0005223486,0.00015953496,0.000111686466,0.000021100259,0.00097772,0.000018017125,0.00016483026,0.038640287],"study_design_scores_gemma":[0.010478683,0.00048771233,0.9550199,0.00017110564,0.00020391552,0.000007470582,0.00012373511,0.00036357754,0.032657288,0.00010090366,0.00022445607,0.0001612555],"about_ca_topic_score_codex":0.00039289624,"about_ca_topic_score_gemma":0.0001452651,"teacher_disagreement_score":0.03847903,"about_ca_system_score_codex":0.000051144805,"about_ca_system_score_gemma":0.000075926204,"threshold_uncertainty_score":0.56714386},"labels":[],"label_agreement":null},{"id":"W4389243316","doi":"10.1182/blood-2023-189747","title":"Bclxl Prevents Progressive Exhaustion in BCMA CAR T Cells with Maintenance of High TCF1 Expressing T Cells","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Stimulation; In vivo; Antigen; Biology; Immunology; Medicine; Cancer research; Endocrinology; Genetics","score_opus":0.01847844680771295,"score_gpt":0.2882705134185854,"score_spread":0.26979206661087246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977832,0.00014961346,0.000017044575,0.000097078584,0.0000812134,0.0009142822,0.00001572938,0.00006973069,0.0008721098],"genre_scores_gemma":[0.99224,0.00011193209,0.0008373462,0.000024637864,0.00010760063,0.00009629736,0.000024994586,0.00004877872,0.0065084076],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998276,0.00008004413,0.00028681647,0.0003501834,0.000548876,0.00045808],"domain_scores_gemma":[0.9991506,0.00007487432,0.00012869781,0.0004055189,0.00012606542,0.00011429603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003052457,0.00016292855,0.00035700042,0.00024322694,0.00003386582,0.00001622354,0.00014134747,0.00009967423,0.0003993531],"category_scores_gemma":[0.000031146148,0.00013046313,0.00006131537,0.00067243533,0.000121496356,0.000075376745,0.00007467211,0.00026225776,0.000045108536],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000496488,0.0006484976,0.0068807984,0.00037157378,0.00008721307,0.000657155,0.00073749915,0.0000865765,0.9847101,0.0000103635675,0.0004509296,0.004862813],"study_design_scores_gemma":[0.006422493,0.0005827098,0.016238967,0.0013426964,0.000077505574,0.000037369042,0.00026556884,0.00014171423,0.97435,0.00005895623,0.0003357914,0.00014624555],"about_ca_topic_score_codex":0.00009443947,"about_ca_topic_score_gemma":0.000009144569,"teacher_disagreement_score":0.01036011,"about_ca_system_score_codex":0.00005889269,"about_ca_system_score_gemma":0.00013520321,"threshold_uncertainty_score":0.5320132},"labels":[],"label_agreement":null},{"id":"W4389243318","doi":"10.1182/blood-2023-189707","title":"Positive Impacts of the Universal Newborn Screening Program on the Outcome of Children with Sickle Cell Disease in the Province of Quebec: A Retrospective Cohort Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"","keywords":"Medicine; Pediatrics; Retrospective cohort study; Cohort; Referral; Newborn screening; Disease; Acute chest syndrome; Internal medicine; Sickle cell anemia; Family medicine","score_opus":0.0058508331805188106,"score_gpt":0.23337507581062328,"score_spread":0.22752424263010446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946367,0.000041549112,0.0000021222922,0.000765028,0.000010224347,0.0036998452,0.000040946525,0.000021935168,0.000781642],"genre_scores_gemma":[0.9997441,0.000008022879,0.000022552682,0.00004917657,0.000010290668,0.000024278623,0.000008220539,0.000014533546,0.00011883548],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988237,0.00015460126,0.0002208203,0.00017343697,0.00044889966,0.00017851572],"domain_scores_gemma":[0.9991782,0.00009517223,0.00019196577,0.00040538155,0.00008387561,0.000045452573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034452448,0.00012495657,0.00026588663,0.000063803825,0.00006147902,0.000006058454,0.00020025056,0.000040349012,0.0000034850211],"category_scores_gemma":[0.00010595629,0.00005179982,0.000092004695,0.0007172498,0.00021382852,0.000029821167,0.000059934246,0.00027440116,8.28865e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003394338,0.0029680077,0.9934337,0.00002912709,0.00025758703,0.000034400815,0.0024145786,0.000064800486,0.000094492054,0.0000840123,0.00002857122,0.0002512538],"study_design_scores_gemma":[0.0029647276,0.0016081247,0.9873825,0.0001929709,0.00058520754,0.0000022327747,0.0062786173,0.00004030356,0.000878448,0.000007860614,0.0000019138827,0.00005712716],"about_ca_topic_score_codex":0.005431244,"about_ca_topic_score_gemma":0.0014468251,"teacher_disagreement_score":0.0060512694,"about_ca_system_score_codex":0.000025575728,"about_ca_system_score_gemma":0.00018533274,"threshold_uncertainty_score":0.8210452},"labels":[],"label_agreement":null},{"id":"W4389243334","doi":"10.1182/blood-2023-174949","title":"The CD47-Blocking Immune Checkpoint Inhibitor Maplirpacept Does Not Interfere with Blood Transfusion Compatibility Testing","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Therapeutics (Canada)","funders":"","keywords":"CD47; In vivo; Immune system; Immunology; Antibody; Cancer research; Medicine; Biology","score_opus":0.01869009301000409,"score_gpt":0.2292024989143222,"score_spread":0.2105124059043181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967935,0.0010880214,0.00003721829,0.00052423315,0.0004422034,0.00042790052,0.000021205859,0.00029337074,0.00037231809],"genre_scores_gemma":[0.99879533,0.000098125915,0.000081419676,0.000019424564,0.00007091955,0.000048186324,0.00006950908,0.00003120904,0.000785854],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982848,0.00021589435,0.0005248445,0.00040746608,0.00008263278,0.00048435645],"domain_scores_gemma":[0.99869394,0.00042566896,0.00020468631,0.0005220677,0.00013021112,0.000023414883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006849289,0.0002544811,0.00033401247,0.000083798885,0.00083310844,0.00006452081,0.00028597904,0.00017430147,0.00005650289],"category_scores_gemma":[0.00017014623,0.00014058611,0.00012840943,0.00041179793,0.00024035115,0.00011676268,0.00014675508,0.000387195,0.00011900936],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015526872,0.00030967942,0.013420855,0.000035248806,0.00024562393,0.000004519004,0.00072940177,0.0000111169475,0.97780764,0.000048677255,0.000031250263,0.0072007454],"study_design_scores_gemma":[0.0029749386,0.0003580971,0.13138908,0.0001773096,0.00018035628,0.00006212845,0.00054320693,0.00003967058,0.8634524,0.00006110904,0.00054508395,0.0002166482],"about_ca_topic_score_codex":0.0001924542,"about_ca_topic_score_gemma":0.0001426986,"teacher_disagreement_score":0.117968224,"about_ca_system_score_codex":0.000022826942,"about_ca_system_score_gemma":0.00005335913,"threshold_uncertainty_score":0.64076805},"labels":[],"label_agreement":null},{"id":"W4389243340","doi":"10.1182/blood-2023-179333","title":"<i>ATM</i> Germline Pathogenic Variants Affect Treatment Outcomes in Children with Acute Lymphoblastic Leukemia/Lymphoma and Ataxia Telangiectasia","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; University of Alberta; Stollery Children's Hospital; Hospital for Sick Children","funders":"","keywords":"Medicine; Ataxia-telangiectasia; Oncology; Cancer; Internal medicine; Cohort; Incidence (geometry); Lymphoma; Immunology; Pediatrics; Biology","score_opus":0.005104371133787049,"score_gpt":0.21705607676019809,"score_spread":0.21195170562641102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988397,0.00031383996,0.00004580437,0.000021390535,0.00004103967,0.00042811103,0.00016405604,0.00007738432,0.00006868178],"genre_scores_gemma":[0.99802345,0.00032529674,0.000517063,0.00006359146,0.000059610993,0.00010657186,0.00035075383,0.000050884173,0.00050276483],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987563,0.000055371846,0.00016893753,0.0005169889,0.00012747323,0.00037492887],"domain_scores_gemma":[0.99939525,0.000017061795,0.00006088675,0.00041173794,0.00001499889,0.0001000651],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009323205,0.00027488332,0.00026990176,0.00008507068,0.00005291046,0.000025089956,0.00013450507,0.0001438046,0.0000045451457],"category_scores_gemma":[0.000018730676,0.00021036185,0.00008004941,0.0001939891,0.000046185352,0.00000518415,0.00012129025,0.000031633164,0.000029401675],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013259037,0.00052960427,0.36308533,0.000012770458,0.0012673299,0.00040730363,0.00006447589,0.000030817388,0.631355,0.000027550712,0.00006909365,0.0030181329],"study_design_scores_gemma":[0.0099942,0.0017172877,0.7690387,0.00002234222,0.0003980528,0.00090485846,0.000017669025,0.000085529115,0.21728525,0.00003588873,0.000103098064,0.00039718184],"about_ca_topic_score_codex":0.000056587505,"about_ca_topic_score_gemma":0.00011535488,"teacher_disagreement_score":0.41406977,"about_ca_system_score_codex":0.000048451417,"about_ca_system_score_gemma":0.00014723082,"threshold_uncertainty_score":0.85783076},"labels":[],"label_agreement":null},{"id":"W4389243360","doi":"10.1182/blood-2023-187754","title":"Low-Cost Automated Microscopy and Morphology-Based Machine Learning Classification of Sickle Cell Disease and Beta-Thalassemia in Nepal and Canada","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Children's Hospital; St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Sickle cell trait; Thalassemia; Pediatrics; Malaria; Alpha-thalassemia; Asymptomatic; Gold standard (test); Disease; Internal medicine; Pathology; Genotype; Biology; Genetics","score_opus":0.00672324464941715,"score_gpt":0.23162162326692137,"score_spread":0.22489837861750422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978212,0.0010076547,0.0000023668867,0.0007279265,0.000024385332,0.00023776005,0.000041437357,0.0000689358,0.000068308436],"genre_scores_gemma":[0.9992411,0.0003181262,0.000078889745,0.00008818137,0.000006320223,0.000009137996,0.0001459828,0.000014436367,0.000097827404],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993293,0.00003788418,0.0001737878,0.00019969406,0.00009041787,0.00016890085],"domain_scores_gemma":[0.9996182,0.00005665342,0.000059913156,0.00009505475,0.00002229417,0.00014791841],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009684001,0.00010144606,0.00019071101,0.00009661411,0.00005066695,0.000007313104,0.00002253659,0.0000810471,0.000007901458],"category_scores_gemma":[0.000050147508,0.00009000339,0.000013511858,0.00017542251,0.00008504623,0.00001927818,0.000022838944,0.00016896924,0.0000010716534],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009987117,0.000154168,0.8406306,0.00040979488,0.000021958445,0.00016343259,0.00010029726,0.00005748994,0.15769441,0.000003436274,0.00031832163,0.00034622522],"study_design_scores_gemma":[0.00584177,0.00010424448,0.9408659,0.0001500333,0.000184128,0.00001569309,0.0002866448,0.036656845,0.015468807,0.0000037319512,0.00029715203,0.00012505776],"about_ca_topic_score_codex":0.024779955,"about_ca_topic_score_gemma":0.011868192,"teacher_disagreement_score":0.1422256,"about_ca_system_score_codex":0.000015299407,"about_ca_system_score_gemma":0.00020652817,"threshold_uncertainty_score":0.9817141},"labels":[],"label_agreement":null},{"id":"W4389243379","doi":"10.1182/blood-2023-187663","title":"CAR T Cell Exhaustion but Not <i>Ex Vivo</i> Cytotoxicity Is Predictive of Patient Clinical Response: An Interim Analysis of ACIT001/EXC002, a Phase Ib/II Trial of Decentralized Production of CAR T Cells for Treatment of Relapsed/Refractory Aggressive NHL and ALL","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Alberta","funders":"","keywords":"Chimeric antigen receptor; Medicine; Immunophenotyping; Ex vivo; Immunotherapy; Oncology; Immunology; Lymphoma; Internal medicine; Cytotoxic T cell; T cell; Antigen; Immune system; In vivo; Biology; In vitro","score_opus":0.0644916410500575,"score_gpt":0.3929571026369683,"score_spread":0.3284654615869108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945057,0.00022950475,0.00002167666,0.00004954833,0.00018822432,0.0034387927,0.0015376048,0.000018729646,0.000010226294],"genre_scores_gemma":[0.99722826,0.0018131201,0.00023936878,0.000009124002,0.00008165294,0.000147115,0.00016271012,0.000032750107,0.000285868],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963918,0.000624898,0.0014964845,0.00054768694,0.00066167023,0.00027751675],"domain_scores_gemma":[0.99610853,0.0006652261,0.001549875,0.00069403066,0.0007949313,0.00018740553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011330292,0.00024117286,0.0015261055,0.0006364969,0.00003187981,0.0000029832563,0.00011468899,0.0002382733,0.000098344746],"category_scores_gemma":[0.0006866224,0.00020598684,0.0006206713,0.0007482924,0.00039892652,0.00007803433,0.00006299795,0.000118614604,2.561532e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26893783,0.013771686,0.0006897497,0.0002787485,0.003031149,0.000009100867,0.0056550205,0.000036134632,0.70585144,4.382724e-7,0.00007135603,0.0016673638],"study_design_scores_gemma":[0.08416624,0.059174933,0.00095646066,0.000149613,0.0058319233,0.0000021994954,0.0008077828,0.0005470861,0.84807587,0.0000036082972,0.00018040207,0.00010386147],"about_ca_topic_score_codex":0.00022679847,"about_ca_topic_score_gemma":0.000018568597,"teacher_disagreement_score":0.18477157,"about_ca_system_score_codex":0.000100670826,"about_ca_system_score_gemma":0.00028792908,"threshold_uncertainty_score":0.83998996},"labels":[],"label_agreement":null},{"id":"W4389243387","doi":"10.1182/blood-2023-180789","title":"Treatment Patterns and Modifications of Tyrosine Kinase Inhibitors (TKI) Therapy in Early Lines in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Real-World Analysis from a Large Commercial Claims Database in the United States (US)","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Bosutinib; Dasatinib; Nilotinib; Discontinuation; Internal medicine; Ponatinib; Imatinib mesylate; Oncology; Tolerability; Imatinib; Myeloid leukemia; Adverse effect","score_opus":0.022833910769530966,"score_gpt":0.2936828101174232,"score_spread":0.27084889934789225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961346,0.0004000196,0.0000038610415,0.00023005088,0.000021071135,0.0016286931,0.0015340386,0.000037732552,0.000009973853],"genre_scores_gemma":[0.9848561,0.0030512835,0.00003037532,0.000056325705,0.00006892556,0.00038894144,0.011483742,0.000044663015,0.000019632118],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99742615,0.00025258237,0.0007844547,0.0005972896,0.00039711205,0.0005424103],"domain_scores_gemma":[0.9985154,0.0002919995,0.00022243056,0.00080093206,0.0000635582,0.00010562286],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002742829,0.00039086555,0.00076619844,0.0016660771,0.000057268626,0.00002649528,0.000183261,0.00010958765,0.00003679136],"category_scores_gemma":[0.000024045477,0.0002757205,0.00008851704,0.004768532,0.00010159079,0.00014944572,0.00006448114,0.000329182,0.0000046998184],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007588805,0.0045472346,0.987413,0.000054376596,0.00043557878,0.00019109416,0.0035408724,0.0009390591,0.00048310225,0.00001091446,0.000011947821,0.001613939],"study_design_scores_gemma":[0.07476246,0.0017262255,0.91523725,0.00037344883,0.00048276084,7.646e-7,0.00025963195,0.005075893,0.0017991487,0.000009562371,0.000060348324,0.00021249554],"about_ca_topic_score_codex":0.17855436,"about_ca_topic_score_gemma":0.35675803,"teacher_disagreement_score":0.17820367,"about_ca_system_score_codex":0.0032398885,"about_ca_system_score_gemma":0.00077143847,"threshold_uncertainty_score":0.9999695},"labels":[],"label_agreement":null},{"id":"W4389243475","doi":"10.1182/blood-2023-174082","title":"Efficacy and Safety of Luspatercept in Patients with HbE/β-Thalassemia from the BELIEVE Study: A Subgroup Analysis","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Thalassemia; Medicine; Blood transfusion; Beta thalassemia; Anemia; Ineffective erythropoiesis; Internal medicine; Pediatrics; Gastroenterology; Erythropoiesis","score_opus":0.005342107623970179,"score_gpt":0.21930780279356166,"score_spread":0.2139656951695915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99884504,0.00013445638,0.0000028117342,0.0002015993,0.000017486318,0.0006007703,0.000023747136,0.000028937035,0.000145154],"genre_scores_gemma":[0.9996685,0.00008522738,0.000022375656,0.000051482195,0.000011605027,0.000009360222,0.00009549028,0.000013210643,0.000042787506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905473,0.000063350584,0.00024265939,0.00022315157,0.00024860678,0.00016749853],"domain_scores_gemma":[0.9994401,0.00011320098,0.000064754604,0.00028471468,0.00004128348,0.000055992485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015903507,0.00011234221,0.000328983,0.00013074974,0.000045823417,0.0000074523596,0.00006987981,0.00006988682,0.000031737713],"category_scores_gemma":[0.00004701564,0.00006298777,0.00004831163,0.0011972459,0.00005781181,0.00002258266,0.000058879752,0.00015739359,0.000008001598],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041017646,0.0013380543,0.99246186,0.000011019706,0.0011250958,0.00002233718,0.0034844805,0.000034422093,0.000047165417,0.00000146104,0.000033675467,0.0010302573],"study_design_scores_gemma":[0.01408227,0.0005940452,0.98118424,0.000071427574,0.0019680222,3.9955538e-7,0.0019136535,0.00005062471,0.000029572784,0.0000044421045,0.00002819757,0.00007308939],"about_ca_topic_score_codex":0.0007531493,"about_ca_topic_score_gemma":0.00040140774,"teacher_disagreement_score":0.013672094,"about_ca_system_score_codex":0.000009835303,"about_ca_system_score_gemma":0.000023207267,"threshold_uncertainty_score":0.25685665},"labels":[],"label_agreement":null},{"id":"W4389243476","doi":"10.1182/blood-2023-178112","title":"Use of Geriatric Assessment and Genetic Profiling to Personalize Selection of Intensive Versus Low Intensity Chemotherapy in Older Adults with Acute Myeloid Leukemia (AML): Final Results of a Phase II Trial","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Oncology; Chemotherapy regimen; Performance status; Chemotherapy; Intensive care medicine","score_opus":0.034495399427425445,"score_gpt":0.3306603888898472,"score_spread":0.29616498946242176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973338,0.00003120992,0.000059121237,0.00033900383,0.000068677975,0.0020470289,0.000075739554,0.000028383682,0.000017003596],"genre_scores_gemma":[0.991464,0.00022941815,0.007862159,0.000069851965,0.00009872904,0.00006749866,0.000061179395,0.000033513035,0.00011365163],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99804056,0.00007983182,0.0005875736,0.00044002803,0.0005266999,0.0003253314],"domain_scores_gemma":[0.997883,0.00020865953,0.0002678998,0.00027005255,0.0012380555,0.00013231143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003333274,0.00020256845,0.0006659295,0.0005681901,0.00003780447,0.000007905746,0.000092845,0.0001303745,0.000011049441],"category_scores_gemma":[0.0005529496,0.00017038331,0.00008130985,0.0013791804,0.00011969068,0.00007577227,0.00010518765,0.0003162204,8.691424e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6909004,0.0019729587,0.004396033,0.00056878006,0.0008923072,0.0003089504,0.0050425576,0.0000640473,0.2890455,0.0000036586807,0.0007189114,0.006085914],"study_design_scores_gemma":[0.57094353,0.030664554,0.08505318,0.0009117692,0.0005888794,0.00016594656,0.0019911043,0.0062748217,0.3031119,0.0000026815758,0.00002137707,0.0002702529],"about_ca_topic_score_codex":0.00053365243,"about_ca_topic_score_gemma":0.000053679607,"teacher_disagreement_score":0.11995684,"about_ca_system_score_codex":0.0002821058,"about_ca_system_score_gemma":0.0011242605,"threshold_uncertainty_score":0.694803},"labels":[],"label_agreement":null},{"id":"W4389243484","doi":"10.1182/blood-2023-179739","title":"Surgical Procedures and Hemostatic Outcome in Patients with Hemophilia Receiving Concizumab Prophylaxis during the Phase 3 explorer7 and explorer8 Trials","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster Children's Hospital","funders":"","keywords":"Medicine; Clinical trial; Surgery; Regimen; Hemarthrosis; Adverse effect; Internal medicine","score_opus":0.056531882392508365,"score_gpt":0.34068338212529664,"score_spread":0.2841514997327883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967831,0.00028682445,1.4366137e-7,0.0011049801,0.00002572388,0.0016434799,0.000013037515,0.00007428625,0.00006847505],"genre_scores_gemma":[0.99899954,0.00020958098,0.00004628481,0.000023539185,0.00006241585,0.00020501965,0.000024730483,0.00003205939,0.00039684516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982087,0.00015647107,0.00042978668,0.0003620751,0.00045292795,0.0003900113],"domain_scores_gemma":[0.9990101,0.00045394947,0.00007635356,0.00022454506,0.00006606836,0.00016899362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007157474,0.00020200203,0.0005526434,0.00020190292,0.00015644998,0.000048499103,0.00006600164,0.00007434531,0.000024218862],"category_scores_gemma":[0.00095675804,0.000102587626,0.000046607132,0.00046584674,0.00017071537,0.000102695085,0.00008466187,0.00023655249,0.000010460168],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015420876,0.0008398624,0.9902914,0.000522778,0.00013063055,0.0006038548,0.001856609,4.4979043e-7,0.00034601497,0.0000074712398,0.000023781922,0.0038350236],"study_design_scores_gemma":[0.06701062,0.0025369262,0.9245246,0.0004438421,0.00016458673,0.00010502678,0.0010633877,0.000030570856,0.0037361921,0.00006939923,0.0000810197,0.00023382716],"about_ca_topic_score_codex":0.000009928986,"about_ca_topic_score_gemma":0.000007955842,"teacher_disagreement_score":0.06576683,"about_ca_system_score_codex":0.00003028066,"about_ca_system_score_gemma":0.00008011758,"threshold_uncertainty_score":0.41834018},"labels":[],"label_agreement":null},{"id":"W4389243511","doi":"10.1182/blood-2023-172434","title":"Reporting of Race and Ethnicity and Representation in Hemophilia Clinical Trials","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ethnic group; Medicine; Clinical trial; Representativeness heuristic; Race (biology); Family medicine; Demography; Gerontology; Pediatrics; Internal medicine; Psychology","score_opus":0.31812730316501253,"score_gpt":0.523590315656112,"score_spread":0.2054630124910995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99703574,0.0003111137,0.0000010369405,0.0017514552,0.000029620023,0.00035118219,0.0000016508402,0.000021827746,0.0004963996],"genre_scores_gemma":[0.9977073,0.0011418398,0.00021369164,0.000015570766,0.00008407326,0.00000853742,0.000010103491,0.000006119404,0.0008127624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99798054,0.00027662047,0.0012580281,0.00020063977,0.00016682506,0.00011735664],"domain_scores_gemma":[0.9984172,0.0009358188,0.0003819528,0.00014422594,0.000042652744,0.00007814343],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0075549614,0.000051845593,0.00053303485,0.0001107244,0.000020108197,0.0000051577167,0.000016875572,0.00008351394,0.000011844296],"category_scores_gemma":[0.017005617,0.00003736038,0.00005772207,0.00026979673,0.000076486474,0.00002877947,0.000048419442,0.00013492977,0.0000043583277],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000115600014,0.00020131686,0.97312665,0.0000931025,0.0000547748,0.00024459802,0.00022813065,2.1508922e-7,0.011616428,0.00001415813,0.00015655537,0.01414847],"study_design_scores_gemma":[0.0047440836,0.00016212155,0.97691035,0.000100038174,0.00009724869,0.000041904786,0.0001871441,0.00015553925,0.017247187,0.00027970708,0.000037794594,0.00003688705],"about_ca_topic_score_codex":0.00005701939,"about_ca_topic_score_gemma":0.000010000113,"teacher_disagreement_score":0.014111583,"about_ca_system_score_codex":0.000004012746,"about_ca_system_score_gemma":0.00004695471,"threshold_uncertainty_score":0.99127454},"labels":[],"label_agreement":null},{"id":"W4389243521","doi":"10.1182/blood-2023-185210","title":"Prevalence and Risk Factors of Diagnostic Delays in Acquired Hemophilia A","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Alberta","funders":"","keywords":"Medicine; Pediatrics; Logistic regression; Cohort; Proportional hazards model; Retrospective cohort study; Comorbidity; Internal medicine","score_opus":0.026103791121245192,"score_gpt":0.2937929239689471,"score_spread":0.2676891328477019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99850506,0.0006820409,3.5962725e-7,0.0001419471,0.000020678017,0.00033113465,0.000024072877,0.000035379886,0.00025932907],"genre_scores_gemma":[0.9946965,0.0045576384,0.000035063706,0.0000038673857,0.000023893897,0.000019119743,0.000011198888,0.00001030892,0.00064238696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99925,0.000039125414,0.0001483736,0.00016887461,0.00019220643,0.00020140185],"domain_scores_gemma":[0.9990479,0.00063913525,0.000028615608,0.00016437052,0.00002602128,0.00009395745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016750055,0.000081248894,0.00017996429,0.00016032878,0.00002578856,0.0000039415117,0.00004693391,0.0000588673,0.0000434666],"category_scores_gemma":[0.0010716849,0.000058906753,0.00003605618,0.00034161826,0.00007645306,0.000030335335,0.00005022082,0.000069614565,0.000026807755],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022245971,0.00031167307,0.9962999,0.00024010622,0.000053714048,0.00015111349,0.0004473224,0.0000010905877,0.0018272786,0.000008635395,0.000043944394,0.0005929464],"study_design_scores_gemma":[0.0021507242,0.00030696456,0.9834833,0.0001643557,0.00013517782,0.000008999889,0.0000744193,0.000074006144,0.013423998,0.00010858674,0.000017890618,0.00005154921],"about_ca_topic_score_codex":0.0000940963,"about_ca_topic_score_gemma":0.00001147298,"teacher_disagreement_score":0.012816601,"about_ca_system_score_codex":0.00000966647,"about_ca_system_score_gemma":0.000040124934,"threshold_uncertainty_score":0.24021477},"labels":[],"label_agreement":null},{"id":"W4389243531","doi":"10.1182/blood-2023-187898","title":"A Survey of Clinician Perspectives on the Management of Catheter-Related Upper Extremity Deep Vein Thrombosis in Patients with Cancer","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Central Venous Catheters and Hemodialysis","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Thrombosis; Deep vein; Catheter; Venous thrombosis; Cancer; Intensive care medicine; Surgery; Internal medicine","score_opus":0.05120188219273269,"score_gpt":0.350470231042214,"score_spread":0.2992683488494813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99771154,0.00008411663,0.0000015155234,0.00019658491,0.00007983266,0.0007034503,0.00011438214,0.000020412346,0.0010881679],"genre_scores_gemma":[0.9993604,0.00031468837,0.000019756255,0.00004688103,0.000009115198,0.00007319229,0.000026197331,0.000019143348,0.00013064976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99838114,0.00040352333,0.000425323,0.00023457437,0.00024656067,0.00030890407],"domain_scores_gemma":[0.9988693,0.00035950358,0.0002510502,0.00034793644,0.00013457482,0.000037614485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007278819,0.00011503509,0.00031742823,0.000111363785,0.00013363952,0.0000022217873,0.00016839027,0.000085884494,0.00028541166],"category_scores_gemma":[0.000041130832,0.000071474584,0.00008188219,0.0006663062,0.000065430504,0.000025427446,0.000074794676,0.00023629848,0.000024225748],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008990057,0.0017115251,0.9793568,0.00007990208,0.00034882597,7.8915747e-7,0.017607681,0.000020004876,0.0000058454075,0.00017371391,0.00006425256,0.00054074125],"study_design_scores_gemma":[0.0016576679,0.00018439343,0.9916142,0.00038358656,0.00013319311,6.1031638e-9,0.005844963,0.000040267332,0.000019818355,0.000032455293,0.000009924773,0.00007947784],"about_ca_topic_score_codex":0.0032264232,"about_ca_topic_score_gemma":0.0031882948,"teacher_disagreement_score":0.01225743,"about_ca_system_score_codex":0.00006428752,"about_ca_system_score_gemma":0.00005163102,"threshold_uncertainty_score":0.4877408},"labels":[],"label_agreement":null},{"id":"W4389243535","doi":"10.1182/blood-2023-174432","title":"Preliminary Findings of a Phase Ib/II Trial Indicate Manageable Safety and Promising Efficacy for Mosunetuzumab in Combination with Lenalidomide (M+Len) in Previously Untreated (1L) Follicular Lymphoma (FL)","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Lenalidomide; Medicine; Internal medicine; Oncology; Follicular lymphoma; Phases of clinical research; Chemotherapy; Chemotherapy regimen; Lymphoma; Multiple myeloma","score_opus":0.023303801925209075,"score_gpt":0.30396566331727964,"score_spread":0.28066186139207056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99308175,0.00033757676,0.000027287722,0.00033176033,0.000021773405,0.005912553,0.0000135320015,0.00006533125,0.00020842878],"genre_scores_gemma":[0.9973974,0.0002732693,0.00026070833,0.000018246395,0.00003248282,0.00025633848,0.00016100638,0.000056533434,0.0015439718],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980177,0.00012215877,0.0005618442,0.00043831472,0.00039151905,0.00046842935],"domain_scores_gemma":[0.9990566,0.00031482324,0.00015024575,0.00029381667,0.00007722372,0.00010731129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011458623,0.00020774362,0.00062602473,0.0007216092,0.00008345499,0.000024308538,0.00011981208,0.00014268653,0.00003671338],"category_scores_gemma":[0.00028710434,0.00018188231,0.00008303899,0.0011882039,0.00009940076,0.000120554076,0.00009029627,0.00014658041,0.0000025515315],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7678294,0.021790227,0.0138479415,0.0026771391,0.0011198473,0.0013599789,0.008219026,0.00018692864,0.100994505,0.0002113145,0.00013559376,0.08162809],"study_design_scores_gemma":[0.8821898,0.019057347,0.026964528,0.0016767295,0.00046414844,0.00009403344,0.00021611252,0.004307719,0.06407965,0.00018915853,0.00045604596,0.00030472377],"about_ca_topic_score_codex":0.00022534338,"about_ca_topic_score_gemma":0.00004616902,"teacher_disagreement_score":0.1143604,"about_ca_system_score_codex":0.00016495914,"about_ca_system_score_gemma":0.00022551192,"threshold_uncertainty_score":0.74169457},"labels":[],"label_agreement":null},{"id":"W4389243538","doi":"10.1182/blood-2023-189863","title":"Danicopan As Add-on Therapy to Ravulizumab or Eculizumab Versus Placebo in Patients with Paroxysmal Nocturnal Hemoglobinuria and Clinically Significant Extravascular Hemolysis: Phase 3 Long-Term Data","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Medicine; Eculizumab; Population; Placebo; Internal medicine; Gastroenterology; Hemoglobinuria; Hemolysis; Double blind; Surgery; Immunology; Antibody; Complement system","score_opus":0.051982810002732645,"score_gpt":0.3343954299850811,"score_spread":0.28241261998234846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967557,0.00043704364,0.000011394951,0.00009029398,0.0003785917,0.001635474,0.00047975525,0.00012940406,0.00008231494],"genre_scores_gemma":[0.9977691,0.00008005522,0.000050320832,0.0001377571,0.000058037742,0.00012292076,0.0015703285,0.000046146593,0.000165302],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970857,0.00044324543,0.00068687194,0.0009869374,0.00018739625,0.000609841],"domain_scores_gemma":[0.9978508,0.00044136282,0.00019848558,0.0013108244,0.00006808537,0.00013049395],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00047375783,0.00038359372,0.000564709,0.00021110795,0.0001597373,0.00006425282,0.0008174248,0.0001620735,0.00092076184],"category_scores_gemma":[0.00025874632,0.0002833806,0.00007835265,0.00038879513,0.00012547086,0.00012674236,0.00036607514,0.0002627124,0.0004949586],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3026708,0.017728325,0.59770006,0.00024447535,0.0057475637,0.0014383073,0.0014361382,0.000043730815,0.015269324,0.00006367516,0.009482268,0.048175305],"study_design_scores_gemma":[0.36979622,0.020878626,0.5945803,0.00058670377,0.000802374,0.000065518085,0.0005571181,0.00001453449,0.008016899,0.000013562606,0.00338102,0.0013071457],"about_ca_topic_score_codex":0.000049322043,"about_ca_topic_score_gemma":0.00010182724,"teacher_disagreement_score":0.06712541,"about_ca_system_score_codex":0.000043894262,"about_ca_system_score_gemma":0.00021393682,"threshold_uncertainty_score":0.99999255},"labels":[],"label_agreement":null},{"id":"W4389243549","doi":"10.1182/blood-2023-180926","title":"Safety and Preliminary Efficacy of Sabestomig (AZD7789), an Anti-PD-1 and Anti-TIM-3 Bispecific Antibody, in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma Previously Treated with Anti-PD-(L)1 Therapy","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Jewish General Hospital","funders":"","keywords":"Medicine; Refractory (planetary science); Antibody; Radioimmunotherapy; Lymphoma; Classical Hodgkin lymphoma; Monoclonal antibody; Internal medicine; Cancer research; Oncology; Immunology; Biology; Hodgkin lymphoma","score_opus":0.014312390929512147,"score_gpt":0.2590484232701427,"score_spread":0.24473603234063057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996506,0.00094878295,0.0000014579516,0.0001894227,0.000037352085,0.0019450588,0.0000767661,0.0001737354,0.00012142835],"genre_scores_gemma":[0.99414,0.004729475,0.00029696428,0.00006156674,0.000051460127,0.000051912873,0.00047446296,0.000106160485,0.00008796836],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997125,0.00019732545,0.0006406439,0.00094722846,0.00049056025,0.0005992338],"domain_scores_gemma":[0.9981717,0.00032809237,0.0002904126,0.0007293235,0.00013857012,0.00034189573],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024019672,0.0005573837,0.0012099079,0.00043257177,0.0001413305,0.000047205074,0.0001373052,0.00025189223,0.000026189678],"category_scores_gemma":[0.00005438785,0.00034182778,0.00007923296,0.0009394002,0.00038014003,0.00024953941,0.00007882939,0.00015341242,0.000008313735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0111922445,0.013903148,0.95520824,0.00014772628,0.00053431257,0.0008009811,0.00067483645,0.000005772129,0.0012186798,0.000014051162,0.00007374531,0.016226232],"study_design_scores_gemma":[0.07848544,0.014986376,0.9013875,0.00086800184,0.00049377204,0.00012881168,0.00013156045,0.000051925155,0.0027640217,0.0000015538628,0.00031296143,0.0003880653],"about_ca_topic_score_codex":0.00016265333,"about_ca_topic_score_gemma":0.000033508357,"teacher_disagreement_score":0.06729319,"about_ca_system_score_codex":0.000094281364,"about_ca_system_score_gemma":0.00025325792,"threshold_uncertainty_score":0.9999034},"labels":[],"label_agreement":null},{"id":"W4389243588","doi":"10.1182/blood-2023-180252","title":"Identification of Multivariable microRNA and Clinical Biomarkers Panels to Predict Imatinib Response in Chronic Myeloid Leukemia at Diagnosis","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; University of British Columbia; BC Cancer Agency; Terry Fox Research Institute","funders":"","keywords":"Nilotinib; Medicine; Imatinib mesylate; Myeloid leukemia; Imatinib; Oncology; Internal medicine; microRNA; Immunology; Biology","score_opus":0.02666562689333428,"score_gpt":0.3199405976593267,"score_spread":0.2932749707659924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99767363,0.00035594363,0.0000084126295,0.00046838363,0.00012148639,0.0011028833,0.000099643774,0.000097213066,0.000072401715],"genre_scores_gemma":[0.9975234,0.0007385684,0.00049662666,0.000053818043,0.00008007061,0.00018463949,0.0000763429,0.000039968025,0.00080654596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99761087,0.00023233294,0.00095019926,0.00054832327,0.0002844597,0.00037378984],"domain_scores_gemma":[0.9978391,0.0010907857,0.000217826,0.0005703121,0.00006208832,0.00021990157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015653188,0.00019739749,0.0004769132,0.00033327547,0.00005010144,0.0000129638165,0.00012932584,0.0001914596,0.00007862499],"category_scores_gemma":[0.0017050614,0.00018772882,0.00010510398,0.0007388804,0.00011850187,0.00007053947,0.0001954648,0.00015846278,0.00022774369],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002431247,0.00049170706,0.5125699,0.0002824903,0.0004510553,0.00016523724,0.00056893216,0.0000350777,0.47728044,0.0000029032444,0.0016313514,0.0040896414],"study_design_scores_gemma":[0.0125635695,0.0007162516,0.8320252,0.00040225583,0.0002869998,0.000039671224,0.00008023352,0.00095639686,0.15220751,0.000009567642,0.0005736805,0.00013868608],"about_ca_topic_score_codex":0.00025068052,"about_ca_topic_score_gemma":0.000047474885,"teacher_disagreement_score":0.32507294,"about_ca_system_score_codex":0.0016390383,"about_ca_system_score_gemma":0.0008218631,"threshold_uncertainty_score":0.7655359},"labels":[],"label_agreement":null},{"id":"W4389243603","doi":"10.1182/blood-2023-179304","title":"Efficacy and Safety of Valemetostat Monotherapy in Patients with Relapsed or Refractory Peripheral T-Cell Lymphomas: Primary Results of the Phase 2 VALENTINE-PTCL01 Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and Retrovirus Studies","field":"Immunology and Microbiology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Internal medicine; Clinical endpoint; Brentuximab vedotin; Peripheral T-cell lymphoma; Anaplastic large-cell lymphoma; Lymphoma; Oncology; Neutropenia; Phases of clinical research; Progression-free survival; Surrogate endpoint; Refractory (planetary science); Gastroenterology; Clinical trial; Chemotherapy; Immunology; Hodgkin lymphoma; T cell; Immune system","score_opus":0.009085163304936425,"score_gpt":0.22657148698235555,"score_spread":0.21748632367741913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976132,0.0008975537,4.2916818e-7,0.000026086396,0.00014610465,0.00075285323,0.00014763503,0.00002799633,0.0003881723],"genre_scores_gemma":[0.9975713,0.0003392082,0.000016778333,0.000018875115,0.0000078234325,0.000013997917,0.00004553064,0.000018648307,0.001967869],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987247,0.00024507294,0.00045029653,0.00027380034,0.0000754962,0.00023065764],"domain_scores_gemma":[0.9991559,0.00019287215,0.00026017427,0.00031975386,0.00005907617,0.000012257476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023455119,0.0001707678,0.0003825432,0.00009521495,0.00011369869,0.000002956355,0.00016662742,0.00009408879,0.000022451824],"category_scores_gemma":[0.000050443166,0.00009298296,0.000049067607,0.00032012744,0.00023393417,0.00003774182,0.000119606004,0.00014456385,0.000004266458],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040286433,0.0193566,0.7548754,0.00013532583,0.00090184784,0.0000118252865,0.010917566,0.000007380092,0.1680731,0.0000034488007,0.00051836023,0.00491269],"study_design_scores_gemma":[0.14536111,0.0043100426,0.8299667,0.00007289829,0.00014567835,0.0000014300622,0.00097480806,2.7434808e-7,0.017417822,0.0000023043135,0.0015960721,0.0001508662],"about_ca_topic_score_codex":0.000088058456,"about_ca_topic_score_gemma":0.000056793724,"teacher_disagreement_score":0.15065528,"about_ca_system_score_codex":0.00001679965,"about_ca_system_score_gemma":0.00006295725,"threshold_uncertainty_score":0.37917352},"labels":[],"label_agreement":null},{"id":"W4389243607","doi":"10.1182/blood-2023-179047","title":"The Role of Gpibα in Control of Megakaryocyte Reactivity to Thrombopoietin","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Thrombopoietin; Megakaryocyte; Platelet; Thrombopoiesis; Haematopoiesis; Internal medicine; Endocrinology; Bone marrow; Chemistry; Immunology; Wild type; Biology; Cell biology; Medicine; Stem cell; Mutant; Biochemistry","score_opus":0.008019635338295797,"score_gpt":0.25078048292467575,"score_spread":0.24276084758637995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995161,0.00037108513,0.0000017857271,0.0005202502,0.000019224437,0.00027702184,0.000015870579,0.000015517462,0.0036182373],"genre_scores_gemma":[0.9997147,0.00008560023,0.000025039068,0.00003220873,0.000008840002,0.000018443427,0.0000046438804,0.000007235082,0.000103330996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994736,0.000022596972,0.00014516864,0.00009284144,0.0001296023,0.0001362151],"domain_scores_gemma":[0.99958795,0.0001270911,0.000045727556,0.00017873736,0.000025282672,0.000035192887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015888865,0.000057886245,0.00023967515,0.000053295134,0.000018443281,0.0000018393922,0.000049471288,0.000031743893,0.000006838993],"category_scores_gemma":[0.00009127443,0.000037957954,0.000047420952,0.00023732892,0.000025543815,0.000015901789,0.000019576848,0.000050968458,0.000022819924],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096419675,0.0033320708,0.5676441,0.000068868736,0.00065923267,0.00029583045,0.0011940175,0.000016394302,0.395517,0.0007628047,0.00035972055,0.02918575],"study_design_scores_gemma":[0.010329851,0.0005811312,0.7382095,0.000095302516,0.00019585156,0.00001690085,0.0004942849,0.00010166984,0.24593627,0.0015887909,0.002371433,0.00007899985],"about_ca_topic_score_codex":0.00025174467,"about_ca_topic_score_gemma":0.00013078962,"teacher_disagreement_score":0.17056538,"about_ca_system_score_codex":0.0000067658166,"about_ca_system_score_gemma":0.000031974156,"threshold_uncertainty_score":0.15478805},"labels":[],"label_agreement":null},{"id":"W4389243624","doi":"10.1182/blood-2023-173385","title":"Serine Phosphorylation Marks Proteins for Degradation By the Mitochondrial Serine Protease Complex, Clpxp","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Protein Hydrolysis and Bioactive Peptides","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Phosphorylation; Proteolysis; Biology; Biochemistry; Serine; Casein kinase 2; Protein degradation; Protein kinase A; Enzyme","score_opus":0.015129496460698399,"score_gpt":0.24935556218502491,"score_spread":0.23422606572432653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908824,0.00018428078,0.0050470466,0.0009806666,0.00008868093,0.002390318,0.00022647179,0.000051373405,0.00014878616],"genre_scores_gemma":[0.9891204,0.000059625487,0.0031971366,0.00013963389,0.0006063105,0.0015608172,0.002713187,0.000034287554,0.0025685537],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99905103,0.0000532448,0.00019270138,0.00032945635,0.00013920288,0.00023437916],"domain_scores_gemma":[0.9994375,0.000013894152,0.000108391956,0.0002993947,0.000089873596,0.000050916817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019252843,0.0001547124,0.00012016101,0.00002635195,0.00018922496,0.00004412825,0.00017750038,0.000103379665,0.000018903173],"category_scores_gemma":[0.000117135125,0.000113739494,0.00010858613,0.00015832603,0.000053489708,0.000005644173,0.00008793714,0.00006471629,0.000010867052],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002078822,0.00015092164,0.00042254134,0.000025233894,0.00008257854,6.142676e-7,0.000010068128,0.00001551506,0.9902512,0.000025876514,0.004217519,0.004590052],"study_design_scores_gemma":[0.0015697046,0.00038251688,0.0025320668,0.000008162766,0.00004921577,0.0000053029025,0.000020224048,0.00040390235,0.92652845,0.00015123567,0.0681726,0.00017661235],"about_ca_topic_score_codex":0.000065113556,"about_ca_topic_score_gemma":0.000073254036,"teacher_disagreement_score":0.063955076,"about_ca_system_score_codex":0.000007970556,"about_ca_system_score_gemma":0.000035663797,"threshold_uncertainty_score":0.4638162},"labels":[],"label_agreement":null},{"id":"W4389243632","doi":"10.1182/blood-2023-189892","title":"Toll-like Receptor-9 Agonist Reverses T Cell Exhaustion in a Murine Model of Pediatric B-ALL","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"CD8; Immunology; B cell; Chimeric antigen receptor; T cell; Leukemia; Immune system; Medicine; Antigen; Cancer research; Biology; Antibody","score_opus":0.032090019185780395,"score_gpt":0.28458952186320857,"score_spread":0.25249950267742816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99588066,0.0001220279,0.00007196341,0.00029604376,0.00009110312,0.00036209842,0.000032693973,0.00009639553,0.0030470283],"genre_scores_gemma":[0.99020815,0.00081548764,0.0017563554,0.00008889221,0.00023871915,0.0000388779,0.000089335226,0.00003696492,0.00672721],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99847436,0.000034380726,0.00034066217,0.00028882528,0.00048598132,0.00037576802],"domain_scores_gemma":[0.99924266,0.00011295794,0.000078849065,0.00033409116,0.00009484096,0.0001365711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003049795,0.00013685654,0.0002903823,0.00042559116,0.000026270696,0.00000772394,0.00013778785,0.00013191668,0.00009363696],"category_scores_gemma":[0.0001795322,0.00012712437,0.00007687587,0.0008447949,0.00004841624,0.00005984251,0.00012729985,0.00021054574,0.00027878096],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023658173,0.009121161,0.12800916,0.006711441,0.00040358744,0.0019557206,0.0038247744,0.008183589,0.5636406,0.00037770715,0.2734994,0.0019070188],"study_design_scores_gemma":[0.16685638,0.0051532076,0.056540016,0.0010951996,0.0039228504,0.00038394696,0.0027378665,0.3745301,0.37384045,0.0013182722,0.010934541,0.002687173],"about_ca_topic_score_codex":0.00012780637,"about_ca_topic_score_gemma":0.00001218742,"teacher_disagreement_score":0.3663465,"about_ca_system_score_codex":0.00016837324,"about_ca_system_score_gemma":0.00053238805,"threshold_uncertainty_score":0.5183981},"labels":[],"label_agreement":null},{"id":"W4389243680","doi":"10.1182/blood-2023-190328","title":"Risk Factors for Postnatal Complications in People with Sickle Cell Disease: A Preliminary Analysis","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Lunenfeld-Tanenbaum Research Institute; Toronto General Hospital; Mount Sinai Hospital","funders":"","keywords":"Medicine; Acute chest syndrome; Pregnancy; Sickle cell anemia; Pediatrics; Anemia; Retrospective cohort study; Cohort; Disease; Obstetrics; Internal medicine","score_opus":0.007414963697423208,"score_gpt":0.23569819136429684,"score_spread":0.22828322766687364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997615,0.0003032483,0.00018199002,0.00054807175,0.00001341117,0.0005596162,0.000244624,0.000100207384,0.00043387077],"genre_scores_gemma":[0.99828905,0.0001239841,0.00017960361,0.000037377224,0.000011317469,0.00009343091,0.00079409825,0.000018285642,0.00045282982],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99929506,0.0000158746,0.00014118475,0.00021966259,0.00012126432,0.0002069741],"domain_scores_gemma":[0.99940395,0.00011114587,0.000049666134,0.0002544846,0.000041281553,0.00013946608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000056516707,0.00010028298,0.0001992879,0.00025385316,0.000088125984,0.00000828377,0.000057979352,0.000052013984,0.000021916794],"category_scores_gemma":[0.000050574978,0.00007421647,0.0001255116,0.0012824847,0.000028590115,0.000028433737,0.000022483708,0.0001062428,0.00002306521],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018454851,0.0010057173,0.99549073,0.00010087771,0.0004098157,0.000040087743,0.0009729516,0.0011691549,0.00011629785,0.000021607886,0.00040792322,0.00008027744],"study_design_scores_gemma":[0.0025794094,0.0003054677,0.98811424,0.000025004569,0.0028352663,0.0000031919337,0.0013556471,0.004270593,0.00016953048,0.00001945819,0.00021496059,0.00010724337],"about_ca_topic_score_codex":0.0002343029,"about_ca_topic_score_gemma":0.00010992524,"teacher_disagreement_score":0.007376513,"about_ca_system_score_codex":0.0000126433015,"about_ca_system_score_gemma":0.000070815986,"threshold_uncertainty_score":0.30264598},"labels":[],"label_agreement":null},{"id":"W4389243690","doi":"10.1182/blood-2023-173700","title":"Heterotopic Ossification in Hemophilia: A Multi-Center Case Series","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Heterotopic Ossification and Related Conditions","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Paul's Hospital","funders":"","keywords":"Hemarthrosis; Medicine; Heterotopic ossification; Myositis ossificans; Hematoma; Complication; Soft tissue; Surgery; Incidence (geometry); Physical therapy; Radiology","score_opus":0.04157086919741121,"score_gpt":0.30741047409100225,"score_spread":0.26583960489359104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950218,0.00003330021,0.00003210382,0.0026952517,0.00010947488,0.0005243186,0.000011440584,0.00018300163,0.0013893022],"genre_scores_gemma":[0.99342275,0.0000470754,0.0002701135,0.00014456791,0.000059049882,0.00020710546,0.00007052547,0.000011461968,0.005767344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99934393,0.000027663029,0.00020936804,0.00017919867,0.00008055428,0.00015930354],"domain_scores_gemma":[0.99960226,0.000012974646,0.000029947887,0.00024705,0.000031646752,0.000076134704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007019899,0.00007774595,0.00011548248,0.0001793451,0.00006487622,0.000014753327,0.00003658407,0.000097331205,0.00010438053],"category_scores_gemma":[0.000038684164,0.00006801228,0.00004904266,0.0003340359,0.000038429196,0.00006762284,0.000015146907,0.00015004436,0.00057066925],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012934169,0.013176203,0.8271473,0.0008448111,0.00049595203,0.044989277,0.008936912,0.000017052971,0.0767246,0.0039006434,0.0028509647,0.02078694],"study_design_scores_gemma":[0.071492404,0.0005397518,0.7077554,0.0008307647,0.00046232497,0.09491699,0.0033211801,0.0033093435,0.030686373,0.00067110604,0.08483973,0.0011746475],"about_ca_topic_score_codex":0.000011493966,"about_ca_topic_score_gemma":0.000026390542,"teacher_disagreement_score":0.119391926,"about_ca_system_score_codex":0.000017220935,"about_ca_system_score_gemma":0.000027117963,"threshold_uncertainty_score":0.73349893},"labels":[],"label_agreement":null},{"id":"W4389243692","doi":"10.1182/blood-2023-189336","title":"Forward Genetic Screen Implicates Drivers of Leukemic Progression in a Novel Model of <i>Trp53 R270H</i> myelodysplastic Syndrome","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Biology; Transposase; Genetics; Insertional mutagenesis; Sleeping Beauty transposon system; Transposable element; Cancer research; Mutation; Mutagenesis; Myeloid; Gene; Genome","score_opus":0.011329412195771542,"score_gpt":0.24127019452442458,"score_spread":0.22994078232865303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99797624,0.0001607675,0.0013491921,0.0000334221,0.00002314061,0.0002536867,0.000063042,0.00001572532,0.00012479656],"genre_scores_gemma":[0.99712527,0.00009992121,0.0024799954,0.000018166395,0.000016123755,0.000035636385,0.000096409094,0.000017894497,0.000110576446],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99911845,0.000016053988,0.0002867233,0.00024321611,0.00014547027,0.00019007747],"domain_scores_gemma":[0.999518,0.000010064291,0.00012540072,0.0002442502,0.00005221678,0.000050099767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009474118,0.00011367783,0.00016957126,0.000115445895,0.000019679568,0.0000040354544,0.00018339629,0.00012218932,0.0000029006615],"category_scores_gemma":[0.000056276993,0.00010772493,0.00007072885,0.00024012144,0.0000738975,0.000004293852,0.00012989978,0.000056784324,0.0000045348484],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029697232,0.0001430689,0.0061812694,0.000053785177,0.000026912114,0.0000022026506,0.000033440592,0.0017789415,0.9912265,0.00002698943,0.00009504708,0.00040217978],"study_design_scores_gemma":[0.0019356203,0.00035695886,0.017900284,0.000106172774,0.000033887914,0.000019500727,0.000029299532,0.0071186367,0.9721532,0.0001063642,0.000080946855,0.00015912802],"about_ca_topic_score_codex":0.000017463068,"about_ca_topic_score_gemma":0.0000093436265,"teacher_disagreement_score":0.019073265,"about_ca_system_score_codex":0.000009426245,"about_ca_system_score_gemma":0.00013124359,"threshold_uncertainty_score":0.4392895},"labels":[],"label_agreement":null},{"id":"W4389243727","doi":"10.1182/blood-2023-187498","title":"Lintuzumab-Ac225, a CD33-Directed Antibody Radiotherapy, Targets AML in a Mutation Agnostic Manner","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"CD33; Cancer research; Myeloid leukemia; Venetoclax; Leukemia; Medicine; Myeloid; Immunology; Oncology; Biology; Stem cell; CD34; Chronic lymphocytic leukemia","score_opus":0.015483427113954236,"score_gpt":0.31914375606771356,"score_spread":0.30366032895375933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99423623,0.00081474904,0.00008016687,0.0018455728,0.00010892218,0.0007975617,0.000015356973,0.00057474675,0.0015266793],"genre_scores_gemma":[0.993636,0.0008066506,0.0015599739,0.00036694208,0.0002818857,0.00011439373,0.0004281125,0.00008301552,0.0027230293],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981788,0.00011470413,0.0003192348,0.00040262088,0.0004257917,0.0005588941],"domain_scores_gemma":[0.9990406,0.00026714557,0.000057092224,0.0003589295,0.00010973165,0.00016652365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037591244,0.00019069752,0.0003621685,0.0006108762,0.000059069855,0.000027960325,0.00013152556,0.00016217028,0.0002780881],"category_scores_gemma":[0.0006961384,0.00017351477,0.00008689681,0.0014443492,0.00007064818,0.00008545946,0.00005718607,0.00038527543,0.0005340817],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013761154,0.0030373377,0.107075065,0.0009212085,0.0011169162,0.024631226,0.006718015,0.00039780492,0.8049207,0.000307357,0.028227568,0.02127071],"study_design_scores_gemma":[0.03911183,0.0018369723,0.86294335,0.0007787994,0.0003271347,0.0010616361,0.00055144617,0.034196883,0.039921798,0.0005256244,0.01787246,0.0008720878],"about_ca_topic_score_codex":0.00027251657,"about_ca_topic_score_gemma":0.000047804588,"teacher_disagreement_score":0.76499885,"about_ca_system_score_codex":0.00021544134,"about_ca_system_score_gemma":0.00030277797,"threshold_uncertainty_score":0.7075727},"labels":[],"label_agreement":null},{"id":"W4389243745","doi":"10.1182/blood-2023-182434","title":"A Phase 1 Study Evaluating PRT2527, a Potent and Highly Selective CDK9 Inhibitor, As Monotherapy and in Combination with Zanubrutinib in Patients with Select Relapsed/Refractory B-Cell Malignancies","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Tolerability; Ibrutinib; Cancer research; Combination therapy; Medicine; Pharmacology; Internal medicine; Adverse effect; Leukemia; Chronic lymphocytic leukemia","score_opus":0.01611992263539499,"score_gpt":0.3019681617558525,"score_spread":0.28584823912045754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967602,0.00020030771,0.0000021466776,0.000060817118,0.000015494103,0.0027675987,0.000004005766,0.00006173716,0.00012768671],"genre_scores_gemma":[0.9992553,0.00004475127,0.00017105289,0.00004385429,0.00002025436,0.00022621594,0.000027009262,0.0000492251,0.00016235249],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9977702,0.00020834152,0.00030821736,0.00052607566,0.00076337415,0.00042378413],"domain_scores_gemma":[0.99908423,0.00021437695,0.000113531285,0.00021089274,0.00026012125,0.00011687021],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069125654,0.00022736161,0.00037185763,0.00044947723,0.00007685104,0.00003743162,0.000058809837,0.00008437445,0.0000034274876],"category_scores_gemma":[0.00018627198,0.00017339537,0.00001387175,0.001231623,0.00008704607,0.00014629081,0.000055102948,0.0003146312,0.00000496953],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017234119,0.042404875,0.8999904,0.00039716426,0.00033583448,0.00085689325,0.02182127,0.000048762835,0.008147984,0.000009659196,0.000063690786,0.008689358],"study_design_scores_gemma":[0.5388954,0.046160586,0.40125847,0.0005252186,0.00015181178,0.0000454747,0.0018410047,0.0027530023,0.008018649,0.00003639955,0.000008771887,0.0003051995],"about_ca_topic_score_codex":0.0005676816,"about_ca_topic_score_gemma":0.00023998704,"teacher_disagreement_score":0.5216613,"about_ca_system_score_codex":0.0013720929,"about_ca_system_score_gemma":0.0020893943,"threshold_uncertainty_score":0.7070858},"labels":[],"label_agreement":null},{"id":"W4389243774","doi":"10.1182/blood-2023-178879","title":"A Real-World Evidence Study of the Temporal Evolution in Treatment Patterns and Outcomes for Chronic Lymphocytic Leukemia","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Chronic lymphocytic leukemia; Population; Cohort; Retrospective cohort study; Asymptomatic; Disease; Pediatrics; Internal medicine; Intensive care medicine; Leukemia","score_opus":0.05157694726498536,"score_gpt":0.35470581568154075,"score_spread":0.3031288684165554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99710107,0.00021331925,0.0000028760037,0.00012784492,0.0000645985,0.0023873665,0.0000113640135,0.000050087616,0.00004150265],"genre_scores_gemma":[0.9977377,0.00019956609,0.000018089158,0.000011223736,0.00006728671,0.00041151076,0.0000058032647,0.000024318462,0.001524477],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984825,0.00008395966,0.00035726227,0.00033331534,0.00038885148,0.0003540679],"domain_scores_gemma":[0.99876714,0.00047473033,0.00008894788,0.00054121774,0.000052512332,0.00007543864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036638285,0.00015906677,0.00040386844,0.00023008342,0.00006306929,0.000011698258,0.00013892625,0.000053052965,0.0000076670885],"category_scores_gemma":[0.00021905317,0.00009980271,0.00009175547,0.00059607625,0.00006709623,0.000059686034,0.00012915047,0.00007277757,0.000006595543],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00017680904,0.0004504178,0.99596727,0.0004403217,0.00017862089,0.0000758282,0.001240288,0.00014272529,0.0004546787,0.000030245961,0.000044902106,0.00079787226],"study_design_scores_gemma":[0.057347037,0.001486542,0.92800945,0.00050008646,0.00026777366,0.000025077241,0.0006552659,0.010415543,0.0011348804,0.000043740434,0.000019174826,0.000095432435],"about_ca_topic_score_codex":0.053015508,"about_ca_topic_score_gemma":0.034899373,"teacher_disagreement_score":0.06795784,"about_ca_system_score_codex":0.05130569,"about_ca_system_score_gemma":0.013317449,"threshold_uncertainty_score":0.99227613},"labels":[],"label_agreement":null},{"id":"W4389243779","doi":"10.1182/blood-2023-190975","title":"Interleukin-17A Directly Signals to Bone Marrow-Derived Hematopoietic Stem and Progenitor Cells to Promote Their Expansion and Differentiation in Vitro","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Haematopoiesis; Progenitor cell; Bone marrow; Biology; Clonogenic assay; Immunology; Stem cell; Cell biology; Stromal cell; CD34; Cancer research; Cell","score_opus":0.013809833714926544,"score_gpt":0.21550681438149294,"score_spread":0.20169698066656638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99772,0.0009905087,0.000014572254,0.00014826677,0.00021328042,0.00075986696,0.00004271984,0.000099237186,0.00001156169],"genre_scores_gemma":[0.9991816,0.00006633978,0.00010087178,0.000040552848,0.000021385513,0.00018417317,0.00005787292,0.000020991769,0.00032621296],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989643,0.00013762077,0.00022093738,0.00036026153,0.000031865304,0.00028503494],"domain_scores_gemma":[0.9996459,0.00007056006,0.000049754868,0.00016007795,0.000023153005,0.00005054342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014276728,0.0001937809,0.00030169473,0.00020890847,0.00008368771,0.000029464378,0.00007181087,0.00013427592,0.000017969114],"category_scores_gemma":[0.00001141205,0.00015685876,0.00004058496,0.00022025684,0.000023235854,0.000054203658,0.00011282152,0.00006417217,0.00010230191],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020957139,0.00019981519,0.0016206367,0.00003750961,0.00009567169,0.000016128197,0.004598508,3.3271095e-7,0.9691735,0.0000011189403,0.000034585908,0.024012642],"study_design_scores_gemma":[0.0017528486,0.0002383366,0.018367467,0.00008243442,0.00007923751,0.00002344135,0.0005608808,0.0000026765779,0.97858936,0.000016679425,0.00011870507,0.00016790807],"about_ca_topic_score_codex":0.000018522827,"about_ca_topic_score_gemma":0.000030096959,"teacher_disagreement_score":0.023844734,"about_ca_system_score_codex":0.000014699343,"about_ca_system_score_gemma":0.000013599701,"threshold_uncertainty_score":0.6396514},"labels":[],"label_agreement":null},{"id":"W4389243803","doi":"10.1182/blood-2023-178270","title":"Remote Monitoring of Patients after Allogeneic Stem Cell Transplantation: A Mobile Phone Application to Report Symptoms, Vital Signs and Activity in Real Time","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Computer science; Wearable computer; Vital signs; Medical emergency; Multimedia; Surgery; Embedded system","score_opus":0.009352996741536107,"score_gpt":0.2507329811656821,"score_spread":0.241379984424146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981717,0.000019696376,0.00052890234,0.000014215328,0.000042074706,0.00088889804,0.000039883118,0.00006325041,0.00023136928],"genre_scores_gemma":[0.99883,0.000108104854,0.0006381046,0.0000043238515,0.0000379157,0.00012355734,0.000091583184,0.000022680984,0.00014370284],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99893296,0.000033812314,0.00031340503,0.00029072186,0.00026397008,0.00016510939],"domain_scores_gemma":[0.9994929,0.00007042324,0.00008457571,0.00020468734,0.000053962776,0.0000934483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018273244,0.000116126124,0.00023168442,0.00015256548,0.000018203467,0.000005401786,0.00003598712,0.0000876107,0.000006827708],"category_scores_gemma":[0.0000031915954,0.00011981133,0.000033745175,0.0003359473,0.000015991169,0.000055817003,0.000010613711,0.00006617548,0.00003662073],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000282472,0.00029269277,0.39976543,0.0006134956,0.000024291247,0.00022247402,0.0019963374,0.000027444323,0.5937651,1.9151823e-7,0.0000021356232,0.0030079603],"study_design_scores_gemma":[0.0017598046,0.00019995095,0.5716154,0.00015616111,0.00011934587,0.0000363928,0.000055031633,0.00004310756,0.42591625,0.0000021175706,0.0000063184157,0.00009008414],"about_ca_topic_score_codex":0.00006828486,"about_ca_topic_score_gemma":0.0000063007265,"teacher_disagreement_score":0.17185,"about_ca_system_score_codex":0.000026756392,"about_ca_system_score_gemma":0.00003349452,"threshold_uncertainty_score":0.48857644},"labels":[],"label_agreement":null},{"id":"W4389243824","doi":"10.1182/blood-2023-183076","title":"Direct Effect of Iron Deficiency Independent of Anemia on Adverse Perinatal Outcomes- a Scoping Review","year":2023,"lang":"en","type":"review","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; St. Michael's Hospital; Sunnybrook Health Science Centre; Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Medicine; Anemia; Pregnancy; Iron deficiency; Iron-deficiency anemia; Systematic review; Pediatrics; Randomized controlled trial; Meta-analysis; Adverse effect; Low birth weight; MEDLINE; Intensive care medicine; Obstetrics; Internal medicine","score_opus":0.029373264987715447,"score_gpt":0.35420831496744376,"score_spread":0.32483504997972834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243824","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017873349,0.99127185,4.120924e-7,0.0000056408344,0.00021211417,0.0031883412,0.000067330344,0.000054858607,0.0034121333],"genre_scores_gemma":[0.00023311035,0.99912584,0.000022067748,0.00003509657,0.000040614374,0.00014276536,0.000085117965,0.000073219664,0.00024215858],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9972754,0.00026945793,0.0010339374,0.00046318717,0.0006521096,0.0003058962],"domain_scores_gemma":[0.99807143,0.00040080817,0.00064018945,0.0007389641,0.000044342287,0.000104236955],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008338281,0.0004653768,0.0040870965,0.00030917334,0.000029157405,0.0000027332887,0.00024184892,0.00023694099,0.00009541689],"category_scores_gemma":[0.0009727725,0.00032079185,0.0010750826,0.00051464007,0.000073338386,0.000028287832,0.00011431773,0.00033748918,0.00011487307],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000159227,0.00023337518,0.00025469123,0.8613304,0.000047867772,0.00006600125,0.000015149298,1.6309802e-7,0.0000015797169,0.000016826109,0.000034765028,0.13798325],"study_design_scores_gemma":[0.0033945264,0.001110053,0.00051439484,0.9706191,0.014261126,0.00006939567,0.000008454884,3.8276298e-8,0.0000758943,5.255877e-7,0.009532771,0.00041371176],"about_ca_topic_score_codex":0.000032186283,"about_ca_topic_score_gemma":0.0000035146927,"teacher_disagreement_score":0.13756953,"about_ca_system_score_codex":0.000027082464,"about_ca_system_score_gemma":0.00037553709,"threshold_uncertainty_score":0.9999244},"labels":[],"label_agreement":null},{"id":"W4389243888","doi":"10.1182/blood-2023-182054","title":"Predicting Major Bleeding in Patients with Venous Thromboembolism on Extended Anticoagulation Therapy Using Follow-up Data and Long Short-Term Memory Based Recurrent Neural Network","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Thrombosis; Prospective cohort study; Major bleeding; Cohort; Venous thrombosis; Clinical trial; Internal medicine; Atrial fibrillation","score_opus":0.045983608279806874,"score_gpt":0.2937262265188843,"score_spread":0.24774261823907742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975822,0.00023552158,0.00003071608,0.000088221124,0.00050499634,0.0013252732,0.000016259677,0.00014270078,0.00007410498],"genre_scores_gemma":[0.9986273,0.00011764101,0.0002524681,0.00017543859,0.0003299576,0.000026994228,0.00040222987,0.000062932624,0.0000050417802],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99796927,0.00006851132,0.00035645053,0.0006108379,0.00048319416,0.0005117212],"domain_scores_gemma":[0.99905646,0.00006915694,0.000119739016,0.000582708,0.00005623594,0.00011572494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004247251,0.00026327884,0.00058904657,0.00023315563,0.00020084162,0.00006696971,0.00016540496,0.00008160288,0.000013964138],"category_scores_gemma":[0.000038927796,0.00022203688,0.000041977557,0.00047694982,0.000043725686,0.00020281588,0.00016560445,0.00021083727,0.0000026917276],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026940377,0.0021009438,0.97480816,0.00013527345,0.000264955,0.000086651184,0.0004645802,0.001270762,0.00020281592,0.000009092255,0.00008061387,0.020306736],"study_design_scores_gemma":[0.008028075,0.0010133187,0.9578014,0.00086334057,0.00046341203,0.0000035473668,0.000086513675,0.03136626,0.00014225877,0.000009900603,0.0000051544685,0.00021683863],"about_ca_topic_score_codex":0.00005380878,"about_ca_topic_score_gemma":0.000057546196,"teacher_disagreement_score":0.030095495,"about_ca_system_score_codex":0.00004437749,"about_ca_system_score_gemma":0.00004623254,"threshold_uncertainty_score":0.90544015},"labels":[],"label_agreement":null},{"id":"W4389243920","doi":"10.1182/blood-2023-178273","title":"Prevention of CMV/EBV Reactivation By Double-Specific T Cells in Patients after Allogeneic Stem Cell Transplantation: Results from the Randomized Phase I/IIa Multivir-01 Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Transplantation; Stem cell; Hematopoietic stem cell transplantation; Immunology; Population; Internal medicine; Graft-versus-host disease; Autologous stem-cell transplantation; Clinical endpoint; Gastroenterology; Clinical trial; Biology","score_opus":0.03489963155199417,"score_gpt":0.30469599150122173,"score_spread":0.26979635994922757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953878,0.0002078179,0.000022952563,0.0001038711,0.000083396946,0.0034152751,0.00048308817,0.000034788278,0.00026104422],"genre_scores_gemma":[0.997534,0.0005784431,0.000029613688,0.00001902657,0.00006607922,0.00028357847,0.0008160469,0.000027441405,0.00064580375],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99762326,0.0003942903,0.0007327878,0.00038873326,0.00061666686,0.0002442326],"domain_scores_gemma":[0.998703,0.0005466957,0.00019682512,0.0003798746,0.00010533509,0.000068275716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011308366,0.00017185934,0.00048708761,0.00017087735,0.000057747307,0.000024587582,0.00012505162,0.00009793519,0.000078990306],"category_scores_gemma":[0.00001744751,0.0001207465,0.00014224858,0.00051979645,0.00006603412,0.00011002206,0.000030065896,0.00022141865,0.00006153288],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7466579,0.022578115,0.032494523,0.00016091815,0.0005120896,0.00010687622,0.020491537,0.000020453055,0.16347905,0.000002899619,0.0018853081,0.011610349],"study_design_scores_gemma":[0.74719334,0.0007007713,0.08146015,0.00014080126,0.00031333204,3.1254527e-7,0.0007838734,0.00005638729,0.16829075,0.000010213748,0.0008968201,0.00015323698],"about_ca_topic_score_codex":0.0006260401,"about_ca_topic_score_gemma":0.0001764469,"teacher_disagreement_score":0.04896563,"about_ca_system_score_codex":0.000036091908,"about_ca_system_score_gemma":0.00005226128,"threshold_uncertainty_score":0.49238995},"labels":[],"label_agreement":null},{"id":"W4389243927","doi":"10.1182/blood-2023-190446","title":"British Columbia Experience in Allogeneic Stem Cell Transplantation for Myelofibrosis with or without Pre-Transplant Ruxolitinib","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Transplantation; Myelofibrosis; Internal medicine; Cohort; Ruxolitinib; Log-rank test; Retrospective cohort study; Survival analysis; Pediatrics; Surgery; Bone marrow","score_opus":0.02448102470018347,"score_gpt":0.27531596360934785,"score_spread":0.25083493890916436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99726945,0.00010460577,0.00008981058,0.00006966967,0.000060230912,0.0017765184,0.00020723087,0.000120117424,0.00030235405],"genre_scores_gemma":[0.9920627,0.0008241628,0.0010762344,0.000116708354,0.000053385444,0.002239466,0.0002834944,0.000041880652,0.003301994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985848,0.00003516151,0.0003000407,0.00044385312,0.00025120255,0.00038495913],"domain_scores_gemma":[0.9994097,0.00015714015,0.000062811065,0.00017080484,0.0000630107,0.00013657357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009709852,0.00016071617,0.0003865156,0.000061881685,0.00009117513,0.000086014275,0.00006889752,0.00008811486,0.00015165955],"category_scores_gemma":[0.0000053471795,0.0001606941,0.00006677084,0.00030011687,0.000046965626,0.00008116922,0.000006330161,0.0000754226,0.000009760075],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007387006,0.0009524121,0.98793495,0.00050615537,0.00008888481,0.0006682621,0.0039331056,0.000013043749,0.0029425297,0.0000037633458,0.00029118505,0.001926984],"study_design_scores_gemma":[0.013678608,0.0020467062,0.92546135,0.001034132,0.0004351325,0.00045665598,0.00063533697,0.00013082898,0.055386707,0.0000063637967,0.00045537588,0.0002728187],"about_ca_topic_score_codex":0.0020434281,"about_ca_topic_score_gemma":0.034756936,"teacher_disagreement_score":0.062473644,"about_ca_system_score_codex":0.000029864657,"about_ca_system_score_gemma":0.00012922115,"threshold_uncertainty_score":0.9828562},"labels":[],"label_agreement":null},{"id":"W4389243936","doi":"10.1182/blood-2023-190089","title":"Pharmacokinetic-Targeting and Dose-Adjustment of I.V. Busulfan for Myeloablative Conditioning in Allogeneic Hematopoietic Cell Transplantation","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Busulfan; Medicine; Fludarabine; Total body irradiation; Transplantation; Internal medicine; Anti-thymocyte globulin; Area under the curve; Gastroenterology; Hematopoietic stem cell transplantation; Regimen; Pharmacokinetics; Proportional hazards model; Univariate analysis; Urology; Oncology; Surgery; Chemotherapy; Multivariate analysis; Cyclophosphamide","score_opus":0.0194323155127938,"score_gpt":0.2829035870268979,"score_spread":0.2634712715141041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965314,0.00042223372,0.0010400285,0.00013700516,0.00006822358,0.0009967069,0.00006296972,0.00005904918,0.0006823837],"genre_scores_gemma":[0.99594486,0.00071441097,0.0026493806,0.00004633187,0.000045218556,0.00013739754,0.00035850258,0.000026987107,0.00007689102],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988692,0.000042447253,0.00041939522,0.00024672173,0.00018737807,0.00023487174],"domain_scores_gemma":[0.9993923,0.00028198928,0.00010693373,0.00008362286,0.00006302948,0.00007215936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029129031,0.00013744933,0.0002832745,0.00021960291,0.000041136638,0.0000058450314,0.000038071295,0.00007133885,0.000034772536],"category_scores_gemma":[0.000021783992,0.00013793398,0.000054159267,0.00029594693,0.000043715543,0.000052903077,0.000006353954,0.00007762544,0.0000075154],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002894106,0.00043475395,0.041636106,0.005983487,0.000115263305,0.0001027137,0.010277607,0.0003669948,0.93948036,0.0003058371,0.00006801325,0.00093946746],"study_design_scores_gemma":[0.01251187,0.00028777632,0.18028453,0.000556755,0.000652436,0.00008985303,0.0012967467,0.00085958745,0.8029707,0.00026906226,0.000035182347,0.00018550038],"about_ca_topic_score_codex":0.000013519078,"about_ca_topic_score_gemma":0.000003966354,"teacher_disagreement_score":0.13864842,"about_ca_system_score_codex":0.000014789136,"about_ca_system_score_gemma":0.000042594038,"threshold_uncertainty_score":0.5624785},"labels":[],"label_agreement":null},{"id":"W4389243948","doi":"10.1182/blood-2023-186559","title":"A Matching-Adjusted Indirect Comparison of the Efficacy of Elranatamab Versus Physician's Choice of Treatment Among Patients with Triple-Class Exposed/Refractory Multiple Myeloma in Canada","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; Université de Montréal; Hôpital Maisonneuve-Rosemont; Pfizer (Canada)","funders":"","keywords":"Medicine; Internal medicine; Propensity score matching; Multiple myeloma; Cohort; Clinical trial; Logistic regression; Oncology","score_opus":0.035783399633189335,"score_gpt":0.2824382959831082,"score_spread":0.24665489634991888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99806964,0.00007987471,2.9981535e-7,0.000018057937,0.000094945615,0.0012858168,0.00021453852,0.000018590377,0.00021821876],"genre_scores_gemma":[0.99962693,0.000011368982,0.000035669127,0.000004958455,0.000019298148,0.000054756376,0.0001621327,0.00003017625,0.0000546794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980406,0.00013049896,0.00048294215,0.00026912687,0.00070904463,0.00036775702],"domain_scores_gemma":[0.9980908,0.000776911,0.00036540572,0.00050510274,0.00013642738,0.00012534321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006683424,0.00022816316,0.0007454915,0.00019707176,0.000047493126,0.0000032786272,0.00018444312,0.000059530063,0.00001149045],"category_scores_gemma":[0.00020327362,0.0001452071,0.00011900414,0.000828082,0.00010532897,0.000053775006,0.000061090665,0.00016248744,0.000001786953],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026828647,0.0038151995,0.98379517,0.00015176661,0.00082599785,0.000023994058,0.00076532987,0.00011360193,0.0018056163,0.0000013120978,0.000032160253,0.0059870123],"study_design_scores_gemma":[0.0563532,0.0016701459,0.8901133,0.00028101576,0.0002580025,2.2433196e-7,0.00061752147,0.000311255,0.050270535,5.086978e-7,0.000028172224,0.00009611892],"about_ca_topic_score_codex":0.5032157,"about_ca_topic_score_gemma":0.67796266,"teacher_disagreement_score":0.174747,"about_ca_system_score_codex":0.00043903186,"about_ca_system_score_gemma":0.0009299147,"threshold_uncertainty_score":0.5921374},"labels":[],"label_agreement":null},{"id":"W4389243971","doi":"10.1182/blood-2023-178856","title":"Targeting Abnormally Increased Expression of ULK1 Sensitizes Acute Myeloid Leukemia Resistant Cells to Venetoclax","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; University of British Columbia","funders":"","keywords":"Myeloid leukemia; Autophagy; Biology; Venetoclax; Cancer research; Cell culture; Ven; Leukemia; Myeloid; Apoptosis; Genetics; Chronic lymphocytic leukemia","score_opus":0.012377031028460293,"score_gpt":0.2665633203097649,"score_spread":0.2541862892813046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960508,0.00008489918,0.00004220078,0.00029784226,0.000092257425,0.00075657386,0.000092933784,0.0002754752,0.002307035],"genre_scores_gemma":[0.99112743,0.00024642897,0.006070655,0.00034386525,0.0003481038,0.00005372973,0.00017376304,0.00009083075,0.0015451718],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972139,0.00014703478,0.000560919,0.00050198205,0.00083727436,0.000738884],"domain_scores_gemma":[0.99815464,0.000285475,0.00014201363,0.0006630479,0.0002910739,0.00046375822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008451368,0.0002663383,0.0005613381,0.0004904374,0.00013480542,0.000025631914,0.00027390243,0.00019540559,0.000102660735],"category_scores_gemma":[0.0004254812,0.00023476128,0.00014970485,0.0011011141,0.000084063184,0.00008662348,0.0003783942,0.00040450008,0.00041407126],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009473696,0.0000646471,0.0006922753,0.00021809722,0.00013976502,0.0012068303,0.00041657095,0.0001574038,0.9786437,0.000012481687,0.017297197,0.00020362035],"study_design_scores_gemma":[0.003847311,0.0004876871,0.006643513,0.00040040843,0.00021149496,0.000052443815,0.00032609573,0.0004926568,0.9840614,0.000015927373,0.0032239729,0.00023709479],"about_ca_topic_score_codex":0.00041430924,"about_ca_topic_score_gemma":0.000008526755,"teacher_disagreement_score":0.014073225,"about_ca_system_score_codex":0.00044333792,"about_ca_system_score_gemma":0.0012318612,"threshold_uncertainty_score":0.9573287},"labels":[],"label_agreement":null},{"id":"W4389243998","doi":"10.1182/blood-2023-186092","title":"Concurrent BCR::-ABL1 and CBFB Rearrangement in De Novo Acute Myeloid Leukemia","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Grand River Hospital; McMaster University; Hamilton Regional Laboratory Medicine Program; Juravinski Cancer Centre","funders":"","keywords":"Fusion transcript; Cancer research; Myeloid leukemia; Fusion gene; Gene rearrangement; ABL; Biology; Bone marrow; Leukemia; Medicine; Internal medicine; Immunology; Genetics; Gene; Tyrosine kinase","score_opus":0.018651809357483503,"score_gpt":0.2835538800367045,"score_spread":0.264902070679221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389243998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951035,0.0008504744,0.0000066025573,0.00061442074,0.0001323522,0.0005133404,0.000024106443,0.00016531146,0.0025899215],"genre_scores_gemma":[0.9952886,0.0015767834,0.00027300883,0.0002652747,0.00014905204,0.000114345494,0.000096424745,0.000038645114,0.002197868],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985668,0.00003651559,0.00026531154,0.00037277178,0.00026212435,0.000496469],"domain_scores_gemma":[0.99934083,0.00006475749,0.00005203393,0.0003151609,0.000027233906,0.0001999697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000231722,0.00019913043,0.00033837723,0.00018646967,0.000047375735,0.000018407896,0.00008264907,0.00010724669,0.00012005493],"category_scores_gemma":[0.00006132852,0.00018128075,0.000058698442,0.00037369994,0.00005951032,0.000050666753,0.0001103576,0.0002187283,0.00024134657],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033041686,0.0019461078,0.72440356,0.00096197025,0.002508367,0.012814094,0.00593346,0.000037130885,0.13580583,0.0005895385,0.015015809,0.09965374],"study_design_scores_gemma":[0.07613973,0.0012804226,0.83785015,0.0009914852,0.0018557457,0.0016460448,0.00069333595,0.0011372488,0.04258924,0.00023408658,0.034811895,0.00077063305],"about_ca_topic_score_codex":0.00019411369,"about_ca_topic_score_gemma":0.0000970978,"teacher_disagreement_score":0.11344659,"about_ca_system_score_codex":0.00087498006,"about_ca_system_score_gemma":0.00049507857,"threshold_uncertainty_score":0.7392414},"labels":[],"label_agreement":null},{"id":"W4389244018","doi":"10.1182/blood-2023-182700","title":"Long-Term Outcome of Multiple Myeloma Patients Receiving Autologous Stem Cell Transplantation (ASCT) - Impact of Therapeutic Strategy Following ASCT","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Melphalan; Multiple myeloma; Autologous stem-cell transplantation; Oncology; Internal medicine; Univariate analysis; Transplantation; Hematopoietic stem cell transplantation; Proportional hazards model; Survival analysis; Multivariate analysis; Progression-free survival; Surgery; Chemotherapy","score_opus":0.04297853181349259,"score_gpt":0.33417248971475394,"score_spread":0.29119395790126135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389244018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99846953,0.0001897227,0.000030237668,0.000007582611,0.000068329435,0.00073074055,0.000102122656,0.00008462842,0.00031712806],"genre_scores_gemma":[0.9992786,0.000086811604,0.00007455129,0.0000042349184,0.000018567887,0.000027208489,0.0002978651,0.000037515976,0.00017462285],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819326,0.000108902794,0.0005058877,0.00027054056,0.0004953978,0.00042602076],"domain_scores_gemma":[0.99900067,0.00025968958,0.00017672384,0.00030488346,0.00009876345,0.00015929414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019482823,0.00021179186,0.0005048441,0.0002622937,0.000059271188,0.000012013602,0.00012220438,0.000110798144,0.000036195375],"category_scores_gemma":[0.000034668177,0.00016292978,0.00039162647,0.00037930484,0.000038173996,0.000106105275,0.00002318025,0.0001413863,0.00003132269],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003468329,0.0010592059,0.95036197,0.00053963077,0.00072761264,0.00027165675,0.00046901047,0.000031558175,0.020544402,7.977695e-7,0.0000027098042,0.025644606],"study_design_scores_gemma":[0.011385571,0.0013857519,0.9511998,0.00016694926,0.00041038805,0.000012349571,0.000056554494,0.0002200841,0.035044584,0.000004685255,2.3643032e-7,0.00011300198],"about_ca_topic_score_codex":0.00022392144,"about_ca_topic_score_gemma":0.00005355112,"teacher_disagreement_score":0.025531605,"about_ca_system_score_codex":0.000059551865,"about_ca_system_score_gemma":0.00010857267,"threshold_uncertainty_score":0.6644083},"labels":[],"label_agreement":null},{"id":"W4389244092","doi":"10.1182/blood-2023-181632","title":"Cross-Community Collaboration and Data Collection to Optimize Patient Care in Hemolytic Anemias","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Stakeholder; Medicine; Health care; Disease; Stakeholder engagement; Patient advocacy; Family medicine; Nursing; Public relations; MEDLINE; Political science; Pathology","score_opus":0.019682742734197328,"score_gpt":0.3077164248193306,"score_spread":0.28803368208513325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389244092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99696064,0.0005099647,0.000004717425,0.00054888846,0.00009782422,0.00048585024,0.000034162797,0.00007342143,0.0012845316],"genre_scores_gemma":[0.9985525,0.00022470612,0.00037577402,0.0002008551,0.000015463225,0.000019581921,0.00035349475,0.000012755218,0.0002448669],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993443,0.00005449437,0.00016365215,0.00017195828,0.00011900798,0.00014657326],"domain_scores_gemma":[0.9993662,0.00003972139,0.000025337882,0.0004025687,0.00008370933,0.00008245963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016259753,0.00007767995,0.00013316279,0.00013797112,0.00015455813,0.00003472252,0.000069993395,0.00010086803,0.000014856629],"category_scores_gemma":[0.00024783562,0.0000716881,0.000010409611,0.0010029129,0.000027949327,0.000088651184,0.00015052829,0.00020726692,0.000020440471],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036952433,0.006377416,0.566681,0.0029836877,0.00062271906,0.0013382854,0.21455167,0.009242526,0.030189162,0.00008350348,0.052777074,0.11145765],"study_design_scores_gemma":[0.06922406,0.01219539,0.597645,0.0017898832,0.001154933,0.00055081403,0.23498762,0.019135445,0.028409952,0.0001892706,0.032906197,0.0018114349],"about_ca_topic_score_codex":0.00032596602,"about_ca_topic_score_gemma":0.0004250587,"teacher_disagreement_score":0.10964622,"about_ca_system_score_codex":0.000042147218,"about_ca_system_score_gemma":0.00010872593,"threshold_uncertainty_score":0.29233557},"labels":[],"label_agreement":null},{"id":"W4389244101","doi":"10.1182/blood-2023-184864","title":"Targeting T-Cell Lymphoma Using CD70-Directed Cord Blood-Derived CAR-NK Cells","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Cancer research; Lymphoma; Chimeric antigen receptor; CD19; Immunotherapy; T cell; Medicine; Immunology; Antigen; Cancer; Internal medicine; Immune system","score_opus":0.03353847504303479,"score_gpt":0.2951050653562019,"score_spread":0.2615665903131671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389244101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99107766,0.000721386,0.000015131615,0.000092795,0.00034148572,0.0007046758,0.000022479675,0.0008518916,0.006172483],"genre_scores_gemma":[0.9796978,0.0007455373,0.0021508182,0.00020469794,0.00085248536,0.000039287268,0.00012179572,0.00019712246,0.015990453],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99721247,0.00015602334,0.00042224026,0.0005825675,0.0007159486,0.0009107413],"domain_scores_gemma":[0.9985027,0.00023330127,0.00011432737,0.0005866554,0.00022710292,0.00033596138],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005001438,0.00030555995,0.0005112663,0.00034001595,0.00020818796,0.00006336815,0.00023554603,0.00020187447,0.001503793],"category_scores_gemma":[0.00015246347,0.00030287134,0.00020406277,0.0012210616,0.000110281246,0.00006609956,0.00018836671,0.00027994535,0.00046179452],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019446375,0.00084851397,0.003918336,0.00025261223,0.00023987125,0.00086500164,0.0003645004,0.000022142425,0.9906976,0.0000015921617,0.0010731597,0.0015221626],"study_design_scores_gemma":[0.011149003,0.0003857154,0.0014187358,0.00012775787,0.00044038217,0.00012329145,0.00028355137,0.002585948,0.9780761,0.000017539747,0.0050493367,0.00034266635],"about_ca_topic_score_codex":0.0003580898,"about_ca_topic_score_gemma":0.000008018475,"teacher_disagreement_score":0.012621572,"about_ca_system_score_codex":0.00008313208,"about_ca_system_score_gemma":0.000321332,"threshold_uncertainty_score":0.99994236},"labels":[],"label_agreement":null},{"id":"W4389244102","doi":"10.1182/blood-2023-184638","title":"Safety and Efficacy of Direct Oral Anticoagulants in Patients with Liver Cirrhosis: A Systematic Review and Meta-Analysis","year":2023,"lang":"en","type":"review","venue":"Blood","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Toronto; McMaster University; University of Ottawa","funders":"","keywords":"Medicine; Apixaban; Dabigatran; Rivaroxaban; Edoxaban; Internal medicine; Population; Randomized controlled trial; Warfarin; Cirrhosis; Context (archaeology); Intensive care medicine; Atrial fibrillation; Surgery","score_opus":0.05951876147896667,"score_gpt":0.31394201467646793,"score_spread":0.25442325319750125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389244102","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00050314673,0.9961351,9.746989e-7,0.000004164218,0.0000032189619,0.002972962,0.00034270703,0.000016505448,0.000021182139],"genre_scores_gemma":[0.002000956,0.99739754,0.00002391839,0.00002699214,0.000003157344,0.000093456714,0.00039068508,0.000025029614,0.000038270457],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9982504,0.0002806959,0.0007469194,0.00032769298,0.00027075116,0.0001235002],"domain_scores_gemma":[0.9989603,0.00021556916,0.00037156846,0.00030286945,0.00006320592,0.00008647723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003069331,0.00027311497,0.007004103,0.00030968408,0.000016905713,0.000008699451,0.00005490211,0.00007838289,0.0000187435],"category_scores_gemma":[0.000031904223,0.00015219704,0.0005589034,0.0007535602,0.000030371402,0.00004008661,0.000019312822,0.0000942719,0.0000057965326],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017435035,0.0002446236,0.0013262309,0.77306813,0.22511412,0.00003870113,0.000036751884,2.5298945e-8,1.987168e-9,0.0000014103495,5.702252e-7,0.00015199865],"study_design_scores_gemma":[0.0012321504,0.00008519203,0.010407203,0.12768535,0.8604419,0.000007038599,0.0000019798958,4.093527e-7,8.831413e-8,1.7632779e-7,0.00001600456,0.00012245166],"about_ca_topic_score_codex":0.000052223615,"about_ca_topic_score_gemma":0.000022324217,"teacher_disagreement_score":0.64538276,"about_ca_system_score_codex":0.00000891723,"about_ca_system_score_gemma":0.00004945352,"threshold_uncertainty_score":0.6206415},"labels":[],"label_agreement":null},{"id":"W4389244115","doi":"10.1182/blood-2023-189358","title":"Gimema Seifem Real-Life Study VS Randomized CPX-351 Registrative Trial for Older Patients with Secondary ACUTE Myeloid Leukemia: An Unanchored Matching-Adjusted Indirect Comparison of Infection Rates and Survival Outcomes","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cytarabine; Internal medicine; Daunorubicin; Regimen; Myeloid leukemia; Chemotherapy regimen; Randomized controlled trial; Clinical trial; Leukemia; Pediatrics; Oncology; Chemotherapy","score_opus":0.03444640972525172,"score_gpt":0.3457785500579785,"score_spread":0.31133214033272677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389244115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989461,0.000029530072,0.000081881866,0.00014925061,0.0002444757,0.009417254,0.0001503925,0.00023186393,0.00023434294],"genre_scores_gemma":[0.9974403,0.00005924561,0.00028093398,0.000040343737,0.00016587345,0.0007285827,0.00075974304,0.00008997989,0.00043502913],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99612737,0.0008308484,0.0010074251,0.00070526695,0.0008104084,0.0005186757],"domain_scores_gemma":[0.99661607,0.0014440827,0.00058840023,0.00053267897,0.00052032736,0.00029847067],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018579847,0.0004455651,0.002467842,0.00046482237,0.0002312099,0.00006542251,0.00015159821,0.00025306956,0.000024435221],"category_scores_gemma":[0.0008090393,0.00031757622,0.00021164492,0.00072869775,0.00026468138,0.00027676582,0.000114110815,0.0005800509,0.0000046798295],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44820464,0.0026937786,0.5367758,0.00030816926,0.004042419,0.000031790383,0.0066284994,0.000013677875,0.0002417495,0.000026133208,0.00046543006,0.000567893],"study_design_scores_gemma":[0.5196899,0.0044320105,0.47117063,0.00006538531,0.0014139481,0.0000029873936,0.0014324825,0.00020672164,0.0013551287,0.000023502378,0.0000065296294,0.00020073194],"about_ca_topic_score_codex":0.0011873214,"about_ca_topic_score_gemma":0.00053685735,"teacher_disagreement_score":0.071485296,"about_ca_system_score_codex":0.00018440935,"about_ca_system_score_gemma":0.0009774257,"threshold_uncertainty_score":0.99992764},"labels":[],"label_agreement":null},{"id":"W4389244147","doi":"10.1182/blood-2023-189950","title":"Monoclonal Immunoglobulin Deposition Disease - a Review of Current and Emerging Data","year":2023,"lang":"en","type":"review","venue":"Blood","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University","funders":"","keywords":"Medicine; Transplantation; Guideline; Autologous stem-cell transplantation; Immunosuppression; Disease; Internal medicine; Intensive care medicine; Pathology","score_opus":0.07317197806822416,"score_gpt":0.3849249339377425,"score_spread":0.31175295586951834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389244147","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001166443,0.99745893,0.000017124165,0.000041243035,0.00011140997,0.0007499454,0.0014735527,0.000017909735,0.000013239603],"genre_scores_gemma":[0.00001747447,0.98905414,0.00018374895,0.000043383738,0.00017220216,0.0002393275,0.010201805,0.00005680273,0.000031112526],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99826396,0.00014044256,0.00058172585,0.0006446579,0.00016685615,0.0002023413],"domain_scores_gemma":[0.9982618,0.0000394318,0.00041229487,0.0011260664,0.000041694486,0.00011870121],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019111852,0.00035264672,0.000893875,0.000057995654,0.000046835947,0.000015344694,0.00045256052,0.000117916956,0.000011246535],"category_scores_gemma":[0.00022448362,0.0002981766,0.0002988121,0.00014611911,0.000049898616,0.0000049652076,0.0007757174,0.0001118951,0.000019783016],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008340474,0.00057866203,0.00048768704,0.21124743,0.0013655038,0.00003062507,0.0000031338993,6.4356406e-8,0.0000197067,0.00001698766,0.0030709151,0.78317094],"study_design_scores_gemma":[0.0004913843,0.00006661012,0.00015836077,0.10868664,0.007364768,0.000030578758,0.0000019901436,8.578986e-7,0.00006084461,0.000005635003,0.8827377,0.00039462966],"about_ca_topic_score_codex":0.000008391998,"about_ca_topic_score_gemma":0.000003078675,"teacher_disagreement_score":0.8796668,"about_ca_system_score_codex":0.000012036022,"about_ca_system_score_gemma":0.00022466402,"threshold_uncertainty_score":0.999947},"labels":[],"label_agreement":null},{"id":"W4389244310","doi":"10.1182/blood-2023-188464","title":"Outcomes of Patients with Acute Myeloid Leukemia with Myelodysplasia Related Changes (AML-MRC) Receiving Intensive Vs. Non-Intensive First Line Treatment","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Cytarabine; Azacitidine; Myeloid leukemia; Decitabine; Hypomethylating agent; Idarubicin; Oncology; Flag (linear algebra); Fludarabine; Leukemia; Hematology; Chemotherapy; Cyclophosphamide","score_opus":0.01398435838151412,"score_gpt":0.25894910589653825,"score_spread":0.24496474751502412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389244310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916895,0.000054798664,0.00001237836,0.0050917794,0.00012068939,0.0018883463,0.00017286645,0.0003529637,0.00061664695],"genre_scores_gemma":[0.9910126,0.0008097625,0.0008349295,0.0006479387,0.00009772976,0.00022882539,0.0007527598,0.00018354347,0.0054319394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967542,0.00006260811,0.0005464329,0.0008070796,0.0009156299,0.000913996],"domain_scores_gemma":[0.9953587,0.0003844592,0.00036846203,0.0009120354,0.002603958,0.00037237865],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018496974,0.00062060065,0.0013295261,0.00064827886,0.00018497751,0.000027626122,0.0002752324,0.0002755739,0.00007999642],"category_scores_gemma":[0.0005417679,0.0003903825,0.00016126355,0.0014346973,0.00034104098,0.00013997837,0.00021635026,0.0005416502,0.00018634279],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057760547,0.0008725237,0.9638609,0.00033851404,0.009433311,0.0034125783,0.0075587076,0.00008275419,0.0018623935,0.000012838622,0.0036769172,0.0031124984],"study_design_scores_gemma":[0.033296432,0.0119403545,0.9274592,0.0009521292,0.0024233668,0.00024145695,0.0020842385,0.00049433607,0.019753205,0.000010264417,0.0007870939,0.00055796077],"about_ca_topic_score_codex":0.00045111048,"about_ca_topic_score_gemma":0.0005496201,"teacher_disagreement_score":0.036401745,"about_ca_system_score_codex":0.0007951857,"about_ca_system_score_gemma":0.0007230975,"threshold_uncertainty_score":0.9998548},"labels":[],"label_agreement":null},{"id":"W4389244501","doi":"10.1182/blood-2023-178127","title":"Impact of Quality and Type of Anticoagulant Treatment, and Inflammatory Biomarkers on Quality of Life and Psychological Morbidity in Patients with Atrial Fibrillation: An Exploratory Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Atrial fibrillation; Quality of life (healthcare); Stroke (engine); Warfarin; Hospital Anxiety and Depression Scale; Intensive care medicine; Internal medicine; Physical therapy; Anxiety; Psychiatry","score_opus":0.22916763219873756,"score_gpt":0.4361704875072953,"score_spread":0.20700285530855775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389244501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992172,0.000052985757,3.1112708e-7,0.000020760337,0.000024152416,0.0006282208,0.000020723475,0.000014694161,0.000020964611],"genre_scores_gemma":[0.99982595,0.000066590306,0.000023365965,0.0000023158493,0.00005136297,3.9312604e-7,0.000021400456,0.0000059809527,0.0000026255966],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891543,0.00022024564,0.000420244,0.00018811617,0.0001769531,0.00007898306],"domain_scores_gemma":[0.99929315,0.00016368058,0.00023467484,0.00017743709,0.00006097964,0.00007005103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046634953,0.00010503501,0.0004658634,0.00014065276,0.000017306622,0.000003978064,0.000017797753,0.000048259677,0.0000053769286],"category_scores_gemma":[0.0001938075,0.00006954207,0.000046942372,0.0002178209,0.000089691464,0.00006657006,0.000026795271,0.000025095225,2.4282102e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004586988,0.00019845385,0.99354565,0.000075410375,0.00031837384,0.0000013095198,0.0004913124,0.0000110363,0.000301,0.000024802424,0.0000019420536,0.00044369316],"study_design_scores_gemma":[0.014621834,0.006315717,0.9784844,0.00002065411,0.00010724649,1.5691288e-7,0.00031995194,0.000009950787,0.00003827249,0.000015811995,0.0000010958083,0.00006489289],"about_ca_topic_score_codex":0.00010798643,"about_ca_topic_score_gemma":0.000038413775,"teacher_disagreement_score":0.015061262,"about_ca_system_score_codex":0.000009226602,"about_ca_system_score_gemma":0.000027638956,"threshold_uncertainty_score":0.28358433},"labels":[],"label_agreement":null},{"id":"W4389246485","doi":"10.1182/blood-2023-175044","title":"Restoration of Mir-185 in Combination with BCR-ABL Downregulation By Therapeutic Delivery of siRNA with Lipid Nanoparticle Carriers Targets Drug Resistant Leukemic Stem/Progenitor Cells","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute","funders":"","keywords":"Cancer research; Progenitor cell; Dasatinib; Stem cell; Medicine; Downregulation and upregulation; Tyrosine kinase; Combination therapy; Myeloid leukemia; Philadelphia chromosome; Immunology; Pharmacology; Biology; Imatinib; Internal medicine; Cell biology; Chromosomal translocation","score_opus":0.01008391813627352,"score_gpt":0.21965202002132775,"score_spread":0.20956810188505423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389246485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982622,0.0005720159,0.000010305979,0.00011482673,0.000044044722,0.0008464092,0.000032312113,0.00005883819,0.00005901877],"genre_scores_gemma":[0.99905777,0.000051596333,0.00025047135,0.000014820123,0.000021514763,0.000059092257,0.00012996006,0.000036325542,0.0003784393],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984593,0.00010119343,0.00041532106,0.00028420455,0.0004931725,0.00024681393],"domain_scores_gemma":[0.9990427,0.00008183403,0.00027684082,0.00033742507,0.00018324792,0.0000779623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024094858,0.0001777446,0.00033732323,0.00018972595,0.000046442357,0.0000085256115,0.00007576863,0.00007810839,0.0000113439055],"category_scores_gemma":[0.000010561815,0.00014207631,0.000040347782,0.00068848167,0.000095781674,0.00014478592,0.000017724966,0.00010000965,0.0000068554905],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001436317,0.0006542923,0.028838597,0.00023857171,0.00021147955,0.000026107196,0.0015323848,0.0002578032,0.9660191,0.000028785858,0.00020698305,0.00054959545],"study_design_scores_gemma":[0.014785221,0.0013032074,0.041967366,0.0003210359,0.000364091,0.000008596112,0.0006944109,0.0010243314,0.93928,0.000018188923,0.000082598875,0.00015099335],"about_ca_topic_score_codex":0.00044985942,"about_ca_topic_score_gemma":0.00022788525,"teacher_disagreement_score":0.026739124,"about_ca_system_score_codex":0.00046153122,"about_ca_system_score_gemma":0.00047568267,"threshold_uncertainty_score":0.5793704},"labels":[],"label_agreement":null},{"id":"W4389246535","doi":"10.1182/blood-2023-188791","title":"An Examination of Aggregate Side-Effects Mapped to Therapies Experienced By Patients with Relapsed Large B-Cell Lymphomas - an Analysis from the Lymphoma Coalition's 2022 Global Patient Survey","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Incidence (geometry); Medicine; Odds ratio; Statistic; Confidence interval; Contingency table; Statistics; Internal medicine; Mathematics","score_opus":0.08118743290582679,"score_gpt":0.39637385794495456,"score_spread":0.31518642503912775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389246535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801791,0.000030703723,0.014077232,0.0000265308,0.00015866423,0.0009828347,0.004348116,0.00012659468,0.0000702427],"genre_scores_gemma":[0.96127146,0.00000844416,0.037666645,0.00016395065,0.00003308509,0.00018971684,0.0006146438,0.00003666043,0.000015398828],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9926428,0.004579305,0.0008032819,0.0006410005,0.00094255497,0.00039103982],"domain_scores_gemma":[0.98115647,0.016749615,0.00053522526,0.0010075129,0.00033793753,0.00021325286],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0028023936,0.0002848807,0.0007180377,0.00009131777,0.00017108412,0.000073627016,0.00046922424,0.00015276436,0.00007877855],"category_scores_gemma":[0.011656563,0.00019613132,0.00012757222,0.0018160809,0.00012190504,0.00014119325,0.00011206457,0.0000658712,0.000013387315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031555588,0.047123156,0.7999811,0.000260141,0.0053576184,0.00007296621,0.02812799,0.00007106213,0.0054146433,0.007930725,0.0023422735,0.100162745],"study_design_scores_gemma":[0.010070473,0.0018699573,0.9512301,0.000059234353,0.00094376906,1.5655742e-7,0.0015430131,0.00049507467,0.009668791,0.023708638,0.000020850888,0.00038991682],"about_ca_topic_score_codex":0.00039870522,"about_ca_topic_score_gemma":0.0002890349,"teacher_disagreement_score":0.151249,"about_ca_system_score_codex":0.000068545625,"about_ca_system_score_gemma":0.000051959843,"threshold_uncertainty_score":0.9966687},"labels":[],"label_agreement":null},{"id":"W4389246546","doi":"10.1182/blood-2023-188258","title":"Reclassification of Ascertain (ASTX727-02) Myelodysplastic Syndrome (MDS) Patients: Outcomes Including Clinical Response, Overall Survival (OS), and Leukemia Free Survival (LFS) Based on IPSS-R and IPSS-M Scoring Systems","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Health Sciences Centre; University of Toronto; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Hôpital Maisonneuve-Rosemont; University of Alberta; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Decitabine; International Prognostic Scoring System; Medicine; Internal medicine; Discontinuation; Chronic myelomonocytic leukemia; Myelodysplastic syndromes; Oncology; Regimen; Bone marrow; DNA methylation","score_opus":0.06943971882286408,"score_gpt":0.3432509982046634,"score_spread":0.27381127938179933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389246546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967211,0.00007517643,0.00008369211,0.0007251719,0.0006528827,0.0010322905,0.00014036945,0.00020445335,0.00036484536],"genre_scores_gemma":[0.99850285,0.00013446734,0.00029024328,0.00006978905,0.00014861183,0.00007387246,0.00013066489,0.00009978145,0.0005497344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947437,0.0011137772,0.0012081093,0.0009087027,0.0013404068,0.0006852776],"domain_scores_gemma":[0.99119735,0.006577027,0.00037709906,0.0010331877,0.00037278005,0.00044257948],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004585497,0.00041794288,0.0011743536,0.0007336008,0.00022341445,0.00008281181,0.00030372315,0.00037331803,0.000016534566],"category_scores_gemma":[0.009863244,0.00036847594,0.00014262083,0.0008279242,0.00029155423,0.0001858548,0.00043490934,0.00078832754,0.000036411177],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033057223,0.00053722766,0.9903567,0.00077403826,0.00035784833,0.00030572197,0.00011959869,0.00012866047,0.0027742083,0.0003211574,0.00043176612,0.00058738765],"study_design_scores_gemma":[0.016455883,0.0017273793,0.96916574,0.00078770716,0.00026008658,0.0000417731,0.00023611316,0.010565355,0.00020371616,0.000028712571,0.00019836286,0.00032919762],"about_ca_topic_score_codex":0.00031767896,"about_ca_topic_score_gemma":0.000030134495,"teacher_disagreement_score":0.02119095,"about_ca_system_score_codex":0.00043303406,"about_ca_system_score_gemma":0.0007311224,"threshold_uncertainty_score":0.99987674},"labels":[],"label_agreement":null},{"id":"W4389246619","doi":"10.1182/blood-2023-177808","title":"Initial Report of Part B Phase 1/2 Efficacy and Safety Results for Bruton Tyrosine Kinase Inhibitor Rilzabrutinib in Patients with Relapsed Immune Thrombocytopenia","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Thrombopoietin; Bruton's tyrosine kinase; Internal medicine; Gastroenterology; Platelet; Concomitant; Thrombopoietin receptor; Antibody; Immunology; Tyrosine kinase; Receptor","score_opus":0.02414532108354637,"score_gpt":0.32428107355702773,"score_spread":0.30013575247348134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389246619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99654776,0.00010154419,0.0000043022987,0.0002369228,0.0001274953,0.0020839244,0.00021825467,0.000072379364,0.0006074161],"genre_scores_gemma":[0.9977429,0.00004144096,0.00031849038,0.000023124523,0.00016791829,0.00006922708,0.0011683413,0.000049779923,0.00041880805],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9974154,0.000060757677,0.0009481541,0.000523892,0.0005730123,0.00047875886],"domain_scores_gemma":[0.99825263,0.00041469917,0.00025650105,0.0006437148,0.00026059657,0.0001718623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009147674,0.00021285997,0.000677857,0.00022956349,0.000073163115,0.000014888035,0.00010584399,0.00014552248,0.000014534758],"category_scores_gemma":[0.0017233767,0.00017218453,0.000065527915,0.0006743863,0.00021238849,0.000094460695,0.00013774862,0.00020743236,0.000009184896],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.66022474,0.082584605,0.058757562,0.008065676,0.003202754,0.024665384,0.009192124,0.00010432609,0.088652894,0.0004910872,0.025162727,0.038896147],"study_design_scores_gemma":[0.78215384,0.00630346,0.107016854,0.0013374438,0.0003342144,0.00021461865,0.000078621866,0.0002843352,0.097815454,0.000017366458,0.004110143,0.00033367053],"about_ca_topic_score_codex":0.00017675631,"about_ca_topic_score_gemma":0.000025893582,"teacher_disagreement_score":0.1219291,"about_ca_system_score_codex":0.00061198906,"about_ca_system_score_gemma":0.002043094,"threshold_uncertainty_score":0.70214814},"labels":[],"label_agreement":null},{"id":"W4389246620","doi":"10.1182/blood-2023-173685","title":"Cell-Free DNA from Blood or Bone Marrow as Alternatives to Bone Marrow Cells for Molecular Diagnostics and Monitoring of Multiple Myeloma","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research; Dalhousie University; University Health Network; University of Toronto; University of New Brunswick; Saint John Regional Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Bone marrow; Multiple myeloma; Concordance; Medicine; Cell-free fetal DNA; Liquid biopsy; Circulating tumor cell; Molecular biology; Cancer research; Oncology; Cancer; Internal medicine; Biology; Metastasis; Genetics","score_opus":0.010285310819798195,"score_gpt":0.24088116334846707,"score_spread":0.23059585252866888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389246620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938464,0.0035098894,0.00041774428,0.0001372368,0.00032989174,0.0005140007,0.0011367765,0.000022751889,0.000085292326],"genre_scores_gemma":[0.98659956,0.0032239186,0.008901874,0.00011727176,0.0004847721,0.0001318506,0.00016176915,0.00007019841,0.00030876882],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99862695,0.000024877287,0.00031843083,0.0005047324,0.00016978345,0.000355244],"domain_scores_gemma":[0.9986996,0.0003090002,0.00013123479,0.00055360224,0.00011486731,0.00019167813],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011710695,0.0002410703,0.00029641038,0.000084100015,0.00006933448,0.000041100004,0.00027163303,0.00015010026,0.00000772658],"category_scores_gemma":[0.00083757826,0.00024799517,0.0001085237,0.00013714866,0.000055918816,0.000004314043,0.00041691127,0.00006613739,0.000008213034],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001739062,0.00028009352,0.0078040417,0.000077199096,0.00015358189,0.00009372867,0.00013603883,0.00009803268,0.9888312,0.00002147164,0.0018161694,0.00051454105],"study_design_scores_gemma":[0.003896135,0.00076210685,0.002847482,0.000057474223,0.00021756989,0.000006987725,0.00015211197,0.000033073564,0.9878279,0.00031489084,0.0035734805,0.00031081066],"about_ca_topic_score_codex":0.00013172557,"about_ca_topic_score_gemma":0.000056304892,"teacher_disagreement_score":0.00848413,"about_ca_system_score_codex":0.0000073301944,"about_ca_system_score_gemma":0.00007925002,"threshold_uncertainty_score":0.99999726},"labels":[],"label_agreement":null},{"id":"W4389246668","doi":"10.1182/blood-2023-173283","title":"Comparative Analysis of Clinical Outcomes and Healthcare Resource Utilization (HRU) in Patients (Pts) with Newly Diagnosed (ND) Acute Myeloid Leukemia (AML) Unfit for High-Intensity Chemotherapy Treated with Venetoclax (VEN) Vs Other Therapies: Results from the AML Real World Evidence (ARC) Initiative","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Ven; Internal medicine; Chemotherapy regimen; Cytarabine; Surgery; Oncology; Leukemia; Chemotherapy","score_opus":0.0969243451126762,"score_gpt":0.37851784483102585,"score_spread":0.2815934997183497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389246668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937537,0.00009947106,0.000060723745,0.0027278855,0.000022472825,0.0023499348,0.0008413128,0.00008538099,0.000059129383],"genre_scores_gemma":[0.9954838,0.00052969996,0.0008216265,0.0014922754,0.0000884083,0.00016667985,0.0011058301,0.000056389672,0.00025526472],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963369,0.0005991544,0.0010244773,0.0008444105,0.00071521976,0.00047987464],"domain_scores_gemma":[0.99261963,0.004856229,0.00065081735,0.00078333786,0.00089744397,0.00019255793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010275864,0.00038292346,0.0017081545,0.00047680148,0.00014663505,0.00003616288,0.0002853953,0.00018713083,0.000014746896],"category_scores_gemma":[0.0006767287,0.0002281403,0.00016829123,0.0029069239,0.00048021573,0.00015991161,0.00007729063,0.0005133615,0.000003352087],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04153969,0.0002992641,0.9413881,0.000036407466,0.0056363214,0.000036860296,0.0087001445,0.00015018924,0.00003727751,0.000022094939,0.00089354714,0.0012601058],"study_design_scores_gemma":[0.03121456,0.0032981741,0.9585362,0.00057656557,0.0016700057,6.9754026e-7,0.0016498087,0.0018343454,0.00079525216,0.000034463606,0.00016428743,0.00022566172],"about_ca_topic_score_codex":0.014377138,"about_ca_topic_score_gemma":0.015575866,"teacher_disagreement_score":0.017148083,"about_ca_system_score_codex":0.00045567052,"about_ca_system_score_gemma":0.0007723605,"threshold_uncertainty_score":0.9921862},"labels":[],"label_agreement":null},{"id":"W4389246672","doi":"10.1182/blood-2023-185151","title":"Global Access to Multiple Myeloma Medications (GLAMM-2 Study): Access and Barriers to Chemoimmunotherapies and Transplant","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Expanded access; Multiple myeloma; Carfilzomib; Bortezomib; Family medicine; Internal medicine; Oncology","score_opus":0.033736136938265264,"score_gpt":0.3546823641972789,"score_spread":0.3209462272590136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389246672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99371827,0.00020725731,0.00004601803,0.003666424,0.00004394322,0.0016816851,0.00015729207,0.00013682996,0.0003422786],"genre_scores_gemma":[0.9984883,0.00020225292,0.00020647439,0.0004451137,0.00005313397,0.00038599697,0.000044172113,0.000020454645,0.00015406468],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859107,0.000041887506,0.00019398694,0.00040423297,0.0003870337,0.00038179845],"domain_scores_gemma":[0.99860454,0.000108117034,0.000023497789,0.0003107847,0.00006163592,0.00089141063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018228882,0.00017490266,0.00027131068,0.00018229529,0.00022660584,0.00014356589,0.0002334276,0.000056050387,0.00007608313],"category_scores_gemma":[0.00027015657,0.00014077769,0.00003199384,0.0006968022,0.000069478534,0.00014821,0.00015495431,0.00008102172,0.000033638014],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036953914,0.00037078818,0.98246527,0.00005615907,0.0005570112,0.00021884558,0.0027700257,0.0000014591069,0.001279878,0.000009880901,0.00034592036,0.011555229],"study_design_scores_gemma":[0.007773055,0.00044664202,0.9882266,0.000067993955,0.00016863455,0.00004521817,0.00082733796,0.000048013546,0.0015939992,0.000029447112,0.0006394561,0.00013360316],"about_ca_topic_score_codex":0.00042831045,"about_ca_topic_score_gemma":0.00080050406,"teacher_disagreement_score":0.0114216255,"about_ca_system_score_codex":0.000031947926,"about_ca_system_score_gemma":0.0001132092,"threshold_uncertainty_score":0.57407475},"labels":[],"label_agreement":null},{"id":"W4389246687","doi":"10.1182/blood-2023-186580","title":"Data-Driven Harmonization of 2022 Who and ICC Classifications of Myelodysplastic Syndromes/Neoplasms (MDS): A Study By the International Consortium for MDS (icMDS)","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Myelodysplastic syndromes; Harmonization; Delphi method; Cluster analysis; Hierarchical clustering; Computational biology; Medicine; Data mining; Computer science; Internal medicine; Biology; Artificial intelligence","score_opus":0.06684282480882796,"score_gpt":0.33751802717289714,"score_spread":0.27067520236406917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389246687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99333066,0.00012396734,0.0010519938,0.0021468173,0.00010088558,0.0013733455,0.0016067621,0.000042821273,0.00022272766],"genre_scores_gemma":[0.9960176,0.00021245242,0.0003484693,0.000040216677,0.000057643963,0.00017153658,0.0012095703,0.000027970744,0.0019145409],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985206,0.00006735601,0.0004035068,0.00033073028,0.0004917054,0.00018609493],"domain_scores_gemma":[0.9981534,0.00069624,0.00017391054,0.00061049825,0.00029327607,0.0000726705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005566464,0.00011261248,0.00027207052,0.00019502119,0.00009782234,0.000021938591,0.00046249854,0.00006038615,0.000062284336],"category_scores_gemma":[0.00092405593,0.00008628902,0.000035993122,0.0005087933,0.00019164123,0.00009702874,0.00032283698,0.00016144449,0.00001148531],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012210673,0.007206775,0.43484604,0.0013345988,0.005855269,0.00009650395,0.005231057,0.00018186867,0.25504535,0.0030863828,0.2801656,0.005729475],"study_design_scores_gemma":[0.04423479,0.004590494,0.630645,0.00050108955,0.004356174,0.00048418215,0.013883805,0.24367543,0.033907734,0.0003294856,0.022652207,0.0007396251],"about_ca_topic_score_codex":0.000047689886,"about_ca_topic_score_gemma":0.00003261107,"teacher_disagreement_score":0.2575134,"about_ca_system_score_codex":0.000041886222,"about_ca_system_score_gemma":0.0002683581,"threshold_uncertainty_score":0.3518764},"labels":[],"label_agreement":null},{"id":"W4389246726","doi":"10.1182/blood-2023-178399","title":"The Atpase Domain of LONP1 Is Necessary for Mitochondrial Protein Solubility and the Viability of Acute Myeloid Leukemia (AML) Cells","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Biology; Cell biology; Mitochondrion; Heat shock protein; Molecular biology; Biochemistry; Gene","score_opus":0.007756426125553914,"score_gpt":0.2330793988179783,"score_spread":0.22532297269242438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389246726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962783,0.0001614372,0.0009464671,0.00057808956,0.0003951106,0.001228246,0.0002375797,0.00001054703,0.00016421964],"genre_scores_gemma":[0.994251,0.0002759703,0.0022728548,0.00021712169,0.0005947925,0.0004226215,0.00011504964,0.000029609333,0.0018209721],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99880046,0.00022767323,0.00033819294,0.00031855993,0.00011215719,0.00020298614],"domain_scores_gemma":[0.9989575,0.00016219573,0.00016236214,0.00056301814,0.0001103696,0.000044556393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065179146,0.00012687546,0.00022437493,0.000018095314,0.00014917745,0.000011012075,0.00021930663,0.00016942451,0.000011531414],"category_scores_gemma":[0.00020324012,0.0000767947,0.0001789234,0.000109115674,0.00052328326,0.0000027625845,0.00015215811,0.000083914725,0.0000026571302],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015543882,0.00006029391,0.00028289828,0.00006404394,0.00013073203,7.036944e-7,0.00015065429,0.0000023411055,0.9947516,0.00023332896,0.0025436725,0.00022539895],"study_design_scores_gemma":[0.0043480084,0.00034616172,0.0003767079,0.0000062844197,0.000104464576,0.0000047466765,0.00010498979,0.000023333097,0.98239887,0.0022799927,0.009915439,0.00009103198],"about_ca_topic_score_codex":0.00003701296,"about_ca_topic_score_gemma":0.000039641767,"teacher_disagreement_score":0.012352705,"about_ca_system_score_codex":0.0000050565623,"about_ca_system_score_gemma":0.00011537793,"threshold_uncertainty_score":0.3131597},"labels":[],"label_agreement":null},{"id":"W4389246744","doi":"10.1182/blood-2023-174703","title":"Pooled Analysis of Safety from Birtamimab Phase 1-3 Studies in Patients with Light Chain (AL) Amyloidosis","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"AL amyloidosis; Medicine; Amyloidosis; Internal medicine; Phases of clinical research; Bortezomib; Gastroenterology; Clinical trial; Immunoglobulin light chain; Surgery; Immunology; Multiple myeloma; Antibody","score_opus":0.01181294448845732,"score_gpt":0.28221658429053115,"score_spread":0.2704036398020738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389246744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976933,0.0010942435,0.000012335061,0.0002770394,0.000064165215,0.00028407996,0.00048814804,0.000031310974,0.00005534936],"genre_scores_gemma":[0.9971589,0.0010558196,0.00018602797,0.00018922865,0.00003264697,0.00009420351,0.0011640082,0.00003195703,0.00008720857],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845284,0.00008956426,0.00039994516,0.00051991857,0.00024010299,0.00029762692],"domain_scores_gemma":[0.9990215,0.00007181547,0.00019941981,0.00052607834,0.00011328914,0.00006791814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012801224,0.00025851862,0.00058488734,0.00036000312,0.00005359395,0.00000913036,0.00019454009,0.000107614826,0.000023749171],"category_scores_gemma":[0.0001267645,0.00020691217,0.00020124367,0.0012147906,0.000080840306,0.0000062119125,0.00014955942,0.000060026683,0.000012532224],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030957098,0.002326065,0.96773463,0.000015345999,0.011836084,0.000014430077,0.0003459083,0.00009668128,0.016181596,0.0000060147777,0.00045925786,0.00067441707],"study_design_scores_gemma":[0.015128533,0.00086346944,0.8414794,0.000052507432,0.0047479146,1.7311582e-7,0.00047601122,0.000030122781,0.13605537,0.000009427837,0.00079977675,0.00035730464],"about_ca_topic_score_codex":0.00011928625,"about_ca_topic_score_gemma":0.00046506277,"teacher_disagreement_score":0.12625523,"about_ca_system_score_codex":0.000028418726,"about_ca_system_score_gemma":0.00003265736,"threshold_uncertainty_score":0.84376335},"labels":[],"label_agreement":null},{"id":"W4389246748","doi":"10.1182/blood-2023-174333","title":"Inactivation of DNA Polymerase Theta (PolΘ) Is Synthetic Lethal in DNMT3A Mutated Myeloid Malignancies - Potential Clinical Applications","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Biology; DNA repair; RAD51; Molecular biology; Homologous recombination; Cell cycle; Cancer research; DNA damage; Non-homologous end joining; DNA; Genetics; Gene","score_opus":0.02970187585995178,"score_gpt":0.334115540610714,"score_spread":0.30441366475076226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389246748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99458677,0.00012823615,0.00016908598,0.0029085209,0.00005116154,0.00079477014,0.00005898833,0.00012014752,0.0011823211],"genre_scores_gemma":[0.99776435,0.00018438943,0.00024145585,0.00016975537,0.00017492093,0.00015351431,0.00011939012,0.00003980976,0.0011524403],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99794006,0.00015104598,0.00064973155,0.00040280377,0.00046449195,0.00039188948],"domain_scores_gemma":[0.9987487,0.00026569952,0.00014672692,0.00054673664,0.00014677593,0.0001453258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006916317,0.00016024538,0.00041194053,0.00042714537,0.00006493013,0.000013314071,0.00020572208,0.00020105117,0.0001529366],"category_scores_gemma":[0.00033303953,0.00014532545,0.0001526062,0.0012245344,0.00024380053,0.00008220889,0.00012893607,0.00040570053,0.00023259701],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071427174,0.0035855626,0.035267726,0.0004324303,0.00051427283,0.0005908813,0.0011295887,0.000026989237,0.9327559,0.00090759265,0.0022371567,0.02183762],"study_design_scores_gemma":[0.0113447765,0.00064537034,0.22638424,0.00028807588,0.00042733114,0.0002670754,0.0010671421,0.0020979492,0.7547323,0.000627763,0.0017290438,0.00038894624],"about_ca_topic_score_codex":0.0002455698,"about_ca_topic_score_gemma":0.000008825007,"teacher_disagreement_score":0.19111651,"about_ca_system_score_codex":0.00007358495,"about_ca_system_score_gemma":0.00041750475,"threshold_uncertainty_score":0.59262},"labels":[],"label_agreement":null},{"id":"W4389246762","doi":"10.1182/blood-2023-186963","title":"Safety and Efficacy of Axatilimab at 3 Different Doses in Patients with Chronic Graft-Versus-Host Disease (AGAVE-201)","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Graft-versus-host disease; Medicine; Agave; Host (biology); Disease; Surgery; Internal medicine; Biology","score_opus":0.009685638422480403,"score_gpt":0.2368443523090944,"score_spread":0.227158713886614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389246762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99817085,0.0004960514,5.4351966e-7,0.000111931906,0.00007015869,0.0008017159,0.000096252224,0.000067833564,0.00018465481],"genre_scores_gemma":[0.9988976,0.00027847476,0.000020702906,0.000013958816,0.000043317763,0.000028453751,0.0003288343,0.000036325237,0.000352342],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998591,0.000036009325,0.0002879014,0.0003700857,0.00037722228,0.00033777865],"domain_scores_gemma":[0.9990067,0.00018333997,0.00011311785,0.00043094004,0.00003921887,0.00022667814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000045359226,0.00022966161,0.00039918156,0.00014335243,0.000051405237,0.000005902169,0.000072449766,0.000056856567,0.0001124265],"category_scores_gemma":[0.00011266544,0.00016425917,0.00006063353,0.00027749734,0.00010992841,0.00004716338,0.00013980594,0.00011151482,0.00004012106],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006163743,0.0018399241,0.989589,0.00027588732,0.00027840232,0.000085882646,0.00020678336,0.0000071078903,0.00019911102,0.000016681539,0.000048853442,0.0012886485],"study_design_scores_gemma":[0.084383704,0.0011426538,0.91250056,0.00032719807,0.00046907246,0.0000015863978,0.000015307682,0.000048296588,0.0008163754,0.0000029777814,0.00015687919,0.00013536098],"about_ca_topic_score_codex":0.000060410457,"about_ca_topic_score_gemma":0.0001947993,"teacher_disagreement_score":0.07821996,"about_ca_system_score_codex":0.00058709946,"about_ca_system_score_gemma":0.00017110948,"threshold_uncertainty_score":0.6698295},"labels":[],"label_agreement":null},{"id":"W4389246769","doi":"10.1182/blood-2023-182128","title":"Favezelimab in Combination with Pembrolizumab in Patients with Anti-PD-1-Naive Relapsed or Refractory Classical Hodgkin Lymphoma: Updated Analysis of an Open-Label Phase 1/2 Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Manitoba; CancerCare Manitoba; Jewish General Hospital","funders":"Genentech; Swedish Orphan Biovitrum; Astellas Pharma; Incyte; BeiGene; Regeneron Pharmaceuticals; Adaptive Biotechnologies; Karyopharm Therapeutics; Gilead Sciences; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb; Takeda Oncology; Amgen","keywords":"Pembrolizumab; Medicine; Internal medicine; Oncology; Refractory (planetary science); Cohort; Phases of clinical research; Chemotherapy regimen; Cancer; Chemotherapy; Immunotherapy","score_opus":0.025602268471923734,"score_gpt":0.31626125814749706,"score_spread":0.29065898967557335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389246769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977523,0.000014494318,0.0000012251965,0.00008053046,0.000021418831,0.0018554223,0.00007865398,0.00005489515,0.00014102533],"genre_scores_gemma":[0.9980905,0.000012368705,0.00015436043,0.000045035697,0.000006791618,0.00020333217,0.0013949837,0.00003757584,0.000055055792],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977658,0.00020835847,0.00052832736,0.0005875459,0.00059062015,0.00031934367],"domain_scores_gemma":[0.99876213,0.0001071631,0.00024510844,0.00055403664,0.00019253326,0.00013901664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024417954,0.0002695327,0.00093832845,0.0010092634,0.000052478088,0.000037454032,0.00019198665,0.000101201214,0.000036734375],"category_scores_gemma":[0.000059527058,0.00017548612,0.000034993496,0.0036231317,0.00006613813,0.00026861735,0.00009199686,0.00009593315,0.000008337213],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008834432,0.19377378,0.7900093,0.000018298462,0.001757091,0.0011099554,0.0008669735,0.000015790356,0.00006638616,0.000017035203,0.00003463654,0.0034963093],"study_design_scores_gemma":[0.26747712,0.021501005,0.70674396,0.00008978804,0.0024038646,0.0000034413213,0.00051266706,0.000773301,0.00032926953,0.0000024642259,0.0000086010305,0.00015451008],"about_ca_topic_score_codex":0.0005741203,"about_ca_topic_score_gemma":0.0011405858,"teacher_disagreement_score":0.2586427,"about_ca_system_score_codex":0.00025204377,"about_ca_system_score_gemma":0.0002974655,"threshold_uncertainty_score":0.71561164},"labels":[],"label_agreement":null},{"id":"W4389246785","doi":"10.1182/blood-2023-191338","title":"Global Burden and Trends of Multiple Myeloma in High-Income North America Countries between 1990-2019, with Projections of Deaths to 2040: A Benchmarking Analysis for the Global Burden of Disease Study 2019","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Disease burden; Incidence (geometry); Epidemiology; Confidence interval; Demography; Burden of disease; Global health; Years of potential life lost; Mortality rate; Public health; Disease; Gerontology; Environmental health; Population; Life expectancy; Surgery; Internal medicine; Pathology","score_opus":0.017176183056148625,"score_gpt":0.307566981431898,"score_spread":0.2903907983757493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389246785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944136,0.00019196876,0.00011153939,0.0003003467,0.000013599583,0.0014706951,0.0034466302,0.000022125882,0.000029454533],"genre_scores_gemma":[0.9987066,0.00004814178,0.0005495703,0.0000033049478,0.000087365814,0.00019252712,0.00032687673,0.000011036479,0.00007461035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983068,0.00006996797,0.00040340284,0.0003377901,0.0005506021,0.0003314533],"domain_scores_gemma":[0.99867594,0.0003350605,0.0001695302,0.0004156176,0.00019653911,0.00020732092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001768787,0.00018528388,0.0006645829,0.00040337598,0.00008601143,0.000013868755,0.00015628044,0.000034482,0.00001240759],"category_scores_gemma":[0.00015835963,0.00012122426,0.00013061309,0.003287119,0.00014278566,0.000050771036,0.0001275933,0.000054586726,0.0000015252389],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016158896,0.00047121377,0.9860071,0.00010970975,0.0036839682,0.000036662408,0.0006038431,0.00085836696,0.000006993645,0.000005698181,0.000028945824,0.0065716137],"study_design_scores_gemma":[0.0073702848,0.0022985102,0.98494244,0.00007403401,0.00336513,0.0000014203629,0.0008116302,0.00095154025,0.000016733684,0.000007170226,0.000063820866,0.000097295844],"about_ca_topic_score_codex":0.027516726,"about_ca_topic_score_gemma":0.009060035,"teacher_disagreement_score":0.018456692,"about_ca_system_score_codex":0.000073339295,"about_ca_system_score_gemma":0.00016422947,"threshold_uncertainty_score":0.97895914},"labels":[],"label_agreement":null},{"id":"W4389246798","doi":"10.1182/blood-2023-181396","title":"The Impact of Iron Deficiency Anemia on Cerebrovascular Physiology, Brain Structure, and Cognitive Function in Otherwise Healthy Women","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Anemia; Montreal Cognitive Assessment; Hemoglobin; Population; Internal medicine; Iron-deficiency anemia; Cognition; Physiology; Pathology; Gastroenterology; Psychiatry; Cognitive impairment","score_opus":0.008220420278340631,"score_gpt":0.269618205048236,"score_spread":0.2613977847698954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389246798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981581,0.0010238802,0.0000015289962,0.00014980485,0.000041289262,0.00028796797,0.000021384012,0.000021516575,0.00029453053],"genre_scores_gemma":[0.99940664,0.00021235747,0.000003595827,0.00024940076,0.000037588754,0.0000123959935,0.000022096992,0.0000120973755,0.000043809],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992533,0.00007801072,0.00013488714,0.00017103515,0.00011302224,0.00024978525],"domain_scores_gemma":[0.99958855,0.00013640248,0.00005151141,0.00014294205,0.00002301962,0.000057561498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021256208,0.000097212294,0.00017922618,0.00010377197,0.000058599104,0.000004569872,0.000034400808,0.00006282591,0.000036147554],"category_scores_gemma":[0.00015460118,0.000059426297,0.000045860004,0.00028530875,0.00009992736,0.000023092562,0.000016741373,0.00012056495,0.000007662664],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012619366,0.0037513373,0.61728173,0.0024581589,0.00030063614,0.000032147316,0.016682466,0.0004895626,0.22932279,0.0018997935,0.0035450456,0.11161697],"study_design_scores_gemma":[0.005288088,0.0011772381,0.99086386,0.000021870126,0.000059196223,0.0000042127194,0.0012077142,0.00001038171,0.00048644157,0.0007977447,0.000022612423,0.00006065877],"about_ca_topic_score_codex":0.00018543944,"about_ca_topic_score_gemma":0.000020908787,"teacher_disagreement_score":0.37358212,"about_ca_system_score_codex":0.000013472617,"about_ca_system_score_gemma":0.00007145288,"threshold_uncertainty_score":0.2423334},"labels":[],"label_agreement":null},{"id":"W4389246804","doi":"10.1182/blood-2023-182412","title":"Inflammatory Signatures Define a New High-Risk T-Lineage ALL Subtype","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Princess Margaret Cancer Centre; University of Guelph; University of Toronto; University Health Network","funders":"","keywords":"Immunophenotyping; Myeloid; Biology; Leukemia; Lineage (genetic); T cell; Immunology; Phenotype; Cancer; Cancer research; Medicine; Antigen; Genetics; Gene; Immune system","score_opus":0.016043733373762886,"score_gpt":0.26917254159480825,"score_spread":0.25312880822104533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389246804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959556,0.0004902,0.00007495625,0.0010778646,0.00017178222,0.0003679842,0.000025191952,0.0005412052,0.0012952102],"genre_scores_gemma":[0.9848199,0.0004183366,0.0016623228,0.0006304636,0.0011405125,0.000026945858,0.00017407171,0.00008760255,0.0110398745],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99816877,0.000059213642,0.00027191048,0.00035618947,0.00060118956,0.0005427567],"domain_scores_gemma":[0.9985807,0.00033456704,0.00007815916,0.000525539,0.000094000505,0.00038704133],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032913388,0.00019702036,0.0003029944,0.00025374585,0.00006575137,0.0000258974,0.0002079439,0.00021954486,0.00025854516],"category_scores_gemma":[0.0009236506,0.00016149304,0.00010340198,0.0005713167,0.000069600304,0.00005613483,0.00016905867,0.0004735908,0.0019667717],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011413138,0.0009913741,0.09077607,0.0005666318,0.0019677107,0.008090495,0.0012171431,0.00024425937,0.09826025,0.002420135,0.78681606,0.007508561],"study_design_scores_gemma":[0.073598385,0.00278029,0.57412845,0.00056170806,0.0028247498,0.0006219847,0.00024447113,0.004339001,0.16548404,0.0024005058,0.17158128,0.0014351099],"about_ca_topic_score_codex":0.0005039629,"about_ca_topic_score_gemma":0.00005887875,"teacher_disagreement_score":0.6152348,"about_ca_system_score_codex":0.00010505206,"about_ca_system_score_gemma":0.00090407423,"threshold_uncertainty_score":0.9988103},"labels":[],"label_agreement":null},{"id":"W4389246812","doi":"10.1182/blood-2023-173951","title":"Glofitamab Monotherapy in Relapsed or Refractory Large B-Cell Lymphoma: Extended Follow-Up from a Pivotal Phase II Study and Subgroup Analyses in Patients with Prior Chimeric Antigen Receptor T-Cell Therapy and by Baseline Total Metabolic Tumor Volume","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Internal medicine; Cytokine release syndrome; Oncology; Diffuse large B-cell lymphoma; Phases of clinical research; Lymphoma; Transplantation; Chimeric antigen receptor; Gastroenterology; Immunology; Cancer; Clinical trial; Immunotherapy","score_opus":0.020556797315697723,"score_gpt":0.2984440166044841,"score_spread":0.2778872192887864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389246812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905719,0.0061194496,0.0000037950633,0.000053552725,0.00008110221,0.0027265635,0.00030183312,0.00011064908,0.00003116015],"genre_scores_gemma":[0.9947625,0.0017284865,0.0002569603,0.000117406984,0.00008826177,0.00020326866,0.0003701616,0.00014512916,0.002327835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99627227,0.00046534755,0.00066723506,0.0010364995,0.00079313247,0.0007655104],"domain_scores_gemma":[0.99854845,0.00020738828,0.0002021254,0.0006207846,0.000110806286,0.00031044576],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006970965,0.00052332325,0.0011095476,0.00065332424,0.00015806199,0.00006192209,0.00018369028,0.00013807711,0.0006814797],"category_scores_gemma":[0.00008095767,0.00039522976,0.0001065871,0.0016296447,0.00010781545,0.00018391876,0.00011924957,0.00034759234,0.00001622237],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034994885,0.07613132,0.47472617,0.000047091595,0.00073808443,0.00038333802,0.0049730656,4.4940572e-7,0.36925757,1.8533736e-7,0.00037459037,0.038373247],"study_design_scores_gemma":[0.39344645,0.016295888,0.5675602,0.000071352944,0.00021789866,0.000007783371,0.0015403565,0.00055815704,0.01852095,0.0000024632457,0.0012038832,0.00057465973],"about_ca_topic_score_codex":0.0010927675,"about_ca_topic_score_gemma":0.00026560997,"teacher_disagreement_score":0.35845155,"about_ca_system_score_codex":0.00007190151,"about_ca_system_score_gemma":0.0002277697,"threshold_uncertainty_score":0.99985},"labels":[],"label_agreement":null},{"id":"W4389246822","doi":"10.1182/blood-2023-178584","title":"Consensus-Based Best Practice Recommendations for Myelofibrosis Management in Routine Clinical Practice with a Focus on Patients with Cytopenias: Systematic Literature Review and Clinical Practice Recommendations from a Global Consensus Group","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Myelofibrosis; Ruxolitinib; Myeloproliferative neoplasm; Clinical trial; Intensive care medicine; Clinical Practice; Family medicine; Internal medicine; Bone marrow","score_opus":0.039101100771556596,"score_gpt":0.3866391842533437,"score_spread":0.3475380834817871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389246822","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12166423,0.019406691,0.00053857703,0.7940549,0.00083558704,0.04809738,0.005340652,0.0005279922,0.009533969],"genre_scores_gemma":[0.19718748,0.05733851,0.6815506,0.048243757,0.0004128336,0.0083413925,0.0063986494,0.00023469653,0.00029207164],"study_design_codex":"observational","study_design_gemma":"systematic_review","domain_scores_codex":[0.9941959,0.0018594544,0.0018396993,0.001078753,0.0005826468,0.00044358536],"domain_scores_gemma":[0.9776224,0.018821351,0.00130999,0.00076421665,0.0011439411,0.00033809984],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002642342,0.0005014488,0.001382208,0.00015685051,0.00024455637,0.00016622515,0.00012505482,0.00020834195,0.000022056518],"category_scores_gemma":[0.012532963,0.00035134255,0.0001679497,0.0011005775,0.0001213682,0.00025859228,0.00008341034,0.0005364739,0.00006359493],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05575816,0.2021707,0.47392717,0.0665024,0.038907506,0.007857283,0.0015131406,0.00001892557,0.0000016748613,0.011864665,0.10514438,0.036333993],"study_design_scores_gemma":[0.19824345,0.057254035,0.15013191,0.3219976,0.11893418,0.001438784,0.008282429,0.000470823,0.000022772372,0.00020704906,0.14051722,0.0024997306],"about_ca_topic_score_codex":0.00009412327,"about_ca_topic_score_gemma":0.0002391613,"teacher_disagreement_score":0.74581116,"about_ca_system_score_codex":0.00016931545,"about_ca_system_score_gemma":0.00022198397,"threshold_uncertainty_score":0.99989384},"labels":[],"label_agreement":null},{"id":"W4389246839","doi":"10.1182/blood-2023-190015","title":"Patient-Reported Outcomes: Danicopan As Add-on Therapy to Ravulizumab or Eculizumab Versus Placebo in Patients with Paroxysmal Nocturnal Hemoglobinuria and Clinically Significant Extravascular Hemolysis","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Medicine; Eculizumab; Internal medicine; Placebo; Anemia; Clinical trial; Hemolysis; Gastroenterology; Pediatrics; Surgery; Immunology; Complement system; Antibody","score_opus":0.022360225811429362,"score_gpt":0.2780826313466097,"score_spread":0.25572240553518033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389246839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970031,0.0001334773,0.0000037293776,0.00011557743,0.0004652239,0.0018264762,0.00009823395,0.00016500166,0.00018922932],"genre_scores_gemma":[0.9989144,0.00002574667,0.000062974534,0.00023038987,0.0000205759,0.00022491338,0.00025894557,0.000049466118,0.00021257516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996931,0.0004250536,0.0009450061,0.00081834325,0.00023611756,0.0006444527],"domain_scores_gemma":[0.99814785,0.0005683908,0.00030925084,0.00073120004,0.00010975338,0.00013355119],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003321544,0.00043033573,0.00069663435,0.000278949,0.0001678058,0.000047277354,0.00030329582,0.00018814538,0.0007572242],"category_scores_gemma":[0.00043600053,0.00030134682,0.00015552156,0.00049902475,0.00010735213,0.000073680465,0.0001531226,0.00025882004,0.00038833712],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.061351977,0.003791596,0.9169511,0.000051789542,0.0030284412,0.0004487634,0.0012540433,0.00006302887,0.00269988,0.000032483793,0.001970265,0.008356625],"study_design_scores_gemma":[0.11750509,0.010922419,0.8625859,0.00019613789,0.00039008513,0.0000280882,0.0009908627,0.000003164934,0.0037121035,0.000018931009,0.002861943,0.0007852976],"about_ca_topic_score_codex":0.00012247264,"about_ca_topic_score_gemma":0.00007284153,"teacher_disagreement_score":0.05615311,"about_ca_system_score_codex":0.000067572204,"about_ca_system_score_gemma":0.00019019486,"threshold_uncertainty_score":0.99994385},"labels":[],"label_agreement":null},{"id":"W4389246847","doi":"10.1182/blood-2023-182027","title":"Preliminary Results from a Phase 1b/2 Open-Label, Multicenter, Dose Optimization Clinical Study of the Safety, Tolerability, and Pharmacokinetic (PK) and Pharmacodynamic (PD) Profiles of Cfi-400945 As a Single Agent or in Combination with Azacitidine in Patients (Pts) with Acute Myeloid Leukemia, Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia (TWT-202)","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Tolerability; Pharmacodynamics; Pharmacokinetics; Internal medicine; Oncology; Pharmacology; Azacitidine; Adverse effect; Neutropenia; Toxicity; Biology","score_opus":0.04174852668020341,"score_gpt":0.3510632918681256,"score_spread":0.3093147651879222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389246847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903573,0.000091452566,0.000034267,0.00017144131,0.00008643353,0.008725537,0.00044405131,0.000054378084,0.000035168094],"genre_scores_gemma":[0.99719584,0.00060810463,0.0008895079,0.000046077632,0.000028739896,0.000376001,0.0005473094,0.00009306549,0.00021535542],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9947802,0.0007565653,0.0018042492,0.0011296197,0.0009420084,0.00058737013],"domain_scores_gemma":[0.9968211,0.0011583773,0.00071443303,0.0006982694,0.00034865993,0.00025918172],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010835769,0.00050743244,0.0012330853,0.000524832,0.00012185013,0.000058994683,0.00053957466,0.00018696638,0.000038152073],"category_scores_gemma":[0.000666483,0.0003255458,0.00003697154,0.0020680977,0.00048243112,0.00039243855,0.0009435139,0.0007513966,0.000003271111],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.58099484,0.1328499,0.19909653,0.0033422054,0.003887451,0.0064544235,0.010713552,0.01763336,0.013687772,0.000004606356,0.00015014132,0.031185174],"study_design_scores_gemma":[0.45708618,0.06762051,0.26146913,0.0025361534,0.0016650589,0.00022064488,0.00086459686,0.20595,0.0021282833,0.0000064410983,0.000006467116,0.00044654222],"about_ca_topic_score_codex":0.0011850502,"about_ca_topic_score_gemma":0.00070039753,"teacher_disagreement_score":0.18831664,"about_ca_system_score_codex":0.001445913,"about_ca_system_score_gemma":0.0021722096,"threshold_uncertainty_score":0.99991965},"labels":[],"label_agreement":null},{"id":"W4389246864","doi":"10.1182/blood-2023-190534","title":"Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; SickKids Foundation; Hospital for Sick Children; BC Children's Hospital; University of Toronto","funders":"","keywords":"Medicine; Thalassemia; Fetal hemoglobin; Clinical endpoint; Internal medicine; Blood transfusion; Pediatrics; Gastroenterology; Surgery; Clinical trial; Biology; Fetus","score_opus":0.01440544004097374,"score_gpt":0.25856402994617456,"score_spread":0.2441585899052008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389246864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98990935,0.00058167276,0.00023757544,0.0021022055,0.00031572825,0.0007133517,0.00002737421,0.00035952384,0.005753196],"genre_scores_gemma":[0.99042606,0.0010875344,0.00042681297,0.0003127698,0.00017846441,0.000106287276,0.0000919537,0.000047672096,0.00732247],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99902284,0.000012761065,0.00020007808,0.0002470656,0.00019206514,0.0003252074],"domain_scores_gemma":[0.99951214,0.000054111166,0.00002712633,0.0002190804,0.000048424292,0.00013914988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017474091,0.00012314742,0.00020782874,0.000104835795,0.00010197443,0.000009961797,0.00006746617,0.00017976621,0.00011478451],"category_scores_gemma":[0.000062357794,0.000099626464,0.00014902452,0.00027653197,0.00002617407,0.000022391794,0.000019003544,0.00013214083,0.00022193253],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005821213,0.004033226,0.03419791,0.0014415683,0.001417524,0.0011759294,0.0026654182,0.00016970823,0.8459238,0.0013554107,0.04354206,0.06349531],"study_design_scores_gemma":[0.10370583,0.0054291734,0.1146256,0.0012241527,0.005482973,0.0017449151,0.0060348837,0.004894333,0.48742256,0.0037070166,0.26337054,0.002358011],"about_ca_topic_score_codex":0.000019584684,"about_ca_topic_score_gemma":0.0000062122735,"teacher_disagreement_score":0.35850126,"about_ca_system_score_codex":0.000014460785,"about_ca_system_score_gemma":0.000092724185,"threshold_uncertainty_score":0.40626493},"labels":[],"label_agreement":null},{"id":"W4389246877","doi":"10.1182/blood-2023-183005","title":"<i>Prospective Symptom Burden Analysis in 784 Patients with Myeloproliferative Neoplasms: High Burden Correlates with Inflammatory/Genetic Biomarkers and Reduced Survival</i>","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Charles-Le Moyne; Université de Sherbrooke; Cegep de Saint Jerome; Université de Montréal; Université Laval; Jewish General Hospital; MPB Technologies & Communications (Canada); Hôpital du Sacré-Cœur de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Internal medicine; Thrombocytosis; Myelofibrosis; Prospective cohort study; Cohort; Population; Pediatrics; Bone marrow","score_opus":0.004731582304750719,"score_gpt":0.21062074301826408,"score_spread":0.20588916071351338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389246877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99676275,0.0002265304,0.0000066602233,0.0004780912,0.00005556445,0.0017326521,0.00007678045,0.00015441519,0.00050653255],"genre_scores_gemma":[0.99794155,0.00026741726,0.000540928,0.000050159528,0.00009421688,0.00053491077,0.00028155753,0.00007077184,0.00021845738],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997241,0.00013748283,0.00048107016,0.0009298225,0.0006492083,0.00056140445],"domain_scores_gemma":[0.9983848,0.00031432812,0.0002109354,0.0004462568,0.00034910336,0.00029462893],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017642336,0.00053062267,0.0009646406,0.00072713644,0.0001758401,0.000081265236,0.00010509165,0.00016258111,0.000064491134],"category_scores_gemma":[0.00008503891,0.0003678353,0.00009718039,0.00242363,0.00020830406,0.00013870833,0.00008018334,0.00024822546,0.00004300448],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009501955,0.00050148106,0.98808074,0.00005981693,0.0064687487,0.00039339674,0.002386005,0.00047366446,0.00020251471,0.000104912586,0.000046033958,0.0003325095],"study_design_scores_gemma":[0.016153611,0.0017157038,0.9750581,0.00027671567,0.0032822909,0.000020885942,0.00077669456,0.00036505502,0.0018346851,0.000057623376,0.000026263706,0.00043237922],"about_ca_topic_score_codex":0.0004624259,"about_ca_topic_score_gemma":0.0007838327,"teacher_disagreement_score":0.015203415,"about_ca_system_score_codex":0.00012496789,"about_ca_system_score_gemma":0.00019887008,"threshold_uncertainty_score":0.99987733},"labels":[],"label_agreement":null},{"id":"W4389246885","doi":"10.1182/blood-2023-185110","title":"Clinical Characteristics, Management, and Allogeneic Hematopoietic Cell Transplantation of Patients with Toll-like Receptor 8 Gain-of-Function Mutations","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Immunology; Medicine; Neutropenia; Transplantation; Congenital Neutropenia; Hypogammaglobulinemia; Bone marrow; Myeloid; Hematopoietic stem cell transplantation; Biology; Internal medicine; Antibody; Chemotherapy","score_opus":0.007403220824039343,"score_gpt":0.23034265005805687,"score_spread":0.22293942923401752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389246885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989326,0.00010007552,0.00039205304,0.0000064020896,0.00006383268,0.0002005326,0.00011100804,0.000007703356,0.00018578126],"genre_scores_gemma":[0.9972577,0.00058162346,0.00052108185,0.000018393845,0.000013501855,0.000017400655,0.0014277464,0.000011807313,0.00015074684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99942726,0.000026709517,0.00020424886,0.00017829011,0.0000766037,0.00008691848],"domain_scores_gemma":[0.99968386,0.0000100565785,0.00010616998,0.00012312966,0.00004556034,0.00003122153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000050224633,0.00007973349,0.00011544821,0.000037060454,0.00002941592,0.0000038792537,0.000038771184,0.000059240032,0.0000063289967],"category_scores_gemma":[0.000003724261,0.00006983543,0.000037565467,0.000075807984,0.000048035705,0.00000286827,0.000016508733,0.000022022356,0.000004259051],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020550714,0.001168566,0.9905583,0.00024025462,0.000324202,0.0000033210902,0.000064856,0.000004909877,0.00405053,0.000027741879,0.00010945113,0.0032423555],"study_design_scores_gemma":[0.0059948545,0.0011052514,0.9613134,0.000034309378,0.00068900874,0.0000013856775,0.000098790566,0.000002772016,0.030103762,0.000052279265,0.00045802112,0.00014614542],"about_ca_topic_score_codex":0.0000023739058,"about_ca_topic_score_gemma":0.0000042601796,"teacher_disagreement_score":0.029244885,"about_ca_system_score_codex":8.2389636e-7,"about_ca_system_score_gemma":0.000010347174,"threshold_uncertainty_score":0.28478062},"labels":[],"label_agreement":null},{"id":"W4389246921","doi":"10.1182/blood-2023-180151","title":"Evaluation of Bone Health Using High Resolution Peripheral Quantitative Computed Tomography in Survivors of Paediatric Acute Lymphoblastic Leukemia","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Quantitative computed tomography; Medicine; Bone mineral; Bone density; Lean body mass; Trabecular bone score; Nuclear medicine; Radiology; Internal medicine; Osteoporosis; Body weight","score_opus":0.06936280400382448,"score_gpt":0.36248706528399804,"score_spread":0.29312426128017355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389246921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967645,0.0015062778,0.0006199344,0.00029493278,0.0001777072,0.0005227243,0.000031440304,0.00004822516,0.00003424962],"genre_scores_gemma":[0.9918721,0.0002160164,0.007666028,0.00007816248,0.000052926458,0.00001199012,0.00008586407,0.000014055122,0.0000028850939],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980098,0.00034542955,0.00059933425,0.00018134213,0.0006245477,0.00023955197],"domain_scores_gemma":[0.9989967,0.000111717956,0.0002920327,0.00013287694,0.00038254002,0.000084164465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020610131,0.000093584706,0.000419157,0.0008238001,0.000052367115,0.000003099898,0.000034013894,0.00006476343,0.000015347046],"category_scores_gemma":[0.0001230756,0.00009719897,0.00006917951,0.0019474125,0.000053539876,0.000050167055,0.000020564894,0.0001039093,0.0000020037494],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002735797,0.006580908,0.79977775,0.013281141,0.001448435,0.00016117474,0.018555587,0.039147552,0.09040912,0.00822722,0.0015206384,0.018154696],"study_design_scores_gemma":[0.01357935,0.0009006844,0.7369186,0.001006551,0.0004983494,0.00002386721,0.00068533485,0.24415031,0.0012451626,0.0008505545,0.000009870189,0.00013136749],"about_ca_topic_score_codex":0.0014868841,"about_ca_topic_score_gemma":0.00022622859,"teacher_disagreement_score":0.20500275,"about_ca_system_score_codex":0.0003001472,"about_ca_system_score_gemma":0.0008328603,"threshold_uncertainty_score":0.3963659},"labels":[],"label_agreement":null},{"id":"W4389246922","doi":"10.1182/blood-2023-182449","title":"Quality of Life in Childhood Immune Thrombocytopenia: Revision of the Kids' ITP Tools (KIT)","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"","keywords":"Immune thrombocytopenia; Medicine; Quality of life (healthcare); Pediatrics; Family medicine; Nursing; Immunology","score_opus":0.038612421930202194,"score_gpt":0.3072146374003306,"score_spread":0.2686022154701284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389246922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99517685,0.0011940704,2.5154142e-7,0.0009624667,0.00005070699,0.0005250948,0.00002199158,0.000020763207,0.0020477965],"genre_scores_gemma":[0.999207,0.0004437822,0.000058768306,0.00011090144,0.000032568445,0.00001444312,0.000018136023,0.000010353931,0.00010404514],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878806,0.0000891861,0.0005208686,0.00016153842,0.00028300018,0.00015735268],"domain_scores_gemma":[0.9990467,0.00017686583,0.00017029303,0.00050818047,0.00005084899,0.00004715599],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041421686,0.00009770689,0.00055765297,0.000053825923,0.00002847861,0.0000056911567,0.00012089883,0.00006268446,0.00006711977],"category_scores_gemma":[0.0005634269,0.00005998762,0.00017980511,0.00040151464,0.000045685272,0.000044198798,0.00013151219,0.00006670402,0.00003427659],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006606504,0.0041700257,0.9796463,0.00031439602,0.00025327076,0.000023374861,0.00091303734,0.0000026316732,0.007107748,0.0016405648,0.00050802104,0.0053545525],"study_design_scores_gemma":[0.006579877,0.00015462707,0.9487467,0.00035652984,0.00010293538,0.0000036893036,0.00018401377,0.0000010442672,0.04351753,0.00007654418,0.00022274759,0.000053773423],"about_ca_topic_score_codex":0.0003831789,"about_ca_topic_score_gemma":0.00001584834,"teacher_disagreement_score":0.03640978,"about_ca_system_score_codex":0.000024563667,"about_ca_system_score_gemma":0.00014007076,"threshold_uncertainty_score":0.24462241},"labels":[],"label_agreement":null},{"id":"W4389246923","doi":"10.1182/blood-2023-187145","title":"Clinical, Cytogenetic and Immunophenotypic Spectra of Post-Transplant Relapse Following Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Transplantation; Oncology; Hematopoietic stem cell transplantation; Population; Myelodysplastic syndromes; Bone marrow","score_opus":0.021733529518776756,"score_gpt":0.292949073751989,"score_spread":0.2712155442332122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389246923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99630827,0.0013125213,0.00046691747,0.00013942763,0.00021930932,0.0011924405,0.0001260566,0.00011767175,0.00011741506],"genre_scores_gemma":[0.9957476,0.0018313571,0.0015474558,0.00005652696,0.00006915446,0.0000894435,0.00018662318,0.00007684511,0.0003949875],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99772894,0.000106273335,0.0007638386,0.000500626,0.00038467054,0.0005156517],"domain_scores_gemma":[0.9982762,0.00085127633,0.00012592733,0.00040224753,0.00012858906,0.00021576093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007282689,0.0002469862,0.00065682805,0.00028476169,0.00011060161,0.00001789476,0.00017750435,0.00021755954,0.00001829059],"category_scores_gemma":[0.00007180176,0.00022592071,0.00029778303,0.00042222504,0.00011677678,0.000060182432,0.000032592867,0.0002848617,0.00005741719],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033764106,0.0016381583,0.15933013,0.011359367,0.0021021212,0.0045709144,0.0051008267,0.00007097421,0.8095053,0.00024335596,0.00014063429,0.0025618423],"study_design_scores_gemma":[0.034862533,0.0072134407,0.78985935,0.0017703348,0.00658195,0.0026571394,0.0011880279,0.00033388342,0.1541931,0.00030327198,0.0001622365,0.0008747176],"about_ca_topic_score_codex":0.00001856971,"about_ca_topic_score_gemma":0.000007719136,"teacher_disagreement_score":0.6553122,"about_ca_system_score_codex":0.000034555404,"about_ca_system_score_gemma":0.00028239118,"threshold_uncertainty_score":0.92127794},"labels":[],"label_agreement":null},{"id":"W4389246942","doi":"10.1182/blood-2023-182119","title":"Open-Label, Randomized, Phase 3 Study of Coformulated Favezelimab and Pembrolizumab Versus Chemotherapy in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma Refractory to Anti-PD-1 Therapy: Keyform-008","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Oncology; Refractory (planetary science); Chemotherapy regimen; Neutropenia; Chemotherapy; Phases of clinical research; Immunotherapy; Cancer; Biology","score_opus":0.03583989734029489,"score_gpt":0.32327395640727447,"score_spread":0.28743405906697955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389246942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938389,0.00019417722,6.1478187e-7,0.00021163144,0.000113273614,0.0052200803,0.00004194637,0.00009292646,0.00028645043],"genre_scores_gemma":[0.9981541,0.0006868978,0.00012451169,0.00021597948,0.000035183464,0.0004310794,0.00012480604,0.00007987158,0.00014757036],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99733144,0.00021410856,0.00071683334,0.0006542721,0.00061347784,0.0004698902],"domain_scores_gemma":[0.9981724,0.000495278,0.00027362467,0.0006262689,0.00016674111,0.00026566026],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004275113,0.00042650514,0.001471777,0.00038452365,0.00010302179,0.000054508495,0.00023534441,0.00016895236,0.00005946269],"category_scores_gemma":[0.00016643255,0.00026482632,0.000068379406,0.00081389165,0.0001123733,0.00021067579,0.0001447325,0.00012668237,0.000020845471],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7756444,0.10390031,0.08091195,0.000048933805,0.0018840869,0.00043674125,0.0027431834,0.0000014881376,0.0004728026,0.000011501866,0.00036099175,0.033583585],"study_design_scores_gemma":[0.70428103,0.027797628,0.26546046,0.00014925127,0.00033434897,0.000006853674,0.00028817696,0.000037298734,0.0009402441,0.0000027539622,0.00047025707,0.00023167806],"about_ca_topic_score_codex":0.0002694063,"about_ca_topic_score_gemma":0.000064721666,"teacher_disagreement_score":0.18454851,"about_ca_system_score_codex":0.00018978848,"about_ca_system_score_gemma":0.00029614838,"threshold_uncertainty_score":0.9999804},"labels":[],"label_agreement":null},{"id":"W4389246947","doi":"10.1182/blood-2023-185025","title":"Incidence and Risk Factors of Veno-Occlusive Disease Are Different in Younger Versus Older Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Gemtuzumab ozogamicin; Transplantation; Univariate analysis; Cumulative incidence; Internal medicine; Defibrotide; Hematopoietic stem cell transplantation; Hepatic veno-occlusive disease; Incidence (geometry); Surgery; Fludarabine; Cyclophosphamide; Multivariate analysis; Chemotherapy; Stem cell; CD34; CD33","score_opus":0.013462194326707309,"score_gpt":0.24147512759719095,"score_spread":0.22801293327048364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389246947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99847144,0.0004555274,0.000098328055,0.00004059263,0.00011965765,0.0006054083,0.00009959855,0.00006304052,0.000046398312],"genre_scores_gemma":[0.99743396,0.0023052292,0.000032207885,0.000009118917,0.000018931722,0.000032192085,0.0001130108,0.000030385294,0.00002498758],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985761,0.00008998375,0.00038070677,0.00034530938,0.0003576766,0.00025020912],"domain_scores_gemma":[0.9988935,0.00049643347,0.00017411783,0.00021245009,0.00004665367,0.00017684944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000109935776,0.00020418782,0.00034516666,0.00021363505,0.000049692517,0.00000961633,0.000067359004,0.00009277125,0.000016889384],"category_scores_gemma":[0.000026921733,0.00018096365,0.00007361172,0.00027621925,0.000047491918,0.00008405264,0.000017913593,0.00013659199,0.000010835102],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088110426,0.000455802,0.97766805,0.0049115196,0.000087948065,0.00046759573,0.011245158,0.000067047484,0.0040955716,0.000025296562,0.0000025732663,0.00009231591],"study_design_scores_gemma":[0.008875772,0.00015780353,0.94203025,0.0019598007,0.0007985718,0.000018066157,0.0036768946,0.000114534014,0.042172268,0.00002812319,3.158442e-7,0.00016762636],"about_ca_topic_score_codex":0.00006806409,"about_ca_topic_score_gemma":0.00014774302,"teacher_disagreement_score":0.038076695,"about_ca_system_score_codex":0.000034970268,"about_ca_system_score_gemma":0.000068661095,"threshold_uncertainty_score":0.73794836},"labels":[],"label_agreement":null},{"id":"W4389246982","doi":"10.1182/blood-2023-185813","title":"The Roles of Immune Cells Derived from Clonal Hematopoiesis in Colorectal Cancer Metastasis","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"Chugai Pharmaceutical; Eisai","keywords":"Immune system; Colorectal cancer; Myeloid; Biology; Haematopoiesis; Cancer research; Cancer; CD8; Metastasis; CD19; Immunology; Stem cell; Pathology; Medicine","score_opus":0.009766436465848322,"score_gpt":0.23591050553369255,"score_spread":0.22614406906784423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389246982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96828955,0.029983485,0.0000018100212,0.00021357677,0.000879742,0.00016939362,0.00018708839,0.000047995258,0.00022733073],"genre_scores_gemma":[0.9971087,0.0021800415,0.000047531204,0.00002378754,0.00002258492,0.000112789254,0.00006024498,0.000021122314,0.00042321844],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987734,0.00018793387,0.0004090332,0.00022053282,0.000049956565,0.00035915172],"domain_scores_gemma":[0.998969,0.0005650049,0.00015811881,0.00025209942,0.000046852092,0.0000089269615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029174847,0.00015037853,0.00033612855,0.00008111308,0.00013492114,0.000009343935,0.0003773407,0.00015961433,0.0005537845],"category_scores_gemma":[0.000049400118,0.00011392159,0.00013156688,0.0003105441,0.00029748038,0.000036054655,0.00018505011,0.0002248021,0.000258796],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012363124,0.000120095145,0.002586052,0.000011678136,0.0005378252,0.000006574781,0.0008876618,0.000021157608,0.9931811,0.000057758232,0.000708363,0.0017580859],"study_design_scores_gemma":[0.0016493992,0.000036188354,0.028391967,0.00003972572,0.00011059132,0.000003371182,0.00077267096,0.000002233939,0.96570164,0.00016102938,0.0030111698,0.000119993354],"about_ca_topic_score_codex":0.001035433,"about_ca_topic_score_gemma":0.0012545066,"teacher_disagreement_score":0.0288191,"about_ca_system_score_codex":0.00002625376,"about_ca_system_score_gemma":0.00009769453,"threshold_uncertainty_score":0.6063552},"labels":[],"label_agreement":null},{"id":"W4389246989","doi":"10.1182/blood-2023-178933","title":"Idecabtagene Vicleucel (ide-cel) Versus Standard (std) Regimens in Patients (pts) with Triple-Class-Exposed (TCE) Relapsed and Refractory Multiple Myeloma (RRMM): Updated Analysis from KarMMa-3","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Calgary","funders":"","keywords":"Daratumumab; Medicine; Lenalidomide; Internal medicine; Regimen; Interim analysis; Clinical endpoint; Oncology; Progression-free survival; Population; Multiple myeloma; Neutropenia; Clinical trial; Chemotherapy","score_opus":0.020853644306228745,"score_gpt":0.2679152240224768,"score_spread":0.24706157971624806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389246989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99678516,0.00024296627,0.000012279099,0.00021482009,0.00010716601,0.0011821584,0.00062073115,0.0002590189,0.00057571975],"genre_scores_gemma":[0.9942927,0.00018002912,0.0009600923,0.00006362063,0.00006337003,0.00009631961,0.0034614168,0.000087065455,0.0007954205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99610716,0.00023582367,0.0006336318,0.0009987027,0.001157008,0.00086766534],"domain_scores_gemma":[0.9975021,0.0004652486,0.00022268998,0.0009098304,0.0002738983,0.0006262479],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035395892,0.00046650576,0.0009733374,0.0010318424,0.00018189508,0.00007054945,0.00019721687,0.00024121227,0.00024762098],"category_scores_gemma":[0.000543047,0.00038191024,0.00018801684,0.002470158,0.00014396495,0.0002150704,0.0001562254,0.00043022592,0.00013710839],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025276426,0.00202216,0.95345455,0.000042754396,0.005166941,0.0014364679,0.00055625295,0.000014488285,0.006507204,0.000003461512,0.00097652077,0.0045427503],"study_design_scores_gemma":[0.12745303,0.0035322527,0.851451,0.00009553281,0.0018465107,0.000002650399,0.00029081348,0.0007594134,0.01288841,0.000010544699,0.001289629,0.0003802343],"about_ca_topic_score_codex":0.00082267245,"about_ca_topic_score_gemma":0.0021098629,"teacher_disagreement_score":0.1021766,"about_ca_system_score_codex":0.0002857882,"about_ca_system_score_gemma":0.00023978352,"threshold_uncertainty_score":0.99986327},"labels":[],"label_agreement":null},{"id":"W4389247022","doi":"10.1182/blood-2023-173878","title":"Novel Multidimensional Pain Assessment Tool Is a Feasible, Valid, and Enjoyable Approach to Communication of Pain Symptoms in Pediatric Sickle Cell Disease","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pain assessment; Population; Physical therapy; Medicine; Rating scale; Disease; Pain scale; Visual analogue scale; Cognition; Physical medicine and rehabilitation; Psychology; Pain management; Developmental psychology; Psychiatry; Pathology","score_opus":0.013198595255044781,"score_gpt":0.25528660921197077,"score_spread":0.242088013956926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389247022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99532413,0.0008947887,0.00070983305,0.0010452883,0.000019459176,0.00077649514,0.000030155794,0.00005473195,0.001145119],"genre_scores_gemma":[0.99016917,0.0005781005,0.007956791,0.0005734641,0.000022337917,0.00008294646,0.000120067336,0.00002366544,0.00047347625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987675,0.00017203335,0.00029876537,0.00025244465,0.00027515405,0.0002341362],"domain_scores_gemma":[0.9991083,0.00023261002,0.00006867307,0.0003551824,0.000058019366,0.00017720264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013539502,0.0001319299,0.00023378008,0.00022983993,0.000059425278,0.000009098125,0.00008025901,0.00009264783,0.000016163925],"category_scores_gemma":[0.00018280454,0.00011637748,0.0000580651,0.0006881656,0.000031341937,0.000039021597,0.00011116997,0.00017666905,0.000009142899],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026953034,0.014244315,0.9496282,0.0026872302,0.00015501873,0.000046317866,0.0033370783,0.0017834352,0.013869025,0.00067903963,0.0090987235,0.0042020977],"study_design_scores_gemma":[0.026761116,0.0010396191,0.8638191,0.00061905413,0.0010618173,0.000017407163,0.0029957637,0.099083565,0.0014528458,0.00026113662,0.0020353952,0.000853159],"about_ca_topic_score_codex":0.00011694811,"about_ca_topic_score_gemma":0.000003209346,"teacher_disagreement_score":0.09730013,"about_ca_system_score_codex":0.000025036972,"about_ca_system_score_gemma":0.0001607115,"threshold_uncertainty_score":0.47457358},"labels":[],"label_agreement":null},{"id":"W4389247030","doi":"10.1182/blood-2023-182671","title":"Risk Factors of Venous Thromboembolism in Lymphoma Patients: A Meta-Analysis","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Meta-analysis; Odds ratio; Confidence interval; Publication bias; Cochrane Library; Lymphoma; Funnel plot; Surgery","score_opus":0.03485901666939704,"score_gpt":0.2756422790333262,"score_spread":0.2407832623639292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389247030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972806,0.0003672905,0.0000067798455,0.00009463037,0.00006785031,0.00049383315,0.000093807386,0.0000879627,0.001507255],"genre_scores_gemma":[0.99907774,0.0003669095,0.00009577594,0.000105323554,0.000023775732,0.00006806089,0.00012865788,0.000027671475,0.00010609884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982716,0.000084484076,0.000497193,0.00035446393,0.00044845708,0.00034378935],"domain_scores_gemma":[0.99894565,0.000109312,0.00021661894,0.00053519564,0.00009138255,0.000101835234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003125752,0.00020615333,0.0019197986,0.0007913544,0.00004821488,0.000011530117,0.0001436937,0.00008608678,0.0003202533],"category_scores_gemma":[0.00014334808,0.00015781306,0.00097427756,0.001995409,0.00004515438,0.000058377842,0.000104144,0.000078463476,0.00006703998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021191361,0.0195588,0.6905342,0.00018400954,0.28256488,0.00008387417,0.003622832,0.00039949865,0.00009017613,0.00048716002,0.0012629683,0.001190437],"study_design_scores_gemma":[0.001579088,0.00028133232,0.7805075,0.000005429016,0.21614884,2.7232366e-7,0.00023109753,0.00003142113,0.00072680076,0.00012756801,0.00024878548,0.00011186409],"about_ca_topic_score_codex":0.0017968594,"about_ca_topic_score_gemma":0.0001887846,"teacher_disagreement_score":0.08997332,"about_ca_system_score_codex":0.00002970162,"about_ca_system_score_gemma":0.000035694506,"threshold_uncertainty_score":0.643543},"labels":[],"label_agreement":null},{"id":"W4389247110","doi":"10.1182/blood-2023-188204","title":"Retrospective, Multi-Center Analysis of Ruxolitinib Tapering after Successful Treatment of Steroid Refractory Chronic Graft Versus Host Disease","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan; Université Laval; Princess Margaret Cancer Centre; University of Toronto; University Health Network; University of Calgary","funders":"","keywords":"Medicine; Tapering; Ruxolitinib; Refractory (planetary science); Internal medicine; Graft-versus-host disease; Surgery; Transplantation; Myelofibrosis; Bone marrow","score_opus":0.023250787093055256,"score_gpt":0.296379348698426,"score_spread":0.27312856160537075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389247110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99689907,0.0015626926,0.0000043234413,0.000045234123,0.00014467494,0.00047903176,0.0005439839,0.000093042996,0.0002279439],"genre_scores_gemma":[0.9978348,0.00077611895,0.00010579406,0.00000940338,0.00011136482,0.0001386023,0.0003604354,0.00004607975,0.0006174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816775,0.00004846528,0.00047166203,0.0004937883,0.00041056468,0.00040776536],"domain_scores_gemma":[0.99855155,0.000073646974,0.00020753813,0.0008070049,0.0001107998,0.0002494414],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000064377055,0.00029071228,0.0007911962,0.0005189798,0.000035992674,0.000008751382,0.00010337795,0.000085279906,0.000392187],"category_scores_gemma":[0.000063340965,0.00024621113,0.0005171075,0.00096201623,0.000114584735,0.00008259739,0.00007048302,0.00008592747,0.000044314853],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014575644,0.0050149667,0.97952205,0.00022872207,0.0075835325,0.00046001046,0.00047821278,0.000017189033,0.004727537,0.0000048688744,0.000010444946,0.00049487496],"study_design_scores_gemma":[0.036409684,0.001417103,0.946814,0.00014405005,0.008659581,0.0000025067327,0.00010470843,0.00042913874,0.0054712472,7.6273346e-7,0.00037975374,0.00016743713],"about_ca_topic_score_codex":0.00029915187,"about_ca_topic_score_gemma":0.00030497892,"teacher_disagreement_score":0.03495212,"about_ca_system_score_codex":0.0012861318,"about_ca_system_score_gemma":0.00032958033,"threshold_uncertainty_score":0.999999},"labels":[],"label_agreement":null},{"id":"W4389247119","doi":"10.1182/blood-2023-188080","title":"The Impact of Soluble BCMA and BCMA Gain on Anti-BCMA Immunotherapies in Multiple Myeloma","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Biology; Chimeric antigen receptor; Antigen; Cancer research; NFAT; Molecular biology; T cell; Immunology; Gene; Immune system; Genetics; Transcription factor","score_opus":0.03253788870408592,"score_gpt":0.3233113030359155,"score_spread":0.29077341433182957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389247119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975076,0.00086202373,9.081051e-7,0.00032499962,0.000036816567,0.0005390009,0.000027107386,0.000054711163,0.00064685725],"genre_scores_gemma":[0.99784786,0.0010866466,0.000060480048,0.000017267332,0.000041456453,0.00005031777,0.000029904457,0.000029163535,0.0008369188],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867743,0.000083821054,0.00024217245,0.00022672926,0.00029840454,0.00047141907],"domain_scores_gemma":[0.9989076,0.0004872486,0.00006038927,0.0003736339,0.000051209016,0.0001198992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034007223,0.00016971584,0.00030672495,0.00020511985,0.0001358694,0.000030523166,0.00010946713,0.00007076307,0.000055378117],"category_scores_gemma":[0.0003153688,0.00010078914,0.00012111495,0.0003804851,0.00013892284,0.00005052195,0.00006691757,0.00016575542,0.00009422731],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009598672,0.0011106784,0.91837347,0.000065270666,0.0006954124,0.00028907336,0.0007499097,0.000024481982,0.050825212,0.00004964984,0.0005918456,0.026265105],"study_design_scores_gemma":[0.011029657,0.0010395647,0.9657683,0.00012686265,0.000024467003,0.00002597101,0.000244884,0.0012326025,0.020126937,0.00010289259,0.00018535012,0.00009254879],"about_ca_topic_score_codex":0.0010374181,"about_ca_topic_score_gemma":0.0001501083,"teacher_disagreement_score":0.047394767,"about_ca_system_score_codex":0.000038310285,"about_ca_system_score_gemma":0.00009450946,"threshold_uncertainty_score":0.41100618},"labels":[],"label_agreement":null},{"id":"W4389247130","doi":"10.1182/blood-2023-186941","title":"Stroma-Driven Notch2 Signaling Controls Naïve B Cell Fate By Regulating Microenvironmental Positioning within the Spleen","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Developmental Biology and Gene Regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Stromal cell; Biology; Cell biology; Notch signaling pathway; Molecular biology; Bone marrow; Cancer research; Signal transduction; Immunology","score_opus":0.004299738050530321,"score_gpt":0.19627181829648213,"score_spread":0.1919720802459518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389247130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99876493,0.0002404108,0.00016787561,0.00023085378,0.00007504537,0.00018903875,0.00004501549,0.000025762149,0.00026105277],"genre_scores_gemma":[0.99695224,0.000017789083,0.0007809892,0.00018390428,0.0001113231,0.000021995156,0.0010342478,0.00001786773,0.00087966595],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991451,0.00007402972,0.00019540082,0.00027588088,0.0000914717,0.0002181087],"domain_scores_gemma":[0.9996607,0.00001856357,0.000112102425,0.00015832992,0.000011498508,0.000038836137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017601598,0.0001321524,0.000097630575,0.00001994428,0.00026592662,0.000025672529,0.00013503309,0.00011634999,0.000010237773],"category_scores_gemma":[0.00001060929,0.000109046785,0.0000609408,0.00007184483,0.00007585326,0.000004562031,0.000107992106,0.00007713268,0.000043183743],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002205959,0.000035966026,0.0123153515,0.0000045249085,0.00007022234,0.0000023536506,0.00007757936,0.0005275427,0.98632693,0.000008881996,0.00047555554,0.00013303959],"study_design_scores_gemma":[0.0010176769,0.000106446896,0.008733335,0.00001148687,0.000038431852,0.00001797652,0.00017483321,0.00017729274,0.988968,0.000043174572,0.0005579832,0.00015335347],"about_ca_topic_score_codex":0.0000061586334,"about_ca_topic_score_gemma":0.000004275561,"teacher_disagreement_score":0.0035820159,"about_ca_system_score_codex":0.0000092976525,"about_ca_system_score_gemma":0.000017637405,"threshold_uncertainty_score":0.4446799},"labels":[],"label_agreement":null},{"id":"W4389247146","doi":"10.1182/blood-2023-190494","title":"SWI/SNF Chromatin Remodeling Complex Orchestrates Sequential Binding of Key Transcription Factors in B Cells and Restricts Aggressive Lymphoma","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; BC Cancer Agency; Spinal Cord Injury BC","funders":"","keywords":"ARID1A; Germinal center; Chromatin; Chromatin remodeling; Biology; Lymphoma; Molecular biology; Diffuse large B-cell lymphoma; Aggressive lymphoma; B cell; Cancer research; Transcription factor; Follicular lymphoma; Mutation; Immunology; Genetics; Gene; Antibody","score_opus":0.034103241581000136,"score_gpt":0.266288934618951,"score_spread":0.23218569303795084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389247146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99914914,0.00036427414,0.00011559028,0.000016352085,0.000067315945,0.0001172498,0.00004759475,0.000024352476,0.000098144825],"genre_scores_gemma":[0.99852234,0.0005471824,0.0006033926,0.000008486059,0.000053033513,0.0000059997633,0.00020166872,0.00001979198,0.00003808785],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990758,0.00004990872,0.00027216246,0.00027014958,0.00012285839,0.00020916501],"domain_scores_gemma":[0.99961084,0.000016636932,0.00013804784,0.00014845667,0.000037189122,0.00004885173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001327256,0.00013589131,0.00016974586,0.00009773271,0.00005110237,0.000019125151,0.00009293209,0.00013375048,0.0000047203744],"category_scores_gemma":[0.000038410722,0.00013355576,0.00005662688,0.00019502894,0.000049385002,0.0000054870347,0.0000381152,0.00004769693,0.0000019517543],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019342508,0.000072787276,0.0015317631,0.00007824811,0.000025624515,0.0000065166155,0.00032691172,0.0009026239,0.99625593,0.0000048671595,0.000040563755,0.0007348376],"study_design_scores_gemma":[0.0016261738,0.00013267164,0.0076233265,0.00014493715,0.000033792036,0.000011242695,0.0003989951,0.0079695545,0.9817724,0.00006317666,0.000051130177,0.00017259059],"about_ca_topic_score_codex":0.00014136752,"about_ca_topic_score_gemma":0.00004361575,"teacher_disagreement_score":0.014483505,"about_ca_system_score_codex":0.000012238649,"about_ca_system_score_gemma":0.00007144879,"threshold_uncertainty_score":0.5446246},"labels":[],"label_agreement":null},{"id":"W4389247209","doi":"10.1182/blood-2023-185735","title":"Multi-Site Randomized Trial of Inpatient Palliative Care for Hospitalized Patients Undergoing Hematopoietic Stem Cell Transplantation","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Quality of life (healthcare); Hematopoietic stem cell transplantation; Randomized controlled trial; Palliative care; Anxiety; Hospital Anxiety and Depression Scale; Depression (economics); Transplantation; Physical therapy; Internal medicine; Psychiatry","score_opus":0.05867581297634249,"score_gpt":0.3517850101395841,"score_spread":0.2931091971632416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389247209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945075,0.000630551,0.0011665431,0.00002403104,0.00022765163,0.0029982151,0.00020803593,0.000051769046,0.00018572186],"genre_scores_gemma":[0.994977,0.0012273578,0.0027597414,0.000019507957,0.000041201518,0.00025489082,0.00059920136,0.000026801443,0.00009429282],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9986083,0.000103357524,0.0005810454,0.00021689758,0.00030581743,0.00018456749],"domain_scores_gemma":[0.9983259,0.00078288885,0.0003291187,0.00015427575,0.0003447851,0.000063071886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001805582,0.00016226147,0.0008097966,0.00014210372,0.00003950252,0.000004737404,0.00005870618,0.00009001545,0.0000052895757],"category_scores_gemma":[0.00016843886,0.00013333163,0.00033025767,0.00021781701,0.000055700762,0.00004288289,0.000013768337,0.00005745421,0.0000060689104],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6986562,0.002863286,0.11956603,0.0110644065,0.00093096355,0.000019973266,0.16278823,0.000056414792,0.0030778886,0.00007967822,0.00008756614,0.0008093458],"study_design_scores_gemma":[0.9240742,0.0014467452,0.0031985953,0.0012417737,0.0010799017,1.2263745e-7,0.0028453292,0.000116505544,0.06579027,0.000027185986,0.000043777032,0.00013563503],"about_ca_topic_score_codex":0.000025881423,"about_ca_topic_score_gemma":0.000014302415,"teacher_disagreement_score":0.22541794,"about_ca_system_score_codex":0.000026507134,"about_ca_system_score_gemma":0.00007783569,"threshold_uncertainty_score":0.5437106},"labels":[],"label_agreement":null},{"id":"W4389247212","doi":"10.1182/blood-2023-179044","title":"CAR-T Therapy for the Treatment of Relapsed/Refractory CD19 Positive Large B Cell Lymphoma: Canadian Real-World Evidence","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Chimeric antigen receptor; Medicine; CAR T-cell therapy; Lymphoma; Clinical trial; Real world data; Refractory (planetary science); Population; Internal medicine; Oncology; Immunotherapy; Cancer; Environmental health","score_opus":0.044600783763291414,"score_gpt":0.3295677116673361,"score_spread":0.2849669279040447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389247212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834229,0.0050686765,0.0000035295518,0.0018815654,0.0001865739,0.0022899287,0.00024389767,0.00006786392,0.0068350756],"genre_scores_gemma":[0.94173205,0.018347874,0.000039494673,0.00023195257,0.00030430238,0.00031331406,0.000068682915,0.00006116173,0.03890117],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998411,0.000086620676,0.00023641346,0.00031769954,0.00035612882,0.0005921168],"domain_scores_gemma":[0.9977267,0.0011176293,0.000071457005,0.0006350161,0.00018797969,0.00026125507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041657194,0.00018937963,0.0003297232,0.00028365102,0.00018507398,0.0000181705,0.00018337354,0.0000894713,0.0004145023],"category_scores_gemma":[0.00004976746,0.00012617806,0.00024204484,0.00060334546,0.00008352594,0.000048454836,0.000016520462,0.00008060677,0.00005848742],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007385268,0.019247925,0.14590923,0.0004766503,0.004346074,0.0013451106,0.024775783,0.000013295772,0.5870878,0.00088485837,0.026227944,0.18230005],"study_design_scores_gemma":[0.044739846,0.009094555,0.26470166,0.0002859026,0.00067718694,0.000028665218,0.0011398403,0.0002038143,0.39637232,0.00010898767,0.28222597,0.00042126703],"about_ca_topic_score_codex":0.10319647,"about_ca_topic_score_gemma":0.1014029,"teacher_disagreement_score":0.25599802,"about_ca_system_score_codex":0.00042565007,"about_ca_system_score_gemma":0.001006149,"threshold_uncertainty_score":0.9149942},"labels":[],"label_agreement":null},{"id":"W4389247222","doi":"10.1182/blood-2023-178564","title":"Plasma Circulating Tumor DNA (ctDNA) as an Alternative to Tissue DNA for Genotyping of DLBCL: Results from the POLARIX Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; Roche (Canada)","funders":"","keywords":"Vincristine; Rituximab; KRAS; Internal medicine; Oncology; Genotyping; Biology; Cyclophosphamide; Cancer research; Lymphoma; Medicine; Genotype; Cancer; Genetics; Chemotherapy; Gene","score_opus":0.021894986831264604,"score_gpt":0.29274110323235136,"score_spread":0.27084611640108675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389247222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976302,0.00007259176,0.00014270599,0.00017764655,0.00019308968,0.0006997126,0.0008897812,0.0000147283445,0.00017955068],"genre_scores_gemma":[0.99810994,0.000013826975,0.0005525688,0.00021921622,0.00062667526,0.00005745771,0.0003284207,0.000032372263,0.000059548864],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989523,0.00004266751,0.0002628777,0.00039861412,0.000121493664,0.00022203662],"domain_scores_gemma":[0.9990862,0.00017047794,0.00012530084,0.00044200016,0.00009728879,0.00007871174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002681639,0.0001305461,0.00015457199,0.000031589083,0.00011559413,0.00003638866,0.00029143807,0.00005099383,0.0000026020277],"category_scores_gemma":[0.0007179732,0.0001160122,0.000055063225,0.0001150614,0.000023598575,0.0000029205748,0.00018744079,0.000051914587,0.000010824925],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002752855,0.000490699,0.003554052,0.000009769631,0.00026237697,0.000019272558,0.0027426314,0.0006110858,0.98885167,0.00012416574,0.0005084346,0.002550532],"study_design_scores_gemma":[0.0054292255,0.0017969747,0.024379889,0.000031548534,0.00015059806,0.0000059384265,0.0020253307,0.00035733014,0.95890826,0.00046683062,0.0061521316,0.0002959719],"about_ca_topic_score_codex":0.00095385814,"about_ca_topic_score_gemma":0.00084044255,"teacher_disagreement_score":0.029943464,"about_ca_system_score_codex":0.000009403745,"about_ca_system_score_gemma":0.000088148,"threshold_uncertainty_score":0.47308403},"labels":[],"label_agreement":null},{"id":"W4389247232","doi":"10.1182/blood-2023-179689","title":"Efficacy and Safety of Extended Duration Postoperative Thromboprophylaxis with Low-Molecular-Weight-Heparin Among Subgroups of Patients Undergoing Surgical Resection of Colorectal Cancer: A Post-Hoc Analysis of the Periop-01 Trial","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Colorectal cancer; Perioperative; Hazard ratio; Surgery; Population; Randomized controlled trial; Colorectal surgery; Low molecular weight heparin; Subgroup analysis; Post-hoc analysis; Cancer; Abdominal surgery; Confidence interval; Internal medicine; Heparin","score_opus":0.0061460153565095245,"score_gpt":0.24504053439981557,"score_spread":0.23889451904330605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389247232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99819124,0.00008383018,0.0000054635607,0.00008052473,0.00006682365,0.0013529067,0.000056656754,0.000012517496,0.00015006312],"genre_scores_gemma":[0.9994723,0.0003220138,0.000034763965,0.000007158115,0.000016102831,0.00004437029,0.000076949174,0.000015365158,0.000010985789],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983735,0.00014520044,0.0005764206,0.0002607647,0.00049219717,0.00015188193],"domain_scores_gemma":[0.9987842,0.0001337631,0.0004528399,0.0002385581,0.00034322822,0.000047449288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023655947,0.00014347622,0.00077331427,0.00026945685,0.000068097936,0.000006409719,0.00008012954,0.0000765046,0.000032742686],"category_scores_gemma":[0.00011093063,0.0000954471,0.00018232237,0.0012936328,0.00021562667,0.000061463135,0.00008903799,0.00008950896,1.4627757e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13282979,0.0138193695,0.68324596,0.0014129095,0.016712762,0.00004319454,0.009458427,0.001373395,0.13769615,0.0016708099,0.000026685373,0.0017105668],"study_design_scores_gemma":[0.032480195,0.007833981,0.90044194,0.00023000075,0.0028010835,8.503624e-7,0.00034717456,0.0002249216,0.055548344,0.0000051673205,0.0000015459512,0.00008478287],"about_ca_topic_score_codex":0.0005493815,"about_ca_topic_score_gemma":0.0016953625,"teacher_disagreement_score":0.21719602,"about_ca_system_score_codex":0.00003819685,"about_ca_system_score_gemma":0.0001199499,"threshold_uncertainty_score":0.389222},"labels":[],"label_agreement":null},{"id":"W4389247235","doi":"10.1182/blood-2023-181250","title":"Involvement of the JAK-STAT Pathway in the Molecular Landscape of Fusion-Free Myeloid Neoplasms with Eosinophilia","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"PDGFRB; Myeloproliferative neoplasm; PDGFRA; Cancer research; Medicine; Myeloid; Myeloproliferative Disorders; Hypereosinophilia; Biology; Internal medicine; Immunology; Eosinophilia; Myelofibrosis; Genetics; Bone marrow","score_opus":0.009507630340322839,"score_gpt":0.2122326533186873,"score_spread":0.20272502297836445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389247235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99360144,0.00055612944,0.0000033784756,0.0021739104,0.000044293403,0.0004691873,0.000023664023,0.00001749304,0.0031105224],"genre_scores_gemma":[0.99916774,0.00008991209,0.000094103976,0.0003561239,0.000014464867,0.00002779799,0.000017602346,0.000016111455,0.00021615285],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880517,0.000059793692,0.00028386523,0.00014791224,0.0005109034,0.00019235715],"domain_scores_gemma":[0.9990151,0.00006597463,0.00010583561,0.0007238229,0.00005563814,0.000033658773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000308531,0.00012221764,0.00026097524,0.00009787022,0.000036574267,0.0000062684417,0.00032191415,0.00005247354,0.000036798345],"category_scores_gemma":[0.000062245854,0.00005931583,0.00008724435,0.0007023221,0.000103349455,0.000020661717,0.000119753226,0.00012658892,0.0000046842156],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038156347,0.005043277,0.82351035,0.0013214594,0.0005941653,0.0005809512,0.020719737,0.00024069559,0.13029605,0.00878515,0.0048712916,0.0036552744],"study_design_scores_gemma":[0.020911345,0.0031241127,0.8410908,0.001348268,0.00050020154,0.00018281807,0.015926402,0.0001919209,0.10802716,0.004527104,0.0037341581,0.00043569197],"about_ca_topic_score_codex":0.000086762346,"about_ca_topic_score_gemma":0.00014450592,"teacher_disagreement_score":0.022268899,"about_ca_system_score_codex":0.000004660565,"about_ca_system_score_gemma":0.00010250438,"threshold_uncertainty_score":0.24188294},"labels":[],"label_agreement":null},{"id":"W4389247301","doi":"10.1182/blood-2023-180919","title":"Identifying Stress Granules As Determinants of Leukemia Stem Cell Maintenance and Stress Adaptation","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Princess Margaret Cancer Centre; McMaster University; University of Toronto; University Health Network","funders":"","keywords":"Stress granule; Stem cell; Biology; Cell biology; Myeloid leukemia; Haematopoiesis; Leukemia; Progenitor cell; Cancer research; Immunology; Gene; Translation (biology); Messenger RNA; Genetics","score_opus":0.019736520501867152,"score_gpt":0.2731681344172462,"score_spread":0.25343161391537905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389247301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990525,0.0005065687,0.00009338852,0.0000059395793,0.000028738279,0.00009454364,0.00005827317,0.000009758784,0.00015028106],"genre_scores_gemma":[0.99735165,0.000701525,0.0001033556,0.0000068622894,0.000034533758,0.000010035714,0.000041138654,0.000012145952,0.0017387818],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992995,0.00003125388,0.0001371346,0.00019898383,0.00012707591,0.00020602728],"domain_scores_gemma":[0.9996543,0.000014368872,0.00006217327,0.00015873685,0.000051321178,0.00005909023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000114096336,0.000077181816,0.00009768699,0.000046049558,0.000054376473,0.000021573995,0.00010915214,0.00006128759,0.0000017929771],"category_scores_gemma":[0.000022844086,0.00007186487,0.000032992313,0.00008087745,0.00004410279,0.0000049424402,0.000095637784,0.000046383226,0.000005884635],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003334023,0.00003829346,0.044853743,0.00021284766,0.000019656309,0.000032209944,0.00015209848,0.00006657092,0.94781417,0.000013783111,0.00006252257,0.006700775],"study_design_scores_gemma":[0.0007754929,0.00013308147,0.019778322,0.00009142489,0.000013943658,0.0000071361446,0.0011566477,0.00075145793,0.9771277,0.000031275657,0.000044143053,0.00008942817],"about_ca_topic_score_codex":0.000120578894,"about_ca_topic_score_gemma":0.0001739669,"teacher_disagreement_score":0.029313488,"about_ca_system_score_codex":0.000004345681,"about_ca_system_score_gemma":0.000050667524,"threshold_uncertainty_score":0.29305646},"labels":[],"label_agreement":null},{"id":"W4389247332","doi":"10.1182/blood-2023-190331","title":"A Zebrafish Model of Parn-Deficiency Reveals Conserved Mechanisms Underlying Marrow Failure and Opportunities for Therapeutic Amelioration of Hematopoiesis","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; SickKids Foundation; AGADA Biosciences; Hospital for Sick Children; Agricultural Research Institute of Ontario","funders":"","keywords":"Dyskeratosis congenita; Biology; Zebrafish; Cancer research; Bone marrow failure; Genetics; Danio; Cell biology; Haematopoiesis; Stem cell; Telomerase; Gene","score_opus":0.13944479922356937,"score_gpt":0.3008427787790765,"score_spread":0.16139797955550714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389247332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99132806,0.0004815764,0.005614143,0.001778694,0.000027879436,0.00053027744,0.00006669486,0.000079319565,0.0000933415],"genre_scores_gemma":[0.9959112,0.00022059453,0.0032053145,0.00023308939,0.00000833896,0.000047194073,0.00003134362,0.000022691194,0.00032027048],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989722,0.000035592235,0.00037151415,0.00019952616,0.00022285606,0.00019835748],"domain_scores_gemma":[0.99921453,0.00013288879,0.00018044152,0.00022870144,0.00017283612,0.00007059387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003298332,0.0001309058,0.0003967153,0.00018395351,0.000070787224,0.000011724056,0.000071224444,0.000089701345,0.000010368387],"category_scores_gemma":[0.000077996745,0.00011793834,0.00008053226,0.00021389159,0.0001022745,0.000083035586,0.000025184572,0.00005524626,7.13678e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010037808,0.00026279743,0.0011080088,0.0018236367,0.000110408415,0.000011653194,0.0017279541,0.000020901249,0.97179353,0.021519152,0.00029251605,0.0012290368],"study_design_scores_gemma":[0.015672646,0.002843571,0.011856392,0.002237561,0.0025591871,0.00018504886,0.053384215,0.03404917,0.7345076,0.1413917,0.00015869258,0.0011542274],"about_ca_topic_score_codex":0.00001531855,"about_ca_topic_score_gemma":0.000016345823,"teacher_disagreement_score":0.23728596,"about_ca_system_score_codex":0.000006531721,"about_ca_system_score_gemma":0.00012756542,"threshold_uncertainty_score":0.48093858},"labels":[],"label_agreement":null},{"id":"W4389247352","doi":"10.1182/blood-2023-172873","title":"CD56 brightCD16 -Perforin - regulatory Natural Killer Cells Associated with the Suppression of Chronic Graft-Versus-Host Disease Prevent CD4 + T Cell Proliferation through PD-1 and LAG-3 Dependent Pathways","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Perforin; Interleukin 21; Granzyme; Biology; Immunology; Cytotoxic T cell; Granzyme B; Population; CD8; Cell sorting; NK-92; Graft-versus-host disease; Interleukin-7 receptor; T cell; Cell biology; Stem cell; Immune system; Flow cytometry; IL-2 receptor; Medicine","score_opus":0.008848144869105155,"score_gpt":0.2043990923397531,"score_spread":0.19555094747064794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389247352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936114,0.0021541482,0.000015829126,0.00015210758,0.0031987333,0.0004956364,0.0000128494175,0.00009410685,0.00026518293],"genre_scores_gemma":[0.98255646,0.0002057734,0.0000034539828,0.00004436264,0.00005128279,0.000047668233,0.00036138197,0.000021202111,0.016708383],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988818,0.0002393514,0.00023799349,0.0002835148,0.000094474686,0.00026285273],"domain_scores_gemma":[0.9992906,0.0001250571,0.0001975388,0.0002767033,0.000087649445,0.000022469694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019136252,0.00018293379,0.00018260449,0.000058608905,0.0002930808,0.000021256034,0.00011700109,0.00014574199,0.0002628743],"category_scores_gemma":[0.000030136509,0.00011673354,0.00007378537,0.00014295423,0.00012059539,0.00019035733,0.00008102386,0.0003039158,0.00009846168],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011739784,0.00083312765,0.000873599,0.000073216026,0.0003897441,0.000008183774,0.001057255,0.000058520567,0.9765347,0.00014523015,0.018679531,0.0001728962],"study_design_scores_gemma":[0.0065046847,0.0007128854,0.02448358,0.00014709118,0.0003695814,0.000009182614,0.0004398054,0.00011734067,0.9572417,0.00002271553,0.009693685,0.00025772257],"about_ca_topic_score_codex":0.00002748137,"about_ca_topic_score_gemma":0.000050957435,"teacher_disagreement_score":0.023609983,"about_ca_system_score_codex":0.000057116897,"about_ca_system_score_gemma":0.000093640985,"threshold_uncertainty_score":0.47602555},"labels":[],"label_agreement":null},{"id":"W4389247375","doi":"10.1182/blood-2023-172972","title":"CD79 Expression Is Associated with Cell-of-Origin and Outcome in Diffuse Large B-Cell Lymphoma","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC","funders":"","keywords":"Diffuse large B-cell lymphoma; Medicine; Internal medicine; Rituximab; Oncology; Cohort; Lymphoma; Immunohistochemistry; Pathology","score_opus":0.017784000998983536,"score_gpt":0.26151111943951993,"score_spread":0.2437271184405364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389247375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997948,0.0003684092,5.586431e-7,0.00014083253,0.00002940915,0.00024547696,0.000044747427,0.00005735981,0.001165208],"genre_scores_gemma":[0.99847525,0.00015410816,0.000072764706,0.00014101402,0.00001626438,0.000040813367,0.000047330555,0.000020954505,0.0010315111],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990841,0.000026153344,0.00020918617,0.00022521341,0.00021166002,0.00024369234],"domain_scores_gemma":[0.9994901,0.000105495725,0.000083221596,0.00019975875,0.00002602415,0.00009542196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000103967934,0.00013799584,0.00032221747,0.000115683804,0.000033766762,0.000009080493,0.000040112463,0.00008369119,0.000020900536],"category_scores_gemma":[0.000027161332,0.00009451612,0.00004676456,0.00027238394,0.000020164653,0.000035136338,0.00004580131,0.000036897705,0.000028959917],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044302873,0.014523646,0.9802083,0.00007138223,0.000046578258,0.00046139065,0.00056150556,1.1100999e-7,0.0033352075,0.000009513534,0.0005525472,0.0001855514],"study_design_scores_gemma":[0.079578966,0.0003564487,0.81612587,0.00024991334,0.0002125082,0.00000917477,0.00016661009,0.00003111957,0.102620125,0.000012711934,0.0005141682,0.00012240784],"about_ca_topic_score_codex":0.000068466026,"about_ca_topic_score_gemma":0.000018580815,"teacher_disagreement_score":0.16408242,"about_ca_system_score_codex":0.0000448917,"about_ca_system_score_gemma":0.00004545808,"threshold_uncertainty_score":0.38542557},"labels":[],"label_agreement":null},{"id":"W4389247395","doi":"10.1182/blood-2023-186950","title":"Refining Diagnostic Subtypes of Peripheral T-Cell Lymphoma Using a Multiparameter Approach","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Peripheral T-cell lymphoma; Lymphoma; Immunophenotyping; Medicine; GATA3; Internal medicine; Not Otherwise Specified; T cell; Oncology; Immunology; Flow cytometry; Biology; Immune system; Gene","score_opus":0.03964803548680238,"score_gpt":0.2756707230290382,"score_spread":0.23602268754223585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389247395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969516,0.0011415926,0.000015564336,0.00003614702,0.0000535078,0.00016319852,0.000008729834,0.00007553255,0.0015541725],"genre_scores_gemma":[0.9914767,0.000056944456,0.008098161,0.000057472247,0.000063426894,0.00005203791,0.000031888118,0.000028937744,0.000134444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913394,0.000028439252,0.00020294522,0.00022420892,0.00018242415,0.00022803113],"domain_scores_gemma":[0.99927706,0.00029774106,0.00006523835,0.00024473408,0.000038623595,0.000076588985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000089724694,0.000127856,0.00028419745,0.00010211689,0.000043117252,0.000010419739,0.000050264705,0.00006230243,0.00002316329],"category_scores_gemma":[0.0001625492,0.00010347414,0.000120392906,0.00027423093,0.00003883356,0.000028812618,0.00004065759,0.000040826682,0.000031544976],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042883563,0.004827983,0.9805641,0.00017464584,0.00021758922,0.00032830785,0.0004797035,0.000089151006,0.0080539,0.000028123508,0.000089315,0.00510429],"study_design_scores_gemma":[0.019858226,0.000526931,0.8942646,0.0003208042,0.0014416053,0.00025150974,0.00046691755,0.0050309445,0.07698278,0.000027510254,0.0005094857,0.00031868793],"about_ca_topic_score_codex":0.00016635259,"about_ca_topic_score_gemma":0.0000029716327,"teacher_disagreement_score":0.08629951,"about_ca_system_score_codex":0.000027988719,"about_ca_system_score_gemma":0.000050480812,"threshold_uncertainty_score":0.42195532},"labels":[],"label_agreement":null},{"id":"W4389247396","doi":"10.1182/blood-2023-189229","title":"Real-World Treatment Patterns and Clinical Outcomes Among Triple-Class Exposed and B-Cell Maturation Antigen (BCMA) Exposed Multiple Myeloma Patients","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Multiple myeloma; Internal medicine; Oncology","score_opus":0.04818474863862107,"score_gpt":0.32692956793264843,"score_spread":0.2787448192940274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389247396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971584,0.00003281394,0.000003030012,0.0001520696,0.00015156346,0.001647519,0.00014348273,0.00019280246,0.0005182815],"genre_scores_gemma":[0.9948384,0.0012245455,0.00029877207,0.000045043227,0.00010722586,0.00012270075,0.0007705165,0.000052493997,0.002540279],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976755,0.00016511738,0.00056957995,0.0006201171,0.00044341598,0.0005262632],"domain_scores_gemma":[0.9983435,0.00048201624,0.00015331137,0.00042228162,0.000093516275,0.0005053197],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020332799,0.00033658592,0.0006132814,0.00029625703,0.00018276963,0.00007314309,0.0000743416,0.00014741231,0.00003751087],"category_scores_gemma":[0.00021356675,0.0002481533,0.00017147913,0.0002583757,0.00010707202,0.00014679549,0.00010036261,0.00015947569,0.00006304196],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046562267,0.00223315,0.9851858,0.00006828679,0.0004525965,0.00026490784,0.00023346783,1.06522506e-7,0.0006823028,0.0000019756853,0.00014000102,0.010271765],"study_design_scores_gemma":[0.038244337,0.0015208845,0.95280993,0.00006160059,0.00025158032,0.0000038496223,0.00012927725,0.00051734503,0.0061167106,0.0000060194257,0.00013806326,0.00020039218],"about_ca_topic_score_codex":0.0010539696,"about_ca_topic_score_gemma":0.0018227495,"teacher_disagreement_score":0.037778713,"about_ca_system_score_codex":0.00007075609,"about_ca_system_score_gemma":0.00006330669,"threshold_uncertainty_score":0.9999971},"labels":[],"label_agreement":null},{"id":"W4389247399","doi":"10.1182/blood-2023-184607","title":"High Prevalence of Iron Deficiency Among Daratumumab-Treated Newly Diagnosed Multiple Myeloma Patients","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Daratumumab; Medicine; Multiple myeloma; Iron deficiency; Internal medicine; Ferritin; Lenalidomide; Anemia; Gastroenterology; AL amyloidosis; Surgery; Immunology; Antibody","score_opus":0.016002078237881568,"score_gpt":0.2633972735357814,"score_spread":0.24739519529789983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389247399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977481,0.00016392692,0.0000038213066,0.00003153166,0.00007883415,0.0009930956,0.00017507316,0.00018339288,0.0006222656],"genre_scores_gemma":[0.9981039,0.00019358839,0.00026192723,0.000011486807,0.000040681003,0.000113506074,0.00032528493,0.000035982175,0.00091361953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979369,0.0000726679,0.000355881,0.00042334868,0.00066744065,0.00054374733],"domain_scores_gemma":[0.99866134,0.00022887345,0.00012251828,0.00051009207,0.00019946574,0.00027771515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012297262,0.00021813592,0.00033564362,0.00024698628,0.00011828195,0.000014687232,0.00017756497,0.00010657795,0.00012684878],"category_scores_gemma":[0.000725041,0.00017717933,0.00011639989,0.00068856525,0.00014445827,0.000112763366,0.000111901405,0.00014827825,0.00024727578],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023326294,0.0022295513,0.99011254,0.0005093829,0.00006887289,0.0003062363,0.00015929119,0.000008206497,0.0022682075,0.00000992289,0.0002759791,0.0038185443],"study_design_scores_gemma":[0.015239656,0.0009272144,0.9576875,0.00018500618,0.00018760811,0.0000036017839,0.00003278551,0.00016926043,0.02540347,0.000012909799,0.000018741057,0.00013227688],"about_ca_topic_score_codex":0.00067815016,"about_ca_topic_score_gemma":0.00006607108,"teacher_disagreement_score":0.032425072,"about_ca_system_score_codex":0.000043340107,"about_ca_system_score_gemma":0.00006663826,"threshold_uncertainty_score":0.7225163},"labels":[],"label_agreement":null},{"id":"W4389247484","doi":"10.1182/blood-2023-181181","title":"Predictors of Cytokine Release Syndrome and Neurotoxicity in Patients with Large B-Cell Lymphoma and Their Impact on Survival","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Eurostars; Legend Biotech; Pharmacyclics; Aptitude Health; Daiichi Sankyo Europe; National Cancer Institute; Gilead Sciences; Servier; Juno Therapeutics; Astellas Pharma; Swedish Orphan Biovitrum; Omeros Corporation; BeiGene; Incyte; CTI Biopharma; bluebird bio; Jazz Pharmaceuticals; Fred Hutchinson Cancer Research Center; Karyopharm Therapeutics; Atara Biotherapeutics; Massachusetts General Hospital; Leukemia and Lymphoma Society; Kite Pharma; Society for Immunotherapy of Cancer; AstraZeneca; Cidara Therapeutics; MorphoSys; Celgene; Eli Lilly and Company; Bristol-Myers Squibb; Amgen","keywords":"Medicine; Cytokine release syndrome; Internal medicine; Proportional hazards model; Oncology; Cancer; Immunotherapy","score_opus":0.01048107823113658,"score_gpt":0.24786097802336715,"score_spread":0.23737989979223056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389247484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99876684,0.000034356686,3.1930531e-7,0.000028984703,0.0000203521,0.0006260655,0.0001476835,0.000034980014,0.0003404219],"genre_scores_gemma":[0.9996276,0.00006177515,0.0000027991491,0.000021798183,0.000017769766,0.00001207864,0.00003619117,0.00003076229,0.00018921631],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989504,0.00007667459,0.00015233389,0.00023766374,0.0003015532,0.00028138075],"domain_scores_gemma":[0.9993717,0.00013483538,0.000042519365,0.00024563435,0.000042473017,0.000162815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024236781,0.00014947365,0.00031632202,0.00021345844,0.000024652198,0.000008224908,0.000051595674,0.000057263318,0.00005442631],"category_scores_gemma":[0.000055403943,0.000093570416,0.00003653992,0.00039151486,0.00006469557,0.000036155845,0.00006294561,0.00012011913,0.000003317016],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014337023,0.0024247044,0.98752517,0.00010849791,0.00007911854,0.00013458969,0.00019350472,0.0000012912094,0.0076142806,0.000001686014,0.000019652194,0.00046383555],"study_design_scores_gemma":[0.023202218,0.0037543082,0.96333873,0.0000807389,0.000026531323,0.000020343714,0.000034312594,0.000066049295,0.009358162,0.0000054133375,0.00003604435,0.00007714435],"about_ca_topic_score_codex":0.000074958334,"about_ca_topic_score_gemma":0.00001885636,"teacher_disagreement_score":0.024186404,"about_ca_system_score_codex":0.00002258396,"about_ca_system_score_gemma":0.00005608398,"threshold_uncertainty_score":0.3815691},"labels":[],"label_agreement":null},{"id":"W4389247513","doi":"10.1182/blood-2023-181972","title":"Clonal Hematopoiesis, Inflammation, Hemostasis, and Cardiometabolic Biomarkers: The Reasons for Geographic and Racial Differences in Stroke Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Internal medicine; Population; Stroke (engine); Biomarker; Cohort; Disease; Prospective cohort study; Oncology; Genetics; Biology","score_opus":0.02663694323042657,"score_gpt":0.29918683684537783,"score_spread":0.27254989361495124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389247513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941876,0.0017503656,0.0000065024105,0.0023348636,0.0000330797,0.0014959833,0.00006406492,0.000054025575,0.00007354687],"genre_scores_gemma":[0.99850786,0.0007124684,0.0001250858,0.000030267593,0.00016368888,0.0003319861,0.000028714883,0.000016905604,0.000083035266],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986934,0.00012085905,0.00023401475,0.00029105975,0.0003439655,0.00031666987],"domain_scores_gemma":[0.9990937,0.00043482505,0.000047558442,0.00024012316,0.00008144326,0.000102331454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009466381,0.000141254,0.00034814453,0.00045276896,0.00018253962,0.0000631797,0.00010561607,0.00007011562,0.000005638286],"category_scores_gemma":[0.00044874428,0.00009514404,0.000056586552,0.00079272833,0.00018034336,0.00006927154,0.000135446,0.00016353292,0.0000027904132],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017423043,0.0001563938,0.98956084,0.000101322934,0.0005284448,0.000038920407,0.0015072952,9.349616e-8,0.0011612609,0.00015820528,0.0002672372,0.0063457815],"study_design_scores_gemma":[0.006047009,0.00022170342,0.98736,0.000032751832,0.00027296736,0.000048409034,0.004349724,0.00008691924,0.0005799863,0.00014671293,0.00075158925,0.00010220819],"about_ca_topic_score_codex":0.00017738948,"about_ca_topic_score_gemma":0.0002525096,"teacher_disagreement_score":0.006243573,"about_ca_system_score_codex":0.000014217182,"about_ca_system_score_gemma":0.00011576053,"threshold_uncertainty_score":0.38798612},"labels":[],"label_agreement":null},{"id":"W4389247523","doi":"10.1182/blood-2023-174338","title":"Disease Characteristics and Outcomes of 504 Young Patients Diagnosed with Multiple Myeloma Treated with Modern Therapies in Canada","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; Memorial University of Newfoundland; Concordia University; McGill University; Juravinski Cancer Centre; Princess Margaret Cancer Centre; Vancouver General Hospital; University of Calgary; University of British Columbia; Dalhousie University; CancerCare Manitoba; Ottawa Hospital; Saint John Regional Hospital; BC Cancer Agency; University of Alberta; Queen Elizabeth II Health Sciences Centre; University of Saskatchewan; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Regeneron Pharmaceuticals; Celgene; Gilead Sciences; Amgen","keywords":"Medicine; Multiple myeloma; Young adult; Internal medicine; Disease; Pediatrics; Retrospective cohort study; Surgery","score_opus":0.011093121874601448,"score_gpt":0.23194306101365342,"score_spread":0.22084993913905196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389247523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99895096,0.00006314746,0.0000011565929,0.000067083485,0.000008447405,0.0005712715,0.0002847668,0.000025624742,0.000027556547],"genre_scores_gemma":[0.99934995,0.00007391798,0.00006271937,0.000022176258,0.0000065905333,0.00008573897,0.00028585154,0.000024790319,0.000088282926],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989826,0.000027735092,0.00015923417,0.00020246688,0.00035811614,0.0002698165],"domain_scores_gemma":[0.9993179,0.0001241619,0.000056498535,0.00019854987,0.000081437036,0.00022144844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000028712127,0.00015356566,0.00031459203,0.00010426131,0.000035373807,0.000008663986,0.000043613054,0.000020163485,0.000008149471],"category_scores_gemma":[0.000096724274,0.00009373608,0.000017613624,0.00020210799,0.00004972907,0.000042706884,0.000023844643,0.00006670617,0.0000014424411],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008360581,0.0006294777,0.9933467,0.00008834781,0.00031912027,0.0011644209,0.00028507778,0.0000014992555,0.00007405018,7.650379e-7,0.000006091791,0.0032484028],"study_design_scores_gemma":[0.015405056,0.0003302343,0.9830124,0.000114563336,0.00011135187,0.0000028437614,0.00013312616,0.0005379356,0.000256108,0.0000022700956,0.000003831887,0.00009028169],"about_ca_topic_score_codex":0.2560264,"about_ca_topic_score_gemma":0.47872338,"teacher_disagreement_score":0.222697,"about_ca_system_score_codex":0.00005979372,"about_ca_system_score_gemma":0.00034092015,"threshold_uncertainty_score":0.74892783},"labels":[],"label_agreement":null},{"id":"W4389247529","doi":"10.1182/blood-2023-179080","title":"Primary Care Management Pathways to Reduce Wait Times in Hematology: Monoclonal Gammopathy of Undetermined Significance","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; Queen's University","funders":"","keywords":"Medicine; Monoclonal gammopathy of undetermined significance; Hematology; Multiple myeloma; Internal medicine; Referral; Asymptomatic; Anemia; Intensive care medicine; Pediatrics; Emergency medicine; Monoclonal; Family medicine; Immunology; Monoclonal antibody","score_opus":0.02037105429917832,"score_gpt":0.26780256620360804,"score_spread":0.24743151190442972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389247529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97800523,0.00021441474,0.000008294272,0.00028864326,0.00011130658,0.0005582524,0.000023219116,0.00009005111,0.020700587],"genre_scores_gemma":[0.9980836,0.00006835863,0.0004550225,0.00019046314,0.00004930922,0.00021294854,0.00003686683,0.000018462802,0.0008850046],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99913645,0.000021266238,0.00022798171,0.00024901415,0.0001541566,0.00021111929],"domain_scores_gemma":[0.9995481,0.000026002259,0.000043233656,0.00026331766,0.000041983458,0.00007738126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006754522,0.00010354306,0.00026734517,0.00020726232,0.000027913342,0.0000046702557,0.00008673357,0.00004413365,0.000042939948],"category_scores_gemma":[0.000007811104,0.00009988251,0.00006183584,0.00050909206,0.000029755127,0.000026602573,0.0000704106,0.00008584731,0.00008833545],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015523433,0.0035881542,0.34059247,0.008034431,0.00078843045,0.005859916,0.008318287,0.0002575083,0.5524691,0.016802592,0.013171733,0.048565045],"study_design_scores_gemma":[0.008149839,0.0010818753,0.59619355,0.00093275204,0.00043749745,0.00019146208,0.0022734052,0.0000161423,0.38409102,0.00046873157,0.005739589,0.0004241384],"about_ca_topic_score_codex":0.000024777839,"about_ca_topic_score_gemma":0.000019858599,"teacher_disagreement_score":0.25560108,"about_ca_system_score_codex":0.000057628844,"about_ca_system_score_gemma":0.00009251739,"threshold_uncertainty_score":0.40730906},"labels":[],"label_agreement":null},{"id":"W4389247583","doi":"10.1182/blood-2023-190649","title":"Early Identification of Refractory/Relapsed Diffuse Large B Cell Lymphoma with Serial Ctdna Sampling","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Simon Fraser University; Spinal Cord Injury BC; McGill University","funders":"","keywords":"Diffuse large B-cell lymphoma; Medicine; Internal medicine; Oncology; Lymphoma; Gastroenterology","score_opus":0.00867856683404564,"score_gpt":0.22638643720466348,"score_spread":0.21770787037061784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389247583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99872744,0.00017109768,0.00045621427,0.000015339265,0.00014841648,0.00011271625,0.00018673045,0.000016501786,0.00016555998],"genre_scores_gemma":[0.9987553,0.0002462489,0.00018424162,0.000026626305,0.0002186684,0.000015521347,0.0002744629,0.000024921668,0.00025405723],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993167,0.000014076206,0.00018250938,0.00022108699,0.00009376277,0.00017185337],"domain_scores_gemma":[0.999449,0.000017942075,0.000117390606,0.00030444973,0.00006413569,0.00004709095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010481391,0.000091013084,0.00009842221,0.00003819528,0.000049264843,0.0000236363,0.00011725134,0.00008821976,0.0000039932534],"category_scores_gemma":[0.000044837194,0.00008845264,0.000045345147,0.00011320063,0.000024913707,0.0000024349183,0.00006376298,0.000026502164,0.000021763546],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010228599,0.0008434696,0.0037508789,0.000026297443,0.000039913637,0.0000033999167,0.00009118102,0.0000241979,0.9945559,0.000043401076,0.00025581467,0.0002632954],"study_design_scores_gemma":[0.009432548,0.00042407052,0.037282735,0.000013512513,0.00008478833,0.0000031645384,0.00008178657,0.000023239063,0.9426376,0.00005304812,0.009765107,0.0001983787],"about_ca_topic_score_codex":0.000028141716,"about_ca_topic_score_gemma":0.000027623968,"teacher_disagreement_score":0.051918242,"about_ca_system_score_codex":0.0000060760062,"about_ca_system_score_gemma":0.000069941976,"threshold_uncertainty_score":0.3606994},"labels":[],"label_agreement":null},{"id":"W4389247626","doi":"10.1182/blood-2023-173092","title":"Oral Decitabine/Cedazuridine Vs Intravenous Decitabine for Acute Myeloid Leukemia: Final Results of a Randomized, Crossover, Registration-Enabling, Pharmacokinetics Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Decitabine; Medicine; Azacitidine; Discontinuation; Internal medicine; Oncology; Pharmacology; Adverse effect; Pharmacokinetics; Myeloid leukemia; Population; Dosing","score_opus":0.03697259444343578,"score_gpt":0.3463116137809439,"score_spread":0.3093390193375081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389247626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989095,0.00037153953,0.00076975545,0.0016660577,0.00030676252,0.006007008,0.0005192149,0.00029273,0.00097194547],"genre_scores_gemma":[0.9840342,0.0012626827,0.0044976473,0.00021000205,0.0008647886,0.00080367696,0.000738594,0.00014275878,0.007445679],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99483055,0.0002397069,0.0017726844,0.0008908118,0.0012447438,0.0010215235],"domain_scores_gemma":[0.99533135,0.0016330286,0.0005623975,0.0009727739,0.0011214864,0.00037898816],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0035049915,0.00050699257,0.0018970142,0.00064657343,0.00023753395,0.00008976169,0.00052325125,0.00025451745,0.00005950103],"category_scores_gemma":[0.0051607504,0.00043034638,0.0005146206,0.0015410889,0.00040121892,0.00017406013,0.00025038645,0.0006719564,0.00005926576],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.80578715,0.0071212337,0.0017638339,0.00087879715,0.009315953,0.002520396,0.004021097,0.0005603748,0.08223418,0.0005220378,0.07996369,0.00531127],"study_design_scores_gemma":[0.9162768,0.00506963,0.0022971383,0.00018879698,0.005271168,0.00035525486,0.00064780633,0.005089142,0.0582062,0.0003788195,0.0056514167,0.0005677877],"about_ca_topic_score_codex":0.00031943375,"about_ca_topic_score_gemma":0.000059637998,"teacher_disagreement_score":0.1104897,"about_ca_system_score_codex":0.00031123118,"about_ca_system_score_gemma":0.0015340106,"threshold_uncertainty_score":0.9998148},"labels":[],"label_agreement":null},{"id":"W4389247633","doi":"10.1182/blood-2023-173320","title":"Development and Validation of the Early-Stage Hodgkin Lymphoma (HL) International Prognostication Index (E-HIPI): A Report from the Hodgkin Lymphoma International Study for Individual Care (HoLISTIC) Consortium","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Internal medicine; Stage (stratigraphy); International Prognostic Index; Cohort; Clinical trial; Oncology; Lymphoma; Diffuse large B-cell lymphoma","score_opus":0.04584341434878424,"score_gpt":0.3080739144749554,"score_spread":0.26223050012617116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389247633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958799,0.00008480657,0.000056672387,0.000847903,0.00053898833,0.0018917973,0.00038408616,0.000059675236,0.00025620055],"genre_scores_gemma":[0.9966648,0.000017387409,0.0007847205,0.00009566839,0.00021706142,0.0008322474,0.0011957188,0.000025000407,0.00016740238],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979905,0.00006705753,0.00057477294,0.00041733653,0.0007615695,0.00018876536],"domain_scores_gemma":[0.9984655,0.0003656817,0.00037170245,0.00038637713,0.0003437208,0.0000670464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000382158,0.00019742954,0.00023772687,0.00011039822,0.00017543185,0.00009456718,0.00028685623,0.00008281772,0.00001939695],"category_scores_gemma":[0.0006402457,0.00012776596,0.0000915671,0.00021604457,0.0000814608,0.00008462769,0.0002441566,0.000042046016,0.000007865726],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013256808,0.0016020732,0.97123575,0.0000216353,0.0010466982,0.00007326668,0.006821393,0.0000042913875,0.00010655849,0.0001678144,0.00023819221,0.018549778],"study_design_scores_gemma":[0.009442604,0.00014431293,0.9680547,0.00010298428,0.00055382546,0.000051531344,0.0042619673,0.00006095692,0.013874607,0.000058680856,0.0032690554,0.00012475961],"about_ca_topic_score_codex":0.00039121855,"about_ca_topic_score_gemma":0.00011489962,"teacher_disagreement_score":0.018425018,"about_ca_system_score_codex":0.00015370065,"about_ca_system_score_gemma":0.000378047,"threshold_uncertainty_score":0.52101445},"labels":[],"label_agreement":null},{"id":"W4389247655","doi":"10.1182/blood-2023-184734","title":"Age Regulates Desmopressin Responses in Patients with Low Von Willebrand Factor and Type 1 Von Willebrand Disease in the Lovic and Win Studies","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Desmopressin; Von Willebrand factor; Von Willebrand disease; Medicine; Internal medicine; Gastroenterology; Endocrinology; Platelet","score_opus":0.014395887643666333,"score_gpt":0.25832386720047174,"score_spread":0.2439279795568054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389247655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99557626,0.0034599418,3.754209e-8,0.00033687567,0.0000205458,0.0005304896,0.000025249326,0.00002383743,0.000026744634],"genre_scores_gemma":[0.99885595,0.00074799475,0.000014219766,0.00009331498,0.000009872028,0.000021821908,0.000048572296,0.000017184979,0.00019106883],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991277,0.000081029895,0.00014499783,0.00025378115,0.00018157564,0.00021093719],"domain_scores_gemma":[0.9995173,0.00017526878,0.00003752104,0.00016991954,0.000026057814,0.000073914096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009987988,0.00016583224,0.00029691003,0.00014870167,0.000066649685,0.000027204069,0.000040141287,0.00004396582,0.000004678955],"category_scores_gemma":[0.00014205155,0.000094923445,0.000016632757,0.00030603062,0.00012416768,0.000091095346,0.000036841917,0.00009011265,0.0000033142633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020442712,0.00053624104,0.9934762,0.00011386051,0.0001229196,0.001058064,0.0018084872,0.0000014342853,0.00007206933,0.0000022572156,0.00008212963,0.0006820722],"study_design_scores_gemma":[0.011320196,0.00042927152,0.9870078,0.00036553692,0.00013522031,0.000006272662,0.0002749331,0.000010837804,0.00012582596,0.0001633822,0.00005240716,0.000108326],"about_ca_topic_score_codex":0.00002603906,"about_ca_topic_score_gemma":0.00012673187,"teacher_disagreement_score":0.009275924,"about_ca_system_score_codex":0.000010674106,"about_ca_system_score_gemma":0.000027822502,"threshold_uncertainty_score":0.38708657},"labels":[],"label_agreement":null},{"id":"W4389247674","doi":"10.1182/blood-2023-186997","title":"Safety and Tolerability of Magrolimab Combinations in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Safety Run-in Results from a Phase 2 Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Tolerability; Pomalidomide; Lenalidomide; Multiple myeloma; Internal medicine; Adverse effect; Dexamethasone; Neutropenia; Pharmacology; Daratumumab; Oncology; Toxicity","score_opus":0.01756551560532309,"score_gpt":0.2862399001126101,"score_spread":0.268674384507287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389247674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99622333,0.000044713506,0.000001994139,0.00013010745,0.000022832519,0.0021159155,0.0009975177,0.000049477607,0.00041409172],"genre_scores_gemma":[0.9985299,0.000036273017,0.00016925515,0.000010267674,0.00001193496,0.000060119728,0.001080561,0.000023175848,0.00007850542],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976927,0.00021822767,0.0006824569,0.0005148993,0.00053158007,0.00036010589],"domain_scores_gemma":[0.99837023,0.0006284001,0.00013047933,0.0005314883,0.00015254598,0.00018683646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004690717,0.00020014143,0.0005446531,0.00032460282,0.00007322032,0.000010802656,0.00009529129,0.00008272004,0.000026548349],"category_scores_gemma":[0.00087946316,0.0001599292,0.000043451793,0.0006725894,0.00009934958,0.00013203445,0.00010068846,0.00027314096,0.00001333624],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01839457,0.033127528,0.9392228,0.000036957492,0.00018017023,0.00024365501,0.0014800269,0.000005680835,0.00010413044,0.0000033606996,0.000011854141,0.007189235],"study_design_scores_gemma":[0.21107762,0.0029663357,0.7847464,0.00011015266,0.00007038177,8.718692e-7,0.00041154068,0.000299059,0.00015433521,0.000019299701,0.000041615665,0.000102366095],"about_ca_topic_score_codex":0.0016748564,"about_ca_topic_score_gemma":0.00185825,"teacher_disagreement_score":0.19268304,"about_ca_system_score_codex":0.00011044663,"about_ca_system_score_gemma":0.00012232391,"threshold_uncertainty_score":0.6521723},"labels":[],"label_agreement":null},{"id":"W4389247677","doi":"10.1182/blood-2023-188649","title":"Once-Weekly Efanesoctocog Alfa Prophylaxis Provided High Sustained Factor VIII Activity Levels, Independent of Blood Group, in Children &amp;lt;12 Years of Age with Severe Hemophilia A","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster Children's Hospital","funders":"","keywords":"Medicine; Partial thromboplastin time; Internal medicine; Population; Clotting factor; Cryoprecipitate; Gastroenterology; Breakthrough bleeding; Bleed; Coagulation; Platelet; Surgery","score_opus":0.02467584443560855,"score_gpt":0.27351270563329677,"score_spread":0.24883686119768822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389247677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959115,0.000080052756,0.0000019810127,0.00027897613,0.000026545868,0.0032112815,0.00018593733,0.000104286846,0.00019944672],"genre_scores_gemma":[0.99657446,0.0000396857,0.00029372025,0.000010882259,0.000090683236,0.00015861791,0.00016000138,0.000068712325,0.0026032152],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99696743,0.00015452085,0.00047481814,0.0006030778,0.0011356097,0.00066455733],"domain_scores_gemma":[0.99856603,0.00014341928,0.00021266568,0.0006803139,0.00015940765,0.0002381623],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000340586,0.0003409208,0.0008509307,0.0005545872,0.000054709923,0.000018733897,0.0002639489,0.00028723446,0.00009833424],"category_scores_gemma":[0.00020986488,0.00026480318,0.00016566474,0.0011371978,0.00019283517,0.00013836304,0.00018692682,0.0004993912,0.000022340397],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016056418,0.0076792836,0.83540416,0.001030051,0.001727532,0.0013433481,0.0015644878,0.0000060954985,0.1436777,0.00006343223,0.000051909363,0.005846343],"study_design_scores_gemma":[0.016807545,0.003097389,0.935939,0.000286479,0.0003501641,0.000121927515,0.000121868194,0.0000034730856,0.04289104,0.00008152595,0.000027019862,0.00027257096],"about_ca_topic_score_codex":0.0009632156,"about_ca_topic_score_gemma":0.000492555,"teacher_disagreement_score":0.100786656,"about_ca_system_score_codex":0.00008703787,"about_ca_system_score_gemma":0.00047013492,"threshold_uncertainty_score":0.9999804},"labels":[],"label_agreement":null},{"id":"W4389247709","doi":"10.1182/blood-2023-189924","title":"A Multi-Modal Analysis of Acquired Resistance to Acalabrutinib and Pirtobrutinib Provides Potential Strategies to Augment Treatment Outcome with BTKi Drugs","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Bruton's tyrosine kinase; Cell culture; Ibrutinib; Carfilzomib; Biology; Chemistry; Cancer research; Genetics; Proteasome inhibitor; Chronic lymphocytic leukemia; Tyrosine kinase; Leukemia","score_opus":0.030795388579599573,"score_gpt":0.3369246149613652,"score_spread":0.30612922638176565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389247709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966147,0.00013289407,0.00019568574,0.0011715451,0.00002673246,0.0013411747,0.0000795661,0.0001175842,0.00032014886],"genre_scores_gemma":[0.9890462,0.000034625016,0.007100531,0.00009916243,0.00004526742,0.00021750074,0.00004972558,0.00003593213,0.0033710678],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99752295,0.0000591467,0.0004841249,0.0006239613,0.0007387704,0.0005710574],"domain_scores_gemma":[0.9985732,0.00013172548,0.00009368717,0.00061911595,0.00016582053,0.00041647203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031740652,0.0002713052,0.00076316856,0.0006456608,0.00008711421,0.00006131143,0.00015831362,0.00008577042,0.000037209265],"category_scores_gemma":[0.000112289745,0.00019494645,0.00015157659,0.001941004,0.00012571544,0.00007296694,0.00015548556,0.00005068084,0.00003391391],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.046478596,0.026301092,0.2192351,0.006708424,0.0785093,0.010865362,0.09853027,0.015237817,0.47222644,0.002263066,0.0031542785,0.020490244],"study_design_scores_gemma":[0.21265072,0.009507893,0.63898015,0.0009745415,0.0216471,0.00013034775,0.01985558,0.019886743,0.07190252,0.00006933807,0.002727475,0.0016675844],"about_ca_topic_score_codex":0.0008989002,"about_ca_topic_score_gemma":0.0011458752,"teacher_disagreement_score":0.41974506,"about_ca_system_score_codex":0.0014421446,"about_ca_system_score_gemma":0.0020807951,"threshold_uncertainty_score":0.79496855},"labels":[],"label_agreement":null},{"id":"W4389247802","doi":"10.1182/blood-2023-189567","title":"A High-Risk Subgroup Multiple Myeloma Classification Based on the Detection of PR Minor Subclones","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Multiple myeloma; Bone marrow; RNA; Gene signature; Gene expression; Biology; Gene; Transcriptome; Molecular biology; Cancer research; Internal medicine; Computational biology; Oncology; Medicine; Immunology; Genetics","score_opus":0.03507370313292706,"score_gpt":0.2737519082806611,"score_spread":0.23867820514773402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389247802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99802744,0.00003729294,0.0001248029,0.00066267647,0.000064838685,0.0007321807,0.00004956282,0.00011327337,0.00018790532],"genre_scores_gemma":[0.9990762,0.000043096345,0.00018473931,0.000032190153,0.00008811318,0.00020309896,0.00009920429,0.000021789114,0.0002515986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988042,0.00012366,0.00019396457,0.00023011003,0.00040990324,0.00023814575],"domain_scores_gemma":[0.9987437,0.0005275004,0.0001027135,0.0004350583,0.00009712337,0.00009388694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002785615,0.000119481556,0.00017242772,0.0001836829,0.00012886758,0.000011954122,0.00008368845,0.00007119257,0.000041670173],"category_scores_gemma":[0.00070586277,0.00007542613,0.00009803841,0.00048978714,0.00006284075,0.000030060233,0.000018942708,0.00014199638,0.00019492889],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010000947,0.0014720089,0.7768869,0.000110619934,0.0002340805,0.00005925884,0.000113761715,0.000013847837,0.19416082,0.00008282338,0.0001355507,0.025730243],"study_design_scores_gemma":[0.0046783327,0.0006216987,0.81433153,0.00004008666,0.00011862372,0.0000038590206,0.000107036416,0.009061519,0.17082796,0.000032568492,0.000121114455,0.000055692824],"about_ca_topic_score_codex":0.00040472526,"about_ca_topic_score_gemma":0.00013159351,"teacher_disagreement_score":0.03744463,"about_ca_system_score_codex":0.000030521172,"about_ca_system_score_gemma":0.000051380626,"threshold_uncertainty_score":0.30757883},"labels":[],"label_agreement":null},{"id":"W4389247812","doi":"10.1182/blood-2023-181468","title":"Genetic Variations in Multiple Myeloma with Extramedullary Disease","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency","funders":"","keywords":"Multiple myeloma; Medicine; Pathology; Exome sequencing; Equidae; Internal medicine; Biology; Gene; Genetics; Mutation","score_opus":0.025483248948040903,"score_gpt":0.27897756674187624,"score_spread":0.25349431779383536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389247812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99801695,0.00019798201,0.000066076245,0.00051422167,0.000019247327,0.00054280803,0.00003382542,0.00011888002,0.0004900111],"genre_scores_gemma":[0.99667454,0.00007281941,0.0022096313,0.00005260184,0.000063542044,0.00018696794,0.00011466387,0.000023618568,0.0006015893],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900687,0.00003328332,0.00012534224,0.00022678179,0.0002818063,0.00032590234],"domain_scores_gemma":[0.9992375,0.00009946887,0.00001880547,0.00028257008,0.000036815774,0.00032487983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000057010435,0.000102780345,0.00013522586,0.00020329937,0.000058554713,0.000014630798,0.000055881857,0.00003304379,0.00008375364],"category_scores_gemma":[0.00019118989,0.00007863651,0.00003737647,0.00052590726,0.000037628328,0.000037204394,0.000031363306,0.00010032384,0.00029625528],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023262396,0.0009006245,0.9903781,0.00005490339,0.00010007442,0.0037206064,0.000087646,0.00002371951,0.00062153715,0.000028575292,0.000091413225,0.0037601942],"study_design_scores_gemma":[0.007804182,0.00016885888,0.988518,0.00006853263,0.00008767776,0.000032739557,0.000030219886,0.0026768877,0.00025334937,0.000075314674,0.00020430419,0.000079949954],"about_ca_topic_score_codex":0.000084438885,"about_ca_topic_score_gemma":0.00012186024,"teacher_disagreement_score":0.007571558,"about_ca_system_score_codex":0.000024367435,"about_ca_system_score_gemma":0.00017549636,"threshold_uncertainty_score":0.38078612},"labels":[],"label_agreement":null},{"id":"W4389247829","doi":"10.1182/blood-2023-173692","title":"Mosunetuzumab Monotherapy Continues to Demonstrate Durable Responses in Patients with Relapsed and/or Refractory Follicular Lymphoma after ≥2 Prior Therapies: 3-Year Follow-up from a Pivotal Phase II Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Jewish General Hospital; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Follicular lymphoma; Internal medicine; Clinical endpoint; Refractory (planetary science); Phases of clinical research; Surrogate endpoint; Adverse effect; Regimen; Gastroenterology; Chemotherapy regimen; Oncology; Surgery; Lymphoma; Clinical trial; Chemotherapy","score_opus":0.016229743080162895,"score_gpt":0.28606857835725663,"score_spread":0.26983883527709374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389247829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959715,0.0003881123,0.000002876766,0.00021393543,0.000076272256,0.0030089817,0.00009469603,0.00016415546,0.00007946881],"genre_scores_gemma":[0.991315,0.0001399867,0.00029227967,0.00019099443,0.00007528701,0.00053145457,0.000039662435,0.000115563795,0.007299748],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971987,0.00030054245,0.0004474051,0.0007198142,0.0007436821,0.000589865],"domain_scores_gemma":[0.9985142,0.00028386092,0.000090857924,0.0006883304,0.00015074262,0.00027204005],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004814895,0.00035903242,0.0006520337,0.00044525263,0.00014667002,0.000079304205,0.00017406957,0.00013930429,0.00054480665],"category_scores_gemma":[0.00015649457,0.00026320296,0.00009507592,0.000853742,0.00009458556,0.00015816296,0.000096772,0.00021986413,0.00004078453],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20271368,0.012150587,0.67677075,0.000036077603,0.001426788,0.0015407226,0.0182246,8.141244e-7,0.044583432,9.851274e-7,0.00024940312,0.04230217],"study_design_scores_gemma":[0.19679196,0.030737098,0.76031756,0.0003089365,0.00021951637,0.0000091012125,0.0031023037,0.000025147308,0.005444872,0.000021042779,0.0025611958,0.00046124752],"about_ca_topic_score_codex":0.00044405324,"about_ca_topic_score_gemma":0.00054704247,"teacher_disagreement_score":0.08354683,"about_ca_system_score_codex":0.00010567565,"about_ca_system_score_gemma":0.0002691302,"threshold_uncertainty_score":0.999982},"labels":[],"label_agreement":null},{"id":"W4389247832","doi":"10.1182/blood-2023-178821","title":"Lymphodepletion Enables Successful BCMA CAR-T Cell Engraftment and Tumour Control in the Syngeneic Vk*MYC Model of Aggressive Myeloma","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; National Research Council Canada; Canada's Michael Smith Genome Sciences Centre; University of Ottawa; Terry Fox Research Institute; University of British Columbia","funders":"","keywords":"Chimeric antigen receptor; CD28; Multiple myeloma; Antigen; Cancer research; Immunology; Biology; T cell; Medicine; Immune system","score_opus":0.019522833264658066,"score_gpt":0.27105707369461324,"score_spread":0.25153424042995515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389247832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99488956,0.0020512012,0.000036269314,0.0006894481,0.000027330036,0.00088719086,0.000040782077,0.000040190735,0.0013380237],"genre_scores_gemma":[0.99740714,0.0011777449,0.000057836318,0.0001840936,0.00008524754,0.00015528203,0.000024802048,0.00003009516,0.0008777866],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983731,0.00017108534,0.0002766153,0.00028511355,0.00053118117,0.00036288786],"domain_scores_gemma":[0.9990537,0.00026478525,0.00015109233,0.0003406532,0.00010263828,0.00008710489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006353458,0.00016023793,0.00033908657,0.00022774462,0.000060889863,0.000024452384,0.00016721345,0.000088761444,0.00008332342],"category_scores_gemma":[0.00010480806,0.00011305255,0.00008453155,0.00037887043,0.00009490483,0.000043952517,0.000058191017,0.0001604941,0.000014378477],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040422735,0.0006739157,0.026449949,0.0003128218,0.00013095172,0.00033891972,0.0021639476,0.00044225878,0.96490115,0.00007240345,0.00030321997,0.00380625],"study_design_scores_gemma":[0.04162794,0.0015628305,0.11287885,0.00057507574,0.0007458878,0.00028638903,0.003673508,0.07201131,0.76442575,0.0011137844,0.00056972384,0.0005289473],"about_ca_topic_score_codex":0.00021105417,"about_ca_topic_score_gemma":0.000065245295,"teacher_disagreement_score":0.20047538,"about_ca_system_score_codex":0.00004721458,"about_ca_system_score_gemma":0.00016537096,"threshold_uncertainty_score":0.4610149},"labels":[],"label_agreement":null},{"id":"W4389247866","doi":"10.1182/blood-2023-178431","title":"An International Multicenter Study of Primary Vitreoretinal Lymphoma from the Australasian Lymphoma Alliance and Collaborators","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Concomitant; Lymphoma; Primary central nervous system lymphoma; Internal medicine; Pediatrics; Intraocular lymphoma; Hematology","score_opus":0.014118959016323679,"score_gpt":0.2724052178235155,"score_spread":0.2582862588071918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389247866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99821913,0.00017199492,3.9128025e-7,0.0005120586,0.00014512103,0.0005193451,0.00012017754,0.000056146484,0.00025563836],"genre_scores_gemma":[0.99913716,0.00016721198,0.00015952805,0.00016311996,0.00015058299,0.00007732607,0.0000892799,0.00002064291,0.000035119305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882746,0.00005516642,0.00024267235,0.00030589855,0.000405471,0.00016335308],"domain_scores_gemma":[0.99922067,0.00010233251,0.000091186834,0.00035682664,0.00012259513,0.0001064051],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001245736,0.00014908456,0.0002401435,0.00004554436,0.00006853019,0.000037504764,0.00014634215,0.0000463364,0.000040442825],"category_scores_gemma":[0.000043421773,0.00010283911,0.000043931657,0.00024645115,0.00007525399,0.0000800594,0.000066377215,0.00002465099,0.000020478594],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021548726,0.0073501337,0.96847904,0.000012002841,0.00049239834,0.00027843693,0.0013380614,9.899252e-7,0.0013115765,0.000023743942,0.0003373185,0.020160828],"study_design_scores_gemma":[0.014786777,0.0006268323,0.97827834,0.000083101906,0.00035620702,0.000015239175,0.0021086321,0.0000574751,0.0027789506,0.0000095037085,0.0008138162,0.00008512138],"about_ca_topic_score_codex":0.00041794326,"about_ca_topic_score_gemma":0.00015086465,"teacher_disagreement_score":0.020075707,"about_ca_system_score_codex":0.00007994118,"about_ca_system_score_gemma":0.00010194562,"threshold_uncertainty_score":0.41936573},"labels":[],"label_agreement":null},{"id":"W4389247895","doi":"10.1182/blood-2023-182897","title":"<i>Ureaplasma</i>-Induced Hyperammonemia Syndrome - an Acute Complication Post Allogeneic Stem Cell Transplant","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Metabolism and Genetic Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Juravinski Hospital; Juravinski Cancer Centre; Population Health Research Institute; McMaster University","funders":"","keywords":"Medicine; Hyperammonemia; Internal medicine; Gastroenterology; Lethargy; Surgery","score_opus":0.010932359970954061,"score_gpt":0.22570300686683686,"score_spread":0.2147706468958828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389247895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981893,0.0003782238,0.00006380158,0.00010295924,0.00013907863,0.00024078858,0.00016716217,0.00006335444,0.0006553722],"genre_scores_gemma":[0.99680996,0.00047294886,0.00017503693,0.00025653795,0.000067780195,0.00004960504,0.0015421513,0.000038030634,0.0005879756],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988053,0.000060736747,0.00020383109,0.0004593482,0.00014886011,0.00032196345],"domain_scores_gemma":[0.9992241,0.000006406413,0.000056262455,0.0005222568,0.0000483255,0.00014260091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011410129,0.00019129405,0.00017378293,0.00005872575,0.00009589598,0.000028480094,0.00030005563,0.00017293108,0.000014454649],"category_scores_gemma":[0.0000019343654,0.00018704412,0.00008557175,0.00016561481,0.00002910439,0.000004502793,0.00004649083,0.00007023215,0.00014605022],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029539508,0.00020886329,0.0012910619,0.000019453671,0.000082737504,0.000024948928,0.00012592612,0.000022326816,0.99667066,0.00001854461,0.00021236486,0.0012935866],"study_design_scores_gemma":[0.0025346559,0.00078930747,0.056105655,0.000010086555,0.0003356725,0.000268048,0.00022798232,0.000044024266,0.9335601,0.000035757064,0.0055666873,0.00052205555],"about_ca_topic_score_codex":0.000023866893,"about_ca_topic_score_gemma":0.000031363074,"teacher_disagreement_score":0.06311058,"about_ca_system_score_codex":0.0000011773498,"about_ca_system_score_gemma":0.000053872307,"threshold_uncertainty_score":0.7627438},"labels":[],"label_agreement":null},{"id":"W4389247966","doi":"10.1182/blood-2023-190347","title":"Effects of Prolonged Tourniquet Application on Coagulation and Fibrinolysis in Rats","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster Children's Hospital; Thrombosis and Atherosclerosis Research Institute; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Tourniquet; Anesthesia; Fibrinolysis; Hemostasis; Thrombosis; Fibrin; Surgery; Pulmonary embolism; Deep vein; Internal medicine","score_opus":0.006900546572982929,"score_gpt":0.2422182289601146,"score_spread":0.2353176823871317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389247966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99775416,0.000043152722,0.00007084244,0.00070244225,0.000011558164,0.00074464636,5.408282e-7,0.00004770748,0.00062493],"genre_scores_gemma":[0.9994639,0.00010290139,0.00008389542,0.00009015124,0.000014651349,0.00008130685,0.000012035785,0.0000057821717,0.00014538925],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9996105,0.000018203531,0.000098731216,0.000111799876,0.000095324955,0.00006543354],"domain_scores_gemma":[0.9998175,0.000030892603,0.000024368146,0.00009020962,0.000012188937,0.000024827457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008848142,0.0000447555,0.00011251638,0.00013755988,0.000011149788,0.0000022265683,0.00001545962,0.0000321957,0.0000029489706],"category_scores_gemma":[0.00001655175,0.000039733677,0.000018105671,0.00023214027,0.000009731639,0.000013820612,0.000010822774,0.000040384602,0.000008538835],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036702317,0.0020389592,0.10941042,0.0020572902,0.00019621127,0.00007634099,0.0011330256,0.00003880051,0.79188097,0.001995027,0.0005695234,0.090236396],"study_design_scores_gemma":[0.0029000535,0.00022332917,0.7338766,0.00009358343,0.00013186922,0.0000015830517,0.000017930817,0.00025524618,0.26211858,0.00008899736,0.00025332588,0.000038880135],"about_ca_topic_score_codex":0.000019483698,"about_ca_topic_score_gemma":0.000016017319,"teacher_disagreement_score":0.6244662,"about_ca_system_score_codex":0.0000035599035,"about_ca_system_score_gemma":0.0000053997464,"threshold_uncertainty_score":0.16202924},"labels":[],"label_agreement":null},{"id":"W4389247975","doi":"10.1182/blood-2023-181195","title":"Health-Related Quality of Life (HRQoL) in Patients with Relapsed/Refractory Follicular Lymphoma (R/R FL) Treated with Zanubrutinib+ Obinutuzumab Versus Obinutuzumab Monotherapy: The Rosewood Trial","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Obinutuzumab; Medicine; Internal medicine; Quality of life (healthcare); Nausea; Vomiting; Progression-free survival; Clinical endpoint; Oncology; Clinical trial; Rituximab; Lymphoma; Chemotherapy","score_opus":0.03201026781181236,"score_gpt":0.29477895216608,"score_spread":0.26276868435426765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389247975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99441344,0.00071218197,0.0000020540028,0.00029567038,0.00018469246,0.003535705,0.00005925758,0.00025546728,0.0005415613],"genre_scores_gemma":[0.9985181,0.00015303539,0.00005948707,0.0001267012,0.00010924246,0.00023257446,0.00030347242,0.00013955588,0.00035779938],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99418217,0.00074228813,0.0014377037,0.00082367647,0.0017611489,0.0010529864],"domain_scores_gemma":[0.99620914,0.000889718,0.00069054944,0.0014827847,0.0003112642,0.00041656123],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014311911,0.00051028375,0.0014130678,0.00039739397,0.00019619694,0.000036219997,0.00044582796,0.00034236148,0.000069783244],"category_scores_gemma":[0.0006321986,0.0003167092,0.00023532409,0.0023346266,0.00038671127,0.00014681938,0.00011546966,0.00048894226,0.00006639104],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.92859596,0.008258225,0.043117564,0.0008178896,0.00465735,0.00047181686,0.0047946987,0.0005793359,0.00021395931,0.00040124808,0.0010945444,0.006997404],"study_design_scores_gemma":[0.8750659,0.0118002575,0.11012172,0.00036262788,0.00023946361,0.000017576529,0.00047711644,0.0006117933,0.000498319,0.000020050946,0.0003820442,0.0004030954],"about_ca_topic_score_codex":0.0106805,"about_ca_topic_score_gemma":0.0006918018,"teacher_disagreement_score":0.06700415,"about_ca_system_score_codex":0.011700554,"about_ca_system_score_gemma":0.021808673,"threshold_uncertainty_score":0.9999285},"labels":[],"label_agreement":null},{"id":"W4389247977","doi":"10.1182/blood-2023-180088","title":"Real-World Response Rates across Lines of Therapy Among Patients with Relapsed/Refractory Follicular Lymphoma","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Obinutuzumab; Medicine; Bendamustine; Rituximab; Internal medicine; Follicular lymphoma; Chemoimmunotherapy; Oncology; Salvage therapy; Vincristine; Chlorambucil; Lenalidomide; Maintenance therapy; Surgery; Lymphoma; Cyclophosphamide; Chemotherapy; Multiple myeloma","score_opus":0.014775043117736685,"score_gpt":0.2817246509657994,"score_spread":0.2669496078480627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389247977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985339,0.0002939485,1.9628449e-7,0.00013589863,0.00007430492,0.00054111506,0.000053196018,0.00012779822,0.00023966306],"genre_scores_gemma":[0.99783415,0.00057112466,0.0000862502,0.000075126685,0.000059096266,0.00011864722,0.000116984025,0.000044327426,0.0010942952],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866736,0.00008351024,0.00028662995,0.0002963323,0.00036174816,0.00030441565],"domain_scores_gemma":[0.9988312,0.0002652051,0.00015273113,0.0004574821,0.00016861045,0.00012474737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022009101,0.00020654405,0.0003793926,0.00013442746,0.000088087414,0.000017178281,0.000081834085,0.000077588295,0.000026441097],"category_scores_gemma":[0.000073496834,0.00013385534,0.00012617119,0.000574207,0.000104333245,0.00007730722,0.000037125268,0.000039408576,0.000042134383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002733263,0.0037461477,0.98749995,0.000028566801,0.00048577983,0.00024281465,0.000501977,0.0000024126648,0.0011133893,0.000009736879,0.00046857953,0.0031673794],"study_design_scores_gemma":[0.024831774,0.0014657145,0.92236984,0.00018349668,0.00014442005,0.0000028213167,0.000085686974,0.0000044532794,0.04898629,0.000008515889,0.0017865846,0.00013038224],"about_ca_topic_score_codex":0.00038512843,"about_ca_topic_score_gemma":0.00009338488,"teacher_disagreement_score":0.06513009,"about_ca_system_score_codex":0.000057335354,"about_ca_system_score_gemma":0.00011835674,"threshold_uncertainty_score":0.5458462},"labels":[],"label_agreement":null},{"id":"W4389247985","doi":"10.1182/blood-2023-177567","title":"Response to Subsequent Novel Therapies and Time to Second Progression-Free Survival Event in the MURANO Trial in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Previously Treated with Fixed-Dose Venetoclax Plus Rituximab","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Incyte; BeiGene; F. Hoffmann-La Roche; TG Therapeutics; Gilead Sciences; Genentech; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Venetoclax; Internal medicine; Bendamustine; Regimen; Progression-free survival; Rituximab; Randomized controlled trial; Oncology; Chronic lymphocytic leukemia; Surgery; Leukemia; Chemotherapy; Lymphoma","score_opus":0.014153826699321803,"score_gpt":0.2723629041360706,"score_spread":0.2582090774367488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389247985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99222136,0.00042561765,0.0000018034714,0.00026666393,0.000046830264,0.006782169,0.00004900399,0.00010571547,0.000100817844],"genre_scores_gemma":[0.99718744,0.000028983102,0.00012890232,0.00017544614,0.00010318153,0.0010971399,0.00007752993,0.00009933528,0.0011020222],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9957691,0.00052620046,0.0005782104,0.00079232804,0.0013777241,0.0009564457],"domain_scores_gemma":[0.99741775,0.00082290056,0.0001257602,0.0011617875,0.00013334947,0.00033846212],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017576062,0.0004370234,0.0007482865,0.00048087843,0.00010836309,0.00007727686,0.0004896878,0.00018662422,0.00010229398],"category_scores_gemma":[0.0005440072,0.00026588587,0.0000685739,0.0015383271,0.00017172817,0.00012717675,0.00024154242,0.00039417716,0.0001427599],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.95202804,0.0033005278,0.012376975,0.0007806903,0.0007788158,0.002960142,0.012555008,0.002321194,0.0063230316,0.000011634888,0.001700169,0.004863805],"study_design_scores_gemma":[0.831948,0.01621829,0.145377,0.0016210476,0.00015506736,0.00011719264,0.000275733,0.0016602331,0.0006424028,0.000005893954,0.0014850356,0.0004941483],"about_ca_topic_score_codex":0.00078183506,"about_ca_topic_score_gemma":0.0010796002,"teacher_disagreement_score":0.13300002,"about_ca_system_score_codex":0.050141126,"about_ca_system_score_gemma":0.029952185,"threshold_uncertainty_score":0.9999793},"labels":[],"label_agreement":null},{"id":"W4389247999","doi":"10.1182/blood-2023-178772","title":"Red Blood Cell Transfusion Independence Status Is an Independent Predictor of Survival: A Post Hoc Time-Dependent Analysis of the Phase 3 Simplify-1, Simplify-2, and Momentum Trials","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Ruxolitinib; Myelofibrosis; Anemia; Internal medicine; Blood transfusion; Post-hoc analysis; International Prognostic Scoring System; Oncology; Bone marrow; Myelodysplastic syndromes","score_opus":0.031653870898847254,"score_gpt":0.3116797957853737,"score_spread":0.28002592488652644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389247999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940118,0.0004645542,0.000019380586,0.00049254234,0.000119118195,0.0019162423,0.0026405202,0.00007940036,0.00025643918],"genre_scores_gemma":[0.99686384,0.0019981693,0.000084958105,0.00010143589,0.00006675983,0.00014055958,0.0003443428,0.000051654974,0.00034828333],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99525505,0.0005787295,0.0013241543,0.0007991215,0.0015078298,0.0005351002],"domain_scores_gemma":[0.9969437,0.0006158049,0.00066880346,0.0009361978,0.0004221404,0.0004133568],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001584149,0.00043749987,0.001765818,0.0006343349,0.00015232604,0.00003873852,0.00025359177,0.0002724005,0.00064372626],"category_scores_gemma":[0.00032546296,0.0002957395,0.0005564208,0.001494787,0.00013157094,0.00013201276,0.0001632474,0.00029163458,0.000009242253],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024519057,0.017860474,0.5664171,0.00044803292,0.011070019,0.00015441242,0.005863946,0.00012233546,0.39344347,0.000050813578,0.0002121289,0.0019053564],"study_design_scores_gemma":[0.049492456,0.006877735,0.28586504,0.00022017669,0.031030847,0.000026602655,0.0013160364,0.0011937639,0.6232292,0.000100166995,0.00018304601,0.0004649206],"about_ca_topic_score_codex":0.00040711882,"about_ca_topic_score_gemma":0.00027030124,"teacher_disagreement_score":0.2805521,"about_ca_system_score_codex":0.00004681301,"about_ca_system_score_gemma":0.00031375882,"threshold_uncertainty_score":0.99994946},"labels":[],"label_agreement":null},{"id":"W4389248024","doi":"10.1182/blood-2023-180233","title":"Real-World Tisagenlecleucel Outcomes in Richter-Transformed Chronic Lymphocytic Leukemia: A Center for International Blood &amp; Marrow Transplant Research (CIBMTR) Analysis","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Juravinski Hospital","funders":"","keywords":"Medicine; Cytokine release syndrome; Internal medicine; Aggressive lymphoma; Oncology; Cumulative incidence; Transplantation; Rituximab; Lymphoma; Chimeric antigen receptor; Cancer; Immunotherapy","score_opus":0.06427681933567496,"score_gpt":0.3831817213200614,"score_spread":0.3189049019843864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389248024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893193,0.00014463246,0.000059426893,0.00085811416,0.00025734075,0.0016100182,0.0003569177,0.00018612413,0.0072081103],"genre_scores_gemma":[0.95225346,0.0019261462,0.00026046566,0.000095138246,0.0004819016,0.00065368623,0.0012493564,0.00009762007,0.042982213],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957045,0.0001891939,0.00071502855,0.0007671724,0.0014022236,0.0012219076],"domain_scores_gemma":[0.99775916,0.0007300298,0.00006526449,0.0007090268,0.00044208826,0.00029442937],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018123533,0.00030921906,0.00077929645,0.003183755,0.00013598854,0.0000821,0.00051655166,0.00019889248,0.0019679966],"category_scores_gemma":[0.00025412187,0.00027785572,0.00059085677,0.003647593,0.0001545886,0.000118009586,0.00008094836,0.00060872466,0.0002145397],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021547365,0.001617159,0.81950814,0.00074671383,0.010659032,0.0008670927,0.0021571273,0.000247676,0.15552495,0.0001241084,0.002119859,0.0042733876],"study_design_scores_gemma":[0.10385809,0.0016702028,0.7848469,0.0007740079,0.005570927,0.0001266064,0.00024588636,0.009667573,0.056515925,0.00051960227,0.034959152,0.0012450975],"about_ca_topic_score_codex":0.0016863263,"about_ca_topic_score_gemma":0.017712446,"teacher_disagreement_score":0.10170335,"about_ca_system_score_codex":0.0028098081,"about_ca_system_score_gemma":0.0016261509,"threshold_uncertainty_score":0.99996734},"labels":[],"label_agreement":null},{"id":"W4389248026","doi":"10.1182/blood-2023-187346","title":"Longitudinal Patient-Reported Outcomes and Clinical Outcomes By VES-13 and Comprehensive Geriatric Assessment in Older Adults with Aggressive Non-Hodgkin Lymphomas","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Frailty in Older Adults","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"AstraZeneca","keywords":"Medicine; Quality of life (healthcare); Hospital Anxiety and Depression Scale; Depression (economics); Anxiety; Geriatric Depression Scale; Physical therapy; Geriatric oncology; Cancer; Internal medicine; Psychiatry","score_opus":0.01796065264430648,"score_gpt":0.32005500353576755,"score_spread":0.3020943508914611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389248026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963517,0.0004483746,0.000009454345,0.0013086151,0.00022691363,0.0013054087,0.000042067903,0.00012712846,0.00018029052],"genre_scores_gemma":[0.9977166,0.00041705678,0.0008254844,0.0004053312,0.00004369296,0.00009779195,0.00012391468,0.000054358938,0.0003157562],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972032,0.00010336551,0.0008681716,0.00079209846,0.00054295495,0.00049023086],"domain_scores_gemma":[0.9978705,0.0006976386,0.00048366882,0.00046512598,0.00017833816,0.0003047043],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018497722,0.00039985997,0.0009894203,0.00027405622,0.00008127653,0.00004559432,0.00009233277,0.00019156912,0.00002513239],"category_scores_gemma":[0.0003046778,0.00029374158,0.000109056295,0.0004850775,0.00021316955,0.00012344058,0.00018574558,0.00036440007,0.000012263766],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023294958,0.0011052381,0.9877502,0.00014037974,0.00061886857,0.0021877778,0.00062949746,0.0000013306632,0.000028711125,0.0000018510303,0.0015958119,0.00570744],"study_design_scores_gemma":[0.033496853,0.0011338212,0.9625944,0.0005388973,0.0004708998,0.00036777058,0.0007772122,0.00013435214,0.000071915754,0.000009395545,0.00008515332,0.0003193302],"about_ca_topic_score_codex":0.0004165351,"about_ca_topic_score_gemma":0.00019125357,"teacher_disagreement_score":0.033263903,"about_ca_system_score_codex":0.0000479139,"about_ca_system_score_gemma":0.00015815235,"threshold_uncertainty_score":0.9999515},"labels":[],"label_agreement":null},{"id":"W4389248037","doi":"10.1182/blood-2023-186763","title":"A Randomized Clinical Trial Testing the Effect of Digital Behavioral Interventions on Pain and Mental Health Among Adults with Sickle Cell Disease","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; SickKids Foundation; Institute for Clinical Evaluative Sciences","funders":"","keywords":"Psychological intervention; Medicine; Psychosocial; Randomized controlled trial; Physical therapy; Anxiety; Cognitive behavioral therapy; Intervention (counseling); Chronic pain; Disease; Psychoeducation; Mental health; Clinical trial; Psychiatry; Internal medicine","score_opus":0.027745089832752208,"score_gpt":0.3303962659903957,"score_spread":0.3026511761576435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389248037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99656314,0.00025561042,0.0000056904705,0.00050488743,0.0000795069,0.002332663,0.000031685347,0.00005999758,0.00016680556],"genre_scores_gemma":[0.99961525,0.00003407178,0.000014803786,0.000033428194,0.00004891764,0.00007309903,0.00007362418,0.000013657514,0.0000931261],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99853647,0.00051210984,0.00043066114,0.00017998369,0.00017313076,0.00016763656],"domain_scores_gemma":[0.9983465,0.0011501369,0.00016326486,0.0001484418,0.000018201943,0.00017342319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018997442,0.00011281729,0.0004496219,0.000049063554,0.00009561679,0.000018526054,0.000042260246,0.00004471125,0.000004916739],"category_scores_gemma":[0.0008970026,0.000056952744,0.00026709956,0.00017908694,0.00024770648,0.000029764173,0.00003407577,0.0001957788,0.000003885526],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7091167,0.003227446,0.2565953,0.0007604262,0.00022802352,0.000081148726,0.00066694815,0.00000540373,0.0000062217146,0.0000051009324,0.00047918275,0.028828107],"study_design_scores_gemma":[0.9680779,0.019353617,0.009101409,0.0015621551,0.000595125,0.000004875229,0.0005315267,0.00065166695,0.000017851638,0.0000057757047,0.000013910764,0.00008417228],"about_ca_topic_score_codex":0.000049091148,"about_ca_topic_score_gemma":0.0000061277947,"teacher_disagreement_score":0.25896123,"about_ca_system_score_codex":0.0000062726303,"about_ca_system_score_gemma":0.000054427575,"threshold_uncertainty_score":0.23224655},"labels":[],"label_agreement":null},{"id":"W4389248060","doi":"10.1182/blood-2023-174093","title":"Survival Patterns of Non-Randomized Patients in the IELSG37 Study: Deauville Score 4 Is Not Necessarily Associated with Poor Outcome in Primary Mediastinal Lymphoma","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Interquartile range; Rituximab; Internal medicine; Randomized controlled trial; Lymphoma; Randomization; Positron emission tomography; Oncology; Surgery; Nuclear medicine","score_opus":0.025186645666516735,"score_gpt":0.2696481536327393,"score_spread":0.24446150796622257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389248060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969625,0.000023062643,0.0000010632571,0.00043598193,0.0000954892,0.0018987381,0.00009027952,0.000029779147,0.00046312268],"genre_scores_gemma":[0.9987897,0.000028004148,0.0000142221925,0.0005245376,0.000030420562,0.00035859036,0.00018247917,0.000027251115,0.000044796852],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975888,0.00028456916,0.0006403672,0.0003264174,0.0008171716,0.0003426459],"domain_scores_gemma":[0.998329,0.00096970465,0.00022977937,0.00030326494,0.00009959522,0.000068701076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093735533,0.00024159535,0.0009834314,0.00022740183,0.000040738476,0.000016324835,0.00017485338,0.00008207891,0.000021812912],"category_scores_gemma":[0.00033908745,0.00013795396,0.00013295755,0.00061989354,0.00006316948,0.000054580065,0.000074016745,0.00009343199,0.00001342583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045954213,0.011798796,0.9781112,0.00005570255,0.0003972117,0.0004807184,0.003443322,0.0000016547724,0.000009883372,0.0000033709528,0.000040119827,0.0010626152],"study_design_scores_gemma":[0.2844939,0.0006839553,0.7132232,0.00021277199,0.00039810335,0.0000029688645,0.0006980872,0.00002187206,0.0001616188,0.0000032988862,0.0000022210627,0.000097975724],"about_ca_topic_score_codex":0.0023754863,"about_ca_topic_score_gemma":0.0013029911,"teacher_disagreement_score":0.2798985,"about_ca_system_score_codex":0.00012438602,"about_ca_system_score_gemma":0.0001427701,"threshold_uncertainty_score":0.5625599},"labels":[],"label_agreement":null},{"id":"W4389248089","doi":"10.1182/blood-2023-173240","title":"Retrospective Study of Blood Transfusion Utilization in Surgical Patients in a Quebec, Canada Health Region: Do We Overestimate the Surgical Risk","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Trauma and Emergency Care Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches; University of Toronto; Cégep de Lévis","funders":"","keywords":"Medicine; Blood transfusion; Retrospective cohort study; Population; Surgery; Elective surgery; Health care; Emergency medicine; General surgery; Environmental health","score_opus":0.02789891621468013,"score_gpt":0.2914041089582857,"score_spread":0.2635051927436056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389248089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99654084,0.0010798073,2.8227106e-7,0.0009102234,0.00015058048,0.0008352207,0.000022534436,0.000029578994,0.0004309126],"genre_scores_gemma":[0.99386215,0.0059339995,0.0000015530765,0.000009514099,0.000042209675,0.000037911617,0.00001808886,0.000013814644,0.00008074086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982536,0.00021954565,0.00047665922,0.0002923577,0.0004788805,0.00027897122],"domain_scores_gemma":[0.99945694,0.00006807158,0.00010231244,0.00021911887,0.00008630083,0.00006725679],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025219432,0.00014158382,0.00042246346,0.00012513116,0.00009519532,0.0000042098386,0.00006986054,0.000050692623,0.000018801475],"category_scores_gemma":[0.00007869302,0.00009845645,0.00005285714,0.001009931,0.000037831596,0.0000316346,0.000035935118,0.0002364562,9.095483e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021295322,0.0020507353,0.98777366,0.00006301868,0.00008026938,0.00043027836,0.0060987794,0.000028814677,9.6058e-7,0.000040268602,0.00044791677,0.002772359],"study_design_scores_gemma":[0.010277659,0.000660577,0.984333,0.00018276939,0.00010647974,0.0000091862585,0.003683124,0.000025940206,0.00001414745,0.00003012459,0.0005922534,0.00008477818],"about_ca_topic_score_codex":0.8347183,"about_ca_topic_score_gemma":0.98426557,"teacher_disagreement_score":0.14954732,"about_ca_system_score_codex":0.00010100759,"about_ca_system_score_gemma":0.00026425163,"threshold_uncertainty_score":0.40149373},"labels":[],"label_agreement":null},{"id":"W4389248091","doi":"10.1182/blood-2023-179316","title":"Caplacizumab Frontline Added to Therapeutic Plasma Exchange and Immunosuppression Prevents Unfavorable Outcomes in Immune-Mediated TTP: An International Real-World Study of the TTP-IWG (The Capla 500 Project)","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Medicine; Rituximab; ADAMTS13; Immunosuppression; Internal medicine; Regimen; Salvage therapy; Thrombotic thrombocytopenic purpura; Gastroenterology; Immunology; Platelet; Chemotherapy","score_opus":0.029216856165470595,"score_gpt":0.30963520356276547,"score_spread":0.2804183473972949,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389248091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956492,0.00025530977,3.6401568e-7,0.00023496892,0.0006830929,0.0026452525,0.00022550747,0.00007389461,0.00023240224],"genre_scores_gemma":[0.996811,0.000052977637,0.0000048746992,0.00003609802,0.000022756141,0.00053473667,0.00021718188,0.00002466254,0.0022957246],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99779683,0.00078547286,0.0005938994,0.0003564523,0.00014411983,0.00032320412],"domain_scores_gemma":[0.9986746,0.00032843172,0.00024015312,0.0006773318,0.00005915513,0.00002034639],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005063582,0.00022231694,0.000389014,0.00029283235,0.00018835028,0.000023830056,0.00072319614,0.00007825552,0.0002022434],"category_scores_gemma":[0.00011478251,0.00013703087,0.000069374204,0.00044715693,0.00007291088,0.000109953355,0.0005139295,0.00019524065,0.000047158],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007169183,0.0040164646,0.87932277,0.00006723947,0.0011441525,0.0000133087515,0.011671641,0.000032185813,0.10057185,0.000028337112,0.0012348423,0.0011802822],"study_design_scores_gemma":[0.009903024,0.00050544593,0.9710524,0.00015900291,0.00017008546,0.000010052301,0.005457753,0.000048871236,0.010624841,0.000019185773,0.0018390897,0.00021022095],"about_ca_topic_score_codex":0.0029035483,"about_ca_topic_score_gemma":0.005179935,"teacher_disagreement_score":0.09172965,"about_ca_system_score_codex":0.000044671204,"about_ca_system_score_gemma":0.000073840005,"threshold_uncertainty_score":0.5587957},"labels":[],"label_agreement":null},{"id":"W4389248130","doi":"10.1182/blood-2023-190180","title":"Single Cell Transcriptomic Analysis of B-Cell Acute Lymphoblastic Leukemia (B-ALL) Reveals Correlation between Leukemia Cell State, Genetic Alterations and Clinical Outcome","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Biology; Transcriptome; Gene; Leukemia; Genetics; Gene expression; Cell cycle; B cell; Gene expression profiling; Molecular biology; Cancer research","score_opus":0.018719256698438054,"score_gpt":0.273539952154337,"score_spread":0.25482069545589897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389248130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99516135,0.00042451685,0.0031389715,0.000015290212,0.00014512455,0.00021778177,0.0006093103,0.000018980692,0.0002686615],"genre_scores_gemma":[0.99589294,0.001252574,0.0009660816,0.00010076597,0.00012443076,0.0000119810875,0.0009623051,0.00003457229,0.00065432227],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982775,0.000074895084,0.00076610025,0.00046486454,0.00013696738,0.0002797117],"domain_scores_gemma":[0.9989463,0.00017529154,0.00024986843,0.00039338373,0.00008346324,0.0001516954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021108692,0.00020091816,0.00042156817,0.00018360913,0.000069047775,0.000039935734,0.00014399571,0.00020325961,0.000009498346],"category_scores_gemma":[0.000047104175,0.00021705704,0.0002562868,0.00038887575,0.00008092648,0.0000053798026,0.0000856352,0.00010153034,0.0000147762985],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041051317,0.00024067471,0.28359535,0.00006892308,0.0008648874,0.00001290533,0.00012720257,0.007821512,0.7062765,0.0000027383312,0.0006421394,0.00030616473],"study_design_scores_gemma":[0.008347347,0.0015514899,0.5540544,0.00002219753,0.013954632,0.000006417713,0.00008520844,0.009974722,0.40948784,0.00012444232,0.0015452363,0.00084611325],"about_ca_topic_score_codex":0.00006913546,"about_ca_topic_score_gemma":0.00011319036,"teacher_disagreement_score":0.2967886,"about_ca_system_score_codex":0.00006195824,"about_ca_system_score_gemma":0.0002175421,"threshold_uncertainty_score":0.8851329},"labels":[],"label_agreement":null},{"id":"W4389248132","doi":"10.1182/blood-2023-190141","title":"Risk-Adjusted Therapies Yield Equivalent Outcomes for Adolescents and Young Adults (AYAs) Treated for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (T-ALL) on Children's Oncology Group (COG) Studies AALL0434 and AALL1231","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Cog; Internal medicine; Young adult; Prednisone; Randomized controlled trial; Pediatrics; Acute lymphocytic leukemia; Lymphoblastic Leukemia; Leukemia","score_opus":0.03205139315743662,"score_gpt":0.310809866144974,"score_spread":0.2787584729875374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389248132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99184966,0.0013418624,0.0001455386,0.00067733397,0.0002828696,0.0047794157,0.00053256814,0.0003369256,0.000053825344],"genre_scores_gemma":[0.99025095,0.0056838416,0.0007939137,0.00059699133,0.00027587186,0.0011546721,0.00027668878,0.00015324273,0.000813861],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99653274,0.0001279494,0.0006496877,0.0010481712,0.00054194423,0.0010995318],"domain_scores_gemma":[0.99555844,0.002950037,0.00029769936,0.00050276594,0.00028428904,0.00040679603],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044359217,0.0006427005,0.0012048539,0.00043790284,0.00033522464,0.00006420099,0.0002556978,0.0003957352,0.000008174198],"category_scores_gemma":[0.0014960613,0.00049058464,0.00024776536,0.000359325,0.0003135465,0.000114521565,0.0002782823,0.0003138411,0.000020332964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024584623,0.0061395774,0.8651052,0.0037099884,0.018702509,0.0012146564,0.011394207,0.000043970264,0.014908153,0.00016405848,0.016845154,0.03718787],"study_design_scores_gemma":[0.16913952,0.015287173,0.7934019,0.0015366246,0.007343066,0.00023486195,0.00274503,0.0026778327,0.0060609225,0.00015983806,0.0003617437,0.0010515084],"about_ca_topic_score_codex":0.00037411758,"about_ca_topic_score_gemma":0.00023214212,"teacher_disagreement_score":0.1445549,"about_ca_system_score_codex":0.0006639201,"about_ca_system_score_gemma":0.00033249607,"threshold_uncertainty_score":0.9997546},"labels":[],"label_agreement":null},{"id":"W4389248139","doi":"10.1182/blood-2023-188108","title":"The Impact of Post-Transplant Cyclophosphamide (PTCy) with or without MMF in the Prevention of <i>De Novo</i> and <i>Progressive / Relapsing</i> Chronic Graft-Versus-Host Disease after HLA-Matched Donor Transplant","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Graft-versus-host disease; Internal medicine; Cumulative incidence; Gastroenterology; Incidence (geometry); Cyclophosphamide; Transplantation; Immunology; Chemotherapy","score_opus":0.010568591538142602,"score_gpt":0.2765577471337818,"score_spread":0.2659891555956392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389248139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99603343,0.0018088724,0.000072537,0.00036227313,0.000049081686,0.001331129,0.00021512102,0.0000426253,0.00008491651],"genre_scores_gemma":[0.99721813,0.0021926148,0.00011633859,0.000031769483,0.00003908688,0.00019488351,0.00010906023,0.000039832314,0.000058290647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824,0.00015184749,0.00048666148,0.000294538,0.00042476715,0.0004022156],"domain_scores_gemma":[0.9987297,0.00045692042,0.00019413955,0.00039252156,0.00008465404,0.00014206878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005099312,0.00025797886,0.00042099576,0.0001015232,0.000076391756,0.000022255977,0.00015626743,0.00009141348,0.000021254838],"category_scores_gemma":[0.000028247689,0.00012776333,0.00015306966,0.00049251836,0.0002452175,0.00009101478,0.000009636954,0.00021350656,0.0000034437999],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055880908,0.0015702777,0.85176927,0.0039023273,0.0010046343,0.0026438646,0.023325289,0.00007121798,0.059250914,0.00006800782,0.00002094001,0.0004923285],"study_design_scores_gemma":[0.02610163,0.0042783935,0.9281248,0.006947001,0.0029707993,0.0009775368,0.0017511578,0.0001943743,0.028187808,0.00006315886,0.000021645072,0.0003817088],"about_ca_topic_score_codex":0.00018281164,"about_ca_topic_score_gemma":0.00053780514,"teacher_disagreement_score":0.0763555,"about_ca_system_score_codex":0.000044051532,"about_ca_system_score_gemma":0.00049987313,"threshold_uncertainty_score":0.5210037},"labels":[],"label_agreement":null},{"id":"W4389248161","doi":"10.1182/blood-2023-174468","title":"Childhood Treatment with Adeno-Associated Viral Gene Therapy Results in Stable FVIII Expression and Improved Bleeding Phenotype in Adult Severe Hemophilia A Dogs","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"","keywords":"Genetic enhancement; Medicine; Factor IX; Adeno-associated virus; Immunology; Internal medicine; Gastroenterology; Vector (molecular biology); Recombinant DNA; Gene; Biology","score_opus":0.010652836205226373,"score_gpt":0.2500932107645833,"score_spread":0.23944037455935693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389248161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998152,0.00087164826,6.6873247e-7,0.00018098594,0.000020128764,0.000542179,0.00007993512,0.000032257103,0.0001201509],"genre_scores_gemma":[0.996425,0.0025368037,0.0001064233,0.00007958548,0.000074683994,0.00010931185,0.00027971476,0.00004485298,0.0003436263],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99845004,0.00011201458,0.00023538171,0.0005401087,0.00017646204,0.00048599887],"domain_scores_gemma":[0.9994507,0.000020896918,0.00007279671,0.00030703368,0.00006046042,0.00008813409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026178322,0.00022707623,0.00022264998,0.00013145032,0.000077758086,0.000033777724,0.0001425225,0.00017703167,0.0000053525364],"category_scores_gemma":[0.00004269099,0.00018155466,0.000037375325,0.00035235746,0.000039317645,0.000009268202,0.00008167116,0.00013170678,0.0000039168235],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003594028,0.00072591944,0.008766887,0.000006508844,0.000117328294,0.000030162184,0.00059285655,0.00004391335,0.98358876,6.2595404e-7,0.00003512256,0.0024979226],"study_design_scores_gemma":[0.026448563,0.0071069743,0.021463564,0.00007050609,0.000015142176,0.000007289863,0.00014483581,0.00014016265,0.9441798,0.00003500288,0.00008567071,0.00030251892],"about_ca_topic_score_codex":0.00029498278,"about_ca_topic_score_gemma":0.0013234807,"teacher_disagreement_score":0.039408956,"about_ca_system_score_codex":0.000045999153,"about_ca_system_score_gemma":0.00013497267,"threshold_uncertainty_score":0.7403584},"labels":[],"label_agreement":null},{"id":"W4389248186","doi":"10.1182/blood-2023-190552","title":"Extended Thromboprophylaxis in Patients Hospitalized with COVID-19 at Time of Discharge from the Hospital Is Not Associated with an Improvement in Quality of Life: Results from the Activ 4c Clinical Trial","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Long-Term Effects of COVID-19","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Apixaban; Placebo; Quality of life (healthcare); Clinical trial; Randomized controlled trial; Internal medicine; Anxiety; Physical therapy; Emergency medicine; Rivaroxaban; Atrial fibrillation; Warfarin","score_opus":0.03538230334710246,"score_gpt":0.3442824778856583,"score_spread":0.30890017453855584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389248186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887183,0.000014581905,0.0000024311553,0.0042984444,0.00015315032,0.0042046937,0.0025220104,0.00006978637,0.000016642554],"genre_scores_gemma":[0.99701434,0.000014004322,0.000072954805,0.001424461,0.000148326,0.000119433695,0.0011184477,0.00005107166,0.00003693499],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948454,0.0011183047,0.001521675,0.0008105701,0.001282849,0.000421226],"domain_scores_gemma":[0.9915415,0.0054695546,0.0012083295,0.0013247966,0.0001709268,0.00028490293],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.002706552,0.0003516152,0.0012394235,0.0000824986,0.00008541482,0.000024710802,0.00051154307,0.00025694465,0.000057147758],"category_scores_gemma":[0.013510646,0.00018402365,0.00020762041,0.00066074723,0.00039500455,0.00015956112,0.0002598329,0.00046205276,0.000013204385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12015842,0.0074787256,0.86456674,0.00004679679,0.00088096043,0.000024188184,0.005240195,0.0000022637726,0.0010540736,0.0000042912616,0.00036162284,0.00018171173],"study_design_scores_gemma":[0.2123398,0.012217391,0.772841,0.00018814662,0.00024497166,5.992864e-8,0.000176552,0.00004023247,0.0016629535,0.00007977979,0.000006693287,0.00020244691],"about_ca_topic_score_codex":0.008687263,"about_ca_topic_score_gemma":0.0011259426,"teacher_disagreement_score":0.09218138,"about_ca_system_score_codex":0.00020145925,"about_ca_system_score_gemma":0.0007085249,"threshold_uncertainty_score":0.99791396},"labels":[],"label_agreement":null},{"id":"W4389248231","doi":"10.1182/blood-2023-179198","title":"Treatment Effectiveness with Venetoclax-Based Therapy after Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real-World Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Venetoclax; Medicine; Internal medicine; Population; Regimen; Ibrutinib; Chronic lymphocytic leukemia; Discontinuation; Oncology; Leukemia","score_opus":0.023765827101584945,"score_gpt":0.32878074646954636,"score_spread":0.30501491936796143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389248231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99635917,0.00020574439,0.0000022935383,0.000035632893,0.00014421085,0.002471019,0.000015075939,0.00024253302,0.00052431657],"genre_scores_gemma":[0.997218,0.0003024646,0.000030674863,0.000034604593,0.00040602105,0.0014264331,0.00014396512,0.00009892701,0.00033890182],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972206,0.00025931167,0.00036123232,0.0007531819,0.00079052156,0.0006151994],"domain_scores_gemma":[0.99853,0.0002557378,0.00007549908,0.00078709045,0.00011759837,0.00023408687],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044136544,0.00037463097,0.0005154198,0.0007361598,0.00006514047,0.000055056506,0.00021555778,0.00011150959,0.00008126251],"category_scores_gemma":[0.000033418077,0.0002791517,0.00010066579,0.0012817644,0.00012462518,0.00015580881,0.00006293508,0.00019657641,0.00008741804],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.035273146,0.010106301,0.80713683,0.00079185836,0.002199765,0.040776417,0.003311216,0.034229945,0.02761458,0.000036984497,0.000052025094,0.038470898],"study_design_scores_gemma":[0.2944004,0.012186651,0.5826175,0.00068643765,0.00024361021,0.000119543314,0.0001679318,0.03788645,0.070552796,0.000008211162,0.0006444753,0.0004860022],"about_ca_topic_score_codex":0.013111158,"about_ca_topic_score_gemma":0.005241976,"teacher_disagreement_score":0.25912726,"about_ca_system_score_codex":0.15684304,"about_ca_system_score_gemma":0.034911327,"threshold_uncertainty_score":0.9999661},"labels":[],"label_agreement":null},{"id":"W4389248242","doi":"10.1182/blood-2023-173302","title":"Dose Escalation of HLA-A2-WT1 CD3 T-Cell Bispecific Antibody in a Phase I Study in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML)","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Myeloid leukemia; Internal medicine; Tolerability; Refractory (planetary science); Leukemia; Oncology; Gastroenterology; Immunology; Adverse effect; Biology","score_opus":0.020594905653847157,"score_gpt":0.31710687491740386,"score_spread":0.2965119692635567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389248242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965004,0.00006684231,0.000002687442,0.000030138019,0.00007048907,0.001932604,0.000024863071,0.00006458723,0.0013074387],"genre_scores_gemma":[0.99781096,0.00011084573,0.000047431357,0.00001597128,0.000055231172,0.00005432157,0.00023226789,0.00006304715,0.0016099298],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975236,0.00016448775,0.00054800074,0.00047106307,0.00085320097,0.00043965608],"domain_scores_gemma":[0.998859,0.00012521735,0.00014340416,0.00059822376,0.00014201314,0.00013215038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005787821,0.0002223523,0.00051478116,0.00089726894,0.00003542918,0.000017058699,0.00016807766,0.0001272182,0.0002831059],"category_scores_gemma":[0.000054944012,0.00018922324,0.0000696357,0.0017668554,0.00007489912,0.00013504474,0.0000818706,0.0005040947,0.00007008635],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038193513,0.0124534415,0.79433686,0.00008449433,0.00014896432,0.0003792616,0.0021210306,0.000018691375,0.18246771,0.000001420847,0.00007870473,0.0040900777],"study_design_scores_gemma":[0.081593305,0.006335859,0.8963336,0.00015235304,0.00013610524,0.0000030548545,0.0005729478,0.00009840134,0.014324289,0.000009045039,0.00024044918,0.0002005912],"about_ca_topic_score_codex":0.00022065536,"about_ca_topic_score_gemma":0.00013773853,"teacher_disagreement_score":0.16814342,"about_ca_system_score_codex":0.00023330688,"about_ca_system_score_gemma":0.0003018658,"threshold_uncertainty_score":0.77163},"labels":[],"label_agreement":null},{"id":"W4389248248","doi":"10.1182/blood-2023-180889","title":"Aberrant Splicing of <i>MBD1</i> Reshapes the Epigenome to Drive Convergent Myeloerythroid Defects in MDS","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University Health Network; University of Toronto; McMaster University","funders":"","keywords":"RNA splicing; Alternative splicing; Biology; Gene isoform; Splicing factor; Epigenetics; Genetics; Cell biology; Gene; RNA","score_opus":0.022712816364243535,"score_gpt":0.28988020337481873,"score_spread":0.2671673870105752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389248248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99119335,0.0003376611,0.000013494538,0.004385265,0.00009289529,0.00094920094,0.000015574135,0.000078145196,0.0029344005],"genre_scores_gemma":[0.9970145,0.0004341234,0.00016127966,0.000885839,0.00015853385,0.00009192054,0.000017006925,0.000043213604,0.0011935446],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980763,0.00009730949,0.0003881687,0.00034725526,0.00051616755,0.00057477166],"domain_scores_gemma":[0.99876046,0.00030998237,0.00006637492,0.0005623026,0.00011223308,0.00018865141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008085705,0.00016846208,0.00039824168,0.00033770222,0.000074576164,0.000011230008,0.00027706113,0.00009170176,0.00010375405],"category_scores_gemma":[0.0003299693,0.000119660755,0.000112483314,0.0013864847,0.000104441664,0.000037383365,0.0002639125,0.00035975556,0.00049207767],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040798998,0.0005844349,0.11043921,0.00047101025,0.00035577855,0.0009952076,0.010204518,0.00026458505,0.86249334,0.0006116984,0.011315332,0.0018569044],"study_design_scores_gemma":[0.012222892,0.001534945,0.5440709,0.00085173093,0.00034909495,0.00015201993,0.0037801017,0.00087606953,0.4152798,0.00041172403,0.01991373,0.0005569962],"about_ca_topic_score_codex":0.00047091037,"about_ca_topic_score_gemma":0.00023057993,"teacher_disagreement_score":0.44721353,"about_ca_system_score_codex":0.00012898092,"about_ca_system_score_gemma":0.00029495527,"threshold_uncertainty_score":0.6324827},"labels":[],"label_agreement":null},{"id":"W4389248268","doi":"10.1182/blood-2023-174599","title":"Trends in Allogeneic Stem Cell Transplantation for Good Risk Acute Myelogenous Leukemia in First Complete Remission: A Longitudinal Study of &amp;gt; 15 Years from the ALWP/EBMT","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Servier; Incyte; Jazz Pharmaceuticals; Astellas Pharma; Alexion Pharmaceuticals; Mallinckrodt Pharmaceuticals; Gilead Sciences","keywords":"Medicine; Internal medicine; NPM1; Transplantation; Cumulative incidence; Proportional hazards model; Leukemia; Hematopoietic stem cell transplantation; Gastroenterology; Oncology; Karyotype","score_opus":0.05455136188636897,"score_gpt":0.30958291891863854,"score_spread":0.25503155703226954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389248268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972034,0.00032455885,0.000051950134,0.00026828665,0.00006221785,0.0012687268,0.0005657072,0.00005774108,0.00019737626],"genre_scores_gemma":[0.9973087,0.0006356646,0.00044671496,0.000035782716,0.00012180637,0.00021251176,0.0005606393,0.000054804797,0.00062340504],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975869,0.00022721056,0.00061382627,0.0005484732,0.00050340715,0.00052017724],"domain_scores_gemma":[0.9983756,0.0006584781,0.00017309788,0.00059464306,0.00007216327,0.00012601411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007543438,0.00024397831,0.0005700286,0.0004287059,0.00011174809,0.0000190635,0.00037445774,0.00017159898,0.00007638314],"category_scores_gemma":[0.000034482473,0.00019140955,0.00014814176,0.0012561696,0.00006404891,0.000055416378,0.00008485724,0.0004689502,0.00003729051],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031622883,0.0020689925,0.9105944,0.0002659351,0.0009211033,0.0018625191,0.029287016,0.0009630075,0.03240539,0.000009759505,0.002426427,0.016033174],"study_design_scores_gemma":[0.020534758,0.0010321491,0.97276896,0.00016609057,0.00079902564,0.0000487409,0.0015925308,0.0005934607,0.0014128467,0.000031358886,0.00081369816,0.00020639117],"about_ca_topic_score_codex":0.0033551082,"about_ca_topic_score_gemma":0.012626829,"teacher_disagreement_score":0.062174566,"about_ca_system_score_codex":0.00034124774,"about_ca_system_score_gemma":0.0002755559,"threshold_uncertainty_score":0.7805455},"labels":[],"label_agreement":null},{"id":"W4389248273","doi":"10.1182/blood-2023-181603","title":"The Relationship between Low Von Willebrand Factor, Type 1 Von Willebrand Disease and Ageing - Novel Insights from the Lovic and Win Cohort Studies","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Von Willebrand disease; Von Willebrand factor; Medicine; Cohort; Internal medicine; Gastroenterology; Cohort study; Platelet","score_opus":0.04250735050243245,"score_gpt":0.2866788832875438,"score_spread":0.24417153278511136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389248273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98532504,0.012572567,0.000002378435,0.0013083476,0.000080559774,0.00048355968,0.00006793896,0.000053431726,0.00010617167],"genre_scores_gemma":[0.99666,0.00261373,0.000010704752,0.00009803167,0.00010708725,0.000017797433,0.0001140818,0.000020782756,0.00035776338],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991404,0.00004463133,0.000173467,0.00026008487,0.00020071585,0.0001807135],"domain_scores_gemma":[0.998204,0.0013466582,0.0000566133,0.00023495095,0.00003790553,0.000119893324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008627514,0.00016689293,0.00026523278,0.000040472558,0.0005128909,0.000055806046,0.000055793313,0.00005708217,0.0000028692377],"category_scores_gemma":[0.0004590825,0.00008759248,0.000037087753,0.0002122888,0.00015472985,0.000086925524,0.000068976005,0.00014548654,0.000016234702],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079430596,0.000071409406,0.9969132,0.00002982429,0.0008741201,0.00015335772,0.0009009632,5.433094e-7,0.00009591407,0.000048234037,0.00024485416,0.0005881687],"study_design_scores_gemma":[0.0034638427,0.00007429482,0.99237895,0.00015516227,0.00094433466,0.000004594783,0.00028858497,0.000020750027,0.00003671628,0.0019216425,0.000610096,0.000101026904],"about_ca_topic_score_codex":0.000053101277,"about_ca_topic_score_gemma":0.00009163659,"teacher_disagreement_score":0.011334975,"about_ca_system_score_codex":0.000011317032,"about_ca_system_score_gemma":0.000034455385,"threshold_uncertainty_score":0.39447942},"labels":[],"label_agreement":null},{"id":"W4389248280","doi":"10.1182/blood-2023-190517","title":"Immune and Genome Profiling of Myeloma Patients Treated with Sequential Immunotherapies Reveal Differential Non-Overlapping Mechanisms of Resistance","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Cytotoxic T cell; Chimeric antigen receptor; Antigen; Peripheral blood mononuclear cell; Immune system; Medicine; Immunotherapy; Immunology; Cancer research; T cell; Biology; In vitro; Genetics","score_opus":0.014123695186511031,"score_gpt":0.24993359265028006,"score_spread":0.23580989746376904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389248280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99837357,0.0002341876,0.0001451229,0.000022362869,0.000029464036,0.00068042683,0.00003981462,0.000043076572,0.00043198228],"genre_scores_gemma":[0.997133,0.00012872605,0.0006874094,0.0000047448943,0.000036360652,0.000028492572,0.00008662613,0.000044614102,0.001850035],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986135,0.000050092167,0.00035874353,0.0002511702,0.00045196828,0.0002745535],"domain_scores_gemma":[0.99923396,0.00004399967,0.00016130367,0.0003164222,0.00018838128,0.0000559426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017470053,0.00015831899,0.00045382834,0.00020368714,0.000057609795,0.000011477044,0.00009907015,0.00007656328,0.00012344687],"category_scores_gemma":[0.000019899104,0.00012853858,0.00007656444,0.0004027237,0.00012627488,0.000046613986,0.000069262525,0.00013312385,0.0000022259221],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017566236,0.00028179088,0.011301409,0.00041571606,0.00051353796,0.000020021733,0.0005014238,4.3467935e-7,0.98465216,0.00007442133,0.0000013160648,0.00048112244],"study_design_scores_gemma":[0.007645423,0.000855152,0.25868315,0.00030971426,0.00014306471,0.0000056219665,0.00014244959,0.0000147471765,0.7320028,0.00007687859,0.000008502843,0.00011247938],"about_ca_topic_score_codex":0.000062182495,"about_ca_topic_score_gemma":0.0000073248693,"teacher_disagreement_score":0.25264937,"about_ca_system_score_codex":0.000024271612,"about_ca_system_score_gemma":0.000063439686,"threshold_uncertainty_score":0.5241651},"labels":[],"label_agreement":null},{"id":"W4389248284","doi":"10.1182/blood-2023-189377","title":"Platelet Count Response to Obstetrical Use of IVIG for Maternal Thrombocytopenia: A 14-Year Retrospective Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Canadian Blood Services; Canadian Electricity Association; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Pregnancy; Retrospective cohort study; Logistic regression; Gestational age; Cohort; Platelet; Immune thrombocytopenia; Pediatrics; Obstetrics; Internal medicine","score_opus":0.03824676012274214,"score_gpt":0.30614154359979023,"score_spread":0.2678947834770481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389248284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976309,0.000030489879,0.000007322294,0.00020815122,0.00010819783,0.0016464895,0.00021678155,0.000077744015,0.000073923235],"genre_scores_gemma":[0.9980614,0.000012219246,0.00048133906,0.00006845291,0.000030271487,0.00011537507,0.000021317228,0.000032044016,0.0011775538],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878496,0.00004258184,0.00024638645,0.00030340743,0.00034358934,0.00027907194],"domain_scores_gemma":[0.9991668,0.0002265038,0.000059126607,0.0002839496,0.00013971889,0.00012390524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001760308,0.00014797672,0.00052005105,0.0002029959,0.000056296518,0.000024039244,0.00007758982,0.000068668574,0.000035070258],"category_scores_gemma":[0.0006120116,0.00011967921,0.00009303022,0.00049826736,0.000022544651,0.0000601014,0.00006380946,0.0000865642,0.00012127785],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014563264,0.007217204,0.95199215,0.000078956364,0.0017482801,0.0047670975,0.0028002493,0.000009219942,0.0116517795,0.00007041013,0.0046809684,0.00042038845],"study_design_scores_gemma":[0.017513407,0.005264054,0.9677288,0.000055845416,0.0003341115,0.000073852236,0.00052229647,0.000017636565,0.007252056,0.000074042706,0.0010322812,0.00013162526],"about_ca_topic_score_codex":0.00008164959,"about_ca_topic_score_gemma":0.000022814454,"teacher_disagreement_score":0.01573661,"about_ca_system_score_codex":0.000064877495,"about_ca_system_score_gemma":0.00006588501,"threshold_uncertainty_score":0.48803765},"labels":[],"label_agreement":null},{"id":"W4389248313","doi":"10.1182/blood-2023-177788","title":"Outcomes of Transplant-Eligible and Transplant-Ineligible Patients with Mantle Cell Lymphoma in Ontario, Canada","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Princess Margaret Cancer Centre; University of Toronto; University Health Network; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences","funders":"","keywords":"Chemoimmunotherapy; Medicine; Mantle cell lymphoma; Rituximab; Bendamustine; Regimen; Internal medicine; Population; Chemotherapy regimen; Transplantation; CHOP; Oncology; Surgery; Lymphoma; Chemotherapy","score_opus":0.006566587970460126,"score_gpt":0.18956007484853263,"score_spread":0.18299348687807251,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389248313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977427,0.0001095169,3.1692417e-7,0.000119246135,0.000039877028,0.0003069656,0.00011205462,0.00002169385,0.0015476071],"genre_scores_gemma":[0.9990681,0.00012006839,0.00006199883,0.00008619068,0.000004647042,0.000031170228,0.00016005417,0.000015591344,0.0004522191],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99904996,0.000009641742,0.00021583804,0.00021159394,0.00026299246,0.00024994757],"domain_scores_gemma":[0.9996165,0.000055178793,0.000041382315,0.00015617299,0.000025423466,0.00010533893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000035491485,0.0001560358,0.00035883702,0.00010761474,0.000026843565,0.000005462839,0.00004505418,0.00004533269,0.000034703273],"category_scores_gemma":[0.0000016460575,0.0001087451,0.000034301727,0.0001628071,0.000019827043,0.000032346026,0.000007914378,0.000035874746,0.000004615681],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012733389,0.0014516537,0.9968647,0.00010976728,0.000118645235,0.0004046432,0.000463025,0.000003195509,0.000056227233,0.000010588547,0.00021421019,0.00017602001],"study_design_scores_gemma":[0.02240554,0.000258415,0.96634763,0.00014420121,0.00027772918,0.0000144576015,0.000041707117,0.000003173028,0.010063847,0.0000059964536,0.00032336492,0.00011394759],"about_ca_topic_score_codex":0.8842207,"about_ca_topic_score_gemma":0.9622327,"teacher_disagreement_score":0.07801203,"about_ca_system_score_codex":0.00009416879,"about_ca_system_score_gemma":0.0004783131,"threshold_uncertainty_score":0.44344965},"labels":[],"label_agreement":null},{"id":"W4389248328","doi":"10.1182/blood-2023-189442","title":"Neuraxial Analgesia in Pregnant Individuals with Bleeding Disorders: A Comprehensive Examination of Obstetric Anesthesia Practices and Outcomes","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Cardiovascular Issues in Pregnancy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Blood Services; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Interquartile range; Pregnancy; Retrospective cohort study; Concordance; Cohort; Gestational age; Obstetrics; Anesthesia; Surgery; Internal medicine","score_opus":0.025941632629220543,"score_gpt":0.2870372011345855,"score_spread":0.2610955685053649,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389248328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99394035,0.004682422,0.000005926926,0.00024366243,0.000029317835,0.0006280137,0.000001924482,0.00006592898,0.00040242862],"genre_scores_gemma":[0.9981654,0.0010887311,0.00056594965,0.000020278854,0.000023775114,0.000040729145,0.000015952706,0.000025295869,0.000053879605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986434,0.00014512178,0.00026014674,0.0002914607,0.00045841787,0.00020143627],"domain_scores_gemma":[0.99883854,0.00049928395,0.00025081573,0.0002776768,0.00008026065,0.000053441083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032778442,0.00015106045,0.00045495815,0.0005340449,0.000035601537,0.00002043426,0.0000754848,0.00007556775,0.000004237071],"category_scores_gemma":[0.00056245027,0.00012030901,0.0000714093,0.0010747951,0.00007969335,0.00018141781,0.00005430075,0.0001658364,0.000003185607],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027086562,0.00035498603,0.98247313,0.0004734865,0.0004365351,0.0006721232,0.0031216543,0.000019181756,0.00050503865,0.00006754274,0.000005750787,0.011843476],"study_design_scores_gemma":[0.004634638,0.00035033026,0.99028593,0.0007749621,0.0006112266,0.0005355464,0.0016215628,0.000062047664,0.00080088765,0.00002712028,0.00016723659,0.00012853503],"about_ca_topic_score_codex":0.000032039516,"about_ca_topic_score_gemma":0.000013913073,"teacher_disagreement_score":0.011714942,"about_ca_system_score_codex":0.000013385701,"about_ca_system_score_gemma":0.000034531935,"threshold_uncertainty_score":0.4906059},"labels":[],"label_agreement":null},{"id":"W4389248396","doi":"10.1182/blood-2023-179916","title":"Improvements in Health-Related Quality of Life after Exagamglogene Autotemcel in Patients with Transfusion-Dependent Beta-Thalassemia","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Quality of life (healthcare); Thalassemia; Visual analogue scale; Blood transfusion; Pediatrics; Internal medicine; Physical therapy","score_opus":0.011294759203688286,"score_gpt":0.2466710280201342,"score_spread":0.2353762688164459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389248396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974793,0.00046614546,0.0000025479178,0.00063421426,0.00008677223,0.0009622727,0.000035112833,0.00005572436,0.00027789816],"genre_scores_gemma":[0.99918777,0.00022091962,0.000046507263,0.0002010003,0.0000074377253,0.000052512143,0.000080493366,0.000029860945,0.00017347278],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976232,0.00012979678,0.0010218432,0.00034024386,0.000470532,0.00041435508],"domain_scores_gemma":[0.99925053,0.00003831384,0.00018345298,0.0002873698,0.00005835843,0.00018195999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006112159,0.00018220958,0.0005771953,0.00028841433,0.000026360984,0.0000043269347,0.00007723974,0.00020643602,0.00009212283],"category_scores_gemma":[0.000058462836,0.00014153402,0.00007622347,0.0007804275,0.0000457885,0.000047835485,0.00003627144,0.0003232828,0.000022478944],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006925047,0.0022832083,0.9927696,0.00042685735,0.00012386616,0.000041162126,0.00094685174,0.000048144986,0.0010757009,0.000007019034,0.000024099767,0.0015609991],"study_design_scores_gemma":[0.020742754,0.0006733842,0.9771544,0.00037099567,0.000040759613,0.000001081193,0.0002906907,0.00002788179,0.00051929854,0.000020236128,0.000018091818,0.00014047386],"about_ca_topic_score_codex":0.0019368861,"about_ca_topic_score_gemma":0.00047765588,"teacher_disagreement_score":0.02005025,"about_ca_system_score_codex":0.00006783416,"about_ca_system_score_gemma":0.00025821125,"threshold_uncertainty_score":0.577159},"labels":[],"label_agreement":null},{"id":"W4389248398","doi":"10.1182/blood-2023-189912","title":"A Phase 3b, Randomized, Open-Label, Parallel Group, Multicenter Study to Assess Efficacy, Safety, and Tolerability of Two Dosing Regimens of Ropeginterferon Alfa-2b-Njft (P1101) in Adult Patients with Polycythemia Vera","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Tolerability; Dosing; Polycythemia vera; Internal medicine; Regimen; Clinical trial; Surgery; Adverse effect","score_opus":0.03332096510326708,"score_gpt":0.3407370386707625,"score_spread":0.3074160735674954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389248398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99257654,0.00004804857,0.00006119058,0.00031598713,0.00004798827,0.0066939336,0.00006391614,0.000026007421,0.00016638504],"genre_scores_gemma":[0.9977002,0.000051436145,0.0016515868,0.000100620135,0.000019530375,0.00032378413,0.000077335055,0.000035729805,0.000039762715],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9975503,0.0003127543,0.0008322129,0.00057274714,0.00040638575,0.0003256126],"domain_scores_gemma":[0.9983105,0.00052795024,0.00026481497,0.00047416383,0.00023768074,0.0001848645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064559816,0.00031598232,0.0014199857,0.00018664148,0.000061715946,0.000034514596,0.00015893242,0.000047606474,0.000024719477],"category_scores_gemma":[0.00026565895,0.00021650716,0.00006349908,0.00035350292,0.00010748087,0.00012698886,0.00025999578,0.00015821434,0.0000054201455],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21911201,0.083112374,0.68889487,0.00016102746,0.000959352,0.00008119203,0.004931361,0.000030774372,0.00061535236,0.000064361295,0.000032786615,0.0020045408],"study_design_scores_gemma":[0.8182236,0.008768729,0.16717285,0.00085431704,0.00072138134,0.0000036057813,0.00044379864,0.00028472097,0.0033061223,0.000007343571,0.000010058603,0.00020346032],"about_ca_topic_score_codex":0.00076624466,"about_ca_topic_score_gemma":0.0005904739,"teacher_disagreement_score":0.5991116,"about_ca_system_score_codex":0.00007152611,"about_ca_system_score_gemma":0.000057698315,"threshold_uncertainty_score":0.8828906},"labels":[],"label_agreement":null},{"id":"W4389248455","doi":"10.1182/blood-2023-182747","title":"An International Multicohort Study of Conditional Survival and Cause of Death after Achieving Event-Free Survival at 24 Months in Patients with Mantle Cell Lymphoma","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Medicine; Mantle cell lymphoma; Population; Internal medicine; Retrospective cohort study; Cohort; Follicular lymphoma; Diffuse large B-cell lymphoma; Clinical endpoint; Cancer registry; Cumulative incidence; Oncology; Cohort study; Lymphoma; Cancer; Clinical trial","score_opus":0.013088101312105305,"score_gpt":0.2569232533274708,"score_spread":0.24383515201536549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389248455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998938,0.000034139528,6.432456e-7,0.000019586645,0.00009242124,0.0005129352,0.0002342846,0.000014420708,0.00015357304],"genre_scores_gemma":[0.9994914,0.000019137617,0.00007208954,0.0000074356226,0.000024243102,0.00007242581,0.0002457425,0.000017311133,0.000050243998],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988202,0.000049774157,0.00026620372,0.00024453268,0.00048015403,0.00013915444],"domain_scores_gemma":[0.99938256,0.00008132071,0.00009146418,0.00027658313,0.000091926086,0.00007612375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011037898,0.0001300637,0.00027634218,0.00013714888,0.000023580254,0.0000068539043,0.00008405143,0.00003765739,0.000035845875],"category_scores_gemma":[0.000023773247,0.00010169086,0.00003234435,0.000105296094,0.000031690943,0.00008160345,0.00010950622,0.00002629682,0.000003445078],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006400906,0.016616909,0.98145926,0.00003598297,0.00032835035,0.00017230537,0.00048814082,0.000017293352,0.00008350997,0.000015216943,0.0000079396,0.0001349775],"study_design_scores_gemma":[0.03624413,0.0013910581,0.96056956,0.00006305687,0.00026481794,0.0000031947793,0.00034034316,0.0000529082,0.0009753346,0.0000054036586,0.0000044507424,0.000085739724],"about_ca_topic_score_codex":0.0003371858,"about_ca_topic_score_gemma":0.0006285522,"teacher_disagreement_score":0.03560404,"about_ca_system_score_codex":0.00006352909,"about_ca_system_score_gemma":0.000039567087,"threshold_uncertainty_score":0.41468328},"labels":[],"label_agreement":null},{"id":"W4389248467","doi":"10.1182/blood-2023-181710","title":"A New Machine Learning-Based Prognostic Prediction Strategy for Patients with Diffuse-Large B-Cell Lymphoma","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Diffuse large B-cell lymphoma; Medicine; Internal medicine; Oncology; Lymphoma; CHOP; ABVD; Rituximab; Chemotherapy; Cyclophosphamide; Vincristine","score_opus":0.01719968098037226,"score_gpt":0.26287813092745027,"score_spread":0.24567844994707802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389248467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959646,0.000091938404,0.00077405095,0.00010847203,0.000057357433,0.0018083863,0.00009979615,0.00037321978,0.0007221728],"genre_scores_gemma":[0.98560673,0.000017229644,0.0002379946,0.000047097365,0.00017421912,0.00017566084,0.0010491294,0.00008412406,0.012607786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984794,0.000045136665,0.00018574187,0.0003263536,0.0004931323,0.00047021089],"domain_scores_gemma":[0.9991486,0.00016306549,0.00006149241,0.0002469738,0.00014598313,0.00023385168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001772883,0.00017125283,0.0002235804,0.00018514848,0.000110425084,0.000033725755,0.000086791544,0.00009059088,0.0003250646],"category_scores_gemma":[0.00013050577,0.00013519486,0.00008494007,0.0004558904,0.000023764616,0.000044416443,0.00002543215,0.00015106301,0.00007027535],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029670226,0.015691143,0.95617497,0.0005318526,0.00027115186,0.000068133195,0.00020991512,0.00012892928,0.0065737097,0.000013416929,0.0017074406,0.015662335],"study_design_scores_gemma":[0.351867,0.024923678,0.5418983,0.0003399115,0.0009204052,0.000018816465,0.0001014954,0.035984192,0.016362509,0.00007533465,0.02696306,0.00054527074],"about_ca_topic_score_codex":0.000043777876,"about_ca_topic_score_gemma":0.000025651383,"teacher_disagreement_score":0.4142766,"about_ca_system_score_codex":0.000043915014,"about_ca_system_score_gemma":0.00031770888,"threshold_uncertainty_score":0.55130863},"labels":[],"label_agreement":null},{"id":"W4389248470","doi":"10.1182/blood-2023-173527","title":"Leukostasis Twist in Mantle Cell Lymphoma: Systematic Review and Case Report","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Western University","funders":"","keywords":"Leukostasis; Leukapheresis; Medicine; Mantle cell lymphoma; Tumor lysis syndrome; Leukocytosis; Lymphoma; Internal medicine; Surgery; Gastroenterology; Leukemia; Chemotherapy","score_opus":0.015389342711114381,"score_gpt":0.2672834175380476,"score_spread":0.2518940748269332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389248470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9413883,0.054342736,1.7173153e-7,0.0005849499,0.000033362532,0.0011343763,0.00001179718,0.000068642876,0.0024356348],"genre_scores_gemma":[0.9914282,0.00658516,0.000055959994,0.0003617865,0.000018363906,0.00028457108,0.000033008626,0.000016495067,0.0012164373],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9990549,0.00003569411,0.0003784915,0.00023072548,0.0001310468,0.00016914961],"domain_scores_gemma":[0.99935126,0.000074905845,0.00009196247,0.0003591064,0.0000264564,0.00009630049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027351972,0.00011960729,0.00053744146,0.00008085218,0.000033264412,0.000012588419,0.000025529982,0.00003886761,0.000018616383],"category_scores_gemma":[0.00012427242,0.00008701391,0.000063802436,0.00027401367,0.000016824417,0.000025628677,0.000037102924,0.00002237506,0.00014388541],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004604021,0.0018733408,0.029365113,0.25606966,0.00017882482,0.70970803,0.00015821813,6.3413154e-8,0.000023723744,0.000029119132,0.0024075261,0.00018174133],"study_design_scores_gemma":[0.031404965,0.00059520715,0.06537859,0.12716979,0.018971466,0.74645615,0.00095086196,0.000031581574,0.007301211,0.000060084407,0.0009847007,0.0006953817],"about_ca_topic_score_codex":0.0002250055,"about_ca_topic_score_gemma":0.00004002624,"teacher_disagreement_score":0.12889987,"about_ca_system_score_codex":0.000057544472,"about_ca_system_score_gemma":0.000056414403,"threshold_uncertainty_score":0.35483244},"labels":[],"label_agreement":null},{"id":"W4389248538","doi":"10.1182/blood-2023-185007","title":"Non-Viral RNA-Lipid Nanoparticles for High Efficiency Genome Editing of CD34+ Hematopoietic Stem and Progenitor Cells for Advanced Cell and Gene Therapies","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Progenitor cell; Haematopoiesis; Stem cell; CD34; Biology; Cord blood; Gene delivery; Hematopoietic stem cell; Genetic enhancement; Cell biology; Molecular biology; Immunology; Gene; Genetics","score_opus":0.005069234897384554,"score_gpt":0.2347832497861119,"score_spread":0.22971401488872734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389248538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994703,0.0021761528,0.0024066265,0.000023053131,0.00011945533,0.0004881587,0.00006149786,0.000015820851,0.0000062470167],"genre_scores_gemma":[0.9957354,0.00021094616,0.0035729313,0.000008809532,0.00022724601,0.00011519193,0.000023242934,0.000025893996,0.00008031251],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99930865,0.000005803161,0.00017062406,0.00023613876,0.000054493416,0.00022428532],"domain_scores_gemma":[0.9997053,0.000024549334,0.000053019772,0.00012719113,0.00004287862,0.00004706129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000107343876,0.00011675173,0.00014468732,0.000029595856,0.00006392208,0.000013404622,0.00006763314,0.000060098653,4.889064e-7],"category_scores_gemma":[0.000008391638,0.0001111705,0.00004459114,0.000049255978,0.000038910865,0.0000028134289,0.000053183412,0.000020612713,3.820701e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023940798,0.000049485465,0.00016051362,0.00027561048,0.00002854757,4.1608791e-7,0.00021492396,0.00016967327,0.9981529,0.000008401487,0.000013137664,0.00090244797],"study_design_scores_gemma":[0.001583138,0.0004533791,0.00039260517,0.000011349188,0.000046654095,0.0000031957093,0.00028155805,0.00016901018,0.996634,0.000028262755,0.00026886057,0.00012799897],"about_ca_topic_score_codex":0.0000011068506,"about_ca_topic_score_gemma":8.582953e-7,"teacher_disagreement_score":0.0019652066,"about_ca_system_score_codex":0.0000015506524,"about_ca_system_score_gemma":0.000014198966,"threshold_uncertainty_score":0.45334014},"labels":[],"label_agreement":null},{"id":"W4389248647","doi":"10.1182/blood-2023-174774","title":"Evaluating Sex-Based Hemoglobin Reference Intervals Using Strict Definitions of Health","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Medicine; Hemoglobin; Transferrin saturation; Ferritin; Cohort; Anemia; Internal medicine; Population; National Health and Nutrition Examination Survey; Iron deficiency; Gastroenterology; Endocrinology; Physiology; Environmental health","score_opus":0.19973178305783823,"score_gpt":0.388012251824126,"score_spread":0.1882804687662878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389248647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960356,0.00056380965,0.00023986894,0.00074246834,0.00006579993,0.00032816624,0.00003856086,0.0001373802,0.0018483526],"genre_scores_gemma":[0.99554896,0.000204836,0.003690798,0.00035548978,0.000020070596,0.000010199942,0.00008932776,0.00002076303,0.000059548118],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99861634,0.00015477357,0.00045629704,0.00019990263,0.00028400272,0.00028868063],"domain_scores_gemma":[0.999253,0.00013252697,0.0001697236,0.0002492448,0.00009831702,0.000097223674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083739735,0.00011234538,0.00032244442,0.00019391936,0.00011836731,0.0000075840535,0.000067848036,0.000093019764,0.00007258843],"category_scores_gemma":[0.00034687636,0.00009877695,0.000091170245,0.0007243769,0.00005048013,0.000026320604,0.00003671228,0.00018794904,0.000037531565],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007679613,0.014907779,0.24513502,0.012023109,0.0024804254,0.0005536163,0.009583361,0.021939216,0.46623844,0.0061885985,0.0070993174,0.21308316],"study_design_scores_gemma":[0.12191394,0.023596827,0.20122398,0.025217624,0.0062856735,0.0010410692,0.0330879,0.32477954,0.24576113,0.009177842,0.003995666,0.003918785],"about_ca_topic_score_codex":0.0002010271,"about_ca_topic_score_gemma":0.0000043945433,"teacher_disagreement_score":0.30284032,"about_ca_system_score_codex":0.00003758126,"about_ca_system_score_gemma":0.0005088284,"threshold_uncertainty_score":0.4028007},"labels":[],"label_agreement":null},{"id":"W4389248703","doi":"10.1182/blood-2023-185194","title":"Prognostic Significance of the Neutrophil/Lymphocyte Ratio in Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis","year":2023,"lang":"en","type":"review","venue":"Blood","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Hazard ratio; Neutrophil to lymphocyte ratio; Internal medicine; International Prognostic Index; Oncology; Meta-analysis; Chemoimmunotherapy; Univariate analysis; Lymphoma; Regimen; Lymphocyte; Confidence interval; Rituximab; Multivariate analysis","score_opus":0.04153811295625663,"score_gpt":0.2846100094312792,"score_spread":0.24307189647502253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389248703","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000017804614,0.9941051,0.0000033984873,0.000024170113,0.00014959673,0.005280784,0.00032836717,0.000035507754,0.00005525587],"genre_scores_gemma":[0.0003444281,0.9927678,0.000008380359,0.00010928869,0.0000073492706,0.0026034722,0.000099608835,0.000067898596,0.0039917803],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9947721,0.0021933247,0.0018504615,0.00064177037,0.00009648293,0.0004458975],"domain_scores_gemma":[0.99584985,0.0009901281,0.0015924613,0.0014640414,0.000084765874,0.000018776353],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010585613,0.0006001385,0.008641737,0.00029976707,0.000095844465,0.000017904316,0.0008690519,0.00044445877,0.00008716048],"category_scores_gemma":[0.00037146415,0.00034093612,0.0024064537,0.0018098027,0.00019009381,0.000037661484,0.00035824254,0.00033804006,0.0001718246],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000019068356,0.0013588459,0.0000026343869,0.8953448,0.10301237,0.000012185069,0.000057394904,2.2474333e-7,0.0000140316415,0.000041018448,0.00007137121,0.00008322904],"study_design_scores_gemma":[0.0022556453,0.000027213353,0.0000031376894,0.03251945,0.9503951,0.00004703807,0.00001144947,2.2147889e-7,0.000085392036,0.0000053997687,0.014316015,0.00033394754],"about_ca_topic_score_codex":0.000052491523,"about_ca_topic_score_gemma":0.0000526964,"teacher_disagreement_score":0.86282533,"about_ca_system_score_codex":0.00009009559,"about_ca_system_score_gemma":0.00039109038,"threshold_uncertainty_score":0.9999043},"labels":[],"label_agreement":null},{"id":"W4389248748","doi":"10.1182/blood-2023-189159","title":"Obstetrical Use of Intravenous Immunoglobulin at a Tertiary Care Canadian Center: A 14-Year Retrospective Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Canadian Blood Services; Canadian Electricity Association; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Pregnancy; Retrospective cohort study; Off-label use; Cohort; Pediatrics; Dosing; Emergency medicine; Family medicine; Intensive care medicine; Internal medicine","score_opus":0.013377247081592875,"score_gpt":0.2389596686607786,"score_spread":0.22558242157918573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389248748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978068,0.0004480483,8.268255e-8,0.00007762636,0.000094209245,0.00065997295,0.00022721547,0.000055049866,0.00063101563],"genre_scores_gemma":[0.9992507,0.00006218232,0.000044386394,0.00005345194,0.00002071202,0.000015929103,0.00015756428,0.000023822899,0.0003712531],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999002,0.000028270462,0.0001878687,0.00024564363,0.0002221376,0.0003140866],"domain_scores_gemma":[0.9993554,0.00002759132,0.00004143492,0.00029140353,0.00009213606,0.00019203428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000024800302,0.00013332689,0.00031443135,0.00022061238,0.00007833526,0.000011455666,0.00006455511,0.00007327975,0.000053445354],"category_scores_gemma":[0.000107788415,0.000115473886,0.000084164596,0.00042145659,0.000028443266,0.00003471873,0.000054581153,0.00011304625,0.00012633424],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006905985,0.0015652026,0.9878651,0.000024204854,0.0004891935,0.0049452125,0.004062777,5.310413e-7,0.00013422595,0.000003383764,0.0003351624,0.00050597644],"study_design_scores_gemma":[0.0075703827,0.0009091683,0.9877882,0.000045287496,0.00029073752,0.000107007174,0.0023671351,0.0000032491785,0.00044635887,0.000006995957,0.0003663651,0.00009911627],"about_ca_topic_score_codex":0.031954214,"about_ca_topic_score_gemma":0.031652767,"teacher_disagreement_score":0.0075013232,"about_ca_system_score_codex":0.00024721396,"about_ca_system_score_gemma":0.00013378679,"threshold_uncertainty_score":0.98601705},"labels":[],"label_agreement":null},{"id":"W4389248758","doi":"10.1182/blood-2023-182171","title":"Multiparametric Flow Cytometry Based Quantification of the Marrow Hematopoietic Stem and Progenitor Compartment in Post Allogeneic Stem Cell Transplant Recipients with Poor Graft Function to Evaluate Hematopoietic Stem Cell Quality and Predict Clinical Outcomes: A Pilot Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Cytopenia; Stem cell; CD34; Transplantation; Haematopoiesis; Medicine; Hematopoietic stem cell transplantation; Progenitor cell; Cord blood; Bone marrow; Hematopoietic stem cell; Internal medicine; Immunology; Biology","score_opus":0.08605759025065907,"score_gpt":0.33594819839926526,"score_spread":0.2498906081486062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389248758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991842,0.00018819276,0.00061486784,0.00021531392,0.0002313855,0.006603618,0.00016195148,0.00012374294,0.000018941417],"genre_scores_gemma":[0.99873257,0.00003282332,0.00039337066,0.000106138425,0.000021996339,0.00048648965,0.00006246965,0.000070102324,0.00009402104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99427617,0.0011449608,0.001764485,0.0009981211,0.0013235284,0.0004927313],"domain_scores_gemma":[0.9970828,0.0010835999,0.000476614,0.00075212814,0.00025050202,0.00035432578],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0030757524,0.00047466476,0.0011381985,0.0006531133,0.00013276785,0.000044604807,0.00022467897,0.00015212716,0.00000941812],"category_scores_gemma":[0.000028680635,0.00032934197,0.00014411112,0.0018359261,0.0001304941,0.000079774014,0.000054178647,0.00032866938,0.000026410311],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023309027,0.007046991,0.96691716,0.0021881496,0.00027270912,0.000055051187,0.002551137,0.0001199276,0.018036034,0.0000024774781,0.000006998717,0.00047245933],"study_design_scores_gemma":[0.018414874,0.005899236,0.9422468,0.00063929893,0.0017379895,0.00006550629,0.0032167123,0.002287483,0.025152994,0.0000019402896,0.0000019936408,0.0003352046],"about_ca_topic_score_codex":0.000058095757,"about_ca_topic_score_gemma":0.000083318344,"teacher_disagreement_score":0.024670394,"about_ca_system_score_codex":0.00007585542,"about_ca_system_score_gemma":0.00021213952,"threshold_uncertainty_score":0.99991584},"labels":[],"label_agreement":null},{"id":"W4389258214","doi":"10.1182/blood-2023-178804","title":"KB-Lanra 1001: A Phase 1b/2 Study of Safety, PK, PD, and Preliminary Efficacy of the Selective SYK Inhibitor Lanraplenib in Combination with the FLT3 Inhibitor Gilteritinib in FLT3-Mutated R/R AML","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Daiichi Sankyo Europe; Servier; Astellas Pharma; Genentech; Actuate Therapeutics; Sierra Oncology; Incyte; Ono Pharmaceutical; Mateon Therapeutics; Jazz Pharmaceuticals; Gilead Sciences; Actinium Pharmaceuticals; Karyopharm Therapeutics; Celgene; Bristol-Myers Squibb; AstraZeneca; Syndax Pharmaceuticals; Constellation Pharmaceuticals; Agios Pharmaceuticals; GlaxoSmithKline; Amgen","keywords":"Syk; Fms-Like Tyrosine Kinase 3; Cancer research; Tyrosine-kinase inhibitor; Medicine; Sorafenib; Tyrosine kinase; Myeloid leukemia; Pharmacology; Immunology; Internal medicine; Biology; Cancer; Receptor; Mutation; Biochemistry","score_opus":0.015804677624155196,"score_gpt":0.29819815791991555,"score_spread":0.28239348029576034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389258214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949375,0.000119310185,0.0000018711684,0.0012695155,0.000038803693,0.0033253056,0.00004499394,0.000048066944,0.0002146724],"genre_scores_gemma":[0.9994378,0.000038374998,0.000028308365,0.000034133638,0.00006865036,0.00017116504,0.000049097547,0.000043769913,0.00012869807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975784,0.00046523885,0.0005414143,0.00039534914,0.00064581074,0.00037379283],"domain_scores_gemma":[0.9984061,0.0006422606,0.00019676078,0.00045183097,0.00022589683,0.00007716204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008680351,0.00022446537,0.00050995353,0.0004193367,0.00008812961,0.000015652375,0.00023873906,0.000115593306,0.000010246724],"category_scores_gemma":[0.00042017744,0.00013695785,0.000050566967,0.0021952158,0.00024563068,0.000092547154,0.0002594468,0.0006115791,0.000005509319],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050422132,0.092440926,0.50895804,0.0017484453,0.0017859095,0.0017541229,0.10187066,0.00020371903,0.21817772,0.00014069371,0.0050855554,0.017412052],"study_design_scores_gemma":[0.1445013,0.011962629,0.75485003,0.00086311327,0.00036888703,0.00011544497,0.0118002985,0.0010550646,0.07409819,0.000034510136,0.000085851294,0.00026464692],"about_ca_topic_score_codex":0.00044891183,"about_ca_topic_score_gemma":0.0004672962,"teacher_disagreement_score":0.24589199,"about_ca_system_score_codex":0.00012859191,"about_ca_system_score_gemma":0.00032897876,"threshold_uncertainty_score":0.55849797},"labels":[],"label_agreement":null},{"id":"W4389258266","doi":"10.1182/blood-2023-188221","title":"Unlocking Insights: A Single Centre Patient-Reported Outcome Experience in Patients with Severe Hemophilia a without Inhibitors on Emicizumab","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Population; Patient-reported outcome; Descriptive statistics; Quality of life (healthcare); Visual analogue scale; Minimal clinically important difference; Physical therapy; Pediatrics; Internal medicine; Randomized controlled trial; Statistics","score_opus":0.03614118665039125,"score_gpt":0.2851805034972113,"score_spread":0.24903931684682007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389258266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969395,0.000028588765,2.0665603e-7,0.00028374986,0.00010578641,0.0010026455,0.0000061857004,0.0001870098,0.0014463593],"genre_scores_gemma":[0.9987843,0.0000043206624,0.000065869965,0.0001163744,0.000057316964,0.00004709808,0.00009914082,0.000050345923,0.00077525864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99754477,0.000052483312,0.0004654058,0.00052816677,0.0008544135,0.000554781],"domain_scores_gemma":[0.99902225,0.00005820806,0.00011707004,0.0004456178,0.00013525564,0.00022162634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006640172,0.00027717988,0.0004035918,0.00042503243,0.00010647111,0.000028495555,0.00009477552,0.00012695811,0.000038169685],"category_scores_gemma":[0.00018013673,0.0001875015,0.00007489984,0.00108276,0.00008158085,0.00011245963,0.00008353358,0.00028697055,0.000089565925],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005182536,0.0025139712,0.989452,0.000056504185,0.00009067675,0.0008552481,0.004063941,0.0000082231845,0.00070709345,0.000004478642,0.00006936766,0.0016602618],"study_design_scores_gemma":[0.032048274,0.0037717763,0.9322871,0.0015612295,0.00018158303,0.000051003823,0.0026727703,0.00007702806,0.025893126,0.000032544987,0.0007753096,0.0006482596],"about_ca_topic_score_codex":0.000035208355,"about_ca_topic_score_gemma":0.000028396053,"teacher_disagreement_score":0.057164885,"about_ca_system_score_codex":0.00016617069,"about_ca_system_score_gemma":0.000094353214,"threshold_uncertainty_score":0.7646089},"labels":[],"label_agreement":null},{"id":"W4389258268","doi":"10.1182/blood-2023-189367","title":"Burden of Illness of Alpha- and Beta-Thalassemia: A Qualitative Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Thalassemia; Quality of life (healthcare); Beta thalassemia; Disease; Blood transfusion; Disease burden; Internal medicine; Pediatrics","score_opus":0.01793732207030204,"score_gpt":0.31632245372790674,"score_spread":0.2983851316576047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389258268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971997,0.0006257836,0.0000020875852,0.0003703679,0.000037027894,0.0003357534,0.000012543315,0.00003132439,0.001385383],"genre_scores_gemma":[0.99934757,0.00016730545,0.000037956754,0.000009978471,0.000018479273,0.000010961203,0.000007425508,0.000011633237,0.0003886988],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9992383,0.00006738646,0.00024511444,0.00013734547,0.00019054602,0.000121322344],"domain_scores_gemma":[0.9995237,0.000111716945,0.000079396894,0.00015186718,0.00007863281,0.0000546633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030255396,0.00007987504,0.000315756,0.00010219862,0.000025795747,0.0000019322572,0.000040789513,0.00007366708,0.00001888287],"category_scores_gemma":[0.000094075425,0.00006052304,0.000047741833,0.00034907064,0.000088974215,0.000020033722,0.00004524392,0.0000985025,0.0000074571326],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002750927,0.0043456764,0.046193045,0.0013638461,0.0025478085,0.00032813798,0.89474434,0.000018017932,0.04104645,0.0006754426,0.0014138514,0.0070482865],"study_design_scores_gemma":[0.01299501,0.00236272,0.027278475,0.00031011563,0.0013208963,0.000036186484,0.937775,0.000057860452,0.01698129,0.00028677867,0.0003920166,0.00020363837],"about_ca_topic_score_codex":0.00018903695,"about_ca_topic_score_gemma":0.0000047448216,"teacher_disagreement_score":0.043030668,"about_ca_system_score_codex":0.0000029792009,"about_ca_system_score_gemma":0.0000370167,"threshold_uncertainty_score":0.2468058},"labels":[],"label_agreement":null},{"id":"W4389258287","doi":"10.1182/blood-2023-189700","title":"Safety of Elranatamab in Patients with Triple-Class Refractory Relapsed/Refractory Multiple Myeloma (RRMM) in Magnetismm-17, a North American Expanded Access Protocol","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Calgary","funders":"","keywords":"Medicine; Tolerability; Internal medicine; Adverse effect; Expanded access; Oncology; Progressive disease; Disease","score_opus":0.019623837999790585,"score_gpt":0.3005322399943265,"score_spread":0.28090840199453593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389258287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9588071,0.000013745416,0.0000024741703,0.00007310073,0.000026929827,0.03991296,0.00015726648,0.000100984995,0.000905418],"genre_scores_gemma":[0.9748326,0.000028868919,0.00024724414,0.000048943366,0.000036646496,0.02389776,0.00041523288,0.000072601106,0.00042010096],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965168,0.00022258172,0.00078142545,0.0006716482,0.0009893812,0.0008181414],"domain_scores_gemma":[0.9981072,0.00029156674,0.000332517,0.00073976204,0.00019134583,0.00033763368],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002712166,0.00038592992,0.0008533841,0.00092018367,0.000065151806,0.000024174546,0.00034789494,0.00011339353,0.00011492231],"category_scores_gemma":[0.0004756242,0.00029640712,0.00010790142,0.0022315641,0.00022557328,0.0003090699,0.00019114099,0.00054307724,0.00003440344],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011815922,0.005869856,0.9584856,0.0002615593,0.00016949324,0.0005403378,0.0002665406,0.00001096236,0.0001896768,0.000001056156,0.0001933782,0.022195585],"study_design_scores_gemma":[0.08057574,0.0034388588,0.913191,0.00028428063,0.000050994993,0.000004141172,0.000095630974,0.00014761934,0.00060312264,0.0000025764525,0.0013532751,0.0002527119],"about_ca_topic_score_codex":0.0013126305,"about_ca_topic_score_gemma":0.0063809096,"teacher_disagreement_score":0.06875982,"about_ca_system_score_codex":0.0002227668,"about_ca_system_score_gemma":0.00040854045,"threshold_uncertainty_score":0.9999488},"labels":[],"label_agreement":null},{"id":"W4389258289","doi":"10.1182/blood-2023-172977","title":"Real World Experience of Ibrutinib in an Ethnically Diverse Canadian Community Hospital","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"William Osler Health System","funders":"","keywords":"Ibrutinib; Bruton's tyrosine kinase; Medicine; Chronic lymphocytic leukemia; Population; Internal medicine; Oncology; Leukemia; Tyrosine kinase; Environmental health","score_opus":0.059583395361537346,"score_gpt":0.3611031074298471,"score_spread":0.30151971206830974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389258289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99164873,0.000013466327,1.1868389e-7,0.00017072637,0.000054286837,0.00025852758,0.00001759716,0.000050624305,0.007785927],"genre_scores_gemma":[0.9991224,0.000036589005,0.00010994231,0.00006295166,0.00004408906,0.000021917402,0.00004316119,0.000015481895,0.00054347585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987085,0.00013773316,0.00023016779,0.00016324973,0.00032442977,0.00043595425],"domain_scores_gemma":[0.9986907,0.00017414243,0.000033286102,0.0006193334,0.00007802591,0.00040449348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048140498,0.00009028305,0.00022044255,0.00032242437,0.00007542865,0.000009207186,0.00030138428,0.00007807887,0.00012785746],"category_scores_gemma":[0.0003259722,0.00008737153,0.00004394594,0.00091708894,0.00021723623,0.000077001954,0.00015276474,0.0003930756,0.000060074286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031369357,0.0038315447,0.9149533,0.00035781643,0.0001223294,0.004244331,0.061329033,0.000025395455,0.00752912,0.00075315434,0.0018864515,0.0046538156],"study_design_scores_gemma":[0.021417037,0.00064640044,0.9639441,0.0001826629,0.000036571306,0.000022678534,0.008106372,0.00074815186,0.004294278,0.0000731598,0.0003413962,0.00018718936],"about_ca_topic_score_codex":0.6838691,"about_ca_topic_score_gemma":0.7494125,"teacher_disagreement_score":0.06554336,"about_ca_system_score_codex":0.0017236107,"about_ca_system_score_gemma":0.0049269176,"threshold_uncertainty_score":0.8740141},"labels":[],"label_agreement":null},{"id":"W4389258981","doi":"10.1182/blood-2023-178722","title":"Real-World Evaluation of Treatment Patterns and Clinical Outcomes Among Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated with Asciminib in US Clinical Practice","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Discontinuation; Dasatinib; Internal medicine; Imatinib mesylate; Bosutinib; Ponatinib; Oncology; Myeloid leukemia; Clinical trial; Philadelphia chromosome; Imatinib; Chromosomal translocation; Biology","score_opus":0.05338237304737282,"score_gpt":0.3981197193294436,"score_spread":0.3447373462820708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389258981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959243,0.00011204575,0.0000012459303,0.00008032174,0.00007963345,0.0030873055,0.00006456348,0.00009616564,0.00055442133],"genre_scores_gemma":[0.99708694,0.0012999639,0.00021021818,0.00003857078,0.00013233181,0.00033305192,0.0005768825,0.00008456691,0.00023749955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950671,0.00070502266,0.0016018824,0.0010046313,0.0009853933,0.0006359366],"domain_scores_gemma":[0.996667,0.0012119764,0.0006875193,0.0008442483,0.00029885632,0.000290388],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017667501,0.00051025744,0.0013288821,0.0005300131,0.00005223821,0.000022474856,0.00012965553,0.00026311397,0.000082194376],"category_scores_gemma":[0.0005566409,0.0003538621,0.00016425806,0.0009970794,0.00027854758,0.00028991114,0.000075108816,0.0004784078,0.000023598168],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015947683,0.004464846,0.97083294,0.000099786004,0.001178488,0.0003229432,0.00017020239,0.00019078272,0.000010301888,0.0000025623935,0.000016526456,0.021115845],"study_design_scores_gemma":[0.15484561,0.012525694,0.82563096,0.00065493723,0.003062275,0.000014513541,0.000069775655,0.0026988378,0.00016008342,0.0000024000162,0.00006975365,0.0002651644],"about_ca_topic_score_codex":0.014721829,"about_ca_topic_score_gemma":0.06258259,"teacher_disagreement_score":0.15325084,"about_ca_system_score_codex":0.009093276,"about_ca_system_score_gemma":0.0053041596,"threshold_uncertainty_score":0.99989134},"labels":[],"label_agreement":null},{"id":"W4389258985","doi":"10.1182/blood-2023-180430","title":"Restrictive Versus Liberal Red Blood Cell Transfusion Strategies for Patients with Hematologic Malignancies Receiving Intensive Chemotherapy","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; Juravinski Hospital; McMaster University; University of Toronto; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Blood transfusion; Anemia; Randomized controlled trial; Internal medicine; Aplastic anemia; Intensive care medicine; Pediatrics; Surgery","score_opus":0.018801070790581246,"score_gpt":0.24971557512511308,"score_spread":0.23091450433453184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389258985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995835,0.00004345787,0.00033862476,0.00034181186,0.00016243728,0.001431005,0.000036531426,0.00027125995,0.0015398359],"genre_scores_gemma":[0.99627763,0.00024353036,0.0026866654,0.00010149521,0.000053637996,0.00015779081,0.00021344978,0.000055433455,0.00021034836],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99861896,0.000035636764,0.00028961903,0.00038505517,0.00030515535,0.00036555406],"domain_scores_gemma":[0.9988422,0.00033218152,0.00010611939,0.00022543797,0.00040246366,0.00009162294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010401779,0.00023205114,0.0003761796,0.00015250558,0.0001104218,0.000030508148,0.00008318997,0.0001430469,0.000024620753],"category_scores_gemma":[0.00006118123,0.00018286587,0.00009741709,0.0004373866,0.000058926238,0.0001225612,0.000008418492,0.00012910995,0.000014100896],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037230525,0.00929936,0.488277,0.0086769415,0.0032051576,0.0013271369,0.05940986,0.0001224504,0.38554424,0.0014083695,0.004028397,0.0014705496],"study_design_scores_gemma":[0.13793051,0.012677515,0.3009147,0.0019847383,0.003014098,0.00014806476,0.017220095,0.00013522604,0.52373314,0.0010059902,0.00017149525,0.0010644417],"about_ca_topic_score_codex":0.000014014254,"about_ca_topic_score_gemma":0.000010932797,"teacher_disagreement_score":0.1873623,"about_ca_system_score_codex":0.000020473804,"about_ca_system_score_gemma":0.00012849203,"threshold_uncertainty_score":0.74570537},"labels":[],"label_agreement":null},{"id":"W4389259058","doi":"10.1182/blood-2023-188472","title":"LSD1 Inhibition Enhances Antigen Presentation and Co-Stimulation in AML to Promote T Cell-Mediated Anti-Leukemia Immune Responses","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Juravinski Cancer Centre; Population Health Research Institute; McMaster University","funders":"","keywords":"CIITA; Myeloid leukemia; Leukemia; Cancer research; Antigen; Immune system; Stem cell; Biology; Immunology; Myeloid; Flow cytometry; Downregulation and upregulation; T cell; Transplantation; Medicine; Cell biology; Internal medicine; MHC class II","score_opus":0.012691000531481292,"score_gpt":0.2660407128686262,"score_spread":0.2533497123371449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389259058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977556,0.0003592522,0.000039812763,0.00014575807,0.00062439434,0.00043050243,0.000010146787,0.00014437624,0.00049018505],"genre_scores_gemma":[0.9953875,0.00029199175,0.00002661431,0.00006096342,0.000025586292,0.000041162,0.00082738063,0.000014746373,0.0033240514],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989756,0.0001866521,0.00031132775,0.00025914767,0.00004301017,0.00022429187],"domain_scores_gemma":[0.9995691,0.00012941292,0.00010123672,0.0001297036,0.00005368927,0.000016865357],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027796067,0.0001249979,0.00016601663,0.00038922252,0.00013292626,0.000027623759,0.000046766363,0.00015992174,0.00019763711],"category_scores_gemma":[0.00015644063,0.00012709935,0.000031791544,0.00039818938,0.00004184484,0.0002202068,0.000036141526,0.00016693698,0.0012163916],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027767094,0.00011126939,0.006620349,0.000019281519,0.000026028833,0.0000061564265,0.00089629105,0.000042285315,0.9901804,0.000005883153,0.0012779089,0.00053652626],"study_design_scores_gemma":[0.0017169805,0.00019618977,0.2316589,0.000047992864,0.00001579314,0.0000121374205,0.00026171922,0.000064618,0.7623997,0.000012289743,0.0034990795,0.000114648334],"about_ca_topic_score_codex":0.00012241716,"about_ca_topic_score_gemma":0.000014751316,"teacher_disagreement_score":0.2277807,"about_ca_system_score_codex":0.000035431633,"about_ca_system_score_gemma":0.000039425235,"threshold_uncertainty_score":0.99956125},"labels":[],"label_agreement":null},{"id":"W4389259069","doi":"10.1182/blood-2023-178822","title":"Oral Decitabine/Cedazuridine Is a Tolerable and Effective Ambulatory Regimen for Patients with Advanced Myeloproliferative Neoplasms","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Silence Therapeutics; Swedish Orphan Biovitrum; Astellas Pharma; Karyopharm Therapeutics; Galecto; Sierra Oncology; Incyte; CTI Biopharma; Gilead Sciences; MorphoSys; Celgene; GlaxoSmithKline; Constellation Pharmaceuticals; Bristol-Myers Squibb","keywords":"Medicine; Decitabine; Internal medicine; Ruxolitinib; Myelofibrosis; Oncology; Bone marrow; Gastroenterology; Febrile neutropenia; Neutropenia; Chemotherapy","score_opus":0.007458680412565143,"score_gpt":0.2499339059953076,"score_spread":0.24247522558274245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389259069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99454886,0.0002810458,0.000029618694,0.0006595064,0.000075676115,0.0036652146,0.00013195965,0.00014902107,0.00045912137],"genre_scores_gemma":[0.9927156,0.00015257961,0.0032946006,0.0005575031,0.00008725428,0.0022837322,0.00020557926,0.0000659109,0.0006372712],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830866,0.00004327731,0.0002525771,0.0006224334,0.0003170803,0.00045594922],"domain_scores_gemma":[0.9986653,0.00035850157,0.00010947008,0.00028413924,0.00034008926,0.00024249768],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013139259,0.00035663162,0.0006077244,0.00015665298,0.00022204682,0.000037609057,0.000053045947,0.00009938062,0.000035762405],"category_scores_gemma":[0.00013717911,0.00025409757,0.00008678338,0.0003599085,0.00007870277,0.00015655461,0.00005017016,0.00013031626,0.000038900776],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035657107,0.0031704693,0.9717473,0.00033085153,0.0018568784,0.000109018496,0.0023858263,0.000024818672,0.000663525,0.00092562195,0.004135515,0.01108447],"study_design_scores_gemma":[0.051507227,0.011487656,0.87860596,0.00043756946,0.00096062367,0.000036717996,0.00021558469,0.00028616877,0.051017996,0.00035022385,0.0045381356,0.00055611454],"about_ca_topic_score_codex":0.000009869333,"about_ca_topic_score_gemma":0.000014302907,"teacher_disagreement_score":0.09314131,"about_ca_system_score_codex":0.00006258199,"about_ca_system_score_gemma":0.000103175254,"threshold_uncertainty_score":0.9999911},"labels":[],"label_agreement":null},{"id":"W4389259078","doi":"10.1182/blood-2023-187573","title":"Clime: CLL Immune Micro-Environment and Risk of Infections Pre- and Post-Diagnosis: A Population-Based Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"Leukemia and Lymphoma Society of Canada; CancerCare Manitoba Foundation; AstraZeneca","keywords":"Medicine; Population; Cancer; Chronic lymphocytic leukemia; Internal medicine; Cancer registry; Pediatrics; Leukemia","score_opus":0.010951435405460562,"score_gpt":0.2800887961759581,"score_spread":0.26913736077049755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389259078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99791837,0.0008519308,0.0000021718147,0.00011827994,0.000023129294,0.00097103487,0.00003763075,0.000051451498,0.000025984204],"genre_scores_gemma":[0.99877095,0.00070172263,0.000105811036,0.000016526958,0.000033248896,0.00016609364,0.000038974205,0.000020835769,0.00014583628],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99894947,0.000089141475,0.00026301638,0.00025087257,0.0002544526,0.00019303375],"domain_scores_gemma":[0.9991434,0.00031715987,0.00007596843,0.00032826007,0.000035540354,0.00009964185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034496945,0.00010761789,0.00023656062,0.00017104755,0.0000958553,0.000013030673,0.0000417451,0.00006137117,0.000040337247],"category_scores_gemma":[0.000242104,0.000095147465,0.0000447883,0.00021375947,0.000060908504,0.00003356819,0.000101197016,0.00013287143,0.000018909464],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000796253,0.0018769773,0.9937735,0.00012806666,0.0002776729,0.000027565327,0.00045516223,0.000048305752,0.0025572283,0.0000023701186,0.000023152914,0.0007503353],"study_design_scores_gemma":[0.023319507,0.0010950884,0.9711692,0.00006927948,0.0006100621,0.000025049716,0.00031756403,0.00052632304,0.0027313025,0.000011623484,0.000044683075,0.000080321304],"about_ca_topic_score_codex":0.0046856934,"about_ca_topic_score_gemma":0.00009737386,"teacher_disagreement_score":0.02323988,"about_ca_system_score_codex":0.00038612218,"about_ca_system_score_gemma":0.00038295035,"threshold_uncertainty_score":0.7083398},"labels":[],"label_agreement":null},{"id":"W4389259098","doi":"10.1182/blood-2023-186256","title":"Symptom Burden in Idiopathic Multicentric Castleman Disease: Protocol for the Development of a Novel Standardized Patient Reported Outcome Measure","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Prom; Medicine; Quality of life (healthcare); Protocol (science); Disease; Clinical trial; Patient-reported outcome; Content validity; Stakeholder; Stage (stratigraphy); Physical therapy; Family medicine; Alternative medicine; Internal medicine; Clinical psychology; Pathology; Psychometrics; Nursing","score_opus":0.05735747909406933,"score_gpt":0.3342032869127249,"score_spread":0.27684580781865553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389259098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7981146,0.00025398107,0.00067192875,0.0012860096,0.0001338649,0.19906168,0.00008731167,0.00017045521,0.00022015795],"genre_scores_gemma":[0.87922055,0.0000024812225,0.0003756969,0.0000544907,0.000034528333,0.120183,0.000017612849,0.000029412608,0.00008223923],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981287,0.000029129988,0.00072877615,0.0002453344,0.0005570491,0.0003109902],"domain_scores_gemma":[0.99905264,0.000065796725,0.00029214617,0.0002755096,0.00020568563,0.00010820304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006798319,0.00015029662,0.00035673252,0.00013254065,0.00009560237,0.000011141721,0.00008505466,0.000069356494,0.000011139218],"category_scores_gemma":[0.0008316572,0.0001017969,0.00012990355,0.00055316446,0.000029085364,0.000026457583,0.00004320686,0.000121135796,0.0000023063271],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01244604,0.008052043,0.88444877,0.0059571876,0.002706824,0.00043817682,0.026449371,0.0013207137,0.011677816,0.000103497034,0.0015536197,0.044845924],"study_design_scores_gemma":[0.21565506,0.0010802117,0.74338293,0.00320783,0.0018138873,0.000018061106,0.006622052,0.0051562423,0.004705075,0.00007810631,0.017382797,0.00089772395],"about_ca_topic_score_codex":0.000045424942,"about_ca_topic_score_gemma":0.0000731609,"teacher_disagreement_score":0.20320901,"about_ca_system_score_codex":0.0001329904,"about_ca_system_score_gemma":0.00074953825,"threshold_uncertainty_score":0.4151157},"labels":[],"label_agreement":null},{"id":"W4389259127","doi":"10.1182/blood-2023-182164","title":"Comparative Efficacy of Ciltacabtagene Autoleucel Versus Elotuzumab, Isatuximab, and Selinexor-Based Regimens in the Treatment of Patients with Relapsed or Refractory Multiple Myeloma with 1-3 Prior Lines of Therapy Using a Matching-Adjusted Indirect Comparison","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pomalidomide; Lenalidomide; Medicine; Daratumumab; Carfilzomib; Internal medicine; Oncology; Multiple myeloma; Population; Bortezomib; Refractory (planetary science)","score_opus":0.10312788611521921,"score_gpt":0.3503873702330216,"score_spread":0.24725948411780235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389259127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972911,0.00039475053,0.000010580105,0.0000362165,0.000017909382,0.0020751148,0.00011044154,0.0000380937,0.000025785579],"genre_scores_gemma":[0.9965418,0.00009144337,0.0030253236,0.000007359732,0.000014149132,0.00006434773,0.00020204607,0.000033992084,0.000019513645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979674,0.0002304285,0.00051161915,0.0003368132,0.0006192143,0.0003345295],"domain_scores_gemma":[0.99767244,0.0011271776,0.0004236592,0.00043240678,0.00023946875,0.00010483153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017414012,0.00030084638,0.000988063,0.00033758066,0.00006961756,0.000008746078,0.00011115075,0.000088074645,0.0000083584555],"category_scores_gemma":[0.000080843034,0.00015430195,0.0000765213,0.00080911943,0.00022058323,0.000054123542,0.00001831002,0.0001368576,9.750572e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09366257,0.02366632,0.8459424,0.00031394322,0.0020885952,0.00021908374,0.013119001,0.00072896277,0.014519452,0.0000021302444,0.000008793108,0.0057287468],"study_design_scores_gemma":[0.12637813,0.016817247,0.78945583,0.00039453516,0.00037842593,0.0000042117026,0.001213406,0.0027122402,0.06247079,5.250637e-7,0.00003160493,0.00014307261],"about_ca_topic_score_codex":0.00047516832,"about_ca_topic_score_gemma":0.00039670855,"teacher_disagreement_score":0.0564866,"about_ca_system_score_codex":0.000087891334,"about_ca_system_score_gemma":0.0003751146,"threshold_uncertainty_score":0.6292251},"labels":[],"label_agreement":null},{"id":"W4389259147","doi":"10.1182/blood-2023-187528","title":"Antiphospholipid Antibody Syndrome (APS) Pediatric Patient Outcomes on Warfarin","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stollery Children's Hospital; University of Alberta","funders":"","keywords":"Medicine; Warfarin; Antiphospholipid syndrome; Vitamin K antagonist; Lupus anticoagulant; Internal medicine; Deep vein; Pulmonary embolism; Thrombosis; Anticoagulant; Medical record; Pediatrics; Atrial fibrillation","score_opus":0.007471082682060106,"score_gpt":0.24896750132624273,"score_spread":0.24149641864418264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389259147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99749625,0.0004141302,0.000003647109,0.00012121316,0.00022718337,0.00018108381,0.00004152254,0.00005502205,0.0014599621],"genre_scores_gemma":[0.9979412,0.00044437905,0.000038946382,0.00025172834,0.000048611128,0.000027008884,0.00034910804,0.00003050191,0.0008685436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989984,0.000022291668,0.0001590054,0.00036022326,0.00015837536,0.0003017088],"domain_scores_gemma":[0.9994771,0.000009917345,0.000054602064,0.00035769367,0.000023215613,0.00007746801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004441465,0.00018128818,0.00016392373,0.00007140042,0.0000840664,0.000019447833,0.0001291202,0.000111883135,0.000016093974],"category_scores_gemma":[0.00002939882,0.00015236928,0.000121344914,0.00020256185,0.000018427505,0.0000023225657,0.00010776833,0.00005800931,0.00032917203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036939764,0.0024251787,0.98002595,0.00003046091,0.00038297387,0.0002901164,0.00005423012,0.000040710667,0.010815007,0.00011525668,0.0035757155,0.002207442],"study_design_scores_gemma":[0.007953567,0.00330092,0.8447378,0.000018052502,0.00038391992,0.00009861352,0.00009870924,0.000012339907,0.12565713,0.0002003114,0.016701942,0.00083666155],"about_ca_topic_score_codex":0.000018380399,"about_ca_topic_score_gemma":0.0000037847774,"teacher_disagreement_score":0.13528813,"about_ca_system_score_codex":0.0000030754345,"about_ca_system_score_gemma":0.000027627622,"threshold_uncertainty_score":0.62134385},"labels":[],"label_agreement":null},{"id":"W4389259281","doi":"10.1182/blood-2023-179448","title":"Treatment of Critical Bleeding Events in Patients with Immune Thrombocytopenia: A Systematic Review","year":2023,"lang":"en","type":"review","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Ottawa; University of Toronto; Saskatchewan Health Authority; Joseph Brant Hospital; McMaster University; London Health Sciences Centre; McMaster Children's Hospital; Hospital for Sick Children; Canadian Blood Services","funders":"","keywords":"Medicine; Splenectomy; Observational study; Rituximab; Pediatrics; Systematic review; Guideline; Bleed; Randomized controlled trial; Internal medicine; MEDLINE; Surgery","score_opus":0.041949912806954266,"score_gpt":0.34098840685922766,"score_spread":0.2990384940522734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389259281","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011635191,0.99216574,1.9866741e-7,0.000016778704,0.000047214555,0.0063873213,0.00006328981,0.00003214235,0.00012381919],"genre_scores_gemma":[0.0008414683,0.99772877,0.00004453276,0.000008429458,0.000012278516,0.0008451362,0.00032167745,0.00008090977,0.00011682521],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9975878,0.000121536345,0.0011911116,0.00038162654,0.0003988583,0.00031906547],"domain_scores_gemma":[0.9987269,0.00020463014,0.00037318276,0.0005178016,0.00008148987,0.00009599541],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011888574,0.00046336098,0.007315888,0.00020784412,0.000027276741,0.0000044973526,0.0001162394,0.0001640543,0.000018452045],"category_scores_gemma":[0.00017874633,0.0002717677,0.00048089414,0.000522787,0.00003592,0.000042963962,0.00003665632,0.00012673525,0.00010936994],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000117123145,0.0052355747,0.00054221856,0.9885003,0.0019159662,0.0004677855,0.000024404524,4.1064596e-9,1.74526e-8,0.000010012616,0.0000018665488,0.003290132],"study_design_scores_gemma":[0.0055424687,0.0016385084,0.0004242278,0.95219857,0.0394956,0.0001424229,0.0000075913463,1.3134726e-7,5.521642e-7,0.000006239797,0.00032645973,0.00021724087],"about_ca_topic_score_codex":0.000031494335,"about_ca_topic_score_gemma":0.00000470665,"teacher_disagreement_score":0.037579633,"about_ca_system_score_codex":0.00016206029,"about_ca_system_score_gemma":0.00018415475,"threshold_uncertainty_score":0.9999735},"labels":[],"label_agreement":null},{"id":"W4389259347","doi":"10.1182/blood-2023-175012","title":"Assessing the Feasibility of Thromboprophylaxis with Apixaban in JAK2-Positive Myeloproliferative Neoplasm Patients: The Airport-MPN Trial","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Ottawa Hospital","funders":"","keywords":"Medicine; Apixaban; Aspirin; Essential thrombocythemia; Internal medicine; Polycythemia vera; Myeloproliferative neoplasm; Surgery; Warfarin; Thrombosis; Randomized controlled trial; Gastroenterology; Myelofibrosis; Rivaroxaban; Atrial fibrillation","score_opus":0.04039808053858123,"score_gpt":0.3288473379887396,"score_spread":0.28844925745015837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389259347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991816,0.00008805279,0.00000819493,0.0015608056,0.0001393275,0.003732902,0.000059310078,0.00005415197,0.0025412643],"genre_scores_gemma":[0.9986155,0.00004026181,0.000165433,0.000266585,0.00014332056,0.00052158127,0.00013123214,0.000032456435,0.00008364228],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99747366,0.00034255345,0.0005797505,0.00051978003,0.000685172,0.0003990616],"domain_scores_gemma":[0.9978967,0.0007502021,0.00029381932,0.00060382887,0.0003596413,0.00009585295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064586004,0.00032584983,0.00063552696,0.00012671103,0.0002803786,0.000075510616,0.00016868477,0.00010691415,0.00003294604],"category_scores_gemma":[0.00037601645,0.00015100488,0.00015872411,0.0009630876,0.00033360496,0.00018792352,0.00008624632,0.00038129656,0.000025666144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032710372,0.004443316,0.9850723,0.00005934128,0.0005618138,0.000097500175,0.0042400374,0.000017385611,0.00019382595,0.00032713756,0.00018245987,0.0015338087],"study_design_scores_gemma":[0.048634745,0.0038598287,0.93653774,0.00022850746,0.00033667887,0.000017135571,0.0014493801,0.00004282068,0.008516328,0.00016646714,0.00004003675,0.00017032876],"about_ca_topic_score_codex":0.00013569351,"about_ca_topic_score_gemma":0.00026855976,"teacher_disagreement_score":0.048534594,"about_ca_system_score_codex":0.00010248355,"about_ca_system_score_gemma":0.00036071893,"threshold_uncertainty_score":0.61578},"labels":[],"label_agreement":null},{"id":"W4389259388","doi":"10.1182/blood-2023-187713","title":"Risk of Bleeding and Thrombosis with CAR T-Cell Therapy: A Scoping Review","year":2023,"lang":"en","type":"review","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Chimeric antigen receptor; Thrombosis; Lymphoma; Internal medicine; Venous thrombosis; CAR T-cell therapy; Malignancy; Pediatrics; Oncology; Cancer; Surgery; Immunotherapy","score_opus":0.12163844875201123,"score_gpt":0.40119066190462427,"score_spread":0.279552213152613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389259388","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020611822,0.9938475,0.0000014050873,0.000020909278,0.000031477328,0.0040110233,0.00003113433,0.000067240115,0.0017831831],"genre_scores_gemma":[0.0000038813378,0.99848616,0.00014585415,0.000037027934,0.00016765003,0.00024413789,0.00003028198,0.00016164567,0.0007233537],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99772036,0.00022419136,0.0006383511,0.00051068503,0.00054999697,0.00035642882],"domain_scores_gemma":[0.9981549,0.00046141265,0.00044947446,0.00064695004,0.00012894228,0.0001583162],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00096623314,0.00038586193,0.0030126486,0.00024500306,0.000059033537,0.000020480842,0.0001825409,0.00019630259,0.0003347663],"category_scores_gemma":[0.000110403875,0.00025973917,0.00040011713,0.0008381317,0.0001206281,0.00003221369,0.00010088737,0.0006067937,0.000028994878],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001278092,0.00018141007,0.000120419536,0.55964684,0.0015890546,0.00003724287,0.000058457597,1.522487e-8,0.000100281395,0.0000019663005,0.000081373335,0.43817016],"study_design_scores_gemma":[0.001999281,0.000731612,0.000011318004,0.88937736,0.009058853,0.000121334226,0.000015023018,3.5242653e-7,0.00013296393,0.0000032909297,0.098239645,0.00030897622],"about_ca_topic_score_codex":0.000070594,"about_ca_topic_score_gemma":0.000010001991,"teacher_disagreement_score":0.4378612,"about_ca_system_score_codex":0.000033735952,"about_ca_system_score_gemma":0.00059040386,"threshold_uncertainty_score":0.99998546},"labels":[],"label_agreement":null},{"id":"W4389259463","doi":"10.1182/blood-2023-190062","title":"The KIR-HLA-CD16a Immunogenetic Profile Influences NK Cell-Mediated ADCC and Response to Rituximab Therapy in B-Cell Lymphomas","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Antibody-dependent cell-mediated cytotoxicity; Immunology; Rituximab; B cell; CD20; Biology; Human leukocyte antigen; Cancer research; Lymphoma; Antibody; Antigen; Monoclonal antibody","score_opus":0.008601615872810036,"score_gpt":0.2244463639005053,"score_spread":0.21584474802769527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389259463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98806554,0.008914236,9.776348e-7,0.00040425602,0.0010360297,0.00041748403,0.00000769358,0.00011018118,0.0010435818],"genre_scores_gemma":[0.98150206,0.00250928,0.000012345927,0.000322328,0.000018491473,0.00013881845,0.000059298603,0.00002129825,0.01541606],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99853754,0.00044153974,0.00030971732,0.00028475988,0.00004639434,0.0003800768],"domain_scores_gemma":[0.99903923,0.00050400017,0.00008358571,0.0002943501,0.000055046043,0.000023761948],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00053161354,0.00017353686,0.00018374447,0.00020016095,0.00030230434,0.000047341284,0.00020519094,0.00017467294,0.00030413776],"category_scores_gemma":[0.00014137533,0.00012834386,0.00005257327,0.00043870125,0.00011175929,0.00007421505,0.00008528292,0.00021199425,0.0030062909],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018616386,0.00037519963,0.0021515642,0.000007353814,0.000049460552,0.0000068479007,0.0010568796,0.0000027624174,0.9885869,0.0000051030324,0.004265682,0.001630578],"study_design_scores_gemma":[0.009422209,0.00087782374,0.04628797,0.000030632156,0.000021361198,0.00003304734,0.0014205739,0.000008702219,0.75709957,0.000016754208,0.18455045,0.0002309339],"about_ca_topic_score_codex":0.00013285504,"about_ca_topic_score_gemma":0.000020168658,"teacher_disagreement_score":0.2314874,"about_ca_system_score_codex":0.000026678996,"about_ca_system_score_gemma":0.00008758889,"threshold_uncertainty_score":0.99777},"labels":[],"label_agreement":null},{"id":"W4389259511","doi":"10.1182/blood-2023-187210","title":"Loss of Autophagy Activity during Storage of Hematopoietic Stem Cell Grafts Is Associated with Reduced Potency","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Ottawa","funders":"","keywords":"Potency; Cord blood; Haematopoiesis; CD34; Stem cell; Andrology; Progenitor cell; Cryopreservation; Hematopoietic stem cell; Transplantation; Biology; Chemistry; Immunology; Cell biology; Medicine; In vitro; Internal medicine; Biochemistry","score_opus":0.014456639447588767,"score_gpt":0.23854619839921154,"score_spread":0.22408955895162277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389259511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99807215,0.000049142764,0.00003881112,0.00007997005,0.000050917104,0.00040681293,0.000046708858,0.00013513776,0.0011203403],"genre_scores_gemma":[0.9985379,0.000032225093,0.00008032342,0.000008218044,0.00001610267,0.000015606609,0.000018880733,0.00004088248,0.0012498338],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985057,0.000070915405,0.00036142344,0.00027237477,0.000512868,0.00027669547],"domain_scores_gemma":[0.99901026,0.00012369205,0.00027587046,0.0003530606,0.0001343618,0.00010274086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023150473,0.00017333232,0.0005289096,0.00017735791,0.00004069708,0.000004379921,0.000092159105,0.0001318435,0.000054475415],"category_scores_gemma":[0.000018093824,0.0001529793,0.000103124665,0.0006579675,0.00006835012,0.000058720747,0.000020674415,0.00014501624,0.000020734098],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022585636,0.0012802016,0.016077787,0.0032635564,0.00030899083,0.0006352829,0.005282631,0.000017865928,0.97278285,0.000018458168,0.00002433614,0.00008216203],"study_design_scores_gemma":[0.004363167,0.00024732322,0.15607917,0.0007197587,0.00040679288,0.000102705875,0.0002492231,0.0000473945,0.83765423,0.000013094373,8.5127397e-7,0.000116266434],"about_ca_topic_score_codex":0.000031255822,"about_ca_topic_score_gemma":0.000004244214,"teacher_disagreement_score":0.14000139,"about_ca_system_score_codex":0.000031690826,"about_ca_system_score_gemma":0.00012969565,"threshold_uncertainty_score":0.62383145},"labels":[],"label_agreement":null},{"id":"W4389259512","doi":"10.1182/blood-2023-188135","title":"Asciminib Enhances Its Treatment Efficacy Synergistically in the Treatment of Chronic Myeloid Leukemia Harboring ABL1 Kinase Domain Mutation When Combined with a Reduced Dose of Ponatinib, Dasatinib, or Bosutinib, but Not with Nilotinib or Imatinib","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Bosutinib; Dasatinib; Ponatinib; Nilotinib; Imatinib; Medicine; Myeloid leukemia; Pharmacology; Tyrosine-kinase inhibitor; Tyrosine kinase; Imatinib mesylate; Cancer research; Internal medicine; Cancer; Receptor","score_opus":0.03312461366678398,"score_gpt":0.2947581460343663,"score_spread":0.2616335323675823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389259512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939307,0.00024220423,0.000017700379,0.00045690354,0.00009097793,0.0041422723,0.00023172525,0.00019418662,0.00069330283],"genre_scores_gemma":[0.9915807,0.00053670345,0.004883488,0.000046241024,0.00019756716,0.0012448748,0.0004219857,0.00013372421,0.0009547014],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9950764,0.00033154615,0.0014349963,0.0010184796,0.001199586,0.0009389604],"domain_scores_gemma":[0.99508774,0.002363753,0.00083207537,0.0011953298,0.00025861638,0.00026249202],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00052046805,0.00087338453,0.001606244,0.00048064886,0.00017513988,0.000047913236,0.00038403648,0.00021388382,0.00023267046],"category_scores_gemma":[0.00043872904,0.00045129165,0.00022363018,0.0014154655,0.00037682863,0.0001618109,0.00005043844,0.00023565657,0.00003895664],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19527923,0.09002048,0.0075416593,0.0051029776,0.012212818,0.026082087,0.1157628,0.0024733623,0.44397494,0.0021624034,0.00019994745,0.099187285],"study_design_scores_gemma":[0.19001919,0.09369786,0.07636495,0.0027366031,0.0034380988,0.0007136614,0.0047770096,0.0013347302,0.6254921,0.000050280978,0.00040104773,0.0009744454],"about_ca_topic_score_codex":0.0005621003,"about_ca_topic_score_gemma":0.0010302968,"teacher_disagreement_score":0.18151715,"about_ca_system_score_codex":0.0019231308,"about_ca_system_score_gemma":0.0041077808,"threshold_uncertainty_score":0.9997939},"labels":[],"label_agreement":null},{"id":"W4389259576","doi":"10.1182/blood-2023-190255","title":"Skp2 Inhibition Diminishes Essential Cell Survival Markers c-Maf and c-Myc, Enhancing Therapeutic Efficacy Against Drug Resistant Multiple Myeloma","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Gene knockdown; Multiple myeloma; Cancer research; Malignancy; Medicine; Cell culture; Biology; Internal medicine; Oncology; Genetics","score_opus":0.017133143004395484,"score_gpt":0.26930654494173956,"score_spread":0.25217340193734405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389259576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958855,0.00044885837,0.000016880289,0.00045322586,0.00014341841,0.0007615512,0.00004623541,0.00023618036,0.0020081347],"genre_scores_gemma":[0.99746245,0.0003712473,0.00024192203,0.000067585075,0.00024423015,0.000062518106,0.0002994733,0.00005949473,0.0011910752],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99778724,0.00016219517,0.00033765085,0.0005141974,0.00057661626,0.00062210084],"domain_scores_gemma":[0.9986113,0.00053603726,0.00008338141,0.00035522378,0.00008118718,0.0003329257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040683494,0.00026894058,0.00036687232,0.00022737875,0.00026144847,0.0000775575,0.000076807635,0.00009864389,0.00005196024],"category_scores_gemma":[0.0001804668,0.00023014842,0.00013044829,0.00039229964,0.000121872195,0.00010401794,0.00011510954,0.00022741532,0.00014818112],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025289007,0.002200274,0.0737027,0.0006247742,0.00068101246,0.0020618313,0.0013240589,0.00000477893,0.90038717,0.000021543778,0.0006941053,0.015768878],"study_design_scores_gemma":[0.022902537,0.00047421898,0.50810534,0.00031390565,0.00034925214,0.00002436122,0.0012209676,0.00052952854,0.4649692,0.000038063306,0.0007091635,0.00036349974],"about_ca_topic_score_codex":0.00010339732,"about_ca_topic_score_gemma":0.000166337,"teacher_disagreement_score":0.43541795,"about_ca_system_score_codex":0.000044933484,"about_ca_system_score_gemma":0.000116662944,"threshold_uncertainty_score":0.938518},"labels":[],"label_agreement":null},{"id":"W4389259609","doi":"10.1182/blood-2023-186142","title":"mRNA Translation Inhibition Targets Bioenergetic Homeostasis in AML Cells <i>in Vitro</i> and <i>In Vivo</i> and Synergizes with Cytarabine and Venetoclax","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University; Concordia University; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"mTORC1; Biology; Cancer research; Myeloid leukemia; Venetoclax; Cytarabine; Myeloid; Leukemia; Cancer cell; Cancer; PI3K/AKT/mTOR pathway; Cell biology; Chronic lymphocytic leukemia; Immunology; Signal transduction; Genetics","score_opus":0.011145903238821071,"score_gpt":0.2371572518239038,"score_spread":0.22601134858508273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389259609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952313,0.0027854368,0.0000059662084,0.0011824277,0.000014977109,0.0005588095,0.000037694168,0.00004065482,0.00014277878],"genre_scores_gemma":[0.99425995,0.0047064424,0.0006672243,0.00012167961,0.000036136138,0.000063785286,0.000051404426,0.000034033896,0.00005933757],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99861276,0.00008168958,0.00027016972,0.00041298431,0.0002391393,0.0003832493],"domain_scores_gemma":[0.99953645,0.00012721294,0.000039223058,0.00014050353,0.000025139834,0.00013148354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037098082,0.00018306104,0.00035029184,0.0005763473,0.000034846264,0.000025356452,0.000031535124,0.00012156998,0.000007445299],"category_scores_gemma":[0.000025409652,0.00016113094,0.000017001334,0.00082652306,0.00013574639,0.00013396272,0.000037656304,0.00026071238,0.000003011078],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010092282,0.00015633629,0.018150764,0.0003480536,0.000026846563,0.00079282257,0.0007519521,0.00009576682,0.9736357,0.000007800916,0.00012548795,0.0048992797],"study_design_scores_gemma":[0.022724366,0.00061621435,0.050474066,0.0005369812,0.00009864673,0.00015356773,0.00037767456,0.0040556686,0.91974616,0.00013241499,0.00072936784,0.00035486897],"about_ca_topic_score_codex":0.00038937476,"about_ca_topic_score_gemma":0.00055689755,"teacher_disagreement_score":0.0538895,"about_ca_system_score_codex":0.00009062302,"about_ca_system_score_gemma":0.000109594796,"threshold_uncertainty_score":0.6570729},"labels":[],"label_agreement":null},{"id":"W4389259644","doi":"10.1182/blood-2023-181821","title":"Interest of Cytoreductive Therapy before Allogenic Hematopoietic Stem Cell Transplantation in Childhood Myelodysplastic Syndromes: A Retrospective Study on Behalf of the Société Francophone De Greffe De Moelle Et De Thérapie Cellulaire (SFGM-TC)","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Busulfan; Hematopoietic stem cell transplantation; Transplantation; Myelodysplastic syndromes; Internal medicine; Umbilical cord; Pediatrics; Retrospective cohort study; Oncology; Surgery; Bone marrow; Immunology","score_opus":0.01884524136926775,"score_gpt":0.2895026362594403,"score_spread":0.27065739489017254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389259644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99729294,0.00021155633,0.000042045016,0.00025922176,0.000086573906,0.0017596426,0.00007744318,0.000058394173,0.0002121641],"genre_scores_gemma":[0.99918824,0.00024844677,0.00006570877,0.000053201926,0.00006206525,0.00018164261,0.000021694772,0.000076179,0.00010283318],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976166,0.00040282405,0.00048646025,0.00042614623,0.0005401972,0.00052779267],"domain_scores_gemma":[0.99875706,0.00026498517,0.0002515733,0.00049872854,0.000105569525,0.00012205355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080759625,0.00028594182,0.00060971285,0.00032013256,0.00008665142,0.000009731101,0.0003670085,0.00019760056,0.000024846564],"category_scores_gemma":[0.00006871088,0.00021441837,0.00022051575,0.001082995,0.0001774649,0.0000558941,0.00007250938,0.0007423307,0.000012199607],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014672697,0.011261673,0.4285703,0.00090891495,0.00132468,0.0008962794,0.2541725,0.0002894287,0.30009532,0.00020329605,0.00007627183,0.0007340699],"study_design_scores_gemma":[0.011234515,0.002876855,0.79366374,0.00046274776,0.00021689243,0.000197519,0.021788169,0.000088042245,0.16901495,0.0003172457,7.512737e-7,0.00013857083],"about_ca_topic_score_codex":0.00024228776,"about_ca_topic_score_gemma":0.00018813094,"teacher_disagreement_score":0.36509347,"about_ca_system_score_codex":0.00050214346,"about_ca_system_score_gemma":0.0010014176,"threshold_uncertainty_score":0.8743727},"labels":[],"label_agreement":null},{"id":"W4389295786","doi":"10.1182/blood.2023022348","title":"Loss of CD20 expression as a mechanism of resistance to mosunetuzumab in relapsed/refractory B-cell lymphomas","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Refractory (planetary science); Cancer research; Mechanism (biology); Medicine; Lymphoma; Biology; Immunology; Physics","score_opus":0.01112497727708489,"score_gpt":0.24913952812169748,"score_spread":0.2380145508446126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389295786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99263936,0.00063861837,0.0000026405366,0.00020961472,0.00007053259,0.0004001138,0.000024545281,0.000044231427,0.0059703235],"genre_scores_gemma":[0.99713975,0.00021252445,0.00054732873,0.000082184815,0.000027300764,0.00008507468,0.000017006425,0.000024697341,0.0018641155],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99872446,0.00003830441,0.0003765648,0.0002824873,0.00035146004,0.00022669374],"domain_scores_gemma":[0.99914634,0.00011091789,0.0001284312,0.00042901677,0.00006365524,0.00012163897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014384706,0.00014457107,0.00039279455,0.00021595966,0.00002111306,0.000003234559,0.000098779565,0.00010386706,0.0000612819],"category_scores_gemma":[0.00008938157,0.00012124465,0.00009758427,0.0004676665,0.000026285243,0.00002806104,0.00007422615,0.00004808373,0.00009708631],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022706282,0.02079813,0.1503576,0.0015464979,0.00028355076,0.003396684,0.005673236,0.000032206728,0.8012105,0.006364403,0.0063802833,0.0016862409],"study_design_scores_gemma":[0.013856479,0.00080442894,0.054232772,0.00087365054,0.00011515003,0.0000124387425,0.00027434505,0.000005252439,0.9279695,0.0007437774,0.0009915761,0.000120639554],"about_ca_topic_score_codex":0.00013551318,"about_ca_topic_score_gemma":0.000039909013,"teacher_disagreement_score":0.12675896,"about_ca_system_score_codex":0.00009131874,"about_ca_system_score_gemma":0.0001674194,"threshold_uncertainty_score":0.49442133},"labels":[],"label_agreement":null},{"id":"W4389296199","doi":"10.1182/blood.2023021234","title":"Transcriptional control of leukemogenesis by the chromatin reader SGF29","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Chromatin; Biology; Transcription factor; Myeloid leukemia; CRISPR; Leukemia; Computational biology; Cancer research; Gene; Genetics","score_opus":0.008717274433925162,"score_gpt":0.2157868901338971,"score_spread":0.20706961569997193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389296199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996334,0.0011101317,0.00071549584,0.0008392738,0.00006486725,0.00014964455,0.00009761112,0.000018051674,0.0006709328],"genre_scores_gemma":[0.9980188,0.000067383124,0.000052518568,0.00023933835,0.00010635672,0.00003032678,0.000147794,0.000008819208,0.0013286523],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99952203,0.000039014336,0.00012406782,0.00011337034,0.000104266604,0.00009722303],"domain_scores_gemma":[0.9997407,0.000008982372,0.000039633007,0.00015632632,0.00003127264,0.00002307956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000119364166,0.0000600276,0.000063556596,0.0000158612,0.000043980286,0.0000059754652,0.00010809736,0.000057915724,0.000037684236],"category_scores_gemma":[0.000034988745,0.000043736032,0.00006337023,0.0000840417,0.000052273925,0.0000015179619,0.000012125762,0.000026866042,0.00001876912],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010448018,0.00004545406,0.0004359695,0.0000064028786,0.000044579363,2.9741025e-7,0.000016295935,0.0000045374227,0.98579305,0.00014474923,0.013030099,0.00046813683],"study_design_scores_gemma":[0.001091236,0.00007152768,0.0029755996,0.000004359309,0.000023451827,0.00000471282,0.00003869585,0.000030346964,0.95073974,0.000028261591,0.044930983,0.00006111174],"about_ca_topic_score_codex":0.000009422175,"about_ca_topic_score_gemma":0.0000029876026,"teacher_disagreement_score":0.035053317,"about_ca_system_score_codex":0.000001805411,"about_ca_system_score_gemma":0.0000312715,"threshold_uncertainty_score":0.17835037},"labels":[],"label_agreement":null},{"id":"W4389431718","doi":"10.1182/blood.2023022018","title":"A peculiar case of cyclin D1–positive lymphoplasmacytic lymphoma","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Lymphoplasmacytic Lymphoma; Lymphoma; Medicine; Cyclin D1; Waldenstrom macroglobulinemia; Cancer research; Pathology; Internal medicine; Cancer; Cell cycle","score_opus":0.01907664835267038,"score_gpt":0.3091593842443556,"score_spread":0.2900827358916852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389431718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99266547,0.0002280455,0.00001049442,0.0002063868,0.00013482929,0.00048991025,0.000049498303,0.00018468502,0.00603068],"genre_scores_gemma":[0.99637866,0.00011854176,0.00029768737,0.000105342864,0.00017155532,0.00004639742,0.00004430482,0.000052513646,0.0027849884],"study_design_codex":"case_report","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980773,0.000069898306,0.00040042814,0.00039566745,0.0005012905,0.00055542996],"domain_scores_gemma":[0.9984471,0.00039652415,0.00008939618,0.0006009142,0.00018325612,0.00028279153],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003553032,0.00019605715,0.00043861812,0.00030695036,0.00008090653,0.000014976435,0.00014432053,0.00014430744,0.00012063161],"category_scores_gemma":[0.0004830247,0.00017540198,0.00018940565,0.0009951337,0.00020049843,0.0000579415,0.00017783893,0.00009574627,0.0008226459],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032976,0.011651066,0.00811376,0.0045996727,0.004578368,0.78422725,0.01168175,0.00014596278,0.08057011,0.0034605297,0.0204865,0.067187466],"study_design_scores_gemma":[0.31153792,0.001763714,0.010797623,0.001190191,0.0019705624,0.20251906,0.0031177995,0.033583615,0.4293904,0.000663718,0.002501277,0.00096412876],"about_ca_topic_score_codex":0.0012622399,"about_ca_topic_score_gemma":0.000055650842,"teacher_disagreement_score":0.5817082,"about_ca_system_score_codex":0.0022087747,"about_ca_system_score_gemma":0.0048835315,"threshold_uncertainty_score":0.99995536},"labels":[],"label_agreement":null},{"id":"W4389455899","doi":"10.1182/blood-2023-191921","title":"Ibrutinib Combined with Venetoclax in Patients with Relapsed/Refractory Mantle Cell Lymphoma: Primary Analysis Results from the Randomized Phase 3 Sympatico Study","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Ibrutinib; Venetoclax; Mantle cell lymphoma; Internal medicine; Tumor lysis syndrome; Oncology; Bendamustine; Ven; Phases of clinical research; Neutropenia; Febrile neutropenia; Clinical endpoint; Tolerability; Rituximab; Clinical trial; Lymphoma; Chronic lymphocytic leukemia; Adverse effect; Leukemia; Chemotherapy","score_opus":0.010872215137858757,"score_gpt":0.25676972606899917,"score_spread":0.24589751093114043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389455899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948361,0.00011086073,0.000005959561,0.0000979289,0.00004361119,0.0036607797,0.0001310387,0.00012108618,0.0009926332],"genre_scores_gemma":[0.99755037,0.00003439865,0.00010487246,0.000106259584,0.00006285217,0.00025493995,0.0012624548,0.00006311208,0.00056072336],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99606234,0.0005818535,0.0007357727,0.0007172656,0.0013347557,0.0005680348],"domain_scores_gemma":[0.99576944,0.0022398876,0.00027984867,0.0013372794,0.00017877216,0.00019477578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013432745,0.0003304444,0.0012412231,0.00038474912,0.00012251355,0.00005063712,0.00034011927,0.000110953704,0.000043532928],"category_scores_gemma":[0.0004214212,0.0001813745,0.00017314084,0.002365369,0.00023028161,0.00008963367,0.00016314037,0.0002731661,0.00009026191],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8084085,0.03367038,0.138483,0.00012125041,0.007971335,0.0018676226,0.0072795846,0.0003651883,0.0000711559,0.0000039170723,0.00091684645,0.00084121135],"study_design_scores_gemma":[0.8398581,0.0025085474,0.15017502,0.00011236092,0.003999199,0.0000021600456,0.00054525613,0.0023342655,0.00020551193,0.0000061492087,0.00004777446,0.00020564992],"about_ca_topic_score_codex":0.0024851195,"about_ca_topic_score_gemma":0.00036373266,"teacher_disagreement_score":0.031449597,"about_ca_system_score_codex":0.0025434124,"about_ca_system_score_gemma":0.0037314212,"threshold_uncertainty_score":0.7396238},"labels":[],"label_agreement":null},{"id":"W4389727985","doi":"10.1182/blood.2023022171","title":"From black and white to fifty shades of grey","year":2023,"lang":"en","type":"letter","venue":"Blood","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"White (mutation); Medicine; Biology","score_opus":0.015052180999118685,"score_gpt":0.24979883914648862,"score_spread":0.23474665814736995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389727985","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.877163,0.00029557312,0.00010349226,0.120806076,0.00019284159,0.00018510572,0.00070206606,0.000013825755,0.00053804216],"genre_scores_gemma":[0.37656063,0.0016639495,0.011851543,0.55845696,0.016942738,0.00014623124,0.009814266,0.0002821195,0.02428157],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989683,0.00008205613,0.0002469007,0.0003971171,0.00007975992,0.00022586774],"domain_scores_gemma":[0.99936813,0.00005091492,0.0001323561,0.00033983152,0.00006486853,0.000043883512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012580643,0.00016432554,0.00030250882,0.000046300083,0.000024315026,0.000009324301,0.00016470559,0.00070738303,0.000024918183],"category_scores_gemma":[0.0002412368,0.00015907615,0.0000850527,0.00005917931,0.00005793956,5.3628554e-7,0.00017963981,0.00019755457,0.000038003152],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000035142912,0.000018623292,0.029551147,0.000028254502,0.00020681073,0.000007629686,0.0000750338,0.000008539644,0.0069154343,4.641301e-7,0.9630505,0.00013405665],"study_design_scores_gemma":[0.0008052874,0.00037356542,0.18443678,0.000062023224,0.00029283203,0.000005305002,0.00008063519,0.000009546069,0.00467166,0.000604835,0.8081707,0.00048686875],"about_ca_topic_score_codex":0.00014510819,"about_ca_topic_score_gemma":0.000052052965,"teacher_disagreement_score":0.50060236,"about_ca_system_score_codex":0.000003098299,"about_ca_system_score_gemma":0.000035347886,"threshold_uncertainty_score":0.64869374},"labels":[],"label_agreement":null},{"id":"W4390097192","doi":"10.1182/blood.2023021953","title":"Long-term outcomes of pulmonary embolism in children and adolescents","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; SickKids Foundation; University of Toronto; Western University; Institute for Clinical Evaluative Sciences; Hospital for Sick Children","funders":"Hospital for Sick Children","keywords":"Medicine; Pulmonary function testing; Pulmonary embolism; Pulmonary hypertension; Internal medicine; Exercise intolerance; Cardiology; Vital capacity; Cohort; Physical therapy; Pediatrics; Heart failure; Diffusing capacity; Lung","score_opus":0.012641243725456445,"score_gpt":0.2669929234485526,"score_spread":0.25435167972309614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390097192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99847144,0.00029922213,8.330617e-7,0.00029298908,0.00004901856,0.00041032687,0.0000071150766,0.000048101723,0.0004209304],"genre_scores_gemma":[0.9986863,0.00086694764,0.000015944153,0.000180931,0.000040343108,0.000016626402,0.000028219909,0.000015887963,0.00014881023],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992761,0.000013553411,0.00018833969,0.00017967472,0.00015502449,0.00018729492],"domain_scores_gemma":[0.9996805,0.000010484673,0.0000417054,0.00019188963,0.000013460996,0.000061940795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000991058,0.00009658466,0.00035437007,0.00018474708,0.000017506138,0.0000055574815,0.00006104866,0.000044662946,0.000018418827],"category_scores_gemma":[0.000018800098,0.00008300523,0.00004754027,0.00018882596,0.000032056327,0.00003257176,0.00010828056,0.000066573644,0.00002579689],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000062559307,0.0013114895,0.993568,0.00013999501,0.00011186256,0.00007851705,0.000102722624,5.476188e-7,0.00027110137,0.0000638244,0.0001202676,0.0042254175],"study_design_scores_gemma":[0.001956283,0.000049478767,0.99706906,0.00022644397,0.0001757695,0.000018064013,0.000019657944,0.000004539334,0.0003673473,0.00003235795,0.000007303302,0.000073693314],"about_ca_topic_score_codex":0.000071405906,"about_ca_topic_score_gemma":0.000010324689,"teacher_disagreement_score":0.0041517243,"about_ca_system_score_codex":0.000005815738,"about_ca_system_score_gemma":0.000011011663,"threshold_uncertainty_score":0.3384855},"labels":[],"label_agreement":null},{"id":"W4390168377","doi":"10.1182/blood.2023022457","title":"Type 1 VWD classification revisited: novel insights from combined analysis of the LoVIC and WiN studies","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Heart, Lung, and Blood Institute; ZonMw; Science Foundation Ireland; CSL Behring","keywords":"Von Willebrand factor; Von Willebrand disease; Desmopressin; Medicine; Context (archaeology); Internal medicine; Confidence interval; Gastroenterology; Endocrinology; Immunology; Platelet; Biology","score_opus":0.04925456011343499,"score_gpt":0.3011432892050212,"score_spread":0.2518887290915862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390168377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997171,0.0018873943,0.0000013815829,0.0004860601,0.000027445214,0.00012669449,0.000022126898,0.00002017958,0.000257722],"genre_scores_gemma":[0.99890226,0.00062203215,0.000039336162,0.00006970981,0.000009456131,0.0000037930317,0.000115361654,0.0000049202636,0.00023311493],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99958134,0.000013795299,0.00011947335,0.00012435408,0.00010555496,0.000055509587],"domain_scores_gemma":[0.9996015,0.000062458486,0.000058874473,0.00019594499,0.000060293303,0.000020946794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000028203105,0.000060191473,0.00025799233,0.000101892074,0.000037439662,0.000003901298,0.000032042197,0.000030793635,0.0000073540264],"category_scores_gemma":[0.00006681045,0.000035731213,0.000049257756,0.0009507381,0.000036587506,0.000017445136,0.000028327082,0.000034930574,0.000010163179],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015115508,0.0016712685,0.9044102,0.000102351216,0.020235708,0.000059167287,0.0022542465,0.000007280556,0.068231404,0.0006361013,0.0010617512,0.0011793671],"study_design_scores_gemma":[0.0021252357,0.00007860713,0.9905926,0.000049707956,0.004790581,9.937629e-7,0.00034546244,0.00045377202,0.0011169572,0.00023876145,0.00016834002,0.0000389657],"about_ca_topic_score_codex":0.00004430715,"about_ca_topic_score_gemma":0.000047539397,"teacher_disagreement_score":0.086182415,"about_ca_system_score_codex":0.000006281544,"about_ca_system_score_gemma":0.00001254331,"threshold_uncertainty_score":0.14570767},"labels":[],"label_agreement":null},{"id":"W4390333622","doi":"10.1182/blood.2023021752","title":"Developmental trajectories and cooperating genomic events define molecular subtypes of <i>BCR</i>::<i>ABL1</i>-positive ALL","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"José Carreras Leukämie-Stiftung; Deutsche Forschungsgemeinschaft; Government of Ontario","keywords":"Biology; CDKN2A; breakpoint cluster region; Cancer research; Fluorescence in situ hybridization; Myeloid; ABL; Myeloid leukemia; Immunology; Genetics; Gene; Tyrosine kinase; Receptor; Chromosome","score_opus":0.013577062274100144,"score_gpt":0.25895492617420507,"score_spread":0.24537786390010494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390333622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99794126,0.00036549824,0.000052062707,0.00017057516,0.000031441206,0.00031966757,0.000038646027,0.000062225954,0.0010186221],"genre_scores_gemma":[0.996483,0.00012019985,0.0027456584,0.00018709694,0.000044084678,0.00002204201,0.00008578122,0.000035782443,0.00027631698],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99878377,0.00004306732,0.00025565733,0.0002653323,0.00032660324,0.000325553],"domain_scores_gemma":[0.9994595,0.00014389773,0.000048147984,0.000107828106,0.00010982961,0.00013081863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020219236,0.00015098244,0.00028408537,0.00012203648,0.000062039566,0.000011241988,0.00008546234,0.000077642624,0.000027740974],"category_scores_gemma":[0.00020675911,0.00013554866,0.00004231584,0.00032485966,0.00009281443,0.000047988546,0.00014949881,0.00012550688,0.00004784735],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015364034,0.00020436387,0.037243493,0.00015973262,0.0004580097,0.00040194084,0.001185331,0.0000073871906,0.9591267,0.00015169347,0.00028645567,0.00062124664],"study_design_scores_gemma":[0.0112213055,0.0006988641,0.1654323,0.0002680115,0.00040994727,0.00072634907,0.0006707085,0.00036557217,0.8194578,0.000090938556,0.00033440857,0.00032376882],"about_ca_topic_score_codex":0.0000820657,"about_ca_topic_score_gemma":0.0000097667635,"teacher_disagreement_score":0.13966888,"about_ca_system_score_codex":0.000095409734,"about_ca_system_score_gemma":0.00045053696,"threshold_uncertainty_score":0.55275136},"labels":[],"label_agreement":null},{"id":"W4390338652","doi":"10.1182/blood.2023022981","title":"Deep learning for platelet transfusion","year":2023,"lang":"en","type":"editorial","venue":"Blood","topic":"Machine Learning in Healthcare","field":"Computer Science","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Calgary","funders":"","keywords":"Platelet; Medicine; Platelet transfusion; Intensive care medicine; Internal medicine","score_opus":0.012960375912884379,"score_gpt":0.28626193193181854,"score_spread":0.27330155601893413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390338652","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010233962,0.00041530316,0.08830679,0.00030266808,0.9089977,0.0004637608,0.000014478307,0.0011763134,0.00022064878],"genre_scores_gemma":[0.00017725419,0.0007482444,0.014773137,0.00002574475,0.98201203,0.00023642927,0.00042039604,0.00014517145,0.0014615837],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972115,0.00018682895,0.00037983595,0.0008661446,0.0007675757,0.00058811624],"domain_scores_gemma":[0.99551857,0.003282929,0.00020743551,0.00060976145,0.00024070674,0.00014058597],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007781897,0.00031435204,0.00042406487,0.00020733761,0.00034920662,0.00019518248,0.0014075921,0.0008702058,0.000010345032],"category_scores_gemma":[0.0027776493,0.00032184523,0.00019686532,0.00037120405,0.00001822421,0.00012227464,0.00023077415,0.0017541682,0.00013497584],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021230893,0.00010820253,0.00008370597,0.0012754573,0.00009902147,0.00009879337,0.0015409135,0.0014039923,0.000021488337,0.0006214824,0.9219353,0.07279041],"study_design_scores_gemma":[0.0011136743,0.00035466455,0.00002273665,0.00014837783,0.00003028872,0.0000031301033,0.000009489094,0.021335354,0.000030029569,0.0002611563,0.9763423,0.00034879128],"about_ca_topic_score_codex":0.00020125117,"about_ca_topic_score_gemma":0.000105400606,"teacher_disagreement_score":0.073533654,"about_ca_system_score_codex":0.00004179675,"about_ca_system_score_gemma":0.00025891425,"threshold_uncertainty_score":0.99992335},"labels":[],"label_agreement":null},{"id":"W4390706534","doi":"10.1182/blood.2023022098","title":"Clinical and functional spectrum of RAC2-related immunodeficiency","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital de l'Enfant-Jésus; Centre Hospitalier de l’Université de Montréal; Université de Montréal; Montreal Clinical Research Institute; Centre hospitalier universitaire de Québec","funders":"National Institute of Allergy and Infectious Diseases; Agence Nationale de la Recherche","keywords":"Biology; Immunodeficiency; Severe combined immunodeficiency; Superoxide; Immunology; Missense mutation; Mutation; Immune system; Genetics; Biochemistry","score_opus":0.008325731024809291,"score_gpt":0.2539929644079974,"score_spread":0.2456672333831881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390706534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768457,0.01988159,0.00007784811,0.000079546946,0.00017192648,0.000052063093,0.000012572947,0.000010090153,0.002868694],"genre_scores_gemma":[0.99864805,0.00064787123,0.000070124814,0.00002023255,0.000042228658,0.0000029809678,0.000044402437,0.000008195619,0.0005159107],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994976,0.00001680512,0.0001566725,0.00019534767,0.000050662078,0.00008289503],"domain_scores_gemma":[0.99981797,0.000008578649,0.000019948668,0.00011870881,0.00001067503,0.000024102723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000801632,0.00006390961,0.00007982952,0.000019021254,0.000023486451,0.000009834435,0.000032487857,0.00008194367,0.000034728495],"category_scores_gemma":[0.0000129676255,0.00005320849,0.00006740285,0.000051826766,0.00007891031,0.0000016722316,0.00004169091,0.000048421985,0.000011130213],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002849396,0.007442859,0.62911534,0.00025366756,0.0044006887,0.00011020046,0.00016588451,0.000024089546,0.276687,0.016575115,0.0037318142,0.0612084],"study_design_scores_gemma":[0.018502053,0.0049848356,0.54324377,0.00019531202,0.0017610902,0.00055986515,0.00020017294,0.00035570053,0.37251735,0.013350313,0.043271642,0.001057888],"about_ca_topic_score_codex":0.000007445288,"about_ca_topic_score_gemma":0.000002816864,"teacher_disagreement_score":0.09583038,"about_ca_system_score_codex":5.927722e-7,"about_ca_system_score_gemma":0.000037497117,"threshold_uncertainty_score":0.21697792},"labels":[],"label_agreement":null},{"id":"W4390706597","doi":"10.1182/blood.2023022499","title":"BCMA- or GPRC5D-targeting bispecific antibodies in multiple myeloma: efficacy, safety, and resistance mechanisms","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Terry Fox Foundation; Sanofi; Pfizer; Amgen; Multiple Myeloma Research Foundation","keywords":"Multiple myeloma; Bispecific antibody; Antibody; Medicine; Immunology; Chimeric antigen receptor; Antigen; Cancer research; Immune system; Oncology; Monoclonal antibody; Immunotherapy","score_opus":0.028554548486618637,"score_gpt":0.296561545064348,"score_spread":0.26800699657772936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390706597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810118,0.012833659,0.0002354394,0.0010247173,0.00015849003,0.00089315383,0.00007048772,0.00024611954,0.003526097],"genre_scores_gemma":[0.9860754,0.0017829824,0.008620118,0.000030403933,0.00011603446,0.000030369503,0.00006359678,0.000045256653,0.0032358386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998226,0.000065725406,0.00033536972,0.00052173086,0.00035607285,0.00049513363],"domain_scores_gemma":[0.9990306,0.0004348615,0.00003108895,0.0002557688,0.000045372064,0.00020232932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003167104,0.0002223632,0.00037270033,0.00026969114,0.00013253305,0.000081607555,0.00008461164,0.00009544644,0.00013241565],"category_scores_gemma":[0.00046315457,0.0001596578,0.00007127146,0.00040915716,0.000085135005,0.00010298263,0.000097644865,0.00026411162,0.00009736548],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016693708,0.00993414,0.42926922,0.007897045,0.0035802794,0.06663737,0.0063808644,0.0000100112,0.3324331,0.01674854,0.005700393,0.10471534],"study_design_scores_gemma":[0.050249327,0.0013439697,0.8129109,0.0046716984,0.00058635615,0.0005857451,0.001415066,0.0022378915,0.08502311,0.0020118305,0.03781887,0.0011452201],"about_ca_topic_score_codex":0.000060994156,"about_ca_topic_score_gemma":0.00039275156,"teacher_disagreement_score":0.3836417,"about_ca_system_score_codex":0.00006165458,"about_ca_system_score_gemma":0.00011500753,"threshold_uncertainty_score":0.6510656},"labels":[],"label_agreement":null},{"id":"W4390732243","doi":"10.1182/blood.2023021342","title":"KBTBD4-mediated reduction of MYC is critical for hematopoietic stem cell expansion upon UM171 treatment","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Haematopoiesis; Stem cell; Cell biology; Hematopoietic stem cell; Biology; Myeloid; Epigenetics; Ubiquitin ligase; Chromatin; Cancer research; Regulator; Lymphopoiesis; Ubiquitin; Genetics; Gene","score_opus":0.02451932989135464,"score_gpt":0.2939174335786866,"score_spread":0.26939810368733197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390732243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99123114,0.0022980133,0.0021720133,0.0010998383,0.0004267068,0.0010310273,0.00011408282,0.00018398033,0.001443213],"genre_scores_gemma":[0.9970901,0.00025983906,0.0014014187,0.000033621505,0.00016509235,0.0001350629,0.00010973311,0.000048141643,0.0007569687],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986278,0.000035022087,0.00043944697,0.00036874835,0.00028219004,0.00024680555],"domain_scores_gemma":[0.99913216,0.00031807792,0.000041551222,0.00026773725,0.00010309628,0.00013736906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013986904,0.00019092603,0.00036157964,0.0001508883,0.00004234044,0.000018055913,0.000043157306,0.00015907788,0.00013397438],"category_scores_gemma":[0.000015090287,0.00015756207,0.000187007,0.00020197866,0.000045305227,0.00006627141,0.000006324072,0.000080605176,0.00009364882],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039064058,0.0028961643,0.000308362,0.0119456835,0.00031057862,0.0001972305,0.011525696,0.000003211939,0.96560925,0.0016142504,0.0008681431,0.004330772],"study_design_scores_gemma":[0.0033672322,0.0013444977,0.000112976166,0.0010292926,0.0014234632,0.0004669929,0.0012736039,0.00057725905,0.98912877,0.00021902609,0.0008993381,0.00015757448],"about_ca_topic_score_codex":0.000013836622,"about_ca_topic_score_gemma":8.999569e-7,"teacher_disagreement_score":0.023519477,"about_ca_system_score_codex":0.000061202925,"about_ca_system_score_gemma":0.00015273054,"threshold_uncertainty_score":0.6425195},"labels":[],"label_agreement":null},{"id":"W4390824558","doi":"10.1182/blood.2023021959","title":"Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baker Hughes (Canada); University of Calgary","funders":"National Cancer Institute","keywords":"Ibrutinib; Medicine; Internal medicine; Oncology; Chemotherapy regimen; Venetoclax; Chronic lymphocytic leukemia; Leukemia; Chemotherapy","score_opus":0.01905375860532399,"score_gpt":0.2983592519735472,"score_spread":0.2793054933682232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390824558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99301445,0.0017268991,0.000041659765,0.0005266388,0.00020576196,0.0034758237,0.00011753803,0.00010151338,0.00078970153],"genre_scores_gemma":[0.9950988,0.000015911255,0.00028443674,0.00010332766,0.00041619744,0.00021167054,0.00005938941,0.00006289542,0.003747322],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980815,0.000071062,0.00033827766,0.00049743993,0.0006327205,0.0003790061],"domain_scores_gemma":[0.9973753,0.0014829104,0.00006494738,0.00078687293,0.00017149045,0.00011848871],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004379171,0.00019868115,0.00042544372,0.000060371527,0.000063398766,0.000048167283,0.0002693138,0.00008732697,0.00014992619],"category_scores_gemma":[0.00038232375,0.00011264408,0.00016512987,0.00029196363,0.00012002925,0.000043190932,0.00009942646,0.00023112407,0.000036664314],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08263663,0.055733543,0.058345567,0.00814058,0.041651353,0.007418609,0.28791603,0.000025225823,0.022371778,0.0019248025,0.3248721,0.10896376],"study_design_scores_gemma":[0.84006655,0.0077036596,0.05393555,0.0059734867,0.007466508,0.00028619677,0.01799963,0.0039881677,0.04129726,0.00010175593,0.020374138,0.0008070706],"about_ca_topic_score_codex":0.00093095977,"about_ca_topic_score_gemma":0.00035760496,"teacher_disagreement_score":0.75742996,"about_ca_system_score_codex":0.0004261474,"about_ca_system_score_gemma":0.002281995,"threshold_uncertainty_score":0.45934922},"labels":[],"label_agreement":null},{"id":"W4391091559","doi":"10.1182/blood.2023023428","title":"<i>CALR</i> mutation burden in essential thrombocythemia and disease outcome","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; MPB Technologies & Communications (Canada); Hôpital Maisonneuve-Rosemont","funders":"Associazione Italiana per la Ricerca sul Cancro; Ministero della Salute","keywords":"Essential thrombocythemia; Myelofibrosis; Calreticulin; Mutation; Polycythemia vera; Medicine; Internal medicine; Genetics; Biology; Gene; Bone marrow","score_opus":0.01326638004264136,"score_gpt":0.2955476349621177,"score_spread":0.28228125491947637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391091559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99321854,0.0022160264,0.000026044501,0.0031181606,0.00008705033,0.0003171898,0.000017424509,0.00005484718,0.0009447425],"genre_scores_gemma":[0.9988599,0.00013713673,0.00023575981,0.00019158341,0.00018235965,0.00007700197,0.000039637776,0.000014953446,0.0002616832],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993261,0.000016999673,0.00016168195,0.00023524727,0.0001358605,0.00012412114],"domain_scores_gemma":[0.99964875,0.00006449855,0.000013671114,0.0001025572,0.000016194885,0.00015432548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000057461435,0.00010609264,0.00017458283,0.000070310634,0.000024907813,0.000039315037,0.000017914126,0.000035637335,0.000097341595],"category_scores_gemma":[0.000057106026,0.00008026552,0.00004467602,0.00010039904,0.000028371944,0.000056356777,0.00001928391,0.00008742734,0.000050901403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014001556,0.0013506231,0.97281516,0.00075950456,0.0003546131,0.0059144497,0.0015098788,0.0000093554445,0.0034250293,0.0048254947,0.000773053,0.008122808],"study_design_scores_gemma":[0.011718654,0.0005184271,0.9577007,0.0009410536,0.0017584846,0.0003163803,0.00020546108,0.0016524788,0.018827634,0.0027981903,0.0031682192,0.00039430385],"about_ca_topic_score_codex":0.000036647078,"about_ca_topic_score_gemma":0.000016091384,"teacher_disagreement_score":0.015402604,"about_ca_system_score_codex":0.000024691879,"about_ca_system_score_gemma":0.00007283112,"threshold_uncertainty_score":0.32731327},"labels":[],"label_agreement":null},{"id":"W4391578663","doi":"10.1182/blood.2023021452","title":"A genetic association study of circulating coagulation factor VIII and von Willebrand factor levels","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Global Health Research","funders":"National Center for Advancing Translational Sciences; National Heart, Lung, and Blood Institute; National Institute of Environmental Health Sciences; Instituto de Salud Carlos III; American Heart Association; Medical Research Council; National Institutes of Health; Yale University; U.S. Department of Health and Human Services","keywords":"Von Willebrand factor; Coagulation; Von Willebrand disease; Blood coagulation factors; Medicine; Immunology; Internal medicine; Platelet","score_opus":0.024326337886624704,"score_gpt":0.2770260163044047,"score_spread":0.25269967841778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391578663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99831593,0.0009650857,0.000024543677,0.000032245636,0.00005624848,0.0004304864,0.000034660883,0.000037669703,0.00010315809],"genre_scores_gemma":[0.9997477,0.00001551605,0.000061025024,0.000008599035,0.000025609203,0.000008049198,0.000008535349,0.000013245274,0.00011171693],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999343,0.000022304921,0.00017343223,0.00016411782,0.00019660725,0.000100548365],"domain_scores_gemma":[0.9997355,0.00006429511,0.000058320282,0.00007601379,0.0000340437,0.000031847834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000036526046,0.00008740512,0.00020510051,0.00006781979,0.00003610021,0.00002239435,0.000013897874,0.000057462214,0.000038354858],"category_scores_gemma":[0.00004542046,0.00007256065,0.000031735,0.00010011488,0.000005624464,0.000054290704,0.000010898381,0.000056316858,0.0000041730173],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011422541,0.0007320393,0.97364724,0.00010415246,0.0005448241,0.00009948987,0.0025960458,0.0000032217354,0.013485245,0.0000026428004,0.0000047950366,0.008768872],"study_design_scores_gemma":[0.0036331688,0.00038546664,0.9937924,0.00007268473,0.00037441193,0.00001991049,0.00017655897,0.0003780429,0.0010353872,0.00004295126,0.000024435483,0.00006459392],"about_ca_topic_score_codex":0.00005252847,"about_ca_topic_score_gemma":0.00001957521,"teacher_disagreement_score":0.020145139,"about_ca_system_score_codex":0.000031439275,"about_ca_system_score_gemma":0.000023925084,"threshold_uncertainty_score":0.29589373},"labels":[],"label_agreement":null},{"id":"W4392388763","doi":"10.1182/blood.2024023880","title":"Smoldering multiple myeloma: taking the narrow over the wide path?","year":2024,"lang":"en","type":"review","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Multiple myeloma; Path (computing); Lenalidomide; Medicine; Daratumumab; Internal medicine; Computer science","score_opus":0.0685273946874271,"score_gpt":0.35706952220406923,"score_spread":0.2885421275166421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392388763","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00054923404,0.99451166,0.0000027616452,0.00021433954,0.00029433647,0.0021214413,0.0000715535,0.00013605256,0.0020986157],"genre_scores_gemma":[0.008465702,0.98773164,0.00008986718,0.00012367484,0.0007388065,0.0006636399,0.00012350197,0.0001527565,0.0019104155],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99741375,0.00020708836,0.0004930158,0.0005641452,0.0006785956,0.00064342667],"domain_scores_gemma":[0.9976215,0.0008515231,0.0002194045,0.0010702661,0.000049026108,0.00018831031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040895838,0.0005498254,0.0010957213,0.00013805793,0.0003052832,0.00016119558,0.00045924998,0.00023023115,0.00020714133],"category_scores_gemma":[0.00072254386,0.0002265407,0.0008544141,0.00047201663,0.00013378344,0.000044567685,0.00030400697,0.0011182833,0.0005897198],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017910665,0.00038706028,0.000984827,0.01676473,0.002957721,0.0023824777,0.00025025458,1.8706183e-7,0.000003754193,0.000050552815,0.003833,0.9723675],"study_design_scores_gemma":[0.0015336694,0.00009730364,0.0013060614,0.013237709,0.0059221624,0.0006446152,0.000038032304,0.0000372596,0.000009138277,0.000018544511,0.9769089,0.0002465932],"about_ca_topic_score_codex":0.00014847427,"about_ca_topic_score_gemma":0.000042417516,"teacher_disagreement_score":0.9730759,"about_ca_system_score_codex":0.00011063203,"about_ca_system_score_gemma":0.00038611933,"threshold_uncertainty_score":0.92380613},"labels":[],"label_agreement":null},{"id":"W4392543341","doi":"10.1182/blood.2023021864","title":"Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis: the ATLAS-PPX trial","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"Genentech; Grifols; Swedish Orphan Biovitrum; CSL Behring; Biogen; Novo Nordisk; Sanofi; Chugai Pharmaceutical; Pfizer","keywords":"Medicine; Tolerability; Pre-exposure prophylaxis; Adverse effect; Clinical endpoint; Internal medicine; Hemostasis; Surgery; Clinical trial; Immunology; Human immunodeficiency virus (HIV)","score_opus":0.022422892828456043,"score_gpt":0.28484359052690966,"score_spread":0.2624206976984536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392543341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895296,0.0016980512,0.0000040643426,0.0038188472,0.00020670911,0.0035614313,0.000031754535,0.00015692483,0.0009925799],"genre_scores_gemma":[0.98860055,0.00011504687,0.00026203558,0.00007747201,0.0010303886,0.00049878086,0.000046421224,0.00007380766,0.0092954775],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9974229,0.00013323982,0.00040462226,0.00068287714,0.00078070705,0.00057570817],"domain_scores_gemma":[0.99858725,0.00040350112,0.000047953494,0.0006700806,0.000085129475,0.00020606797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036674718,0.0003381504,0.00058490917,0.00023431276,0.00013667288,0.00014398398,0.00025927997,0.00023185792,0.0004427332],"category_scores_gemma":[0.00025107726,0.00015364919,0.00016279564,0.0012198909,0.00014984423,0.00010866004,0.000100597215,0.0007564699,0.00024889936],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3257191,0.028716285,0.29537752,0.005889363,0.0081148725,0.033019684,0.0582288,0.000011924958,0.06976849,0.00054553786,0.006065579,0.16854283],"study_design_scores_gemma":[0.57779706,0.08897457,0.17928198,0.00746755,0.0034606522,0.0011350528,0.0045238193,0.0013216488,0.102625325,0.0014642163,0.02920582,0.0027422754],"about_ca_topic_score_codex":0.00057358417,"about_ca_topic_score_gemma":0.001126868,"teacher_disagreement_score":0.252078,"about_ca_system_score_codex":0.00009895613,"about_ca_system_score_gemma":0.0009621428,"threshold_uncertainty_score":0.62656325},"labels":[],"label_agreement":null},{"id":"W4392543343","doi":"10.1182/blood.2023022589","title":"Vector integration and fate in the hemophilia dog liver multiple years after AAV-FVIII gene transfer","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"BioMarin Pharmaceutical; CSL Behring; Novo Nordisk; Sanofi; Pfizer","keywords":"Gene transfer; Vector (molecular biology); Virology; Medicine; Biology; Immunology; Gene; Recombinant DNA; Genetics","score_opus":0.011763053892209586,"score_gpt":0.2576919423836133,"score_spread":0.24592888849140374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392543343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935424,0.005838748,0.00009696812,0.0001831827,0.00004207196,0.00020577386,0.000028191072,0.000009099441,0.00005358936],"genre_scores_gemma":[0.99868315,0.0006654047,0.00006631212,0.00019260644,0.00014843544,0.000065737,0.00003817811,0.000018029514,0.0001221592],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99932235,0.000081571925,0.00009181855,0.00023917081,0.000108488195,0.00015659691],"domain_scores_gemma":[0.9997438,0.000016330607,0.0000039855577,0.00018937327,0.000016278442,0.00003018931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019583279,0.00009161434,0.00006334614,0.00004300881,0.000021126596,0.000051008738,0.00010803898,0.000082410006,0.000029424602],"category_scores_gemma":[0.000013265834,0.00006751924,0.000045222623,0.00009396584,0.00004876336,0.0000040219907,0.000024427298,0.00011664474,0.000019115181],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021085047,0.00008230494,0.0008319907,0.000017636496,0.00003835649,0.00007467549,0.0005350786,0.0000026735677,0.9921964,0.000010417382,0.000070552276,0.005929073],"study_design_scores_gemma":[0.0010515769,0.0007306883,0.019089611,0.000023400848,0.000026987746,0.00003499341,0.000048676542,0.0002077568,0.9757272,0.00004086363,0.0028678926,0.00015036525],"about_ca_topic_score_codex":0.000025249432,"about_ca_topic_score_gemma":0.00044767087,"teacher_disagreement_score":0.018257622,"about_ca_system_score_codex":0.0000051175743,"about_ca_system_score_gemma":0.000031256615,"threshold_uncertainty_score":0.27533546},"labels":[],"label_agreement":null},{"id":"W4392579077","doi":"10.1182/blood.2023023692","title":"Hemoglobin Bart’s hydrops fetalis: charting the past and envisioning the future","year":2024,"lang":"en","type":"review","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Hydrops fetalis; Medicine; Hypoxia (environmental); Haemolysis; Pediatrics; Intensive care medicine; Thalassemia; Fetus; Immunology; Pregnancy; Internal medicine; Biology; Genetics; Chemistry","score_opus":0.013282124930997636,"score_gpt":0.27547826751176885,"score_spread":0.26219614258077123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392579077","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021955879,0.99147177,0.0000011289752,0.003772453,0.00059938844,0.0009643809,0.000023841723,0.00009666163,0.0028508469],"genre_scores_gemma":[0.00025350074,0.99600196,0.000022479691,0.00042406894,0.0018472946,0.000071453986,0.000059916947,0.00008943832,0.001229901],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981637,0.00014618064,0.00053472846,0.0004620754,0.0003045228,0.00038880936],"domain_scores_gemma":[0.9989602,0.00012502441,0.0001816921,0.00058043713,0.000026943833,0.00012572386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050087465,0.00046088966,0.0009774499,0.00008238352,0.0003929875,0.00013759655,0.00023524817,0.0004425247,0.000060524264],"category_scores_gemma":[0.000060416864,0.0001797824,0.00049918256,0.00043724212,0.00015880693,0.00003197761,0.0002315306,0.0014854013,0.00020695888],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000034563964,0.000092457885,0.000017877159,0.012997463,0.0008912939,0.00023971128,0.00060446374,1.8294374e-7,0.0000020655582,0.0003000071,0.0069733746,0.9778776],"study_design_scores_gemma":[0.0004096753,0.00006009617,0.0000043823347,0.012570932,0.008067147,0.001705737,0.0007707814,0.000016899618,8.3486844e-7,0.000030378907,0.9761504,0.00021274362],"about_ca_topic_score_codex":0.000010499734,"about_ca_topic_score_gemma":0.0000031480731,"teacher_disagreement_score":0.9776649,"about_ca_system_score_codex":0.000022930091,"about_ca_system_score_gemma":0.00013309957,"threshold_uncertainty_score":0.7331313},"labels":[],"label_agreement":null},{"id":"W4392598142","doi":"10.1182/blood.2023021184","title":"MRD at the end of induction and EFS in T-cell lymphoblastic lymphoma: Children’s Oncology Group trial AALL1231","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Hospital for Sick Children; Stollery Children's Hospital; University of Alberta","funders":"National Cancer Institute","keywords":"Medicine; Oncology; Internal medicine; Lymphoma","score_opus":0.010493719434570004,"score_gpt":0.2502497193253536,"score_spread":0.2397559998907836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392598142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99078476,0.005824869,0.0000010770832,0.0005798978,0.0003482615,0.0006397002,0.000018311881,0.000025403704,0.0017777303],"genre_scores_gemma":[0.99858075,0.00060671376,0.00004346507,0.0000758591,0.00025903957,0.00011562513,0.000030474135,0.00001629235,0.00027176333],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905074,0.00006440876,0.0002730615,0.0002759063,0.00016201119,0.00017390183],"domain_scores_gemma":[0.99942505,0.0002542426,0.00005526947,0.00018549942,0.000014098851,0.00006584993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017554122,0.00013657907,0.0002873344,0.00011165893,0.000041798306,0.000015105668,0.00004496643,0.0001216386,0.00007488016],"category_scores_gemma":[0.000035120032,0.00008529976,0.00008110383,0.0001681645,0.00011865546,0.000037757083,0.000060638955,0.000050274364,0.000030822022],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02842584,0.056079354,0.438412,0.0010455584,0.0031453182,0.0025525857,0.006689616,0.000010421713,0.04166269,0.0041177175,0.006936015,0.41092286],"study_design_scores_gemma":[0.27899462,0.006280704,0.6560626,0.00034953133,0.001963356,0.0016025908,0.00018255232,0.00004542399,0.04747388,0.0002274214,0.006559823,0.00025747577],"about_ca_topic_score_codex":0.0004773751,"about_ca_topic_score_gemma":0.00026980077,"teacher_disagreement_score":0.4106654,"about_ca_system_score_codex":0.00028332608,"about_ca_system_score_gemma":0.00018178091,"threshold_uncertainty_score":0.34784234},"labels":[],"label_agreement":null},{"id":"W4393057611","doi":"10.1182/blood.2024023983","title":"Genetic regulation of carnitine metabolism controls lipid damage repair and aging RBC hemolysis in vivo and in vitro","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Metabolism and Genetic Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; University of British Columbia","funders":"National Institute of General Medical Sciences; National Cancer Institute; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Carnitine; Hemolysis; Biology; In vivo; Lipid metabolism; Genome-wide association study; Biochemistry; Genetics; Single-nucleotide polymorphism; Immunology; Gene; Genotype","score_opus":0.003495869740861723,"score_gpt":0.21014728774245167,"score_spread":0.20665141800158995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393057611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9684775,0.030852666,0.0000622112,0.00006600797,0.000048374644,0.00014751608,0.000021178455,0.000009230847,0.00031532833],"genre_scores_gemma":[0.99725664,0.0013950045,0.0010270056,0.00004655295,0.000093812894,0.000016514996,0.0000175956,0.000014519726,0.00013233072],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99915814,0.000069571965,0.00024038371,0.0003063057,0.00007719899,0.00014840993],"domain_scores_gemma":[0.99970645,0.00001737858,0.000036540005,0.00018039164,0.000020178315,0.000039066577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019714457,0.000113590846,0.00020875296,0.00012292554,0.000014348476,0.00001870359,0.000049060916,0.00007991679,0.000010083592],"category_scores_gemma":[0.000049859347,0.00011192691,0.00004560213,0.00013951378,0.000058471356,0.0000044090625,0.000059196645,0.00005313015,3.1342356e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003814229,0.000054672717,0.009960678,0.00009100321,0.000048641,0.0000059739937,0.00012648181,0.000037370017,0.9857417,0.00003487286,0.000020788371,0.003839688],"study_design_scores_gemma":[0.003138206,0.000051476512,0.2763993,0.000059895432,0.0002153576,0.000021440856,0.00015218492,0.0014859104,0.711282,0.0002840604,0.0066568926,0.00025322015],"about_ca_topic_score_codex":0.00007591807,"about_ca_topic_score_gemma":0.00009348264,"teacher_disagreement_score":0.27445966,"about_ca_system_score_codex":9.0875494e-7,"about_ca_system_score_gemma":0.00002618972,"threshold_uncertainty_score":0.45642468},"labels":[],"label_agreement":null},{"id":"W4393161269","doi":"10.1182/blood.2023022916","title":"Excess of circulating apotransferrin enhances dietary iron absorption in mice","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Transferrin; Transferrin receptor; Chemistry; Iron-binding proteins; Lamina propria; Absorption (acoustics); DMT1; Dietary iron; Biochemistry; Biology; Iron deficiency; Internal medicine; Medicine; Anemia; Epithelium; Transporter; Materials science","score_opus":0.01588680958429409,"score_gpt":0.2713976766354337,"score_spread":0.25551086705113957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393161269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862829,0.008720682,0.000112605776,0.000117705735,0.00013865129,0.00013082806,0.000003953046,0.000037760285,0.004454936],"genre_scores_gemma":[0.9991503,0.0003413197,0.00024057963,0.000042430147,0.00009148494,0.0000077447,0.000014952092,0.000011396131,0.00009980727],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99937826,0.000019287996,0.00019402178,0.00015471417,0.0001330447,0.00012065335],"domain_scores_gemma":[0.9998304,0.000028967335,0.0000150212845,0.00008510455,0.000011740442,0.000028750637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012174946,0.00007299791,0.00015768969,0.00010570542,0.000010915197,0.0000066879998,0.000037113154,0.00004903969,0.000073724616],"category_scores_gemma":[0.000018463428,0.00006476782,0.000052019885,0.0001790689,0.00002802734,0.00007465862,0.0000074605323,0.00009839812,0.000015067605],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048320097,0.0004730599,0.013957889,0.0026062303,0.000022947803,0.00007198537,0.0020839805,0.000040355993,0.9636315,0.00046992718,0.00003103567,0.016562765],"study_design_scores_gemma":[0.00697872,0.00037450902,0.5528337,0.0019290275,0.00095300615,0.00008985663,0.0020100377,0.00086336175,0.43146485,0.0012851153,0.00073065056,0.00048720365],"about_ca_topic_score_codex":0.00017318274,"about_ca_topic_score_gemma":0.000048438676,"teacher_disagreement_score":0.53887576,"about_ca_system_score_codex":0.000004785116,"about_ca_system_score_gemma":0.000032995675,"threshold_uncertainty_score":0.26411548},"labels":[],"label_agreement":null},{"id":"W4393256071","doi":"10.1182/blood.2023023487","title":"<i>TP53</i> function over forms in multiple myeloma","year":2024,"lang":"en","type":"letter","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Multiple myeloma; Lenalidomide; Medicine; Internal medicine","score_opus":0.02448921042199161,"score_gpt":0.2753981944926289,"score_spread":0.25090898407063733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393256071","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45109332,0.009086139,0.00004914806,0.48377478,0.0021904316,0.005796232,0.0007809359,0.0009168713,0.046312157],"genre_scores_gemma":[0.45508775,0.00033143724,0.00040235164,0.48035234,0.0087942155,0.00093581673,0.0060101408,0.00043423564,0.04765172],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99754995,0.00004355311,0.00035570728,0.0006386184,0.0007105723,0.000701572],"domain_scores_gemma":[0.9990667,0.00012866013,0.00006131877,0.00054805254,0.000052188756,0.00014308459],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011754679,0.00039418985,0.0005327992,0.00048696034,0.000046898833,0.0000612126,0.00012076951,0.0007416104,0.00041173666],"category_scores_gemma":[0.00010571511,0.0002937369,0.00026898354,0.0003320418,0.000052693096,0.000087632696,0.00010049674,0.0019534675,0.001356238],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002836787,0.00064012816,0.06259956,0.0012777061,0.0008749618,0.016729796,0.000052527932,1.8334782e-7,0.0006084005,0.000008051609,0.9108486,0.006076382],"study_design_scores_gemma":[0.011015296,0.00062491273,0.06037229,0.0007378567,0.00066799583,0.00024354075,0.000008597954,0.00008315637,0.0008630306,0.0002622202,0.92477787,0.0003432233],"about_ca_topic_score_codex":0.00028596274,"about_ca_topic_score_gemma":0.00014148105,"teacher_disagreement_score":0.016486255,"about_ca_system_score_codex":0.00015164285,"about_ca_system_score_gemma":0.0001844705,"threshold_uncertainty_score":0.9999515},"labels":[],"label_agreement":null},{"id":"W4393385075","doi":"10.1182/blood.2023021620","title":"Axicabtagene ciloleucel vs standard of care in second-line large B-cell lymphoma: outcomes by metabolic tumor volume","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; bluebird bio; Seagen; Gilead Sciences; Leukemia and Lymphoma Society; Celgene; AstraZeneca; TG Therapeutics; Amgen; Pfizer; Bristol-Myers Squibb","keywords":"Chemoimmunotherapy; Medicine; Internal medicine; Oncology; Cytokine release syndrome; Lymphoma; Diffuse large B-cell lymphoma; Gastroenterology; Immunotherapy; Rituximab; Cancer; Chimeric antigen receptor","score_opus":0.0058238696159880485,"score_gpt":0.24535100752126743,"score_spread":0.23952713790527938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393385075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93123025,0.06400504,0.0000047148656,0.00050397514,0.0001743534,0.00038888585,0.0013736321,0.00007775267,0.0022413738],"genre_scores_gemma":[0.9962453,0.00042717103,0.0002371643,0.00039559754,0.00006258037,0.00008837905,0.00017851936,0.0000440823,0.0023211949],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99844134,0.000036646732,0.00043372047,0.00039028964,0.00034131776,0.0003566959],"domain_scores_gemma":[0.9992893,0.000059404156,0.00006382971,0.00036444585,0.000074876516,0.00014817239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013639645,0.000255687,0.00078205724,0.00016746324,0.000031611304,0.000026359014,0.00009624925,0.00008313617,0.0004634503],"category_scores_gemma":[0.000027638527,0.00019482934,0.00024936438,0.00027269698,0.000033182587,0.000063671,0.00006280356,0.00007321155,0.000093829134],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077185174,0.023048373,0.92431015,0.0027198482,0.0016671942,0.0037590684,0.0028608828,0.0000017973924,0.008102902,0.0010171167,0.019117957,0.012622852],"study_design_scores_gemma":[0.058026955,0.0023381854,0.16559283,0.00040173045,0.0017106647,0.00008774163,0.00064959377,0.0000480588,0.46730223,0.000038211758,0.3033715,0.00043230047],"about_ca_topic_score_codex":0.00009741266,"about_ca_topic_score_gemma":0.00015549969,"teacher_disagreement_score":0.7587173,"about_ca_system_score_codex":0.000116500676,"about_ca_system_score_gemma":0.00029293526,"threshold_uncertainty_score":0.794491},"labels":[],"label_agreement":null},{"id":"W4394714668","doi":"10.1182/blood.2023023630","title":"Rac’n’rolling the immune system","year":2024,"lang":"en","type":"letter","venue":"Blood","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Immune system; Medicine; Immunology","score_opus":0.007404901181738822,"score_gpt":0.1967633038489186,"score_spread":0.1893584026671798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394714668","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022434576,0.7305792,0.00006543158,0.23013614,0.010443704,0.00074406964,0.00016305495,0.0008055122,0.024819434],"genre_scores_gemma":[0.8078221,0.0004573954,0.000013215159,0.1348055,0.00060019316,0.00031681417,0.0015184609,0.00028705734,0.054179244],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977392,0.00023054678,0.00061444525,0.00055536674,0.000109282126,0.00075115525],"domain_scores_gemma":[0.9984635,0.00024523336,0.0002224705,0.0009825857,0.00008368969,0.0000025284212],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00060482963,0.0004948283,0.0005891487,0.0001570374,0.0005683662,0.00010901903,0.0010644385,0.0014119532,0.0002377642],"category_scores_gemma":[0.00005013883,0.00032296145,0.00051273475,0.00025348185,0.0003176965,0.00004841361,0.00023600766,0.003894075,0.0062281424],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056826597,0.0005527915,0.00001212864,0.0024954493,0.006295121,0.00058479933,0.0024248827,0.000021651762,0.12758614,0.0038664467,0.8525432,0.0035605584],"study_design_scores_gemma":[0.0009712316,0.00004696554,0.000028070588,0.00050934835,0.00086824497,0.00061331416,0.00046282096,0.0000032881262,0.013276851,0.000034553446,0.982773,0.0004123076],"about_ca_topic_score_codex":0.00020820566,"about_ca_topic_score_gemma":5.0728784e-7,"teacher_disagreement_score":0.80557865,"about_ca_system_score_codex":0.000046878322,"about_ca_system_score_gemma":0.00018478642,"threshold_uncertainty_score":0.9999222},"labels":[],"label_agreement":null},{"id":"W4394917897","doi":"10.1182/blood.2023023755","title":"HOXA9 and β-catenin safeguard HSC integrity","year":2024,"lang":"en","type":"letter","venue":"Blood","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Medical Research Council","keywords":"Safeguard; Political science; Law","score_opus":0.00895812567290441,"score_gpt":0.23122885860207737,"score_spread":0.22227073292917296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394917897","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.51705545,0.037580777,0.00020549937,0.4385459,0.0021654333,0.00073695154,0.0003891164,0.0001378463,0.0031829977],"genre_scores_gemma":[0.339946,0.008293468,0.0031248592,0.4542884,0.06854499,0.00036401526,0.016450558,0.000894144,0.108093575],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99879366,0.000046284917,0.00020025465,0.0005765991,0.00014647486,0.00023673053],"domain_scores_gemma":[0.99947536,0.000008570168,0.00007312357,0.0003506697,0.00005215545,0.00004010361],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009024871,0.0002614614,0.00020538694,0.00007844574,0.00003693365,0.00005364825,0.00013994133,0.0012600546,0.000026709033],"category_scores_gemma":[0.000024777568,0.00025171015,0.00012388235,0.000082446895,0.00007953484,0.0000015670312,0.00015065694,0.00090257486,0.00005463583],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008080281,0.000017802859,0.000118247226,0.00014223334,0.00026287793,0.0000270292,0.000020567772,8.698078e-7,0.043393865,0.0000044971257,0.9548542,0.0011497696],"study_design_scores_gemma":[0.0004143195,0.00009884352,0.0004801726,0.00007958743,0.00023592336,0.00010745986,0.0000046566356,0.00000721105,0.035673153,0.00017986841,0.9624014,0.00031743766],"about_ca_topic_score_codex":0.000028720913,"about_ca_topic_score_gemma":0.000019721107,"teacher_disagreement_score":0.17710948,"about_ca_system_score_codex":0.000017125778,"about_ca_system_score_gemma":0.00011043371,"threshold_uncertainty_score":0.9999935},"labels":[],"label_agreement":null},{"id":"W4395068276","doi":"10.1182/blood.2023023153","title":"How I treat Philadelphia chromosome–like acute lymphoblastic leukemia in children, adolescents, and young adults","year":2024,"lang":"en","type":"review","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"National Cancer Institute","keywords":"Medicine; Clinical trial; Oncology; Philadelphia chromosome; Population; Internal medicine; Adverse effect; Acute lymphocytic leukemia; Pediatrics; Lymphoblastic Leukemia; Leukemia; Biology; Genetics; Chromosomal translocation","score_opus":0.014523209109085363,"score_gpt":0.2804288934406625,"score_spread":0.26590568433157713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395068276","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038378243,0.9918347,0.000006898838,0.00011597446,0.00034877454,0.0029778772,0.00042826365,0.00024456484,0.00020514509],"genre_scores_gemma":[0.007829256,0.98719454,0.000088065295,0.000072757946,0.0011192044,0.0003871568,0.00073640404,0.00038201537,0.0021905822],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9946625,0.00017716494,0.0009970154,0.0018198773,0.0010672994,0.0012761466],"domain_scores_gemma":[0.99767846,0.00012232618,0.00027581016,0.0011244859,0.00011034331,0.0006885616],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00023819515,0.0013768069,0.00338126,0.0012244005,0.000095319054,0.00028437233,0.00055992417,0.0011427563,0.000029424473],"category_scores_gemma":[0.00018908411,0.0010273453,0.0006764952,0.0014347594,0.0003192325,0.00018308456,0.00063393475,0.0015825266,0.00033299925],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005903925,0.0021610425,0.0040568863,0.26736817,0.01053929,0.020129815,0.000553238,4.7614728e-7,0.000037642378,0.000074297524,0.01720739,0.6772814],"study_design_scores_gemma":[0.053082775,0.0021050298,0.0026734383,0.46084586,0.080568545,0.09405022,0.00011081311,0.00044119678,0.000040940497,0.00003846419,0.30186203,0.00418069],"about_ca_topic_score_codex":0.00020357457,"about_ca_topic_score_gemma":0.000047915455,"teacher_disagreement_score":0.67310065,"about_ca_system_score_codex":0.0036693953,"about_ca_system_score_gemma":0.0043939245,"threshold_uncertainty_score":0.99989825},"labels":[],"label_agreement":null},{"id":"W4395068649","doi":"10.1182/blood.2023022823","title":"Correlation of immune fitness with response to teclistamab in relapsed/refractory multiple myeloma in the MajesTEC-1 study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute","keywords":"Multiple myeloma; Immune system; Correlation; Hematologic Neoplasms; Medicine; Immunology; Pomalidomide; Oncology; Transplantation; Internal medicine; Biology; Lenalidomide; Mathematics","score_opus":0.018647312058973273,"score_gpt":0.29985646662594817,"score_spread":0.2812091545669749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395068649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99670166,0.0006111986,0.000018259221,0.0004265572,0.000041553045,0.0018676982,0.00001595771,0.000032778167,0.00028431663],"genre_scores_gemma":[0.99910283,0.0000073564097,0.00015329935,0.000020741607,0.000021357408,0.0002391102,0.000017156224,0.000024307883,0.00041384684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830955,0.00033143902,0.00034635494,0.00028438977,0.000477121,0.0002511417],"domain_scores_gemma":[0.9986532,0.0007400759,0.00003862009,0.00044251853,0.000054536915,0.00007105402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096862786,0.00014344559,0.00026359415,0.00043335382,0.00003289259,0.000023394005,0.00013053275,0.000060937942,0.0000255408],"category_scores_gemma":[0.000549095,0.00008723853,0.00004500034,0.00087000063,0.000043295266,0.00006345994,0.000042865908,0.0003196619,0.00003765287],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0137216365,0.0071659144,0.9495501,0.00014767505,0.00017993379,0.0041672667,0.009070623,0.0000703627,0.010299922,0.000018497563,0.000025089508,0.0055829827],"study_design_scores_gemma":[0.014477835,0.0032399748,0.9770087,0.00045271334,0.00007591466,0.00006379274,0.0027304366,0.0003882625,0.0012902318,0.0000072607045,0.00017871897,0.00008617999],"about_ca_topic_score_codex":0.00054221624,"about_ca_topic_score_gemma":0.0009042208,"teacher_disagreement_score":0.027458582,"about_ca_system_score_codex":0.000081703874,"about_ca_system_score_gemma":0.00017652899,"threshold_uncertainty_score":0.3557484},"labels":[],"label_agreement":null},{"id":"W4395660893","doi":"10.1182/blood.2024024038","title":"Outcomes of HLA-mismatched HSCT with TCRαβ/CD19 depletion or post-HSCT cyclophosphamide for inborn errors of immunity","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre","funders":"","keywords":"Medicine; Human leukocyte antigen; Cyclophosphamide; Immunology; Immunity; CD19; Pediatrics; Internal medicine; Immune system; Antigen; Chemotherapy","score_opus":0.009328402476582977,"score_gpt":0.24117233939191113,"score_spread":0.23184393691532815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395660893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819676,0.015964689,0.00024791792,0.00019223304,0.00048318514,0.00051768165,0.0001676228,0.00011189358,0.00034713603],"genre_scores_gemma":[0.9979165,0.00015631622,0.00018976475,0.00006674867,0.0000025184763,0.00006158809,0.00024902675,0.0000366861,0.0013208148],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986266,0.00010621325,0.00055155356,0.00028883177,0.00006233677,0.00036447588],"domain_scores_gemma":[0.99882203,0.0003705876,0.00019935159,0.00044275282,0.00015783113,0.000007417794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037016842,0.00025976793,0.00056116073,0.00016404402,0.00014572064,0.00001088006,0.0003307088,0.00023698942,0.00014757858],"category_scores_gemma":[0.00018797812,0.00018062092,0.00023404024,0.00032653578,0.00031381944,0.000119112236,0.00006913232,0.0002725636,0.000033166903],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017328132,0.0017884495,0.011508747,0.0007255746,0.001980185,0.0000104150095,0.004554938,0.000041156836,0.96863467,0.0023678935,0.00009297171,0.006562194],"study_design_scores_gemma":[0.011745273,0.0030506952,0.21661966,0.0006146602,0.0012775589,0.00014055986,0.007638022,0.000021582375,0.7458425,0.0005080042,0.0117345555,0.0008069307],"about_ca_topic_score_codex":0.00047403597,"about_ca_topic_score_gemma":0.00003906391,"teacher_disagreement_score":0.22279216,"about_ca_system_score_codex":0.000014041958,"about_ca_system_score_gemma":0.00021222407,"threshold_uncertainty_score":0.73655075},"labels":[],"label_agreement":null},{"id":"W4396626528","doi":"10.1182/blood.2024024251","title":"Motive and opportunity: <i>MYC</i> rearrangements in high-grade B-cell lymphoma with <i>MYC</i> and <i>BCL2</i> rearrangements (an LLMPP study)","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of Toronto; University Health Network; Terry Fox Research Institute; Simon Fraser University; BC Cancer Agency; University of British Columbia; Spinal Cord Injury BC","funders":"National Cancer Institute","keywords":"Somatic hypermutation; BCL6; Gene rearrangement; Biology; Lymphoma; Follicular lymphoma; Cancer research; Diffuse large B-cell lymphoma; B cell; Genetics; Germinal center; Gene; Antibody; Immunology","score_opus":0.016528980564083445,"score_gpt":0.25229560774036597,"score_spread":0.23576662717628252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396626528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900955,0.0034562266,0.0000019386105,0.0005510959,0.00011469513,0.0015862021,0.00006805016,0.0001474109,0.003978866],"genre_scores_gemma":[0.9963178,0.0013465298,0.00039477876,0.0007278417,0.00010386398,0.00028418997,0.0000876098,0.000075675714,0.0006616894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976454,0.00012068407,0.00037935906,0.0008794278,0.00051188166,0.0004632714],"domain_scores_gemma":[0.9988099,0.00008455803,0.000073354415,0.00048569436,0.000055557663,0.00049096433],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030480314,0.0004281376,0.00056716043,0.0002629441,0.0001144553,0.00015683055,0.00009842036,0.000110768546,0.000037494003],"category_scores_gemma":[0.000016715707,0.00032402645,0.00005091146,0.00038688292,0.000110473644,0.00028493063,0.00012245004,0.0001359918,0.000021790369],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044980212,0.02768115,0.9347031,0.0004720464,0.0011839581,0.007718252,0.003432857,5.7062203e-7,0.0014830297,0.00014589855,0.0014040724,0.021325227],"study_design_scores_gemma":[0.10974586,0.011737498,0.8456588,0.0014282252,0.0045993384,0.0008660102,0.004618825,0.000059669914,0.008909391,0.00021686421,0.011099073,0.0010604616],"about_ca_topic_score_codex":0.0010845991,"about_ca_topic_score_gemma":0.00040429953,"teacher_disagreement_score":0.10929606,"about_ca_system_score_codex":0.00010563361,"about_ca_system_score_gemma":0.00016493382,"threshold_uncertainty_score":0.9999212},"labels":[],"label_agreement":null},{"id":"W4396978251","doi":"10.1182/blood.2023023659","title":"Mutational profile in previously treated patients with chronic lymphocytic leukemia progression on acalabrutinib or ibrutinib","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"National Cancer Institute","keywords":"Ibrutinib; Chronic lymphocytic leukemia; Medicine; Leukemia; Internal medicine; Cancer research; Immunology","score_opus":0.014019304135587387,"score_gpt":0.3052712973451345,"score_spread":0.2912519932095471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396978251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931377,0.0008069237,0.0000048996526,0.00006987245,0.00008707999,0.0026082979,0.000032947057,0.00030819536,0.0029440427],"genre_scores_gemma":[0.995293,0.000048640268,0.0003611579,0.000076999,0.00023426392,0.0005047851,0.0004186366,0.00009787605,0.002964635],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99683756,0.00009212816,0.00046489373,0.000756496,0.0010943852,0.0007545147],"domain_scores_gemma":[0.99876016,0.00031484597,0.000071211616,0.0004532185,0.00014032082,0.0002602599],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002722069,0.00034115106,0.00041704485,0.00036687078,0.00007584047,0.000081015394,0.00017431608,0.00021265898,0.0006595105],"category_scores_gemma":[0.00023840868,0.00021042128,0.000083939034,0.0010338214,0.00015775756,0.00014585015,0.00007864932,0.00041125805,0.0005122732],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.08987828,0.025800912,0.19429867,0.0414085,0.0064527807,0.08341615,0.01032876,0.0040837396,0.0045197764,0.0027960269,0.02758924,0.50942713],"study_design_scores_gemma":[0.5533857,0.02753421,0.15262347,0.032937214,0.0014982442,0.00296064,0.00014227496,0.16318244,0.053279933,0.00010277154,0.010212554,0.0021405786],"about_ca_topic_score_codex":0.00020540507,"about_ca_topic_score_gemma":0.000073160045,"teacher_disagreement_score":0.50728655,"about_ca_system_score_codex":0.04494559,"about_ca_system_score_gemma":0.046427257,"threshold_uncertainty_score":0.9589786},"labels":[],"label_agreement":null},{"id":"W4399072471","doi":"10.1182/blood.2023021426","title":"Adaptation to ex vivo culture reduces human hematopoietic stem cell activity independently of the cell cycle","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Cancer Research UK Cambridge Institute, University of Cambridge; NIHR Cambridge Biomedical Research Centre; Cambridge Institute for Medical Research, University of Cambridge; Blood Cancer UK; Wellcome Trust; Cambridge Trust; Gates Cambridge Trust; GlaxoSmithKline; Deutsche Forschungsgemeinschaft; National Institute for Health and Care Research; Cancer Research UK; Canada First Research Excellence Fund; Medical Research Council; Alborada Trust; University of Toronto","keywords":"Ex vivo; Biology; Haematopoiesis; Stem cell; Cell biology; Hematopoietic stem cell; Cell cycle; Cancer research; Immunology; In vivo; Cell; Genetics","score_opus":0.01658238908918237,"score_gpt":0.26078794121977195,"score_spread":0.2442055521305896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399072471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98496264,0.0004143259,0.00033746933,0.00021966177,0.000212743,0.00065481215,0.000024734903,0.00008760196,0.013086007],"genre_scores_gemma":[0.9955914,0.000021244732,0.00026160298,0.000047846854,0.000083078776,0.000025231779,0.000006302922,0.000032743683,0.0039305533],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986669,0.00007185758,0.00027649925,0.0003101008,0.00048300985,0.00019163982],"domain_scores_gemma":[0.9993711,0.000055619814,0.00007889816,0.00032574454,0.00006343468,0.00010521673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017641664,0.00016574691,0.00024108351,0.00008499465,0.00007090364,0.000033484022,0.00014372467,0.00012975108,0.00007721641],"category_scores_gemma":[0.000004492038,0.00011782714,0.00013257067,0.00033556065,0.00003394634,0.000082083054,0.000030338697,0.0002183494,0.000073912335],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025085392,0.0005020969,0.0003473758,0.0016859589,0.00004706059,0.000036249003,0.016219689,0.000030596162,0.98034185,0.000103209255,0.00026858866,0.00039225508],"study_design_scores_gemma":[0.0009364032,0.00017105766,0.0017649609,0.0005903736,0.00040272585,0.00007094808,0.0018001003,0.00007559288,0.9937463,0.00007436233,0.00024399285,0.00012320348],"about_ca_topic_score_codex":0.0000457746,"about_ca_topic_score_gemma":0.00001779836,"teacher_disagreement_score":0.014419589,"about_ca_system_score_codex":0.000032758857,"about_ca_system_score_gemma":0.00010255041,"threshold_uncertainty_score":0.48048514},"labels":[],"label_agreement":null},{"id":"W4399201500","doi":"10.1182/blood.2023023707","title":"Interleukin-1–mediated hyperinflammation in XIAP deficiency is associated with defective autophagy","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Autophagy; Immunology; Medicine; XIAP; Interleukin; Cancer research; Biology; Cytokine; Apoptosis; Programmed cell death; Genetics","score_opus":0.01213346500369091,"score_gpt":0.26341413487748494,"score_spread":0.25128066987379405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399201500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984069,0.0020827453,0.000038621816,0.0002621876,0.00005010254,0.00041783552,0.0000071225218,0.00020596517,0.012866421],"genre_scores_gemma":[0.9986153,0.000092960465,0.000029011606,0.00009820815,0.000026078094,0.000066329776,0.00005345299,0.000032980282,0.0009856314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868035,0.000057610763,0.0002931159,0.00029667583,0.00034613875,0.0003261004],"domain_scores_gemma":[0.99948734,0.00011404492,0.00004168006,0.00019371569,0.00009824138,0.000064981214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030116946,0.00015216059,0.00027362225,0.0002663139,0.000046904977,0.000048855796,0.000084804924,0.00012201537,0.0003042898],"category_scores_gemma":[0.00027367717,0.000119185584,0.00006884417,0.0007785364,0.00007600303,0.00017273684,0.00003841807,0.00037038722,0.0002677254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017222444,0.010458642,0.4399772,0.0035309352,0.0034401943,0.011203965,0.0509901,0.000105610525,0.39242345,0.0058792816,0.004892157,0.07537622],"study_design_scores_gemma":[0.018298764,0.0033715726,0.7695823,0.003372892,0.00058210193,0.0004526045,0.0024623245,0.010451706,0.18096755,0.000621632,0.008823465,0.0010131241],"about_ca_topic_score_codex":0.000042675525,"about_ca_topic_score_gemma":0.00003728169,"teacher_disagreement_score":0.32960504,"about_ca_system_score_codex":0.00011811116,"about_ca_system_score_gemma":0.0003541136,"threshold_uncertainty_score":0.4860247},"labels":[],"label_agreement":null},{"id":"W4399202399","doi":"10.1182/blood.2024023962","title":"Randomized study of induction with bendamustine-rituximab ± bortezomib and maintenance with rituximab ± lenalidomide for MCL","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Moncton Hospital; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Mantle cell lymphoma; Bendamustine; Lenalidomide; Bortezomib; Rituximab; Medicine; Oncology; Multiple myeloma; Internal medicine; Lymphoma","score_opus":0.013759621593156638,"score_gpt":0.2607973280820516,"score_spread":0.24703770648889495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399202399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99421906,0.0019492828,0.00015975854,0.0005262931,0.000060056358,0.0026698096,0.000026199392,0.00006777853,0.00032173106],"genre_scores_gemma":[0.99691814,0.00012099839,0.0018442388,0.000046672143,0.00009999128,0.0007243705,0.000019832945,0.000034217523,0.00019152183],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9988541,0.00004111452,0.00029744348,0.0003804865,0.00022550336,0.00020135319],"domain_scores_gemma":[0.99924695,0.00022786317,0.00008727263,0.00021937938,0.00013556745,0.00008298414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026689228,0.00020704519,0.00080945384,0.000112917754,0.000056529138,0.000034414188,0.000035173358,0.000048192167,0.0000095673895],"category_scores_gemma":[0.000056883204,0.00011339568,0.000081805265,0.00016739311,0.00011437134,0.00008438247,0.000017001108,0.00007451224,0.000002284994],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.70212597,0.1150393,0.09578585,0.0048046666,0.023887362,0.0026474458,0.01299706,0.000027012191,0.0022660475,0.008186006,0.0021175423,0.030115763],"study_design_scores_gemma":[0.9740491,0.004703353,0.0059431805,0.0008687614,0.0058011715,0.00064184563,0.0016024667,0.000120116696,0.0055632344,0.00007777328,0.0004450046,0.00018397847],"about_ca_topic_score_codex":0.00024502893,"about_ca_topic_score_gemma":0.00008647606,"teacher_disagreement_score":0.27192315,"about_ca_system_score_codex":0.00003332506,"about_ca_system_score_gemma":0.00011600495,"threshold_uncertainty_score":0.46241418},"labels":[],"label_agreement":null},{"id":"W4399202403","doi":"10.1182/blood.2023022608","title":"4D intravital imaging studies identify platelets as the predominant cellular procoagulant surface in a mouse hemostasis model","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Hemostasis; Platelet; Intravital microscopy; Pathology; Cell biology; Medicine; Biology; Immunology; Microcirculation; Internal medicine","score_opus":0.034461330284202854,"score_gpt":0.3219318247237952,"score_spread":0.2874704944395924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399202403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878498,0.007816566,0.00066308136,0.0022842837,0.00017525417,0.00081020093,0.000015692636,0.00017471271,0.0002104656],"genre_scores_gemma":[0.9973706,0.0002316172,0.0010806206,0.00030264768,0.00007215227,0.00005494694,0.000014404397,0.00004965603,0.0008233542],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984302,0.000054048374,0.00037303788,0.00042018513,0.00037838265,0.00034414744],"domain_scores_gemma":[0.99936277,0.0000765734,0.00005086548,0.00034487748,0.000077548524,0.000087362285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004437952,0.00023181588,0.00037714743,0.000112502516,0.000121960904,0.0001268749,0.0001331603,0.00007152498,0.00003352704],"category_scores_gemma":[0.00007611561,0.00015673856,0.000115725656,0.00029503438,0.000094956835,0.00013649881,0.00011941725,0.00030552832,0.00007943627],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001251806,0.0015276727,0.0017637899,0.0008955915,0.0010792385,0.0019494384,0.01294016,0.0011658886,0.9635556,0.011524172,0.00048285432,0.0029904686],"study_design_scores_gemma":[0.0029471412,0.0001356066,0.0002449456,0.00067678187,0.00066234026,0.00038823317,0.002530978,0.07817566,0.9090355,0.0046997713,0.00018717123,0.000315895],"about_ca_topic_score_codex":0.000049525886,"about_ca_topic_score_gemma":0.000027059375,"teacher_disagreement_score":0.07700977,"about_ca_system_score_codex":0.00005090548,"about_ca_system_score_gemma":0.00016157854,"threshold_uncertainty_score":0.63916135},"labels":[],"label_agreement":null},{"id":"W4399422505","doi":"10.1182/blood.2023022901","title":"How I manage major hemorrhage","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Trauma, Hemostasis, Coagulopathy, Resuscitation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Women's College Hospital; Queen's University; Sunnybrook Hospital; University Health Network; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Tranexamic acid; Intensive care medicine; Resuscitation; Hematologist; Blood management; Coagulation testing; Coagulation; Surgery; Internal medicine; Blood transfusion; Blood loss","score_opus":0.015127672319681774,"score_gpt":0.2550983990903876,"score_spread":0.23997072677070586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399422505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95748216,0.005176611,0.0010110044,0.008837137,0.00067555194,0.00050393515,0.000029419,0.00067528,0.025608877],"genre_scores_gemma":[0.98333293,0.00003262718,0.0040909434,0.0003039603,0.00041763578,0.000028550063,0.000046592133,0.000047038786,0.011699715],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999009,0.000020768253,0.0001359455,0.00031420353,0.0002795519,0.00024050001],"domain_scores_gemma":[0.9994551,0.000049877533,0.000022011302,0.00031754773,0.000039092953,0.000116364725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012796582,0.00013976301,0.00017316038,0.00015979115,0.00004264931,0.00013015587,0.00007676943,0.000078296645,0.000093080285],"category_scores_gemma":[0.000088319575,0.00012284072,0.00009924018,0.00032930076,0.00003390685,0.00013947305,0.000032248918,0.00018560408,0.00037070512],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024884584,0.002160111,0.010992829,0.00818596,0.0010527867,0.024052985,0.0032628237,0.0000019326133,0.18654546,0.010959327,0.019067284,0.73346967],"study_design_scores_gemma":[0.022360643,0.0019769087,0.20163535,0.0021879598,0.006452191,0.0045677456,0.0036742717,0.0026589509,0.43158275,0.005176799,0.31565896,0.0020674663],"about_ca_topic_score_codex":0.0000072231537,"about_ca_topic_score_gemma":0.000011343756,"teacher_disagreement_score":0.7314022,"about_ca_system_score_codex":0.000032170465,"about_ca_system_score_gemma":0.000044691456,"threshold_uncertainty_score":0.50092995},"labels":[],"label_agreement":null},{"id":"W4399663404","doi":"10.1182/blood.2024025038","title":"Early-life infection depletes preleukemic cells in a mouse model of hyperdiploid B-cell acute lymphoblastic leukemia","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Dalhousie University; University of British Columbia; BC Children's Hospital","funders":"Canadian Institutes of Health Research; BC Children's Hospital","keywords":"Immunology; Leukemia; Preleukemia; Biology; Cytomegalovirus; Cytokine; Medicine; Virus; Herpesviridae; Viral disease","score_opus":0.013011187786569327,"score_gpt":0.24988066776784693,"score_spread":0.2368694799812776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399663404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945809,0.00048477922,0.002122895,0.000045037275,0.00011709754,0.0006733056,0.00009881732,0.00026306172,0.0016140966],"genre_scores_gemma":[0.99454594,0.0005632779,0.001605122,0.00009571532,0.00015026955,0.00010547189,0.00002420414,0.00012467914,0.002785338],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972725,0.00007192468,0.0006632242,0.00062915345,0.00070731447,0.0006558931],"domain_scores_gemma":[0.9985447,0.00034686978,0.000089664565,0.00054999074,0.0001348666,0.00033393435],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028568017,0.0003474938,0.0006182084,0.0006740104,0.00004437945,0.000053153723,0.00021016489,0.00032095608,0.00004591951],"category_scores_gemma":[0.00018729139,0.00031281417,0.00022295711,0.00073859555,0.00015042994,0.00022165653,0.00018380446,0.00051444344,0.00025120078],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031099748,0.00067994604,0.003426613,0.0011979678,0.00036746383,0.00022074819,0.00052301714,0.0042322744,0.98793876,0.00008744508,0.00067423366,0.00034052413],"study_design_scores_gemma":[0.011090181,0.00073462434,0.0011897108,0.00051892287,0.00078300503,0.00013290746,0.000031287207,0.31912208,0.6658199,0.00013440532,0.00009141874,0.00035157296],"about_ca_topic_score_codex":0.0005921098,"about_ca_topic_score_gemma":0.00002211293,"teacher_disagreement_score":0.32211888,"about_ca_system_score_codex":0.0013994048,"about_ca_system_score_gemma":0.0041956925,"threshold_uncertainty_score":0.9999324},"labels":[],"label_agreement":null},{"id":"W4399996130","doi":"10.1182/blood.2024024283","title":"<i>ATM</i> germ line pathogenic variants affect outcomes in children with ataxia-telangiectasia and hematological malignancies","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; University of Alberta; Stollery Children's Hospital; Hospital for Sick Children","funders":"National Cancer Institute; Children's Hospital of Philadelphia; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Israel Cancer Association; Israel Cancer Research Fund","keywords":"Medicine; Internal medicine; Lymphoma; Confidence interval; Gastroenterology; Ataxia-telangiectasia; Hazard ratio; Incidence (geometry); Leukemia; Oncology; Biology; Genetics","score_opus":0.006167313470606022,"score_gpt":0.22345076469139674,"score_spread":0.2172834512207907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399996130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99493957,0.0042929286,0.00017282774,0.000059613798,0.00004221893,0.00025978847,0.00005635124,0.00005937958,0.00011731913],"genre_scores_gemma":[0.99818075,0.00013966393,0.0012017064,0.000098694996,0.000052551353,0.000040598974,0.000071754264,0.000027224185,0.00018708388],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990376,0.000046105026,0.00013777573,0.000432918,0.00010028368,0.000245302],"domain_scores_gemma":[0.99964315,0.0000139247795,0.00002606095,0.00024558892,0.00001171541,0.000059549526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012940675,0.00018308636,0.00020586964,0.00004300299,0.000026987223,0.000039400446,0.00011237984,0.00014816692,0.000009379562],"category_scores_gemma":[0.000028846602,0.00013008027,0.00006140772,0.00009711032,0.00005325085,0.0000046796513,0.00011956878,0.000091531896,0.000010596748],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032858447,0.0003010773,0.30301484,0.00005340901,0.00031330434,0.0002965473,0.000039884417,0.0000020763637,0.6947387,0.00061019557,0.00007793559,0.0005191538],"study_design_scores_gemma":[0.0026633083,0.0013709686,0.32715285,0.0001242635,0.00024267963,0.0032080314,0.000030348292,0.00004214167,0.6638505,0.00035201103,0.00035671744,0.0006061894],"about_ca_topic_score_codex":0.000008197397,"about_ca_topic_score_gemma":0.000028043205,"teacher_disagreement_score":0.030888231,"about_ca_system_score_codex":0.000004106457,"about_ca_system_score_gemma":0.00003945967,"threshold_uncertainty_score":0.5304519},"labels":[],"label_agreement":null},{"id":"W4400108462","doi":"10.1182/blood.2023022501","title":"How I treat iron overload in adult MDS","year":2024,"lang":"en","type":"review","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Myelodysplastic syndromes; Medicine; Chelation therapy; Intensive care medicine; Anemia; Life expectancy; Thalassemia; Internal medicine; Bone marrow; Population","score_opus":0.03732698773936028,"score_gpt":0.3471964996443165,"score_spread":0.3098695119049562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400108462","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000110392095,0.985705,4.964275e-7,0.0005038392,0.00012896661,0.0012439281,0.000080121325,0.00011031824,0.01211694],"genre_scores_gemma":[0.000012774259,0.948065,0.00011865045,0.000066304034,0.00076144875,0.00024813597,0.00024233984,0.00014317685,0.050342176],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99771726,0.00011929169,0.00041078372,0.00068332214,0.0005161675,0.00055317767],"domain_scores_gemma":[0.99876,0.0001169421,0.00008373816,0.0007600474,0.00006194055,0.00021737034],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018908178,0.000509872,0.0019000829,0.00061313587,0.00002167289,0.00009041793,0.0002799689,0.0006184976,0.00009075554],"category_scores_gemma":[0.0002905566,0.000345396,0.0005653829,0.00080965454,0.00006663439,0.00005476324,0.00019342308,0.0015871617,0.0012656412],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012573295,0.00032105632,0.000019898791,0.08225691,0.00029039133,0.0037433896,0.000060307288,5.6050493e-9,0.0000051653337,0.00013164581,0.018808663,0.89435],"study_design_scores_gemma":[0.0018409396,0.0002015501,0.0000050312933,0.028710531,0.0042606927,0.00078549836,0.000022791115,0.0000026784169,0.000010115219,0.000009193002,0.96386886,0.0002820981],"about_ca_topic_score_codex":0.00011335315,"about_ca_topic_score_gemma":0.00003677043,"teacher_disagreement_score":0.9450602,"about_ca_system_score_codex":0.00060414826,"about_ca_system_score_gemma":0.0011405807,"threshold_uncertainty_score":0.9998998},"labels":[],"label_agreement":null},{"id":"W4400189917","doi":"10.1182/blood.2023023349","title":"Use of HSC-targeted LNP to generate a mouse model of lethal α-thalassemia and treatment via lentiviral gene therapy","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Acuitas Therapeutics (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; University of Pennsylvania; National Cancer Institute; National Institutes of Health; Pennsylvania Department of Health; National and Kapodistrian University of Athens; Eunice Kennedy Shriver National Institute of Child Health and Human Development; Children's Hospital of Philadelphia","keywords":"Genetic enhancement; Haematopoiesis; CD34; Progenitor cell; Biology; Stem cell; Viral vector; Bone marrow; Thalassemia; Transplantation; Ex vivo; Erythropoiesis; Severe combined immunodeficiency; Cancer research; Immunology; Molecular biology; Medicine; In vivo; Gene; Anemia; Internal medicine; Cell biology; Recombinant DNA; Genetics","score_opus":0.039718350114193286,"score_gpt":0.2670252972844952,"score_spread":0.22730694717030192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400189917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993001,0.005492305,0.00073688285,0.00013408982,0.000056287106,0.00035102054,0.00009952115,0.000037365546,0.00009152591],"genre_scores_gemma":[0.9912599,0.0015304264,0.005136722,0.00009705626,0.00006013945,0.000023779066,0.00002905099,0.00003074338,0.0018322188],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99918115,0.000027884105,0.00022029554,0.00023800637,0.00016016865,0.00017251077],"domain_scores_gemma":[0.99957484,0.000020990734,0.000034124052,0.00023021424,0.00004418984,0.00009565156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006142872,0.0001577079,0.00032014426,0.0001330398,0.0000181527,0.000013210936,0.000036523175,0.00006714019,0.000020217969],"category_scores_gemma":[0.000011023437,0.00011811753,0.000094601506,0.00012901738,0.000042387248,0.000071397764,0.000020895237,0.000050493094,0.000004779211],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019220228,0.0007155187,0.0032495323,0.000072500145,0.00016743602,0.00001750498,0.0009193649,0.00025284,0.98677945,0.00010401721,0.0001429474,0.0073866667],"study_design_scores_gemma":[0.0032338721,0.0005765515,0.0024922276,0.0000257465,0.00032892695,0.000011430062,0.00003100888,0.0041439137,0.9887234,0.000040264018,0.00027160818,0.00012102357],"about_ca_topic_score_codex":0.00023381218,"about_ca_topic_score_gemma":0.000013227702,"teacher_disagreement_score":0.007265643,"about_ca_system_score_codex":0.000009954546,"about_ca_system_score_gemma":0.000086454515,"threshold_uncertainty_score":0.4816693},"labels":[],"label_agreement":null},{"id":"W4400351716","doi":"10.1182/blood.2024025106","title":"Novel MAGIC composite scores using both clinical symptoms and biomarkers best predict treatment outcomes of acute GVHD","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Internal medicine; Intensive care medicine","score_opus":0.05144761525706411,"score_gpt":0.3661012033585625,"score_spread":0.3146535881014984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400351716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99004227,0.0034691456,0.0001178822,0.00009950242,0.0002776952,0.00014191764,0.0001150556,0.000060333918,0.0056761694],"genre_scores_gemma":[0.99793,0.00041449754,0.0012829171,0.00003272799,0.00011009537,0.000002158712,0.0000107299875,0.000014736844,0.00020216088],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99924606,0.000017177186,0.00027622623,0.00020633296,0.00014302222,0.00011120413],"domain_scores_gemma":[0.9995411,0.00016842083,0.000044894983,0.00014445194,0.00002792933,0.00007321686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010025721,0.000116348085,0.0004376686,0.000091366215,0.000038309812,0.000021002996,0.000008290923,0.000051257874,0.000004104547],"category_scores_gemma":[0.000019875659,0.000083584724,0.00020595455,0.00010603511,0.00013603402,0.000029613699,0.00003535552,0.000041294516,0.000005579695],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005474378,0.00023585411,0.9871048,0.00007714047,0.0061071343,0.000037479036,0.00017251274,0.0000023716807,0.00388461,0.00003656241,0.00011461726,0.0021722156],"study_design_scores_gemma":[0.0039164317,0.0006745792,0.9853069,0.00026690483,0.0064407657,0.0007316775,0.00008387494,0.00031133904,0.0013362964,0.000008185399,0.00080070563,0.00012234935],"about_ca_topic_score_codex":0.00006889239,"about_ca_topic_score_gemma":0.0000016572766,"teacher_disagreement_score":0.007887677,"about_ca_system_score_codex":0.0000148881545,"about_ca_system_score_gemma":0.000048388596,"threshold_uncertainty_score":0.34084862},"labels":[],"label_agreement":null},{"id":"W4400576900","doi":"10.1182/blood.2024024756","title":"Risk prediction for clonal cytopenia: multicenter real-world evidence","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; Takeda Oncology; Center for Clinical and Translational Science, Mayo Clinic; Genentech; National Institutes of Health; Cancer Research UK; Alexion Pharmaceuticals; Apellis Pharmaceuticals; Sierra Oncology; Pfizer; Incyte; CTI Biopharma; TG Therapeutics; bluebird bio; Agios Pharmaceuticals; MEI Pharma; Eli Lilly and Company; Associazione Italiana per la Ricerca sul Cancro; Astex Pharmaceuticals; Acceleron; Edward P. Evans Foundation; Moffitt Cancer Center; National Cancer Institute; Gilead Sciences; Syndax Pharmaceuticals; BeiGene; MorphoSys; Celgene; AstraZeneca","keywords":"Cytopenia; Internal medicine; Cumulative incidence; Medicine; Proportional hazards model; Oncology; Cohort; Framingham Risk Score; Severe fever with thrombocytopenia syndrome; Incidence (geometry); Disease; Immunology; Bone marrow","score_opus":0.03653534945482608,"score_gpt":0.3459327650009426,"score_spread":0.30939741554611655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400576900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802782,0.0027969098,0.0023120192,0.0042703454,0.0006823305,0.0023334015,0.00031540383,0.00052306044,0.0064883446],"genre_scores_gemma":[0.9798731,0.0012723595,0.00476042,0.00016931756,0.0013582158,0.00024640185,0.000059250822,0.000049355243,0.0122115575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986925,0.000046592904,0.0002385567,0.00037389438,0.00033810042,0.0003103334],"domain_scores_gemma":[0.99891055,0.00049637177,0.000029954272,0.0002886288,0.00012431148,0.00015020689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005234514,0.00012235461,0.00018424641,0.00017850994,0.00008227129,0.000057873327,0.000110531335,0.00007782587,0.00018487455],"category_scores_gemma":[0.00048494313,0.0000979454,0.0001296712,0.0002799356,0.000054759024,0.00017702926,0.000066571316,0.0003886363,0.00023524617],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003790025,0.0017144878,0.58014244,0.003932501,0.0025026943,0.0013179058,0.0016235685,0.00002410968,0.10532237,0.0023167823,0.25356695,0.04374617],"study_design_scores_gemma":[0.020996612,0.0028712936,0.52068996,0.0048799356,0.004740976,0.0004601685,0.00019218208,0.061800744,0.095490634,0.00064746675,0.2865469,0.0006831319],"about_ca_topic_score_codex":0.0002341215,"about_ca_topic_score_gemma":0.00009159565,"teacher_disagreement_score":0.061776634,"about_ca_system_score_codex":0.00019666518,"about_ca_system_score_gemma":0.0003169184,"threshold_uncertainty_score":0.39940974},"labels":[],"label_agreement":null},{"id":"W4400948152","doi":"10.1182/blood.2024025077","title":"Diagnostic guidelines for familial hemophagocytic lymphohistiocytosis revisited","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Institute of General Medical Sciences","keywords":"Hemophagocytic lymphohistiocytosis; Medicine; Macrophage activation syndrome; Immunology; Pediatrics; Expert opinion; Internal medicine; Arthritis; Disease; Intensive care medicine","score_opus":0.051885904500307195,"score_gpt":0.3574104626413462,"score_spread":0.30552455814103896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400948152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8833827,0.09694743,0.0027854806,0.0064479373,0.00061121245,0.0025411295,0.00012228044,0.0008015765,0.006360284],"genre_scores_gemma":[0.98317,0.0025446946,0.002265916,0.0014158178,0.0011854931,0.00041025417,0.00019254755,0.00009558392,0.008719703],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987153,0.000019470805,0.00040784955,0.00029857343,0.00026366976,0.000295154],"domain_scores_gemma":[0.9988807,0.00038288202,0.000025577849,0.00029066176,0.00032187506,0.00009834103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028308458,0.00014751751,0.00030553926,0.00015653095,0.00008707938,0.000052021205,0.000099247736,0.00009295947,0.00018376054],"category_scores_gemma":[0.0032854744,0.000121060926,0.00019633205,0.00028080016,0.000054334992,0.00007563607,0.000041162148,0.00010657931,0.00028441387],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079170126,0.0021237389,0.020312257,0.014427309,0.0024574946,0.0023338373,0.00085928466,0.000032700013,0.09209987,0.007378297,0.61634845,0.24083509],"study_design_scores_gemma":[0.017584812,0.0016898672,0.01620203,0.0036138243,0.0024514017,0.00062746415,0.00036849457,0.015416407,0.046758793,0.0012098876,0.8931886,0.000888395],"about_ca_topic_score_codex":0.00001881961,"about_ca_topic_score_gemma":9.842151e-7,"teacher_disagreement_score":0.2768402,"about_ca_system_score_codex":0.000051929794,"about_ca_system_score_gemma":0.00038398823,"threshold_uncertainty_score":0.49367213},"labels":[],"label_agreement":null},{"id":"W4400948677","doi":"10.1182/blood.2023022565","title":"Ruxolitinib for pediatric patients with treatment-naïve and steroid-refractory acute graft-versus-host disease: the REACH4 study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Ruxolitinib; Medicine; Internal medicine; Dosing; Adverse effect; Refractory (planetary science); Pharmacokinetics; Gastroenterology; Confidence interval; Bone marrow; Myelofibrosis","score_opus":0.016516227376206647,"score_gpt":0.27574559865333476,"score_spread":0.2592293712771281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400948677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99559873,0.0010898957,0.00003725173,0.00017002504,0.00018148126,0.0023080125,0.00027275537,0.00009166583,0.00025018997],"genre_scores_gemma":[0.9985866,0.0001570409,0.000104735045,0.00003170268,0.0002160249,0.00029681646,0.0001804433,0.00004234849,0.00038431803],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897486,0.000039902745,0.00018584657,0.0003290547,0.00026120563,0.00020910644],"domain_scores_gemma":[0.9991493,0.00033479507,0.000039486953,0.00026477827,0.000055281045,0.00015633035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000084918465,0.00018708146,0.0001984367,0.00007649383,0.00009078801,0.000047451886,0.00005029911,0.000037483624,0.000016421576],"category_scores_gemma":[0.000016415655,0.000104804065,0.00005829182,0.00013368277,0.00003378029,0.00007661804,0.000010224007,0.000075332195,0.000013288582],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038134328,0.005977805,0.97660524,0.0011118089,0.002340205,0.0004150853,0.0068861837,2.810596e-7,0.00014869242,0.0001357507,0.00029563275,0.0022698853],"study_design_scores_gemma":[0.040935334,0.0085535515,0.92644185,0.0001717405,0.020065112,0.00002251454,0.001075178,0.000025518128,0.00029424267,0.000023537628,0.0020828634,0.00030854382],"about_ca_topic_score_codex":0.000013840803,"about_ca_topic_score_gemma":0.000013646085,"teacher_disagreement_score":0.05016337,"about_ca_system_score_codex":0.000032158554,"about_ca_system_score_gemma":0.00010151637,"threshold_uncertainty_score":0.4273786},"labels":[],"label_agreement":null},{"id":"W4400980507","doi":"10.1182/blood.2024025017","title":"Varied roles for LGR6 in the immune response","year":2024,"lang":"en","type":"letter","venue":"Blood","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University of Calgary","funders":"","keywords":"Immune system; Biology; Immunology","score_opus":0.011148896458402828,"score_gpt":0.23519459412057528,"score_spread":0.22404569766217244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400980507","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06753032,0.04535764,0.000035000783,0.8821835,0.001817916,0.0015545773,0.00015387141,0.00014024379,0.0012269136],"genre_scores_gemma":[0.1246887,0.000854248,0.00016832404,0.710746,0.0037498141,0.0032631608,0.009415753,0.00038712932,0.14672686],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99775136,0.0010150139,0.00045188676,0.00031719406,0.00004625937,0.00041829783],"domain_scores_gemma":[0.99788785,0.0013898425,0.00012283954,0.0005547413,0.0000417167,0.000003021457],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001441027,0.00026883135,0.00035529613,0.00028130092,0.00012680251,0.00005835921,0.0005035006,0.0012315778,0.00012641076],"category_scores_gemma":[0.00028967593,0.00018483413,0.00024119644,0.00015503497,0.00009917536,0.000050444945,0.000065898625,0.001562182,0.0010531473],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001392605,0.00009135777,0.0000027687483,0.0001265955,0.00038480866,0.0001673425,0.0012568989,2.910017e-7,0.12968677,0.0002504646,0.8660884,0.00055169786],"study_design_scores_gemma":[0.0015590511,0.00020561428,0.00029702976,0.00013046697,0.0002585638,0.00017713093,0.0000968671,5.8543424e-7,0.04924943,0.00053878553,0.9472684,0.00021803612],"about_ca_topic_score_codex":0.000028453276,"about_ca_topic_score_gemma":0.000005258659,"teacher_disagreement_score":0.1714375,"about_ca_system_score_codex":0.000025817584,"about_ca_system_score_gemma":0.00017778274,"threshold_uncertainty_score":0.9997246},"labels":[],"label_agreement":null},{"id":"W4401178837","doi":"10.1182/blood.2024024631","title":"Venetoclax-obinutuzumab for previously untreated chronic lymphocytic leukemia: 6-year results of the randomized phase 3 CLL14 study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":127,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Obinutuzumab; Ven; IGHV@; Venetoclax; Internal medicine; Chronic lymphocytic leukemia; Gastroenterology; Chlorambucil; Population; Leukemia; Oncology; Chemotherapy; Cyclophosphamide","score_opus":0.018333618527857205,"score_gpt":0.32429537085623106,"score_spread":0.30596175232837386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401178837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98237914,0.0058201486,0.00004560082,0.000090217196,0.0003641304,0.009530389,0.00011349758,0.00022377961,0.0014331188],"genre_scores_gemma":[0.99382174,0.0002593298,0.00010868193,0.00003366494,0.0004960115,0.0007787231,0.00006475614,0.00009713682,0.0043399474],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99642247,0.00034207795,0.0010162763,0.00071672676,0.0008147335,0.0006877188],"domain_scores_gemma":[0.9966815,0.0014446264,0.00017836377,0.0012530125,0.00024745718,0.00019503146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018256826,0.00035136056,0.0011369165,0.00020680773,0.00012008563,0.000066530505,0.0004371714,0.0002007445,0.00006723021],"category_scores_gemma":[0.0016663218,0.00021723186,0.0006248971,0.0008027323,0.00035648656,0.00007666454,0.00019079408,0.00032494322,0.00006634901],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.8673036,0.005365117,0.00006924615,0.015084217,0.020517012,0.0027704602,0.016456427,0.0039654984,0.024423348,0.0018348142,0.027070096,0.015140128],"study_design_scores_gemma":[0.9036418,0.0022285164,0.00001045065,0.0010524964,0.0031321764,0.0002652797,0.0002005585,0.06348215,0.02364224,0.00011282223,0.0020234734,0.00020800535],"about_ca_topic_score_codex":0.0017087762,"about_ca_topic_score_gemma":0.000114704875,"teacher_disagreement_score":0.059516653,"about_ca_system_score_codex":0.08144873,"about_ca_system_score_gemma":0.09500516,"threshold_uncertainty_score":0.9220774},"labels":[],"label_agreement":null},{"id":"W4401214578","doi":"10.1182/blood.2024025016","title":"Plasma cells’ fate: it is a complex “orchestra”","year":2024,"lang":"en","type":"letter","venue":"Blood","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Chemistry; Cell biology; Biology","score_opus":0.03547894503723267,"score_gpt":0.2469301921682426,"score_spread":0.21145124713100993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401214578","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028839672,0.012378429,0.00001607683,0.9268419,0.005599657,0.00087641244,0.0013083201,0.00051930785,0.023620209],"genre_scores_gemma":[0.06448252,0.00059215986,0.00014171973,0.76120126,0.002620279,0.00011951784,0.008147912,0.00025137403,0.16244327],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982261,0.0001381362,0.00044087277,0.00058883894,0.00006529675,0.00054076855],"domain_scores_gemma":[0.99915075,0.00009461585,0.00015940443,0.0005352368,0.000046145928,0.000013821734],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000101806894,0.00042933362,0.0005411396,0.0001780446,0.00012629644,0.000065911576,0.00039865926,0.0016689412,0.0028427246],"category_scores_gemma":[0.000008210502,0.00038469498,0.00032234564,0.00012984421,0.00016658539,0.000055029224,0.00014719012,0.0017707049,0.009712563],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007915276,0.00008436136,0.0000063995662,0.00015359468,0.00064955815,0.00006820909,0.00020013514,2.1964264e-7,0.15934466,0.000013123896,0.8390489,0.00042288995],"study_design_scores_gemma":[0.0009865069,0.00008702367,0.00007071003,0.00012312991,0.00047930636,0.00018409823,0.000014985961,0.0000039107226,0.15075944,0.0000901931,0.8468445,0.00035621],"about_ca_topic_score_codex":0.000047183454,"about_ca_topic_score_gemma":0.0000037785235,"teacher_disagreement_score":0.16564065,"about_ca_system_score_codex":0.000037645135,"about_ca_system_score_gemma":0.000096355594,"threshold_uncertainty_score":0.9998605},"labels":[],"label_agreement":null},{"id":"W4401413268","doi":"10.1182/blood.2024025802","title":"Proposals for revised International Working Group–European LeukemiaNet criteria for anemia response in myelofibrosis","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont; McGill University; Jewish General Hospital; Princess Margaret Cancer Centre","funders":"Daiichi Sankyo Europe; National Cancer Institute; Genentech; National Institutes of Health; AOP Orphan; Swedish Orphan Biovitrum; Servier; Astellas Pharma; Galecto; Sierra Oncology; Incyte; CTI Biopharma; Astex Pharmaceuticals; Jazz Pharmaceuticals; Celgene; Amgen; Ariad Pharmaceuticals; Gilead Sciences; Bristol-Myers Squibb; American Society of Clinical Oncology; Pfizer; Constellation Pharmaceuticals; Agios Pharmaceuticals","keywords":"Medicine; Myelofibrosis; Anemia; Internal medicine; Bone marrow","score_opus":0.0340283563664436,"score_gpt":0.3251509218668734,"score_spread":0.2911225655004298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401413268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887252,0.0011455263,0.00054759905,0.0040754266,0.00050532044,0.0023553462,0.0001572307,0.00010963301,0.0023787345],"genre_scores_gemma":[0.98489815,0.00011322699,0.012111687,0.00038118492,0.0005962615,0.000783572,0.00024386421,0.000058274443,0.0008137815],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987219,0.000107511354,0.0003481841,0.00042050882,0.00015545754,0.00024641235],"domain_scores_gemma":[0.9990899,0.000539762,0.000044066444,0.00017581528,0.000065143926,0.000085296044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007323386,0.00018305113,0.00027249186,0.00018843627,0.000054099335,0.00011934777,0.0000886693,0.000061884486,0.00014506972],"category_scores_gemma":[0.0003330226,0.00014899498,0.0001403225,0.0001361039,0.000025619587,0.00007080836,0.00003312437,0.000094101786,0.000035116624],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0469308,0.008158671,0.26197368,0.0068753213,0.0030558133,0.0036209112,0.0068256143,0.000020667207,0.41064364,0.01402195,0.06693545,0.17093746],"study_design_scores_gemma":[0.046187084,0.008343312,0.34464732,0.011367051,0.0016889727,0.0005408047,0.0002734739,0.0031352504,0.1009587,0.0008855147,0.48075792,0.0012145938],"about_ca_topic_score_codex":0.00000648276,"about_ca_topic_score_gemma":0.000011584405,"teacher_disagreement_score":0.41382247,"about_ca_system_score_codex":0.00014371851,"about_ca_system_score_gemma":0.00011060747,"threshold_uncertainty_score":0.6075839},"labels":[],"label_agreement":null},{"id":"W4401504076","doi":"10.1182/blood.2024024944","title":"Genetic risk stratification and outcomes among treatment-naive patients with AML treated with venetoclax and azacitidine","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Venetoclax; Azacitidine; Medicine; Internal medicine; Oncology; Myeloid leukemia; Placebo; Leukemia; Pathology; Biology; Genetics","score_opus":0.00841584144224182,"score_gpt":0.24473667503364538,"score_spread":0.23632083359140355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401504076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981282,0.00050087256,0.000025554044,0.000070287126,0.000007213174,0.0008212608,0.00006181085,0.00007974919,0.0003050684],"genre_scores_gemma":[0.99801505,0.00029166893,0.00085174816,0.000011840277,0.000034700686,0.00008452024,0.00009465009,0.000036682937,0.00057914044],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905044,0.000037562462,0.00013544905,0.0003637925,0.00020954094,0.00020323355],"domain_scores_gemma":[0.99943584,0.0000754352,0.000039763974,0.00021988236,0.00007226801,0.00015681393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000041337647,0.00018674154,0.00023286509,0.00011890311,0.000071962335,0.00006538776,0.000029734581,0.00006162718,0.000018562705],"category_scores_gemma":[0.000017704935,0.00010740554,0.000019697938,0.00018627805,0.00015769777,0.000081862614,0.000014204162,0.00012662551,0.000007309117],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001561477,0.00015364596,0.9914273,0.00006253629,0.00052917574,0.00012751904,0.00027514488,0.0000025446786,0.00021789488,0.000011668804,0.000021825259,0.007014616],"study_design_scores_gemma":[0.006566718,0.002500228,0.98745537,0.000104882136,0.0009102036,0.00004095878,0.00007545609,0.00045281264,0.0016852819,0.000012431298,0.00007394388,0.000121711404],"about_ca_topic_score_codex":0.0005206454,"about_ca_topic_score_gemma":0.00012652526,"teacher_disagreement_score":0.0068929046,"about_ca_system_score_codex":0.00013735182,"about_ca_system_score_gemma":0.0001553266,"threshold_uncertainty_score":0.4379871},"labels":[],"label_agreement":null},{"id":"W4401504256","doi":"10.1182/blood.2024025603","title":"Unbalanced <i>MYC</i> break-apart FISH patterns indicate the presence of a <i>MYC</i> rearrangement in HGBCL-DH-<i>BCL2</i>","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Simon Fraser University; BC Cancer Agency; Spinal Cord Injury BC; University of British Columbia","funders":"National Cancer Institute","keywords":"Biology; Gene rearrangement; Fluorescence in situ hybridization; Context (archaeology); Fish <Actinopterygii>; Immunohistochemistry; Lymphoma; Gene; Molecular biology; Chromosome; Cancer research; Genetics; Immunology","score_opus":0.011007390692018592,"score_gpt":0.24916259809207478,"score_spread":0.2381552074000562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401504256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861848,0.0020278865,0.0000067641668,0.0054531875,0.0002703908,0.000880493,0.00018305799,0.000095691445,0.0048977616],"genre_scores_gemma":[0.9958697,0.0015502,0.00008691408,0.0015733504,0.00016561091,0.00033136565,0.000062745545,0.00003337806,0.000326721],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819905,0.00006340371,0.00044493296,0.00045104124,0.00046385813,0.00037774636],"domain_scores_gemma":[0.99889755,0.00022323671,0.000090231995,0.0006192529,0.00004758455,0.00012211187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029011795,0.00023853511,0.00039021412,0.00011125481,0.000049017195,0.000049893995,0.00021883335,0.000113897106,0.000110128574],"category_scores_gemma":[0.000050421335,0.00015293948,0.00016847925,0.00042658029,0.000100481666,0.00008025493,0.0001085708,0.00025917098,0.00005838467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018877727,0.0058744336,0.92947453,0.00078897725,0.0008916884,0.0014233898,0.0027234282,0.0000075557186,0.023786107,0.0006430165,0.019797288,0.014400778],"study_design_scores_gemma":[0.017359117,0.001124551,0.6109979,0.0032762748,0.0017521182,0.0006240667,0.00046324963,0.00017932706,0.23622853,0.00028369034,0.12710033,0.00061080826],"about_ca_topic_score_codex":0.0005325997,"about_ca_topic_score_gemma":0.00044250293,"teacher_disagreement_score":0.31847662,"about_ca_system_score_codex":0.00005163232,"about_ca_system_score_gemma":0.00014578167,"threshold_uncertainty_score":0.6236691},"labels":[],"label_agreement":null},{"id":"W4401610295","doi":"10.1182/blood.2024025269","title":"Role and timing of chromosome deletions in multiple myeloma","year":2024,"lang":"en","type":"letter","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Multiple myeloma; Chromosome abnormality; Genetics; Biology; Lenalidomide; Chromosome; Medicine; Karyotype; Immunology; Gene","score_opus":0.030481328256618447,"score_gpt":0.2861796986766263,"score_spread":0.25569837042000787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401610295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86846703,0.00842268,0.0000025564286,0.11730158,0.00009704244,0.0011906262,0.0003692041,0.00008633113,0.0040629352],"genre_scores_gemma":[0.96921283,0.0004702462,0.001521102,0.022256035,0.0013588946,0.00022375345,0.0010006796,0.00012262759,0.003833818],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99869865,0.000037931317,0.00026374325,0.00034557012,0.00031705236,0.00033704846],"domain_scores_gemma":[0.9993888,0.00014728874,0.000048043432,0.0002837753,0.000045071753,0.00008700771],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006935955,0.00020186194,0.00043483265,0.00037493484,0.000028197263,0.000017484283,0.00007091623,0.0003321363,0.00011450566],"category_scores_gemma":[0.00011507029,0.00016936842,0.00009735998,0.00018560556,0.000081083555,0.00002973935,0.00008769865,0.00084336416,0.00007732565],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036434704,0.00410267,0.33535677,0.01473207,0.005265892,0.05136047,0.001862772,0.0000018066131,0.053751856,0.000030196446,0.49290836,0.0402628],"study_design_scores_gemma":[0.0376479,0.002248697,0.32725927,0.008848954,0.0031750815,0.0028497027,0.00021988917,0.0023990837,0.03110535,0.0006500198,0.58221567,0.0013803575],"about_ca_topic_score_codex":0.00023841439,"about_ca_topic_score_gemma":0.00007136191,"teacher_disagreement_score":0.1007458,"about_ca_system_score_codex":0.000040072817,"about_ca_system_score_gemma":0.00011532211,"threshold_uncertainty_score":0.69066435},"labels":[],"label_agreement":null},{"id":"W4401705615","doi":"10.1182/blood.2023023644","title":"Epigenetic regulation of noncanonical menin targets modulates menin inhibitor response in acute myeloid leukemia","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McMaster University; University of Toronto; University Health Network","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Cancer research; Epigenetics; Myeloid leukemia; Biology; Chromatin; Leukemia; Genetics; Gene","score_opus":0.012328534159373038,"score_gpt":0.28484714494871377,"score_spread":0.27251861078934075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401705615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934673,0.0036772517,0.00013300883,0.0012022442,0.00012793834,0.0006352289,0.000032627595,0.000108965454,0.0006154702],"genre_scores_gemma":[0.99328476,0.00028159784,0.003375807,0.00005299842,0.00021830041,0.000066389795,0.000057342084,0.00006921237,0.0025935648],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99743044,0.0002767337,0.00063701125,0.0005361418,0.00062446215,0.0004952111],"domain_scores_gemma":[0.9987008,0.00041964676,0.000068079324,0.0004930926,0.00011557848,0.00020277793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001147937,0.00023943077,0.0005082361,0.00056508917,0.000038753635,0.00003079248,0.00018150832,0.00027284815,0.00019556763],"category_scores_gemma":[0.0003598624,0.00021378769,0.0001448644,0.000925416,0.00016112364,0.00012420214,0.00014494614,0.0005490269,0.00011192489],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025486427,0.00020586509,0.0014150429,0.00018800754,0.00026196742,0.000650154,0.00066611357,0.00011133828,0.9902457,0.00014535635,0.0011898617,0.0023719403],"study_design_scores_gemma":[0.005613573,0.0012486456,0.078898735,0.0007997782,0.00033808805,0.00028988483,0.0000663981,0.009718333,0.9000218,0.0003796239,0.0023451908,0.00027994197],"about_ca_topic_score_codex":0.00008820627,"about_ca_topic_score_gemma":0.000016614651,"teacher_disagreement_score":0.0902239,"about_ca_system_score_codex":0.0007662307,"about_ca_system_score_gemma":0.0017357634,"threshold_uncertainty_score":0.8718009},"labels":[],"label_agreement":null},{"id":"W4401749349","doi":"10.1182/blood.2023023616","title":"Efficacy and safety of teclistamab in patients with relapsed/refractory multiple myeloma after BCMA-targeting therapies","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Neutropenia; Internal medicine; Adverse effect; Multiple myeloma; Febrile neutropenia; Cytokine release syndrome; Gastroenterology; Refractory (planetary science); Anemia; Toxicity; Oncology; Surgery; Chimeric antigen receptor; Immunotherapy; Cancer","score_opus":0.00809974756133244,"score_gpt":0.24497383491490463,"score_spread":0.23687408735357218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401749349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949444,0.003909386,0.0000055939936,0.00007424271,0.000028258442,0.00062069285,0.00004223705,0.00004510658,0.00033009142],"genre_scores_gemma":[0.99869746,0.00015395548,0.00085156935,0.000017512893,0.0000336737,0.000041957093,0.00005567309,0.000031636842,0.00011655726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886405,0.000047222286,0.00023935827,0.00028332314,0.0003047044,0.00026130857],"domain_scores_gemma":[0.9993931,0.00021004787,0.00003458535,0.00019116503,0.000059486156,0.000111583395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012271601,0.00015519801,0.00025489263,0.00016875353,0.000032079886,0.000019827481,0.000042724067,0.000066114946,0.00006935282],"category_scores_gemma":[0.00013348952,0.0001033714,0.00003974093,0.00019182875,0.000090542366,0.00009679887,0.000041480722,0.0002012225,0.000011711454],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004462829,0.0015288604,0.97114104,0.00027591517,0.00032926325,0.00023614803,0.0008049144,3.966404e-7,0.0007319778,0.000007689204,0.000015794722,0.020465184],"study_design_scores_gemma":[0.021962957,0.00092564255,0.97433674,0.0005735082,0.00008377354,0.000004656575,0.00006803353,0.00003333114,0.0010257511,0.0000066297694,0.0008790258,0.00009994874],"about_ca_topic_score_codex":0.00005572859,"about_ca_topic_score_gemma":0.000028550645,"teacher_disagreement_score":0.020365234,"about_ca_system_score_codex":0.000034125427,"about_ca_system_score_gemma":0.00006304639,"threshold_uncertainty_score":0.42153633},"labels":[],"label_agreement":null},{"id":"W4401755999","doi":"10.1182/blood.2024025049","title":"AML, myelodysplasia related, with STAG2 and SRSF2 comutations with myelocyte arrest","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Royal Jubilee Hospital","funders":"","keywords":"Cancer research; Preleukemia; Medicine; Leukemia; Internal medicine","score_opus":0.00864202056460471,"score_gpt":0.2570714231849809,"score_spread":0.24842940262037616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401755999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793369,0.0015686927,0.00015569836,0.0033792006,0.00005558224,0.0005740505,0.000027835347,0.0002972352,0.014604784],"genre_scores_gemma":[0.9905148,0.00024582574,0.0029610805,0.00014548797,0.00012545889,0.00006146032,0.00006683877,0.000078429206,0.0058005787],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985608,0.000037517584,0.00018908028,0.0004284088,0.00041897356,0.00036524792],"domain_scores_gemma":[0.9991078,0.0001541895,0.000030469504,0.0003387957,0.000104733444,0.0002640587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016816781,0.0002034833,0.00025522074,0.00021430413,0.00012270958,0.00010081023,0.000084889405,0.000104406885,0.00013563578],"category_scores_gemma":[0.000039311893,0.00013469123,0.00003050499,0.0006143468,0.00028301103,0.00015202376,0.000048773738,0.0006056768,0.00016686204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010491787,0.0067973263,0.40728304,0.014394323,0.027774312,0.14774726,0.03674737,0.0007047606,0.11621361,0.08590725,0.06996728,0.07597168],"study_design_scores_gemma":[0.10822884,0.023363264,0.36749414,0.013031188,0.013677067,0.07191767,0.010827386,0.019113453,0.07071178,0.0021932798,0.29477835,0.004663585],"about_ca_topic_score_codex":0.000066401866,"about_ca_topic_score_gemma":0.00007318489,"teacher_disagreement_score":0.22481108,"about_ca_system_score_codex":0.00008225467,"about_ca_system_score_gemma":0.0006337408,"threshold_uncertainty_score":0.5492549},"labels":[],"label_agreement":null},{"id":"W4401908914","doi":"10.1182/blood.2024024405","title":"Genetic engineering of transfusable platelets with mRNA-lipid nanoparticles is compatible with blood banking practices","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; iCo Therapeutics (Canada); University of British Columbia","funders":"","keywords":"Platelet; Hemostasis; Transfection; Platelet activation; Medicine; Messenger RNA; Immunology; Platelet transfusion; Chemistry; Internal medicine; Biochemistry; Gene","score_opus":0.009386797886174142,"score_gpt":0.22014268535343806,"score_spread":0.21075588746726392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401908914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996304,0.0026498083,0.00043113867,0.000056030498,0.000048811944,0.00012101708,0.000014899512,0.00002665829,0.00034766816],"genre_scores_gemma":[0.9969547,0.0003170356,0.0024173653,0.000041538955,0.00011591002,0.000017264578,0.000010149756,0.000029991415,0.00009609051],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99913394,0.000015182077,0.00017308179,0.00031440583,0.00014278461,0.00022057505],"domain_scores_gemma":[0.9995638,0.000018384215,0.000077212404,0.00022941176,0.000060632465,0.000050533836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000065378226,0.00015940078,0.00015421073,0.000051697505,0.00003425873,0.000054647673,0.00013709882,0.00006875747,0.000043632994],"category_scores_gemma":[0.000009075142,0.00012276745,0.000045648925,0.000139778,0.00003889995,0.000013817611,0.00002328899,0.000084764215,0.0000071167015],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008045997,0.00018321189,0.006788248,0.00018148277,0.0004993711,0.000058772162,0.00021729899,0.0009646961,0.99056196,0.000016641217,0.000077883524,0.00036998623],"study_design_scores_gemma":[0.00077661127,0.0012353358,0.0011099965,0.00021204885,0.00029727747,0.00022173044,0.00006383039,0.000443991,0.99375474,0.0000046765203,0.0016847688,0.00019496531],"about_ca_topic_score_codex":0.000052438743,"about_ca_topic_score_gemma":0.000049446862,"teacher_disagreement_score":0.0056782514,"about_ca_system_score_codex":0.0000023100386,"about_ca_system_score_gemma":0.000076422715,"threshold_uncertainty_score":0.50063115},"labels":[],"label_agreement":null},{"id":"W4401942365","doi":"10.1182/blood.2024024582","title":"Ide-cel vs standard regimens in triple-class–exposed relapsed and refractory multiple myeloma: updated KarMMa-3 analyses","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Calgary","funders":"Pharmacyclics; Chugai Pharmaceutical; BeiGene; Regeneron Pharmaceuticals; American Society of Clinical Oncology; Bristol-Myers Squibb; AstraZeneca; National Cancer Research Institute; Gilead Sciences; Sanofi; Celgene; Amgen; Pfizer; GlaxoSmithKline","keywords":"Medicine; Hazard ratio; Internal medicine; Clinical endpoint; Progression-free survival; Confidence interval; Interim analysis; Multiple myeloma; Lenalidomide; Refractory (planetary science); Gastroenterology; Tolerability; Surgery; Randomized controlled trial; Adverse effect; Overall survival","score_opus":0.041943455543660677,"score_gpt":0.33497596063706037,"score_spread":0.2930325050933997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401942365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902637,0.0051809414,0.000022082819,0.0008055049,0.0001396628,0.0008517615,0.00015514418,0.00025040147,0.002330777],"genre_scores_gemma":[0.9951707,0.0005172903,0.0009660068,0.000095260686,0.000115011324,0.00007319721,0.00031452908,0.000065073524,0.0026829108],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974685,0.00015963565,0.00048139875,0.0006843258,0.0006047097,0.00060144404],"domain_scores_gemma":[0.9985826,0.0003295021,0.00006391661,0.0005023582,0.000109815075,0.0004118225],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036612395,0.00032303977,0.0006090975,0.00059872435,0.000098125,0.000097372795,0.000110133915,0.00019757403,0.0002199675],"category_scores_gemma":[0.00054120587,0.00025648065,0.00014409839,0.0007119494,0.00013058893,0.00019359584,0.00008816187,0.000511412,0.00010270496],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011580863,0.005313729,0.44615307,0.0011848573,0.004660109,0.025050078,0.0018684183,0.0000053451486,0.46223244,0.00024412453,0.01986975,0.021837195],"study_design_scores_gemma":[0.122939184,0.006444091,0.54989743,0.0017850391,0.0021262104,0.0006739582,0.00084436237,0.004215505,0.25156677,0.00030847106,0.057943363,0.0012556171],"about_ca_topic_score_codex":0.00020981557,"about_ca_topic_score_gemma":0.0002539459,"teacher_disagreement_score":0.21066567,"about_ca_system_score_codex":0.00017368101,"about_ca_system_score_gemma":0.0003248295,"threshold_uncertainty_score":0.99998873},"labels":[],"label_agreement":null},{"id":"W4401994938","doi":"10.1182/blood.2024025248","title":"Circulating composite B- and T-cell lymphoma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Lymphoma; Medicine; Cancer research; Internal medicine; Immunology","score_opus":0.009958353825372837,"score_gpt":0.23855696701245074,"score_spread":0.22859861318707791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401994938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9736932,0.011261849,0.000004885512,0.0002979873,0.00006266626,0.00010854944,0.000003969348,0.000092389586,0.014474534],"genre_scores_gemma":[0.99877703,0.0001317615,0.00051436655,0.00016306588,0.00009442331,0.00001316952,0.0000104168,0.000012344835,0.00028341467],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999556,0.0000066228404,0.00008444224,0.00016363924,0.0000847805,0.000104491985],"domain_scores_gemma":[0.9997649,0.000044610006,0.00000921431,0.00009704542,0.000009927568,0.000074258845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000030717125,0.00007548539,0.00010983309,0.00003701075,0.00003628321,0.000041874857,0.0000137761635,0.00003061845,0.00002131065],"category_scores_gemma":[0.0000037905088,0.00005761067,0.00004391216,0.00006603289,0.00001574376,0.00002676933,0.000019408166,0.000018873243,0.000065871856],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003666398,0.0063122506,0.691009,0.0012928125,0.00096454896,0.011993138,0.0013189261,0.0000013735344,0.09140411,0.0027521518,0.0016091154,0.1913059],"study_design_scores_gemma":[0.022623384,0.0006427189,0.78453,0.0012320644,0.0023323242,0.005284646,0.00012132824,0.0011327695,0.16414918,0.00034057762,0.01722902,0.0003820041],"about_ca_topic_score_codex":0.000029666611,"about_ca_topic_score_gemma":7.56568e-7,"teacher_disagreement_score":0.1909239,"about_ca_system_score_codex":0.000022282851,"about_ca_system_score_gemma":0.000032746084,"threshold_uncertainty_score":0.23492949},"labels":[],"label_agreement":null},{"id":"W4402184323","doi":"10.1182/blood.2024025679","title":"Clinical features, pathophysiology, and management of acute myelopathy following CAR T-cell therapy","year":2024,"lang":"en","type":"review","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Royal College of Physicians and Surgeons of Canada","keywords":"Cytokine release syndrome; Medicine; Chimeric antigen receptor; Myelopathy; Cell therapy; Pathophysiology; Immunology; Immunotherapy; Intensive care medicine; Myelitis; Immune system; Internal medicine; Cell; Spinal cord; Biology","score_opus":0.055000010301930566,"score_gpt":0.40441695368018465,"score_spread":0.3494169433782541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402184323","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016171543,0.99253947,6.492806e-7,0.000036190915,0.0004509186,0.001880623,0.000060494745,0.00005638305,0.0033581033],"genre_scores_gemma":[0.00002228161,0.9875396,0.000514651,0.00007468288,0.00040739187,0.00014082686,0.00013766704,0.00012576098,0.011037136],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973928,0.00027908766,0.00078310265,0.00076178985,0.00040460678,0.00037863688],"domain_scores_gemma":[0.99865305,0.00015609563,0.00017033792,0.00080085074,0.00003925652,0.0001803917],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00075028144,0.00046054774,0.0024565354,0.00022155489,0.00003629668,0.000023735074,0.00026896189,0.00051386945,0.000087786684],"category_scores_gemma":[0.000008290138,0.00031064037,0.0014959406,0.000366357,0.00013009047,0.000018741412,0.00029097826,0.0010261793,0.000050449664],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006684783,0.0005229602,0.000024601793,0.026838897,0.007396496,0.0023942438,0.000038217964,2.2232836e-9,0.00029587973,0.000026327672,0.0011190563,0.9612765],"study_design_scores_gemma":[0.003219454,0.0009538428,0.00008418396,0.013592381,0.016194388,0.00014306381,0.000016811795,2.1392555e-7,0.000045452172,0.000071190785,0.96537775,0.00030126347],"about_ca_topic_score_codex":0.000008309594,"about_ca_topic_score_gemma":4.6314804e-7,"teacher_disagreement_score":0.9642587,"about_ca_system_score_codex":0.000032473617,"about_ca_system_score_gemma":0.00020322835,"threshold_uncertainty_score":0.99993455},"labels":[],"label_agreement":null},{"id":"W4402184450","doi":"10.1182/blood.2023022596","title":"Whole-genome analysis of plasma fibrinogen reveals population-differentiated genetic regulators with putative liver roles","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Global Health Research","funders":"Common Fund; National Institute on Minority Health and Health Disparities; NIH Office of the Director; National Institute of Mental Health; National Heart, Lung, and Blood Institute; Université de Bordeaux; Novo Nordisk; Office of Research and Development; Instituto de Salud Carlos III; U.S. Department of Veterans Affairs; National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Biology; Genetics; Population; Genome; Genome-wide association study; Fibrinogen; Computational biology; Medicine; Gene; Single-nucleotide polymorphism; Genotype; Biochemistry","score_opus":0.007831885142606352,"score_gpt":0.23190330298663084,"score_spread":0.22407141784402448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402184450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964352,0.0019607868,0.0010183138,0.000044092558,0.000028796916,0.0001349174,0.00025081538,0.000017553986,0.00010951708],"genre_scores_gemma":[0.9956276,0.00011329788,0.0022689998,0.000022173142,0.00006491893,0.000017201306,0.0013899789,0.000021518872,0.00047434916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998851,0.00011862287,0.0003242086,0.0003809643,0.00011618776,0.00020901814],"domain_scores_gemma":[0.9994095,0.000037326503,0.00013370493,0.0002675186,0.000090635775,0.00006130145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001306767,0.00015668507,0.00032058472,0.00018657274,0.00004983502,0.000017703438,0.000115218936,0.00015292573,0.000034321067],"category_scores_gemma":[0.000044858298,0.00013053104,0.00016990551,0.00047004313,0.000053583877,0.0000029118482,0.000054544536,0.00005384955,0.00000738504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037353842,0.00015587002,0.5806383,0.000059762384,0.007857464,0.000012548514,0.0002680717,0.011818253,0.39815345,0.0000986876,0.000120105906,0.00078015774],"study_design_scores_gemma":[0.00033523366,0.00021880785,0.98684645,0.000015253401,0.0020679936,0.000009063914,0.00004993779,0.0020460014,0.007848644,0.00009538135,0.00028882708,0.00017841307],"about_ca_topic_score_codex":0.00007145079,"about_ca_topic_score_gemma":0.00013835312,"teacher_disagreement_score":0.4062082,"about_ca_system_score_codex":0.000010929726,"about_ca_system_score_gemma":0.000038288403,"threshold_uncertainty_score":0.53229016},"labels":[],"label_agreement":null},{"id":"W4402794913","doi":"10.1182/blood.2024024300","title":"Focal deletions of a promoter tether activate the <i>IRX3</i> oncogene in T-cell acute lymphoblastic leukemia","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Narodowe Centrum Badań i Rozwoju; Medical Research Council; Blood Cancer UK; European Commission; Cancer Research UK; Leukaemia UK; Hospital for Sick Children; Wellcome Trust; Francis Crick Institute; Cancer Prevention and Research Institute of Texas","keywords":"Enhancer; Biology; Gene; CTCF; Oncogene; Promoter; Genetics; Gene expression","score_opus":0.006790374087163123,"score_gpt":0.234018580500722,"score_spread":0.22722820641355887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402794913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943871,0.0016976489,0.0012135406,0.00022856922,0.00006672379,0.0001497799,0.000032186577,0.000008560634,0.002215902],"genre_scores_gemma":[0.9980229,0.00028113992,0.00017819215,0.00009188233,0.00009519998,0.00007357742,0.00002076568,0.000017663773,0.0012186862],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994298,0.000030833584,0.00013919857,0.00019943222,0.00007097299,0.00012972859],"domain_scores_gemma":[0.99964935,0.000011616983,0.000027148075,0.00026141803,0.000026341955,0.000024144018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000083147126,0.000084833635,0.00007658348,0.000028681132,0.000030127974,0.000017515995,0.00013843951,0.000077530516,0.000020484387],"category_scores_gemma":[0.000007342522,0.00005885948,0.00006711342,0.00013214897,0.000055806242,0.0000026357136,0.000042985994,0.00006652864,0.000012299507],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014862063,0.00012041776,0.00012702469,0.000019215855,0.00007013682,0.000004466133,0.000063529995,0.00004878231,0.99668634,0.00008292263,0.0005701556,0.0021921184],"study_design_scores_gemma":[0.0006223296,0.00012742236,0.0005448899,0.000031272826,0.00009140459,0.000022263568,0.0000304231,0.00019415421,0.96922946,0.000096953314,0.0289065,0.00010294976],"about_ca_topic_score_codex":0.000026267418,"about_ca_topic_score_gemma":0.000026419559,"teacher_disagreement_score":0.028336344,"about_ca_system_score_codex":0.000019422325,"about_ca_system_score_gemma":0.00019933755,"threshold_uncertainty_score":0.240022},"labels":[],"label_agreement":null},{"id":"W4402824750","doi":"10.1182/blood.2024026212","title":"Impact of soluble BCMA and non–T-cell factors on refractoriness to BCMA-targeting T-cell engagers in multiple myeloma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research; Leukemia and Lymphoma Society; Multiple Myeloma Research Foundation","keywords":"Chimeric antigen receptor; Medicine; Multiple myeloma; Antigen; Cytotoxic T cell; Immunology; T cell; Internal medicine; Cancer research; Oncology; Biology; In vitro; Immune system","score_opus":0.026364824498237616,"score_gpt":0.3097894521498539,"score_spread":0.2834246276516163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402824750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969079,0.0005549715,0.000008038863,0.00005181728,0.00012123692,0.0006684538,0.00004601264,0.00005649885,0.0015851007],"genre_scores_gemma":[0.99866414,0.00009256453,0.000370099,0.000012861134,0.00008684559,0.000033134016,0.000059461938,0.00005137869,0.00062951935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829894,0.00006644644,0.00030922735,0.00044605028,0.00036230293,0.0005170148],"domain_scores_gemma":[0.99875826,0.00045189328,0.000045731562,0.0002853929,0.00006234085,0.0003963675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002611448,0.0002640764,0.00040437625,0.00041413167,0.00007266249,0.000041485375,0.00009435303,0.00010693846,0.000087971675],"category_scores_gemma":[0.00033370024,0.00019357628,0.00014473786,0.00043178807,0.000034465866,0.00009865375,0.00007867791,0.00038087668,0.00006121232],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035775718,0.0015245286,0.8014616,0.00048167064,0.0001482564,0.00044231027,0.0015576788,0.00002153664,0.19224076,7.36277e-7,0.00022621617,0.0015369748],"study_design_scores_gemma":[0.007965202,0.0018527593,0.6776281,0.0003713935,0.00009061594,0.0000087745475,0.0003424909,0.0006044429,0.31050414,0.0000046401774,0.00039680264,0.00023066024],"about_ca_topic_score_codex":0.0013662683,"about_ca_topic_score_gemma":0.00004282761,"teacher_disagreement_score":0.123833485,"about_ca_system_score_codex":0.00011994843,"about_ca_system_score_gemma":0.00016369227,"threshold_uncertainty_score":0.7893812},"labels":[],"label_agreement":null},{"id":"W4403097441","doi":"10.1182/blood.2024025262","title":"A rare glimpse of Fessas bodies in a patient with β-thalassemia major postsplenectomy","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Abdominal Trauma and Injuries","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fraser Health; University of British Columbia","funders":"","keywords":"Thalassemia; Medicine; Splenectomy; Pediatrics; Internal medicine; Spleen","score_opus":0.00804402539443886,"score_gpt":0.2532841634642161,"score_spread":0.24524013806977726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403097441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900363,0.0030878922,0.000002465864,0.00039590674,0.00004690487,0.00024077686,0.000018406674,0.000048408307,0.0061229314],"genre_scores_gemma":[0.9989019,0.000036892223,0.0005557674,0.000062440595,0.000036056277,0.00003270221,0.000009046471,0.00001951733,0.0003456456],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992739,0.000016633392,0.00019774365,0.00017234556,0.00018052361,0.00015887099],"domain_scores_gemma":[0.9996633,0.00005238293,0.000029580278,0.00015552652,0.00004679008,0.00005243113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000051050134,0.00011432289,0.00025236476,0.00013247602,0.000015289452,0.00001107526,0.00003900928,0.00004926198,0.000075798125],"category_scores_gemma":[0.00003229483,0.00007729403,0.000053256506,0.0001652953,0.000064212785,0.00007030601,0.00002283329,0.00013305606,0.000013733033],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007088225,0.007028946,0.7186652,0.010448882,0.0020234392,0.0264721,0.047716405,0.000004181137,0.13800098,0.0052922913,0.0081111835,0.029148176],"study_design_scores_gemma":[0.014406242,0.013144836,0.25804493,0.010559463,0.0019204789,0.003727784,0.008925988,0.00008196425,0.6785155,0.00063080806,0.009281955,0.000760072],"about_ca_topic_score_codex":0.000059960646,"about_ca_topic_score_gemma":0.00006901902,"teacher_disagreement_score":0.5405145,"about_ca_system_score_codex":0.000019013321,"about_ca_system_score_gemma":0.00011095158,"threshold_uncertainty_score":0.31519592},"labels":[],"label_agreement":null},{"id":"W4403629204","doi":"10.1182/blood.2024025415","title":"Comparison of progression risk of monoclonal gammopathy of undetermined significance by method of detection","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Cancer Institute","keywords":"Monoclonal gammopathy of undetermined significance; Medicine; Internal medicine; Asymptomatic; Cumulative incidence; Cohort; Incidence (geometry); Population; Gastroenterology; Oncology; Immunology; Monoclonal; Antibody; Monoclonal antibody","score_opus":0.0332881193770181,"score_gpt":0.400594317533617,"score_spread":0.36730619815659893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403629204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928395,0.0024704621,0.0038972108,0.000012584409,0.00003421036,0.00040902576,0.00013448465,0.000015937374,0.00018658361],"genre_scores_gemma":[0.9885578,0.00008220558,0.011239353,5.379116e-7,0.000017004886,0.000023041825,0.000019819652,0.000012036121,0.000048198322],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988011,0.00011729561,0.00041285474,0.00016842569,0.00037676186,0.00012355375],"domain_scores_gemma":[0.9991613,0.00022482206,0.00023247213,0.00019019947,0.00012274597,0.000068468966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026508133,0.00009161828,0.00041535683,0.00012452222,0.000012845031,0.0000021147164,0.00005740568,0.00006374921,0.000025204678],"category_scores_gemma":[0.00015082874,0.00006815944,0.00011684824,0.00022887526,0.00008279404,0.000029818859,0.000024647312,0.00011219092,0.0000012085301],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057730684,0.0015680579,0.1398849,0.00093205046,0.00035264948,0.000009493535,0.00019400568,0.0000034644004,0.7493066,0.0000070520714,0.000025093774,0.107139304],"study_design_scores_gemma":[0.0022132604,0.0019172691,0.03674325,0.0004058392,0.00036522752,0.000008025782,0.00006384484,0.0047701765,0.95339257,0.000047116715,0.00003283003,0.000040583163],"about_ca_topic_score_codex":0.00023628645,"about_ca_topic_score_gemma":0.000011697093,"teacher_disagreement_score":0.20408596,"about_ca_system_score_codex":0.00001532515,"about_ca_system_score_gemma":0.00008300459,"threshold_uncertainty_score":0.2779461},"labels":[],"label_agreement":null},{"id":"W4403630043","doi":"10.1182/blood.2024024769","title":"Ascorbate deficiency increases quiescence and self-renewal in hematopoietic stem cells and multipotent progenitors","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Vitamin C and Antioxidants Research","field":"Nursing","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation; National Institutes of Health; University of Texas Southwestern Medical Center; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Damon Runyon Cancer Research Foundation","keywords":"Haematopoiesis; Stem cell; Progenitor cell; Biology; Cell biology; Transplantation; Hematopoietic stem cell; Cancer research; Immunology; Internal medicine; Medicine","score_opus":0.01156987136543873,"score_gpt":0.25438048902545474,"score_spread":0.242810617660016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403630043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99053854,0.008676715,0.000005638015,0.00010214742,0.00014083004,0.00030282958,0.00000971465,0.00010874201,0.00011484077],"genre_scores_gemma":[0.99919224,0.00038481582,0.00022649864,0.000013086905,0.00005012684,0.000019691262,7.5403426e-7,0.00001994254,0.00009286032],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99882555,0.00007759749,0.0001860645,0.00035843064,0.00022745536,0.00032491097],"domain_scores_gemma":[0.99961245,0.00012118325,0.000019153409,0.000121526326,0.000020777383,0.000104932704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002161592,0.00013657416,0.00015167372,0.00014354159,0.00008733327,0.00016924864,0.00008866838,0.00006230861,0.00000510199],"category_scores_gemma":[0.00001635454,0.00011570377,0.000028985924,0.0002529146,0.000088508095,0.00012360986,0.000088944515,0.0001485817,0.000017930903],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001394183,0.005488539,0.42396173,0.0073472955,0.00014371918,0.001559063,0.011425777,0.0000106772395,0.46631327,0.000655672,0.00020287881,0.082751945],"study_design_scores_gemma":[0.005029945,0.0012851461,0.057288866,0.0034823709,0.00038097508,0.0010811852,0.0040189247,0.004385607,0.9201954,0.0007209764,0.0009034391,0.0012271785],"about_ca_topic_score_codex":0.00018346019,"about_ca_topic_score_gemma":0.000039486193,"teacher_disagreement_score":0.4538821,"about_ca_system_score_codex":0.000019468633,"about_ca_system_score_gemma":0.000034388177,"threshold_uncertainty_score":0.4718263},"labels":[],"label_agreement":null},{"id":"W4403674819","doi":"10.1182/blood.2024025725","title":"CNS relapse in high-grade B-cell lymphoma with <i>MYC</i> and <i>BCL2</i> rearrangements and dark-zone signature–expressing DLBCL","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Germinal center; International Prognostic Index; Oncology; Population; Pathology; Internal medicine; Medicine; Biology; B cell; Immunology; Antibody","score_opus":0.006934219425772003,"score_gpt":0.21849927728654864,"score_spread":0.21156505786077665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403674819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9700804,0.02631415,0.00001050087,0.0008085539,0.00009249016,0.00044226524,0.000031452248,0.00009936055,0.002120843],"genre_scores_gemma":[0.99580634,0.0016572879,0.001408067,0.00037591744,0.00009459058,0.00007166949,0.000043669275,0.000055811444,0.00048662702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861217,0.00003529787,0.00022814456,0.0005407565,0.00026973113,0.0003139241],"domain_scores_gemma":[0.99938536,0.00010351393,0.00004267394,0.00026255587,0.00002137629,0.00018449542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011953002,0.0002655312,0.000357037,0.00016031074,0.000074530995,0.00011580212,0.000047690497,0.00012558063,0.000012346411],"category_scores_gemma":[0.000010334323,0.00019689056,0.00004328978,0.00026031028,0.00008947266,0.00013140435,0.00006790973,0.00013301223,0.000010852899],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012518428,0.03293899,0.6320619,0.0030722779,0.0020243016,0.024280174,0.0048607923,0.0000054519664,0.12821329,0.0015198748,0.016178314,0.15359282],"study_design_scores_gemma":[0.16674075,0.0038249819,0.597188,0.008744995,0.005155562,0.003643529,0.00083060766,0.00022332615,0.16410467,0.00051986455,0.047373038,0.0016507143],"about_ca_topic_score_codex":0.00026372864,"about_ca_topic_score_gemma":0.00008445117,"teacher_disagreement_score":0.1654889,"about_ca_system_score_codex":0.000060441285,"about_ca_system_score_gemma":0.000080363316,"threshold_uncertainty_score":0.8028964},"labels":[],"label_agreement":null},{"id":"W4403709325","doi":"10.1182/blood.2024025454","title":"Long-term 3-year follow-up of mosunetuzumab in relapsed or refractory follicular lymphoma after ≥2 prior therapies","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Spinal Cord Injury BC; Jewish General Hospital; BC Cancer Agency","funders":"Daiichi Sankyo Europe; Janssen Research and Development; Royal Adelaide Hospital; BeiGene; Incyte; F. Hoffmann-La Roche; Pharmacyclics; Genentech; MEI Pharma; Teva Pharmaceutical Industries; Kite Pharma; Gilead Sciences; TG Therapeutics; Amgen; Pfizer; MorphoSys; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; Follicular lymphoma; Confidence interval; Refractory (planetary science); Gastroenterology; Adverse effect; Cytokine release syndrome; Surgery; Lymphoma; Immunotherapy; Cancer","score_opus":0.01866792604861877,"score_gpt":0.2919711297431507,"score_spread":0.2733032036945319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403709325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98649627,0.010652905,0.0000057433595,0.0002311476,0.0002447455,0.0006967423,0.000013663423,0.000100497426,0.0015582975],"genre_scores_gemma":[0.9777855,0.0009375326,0.00018981667,0.00008793171,0.00019980856,0.000120274024,0.000015328686,0.00008976229,0.020574043],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980583,0.00010053496,0.00041189833,0.00043107753,0.00059535855,0.00040283898],"domain_scores_gemma":[0.9989505,0.00016709647,0.0000450799,0.00062696624,0.00008310074,0.00012724675],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003702033,0.00022589925,0.00046674735,0.00035447895,0.000024188394,0.00004056824,0.00017150525,0.00020018355,0.004127756],"category_scores_gemma":[0.0000892104,0.00016756683,0.00024854674,0.0005609239,0.00011330005,0.000081578764,0.00007424782,0.00025602558,0.00010438854],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019353274,0.004469026,0.2563124,0.0031282704,0.0029867021,0.013686633,0.010134186,0.0000013027674,0.48482567,0.00015520779,0.00074923167,0.20419809],"study_design_scores_gemma":[0.07187207,0.005141206,0.73994815,0.0040014535,0.0009534694,0.00067515695,0.0005796507,0.00012973994,0.15130964,0.00024960638,0.024196258,0.0009435951],"about_ca_topic_score_codex":0.000071070375,"about_ca_topic_score_gemma":0.0001564537,"teacher_disagreement_score":0.48363575,"about_ca_system_score_codex":0.00013953779,"about_ca_system_score_gemma":0.0004329758,"threshold_uncertainty_score":0.9967826},"labels":[],"label_agreement":null},{"id":"W4404124004","doi":"10.1182/blood.2024026567","title":"Are D+ units safe for D+ patients with anti-D?","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Internal medicine","score_opus":0.012423121455168317,"score_gpt":0.22743729083882747,"score_spread":0.21501416938365914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404124004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972598,0.000402829,0.00018163302,0.00038854408,0.00012963855,0.00043971508,0.000057302746,0.00008535408,0.0010552094],"genre_scores_gemma":[0.99873185,0.000019472038,0.0004270787,0.00018315208,0.0001317596,0.000019955496,0.00006705634,0.0000257902,0.00039389386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99948543,0.000004382073,0.000083143284,0.00016756069,0.00012610128,0.00013337351],"domain_scores_gemma":[0.99967134,0.000028588298,0.000016696953,0.00011861694,0.00010031937,0.0000644242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003359279,0.000083193365,0.00013364576,0.000049385282,0.00004104682,0.000016485657,0.000026967591,0.000045968445,0.00003447963],"category_scores_gemma":[0.000016942693,0.00005504553,0.000033717253,0.00019899271,0.000015571764,0.00003974447,0.0000063081243,0.000077103585,0.000019282634],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003280225,0.0029675947,0.97299725,0.0016714948,0.0006930961,0.00024861738,0.00038359067,0.0000010177395,0.0010253643,0.0014819305,0.003469893,0.014732144],"study_design_scores_gemma":[0.014644691,0.0018367232,0.9113295,0.0013867883,0.0016243969,0.000041386887,0.000082911196,0.000048473925,0.006891859,0.00012670079,0.061730757,0.00025580128],"about_ca_topic_score_codex":0.000005241646,"about_ca_topic_score_gemma":0.000008108765,"teacher_disagreement_score":0.061667725,"about_ca_system_score_codex":0.0000040505797,"about_ca_system_score_gemma":0.00003368994,"threshold_uncertainty_score":0.22446916},"labels":[],"label_agreement":null},{"id":"W4404368680","doi":"10.1182/blood.2024026109","title":"Ferroptosis regulates hemolysis in stored murine and human red blood cells","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"National Institute of General Medical Sciences; National Cancer Institute; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Hemolysis; Biology; Population; Quantitative trait locus; Genetics; Allele; Immunology; Gene; Medicine","score_opus":0.006359626354233516,"score_gpt":0.2294674276000173,"score_spread":0.22310780124578378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404368680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887718,0.0062051807,9.913218e-7,0.0013809504,0.0000932477,0.00024203643,0.000005663324,0.00014770872,0.0031524408],"genre_scores_gemma":[0.9968101,0.00066334876,0.000274782,0.000090940914,0.000075184784,0.000013799227,0.000022016462,0.000036883263,0.0020129592],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989104,0.00002841537,0.00027070128,0.00036071124,0.00016294075,0.00026680293],"domain_scores_gemma":[0.9995484,0.00002768992,0.000025964253,0.00024710761,0.000023406068,0.0001274533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013340922,0.00017139921,0.00030388715,0.00023782454,0.00006212209,0.00003760856,0.00005464952,0.00017383708,0.00014249129],"category_scores_gemma":[0.000020239111,0.00014040442,0.00009058962,0.00041368455,0.00007245677,0.000049045742,0.000050070375,0.00026235488,0.00001952904],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008986097,0.0027350914,0.03781604,0.0013657693,0.0011982355,0.0023975594,0.0021395846,0.00001705147,0.9457864,0.00059281796,0.0021947785,0.003666816],"study_design_scores_gemma":[0.02673301,0.0019440672,0.070779845,0.0031776691,0.0061029005,0.0010436353,0.0018412889,0.0007393515,0.8669158,0.0014522922,0.017980838,0.0012892551],"about_ca_topic_score_codex":0.00015823089,"about_ca_topic_score_gemma":0.000029632814,"teacher_disagreement_score":0.07887054,"about_ca_system_score_codex":0.000015949885,"about_ca_system_score_gemma":0.000035350247,"threshold_uncertainty_score":0.57255256},"labels":[],"label_agreement":null},{"id":"W4404573147","doi":"10.1182/blood.2024025895","title":"Understanding fibrinogen genetics","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Blood properties and coagulation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada)","funders":"","keywords":"Genetics; Medicine; Biology","score_opus":0.12708664853969184,"score_gpt":0.2761266344596678,"score_spread":0.14903998591997594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404573147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9595474,0.011378654,0.001753891,0.001204713,0.00021513179,0.00015888562,0.000002526208,0.00020500876,0.025533784],"genre_scores_gemma":[0.997926,0.0001133027,0.00039702503,0.0001141045,0.00025121972,0.000002622721,0.000005518621,0.000013861699,0.0011763324],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99963474,0.0000049646974,0.00007217317,0.00010229454,0.00009405751,0.0000917815],"domain_scores_gemma":[0.9998409,0.000009031941,0.0000054772545,0.00009527454,0.000009175477,0.000040154402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000036218968,0.000047131387,0.00006291204,0.000034254397,0.00002735787,0.000029565063,0.00001871986,0.00003558215,0.00011243648],"category_scores_gemma":[0.0000039795677,0.000036951442,0.000038247337,0.000084979714,0.000012267973,0.000023384098,0.000014436609,0.00005384672,0.0000708295],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002840972,0.0015951815,0.2177515,0.0042182803,0.0036297175,0.0018635887,0.0051592886,0.00017226707,0.5525066,0.09846457,0.029677987,0.084676914],"study_design_scores_gemma":[0.01013286,0.0030489059,0.07181656,0.0027472952,0.006246382,0.0028564236,0.0017254142,0.027810749,0.608742,0.022100491,0.24140315,0.0013697707],"about_ca_topic_score_codex":0.000003851814,"about_ca_topic_score_gemma":0.0000012178922,"teacher_disagreement_score":0.21172516,"about_ca_system_score_codex":0.000017785405,"about_ca_system_score_gemma":0.000034617955,"threshold_uncertainty_score":0.15068361},"labels":[],"label_agreement":null},{"id":"W4405034481","doi":"10.1182/blood-2024-204743","title":"Caplacizumab in Immune-Mediated Acquired Thrombotic Thrombocytopenic Purpura: A Systematic Literature Review and Meta-Analyses of Clinical Trials and Observational Studies","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"","keywords":"Medicine; Observational study; Randomized controlled trial; Exacerbation; Systematic review; Internal medicine; Rituximab; Clinical trial; Pediatrics; MEDLINE","score_opus":0.48684239948054175,"score_gpt":0.5103547649125479,"score_spread":0.023512365432006188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405034481","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20036142,0.7971657,0.0000015144802,0.0005018234,0.0001933559,0.0014917307,0.00023739296,0.00003374624,0.0000132950245],"genre_scores_gemma":[0.92361134,0.07546193,0.00004682913,0.00014398058,0.000019395424,0.0003236613,0.00018310774,0.000014909299,0.00019483322],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9927118,0.0036908912,0.0028721208,0.00044060338,0.0000874382,0.00019713743],"domain_scores_gemma":[0.992722,0.0061532715,0.0005854233,0.00036107487,0.00015265612,0.000025586285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053031566,0.00027500422,0.004545173,0.0001585572,0.00005508304,0.000041743868,0.00017568636,0.00015429448,0.0002646557],"category_scores_gemma":[0.0072601927,0.00016676496,0.0004968901,0.00038396675,0.00021932548,0.00016505668,0.00016767679,0.00016051026,0.000023975963],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001927134,0.0014923812,0.009352222,0.68148726,0.22984593,0.00019682254,0.0021462487,0.0000017106562,0.06611677,0.0032456212,0.0058249473,0.000097381926],"study_design_scores_gemma":[0.01830081,0.0012789083,0.11462465,0.18641695,0.665674,0.0011988591,0.0024137802,0.000035544148,0.0060322625,0.001788665,0.0006085447,0.0016270584],"about_ca_topic_score_codex":0.000014961863,"about_ca_topic_score_gemma":0.000025351708,"teacher_disagreement_score":0.7232499,"about_ca_system_score_codex":0.000013972197,"about_ca_system_score_gemma":0.00009794253,"threshold_uncertainty_score":0.8691653},"labels":[],"label_agreement":null},{"id":"W4405034490","doi":"10.1182/blood-2024-193193","title":"Updated Results from the Phase 3 Manifest-2 Study of Pelabresib in Combination with Ruxolitinib for Janus Kinase Inhibitor-Naïve Patients with Myelofibrosis","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ruxolitinib; Myelofibrosis; Janus kinase inhibitor; Medicine; Internal medicine; Janus kinase 2; Janus; Janus kinase; Phases of clinical research; Janus kinase 1; Phase (matter); Oncology; Clinical trial; Chemistry; Bone marrow; Computer science; Receptor","score_opus":0.01474007386459411,"score_gpt":0.26935648544036855,"score_spread":0.25461641157577447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405034490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99500906,0.000113750626,0.0000070568635,0.0004541765,0.000060870952,0.0032445467,0.00084522733,0.000033384847,0.00023193152],"genre_scores_gemma":[0.9977727,0.00000877554,0.00033308883,0.000058051817,0.000068379,0.00045093163,0.0011995101,0.0000341044,0.00007446751],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984736,0.00008039306,0.00041012996,0.00043792214,0.00039391025,0.00020407826],"domain_scores_gemma":[0.99882716,0.00041787614,0.00012032393,0.0003229403,0.00023738989,0.000074324664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015111416,0.0002243337,0.00034391863,0.00010735953,0.00007150753,0.0000428045,0.000069993745,0.000056313722,0.000024546325],"category_scores_gemma":[0.00007158738,0.0001226373,0.00004322883,0.00032870632,0.000045907942,0.00009259555,0.000025073477,0.00012993885,0.0000075016537],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011218402,0.051473845,0.92285115,0.00013067551,0.0011460395,0.0002987668,0.007130261,0.000009459385,0.000268337,0.00031781857,0.0008822287,0.004273025],"study_design_scores_gemma":[0.123124756,0.021427257,0.83597773,0.00092647586,0.0012282259,0.000006172115,0.0012202441,0.000089013934,0.015391637,0.000049773353,0.0003619515,0.00019674533],"about_ca_topic_score_codex":0.00059499405,"about_ca_topic_score_gemma":0.00087744754,"teacher_disagreement_score":0.11190636,"about_ca_system_score_codex":0.000050310235,"about_ca_system_score_gemma":0.00009948312,"threshold_uncertainty_score":0.5001004},"labels":[],"label_agreement":null},{"id":"W4405034526","doi":"10.1182/blood-2024-200881","title":"A Phase 3, Randomized, Double-Blind, Active-Comparator-Controlled Study of Bomedemstat Versus Hydroxyurea in Patients with Essential Thrombocythemia Naïve to Cytoreductive Therapy","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Swedish Orphan Biovitrum; RWTH Aachen University; Daiichi-Sankyo; Novartis Pharma; Galecto; Sierra Oncology; Incyte; Baxalta; Novartis Foundation; Astellas Pharma; Nippon Shinyaku; Bristol-Myers Squibb; AstraZeneca; Active Biotech; MorphoSys; Celgene; Alexion Pharmaceuticals; Ariad Pharmaceuticals","keywords":"Medicine; Essential thrombocythemia; Thrombocytosis; Internal medicine; Myelofibrosis; Anagrelide; Myeloproliferative neoplasm; Gastroenterology; Hydroxycarbamide; Oncology; Bone marrow; Surgery; Polycythemia vera; Chemotherapy; Platelet","score_opus":0.0260369682254912,"score_gpt":0.33580788874330114,"score_spread":0.30977092051780997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405034526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876541,0.0004083889,0.000010460685,0.00012470644,0.00025834542,0.010907036,0.000039878094,0.000050832106,0.0005462823],"genre_scores_gemma":[0.9970627,0.00004258011,0.00009369777,0.000027968174,0.0001377201,0.002493645,0.00006048392,0.000048005848,0.00003321074],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9976625,0.00018295553,0.0005920332,0.0006102422,0.00062235317,0.0003299239],"domain_scores_gemma":[0.99865454,0.00045730663,0.00014656379,0.00033596752,0.00021700705,0.00018860986],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025926757,0.00040923335,0.0017754771,0.00037765008,0.000057798556,0.000046029596,0.00009961535,0.00008383174,0.0000998963],"category_scores_gemma":[0.000047336245,0.0002510444,0.00021692184,0.0005392225,0.00009296621,0.00013792052,0.000032160046,0.00023090863,0.000021573822],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92055345,0.048329055,0.013736834,0.000032176606,0.0070560225,0.00012907166,0.009028641,0.000019276713,0.00043627914,0.00009798255,0.000051602838,0.000529611],"study_design_scores_gemma":[0.95007616,0.014339208,0.0050077327,0.00018406635,0.0016305227,0.0000038857906,0.0009930502,0.000031631247,0.027481828,0.000012597892,0.000018544662,0.00022075532],"about_ca_topic_score_codex":0.00014828617,"about_ca_topic_score_gemma":0.00009714449,"teacher_disagreement_score":0.033989847,"about_ca_system_score_codex":0.00012333127,"about_ca_system_score_gemma":0.00023063843,"threshold_uncertainty_score":0.99999416},"labels":[],"label_agreement":null},{"id":"W4405034535","doi":"10.1182/blood-2024-211477","title":"Uncovering the HOXA9 Translational Regulatory Complex That Promotes AML Leukemic Stem Cells","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University of British Columbia","funders":"","keywords":"Biology; RNA-binding protein; Translational regulation; Untranslated region; Cell biology; Transcription factor; Phenocopy; Translation (biology); Messenger RNA; Genetics; Gene","score_opus":0.022650816302519482,"score_gpt":0.2523442020191031,"score_spread":0.22969338571658365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405034535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99602956,0.0025867524,0.00032675234,0.00024372712,0.00007121723,0.00014927732,0.000022749009,0.000023363,0.0005466092],"genre_scores_gemma":[0.9970151,0.0000809278,0.00011595453,0.00006363883,0.00021109487,0.000012798267,0.000030226247,0.000018205348,0.0024520608],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992728,0.000038950104,0.000093216004,0.00022063,0.00017551146,0.00019885771],"domain_scores_gemma":[0.99968344,0.000022919286,0.000014464237,0.00021129835,0.000019062843,0.000048812344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017322849,0.000092359434,0.00006632751,0.000022783415,0.00008993556,0.00007046823,0.00016279398,0.00006008729,0.000025033203],"category_scores_gemma":[0.000003457399,0.00006547338,0.00007916303,0.000060408598,0.00005670666,0.000004214804,0.000046256482,0.00010113471,0.00001846897],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009733183,0.000021901687,0.0006020192,0.000042717464,0.000072754396,0.0000057650395,0.000047121866,0.00011362093,0.99607867,0.00009151347,0.0009277711,0.0019864365],"study_design_scores_gemma":[0.00039608602,0.000085080996,0.0037198428,0.000037772523,0.00002524685,0.000028305705,0.000055637756,0.00088805653,0.97525805,0.00012470938,0.019251367,0.00012983629],"about_ca_topic_score_codex":0.000012597733,"about_ca_topic_score_gemma":0.0000143798625,"teacher_disagreement_score":0.020820588,"about_ca_system_score_codex":0.000007314103,"about_ca_system_score_gemma":0.000104684055,"threshold_uncertainty_score":0.26699272},"labels":[],"label_agreement":null},{"id":"W4405034536","doi":"10.1182/blood-2024-207139","title":"Olverembatinib (HQP1351) Overcomes Resistance/Intolerance to Asciminib and Ponatinib in Patients (pts) with Heavily Pretreated Chronic-Phase Chronic Myeloid Leukemia (CP-CML): A 1.5-Year Follow-up Update with Comprehensive Exposure-Response (E-R) Analyses","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Ponatinib; Medicine; Internal medicine; Myeloid leukemia; Nilotinib; Gastroenterology; Imatinib","score_opus":0.01730730187031699,"score_gpt":0.2943689783184971,"score_spread":0.27706167644818014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405034536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876363,0.007962503,0.000037694135,0.00042950708,0.00015646445,0.0026716848,0.0003276416,0.00032083102,0.0004573528],"genre_scores_gemma":[0.9948946,0.00035238176,0.0019326011,0.00026342098,0.00016068836,0.00037106583,0.0003381619,0.00019579292,0.0014912424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949899,0.00027784746,0.00088808755,0.0016470911,0.0011232493,0.0010738284],"domain_scores_gemma":[0.997264,0.00042858475,0.00023401045,0.0011279775,0.0003660331,0.000579339],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028358752,0.0009554903,0.0013511714,0.00073356787,0.00017938844,0.00018447934,0.00028722725,0.0002624543,0.00020226518],"category_scores_gemma":[0.00014683128,0.00073116197,0.00017833292,0.00171554,0.0002826772,0.0004001257,0.00014914534,0.0006443904,0.0000953252],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34845564,0.013888683,0.39212468,0.011351376,0.021000119,0.018177247,0.017277528,0.001985973,0.113618486,0.00050072215,0.009793427,0.051826138],"study_design_scores_gemma":[0.33611426,0.038564056,0.529535,0.015482294,0.0044441777,0.00045016082,0.000768521,0.0009556673,0.05478922,0.000040202052,0.016005171,0.0028512788],"about_ca_topic_score_codex":0.0003016626,"about_ca_topic_score_gemma":0.001991733,"teacher_disagreement_score":0.13741031,"about_ca_system_score_codex":0.0040426836,"about_ca_system_score_gemma":0.0034233292,"threshold_uncertainty_score":0.9997806},"labels":[],"label_agreement":null},{"id":"W4405034545","doi":"10.1182/blood-2024-207500","title":"T Lymphopenia and Aged Immune System Characterize Immunodeficiency in Adult Patients with Telomere Biology Disorders","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Neutropenia; Immunology; Immunodeficiency; Immunophenotyping; Medicine; Internal medicine; Lymphocytopenia; CD8; Immune system; Hypogammaglobulinemia; Lymphocyte; Gastroenterology; Biology; Antibody; Chemotherapy; Antigen","score_opus":0.0037688389605641027,"score_gpt":0.20117786579157312,"score_spread":0.19740902683100903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405034545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99400944,0.004228548,0.000012408322,0.00016546529,0.00023975526,0.00052990194,0.000044057968,0.00015852015,0.00061189383],"genre_scores_gemma":[0.9990377,0.00043581598,0.00013876469,0.00006391317,0.000039545128,0.000046271736,0.0000997591,0.00003762103,0.00010060712],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998585,0.000058383648,0.00036100505,0.00045574058,0.00016890415,0.00037098458],"domain_scores_gemma":[0.9994297,0.00005876733,0.00006052081,0.0003094497,0.000055069813,0.000086482265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012611673,0.00023593822,0.00041971618,0.00023812872,0.00007513386,0.00004379041,0.00011182272,0.000114927505,0.00002456252],"category_scores_gemma":[0.000043003914,0.00017115044,0.00005136058,0.0004483795,0.0001326368,0.00012189491,0.000054972505,0.00020207936,0.000032271324],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003917204,0.0009603245,0.94286996,0.0012223987,0.00016766775,0.0001638597,0.0016069757,1.9256237e-7,0.02736911,0.0010202032,0.000008980615,0.024218611],"study_design_scores_gemma":[0.0060851504,0.00051835115,0.9899297,0.0010356735,0.00012906392,0.00008706202,0.00043802705,0.000048076796,0.0011486338,0.000009718475,0.00030405362,0.0002665422],"about_ca_topic_score_codex":0.00038634706,"about_ca_topic_score_gemma":0.000052914587,"teacher_disagreement_score":0.047059692,"about_ca_system_score_codex":0.000050340146,"about_ca_system_score_gemma":0.00009860142,"threshold_uncertainty_score":0.69793123},"labels":[],"label_agreement":null},{"id":"W4405034609","doi":"10.1182/blood-2024-207425","title":"Patient and Caregiver Preferences for Hemophilia Prophylactic Treatments: A Discrete Choice Experiment","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Medicine; Mixed logit; Residence; Preference; Logistic regression; Discrete choice; Demography; Internal medicine","score_opus":0.030452909037258547,"score_gpt":0.32165866286082884,"score_spread":0.2912057538235703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405034609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98757994,0.008214784,0.000008317361,0.0008521812,0.000099354475,0.001385891,0.000029846196,0.000076385164,0.0017532861],"genre_scores_gemma":[0.9949433,0.00016117307,0.00037005337,0.000027066639,0.00015050478,0.000529952,0.000037095768,0.00002272025,0.0037581413],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990198,0.000019671554,0.00013257348,0.00035457622,0.00022557928,0.00024781917],"domain_scores_gemma":[0.99951965,0.00009250347,0.000016095575,0.00017274151,0.00004378187,0.00015525866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003902383,0.00015799534,0.00019120637,0.000082598905,0.00008026229,0.00005903117,0.000032686447,0.000058216516,0.00005490186],"category_scores_gemma":[0.000031941807,0.00009588109,0.00008123274,0.00009750694,0.00006399629,0.000078067955,0.000034746343,0.00007727775,0.000020160147],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003220368,0.01848895,0.18408279,0.014781997,0.014054671,0.0035443509,0.06031482,0.000002948165,0.18382803,0.0025409977,0.005775324,0.5093647],"study_design_scores_gemma":[0.039035328,0.0400892,0.04536833,0.0029872668,0.0075899246,0.00066013495,0.0052029397,0.0010784802,0.77407813,0.0023923884,0.079858966,0.0016588991],"about_ca_topic_score_codex":0.000041507,"about_ca_topic_score_gemma":0.0000036489807,"teacher_disagreement_score":0.59025013,"about_ca_system_score_codex":0.000053812728,"about_ca_system_score_gemma":0.00009663519,"threshold_uncertainty_score":0.39099175},"labels":[],"label_agreement":null},{"id":"W4405034614","doi":"10.1182/blood-2024-198798","title":"A Randomized Pilot Trial Comparing Anti-Thymocyte Globulin (ATG) with ATG Plus Post Transplant Cyclophosphamide (PTCy) for Prophylaxis Against Acute and Chronic Graft Versus Host Disease (GVHD) in Matched Donor Hematopoietic Cell Transplants (HCT)","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Western University; University of Toronto; Dalhousie University; CancerCare Manitoba; Saskatchewan Cancer Agency; BC Children's Hospital; Université Laval; University of Saskatchewan; University of Calgary; Princess Margaret Cancer Centre; Juravinski Hospital; McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Anti-thymocyte globulin; Graft-versus-host disease; Medicine; Cyclophosphamide; Immunology; Hematopoietic stem cell transplantation; Hematopoietic cell; Globulin; Transplantation; Internal medicine; Haematopoiesis; Chemotherapy; Biology; Stem cell","score_opus":0.01684585902876895,"score_gpt":0.2566300214420941,"score_spread":0.23978416241332517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405034614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816262,0.0063738376,0.0014088199,0.00029281375,0.0005579923,0.008604201,0.00049572735,0.00028733464,0.0003530535],"genre_scores_gemma":[0.9941247,0.002755635,0.0009181176,0.00006160944,0.00020626569,0.001070059,0.0006255836,0.00015209685,0.00008590875],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9961206,0.00019113097,0.001147585,0.0010682518,0.0006211532,0.0008512787],"domain_scores_gemma":[0.9978434,0.00091151905,0.00016137617,0.00045576115,0.00008967735,0.0005382576],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006740715,0.0007215434,0.0019146662,0.00035391777,0.00014039679,0.00014842,0.0002147503,0.00020621099,0.000034831482],"category_scores_gemma":[0.00003531246,0.0005710234,0.00036268515,0.00048423262,0.00026410798,0.00020107008,0.000019545712,0.00045877052,0.00002858547],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.946689,0.0014893358,0.0020255581,0.013382633,0.001340917,0.004888095,0.0033426494,0.00008315494,0.026490983,0.00010869557,0.00000700236,0.00015196776],"study_design_scores_gemma":[0.95056695,0.00332053,0.0048538614,0.0034139599,0.0061845607,0.00026084235,0.00014971642,0.0017283406,0.02868446,0.000020656686,0.000029333814,0.0007868146],"about_ca_topic_score_codex":0.00011674387,"about_ca_topic_score_gemma":0.00021821719,"teacher_disagreement_score":0.012498504,"about_ca_system_score_codex":0.00019493325,"about_ca_system_score_gemma":0.0009059403,"threshold_uncertainty_score":0.99967414},"labels":[],"label_agreement":null},{"id":"W4405034657","doi":"10.1182/blood-2024-211420","title":"A Therapeutic siRNA Targeting Plasminogen Acts As a Long-Lasting Antifibrinolytic in Nonhuman Primates","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University of British Columbia","funders":"","keywords":"Fibrinolysis; Antifibrinolytic; Hemostasis; Medicine; Fibrin; Coagulation; Tranexamic acid; Thrombosis; Pharmacology; Anesthesia; Immunology; Surgery; Internal medicine","score_opus":0.016700154361354157,"score_gpt":0.27696849207225976,"score_spread":0.26026833771090563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405034657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859794,0.0066309124,0.0000075461303,0.00017353173,0.0000889803,0.00031229446,0.0000038891035,0.00015204684,0.006651417],"genre_scores_gemma":[0.9989279,0.00011611547,0.00018075804,0.00009741424,0.00006886952,0.000018977695,0.00003194604,0.00003967204,0.00051832746],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998906,0.000016713622,0.00022261201,0.000317771,0.00017545842,0.0003614045],"domain_scores_gemma":[0.99964255,0.0000938639,0.000032373468,0.00013541082,0.000018079145,0.0000777298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009616599,0.00017668858,0.0002743467,0.00016180672,0.000056680445,0.0000709791,0.00005818841,0.00007129784,0.000076000535],"category_scores_gemma":[0.00004495862,0.00014360849,0.00007535015,0.00023405209,0.000026201456,0.00009323847,0.00003630607,0.0001655405,0.00026499075],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002695647,0.004563931,0.6855717,0.0028816964,0.0024905575,0.050820876,0.004905772,0.00003114654,0.21528444,0.0008311591,0.00017725505,0.032171953],"study_design_scores_gemma":[0.032418605,0.00306544,0.45230302,0.008759348,0.004224004,0.008584221,0.0011630454,0.0096150255,0.46941948,0.003418177,0.004912515,0.0021171207],"about_ca_topic_score_codex":0.00005442509,"about_ca_topic_score_gemma":0.000021958687,"teacher_disagreement_score":0.25413504,"about_ca_system_score_codex":0.000036322064,"about_ca_system_score_gemma":0.000096622745,"threshold_uncertainty_score":0.58561844},"labels":[],"label_agreement":null},{"id":"W4405034695","doi":"10.1182/blood-2024-204618","title":"Anthracycline Exposure and Breast Cancer Risk in Female Hodgkin Lymphoma Survivors","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences","funders":"","keywords":"Anthracycline; Medicine; Breast cancer; Cumulative incidence; Internal medicine; Oncology; Hazard ratio; Population; Chemotherapy; Cohort; Cancer; Incidence (geometry); Surgery; Confidence interval","score_opus":0.00951813058039922,"score_gpt":0.267181504793005,"score_spread":0.25766337421260577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405034695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9763087,0.021420287,0.0000012761859,0.0010541916,0.00017554045,0.00022052879,0.00017409647,0.00007133625,0.0005740187],"genre_scores_gemma":[0.9928846,0.0063426895,0.00010403597,0.000099654215,0.00020366037,0.00008857623,0.000016793765,0.000023859686,0.00023617416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990993,0.00003473199,0.00019095457,0.00032255464,0.00014451605,0.000207915],"domain_scores_gemma":[0.9995654,0.000092474984,0.00002795535,0.00018106017,0.000021293054,0.00011179054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000121120596,0.00015250778,0.00025284634,0.00010684278,0.000037186583,0.000037310958,0.00003281871,0.000076052165,0.00015334034],"category_scores_gemma":[0.000016662472,0.00011258969,0.000061372906,0.00021576173,0.00004359793,0.000062567684,0.00003187253,0.00005882244,0.000029962526],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004626861,0.0012925623,0.9160885,0.00010972752,0.0001881073,0.00087309646,0.00033258664,0.0000011059366,0.00018217812,0.000056084522,0.00014202276,0.08068772],"study_design_scores_gemma":[0.006077803,0.00016466685,0.9881853,0.00042015623,0.0003951175,0.00040249652,0.000108576605,0.00007590222,0.0025974403,0.00003413986,0.001418766,0.000119626515],"about_ca_topic_score_codex":0.004400978,"about_ca_topic_score_gemma":0.0018170971,"teacher_disagreement_score":0.08056809,"about_ca_system_score_codex":0.00006408687,"about_ca_system_score_gemma":0.00010449228,"threshold_uncertainty_score":0.6652992},"labels":[],"label_agreement":null},{"id":"W4405034713","doi":"10.1182/blood-2024-205583","title":"Comparing Estimated Glomerular Filtration (eGFR) Equations in Patients with Transfusion-Dependent Thalassemia","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Renal function; Cystatin C; Medicine; Creatinine; Urology; Thalassemia; Nephrotoxicity; Internal medicine; Gastroenterology; Kidney","score_opus":0.012477000896998896,"score_gpt":0.23994035956275603,"score_spread":0.22746335866575712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405034713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99505687,0.0006479627,0.00083979376,0.00028783572,0.000098230004,0.00043250975,0.0000066220255,0.0001319875,0.002498181],"genre_scores_gemma":[0.99932694,0.000076073615,0.0002687967,0.0000369558,0.000018133478,0.000018904873,0.00015228793,0.000020963666,0.00008096807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991337,0.00001931843,0.00020664473,0.00021161261,0.00025248367,0.0001762572],"domain_scores_gemma":[0.9997036,0.00003399412,0.000018965991,0.00013195373,0.000041850522,0.000069653375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008051143,0.000113552655,0.00016324264,0.00013978168,0.000053079995,0.00003314737,0.00003710089,0.000094354175,0.000072563365],"category_scores_gemma":[0.000026143629,0.00008490806,0.000036310426,0.00036436712,0.00002334224,0.00009159575,0.000008315381,0.000230919,0.000041885913],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014041155,0.0018935375,0.9874922,0.00031704822,0.00023195097,0.00017438574,0.0013061251,0.0013671274,0.0033626046,0.0005245124,0.000095233976,0.0030948697],"study_design_scores_gemma":[0.017031886,0.00096284284,0.93713224,0.002771021,0.0009847826,0.000047169877,0.0005107654,0.035490725,0.004186833,0.00014478341,0.00026843953,0.00046850916],"about_ca_topic_score_codex":0.00010433312,"about_ca_topic_score_gemma":0.000068226334,"teacher_disagreement_score":0.05035995,"about_ca_system_score_codex":0.000042449712,"about_ca_system_score_gemma":0.00008749768,"threshold_uncertainty_score":0.34624502},"labels":[],"label_agreement":null},{"id":"W4405034714","doi":"10.1182/blood-2024-197897","title":"Mosunetuzumab Continues to Demonstrate Clinically Meaningful Outcomes in Patients with Relapsed and/or Refractory Follicular Lymphoma after ≥2 Prior Therapies Including Those with a History of POD24: 4-Year Follow-up of a Pivotal Phase II Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Spinal Cord Injury BC; University of British Columbia; Jewish General Hospital","funders":"","keywords":"Follicular lymphoma; Refractory (planetary science); Medicine; Lymphoma; Oncology; Internal medicine; Hematologic Neoplasms; Cancer; Biology","score_opus":0.019346873056893303,"score_gpt":0.28652010574810005,"score_spread":0.26717323269120674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405034714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964961,0.0017030026,0.000002067672,0.00006101406,0.000084233325,0.0014473313,0.000031823223,0.000045142708,0.0001292914],"genre_scores_gemma":[0.9981189,0.000038636328,0.0011033015,0.000070676884,0.000017054843,0.00021533376,0.00000806847,0.000041968928,0.000386104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99814075,0.00008772176,0.00063285895,0.0004559566,0.00045099115,0.00023170954],"domain_scores_gemma":[0.9990146,0.00019186146,0.00018456926,0.00034472483,0.00013154627,0.00013266208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025192142,0.00029095073,0.00083416066,0.00022055839,0.00003295334,0.000014441183,0.000078475685,0.000080302685,0.000020150947],"category_scores_gemma":[0.00009746444,0.00016912086,0.00011219633,0.00019958572,0.00010776378,0.0001159175,0.00008481785,0.000082965846,0.0000014833647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013359819,0.019985644,0.94024813,0.00013905414,0.0017740914,0.00064356724,0.013825268,2.0437741e-7,0.00019145517,0.000009577416,0.000031564923,0.009791643],"study_design_scores_gemma":[0.100594826,0.045557585,0.84871894,0.001392574,0.0015297834,0.000012909838,0.001328162,0.000006339632,0.00036624845,0.0000042230486,0.00024966727,0.00023872755],"about_ca_topic_score_codex":0.00014925389,"about_ca_topic_score_gemma":0.00022212202,"teacher_disagreement_score":0.09152915,"about_ca_system_score_codex":0.00022353232,"about_ca_system_score_gemma":0.00044355833,"threshold_uncertainty_score":0.6896549},"labels":[],"label_agreement":null},{"id":"W4405034729","doi":"10.1182/blood-2024-205681","title":"Retrospective Study to Compare Treatment Outcomes of Asciminib Vs. Ponatinib in 99 Patients with T315I Mutated Chronic Myeloid Leukemia","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Ponatinib; Internal medicine; Discontinuation; Myeloid leukemia; Oncology; Nilotinib; Imatinib","score_opus":0.01279472955425322,"score_gpt":0.27741831078743623,"score_spread":0.264623581233183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405034729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949419,0.0003401248,0.000002356275,0.00013387803,0.00014244622,0.0032322458,0.00017577165,0.00015542225,0.0008758829],"genre_scores_gemma":[0.9984709,0.000019370069,0.00025158006,0.000047201956,0.000058007146,0.0002580392,0.00019574694,0.00007801334,0.00062114774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99742514,0.00007260949,0.00058393006,0.0007613903,0.00068159885,0.00047533857],"domain_scores_gemma":[0.99881464,0.000089005494,0.00010835061,0.0006254891,0.0001549138,0.00020760504],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012651952,0.00045853973,0.001053885,0.00041851203,0.000047540485,0.000027520315,0.00014785281,0.0000555237,0.00018349035],"category_scores_gemma":[0.000066978166,0.00031889632,0.0001305497,0.000840533,0.00006428448,0.00009290579,0.00007890345,0.00022826705,0.00008893122],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047703105,0.0072012376,0.98326904,0.000114746814,0.0017495117,0.0005726959,0.0046301214,0.00005676609,0.00008066117,0.000019309744,0.000085115986,0.0017437543],"study_design_scores_gemma":[0.033680603,0.010910782,0.9511214,0.00044923092,0.0009730257,0.000017765253,0.00054226187,0.00008023441,0.0018036381,0.000008123492,0.00014915798,0.0002637751],"about_ca_topic_score_codex":0.0016106096,"about_ca_topic_score_gemma":0.0026479973,"teacher_disagreement_score":0.033203572,"about_ca_system_score_codex":0.006900883,"about_ca_system_score_gemma":0.0013474865,"threshold_uncertainty_score":0.9999263},"labels":[],"label_agreement":null},{"id":"W4405034738","doi":"10.1182/blood-2024-198253","title":"Validation of a Simplified Diagnostic Algorithm for Deep Vein Thrombosis","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Impact; Queen's University; McMaster University; Western University; Ottawa Hospital; University of British Columbia","funders":"","keywords":"Deep vein; Thrombosis; Algorithm; Medicine; Radiology; Computer science; Surgery","score_opus":0.019693495817850078,"score_gpt":0.29239368655348735,"score_spread":0.2727001907356373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405034738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9070146,0.0057807015,0.07606567,0.0019066929,0.00094414264,0.0031465327,0.00011434764,0.00036637942,0.0046609193],"genre_scores_gemma":[0.99064523,0.00058358663,0.0077512795,0.00020515811,0.00027594678,0.00027997632,0.00009755302,0.000035315647,0.00012594114],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991651,0.000013514098,0.00023653981,0.00022834375,0.00017750725,0.00017897032],"domain_scores_gemma":[0.9992578,0.00036552866,0.000039908195,0.00020416331,0.000070611866,0.000062005936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017162526,0.00010901111,0.00031314822,0.0001137364,0.00003439427,0.000031457963,0.000060719485,0.000058438454,0.00010966153],"category_scores_gemma":[0.00015833514,0.00009505984,0.00013753776,0.00017608097,0.000025450634,0.00006523453,0.000032496893,0.000055814548,0.000032929634],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035850935,0.014606442,0.0045783054,0.0073766746,0.005863667,0.00015850684,0.004077497,0.00009783003,0.044750277,0.028581236,0.040734377,0.84913933],"study_design_scores_gemma":[0.013957487,0.0059453007,0.13301122,0.003236163,0.018156001,0.00006411217,0.0010910631,0.015689576,0.735478,0.01142378,0.060795337,0.001151997],"about_ca_topic_score_codex":0.00003070147,"about_ca_topic_score_gemma":0.0000025943498,"teacher_disagreement_score":0.84798735,"about_ca_system_score_codex":0.000019040246,"about_ca_system_score_gemma":0.000040787385,"threshold_uncertainty_score":0.3876428},"labels":[],"label_agreement":null},{"id":"W4405034776","doi":"10.1182/blood-2024-207816","title":"A Phase I/II Study of AZD0305, a Novel Antibody-Drug Conjugate (ADC) Targeting GPRC5D, in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"","keywords":"Antibody-drug conjugate; Medicine; Multiple myeloma; Refractory (planetary science); Phases of clinical research; Lenalidomide; Conjugate; Internal medicine; Pomalidomide; Oncology; Drug; Antibody; Pharmacology; Monoclonal antibody; Immunology; Clinical trial; Biology","score_opus":0.016775214664985792,"score_gpt":0.30284185576448125,"score_spread":0.2860666410994955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405034776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965797,0.000628507,0.00001550557,0.000053318527,0.00010020209,0.0020860764,0.00014662024,0.00010745392,0.0002826156],"genre_scores_gemma":[0.99849194,0.000022896116,0.00066438684,0.00002339681,0.00007119629,0.000103124745,0.00028163375,0.00007219963,0.00026920933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973773,0.00008975796,0.000560069,0.000621352,0.00079023023,0.00056131993],"domain_scores_gemma":[0.99878013,0.00020031702,0.00011535232,0.00044613314,0.00018808096,0.00026997062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030520564,0.0003264953,0.00057895517,0.00042246358,0.00011620553,0.000033331773,0.00014667677,0.00008145682,0.00007046502],"category_scores_gemma":[0.00028127263,0.00023980826,0.000095739146,0.00058453315,0.00008427885,0.0002066948,0.00013785799,0.00044183986,0.000032139782],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039910707,0.09602137,0.86342686,0.00045394833,0.0011648575,0.0012718043,0.003918873,0.0000054117963,0.023957077,0.000007934034,0.000124295,0.0056564976],"study_design_scores_gemma":[0.31418508,0.034454238,0.6304281,0.0017501729,0.0007718642,0.00002972989,0.0017953019,0.001719619,0.013221024,0.0000070534975,0.0010472136,0.00059059705],"about_ca_topic_score_codex":0.00058266445,"about_ca_topic_score_gemma":0.00019794806,"teacher_disagreement_score":0.31019402,"about_ca_system_score_codex":0.00007846314,"about_ca_system_score_gemma":0.00021658966,"threshold_uncertainty_score":0.9779097},"labels":[],"label_agreement":null},{"id":"W4405034785","doi":"10.1182/blood-2024-208884","title":"What Is the Prognostic Relevance of Responses Less Than a CR(Sub-CR) to Initial AML Treatment?","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Context (archaeology); Population; Logistic regression; Log-rank test; Proportional hazards model","score_opus":0.04269977279992594,"score_gpt":0.34940184623842596,"score_spread":0.30670207343850003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405034785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97887146,0.0063103493,0.000014373473,0.0125956405,0.00022596947,0.0010590353,0.00005228637,0.00009112516,0.0007797566],"genre_scores_gemma":[0.9930644,0.0017218265,0.00025965675,0.00064753596,0.00038834143,0.00020689574,0.000011710342,0.000047458678,0.0036521568],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984492,0.00013160399,0.00024538432,0.0003721417,0.0004473194,0.00035433954],"domain_scores_gemma":[0.9979629,0.0011743678,0.000031684296,0.0005663121,0.00011767516,0.00014705319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028909382,0.00017980502,0.00028402597,0.00017610478,0.00006898038,0.00010588535,0.00019864587,0.00011327208,0.00006944707],"category_scores_gemma":[0.0006747274,0.0001093931,0.00012955141,0.0005340862,0.00014394447,0.00014668764,0.000102479804,0.00030858352,0.00021176938],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011916787,0.0060044522,0.04670779,0.0028894285,0.0052354373,0.014151553,0.042493895,0.0000068750983,0.30840042,0.0026800528,0.028200269,0.53131306],"study_design_scores_gemma":[0.0068023507,0.006199555,0.03514254,0.003300236,0.0015029699,0.0011961339,0.0036686356,0.0003062508,0.8863264,0.0005110011,0.054620072,0.000423905],"about_ca_topic_score_codex":0.00008632491,"about_ca_topic_score_gemma":0.00004953489,"teacher_disagreement_score":0.5779259,"about_ca_system_score_codex":0.00010656012,"about_ca_system_score_gemma":0.0006692769,"threshold_uncertainty_score":0.4460921},"labels":[],"label_agreement":null},{"id":"W4405034798","doi":"10.1182/blood-2024-193406","title":"Investigating the Impact of FIX Fc Fusion on Its Extravascular Distribution and Hemostatic Properties","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Cardiac Imaging and Diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Medicine; Immunology","score_opus":0.027119534929702177,"score_gpt":0.2843713968580885,"score_spread":0.25725186192838634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405034798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906224,0.008179502,0.00003477236,0.0006458817,0.000045055083,0.00018040522,0.000045415236,0.000037592676,0.00020898787],"genre_scores_gemma":[0.999648,0.00010774968,0.000031488576,0.00005157338,0.00006319725,0.0000064843102,0.000043077864,0.000008765333,0.000039672756],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9995469,0.000027212041,0.00010131427,0.00009945911,0.00013525659,0.000089860296],"domain_scores_gemma":[0.9996603,0.00012667215,0.00001782578,0.00010775538,0.000040419734,0.00004704227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015191837,0.00007063854,0.000113337934,0.000020249108,0.0000437714,0.000027778584,0.00001815019,0.00002316407,0.000005059491],"category_scores_gemma":[0.0006902476,0.000037510843,0.00007810225,0.00009682567,0.000060206283,0.000026068548,0.000018142722,0.00010269988,0.0000077325585],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017657422,0.0015752541,0.26279423,0.00496901,0.0019619924,0.00032900713,0.0125386305,0.00059501117,0.62724715,0.0015382805,0.026355073,0.05991976],"study_design_scores_gemma":[0.003380117,0.0018941268,0.5820143,0.0066929124,0.0018172401,0.00057668827,0.0006749744,0.013065528,0.38794255,0.00042430064,0.0011836028,0.00033364768],"about_ca_topic_score_codex":0.00006790228,"about_ca_topic_score_gemma":5.0250117e-7,"teacher_disagreement_score":0.31922007,"about_ca_system_score_codex":0.000014566459,"about_ca_system_score_gemma":0.000069096255,"threshold_uncertainty_score":0.15296479},"labels":[],"label_agreement":null},{"id":"W4405034804","doi":"10.1182/blood-2024-207634","title":"5-Year Follow-up of the Phase 2 Optic Study in Patients with Chronic-Phase Chronic Myeloid Leukemia: Efficacy, Safety, and First End-of-Treatment Mutational Results","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Scheme for Promotion of Academic and Research Collaboration; Sun Pharma; Otsuka Pharmaceutical; Ascentage Pharma; Ipsen Biopharmaceuticals; Ipsen; Jazz Pharmaceuticals; Bristol-Myers Squibb; Incyte; Amgen","keywords":"Medicine; Myeloid leukemia; Phases of clinical research; Phase (matter); Oncology; Internal medicine; Clinical trial; Chemistry","score_opus":0.012090670285373627,"score_gpt":0.2761671150953434,"score_spread":0.2640764448099698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405034804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949023,0.0014973097,0.0000036671854,0.00012358089,0.0001552883,0.002625973,0.00036024002,0.000039365725,0.00029224306],"genre_scores_gemma":[0.9989876,0.000112791226,0.0001275052,0.000005398453,0.000098682685,0.0000851941,0.00023761268,0.000049324404,0.00029589576],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9977778,0.000074591364,0.0006937357,0.00056815246,0.00054563576,0.00034007992],"domain_scores_gemma":[0.99868923,0.00030473885,0.00018513379,0.00061335816,0.000087819724,0.00011973337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018752873,0.00033834678,0.00056905474,0.00018164127,0.0000844077,0.000017976332,0.00014105187,0.00009915959,0.0000749526],"category_scores_gemma":[0.000092293485,0.00021388155,0.00012703851,0.0004759016,0.00019021476,0.00008942093,0.000099407735,0.00021771462,0.000010618176],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.070626,0.14690638,0.5651291,0.005391636,0.020654002,0.0035016995,0.034598704,0.0036370412,0.0032177467,0.0008925233,0.00052895106,0.14491624],"study_design_scores_gemma":[0.64399856,0.044557273,0.29686883,0.00217983,0.003226706,0.000090935544,0.00026833304,0.001094579,0.0062326477,0.00001246206,0.0010758016,0.00039405987],"about_ca_topic_score_codex":0.00046923148,"about_ca_topic_score_gemma":0.0010969848,"teacher_disagreement_score":0.57337254,"about_ca_system_score_codex":0.0035425203,"about_ca_system_score_gemma":0.0031089645,"threshold_uncertainty_score":0.92635673},"labels":[],"label_agreement":null},{"id":"W4405034852","doi":"10.1182/blood-2024-207798","title":"Ultra-Sensitive <i>KIT</i> testing Uncovers Previously Undetected <i>KIT</i> mutations in Patients with Indolent Systemic Mastocytosis: Results from the Pioneer Trial","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Systemic mastocytosis; Medicine; Internal medicine; Pathology; Bone marrow","score_opus":0.009583102273054579,"score_gpt":0.1902983011284754,"score_spread":0.1807151988554208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405034852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946971,0.0011928527,0.00004479764,0.00010110548,0.0006788377,0.001263283,0.0006968619,0.0001400989,0.0011850428],"genre_scores_gemma":[0.9986842,0.000017300095,0.000060547216,0.000098815624,0.00008382673,0.00007907263,0.0006318127,0.000031610918,0.00031276542],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982751,0.00030259968,0.0005002754,0.00047779398,0.00009598309,0.00034823047],"domain_scores_gemma":[0.9982981,0.0011001715,0.00015060871,0.00031063837,0.000114462644,0.000026023597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027392118,0.00023768343,0.0002984349,0.00009218711,0.0001710426,0.000057335805,0.00016235533,0.0001747231,0.000023668648],"category_scores_gemma":[0.00027439368,0.00015836165,0.000069093396,0.00044069797,0.00013214251,0.00008225968,0.00003649692,0.00044583288,0.00013473936],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17495783,0.014013995,0.09367996,0.0011424191,0.0107311,0.00083389896,0.08535799,0.0033151982,0.57654876,0.0010453472,0.012679546,0.02569395],"study_design_scores_gemma":[0.712741,0.010678644,0.095588826,0.01075536,0.0050069923,0.00028736025,0.007618656,0.00008581919,0.13855302,0.00020591689,0.015434835,0.0030435727],"about_ca_topic_score_codex":0.0007832665,"about_ca_topic_score_gemma":0.0003484351,"teacher_disagreement_score":0.53778315,"about_ca_system_score_codex":0.00007333215,"about_ca_system_score_gemma":0.00016521441,"threshold_uncertainty_score":0.6457801},"labels":[],"label_agreement":null},{"id":"W4405034860","doi":"10.1182/blood-2024-205584","title":"Clonal Hematopoiesis Is Associated with Changes to T Cell Contexture in Solid Tumours","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Hematologic Neoplasms; Haematopoiesis; Biology; Cancer research; Immunology; Genetics; Stem cell; Cancer","score_opus":0.015521683364364198,"score_gpt":0.28692768258107243,"score_spread":0.2714059992167082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405034860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9764471,0.0011977343,0.000011892226,0.016915822,0.000050068822,0.0004942448,0.00007901308,0.0001301833,0.0046739075],"genre_scores_gemma":[0.9898563,0.00003810096,0.00021241687,0.0026674084,0.00016744452,0.00007071658,0.00004239221,0.000050434104,0.006894785],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986111,0.000038398033,0.00014253499,0.00034092623,0.00043718968,0.00042984713],"domain_scores_gemma":[0.99933815,0.00013194852,0.000021492771,0.00021195391,0.00009476193,0.00020171296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025018014,0.00016430361,0.00032961206,0.0002706076,0.00003201529,0.00004382897,0.0001188838,0.00012986096,0.00027207017],"category_scores_gemma":[0.00012050519,0.00012320299,0.000049365048,0.00067671837,0.000042232372,0.000039336333,0.00006632934,0.0004442688,0.000207167],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015253354,0.004913369,0.08770489,0.002527074,0.002337066,0.034092627,0.033643074,0.000012976428,0.22076176,0.0006595515,0.60750663,0.0043156547],"study_design_scores_gemma":[0.022251388,0.004323226,0.06757672,0.005658437,0.0011731758,0.0012898394,0.0039167795,0.0008428191,0.8456083,0.00020294127,0.045844123,0.0013122705],"about_ca_topic_score_codex":0.00009041307,"about_ca_topic_score_gemma":0.00036685792,"teacher_disagreement_score":0.6248465,"about_ca_system_score_codex":0.00019037644,"about_ca_system_score_gemma":0.0003489496,"threshold_uncertainty_score":0.50240725},"labels":[],"label_agreement":null},{"id":"W4405035130","doi":"10.1182/blood-2024-200769","title":"Transcriptomic Analysis of Clonal Hematopoiesis in Non-Small Cell Lung Carcinoma Unveils a Tumorigenic and Dysregulated Immune Profile","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Immune system; Small Cell Lung Carcinoma; Transcriptome; Cancer research; Biology; Haematopoiesis; Lung; Carcinoma; Stem cell; Immunology; Medicine; Small-cell carcinoma; Internal medicine; Genetics; Gene; Gene expression","score_opus":0.005720436749283372,"score_gpt":0.2531410656925709,"score_spread":0.2474206289432875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405035130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98844314,0.009810489,0.000035118115,0.00011610329,0.00005211491,0.00043432647,0.00008520829,0.000030434714,0.0009930908],"genre_scores_gemma":[0.99854094,0.000058344984,0.00037379353,0.000015338539,0.000019030766,0.000064684595,0.00012630767,0.000018279272,0.0007832641],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991579,0.000017230734,0.00029861403,0.00024664795,0.000112611975,0.00016700303],"domain_scores_gemma":[0.99965584,0.000032525815,0.000037354817,0.00017493549,0.00003574939,0.00006358808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000074228345,0.00012662419,0.00039766674,0.00043784032,0.000024332781,0.000015020649,0.000040217587,0.000055018503,0.00013787678],"category_scores_gemma":[0.0000032321263,0.00010458539,0.00016418801,0.0009056824,0.00003413078,0.00004086855,0.000011303814,0.00008431847,0.000003309642],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017161242,0.0022975923,0.6396328,0.003095728,0.01047559,0.0007537409,0.0130744865,0.000049434395,0.3292089,0.00030720021,0.00015468385,0.000778172],"study_design_scores_gemma":[0.004504574,0.00019991522,0.86296624,0.00025691174,0.018360244,0.000041614396,0.00043170527,0.006041653,0.10697663,0.000025568275,0.000036777103,0.00015813735],"about_ca_topic_score_codex":0.0005103621,"about_ca_topic_score_gemma":0.00012518508,"teacher_disagreement_score":0.22333342,"about_ca_system_score_codex":0.000056461693,"about_ca_system_score_gemma":0.0001818064,"threshold_uncertainty_score":0.42648685},"labels":[],"label_agreement":null},{"id":"W4405035165","doi":"10.1182/blood-2024-200797","title":"Renew Trial in Progress: A Phase 3, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Elritercept (KER-050) for the Treatment of Transfusion-Dependent Anemia in Adult Participants with Very Low-, Low-, or Intermediate-Risk Myelodysplastic Neoplasms (MDS)","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Placebo; Medicine; Anemia; Clinical trial; Double blind; Internal medicine; Alternative medicine; Pathology","score_opus":0.03583961702305943,"score_gpt":0.3624273305544276,"score_spread":0.3265877135313682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405035165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9714348,0.00059997773,0.000052656378,0.0005038434,0.00016177414,0.027106948,0.00009961927,0.000030020265,0.000010375245],"genre_scores_gemma":[0.9934111,0.0010851166,0.00007952841,0.000020067326,0.0001827816,0.0050458587,0.000019364032,0.00005991686,0.00009622029],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99628687,0.00044414675,0.0011583958,0.00066051545,0.0008168373,0.00063321047],"domain_scores_gemma":[0.9947862,0.004063851,0.00014159779,0.00060401304,0.00018692079,0.00021739434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018033335,0.0004075012,0.0011705862,0.00041308315,0.00008840549,0.000056942194,0.00027557052,0.00011716967,0.00005671561],"category_scores_gemma":[0.0006296753,0.00018256328,0.00015770397,0.0007561579,0.00023404024,0.00007692401,0.00006619148,0.0003771492,0.0000047694703],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9422341,0.015237696,0.004954627,0.00037903304,0.001301453,0.00035507255,0.021749353,0.00027680153,0.0006917467,0.000003253017,0.00001381375,0.012803054],"study_design_scores_gemma":[0.932656,0.044959143,0.0039407564,0.0013038845,0.0034257642,0.000033131153,0.0041318503,0.005884114,0.0034494551,0.0000041519106,0.000011918285,0.00019985386],"about_ca_topic_score_codex":0.00052246696,"about_ca_topic_score_gemma":0.006223445,"teacher_disagreement_score":0.029721446,"about_ca_system_score_codex":0.00024522407,"about_ca_system_score_gemma":0.0010458364,"threshold_uncertainty_score":0.74447143},"labels":[],"label_agreement":null},{"id":"W4405035174","doi":"10.1182/blood-2024-193803","title":"Unmet Needs, Factor Consumption, and Healthcare Resource Use Among People with Hemophilia a: Real-World Analysis of the Adelphi Hemophilia Disease Specific ProgrammeTM","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Disease; Resource consumption; Medicine; Resource (disambiguation); Consumption (sociology); Health care; Gerontology; Intensive care medicine; Computer science; Internal medicine; Economic growth; Biology; Economics","score_opus":0.04155908663270807,"score_gpt":0.3028824207697018,"score_spread":0.2613233341369937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405035174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98939437,0.003688591,0.0000035332714,0.005110408,0.000045350578,0.0012558766,0.00027407333,0.00012388811,0.000103884544],"genre_scores_gemma":[0.9941737,0.001111259,0.00012283876,0.00005679038,0.00011703062,0.00007108192,0.00019577774,0.000049549475,0.004101948],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977263,0.00014932494,0.00039735058,0.0005369137,0.00074060366,0.000449505],"domain_scores_gemma":[0.9981379,0.000254223,0.00008931959,0.00081420294,0.0001588196,0.00054552214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020822849,0.00029105524,0.00059842016,0.00085180043,0.00017704871,0.00012025491,0.00015085601,0.00009261713,0.000120913646],"category_scores_gemma":[0.00006013754,0.00016824898,0.00028280247,0.0034896135,0.00041162604,0.00012835498,0.000107114436,0.0003634848,0.000007716741],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026531809,0.00049376057,0.9935982,0.00071989384,0.0019182488,0.00017952643,0.00077184715,0.0000030528201,0.00014870543,0.0003530437,0.00035188705,0.0011964865],"study_design_scores_gemma":[0.0013503132,0.00022073263,0.9897853,0.00044733495,0.0037141314,0.000018705035,0.0001798715,0.0002526507,0.0005292129,0.000027833941,0.0032904933,0.00018339865],"about_ca_topic_score_codex":0.00057205313,"about_ca_topic_score_gemma":0.0013698146,"teacher_disagreement_score":0.005053618,"about_ca_system_score_codex":0.0000750989,"about_ca_system_score_gemma":0.0002055323,"threshold_uncertainty_score":0.68609947},"labels":[],"label_agreement":null},{"id":"W4405035210","doi":"10.1182/blood-2024-200529","title":"Expanding the Eureka Study: Integrating a Comprehensive Clinical Registry with Molecular Profiling to Advance AL Amyloidosis Research","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Profiling (computer programming); Medicine; Amyloidosis; Internal medicine; Computer science","score_opus":0.04602649382874621,"score_gpt":0.40841996656299706,"score_spread":0.3623934727342508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405035210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919985,0.0037120613,0.0007173179,0.0016191532,0.00016209792,0.0012839495,0.000020280544,0.00006662927,0.00041998748],"genre_scores_gemma":[0.99354464,0.0002497337,0.0042231316,0.00077246624,0.00026287843,0.00062489504,0.000028361397,0.000075452124,0.00021842451],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971247,0.00049373,0.00041397804,0.0009718472,0.00046851326,0.000527257],"domain_scores_gemma":[0.99830526,0.00034970095,0.00007609573,0.0008706866,0.00023614259,0.0001621306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008099105,0.0002982175,0.0003039406,0.00009649992,0.00027725712,0.00019383393,0.0004835555,0.00012500756,0.0000063747893],"category_scores_gemma":[0.0005398662,0.00019460269,0.00016027536,0.0004991963,0.0001942373,0.000009714212,0.00041464804,0.0005437694,0.00003221539],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004028646,0.002372846,0.52087307,0.00013497034,0.0023894303,0.000944714,0.0011856043,0.00016127742,0.45898336,0.00040835098,0.0042380923,0.007905412],"study_design_scores_gemma":[0.004845355,0.0075878007,0.024688605,0.00083133794,0.0007191144,0.0002038854,0.017771281,0.00007742606,0.9106873,0.000093908515,0.03136795,0.0011260002],"about_ca_topic_score_codex":0.000044876047,"about_ca_topic_score_gemma":0.00007139991,"teacher_disagreement_score":0.49618447,"about_ca_system_score_codex":0.000034755107,"about_ca_system_score_gemma":0.00017594003,"threshold_uncertainty_score":0.7935667},"labels":[],"label_agreement":null},{"id":"W4405035248","doi":"10.1182/blood-2024-203915","title":"Mosaic Chromosomal Alterations Driving Clonal Hematopoiesis Show Shared and Divergent Patterns of Accumulation Among Humans of Diverse Ancestries","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Prenatal Screening and Diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Biology; Genetics; Haematopoiesis; Stem cell","score_opus":0.03453194432487441,"score_gpt":0.2897465106604118,"score_spread":0.2552145663355374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405035248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982077,0.0005563718,0.00056667096,0.00006154092,0.00006413184,0.00012565186,0.00028116233,0.00003957131,0.00009719959],"genre_scores_gemma":[0.99915564,0.00007197035,0.0004462891,0.0000067449996,0.000078444406,0.0000074275677,0.00018086577,0.0000069398657,0.000045706016],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993777,0.0000137521565,0.00019290356,0.00014308414,0.00017827857,0.00009427376],"domain_scores_gemma":[0.999598,0.0001344879,0.000051831867,0.000109338725,0.000047161815,0.000059163638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005040302,0.000080308055,0.00016456045,0.000067447494,0.00005134453,0.000021932165,0.000039102688,0.0000445927,0.0001017262],"category_scores_gemma":[0.00012201725,0.00007214895,0.000050881936,0.00008736604,0.00005939741,0.0001436596,0.000069972106,0.00006367862,0.0000013220935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009347062,0.0001468358,0.9944699,0.0003470185,0.00011329046,0.00003638182,0.00083384593,0.000055343247,0.0030602717,0.0004885971,0.00014237323,0.0002968284],"study_design_scores_gemma":[0.0007472541,0.00016459032,0.9687032,0.0010594903,0.00036758243,0.000013895624,0.00020936625,0.0018143358,0.026741043,0.000056969224,0.000039637343,0.00008264727],"about_ca_topic_score_codex":0.00016218096,"about_ca_topic_score_gemma":0.00009356146,"teacher_disagreement_score":0.025766678,"about_ca_system_score_codex":0.000007935925,"about_ca_system_score_gemma":0.000030606814,"threshold_uncertainty_score":0.29421487},"labels":[],"label_agreement":null},{"id":"W4405035264","doi":"10.1182/blood-2024-198737","title":"CELESTIAL-TNCLL: An Ongoing, Open-Label, Multiregional, Phase 3 Study of Sonrotoclax (BGB-11417) + Zanubrutinib vs Venetoclax + Obinutuzumab for Treatment-Naive CLL","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Obinutuzumab; Venetoclax; Ibrutinib; Medicine; Oncology; Internal medicine; Leukemia; Chronic lymphocytic leukemia","score_opus":0.12741732976963152,"score_gpt":0.445436246826477,"score_spread":0.3180189170568455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405035264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847994,0.0009781615,0.00005060994,0.000119961194,0.0002629212,0.012678406,0.0002185145,0.00022265695,0.0006693874],"genre_scores_gemma":[0.9906703,0.000107165564,0.0018141321,0.00009605816,0.0007019475,0.0032240448,0.00030844586,0.00017332361,0.002904586],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9961626,0.00017307948,0.00080604857,0.001168315,0.00083945016,0.00085050665],"domain_scores_gemma":[0.997177,0.00058876607,0.00017346998,0.0012329153,0.00031429625,0.0005135186],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004897895,0.00051381474,0.0010390499,0.00026445405,0.00021051838,0.00020190957,0.0007160849,0.0002283697,0.00018664362],"category_scores_gemma":[0.00024765544,0.00042682022,0.00018261906,0.00052164606,0.0002065876,0.00029612493,0.00030875416,0.00022347417,0.000078486206],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.07585504,0.3504941,0.0023147422,0.011565278,0.025651107,0.022177925,0.06735723,0.0006157572,0.17947142,0.004760212,0.06056347,0.19917375],"study_design_scores_gemma":[0.72123533,0.09415423,0.00018521414,0.0012358739,0.0032430475,0.00096493796,0.0026163317,0.07280334,0.051407818,0.00022403974,0.05096877,0.00096107164],"about_ca_topic_score_codex":0.004700256,"about_ca_topic_score_gemma":0.00043079336,"teacher_disagreement_score":0.6453803,"about_ca_system_score_codex":0.011518969,"about_ca_system_score_gemma":0.02146149,"threshold_uncertainty_score":0.9998184},"labels":[],"label_agreement":null},{"id":"W4405035290","doi":"10.1182/blood-2024-200754","title":"How Balanced Is Gender Representation at ASH? a Cross-Sectional Analysis","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Gender Studies in Language","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cross-sectional study; Representation (politics); Medicine; Psychology; Mathematics; Statistics; Political science; Politics","score_opus":0.05406922472588245,"score_gpt":0.3778593235648916,"score_spread":0.32379009883900917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405035290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92587155,0.002029589,0.000651586,0.0011079281,0.00074136123,0.00013838,0.000043906126,0.00021992043,0.069195755],"genre_scores_gemma":[0.97647315,0.00007115732,0.00033478427,0.00010998136,0.0004845233,0.000024859764,0.000016166548,0.000008208811,0.02247714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99872035,0.000077601915,0.00011385475,0.00036356295,0.0004889456,0.00023570587],"domain_scores_gemma":[0.999551,0.000091778,0.000034290042,0.0001915084,0.0000736653,0.000057783727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028488017,0.000079469086,0.00011516255,0.00008647475,0.00047417582,0.00036974304,0.00014627552,0.00007671172,0.0008987998],"category_scores_gemma":[0.00014410003,0.0000764069,0.00018902957,0.0009967164,0.00014751093,0.00016140899,0.00008594118,0.000078992955,0.00009380279],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000033632614,0.000045594235,0.96344346,0.000014420885,0.0013160945,0.000029636398,0.029093467,0.000014844492,0.00048516865,0.0021005643,0.00321576,0.0002376126],"study_design_scores_gemma":[0.0003339399,0.000011622712,0.9712251,0.000002893085,0.00053340144,0.0000039477372,0.005229702,0.00010034041,0.0011090966,0.0012383888,0.020015156,0.00019641868],"about_ca_topic_score_codex":0.00032019315,"about_ca_topic_score_gemma":0.0007537203,"teacher_disagreement_score":0.0506016,"about_ca_system_score_codex":0.00009385083,"about_ca_system_score_gemma":0.000048089485,"threshold_uncertainty_score":0.98412275},"labels":[],"label_agreement":null},{"id":"W4405035337","doi":"10.1182/blood-2024-198905","title":"“I Didn't Know I Had a Choice” - Patient Values and Preferences Regarding Resumption of Oral Anticoagulants after Gastrointestinal Bleeding","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Ottawa Hospital; McMaster University","funders":"","keywords":"Medicine; Gastrointestinal bleeding; Dabigatran; Rivaroxaban; Apixaban; Warfarin; Intensive care medicine; Gastroenterology; Internal medicine; Atrial fibrillation","score_opus":0.016625647636525222,"score_gpt":0.26303119634408106,"score_spread":0.24640554870755585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405035337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98274577,0.016444175,0.00012703221,0.000039226183,0.00007045702,0.00017392357,0.00001571,0.00007316553,0.00031057172],"genre_scores_gemma":[0.998259,0.0007142581,0.0007794934,0.000020705413,0.00011578911,0.000013559365,0.000011608786,0.000015386946,0.00007019649],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990961,0.000042600597,0.00019139903,0.00024442785,0.0002538286,0.00017162912],"domain_scores_gemma":[0.9996457,0.00004573143,0.00003476971,0.00013630393,0.000051091916,0.00008640188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015408269,0.00012470451,0.00028007603,0.000096249045,0.000038576727,0.00004085319,0.000032893342,0.000035584373,0.000040076942],"category_scores_gemma":[0.00006115417,0.000095538504,0.00015699358,0.00010130339,0.00007765146,0.000112423964,0.000033933946,0.00010206922,0.0000051654656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072807586,0.0005906322,0.87962735,0.0016370115,0.0015842265,0.000691946,0.0008210003,0.000005010143,0.025341509,0.00006729902,0.00021793542,0.08868799],"study_design_scores_gemma":[0.0057230885,0.002497327,0.92830324,0.015017677,0.0045764796,0.0028570006,0.0008318527,0.0007934845,0.036230452,0.0006602144,0.0019968082,0.0005123482],"about_ca_topic_score_codex":0.00002081318,"about_ca_topic_score_gemma":0.000002072263,"teacher_disagreement_score":0.08817565,"about_ca_system_score_codex":0.000007842281,"about_ca_system_score_gemma":0.00003554446,"threshold_uncertainty_score":0.3895947},"labels":[],"label_agreement":null},{"id":"W4405035341","doi":"10.1182/blood-2024-206590","title":"Serious Adverse Drug Reactions (sADRs) Involving Hematology and Resulting in Black Box Warnings or FDA Non-Approval: Results from the First Quarter Century of RADAR/Sonar","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Quarter (Canadian coin); Hematology; Drug approval; Adverse effect; Drug; Internal medicine; Pharmacology; History","score_opus":0.03813034272224414,"score_gpt":0.34989285379049095,"score_spread":0.3117625110682468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405035341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914471,0.0019231371,0.0000069712887,0.0033168553,0.00088523526,0.0005241578,0.00052587886,0.00014175802,0.0012289067],"genre_scores_gemma":[0.9952769,0.002869038,0.00018040005,0.0008194833,0.00031806334,0.00005116554,0.00008784321,0.000036602236,0.00036045338],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978164,0.00026799084,0.000731003,0.00056594383,0.00014661484,0.00047206713],"domain_scores_gemma":[0.9970534,0.0022383544,0.00024093194,0.0002782848,0.000053971115,0.00013505694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081573613,0.0002839946,0.00037918458,0.00015616493,0.00031323772,0.000030368243,0.0002612343,0.0002762574,0.000112686655],"category_scores_gemma":[0.00020917112,0.00021905945,0.00011913498,0.0004742623,0.00030576956,0.0003688261,0.00012660562,0.001432728,0.00006214822],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010651937,0.0074829017,0.1612958,0.0032322828,0.0057233064,0.007374451,0.31205368,0.003229509,0.3402734,0.0026054217,0.13200206,0.014075242],"study_design_scores_gemma":[0.022760702,0.00021731442,0.021301331,0.0014113357,0.0017361228,0.00064170844,0.022468604,0.022551095,0.07285938,0.0006783179,0.8321216,0.0012524873],"about_ca_topic_score_codex":0.00068899867,"about_ca_topic_score_gemma":0.00052191754,"teacher_disagreement_score":0.70011955,"about_ca_system_score_codex":0.000050307888,"about_ca_system_score_gemma":0.00014035555,"threshold_uncertainty_score":0.8932985},"labels":[],"label_agreement":null},{"id":"W4405035355","doi":"10.1182/blood-2024-199752","title":"Monumental-6: A Phase 3 Study of Talquetamab + Pomalidomide or Talquetamab + Teclistamab Vs Elotuzumab + Pomalidomide + Dexamethasone (EPd) or Pomalidomide + Bortezomib + Dexamethasone (PVd) in Patients with Relapsed/Refractory Multiple Myeloma Who Received 1-4 Prior Lines of Therapy, Including Lenalidomide and an Anti-CD38 Monoclonal Antibody","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Pomalidomide; Dexamethasone; Bortezomib; Multiple myeloma; Medicine; Lenalidomide; Internal medicine; Refractory (planetary science); Oncology; Biology","score_opus":0.04045807147465276,"score_gpt":0.35374473819284347,"score_spread":0.3132866667181907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405035355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98842233,0.002624765,0.000052351603,0.00013082587,0.00015519254,0.0076155984,0.0006369135,0.00027505215,0.0000869704],"genre_scores_gemma":[0.9910215,0.0011181674,0.0058530723,0.0000736803,0.00019321575,0.000481008,0.00058693823,0.00037826292,0.00029413626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99004066,0.0011855526,0.0027670383,0.002269113,0.0021481244,0.0015895198],"domain_scores_gemma":[0.99366075,0.001956489,0.0010381839,0.0016390826,0.0007547375,0.000950753],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0016752818,0.0015223945,0.0034692022,0.0019394453,0.00034554253,0.00024133424,0.00068803923,0.0005381762,0.00023791002],"category_scores_gemma":[0.0015897956,0.0010613202,0.00039964454,0.0021995166,0.00070124894,0.0013502093,0.00048814094,0.0011359561,0.0000096038675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13893709,0.043296095,0.68234533,0.0011094551,0.0040821224,0.0039369636,0.003320194,0.000031818192,0.1075673,0.0000128902575,0.000027106045,0.015333645],"study_design_scores_gemma":[0.2751056,0.03492979,0.5833788,0.0026636522,0.0015028999,0.0003774353,0.0025929306,0.0016770785,0.09638129,0.00002391145,0.00014347928,0.0012231295],"about_ca_topic_score_codex":0.0024435667,"about_ca_topic_score_gemma":0.0013021817,"teacher_disagreement_score":0.13616852,"about_ca_system_score_codex":0.0004454283,"about_ca_system_score_gemma":0.0011983848,"threshold_uncertainty_score":0.99975246},"labels":[],"label_agreement":null},{"id":"W4405035424","doi":"10.1182/blood-2024-198579","title":"From Theory to Therapy: Evaluating Canadian Hemophilia Treatment Centres' Readiness for Gene Therapy Implementation","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; St. Michael's Hospital; University of Toronto; St. John’s Health Sciences Centre; Canadian Hemophilia Society; Hamilton Health Sciences; McMaster Children's Hospital; McMaster University; University of Ottawa; Thrombosis and Atherosclerosis Research Institute; Impact; Ottawa Hospital","funders":"","keywords":"Genetic enhancement; Medicine; Intensive care medicine; Oncology; Gene; Biology; Genetics","score_opus":0.060934820970393495,"score_gpt":0.3971974096146166,"score_spread":0.3362625886442231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405035424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9745396,0.0034291716,0.0008145107,0.018994473,0.00040994212,0.0014005249,0.00023367867,0.00006031266,0.000117805874],"genre_scores_gemma":[0.99250686,0.00044311883,0.0028605233,0.0013591067,0.0011495512,0.0001884499,0.0009049858,0.00003571517,0.0005516798],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991101,0.000044512777,0.00017529822,0.0002592224,0.00019615328,0.00021468727],"domain_scores_gemma":[0.9993936,0.00011705926,0.000021200838,0.0001617095,0.00007271721,0.00023373653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033323583,0.000116468145,0.00014170035,0.00011137159,0.00009198484,0.000038703685,0.00004131688,0.00010037807,0.00039952007],"category_scores_gemma":[0.000014913163,0.00007835332,0.00007790125,0.00015138855,0.000037572474,0.000025599496,0.0000049137366,0.000055601722,0.000014744983],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015827529,0.0001514041,0.0003832455,0.000019503874,0.0003993557,0.000015124657,0.0042354274,0.0000019385602,0.07662801,0.0014290445,0.0003416746,0.916237],"study_design_scores_gemma":[0.03302747,0.007334274,0.06322197,0.000535984,0.0011549819,0.00004534649,0.0028123027,0.0032475821,0.45883724,0.07412287,0.3548104,0.00084958103],"about_ca_topic_score_codex":0.02002471,"about_ca_topic_score_gemma":0.0065858923,"teacher_disagreement_score":0.9153874,"about_ca_system_score_codex":0.00012678985,"about_ca_system_score_gemma":0.00048430776,"threshold_uncertainty_score":0.98650104},"labels":[],"label_agreement":null},{"id":"W4405035446","doi":"10.1182/blood-2024-211634","title":"Single-Cell Proteogenomic Analysis of Clonal Evolution in Patient-Derived Xenograft Models of AML Treated with IDH Inhibitors","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Hematologic Neoplasms; Biology; Somatic evolution in cancer; Proteogenomics; Cancer research; Computational biology; Medicine; Genetics; Cancer; Genomics; Gene; Genome","score_opus":0.007445597993805424,"score_gpt":0.19649090549341489,"score_spread":0.18904530749960946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405035446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974008,0.0011367259,0.000775844,0.000012205144,0.00001933569,0.00028515252,0.00005516873,0.00001164704,0.00030312905],"genre_scores_gemma":[0.99912566,0.000019948006,0.0005434061,0.000006001505,0.000023753679,0.000029791692,0.00020503163,0.000014832649,0.000031591466],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991239,0.000048173053,0.00030742108,0.00025825642,0.00013290478,0.00012935251],"domain_scores_gemma":[0.9995926,0.000005247976,0.00010852657,0.00018570888,0.00007191935,0.00003599312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006949491,0.00011917721,0.00018896337,0.00028617267,0.00001449552,0.000009375284,0.00007071951,0.0001034919,0.000008443712],"category_scores_gemma":[0.000009387575,0.000101886224,0.000120098666,0.0005996469,0.000063795735,0.000008508283,0.000033962147,0.000054445336,7.1383823e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008016793,0.000419495,0.004550222,0.00004326525,0.00030647742,0.0000032744856,0.000082825325,0.001060277,0.99307585,0.000024837333,0.00001580003,0.00033750417],"study_design_scores_gemma":[0.0006721054,0.0006506862,0.00087163,0.000046105113,0.0003050141,0.0000021498352,0.00005827739,0.0012984854,0.995892,0.000022364517,0.000064737964,0.000116444244],"about_ca_topic_score_codex":0.00010033261,"about_ca_topic_score_gemma":0.000073663825,"teacher_disagreement_score":0.0036785922,"about_ca_system_score_codex":0.000018119184,"about_ca_system_score_gemma":0.00007500566,"threshold_uncertainty_score":0.41548},"labels":[],"label_agreement":null},{"id":"W4405037693","doi":"10.1182/blood-2024-204140","title":"Haploidentical and Mismatched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis: A Retrospective Cohort Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Hematopoietic cell; Myelofibrosis; Medicine; Retrospective cohort study; Hematopoietic stem cell transplantation; Transplantation; Cohort; Graft-versus-host disease; Internal medicine; Oncology; Immunology; Haematopoiesis; Stem cell; Biology; Bone marrow; Genetics","score_opus":0.004580391393654998,"score_gpt":0.21856394297392626,"score_spread":0.21398355158027127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405037693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971229,0.0004327928,0.000015505515,0.00011563074,0.00004128625,0.0019574736,0.000019418228,0.00006911671,0.00022589149],"genre_scores_gemma":[0.9991638,0.00011756188,0.0001986393,0.000032474025,0.000017458242,0.00029820137,0.00006736158,0.00003120557,0.00007330853],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986788,0.000056909696,0.00026300494,0.0004759017,0.00032736376,0.0001980428],"domain_scores_gemma":[0.9995841,0.000062546984,0.00003135239,0.00014710502,0.000066909284,0.000107981745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000116701754,0.00020778377,0.000380254,0.0001326191,0.000044804478,0.00005307695,0.00002898438,0.00007699208,0.00004404144],"category_scores_gemma":[0.0000104044075,0.00014777025,0.000040079874,0.00025947153,0.000038283622,0.00007423301,0.000011693923,0.00016201122,0.000021555812],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028454335,0.0045488887,0.9913983,0.00020367898,0.0004384089,0.00039794313,0.0023904939,0.0000010437591,0.00022348868,0.000043984754,0.00000908696,0.000060143957],"study_design_scores_gemma":[0.0102505395,0.0022178905,0.98076653,0.00038910654,0.0016046757,0.0000336899,0.00018432249,0.000014368818,0.0043555894,0.000034025343,0.0000020469272,0.00014721113],"about_ca_topic_score_codex":0.00005883776,"about_ca_topic_score_gemma":0.000086435146,"teacher_disagreement_score":0.0106317615,"about_ca_system_score_codex":0.00007009709,"about_ca_system_score_gemma":0.000047481983,"threshold_uncertainty_score":0.60258955},"labels":[],"label_agreement":null},{"id":"W4405038017","doi":"10.1182/blood-2024-206948","title":"Impact of Luspatercept on Healthcare Resource Use (HCRU) Among Patients with Lower-Risk, Myelodysplastic Syndromes (LR-MDS): A Medical Record Review in Canada, Germany, and Spain","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Myelodysplastic syndromes; Medicine; Health care; Family medicine; Gerontology; Internal medicine; Political science; Bone marrow","score_opus":0.011846007580593235,"score_gpt":0.27380277338951664,"score_spread":0.2619567658089234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940908,0.003417493,0.0000029518453,0.0012189987,0.000050801107,0.00096163835,0.00013168808,0.000032750624,0.000092857634],"genre_scores_gemma":[0.9953883,0.0037330803,0.00005045227,0.0004061434,0.000048466252,0.000039038434,0.00006665099,0.000060943144,0.00020690665],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969852,0.00034567705,0.00048770366,0.0005072774,0.001132203,0.00054192444],"domain_scores_gemma":[0.99798715,0.0007424839,0.000111338784,0.00045662795,0.000110524685,0.0005918982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058306917,0.00028355597,0.0007169124,0.00027111836,0.000043199434,0.000022141865,0.00016296099,0.00013381819,0.0002689847],"category_scores_gemma":[0.0011687683,0.00019102183,0.00008213313,0.0005717854,0.00013505576,0.00009236895,0.00010956546,0.0010044972,0.000010138679],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038913338,0.0002605012,0.9721042,0.0035895517,0.00024963397,0.002453938,0.00014610113,0.0000018543907,0.0000034081575,0.00000201904,0.006722603,0.014077082],"study_design_scores_gemma":[0.0029702478,0.002394289,0.972813,0.019791003,0.0002141779,0.00014450643,0.000026749176,0.00040476504,0.000005232003,0.0000014507822,0.0010416165,0.00019296473],"about_ca_topic_score_codex":0.6335617,"about_ca_topic_score_gemma":0.49880236,"teacher_disagreement_score":0.13475928,"about_ca_system_score_codex":0.0009042772,"about_ca_system_score_gemma":0.0035412686,"threshold_uncertainty_score":0.7789644},"labels":[],"label_agreement":null},{"id":"W4405038023","doi":"10.1182/blood-2024-200008","title":"Burden of Treatment on People with Hemophilia: Global Real-World Data","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Haemophilia; Receipt; Quality of life (healthcare); Family medicine; Pediatrics; Physical therapy; Nursing","score_opus":0.048746168618584884,"score_gpt":0.3494016134181342,"score_spread":0.3006554447995493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9578284,0.00054067635,0.000001494736,0.0032643653,0.00005197096,0.00045170743,0.00022731978,0.00009717986,0.037536882],"genre_scores_gemma":[0.98947006,0.0004772961,0.00032783402,0.000015128471,0.00032005334,0.000019817684,0.0002841359,0.000020549418,0.00906515],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988657,0.00002216371,0.00014831038,0.00039347252,0.000329902,0.00024042363],"domain_scores_gemma":[0.9989104,0.00007174158,0.000020910971,0.0008207719,0.00003668811,0.00013947785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008950115,0.00015625589,0.00030821713,0.00009935535,0.00003344265,0.000020180867,0.00013988913,0.00003626394,0.00010501497],"category_scores_gemma":[0.000013629804,0.00008851862,0.0000574462,0.00053960265,0.00007252574,0.000046173336,0.00006770325,0.00008205761,0.00013561944],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035858848,0.012972033,0.7977782,0.002255243,0.010209983,0.009671484,0.0021568453,0.00003936769,0.0056876778,0.011180515,0.015464925,0.12899783],"study_design_scores_gemma":[0.072314024,0.09392175,0.48135915,0.008292818,0.017449465,0.0023531255,0.0018208532,0.006048608,0.11992413,0.0014782879,0.19272095,0.0023168237],"about_ca_topic_score_codex":0.0017454271,"about_ca_topic_score_gemma":0.001004595,"teacher_disagreement_score":0.31641904,"about_ca_system_score_codex":0.00014362311,"about_ca_system_score_gemma":0.0003820603,"threshold_uncertainty_score":0.36096844},"labels":[],"label_agreement":null},{"id":"W4405038062","doi":"10.1182/blood-2024-200017","title":"Asciminib Shows High Efficacy and Favorable Tolerability at 80 Mg Once Daily and 40 Mg Twice Daily in Patients with Chronic Phase Chronic Myelogenous Leukemia Previously Treated with 2 or More Tyrosine Kinase Inhibitors: Primary Analysis from the ASC4OPT Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Tolerability; Internal medicine; Chronic myelogenous leukemia; Regimen; Bosutinib; Philadelphia chromosome; Adverse effect; Imatinib mesylate; Nilotinib; Gastroenterology; Imatinib; Leukemia; Chromosomal translocation","score_opus":0.009846299612478682,"score_gpt":0.24839092848246946,"score_spread":0.23854462886999078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813982,0.013446288,0.0000068658437,0.00014197406,0.000046333935,0.0044538,0.00029214355,0.00017595195,0.000038442326],"genre_scores_gemma":[0.99726194,0.00026751525,0.00026373187,0.000104433755,0.00021503211,0.00031570208,0.0011985828,0.00011045605,0.00026259918],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99552965,0.00028276411,0.00079342606,0.0017324893,0.00084517064,0.0008164857],"domain_scores_gemma":[0.99727666,0.00055593933,0.00024035011,0.0014297885,0.00014233557,0.0003549335],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004147173,0.0008059072,0.0014126735,0.00027495954,0.00030268522,0.00018057399,0.00025837286,0.00020189266,0.0001903755],"category_scores_gemma":[0.00008678011,0.00046410688,0.00012708585,0.0017219232,0.0004126478,0.0003151462,0.00027908216,0.0006077346,0.000009576153],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010389172,0.009067333,0.95179826,0.0006409521,0.007334814,0.0017011823,0.004799767,0.00022705694,0.0018555556,0.0000010909446,0.00013128394,0.012053538],"study_design_scores_gemma":[0.10018718,0.016115988,0.86343855,0.0012114054,0.01567915,0.00006571009,0.00029790157,0.0009336465,0.00126941,0.0000018598381,0.00016609309,0.00063312904],"about_ca_topic_score_codex":0.0060510486,"about_ca_topic_score_gemma":0.010358322,"teacher_disagreement_score":0.08979801,"about_ca_system_score_codex":0.0056252144,"about_ca_system_score_gemma":0.0022971598,"threshold_uncertainty_score":0.9997811},"labels":[],"label_agreement":null},{"id":"W4405038074","doi":"10.1182/blood-2024-210343","title":"Reni-Cel, an Investigational AsCas12a Gene-Edited Cell Medicine, Led to Sustained Hemoglobin Normalization and Increased Fetal Hemoglobin in Patients with Severe Sickle Cell Disease Treated in the RUBY Trial","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Prenatal Screening and Diagnostics","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Fetal hemoglobin; Medicine; CD34; Stem cell; Genetic enhancement; Progenitor cell; Tolerability; Immunology; Cancer research; Internal medicine; Biology; Adverse effect; Gene; Fetus; Genetics","score_opus":0.006859896190244973,"score_gpt":0.22205516588369292,"score_spread":0.21519526969344796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996557,0.0002376114,0.000044961693,0.0006840148,0.00006710247,0.0015767365,0.00014406852,0.0000909106,0.0005976257],"genre_scores_gemma":[0.9958657,0.000007767208,0.00037413888,0.0005157095,0.00025411905,0.00008547547,0.0027695757,0.00003307208,0.00009444946],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99806833,0.000221032,0.00039829814,0.00044748557,0.0005529148,0.00031193157],"domain_scores_gemma":[0.99883723,0.00026056654,0.00006772881,0.00029406778,0.0001146055,0.00042581945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034721784,0.00026687013,0.00031100152,0.00030217288,0.00006786025,0.00005897332,0.00013002138,0.00010941972,0.000028452041],"category_scores_gemma":[0.00054924685,0.00018028726,0.00003411682,0.0009553696,0.00009289017,0.00019255072,0.000046972305,0.00022142615,0.0000060485404],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040011477,0.005271848,0.9451677,0.00053835183,0.00007753277,0.0011936863,0.002393504,0.00038157214,0.0010692544,0.00016990093,0.003123226,0.00060192734],"study_design_scores_gemma":[0.1591953,0.00412242,0.8274545,0.0006590199,0.0006656332,0.000026455178,0.00046338752,0.0043465323,0.0023243,0.00012049629,0.00014602384,0.00047591756],"about_ca_topic_score_codex":0.00093921885,"about_ca_topic_score_gemma":0.0002127542,"teacher_disagreement_score":0.11918382,"about_ca_system_score_codex":0.00007376226,"about_ca_system_score_gemma":0.0002541559,"threshold_uncertainty_score":0.7351901},"labels":[],"label_agreement":null},{"id":"W4405038077","doi":"10.1182/blood-2024-200914","title":"Outcomes By Refractory Status and Prior Therapies Received in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) from the ECHELON-3 Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Diffuse large B-cell lymphoma; Refractory (planetary science); Medicine; Internal medicine; Lymphoma; Oncology; Ibrutinib; Leukemia; Biology; Chronic lymphocytic leukemia","score_opus":0.006753079207637134,"score_gpt":0.2281801692373907,"score_spread":0.22142709002975358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854176,0.012387218,3.7766912e-7,0.00036233175,0.00013768476,0.001199791,0.00022956925,0.000097589356,0.00016780556],"genre_scores_gemma":[0.99789256,0.0009083709,0.000058061913,0.00042871,0.00003562766,0.0001502485,0.00013899938,0.00005873506,0.0003286626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982173,0.00013610932,0.00031325794,0.0005318737,0.000418757,0.0003826878],"domain_scores_gemma":[0.99868023,0.0005386468,0.00008344339,0.00050751906,0.000044481603,0.00014570108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001472039,0.0003287307,0.00043893937,0.00008070934,0.000110101086,0.00008901053,0.00010096395,0.00010406677,0.00003918306],"category_scores_gemma":[0.00004758817,0.00017278062,0.00006951961,0.0001636779,0.000059760125,0.00013822655,0.00007069623,0.000161678,0.000029117644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030377306,0.062838405,0.9208187,0.000024658159,0.00070530386,0.0001339084,0.0056559206,1.2996177e-8,0.000043201628,0.0000038265957,0.0006317556,0.008840551],"study_design_scores_gemma":[0.08603846,0.0016194901,0.90038043,0.00014276335,0.0005472997,0.0000011147308,0.0014754884,0.0000016393266,0.00019253051,0.00001249358,0.009398462,0.00018983692],"about_ca_topic_score_codex":0.00072105374,"about_ca_topic_score_gemma":0.0002769357,"teacher_disagreement_score":0.08573469,"about_ca_system_score_codex":0.00016628916,"about_ca_system_score_gemma":0.00013612468,"threshold_uncertainty_score":0.70457894},"labels":[],"label_agreement":null},{"id":"W4405038098","doi":"10.1182/blood-2024-198369","title":"Up-Front Matched Unrelated Donor Transplantation in Pediatric Patients with Idiopathic Aplastic Anemia: A Phase II Feasibility Study, on Behalf of Société Francophone De Greffe De Moelle Et De Thérapie Cellulaire (SFGM-TC) and French Reference National Center of Severe Aplastic Anemia","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Cumulative incidence; Transplantation; Aplastic anemia; Graft-versus-host disease; Hematopoietic stem cell transplantation; Incidence (geometry); Pediatrics; Internal medicine; Surgery; Bone marrow","score_opus":0.013733794800129706,"score_gpt":0.2789423146413927,"score_spread":0.265208519841263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970148,0.00032949972,0.0009813724,0.000032141787,0.00009183398,0.0010619784,0.00029017872,0.000048362126,0.00014980636],"genre_scores_gemma":[0.9990614,0.00012244235,0.00041727998,0.000021153503,0.000032008516,0.00006131922,0.00023226778,0.000034768836,0.000017350161],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978401,0.0002204851,0.0006189179,0.000442922,0.0005807197,0.00029687514],"domain_scores_gemma":[0.99898255,0.00038071675,0.00016419354,0.00017126866,0.00016231128,0.00013894154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058496953,0.00026319324,0.00045903132,0.00027528268,0.000054161686,0.000012005621,0.00008572871,0.00023194904,0.00003987075],"category_scores_gemma":[0.00008373514,0.0002296096,0.000053603082,0.0003847601,0.00006351955,0.00009404803,0.000014180335,0.000445482,0.0000034543914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021593075,0.009927453,0.94526654,0.008071813,0.00013931574,0.00028333778,0.024338208,0.00030448093,0.009319176,0.00002290688,0.000014804727,0.00015266184],"study_design_scores_gemma":[0.035462506,0.0043901796,0.94912344,0.0020092074,0.0011116222,0.00019098041,0.0005860454,0.00067554676,0.0060761753,0.00011688842,3.3472895e-7,0.00025707958],"about_ca_topic_score_codex":0.00015202745,"about_ca_topic_score_gemma":0.00020404827,"teacher_disagreement_score":0.0333032,"about_ca_system_score_codex":0.00017721434,"about_ca_system_score_gemma":0.00073187926,"threshold_uncertainty_score":0.9363208},"labels":[],"label_agreement":null},{"id":"W4405038107","doi":"10.1182/blood-2024-207178","title":"Factors Associated with Early Quality of Life Response to Palliative Care during Hematopoietic Cell Transplantation","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Anxiety; Hospital Anxiety and Depression Scale; Quality of life (healthcare); Transplantation; Coping (psychology); Palliative care; Randomized controlled trial; Univariate analysis; Clinical trial; Internal medicine; Physical therapy; Multivariate analysis; Psychiatry","score_opus":0.12091194416198417,"score_gpt":0.3850926061595751,"score_spread":0.26418066199759094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974382,0.0016296582,0.000076276956,0.00007849307,0.00003551021,0.00023478254,0.00017511671,0.000060231156,0.0002717303],"genre_scores_gemma":[0.99957526,0.000055494198,0.00012454871,0.000018237066,0.000019482084,0.000009766446,0.000045869278,0.000019767911,0.0001315922],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895316,0.00012474364,0.000286495,0.00018854719,0.00030744929,0.00013962627],"domain_scores_gemma":[0.99903333,0.00046558425,0.00008298054,0.00012981347,0.00017845703,0.0001098244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001502345,0.00012951388,0.00035447453,0.00011566514,0.000023096696,0.000007890154,0.00004881582,0.00007075621,0.000018352044],"category_scores_gemma":[0.00030142418,0.00009724898,0.00008828732,0.00030255862,0.00003319212,0.00004314211,0.0000078175,0.00010413707,0.0000040489776],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014271602,0.00020931021,0.7752735,0.0023260813,0.0003434554,0.000048003356,0.14033255,0.000009342504,0.07999384,0.000017364959,0.000007315425,0.000012092904],"study_design_scores_gemma":[0.0014969308,0.00037967798,0.6418449,0.0017717546,0.00023721725,1.987383e-7,0.005873919,5.113311e-7,0.3482953,0.0000037838954,0.000012119183,0.00008363712],"about_ca_topic_score_codex":0.000104276485,"about_ca_topic_score_gemma":0.00004245972,"teacher_disagreement_score":0.26830146,"about_ca_system_score_codex":0.00004186406,"about_ca_system_score_gemma":0.00013462115,"threshold_uncertainty_score":0.39656982},"labels":[],"label_agreement":null},{"id":"W4405038113","doi":"10.1182/blood-2024-208892","title":"Communication Training in Pediatric Hematology/Oncology: A Canadian National Needs Assessment","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Hematology; Medicine; Internal medicine; Oncology; Family medicine","score_opus":0.044921848781036756,"score_gpt":0.3638274579540887,"score_spread":0.31890560917305194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8748079,0.0059896843,0.000029750474,0.03857753,0.00033040598,0.00041307253,0.000025781754,0.0001459429,0.07967996],"genre_scores_gemma":[0.99575704,0.000200412,0.0016813207,0.0017963109,0.00028644677,0.000063824955,0.000082059254,0.000018859788,0.00011371348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988404,0.0001350654,0.0003295643,0.0001761298,0.00027644937,0.0002424032],"domain_scores_gemma":[0.99920917,0.00030629922,0.000042025116,0.00020149296,0.00006256194,0.00017847164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010247951,0.000101141166,0.00024989792,0.0006706593,0.00005770048,0.000025245014,0.00011987981,0.00013597391,0.00010208426],"category_scores_gemma":[0.00015498478,0.00010754964,0.000056989124,0.0006397762,0.000038019145,0.00007442455,0.000029066108,0.00042252874,0.00004255279],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000063527215,0.0019344147,0.604316,0.0017998647,0.0007848601,0.0010080606,0.15187888,0.000038790247,0.00018014364,0.20216265,0.02243617,0.013396621],"study_design_scores_gemma":[0.0143128345,0.0010666712,0.7798867,0.0017536597,0.0012233442,0.0024468699,0.026170878,0.0023721,0.00022200574,0.013822705,0.15555346,0.0011687484],"about_ca_topic_score_codex":0.013012133,"about_ca_topic_score_gemma":0.13597101,"teacher_disagreement_score":0.18833995,"about_ca_system_score_codex":0.00039232135,"about_ca_system_score_gemma":0.004953798,"threshold_uncertainty_score":0.9935603},"labels":[],"label_agreement":null},{"id":"W4405038138","doi":"10.1182/blood-2024-209963","title":"Validitation of the Rowland Universal Dementia Assessment Scale (RUDAS) for the Detection of Cognitive Impairment Among Adults with Sickle Cell Disease","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; Institut Universitaire de Gériatrie de Montréal; University Health Network; University of Toronto; Centre Hospitalier de l’Université de Montréal; Université Laval; Université de Montréal","funders":"","keywords":"Dementia; Disease; Cognitive impairment; Medicine; Cognition; Gerontology; Psychiatry; Internal medicine","score_opus":0.0036937272334099385,"score_gpt":0.21735631410266465,"score_spread":0.2136625868692547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940971,0.0009403885,0.0032449134,0.00019588447,0.00010317226,0.0010743454,0.000045340214,0.000016174212,0.00028267936],"genre_scores_gemma":[0.9996627,0.00008519299,0.00005714824,0.00001397554,0.000024321302,0.000039643433,0.000016932972,0.000011297522,0.00008877343],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99946225,0.00002852719,0.00012463986,0.000117306874,0.00017589457,0.00009137634],"domain_scores_gemma":[0.99958646,0.00010837047,0.00006692508,0.00009962151,0.00009733184,0.000041312862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010010894,0.00007215829,0.00008849764,0.000031261927,0.0000680269,0.0000073435885,0.000036879195,0.00003314485,0.000011166728],"category_scores_gemma":[0.000012320153,0.000036153797,0.00008848064,0.00014297436,0.00008585794,0.000036760906,0.000015929027,0.00007932097,5.564594e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008225838,0.011072604,0.8717081,0.009652624,0.0066780574,0.000082923114,0.022633798,0.001274648,0.03899836,0.00030775048,0.0006484486,0.028716857],"study_design_scores_gemma":[0.018297661,0.003212825,0.827585,0.0033903453,0.012961362,0.000010129431,0.018371342,0.017082335,0.098572515,0.000120443845,0.00017553548,0.0002205452],"about_ca_topic_score_codex":0.00006440045,"about_ca_topic_score_gemma":0.000038761893,"teacher_disagreement_score":0.059574157,"about_ca_system_score_codex":0.000015973554,"about_ca_system_score_gemma":0.00011870585,"threshold_uncertainty_score":0.14743091},"labels":[],"label_agreement":null},{"id":"W4405038156","doi":"10.1182/blood-2024-198052","title":"Global Prevalence of Iron Deficiency Utilizing Differing Ferritin Cut-Offs - 15, 30, and 50 μg/L","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ferritin; Iron deficiency; Medicine; Internal medicine; Anemia","score_opus":0.014037101425835904,"score_gpt":0.2686500703229248,"score_spread":0.2546129688970889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9419216,0.046953477,0.000118333395,0.000090161586,0.0001490467,0.00016109787,0.000029259218,0.000079116566,0.010497928],"genre_scores_gemma":[0.998075,0.0010881708,0.00044005437,0.00005621328,0.0000743786,0.0000055835876,0.0000032405098,0.000012886923,0.00024445422],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908483,0.000019199502,0.0001954398,0.00026666143,0.00020948409,0.00022438829],"domain_scores_gemma":[0.9996603,0.00002799181,0.000025902978,0.00018231607,0.000018087787,0.00008538442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000113018956,0.0001230702,0.00019076666,0.00005012743,0.000040719682,0.000021909349,0.00006822668,0.00005879091,0.00013042908],"category_scores_gemma":[0.00006517903,0.000106343745,0.000053643405,0.0001493878,0.00008702775,0.00006637416,0.00006351934,0.000084044346,0.000014468037],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001534226,0.0018409756,0.8142984,0.03468375,0.00006683935,0.0002823271,0.0024481986,0.000008699631,0.056567814,0.025171043,0.0008905208,0.06358804],"study_design_scores_gemma":[0.0039064675,0.00040344315,0.9814978,0.0013036719,0.0014196528,0.00027219567,0.0011066641,0.00023510176,0.0061472487,0.0011773102,0.0021197735,0.00041063843],"about_ca_topic_score_codex":0.00005641097,"about_ca_topic_score_gemma":0.000005769852,"teacher_disagreement_score":0.16719946,"about_ca_system_score_codex":0.000009003958,"about_ca_system_score_gemma":0.00005128081,"threshold_uncertainty_score":0.4336572},"labels":[],"label_agreement":null},{"id":"W4405038158","doi":"10.1182/blood-2024-200739","title":"Clinical Monitoring Practices Among Adult Patients with Pyruvate Kinase Deficiency Who Have Never Been Transfused","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Pyruvate kinase deficiency; Pediatrics; Anemia; Observational study; Internal medicine; Pyruvate kinase","score_opus":0.026305873271450488,"score_gpt":0.30997108692981085,"score_spread":0.28366521365836034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957433,0.0002861019,0.000064181964,0.00026671914,0.00063472905,0.0003345138,0.000010165755,0.00015864523,0.0025016519],"genre_scores_gemma":[0.9974475,0.00020755909,0.00041503378,0.00026272694,0.0006016573,0.000025164494,0.000025760526,0.000035652614,0.0009789706],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99864364,0.00008396737,0.00032541683,0.0004376479,0.0002588642,0.0002504789],"domain_scores_gemma":[0.999106,0.00019135779,0.00011924145,0.00025328514,0.00016966941,0.00016043808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016013805,0.00016750445,0.00028920305,0.000086150845,0.00007933638,0.000034693116,0.00006661003,0.00015079025,0.00007362288],"category_scores_gemma":[0.00021281395,0.00012038442,0.000113171955,0.00018947886,0.00010671385,0.00028861477,0.000017392056,0.00043930687,0.00007559176],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035669754,0.0010009342,0.99249333,0.00017699908,0.0001419202,0.00016255178,0.0003891704,0.0000021036203,0.0008265499,0.00003851453,0.0002000231,0.004211192],"study_design_scores_gemma":[0.0050585503,0.0017264304,0.98662907,0.00045502055,0.0006506285,0.000009929163,0.00023538794,0.00009959825,0.0020081522,0.000014820725,0.0029267252,0.00018571447],"about_ca_topic_score_codex":0.0000799077,"about_ca_topic_score_gemma":0.00001953669,"teacher_disagreement_score":0.0058643017,"about_ca_system_score_codex":0.00001547947,"about_ca_system_score_gemma":0.00009304231,"threshold_uncertainty_score":0.49091342},"labels":[],"label_agreement":null},{"id":"W4405038162","doi":"10.1182/blood-2024-209476","title":"FLAG-IDA Plus Venetoclax in High-Risk Newly Diagnosed and Relapsed or Refractory Acute Myeloid Leukemia: The Princess Margaret Cancer Center Experience","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Venetoclax; Flag (linear algebra); Myeloid leukemia; Refractory (planetary science); Medicine; Oncology; Cancer; Internal medicine; Center (category theory); Leukemia; Gerontology; Chronic lymphocytic leukemia; Biology","score_opus":0.015883203395651534,"score_gpt":0.29832851439194685,"score_spread":0.28244531099629533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99198115,0.0042418423,0.000026188289,0.001589989,0.00041151143,0.0010413498,0.000092821836,0.00014606223,0.00046910276],"genre_scores_gemma":[0.98224884,0.012471813,0.00032013844,0.00065437047,0.00051614473,0.00064248615,0.000035257883,0.000086133434,0.003024823],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973593,0.00018502898,0.00042527492,0.0007459725,0.00060490135,0.0006795517],"domain_scores_gemma":[0.998384,0.0005216555,0.00008541506,0.0006786976,0.00007602689,0.0002542114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004134427,0.0003264331,0.00046322474,0.00020549688,0.00015017939,0.00012872893,0.0003999737,0.0002596117,0.000290283],"category_scores_gemma":[0.00026884075,0.00020052813,0.00008070517,0.00066921214,0.00031377823,0.00024749676,0.00031497178,0.0013488345,0.000051231043],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011616948,0.0013812218,0.59129673,0.003174614,0.0045878394,0.056101996,0.075847164,0.00036821282,0.05093184,0.0009428477,0.060644858,0.14310575],"study_design_scores_gemma":[0.07197023,0.0027946346,0.62755007,0.0047882753,0.002020655,0.0017440056,0.0051713185,0.009007955,0.03580026,0.0002760058,0.23684719,0.0020293968],"about_ca_topic_score_codex":0.0044493857,"about_ca_topic_score_gemma":0.0015069802,"teacher_disagreement_score":0.17620234,"about_ca_system_score_codex":0.0017912721,"about_ca_system_score_gemma":0.0025548553,"threshold_uncertainty_score":0.81772995},"labels":[],"label_agreement":null},{"id":"W4405038178","doi":"10.1182/blood-2024-212183","title":"Measuring the Utility of the Adolescent Menstrual Bleeding Questionnaire (aMBQ) in a Culturally Diverse Adolescent Population","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Menstrual Health and Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Medicine; Population; Psychology; Clinical psychology; Pediatrics; Developmental psychology; Environmental health","score_opus":0.03929118334785057,"score_gpt":0.2910467650319962,"score_spread":0.25175558168414564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955122,0.0015329487,0.000014138792,0.0014023107,0.00038105913,0.00055619597,0.0000051387833,0.00004518319,0.00055084616],"genre_scores_gemma":[0.99952114,0.000060862905,0.00003683564,0.00021846642,0.000105962936,0.000009710864,0.0000047548174,0.000008528866,0.000033729888],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988439,0.00008146494,0.00031150086,0.00019379551,0.00035704544,0.00021230427],"domain_scores_gemma":[0.99958384,0.000018102524,0.0000577547,0.0002067589,0.00005557796,0.00007796447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036754739,0.00010965588,0.00015490729,0.00005054479,0.000100199344,0.000014906397,0.00008986339,0.00006249383,0.000021025991],"category_scores_gemma":[0.0001318491,0.000059205388,0.00008838848,0.0002775917,0.000058088066,0.00005895138,0.000055108216,0.00029247388,0.0000052033156],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001219042,0.0004796973,0.978872,0.0019181786,0.000033796492,0.000014896383,0.0018230331,0.000010839037,0.0008367935,0.00046463677,0.0003296442,0.0150945885],"study_design_scores_gemma":[0.0011003416,0.000042446958,0.99287623,0.0027689938,0.00011316233,0.00003057825,0.0009952702,0.0009952368,0.0008004806,0.00009853316,0.00011358381,0.00006514789],"about_ca_topic_score_codex":0.0005034538,"about_ca_topic_score_gemma":0.000331192,"teacher_disagreement_score":0.015029441,"about_ca_system_score_codex":0.000061050276,"about_ca_system_score_gemma":0.00011577563,"threshold_uncertainty_score":0.24143256},"labels":[],"label_agreement":null},{"id":"W4405038201","doi":"10.1182/blood-2024-207298","title":"Complement Activation and Its Implication in the Pathophysiology of Hemolytic Anemia and Aging in Mouse Models of Sickle Cell Disease and Beta-Thalassemia","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Complement system; Hemolytic anemia; Immunology; Hemolysis; Thalassemia; Complement factor B; Beta thalassemia; Medicine; Antibody opsonization; Hemoglobinopathy; Internal medicine; Immune system; Antibody; Opsonin","score_opus":0.011900751084691642,"score_gpt":0.25027065444382524,"score_spread":0.2383699033591336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994746,0.0041485033,0.000019085695,0.00068337907,0.0000044103695,0.00030129286,0.000011308395,0.0000053701287,0.00008064359],"genre_scores_gemma":[0.99875224,0.0011084798,0.000034613535,0.000053667372,0.000005889471,0.00001188759,0.000015510226,0.0000057346206,0.000012000968],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9995339,0.00002975699,0.00016316857,0.00013221151,0.000062277155,0.0000787134],"domain_scores_gemma":[0.999778,0.00006211295,0.000034479373,0.000080657825,0.000014539217,0.000030230289],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001059379,0.000060214174,0.0001283795,0.00007338306,0.000012477197,0.0000044030276,0.000020267937,0.000037739417,0.0000015928742],"category_scores_gemma":[0.0000097140855,0.00004247079,0.00001206936,0.000102194244,0.000031672887,0.000045264485,0.000023424493,0.0000886277,1.1339599e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000832876,0.0005072588,0.0150590865,0.002497543,0.000028456321,0.000019325551,0.0039180852,0.0001779261,0.9728834,0.0014041397,0.000021863447,0.0033996317],"study_design_scores_gemma":[0.015644642,0.0010758057,0.4774416,0.00208062,0.0009499358,0.000058210422,0.006406593,0.09838297,0.38385493,0.0135172345,0.00007705516,0.00051039516],"about_ca_topic_score_codex":0.000045260887,"about_ca_topic_score_gemma":0.0000035955047,"teacher_disagreement_score":0.5890285,"about_ca_system_score_codex":0.0000068755226,"about_ca_system_score_gemma":0.000026763732,"threshold_uncertainty_score":0.17319085},"labels":[],"label_agreement":null},{"id":"W4405038296","doi":"10.1182/blood-2024-197948","title":"Matching-Adjusted Indirect Comparison (MAIC) of Efficacy and Safety Outcomes for Lisocabtagene Maraleucel (liso-cel) Versus Axicabtagene Ciloleucel (axi-cel) and Tisagenlecleucel (tisa-cel) for the Treatment of Third-Line or Later (3L+) Relapsed or Refractory (R/R) Follicular Lymphoma (FL)","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Internal medicine","score_opus":0.06928148602245389,"score_gpt":0.3452610976245043,"score_spread":0.2759796116020504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9747808,0.017645285,0.00040778462,0.0009538998,0.0005360408,0.0047815978,0.0005300848,0.00016415329,0.00020038453],"genre_scores_gemma":[0.97280407,0.009572942,0.0028670582,0.00013090418,0.00034373716,0.0005556217,0.00024837325,0.00023417485,0.013243139],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99618584,0.00018856839,0.0012219512,0.0009455713,0.00069935963,0.00075873896],"domain_scores_gemma":[0.9934498,0.0046856576,0.00032700502,0.000984059,0.00023838408,0.000315099],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00084716314,0.00066929654,0.001764878,0.00037546677,0.00027732167,0.00009285968,0.0003127566,0.00041111215,0.00031120464],"category_scores_gemma":[0.00030341005,0.00040926348,0.00061831856,0.000504521,0.0003594297,0.00012836324,0.0001334486,0.0002491156,0.0000069992243],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13947262,0.01690093,0.0053714034,0.0059151514,0.019984119,0.0004936089,0.01351816,0.00006966768,0.43153998,0.0002349204,0.00224361,0.36425585],"study_design_scores_gemma":[0.2439772,0.048610263,0.041168034,0.0015128271,0.0142000215,0.00031112268,0.0031928841,0.004865761,0.50212187,0.0001914611,0.13809937,0.0017491851],"about_ca_topic_score_codex":0.00028730938,"about_ca_topic_score_gemma":0.00032259914,"teacher_disagreement_score":0.36250666,"about_ca_system_score_codex":0.00023317235,"about_ca_system_score_gemma":0.00041745146,"threshold_uncertainty_score":0.9998359},"labels":[],"label_agreement":null},{"id":"W4405038298","doi":"10.1182/blood-2024-205959","title":"Treatment Strategies and Outcomes of the Rare Histiocytic Disorders: Long-Term Results of the International Rare Histiocytic Disorders Registry (IRHDR)","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Histiocyte; Medicine; Term (time); Pathology; Physics","score_opus":0.012081844797311824,"score_gpt":0.2646420519305393,"score_spread":0.25256020713322747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98167646,0.0048478474,0.000028113416,0.0033614985,0.0006128621,0.0007526429,0.00027907768,0.000054716253,0.0083867805],"genre_scores_gemma":[0.99318904,0.0006729074,0.000061873645,0.000035687193,0.000042089487,0.000047722344,0.0000678546,0.000029573677,0.00585324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984648,0.000045269924,0.0004759975,0.000382467,0.0004248973,0.00020654431],"domain_scores_gemma":[0.998899,0.00014736326,0.00019211955,0.0006386827,0.00005737154,0.000065499116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006850154,0.00027787124,0.00039077838,0.000086641034,0.00011148621,0.000060559247,0.0002636268,0.00009580023,0.000047540296],"category_scores_gemma":[0.00014308238,0.00014981892,0.00028936955,0.00020929491,0.00038881836,0.00011571276,0.000102312835,0.0001365954,0.0000048432194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004834141,0.0047351504,0.94832176,0.0014006973,0.0041598193,0.0001427025,0.0038806882,0.00006223601,0.00049047347,0.008959124,0.0010072449,0.026356688],"study_design_scores_gemma":[0.024034658,0.0010368288,0.9561832,0.0015765429,0.0038610757,0.00018718916,0.0016300549,0.0003641919,0.0013875569,0.004136704,0.0051635313,0.00043847002],"about_ca_topic_score_codex":0.00045893615,"about_ca_topic_score_gemma":0.00084564154,"teacher_disagreement_score":0.025918217,"about_ca_system_score_codex":0.00021026423,"about_ca_system_score_gemma":0.0005296088,"threshold_uncertainty_score":0.61094385},"labels":[],"label_agreement":null},{"id":"W4405038326","doi":"10.1182/blood-2024-208976","title":"The Serious Illness Conversation Guide Is Meaningful to Patients with Hematologic Malignancies and Impacts Death in Acute Care","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Conversation; Hematologic Neoplasms; Medicine; Intensive care medicine; Advance care planning; Palliative care; Gerontology; Internal medicine; Psychology; Cancer; Nursing","score_opus":0.025252552791319296,"score_gpt":0.3310954353092941,"score_spread":0.3058428825179748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99503106,0.0036165398,0.000018123235,0.0005531327,0.000053524924,0.00027103582,0.000022517284,0.000027335156,0.00040675694],"genre_scores_gemma":[0.998782,0.0005091628,0.0003305232,0.00026042602,0.000014475045,0.000015488604,0.000015338857,0.00000992783,0.0000626821],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999429,0.000014978655,0.00013001336,0.00014342237,0.00014724428,0.00013536544],"domain_scores_gemma":[0.9996247,0.00006384586,0.00002753917,0.00011153671,0.00011871053,0.000053661777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000052614494,0.00009214683,0.0001665155,0.000052160343,0.00003463975,0.00002115074,0.000039201277,0.00003666616,0.0000039518395],"category_scores_gemma":[0.000077920326,0.00005228864,0.000020133326,0.00014804199,0.000030446457,0.0000483844,0.000025562438,0.00005216271,0.000004769882],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000087898195,0.00003850818,0.9601213,0.00022374468,0.0001577572,0.000116750816,0.037448134,6.598183e-7,0.000412553,0.00016273219,0.00036074736,0.00086924445],"study_design_scores_gemma":[0.0062376964,0.0017311266,0.8338558,0.0056726313,0.00091969356,0.00009100217,0.01856906,0.000038772523,0.11295058,0.00014769357,0.019354638,0.00043132604],"about_ca_topic_score_codex":0.00013554632,"about_ca_topic_score_gemma":0.00010971106,"teacher_disagreement_score":0.12626548,"about_ca_system_score_codex":0.00003093673,"about_ca_system_score_gemma":0.000055728262,"threshold_uncertainty_score":0.21322688},"labels":[],"label_agreement":null},{"id":"W4405038337","doi":"10.1182/blood-2024-200836","title":"Outcomes in Older Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) from the ECHELON-3 Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Victoria Hospital; Centre intégré de santé et de services sociaux de la Montérégie-Centre; Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Centre Intégré de Santé et de Services Sociaux des Laurentides; Santé Montérégie; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Diffuse large B-cell lymphoma; Medicine; Lymphoma; Refractory (planetary science); Ibrutinib; Hematologic Neoplasms; Large-cell lymphoma; Oncology; Internal medicine; Cancer; Leukemia; Biology; Chronic lymphocytic leukemia","score_opus":0.007211173418807461,"score_gpt":0.2324425596235811,"score_spread":0.22523138620477365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957976,0.0016917356,0.0000010631541,0.0003513712,0.00020198304,0.0011367397,0.00010404748,0.000098221106,0.0006172432],"genre_scores_gemma":[0.9985511,0.000050794635,0.000046486533,0.00046487444,0.00007126246,0.00018990006,0.00008912896,0.000047270725,0.00048923306],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985118,0.00007056999,0.000266372,0.00043597491,0.00041500863,0.00030027376],"domain_scores_gemma":[0.99893343,0.00033826285,0.000047292597,0.00054386974,0.000035521574,0.00010160691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010793335,0.0002583365,0.00035651212,0.00007659655,0.00006896182,0.000058642596,0.00012156179,0.000079652134,0.000070343565],"category_scores_gemma":[0.000031802243,0.00012999542,0.00010136865,0.00020273327,0.00002585658,0.00008444333,0.00007430415,0.000116231895,0.0001730083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006779056,0.12931599,0.8654595,0.000019820685,0.00043542212,0.00058311236,0.002067244,4.646221e-8,0.0000051437896,0.0000131744555,0.00048927474,0.0015434579],"study_design_scores_gemma":[0.096136466,0.0007722934,0.8995908,0.00015465003,0.0007189435,0.0000026298796,0.0005553043,0.0000045657016,0.0002062523,0.000011253271,0.0017029002,0.00014395975],"about_ca_topic_score_codex":0.00048195664,"about_ca_topic_score_gemma":0.00031751205,"teacher_disagreement_score":0.12854369,"about_ca_system_score_codex":0.00012785222,"about_ca_system_score_gemma":0.0001129408,"threshold_uncertainty_score":0.53010595},"labels":[],"label_agreement":null},{"id":"W4405038355","doi":"10.1182/blood-2024-211761","title":"Multicenter Retrospective Analysis on the Clinical Benefit of Post-Transplant Tyrosine Kinase Inhibitor (TKI) Maintenance Therapy in Ph-Positive Acute Lymphoblastic Leukemia Suggests Improved GvHD-Free, Relapse Free Survival and Non-Relapse Mortality, but Not the Risk of Relapse","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Maintenance therapy; Oncology; Tyrosine-kinase inhibitor; Acute lymphocytic leukemia; Retrospective cohort study; Hematology; Lymphoblastic Leukemia; Progression-free survival; Overall survival; Leukemia; Immunology; Chemotherapy; Cancer","score_opus":0.012764887577471254,"score_gpt":0.28272191131269203,"score_spread":0.2699570237352208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99214524,0.0006159245,0.00012237605,0.0014244333,0.00038870246,0.0017454374,0.0032411444,0.000055147393,0.00026156547],"genre_scores_gemma":[0.99567634,0.0030779757,0.00018378579,0.00028709212,0.0002359262,0.00010928669,0.000084042316,0.00009801978,0.00024752194],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9946301,0.0005911822,0.0015551738,0.0011536839,0.0013082885,0.00076155405],"domain_scores_gemma":[0.99246794,0.003933584,0.00049543043,0.0021121807,0.0007002934,0.00029056263],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0026809236,0.00061185186,0.0014485319,0.0004889459,0.00015515165,0.000071839335,0.0008677893,0.0004430781,0.00005317641],"category_scores_gemma":[0.002289349,0.00034597257,0.0007506884,0.0016065764,0.0011891255,0.0001609334,0.00045880926,0.0014680963,0.0000106682755],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025609635,0.0059741396,0.7334944,0.00066990376,0.033200588,0.0042655417,0.0058725234,0.00013246179,0.18554197,0.0027586569,0.0008001024,0.001680049],"study_design_scores_gemma":[0.024439305,0.0030944447,0.8803397,0.0009986124,0.0069470047,0.00006655432,0.00042962455,0.009503093,0.0735551,0.00024390128,0.0000053066533,0.00037735407],"about_ca_topic_score_codex":0.0047392556,"about_ca_topic_score_gemma":0.0022491345,"teacher_disagreement_score":0.14684528,"about_ca_system_score_codex":0.00072862545,"about_ca_system_score_gemma":0.0009010952,"threshold_uncertainty_score":0.9998992},"labels":[],"label_agreement":null},{"id":"W4405038380","doi":"10.1182/blood-2024-211342","title":"Inhibitors Significantly Impair Quality of Life for Hemophilia a Patients","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Quality of life (healthcare); Internal medicine; Intensive care medicine","score_opus":0.041050423775483784,"score_gpt":0.3388596267595087,"score_spread":0.2978092029840249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965889,0.0005825398,0.000009615546,0.0008301727,0.0001467485,0.0007968837,0.0000804983,0.000072825365,0.00089184515],"genre_scores_gemma":[0.99804354,0.000022221559,0.00025327568,0.000045632714,0.0003158695,0.00005827238,0.00007210683,0.000022419663,0.0011666695],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885905,0.000033430133,0.00032593633,0.0002294904,0.0003280943,0.00022401004],"domain_scores_gemma":[0.9992579,0.0001921777,0.000033735232,0.00019744973,0.00013770846,0.00018098025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029560394,0.00010839745,0.00027800974,0.00011708666,0.00003391577,0.000012622003,0.000054399232,0.000082626364,0.000050383933],"category_scores_gemma":[0.00028056034,0.00007567922,0.00020232865,0.00021105065,0.0000590262,0.00003938565,0.000026169102,0.000097510296,0.000033862812],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089170685,0.0064881244,0.9148301,0.0050360933,0.001149203,0.000048427075,0.00097238296,4.217805e-7,0.046860766,0.00073557976,0.013802095,0.009185128],"study_design_scores_gemma":[0.035956196,0.008757957,0.59302545,0.001370254,0.0013050963,0.000012027675,0.0005285596,0.00022785761,0.34198055,0.0018818096,0.014197778,0.00075648224],"about_ca_topic_score_codex":0.000020743684,"about_ca_topic_score_gemma":0.0000019584438,"teacher_disagreement_score":0.3218046,"about_ca_system_score_codex":0.000023290731,"about_ca_system_score_gemma":0.00019992163,"threshold_uncertainty_score":0.3086109},"labels":[],"label_agreement":null},{"id":"W4405038418","doi":"10.1182/blood-2024-207342","title":"Costs of Healthcare Resource Utilization in the Management of Patients with Higher-Risk Myelodysplastic Syndrome in Canada","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Université Laval; Ottawa Hospital","funders":"AbbVie Canada","keywords":"Medicine; Myelodysplastic syndromes; Health care; Intensive care medicine; Internal medicine","score_opus":0.01378936709395237,"score_gpt":0.25594640395800916,"score_spread":0.2421570368640568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99750763,0.0005584055,0.000007726109,0.00062427233,0.000027426322,0.0006322175,0.000051588133,0.000006570632,0.00058418995],"genre_scores_gemma":[0.9996155,0.00007306322,0.000076640856,0.00005564301,0.0000064031897,0.00002707061,0.00005805644,0.00001486316,0.0000727746],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873257,0.00009927973,0.00025405426,0.0001687274,0.00055785716,0.00018752509],"domain_scores_gemma":[0.9994995,0.00012011711,0.000049737653,0.00023736902,0.00005051487,0.00004276349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021456393,0.00008179664,0.00017852102,0.0001533011,0.00001251114,0.0000041310914,0.0001184858,0.000031204134,0.000017490209],"category_scores_gemma":[0.000016593587,0.00005348652,0.00001386814,0.00076389173,0.000029432977,0.000023598739,0.000037711845,0.00022543003,0.0000013717433],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034786898,0.00048018817,0.9845524,0.0031333768,0.00022700398,0.0015008608,0.0005943628,0.00010890834,0.000008519457,0.0010482518,0.0004315165,0.0075667575],"study_design_scores_gemma":[0.0026377654,0.0003485006,0.9940904,0.0013678299,0.000097140735,0.000011498732,0.00052620994,0.00020576241,0.00006293345,0.0000117824575,0.00058932515,0.00005084526],"about_ca_topic_score_codex":0.32325396,"about_ca_topic_score_gemma":0.29781285,"teacher_disagreement_score":0.025441093,"about_ca_system_score_codex":0.00047266384,"about_ca_system_score_gemma":0.0005665148,"threshold_uncertainty_score":0.7150002},"labels":[],"label_agreement":null},{"id":"W4405038423","doi":"10.1182/blood-2024-200937","title":"Matching-Adjusted Indirect Comparison (MAIC) of Lisocabtagene Maraleucel (liso-cel) Versus Axicabtagene Ciloleucel (axi-cel) for Second-Line (2L) Treatment of Patients (pts) with Refractory/Early Relapsed (R/R) Large B-Cell Lymphoma (LBCL): Update with 34 Months of Liso-Cel Follow-up","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Refractory (planetary science); Medicine; Internal medicine; Second line treatment; Nuclear medicine; Gastroenterology; Oncology; Physics; Chemotherapy","score_opus":0.027326737559294444,"score_gpt":0.28131938889399033,"score_spread":0.2539926513346959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874224,0.004302579,0.00019827156,0.00008204974,0.00047714307,0.003464281,0.0018355502,0.00018098523,0.002036752],"genre_scores_gemma":[0.9874635,0.00058413035,0.0019004105,0.000036625857,0.00019148426,0.00033521932,0.0012282374,0.0003247557,0.007935647],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9942512,0.00025060616,0.001589655,0.001220011,0.0015572438,0.0011313104],"domain_scores_gemma":[0.99573386,0.00059777,0.000869604,0.0014894186,0.0008225524,0.00048681872],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005900652,0.0009343193,0.0023584457,0.00081558194,0.0001543209,0.00006498282,0.0005067131,0.00047432145,0.0007959737],"category_scores_gemma":[0.000057607293,0.00072536804,0.00065676286,0.0011750188,0.00030579467,0.00027086207,0.0001452155,0.00040097316,0.00002702063],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19162288,0.1282175,0.0789433,0.011183243,0.018965961,0.0007511709,0.019927057,0.00011530266,0.50865614,0.00029229038,0.0027979636,0.03852719],"study_design_scores_gemma":[0.22480704,0.052828714,0.011703153,0.001146913,0.004369085,0.000022869304,0.0013101122,0.0005994272,0.6884345,0.000037716327,0.013680928,0.0010595695],"about_ca_topic_score_codex":0.00072539743,"about_ca_topic_score_gemma":0.0009227286,"teacher_disagreement_score":0.17977832,"about_ca_system_score_codex":0.00048271165,"about_ca_system_score_gemma":0.00084694277,"threshold_uncertainty_score":0.99951977},"labels":[],"label_agreement":null},{"id":"W4405038457","doi":"10.1182/blood-2024-201543","title":"Efficacy Outcomes By Minimal Residual Disease (MRD) Negativity in Patients with Relapsed or Refractory Multiple Myeloma Treated with Belantamab Mafodotin Plus Bortezomib and Dexamethasone Vs Daratumumab, Bortezomib, and Dexamethasone: Analysis from the Dreamm-7 Trial","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada); University of Alberta","funders":"","keywords":"Daratumumab; Bortezomib; Dexamethasone; Medicine; Internal medicine; Oncology; Multiple myeloma; Minimal residual disease; Refractory (planetary science); Carfilzomib; Bone marrow; Biology","score_opus":0.014830320408139985,"score_gpt":0.26912738377670514,"score_spread":0.25429706336856517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933867,0.0014812517,0.000019447256,0.0005226212,0.000036887515,0.0028905466,0.0014914793,0.00013535921,0.00003573229],"genre_scores_gemma":[0.9962233,0.00013503886,0.0011284976,0.00008027448,0.0000853779,0.0002320307,0.0016414621,0.00009554919,0.00037851895],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957092,0.000594235,0.0006217848,0.001286553,0.0010376084,0.0007506317],"domain_scores_gemma":[0.9947548,0.003353522,0.00019600666,0.0008434532,0.00011626725,0.0007359722],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044463243,0.0006693065,0.0012983856,0.00041247928,0.0002668058,0.00023400149,0.00019615267,0.0002078598,0.00008180035],"category_scores_gemma":[0.0011920988,0.00035615324,0.0001620408,0.0012484103,0.00044214158,0.00028981696,0.00014379447,0.0006897487,0.0000071567583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20124668,0.0028569251,0.78472435,0.000056575635,0.00480669,0.0012131865,0.0004374972,0.0000020168607,0.00007422928,0.0000013323888,0.00018813585,0.0043924055],"study_design_scores_gemma":[0.20935702,0.0034828957,0.78045326,0.00023028089,0.0050951866,0.000008349369,0.00013808542,0.0005121701,0.0002750124,0.000002413418,0.000099502075,0.00034580549],"about_ca_topic_score_codex":0.0034803809,"about_ca_topic_score_gemma":0.0034639603,"teacher_disagreement_score":0.008110356,"about_ca_system_score_codex":0.00016627552,"about_ca_system_score_gemma":0.00044666493,"threshold_uncertainty_score":0.999889},"labels":[],"label_agreement":null},{"id":"W4405038497","doi":"10.1182/blood-2024-208983","title":"“I Really Wish We Had a Talk on Advocacy That Wasn't Boring”: Toward a Health Advocacy Curriculum That Meets the Needs of Canadian Hematology Residents","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Nursing Education, Practice, and Leadership","field":"Nursing","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Wish; Curriculum; Patient advocacy; Medicine; Consumer Advocacy; Political science; Public relations; Nursing; Sociology; MEDLINE; Law","score_opus":0.03971793992954116,"score_gpt":0.31517992367053876,"score_spread":0.2754619837409976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5396457,0.018425167,0.0000075161233,0.42296037,0.007510637,0.0009790797,0.000025180312,0.0002854087,0.010160962],"genre_scores_gemma":[0.9953391,0.00054061605,0.00015987165,0.0026011623,0.00051200314,0.00004809419,0.000033162916,0.000084066094,0.0006819144],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972021,0.0004840753,0.00044092326,0.0004586412,0.00054659555,0.00086766435],"domain_scores_gemma":[0.9980432,0.00045563994,0.00026778696,0.000728242,0.00009251303,0.00041261906],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009025943,0.00033207273,0.0004378723,0.0010493096,0.00036719133,0.00022652649,0.00056951836,0.00020065028,0.0000829784],"category_scores_gemma":[0.0002714961,0.00027202078,0.00017065565,0.0011503743,0.00017365947,0.0003446862,0.000018663186,0.0006717168,0.000086354565],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047764933,0.0035217656,0.05092332,0.003446126,0.00083414,0.000297878,0.4361215,0.000014701238,0.00036862973,0.015900644,0.45663467,0.031458978],"study_design_scores_gemma":[0.004211441,0.002319293,0.09712352,0.009386895,0.0013828097,0.0022125004,0.21333827,0.00007184364,0.018732185,0.0052840193,0.644323,0.0016142156],"about_ca_topic_score_codex":0.26907656,"about_ca_topic_score_gemma":0.056590583,"teacher_disagreement_score":0.45569342,"about_ca_system_score_codex":0.0002636213,"about_ca_system_score_gemma":0.0018301308,"threshold_uncertainty_score":0.9999732},"labels":[],"label_agreement":null},{"id":"W4405038508","doi":"10.1182/blood-2024-210449","title":"Retrospective Evaluation of <i>BCR::ABL</i> Kinase Domain Mutation Profiles and Treatment Outcomes in Patients with Chronic Myeloid Leukemia to Confirm Clinical Relevance of in Vitro Sensitivity-Based Treatment Switch: Real-World Experience","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Myeloid leukemia; Medicine; Oncology; Mutation; Protein kinase domain; Internal medicine; Cancer research; Immunology; Biology; Genetics; Gene","score_opus":0.024132269505190866,"score_gpt":0.32404373131770464,"score_spread":0.29991146181251377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99614215,0.00026239737,0.000018458792,0.000108549604,0.00008229774,0.0030789091,0.00013438087,0.000039848128,0.00013298527],"genre_scores_gemma":[0.9971867,0.00008451124,0.0019089209,0.000023258546,0.000042231353,0.000500872,0.00017366723,0.000039506867,0.000040307725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971356,0.00030562637,0.00080416584,0.00073988014,0.00069987384,0.00031488246],"domain_scores_gemma":[0.99848425,0.0004906527,0.00022635526,0.00045383762,0.00021250635,0.00013241624],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005969151,0.0003565572,0.0009354722,0.0003999562,0.00002854875,0.000013327867,0.00004218016,0.000109515226,0.000014085704],"category_scores_gemma":[0.00021479452,0.00026372925,0.00010899938,0.00061798736,0.00015458831,0.00011287837,0.000022413533,0.0001375504,0.0000036127274],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021785614,0.003422175,0.96169287,0.00014597957,0.0003103521,0.0002394952,0.0028418228,0.00025337408,0.008981953,0.000041141044,0.0000017933788,0.019890472],"study_design_scores_gemma":[0.035114527,0.004457403,0.8431841,0.0007353632,0.00054005947,0.000005837886,0.00017035198,0.0013282243,0.114232406,0.000029978599,0.00001327693,0.00018848278],"about_ca_topic_score_codex":0.0025147714,"about_ca_topic_score_gemma":0.005348907,"teacher_disagreement_score":0.118508786,"about_ca_system_score_codex":0.00724973,"about_ca_system_score_gemma":0.0020005098,"threshold_uncertainty_score":0.99998146},"labels":[],"label_agreement":null},{"id":"W4405038512","doi":"10.1182/blood-2024-210205","title":"How Does Cognition Impact Healthcare Transition Skills, Engagement and Utilization in Young Adults Living with Sickle Cell Disease?","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"","keywords":"Disease; Cognition; Gerontology; Medicine; Young adult; Psychology; Psychiatry","score_opus":0.007371359820848105,"score_gpt":0.23849878063997165,"score_spread":0.23112742081912355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918239,0.0051660184,0.00026535123,0.001886644,0.000057586225,0.00049621036,0.000035134188,0.00008397438,0.00018519515],"genre_scores_gemma":[0.9974045,0.0021566746,0.0000536991,0.000074671305,0.000049045262,0.000023031025,0.00015041862,0.000020936712,0.00006703339],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999301,0.00005495621,0.00010714316,0.00022322885,0.00014785556,0.00016577201],"domain_scores_gemma":[0.99971104,0.000029686893,0.00002021413,0.000076432516,0.000037752874,0.00012486623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010505131,0.00011444511,0.0001166843,0.00011095904,0.00005970022,0.000055910652,0.000013839942,0.00006396461,0.000017502263],"category_scores_gemma":[0.000020596788,0.00007243319,0.00003478685,0.00019244487,0.00002431461,0.00012864296,0.000006855936,0.00017622342,0.0000018479493],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017161397,0.011566514,0.7408551,0.03238617,0.00089011993,0.002181971,0.108871505,0.00019122595,0.008950927,0.00035352953,0.00036929635,0.09166753],"study_design_scores_gemma":[0.013123775,0.0026948678,0.91852146,0.021863066,0.0020723871,0.00018388909,0.026168182,0.0105090095,0.0035200396,0.00037448865,0.000196117,0.0007726928],"about_ca_topic_score_codex":0.00010592701,"about_ca_topic_score_gemma":0.00017553144,"teacher_disagreement_score":0.17766641,"about_ca_system_score_codex":0.00002934873,"about_ca_system_score_gemma":0.00007611262,"threshold_uncertainty_score":0.29537398},"labels":[],"label_agreement":null},{"id":"W4405038516","doi":"10.1182/blood-2024-206089","title":"Disparities in Clinical Trial Participation Among Medicare Beneficiaries with Hematologic Malignancies from 2006 to 2019: A SEER-Medicare Analysis","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Hematologic Neoplasms; Internal medicine; Gerontology; Cancer","score_opus":0.03411505637659575,"score_gpt":0.2850551019978854,"score_spread":0.2509400456212897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873402,0.0070136725,0.0012515748,0.0011550147,0.0005870004,0.00036421706,0.00089868397,0.0000764993,0.0013131177],"genre_scores_gemma":[0.9980643,0.0003320637,0.00027686593,0.00031743097,0.00040812892,0.00016231604,0.00012999521,0.000024509389,0.00028439992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976519,0.000030915708,0.0011946241,0.0006336286,0.00007692312,0.0004120446],"domain_scores_gemma":[0.99891675,0.00027213027,0.00023518006,0.00034734656,0.000035726214,0.00019289146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007198065,0.00021294155,0.0009353656,0.00042124614,0.00006564619,0.00020242193,0.00023331583,0.00024312302,0.00033260338],"category_scores_gemma":[0.00052203523,0.00019958103,0.00023011175,0.0006804461,0.00013990751,0.00033346814,0.00006627061,0.00024780093,0.00017087968],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004827591,0.00023668673,0.9756091,0.00002949851,0.0006228354,0.000046127192,0.0006370233,0.00029248875,4.5104647e-7,0.020161767,0.0011983183,0.00068294874],"study_design_scores_gemma":[0.0072130226,0.00044390184,0.9769732,0.00016166201,0.00043275082,0.000001011205,0.00019832107,0.001086335,0.000028539993,0.008096859,0.0049005435,0.00046388258],"about_ca_topic_score_codex":0.0058664423,"about_ca_topic_score_gemma":0.013931198,"teacher_disagreement_score":0.012064909,"about_ca_system_score_codex":0.000066844346,"about_ca_system_score_gemma":0.0000953124,"threshold_uncertainty_score":0.88683456},"labels":[],"label_agreement":null},{"id":"W4405038536","doi":"10.1182/blood-2024-206260","title":"Diagnostic Accuracy of Erythropoietin and Jakpot in Predicting JAK2-Postiive Erythrocytosis: A Retrospective Cohort Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Joseph's Hospital; McMaster University","funders":"","keywords":"Erythropoietin; Medicine; Retrospective cohort study; Cohort; Internal medicine","score_opus":0.009680853439043081,"score_gpt":0.2768538329675442,"score_spread":0.2671729795285011,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99150217,0.004044902,0.000006859436,0.00046276578,0.00012923166,0.0025337425,0.00005126083,0.000091101785,0.0011779682],"genre_scores_gemma":[0.99782425,0.001059157,0.00023180604,0.000044370554,0.00013634433,0.0005980614,0.000017511993,0.000038190843,0.000050323226],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981111,0.000095996955,0.00049136725,0.0006209151,0.00040229017,0.00027828052],"domain_scores_gemma":[0.9979592,0.0014208792,0.0000978183,0.00027423038,0.0001255449,0.0001223328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036282264,0.00026653137,0.0006693806,0.00022074793,0.00006689461,0.00004534403,0.00005684199,0.00008811955,0.00009226848],"category_scores_gemma":[0.0018685733,0.00021380774,0.00008174924,0.0004242681,0.00010192785,0.00011931505,0.000093635615,0.0002983577,0.000015715856],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006971494,0.0036632402,0.9895984,0.00022101485,0.0008858993,0.0008336744,0.003563639,0.000002141726,0.00023432293,0.00018607633,0.00010752008,0.0006343639],"study_design_scores_gemma":[0.00435378,0.0026220048,0.9833923,0.0012716772,0.0012649222,0.00014479182,0.0015386752,0.00008941648,0.005028832,0.00010151299,0.0000310572,0.00016102343],"about_ca_topic_score_codex":0.00040741442,"about_ca_topic_score_gemma":0.000277844,"teacher_disagreement_score":0.006322067,"about_ca_system_score_codex":0.00011577651,"about_ca_system_score_gemma":0.00013209585,"threshold_uncertainty_score":0.8718827},"labels":[],"label_agreement":null},{"id":"W4405038567","doi":"10.1182/blood-2024-203957","title":"Deciphering Genotype-Phenotype Correlations and the Mechanism of the Action of Neutrophil Elastase Inhibitors during <i>ELANE</i> Associated Neutropenia Utilizing Molecular Modeling Software","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neutrophil elastase; Neutropenia; Immunology; Phenotype; Genotype; Elastase; Biology; Medicine; Genetics; Gene; Inflammation; Enzyme; Chemotherapy; Biochemistry","score_opus":0.0077702418743305175,"score_gpt":0.21304701771064666,"score_spread":0.20527677583631615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933652,0.004027496,0.0020876438,0.000048836115,0.00013678071,0.00021353924,0.000025574669,0.000015482548,0.0000794319],"genre_scores_gemma":[0.9994469,0.00021109745,0.00020981101,0.000019022511,0.00002944255,0.000013135991,0.000021815762,0.00002524165,0.000023479968],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99927557,0.00006499416,0.00020609137,0.00020387769,0.00011697272,0.00013249415],"domain_scores_gemma":[0.9996017,0.000018345161,0.00008538785,0.00021655149,0.000051771156,0.000026247511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009291644,0.00012275596,0.00013473915,0.000023110644,0.00012888126,0.000021583084,0.000100611054,0.00009549959,0.0000022700929],"category_scores_gemma":[0.000053306198,0.000082501225,0.000109340166,0.00013091112,0.000057805413,0.0000068816503,0.00012903391,0.00010375297,6.0253933e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015266296,0.0002793262,0.0018096862,0.00013027184,0.0008694395,0.000009251615,0.00031985642,0.010987731,0.9825882,0.0018635644,0.000008960353,0.0009810654],"study_design_scores_gemma":[0.0069178985,0.00021309781,0.0011121631,0.00029459532,0.0014206343,0.000040254403,0.00039702558,0.009449846,0.9767065,0.00307453,0.00004029275,0.00033315254],"about_ca_topic_score_codex":0.00007611785,"about_ca_topic_score_gemma":0.000049993836,"teacher_disagreement_score":0.006765235,"about_ca_system_score_codex":0.0000065692307,"about_ca_system_score_gemma":0.000043830016,"threshold_uncertainty_score":0.33643025},"labels":[],"label_agreement":null},{"id":"W4405038568","doi":"10.1182/blood-2024-212330","title":"Gene Expression Profile of Enriched T-Cells Prior to Chimeric Antigen Receptor (CAR) T-Cell Manufacturing Is Predictive of CAR T-Cell Response","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Chimeric antigen receptor; Antigen; T cell; Receptor; Molecular biology; Cytotoxic T cell; Biology; Immunology; Immune system; Genetics; In vitro","score_opus":0.014504562979752913,"score_gpt":0.27722097428775544,"score_spread":0.26271641130800255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926803,0.0021643606,0.000140891,0.00014007166,0.00024757528,0.0018710617,0.00021931816,0.000111471505,0.0024249265],"genre_scores_gemma":[0.97463506,0.00042217443,0.005908615,0.000061031602,0.0002307583,0.00010100967,0.00003530501,0.000117498836,0.018488526],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970975,0.00025037053,0.0005855895,0.0006909469,0.0008673856,0.0005082428],"domain_scores_gemma":[0.9982112,0.00032301864,0.00014165317,0.0008203931,0.00017896174,0.00032476828],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00070279726,0.00031614696,0.0006276267,0.0005088159,0.000056552482,0.000023304721,0.0003008529,0.00020806494,0.002821982],"category_scores_gemma":[0.00007531975,0.00027343037,0.0002698034,0.00055004697,0.000100034,0.00008126262,0.00021969141,0.0003952926,0.00017672428],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004081233,0.0010215441,0.00047338085,0.0008575638,0.00019603908,0.000065351436,0.003807661,0.000009268065,0.98432356,2.7433563e-7,0.0027851688,0.0023789315],"study_design_scores_gemma":[0.0029656098,0.0018843435,0.0014307362,0.00035332638,0.00017967135,0.000015071746,0.0003741001,0.00006103382,0.98826814,0.0000054113266,0.004238415,0.00022411461],"about_ca_topic_score_codex":0.00007336692,"about_ca_topic_score_gemma":6.4585686e-7,"teacher_disagreement_score":0.018045243,"about_ca_system_score_codex":0.000096056996,"about_ca_system_score_gemma":0.00041850007,"threshold_uncertainty_score":0.9999718},"labels":[],"label_agreement":null},{"id":"W4405038581","doi":"10.1182/blood-2024-199249","title":"Development of a National Needs Driven Intrinsic Roles Curriculum for Canadian Hematology Residency Training Programs","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa; McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Hematology; Medical education; Medicine; Curriculum; Internal medicine; Graduate medical education; Residency training; Family medicine; Psychology; Accreditation; Pedagogy; Continuing education","score_opus":0.025433355049027974,"score_gpt":0.3423262316994433,"score_spread":0.3168928766504153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97958624,0.007881115,0.0027551462,0.0030103803,0.00070809614,0.0010793773,0.000012460525,0.00012717149,0.0048400215],"genre_scores_gemma":[0.874833,0.00003631059,0.12431178,0.00016564,0.0002596624,0.00014375562,0.000034506567,0.000014619172,0.00020075835],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99937445,0.00001030602,0.00020450444,0.0001241638,0.000099106815,0.00018748286],"domain_scores_gemma":[0.99968076,0.00006845722,0.000031600914,0.00005404701,0.000081092345,0.000084019586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014334952,0.0000745111,0.0001901278,0.00022314745,0.00006899298,0.0000044742274,0.00005443027,0.00009844207,0.000029284663],"category_scores_gemma":[0.00006675488,0.000061641134,0.000046578025,0.00019406229,0.00006974706,0.00003315502,0.000006034699,0.000093525065,0.0000039031506],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010977974,0.0011416149,0.06367666,0.0011033554,0.001712713,0.00031150389,0.042472303,0.000010658184,0.001486159,0.22487286,0.0022339527,0.66086847],"study_design_scores_gemma":[0.01036199,0.0019562251,0.00958381,0.002486868,0.00051112735,0.0032020553,0.009187371,0.00088025164,0.008276544,0.01767827,0.93513376,0.00074172666],"about_ca_topic_score_codex":0.00008530726,"about_ca_topic_score_gemma":0.008501952,"teacher_disagreement_score":0.93289983,"about_ca_system_score_codex":0.00008356386,"about_ca_system_score_gemma":0.002244419,"threshold_uncertainty_score":0.47442886},"labels":[],"label_agreement":null},{"id":"W4405038597","doi":"10.1182/blood-2024-198424","title":"Primary Results of Patient-Reported Outcomes in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated with Glofitamab Plus Gemcitabine and Oxaliplatin (Glofit-GemOx) Versus Rituximab Plus GemOx (R-GemOx) from the Phase III Starglo Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Rituximab; Oxaliplatin; Gemcitabine; Diffuse large B-cell lymphoma; Internal medicine; Refractory (planetary science); Oncology; Lymphoma; Chemotherapy; Cancer; Colorectal cancer","score_opus":0.009550830445306644,"score_gpt":0.23689357618990545,"score_spread":0.2273427457445988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99264085,0.0016945068,0.000002152694,0.00015408943,0.00018393862,0.0034418395,0.001223383,0.00017352348,0.00048570952],"genre_scores_gemma":[0.9977162,0.00007797829,0.00023711426,0.00011596216,0.000049933198,0.00022645581,0.0012904328,0.000109739856,0.00017617349],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99569416,0.00019324162,0.0012075866,0.0011321673,0.0011332388,0.0006396195],"domain_scores_gemma":[0.9970667,0.0007813303,0.00049612566,0.0011643101,0.00022249123,0.00026905627],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024773038,0.00074453355,0.0014385158,0.00026199533,0.00016319213,0.00009337558,0.00019016399,0.0001872702,0.000025359497],"category_scores_gemma":[0.00011823802,0.00042319254,0.00015043492,0.00065041776,0.00016903454,0.00027134648,0.00018889926,0.00024790136,0.000010598375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04434546,0.1251641,0.8151049,0.00013175557,0.0033200516,0.0028719837,0.0045599295,0.0000037287255,0.00006676072,0.0000062131944,0.0002544982,0.004170625],"study_design_scores_gemma":[0.47067925,0.009294099,0.5151201,0.0003337592,0.0025469218,0.000012108003,0.0010051192,0.00005967887,0.00039300078,0.000002036124,0.00023144479,0.00032248226],"about_ca_topic_score_codex":0.0026186912,"about_ca_topic_score_gemma":0.00073467585,"teacher_disagreement_score":0.4263338,"about_ca_system_score_codex":0.00061175006,"about_ca_system_score_gemma":0.00052309514,"threshold_uncertainty_score":0.99982196},"labels":[],"label_agreement":null},{"id":"W4405038598","doi":"10.1182/blood-2024-209131","title":"Incidence and Severity of Hypogammaglobulinemia, and Profile of Infections in Patients with Relapsed Multiple Myeloma Treated with Belantamab Mafodotin","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Hypogammaglobulinemia; Multiple myeloma; Medicine; Incidence (geometry); Internal medicine; Gastroenterology; Pediatrics; Immunology; Antibody","score_opus":0.007209675090959893,"score_gpt":0.23586235475856795,"score_spread":0.22865267966760805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986185,0.00025512706,0.0000058758246,0.00002729191,0.0000057968473,0.0007127884,0.000107627464,0.000028684086,0.00023832428],"genre_scores_gemma":[0.9984416,0.000045379762,0.001285312,0.0000032951864,0.000006918816,0.000037379155,0.00006738937,0.000015410538,0.00009731476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914056,0.000035127676,0.0001883192,0.00024000296,0.00022944935,0.00016654971],"domain_scores_gemma":[0.9994677,0.00012440536,0.000048191163,0.00015094965,0.00010377281,0.00010501648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000073414434,0.00012601666,0.00026913724,0.00017324396,0.000027172051,0.000008960892,0.00002666188,0.00005595633,0.00001800339],"category_scores_gemma":[0.00009599546,0.000083468345,0.00001750503,0.00034755695,0.00013718306,0.00008922351,0.000036105976,0.00013407103,0.0000016416808],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010079356,0.0011419888,0.993236,0.0004221556,0.00018828327,0.000121185374,0.0001531908,7.0150395e-7,0.0007111909,0.0000053327462,0.0000074852805,0.0030045193],"study_design_scores_gemma":[0.0135498885,0.002320549,0.9729781,0.0006099434,0.00016238194,0.00007255149,0.000034919678,0.00027164197,0.009911215,0.0000041645217,0.000008796095,0.000075859854],"about_ca_topic_score_codex":0.000641593,"about_ca_topic_score_gemma":0.00044176003,"teacher_disagreement_score":0.020257942,"about_ca_system_score_codex":0.00002138588,"about_ca_system_score_gemma":0.00009627882,"threshold_uncertainty_score":0.34037405},"labels":[],"label_agreement":null},{"id":"W4405038601","doi":"10.1182/blood-2024-198797","title":"Handgrip Strength - Finetuning an Objective Measure of Frailty in Transplant-Eligible Patients with Multiple Myeloma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Windsor Regional Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Multiple myeloma; Gerontology; Internal medicine","score_opus":0.021203817859159913,"score_gpt":0.27429770396881803,"score_spread":0.2530938861096581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973252,0.0005271832,0.00003985892,0.000024678919,0.000032420754,0.0005651388,0.00019413729,0.000061590006,0.0012298152],"genre_scores_gemma":[0.9986747,0.0000268608,0.00080999266,0.000009952825,0.000038871134,0.000043920645,0.0002687262,0.000029931376,0.000097068354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986359,0.00005709241,0.00020628399,0.0003272278,0.00045649768,0.00031699447],"domain_scores_gemma":[0.9993416,0.0001076789,0.000029760824,0.00023316912,0.00010696947,0.000180831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000106169966,0.00017373658,0.00029296902,0.00023665781,0.00003775268,0.000020566933,0.000075920834,0.00008046617,0.00005597688],"category_scores_gemma":[0.00006756233,0.00012098651,0.000055767356,0.00033592485,0.000051562198,0.00014460973,0.000014013845,0.000227165,0.000011343164],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00097145647,0.002162454,0.9770136,0.0002493687,0.0003972952,0.00034738914,0.0012761803,0.0000057732013,0.002661712,0.000015926838,0.000014587657,0.014884282],"study_design_scores_gemma":[0.014833256,0.0018193504,0.94556016,0.0010444862,0.00019500797,0.000016737811,0.00012192786,0.00077253877,0.035387766,0.000015544361,0.00008681433,0.00014639116],"about_ca_topic_score_codex":0.00049540086,"about_ca_topic_score_gemma":0.0009994097,"teacher_disagreement_score":0.032726053,"about_ca_system_score_codex":0.00003774159,"about_ca_system_score_gemma":0.00017092383,"threshold_uncertainty_score":0.49336866},"labels":[],"label_agreement":null},{"id":"W4405038608","doi":"10.1182/blood-2024-204052","title":"Tolerability and Efficacy of Post-Transplant Cyclophosphamide in Older Adults Undergoing Matched Sibling Donor Allogeneic Transplantation: A Retrospective Analysis","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Sibling; Tolerability; Transplantation; Cyclophosphamide; Retrospective cohort study; Internal medicine; Surgery; Pediatrics; Adverse effect; Chemotherapy; Psychology","score_opus":0.00811949416387338,"score_gpt":0.26410391503307035,"score_spread":0.255984420869197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99676025,0.0016329084,0.000549532,0.00018440132,0.000045412842,0.00045355456,0.0001340834,0.000053523603,0.000186312],"genre_scores_gemma":[0.9967057,0.002079612,0.00087122055,0.00004519873,0.0000193304,0.000020029815,0.00020977177,0.000017043383,0.000032062315],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866074,0.000039589395,0.00046253979,0.00042403088,0.00022355274,0.00018953948],"domain_scores_gemma":[0.9993506,0.00027998883,0.000053708045,0.00016489824,0.00005902129,0.00009180157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014571322,0.00018213787,0.00051838916,0.00038333362,0.00003218988,0.000023418994,0.000042484495,0.000085221734,0.00005588051],"category_scores_gemma":[0.000015078164,0.00014772615,0.0002072842,0.0008656208,0.00004130991,0.00008912398,0.0000044953663,0.00013508335,0.0000029640478],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006403416,0.00066926,0.98767614,0.001980983,0.0017891093,0.00065794634,0.004582429,0.000104834064,0.0014799655,0.00007798928,1.07913074e-7,0.00034092006],"study_design_scores_gemma":[0.0076003983,0.00021554221,0.9788551,0.0017535111,0.0040692263,0.00012480009,0.00016780866,0.00013981659,0.0069098906,0.00003680989,4.6789532e-7,0.00012665073],"about_ca_topic_score_codex":0.00033509627,"about_ca_topic_score_gemma":0.0007671531,"teacher_disagreement_score":0.008821037,"about_ca_system_score_codex":0.00003964931,"about_ca_system_score_gemma":0.0000772171,"threshold_uncertainty_score":0.6024098},"labels":[],"label_agreement":null},{"id":"W4405038610","doi":"10.1182/blood-2024-208192","title":"MagnetisMM-3: Long-Term Update and Efficacy and Safety of Less Frequent Dosing of Elranatamab in Patients with Relapsed or Refractory Multiple Myeloma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary","funders":"","keywords":"Medicine; Dosing; Multiple myeloma; Refractory (planetary science); Term (time); Internal medicine; Intensive care medicine; Oncology; Surgery","score_opus":0.015081073140971075,"score_gpt":0.26859676719311715,"score_spread":0.2535156940521461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99621606,0.0027868028,0.000013028622,0.00005309695,0.000025228992,0.00073261146,0.00009206564,0.000020687348,0.00006043488],"genre_scores_gemma":[0.9984105,0.0005844888,0.00079708756,0.000009416561,0.000014143367,0.0000120182,0.00010165033,0.000026362704,0.00004429258],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877876,0.000053793774,0.00031540237,0.00030726485,0.00031506686,0.00022968833],"domain_scores_gemma":[0.99931586,0.0001760661,0.00006503466,0.00023564747,0.00006361304,0.00014378053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011832253,0.00015851767,0.000354944,0.00020523909,0.000029338868,0.000015314996,0.000051038653,0.00007253649,0.0000363704],"category_scores_gemma":[0.000093094626,0.000105777195,0.000026960613,0.00019871084,0.00014306852,0.000102675505,0.00005945527,0.00016762562,0.0000017982096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050222077,0.0015060933,0.91367656,0.000951183,0.00028749445,0.00046529085,0.0002333786,4.3221425e-7,0.0021140883,0.000015014041,0.000004069699,0.07572417],"study_design_scores_gemma":[0.03323149,0.0017929765,0.9591389,0.0013692398,0.00017872946,0.000023890001,0.000026225403,0.00004848355,0.0040685777,0.0000036601268,0.000021393544,0.00009645738],"about_ca_topic_score_codex":0.00012843659,"about_ca_topic_score_gemma":0.00016292093,"teacher_disagreement_score":0.075627714,"about_ca_system_score_codex":0.00003245796,"about_ca_system_score_gemma":0.00009012977,"threshold_uncertainty_score":0.43134686},"labels":[],"label_agreement":null},{"id":"W4405038614","doi":"10.1182/blood-2024-209661","title":"Measurable Residual Disease and Peripheral Residual Disease to Assess Treatment Response in Real-World Patients with Newly Diagnosed Multiple Myeloma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Multiple myeloma; Residual; Minimal residual disease; Internal medicine; Peripheral; Disease; Pomalidomide; Oncology; Lenalidomide; Bone marrow","score_opus":0.03498846860530305,"score_gpt":0.30830685385841694,"score_spread":0.2733183852531139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99437207,0.000849982,0.000006519067,0.001496565,0.00005838516,0.0022633485,0.00051523576,0.00016487791,0.00027300164],"genre_scores_gemma":[0.9950386,0.00012940106,0.0008152681,0.000099948855,0.00014444794,0.0007259314,0.00031983794,0.00008692773,0.0026395873],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99687356,0.0003508082,0.00034134008,0.0008728794,0.0008321192,0.0007292699],"domain_scores_gemma":[0.9969217,0.00060877466,0.00003660724,0.00059318775,0.00012251824,0.0017171862],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027140934,0.00041909318,0.0004479227,0.00048872706,0.00015098664,0.00017664928,0.00010609821,0.000055520697,0.00008981936],"category_scores_gemma":[0.00070923445,0.00030006794,0.00008283888,0.0005461768,0.00009731295,0.00022005117,0.00008472969,0.00018895726,0.000041517666],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.053792726,0.0035785064,0.9262921,0.00018007128,0.00041467787,0.010998246,0.00043365388,0.000037934293,0.0001839636,0.000026313006,0.00036226402,0.0036995083],"study_design_scores_gemma":[0.024217613,0.002402608,0.9703934,0.00065517926,0.00046427257,0.0000057957404,0.00006885332,0.0002653877,0.00042250307,0.00001735107,0.0007840886,0.00030293915],"about_ca_topic_score_codex":0.0011215797,"about_ca_topic_score_gemma":0.0022795112,"teacher_disagreement_score":0.044101276,"about_ca_system_score_codex":0.0004364194,"about_ca_system_score_gemma":0.00089873,"threshold_uncertainty_score":0.99994516},"labels":[],"label_agreement":null},{"id":"W4405038649","doi":"10.1182/blood-2024-201731","title":"The Roadmap to Integrate Diversity, Equity, and Inclusion in Hematology Clinical Trials: An ASH Initiative Submitted on Behalf of the Entire Roadmap to Improve DEI in Clinical Trials Working Group","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"Novo Nordisk; Teva Pharmaceutical Industries","keywords":"Clinical trial; Inclusion (mineral); Equity (law); Diversity (politics); Medicine; Hematology; Internal medicine; Family medicine; Political science; Psychology","score_opus":0.32127206564750965,"score_gpt":0.5209066812045254,"score_spread":0.19963461555701578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9576421,0.00070518546,0.00015731092,0.037746813,0.0016183638,0.0017292617,0.000016680055,0.000027528959,0.00035675],"genre_scores_gemma":[0.9969755,0.00036178617,0.00012402085,0.0019998858,0.00045393794,0.000026681617,0.000013560477,0.000016240136,0.000028397335],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.989452,0.0065370295,0.002397171,0.00056922063,0.00073911535,0.00030547281],"domain_scores_gemma":[0.98903733,0.00979351,0.00040286488,0.00038873433,0.00009483848,0.00028269444],"candidate_categories":["metaresearch","open_science"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.06690654,0.00018971102,0.0012128408,0.0002442498,0.0003068097,0.000057379933,0.00043187657,0.00066115794,0.000012480629],"category_scores_gemma":[0.017198186,0.000097743236,0.00032046463,0.0006888259,0.0004938433,0.000053103802,0.011442008,0.0012356921,0.000004045454],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024126892,0.0019232972,0.050073057,0.00012420148,0.00025779993,0.00009322621,0.005559589,0.0000011054684,0.0016244748,0.009249273,0.00020593077,0.9284754],"study_design_scores_gemma":[0.04078334,0.013074852,0.7422459,0.010455362,0.002185688,0.00006711894,0.0041758423,0.0038153636,0.0058065713,0.17117436,0.005292399,0.0009231916],"about_ca_topic_score_codex":0.00020918426,"about_ca_topic_score_gemma":0.0024323354,"teacher_disagreement_score":0.92755216,"about_ca_system_score_codex":0.00005387097,"about_ca_system_score_gemma":0.00023526482,"threshold_uncertainty_score":0.99655324},"labels":[],"label_agreement":null},{"id":"W4405038679","doi":"10.1182/blood-2024-199312","title":"The Use of the Montreal Cognitive Assessment to Predict Neurotoxicity Post CD19 and BCMA CART","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cart; Montreal Cognitive Assessment; Medicine; Cognition; Neurotoxicity; Internal medicine; Psychology; Cognitive impairment; Psychiatry; Toxicity; History","score_opus":0.021070437913486378,"score_gpt":0.28667794687227155,"score_spread":0.26560750895878515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906416,0.00057623704,0.000022930762,0.0048985733,0.00025712533,0.0015044592,0.00022980256,0.000054883887,0.0018143738],"genre_scores_gemma":[0.9979986,0.00021103855,0.000021097167,0.0006977445,0.00011560886,0.00012159722,0.0000043387454,0.000018568371,0.0008114121],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99902385,0.00007042109,0.00018382809,0.00023287498,0.0002960572,0.00019296371],"domain_scores_gemma":[0.9990081,0.00051712437,0.000038427574,0.00016927595,0.00018786496,0.00007916037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012254527,0.00013333106,0.00017830839,0.000042505962,0.00015951619,0.00004625823,0.000054469805,0.000037819456,0.000010694556],"category_scores_gemma":[0.0003733073,0.00007187548,0.0000822165,0.00021401634,0.0001722871,0.000054234657,0.00016544617,0.00022857974,0.000005266553],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025524655,0.0040414245,0.7531261,0.0012685324,0.0107264,0.000753745,0.010679052,0.000023791576,0.06847124,0.0010161232,0.04400089,0.10334027],"study_design_scores_gemma":[0.00177418,0.0010523477,0.9862075,0.0006811615,0.0011844455,0.00008010717,0.00050755637,0.00015470762,0.005372555,0.000027139577,0.0028743725,0.00008394693],"about_ca_topic_score_codex":0.00022265445,"about_ca_topic_score_gemma":0.00025370083,"teacher_disagreement_score":0.23308142,"about_ca_system_score_codex":0.000032088064,"about_ca_system_score_gemma":0.000127365,"threshold_uncertainty_score":0.2930997},"labels":[],"label_agreement":null},{"id":"W4405038688","doi":"10.1182/blood-2024-206911","title":"Phase I Safety Study of Anti-Transferrin Receptor 1 Antibody (PPMX-T003) in Patients with Polycythemia Vera and Erythrocythemia","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Daiichi Sankyo Europe; Chugai Pharmaceutical; Teijin Pharma; Eisai; Sierra Oncology; Novartis Pharma; Otsuka Pharmaceutical; JCR Pharmaceuticals","keywords":"Polycythemia vera; Medicine; Transferrin receptor; Antibody; Internal medicine; Transferrin; Soluble transferrin receptor; Immunology; Anemia; Iron deficiency; Iron status","score_opus":0.007775493434966133,"score_gpt":0.2774428740026725,"score_spread":0.26966738056770634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976386,0.00044399672,0.000008290522,0.0001796024,0.00006906866,0.0012636362,0.00009168394,0.000042929296,0.0002621816],"genre_scores_gemma":[0.999295,0.00021150618,0.00017312496,0.000030828585,0.000045435554,0.00005279233,0.00010066671,0.000034121855,0.00005649794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865305,0.00004348936,0.0003494867,0.00042337802,0.00030925736,0.00022132958],"domain_scores_gemma":[0.99947256,0.00007689743,0.000037812737,0.00023618563,0.000063682455,0.00011285156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010212138,0.00023846538,0.0005015695,0.00015818652,0.000044203673,0.000021629849,0.00004581424,0.000067049754,0.0001122808],"category_scores_gemma":[0.000015973847,0.00015004599,0.000043485277,0.00030177046,0.000055810804,0.000085972446,0.00002472236,0.00017722482,0.000008863842],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011819242,0.024396164,0.96490014,0.00021017726,0.0006149357,0.00016002511,0.002111426,0.0000010162619,0.0032018367,0.000049254468,0.00006244832,0.0031106512],"study_design_scores_gemma":[0.08153884,0.017946567,0.8524576,0.0011285124,0.00092188903,0.000030903288,0.0005619725,0.000023484374,0.04427992,0.000006637518,0.00079156604,0.00031212321],"about_ca_topic_score_codex":0.000071494345,"about_ca_topic_score_gemma":0.000040571424,"teacher_disagreement_score":0.11244256,"about_ca_system_score_codex":0.00004244203,"about_ca_system_score_gemma":0.000090938345,"threshold_uncertainty_score":0.6118698},"labels":[],"label_agreement":null},{"id":"W4405038698","doi":"10.1182/blood-2024-200297","title":"Patient Characteristics and Outcomes of Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease in Allogeneic Stem Cell Transplant Patients - a Multicenter Canadian Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; Hamilton Health Sciences; University of Ottawa; McMaster University","funders":"","keywords":"Medicine; Hepatic veno-occlusive disease; Stem cell; Internal medicine; Transplantation; Surgery; Hematopoietic stem cell transplantation","score_opus":0.0067903275268274,"score_gpt":0.21821750279315308,"score_spread":0.21142717526632568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99787444,0.00013951452,0.000006304315,0.000040465762,0.00021028046,0.0011647298,0.00050752173,0.00002165471,0.000035109166],"genre_scores_gemma":[0.9996684,0.000025483161,0.000041381278,0.00003423008,0.000008949072,0.000037067326,0.00013662272,0.00002565311,0.000022209018],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987669,0.00005580352,0.0004266327,0.0002826826,0.00025327748,0.00021471725],"domain_scores_gemma":[0.99941474,0.000058114074,0.000053390395,0.0001533847,0.000047057696,0.00027332254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006483948,0.00016830431,0.00031062178,0.00025545357,0.000029616938,0.000016645254,0.000037738893,0.000058611735,0.000019981582],"category_scores_gemma":[0.000006440994,0.00014697535,0.000051653507,0.0001238657,0.000026083897,0.00005468989,0.000009100629,0.0001127845,0.000007007268],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000085572865,0.0012791433,0.9864011,0.0009648955,0.00010857261,0.0017472719,0.008343773,0.0000020671862,0.00037790547,0.0000028655277,0.0000010002402,0.00068582396],"study_design_scores_gemma":[0.003253597,0.00044027003,0.9935476,0.00050833344,0.0006245362,0.000043299555,0.0006050232,0.00011897414,0.0007168049,0.0000018980845,0.000009990771,0.00012966683],"about_ca_topic_score_codex":0.0034769508,"about_ca_topic_score_gemma":0.0037709102,"teacher_disagreement_score":0.00773875,"about_ca_system_score_codex":0.00007012075,"about_ca_system_score_gemma":0.000120934645,"threshold_uncertainty_score":0.59934807},"labels":[],"label_agreement":null},{"id":"W4405038770","doi":"10.1182/blood-2024-203456","title":"Additional Induction Intrathecal Cytarabine for Patients with CNS2 Disease at Diagnosis Is Not Beneficial for Patients with B-ALL Treated on Children's Oncology Group Protocols AALL0932 and AALL1131","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Cytarabine; Internal medicine; Oncology; Intrathecal; Group B; Chemotherapy; Surgery","score_opus":0.014056087329352812,"score_gpt":0.27839198370016494,"score_spread":0.2643358963708121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9438616,0.000010734733,0.000050933446,0.00068207004,0.000041646097,0.027868444,0.027370328,0.000089582296,0.000024656472],"genre_scores_gemma":[0.87383485,0.000009205352,0.0018615193,0.00064672215,0.00071378594,0.09151248,0.031148901,0.00013606827,0.00013647677],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99787486,0.0000391752,0.00029293547,0.0007170957,0.0006165577,0.00045939322],"domain_scores_gemma":[0.99832124,0.00067794544,0.0000961022,0.00022736425,0.0003149775,0.0003623657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007339369,0.0003214373,0.00037230045,0.00019345728,0.00016831883,0.00005159351,0.000091672344,0.0001837035,0.00059749617],"category_scores_gemma":[0.0002486343,0.00021780828,0.00008826422,0.00020358193,0.00015493298,0.0001590637,0.000055979322,0.0001967916,0.000013705114],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15051319,0.047796577,0.5871886,0.0017996974,0.004366409,0.0001657115,0.00075696816,0.000016783464,0.00011060046,0.00085320655,0.15230842,0.054123867],"study_design_scores_gemma":[0.06928498,0.05037443,0.8442006,0.0013546663,0.001578908,0.000023551227,0.00000775828,0.00039277523,0.00089004525,0.0000851144,0.03123208,0.0005750618],"about_ca_topic_score_codex":0.000022461894,"about_ca_topic_score_gemma":0.000021882894,"teacher_disagreement_score":0.25701204,"about_ca_system_score_codex":0.0006266533,"about_ca_system_score_gemma":0.00043677073,"threshold_uncertainty_score":0.88819635},"labels":[],"label_agreement":null},{"id":"W4405038827","doi":"10.1182/blood-2024-201513","title":"Immunotherapy with pVAX14 Nucleic Acid in Combination with All-Trans Retinoic Acid (ATRA) in an Acute Promyelocytic Leukemia (APL) Mouse Model Activates Cytotoxic T-Cells and Enhances Immune Responses: A Strategy for Turning “Cold” Tumors “Hot”","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Acute promyelocytic leukemia; Cytotoxic T cell; Retinoic acid; Tretinoin; Immune system; Cancer research; Leukemia; Immunology; Immunotherapy; Nucleic acid; Biology; Medicine; Biochemistry; Cell culture; In vitro; Genetics","score_opus":0.008806819354933864,"score_gpt":0.2475471334518146,"score_spread":0.23874031409688073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99421364,0.0025809347,0.002090084,0.000038755727,0.000023201354,0.00092746643,0.00003473157,0.0000522299,0.00003896499],"genre_scores_gemma":[0.9959507,0.0008852339,0.002205699,0.000040988532,0.00003970412,0.00038240402,0.00013685827,0.000097125754,0.00026131223],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99814177,0.00011256403,0.00037747045,0.0007272117,0.0001925086,0.00044846395],"domain_scores_gemma":[0.9993668,0.000035633668,0.00011643248,0.000332662,0.00007446342,0.00007396925],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035396504,0.00037430794,0.0003425809,0.00017554982,0.00008876589,0.00017894572,0.0002721785,0.00023899128,0.0000026575105],"category_scores_gemma":[0.000014899753,0.00030835366,0.000059464954,0.00025419868,0.00016605077,0.00006735834,0.000030291782,0.00029660267,5.052816e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021858402,0.00023782747,0.00025040715,0.00027889456,0.00017052659,0.00004656356,0.0009003608,0.0007887547,0.99469626,0.000052203475,0.000002396299,0.00038995946],"study_design_scores_gemma":[0.004508842,0.0031524894,0.00017279484,0.00033059623,0.000087460765,0.000055064196,0.00042051732,0.0041463613,0.98652506,0.0001128968,0.00003346989,0.00045447148],"about_ca_topic_score_codex":0.000021032898,"about_ca_topic_score_gemma":0.0000881271,"teacher_disagreement_score":0.00817123,"about_ca_system_score_codex":0.00008465107,"about_ca_system_score_gemma":0.0006653343,"threshold_uncertainty_score":0.9999369},"labels":[],"label_agreement":null},{"id":"W4405038833","doi":"10.1182/blood-2024-199281","title":"Preliminary Results of a Phase 1, Dose-Escalation Study of PRT2527, a Potent and Highly Selective CDK9 Inhibitor, As Monotherapy and in Combination with Zanubrutinib in Patients with Relapsed/Refractory Lymphoid Malignancies","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"MorphoSys; Swedish Orphan Biovitrum; Incyte; BeiGene; Gilead Sciences; Merck KGaA; Genentech; MEI Pharma; NYU Grossman School of Medicine; Regeneron Pharmaceuticals; Seagen; AstraZeneca; Eli Lilly and Company; Amgen","keywords":"Refractory (planetary science); Medicine; Salvage therapy; Ibrutinib; Internal medicine; Maximum tolerated dose; Oncology; Adverse effect; Chemotherapy; Leukemia; Biology","score_opus":0.00930047824764595,"score_gpt":0.2679317796691109,"score_spread":0.25863130142146495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99721324,0.00061386364,0.000003929676,0.000051036648,0.000017901737,0.0019627109,0.000014878623,0.00002134251,0.00010109306],"genre_scores_gemma":[0.99960643,0.00007250928,0.000118939584,0.000008381982,0.000012294905,0.00007270969,0.000029977244,0.000028586139,0.00005014574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983148,0.00011343869,0.000438781,0.00039834084,0.00054052385,0.00019410046],"domain_scores_gemma":[0.999186,0.00019552473,0.00013468103,0.00019894479,0.00021890468,0.00006596405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003285469,0.00016818623,0.0003501951,0.00042563642,0.000022156912,0.000014721517,0.000043459153,0.00008830225,0.0000011235379],"category_scores_gemma":[0.00010664508,0.00012428059,0.000014180856,0.0006785625,0.00012080783,0.00017053181,0.0000373022,0.0001609248,3.6591976e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2422619,0.09878564,0.5417002,0.0024365939,0.0010415884,0.0009629534,0.0725787,0.00012532479,0.013825584,0.00007980506,0.00007015901,0.026131563],"study_design_scores_gemma":[0.37872326,0.055922955,0.546158,0.0018126166,0.00017623186,0.00006972035,0.0012425644,0.0018470762,0.013833157,0.00003562039,0.000007922976,0.00017087709],"about_ca_topic_score_codex":0.00091781886,"about_ca_topic_score_gemma":0.00016196724,"teacher_disagreement_score":0.13646136,"about_ca_system_score_codex":0.0009101253,"about_ca_system_score_gemma":0.0014336057,"threshold_uncertainty_score":0.50680155},"labels":[],"label_agreement":null},{"id":"W4405038834","doi":"10.1182/blood-2024-201022","title":"ASC4REAL: Efficacy and Tolerability Comparison between Ascembl Study, a Phase 3 Randomized Clinical Trial (RCT), and Consolidated Real-World (RW) Evidence with Asciminib in CML Patients Beyond 2 TKIs","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Randomized controlled trial; Tolerability; Medicine; Internal medicine; Adverse effect","score_opus":0.07919037351382231,"score_gpt":0.4299993825019653,"score_spread":0.350809008988143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98999625,0.0011942834,0.0000068176264,0.0002531166,0.0001878502,0.0078052334,0.000048883474,0.00015348887,0.00035406344],"genre_scores_gemma":[0.9985478,0.00033500692,0.0002937896,0.000047356636,0.00024430113,0.00025847394,0.0001236509,0.00004909691,0.00010054584],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9947529,0.0013578734,0.0017097623,0.0011364333,0.000602792,0.00044028249],"domain_scores_gemma":[0.99176484,0.006817157,0.00026408196,0.00062835973,0.000117510295,0.0004080524],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0031838838,0.00044262296,0.0024821449,0.00027373357,0.0000833576,0.0001103498,0.0001281145,0.00017867058,0.000054958415],"category_scores_gemma":[0.0020833951,0.00031615476,0.00014795848,0.0005453729,0.0004937162,0.00017826486,0.00014745122,0.00069673586,0.000012379804],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.318609,0.011227795,0.65198576,0.00020310697,0.0012511364,0.0002282747,0.0013869143,3.7235165e-7,0.000007863741,0.000005683709,0.00017582551,0.014918266],"study_design_scores_gemma":[0.7397391,0.007392885,0.24771607,0.00085244334,0.003534808,0.000010523271,0.00009968025,0.00022117633,0.00008041166,0.00001803313,0.00009922214,0.00023561141],"about_ca_topic_score_codex":0.0011758641,"about_ca_topic_score_gemma":0.0006976043,"teacher_disagreement_score":0.42113012,"about_ca_system_score_codex":0.00023914989,"about_ca_system_score_gemma":0.0006311928,"threshold_uncertainty_score":0.9999291},"labels":[],"label_agreement":null},{"id":"W4405038873","doi":"10.1182/blood-2024-201150","title":"Outcomes of Patients Intended for Autologous Stem Cell Transplantation with CT-Based Partial Response but PET-Based Deauville Score of 5 after Salvage Chemotherapy","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Transplantation; Stem cell; Autologous stem-cell transplantation; Chemotherapy; Chemotherapy regimen; Salvage therapy; Internal medicine; Oncology; Nuclear medicine; Biology","score_opus":0.012702914135207213,"score_gpt":0.272934160811331,"score_spread":0.2602312466761238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96693176,0.000041843996,0.03060698,0.0012288562,0.000022686569,0.00081239844,0.00021463438,0.00011562238,0.00002522413],"genre_scores_gemma":[0.9807885,0.0000048081856,0.018367084,0.00034028225,0.000010996638,0.00028701173,0.00009817984,0.000026974962,0.00007610883],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991716,0.000031319585,0.0002786416,0.00019198998,0.00019573615,0.00013067953],"domain_scores_gemma":[0.99933827,0.00020449788,0.000075588665,0.00021920245,0.000096268326,0.00006615543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001570937,0.0001156881,0.00025925649,0.00009507517,0.000016673524,0.0000055267246,0.00006335589,0.000032072443,0.000034546596],"category_scores_gemma":[0.000015735455,0.00008100676,0.00010079771,0.000117554875,0.000098946555,0.000019550851,0.000003523505,0.000081423466,0.0000012159554],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049189486,0.014618267,0.63067335,0.014876923,0.00087112584,0.000654652,0.0016626292,0.000022564362,0.26430234,0.0005368293,0.002481858,0.020109978],"study_design_scores_gemma":[0.008100938,0.0014265367,0.08633646,0.0005469411,0.00058359094,0.000010067322,0.000030584113,0.0019130183,0.9002009,0.000021874564,0.0006879972,0.00014107146],"about_ca_topic_score_codex":0.000016103737,"about_ca_topic_score_gemma":0.000002343868,"teacher_disagreement_score":0.6358986,"about_ca_system_score_codex":0.000013049202,"about_ca_system_score_gemma":0.00015766357,"threshold_uncertainty_score":0.33033594},"labels":[],"label_agreement":null},{"id":"W4405038879","doi":"10.1182/blood-2024-206450","title":"Disparities in Phase II and III Clinical Trial Enrollment for Hematologic Malignancies","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Hematologic Neoplasms; Medicine; Hematologic malignancy; Clinical trial; Internal medicine; Cancer","score_opus":0.030856340312077186,"score_gpt":0.34006246804210266,"score_spread":0.3092061277300255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98982054,0.008752445,0.0002460333,0.00025167313,0.00038548096,0.00035278127,0.00007631164,0.000008057416,0.000106706844],"genre_scores_gemma":[0.9967777,0.0019003971,0.0003456553,0.00019020354,0.00039668425,0.00012926757,0.000055157267,0.000009880867,0.00019504009],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99932367,0.000013617872,0.00024024602,0.0002455779,0.00003516355,0.00014175496],"domain_scores_gemma":[0.99973804,0.00007155395,0.000023654555,0.00011188115,0.000013648514,0.000041207484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020296009,0.000082688544,0.00015279847,0.000021968728,0.00003936486,0.000035226636,0.000055000357,0.00009862057,0.0000035842038],"category_scores_gemma":[0.0001268055,0.00007372594,0.000073894145,0.00002536681,0.000054430966,0.0000014921615,0.00008861356,0.00004322963,6.356993e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08847775,0.031048026,0.035259362,0.0024269596,0.0023710139,0.0006032457,0.0012797723,0.000070520844,0.5494516,0.10730511,0.10302559,0.078681074],"study_design_scores_gemma":[0.36269954,0.026450276,0.0012779215,0.00024426216,0.0005046984,0.000110182904,0.00022120666,0.00052839576,0.22105488,0.008706152,0.37706834,0.0011341162],"about_ca_topic_score_codex":0.0000154323,"about_ca_topic_score_gemma":0.00005274533,"teacher_disagreement_score":0.32839668,"about_ca_system_score_codex":0.0000037237346,"about_ca_system_score_gemma":0.0000690036,"threshold_uncertainty_score":0.30064568},"labels":[],"label_agreement":null},{"id":"W4405038897","doi":"10.1182/blood-2024-202191","title":"An Evaluation of Andexanet Alfa v. Standard of Care for Reversal of Doac-Induced Intracranial Hemorrhage - a Systematic Review and Meta-Analysis","year":2024,"lang":"en","type":"review","venue":"Blood","topic":"Healthcare Decision-Making and Restraints","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph; University of Toronto; McMaster University","funders":"","keywords":"Standard of care; Meta-analysis; Medicine; Intensive care medicine; Internal medicine; Anesthesia","score_opus":0.16904624039108557,"score_gpt":0.4852216247910721,"score_spread":0.31617538439998655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038897","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00039483095,0.99022675,0.000054535398,0.000022632343,0.000135063,0.005554197,0.0035155255,0.00001408823,0.00008236458],"genre_scores_gemma":[0.019752624,0.97795737,0.0009428073,0.000021948359,0.000062634615,0.00076596404,0.00039371487,0.000068561676,0.00003438862],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9937135,0.0021996996,0.002437198,0.0006159976,0.0008200339,0.00021359159],"domain_scores_gemma":[0.99557275,0.00057513657,0.0017096179,0.0011264051,0.0009110539,0.00010501963],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0052099754,0.00040098894,0.00959385,0.00049907324,0.000031056145,0.000014231066,0.00032490524,0.00044522109,0.00025258743],"category_scores_gemma":[0.00073999044,0.00025349605,0.0021282309,0.0007983811,0.00005120712,0.000031352098,0.000033611064,0.00025808957,0.0000033552178],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013271586,0.000114606126,8.490516e-8,0.8948422,0.06498609,0.000042536078,0.00043054888,2.4939473e-7,6.2107114e-7,0.000025373358,0.000009913416,0.039534505],"study_design_scores_gemma":[0.00042594812,0.00059848453,4.6371252e-7,0.040594205,0.9573007,0.00018658076,0.00030794617,0.000010508196,0.0000016666537,0.000055405646,0.0003297121,0.00018835708],"about_ca_topic_score_codex":0.0000755447,"about_ca_topic_score_gemma":0.000068536276,"teacher_disagreement_score":0.8923146,"about_ca_system_score_codex":0.000043657765,"about_ca_system_score_gemma":0.000490096,"threshold_uncertainty_score":0.9999917},"labels":[],"label_agreement":null},{"id":"W4405038899","doi":"10.1182/blood-2024-202071","title":"Timing of End-of-Treatment PET Scans and Impact on Subsequent Testing in Diffuse Large B-Cell Lymphoma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Diffuse large B-cell lymphoma; Medicine; Lymphoma; Nuclear medicine; Radiology; Pathology","score_opus":0.02708134883324766,"score_gpt":0.29160277034892296,"score_spread":0.2645214215156753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946314,0.0028411478,0.0000010150768,0.000058821617,0.000033931523,0.00027902756,0.000080522725,0.000026081645,0.0020480219],"genre_scores_gemma":[0.9992778,0.00023481304,0.00030940594,0.00001744573,0.000030674073,0.000033673572,0.000019629655,0.00001946725,0.000057132387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991829,0.000020490932,0.00023272223,0.00022268703,0.00013143219,0.0002097791],"domain_scores_gemma":[0.99940854,0.00025005807,0.00004915611,0.00018074593,0.00002156427,0.00008991035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008250248,0.00016515596,0.00031830434,0.00015046782,0.000018751813,0.000011873291,0.000026942955,0.00003282394,0.000022201983],"category_scores_gemma":[0.00002855034,0.00010819034,0.000098341414,0.00017333665,0.000026840908,0.000028394252,0.000022084783,0.000025606645,0.0000058290543],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000119067234,0.040587146,0.91687673,0.00053515064,0.0004923169,0.0024092405,0.0012978405,0.000008870429,0.010306017,0.00025605087,0.000040297964,0.027071299],"study_design_scores_gemma":[0.0684462,0.0073743127,0.67834824,0.002649636,0.0013444639,0.0005668446,0.00026483618,0.0021836252,0.2382562,0.00006676078,0.00022656893,0.00027231494],"about_ca_topic_score_codex":0.0008949035,"about_ca_topic_score_gemma":0.000049374456,"teacher_disagreement_score":0.23852846,"about_ca_system_score_codex":0.00026129445,"about_ca_system_score_gemma":0.00021282626,"threshold_uncertainty_score":0.4411874},"labels":[],"label_agreement":null},{"id":"W4405038931","doi":"10.1182/blood-2024-204001","title":"Durable Clinical Benefits with Exagamglogene Autotemcel for Severe Sickle Cell Disease","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Disease; Intensive care medicine; Internal medicine","score_opus":0.015914687306308427,"score_gpt":0.266319517157481,"score_spread":0.2504048298511726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97241515,0.016632754,0.00015104593,0.0024299435,0.0003583185,0.0008031713,0.00009590911,0.0002810435,0.0068326555],"genre_scores_gemma":[0.98842204,0.00086019735,0.001148553,0.0005475952,0.00030513265,0.00005737115,0.00007837341,0.00006173468,0.008519024],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988305,0.00001906736,0.00027547506,0.00038776876,0.00017301385,0.0003141693],"domain_scores_gemma":[0.9991591,0.00010632179,0.000032584543,0.0002835303,0.00006134013,0.0003571056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017147526,0.0001653101,0.00026116765,0.000051668387,0.00007942239,0.00003346972,0.00006852535,0.00014881826,0.00011446045],"category_scores_gemma":[0.000051770097,0.000112675545,0.00018505128,0.00017718908,0.00006000762,0.000050004168,0.000024585239,0.00022652315,0.00012766631],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01223386,0.04306651,0.38394672,0.028485937,0.008567644,0.01224645,0.0027035058,0.00348697,0.013165452,0.012963124,0.29177454,0.18735929],"study_design_scores_gemma":[0.09146051,0.013182157,0.124615654,0.0072215376,0.022065477,0.0015449603,0.0016367027,0.016200902,0.015663523,0.0020484072,0.70077485,0.003585344],"about_ca_topic_score_codex":0.0000085934635,"about_ca_topic_score_gemma":0.000003347304,"teacher_disagreement_score":0.40900028,"about_ca_system_score_codex":0.000013338701,"about_ca_system_score_gemma":0.0003572949,"threshold_uncertainty_score":0.4594775},"labels":[],"label_agreement":null},{"id":"W4405038934","doi":"10.1182/blood-2024-198359","title":"Satisfy: A Eurobloodnet Multicenter, Single-Arm Phase 2 Trial of Mitapivat in Adult Patients with Erythrocyte Membranopathies and Congenital Dyserythropoietic Anemia Type II - Results from the 8-Week Dose-Escalation Period","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Anemia; Internal medicine; Surgery; Gastroenterology","score_opus":0.017228651273184726,"score_gpt":0.24614202645970587,"score_spread":0.22891337518652113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99649405,0.0007173923,0.0000058749547,0.00054217817,0.0006113555,0.0009748324,0.00026188404,0.00007204849,0.0003203577],"genre_scores_gemma":[0.99846554,0.0001524244,0.00031011956,0.00018438805,0.0002510659,0.000018994306,0.0005113725,0.000038108727,0.00006798877],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982853,0.00014968721,0.0005633947,0.0004726645,0.00029719385,0.00023177984],"domain_scores_gemma":[0.9988923,0.00031168404,0.00014599752,0.0003201177,0.00023761268,0.000092263974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012928498,0.00024998514,0.00042620255,0.00011841441,0.00010054709,0.00003672612,0.00007270863,0.00014606868,0.000063538006],"category_scores_gemma":[0.00045286474,0.0001661797,0.000060778868,0.00040549377,0.0002727915,0.0001336414,0.000064543936,0.00030205745,0.000010829463],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.64397234,0.054014254,0.03254089,0.0010804639,0.00168578,0.00075957365,0.04056834,0.000020180516,0.20683263,0.00030372562,0.0015985203,0.01662329],"study_design_scores_gemma":[0.79053634,0.0682724,0.11492933,0.001811206,0.0024234226,0.000112055815,0.0020220033,0.0009547096,0.016673641,0.00009061185,0.0014417187,0.0007325537],"about_ca_topic_score_codex":0.00015970084,"about_ca_topic_score_gemma":0.00021080534,"teacher_disagreement_score":0.190159,"about_ca_system_score_codex":0.000026884787,"about_ca_system_score_gemma":0.00011733443,"threshold_uncertainty_score":0.6776611},"labels":[],"label_agreement":null},{"id":"W4405038949","doi":"10.1182/blood-2024-208740","title":"Cell-Free DNA Whole Genome Sequencing for Non-Invasive MRD Detection in Multiple Myeloma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research; University of British Columbia; Queen Elizabeth II Health Sciences Centre; Dalhousie University; Health Sciences Centre; University Health Network; University of Toronto; University of New Brunswick; Princess Margaret Cancer Centre; Vancouver General Hospital; Saint John Regional Hospital; BC Cancer Agency","funders":"","keywords":"Multiple myeloma; Cell-free fetal DNA; Biology; Genome; Whole genome sequencing; DNA sequencing; DNA; Computational biology; Genetics; Cancer research; Gene; Immunology","score_opus":0.027899975355678914,"score_gpt":0.273542996899855,"score_spread":0.24564302154417608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99566346,0.0008899511,0.00058900384,0.00020583982,0.00012590537,0.0012940097,0.00012903547,0.000109482164,0.0009932818],"genre_scores_gemma":[0.9961491,0.000052959178,0.0019498658,0.00004313223,0.00026480324,0.00036965247,0.000111587804,0.000046434085,0.0010124262],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99866974,0.000025177133,0.00022283885,0.00039383344,0.0002410914,0.0004473416],"domain_scores_gemma":[0.9991213,0.00025472385,0.000026923319,0.00035005438,0.000065691354,0.00018129028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016897432,0.00017017372,0.00023345066,0.0002800858,0.000086087006,0.000048265098,0.00010846236,0.00010369196,0.000026568061],"category_scores_gemma":[0.00032809546,0.00014776645,0.00013135432,0.00028614549,0.00003285899,0.00010859056,0.00006230433,0.00019178269,0.00015069472],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021376998,0.00039224495,0.008062376,0.0008236303,0.00018771122,0.0010485837,0.0005870786,0.000008464669,0.98203456,0.0000049520736,0.00012327815,0.006513335],"study_design_scores_gemma":[0.017003173,0.0011453258,0.046763945,0.0003755952,0.00021734061,0.00014304795,0.00039494262,0.0050909873,0.9263268,0.00023658012,0.0020527788,0.00024948872],"about_ca_topic_score_codex":0.00019567244,"about_ca_topic_score_gemma":0.0006206614,"teacher_disagreement_score":0.05570778,"about_ca_system_score_codex":0.0002416842,"about_ca_system_score_gemma":0.0002691095,"threshold_uncertainty_score":0.60257405},"labels":[],"label_agreement":null},{"id":"W4405038956","doi":"10.1182/blood-2024-211107","title":"Autologous Stem Cell Transplant for HIV-Associated Lymphoma: A Systematic Review and Meta-Analysis","year":2024,"lang":"en","type":"review","venue":"Blood","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Stem cell; Medicine; Meta-analysis; Lymphoma; Transplantation; Human immunodeficiency virus (HIV); Oncology; Immunology; Internal medicine; Biology; Genetics","score_opus":0.046801131873359984,"score_gpt":0.3075520234376803,"score_spread":0.2607508915643203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405038956","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000013037878,0.99113727,0.00001550421,0.00023089389,0.00004672475,0.0059236847,0.0021107004,0.00015843475,0.00037550877],"genre_scores_gemma":[0.000068580644,0.9892138,0.000027056618,0.00047099168,0.00001915784,0.0026718047,0.00077275804,0.000108417844,0.0066474164],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99660623,0.0003211394,0.0014908675,0.0007658807,0.0003605849,0.00045530486],"domain_scores_gemma":[0.9980528,0.0002450096,0.0008398511,0.00056715583,0.00010647021,0.00018876212],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00080232404,0.0007575634,0.014727079,0.00034783845,0.00008251053,0.000058492336,0.0001965137,0.00052729686,0.000053259082],"category_scores_gemma":[0.000054491356,0.00045490052,0.006751304,0.0011446358,0.000034472567,0.000029378227,0.000029219967,0.00023870754,0.000056193996],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000019264899,0.00022156931,2.4954682e-7,0.7018456,0.29599524,0.00006335044,0.00004785484,2.9073089e-8,1.7865306e-8,0.000010630757,0.0013468316,0.00046675635],"study_design_scores_gemma":[0.0012039284,0.0001300109,1.379516e-7,0.07008546,0.90547746,0.000079798825,0.000024141556,0.0000046806404,2.1224623e-7,0.000007516301,0.02260844,0.0003782218],"about_ca_topic_score_codex":0.000021590851,"about_ca_topic_score_gemma":0.00002603369,"teacher_disagreement_score":0.6317601,"about_ca_system_score_codex":0.00017474362,"about_ca_system_score_gemma":0.0004211533,"threshold_uncertainty_score":0.99990034},"labels":[],"label_agreement":null},{"id":"W4405039025","doi":"10.1182/blood-2024-210712","title":"HLH: Time to Transplant; A 10-Year UK Retrospective Cohort Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Retrospective cohort study; Medicine; Cohort; Internal medicine; Pediatrics","score_opus":0.007374435877210929,"score_gpt":0.24249897586793165,"score_spread":0.23512453999072072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9729437,0.0002946556,0.0000040817363,0.00018321213,0.00006830237,0.00080744585,0.00008993469,0.00014018445,0.025468446],"genre_scores_gemma":[0.98566204,0.000014464481,0.00003588504,0.00010631313,0.00016644751,0.00003717171,0.00002936322,0.000020516254,0.013927769],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99920714,0.000029491564,0.00011650977,0.00024613016,0.00024028629,0.0001604188],"domain_scores_gemma":[0.9994838,0.000021693546,0.000008584804,0.00028507804,0.000050001574,0.00015083585],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000133962,0.000106436644,0.00021282301,0.00006883237,0.000046238685,0.0000325753,0.00007300726,0.00003360295,0.00645997],"category_scores_gemma":[0.00002461029,0.00008675449,0.000087615634,0.00022183158,0.000015977808,0.00003552938,0.000027738031,0.00013330052,0.0035630472],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020682551,0.0018726083,0.9836557,0.00006366837,0.0009799688,0.00046326764,0.0012945139,1.5307475e-7,0.001662435,0.00004111087,0.009620288,0.00013949572],"study_design_scores_gemma":[0.0015029232,0.001381409,0.9929529,0.00012230239,0.0014249097,0.00002906814,0.00015030547,0.000011285406,0.00045195874,0.000022761495,0.0018373217,0.0001128754],"about_ca_topic_score_codex":0.00010308365,"about_ca_topic_score_gemma":0.0000033484198,"teacher_disagreement_score":0.012718333,"about_ca_system_score_codex":0.000037370883,"about_ca_system_score_gemma":0.00006597628,"threshold_uncertainty_score":0.99721277},"labels":[],"label_agreement":null},{"id":"W4405039028","doi":"10.1182/blood-2024-206247","title":"Final Results of the Canadian Myeloma Research Group Trial of Cybord Induction, Double-Alkylator Conditioning with High-Dose Intravenous Busulfan + Melphalan, ASCT and Continuous Lenalidomide Maintenance for Patients with Newly Diagnosed Multiple Myeloma (CMRG-001)","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Princess Margaret Cancer Centre; Vancouver General Hospital; BC Cancer Agency; Saint John Regional Hospital; Hôpital Maisonneuve-Rosemont; Concordia University; McGill University; University of Saskatchewan; Queen Elizabeth II Health Sciences Centre; Ottawa Hospital; University Health Network; Dalhousie University","funders":"","keywords":"Melphalan; Medicine; Busulfan; Lenalidomide; Multiple myeloma; Maintenance therapy; Plerixafor; Surgery; Oncology; Internal medicine; Chemotherapy; Cyclophosphamide","score_opus":0.03033523071453066,"score_gpt":0.28672348037757434,"score_spread":0.2563882496630437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993026,0.00019785257,0.000014000229,0.0007189408,0.0001619762,0.0045434586,0.0010885716,0.00003453282,0.00021462854],"genre_scores_gemma":[0.9970407,0.000031043855,0.0012776853,0.000020190331,0.0002197633,0.00047341775,0.00055479794,0.00006194469,0.00032049572],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99691284,0.00018035634,0.00057686487,0.00060116954,0.00096771197,0.0007610467],"domain_scores_gemma":[0.99712044,0.0006980856,0.00020161821,0.0005170509,0.0010309193,0.00043189042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008009356,0.00028653888,0.00058078393,0.00041675218,0.00040079278,0.00009312245,0.00020435278,0.00016257007,0.0000155321],"category_scores_gemma":[0.00086542545,0.00017439509,0.00009036277,0.0006648685,0.00059199746,0.00016656879,0.00006002368,0.00046782885,0.0000030573226],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.69595444,0.011257794,0.21913381,0.0019585846,0.005328239,0.0016550539,0.0034785548,0.00002865545,0.0041677677,0.0028737497,0.0033724145,0.050790943],"study_design_scores_gemma":[0.48500258,0.012032509,0.49043792,0.0014647035,0.0004414394,0.00010424657,0.00034201858,0.000077450386,0.008404714,0.000121562545,0.0013045965,0.00026626905],"about_ca_topic_score_codex":0.076488696,"about_ca_topic_score_gemma":0.13431811,"teacher_disagreement_score":0.2713041,"about_ca_system_score_codex":0.00020846742,"about_ca_system_score_gemma":0.001171634,"threshold_uncertainty_score":0.92966104},"labels":[],"label_agreement":null},{"id":"W4405039042","doi":"10.1182/blood-2024-209732","title":"Real-World Clinical Outcomes for Complement Inhibitor Experienced and Naïve Paroxysmal Nocturnal Hemoglobinuria Patients Prescribed Pegcetacoplan in Europe and Canada","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Medicine; Complement (music); Eculizumab; Pediatrics; Internal medicine; Immunology; Complement system; Antibody","score_opus":0.023785198260685,"score_gpt":0.3029364197729831,"score_spread":0.2791512215122981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963211,0.00076445704,0.0000027603328,0.00016787993,0.0012463209,0.00080762454,0.00051163905,0.00003854877,0.00013966937],"genre_scores_gemma":[0.9989431,0.000021304217,0.0000714177,0.000093701245,0.000053577114,0.00011362664,0.00020214051,0.000017148714,0.00048396795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983848,0.00018555894,0.00060623407,0.0004271569,0.00006208487,0.0003341792],"domain_scores_gemma":[0.9992084,0.0004200089,0.000080989645,0.00016901117,0.000059266928,0.000062307314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020952085,0.00019293357,0.00035870023,0.00007788308,0.00010320364,0.00004589036,0.00012739778,0.00005302272,0.00011421919],"category_scores_gemma":[0.00012702149,0.00015979928,0.000046499168,0.00008823535,0.00009863997,0.00006160144,0.00015467126,0.00013666377,0.000004576229],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001177431,0.00024181606,0.98297817,0.000113809816,0.00019032876,0.000019410112,0.0002815442,2.1400781e-7,0.0010088298,0.0002146157,0.014398668,0.00043485715],"study_design_scores_gemma":[0.00638716,0.0002853886,0.9613144,0.00014546262,0.000118980344,0.000011129249,0.00026212208,0.000008808081,0.001227718,0.00002395287,0.029973555,0.0002413546],"about_ca_topic_score_codex":0.043279845,"about_ca_topic_score_gemma":0.24906267,"teacher_disagreement_score":0.20578283,"about_ca_system_score_codex":0.00004127817,"about_ca_system_score_gemma":0.00023289685,"threshold_uncertainty_score":0.963091},"labels":[],"label_agreement":null},{"id":"W4405039051","doi":"10.1182/blood-2024-204328","title":"Clinical Characteristics and Outcomes of Aggressive Transformation in Splenic Marginal Zone Lymphoma: An International Study of 111 Patients","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Splenic marginal zone lymphoma; Medicine; Lymphoma; Aggressive lymphoma; Internal medicine; Oncology; Splenectomy; Spleen; Rituximab","score_opus":0.018754896625669693,"score_gpt":0.32644066873014,"score_spread":0.3076857721044703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99917907,0.00010843783,0.000002352355,0.00005480224,0.00016045195,0.00033263027,0.00006780686,0.00000883008,0.00008561405],"genre_scores_gemma":[0.99956125,0.00020453912,0.0000706134,0.000015158562,0.000028419843,0.000020158901,0.00008436017,0.000006489653,0.000008982737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991092,0.000033298234,0.00046014247,0.000136453,0.00019537476,0.0000655412],"domain_scores_gemma":[0.9995792,0.00007261097,0.00014618777,0.00009899237,0.000059890503,0.000043105043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010972158,0.000078787045,0.00028225168,0.00010776907,0.0000078505445,0.00000796311,0.000038292776,0.0000390796,0.000016009939],"category_scores_gemma":[0.000047890935,0.000058479774,0.00004685962,0.000061738254,0.000027340828,0.00009808053,0.000015590214,0.000031714393,0.0000017943513],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013771991,0.0144417565,0.9360591,0.000069975475,0.00028438284,0.00007469624,0.0013491495,7.622401e-8,0.000009381858,0.00006708295,0.0000021319886,0.047504507],"study_design_scores_gemma":[0.013806466,0.0019906347,0.98313457,0.0001814622,0.0003192644,0.000011114096,0.00023813063,0.0000885643,0.0001501653,0.0000069673324,0.000028850558,0.000043800417],"about_ca_topic_score_codex":0.00006355316,"about_ca_topic_score_gemma":0.00002751907,"teacher_disagreement_score":0.04746071,"about_ca_system_score_codex":0.000024385488,"about_ca_system_score_gemma":0.00003983806,"threshold_uncertainty_score":0.2384736},"labels":[],"label_agreement":null},{"id":"W4405039078","doi":"10.1182/blood-2024-201424","title":"Incremental Effectiveness of Iptacopan Compared with C5 Inhibitors in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria: Results from a Modelling Analysis","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Medicine; Internal medicine; Nocturnal","score_opus":0.00740930805393758,"score_gpt":0.21123094361591385,"score_spread":0.20382163556197627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99695647,0.0007071254,0.000296042,0.0000064503015,0.00014946966,0.0005300282,0.0012014162,0.000054692402,0.00009828354],"genre_scores_gemma":[0.99841166,0.0000028063644,0.00016594751,0.000004555797,0.000021083952,0.000044320645,0.0013223923,0.000019118257,0.000008118869],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982153,0.00038855823,0.0005139243,0.00048587966,0.00012294592,0.00027335016],"domain_scores_gemma":[0.9990959,0.00031667578,0.00015952413,0.0002821578,0.00011517832,0.00003055616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022067495,0.00023484326,0.00052733807,0.0003117917,0.000057585527,0.0000255321,0.00017358159,0.00008695995,0.000061356484],"category_scores_gemma":[0.000018116187,0.00017369846,0.000110868474,0.00064568216,0.000100586534,0.00010805317,0.000068870795,0.00018232912,0.000014794372],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058568227,0.0014926459,0.9677544,0.00022114153,0.005452439,0.000039829025,0.0007801878,0.0083712535,0.0098827975,0.000025741212,0.000045823628,0.000076879885],"study_design_scores_gemma":[0.04384174,0.0012404089,0.81734407,0.0035183255,0.0055710794,0.000011082581,0.00082300894,0.001880332,0.124920376,0.000053121155,0.000054327407,0.00074210827],"about_ca_topic_score_codex":0.0024782415,"about_ca_topic_score_gemma":0.00077018654,"teacher_disagreement_score":0.15041035,"about_ca_system_score_codex":0.00006952674,"about_ca_system_score_gemma":0.00007901691,"threshold_uncertainty_score":0.70832175},"labels":[],"label_agreement":null},{"id":"W4405039089","doi":"10.1182/blood-2024-211173","title":"Replication Stress Induces Hyper-Apobec Mutagenesis in Multiple Myeloma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; Terry Fox Research Institute","funders":"","keywords":"APOBEC; Mutagenesis; Biology; Genetics; Replication (statistics); Mutation; Virology; Genome; Gene","score_opus":0.04264487445024339,"score_gpt":0.31857309672138456,"score_spread":0.27592822227114117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99469775,0.0022780222,0.0000075750963,0.000511366,0.000059843274,0.0004748391,0.000042552994,0.00013977961,0.0017882505],"genre_scores_gemma":[0.9979575,0.00020114596,0.00054859224,0.000037212565,0.00013900017,0.00016171024,0.00013500548,0.000027880791,0.00079191127],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998766,0.000040583895,0.00019610445,0.0004487947,0.00027112872,0.00027739455],"domain_scores_gemma":[0.9991584,0.00012482463,0.000019083778,0.0005096312,0.00004024736,0.00014780392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001488462,0.00012752392,0.00017999337,0.00023034532,0.000045350043,0.00004315378,0.00008738747,0.0000845121,0.00010546779],"category_scores_gemma":[0.00027386766,0.00010288579,0.000067550136,0.0003631215,0.00003464616,0.00009263019,0.000043691936,0.00015502446,0.00021191179],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012522847,0.0016739065,0.6189173,0.00031427311,0.00025411503,0.0012236492,0.00038857735,0.0000017786895,0.0895203,0.000064520864,0.00016792952,0.28734845],"study_design_scores_gemma":[0.0034398234,0.00019780877,0.70402277,0.00029666143,0.00007860518,0.00009773887,0.00012574067,0.00061061647,0.28842255,0.000037846265,0.0025436971,0.00012611563],"about_ca_topic_score_codex":0.00046302192,"about_ca_topic_score_gemma":0.00021886178,"teacher_disagreement_score":0.28722236,"about_ca_system_score_codex":0.000059079353,"about_ca_system_score_gemma":0.000115225106,"threshold_uncertainty_score":0.41955608},"labels":[],"label_agreement":null},{"id":"W4405039101","doi":"10.1182/blood-2024-207893","title":"Quality of Life, Physical and Mental Health of Patients with Vaccine Induced Immune Thrombotic Thrombocytopenia after Extended Followup","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Quality of life (healthcare); Immune system; Immune thrombocytopenia; Immunology; Internal medicine; Platelet","score_opus":0.019786398835446715,"score_gpt":0.3041503394866456,"score_spread":0.2843639406511989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968617,0.00093416055,0.000008667286,0.0005320834,0.00015222485,0.0009923133,0.00010076577,0.00006824847,0.00034981917],"genre_scores_gemma":[0.99903774,0.00007920218,0.00049106753,0.000110607536,0.00006868624,0.000031374653,0.00008933466,0.00005982767,0.000032132717],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997619,0.00013711065,0.0007991394,0.0005247548,0.0005321775,0.00038785374],"domain_scores_gemma":[0.99871147,0.000098784025,0.00023384913,0.0005363389,0.00012858112,0.00029098458],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031007035,0.00033583952,0.0016404735,0.00015496783,0.000054186556,0.000023405324,0.00012425856,0.00011170472,0.00007822489],"category_scores_gemma":[0.000059667436,0.0002470784,0.00019311503,0.0004358128,0.00011046958,0.00020604355,0.00014861187,0.00030115232,0.000014476684],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019452448,0.01019837,0.7587998,0.0037796255,0.0034309777,0.00002229063,0.005016832,2.3186507e-7,0.21212462,0.0014369265,0.00010330345,0.003141782],"study_design_scores_gemma":[0.008662375,0.0025168972,0.97204274,0.0005324648,0.0003215328,0.000008154564,0.0001465792,0.000013365321,0.015342191,0.000145933,0.000026742902,0.00024101589],"about_ca_topic_score_codex":0.00028067996,"about_ca_topic_score_gemma":0.00006410212,"teacher_disagreement_score":0.21324295,"about_ca_system_score_codex":0.00005516121,"about_ca_system_score_gemma":0.00037371647,"threshold_uncertainty_score":0.99999815},"labels":[],"label_agreement":null},{"id":"W4405039113","doi":"10.1182/blood-2024-202536","title":"Strength to Endure: Superiority of MAC over RIC in Patients &amp;lt;65 Years Undergoing Stem Cell Transplantation Using ATG-Ptcy-CSA for Gvhd Prophylaxis","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Transplantation: Methods and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Transplantation; Graft-versus-host disease; Stem cell; Hematopoietic stem cell transplantation; Internal medicine; Surgery; Gastroenterology; Biology","score_opus":0.02658423373699685,"score_gpt":0.30402373094752644,"score_spread":0.2774394972105296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947457,0.00028898887,0.003553063,0.000021777922,0.00026416147,0.0007290024,0.00026036022,0.000039826165,0.00009714704],"genre_scores_gemma":[0.97438896,0.00006325237,0.02521049,0.000031998137,0.00006336132,0.000017803042,0.00009863678,0.000031412503,0.00009409268],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988613,0.000059498412,0.0003454931,0.00027273854,0.00025224857,0.00020872663],"domain_scores_gemma":[0.9994675,0.00022767251,0.000040984396,0.00014301274,0.00004275164,0.000078094556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018866544,0.00014142969,0.00027799697,0.00022708104,0.00002876176,0.000021262329,0.000055620887,0.00009747245,0.000032229746],"category_scores_gemma":[0.000017555521,0.00013143646,0.00010508231,0.00034547353,0.000015848322,0.000095164425,0.0000070395226,0.00012339884,0.0000037695067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004895443,0.0007378232,0.9381884,0.006381002,0.00014529351,0.00006455028,0.006079991,0.000071811155,0.032619115,0.00018420063,0.000015723022,0.015022576],"study_design_scores_gemma":[0.0049457205,0.0005346298,0.96873236,0.0005011616,0.0005122383,0.0000091208285,0.00010778875,0.000048939015,0.024145862,0.00004565938,0.00022872038,0.00018781946],"about_ca_topic_score_codex":0.00011117715,"about_ca_topic_score_gemma":0.00030369827,"teacher_disagreement_score":0.03054397,"about_ca_system_score_codex":0.000051185205,"about_ca_system_score_gemma":0.0001239445,"threshold_uncertainty_score":0.5359823},"labels":[],"label_agreement":null},{"id":"W4405039172","doi":"10.1182/blood-2024-199648","title":"The Transcription Factor IRF8 Regulates the Sensitivity of AML Cells to LSD1 Inhibition and All-Trans Retinoic Acid","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Population Health Research Institute; McMaster University","funders":"","keywords":"Retinoic acid; Transcription factor; IRF8; Tretinoin; Cancer research; Biology; Chemistry; Medicine; Gene; Genetics","score_opus":0.00989444319153693,"score_gpt":0.21312681216406024,"score_spread":0.2032323689725233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992405,0.002923128,0.0003195656,0.001879888,0.0018558264,0.00023671635,0.000019283509,0.00006119467,0.00029941596],"genre_scores_gemma":[0.9969543,0.00036266074,0.0000062415234,0.00014600743,0.000035184854,0.000009481757,0.000029504683,0.000009794259,0.00244682],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992394,0.00024460373,0.0001792873,0.00016310935,0.000029246052,0.00014434228],"domain_scores_gemma":[0.9995886,0.00017725627,0.000034531375,0.00014960775,0.000039742237,0.000010245487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029192306,0.00009950309,0.000099454366,0.000043672073,0.00017457137,0.000036486203,0.000037473117,0.00010855358,0.00013186062],"category_scores_gemma":[0.00002303227,0.000059496397,0.00007470155,0.00008455532,0.00011016488,0.00008478064,0.000013622218,0.00021196515,0.00008492227],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009087477,0.000048075646,0.000012860115,0.00002129681,0.0001538721,0.0000013857853,0.0014360603,0.0000013004826,0.9926927,0.00018316021,0.0026493955,0.0027090304],"study_design_scores_gemma":[0.00029761478,0.00014638908,0.001558193,0.000050471775,0.000115111085,0.000064014894,0.00031256693,0.000011382443,0.93802625,0.000041558207,0.059309468,0.00006697362],"about_ca_topic_score_codex":0.000050692004,"about_ca_topic_score_gemma":0.00004776075,"teacher_disagreement_score":0.05666007,"about_ca_system_score_codex":0.000009941346,"about_ca_system_score_gemma":0.000011825148,"threshold_uncertainty_score":0.24261928},"labels":[],"label_agreement":null},{"id":"W4405039205","doi":"10.1182/blood-2024-210432","title":"Inhibition of Peroxisome Proliferation-Activated Receptor Delta (PPARδ) Selectively Kills Acute Myeloid Leukemia Cells","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Peroxisome Proliferator-Activated Receptors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Waterloo; University of Toronto; University Health Network; University of Guelph","funders":"","keywords":"Myeloid leukemia; Cancer research; Receptor; Myeloid; Biology; Peroxisome proliferator-activated receptor delta; Immunology; Nuclear receptor; Biochemistry; Transcription factor; Gene","score_opus":0.006345620975739975,"score_gpt":0.22734212928141043,"score_spread":0.22099650830567044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969567,0.00076424924,0.0004284705,0.00008331323,0.00041980488,0.00050066033,0.00026083685,0.00012184404,0.00046409338],"genre_scores_gemma":[0.996337,0.00049572537,0.0010639748,0.00010303045,0.00049895106,0.0001215149,0.00066244835,0.00008834113,0.00062904047],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980453,0.00012642906,0.0004486221,0.0006964897,0.0002790802,0.00040405663],"domain_scores_gemma":[0.9991045,0.00002591317,0.00013415432,0.0003401102,0.00024984014,0.00014550019],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018738008,0.0003491199,0.00030588827,0.000178135,0.00010999434,0.00008283115,0.00018388912,0.000415239,0.000110952176],"category_scores_gemma":[0.00007177203,0.00033333706,0.00017147111,0.00050497765,0.00011238202,0.000035640176,0.00010687855,0.0002905626,0.000065445805],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013026838,0.00024796766,0.00047053318,0.00008776433,0.0005828082,0.0000065317217,0.00019028311,0.000035358673,0.9952168,0.00004002519,0.002470658,0.00052103825],"study_design_scores_gemma":[0.00094085373,0.00054701796,0.00008918915,0.000096491785,0.00012204631,0.000034646586,0.00004039493,0.000050517225,0.991086,0.000036268728,0.006583421,0.0003731282],"about_ca_topic_score_codex":0.000016766828,"about_ca_topic_score_gemma":0.0000055311393,"teacher_disagreement_score":0.004130739,"about_ca_system_score_codex":0.000098966884,"about_ca_system_score_gemma":0.000537312,"threshold_uncertainty_score":0.99991184},"labels":[],"label_agreement":null},{"id":"W4405039206","doi":"10.1182/blood-2024-212184","title":"Outcomes of Patients with Refractory and Relapsed Primary Mediastinal B Cell Lymphoma: A Canadian Single-Center Analysis","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Ipsen; Eisai; Gilead Sciences; AstraZeneca; Incyte; Amgen","keywords":"Medicine; Refractory (planetary science); Single Center; Lymphoma; Center (category theory); Internal medicine; Diffuse large B-cell lymphoma; Oncology","score_opus":0.006428186327959113,"score_gpt":0.196676574980264,"score_spread":0.1902483886523049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995434,0.0009655938,0.0000013419248,0.00017082233,0.000051255043,0.00020727662,0.00012695881,0.000023909413,0.0030188377],"genre_scores_gemma":[0.9990236,0.00002898836,0.00033299887,0.00018727673,0.000019773997,0.000018882158,0.00019201763,0.000016930566,0.00017950444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991286,0.000016792188,0.00018605313,0.00024533688,0.00023739014,0.00018586664],"domain_scores_gemma":[0.9993853,0.000078874495,0.000045761444,0.00019014395,0.000059646798,0.00024025002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004246653,0.00014187612,0.0003481465,0.00031433004,0.00002980484,0.000018567756,0.000033360095,0.00005451484,0.000049683807],"category_scores_gemma":[0.000013892023,0.000092983406,0.000099108205,0.00029800736,0.000046924186,0.000050593888,0.000016537826,0.000033750075,0.000007076781],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049885148,0.0035997494,0.9913147,0.00011548898,0.001643033,0.00025797045,0.00019232443,1.3401214e-7,0.000029467932,0.0000056572676,0.00015486233,0.0026367079],"study_design_scores_gemma":[0.009009374,0.0006076609,0.98436964,0.00008306294,0.004258969,0.000009961848,0.000026103879,0.0000044487565,0.00036894088,0.0000014725935,0.0011692318,0.00009114895],"about_ca_topic_score_codex":0.005599618,"about_ca_topic_score_gemma":0.0066917217,"teacher_disagreement_score":0.008959489,"about_ca_system_score_codex":0.00016913249,"about_ca_system_score_gemma":0.00028822193,"threshold_uncertainty_score":0.8464985},"labels":[],"label_agreement":null},{"id":"W4405039227","doi":"10.1182/blood-2024-199282","title":"Belantamab Mafodotin Plus Pomalidomide and Dexamethasone Vs Pomalidomide Plus Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma: A Subset Analysis in Patients Who Have Received 1 Prior Line of Therapy Including Lenalidomide","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pomalidomide; Dexamethasone; Bortezomib; Medicine; Multiple myeloma; Internal medicine; Oncology; Lenalidomide; Refractory (planetary science); Biology","score_opus":0.02230919046572011,"score_gpt":0.2789554290237184,"score_spread":0.2566462385579983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99325186,0.0034844668,0.000040690305,0.00013002112,0.000045905417,0.0025917909,0.00031186166,0.00006749111,0.00007589832],"genre_scores_gemma":[0.9949342,0.001144276,0.002812014,0.000070997536,0.000052764204,0.00016531354,0.00055467495,0.000119283715,0.00014647654],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950653,0.0005267716,0.0012083078,0.001240106,0.0010257075,0.00093382347],"domain_scores_gemma":[0.9968845,0.0013082718,0.00035917663,0.0006627947,0.00029359927,0.00049162953],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001009062,0.00069191103,0.0019506565,0.0018979253,0.00012748923,0.00010107836,0.00020884411,0.0003354918,0.00005455212],"category_scores_gemma":[0.0009596871,0.00054464187,0.00021699665,0.0016677752,0.00030182116,0.00039200552,0.00024188995,0.0007619023,0.000004578372],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024407998,0.002505896,0.95845634,0.00034149285,0.0027881055,0.00047402916,0.0020263062,0.000045724675,0.0007164843,0.0000032354565,0.000015735553,0.008218669],"study_design_scores_gemma":[0.11600112,0.002621156,0.871223,0.0009759662,0.001026911,0.000015252847,0.00022802377,0.003225644,0.0041982564,0.000013863615,0.00003113887,0.00043966653],"about_ca_topic_score_codex":0.0024749502,"about_ca_topic_score_gemma":0.0024523248,"teacher_disagreement_score":0.091593124,"about_ca_system_score_codex":0.0004600408,"about_ca_system_score_gemma":0.0003440151,"threshold_uncertainty_score":0.9997005},"labels":[],"label_agreement":null},{"id":"W4405039231","doi":"10.1182/blood-2024-208803","title":"Patient Preferences on Clinical Decision-Making in Myeloma: A 747-Patient Survey","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Multiple myeloma; Medicine; Clinical decision making; Family medicine; Internal medicine","score_opus":0.07321582580118782,"score_gpt":0.3994079923189591,"score_spread":0.3261921665177713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951722,0.0010343811,0.0000138387895,0.00006959044,0.0002883029,0.0005454755,0.000049676128,0.00006343715,0.0027631118],"genre_scores_gemma":[0.99886423,0.0001280948,0.00067857414,0.00009383404,0.00007271295,0.00006105001,0.000039921535,0.000020393345,0.00004116389],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99796224,0.00019349011,0.00048416268,0.00045956703,0.00056197605,0.00033857065],"domain_scores_gemma":[0.9977058,0.001693305,0.000038568884,0.00030522502,0.00006465911,0.00019241644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046084786,0.00015725904,0.0003006951,0.00022961742,0.000039874285,0.000050267667,0.00007586542,0.00010073482,0.00016661617],"category_scores_gemma":[0.0014665991,0.000107455664,0.000110441084,0.00033647617,0.000045188986,0.00004909748,0.00008308664,0.00034176125,0.0003449921],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006269734,0.0023018697,0.5027193,0.000036349764,0.00015494012,0.001434734,0.00021446969,0.000002153417,0.000014762501,0.000021268848,0.00044723097,0.49202594],"study_design_scores_gemma":[0.0025599115,0.0036190446,0.99040216,0.0013694309,0.00004478904,0.00003220699,0.000053444484,0.00027383902,0.00030466085,0.0002615995,0.00096179877,0.00011713298],"about_ca_topic_score_codex":0.00013808918,"about_ca_topic_score_gemma":0.0004527181,"teacher_disagreement_score":0.49190882,"about_ca_system_score_codex":0.000057622437,"about_ca_system_score_gemma":0.00020463305,"threshold_uncertainty_score":0.44342905},"labels":[],"label_agreement":null},{"id":"W4405039253","doi":"10.1182/blood-2024-210831","title":"Diagnostic Test Accuracy of Cardiac Imaging for AL Amyloidosis: A Systematic Review and Meta-Analysis","year":2024,"lang":"en","type":"review","venue":"Blood","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; University of British Columbia; Princess Margaret Cancer Centre","funders":"","keywords":"Meta-analysis; Medicine; Cardiac amyloidosis; Amyloidosis; Internal medicine; Pathology","score_opus":0.034280809931679486,"score_gpt":0.34608084480151174,"score_spread":0.31180003486983227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039253","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000004122663,0.99198526,0.00001516472,0.00021631633,0.000053074804,0.0050403974,0.0026333702,0.00002644862,0.000025865294],"genre_scores_gemma":[0.00015042973,0.98865914,0.0002851075,0.00039741158,0.000062114275,0.009233196,0.00082416186,0.00012058138,0.00026785643],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99659765,0.0003089878,0.0014611874,0.0010244206,0.00023516503,0.0003725974],"domain_scores_gemma":[0.9947151,0.0026981863,0.0010469524,0.0012497674,0.00015389081,0.00013608763],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006018884,0.00085766456,0.008319082,0.00024031913,0.00006139682,0.00007521469,0.00043565905,0.00022144025,0.000019059784],"category_scores_gemma":[0.0064032464,0.0005664871,0.006676147,0.0005369334,0.00008333878,0.000007079224,0.0002923341,0.00014828256,0.00001980779],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[4.3892425e-7,0.00020124645,0.000048779257,0.7081503,0.2887562,0.0000059425874,0.000005936631,6.406226e-8,0.000005975861,0.000007194289,0.0019533408,0.0008645604],"study_design_scores_gemma":[0.00013535301,0.00007471047,0.0000017809268,0.024586666,0.89735854,0.000026308204,0.000008504881,3.219173e-7,0.00008288764,0.0000036862918,0.077284105,0.000437146],"about_ca_topic_score_codex":0.000016952441,"about_ca_topic_score_gemma":0.0000067502215,"teacher_disagreement_score":0.68356365,"about_ca_system_score_codex":0.000024666746,"about_ca_system_score_gemma":0.00016068769,"threshold_uncertainty_score":0.9996787},"labels":[],"label_agreement":null},{"id":"W4405039259","doi":"10.1182/blood-2024-208194","title":"Prevalence of Food Insecurity in Patients with Lymphoid Malignancies: A Systematic Review and Meta-Analysis","year":2024,"lang":"en","type":"review","venue":"Blood","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Meta-analysis; Hematologic Neoplasms; Medicine; Internal medicine; Oncology; Cancer","score_opus":0.08010210057108995,"score_gpt":0.35068128489405803,"score_spread":0.27057918432296807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039259","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000049801376,0.99524486,9.580909e-7,0.000039126735,0.000009658646,0.0042905556,0.00029751367,0.000019694098,0.00004784966],"genre_scores_gemma":[0.00029768466,0.99840367,0.00015881105,0.00026596404,0.0000068478066,0.0006748633,0.000041215724,0.000026479205,0.0001244614],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.997456,0.00026035303,0.0013253677,0.000403275,0.00037588918,0.0001790742],"domain_scores_gemma":[0.99855727,0.00009088948,0.0005835815,0.000524826,0.00013428368,0.0001091584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063786114,0.0003214522,0.0074860444,0.00046917793,0.000016551821,0.000010440784,0.00010886983,0.00011408023,0.00006951283],"category_scores_gemma":[0.00011808763,0.00017800451,0.00090145465,0.0011984267,0.00003951544,0.00003133247,0.000047461046,0.00022069631,0.00000787793],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000001616274,0.00031977112,0.00025730583,0.95283604,0.0464554,0.000008234288,0.000032181102,1.4957041e-9,2.0187259e-9,0.000036258476,0.000014754208,0.00003844606],"study_design_scores_gemma":[0.00036928072,0.00015134831,0.00002655108,0.34694216,0.65169096,0.000026151403,0.0000018694393,8.16074e-8,8.969901e-8,0.0000059052563,0.0006884719,0.00009711695],"about_ca_topic_score_codex":0.000006357881,"about_ca_topic_score_gemma":0.000006378002,"teacher_disagreement_score":0.60589385,"about_ca_system_score_codex":0.000046529065,"about_ca_system_score_gemma":0.00020078373,"threshold_uncertainty_score":0.72588134},"labels":[],"label_agreement":null},{"id":"W4405039268","doi":"10.1182/blood-2024-199378","title":"Findings from a Longitudinal Series of Continuing Education and Quality Improvement Programs in Myelofibrosis","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Sierra Oncology; Swedish Orphan Biovitrum; Incyte; AOP Orphan; GlaxoSmithKline; Exelixis; Celgene; CTI Biopharma; Gilead Sciences; Bristol-Myers Squibb","keywords":"Myelofibrosis; Series (stratigraphy); Medicine; Quality (philosophy); Internal medicine; Biology; Bone marrow","score_opus":0.030046561866453988,"score_gpt":0.2960412193980795,"score_spread":0.2659946575316255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965722,0.0022767703,0.0000047772705,0.00038722678,0.00007457154,0.00044975357,0.000018711386,0.000020383588,0.00019558312],"genre_scores_gemma":[0.9978123,0.00021569605,0.0014406851,0.000021344735,0.000054156833,0.00020534113,0.00004857424,0.0000093237895,0.0001925965],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99923295,0.000018500874,0.00025654968,0.00024705875,0.00013150647,0.00011341217],"domain_scores_gemma":[0.99970734,0.00005697396,0.000036261314,0.00010407032,0.000043342192,0.00005198842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000114677794,0.0001064338,0.00024463903,0.0000677664,0.000016208733,0.00003953936,0.000019710233,0.00004310425,0.000040207244],"category_scores_gemma":[0.00003217568,0.00008432931,0.000043660853,0.00012099585,0.000038738563,0.00008330864,0.00002432752,0.0000662015,0.0000035440046],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005088699,0.0012395683,0.91705906,0.00027776332,0.00012707885,0.00000977315,0.0018839196,2.7710312e-8,0.0153185455,0.0008828001,0.000014238821,0.06313633],"study_design_scores_gemma":[0.0012783682,0.0006713427,0.899731,0.0012136734,0.00020193182,0.000009407294,0.00071721215,0.0000036439674,0.09568998,0.00018450928,0.00021919752,0.00007974254],"about_ca_topic_score_codex":0.0008133178,"about_ca_topic_score_gemma":0.00040081982,"teacher_disagreement_score":0.08037144,"about_ca_system_score_codex":0.000030586874,"about_ca_system_score_gemma":0.00006285886,"threshold_uncertainty_score":0.34388494},"labels":[],"label_agreement":null},{"id":"W4405039282","doi":"10.1182/blood-2024-202290","title":"Prior History of Severe Infection in Children, Adolescents and Young Adults with Lymphoma As Proxy for Inborn Errors of Immunity: Prevalence and Impact on Post-Lymphoma Outcomes","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Lymphoma; Pediatrics; Immunity; Immunology; Proxy (statistics); Young adult; Immune system; Internal medicine","score_opus":0.003840771098684349,"score_gpt":0.21484557099000934,"score_spread":0.21100479989132498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9630019,0.035917837,0.0000015138228,0.000012171681,0.00018564708,0.00071044185,0.00006882639,0.000032528438,0.000069126734],"genre_scores_gemma":[0.9990859,0.0005151408,0.000006540288,0.00002014343,0.0000012030855,0.00003571594,0.00004269237,0.000019265603,0.0002734148],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909514,0.00008781552,0.00028954397,0.00026346985,0.000044196826,0.00021981678],"domain_scores_gemma":[0.99954003,0.00006124427,0.0001298293,0.00020004025,0.00006166876,0.000007211734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017424153,0.0002056534,0.00031861663,0.00022509303,0.00005763718,0.00000665879,0.000099262164,0.00015990436,0.000010916495],"category_scores_gemma":[0.00007382226,0.00015581316,0.0000780943,0.00012060103,0.0002524506,0.00013271613,0.000050165963,0.000110601926,0.0000028450038],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014560784,0.0014626256,0.9561336,0.0010765569,0.00036912446,0.0000020152916,0.004365053,0.000003223303,0.01295434,0.00005393566,0.0000060372236,0.0221174],"study_design_scores_gemma":[0.006820184,0.0015074712,0.9854103,0.0012934948,0.00014776486,0.0001778713,0.00020107033,0.0000067908027,0.004194512,0.000016463713,0.00004664262,0.00017745155],"about_ca_topic_score_codex":0.0019960203,"about_ca_topic_score_gemma":0.000030238756,"teacher_disagreement_score":0.036083974,"about_ca_system_score_codex":0.0000692803,"about_ca_system_score_gemma":0.00022085916,"threshold_uncertainty_score":0.6353876},"labels":[],"label_agreement":null},{"id":"W4405039302","doi":"10.1182/blood-2024-200071","title":"Validation of the EBMT Multiple Myeloma Early Relapse Score within Worldwide Network for Blood and Marrow Transplantation (WBMT) Global Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; McMaster University","funders":"","keywords":"Multiple myeloma; Medicine; Transplantation; Internal medicine; Oncology; Bone marrow transplantation; Hematologic Neoplasms","score_opus":0.022009571042101998,"score_gpt":0.2868463553171174,"score_spread":0.2648367842750154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99619174,0.0007765354,0.000104156024,0.0002036633,0.00017036343,0.0022007516,0.00015742065,0.000059617345,0.000135755],"genre_scores_gemma":[0.99785006,0.00003808467,0.0013644618,0.000018507148,0.00014998042,0.0001607447,0.00007897926,0.000022904216,0.00031629152],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868006,0.000095065036,0.00029369496,0.00031423804,0.0003641212,0.0002527964],"domain_scores_gemma":[0.99928856,0.00020076324,0.0000645819,0.0002520622,0.00008176147,0.00011229412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030545314,0.00015737556,0.00022368415,0.000050908096,0.00012189852,0.00005065005,0.00008594475,0.00006370109,0.000010522669],"category_scores_gemma":[0.00012570301,0.00010540305,0.00009923651,0.00035403296,0.000058615577,0.00009817907,0.000027354507,0.00012583585,0.0000037097695],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007985271,0.0010038429,0.9898908,0.00044933203,0.0008297657,0.0001463634,0.001079507,0.000028463708,0.0036464424,0.00016883336,0.00008399591,0.0018740849],"study_design_scores_gemma":[0.015080103,0.001339103,0.9541455,0.00062085316,0.0021805274,0.00014423503,0.00016977896,0.0005322399,0.025174942,0.00044099404,0.000036186488,0.00013553954],"about_ca_topic_score_codex":0.00019392054,"about_ca_topic_score_gemma":0.00045783722,"teacher_disagreement_score":0.035745345,"about_ca_system_score_codex":0.000024220362,"about_ca_system_score_gemma":0.00010347832,"threshold_uncertainty_score":0.42982116},"labels":[],"label_agreement":null},{"id":"W4405039315","doi":"10.1182/blood-2024-206375","title":"A Real-World Comparison of CAR T-Cell Therapy Versus a Historical Standard-of-Care Approach for Relapsed-Refractory Large B-Cell Lymphoma in Ontario, Canada","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Princess Margaret Cancer Centre; Health Sciences Centre; University Health Network","funders":"Ipsen; Eisai; BeiGene; AstraZeneca; Eli Lilly and Company","keywords":"Refractory (planetary science); Medicine; Lymphoma; Standard of care; Chemotherapy regimen; Oncology; Internal medicine; Chemotherapy; Biology","score_opus":0.03787083616924094,"score_gpt":0.3061754718049588,"score_spread":0.2683046356357179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9521687,0.012882987,0.00004219699,0.00005613665,0.00046871667,0.0012188156,0.00013206166,0.000038980394,0.03299143],"genre_scores_gemma":[0.9890098,0.0001856593,0.00096873724,0.0000155239,0.00010103506,0.0000965868,0.00013620316,0.00006886883,0.009417584],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977386,0.00007777885,0.00053592847,0.00042591192,0.0007701911,0.00045159843],"domain_scores_gemma":[0.99873286,0.000334213,0.00010112737,0.00047453423,0.00019152035,0.00016572095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031935907,0.00022627493,0.0007939766,0.0002897821,0.000039307713,0.000011404941,0.0001926522,0.0001434898,0.00029754726],"category_scores_gemma":[0.000026089887,0.00020674196,0.0002170896,0.00043073943,0.00004244183,0.000036587666,0.000041398864,0.00039258428,8.2874686e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12005903,0.050378576,0.31251657,0.015577612,0.0027753718,0.0010575561,0.056702826,0.00009082327,0.294667,0.0009896267,0.10129151,0.043893524],"study_design_scores_gemma":[0.099848606,0.008280519,0.0036486238,0.00030043186,0.00041425604,0.0000067975943,0.0026115025,0.00046491312,0.1511122,0.00001324785,0.732791,0.0005079229],"about_ca_topic_score_codex":0.8123217,"about_ca_topic_score_gemma":0.9360045,"teacher_disagreement_score":0.63149947,"about_ca_system_score_codex":0.004313549,"about_ca_system_score_gemma":0.00534991,"threshold_uncertainty_score":0.99950874},"labels":[],"label_agreement":null},{"id":"W4405039364","doi":"10.1182/blood-2024-202138","title":"Health-Related Communication in Adolescents and Young Adults with Sickle Cell Disease","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University","funders":"","keywords":"Disease; Medicine; Sickle cell anemia; Young adult; Pediatrics; Gerontology; Internal medicine","score_opus":0.0042620187932815275,"score_gpt":0.21854128608148815,"score_spread":0.21427926728820662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9530221,0.043087002,0.0000031671264,0.0023609134,0.00003868095,0.00035329792,0.000004402246,0.00007584728,0.0010545887],"genre_scores_gemma":[0.9971556,0.0023363952,0.00005610354,0.00015059854,0.000007679122,0.000009716858,0.000034872694,0.000017757968,0.00023124253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993863,0.00003522028,0.00016593667,0.00016280083,0.000099217556,0.00015052843],"domain_scores_gemma":[0.999605,0.0000071082814,0.00002492041,0.00019116969,0.000015329959,0.0001564538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008223153,0.00008338999,0.0001310979,0.00007083385,0.000042719847,0.000015644919,0.000035179597,0.000053338383,0.000007955567],"category_scores_gemma":[0.000008804081,0.00006253667,0.00001985165,0.00019990184,0.000045413944,0.00004389529,0.000022855527,0.00024212085,0.000018512143],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010654613,0.0038715976,0.95582116,0.0069378307,0.00014236502,0.00091753906,0.010360948,0.00002258,0.00026783944,0.00029316993,0.0010165416,0.019282967],"study_design_scores_gemma":[0.030219717,0.0011483424,0.92566586,0.030266989,0.00060501543,0.00033774032,0.0033684117,0.00563676,0.00023893506,0.00026549585,0.001687863,0.00055887614],"about_ca_topic_score_codex":0.000336275,"about_ca_topic_score_gemma":0.000101504505,"teacher_disagreement_score":0.044133533,"about_ca_system_score_codex":0.000018852896,"about_ca_system_score_gemma":0.0001026735,"threshold_uncertainty_score":0.25501713},"labels":[],"label_agreement":null},{"id":"W4405039369","doi":"10.1182/blood-2024-199731","title":"Development and Evaluation of a Procedural Skills Clinic for Teaching Residents Bone Marrow Biopsies and Lumbar Punctures on Adult Hematology Patients","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hematological disorders and diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Hematology; Medicine; Bone marrow; Internal medicine","score_opus":0.020573785333940033,"score_gpt":0.32262666393880146,"score_spread":0.3020528786048614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99672735,0.0017605321,0.000010226858,0.0003986196,0.00005084428,0.00073624693,0.000008974165,0.000024339088,0.00028287113],"genre_scores_gemma":[0.99682593,0.00007606649,0.0026031812,0.00030048494,0.000015921496,0.000086277505,0.000037115504,0.000010355831,0.00004466807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990981,0.000034687997,0.00028979388,0.00021670721,0.00023098823,0.0001296877],"domain_scores_gemma":[0.9994408,0.00024228574,0.000053580054,0.00006758093,0.0001363296,0.000059448674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003177635,0.000105336,0.00025726674,0.00007462193,0.00005168604,0.000013710338,0.000020744834,0.00009355797,0.000010650853],"category_scores_gemma":[0.0032201896,0.00007198313,0.000029746856,0.000040004717,0.000053636435,0.000028043549,0.000025589978,0.00008657061,0.00000323875],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068343343,0.008301514,0.85015845,0.011332345,0.0008738482,0.0000850595,0.010186691,0.0000020417745,0.0019947058,0.011414912,0.011366299,0.093600675],"study_design_scores_gemma":[0.0132583445,0.001988499,0.95912474,0.0031413357,0.0012104084,0.00010978036,0.0009633234,0.000490349,0.014108061,0.0047458056,0.00053228915,0.00032705753],"about_ca_topic_score_codex":0.0000034574168,"about_ca_topic_score_gemma":0.000011935816,"teacher_disagreement_score":0.108966276,"about_ca_system_score_codex":0.000008884116,"about_ca_system_score_gemma":0.00007848166,"threshold_uncertainty_score":0.38551003},"labels":[],"label_agreement":null},{"id":"W4405039376","doi":"10.1182/blood-2024-211410","title":"Cilta-Cel Is Associated with Improved Outcomes and Distinct Cellular Dynamics Compared with Ide-Cel for Relapsed or Refractory Multiple Myeloma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cilag; Astellas Pharma; Incyte; Mallinckrodt Pharmaceuticals; Jazz Pharmaceuticals; Springworks Therapeutics; Regeneron Pharmaceuticals; Swedish Orphan Biovitrum; Therakos; Alexion Pharmaceuticals; Gilead Sciences; Les Laboratories Pierre Fabre; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb; Amgen","keywords":"Multiple myeloma; Refractory (planetary science); Lenalidomide; Medicine; Daratumumab; Dynamics (music); Cancer research; Hematologic Neoplasms; Internal medicine; Oncology; Biology; Cancer; Psychology","score_opus":0.02366276717185334,"score_gpt":0.27922762802130685,"score_spread":0.2555648608494535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951455,0.00051300845,0.0007042749,0.0004787738,0.00006119137,0.0017805615,0.0007423503,0.00025045252,0.0003239015],"genre_scores_gemma":[0.9900907,0.000022273882,0.0024965026,0.000078284946,0.000050364688,0.0002564748,0.00085636775,0.0001033433,0.006045664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99801,0.000049550163,0.0003159654,0.0006090688,0.0004395928,0.0005758632],"domain_scores_gemma":[0.9981605,0.0007717724,0.0001019049,0.0004128061,0.0001965837,0.00035645068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019412013,0.00037504424,0.00064349425,0.00014802643,0.00018037883,0.00010549942,0.00010844125,0.00014556054,0.000050627084],"category_scores_gemma":[0.0004596158,0.00021639922,0.00011113563,0.00027140084,0.00014709479,0.00011991671,0.000054736116,0.00029381382,0.000011858009],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0090707615,0.005326979,0.95033944,0.0012994807,0.008357258,0.0034328315,0.00091914815,0.0000010423607,0.012253601,0.000052737207,0.0008816123,0.00806513],"study_design_scores_gemma":[0.12647791,0.014350993,0.7228636,0.0017725495,0.004376518,0.00027867558,0.00079486443,0.10921545,0.016282067,0.00007491076,0.0022606868,0.0012517598],"about_ca_topic_score_codex":0.000205885,"about_ca_topic_score_gemma":0.0013568964,"teacher_disagreement_score":0.2274758,"about_ca_system_score_codex":0.00017874883,"about_ca_system_score_gemma":0.0003082525,"threshold_uncertainty_score":0.8824504},"labels":[],"label_agreement":null},{"id":"W4405039389","doi":"10.1182/blood-2024-208314","title":"Metabolic and Cell Cycle Proteins As Novel Targets of Selinexor Activity in Diffuse Large B Cell Lymphoma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Cell cycle; Computational biology; Cell; Biology; Cell biology; Cancer research; Medicine; Biochemistry; Immunology","score_opus":0.005173776696513386,"score_gpt":0.22244126560048524,"score_spread":0.21726748890397185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96285605,0.035340838,0.00022944697,0.00003723681,0.00027081397,0.00026760393,0.00014896145,0.000015109892,0.00083394145],"genre_scores_gemma":[0.99539834,0.0027427361,0.0004906529,0.00006282307,0.00047815577,0.000045737273,0.000022762595,0.00002982588,0.0007289533],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990691,0.00003180896,0.00016420337,0.0003696716,0.00010725344,0.00025795653],"domain_scores_gemma":[0.9995736,0.0000092105665,0.00004944778,0.00025477444,0.000031145115,0.000081814695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015069207,0.0001613453,0.00022185783,0.000068293804,0.00002741008,0.000021299778,0.00010709036,0.00014145771,0.000007766738],"category_scores_gemma":[0.00002493639,0.00015105175,0.00008596509,0.00012602333,0.00003806892,0.0000074197364,0.000114112554,0.00007245542,0.0000057409957],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003933226,0.0032701562,0.00019486915,0.00014657376,0.000035996818,0.0000034730579,0.0001359025,0.0000010846514,0.9942108,0.00007208586,0.00009676002,0.0017929614],"study_design_scores_gemma":[0.0059906677,0.00008094136,0.0035838434,0.000015594038,0.000078924146,0.000011321739,0.000026903215,0.000059210746,0.894922,0.000032916043,0.09503165,0.00016600215],"about_ca_topic_score_codex":0.00016881182,"about_ca_topic_score_gemma":0.00011083907,"teacher_disagreement_score":0.099288784,"about_ca_system_score_codex":0.0000037934183,"about_ca_system_score_gemma":0.00014303393,"threshold_uncertainty_score":0.61597115},"labels":[],"label_agreement":null},{"id":"W4405039420","doi":"10.1182/blood-2024-201926","title":"Sirolimus Plus Roxadustat in Patients with Pure Red Cell Aplasia: Results from a Prospective Multi-Center Clinical Trial","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"The Scarborough Hospital; University of Toronto","funders":"","keywords":"Medicine; Sirolimus; Center (category theory); Clinical trial; Internal medicine; Chemistry","score_opus":0.02842309607592527,"score_gpt":0.2913364619168094,"score_spread":0.26291336584088415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956807,0.00011266578,0.000020456147,0.00024199598,0.0011357914,0.0012739506,0.00019495009,0.00011316501,0.0012263573],"genre_scores_gemma":[0.9968964,0.000036331243,0.00065806153,0.00023044227,0.0007253232,0.00004918192,0.0004502971,0.000034403736,0.0009195577],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998282,0.00012685057,0.0005216177,0.0006159079,0.00020708282,0.00024654326],"domain_scores_gemma":[0.9992055,0.00019544883,0.0000851116,0.00030232966,0.00008004678,0.00013153891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015065925,0.00018741311,0.0004402454,0.00009971718,0.00002858924,0.000018759101,0.000060948496,0.00024861225,0.00005061633],"category_scores_gemma":[0.00018509985,0.00013226998,0.00011667072,0.00020715213,0.00006651616,0.000058386548,0.000040240262,0.00060233293,0.0001202788],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.64878875,0.032699276,0.30271095,0.00024348416,0.0007691496,0.0016481907,0.003053645,0.000014509163,0.0005602027,0.000017008482,0.008013728,0.0014810951],"study_design_scores_gemma":[0.69367975,0.007903933,0.29357922,0.0002982348,0.00030630836,0.000007686491,0.000116913034,0.00022059683,0.00030463008,0.000030059806,0.0033380378,0.00021461131],"about_ca_topic_score_codex":0.000031505617,"about_ca_topic_score_gemma":0.000056637648,"teacher_disagreement_score":0.044891007,"about_ca_system_score_codex":0.000060726292,"about_ca_system_score_gemma":0.00017582098,"threshold_uncertainty_score":0.5393814},"labels":[],"label_agreement":null},{"id":"W4405039437","doi":"10.1182/blood-2024-200444","title":"Development of an Electronic Learning Module for CAR-T Education in Canadian Hematology Residents","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Biomedical and Engineering Education","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hamilton Health Sciences; Juravinski Cancer Centre; McMaster University","funders":"","keywords":"Hematology; Medicine; Internal medicine; Medical education","score_opus":0.004334377493956108,"score_gpt":0.22466216596680777,"score_spread":0.22032778847285167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973534,0.0011666969,0.00074950955,0.000039095292,0.0002802749,0.000068033114,9.47146e-7,0.00006813012,0.0002739627],"genre_scores_gemma":[0.99713373,0.00001047581,0.0026521422,0.0000032480148,0.000047294587,0.000035405556,0.00004368539,0.0000139488375,0.00006008214],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9996026,0.0000047008198,0.000105841726,0.00007077283,0.000032837055,0.00018322912],"domain_scores_gemma":[0.9998726,0.000008475343,0.0000040460445,0.00004214571,0.000008156735,0.00006455756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011127955,0.00004389656,0.00005416769,0.00015235708,0.000013048004,0.0000070331257,0.00004294696,0.00004295932,0.0000067551555],"category_scores_gemma":[0.000012061678,0.000048016493,0.000009399115,0.00010401111,0.0000036485453,0.00003639637,0.0000022893985,0.00007815157,0.0000050261337],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015195906,0.0012227438,0.021195436,0.01655082,0.000642763,0.000021616614,0.025998438,0.027297027,0.099615104,0.034398522,0.0033729894,0.76966935],"study_design_scores_gemma":[0.0020703769,0.0002737995,0.2918025,0.0020505672,0.00015556233,0.00013498636,0.0013786417,0.25009137,0.2122059,0.004542198,0.23379219,0.0015019068],"about_ca_topic_score_codex":0.0039580944,"about_ca_topic_score_gemma":0.03917982,"teacher_disagreement_score":0.76816744,"about_ca_system_score_codex":0.00010534325,"about_ca_system_score_gemma":0.0005509418,"threshold_uncertainty_score":0.97835267},"labels":[],"label_agreement":null},{"id":"W4405039445","doi":"10.1182/blood-2024-211149","title":"Diagnostic Test Accuracy of Bone Scintigraphy in the Diagnosis of Attr Amyloidosis: A Systematic Review and Meta-Analysis","year":2024,"lang":"en","type":"review","venue":"Blood","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; University of British Columbia; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Meta-analysis; Amyloidosis; Bone scintigraphy; Systematic review; MEDLINE; Radiology; Medical physics; Pathology","score_opus":0.048392823330150124,"score_gpt":0.3386201819948453,"score_spread":0.2902273586646952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039445","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021120044,0.9946874,0.000001346639,0.00023607013,0.000020757398,0.0038996595,0.0009017666,0.0000111398285,0.000030664167],"genre_scores_gemma":[0.0069185765,0.9846053,0.00007383075,0.00026937143,0.000026312668,0.007790389,0.00020775112,0.00006607789,0.000042355052],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9953051,0.00082651374,0.0022350017,0.00088559196,0.00041144702,0.00033632654],"domain_scores_gemma":[0.99194634,0.0045120977,0.0016248688,0.0017087436,0.00012210569,0.00008587112],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011718913,0.00082983705,0.008330305,0.00057531404,0.000041957857,0.00004881507,0.000725732,0.00034181675,0.00003884249],"category_scores_gemma":[0.007106987,0.0004563144,0.005040019,0.0020338625,0.00019404494,0.000008115079,0.0002972526,0.000255919,0.000012404775],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[7.303721e-7,0.001076995,0.0014363307,0.8256432,0.1707084,0.00003154375,0.000039829472,2.6117334e-7,0.0000024645833,0.00001973624,0.0006797322,0.00036079803],"study_design_scores_gemma":[0.00021183482,0.0001803372,0.00007885506,0.046785217,0.9462621,0.000045149925,0.000029789042,8.5057174e-8,0.00009908715,0.0000074694094,0.0059253834,0.00037469142],"about_ca_topic_score_codex":0.00008402783,"about_ca_topic_score_gemma":0.00012268513,"teacher_disagreement_score":0.77885795,"about_ca_system_score_codex":0.000014090194,"about_ca_system_score_gemma":0.00012164352,"threshold_uncertainty_score":0.9997889},"labels":[],"label_agreement":null},{"id":"W4405039469","doi":"10.1182/blood-2024-207510","title":"Treatment Adherence, Satisfaction and Quality of Life of Adult Patients with Severe Haemophilia a: Results from a Real-World Survey of Physicians and Patients","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Medicine; Haemophilia; Quality of life (healthcare); Patient satisfaction; Family medicine; Pediatrics; Surgery; Nursing","score_opus":0.04090000227233511,"score_gpt":0.31009506531155717,"score_spread":0.2691950630392221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963944,0.00014676955,3.4745156e-7,0.00004469455,0.000030553387,0.00054759864,0.0023487525,0.000013299417,0.00047356915],"genre_scores_gemma":[0.9987649,0.00035377202,0.0001150212,0.0000047786057,0.00001826577,0.000010310441,0.00053437595,0.000013627047,0.00018500451],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986756,0.00012018095,0.00042239347,0.00028518113,0.00037057034,0.00012609024],"domain_scores_gemma":[0.99887747,0.0003145806,0.00015829525,0.00022182486,0.00034805818,0.00007977298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009918557,0.00014284429,0.00047569844,0.000109493165,0.000023686123,0.0000062207164,0.000023564504,0.000057418845,0.000008174927],"category_scores_gemma":[0.00014911608,0.00009280212,0.00004100852,0.00026758015,0.00013016877,0.000061053935,0.00002380671,0.00006675196,0.0000010108356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00200923,0.001486929,0.9812009,0.00030326794,0.00056334876,0.0000027561302,0.00071379996,2.2478751e-7,0.00028596845,0.000011474502,0.00004020804,0.013381937],"study_design_scores_gemma":[0.012830708,0.0026045803,0.9806675,0.00048932235,0.00024325121,1.9770201e-7,0.00005059633,0.000013071153,0.0030048972,0.000016059854,0.0000035785533,0.000076274344],"about_ca_topic_score_codex":0.034432054,"about_ca_topic_score_gemma":0.0074013397,"teacher_disagreement_score":0.027030714,"about_ca_system_score_codex":0.000027599966,"about_ca_system_score_gemma":0.00011232055,"threshold_uncertainty_score":0.97199774},"labels":[],"label_agreement":null},{"id":"W4405039497","doi":"10.1182/blood-2024-202580","title":"“There Is so Much Power in Just Believing Someone”: Understanding the Lived Experiences of Women with Heavy Vaginal Blood Loss","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Grief, Bereavement, and Mental Health","field":"Psychology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Medicine; Power (physics); Obstetrics; Physics","score_opus":0.04154149467246982,"score_gpt":0.3247529404308467,"score_spread":0.28321144575837687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888091,0.0029489542,0.00006136581,0.00049437786,0.00041554868,0.00034084517,0.000009585664,0.000048903486,0.006871339],"genre_scores_gemma":[0.9986453,0.0000901401,0.000041730433,0.0003584824,0.00007644275,0.00011767908,0.0000022328713,0.000030228717,0.0006377778],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9982674,0.00011274693,0.00031824913,0.00039903336,0.0002717328,0.0006308116],"domain_scores_gemma":[0.99935776,0.000109122346,0.00008507994,0.00031257982,0.000017029577,0.00011839904],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004620094,0.00019299665,0.00024988866,0.00012279168,0.00017147313,0.000067333254,0.00023435507,0.000080729624,0.0011710817],"category_scores_gemma":[0.000004376739,0.00013015121,0.000043141485,0.0003384625,0.00026582074,0.00009786858,0.000052216077,0.00027795328,0.00003710509],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023001895,0.0015569578,0.021190371,0.00040606197,0.00042722598,0.00042995194,0.9620062,7.1287707e-7,0.00045777435,0.012642803,0.00036150322,0.00029041397],"study_design_scores_gemma":[0.002908237,0.0015292454,0.0061745774,0.00063815154,0.0001079977,0.00016748684,0.98404473,0.000003800273,0.0023629689,0.0011640635,0.00062418886,0.00027455884],"about_ca_topic_score_codex":0.00030206473,"about_ca_topic_score_gemma":0.00015552352,"teacher_disagreement_score":0.02203852,"about_ca_system_score_codex":0.00013771885,"about_ca_system_score_gemma":0.00018645756,"threshold_uncertainty_score":0.999742},"labels":[],"label_agreement":null},{"id":"W4405039556","doi":"10.1182/blood-2024-194254","title":"Impact of Obesity on Anticoagulation Dosing and Clinical Outcomes in Pediatric Patients with Venous Thrombo-Embolism","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval","funders":"","keywords":"Medicine; Dosing; Venous thromboembolism; Pulmonary embolism; Warfarin; Obesity; Intensive care medicine; Internal medicine; Thrombosis; Atrial fibrillation","score_opus":0.01621152123091843,"score_gpt":0.31996453762905847,"score_spread":0.30375301639814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99879926,0.00022443221,0.0000061917917,0.000051796527,0.00011591814,0.00045837805,0.000007817517,0.00003472109,0.00030150267],"genre_scores_gemma":[0.9994346,0.00028175212,0.000111107554,0.000041089967,0.00008839449,0.000004217728,0.000012811409,0.000018614453,0.000007396796],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990392,0.00003344549,0.00029935286,0.0002448674,0.00021893386,0.00016419965],"domain_scores_gemma":[0.9995434,0.00011629105,0.00006316383,0.00017268496,0.000035703935,0.00006873926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017980488,0.0001270032,0.00050261704,0.00019271778,0.00002443955,0.000020876163,0.00003508473,0.0000656718,0.000012743521],"category_scores_gemma":[0.00005208737,0.00008518762,0.00010029713,0.00019634284,0.000032589734,0.00006818498,0.000032311757,0.00013623461,0.0000064558967],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032895357,0.0075391377,0.98982584,0.00016454958,0.0002448078,0.00002607326,0.00020221653,0.000011323,0.000005012114,0.000109448054,0.000042871805,0.0017958303],"study_design_scores_gemma":[0.0027657181,0.0023273504,0.99372953,0.00017663492,0.0007849528,0.0000013283527,0.000008382628,0.000046795856,0.0000140028915,0.000053484127,0.0000043369937,0.00008748126],"about_ca_topic_score_codex":0.00013307475,"about_ca_topic_score_gemma":0.000015901,"teacher_disagreement_score":0.0052117873,"about_ca_system_score_codex":0.000028914726,"about_ca_system_score_gemma":0.00005489586,"threshold_uncertainty_score":0.34738502},"labels":[],"label_agreement":null},{"id":"W4405039580","doi":"10.1182/blood-2024-203442","title":"Translational Disruption of NRF2 By Zotatifin Enhances Sensitivity to Ferroptosis and CAR-T Cells in Diffuse Large B-Cell Lymphoma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Genomics, phytochemicals, and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bioinformatics Solutions (Canada)","funders":"","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Sensitivity (control systems); Cancer research; Medicine; Chemistry; Immunology","score_opus":0.004554337386361424,"score_gpt":0.22487853636718041,"score_spread":0.22032419898081898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967499,0.0012874111,0.0010553012,0.000064795444,0.000049994636,0.00012308339,0.00052902283,0.0000054223588,0.00013511488],"genre_scores_gemma":[0.9990042,0.00019340069,0.0004146098,0.00003932351,0.000054267763,0.000011298779,0.00016289183,0.000011796532,0.00010821231],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993097,0.00004371799,0.00014816529,0.00028550567,0.000071772134,0.00014111804],"domain_scores_gemma":[0.99977416,0.000023851624,0.000024930621,0.00010109849,0.00002492812,0.000051057108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009804465,0.00010547062,0.00012096044,0.000034190485,0.00001932086,0.000015651118,0.000041755593,0.00007784464,0.000003516102],"category_scores_gemma":[0.000011342221,0.00010643183,0.000043921245,0.00006223674,0.000037248257,0.0000040844143,0.000032349642,0.000033278313,0.0000028866823],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027631962,0.0008169016,0.001235355,0.000070289774,0.000022111979,0.0000022682136,0.00029628002,0.000002881702,0.99679524,0.000012876897,0.00014691957,0.00057122903],"study_design_scores_gemma":[0.0015569858,0.0000655511,0.0025617837,0.00002358544,0.0000219336,0.0000018067353,0.00007370895,0.00006047479,0.994354,0.000037114158,0.0011215676,0.00012149555],"about_ca_topic_score_codex":0.00002835408,"about_ca_topic_score_gemma":0.00011135193,"teacher_disagreement_score":0.0024412614,"about_ca_system_score_codex":0.000004575344,"about_ca_system_score_gemma":0.000025352258,"threshold_uncertainty_score":0.43401638},"labels":[],"label_agreement":null},{"id":"W4405039612","doi":"10.1182/blood-2024-193201","title":"Treatment with Asciminib As a Second Line after One Prior Tyrosine Kinase Inhibitor (TKI) in Patients with Chronic-Phase Chronic Myeloid Leukemia (CML-CP) - a Chart Review Study in the United States","year":2024,"lang":"en","type":"review","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Myeloid leukemia; Dasatinib; Medicine; Nilotinib; Tyrosine-kinase inhibitor; Bosutinib; Internal medicine; Imatinib; Oncology; Cancer","score_opus":0.026122440919423676,"score_gpt":0.31621558707558883,"score_spread":0.29009314615616516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039612","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21103296,0.7696785,2.2211877e-7,0.00013973875,0.000079523765,0.018392792,0.0005163329,0.0000991095,0.00006087162],"genre_scores_gemma":[0.008686448,0.97322667,0.00006962175,0.00032351294,0.0005018797,0.009235736,0.0066257627,0.0003895756,0.00094078307],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9929057,0.00064774015,0.0020044625,0.0019203321,0.0012986789,0.0012231328],"domain_scores_gemma":[0.9963118,0.00022592122,0.0007071715,0.0021876188,0.00019431539,0.00037321096],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00056120474,0.0020112249,0.0046980204,0.0010969392,0.000100347424,0.00012396232,0.0004873263,0.00040563365,0.00067209813],"category_scores_gemma":[0.00005500761,0.0010605946,0.00047324944,0.0030417922,0.0002036436,0.00017335874,0.0002018749,0.0015292087,0.00034154908],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0041574817,0.086395375,0.002850488,0.26125658,0.012938871,0.027192943,0.004171189,0.0000049166665,0.0000028359084,0.000008328606,0.0009243358,0.60009664],"study_design_scores_gemma":[0.1015983,0.063408226,0.0009220948,0.24555434,0.035422232,0.0006220365,0.000116128256,0.000012037786,0.000017499486,0.0000018629612,0.55088395,0.0014413124],"about_ca_topic_score_codex":0.00079609937,"about_ca_topic_score_gemma":0.0046094325,"teacher_disagreement_score":0.59865534,"about_ca_system_score_codex":0.013446177,"about_ca_system_score_gemma":0.008760042,"threshold_uncertainty_score":0.99926305},"labels":[],"label_agreement":null},{"id":"W4405039623","doi":"10.1182/blood-2024-201539","title":"Real-World Comparison of Healthcare Costs and Resource Utilization Among Patients with Relapsed-Refractory Large B-Cell Lymphoma Treated with CAR T-Cell Therapy Versus Historical Standard-of-Care: A Cost-Consequence Analysis in Ontario, Canada","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Princess Margaret Cancer Centre; Health Sciences Centre; University Health Network","funders":"","keywords":"Medicine; Refractory (planetary science); Standard of care; Health care; Lymphoma; Internal medicine; Economic growth; Economics","score_opus":0.02531581132739111,"score_gpt":0.2880469772701274,"score_spread":0.26273116594273627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939614,0.0033433675,0.000006581512,0.000046060595,0.000036584825,0.0009543855,0.00011513679,0.000028367851,0.001508149],"genre_scores_gemma":[0.9984635,0.00018609068,0.000060339848,0.000014790503,0.00001003265,0.000034099718,0.00034450792,0.00004410236,0.000842543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99763846,0.0001840352,0.00045666873,0.00046879504,0.0009039969,0.00034803324],"domain_scores_gemma":[0.99858665,0.00022682935,0.00017990168,0.00041688076,0.0003705386,0.00021917466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018241366,0.0002379538,0.0007725482,0.00050442567,0.000055861616,0.00001649882,0.00010004554,0.00010709602,0.00008634729],"category_scores_gemma":[0.000015124803,0.00018856688,0.000066820685,0.0015301551,0.00011166485,0.0000592999,0.000023386518,0.00031906847,1.6004952e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012235642,0.0012189007,0.9804093,0.0002652503,0.00046781838,0.00018990636,0.0020833916,0.000017100652,0.00049466174,0.0000049857085,0.00011797996,0.0024950558],"study_design_scores_gemma":[0.0676589,0.010744122,0.8807546,0.0007334583,0.0015430008,0.000004370644,0.0014101082,0.00026954117,0.022255566,6.9581165e-7,0.014167286,0.0004583615],"about_ca_topic_score_codex":0.9393347,"about_ca_topic_score_gemma":0.9921956,"teacher_disagreement_score":0.09965472,"about_ca_system_score_codex":0.0045808842,"about_ca_system_score_gemma":0.0026513897,"threshold_uncertainty_score":0.99924034},"labels":[],"label_agreement":null},{"id":"W4405039628","doi":"10.1182/blood-2024-199019","title":"Biomarker Analyses of the CC-92480-MM-001 Trial to Guide Combinatorial Strategies for Mezigdomide","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Toronto","funders":"","keywords":"Biomarker; Medicine; Oncology; Internal medicine; Computational biology; Biology; Genetics","score_opus":0.44940300104304215,"score_gpt":0.49193161262075297,"score_spread":0.04252861157771082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91885895,0.005627646,0.004281584,0.028821813,0.014642914,0.004689487,0.00178852,0.00017094637,0.021118142],"genre_scores_gemma":[0.99359214,0.000030163508,0.0015085529,0.0016905066,0.0013380329,0.00041190287,0.00003273447,0.000051857896,0.0013440804],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.995725,0.0002025518,0.0031389194,0.00049160956,0.00010970902,0.00033226152],"domain_scores_gemma":[0.9970526,0.0013973073,0.0007714069,0.0005791655,0.000084464664,0.0001150271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0082127,0.00018550194,0.0008298664,0.00029585385,0.00016496316,0.00019398067,0.00042951774,0.00014150498,0.00013775326],"category_scores_gemma":[0.0027497446,0.00017314147,0.00033122837,0.00036654776,0.00007417061,0.00028850834,0.000076526274,0.00010016579,0.00030331413],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084756745,0.0021928132,0.00063073,0.0009392853,0.000993909,0.0000013813009,0.0012131742,0.0000787934,0.00023267069,0.8122546,0.18038976,0.0002253119],"study_design_scores_gemma":[0.1454927,0.0011418785,0.002047212,0.0004252153,0.00039122166,0.00000875095,0.0024305528,0.0035572262,0.0014500775,0.2694839,0.57249016,0.0010811134],"about_ca_topic_score_codex":0.0012734439,"about_ca_topic_score_gemma":0.00012660875,"teacher_disagreement_score":0.54277074,"about_ca_system_score_codex":0.00014715122,"about_ca_system_score_gemma":0.00041802996,"threshold_uncertainty_score":0.7060504},"labels":[],"label_agreement":null},{"id":"W4405039637","doi":"10.1182/blood-2024-201816","title":"Implementation of American Society of Hematology (ASH) Neuro-Related Guidelines at a Sickle Cell Center: How Are We Doing?","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hematology; Medicine; Internal medicine; Center (category theory); Chemistry","score_opus":0.01547985752167789,"score_gpt":0.29385845486048456,"score_spread":0.27837859733880665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9787845,0.0049379156,0.000060739065,0.01522908,0.00014698492,0.00026811505,0.000052675226,0.00007922566,0.000440753],"genre_scores_gemma":[0.995289,0.0028399373,0.00097549794,0.00037092436,0.000028671777,0.0000066641974,0.00004639565,0.000028808252,0.00041406017],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99896413,0.00003028148,0.0004102354,0.00022327418,0.00017176852,0.0002003009],"domain_scores_gemma":[0.9993823,0.000046054738,0.0002113469,0.00018018944,0.00011682163,0.00006324669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000083216764,0.00013216073,0.00036103776,0.000068260735,0.00003155919,0.0000058381515,0.000059165388,0.0000862932,0.00010397345],"category_scores_gemma":[0.000012537483,0.00010567661,0.00023357359,0.00033299305,0.00013038317,0.00003098637,0.000057931546,0.00013742034,0.000008929067],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014109795,0.002150208,0.29765072,0.0064438465,0.0018928737,0.00026419613,0.007075302,0.00004287023,0.39540055,0.00035573138,0.26644605,0.02213657],"study_design_scores_gemma":[0.02297606,0.0030278591,0.008969232,0.0023942955,0.0033527513,0.0012082167,0.048237216,0.00285617,0.6563226,0.00013842755,0.24970844,0.00080871425],"about_ca_topic_score_codex":0.00012564771,"about_ca_topic_score_gemma":0.0000265856,"teacher_disagreement_score":0.28868148,"about_ca_system_score_codex":0.000016746892,"about_ca_system_score_gemma":0.00007036533,"threshold_uncertainty_score":0.43093672},"labels":[],"label_agreement":null},{"id":"W4405039664","doi":"10.1182/blood-2024-207293","title":"Characteristics of Myelodysplastic Syndromes with Idiopathic Pulmonary Fibrosis","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Myelodysplastic syndromes; Idiopathic pulmonary fibrosis; Pulmonary fibrosis; Internal medicine; Fibrosis; Gastroenterology; Lung; Bone marrow","score_opus":0.008046921690209749,"score_gpt":0.22650520289186413,"score_spread":0.2184582812016544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891403,0.007154846,0.00019701768,0.00024038434,0.00028083153,0.00025991202,0.00016729301,0.00017753943,0.0023819276],"genre_scores_gemma":[0.99860823,0.0002506923,0.00019836753,0.000044351542,0.00032964713,0.000025377905,0.00004893839,0.000049236438,0.0004451463],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987576,0.000024711038,0.0003292056,0.00031698027,0.0003190562,0.00025246487],"domain_scores_gemma":[0.99936247,0.000040552204,0.000060404916,0.00027805052,0.00009400608,0.00016454369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009782253,0.00020332719,0.00041647587,0.00015356233,0.000046098085,0.000031818105,0.00009008518,0.00009690781,0.0000983537],"category_scores_gemma":[0.000035679866,0.00015224148,0.00016998868,0.000278924,0.00012789253,0.00010614594,0.000041492898,0.00020237542,0.000065256274],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027205532,0.014010821,0.1766041,0.087626226,0.0057115834,0.062046427,0.001885279,0.000013493558,0.5671859,0.017657852,0.0012488919,0.03880391],"study_design_scores_gemma":[0.0063147703,0.055057533,0.7364862,0.091919586,0.019684361,0.033049986,0.000580809,0.006145884,0.037484135,0.0008235772,0.009784642,0.002668542],"about_ca_topic_score_codex":0.00001699283,"about_ca_topic_score_gemma":4.0290075e-7,"teacher_disagreement_score":0.55988204,"about_ca_system_score_codex":0.000024269364,"about_ca_system_score_gemma":0.00021913896,"threshold_uncertainty_score":0.6208227},"labels":[],"label_agreement":null},{"id":"W4405039742","doi":"10.1182/blood-2024-204123","title":"Monocytes Matter: Impact of Monocyte Recovery on Allogeneic Hematopoietic Stem Cell Transplant Outcomes with Post-Transplantation Cyclophosphamide As Graft Versus Host Disease Prophylaxis","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Graft-versus-host disease; Transplantation; Hematopoietic stem cell transplantation; Medicine; Stem cell; Cyclophosphamide; Immunology; Hematopoietic cell; Monocyte; Haematopoiesis; Internal medicine; Biology; Chemotherapy","score_opus":0.010956139956532194,"score_gpt":0.2579526594709794,"score_spread":0.2469965195144472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943328,0.0017266406,0.00023178043,0.000284149,0.00027780025,0.0012886376,0.00065608684,0.00020566101,0.0009964564],"genre_scores_gemma":[0.9977039,0.0010242198,0.00024786312,0.00010679502,0.000042924272,0.00011020939,0.00035016527,0.00012384793,0.0002900431],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974135,0.00010821163,0.0006446732,0.00068449526,0.0006729398,0.0004761692],"domain_scores_gemma":[0.99832034,0.0005273334,0.0001388481,0.0005495752,0.00007504972,0.00038883652],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017691935,0.0005454173,0.00067868136,0.00035222736,0.00008005907,0.000061896855,0.00016527924,0.00016725248,0.00019242566],"category_scores_gemma":[0.0000070931997,0.0003901363,0.0004750054,0.0003799908,0.00009341418,0.00018389785,0.0000086310365,0.00032827485,0.00031397204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04384129,0.004365067,0.77232414,0.027718745,0.00446495,0.011707886,0.0110055255,0.00099341,0.121943444,0.0002443347,0.00008891691,0.0013023003],"study_design_scores_gemma":[0.012717324,0.009080986,0.659933,0.0040351213,0.0052498346,0.0008539821,0.0004073263,0.00004405263,0.30676293,0.00004536431,0.000016270624,0.00085381186],"about_ca_topic_score_codex":0.0002012375,"about_ca_topic_score_gemma":0.000019968922,"teacher_disagreement_score":0.18481949,"about_ca_system_score_codex":0.00011414155,"about_ca_system_score_gemma":0.00045230595,"threshold_uncertainty_score":0.99985504},"labels":[],"label_agreement":null},{"id":"W4405039748","doi":"10.1182/blood-2024-207936","title":"Identification of High-Risk Patients and Establishment of a Clinical Prediction Model for Frontline Steroid Failure in Chronic Graft-Versus-Host-Disease","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Pressure Ulcer Prevention and Management","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Host (biology); Disease; Graft-versus-host disease; Steroid; Identification (biology); Intensive care medicine; Internal medicine; Biology","score_opus":0.03968157800251227,"score_gpt":0.38696230012497457,"score_spread":0.3472807221224623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97487384,0.00057042006,0.020138877,0.0002506487,0.0008525613,0.0023755538,0.0008355344,0.00007023068,0.000032306936],"genre_scores_gemma":[0.9979713,0.00034596171,0.000691427,0.000020602407,0.00009091104,0.00034856683,0.00014282092,0.000014868086,0.0003735561],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981068,0.00023559458,0.0010211051,0.00028929734,0.00018980257,0.00015740957],"domain_scores_gemma":[0.9990576,0.00018840593,0.00032402668,0.00022903296,0.00012025762,0.000080681675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010555154,0.000090346446,0.00022431146,0.00014128415,0.000061235456,0.000008015688,0.0000890648,0.000097149066,0.000019138464],"category_scores_gemma":[0.00019388455,0.00008451249,0.00007756832,0.00009826015,0.000025417028,0.0001798322,0.000109099296,0.00017976089,0.0000035831142],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066715325,0.016560383,0.7927913,0.040100906,0.0034244175,0.000008009065,0.013330631,0.005453504,0.0022335236,0.023463408,0.05166548,0.04429692],"study_design_scores_gemma":[0.030427488,0.0007392375,0.5779012,0.0009220979,0.0018184675,3.69497e-8,0.0003619083,0.3800123,0.00018518264,0.0031555144,0.0042516594,0.00022489575],"about_ca_topic_score_codex":0.00006958659,"about_ca_topic_score_gemma":0.00045649876,"teacher_disagreement_score":0.3745588,"about_ca_system_score_codex":0.000054845106,"about_ca_system_score_gemma":0.00019008586,"threshold_uncertainty_score":0.3446319},"labels":[],"label_agreement":null},{"id":"W4405039791","doi":"10.1182/blood-2024-209905","title":"A National UK Survey of Multiple Myeloma Patient Led Research Priorities: Embedding PROMs, Patient Characteristics and Patient Perspectives","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Multiple myeloma; Medicine; Family medicine; Internal medicine","score_opus":0.05425260997543508,"score_gpt":0.3610040198404346,"score_spread":0.30675140986499955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936717,0.0036288947,0.0000063153107,0.00012375737,0.00009279039,0.0012286581,0.00065599906,0.00004883858,0.00054304756],"genre_scores_gemma":[0.9984705,0.00026934218,0.000719756,0.000013052748,0.00005828778,0.00017586237,0.00017817231,0.000035414854,0.00007965163],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969577,0.0002948188,0.00044220182,0.00049431116,0.0013545334,0.00045640703],"domain_scores_gemma":[0.9972917,0.0008951444,0.00007342715,0.00023290084,0.0012562874,0.0002505838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005078074,0.0001999073,0.00035603024,0.00040693456,0.00015843906,0.00007664955,0.00006863447,0.00009317252,0.00009997344],"category_scores_gemma":[0.0026797345,0.00016207561,0.00007489547,0.00042773422,0.00022094339,0.000087242595,0.0001731875,0.00035722525,0.000019477544],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022033353,0.0068616606,0.80602396,0.002103538,0.002151169,0.0011929604,0.049367316,0.000003090309,0.011384694,0.0005369333,0.0011428669,0.11702846],"study_design_scores_gemma":[0.0038047226,0.0043193744,0.9711299,0.0010000985,0.00008060673,0.00012211184,0.0049544116,0.003447626,0.010028586,0.00008032941,0.0007694566,0.0002627885],"about_ca_topic_score_codex":0.0006093306,"about_ca_topic_score_gemma":0.00007387144,"teacher_disagreement_score":0.16510591,"about_ca_system_score_codex":0.0001937684,"about_ca_system_score_gemma":0.00058601703,"threshold_uncertainty_score":0.66092515},"labels":[],"label_agreement":null},{"id":"W4405039792","doi":"10.1182/blood-2024-203735","title":"Patient Characteristics, Treatment Patterns and Early Outcomes of Patients with Relapsed or Refractory Multiple Myeloma (RRMM) Initiated on Talquetamab: An Electronic Medical Record and Chart Review Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Pharmacyclics; Bausch Health; Biogen; AstraZeneca","keywords":"Medicine; Multiple myeloma; Lenalidomide; Medical record; Refractory (planetary science); Chart; Pediatrics; Internal medicine; Oncology","score_opus":0.02605670403598028,"score_gpt":0.30621008701527036,"score_spread":0.2801533829792901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99562675,0.0014924188,0.0000010453545,0.00016217545,0.000050783037,0.002382145,0.00019216567,0.00007101292,0.000021518725],"genre_scores_gemma":[0.99409413,0.0050870725,0.00003504531,0.00012958692,0.000032320087,0.00022856165,0.00026577673,0.000052273237,0.00007521962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976487,0.00019301324,0.00049546524,0.0005500444,0.0007114278,0.0004013274],"domain_scores_gemma":[0.9986893,0.00024298727,0.00011975995,0.0003970392,0.00011956809,0.0004313765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017161435,0.00033349896,0.000759281,0.00016322041,0.000065020606,0.000029515868,0.00006178098,0.000090132904,0.00015845831],"category_scores_gemma":[0.0002974173,0.00018683818,0.00006137633,0.00014152941,0.00007145313,0.00011258141,0.000047421592,0.00026436982,0.00000980204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014481161,0.008132139,0.88964593,0.0005821584,0.001149412,0.0008007915,0.0004381131,2.2775717e-9,0.000012791697,0.0000018775944,0.000009068553,0.097779624],"study_design_scores_gemma":[0.013273229,0.04133663,0.9419291,0.0019766104,0.0006813707,0.000022667587,0.00006441817,0.000017084603,0.000113521724,0.0000010210846,0.00041532738,0.00016902137],"about_ca_topic_score_codex":0.00034429663,"about_ca_topic_score_gemma":0.00038716933,"teacher_disagreement_score":0.0976106,"about_ca_system_score_codex":0.00009764693,"about_ca_system_score_gemma":0.00024016907,"threshold_uncertainty_score":0.761904},"labels":[],"label_agreement":null},{"id":"W4405039826","doi":"10.1182/blood-2024-194441","title":"Improvement in Quality of Life in MDS Patients Who Become Transfusion Independent after Treatment","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Pharmacy and Medical Practices","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Saskatchewan; University of Toronto; McGill University Health Centre; McGill University; McMaster University; St. Paul's Hospital; Dr. Georges-L.-Dumont University Hospital Centre; Queen Elizabeth II Health Sciences Centre; MPB Technologies & Communications (Canada); University of Alberta; Baker Hughes (Canada); Princess Margaret Cancer Centre; University of Calgary; University of Manitoba; Juravinski Cancer Centre; Jewish General Hospital; Sunnybrook Health Science Centre; Saskatchewan Cancer Agency; Ottawa Hospital; Health Sciences Centre; University Health Network; University of British Columbia","funders":"","keywords":"Medicine; Blood transfusion; Quality of life (healthcare); Intensive care medicine; Internal medicine; Nursing","score_opus":0.10494588373217402,"score_gpt":0.4547039329483889,"score_spread":0.3497580492162149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994444,0.0021507572,0.000005352671,0.00076811423,0.0007350776,0.0005612334,0.000087681765,0.000026056914,0.0012217424],"genre_scores_gemma":[0.9966482,0.0018928361,0.000011498924,0.000988046,0.000088259156,0.00018104841,0.000017644883,0.000012694887,0.00015978597],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980188,0.0004737219,0.00065794337,0.0003091366,0.00023005604,0.00031035396],"domain_scores_gemma":[0.99915534,0.0004306005,0.00007989722,0.00011842768,0.000023439028,0.00019227085],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010137451,0.00017379195,0.00032614497,0.00017542818,0.000026370064,0.000010159839,0.00011238547,0.00020552443,0.0012099578],"category_scores_gemma":[0.00009471911,0.00014436245,0.00009576549,0.00021458494,0.00006490433,0.00017940476,0.000043780343,0.0005737739,0.00003374828],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001725176,0.011797744,0.8875881,0.0005374571,0.00032950286,0.0001636267,0.003966217,0.00002810751,0.014183423,0.00014527561,0.00012817381,0.07940719],"study_design_scores_gemma":[0.03990157,0.001659761,0.813173,0.000227955,0.00048933254,0.0000031953957,0.00031847958,0.00068074046,0.08636857,0.00053313666,0.05610101,0.00054327154],"about_ca_topic_score_codex":0.0006017583,"about_ca_topic_score_gemma":0.00081899646,"teacher_disagreement_score":0.078863926,"about_ca_system_score_codex":0.000100377605,"about_ca_system_score_gemma":0.00013947365,"threshold_uncertainty_score":0.99970305},"labels":[],"label_agreement":null},{"id":"W4405039835","doi":"10.1182/blood-2024-210518","title":"Long-Term Follow-up of Real-World Teclistamab Therapy for Relapsed/Refractory Multiple Myeloma from the IMWG Immunotherapy Working Group Committee","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Multiple myeloma; Pomalidomide; Refractory (planetary science); Internal medicine; Oncology; Term (time); Lenalidomide; Pediatrics","score_opus":0.0387345179316094,"score_gpt":0.31291491762960755,"score_spread":0.2741803996979981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9775845,0.01787923,0.00021179928,0.0006170557,0.00050409493,0.0019110503,0.00021561167,0.0001890336,0.0008876487],"genre_scores_gemma":[0.99238235,0.0032893643,0.0010230764,0.00017776414,0.0005590473,0.00035880227,0.00045789892,0.0001194618,0.0016322408],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997779,0.00013496885,0.00050142105,0.0005192027,0.0005271146,0.00053825945],"domain_scores_gemma":[0.99684864,0.0018602172,0.00012804112,0.000911135,0.000100895435,0.00015107397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003896939,0.00034102538,0.0005360744,0.00018275705,0.00021438295,0.00010070969,0.00035906603,0.00014260251,0.00022158076],"category_scores_gemma":[0.000105633895,0.00021773501,0.0004725012,0.00039678378,0.0001728148,0.00010982337,0.000065191336,0.00041096515,0.00003118219],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046965163,0.0018602709,0.73767924,0.00015396772,0.0032524136,0.0002471511,0.00114366,2.0949253e-7,0.054104265,0.00021691801,0.0012642666,0.19538113],"study_design_scores_gemma":[0.038186193,0.0012278688,0.92190146,0.00095391704,0.00034832975,0.000016446718,0.00011075759,0.00012232023,0.02069812,0.00032318415,0.015826149,0.0002852443],"about_ca_topic_score_codex":0.0011288789,"about_ca_topic_score_gemma":0.0012059081,"teacher_disagreement_score":0.1950959,"about_ca_system_score_codex":0.00009704448,"about_ca_system_score_gemma":0.00015010436,"threshold_uncertainty_score":0.88789755},"labels":[],"label_agreement":null},{"id":"W4405039859","doi":"10.1182/blood-2024-204004","title":"Real-World Experience with CPX-351 for Secondary Acute Myeloid Leukemia: Comparison with FLAG-IDA in a Propensity Score Matching Analysis","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; London Health Sciences Centre; University Health Network; Windsor Regional Hospital; Health Sciences Centre; Juravinski Cancer Centre; Jewish General Hospital; Sunnybrook Health Science Centre; University of Alberta; University of Calgary; Vancouver General Hospital; Princess Margaret Cancer Centre; McGill University","funders":"","keywords":"Flag (linear algebra); Propensity score matching; Myeloid leukemia; Medicine; Internal medicine; Matching (statistics); Oncology; Mathematics; Pathology","score_opus":0.03351969617593854,"score_gpt":0.3171465489825213,"score_spread":0.2836268528065828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99285173,0.00031244816,0.0015223384,0.00051720924,0.000038435835,0.0015544416,0.000047235528,0.0002206897,0.0029354556],"genre_scores_gemma":[0.9890737,0.000066979606,0.007542833,0.00017658362,0.00015481153,0.0004203417,0.0001626886,0.00008676563,0.0023152786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970989,0.0000757059,0.0004907354,0.00093253446,0.00067192235,0.0007301693],"domain_scores_gemma":[0.9985355,0.00019429436,0.00010163546,0.00070838846,0.00018218525,0.00027800174],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004925937,0.00037551406,0.0010124098,0.000902378,0.00015575122,0.00016889042,0.0002985965,0.00013415422,0.00009753949],"category_scores_gemma":[0.00003116884,0.00025683254,0.00016375504,0.002917526,0.0002157685,0.00032833772,0.00014986926,0.0010471573,0.000023173601],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057943272,0.0009944194,0.90956736,0.0022471473,0.009439926,0.0077325786,0.021081356,0.00060784793,0.03387333,0.0004792282,0.0020888953,0.006093586],"study_design_scores_gemma":[0.027610024,0.004453387,0.8120125,0.003658181,0.014237353,0.0013573007,0.0048806844,0.02033402,0.104490764,0.00017843631,0.0047510015,0.002036347],"about_ca_topic_score_codex":0.0023387747,"about_ca_topic_score_gemma":0.008092424,"teacher_disagreement_score":0.09755486,"about_ca_system_score_codex":0.0007440677,"about_ca_system_score_gemma":0.0018469365,"threshold_uncertainty_score":0.9999884},"labels":[],"label_agreement":null},{"id":"W4405039867","doi":"10.1182/blood-2024-211972","title":"UM171 Cord Blood Transplantation for TP53 Mutated and EVI1 Rearranged Myelodysplasia/Acute Myeloid Leukemia","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Myeloid leukemia; Medicine; Transplantation; Cord blood; Leukemia; Myeloid; Cancer research; Internal medicine; Oncology; Biology","score_opus":0.017167530271241176,"score_gpt":0.2964343957768523,"score_spread":0.27926686550561114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887964,0.0028473737,0.00087162154,0.0016019932,0.00022842486,0.0017475698,0.00032994343,0.00050258863,0.0030740546],"genre_scores_gemma":[0.98189414,0.004300814,0.006038564,0.00036402326,0.00062449824,0.0003666279,0.0008195409,0.00017071623,0.005421054],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975895,0.00007413933,0.000454937,0.0007477841,0.00048255676,0.0006510433],"domain_scores_gemma":[0.998649,0.00038389294,0.00005706255,0.0003836832,0.00017935576,0.000347031],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048091315,0.0003530414,0.00052582374,0.00037189107,0.00017344531,0.00013471088,0.0001621948,0.00029021906,0.000106835534],"category_scores_gemma":[0.0001222855,0.00031174198,0.0001763666,0.000554249,0.00016186957,0.00021747054,0.000039227616,0.0005704048,0.00009311452],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038593481,0.0004995514,0.0014093526,0.004883687,0.0040247645,0.006082133,0.002766171,0.0000039102365,0.9254337,0.0011100292,0.007250071,0.042677306],"study_design_scores_gemma":[0.07071753,0.009351645,0.032738153,0.0034980236,0.02639265,0.025902828,0.0007912299,0.008661899,0.7654989,0.001436142,0.05284834,0.0021626651],"about_ca_topic_score_codex":0.000099098135,"about_ca_topic_score_gemma":0.000033392967,"teacher_disagreement_score":0.15993479,"about_ca_system_score_codex":0.00017147764,"about_ca_system_score_gemma":0.00074815575,"threshold_uncertainty_score":0.9999335},"labels":[],"label_agreement":null},{"id":"W4405039883","doi":"10.1182/blood-2024-202786","title":"Prospective Patient Preference Study for Bruton Tyrosine Kinase Inhibitor (BTKi) Treatment Attributes and Factors Affecting Patient Shared Decision-Making in Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL) in the United States (USA)","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Chronic lymphocytic leukemia; Medicine; Leukemia; Ibrutinib; Immunology; Lymphoma; Preference; Internal medicine","score_opus":0.03744102376382475,"score_gpt":0.30057432204871115,"score_spread":0.2631332982848864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98671687,0.006197975,0.000029270503,0.000021948279,0.0001310228,0.00664379,0.0001316425,0.00010679535,0.000020712481],"genre_scores_gemma":[0.9980377,0.00044255203,0.00019767,0.000047061254,0.00009510681,0.0009363506,0.00013718735,0.00009049014,0.000015909214],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99606055,0.00026868048,0.00083675404,0.0012064355,0.0006806085,0.0009469788],"domain_scores_gemma":[0.9951796,0.003696426,0.00015234605,0.00058222836,0.00017248033,0.00021691593],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00057344546,0.0006347066,0.00078270194,0.00081454794,0.00023831228,0.00032723247,0.0002021932,0.00019500857,0.00001387247],"category_scores_gemma":[0.0008682874,0.00042966186,0.000118725904,0.0014015287,0.00017055412,0.00019950786,0.000285823,0.00022026306,0.0000054321545],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.011761645,0.012246326,0.36106244,0.008334101,0.003036621,0.011845363,0.29925904,0.013003021,0.0051105795,0.00019433367,0.00021341469,0.2739331],"study_design_scores_gemma":[0.21448424,0.033403173,0.28517243,0.013132357,0.0016267451,0.0012770654,0.031386398,0.38761002,0.029128384,0.0005970922,0.00036962883,0.0018124387],"about_ca_topic_score_codex":0.008011028,"about_ca_topic_score_gemma":0.004185289,"teacher_disagreement_score":0.374607,"about_ca_system_score_codex":0.108284615,"about_ca_system_score_gemma":0.012598614,"threshold_uncertainty_score":0.9998155},"labels":[],"label_agreement":null},{"id":"W4405039971","doi":"10.1182/blood-2024-198028","title":"Richter Transformation (RT) in Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL): A Comparison of Two Eras","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Research Canada; Providence Health Care; Providence Health Care Research Institute; Vancouver General Hospital; University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Chronic lymphocytic leukemia; Ibrutinib; Medicine; Lymphoma; Leukemia; Immunology; Cancer research","score_opus":0.02685232889152144,"score_gpt":0.3261727267738416,"score_spread":0.2993203978823202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9774722,0.017688086,0.00024175686,0.000071620736,0.00016738469,0.0009954952,0.000017712931,0.00018749338,0.003158253],"genre_scores_gemma":[0.99798846,0.0006998405,0.00039900164,0.0000840155,0.0002332418,0.000104063925,0.0000527479,0.000085795036,0.00035282722],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.996643,0.00012265235,0.001058702,0.00066086976,0.00071747374,0.00079730543],"domain_scores_gemma":[0.99852365,0.00038825627,0.00010752604,0.0005766652,0.000108062595,0.000295836],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006032376,0.00041425662,0.00089295453,0.00071579963,0.000069430396,0.000095844254,0.00024249514,0.00026753772,0.00009727338],"category_scores_gemma":[0.000097306525,0.0003721654,0.00019465506,0.0009975155,0.00023584122,0.0002581624,0.00011183874,0.00026487792,0.00013218727],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0068055964,0.0044466904,0.014652278,0.06641003,0.006037209,0.01044065,0.0694851,0.014886347,0.22283621,0.021627335,0.0024709925,0.55990154],"study_design_scores_gemma":[0.13745718,0.001056303,0.0029026964,0.0029566826,0.0009115165,0.002477083,0.0004582397,0.7644756,0.08424388,0.00045461775,0.0019945856,0.0006116581],"about_ca_topic_score_codex":0.003884294,"about_ca_topic_score_gemma":0.0008294484,"teacher_disagreement_score":0.7495892,"about_ca_system_score_codex":0.09827563,"about_ca_system_score_gemma":0.04751379,"threshold_uncertainty_score":0.99987304},"labels":[],"label_agreement":null},{"id":"W4405039972","doi":"10.1182/blood-2024-194132","title":"Long Term Follow up of UM171 Expanded Cord Blood Transplantation Patients Does Not Reveal Any Late Toxicity","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Transplantation: Methods and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Toxicity; Transplantation; Term (time); Surgery; Internal medicine","score_opus":0.0218144078262784,"score_gpt":0.30370790673346554,"score_spread":0.2818934989071871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405039972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972478,0.00020117061,0.0006279764,0.00015327895,0.0006585033,0.00040606144,0.0002573599,0.00012261538,0.00032523353],"genre_scores_gemma":[0.9947178,0.0003714316,0.0033312072,0.00013516271,0.0001271555,0.00001780414,0.00020342406,0.00002991742,0.0010661099],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985934,0.00007614327,0.0004402606,0.00031114352,0.00034986172,0.0002291899],"domain_scores_gemma":[0.99932605,0.00020949535,0.00007830258,0.00019899932,0.000078012294,0.00010913273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021651936,0.00018925115,0.0003765322,0.00013616189,0.000051590938,0.000025795847,0.00008076925,0.000118711476,0.000090438225],"category_scores_gemma":[0.00003547078,0.00013410604,0.00018824413,0.00018225027,0.000043439064,0.00013505724,0.0000077804525,0.00016570203,0.00000933707],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008492457,0.00066780346,0.8521606,0.0026042694,0.0004912494,0.00031600797,0.0020331405,4.6083238e-7,0.13003172,0.00008193215,0.000015920616,0.010747659],"study_design_scores_gemma":[0.006150587,0.00039730378,0.6370019,0.0005451721,0.0016484875,0.000045873912,0.000016457898,0.000005593129,0.35400373,0.000049068454,0.000009313266,0.0001265493],"about_ca_topic_score_codex":0.00004215713,"about_ca_topic_score_gemma":0.00007302629,"teacher_disagreement_score":0.22397201,"about_ca_system_score_codex":0.000010999229,"about_ca_system_score_gemma":0.00006051318,"threshold_uncertainty_score":0.54686856},"labels":[],"label_agreement":null},{"id":"W4405040001","doi":"10.1182/blood-2024-205985","title":"Zilovertamab Vedotin in Combination with Nemtabrutinib for Patients with Relapsed or Refractory Mantle Cell Lymphoma: Cohort C of the Open-Label, Phase 2 Waveline-006 Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Mantle cell lymphoma; Medicine; Internal medicine; Refractory (planetary science); Open label; Oncology; Phases of clinical research; Cohort; Lymphoma; Clinical trial; Materials science","score_opus":0.017048808674541633,"score_gpt":0.2905989565411042,"score_spread":0.27355014786656257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405040001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99401313,0.00017972958,0.0000048776496,0.00012860504,0.00011539135,0.0046338034,0.00007706835,0.000025962852,0.000821448],"genre_scores_gemma":[0.99815005,0.000016958587,0.00037518362,0.00007157286,0.000023290733,0.00044772553,0.00011408976,0.00004290258,0.0007582054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865836,0.000054290944,0.00034335122,0.00037729758,0.00036649755,0.00020020542],"domain_scores_gemma":[0.9990885,0.00018326125,0.00013337671,0.0003948047,0.00013985577,0.00006015532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018997748,0.00020087796,0.00037531892,0.00008389758,0.000061726445,0.00004109284,0.00015567325,0.00005706928,0.00002254153],"category_scores_gemma":[0.000047432863,0.000100199075,0.000033741646,0.0003405721,0.000039183687,0.00011021184,0.000068388,0.000060925133,0.0000052094283],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049271393,0.19232741,0.79511034,0.00025766497,0.0005645054,0.00015749157,0.0006871425,9.0419593e-7,0.00017991997,0.00007781917,0.0008822968,0.004827394],"study_design_scores_gemma":[0.34498346,0.02583886,0.61666036,0.00073339685,0.0018198922,0.00001409574,0.00034557751,0.00016811717,0.007762656,0.000013511197,0.0014404473,0.00021960044],"about_ca_topic_score_codex":0.00021741043,"about_ca_topic_score_gemma":0.0001709405,"teacher_disagreement_score":0.34005633,"about_ca_system_score_codex":0.0001347757,"about_ca_system_score_gemma":0.0003750574,"threshold_uncertainty_score":0.40859997},"labels":[],"label_agreement":null},{"id":"W4405040029","doi":"10.1182/blood-2024-199996","title":"Presence of Leukemia-Related Basophils and Mast Cells with Atypical Immunophenotype during Induction Should Not be Interpreted As Measurable Residual Disease in Children with Acute Myeloid Leukemia with <i>RUNX1</i>::<i>RUNX1T1</i>","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Terry Fox Research Institute; University of British Columbia; University Health Network","funders":"","keywords":"Immunophenotyping; Myeloid leukemia; RUNX1; Leukemia; Immunology; Medicine; Preleukemia; Biology; Haematopoiesis; Flow cytometry; Genetics; Stem cell","score_opus":0.009527451395144439,"score_gpt":0.22748793660838887,"score_spread":0.21796048521324443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405040029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957669,0.0015649436,0.000009213458,0.0004156874,0.00006818103,0.0015078621,0.000094503936,0.00021706842,0.00035564628],"genre_scores_gemma":[0.997791,0.00032028358,0.0006462601,0.000088516994,0.0000904835,0.00012530443,0.000129846,0.00014229227,0.0006660482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996639,0.00011441588,0.0005823831,0.0010592667,0.00095472304,0.0006501774],"domain_scores_gemma":[0.9983965,0.00011677101,0.00017564991,0.0007780334,0.00013575747,0.00039728192],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002274276,0.0005987121,0.00073685107,0.0003419074,0.00011721513,0.00008201036,0.00021754304,0.00025300996,0.000067178604],"category_scores_gemma":[0.00005684033,0.00042054156,0.000074761454,0.0008836053,0.00044050007,0.00044705922,0.00014002476,0.0010011846,0.000015164127],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07005195,0.0021358277,0.49346778,0.0023044867,0.013889644,0.008603249,0.005267208,0.0038524077,0.39819452,0.00035521045,0.00021463857,0.0016630706],"study_design_scores_gemma":[0.03549502,0.004027314,0.62167835,0.0064604543,0.005579396,0.004125426,0.00022921557,0.0006684694,0.32055908,0.000056088287,0.000041247094,0.0010799256],"about_ca_topic_score_codex":0.0010547846,"about_ca_topic_score_gemma":0.00012262212,"teacher_disagreement_score":0.12821059,"about_ca_system_score_codex":0.0011071188,"about_ca_system_score_gemma":0.0024763083,"threshold_uncertainty_score":0.99982464},"labels":[],"label_agreement":null},{"id":"W4405040041","doi":"10.1182/blood-2024-209364","title":"Evaluating the Impact of Socioeconomic Disparities on Access and Outcomes of CAR T-Cell Therapy for Relapsed/Refractory B-Cell Lymphomas in Ontario, Canada","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Socioeconomic status; Medicine; Refractory (planetary science); B cell; Oncology; Immunology; Environmental health; Population; Antibody; Biology","score_opus":0.052192684676009835,"score_gpt":0.3693888399222971,"score_spread":0.31719615524628725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405040041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99424016,0.0024057953,3.8260868e-7,0.00021010119,0.00008994776,0.0007709164,0.00004623717,0.000007901555,0.0022285697],"genre_scores_gemma":[0.99619097,0.00023250407,0.000021051728,0.00008099485,0.00003456917,0.000056679502,0.0000117083655,0.00003214827,0.0033393493],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989261,0.00006516761,0.00031050626,0.00021944888,0.00024209057,0.00023666248],"domain_scores_gemma":[0.99856955,0.0009585547,0.000079681406,0.00028182182,0.000051951367,0.00005845316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053008524,0.00015139816,0.00039166395,0.00010482807,0.00003711374,0.000029508234,0.00015903023,0.0000664091,0.00050870824],"category_scores_gemma":[0.000035476078,0.00009587895,0.000156435,0.000059544316,0.00008256272,0.0000602933,0.000038873182,0.00022847591,5.715924e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095898396,0.0007944448,0.8915469,0.00040579107,0.0005479502,0.000014403219,0.0020515586,0.000103520964,0.09697195,0.0000420053,0.0007922672,0.005770233],"study_design_scores_gemma":[0.01584157,0.003620195,0.89509773,0.00017226837,0.00016430543,0.000009215066,0.0003900228,0.00071284146,0.08288611,0.000410132,0.00047508557,0.00022050682],"about_ca_topic_score_codex":0.8802214,"about_ca_topic_score_gemma":0.66346776,"teacher_disagreement_score":0.21675363,"about_ca_system_score_codex":0.00050118624,"about_ca_system_score_gemma":0.0029217585,"threshold_uncertainty_score":0.55699986},"labels":[],"label_agreement":null},{"id":"W4405040089","doi":"10.1182/blood-2024-203393","title":"Evaluating the Effect of Hydroxyurea on Fertility in Individuals Identifying As Women","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Pregnancy and preeclampsia studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital; Western University","funders":"","keywords":"Fertility; Medicine; Psychology; Population; Environmental health","score_opus":0.04809814159063722,"score_gpt":0.37534309599602617,"score_spread":0.3272449544053889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405040089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856197,0.006274167,0.0000010847613,0.00027775872,0.000097602606,0.00042774907,0.000004050816,0.000042165473,0.007255677],"genre_scores_gemma":[0.9995253,0.000035539335,0.000020461237,0.000075623946,0.00004008966,0.00012541523,0.0000022903287,0.000009306041,0.00016596288],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989269,0.00020502452,0.0002067629,0.00018447857,0.000293558,0.00018329525],"domain_scores_gemma":[0.9989219,0.0007718109,0.000031639778,0.00023731372,0.000010371892,0.000026984762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017722182,0.00010128681,0.00024607682,0.000072633506,0.000049499475,0.000015769163,0.0000808927,0.000046835743,0.000047819525],"category_scores_gemma":[0.0006336904,0.000058879574,0.00006615072,0.0002178874,0.000046344667,0.000037990834,0.00006568485,0.00023017448,0.000035282905],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042744304,0.0003552576,0.9088266,0.0033406233,0.0010954214,0.000107238135,0.024035348,0.00002117186,0.013863188,0.00029040585,0.00010885393,0.04752846],"study_design_scores_gemma":[0.0039368155,0.0037195603,0.8989032,0.004776651,0.00051154074,0.00002327545,0.0003225499,0.00019059915,0.084464625,0.0028677718,0.00014017594,0.00014325866],"about_ca_topic_score_codex":0.00002782176,"about_ca_topic_score_gemma":0.000004521925,"teacher_disagreement_score":0.07060143,"about_ca_system_score_codex":0.000026858834,"about_ca_system_score_gemma":0.000036777863,"threshold_uncertainty_score":0.24010395},"labels":[],"label_agreement":null},{"id":"W4405040132","doi":"10.1182/blood-2024-202826","title":"Decoding the Epigenetic and Transcriptional Signatures of Pathogenic B-Cells in Patients at High Risk of Transformation to Lymphoma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Spinal Cord Injury BC; University of British Columbia; University Health Network","funders":"","keywords":"Epigenetics; Lymphoma; Biology; Genetics; Transformation (genetics); Cancer research; Medicine; Immunology; Gene","score_opus":0.007769884272256131,"score_gpt":0.23861996388942588,"score_spread":0.23085007961716975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405040132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966541,0.0024573712,0.000056017765,0.000076850825,0.000060718077,0.00048188903,0.000101797385,0.0000089101995,0.00010232516],"genre_scores_gemma":[0.9993105,0.0003878867,0.00017005485,0.000023820197,0.000022322325,0.000015675685,0.000018788098,0.000011955962,0.000039031544],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990072,0.000056535948,0.00028363604,0.00014666948,0.0003554718,0.0001504657],"domain_scores_gemma":[0.9995818,0.00014882366,0.000028571305,0.00013481115,0.000048906804,0.000057082663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027163472,0.0000807495,0.00016296288,0.00014127421,0.000025708687,0.0000068504637,0.000067602654,0.00006537767,0.00003317068],"category_scores_gemma":[0.000040440125,0.000055525325,0.00006218625,0.00023639874,0.000056143148,0.000035922876,0.000020085541,0.00007140847,0.0000056802],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002294274,0.0032630884,0.025149236,0.0043079956,0.00097264745,0.00007209741,0.029365616,0.0009923641,0.7874717,0.0024598634,0.00024724094,0.14340387],"study_design_scores_gemma":[0.046175484,0.0009871589,0.51286364,0.0007720139,0.00057296647,0.000034099947,0.00018368132,0.0055885375,0.43190134,0.00035927494,0.00037900195,0.00018280209],"about_ca_topic_score_codex":0.00024395247,"about_ca_topic_score_gemma":0.00008358439,"teacher_disagreement_score":0.4877144,"about_ca_system_score_codex":0.00056733063,"about_ca_system_score_gemma":0.00048395927,"threshold_uncertainty_score":0.2264257},"labels":[],"label_agreement":null},{"id":"W4405040167","doi":"10.1182/blood-2024-210782","title":"Multi-Pronged Effects of Cohesin Mutations in the Myeloid Leukemia of Down Syndrome","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Myeloid leukemia; Cohesin; Cancer research; Genetics; Mutation; Leukemia; Medicine; Myeloid; Biology; Gene; Chromosome","score_opus":0.012481530175688444,"score_gpt":0.2660339515104317,"score_spread":0.25355242133474326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405040167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952763,0.0029578675,0.000026556274,0.0001438217,0.00009561992,0.000842768,0.000017001874,0.00004219631,0.0005979258],"genre_scores_gemma":[0.99813354,0.000057346864,0.0012960635,0.000034000073,0.000025578238,0.000098118726,0.00003357169,0.00002172839,0.00030005336],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99894077,0.000080214915,0.00031727948,0.00021158595,0.0002680589,0.0001820749],"domain_scores_gemma":[0.9990337,0.00047098682,0.000059450227,0.00036157138,0.000032102213,0.000042202104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019802479,0.00013773456,0.00032107483,0.00016545564,0.00002020139,0.000008034715,0.00012007045,0.00008557777,0.000040794457],"category_scores_gemma":[0.00018331961,0.00009284325,0.000108761735,0.0004406464,0.000096657175,0.00004708504,0.000025834925,0.0002007225,0.000037410784],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038703985,0.0124801565,0.110817,0.02684291,0.004947672,0.018030623,0.035017584,0.00021165384,0.7656,0.0017182961,0.001406887,0.02254013],"study_design_scores_gemma":[0.020426216,0.0012502638,0.77150744,0.0030260254,0.0022059898,0.0014216366,0.0005183311,0.0011921383,0.19780678,0.00014233463,0.00026519888,0.00023765716],"about_ca_topic_score_codex":0.00027301203,"about_ca_topic_score_gemma":0.000052802978,"teacher_disagreement_score":0.6606904,"about_ca_system_score_codex":0.0002584547,"about_ca_system_score_gemma":0.00054596126,"threshold_uncertainty_score":0.3786038},"labels":[],"label_agreement":null},{"id":"W4405040176","doi":"10.1182/blood-2024-194861","title":"AML Cells Have Increased Mitochondrial RNA Degradation and Inhibiting This Degradation Promotes Cell Differentiation, Decreases Viability, and Increases Sensitivity to Immune-Mediated Killing","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Immune system; Viability assay; Degradation (telecommunications); Cell biology; Biology; RNA; Mitochondrion; Chemistry; Cell; Immunology; Biochemistry","score_opus":0.007545752955306061,"score_gpt":0.21414219364945963,"score_spread":0.20659644069415356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405040176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98903173,0.00865825,0.0007214413,0.00014339184,0.00032363826,0.0007245483,0.00012305414,0.00021586369,0.000058053116],"genre_scores_gemma":[0.99787426,0.0003976712,0.00048296308,0.000056624493,0.00006766381,0.00004908105,0.0005807393,0.000041214695,0.00044976344],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975968,0.00086216844,0.0005099651,0.0005701056,0.00008473028,0.00037620234],"domain_scores_gemma":[0.9976617,0.001767891,0.00013964338,0.0002480781,0.000121212805,0.00006148111],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005391367,0.0003417636,0.00039229915,0.00029535274,0.00042321862,0.00019954836,0.00008340816,0.0002704638,0.000110801906],"category_scores_gemma":[0.0006752295,0.00031257645,0.00009429307,0.00022373965,0.00017632064,0.00034571797,0.00012921932,0.00028744983,0.000052995587],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037912937,0.00045301934,0.0028494466,0.00012933312,0.00018705936,0.000011167254,0.0006555701,8.228326e-7,0.9916817,0.00002516932,0.000066569126,0.0035610192],"study_design_scores_gemma":[0.002108133,0.00028094542,0.011176657,0.00027839444,0.00026146972,0.00009971961,0.00026294327,0.00018842854,0.9843757,0.000056452478,0.0005491452,0.00036197336],"about_ca_topic_score_codex":0.0022521524,"about_ca_topic_score_gemma":0.00011871341,"teacher_disagreement_score":0.0088425195,"about_ca_system_score_codex":0.000037324895,"about_ca_system_score_gemma":0.00011573397,"threshold_uncertainty_score":0.99993265},"labels":[],"label_agreement":null},{"id":"W4405040200","doi":"10.1182/blood-2024-209251","title":"Incidence and Prevalence of Clinically Detected Smoldering Multiple Myeloma Among the General Population","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Ottawa Hospital; Alberta Health Services; University of Alberta; University of Calgary","funders":"","keywords":"Incidence (geometry); Multiple myeloma; Medicine; Population; Internal medicine; Environmental health","score_opus":0.025518910987700167,"score_gpt":0.322855379856127,"score_spread":0.29733646886842685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405040200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99804574,0.0012289375,0.00007981959,0.00007589559,0.00003965491,0.0003884611,0.000010021751,0.000053976873,0.000077505334],"genre_scores_gemma":[0.9976614,0.00019863508,0.0017170799,0.000012122866,0.00007703544,0.000029746587,0.000008546631,0.000012580009,0.00028281502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99907225,0.000053035954,0.00026252447,0.00021012589,0.00024234313,0.00015973543],"domain_scores_gemma":[0.99934417,0.00026655575,0.00004246158,0.0002073949,0.00004840622,0.000090988535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023092575,0.000084785184,0.00013011973,0.00005420357,0.0000538328,0.000024562061,0.000065283,0.000050746283,0.000023976025],"category_scores_gemma":[0.0005410916,0.000053524174,0.000051601386,0.00013426592,0.00008816153,0.00007659817,0.000065237975,0.0001372242,0.000004939988],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000622081,0.00008489342,0.9700941,0.0003640659,0.00009965849,0.000085727515,0.00011609564,0.0000025234153,0.015317324,0.000014369325,0.0000048030265,0.013754229],"study_design_scores_gemma":[0.0011551599,0.00022807927,0.98220414,0.00030595998,0.00013765134,0.00006605698,0.00001056661,0.0064825206,0.009308635,0.000045420486,0.00000793467,0.00004786332],"about_ca_topic_score_codex":0.00032046498,"about_ca_topic_score_gemma":0.000068010326,"teacher_disagreement_score":0.013706366,"about_ca_system_score_codex":0.000012643446,"about_ca_system_score_gemma":0.000037232152,"threshold_uncertainty_score":0.21826525},"labels":[],"label_agreement":null},{"id":"W4405040232","doi":"10.1182/blood-2024-210688","title":"Depletion of CD59 Inhibits the Proliferation and Survival of Acute Myeloid Leukemia Cells By Altering Lipid Raft Composition and Suppression of Raf/MEK/ERK Signaling","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"MAPK/ERK pathway; Myeloid leukemia; Cancer research; Leukemia; Cell biology; Signal transduction; Myeloid; Immunology; Biology; Chemistry","score_opus":0.011030678194281983,"score_gpt":0.26358022582075824,"score_spread":0.25254954762647625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405040232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997054,0.0010861865,0.0007638754,0.00028973183,0.000077885365,0.00054393825,0.00007537697,0.00002711641,0.00008192365],"genre_scores_gemma":[0.99848205,0.00057859847,0.0005984409,0.000021482278,0.00012794968,0.000015288648,0.00009891648,0.000025620304,0.000051640727],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99863446,0.0001325401,0.0004152753,0.00024874738,0.00039825824,0.00017071734],"domain_scores_gemma":[0.9992758,0.00021099333,0.00012324257,0.00018157848,0.00013730029,0.00007108246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005550525,0.0001391012,0.00032719798,0.00013158149,0.000061073,0.000025509775,0.000067034685,0.00011356603,0.00001400421],"category_scores_gemma":[0.000029912468,0.000100722325,0.00005245247,0.00020450237,0.00015140558,0.00013208594,0.00010522692,0.00024457616,9.939059e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028346694,0.000081866485,0.0019565944,0.000979633,0.00017813279,0.000007068917,0.00074675324,0.000021950076,0.99454033,0.00003776297,0.00029219838,0.00087423256],"study_design_scores_gemma":[0.0020442426,0.00035388942,0.0014739765,0.0008274691,0.00033098832,0.00006362594,0.00009966285,0.003753258,0.9908749,0.00001796335,0.00007895164,0.000081086226],"about_ca_topic_score_codex":0.00004919279,"about_ca_topic_score_gemma":0.0000020789257,"teacher_disagreement_score":0.0037313078,"about_ca_system_score_codex":0.000054268174,"about_ca_system_score_gemma":0.00015129038,"threshold_uncertainty_score":0.41073373},"labels":[],"label_agreement":null},{"id":"W4405040252","doi":"10.1182/blood-2024-200148","title":"The Exportin, CSE1L, Regulates Ribosome Biogenesis and Is a Selective Dependency in Childhood and Young Adult Acute Myeloid Leukemia","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Hospital for Sick Children; University Health Network","funders":"","keywords":"Myeloid leukemia; Leukemia; Dependency (UML); Myeloid; Biogenesis; Medicine; Biology; Cancer research; Cell biology; Immunology; Genetics; Gene; Computer science","score_opus":0.0037828123577474736,"score_gpt":0.22976619641654888,"score_spread":0.22598338405880142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405040252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848697,0.0143932905,0.000007283462,0.00022306955,0.000042263688,0.0001764197,0.000024810786,0.000013785423,0.00024934424],"genre_scores_gemma":[0.9902926,0.008413681,0.000083109764,0.000069087575,0.0001223983,0.000037933816,0.000016403683,0.000020005276,0.0009447922],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99899507,0.00003826968,0.00016289284,0.00038135276,0.000118801094,0.00030361506],"domain_scores_gemma":[0.99961877,0.000020980879,0.000026846916,0.00018170249,0.00006751381,0.000084184365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001667959,0.00013413202,0.00011232629,0.000055287743,0.00013516714,0.000112486014,0.0001071344,0.00011028471,0.0000023430657],"category_scores_gemma":[0.00010727016,0.00009705242,0.00004215863,0.00015270851,0.00007630184,0.000008040565,0.00012539567,0.000121432065,0.000002550818],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046604844,0.00004614126,0.040896315,0.00003250768,0.0003203097,0.00005204128,0.00045309143,4.321576e-7,0.9493063,0.00008112263,0.00060981524,0.008155304],"study_design_scores_gemma":[0.0010323148,0.00032936365,0.09784774,0.000066791734,0.00007960133,0.0002348896,0.00025688406,0.00015481401,0.8986367,0.00048001975,0.00063679914,0.00024409554],"about_ca_topic_score_codex":0.00020502643,"about_ca_topic_score_gemma":0.0004031982,"teacher_disagreement_score":0.05695142,"about_ca_system_score_codex":0.000012988039,"about_ca_system_score_gemma":0.00011971401,"threshold_uncertainty_score":0.39576828},"labels":[],"label_agreement":null},{"id":"W4405040288","doi":"10.1182/blood-2024-200747","title":"An Erythroid-Specific Lentiviral Vector Improves Anemia and Iron Metabolism in a New Model of Xlsa","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Acuitas Therapeutics (Canada)","funders":"","keywords":"Virology; Viral vector; Anemia; Medicine; Biology; Computational biology; Internal medicine; Genetics; Recombinant DNA","score_opus":0.019213403871848216,"score_gpt":0.2569520739891047,"score_spread":0.23773867011725647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405040288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99144787,0.007012272,0.00016866988,0.00022209907,0.00022247902,0.00015550648,0.0000105878835,0.000058339498,0.00070218317],"genre_scores_gemma":[0.99666095,0.00068558566,0.001275544,0.00011778019,0.00031453616,0.000005159051,0.000019713672,0.00001988582,0.0009008229],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99926114,0.000027718275,0.00018939823,0.00027534846,0.00009372636,0.00015267273],"domain_scores_gemma":[0.99964845,0.000024267354,0.00002611663,0.00019040512,0.000018361883,0.000092388094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007605254,0.00011507047,0.00026852766,0.00013502188,0.000014518822,0.000012313229,0.00003778466,0.000104851715,0.000048373502],"category_scores_gemma":[0.00001052583,0.00009671423,0.000052201267,0.00014438228,0.000059208625,0.00010203312,0.000020175896,0.00018160074,0.000011231823],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001393707,0.00025491396,0.0004099923,0.00019285257,0.000021533306,0.000025688256,0.00076333835,0.000010021381,0.9885444,0.0017048538,0.00045785343,0.0074752048],"study_design_scores_gemma":[0.035738606,0.0062266854,0.3850512,0.0011869607,0.0019142381,0.0006504695,0.0015591729,0.05451664,0.47874898,0.010409766,0.022320054,0.0016772654],"about_ca_topic_score_codex":0.00004861245,"about_ca_topic_score_gemma":0.00003200703,"teacher_disagreement_score":0.5097954,"about_ca_system_score_codex":0.00000878399,"about_ca_system_score_gemma":0.00013630126,"threshold_uncertainty_score":0.3943892},"labels":[],"label_agreement":null},{"id":"W4405040316","doi":"10.1182/blood-2024-201189","title":"Inferior Survival in Double Refractory Large B-Cell Lymphoma Eligible for Third-Line CD19 Chimeric Antigen T-Cell Therapy","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"CD19; Medicine; Chimeric antigen receptor; Lymphoma; Antigen; Refractory (planetary science); Oncology; Immunology; Internal medicine; Virology; Immunotherapy; Biology; Cancer","score_opus":0.03537496092950763,"score_gpt":0.3317406471556205,"score_spread":0.29636568622611287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405040316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9589579,0.013899083,0.00007726479,0.0003742244,0.0004824214,0.0015470213,0.0000482184,0.00023600778,0.024377866],"genre_scores_gemma":[0.9542159,0.007009282,0.00038598894,0.00030005063,0.000793827,0.00021665964,0.00013057694,0.00016218472,0.036785543],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99749464,0.00007794939,0.00045451891,0.00062237104,0.0005353572,0.00081514934],"domain_scores_gemma":[0.998757,0.0002414219,0.000057717985,0.00061868114,0.00011494668,0.00021023303],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00094735745,0.00032115006,0.00056241936,0.0004247857,0.0000837169,0.000097215554,0.00025353677,0.00022707993,0.00082251255],"category_scores_gemma":[0.000024915907,0.0002739463,0.00028030897,0.00076124276,0.000057432582,0.00013656987,0.000081788065,0.00034065483,0.00024319152],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020617817,0.0084642535,0.013835129,0.0005769473,0.0002480101,0.00028809655,0.0010306487,0.0000024077056,0.96293217,0.00015203486,0.0021737558,0.008234767],"study_design_scores_gemma":[0.05353731,0.0017004469,0.005213463,0.00015446574,0.000084510764,0.00003762307,0.00014115773,0.00030674814,0.541957,0.00011389983,0.39633432,0.00041903407],"about_ca_topic_score_codex":0.0002949371,"about_ca_topic_score_gemma":0.00008179515,"teacher_disagreement_score":0.42097515,"about_ca_system_score_codex":0.00010746115,"about_ca_system_score_gemma":0.0006660469,"threshold_uncertainty_score":0.9999713},"labels":[],"label_agreement":null},{"id":"W4405040342","doi":"10.1182/blood-2024-200461","title":"Longitudinal Changes in Cognition in Older Individuals Receiving Lymphoma-Directed Therapy: A Pilot Feasibility Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Hamilton Health Sciences; Juravinski Hospital; Juravinski Cancer Centre","funders":"","keywords":"Cognition; Medicine; Gerontology; Lymphoma; Oncology; Internal medicine; Psychiatry","score_opus":0.056129290729642935,"score_gpt":0.32831068782557,"score_spread":0.27218139709592704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405040342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911207,0.0038750812,0.0000025663562,0.00081369973,0.00021313409,0.0027416607,0.000027822907,0.0003378951,0.00086742494],"genre_scores_gemma":[0.99845743,0.00050354225,0.000029837214,0.00014110979,0.00016697912,0.00053042395,0.000026636319,0.00003882748,0.00010524118],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998095,0.00020026679,0.0003497812,0.0006059961,0.00037175464,0.00037720104],"domain_scores_gemma":[0.99933606,0.00024760468,0.000053208136,0.000196987,0.00009904666,0.000067084446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072773,0.00025089606,0.00043883643,0.00054256927,0.000058011225,0.000047258018,0.000063428815,0.00007577554,0.00018755303],"category_scores_gemma":[0.0002635955,0.00022468649,0.00005290928,0.0010641526,0.00005741448,0.00011264036,0.00007082001,0.00025767472,0.000030156585],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037416344,0.010314708,0.97244346,0.00014515876,0.00048787086,0.00040173793,0.0040833615,3.51306e-7,0.0010717427,0.0000015292486,0.00011570232,0.010560211],"study_design_scores_gemma":[0.016925298,0.0023416383,0.9756499,0.001401714,0.00031948532,0.000052815223,0.0012778348,0.000022229082,0.0016806585,0.00008076045,0.000037084414,0.00021058942],"about_ca_topic_score_codex":0.0002728027,"about_ca_topic_score_gemma":0.0034578885,"teacher_disagreement_score":0.016551133,"about_ca_system_score_codex":0.00023048636,"about_ca_system_score_gemma":0.00013217812,"threshold_uncertainty_score":0.91624486},"labels":[],"label_agreement":null},{"id":"W4405040379","doi":"10.1182/blood-2024-208184","title":"Navigating Lineage Options: A Data-Driven Quest to Uncover T Cell Fate Decision Trajectories","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Biology; Haematopoiesis; Myeloid; Progenitor cell; IRF8; Stem cell; Cell biology; Lymphopoiesis; Cellular differentiation; CD33; Immunology; CD34; Cell fate determination; Transcription factor; Lineage markers; Genetics; Gene","score_opus":0.02058931571358342,"score_gpt":0.28799351669510553,"score_spread":0.2674042009815221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405040379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852333,0.0028140116,0.01065342,0.00005894016,0.00052148785,0.0001483382,0.0002233292,0.000050800503,0.00029637734],"genre_scores_gemma":[0.98424953,0.00030072726,0.013895687,0.00015610455,0.00062101317,0.000012235013,0.0005225963,0.000034400648,0.00020772209],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990335,0.000025467461,0.00019139508,0.00044895775,0.00011729983,0.0001833503],"domain_scores_gemma":[0.99937123,0.000027942591,0.000020046895,0.0004580473,0.000040202714,0.00008251081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012918784,0.0001392352,0.00010955141,0.000017477283,0.000072953335,0.00011434069,0.00029164014,0.000108662185,0.000013800099],"category_scores_gemma":[0.00005590192,0.00012701818,0.00005970842,0.00012499343,0.00002368823,0.0000094846855,0.00013776755,0.00014129125,0.0000476698],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031582244,0.00018487828,0.0008769886,0.000056953097,0.000049652797,0.000024980134,0.00018279791,0.000344372,0.99287415,0.000031601052,0.0009254684,0.0044165747],"study_design_scores_gemma":[0.0009218929,0.0004179801,0.00032935853,0.00029352738,0.00013633464,0.000025059779,0.000083121406,0.0016212395,0.91039675,0.000051863153,0.08530638,0.00041648108],"about_ca_topic_score_codex":0.00007270473,"about_ca_topic_score_gemma":0.00014926525,"teacher_disagreement_score":0.08438092,"about_ca_system_score_codex":0.0000068288973,"about_ca_system_score_gemma":0.00006250969,"threshold_uncertainty_score":0.51796514},"labels":[],"label_agreement":null},{"id":"W4405040397","doi":"10.1182/blood-2024-202621","title":"Treatment Intensification Does Not Improve Outcome for Children with Myeloid Leukemia of Down Syndrome (ML-DS) Who Are MRD-Positive after Induction Therapy: A Report from the Children's Oncology Group","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Agricultural Research Institute of Ontario; Hospital for Sick Children","funders":"","keywords":"Medicine; Internal medicine; Oncology; Myeloid leukemia; Down syndrome; Leukemia; Pediatrics","score_opus":0.013940598050119029,"score_gpt":0.2664940596437294,"score_spread":0.25255346159361036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405040397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921412,0.0011363968,0.00009961876,0.0018095463,0.0002872581,0.0034034753,0.00094416353,0.00013277415,0.000045604098],"genre_scores_gemma":[0.99530554,0.00024604725,0.00077885087,0.00024988558,0.00046834134,0.0011576107,0.001142902,0.00008195564,0.00056886283],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99781877,0.00007605248,0.0006222692,0.00083086785,0.00032074677,0.0003312702],"domain_scores_gemma":[0.99828297,0.00024713395,0.0003791731,0.0008066006,0.00017942247,0.00010467761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017707303,0.00041693167,0.0007574991,0.00011830923,0.000096906915,0.000042218107,0.00012694813,0.00025927124,0.000039790157],"category_scores_gemma":[0.00006973646,0.00020973315,0.0002654232,0.00019907656,0.00017517341,0.0001421486,0.000040713323,0.00028601268,0.00001341358],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045270156,0.0029626875,0.87077135,0.00012669251,0.014274101,0.0014590927,0.0049599777,0.0000044214453,0.034232963,0.000090684196,0.00017304957,0.06641796],"study_design_scores_gemma":[0.01113979,0.0036628733,0.939024,0.00030773884,0.0025857396,0.0032348651,0.00026933133,0.000023621871,0.039251726,0.0000500683,0.00020424585,0.00024601657],"about_ca_topic_score_codex":0.0023455664,"about_ca_topic_score_gemma":0.00024886744,"teacher_disagreement_score":0.06825263,"about_ca_system_score_codex":0.0017780256,"about_ca_system_score_gemma":0.0005708758,"threshold_uncertainty_score":0.8552669},"labels":[],"label_agreement":null},{"id":"W4405040408","doi":"10.1182/blood-2024-198504","title":"Time to Response and Overall Survival in Patients with m<i>IDH1</i> Relapsed/Refractory Acute Myeloid Leukemia Treated with Olutasidenib","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Myeloid leukemia; Medicine; Internal medicine; Refractory (planetary science); Leukemia; Oncology; Gastroenterology; Biology","score_opus":0.00732204916881292,"score_gpt":0.23929702417973633,"score_spread":0.2319749750109234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405040408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99634916,0.00022676119,0.0000048998795,0.00072976825,0.000023790877,0.001038191,0.00009061235,0.00019805814,0.0013387486],"genre_scores_gemma":[0.9888579,0.0000412561,0.0005822425,0.0003707203,0.00008696579,0.00007026505,0.00010547327,0.00013539878,0.009749758],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997409,0.00020672035,0.0003047136,0.0007282215,0.0007364478,0.00061491097],"domain_scores_gemma":[0.99851745,0.00034304176,0.00004212197,0.00052527146,0.00014361076,0.00042850757],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00049186987,0.000356732,0.00051644986,0.0005150906,0.00006371283,0.000080320475,0.00015278057,0.00017931723,0.00015100109],"category_scores_gemma":[0.0001353576,0.00025088494,0.000046139463,0.00078156334,0.00015108625,0.00023804531,0.00012443739,0.0006862665,0.00044065193],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18969958,0.0029713325,0.6487679,0.0007001885,0.004201364,0.021049082,0.003740799,0.00009946989,0.10019315,0.000058790683,0.020497175,0.008021219],"study_design_scores_gemma":[0.03508079,0.009980729,0.9345348,0.0011455085,0.0007849584,0.0003192091,0.00006376296,0.00019309999,0.0058408426,0.00000877697,0.011350932,0.0006965907],"about_ca_topic_score_codex":0.00017169387,"about_ca_topic_score_gemma":0.000039655228,"teacher_disagreement_score":0.28576693,"about_ca_system_score_codex":0.00072652625,"about_ca_system_score_gemma":0.0010205008,"threshold_uncertainty_score":0.99999434},"labels":[],"label_agreement":null},{"id":"W4405040476","doi":"10.1182/blood-2024-212136","title":"Survival Following Quadruplet and Triple Therapy in Transplant in-Eligible Multiple Myeloma - a Meta-Analysis of Recent Clinical Trials","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Multiple myeloma; Meta-analysis; Medicine; Clinical trial; Oncology; Internal medicine","score_opus":0.3302126182422315,"score_gpt":0.47250223191591906,"score_spread":0.14228961367368753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405040476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98180467,0.01604049,0.000030291896,0.0005924209,0.00012766047,0.000998021,0.00015135424,0.000029239614,0.00022583251],"genre_scores_gemma":[0.9914842,0.0076746508,0.0004024848,0.00004037203,0.00004265555,0.00012194848,0.00011690826,0.000021392261,0.00009534213],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99629784,0.0010647917,0.0013198138,0.0005004392,0.0004740305,0.00034308806],"domain_scores_gemma":[0.99669564,0.0026676916,0.000089492256,0.00031663504,0.00003773787,0.00019278383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005980991,0.00020958256,0.002547659,0.00080652273,0.000021944308,0.00003243047,0.00008708241,0.00013621156,0.00029819214],"category_scores_gemma":[0.0010449222,0.00013615731,0.0015277533,0.0013269077,0.000044635202,0.00006827303,0.000021609992,0.0002684522,0.0000055986043],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021117465,0.0032700808,0.74599457,0.00013673137,0.218624,0.001863653,0.0008053306,0.00000855849,0.003936973,0.000045636723,0.000025129284,0.023177564],"study_design_scores_gemma":[0.05777579,0.0017978105,0.71971846,0.00014702657,0.20093277,0.000018919956,0.0002875335,0.0054089935,0.011227526,0.00012656058,0.0021392412,0.00041939452],"about_ca_topic_score_codex":0.0009283266,"about_ca_topic_score_gemma":0.0017596835,"teacher_disagreement_score":0.055664044,"about_ca_system_score_codex":0.000024982504,"about_ca_system_score_gemma":0.0001586908,"threshold_uncertainty_score":0.5552334},"labels":[],"label_agreement":null},{"id":"W4405040531","doi":"10.1182/blood-2024-209501","title":"The Immune Inhibitory Hematopoietic Adaptor Protein Hacs1(Sly2) Suppresses the Proinflammatory Macrophage Function Contributing to Multiple Myeloma Progression","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Toronto; Discovery Centre; University Health Network","funders":"","keywords":"Proinflammatory cytokine; Multiple myeloma; Signal transducing adaptor protein; Immune system; Immunology; Haematopoiesis; Macrophage; Cancer research; Medicine; Biology; Inflammation; Signal transduction; Cell biology; Stem cell; In vitro","score_opus":0.0058580967114742226,"score_gpt":0.220273976817769,"score_spread":0.21441588010629478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405040531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9337609,0.048051458,0.00057715666,0.0024719725,0.010269961,0.0030068005,0.00001612228,0.0007164055,0.0011292169],"genre_scores_gemma":[0.9857152,0.00004017572,0.000022336575,0.000078138255,0.00025426492,0.0006266088,0.00005779798,0.000042524323,0.013162936],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99806994,0.00036173113,0.00049908453,0.0003850577,0.000100442325,0.00058375887],"domain_scores_gemma":[0.9988626,0.00036976265,0.00013658077,0.00046385545,0.00013657259,0.00003063146],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008180498,0.00025767396,0.00020475534,0.00008394397,0.00135238,0.00021205308,0.0002672059,0.00021463654,0.00024743425],"category_scores_gemma":[0.00037480734,0.0001469784,0.00016535612,0.00022091255,0.00016698394,0.0001989032,0.00020715632,0.000663583,0.0014021752],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043328886,0.00015113704,0.00012154612,0.000082341954,0.0002631943,0.000012299392,0.00042360253,0.000002314515,0.98415697,0.00083845615,0.006436156,0.007078704],"study_design_scores_gemma":[0.0008313853,0.00026763757,0.0011664509,0.00033426058,0.0000963458,0.00011337439,0.00064292975,0.000023009936,0.746605,0.000036459704,0.24972023,0.0001629155],"about_ca_topic_score_codex":0.00002333546,"about_ca_topic_score_gemma":0.000014971759,"teacher_disagreement_score":0.24328408,"about_ca_system_score_codex":0.000055298817,"about_ca_system_score_gemma":0.00011840387,"threshold_uncertainty_score":0.9999477},"labels":[],"label_agreement":null},{"id":"W4405040538","doi":"10.1182/blood-2024-205644","title":"The Arginine Methyltransferase PRMT5 Regulates Maintenance and TKI Resistance of Self-Renewing FLT3-ITD AML LSC","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Myeloid leukemia; Protein arginine methyltransferase 5; Cancer research; Methyltransferase; Leukemia; Fms-Like Tyrosine Kinase 3; Medicine; Decitabine; Pharmacology; Biology; Immunology; Methylation; DNA methylation","score_opus":0.0038119729963716773,"score_gpt":0.21372591909878955,"score_spread":0.20991394610241787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405040538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9410229,0.056363232,0.00047230034,0.0007917672,0.00019757521,0.00021277663,0.000027722128,0.000043829477,0.00086790096],"genre_scores_gemma":[0.9937864,0.0031904862,0.0008411191,0.000018121476,0.00019822859,0.000020082753,0.000027909457,0.000027325552,0.0018903404],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990814,0.000047755588,0.00022680245,0.0003229763,0.000119429846,0.00020167172],"domain_scores_gemma":[0.9994819,0.000045984936,0.000045794808,0.0003137549,0.000067033565,0.000045504927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025003363,0.00013524102,0.00012542444,0.000031340944,0.00008929188,0.000039260445,0.00011469789,0.00011407087,0.000003953591],"category_scores_gemma":[0.00004253688,0.00010440753,0.0000731062,0.00015182284,0.000100967874,0.0000054933903,0.000038863625,0.00008383859,0.0000014466635],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008701462,0.00004911106,0.00028420225,0.00015226634,0.00034778376,0.000005848657,0.00015920462,0.00007753266,0.9923642,0.0013479601,0.0013983764,0.0037264607],"study_design_scores_gemma":[0.0007397931,0.00011112286,0.0018342868,0.00016042663,0.00016467975,0.000025965359,0.00005036403,0.00019009876,0.93882406,0.0005684058,0.05715407,0.00017672764],"about_ca_topic_score_codex":0.000009582982,"about_ca_topic_score_gemma":0.00010309626,"teacher_disagreement_score":0.055755693,"about_ca_system_score_codex":0.000011041403,"about_ca_system_score_gemma":0.00007798976,"threshold_uncertainty_score":0.42576155},"labels":[],"label_agreement":null},{"id":"W4405040542","doi":"10.1182/blood-2024-205709","title":"Maintenance after Autologous Hematopoietic Cell Transplantation Improves Overall Survival and Progression Free Survival Regardless of Disease Stage at Transplant in Newly Diagnosed Myeloma Patients: A Global, Real-World Analysis from the Worldwide Network for Blood and Marrow Transplantation Global Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; McMaster University","funders":"","keywords":"Medicine; Multiple myeloma; Transplantation; Internal medicine; Oncology","score_opus":0.009863182357684179,"score_gpt":0.27595382173681715,"score_spread":0.26609063937913296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405040542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98807997,0.00214537,0.00024462014,0.00023583583,0.000097761644,0.0027308178,0.0063537243,0.00005371083,0.00005821519],"genre_scores_gemma":[0.9962778,0.0014040688,0.0005302355,0.000021967287,0.00005463191,0.00044911954,0.0011686429,0.000026244357,0.00006729211],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99734265,0.00029443917,0.00056072517,0.00071254175,0.00059579563,0.0004938606],"domain_scores_gemma":[0.99851644,0.0006256615,0.000120986566,0.00038707542,0.00007962809,0.00027023503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033967427,0.00034782136,0.0006298018,0.000108657274,0.00010923833,0.000075905264,0.00014403368,0.00008193335,0.000014032606],"category_scores_gemma":[0.000036522622,0.00023858456,0.0001852405,0.00063482736,0.00012178009,0.00013205419,0.000037115093,0.0001343754,5.872502e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011668245,0.00202997,0.979508,0.0012835516,0.001347191,0.0016604551,0.0010751397,0.000024778572,0.00014091161,0.00006817312,0.0000149913485,0.0011786058],"study_design_scores_gemma":[0.023004139,0.00066669716,0.9674666,0.0007289074,0.006898134,0.0000065263166,0.00014194135,0.00048666194,0.00018174307,0.00020311312,0.0000055765477,0.00020998878],"about_ca_topic_score_codex":0.0023680555,"about_ca_topic_score_gemma":0.046967972,"teacher_disagreement_score":0.044599917,"about_ca_system_score_codex":0.00008511742,"about_ca_system_score_gemma":0.00010253576,"threshold_uncertainty_score":0.9729196},"labels":[],"label_agreement":null},{"id":"W4405040604","doi":"10.1182/blood-2024-199227","title":"Multiomic Profiling Reveals Pleiotropic Effects of Somatic IRF4-C99R Mutations in Primary Mediastinal Large B-Cell Lymphomas","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Simon Fraser University; University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Somatic cell; Biology; B cell; Cancer research; Profiling (computer programming); IRF4; Genetics; Immunology; Antibody; Gene; Transcription factor","score_opus":0.006549509104057437,"score_gpt":0.24393117999976213,"score_spread":0.2373816708957047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405040604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910369,0.0066395723,0.000030249115,0.000116637675,0.00017668423,0.0008569528,0.00002378101,0.00007945462,0.0010397475],"genre_scores_gemma":[0.99605334,0.00012153603,0.0031263253,0.000070674214,0.000093835115,0.00023199974,0.00010182099,0.000028474828,0.00017198568],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877197,0.000055197943,0.00038697512,0.00027456248,0.00024195787,0.00026936966],"domain_scores_gemma":[0.9991437,0.0004470928,0.00006756695,0.00021423178,0.00003319304,0.00009420625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012002998,0.00016742012,0.00037858944,0.00022781563,0.000032399046,0.000016310125,0.00005761009,0.00007786038,0.000025590136],"category_scores_gemma":[0.00011820372,0.00013528536,0.00012019075,0.00028483418,0.000026414264,0.00006465983,0.000035814297,0.00007830218,0.00007353564],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000063648426,0.016315648,0.74618834,0.015232289,0.00054883363,0.0033690333,0.0022869622,0.000007586246,0.21037261,0.0013024389,0.00020148346,0.0041110935],"study_design_scores_gemma":[0.021268206,0.00048416565,0.7182012,0.0026942368,0.0010902173,0.0001478161,0.00010195834,0.0006038235,0.2549476,0.00023629982,0.000043410146,0.00018101552],"about_ca_topic_score_codex":0.00003559623,"about_ca_topic_score_gemma":0.000008143929,"teacher_disagreement_score":0.044575,"about_ca_system_score_codex":0.0001677172,"about_ca_system_score_gemma":0.00026809887,"threshold_uncertainty_score":0.5516777},"labels":[],"label_agreement":null},{"id":"W4405040632","doi":"10.1182/blood-2024-211167","title":"Real World Evidence of Outcomes of Patients Treated with Talquetamab in a Heavily Pretreated Population with Multiple Myeloma with High Exposure to Prior BCMA Therapies- a Report from the IMWG Consortium","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Multiple myeloma; Pomalidomide; Population; Internal medicine; Carfilzomib; Oncology; Lenalidomide","score_opus":0.019905287953075213,"score_gpt":0.2882926644433249,"score_spread":0.2683873764902497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405040632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99685276,0.00031525054,0.0000075020407,0.0003119846,0.0000150726055,0.0022201487,0.00013525125,0.000071954775,0.00007005242],"genre_scores_gemma":[0.9975949,0.00002290523,0.0015125632,0.00002042596,0.000017638004,0.00018723385,0.00028004675,0.00004925507,0.00031503357],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99775934,0.00012595838,0.0005367943,0.0005031776,0.0007642351,0.000310479],"domain_scores_gemma":[0.9982668,0.0004652882,0.00020488136,0.0006355594,0.00028168762,0.00014578673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016117441,0.0002906988,0.00062883407,0.00024715072,0.000045038607,0.000028900628,0.00011799782,0.00006337165,0.00003568933],"category_scores_gemma":[0.00018048761,0.00013777817,0.00006541017,0.000960161,0.00011619804,0.00015398356,0.00003415338,0.00017723646,0.0000028123065],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008188119,0.0011900176,0.98451465,0.00013742401,0.0013469582,0.0011037685,0.0008434179,0.000012403761,0.0012818655,0.000005018154,0.000012876726,0.001363492],"study_design_scores_gemma":[0.010307254,0.003917901,0.9744459,0.0022570523,0.0005279786,0.000033376502,0.00010285804,0.000043231656,0.008210321,0.0000033730998,0.0000047991707,0.00014598375],"about_ca_topic_score_codex":0.025616294,"about_ca_topic_score_gemma":0.017132021,"teacher_disagreement_score":0.010068769,"about_ca_system_score_codex":0.00009438679,"about_ca_system_score_gemma":0.00027106074,"threshold_uncertainty_score":0.9808722},"labels":[],"label_agreement":null},{"id":"W4405040677","doi":"10.1182/blood-2024-209455","title":"A Retrospective Study of Inotuzumab Ozogamicin in Individuals with Down Syndrome and B-Cell Acute Lymphoblastic Leukemia","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Lymphoblastic Leukemia; Medicine; CD22; Acute lymphocytic leukemia; Retrospective cohort study; Oncology; Pediatrics; Leukemia; Internal medicine; Immunology; B cell; Antibody","score_opus":0.010560562670765536,"score_gpt":0.2686793725623277,"score_spread":0.25811880989156216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405040677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960614,0.00058611244,0.000003401874,0.000037199392,0.000029357227,0.0010749742,0.000024610239,0.000051680465,0.0021312651],"genre_scores_gemma":[0.9980634,0.000085752275,0.00008192811,0.000017443903,0.000028381475,0.00005260325,0.0000063469884,0.000042822518,0.0016213146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839693,0.00006798012,0.00026883406,0.0004355721,0.0005419839,0.00028870322],"domain_scores_gemma":[0.99938667,0.00008931699,0.000042255895,0.00032061717,0.000058094043,0.000103077444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029739487,0.00018295331,0.0004980048,0.00045911726,0.000025161306,0.00003584687,0.00010000486,0.00008409737,0.00021829763],"category_scores_gemma":[0.000026307414,0.00013992359,0.000037505128,0.00078747765,0.00010054222,0.00007101662,0.00009489755,0.00034182667,0.000014123861],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006182441,0.003859795,0.8824849,0.0005889349,0.0019002808,0.005943761,0.01165514,0.000009631133,0.09173412,0.000060944047,0.00006972413,0.0010745259],"study_design_scores_gemma":[0.03384009,0.015153692,0.9266707,0.00084984384,0.0012645411,0.0022988517,0.0020798107,0.0001657491,0.017148394,0.00013261176,0.00008075985,0.00031500883],"about_ca_topic_score_codex":0.00036839195,"about_ca_topic_score_gemma":0.00012993555,"teacher_disagreement_score":0.07458572,"about_ca_system_score_codex":0.00031262042,"about_ca_system_score_gemma":0.00038160762,"threshold_uncertainty_score":0.57059187},"labels":[],"label_agreement":null},{"id":"W4405040692","doi":"10.1182/blood-2024-199174","title":"First Results from the Dose Escalation Part of the Phase 1 Study of KTX1001, an Oral, First-in-Class, Potent Inhibitor of MMSET/NSD2 for Relapsed/Refractory Multiple Myeloma (RRMM)","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Multiple myeloma; Medicine; Lenalidomide; Internal medicine; Class (philosophy); Refractory (planetary science); Oncology; Physics; Computer science","score_opus":0.02047918779872972,"score_gpt":0.264486604641157,"score_spread":0.24400741684242724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405040692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99701786,0.00062756863,0.00003337822,0.00035163108,0.00032059677,0.000978438,0.00061335124,0.00000937786,0.000047788628],"genre_scores_gemma":[0.99910676,0.00006531439,0.00013656306,0.000026505213,0.00021953354,0.000067548375,0.0002627726,0.000020158614,0.000094824565],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986382,0.000113849,0.00057237205,0.0003327493,0.0002075202,0.00013530412],"domain_scores_gemma":[0.99890226,0.00012812331,0.00023622574,0.0005927662,0.0001030562,0.000037570153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034180612,0.00014256689,0.0001877051,0.000038561473,0.00007344384,0.000014691448,0.0002523144,0.00013113685,0.000006440707],"category_scores_gemma":[0.0004178851,0.00009256012,0.00012496384,0.00016065752,0.000085310516,0.000013716695,0.000093867435,0.00010179564,8.338825e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034575702,0.015741372,0.016259879,0.0002539562,0.0005669228,0.0000063560105,0.0037500868,0.0005654311,0.93689847,0.00009627752,0.014013746,0.00838994],"study_design_scores_gemma":[0.014483718,0.0028771772,0.014531254,0.00024792433,0.00016037916,0.0000013266255,0.0008238396,0.0013691817,0.916291,0.00006296191,0.04895212,0.0001991032],"about_ca_topic_score_codex":0.0002498934,"about_ca_topic_score_gemma":0.0015646324,"teacher_disagreement_score":0.034938376,"about_ca_system_score_codex":0.0000111321815,"about_ca_system_score_gemma":0.00007802459,"threshold_uncertainty_score":0.3774492},"labels":[],"label_agreement":null},{"id":"W4405040781","doi":"10.1182/blood-2024-198119","title":"Randomized Phase 2 Dose Optimization Trial of Modakafusp Alfa in Relapsed/Refractory Multiple Myeloma (RRMM)","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Pomalidomide; Multiple myeloma; Randomized controlled trial; Internal medicine; Refractory (planetary science); Oncology; Lenalidomide; Nuclear medicine; Materials science","score_opus":0.03050820499688557,"score_gpt":0.3314219374434796,"score_spread":0.30091373244659403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405040781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916597,0.0022856107,0.00050123385,0.00020624026,0.0002396646,0.002804119,0.00005012201,0.000098614924,0.0021546977],"genre_scores_gemma":[0.9955579,0.00047520598,0.0026162213,0.00001906941,0.00019038786,0.00028153928,0.00019699908,0.000039101655,0.000623556],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998092,0.0002430705,0.000566411,0.0003461902,0.00044553305,0.00030679253],"domain_scores_gemma":[0.9986479,0.0006873024,0.000080064616,0.000325752,0.00007763717,0.00018131832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006246241,0.00019253195,0.00070357195,0.0003955903,0.000031300508,0.000024919396,0.000082737606,0.0001374912,0.00027030008],"category_scores_gemma":[0.0012509829,0.00014600712,0.000263244,0.00037660645,0.00010575649,0.00010225003,0.00003842849,0.00024832442,0.00004017789],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9618903,0.010025437,0.00053149153,0.00030751823,0.00086644327,0.0010554394,0.00043485878,0.00037489095,0.0047657695,0.00008105594,0.00012323407,0.01954361],"study_design_scores_gemma":[0.93158865,0.0011548258,0.000164431,0.00026191399,0.00034274516,0.000022005692,0.000025467736,0.06025638,0.0058157975,0.00005667881,0.00020004761,0.00011107914],"about_ca_topic_score_codex":0.00015566206,"about_ca_topic_score_gemma":0.000020361424,"teacher_disagreement_score":0.05988149,"about_ca_system_score_codex":0.00006135291,"about_ca_system_score_gemma":0.00025901775,"threshold_uncertainty_score":0.5953998},"labels":[],"label_agreement":null},{"id":"W4405040849","doi":"10.1182/blood-2024-198979","title":"Dose Optimization of Check-Point Inhibitors: A Comparison of Standard Dose and Low Dose Nivolumab in Relapsed/Refractory Hodgkin Lymphoma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Nivolumab; Medicine; Refractory (planetary science); Lymphoma; Nuclear medicine; Hodgkin lymphoma; Oncology; Internal medicine; Immunotherapy; Cancer; Biology","score_opus":0.012153910540274026,"score_gpt":0.2723099036470323,"score_spread":0.26015599310675824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405040849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890561,0.009376954,0.000028945486,0.00020324445,0.00014353245,0.0005332863,0.000055352564,0.000050717303,0.00055187655],"genre_scores_gemma":[0.9975539,0.0005551669,0.0016270482,0.000023868552,0.00007392125,0.000045887668,0.00004454755,0.000032570468,0.00004307478],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839926,0.00005887623,0.0006312974,0.00035049213,0.00035471187,0.00020534464],"domain_scores_gemma":[0.99921584,0.00012756181,0.00015553915,0.0002966274,0.000088921144,0.000115510215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022778467,0.00021113124,0.0006167698,0.00027456734,0.000025581106,0.000024617277,0.000054071465,0.00015342644,0.00005830277],"category_scores_gemma":[0.00008414565,0.0001763037,0.000115605275,0.0003514358,0.0001057639,0.000102448,0.00005974935,0.00008716119,0.0000050106582],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00482119,0.04035762,0.7422025,0.0054381327,0.0018315169,0.0015062231,0.015320774,0.0019850025,0.022887422,0.0007418701,0.0038461112,0.15906164],"study_design_scores_gemma":[0.112231046,0.010427724,0.55943364,0.009861022,0.002234372,0.0002318626,0.0021551084,0.015261147,0.28555104,0.00020347383,0.0015740402,0.00083552086],"about_ca_topic_score_codex":0.00024697697,"about_ca_topic_score_gemma":0.00004812316,"teacher_disagreement_score":0.2626636,"about_ca_system_score_codex":0.00019015692,"about_ca_system_score_gemma":0.0003078924,"threshold_uncertainty_score":0.7189456},"labels":[],"label_agreement":null},{"id":"W4405040852","doi":"10.1182/blood-2024-206495","title":"HPK1 Inhibition and Venetoclax Combination Suppressed AML By Enhancing Cytotoxic T-Cell Response to Leukaemia","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Viral Infectious Diseases and Gene Expression in Insects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Venetoclax; Cytotoxic T cell; Cancer research; Leukemia; Medicine; Oncology; Internal medicine; Biology; Genetics; Chronic lymphocytic leukemia; In vitro","score_opus":0.0038151611774081377,"score_gpt":0.23126788758391603,"score_spread":0.2274527264065079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405040852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99625444,0.0022214702,0.0005498112,0.0001092438,0.00016492413,0.00022375098,0.00006158345,0.000046092613,0.00036869964],"genre_scores_gemma":[0.99837464,0.000100657,0.00007228625,0.00026758356,0.00012156995,0.00007084619,0.00013584863,0.000026115122,0.0008304347],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991251,0.00008669954,0.00014821124,0.00036073834,0.00010377237,0.00017547974],"domain_scores_gemma":[0.9996097,0.000024946326,0.00002661929,0.00018126689,0.000036403646,0.0001210736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015318858,0.00013142318,0.000086344044,0.000060151964,0.00009523692,0.000094439994,0.000052575895,0.00012286565,0.000025848798],"category_scores_gemma":[0.00006353214,0.00013170548,0.000052290266,0.00009922763,0.000024298943,0.000007972059,0.000082528204,0.00007200036,0.000025678291],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015121752,0.00009683931,0.000108201995,0.000058009955,0.0000183564,0.00000906287,0.000058289887,0.00002519305,0.9818537,0.000013201255,0.017403986,0.00020392911],"study_design_scores_gemma":[0.00078467524,0.0006378346,0.00031393848,0.00007141101,0.000030535775,0.000013514492,0.000023844686,0.000034572353,0.98237395,0.00014319248,0.015400244,0.0001722903],"about_ca_topic_score_codex":0.000016441352,"about_ca_topic_score_gemma":0.0000071122663,"teacher_disagreement_score":0.0021208131,"about_ca_system_score_codex":0.000022086639,"about_ca_system_score_gemma":0.00008381957,"threshold_uncertainty_score":0.5370794},"labels":[],"label_agreement":null},{"id":"W4405040856","doi":"10.1182/blood-2024-200956","title":"Secondary Cancers Among Patients with Multiple Myeloma: A 15-Year Analysis of a Population-Based Cohort in Ontario, Canada","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; McMaster University; McMaster University Medical Centre; Ottawa Hospital","funders":"Celgene; Gilead Sciences; Bristol-Myers Squibb; Juno Therapeutics; Amgen","keywords":"Multiple myeloma; Medicine; Cohort; Hematologic Neoplasms; Oncology; Population; Internal medicine; Demography; Cancer; Family medicine; Environmental health","score_opus":0.006318723466510849,"score_gpt":0.22504646639636453,"score_spread":0.21872774292985367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405040856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985687,0.00007532469,0.000003139433,0.000020135802,0.00003204016,0.0005496066,0.0002043091,0.000018274384,0.000528434],"genre_scores_gemma":[0.9980312,0.0000011036536,0.00022760822,0.00002629559,0.0000080175705,0.00006798657,0.0014207343,0.000017077062,0.00019995129],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998704,0.000026918635,0.00023657258,0.00028429297,0.0005022018,0.00024600583],"domain_scores_gemma":[0.9993806,0.00009950139,0.00004464315,0.0002321534,0.000083950144,0.00015917396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006562073,0.00013153774,0.00036322538,0.0003997944,0.000028165205,0.000012532361,0.000051208604,0.00004334316,0.0005827487],"category_scores_gemma":[0.000046533874,0.00010173536,0.00007921307,0.0007768423,0.00002816264,0.00005248621,0.000012962759,0.00018546684,0.0000013667986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021543948,0.00028954874,0.99571013,0.000076978606,0.0026394555,0.00024123059,0.00008134667,0.0003337537,0.000008052243,0.0000013540887,0.00006249162,0.0003402259],"study_design_scores_gemma":[0.0055616377,0.00015614071,0.9895747,0.00013572737,0.0012982703,4.6588275e-7,0.000024601397,0.002963642,0.00013647586,6.8279394e-7,0.000056043737,0.00009164505],"about_ca_topic_score_codex":0.99579346,"about_ca_topic_score_gemma":0.99956,"teacher_disagreement_score":0.0061354553,"about_ca_system_score_codex":0.00089153234,"about_ca_system_score_gemma":0.002617345,"threshold_uncertainty_score":0.6380689},"labels":[],"label_agreement":null},{"id":"W4405040857","doi":"10.1182/blood-2024-208408","title":"Effects of Splenomegaly in Children with Sickle Cell Anemia Treated with Hydroxyurea: Secondary Analysis of the Sphere Trial","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Sickle cell anemia; Medicine; Anemia; Pediatrics; Fetal hemoglobin; Internal medicine; Disease; Pregnancy; Genetics; Biology","score_opus":0.0018769459491527378,"score_gpt":0.1837463129818732,"score_spread":0.18186936703272044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405040857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99195826,0.0030046108,0.0000024794056,0.00004822723,0.00001967581,0.00077951315,0.000019051344,0.0000271101,0.004141086],"genre_scores_gemma":[0.99939704,0.00007755928,0.000038008482,0.000022171556,0.00002321017,0.000012800073,0.00002975609,0.000022200735,0.00037726128],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911684,0.00004800361,0.00024434255,0.00022525564,0.00020358751,0.00016195209],"domain_scores_gemma":[0.99951816,0.000057917867,0.00008333284,0.000263236,0.000027158912,0.000050226023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008170826,0.0001499095,0.0004832711,0.00018468472,0.00001932078,0.0000070468595,0.00008346176,0.000117021715,0.000078526304],"category_scores_gemma":[0.000010155867,0.000075437485,0.00016054307,0.0016906735,0.00010311652,0.000029805804,0.000019120578,0.00027012388,0.0000020137043],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01019007,0.004801477,0.9436951,0.0020241248,0.013377204,0.0003292548,0.0016985247,0.0009992516,0.020059677,0.000044746528,0.00021897702,0.0025615762],"study_design_scores_gemma":[0.15396403,0.005497331,0.66532004,0.0012523835,0.041376468,0.000079491714,0.00035890218,0.00042199256,0.131192,0.000012788975,0.00013506197,0.00038951408],"about_ca_topic_score_codex":0.0005140986,"about_ca_topic_score_gemma":0.00014630283,"teacher_disagreement_score":0.27837506,"about_ca_system_score_codex":0.000015486332,"about_ca_system_score_gemma":0.00020435447,"threshold_uncertainty_score":0.30762514},"labels":[],"label_agreement":null},{"id":"W4405040868","doi":"10.1182/blood-2024-207031","title":"Inhibition of the Complement Alternative Pathway Attenuates Hemolysis and Preserves Renal Function in a Mouse Model of Sickle Cell Disease","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Hemolysis; Alternative complement pathway; Disease; Complement (music); Complement system; Immunology; Medicine; Cell; Biology; Immune system; Phenotype; Internal medicine; Genetics; Gene","score_opus":0.01299721114451149,"score_gpt":0.22282218377024365,"score_spread":0.20982497262573216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405040868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973798,0.0014336893,0.00012973181,0.00037937312,0.000020058491,0.00025290105,0.00010045415,0.0000112144935,0.00029279574],"genre_scores_gemma":[0.999343,0.00014658718,0.000052117928,0.000030687483,0.000012088512,0.000012718045,0.000017310338,0.000008090603,0.00037739926],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99943054,0.000028012637,0.00018659761,0.00012571597,0.00015023313,0.00007889587],"domain_scores_gemma":[0.9997469,0.000020812593,0.000045360153,0.00011337171,0.00003351723,0.000040047267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008290793,0.00006657794,0.00012045303,0.00006317137,0.000018212319,0.0000051438496,0.00002457384,0.00002832342,0.00001336861],"category_scores_gemma":[0.000015698572,0.00004256313,0.000060157334,0.00011771295,0.000054856104,0.000040675353,0.000044657456,0.00008717714,6.5165983e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045012808,0.0022439514,0.02897454,0.0020833355,0.00027853198,0.00002468248,0.0038056767,0.0067705107,0.95300496,0.00081942225,0.00017836165,0.0013659172],"study_design_scores_gemma":[0.005037673,0.0003804987,0.0057049934,0.0009857712,0.00063304364,0.0000027807557,0.0010539957,0.11906014,0.86423343,0.0026995004,0.00007039955,0.00013778015],"about_ca_topic_score_codex":0.00009316909,"about_ca_topic_score_gemma":0.000020248062,"teacher_disagreement_score":0.11228962,"about_ca_system_score_codex":0.000009423437,"about_ca_system_score_gemma":0.000050876362,"threshold_uncertainty_score":0.1735674},"labels":[],"label_agreement":null},{"id":"W4405040880","doi":"10.1182/blood-2024-201710","title":"Combination of Olutasidenib and Azacitidine Induces Durable Complete Remissions in m<i>IDH1</i> Acute Myeloid Leukemia: A Multicohort Open-Label Phase 1/2 Trial","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Azacitidine; Myeloid leukemia; Medicine; Internal medicine; Open label; Leukemia; Phases of clinical research; Oncology; Cancer research; Clinical trial; Biology","score_opus":0.06387992848415537,"score_gpt":0.3703111879506398,"score_spread":0.3064312594664844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405040880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99221057,0.0010455186,0.000027618862,0.0018378661,0.00013063988,0.0022870726,0.00015261682,0.00008260089,0.002225518],"genre_scores_gemma":[0.9958133,0.0008196048,0.0015674274,0.00013562184,0.00013254287,0.00017850865,0.00017788298,0.00005506095,0.001120013],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9976223,0.00013980077,0.0006963948,0.0005748528,0.0005210703,0.0004455498],"domain_scores_gemma":[0.9986494,0.00039899538,0.000104008366,0.00041672593,0.0001557509,0.00027511682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008864086,0.00025516227,0.0007068095,0.00047604088,0.00010738221,0.00011569902,0.00030963361,0.00022723222,0.00007974322],"category_scores_gemma":[0.00049773435,0.00022173852,0.000058597725,0.00087373884,0.00018957457,0.0003769361,0.00036093724,0.00076018885,0.00002221384],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010460667,0.0037123675,0.0004385546,0.00046982424,0.0005778433,0.0012576159,0.0006368707,0.0000016837522,0.97334355,0.0008540898,0.0030382602,0.005208701],"study_design_scores_gemma":[0.6782538,0.0059351013,0.0016483292,0.0021170387,0.0014832268,0.0010680641,0.00041506748,0.0105235865,0.2929227,0.000904718,0.0041087265,0.0006195966],"about_ca_topic_score_codex":0.000497787,"about_ca_topic_score_gemma":0.000030157898,"teacher_disagreement_score":0.6804208,"about_ca_system_score_codex":0.00031429128,"about_ca_system_score_gemma":0.0011440201,"threshold_uncertainty_score":0.90422344},"labels":[],"label_agreement":null},{"id":"W4405040900","doi":"10.1182/blood-2024-211538","title":"Increased Environmental Temperature Damages DNA and Is an Emerging Health Risk That Correlates with Rates of Acute Lymphoblastic Leukemia (ALL) in Europe","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Carcinogens and Genotoxicity Assessment","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"","keywords":"Lymphoblastic Leukemia; Medicine; Acute lymphocytic leukemia; Leukemia; Damages; Environmental health; Immunology; Oncology; Internal medicine","score_opus":0.008203766389151448,"score_gpt":0.24771855334773804,"score_spread":0.23951478695858658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405040900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959764,0.0034757915,0.000015189385,0.000059696045,0.000027771746,0.00014036443,0.00027296387,0.000007975742,0.00002386366],"genre_scores_gemma":[0.9959193,0.0034382378,0.00015793875,0.00015043667,0.00003665185,0.000007134032,0.00021563328,0.00002331458,0.000051386363],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991954,0.00007223634,0.00013527452,0.00032862776,0.000096960124,0.00017148706],"domain_scores_gemma":[0.99966806,0.000011190156,0.000053324842,0.00017938501,0.000008759365,0.00007927996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000119061435,0.00014824305,0.00015271899,0.00004997876,0.000047516536,0.000036432324,0.000070110174,0.00007137422,0.000011375782],"category_scores_gemma":[0.000003815797,0.000120530225,0.000027272934,0.00008355463,0.0000632796,0.000007504359,0.00006878876,0.00009864806,9.786496e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006346895,0.00012479468,0.10952717,0.00005542527,0.00023116946,0.00003929896,0.00041981981,0.000026550975,0.8890526,0.0000058760024,0.000085985535,0.00036783805],"study_design_scores_gemma":[0.0016559782,0.0012836154,0.18610229,0.00010998993,0.00021588571,0.00011882568,0.00042542643,0.00040287225,0.8089075,0.000009471711,0.0005153239,0.00025280402],"about_ca_topic_score_codex":0.0001561629,"about_ca_topic_score_gemma":0.00011025685,"teacher_disagreement_score":0.08014508,"about_ca_system_score_codex":0.000020024094,"about_ca_system_score_gemma":0.00012734326,"threshold_uncertainty_score":0.49150798},"labels":[],"label_agreement":null},{"id":"W4405040905","doi":"10.1182/blood-2024-209286","title":"Comprehensive Characterization of the Plasma Proteome of Multiple Myeloma and Its Precursor Conditions and Identification of a Proteomic Signature to Improve Risk Prediction of Disease Progression","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Monoclonal gammopathy of undetermined significance; Multiple myeloma; Proteome; Disease; Medicine; Oncology; Computational biology; Biology; Internal medicine; Immunology; Cancer research; Antibody; Bioinformatics; Monoclonal; Monoclonal antibody","score_opus":0.011688222118667293,"score_gpt":0.27525359962219054,"score_spread":0.26356537750352327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405040905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99176913,0.0003035617,0.000041416308,0.00010575936,0.000042954696,0.004475947,0.0032429153,0.000014456543,0.0000038661137],"genre_scores_gemma":[0.9991352,0.00008253772,0.00014596862,0.0000015876033,0.000021844233,0.000362061,0.0001844104,0.00001182368,0.000054556232],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99899876,0.000076234566,0.0003424779,0.00021073736,0.0002790382,0.0000927409],"domain_scores_gemma":[0.99913025,0.000059517868,0.00024474296,0.00018140288,0.0002854493,0.000098644334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000091429974,0.00009677048,0.00020145898,0.0001437962,0.000041543517,0.000007671751,0.00004478193,0.000062706524,0.000004759332],"category_scores_gemma":[0.000276187,0.000065224325,0.000049699862,0.0002325508,0.00009614474,0.00009671619,0.00005194465,0.00009925879,6.420982e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006305438,0.00050495344,0.063032515,0.0024955783,0.0001780722,0.0000018071412,0.00042443402,0.0000017486572,0.9306529,0.00001891707,0.0000023796185,0.0020561258],"study_design_scores_gemma":[0.0013316702,0.00035785904,0.49260417,0.0006296115,0.00018370975,0.000002638407,0.000016164404,0.0025871156,0.50224423,0.000017231274,0.0000034764637,0.000022113069],"about_ca_topic_score_codex":0.000008071925,"about_ca_topic_score_gemma":0.0000011793189,"teacher_disagreement_score":0.42957166,"about_ca_system_score_codex":0.000011310659,"about_ca_system_score_gemma":0.00008959679,"threshold_uncertainty_score":0.26597705},"labels":[],"label_agreement":null},{"id":"W4405040920","doi":"10.1182/blood-2024-205672","title":"Public Insurance As a Proxy Measure of Household Poverty-Exposures Among Children with Hematologic Malignancies","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Centre hospitalier universitaire de Québec","funders":"","keywords":"Proxy (statistics); Hematologic Neoplasms; Medicine; Environmental health; Poverty; Cancer; Internal medicine; Economic growth; Statistics","score_opus":0.031041967559233993,"score_gpt":0.2504872125222704,"score_spread":0.2194452449630364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405040920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98632634,0.0074083004,0.00003330062,0.0022371397,0.00010947465,0.00081920915,0.00007870505,0.00048730304,0.0025002453],"genre_scores_gemma":[0.9981788,0.00008393424,0.0003594536,0.00078044285,0.00018451817,0.00007511329,0.000025348387,0.00006882828,0.00024359308],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99762684,0.00010203225,0.00048574372,0.00052282587,0.0008676587,0.00039492772],"domain_scores_gemma":[0.9987998,0.000108377775,0.0001500086,0.0006016606,0.0001509089,0.0001892527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046630792,0.00029849136,0.0006449571,0.0001896597,0.000067953624,0.00007518045,0.00023063029,0.00015724223,0.000046018682],"category_scores_gemma":[0.0003972352,0.00021698052,0.0001716728,0.000615179,0.0002323531,0.0002377027,0.00006504317,0.00035072005,0.000023168303],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076408425,0.0007302947,0.99233234,0.0007792702,0.00081332977,0.0000954351,0.001264551,0.0000015800093,0.0011796968,0.0012661793,0.0012899904,0.00017089951],"study_design_scores_gemma":[0.0028039434,0.0009915711,0.9662411,0.0020529176,0.0003828138,0.0011365933,0.00025247398,0.0000033052374,0.025081264,0.00027223612,0.00043961324,0.00034217257],"about_ca_topic_score_codex":0.00039081453,"about_ca_topic_score_gemma":0.00020807468,"teacher_disagreement_score":0.02609127,"about_ca_system_score_codex":0.00002750626,"about_ca_system_score_gemma":0.00043338604,"threshold_uncertainty_score":0.88482094},"labels":[],"label_agreement":null},{"id":"W4405040925","doi":"10.1182/blood-2024-211926","title":"Subsequent Primary Malignancies in Patients with Indolent B Cell Non-Hodgkin Lymphoma Receiving Frontline Bendamustine Rituximab Therapy","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Princess Margaret Cancer Centre; University Health Network; University of Toronto; McMaster University; Sunnybrook Health Science Centre; Juravinski Cancer Centre","funders":"","keywords":"Bendamustine; Medicine; Rituximab; Internal medicine; Oncology; Lymphoma","score_opus":0.0070960583230896485,"score_gpt":0.20959559229100455,"score_spread":0.2024995339679149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405040925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899233,0.006924217,0.000011760064,0.00033604898,0.0001827581,0.0008897147,0.00004663754,0.00011104428,0.0015745012],"genre_scores_gemma":[0.99705374,0.0007060112,0.0010274823,0.00037355023,0.00013391642,0.00018017164,0.00021521865,0.00006197948,0.00024790553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822676,0.00003591266,0.0003729261,0.0005093743,0.00044677942,0.00040826143],"domain_scores_gemma":[0.9992911,0.00007013294,0.00006851815,0.00035428448,0.00007885713,0.00013705628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001421969,0.00032219573,0.00048577128,0.00020520871,0.00005071377,0.0000579376,0.00009304061,0.00009965965,0.00008451245],"category_scores_gemma":[0.000007952148,0.00021962212,0.00010832833,0.00031305032,0.000045131477,0.00011519892,0.000049728296,0.00009747548,0.00006483647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059024815,0.017429287,0.9388585,0.000326662,0.00029459057,0.000957342,0.00077596225,0.000004814884,0.0008906949,0.000020589048,0.0005241589,0.03932712],"study_design_scores_gemma":[0.0410891,0.0016619262,0.9323186,0.0010668355,0.00021492469,0.000026405767,0.000037058562,0.000020896008,0.021670878,0.000007680285,0.0016384032,0.0002472889],"about_ca_topic_score_codex":0.00022542197,"about_ca_topic_score_gemma":0.00003696223,"teacher_disagreement_score":0.04049885,"about_ca_system_score_codex":0.00034477463,"about_ca_system_score_gemma":0.00028384844,"threshold_uncertainty_score":0.89559305},"labels":[],"label_agreement":null},{"id":"W4405040930","doi":"10.1182/blood-2024-208943","title":"Global Access to Chimeric Antigen Receptor (CAR) T-Cell Therapies: Health Technology Assessment (HTA) of CAR T in G7 Countries and Australia","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Chimeric antigen receptor; Health technology; Medicine; Health care; Cancer; Immunotherapy; Internal medicine; Political science","score_opus":0.0311121393473149,"score_gpt":0.37298388317416625,"score_spread":0.34187174382685137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405040930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9749476,0.017409865,0.00018432205,0.0061909854,0.0004314505,0.0003415618,0.0002139846,0.000060623926,0.00021964224],"genre_scores_gemma":[0.99505675,0.0012418915,0.0029492816,0.00045249166,0.0000190969,0.00001660629,0.000010685865,0.000009049291,0.00024416464],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988174,0.00014151713,0.00032498458,0.00034215604,0.000038835547,0.00033512572],"domain_scores_gemma":[0.9996204,0.00006193175,0.00006110463,0.00018974402,0.000032809385,0.000034002936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003525383,0.00015756945,0.00039155412,0.0001621801,0.000050115734,0.000032228687,0.00023342868,0.00027471493,0.000249135],"category_scores_gemma":[0.0000169542,0.00012397734,0.000047074376,0.0005936306,0.00024459156,0.000051091927,0.00013574709,0.00020306856,0.000018239669],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014509699,0.0012036079,0.5821712,0.00066870556,0.0009863024,0.000027867798,0.0006519348,0.0000017061295,0.36370158,0.012429741,0.014711421,0.023300853],"study_design_scores_gemma":[0.0040808003,0.0033399279,0.35760558,0.00065007136,0.00026946512,0.000114106304,0.0017720155,0.0000068312047,0.33031228,0.0022153275,0.29874766,0.0008859349],"about_ca_topic_score_codex":0.00034338754,"about_ca_topic_score_gemma":0.00015923497,"teacher_disagreement_score":0.28403625,"about_ca_system_score_codex":0.000042009488,"about_ca_system_score_gemma":0.00013507812,"threshold_uncertainty_score":0.5055649},"labels":[],"label_agreement":null},{"id":"W4405040944","doi":"10.1182/blood-2024-209214","title":"Comparing Antihistamine Premedication Regimens for Preventing Rituximab-Associated Infusion Reactions in Hemato-Oncology Patients: A Retrospective Analysis","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Antihistamine; Medicine; Premedication; Rituximab; Loratadine; Tolerability; Diphenhydramine; Retrospective cohort study; Dosing; Anesthesia; Internal medicine; Adverse effect; Lymphoma; Histamine","score_opus":0.022720973810420264,"score_gpt":0.32943936569431703,"score_spread":0.30671839188389677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405040944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99577004,0.00032179418,0.00050332706,0.0002483482,0.00010341621,0.0010478337,0.00002043662,0.00013719987,0.0018475913],"genre_scores_gemma":[0.9977117,0.00007637074,0.00065183814,0.000022356486,0.00008774889,0.0001912983,0.00046156012,0.000026894704,0.0007702036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99817276,0.00008372816,0.00052520266,0.00044664455,0.00040761367,0.0003640284],"domain_scores_gemma":[0.99886703,0.00033655277,0.00014331617,0.00028898078,0.00026363478,0.00010048639],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080898305,0.00013505474,0.00052607607,0.0006543817,0.00009029878,0.000030478575,0.00008764952,0.00016366888,0.000038610026],"category_scores_gemma":[0.001467591,0.00012852541,0.00017957247,0.0017070031,0.00006023863,0.0001157687,0.000077207274,0.00029155018,0.00001431454],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064427475,0.024488442,0.9310735,0.0030093938,0.008773822,0.00037004132,0.006420539,0.00009254905,0.014896833,0.0016554821,0.0034183583,0.0051567685],"study_design_scores_gemma":[0.13527673,0.0016821595,0.51560605,0.0028622104,0.008292262,0.00010170003,0.0006524959,0.32141334,0.00702144,0.0007470203,0.0057576317,0.00058693945],"about_ca_topic_score_codex":0.00059877697,"about_ca_topic_score_gemma":0.0008444664,"teacher_disagreement_score":0.41546744,"about_ca_system_score_codex":0.009896024,"about_ca_system_score_gemma":0.0015530301,"threshold_uncertainty_score":0.9939048},"labels":[],"label_agreement":null},{"id":"W4405040982","doi":"10.1182/blood-2024-204788","title":"Improving Quality of Life Based on Electronic Patient Reported Outcomes in Patients with CLL and MDS: The Mypal Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Quality of life (healthcare); Quality (philosophy); Internal medicine","score_opus":0.016228905743434996,"score_gpt":0.2991573955909816,"score_spread":0.2829284898475466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405040982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99827814,0.00017092681,0.0000049047035,0.00012539494,0.00002923953,0.0012339992,0.0000054326665,0.000031195665,0.00012078941],"genre_scores_gemma":[0.99975,0.0000023353737,0.00001728426,0.000104681545,0.000015210187,0.000050816896,0.000006919001,0.000020705496,0.00003204593],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99810195,0.00013894726,0.0004383473,0.00032003832,0.00071079086,0.00028993437],"domain_scores_gemma":[0.9989119,0.00036541122,0.00009406252,0.00047327075,0.00007803059,0.00007728967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006569203,0.00013002304,0.00031396272,0.00011813331,0.000029919218,0.00002035021,0.00006995341,0.00004305672,0.000011414149],"category_scores_gemma":[0.000637833,0.00007028591,0.000042664306,0.00026912199,0.00006401404,0.000032558102,0.000053799882,0.00027675627,0.0000016981194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011037393,0.0043008137,0.99046797,0.00029960374,0.0003151406,0.00008399939,0.000914918,0.000013547191,0.00007538725,0.000029502338,0.000012743362,0.0023826566],"study_design_scores_gemma":[0.052281037,0.0050368267,0.93835676,0.0001603462,0.00019387828,0.0000045020633,0.0005137045,0.002844718,0.00045685365,0.000010857813,0.000018647926,0.00012185417],"about_ca_topic_score_codex":0.0014167143,"about_ca_topic_score_gemma":0.00026415833,"teacher_disagreement_score":0.052111175,"about_ca_system_score_codex":0.0010695977,"about_ca_system_score_gemma":0.0035553512,"threshold_uncertainty_score":0.63070405},"labels":[],"label_agreement":null},{"id":"W4405040983","doi":"10.1182/blood-2024-201712","title":"Real-World Characteristics and Treatment Patterns of Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma Treated with Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (DVRd) As Front-Line Treatment: Results from a Multicenter Chart Review Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Daratumumab; Lenalidomide; Bortezomib; Medicine; Dexamethasone; Multiple myeloma; Internal medicine; Oncology","score_opus":0.02329557136254877,"score_gpt":0.2876899346676038,"score_spread":0.264394363305055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405040983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98490083,0.003940836,0.000008557247,0.00020453865,0.00003436663,0.0052217087,0.005441646,0.00012162986,0.00012585863],"genre_scores_gemma":[0.968284,0.025957799,0.000602914,0.00006229806,0.00009323109,0.0005214586,0.003735034,0.000104661136,0.00063856464],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99660844,0.0002504192,0.00083455665,0.0011344648,0.0005941427,0.00057797914],"domain_scores_gemma":[0.99751973,0.0007811164,0.00023785312,0.0007204369,0.000192856,0.0005479954],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001761429,0.0007450905,0.001482118,0.00029884846,0.0001331251,0.0000876522,0.00009450111,0.0000879134,0.000068433175],"category_scores_gemma":[0.00009909822,0.00043868454,0.00012580233,0.00028228766,0.00011878157,0.00018274668,0.000036973677,0.00018128581,0.000018469555],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021109095,0.011031554,0.93738216,0.00065753056,0.00459772,0.0034684502,0.0017401212,3.115869e-7,0.0002312334,7.975657e-7,0.00001988964,0.01976115],"study_design_scores_gemma":[0.12156966,0.015674174,0.8457799,0.006299213,0.0055322545,0.00003779966,0.0001434162,0.00018799418,0.0039874557,6.5675385e-7,0.00040772549,0.00037972987],"about_ca_topic_score_codex":0.020949436,"about_ca_topic_score_gemma":0.0091604395,"teacher_disagreement_score":0.100460574,"about_ca_system_score_codex":0.00016823942,"about_ca_system_score_gemma":0.00016096456,"threshold_uncertainty_score":0.99980646},"labels":[],"label_agreement":null},{"id":"W4405041011","doi":"10.1182/blood-2024-210922","title":"Rate of Transformation and Secondary Malignancies in Follicular Lymphoma Patients Treated with First-Line Bendamustine Rituximab and Rituximab Maintenance","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Rituximab; Bendamustine; Follicular lymphoma; Medicine; Oncology; Lymphoma; Internal medicine; Immunology","score_opus":0.005882372212843601,"score_gpt":0.20399034437020896,"score_spread":0.19810797215736536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405041011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99417096,0.0043298756,0.000017117352,0.00047296664,0.000019092291,0.0005025616,0.00011915915,0.000038055565,0.0003302162],"genre_scores_gemma":[0.99809754,0.0012934235,0.00027092418,0.000071188915,0.000013599583,0.00006886391,0.00011963828,0.00001823189,0.000046574103],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914867,0.000019365245,0.00028054352,0.00025142592,0.000116385796,0.00018361222],"domain_scores_gemma":[0.99963766,0.00006172681,0.000045592467,0.00011788398,0.00006442953,0.00007267943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008592535,0.00018066732,0.00037357726,0.00013571508,0.00003709011,0.000024558602,0.000023495586,0.00006147745,0.000014308078],"category_scores_gemma":[0.000017535533,0.00012270715,0.000040255734,0.00020936567,0.000072826595,0.0001487378,0.000013782968,0.000040746025,0.0000030017604],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015678843,0.01957357,0.88305527,0.0052083605,0.0010742215,0.001724293,0.003358006,0.00000512303,0.00087080867,0.0016775397,0.00022437933,0.08166053],"study_design_scores_gemma":[0.09048728,0.0018986182,0.88084656,0.0024218706,0.00077206036,0.00025422339,0.00010716814,0.0004087608,0.021197956,0.00010287668,0.0012836359,0.00021897102],"about_ca_topic_score_codex":0.0002100115,"about_ca_topic_score_gemma":0.000184439,"teacher_disagreement_score":0.08891939,"about_ca_system_score_codex":0.000043909822,"about_ca_system_score_gemma":0.00007134966,"threshold_uncertainty_score":0.5003852},"labels":[],"label_agreement":null},{"id":"W4405041154","doi":"10.1182/blood-2024-206056","title":"Outcomes and Predictors of Survival for Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma: A Large Population-Based Analysis","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Princess Margaret Cancer Centre; Health Sciences Centre; University Health Network","funders":"","keywords":"Diffuse large B-cell lymphoma; Medicine; Lymphoma; Refractory (planetary science); Population; Internal medicine; Oncology; Survival analysis; Biology","score_opus":0.007412395196389881,"score_gpt":0.24189963578463985,"score_spread":0.23448724058824996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405041154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99795836,0.00034335174,0.000078263816,0.000057681616,0.00009605532,0.00056261505,0.0007854538,0.00006114956,0.00005705466],"genre_scores_gemma":[0.9983815,0.000018406743,0.00035056693,0.000052800217,0.00002921467,0.00009291004,0.0007899496,0.00002883411,0.00025583152],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988948,0.000027757676,0.00027317205,0.00030419513,0.00028727457,0.00021281646],"domain_scores_gemma":[0.9991027,0.0003576374,0.000089156776,0.0002560866,0.00008149906,0.00011288151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010334366,0.00017799955,0.0004873182,0.00022237308,0.000056525445,0.00001955912,0.000036314024,0.00007740088,0.000029617875],"category_scores_gemma":[0.000067153014,0.00010409361,0.00018245926,0.00033801253,0.000015756938,0.000053684802,0.000016606458,0.000027191596,0.0000016167204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033059833,0.022186711,0.9748602,0.00028313356,0.0019377281,0.000026996453,0.00013015927,8.139599e-7,0.0000041959734,0.000040581628,0.000054995402,0.00014391301],"study_design_scores_gemma":[0.052740987,0.0010095245,0.93816346,0.00007803832,0.0068581416,4.6122713e-7,0.000031833355,0.00023003887,0.00021592001,0.000003319112,0.0005588481,0.000109451765],"about_ca_topic_score_codex":0.00009470443,"about_ca_topic_score_gemma":0.00017280702,"teacher_disagreement_score":0.05241039,"about_ca_system_score_codex":0.000058914644,"about_ca_system_score_gemma":0.00011052957,"threshold_uncertainty_score":0.42448142},"labels":[],"label_agreement":null},{"id":"W4405041194","doi":"10.1182/blood-2024-205936","title":"Targeting the SWI/SNF Chromatin Remodeling Complex Subunit SMARCA4 in ALL","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"SMARCA4; SWI/SNF; Chromatin remodeling; Protein subunit; Chromatin; Biology; Cell biology; Medicine; Chemistry; Cancer research; Genetics; DNA","score_opus":0.029131564767401183,"score_gpt":0.2831570278677704,"score_spread":0.2540254631003692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405041194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98939675,0.0070115076,0.0010368847,0.00045892014,0.00012918435,0.00013212883,0.000010882124,0.000046384546,0.0017773556],"genre_scores_gemma":[0.9971716,0.00033237325,0.0013556317,0.00033714704,0.00039066956,0.00001801851,0.00011706183,0.00003124602,0.00024628828],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9990229,0.00005849132,0.00024251336,0.0003007058,0.00012326761,0.00025212625],"domain_scores_gemma":[0.9996143,0.00002373206,0.000031311225,0.00026397026,0.000029653915,0.00003704684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003496606,0.00013456936,0.00010944064,0.000033009324,0.00006682479,0.00006467305,0.00020707022,0.00009173866,0.000041798045],"category_scores_gemma":[0.000052229552,0.000102612685,0.00007534811,0.0001152237,0.000035759113,0.000003095597,0.00009725206,0.0001551828,0.000022774175],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009462997,0.00006135793,0.00022555265,0.00007993645,0.000059366295,0.000010988444,0.00026254338,0.003304606,0.9895022,0.00006444307,0.0024184368,0.004001095],"study_design_scores_gemma":[0.0029830046,0.00030927773,0.0011809728,0.0006044541,0.00022751858,0.00021770656,0.0010098859,0.5092238,0.31347486,0.0015172157,0.168045,0.0012062605],"about_ca_topic_score_codex":0.00010263245,"about_ca_topic_score_gemma":0.000057937163,"teacher_disagreement_score":0.67602736,"about_ca_system_score_codex":0.000013217463,"about_ca_system_score_gemma":0.0000728247,"threshold_uncertainty_score":0.41844237},"labels":[],"label_agreement":null},{"id":"W4405041234","doi":"10.1182/blood-2024-212150","title":"Anticoagulation Therapy for Venous Thromboembolism in the Pediatric Population: A Systematic Review and Meta-Analysis","year":2024,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster Children's Hospital; SickKids Foundation; Hospital for Sick Children; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Venous thromboembolism; Meta-analysis; Intensive care medicine; Population; Internal medicine; Thrombosis","score_opus":0.100753001509001,"score_gpt":0.38130486366706856,"score_spread":0.28055186215806754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405041234","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000027680528,0.9854271,0.000009884167,0.00041006898,0.000049524533,0.013926887,0.000047377092,0.00004161106,0.00005986416],"genre_scores_gemma":[0.00063230755,0.9932457,0.00007910132,0.0008726684,0.00016902189,0.0045893923,0.0002739271,0.000060899238,0.000076937555],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9972172,0.00034530307,0.0012303403,0.0005631059,0.00038609988,0.00025795645],"domain_scores_gemma":[0.9983107,0.00028503448,0.0004951382,0.00079492555,0.00006057668,0.000053637385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013890516,0.0004938691,0.010531299,0.0005851828,0.00007839327,0.00010354883,0.00021620392,0.00017524938,0.00003772651],"category_scores_gemma":[0.00009329189,0.0002430913,0.0026855029,0.0015610479,0.000015597521,0.000050161954,0.000046295103,0.0002311364,0.000018227354],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[4.566393e-7,0.0007190812,0.00000803621,0.87519807,0.12246208,0.000017024253,0.000119442666,2.3386409e-7,2.512938e-9,0.00048613388,0.00030088658,0.00068855874],"study_design_scores_gemma":[0.00024139891,0.00013669257,0.00022032707,0.015360435,0.97809786,0.000056042398,0.000014227701,0.0000024971296,8.0525835e-9,0.00008393169,0.005566125,0.00022043902],"about_ca_topic_score_codex":0.000051291277,"about_ca_topic_score_gemma":0.0000145519825,"teacher_disagreement_score":0.85983765,"about_ca_system_score_codex":0.000031167478,"about_ca_system_score_gemma":0.00006133576,"threshold_uncertainty_score":0.99129754},"labels":[],"label_agreement":null},{"id":"W4405041300","doi":"10.1182/blood-2024-201015","title":"Inhibiting Free Fatty Acid Transport to Improve CAR-T Cell Therapy of Relapsed B-Cell Acute Lymphoblastic Leukemia","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Lymphoblastic Leukemia; Acute lymphocytic leukemia; Medicine; Cancer research; Leukemia; Oncology; Internal medicine","score_opus":0.009836731386799517,"score_gpt":0.24826636362591242,"score_spread":0.2384296322391129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405041300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845352,0.0016173593,0.0025529745,0.00033742856,0.00032324516,0.0011013756,0.00024181485,0.00027928167,0.009011306],"genre_scores_gemma":[0.99236965,0.00029600563,0.0041358904,0.00036534286,0.00040766463,0.00010624631,0.00006086085,0.00015612389,0.0021022423],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99660534,0.000054454908,0.00073104637,0.00081775483,0.00098398,0.0008074152],"domain_scores_gemma":[0.9979842,0.00029012535,0.00010027454,0.0009160422,0.00021914708,0.0004902394],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004032862,0.00042766315,0.0007035895,0.00037926715,0.00008035812,0.000039622828,0.00045662245,0.0003075292,0.00017024837],"category_scores_gemma":[0.000115574694,0.00035675787,0.0003350031,0.00085794285,0.00013826028,0.00013169931,0.00014360604,0.000506641,0.00020701608],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005337009,0.00051028706,0.00073533255,0.0007373467,0.0003700708,0.0013882935,0.0013300381,0.000014946356,0.99066204,0.000039806004,0.00163589,0.002042238],"study_design_scores_gemma":[0.016993728,0.0016192363,0.0008257517,0.00045848364,0.00054795085,0.0001849209,0.00018510915,0.0007411612,0.9769675,0.00006344862,0.001070308,0.00034236896],"about_ca_topic_score_codex":0.00022853,"about_ca_topic_score_gemma":0.0000110407145,"teacher_disagreement_score":0.016460026,"about_ca_system_score_codex":0.000744203,"about_ca_system_score_gemma":0.0026858486,"threshold_uncertainty_score":0.9998884},"labels":[],"label_agreement":null},{"id":"W4405041348","doi":"10.1182/blood-2024-203307","title":"Systematic Transcranial Doppler Examination in Adults with Sickle Cell Disease : A Cross-Sectional Single Center Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Cross-sectional study; Transcranial Doppler; Single Center; Disease; Sickle cell anemia; Internal medicine; Pathology","score_opus":0.007131767212448616,"score_gpt":0.23044283620665568,"score_spread":0.22331106899420705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405041348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960311,0.00084963435,0.000050324372,0.00006200553,0.00014960532,0.0013889008,0.000016827029,0.00009082225,0.0013607683],"genre_scores_gemma":[0.9991722,0.000010934787,0.000022883803,0.000029304809,0.000069692804,0.00009871892,0.00003394985,0.000026380249,0.00053593755],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888045,0.00006267068,0.0002890106,0.00028249004,0.00030976965,0.00017562593],"domain_scores_gemma":[0.99964255,0.000035586123,0.000027113974,0.00014129092,0.000046179604,0.00010727117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017207843,0.00013193866,0.0001917629,0.0001323216,0.000042385145,0.000059447528,0.000041880605,0.00006199946,0.0000798261],"category_scores_gemma":[0.00001851926,0.000090744834,0.000064484615,0.00025540972,0.00003226592,0.00008483121,0.000007969167,0.00017048423,0.000041903382],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010285006,0.021525454,0.92239404,0.04076118,0.00032726192,0.0023421964,0.010163563,0.00008510195,0.001192673,0.000035682948,0.00004006466,0.00010425677],"study_design_scores_gemma":[0.028319227,0.0022757074,0.95160556,0.011606167,0.0008296574,0.00028240497,0.0030536752,0.0014683796,0.00018376701,0.000015895565,0.000029301062,0.00033023875],"about_ca_topic_score_codex":0.000029692023,"about_ca_topic_score_gemma":0.000047686153,"teacher_disagreement_score":0.029211516,"about_ca_system_score_codex":0.00004229145,"about_ca_system_score_gemma":0.00007100458,"threshold_uncertainty_score":0.37004668},"labels":[],"label_agreement":null},{"id":"W4405041357","doi":"10.1182/blood-2024-204141","title":"Feasibility of Validating a Screening Tool for Neurocognitive Function in Adults with SCD","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Congenital Heart Disease Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Neurocognitive; Internal medicine; Intensive care medicine; Cognition; Psychiatry","score_opus":0.03498112877584921,"score_gpt":0.30015357718686625,"score_spread":0.26517244841101706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405041357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971399,0.00051723735,0.0005573032,0.00006133751,0.000031504867,0.000996251,0.000043936347,0.000054855933,0.00059771695],"genre_scores_gemma":[0.9986842,0.0000029321232,0.0010233315,0.00003527705,0.00006898849,0.000104388695,0.000012974526,0.000014548104,0.00005330251],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993607,0.000017091043,0.00015634323,0.00022055574,0.00012171135,0.00012359656],"domain_scores_gemma":[0.99957544,0.00016369938,0.000016991113,0.0000910969,0.0001213687,0.00003141719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011651901,0.00007860916,0.00015902137,0.00007484461,0.000026298012,0.0000075267753,0.000014314,0.000020751573,0.000011592052],"category_scores_gemma":[0.00024198627,0.00006338437,0.00005724337,0.00020461505,0.000033542965,0.00006665005,0.00002190979,0.00007588969,0.000002276333],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055828355,0.00090308447,0.89940035,0.004576497,0.00037439456,0.00012975057,0.001713145,0.0000014892305,0.003383837,0.000055020864,0.000042624626,0.08383699],"study_design_scores_gemma":[0.011542855,0.0023589898,0.97091156,0.0044274675,0.0011580362,0.000045925004,0.0018463923,0.0015786996,0.00571423,0.00015550952,0.00006174487,0.00019858674],"about_ca_topic_score_codex":0.00001732066,"about_ca_topic_score_gemma":0.000045905555,"teacher_disagreement_score":0.0836384,"about_ca_system_score_codex":0.000010208543,"about_ca_system_score_gemma":0.000058575482,"threshold_uncertainty_score":0.25847393},"labels":[],"label_agreement":null},{"id":"W4405041412","doi":"10.1182/blood-2024-202069","title":"Intensive Chemotherapy Vs. Azacitidine + Venetoclax for AML with Secondary Mutations","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Venetoclax; Azacitidine; Chemotherapy regimen; Medicine; Internal medicine; Chemotherapy; Oncology; Leukemia; Genetics; Biology; Chronic lymphocytic leukemia; DNA methylation; Gene","score_opus":0.015333866735165793,"score_gpt":0.2955157901546872,"score_spread":0.2801819234195214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405041412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97517025,0.0014777068,0.002525467,0.01254584,0.00013616045,0.0016874052,0.0001631837,0.00032438975,0.005969574],"genre_scores_gemma":[0.9821728,0.000103396604,0.007059361,0.0029866,0.0005949202,0.00032851635,0.00029476595,0.00010313659,0.0063565155],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.999087,0.000012386256,0.00014352702,0.00028986437,0.00018701455,0.0002802049],"domain_scores_gemma":[0.99912876,0.00016218518,0.000019575522,0.00023023649,0.0003333642,0.00012588435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001115471,0.00013426063,0.0002186189,0.00015191516,0.000059677302,0.0000412326,0.00007689129,0.00007372788,0.00029005442],"category_scores_gemma":[0.000094109055,0.00010081162,0.00008317157,0.00027798302,0.0001066508,0.000072974995,0.000019331008,0.00029461464,0.00008405105],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0089170085,0.0015468153,0.006338081,0.007838394,0.01195485,0.007249538,0.016808435,0.00007615244,0.33775207,0.013047919,0.4258348,0.16263592],"study_design_scores_gemma":[0.03939131,0.008120162,0.010280557,0.0015484516,0.0016449038,0.004187451,0.002597817,0.0075303605,0.42923492,0.0023663873,0.49219862,0.0008990553],"about_ca_topic_score_codex":0.000022925024,"about_ca_topic_score_gemma":0.000010028506,"teacher_disagreement_score":0.16173686,"about_ca_system_score_codex":0.00016730635,"about_ca_system_score_gemma":0.0011067826,"threshold_uncertainty_score":0.41109788},"labels":[],"label_agreement":null},{"id":"W4405041413","doi":"10.1182/blood-2024-201920","title":"Inhibition of Threonine Tyrosine Kinase Suppressed <i>TP53-</i>mutated Acute Myeloid Leukaemia Via Synergism with Venetoclax and Activation of the Cgas-Sting Pathway","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Venetoclax; Tyrosine kinase; Cancer research; Myeloid leukemia; Tyrosine; Medicine; Myeloid; Biology; Bruton's tyrosine kinase; Immunology; Signal transduction; Leukemia; Chemistry; Genetics; Biochemistry; Chronic lymphocytic leukemia","score_opus":0.009624015995524883,"score_gpt":0.24160543184544725,"score_spread":0.23198141584992238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405041413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99707144,0.00048706334,0.00042299842,0.0006309658,0.00004484537,0.0006479516,0.000060851067,0.000080160105,0.0005537086],"genre_scores_gemma":[0.9986414,0.0000768522,0.0007027822,0.00007424894,0.00010773578,0.000036949637,0.000107863445,0.000052421306,0.0001997565],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99844843,0.000074144154,0.00036630276,0.00033662148,0.00050123234,0.00027329102],"domain_scores_gemma":[0.99898374,0.00016396934,0.00014616345,0.00038284194,0.00023398042,0.00008928395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000266411,0.00020341469,0.00035082005,0.00016899247,0.000075470096,0.00002463915,0.00009942818,0.00013349015,0.000025162504],"category_scores_gemma":[0.000105765364,0.00013107587,0.00007201609,0.0007485682,0.00024079795,0.00016937852,0.000118147065,0.0004146626,0.0000025048812],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035936036,0.00012246521,0.0016502069,0.00065188046,0.00029296114,0.0001365278,0.00045080183,0.00006150229,0.99407774,0.00017642291,0.00012594089,0.0018942079],"study_design_scores_gemma":[0.0036016034,0.0005717441,0.0069221933,0.0015026417,0.00041718758,0.00027389525,0.00007804592,0.0026517273,0.98362374,0.00010417252,0.00012512511,0.00012792902],"about_ca_topic_score_codex":0.00015864591,"about_ca_topic_score_gemma":0.000009190479,"teacher_disagreement_score":0.010453988,"about_ca_system_score_codex":0.00014229554,"about_ca_system_score_gemma":0.00058666227,"threshold_uncertainty_score":0.53451186},"labels":[],"label_agreement":null},{"id":"W4405041516","doi":"10.1182/blood-2024-198509","title":"Lisocabtagene Maraleucel (liso-cel) in Patients (pts) with Relapsed or Refractory (R/R) Follicular Lymphoma (FL): Transcend FL 2-Year Follow-up","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Princess Margaret Cancer Centre","funders":"","keywords":"Follicular lymphoma; Refractory (planetary science); Medicine; Internal medicine; Oncology; Lymphoma; Gastroenterology; Cancer research; Biology","score_opus":0.010397018450015252,"score_gpt":0.22791181545587202,"score_spread":0.21751479700585677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405041516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99302906,0.0028278197,0.000005542245,0.00038638443,0.00039196663,0.00097060646,0.00006722635,0.00018695027,0.0021344358],"genre_scores_gemma":[0.9953067,0.00052926934,0.0004913541,0.00028611944,0.00015624388,0.00022589248,0.00020099619,0.000105295716,0.002698182],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976399,0.00007015275,0.0004523999,0.00071348797,0.0005988533,0.00052521337],"domain_scores_gemma":[0.9989265,0.00010164792,0.00006749089,0.0005627127,0.00007684179,0.00026480752],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014186415,0.0004145755,0.0005854383,0.00025472965,0.00007773344,0.00007330221,0.00013763641,0.00022463067,0.00029003652],"category_scores_gemma":[0.00004162198,0.00027754254,0.00024989306,0.0005517006,0.00006112254,0.00017675612,0.00003155816,0.00014724123,0.00019866184],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058913045,0.02551925,0.8925323,0.0010151727,0.0028802697,0.010243731,0.0023885884,0.0000044286007,0.0016515056,0.000315991,0.007007139,0.05055031],"study_design_scores_gemma":[0.14091408,0.0075442097,0.7844171,0.0022047344,0.0027700802,0.00015513695,0.00025984147,0.00005040267,0.011869291,0.000041393785,0.048929147,0.00084461155],"about_ca_topic_score_codex":0.00019948548,"about_ca_topic_score_gemma":0.00019415807,"teacher_disagreement_score":0.13502277,"about_ca_system_score_codex":0.00033012743,"about_ca_system_score_gemma":0.00036633894,"threshold_uncertainty_score":0.9999677},"labels":[],"label_agreement":null},{"id":"W4405041543","doi":"10.1182/blood-2024-203228","title":"Associations of Lineage-Specific Clonal Hematopoiesis with COVID-19 Hospitalization and Mortality","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Queen's University","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); Haematopoiesis; Lineage (genetic); Biology; Pneumonia; 2019-20 coronavirus outbreak; Immunology; Pandemic; Medicine; Virology; Genetics; Outbreak; Stem cell; Internal medicine; Disease; Gene; Infectious disease (medical specialty)","score_opus":0.019750098411071636,"score_gpt":0.28177573035931175,"score_spread":0.26202563194824013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405041543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99138844,0.0048031197,0.0009948382,0.0009249386,0.000059460053,0.00019893471,0.0000634094,0.00008723592,0.001479638],"genre_scores_gemma":[0.9985955,0.00060633646,0.00036961242,0.00014684748,0.000045286182,0.0000064172323,0.00009177075,0.0000130754925,0.00012515161],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99938077,0.00001624192,0.00017633344,0.00015475335,0.00017859708,0.000093281145],"domain_scores_gemma":[0.99964106,0.00005335863,0.00004230678,0.00010991881,0.000050892435,0.00010246857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012612119,0.00007499257,0.00016421486,0.00006171522,0.000052332907,0.000017801289,0.000021310123,0.0000870846,0.000065150954],"category_scores_gemma":[0.00007721432,0.00005544152,0.000041600564,0.00026061852,0.00007412167,0.00004180469,0.000012058474,0.000088434455,0.0000040023483],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053928594,0.0015596214,0.9560559,0.0018495114,0.0016146812,0.00034824846,0.004709176,0.00008406321,0.0029810022,0.024182282,0.005918119,0.00064348226],"study_design_scores_gemma":[0.012577275,0.0015893432,0.92502236,0.0011104083,0.0043068314,0.0005838269,0.0035005761,0.0016717908,0.014666426,0.002167112,0.03197834,0.00082573184],"about_ca_topic_score_codex":0.00005405478,"about_ca_topic_score_gemma":0.000014241313,"teacher_disagreement_score":0.031033546,"about_ca_system_score_codex":0.000021761953,"about_ca_system_score_gemma":0.00014559028,"threshold_uncertainty_score":0.22608396},"labels":[],"label_agreement":null},{"id":"W4405041550","doi":"10.1182/blood-2024-194926","title":"Multiome Single Cell Analyses Identify a Distinct CD8+ T Cell Phenotype Linked to Treatment Response in PTLD","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Spinal Cord Injury BC; University Health Network","funders":"","keywords":"Phenotype; Biology; CD8; Cell; Immunology; Cytotoxic T cell; Genetics; Molecular biology; Immune system; Gene","score_opus":0.039948658420272766,"score_gpt":0.3355604002650189,"score_spread":0.2956117418447461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405041550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99084014,0.004032746,0.00003254187,0.0007419756,0.00019409604,0.00039827736,0.000039934668,0.00012903931,0.003591229],"genre_scores_gemma":[0.99471223,0.00006372017,0.0002245278,0.00020306517,0.000097691045,0.000054028373,0.00003893187,0.00003875949,0.0045670355],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99873126,0.000082520535,0.0002713411,0.00038312713,0.00021280725,0.00031895057],"domain_scores_gemma":[0.9993798,0.00012579958,0.000040046198,0.00025553702,0.000036742535,0.00016203958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016915845,0.00019383675,0.00031192286,0.00031661039,0.000044667137,0.0000638022,0.00006873933,0.000104814295,0.00014256597],"category_scores_gemma":[0.000099347875,0.0001609232,0.00015477574,0.00071979227,0.000021416947,0.00005037264,0.000028036724,0.0001243342,0.00030459536],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033110739,0.0067569693,0.01889385,0.00029390515,0.00033921146,0.0016691645,0.0050215526,0.00013589763,0.9569424,0.0000042534766,0.001758348,0.0048734066],"study_design_scores_gemma":[0.06976336,0.020856373,0.43773982,0.0016512198,0.006586089,0.00004598515,0.0050412402,0.001969582,0.39956173,0.00040789897,0.05419001,0.0021866895],"about_ca_topic_score_codex":0.00068272185,"about_ca_topic_score_gemma":0.00037862762,"teacher_disagreement_score":0.5573806,"about_ca_system_score_codex":0.00031792469,"about_ca_system_score_gemma":0.00018954591,"threshold_uncertainty_score":0.65622574},"labels":[],"label_agreement":null},{"id":"W4405041581","doi":"10.1182/blood-2024-199134","title":"Macrophages in Waldenstrom Macroglobulinemia: Implications for the Tumor Microenvironment","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Macroglobulinemia; Waldenstrom macroglobulinemia; Medicine; Immunology; Cancer research; Multiple myeloma; Lymphoma","score_opus":0.018022482244600093,"score_gpt":0.30742209070826876,"score_spread":0.2893996084636687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405041581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96448565,0.016865682,0.0003915125,0.015741525,0.00013476152,0.0016325449,0.0001126877,0.00009173657,0.0005438971],"genre_scores_gemma":[0.9953232,0.00045740107,0.00119457,0.0003429131,0.00028071474,0.00047803827,0.000024536326,0.000034927994,0.001863731],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.998993,0.0000143460375,0.00020951021,0.00029659638,0.00014772595,0.0003388638],"domain_scores_gemma":[0.99911773,0.00035017202,0.000016373178,0.0004200424,0.00001805898,0.000077647455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019927522,0.00011176357,0.00014745133,0.000065545166,0.00006513833,0.00004404518,0.00015911082,0.0000472408,0.00008898778],"category_scores_gemma":[0.00007061244,0.00007363504,0.000101219404,0.00018971122,0.00010292302,0.000025440582,0.00008082566,0.00019543857,0.0001168064],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087639235,0.0067667724,0.018863665,0.005639087,0.0025381292,0.004750188,0.0025092564,0.00024655965,0.679111,0.0112348525,0.112144284,0.15531984],"study_design_scores_gemma":[0.12173896,0.0012562854,0.18340598,0.0016584047,0.002750446,0.013542548,0.0009259579,0.025440007,0.23644932,0.003559122,0.40816253,0.0011104324],"about_ca_topic_score_codex":0.0001055935,"about_ca_topic_score_gemma":0.000029824932,"teacher_disagreement_score":0.44266167,"about_ca_system_score_codex":0.0017506703,"about_ca_system_score_gemma":0.0011302745,"threshold_uncertainty_score":0.4577942},"labels":[],"label_agreement":null},{"id":"W4405041593","doi":"10.1182/blood-2024-193994","title":"Identification of Novel Protein Biomarkers in Bone Marrow Interstitial Fluid Links Coagulation Cascade Proteins to Survival Outcomes in Multiple Myeloma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Queen Elizabeth II Health Sciences Centre; Nova Scotia Health Authority; Dalhousie University","funders":"","keywords":"Multiple myeloma; Bone marrow; Medicine; Coagulation; Immunology; Myeloma protein; Cancer research; Pathology; Internal medicine","score_opus":0.0350872227502858,"score_gpt":0.3147350536602894,"score_spread":0.2796478309100036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405041593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994802,0.00018358452,0.0007614798,0.00094334234,0.000117020536,0.0029553052,0.000093297596,0.00005392138,0.00009006135],"genre_scores_gemma":[0.9975907,0.0000046917958,0.0015004214,0.00001201726,0.000052071955,0.00045432005,0.00009454492,0.000029692921,0.00026149684],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982088,0.00007046153,0.0005842828,0.0003883555,0.00044222604,0.00030586138],"domain_scores_gemma":[0.9993624,0.000095231066,0.000057839254,0.0002745857,0.00007154223,0.00013837893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004661272,0.00017048941,0.0003554269,0.0007046456,0.00002479468,0.00003433875,0.00008955419,0.00016642301,0.000024420371],"category_scores_gemma":[0.0006560746,0.00014973812,0.00009153728,0.0005933004,0.000051459003,0.00012763678,0.00006066386,0.00024304877,0.000033442913],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061408675,0.0016972233,0.1742585,0.00038754006,0.00021897689,0.00025035444,0.00044000635,0.000013727997,0.81738114,0.00006013201,0.000008813135,0.004669525],"study_design_scores_gemma":[0.008856736,0.00038029996,0.68443274,0.00072605535,0.000051997213,0.000017168011,0.00013156497,0.007915523,0.29728124,0.000018568855,0.000038603983,0.00014948475],"about_ca_topic_score_codex":0.001254645,"about_ca_topic_score_gemma":0.0018908719,"teacher_disagreement_score":0.5200999,"about_ca_system_score_codex":0.00015142102,"about_ca_system_score_gemma":0.00013856849,"threshold_uncertainty_score":0.6106143},"labels":[],"label_agreement":null},{"id":"W4405041602","doi":"10.1182/blood-2024-204908","title":"Incidence, Time to Diagnosis, and Therapeutic Landscape of Aplastic Anemia: Results from a Large United States Claims Database","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada); Merck Canada Inc. (Canada)","funders":"","keywords":"Aplastic anemia; Incidence (geometry); Medicine; Database; Anemia; Internal medicine; Computer science; Bone marrow","score_opus":0.012451561826324956,"score_gpt":0.26417245314867327,"score_spread":0.2517208913223483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405041602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99022084,0.005344645,0.000013979823,0.002108788,0.00004329994,0.00026992057,0.0016243433,0.00008846652,0.00028570511],"genre_scores_gemma":[0.9951215,0.0012825958,0.00061624136,0.00045392057,0.00009672863,0.000030856,0.0017417662,0.000023111728,0.0006332983],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990563,0.000032908072,0.00023113827,0.00030753823,0.00018276006,0.00018937349],"domain_scores_gemma":[0.998966,0.0005601799,0.00003182889,0.0002533876,0.00004076159,0.00014786157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001252662,0.00014419592,0.00023561598,0.00015229502,0.000034853376,0.000022511003,0.00005145926,0.000064751715,0.00042081677],"category_scores_gemma":[0.00008126257,0.00010478966,0.000035782108,0.0003297688,0.000038892045,0.00003031371,0.000062114945,0.00013097945,0.00019234404],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005766245,0.021422576,0.536356,0.005222309,0.0057387315,0.01283915,0.02659717,0.000075209784,0.093721904,0.0011120503,0.26446092,0.026687777],"study_design_scores_gemma":[0.09508754,0.015029145,0.28101644,0.02522247,0.01567275,0.0010565411,0.005550216,0.012458776,0.22747879,0.0016017023,0.31703517,0.0027904646],"about_ca_topic_score_codex":0.00015308158,"about_ca_topic_score_gemma":0.00002090947,"teacher_disagreement_score":0.2553395,"about_ca_system_score_codex":0.000011861412,"about_ca_system_score_gemma":0.0000531843,"threshold_uncertainty_score":0.46076486},"labels":[],"label_agreement":null},{"id":"W4405041605","doi":"10.1182/blood-2024-209687","title":"Survival Outcomes for Patients with Acute Myeloid Leukemia with Myelodysplasia Related Changes (AML-MRC) in a Real-World, Retrospective Cohort Receiving Intensive Chemotherapy","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Myeloid leukemia; Retrospective cohort study; Internal medicine; Chemotherapy regimen; Chemotherapy; Cohort; Oncology; Overall survival; Leukemia; Hematologic Neoplasms; Cancer","score_opus":0.011178092107257075,"score_gpt":0.2789832337837818,"score_spread":0.26780514167652475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405041605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891847,0.00009595476,0.000039700895,0.0028748943,0.00021789434,0.0034196752,0.000114736125,0.00046811157,0.0035843789],"genre_scores_gemma":[0.9877763,0.0005626043,0.0025402703,0.00044114678,0.0001757112,0.00061220326,0.00027937672,0.00027578577,0.0073366477],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965297,0.000090706075,0.00046803924,0.0010869111,0.00091450376,0.00091016944],"domain_scores_gemma":[0.9976043,0.00042286274,0.00015078299,0.0006329492,0.00093580823,0.000253301],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005725075,0.0005550728,0.0011595758,0.0007868912,0.000119399694,0.00009431623,0.00025039786,0.00025030732,0.00007813083],"category_scores_gemma":[0.00029615161,0.00038296072,0.00013366909,0.0016639716,0.00023923755,0.00022198148,0.00009188812,0.0009867704,0.000029130371],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002465825,0.00028778316,0.9885936,0.00021053181,0.003275735,0.00072571915,0.0016933207,0.000002238058,0.0006365204,0.00023112599,0.0007927891,0.0010848126],"study_design_scores_gemma":[0.016666058,0.0024558916,0.9758239,0.0010121342,0.0008223553,0.000094571864,0.00043581243,0.00031791365,0.0012068012,0.000091684335,0.0005846389,0.00048825232],"about_ca_topic_score_codex":0.0007440873,"about_ca_topic_score_gemma":0.0022120003,"teacher_disagreement_score":0.014200233,"about_ca_system_score_codex":0.0020375012,"about_ca_system_score_gemma":0.0009919226,"threshold_uncertainty_score":0.99986225},"labels":[],"label_agreement":null},{"id":"W4405041624","doi":"10.1182/blood-2024-202013","title":"Inflammatory Reprogramming of the Tumor Microenvironment By Clonal Hematopoiesis Is Associated with Clinical Outcomes in Solid Cancer","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; Queen's University","funders":"","keywords":"Solid tumor; Hematologic Neoplasms; Tumor microenvironment; Reprogramming; Cancer; Cancer research; Haematopoiesis; Biology; Medicine; Immunology; Tumor cells; Internal medicine; Genetics; Stem cell; Cell","score_opus":0.016407697835417175,"score_gpt":0.2961465468498597,"score_spread":0.2797388490144425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405041624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978423,0.0008057077,0.0000024220633,0.0008146347,0.00018685832,0.00021022077,0.000025309957,0.00003046339,0.000082043814],"genre_scores_gemma":[0.9976101,0.00010629341,0.000065833396,0.0011539633,0.000059045597,0.000041428502,0.000008062429,0.000017651102,0.0009376489],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990197,0.000067779016,0.0003604523,0.0002345155,0.00016332028,0.00015424559],"domain_scores_gemma":[0.9995009,0.00013041528,0.00009447942,0.00021204914,0.000017354389,0.00004481124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020277273,0.00010339615,0.00033265917,0.0000324354,0.000024297917,0.0000051544484,0.00005609486,0.00007592928,0.00015499465],"category_scores_gemma":[0.000077640034,0.000060944785,0.00013756265,0.000119585624,0.00013641267,0.000019100462,0.000039544248,0.00024275758,0.000010167355],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067989495,0.00062605756,0.9849691,0.00009554814,0.0003948558,0.00006713639,0.00027053582,0.0000012622944,0.011641928,0.000008667471,0.0014797822,0.000377158],"study_design_scores_gemma":[0.0026077498,0.00029359187,0.9682443,0.000597894,0.00035280787,0.000042790867,0.00015105896,0.000026845079,0.022146264,0.000019003153,0.005400194,0.0001174972],"about_ca_topic_score_codex":0.00002974974,"about_ca_topic_score_gemma":0.000048342295,"teacher_disagreement_score":0.016724775,"about_ca_system_score_codex":0.0000374986,"about_ca_system_score_gemma":0.00010344964,"threshold_uncertainty_score":0.24852562},"labels":[],"label_agreement":null},{"id":"W4405041646","doi":"10.1182/blood-2024-199677","title":"Shallow Whole Genome Sequencing of Circulating Tumor DNA Is Predictive of Outcome in Diffuse Large B-Cell Lymphoma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto; University Health Network","funders":"Eisai; AstraZeneca","keywords":"Diffuse large B-cell lymphoma; Circulating tumor DNA; Lymphoma; DNA; Biology; Genome; Whole genome sequencing; Computational biology; Medicine; Cancer research; Genetics; Cancer; Immunology; Gene","score_opus":0.018836650703115066,"score_gpt":0.25801323572019697,"score_spread":0.2391765850170819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405041646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99457055,0.0024914788,0.000011428062,0.000092316266,0.00006141678,0.00035231217,0.00023311314,0.00004383275,0.0021435423],"genre_scores_gemma":[0.99933386,0.00002695086,0.00023617291,0.000113621565,0.000054405657,0.000040822466,0.000032926793,0.000029566918,0.00013166864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986449,0.000025681557,0.00050332147,0.00030061448,0.0002699966,0.00025549243],"domain_scores_gemma":[0.9993987,0.00009474203,0.00010490078,0.0002695474,0.000048989437,0.00008312622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016352591,0.00016543259,0.000459733,0.00017802628,0.00002080573,0.000011027428,0.00007086504,0.00006328269,0.000040290714],"category_scores_gemma":[0.000043279968,0.00013640581,0.00017766829,0.00026663483,0.00003147512,0.000067650886,0.000059571692,0.000057416502,0.000020875234],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036884157,0.011912376,0.8876788,0.0013264433,0.0003899605,0.0015813897,0.0050731073,0.0000060800962,0.09136951,0.00017397293,0.000015704401,0.00043577788],"study_design_scores_gemma":[0.039292883,0.0007351523,0.8291927,0.0013365039,0.0010139975,0.00017954392,0.0011254983,0.0019157033,0.12456981,0.00011430938,0.00027472663,0.00024919596],"about_ca_topic_score_codex":0.00019244596,"about_ca_topic_score_gemma":0.00001758565,"teacher_disagreement_score":0.05848612,"about_ca_system_score_codex":0.00022484506,"about_ca_system_score_gemma":0.0001860337,"threshold_uncertainty_score":0.55624676},"labels":[],"label_agreement":null},{"id":"W4405041653","doi":"10.1182/blood-2024-210900","title":"Predictive Modeling of Clonal Hematopoiesis across Diverse Cohorts","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Biology; Haematopoiesis; Immunology; Computational biology; Medicine; Genetics; Stem cell","score_opus":0.022145515399113178,"score_gpt":0.29845280279792136,"score_spread":0.27630728739880817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405041653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994426,0.0018243167,0.00038603166,0.00023862209,0.00012727556,0.00032493658,0.0001594747,0.00007908033,0.0024342407],"genre_scores_gemma":[0.9987103,0.00019208562,0.0006072668,0.000054249376,0.00012891406,0.00007241053,0.000033563738,0.000017761935,0.00018349853],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990539,0.000015424393,0.00021496248,0.00026073944,0.000269626,0.00018532426],"domain_scores_gemma":[0.9995467,0.00007597267,0.00002702203,0.00015949667,0.000095879834,0.00009491954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000099949124,0.0001330036,0.00030183408,0.000047784408,0.000057864418,0.000018736158,0.000036269124,0.00006453416,0.0001481629],"category_scores_gemma":[0.000035880246,0.00010036328,0.00013468208,0.00012689774,0.000047042504,0.00006248121,0.000049614457,0.000099766505,0.00003633474],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007060797,0.0087567195,0.93658173,0.0024087164,0.008488621,0.0035658898,0.016317176,0.001750319,0.0044114203,0.009175199,0.0030998313,0.0047382787],"study_design_scores_gemma":[0.031515058,0.007403867,0.19469035,0.009403192,0.012610327,0.002482963,0.008512949,0.23475695,0.488433,0.004341415,0.0041035605,0.0017463814],"about_ca_topic_score_codex":0.00004320341,"about_ca_topic_score_gemma":0.000010799848,"teacher_disagreement_score":0.7418914,"about_ca_system_score_codex":0.0000301182,"about_ca_system_score_gemma":0.00008429884,"threshold_uncertainty_score":0.40926957},"labels":[],"label_agreement":null},{"id":"W4405041772","doi":"10.1182/blood-2024-199172","title":"Imaging Predictors of Intracerebral Hemorrhage in Patients with Brain Tumors Treated with Anticoagulation","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Intracerebral hemorrhage; Glioma; Internal medicine; Radiology; Subarachnoid hemorrhage","score_opus":0.004367332322644473,"score_gpt":0.21282696064047998,"score_spread":0.20845962831783552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405041772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99882096,0.00016751098,0.000057863752,0.00023254093,0.000019079347,0.0004078572,0.00002737386,0.000054556487,0.0002122792],"genre_scores_gemma":[0.99860287,8.606343e-7,0.0010962994,0.00003560543,0.000027034666,0.000010450182,0.00014523524,0.000024632413,0.000056999183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99925005,0.000025405061,0.00017131395,0.00020094193,0.00020331443,0.00014898987],"domain_scores_gemma":[0.9996914,0.000034798075,0.000039130406,0.0001440923,0.000035311892,0.00005524107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000730758,0.00012306977,0.00021050878,0.0001462325,0.000014083335,0.000013490244,0.000023177328,0.00001975063,0.000036563197],"category_scores_gemma":[0.0000140557095,0.00007629848,0.000029215727,0.00030621336,0.000043497726,0.0000841831,0.000009000724,0.00008019057,0.0000028207976],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020310044,0.0008969333,0.9948775,0.00016085991,0.00014934636,0.00038472385,0.0001550553,0.000014810025,0.000115180526,0.000035819856,0.000022776696,0.0029838688],"study_design_scores_gemma":[0.0075538233,0.001018881,0.98638874,0.0005042084,0.00042897376,0.00005117999,0.000052318937,0.0006823902,0.003213965,0.000007291135,0.0000133401245,0.00008489639],"about_ca_topic_score_codex":0.00008427028,"about_ca_topic_score_gemma":0.000015429963,"teacher_disagreement_score":0.008488793,"about_ca_system_score_codex":0.000027236229,"about_ca_system_score_gemma":0.000051865907,"threshold_uncertainty_score":0.31113616},"labels":[],"label_agreement":null},{"id":"W4405041821","doi":"10.1182/blood-2024-206054","title":"Exposure-Response (ER) and Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Optimal Step-up Dose (SUD) Selection to Improve Cytokine Release Syndrome (CRS) Safety Profile of Abbv-383 in Patients with Relapsed or Refractory Multiple Myeloma (RRMM)","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Pharmacodynamics; Pharmacokinetics; Medicine; Cytokine; Pharmacology; Internal medicine","score_opus":0.018916802492688196,"score_gpt":0.3205301772789801,"score_spread":0.3016133747862919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405041821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993597,0.00042778396,0.00043284084,0.00010219945,0.00012849597,0.0041334555,0.0010413765,0.00011540396,0.000021453998],"genre_scores_gemma":[0.9914057,0.000068729474,0.0062428466,0.00004003989,0.00006086074,0.00059828104,0.0003163758,0.00010003447,0.0011670975],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99710554,0.00021985458,0.00065395323,0.0007946318,0.0006005318,0.0006255148],"domain_scores_gemma":[0.9981327,0.0006127152,0.00014030152,0.00033191137,0.00030487086,0.00047749162],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041260518,0.0004166632,0.0006572863,0.00072920683,0.00010131674,0.000041134906,0.00012690769,0.00013846815,0.00013880392],"category_scores_gemma":[0.0005390746,0.00030197427,0.00012839398,0.0008662124,0.00008933806,0.00023423709,0.00008579165,0.00034934265,0.000016056461],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.321142,0.006193185,0.12018566,0.0022015953,0.0026259143,0.001272144,0.0006791241,0.00015415122,0.48710817,0.000003200672,0.00029346385,0.058141414],"study_design_scores_gemma":[0.09378386,0.021814398,0.77276355,0.0009012223,0.0014229442,0.00015300578,0.00015126841,0.025472341,0.08208549,0.000001484412,0.000901008,0.0005494098],"about_ca_topic_score_codex":0.00016025032,"about_ca_topic_score_gemma":0.00006330507,"teacher_disagreement_score":0.65257794,"about_ca_system_score_codex":0.00021628442,"about_ca_system_score_gemma":0.0004221974,"threshold_uncertainty_score":0.99994326},"labels":[],"label_agreement":null},{"id":"W4405041836","doi":"10.1182/blood-2024-212294","title":"Timing Antigenic Escape in Multiple Myeloma Treated with T-Cell Redirecting Immunotherapies","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Multiple myeloma; Antigen; Immunology; Immunotherapy; Daratumumab; Medicine; Biology; Virology; Cancer research; Bortezomib; Immune system","score_opus":0.025718262907941953,"score_gpt":0.2762986199602764,"score_spread":0.25058035705233445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405041836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882662,0.0068692653,0.0000133939575,0.000099490186,0.00003426829,0.00046402751,0.000008009596,0.00022138329,0.0040239417],"genre_scores_gemma":[0.9963025,0.00024721734,0.0016030967,0.000018733312,0.00007755984,0.000059072005,0.00003785025,0.000054838518,0.0015991316],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99873763,0.000045056247,0.00019854888,0.00034988683,0.0002560058,0.00041287259],"domain_scores_gemma":[0.9994223,0.00016214022,0.00002493111,0.00024285175,0.000038807982,0.00010895932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014235733,0.00018670245,0.00025554406,0.00027700543,0.00007722456,0.00005957806,0.00006497384,0.000069027315,0.00011802224],"category_scores_gemma":[0.00005263919,0.0001331792,0.00007439324,0.00047991812,0.000046280635,0.00009418252,0.00002524146,0.00023282239,0.00010272274],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006351073,0.0012515711,0.7385151,0.0003558391,0.00067955366,0.004306406,0.0011447822,0.000004496849,0.21703072,0.000005944694,0.00004979258,0.036020715],"study_design_scores_gemma":[0.0260287,0.0015913215,0.4071975,0.0019974904,0.0003786354,0.000636218,0.00076023646,0.00491895,0.5545263,0.0000146580405,0.0014754863,0.00047444596],"about_ca_topic_score_codex":0.00043764638,"about_ca_topic_score_gemma":0.00012917563,"teacher_disagreement_score":0.33749563,"about_ca_system_score_codex":0.000057714373,"about_ca_system_score_gemma":0.00011120495,"threshold_uncertainty_score":0.54308903},"labels":[],"label_agreement":null},{"id":"W4405041848","doi":"10.1182/blood-2024-208086","title":"Efficacy and Safety of Selinexor, Pomalidomide, and Dexamethasone (SPd) for Treatment of Patients with Relapsed or Refractory Multiple Myeloma (RRMM)","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University; Vancouver General Hospital; CancerCare Manitoba; Institute of Cancer Research; University of Calgary","funders":"","keywords":"Pomalidomide; Multiple myeloma; Dexamethasone; Lenalidomide; Medicine; Internal medicine; Oncology; Carfilzomib; Refractory (planetary science)","score_opus":0.02489133715367356,"score_gpt":0.29655424616642034,"score_spread":0.2716629090127468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405041848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945692,0.0029332708,0.00006671242,0.000072005096,0.000028661312,0.0018738161,0.00034676533,0.000035941674,0.00007365424],"genre_scores_gemma":[0.9902482,0.0007059624,0.00826123,0.000008240719,0.000043140728,0.00008934382,0.0001702686,0.000039147737,0.0004344511],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876773,0.00004490305,0.00033140535,0.0003528122,0.0002572197,0.00024589704],"domain_scores_gemma":[0.9983738,0.0009414069,0.00008367285,0.00025350033,0.00014573295,0.00020186653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010838858,0.000207712,0.0005168609,0.00014871937,0.00004833815,0.000011611501,0.0000354564,0.000085165055,0.000028708137],"category_scores_gemma":[0.00030805168,0.00012125111,0.00006633557,0.00016203213,0.00013090862,0.00006419748,0.000025870082,0.00005125201,0.0000014829611],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06473139,0.010741234,0.69765407,0.0020049459,0.0038290517,0.00024481726,0.0011595878,0.0000014324921,0.009046682,0.00004846723,0.000085123174,0.2104532],"study_design_scores_gemma":[0.12725282,0.019409515,0.8210239,0.00065997813,0.0012856984,0.000037731093,0.00008680095,0.0003759634,0.026518872,0.000012651999,0.0031410626,0.00019500947],"about_ca_topic_score_codex":0.00007323855,"about_ca_topic_score_gemma":0.000044664997,"teacher_disagreement_score":0.21025819,"about_ca_system_score_codex":0.000041428804,"about_ca_system_score_gemma":0.00014535092,"threshold_uncertainty_score":0.49444768},"labels":[],"label_agreement":null},{"id":"W4405041871","doi":"10.1182/blood-2024-212205","title":"Ph-like ALL Is Associated with Unfavorable Outcomes in Hispanics and Native Americans: A Multicenter Analysis","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Swedish Orphan Biovitrum; Sierra Oncology; Incyte; Bristol-Myers Squibb","keywords":"Medicine; Gerontology; Internal medicine; Demography; Sociology","score_opus":0.016855299848175506,"score_gpt":0.29952677278767764,"score_spread":0.2826714729395021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405041871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965863,0.0005645484,0.0002340078,0.0014194307,0.000025830353,0.0003200146,0.000059875478,0.0000786553,0.0007113297],"genre_scores_gemma":[0.9953978,0.0001219471,0.000646674,0.0010987358,0.000015701677,0.000033770728,0.000039075814,0.00003073495,0.0026155694],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853575,0.00006356571,0.00021048714,0.00039012538,0.00044711074,0.00035294186],"domain_scores_gemma":[0.9990795,0.0004276183,0.000043993376,0.00021110698,0.00009836828,0.00013938422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002134462,0.00016957712,0.00049716653,0.00043199366,0.000025532549,0.0000491511,0.00007913455,0.000080965154,0.00010293226],"category_scores_gemma":[0.0002549219,0.000117407886,0.000085557615,0.0013673579,0.00010658898,0.000085186,0.00006487562,0.00027417438,0.000019666568],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027711442,0.0019672732,0.96008635,0.00019642522,0.022506535,0.002820549,0.007856709,0.000025576393,0.0011183855,0.00005683836,0.0022178807,0.00087035866],"study_design_scores_gemma":[0.05378432,0.002795567,0.65184987,0.0016180355,0.028624916,0.0001844451,0.0043613976,0.24443041,0.004248403,0.00013283046,0.006616359,0.0013534479],"about_ca_topic_score_codex":0.0007455939,"about_ca_topic_score_gemma":0.0005241887,"teacher_disagreement_score":0.30823648,"about_ca_system_score_codex":0.00038841972,"about_ca_system_score_gemma":0.00030341462,"threshold_uncertainty_score":0.47877547},"labels":[],"label_agreement":null},{"id":"W4405041890","doi":"10.1182/blood-2024-193893","title":"Examining Disparities By Race, Ethnicity, and Socioeconomic Factors in Children and Young Adults with Relapsed Acute Lymphoblastic Leukemia: A Report from the Children's Oncology Group","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Lymphoblastic Leukemia; Ethnic group; Socioeconomic status; Race (biology); Medicine; Acute lymphocytic leukemia; Childhood cancer; Oncology; Internal medicine; Leukemia; Gerontology; Demography; Pediatrics; Cancer; Environmental health; Population; Biology","score_opus":0.008007356834487982,"score_gpt":0.24420066345651512,"score_spread":0.23619330662202714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405041890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947801,0.00323478,0.00007490032,0.0005025298,0.000095968804,0.0008125225,0.00020084676,0.00011764096,0.00018066763],"genre_scores_gemma":[0.99734616,0.0011977849,0.00020907124,0.00017703247,0.00019079805,0.00007376113,0.0005043496,0.00007746613,0.00022356403],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997703,0.00012945493,0.00047042238,0.0008505246,0.0003217553,0.0005248263],"domain_scores_gemma":[0.99819165,0.0010774857,0.00009504551,0.00039164495,0.00003137808,0.0002127765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003891254,0.00035638403,0.00061555614,0.00014237304,0.00014810513,0.00012679036,0.00017859215,0.00032775174,0.000028765662],"category_scores_gemma":[0.00017945973,0.00023381185,0.000050888393,0.00017936397,0.0005716173,0.00019992342,0.00027956592,0.00074633834,0.00000892341],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003578638,0.00014333354,0.9913616,0.000044202552,0.0011970598,0.00087098806,0.0021315124,0.0000012501226,0.0008629953,0.000029479597,0.0020843546,0.0009153691],"study_design_scores_gemma":[0.011315917,0.00080934784,0.9785909,0.00038270047,0.0008914452,0.006189393,0.0006041131,0.00041490755,0.00041599036,0.0000550276,0.00004500542,0.0002852343],"about_ca_topic_score_codex":0.0073006735,"about_ca_topic_score_gemma":0.0007226042,"teacher_disagreement_score":0.012770672,"about_ca_system_score_codex":0.0007787787,"about_ca_system_score_gemma":0.0008161419,"threshold_uncertainty_score":0.9993098},"labels":[],"label_agreement":null},{"id":"W4405041895","doi":"10.1182/blood-2024-203618","title":"Investigating the Metabolic Underpinnings of Venetoclax Resistance in DLBCL","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Gilead Sciences; AstraZeneca; Incyte; Amgen","keywords":"Venetoclax; Ibrutinib; Medicine; Internal medicine; Oncology; Leukemia; Chronic lymphocytic leukemia","score_opus":0.02608518767290764,"score_gpt":0.31000399486147656,"score_spread":0.28391880718856893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405041895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9646411,0.026480485,0.000008969049,0.0011314724,0.00005360109,0.00026233916,0.0000026628334,0.000044685545,0.00737472],"genre_scores_gemma":[0.99732494,0.00017653931,0.0007379819,0.00016525298,0.000119602155,0.000027606135,0.000002824399,0.00002249577,0.0014227787],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989051,0.00005105049,0.0002492491,0.00019860505,0.00035684725,0.00023915504],"domain_scores_gemma":[0.9992787,0.00026634545,0.000031526604,0.0003232036,0.000037431215,0.00006279434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004981889,0.00008481997,0.00020068572,0.00010790337,0.00002690893,0.000021225487,0.00014016138,0.000055088043,0.000024510273],"category_scores_gemma":[0.00040656317,0.0000570266,0.000058641755,0.0006770947,0.00018616758,0.000042221593,0.00006673549,0.00025990786,0.000025449606],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051588315,0.0027033782,0.04915739,0.019953677,0.003817059,0.0052095135,0.06950268,0.00032796533,0.30593863,0.48997217,0.02571252,0.027189126],"study_design_scores_gemma":[0.1168237,0.000511587,0.12548035,0.017185772,0.0018824188,0.0012471018,0.002911928,0.03270553,0.46848616,0.044709425,0.18687803,0.0011779991],"about_ca_topic_score_codex":0.00053741393,"about_ca_topic_score_gemma":0.00017421192,"teacher_disagreement_score":0.44526276,"about_ca_system_score_codex":0.0009909025,"about_ca_system_score_gemma":0.005232364,"threshold_uncertainty_score":0.92819893},"labels":[],"label_agreement":null},{"id":"W4405041908","doi":"10.1182/blood-2024-211039","title":"<i>KMT2C</i> Mutations Co-Operate with <i>KMT2A-MLLT1</i> Fusion to Inhibit Hematopoietic Differentiation in a Zebrafish Model of Infant Leukemia","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Toronto; University of Calgary; University of Ottawa; Agricultural Research Institute of Ontario","funders":"","keywords":"Zebrafish; Leukemia; Mutation; Haematopoiesis; Cancer research; Biology; Genetics; Medicine; Computational biology; Gene; Stem cell","score_opus":0.014271569384186483,"score_gpt":0.2731708813765468,"score_spread":0.2588993119923603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405041908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993096,0.0002022661,0.002127098,0.0012576806,0.000036302725,0.0010422714,0.00007554251,0.00012654299,0.002036313],"genre_scores_gemma":[0.99616694,0.000042035954,0.0020936474,0.00046043895,0.00007510665,0.00016171348,0.00016249115,0.0000674046,0.0007702285],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979056,0.000058210055,0.00050615,0.00048852415,0.0006318938,0.0004095859],"domain_scores_gemma":[0.9990407,0.00008732788,0.00005661055,0.0004187696,0.00016518694,0.00023139754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029469983,0.0002422523,0.00046615698,0.0005460132,0.000058917863,0.00006223591,0.00014231038,0.00014146765,0.00007196854],"category_scores_gemma":[0.00008655064,0.00019127126,0.00008548502,0.00095697626,0.000082213824,0.00017710227,0.00010050844,0.00046721188,0.00009046037],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063429296,0.0010636731,0.009586278,0.0017010038,0.0002778173,0.00048596744,0.008209471,0.007304022,0.96414214,0.001098609,0.0044710697,0.0010256432],"study_design_scores_gemma":[0.014875151,0.0015719285,0.00986095,0.0037470113,0.00072224956,0.00048694544,0.00086768286,0.17969844,0.78626835,0.00047751464,0.000651869,0.00077191176],"about_ca_topic_score_codex":0.00022446326,"about_ca_topic_score_gemma":0.00016126232,"teacher_disagreement_score":0.1778738,"about_ca_system_score_codex":0.00031923238,"about_ca_system_score_gemma":0.0011078656,"threshold_uncertainty_score":0.7799816},"labels":[],"label_agreement":null},{"id":"W4405041947","doi":"10.1182/blood-2024-201725","title":"Blood-Based Proteomic Profiling Identifies Osmr As a Novel Biomarker","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Genentech; Servier; Astellas Pharma; Daiichi-Sankyo; Ipsen; Syndax Pharmaceuticals; Incyte; Bristol-Myers Squibb; AstraZeneca; Foghorn Therapeutics; Astex Pharmaceuticals; Celgene; Ipsen Biopharmaceuticals; Regeneron Pharmaceuticals; Gilead Sciences; Chugai Pharmaceutical; Menarini Group; Agios Pharmaceuticals; GlaxoSmithKline; Amgen","keywords":"Biomarker; Profiling (computer programming); Computational biology; Biology; Medicine; Computer science; Genetics","score_opus":0.0173241895008815,"score_gpt":0.2868026383596222,"score_spread":0.2694784488587407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405041947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97050136,0.0007445122,0.017506333,0.00031238334,0.000042891843,0.0005497936,0.000116167605,0.0011856719,0.009040885],"genre_scores_gemma":[0.9107636,0.00003109441,0.08496072,0.000064146225,0.0001595433,0.0015177575,0.00008521654,0.000077592864,0.0023403112],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988774,0.0000045459033,0.00025664747,0.00045016062,0.00015521536,0.00025601135],"domain_scores_gemma":[0.9993397,0.000044860986,0.000060117356,0.0004419648,0.00004499613,0.000068344685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010411538,0.0001880579,0.00013974479,0.00007093161,0.000118401935,0.00014415693,0.00024172285,0.00013494388,0.00022099804],"category_scores_gemma":[0.00004046123,0.00018242387,0.00011844919,0.00021284689,0.000063272266,0.0000982183,0.00007116951,0.00023538654,0.00010237955],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000735943,0.0002883503,0.00023296523,0.00032925382,0.0000814188,0.000018176046,0.000019231577,0.000005725894,0.9946216,0.003911302,0.000054851185,0.00042977466],"study_design_scores_gemma":[0.0005000271,0.000013423338,0.000011479824,0.0002121261,0.00015933109,0.000031884105,0.000013453459,0.00087078434,0.9896183,0.005392022,0.0029441265,0.0002330466],"about_ca_topic_score_codex":0.000026523958,"about_ca_topic_score_gemma":0.0000015894796,"teacher_disagreement_score":0.06745439,"about_ca_system_score_codex":0.000021129037,"about_ca_system_score_gemma":0.00011643415,"threshold_uncertainty_score":0.7439029},"labels":[],"label_agreement":null},{"id":"W4405041955","doi":"10.1182/blood-2024-203960","title":"Examining the Clinical Relevance of the AML Plasma Metabolome","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Metabolome; Medicine; Internal medicine; Metabolite","score_opus":0.03586480585862123,"score_gpt":0.3264679816171502,"score_spread":0.29060317575852895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405041955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929398,0.004185195,0.000024669567,0.00030358773,0.00039141093,0.0001280021,0.000016621056,0.000010850818,0.00199989],"genre_scores_gemma":[0.99633944,0.0002858965,0.00014543266,0.000059866823,0.00041269907,0.000016218852,0.000004903274,0.000018121287,0.0027174454],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989656,0.00018254385,0.0002381905,0.00025579453,0.00019319708,0.00016464847],"domain_scores_gemma":[0.99922067,0.00013842777,0.000040585768,0.0005217,0.000044335822,0.000034281937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006310026,0.00008097241,0.00010648173,0.000016407168,0.00006682825,0.000018444678,0.00035440698,0.00010338887,0.000013264639],"category_scores_gemma":[0.00060958613,0.000044661567,0.0001292668,0.00015421546,0.00026121247,0.0000018664116,0.00021128108,0.0002384891,0.0000292233],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024592428,0.00013353882,0.0018546875,0.00004119735,0.00018307331,0.000010395819,0.000092456066,0.000010317492,0.9822254,0.00025908076,0.008928667,0.00623657],"study_design_scores_gemma":[0.00032562917,0.00013211722,0.002028046,0.000034934725,0.000049736132,0.00002876314,0.000038023845,0.00004491509,0.80907047,0.00002358755,0.18815155,0.00007220481],"about_ca_topic_score_codex":0.0000059547415,"about_ca_topic_score_gemma":0.0000151664,"teacher_disagreement_score":0.1792229,"about_ca_system_score_codex":0.0000035807964,"about_ca_system_score_gemma":0.00013407861,"threshold_uncertainty_score":0.18212458},"labels":[],"label_agreement":null},{"id":"W4405041976","doi":"10.1182/blood-2024-211600","title":"Safeguarding Lungs: Evaluating Pneumocystis Pneumonia Prophylaxis in Lymphoma Patients Receiving Rituximab-Inclusive Therapies","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Pneumocystis jirovecii pneumonia detection and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rituximab; Medicine; Pneumonia; Lymphoma; Intensive care medicine; Internal medicine; Obinutuzumab; Oncology","score_opus":0.010801594086997195,"score_gpt":0.2874128996539501,"score_spread":0.2766113055669529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405041976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99110585,0.0027348513,0.000026245738,0.0006297949,0.00069463585,0.001126252,0.000027941916,0.00045541656,0.0031990074],"genre_scores_gemma":[0.9979307,0.0002121705,0.00065508805,0.00014476187,0.0002352085,0.00024465343,0.000033724333,0.0001054794,0.00043822805],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9968694,0.00018254276,0.00068207795,0.0008639714,0.00078151096,0.0006204952],"domain_scores_gemma":[0.99876636,0.0002758406,0.00012219243,0.00046950975,0.00015762862,0.0002084853],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004472761,0.00045753294,0.0006419714,0.00058990455,0.00023427268,0.00017718688,0.0001552883,0.00019934132,0.00008083549],"category_scores_gemma":[0.00036716653,0.00039374188,0.0002534142,0.0008816594,0.00006091486,0.00026687558,0.00014664569,0.00034907105,0.0002775631],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003440542,0.005527681,0.18101983,0.0009899337,0.0010871321,0.0024810212,0.005894295,0.000024208164,0.16372202,0.00017064234,0.00004311033,0.6386961],"study_design_scores_gemma":[0.024554899,0.0047993995,0.9349379,0.0039122025,0.0009806979,0.0012714361,0.00078115397,0.0028599834,0.021185271,0.00061576685,0.003017098,0.0010842134],"about_ca_topic_score_codex":0.00012528646,"about_ca_topic_score_gemma":0.000062417006,"teacher_disagreement_score":0.75391805,"about_ca_system_score_codex":0.00063964975,"about_ca_system_score_gemma":0.00026543674,"threshold_uncertainty_score":0.99985147},"labels":[],"label_agreement":null},{"id":"W4405042012","doi":"10.1182/blood-2024-209597","title":"Phase II Study of Isatuximab, and Weekly Carfilzomib + Dexamethasone in Relapsed and Refractory Multiple Myeloma (RRMM)","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Carfilzomib; Multiple myeloma; Lenalidomide; Medicine; Oncology; Internal medicine; Dexamethasone","score_opus":0.03124142184940028,"score_gpt":0.3292639495267669,"score_spread":0.29802252767736664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921571,0.00626367,0.0000017587762,0.00014276583,0.000046760146,0.00095737557,0.000039327122,0.00005177733,0.0003394889],"genre_scores_gemma":[0.99860704,0.00023462414,0.00047198814,0.000016430147,0.00005028169,0.000065244065,0.000017709172,0.000030686668,0.0005060117],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99856955,0.00009725293,0.00030363168,0.0004306018,0.00031128828,0.00028765984],"domain_scores_gemma":[0.99911326,0.00029429302,0.00003894244,0.000287074,0.000047279656,0.00021912581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002705152,0.00018339332,0.00042064875,0.00030815313,0.00006366258,0.000021235648,0.000052619565,0.00008863658,0.00003264472],"category_scores_gemma":[0.00031117233,0.00014732667,0.000040127255,0.0002862571,0.000094256466,0.00007722078,0.00011562273,0.000285255,0.000005480038],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003909307,0.062473454,0.5619498,0.0010773283,0.001687819,0.0059778984,0.012104534,5.627464e-7,0.13586783,0.00003237222,0.00029324964,0.21462585],"study_design_scores_gemma":[0.27815467,0.045383833,0.64046013,0.00093734387,0.0010440839,0.00036258064,0.00489311,0.0021067446,0.024250502,0.000077967816,0.0018401868,0.000488858],"about_ca_topic_score_codex":0.0005959252,"about_ca_topic_score_gemma":0.00034987123,"teacher_disagreement_score":0.27424535,"about_ca_system_score_codex":0.00003533264,"about_ca_system_score_gemma":0.00009552145,"threshold_uncertainty_score":0.6007808},"labels":[],"label_agreement":null},{"id":"W4405042087","doi":"10.1182/blood-2024-206912","title":"A Phase 1b Study of Step-up Dosing with ABBV-383, a B-Cell Maturation Antigen (BCMA) x CD3 Bispecific Antibody, in Patients with Relapsed or Refractory Multiple Myeloma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Bispecific antibody; Medicine; Multiple myeloma; Refractory (planetary science); Antibody; Antigen; Cancer research; Internal medicine; Immunology; Monoclonal antibody; Materials science","score_opus":0.022120398361263754,"score_gpt":0.3101483756464769,"score_spread":0.2880279772852131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99650365,0.00035925827,0.00008322834,0.000022352417,0.000082864695,0.0025846078,0.0000618011,0.000093164075,0.00020904529],"genre_scores_gemma":[0.99785656,0.000048012902,0.0012126392,0.000008584145,0.00005484814,0.000073419156,0.00029817093,0.00007117106,0.00037661372],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975973,0.00012279967,0.00043767705,0.00057807774,0.0008355029,0.00042866362],"domain_scores_gemma":[0.99884284,0.00015003268,0.00013007293,0.000495299,0.000188343,0.0001934405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016598316,0.0003032221,0.0004849581,0.00049251295,0.00008760546,0.000067618894,0.00011029654,0.00009417582,0.000054530406],"category_scores_gemma":[0.000065432076,0.00018578494,0.00005369889,0.0008078715,0.000072051356,0.0002586417,0.0000448893,0.00032977524,0.000025608651],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0277725,0.07310085,0.862276,0.00062321586,0.00085044646,0.0025693804,0.0033527217,0.0000023173843,0.015207483,0.000002241383,0.00008328265,0.014159547],"study_design_scores_gemma":[0.1985461,0.028030887,0.7602881,0.0013275143,0.00040379452,0.0000339335,0.0017319695,0.0009803148,0.008080762,9.725567e-7,0.00025794763,0.00031768225],"about_ca_topic_score_codex":0.00030002865,"about_ca_topic_score_gemma":0.0004093427,"teacher_disagreement_score":0.17077361,"about_ca_system_score_codex":0.000095283576,"about_ca_system_score_gemma":0.00026036793,"threshold_uncertainty_score":0.757609},"labels":[],"label_agreement":null},{"id":"W4405042096","doi":"10.1182/blood-2024-197988","title":"Chemotherapy-Induced Bone Defects Stem from Skeletal Progenitor Dysfunction","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Princess Margaret Cancer Centre; Ottawa Hospital; University Health Network","funders":"","keywords":"Stem cell; Progenitor cell; Medicine; Chemotherapy; Pathology; Cancer research; Biology; Internal medicine; Cell biology","score_opus":0.016849714406698857,"score_gpt":0.2541860513920383,"score_spread":0.23733633698533946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993198,0.0018400956,0.00022235129,0.00064119423,0.00051136315,0.00070100627,0.000017372338,0.0003838642,0.0024847481],"genre_scores_gemma":[0.9958883,0.000019415218,0.0007155299,0.00041383225,0.00056410854,0.00007611387,0.00006961208,0.000051767314,0.0022013222],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988074,0.000036231413,0.0002092109,0.0003604258,0.00037958208,0.00020719787],"domain_scores_gemma":[0.9994139,0.00004315588,0.000036182362,0.0003189295,0.000032853513,0.0001549933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014166518,0.00016645013,0.00022549569,0.00011073147,0.00003352304,0.000059939193,0.000052423577,0.00005777148,0.000520317],"category_scores_gemma":[0.000026604761,0.0001435901,0.00015284943,0.00020097542,0.000017021966,0.00008576584,0.000026692587,0.0001382529,0.0005128794],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088227954,0.0072832233,0.023853272,0.0039060654,0.0056238375,0.004135793,0.0014187947,0.0000010371152,0.63588536,0.0015602245,0.022269014,0.2931811],"study_design_scores_gemma":[0.058941595,0.0041893767,0.17625491,0.002794462,0.021622185,0.00035816495,0.0019765424,0.0031036017,0.5722487,0.0021976607,0.15394965,0.0023631752],"about_ca_topic_score_codex":0.000016527176,"about_ca_topic_score_gemma":0.0000019917748,"teacher_disagreement_score":0.29081792,"about_ca_system_score_codex":0.00002913546,"about_ca_system_score_gemma":0.00007707161,"threshold_uncertainty_score":0.6592198},"labels":[],"label_agreement":null},{"id":"W4405042147","doi":"10.1182/blood-2024-211979","title":"Tumor Intrinsic and Antigen-Independent Resistance Mechanisms to Bispecific T Cell Engagers in Multiple Myeloma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Antigen; Multiple myeloma; Medicine; Cancer research; Immunology","score_opus":0.021012203019411934,"score_gpt":0.2673147068565748,"score_spread":0.2463025038371629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98955256,0.004524997,0.00007007989,0.0013727143,0.00015201983,0.00044882848,0.00002942903,0.000064785716,0.003784574],"genre_scores_gemma":[0.9911196,0.0004163017,0.00219667,0.0002478806,0.0001465752,0.000032286214,0.000009858476,0.000028582817,0.005802205],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985187,0.000055938763,0.00022823836,0.00043428835,0.0003874544,0.0003753647],"domain_scores_gemma":[0.99933225,0.00016785221,0.000015854965,0.00019601487,0.000037158286,0.00025089557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032991506,0.00015973179,0.00024417837,0.00029501526,0.00008105124,0.00006003116,0.00009898649,0.00005535969,0.0001300029],"category_scores_gemma":[0.000067855086,0.0001321298,0.00005996915,0.00038980495,0.000045172146,0.00004966782,0.00010851948,0.00039542385,0.00021371801],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012216319,0.001102552,0.03510394,0.0018196808,0.00016131408,0.013273346,0.0025280928,0.0000025292507,0.91711974,0.0065845004,0.0041801697,0.016902504],"study_design_scores_gemma":[0.004123032,0.00062719156,0.3346487,0.0009999906,0.00007341969,0.00032242906,0.00085991266,0.0001624472,0.5597845,0.0012487744,0.09659502,0.0005546025],"about_ca_topic_score_codex":0.00008829195,"about_ca_topic_score_gemma":0.0002920391,"teacher_disagreement_score":0.35733527,"about_ca_system_score_codex":0.00003539952,"about_ca_system_score_gemma":0.000092378315,"threshold_uncertainty_score":0.5388097},"labels":[],"label_agreement":null},{"id":"W4405042148","doi":"10.1182/blood-2024-194652","title":"Clinical and Serological Characteristics of Vaccine-Associated Immune Thrombocytopenia Following COVID-19 Vaccination","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Serology; Coronavirus disease 2019 (COVID-19); Vaccination; Medicine; Virology; Immunology; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Immune thrombocytopenia; Immune system; Antibody; Outbreak; Internal medicine; Infectious disease (medical specialty); Disease","score_opus":0.03189850760721224,"score_gpt":0.34745113191038024,"score_spread":0.315552624303168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967607,0.0015624631,0.00003275722,0.0008173422,0.00016425505,0.00024303689,0.000022457078,0.00008354616,0.000313446],"genre_scores_gemma":[0.99883986,0.0004824031,0.00013385649,0.00024778166,0.000033536784,0.0000073561905,0.00011174194,0.000013390422,0.00013006837],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999066,0.00005282996,0.00038841658,0.00022557453,0.00012686427,0.0001403056],"domain_scores_gemma":[0.9994759,0.0001904782,0.000067080386,0.00011897686,0.000027981669,0.00011958378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032701372,0.000111070076,0.0005386724,0.000055036126,0.000045634726,0.000019491019,0.00004049941,0.00015101838,0.00008938565],"category_scores_gemma":[0.0004893406,0.000084685315,0.00013974543,0.00013527412,0.00001388157,0.00005372081,0.000040520354,0.00014994603,0.000012905322],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001478905,0.0017830249,0.9841155,0.00020125782,0.0013355749,0.0022078368,0.0001774783,1.02516154e-7,0.002093996,0.00021247721,0.00021612989,0.0075087314],"study_design_scores_gemma":[0.0067294003,0.0006321689,0.99014133,0.00008130648,0.000992286,0.00010641895,0.000024714527,0.00013111177,0.0002572521,0.00037911348,0.00043922442,0.00008566502],"about_ca_topic_score_codex":0.000026098593,"about_ca_topic_score_gemma":0.000008259847,"teacher_disagreement_score":0.0074230665,"about_ca_system_score_codex":0.000019760115,"about_ca_system_score_gemma":0.000090883725,"threshold_uncertainty_score":0.3453367},"labels":[],"label_agreement":null},{"id":"W4405042153","doi":"10.1182/blood-2024-211344","title":"ATLAS-AML: An Automated Bioinformatics Pipeline for Drug Target Characterization in Acute Myeloid Leukemia","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Genetics, Bioinformatics, and Biomedical Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Myeloid leukemia; Medicine; Atlas (anatomy); Leukemia; Drug; Bioinformatics; Myeloid; Computational biology; Cancer research; Biology; Internal medicine; Pharmacology","score_opus":0.009587297429028542,"score_gpt":0.277429740822998,"score_spread":0.26784244339396945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9796935,0.00034125426,0.01698331,0.00039211212,0.0004309122,0.00074440724,0.00076810864,0.00020437423,0.00044202697],"genre_scores_gemma":[0.9474965,0.0018382258,0.025899366,0.0006261682,0.000939489,0.00015841667,0.01975876,0.00009077315,0.0031923044],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985191,0.000030522526,0.0005030414,0.0002641628,0.00024858487,0.0004345498],"domain_scores_gemma":[0.9993276,0.000019808886,0.00006430456,0.0002951237,0.000114439914,0.00017872611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042933977,0.00019521182,0.00019140665,0.00016628341,0.00006338857,0.00013314844,0.00028301348,0.00022807597,0.000018573779],"category_scores_gemma":[0.00011636534,0.00016901473,0.000088782246,0.00022360482,0.000085530584,0.000024667122,0.00011393882,0.00013483754,0.000044712808],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011954183,0.00032894066,0.0006035049,0.0007513056,0.00017840303,0.000016589685,0.0007891039,0.000038096434,0.96498877,0.00006286402,0.008455561,0.023667293],"study_design_scores_gemma":[0.0021567042,0.0005523285,0.001672159,0.00010617651,0.00007968149,0.000032969958,0.00018446702,0.44492045,0.4548522,0.000104543156,0.09487067,0.00046766264],"about_ca_topic_score_codex":0.000009239114,"about_ca_topic_score_gemma":0.000024643341,"teacher_disagreement_score":0.5101366,"about_ca_system_score_codex":0.000030442383,"about_ca_system_score_gemma":0.0003210873,"threshold_uncertainty_score":0.6892221},"labels":[],"label_agreement":null},{"id":"W4405042170","doi":"10.1182/blood-2024-212079","title":"Hallmarks of Transcriptional Heterogeneity in Human Hematopoietic Stem Cells across 382 Donors","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Stem cell; Haematopoiesis; Biology; Hematopoietic stem cell transplantation; Immunology; Cancer research; Genetics","score_opus":0.024421824856726438,"score_gpt":0.2966698890866235,"score_spread":0.27224806422989706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99639714,0.0010967961,0.0005201569,0.0001027852,0.00018143866,0.0003776034,0.00006777198,0.000079454,0.001176831],"genre_scores_gemma":[0.99916327,0.000077699035,0.00030465212,0.000038252194,0.000055207332,0.000031018844,0.000034230387,0.000032986547,0.00026271064],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984425,0.000050710707,0.00055118976,0.0003321445,0.00034234687,0.00028113744],"domain_scores_gemma":[0.99949867,0.000075550204,0.00004312469,0.00024079568,0.000039272927,0.00010260139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003404076,0.00017061552,0.00037138874,0.000126895,0.00003452781,0.000022885559,0.00009343101,0.00014379722,0.00012681856],"category_scores_gemma":[0.0000020610476,0.00015991004,0.00017619062,0.00024123672,0.00007944401,0.00007052195,0.000011068179,0.00020152291,0.000037368474],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000065238906,0.0010207783,0.027061487,0.0055097314,0.00021041662,0.00052159093,0.0058822436,0.000042148833,0.9576385,0.0016251947,0.000039984232,0.00038270955],"study_design_scores_gemma":[0.0034606757,0.00020855722,0.02045453,0.0015614532,0.00028457833,0.00043960084,0.00048564278,0.00018137842,0.9722974,0.00014198855,0.0002745063,0.00020973574],"about_ca_topic_score_codex":0.00005573367,"about_ca_topic_score_gemma":0.000092010356,"teacher_disagreement_score":0.014658877,"about_ca_system_score_codex":0.000033484484,"about_ca_system_score_gemma":0.00007254486,"threshold_uncertainty_score":0.65209424},"labels":[],"label_agreement":null},{"id":"W4405042174","doi":"10.1182/blood-2024-200018","title":"Glofitamab Induces High Response Rates and Durable Remissions in Patients (Pts) with Heavily Pretreated Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL), Including Those with a Poor Prognosis: Subgroup Results from a Phase I/II Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Mantle cell lymphoma; Medicine; Refractory (planetary science); Internal medicine; Lymphoma; Oncology; Gastroenterology; Biology","score_opus":0.017680364791631657,"score_gpt":0.2715621329628678,"score_spread":0.25388176817123614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99367094,0.0027036802,3.0035898e-7,0.0004926568,0.000064512016,0.0023097852,0.00037917015,0.00019983646,0.00017912248],"genre_scores_gemma":[0.9981557,0.00015968886,0.00038810034,0.000063186555,0.000038835333,0.0005200699,0.0002826665,0.00008444831,0.00030726395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99706197,0.00028077944,0.0005777529,0.0010551449,0.0005485371,0.0004758057],"domain_scores_gemma":[0.9984197,0.00053368806,0.00017232937,0.00046937118,0.00012432324,0.00028061453],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038433756,0.00049363344,0.0006344561,0.00035599424,0.00027870963,0.00013892972,0.00011628954,0.00016497438,0.000020293232],"category_scores_gemma":[0.00016309955,0.00031259772,0.000056144418,0.0007806377,0.000082776576,0.0003043311,0.00013632256,0.00019877472,0.000012384999],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08338982,0.15614295,0.7124619,0.00024843257,0.0017649118,0.0075256885,0.014870809,0.0000023243067,0.012122472,0.000006056658,0.0006774969,0.010787131],"study_design_scores_gemma":[0.18453744,0.037122842,0.7098955,0.0042967224,0.0018538511,0.000058656944,0.0024708665,0.0000440107,0.058859773,0.00001150494,0.00033537246,0.00051344174],"about_ca_topic_score_codex":0.0019619584,"about_ca_topic_score_gemma":0.00015006568,"teacher_disagreement_score":0.119020104,"about_ca_system_score_codex":0.00030212427,"about_ca_system_score_gemma":0.00045058105,"threshold_uncertainty_score":0.9999326},"labels":[],"label_agreement":null},{"id":"W4405042181","doi":"10.1182/blood-2024-201578","title":"Nemtabrutinib, a Noncovalent Reversible BTK Inhibitor in Relapsed or Refractory Follicular Lymphoma: Results from the Phase 2 Bellwave-003 Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Follicular lymphoma; Bruton's tyrosine kinase; Refractory (planetary science); Ibrutinib; Medicine; Cancer research; Lymphoma; Follicular phase; Internal medicine; Chronic lymphocytic leukemia; Oncology; Biology; Leukemia; Tyrosine kinase; Receptor","score_opus":0.034082989474657925,"score_gpt":0.33355987014664784,"score_spread":0.2994768806719899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98948973,0.0045778514,0.000004490972,0.0011470563,0.00055348274,0.0021786985,0.00017154892,0.00019066906,0.0016864389],"genre_scores_gemma":[0.9933989,0.00028994482,0.00021662265,0.00027444214,0.0010440056,0.00013310129,0.00011292922,0.000088714005,0.0044413516],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9958547,0.00034985377,0.00086970994,0.001017927,0.00120553,0.00070228573],"domain_scores_gemma":[0.9965713,0.00153112,0.00010256728,0.0014237837,0.00009660462,0.00027460253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016125139,0.0003606097,0.00058068166,0.00024269984,0.0001486683,0.00011036427,0.000400528,0.00023327857,0.00020757019],"category_scores_gemma":[0.0015228922,0.00022610286,0.00021291598,0.0012649677,0.00013841112,0.00012285014,0.00031403714,0.00056529447,0.00037453492],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.07387766,0.16234893,0.006441646,0.0022466928,0.009090645,0.24761525,0.08773282,0.000060375816,0.042468835,0.00017416276,0.2821364,0.08580657],"study_design_scores_gemma":[0.7805919,0.007105838,0.003283246,0.0033401607,0.0021661578,0.00086923724,0.008777064,0.0046863784,0.017231349,0.0000991945,0.17093518,0.0009143057],"about_ca_topic_score_codex":0.0042422893,"about_ca_topic_score_gemma":0.00070497754,"teacher_disagreement_score":0.7067142,"about_ca_system_score_codex":0.0048439903,"about_ca_system_score_gemma":0.010123757,"threshold_uncertainty_score":0.99897623},"labels":[],"label_agreement":null},{"id":"W4405042182","doi":"10.1182/blood-2024-211906","title":"Screening for Cognitive Impairment and Depression in Sickle Cell Disease: How Are We Doing?","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Depression (economics); Medicine; Sickle cell anemia; Disease; Cognitive impairment; Cognition; Psychiatry; Internal medicine; Clinical psychology","score_opus":0.010631982563181491,"score_gpt":0.2527085408280827,"score_spread":0.2420765582649012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9542387,0.040877923,0.0008674226,0.0025672123,0.00008872696,0.0007406796,0.00004928102,0.0000773169,0.0004927479],"genre_scores_gemma":[0.9978505,0.00094622263,0.00041845377,0.00011729275,0.00007362226,0.000052655265,0.000025140715,0.00002034281,0.000495787],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99940693,0.000013004121,0.00008609449,0.0002213732,0.00009558501,0.000177014],"domain_scores_gemma":[0.99969494,0.00007018172,0.000020130788,0.00006405341,0.000021481861,0.00012922013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006971624,0.000096770804,0.00013056083,0.00007753883,0.000045598794,0.000030685565,0.000018684686,0.00006534317,0.000011657594],"category_scores_gemma":[0.000028525747,0.000072897165,0.000053492033,0.000100410885,0.000025744894,0.000044926703,0.000028958151,0.00012898902,0.0000024185897],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025533624,0.0050668293,0.80402637,0.013669029,0.0006789362,0.0044748057,0.007171513,0.000055955414,0.008011505,0.00008517396,0.013636497,0.14057006],"study_design_scores_gemma":[0.13036649,0.0040737493,0.5114526,0.08407035,0.009725562,0.0004269786,0.06483534,0.038749173,0.062169477,0.001161532,0.09004474,0.0029239645],"about_ca_topic_score_codex":0.000005408283,"about_ca_topic_score_gemma":0.000003090729,"teacher_disagreement_score":0.2925737,"about_ca_system_score_codex":0.000008092533,"about_ca_system_score_gemma":0.000037563495,"threshold_uncertainty_score":0.297266},"labels":[],"label_agreement":null},{"id":"W4405042184","doi":"10.1182/blood-2024-194386","title":"Infectious Risk in Multiple Myeloma Patients Undergoing Treatment with Teclistamab","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Multiple myeloma; Medicine; Lenalidomide; Internal medicine; Oncology","score_opus":0.014774548582116501,"score_gpt":0.26589547331245583,"score_spread":0.2511209247303393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950219,0.00075082155,0.000028822242,0.00005763866,0.000056063036,0.0008049034,0.000047510308,0.00016983224,0.0030625346],"genre_scores_gemma":[0.9983549,0.0003548102,0.00042611334,0.000015176076,0.00006517303,0.00015901668,0.00009030437,0.000041292205,0.0004932103],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987145,0.00005311966,0.00018456505,0.00037571907,0.00029099156,0.000381102],"domain_scores_gemma":[0.9992521,0.0002348621,0.000029687302,0.00025792085,0.000044847115,0.00018059507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006343118,0.00020538304,0.00024454604,0.00026321944,0.000080799975,0.000054501877,0.000039225262,0.00006584757,0.000050945262],"category_scores_gemma":[0.000113762304,0.0001348975,0.000077269025,0.0003548775,0.000042523316,0.000090516216,0.000025077006,0.00017041064,0.00015301334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026846977,0.002658897,0.95209366,0.0001056369,0.00049493625,0.0011992533,0.00024945888,0.0000049395862,0.000099983845,0.000015053211,0.000019756173,0.04278994],"study_design_scores_gemma":[0.036305632,0.0057680397,0.9514596,0.00044275486,0.00035077412,0.000091501555,0.00006599679,0.0006468001,0.0031872229,0.00005539195,0.0014356448,0.000190679],"about_ca_topic_score_codex":0.00081135734,"about_ca_topic_score_gemma":0.0027390644,"teacher_disagreement_score":0.04259926,"about_ca_system_score_codex":0.00028415787,"about_ca_system_score_gemma":0.00022305532,"threshold_uncertainty_score":0.55009604},"labels":[],"label_agreement":null},{"id":"W4405042202","doi":"10.1182/blood-2024-200157","title":"Improvement of Iron Overload Parameters in Patients with Transfusion-Dependent β-Thalassemia Treated with Luspatercept: Data from the Phase 3b Long-Term Rollover Study Following the BELIEVE Trial","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Thalassemia; Medicine; Term (time); Blood transfusion; Beta thalassemia; Deferasirox; Pediatrics; Intensive care medicine; Surgery; Internal medicine","score_opus":0.013833569523701456,"score_gpt":0.2672611371947593,"score_spread":0.25342756767105784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99480325,0.00045524802,0.000015902753,0.00017492978,0.00020077359,0.0040740385,0.00018205935,0.00003916036,0.00005464966],"genre_scores_gemma":[0.9992777,0.0000753026,0.000013977279,0.00008058572,0.000042404365,0.00006957178,0.00033637148,0.000044233602,0.00005983938],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99784416,0.00010577666,0.00045779845,0.0005699332,0.00072523544,0.00029710733],"domain_scores_gemma":[0.99869543,0.00014781303,0.0000902745,0.00095901504,0.000030182688,0.00007727776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032331908,0.00028749922,0.00041520497,0.00006645172,0.00008546835,0.000058475904,0.00033590052,0.000105723564,0.000049784434],"category_scores_gemma":[0.000022897208,0.00012426561,0.000099773315,0.0003218532,0.00006925537,0.000133029,0.000099634155,0.00040481886,0.00000558844],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034709528,0.015827961,0.9289012,0.00008154737,0.002790517,0.000542389,0.006182635,0.000037788337,0.0020757595,4.0245507e-7,0.000074881435,0.008775365],"study_design_scores_gemma":[0.51214826,0.025824783,0.4430238,0.0015406144,0.0083130095,0.000008361386,0.005690986,0.00024067015,0.002698434,0.000003656445,0.000019947449,0.00048749553],"about_ca_topic_score_codex":0.0018297202,"about_ca_topic_score_gemma":0.00095846114,"teacher_disagreement_score":0.48587742,"about_ca_system_score_codex":0.000051411367,"about_ca_system_score_gemma":0.00012408869,"threshold_uncertainty_score":0.50674045},"labels":[],"label_agreement":null},{"id":"W4405042203","doi":"10.1182/blood-2024-210717","title":"Analysis of Chip Mutations Pre-and Post-Transplant in Multiple Myeloma (MM): Expanded Results from a Prospective Longitudinal Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; Windsor Regional Hospital","funders":"","keywords":"Multiple myeloma; Hematologic Neoplasms; Medicine; Internal medicine; Oncology; Prospective cohort study; Transplantation","score_opus":0.029332789454426987,"score_gpt":0.3191707154345213,"score_spread":0.28983792598009434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99660987,0.000574436,0.000019231631,0.000078371,0.000020194297,0.0011786375,0.0012915278,0.000046732282,0.00018099547],"genre_scores_gemma":[0.99878395,0.00003257234,0.0002978547,0.0000038119995,0.000028715614,0.00013778279,0.00058658567,0.000014585596,0.00011415617],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849826,0.00007426477,0.0003687687,0.00048667577,0.00035078655,0.00022121565],"domain_scores_gemma":[0.99902564,0.00044107594,0.000042051513,0.00026726015,0.000089240784,0.00013471946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017089046,0.00015376623,0.00042920338,0.0005913328,0.00004882946,0.00003058729,0.00005828541,0.000043964825,0.000031177944],"category_scores_gemma":[0.0002453407,0.00011858068,0.00011755457,0.00087810535,0.000062691215,0.00007309021,0.00003053869,0.00017122466,0.0000063388684],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019262766,0.0032099332,0.97270983,0.000046450263,0.0065044714,0.001164127,0.009778842,0.000010896588,0.003618104,0.000008433013,0.0000010005683,0.0010216312],"study_design_scores_gemma":[0.0130747445,0.0008258707,0.9762176,0.0001467214,0.0038691163,0.000015580285,0.0007691268,0.0017479879,0.003215314,0.000024904328,9.685784e-7,0.000092050184],"about_ca_topic_score_codex":0.0063938512,"about_ca_topic_score_gemma":0.009419555,"teacher_disagreement_score":0.011148469,"about_ca_system_score_codex":0.000038466747,"about_ca_system_score_gemma":0.00009814661,"threshold_uncertainty_score":0.9665633},"labels":[],"label_agreement":null},{"id":"W4405042220","doi":"10.1182/blood-2024-206028","title":"ULK1 Presents As a Therapeutic Target to Sensitize Resistant Acute Myeloid Leukemia Cells to Venetoclax","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; University of British Columbia","funders":"","keywords":"Venetoclax; Myeloid leukemia; Medicine; Cancer research; Leukemia; Immunology; Chronic lymphocytic leukemia","score_opus":0.01491722503326445,"score_gpt":0.2987653702526226,"score_spread":0.2838481452193582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97274816,0.0012787265,0.00028782585,0.007435032,0.0004729922,0.002276152,0.00013513917,0.0004930097,0.01487299],"genre_scores_gemma":[0.95150346,0.00014391774,0.004556158,0.0044730017,0.0008965903,0.00020044294,0.00005415247,0.00018725215,0.037985038],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965687,0.00012403475,0.0004173345,0.00089770585,0.0010060715,0.0009861748],"domain_scores_gemma":[0.99772304,0.00020421398,0.00003219687,0.00095593306,0.00018509635,0.00089954474],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00039866552,0.0003827853,0.00052842963,0.0004550155,0.00012036071,0.0001711093,0.0003645442,0.00021573389,0.00038147997],"category_scores_gemma":[0.00012924246,0.00032642245,0.00020671317,0.0010885324,0.00006551666,0.00009444663,0.00033248318,0.0006598999,0.0057988963],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010572276,0.00012108711,0.00010914662,0.00025676115,0.001112624,0.006826012,0.0012526108,0.000059478694,0.94518286,0.00030573655,0.041782994,0.0019334754],"study_design_scores_gemma":[0.0036163235,0.0021102636,0.0021458506,0.0005520588,0.000891138,0.00093573664,0.00023822594,0.0010259437,0.6406417,0.0004575394,0.346747,0.00063824374],"about_ca_topic_score_codex":0.00031760224,"about_ca_topic_score_gemma":0.000014042946,"teacher_disagreement_score":0.304964,"about_ca_system_score_codex":0.0013762055,"about_ca_system_score_gemma":0.0023776467,"threshold_uncertainty_score":0.99991876},"labels":[],"label_agreement":null},{"id":"W4405042223","doi":"10.1182/blood-2024-198302","title":"Outcomes of Immunosuppressive Therapy in Children Less Than Three Years of Age with Idiopathic Severe Aplastic Anemia: A North American Collaboration","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Aplastic anemia; Pediatrics; Immunology; Bone marrow","score_opus":0.008358138705171199,"score_gpt":0.23966695217700684,"score_spread":0.23130881347183566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985179,0.0006344432,0.00009331211,0.00004705441,0.000029058967,0.00052871276,0.000053350475,0.00002989986,0.00006629133],"genre_scores_gemma":[0.99946296,0.00016063021,0.00024012597,0.000012000489,0.000017236654,0.000025689771,0.00004755537,0.000023835088,0.000009972875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991039,0.000038115315,0.00028543832,0.00018133911,0.00026989554,0.0001212901],"domain_scores_gemma":[0.99952644,0.000076137854,0.00010941843,0.00019497109,0.000060298924,0.00003276229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008103334,0.0001165332,0.00039025277,0.00014782888,0.000009560242,0.0000093796025,0.00006750542,0.000044542045,0.0000044887493],"category_scores_gemma":[0.000017242786,0.00009153752,0.00004037393,0.0005965891,0.000103050595,0.00005299876,0.0000068265877,0.0001331645,0.000002307667],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019293487,0.00025791756,0.9891742,0.00033463284,0.00022731729,0.00015606669,0.0025054626,0.000035837944,0.005655772,0.000033074677,0.0000012490968,0.0014255621],"study_design_scores_gemma":[0.0028966982,0.00070519093,0.98425144,0.0006848346,0.00021499344,0.00012643149,0.0003423238,0.000018067436,0.010659372,0.000009513122,6.085407e-7,0.000090532754],"about_ca_topic_score_codex":0.0003095582,"about_ca_topic_score_gemma":0.000980329,"teacher_disagreement_score":0.0050036,"about_ca_system_score_codex":0.000014926591,"about_ca_system_score_gemma":0.00017103416,"threshold_uncertainty_score":0.37327915},"labels":[],"label_agreement":null},{"id":"W4405042283","doi":"10.1182/blood-2024-205308","title":"The Mitochondrial Unfolded Protein Response (UPRmt) Is Upregulated in Acute Myeloid Leukemia (AML) and Inhibiting the UPRmt Protease, LONP1, Leads to Mitochondrial Protein Aggregation and Cell Death Selectively in AML","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Unfolded protein response; Myeloid leukemia; Venetoclax; Mitochondrion; Programmed cell death; Downregulation and upregulation; Cancer research; Apoptosis; Myeloid; Leukemia; Biology; Cell biology; Immunology; Genetics; Gene","score_opus":0.00720104452863215,"score_gpt":0.22801673008245962,"score_spread":0.22081568555382747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99281126,0.000998319,0.0003633186,0.001549548,0.00030878774,0.0037758462,0.000037916165,0.000041350093,0.00011363032],"genre_scores_gemma":[0.9937624,0.0000785196,0.0017648449,0.00021779738,0.0005916781,0.0011622976,0.000039307957,0.000058885573,0.0023242794],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99711466,0.0007647907,0.0005018516,0.0008665442,0.00023018812,0.0005219419],"domain_scores_gemma":[0.99916303,0.000107739645,0.00011795343,0.00037669713,0.000098584416,0.00013600655],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00059358554,0.00035013785,0.00026526503,0.00018033656,0.00027876216,0.00023284071,0.00022264886,0.0003997061,0.0000091633065],"category_scores_gemma":[0.0005163012,0.00025480395,0.000081515114,0.00052528275,0.00014929382,0.000024167972,0.00020369783,0.00045731588,0.000012014944],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031802307,0.00006811659,0.00051124376,0.000043890162,0.000046579877,0.000053700845,0.00067591626,0.000009098658,0.9933465,0.00007705967,0.0003075745,0.001680066],"study_design_scores_gemma":[0.0035732184,0.00087200716,0.0012286637,0.00020798594,0.000052888405,0.000111003406,0.000112148016,0.00014314956,0.98739845,0.00036709136,0.005577115,0.00035629686],"about_ca_topic_score_codex":0.00010900998,"about_ca_topic_score_gemma":0.00044214,"teacher_disagreement_score":0.0059480905,"about_ca_system_score_codex":0.00007516685,"about_ca_system_score_gemma":0.00046168637,"threshold_uncertainty_score":0.9999904},"labels":[],"label_agreement":null},{"id":"W4405042301","doi":"10.1182/blood-2024-207919","title":"Outcomes of Relapsed/Refractory Multiple Myeloma Patients Receiving Sequential Therapies after Exposure to T-Cell Redirected or BCMA-Targeted Novel Immunotherapies","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Multiple myeloma; Daratumumab; Oncology; Internal medicine; Carfilzomib; Refractory (planetary science); Lenalidomide; Pomalidomide; Immunotherapy; Immunology; Cancer","score_opus":0.018682784518157174,"score_gpt":0.27276798593326435,"score_spread":0.25408520141510715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993694,0.003767703,0.000049878123,0.00019982057,0.0004170179,0.0010492523,0.0002522351,0.00024284644,0.0003272679],"genre_scores_gemma":[0.99215907,0.00016407903,0.003976927,0.00011166189,0.00011656903,0.00021867752,0.00012708349,0.00010170473,0.0030242282],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99767417,0.000091822454,0.0005330783,0.0005126463,0.00066996337,0.0005183186],"domain_scores_gemma":[0.99854344,0.00034334944,0.0000882143,0.0005317276,0.00025510674,0.00023816265],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017411976,0.00036154257,0.0005611498,0.00038146303,0.00008239879,0.00006081737,0.00016856121,0.00017204734,0.0005678001],"category_scores_gemma":[0.0003974516,0.00024523685,0.0002448136,0.0004533795,0.00008317408,0.00017712761,0.00009687499,0.00028535508,0.00009464353],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035940025,0.004362766,0.6824549,0.00043656048,0.00232553,0.00027651634,0.0041839075,0.0000011735867,0.2884002,0.0000024967603,0.00026918147,0.013692783],"study_design_scores_gemma":[0.01418385,0.0020199132,0.9117163,0.00046652454,0.00024690817,0.0000125173065,0.0001903139,0.000027621065,0.06843493,0.000005092272,0.002423239,0.00027278299],"about_ca_topic_score_codex":0.00016877434,"about_ca_topic_score_gemma":0.00010216624,"teacher_disagreement_score":0.22926143,"about_ca_system_score_codex":0.000088524364,"about_ca_system_score_gemma":0.00019520262,"threshold_uncertainty_score":1},"labels":[],"label_agreement":null},{"id":"W4405042336","doi":"10.1182/blood-2024-199506","title":"Danicopan As Add-on Therapy to Ravulizumab or Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria: Long-Term Patient-Reported Outcomes from the Phase 3 ALPHA Trial","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Eculizumab; Medicine; Hemoglobinuria; Pediatrics; Immunology; Internal medicine; Anemia; Antibody","score_opus":0.02324015272475975,"score_gpt":0.29366442911215396,"score_spread":0.2704242763873942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928291,0.00135612,0.000006143548,0.00027715432,0.0017657821,0.0029847075,0.0004948589,0.00015063865,0.00013553177],"genre_scores_gemma":[0.99804157,0.000010810324,0.000012498142,0.000549233,0.00012752487,0.00032147695,0.0006547766,0.000051676485,0.00023044866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973465,0.0004236645,0.0007790264,0.00070773065,0.00021468557,0.0005283485],"domain_scores_gemma":[0.99841106,0.00049118884,0.00020575956,0.00074447686,0.00007141741,0.000076103264],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015431052,0.000443572,0.0005485112,0.00014302552,0.00017622639,0.000118201024,0.00047719444,0.00015638077,0.0035358209],"category_scores_gemma":[0.0001516957,0.00024152646,0.00018239497,0.00029830672,0.000086358006,0.00011436959,0.00012457832,0.00033343528,0.0004459321],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32209277,0.017745076,0.5781065,0.000057197278,0.0060671587,0.0011926166,0.0034245017,0.000008168573,0.0031318692,0.000089451496,0.011938884,0.056145772],"study_design_scores_gemma":[0.45294622,0.016367603,0.50791484,0.0006032462,0.0006303036,0.000078706806,0.00027278857,0.0000010852117,0.010951003,0.00004661301,0.009347805,0.0008397745],"about_ca_topic_score_codex":0.00022493681,"about_ca_topic_score_gemma":0.00023779579,"teacher_disagreement_score":0.13085343,"about_ca_system_score_codex":0.00009537037,"about_ca_system_score_gemma":0.000276432,"threshold_uncertainty_score":0.9973751},"labels":[],"label_agreement":null},{"id":"W4405042337","doi":"10.1182/blood-2024-208364","title":"Clonal Persistence of Anti-PF4 Antibodies in VITT Represents an MGTS-like State","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Cardiac tumors and thrombi","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"","keywords":"Persistence (discontinuity); Antibody; Immunology; Biology; Medicine; Computational biology","score_opus":0.022165584813471688,"score_gpt":0.2915042525226171,"score_spread":0.2693386677091454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99447644,0.001688661,0.0000039643573,0.00014152421,0.0002654287,0.00013567855,0.000042862026,0.0000451154,0.0032003333],"genre_scores_gemma":[0.998942,0.00021198172,0.00016683276,0.000043977034,0.00009008785,0.0000034120555,0.000020629845,0.000016365417,0.0005046953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99906546,0.000021702714,0.00021044778,0.000274018,0.0002443297,0.00018402557],"domain_scores_gemma":[0.9995503,0.0000298437,0.000027498385,0.0002728379,0.000043825847,0.000075714655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018156598,0.00009767237,0.00030065177,0.00012547862,0.000018712415,0.00001739347,0.00005964239,0.00003551651,0.000046216464],"category_scores_gemma":[0.00003137216,0.000084408435,0.0001287482,0.00021565538,0.000084088046,0.00008864988,0.00005009607,0.0001345314,0.00001893503],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008120471,0.0012107937,0.8768322,0.0006815225,0.0003048166,0.002196021,0.0025846036,0.000010100153,0.113004856,0.00035187873,0.0006614698,0.0020805553],"study_design_scores_gemma":[0.0015645913,0.0002923112,0.9650717,0.0004657656,0.00022586592,0.00029740407,0.0004999733,0.00020321202,0.030000523,0.00032574483,0.000900667,0.00015224573],"about_ca_topic_score_codex":0.00016372767,"about_ca_topic_score_gemma":0.000026608983,"teacher_disagreement_score":0.08823952,"about_ca_system_score_codex":0.000012887402,"about_ca_system_score_gemma":0.00007366273,"threshold_uncertainty_score":0.3442076},"labels":[],"label_agreement":null},{"id":"W4405042362","doi":"10.1182/blood-2024-205920","title":"Single Cell Profiling of Hematopoietic Stem and Progenitor Cells in Pediatric Acquired Aplastic Anemia","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Canada's Michael Smith Genome Sciences Centre; Hospital for Sick Children; BC Children's Hospital; University of Toronto","funders":"","keywords":"Aplastic anemia; Haematopoiesis; Progenitor cell; Stem cell; Immunology; Medicine; Hematopoietic stem cell transplantation; Biology; Bone marrow; Cell biology","score_opus":0.014595985270209466,"score_gpt":0.22800140531739618,"score_spread":0.2134054200471867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99550647,0.0033253226,0.000025643874,0.000025409943,0.0003163596,0.00027727784,0.0000055934693,0.000056610043,0.0004613275],"genre_scores_gemma":[0.9986484,0.000116094496,0.00060953834,0.00002245075,0.00023813144,0.000014711359,0.000006231749,0.000018302151,0.00032610973],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992831,0.000027859882,0.00022578899,0.00021835201,0.00009584158,0.00014910674],"domain_scores_gemma":[0.9996593,0.00010325967,0.0000373002,0.00010956281,0.000026866228,0.000063694395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006991358,0.00009908596,0.00021695811,0.00014753279,0.000013544195,0.000007947273,0.000027292674,0.000092436734,0.000026117214],"category_scores_gemma":[0.000011489932,0.000084254934,0.000040269675,0.00025052569,0.000031534204,0.00002890935,0.000023750319,0.00008933317,0.000030034615],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007267712,0.00056531635,0.015566057,0.0044257785,0.000013223544,0.00015555778,0.00045317932,0.0000030822698,0.97839206,0.000030013452,0.000086385444,0.00023668683],"study_design_scores_gemma":[0.002195024,0.00093698385,0.0026092709,0.0001902278,0.00036046508,0.00015718269,0.00027329745,0.00020825157,0.9927673,0.00003532048,0.000130847,0.00013586927],"about_ca_topic_score_codex":0.0000017336946,"about_ca_topic_score_gemma":8.8220486e-7,"teacher_disagreement_score":0.014375216,"about_ca_system_score_codex":0.000011675806,"about_ca_system_score_gemma":0.000080752485,"threshold_uncertainty_score":0.34358165},"labels":[],"label_agreement":null},{"id":"W4405042383","doi":"10.1182/blood-2024-209041","title":"UM171 Expands Immature Bone Marrow CD34+ Cells of Patients with Telomere-Biology Disorder","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Telomere; Bone marrow; Biology; CD34; Immunology; Medicine; Cancer research; Stem cell; Genetics; DNA","score_opus":0.004204095950959342,"score_gpt":0.21856626155251407,"score_spread":0.21436216560155474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929105,0.0044781,0.00005740888,0.00025486475,0.0003112615,0.00035933036,0.00011052274,0.0001247442,0.0013932402],"genre_scores_gemma":[0.99718463,0.0001790704,0.00071817474,0.00015325869,0.00015059974,0.0000196236,0.0001402764,0.00004813741,0.0014061981],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99862057,0.000033222444,0.00032276052,0.0004092858,0.00026102312,0.00035316375],"domain_scores_gemma":[0.999196,0.00007070774,0.00007486422,0.000400054,0.00011801719,0.00014036451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000086387,0.00024257693,0.00045929357,0.000186179,0.000044852488,0.000016524255,0.00011273418,0.00018002246,0.0002992056],"category_scores_gemma":[0.000029440253,0.00016683193,0.00010871986,0.00041144542,0.00015102053,0.000075556905,0.00004627829,0.00028450284,0.000056555826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016382069,0.004714257,0.7635031,0.002554709,0.0010427174,0.00042024092,0.0025750764,0.000002948638,0.1885418,0.0011710323,0.004900033,0.02893591],"study_design_scores_gemma":[0.01793504,0.0043528816,0.7476068,0.0016477639,0.0017513841,0.00014538632,0.0006664464,0.00005780996,0.1550523,0.0005685394,0.068943396,0.0012722559],"about_ca_topic_score_codex":0.00004359086,"about_ca_topic_score_gemma":0.000017519256,"teacher_disagreement_score":0.064043365,"about_ca_system_score_codex":0.000014600223,"about_ca_system_score_gemma":0.00010456483,"threshold_uncertainty_score":0.68032086},"labels":[],"label_agreement":null},{"id":"W4405042392","doi":"10.1182/blood-2024-202410","title":"The Fusion Landscape of Anaplastic Large Cell Lymphoma: An L.L.M.P.P. Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Simon Fraser University; University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Anaplastic large-cell lymphoma; Medicine; Lymphoma; Cancer research; Internal medicine","score_opus":0.008573535445317285,"score_gpt":0.2539957262234783,"score_spread":0.24542219077816105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915184,0.0050288974,0.0000024581707,0.0001055501,0.0001749338,0.00034861444,0.000017356448,0.00005844573,0.0027453469],"genre_scores_gemma":[0.99918413,0.00018681247,0.00002498877,0.000025570991,0.00010706958,0.000040369785,0.000016318176,0.00001555094,0.000399177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99920857,0.00003541447,0.00016950737,0.0001970676,0.00021765014,0.00017179847],"domain_scores_gemma":[0.9994236,0.0001415161,0.000026744876,0.0002944191,0.00003338614,0.00008029816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015255286,0.00010480458,0.0001624423,0.000049309994,0.000091910224,0.000033749577,0.00006494136,0.000034477638,0.000049271177],"category_scores_gemma":[0.000016669948,0.00005606355,0.00006995469,0.00016060633,0.000015974027,0.000034646062,0.000040212977,0.000029965955,0.000059668328],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043776282,0.10430877,0.8494589,0.00038980122,0.0011158739,0.0023966327,0.0039279666,0.0000019182928,0.0019405341,0.0012844651,0.004552444,0.030184938],"study_design_scores_gemma":[0.043582104,0.009783764,0.9039567,0.0002465306,0.0028416165,0.00015720598,0.0038133992,0.0007313492,0.017354367,0.00008470838,0.017200507,0.00024771996],"about_ca_topic_score_codex":0.000032981523,"about_ca_topic_score_gemma":0.00007846745,"teacher_disagreement_score":0.09452501,"about_ca_system_score_codex":0.000017989138,"about_ca_system_score_gemma":0.00008964591,"threshold_uncertainty_score":0.22862051},"labels":[],"label_agreement":null},{"id":"W4405042408","doi":"10.1182/blood-2024-206279","title":"HIV-Associated Diffuse Large B-Cell Lymphoma Shows Different Genomic Patterns between EBV-Positive and EBV-Negative Tumors","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Human immunodeficiency virus (HIV); Epstein–Barr virus; Medicine; Virology; Biology; Virus; Immunology","score_opus":0.008099279959131084,"score_gpt":0.22829520443029247,"score_spread":0.22019592447116138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99290997,0.0019225429,0.000050603066,0.0005031812,0.0001297296,0.00053376413,0.0014522654,0.00022041831,0.0022775077],"genre_scores_gemma":[0.9968619,0.0003035101,0.000013194985,0.00044308,0.00020242207,0.00004920518,0.00034753163,0.00008339204,0.0016958127],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980586,0.00010223194,0.00035191388,0.00056156307,0.00032148752,0.00060419505],"domain_scores_gemma":[0.9991488,0.00019186905,0.00011383864,0.00021494848,0.000056731402,0.00027381984],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013828446,0.00036854288,0.0006157696,0.00015305808,0.00015430506,0.00010165524,0.00010691042,0.00020735817,0.00010226423],"category_scores_gemma":[0.000056846915,0.00031206364,0.00020083615,0.00019794476,0.00006377033,0.000090837464,0.00011243758,0.00027355851,0.000056486457],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017093023,0.00789794,0.96629894,0.0004474575,0.002296636,0.00066982384,0.0076137837,4.3416648e-7,0.00817979,0.00014257121,0.0021490792,0.0041326443],"study_design_scores_gemma":[0.04181997,0.0008391985,0.9397737,0.0007113156,0.002056201,0.00001723109,0.0017472417,0.00018905987,0.011525991,0.00036762762,0.00035168976,0.00060080725],"about_ca_topic_score_codex":0.00025056943,"about_ca_topic_score_gemma":0.00016792965,"teacher_disagreement_score":0.041649044,"about_ca_system_score_codex":0.00030760403,"about_ca_system_score_gemma":0.00013847434,"threshold_uncertainty_score":0.9999331},"labels":[],"label_agreement":null},{"id":"W4405042605","doi":"10.1182/blood-2024-198612","title":"Efficacy and Safety of Apixaban for Pediatric Patients Requiring Anticoagulation for Treatment of Venous Thromboembolism","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Hospital for Sick Children; Stollery Children's Hospital; University of Alberta","funders":"Case Western Reserve University; Swedish Orphan Biovitrum; CSL Behring; Genentech; Bayer; AstraZeneca; U.S. Food and Drug Administration; Bristol-Myers Squibb","keywords":"Apixaban; Medicine; Venous thromboembolism; Intensive care medicine; Surgery; Warfarin; Internal medicine; Rivaroxaban; Thrombosis; Atrial fibrillation","score_opus":0.0222474118155682,"score_gpt":0.29298550576077553,"score_spread":0.2707380939452073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99447685,0.0022787293,0.00047557836,0.00008334325,0.0001924565,0.0022304049,0.000073606265,0.000033559816,0.000155459],"genre_scores_gemma":[0.9972165,0.0010003773,0.0013074507,0.00001238723,0.00022252763,0.00009768971,0.000084690146,0.000027883107,0.000030484052],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99915576,0.000008512053,0.00032731256,0.00022246927,0.00012308896,0.00016283258],"domain_scores_gemma":[0.99946576,0.00015801222,0.000088243,0.0001557601,0.00008300957,0.000049235387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009291566,0.00012060636,0.00053107605,0.00013599031,0.00004523972,0.000009819169,0.000030427433,0.00005220465,0.000005388943],"category_scores_gemma":[0.00004363721,0.00009997749,0.000118121505,0.00010576363,0.00002587955,0.00004667208,0.000017469774,0.000014815456,7.6026635e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003073407,0.1123072,0.24020897,0.044719666,0.009683345,0.000032176078,0.02176764,0.00028359948,0.024660202,0.035143368,0.0027497234,0.5053707],"study_design_scores_gemma":[0.019190254,0.0100602945,0.9466607,0.00040029586,0.0066384515,0.0000029024884,0.000067417765,0.00033061294,0.013074563,0.00060541066,0.002761654,0.00020744391],"about_ca_topic_score_codex":0.000015054581,"about_ca_topic_score_gemma":0.0000016759517,"teacher_disagreement_score":0.7064517,"about_ca_system_score_codex":0.000025947746,"about_ca_system_score_gemma":0.00003745807,"threshold_uncertainty_score":0.4076964},"labels":[],"label_agreement":null},{"id":"W4405042653","doi":"10.1182/blood-2024-209396","title":"An Llmpp Study: Genomic Characterization of Novel PTCL- Biological Subtypes Reveal Distinctive Therapeutic Vulnerabilities","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Biology; Computational biology; Genetics; Medicine","score_opus":0.024099482260968908,"score_gpt":0.2838887762171213,"score_spread":0.25978929395615236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99708474,0.00075552234,0.0013681117,0.00002413374,0.00024605275,0.0002520626,0.00014824921,0.00003400944,0.000087146436],"genre_scores_gemma":[0.9989827,0.000035157464,0.00013311904,0.000047817513,0.00042937894,0.000048234382,0.00019739465,0.000024063278,0.000102097314],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99906486,0.00009231659,0.00020821314,0.00038944898,0.000091494025,0.00015364765],"domain_scores_gemma":[0.9995363,0.000024173018,0.00005650938,0.0002789597,0.00006622238,0.000037865342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021313544,0.00014060516,0.00015619434,0.000034012926,0.00004451938,0.000029536835,0.00017233222,0.00012489165,0.000028203513],"category_scores_gemma":[0.000029013392,0.000115924704,0.00006193569,0.000078818935,0.00009991451,0.0000057904253,0.000050751616,0.00009023898,0.0000034955149],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006441853,0.00068479485,0.022124385,0.00002693121,0.00015603926,0.000002068841,0.00027082802,0.000009442047,0.9757461,0.00007838735,0.0000044934964,0.00083213486],"study_design_scores_gemma":[0.0010811568,0.0029238397,0.19404235,0.000035672943,0.0001561255,0.000016349875,0.00027504182,0.000113317255,0.799388,0.00011667197,0.0015183665,0.00033312253],"about_ca_topic_score_codex":0.000014231782,"about_ca_topic_score_gemma":0.000008206162,"teacher_disagreement_score":0.17635809,"about_ca_system_score_codex":0.000014091569,"about_ca_system_score_gemma":0.00007773613,"threshold_uncertainty_score":0.4727272},"labels":[],"label_agreement":null},{"id":"W4405042663","doi":"10.1182/blood-2024-198408","title":"Mezigdomide (MEZI) Plus Dexamethasone (DEX) and Bortezomib (BORT) or Carfilzomib (CFZ) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Updated Results from the CC-92480-MM-002 Trial","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University; Université de Montréal; Hôpital Maisonneuve-Rosemont; University of Alberta","funders":"","keywords":"Carfilzomib; Bortezomib; Medicine; Dexamethasone; Multiple myeloma; Lenalidomide; Internal medicine; Refractory (planetary science); Oncology; Pomalidomide","score_opus":0.026743721818984715,"score_gpt":0.2772049587992465,"score_spread":0.2504612369802618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99212396,0.0015395548,0.000010262229,0.0006085334,0.0003304841,0.003258352,0.0011832488,0.0002094477,0.0007361312],"genre_scores_gemma":[0.99459535,0.00034014965,0.0010595695,0.000183596,0.00045236238,0.0002638376,0.0016698213,0.00012349944,0.0013118422],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9955873,0.00039460213,0.0008934844,0.0011972252,0.0010445219,0.0008828591],"domain_scores_gemma":[0.996261,0.0018169087,0.00018750224,0.0010299851,0.00017861773,0.0005259584],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006413568,0.00058284693,0.0008972604,0.00029473423,0.00020770497,0.00018100276,0.00030383468,0.00031804107,0.00014316074],"category_scores_gemma":[0.0016629449,0.00032972964,0.00015573027,0.00078253925,0.00026964414,0.00029631238,0.0002003975,0.00093876664,0.000111155954],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.67195255,0.017881397,0.22498642,0.00024660278,0.005080357,0.0077969776,0.0041170754,0.000009327397,0.0012445711,0.000029448096,0.010530481,0.056124795],"study_design_scores_gemma":[0.7412782,0.0050220694,0.23750913,0.0007382789,0.0009753378,0.000057682628,0.00036762588,0.0011238245,0.0022887965,0.000028470777,0.010070282,0.0005403059],"about_ca_topic_score_codex":0.003985859,"about_ca_topic_score_gemma":0.0041326294,"teacher_disagreement_score":0.06932564,"about_ca_system_score_codex":0.0002995626,"about_ca_system_score_gemma":0.0007687695,"threshold_uncertainty_score":0.9999155},"labels":[],"label_agreement":null},{"id":"W4405042667","doi":"10.1182/blood-2024-200877","title":"Outcomes of Frailty Subgroups Treated with Teclistamab in the Real-World: An International Myeloma Foundation Study Database Analysis","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Multiple myeloma; Discontinuation; Internal medicine; Clinical trial; Comorbidity; Database; Oncology","score_opus":0.046269374636048514,"score_gpt":0.3783891061889204,"score_spread":0.3321197315528719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99691314,0.00002030423,0.000035617762,0.00018127241,0.000016898799,0.0006292628,0.00009237565,0.000041672258,0.002069456],"genre_scores_gemma":[0.99795586,0.000018315786,0.00029456127,0.000017384908,0.000034464796,0.00008670668,0.0011652549,0.000012936809,0.00041453983],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985845,0.00012595682,0.00024988785,0.0002981168,0.0005842908,0.00015724407],"domain_scores_gemma":[0.9991754,0.00014748353,0.000044757267,0.00048359504,0.00008198932,0.00006674684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034309993,0.00012799502,0.0002722833,0.00072135107,0.000037126167,0.00006225592,0.00016344663,0.000021545973,0.00018403205],"category_scores_gemma":[0.00005872775,0.00006927518,0.0000732576,0.0013836622,0.00004512449,0.00020691172,0.00003105898,0.00013224299,0.000011847861],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002948967,0.00396074,0.9877203,0.00002374563,0.0033190532,0.0008991007,0.0006133725,0.0000028508314,0.00021352559,0.00020318896,0.000004741039,0.0027444996],"study_design_scores_gemma":[0.004575455,0.00062917947,0.9912239,0.000029206916,0.0016488966,0.000009680338,0.0005919381,0.000810592,0.00035571767,0.000009084558,0.00005406263,0.000062308485],"about_ca_topic_score_codex":0.0039437143,"about_ca_topic_score_gemma":0.01231273,"teacher_disagreement_score":0.0083690155,"about_ca_system_score_codex":0.000052901458,"about_ca_system_score_gemma":0.000070723836,"threshold_uncertainty_score":0.6870792},"labels":[],"label_agreement":null},{"id":"W4405042670","doi":"10.1182/blood-2024-201997","title":"Derivation and External Validation of a Venous Thromboembolism Risk Prediction Model in Patients with Acute Lymphoblastic Leukemia Receiving Asparaginase Therapy","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Lymphoblastic Leukemia; Medicine; Asparaginase; Venous thromboembolism; Leukemia; Acute lymphocytic leukemia; Oncology; Intensive care medicine; Internal medicine; Pediatrics; Thrombosis","score_opus":0.009975767509150088,"score_gpt":0.24936880618761229,"score_spread":0.2393930386784622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99397546,0.00033738767,0.0049203457,0.000033652672,0.00003915899,0.0005193555,0.00004046744,0.00005738501,0.000076791526],"genre_scores_gemma":[0.9973999,0.0005774475,0.0017883325,0.000018572924,0.000058050136,0.000037264024,0.000060347167,0.0000330557,0.000026982494],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886316,0.000051923882,0.00024370798,0.00028003336,0.00037250656,0.00018865563],"domain_scores_gemma":[0.9995023,0.0000653835,0.00007354447,0.00018095999,0.00011046365,0.00006735353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021743814,0.0001314485,0.00023826696,0.00025408843,0.00004172426,0.00003132307,0.000052432944,0.000087499124,0.000008714707],"category_scores_gemma":[0.00005793482,0.000104760176,0.00002576228,0.00030355167,0.000056296412,0.00023142318,0.000027407015,0.00022512635,0.000003220749],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027744905,0.0020617142,0.87108403,0.0006001671,0.0011354923,0.00018447742,0.0060274852,0.006834467,0.059995137,0.00013722411,0.00011673274,0.04904859],"study_design_scores_gemma":[0.009681535,0.0012736645,0.8575152,0.0006757012,0.00033853337,0.00005411933,0.000024679453,0.10798489,0.021927377,0.00040113484,0.0000043673886,0.00011875281],"about_ca_topic_score_codex":0.00012349641,"about_ca_topic_score_gemma":0.0000032860887,"teacher_disagreement_score":0.10115042,"about_ca_system_score_codex":0.00028238163,"about_ca_system_score_gemma":0.00042844686,"threshold_uncertainty_score":0.4271996},"labels":[],"label_agreement":null},{"id":"W4405042676","doi":"10.1182/blood-2024-205524","title":"Trajectories of Frailty Categorization over Time Among Real-World Patients with Multiple Myeloma: A Prospective Cohort Study (MFRAIL)","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; London Health Sciences Centre; McMaster University; Population Health Research Institute","funders":"","keywords":"Multiple myeloma; Medicine; Prospective cohort study; Categorization; Hematologic Neoplasms; Cohort; Internal medicine; Cohort study; Oncology; Cancer; Computer science; Artificial intelligence","score_opus":0.009789723285105986,"score_gpt":0.26951941573971544,"score_spread":0.2597296924546095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99354434,0.00005468311,0.000020226713,0.000008826359,0.000055806002,0.0032839351,0.00008982388,0.00014605619,0.0027962737],"genre_scores_gemma":[0.9968675,0.0000068661184,0.00017313001,0.0000029685852,0.000079868005,0.0002928051,0.0002749634,0.000050522438,0.0022514],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819136,0.000058898233,0.00027530116,0.00046076826,0.00072349375,0.00029017596],"domain_scores_gemma":[0.9990735,0.00011300676,0.000069493755,0.00033198146,0.00025346773,0.00015854446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012250758,0.0002228842,0.00039813272,0.00023610429,0.00007569519,0.000038879785,0.00007133513,0.00005571965,0.00018229835],"category_scores_gemma":[0.00011115227,0.0001547943,0.000069476926,0.0006739037,0.000107555265,0.00018608448,0.000042097072,0.00017537383,0.000038746817],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048747298,0.004340446,0.9917915,0.000116355375,0.0015011092,0.00014348909,0.00082818244,0.0000012472238,0.00025273056,0.000036726287,0.000067532215,0.00043322792],"study_design_scores_gemma":[0.009467124,0.0017186803,0.9849618,0.00012246291,0.00059353845,0.0000019245697,0.000060519273,0.00017892165,0.0027117098,0.000020900006,0.000022949398,0.00013946126],"about_ca_topic_score_codex":0.001809119,"about_ca_topic_score_gemma":0.0013001477,"teacher_disagreement_score":0.00897965,"about_ca_system_score_codex":0.00011697072,"about_ca_system_score_gemma":0.00015901348,"threshold_uncertainty_score":0.6312328},"labels":[],"label_agreement":null},{"id":"W4405042679","doi":"10.1182/blood-2024-199981","title":"<i>CSF2RB</i> Mutations Result in Cytokine-Dependent Gain-of-Function Phenotypes in Classic Hodgkin Lymphoma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; Princess Margaret Cancer Centre; University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Biology; Cancer research; Exome sequencing; Cytokine; Mutation; Genetics; Gene","score_opus":0.01419930214028463,"score_gpt":0.26067772837866476,"score_spread":0.24647842623838012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896796,0.0027285682,0.000034929613,0.00076655403,0.00025088203,0.00037579602,0.000033768385,0.000075705444,0.0060541998],"genre_scores_gemma":[0.99883443,0.00017611956,0.0002439075,0.00014388426,0.00009809121,0.00012615041,0.000065063556,0.000023237788,0.000289106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988195,0.00004620204,0.0003767807,0.0003093208,0.00024254137,0.0002056823],"domain_scores_gemma":[0.99947894,0.00015688986,0.00004469905,0.00022141938,0.000036013746,0.000062053514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016241212,0.00014602355,0.0002621593,0.0003151378,0.000021150629,0.00002287277,0.00004857177,0.00009298302,0.00004799628],"category_scores_gemma":[0.000063501764,0.000121495636,0.00008572182,0.0004928144,0.000034452674,0.00007691116,0.000024832736,0.00007406729,0.00009203725],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011133463,0.022415023,0.741338,0.001059486,0.0011380193,0.0059248977,0.0042596143,0.0005507948,0.031606045,0.015821954,0.0028248155,0.17194797],"study_design_scores_gemma":[0.02173266,0.0009553541,0.9053361,0.0012841185,0.0007870604,0.00016597589,0.0004448804,0.00075722113,0.062564716,0.0017950773,0.0038849937,0.00029185537],"about_ca_topic_score_codex":0.00048451638,"about_ca_topic_score_gemma":0.0005213694,"teacher_disagreement_score":0.17165612,"about_ca_system_score_codex":0.00018845074,"about_ca_system_score_gemma":0.00021558517,"threshold_uncertainty_score":0.4954448},"labels":[],"label_agreement":null},{"id":"W4405042683","doi":"10.1182/blood-2024-203216","title":"Characterizing Diagnostic Investigations for Suspected Pulmonary Embolism in Postpartum Individuals","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital; University of Calgary","funders":"","keywords":"Pulmonary embolism; Medicine; Intensive care medicine; Internal medicine","score_opus":0.018843075309203067,"score_gpt":0.27166535768797045,"score_spread":0.25282228237876736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98297805,0.0020797662,0.000038090122,0.010102468,0.00040742158,0.0014848909,0.000074167394,0.00024110994,0.0025940468],"genre_scores_gemma":[0.99575233,0.0006030659,0.00067726924,0.0012291588,0.00042992173,0.000684,0.0002997121,0.00004893626,0.0002756303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877053,0.00002770093,0.0003219075,0.00035287163,0.00017948018,0.00034749313],"domain_scores_gemma":[0.9991429,0.0004173003,0.00003884282,0.00022567972,0.000040771978,0.00013450759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022748706,0.00016717972,0.00035914543,0.00032954928,0.00006729948,0.00008271308,0.00008902406,0.000082176084,0.00008217793],"category_scores_gemma":[0.0004751903,0.0001587016,0.000099787896,0.00038910852,0.000042425178,0.00013769703,0.00006166555,0.00015872474,0.00006741993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008981497,0.023258675,0.50557977,0.011471848,0.0036210665,0.0055360566,0.016675886,0.000032141477,0.13557091,0.22752126,0.039570767,0.031071786],"study_design_scores_gemma":[0.0014826669,0.00025864877,0.9518393,0.0016413033,0.000883032,0.00008278258,0.0002232931,0.00024233131,0.0062452876,0.0031043508,0.033703897,0.00029307767],"about_ca_topic_score_codex":0.0000460646,"about_ca_topic_score_gemma":0.000018009583,"teacher_disagreement_score":0.44625953,"about_ca_system_score_codex":0.000038389473,"about_ca_system_score_gemma":0.00011239218,"threshold_uncertainty_score":0.6471663},"labels":[],"label_agreement":null},{"id":"W4405042710","doi":"10.1182/blood-2024-201848","title":"Impact of Extramedullary Disease on the Outcomes after Allogeneic Hematopoietic Cell Transplantation in Children and Young Adults with Acute Myeloid Leukemia - a CIBMTR Analysis","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Hematopoietic cell; Medicine; Transplantation; Myeloid leukemia; Hematopoietic stem cell transplantation; Disease; Leukemia; Myeloid; Immunology; Haematopoiesis; Internal medicine; Stem cell; Biology; Genetics","score_opus":0.005107032728246125,"score_gpt":0.2539863918028676,"score_spread":0.24887935907462147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971003,0.0015219167,0.000034687757,0.00029356228,0.000009116005,0.0007127994,0.00021398194,0.00003435955,0.00007929736],"genre_scores_gemma":[0.998376,0.0010109503,0.00010196698,0.00007676871,0.000025143085,0.0000962829,0.00015807363,0.000035005713,0.000119778655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985462,0.000078680154,0.00026265276,0.00039720713,0.00042068638,0.00029457224],"domain_scores_gemma":[0.9992034,0.00013238988,0.00004271337,0.00039311952,0.000038372862,0.0001899958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018023387,0.00023222345,0.00038384763,0.00044753132,0.000029990677,0.000037078597,0.00011489268,0.000067633635,0.00008629901],"category_scores_gemma":[0.000017303251,0.00012550253,0.00023800343,0.0008230461,0.000111720365,0.00007466168,0.000024608435,0.00032545064,0.000008319507],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015928416,0.0002505288,0.9911509,0.00023197867,0.0031901866,0.0013402028,0.0011174729,0.000034713234,0.00085616414,0.000010021601,0.000019307456,0.00020567041],"study_design_scores_gemma":[0.0028794373,0.0003275016,0.9895203,0.00025117677,0.0052441345,0.00024355104,0.00004762211,0.0002666921,0.0010692858,0.000012905336,3.453729e-7,0.00013706357],"about_ca_topic_score_codex":0.00040557803,"about_ca_topic_score_gemma":0.00010257318,"teacher_disagreement_score":0.0020539481,"about_ca_system_score_codex":0.00014599624,"about_ca_system_score_gemma":0.00044704217,"threshold_uncertainty_score":0.51178443},"labels":[],"label_agreement":null},{"id":"W4405042792","doi":"10.1182/blood-2024-209097","title":"Efficacy and Safety of Uproleselan Combined with Chemotherapy Vs. Chemotherapy Alone in Relapsed/Refractory Acute Myeloid Leukemia: Findings from an International Phase 3 Trial","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University Health Network","funders":"","keywords":"Medicine; Chemotherapy; Chemotherapy regimen; Myeloid leukemia; Internal medicine; Refractory (planetary science); Oncology; Phases of clinical research; Biology","score_opus":0.012497339251086812,"score_gpt":0.3048294359654016,"score_spread":0.29233209671431476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950188,0.0002965892,0.00004881582,0.0024643533,0.00014542701,0.0013421848,0.000114962,0.000120829354,0.00044805888],"genre_scores_gemma":[0.9956586,0.0012939345,0.0012277523,0.0004719111,0.00040139095,0.000056212437,0.00037074272,0.00009576313,0.00042369435],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9978028,0.000077706405,0.0005249534,0.000635883,0.00060654915,0.00035210047],"domain_scores_gemma":[0.9988951,0.00024667534,0.00009152297,0.0004561458,0.00009212672,0.00021843104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004537012,0.00030374786,0.00065269455,0.0003877152,0.00004404908,0.000059145266,0.0002863181,0.0002612848,0.0003073379],"category_scores_gemma":[0.000062336054,0.00024136946,0.000083967956,0.00041560334,0.00021301955,0.00022335406,0.000054869983,0.0007946173,0.0000123464615],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7538657,0.007074332,0.010355346,0.00016704842,0.003467925,0.0011636836,0.004766373,0.000003835449,0.18826473,0.0002121793,0.00089247926,0.029766385],"study_design_scores_gemma":[0.8633571,0.014346841,0.050515864,0.0007062945,0.00043382286,0.00015403844,0.00014753347,0.0015619124,0.06236536,0.00010861448,0.005835718,0.00046689456],"about_ca_topic_score_codex":0.00020573958,"about_ca_topic_score_gemma":0.000028035409,"teacher_disagreement_score":0.12589936,"about_ca_system_score_codex":0.00036223608,"about_ca_system_score_gemma":0.0006821919,"threshold_uncertainty_score":0.9842761},"labels":[],"label_agreement":null},{"id":"W4405042793","doi":"10.1182/blood-2024-209158","title":"Using the Serious Illness Conversation Guide (SICG) in Patients with Hematological Malignancies As a Tool to Address Their Perspectives on Palliative Care","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Conversation; Palliative care; Medicine; Intensive care medicine; Hematologic Neoplasms; Advance care planning; Terminally ill; Internal medicine; Psychology; Nursing; Cancer","score_opus":0.06248264915351893,"score_gpt":0.3667884790578172,"score_spread":0.3043058299042983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956539,0.002228955,0.000076365955,0.00030537992,0.000067171284,0.0006670791,0.0000393012,0.00004295787,0.0009188706],"genre_scores_gemma":[0.99907637,0.000068980655,0.0004947335,0.00020184582,0.000048852562,0.000042832013,0.000017420347,0.000016588136,0.000032409913],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.99906534,0.000055567223,0.00018028777,0.00027087485,0.00025778252,0.00017012145],"domain_scores_gemma":[0.9993394,0.00014806227,0.000046271864,0.00017788164,0.0002472219,0.000041153628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000070488255,0.00015887764,0.000274351,0.00009215031,0.00004748845,0.000022488946,0.00007826187,0.000061660074,0.000020641444],"category_scores_gemma":[0.00021072356,0.00008616747,0.00005660934,0.00029632467,0.000082410246,0.000054893804,0.000033916243,0.00012848222,0.0000086239],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009776619,0.0006933242,0.54754734,0.00050642295,0.0004819154,0.00023698335,0.44320446,0.00013082934,0.00095874583,0.003290437,0.00013054813,0.0018413506],"study_design_scores_gemma":[0.007982766,0.003607551,0.38316253,0.011526479,0.0005575587,0.000016912369,0.50042677,0.00014844893,0.08613392,0.00019332004,0.0055309185,0.000712844],"about_ca_topic_score_codex":0.000110598856,"about_ca_topic_score_gemma":0.00003300966,"teacher_disagreement_score":0.16438478,"about_ca_system_score_codex":0.00010618388,"about_ca_system_score_gemma":0.00010302718,"threshold_uncertainty_score":0.35138074},"labels":[],"label_agreement":null},{"id":"W4405042803","doi":"10.1182/blood-2024-203980","title":"Clinical Outcomes after Hospitalization for Oral Anticoagulant-Related Bleeding","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Case Reports on Hematomas","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; University of Ottawa; Institute for Clinical Evaluative Sciences; University of British Columbia","funders":"","keywords":"Medicine; Intensive care medicine; Oral anticoagulant; Anticoagulant; Bleeding diathesis; Rivaroxaban; Apixaban; Warfarin; Internal medicine; Atrial fibrillation; Platelet","score_opus":0.030463298202849577,"score_gpt":0.3636774648375508,"score_spread":0.3332141666347012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958511,0.0010182925,0.00041117193,0.0005917202,0.0007907399,0.00054684887,0.000009212307,0.00031593328,0.00046500415],"genre_scores_gemma":[0.99682015,0.000044599234,0.0013282214,0.0001388671,0.00018243925,0.000046234694,0.000037859485,0.00004367928,0.0013579503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988295,0.000011866336,0.00050598773,0.00028586554,0.00018130224,0.00018547259],"domain_scores_gemma":[0.9994407,0.00013583904,0.000050061437,0.0001999627,0.00007121257,0.00010218692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003503311,0.00011838631,0.00033980858,0.000098026685,0.000023365776,0.000040334977,0.000025856918,0.00013752452,0.00011058853],"category_scores_gemma":[0.00029467148,0.000091950205,0.00027430317,0.00015095854,0.000035034027,0.00007722396,0.00002385634,0.000113586524,0.000052322972],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003284505,0.0004250502,0.9931944,0.00037589294,0.00054492144,0.0018204784,0.00009657536,2.3933177e-7,0.00034267982,0.00074420247,0.0009031248,0.0015195771],"study_design_scores_gemma":[0.0068993806,0.0006176755,0.9650868,0.0012263209,0.004228559,0.0031479683,0.00007255408,0.002588254,0.002232449,0.0009048746,0.012540447,0.00045469217],"about_ca_topic_score_codex":0.000005965459,"about_ca_topic_score_gemma":0.0000024306366,"teacher_disagreement_score":0.028107587,"about_ca_system_score_codex":0.000015419644,"about_ca_system_score_gemma":0.00007881879,"threshold_uncertainty_score":0.37496206},"labels":[],"label_agreement":null},{"id":"W4405042850","doi":"10.1182/blood-2024-202703","title":"Accuracy of a Bleeding Assessment Tool in Predicting the Diagnosis of an Inherited Bleeding Disorder: Systematic Review and Meta-Analysis","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Meta-analysis; Medicine; Bleeding diathesis; Systematic review; MEDLINE; Intensive care medicine; Internal medicine; Platelet; Biology","score_opus":0.06824759204331168,"score_gpt":0.3810172699668725,"score_spread":0.3127696779235608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8093383,0.1869812,0.000008546152,0.0017987567,0.000008654098,0.0016865301,0.000019954248,0.000023452694,0.00013466406],"genre_scores_gemma":[0.9876901,0.011451518,0.00025789218,0.000038493235,0.00001439944,0.0004591922,0.000012229448,0.000013388395,0.00006280574],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.998337,0.00018901964,0.0006709135,0.0002301121,0.00040905515,0.00016393005],"domain_scores_gemma":[0.9985296,0.0008883009,0.00014227857,0.0003111873,0.000084179024,0.00004444407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001616853,0.00013531449,0.0013889681,0.00028665995,0.000040845134,0.000032754437,0.0001024625,0.000045384,0.00010292176],"category_scores_gemma":[0.00055570895,0.000068477144,0.00037425765,0.0013077874,0.00004607105,0.00012559995,0.00006725098,0.00017640273,6.162849e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001012794,0.0014103975,0.26557273,0.5442625,0.18529442,0.0001036761,0.0017472939,0.000009668845,0.0010201519,0.00019991299,0.000016533804,0.00035258092],"study_design_scores_gemma":[0.00080659025,0.0003391711,0.009008819,0.014575403,0.96924573,0.000030131445,0.0010599161,0.003641441,0.0011344823,0.000035154873,0.0000056185336,0.00011754364],"about_ca_topic_score_codex":0.00012489846,"about_ca_topic_score_gemma":0.000026244601,"teacher_disagreement_score":0.78395134,"about_ca_system_score_codex":0.000020730842,"about_ca_system_score_gemma":0.00006338837,"threshold_uncertainty_score":0.27924168},"labels":[],"label_agreement":null},{"id":"W4405042879","doi":"10.1182/blood-2024-201454","title":"Rap-536, a Murine Luspatercept Analog Ameliorates Anemia and Vaso-Occlusion in Experimental Model of Sickle Cell Disease","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Anemia; Disease; Sickle cell anemia; Cell; Pathology; Internal medicine; Biology","score_opus":0.006767395886082552,"score_gpt":0.23315174985904902,"score_spread":0.22638435397296647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99026555,0.0092278775,0.00013748571,0.000020750651,0.000024304045,0.0001417807,0.00005694303,0.000012007842,0.00011333164],"genre_scores_gemma":[0.99911845,0.00015610512,0.00034982295,0.000022136697,0.000045417546,0.00000959589,0.00015058061,0.000018237952,0.00012966467],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993534,0.000023891838,0.00014948468,0.00027602416,0.000076827455,0.0001203804],"domain_scores_gemma":[0.9996896,0.0000041188496,0.000029109273,0.00017697267,0.00001814852,0.000082061415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000051475763,0.000112216876,0.00009455761,0.00006683894,0.000019316429,0.000016472408,0.000064452084,0.00006366987,0.000024896734],"category_scores_gemma":[0.000006176629,0.00010832545,0.000046894424,0.00007780296,0.000048723854,0.000005732333,0.00012660559,0.000037114867,0.0000022796883],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060648723,0.00027266864,0.00437882,0.00014993973,0.000011338945,0.000016998405,0.00010277402,0.00058175606,0.9942069,0.000011839589,0.00012483454,0.00008150156],"study_design_scores_gemma":[0.0008052796,0.00008583644,0.0060406597,0.0000498123,0.000042062158,0.0000036980396,0.00004331653,0.009247405,0.983386,0.000093176066,0.000064302294,0.0001384832],"about_ca_topic_score_codex":0.00001347424,"about_ca_topic_score_gemma":0.0000060947414,"teacher_disagreement_score":0.010820911,"about_ca_system_score_codex":0.000008390368,"about_ca_system_score_gemma":0.000057981,"threshold_uncertainty_score":0.44173834},"labels":[],"label_agreement":null},{"id":"W4405042905","doi":"10.1182/blood-2024-200300","title":"Pharmacodynamic Signatures and Correlatives of Response in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Treated with Talquetamab or Teclistamab Plus Daratumumab and Pomalidomide","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Princess Margaret Cancer Centre","funders":"Kite Pharma; Adaptive Biotechnologies; Regeneron Pharmaceuticals; Janssen Pharmaceuticals; Genentech; Celgene; Bristol-Myers Squibb; GlaxoSmithKline; Servier; Amgen","keywords":"Daratumumab; Pomalidomide; Medicine; Multiple myeloma; Lenalidomide; Internal medicine; Refractory (planetary science); Oncology; Pharmacodynamics; Biology; Pharmacokinetics","score_opus":0.00999610232743083,"score_gpt":0.26660087542740096,"score_spread":0.25660477309997015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99528134,0.0029187873,0.000010435116,0.000056678935,0.000021398624,0.0012162717,0.00018805216,0.000078405814,0.00022865678],"genre_scores_gemma":[0.99837196,0.00013107335,0.00052653777,0.000016694667,0.00001513616,0.000069737536,0.00011482421,0.000059991104,0.0006940579],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981654,0.00020116096,0.00030482866,0.00053136173,0.0004298638,0.0003673821],"domain_scores_gemma":[0.99865246,0.0006637151,0.00008742794,0.0002492904,0.00011233631,0.00023478358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001841202,0.0003282475,0.0005131935,0.0004451085,0.000078423196,0.00004252987,0.0000658189,0.00013160282,0.000037603815],"category_scores_gemma":[0.00022545441,0.0001937695,0.00003852903,0.00046277817,0.0003196061,0.00022039177,0.000056600074,0.00041758962,0.000003238219],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19093141,0.0021443507,0.7862298,0.0005769811,0.001264785,0.003670497,0.0011073707,0.000014137694,0.010110455,0.000013327201,0.000041213,0.0038956723],"study_design_scores_gemma":[0.07033332,0.0068244194,0.9145055,0.0010582899,0.00042206605,0.00011618772,0.00018107475,0.0017641798,0.004451728,0.0000041852873,0.000099646975,0.00023943977],"about_ca_topic_score_codex":0.00014123536,"about_ca_topic_score_gemma":0.00015568256,"teacher_disagreement_score":0.12827566,"about_ca_system_score_codex":0.000106493244,"about_ca_system_score_gemma":0.00030427772,"threshold_uncertainty_score":0.7901691},"labels":[],"label_agreement":null},{"id":"W4405042906","doi":"10.1182/blood-2024-202842","title":"Targeting Deacetylase Sirt-1 Reprograms Treg Function in Immune Thrombocytopenia","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Immunology; Immune system; Medicine; Biology","score_opus":0.01292943118774768,"score_gpt":0.2619953467951698,"score_spread":0.2490659156074221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853574,0.010301021,0.000026031457,0.0003130206,0.00017144362,0.00031163412,0.000003192697,0.00016274602,0.0033535156],"genre_scores_gemma":[0.998424,0.00021481686,0.00030513143,0.000061435065,0.00007271499,0.000038921236,0.000095697964,0.000024786961,0.000762495],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99916273,0.000017288317,0.00020180443,0.00028140927,0.000121075725,0.00021566259],"domain_scores_gemma":[0.99971956,0.000023688373,0.000021764066,0.00016808152,0.000014708419,0.0000521826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012914598,0.000119510056,0.00026095318,0.00008390795,0.00003696576,0.000037258917,0.000031544667,0.000071910596,0.00011678965],"category_scores_gemma":[0.00003301603,0.000096359065,0.00008029025,0.00027270464,0.00001774855,0.00008562969,0.000021493954,0.0001544328,0.00019665931],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013941893,0.017366763,0.19293927,0.001569384,0.0036400782,0.040716004,0.0032460229,0.00004505446,0.23994379,0.0018635452,0.004276878,0.49299902],"study_design_scores_gemma":[0.113947935,0.011372208,0.51001006,0.006345428,0.008928341,0.0050980337,0.0040950235,0.006792437,0.16042902,0.0076159695,0.16213441,0.0032311124],"about_ca_topic_score_codex":0.00014604822,"about_ca_topic_score_gemma":0.000028595456,"teacher_disagreement_score":0.4897679,"about_ca_system_score_codex":0.000030536172,"about_ca_system_score_gemma":0.00004439913,"threshold_uncertainty_score":0.39294088},"labels":[],"label_agreement":null},{"id":"W4405042935","doi":"10.1182/blood-2024-203757","title":"Asciminib (ASC) Demonstrates Favorable Safety and Tolerability Compared with Each Investigator-Selected Tyrosine Kinase Inhibitor (IS TKI) in Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) in the Pivotal Phase 3 ASC4FIRST Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Tolerability; Medicine; Myeloid leukemia; Tyrosine-kinase inhibitor; Internal medicine; Tyrosine kinase; Nilotinib; Phases of clinical research; Oncology; Imatinib; Pharmacology; Adverse effect; Clinical trial; Cancer; Receptor","score_opus":0.01849470641750113,"score_gpt":0.2865542485673685,"score_spread":0.2680595421498674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847217,0.009275536,0.000007021879,0.00066964957,0.000102946775,0.004709022,0.0001365108,0.00018389798,0.00019372406],"genre_scores_gemma":[0.9980341,0.00032642463,0.00014707171,0.00016776902,0.0002694426,0.00060053606,0.00029938552,0.00010034259,0.000054920783],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9946915,0.00056126894,0.0013608455,0.0015017901,0.00077473157,0.0011098911],"domain_scores_gemma":[0.9975636,0.0006956191,0.00017895138,0.0010038705,0.000107290965,0.00045064854],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011427611,0.000826672,0.0013410675,0.0005550819,0.00017765218,0.0002001247,0.0003509501,0.00027452272,0.00012554399],"category_scores_gemma":[0.00039855557,0.0006184678,0.000109638706,0.00295143,0.0005029397,0.00042913374,0.00012759453,0.0014423628,0.000022881626],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0075525143,0.049167987,0.79894096,0.0033608673,0.0015374703,0.020905137,0.03162359,0.001017382,0.065621935,0.00008478431,0.0013631661,0.01882419],"study_design_scores_gemma":[0.48826236,0.026554747,0.3921655,0.0062463954,0.0020035685,0.0010522164,0.005980882,0.030556817,0.043361895,0.00012026349,0.0015697625,0.002125591],"about_ca_topic_score_codex":0.0060391296,"about_ca_topic_score_gemma":0.026446847,"teacher_disagreement_score":0.48070985,"about_ca_system_score_codex":0.007971295,"about_ca_system_score_gemma":0.010359843,"threshold_uncertainty_score":0.99962664},"labels":[],"label_agreement":null},{"id":"W4405042939","doi":"10.1182/blood-2024-206347","title":"NF-Kb Pathway Activation Driven By TRAF3 Loss Mediates Resistance to Anti-BCMA T-Cell Based Therapies in Multiple Myeloma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Quinazolinone synthesis and applications","field":"Chemistry","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Multiple myeloma; Cancer research; NFKB1; Bortezomib; Medicine; Immunology; Biology; Transcription factor; Genetics; Gene","score_opus":0.009108858396391584,"score_gpt":0.21541059534385562,"score_spread":0.20630173694746404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948267,0.0006698732,0.0002021151,0.0013519461,0.000023143679,0.00014182946,0.00019354714,0.00015630691,0.0024345608],"genre_scores_gemma":[0.9977629,0.000043658947,0.0007125884,0.00007784981,0.00011454692,0.00021203511,0.000082781364,0.000039709714,0.00095389446],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99893844,0.000020062756,0.000244211,0.00038056023,0.0001788799,0.00023784333],"domain_scores_gemma":[0.9992295,0.00031302447,0.000048206,0.0003104558,0.000026971486,0.00007182841],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000092019094,0.00016801883,0.00017312939,0.00006548323,0.00007252693,0.000072559924,0.00020290507,0.00010606249,0.00021590904],"category_scores_gemma":[0.000046789544,0.00015929417,0.00006761529,0.0002437419,0.00003536167,0.000081393,0.000020696842,0.00014180392,0.00007309646],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001284044,0.00049003516,0.0035910225,0.00015376732,0.000020518499,0.000008178448,0.000561231,0.000023933655,0.99232614,0.00009505214,0.00094257353,0.0017747261],"study_design_scores_gemma":[0.00058193394,0.000008469895,0.0022739791,0.00017142318,0.000015099191,4.566158e-7,0.00014362302,0.000328574,0.9722596,0.00010482504,0.023910709,0.00020130149],"about_ca_topic_score_codex":0.000025014646,"about_ca_topic_score_gemma":0.00007269785,"teacher_disagreement_score":0.022968136,"about_ca_system_score_codex":0.00003266862,"about_ca_system_score_gemma":0.000059618742,"threshold_uncertainty_score":0.6495828},"labels":[],"label_agreement":null},{"id":"W4405042940","doi":"10.1182/blood-2024-205424","title":"Clinical Outcomes of Neonatal Central Line-Related Thrombosis: A Multicentric Retrospective Cohort Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Neonatal and fetal brain pathology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; BC Children's Hospital; Université Laval; Hospital for Sick Children; Centre hospitalier universitaire de Québec; Montreal Children's Hospital; McMaster University; McMaster Children's Hospital; London Health Sciences Centre; Centre Hospitalier Universitaire Sainte-Justine; McGill University Health Centre; Children's Hospital of Eastern Ontario","funders":"","keywords":"Medicine; Retrospective cohort study; Thrombosis; Pediatrics; Internal medicine","score_opus":0.019470324378776434,"score_gpt":0.3264998474094487,"score_spread":0.30702952303067227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99525064,0.0013217293,0.00003453843,0.00022590753,0.00087242544,0.001071197,0.00004827607,0.00017618906,0.0009990745],"genre_scores_gemma":[0.998592,0.000083999155,0.0002963234,0.0001016928,0.00014563747,0.00002300798,0.000026082227,0.000028983677,0.0007022791],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980719,0.00009837634,0.00067948515,0.0004998787,0.000339714,0.0003106446],"domain_scores_gemma":[0.9991293,0.0002264297,0.00008244289,0.00031934356,0.0000882382,0.00015426127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040583027,0.00018873882,0.0007561831,0.00012624187,0.000032123033,0.000010413364,0.000109702756,0.0001652068,0.00018707907],"category_scores_gemma":[0.00039625153,0.00013801757,0.0003233586,0.00038785822,0.00016474014,0.00006284928,0.00009891953,0.0004897341,0.00009693442],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006165359,0.0027728032,0.9913249,0.000063013584,0.0017377832,0.0009883748,0.00071641145,3.6461083e-7,0.00018390572,0.00017936378,0.000054859902,0.0019165567],"study_design_scores_gemma":[0.004627121,0.0014326454,0.991063,0.00006736453,0.0015943624,0.0001421857,0.00032194005,0.00011936909,0.00026576573,0.00014655897,0.00009127596,0.00012842355],"about_ca_topic_score_codex":0.00004430513,"about_ca_topic_score_gemma":0.000010329096,"teacher_disagreement_score":0.0045654676,"about_ca_system_score_codex":0.000026254582,"about_ca_system_score_gemma":0.00008539872,"threshold_uncertainty_score":0.56281936},"labels":[],"label_agreement":null},{"id":"W4405042947","doi":"10.1182/blood-2024-199105","title":"Complementary and Alternative Medicine (CAM) Use Reported Among Individuals with Immune Thrombocytopenia (ITP): Data from the ITP Natural History Study Registry","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Complementary and Alternative Medicine Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Kingston Health Sciences Centre","funders":"","keywords":"Immune thrombocytopenia; Medicine; Natural history; Eltrombopag; Immunology; Pediatrics; Intensive care medicine; Internal medicine; Platelet","score_opus":0.14209436785291676,"score_gpt":0.3508503229379793,"score_spread":0.20875595508506253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97516364,0.018919604,0.000017138682,0.0027317826,0.00080041174,0.0014443551,0.00037503632,0.0001103016,0.00043772862],"genre_scores_gemma":[0.995045,0.00036824064,0.00028032638,0.0005452379,0.0011768163,0.000044338685,0.0017601446,0.00004175928,0.00073813746],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99710727,0.0001882069,0.00066917675,0.0009099473,0.0008141569,0.0003112708],"domain_scores_gemma":[0.99726367,0.00091167726,0.00025423645,0.001346345,0.00010487849,0.00011918143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071196194,0.00038983207,0.00078659935,0.000108192355,0.00022405692,0.00004881677,0.0005278247,0.000016885695,0.0007320345],"category_scores_gemma":[0.0002764907,0.0002126224,0.00004464741,0.00020382424,0.00084366056,0.00040462363,0.00091097306,0.0006293345,0.0000052101004],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016918412,0.00056529336,0.9557073,0.000064365304,0.007013037,0.002043182,0.009293109,1.4182474e-7,0.0009463046,0.000050430695,0.023379674,0.0007679616],"study_design_scores_gemma":[0.008855054,0.001666579,0.9378489,0.0011721139,0.004227813,0.0002457988,0.015354511,0.00009615387,0.00016832154,0.000057641253,0.030039553,0.00026756513],"about_ca_topic_score_codex":0.012457751,"about_ca_topic_score_gemma":0.0027590208,"teacher_disagreement_score":0.019881357,"about_ca_system_score_codex":0.00010337021,"about_ca_system_score_gemma":0.000103664,"threshold_uncertainty_score":0.9941184},"labels":[],"label_agreement":null},{"id":"W4405042948","doi":"10.1182/blood-2024-200639","title":"Oxygen Gradient Ektacytometry Is Associated with Markers of Hemolysis and Inflammation in a Large Sickle Cell Disease Cohort within the GenoMed4ALL Project","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Cohort; Disease; Inflammation; Hemolysis; Immunology; Internal medicine","score_opus":0.004829985071067417,"score_gpt":0.21483448664629606,"score_spread":0.21000450157522865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940927,0.003388371,0.000007821042,0.000609744,0.00003145404,0.0008027837,0.000049936327,0.000043071614,0.0009741114],"genre_scores_gemma":[0.9990216,0.00030536132,0.000044432727,0.00010166064,0.000017422912,0.000040964977,0.00006193465,0.000022703603,0.00038394795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989684,0.000057971294,0.00026408333,0.00023780465,0.0002731791,0.00019854661],"domain_scores_gemma":[0.999542,0.000058397727,0.000080106176,0.00018850826,0.000046576635,0.0000843853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045827625,0.00013319583,0.00022991799,0.000220921,0.00004612784,0.00002326816,0.000053733063,0.00008048897,0.00002046024],"category_scores_gemma":[0.00008180882,0.000079553814,0.00006265518,0.0008373022,0.0000690789,0.00005210872,0.000033994904,0.00020968488,0.0000034050327],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007120207,0.0015778105,0.9770019,0.0015434142,0.0017785972,0.00073163124,0.010741129,0.00003639526,0.0043882458,0.00011784567,0.0006281446,0.000742843],"study_design_scores_gemma":[0.011937646,0.0010552474,0.95689917,0.0018222835,0.004620712,0.000068736925,0.0056025316,0.009674115,0.006454262,0.00014410028,0.001194937,0.00052624964],"about_ca_topic_score_codex":0.00010259529,"about_ca_topic_score_gemma":0.000054949007,"teacher_disagreement_score":0.020102745,"about_ca_system_score_codex":0.000041209933,"about_ca_system_score_gemma":0.00020065885,"threshold_uncertainty_score":0.32441103},"labels":[],"label_agreement":null},{"id":"W4405042974","doi":"10.1182/blood-2024-203269","title":"First-Line Ibrutinib Plus Venetoclax Vs Chlorambucil Plus Obinutuzumab in Elderly or Comorbid Patients (Pts) with Chronic Lymphocytic Leukemia (CLL): Glow Study 64-Month Follow-up (FU) and Adverse Event (AE)-Free Progression-Free Survival (PFS) Analysis","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baker Hughes (Canada); University of Calgary","funders":"","keywords":"Venetoclax; Ibrutinib; Obinutuzumab; Chlorambucil; Chronic lymphocytic leukemia; Medicine; Adverse effect; Internal medicine; Oncology; Leukemia; Chemotherapy; Cyclophosphamide","score_opus":0.01900988019883937,"score_gpt":0.2961543045955663,"score_spread":0.27714442439672693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98929334,0.004341875,0.000077639656,0.000095094205,0.00047681533,0.004857959,0.00017584646,0.00036727524,0.00031417006],"genre_scores_gemma":[0.99566483,0.00061057956,0.00030610897,0.000047627917,0.00042212763,0.0007485586,0.00028938177,0.00020465073,0.001706148],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9917466,0.00032122363,0.0013944914,0.0019618121,0.0029385644,0.0016373245],"domain_scores_gemma":[0.99490714,0.00069062994,0.00029799668,0.0029238942,0.00037036842,0.0008099779],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001277745,0.0009910018,0.0019730555,0.0010516698,0.0003088294,0.00022123184,0.0011504588,0.00041647613,0.00029016883],"category_scores_gemma":[0.00092660234,0.0007264441,0.00043233114,0.0035785409,0.00040294044,0.00037330535,0.0012213141,0.0008745617,0.00007749693],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.19118588,0.014504308,0.2080986,0.033039417,0.067809306,0.13522084,0.037595123,0.21123748,0.0001813542,0.00031987156,0.009725919,0.091081895],"study_design_scores_gemma":[0.43025997,0.018949294,0.023673411,0.003202258,0.008759809,0.00046498468,0.0010614196,0.5101348,0.00028262398,0.00004872779,0.0017728423,0.0013898632],"about_ca_topic_score_codex":0.015027604,"about_ca_topic_score_gemma":0.062723435,"teacher_disagreement_score":0.29889733,"about_ca_system_score_codex":0.18713437,"about_ca_system_score_gemma":0.09270419,"threshold_uncertainty_score":0.9995187},"labels":[],"label_agreement":null},{"id":"W4405042986","doi":"10.1182/blood-2024-203291","title":"Targeting Lymphoma Associated Myeloid-Monocytic Cells through CSF1R Blockade Enhances CAR-T Cell Response in Aggressive B Cell Lymphoma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Cilag; Swedish Orphan Biovitrum; Sangamo Therapeutics; Science and Engineering Research Board; Incyte; BeiGene; AstraZeneca; Celgene; Takeda Oncology; Gilead Sciences; Amgen","keywords":"Lymphoma; Myeloid; Cancer research; Medicine; Blockade; Aggressive lymphoma; Immunology; Myeloid cells; Biology; Internal medicine; Rituximab; Receptor","score_opus":0.0076831943946641034,"score_gpt":0.23297916144500777,"score_spread":0.22529596705034366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405042986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.891659,0.100574374,0.000020003128,0.00010066784,0.0033062727,0.00041953166,0.00009256457,0.00029413062,0.003533413],"genre_scores_gemma":[0.9856682,0.0024900923,0.00019098377,0.00018081961,0.000113251204,0.00010953018,0.000102168204,0.000111949,0.011032994],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.995988,0.0009876058,0.0008016072,0.0009488061,0.00012803734,0.001145956],"domain_scores_gemma":[0.99767274,0.0012500605,0.00040199084,0.00054403103,0.00009216256,0.000039001523],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008126384,0.0005509699,0.00065696967,0.00026624746,0.00026041505,0.00009559166,0.0006468836,0.0007865709,0.00048231924],"category_scores_gemma":[0.00024265857,0.0005433985,0.00024390088,0.00069701404,0.00031105662,0.00022910898,0.0002829405,0.00044358082,0.0019441167],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057145976,0.0011415527,0.00019598544,0.00014601549,0.000254667,0.00061189086,0.0042613903,0.00006439309,0.9889153,0.000010599697,0.0030080078,0.00081873406],"study_design_scores_gemma":[0.0069528837,0.00028808066,0.00076319627,0.00040920626,0.00022484566,0.00005710377,0.00080570887,0.000030342395,0.9655588,0.00011318241,0.02417124,0.0006253904],"about_ca_topic_score_codex":0.0005266572,"about_ca_topic_score_gemma":0.00003185856,"teacher_disagreement_score":0.09808428,"about_ca_system_score_codex":0.00052272365,"about_ca_system_score_gemma":0.000724665,"threshold_uncertainty_score":0.99970174},"labels":[],"label_agreement":null},{"id":"W4405043000","doi":"10.1182/blood-2024-208948","title":"Optical Genome Mapping As Standard-of-Care in Acute Leukemia: Diagnostic and Clinical Impacts 10 Months Post-Implementation","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Medicine; Acute leukemia; Leukemia; Intensive care medicine; Pediatrics; Internal medicine","score_opus":0.008759657285408064,"score_gpt":0.3118806541571352,"score_spread":0.3031209968717271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405043000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877497,0.010964334,0.0000805788,0.00014084962,0.00012727581,0.00024846368,0.000323893,0.000008326305,0.00035656348],"genre_scores_gemma":[0.9930738,0.005647346,0.00059638225,0.00011899897,0.00018800762,0.000015935231,0.0003192362,0.000021064412,0.000019189603],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999031,0.000025726726,0.00033559496,0.000310403,0.000096687945,0.00020057116],"domain_scores_gemma":[0.99945796,0.00015822856,0.00004318842,0.00016757807,0.00007345738,0.00009959435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016565502,0.00012110998,0.00018528059,0.000059785052,0.000025055111,0.00004847969,0.00008017011,0.00013950291,0.00003179817],"category_scores_gemma":[0.00032858434,0.00012188824,0.000077942685,0.000077421966,0.000059572252,0.0000049597584,0.00012718525,0.00010568997,0.0000070561214],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002104514,0.00081272534,0.16869731,0.0014440835,0.0025331168,0.0014364135,0.0033515536,0.00018813174,0.667667,0.0031266415,0.0021489046,0.14648962],"study_design_scores_gemma":[0.017705636,0.02026393,0.5824344,0.00064804504,0.0017434122,0.00029213363,0.0048064,0.00012650777,0.29388708,0.0008470239,0.07557027,0.0016751658],"about_ca_topic_score_codex":0.00005638086,"about_ca_topic_score_gemma":0.00038013386,"teacher_disagreement_score":0.4137371,"about_ca_system_score_codex":0.000042253436,"about_ca_system_score_gemma":0.00041828418,"threshold_uncertainty_score":0.4970458},"labels":[],"label_agreement":null},{"id":"W4405043055","doi":"10.1182/blood-2024-203723","title":"The Effect of Elranatamab on Patient-Reported Outcomes in Patients with Relapsed/Refractory Multiple Myeloma Naïve and Exposed to B-Cell Maturation Antigen (BCMA)-Directed Therapies: Updated Follow-Up from the MagnetisMM-3 Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Multiple myeloma; Refractory (planetary science); Lenalidomide; Carfilzomib; Hematologic Neoplasms; Internal medicine; Oncology; Cancer; Biology","score_opus":0.008222179153024665,"score_gpt":0.24464309202882356,"score_spread":0.2364209128757989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405043055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942557,0.0007150799,0.0000016383526,0.00016373632,0.00016381765,0.004414461,0.00011489149,0.00010375623,0.00006689713],"genre_scores_gemma":[0.99916095,0.000034863377,0.00006677911,0.000040042924,0.000019796931,0.0002122423,0.00028048403,0.0000479493,0.00013692245],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99760544,0.0004081226,0.0004452428,0.00048117712,0.00073417515,0.0003258293],"domain_scores_gemma":[0.99777603,0.0012506255,0.000120384,0.0006066952,0.000116600444,0.00012965561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025883532,0.00030920943,0.00043946813,0.0001560919,0.00015899673,0.00008201972,0.00014073988,0.00008273296,0.00002851776],"category_scores_gemma":[0.00035366783,0.00014145092,0.0000767736,0.0004268263,0.0000646411,0.000095703464,0.00006289956,0.0002827052,0.000015623587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009023601,0.0019115189,0.9625814,0.000029045785,0.001213487,0.00017466732,0.002736905,7.321523e-7,0.0024208466,5.6281385e-7,0.00014533945,0.0197619],"study_design_scores_gemma":[0.035687942,0.010685872,0.9433567,0.00016930056,0.00027355872,0.000001549672,0.0005325906,0.000088073575,0.008933757,0.0000026874966,0.00012974803,0.00013820783],"about_ca_topic_score_codex":0.0006317992,"about_ca_topic_score_gemma":0.00055357546,"teacher_disagreement_score":0.026664343,"about_ca_system_score_codex":0.0000518758,"about_ca_system_score_gemma":0.000060079685,"threshold_uncertainty_score":0.57682014},"labels":[],"label_agreement":null},{"id":"W4405043059","doi":"10.1182/blood-2024-211209","title":"Diagnostic Test Accuracy of Cardiac Biomarkers for Light Chain Amyloidosis: A Systematic Review and Meta-Analysis","year":2024,"lang":"en","type":"review","venue":"Blood","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; University of British Columbia; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Amyloidosis; AL amyloidosis; Cardiac amyloidosis; Meta-analysis; Internal medicine; Immunoglobulin light chain; Pathology; Immunology; Antibody","score_opus":0.033179502700004845,"score_gpt":0.3288684445112939,"score_spread":0.295688941811289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405043059","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000004781125,0.9898397,0.000008993678,0.00024806274,0.00006297272,0.00682172,0.002946751,0.00002934098,0.00003770007],"genre_scores_gemma":[0.00011203291,0.9855526,0.0002376601,0.00016628379,0.000071671995,0.012373974,0.00089051656,0.00013232947,0.00046289753],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9961054,0.00042978118,0.0016588474,0.001137617,0.00025877968,0.00040962064],"domain_scores_gemma":[0.99421054,0.0027710246,0.0012368495,0.0014583153,0.00015104795,0.00017222442],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007824296,0.0009904305,0.00924998,0.00033589225,0.0000663995,0.00006781958,0.00050656876,0.00045442002,0.000021820993],"category_scores_gemma":[0.0073484136,0.00063831086,0.0075931908,0.0008172075,0.00008133686,0.0000061748956,0.00028311918,0.00013500464,0.000023135239],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[7.289132e-7,0.00021522664,0.000015094557,0.61355734,0.384143,0.000004567231,0.0000066390685,2.9411568e-8,0.000009551225,0.00000770635,0.0015334297,0.0005067212],"study_design_scores_gemma":[0.00015813333,0.00016144964,0.0000013286168,0.027337817,0.8899838,0.000017613133,0.0000098509845,1.5865074e-7,0.00022359313,0.0000033648091,0.08159984,0.0005030841],"about_ca_topic_score_codex":0.000015717796,"about_ca_topic_score_gemma":0.000012179983,"teacher_disagreement_score":0.5862195,"about_ca_system_score_codex":0.000030228048,"about_ca_system_score_gemma":0.00017872732,"threshold_uncertainty_score":0.99960685},"labels":[],"label_agreement":null},{"id":"W4405043067","doi":"10.1182/blood-2024-199164","title":"Ferric Derisomaltose Versus Iron Sucrose in Pregnancy (FLIP): A Retrospective Observational Study on Outpatient Intravenous Iron Infusion Capacity","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; Health Sciences Centre; Mount Sinai Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Iron sucrose; Intravenous iron; Observational study; Medicine; Retrospective cohort study; Pregnancy; Iron deficiency; Internal medicine; Anemia","score_opus":0.05113077230981585,"score_gpt":0.2955988697343233,"score_spread":0.24446809742450745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405043067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941798,0.0015898845,0.000007789033,0.00016238943,0.0007668963,0.0013443313,0.000028644705,0.00012561757,0.0017946725],"genre_scores_gemma":[0.9991161,0.000093586015,0.00013805284,0.000084405,0.00015018003,0.00012175318,0.000053515327,0.000037661284,0.00020474645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99810916,0.00009566563,0.00036532021,0.00053602376,0.0005489473,0.000344896],"domain_scores_gemma":[0.9993246,0.00007888446,0.00006013828,0.0003558207,0.00006419681,0.00011634997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017777678,0.00025313665,0.00034037782,0.0002491576,0.00008914633,0.000040249,0.00009587738,0.00013266783,0.000082218015],"category_scores_gemma":[0.00026282476,0.00022280784,0.000084159336,0.0004962063,0.000054168417,0.00012712507,0.000060227427,0.0004544972,0.00007802372],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021437667,0.024253273,0.92833525,0.00061414874,0.00010210786,0.0007329482,0.028323844,0.00007938802,0.0034374222,0.0021533843,0.00021797078,0.009606482],"study_design_scores_gemma":[0.0109199295,0.0043073627,0.9817136,0.00036694232,0.00024654972,0.000007759949,0.0013817288,0.00006224077,0.00055844913,0.00010437772,0.00010272541,0.00022832796],"about_ca_topic_score_codex":0.00032757595,"about_ca_topic_score_gemma":0.00031413228,"teacher_disagreement_score":0.053378344,"about_ca_system_score_codex":0.00017066664,"about_ca_system_score_gemma":0.00015129986,"threshold_uncertainty_score":0.908584},"labels":[],"label_agreement":null},{"id":"W4405043136","doi":"10.1182/blood-2024-209623","title":"Integrating the Sunnybrook Biobank into the Future of Healthcare - Exploring Patient and Healthworker Biobanking Perspectives","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Western University; Sunnybrook Health Science Centre","funders":"","keywords":"Biobank; Medicine; Health care; MEDLINE; Bioinformatics; Biology","score_opus":0.22684176535566578,"score_gpt":0.4849259875615483,"score_spread":0.25808422220588256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405043136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8055324,0.10485204,0.000024801628,0.08830406,0.00036635352,0.00043999142,0.000004076306,0.000054656397,0.00042161503],"genre_scores_gemma":[0.9872357,0.010498803,0.0008619821,0.0005452779,0.0007103983,0.000064233274,0.0000017940727,0.000025790961,0.000055982142],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"qualitative","domain_scores_codex":[0.9981525,0.00019816346,0.0003914168,0.00034885696,0.00063595315,0.0002730867],"domain_scores_gemma":[0.9955278,0.003564234,0.000064409156,0.0004489824,0.00028424218,0.00011035717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021885694,0.00012876613,0.00021930147,0.00008207662,0.00028326325,0.00006455621,0.0001750916,0.00014575233,0.000021563712],"category_scores_gemma":[0.0017303483,0.000061480525,0.000098382756,0.00042055498,0.0004138003,0.000066130146,0.00020893304,0.002123131,0.0000041922685],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016283644,0.00037539628,0.025665503,0.0035885226,0.00040147858,0.000085024105,0.3246648,0.0000012013338,0.0016394664,0.363637,0.00023379325,0.279545],"study_design_scores_gemma":[0.0019571092,0.003686955,0.02102197,0.013076795,0.00041803438,0.00020334515,0.83327734,0.00047290942,0.010516229,0.089951456,0.024951216,0.00046661016],"about_ca_topic_score_codex":0.0007866719,"about_ca_topic_score_gemma":0.001071571,"teacher_disagreement_score":0.5086126,"about_ca_system_score_codex":0.000063308325,"about_ca_system_score_gemma":0.00039384258,"threshold_uncertainty_score":0.92240655},"labels":[],"label_agreement":null},{"id":"W4405043149","doi":"10.1182/blood-2024-200033","title":"Physical and Psychological Burden on People with Hemophilia: Global Real-World Data","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Real world data; Medicine; Psychology; Gerontology; Data science; Computer science","score_opus":0.06504847249851271,"score_gpt":0.3864878563966663,"score_spread":0.3214393838981536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405043149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9683947,0.0002122029,0.000001578645,0.006366424,0.000037845624,0.00026173625,0.00006427148,0.00012736354,0.02453388],"genre_scores_gemma":[0.9963585,0.00017147559,0.00022721954,0.00006430116,0.00070769415,0.000012662109,0.00010893991,0.000014641612,0.0023345347],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998789,0.000025500674,0.00008284899,0.00052369165,0.00032987076,0.00024909966],"domain_scores_gemma":[0.9991606,0.00008043197,0.000009516976,0.00055107585,0.00001891285,0.00017948369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000092140945,0.00013821828,0.00023759603,0.000050634295,0.00004856026,0.000048372232,0.00012749137,0.000040262785,0.00004086228],"category_scores_gemma":[0.000021699836,0.00007682137,0.00003172691,0.0004030802,0.00012442116,0.000051161936,0.00011378647,0.00021052944,0.0001551469],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036360847,0.018487575,0.7354923,0.0012461672,0.002963211,0.018703088,0.0013209638,0.0000027268682,0.004420073,0.025719356,0.039867032,0.14814144],"study_design_scores_gemma":[0.014608608,0.015409847,0.93841887,0.0011583212,0.0020541814,0.0019729598,0.00023082067,0.0021720044,0.0019694509,0.0025410329,0.01869093,0.0007729691],"about_ca_topic_score_codex":0.00010043638,"about_ca_topic_score_gemma":0.00013987905,"teacher_disagreement_score":0.2029266,"about_ca_system_score_codex":0.00002396858,"about_ca_system_score_gemma":0.000050940514,"threshold_uncertainty_score":0.31326845},"labels":[],"label_agreement":null},{"id":"W4405043173","doi":"10.1182/blood-2024-204166","title":"Comprehensive Characterization and Validation of the Tumor Microenvironment in Patients with Relapsed/Refractory Large B-Cell Lymphoma Identifies Subgroups with Greatest Benefit from CD19 CAR T-Cell Therapy","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"Daiichi Sankyo Europe; National Cancer Institute; EMD Serono; Pharmacyclics; Genentech; Incyte; BeiGene; Regeneron Pharmaceuticals; Seagen; Janssen Pharmaceuticals; Gilead Sciences; MorphoSys; Cancer Prevention and Research Institute of Texas; Celgene; AstraZeneca; Bristol-Myers Squibb; TG Therapeutics; Amgen","keywords":"Tumor microenvironment; Lymphoma; Medicine; Refractory (planetary science); Diffuse large B-cell lymphoma; CD19; Oncology; Cancer research; Internal medicine; Tumor cells; Biology; Peripheral blood","score_opus":0.008359443956642763,"score_gpt":0.20839313540628784,"score_spread":0.20003369144964508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405043173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979062,0.0008346355,0.000009234119,0.000053052958,0.000058810638,0.0009078211,0.00015156224,0.00002123513,0.000057415797],"genre_scores_gemma":[0.99825567,0.00035765977,0.000029928267,0.00006776666,0.000038130132,0.000032478423,0.00041058412,0.000050481,0.0007573282],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987308,0.00006904158,0.00022725725,0.00034482614,0.0004259703,0.00020210035],"domain_scores_gemma":[0.99936193,0.000068920905,0.000101073565,0.00034113025,0.00007095797,0.000056013017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007766996,0.00018498875,0.00024774784,0.00011051413,0.000050988434,0.00004494071,0.00008912833,0.000058165027,0.00014452249],"category_scores_gemma":[0.000002725123,0.00011753346,0.000040950108,0.00021095118,0.00009441722,0.00012820042,0.000047760666,0.00013912836,0.0000072505895],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005868566,0.0016323252,0.44018254,0.000108875036,0.0000814294,0.000019883384,0.00093246443,0.0000013182354,0.555773,0.0000013114671,0.0000035434232,0.0006764485],"study_design_scores_gemma":[0.011552656,0.00057644077,0.64026564,0.0001997459,0.00007930506,0.0000042496536,0.000096157644,0.000013557792,0.34657952,0.000003886384,0.0005360455,0.000092808004],"about_ca_topic_score_codex":0.00014423572,"about_ca_topic_score_gemma":0.000019048373,"teacher_disagreement_score":0.20919348,"about_ca_system_score_codex":0.00007207176,"about_ca_system_score_gemma":0.000052621162,"threshold_uncertainty_score":0.47928753},"labels":[],"label_agreement":null},{"id":"W4405043182","doi":"10.1182/blood-2024-209217","title":"FRAIL-HRU-AML: Impact of Frailty Assessment on Health Resource Utilization in Acute Myeloid Leukemia Patients: A Population-Based Study from Ontario, Canada","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Myeloid leukemia; Medicine; Leukemia; Population; Hematologic Neoplasms; Gerontology; Intensive care medicine; Immunology; Environmental health; Cancer; Internal medicine","score_opus":0.029339860549746133,"score_gpt":0.3437619648931933,"score_spread":0.31442210434344714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405043182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99685234,0.00009795004,0.00005959883,0.00047657706,0.00009744118,0.0015626221,0.00034700148,0.0000600306,0.00044646155],"genre_scores_gemma":[0.99686486,0.0000064850387,0.00035581694,0.00042075693,0.00006700469,0.000063990425,0.0019472091,0.00005738947,0.00021649229],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968549,0.00024755896,0.00069707166,0.0005761493,0.0011673315,0.00045696858],"domain_scores_gemma":[0.9985498,0.00030013308,0.00015490707,0.0005967452,0.00012588485,0.00027252943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003876928,0.00028385036,0.0005790086,0.0003811615,0.000078455596,0.000038335435,0.00018404846,0.000117820935,0.0004149325],"category_scores_gemma":[0.00012280548,0.0002393426,0.00012032731,0.0006967508,0.00001955149,0.00008382054,0.00006135618,0.00074581575,0.000005450599],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0003135467,0.0014468628,0.98781294,0.00008150906,0.00047499457,0.00014433563,0.0008876361,0.000650433,0.00009396591,0.000009594819,0.004581947,0.0035022527],"study_design_scores_gemma":[0.006976948,0.0024264173,0.9863018,0.00040977873,0.00015361598,0.0000016741121,0.00019943953,0.0025109644,0.00013993534,0.00001726633,0.0006918699,0.00017032739],"about_ca_topic_score_codex":0.9850278,"about_ca_topic_score_gemma":0.95692974,"teacher_disagreement_score":0.028098034,"about_ca_system_score_codex":0.0138545735,"about_ca_system_score_gemma":0.018936884,"threshold_uncertainty_score":0.98993105},"labels":[],"label_agreement":null},{"id":"W4405043193","doi":"10.1182/blood-2024-200336","title":"Belantamab Mafodotin, Bortezomib, and Dexamethasone Vs Daratumumab, Bortezomib, and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Overall Survival Analysis and Updated Efficacy Outcomes of the Phase 3 Dreamm-7 Trial","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Daratumumab; Bortezomib; Dexamethasone; Medicine; Multiple myeloma; Internal medicine; Oncology; Refractory (planetary science); Lenalidomide; Biology","score_opus":0.022583204831675897,"score_gpt":0.31777974230081707,"score_spread":0.29519653746914115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405043193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929832,0.0042085648,0.0000247204,0.00041687634,0.00016977383,0.00162318,0.00030877767,0.00007945659,0.00018544424],"genre_scores_gemma":[0.9976397,0.00074711535,0.0007504699,0.000047515045,0.00009204212,0.00005790174,0.0001993722,0.000059586262,0.0004063088],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965558,0.00044064238,0.0007931987,0.00090135646,0.00069514214,0.0006138693],"domain_scores_gemma":[0.99713564,0.0014657516,0.00018740683,0.0006951606,0.000100994075,0.0004150663],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000915581,0.00048172942,0.0013866712,0.00068964215,0.00015878509,0.0001101849,0.00017135145,0.00026519987,0.00007213666],"category_scores_gemma":[0.0011271125,0.00032767677,0.00028402923,0.0011696737,0.00039073554,0.00016462244,0.00025960946,0.00066189276,0.0000042429874],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022113765,0.004939555,0.94278806,0.00023345363,0.0064333705,0.00061300845,0.0006127617,0.0000019829452,0.00726657,0.00005904825,0.00008174208,0.014856671],"study_design_scores_gemma":[0.19743282,0.0013205595,0.7921179,0.00013104659,0.003455541,0.00006930914,0.00010141194,0.0013343955,0.0034810298,0.00002700819,0.00025892988,0.00027004772],"about_ca_topic_score_codex":0.0014096391,"about_ca_topic_score_gemma":0.0010424458,"teacher_disagreement_score":0.17531905,"about_ca_system_score_codex":0.000071090435,"about_ca_system_score_gemma":0.00018995834,"threshold_uncertainty_score":0.9999175},"labels":[],"label_agreement":null},{"id":"W4405043212","doi":"10.1182/blood-2024-194207","title":"Effectiveness and Safety of Rivaroxaban Versus Warfarin in Patients with Pulmonary Embolism and Right Ventricular Dysfunction","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Rivaroxaban; Pulmonary embolism; Medicine; Warfarin; Internal medicine; Cardiology; Right ventricular failure; Atrial fibrillation; Heart failure","score_opus":0.009977191571643123,"score_gpt":0.24442266821292605,"score_spread":0.23444547664128293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405043212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982511,0.0006378832,0.000042815478,0.00007686782,0.00013638454,0.0003900515,0.0000025176914,0.000022377666,0.00044002128],"genre_scores_gemma":[0.99976957,0.000045050292,0.000046485686,0.0000028832626,0.000060199996,0.0000017145866,0.00002116359,0.000008131874,0.00004480888],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995208,0.000028610202,0.00010970017,0.0001480106,0.000120837685,0.00007205909],"domain_scores_gemma":[0.9997757,0.00008529507,0.000022119597,0.00006872658,0.000018703258,0.000029447885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010459885,0.00007260115,0.0001605707,0.000114731345,0.000019938496,0.00000854387,0.0000119001725,0.000035916277,0.000014093854],"category_scores_gemma":[0.000019039817,0.000052035608,0.000022045004,0.00017381454,0.0000249897,0.000071812305,0.00002636841,0.00004749043,0.0000015557252],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015571783,0.000043600136,0.9922527,0.0004455967,0.00014834639,0.000075685784,0.00003602773,0.0000057664497,0.00008295963,0.0006623654,0.0000026953612,0.0046870587],"study_design_scores_gemma":[0.0074795415,0.00027446277,0.9904278,0.00019642066,0.00028610532,0.0000045063866,0.000011101483,0.00006516033,0.00046695935,0.000053480075,0.00067571166,0.00005878641],"about_ca_topic_score_codex":0.000017795688,"about_ca_topic_score_gemma":0.000001456924,"teacher_disagreement_score":0.005922363,"about_ca_system_score_codex":0.00001354916,"about_ca_system_score_gemma":0.000009489198,"threshold_uncertainty_score":0.21219505},"labels":[],"label_agreement":null},{"id":"W4405043213","doi":"10.1182/blood-2024-207419","title":"Pediatric Autoimmune Hemolytic Anemia Is Associated with a High Incidence of an Underlying Immune Disorder and High Mortality Rate","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; McMaster University; McMaster Children's Hospital; Alberta Children's Hospital","funders":"","keywords":"Autoimmune hemolytic anemia; Medicine; Incidence (geometry); Immune system; Anemia; Mortality rate; Immunology; Pediatrics; Internal medicine","score_opus":0.013390105082330335,"score_gpt":0.257048083911367,"score_spread":0.2436579788290367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405043213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946713,0.0043915855,0.000090711146,0.00023805781,0.00007736867,0.00032116292,0.000028608845,0.00013234917,0.00004884985],"genre_scores_gemma":[0.99909973,0.000412651,0.00017594716,0.00005736637,0.000043823387,0.00001244987,0.00005892285,0.000037654663,0.0001014434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99872607,0.000055268483,0.00033472825,0.00036421724,0.0002822739,0.0002374719],"domain_scores_gemma":[0.99933213,0.00009709921,0.000082948296,0.00031609842,0.00007885664,0.00009289576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033266278,0.00019411229,0.0004185464,0.00011607122,0.00008344524,0.000037659272,0.0000749527,0.00012822168,0.00006686207],"category_scores_gemma":[0.00003583509,0.00014870994,0.00005645691,0.0005595594,0.00007885965,0.00017130833,0.000035393736,0.00027034507,0.000003250843],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035708287,0.004865246,0.88392544,0.0038237674,0.0018732817,0.0020986495,0.0027899055,0.000020733089,0.09177545,0.0016575783,0.000019999898,0.0067928447],"study_design_scores_gemma":[0.0043142317,0.0008414879,0.98661053,0.00039247432,0.0023061607,0.00008311949,0.00006897512,0.0004289014,0.0043502925,0.0004059517,0.0000056393574,0.0001922465],"about_ca_topic_score_codex":0.0014850528,"about_ca_topic_score_gemma":0.000117810625,"teacher_disagreement_score":0.10268506,"about_ca_system_score_codex":0.000017747352,"about_ca_system_score_gemma":0.000135945,"threshold_uncertainty_score":0.60642153},"labels":[],"label_agreement":null},{"id":"W4405043227","doi":"10.1182/blood-2024-206225","title":"<i>Understanding the Lived Experience of Fatigue in Adolescents and Young Adults with Myeloproliferative Neoplasms: A Mixed Methods Study</i>","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Sherbrooke; Cegep de Saint Jerome; Centre Hospitalier de l’Université de Montréal; Hôpital Charles-Le Moyne; McGill University; Jewish General Hospital; Hôpital du Sacré-Cœur de Montréal; Hôpital Maisonneuve-Rosemont; Concordia University; Université Laval; Université de Montréal","funders":"","keywords":"Medicine; Pediatrics; Polycythemia vera; Psychology; Gerontology; Internal medicine","score_opus":0.06620166686141943,"score_gpt":0.34359963880992206,"score_spread":0.27739797194850263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405043227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943469,0.0018879654,0.0014520108,0.00020299671,0.00010865972,0.0016693121,0.000006565155,0.000039499548,0.00028609153],"genre_scores_gemma":[0.9969423,0.00021636329,0.002215976,0.00006361761,0.000037991194,0.0004675524,0.0000035372236,0.000026170621,0.00002652971],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983533,0.00026144303,0.00034840335,0.00046918515,0.00031975322,0.00024789385],"domain_scores_gemma":[0.9992866,0.00022808628,0.00007369754,0.00024342877,0.00006995785,0.000098226585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003468383,0.00025460206,0.00043982998,0.00013842818,0.000100773614,0.000059879436,0.00007609484,0.00005779612,0.000011743849],"category_scores_gemma":[0.00009163479,0.00014313009,0.000049826183,0.00043141027,0.00015681575,0.00010527765,0.000060813618,0.00023056084,0.0000014479205],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005708556,0.0021030062,0.8772239,0.00032254917,0.00044720565,0.00036984275,0.11615572,0.000004998163,0.0006925751,0.00044478607,0.000017204711,0.0016473768],"study_design_scores_gemma":[0.01952703,0.005452581,0.7358833,0.008100347,0.0010394874,0.00046097607,0.17945905,0.001705242,0.047660917,0.00019234768,0.00002725455,0.00049149024],"about_ca_topic_score_codex":0.00015087168,"about_ca_topic_score_gemma":0.0006658653,"teacher_disagreement_score":0.1413406,"about_ca_system_score_codex":0.000068794434,"about_ca_system_score_gemma":0.00010742498,"threshold_uncertainty_score":0.5836676},"labels":[],"label_agreement":null},{"id":"W4405043258","doi":"10.1182/blood-2024-205779","title":"Durable Clinical Benefits with Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; SickKids Foundation; Hospital for Sick Children; BC Children's Hospital; University of Toronto","funders":"","keywords":"Thalassemia; Medicine; Blood transfusion; Intensive care medicine; Pediatrics; Immunology; Internal medicine","score_opus":0.018724422057628472,"score_gpt":0.28361893454011045,"score_spread":0.26489451248248197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405043258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814013,0.008805934,0.0006344746,0.002419479,0.0005091982,0.0008765143,0.00004020336,0.00027237824,0.0050404826],"genre_scores_gemma":[0.991382,0.0030434777,0.0013993131,0.00031431136,0.00031027436,0.00008186348,0.000043630134,0.00006786851,0.0033572405],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985935,0.000022999924,0.0003719328,0.0004371935,0.00023995459,0.00033440543],"domain_scores_gemma":[0.99929386,0.0001371727,0.0000295481,0.00025844888,0.00007079148,0.00021017644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032190245,0.0001807843,0.0003300607,0.00007660944,0.000090717425,0.000035732835,0.00007609643,0.00027398122,0.00013228675],"category_scores_gemma":[0.000046968034,0.00012072327,0.00020170849,0.00019890693,0.000055394186,0.000049434428,0.0000151366585,0.00032806862,0.000071387665],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006427217,0.026213333,0.22142702,0.010891816,0.0140381325,0.007951346,0.004249998,0.0010542468,0.12426234,0.015048913,0.049072407,0.5193632],"study_design_scores_gemma":[0.15923883,0.03655849,0.14419492,0.015328704,0.028196992,0.0136204865,0.00438859,0.013647844,0.16154085,0.0021313818,0.41598433,0.005168551],"about_ca_topic_score_codex":0.000024687222,"about_ca_topic_score_gemma":0.000022594,"teacher_disagreement_score":0.51419467,"about_ca_system_score_codex":0.00001920218,"about_ca_system_score_gemma":0.0002721908,"threshold_uncertainty_score":0.49229524},"labels":[],"label_agreement":null},{"id":"W4405043317","doi":"10.1182/blood-2024-205975","title":"Descriptive Characterization of Bleeding Events in Participants with Severe Hemophilia Α or B without Inhibitors, Receiving Prophylactic Marstacimab Treatment","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Hemarthrosis; Factor IX; Internal medicine; Prophylactic treatment; Bleeding diathesis; Gastroenterology; Surgery; Platelet","score_opus":0.046269271586479276,"score_gpt":0.30565365655054655,"score_spread":0.2593843849640673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405043317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979796,0.00014955305,0.0000070670935,0.00031506017,0.0000875575,0.0010917714,0.0000144148435,0.000062533865,0.0002924802],"genre_scores_gemma":[0.996167,0.00013551765,0.00023223019,0.0000073700876,0.000121250356,0.00013091839,0.000045554614,0.000042888503,0.003117243],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99851656,0.000060784103,0.0003091213,0.0003581849,0.00036302136,0.00039235834],"domain_scores_gemma":[0.9994986,0.00004852275,0.00005947963,0.00018829378,0.000073204195,0.00013191816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017357871,0.00021101892,0.00038912153,0.00026767195,0.00004535553,0.000021197466,0.000046873556,0.00008685828,0.00006670586],"category_scores_gemma":[0.00004828345,0.00012363776,0.00005748806,0.0005684533,0.000048384925,0.00021158945,0.00002673344,0.0001480762,0.00001906883],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015376344,0.0023078027,0.76706177,0.0009130917,0.0004853254,0.0007192816,0.003996835,0.0000012406372,0.216982,0.000009870026,0.0000023339448,0.00598284],"study_design_scores_gemma":[0.018538408,0.009922755,0.4380045,0.007895272,0.0017030351,0.0006519231,0.0011434804,0.0010319283,0.5203329,0.00005359502,0.0001611784,0.00056104903],"about_ca_topic_score_codex":0.00005545757,"about_ca_topic_score_gemma":0.00004383952,"teacher_disagreement_score":0.32905725,"about_ca_system_score_codex":0.0002622685,"about_ca_system_score_gemma":0.00039984,"threshold_uncertainty_score":0.5041802},"labels":[],"label_agreement":null},{"id":"W4405043362","doi":"10.1182/blood-2024-203612","title":"Effect of Prior Treatments on the Clinical Activity of Imetelstat in Transfusion-Dependent Patients with Erythropoiesis-Stimulating Agent, Relapsed or Refractory/Ineligible Lower-Risk Myelodysplastic Syndromes","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Agios Pharmaceuticals; Swedish Orphan Biovitrum; Astex Pharmaceuticals; Sierra Oncology; Jazz Pharmaceuticals; MorphoSys; FibroGen; Celgene; Gilead Sciences","keywords":"Medicine; Refractory (planetary science); Erythropoiesis; Myelodysplastic syndromes; Internal medicine; Anemia; Blood transfusion; Oncology; Intensive care medicine; Surgery; Bone marrow","score_opus":0.024571749615571025,"score_gpt":0.33798995448954816,"score_spread":0.31341820487397715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405043362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973691,0.00012415928,0.000037107275,0.000100699595,0.00016473529,0.0018703551,0.000098631164,0.000047827387,0.00018739524],"genre_scores_gemma":[0.99899966,0.000347016,0.00017090834,0.00001062931,0.000040806088,0.00006430253,0.000015661366,0.000062863845,0.00028814317],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99692184,0.00069504976,0.00059682917,0.0005361896,0.0008778569,0.00037226256],"domain_scores_gemma":[0.9928905,0.0061162272,0.00019497551,0.0005689105,0.00009566481,0.00013376924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012191888,0.0003111462,0.0008156803,0.0002888017,0.00007740586,0.000017957376,0.00017425418,0.00017699451,0.00015154891],"category_scores_gemma":[0.0015206563,0.00015301866,0.0002122913,0.0006283962,0.00020440097,0.00010111358,0.000069562724,0.0007808995,0.000026879681],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03238798,0.008998578,0.88022286,0.002061589,0.0028610358,0.0012905604,0.00076327747,0.00011508039,0.00798316,0.000008106777,0.00016631317,0.06314147],"study_design_scores_gemma":[0.062397253,0.09035557,0.7500334,0.0055658715,0.0043909797,0.00007247018,0.00011451713,0.0022699928,0.08418603,0.000016110267,0.000077076,0.00052077166],"about_ca_topic_score_codex":0.00020323678,"about_ca_topic_score_gemma":0.000047296635,"teacher_disagreement_score":0.13018948,"about_ca_system_score_codex":0.00021180868,"about_ca_system_score_gemma":0.00041255218,"threshold_uncertainty_score":0.62399197},"labels":[],"label_agreement":null},{"id":"W4405043407","doi":"10.1182/blood-2024-208622","title":"Multicenter, Real-World Experience Study of FLT3-Inhibitor Post-Transplant Maintenance Therapy Following Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia with FLT3-ITD","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan; Université Laval; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Myeloid leukemia; Stem cell; Medicine; Transplantation; Maintenance therapy; Haematopoiesis; Hematopoietic stem cell transplantation; Fms-Like Tyrosine Kinase 3; Immunology; Leukemia; Acute leukemia; Oncology; Cancer research; Internal medicine; Chemotherapy; Biology","score_opus":0.014165538939920492,"score_gpt":0.2810204897333979,"score_spread":0.2668549507934774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405043407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958141,0.0010039124,0.000117837866,0.00013733811,0.00018587887,0.002135532,0.00005244375,0.0001549476,0.0003980173],"genre_scores_gemma":[0.99624926,0.0018834651,0.00047657534,0.00007767588,0.00007828361,0.00030623793,0.000057611756,0.00010577474,0.0007651001],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966678,0.00017234478,0.0007459619,0.00082240294,0.0008945011,0.00069696864],"domain_scores_gemma":[0.99878526,0.00020370784,0.000103900944,0.00057400734,0.00012275316,0.00021035205],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039852117,0.0004298902,0.0007002242,0.00052499975,0.00008240442,0.00005605359,0.00033567357,0.0001283478,0.000029897003],"category_scores_gemma":[0.0000049965242,0.0003213508,0.00018462258,0.0009651746,0.00009917001,0.0002501057,0.000034268403,0.00057306857,0.000024648245],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004510555,0.0029980536,0.22406404,0.001466232,0.0009740223,0.016225869,0.08656679,0.000064010856,0.661584,0.000027855493,0.000041718147,0.0014768573],"study_design_scores_gemma":[0.047564417,0.004692596,0.13947123,0.0044708126,0.001535656,0.0007964367,0.020968638,0.00065900426,0.7787341,0.000005888226,0.00013130208,0.0009699299],"about_ca_topic_score_codex":0.0012213505,"about_ca_topic_score_gemma":0.0012420666,"teacher_disagreement_score":0.11715008,"about_ca_system_score_codex":0.00038371806,"about_ca_system_score_gemma":0.00059463823,"threshold_uncertainty_score":0.9999239},"labels":[],"label_agreement":null},{"id":"W4405043414","doi":"10.1182/blood-2024-200871","title":"Phase 3 Randomized Study of Daratumumab (DARA) + Bortezomib, Lenalidomide and Dexamethasone (VRd) Versus Alone in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma or for Whom Transplant Is Not Planned As Initial Therapy: Analysis of Minimal Residual Disease in the Cepheus Trial","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Institute of Cancer Research; University of Alberta; University of Calgary","funders":"","keywords":"Lenalidomide; Daratumumab; Bortezomib; Medicine; Multiple myeloma; Dexamethasone; Internal medicine; Oncology; Transplantation; Thalidomide; Surgery","score_opus":0.04351882518375011,"score_gpt":0.3480125436039243,"score_spread":0.3044937184201742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405043414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882868,0.0006128072,0.000020720492,0.00017136542,0.000061725215,0.008111983,0.0027041018,0.000021562288,0.000008924329],"genre_scores_gemma":[0.9975583,0.00023508846,0.0001607356,0.000044596236,0.000066144,0.0010189294,0.00086782844,0.00003898005,0.000009414253],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99647486,0.0006160585,0.00095308135,0.0006078159,0.0008898579,0.00045830946],"domain_scores_gemma":[0.9946383,0.0044499543,0.00016633484,0.00041206533,0.00010993598,0.00022340822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008759662,0.00038076137,0.001668167,0.000851369,0.00008401935,0.000058290338,0.00018662114,0.00009453759,0.000035963163],"category_scores_gemma":[0.0005002346,0.00021598434,0.00029502745,0.000997934,0.00021380313,0.00013059608,0.00001577344,0.00023623607,6.4632536e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8858252,0.024259893,0.068585895,0.00019774138,0.0074702348,0.0016554547,0.010353567,0.000015588626,0.00015663312,0.0000019738445,0.000011213971,0.0014665764],"study_design_scores_gemma":[0.88576615,0.024554944,0.07612025,0.00026763155,0.0079669,0.000003148707,0.00068240217,0.0013227306,0.0031046602,0.0000035186438,0.0000067269834,0.00020095675],"about_ca_topic_score_codex":0.0018935682,"about_ca_topic_score_gemma":0.0028901251,"teacher_disagreement_score":0.009671165,"about_ca_system_score_codex":0.0000296812,"about_ca_system_score_gemma":0.00042035672,"threshold_uncertainty_score":0.8807586},"labels":[],"label_agreement":null},{"id":"W4405043418","doi":"10.1182/blood-2024-201057","title":"Phase 3 Randomized Study of Daratumumab Monotherapy Versus Active Monitoring in Patients with High-Risk Smoldering Multiple Myeloma: Primary Results of the Aquila Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Daratumumab; Medicine; Multiple myeloma; Internal medicine; Oncology; Lenalidomide","score_opus":0.019061961283635,"score_gpt":0.29999737200296356,"score_spread":0.28093541071932854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405043418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937691,0.00021516312,0.000002470725,0.0000100472025,0.00019837606,0.0055784346,0.000091149035,0.000033867458,0.00010140554],"genre_scores_gemma":[0.9994268,0.000029368091,0.00014538509,8.572786e-7,0.000048889902,0.00026263643,0.000019616842,0.00003856394,0.000027921913],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9975701,0.0004098155,0.0005494851,0.0004189158,0.0007803213,0.00027137971],"domain_scores_gemma":[0.9982477,0.0007718629,0.00019608105,0.00056711846,0.00013381867,0.00008345446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042099835,0.00023598455,0.00077338214,0.00022827736,0.00007342125,0.000018255792,0.00016244085,0.000049462382,0.0000033573797],"category_scores_gemma":[0.00036353729,0.00013584488,0.00010920961,0.00050337194,0.000086542816,0.0001082763,0.000094004245,0.0003148521,0.0000012574735],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4389732,0.03753435,0.5031608,0.000072691466,0.003060435,0.00011749112,0.006568664,0.000021760521,0.0006148207,4.407024e-7,0.0000015042411,0.009873886],"study_design_scores_gemma":[0.53803927,0.0065137167,0.44473147,0.00018392026,0.00048207358,4.3710102e-7,0.0011139495,0.00004887324,0.008817843,0.0000011546449,9.670011e-7,0.00006633285],"about_ca_topic_score_codex":0.001697201,"about_ca_topic_score_gemma":0.0001830218,"teacher_disagreement_score":0.09906607,"about_ca_system_score_codex":0.00010614725,"about_ca_system_score_gemma":0.000117852614,"threshold_uncertainty_score":0.5539593},"labels":[],"label_agreement":null},{"id":"W4405043429","doi":"10.1182/blood-2024-202491","title":"Lifetime Prevalence of Stroke within an Adult Population with Sickle Cell Disease: A Cross-Sectional Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Hôpital Maisonneuve-Rosemont; Université de Montréal","funders":"","keywords":"Cross-sectional study; Medicine; Stroke (engine); Population; Disease; Internal medicine; Pediatrics; Pathology; Environmental health","score_opus":0.0074352676554919235,"score_gpt":0.25968861880037775,"score_spread":0.25225335114488584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405043429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977772,0.00096942513,0.000019592799,0.000037553957,0.00010978119,0.00051672984,0.00006154982,0.00010620801,0.0004019608],"genre_scores_gemma":[0.99737877,0.000026702763,0.00018106778,0.000024738298,0.00008470308,0.000020124698,0.000039732797,0.000023442153,0.0022207133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891144,0.00003344116,0.00025487636,0.0002903937,0.00037917655,0.00013069215],"domain_scores_gemma":[0.9994524,0.000017907994,0.0000538026,0.00022164684,0.00010694501,0.00014729745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012696166,0.000115397626,0.0001372882,0.00007634678,0.00005595249,0.000033378885,0.00005641686,0.00006379868,0.00010131287],"category_scores_gemma":[0.000028542141,0.000082575534,0.00005246115,0.00017227286,0.00005266979,0.00011618725,0.000016563185,0.00017460756,0.00001626079],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003043841,0.0022856514,0.99444574,0.00081335666,0.0001066391,0.00008773205,0.0007231708,0.00027402723,0.00083810446,0.000052706033,0.000011157406,0.000057355635],"study_design_scores_gemma":[0.0025980463,0.0014435075,0.99315584,0.0001970743,0.00051153835,0.00002619356,0.0002527689,0.0011515499,0.0005262739,0.000023584214,0.000008500641,0.00010513736],"about_ca_topic_score_codex":0.00015070516,"about_ca_topic_score_gemma":0.000018134268,"teacher_disagreement_score":0.0022936622,"about_ca_system_score_codex":0.00001462568,"about_ca_system_score_gemma":0.00012363507,"threshold_uncertainty_score":0.33673325},"labels":[],"label_agreement":null},{"id":"W4405043434","doi":"10.1182/blood-2024-200701","title":"Fixed-Duration Acalabrutinib Plus Venetoclax with or without Obinutuzumab Versus Chemoimmunotherapy for First-Line Treatment of Chronic Lymphocytic Leukemia: Interim Analysis of the Multicenter, Open-Label, Randomized, Phase 3 AMPLIFY Trial","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada); University of Calgary; Foothills Medical Centre; University of Ottawa","funders":"","keywords":"Obinutuzumab; Venetoclax; Chemoimmunotherapy; Medicine; Internal medicine; Oncology; Chronic lymphocytic leukemia; Interim analysis; Fludarabine; Leukemia; Randomized controlled trial; Cyclophosphamide; Chemotherapy","score_opus":0.0857842112642104,"score_gpt":0.4075480686450218,"score_spread":0.32176385738081137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405043434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850712,0.0031834608,0.0012747209,0.00007898628,0.00045282775,0.009588953,0.00018570584,0.00006075825,0.000103392624],"genre_scores_gemma":[0.99469155,0.001351186,0.0005838846,0.000025773043,0.00029728704,0.0016223587,0.00026584405,0.000081159335,0.0010809425],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99703795,0.00017100309,0.0011223799,0.00061279186,0.00059867045,0.00045718497],"domain_scores_gemma":[0.99664783,0.0015536027,0.00042110705,0.0010185878,0.00023788393,0.00012101347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006262265,0.0004080772,0.0019742784,0.00030198004,0.0001153608,0.00009261098,0.00047977775,0.00021888374,0.00019390378],"category_scores_gemma":[0.0003713008,0.00021874293,0.0004905782,0.0011442882,0.00042684635,0.00013033996,0.00012239834,0.00015802562,0.000005128686],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.9706031,0.0015596224,0.0000029312607,0.00070222304,0.01618216,0.000038817307,0.0012210339,0.0012315589,0.0037651258,0.000052464206,0.000049147908,0.0045918194],"study_design_scores_gemma":[0.59868777,0.009765439,8.8327187e-7,0.0004366188,0.009666821,0.000026485168,0.00006539714,0.35311824,0.027467787,0.000002784352,0.00062970613,0.00013207368],"about_ca_topic_score_codex":0.003035274,"about_ca_topic_score_gemma":0.0012039298,"teacher_disagreement_score":0.3719153,"about_ca_system_score_codex":0.07885749,"about_ca_system_score_gemma":0.052063115,"threshold_uncertainty_score":0.9533108},"labels":[],"label_agreement":null},{"id":"W4405043549","doi":"10.1182/blood-2024-194613","title":"Disparities in Clinical Trial Enrollment for Patients with Hematologic Malignancies - a 15-Year Princess Margaret Cancer Centre Experience","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Hematologic Neoplasms; Medicine; Hematologic malignancy; Cancer; Gerontology; Clinical trial; Internal medicine; Family medicine; Oncology","score_opus":0.015955772826541103,"score_gpt":0.29370418014236904,"score_spread":0.27774840731582795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405043549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968795,0.001625284,0.00007993672,0.00012458883,0.00044790638,0.00060597504,0.00016939463,0.000010152082,0.000057273024],"genre_scores_gemma":[0.9980175,0.00068569375,0.0003839915,0.00013394958,0.00024059915,0.00032587236,0.00008637341,0.000016869733,0.00010914323],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990592,0.000020494585,0.00025625946,0.00035086504,0.00009183416,0.00022132118],"domain_scores_gemma":[0.99963653,0.000053810832,0.000046333007,0.00016590224,0.00004515928,0.000052282856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000087791195,0.00012027773,0.00016803884,0.000021382248,0.000031123756,0.00005143057,0.00012144586,0.00009520476,0.000014232383],"category_scores_gemma":[0.00009228187,0.00009499236,0.000070958355,0.000051531348,0.00007052179,0.0000037370712,0.00007473094,0.000053948224,0.0000013122589],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066438867,0.0014399597,0.9863435,0.00020801536,0.00015059563,0.000020189782,0.0002435283,0.000028525776,0.0006088013,0.0013956492,0.002067512,0.00084983266],"study_design_scores_gemma":[0.28905714,0.013863416,0.3637307,0.0015821559,0.00070592004,0.000016736452,0.0013302931,0.00023835847,0.09402188,0.0015425113,0.23076102,0.0031498785],"about_ca_topic_score_codex":0.00006144752,"about_ca_topic_score_gemma":0.00036067519,"teacher_disagreement_score":0.6226128,"about_ca_system_score_codex":0.000014558262,"about_ca_system_score_gemma":0.00013762082,"threshold_uncertainty_score":0.3873676},"labels":[],"label_agreement":null},{"id":"W4405043558","doi":"10.1182/blood-2024-194886","title":"Survival and Engraftment Post Allogeneic Hematopoietic Stem Cell Transplantation: ABO Mismatch Matters in RIC","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Transplantation; Stem cell; ABO blood group system; Hematopoietic stem cell transplantation; Immunology; Haematopoiesis; Medicine; Biology; Internal medicine; Genetics","score_opus":0.011245892790777012,"score_gpt":0.23841202876231932,"score_spread":0.2271661359715423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405043558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99206,0.0028606832,0.00032919354,0.0020219672,0.00024258572,0.0005656806,0.000040026323,0.00012511306,0.0017547418],"genre_scores_gemma":[0.9977117,0.0008665913,0.00047373428,0.0003099175,0.000056326877,0.00005471512,0.000081902115,0.00004448567,0.00040059516],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99855185,0.00006829122,0.00038893666,0.00039703323,0.0003109363,0.0002829305],"domain_scores_gemma":[0.99944395,0.00017165852,0.000029536988,0.00018559652,0.000027835578,0.00014142963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023785567,0.00021513566,0.00031134454,0.00020635813,0.000034610806,0.000048983267,0.000061549435,0.00011018284,0.000102688864],"category_scores_gemma":[0.0000011958115,0.0001953436,0.00007238458,0.00026219207,0.000038981656,0.00006933277,0.000007815795,0.00017009636,0.00011847967],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007634555,0.0038880347,0.12578069,0.06693321,0.0010165481,0.02349867,0.07401341,0.0000563853,0.6935122,0.003014544,0.0006099446,0.006912902],"study_design_scores_gemma":[0.025244549,0.0012435185,0.25587067,0.006564535,0.004286962,0.012141503,0.008907986,0.00033936932,0.68106914,0.00031912522,0.0023332918,0.0016793932],"about_ca_topic_score_codex":0.000048337355,"about_ca_topic_score_gemma":0.00004048915,"teacher_disagreement_score":0.13008998,"about_ca_system_score_codex":0.000032663236,"about_ca_system_score_gemma":0.00008183832,"threshold_uncertainty_score":0.79658806},"labels":[],"label_agreement":null},{"id":"W4405043607","doi":"10.1182/blood-2024-202098","title":"Eliminating the Need for Sequential Confirmation of Response in Multiple Myeloma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Multiple myeloma; Medicine; Lenalidomide; Internal medicine; Oncology","score_opus":0.04614598840469218,"score_gpt":0.3359464436156041,"score_spread":0.2898004552109119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405043607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99716675,0.00038697405,0.0002631794,0.0010968993,0.000051569623,0.0007764659,0.00003607344,0.000027938684,0.00019415807],"genre_scores_gemma":[0.9984824,0.000008722833,0.0010542899,0.000024315967,0.000056216486,0.00011573905,0.000036339356,0.000011851649,0.00021010563],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992945,0.00008038904,0.00018292366,0.00011426,0.00017026575,0.00015761967],"domain_scores_gemma":[0.9990091,0.00073588965,0.000025308524,0.00013168473,0.000058098518,0.00003996135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048478282,0.00006400248,0.00011701778,0.00012499129,0.000037816353,0.000017400782,0.000046413086,0.00003792588,0.00002415999],"category_scores_gemma":[0.00082714343,0.000041698757,0.00006580798,0.00016141337,0.00003944687,0.000043316566,0.000019095864,0.000082076665,0.000010617625],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015004958,0.0016002876,0.058338676,0.0016132105,0.00078625954,0.00051474123,0.005406176,0.000027090175,0.82344306,0.00096630154,0.00037141202,0.09192785],"study_design_scores_gemma":[0.024061035,0.0018362184,0.41854072,0.0008130818,0.00031604382,0.00013370535,0.0012787508,0.046950813,0.5034312,0.00030810956,0.002169577,0.00016078686],"about_ca_topic_score_codex":0.00007079551,"about_ca_topic_score_gemma":0.000024652,"teacher_disagreement_score":0.360202,"about_ca_system_score_codex":0.000026423437,"about_ca_system_score_gemma":0.000110378445,"threshold_uncertainty_score":0.17004259},"labels":[],"label_agreement":null},{"id":"W4405043763","doi":"10.1182/blood-2024-203896","title":"Frailty and Long-Term Survival Among Older Adults with Blood Cancers","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Frailty in Older Adults","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Gerontology; Hematologic Neoplasms; Term (time); Cancer; Internal medicine; Oncology","score_opus":0.011864041862859014,"score_gpt":0.2563313475510814,"score_spread":0.24446730568822236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405043763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917843,0.0037409028,0.000041275714,0.0005222577,0.0003243751,0.00058079785,0.00003417119,0.00030429932,0.002667672],"genre_scores_gemma":[0.99595535,0.00023900387,0.00025943984,0.00012585918,0.00041004425,0.000055437933,0.00004354312,0.00007261069,0.002838711],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839574,0.000026320311,0.00021992334,0.00056636357,0.0003991,0.00039256932],"domain_scores_gemma":[0.99912596,0.000088407076,0.000038706774,0.00039491506,0.00007645231,0.0002755372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009877191,0.000268536,0.00033019268,0.00011312505,0.00006068258,0.00007782986,0.00009788607,0.00013354306,0.00023246212],"category_scores_gemma":[0.00004154463,0.00020695053,0.00006537944,0.0002660574,0.00020053872,0.00015258441,0.000055895845,0.000352927,0.00003572583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014085592,0.00046513218,0.98200953,0.0016080424,0.0009976536,0.002869398,0.0023508205,0.0000014938253,0.0005375654,0.000051226536,0.0005887794,0.00837951],"study_design_scores_gemma":[0.009566551,0.00066278444,0.97800446,0.0038733021,0.0013765512,0.00074857543,0.00019256028,0.000057098816,0.0049320385,0.0000084274625,0.00022904824,0.00034863167],"about_ca_topic_score_codex":0.00038823884,"about_ca_topic_score_gemma":0.0016224647,"teacher_disagreement_score":0.009425695,"about_ca_system_score_codex":0.000037869246,"about_ca_system_score_gemma":0.00019166699,"threshold_uncertainty_score":0.8439198},"labels":[],"label_agreement":null},{"id":"W4405043806","doi":"10.1182/blood-2024-209760","title":"Tumor Microenvironment Differences between Diagnostic and Relapsed Classic Hodgkin Lymphoma Revealed By Single Cell Transcriptome Sequencing","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Toronto; Princess Margaret Cancer Centre; Spinal Cord Injury BC","funders":"","keywords":"Transcriptome; Lymphoma; Biology; Tumor microenvironment; Cancer research; Medicine; Pathology; Genetics; Tumor cells; Gene","score_opus":0.015546759578168241,"score_gpt":0.214408723331779,"score_spread":0.19886196375361076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405043806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.976182,0.021600036,0.000020326324,0.0008055783,0.0001166128,0.00050505507,0.00012443667,0.00012616877,0.000519801],"genre_scores_gemma":[0.9975241,0.0009156605,0.00031641478,0.0002215107,0.00014376598,0.00011459883,0.00007503035,0.00004524059,0.0006436938],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841434,0.000060523078,0.00033712908,0.00054680347,0.0002728218,0.00036840982],"domain_scores_gemma":[0.9989403,0.0005035584,0.000053191496,0.0002451043,0.000010178731,0.0002476578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000970355,0.00029854235,0.00045622428,0.0000936083,0.000092106566,0.00009264862,0.00007472506,0.000091369664,0.000059774648],"category_scores_gemma":[0.00003658981,0.00023160152,0.00012429192,0.00013807577,0.00010643372,0.00007835973,0.00003187702,0.00008856265,0.00007062787],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040650422,0.0031450323,0.6728971,0.0009382755,0.00068999105,0.0022515475,0.0012214653,2.1816382e-7,0.2974895,0.00003306016,0.003538334,0.01775482],"study_design_scores_gemma":[0.011725539,0.002099315,0.72830033,0.0014843586,0.0033562405,0.00034753047,0.00025999566,0.000023356868,0.24541539,0.0001287151,0.0063437824,0.000515458],"about_ca_topic_score_codex":0.00007687966,"about_ca_topic_score_gemma":0.0000045360616,"teacher_disagreement_score":0.05540322,"about_ca_system_score_codex":0.00027966316,"about_ca_system_score_gemma":0.000088915236,"threshold_uncertainty_score":0.9444436},"labels":[],"label_agreement":null},{"id":"W4405043850","doi":"10.1182/blood-2024-211666","title":"Hydroxyurea Decreases Transfusion Utilization in Ugandan Children with Sickle Cell Anemia: Main Results from the Alternative Dosing and Prevention of Transfusions (ADAPT) Trial","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Dosing; Medicine; Sickle cell anemia; Anemia; Blood transfusion; Intensive care medicine; Pediatrics; Immunology; Internal medicine; Disease","score_opus":0.013529645051238853,"score_gpt":0.24578299781404145,"score_spread":0.2322533527628026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405043850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99452287,0.0025998151,0.00052032276,0.00052913383,0.000055084176,0.0009919435,0.000097497934,0.00003197563,0.0006513519],"genre_scores_gemma":[0.9966425,0.002846352,0.00016176417,0.000021629301,0.000071872826,0.0000105539075,0.00017289043,0.000016929322,0.000055523775],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990665,0.000086459055,0.00028265765,0.00025367673,0.00019002488,0.000120710254],"domain_scores_gemma":[0.9996123,0.00013838835,0.000045820772,0.00013178625,0.000018956069,0.000052793752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019251836,0.000119379205,0.00018466289,0.00007512615,0.00006652298,0.000018423423,0.00004257444,0.00011072828,0.000016744754],"category_scores_gemma":[0.000037160706,0.0000720589,0.00005686803,0.0002717094,0.00007180841,0.000065832624,0.000008681217,0.00021175129,6.0838806e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22063006,0.02274507,0.08592207,0.0015057226,0.0031131592,0.0010136985,0.13772805,0.002455673,0.2872583,0.0012685756,0.0012940392,0.2350656],"study_design_scores_gemma":[0.5972786,0.010209517,0.15411665,0.010638911,0.0070421044,0.00034839628,0.007953351,0.0062705325,0.20197916,0.0025445628,0.00063550967,0.000982729],"about_ca_topic_score_codex":0.0017765113,"about_ca_topic_score_gemma":0.00069933385,"teacher_disagreement_score":0.37664852,"about_ca_system_score_codex":0.000013157399,"about_ca_system_score_gemma":0.00011100808,"threshold_uncertainty_score":0.29384765},"labels":[],"label_agreement":null},{"id":"W4405043872","doi":"10.1182/blood-2024-210347","title":"Hydroxyurea Treatment Reduces Infection Rates in African Children with Sickle Cell Anemia","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Sickle cell anemia; Medicine; Anemia; Pediatrics; Fetal hemoglobin; Immunology; Intensive care medicine; Disease; Internal medicine; Biology; Genetics; Pregnancy","score_opus":0.005336938512277571,"score_gpt":0.2259906833075443,"score_spread":0.22065374479526673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405043872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980924,0.003041707,0.0000020717462,0.0004783362,0.000054279117,0.0003241354,0.000003961634,0.00012151335,0.015050001],"genre_scores_gemma":[0.99788994,0.00086221163,0.00005645182,0.000027932087,0.000076506345,0.000026377209,0.000038049115,0.000021495644,0.001001013],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993772,0.000016692185,0.000119609685,0.00021517788,0.000093030096,0.0001782935],"domain_scores_gemma":[0.99977255,0.000014690994,0.000018442093,0.000113859096,0.000010899128,0.00006955199],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004207916,0.0001301776,0.00015715964,0.00012314889,0.00003279777,0.000023728557,0.000020859972,0.00008559154,0.000048107875],"category_scores_gemma":[0.000004514466,0.00008206238,0.000045837976,0.00033776666,0.000036716254,0.00004357562,0.0000072110024,0.00013747223,0.00005065482],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029059706,0.0070675085,0.911639,0.0003835891,0.0009222637,0.0010325665,0.005926524,0.00039913808,0.03732332,0.00012530586,0.0014091812,0.03348103],"study_design_scores_gemma":[0.02419852,0.010612086,0.48027822,0.0014558018,0.0032129993,0.0013464089,0.001392408,0.0006086459,0.4631288,0.00020915632,0.0124967005,0.0010602287],"about_ca_topic_score_codex":0.0007928291,"about_ca_topic_score_gemma":0.00008719449,"teacher_disagreement_score":0.43136075,"about_ca_system_score_codex":0.000049890477,"about_ca_system_score_gemma":0.00010841076,"threshold_uncertainty_score":0.33464068},"labels":[],"label_agreement":null},{"id":"W4405043875","doi":"10.1182/blood-2024-205848","title":"Growth and Puberty in African Children with Sickle Cell Anemia Treated with Hydroxyurea","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"Wellcome Trust; National Heart, Lung, and Blood Institute; Cincinnati Children's Hospital Medical Center; Bristol-Myers Squibb","keywords":"Sickle cell anemia; Medicine; Pediatrics; Anemia; Fetal hemoglobin; Internal medicine; Disease; Biology; Genetics; Pregnancy","score_opus":0.0027723164649229295,"score_gpt":0.17890124556426273,"score_spread":0.1761289290993398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405043875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97035617,0.0021740296,0.0000038384446,0.00060695264,0.000008635264,0.0003203094,0.0000068668255,0.00011508643,0.026408125],"genre_scores_gemma":[0.998878,0.00024156705,0.0001311925,0.00008671535,0.000028215449,0.00001322298,0.00003107376,0.000033280245,0.00055673305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992147,0.000014990005,0.00011486723,0.00028230558,0.00013644592,0.00023670166],"domain_scores_gemma":[0.9996865,0.00001790487,0.000018186518,0.00013676033,0.000014706478,0.00012593252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000044393302,0.0001580465,0.00020295469,0.000120300494,0.00003177968,0.000028968498,0.000036630405,0.00009820811,0.000024253242],"category_scores_gemma":[0.000005432569,0.000090362075,0.000021850201,0.00045147835,0.00008483591,0.000054476495,0.000014651854,0.000255499,0.000009818122],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034023062,0.0011229608,0.98970824,0.0004033323,0.0003378773,0.0014108315,0.001406548,0.000010079372,0.0029841163,0.00013341919,0.00044838845,0.0016939603],"study_design_scores_gemma":[0.034487795,0.006448196,0.9044864,0.0018713841,0.0033146536,0.0039261244,0.0016203442,0.00047692985,0.040645517,0.00013523515,0.0013360417,0.001251362],"about_ca_topic_score_codex":0.0005913136,"about_ca_topic_score_gemma":0.0000706461,"teacher_disagreement_score":0.08522184,"about_ca_system_score_codex":0.000012069397,"about_ca_system_score_gemma":0.00007921659,"threshold_uncertainty_score":0.36848584},"labels":[],"label_agreement":null},{"id":"W4405043889","doi":"10.1182/blood-2024-199542","title":"Cevostamab in Patients with Heavily Pretreated Relapsed/Refractory Multiple Myeloma (RRMM): Updated Results from an Ongoing Phase I Study Demonstrate Clinically Meaningful Activity and Manageable Safety and Inform the Doses and Regimen for Combination Studies","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; University of Calgary; Princess Margaret Cancer Centre","funders":"Juno Therapeutics; Genentech; City of Hope; Pharmacyclics; Gilead Sciences; Kite Pharma; Regeneron Pharmaceuticals; University of Pennsylvania; Bristol-Myers Squibb; AstraZeneca; Celgene; Amgen","keywords":"Medicine; Multiple myeloma; Pomalidomide; Regimen; Lenalidomide; Oncology; Internal medicine; Refractory (planetary science); Phases of clinical research; Clinical trial; Intensive care medicine; Biology","score_opus":0.0287834125894258,"score_gpt":0.3350266829619709,"score_spread":0.3062432703725451,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405043889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99576914,0.00051776815,0.0000064612364,0.0002249558,0.000029348203,0.0029388166,0.00031331848,0.00007684825,0.00012331114],"genre_scores_gemma":[0.9987734,0.00030387973,0.00028795408,0.000021213933,0.000019602956,0.00008372639,0.00038706794,0.000028550303,0.00009458125],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99828696,0.00011719643,0.0004285059,0.0005619127,0.00031074902,0.00029466767],"domain_scores_gemma":[0.9981527,0.0010865229,0.00012732814,0.00030174936,0.00016467586,0.00016702263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006214506,0.00024709353,0.00042034214,0.00015043022,0.00024693395,0.000120288874,0.000060983806,0.00008366681,0.0000015850511],"category_scores_gemma":[0.0005442947,0.00015382851,0.000023904287,0.00022700483,0.00016680988,0.00047180464,0.00009663508,0.00026404797,6.70472e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037647113,0.0066758464,0.8749575,0.00017384553,0.001935671,0.00017673637,0.005079702,0.0000013007518,0.00022312446,0.000012736859,0.00002229787,0.07309414],"study_design_scores_gemma":[0.09357252,0.009562814,0.8916389,0.00036080688,0.00045970076,0.0000044056333,0.0020428614,0.0017181177,0.00038202762,0.00004941826,0.00005058025,0.00015786174],"about_ca_topic_score_codex":0.0004855164,"about_ca_topic_score_gemma":0.000988281,"teacher_disagreement_score":0.072936274,"about_ca_system_score_codex":0.000064257234,"about_ca_system_score_gemma":0.00007518618,"threshold_uncertainty_score":0.6272945},"labels":[],"label_agreement":null},{"id":"W4405043921","doi":"10.1182/blood-2024-210872","title":"Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry: Tagraxofusp Cohort Treatment Results","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa; Foothills Medical Centre; University of Calgary","funders":"","keywords":"Medicine; Cohort; Internal medicine; Hematologic Neoplasms; Oncology; Cancer","score_opus":0.014214239178459388,"score_gpt":0.2900948102327291,"score_spread":0.2758805710542697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405043921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9171377,0.0014845999,0.00007384936,0.0019846007,0.0005896555,0.00087471784,0.00032058588,0.00027754155,0.077256784],"genre_scores_gemma":[0.95898354,0.0005707441,0.00033836896,0.00009491995,0.00041952325,0.00013241863,0.00038075427,0.000058964364,0.03902078],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99779457,0.000052566265,0.00037670965,0.0006593098,0.00067470834,0.00044215453],"domain_scores_gemma":[0.99876267,0.0003260636,0.000042366646,0.000461484,0.00015493702,0.00025246388],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014111715,0.00027741975,0.00032189715,0.00026125007,0.000091613554,0.00016538541,0.00018822285,0.000120571676,0.00033709436],"category_scores_gemma":[0.0003529471,0.0002328244,0.00017762795,0.00028905066,0.00012868915,0.000071507,0.0000692269,0.00024224064,0.0008683403],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010081519,0.03140313,0.42953712,0.0033344843,0.014249867,0.11140734,0.008352112,0.0003788583,0.2305291,0.0032168047,0.11857296,0.0389367],"study_design_scores_gemma":[0.06493085,0.00895737,0.022739103,0.0021370866,0.0041422998,0.04380107,0.0017097932,0.024979828,0.34551027,0.00085827895,0.4780122,0.002221824],"about_ca_topic_score_codex":0.00015360338,"about_ca_topic_score_gemma":0.000117831674,"teacher_disagreement_score":0.406798,"about_ca_system_score_codex":0.00034926916,"about_ca_system_score_gemma":0.0006086472,"threshold_uncertainty_score":0.9999096},"labels":[],"label_agreement":null},{"id":"W4405043929","doi":"10.1182/blood-2024-198542","title":"Follicular Dendritic Cells Represent a Therapeutic Vulnerability in Early Follicular Lymphoma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Follicular lymphoma; Follicular phase; Follicular dendritic cells; Medicine; Lymphoma; Immunology; Cancer research; Biology; Internal medicine; Antigen-presenting cell; Immune system; T cell","score_opus":0.01199529753423114,"score_gpt":0.24131837293118144,"score_spread":0.2293230753969503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405043929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9780984,0.015407932,0.00021521951,0.00018926882,0.003675712,0.00030244308,0.000002916279,0.00017834295,0.0019297586],"genre_scores_gemma":[0.9920333,0.000120265424,0.000015581169,0.0001555266,0.000047599282,0.00007091898,0.000029269573,0.000023799115,0.007503742],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985363,0.00030317646,0.0003369983,0.00044437803,0.000048069425,0.00033106792],"domain_scores_gemma":[0.9993695,0.00013932034,0.000033886372,0.00040043928,0.000037632817,0.000019191899],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029193205,0.00017998049,0.0002233198,0.00016858817,0.00009108039,0.00006109862,0.00014159872,0.00022656209,0.0008898594],"category_scores_gemma":[0.00003572947,0.00015924912,0.00020187949,0.00025510154,0.00007029013,0.00015257167,0.000047996546,0.000279986,0.002015637],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000084271065,0.0009316055,0.002353778,0.000060367925,0.0004909703,0.0001166562,0.000646782,0.000009649331,0.9893092,0.0008701534,0.0014926424,0.0036339366],"study_design_scores_gemma":[0.0028534897,0.00027715488,0.014735093,0.00013214907,0.00023322251,0.0002605864,0.00020585491,0.000061532475,0.8480345,0.00048168717,0.1324005,0.0003242041],"about_ca_topic_score_codex":0.00035995766,"about_ca_topic_score_gemma":0.000022024453,"teacher_disagreement_score":0.14127466,"about_ca_system_score_codex":0.00006683314,"about_ca_system_score_gemma":0.000052644176,"threshold_uncertainty_score":0.9987614},"labels":[],"label_agreement":null},{"id":"W4405044004","doi":"10.1182/blood-2024-198403","title":"Mezigdomide (MEZI) in Novel-Novel Combinations for Relapsed or Refractory Multiple Myeloma (RRMM): Preliminary Results from the CA057-003 Trial","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Calgary; University of Alberta","funders":"","keywords":"Lenalidomide; Medicine; Pomalidomide; Multiple myeloma; Internal medicine; Oncology; Refractory (planetary science); Biology","score_opus":0.06561095051632172,"score_gpt":0.33243927684294644,"score_spread":0.26682832632662473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816326,0.0013594859,0.00041095025,0.004907645,0.00085228466,0.006014259,0.0032682118,0.00023322944,0.0013213392],"genre_scores_gemma":[0.9881632,0.000082313534,0.00401045,0.00016728658,0.00057899224,0.0009865178,0.0013627367,0.00007569193,0.0045728493],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99748653,0.00009860901,0.0006727069,0.00067124853,0.0005303833,0.00054051593],"domain_scores_gemma":[0.99361944,0.0052389214,0.000101226586,0.00070440135,0.00011416669,0.0002218555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006454143,0.00029178208,0.00044095115,0.00021180474,0.00019854218,0.000091557224,0.00025669602,0.00021974856,0.000055640958],"category_scores_gemma":[0.0051342337,0.00018150822,0.00022758517,0.0004555956,0.000111255504,0.00016921254,0.0001061806,0.0005019914,0.00006192133],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8328183,0.046641607,0.0036336542,0.00050482416,0.0038708693,0.0021283568,0.0064816047,0.000024716128,0.046865474,0.0013718111,0.019223584,0.036435198],"study_design_scores_gemma":[0.87331265,0.008403696,0.04966585,0.0010350607,0.0009006599,0.00009203582,0.0005317995,0.008755777,0.009207849,0.00027772874,0.047367096,0.00044979656],"about_ca_topic_score_codex":0.0011028865,"about_ca_topic_score_gemma":0.0009760071,"teacher_disagreement_score":0.046032198,"about_ca_system_score_codex":0.00021047649,"about_ca_system_score_gemma":0.0008683738,"threshold_uncertainty_score":0.74016905},"labels":[],"label_agreement":null},{"id":"W4405044026","doi":"10.1182/blood-2024-206253","title":"Modeling Clonal Hematopoiesis Due to Chromosome 13q Deletion in Human Hematopoietic Stem Cells","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Princess Margaret Cancer Centre; University of Toronto; Ottawa Hospital; University Health Network","funders":"","keywords":"Haematopoiesis; Stem cell; Biology; Chromosome abnormality; Immunology; Genetics; Chromosome; Karyotype; Gene","score_opus":0.023504428920999642,"score_gpt":0.29199892653441206,"score_spread":0.26849449761341243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940293,0.0009396576,0.0015108624,0.0013688692,0.000106365114,0.0006266728,0.0000121058465,0.00020578048,0.0012004063],"genre_scores_gemma":[0.9970808,0.000026845453,0.0010476685,0.0002468138,0.00030983973,0.000111259,0.000018933166,0.00007258735,0.0010852208],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978973,0.00005889505,0.0004386145,0.000528472,0.00055292825,0.00052376866],"domain_scores_gemma":[0.9991601,0.00007092963,0.000018129269,0.0004067707,0.00007932436,0.00026473743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004568746,0.00021760847,0.00042479113,0.00047814756,0.00008065564,0.000077451914,0.0001812667,0.0001621388,0.00021370273],"category_scores_gemma":[0.000020430287,0.00020235457,0.000123357,0.00068365934,0.000036499536,0.000102754406,0.00014491523,0.00049885,0.000517554],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012742064,0.0012217534,0.0006443012,0.003506258,0.0003371766,0.009145988,0.004520399,0.0016949041,0.96949816,0.004326444,0.0032345348,0.0017426406],"study_design_scores_gemma":[0.0072676786,0.000947458,0.000314147,0.004205693,0.00048693316,0.003629816,0.0014958617,0.13239405,0.8443786,0.0016862805,0.0021387935,0.0010547085],"about_ca_topic_score_codex":0.00011998224,"about_ca_topic_score_gemma":0.000032033644,"teacher_disagreement_score":0.13069913,"about_ca_system_score_codex":0.0003213788,"about_ca_system_score_gemma":0.00026986835,"threshold_uncertainty_score":0.82517797},"labels":[],"label_agreement":null},{"id":"W4405044030","doi":"10.1182/blood-2024-206532","title":"Non-Invasive Characterization and Early Detection of Post-Transplant Lymphoproliferative Disorders","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Transplantation: Methods and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"Lymphoproliferative disorders; Medicine; Immunology; Lymphoma","score_opus":0.007068464503035894,"score_gpt":0.24825798138965674,"score_spread":0.24118951688662085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850136,0.00025482223,0.013897137,0.0002605517,0.00013084784,0.00025658213,0.000054676428,0.00004484357,0.00008695861],"genre_scores_gemma":[0.99837023,0.0006990827,0.00062835607,0.000055992827,0.00006586488,0.00001505004,0.00004961685,0.000013517524,0.00010226164],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9994888,0.000020591535,0.00015454194,0.00015095643,0.00010091042,0.000084231535],"domain_scores_gemma":[0.9997521,0.00007076519,0.000027422879,0.000063673535,0.000042253905,0.000043750944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007135302,0.00008688624,0.00015691672,0.00010375287,0.00003203977,0.00001620353,0.000017038215,0.00005601129,0.000008425842],"category_scores_gemma":[0.000012193911,0.00006964585,0.000049940005,0.000118151715,0.000033230863,0.000099024175,0.0000029624834,0.00006035388,0.0000030920542],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117475836,0.0000680434,0.15001878,0.00057732867,0.00013081476,0.000024007284,0.0037442222,1.7152709e-7,0.8358416,0.00009534915,1.5518985e-7,0.009382058],"study_design_scores_gemma":[0.0010204469,0.00031161937,0.6808453,0.00023702797,0.0003238705,0.00007765068,0.00006532283,0.000029846375,0.3169612,0.00003296856,0.000034028475,0.00006070583],"about_ca_topic_score_codex":0.00006352142,"about_ca_topic_score_gemma":0.00004714301,"teacher_disagreement_score":0.53082657,"about_ca_system_score_codex":0.0000060370403,"about_ca_system_score_gemma":0.0000509511,"threshold_uncertainty_score":0.28400755},"labels":[],"label_agreement":null},{"id":"W4405044058","doi":"10.1182/blood-2024-201819","title":"Retreatment with R-CHOP-like Therapy in Patients with Late Relapse of Diffuse Large B-Cell Lymphoma (DLBCL)","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Diffuse large B-cell lymphoma; Medicine; Lymphoma; Rituximab; Oncology; CHOP; Internal medicine","score_opus":0.004987517875997582,"score_gpt":0.2040393088167558,"score_spread":0.19905179094075823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952948,0.00251438,0.0000010945886,0.00011622675,0.000059099817,0.0007393107,0.00005093042,0.000064643085,0.0011595134],"genre_scores_gemma":[0.99820817,0.00051862566,0.00026595072,0.00013386291,0.000022251008,0.0001042201,0.00007123969,0.000048236485,0.0006274675],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987357,0.000028343986,0.00023417817,0.000367091,0.00034994373,0.00028470575],"domain_scores_gemma":[0.9993241,0.000051485764,0.00006202796,0.00039225307,0.000056945853,0.00011319779],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006130444,0.00024483915,0.000360269,0.00013717033,0.000029151595,0.000020280144,0.00005449144,0.00007449899,0.000032530963],"category_scores_gemma":[0.0000036103856,0.00013676216,0.00007833618,0.0003057173,0.000037172187,0.000068966554,0.000021206262,0.00005437787,0.000032091757],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009851132,0.0713582,0.9203873,0.0001057037,0.00061070896,0.0008596537,0.00065657566,5.771683e-7,0.000059768823,0.00006117327,0.00013801162,0.0047772224],"study_design_scores_gemma":[0.15920414,0.005751737,0.825679,0.0006168962,0.0004627245,0.000017687693,0.0000395107,0.000011471112,0.005986491,0.000010044719,0.0020465555,0.00017371561],"about_ca_topic_score_codex":0.00011060635,"about_ca_topic_score_gemma":0.00004495734,"teacher_disagreement_score":0.15821904,"about_ca_system_score_codex":0.00013156133,"about_ca_system_score_gemma":0.00013697566,"threshold_uncertainty_score":0.55769986},"labels":[],"label_agreement":null},{"id":"W4405044069","doi":"10.1182/blood-2024-203020","title":"Baseline Neurological Morbidity Assessment in Adult Patients with Sickle Cell Disease : The Montreal Brain-SCD Cohort","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institut Universitaire de Gériatrie de Montréal; Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Cohort; Sickle cell anemia; Disease; Internal medicine; Pediatrics","score_opus":0.004557385756492076,"score_gpt":0.22297191728654014,"score_spread":0.21841453153004806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98735476,0.0003923593,0.00003842616,0.0077710403,0.000107688276,0.0006703833,0.000036060264,0.000089588284,0.00353971],"genre_scores_gemma":[0.9973427,0.00013234759,0.00005967717,0.0019248859,0.0000702125,0.00004589067,0.0000979847,0.000021470838,0.0003048484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879014,0.00009569556,0.00020026608,0.0003302062,0.00032811414,0.0002555476],"domain_scores_gemma":[0.9993346,0.0001310228,0.000026330654,0.00027083472,0.00005792241,0.00017930218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018318645,0.00015635307,0.00018043503,0.000047395646,0.000055560886,0.000026396794,0.000081294296,0.00007712013,0.000097331686],"category_scores_gemma":[0.00007522801,0.00007979018,0.00007077412,0.00022368839,0.00007277487,0.000037807156,0.000043943393,0.00048186374,0.000025985442],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023297554,0.0029842327,0.98930895,0.00011564854,0.0000739105,0.0009595164,0.00010516454,0.00010298508,0.000026547785,0.000082536484,0.0037125826,0.0022949227],"study_design_scores_gemma":[0.0040076342,0.0005349186,0.98766214,0.000084195526,0.00038609118,0.000007241267,0.0000480023,0.005338118,0.000018136529,0.000046519122,0.0017460044,0.00012101772],"about_ca_topic_score_codex":0.00027557474,"about_ca_topic_score_gemma":0.00009879738,"teacher_disagreement_score":0.009987938,"about_ca_system_score_codex":0.000017246568,"about_ca_system_score_gemma":0.00015788866,"threshold_uncertainty_score":0.3253749},"labels":[],"label_agreement":null},{"id":"W4405044137","doi":"10.1182/blood-2024-208605","title":"Feasibility of Adjusting Risk Group and Risk Group-Based Therapy during Induction in the Treatment of B-Cell Acute Lymphoblastic Leukemia: Results from DFCI ALL Consortium Protocol 16-001","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Lymphoblastic Leukemia; Internal medicine; Oncology; Induction therapy; Leukemia; Acute lymphocytic leukemia; Pediatrics; Chemotherapy","score_opus":0.029809940613091234,"score_gpt":0.3034650695666534,"score_spread":0.2736551289535622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9740774,0.00034465152,0.00008083874,0.00004191358,0.00005925792,0.024651198,0.0005103481,0.00006978373,0.00016463299],"genre_scores_gemma":[0.99067354,0.0006602984,0.00074290123,0.000016216238,0.0001852288,0.007505934,0.00013203923,0.00004624715,0.000037584698],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99682826,0.0005017684,0.0008914192,0.000730446,0.00062490336,0.0004231989],"domain_scores_gemma":[0.99710834,0.001587084,0.00037035975,0.0007106812,0.000093144765,0.0001303784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008682385,0.00033585547,0.00058074313,0.00024481874,0.000090343994,0.000037522354,0.00017695277,0.00024024892,0.000023170858],"category_scores_gemma":[0.0003143112,0.00021512565,0.00015463709,0.00048454624,0.00028246338,0.00010520967,0.000047547994,0.00039059253,0.000004774968],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05071704,0.038923696,0.39757305,0.003839728,0.0045820787,0.0018446159,0.015433488,0.00031136954,0.45436904,0.000035064404,0.0003063579,0.032064475],"study_design_scores_gemma":[0.27851173,0.010886577,0.40572464,0.0013870307,0.0034954087,0.00020517169,0.0013303559,0.013316298,0.28383455,0.0002544063,0.00044881462,0.00060500804],"about_ca_topic_score_codex":0.007208851,"about_ca_topic_score_gemma":0.00031355617,"teacher_disagreement_score":0.22779469,"about_ca_system_score_codex":0.0011749042,"about_ca_system_score_gemma":0.00058882905,"threshold_uncertainty_score":0.9994022},"labels":[],"label_agreement":null},{"id":"W4405044171","doi":"10.1182/blood-2024-199697","title":"Targeted Protein Degradation Reveals a Repressive Role of Mecom at the <i>CEBPA</i> Locus to Prevent Differentiation in High-Risk Acute Myeloid Leukemia","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"CEBPA; Myeloid leukemia; Biology; Leukemia; Myeloid; Genetics; Cancer research; Gene; Mutation","score_opus":0.006994282316369191,"score_gpt":0.25246213565755204,"score_spread":0.24546785334118285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927855,0.0021669792,0.00021410282,0.0015886624,0.00006952487,0.0027174645,0.00011299641,0.00008460006,0.00026013528],"genre_scores_gemma":[0.9940428,0.00018097942,0.00064938905,0.000080228245,0.00013699397,0.0005880069,0.00020340462,0.00005195734,0.0040662433],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99755996,0.0003130094,0.0005689935,0.00054935797,0.00061478344,0.00039388274],"domain_scores_gemma":[0.9986681,0.00017616244,0.00017123255,0.00069426745,0.0001463208,0.00014395367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064248237,0.00022696273,0.0004232114,0.00028267858,0.000085310516,0.000038669292,0.00024193006,0.00016474063,0.00014130995],"category_scores_gemma":[0.00039377922,0.00015672688,0.00012640056,0.0007676603,0.00005851337,0.00012221052,0.000265661,0.0005261876,0.00010699067],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041742748,0.00034592982,0.0063240835,0.00022228563,0.0005539405,0.00009826944,0.0013519565,0.000061931525,0.97935677,0.00028366895,0.0022600882,0.008723669],"study_design_scores_gemma":[0.0026200176,0.00045619704,0.04007253,0.00067063497,0.0006053918,0.000046849567,0.00012344254,0.00080283213,0.95224786,0.0012169387,0.0009355548,0.00020176375],"about_ca_topic_score_codex":0.0010337279,"about_ca_topic_score_gemma":0.00033471503,"teacher_disagreement_score":0.033748444,"about_ca_system_score_codex":0.0007772985,"about_ca_system_score_gemma":0.00040824735,"threshold_uncertainty_score":0.63911366},"labels":[],"label_agreement":null},{"id":"W4405044205","doi":"10.1182/blood-2024-204219","title":"A Novel Genetics-Based Classification of Advanced Follicular Lymphoma Identifies Prognostic Subgroups Following Bendamustine-Rituximab Immunochemotherapy","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Terry Fox Research Institute; University of British Columbia; Spinal Cord Injury BC; Simon Fraser University","funders":"","keywords":"Follicular lymphoma; Bendamustine; Rituximab; Oncology; Medicine; Internal medicine; Regimen; Lymphoma; Somatic hypermutation; Cohort; Immunology; B cell","score_opus":0.01586826079335281,"score_gpt":0.27276425969778473,"score_spread":0.25689599890443193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98071754,0.016856758,0.00062980864,0.00041691322,0.00026293693,0.00074553525,0.00002911125,0.00015346192,0.00018790635],"genre_scores_gemma":[0.99442524,0.00017553987,0.004720734,0.00007886262,0.00008073359,0.00023945923,0.00014025444,0.000052188236,0.0000870147],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99853235,0.000019667128,0.0004093431,0.00041637075,0.00036948992,0.000252793],"domain_scores_gemma":[0.999162,0.00014691052,0.0000892913,0.00042304685,0.00009480194,0.000083909596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012609934,0.0002328931,0.00038936725,0.0001661598,0.00006380305,0.00005957216,0.000099124925,0.000100728306,0.00002750732],"category_scores_gemma":[0.00006610937,0.00019690041,0.00036375655,0.00035177654,0.000051820356,0.000075276155,0.000020018753,0.00004710406,0.00002703614],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015164523,0.009589502,0.055007562,0.0007584078,0.0015420364,0.0003233086,0.00037707298,0.000018183862,0.8902942,0.00044342037,0.00007353558,0.041421108],"study_design_scores_gemma":[0.025737042,0.00068567443,0.39587364,0.0013920764,0.0021668307,0.00010476831,0.00016524791,0.0018873909,0.570433,0.00007523277,0.0011851031,0.0002939738],"about_ca_topic_score_codex":0.000036443973,"about_ca_topic_score_gemma":0.0000072618263,"teacher_disagreement_score":0.34086606,"about_ca_system_score_codex":0.00009558894,"about_ca_system_score_gemma":0.00025193617,"threshold_uncertainty_score":0.8029366},"labels":[],"label_agreement":null},{"id":"W4405044220","doi":"10.1182/blood-2024-211364","title":"Identification of DLK1 As a Novel Therapeutic Target in Down Syndrome Myeloid Leukemia","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Myeloid leukemia; GATA1; Bone marrow; Cancer research; Leukemia; Myeloid; Haematopoiesis; CD34; Biology; Transcriptome; Decitabine; Medicine; Gene; Immunology; Gene expression; Stem cell; Genetics; DNA methylation","score_opus":0.016969054788371466,"score_gpt":0.29469396685602994,"score_spread":0.2777249120676585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927487,0.0025322763,0.0004548289,0.00094778696,0.00012498964,0.00054892845,0.000025753652,0.00010072352,0.0025160378],"genre_scores_gemma":[0.9960312,0.00013809101,0.0003927263,0.00013839954,0.000075715325,0.000066476096,0.000038015605,0.00004288641,0.003076493],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983519,0.0000397415,0.00046054757,0.00036939167,0.00046533855,0.00031313224],"domain_scores_gemma":[0.99920666,0.00011797757,0.000054775446,0.0004381412,0.000083503975,0.000098913624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005771768,0.00014915245,0.0003194763,0.00043408165,0.00002499599,0.00003703667,0.00019055157,0.00014581578,0.00024480894],"category_scores_gemma":[0.0001352404,0.0001291261,0.00010166928,0.0008137113,0.000095049516,0.00012302845,0.00006353051,0.0004341395,0.00040719614],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008485804,0.00048588545,0.002934621,0.0006830692,0.00028793776,0.0005964406,0.0007099583,0.000014056519,0.9893453,0.002613152,0.00027185454,0.001972844],"study_design_scores_gemma":[0.014303725,0.0014109286,0.22103909,0.0016866721,0.0008594958,0.0059366897,0.00078446674,0.014222689,0.723961,0.0041510253,0.010874534,0.00076966546],"about_ca_topic_score_codex":0.00017329858,"about_ca_topic_score_gemma":0.000007322573,"teacher_disagreement_score":0.26538432,"about_ca_system_score_codex":0.00035355732,"about_ca_system_score_gemma":0.0009689966,"threshold_uncertainty_score":0.52656096},"labels":[],"label_agreement":null},{"id":"W4405044221","doi":"10.1182/blood-2024-210935","title":"Long-Term Outcomes of Patients with Isolated Sub-Segmental Pulmonary Embolism Managed without Anticoagulant Therapy","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Pulmonary embolism; Anticoagulant therapy; Term (time); Internal medicine; Intensive care medicine; Cardiology; Surgery","score_opus":0.013084204711155779,"score_gpt":0.25762337555691384,"score_spread":0.24453917084575805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99616194,0.0013026434,0.00007146306,0.00023233808,0.00021736171,0.0010882665,0.000027686236,0.00015963656,0.0007386868],"genre_scores_gemma":[0.9982248,0.0008215586,0.00010722526,0.00028104795,0.000060328744,0.00004330435,0.00013633765,0.00006364708,0.00026176329],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985545,0.000030584062,0.00031849754,0.00037099444,0.0004206278,0.0003047735],"domain_scores_gemma":[0.999355,0.000026677268,0.0000787371,0.00037417273,0.00005947871,0.0001059039],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000096650285,0.00025857976,0.00063218566,0.00019562768,0.00005529864,0.00003797148,0.00012087359,0.00006952842,0.000115043964],"category_scores_gemma":[0.00000488857,0.00017290686,0.00013646456,0.00021990683,0.000072690855,0.000108488435,0.00006781219,0.00013865133,0.000033219465],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015978856,0.005409367,0.9826031,0.00039462236,0.001777725,0.00039927618,0.00026475624,9.5239955e-7,0.0019799708,0.00013051499,0.00014612124,0.0067338385],"study_design_scores_gemma":[0.0037892617,0.00076646736,0.9898257,0.00039162108,0.00085274933,0.000018108301,0.000032990785,0.00003599586,0.003965734,0.000013257129,0.00010361834,0.00020445987],"about_ca_topic_score_codex":0.00003871558,"about_ca_topic_score_gemma":0.0000076215692,"teacher_disagreement_score":0.0072226687,"about_ca_system_score_codex":0.000023007653,"about_ca_system_score_gemma":0.000034200275,"threshold_uncertainty_score":0.70509374},"labels":[],"label_agreement":null},{"id":"W4405044256","doi":"10.1182/blood-2024-194610","title":"Efficacy and Safety of Pozelimab Plus Cemdisiran Vs Ravulizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria Who Are Naïve to Complement Inhibition","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Medicine; Internal medicine; Eculizumab; Clinical endpoint; Gastroenterology; Interim analysis; Neutropenia; Clinical trial; Surgery; Antibody; Immunology; Chemotherapy; Complement system","score_opus":0.00829089565356706,"score_gpt":0.22662101625471492,"score_spread":0.21833012060114787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99646777,0.0013897526,0.000041748768,0.00021947712,0.0001834953,0.0010333725,0.00047309537,0.000046701294,0.00014461343],"genre_scores_gemma":[0.99945706,0.000008581294,0.000055128334,0.000060760583,0.00002443006,0.00003658091,0.00028843372,0.00001934078,0.000049690298],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998609,0.00014463246,0.00047161317,0.00037124282,0.00009351917,0.00030997614],"domain_scores_gemma":[0.99946356,0.000094704505,0.00010778131,0.00022502171,0.00006425066,0.00004465639],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013489887,0.00020720853,0.0004031181,0.00017703972,0.000078500256,0.000025844358,0.000108708446,0.00007205825,0.0003334229],"category_scores_gemma":[0.000025322553,0.00017252115,0.000048018486,0.00020181641,0.00007624457,0.000069592956,0.00013393532,0.00014079877,0.000044866152],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023332082,0.0053796973,0.92607343,0.0022153398,0.0020652995,0.00015618818,0.0065321648,0.00021055098,0.015904114,0.0020396137,0.010895243,0.005196296],"study_design_scores_gemma":[0.027336793,0.0012823495,0.95984256,0.0017483121,0.00019261312,0.000025490353,0.0003142224,0.000005007885,0.005925865,0.0000317428,0.0030039574,0.00029110638],"about_ca_topic_score_codex":0.000064101754,"about_ca_topic_score_gemma":0.00011612222,"teacher_disagreement_score":0.033769127,"about_ca_system_score_codex":0.000081963095,"about_ca_system_score_gemma":0.00006562837,"threshold_uncertainty_score":0.70352083},"labels":[],"label_agreement":null},{"id":"W4405044297","doi":"10.1182/blood-2024-198794","title":"Utility of the Central Nervous System International Prognostic Index (CNS-IPI) in Patients with Primary Mediastinal B-Cell Lymphoma Treated with Rituximab-Containing Chemoimmunotherapy","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Rituximab; Chemoimmunotherapy; International Prognostic Index; Internal medicine; Diffuse large B-cell lymphoma; Oncology; Lymphoma","score_opus":0.004827238272667484,"score_gpt":0.19048472047735954,"score_spread":0.18565748220469205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99626577,0.0005250001,0.000007609013,0.00007848041,0.0001141665,0.0008646281,0.000041102572,0.00006750925,0.0020357596],"genre_scores_gemma":[0.99953383,0.000010030737,0.00011389047,0.000046396173,0.00004998411,0.0000870786,0.00008687141,0.000030626597,0.0000412647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985558,0.000044950866,0.00031413927,0.00031732034,0.00049736677,0.00027045273],"domain_scores_gemma":[0.99937034,0.00008480352,0.000107106185,0.00026050324,0.00010682279,0.00007045312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008018121,0.00021870236,0.00035015208,0.0000932877,0.000036587076,0.000032595763,0.00013225735,0.00006593004,0.00002206606],"category_scores_gemma":[0.000012567298,0.00011822061,0.00008037915,0.000278942,0.00008693814,0.0000755164,0.000036155943,0.00008481558,0.0000033230494],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015187016,0.007365395,0.98215425,0.00031463173,0.00043439167,0.00020623888,0.0003767328,0.0000020998732,0.000035729783,0.00002463902,0.0000095752985,0.007557617],"study_design_scores_gemma":[0.035617433,0.0008443009,0.9584722,0.0016967177,0.00035570288,0.000076654025,0.000117411335,0.0002922445,0.0023756742,0.0000011190134,0.00003674631,0.0001138124],"about_ca_topic_score_codex":0.0003523276,"about_ca_topic_score_gemma":0.000041903957,"teacher_disagreement_score":0.03409873,"about_ca_system_score_codex":0.00023259419,"about_ca_system_score_gemma":0.00037029677,"threshold_uncertainty_score":0.48208967},"labels":[],"label_agreement":null},{"id":"W4405044300","doi":"10.1182/blood-2024-194858","title":"Omission of Bleomycin in Limited Stage Classic Hodgkin Lymphoma Patients with a Negative PET Scan Following 2 Cycles of ABVD Is Associated with Comparable Outcomes and Reduced Pulmonary Toxicity","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"ABVD; Bleomycin; Medicine; Pulmonary toxicity; Lymphoma; Dacarbazine; Vinblastine; Hodgkin lymphoma; Toxicity; Nuclear medicine; Stage (stratigraphy); Internal medicine; Oncology; Radiology; Chemotherapy; Vincristine; Cyclophosphamide","score_opus":0.012877484421636625,"score_gpt":0.25103095137538667,"score_spread":0.23815346695375003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981745,0.00036833136,7.6016374e-7,0.00016364768,0.000023765733,0.00058641244,0.00010302078,0.000034979155,0.000544614],"genre_scores_gemma":[0.9992446,0.0000265824,0.00035630574,0.000047498448,0.0000049604887,0.000034363846,0.00006195182,0.000025931045,0.0001978496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986821,0.0000680574,0.00033621048,0.00033132022,0.00036490202,0.00021743753],"domain_scores_gemma":[0.99921185,0.00025630233,0.00015701597,0.00018785859,0.00008840335,0.00009856714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010999864,0.0002225094,0.00066269765,0.00019721812,0.00003880255,0.00002175512,0.000049235456,0.000060566705,0.000010714711],"category_scores_gemma":[0.00007286174,0.00014133428,0.00008346188,0.0004290661,0.00006905545,0.00013762683,0.00003495782,0.000060626997,6.0401896e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004391111,0.004772166,0.9885107,0.00016568259,0.0009902783,0.00046775787,0.00070312264,0.0000025218915,0.0029184676,0.00001635617,0.000024345292,0.0009894836],"study_design_scores_gemma":[0.014308973,0.0009847587,0.92528105,0.0026205613,0.00058866513,0.000010498699,0.00035668013,0.0001868822,0.05550232,0.000016468259,0.0000046501823,0.00013850146],"about_ca_topic_score_codex":0.0005350476,"about_ca_topic_score_gemma":0.00013227359,"teacher_disagreement_score":0.063229665,"about_ca_system_score_codex":0.00017200397,"about_ca_system_score_gemma":0.00018913436,"threshold_uncertainty_score":0.57634443},"labels":[],"label_agreement":null},{"id":"W4405044303","doi":"10.1182/blood-2024-209438","title":"Addition of Inotuzumab to a Pediatric Inspired Chemotherapy Regimen in Young Adult Patients with B-Cell Acute Lymphoblastic Leukemia: Findings from the Alliance A041501 Phase 3 Randomized Trial","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Daiichi Sankyo Europe; Servier; Astellas Pharma; CTI Biopharma; Incyte; MacroGenics; Syndax Pharmaceuticals; BeiGene; Jazz Pharmaceuticals; Alexion Pharmaceuticals; Seagen; Gilead Sciences; GlaxoSmithKline; Amgen","keywords":"Medicine; Regimen; Chemotherapy regimen; Acute lymphocytic leukemia; Chemotherapy; Lymphoblastic Leukemia; Oncology; Pediatrics; Randomized controlled trial; Internal medicine; Leukemia","score_opus":0.0063961326661716176,"score_gpt":0.2523164362831921,"score_spread":0.2459203036170205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941403,0.00025124414,0.00028410164,0.000405252,0.00021146427,0.003911643,0.00033364876,0.00008756847,0.00037475675],"genre_scores_gemma":[0.9967592,0.00029390855,0.00080983504,0.00037167955,0.0004996519,0.00058528467,0.0003069439,0.000082864695,0.00029064107],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9969731,0.00018083921,0.0007431275,0.0006161657,0.0010017467,0.0004850311],"domain_scores_gemma":[0.99754846,0.001327171,0.00016655668,0.0005092289,0.00025579517,0.0001928164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004353076,0.00034397593,0.00089744775,0.00026340538,0.000060573067,0.00005907188,0.000323565,0.00020604531,0.00009743974],"category_scores_gemma":[0.0006894554,0.00021629712,0.00019845106,0.0011987772,0.00014271315,0.00016131827,0.00007842187,0.0003666155,0.0000652949],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9804386,0.0028244848,0.0033728313,0.00024251374,0.00088397524,0.00023593665,0.0028180564,0.000007881354,0.0034099517,0.000036743702,0.0049307607,0.00079829636],"study_design_scores_gemma":[0.9863341,0.0021913503,0.0020798368,0.0005526292,0.0013746802,0.000013855675,0.00006281505,0.0011656921,0.005868242,0.000053373184,0.00005677187,0.0002466485],"about_ca_topic_score_codex":0.00053181336,"about_ca_topic_score_gemma":0.000045076144,"teacher_disagreement_score":0.005895537,"about_ca_system_score_codex":0.0009626487,"about_ca_system_score_gemma":0.0016542759,"threshold_uncertainty_score":0.88203406},"labels":[],"label_agreement":null},{"id":"W4405044326","doi":"10.1182/blood-2024-198639","title":"Mis-Splicing Derived Neoantigens and Cognate T Cell Receptors in Splicing Factor Mutant Myeloid Neoplasms","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"RNA splicing; Alternative splicing; Receptor; Splicing factor; Mutant; Biology; Myeloid; Cell biology; Myeloid cells; Cancer research; Exon; Molecular biology; Genetics; Gene; RNA","score_opus":0.01578556656676792,"score_gpt":0.269878691880193,"score_spread":0.25409312531342504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99383533,0.002253544,0.00006483991,0.00037715252,0.00016481419,0.00051322504,0.000010218566,0.00012842633,0.0026524626],"genre_scores_gemma":[0.99683714,0.00062601216,0.0006948033,0.00013652386,0.00010429729,0.000016351769,0.00001574237,0.00006941342,0.0014997283],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981478,0.0000613285,0.00033785708,0.00054762897,0.00038594013,0.00051946304],"domain_scores_gemma":[0.99915576,0.00021217615,0.000034441306,0.0002694837,0.00005111042,0.00027700196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001990631,0.0002298011,0.00034476377,0.00038005726,0.00006800511,0.00008567027,0.00009897333,0.00013827386,0.00030147942],"category_scores_gemma":[0.000106210355,0.00020087545,0.00008304368,0.0004936742,0.000068413356,0.000064585394,0.000078948346,0.0005226088,0.00016614099],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050519906,0.00017148085,0.010549468,0.0004618777,0.00004677599,0.0010768563,0.0014324945,0.0000025860966,0.9795175,0.0000092568525,0.000077746976,0.0066034207],"study_design_scores_gemma":[0.002562359,0.00029638002,0.013416323,0.0006715478,0.00009625144,0.0002329935,0.00066751684,0.0015513824,0.9766325,0.00001480454,0.003593369,0.00026461022],"about_ca_topic_score_codex":0.00022234874,"about_ca_topic_score_gemma":0.00008477108,"teacher_disagreement_score":0.0063388105,"about_ca_system_score_codex":0.00006352437,"about_ca_system_score_gemma":0.00015664972,"threshold_uncertainty_score":0.81914634},"labels":[],"label_agreement":null},{"id":"W4405044335","doi":"10.1182/blood-2024-197938","title":"Five-Year Analysis of the POLARIX Study: Prolonged Follow-up Confirms Positive Impact of Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (Pola-R-CHP) on Outcomes","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Prednisone; Rituximab; Medicine; Cyclophosphamide; Internal medicine; Doxorubicin; Oncology; Chemotherapy; Lymphoma","score_opus":0.009204980291732019,"score_gpt":0.28513701449659884,"score_spread":0.27593203420486684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943978,0.0028453215,0.0000013380912,0.00032840064,0.000132674,0.0013541258,0.00041094385,0.000043650263,0.00048570076],"genre_scores_gemma":[0.9993478,0.00008237667,0.000043835258,0.00006516116,0.000028819919,0.000043334596,0.000041267947,0.000030905412,0.00031648428],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99814415,0.00011096564,0.00048114432,0.00047267607,0.0005074153,0.0002836547],"domain_scores_gemma":[0.99863267,0.00033753412,0.00018246441,0.0005835167,0.00012933835,0.0001344528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019141696,0.00032406702,0.0011058645,0.00033068354,0.000088662186,0.000037938324,0.00013650196,0.00011610079,0.00005421476],"category_scores_gemma":[0.00013457653,0.0001822553,0.00071462494,0.0009206586,0.00013702226,0.00006329773,0.00010399799,0.00016902285,0.0000069744915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070504117,0.0050413697,0.96771264,0.00006770873,0.02026879,0.00011225477,0.0036729798,0.00001646289,0.00159751,0.00023271759,0.00006505257,0.00050747825],"study_design_scores_gemma":[0.018006373,0.003019115,0.9567388,0.00022598385,0.01241853,0.000014250764,0.0005564743,0.00017257873,0.008668027,0.000024115707,0.0000085795955,0.0001471177],"about_ca_topic_score_codex":0.005022827,"about_ca_topic_score_gemma":0.00027616828,"teacher_disagreement_score":0.017301332,"about_ca_system_score_codex":0.0001966582,"about_ca_system_score_gemma":0.00031490016,"threshold_uncertainty_score":0.7593046},"labels":[],"label_agreement":null},{"id":"W4405044345","doi":"10.1182/blood-2024-211949","title":"COVID-19 Humoral Immunity Improves with Third and Subsequent Vaccine Doses in Patients with Plasma Cell Dyscrasias, Particularly in Those Receiving antiCD38 Therapy","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Saint John Regional Hospital; Alberta Health Services; Western University; Juravinski Cancer Centre; St. Michael's Hospital; Jewish General Hospital; Toronto General Hospital; McMaster University; Queen's University; University of Alberta; University of Ottawa; McGill University; University Health Network; Ottawa Hospital; Vancouver General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Immunology; Dyscrasia; Medicine; Humoral immunity; Plasma cell; Coronavirus disease 2019 (COVID-19); Virology; Immunity; Cellular immunity; Convalescent plasma; Immune system; Antibody; Internal medicine","score_opus":0.02129312880879864,"score_gpt":0.28676161734710426,"score_spread":0.2654684885383056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961991,0.0020165194,0.000004736909,0.00042475332,0.000020802894,0.0011180999,0.000015913783,0.000064493506,0.00013562571],"genre_scores_gemma":[0.99866545,0.00043839362,0.00048925047,0.00010286068,0.000020018848,0.00009479391,0.00006318924,0.000034823654,0.00009122258],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984598,0.00013087154,0.00023817805,0.000384504,0.00034776804,0.0004388827],"domain_scores_gemma":[0.9991172,0.00015361395,0.000042713375,0.00029349249,0.000049977152,0.00034298742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002559296,0.00023690445,0.00033818532,0.0002457008,0.00007148557,0.000089174326,0.000079011654,0.000067596426,0.00002515149],"category_scores_gemma":[0.0001160357,0.00014479118,0.000030598258,0.00041588172,0.000062544525,0.00018737014,0.000046009744,0.00034081726,0.0000054345983],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022638512,0.0023429045,0.9858273,0.00030427522,0.00018061021,0.0012692368,0.0013635722,0.0000029472087,0.0037747598,0.000009387269,0.00002038053,0.002640721],"study_design_scores_gemma":[0.028137146,0.0028046789,0.9571987,0.0003844265,0.00007360987,0.000032537693,0.0002709709,0.00014762869,0.010638032,0.000018520823,0.00012121938,0.00017254573],"about_ca_topic_score_codex":0.001453707,"about_ca_topic_score_gemma":0.0009118077,"teacher_disagreement_score":0.02862867,"about_ca_system_score_codex":0.0001282659,"about_ca_system_score_gemma":0.0004431335,"threshold_uncertainty_score":0.5904413},"labels":[],"label_agreement":null},{"id":"W4405044372","doi":"10.1182/blood-2024-201056","title":"Convergent Evolution Towards CD38 Biallelic Loss Is a Recurrent Mechanism of Resistance to Anti-CD38 Antibodies in Multiple Myeloma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Multiple myeloma; CD38; Antibody; Mechanism (biology); Medicine; Immunology; Cancer research; Biology; Genetics; Stem cell; Physics","score_opus":0.03242307861881754,"score_gpt":0.3096346920862939,"score_spread":0.27721161346747636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914371,0.00475871,0.0003103012,0.0014387675,0.00029228168,0.0009541046,0.00019174405,0.00008259142,0.0005344232],"genre_scores_gemma":[0.99678934,0.00079414534,0.0012555202,0.00005511298,0.000099770325,0.00007872813,0.000044113734,0.00003070934,0.0008525502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99798894,0.00006657313,0.00041343822,0.0004929303,0.0005825934,0.00045552367],"domain_scores_gemma":[0.9991264,0.00006512835,0.00004808121,0.00037269227,0.00014658076,0.00024113066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000248931,0.00021895814,0.00043594572,0.00042913036,0.000051195184,0.000023899716,0.00012525557,0.00009958431,0.00013608277],"category_scores_gemma":[0.0002537533,0.00018559954,0.00015411054,0.00058002333,0.00006099862,0.00007711129,0.00010450077,0.00018128891,0.00015031685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004832237,0.012675831,0.5354384,0.0094882585,0.003705109,0.007964331,0.010857873,0.000011374421,0.35309574,0.011663512,0.010829014,0.039438307],"study_design_scores_gemma":[0.012866649,0.0013953601,0.5805745,0.003583144,0.00034245732,0.00008118917,0.00037990455,0.0017754352,0.39187902,0.0013364024,0.0052802004,0.0005057304],"about_ca_topic_score_codex":0.0003660486,"about_ca_topic_score_gemma":0.00046733973,"teacher_disagreement_score":0.045136094,"about_ca_system_score_codex":0.00017164867,"about_ca_system_score_gemma":0.0002727757,"threshold_uncertainty_score":0.756853},"labels":[],"label_agreement":null},{"id":"W4405044374","doi":"10.1182/blood-2024-198147","title":"BRUIN CLL-321: Randomized Phase III Trial of Pirtobrutinib Versus Idelalisib Plus Rituximab (IdelaR) or Bendamustine Plus Rituximab (BR) in BTK Inhibitor Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Bendamustine; Idelalisib; Rituximab; Chronic lymphocytic leukemia; Ibrutinib; Medicine; Ofatumumab; Obinutuzumab; Bruton's tyrosine kinase; Venetoclax; Internal medicine; Oncology; Leukemia; Lymphoma; Tyrosine kinase; Receptor","score_opus":0.037464516726009346,"score_gpt":0.3310610606163402,"score_spread":0.29359654389033085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9662197,0.017428242,0.00023660986,0.00015479483,0.0025632007,0.009257351,0.00027843931,0.0009029506,0.0029586968],"genre_scores_gemma":[0.9884765,0.0024088873,0.00070774514,0.00012846991,0.0024133269,0.0013190692,0.0006243772,0.00045276547,0.0034688537],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98653173,0.00096645055,0.0045251655,0.0025635967,0.0026763547,0.0027366714],"domain_scores_gemma":[0.9903462,0.0048053646,0.000781232,0.0023631721,0.0006089505,0.0010950628],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.003740025,0.0016933418,0.0058226148,0.00206881,0.00025082618,0.0003139599,0.0011740477,0.0013035171,0.0009267868],"category_scores_gemma":[0.0048060273,0.0013972758,0.0015759828,0.0037138378,0.0014033808,0.00054575485,0.00075478235,0.0010095135,0.000491435],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.9644564,0.0041229427,0.0000015924483,0.0038991494,0.0029769174,0.010603431,0.0013878783,0.0008805374,0.003005653,0.0003396665,0.0013730312,0.0069528483],"study_design_scores_gemma":[0.74178076,0.0043346663,0.0000017968966,0.0031353433,0.0035711268,0.0018331751,0.0002583838,0.22170857,0.02128066,0.00006437065,0.0010515128,0.0009796481],"about_ca_topic_score_codex":0.014094162,"about_ca_topic_score_gemma":0.0012912606,"teacher_disagreement_score":0.2226756,"about_ca_system_score_codex":0.20506553,"about_ca_system_score_gemma":0.22081374,"threshold_uncertainty_score":0.999993},"labels":[],"label_agreement":null},{"id":"W4405044434","doi":"10.1182/blood-2024-193946","title":"Sinusoidal Obstruction Syndrome in Children with CD22+ B-Cell Precursors Acute Lymphoblastic Leukemia (BCP-ALL) Treated with Inotuzumab Ozogamicin in Trial ITCC-059: Risk Factors and Outcomes","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"CD22; Medicine; Lymphoblastic Leukemia; Internal medicine; Pediatrics; Leukemia; CD20; Lymphoma","score_opus":0.007429589898990763,"score_gpt":0.23930442215422873,"score_spread":0.23187483225523797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969127,0.00022027244,0.000031040967,0.0000590784,0.00008893623,0.002169051,0.00012055713,0.00022323254,0.00017511075],"genre_scores_gemma":[0.9985902,0.00012383355,0.00033415365,0.00002422699,0.000076379234,0.00010918024,0.0001539459,0.00013602809,0.00045205967],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964799,0.00017765783,0.00063665514,0.001026252,0.0008288567,0.0008506595],"domain_scores_gemma":[0.998523,0.0004570831,0.00014926972,0.0004800587,0.00006254223,0.0003280731],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025638676,0.0006502466,0.0009987409,0.0010255834,0.00007576686,0.00013031004,0.0002065467,0.00036584042,0.000035722303],"category_scores_gemma":[0.0001450464,0.00042431615,0.00010974553,0.0012091362,0.0002704508,0.000318752,0.000103509934,0.0008232812,0.000027626467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011571963,0.0008731341,0.9814579,0.0001777447,0.0015389689,0.0019614152,0.0009243904,0.00018456083,0.00057851104,0.000012230347,0.000029991656,0.00068922015],"study_design_scores_gemma":[0.17145513,0.0043304325,0.8124637,0.000632778,0.0017903937,0.003449953,0.00026129975,0.0018457181,0.0031785136,0.000022402493,0.000011609867,0.00055807206],"about_ca_topic_score_codex":0.004135444,"about_ca_topic_score_gemma":0.0005854667,"teacher_disagreement_score":0.16899416,"about_ca_system_score_codex":0.0020495027,"about_ca_system_score_gemma":0.0014509112,"threshold_uncertainty_score":0.9998209},"labels":[],"label_agreement":null},{"id":"W4405044459","doi":"10.1182/blood-2024-199781","title":"Prognostication and Treatment-Related Outcomes in Secondary Central Nervous System Involvement of Large B-Cell Lymphoma (SCNSL): Evidence from a Large International Cohort","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Interquartile range; Oncology; BCL6; Proportional hazards model; Median follow-up; Progression-free survival; ThioTEPA; Concomitant; Chemotherapy regimen; Cohort; Rituximab; Chemotherapy; Surgery; Lymphoma; Germinal center; Immunology; Cyclophosphamide; B cell","score_opus":0.010600910495147336,"score_gpt":0.2566997809161092,"score_spread":0.24609887042096185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98887813,0.008572966,0.000009047532,0.00044513133,0.00025464207,0.0009310777,0.00036208724,0.000079363715,0.0004675746],"genre_scores_gemma":[0.99816084,0.00080073567,0.00018729438,0.00003710512,0.000046290013,0.00022068364,0.00036435574,0.000021664699,0.00016103094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986392,0.000041715495,0.00043290085,0.00038752213,0.00025053715,0.00024810014],"domain_scores_gemma":[0.99934894,0.00020519139,0.000080902064,0.00021633586,0.00004386939,0.00010475713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013112869,0.00019170837,0.0003722063,0.00015105566,0.000028585966,0.00003753804,0.00006204039,0.00008643604,0.00007772446],"category_scores_gemma":[0.000033875727,0.00014586218,0.000109717446,0.0001351888,0.000024243938,0.0001113423,0.00005234284,0.00004612726,0.0000217972],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052767366,0.0070108986,0.97981536,0.00020294718,0.0009675908,0.0005057669,0.0010291344,3.648713e-7,0.00058646325,0.00036836116,0.00004963877,0.00941068],"study_design_scores_gemma":[0.012911926,0.0003511836,0.9755743,0.0012557964,0.0009118733,0.00004098304,0.00034107594,0.0008543881,0.007229893,0.000013108935,0.0004039968,0.000111485555],"about_ca_topic_score_codex":0.0008844768,"about_ca_topic_score_gemma":0.00021217324,"teacher_disagreement_score":0.012859159,"about_ca_system_score_codex":0.00038196327,"about_ca_system_score_gemma":0.00020200321,"threshold_uncertainty_score":0.59480876},"labels":[],"label_agreement":null},{"id":"W4405044472","doi":"10.1182/blood-2024-200867","title":"ENERGIZE-T: A Global, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Mitapivat in Adults with Transfusion-Dependent Alpha- or Beta-Thalassemia","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Placebo; Thalassemia; Double blind; Beta thalassemia; Blood transfusion; Alpha (finance); BETA (programming language); Internal medicine; Surgery; Pathology","score_opus":0.012247449996997633,"score_gpt":0.285217193466863,"score_spread":0.27296974346986536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832069,0.0055537797,0.000047156485,0.0006015169,0.00020644828,0.007339387,0.000022427328,0.0001275081,0.0028948756],"genre_scores_gemma":[0.9970523,0.001376511,0.00008671443,0.00005741449,0.000072957744,0.0007237415,0.000025084582,0.00004790084,0.00055738137],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9970513,0.00020695219,0.0010065506,0.0006157801,0.00069064344,0.00042876852],"domain_scores_gemma":[0.99882376,0.00031222738,0.00012919064,0.00040797834,0.00011220861,0.0002146521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007353529,0.00040719067,0.0017409027,0.00028755743,0.000057925827,0.00003997106,0.00015798763,0.00025485797,0.00022169024],"category_scores_gemma":[0.00007406896,0.00022712888,0.00033084775,0.00083205634,0.000112207235,0.000101309895,0.0000348718,0.0004170979,0.000015900274],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9732825,0.013937079,0.0009861855,0.0004925111,0.0026717333,0.0027512014,0.0034983319,0.00008657115,0.0004186573,0.00010677532,0.0000985942,0.0016698589],"study_design_scores_gemma":[0.9835335,0.0036908428,0.000033985372,0.0014601068,0.0039227875,0.00031128514,0.0050210166,0.0005503644,0.001124998,0.000013938391,0.00007345344,0.00026372666],"about_ca_topic_score_codex":0.0008137703,"about_ca_topic_score_gemma":0.0012891595,"teacher_disagreement_score":0.013845393,"about_ca_system_score_codex":0.00006046076,"about_ca_system_score_gemma":0.00038571932,"threshold_uncertainty_score":0.9262047},"labels":[],"label_agreement":null},{"id":"W4405044516","doi":"10.1182/blood-2024-203719","title":"A Phase 1b Study of DISC-0974, an Anti-Hemojuvelin Antibody, in Patients with Myelofibrosis and Anemia","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Servier; Ionis Pharmaceuticals; Astellas Pharma; Karyopharm Therapeutics; Galecto; Sierra Oncology; CTI Biopharma; Incyte; Agios Pharmaceuticals; Jazz Pharmaceuticals; Gilead Sciences; MorphoSys; Celgene","keywords":"Myelofibrosis; Medicine; Anemia; Antibody; Internal medicine; Immunology; Bone marrow","score_opus":0.009992879252824242,"score_gpt":0.29898833286682747,"score_spread":0.28899545361400325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982786,0.0003560844,0.000003939529,0.000083884705,0.000033394947,0.0010394126,0.00005520348,0.00003564603,0.000113804395],"genre_scores_gemma":[0.9993644,0.000057280806,0.00030429932,0.000028029166,0.00003393916,0.00005803262,0.000103794606,0.000027337934,0.000022899478],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880725,0.00004644882,0.0002781964,0.00040743224,0.00027588836,0.00018480982],"domain_scores_gemma":[0.9994779,0.000050148177,0.000046587586,0.0002399322,0.000063453386,0.00012193373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008762283,0.00019733251,0.00042049776,0.00017115063,0.000036373007,0.00003549616,0.0000414433,0.000049990584,0.000031842643],"category_scores_gemma":[0.000016162427,0.00013000934,0.000028987837,0.00028489545,0.000045991477,0.00013035603,0.0000327151,0.0001104485,0.0000039601236],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028557755,0.05229355,0.93972385,0.00017590962,0.0002003652,0.00020002674,0.0020814228,6.6447325e-7,0.0009567064,0.00002922596,0.000019731648,0.0040329625],"study_design_scores_gemma":[0.041160643,0.016007762,0.9347738,0.00047681294,0.00055492553,0.000013428851,0.0004961634,0.00005143993,0.0062827487,0.000007402459,0.000027874714,0.0001469733],"about_ca_topic_score_codex":0.0001107268,"about_ca_topic_score_gemma":0.00009360237,"teacher_disagreement_score":0.040875062,"about_ca_system_score_codex":0.000017730254,"about_ca_system_score_gemma":0.00005507971,"threshold_uncertainty_score":0.5301627},"labels":[],"label_agreement":null},{"id":"W4405044519","doi":"10.1182/blood-2024-193678","title":"Apex Part 1: Updated Assessment of Bezuclastinib (CGT9486), a Selective KIT D816V Tyrosine Kinase Inhibitor, in Patients with Advanced Systemic Mastocytosis (AdvSM)","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Systemic mastocytosis; Apex (geometry); Tyrosine-kinase inhibitor; Medicine; Tyrosine kinase; Internal medicine; Cancer research; Bone marrow; Cancer; Receptor","score_opus":0.004700900751679946,"score_gpt":0.20993010783730326,"score_spread":0.2052292070856233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99537706,0.0018872349,0.00004339544,0.000031468517,0.0004432535,0.00063608994,0.0002576138,0.00007983404,0.0012440402],"genre_scores_gemma":[0.99821454,0.000037769598,0.00018722838,0.000020586333,0.000026813697,0.00008648629,0.00058064057,0.000036999827,0.00080891786],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984997,0.00012253571,0.00046509298,0.0004659447,0.00008201695,0.00036469963],"domain_scores_gemma":[0.99936515,0.0000675934,0.00014407953,0.00025375048,0.00013803181,0.000031389074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012832586,0.0002575895,0.00045515326,0.0002286417,0.00006388382,0.00001642066,0.00013601143,0.00017718307,0.00035152823],"category_scores_gemma":[0.000014935303,0.00021016419,0.00006498254,0.0004795214,0.00011505523,0.00010068688,0.000069478636,0.00033657486,0.000061327155],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015493707,0.006617883,0.1923501,0.0011943952,0.0013592199,0.000101998055,0.0010182022,0.00014327215,0.78604114,0.0012262921,0.003588246,0.0048098555],"study_design_scores_gemma":[0.058211565,0.011096884,0.31134012,0.0060581192,0.0016751797,0.0001617919,0.00063603005,0.00012668919,0.5414588,0.000046959318,0.06700253,0.0021853382],"about_ca_topic_score_codex":0.000058258687,"about_ca_topic_score_gemma":0.00007472101,"teacher_disagreement_score":0.24458238,"about_ca_system_score_codex":0.00008090816,"about_ca_system_score_gemma":0.00016591538,"threshold_uncertainty_score":0.85702467},"labels":[],"label_agreement":null},{"id":"W4405044540","doi":"10.1182/blood-2024-202224","title":"A High-Fiber Dietary Intervention (NUTRIVENTION) in Precursor Plasma Cell Disorders Improves Biomarkers of Disease and May Delay Progression to Myeloma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Pharmacyclics; Genentech; Seagen; Alexion Pharmaceuticals; Prothena; SkylineDx; Springworks Therapeutics; Regeneron Pharmaceuticals; Bristol-Myers Squibb; CSL Behring; Memorial Sloan-Kettering Cancer Center; Legend Biotech; Celgene; Omeros Corporation; Array BioPharma; Gilead Sciences; Seres Therapeutics; Amgen","keywords":"Multiple myeloma; Disease; Plasma cell; Medicine; Oncology; Internal medicine","score_opus":0.010503309799121391,"score_gpt":0.29497132270508253,"score_spread":0.28446801290596113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99522024,0.0026164132,0.00001738278,0.0005736629,0.00007216611,0.0012129254,0.000053147665,0.000045664303,0.00018842176],"genre_scores_gemma":[0.9971232,0.00016152977,0.0016515695,0.000005977632,0.000027906832,0.00021569335,0.000112445035,0.000023700517,0.00067802385],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988542,0.00006366124,0.00025534947,0.0003420862,0.00024319117,0.00024148542],"domain_scores_gemma":[0.9994271,0.00005787784,0.00003781641,0.00016769044,0.000028557428,0.00028095677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012697649,0.00014794308,0.0001951357,0.00031891145,0.000028285904,0.000026155214,0.000053049123,0.000051947925,0.00006169224],"category_scores_gemma":[0.00005429749,0.00011448381,0.000119383345,0.0002781072,0.0000597406,0.00011135795,0.00008374866,0.00009828015,0.00003566543],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068105496,0.008790653,0.20269987,0.005939774,0.001155451,0.00087597355,0.00045941726,0.0000023492526,0.037526533,0.000037478287,0.00056603557,0.7351359],"study_design_scores_gemma":[0.014319184,0.0033192027,0.9299237,0.0035737737,0.0006492867,0.000017141372,0.00011698461,0.0009183024,0.045913376,0.0002423201,0.00075579423,0.00025093785],"about_ca_topic_score_codex":0.000108160675,"about_ca_topic_score_gemma":0.00006736399,"teacher_disagreement_score":0.734885,"about_ca_system_score_codex":0.00003681555,"about_ca_system_score_gemma":0.00006491791,"threshold_uncertainty_score":0.4668514},"labels":[],"label_agreement":null},{"id":"W4405044602","doi":"10.1182/blood-2024-207439","title":"Creation of a Multistate Model to Improve Prognostication across the Disease Course in Advanced Stage Classic Hodgkin Lymphoma (cHL): A Report from the Holistic Consortium","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre","funders":"","keywords":"Stage (stratigraphy); Lymphoma; Classical Hodgkin lymphoma; Hodgkin lymphoma; Disease; Medicine; Internal medicine; Biology","score_opus":0.022539320628567727,"score_gpt":0.33646711895915277,"score_spread":0.31392779833058504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99267185,0.0017083166,0.0005931529,0.0022374464,0.00010435226,0.0016733834,0.00085003284,0.00005279161,0.00010864857],"genre_scores_gemma":[0.99764436,0.000075483105,0.00049575063,0.00024203508,0.00006484569,0.0009159261,0.00019001061,0.000023933546,0.00034765608],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867815,0.000044658533,0.00040136697,0.00038333246,0.0002767705,0.00021571579],"domain_scores_gemma":[0.99870366,0.00039109093,0.000119809454,0.00056735595,0.00009594751,0.00012212012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021131222,0.00015718065,0.00021657553,0.000027609654,0.00006438574,0.000055848333,0.00009122282,0.000041002706,0.000007616435],"category_scores_gemma":[0.00049883936,0.00008867575,0.00008651489,0.00020911069,0.00010504137,0.000068934176,0.000048534468,0.000055829558,0.000014191263],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025099642,0.013556449,0.77508944,0.00057262386,0.0012049979,0.0056071617,0.011298888,0.0027429147,0.01414639,0.003110212,0.0009220703,0.1692389],"study_design_scores_gemma":[0.005630578,0.00017609012,0.946409,0.00049541256,0.000994843,0.000028959643,0.00048045334,0.039800085,0.0049293744,0.000348308,0.0005694581,0.00013743267],"about_ca_topic_score_codex":0.0005486199,"about_ca_topic_score_gemma":0.0002133946,"teacher_disagreement_score":0.17131957,"about_ca_system_score_codex":0.000113328286,"about_ca_system_score_gemma":0.00043917092,"threshold_uncertainty_score":0.36160922},"labels":[],"label_agreement":null},{"id":"W4405044640","doi":"10.1182/blood-2024-193274","title":"Oral Decitabine/Cedazuridine in Patients with MDS and <i>TP53</i> Mutations: A Propensity Score Matching Analysis from the Phase II and III Trials","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Propensity score matching; Decitabine; Internal medicine; Medicine; Oncology; Genetics; Biology; DNA methylation; Gene","score_opus":0.04574344996091538,"score_gpt":0.3246069895077334,"score_spread":0.27886353954681803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965069,0.0018496579,0.000071884024,0.00044315978,0.000025045896,0.0009416075,0.00007592804,0.00003683923,0.000048953018],"genre_scores_gemma":[0.99911785,0.000072942436,0.00033016555,0.000113126,0.000077457946,0.000044832435,0.00016359695,0.000019718525,0.000060334278],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9984475,0.00016021557,0.00036560744,0.00038879464,0.000413233,0.0002246979],"domain_scores_gemma":[0.99883884,0.00061782385,0.00005931226,0.00028557357,0.00008194289,0.00011648152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097556907,0.00015575219,0.0005734854,0.0001911248,0.00012337214,0.00010142825,0.000073734336,0.000057253634,0.000044845965],"category_scores_gemma":[0.00042040987,0.00008490074,0.00006421214,0.0008438152,0.00012224044,0.00013422621,0.00013337955,0.00021196391,0.000002671991],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0141271185,0.01092583,0.83214146,0.0010022683,0.018144522,0.0028523447,0.025504332,0.00013483038,0.0049758125,0.0003433236,0.0011016028,0.08874656],"study_design_scores_gemma":[0.48639214,0.0034289306,0.4697468,0.0020364206,0.01993633,0.00016018872,0.0008738551,0.010806055,0.0041760607,0.0011152608,0.00060237,0.00072559575],"about_ca_topic_score_codex":0.002518866,"about_ca_topic_score_gemma":0.0006891032,"teacher_disagreement_score":0.47226503,"about_ca_system_score_codex":0.0003833468,"about_ca_system_score_gemma":0.0010482634,"threshold_uncertainty_score":0.38077888},"labels":[],"label_agreement":null},{"id":"W4405044676","doi":"10.1182/blood-2024-207450","title":"Blinatumomab Added to Chemotherapy Improves Disease-Free Survival in Newly Diagnosed NCI Standard Risk Pediatric B-Acute Lymphoblastic Leukemia: Results from the Randomized Children's Oncology Group Study AALL1731","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia; Hospital for Sick Children","funders":"","keywords":"Medicine; Blinatumomab; Oncology; Internal medicine; Chemotherapy; Lymphoblastic Leukemia; Acute lymphocytic leukemia; Chemotherapy regimen; Pediatric oncology; Leukemia; Pediatrics; Cancer","score_opus":0.008095715751238741,"score_gpt":0.27244266669549305,"score_spread":0.2643469509442543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827962,0.0023128106,0.00047835114,0.0032565107,0.0008135925,0.007158879,0.0025359394,0.00039392628,0.00025380528],"genre_scores_gemma":[0.99232537,0.0021220443,0.0009725944,0.00058574014,0.0022828323,0.00092371355,0.000351631,0.00019791049,0.00023815533],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99237937,0.0015361783,0.0014605189,0.0016439075,0.0018198835,0.0011601701],"domain_scores_gemma":[0.984795,0.012022001,0.00027399027,0.0018614408,0.00024369912,0.0008039233],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0033771452,0.00074813806,0.0019056259,0.00060190144,0.0002210085,0.00024806368,0.0011743312,0.00034526203,0.00008786514],"category_scores_gemma":[0.010512611,0.0004966729,0.0005084192,0.0018709056,0.0002963282,0.00017788149,0.0006365096,0.0012118894,0.00012935587],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.81401235,0.0095362915,0.086842194,0.0002151361,0.009091151,0.017588306,0.011638976,0.00013832445,0.0011240302,0.00016583985,0.03164376,0.01800365],"study_design_scores_gemma":[0.7206443,0.0034097396,0.26620224,0.00020012153,0.0054865596,0.000056771038,0.0005661041,0.0017374156,0.00012663627,0.0005455887,0.00041320926,0.0006113074],"about_ca_topic_score_codex":0.0045194807,"about_ca_topic_score_gemma":0.0011929601,"teacher_disagreement_score":0.17936006,"about_ca_system_score_codex":0.00224159,"about_ca_system_score_gemma":0.0049137976,"threshold_uncertainty_score":0.99974847},"labels":[],"label_agreement":null},{"id":"W4405044679","doi":"10.1182/blood-2024-193644","title":"Efficacy Findings in a Phase 3, Randomized Trial of Eltrombopag Vs. Standard First-Line Treatment for Newly Diagnosed Immune Thrombocytopenia in Children","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Eltrombopag; Medicine; Randomized controlled trial; Internal medicine; Immune thrombocytopenia; Pediatrics; Platelet","score_opus":0.01542588856377935,"score_gpt":0.3124714105372879,"score_spread":0.29704552197350853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988303,0.003302667,0.000030947238,0.000512711,0.00011342635,0.007366972,0.00022858335,0.00004671097,0.000094956056],"genre_scores_gemma":[0.99651825,0.0017477738,0.00035761468,0.000021092708,0.00007140965,0.00076492375,0.0003808657,0.000039482085,0.0000985865],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99830925,0.000059383903,0.0007346218,0.00037599294,0.0001995194,0.0003212082],"domain_scores_gemma":[0.9989487,0.00062470615,0.00008269338,0.00024193813,0.00002585788,0.00007613153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000381515,0.00027531793,0.0018801795,0.00029525536,0.000032382402,0.00002659626,0.00007786673,0.00011427622,0.00006507221],"category_scores_gemma":[0.00028871512,0.00019779553,0.00042061615,0.00030723706,0.000060980907,0.00006942364,0.000020193154,0.00010977432,0.0000072752778],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.964528,0.019457204,0.002551287,0.000110185814,0.0017665167,0.00070711126,0.00093657937,0.000009406395,0.0007378122,0.000075749005,0.00005216507,0.009067956],"study_design_scores_gemma":[0.9795059,0.007296398,0.0027770414,0.0004670257,0.0013307371,0.000035249024,0.000014658522,0.000116826515,0.007909331,0.00019020843,0.00020242346,0.0001542141],"about_ca_topic_score_codex":0.0005127336,"about_ca_topic_score_gemma":0.00016068741,"teacher_disagreement_score":0.014977861,"about_ca_system_score_codex":0.00012512517,"about_ca_system_score_gemma":0.00018883984,"threshold_uncertainty_score":0.80658674},"labels":[],"label_agreement":null},{"id":"W4405044719","doi":"10.1182/blood-2024-194414","title":"The Composite Health Risk Assessment Model (CHARM) Predicts Risks of Toxicities, Functional and Cognitive Decline Among Survivors of Allogeneic Hematopoietic Cell Transplantation (allo-HCT): A Prospective BMT-CTN Study 1704","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hematopoietic cell; Medicine; Transplantation; Hematopoietic stem cell transplantation; Prospective cohort study; Internal medicine; Oncology; Cognition; Immunology; Haematopoiesis; Intensive care medicine; Stem cell; Biology; Psychiatry","score_opus":0.026184821461170696,"score_gpt":0.31802550209043207,"score_spread":0.2918406806292614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863097,0.0046936073,0.004522229,0.0001947925,0.0001440136,0.0028953298,0.00072135916,0.00007141727,0.00044753787],"genre_scores_gemma":[0.99612427,0.0031222312,0.0001393321,0.00005228883,0.00006189699,0.0002818283,0.0000811097,0.000037388803,0.00009968454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977976,0.0002210753,0.0006399972,0.0004318786,0.00063087826,0.00027855785],"domain_scores_gemma":[0.998486,0.0005897387,0.00030276127,0.00014421873,0.000362865,0.000114443916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007140417,0.00026532947,0.00052867486,0.00014560038,0.00025019146,0.000024998606,0.00005906101,0.000069252084,0.000012234641],"category_scores_gemma":[0.000040609473,0.00019905214,0.00011558612,0.00026636763,0.00033031634,0.00009240275,0.000065189444,0.00036729043,0.0000013229513],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011564625,0.003141562,0.9788755,0.001280476,0.0026230866,0.000031444764,0.010376329,0.00035486463,0.0014388658,0.00006464658,0.000035185203,0.00062155264],"study_design_scores_gemma":[0.007924451,0.0033012892,0.97003454,0.00091793423,0.0033350405,0.000037098456,0.005466443,0.0032333303,0.005292998,0.00028796037,0.00000173133,0.00016721038],"about_ca_topic_score_codex":0.0007016575,"about_ca_topic_score_gemma":0.0008684275,"teacher_disagreement_score":0.009814526,"about_ca_system_score_codex":0.000090080095,"about_ca_system_score_gemma":0.0003755484,"threshold_uncertainty_score":0.8117111},"labels":[],"label_agreement":null},{"id":"W4405044741","doi":"10.1182/blood-2024-209759","title":"Annualized Bleeding Rates in Patients with Hemophilia a or B and Inhibitors with and without Target Joints at Baseline: Results from the Concizumab Phase 3 Explorer7 Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Medicine; Internal medicine; Surgery","score_opus":0.02788028533757,"score_gpt":0.31208589756472666,"score_spread":0.2842056122271567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962069,0.00083875493,7.890803e-7,0.00087431865,0.000040354706,0.0017187675,0.00017512546,0.000061593986,0.00008340616],"genre_scores_gemma":[0.9986596,0.000088858906,0.00027832726,0.000054550852,0.00013253049,0.00008388381,0.00015288737,0.000042791726,0.0005065655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982003,0.00012332626,0.00031339063,0.00056696386,0.0004933406,0.00030270862],"domain_scores_gemma":[0.9990606,0.00034214393,0.00004902617,0.00026252778,0.00010327909,0.00018247729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004433251,0.00026001062,0.00039812768,0.00012977711,0.0001351623,0.00008615082,0.000059078644,0.000063067484,0.000039075458],"category_scores_gemma":[0.00021938675,0.000113833376,0.000021572552,0.00037327583,0.00017430988,0.00014624285,0.00009619137,0.0002476605,0.0000065380777],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015955074,0.0023361202,0.97043085,0.00007026784,0.0005240659,0.00064667605,0.00841246,3.0974118e-7,0.00031427655,0.000001349027,0.0003312961,0.0009772428],"study_design_scores_gemma":[0.40925887,0.024405733,0.52461594,0.003927807,0.0019580442,0.00013438592,0.01499565,0.00081838877,0.017801957,0.000043614247,0.0011897966,0.0008498007],"about_ca_topic_score_codex":0.0001491575,"about_ca_topic_score_gemma":0.00017527463,"teacher_disagreement_score":0.4458149,"about_ca_system_score_codex":0.00004470281,"about_ca_system_score_gemma":0.00013160729,"threshold_uncertainty_score":0.46419904},"labels":[],"label_agreement":null},{"id":"W4405044760","doi":"10.1182/blood-2024-193764","title":"Real-World Experience of Switching to Prophylactic Efanesoctocog Alfa in Patients with Moderate and Severe Hemophilia a: An Analysis of the Adelphi Hemophilia Wave III Disease Specific Programme","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Disease; Pediatrics; Internal medicine","score_opus":0.027384221439303417,"score_gpt":0.2883897279966566,"score_spread":0.26100550655735316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972059,0.00020789243,0.0000050749354,0.00048120104,0.000028680155,0.0018632887,0.000029081039,0.000029531313,0.00014931183],"genre_scores_gemma":[0.9990374,0.000029411365,0.00029216733,0.00002114082,0.000037674585,0.00013085607,0.000036254707,0.000030521816,0.0003846023],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979287,0.00007769802,0.00039830565,0.0005473529,0.00067625724,0.0003716969],"domain_scores_gemma":[0.9987791,0.00005761493,0.00007531885,0.0005950724,0.00014885067,0.0003440177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018014449,0.00023282383,0.0005203829,0.0005417245,0.0000738987,0.000045716246,0.00013343836,0.00005249767,0.000030486777],"category_scores_gemma":[0.00003568221,0.00013421431,0.00012424933,0.002160829,0.00013110331,0.00015476916,0.00010156693,0.00021617055,0.000001220463],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002718433,0.0028530397,0.977762,0.0006601402,0.0007428575,0.00027266052,0.0066297986,0.00012106808,0.0012883937,0.00015499553,0.0000041796593,0.0067924415],"study_design_scores_gemma":[0.0038070637,0.0008804927,0.98509693,0.0005483752,0.0014382934,0.000006236278,0.00042039636,0.0042297137,0.0032092982,0.0001103998,0.000023764238,0.00022901125],"about_ca_topic_score_codex":0.00026322695,"about_ca_topic_score_gemma":0.00021029222,"teacher_disagreement_score":0.007334963,"about_ca_system_score_codex":0.000071581875,"about_ca_system_score_gemma":0.00016867879,"threshold_uncertainty_score":0.54731005},"labels":[],"label_agreement":null},{"id":"W4405044791","doi":"10.1182/blood-2024-204533","title":"Clinical Outcomes over 3 Years of Once-Weekly Efanesoctocog Alfa Treatment in Adults and Adolescents with Severe Hemophilia A: Second Interim Analysis from the Phase 3 XTEND-ed Long-Term Extension Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Interim analysis; Interim; Pediatrics; Term (time); Clinical trial; Internal medicine","score_opus":0.035645350836437405,"score_gpt":0.3805165965895844,"score_spread":0.34487124575314704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997066,0.0009919389,8.7412786e-7,0.0002063478,0.0000599195,0.0015378803,0.000080043006,0.000028358785,0.000028624083],"genre_scores_gemma":[0.9988603,0.0003099245,0.000032762957,0.00004599768,0.000086422086,0.00005168769,0.00006845405,0.00002612468,0.00051832316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980562,0.00017046336,0.0004909075,0.0005856553,0.0004519572,0.00024481385],"domain_scores_gemma":[0.99894834,0.00024974556,0.000071939525,0.0005212657,0.000054758246,0.000153983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025244764,0.00023944197,0.0007537566,0.00020060423,0.000034882327,0.000034012326,0.00010558449,0.000101601814,0.00017721752],"category_scores_gemma":[0.00004520811,0.00012716338,0.00024419333,0.00043647375,0.00013657604,0.00006530868,0.00008377026,0.00024782764,0.00001055427],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017725292,0.010525945,0.9575005,0.00009841614,0.0031874795,0.0023741394,0.0013634997,2.94999e-7,0.00010513604,3.316104e-7,0.000021696309,0.023050006],"study_design_scores_gemma":[0.02743234,0.0035466198,0.964229,0.0009039794,0.00311231,0.000021346787,0.00038951755,0.00009767677,0.00012676422,0.0000031022455,0.00001445764,0.00012288394],"about_ca_topic_score_codex":0.00030526638,"about_ca_topic_score_gemma":0.00096124364,"teacher_disagreement_score":0.02565981,"about_ca_system_score_codex":0.0000532049,"about_ca_system_score_gemma":0.000104423336,"threshold_uncertainty_score":0.51855725},"labels":[],"label_agreement":null},{"id":"W4405044799","doi":"10.1182/blood-2024-202551","title":"Clinical and Economic Outcome Analysis of First-Line Immunosuppression in Acquired Hemophilia a","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. John’s Health Sciences Centre; University of Ottawa; Newfoundland and Labrador Centre for Applied Health Research; Queen's University; Ottawa Hospital; St. Michael's Hospital; Western University; University of Alberta; University of Saskatchewan; University of Calgary","funders":"","keywords":"Immunosuppression; Medicine; Intensive care medicine; Internal medicine; Immunology; Pediatrics","score_opus":0.04948423307295349,"score_gpt":0.3842474304118846,"score_spread":0.3347631973389311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99555284,0.0023945924,0.0000021586004,0.0012621997,0.000076912285,0.00018625769,0.000020298943,0.000023907834,0.00048082563],"genre_scores_gemma":[0.9978769,0.00094691914,0.00011845974,0.000016793932,0.00007517531,0.00000935835,0.000035257606,0.000010860808,0.0009103061],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989402,0.000038670318,0.00049358944,0.00026340672,0.00011174898,0.00015236414],"domain_scores_gemma":[0.9994079,0.00021424062,0.00002775325,0.00024593165,0.00001516961,0.00008901737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039478528,0.00009421734,0.00050379394,0.00042992146,0.000018376162,0.000012809279,0.000054555898,0.000107792905,0.00022922609],"category_scores_gemma":[0.00006868026,0.000065577035,0.00020966439,0.00033580087,0.00010017422,0.000042244756,0.00006661289,0.00010991064,0.000023502014],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009874115,0.0004623244,0.9943654,0.00014836577,0.0011726881,0.00017058576,0.00009359572,0.000004826486,0.0006769615,0.000033356067,0.00003810913,0.002735024],"study_design_scores_gemma":[0.0038824556,0.00037205874,0.9827081,0.00019937585,0.002378201,0.000015681295,0.00002814895,0.0077739097,0.0018518164,0.00007876431,0.0006225279,0.000088961],"about_ca_topic_score_codex":0.000075597265,"about_ca_topic_score_gemma":0.00008572141,"teacher_disagreement_score":0.011657323,"about_ca_system_score_codex":0.000020060172,"about_ca_system_score_gemma":0.000050285722,"threshold_uncertainty_score":0.26741537},"labels":[],"label_agreement":null},{"id":"W4405044807","doi":"10.1182/blood-2024-203756","title":"TCL1A Is Associated with Blinatumomab Response and Immune Activation in Pediatric B-ALL","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Blinatumomab; Medicine; Immune system; Internal medicine; Immunology; CD19","score_opus":0.012614270382890917,"score_gpt":0.27623328255571833,"score_spread":0.2636190121728274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99589014,0.00080426387,0.00003222922,0.0022050291,0.000027742724,0.00027895917,0.000006172004,0.000090323185,0.0006651277],"genre_scores_gemma":[0.9979409,0.000095913754,0.00011301781,0.00015953058,0.00008306711,0.00002272748,0.000019048142,0.000032170974,0.0015336034],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99884254,0.0000899687,0.00017660756,0.00026950904,0.00036147432,0.00025990856],"domain_scores_gemma":[0.9990517,0.00059495604,0.000030522697,0.0001689766,0.00006807188,0.00008577557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053240464,0.000116339375,0.00019042195,0.00039654554,0.000026085529,0.000040808158,0.000055189004,0.00012211873,0.00003793073],"category_scores_gemma":[0.00069105934,0.000089858266,0.000026413481,0.00079971395,0.000039137543,0.000104046616,0.00004920871,0.0003168932,0.000028433771],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03995521,0.010443243,0.2985917,0.0037848537,0.0038471704,0.024282012,0.02259404,0.000012843074,0.5562177,0.0010422936,0.0225048,0.016724186],"study_design_scores_gemma":[0.02223257,0.0018496674,0.9362163,0.00076728105,0.00065807975,0.00034820702,0.0001687193,0.002195768,0.0344062,0.0001951904,0.0006346771,0.00032737132],"about_ca_topic_score_codex":0.000043319575,"about_ca_topic_score_gemma":0.000006001506,"teacher_disagreement_score":0.63762456,"about_ca_system_score_codex":0.00027739268,"about_ca_system_score_gemma":0.0006586515,"threshold_uncertainty_score":0.3664314},"labels":[],"label_agreement":null},{"id":"W4405044886","doi":"10.1182/blood-2024-198507","title":"Prognostic Impact of t(1;19) in Pediatric B-Cell Acute Lymphoblastic Leukemia (B-ALL) Patients Treated on Contemporary Children's Oncology Group (COG) Protocols","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Cog; Lymphoblastic Leukemia; Medicine; Oncology; Pediatric oncology; Internal medicine; Acute lymphocytic leukemia; Leukemia; Pediatrics; Cancer","score_opus":0.02051046883953976,"score_gpt":0.32159531420483184,"score_spread":0.30108484536529206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97383606,0.0002652747,0.000014779656,0.000044495322,0.00007038407,0.021631122,0.00020552636,0.00020768335,0.003724656],"genre_scores_gemma":[0.99323547,0.000057614678,0.000130482,0.000094184135,0.00024601197,0.0054513942,0.00043727068,0.00012496005,0.00022259512],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963113,0.00025036038,0.0009383381,0.0008402059,0.0008427405,0.0008170511],"domain_scores_gemma":[0.9976029,0.000931698,0.00022214149,0.0005653177,0.00017625882,0.0005017004],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036207755,0.00051911693,0.000930792,0.0010554544,0.000044456803,0.00004644076,0.00034366656,0.00044204097,0.00008612769],"category_scores_gemma":[0.0005289961,0.00039059465,0.0003509302,0.0013255522,0.00015357282,0.00015977955,0.00016450518,0.0006276121,0.00019875486],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029029108,0.008301541,0.9757362,0.0010285522,0.0010828355,0.0024968132,0.00031570083,0.000032699125,0.0018052552,0.0000279117,0.004876969,0.0013925881],"study_design_scores_gemma":[0.05100138,0.025754187,0.916365,0.0008770612,0.0015339402,0.00029401726,0.000013573646,0.001490535,0.001984912,0.000045030854,0.00013600607,0.00050431],"about_ca_topic_score_codex":0.00056526763,"about_ca_topic_score_gemma":0.0000100974285,"teacher_disagreement_score":0.059371177,"about_ca_system_score_codex":0.0030422164,"about_ca_system_score_gemma":0.0062470487,"threshold_uncertainty_score":0.9998546},"labels":[],"label_agreement":null},{"id":"W4405044925","doi":"10.1182/blood-2024-210851","title":"Critical Bleeding in Adults and Children with Immune Thrombocytopenia: A Multicentre Cohort Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; St Joseph's Health Care; Western University; Stollery Children's Hospital; Hospital for Sick Children; London Health Sciences Centre; McMaster University; Impact","funders":"","keywords":"Immune thrombocytopenia; Medicine; Romiplostim; Cohort; Eltrombopag; Cohort study; Pediatrics; Platelet; Internal medicine; Thrombopoietin","score_opus":0.006060347120005382,"score_gpt":0.26178334427565547,"score_spread":0.2557229971556501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953917,0.002656707,0.0000011941132,0.00020120319,0.000028109103,0.0009356926,0.0000061610235,0.00005350068,0.00072568026],"genre_scores_gemma":[0.9995902,0.000102166785,0.00014675251,0.000021501859,0.000025257208,0.000038780923,0.000013597966,0.000018200117,0.000043548494],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99924,0.000013387352,0.00013057783,0.000285449,0.00014353202,0.00018704766],"domain_scores_gemma":[0.99975127,0.000040925075,0.000008113199,0.00011196471,0.0000192546,0.000068457426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000068065856,0.00012028009,0.0003068766,0.00006790484,0.000034909583,0.00003883488,0.000027500511,0.000038115173,0.000030180285],"category_scores_gemma":[0.00003026804,0.00008348232,0.000020603416,0.00013675657,0.00003617703,0.00008453257,0.000029677014,0.00014137075,0.000015721203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011703152,0.0023453801,0.9925941,0.000059344537,0.0005153713,0.0026276745,0.0009194026,1.1919811e-7,0.00006759465,0.00002733622,0.0000063156567,0.00072028843],"study_design_scores_gemma":[0.009696202,0.0007274568,0.9868333,0.000511753,0.00076819974,0.00056507706,0.0005485126,0.000083521765,0.0001580901,0.000012763117,0.000003600307,0.00009152871],"about_ca_topic_score_codex":0.0003065881,"about_ca_topic_score_gemma":0.00017442297,"teacher_disagreement_score":0.009579171,"about_ca_system_score_codex":0.000014664602,"about_ca_system_score_gemma":0.000027900935,"threshold_uncertainty_score":0.34043103},"labels":[],"label_agreement":null},{"id":"W4405044949","doi":"10.1182/blood-2024-201288","title":"Genomic Determinants of Resistance to Anti-BCMA Chimeric Antigen Receptor T-Cell (CART) Therapies in Patients with Relapsed/Refractory Multiple Myeloma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Chimeric antigen receptor; Medicine; Cart; Multiple myeloma; Refractory (planetary science); Oncology; Lenalidomide; Internal medicine; Cancer research; Immunology; Immunotherapy; Biology; Cancer","score_opus":0.010942681774476,"score_gpt":0.2501756502306125,"score_spread":0.2392329684561365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958104,0.002424332,0.0000037740394,0.000047113,0.00009073153,0.001027051,0.000114880684,0.000057033198,0.00042472407],"genre_scores_gemma":[0.99688095,0.00023779334,0.0018821798,0.000025491974,0.000048920156,0.00005904368,0.00005602586,0.00006352527,0.00074605324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824065,0.00006947522,0.00035383506,0.00046890855,0.00042317522,0.00044398187],"domain_scores_gemma":[0.99908674,0.00011019022,0.00007293539,0.0004322937,0.00009151543,0.00020634916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012698259,0.00024107646,0.00044673032,0.00032537707,0.00005142447,0.000024860357,0.00014548615,0.00008268848,0.00007695026],"category_scores_gemma":[0.00006922211,0.00017902386,0.00008169509,0.00045995877,0.000074568365,0.00010593355,0.00005569498,0.00018586473,0.00013968372],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009419044,0.0016951405,0.9575127,0.00028880907,0.00017309627,0.00016948878,0.00066990167,8.206327e-7,0.032416575,0.0000011722033,0.00015231936,0.005978107],"study_design_scores_gemma":[0.008262395,0.0011562856,0.9460136,0.000581311,0.000055265715,0.0000028355048,0.000080737926,0.00001748892,0.04192884,0.000002324166,0.0017358144,0.00016305172],"about_ca_topic_score_codex":0.00008432093,"about_ca_topic_score_gemma":0.00018119418,"teacher_disagreement_score":0.011499017,"about_ca_system_score_codex":0.00007716191,"about_ca_system_score_gemma":0.00017075114,"threshold_uncertainty_score":0.7300381},"labels":[],"label_agreement":null},{"id":"W4405044952","doi":"10.1182/blood-2024-207273","title":"Efficacy and Toxicity of Fixed Dose Versus Reduced/PK-Adjusted Dose Pegaspargase in Pediatric Patients with Newly Diagnosed Acute Lymphoblastic Leukemia: Results of DFCI ALL Consortium Protocol 16-001","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Centre hospitalier universitaire de Québec; Université de Montréal","funders":"","keywords":"Medicine; Asparaginase; Dosing; Internal medicine; Toxicity; Gastroenterology; Surgery; Leukemia; Lymphoblastic Leukemia","score_opus":0.019127197547427623,"score_gpt":0.29085524858927475,"score_spread":0.2717280510418471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9695924,0.00009271583,0.000009733877,0.000101913356,0.0001149373,0.029022345,0.00026713553,0.0001044535,0.00069440005],"genre_scores_gemma":[0.99295276,0.000059797894,0.00054912956,0.000035553592,0.00015988378,0.005761606,0.00019268377,0.00008664344,0.00020194668],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9959603,0.00018790372,0.0011570047,0.0008760719,0.001081647,0.0007370913],"domain_scores_gemma":[0.9963319,0.0017642044,0.0003444643,0.0007164481,0.0003887383,0.00045426196],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004279465,0.00046889143,0.00089280965,0.00067453436,0.00004604758,0.000040036895,0.00027843294,0.00032579195,0.000044637894],"category_scores_gemma":[0.0017833486,0.00036536166,0.000102587066,0.0013608453,0.0003452522,0.00019189951,0.00023875023,0.0004947026,0.000021915504],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.59385824,0.067037806,0.14994958,0.024549024,0.008228441,0.01716815,0.007630954,0.00067185593,0.080870666,0.00021951017,0.035051055,0.014764739],"study_design_scores_gemma":[0.65778327,0.013120765,0.27827343,0.0018037792,0.003818157,0.00014149644,0.00012450729,0.0016934187,0.04203964,0.000015723333,0.00035696666,0.0008288641],"about_ca_topic_score_codex":0.0004469958,"about_ca_topic_score_gemma":0.00009461681,"teacher_disagreement_score":0.12832385,"about_ca_system_score_codex":0.0008347596,"about_ca_system_score_gemma":0.0027398523,"threshold_uncertainty_score":0.99987984},"labels":[],"label_agreement":null},{"id":"W4405044954","doi":"10.1182/blood-2024-205608","title":"Phase 3 Study of Teclistamab (Tec) in Combination with Lenalidomide (Len) and Tec Alone Versus Len Alone in Newly Diagnosed Multiple Myeloma (NDMM) As Maintenance Therapy Following Autologous Stem Cell Transplantation (ASCT): Safety Run-in (SRI) Results from the Majestec-4/EMN30 Trial","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; TEC; Lenalidomide; Internal medicine; Oncology; Multiple myeloma; Cohort; Autologous stem-cell transplantation; Surgery","score_opus":0.02588443696714383,"score_gpt":0.2991773898175876,"score_spread":0.2732929528504438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928761,0.0013446284,0.000025651754,0.0004971494,0.00014425525,0.0047204955,0.00020618102,0.00006153053,0.00012401793],"genre_scores_gemma":[0.998327,0.0007161581,0.00019175446,0.00002157518,0.00004621793,0.0003235936,0.0002791123,0.000040155923,0.000054436532],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9969659,0.00046418415,0.000828597,0.00067014934,0.0006216187,0.00044954597],"domain_scores_gemma":[0.99718034,0.0020982102,0.00014885468,0.00040794854,0.00005689195,0.00010772583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008588829,0.00032405448,0.0006869995,0.00034308725,0.000081149825,0.000054762033,0.00016788304,0.00014327042,0.0000061720375],"category_scores_gemma":[0.00019436194,0.00022155143,0.00009130604,0.0006692757,0.000082899074,0.0002128663,0.00002961755,0.00043771535,0.0000046914747],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.78614026,0.025269065,0.06792052,0.00020714318,0.0009301263,0.017234182,0.024336226,0.00007377493,0.008175013,0.000015447495,0.00001445356,0.06968376],"study_design_scores_gemma":[0.76231664,0.009650543,0.21050034,0.00077812356,0.00024131208,0.000025357826,0.003798409,0.0007962509,0.011626707,0.00002146809,0.00003697649,0.00020786648],"about_ca_topic_score_codex":0.011829871,"about_ca_topic_score_gemma":0.01705805,"teacher_disagreement_score":0.14257982,"about_ca_system_score_codex":0.00016629744,"about_ca_system_score_gemma":0.00022503723,"threshold_uncertainty_score":0.99475044},"labels":[],"label_agreement":null},{"id":"W4405044960","doi":"10.1182/blood-2024-194581","title":"A Randomized Phase II Study of Mosunetuzumab SC Plus Polatuzumab Vedotin Demonstrates Improved Outcomes Versus Rituximab Plus Polatuzumab Vedotin in Patients (Pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL)","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Juravinski Hospital; McGill University; Jewish General Hospital","funders":"","keywords":"Rituximab; Medicine; Internal medicine; Brentuximab vedotin; Refractory (planetary science); Oncology; Phases of clinical research; Lymphoma; Clinical trial; Hodgkin lymphoma","score_opus":0.013819270255672847,"score_gpt":0.2782877504936997,"score_spread":0.2644684802380268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884768,0.004378025,0.000007273765,0.00009583051,0.00059386017,0.005317982,0.00016948293,0.00027710118,0.00068365195],"genre_scores_gemma":[0.9975994,0.00016018352,0.0004575079,0.00007487841,0.000091014255,0.00068627583,0.00025952808,0.00017170102,0.00049946917],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99456173,0.0004116178,0.0016816983,0.0013011702,0.0010382765,0.0010055108],"domain_scores_gemma":[0.99657726,0.0011510261,0.00052574446,0.0010841868,0.00025550261,0.00040629684],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00052218436,0.00097297726,0.0030027572,0.00072681945,0.0002507974,0.000109541485,0.0003469836,0.0003664985,0.000099612604],"category_scores_gemma":[0.0004468157,0.00066278956,0.00052512955,0.0010021033,0.00020704202,0.00032802997,0.00024311902,0.00041690806,0.00004848215],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.64876264,0.2938466,0.027325686,0.00078572426,0.006527565,0.0029157065,0.010695148,0.000013568612,0.00045978758,0.00013712901,0.000186289,0.008344155],"study_design_scores_gemma":[0.9467576,0.029655479,0.011576778,0.0006894818,0.004422015,0.000033987533,0.002284877,0.002061864,0.001644733,0.000011192125,0.0001885234,0.00067344896],"about_ca_topic_score_codex":0.0015944799,"about_ca_topic_score_gemma":0.00076623686,"teacher_disagreement_score":0.297995,"about_ca_system_score_codex":0.0014574379,"about_ca_system_score_gemma":0.0022694145,"threshold_uncertainty_score":0.99958235},"labels":[],"label_agreement":null},{"id":"W4405044961","doi":"10.1182/blood-2024-206006","title":"Resolving Human Hematopoietic Stem Cell Functional Heterogeneity with ATP2B1 Surface Expression","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Stem cell; Haematopoiesis; Biology; Hematopoietic stem cell; Cell biology; Cancer research; Immunology","score_opus":0.013150755243407943,"score_gpt":0.2295182478265196,"score_spread":0.21636749258311166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865824,0.010464259,0.0017481226,0.00002938884,0.00007453834,0.000075564305,0.0000068261324,0.000045549223,0.0009733626],"genre_scores_gemma":[0.997388,0.00002820498,0.00039458682,0.000040512685,0.00029590607,0.0000074426616,0.000059491544,0.00003082682,0.0017550143],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999167,0.00003351732,0.0001293622,0.00034859765,0.00014242539,0.00017906136],"domain_scores_gemma":[0.9996375,0.000011385201,0.000029835262,0.00022805714,0.000030882817,0.000062370724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000086987675,0.00013834404,0.000093368035,0.000020073257,0.000114863135,0.000049741022,0.000091182475,0.000093458955,0.000043653785],"category_scores_gemma":[0.0000014083492,0.00011019305,0.000063342464,0.00006770498,0.000028264414,0.0000046705895,0.00007742939,0.000092245245,0.000016848702],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020000427,0.000092100905,0.0025461642,0.00008497846,0.00004241006,0.00003715,0.000046323872,0.00035409644,0.9915583,0.00003233051,0.0051701833,0.000015920898],"study_design_scores_gemma":[0.00045690755,0.00017633349,0.00023632898,0.000086791064,0.000047547666,0.0000782069,0.00005303628,0.000025210045,0.9924565,0.000013357225,0.0061983573,0.00017143825],"about_ca_topic_score_codex":0.0000051159036,"about_ca_topic_score_gemma":0.0000021855863,"teacher_disagreement_score":0.0108056255,"about_ca_system_score_codex":0.0000047250305,"about_ca_system_score_gemma":0.000041126317,"threshold_uncertainty_score":0.4493542},"labels":[],"label_agreement":null},{"id":"W4405044966","doi":"10.1182/blood-2024-209077","title":"Metabolic Determinants of Ferroptosis in B-Cell Lymphoma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Lymphoma; Cancer research; Diffuse large B-cell lymphoma; Immunology; Biology; Medicine","score_opus":0.016908581271986207,"score_gpt":0.2735698960071048,"score_spread":0.2566613147351186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405044966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98108226,0.014526082,0.0000024189728,0.00010614301,0.00012540001,0.00016245246,0.000009325302,0.000043683074,0.003942216],"genre_scores_gemma":[0.99817437,0.0009501813,0.00027967838,0.00008599047,0.00007546999,0.000046620127,0.0000024175436,0.000024712845,0.0003605876],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991241,0.000019346875,0.00026759485,0.0002207852,0.00017827685,0.00018987921],"domain_scores_gemma":[0.99965155,0.000024179973,0.000029875133,0.00020121172,0.000028189643,0.00006496341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011461473,0.00011069262,0.00032698445,0.0001762892,0.000011341849,0.000012666009,0.00007122853,0.00006840324,0.00011668789],"category_scores_gemma":[0.00001562012,0.00008982401,0.00012249203,0.00039289106,0.000032043583,0.00005057435,0.000031574284,0.00006056025,0.000041997537],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009667054,0.0045384113,0.7836614,0.0016443594,0.00017687904,0.00031984624,0.00095882075,8.8617406e-7,0.06128234,0.00026153086,0.0005295501,0.1465293],"study_design_scores_gemma":[0.0037495752,0.00025438686,0.21794029,0.0005106603,0.0004795277,0.000052224874,0.00010220363,0.00016438693,0.7699456,0.000030240211,0.006634106,0.00013680468],"about_ca_topic_score_codex":0.00012314167,"about_ca_topic_score_gemma":0.000033234166,"teacher_disagreement_score":0.7086632,"about_ca_system_score_codex":0.000014684798,"about_ca_system_score_gemma":0.000114308605,"threshold_uncertainty_score":0.36629167},"labels":[],"label_agreement":null},{"id":"W4405045016","doi":"10.1182/blood-2024-198393","title":"The Burden of Transfusion Dependence on Caregivers of Patients with Lower-Risk Myelodysplastic Syndromes in North America and Europe","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Myelodysplastic syndromes; Medicine; Blood transfusion; Hematologic Neoplasms; International Prognostic Scoring System; Intensive care medicine; Internal medicine; Pediatrics; Cancer; Bone marrow","score_opus":0.005946706165247346,"score_gpt":0.2221604071104836,"score_spread":0.21621370094523626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405045016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986477,0.00036756223,0.000016520704,0.00014086613,0.000030252919,0.00031430673,0.000038114,0.00001237212,0.0004323393],"genre_scores_gemma":[0.9985103,0.0012594941,0.0000515857,0.000004451296,0.000015172181,0.000005946462,0.0000076214938,0.000016552582,0.00012887083],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990599,0.00005359619,0.00013939213,0.00019857835,0.00039282924,0.00015570608],"domain_scores_gemma":[0.9993365,0.00028248274,0.000039387887,0.00019178208,0.00009188111,0.00005798826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006881634,0.000093790164,0.00018232659,0.00011934712,0.000032932163,0.000008263615,0.000096704214,0.000028561091,0.0000148884055],"category_scores_gemma":[0.00012891262,0.00005415675,0.000023932138,0.00048165445,0.00018496031,0.000035220393,0.000033471788,0.00024952352,0.0000069807243],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005381895,0.0011980732,0.90942293,0.0016882817,0.0008640658,0.0017360243,0.012118759,0.0007569564,0.0026081973,0.000057239147,0.0004560889,0.06371147],"study_design_scores_gemma":[0.010815194,0.010226861,0.9675096,0.0016323393,0.0007003541,0.000059150083,0.0016001933,0.0020225951,0.0020467245,0.000007887973,0.0031071582,0.00027190437],"about_ca_topic_score_codex":0.00041151745,"about_ca_topic_score_gemma":0.00012498781,"teacher_disagreement_score":0.06343956,"about_ca_system_score_codex":0.000027171442,"about_ca_system_score_gemma":0.00014985603,"threshold_uncertainty_score":0.2208448},"labels":[],"label_agreement":null},{"id":"W4405045028","doi":"10.1182/blood-2024-202199","title":"Identification of a Novel Function of B2M Involving T-Cell Exhaustion Via P-Selectin Ligand Upregulation in Diffuse Large B-Cell Lymphoma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Diffuse large B-cell lymphoma; Downregulation and upregulation; Identification (biology); Lymphoma; Cancer research; Chemistry; Medicine; Immunology; Biology; Biochemistry","score_opus":0.017036348487291457,"score_gpt":0.27130329152062194,"score_spread":0.2542669430333305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405045028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99320364,0.0014335436,0.0041420767,0.0000372923,0.00014219627,0.0005058759,0.0000092813725,0.000049112306,0.00047696574],"genre_scores_gemma":[0.9972403,0.00012213485,0.00010093315,0.000009017413,0.00010779919,0.000027727398,0.00005879062,0.000034041066,0.0022992417],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985605,0.00004400231,0.00050487916,0.00028863078,0.00040245356,0.00019954616],"domain_scores_gemma":[0.99929494,0.00008948977,0.00013063563,0.00027639174,0.00015851737,0.00005000275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006482551,0.00011719655,0.00022410865,0.00045040785,0.000027545706,0.000023043402,0.00006252529,0.00013565956,0.00007441288],"category_scores_gemma":[0.000057999616,0.00011895665,0.00008958986,0.0007900483,0.000031369305,0.00014181866,0.000029917845,0.00012857323,0.00001166536],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026057367,0.007749787,0.005000667,0.00090246176,0.0000408249,0.0000044359845,0.0006308308,0.000013505653,0.981859,0.00008499154,0.00003132061,0.003421581],"study_design_scores_gemma":[0.014566087,0.00029086202,0.035601024,0.00026235153,0.00016926133,0.000012793189,0.00011555046,0.01744991,0.93121606,0.00010881672,0.00011278031,0.000094489646],"about_ca_topic_score_codex":0.00009312523,"about_ca_topic_score_gemma":0.00004680624,"teacher_disagreement_score":0.050642945,"about_ca_system_score_codex":0.000096998934,"about_ca_system_score_gemma":0.00011394609,"threshold_uncertainty_score":0.48509112},"labels":[],"label_agreement":null},{"id":"W4405045036","doi":"10.1182/blood-2024-204342","title":"Sex-Related Differences in CML Outcomes in a Real-World Prospective Registry (GQR LMC-NMP)","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Université Laval; Jewish General Hospital; McGill University; Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Centre Intégré de Santé et de Services Sociaux des Laurentides","funders":"","keywords":"Medicine","score_opus":0.017467691490128792,"score_gpt":0.2875683838844543,"score_spread":0.27010069239432555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405045036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9710439,0.0010375711,6.010374e-7,0.0007351989,0.00016932879,0.0007177805,0.000015178541,0.00020450368,0.026075961],"genre_scores_gemma":[0.9750648,0.00016283189,0.000119513395,0.000046525372,0.000059194404,0.00013115624,0.00002412175,0.000034985518,0.024356842],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835587,0.00005398947,0.00041745853,0.00052187743,0.00028787612,0.00036295355],"domain_scores_gemma":[0.99925596,0.00018254694,0.000053047832,0.00039461357,0.000018558012,0.000095258874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001565707,0.0002487808,0.00057253346,0.00035365252,0.000023842522,0.000033052936,0.000113773545,0.0001386038,0.00016477349],"category_scores_gemma":[0.000104536,0.00019118747,0.00009701114,0.00072078087,0.000073848634,0.00007824115,0.000060298466,0.0005101595,0.00010992695],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036910184,0.0009664089,0.99300814,0.00016192792,0.00031961754,0.0020587232,0.0015582686,6.886281e-7,0.00026672162,0.0006912316,0.0001191206,0.0008122712],"study_design_scores_gemma":[0.008290262,0.00020670341,0.9871193,0.0009093827,0.00021082527,0.0000758306,0.00026357875,0.00017301092,0.0013873613,0.0010474615,0.00012353764,0.0001927528],"about_ca_topic_score_codex":0.00224996,"about_ca_topic_score_gemma":0.0027806442,"teacher_disagreement_score":0.008253352,"about_ca_system_score_codex":0.00087431737,"about_ca_system_score_gemma":0.0004276837,"threshold_uncertainty_score":0.7796399},"labels":[],"label_agreement":null},{"id":"W4405045134","doi":"10.1182/blood-2024-199107","title":"Anticoagulation Management of Splanchnic Vein Thrombosis in Myeloproliferative Neoplasms: A Global Abdominal/Splanchnic Thrombosis Retrospective Observational Study in 486 MPN Patients (GASTRO-MPN)","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"ZonMw; Sierra Oncology; Regeneron Pharmaceuticals; Gilead Sciences; Incyte; Swedish Orphan Biovitrum; CSL Behring; GlaxoSmithKline","keywords":"Medicine; Thrombosis; Splanchnic Circulation; Retrospective cohort study; Internal medicine; Portal vein thrombosis; Splanchnic; Surgery; Radiology; Hemodynamics","score_opus":0.0473868436243069,"score_gpt":0.3367112398238378,"score_spread":0.28932439619953093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405045134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994115,0.0004007472,0.00003900824,0.00032090343,0.00025912462,0.0033593578,0.00021143549,0.000075890624,0.0012185532],"genre_scores_gemma":[0.99675417,0.0003067158,0.0017069851,0.00007459188,0.00009408222,0.00072343607,0.00026336632,0.00004054406,0.00003608152],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99643815,0.00018038541,0.0010108954,0.0009291131,0.0009345695,0.0005068619],"domain_scores_gemma":[0.9988923,0.00014912365,0.00020202022,0.00040916723,0.00022441539,0.00012298227],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040828562,0.0004845846,0.0010001587,0.0003552268,0.00007634423,0.00006312549,0.00015343106,0.00015513304,0.00012282681],"category_scores_gemma":[0.00006374633,0.00042867835,0.00017356395,0.0014660214,0.00008151832,0.00030835677,0.00012236545,0.00031300524,0.000040882038],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002639245,0.010452566,0.98260546,0.00036421596,0.0011829379,0.0002046042,0.0014693956,0.00005543776,0.0001477334,0.002587151,0.00012196371,0.0005445926],"study_design_scores_gemma":[0.01018968,0.0022899744,0.9822067,0.0015296408,0.00080406404,0.000011400881,0.00066021836,0.0004992662,0.0009030062,0.00059983955,0.000014723906,0.0002914837],"about_ca_topic_score_codex":0.00022913315,"about_ca_topic_score_gemma":0.0007698078,"teacher_disagreement_score":0.009925756,"about_ca_system_score_codex":0.0007964533,"about_ca_system_score_gemma":0.0001840515,"threshold_uncertainty_score":0.9998165},"labels":[],"label_agreement":null},{"id":"W4405045156","doi":"10.1182/blood-2024-204962","title":"Etavopivat Reduces Incidence of Vaso-Occlusive Crises in Patients with Sickle Cell Disease: HIBISCUS Trial Phase 2 Results through 52 Weeks","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; Centers for Disease Control and Prevention; National Institutes of Health; Bausch Health; Novo Nordisk; CSL Behring; Bristol-Myers Squibb; Agios Pharmaceuticals; State of Connecticut Department of Public Health; Health Resources and Services Administration; bluebird bio","keywords":"Medicine; Vaso-occlusive crisis; Incidence (geometry); Internal medicine; Disease; Sickle cell anemia; Surgery; Gastroenterology","score_opus":0.009739962490781705,"score_gpt":0.27065584339568055,"score_spread":0.26091588090489887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405045156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99114347,0.0038404036,0.0000067089304,0.0006797372,0.00030189444,0.0010199181,0.0001454236,0.0000684923,0.0027939584],"genre_scores_gemma":[0.99867564,0.00036547618,0.00015469937,0.0000869932,0.000115420575,0.000022856932,0.000118817305,0.000030809893,0.00042925312],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99828863,0.00005864103,0.00048951356,0.00042365261,0.00045255982,0.0002869855],"domain_scores_gemma":[0.9992004,0.000108031934,0.00011510392,0.0003231451,0.00010740522,0.00014590999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001346386,0.00020769537,0.00036790545,0.00011936182,0.000050460807,0.000022696857,0.00011338484,0.00012310817,0.000046795674],"category_scores_gemma":[0.0002175288,0.00013933129,0.00010752676,0.00046974048,0.0001392642,0.00016523052,0.00006113531,0.0003240664,0.000018856654],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6527489,0.120676264,0.083082534,0.008729419,0.0026626107,0.009098237,0.048110668,0.000551206,0.01553925,0.0009222051,0.0376661,0.020212606],"study_design_scores_gemma":[0.8631857,0.020407122,0.021979766,0.0069767,0.004209464,0.00002317253,0.0035056013,0.00021490478,0.06797865,0.00070594146,0.009501893,0.0013110839],"about_ca_topic_score_codex":0.00013105974,"about_ca_topic_score_gemma":0.000009828199,"teacher_disagreement_score":0.2104368,"about_ca_system_score_codex":0.00003206191,"about_ca_system_score_gemma":0.00038416302,"threshold_uncertainty_score":0.5681765},"labels":[],"label_agreement":null},{"id":"W4405045169","doi":"10.1182/blood-2024-201058","title":"10 Year Follow-up of CALGB 10603/Ratify: Midostaurin Versus Placebo Plus Intensive Chemotherapy in Newly Diagnosed <i>FLT3</i> Mutant Acute Myeloid Leukemia Patients Aged 18-60 Years","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Midostaurin; Medicine; Myeloid leukemia; Chemotherapy regimen; Internal medicine; Chemotherapy; Oncology; Cytarabine; Leukemia","score_opus":0.01727424317486516,"score_gpt":0.27821591567018494,"score_spread":0.2609416724953198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405045169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99383485,0.0004792286,0.0000104155,0.0004282491,0.0005783332,0.0016140623,0.00016703598,0.00015979489,0.002728011],"genre_scores_gemma":[0.99099123,0.0005776219,0.0005764241,0.000440294,0.00026556393,0.00014790556,0.0002926754,0.00018352545,0.006524774],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9966223,0.0001502639,0.000703281,0.0007820112,0.0009434671,0.00079865206],"domain_scores_gemma":[0.99788594,0.0005356866,0.00013430169,0.0007432065,0.00037344074,0.00032740174],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00039837917,0.00043544377,0.0008607878,0.0005267535,0.000050852956,0.00006400573,0.00039780655,0.00035609084,0.0012691093],"category_scores_gemma":[0.0007412863,0.0004097939,0.00029325482,0.0010272417,0.00022789655,0.00016983293,0.00021121006,0.0009988485,0.0006106474],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15694404,0.004097081,0.025735335,0.0030888438,0.012444554,0.053514954,0.04402805,0.00013459224,0.30110052,0.0002650273,0.33202887,0.066618174],"study_design_scores_gemma":[0.60462654,0.011190351,0.10398946,0.0034709154,0.002690342,0.00021598197,0.005421939,0.0026715838,0.21842757,0.00012850869,0.04464387,0.0025229265],"about_ca_topic_score_codex":0.0006158499,"about_ca_topic_score_gemma":0.00022545774,"teacher_disagreement_score":0.44768253,"about_ca_system_score_codex":0.001304874,"about_ca_system_score_gemma":0.0018201504,"threshold_uncertainty_score":0.9998354},"labels":[],"label_agreement":null},{"id":"W4405045193","doi":"10.1182/blood-2024-204010","title":"Serial Clinical and Biomarker Monitoring during Treatment Can Stratify Patients with Low Risk Gvhd","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Biomarker; Internal medicine; Clinical trial; Prospective cohort study; Graft-versus-host disease; Disease; Oncology","score_opus":0.033185414406882344,"score_gpt":0.3383758661485337,"score_spread":0.3051904517416514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405045193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978279,0.00047789354,0.000001502385,0.000041116455,0.00035529796,0.0004746997,0.000024872917,0.00005949919,0.0007372294],"genre_scores_gemma":[0.998194,0.0002927622,0.0003221168,0.0000018446074,0.0005437682,0.000025419979,0.00001058874,0.000027565402,0.00058195565],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875385,0.00007666265,0.00022939772,0.00035113186,0.00032665202,0.00026228503],"domain_scores_gemma":[0.99931407,0.00012678916,0.000027744632,0.00020896811,0.00006408554,0.00025835587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017394073,0.00014021737,0.00022314514,0.000067939,0.00007508484,0.00006582156,0.000037422575,0.000083344356,0.00008764299],"category_scores_gemma":[0.00009587629,0.00009092333,0.00005174624,0.00012845223,0.00007045941,0.000041069903,0.000036881138,0.00017728862,0.000019090645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002797456,0.0005303157,0.9744053,0.00019194483,0.00033626411,0.0003169383,0.00011239865,3.3402813e-7,0.0008569486,0.0000018181183,0.000008682082,0.022959294],"study_design_scores_gemma":[0.0064871814,0.0012118893,0.98392284,0.00020849537,0.0002566035,0.0000118956805,0.000035137808,0.000026492438,0.0075668436,0.0000033495717,0.00017308083,0.00009619232],"about_ca_topic_score_codex":0.0001925012,"about_ca_topic_score_gemma":0.00004521349,"teacher_disagreement_score":0.022863101,"about_ca_system_score_codex":0.000046739904,"about_ca_system_score_gemma":0.00015037291,"threshold_uncertainty_score":0.37077457},"labels":[],"label_agreement":null},{"id":"W4405045207","doi":"10.1182/blood-2024-207207","title":"Pharmacokinetics/Pharmacodynamics, Safety, and Efficacy of Crizanlizumab in Patients with Sickle Cell Disease Aged 6 to &amp;lt;12 Years: 2-Year Data from the Phase 2 Solace-Kids Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto","funders":"","keywords":"Medicine; Dosing; Pharmacokinetics; Pharmacodynamics; Internal medicine; Clinical trial; Adverse effect; Pediatrics; Gastroenterology","score_opus":0.014093194370820183,"score_gpt":0.2866161024950908,"score_spread":0.2725229081242706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405045207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950137,0.001833213,0.000042446027,0.00035957183,0.00014091817,0.0014510439,0.0009121606,0.000049844835,0.00019707979],"genre_scores_gemma":[0.9984537,0.00036399934,0.00014308341,0.00016786664,0.000072695315,0.000008808377,0.000624649,0.000047759317,0.00011746943],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851507,0.000095459916,0.0003273109,0.00047501223,0.000344351,0.0002428215],"domain_scores_gemma":[0.99886346,0.00015272156,0.000046624296,0.00065815216,0.000035378587,0.00024364328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018920036,0.00019466733,0.0002797045,0.00009475504,0.00004436909,0.000036907913,0.00026334662,0.00004635306,0.00012494852],"category_scores_gemma":[0.00008204413,0.00013146966,0.00003600699,0.00030194744,0.000081061895,0.00007597421,0.00027095457,0.00031675326,0.000030201281],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03432604,0.08252466,0.77633566,0.0009844614,0.0035956996,0.0014963795,0.025406055,0.00046065045,0.0077647446,0.000021834121,0.016539386,0.050544437],"study_design_scores_gemma":[0.15861735,0.0027930916,0.81062603,0.00089541194,0.0063923784,0.000003526869,0.001629706,0.002085078,0.00024048166,0.00001780714,0.016019573,0.00067953806],"about_ca_topic_score_codex":0.00014670349,"about_ca_topic_score_gemma":0.00006841228,"teacher_disagreement_score":0.12429131,"about_ca_system_score_codex":0.000019021298,"about_ca_system_score_gemma":0.00011311402,"threshold_uncertainty_score":0.53611773},"labels":[],"label_agreement":null},{"id":"W4405045282","doi":"10.1182/blood-2024-201171","title":"Spatially Resolved Single-Cell Transcriptomics of T Cells in Follicular Lymphoma Reveals Distinct Immune Ecosystems","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"Chugai Pharmaceutical; Eisai; Astellas Pharma; Bristol-Myers Squibb","keywords":"Transcriptome; Biology; Follicular lymphoma; Stromal cell; Single-cell analysis; Laser capture microdissection; Immune system; Gene expression profiling; Cell; Molecular biology; Immunology; Lymphoma; Cancer research; Gene expression; Gene; Genetics","score_opus":0.010314841918116706,"score_gpt":0.2032729386372557,"score_spread":0.192958096719139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405045282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98736095,0.00782704,0.0019829443,0.000034887224,0.0006366384,0.0003567588,0.00013709466,0.000037454483,0.0016262429],"genre_scores_gemma":[0.9980909,0.0002563747,0.00067663804,0.000032008233,0.00021891264,0.000022108865,0.00016851004,0.00007255467,0.00046199764],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99809855,0.0001117196,0.0006975364,0.0005277243,0.00019516215,0.00036932557],"domain_scores_gemma":[0.9992473,0.0000326097,0.00009805085,0.0004702708,0.00006281593,0.00008893511],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003368197,0.0002871559,0.0004055852,0.00011664497,0.000039293274,0.00005596393,0.00032203243,0.00028978378,0.00001594475],"category_scores_gemma":[0.000024819732,0.00028392478,0.00030375246,0.00022728377,0.00006885009,0.000007670257,0.00004285543,0.00010774605,0.000010408797],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010220592,0.0009378658,0.0016178559,0.00044262587,0.00009574348,0.000053592783,0.00016742403,0.00003917297,0.9954023,0.000037276888,0.000097131415,0.0010068081],"study_design_scores_gemma":[0.002481551,0.00043722367,0.00044733053,0.00022881188,0.00011702912,0.00001892529,0.000031498843,0.0003684992,0.98589975,0.000048597678,0.00958917,0.00033161638],"about_ca_topic_score_codex":0.0002743526,"about_ca_topic_score_gemma":0.00038155614,"teacher_disagreement_score":0.010729956,"about_ca_system_score_codex":0.000026828455,"about_ca_system_score_gemma":0.00012738488,"threshold_uncertainty_score":0.9999613},"labels":[],"label_agreement":null},{"id":"W4405045328","doi":"10.1182/blood-2024-207793","title":"Genetic or Epigenetic CR1 Deficiency Defines Catastrophic Antiphospholipid Syndrome (CAPS) and Response to Complement Inhibition","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph's Hospital","funders":"","keywords":"Catastrophic antiphospholipid syndrome; Antiphospholipid syndrome; Immunology; Medicine; Epigenetics; Genetics; Biology; Antibody; Gene","score_opus":0.010455540697703481,"score_gpt":0.23224276581405437,"score_spread":0.22178722511635088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405045328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9193309,0.07881049,0.0002669996,0.00037671305,0.00052018045,0.000384554,0.00010673242,0.00013427367,0.0000691812],"genre_scores_gemma":[0.99860156,0.00036661158,0.00017980495,0.00016239808,0.0000044677454,0.00006603408,0.00006501119,0.00002986413,0.000524278],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99833274,0.00018462111,0.00039468883,0.00050599826,0.00006307268,0.0005188724],"domain_scores_gemma":[0.9994311,0.00013903406,0.000044300454,0.00032975746,0.000036917398,0.000018943527],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033168303,0.00025290798,0.00026600776,0.0002477941,0.00031288687,0.000070025126,0.00017247646,0.00012582875,0.00041665792],"category_scores_gemma":[0.00008272287,0.0002115349,0.00007158934,0.00041641123,0.00019017467,0.00006566158,0.00015170095,0.00019796721,0.00082187145],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006344695,0.0006900563,0.0010944954,0.00017665107,0.00013755764,0.00029731824,0.0017882918,0.00005593002,0.9844959,0.00038452997,0.00039299057,0.009851861],"study_design_scores_gemma":[0.008850585,0.0061872774,0.6755109,0.0011743421,0.00083716144,0.009299816,0.0023729356,0.000042199787,0.19504197,0.00057682005,0.09810732,0.001998668],"about_ca_topic_score_codex":0.00012271476,"about_ca_topic_score_gemma":0.000009715681,"teacher_disagreement_score":0.78945386,"about_ca_system_score_codex":0.000023033803,"about_ca_system_score_gemma":0.00013290044,"threshold_uncertainty_score":0.99995613},"labels":[],"label_agreement":null},{"id":"W4405045339","doi":"10.1182/blood-2024-208486","title":"Efficacy and Safety of Giroctocogene Fitelparvovec in Adults with Moderately Severe to Severe Hemophilia Α: Primary Analysis Results from the Phase 3 ΑFFINE Gene Therapy Trial","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada); St. Michael's Hospital; University of Toronto; McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Medicine; Pediatrics; Intention-to-treat analysis; Clinical trial; Internal medicine","score_opus":0.026412384528012173,"score_gpt":0.30346275410299656,"score_spread":0.2770503695749844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405045339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99051034,0.002700452,0.000013319946,0.002937077,0.00003127649,0.0026378024,0.00061521266,0.000042448493,0.0005120764],"genre_scores_gemma":[0.996464,0.0011019254,0.0006490449,0.00016389458,0.0002808528,0.00007947978,0.0006534273,0.000032210162,0.00057517085],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99794966,0.00011352829,0.00050940266,0.0006203448,0.00050032325,0.00030675693],"domain_scores_gemma":[0.99857175,0.00053046836,0.000058336907,0.00055543886,0.00009490124,0.00018912653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035911953,0.00026074433,0.0006302628,0.00026032957,0.00006788607,0.00004312468,0.0001412168,0.000121986144,0.00007864796],"category_scores_gemma":[0.000094913295,0.00014119527,0.00014025992,0.0013257514,0.00007730581,0.0000657822,0.00006457586,0.00025049833,0.000010528815],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8956898,0.006500866,0.0047725462,0.00016430976,0.0068526226,0.0010934791,0.00492347,0.0003580481,0.012987794,0.000011146378,0.00041384535,0.066232115],"study_design_scores_gemma":[0.82809067,0.008901156,0.118660346,0.001137101,0.0030412094,0.00011575596,0.00019473424,0.0015938275,0.03595115,0.000051271316,0.0016796206,0.0005831439],"about_ca_topic_score_codex":0.00027473085,"about_ca_topic_score_gemma":0.00015155031,"teacher_disagreement_score":0.1138878,"about_ca_system_score_codex":0.00004683486,"about_ca_system_score_gemma":0.00025037187,"threshold_uncertainty_score":0.5757776},"labels":[],"label_agreement":null},{"id":"W4405045387","doi":"10.1182/blood-2024-194258","title":"Opportunities for Standardizing Conversations about Curative Therapy for Sickle Cell Disease","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Disease; Intensive care medicine; Sickle cell anemia; Internal medicine","score_opus":0.2237897742533013,"score_gpt":0.42269314407069924,"score_spread":0.19890336981739795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405045387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8061821,0.11334486,0.04446359,0.009529465,0.0010706919,0.004149787,0.006380566,0.00039602976,0.014482899],"genre_scores_gemma":[0.9873045,0.0040133134,0.0035897484,0.00047788478,0.0004031703,0.00032768425,0.00031105996,0.00003696451,0.003535666],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99947673,0.000011947741,0.00014248265,0.0001371707,0.00010676567,0.000124905],"domain_scores_gemma":[0.9992364,0.00034160158,0.00003395617,0.000102993545,0.0001918202,0.000093199764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009272224,0.00009178078,0.00017798021,0.00006043639,0.000053307653,0.000019331766,0.00003430315,0.000028191671,0.00004146823],"category_scores_gemma":[0.000090321366,0.000074341144,0.00014810743,0.000052923806,0.000056082903,0.00007524178,0.0000063595503,0.000039329072,0.0000019671793],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010150126,0.0067470237,0.052641988,0.024694012,0.009994815,0.0007367591,0.17099418,0.000064122745,0.10210163,0.15519916,0.35730696,0.10936922],"study_design_scores_gemma":[0.0052313204,0.0007019976,0.00034404115,0.0010291362,0.000635875,0.0000011138338,0.008217874,0.0003695995,0.119808115,0.0016207369,0.8618608,0.00017940484],"about_ca_topic_score_codex":0.0000048368497,"about_ca_topic_score_gemma":0.000001407665,"teacher_disagreement_score":0.5045538,"about_ca_system_score_codex":0.000017311884,"about_ca_system_score_gemma":0.00029281265,"threshold_uncertainty_score":0.30315438},"labels":[],"label_agreement":null},{"id":"W4405045409","doi":"10.1182/blood-2024-202603","title":"Sickle Cell Disease-Related Worry and Associations with Healthcare Utilization in Youth with Sickle Cell Disease","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University","funders":"","keywords":"Disease; Medicine; Worry; Sickle cell anemia; Cell; Health care; Acute chest syndrome; Intensive care medicine; Internal medicine; Anxiety; Psychiatry; Genetics; Biology","score_opus":0.01145591129465589,"score_gpt":0.22978774999618512,"score_spread":0.21833183870152922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405045409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9790475,0.015450747,0.00003545213,0.0022246838,0.000065129265,0.0006631021,0.00018173532,0.00018714071,0.002144538],"genre_scores_gemma":[0.99734604,0.00067636743,0.000063721054,0.00021050601,0.00003315957,0.000021483658,0.0004918904,0.000050849187,0.0011059812],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988028,0.000052933687,0.00022591474,0.0003656986,0.00025950602,0.00029315831],"domain_scores_gemma":[0.9992297,0.00003661387,0.000055768967,0.0002053461,0.00006309288,0.00040946202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008645489,0.00018701173,0.00021345042,0.0001456918,0.00010153699,0.00004382795,0.000040165472,0.000107833985,0.000032548538],"category_scores_gemma":[0.000021402086,0.00013525829,0.00004367745,0.00061949104,0.00006730962,0.00009941636,0.000020951085,0.00031391805,0.000020421925],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008166808,0.0041181464,0.97417265,0.0027388404,0.00029762866,0.0020066942,0.01198267,0.00060165056,0.0002134739,0.0007143538,0.0006505683,0.0016866344],"study_design_scores_gemma":[0.035679273,0.0027127522,0.9104214,0.0067977468,0.008647999,0.000058649086,0.017238785,0.012540032,0.00082888827,0.0010216255,0.002125724,0.0019271419],"about_ca_topic_score_codex":0.00014285486,"about_ca_topic_score_gemma":0.00008723515,"teacher_disagreement_score":0.06375127,"about_ca_system_score_codex":0.000053520365,"about_ca_system_score_gemma":0.00043811326,"threshold_uncertainty_score":0.5515673},"labels":[],"label_agreement":null},{"id":"W4405045412","doi":"10.1182/blood-2024-198669","title":"Phase I Study of Belantamab Mafodotin in Combination with Standard of Care in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Dreamm-9 Updated Interim Analysis","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Tolerability; Medicine; Lenalidomide; Multiple myeloma; Interim analysis; Adverse effect; Clinical endpoint; Internal medicine; Bortezomib; Data monitoring committee; Oncology; Surgery; Urology; Clinical trial","score_opus":0.015078072237765125,"score_gpt":0.315646823370327,"score_spread":0.3005687511325619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405045412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99759805,0.0005687232,0.000059006135,0.00003988215,0.00001620592,0.0012135342,0.00035727813,0.00003600377,0.000111292924],"genre_scores_gemma":[0.9987849,0.00006994023,0.00021544273,0.000002829992,0.0000073352344,0.000082052924,0.0007936388,0.000022533959,0.000021339154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99834573,0.00011215772,0.00047975453,0.0003391808,0.0004693914,0.0002538061],"domain_scores_gemma":[0.9993027,0.00013141776,0.000068363326,0.0002672015,0.00013488345,0.00009547548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017615687,0.00018002243,0.0006833072,0.0011467001,0.00001743313,0.000014984043,0.00009560405,0.000063408384,0.000049968614],"category_scores_gemma":[0.00003984686,0.00013789149,0.00008963986,0.0017275296,0.00004059878,0.00008182939,0.000023004317,0.00018228384,0.0000022137112],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0096452525,0.018142799,0.94688535,0.00052503566,0.0020985967,0.0030888817,0.011472682,0.000056078417,0.0032293196,0.0000077531895,0.000007416293,0.0048408327],"study_design_scores_gemma":[0.23035222,0.028194722,0.6196019,0.0012295351,0.0034596084,0.00002796904,0.011569088,0.0032078768,0.10206154,0.000006939168,0.000022402128,0.0002661902],"about_ca_topic_score_codex":0.002737595,"about_ca_topic_score_gemma":0.017071715,"teacher_disagreement_score":0.32728344,"about_ca_system_score_codex":0.0001072192,"about_ca_system_score_gemma":0.00014644394,"threshold_uncertainty_score":0.9526417},"labels":[],"label_agreement":null},{"id":"W4405045423","doi":"10.1182/blood-2024-194827","title":"Phase 1 Results: First-in-Human Phase 1/2 Study of the Menin-MLL Inhibitor Enzomenib (DSP-5336) in Patients with Relapsed or Refractory Acute Leukemia","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Internal medicine; Phases of clinical research; Tolerability; Leukemia; Oncology; Refractory (planetary science); Acute leukemia; Gastroenterology; Adverse effect; Clinical trial; Biology","score_opus":0.008586955842984497,"score_gpt":0.2690134804382673,"score_spread":0.26042652459528276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405045423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99823374,0.00016630297,0.0000032142868,0.000055513105,0.00016338643,0.00091130676,0.00020552834,0.000014938778,0.0002460861],"genre_scores_gemma":[0.9985448,0.000019241832,0.00003835053,0.00004365744,0.000101359255,0.00008331642,0.00018379944,0.000030530584,0.000954922],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984345,0.000107675936,0.0004976989,0.00046428302,0.0002718389,0.00022403421],"domain_scores_gemma":[0.99920684,0.000020200567,0.00013933968,0.0005146342,0.000060518327,0.00005847556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021258321,0.00020461286,0.00021125897,0.00012120403,0.000067949964,0.000028601951,0.0002445994,0.00013212247,0.000015130118],"category_scores_gemma":[0.00009424713,0.0001311905,0.00005639554,0.00036637532,0.000064350716,0.000016563825,0.000114753035,0.00022415502,0.000002517014],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017188724,0.06933136,0.025044592,0.00028185153,0.0012739341,0.0004236937,0.005110715,0.000056487406,0.85714453,0.00004258021,0.018359866,0.0057416293],"study_design_scores_gemma":[0.12403861,0.023098808,0.004026523,0.0004811267,0.000225136,0.0000055267114,0.000643311,0.000038149614,0.8256279,0.00001189459,0.021251597,0.0005513942],"about_ca_topic_score_codex":0.00008781417,"about_ca_topic_score_gemma":0.0005805635,"teacher_disagreement_score":0.10684988,"about_ca_system_score_codex":0.000063324296,"about_ca_system_score_gemma":0.00017578178,"threshold_uncertainty_score":0.53497934},"labels":[],"label_agreement":null},{"id":"W4405045446","doi":"10.1182/blood-2024-200925","title":"Safety and Efficacy of Bromodomain and Extra-Terminal Inhibitor INCB057643 in Patients with Relapsed or Refractory Myelofibrosis and Other Advanced Myeloid Neoplasms: A Phase 1 Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Tolerability; Myelofibrosis; Internal medicine; Anemia; Phases of clinical research; Gastroenterology; Neutropenia; Ruxolitinib; Oncology; Adverse effect; Clinical trial; Chemotherapy; Bone marrow","score_opus":0.010356650701533321,"score_gpt":0.2722896965138336,"score_spread":0.2619330458123003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405045446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967864,0.0012537803,0.000005416543,0.00006425356,0.00003556656,0.0016293353,0.00009296371,0.000034361892,0.000097884935],"genre_scores_gemma":[0.99852234,0.00018977563,0.0009642324,0.000051841682,0.000034956323,0.00009506403,0.000016433636,0.000043870456,0.00008148366],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984481,0.000091554386,0.00041886148,0.0005478038,0.00027242224,0.00022129898],"domain_scores_gemma":[0.9991162,0.00036889373,0.000089603185,0.00020958408,0.000047188496,0.00016857366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016434942,0.00029071304,0.0005630908,0.00018818023,0.00006287448,0.0000351231,0.00003226927,0.000084203464,0.000041317006],"category_scores_gemma":[0.000070406204,0.0001894856,0.000029308592,0.00022662208,0.00013366962,0.0001373736,0.00006577948,0.00017614901,0.0000014354632],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014783088,0.014319678,0.90210575,0.00047252353,0.0005490449,0.00048930437,0.0051673055,6.6690114e-7,0.0016441328,0.000034177574,0.000016569304,0.060417764],"study_design_scores_gemma":[0.09615148,0.023253707,0.87345135,0.0016054257,0.0007570289,0.00009694243,0.00062574644,0.00002729874,0.003169693,0.000012250091,0.0005536835,0.0002953821],"about_ca_topic_score_codex":0.000035405777,"about_ca_topic_score_gemma":0.00010324209,"teacher_disagreement_score":0.08136839,"about_ca_system_score_codex":0.00003923384,"about_ca_system_score_gemma":0.000092110546,"threshold_uncertainty_score":0.77269983},"labels":[],"label_agreement":null},{"id":"W4405045474","doi":"10.1182/blood-2024-211916","title":"Simplifying Eligibility Criteria for Clinical Trials in Immune Thrombocytopenia Using the Platelet Count Variability Index","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McMaster University","funders":"","keywords":"Medicine; Immune thrombocytopenia; Platelet; Clinical trial; Internal medicine","score_opus":0.18763302183509606,"score_gpt":0.500654885514591,"score_spread":0.31302186367949497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405045474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99376315,0.0017369282,0.0010872602,0.0005727327,0.000502763,0.0019500275,0.000098721495,0.000064469445,0.0002239754],"genre_scores_gemma":[0.99844444,0.0001812039,0.000795294,0.00019761802,0.00021136811,0.00008032957,0.000044325523,0.000026951886,0.000018467548],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99704313,0.00063068926,0.0013059572,0.00050977914,0.00018757905,0.00032286425],"domain_scores_gemma":[0.99586225,0.0033631714,0.00012643232,0.00050513446,0.000064438005,0.00007859093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011832209,0.00020141838,0.0012744603,0.00006020941,0.0001006786,0.000099244484,0.00011998703,0.00020567552,0.000098717246],"category_scores_gemma":[0.0031715466,0.00012374471,0.00038704483,0.00021864424,0.000097289114,0.00010095561,0.000065121785,0.00032153892,0.0000089061905],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008149763,0.020917606,0.831411,0.004286959,0.0077582397,0.003265841,0.0032258101,0.000049995357,0.046627942,0.0022409803,0.0026555543,0.06941033],"study_design_scores_gemma":[0.08830675,0.0026062597,0.7335512,0.0025342063,0.0059708524,0.001388656,0.0008660598,0.05881,0.017870774,0.057253763,0.029209748,0.0016317416],"about_ca_topic_score_codex":0.00020011695,"about_ca_topic_score_gemma":0.00003145805,"teacher_disagreement_score":0.097859785,"about_ca_system_score_codex":0.00008485094,"about_ca_system_score_gemma":0.00029794112,"threshold_uncertainty_score":0.5046163},"labels":[],"label_agreement":null},{"id":"W4405045589","doi":"10.1182/blood-2024-198728","title":"BGB-11417-203, an Ongoing, Phase 2 Study of Sonrotoclax (BGB-11417), a Next-Generation BCL2 Inhibitor, in Patients With Waldenström Macroglobulinemia","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Waldenstrom macroglobulinemia; Macroglobulinemia; Ibrutinib; Medicine; Immunology; Leukemia; Multiple myeloma; Lymphoma; Chronic lymphocytic leukemia","score_opus":0.03512004748815195,"score_gpt":0.324881224338984,"score_spread":0.289761176850832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405045589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99511194,0.0003092897,0.0000148888785,0.00006792317,0.0001802272,0.003842365,0.000037402395,0.00013370941,0.00030227524],"genre_scores_gemma":[0.9979324,0.000016074806,0.00044062914,0.00006312383,0.00057035085,0.00031707648,0.00023096918,0.00009387168,0.0003355162],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9964092,0.00016368977,0.00074740703,0.0008143001,0.00126029,0.00060512155],"domain_scores_gemma":[0.9983988,0.000081687016,0.00011896521,0.0008087115,0.0002743659,0.00031751135],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004558145,0.00036219612,0.0005781609,0.00044041392,0.000077419616,0.00012220876,0.00023355456,0.00019092114,0.00017436076],"category_scores_gemma":[0.00013344972,0.0002913569,0.00008624311,0.000861372,0.000114650764,0.00036360938,0.0001331639,0.00048876426,0.000047713977],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0153517565,0.24076137,0.37336984,0.006584115,0.004409096,0.014954864,0.044752516,0.0006696582,0.11976766,0.0003976966,0.009743113,0.1692383],"study_design_scores_gemma":[0.74358684,0.055849507,0.025141425,0.003475968,0.0021122575,0.0005378923,0.00405575,0.059227135,0.101125434,0.000059023958,0.0029550549,0.0018737278],"about_ca_topic_score_codex":0.0014776011,"about_ca_topic_score_gemma":0.0011862566,"teacher_disagreement_score":0.72823507,"about_ca_system_score_codex":0.0026188246,"about_ca_system_score_gemma":0.0042665387,"threshold_uncertainty_score":0.99995387},"labels":[],"label_agreement":null},{"id":"W4405045637","doi":"10.1182/blood-2024-206364","title":"Analysis of the Hematology Health Equity Literature: Trends By Topic and Disparity, across Journals, and over Time","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Hamilton Health Sciences","funders":"","keywords":"Medicine; Impact factor; Equity (law); Citation; Publication; MEDLINE; Family medicine; Internal medicine; Library science; Political science; Computer science","score_opus":0.021726864373677053,"score_gpt":0.37974116699492555,"score_spread":0.3580143026212485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405045637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8999585,0.08408186,0.000013833998,0.015325561,0.00009102339,0.00007334435,0.00019204705,0.000024689021,0.00023915847],"genre_scores_gemma":[0.9966832,0.00091301656,0.000044606335,0.0014690383,0.00008992631,0.0000023831751,0.000028176597,0.000009700181,0.00075996225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882907,0.00011431307,0.00033357015,0.00024869337,0.00026344424,0.00021093676],"domain_scores_gemma":[0.9993552,0.00011041262,0.000098876146,0.00027516624,0.000024408655,0.00013594549],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006062088,0.00011356779,0.00053624157,0.00010936568,0.000076782846,0.000080442915,0.00008161627,0.000086028274,0.000085509215],"category_scores_gemma":[0.000056721972,0.00007642342,0.00013774358,0.00078634045,0.00011232199,0.000060398783,0.00018796923,0.00025317355,6.776832e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000082547915,0.001032656,0.9027525,0.0026755824,0.0071894694,0.000057446006,0.02085374,7.710766e-7,0.0015675329,0.0014385513,0.028261058,0.034088146],"study_design_scores_gemma":[0.0015951719,0.0001904842,0.9893669,0.00076710945,0.0018125819,0.00026204527,0.00007727786,0.0002258107,0.0006837115,0.00031125927,0.004569697,0.00013796505],"about_ca_topic_score_codex":0.00022248492,"about_ca_topic_score_gemma":0.00043350054,"teacher_disagreement_score":0.096724704,"about_ca_system_score_codex":0.000017813898,"about_ca_system_score_gemma":0.00006351196,"threshold_uncertainty_score":0.31164566},"labels":[],"label_agreement":null},{"id":"W4405045661","doi":"10.1182/blood-2024-198896","title":"Distinguishing Germline from Acquired Pathogenic <i>CSF3R</i> Variants: Key Diagnostic Features and Clinical Implications","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Charles-Le Moyne; Centre Hospitalier Universitaire de Sherbrooke; Hôpital Maisonneuve-Rosemont; MPB Technologies & Communications (Canada); Université de Montréal","funders":"","keywords":"Germline; Biology; Medicine; Genetics; Immunology; Gene","score_opus":0.018047742693348728,"score_gpt":0.30267593931640363,"score_spread":0.2846281966230549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405045661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.963585,0.025638461,0.00015043089,0.006856327,0.00039036648,0.00032223843,0.0002446738,0.0002293494,0.0025831566],"genre_scores_gemma":[0.99469554,0.0015869746,0.0017154901,0.000720309,0.0005692053,0.000028754288,0.00020646646,0.00003792171,0.00043934197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871,0.000050296876,0.00038681235,0.00048062328,0.00014734436,0.0002249752],"domain_scores_gemma":[0.9980809,0.0012549149,0.00004750957,0.00037788288,0.000047031554,0.00019176402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022807639,0.00016519979,0.00033818607,0.00005339116,0.00009883574,0.00012566298,0.000101346246,0.00014400085,0.00007438943],"category_scores_gemma":[0.0018165414,0.00013451185,0.00013999172,0.0001738192,0.00010090106,0.000075863056,0.000083394785,0.00020028783,0.00003654038],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000101159974,0.0049360986,0.7984291,0.00063692924,0.0027350734,0.0026594852,0.0020589055,8.241484e-7,0.016112542,0.013688044,0.035204522,0.12343734],"study_design_scores_gemma":[0.0017936414,0.00020966046,0.9847716,0.00044937345,0.0012907259,0.0004341434,0.000056115143,0.0000734241,0.000043287637,0.005771299,0.004903257,0.0002034601],"about_ca_topic_score_codex":0.00009585725,"about_ca_topic_score_gemma":0.000038438207,"teacher_disagreement_score":0.18634254,"about_ca_system_score_codex":0.000008802175,"about_ca_system_score_gemma":0.000088025794,"threshold_uncertainty_score":0.5485234},"labels":[],"label_agreement":null},{"id":"W4405045778","doi":"10.1182/blood-2024-201624","title":"Safety and Efficacy in Pediatric Patients with Relapsed/Refractory Classic Hodgkin Lymphoma Enrolled on an Intergroup Randomized Phase II Study of the Combinations of Ipilimumab, Nivolumab and Brentuximab Vedotin (E4412)","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Brentuximab vedotin; Medicine; Nivolumab; Internal medicine; Oncology; Ipilimumab; Refractory (planetary science); Hodgkin lymphoma; Randomized controlled trial; Adverse effect; Phases of clinical research; Lymphoma; Clinical trial; Cancer; Immunotherapy","score_opus":0.006462541439846968,"score_gpt":0.2460965308151292,"score_spread":0.2396339893752822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405045778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964099,0.0009922658,0.0000013693434,0.00008136212,0.00010279049,0.0021781637,0.000029354936,0.000024944891,0.00017982801],"genre_scores_gemma":[0.9995247,0.00023204563,0.000018346254,0.000017379254,0.000022498007,0.00009283991,0.000026923017,0.000024620647,0.000040617542],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982679,0.00034335346,0.0005391427,0.00035714317,0.00034049415,0.00015197521],"domain_scores_gemma":[0.9987544,0.00057324953,0.00018325388,0.00033417062,0.00007214912,0.00008278641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033066518,0.00021514502,0.00073045405,0.0002635903,0.00009133775,0.000017468616,0.00007844232,0.000064118765,0.00000994908],"category_scores_gemma":[0.000127906,0.00012540584,0.0000895305,0.00035952323,0.00012092852,0.00008189396,0.00008007271,0.00009951272,7.145435e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.093497254,0.42843166,0.40754992,0.00031011744,0.0013863258,0.000081840015,0.009703205,0.000005268422,0.000068137604,0.00036362463,0.000042391566,0.05856028],"study_design_scores_gemma":[0.55926573,0.009728337,0.42917135,0.00020317512,0.0011585369,0.0000040627924,0.00017049476,0.000093702736,0.0001071289,0.000011393733,0.000009370717,0.00007670016],"about_ca_topic_score_codex":0.00008854607,"about_ca_topic_score_gemma":0.000080367536,"teacher_disagreement_score":0.4657685,"about_ca_system_score_codex":0.000076063174,"about_ca_system_score_gemma":0.00011433635,"threshold_uncertainty_score":0.51139015},"labels":[],"label_agreement":null},{"id":"W4405045812","doi":"10.1182/blood-2024-203724","title":"A Children's Oncology Group Clinical Trial of Long-Term Outcomes in Survivors of Down Syndrome-Associated Acute Leukemia (ALTE22C1): <i>Clinical Trial in Progress</i>","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; BC Children's Hospital; Children's Hospital of Eastern Ontario; University of British Columbia; Hospital for Sick Children","funders":"","keywords":"Medicine; Internal medicine; Clinical trial; Oncology; Pediatrics; Leukemia","score_opus":0.06197152321591817,"score_gpt":0.4241038063877069,"score_spread":0.3621322831717887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405045812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898956,0.00074623467,0.000003577861,0.0016113396,0.0034462775,0.0038548668,0.000162931,0.00014461274,0.00013457189],"genre_scores_gemma":[0.99750286,0.00054845656,0.00025022004,0.00030266005,0.0008742832,0.00015909024,0.00020058901,0.00008007492,0.00008177933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98958826,0.0021920064,0.0054290635,0.0010662322,0.0010303579,0.00069408753],"domain_scores_gemma":[0.99404407,0.00361535,0.001048336,0.00085709523,0.00011217427,0.00032298188],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.009160164,0.000473252,0.0038224258,0.0005492916,0.000027609842,0.000026836937,0.00051694165,0.0010848673,0.000060361217],"category_scores_gemma":[0.002981561,0.00041827778,0.0012252033,0.001057676,0.0006793433,0.00015230008,0.00026479774,0.0017136248,0.000017721644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10433707,0.019172734,0.8678715,0.00028421122,0.0024892392,0.0012028121,0.00050489354,4.0557427e-7,0.000011508555,0.00005727909,0.00018011915,0.00388819],"study_design_scores_gemma":[0.379545,0.013954422,0.6041774,0.0008242359,0.0010033188,0.00008320295,0.00003147953,0.0000060001685,0.000041380164,0.0000554375,0.000032442855,0.0002456781],"about_ca_topic_score_codex":0.001390342,"about_ca_topic_score_gemma":0.0061613633,"teacher_disagreement_score":0.27520794,"about_ca_system_score_codex":0.00028898235,"about_ca_system_score_gemma":0.0019822868,"threshold_uncertainty_score":0.9998269},"labels":[],"label_agreement":null},{"id":"W4405045833","doi":"10.1182/blood-2024-200966","title":"POIESIS: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Global Phase 3 Study of Navtemadlin As Add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients with Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Daiichi Sankyo Europe; Genentech; Swedish Orphan Biovitrum; Servier; Astellas Pharma; Galecto; Sierra Oncology; CTI Biopharma; Incyte; Astex Pharmaceuticals; Jazz Pharmaceuticals; MorphoSys; Celgene; Amgen; Ariad Pharmaceuticals; Alexion Pharmaceuticals; Gilead Sciences; Constellation Pharmaceuticals; Bristol-Myers Squibb","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Placebo; Internal medicine; Phases of clinical research; Double blind; Tofacitinib; Clinical trial; Oncology; Bone marrow; Pathology","score_opus":0.017571251566661904,"score_gpt":0.32326592481535626,"score_spread":0.30569467324869437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405045833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9760438,0.00028939816,0.000010430657,0.0010928594,0.0001772262,0.020648403,0.000460293,0.00010583681,0.0011717048],"genre_scores_gemma":[0.9906962,0.000014470494,0.0005785507,0.00050025515,0.00019000747,0.007463613,0.00008342513,0.00008877693,0.00038468567],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99431944,0.00084331975,0.0015209062,0.0012431614,0.0012461073,0.00082703854],"domain_scores_gemma":[0.9962554,0.0016069186,0.0002518101,0.0006988781,0.00046884926,0.00071814156],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001334931,0.0007981939,0.0025470355,0.0007453613,0.000111948975,0.00014941947,0.00020705326,0.00019423568,0.00015341122],"category_scores_gemma":[0.0010442714,0.00055956526,0.00041725233,0.0008350417,0.00009302094,0.00015567582,0.00014754642,0.00034096674,0.00017351542],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9110835,0.03264518,0.04581409,0.00017439044,0.0020640881,0.000706,0.0063258354,0.00006213118,0.00009743978,0.00016505549,0.0002846039,0.0005776946],"study_design_scores_gemma":[0.94910866,0.02548262,0.011615344,0.0030709978,0.0021135947,0.000025542051,0.002208235,0.00011772951,0.005569899,0.000007991296,0.00019229083,0.00048709975],"about_ca_topic_score_codex":0.00057283195,"about_ca_topic_score_gemma":0.00041627596,"teacher_disagreement_score":0.038025163,"about_ca_system_score_codex":0.00035569363,"about_ca_system_score_gemma":0.0003922314,"threshold_uncertainty_score":0.9996856},"labels":[],"label_agreement":null},{"id":"W4405045857","doi":"10.1182/blood-2024-210392","title":"Pre-Hematopoietic Cell Transplantation (HCT) Frailty Is Associated with Lower Cognitive Function and Health-Related Quality of Life (HRQOL) in Older Adults Undergoing HCT","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Frailty in Older Adults","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Quality of life (healthcare); Gerontology; Transplantation; Cognition; Psychological intervention; Cohort study; Cohort; Physical therapy; Internal medicine; Psychiatry","score_opus":0.022169558255276636,"score_gpt":0.28132133643734797,"score_spread":0.25915177818207136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405045857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942071,0.0026360445,0.00036038543,0.0008687907,0.00012052927,0.0009953998,0.00008698038,0.00013096574,0.0005938453],"genre_scores_gemma":[0.99872804,0.00021030997,0.00005424302,0.0003330137,0.000024461964,0.000035251353,0.00021613718,0.00004168304,0.0003568652],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99802196,0.00015721029,0.000695295,0.00044945913,0.00039653023,0.0002795463],"domain_scores_gemma":[0.99891007,0.00044867583,0.00020398486,0.00015227907,0.00013236467,0.00015262523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047218212,0.00021742571,0.0005039609,0.00017418829,0.00004579556,0.000021236247,0.00003733028,0.00019843849,0.000121358586],"category_scores_gemma":[0.00016915526,0.00019228198,0.00006825475,0.000478205,0.000079628044,0.00015286972,0.000011662287,0.00035471836,0.000011253224],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076770815,0.00873478,0.85898125,0.02881815,0.0025153377,0.00043358046,0.08555501,0.00003468296,0.0021666782,0.00018427486,0.0010386343,0.0038605256],"study_design_scores_gemma":[0.021123823,0.0014178576,0.9616845,0.010985086,0.000626562,0.00005135381,0.0013476334,0.0002496725,0.0021201398,0.00014603703,0.0000022415531,0.0002450797],"about_ca_topic_score_codex":0.0007602126,"about_ca_topic_score_gemma":0.0015742911,"teacher_disagreement_score":0.10270325,"about_ca_system_score_codex":0.000063214415,"about_ca_system_score_gemma":0.0003469351,"threshold_uncertainty_score":0.78410316},"labels":[],"label_agreement":null},{"id":"W4405045956","doi":"10.1182/blood-2024-209001","title":"Burden of Anemia in Myelofibrosis Patients in Japan, South Korea, Taiwan, and Canada: A Real-World Survey and Multinational Database Analysis","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Myelofibrosis; Multinational corporation; Medicine; Anemia; Database; Political science; Internal medicine; Bone marrow; Computer science","score_opus":0.013716439286719367,"score_gpt":0.25886145044872333,"score_spread":0.24514501116200396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405045956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99800736,0.00037458376,8.849492e-7,0.00019696227,0.000018969235,0.0002954533,0.0009449647,0.0000071739114,0.00015366316],"genre_scores_gemma":[0.9984566,0.00014141948,0.00024608927,0.00002881621,0.000018846431,0.000043935153,0.000942303,0.00001119528,0.00011082092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988102,0.00007562268,0.00032922594,0.00035059013,0.00027280097,0.00016159307],"domain_scores_gemma":[0.99938893,0.00021762551,0.00005490691,0.00014571981,0.00008939916,0.0001034009],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023249301,0.00014601847,0.0003947161,0.0004764074,0.00002226255,0.000017011029,0.00003116565,0.000038850794,0.000040912477],"category_scores_gemma":[0.0001390348,0.00012135254,0.000030127061,0.0007266259,0.00004093403,0.000054245862,0.000048452275,0.00010085893,5.536473e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054926222,0.0003393741,0.9975625,0.00013734118,0.0003133608,0.000060890925,0.0007506147,0.000009926372,0.000056504672,0.000055647193,0.00009732275,0.00056155457],"study_design_scores_gemma":[0.002832367,0.000098882876,0.9951528,0.00017854721,0.00045399216,0.0000018129557,0.00013161667,0.0005420434,0.00047795003,0.00000399838,0.000028047169,0.00009795747],"about_ca_topic_score_codex":0.72600996,"about_ca_topic_score_gemma":0.9538131,"teacher_disagreement_score":0.22780313,"about_ca_system_score_codex":0.000095239106,"about_ca_system_score_gemma":0.00028121835,"threshold_uncertainty_score":0.4948613},"labels":[],"label_agreement":null},{"id":"W4405045962","doi":"10.1182/blood-2024-197898","title":"Outcomes of Patients with <i>IDH1/2</i> Mutated Accelerated/Blast-Phase Myeloproliferative Neoplasms in the Era of IDH Inhibitors","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Hematologic Neoplasms; Medicine; IDH1; Cancer research; Internal medicine; Oncology; Mutation; Genetics; Biology; Gene; Cancer","score_opus":0.012591655478528673,"score_gpt":0.2781960324993265,"score_spread":0.2656043770207978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405045962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99632937,0.0004979896,0.000007568029,0.0008620749,0.000104135965,0.0014026796,0.00019336026,0.000042207972,0.00056061766],"genre_scores_gemma":[0.99886024,0.00007645791,0.00025999223,0.0002969717,0.000043961216,0.00021288818,0.00017555188,0.000036973557,0.00003696793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99799305,0.000117638665,0.0006309984,0.0003863231,0.0005847541,0.00028722288],"domain_scores_gemma":[0.9987893,0.0003696051,0.00015266717,0.00031975703,0.0002779449,0.000090742615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018917394,0.00033091576,0.00068492006,0.00018740355,0.000050696308,0.000036346897,0.000119090015,0.000101437305,0.00009059235],"category_scores_gemma":[0.000087568325,0.0001743353,0.00013264696,0.00077868137,0.00013747414,0.00014115579,0.00003434472,0.00035560204,0.000013945176],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057540735,0.008846758,0.9811382,0.00023283785,0.001057523,0.0002562312,0.004205795,0.000018600958,0.00075786427,0.000526599,0.00034782942,0.0020363224],"study_design_scores_gemma":[0.024974596,0.005446034,0.7558708,0.00095410406,0.0009600857,0.0000337868,0.0005582124,0.00011019516,0.21039094,0.00007618646,0.0003208775,0.00030416483],"about_ca_topic_score_codex":0.0000758546,"about_ca_topic_score_gemma":0.000096745185,"teacher_disagreement_score":0.22526741,"about_ca_system_score_codex":0.00003754292,"about_ca_system_score_gemma":0.0002434621,"threshold_uncertainty_score":0.7109187},"labels":[],"label_agreement":null},{"id":"W4405045978","doi":"10.1182/blood-2024-199776","title":"BK Virus Reactivation and Disease after Allogeneic Hematopoietic-Cell Transplantation: A Natural History Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; BK virus; Hemorrhagic cystitis; Transplantation; Internal medicine; Dysuria; Hematopoietic stem cell transplantation; Immunology; Viral load; Gastroenterology; Urinary system; Virus; Kidney transplantation","score_opus":0.008333446259593844,"score_gpt":0.23272115615583383,"score_spread":0.22438770989624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405045978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9281422,0.0705006,0.0000060614725,0.00018468518,0.00021722382,0.00032530224,0.000021114687,0.00010332253,0.00049950066],"genre_scores_gemma":[0.9976781,0.00053967617,0.00002445363,0.00023702392,0.00011415003,0.00005997302,0.000034236713,0.000020583928,0.0012917817],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99931157,0.000025365227,0.00013532524,0.00024063382,0.00016901986,0.0001181152],"domain_scores_gemma":[0.9995854,0.000028846209,0.000017275343,0.00013373118,0.000017777807,0.0002169973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000041603842,0.000116901654,0.00011947865,0.0000849691,0.000028706634,0.000016616794,0.000024476743,0.000043288444,0.00010927877],"category_scores_gemma":[0.000011547581,0.00008977051,0.00006224533,0.00006688108,0.000036093134,0.00008222013,0.0000089192845,0.00012903754,0.000029882549],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010206467,0.03384656,0.44935715,0.010574234,0.0034878727,0.061768338,0.031070793,0.0000059196695,0.37755454,0.0007404772,0.011491916,0.009895735],"study_design_scores_gemma":[0.011610373,0.0007999446,0.94859344,0.0009984918,0.0112101715,0.0005512404,0.0005452459,0.00012355215,0.011527577,0.0002612185,0.0130478265,0.00073089544],"about_ca_topic_score_codex":0.000025373238,"about_ca_topic_score_gemma":0.000005293513,"teacher_disagreement_score":0.49923632,"about_ca_system_score_codex":0.0000352668,"about_ca_system_score_gemma":0.00014513542,"threshold_uncertainty_score":0.36607352},"labels":[],"label_agreement":null},{"id":"W4405046103","doi":"10.1182/blood-2024-194116","title":"New Insights in Current Practice in the Management of DNA Viruses in Children Following Allogeneic HSCT at EBMT Centers","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"","keywords":"Medicine; Hematopoietic stem cell transplantation; Pediatrics; Internal medicine; Transplantation","score_opus":0.027692495962271423,"score_gpt":0.34105123629391737,"score_spread":0.31335874033164596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405046103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9738063,0.02139689,0.0000050981366,0.000576293,0.00010502816,0.0007818269,0.0000040247087,0.000016365735,0.0033081733],"genre_scores_gemma":[0.99649566,0.0028847884,0.00015328499,0.00020404425,0.000070735405,0.0000378911,0.000014810606,0.000020392672,0.00011840363],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984253,0.000114723545,0.0003570326,0.00030511606,0.0004951607,0.0003026449],"domain_scores_gemma":[0.9994643,0.00013721625,0.000034730405,0.000284883,0.00001143553,0.00006748597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005043627,0.00013864048,0.00024255674,0.00041461858,0.000023204651,0.000034472738,0.00019545891,0.000051906198,0.00004138814],"category_scores_gemma":[0.00004112054,0.000098041,0.000107809145,0.000778079,0.000021188083,0.000130294,0.00014491148,0.00035338962,0.000049212205],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076526625,0.005248814,0.8531138,0.0011032383,0.0014758988,0.004540679,0.01229508,0.000038976817,0.011397409,0.0022626065,0.0013755213,0.10638274],"study_design_scores_gemma":[0.011294594,0.00032178132,0.8298638,0.0032265114,0.0005557313,0.000110695255,0.0010633843,0.000056324312,0.006769159,0.00020442191,0.14619465,0.00033896475],"about_ca_topic_score_codex":0.001245,"about_ca_topic_score_gemma":0.0012163062,"teacher_disagreement_score":0.14481913,"about_ca_system_score_codex":0.000121274534,"about_ca_system_score_gemma":0.00010571349,"threshold_uncertainty_score":0.3997996},"labels":[],"label_agreement":null},{"id":"W4405046163","doi":"10.1182/blood-2024-206349","title":"Medical and Surgical Management for Heavy Menstrual Bleeding in Women with Ehlers-Danlos Syndrome","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Connective tissue disorders research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Bleeding diathesis; Von Willebrand disease; Cohort; Menstrual bleeding; Ehlers–Danlos syndrome; Retrospective cohort study; Pediatrics; Surgery; Obstetrics; Internal medicine; Von Willebrand factor","score_opus":0.009455641493836844,"score_gpt":0.2791767968808926,"score_spread":0.26972115538705577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405046163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962536,0.0020333044,0.00012195184,0.00039135883,0.000026041587,0.00030366378,0.000008558105,0.000012233911,0.0008492889],"genre_scores_gemma":[0.9989041,0.0002913494,0.0001787113,0.000027062813,0.00004763122,0.00018975999,0.000013299694,0.000017976578,0.00033008552],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990697,0.000023264283,0.00009705979,0.0003344558,0.00018866842,0.00028688795],"domain_scores_gemma":[0.99974304,0.00003014335,0.0000073332794,0.00010098906,0.000017441773,0.00010106705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028860607,0.000092897615,0.00010893857,0.00007260889,0.000029378582,0.000027828117,0.00009185318,0.00007954027,0.000045439392],"category_scores_gemma":[0.000025295989,0.00007912036,0.000018579283,0.00011015755,0.00006993197,0.0000028722734,0.000118275435,0.00008500552,0.0000026889243],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016241916,0.009376044,0.12188142,0.017351098,0.01519825,0.06254128,0.007103938,0.00008142995,0.13103391,0.030971687,0.0077173575,0.5805017],"study_design_scores_gemma":[0.12807098,0.032672595,0.14910647,0.005487915,0.0008724164,0.023633895,0.019458495,0.0055962126,0.12861331,0.0062000584,0.49357712,0.0067105507],"about_ca_topic_score_codex":0.00000846584,"about_ca_topic_score_gemma":0.000029038387,"teacher_disagreement_score":0.57379115,"about_ca_system_score_codex":0.000014205554,"about_ca_system_score_gemma":0.00004724121,"threshold_uncertainty_score":0.32264343},"labels":[],"label_agreement":null},{"id":"W4405046175","doi":"10.1182/blood-2024-210986","title":"Isomarker: An Explainable Machine Learning Framework for Identification of Cell State Markers in Acute Myeloid Leukemia","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Digital Imaging for Blood Diseases","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Myeloid leukemia; Identification (biology); Myeloid; Computational biology; Leukemia; Medicine; Computer science; Immunology; Cancer research; Biology","score_opus":0.008170937574935347,"score_gpt":0.24612124653861223,"score_spread":0.2379503089636769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405046175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7492288,0.0016071757,0.24721254,0.000115380826,0.0002883411,0.000393386,0.00007983535,0.00037822718,0.00069634547],"genre_scores_gemma":[0.9651727,0.000058011196,0.033665657,0.00003503471,0.00002015576,0.000062873674,0.000041344232,0.000028929173,0.0009152951],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.998598,0.000041633855,0.00035693252,0.00047343,0.00021966554,0.0003103486],"domain_scores_gemma":[0.9991186,0.00018726793,0.00010477665,0.0004356296,0.000058127313,0.00009559836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038420016,0.00014999189,0.0001715868,0.00023780114,0.000057025416,0.0004916417,0.000607664,0.00004375977,0.0000044119224],"category_scores_gemma":[0.00010710777,0.00015755558,0.00009120771,0.0005516125,0.00003897045,0.0014908642,0.0001469964,0.00015679911,0.000016176462],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082115654,0.009998215,0.05304966,0.008338889,0.0018274732,0.0015412599,0.017334323,0.019180574,0.21772325,0.21071811,0.0026088103,0.45685828],"study_design_scores_gemma":[0.0025347108,0.0006775246,0.0099940235,0.0005869671,0.00028154466,0.00004050757,0.00027604055,0.586784,0.26882392,0.12612744,0.0029194609,0.0009538182],"about_ca_topic_score_codex":0.000044527653,"about_ca_topic_score_gemma":0.0000050854123,"teacher_disagreement_score":0.56760347,"about_ca_system_score_codex":0.000051084495,"about_ca_system_score_gemma":0.00016137768,"threshold_uncertainty_score":0.642493},"labels":[],"label_agreement":null},{"id":"W4405046210","doi":"10.1182/blood-2024-200374","title":"Fat Mass Obesity-Associated (FTO) Driven Gene Regulatory Networks Control Hematopoietic Stem Cell Expansion and Homing","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Ottawa","funders":"","keywords":"Stem cell; Homing (biology); Haematopoiesis; Hematopoietic stem cell; Biology; Gene; Cell biology; Genetics","score_opus":0.0059579012649344275,"score_gpt":0.18948898040338327,"score_spread":0.18353107913844885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405046210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9487552,0.048442345,0.0016818908,0.000053545144,0.0005231407,0.00024058453,0.000013293455,0.0001669362,0.00012307499],"genre_scores_gemma":[0.9983976,0.00030140442,0.000025784995,0.00004767063,0.00005774829,0.000018058854,0.00007299496,0.00003076044,0.0010479861],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987854,0.00020156491,0.00029177786,0.00034503284,0.000044211465,0.00033206583],"domain_scores_gemma":[0.9994847,0.0001290063,0.00009083801,0.00023064297,0.000036461275,0.000028342645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021731007,0.00019785728,0.00033173562,0.00008580158,0.00020298445,0.000053069165,0.00010479508,0.0003493436,0.00004578218],"category_scores_gemma":[0.00000569727,0.00017979923,0.00010433108,0.000120878925,0.00008212081,0.00012255686,0.000053287233,0.00024919244,0.00006231817],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021832851,0.0001680669,0.0024984116,0.000041025593,0.0002477966,0.000014553745,0.00034124564,0.0000844932,0.99413425,0.00016023467,0.00039209847,0.0018960148],"study_design_scores_gemma":[0.0064902767,0.0002556912,0.043781508,0.0004432618,0.00076327653,0.000116663294,0.0002581193,0.0037760339,0.9425791,0.00019909922,0.00079546776,0.0005414837],"about_ca_topic_score_codex":0.000008900061,"about_ca_topic_score_gemma":0.0000023330024,"teacher_disagreement_score":0.05155511,"about_ca_system_score_codex":0.000037449736,"about_ca_system_score_gemma":0.000026268019,"threshold_uncertainty_score":0.73319995},"labels":[],"label_agreement":null},{"id":"W4405046305","doi":"10.1182/blood-2024-200196","title":"Large Scale Analysis of the Real-World Association between Fetal Hemoglobin and Vaso-Occlusive Crises in Sickle Cell Disease","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Vaso-occlusive crisis; Fetal hemoglobin; Medicine; Sickle cell anemia; Disease; Internal medicine; Hemoglobin; Fetus; Pregnancy; Biology; Genetics","score_opus":0.0061549597131807495,"score_gpt":0.24837773844328676,"score_spread":0.242222778730106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405046305","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926127,0.0019396072,0.0000067835667,0.0011837842,0.000054136843,0.0002375011,0.00015207616,0.000032860604,0.003780536],"genre_scores_gemma":[0.9974036,0.00038511306,0.000020747866,0.00008530983,0.000048639307,0.0000060785123,0.000057727084,0.000012992693,0.00197976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990145,0.000062072235,0.00024878618,0.00021908613,0.00025106833,0.00020446669],"domain_scores_gemma":[0.99947643,0.00011770947,0.00007202224,0.00019019084,0.000040562725,0.00010306698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002267011,0.00010713903,0.000310693,0.00024951497,0.000055788554,0.000018748007,0.000058641675,0.0000863879,0.000046258334],"category_scores_gemma":[0.00006561372,0.000074204,0.0001962591,0.0013613971,0.00003463009,0.000046150475,0.000072077346,0.00019906607,0.0000057099646],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012341909,0.0003237281,0.9970187,0.00016393399,0.00067719124,0.000025785592,0.0008752916,0.00002044009,0.00033225917,0.000047798967,0.0003712057,0.00013134495],"study_design_scores_gemma":[0.0016367956,0.000033993187,0.983649,0.00016728525,0.010013252,4.945873e-7,0.00055367977,0.0011924679,0.0015574334,0.00013586823,0.00095088425,0.000108822576],"about_ca_topic_score_codex":0.00024878437,"about_ca_topic_score_gemma":0.00048388,"teacher_disagreement_score":0.013369655,"about_ca_system_score_codex":0.00006444714,"about_ca_system_score_gemma":0.000100200254,"threshold_uncertainty_score":0.30259514},"labels":[],"label_agreement":null},{"id":"W4405046335","doi":"10.1182/blood-2024-209372","title":"Machine Learning Classification of Spatial Patterns of Malignant Cells Reveals Implications in Prognosis and Tumor Microenvironment Composition in Lymphoma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"AI in cancer detection","field":"Computer Science","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"Tumor microenvironment; Lymphoma; Cancer research; Medicine; Pathology; Biology; Tumor cells","score_opus":0.01148385358076656,"score_gpt":0.2232925651426285,"score_spread":0.21180871156186193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405046335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9577214,0.00032230935,0.041334566,0.00028400452,0.00004522444,0.00023786536,0.000014774112,0.000022243423,0.000017612196],"genre_scores_gemma":[0.9975607,0.0001440396,0.0021946437,0.00000899071,0.000011383429,0.000061982835,0.0000063667117,0.0000065368954,0.0000053894164],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991827,0.000073860596,0.00029686105,0.00025135724,0.000100503166,0.00009474198],"domain_scores_gemma":[0.9996593,0.000046493897,0.00010822351,0.00015503216,0.000011906308,0.000019071773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018185773,0.00006809053,0.000113370275,0.00016291575,0.000018265839,0.00002143947,0.00012531932,0.000028199338,0.000002568972],"category_scores_gemma":[0.0000031749494,0.00007040405,0.00002120521,0.00018089215,0.000021545906,0.000115786504,0.00006908811,0.00005870105,0.0000014261368],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000415601,0.0002487694,0.30879548,0.00014599792,0.000007720697,0.0000033198742,0.00039230654,0.000102847946,0.66568094,0.00048664224,0.0000010186616,0.024130777],"study_design_scores_gemma":[0.00033251807,0.00009187982,0.7273615,0.00020802305,0.0000105945655,0.000013095173,0.000012417018,0.01849237,0.2532436,0.00015074128,0.000025211213,0.00005805425],"about_ca_topic_score_codex":0.00041004352,"about_ca_topic_score_gemma":0.00008040656,"teacher_disagreement_score":0.41856605,"about_ca_system_score_codex":0.00006786919,"about_ca_system_score_gemma":0.000019837491,"threshold_uncertainty_score":0.2870994},"labels":[],"label_agreement":null},{"id":"W4405046397","doi":"10.1182/blood-2024-193453","title":"Use of Fidanacogene Elaparvovec, a Gene Therapy Vector, to Deliver a Stable, Fully Functional Human Factor IX Transgene for the Treatment of Hemophilia B: A Combined Analysis of Safety","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pfizer (Canada); University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Adverse effect; Factor IX; Internal medicine; Dosing; Alanine transaminase; Genetic enhancement; Transaminase; Gastroenterology; Adeno-associated virus; Phases of clinical research; Clinical trial; Surgery; Recombinant DNA; Vector (molecular biology); Biology","score_opus":0.04809121494100693,"score_gpt":0.3024543024984749,"score_spread":0.25436308755746795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405046397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897984,0.0056681596,0.0016384018,0.00010061388,0.000043968026,0.0007820194,0.0019552207,0.000008008964,0.0000052047576],"genre_scores_gemma":[0.99679154,0.0019563697,0.00029166284,0.000038378617,0.00007051638,0.00013071022,0.0003718107,0.00003308962,0.00031592042],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986673,0.00007801394,0.0003964248,0.00036142304,0.00026518665,0.0002316739],"domain_scores_gemma":[0.998959,0.00010620625,0.00007923103,0.00052932213,0.0002513417,0.000074911855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015273165,0.00019853584,0.00039081014,0.00019572467,0.0000658391,0.000014224833,0.00018664284,0.000098932236,0.0001830977],"category_scores_gemma":[0.000013094631,0.00014139287,0.0005394158,0.0005491818,0.00008322933,0.000004422853,0.000021166436,0.000036011133,8.0997927e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056273,0.0011507564,0.00057276065,0.00003480901,0.009391456,0.0000013353236,0.00022329087,0.0021427998,0.9761992,0.00002359326,0.00006001354,0.004572656],"study_design_scores_gemma":[0.0023157147,0.009770831,0.00855116,0.000008363508,0.00091895775,8.577332e-7,0.00001504952,0.00034817573,0.97491264,0.000007769741,0.0030193718,0.00013113444],"about_ca_topic_score_codex":0.0001298419,"about_ca_topic_score_gemma":0.00057462556,"teacher_disagreement_score":0.008620075,"about_ca_system_score_codex":0.000024685954,"about_ca_system_score_gemma":0.00012479471,"threshold_uncertainty_score":0.5765834},"labels":[],"label_agreement":null},{"id":"W4405046417","doi":"10.1182/blood-2024-211315","title":"Targeting Metabolism to Restore Hematopoiesis in Inherited Bone Marrow Failure Syndromes: Preclinical Insights from Zebrafish Models","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Children's Hospital of Eastern Ontario; National Research Council Canada; AGADA Biosciences; University of Ottawa; SickKids Foundation; Agricultural Research Institute of Ontario","funders":"","keywords":"Zebrafish; Bone marrow; Haematopoiesis; Medicine; Bone marrow failure; Biology; Cancer research; Bioinformatics; Immunology; Stem cell; Genetics; Gene","score_opus":0.03479410346718446,"score_gpt":0.30586311105994973,"score_spread":0.27106900759276525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405046417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9796443,0.012169194,0.00023444617,0.0057465797,0.00019871425,0.00088021765,0.000060398615,0.00035041038,0.0007157262],"genre_scores_gemma":[0.984295,0.00015149862,0.012962855,0.0007118743,0.0005608995,0.00017156494,0.00014561077,0.0001201695,0.0008804926],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968244,0.00020253613,0.0007599297,0.0008922794,0.00073489937,0.00058594724],"domain_scores_gemma":[0.9982338,0.0004781688,0.0000510794,0.00065215875,0.00012778555,0.00045702085],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004555396,0.0003278907,0.00085450656,0.0005695657,0.00006520995,0.00011681417,0.00029548444,0.00039440434,0.0002344582],"category_scores_gemma":[0.00090671657,0.00028019992,0.00017969061,0.0012889755,0.0000798646,0.0003169222,0.0003156497,0.0011058684,0.0002924645],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022841878,0.0061344462,0.010894272,0.0041003358,0.004862449,0.05204186,0.038200684,0.0008198805,0.620282,0.01109075,0.24495527,0.0043338435],"study_design_scores_gemma":[0.08287362,0.0035339624,0.11566095,0.027765013,0.0072867014,0.004337124,0.015211417,0.17442353,0.12254213,0.053952795,0.38354325,0.008869496],"about_ca_topic_score_codex":0.00048863696,"about_ca_topic_score_gemma":0.0001660811,"teacher_disagreement_score":0.4977399,"about_ca_system_score_codex":0.000178561,"about_ca_system_score_gemma":0.00046609767,"threshold_uncertainty_score":0.999965},"labels":[],"label_agreement":null},{"id":"W4405046448","doi":"10.1182/blood-2024-211407","title":"Enhancing Diversity, Equity and Inclusion in Clinical Research: Strategies Used By Clinical Investigators","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Health and Medical Research Impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Equity (law); Medicine; Inclusion (mineral); Diversity (politics); Internal medicine; Psychology; Political science; Social psychology","score_opus":0.5378477318634218,"score_gpt":0.598470579897537,"score_spread":0.06062284803411522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405046448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97477144,0.002316491,0.000025240664,0.018857347,0.0001918457,0.00041748374,0.00000806824,0.000068495305,0.003343605],"genre_scores_gemma":[0.99427253,0.002294711,0.00015739452,0.0026959106,0.00038863224,0.0000057561765,0.000011074969,0.000014142632,0.00015986714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99527407,0.0008429299,0.0006812014,0.00045600915,0.0017854876,0.0009602877],"domain_scores_gemma":[0.9905962,0.003400875,0.000032096374,0.00026365425,0.00009605433,0.005611122],"candidate_categories":["metaresearch","open_science"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.03017291,0.0001099312,0.00038786986,0.00023485077,0.0004444274,0.00008714765,0.00023634493,0.0003201196,0.00005073046],"category_scores_gemma":[0.05123192,0.000085129446,0.00007187049,0.00051333895,0.00072862534,0.00018170282,0.021987012,0.0021082268,0.000039882394],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007714423,0.004494666,0.5057931,0.004900618,0.000230598,0.0053227986,0.011428965,9.980404e-8,0.013836375,0.0022619716,0.10107165,0.3498877],"study_design_scores_gemma":[0.063364126,0.031895217,0.42141291,0.021013685,0.0007165682,0.00037416306,0.012637203,0.0016385933,0.021883057,0.20051087,0.22276545,0.0017881488],"about_ca_topic_score_codex":0.0006547109,"about_ca_topic_score_gemma":0.00035633513,"teacher_disagreement_score":0.34809956,"about_ca_system_score_codex":0.00008739309,"about_ca_system_score_gemma":0.00625908,"threshold_uncertainty_score":0.9993745},"labels":[],"label_agreement":null},{"id":"W4405046457","doi":"10.1182/blood-2024-204145","title":"Reporting of Race and Ethnicity in Randomized Controlled Trials in Hematology","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Clinical Laboratory Practices and Quality Control","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Randomized controlled trial; Ethnic group; Medicine; Race (biology); Internal medicine; Hematology; Biology; Political science","score_opus":0.10500930963805005,"score_gpt":0.450306384958953,"score_spread":0.3452970753209029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405046457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97531736,0.016936753,0.000042301224,0.005422544,0.00010466492,0.0014120985,0.0000026350442,0.000020533864,0.0007410972],"genre_scores_gemma":[0.99867725,0.00055412564,0.00028176466,0.00025340996,0.00006136791,0.000069296315,0.000001576647,0.0000073893566,0.00009381338],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99071753,0.0027938501,0.0059765535,0.00023489124,0.00014144108,0.00013573057],"domain_scores_gemma":[0.9476529,0.049232908,0.0027358723,0.00021366244,0.000090758665,0.00007394648],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.060905967,0.00009400011,0.0064118765,0.00015238578,0.000007060052,0.000013552956,0.000024622232,0.00013348015,0.00005924493],"category_scores_gemma":[0.28567782,0.00005816366,0.0003885923,0.00020026225,0.000071092116,0.00005259678,0.000019958336,0.00030784198,0.0000017220884],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.78352815,0.003952544,0.11571229,0.0031566343,0.0041140155,0.004147747,0.0029890619,0.000007937017,0.031503502,0.043451678,0.00014394318,0.0072925133],"study_design_scores_gemma":[0.9880992,0.00014572272,0.0033749857,0.0010136629,0.0019114675,0.00009345958,0.00019809326,0.0017896073,0.0015468559,0.0014149903,0.00031224065,0.00009968947],"about_ca_topic_score_codex":0.00014104735,"about_ca_topic_score_gemma":0.00012229724,"teacher_disagreement_score":0.22477186,"about_ca_system_score_codex":0.0000065006484,"about_ca_system_score_gemma":0.0001610056,"threshold_uncertainty_score":0.96699494},"labels":[],"label_agreement":null},{"id":"W4405046465","doi":"10.1182/blood-2024-210593","title":"Assessing Risk of Infectious Episodes in Patients Post Hematopoietic Stem Cell Transplantation Using Pre-Transplant Baseline Colonization Screening","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Mycobacterium research and diagnosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Electricity Association; University of Ottawa; Ottawa Hospital","funders":"","keywords":"Hematopoietic stem cell transplantation; Transplantation; Stem cell; Medicine; Colonization; Internal medicine; Immunology; Haematopoiesis; Graft-versus-host disease; Oncology; Biology; Microbiology; Genetics","score_opus":0.014068561965483442,"score_gpt":0.28105847130532235,"score_spread":0.2669899093398389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405046465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890955,0.00039651507,0.009755424,0.00002511646,0.00005639128,0.00039128706,0.00015155946,0.000054270327,0.00007391334],"genre_scores_gemma":[0.9983036,0.0003735201,0.00091172993,0.000022021928,0.000041859417,0.000011978953,0.00030515942,0.000024135134,0.0000059774516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987964,0.00015555102,0.00034070652,0.00021134331,0.00029260854,0.00020340894],"domain_scores_gemma":[0.99929994,0.00027241083,0.000071240764,0.00010955626,0.0001631033,0.00008371736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036523066,0.000116243325,0.00021618736,0.00028181245,0.000048654412,0.00005972727,0.00003762983,0.00008129503,0.000027109223],"category_scores_gemma":[0.00006117683,0.00010530391,0.00006192771,0.0003874896,0.000023071172,0.00025866434,0.000008403163,0.00017784498,0.0000026450098],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015725818,0.0007320711,0.9675558,0.0023107997,0.000055137556,0.00008820988,0.0010957462,0.00032049965,0.026012521,0.0000038581106,0.0000041214316,0.0016639618],"study_design_scores_gemma":[0.0035154063,0.0004776879,0.8782651,0.0025425565,0.0006390714,0.00004352585,0.000115185605,0.007608085,0.10664837,0.000008226699,0.0000036538424,0.00013312811],"about_ca_topic_score_codex":0.00059841556,"about_ca_topic_score_gemma":0.00006782473,"teacher_disagreement_score":0.089290716,"about_ca_system_score_codex":0.000032404183,"about_ca_system_score_gemma":0.000103732906,"threshold_uncertainty_score":0.42941687},"labels":[],"label_agreement":null},{"id":"W4405046497","doi":"10.1182/blood-2024-206153","title":"Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy?","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Calgary; Saskatchewan Cancer Agency; Vancouver General Hospital; University of British Columbia; University of Saskatchewan; Université Laval; Juravinski Hospital; McMaster University; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Lymphoblastic Leukemia; Myeloid leukemia; Internal medicine; Leukemia; Chemotherapy regimen; Oncology; Overall survival","score_opus":0.017448784350652086,"score_gpt":0.30183762872268205,"score_spread":0.28438884437202994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405046497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97378194,0.0009522142,0.00056443305,0.019819472,0.000121704405,0.002227586,0.002447401,0.000022027987,0.000063231986],"genre_scores_gemma":[0.9891995,0.008110927,0.00009270517,0.001769713,0.00012484824,0.00021082703,0.0003496339,0.000039164017,0.00010265567],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9977948,0.0002866317,0.00057283626,0.00042746923,0.00052832026,0.00038995472],"domain_scores_gemma":[0.9953061,0.0036632947,0.00018331829,0.00040696317,0.00034917644,0.00009118457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006553639,0.0003119536,0.00043909665,0.00022603483,0.00013244274,0.00008292354,0.00021306107,0.00015801057,0.000012744601],"category_scores_gemma":[0.00027106566,0.00016571747,0.00015269581,0.00035587503,0.000303937,0.00035811582,0.000055735298,0.00026733975,0.000005810331],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.149889,0.015078424,0.09347769,0.003792161,0.05384595,0.0056186384,0.13928509,0.0010186844,0.4414465,0.03250234,0.0030078623,0.061037634],"study_design_scores_gemma":[0.052803695,0.010471435,0.64706403,0.006988433,0.0042176037,0.0026063793,0.0031665775,0.025839956,0.24468777,0.0002477972,0.0011040347,0.0008023196],"about_ca_topic_score_codex":0.005686137,"about_ca_topic_score_gemma":0.00056457665,"teacher_disagreement_score":0.5535863,"about_ca_system_score_codex":0.0016104729,"about_ca_system_score_gemma":0.002331637,"threshold_uncertainty_score":0.8595776},"labels":[],"label_agreement":null},{"id":"W4405046512","doi":"10.1182/blood-2024-206114","title":"The Incidence and Risk of Venous Thromboembolism in Patients with Active Malignancy and Isolated Superficial Venous Thrombosis: A Systematic Review and Meta-Analysis. (The IROVAM-iSVT review)","year":2024,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Concordia University; McGill University Health Centre; McGill University; Cargill (Canada)","funders":"","keywords":"Medicine; Venous thrombosis; Incidence (geometry); Venous thromboembolism; Meta-analysis; Thrombosis; Malignancy; Cardiology; Surgery; Internal medicine","score_opus":0.022719398065778426,"score_gpt":0.29392324903373634,"score_spread":0.2712038509679579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405046512","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012288559,0.9870172,0.0000010555042,0.00022885451,0.000036206922,0.01124898,0.00017412752,0.000026558662,0.000038145772],"genre_scores_gemma":[0.0020461655,0.99585295,0.00002318478,0.00039079943,0.0000239242,0.001510633,0.000050461906,0.00008059058,0.000021321235],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9952475,0.0009955298,0.0017791085,0.00088691263,0.0006486219,0.0004423331],"domain_scores_gemma":[0.9966108,0.0005081246,0.0013187317,0.0012022725,0.00022538762,0.0001346472],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017282538,0.0008081985,0.013694226,0.00026708993,0.0002294906,0.00007777991,0.0003520693,0.00019629487,0.000019222674],"category_scores_gemma":[0.0003354325,0.00036253277,0.0009783178,0.001437407,0.00029952286,0.00009747828,0.0003508744,0.0006986191,0.000008153366],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000058471023,0.0010327476,0.000045925117,0.7922515,0.20223817,0.000024079656,0.0003524425,6.828794e-8,2.0002997e-8,0.00007581738,0.00010392444,0.0038694222],"study_design_scores_gemma":[0.00034553802,0.0006558807,0.0023097636,0.20162952,0.7936487,0.00003688965,0.000046272944,8.85224e-7,1.08725565e-7,0.000022387132,0.0010169875,0.0002870371],"about_ca_topic_score_codex":0.00024255391,"about_ca_topic_score_gemma":0.00018688144,"teacher_disagreement_score":0.5914106,"about_ca_system_score_codex":0.000049477174,"about_ca_system_score_gemma":0.00016472158,"threshold_uncertainty_score":0.99988264},"labels":[],"label_agreement":null},{"id":"W4405046519","doi":"10.1182/blood-2024-202081","title":"Outcomes in AML Patients Admitted to the ICU Following Allogeneic Stem Cell Transplantation","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Sepsis; Intensive care unit; Transplantation; Internal medicine; Hematopoietic stem cell transplantation; Retrospective cohort study; Mechanical ventilation; Graft-versus-host disease; Surgery","score_opus":0.012359279540139932,"score_gpt":0.2641155883959533,"score_spread":0.25175630885581335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405046519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99663234,0.00019650193,0.00004240562,0.00076636503,0.00045967693,0.00039134594,0.000013921184,0.00005701444,0.0014404532],"genre_scores_gemma":[0.99845815,0.000026633787,0.00002445311,0.00050830847,0.000049583738,0.00007746933,0.000015635324,0.000014232072,0.00082555466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99944645,0.000022862178,0.00013190319,0.00014560191,0.00013013885,0.00012304535],"domain_scores_gemma":[0.99978,0.00003493907,0.000009389842,0.00011541471,0.000012096468,0.000048153408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000056196553,0.00007420171,0.000110711044,0.00008022759,0.0000377754,0.000020793523,0.000045380053,0.000029117138,0.000023908753],"category_scores_gemma":[0.0000024726696,0.000048108057,0.0000837622,0.00023772247,0.0000038977905,0.00003983143,0.0000073653414,0.00009501456,0.00009635924],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020577465,0.00026957897,0.9903173,0.00008092745,0.000076407996,0.00008916613,0.0010385605,0.000012118887,0.0049387207,0.00002199775,0.00017304422,0.0029616174],"study_design_scores_gemma":[0.0018688965,0.00018669161,0.97595257,0.00011473383,0.00037405977,0.000009397118,0.00008062599,0.000002970792,0.015618215,0.0000060055904,0.005704969,0.00008087429],"about_ca_topic_score_codex":0.000048559632,"about_ca_topic_score_gemma":0.0001763434,"teacher_disagreement_score":0.014364723,"about_ca_system_score_codex":0.00002489958,"about_ca_system_score_gemma":0.000039920174,"threshold_uncertainty_score":0.19617897},"labels":[],"label_agreement":null},{"id":"W4405046554","doi":"10.1182/blood-2024-194612","title":"Subcutaneous Mosunetuzumab Leads to High Rates of Durable Responses, Low Rates of Cytokine Release Syndrome, and Non-Inferior Exposure Compared with Intravenous Administration in Patients with Relapsed/Refractory Follicular Lymphoma: Primary Analysis of a Pivotal Phase II","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Jewish General Hospital; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Cytokine release syndrome; Refractory (planetary science); Cytokine; Internal medicine; Lymphoma; Gastroenterology; Surgery; Immunotherapy; Cancer; Chimeric antigen receptor","score_opus":0.005541275097004713,"score_gpt":0.23355324115830206,"score_spread":0.22801196606129734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405046554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977197,0.00091602135,0.0000096541,0.000059388443,0.000017443144,0.00089087465,0.0003490025,0.000020969768,0.000016957838],"genre_scores_gemma":[0.9986651,0.00007034346,0.0005527239,0.00002126562,0.000007437285,0.000075776756,0.0005326337,0.00003268231,0.00004205174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820155,0.0000684348,0.00065245153,0.0004243019,0.00042601707,0.00022724748],"domain_scores_gemma":[0.9988366,0.00017289112,0.00024050422,0.00038438998,0.0002129504,0.0001526807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011920296,0.00028503567,0.0010565725,0.0005505435,0.00004291913,0.000017747954,0.00006711878,0.00009667799,0.00001976569],"category_scores_gemma":[0.000041010473,0.00020629932,0.000101226105,0.0011163114,0.00011185799,0.00010118977,0.00003057416,0.00006548499,7.766278e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03376172,0.034934256,0.8943073,0.001262051,0.0052073887,0.0052279057,0.0011178078,0.00022258087,0.02223396,0.000017911818,0.000021888238,0.0016852099],"study_design_scores_gemma":[0.028722068,0.04270324,0.84619576,0.0011255405,0.004803434,0.00026525417,0.00008200758,0.00012734075,0.07575415,0.0000015666127,0.000007716207,0.00021193732],"about_ca_topic_score_codex":0.00038471966,"about_ca_topic_score_gemma":0.00018879295,"teacher_disagreement_score":0.053520195,"about_ca_system_score_codex":0.00014925754,"about_ca_system_score_gemma":0.00057261274,"threshold_uncertainty_score":0.8412642},"labels":[],"label_agreement":null},{"id":"W4405046626","doi":"10.1182/blood-2024-208893","title":"Ibrutinib in Elderly Patients with Chronic Lymphocytic Leukemia: Adverse Event Incidence, Management, and Outcome in a Canadian Real-World Setting","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Saskatchewan Health Authority; Saskatchewan Health; Saskatchewan Cancer Agency; University of Saskatchewan","funders":"","keywords":"Ibrutinib; Medicine; Internal medicine; Discontinuation; Adverse effect; Chronic lymphocytic leukemia; Neutropenia; Fludarabine; Rash; Oncology; Leukemia; Chemotherapy","score_opus":0.00995485069152188,"score_gpt":0.28130562386847063,"score_spread":0.2713507731769488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405046626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902255,0.0007427287,0.0000018043522,0.00010731758,0.000081355545,0.0011764686,0.000013598907,0.00006972775,0.007581517],"genre_scores_gemma":[0.9970688,0.00016553496,0.00020027459,0.00012563105,0.00006960082,0.00011302251,0.000040027862,0.000054880693,0.0021622065],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99727666,0.000059143153,0.0005267083,0.00062074565,0.00053027854,0.000986434],"domain_scores_gemma":[0.9989315,0.00012572826,0.000049894443,0.00041229578,0.000040360257,0.00044021735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000547394,0.00026042757,0.00037310118,0.0012389652,0.00005747043,0.000050292798,0.00016008507,0.000112538124,0.00006899018],"category_scores_gemma":[0.00007157693,0.0002247587,0.00005163141,0.0012723146,0.00009856286,0.00017726558,0.00012838357,0.00039944783,0.00006738398],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00015186152,0.00011908727,0.9799474,0.0022061435,0.0001813833,0.009779027,0.000596679,0.00025079295,0.000008952943,0.00040218496,0.00023142947,0.006125092],"study_design_scores_gemma":[0.07700464,0.00058089924,0.8943063,0.004576064,0.00031047955,0.00022275797,0.00022247866,0.018843675,0.000083126986,0.00008173176,0.0032404042,0.0005274294],"about_ca_topic_score_codex":0.46966237,"about_ca_topic_score_gemma":0.739947,"teacher_disagreement_score":0.27028465,"about_ca_system_score_codex":0.098463885,"about_ca_system_score_gemma":0.027618656,"threshold_uncertainty_score":0.9778938},"labels":[],"label_agreement":null},{"id":"W4405046645","doi":"10.1182/blood-2024-201747","title":"Landscape Assessment of the Perceptions of Distress and Symptom Burden in Patients with Monoclonal Gammopathy of Unknown Significance (MGUS) and Smoldering Multiple Myeloma (SMM)","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Leprosy Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Monoclonal gammopathy of undetermined significance; Multiple myeloma; Monoclonal gammopathy; Medicine; Distress; Monoclonal; Oncology; Internal medicine; Immunology; Monoclonal antibody; Clinical psychology; Antibody","score_opus":0.006078520431558546,"score_gpt":0.2505373372068243,"score_spread":0.24445881677526576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405046645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988233,0.00044788438,0.0000085776555,0.00007091899,0.000010269054,0.00038972916,0.00009086497,0.0000053526305,0.00015309124],"genre_scores_gemma":[0.9995615,0.000053820622,0.00028442848,0.0000014751271,0.000011605256,0.000028262813,0.000016379789,0.000007985004,0.000034582117],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993483,0.000023645332,0.00014919178,0.00015014154,0.00022430481,0.00010445116],"domain_scores_gemma":[0.99965364,0.00006671759,0.000036854413,0.00014364082,0.00004943148,0.000049688548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006141071,0.00007459151,0.00017429465,0.00005313478,0.00001876649,0.0000071537734,0.00003761506,0.000024135836,0.000013497754],"category_scores_gemma":[0.000015606955,0.000043228716,0.000025567408,0.00012279417,0.000099479046,0.00003087901,0.000049069535,0.00008013537,1.2458266e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006657545,0.00050450326,0.9924487,0.0003960145,0.00010824876,0.000008717614,0.0004973909,0.00000895117,0.003920834,0.000041029598,0.000002009582,0.0019970464],"study_design_scores_gemma":[0.0033511084,0.0005205441,0.99176174,0.0005007513,0.000101959486,0.0000040250243,0.00018043467,0.0005077631,0.0030168733,0.000009980334,0.0000057802563,0.00003901728],"about_ca_topic_score_codex":0.00012461022,"about_ca_topic_score_gemma":0.00006475261,"teacher_disagreement_score":0.003284533,"about_ca_system_score_codex":0.00001390949,"about_ca_system_score_gemma":0.000070734684,"threshold_uncertainty_score":0.17628159},"labels":[],"label_agreement":null},{"id":"W4405046734","doi":"10.1182/blood-2024-211092","title":"Routine Prophylactic Granulocyte Colony-Stimulating Factor Use Post Autologous Peripheral Blood Stem Cell Transplantation for Hodgkin's Disease, Non-Hodgkin's Lymphoma and Germ Cell Tumors Shortens Duration of Hospital Stay and Reduces Mortality: A Retrospective Single Center Experience","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of British Columbia; Vancouver General Hospital","funders":"","keywords":"Medicine; Granulocyte colony-stimulating factor; Lymphoma; Transplantation; Stem cell; Peripheral Blood Stem Cells; Autologous stem-cell transplantation; Non-Hodgkin's lymphoma; Oncology; Internal medicine; Hematopoietic stem cell transplantation; Immunology; Chemotherapy; Biology","score_opus":0.014616416623873982,"score_gpt":0.25909486140285964,"score_spread":0.24447844477898567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405046734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967148,0.0003347341,0.00025685382,0.00007778463,0.00024720587,0.0015377408,0.0006790799,0.00009880449,0.000053007054],"genre_scores_gemma":[0.9990081,0.00006787581,0.0003280093,0.0000305358,0.00011905841,0.00018643936,0.000106403044,0.000047648293,0.00010592583],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984269,0.0000468152,0.0004204068,0.00056597794,0.00025500293,0.00028486003],"domain_scores_gemma":[0.99917895,0.000088059074,0.00017167222,0.00018104831,0.00020317313,0.00017711242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007096336,0.00026922495,0.00039521206,0.00010641596,0.00017476006,0.00015179854,0.000047777812,0.00008227679,0.000011799459],"category_scores_gemma":[0.000024019982,0.00023795568,0.00011312121,0.00018278112,0.00015229697,0.00042679426,0.000021490794,0.00011091807,3.699581e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006752931,0.0016262747,0.679244,0.0014768174,0.00017866792,0.0002986425,0.008707481,0.000008451966,0.307067,0.000022614257,0.0000039824936,0.000690791],"study_design_scores_gemma":[0.0042717527,0.0035222257,0.7974508,0.00027540492,0.0013561023,0.00012668235,0.000697547,0.0005302865,0.19145422,0.000012216722,0.000008233688,0.00029452247],"about_ca_topic_score_codex":0.00012013283,"about_ca_topic_score_gemma":0.000039241306,"teacher_disagreement_score":0.118206814,"about_ca_system_score_codex":0.000080519676,"about_ca_system_score_gemma":0.00015952394,"threshold_uncertainty_score":0.9703551},"labels":[],"label_agreement":null},{"id":"W4405046742","doi":"10.1182/blood-2024-210038","title":"Don't Fly and Freeze: Impact of Ex-Vivo-Time, Cell Concentration and Cryopreservation on the Composition of Allogeneic Stem Cell Grafts","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Cryopreservation; Leukapheresis; Andrology; Stem cell; Viability assay; Apheresis; Biology; Ex vivo; Immunology; Transplantation; CD34; Medicine; Cell; In vivo; Internal medicine; Biotechnology; Cell biology; Biochemistry; Platelet","score_opus":0.013201201856422522,"score_gpt":0.24550437281516,"score_spread":0.23230317095873748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405046742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99654627,0.00094332465,0.00019594072,0.00014241677,0.00003348869,0.0004964002,0.000057558987,0.000023957276,0.001560625],"genre_scores_gemma":[0.9993692,0.00023028346,0.00015101019,0.000026410022,0.000030462434,0.000007553307,0.00005466145,0.0000143459165,0.0001160913],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99917924,0.000069434056,0.00026547821,0.0001695196,0.00021494618,0.000101395875],"domain_scores_gemma":[0.99941283,0.00023528932,0.00008428969,0.0001525097,0.00006346007,0.000051624498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019686857,0.000111701454,0.00018963244,0.000043058277,0.000028323191,0.000018349416,0.000036082565,0.0000756739,0.000068436246],"category_scores_gemma":[0.0000038086175,0.00007664502,0.000054290358,0.00011599371,0.000058829974,0.000069435366,0.00000823585,0.00007899452,0.0000057056573],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009234818,0.00020297129,0.019316718,0.000950791,0.000070980896,0.000009514247,0.0010141196,0.00002339231,0.97785527,0.00016625925,0.00016608449,0.00013154688],"study_design_scores_gemma":[0.0015869868,0.0006531927,0.060396187,0.0004666703,0.00038695364,0.00003717008,0.00009546119,0.0016541849,0.93457526,0.00006043159,0.000012871767,0.00007463648],"about_ca_topic_score_codex":0.000065933345,"about_ca_topic_score_gemma":0.0000022470222,"teacher_disagreement_score":0.04328002,"about_ca_system_score_codex":0.000015003912,"about_ca_system_score_gemma":0.000056578894,"threshold_uncertainty_score":0.31254932},"labels":[],"label_agreement":null},{"id":"W4405046826","doi":"10.1182/blood-2024-202535","title":"Impact of Cyclosporine Exposure Levels on Outcomes in Allogeneic Hematopoietic Cell Transplantation: A Retrospective Analysis","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Hematopoietic cell; Transplantation; Medicine; Hematopoietic stem cell transplantation; Retrospective cohort study; Oncology; Internal medicine; Immunology; Haematopoiesis; Stem cell; Biology","score_opus":0.01699587983693617,"score_gpt":0.31035367576607525,"score_spread":0.2933577959291391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405046826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976721,0.0003356662,0.00012214437,0.000057434445,0.00003830061,0.00023978333,0.00023714756,0.00003756454,0.0012598643],"genre_scores_gemma":[0.9987918,0.00022290421,0.0002512035,0.000019385041,0.000016491711,0.000016753382,0.00010317272,0.000017006305,0.00056129316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989586,0.000024978786,0.00033089233,0.0002628314,0.00026582592,0.0001568971],"domain_scores_gemma":[0.99957234,0.00008136756,0.000048228932,0.00019082137,0.000034547626,0.000072696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000053725886,0.00017640406,0.0005180447,0.00042781807,0.000014169067,0.000011295449,0.000045835077,0.00006483295,0.00019903806],"category_scores_gemma":[0.000004811752,0.000118835946,0.0005014357,0.00075598236,0.000018788123,0.000045837267,0.0000027717363,0.000112337446,0.000019200595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000097828226,0.0010248866,0.9919698,0.00038326642,0.002907642,0.0009119729,0.0005859686,0.00018900726,0.0017896292,0.0000862769,0.0000011464372,0.000052566942],"study_design_scores_gemma":[0.0035089115,0.00079640624,0.98289335,0.0002307239,0.0034234684,0.000057485864,0.000022407292,0.000011119659,0.008891496,0.000068915346,6.8618345e-7,0.0000950387],"about_ca_topic_score_codex":0.00009476634,"about_ca_topic_score_gemma":0.000045523546,"teacher_disagreement_score":0.009076468,"about_ca_system_score_codex":0.000057599245,"about_ca_system_score_gemma":0.000058745347,"threshold_uncertainty_score":0.48459893},"labels":[],"label_agreement":null},{"id":"W4405046828","doi":"10.1182/blood-2024-204178","title":"Comparison of Prophylactic and Therapeutic Platelet Transfusion Strategies in Manitoba: A Retrospective Cohort Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Medicine; Retrospective cohort study; Platelet transfusion; Blood transfusion; Cohort; Platelet; Internal medicine; Intensive care medicine","score_opus":0.022705437839576497,"score_gpt":0.3031524015212647,"score_spread":0.2804469636816882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405046828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928921,0.0020887337,0.00004528833,0.00015222195,0.00008508265,0.0019090956,0.0000021434978,0.00006883603,0.00275654],"genre_scores_gemma":[0.99951744,0.00027197803,0.000047915608,0.000021529331,0.000024308618,0.00006334757,0.0000023004877,0.000016932858,0.000034266686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900895,0.000043367134,0.00026368158,0.00028878605,0.0002646471,0.00013053983],"domain_scores_gemma":[0.9997317,0.00002452199,0.000022725002,0.0001523273,0.000028969864,0.00003974416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020779764,0.00012630947,0.00037727563,0.00017771979,0.000026872525,0.000031577863,0.00003947259,0.000049934813,0.000039900675],"category_scores_gemma":[0.0000039979527,0.00009882134,0.000040422565,0.0002790916,0.00004457692,0.000052911986,0.000014898758,0.00022526682,0.000003748384],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001864564,0.0045679207,0.9725252,0.00064678583,0.00043977814,0.00023998234,0.005796675,0.0000022185984,0.007979755,0.001351054,0.0000050786075,0.006259098],"study_design_scores_gemma":[0.0036886865,0.001990464,0.978711,0.00015178934,0.0007239127,0.000025187352,0.011229656,0.00013772359,0.002914552,0.00022914544,0.00009637582,0.00010147241],"about_ca_topic_score_codex":0.00038749218,"about_ca_topic_score_gemma":0.0010856193,"teacher_disagreement_score":0.0066253627,"about_ca_system_score_codex":0.00002315949,"about_ca_system_score_gemma":0.000044273762,"threshold_uncertainty_score":0.40298173},"labels":[],"label_agreement":null},{"id":"W4405046844","doi":"10.1182/blood-2024-206096","title":"R289, a Dual Irak 1/4 Inhibitor, in Patients with Relapsed/Refractory (R/R) Lower-Risk Myelodysplastic Syndrome (LR-MDS): Initial Results from a Phase 1b Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Genentech; Sierra Oncology; Incyte; Swedish Orphan Biovitrum; Astex Pharmaceuticals; Jazz Pharmaceuticals; MorphoSys; Celgene; Bristol-Myers Squibb; Helsinn; Servier; Amgen","keywords":"Medicine; Internal medicine; Refractory (planetary science); Myelodysplastic syndromes; Lenalidomide; Oncology; Gastroenterology; Bone marrow; Biology; Multiple myeloma","score_opus":0.015385067720385746,"score_gpt":0.28987608832230516,"score_spread":0.27449102060191943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405046844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99473363,0.00035464962,0.000006510435,0.000062418854,0.00042103173,0.0020293894,0.0017717874,0.00019018498,0.00043038302],"genre_scores_gemma":[0.998099,0.00002432849,0.00018198199,0.000024322726,0.000272525,0.00016590148,0.0008932056,0.00009091319,0.00024777264],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963131,0.00024072919,0.00061295036,0.0009815881,0.0011688985,0.0006827182],"domain_scores_gemma":[0.9980524,0.0005786654,0.00011546828,0.0006494073,0.0001263313,0.00047768775],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030401195,0.00044079803,0.0006098823,0.00051256287,0.000114671646,0.00010472967,0.00013636767,0.00017087952,0.00014066602],"category_scores_gemma":[0.00065747753,0.00032803713,0.000110373985,0.00063848024,0.000110265166,0.00026593645,0.00012849442,0.0008844957,0.00037756574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047086302,0.15938653,0.6663831,0.00023955252,0.004226818,0.09832168,0.004239003,0.0000058918613,0.00029993214,0.0000052693317,0.0009851772,0.018820776],"study_design_scores_gemma":[0.26078954,0.03537998,0.69950086,0.0011902191,0.0012126748,0.000101413294,0.00031255197,0.00016781369,0.0003027684,0.000023343815,0.00055444165,0.00046438377],"about_ca_topic_score_codex":0.0010494963,"about_ca_topic_score_gemma":0.0004020443,"teacher_disagreement_score":0.21370323,"about_ca_system_score_codex":0.0001766953,"about_ca_system_score_gemma":0.000448358,"threshold_uncertainty_score":0.99991715},"labels":[],"label_agreement":null},{"id":"W4405046963","doi":"10.1182/blood-2024-202708","title":"Superior Survival of Myeloablative over Reduced-Intensity Conditioning in MDS Patients below 65 Years Using a Combination of Antithymocyte Globulin and Post-Transplantation Cyclophosphamide As Gvhd Prophylaxis","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Cyclophosphamide; Internal medicine; Transplantation; Gastroenterology; Surgery; Chemotherapy","score_opus":0.011757529092905132,"score_gpt":0.2845708924898774,"score_spread":0.27281336339697226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405046963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99874854,0.00037912634,0.000011809589,0.000034164794,0.00014289483,0.00042028597,0.000074692805,0.000019503503,0.0001689524],"genre_scores_gemma":[0.99961793,0.00013093982,0.00013540113,0.000036471625,0.000015658758,0.0000048864786,0.000040769228,0.000008533551,0.00000939409],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992156,0.000051281033,0.00023857788,0.00018133147,0.00019933726,0.00011384457],"domain_scores_gemma":[0.9995886,0.00011452981,0.00006146378,0.0000458072,0.00015233996,0.00003726848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015145342,0.000097976,0.00030105683,0.000113564005,0.000032534776,0.000008778956,0.000022995007,0.00006478454,0.00002747126],"category_scores_gemma":[0.000150477,0.00008514938,0.000044119806,0.00023807483,0.00011287521,0.000103422564,0.000025113173,0.0001274737,0.0000010126223],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081300695,0.0011599859,0.5783995,0.0011788885,0.0003367441,0.00026044287,0.0033994704,0.000022173992,0.4119148,0.00020705716,0.0000034892096,0.002304464],"study_design_scores_gemma":[0.0027656483,0.0010388453,0.8926808,0.00034947557,0.00019511639,0.00001184464,0.00011082969,0.00021771844,0.10248005,0.00007381824,0.0000013277534,0.00007449881],"about_ca_topic_score_codex":0.00037092238,"about_ca_topic_score_gemma":0.000011800448,"teacher_disagreement_score":0.31428134,"about_ca_system_score_codex":0.0000336249,"about_ca_system_score_gemma":0.00005054504,"threshold_uncertainty_score":0.3472291},"labels":[],"label_agreement":null},{"id":"W4405046976","doi":"10.1182/blood-2024-203265","title":"Both Pre- and Post-Allogeneic Stem Cell Transplant Ferritin Are Associated with Relapse: A Large Single Centre Retrospective Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Ferritin; Medicine; Internal medicine; Transplantation; Cumulative incidence; Hematopoietic stem cell transplantation; Gastroenterology; Incidence (geometry); Retrospective cohort study; Immunology","score_opus":0.006632637823083737,"score_gpt":0.21082244001225411,"score_spread":0.20418980218917038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405046976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901097,0.007011889,0.000010933009,0.000214161,0.00008093013,0.0007524066,0.00029558467,0.00017954031,0.0013448481],"genre_scores_gemma":[0.99614775,0.00006346083,0.000024732624,0.00013913495,0.000056931734,0.000014941981,0.000060918486,0.000046948273,0.003445206],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986851,0.00008323682,0.00018099904,0.00042268285,0.00029954853,0.00032843623],"domain_scores_gemma":[0.9995345,0.000032867098,0.000050805364,0.00018889943,0.00006400239,0.0001289183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017364834,0.0002046464,0.0003434362,0.00008675952,0.000086760214,0.000050943272,0.000052714015,0.00009700448,0.00003690381],"category_scores_gemma":[0.000016095404,0.00015474716,0.00005568901,0.00022547074,0.000032011358,0.00005324362,0.000019689393,0.00023731268,0.00000774248],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004221703,0.00904197,0.9578368,0.00047938534,0.00042940903,0.0017521114,0.01965166,8.0017736e-7,0.009753088,0.0001276437,0.0002380032,0.00026696362],"study_design_scores_gemma":[0.01096377,0.0016148889,0.9718366,0.0004453678,0.0020426065,0.000054004908,0.010878211,0.000009433505,0.0016382486,0.000011027863,0.000238479,0.00026734787],"about_ca_topic_score_codex":0.000043684537,"about_ca_topic_score_gemma":0.00058896927,"teacher_disagreement_score":0.01399982,"about_ca_system_score_codex":0.0000324548,"about_ca_system_score_gemma":0.000073149764,"threshold_uncertainty_score":0.6310406},"labels":[],"label_agreement":null},{"id":"W4405047039","doi":"10.1182/blood-2024-210101","title":"Performance Status, Cancer-Associated Thrombosis, and Bleeding: A Post-Hoc Analysis of the Avert Trial","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Performance status; Deep vein; Pulmonary embolism; Cancer; Confidence interval; Thrombosis; Surgery","score_opus":0.029107800812314795,"score_gpt":0.3362708158909196,"score_spread":0.30716301507860483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405047039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99375945,0.003580042,8.044427e-8,0.001051542,0.00036946047,0.00029736507,0.000104545165,0.00003288891,0.0008045964],"genre_scores_gemma":[0.99488014,0.004123382,0.0000063415528,0.00015675217,0.0001236569,0.000036053534,0.000029643483,0.0000095089645,0.0006345468],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99934715,0.000023910732,0.00015774599,0.00015987239,0.00014723247,0.00016410829],"domain_scores_gemma":[0.9996795,0.00006349624,0.000050004455,0.000100956415,0.000052342228,0.00005369381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008982654,0.00009130378,0.00029567778,0.00012112545,0.000049023398,0.0000115624425,0.00004202461,0.000055797438,0.00032260414],"category_scores_gemma":[0.000012435303,0.00005780054,0.00014244854,0.0007059794,0.00005554225,0.000036856563,0.000029906141,0.000105450745,0.000001630259],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008389562,0.0023098253,0.8920532,0.00037632964,0.03563418,0.00001376975,0.004027982,0.000015904183,0.048469972,0.0001002411,0.0039191525,0.0046899035],"study_design_scores_gemma":[0.06612387,0.0038961943,0.8434731,0.00027440776,0.06416371,0.0000050394215,0.00013677892,0.0027182898,0.011689022,0.000008897644,0.007308176,0.00020253102],"about_ca_topic_score_codex":0.00047817957,"about_ca_topic_score_gemma":0.00033277704,"teacher_disagreement_score":0.05773431,"about_ca_system_score_codex":0.0000630631,"about_ca_system_score_gemma":0.0001977039,"threshold_uncertainty_score":0.35322893},"labels":[],"label_agreement":null},{"id":"W4405047042","doi":"10.1182/blood-2024-209646","title":"Alberta Cellular and Immunotherapy (ACIT) 001, Updated Results of Decentralized Production of Second Generation, Anti-CD19/41BB/CD3z Chimeric Antigen Receptor (CAR) T-Cells in Relapsed/Refractory (R/R) Acute Lymphoblastic Leukemia (ALL) and Aggressive Non-Hodgkin Lymphoma (NHL)","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Stollery Children's Hospital; University of Calgary; University of Alberta","funders":"","keywords":"Chimeric antigen receptor; Medicine; Immunotherapy; Refractory (planetary science); Cancer research; CD19; Blinatumomab; Hematologic Neoplasms; Antigen; Internal medicine; Immunology; Oncology; Cancer; Biology","score_opus":0.010193334808513416,"score_gpt":0.2535019991890671,"score_spread":0.24330866438055365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405047042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99029183,0.0074864263,0.000009679662,0.00013907847,0.0005325509,0.0012164455,0.00012589396,0.00004338605,0.00015467963],"genre_scores_gemma":[0.98099536,0.014117825,0.0005888476,0.000046305886,0.00020508109,0.00003858583,0.00052674685,0.00010799885,0.0033732592],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969042,0.00023979203,0.0009992494,0.0008714137,0.00049343635,0.0004919297],"domain_scores_gemma":[0.9983483,0.00018861362,0.00040678453,0.00063015445,0.000244203,0.00018196658],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005815099,0.00040140175,0.0008401623,0.00055925915,0.00006892597,0.000055923247,0.00016703921,0.00029010355,0.00054847135],"category_scores_gemma":[0.00013685026,0.00036574656,0.00012373488,0.00078662345,0.00033506847,0.00019857768,0.00007558708,0.00025628094,0.000013104139],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020367776,0.0007276954,0.0011209326,0.00033396124,0.0011209557,0.00013697453,0.001885973,0.000012517681,0.98406607,0.000006083433,0.0018724799,0.0066795773],"study_design_scores_gemma":[0.01949994,0.0009111629,0.0055681146,0.0005858345,0.00029432197,0.00021975239,0.00009467958,0.00102927,0.96363777,0.000013170672,0.007811879,0.00033413045],"about_ca_topic_score_codex":0.0010731528,"about_ca_topic_score_gemma":0.0002053832,"teacher_disagreement_score":0.020428328,"about_ca_system_score_codex":0.00021391059,"about_ca_system_score_gemma":0.00057297084,"threshold_uncertainty_score":0.9998794},"labels":[],"label_agreement":null},{"id":"W4405047064","doi":"10.1182/blood-2024-206330","title":"The Utility of Maternal Placental Growth Factor (PlGF) for Prediction of Pre-Eclampsia in Pregnancies Complicated By Sickle Cell Disease","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Placental growth factor; Eclampsia; Medicine; Disease; Obstetrics; Preeclampsia; Pregnancy; Internal medicine; Biology; Genetics","score_opus":0.008732483986128454,"score_gpt":0.2288247914609492,"score_spread":0.22009230747482075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405047064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914748,0.005681955,0.00008584265,0.00022222765,0.00011055432,0.00075967587,0.0011561995,0.00004609638,0.0004626651],"genre_scores_gemma":[0.99924934,0.00028886725,0.000025429486,0.000009237629,0.000015468195,0.000039963234,0.00009457464,0.000014252958,0.00026288885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991992,0.000023400109,0.00029323975,0.00016581517,0.0001560715,0.00016225607],"domain_scores_gemma":[0.9996024,0.00007172224,0.000056701003,0.00015072699,0.000045292414,0.000073186406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000079847945,0.000097307726,0.00016418524,0.000035535762,0.00004462743,0.0000123798,0.00007274623,0.00007081077,0.000023712331],"category_scores_gemma":[0.00003461622,0.00006333793,0.00009284959,0.00012021939,0.00014015698,0.00003884526,0.000024181263,0.0001118995,0.000001521873],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028557857,0.00430924,0.83163416,0.007582808,0.00040413777,0.000022866807,0.0022730595,0.00000724885,0.14092489,0.000346733,0.0077365916,0.0019024634],"study_design_scores_gemma":[0.0055140196,0.00053860183,0.8048946,0.0010732096,0.0004150958,0.000010558966,0.00037343724,0.0074101947,0.17752889,0.00039012084,0.0017264293,0.00012482094],"about_ca_topic_score_codex":0.0000684878,"about_ca_topic_score_gemma":0.0000044631524,"teacher_disagreement_score":0.03660399,"about_ca_system_score_codex":0.000013719585,"about_ca_system_score_gemma":0.00009600372,"threshold_uncertainty_score":0.2582846},"labels":[],"label_agreement":null},{"id":"W4405047134","doi":"10.1182/blood-2024-205130","title":"Five-Year Outcomes of the “Abatacept Combined with a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease (GVHD) Prophylaxis: A Randomized Controlled Trial” (‘ABA2‘)","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Medicine; Calcineurin; Randomized controlled trial; Graft-versus-host disease; Methotrexate; Abatacept; Tofacitinib; Internal medicine; Surgery; Immunology; Transplantation; Rheumatoid arthritis; Rituximab","score_opus":0.012518440837468843,"score_gpt":0.27237860905961575,"score_spread":0.2598601682221469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405047134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98366976,0.0007686996,0.0002537057,0.0013006567,0.0005115164,0.013055529,0.000117812684,0.00007844897,0.00024385209],"genre_scores_gemma":[0.9967774,0.000043441563,0.0007240316,0.000035967456,0.0000831067,0.0013641944,0.000016868815,0.0000421293,0.00091286836],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983341,0.0002655411,0.0005356051,0.00031273204,0.000357573,0.00019445979],"domain_scores_gemma":[0.9968872,0.0024294376,0.00014275021,0.00029306527,0.0001033332,0.00014422734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006541899,0.00023484137,0.0013225264,0.00011067209,0.000049711765,0.000033333086,0.000073141535,0.000068044006,0.000030152027],"category_scores_gemma":[0.0009440146,0.00011474813,0.0004266704,0.00018864407,0.00016670703,0.000047916827,0.000019345729,0.00013251195,0.0000028491552],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9928425,0.0005631725,0.0009611615,0.0013326083,0.0016118588,0.000059891325,0.0007766863,7.1594144e-7,0.0011156034,0.0006544193,0.000022927357,0.00005844228],"study_design_scores_gemma":[0.98366207,0.0017182955,0.0023919728,0.0003950293,0.0062916307,0.000009251221,0.00015644013,0.00015540769,0.005009678,0.000058129506,0.000017212442,0.0001348906],"about_ca_topic_score_codex":0.000011247332,"about_ca_topic_score_gemma":0.0000056395697,"teacher_disagreement_score":0.013107614,"about_ca_system_score_codex":0.000012541195,"about_ca_system_score_gemma":0.00020614077,"threshold_uncertainty_score":0.4679293},"labels":[],"label_agreement":null},{"id":"W4405047262","doi":"10.1182/blood-2024-194341","title":"Clinical Significance of Incidental Central Venous Catheter-Related Thrombosis in Children Previously Treated for Cancer","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Central Venous Catheters and Hemodialysis","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Interquartile range; Confidence interval; Central venous catheter; Thrombosis; Surgery; Internal medicine; Catheter","score_opus":0.04155004098661116,"score_gpt":0.3899786977893106,"score_spread":0.34842865680269947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405047262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99433106,0.0023344893,0.00001936426,0.00015893498,0.00048014894,0.002046245,0.0003607886,0.000098546996,0.00017043912],"genre_scores_gemma":[0.9975671,0.0012067617,0.0001063551,0.00008401292,0.00026571666,0.00036393496,0.00010721293,0.00004846949,0.00025044824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974097,0.00025156568,0.0010217592,0.00044674752,0.00015888485,0.00071135286],"domain_scores_gemma":[0.9989996,0.00034858362,0.0001937665,0.00025641877,0.00005840812,0.00014322762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052841526,0.00018841142,0.0006176382,0.00012207826,0.00014822869,0.0000108248605,0.00019816968,0.00028662043,0.00024766967],"category_scores_gemma":[0.00005953173,0.00016199556,0.00037276404,0.00033956685,0.00008040877,0.00007405566,0.000051323732,0.00045413786,0.00002939381],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005588014,0.0022564225,0.9857895,0.0002775264,0.0005570343,0.0000057082816,0.005602727,0.000013182914,0.00097612257,0.000111251386,0.0003650617,0.0039895857],"study_design_scores_gemma":[0.003924622,0.0007641358,0.99069077,0.00091582484,0.0010544178,0.000003736965,0.0002591879,0.00031654225,0.0007835437,0.00026664842,0.0007095784,0.00031098368],"about_ca_topic_score_codex":0.0038226394,"about_ca_topic_score_gemma":0.0016226425,"teacher_disagreement_score":0.005343539,"about_ca_system_score_codex":0.00016867847,"about_ca_system_score_gemma":0.0004139421,"threshold_uncertainty_score":0.6605987},"labels":[],"label_agreement":null},{"id":"W4405047353","doi":"10.1182/blood-2024-205223","title":"Treatment Outcomes of Patients Treated with Venetoclax-Obinutuzumab Therapy Vs Btki Therapies in 1L CLL: An International Real-World Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Venetoclax; Obinutuzumab; Medicine; Internal medicine; Oncology; Intensive care medicine; Chronic lymphocytic leukemia; Leukemia","score_opus":0.028670731014651975,"score_gpt":0.34203698722185527,"score_spread":0.3133662562072033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405047353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99643123,0.00015665388,3.7072567e-7,0.00007215652,0.00007201441,0.0012835709,0.000024725527,0.00008315814,0.0018761258],"genre_scores_gemma":[0.9977773,0.00052347715,0.00006100982,0.000020882133,0.00006525279,0.00017695023,0.00009723759,0.000047708934,0.0012302225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836725,0.00008809503,0.0003307705,0.00038640053,0.00057422696,0.00025328668],"domain_scores_gemma":[0.9991946,0.00011907575,0.000051796316,0.00043998615,0.00010573613,0.000088809786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012140676,0.00022062157,0.00042207522,0.00036830324,0.00002395066,0.000036738413,0.00016281153,0.000049471877,0.00011455372],"category_scores_gemma":[0.00001348552,0.00013335262,0.000076278186,0.00039041854,0.000070929025,0.000118245494,0.000029822135,0.00011034796,0.000010443614],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016840659,0.0054468717,0.97647196,0.00003201722,0.0015904179,0.00046009777,0.004240027,0.0000147762485,0.00011059054,0.000050657294,0.000011092106,0.009887441],"study_design_scores_gemma":[0.07924184,0.00820307,0.90773153,0.000108502245,0.00015608761,0.000015198237,0.0003820982,0.00080902467,0.0022006123,0.000011886332,0.0009893631,0.00015075246],"about_ca_topic_score_codex":0.0072047925,"about_ca_topic_score_gemma":0.00204288,"teacher_disagreement_score":0.07755778,"about_ca_system_score_codex":0.008226877,"about_ca_system_score_gemma":0.0027983931,"threshold_uncertainty_score":0.99940634},"labels":[],"label_agreement":null},{"id":"W4405047413","doi":"10.1182/blood-2024-202053","title":"Deciphering Minor Histocompatibility Antigen Immunoreactivity through Optimized T Cell Expansion Strategies","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Minor histocompatibility antigen; Immunology; Antigen; Biology; Histocompatibility; Major histocompatibility complex; Human leukocyte antigen","score_opus":0.036205202794188644,"score_gpt":0.3257998966375804,"score_spread":0.28959469384339176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405047413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9510372,0.0039582155,0.0009675708,0.00009685847,0.0001775295,0.00080267136,0.0000077583445,0.00027052857,0.042681616],"genre_scores_gemma":[0.9912215,0.0003422547,0.0054850294,0.000026693593,0.00018978314,0.000059063295,0.000023711575,0.000050616924,0.0026013483],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983442,0.0000930511,0.00027641372,0.00048846775,0.0004245771,0.00037329004],"domain_scores_gemma":[0.99896526,0.00019079159,0.000035298646,0.00063134957,0.00007567671,0.00010164758],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037959724,0.00020989554,0.00038068212,0.00007261239,0.00008584002,0.00012242583,0.00013999433,0.00011570511,0.002131309],"category_scores_gemma":[0.000030978325,0.00017795806,0.00020592262,0.0002684507,0.00010911456,0.00029811938,0.00008903062,0.00040543094,0.00008832852],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039178235,0.0009694505,0.0017605867,0.00039857582,0.00015059162,0.00022856875,0.0013332615,0.000027542657,0.98694384,0.000051573097,0.00020818287,0.007536029],"study_design_scores_gemma":[0.0074912114,0.000740068,0.021634115,0.0004087077,0.00029534724,0.00016205186,0.0010551747,0.0014350585,0.9485436,0.00097525376,0.016771583,0.00048783538],"about_ca_topic_score_codex":0.00062055816,"about_ca_topic_score_gemma":0.000021563641,"teacher_disagreement_score":0.04018425,"about_ca_system_score_codex":0.00013111088,"about_ca_system_score_gemma":0.0003793825,"threshold_uncertainty_score":0.9987809},"labels":[],"label_agreement":null},{"id":"W4405047419","doi":"10.1182/blood-2024-204138","title":"Thrombosis Risk Assessment in Polycythemia Vera (TRAP): A 4,636-Patient-Year Analysis of Arterial and Venous Thrombosis in Low-Risk Patients","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Polycythemia vera; Thrombosis; Medicine; Venous thrombosis; Internal medicine; Cardiology","score_opus":0.008621146025015554,"score_gpt":0.2732172179531038,"score_spread":0.2645960719280882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405047419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99798167,0.00035402444,0.000007837245,0.000101053796,0.00013350672,0.0006482901,0.00039458563,0.000027211456,0.00035181682],"genre_scores_gemma":[0.9976237,0.0013466653,0.0006566238,0.00003793978,0.0000395213,0.0001367637,0.00012760877,0.000027806398,0.0000034155241],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980589,0.00014588766,0.0005843541,0.0005244765,0.00038649552,0.0002998581],"domain_scores_gemma":[0.99916416,0.00019922227,0.00015556566,0.00030194118,0.00006407905,0.00011501219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018951752,0.00026325946,0.0008574089,0.00067763915,0.00004823452,0.000044782624,0.00005870719,0.00012547174,0.00017596642],"category_scores_gemma":[0.000065852735,0.00021659164,0.00020100409,0.0010239583,0.00006485214,0.00010040839,0.000055290002,0.00028688417,0.000007847988],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011329045,0.006508187,0.9848453,0.000113892165,0.0029237894,0.000036048506,0.0025298588,0.00002567213,0.00040358794,0.000055789646,0.000029038696,0.0024155453],"study_design_scores_gemma":[0.005676363,0.0015937227,0.98278964,0.00041724398,0.0045303814,0.0000013487784,0.00022697069,0.0005258561,0.003979488,0.000055627606,0.000031514097,0.00017187293],"about_ca_topic_score_codex":0.0011014219,"about_ca_topic_score_gemma":0.00063921243,"teacher_disagreement_score":0.005563073,"about_ca_system_score_codex":0.00014281926,"about_ca_system_score_gemma":0.000120259465,"threshold_uncertainty_score":0.88323504},"labels":[],"label_agreement":null},{"id":"W4405047439","doi":"10.1182/blood-2024-211833","title":"BCMA Extracellular Domain Functional Hotspots and Resistance to Variable Anti-BCMA T Cell Engagers in Multiple Myeloma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Multiple myeloma; Medicine; Computer science; Immunology","score_opus":0.020111423298800016,"score_gpt":0.25240620912103845,"score_spread":0.23229478582223845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405047439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864666,0.0064518373,0.0004906468,0.00053783477,0.00013237828,0.00069255556,0.000057990615,0.00010216074,0.0050680176],"genre_scores_gemma":[0.97945845,0.000105914034,0.012502344,0.000073865915,0.00014442869,0.00010140651,0.000051957257,0.00004107443,0.0075205727],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99818146,0.00009808018,0.0002538112,0.0005557277,0.00041439454,0.0004965272],"domain_scores_gemma":[0.998961,0.0003109381,0.00002174714,0.0002939386,0.000049174247,0.00036324907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044392672,0.00020999844,0.00028409902,0.0003126279,0.000121637124,0.000074233234,0.00007164079,0.00010840397,0.00027159785],"category_scores_gemma":[0.00018255202,0.00018561492,0.000061102306,0.00054847717,0.00005583095,0.00010892232,0.00006193188,0.00033882124,0.00018608026],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014085437,0.0026987412,0.3308734,0.0014476109,0.00045876292,0.009959168,0.0012733192,0.000031048497,0.64225036,0.0015754653,0.0045216163,0.0035019466],"study_design_scores_gemma":[0.019633774,0.00051032123,0.8699499,0.0010068926,0.00022281717,0.00023246084,0.0005128404,0.0007102065,0.05746017,0.00082115486,0.048351124,0.00058838225],"about_ca_topic_score_codex":0.00007539359,"about_ca_topic_score_gemma":0.000073592884,"teacher_disagreement_score":0.5847902,"about_ca_system_score_codex":0.0000773421,"about_ca_system_score_gemma":0.00017114558,"threshold_uncertainty_score":0.7569156},"labels":[],"label_agreement":null},{"id":"W4405047446","doi":"10.1182/blood-2024-201096","title":"Iron and B12 Deficiency Has Rarely Been Considered in Studies Defining Hemoglobin Concentration Reference Intervals in Pregnancy: A Systematic Review","year":2024,"lang":"en","type":"review","venue":"Blood","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of British Columbia; University of Toronto","funders":"","keywords":"Medicine; Mean corpuscular volume; Pregnancy; Vitamin B12; Anemia; Iron deficiency; Iron-deficiency anemia; Population; Hemoglobin; Observational study; Pediatrics; Obstetrics; Internal medicine; Environmental health","score_opus":0.1787603892980997,"score_gpt":0.41359700906173863,"score_spread":0.23483661976363893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405047446","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00046300364,0.9940598,3.261558e-7,0.00011682554,0.00004892387,0.004581592,0.000028308576,0.00003642464,0.0006648078],"genre_scores_gemma":[0.0035668449,0.9952487,0.00007716369,0.000059168382,0.000012756334,0.0007465436,0.0000752415,0.000039040617,0.00017458759],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9965512,0.00051775505,0.001534767,0.0006191622,0.00037801758,0.00039905647],"domain_scores_gemma":[0.99868405,0.00042696658,0.00029095815,0.00041557688,0.00010092652,0.000081497696],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001005931,0.00040947812,0.0035910236,0.00030268467,0.000039035418,0.000072770235,0.0001554788,0.00023294732,0.000007306224],"category_scores_gemma":[0.0017455006,0.0002833126,0.00017623749,0.0007278926,0.00013156599,0.00008927394,0.00018598615,0.00071120285,0.00008850986],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000032216087,0.00014699454,0.000032804168,0.98101246,0.00018531458,0.0006490788,0.00043767085,4.860926e-9,0.0000018746024,0.00014603535,0.0000945196,0.017290035],"study_design_scores_gemma":[0.0008073403,0.00027610137,0.00001566876,0.99166834,0.005141761,0.00053857674,0.00017735828,0.0000034259067,0.0000018960103,0.000038079394,0.001093118,0.00023830726],"about_ca_topic_score_codex":0.000041605737,"about_ca_topic_score_gemma":0.000109165565,"teacher_disagreement_score":0.017051728,"about_ca_system_score_codex":0.00018475819,"about_ca_system_score_gemma":0.0006154821,"threshold_uncertainty_score":0.9999619},"labels":[],"label_agreement":null},{"id":"W4405047455","doi":"10.1182/blood-2024-208842","title":"Immune and Tumor Mediators of Resistance to Daratumumab-IMiDs Based Therapies in Relapsed Multiple Myeloma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Daratumumab; Pomalidomide; Lenalidomide; CD38; Multiple myeloma; Cancer research; Immune system; Immunology; Medicine; Internal medicine; Biology; Oncology; CD34; Stem cell","score_opus":0.012634975666536784,"score_gpt":0.27417086489991216,"score_spread":0.2615358892333754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405047455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896472,0.008109884,0.000010298598,0.00084122893,0.00006236575,0.00060968427,0.000054364777,0.000055537286,0.0006094516],"genre_scores_gemma":[0.997249,0.000058718986,0.001985035,0.000057043864,0.000036639893,0.0001054941,0.000021617236,0.000027675418,0.0004587863],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998794,0.00005642447,0.00027395802,0.00029218107,0.00031093784,0.00027245205],"domain_scores_gemma":[0.99920595,0.0002673387,0.000027342756,0.0002772964,0.000049229537,0.00017284494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021377853,0.00014526822,0.0003109062,0.000291134,0.000036808,0.000020517125,0.000073861374,0.000049612136,0.000052394553],"category_scores_gemma":[0.0003303598,0.00011390515,0.00006141823,0.00043954668,0.00007984118,0.00003985044,0.000035656587,0.00015428364,0.000018604262],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045145345,0.0026687435,0.7282325,0.0023426241,0.0008428406,0.0044191843,0.0036802527,0.0000049042424,0.24177982,0.00039415568,0.00084760395,0.010272827],"study_design_scores_gemma":[0.014741171,0.0007285393,0.8122514,0.0012176399,0.00010429271,0.00002102651,0.00030479283,0.0005410471,0.16744496,0.00007538342,0.0023787546,0.00019102296],"about_ca_topic_score_codex":0.00007873829,"about_ca_topic_score_gemma":0.000339515,"teacher_disagreement_score":0.084018864,"about_ca_system_score_codex":0.00003906212,"about_ca_system_score_gemma":0.00014383093,"threshold_uncertainty_score":0.46449172},"labels":[],"label_agreement":null},{"id":"W4405047501","doi":"10.1182/blood-2024-203718","title":"A Phase 1, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered SRSD107 in Healthy Subjects","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Tolerability; Pharmacodynamics; Hemostasis; Thrombosis; Pharmacokinetics; Pharmacology; Deep vein; Stroke (engine); Internal medicine; Adverse effect","score_opus":0.040409646524041505,"score_gpt":0.36912337014500546,"score_spread":0.32871372362096396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405047501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913654,0.0039786655,0.000025809924,0.0019901963,0.00038138998,0.0018579904,0.00004689263,0.00008608293,0.00026759598],"genre_scores_gemma":[0.9988974,0.00021668393,0.00011121787,0.00037762712,0.00019456643,0.00003095706,0.000020205063,0.000044795335,0.00010655795],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9977963,0.00018652937,0.00071176875,0.00049724145,0.000432264,0.0003758932],"domain_scores_gemma":[0.9989041,0.0003713462,0.00006953139,0.00032882884,0.000095638636,0.00023054148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096593786,0.00024889546,0.00047750474,0.00024323496,0.00009144493,0.000059848517,0.00013926679,0.000047528905,0.00008251113],"category_scores_gemma":[0.00013291788,0.00019554899,0.000097652664,0.0005896278,0.00008670527,0.000073694995,0.0001252282,0.00022403427,0.000007633748],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02708918,0.08895774,0.29149804,0.004631915,0.0022781538,0.0041405656,0.08711535,0.00025232314,0.27276668,0.00067373127,0.0007363693,0.21985996],"study_design_scores_gemma":[0.2914429,0.12817298,0.23470946,0.0059928657,0.014303023,0.0059251133,0.017618971,0.12222998,0.16386834,0.0015224147,0.010091214,0.004122759],"about_ca_topic_score_codex":0.00015631199,"about_ca_topic_score_gemma":0.00026907455,"teacher_disagreement_score":0.26435372,"about_ca_system_score_codex":0.00008279095,"about_ca_system_score_gemma":0.00020659834,"threshold_uncertainty_score":0.7974256},"labels":[],"label_agreement":null},{"id":"W4405047598","doi":"10.1182/blood-2024-202145","title":"Feasibility, Safety and Effectiveness of Intranasal Fentanyl in the Treatment of Acute Pain Episodes Among Adults with Sickle Cell Disease: A Retrospective Single Center Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Fentanyl; Single Center; Retrospective cohort study; Nasal administration; Acute pain; Sickle cell anemia; Disease; Anesthesia; Surgery; Internal medicine; Pharmacology","score_opus":0.011076720387098008,"score_gpt":0.27656348681509924,"score_spread":0.26548676642800123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405047598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99628335,0.0009610563,0.000021738288,0.000093303715,0.000021151503,0.0023487997,0.0000892951,0.000019496056,0.00016179557],"genre_scores_gemma":[0.9996887,0.0001731133,0.000012749027,0.000014806885,0.000022018274,0.000065272565,0.0000071348345,0.000009356098,0.0000068891295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99874514,0.00046022574,0.00017543227,0.00028614773,0.00018996042,0.00014309493],"domain_scores_gemma":[0.9991628,0.00056399766,0.00003895162,0.00014184357,0.000035590172,0.00005680618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050271663,0.00015272097,0.00041892746,0.00004772861,0.000034372548,0.000009112878,0.00004449932,0.000024932362,0.000005223889],"category_scores_gemma":[0.000029563034,0.000075162825,0.000070303526,0.0002029741,0.00018946572,0.000036032285,0.000024135301,0.00008432295,1.8286518e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004713472,0.019789945,0.9663387,0.000731335,0.0007216701,0.00043718793,0.0038491748,0.0000016110506,0.0030479615,0.000013685012,0.000002188591,0.0003530562],"study_design_scores_gemma":[0.010944663,0.014078135,0.9656359,0.0004825494,0.001160792,0.000004870841,0.0008315754,0.00007262031,0.006663999,0.00004873391,0.000002722359,0.000073468735],"about_ca_topic_score_codex":0.00009421519,"about_ca_topic_score_gemma":0.00014336778,"teacher_disagreement_score":0.006231191,"about_ca_system_score_codex":0.00007532737,"about_ca_system_score_gemma":0.00001898495,"threshold_uncertainty_score":0.3065051},"labels":[],"label_agreement":null},{"id":"W4405047616","doi":"10.1182/blood-2024-207584","title":"Clinical Approach to “Pathologically Ambiguous Follicular Lymphoma”: A Real-World Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Follicular lymphoma; Lymphoma; Referral; Cohort; Incidence (geometry); Internal medicine; Pediatrics; Pathology; Family medicine","score_opus":0.044821113352813996,"score_gpt":0.3485662788225161,"score_spread":0.3037451654697021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405047616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96140206,0.00077409163,0.000034154546,0.00039897877,0.00022853786,0.0013786452,0.00001007152,0.00035484857,0.035418626],"genre_scores_gemma":[0.9929671,0.00012484448,0.0032005557,0.00073543016,0.00040494543,0.00047752573,0.0000229406,0.00003731295,0.0020292923],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979059,0.00012314082,0.0004958772,0.00076491106,0.00037616352,0.0003340253],"domain_scores_gemma":[0.99888486,0.000094826486,0.00003338507,0.0005839248,0.00005101369,0.0003520152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005036279,0.00024120869,0.00055953296,0.00015249554,0.00007309807,0.00008188913,0.00012838833,0.00010053126,0.000038159807],"category_scores_gemma":[0.00008659061,0.0001612215,0.000315326,0.00050164526,0.00003902406,0.00003366316,0.00011604121,0.00009581678,0.00048781963],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021684587,0.08567211,0.7849907,0.00013771797,0.0019957246,0.016038349,0.0012295652,0.0000034371412,0.00015458843,0.0017780516,0.0044376296,0.10334526],"study_design_scores_gemma":[0.007912488,0.003005957,0.97740567,0.00010891702,0.0016117404,0.0002805637,0.00019263267,0.00003649174,0.00019187947,0.000057815334,0.008982646,0.00021320953],"about_ca_topic_score_codex":0.000265362,"about_ca_topic_score_gemma":0.00003380889,"teacher_disagreement_score":0.19241494,"about_ca_system_score_codex":0.00009011069,"about_ca_system_score_gemma":0.00014586665,"threshold_uncertainty_score":0.6574422},"labels":[],"label_agreement":null},{"id":"W4405047635","doi":"10.1182/blood-2024-203274","title":"Improvements in Hematological Parameters and Quality of Life (QOL) with Elritercept (KER-050): Results from an Ongoing Phase 2 Trial in Participants with Lower-Risk (LR) Myelodysplastic Neoplasms (MDS)","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; International Prognostic Scoring System; Anemia; Myelodysplastic syndromes; Quality of life (healthcare); Internal medicine; Population; Physical therapy; Oncology; Bone marrow","score_opus":0.05733324950854096,"score_gpt":0.3573693669964672,"score_spread":0.30003611748792625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405047635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976892,0.00017069788,0.00009366107,0.00020989394,0.00007680688,0.0013867924,0.0002321813,0.00006831971,0.00007246944],"genre_scores_gemma":[0.9975127,0.00007585861,0.0019525565,0.00008289406,0.00008227202,0.000113662776,0.00010252302,0.000044088792,0.00003343976],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9962626,0.00043567168,0.0009894903,0.0009069321,0.00070545723,0.0006998489],"domain_scores_gemma":[0.9974209,0.0013062872,0.0002067857,0.0005403787,0.00006487012,0.0004607989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001326901,0.00033047635,0.0009667907,0.00030951804,0.00004283845,0.00007389252,0.00017141143,0.00021316606,0.000034542867],"category_scores_gemma":[0.0017260944,0.00022600978,0.000058807287,0.00061941246,0.0002881427,0.00022613745,0.00010561714,0.0008015264,0.0000086492955],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5688467,0.012161406,0.38072667,0.0009519473,0.0012690679,0.004339094,0.0073149554,0.0001326712,0.015945958,0.00005799436,0.00009311711,0.008160433],"study_design_scores_gemma":[0.78449017,0.030699288,0.14830746,0.0028810443,0.0009960037,0.00008347129,0.002756436,0.017650766,0.0110389665,0.00012213232,0.00004376687,0.0009304861],"about_ca_topic_score_codex":0.004143489,"about_ca_topic_score_gemma":0.003289047,"teacher_disagreement_score":0.23241921,"about_ca_system_score_codex":0.00011137473,"about_ca_system_score_gemma":0.0005651288,"threshold_uncertainty_score":0.9216412},"labels":[],"label_agreement":null},{"id":"W4405047640","doi":"10.1182/blood-2024-208908","title":"Impact of Cooperating Myeloid Gene Mutations on Disease Progression and Survival in Japanese MPN Patients: A Multicenter Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Chugai Pharmaceutical; Sierra Oncology; Eisai","keywords":"Myelofibrosis; Essential thrombocythemia; Internal medicine; Myeloid leukemia; Polycythemia vera; Medicine; Myeloid; Oncology; Gene mutation; Immunology; Gastroenterology; Mutation; Biology; Bone marrow; Genetics; Gene","score_opus":0.015254960949132115,"score_gpt":0.32894043992126243,"score_spread":0.31368547897213034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405047640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99804765,0.00037937818,4.6393237e-7,0.00007421735,0.00004998367,0.0012634033,0.00006671677,0.000023143253,0.00009504399],"genre_scores_gemma":[0.9995089,0.00002909979,0.00008753376,0.000015349426,0.000037296875,0.00020229195,0.00008302231,0.000017306993,0.000019164185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908245,0.000077410856,0.0002325874,0.0002628699,0.00021154658,0.00013312316],"domain_scores_gemma":[0.9994978,0.00012651696,0.00003328952,0.00012958406,0.00008199086,0.00013086434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008882768,0.00014243324,0.00022215252,0.00011660361,0.00004123996,0.000028947226,0.000021062622,0.000023949538,0.00003448733],"category_scores_gemma":[0.00014715033,0.00009035209,0.000055308694,0.00015803262,0.000024675788,0.000057170302,0.000025336138,0.000087611785,0.0000065801655],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030224,0.012870909,0.98074645,0.00008729299,0.00023163122,0.00020180136,0.0031964928,0.000017623031,0.00036355658,0.000007973587,0.000006226044,0.0019677968],"study_design_scores_gemma":[0.0074636065,0.0027553008,0.9874456,0.00047401123,0.00025985428,0.0000017483719,0.0002627814,0.00045251145,0.0008043942,0.0000016866015,0.0000023525577,0.00007615178],"about_ca_topic_score_codex":0.00007935704,"about_ca_topic_score_gemma":0.00004930077,"teacher_disagreement_score":0.010115608,"about_ca_system_score_codex":0.000042254032,"about_ca_system_score_gemma":0.000073743766,"threshold_uncertainty_score":0.36844516},"labels":[],"label_agreement":null},{"id":"W4405047663","doi":"10.1182/blood-2024-211815","title":"Development of a UM171-Supported, CD33 Epitope-Engineered Blood Stem Cell Graft for Advanced AML Therapies","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Université de Montréal","funders":"","keywords":"Stem cell; Epitope; CD33; Medicine; Peripheral Blood Stem Cells; Immunology; Internal medicine; Transplantation; Biology; Hematopoietic stem cell transplantation; Antibody; CD34; Cell biology","score_opus":0.010122317741097243,"score_gpt":0.23222767857708762,"score_spread":0.2221053608359904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405047663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886293,0.008251643,0.0022321097,0.000033316785,0.00020054198,0.00026276943,0.00006050137,0.00002856249,0.0003012671],"genre_scores_gemma":[0.99081314,0.0005574484,0.0068224072,0.00004219266,0.00011094134,0.00010305854,0.00012007437,0.000031135078,0.0013996072],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99906117,0.00001243244,0.00028325635,0.00032332138,0.000093929455,0.00022588857],"domain_scores_gemma":[0.9995652,0.0000135478995,0.000050541068,0.00023808377,0.00008160479,0.000051041574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000099556324,0.00017210844,0.00016953619,0.00005404505,0.000039669034,0.000023496334,0.00018144322,0.00011286264,0.000017226224],"category_scores_gemma":[0.0000053042795,0.000152966,0.00013191784,0.00007230777,0.000024701154,0.0000053308445,0.000053779942,0.000055320204,0.000011395814],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040126113,0.00021081345,0.000068934976,0.00017591062,0.00033777338,0.00000583234,0.00040033952,0.000009377483,0.98436224,0.000025929969,0.00034023554,0.014022493],"study_design_scores_gemma":[0.0009805191,0.00035374277,0.00010034064,0.000057656056,0.00010529018,0.000010441598,0.00027958033,0.000017756702,0.96061224,0.000022236587,0.037265263,0.00019491844],"about_ca_topic_score_codex":0.0000015825734,"about_ca_topic_score_gemma":0.000009747359,"teacher_disagreement_score":0.036925025,"about_ca_system_score_codex":0.0000036988752,"about_ca_system_score_gemma":0.00013892956,"threshold_uncertainty_score":0.6237772},"labels":[],"label_agreement":null},{"id":"W4405047874","doi":"10.1182/blood-2024-193368","title":"Results from the Hemophilia Α Cohort of the Non-Investigational Lead-in Study: Prospective Collection of Bleeding Rate in Participants with Hemophilia Α Prior to Phase 3 Study (AFFINE) of Giroctocogene Fitelparvovec","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada); McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Medicine; Clinical endpoint; Clinical trial; Prospective cohort study; Hemarthrosis; Internal medicine; Cohort; Phases of clinical research; Pediatrics; Surgery","score_opus":0.04122781204670945,"score_gpt":0.3353218732716381,"score_spread":0.29409406122492865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405047874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99122506,0.000081194186,0.0000015556898,0.0010025944,0.00006614732,0.007292228,0.00009713608,0.000014916968,0.00021914695],"genre_scores_gemma":[0.99881804,0.000007806871,0.000081093756,0.000015802172,0.00008497653,0.00038737553,0.000012628486,0.000024585917,0.0005676669],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99756515,0.00019184979,0.0007453343,0.00047926247,0.00073032064,0.00028810176],"domain_scores_gemma":[0.99864125,0.00046431503,0.0001405881,0.0004448616,0.00022136186,0.000087616005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011802496,0.00020257781,0.00054193824,0.00022967838,0.00006817388,0.000015168315,0.00019130486,0.00005999869,0.000018948092],"category_scores_gemma":[0.00054685964,0.00010943605,0.000073757576,0.0019072602,0.00016462062,0.00006616498,0.00009932047,0.0002677352,0.0000037057282],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024950851,0.00867634,0.9155222,0.00007799273,0.0006637114,0.00009063587,0.0124799935,0.0001046699,0.059615742,0.000007831158,0.000048459402,0.00021734455],"study_design_scores_gemma":[0.015996525,0.0032469665,0.8036065,0.0006476122,0.00045052634,0.00000348134,0.0019902363,0.00053970685,0.17338064,0.000048383557,0.0000029683274,0.00008645918],"about_ca_topic_score_codex":0.00096243917,"about_ca_topic_score_gemma":0.0014288457,"teacher_disagreement_score":0.113764904,"about_ca_system_score_codex":0.000112033915,"about_ca_system_score_gemma":0.0005191174,"threshold_uncertainty_score":0.44626728},"labels":[],"label_agreement":null},{"id":"W4405047886","doi":"10.1182/blood-2024-194382","title":"Treatment with First-Line Ibrutinib Improves Overall Survival in Patients with Chronic Lymphocytic Leukemia (CLL) and High-Risk Genomic Features to Rates Approximating an Age-Matched US Population: Pooled Analysis of Phase 3 Trials with 10 Years of Follow-up","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Moderna; Juno Therapeutics; Incyte; BeiGene; Pharmacyclics; Genentech; MEI Pharma; TG Therapeutics; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; MorphoSys; Celgene; Seagen; Gilead Sciences","keywords":"Ibrutinib; Chronic lymphocytic leukemia; Internal medicine; Medicine; Oncology; Population; Survival analysis; Leukemia; Immunology","score_opus":0.017889824188294642,"score_gpt":0.3004515958929991,"score_spread":0.2825617717047044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405047886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99710757,0.00081952114,0.00004258213,0.000015141829,0.000033174925,0.0017469868,0.00017035911,0.000050666888,0.000013988941],"genre_scores_gemma":[0.99716467,0.00010005108,0.0017705306,0.0000073812475,0.00008084742,0.00010126854,0.0005668539,0.00006950465,0.00013887757],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971935,0.00020389167,0.00083372585,0.0006830398,0.00065772544,0.0004281051],"domain_scores_gemma":[0.99810976,0.00056540605,0.00036549979,0.00059403584,0.00014214596,0.00022314329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059139426,0.00037163534,0.0016907493,0.00066718296,0.00005321932,0.0000694759,0.00013084037,0.00012589984,0.000037115566],"category_scores_gemma":[0.0002094755,0.00024136773,0.00014095429,0.0011820658,0.00011533816,0.00014093527,0.000058301157,0.00013310392,0.0000014405595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.14942373,0.009131881,0.5179782,0.007699777,0.08474431,0.0022780914,0.016256083,0.08081994,0.027396958,0.00017241729,0.00003213522,0.104066454],"study_design_scores_gemma":[0.3524104,0.024713304,0.5423595,0.0011497572,0.020012321,0.00003728606,0.00019969135,0.0503869,0.008117612,0.000022915914,0.000012493837,0.0005778425],"about_ca_topic_score_codex":0.020588897,"about_ca_topic_score_gemma":0.009650423,"teacher_disagreement_score":0.20298667,"about_ca_system_score_codex":0.009772654,"about_ca_system_score_gemma":0.0057709566,"threshold_uncertainty_score":0.9998654},"labels":[],"label_agreement":null},{"id":"W4405047896","doi":"10.1182/blood-2024-194550","title":"Apex Part 2 Trial in Progress: A Phase 2 Open-Label Clinical Study of Bezuclastinib in Adult Patients with Advanced Systemic Mastocytosis","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Samsung; Italfarmaco; Scheme for Promotion of Academic and Research Collaboration; Swedish Orphan Biovitrum; Servier; Department of Health, Government of Western Australia; Astellas Pharma; CTI Biopharma; F. Hoffmann-La Roche; Incyte; Ascentage Pharma; Jazz Pharmaceuticals; Regeneron Pharmaceuticals; Alexion Pharmaceuticals; Gilead Sciences; MorphoSys; Celgene; AstraZeneca; Bristol-Myers Squibb; Amgen","keywords":"Systemic mastocytosis; Medicine; Apex (geometry); Clinical trial; Phases of clinical research; Internal medicine; Bone marrow","score_opus":0.030096330908621734,"score_gpt":0.3280439072700009,"score_spread":0.29794757636137914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405047896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99514073,0.001124209,0.0000014424511,0.000017009177,0.00057620887,0.0028263717,0.00008625261,0.00002520585,0.00020254709],"genre_scores_gemma":[0.99909484,0.000033992732,0.00005819139,0.000011546481,0.000029900148,0.00040772182,0.00009508527,0.000020950563,0.00024775288],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99805707,0.0002969466,0.00086217414,0.0004630468,0.00005780362,0.00026297907],"domain_scores_gemma":[0.99932265,0.00014668274,0.00016890645,0.00026421904,0.00007464047,0.000022884591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000343252,0.000174541,0.00058330136,0.00014639169,0.00003170661,0.000020839358,0.0002795412,0.0001532229,0.000102319726],"category_scores_gemma":[0.000071977825,0.00013291831,0.000029024937,0.00032522457,0.00011138362,0.00009047965,0.00013301214,0.0003229543,0.000033413726],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20119418,0.32271862,0.37452465,0.0009665949,0.0015119595,0.00034739752,0.0049894094,0.0000073301176,0.003726808,0.00028223282,0.00085741497,0.08887341],"study_design_scores_gemma":[0.94959575,0.03683923,0.0058472836,0.0015102932,0.00032556037,0.000013861403,0.0010215037,0.000014173029,0.00059250876,0.00000458845,0.0038712344,0.00036400725],"about_ca_topic_score_codex":0.00005871756,"about_ca_topic_score_gemma":0.0004495282,"teacher_disagreement_score":0.7484016,"about_ca_system_score_codex":0.000017647142,"about_ca_system_score_gemma":0.000101214035,"threshold_uncertainty_score":0.54202515},"labels":[],"label_agreement":null},{"id":"W4405047918","doi":"10.1182/blood-2024-208203","title":"Mutational and Clinical Characteristics Associated with Atherosclerotic Disease Burden in the MDS Canada Database: A Single-Center Analysis of CT Coronary Artery Calcium Scores","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Coronary artery disease; Internal medicine; Myelodysplastic syndromes; Database; Cardiology; Family history; Oncology; Bone marrow","score_opus":0.040636675609001506,"score_gpt":0.31023647736809995,"score_spread":0.2695998017590984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405047918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973493,0.00019738055,0.000023962997,0.0009935845,0.000035137582,0.00031261996,0.001043286,0.000012815415,0.000031865577],"genre_scores_gemma":[0.99815124,0.000024469779,0.00003811576,0.00031362078,0.000085441134,0.000019674217,0.0012680572,0.000016961094,0.00008241086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984693,0.00017738709,0.00034692188,0.00026649353,0.0005358446,0.00020403475],"domain_scores_gemma":[0.99864286,0.00081272924,0.00006207938,0.0002556757,0.00008100101,0.00014567863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043698677,0.00011623808,0.0003248981,0.00015715725,0.000031738346,0.000031340976,0.00010755531,0.000028475846,0.000052267438],"category_scores_gemma":[0.00044893473,0.000074927506,0.000066481625,0.00061275624,0.00016499306,0.000050427352,0.000051056417,0.00029776583,0.0000011633435],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019986524,0.0006719736,0.9916166,0.00009662034,0.0021405471,0.0041829976,0.00013245079,0.0000040869063,0.00022245814,0.0000141720075,0.00035527578,0.00036292645],"study_design_scores_gemma":[0.00194685,0.00017133354,0.98755944,0.0003268486,0.0028151164,0.000076401404,0.00012756296,0.0068221823,0.000009893793,0.0000022835334,0.0000633866,0.00007868857],"about_ca_topic_score_codex":0.012509975,"about_ca_topic_score_gemma":0.04876335,"teacher_disagreement_score":0.036253378,"about_ca_system_score_codex":0.0001409222,"about_ca_system_score_gemma":0.001358461,"threshold_uncertainty_score":0.9940658},"labels":[],"label_agreement":null},{"id":"W4405047930","doi":"10.1182/blood-2024-204999","title":"Prognostic Implication of Framingham Risk Score As a Comorbidity Measure on Treatment Outcomes Following First-Line Tyrosine Kinase Inhibitor in Newly Diagnosed CML Patients","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Comorbidity; Internal medicine; Framingham Risk Score; Tyrosine-kinase inhibitor; Oncology; Second line treatment; Tyrosine kinase; Disease; Cancer; Overall survival","score_opus":0.020487231727785323,"score_gpt":0.2813010690425929,"score_spread":0.26081383731480756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405047930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955658,0.0014162549,0.000010554817,0.00029814485,0.00028305053,0.002029703,0.00013154837,0.00013503426,0.00012993725],"genre_scores_gemma":[0.99860567,0.00020373655,0.00018753445,0.00004640189,0.000102757884,0.00036334732,0.00031521032,0.000059531438,0.0001158032],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998002,0.000067867586,0.000530936,0.00055197557,0.00051329687,0.00033390746],"domain_scores_gemma":[0.99859846,0.00048715892,0.0001434619,0.00053501263,0.000078204255,0.00015769496],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000156071,0.0003680101,0.0006029679,0.0002455307,0.00006784043,0.00002630362,0.000089308116,0.00016086377,0.000028889148],"category_scores_gemma":[0.0009605523,0.00027247425,0.0002834234,0.00042341292,0.000037021055,0.0000870113,0.00004194334,0.00023310562,0.00007108795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010360561,0.008086224,0.97510433,0.00020148268,0.00048348436,0.00040974427,0.0005725291,0.000021676895,0.00035977247,0.00001614825,0.00004876586,0.0145922275],"study_design_scores_gemma":[0.022384865,0.0035851516,0.95623195,0.0018187915,0.001408443,0.0000075270195,0.000024914147,0.00013898253,0.01390636,0.000063583095,0.00022096095,0.00020848648],"about_ca_topic_score_codex":0.0021021573,"about_ca_topic_score_gemma":0.0005893604,"teacher_disagreement_score":0.02228126,"about_ca_system_score_codex":0.001045085,"about_ca_system_score_gemma":0.00039763493,"threshold_uncertainty_score":0.99997276},"labels":[],"label_agreement":null},{"id":"W4405047933","doi":"10.1182/blood-2024-205652","title":"Primary Care Screening for Von Willebrand Disease in African American Adolescents with Heavy Menstrual Bleeding","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Von Willebrand disease; Medicine; Menstrual bleeding; Von Willebrand factor; Primary care; Internal medicine; Pediatrics; Gynecology; Family medicine; Platelet","score_opus":0.009325300885702862,"score_gpt":0.24408023048229008,"score_spread":0.23475492959658723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405047933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959589,0.00235905,0.00010570068,0.00022306737,0.000038280665,0.0005797155,0.00006904027,0.00007722543,0.0005890163],"genre_scores_gemma":[0.998287,0.00004428589,0.0011954915,0.000114950686,0.00006839991,0.00006925838,0.00013208528,0.000037838672,0.000050661292],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909484,0.000009472574,0.00012918175,0.0003059786,0.0001798486,0.00028066194],"domain_scores_gemma":[0.9996353,0.000017513978,0.000027540154,0.000118774515,0.000026319609,0.00017455597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000032876866,0.00015618475,0.0002819094,0.00012918416,0.000051224582,0.000031192038,0.000040176346,0.000023361534,0.000002646828],"category_scores_gemma":[0.00000856769,0.00011932284,0.00006477939,0.00025489018,0.000055325054,0.000069612615,0.000018833554,0.00010131652,0.000002417752],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021287212,0.000780317,0.9531892,0.0016711822,0.000324297,0.0025364405,0.0012561757,0.000013202763,0.0003002097,0.000018673052,0.000052238727,0.037729353],"study_design_scores_gemma":[0.037305865,0.0033465503,0.9338624,0.0124971615,0.0029632046,0.00021439214,0.0042819544,0.0009360109,0.001520582,0.00007378133,0.0021448804,0.0008532418],"about_ca_topic_score_codex":0.00009893545,"about_ca_topic_score_gemma":0.00005393672,"teacher_disagreement_score":0.03687611,"about_ca_system_score_codex":0.000055608663,"about_ca_system_score_gemma":0.000110468034,"threshold_uncertainty_score":0.48658442},"labels":[],"label_agreement":null},{"id":"W4405047980","doi":"10.1182/blood-2024-193118","title":"Revised International Working Group Risk Model for Survival in Polycythemia Vera","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Polycythemia vera; Internal medicine; Receiver operating characteristic; Venous thrombosis; Cohort; Leukocytosis; Thrombosis; Gastroenterology; Surgery","score_opus":0.03004400889671403,"score_gpt":0.2971240487684494,"score_spread":0.26708003987173534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405047980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98717856,0.0019893157,0.003398826,0.0017543421,0.0005155827,0.0007152467,0.00007252873,0.00008998133,0.004285624],"genre_scores_gemma":[0.9945431,0.00046933576,0.0036669096,0.0001186749,0.0003524056,0.00022713543,0.00007594394,0.000023683402,0.0005228523],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9992085,0.00001730961,0.00019035477,0.0002629427,0.00016352898,0.00015735108],"domain_scores_gemma":[0.99960387,0.00017162856,0.000027973592,0.00011545524,0.000025155363,0.000055919754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001829628,0.00011702403,0.00019288377,0.00009962937,0.000031562628,0.0000411714,0.000051032763,0.00005294469,0.000051486837],"category_scores_gemma":[0.00007380494,0.0000936013,0.00010407544,0.00009542003,0.000012357261,0.000042094674,0.000022040274,0.00012996608,0.000017617971],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007769396,0.0032539768,0.912749,0.00033010734,0.0015970157,0.00041774326,0.0020385247,0.00031987342,0.0020939764,0.024663411,0.0020059003,0.049753524],"study_design_scores_gemma":[0.046469554,0.0013644713,0.1697733,0.0052862396,0.0024294937,0.0001565779,0.00023469349,0.70985687,0.015261627,0.007879697,0.040224086,0.0010633975],"about_ca_topic_score_codex":0.000020806894,"about_ca_topic_score_gemma":0.00004983315,"teacher_disagreement_score":0.7429757,"about_ca_system_score_codex":0.0000684613,"about_ca_system_score_gemma":0.00005692892,"threshold_uncertainty_score":0.38169503},"labels":[],"label_agreement":null},{"id":"W4405048013","doi":"10.1182/blood-2024-209053","title":"A Hgb Exceeding 120g/L Does Not Increase Risk of Vascular Complications or Disease Progression in Patients with MDS Treated with Erythropoietic Stimulating Agents, a Single-Institution Retrospective Study of the MDS-CAN Registry","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Anemia; Internal medicine; Logistic regression; Incidence (geometry); Retrospective cohort study; Log-rank test; Surgery; Survival analysis","score_opus":0.014593071036558826,"score_gpt":0.26879154635727515,"score_spread":0.2541984753207163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405048013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997434,0.00009036831,0.000017532622,0.00016069041,0.000025492129,0.0019869078,0.0000957747,0.0000655509,0.00012363539],"genre_scores_gemma":[0.99920654,0.000020274434,0.00051464804,0.000009032127,0.000027273332,0.000113358576,0.00004593831,0.00003026006,0.000032679796],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835527,0.000105344385,0.000366515,0.00042481555,0.00056244055,0.00018563944],"domain_scores_gemma":[0.99885446,0.000051377585,0.00024663625,0.0005042129,0.00022546563,0.00011786569],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012286694,0.00022610663,0.00035828928,0.000121612655,0.0001539379,0.000023341716,0.0000905875,0.000049577888,0.000012852077],"category_scores_gemma":[0.00017838737,0.00010406668,0.000073651376,0.00073497597,0.00024708558,0.00006850547,0.00005943119,0.00019807638,5.449977e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095999904,0.01088655,0.9848258,0.00039327712,0.0004766933,0.00008030475,0.0013850528,0.000075573385,0.00044458828,0.00002207141,0.0000039979086,0.00044608128],"study_design_scores_gemma":[0.011254068,0.0029942829,0.9760787,0.0045247567,0.002256315,0.0000069473294,0.0012738332,0.00023457264,0.0012278459,0.000009747161,0.0000032173089,0.00013570079],"about_ca_topic_score_codex":0.0007847575,"about_ca_topic_score_gemma":0.00023907307,"teacher_disagreement_score":0.010294069,"about_ca_system_score_codex":0.00017910947,"about_ca_system_score_gemma":0.00018194766,"threshold_uncertainty_score":0.42437163},"labels":[],"label_agreement":null},{"id":"W4405048092","doi":"10.1182/blood-2024-207932","title":"Expression of Major Enzymes in NAD+ Synthesis in Patients with Multiple Myeloma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Beetle Biology and Toxicology Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Beatrice Hunter Cancer Research Institute; Nova Scotia Health Authority; Dalhousie University","funders":"","keywords":"NAD+ kinase; Multiple myeloma; Immunohistochemistry; Cancer research; Nicotinamide adenine dinucleotide; Pathology; In vivo; Downregulation and upregulation; Biopsy; Cancer; Medicine; Biology; Internal medicine; Enzyme; Biochemistry; Gene","score_opus":0.004737836988602501,"score_gpt":0.20610680461628933,"score_spread":0.20136896762768683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405048092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996922,0.0026490283,0.0000045046568,0.00003589452,0.00005063695,0.00010092788,0.000020096968,0.0000057348675,0.00021114679],"genre_scores_gemma":[0.99960953,0.000040342235,0.000198142,0.00002036752,0.00002424977,0.000040764437,0.000015468147,0.00000788185,0.000043225864],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99947166,0.000044144992,0.00011919884,0.00020305475,0.00003877942,0.00012318137],"domain_scores_gemma":[0.99979013,0.00004423838,0.00002242887,0.0001134798,0.000015541833,0.000014190657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006665966,0.000082028375,0.0001195699,0.0000549595,0.00001587243,0.000002178965,0.00006777065,0.00013868518,0.000007133355],"category_scores_gemma":[0.00008631397,0.00006085096,0.000023973646,0.00006916175,0.0000785032,0.000002147844,0.000057572342,0.000059273974,0.0000022349875],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015113817,0.00034323288,0.86664915,0.00003353345,0.00005099768,0.000009179859,0.000045897126,0.0000015450084,0.13202028,0.000029001718,0.00009955876,0.0005664947],"study_design_scores_gemma":[0.0006833589,0.00014682065,0.47035182,0.000056580444,0.000011728823,7.022634e-7,0.000019297711,9.409149e-7,0.52840114,0.00000853019,0.00026346164,0.00005561647],"about_ca_topic_score_codex":0.000010270682,"about_ca_topic_score_gemma":0.00021676444,"teacher_disagreement_score":0.39638087,"about_ca_system_score_codex":0.0000033139906,"about_ca_system_score_gemma":0.00002139343,"threshold_uncertainty_score":0.24814302},"labels":[],"label_agreement":null},{"id":"W4405048123","doi":"10.1182/blood-2024-210635","title":"Patients with Poor Functional Status at Intake Experience Early Failure of CAR T-Cell Therapy for Third Line Treatment of RR-LBCL","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Cart; Population; Internal medicine; Salvage therapy; Cohort; Univariate analysis; Retrospective cohort study; Surgery; Multivariate analysis; Chemotherapy","score_opus":0.024248885918860624,"score_gpt":0.2822549505573605,"score_spread":0.25800606463849984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405048123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99640405,0.0015808997,0.00004486835,0.00009526164,0.00008353323,0.0011104618,0.00016830929,0.000030943607,0.00048166685],"genre_scores_gemma":[0.9927626,0.00023313702,0.0005449305,0.00002634022,0.00011645814,0.0001778968,0.00012938959,0.000037512127,0.005971701],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987427,0.000021398771,0.00023059077,0.00028165552,0.00046638478,0.00025729992],"domain_scores_gemma":[0.9992224,0.00010892082,0.000055763136,0.00026309272,0.0002366207,0.00011320166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000054942124,0.00015764002,0.00029745122,0.00011091207,0.00003373209,0.000010747719,0.000051845585,0.00006794552,0.0006587391],"category_scores_gemma":[0.0000098377495,0.00010285913,0.0001318585,0.00019960724,0.000104142404,0.0000477157,0.000017145765,0.00007007473,0.0000074217787],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008970831,0.006653815,0.29108682,0.00036814698,0.001037604,0.000029908426,0.008833145,0.000007693271,0.6656695,0.000046278587,0.00065787777,0.016638374],"study_design_scores_gemma":[0.025858443,0.022732386,0.05765577,0.00013636467,0.00021364204,0.000009781279,0.00041977,0.000048018366,0.8621398,0.000019065541,0.030586604,0.00018032423],"about_ca_topic_score_codex":0.0001197578,"about_ca_topic_score_gemma":0.000029932597,"teacher_disagreement_score":0.23343106,"about_ca_system_score_codex":0.00009558616,"about_ca_system_score_gemma":0.00018748369,"threshold_uncertainty_score":0.7212732},"labels":[],"label_agreement":null},{"id":"W4405048320","doi":"10.1182/blood-2024-193967","title":"CMV Reactivation Pre and Post Letermovir Prophylaxis, a Single Centre Review of Clinical Outcomes and Resource Utilization","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital; BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Incidence (geometry); Umbilical cord; Hematopoietic stem cell transplantation; Single Center; Clinical trial; Graft-versus-host disease; Transplantation; Gastroenterology; Immunology","score_opus":0.06856027079555839,"score_gpt":0.3813176572485588,"score_spread":0.31275738645300044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405048320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96302617,0.03283489,0.000005913164,0.0019221313,0.00002735953,0.00055486965,0.000021078604,0.00003850437,0.0015690967],"genre_scores_gemma":[0.9871185,0.0107470825,0.00015516223,0.0004495533,0.000101823796,0.00000685923,0.000050081733,0.000021015949,0.0013499445],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989346,0.00007813184,0.0003802725,0.0002472237,0.00024294133,0.00011682556],"domain_scores_gemma":[0.9993778,0.000189383,0.000061749546,0.00017467345,0.00010116135,0.00009523217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046343624,0.00008975497,0.00032355246,0.00008402354,0.000029936306,0.000026088632,0.000031320888,0.00008641156,0.000045039145],"category_scores_gemma":[0.0007367531,0.00006517777,0.00006783012,0.00017431488,0.00009459982,0.00007592399,0.000052419542,0.00019108446,0.0000048619604],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043600102,0.0017028803,0.31365335,0.039354753,0.00044405856,0.00012287345,0.00088104466,4.036125e-8,0.036272023,0.00061521906,0.0025272048,0.60399055],"study_design_scores_gemma":[0.0027414348,0.001507092,0.75065655,0.014686644,0.00047245057,0.000094876275,0.000096911026,0.00008658859,0.004659217,0.00004271124,0.22475287,0.0002026647],"about_ca_topic_score_codex":0.00004046999,"about_ca_topic_score_gemma":0.000008820013,"teacher_disagreement_score":0.6037879,"about_ca_system_score_codex":0.0000096405465,"about_ca_system_score_gemma":0.00008091408,"threshold_uncertainty_score":0.2657872},"labels":[],"label_agreement":null},{"id":"W4405048325","doi":"10.1182/blood-2024-200265","title":"Open-Label Phase 1 Study to Evaluate the Safety of SGN-35T in Patients with Relapsed/Refractory CD30-Expressing Lymphoid Malignancies (SGN35T-001; trial in progress)","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Galderma; Eisai; Regeneron Pharmaceuticals; Alexion Pharmaceuticals","keywords":"Medicine; Refractory (planetary science); Open label; Internal medicine; Oncology; Phases of clinical research; Hematologic Neoplasms; Clinical trial; Cancer; Biology","score_opus":0.033274451831716796,"score_gpt":0.3390484901438522,"score_spread":0.3057740383121354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405048325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991719,0.0015867329,4.917243e-7,0.00028675154,0.00019025913,0.0057475464,0.00004833441,0.000031633692,0.00038924583],"genre_scores_gemma":[0.9986612,0.000029963496,0.00019660131,0.00009315537,0.00006573875,0.00076683314,0.000037461657,0.00003866939,0.00011033067],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9977248,0.0002177882,0.0006124095,0.0005027495,0.0006175368,0.0003247219],"domain_scores_gemma":[0.9989973,0.00017823411,0.00009496464,0.00051966705,0.00010574566,0.00010414723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007512343,0.00025989825,0.0005481548,0.00019684085,0.00006978516,0.000101552694,0.0002592049,0.000055954002,0.000043864587],"category_scores_gemma":[0.00010303456,0.00014680486,0.000043855493,0.0005410387,0.00007225581,0.00018811191,0.00020210083,0.00011941685,0.000019259767],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.059440896,0.18938705,0.70531267,0.00015299873,0.00071991474,0.00066183246,0.006081232,0.000007369008,0.00028558102,0.000059174017,0.0004326791,0.037458614],"study_design_scores_gemma":[0.6971803,0.020515414,0.27534744,0.0020801253,0.0009219153,0.000010925027,0.00069900154,0.000038909184,0.0020222766,0.000015963533,0.00090721535,0.00026054267],"about_ca_topic_score_codex":0.0002716258,"about_ca_topic_score_gemma":0.000106599364,"teacher_disagreement_score":0.63773936,"about_ca_system_score_codex":0.00022395013,"about_ca_system_score_gemma":0.00041511602,"threshold_uncertainty_score":0.59865284},"labels":[],"label_agreement":null},{"id":"W4405048335","doi":"10.1182/blood-2024-206077","title":"Excellent Outcome of Myeloablative TBI-Based Allogeneic Stem Cell Transplant in Adult Patients with Acute Lymphocytic Leukemia in MRD Negative CR1: Results from a Retrospective Canadian Cohort","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Medicine; Stem cell; Internal medicine; Oncology; Retrospective cohort study; Cohort; Acute lymphocytic leukemia; Leukemia; Transplantation; Total body irradiation; Cyclophosphamide; Chemotherapy; Lymphoblastic Leukemia","score_opus":0.008381379722225307,"score_gpt":0.23007441296624717,"score_spread":0.22169303324402187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405048335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930801,0.00010006646,0.000042120148,0.0001542347,0.000093591305,0.0018182086,0.0029092603,0.0000526514,0.0017497966],"genre_scores_gemma":[0.998316,0.000050420884,0.0004818806,0.00019513408,0.000035837333,0.0001339063,0.0004348403,0.00007823289,0.00027374996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962288,0.00016895423,0.0009325499,0.0009442274,0.00095060456,0.0007748275],"domain_scores_gemma":[0.99793786,0.0006164223,0.00015587544,0.0005153927,0.00032981872,0.00044461217],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030456905,0.00042903773,0.0008765993,0.0008091297,0.00004559744,0.00002829645,0.00025677608,0.0002766205,0.000042122385],"category_scores_gemma":[0.000099691024,0.00034027421,0.000121787794,0.0011271994,0.00019615165,0.00011033968,0.000037560636,0.0005662147,0.00003554063],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0046350444,0.00041014302,0.97854096,0.00028597531,0.00088907353,0.005644546,0.007894362,0.0006479435,0.0007175866,0.000027733036,0.0001402483,0.0001663582],"study_design_scores_gemma":[0.058133747,0.0014907349,0.89915,0.0021228916,0.0008854254,0.000015080667,0.0005643125,0.014871816,0.022198342,0.000045040757,0.00001942921,0.00050316093],"about_ca_topic_score_codex":0.37664956,"about_ca_topic_score_gemma":0.2320257,"teacher_disagreement_score":0.14462386,"about_ca_system_score_codex":0.018265234,"about_ca_system_score_gemma":0.011142511,"threshold_uncertainty_score":0.99990493},"labels":[],"label_agreement":null},{"id":"W4405048438","doi":"10.1182/blood-2024-211086","title":"Patient Reflections on the Consent Process for Donating Extra Bone Marrow Research Samples to a Hematology Biobank: A Qualitative Interview Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Bone marrow; Biobank; Informed consent; Clinical research; Hematology; Qualitative research; Intensive care medicine; Internal medicine; Family medicine; Surgery; Pathology; Alternative medicine; Bioinformatics","score_opus":0.8755925984100764,"score_gpt":0.7121146426838538,"score_spread":0.1634779557262226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405048438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91113704,0.001326197,0.00038000476,0.07942487,0.0001785751,0.004728897,0.000054783093,0.00009826869,0.0026713714],"genre_scores_gemma":[0.9941664,0.000060176826,0.0011193029,0.0009959037,0.000112166716,0.002697937,0.0000055363216,0.00003684028,0.0008057458],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9956732,0.001477349,0.0006024855,0.00061460614,0.0011546658,0.00047773164],"domain_scores_gemma":[0.9331287,0.064967714,0.00004757633,0.00049712573,0.0011796963,0.00017916191],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0150558185,0.0001384982,0.00033956312,0.00031325562,0.00032445672,0.00008197973,0.00021080513,0.00014241328,0.00010444841],"category_scores_gemma":[0.0668396,0.00008634084,0.000120407916,0.0009418527,0.00030188364,0.00002427563,0.00020315801,0.0018402529,0.000086327454],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016242327,0.017230108,0.000993162,0.009924433,0.0018847636,0.0006118122,0.47591314,0.000004180987,0.0068391855,0.46341264,0.009632966,0.011929385],"study_design_scores_gemma":[0.0049626557,0.040905766,0.0005342666,0.014597889,0.00047669833,0.00027720165,0.6024207,0.00014061306,0.021760125,0.2991178,0.014267158,0.0005391348],"about_ca_topic_score_codex":0.0001087128,"about_ca_topic_score_gemma":0.0015456022,"teacher_disagreement_score":0.16429484,"about_ca_system_score_codex":0.000089981855,"about_ca_system_score_gemma":0.00081375794,"threshold_uncertainty_score":0.9410208},"labels":[],"label_agreement":null},{"id":"W4405048568","doi":"10.1182/blood-2024-203983","title":"In Vitro and In Vivo Potency Differences between AAVRh74var and AAV5 Vectors Encoding the Same High-Activity Human Factor IX Variant, FIX-R338L, Expression Cassette: Implications for Hemophilia B Gene Therapy","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Capsid; Factor IX; Adeno-associated virus; Genetic enhancement; In vivo; Biology; Molecular biology; In vitro; Transgene; Recombinant DNA; Virology; Vector (molecular biology); Gene; Virus; Genetics","score_opus":0.03499840181854922,"score_gpt":0.31922121949552656,"score_spread":0.2842228176769773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405048568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957004,0.0022669896,0.00009315248,0.0010337414,0.000039677343,0.0005286045,0.00031402372,0.000012768622,0.000010643529],"genre_scores_gemma":[0.9986346,0.00070131174,0.000111605834,0.000058699636,0.00020884803,0.00015833383,0.000035585814,0.00002586239,0.00006519612],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99885684,0.00013275941,0.0001716287,0.00046365548,0.00009498525,0.0002801085],"domain_scores_gemma":[0.99946266,0.00011982594,0.000038973456,0.0002904718,0.000023372197,0.0000647173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023851212,0.0001757482,0.00018768893,0.0000941772,0.00015902461,0.00007829556,0.00018980917,0.0001418091,0.000010963755],"category_scores_gemma":[0.00002727061,0.00012876169,0.000044107925,0.00013863793,0.00008799727,0.000014282397,0.0000909136,0.0001621836,3.2804078e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016945464,0.00009017749,0.010290749,0.000023914306,0.000046332912,0.0000034722427,0.00015401703,9.25839e-7,0.98644525,0.000011068602,0.000029826348,0.0027347857],"study_design_scores_gemma":[0.0008649175,0.00048598525,0.08374973,0.00001923207,0.000011958318,0.000006130229,0.0000138438745,0.000015559863,0.91388655,0.0006304433,0.00016358681,0.0001520904],"about_ca_topic_score_codex":0.00016412692,"about_ca_topic_score_gemma":0.00017809072,"teacher_disagreement_score":0.07345898,"about_ca_system_score_codex":0.000015640424,"about_ca_system_score_gemma":0.00006084491,"threshold_uncertainty_score":0.52507496},"labels":[],"label_agreement":null},{"id":"W4405048644","doi":"10.1182/blood-2024-202554","title":"Improved Outcomes with Myeloablative Conditioning in AML Patients below 65 Years Using a Combination of Antithymocyte Globulin and Post-Transplantation Cyclophosphamide As Gvhd Prophylaxis","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Intensive Care Unit Cognitive Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Cyclophosphamide; Transplantation; Internal medicine; Bone marrow transplantation; Surgery; Oncology; Chemotherapy","score_opus":0.00533279151021928,"score_gpt":0.24464824714761454,"score_spread":0.23931545563739526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405048644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982703,0.00019636289,0.00015515044,0.00008394765,0.00007779624,0.0007285969,0.00008897934,0.000031805674,0.0003670682],"genre_scores_gemma":[0.9986683,0.000031141775,0.0005726626,0.00038433474,0.0000063883936,0.000014389936,0.00026983584,0.000025850148,0.000027082198],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913865,0.00003920404,0.0002295542,0.00023738203,0.00020689638,0.00014831848],"domain_scores_gemma":[0.99816805,0.00009867115,0.000077936704,0.000070309565,0.0015442569,0.000040800907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007412586,0.00013988737,0.0002419575,0.00027706902,0.00003333956,0.000021176622,0.000026245481,0.000071510054,0.00002276159],"category_scores_gemma":[0.00047819858,0.00012465437,0.000039695966,0.00032168633,0.00011405788,0.00016916849,0.000012216119,0.00016184297,0.0000028723912],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005958859,0.00051660603,0.9663147,0.0006796956,0.00036510275,0.00034381598,0.004900898,0.000008387495,0.021712877,0.0002283486,0.0000027618653,0.0043309354],"study_design_scores_gemma":[0.005666248,0.0014717708,0.97107124,0.00071028696,0.00028754637,0.000036527217,0.0015283528,0.00016300366,0.018847583,0.00007395148,0.0000014364746,0.00014207342],"about_ca_topic_score_codex":0.0003940461,"about_ca_topic_score_gemma":0.000050550916,"teacher_disagreement_score":0.005070362,"about_ca_system_score_codex":0.000049732513,"about_ca_system_score_gemma":0.00012808498,"threshold_uncertainty_score":0.50832576},"labels":[],"label_agreement":null},{"id":"W4405048671","doi":"10.1182/blood-2024-193298","title":"Feasibility of Discontinuation of Bruton's Tyrosine Kinase Inhibitors in Patients with Chronic Lymphocytic Leukemia: A Patient Survey","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Discontinuation; Chronic lymphocytic leukemia; Medicine; Population; Internal medicine; Leukemia","score_opus":0.015283897965878118,"score_gpt":0.26981718027974205,"score_spread":0.25453328231386396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405048671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967005,0.0017105045,0.000009889196,0.000012850518,0.00010097235,0.0011872844,0.00008693282,0.000038138267,0.00015289338],"genre_scores_gemma":[0.9995346,0.000029743043,0.00007100069,0.000007239055,0.00004380169,0.000033154123,0.00017001029,0.000039586565,0.000070857895],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975307,0.00015262903,0.00066620007,0.00045921298,0.00083371624,0.00035753622],"domain_scores_gemma":[0.9986195,0.00024703195,0.00014254084,0.00055986526,0.00030951612,0.000121532175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059053925,0.00020847032,0.0005137487,0.0002977182,0.000018338824,0.000014670644,0.00011232564,0.00012880118,0.00004082654],"category_scores_gemma":[0.0004344382,0.00015777169,0.00009449427,0.00095902185,0.00022678275,0.00013372404,0.000101111815,0.00020237743,0.000008834604],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0027304494,0.0032587326,0.97260594,0.00342766,0.0003283081,0.00019438952,0.0011754368,0.0004230298,0.0034689342,0.00006451077,0.0002031143,0.012119472],"study_design_scores_gemma":[0.06744795,0.0032855833,0.86083394,0.0027207083,0.00022850993,0.000018885214,0.00004429266,0.004813014,0.060305763,0.000019261775,0.000032944274,0.00024912736],"about_ca_topic_score_codex":0.0062679886,"about_ca_topic_score_gemma":0.0013595261,"teacher_disagreement_score":0.111772,"about_ca_system_score_codex":0.029529307,"about_ca_system_score_gemma":0.02220245,"threshold_uncertainty_score":0.98334074},"labels":[],"label_agreement":null},{"id":"W4405048675","doi":"10.1182/blood-2024-210720","title":"Assessing Gender and Racial Inclusion in CAR-T Cell Therapy Clinical Studies: A Scoping Review","year":2024,"lang":"en","type":"review","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Inclusion (mineral); MEDLINE; Inclusion and exclusion criteria; Family medicine; Demography; Gerontology; Alternative medicine; Psychology; Pathology","score_opus":0.38324976935478167,"score_gpt":0.5774928269549707,"score_spread":0.19424305760018906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405048675","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018115196,0.9931602,9.388e-7,0.00007359683,0.00033473605,0.0042335726,0.000004485818,0.00005679591,0.0019545276],"genre_scores_gemma":[0.0000150012065,0.99755895,0.00015724753,0.00047019808,0.001013412,0.00024504904,0.000031268017,0.00012976545,0.00037912876],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99545443,0.00092527986,0.0015571389,0.0009071604,0.00070642604,0.00044954618],"domain_scores_gemma":[0.99799496,0.00083982374,0.0002701323,0.00059091067,0.00011585231,0.00018831779],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0040891846,0.0005030158,0.003957736,0.0003454995,0.00013340637,0.000090422705,0.00023057245,0.00044540135,0.00021346555],"category_scores_gemma":[0.00043308624,0.00035377056,0.0006995881,0.0007343086,0.00014985104,0.000082775885,0.0016208888,0.0016727399,0.000047338573],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009722052,0.00027032275,0.000017114991,0.31356832,0.00035956173,0.00038090016,0.00028296656,1.9488322e-9,0.000010561844,0.0000011882979,0.00014182877,0.6849575],"study_design_scores_gemma":[0.0017600863,0.00018975434,0.0000044484514,0.6230013,0.002500392,0.00013219602,0.000035036213,5.862208e-7,0.000004534699,0.00002638029,0.37206906,0.00027625574],"about_ca_topic_score_codex":0.0000081739945,"about_ca_topic_score_gemma":0.000008849332,"teacher_disagreement_score":0.68468124,"about_ca_system_score_codex":0.00014953932,"about_ca_system_score_gemma":0.0017093637,"threshold_uncertainty_score":0.9998914},"labels":[],"label_agreement":null},{"id":"W4405048695","doi":"10.1182/blood-2024-201856","title":"Assessment of Sarcopenia As a Measure of Frailty in Older Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Parkwood Institute; Toronto General Hospital; University Health Network; Western University","funders":"","keywords":"Sarcopenia; Medicine; Diffuse large B-cell lymphoma; Internal medicine; Adverse effect; Lymphoma; Retrospective cohort study; Cohort; Cancer; Oncology","score_opus":0.02083736243400212,"score_gpt":0.3189945912372351,"score_spread":0.298157228803233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405048695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994192,0.00062587095,0.000025307172,0.00018560395,0.000081345745,0.00052113517,0.000036073485,0.00003383602,0.0042988122],"genre_scores_gemma":[0.9975841,0.00006197363,0.0014125839,0.00029412113,0.000028438093,0.00002467525,0.000030143767,0.000026227623,0.000537744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987829,0.0000547686,0.00035791783,0.0002026186,0.00041267683,0.00018911879],"domain_scores_gemma":[0.999395,0.000069023416,0.00009121992,0.00022854406,0.00011550084,0.00010068644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023060717,0.00010827857,0.00031673684,0.0001761696,0.000020256382,0.0000062046906,0.000056756307,0.00008331195,0.00022389583],"category_scores_gemma":[0.000039111696,0.00007554098,0.00004350607,0.00028389925,0.000027493286,0.000056814715,0.000023950472,0.00016715245,0.0000089318255],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012878948,0.07712203,0.89634407,0.008701885,0.00020001103,0.0004000078,0.0019799657,1.8938412e-7,0.008062066,0.0005910368,0.0017343084,0.0035765376],"study_design_scores_gemma":[0.08419181,0.0016189108,0.8984828,0.0041176607,0.00019814156,0.0000126604455,0.00020723093,0.000048937014,0.004548672,0.000030995878,0.0063978913,0.00014430078],"about_ca_topic_score_codex":0.000044136355,"about_ca_topic_score_gemma":0.000039323037,"teacher_disagreement_score":0.082903914,"about_ca_system_score_codex":0.00006269428,"about_ca_system_score_gemma":0.00046421887,"threshold_uncertainty_score":0.30804718},"labels":[],"label_agreement":null},{"id":"W4405048799","doi":"10.1182/blood-2024-206125","title":"Validation and Implementation of Flow Cytometry Based Minimal Residual Disease (MRD) Assay for Chronic Lymphocytic Leukemia (CLL) Clinical Studies","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Chronic lymphocytic leukemia; Minimal residual disease; Flow cytometry; Leukemia; Medicine; Immunology; Cancer research; Oncology","score_opus":0.05746857858536577,"score_gpt":0.428026771784263,"score_spread":0.37055819319889727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405048799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98755896,0.009812953,0.00059938384,0.0003004526,0.00023684389,0.00117847,0.00017731977,0.00009880196,0.000036819285],"genre_scores_gemma":[0.99552536,0.00059839326,0.0023832864,0.000077313,0.0007393918,0.00018494965,0.00024216964,0.00004984417,0.00019930239],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.997613,0.00015089025,0.00072628836,0.0005497814,0.000573497,0.00038650492],"domain_scores_gemma":[0.99733573,0.0017153771,0.00010206278,0.00036115493,0.00023320438,0.0002524786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015883738,0.0002056595,0.00047244143,0.0002950117,0.000077100245,0.00004672604,0.00009904445,0.0001160914,0.000072501716],"category_scores_gemma":[0.0011334936,0.00017647579,0.00018673582,0.0003681852,0.00024140664,0.00013026243,0.0000967486,0.00014293438,0.000014207689],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.02009083,0.0040157,0.08553191,0.14897065,0.023342375,0.0038592054,0.00600444,0.0019625428,0.077057496,0.0034526547,0.07973837,0.54597384],"study_design_scores_gemma":[0.25735894,0.0066434736,0.03822176,0.0034702914,0.009446999,0.00025071012,0.0020779094,0.46683812,0.21035168,0.00078079564,0.0034870405,0.0010722773],"about_ca_topic_score_codex":0.000086725224,"about_ca_topic_score_gemma":0.000027404016,"teacher_disagreement_score":0.54490155,"about_ca_system_score_codex":0.0134987105,"about_ca_system_score_gemma":0.034017723,"threshold_uncertainty_score":0.9902883},"labels":[],"label_agreement":null},{"id":"W4405048868","doi":"10.1182/blood-2024-211188","title":"Non-Factor Therapy Reduces Burden of Care for Caregivers of Children with Severe Hemophilia a: A Longitudinal Cohort Study Using the Hemophilia Family Impact Tool (H-FIT v1.1)","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Hospital for Sick Children","funders":"Novo Nordisk","keywords":"Medicine; Haemophilia; Clotting factor; Pediatrics; Cohort; Factor IX; Internal medicine; Physical therapy","score_opus":0.03389536429052385,"score_gpt":0.33072084820850367,"score_spread":0.2968254839179798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405048868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907852,0.0036716242,0.000002626271,0.0001385455,0.00007581718,0.0048374804,0.00028990474,0.00004168745,0.00015714753],"genre_scores_gemma":[0.9988678,0.00019193205,0.00015230509,0.000005209869,0.00031408542,0.00009201782,0.000052301624,0.00006372456,0.00026061467],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979075,0.000048082715,0.00035501,0.0005278514,0.0007506601,0.00041089553],"domain_scores_gemma":[0.9986833,0.000120354925,0.00010389332,0.00058468594,0.00038852132,0.00011925149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021151442,0.00034575036,0.0007177854,0.00020329667,0.00015216974,0.000044000288,0.00025292565,0.00011471271,0.000049347265],"category_scores_gemma":[0.000025468033,0.00018180716,0.0003474391,0.00049768,0.00020637401,0.000106166764,0.00006144102,0.00024466417,0.000002442807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011833125,0.0009866669,0.96091765,0.00038157296,0.0059824474,0.00010504742,0.009429674,0.000050519102,0.018644007,0.0000031766385,0.0000970272,0.0022189033],"study_design_scores_gemma":[0.010242303,0.008790162,0.93226975,0.00073378265,0.0022988948,0.00023990194,0.007955426,0.0001408451,0.036943905,0.00000966935,0.000028918344,0.00034644842],"about_ca_topic_score_codex":0.0009632059,"about_ca_topic_score_gemma":0.000019774012,"teacher_disagreement_score":0.028647903,"about_ca_system_score_codex":0.0001244492,"about_ca_system_score_gemma":0.0006774971,"threshold_uncertainty_score":0.7413881},"labels":[],"label_agreement":null},{"id":"W4405048924","doi":"10.1182/blood-2024-211444","title":"Unwavering Priorities: Global Physician Alignment on Gene Therapy for Hemophilia","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Specialty; Family medicine; Demographics; Demography","score_opus":0.029531622374197895,"score_gpt":0.3249777534739233,"score_spread":0.29544613109972545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405048924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97834873,0.0028499905,0.00012505689,0.0012230182,0.00036475257,0.0011785396,0.00007744326,0.00019075125,0.015641715],"genre_scores_gemma":[0.9873207,0.0007448308,0.0006688543,0.0012903409,0.0018238595,0.00016916433,0.000032741777,0.000065453554,0.007884025],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988103,0.00001678813,0.00014218467,0.0003212886,0.000377281,0.0003321446],"domain_scores_gemma":[0.99947345,0.00006555688,0.000013372962,0.0003048974,0.000038363534,0.00010434703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015266574,0.0001505602,0.00020328775,0.000049606766,0.00005483869,0.000056228408,0.00009242958,0.00005984632,0.00022578597],"category_scores_gemma":[0.000010410642,0.00012723361,0.00017245293,0.00017971486,0.000036298847,0.000032960907,0.000025091644,0.00011069766,0.000063335516],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008565216,0.0011006844,0.0005675241,0.00040785485,0.0009859266,0.00022814199,0.00050905545,0.0000074177447,0.74099946,0.0038946886,0.0021077944,0.24833491],"study_design_scores_gemma":[0.007531773,0.0028852557,0.0016778621,0.0003803293,0.00013185815,0.000067895606,0.0001116871,0.00029200266,0.7681378,0.0029000936,0.21558972,0.000293716],"about_ca_topic_score_codex":0.000014817994,"about_ca_topic_score_gemma":0.0000017351869,"teacher_disagreement_score":0.2480412,"about_ca_system_score_codex":0.00015655623,"about_ca_system_score_gemma":0.00012677709,"threshold_uncertainty_score":0.5188436},"labels":[],"label_agreement":null},{"id":"W4405049039","doi":"10.1182/blood-2024-206567","title":"Disparities in Real-World Treatment Patterns Among Patients with Von Willebrand Disease in a Large US Population-Based Dataset","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Disease; Von Willebrand disease; Population; Medicine; Von Willebrand factor; Internal medicine; Environmental health; Platelet","score_opus":0.008084940522958684,"score_gpt":0.2513212598081216,"score_spread":0.2432363192851629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405049039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99337983,0.00017005122,0.0000020227847,0.000098391545,0.00003382862,0.00061699725,0.005603269,0.000037823964,0.00005778241],"genre_scores_gemma":[0.97284216,0.000047241596,0.000016695727,0.000066555745,0.000014680253,0.0001266291,0.026775008,0.000024394989,0.0000866431],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990515,0.000026296193,0.00019087446,0.00029949183,0.00017935682,0.00025244517],"domain_scores_gemma":[0.99958146,0.000038820126,0.00002621909,0.00022086193,0.0000088727065,0.00012376867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000031341886,0.00018002078,0.0002635636,0.00024311083,0.000029951712,0.00003342906,0.000031635143,0.000031316413,0.000057810063],"category_scores_gemma":[0.000007724714,0.00012639338,0.00003857068,0.000219436,0.0000139785325,0.00011450175,0.000011308175,0.000070490634,0.000007684007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002624436,0.0036285867,0.9933909,0.00013569983,0.000094235766,0.0021339438,0.000042434818,0.000025439422,2.0967785e-7,0.000014701483,0.000042510994,0.00022886036],"study_design_scores_gemma":[0.01229996,0.00023619119,0.98585683,0.00056917244,0.00026808714,7.4933047e-7,0.000005515421,0.0004798488,0.000010521816,0.00002242633,0.00012479648,0.00012592188],"about_ca_topic_score_codex":0.018235806,"about_ca_topic_score_gemma":0.060800202,"teacher_disagreement_score":0.042564396,"about_ca_system_score_codex":0.000108747474,"about_ca_system_score_gemma":0.00006221132,"threshold_uncertainty_score":0.9883019},"labels":[],"label_agreement":null},{"id":"W4405049040","doi":"10.1182/blood-2024-206631","title":"Diagnosis and Disease Burden of Von Willebrand Disease in a Large US Population Based-Dataset","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Disease; Medicine; Von Willebrand disease; Population; Internal medicine; Von Willebrand factor; Platelet; Environmental health","score_opus":0.009460842669002469,"score_gpt":0.2651853942161892,"score_spread":0.2557245515471867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405049040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897202,0.0057721087,0.000012318565,0.0021115788,0.00006643961,0.0005410908,0.0017001005,0.000035714944,0.000040409097],"genre_scores_gemma":[0.9967268,0.0007622526,0.00005186455,0.0003718005,0.000094596246,0.0001336747,0.0018207451,0.00001901786,0.000019223364],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913067,0.000029743398,0.00020380228,0.00026858068,0.00019508644,0.00017213979],"domain_scores_gemma":[0.99938905,0.000056419758,0.000028733097,0.00023950683,0.00001267588,0.00027361122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013711535,0.00011496773,0.00025146882,0.0001818594,0.000026845282,0.000026263086,0.00004088535,0.000028368877,0.00015383368],"category_scores_gemma":[0.0001248071,0.00010066312,0.000056362303,0.00017048903,0.000018553244,0.00008876788,0.000051622083,0.000063787775,0.000008800708],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000802478,0.0017901704,0.9875138,0.0018404014,0.00008587615,0.00046953518,0.00010605601,0.00006455546,0.00002290543,0.0006514687,0.005901249,0.0014737397],"study_design_scores_gemma":[0.0019741957,0.00007972585,0.9841481,0.0009328477,0.0009376973,7.366026e-7,0.000016496246,0.0018032957,0.000044917128,0.000248629,0.009701228,0.000112131864],"about_ca_topic_score_codex":0.00047644795,"about_ca_topic_score_gemma":0.00005922683,"teacher_disagreement_score":0.007006586,"about_ca_system_score_codex":0.000017755774,"about_ca_system_score_gemma":0.000057147983,"threshold_uncertainty_score":0.41049227},"labels":[],"label_agreement":null},{"id":"W4405049041","doi":"10.1182/blood-2024-207891","title":"Alcohol Consumption and Hematological Malignancies: A Systematic Review and Meta-Analysis","year":2024,"lang":"en","type":"review","venue":"Blood","topic":"Alcohol Consumption and Health Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Meta-analysis; Systematic review; Cochrane Library; Multiple myeloma; Internal medicine; Lymphoma; MEDLINE; Oncology; Environmental health","score_opus":0.3246814655564486,"score_gpt":0.4603036349417605,"score_spread":0.1356221693853119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405049041","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000056035556,0.99368453,0.000007075344,0.00031017448,0.000021740047,0.005718671,0.000068900394,0.000114233015,0.00006908691],"genre_scores_gemma":[0.000017294553,0.9957574,0.00013966436,0.0014433182,0.000018541623,0.0015940991,0.0000774543,0.00003608897,0.0009161421],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99705744,0.000486454,0.0012234604,0.00067836215,0.00028930727,0.0002649801],"domain_scores_gemma":[0.9982211,0.00040725112,0.00044721644,0.0005535477,0.00006975356,0.0003011385],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010603217,0.0005351341,0.011777237,0.0003798366,0.00006986259,0.00005655186,0.000078457226,0.00035483178,0.0003616811],"category_scores_gemma":[0.00034307424,0.00028702797,0.0018638355,0.0005121638,0.00010857647,0.000031760013,0.00009405012,0.0004474032,0.00039281146],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[6.695076e-7,0.00005351949,0.000004309891,0.87668097,0.12255085,0.00014040062,0.000010035073,3.9913095e-10,3.1081527e-8,0.00023276205,0.0001947718,0.00013166302],"study_design_scores_gemma":[0.00019347394,0.000045862977,0.0000027396816,0.14528014,0.83491975,0.002621269,0.0000020902019,8.0555304e-7,5.1828714e-8,0.000005616617,0.016732287,0.00019591929],"about_ca_topic_score_codex":0.0000028467512,"about_ca_topic_score_gemma":0.0000026707141,"teacher_disagreement_score":0.73140085,"about_ca_system_score_codex":0.00002737195,"about_ca_system_score_gemma":0.00011420069,"threshold_uncertainty_score":0.99995816},"labels":[],"label_agreement":null},{"id":"W4405049075","doi":"10.1182/blood-2024-210199","title":"A Canadian Cost-Utility Analysis of Epcoritamab Versus Current Therapies in Third-Line or Later Large B-Cell Lymphoma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Lenalidomide; Rituximab; Population; Chemoimmunotherapy; Internal medicine; Oncology; Lymphoma; Multiple myeloma","score_opus":0.041577474496117525,"score_gpt":0.34036101461906393,"score_spread":0.2987835401229464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405049075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986857,0.0077777277,0.0000076085626,0.00054263056,0.000265054,0.0005012746,0.00026258448,0.000045192177,0.0037409158],"genre_scores_gemma":[0.9966076,0.0006981791,0.00003766797,0.000052187163,0.000096613716,0.000040356805,0.0001087345,0.000026836185,0.0023318299],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99832207,0.00009517138,0.00033515797,0.00036275628,0.00038843864,0.0004964021],"domain_scores_gemma":[0.99893373,0.00020655821,0.00002866411,0.00047320564,0.000105596,0.0002522701],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005732576,0.00016964349,0.00047761828,0.00096347247,0.000034024833,0.000033924698,0.00015052974,0.00010725343,0.0041900165],"category_scores_gemma":[0.00006751409,0.00012819485,0.0002456475,0.0018395617,0.00005406594,0.000050792154,0.000043732496,0.00023558905,0.00004762978],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01382831,0.023197215,0.51202583,0.0029240744,0.02022366,0.00441204,0.016717307,0.000020629053,0.02907588,0.0005271404,0.00388225,0.37316567],"study_design_scores_gemma":[0.11092205,0.003198301,0.31962952,0.0008504253,0.01163725,0.00005752227,0.0021928162,0.027681502,0.05582407,0.00019362934,0.46653897,0.0012739522],"about_ca_topic_score_codex":0.023128761,"about_ca_topic_score_gemma":0.2934271,"teacher_disagreement_score":0.4626567,"about_ca_system_score_codex":0.0002553482,"about_ca_system_score_gemma":0.0009218807,"threshold_uncertainty_score":0.9967203},"labels":[],"label_agreement":null},{"id":"W4405049108","doi":"10.1182/blood-2024-205736","title":"Routine Pre-Apheresis Markers As Predictors for Efficacy and Safety Outcomes Following CD19 CAR-T Cell Therapy - a Single Center Experience","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Apheresis; Medicine; Single Center; CAR T-cell therapy; Internal medicine; Oncology; Surgery; Chimeric antigen receptor; Immunotherapy; Cancer","score_opus":0.02096156753019747,"score_gpt":0.31125163888140317,"score_spread":0.2902900713512057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405049108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99033004,0.0031944516,0.00005953265,0.0004918495,0.00042899384,0.0016306447,0.00003480252,0.00019705143,0.003632663],"genre_scores_gemma":[0.982554,0.00029673224,0.000423142,0.0002140801,0.00015907733,0.00015104355,0.000029916677,0.00008920489,0.016082814],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980751,0.00006574398,0.00032542052,0.0005603008,0.0004633248,0.00051010284],"domain_scores_gemma":[0.998774,0.0004940919,0.000035132118,0.00041174953,0.000045875397,0.00023916051],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003187481,0.0002693453,0.00040699195,0.00013210638,0.00012021594,0.00011724394,0.00015113571,0.00012232065,0.0008110829],"category_scores_gemma":[0.00013479755,0.00020962815,0.00030745275,0.00024111354,0.00009164606,0.00011550432,0.000074022326,0.00020603451,0.000010865763],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039894795,0.0024763502,0.44292566,0.0004498511,0.0018666313,0.00027130754,0.011030019,0.0000019662366,0.5086936,0.000026523807,0.0011806359,0.027087955],"study_design_scores_gemma":[0.09298333,0.009259721,0.3410771,0.0016905813,0.0013227654,0.00025354102,0.0035415932,0.00041214214,0.34885493,0.00010878618,0.19885454,0.0016409836],"about_ca_topic_score_codex":0.00008687599,"about_ca_topic_score_gemma":0.000009764724,"teacher_disagreement_score":0.1976739,"about_ca_system_score_codex":0.00007104004,"about_ca_system_score_gemma":0.00010615308,"threshold_uncertainty_score":0.88807887},"labels":[],"label_agreement":null},{"id":"W4405049116","doi":"10.1182/blood-2024-198044","title":"Outcomes of Patients with Primary Central Nervous System Lymphoma Treated with Matrix Followed By High-Dose Chemotherapy and Autologous Stem Cell Transplant - a Multicentre, Retrospective Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Juravinski Hospital; University Health Network; University of Toronto; Hamilton Health Sciences; Princess Margaret Cancer Centre","funders":"","keywords":"Primary central nervous system lymphoma; Medicine; Autologous stem-cell transplantation; Stem cell; Chemotherapy; Lymphoma; Chemotherapy regimen; Central nervous system; Oncology; Retrospective cohort study; Internal medicine; Surgery","score_opus":0.0031443079657596127,"score_gpt":0.19761147345823973,"score_spread":0.1944671654924801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405049116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99558055,0.001309932,0.0000050959384,0.000042267584,0.0000537536,0.0023263139,0.0004076729,0.00019703552,0.00007734613],"genre_scores_gemma":[0.99925876,0.00006238729,0.00013656133,0.000021784846,0.000013948516,0.00011693647,0.00012834388,0.000069076195,0.00019217882],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982851,0.000054298762,0.0003443088,0.0005361568,0.00042698678,0.00035315202],"domain_scores_gemma":[0.9992743,0.000062685285,0.00011961297,0.00030124994,0.000070016686,0.00017214779],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000047519465,0.0003798777,0.00084292446,0.000103860475,0.000058541456,0.000037286274,0.00006275219,0.0000831617,0.000007304766],"category_scores_gemma":[9.314099e-7,0.00022311948,0.00009188893,0.00022720858,0.000055960623,0.00006319729,0.000013367075,0.00006042138,0.0000026645241],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021355283,0.012736893,0.9748197,0.00052793365,0.002508161,0.0012837846,0.0019579618,9.96242e-7,0.00018368107,0.000009013951,0.00003637653,0.0037999237],"study_design_scores_gemma":[0.048693806,0.004666671,0.9388099,0.0003678081,0.0032361674,0.000067358895,0.00054661743,0.000027576238,0.0033583615,1.8175862e-7,0.000009522347,0.0002160848],"about_ca_topic_score_codex":0.00053282245,"about_ca_topic_score_gemma":0.00004134259,"teacher_disagreement_score":0.04655828,"about_ca_system_score_codex":0.000295207,"about_ca_system_score_gemma":0.00010180901,"threshold_uncertainty_score":0.9098548},"labels":[],"label_agreement":null},{"id":"W4405049126","doi":"10.1182/blood-2024-203317","title":"Indolent Lymphoma: Well Tolerated, Fixed Duration Treatment Involving Bendamustine, Rituximab and Acalabrutinib for Front-Line Waldenström's Macroglobulinaemia That Induce Deep Clinical Responses","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Spinal Cord Injury BC; University Health Network; Ottawa Hospital; Concordia University; McGill University Health Centre; McGill University; University of Calgary; University of Toronto; Health Sciences North; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Bendamustine; Medicine; Rituximab; Ibrutinib; Lymphoplasmacytic Lymphoma; Internal medicine; Lymphoma; Oncology; Waldenstrom macroglobulinemia; Chronic lymphocytic leukemia; Leukemia","score_opus":0.06659272547137153,"score_gpt":0.3658344261726806,"score_spread":0.29924170070130907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405049126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98480123,0.010603532,0.00029017878,0.0014424915,0.0004971688,0.0017145574,0.00009565646,0.00025567904,0.00029950595],"genre_scores_gemma":[0.9902367,0.0019288388,0.003533609,0.0002377483,0.0010336479,0.00025270824,0.00025741573,0.00009107774,0.0024282548],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99670976,0.00020381424,0.00089296576,0.0009643059,0.0005274111,0.0007017157],"domain_scores_gemma":[0.99731946,0.001384244,0.00013129755,0.00054024527,0.0002030267,0.00042175123],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00084394147,0.00042589995,0.00076100655,0.00023033042,0.00020140661,0.00023375345,0.00015329561,0.00046024,0.00011755765],"category_scores_gemma":[0.0008816574,0.00034015288,0.00024914165,0.00025487953,0.00021863935,0.00017590831,0.00015877098,0.0002939828,0.00012339694],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04161561,0.035359014,0.045528535,0.0087565575,0.008435931,0.025887605,0.009687327,0.00004676535,0.028397152,0.001694662,0.017196367,0.7773945],"study_design_scores_gemma":[0.49357575,0.011153431,0.024449242,0.0035673515,0.005289025,0.010488893,0.0019627025,0.18762986,0.196074,0.00037671582,0.063483775,0.0019492637],"about_ca_topic_score_codex":0.00025919,"about_ca_topic_score_gemma":0.00017570551,"teacher_disagreement_score":0.7754452,"about_ca_system_score_codex":0.0032996878,"about_ca_system_score_gemma":0.004792415,"threshold_uncertainty_score":0.99990505},"labels":[],"label_agreement":null},{"id":"W4405049155","doi":"10.1182/blood-2024-207623","title":"Addressing Unmet Needs in the Management of Drug-Induced Secondary Erythrocytosis: Results from an International Physician Survey","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; McGill University; Centre Hospitalier de l’Université de Montréal; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Referral; Family medicine; Hematocrit; Internal medicine; Hematology; Drug; Intensive care medicine; Pharmacology","score_opus":0.061377999420227515,"score_gpt":0.33675321064106517,"score_spread":0.27537521122083763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405049155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871162,0.0004219912,0.0000030896492,0.0011868088,0.00022385753,0.00033539205,0.0004233799,0.000028378774,0.010260903],"genre_scores_gemma":[0.9980781,0.00015473923,0.00030849208,0.00042601296,0.00018221795,0.00006354252,0.0007043998,0.000016618595,0.00006588349],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988039,0.0001421262,0.00031290218,0.0002770074,0.00032553964,0.00013850101],"domain_scores_gemma":[0.99932617,0.00022333494,0.000060596165,0.00030190634,0.000046190355,0.000041780415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004117879,0.00014146128,0.00022353392,0.00014557979,0.000035803238,0.00006265257,0.00014457642,0.000038968723,0.0000408003],"category_scores_gemma":[0.000015791205,0.00009573898,0.00006633317,0.00031094023,0.000024461357,0.00013073653,0.000043680524,0.00016697409,0.000015968826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031705042,0.033161584,0.47664198,0.0014133464,0.018489415,0.0055081807,0.077341355,0.00005455646,0.014931857,0.010770936,0.008433847,0.35008246],"study_design_scores_gemma":[0.0055744476,0.00022784398,0.9581877,0.0012522391,0.000415728,0.000009242791,0.0022460502,0.00013188043,0.030786041,0.00016688523,0.000867608,0.00013433168],"about_ca_topic_score_codex":0.0005990164,"about_ca_topic_score_gemma":0.0003977715,"teacher_disagreement_score":0.48154575,"about_ca_system_score_codex":0.000038273254,"about_ca_system_score_gemma":0.00005625864,"threshold_uncertainty_score":0.3904122},"labels":[],"label_agreement":null},{"id":"W4405049156","doi":"10.1182/blood-2024-208762","title":"Harnessing Favorable Dendritic Cells Features to Improve Antigen-Specific T Cell Expansion","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Priming (agriculture); Antigen; Immunology; Immune system; Antigen-presenting cell; Dendritic cell; Cancer research; T cell; Biology; Medicine","score_opus":0.00817891618247281,"score_gpt":0.22466087520823572,"score_spread":0.2164819590257629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405049156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8272061,0.1672065,0.0003310687,0.0001646802,0.0031170174,0.0002827661,0.000029877252,0.00024315536,0.0014188578],"genre_scores_gemma":[0.9752784,0.0023891868,0.00029666204,0.00022707325,0.00009009586,0.000029650944,0.000032441738,0.000055029977,0.021601498],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985226,0.00017694163,0.00026635625,0.00046397545,0.000047517435,0.00052262284],"domain_scores_gemma":[0.99931014,0.0001725907,0.000035571837,0.0004111515,0.0000426528,0.000027925404],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021788776,0.00025147395,0.00026653998,0.00021704847,0.00030571877,0.00016255792,0.0002620984,0.00025949182,0.00055452023],"category_scores_gemma":[0.000012965939,0.00021878934,0.00014644994,0.000268945,0.00008691527,0.0001614416,0.000080043894,0.00038567447,0.0028017014],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014298088,0.00026183008,0.000020914202,0.000049137805,0.00010092452,0.000050031456,0.0008838069,0.0000022415052,0.9764023,0.00012771372,0.007204483,0.014753634],"study_design_scores_gemma":[0.0007789913,0.00019067933,0.00045880387,0.00013497006,0.000023336133,0.000076691984,0.0002206338,4.9417525e-7,0.7438979,0.000030455485,0.25396946,0.00021757923],"about_ca_topic_score_codex":0.00004095752,"about_ca_topic_score_gemma":0.000002005673,"teacher_disagreement_score":0.24676497,"about_ca_system_score_codex":0.000024400304,"about_ca_system_score_gemma":0.00010117342,"threshold_uncertainty_score":0.99797475},"labels":[],"label_agreement":null},{"id":"W4405049186","doi":"10.1182/blood-2024-194223","title":"Biomarkers of Renal Health in Patients (pts) Treated with Fedratinib in the FREEDOM and FREEDOM2 Trials","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Intensive care medicine","score_opus":0.022741468250481678,"score_gpt":0.2896173974461189,"score_spread":0.26687592919563724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405049186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961425,0.0011294944,0.0000017583036,0.0005090293,0.000033427605,0.0015784323,0.000046406534,0.000021767757,0.00053715234],"genre_scores_gemma":[0.99947125,0.000060897997,0.00020078904,0.00005832372,0.000039352497,0.000054322623,0.000060438357,0.000017372957,0.00003722747],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984329,0.00031856852,0.00052964146,0.0002695025,0.0002495681,0.00019986278],"domain_scores_gemma":[0.9992483,0.00030406573,0.00010639867,0.00025862697,0.000022240967,0.00006033106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009478392,0.00015098903,0.00053653744,0.0002159118,0.000020802543,0.0000181306,0.000064666914,0.00005416836,0.000026171054],"category_scores_gemma":[0.00015916902,0.00008213481,0.000043609693,0.0005014243,0.000070744856,0.000044864995,0.00001793026,0.0001450334,0.0000027736955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012095209,0.003903998,0.9795672,0.00023322989,0.00069848425,0.00025215183,0.0032120964,0.000003893258,0.00023132843,0.000040725612,0.0008063701,0.009840986],"study_design_scores_gemma":[0.069750175,0.006756782,0.9199171,0.0013129102,0.0004909443,0.000042590942,0.0007067863,0.00016234025,0.00048270606,0.000027997954,0.0002081548,0.0001414836],"about_ca_topic_score_codex":0.0027275472,"about_ca_topic_score_gemma":0.001319128,"teacher_disagreement_score":0.068540655,"about_ca_system_score_codex":0.00016227124,"about_ca_system_score_gemma":0.00036576577,"threshold_uncertainty_score":0.41232538},"labels":[],"label_agreement":null},{"id":"W4405049187","doi":"10.1182/blood-2024-211439","title":"Real-World Experience of Asciminib Treatment and Its Clinical Outcomes Including Cardiovascular (CV) Event-Free, Failure-Free Survival Associated with CV Comorbidity and Framingham CV Risk Score in Patients with Chronic Myeloid Leukemia","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Framingham Risk Score; Tolerability; Nilotinib; Blood pressure; Myocardial infarction; Hazard ratio; Coronary artery disease; Myeloid leukemia; Disease; Adverse effect; Imatinib; Confidence interval","score_opus":0.03312432397367527,"score_gpt":0.2997797406652448,"score_spread":0.26665541669156956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405049187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99495757,0.002904833,0.000009242152,0.00006371576,0.00015992191,0.0014194482,0.00022273396,0.00012010289,0.00014240891],"genre_scores_gemma":[0.9974185,0.0015688875,0.0003173631,0.0000124032495,0.000099751494,0.00012754962,0.0001247377,0.000085475825,0.00024531584],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99630314,0.00031537915,0.0008221476,0.0010459357,0.00092208944,0.0005912997],"domain_scores_gemma":[0.9973868,0.00065644516,0.0002883434,0.0012183076,0.00014841756,0.0003016568],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00073399075,0.00058421236,0.001606667,0.00027046568,0.0001433891,0.00005192235,0.0002615557,0.00024351773,0.000021948003],"category_scores_gemma":[0.00065522623,0.00040672952,0.00027212768,0.0006250679,0.00031330626,0.00022782123,0.00035828594,0.0005305687,0.000002773381],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029260843,0.00097621913,0.99068964,0.00020447808,0.004073723,0.00026971154,0.0010269526,0.000031742085,0.00003069168,0.000022116516,0.000027062133,0.0023550524],"study_design_scores_gemma":[0.042235028,0.0025110827,0.94967616,0.001397416,0.0026255841,0.00001960466,0.00015154615,0.0003009367,0.00058387296,0.000020038198,0.00010434345,0.0003743975],"about_ca_topic_score_codex":0.0034755643,"about_ca_topic_score_gemma":0.008540049,"teacher_disagreement_score":0.04194242,"about_ca_system_score_codex":0.0021805281,"about_ca_system_score_gemma":0.0011499627,"threshold_uncertainty_score":0.9998385},"labels":[],"label_agreement":null},{"id":"W4405049212","doi":"10.1182/blood-2024-207794","title":"A Longitudinal Examination of the Quality of Life of Persons with Hemophilia a Switching from Intravenous Recombinant Factor VIII Concentrate to Subcutaneous Non-FVIII Replacement Therapy","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Medicine; Quality of life (healthcare); Pediatrics; Internal medicine; Physical therapy; Nursing","score_opus":0.04206849777389212,"score_gpt":0.3107381378841945,"score_spread":0.2686696401103024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405049212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970823,0.0006345183,0.00006317798,0.00083096186,0.00010155075,0.0009819363,0.00007847105,0.000018045628,0.00020904781],"genre_scores_gemma":[0.99927866,0.00013205815,0.00019481868,0.000022165685,0.000047588957,0.000021264936,0.000013323141,0.000020740763,0.0002693698],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983201,0.00012484715,0.0004454354,0.0003035226,0.00058855145,0.00021756906],"domain_scores_gemma":[0.99896646,0.00021662847,0.0001434872,0.00040074554,0.00015220378,0.00012046295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003596777,0.00016012444,0.00046113212,0.000090974645,0.000050755683,0.000012562042,0.00012829171,0.000069359085,0.000091196336],"category_scores_gemma":[0.000093029186,0.00008905765,0.00012572308,0.00031944882,0.00008708302,0.00003428757,0.000041445044,0.000175844,0.000002795197],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045771883,0.0049484847,0.21612398,0.001113744,0.002379418,0.00020405275,0.025660122,0.000007932476,0.72892827,0.00017857425,0.000049329326,0.015828885],"study_design_scores_gemma":[0.007685884,0.008020337,0.53187495,0.0015747322,0.00034262385,0.000065608976,0.0015621971,0.00022659359,0.44833484,0.000051864743,0.00005142003,0.00020896916],"about_ca_topic_score_codex":0.00075526757,"about_ca_topic_score_gemma":0.000063818006,"teacher_disagreement_score":0.31575096,"about_ca_system_score_codex":0.000059825477,"about_ca_system_score_gemma":0.00034770754,"threshold_uncertainty_score":0.36316657},"labels":[],"label_agreement":null},{"id":"W4405049238","doi":"10.1182/blood-2024-193373","title":"Polycythemia Vera Vs. <i>JAK2</i> Mutated or Wild-Type Essential Thrombocythemia: Clinical and Molecular Comparisons and Long-Term Outcome Among 2,010 Patients","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Essential thrombocythemia; Polycythemia vera; Myelofibrosis; Medicine; Leukocytosis; Internal medicine; Gastroenterology; Myeloproliferative neoplasm; Bone marrow","score_opus":0.024476581753653182,"score_gpt":0.3361209585768312,"score_spread":0.311644376823178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405049238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99672055,0.001281818,0.00003332046,0.00055980106,0.00034819168,0.00068678695,0.000037808608,0.00012405244,0.00020766667],"genre_scores_gemma":[0.99813193,0.00048900465,0.00041668213,0.00043950035,0.00014354032,0.000040283943,0.00013698291,0.000052623003,0.00014947445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99811983,0.000069952686,0.00056201435,0.0006223057,0.00030159415,0.00032433163],"domain_scores_gemma":[0.99901927,0.00020067146,0.00008092843,0.00029066164,0.00008835528,0.00032014452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013726696,0.00032851685,0.0007121263,0.00008870191,0.000104034785,0.000104508756,0.00006644431,0.00022062098,0.00012187788],"category_scores_gemma":[0.00010630307,0.00023148504,0.00012469114,0.00019793802,0.0003336212,0.00009621527,0.00011681526,0.00041302346,0.0000333426],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034186008,0.0016180164,0.9935961,0.0001912858,0.0008544847,0.001164188,0.00016459062,2.2984736e-7,0.00037914087,0.00006970833,0.0008781427,0.0007423029],"study_design_scores_gemma":[0.00922148,0.0015076073,0.97170174,0.00038607145,0.0018802127,0.00016365456,0.000022531363,0.000096553136,0.014419321,0.000014815563,0.00031051217,0.00027549546],"about_ca_topic_score_codex":0.000028256065,"about_ca_topic_score_gemma":0.000039211995,"teacher_disagreement_score":0.021894304,"about_ca_system_score_codex":0.000025173154,"about_ca_system_score_gemma":0.000103967875,"threshold_uncertainty_score":0.94396865},"labels":[],"label_agreement":null},{"id":"W4405049288","doi":"10.1182/blood-2024-205817","title":"The Use of Post-Transplant Cyclophosphamide Leads to Increased Cardiac Complications without Affecting Survival in Haploidentical Stem Cell Transplantation","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Transplantation: Methods and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Transplantation; Stem cell; Medicine; Cyclophosphamide; Internal medicine; Immunology; Chemotherapy; Biology","score_opus":0.03250493575526666,"score_gpt":0.30325180989475276,"score_spread":0.2707468741394861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405049288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913128,0.00059952354,0.005840156,0.0007467904,0.0002778179,0.00069367466,0.00021787069,0.000093965515,0.0002173979],"genre_scores_gemma":[0.9938782,0.00040060288,0.0052628177,0.0001031479,0.00005384277,0.00004584079,0.000092402275,0.00003229478,0.00013089117],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984926,0.00022596393,0.00044038,0.00028183404,0.00030929883,0.000249942],"domain_scores_gemma":[0.99805355,0.0014531378,0.000040715084,0.00024620263,0.00007988579,0.00012650668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005375737,0.00016391058,0.00034050184,0.00014542334,0.00009412894,0.00006383798,0.00009245088,0.000076575605,0.0000045023203],"category_scores_gemma":[0.000030528143,0.00012052656,0.00015556102,0.00036875936,0.00005280171,0.00010546592,0.0000071256513,0.00022409688,0.000015872789],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038493454,0.00022508689,0.8585558,0.0009832158,0.00012565439,0.00011976688,0.0031924287,0.000058601465,0.13328527,0.0009666711,0.000009138598,0.0020934406],"study_design_scores_gemma":[0.0012813191,0.00014176867,0.94189847,0.0006288422,0.0008034247,0.00006383385,0.00025010572,0.000075252145,0.054426253,0.000014695617,0.00026679639,0.00014926102],"about_ca_topic_score_codex":0.0005996184,"about_ca_topic_score_gemma":0.00050043454,"teacher_disagreement_score":0.083342664,"about_ca_system_score_codex":0.000025027064,"about_ca_system_score_gemma":0.00010252675,"threshold_uncertainty_score":0.49149305},"labels":[],"label_agreement":null},{"id":"W4405049338","doi":"10.1182/blood-2024-206502","title":"Single-Cell Immuno-Metabolic Profiling of Apheresis Samples for Chimeric Antigen T Cell Receptor Therapy Using Cytometry By Time of Flight","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Flow cytometry; Mass cytometry; Chimeric antigen receptor; Antigen; Apheresis; Cell; Cell therapy; Immunology; Medicine; Molecular biology; Biology; Immunotherapy; Immune system; Platelet; Biochemistry","score_opus":0.03654596276350723,"score_gpt":0.2995784964865683,"score_spread":0.26303253372306107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405049338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.935388,0.06139368,0.00035498172,0.00004463489,0.0001240195,0.0011152137,0.00020106256,0.00007078732,0.0013076143],"genre_scores_gemma":[0.9644496,0.004398381,0.024730887,0.000053708292,0.00041638603,0.0000527539,0.00019618399,0.00022525078,0.0054768356],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981003,0.000087384324,0.0005200743,0.00040016611,0.00046692282,0.0004251536],"domain_scores_gemma":[0.99877125,0.00033215524,0.00014838389,0.00045960015,0.00018715742,0.000101455225],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004673736,0.00024465247,0.0006691543,0.00039384826,0.000057263725,0.000032336928,0.0002154819,0.00014802694,0.0016840249],"category_scores_gemma":[0.000051476698,0.000207846,0.00034030518,0.0010033908,0.0001224577,0.00007662935,0.0000507565,0.00019276477,0.000024558238],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039604583,0.0013510657,0.0019015786,0.0007391362,0.00045359455,0.000002840716,0.0003595989,0.0000013192622,0.9864529,0.0000053101144,0.00041146667,0.007925147],"study_design_scores_gemma":[0.0030617232,0.0007217088,0.00011737665,0.00018682258,0.00019646679,0.000009280061,0.00012156675,0.00020621798,0.98068964,0.000015347292,0.014490879,0.00018297962],"about_ca_topic_score_codex":0.00007754438,"about_ca_topic_score_gemma":3.0151207e-7,"teacher_disagreement_score":0.0569953,"about_ca_system_score_codex":0.000031316777,"about_ca_system_score_gemma":0.00022914125,"threshold_uncertainty_score":0.9992286},"labels":[],"label_agreement":null},{"id":"W4405049365","doi":"10.1182/blood-2024-203809","title":"Health Care Utilization for Patients with Triple Class Exposed Relapsed and Refractory Multiple Myeloma: Experience from a Canadian Center","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Multiple myeloma; Medicine; Center (category theory); Refractory (planetary science); Lenalidomide; Family medicine; Pediatrics; Internal medicine","score_opus":0.025417387844696333,"score_gpt":0.2923889276660677,"score_spread":0.2669715398213714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405049365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99465555,0.0022435684,0.000058779646,0.0002924488,0.00011997193,0.0015111271,0.0008827589,0.00006413622,0.00017167693],"genre_scores_gemma":[0.99589145,0.000068744215,0.0013315695,0.00016836119,0.00006528963,0.00019805318,0.0021101774,0.000036420774,0.00012990809],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987795,0.00003498643,0.000172671,0.00039343376,0.00023780874,0.0003816533],"domain_scores_gemma":[0.99903417,0.000083442304,0.00003262242,0.00021688725,0.00011610454,0.00051677093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000036040594,0.00015135997,0.00021496059,0.00014660008,0.00015378626,0.00004897734,0.000047852016,0.000069337126,0.000027781425],"category_scores_gemma":[0.00010573066,0.00011469025,0.000039073286,0.0001352117,0.00004363688,0.00011328103,0.000015226641,0.00010358607,0.0000072300177],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001021123,0.00080357125,0.9474514,0.00034556637,0.00027280688,0.000118251424,0.008408983,1.3401889e-7,0.00020697218,0.00001540502,0.0008055126,0.040550265],"study_design_scores_gemma":[0.042540133,0.0032915426,0.90731055,0.0006775774,0.00013241387,0.0000108261365,0.0018750918,0.00070159393,0.0016585945,0.000008317194,0.041504193,0.00028915727],"about_ca_topic_score_codex":0.01438241,"about_ca_topic_score_gemma":0.04960447,"teacher_disagreement_score":0.04151901,"about_ca_system_score_codex":0.00021993577,"about_ca_system_score_gemma":0.00051386224,"threshold_uncertainty_score":0.9921809},"labels":[],"label_agreement":null},{"id":"W4405049369","doi":"10.1182/blood-2024-209337","title":"“I Know You'Re a Nurse or a Doctor but I'm the Expert on Hemophilia”: Insights into Healthcare Professional Knowledge and Patient Care Experiences in Hemophilia","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Health care; Nursing; Family medicine","score_opus":0.030246767782961596,"score_gpt":0.35601965208073566,"score_spread":0.32577288429777407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405049369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9127303,0.07591794,1.4094768e-7,0.008028328,0.00066010765,0.0013353829,0.000009788436,0.00010078561,0.0012172601],"genre_scores_gemma":[0.9926573,0.001108636,0.000060157614,0.00037227155,0.0004459107,0.0009404252,0.00003170805,0.0000403662,0.0043431963],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9977977,0.00017151411,0.00035903064,0.0006591622,0.00055521226,0.00045738276],"domain_scores_gemma":[0.9988823,0.00023336195,0.00003178591,0.00041117307,0.00013037412,0.0003110204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000100811936,0.00032389857,0.00037620764,0.0002818925,0.0002855147,0.00006303422,0.00016687252,0.0001994492,0.00016997824],"category_scores_gemma":[0.00009680971,0.00015705048,0.000104018996,0.0005593481,0.00024611695,0.000102666,0.0001136348,0.0005195984,0.00009905759],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012685336,0.003352695,0.0051846886,0.0016808464,0.00018390725,0.002763317,0.8509028,2.845412e-7,0.002536094,0.0008472071,0.00447658,0.12680306],"study_design_scores_gemma":[0.013843223,0.013070141,0.007018237,0.014670692,0.00024094067,0.0005156975,0.6381434,0.000663114,0.06425298,0.00072144944,0.2454863,0.001373799],"about_ca_topic_score_codex":0.00015145743,"about_ca_topic_score_gemma":0.00035155017,"teacher_disagreement_score":0.24100973,"about_ca_system_score_codex":0.00019616602,"about_ca_system_score_gemma":0.0007076839,"threshold_uncertainty_score":0.6404333},"labels":[],"label_agreement":null},{"id":"W4405049412","doi":"10.1182/blood-2024-202728","title":"Point-of-Care Bispectral Electroencephalogram (BSEEG) As a New Tool in Detecting Immune Effector Cell Associated Neurotoxicity (ICANS) in Patients Treated with Chimeric Antigen Receptor T-Cell (CAR-T)","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Neuroscience and Neural Engineering","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neurotoxicity; Immune system; Antigen; Cell; Chimeric antigen receptor; Medicine; Effector; T cell; Immunology; Internal medicine; Chemistry; Toxicity; Biochemistry","score_opus":0.006298919154708133,"score_gpt":0.2092743721571232,"score_spread":0.20297545300241507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405049412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981752,0.0001773361,0.000007507635,0.000017915476,0.000187674,0.0010164928,0.00001675992,0.00024571965,0.00015538203],"genre_scores_gemma":[0.99959403,0.00007179141,0.00005677913,0.000068247646,0.000025026493,0.000043852942,0.000006372512,0.00006336812,0.0000705503],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99730706,0.00020014388,0.0004581275,0.00082671695,0.00042434095,0.0007836363],"domain_scores_gemma":[0.99920666,0.00024224792,0.00012888871,0.00027313974,0.000024609235,0.00012447128],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012987922,0.00035577072,0.00041749518,0.0004502696,0.000075200674,0.000105091225,0.00039971797,0.00009708557,0.000018037992],"category_scores_gemma":[0.0004902075,0.00031378958,0.00012203946,0.0030156407,0.00006870083,0.00037167815,0.000070024216,0.00059412385,0.000019281],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000091145936,0.00049047166,0.045585714,0.000082345985,0.0000037740244,0.00013414316,0.0002841313,0.00009745024,0.9526861,0.000002227792,0.000003796952,0.0005387369],"study_design_scores_gemma":[0.002165177,0.0025036556,0.04767194,0.00019527265,0.00002177782,0.000009334714,0.00001692908,0.00074945274,0.94634,0.0000033314298,0.000016254146,0.00030685856],"about_ca_topic_score_codex":0.0003158304,"about_ca_topic_score_gemma":0.000042806663,"teacher_disagreement_score":0.0063460446,"about_ca_system_score_codex":0.000103062725,"about_ca_system_score_gemma":0.00015976543,"threshold_uncertainty_score":0.9999314},"labels":[],"label_agreement":null},{"id":"W4405049414","doi":"10.1182/blood-2024-211615","title":"Real-World Efficacy of Belumosudil in Treating Fibrotic Symptom Burden in Chronic Gvhd: Modified Lee Symptom Score Assessment after Multiple Treatment Failures","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Saskatchewan Cancer Agency; University of Calgary; University of Toronto; University Health Network; University of Saskatchewan; Université Laval; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Intensive care medicine","score_opus":0.013934117934827987,"score_gpt":0.2912586181093314,"score_spread":0.27732450017450344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405049414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920397,0.0034462716,0.00001850601,0.00032721146,0.00013787243,0.0010393005,0.00007722635,0.000096460855,0.002817441],"genre_scores_gemma":[0.99785566,0.00028263725,0.0003643776,0.0000145539225,0.0003664727,0.0003037541,0.00011539304,0.000057841775,0.000639319],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997917,0.00008905322,0.0006418435,0.0005661172,0.00032332784,0.00046264814],"domain_scores_gemma":[0.9990723,0.00024235787,0.00008070724,0.00041493645,0.000040184725,0.00014952748],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013858588,0.00033888858,0.0006262335,0.00048160407,0.00003763983,0.000044507746,0.00011453017,0.000117905176,0.00020006271],"category_scores_gemma":[0.000030024612,0.00028270457,0.00029087104,0.00043629046,0.000077341596,0.00012044439,0.00007009501,0.00023107232,0.000018505914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007744359,0.011066046,0.8326571,0.0097225215,0.0022610396,0.009803285,0.0073695127,0.006763757,0.06725442,0.0035564255,0.00012833107,0.041673202],"study_design_scores_gemma":[0.020524187,0.01004442,0.9087827,0.012681745,0.0018312624,0.000070261995,0.00045431993,0.03796404,0.0060818377,0.00010908973,0.00064792245,0.00080821133],"about_ca_topic_score_codex":0.0060700458,"about_ca_topic_score_gemma":0.0014802987,"teacher_disagreement_score":0.0761256,"about_ca_system_score_codex":0.0010374865,"about_ca_system_score_gemma":0.00062331173,"threshold_uncertainty_score":0.9999625},"labels":[],"label_agreement":null},{"id":"W4405049459","doi":"10.1182/blood-2024-208588","title":"<i>The Impact of the after-Hours Carechart Program in Assessing and Triaging after-Hours Patients with Malignancies Inquiries and an Analysis of the Changes to Service Access over the Course of the Covid-19 Pandemic</i>","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Geriatric Care and Nursing Homes","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Intensive care medicine; Internal medicine; Emergency medicine","score_opus":0.04437442742794146,"score_gpt":0.4296958402473122,"score_spread":0.38532141281937077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405049459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99300283,0.0020459783,0.0000044782473,0.003086735,0.00026726138,0.0013591293,0.00020079463,0.000024112882,0.000008648538],"genre_scores_gemma":[0.9991308,0.000072993855,0.000009541436,0.0004875371,0.000051742816,0.00020943146,0.0000038554517,0.00002187878,0.000012245844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979565,0.0007466926,0.00036431281,0.00025295626,0.00035121164,0.00032832628],"domain_scores_gemma":[0.99807364,0.0007323528,0.00032256133,0.0005995767,0.00019303357,0.000078839534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091787166,0.0001935207,0.00037469607,0.000118842654,0.0004141634,0.000106224084,0.0004470715,0.0000986648,0.0000070953815],"category_scores_gemma":[0.0001268917,0.00007027703,0.00012829965,0.0018139295,0.0003966113,0.0001444552,0.0003511619,0.00029614265,7.268456e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015052505,0.000119733,0.9619423,0.00020356035,0.00025776628,5.7534294e-7,0.03535876,0.00002997774,0.000055006534,0.0000037263292,0.00012923694,0.0017487967],"study_design_scores_gemma":[0.0007323976,0.00012258817,0.9796027,0.0006671572,0.0011311963,0.0000012327807,0.017327411,0.00003220304,0.000090178095,0.000036893165,0.00016156734,0.00009448725],"about_ca_topic_score_codex":0.0032956866,"about_ca_topic_score_gemma":0.020194959,"teacher_disagreement_score":0.018031351,"about_ca_system_score_codex":0.00007619501,"about_ca_system_score_gemma":0.00047167757,"threshold_uncertainty_score":0.99768394},"labels":[],"label_agreement":null},{"id":"W4405049461","doi":"10.1182/blood-2024-202565","title":"Inflammation in Myeloproliferative Philadelphia Chromosome Negative Neoplasms - Relationship with Biomarkers of Disease Activity","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Windsor Regional Hospital; Ottawa Hospital; University of Ottawa; Juravinski Cancer Centre; Population Health Research Institute; McMaster University","funders":"","keywords":"Inflammation; Disease; Philadelphia chromosome; Medicine; Polycythemia vera; Internal medicine; Immunology; Pathology; Oncology; Genetics; Biology; Chromosomal translocation","score_opus":0.016408615710562548,"score_gpt":0.26489348507884714,"score_spread":0.2484848693682846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405049461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962173,0.00028070662,0.000054669952,0.0016243758,0.00004288206,0.00077359495,0.000040353447,0.000081256316,0.0008848448],"genre_scores_gemma":[0.99905646,0.00002269868,0.000481687,0.000011600135,0.000081524566,0.00011002785,0.00006069575,0.000026601585,0.00014867846],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989284,0.000070456284,0.00023120973,0.000307725,0.00028377632,0.00017842422],"domain_scores_gemma":[0.99920833,0.00028696368,0.00007794161,0.00024028146,0.00005707367,0.0001294006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011684518,0.00017554424,0.0002478314,0.00025236516,0.000035392695,0.000017226559,0.00004387112,0.0000744812,0.000057006502],"category_scores_gemma":[0.00018351055,0.00013724026,0.000058840113,0.0006423758,0.00010786601,0.0002679,0.000021659485,0.00020809677,0.000026089747],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007623493,0.002585151,0.9235204,0.002979463,0.003165939,0.0021332218,0.008739651,0.0004130507,0.03862183,0.0034269423,0.00015658264,0.0066343104],"study_design_scores_gemma":[0.0100802025,0.0007367688,0.91730946,0.0016169547,0.00076721073,0.00006440105,0.00015240161,0.0022588926,0.06606786,0.00066222344,0.00005284874,0.00023076756],"about_ca_topic_score_codex":0.000084524974,"about_ca_topic_score_gemma":0.00010061093,"teacher_disagreement_score":0.027446032,"about_ca_system_score_codex":0.000370756,"about_ca_system_score_gemma":0.0009968441,"threshold_uncertainty_score":0.5596496},"labels":[],"label_agreement":null},{"id":"W4405049511","doi":"10.1182/blood-2024-200268","title":"A Phase 1/2 Study of Nuvisertib (TP-3654), an Investigational Selective PIM1 Kinase Inhibitor, in Combination with JAK Inhibitors Ruxolitinib or Momelotinib in Patients with Myelofibrosis","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Tofacitinib; Phases of clinical research; Janus kinase inhibitor; Pharmacology; Investigational Drugs; Internal medicine; Clinical trial","score_opus":0.013004740136055747,"score_gpt":0.27246177253010545,"score_spread":0.2594570323940497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405049511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979123,0.000051928935,0.000011989408,0.00007816221,0.00007968481,0.0017054658,0.000037497084,0.000050132137,0.00007286236],"genre_scores_gemma":[0.9990717,0.0000034375994,0.00036610055,0.00007037725,0.00007511945,0.00020977239,0.00010729477,0.000052446478,0.00004376159],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820393,0.00008807104,0.00043689556,0.0004626164,0.0005576604,0.0002508354],"domain_scores_gemma":[0.99925876,0.00005529854,0.000110087596,0.00020834756,0.00022379578,0.00014368902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019879562,0.00023583577,0.0003928359,0.00049088843,0.0000387442,0.000032030817,0.00006556431,0.000079548954,0.000051115887],"category_scores_gemma":[0.000034555353,0.00017088288,0.00002969569,0.0012808659,0.00006281346,0.00028080706,0.000019440718,0.0002487413,0.0000023144457],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015323188,0.093977556,0.84353405,0.0004993952,0.0004407857,0.00029284167,0.021789767,0.00004705597,0.013265789,0.0011187604,0.000054367087,0.009656413],"study_design_scores_gemma":[0.15873317,0.09423481,0.63959783,0.0023866203,0.0003435218,0.000016869766,0.0030164775,0.00038709983,0.1001663,0.0005132252,0.00005829486,0.0005458069],"about_ca_topic_score_codex":0.00053601235,"about_ca_topic_score_gemma":0.0014338988,"teacher_disagreement_score":0.20393626,"about_ca_system_score_codex":0.00012781125,"about_ca_system_score_gemma":0.00045773573,"threshold_uncertainty_score":0.69684017},"labels":[],"label_agreement":null},{"id":"W4405049560","doi":"10.1182/blood-2024-206266","title":"Racial Disparity in Outcomes after Myeloablative Conditioning for Hematological Malignancies in Patients Above the Age of 45 Years Undergoing Hematopoietic Stem Cell Transplantation","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Hematologic Neoplasms; Stem cell; Hematopoietic stem cell transplantation; Transplantation; Medicine; Conditioning regimen; Hematology; Haematopoiesis; Conditioning; Hematopoietic cell; Internal medicine; Leukemia; Oncology; Immunology; Biology; Genetics","score_opus":0.0396595739014474,"score_gpt":0.3308066704193945,"score_spread":0.29114709651794707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405049560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99797946,0.0008778862,0.00040035613,0.00006998946,0.000057005156,0.00035866318,0.00006699109,0.000011015783,0.00017863038],"genre_scores_gemma":[0.99937594,0.000087840584,0.00033516568,0.000046827026,0.000011127988,0.0000545963,0.000047616933,0.000007726482,0.000033171844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992908,0.000043345826,0.0002806151,0.00012932131,0.0001369016,0.00011899732],"domain_scores_gemma":[0.999302,0.000533307,0.000050990042,0.00006566941,0.000031810367,0.00001619823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011896548,0.00008332054,0.0002767341,0.00007660882,0.000012208774,0.0000075277903,0.00003795426,0.00006119672,0.000009664079],"category_scores_gemma":[0.000045778,0.000058137553,0.00007754533,0.00012987944,0.000059995433,0.00005705263,0.000009627452,0.000090119196,0.0000017181721],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014550037,0.00025908145,0.97743785,0.0012618545,0.000042774103,0.0000925822,0.019805592,0.000008257659,0.00026251,0.0005923589,0.0000079398,0.00008369759],"study_design_scores_gemma":[0.0028115085,0.00017345375,0.9799978,0.0020701326,0.0001428252,0.0000019977413,0.0017680532,0.000021658032,0.012252397,0.0006513608,0.000029536306,0.00007927273],"about_ca_topic_score_codex":0.000016058442,"about_ca_topic_score_gemma":0.00012391164,"teacher_disagreement_score":0.018037539,"about_ca_system_score_codex":0.000019926054,"about_ca_system_score_gemma":0.00003549445,"threshold_uncertainty_score":0.23707807},"labels":[],"label_agreement":null},{"id":"W4405049588","doi":"10.1182/blood-2024-207213","title":"Impact of Adverse Events on Health-Related Quality of Life in Patients with Chronic Myeloid Leukemia (CML) Treated with Tyrosine Kinase Inhibitors (TKIs) - Early Results of the Survey on Humanistic Burden of Intolerance to First or Second TKIs (SHIFT) Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Myeloid leukemia; Adverse effect; Quality of life (healthcare); Tyrosine kinase; Tyrosine-kinase inhibitor; Leukemia; Imatinib; Oncology; Internal medicine; Immunology; Cancer; Receptor","score_opus":0.0210851803101542,"score_gpt":0.2880698534737959,"score_spread":0.26698467316364166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405049588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99526316,0.0001692462,3.097241e-7,0.00003889303,0.00006042848,0.003125008,0.0012702488,0.000029112412,0.00004362191],"genre_scores_gemma":[0.9995285,0.000010242604,0.000013269543,0.000011315127,0.000025790376,0.00004265506,0.0001657252,0.000067338435,0.00013516391],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957991,0.0004895936,0.0017307495,0.00063890044,0.00094369485,0.00039794797],"domain_scores_gemma":[0.99706835,0.000482377,0.0009424645,0.0010394383,0.00025303708,0.000214338],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00076668477,0.00044943497,0.001349937,0.00035653036,0.000053717984,0.0000040558525,0.00024713206,0.00013371928,0.0000689702],"category_scores_gemma":[0.0004807027,0.00025799993,0.00015773693,0.0014795996,0.00015264173,0.000077829194,0.000076919285,0.00038250626,0.0000057905745],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02906135,0.0061758915,0.9550619,0.001050305,0.0013570567,0.000029785118,0.004928029,0.0017936343,0.00028670882,0.0000026367584,0.00007265596,0.00018004587],"study_design_scores_gemma":[0.04722404,0.03652993,0.9082095,0.0050389473,0.00023953318,0.0000012252914,0.00007797434,0.000025800286,0.0024606842,0.0000012792843,0.0000018571333,0.00018921353],"about_ca_topic_score_codex":0.08414847,"about_ca_topic_score_gemma":0.03300291,"teacher_disagreement_score":0.051145554,"about_ca_system_score_codex":0.0023871271,"about_ca_system_score_gemma":0.0026204449,"threshold_uncertainty_score":0.99998724},"labels":[],"label_agreement":null},{"id":"W4405049622","doi":"10.1182/blood-2024-205639","title":"The Role of JAK2 Allele Burden on Muscle Strength and Physical Functioning in Patients with Myeloproliferative Neoplasm: A Systematic Review and Prospective Cohort Analysis","year":2024,"lang":"en","type":"review","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University; Population Health Research Institute","funders":"","keywords":"Myeloproliferative neoplasm; Medicine; Cohort; Prospective cohort study; Internal medicine; Cohort study; Hematologic Neoplasms; Allele; Oncology; Physical therapy; Myelofibrosis; Gerontology; Genetics; Cancer; Biology; Bone marrow; Gene","score_opus":0.006366189304538765,"score_gpt":0.2560722394649221,"score_spread":0.2497060501603833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405049622","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023058476,0.96970564,3.3570382e-7,0.00003352615,0.00001225252,0.0066549233,0.0000748806,0.000017535216,0.0004424516],"genre_scores_gemma":[0.04161046,0.95545495,0.000025857176,0.000017135866,0.00005483854,0.0025553596,0.00014130223,0.000043336266,0.00009677013],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9977599,0.00024971497,0.00067847123,0.00064423674,0.0004290453,0.00023865074],"domain_scores_gemma":[0.99845695,0.0004573137,0.0004060539,0.00039922347,0.00016868502,0.000111747344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027466388,0.0005161594,0.0035919975,0.00022709221,0.00011951565,0.000053108957,0.00006877225,0.00010082646,0.0000044687667],"category_scores_gemma":[0.00017073887,0.0002441747,0.00028458794,0.0008034847,0.000099190256,0.000042367734,0.0000643695,0.0003711179,0.000007452993],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008881684,0.0029832697,0.15034606,0.76595885,0.046280112,0.000047930956,0.0018947478,0.000001579429,6.808909e-8,0.00081429404,0.000020815014,0.031563472],"study_design_scores_gemma":[0.0035997548,0.0032130077,0.051995687,0.55574036,0.38161433,0.00003763714,0.0003839241,0.000053803487,0.000007087255,0.000051037838,0.0026389358,0.0006644752],"about_ca_topic_score_codex":0.000048098416,"about_ca_topic_score_gemma":0.00011206449,"teacher_disagreement_score":0.3353342,"about_ca_system_score_codex":0.00014219122,"about_ca_system_score_gemma":0.00020006973,"threshold_uncertainty_score":0.9957155},"labels":[],"label_agreement":null},{"id":"W4405049650","doi":"10.1182/blood-2024-209470","title":"Patient and Clinical Experience on Concizumab Clinical Trial: A Case Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; McMaster Children's Hospital","funders":"","keywords":"Medicine; Clinical trial; Intensive care medicine; Internal medicine","score_opus":0.10318064443497804,"score_gpt":0.4446980587432384,"score_spread":0.3415174143082604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405049650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99487704,0.0009405353,0.000002950361,0.0001507796,0.0022217252,0.00087361573,0.0000068337904,0.00010134315,0.0008251764],"genre_scores_gemma":[0.9984429,0.00008478794,0.000015036019,0.00052326114,0.0006911147,0.00007714219,0.0000017955849,0.000018160954,0.00014578366],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9984124,0.00018675275,0.00056518766,0.00045732546,0.00023292961,0.00014544159],"domain_scores_gemma":[0.99887586,0.0005008456,0.000038866736,0.00033017996,0.000039297425,0.00021493917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005016412,0.000117273456,0.00034009712,0.000040435687,0.000041839416,0.000041206426,0.00003574012,0.000096663825,0.00006298775],"category_scores_gemma":[0.00028678792,0.00008747095,0.00015303744,0.000116446114,0.00010041816,0.000029237372,0.000052113555,0.0003407105,0.000026538246],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028432218,0.021106211,0.3229112,0.00018681391,0.0010838525,0.1448721,0.04633686,1.00107066e-7,0.000009798527,0.0002044013,0.0024398058,0.43241665],"study_design_scores_gemma":[0.44749612,0.1976635,0.050771132,0.0011689868,0.0048426595,0.016646931,0.16885556,0.00022754756,0.00027982148,0.000070504175,0.110690005,0.001287246],"about_ca_topic_score_codex":0.00034486823,"about_ca_topic_score_gemma":0.00046968987,"teacher_disagreement_score":0.4311294,"about_ca_system_score_codex":0.000013947948,"about_ca_system_score_gemma":0.00012495655,"threshold_uncertainty_score":0.3566962},"labels":[],"label_agreement":null},{"id":"W4405049845","doi":"10.1182/blood-2024-204683","title":"Thromboembolism in Multiple Myeloma: A Single Centre Retrospective Review","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Multiple myeloma; Medicine; Retrospective cohort study; Lenalidomide; Internal medicine; Oncology","score_opus":0.029048022117262234,"score_gpt":0.2999584004392421,"score_spread":0.27091037832197984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405049845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8685477,0.11029457,0.000007955871,0.003143313,0.00018462988,0.0016471959,0.000065016815,0.00026923936,0.015840396],"genre_scores_gemma":[0.9946678,0.0034311118,0.00044580468,0.00021828942,0.00014340658,0.00004968345,0.00006214524,0.000032796783,0.00094891083],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998616,0.000051516177,0.00022265983,0.00038587052,0.00033683976,0.00038712946],"domain_scores_gemma":[0.99937266,0.000080952515,0.000020317557,0.0002883585,0.000060368104,0.00017732484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001461671,0.00015557268,0.00041177348,0.00013464253,0.000035125642,0.000029091329,0.00006814094,0.00006522606,0.00034362357],"category_scores_gemma":[0.0003751909,0.00012533189,0.00012552805,0.00047191905,0.00004535601,0.00008509846,0.000050165974,0.0002567911,0.00046254395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002486544,0.012312541,0.7842908,0.013424474,0.0020128032,0.019422974,0.001590238,3.9285223e-7,0.03352036,0.0014168302,0.016090447,0.1156695],"study_design_scores_gemma":[0.010355593,0.0005955696,0.9435956,0.01530927,0.0006063915,0.0003226669,0.000089675945,0.0002642892,0.013197268,0.0004342411,0.014874804,0.00035462293],"about_ca_topic_score_codex":0.00008820138,"about_ca_topic_score_gemma":0.00013591003,"teacher_disagreement_score":0.15930481,"about_ca_system_score_codex":0.0001481004,"about_ca_system_score_gemma":0.00010679263,"threshold_uncertainty_score":0.59452206},"labels":[],"label_agreement":null},{"id":"W4405049854","doi":"10.1182/blood-2024-193438","title":"UBE2E3 Supports Survival of Leukemia Stem Cells By Regulation of Polycomb Repression Complex (PRC) 1.1","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Psychological repression; Polycomb-group proteins; Stem cell; Leukemia; BMI1; Biology; Cancer research; Haematopoiesis; Repressor; Cell biology; Genetics; Gene; Transcription factor; Gene expression","score_opus":0.013556142941996691,"score_gpt":0.2683738063400698,"score_spread":0.2548176633980731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405049854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996475,0.0012813137,0.00016420915,0.00003079055,0.00017061613,0.00016195184,0.00012972983,0.000016367509,0.0015700494],"genre_scores_gemma":[0.99656713,0.0000652223,0.00016444332,0.000005341731,0.00008620903,0.000006010268,0.00023755062,0.000026908601,0.002841172],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987776,0.000095904834,0.00032564587,0.0003277143,0.00029438105,0.00017872694],"domain_scores_gemma":[0.9993084,0.000025352376,0.00008461917,0.00042682645,0.00008918592,0.00006559624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026783958,0.00011427071,0.00018068546,0.00006400188,0.000028952263,0.00001100161,0.00014458371,0.0001551901,0.00008205226],"category_scores_gemma":[0.000017281613,0.00010958263,0.00010405193,0.00013105321,0.000097741664,0.0000043024866,0.000112485475,0.000090614885,0.000009540048],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040011713,0.00010510158,0.00031487303,0.00015252075,0.00005010844,0.000005724051,0.000050756647,0.000022188571,0.97775954,0.000028704446,0.020751622,0.0007188587],"study_design_scores_gemma":[0.00043292707,0.00018233476,0.0003889206,0.000060541235,0.000026096675,0.000009001279,0.00002992407,0.00016570496,0.98606455,0.000010814104,0.012526798,0.000102355494],"about_ca_topic_score_codex":0.000067035864,"about_ca_topic_score_gemma":0.000007902463,"teacher_disagreement_score":0.00830505,"about_ca_system_score_codex":0.000020462418,"about_ca_system_score_gemma":0.00015538816,"threshold_uncertainty_score":0.446865},"labels":[],"label_agreement":null},{"id":"W4405049933","doi":"10.1182/blood-2024-198626","title":"Unmet Needs in Multiple Myeloma and Potential Solutions: A Systemic Literature Review","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Multiple myeloma; Lenalidomide; Medicine; Ixazomib; Intensive care medicine; Internal medicine; Carfilzomib","score_opus":0.020357993317921805,"score_gpt":0.2861096032675662,"score_spread":0.26575160994964436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405049933","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4163024,0.5814747,0.000022287362,0.0007731235,0.00007777091,0.0008170586,0.000052452135,0.00007818424,0.0004020247],"genre_scores_gemma":[0.9394192,0.059159495,0.00028045668,0.00010497296,0.00011252207,0.000113289105,0.00009876023,0.000017828286,0.00069346523],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99897987,0.00006828063,0.00020846976,0.000230492,0.00022011135,0.00029277772],"domain_scores_gemma":[0.99952495,0.000058772366,0.000016033191,0.00020205855,0.000043909633,0.00015426548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020738653,0.00012718396,0.0002635629,0.000275857,0.00004761158,0.000059526457,0.000045882218,0.00007758651,0.000033520624],"category_scores_gemma":[0.00016728175,0.00009809797,0.00007740727,0.0006093725,0.000033605214,0.00009163257,0.000053063228,0.00023282961,0.00006544077],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008575749,0.008321143,0.25614938,0.18200085,0.004418514,0.115348384,0.0040328447,0.0000046212062,0.073168255,0.002632318,0.0128045,0.3402616],"study_design_scores_gemma":[0.05412608,0.002435596,0.36815563,0.44322413,0.0040194746,0.09323124,0.00059886393,0.007796055,0.0038402872,0.00053248595,0.020458184,0.001581979],"about_ca_topic_score_codex":0.000019993855,"about_ca_topic_score_gemma":0.0000068145596,"teacher_disagreement_score":0.5231168,"about_ca_system_score_codex":0.000037582704,"about_ca_system_score_gemma":0.000080753474,"threshold_uncertainty_score":0.4000319},"labels":[],"label_agreement":null},{"id":"W4405049957","doi":"10.1182/blood-2024-204282","title":"Lintuzumab-Ac225 Exerts Mutation Agnostic Antileukemic Activity in Preclinical Models of AML","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Mutation; Cancer research; Leukemia; Medicine; Biology; Genetics; Immunology; Gene","score_opus":0.060134507179108974,"score_gpt":0.37524637745984196,"score_spread":0.315111870280733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405049957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930284,0.001048442,0.00020643642,0.00018820664,0.00010685366,0.0004785121,0.000010354126,0.00006663468,0.0048661665],"genre_scores_gemma":[0.9979906,0.0003621992,0.000167964,0.0000254274,0.00011119243,0.000031825188,0.000013560105,0.00002941635,0.0012677903],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998759,0.00008153745,0.00028850022,0.00030483858,0.0003450682,0.00022106999],"domain_scores_gemma":[0.9989489,0.0005898121,0.000033803128,0.0002840744,0.000058674963,0.00008474307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041140296,0.00010780932,0.0003036136,0.00021126393,0.000012374586,0.000016541417,0.000079245896,0.00013290429,0.00039981696],"category_scores_gemma":[0.0002666216,0.00009780439,0.00011054709,0.00034418976,0.00007459509,0.000110092,0.000043532298,0.00038139764,0.000033289034],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013731611,0.003020978,0.0068876874,0.0017005042,0.00036395845,0.0014226285,0.0017737957,0.0008149835,0.8416465,0.0003385564,0.00039558538,0.1402617],"study_design_scores_gemma":[0.013939816,0.0029763726,0.047948558,0.0033641334,0.0006363916,0.00049406127,0.00010852976,0.1611328,0.7604042,0.0074837813,0.0009833929,0.000527917],"about_ca_topic_score_codex":0.0001483314,"about_ca_topic_score_gemma":0.000037952068,"teacher_disagreement_score":0.16031782,"about_ca_system_score_codex":0.00008265453,"about_ca_system_score_gemma":0.00033199473,"threshold_uncertainty_score":0.43777153},"labels":[],"label_agreement":null},{"id":"W4405049996","doi":"10.1182/blood-2024-201631","title":"Major Bleeding Post-Renal Transplant in Anticoagulated Patients: A Retrospective Cohort Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Renal and Vascular Pathologies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; McGill University","funders":"","keywords":"Medicine; Retrospective cohort study; Renal transplant; Cohort; Surgery; Internal medicine; Transplantation","score_opus":0.01002529060057496,"score_gpt":0.25217060254405393,"score_spread":0.24214531194347896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405049996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976478,0.00042870807,0.000012980324,0.000088170054,0.00013359927,0.00088426203,0.0000234931,0.00014529572,0.0006356586],"genre_scores_gemma":[0.99959975,0.000037594284,0.00004877807,0.00003315972,0.00006840645,0.000038976355,0.00004213899,0.000019067396,0.000112148264],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99887997,0.000040661227,0.00023184778,0.00033708574,0.00029578677,0.00021462064],"domain_scores_gemma":[0.99967706,0.000023452936,0.000018955898,0.0001498608,0.00007731925,0.000053374868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024821307,0.00013919231,0.00031864474,0.00018805741,0.00003299756,0.00003130655,0.000056616267,0.000064743675,0.00004338113],"category_scores_gemma":[0.00005854635,0.000099594065,0.00009943913,0.00033436297,0.000027958795,0.00007246585,0.000022011181,0.00024099526,0.000033675376],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076859076,0.0016182559,0.98415065,0.000059198614,0.0004103539,0.0018358406,0.001240972,0.0000012301364,0.010392139,0.000021285176,0.000014703274,0.0001785347],"study_design_scores_gemma":[0.0037396206,0.0012355052,0.9894036,0.00036267168,0.0006744343,0.00012229329,0.00017419542,0.000063567386,0.004069626,0.000028253402,0.000009014888,0.000117208314],"about_ca_topic_score_codex":0.00014965524,"about_ca_topic_score_gemma":0.000047506637,"teacher_disagreement_score":0.0063225133,"about_ca_system_score_codex":0.00004077285,"about_ca_system_score_gemma":0.000035487203,"threshold_uncertainty_score":0.40613282},"labels":[],"label_agreement":null},{"id":"W4405050026","doi":"10.1182/blood-2024-203588","title":"A Novel Three-Way Translocation Involving <i>ETV6-IL3</i> Drives AML with Eosinophilia","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Silence Therapeutics; Oryzon Genomics; Sierra Oncology; CTI Biopharma; Taiho Pharmaceutical; Incyte; Swedish Orphan Biovitrum; Astellas Pharma; Ariad Pharmaceuticals; MorphoSys; Celgene; Gilead Sciences; Agios Pharmaceuticals; Bristol-Myers Squibb","keywords":"Chromosomal translocation; Eosinophilia; Medicine; Internal medicine; Cancer research; Pharmacology; Biology; Genetics; Gene","score_opus":0.01348020016196831,"score_gpt":0.23251727741304076,"score_spread":0.21903707725107247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405050026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9712227,0.014680885,0.0032102948,0.003626214,0.00019035359,0.0005082618,0.000017010747,0.00034784185,0.0061964463],"genre_scores_gemma":[0.9958819,0.0003108264,0.0023370301,0.00037644967,0.000178888,0.00004258803,0.00003825037,0.000054651086,0.0007794223],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99874717,0.000010668747,0.00023809327,0.00040123722,0.00032030113,0.00028255713],"domain_scores_gemma":[0.99941856,0.000047283324,0.000031377516,0.0003136662,0.00006264219,0.00012644795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012670358,0.00021204368,0.00029348332,0.00014207728,0.00008403928,0.00008280066,0.00009741331,0.000095297124,0.00009091846],"category_scores_gemma":[0.000018926605,0.0001569884,0.000099904755,0.00038388587,0.00010795481,0.00016852368,0.000016785805,0.000214801,0.00005633118],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045483498,0.009039595,0.11700673,0.0048886463,0.0033635122,0.0016376046,0.015252358,0.0000523212,0.69645286,0.044203985,0.003632271,0.10401527],"study_design_scores_gemma":[0.06483052,0.014741718,0.6083625,0.025951095,0.010971944,0.013893028,0.005652561,0.013812236,0.1490052,0.017467294,0.06935607,0.0059558544],"about_ca_topic_score_codex":0.000082340375,"about_ca_topic_score_gemma":0.00019196478,"teacher_disagreement_score":0.5474477,"about_ca_system_score_codex":0.000018358189,"about_ca_system_score_gemma":0.00015210203,"threshold_uncertainty_score":0.6401802},"labels":[],"label_agreement":null},{"id":"W4405050034","doi":"10.1182/blood-2024-198804","title":"Efficacy and Safety of Teclistamab in Relapsed or Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis","year":2024,"lang":"en","type":"review","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Multiple myeloma; Internal medicine; Refractory (planetary science); Lenalidomide; Oncology; Meta-analysis; Pomalidomide; Biology","score_opus":0.09983939720085885,"score_gpt":0.3863450865801625,"score_spread":0.28650568937930365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405050034","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000038062826,0.9925053,8.957459e-7,0.000056710793,0.000008751944,0.0068876115,0.0003626105,0.000032305405,0.00010771531],"genre_scores_gemma":[0.0005363094,0.99636084,0.0002764635,0.000029561379,0.000012962049,0.00089890364,0.00019821037,0.00006214828,0.0016245873],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9960492,0.00062698673,0.0017593862,0.00073967734,0.00049396907,0.00033077362],"domain_scores_gemma":[0.99696344,0.0012093531,0.0005219693,0.0009499113,0.000090272304,0.00026502437],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009911547,0.0005958036,0.011901553,0.00081764103,0.000036392285,0.000027210692,0.00015288251,0.0002630481,0.00013583072],"category_scores_gemma":[0.0020437797,0.00029957938,0.0015377689,0.0014938045,0.00010078515,0.000034892833,0.00016416487,0.00053677993,0.000029334988],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006120592,0.00054317515,0.000011451889,0.7929166,0.20311143,0.0005794209,0.000026212503,7.4325293e-9,2.1221138e-7,0.000004577572,0.000021075644,0.0027246543],"study_design_scores_gemma":[0.002986831,0.00023735686,0.000047226702,0.13140851,0.8584382,0.00021978808,0.000008040123,0.0000029813204,4.5772381e-7,0.0000010908835,0.006453958,0.0001955574],"about_ca_topic_score_codex":0.00006830322,"about_ca_topic_score_gemma":0.00009917084,"teacher_disagreement_score":0.6615081,"about_ca_system_score_codex":0.00007994656,"about_ca_system_score_gemma":0.00028300728,"threshold_uncertainty_score":0.99994564},"labels":[],"label_agreement":null},{"id":"W4405050041","doi":"10.1182/blood-2024-201855","title":"Long-Term Outcomes and Adverse Events of CAR T-19 Cell Therapy in Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia - a Systematic Review and Meta-Analysis","year":2024,"lang":"en","type":"review","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Adverse effect; Meta-analysis; Lymphoblastic Leukemia; Oncology; Refractory (planetary science); Leukemia; CAR T-cell therapy; Acute lymphocytic leukemia; Internal medicine; Cancer; Chimeric antigen receptor; Biology; Immunotherapy","score_opus":0.08288058284013552,"score_gpt":0.3791185913339176,"score_spread":0.2962380084937821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405050041","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002263661,0.9910733,0.0000011532708,0.000023192277,0.00003511487,0.006270036,0.00017168882,0.000033370412,0.00012849062],"genre_scores_gemma":[0.00034266585,0.974963,0.000046589732,0.00014722392,0.000018578536,0.00074027677,0.00009869734,0.00013522281,0.023507738],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99479,0.00095733994,0.0020531311,0.0009417887,0.00082507415,0.00043262253],"domain_scores_gemma":[0.9964196,0.00088674354,0.00085263315,0.001416315,0.00011516444,0.00030956377],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014205188,0.0008784568,0.013249256,0.001131329,0.000033239503,0.000019784962,0.0003493199,0.0004115099,0.00088950683],"category_scores_gemma":[0.00019002949,0.00047668282,0.0030139922,0.0015719808,0.000104063205,0.00005194754,0.00018100197,0.00068475516,0.000041850224],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004449179,0.00041911015,0.00013146832,0.83897495,0.15902025,0.00068423455,0.00009573264,6.8284855e-8,0.000020122752,3.6629848e-7,0.000028960656,0.0005802388],"study_design_scores_gemma":[0.0033142143,0.00046417338,0.000036441863,0.055516552,0.9387133,0.00023550774,0.00001211136,0.0000016473398,0.00000988388,0.0000014226956,0.0013069686,0.0003877429],"about_ca_topic_score_codex":0.00006510687,"about_ca_topic_score_gemma":0.00003589657,"teacher_disagreement_score":0.7834584,"about_ca_system_score_codex":0.0003545901,"about_ca_system_score_gemma":0.0010069509,"threshold_uncertainty_score":0.9997685},"labels":[],"label_agreement":null},{"id":"W4405050054","doi":"10.1182/blood-2024-206915","title":"Clinical Outcomes over 2 Years of Once-Weekly Efanesoctocog Alfa Treatment in Children with Severe Hemophilia A: Second Interim Analysis from the Phase 3 XTEND-ed Long-Term Extension Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Canadian Institutes of Health Research; Novo Nordisk; CSL Behring; Swedish Orphan Biovitrum; Canadian Hemophilia Society; Genentech","keywords":"Interim; Medicine; Interim analysis; Pediatrics; Term (time); Clinical trial; Internal medicine; History","score_opus":0.04113550274078684,"score_gpt":0.39181253940952615,"score_spread":0.3506770366687393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405050054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966586,0.0008624018,0.0000013614276,0.00028832193,0.000057860947,0.0018823094,0.0001312965,0.000043244792,0.00007455917],"genre_scores_gemma":[0.9978894,0.00018368174,0.00005663231,0.000054002452,0.00014253113,0.000079615704,0.00020549815,0.000033775763,0.0013548534],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977667,0.00020539976,0.00056987046,0.0006275153,0.000544106,0.00028640698],"domain_scores_gemma":[0.9985649,0.00041466605,0.000082514394,0.0007371464,0.00005278469,0.00014797827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033509755,0.00027057398,0.0008831735,0.00024639646,0.00004127619,0.000040891944,0.00016602989,0.00011541949,0.0007015423],"category_scores_gemma":[0.00004831701,0.00014145585,0.00042839834,0.0006337264,0.00013985066,0.000069824964,0.000088473316,0.0002994562,0.000028380377],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005447296,0.011765656,0.95536864,0.000016343633,0.010714087,0.0012583466,0.0008167333,0.0000010680078,0.00014200748,9.549635e-7,0.00005375477,0.019317662],"study_design_scores_gemma":[0.01942137,0.003679452,0.9703078,0.00014060027,0.0057687955,0.00003813421,0.0001853705,0.00004889937,0.00023799916,0.000005735897,0.000023861676,0.00014194683],"about_ca_topic_score_codex":0.0004481114,"about_ca_topic_score_gemma":0.0006571649,"teacher_disagreement_score":0.019175716,"about_ca_system_score_codex":0.00007358141,"about_ca_system_score_gemma":0.00016671744,"threshold_uncertainty_score":0.7681396},"labels":[],"label_agreement":null},{"id":"W4405050108","doi":"10.1182/blood-2024-198536","title":"Gemtuzumab Ozogamicin in Favorable and Intermediate Risk Acute Myeloid Leukemia: A Single-Center Experience","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Gemtuzumab ozogamicin; Medicine; Myeloid leukemia; Calicheamicin; Leukemia; Internal medicine; Oncology; CD33; Biology","score_opus":0.024610560995963298,"score_gpt":0.3166875365898274,"score_spread":0.2920769755938641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405050108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929131,0.0026655332,0.00003584811,0.00031673413,0.00026315183,0.000433798,0.000038431735,0.00011415169,0.0032192357],"genre_scores_gemma":[0.99609184,0.0017035089,0.00031241312,0.00017637934,0.00019289013,0.0001015946,0.000010603834,0.00004473525,0.0013660577],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99830663,0.00006653577,0.00028378388,0.000504542,0.0003511193,0.0004873941],"domain_scores_gemma":[0.9993148,0.00009966084,0.000030146733,0.0003281075,0.000039415696,0.00018789785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029085978,0.0001776781,0.00029140522,0.00026655308,0.000044008168,0.000100268655,0.00014455512,0.000120695346,0.00016896304],"category_scores_gemma":[0.00013314339,0.00015297267,0.000056548295,0.00041402446,0.00017203072,0.00014901363,0.00017170665,0.00065120857,0.00011774983],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013890356,0.0024829856,0.5198816,0.0026064555,0.00097139156,0.014663206,0.032555334,0.000007735094,0.22468258,0.00021404642,0.009351209,0.19119443],"study_design_scores_gemma":[0.06759973,0.015014506,0.17952737,0.017953223,0.0020444035,0.008378537,0.009595785,0.012095884,0.44422537,0.001604096,0.23861031,0.0033507722],"about_ca_topic_score_codex":0.00031915487,"about_ca_topic_score_gemma":0.00015434326,"teacher_disagreement_score":0.3403542,"about_ca_system_score_codex":0.00040248389,"about_ca_system_score_gemma":0.00035423366,"threshold_uncertainty_score":0.62380445},"labels":[],"label_agreement":null},{"id":"W4405050175","doi":"10.1182/blood-2024-212360","title":"Global Burden and Trend of Anemia Due to Chronic Kidney Disease in G20 Countries from 1990-2021: A Benchmarking Systematic Analysis","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Kidney disease; Medicine; Benchmarking; Anemia; Burden of disease; Disease burden; Intensive care medicine; Environmental health; Internal medicine; Disease; Business","score_opus":0.005810986531253374,"score_gpt":0.25144160969790036,"score_spread":0.245630623166647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405050175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803434,0.01697985,0.000021480513,0.0013853423,0.00007032851,0.00052079407,0.00032534666,0.000030245037,0.00032320013],"genre_scores_gemma":[0.99888355,0.00017351679,0.00028327215,0.00006994865,0.00024523077,0.000058618476,0.00017423095,0.000010175793,0.00010146785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881476,0.000043556007,0.00034420393,0.00033818258,0.0002760523,0.00018323478],"domain_scores_gemma":[0.999229,0.0001228602,0.000047693557,0.00028129446,0.000017014941,0.00030212422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011659898,0.00016305585,0.00058141595,0.00018295432,0.00002534366,0.000044731343,0.00005856462,0.00005386212,0.00022443688],"category_scores_gemma":[0.000089358604,0.00012625834,0.0001272495,0.0007096378,0.000048064307,0.00003413839,0.00004919336,0.0000587595,0.000012267651],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020192394,0.00119254,0.8915489,0.080800086,0.0068189013,0.00877083,0.0045531564,0.000106457934,0.0006257504,0.0009589568,0.0016565379,0.000948641],"study_design_scores_gemma":[0.1059209,0.0045589707,0.60006094,0.15278636,0.11869624,0.00027816903,0.002998054,0.0077341315,0.001742094,0.0008289075,0.0025325678,0.0018626471],"about_ca_topic_score_codex":0.001280189,"about_ca_topic_score_gemma":0.00068021,"teacher_disagreement_score":0.29148796,"about_ca_system_score_codex":0.00015894824,"about_ca_system_score_gemma":0.0002264245,"threshold_uncertainty_score":0.5148666},"labels":[],"label_agreement":null},{"id":"W4405050191","doi":"10.1182/blood-2024-208861","title":"ULTRA FRAIL-MM Clinical Trial: Go-Slow Approach Incorporating Isatuximab, Lenalidomide and Dexamethasone for Ultra-Frail Newly Diagnosed Myeloma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Lenalidomide; Dexamethasone; Multiple myeloma; Medicine; Carfilzomib; Internal medicine; Oncology; Pomalidomide","score_opus":0.08088941607811272,"score_gpt":0.36705118882494575,"score_spread":0.286161772746833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405050191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98477733,0.0042197797,0.0019096443,0.0010901443,0.0003924382,0.003931235,0.00016644964,0.00031958634,0.0031934015],"genre_scores_gemma":[0.9592967,0.00046346342,0.03605807,0.00027892707,0.0014485802,0.0007682056,0.000310261,0.00011870062,0.0012571159],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99638695,0.0003012361,0.00094493263,0.001034769,0.00059438316,0.00073772337],"domain_scores_gemma":[0.9948543,0.0035846548,0.00016146658,0.00057103275,0.00014376169,0.0006848065],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017020886,0.00042799863,0.0009709176,0.00022524827,0.0001952528,0.00022358076,0.00019195538,0.0003542842,0.00004325459],"category_scores_gemma":[0.00396638,0.0003333834,0.00043533836,0.00040507384,0.0002844791,0.00020180586,0.00005110395,0.0006653644,0.00006538982],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07105529,0.022015367,0.22154345,0.005034733,0.009198316,0.0043099574,0.0019067116,0.000007899679,0.036140103,0.0018081134,0.018811712,0.60816836],"study_design_scores_gemma":[0.8552817,0.014379601,0.06175693,0.0015830687,0.0039834003,0.0008944706,0.00095496344,0.004584218,0.032644458,0.0019296381,0.020388624,0.0016189187],"about_ca_topic_score_codex":0.0001143175,"about_ca_topic_score_gemma":0.000027091819,"teacher_disagreement_score":0.7842264,"about_ca_system_score_codex":0.00006259527,"about_ca_system_score_gemma":0.00047552394,"threshold_uncertainty_score":0.99991184},"labels":[],"label_agreement":null},{"id":"W4405050202","doi":"10.1182/blood-2024-209461","title":"Population-Based Analysis of Outcomes in Acute Myeloid Leukemia from a Provincial Cancer Registry and the Canadian Cancer Registry: A Population-Based Retrospective Cohort Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; CancerCare Manitoba","funders":"","keywords":"Cancer registry; Medicine; Myeloid leukemia; Cancer; Retrospective cohort study; Population; Internal medicine; Cohort; Oncology; Demography; Environmental health","score_opus":0.010969328582177423,"score_gpt":0.302139493982315,"score_spread":0.29117016540013757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405050202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925358,0.0005783804,0.000011870711,0.002935818,0.00010997097,0.0021134387,0.0015215292,0.00005737202,0.00013578912],"genre_scores_gemma":[0.99757266,0.00003235537,0.00013062802,0.00032312342,0.00015173119,0.00069625274,0.0006318094,0.000048394362,0.00041303196],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970944,0.00020962818,0.00060954003,0.0007580755,0.0009007301,0.00042763638],"domain_scores_gemma":[0.9981505,0.00037398978,0.00022138072,0.0007888861,0.00022345931,0.00024177345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006914158,0.0003028471,0.0011324702,0.0008842893,0.00018029999,0.00010701615,0.000245492,0.00021423961,0.00017817112],"category_scores_gemma":[0.00052513386,0.00021903239,0.00023130624,0.0020935165,0.00016374516,0.00008148697,0.00004374199,0.00065218005,0.0000015647721],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00037589466,0.00013524144,0.99286115,0.00006138101,0.0048311614,0.00019761366,0.0004501465,0.00064634404,0.00005184941,0.00006001044,0.00011779521,0.00021142139],"study_design_scores_gemma":[0.0061513246,0.000076679826,0.9605164,0.00014887289,0.0074544568,0.000001434003,0.00012774099,0.025191179,0.000058807385,0.00004984299,0.000022345199,0.00020091343],"about_ca_topic_score_codex":0.9813653,"about_ca_topic_score_gemma":0.97422314,"teacher_disagreement_score":0.03234474,"about_ca_system_score_codex":0.004986937,"about_ca_system_score_gemma":0.0070252777,"threshold_uncertainty_score":0.99883276},"labels":[],"label_agreement":null},{"id":"W4405050250","doi":"10.1182/blood-2024-211936","title":"Can Optical Genome Mapping Replace Bone Marrow Biopsies in Acute Myeloid Leukemia?","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"","keywords":"Bone marrow; Myeloid leukemia; Leukemia; Medicine; Cancer research; Pathology; Biology; Immunology","score_opus":0.017689500159258017,"score_gpt":0.272891301789172,"score_spread":0.25520180162991396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405050250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9749028,0.003698562,0.000051989045,0.009839486,0.00015085001,0.0005550106,0.000038861905,0.0003147697,0.010447676],"genre_scores_gemma":[0.9809334,0.00074566563,0.0042697694,0.00053327,0.0005013548,0.000091334136,0.00009143019,0.000096269265,0.012737474],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974683,0.000059125472,0.00045684556,0.00068063464,0.00053734414,0.0007977456],"domain_scores_gemma":[0.9988,0.00017037021,0.000031595137,0.00060428143,0.0000705083,0.00032327086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006428814,0.00027336078,0.00051340705,0.0006187568,0.00006721717,0.000104730934,0.00021647174,0.00023949715,0.00021818938],"category_scores_gemma":[0.00023562157,0.00024289612,0.00014025057,0.0010378694,0.00017604665,0.00011559058,0.0002437213,0.0010097512,0.00037692176],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003375149,0.00036039038,0.006663184,0.0011510815,0.0010018931,0.03000302,0.0025382424,0.000016085212,0.94589967,0.0018393457,0.0052219704,0.0049676113],"study_design_scores_gemma":[0.046889137,0.003492086,0.21905793,0.0060416725,0.0034995652,0.042389795,0.0060578953,0.0141378315,0.3488305,0.0023260934,0.30273575,0.004541763],"about_ca_topic_score_codex":0.00022461783,"about_ca_topic_score_gemma":0.000060453003,"teacher_disagreement_score":0.5970692,"about_ca_system_score_codex":0.0010225457,"about_ca_system_score_gemma":0.0012784773,"threshold_uncertainty_score":0.9905016},"labels":[],"label_agreement":null},{"id":"W4405050368","doi":"10.1182/blood-2024-199315","title":"Infectious Complications and Antibiotic Prophylaxis during Induction Therapy with Venetoclax Plus Azacitidine for Previously Untreated AML: A Real-World Experience","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Venetoclax; Azacitidine; Medicine; Induction therapy; Antibiotics; Intensive care medicine; Leukemia; Internal medicine; Immunology; Oncology; Chemotherapy; Chronic lymphocytic leukemia; Microbiology; Biology","score_opus":0.01525518882374968,"score_gpt":0.28898036319444953,"score_spread":0.2737251743706999,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405050368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997381,0.0011244564,0.00014702063,0.00004566423,0.000039910803,0.0008153046,0.000019184612,0.00006616174,0.00036133372],"genre_scores_gemma":[0.9983416,0.0004891984,0.00021407015,0.000010643662,0.00014200504,0.00022819862,0.00008018655,0.000036439782,0.00045763972],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999098,0.00003304452,0.00013153249,0.00041661598,0.000099892175,0.00022093605],"domain_scores_gemma":[0.9995408,0.0000141296505,0.00003107986,0.00025252395,0.00008904065,0.00007242945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006563027,0.00013414402,0.00011412302,0.00010780915,0.00016127875,0.000064866734,0.000071775394,0.000076083656,0.0000026976695],"category_scores_gemma":[0.000022324311,0.00011408256,0.000035653735,0.0002632477,0.000131746,0.000008597861,0.000033877528,0.00009360061,0.0000030297424],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013383578,0.00008097903,0.0017995505,0.00013889266,0.00009465071,0.000010114784,0.00039789896,0.000049097926,0.9956033,0.00005148092,0.000052408952,0.0015877656],"study_design_scores_gemma":[0.0015799719,0.0014879005,0.006913721,0.00011096434,0.000022567952,0.0001534979,0.000044137792,0.0001287566,0.98705864,0.000010347007,0.0022920351,0.00019744353],"about_ca_topic_score_codex":0.0001764389,"about_ca_topic_score_gemma":0.000290638,"teacher_disagreement_score":0.008544668,"about_ca_system_score_codex":0.00007634079,"about_ca_system_score_gemma":0.00019220573,"threshold_uncertainty_score":0.46521518},"labels":[],"label_agreement":null},{"id":"W4405050384","doi":"10.1182/blood-2024-200679","title":"Comparative Effectiveness of Linvoseltamab Versus Current Real-World (RW) Standard-of-Care (SOC) Therapies in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma (RRMM): Key Subgroups Analysis","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Multiple myeloma; Medicine; Lenalidomide; Oncology; Pomalidomide; Internal medicine; Refractory (planetary science); Biology","score_opus":0.04334734194192181,"score_gpt":0.34909795020215906,"score_spread":0.30575060826023726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405050384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9775807,0.018947322,0.000061510924,0.000023369785,0.00031761866,0.0014372609,0.00048202224,0.000094300995,0.0010558546],"genre_scores_gemma":[0.99749225,0.001213225,0.00040905186,0.0000019417898,0.000073950076,0.00018293831,0.00052293896,0.00004505625,0.000058646092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99664646,0.00062445505,0.0006992399,0.0006541768,0.00088317855,0.0004924948],"domain_scores_gemma":[0.99656206,0.0020274718,0.00018282262,0.00059992657,0.0003993228,0.00022841067],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00056845794,0.0004005346,0.0015611998,0.0012779745,0.00006975623,0.000032453732,0.00020457906,0.00013747497,0.00009092087],"category_scores_gemma":[0.00023675855,0.00032280415,0.0005607607,0.002213974,0.00022393104,0.00015010654,0.00008658665,0.00049939484,0.000015531697],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06448428,0.0071855863,0.81774443,0.0062866653,0.021466173,0.0008361573,0.0173226,0.000094389965,0.03517088,0.00067079597,0.000086486354,0.028651541],"study_design_scores_gemma":[0.057230495,0.005180107,0.76984537,0.0020761178,0.0034553779,0.0000037459606,0.002408351,0.001081134,0.15717603,0.000048792084,0.0010656811,0.00042882512],"about_ca_topic_score_codex":0.0004854912,"about_ca_topic_score_gemma":0.0027566107,"teacher_disagreement_score":0.12200516,"about_ca_system_score_codex":0.00042261276,"about_ca_system_score_gemma":0.0005042393,"threshold_uncertainty_score":0.9999224},"labels":[],"label_agreement":null},{"id":"W4405050423","doi":"10.1182/blood-2024-204937","title":"Diagnosis, Management, and Outcomes of Drug-Induced Erythrocytosis: A Systematic Review","year":2024,"lang":"en","type":"review","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; Drug; Intensive care medicine; Internal medicine; Pharmacology","score_opus":0.017751454106091746,"score_gpt":0.3021972033442474,"score_spread":0.28444574923815563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405050423","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008973197,0.9972554,4.458033e-7,0.000015494203,0.00007441085,0.00215209,0.00008044639,0.000014152673,0.00031785163],"genre_scores_gemma":[0.00018456437,0.9972879,0.00004725568,0.0000793519,0.000022442598,0.0016560579,0.0001544636,0.00005704602,0.0005108651],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9984468,0.000106256855,0.0006399191,0.0004886465,0.0001363274,0.00018202278],"domain_scores_gemma":[0.9989873,0.00001945226,0.00030678185,0.0006028121,0.000023696115,0.000059925864],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001318142,0.00041388004,0.0020159918,0.000077988996,0.000027714988,0.000022594008,0.00021999581,0.00016445798,0.000003346149],"category_scores_gemma":[0.000034998677,0.0002843994,0.0005572572,0.00014479713,0.000026042908,0.0000018774854,0.00024458478,0.00008438966,0.000026998556],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[3.3139005e-7,0.0003115003,0.00003437337,0.97452503,0.0049472856,0.00001964066,0.0000039526017,8.234258e-10,3.280334e-7,0.000031318355,0.0007543541,0.019371895],"study_design_scores_gemma":[0.0007125216,0.00011054552,0.000005478365,0.8107254,0.091793545,0.00006936975,0.000017884993,1.8108661e-8,0.00007377617,0.000026793872,0.095986515,0.00047817736],"about_ca_topic_score_codex":0.0000057351076,"about_ca_topic_score_gemma":0.000007570378,"teacher_disagreement_score":0.16379964,"about_ca_system_score_codex":0.0000052118153,"about_ca_system_score_gemma":0.00003750211,"threshold_uncertainty_score":0.99996084},"labels":[],"label_agreement":null},{"id":"W4405050440","doi":"10.1182/blood-2024-204116","title":"Expansion of <i>GATA1</i>-Mutant Clones in Blood Samples of Patients with Transient Abnormal Myelopoiesis (TAM) during Clinical Follow up Heralds Transformation to Myeloid Leukemia Associated with Down Syndrome (ML-DS)","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"GATA1; Myelopoiesis; Myeloid; Myeloid leukemia; Transformation (genetics); Leukemia; Medicine; Mutant; Mutation; Biology; Cancer research; Immunology; Internal medicine; Genetics; Erythropoiesis; Haematopoiesis; Gene; Anemia","score_opus":0.016319840829150153,"score_gpt":0.2658330986708299,"score_spread":0.24951325784167971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405050440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971378,0.0001494235,0.00015512964,0.00029756388,0.00010227042,0.001647038,0.00029787055,0.0001206593,0.00009225104],"genre_scores_gemma":[0.99798775,0.00019984427,0.0011462353,0.000056353827,0.00004096119,0.000100474186,0.00031705,0.00008863716,0.000062688225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99563915,0.000211565,0.0014454904,0.000641925,0.0013689802,0.0006929036],"domain_scores_gemma":[0.99823296,0.0003423612,0.00020915622,0.00048586642,0.00040857334,0.00032107174],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008980457,0.00042284676,0.001138894,0.0006432939,0.00008122965,0.000034254943,0.00026588887,0.00031971064,0.000053059826],"category_scores_gemma":[0.00021212788,0.00030910273,0.00022819443,0.0015889211,0.00019412734,0.00039815207,0.000056828,0.00069321325,0.0000075469334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015196438,0.005834095,0.8479753,0.005312586,0.0046178605,0.0018578278,0.018946292,0.00068314,0.09226807,0.00008734563,0.00009621615,0.0071248226],"study_design_scores_gemma":[0.027646264,0.004629644,0.8812951,0.0035149744,0.0010683467,0.00013736894,0.00052032457,0.00013334853,0.08057223,0.000006530355,0.000054990272,0.00042091528],"about_ca_topic_score_codex":0.0003298644,"about_ca_topic_score_gemma":0.0003606268,"teacher_disagreement_score":0.033319756,"about_ca_system_score_codex":0.0003455535,"about_ca_system_score_gemma":0.0010020306,"threshold_uncertainty_score":0.9999361},"labels":[],"label_agreement":null},{"id":"W4405050476","doi":"10.1182/blood-2024-206197","title":"Changing the Serum Ferritin Lower Limit of Normal to a Clinical Decision Limit: An Acceptability Survey","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; St. Michael's Hospital; St. Joseph's Hospital; University of Toronto","funders":"","keywords":"Limit (mathematics); Ferritin; Medicine; Internal medicine; Statistics; Mathematics","score_opus":0.044680254490308435,"score_gpt":0.3578733497745437,"score_spread":0.3131930952842353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405050476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99608374,0.0007794571,0.00028392955,0.00057155354,0.00076584937,0.00036215203,0.000057767873,0.00006562991,0.0010299028],"genre_scores_gemma":[0.99768925,0.00006704634,0.000845982,0.00075145037,0.00040808294,0.000011029516,0.000014313497,0.000024187284,0.00018866303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837387,0.00021428507,0.00044926238,0.000343023,0.00031340966,0.00030617206],"domain_scores_gemma":[0.99844825,0.0006639673,0.000034847653,0.0005702001,0.00009678293,0.0001859726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026947174,0.00013267067,0.00031432675,0.00011623649,0.00006348365,0.000036628408,0.00018927465,0.00011184928,0.00050437305],"category_scores_gemma":[0.0014919287,0.000086746135,0.00017301369,0.0004762291,0.00007595527,0.00009828801,0.00014066513,0.00025039044,0.000085448875],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009327649,0.0028319024,0.7512899,0.0002311019,0.000081298094,0.000062772,0.0017204785,0.000009866278,0.00025793567,0.00022163276,0.0010904807,0.24126989],"study_design_scores_gemma":[0.001315609,0.00048661642,0.99382836,0.00006634308,0.00019042661,0.000013330634,0.00046910738,0.00008358718,0.0007556695,0.00006975598,0.002611577,0.00010962671],"about_ca_topic_score_codex":0.00008477645,"about_ca_topic_score_gemma":0.00032189782,"teacher_disagreement_score":0.24253847,"about_ca_system_score_codex":0.0000060144944,"about_ca_system_score_gemma":0.0001172016,"threshold_uncertainty_score":0.5522531},"labels":[],"label_agreement":null},{"id":"W4405050586","doi":"10.1182/blood-2024-202475","title":"Lamotrigine and Anti-Epileptic Medications in HLH: A Systematic Review","year":2024,"lang":"en","type":"review","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Dalhousie University","funders":"","keywords":"Lamotrigine; Medicine; Epilepsy; Pharmacology; Psychiatry","score_opus":0.030019270485542513,"score_gpt":0.34494958712287566,"score_spread":0.3149303166373331,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405050586","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000010593138,0.99375314,5.756297e-7,0.00018474364,0.00008673489,0.005228413,0.000032192802,0.00008940425,0.00061421434],"genre_scores_gemma":[0.000014606482,0.9968599,0.00010032434,0.00013080245,0.00011038173,0.0012505273,0.00022026166,0.00007791603,0.0012352923],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99750674,0.00016189563,0.0011992309,0.00052857527,0.00033075255,0.00027280903],"domain_scores_gemma":[0.9984791,0.0002189682,0.0002831754,0.000812165,0.000031572745,0.00017499724],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047000733,0.00044214822,0.004205891,0.00034790486,0.000021788648,0.000019670953,0.00015317909,0.00023232172,0.00007624307],"category_scores_gemma":[0.0004198586,0.00029291338,0.0003568544,0.0007524283,0.000052973475,0.000028923447,0.00008730135,0.00052925147,0.000703071],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[2.0488852e-7,0.00021092093,0.000004342652,0.9890146,0.0010137287,0.00051344576,0.000017309665,1.1946739e-9,6.3219964e-8,0.000051217343,0.00044620284,0.00872791],"study_design_scores_gemma":[0.000895791,0.00004180185,0.0000034765696,0.8382578,0.07324846,0.002285388,0.000002626412,0.0000016748819,8.04023e-8,0.0000056892973,0.08508671,0.00017048011],"about_ca_topic_score_codex":0.000017774264,"about_ca_topic_score_gemma":0.000008740339,"teacher_disagreement_score":0.15075684,"about_ca_system_score_codex":0.00040314082,"about_ca_system_score_gemma":0.0010729843,"threshold_uncertainty_score":0.9999523},"labels":[],"label_agreement":null},{"id":"W4405050632","doi":"10.1182/blood-2024-211349","title":"Leptin-Enhanced JAK-STAT Signaling in Acute Myeloid Leukemia-Derived Mesenchymal Stromal Cells and Its Implications for Disease Progression","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Mesenchymal stem cell; stat; Cancer research; Myeloid leukemia; Stromal cell; Medicine; Disease; Leukemia; Immunology; Signal transduction; Biology; STAT3; Internal medicine; Cell biology; Pathology","score_opus":0.021571080516680767,"score_gpt":0.3126843885532266,"score_spread":0.29111330803654584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405050632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994857,0.0012588566,0.0013250881,0.00097453845,0.00015538005,0.0008489036,0.00024873813,0.00013116539,0.00020033444],"genre_scores_gemma":[0.9968457,0.00011801008,0.0020188175,0.00007054583,0.00019565198,0.00029979585,0.0001328052,0.00003593601,0.0002827172],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989312,0.000019111076,0.0002794291,0.00038873265,0.000113108654,0.00026836002],"domain_scores_gemma":[0.99938136,0.00012042767,0.000049125632,0.00015830324,0.00008715686,0.0002036073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009620968,0.00016274212,0.00020946382,0.00015186958,0.00011160376,0.000069225425,0.000057092177,0.000060800827,0.000049495542],"category_scores_gemma":[0.00004953239,0.00013963373,0.000108439315,0.00019298187,0.000028490205,0.00014560139,0.000039908893,0.00019651756,0.000011614135],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013857773,0.00020695443,0.00032223493,0.0002051332,0.00008972996,0.000035920177,0.00027584535,0.000026669213,0.9959586,0.00023242879,0.00014911835,0.0023587367],"study_design_scores_gemma":[0.0023407722,0.00043850226,0.004978886,0.0009591352,0.0005675821,0.00004547714,0.00011151571,0.004042618,0.9849701,0.00019212585,0.0011467618,0.00020653405],"about_ca_topic_score_codex":0.000005711605,"about_ca_topic_score_gemma":0.0000043770665,"teacher_disagreement_score":0.010988561,"about_ca_system_score_codex":0.00006242238,"about_ca_system_score_gemma":0.00026544253,"threshold_uncertainty_score":0.56940985},"labels":[],"label_agreement":null},{"id":"W4405050748","doi":"10.1182/blood-2024-208480","title":"Zelenirstat Nmt Inhibitor in Patients with Relapsed/Refractory B-Cell Lymphoma and Acute Myelogenous Leukemia: Mechanistic Insights and Clinical Outcomes","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Spinal Cord Injury BC; University of British Columbia; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Leukemia; Refractory (planetary science); Internal medicine; Lymphoma; Oncology; Cancer research; Biology","score_opus":0.008041097237837361,"score_gpt":0.24283727096826185,"score_spread":0.2347961737304245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405050748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99579126,0.002649098,0.00000815226,0.00005680294,0.00026061575,0.0007119831,0.00003433314,0.00011708207,0.00037064884],"genre_scores_gemma":[0.9974526,0.0009079262,0.0006585388,0.00018305545,0.00009842663,0.000029726803,0.00006934753,0.00007175844,0.00052860385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980208,0.00006899879,0.0005039399,0.0006934001,0.00034905897,0.00036377093],"domain_scores_gemma":[0.9989081,0.00032023058,0.0000838661,0.0003630457,0.000049860424,0.00027489732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012886061,0.00034931378,0.0006184299,0.0002012917,0.00007057507,0.00004876993,0.00006904455,0.00027081228,0.000014733091],"category_scores_gemma":[0.000065821194,0.0002451629,0.00007834718,0.00019502632,0.00013858998,0.00013659902,0.00010828455,0.00033918535,0.000040357274],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008464008,0.004766338,0.9708341,0.00052463217,0.0015212928,0.0038783478,0.0010375007,2.9698055e-7,0.00033813814,0.00014147686,0.00022909188,0.015882393],"study_design_scores_gemma":[0.075946644,0.0051381267,0.91235685,0.0005954528,0.0026032543,0.00020537278,0.00008905672,0.00009488904,0.00095990696,0.00019103958,0.001338375,0.00048102954],"about_ca_topic_score_codex":0.00011046155,"about_ca_topic_score_gemma":0.00012426918,"teacher_disagreement_score":0.07510024,"about_ca_system_score_codex":0.0006265222,"about_ca_system_score_gemma":0.0008161346,"threshold_uncertainty_score":0.9997453},"labels":[],"label_agreement":null},{"id":"W4405050814","doi":"10.1182/blood-2024-210952","title":"Evaluating Neuroprotective Effects of Caplacizumab in Immune-Mediated Thrombotic Thrombocytopenic Purpura","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University Health Network; Lawson Health Research Institute; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Immunology; Immune system; Thrombocytopenic purpura; Thrombotic thrombocytopenic purpura; Platelet","score_opus":0.02183747265801701,"score_gpt":0.30448848509438403,"score_spread":0.28265101243636703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405050814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97781014,0.019647319,0.000017295566,0.00003700804,0.00080685096,0.0011591804,0.000029546183,0.00013414772,0.00035852726],"genre_scores_gemma":[0.99955887,0.000031153257,0.000029024335,0.000012585589,0.000020043257,0.00017015752,0.00005076105,0.000028574312,0.00009885595],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99817014,0.00054529466,0.00048893277,0.0003839047,0.0000760888,0.0003356584],"domain_scores_gemma":[0.9986056,0.0008735026,0.00010547364,0.0003506318,0.00004909722,0.000015710397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033260646,0.00019785835,0.00044316275,0.00020951877,0.000059729973,0.00001965398,0.00025774344,0.000112859445,0.00043349687],"category_scores_gemma":[0.0005404621,0.00017834152,0.00012411174,0.00038070662,0.00010853853,0.00009780996,0.00015160277,0.00028323318,0.0004920748],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004575565,0.00041647788,0.0020495087,0.0007347329,0.00039820827,0.0000743521,0.0006710457,0.000013357226,0.9942212,0.00030555617,0.000064307824,0.0010054854],"study_design_scores_gemma":[0.008117976,0.001425479,0.19567546,0.0020129858,0.0006063,0.00016089065,0.000342777,0.00014052501,0.790332,0.00058081804,0.00016059398,0.00044418525],"about_ca_topic_score_codex":0.00019629733,"about_ca_topic_score_gemma":0.0000250705,"teacher_disagreement_score":0.2038892,"about_ca_system_score_codex":0.000049040078,"about_ca_system_score_gemma":0.00014257722,"threshold_uncertainty_score":0.7272556},"labels":[],"label_agreement":null},{"id":"W4405050835","doi":"10.1182/blood-2024-194458","title":"A First Report from the COMPLETE Study on the Real-World Effectiveness of Pegcetacoplan in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Medicine; Pediatrics; Internal medicine","score_opus":0.015615221613669569,"score_gpt":0.2445307912986067,"score_spread":0.22891556968493712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405050835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968798,0.00037464392,0.0000028654651,0.00009183965,0.00039628867,0.0014208887,0.00031206658,0.00003943228,0.00048218234],"genre_scores_gemma":[0.99957913,0.0000012231043,0.0000023812022,0.000018760282,0.000032870375,0.00012757987,0.00016077586,0.000017036904,0.000060256214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99817324,0.000789908,0.00038167275,0.0003396874,0.000104863764,0.00021064337],"domain_scores_gemma":[0.99747956,0.0017597097,0.00013340337,0.0005698781,0.000044317087,0.000013117919],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057047966,0.00018469187,0.0003083814,0.00006354937,0.00013656383,0.000027724578,0.0003267875,0.000038587914,0.00023222284],"category_scores_gemma":[0.000063350366,0.00009169375,0.000072967996,0.00022809651,0.00011095249,0.000031643434,0.00010543859,0.00022919907,0.000057452777],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006335327,0.0013247769,0.9953056,0.000055636785,0.00075338985,0.00008807888,0.0005620295,0.000009802075,0.0005568267,0.00014830871,0.0005414024,0.000020600184],"study_design_scores_gemma":[0.0034504635,0.0005183624,0.9932798,0.0005462978,0.00024378089,0.000010742826,0.00029591555,0.0000012201591,0.0007217054,0.00007387712,0.0007457422,0.00011207074],"about_ca_topic_score_codex":0.0015183177,"about_ca_topic_score_gemma":0.0020378823,"teacher_disagreement_score":0.0028169309,"about_ca_system_score_codex":0.00003769327,"about_ca_system_score_gemma":0.00006127549,"threshold_uncertainty_score":0.37391624},"labels":[],"label_agreement":null},{"id":"W4405050899","doi":"10.1182/blood-2024-207194","title":"Trials in Progress: The START (STrategies for Anticoagulation in patients with thRombocytopenia and cancer-associated Thrombosis) Pilot Randomized Controlled Trial","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Windsor Regional Hospital; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Randomized controlled trial; Thrombosis; Cancer; Internal medicine; Intensive care medicine; Surgery","score_opus":0.03715308469632035,"score_gpt":0.32723232421290577,"score_spread":0.29007923951658543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405050899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97245806,0.00193203,0.000016544302,0.0014814559,0.00026819206,0.023602149,0.000017723834,0.00005147208,0.00017238475],"genre_scores_gemma":[0.9934343,0.000551878,0.000082114646,0.00011605265,0.00011712965,0.005604931,0.000039992534,0.000028285287,0.000025277062],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99765366,0.0005600436,0.0009001109,0.00031315457,0.00030199485,0.0002710294],"domain_scores_gemma":[0.9982319,0.0012526964,0.00024205806,0.00015014954,0.00008442728,0.000038790284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003966279,0.00021183645,0.0028091597,0.00017325499,0.00006421429,0.00019135517,0.00006526659,0.00006792379,0.000032626456],"category_scores_gemma":[0.00065188576,0.00010813602,0.00018321081,0.00025036314,0.00012042503,0.00016393547,0.000024938276,0.00012606115,8.6673555e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97170144,0.0057766526,0.013898086,0.00030992093,0.0026838498,0.0000067550595,0.0013364746,0.000025008525,0.000055902143,0.0031341896,0.00034515385,0.0007265589],"study_design_scores_gemma":[0.8922259,0.0023749277,0.1005741,0.000718654,0.002711918,1.6081407e-7,0.00017920566,0.00030923207,0.00003514496,0.0007011098,0.000043468637,0.00012614866],"about_ca_topic_score_codex":0.00031837748,"about_ca_topic_score_gemma":0.00048161694,"teacher_disagreement_score":0.08667601,"about_ca_system_score_codex":0.000056436944,"about_ca_system_score_gemma":0.0002188615,"threshold_uncertainty_score":0.4409659},"labels":[],"label_agreement":null},{"id":"W4405051024","doi":"10.1182/blood-2024-203878","title":"Uncovering Therapeutic Vulnerabilities in Adverse-Risk Pediatric Acute Myeloid Leukemia","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Hôpital de l'Enfant-Jésus; Institute for Research in Immunology and Cancer; McGill University; Université Laval; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Myeloid leukemia; Adverse effect; Intensive care medicine; Internal medicine","score_opus":0.026301087435568873,"score_gpt":0.32054324191064476,"score_spread":0.2942421544750759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405051024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96455044,0.024793588,0.000012583565,0.0007192789,0.00033880482,0.00019632977,0.000014368622,0.00012452109,0.009250077],"genre_scores_gemma":[0.9864785,0.011876156,0.00010489193,0.00037534113,0.00051150226,0.000027260972,0.0000031421139,0.000020894056,0.00060230703],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99901366,0.00005677432,0.00020841947,0.0002518495,0.0001923511,0.0002769668],"domain_scores_gemma":[0.9991648,0.00056176423,0.000030167821,0.000140628,0.000018560364,0.000084061074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029781248,0.00013788448,0.00022167143,0.000090494475,0.00006975419,0.000028371596,0.00006167931,0.00006210069,0.0002159164],"category_scores_gemma":[0.00012727875,0.0001055291,0.000091897586,0.00034060463,0.000034397195,0.00015750606,0.000057112567,0.0004996742,0.00011459272],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007479782,0.0009993374,0.9060123,0.0023634061,0.002981932,0.0024356998,0.005030829,0.00026790344,0.0053201253,0.0011320711,0.0015192752,0.07118912],"study_design_scores_gemma":[0.013884053,0.001709119,0.45536837,0.00045744574,0.013547614,0.00055351906,0.0027128975,0.0025585461,0.009969858,0.0061990405,0.49174258,0.0012969727],"about_ca_topic_score_codex":0.00017490725,"about_ca_topic_score_gemma":0.000028483744,"teacher_disagreement_score":0.4902233,"about_ca_system_score_codex":0.00010008353,"about_ca_system_score_gemma":0.00012217468,"threshold_uncertainty_score":0.4303352},"labels":[],"label_agreement":null},{"id":"W4405051120","doi":"10.1182/blood-2024-204479","title":"Barriers and Facilitators for Diagnosing and Managing Iron Deficiency Anemia from Healthcare Professionals' Perspective in Alberta, Canada: A Qualitative Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa; University of Alberta","funders":"","keywords":"Medicine; Focus group; Snowball sampling; Thematic analysis; Health care; Qualitative research; Family medicine; Psychological intervention; Nursing; Reproductive health; Referral; Population; Environmental health; Political science","score_opus":0.010619616661970192,"score_gpt":0.3253984410641212,"score_spread":0.314778824402151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405051120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97148067,0.022011263,0.000011294597,0.0051331567,0.00012383462,0.0009849282,0.00010767249,0.00001597401,0.0001311805],"genre_scores_gemma":[0.99919343,0.00007498902,0.0001570813,0.00029600575,0.000030362104,0.0001161213,0.000014056864,0.000016096605,0.000101879035],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9988473,0.00012726178,0.00018742669,0.0004208297,0.0001815903,0.00023556004],"domain_scores_gemma":[0.9990557,0.00061779766,0.000024676046,0.000096839656,0.000042092106,0.00016289022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024708718,0.0001417818,0.0002435134,0.00011097627,0.00011639393,0.00002097848,0.000032048934,0.000044241373,0.000010462862],"category_scores_gemma":[0.0003952356,0.00012058569,0.000020447045,0.00015230414,0.00005631049,0.000076564436,0.000030086327,0.00015584435,3.8927246e-7],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019294134,0.00038073963,0.24408296,0.0015982352,0.000039866576,0.00013929514,0.7453567,0.0000015632627,0.00005662466,0.0054692873,0.0004906412,0.0021911599],"study_design_scores_gemma":[0.0030556223,0.00024305876,0.089568116,0.0002582448,0.00020455361,0.0000043991968,0.9046218,0.000028057158,0.000032002703,0.0017443008,0.000072767136,0.00016709391],"about_ca_topic_score_codex":0.71783733,"about_ca_topic_score_gemma":0.6369825,"teacher_disagreement_score":0.1592651,"about_ca_system_score_codex":0.00009028117,"about_ca_system_score_gemma":0.0005866589,"threshold_uncertainty_score":0.49173418},"labels":[],"label_agreement":null},{"id":"W4405051123","doi":"10.1182/blood-2024-201875","title":"Efficacy and Safety of Revumenib in the Treatment of Acute Myeloid Leukemia with KMT2A Rearrangements or NPM1 Mutations: A Systematic Review","year":2024,"lang":"en","type":"review","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"NPM1; Myeloid leukemia; Medicine; Oncology; Internal medicine; Leukemia; Myeloid; Bone marrow; Cancer research; Biology; Genetics; Karyotype","score_opus":0.04547199090986818,"score_gpt":0.3658874416028316,"score_spread":0.3204154506929634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405051123","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023817521,0.98534226,0.0000016243583,0.00011526406,0.000021355494,0.0137196295,0.0001702136,0.000021491256,0.00036997034],"genre_scores_gemma":[0.000031814565,0.99615645,0.000392934,0.000045108198,0.00005363652,0.0018396694,0.00024103667,0.000076567645,0.0011627752],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9963096,0.00057504786,0.0016122538,0.0004978038,0.0007018503,0.0003034805],"domain_scores_gemma":[0.9973879,0.000681487,0.00061430346,0.0010918371,0.00012580566,0.00009869968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009340256,0.00050272484,0.0042444826,0.00036498485,0.000036125857,0.000019276598,0.0003161728,0.00018345079,0.00003078384],"category_scores_gemma":[0.00023850636,0.000219637,0.0003560105,0.0012686966,0.00015716664,0.00004158882,0.000058919737,0.0003717805,0.000031134492],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015995564,0.00057414884,0.0000026127602,0.96796435,0.0049584615,0.0006382981,0.00054918544,2.7891092e-8,0.0000023728137,0.000024300467,0.00019246021,0.02493384],"study_design_scores_gemma":[0.0048250267,0.0021247307,0.000009847397,0.8588625,0.083425984,0.0014490387,0.00009331786,0.0000014794379,0.000005917298,0.0000025753045,0.049004503,0.00019503107],"about_ca_topic_score_codex":0.000054387718,"about_ca_topic_score_gemma":0.000014644653,"teacher_disagreement_score":0.10910179,"about_ca_system_score_codex":0.0006591149,"about_ca_system_score_gemma":0.0017763453,"threshold_uncertainty_score":0.89565367},"labels":[],"label_agreement":null},{"id":"W4405051177","doi":"10.1182/blood-2024-211507","title":"Longitudinal Laboratory and Clinical Outcomes in Vaccine-Induced Immune Thrombotic Thrombocytopenia after 3 Years","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Immunology; Immune thrombocytopenia; Immune system; Internal medicine; Platelet","score_opus":0.031974422929486816,"score_gpt":0.3373244113639723,"score_spread":0.30534998843448546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405051177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950591,0.0017168291,0.0000034412546,0.000834278,0.00070459244,0.0006073473,0.000019894052,0.00020406664,0.000850485],"genre_scores_gemma":[0.99824196,0.0004258275,0.00047956122,0.00027874878,0.00023997683,0.00005438603,0.000011332831,0.00008753967,0.00018065055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99723166,0.000144915,0.0009044301,0.00083884085,0.00031968602,0.00056044117],"domain_scores_gemma":[0.9986293,0.00027590952,0.00006907914,0.00065082347,0.00007030445,0.00030459944],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006881217,0.00038569325,0.0013441454,0.00030321753,0.000042518073,0.00013141807,0.00017219676,0.00035247343,0.00032455949],"category_scores_gemma":[0.0001929418,0.0003311941,0.0002703365,0.00060463365,0.00009384143,0.0003092916,0.00021437618,0.0008469162,0.00043026125],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007716529,0.001029545,0.98221517,0.00016928143,0.0008000078,0.0018260296,0.00026960613,7.7565566e-8,0.01216727,0.00025339835,0.00006349058,0.0011289732],"study_design_scores_gemma":[0.0042721,0.00053538225,0.99063015,0.00041904117,0.0008657429,0.00013998969,0.000070782095,0.000020325442,0.0021998847,0.0001525358,0.00033404236,0.0003600347],"about_ca_topic_score_codex":0.00021862322,"about_ca_topic_score_gemma":0.00030914383,"teacher_disagreement_score":0.009967386,"about_ca_system_score_codex":0.00007625496,"about_ca_system_score_gemma":0.00032658703,"threshold_uncertainty_score":0.999914},"labels":[],"label_agreement":null},{"id":"W4405051204","doi":"10.1182/blood-2024-194552","title":"Suboptimal Management of Cancer-Associated Thrombotic Microangiopathies in Newly Diagnosed and Known Cancers: A 15-Year Provincial Retrospective Cohort Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Cardiac tumors and thrombi","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Retrospective cohort study; Cancer; Cohort; Internal medicine; Oncology","score_opus":0.0065453104724110586,"score_gpt":0.25964527962940703,"score_spread":0.25309996915699595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405051204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99227834,0.0042138393,8.935855e-7,0.000067759254,0.0002405364,0.001603258,0.00007009068,0.00006480341,0.0014604534],"genre_scores_gemma":[0.99875885,0.0006234245,0.00006691089,0.000013957163,0.00012100484,0.00018531391,0.0000096195245,0.000030420832,0.00019052236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873,0.000042362542,0.00027532538,0.00040203764,0.00030137715,0.00024887358],"domain_scores_gemma":[0.9996037,0.000030549192,0.000059488997,0.00017814589,0.00006412834,0.00006400778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029615563,0.00016904093,0.0005736484,0.00014416367,0.00003405367,0.00003151138,0.000051595907,0.000058069516,0.000043754277],"category_scores_gemma":[0.000028222441,0.00015358109,0.0000996719,0.00045583418,0.00008055262,0.000057241137,0.00008021123,0.00018610818,0.0000035488101],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007409316,0.001063133,0.9934356,0.00028839055,0.0011682009,0.0010718,0.0017150893,0.0000035606702,0.00049593265,0.00015328366,0.00018199021,0.0003489253],"study_design_scores_gemma":[0.0049491758,0.0007763785,0.9896467,0.0007642744,0.0015589357,0.000009406513,0.0015252269,0.000030441595,0.00053291407,0.00004559903,0.000017316344,0.00014367323],"about_ca_topic_score_codex":0.00824713,"about_ca_topic_score_gemma":0.0048326016,"teacher_disagreement_score":0.00648046,"about_ca_system_score_codex":0.00033373397,"about_ca_system_score_gemma":0.00017792918,"threshold_uncertainty_score":0.99835706},"labels":[],"label_agreement":null},{"id":"W4405051217","doi":"10.1182/blood-2024-204446","title":"Effects of Obesity on Stem Cell Transplant Outcomes in Acute Myeloid Leukemia Patients: A Systematic Review and Meta-Analysis","year":2024,"lang":"en","type":"review","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Hematopoietic stem cell transplantation; Myeloid leukemia; Transplantation; Oncology; Leukemia; Meta-analysis; Cancer; Stem cell; Biology","score_opus":0.03137697215744272,"score_gpt":0.31600252980620047,"score_spread":0.28462555764875774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405051217","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005130658,0.98918986,0.0000023869213,0.000039089788,0.000026631787,0.009596285,0.00047626882,0.00004369777,0.00011271135],"genre_scores_gemma":[0.00037362988,0.9956861,0.00004283536,0.00019861128,0.00001030075,0.0013445354,0.0001843012,0.00009643952,0.0020632192],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9945663,0.001037281,0.0020575048,0.0009172096,0.0009578546,0.0004638383],"domain_scores_gemma":[0.996733,0.0011176597,0.0006660973,0.0011209883,0.00011982723,0.00024242673],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0010598013,0.0009199187,0.018912561,0.0011997777,0.00002967959,0.000028838444,0.00042445795,0.00041857787,0.00002900957],"category_scores_gemma":[0.00010770594,0.0004989579,0.004258657,0.0018034716,0.0000641631,0.000049550792,0.00013814626,0.0011203488,0.00010898619],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005437385,0.00047885653,0.00002838875,0.7855709,0.21313938,0.0004320368,0.0000634133,3.268221e-8,3.4959493e-7,0.0000062787167,0.00005327703,0.00022161381],"study_design_scores_gemma":[0.0010143109,0.00027364455,0.000024476572,0.14955576,0.8482378,0.00003653343,0.0000033634565,0.0000011550088,0.000021175563,0.0000010428897,0.00053395896,0.000296748],"about_ca_topic_score_codex":0.000050013627,"about_ca_topic_score_gemma":0.000010592758,"teacher_disagreement_score":0.6360152,"about_ca_system_score_codex":0.00052843377,"about_ca_system_score_gemma":0.0005362833,"threshold_uncertainty_score":0.9997462},"labels":[],"label_agreement":null},{"id":"W4405051237","doi":"10.1182/blood-2024-208502","title":"Long Term Survivors (&amp;gt;15 years) of Multiple Myeloma: Patient Characteristics and Morbidity Burden","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Multiple myeloma; Term (time); Pediatrics; Internal medicine; Intensive care medicine; Gerontology","score_opus":0.02803883137723486,"score_gpt":0.2907828724479438,"score_spread":0.262744041070709,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405051237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975076,0.0013576223,0.000019131832,0.00006757922,0.00013228953,0.0003868958,0.00017961326,0.000064380605,0.00028493043],"genre_scores_gemma":[0.9985907,0.0002889726,0.00034932708,0.000010881722,0.00015859376,0.000023349034,0.00016858804,0.000027946095,0.00038162898],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885297,0.00003898749,0.00023740876,0.00027408483,0.0003352112,0.00026135342],"domain_scores_gemma":[0.999248,0.00015332608,0.000042805084,0.00027809397,0.000066494504,0.00021126588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000104961204,0.00013718862,0.00028243486,0.00012147896,0.000033566594,0.000032319516,0.000056646408,0.00007477661,0.00012529595],"category_scores_gemma":[0.00021800726,0.00011793357,0.000074373944,0.00013452016,0.00008486323,0.000054424552,0.00009162403,0.00015091898,0.000073604],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014784656,0.00073452253,0.8409956,0.00067577313,0.0004639657,0.0012301196,0.0008503558,1.9564823e-7,0.020138664,0.0000148094205,0.00010775396,0.13464037],"study_design_scores_gemma":[0.0020290606,0.0002880259,0.9907157,0.00027579512,0.00018044157,0.000097098215,0.000024107048,0.00014192992,0.0048885467,0.00000707013,0.0012455031,0.000106727704],"about_ca_topic_score_codex":0.00033254345,"about_ca_topic_score_gemma":0.000112394,"teacher_disagreement_score":0.14972006,"about_ca_system_score_codex":0.000023707022,"about_ca_system_score_gemma":0.0000663316,"threshold_uncertainty_score":0.48091912},"labels":[],"label_agreement":null},{"id":"W4405051335","doi":"10.1182/blood-2024-203473","title":"Canadian Real-World Data for Acute Myeloid Leukemia Chemotherapy-Ineligible Patients on Venetoclax: An Interim Analysis from the Prospective Liven Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Juravinski Cancer Centre; BC Cancer Agency; University of British Columbia; Baker Hughes (Canada); Vancouver General Hospital; University of Calgary; Memorial University of Newfoundland; Thunder Bay Regional Research Institute; Université de Sherbrooke; London Health Sciences Centre; CancerCare Manitoba","funders":"","keywords":"Venetoclax; Medicine; Internal medicine; Interim analysis; Cytarabine; Chemotherapy regimen; Regimen; Myeloid leukemia; Induction chemotherapy; Oncology; Pediatrics; Leukemia; Clinical trial; Chemotherapy; Chronic lymphocytic leukemia","score_opus":0.036425546038290506,"score_gpt":0.35863587391827373,"score_spread":0.3222103278799832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405051335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919656,0.00009520777,0.00002918266,0.0010700403,0.00012347243,0.0029542767,0.0023396662,0.00012442682,0.0012981134],"genre_scores_gemma":[0.99299437,0.00010012322,0.00044048185,0.0007012836,0.0006331652,0.00029521144,0.0031982667,0.00009541379,0.0015416656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99744135,0.00011456542,0.0003372334,0.0010424595,0.00050254626,0.0005618149],"domain_scores_gemma":[0.9970159,0.000275553,0.00006710893,0.0020605174,0.00019626375,0.00038467924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000493933,0.00029805626,0.0005397001,0.00056352717,0.00020011903,0.0002032438,0.00095426675,0.000081061604,0.00012889178],"category_scores_gemma":[0.00010644029,0.00020526187,0.00015184702,0.001650682,0.00007845214,0.00018353302,0.00020524458,0.000499784,0.000074545394],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019030009,0.0016294852,0.9140162,0.00005472547,0.0310427,0.00039262694,0.0069419923,0.00003038909,0.00072174234,0.00011613004,0.031260993,0.011890053],"study_design_scores_gemma":[0.008823962,0.004071107,0.94948125,0.00015944803,0.010661208,0.000004259264,0.0012509964,0.009635853,0.0020979133,0.0001644962,0.013165274,0.00048426434],"about_ca_topic_score_codex":0.3798532,"about_ca_topic_score_gemma":0.5458344,"teacher_disagreement_score":0.16598126,"about_ca_system_score_codex":0.0027004236,"about_ca_system_score_gemma":0.0023040255,"threshold_uncertainty_score":0.83703357},"labels":[],"label_agreement":null},{"id":"W4405051341","doi":"10.1182/blood-2024-200399","title":"Gender Disparity in Platelet Adhesion and Aggregation Disorders: A Quarter Century Analysis of Bernard Soulier Syndrome and Glanzmann Thrombasthenia Clinical Trials","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Thrombasthenia; Platelet disorder; Glanzmann's thrombasthenia; Bernard–Soulier syndrome; Randomized controlled trial; Clinical trial; Internal medicine; Blood Platelet Disorders; Pediatrics; Platelet; Platelet aggregation","score_opus":0.04270917837250362,"score_gpt":0.35140826254685187,"score_spread":0.30869908417434827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405051341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99155194,0.0074346946,0.00003089511,0.00033050904,0.000068106914,0.00038656744,0.000060370687,0.000025533633,0.00011139048],"genre_scores_gemma":[0.9951907,0.0044345064,0.0001533265,0.00004178748,0.00002125821,0.000013994573,0.00011575969,0.000013241553,0.00001546073],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844694,0.0001940623,0.0006338729,0.00037440495,0.00018340925,0.00016730404],"domain_scores_gemma":[0.9992693,0.00033459405,0.0001093023,0.00017023282,0.000016626043,0.0000999283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008316915,0.00015730965,0.00095126935,0.00030157098,0.000026546038,0.000028212196,0.00003089281,0.00016168086,0.00006206228],"category_scores_gemma":[0.00012285553,0.00011487922,0.00020674508,0.00037673782,0.00007117009,0.0000966184,0.000029099809,0.00016190836,0.0000046899404],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029153627,0.0016527018,0.97028244,0.0002681519,0.004927717,0.00066715886,0.0009553485,0.0000019152415,0.00015413236,0.0000933356,0.00009523488,0.020610355],"study_design_scores_gemma":[0.0064199273,0.000500729,0.9839891,0.0002223366,0.0056165694,0.00012887952,0.00019884306,0.0014194825,0.00006476625,0.0010483582,0.00024644018,0.00014456817],"about_ca_topic_score_codex":0.00011207629,"about_ca_topic_score_gemma":0.00019814573,"teacher_disagreement_score":0.020465786,"about_ca_system_score_codex":0.0000105793115,"about_ca_system_score_gemma":0.000031642747,"threshold_uncertainty_score":0.4684639},"labels":[],"label_agreement":null},{"id":"W4405051387","doi":"10.1182/blood-2024-212070","title":"Detection of M-Protein in Transplant-Ineligible Multiple Myeloma Patients on Daratumumab Using Liquid Chromatography Quadruple Time of Flight Mass Spectrometry","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Chromatography; Mass spectrometry; Chemistry; Multiple myeloma; Liquid chromatography–mass spectrometry; Medicine; Immunology","score_opus":0.012684650673471744,"score_gpt":0.2592106278680797,"score_spread":0.24652597719460795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405051387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99771243,0.0006495291,0.00013283415,0.000014739926,0.00005703076,0.00076442497,0.00012451383,0.0000576605,0.00048682422],"genre_scores_gemma":[0.9985601,0.00003884924,0.0011701648,0.0000037949694,0.000042550368,0.000029577723,0.000076755445,0.000037335274,0.000040894545],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983274,0.00006626932,0.00042318425,0.00033911644,0.00049884315,0.0003452245],"domain_scores_gemma":[0.9993753,0.0000788535,0.00007396519,0.0002785279,0.00007001435,0.00012336957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013984783,0.00020234848,0.00041755856,0.0009986142,0.000038284852,0.0000119498645,0.00008651557,0.00011746033,0.000068005385],"category_scores_gemma":[0.00005517122,0.00017059433,0.00018339408,0.0010058117,0.000056055247,0.000088478555,0.000016939324,0.00020393591,0.000032712705],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016482798,0.0017645054,0.05234557,0.0006856314,0.00032906677,0.00018490365,0.0001777988,0.0000046619984,0.9422133,0.000011009481,0.000002456508,0.0006328153],"study_design_scores_gemma":[0.006940589,0.0024390137,0.06271881,0.0011140711,0.00012927651,0.00001749783,0.0000190465,0.0018752066,0.9245817,0.000018124592,0.00002034537,0.0001262848],"about_ca_topic_score_codex":0.0002858664,"about_ca_topic_score_gemma":0.000037901453,"teacher_disagreement_score":0.017631564,"about_ca_system_score_codex":0.00006670154,"about_ca_system_score_gemma":0.00007671628,"threshold_uncertainty_score":0.6956635},"labels":[],"label_agreement":null},{"id":"W4405051471","doi":"10.1182/blood-2024-199371","title":"Evaluating the Impact of Local Genetic Testing for Hereditary Hematologic Malignancies on Patient Reported Outcomes","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Nova Scotia Health Authority; Dalhousie University","funders":"","keywords":"Hematologic Neoplasms; Medicine; Genetic testing; Intensive care medicine; Cancer; Internal medicine; Genetics; Biology","score_opus":0.04131488298525863,"score_gpt":0.3142243791572463,"score_spread":0.2729094961719877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405051471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978849,0.0010167138,0.000507959,0.000041088784,0.00009783602,0.00023153175,0.000048323982,0.000014870575,0.00015677085],"genre_scores_gemma":[0.99772495,0.0000039861075,0.0019854535,0.000029413775,0.00007828494,0.00006741302,0.000030402456,0.00001349117,0.00006658014],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992616,0.000033373606,0.00027332973,0.00019091189,0.000089469795,0.00015131207],"domain_scores_gemma":[0.9994819,0.00009868487,0.000087220804,0.00022344467,0.00008717608,0.000021535629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001493625,0.00011129875,0.00012015673,0.000020551117,0.00007485807,0.000019551258,0.000086719636,0.000057242007,0.000008157106],"category_scores_gemma":[0.00019000602,0.00006573094,0.00015262031,0.00006047403,0.000045138335,0.0000017791693,0.000046804962,0.00003948003,0.0000014398069],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013982783,0.00079011323,0.11069384,0.00043495646,0.0019400372,0.000082550134,0.000848167,0.02356866,0.84617865,0.00075821695,0.001128117,0.013436876],"study_design_scores_gemma":[0.0020182398,0.015084338,0.21154001,0.0002903499,0.0006305813,0.0011913559,0.0017493926,0.0072542154,0.75651455,0.0028549922,0.00020779994,0.0006641925],"about_ca_topic_score_codex":0.00005820857,"about_ca_topic_score_gemma":0.000002977545,"teacher_disagreement_score":0.10084618,"about_ca_system_score_codex":0.000009706806,"about_ca_system_score_gemma":0.00012988338,"threshold_uncertainty_score":0.268043},"labels":[],"label_agreement":null},{"id":"W4405051523","doi":"10.1182/blood-2024-199147","title":"Intravenous Treatment Workflow for Paroxysmal Nocturnal Hemoglobinuria from the Perspective of Nurses and Pharmacists in US Clinical Practices","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Medicine; Perspective (graphical); Intensive care medicine; Family medicine; Internal medicine","score_opus":0.05096224250659517,"score_gpt":0.3857093855934427,"score_spread":0.3347471430868475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405051523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96619505,0.03121658,0.000007758589,0.0004004548,0.0009051997,0.0006128693,0.0004685901,0.000025481171,0.00016801339],"genre_scores_gemma":[0.9991044,0.00028424134,0.00010906079,0.00003372455,0.00018266139,0.000083757404,0.000039210438,0.000010015014,0.00015296835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891883,0.0002639463,0.00033210902,0.00028733807,0.000026737991,0.00017105517],"domain_scores_gemma":[0.99779975,0.0018250202,0.00016345354,0.00015655467,0.00003797782,0.000017243225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021721152,0.00012698388,0.0002570261,0.00003316512,0.000058677033,0.000027774046,0.0001234959,0.00007458094,0.00019037753],"category_scores_gemma":[0.00021253072,0.00008182137,0.0001067076,0.000058425205,0.00015246641,0.000052531206,0.00003354076,0.00011639072,0.000015991604],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003865418,0.008567957,0.84359723,0.00018428724,0.008369957,0.00017898681,0.015423966,0.000007300918,0.049103785,0.0036141365,0.006070208,0.06101676],"study_design_scores_gemma":[0.05148622,0.0066884044,0.7077028,0.0012710445,0.007849978,0.00095104624,0.014986731,0.0001615788,0.108849026,0.013636925,0.085245185,0.0011710237],"about_ca_topic_score_codex":0.0003696336,"about_ca_topic_score_gemma":0.00018688469,"teacher_disagreement_score":0.1358944,"about_ca_system_score_codex":0.000038270533,"about_ca_system_score_gemma":0.0001105062,"threshold_uncertainty_score":0.33365786},"labels":[],"label_agreement":null},{"id":"W4405051535","doi":"10.1182/blood-2024-211007","title":"Delays from Progression to Initial Appointment Occur with External Referrals for CAR T-Cell Therapy but Do Not Impact Survival","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University Health Network; Princess Margaret Cancer Centre","funders":"Eisai; BeiGene; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Internal medicine; Intensive care medicine","score_opus":0.06841936375932402,"score_gpt":0.39594189204138525,"score_spread":0.32752252828206124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405051535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99198806,0.0021110114,0.0009110492,0.00039124003,0.00022796482,0.0021802867,0.00030855957,0.00013099775,0.0017508285],"genre_scores_gemma":[0.9935555,0.00013427158,0.0028104316,0.00021145234,0.0012575203,0.00034837873,0.000104285755,0.000101695696,0.0014764867],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978438,0.00008422252,0.00026917664,0.000546316,0.0007447984,0.0005116913],"domain_scores_gemma":[0.99879587,0.00020407881,0.000041173695,0.00045866714,0.00013630388,0.00036390134],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000411781,0.0002805247,0.00039625925,0.00015994732,0.00007036829,0.00014931317,0.00017279651,0.00012036999,0.0014765967],"category_scores_gemma":[0.000022051876,0.00017785875,0.00021124363,0.00020259796,0.000045289715,0.00007417051,0.000056716453,0.00030242282,0.00008410751],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009500839,0.0010997804,0.0038822573,0.00011063187,0.0006017955,0.0006121339,0.0012157309,0.0000042769148,0.8974951,0.000018645145,0.00066060305,0.08479824],"study_design_scores_gemma":[0.019028565,0.013775862,0.006244027,0.0008997553,0.00031093156,0.00018143264,0.00022348088,0.00016829383,0.94358486,0.0002040531,0.014886048,0.00049271155],"about_ca_topic_score_codex":0.00029727048,"about_ca_topic_score_gemma":0.000019468927,"teacher_disagreement_score":0.084305525,"about_ca_system_score_codex":0.00014470346,"about_ca_system_score_gemma":0.0004976466,"threshold_uncertainty_score":0.9994362},"labels":[],"label_agreement":null},{"id":"W4405051936","doi":"10.1182/blood-2024-201980","title":"Targeting PRMT5-Mediated DNA Repair Pathway in Extra-Nodal NK/T-Cell Lymphoma (ENKTL)","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"T-cell lymphoma; Lymphoma; Cancer research; Biology; Medicine; Immunology","score_opus":0.004760233435654468,"score_gpt":0.2046829522103933,"score_spread":0.19992271877473883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405051936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853159,0.012252763,0.00011628598,0.00007345938,0.00037304906,0.000218475,0.000029995888,0.000125685,0.0014943767],"genre_scores_gemma":[0.9971444,0.00029552862,0.00045438868,0.000048507845,0.0005122953,0.000036196452,0.00040363634,0.000049869155,0.0010551941],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986978,0.000061004415,0.0002926226,0.0004988526,0.00014542308,0.0003042517],"domain_scores_gemma":[0.99955165,0.000019180823,0.000050478415,0.00027191892,0.000036252404,0.00007050886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022077555,0.00017826987,0.00013186545,0.000087892055,0.000041018437,0.000032934156,0.000112348316,0.00027187995,0.00003274142],"category_scores_gemma":[0.000064397,0.00018541097,0.00012099032,0.0002487689,0.00003618214,0.000006296642,0.000069505484,0.00009197182,0.000051886356],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029789366,0.00022888702,0.0007503129,0.00008949192,0.0000555287,0.00004769987,0.000099284196,0.0001554753,0.9948819,0.000025819483,0.0016486706,0.0019871253],"study_design_scores_gemma":[0.0022904389,0.0001932368,0.0014209688,0.000091291826,0.000040265826,0.000041686406,0.00005450311,0.0023871553,0.91614276,0.000051386338,0.07692438,0.00036190866],"about_ca_topic_score_codex":0.00003021541,"about_ca_topic_score_gemma":0.000044450488,"teacher_disagreement_score":0.07873914,"about_ca_system_score_codex":0.000041366202,"about_ca_system_score_gemma":0.00021958699,"threshold_uncertainty_score":0.756084},"labels":[],"label_agreement":null},{"id":"W4405052057","doi":"10.1182/blood-2024-212361","title":"Demystifying Genomic and Transcriptomic Landscape of Acute Myeloid Leukaemia-Normal Karyotype Using Deep Sequencing Technology","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Foothills Medical Centre","funders":"","keywords":"Karyotype; Myeloid leukaemia; Biology; Genetics; Deep sequencing; Computational biology; Transcriptome; Cancer research; Genome; Gene; Chromosome","score_opus":0.02101900462722959,"score_gpt":0.28051397462079897,"score_spread":0.25949496999356936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405052057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98674744,0.010518188,0.0009027479,0.00042555292,0.00010537084,0.00032053498,0.000019086341,0.00020223141,0.00075881934],"genre_scores_gemma":[0.99119294,0.00063447526,0.0077409847,0.000062078354,0.00015662466,0.000011406347,0.000015300006,0.00006326517,0.0001229092],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984931,0.00003267418,0.00036078496,0.00041417655,0.00022555828,0.0004737311],"domain_scores_gemma":[0.99938655,0.00006584638,0.00004843489,0.00029365957,0.00007031752,0.00013517424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029302982,0.0002087106,0.00042664006,0.0006749183,0.00008816924,0.000033936976,0.00016065716,0.00026947516,0.00007127443],"category_scores_gemma":[0.000038970793,0.00018932729,0.00009378805,0.00062921556,0.00018437346,0.0001337354,0.00011391967,0.0006166297,0.000021845693],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009920409,0.000034081262,0.01797642,0.00057939853,0.00066096144,0.0007175157,0.0005268472,0.000017664843,0.97573924,0.00028535165,0.000027306329,0.0033359942],"study_design_scores_gemma":[0.011302726,0.0011806982,0.015219498,0.0017172347,0.0059616277,0.020056799,0.001818693,0.0799299,0.8598299,0.000978214,0.0010460331,0.000958649],"about_ca_topic_score_codex":0.0000647367,"about_ca_topic_score_gemma":0.000011504289,"teacher_disagreement_score":0.11590933,"about_ca_system_score_codex":0.0002291334,"about_ca_system_score_gemma":0.00070297456,"threshold_uncertainty_score":0.77205426},"labels":[],"label_agreement":null},{"id":"W4405052597","doi":"10.1182/blood-2024-211150","title":"Laboratory Reference Intervals Influence Referral Patterns for Hemoglobin Abnormalities in the Ontario Virtual Care System","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Healthcare Systems and Technology","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Referral; Medicine; Hemoglobin; Anemia; Megaloblastic anemia; Pediatrics; Internal medicine; Family medicine","score_opus":0.023554801574752718,"score_gpt":0.25291579155993155,"score_spread":0.22936098998517884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405052597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99502456,0.0005127963,0.000036501002,0.00042392768,0.00044325032,0.0005080935,0.00006529858,0.0002701921,0.0027153646],"genre_scores_gemma":[0.9985441,0.000002729527,0.000018230492,0.0006146353,0.00039867806,0.00024784324,0.000030340601,0.000019656196,0.00012376686],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99882853,0.000029536279,0.00036798615,0.0002884367,0.00016870642,0.00031681804],"domain_scores_gemma":[0.99939793,0.00005837707,0.00007727112,0.00030048785,0.00015752346,0.000008421868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005056207,0.00016084495,0.0002120876,0.00019546518,0.00010351402,0.0003120873,0.00038534374,0.00014700896,0.000015975113],"category_scores_gemma":[0.000042623764,0.00011631911,0.00005168598,0.00028123305,0.000028966275,0.000504735,0.00010076112,0.00028386468,0.0000637127],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047310037,0.00015284921,0.26944137,0.017057706,0.00012300242,0.00042750474,0.014013991,0.000016308908,0.00025468826,0.6854133,0.0016120913,0.01143987],"study_design_scores_gemma":[0.0020076635,0.00023545978,0.13720869,0.004840561,0.0001763426,0.00006475663,0.08441836,0.00016470157,0.00028888416,0.0007024052,0.76903,0.0008621947],"about_ca_topic_score_codex":0.07542957,"about_ca_topic_score_gemma":0.17959604,"teacher_disagreement_score":0.7674179,"about_ca_system_score_codex":0.000120662065,"about_ca_system_score_gemma":0.000115282026,"threshold_uncertainty_score":0.93072724},"labels":[],"label_agreement":null},{"id":"W4405052607","doi":"10.1182/blood-2024-201658","title":"Detection of Recurrent Mutations, Immunoglobulin Rearrangements and Copy Number Changes in Cell-Free DNA and Bone Marrow on Patients with Waldenstrom's Macroglobulinemia over a Course of Treatment","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Waldenstrom macroglobulinemia; Macroglobulinemia; Minimal residual disease; Bone marrow; Rituximab; Lymphoplasmacytic Lymphoma; Ibrutinib; Biology; Medicine; Cancer research; Multiple myeloma; Antibody; Internal medicine; Immunology; Chronic lymphocytic leukemia; Leukemia; Lymphoma","score_opus":0.007793197698363951,"score_gpt":0.26598375322855866,"score_spread":0.2581905555301947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405052607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99684304,0.0019193072,0.0000018391498,0.000085760475,0.000056750247,0.00071826216,0.000120293626,0.000017199265,0.00023752151],"genre_scores_gemma":[0.9987971,0.0006772151,0.00017941312,0.000009224339,0.000030486486,0.00005562635,0.000052761254,0.000022930266,0.00017523787],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99893814,0.000040163697,0.00023690764,0.00027940478,0.00031351074,0.00019186163],"domain_scores_gemma":[0.99942815,0.00008041024,0.00007235559,0.000267898,0.000074612304,0.00007658573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000113154456,0.00015974922,0.00029131444,0.00012529941,0.000018838833,0.000013033332,0.00004050199,0.0000728452,0.000043016924],"category_scores_gemma":[0.000027963983,0.00011836367,0.00002984209,0.0002121135,0.00010948453,0.0000373471,0.000045710283,0.00009985766,0.0000032560686],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015148568,0.02036982,0.4977954,0.009030093,0.0026030454,0.0011094847,0.009050044,0.000015789832,0.1344684,0.00005911513,0.0008878404,0.3094624],"study_design_scores_gemma":[0.21697938,0.014492799,0.25204775,0.0043692463,0.0015350096,0.00029114424,0.000641936,0.0015451163,0.5063552,0.00007946165,0.0011563336,0.0005066238],"about_ca_topic_score_codex":0.00042316865,"about_ca_topic_score_gemma":0.0003527439,"teacher_disagreement_score":0.3718868,"about_ca_system_score_codex":0.0011159797,"about_ca_system_score_gemma":0.0004780863,"threshold_uncertainty_score":0.48267302},"labels":[],"label_agreement":null},{"id":"W4405052688","doi":"10.1182/blood-2024-210098","title":"Unfractionated Heparin Vs Enoxaparin Thromboprophylaxis in Medical-Surgical Patients: A Systematic Review and Meta-Analysis","year":2024,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pulmonary embolism; Odds ratio; Population; Meta-analysis; Randomized controlled trial; Deep vein; Warfarin; Internal medicine; Low molecular weight heparin; Cohort study; Surgery; Thrombosis; Atrial fibrillation","score_opus":0.04249054083066639,"score_gpt":0.35283702758979407,"score_spread":0.3103464867591277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405052688","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000009522821,0.9921419,0.0000010638653,0.0004221636,0.000069771995,0.005920494,0.00007202311,0.00009128472,0.0012717672],"genre_scores_gemma":[0.00011057152,0.9951734,0.000035805595,0.0006969568,0.00004697607,0.002615824,0.0004133483,0.00008362692,0.0008235168],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99451977,0.00056443363,0.002268419,0.0010505818,0.0011819216,0.00041487542],"domain_scores_gemma":[0.9977075,0.0002819147,0.0005734192,0.0009725454,0.00012586526,0.000338798],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013572368,0.000781989,0.017717553,0.00089692033,0.000049750353,0.00007258446,0.0003023495,0.00045600516,0.0018717024],"category_scores_gemma":[0.00050188357,0.0004578158,0.0031681894,0.0024404316,0.00007502318,0.00006413123,0.0003441971,0.0008374935,0.00032657722],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000011223246,0.0016984986,0.000004417312,0.7479887,0.24748218,0.00045318942,0.000014628547,3.329607e-8,7.77844e-10,0.000169684,0.00064084335,0.0015467025],"study_design_scores_gemma":[0.00044453872,0.00015285336,0.000023885459,0.09012349,0.80337334,0.000096849784,0.0000035382136,0.0000020435107,2.6241503e-8,0.000012237029,0.10545417,0.00031306225],"about_ca_topic_score_codex":0.00018583896,"about_ca_topic_score_gemma":0.00007705739,"teacher_disagreement_score":0.6578652,"about_ca_system_score_codex":0.00013417326,"about_ca_system_score_gemma":0.00020725456,"threshold_uncertainty_score":0.99978733},"labels":[],"label_agreement":null},{"id":"W4405052776","doi":"10.1182/blood-2024-210718","title":"Allogeneic Hematopoietic Stem Cell Transplant for B-Cell Lymphomas in the Era of Novel Cellular Therapies: Experience from a Tertiary Canadian Center","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Internal medicine; Oncology; Follicular lymphoma; Lymphoma; Mantle cell lymphoma; Hematopoietic stem cell transplantation; Diffuse large B-cell lymphoma; Plerixafor; Salvage therapy; Transplantation; Chemotherapy; CXCR4","score_opus":0.01444469021835099,"score_gpt":0.22761697860543728,"score_spread":0.2131722883870863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405052776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98499274,0.012563277,0.00006367565,0.00076526724,0.00011109079,0.0007234372,0.00036289668,0.000018009609,0.00039958768],"genre_scores_gemma":[0.9982908,0.0002433633,0.0002755714,0.0006425375,0.000055768945,0.00032700866,0.00008408928,0.000025542176,0.000055329936],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989441,0.00002511766,0.00026915953,0.00029996855,0.00017572624,0.00028592447],"domain_scores_gemma":[0.9993787,0.00014816373,0.00003040401,0.0003108782,0.000017292115,0.0001145562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008234211,0.00017840766,0.000244398,0.00007204805,0.000040109277,0.0000269855,0.00015213093,0.00007952954,0.00005028465],"category_scores_gemma":[0.0000010276623,0.00011169045,0.00016159548,0.00011406615,0.0000466082,0.000035186524,0.00000787868,0.00006279362,0.000008625481],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002500382,0.023995625,0.40449682,0.0019761282,0.0009908624,0.003688379,0.29404098,0.000008727545,0.2653353,0.00056485145,0.0006891112,0.0039631943],"study_design_scores_gemma":[0.026913263,0.0006935381,0.034689955,0.0015849657,0.0010567101,0.00020783038,0.009965292,0.0003760482,0.91598594,0.000067761524,0.007995266,0.00046343615],"about_ca_topic_score_codex":0.015328858,"about_ca_topic_score_gemma":0.0045985933,"teacher_disagreement_score":0.6506507,"about_ca_system_score_codex":0.00007538257,"about_ca_system_score_gemma":0.00026045344,"threshold_uncertainty_score":0.99122816},"labels":[],"label_agreement":null},{"id":"W4405052861","doi":"10.1182/blood-2024-212017","title":"Venous Thromboembolism in Transgender Individuals Receiving Hormone Replacement Therapy in Alberta, Canada","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"LGBTQ Health, Identity, and Policy","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Transgender; Hormone therapy; Population; Hormone replacement therapy (female-to-male); Gynecology; Family medicine; Testosterone (patch); Internal medicine; Cancer; Breast cancer; Psychology","score_opus":0.02606570753345563,"score_gpt":0.31591431524901953,"score_spread":0.2898486077155639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405052861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95747983,0.010366071,0.0000016732955,0.0032616449,0.0010187778,0.00039701827,0.000028809554,0.000035312143,0.027410856],"genre_scores_gemma":[0.99381536,0.0016709568,0.00001639711,0.0008959659,0.000295351,0.00008757961,0.000016305079,0.000040433817,0.0031616527],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981458,0.00020115463,0.0004250893,0.00042064532,0.00023240075,0.00057488406],"domain_scores_gemma":[0.999321,0.00017976733,0.000040716484,0.00034534716,0.000012502385,0.00010071238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004300182,0.000180948,0.00031074428,0.00024363282,0.00005877367,0.00004921657,0.00020670821,0.00015053785,0.00051952025],"category_scores_gemma":[0.00001880907,0.00018098962,0.000046206475,0.00042615997,0.000024728664,0.00007846581,0.000017878228,0.0003799756,0.0000896139],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017995435,0.005388238,0.73759073,0.00094976503,0.0010257143,0.001075664,0.099915944,0.000023189985,0.00064098166,0.010365937,0.107893705,0.034950163],"study_design_scores_gemma":[0.0031809576,0.00025833072,0.9715947,0.00004433976,0.000045856275,0.000042413925,0.00028862807,0.0000032822206,0.000047273606,0.0011371542,0.023080435,0.00027661704],"about_ca_topic_score_codex":0.96277016,"about_ca_topic_score_gemma":0.95033294,"teacher_disagreement_score":0.23400396,"about_ca_system_score_codex":0.0001511157,"about_ca_system_score_gemma":0.00064682396,"threshold_uncertainty_score":0.7380542},"labels":[],"label_agreement":null},{"id":"W4405052898","doi":"10.1182/blood-2024-209110","title":"Prospective Evaluation of the Prevalence of Pulmonary Embolism in Patients with Chronic Obstructive Pulmonary Disease Exacerbation: Challenges and Feasibility","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Prospective cohort study; Exacerbation; Pulmonary embolism; D-dimer; Internal medicine; Acute exacerbation of chronic obstructive pulmonary disease; Cohort; Pulmonary disease","score_opus":0.02432704655986836,"score_gpt":0.289421396031286,"score_spread":0.2650943494714177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405052898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94393414,0.051286384,8.644369e-7,0.00021518477,0.00006933317,0.0030746136,0.00015092263,0.000022111708,0.0012464301],"genre_scores_gemma":[0.99898636,0.00056319305,0.00001910885,0.0000027115295,0.000073243114,0.00020448773,0.000017497612,0.000027388925,0.00010598603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99728835,0.00027187256,0.00032624594,0.0006296409,0.0012454381,0.00023843284],"domain_scores_gemma":[0.99851155,0.00010359117,0.00011405065,0.0005859677,0.00054846314,0.00013638329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048518358,0.00020084193,0.0002903282,0.00015185644,0.000044486922,0.000008168546,0.00014380686,0.00006903963,0.000085525135],"category_scores_gemma":[0.00020320082,0.00014051922,0.00008350989,0.00038274613,0.0004940399,0.00025429952,0.00015075401,0.00025249482,0.0000013702144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006722729,0.0017196101,0.9606014,0.008350504,0.00011200978,0.000024568793,0.00050860416,0.000020514666,0.0001919403,0.00049746165,6.461528e-7,0.027300494],"study_design_scores_gemma":[0.0024568178,0.00015431669,0.9899715,0.0012429513,0.00077592646,0.000013025402,0.00014377235,0.002147421,0.00036340198,0.0026006647,0.0000035584574,0.00012659955],"about_ca_topic_score_codex":0.00001754355,"about_ca_topic_score_gemma":0.000011796126,"teacher_disagreement_score":0.05505223,"about_ca_system_score_codex":0.0005084812,"about_ca_system_score_gemma":0.0010536689,"threshold_uncertainty_score":0.57302076},"labels":[],"label_agreement":null},{"id":"W4405052961","doi":"10.1182/blood-2024-194331","title":"Glofitamab in Combination with R-ICE Chemoimmunotherapy or as Monotherapy in Children and Adolescents with Relapsed/Refractory B-cell non-Hodgkin Lymphoma: Initial Safety and Efficacy Results from the Ongoing iMATRIX-GLO Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Chemoimmunotherapy; Internal medicine; Rituximab; Cohort; Oncology; Lymphoma","score_opus":0.009643382075257279,"score_gpt":0.2786636109654514,"score_spread":0.2690202288901941,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405052961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944031,0.0019669642,0.000015533931,0.00038325836,0.00003562803,0.0027480596,0.00003170015,0.00006466746,0.0003510829],"genre_scores_gemma":[0.9977933,0.0013752425,0.00011761631,0.00017058967,0.00010936646,0.000046546487,0.000051552375,0.000095972595,0.00023977766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976499,0.00023756015,0.00046833322,0.0007033522,0.0005737508,0.0003671034],"domain_scores_gemma":[0.9988016,0.00044251577,0.00009765549,0.0005005293,0.000059616053,0.0000980773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007824356,0.0003315481,0.00046624808,0.00025416902,0.000102657505,0.00015384497,0.00018128971,0.00013523703,0.000042151703],"category_scores_gemma":[0.000049943163,0.00020475035,0.000036459718,0.00069512194,0.00015139532,0.00018322663,0.00006211455,0.0005317866,0.000007057438],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15922382,0.019184012,0.6332173,0.0001621977,0.0010567926,0.0012452055,0.02768815,0.000010843297,0.016146032,0.000011002013,0.000042820215,0.14201182],"study_design_scores_gemma":[0.16482039,0.004837608,0.82516545,0.001212112,0.00012185266,0.00015189947,0.00083830976,0.00011667617,0.002339484,0.000013275503,0.000120231256,0.00026271574],"about_ca_topic_score_codex":0.0029169049,"about_ca_topic_score_gemma":0.0007252704,"teacher_disagreement_score":0.19194815,"about_ca_system_score_codex":0.00015525562,"about_ca_system_score_gemma":0.00034108333,"threshold_uncertainty_score":0.8349477},"labels":[],"label_agreement":null},{"id":"W4405053172","doi":"10.1182/blood-2024-205517","title":"Clinical Outcomes for Patients with Triple Class Exposed Relapsed and Refractory Multiple Myeloma in Alberta, Canada","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Multiple myeloma; Internal medicine; Cohort; Population; Lenalidomide; Oncology; Environmental health","score_opus":0.022235365477753177,"score_gpt":0.29816021716723295,"score_spread":0.2759248516894798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405053172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99748874,0.00019566408,0.000004521895,0.0004885235,0.00017313437,0.0012289574,0.00009066495,0.00002789827,0.00030186962],"genre_scores_gemma":[0.99678135,0.000030159474,0.0007280075,0.00014695089,0.0000526605,0.00014324862,0.00017978663,0.000036661404,0.00190119],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985142,0.00005456838,0.00035253086,0.00040377915,0.00031752267,0.00035741067],"domain_scores_gemma":[0.9980852,0.0012806301,0.000039542992,0.00024582233,0.00006763884,0.0002811741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014662169,0.00017578945,0.00038997032,0.000101633224,0.000048887854,0.000024318302,0.000058727346,0.000095747484,0.00001989485],"category_scores_gemma":[0.0008156484,0.00011806992,0.000072896415,0.00013006828,0.000051086467,0.000072769886,0.000029140941,0.00022299035,0.0000056917947],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090682675,0.0011307149,0.987703,0.00013003945,0.00036528122,0.00021540448,0.000059947906,9.845805e-8,0.000017104601,0.000013320692,0.00083711464,0.008621136],"study_design_scores_gemma":[0.031394947,0.0012447607,0.95601314,0.00014138424,0.00013115497,0.0000052516302,0.000032797594,0.0002574699,0.000103868995,0.000009086003,0.010538041,0.00012807881],"about_ca_topic_score_codex":0.106312566,"about_ca_topic_score_gemma":0.5927781,"teacher_disagreement_score":0.4864655,"about_ca_system_score_codex":0.0000984521,"about_ca_system_score_gemma":0.00062244857,"threshold_uncertainty_score":0.8996386},"labels":[],"label_agreement":null},{"id":"W4405053179","doi":"10.1182/blood-2024-208613","title":"Risks and Harms to Physicians Reporting Hematologic Adverse Drug Reactions (ADRs) to Health Authorities","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Family medicine; Government (linguistics); Adverse effect; Internal medicine","score_opus":0.07458094876449868,"score_gpt":0.38580629978587433,"score_spread":0.31122535102137566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405053179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8324739,0.001231116,0.0011239947,0.16239947,0.0005284782,0.0004906672,0.000013681251,0.0002756311,0.0014631035],"genre_scores_gemma":[0.9933984,0.00008587024,0.0024407587,0.0018433186,0.00027723185,0.00002104275,0.000013007978,0.000013483859,0.0019068839],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99896324,0.000022275082,0.0004033785,0.00024016447,0.00019697823,0.00017399216],"domain_scores_gemma":[0.9994579,0.000050692794,0.00010124427,0.00013570358,0.00004127684,0.00021320264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005510379,0.00007912294,0.00020730769,0.000105033076,0.00012029494,0.000021119567,0.00002326786,0.000070911854,0.000016000056],"category_scores_gemma":[0.00020679767,0.000061042156,0.000049083676,0.0002638074,0.00007504524,0.000035311623,0.000033735323,0.00023811044,0.000024202345],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022228714,0.0036143295,0.01598298,0.015977018,0.0014131925,0.0028761853,0.09925069,0.00011023096,0.10676544,0.14437705,0.10700674,0.50240386],"study_design_scores_gemma":[0.004692966,0.0026468248,0.30373406,0.017284764,0.0013688236,0.0037326773,0.030382097,0.0038512824,0.02846377,0.027609373,0.57468146,0.0015518814],"about_ca_topic_score_codex":0.00032814968,"about_ca_topic_score_gemma":0.000051941075,"teacher_disagreement_score":0.500852,"about_ca_system_score_codex":0.000026971387,"about_ca_system_score_gemma":0.00011246943,"threshold_uncertainty_score":0.24892268},"labels":[],"label_agreement":null},{"id":"W4405053344","doi":"10.1182/blood-2024-206645","title":"Utilization of Multiple Myeloma Treatments in Developing Countries: Systematic Review and Meta-Analysis","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Multiple myeloma; Medicine; Pomalidomide; Meta-analysis; Internal medicine; Lenalidomide; Oncology; Intensive care medicine","score_opus":0.09550213315032745,"score_gpt":0.36283175536153517,"score_spread":0.2673296222112077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405053344","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16510905,0.82708514,0.00048311029,0.001610597,0.000017983662,0.0049862103,0.00018083422,0.00009212962,0.00043492837],"genre_scores_gemma":[0.9791551,0.01882062,0.0008938266,0.00017092116,0.000004065306,0.00032189293,0.00009324485,0.000014932066,0.0005253739],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99879235,0.00009542559,0.0004441481,0.00024042002,0.00027274597,0.00015492152],"domain_scores_gemma":[0.9993577,0.00019536886,0.000063433625,0.00023360732,0.00007989582,0.000069994036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027217457,0.00014026408,0.0013164842,0.000315408,0.00002229546,0.000018996245,0.000040394872,0.0000393944,0.00010224383],"category_scores_gemma":[0.00022109128,0.000087638466,0.00026016912,0.00079500483,0.000026336116,0.00006790218,0.000023611146,0.00004434837,0.000016664666],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003050083,0.00053963065,0.04051055,0.5685346,0.38901007,0.00043774734,0.00041522068,0.0000011372678,0.000045224257,0.00037162352,0.000025385021,0.00007828345],"study_design_scores_gemma":[0.0018945097,0.00012227766,0.015629245,0.0070968284,0.9725872,0.00004888546,0.0000417529,0.0005667976,0.0018272507,0.000017516379,0.000048700764,0.00011900202],"about_ca_topic_score_codex":0.000088845445,"about_ca_topic_score_gemma":0.00008498868,"teacher_disagreement_score":0.8140461,"about_ca_system_score_codex":0.000047850408,"about_ca_system_score_gemma":0.00008337475,"threshold_uncertainty_score":0.35737932},"labels":[],"label_agreement":null},{"id":"W4405053499","doi":"10.1182/blood-2024-211014","title":"Inferior Vena Cava Filters for Pulmonary Emboli in the Absence of Residual Deep Venous Thrombosis: A Survey of Current Physician Practices in Nova Scotia, Canada","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Moncton Hospital; Nova Scotia Health Authority; Dalhousie University","funders":"","keywords":"Medicine; Contraindication; Pulmonary embolism; Deep vein; Inferior vena cava; Nova scotia; Venous thrombosis; Thrombosis; Inferior vena cava filter; Venous thromboembolism; Emergency medicine; Radiology; Surgery","score_opus":0.05877542205733423,"score_gpt":0.33852461330589867,"score_spread":0.27974919124856445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405053499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99183583,0.005616536,0.0000071870936,0.00060111843,0.00034474302,0.0010045903,0.00011125341,0.000009572147,0.0004691884],"genre_scores_gemma":[0.9992244,0.0002748278,0.000054802396,0.00021280244,0.00008683551,0.00006631176,0.00005525447,0.00002130507,0.0000034206737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984803,0.00012871786,0.0004515837,0.0002828059,0.00037053096,0.00028602977],"domain_scores_gemma":[0.9988088,0.00050215004,0.00023605062,0.0003290793,0.00008482737,0.00003909481],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007744188,0.00015500326,0.0005291734,0.00014989344,0.000022272221,0.000018117806,0.00021768513,0.00004091571,0.000010780508],"category_scores_gemma":[0.00031482006,0.00012125027,0.00006012858,0.0005159371,0.00006185115,0.00009470234,0.000055598786,0.00019434263,0.0000018805233],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005432541,0.044519823,0.81910586,0.021235634,0.0021752524,0.00097410637,0.024264373,0.00061081344,0.010753987,0.002626232,0.017926715,0.055263937],"study_design_scores_gemma":[0.00075711875,0.00039898828,0.9939549,0.0013251414,0.00025525657,0.0000061895144,0.0011087427,0.00016933378,0.0013179393,0.000054576387,0.00052329706,0.00012850176],"about_ca_topic_score_codex":0.6195627,"about_ca_topic_score_gemma":0.8409473,"teacher_disagreement_score":0.22138461,"about_ca_system_score_codex":0.00006546478,"about_ca_system_score_gemma":0.00073773664,"threshold_uncertainty_score":0.49444425},"labels":[],"label_agreement":null},{"id":"W4405053632","doi":"10.1182/blood-2024-206588","title":"Is It Safe to Correct Iron Deficiency Anemia with Intravenous Iron in Pregnancy? a Systematic Review and Meta-Analysis","year":2024,"lang":"en","type":"review","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Intravenous iron; Medicine; Pregnancy; Anemia; Iron deficiency; Iron-deficiency anemia; Meta-analysis; Internal medicine; Biology","score_opus":0.047601596691211466,"score_gpt":0.3281778039314741,"score_spread":0.28057620724026267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405053632","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000075641074,0.9916008,0.000016295728,0.00027059173,0.000035514586,0.0062411833,0.00010297902,0.000032985707,0.0016920812],"genre_scores_gemma":[0.000035877794,0.9932862,0.00026661227,0.0010191117,0.000018171328,0.0011034065,0.0000779119,0.00007589416,0.004116811],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99644464,0.00030876408,0.0013369677,0.00095604995,0.0005190061,0.00043458186],"domain_scores_gemma":[0.9981399,0.000101404235,0.00038820435,0.0010852803,0.000060760387,0.0002244254],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005940469,0.00075881474,0.010013365,0.000744501,0.000040631367,0.000053997424,0.00024580056,0.00023357364,0.00040496458],"category_scores_gemma":[0.00019195321,0.00041723953,0.0013266059,0.0023464174,0.00004885145,0.000042961623,0.00008771641,0.00046400307,0.00025942732],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000028155066,0.00025207363,0.0000025642735,0.9900405,0.0063594785,0.00019054633,0.00034044113,2.6784193e-7,4.149028e-8,0.000017327759,0.00041217657,0.0023818132],"study_design_scores_gemma":[0.00027812313,0.00018068,0.0000016768075,0.17726602,0.81642425,0.00031354703,0.00006244334,1.6886966e-7,1.728449e-7,0.0000015870141,0.005115303,0.00035600842],"about_ca_topic_score_codex":0.000080382466,"about_ca_topic_score_gemma":0.000106778396,"teacher_disagreement_score":0.8127744,"about_ca_system_score_codex":0.000048669197,"about_ca_system_score_gemma":0.00028874108,"threshold_uncertainty_score":0.9998279},"labels":[],"label_agreement":null},{"id":"W4405053703","doi":"10.1182/blood-2024-202159","title":"Daily Versus Non-Daily Oral Iron Supplementation for the Treatment of Iron Deficiency Anemia: A Systematic Review and Meta-Analysis of Randomized Trials","year":2024,"lang":"en","type":"review","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Anemia; Iron deficiency; Meta-analysis; Iron-deficiency anemia; Randomized controlled trial; Internal medicine; Gastroenterology","score_opus":0.1353840793699855,"score_gpt":0.415755927016273,"score_spread":0.28037184764628753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405053703","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000013712855,0.9796697,0.00008171242,0.00011081313,0.00010064146,0.019033775,0.0009081081,0.000010052895,0.00007149287],"genre_scores_gemma":[0.00005412103,0.99378586,0.00041869117,0.00003246993,0.000029111088,0.004467225,0.00076331553,0.000036609646,0.00041258463],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9946205,0.0011976996,0.003135404,0.0004240112,0.00042172818,0.00020067264],"domain_scores_gemma":[0.9939397,0.003188891,0.0019938145,0.0006959693,0.000120584125,0.00006103703],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.004699646,0.00051789917,0.022898639,0.0003969327,0.0000444514,0.000021976073,0.00014572481,0.00015117702,0.0001874114],"category_scores_gemma":[0.0013277928,0.00021610086,0.008045518,0.0007132622,0.00010578913,0.000031045085,0.000021804984,0.000079780206,0.0000044711446],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012589837,0.00047541538,1.2162664e-7,0.93230724,0.06318757,0.0000018002246,0.0002103868,3.8592057e-7,5.215127e-7,0.00009499261,0.00019664959,0.0022659537],"study_design_scores_gemma":[0.06357938,0.0004401925,1.6294702e-7,0.00712664,0.92688304,0.000004162864,0.00013713852,0.0000022950144,0.0000025744578,0.0000041657986,0.0016786947,0.00014155165],"about_ca_topic_score_codex":0.00009258341,"about_ca_topic_score_gemma":0.000022935954,"teacher_disagreement_score":0.92518055,"about_ca_system_score_codex":0.000032318618,"about_ca_system_score_gemma":0.00018775232,"threshold_uncertainty_score":0.9916074},"labels":[],"label_agreement":null},{"id":"W4405053763","doi":"10.1182/blood-2024-205750","title":"Title:Revision of the Diagnostic Methods Used for the Detection of Pulmonary Embolism in Pregnant Women at the “Centre Hospitalier Universitaire De Sherbrooke”","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pulmonary embolism; Medicine; Gynecology; Surgery","score_opus":0.008897742585383618,"score_gpt":0.26558208403589384,"score_spread":0.2566843414505102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405053763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9790014,0.01293556,0.00091757166,0.0024553093,0.00041894888,0.0015863894,0.000013639271,0.000025771506,0.0026454183],"genre_scores_gemma":[0.9971986,0.0010423701,0.00009259381,0.00005085852,0.00004462509,0.00002292545,0.0000012672176,0.000012527732,0.0015342656],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995018,0.000058346897,0.00011380835,0.00010310264,0.000102603044,0.00012030618],"domain_scores_gemma":[0.99927294,0.00042929433,0.000036630223,0.00022396345,0.000018769955,0.000018400895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030998068,0.000062529594,0.00014088876,0.000031801195,0.00004790567,0.000005637684,0.00010267365,0.000036799393,0.00011165702],"category_scores_gemma":[0.00009683283,0.000030048895,0.000087609915,0.00014803097,0.000047612295,0.000019086872,0.00008332255,0.00006402488,0.0000051905467],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007777528,0.0021643203,0.008763503,0.0029977595,0.0011920007,0.000057713376,0.015731469,0.00015519706,0.02901857,0.0048092897,0.009415736,0.9256167],"study_design_scores_gemma":[0.0033374543,0.00086785166,0.2878764,0.0058121127,0.0041236985,0.000040329596,0.009388386,0.007255685,0.1489649,0.0018606979,0.530072,0.00040049577],"about_ca_topic_score_codex":0.000031060685,"about_ca_topic_score_gemma":0.00001987392,"teacher_disagreement_score":0.9252162,"about_ca_system_score_codex":0.00007160756,"about_ca_system_score_gemma":0.000033097123,"threshold_uncertainty_score":0.12253584},"labels":[],"label_agreement":null},{"id":"W4405053899","doi":"10.1182/blood-2024-204115","title":"Health-Related Quality-of-Life Improvements after Exagamglogene Autotemcel in Patients with Transfusion-Dependent Beta-Thalassemia","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; SickKids Foundation; Hospital for Sick Children; BC Children's Hospital; University of Toronto","funders":"","keywords":"Thalassemia; Medicine; Beta thalassemia; Blood transfusion; Quality of life (healthcare); Pediatrics; Intensive care medicine; Internal medicine","score_opus":0.009673055675684042,"score_gpt":0.25070706284451405,"score_spread":0.24103400716883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405053899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923089,0.004709464,0.000024511368,0.0009634222,0.00023309074,0.00093807065,0.000052001044,0.00008952559,0.00068102084],"genre_scores_gemma":[0.99881816,0.00026890714,0.00011253605,0.00029428047,0.000019453302,0.000046956917,0.000074989424,0.000046976053,0.00031771997],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976705,0.00011185115,0.00089057215,0.00041880895,0.0005200268,0.00038829527],"domain_scores_gemma":[0.9992499,0.00004573529,0.00010917444,0.00029708887,0.00006419947,0.0002339045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045601017,0.00022812626,0.00057159906,0.00021519784,0.00003786532,0.000014531054,0.00007759346,0.00021887482,0.00018057095],"category_scores_gemma":[0.00002880408,0.00016477263,0.00012210711,0.00043519938,0.000056347628,0.00007090591,0.000030134705,0.00040877014,0.00003253112],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015573015,0.005418158,0.96214646,0.0026722867,0.0010552669,0.00017948991,0.0025088296,0.000024128864,0.0025921038,0.000107803884,0.0001454755,0.02159269],"study_design_scores_gemma":[0.024604475,0.0027665964,0.9672787,0.0018262966,0.00040347796,0.000014300046,0.000302301,0.00006857796,0.0019317833,0.000051656938,0.00033368604,0.0004181142],"about_ca_topic_score_codex":0.0007244024,"about_ca_topic_score_gemma":0.00010660981,"teacher_disagreement_score":0.023047173,"about_ca_system_score_codex":0.000076918426,"about_ca_system_score_gemma":0.00040485174,"threshold_uncertainty_score":0.67192334},"labels":[],"label_agreement":null},{"id":"W4405053953","doi":"10.1182/blood-2024-203541","title":"Real-World Adherence with Pegcetacoplan in Paroxysmal Nocturnal Hemoglobinuria Compared with Previously Reported Oral Medication Adherence Rates","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Medicine; Medication adherence; Internal medicine; Pediatrics; Intensive care medicine","score_opus":0.029487267761649474,"score_gpt":0.29658208338668,"score_spread":0.26709481562503057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405053953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941823,0.0025086254,0.000043776276,0.00010577067,0.0003186466,0.00073703815,0.000046626832,0.00023956138,0.0018176418],"genre_scores_gemma":[0.99803054,0.00003496398,0.00024474857,0.000024958967,0.000042046533,0.0002012258,0.00040096111,0.00002507251,0.0009955041],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99809426,0.00024519282,0.0005555359,0.00055907376,0.00011582218,0.00043008736],"domain_scores_gemma":[0.9990698,0.0001517477,0.00022383378,0.00043141737,0.00006534152,0.0000578494],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027143455,0.00026993878,0.0004079019,0.00017426905,0.00009186127,0.00006460402,0.00029295098,0.000085514126,0.0010227223],"category_scores_gemma":[0.000034591314,0.00019183035,0.00004612164,0.0004708971,0.00019846662,0.00014654781,0.000054891105,0.00029248188,0.0001457529],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009950426,0.0007983681,0.94505143,0.0004271472,0.001035641,0.00080026936,0.0011106534,0.000025836312,0.043486487,0.00049553026,0.004941535,0.0008320793],"study_design_scores_gemma":[0.014250657,0.002442702,0.9158816,0.005039722,0.001338259,0.0024743404,0.0009326491,0.00014759414,0.05132997,0.00022957823,0.0047465647,0.0011863798],"about_ca_topic_score_codex":0.0011741554,"about_ca_topic_score_gemma":0.0063048927,"teacher_disagreement_score":0.029169828,"about_ca_system_score_codex":0.00004862291,"about_ca_system_score_gemma":0.00043943254,"threshold_uncertainty_score":0.9998905},"labels":[],"label_agreement":null},{"id":"W4405053975","doi":"10.1182/blood-2024-212068","title":"<i>A Multicenter Review of Quality Care Metrics for Patients with Sickle Cell Disease Presenting to Community Hospitals in Southwestern Ontario</i>","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Windsor; Windsor Regional Hospital; Western University","funders":"","keywords":"Medicine; Disease; Sickle cell anemia; Multicenter study; Pediatrics; Intensive care medicine; Internal medicine; Randomized controlled trial","score_opus":0.012702632830319265,"score_gpt":0.2738446507613528,"score_spread":0.26114201793103353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405053975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840818,0.013442998,0.000020286221,0.00017190578,0.00006824325,0.001609944,0.00013106114,0.000025428651,0.00044831343],"genre_scores_gemma":[0.9985051,0.00029567553,0.0003451216,0.0004511094,0.000010198502,0.000052544525,0.00017109497,0.00002176501,0.00014736067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899834,0.000080815626,0.00034507978,0.00016544032,0.00022343511,0.00018691123],"domain_scores_gemma":[0.99917287,0.00012252401,0.00006428862,0.00031245005,0.00018317069,0.00014468576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024274817,0.00012220565,0.0003055751,0.00008873906,0.000040171737,0.000012482607,0.000087359724,0.000046152705,0.000015572874],"category_scores_gemma":[0.00021316962,0.000088904046,0.00010818111,0.0003048502,0.00002179594,0.000057403948,0.00006667915,0.00024479174,0.0000050823073],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000086753505,0.0015157721,0.96144,0.03125628,0.00006072928,0.0000104867095,0.004826577,0.0000024823778,0.000015840376,0.0000031207458,0.000106488136,0.0006754477],"study_design_scores_gemma":[0.011152406,0.0010456407,0.9452872,0.03147782,0.0018148646,6.591347e-7,0.0028213798,0.000016937593,0.00055477634,0.000016255775,0.0053965203,0.00041548314],"about_ca_topic_score_codex":0.003792082,"about_ca_topic_score_gemma":0.0017510552,"teacher_disagreement_score":0.016152764,"about_ca_system_score_codex":0.000050278675,"about_ca_system_score_gemma":0.00012789093,"threshold_uncertainty_score":0.5732519},"labels":[],"label_agreement":null},{"id":"W4405054010","doi":"10.1182/blood-2024-208843","title":"Growth Curves for Children Living with Sickle Cell Anemia in Kilifi County, Kenya, Do Not Follow Who Curves for Normal Children","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Sickle cell anemia; Medicine; Pediatrics; Anemia; Internal medicine; Disease","score_opus":0.004752970869433686,"score_gpt":0.21428912201788353,"score_spread":0.20953615114844984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405054010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9521334,0.03962517,0.00019261934,0.0020380034,0.00017131896,0.0030117987,0.000355196,0.00020778169,0.0022647083],"genre_scores_gemma":[0.9885272,0.006965811,0.00074995024,0.0012455661,0.00031177004,0.00023760783,0.0003491417,0.00011640798,0.0014965689],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981581,0.000031128548,0.00038834312,0.00054762466,0.00030687082,0.0005679458],"domain_scores_gemma":[0.9991388,0.0002301849,0.00007715343,0.00029305424,0.00010479537,0.00015606065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004337083,0.0003158197,0.0004925027,0.00016553761,0.000118147575,0.000060487568,0.0001739988,0.00020790625,0.000046031593],"category_scores_gemma":[0.00015814559,0.00024203956,0.00020741069,0.00037003652,0.000081468024,0.00017402139,0.000053052063,0.00036171763,0.000011477277],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006322297,0.0033969097,0.86993545,0.018146949,0.0012649966,0.00010172404,0.0017622757,0.00004448443,0.0017497841,0.0005667626,0.09945964,0.0029387937],"study_design_scores_gemma":[0.048330862,0.008174361,0.8349395,0.06868943,0.0079528885,0.0012532762,0.0007845379,0.0010109681,0.019938514,0.0003566964,0.0054001706,0.0031688171],"about_ca_topic_score_codex":0.00024718657,"about_ca_topic_score_gemma":0.000073357754,"teacher_disagreement_score":0.09405947,"about_ca_system_score_codex":0.00003455493,"about_ca_system_score_gemma":0.0002497704,"threshold_uncertainty_score":0.9870087},"labels":[],"label_agreement":null},{"id":"W4405054049","doi":"10.1182/blood-2024-203775","title":"Impact of Clonal Size and High Disease Activity on Clinical Outcomes of Paroxysmal Nocturnal Hemoglobinuria: A Multicenter Registry","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Medicine; Internal medicine; Disease; Pediatrics; Immunology","score_opus":0.022946817680880315,"score_gpt":0.34001519680198644,"score_spread":0.31706837912110614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405054049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970096,0.0010714066,0.0000050153753,0.00013188872,0.0004981556,0.00023022275,0.00095706736,0.000034772736,0.00006189907],"genre_scores_gemma":[0.9996056,0.00002113483,0.000026964135,0.000020259291,0.000055007586,0.00001044758,0.000021992255,0.000012375204,0.00022620369],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876225,0.00024056634,0.00043361826,0.00029833496,0.00006265463,0.00020258597],"domain_scores_gemma":[0.998366,0.0010417689,0.00016625224,0.0003220018,0.00003839625,0.00006561038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001987404,0.00017364151,0.0004306206,0.00004755329,0.000034509707,0.000011806192,0.00014334479,0.00010788133,0.0005371531],"category_scores_gemma":[0.0003611238,0.00012457096,0.0003748981,0.000052717653,0.00023526115,0.00005198049,0.00010583277,0.00020332761,0.000023972472],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015257613,0.0020171069,0.975189,0.00017487483,0.0017561754,0.00004010471,0.000034169618,0.0000017672161,0.0174688,0.00016934189,0.001084507,0.00053842907],"study_design_scores_gemma":[0.003589003,0.0005637773,0.9926481,0.00015121126,0.00043345563,0.000015299212,0.000010849075,0.0000038222724,0.0022938002,0.000067149296,0.000113617505,0.000109869],"about_ca_topic_score_codex":0.00012304178,"about_ca_topic_score_gemma":0.0000055166183,"teacher_disagreement_score":0.017459186,"about_ca_system_score_codex":0.00001848494,"about_ca_system_score_gemma":0.00014239179,"threshold_uncertainty_score":0.588145},"labels":[],"label_agreement":null},{"id":"W4405054054","doi":"10.1182/blood-2024-209411","title":"Real World Outcomes in Adult Histiocytosis: 23-Year Canadian Single Center Analysis","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Center (category theory); Pediatrics","score_opus":0.007978526425703986,"score_gpt":0.21195928400167638,"score_spread":0.2039807575759724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405054054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9404954,0.0011094927,0.0000037860702,0.000792017,0.0005783962,0.00010706784,0.00024907294,0.00008176768,0.056583006],"genre_scores_gemma":[0.96417105,0.000046170095,0.00004281729,0.00012722028,0.000023432302,0.000010252548,0.00026841855,0.000012190726,0.03529843],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99916285,0.000044162567,0.0002028109,0.00025389993,0.000022320577,0.00031397765],"domain_scores_gemma":[0.9996931,0.000032583714,0.000020949083,0.00018928386,0.000024275587,0.000039816783],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00006608319,0.00011779126,0.0002484837,0.0007064911,0.0000547997,0.000027823151,0.000111864116,0.00010212319,0.0017801818],"category_scores_gemma":[0.000013297118,0.00010461065,0.00012907248,0.0005123374,0.000047876125,0.000034283144,0.000022236292,0.00016973804,0.00073181314],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022449838,0.0006695433,0.9690513,0.00005023663,0.0020692004,0.00018216844,0.00059196615,0.0000037296502,0.016218094,0.0036896307,0.0064648464,0.0009868371],"study_design_scores_gemma":[0.005541823,0.0002446261,0.36749652,0.00018128689,0.002946567,0.00004230337,0.00050288386,0.000030324256,0.015592954,0.000106379375,0.60636187,0.0009524636],"about_ca_topic_score_codex":0.15403949,"about_ca_topic_score_gemma":0.8494016,"teacher_disagreement_score":0.69536215,"about_ca_system_score_codex":0.00009045388,"about_ca_system_score_gemma":0.000078910154,"threshold_uncertainty_score":0.99913234},"labels":[],"label_agreement":null},{"id":"W4405054112","doi":"10.1182/blood-2024-199839","title":"Beyond Bleeding: Unpacking Gender Disparities in Von Willebrand Disease Clinical Trials of the Past Half-Century","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Unpacking; Medicine; Von Willebrand disease; Von Willebrand factor; Clinical trial; Disease; Internal medicine; Platelet","score_opus":0.07835661219272597,"score_gpt":0.37022684736031647,"score_spread":0.2918702351675905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405054112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812139,0.011492003,0.000004794746,0.0040415507,0.0006683191,0.0007177273,0.00006660386,0.000031189957,0.0017638884],"genre_scores_gemma":[0.99711406,0.0016773688,0.00006428468,0.00029937353,0.00056114065,0.00008315379,0.000023082355,0.000022610491,0.00015493356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99803406,0.00030934156,0.0008206261,0.0003173463,0.00030890413,0.00020974074],"domain_scores_gemma":[0.99840367,0.0010185364,0.00011596345,0.00025637858,0.00004571001,0.00015973252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012418071,0.0001733758,0.0006309832,0.000094347895,0.000051235773,0.000044768665,0.0000750816,0.000085749656,0.00011668169],"category_scores_gemma":[0.00080919435,0.00009730876,0.00038083803,0.00020254095,0.00010977286,0.000062503655,0.00006236696,0.00023721391,0.000008679358],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017490209,0.0014920945,0.98808235,0.00038313822,0.00046122013,0.0001371247,0.0003029685,0.0000026340626,0.00014910025,0.005921188,0.0011900367,0.0017032466],"study_design_scores_gemma":[0.007884778,0.00022382036,0.9792513,0.0013492996,0.0021701981,0.00002103999,0.00016945842,0.00010604991,0.0025429572,0.0016632947,0.004441461,0.00017629488],"about_ca_topic_score_codex":0.000018939709,"about_ca_topic_score_gemma":0.0000170287,"teacher_disagreement_score":0.015900128,"about_ca_system_score_codex":0.000027721762,"about_ca_system_score_gemma":0.00016801285,"threshold_uncertainty_score":0.3968136},"labels":[],"label_agreement":null},{"id":"W4405054136","doi":"10.1182/blood-2024-204066","title":"Age ≥60 Is an Added Risk Factor for Mortality in High-Risk HCT-CI Patients Undergoing Allogeneic Stem Cell Transplant","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Medicine; Stem cell; Risk factor; Internal medicine; Transplantation; Oncology; Surgery; Biology","score_opus":0.03110526254752802,"score_gpt":0.28873127130911747,"score_spread":0.2576260087615894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405054136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936423,0.00049982296,0.00024242188,0.0000603851,0.00017019549,0.0012649064,0.0037883797,0.0001383201,0.00019332716],"genre_scores_gemma":[0.99758273,0.0006676204,0.0005322884,0.000107206724,0.00017877526,0.000097664975,0.00030939907,0.000081922015,0.0004423785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99763954,0.00018100486,0.00044336848,0.0006586767,0.00049169525,0.00058572233],"domain_scores_gemma":[0.998754,0.00031413033,0.000077726894,0.00051197695,0.00006585935,0.00027627905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038070336,0.000272056,0.00042850059,0.00022984672,0.00009085217,0.000058840753,0.00020974678,0.00022033039,0.00014437371],"category_scores_gemma":[0.000039795712,0.00022840439,0.00017661828,0.00029798018,0.000049146478,0.00012798572,0.000043363932,0.0005669082,0.000068792295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005090108,0.002251946,0.95774126,0.0020843153,0.00094465463,0.0017044088,0.008383431,0.00002463552,0.0098734815,0.00003077427,0.0007706199,0.015681485],"study_design_scores_gemma":[0.022026094,0.0025083772,0.8933638,0.00048993994,0.001661157,0.000015137061,0.0005131368,0.0019850167,0.07524934,0.00027098972,0.0012803486,0.00063671754],"about_ca_topic_score_codex":0.00080570224,"about_ca_topic_score_gemma":0.0010210681,"teacher_disagreement_score":0.06537585,"about_ca_system_score_codex":0.00022609333,"about_ca_system_score_gemma":0.0003963868,"threshold_uncertainty_score":0.931406},"labels":[],"label_agreement":null},{"id":"W4405054239","doi":"10.1182/blood-2024-199823","title":"Detection of Molecular Biomarkers in Fanconi Anemia Mucosa","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Fanconi anemia; Medicine; Biology; Cancer research; Pathology; Internal medicine; Genetics; DNA; DNA repair","score_opus":0.004089548764533464,"score_gpt":0.2183106381517031,"score_spread":0.21422108938716963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405054239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950869,0.0024889784,0.001218184,0.000016762195,0.0001386681,0.000098676384,0.0000062976105,0.000022612174,0.0009229244],"genre_scores_gemma":[0.99931794,0.000045445842,0.00048556717,0.000022182101,0.000033141107,0.000013926019,0.000014222914,0.000016712258,0.000050888324],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99942887,0.000028062923,0.00012822793,0.00022464036,0.000070871894,0.000119323835],"domain_scores_gemma":[0.9997431,0.0000043512646,0.00002014303,0.00018917919,0.000016273189,0.000026931031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011351545,0.00007846337,0.00007279288,0.000068206755,0.0000075445137,0.000008811588,0.00007427553,0.0001111036,0.000007449632],"category_scores_gemma":[0.00002699048,0.00008086089,0.00006506623,0.00013516987,0.000021395255,0.000001853508,0.000041535015,0.000046971927,0.0000065004983],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012374184,0.00005118166,0.00015807021,0.000052088784,0.00006208034,0.000037951137,0.000017537548,0.0000043470945,0.995781,0.00006538451,0.000015765992,0.0037422287],"study_design_scores_gemma":[0.00036132877,0.00014927574,0.00022945333,0.000026791551,0.00002621525,0.000028596865,0.000024314388,0.000057922392,0.99777853,0.0001684819,0.0010625032,0.00008655799],"about_ca_topic_score_codex":0.000021478696,"about_ca_topic_score_gemma":0.000032074397,"teacher_disagreement_score":0.0042310175,"about_ca_system_score_codex":0.0000062221825,"about_ca_system_score_gemma":0.00003629004,"threshold_uncertainty_score":0.32974115},"labels":[],"label_agreement":null},{"id":"W4405054257","doi":"10.1182/blood-2024-211416","title":"Review of High Altitude Simulation Test (HAST) in Pediatric and Adult Patients with Sickle Cell Disease","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Effects of high altitude on humans; Disease; Medicine; Acute chest syndrome; Sickle cell anemia; Pediatrics; Internal medicine","score_opus":0.002916274662674866,"score_gpt":0.21222582848782118,"score_spread":0.20930955382514632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405054257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92941713,0.06962384,0.000006271561,0.0002352695,0.0000251143,0.00037789697,0.0000173098,0.000022772812,0.0002744088],"genre_scores_gemma":[0.97520673,0.024368221,0.00006175939,0.00022482213,0.000029113859,0.000006380933,0.000049442184,0.000012253564,0.00004129846],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99945253,0.000010876088,0.00017136845,0.00014446165,0.0001283807,0.000092366216],"domain_scores_gemma":[0.99966556,0.00005283297,0.000032771204,0.000101280886,0.000064667285,0.00008289723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000041684983,0.000077119046,0.00014862482,0.00006650178,0.000011403862,0.0000045552183,0.000019424288,0.00003406571,0.000022527498],"category_scores_gemma":[0.000100656696,0.00005282511,0.000023593297,0.0002532623,0.000017828192,0.000038543563,0.000012963797,0.00009050514,0.0000083613495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005348117,0.0016819726,0.96879464,0.02685938,0.000021886644,0.000054374414,0.00010420059,0.00011332921,0.0000105443,0.000022365874,0.0003526735,0.0019311446],"study_design_scores_gemma":[0.010568164,0.00096966885,0.9680221,0.015161619,0.0022435857,0.0000031159673,0.000030010422,0.0014463629,0.000066651926,0.000057400997,0.0011597475,0.0002715785],"about_ca_topic_score_codex":0.00002101083,"about_ca_topic_score_gemma":0.000003059492,"teacher_disagreement_score":0.045789596,"about_ca_system_score_codex":0.000007170547,"about_ca_system_score_gemma":0.00006192194,"threshold_uncertainty_score":0.21541455},"labels":[],"label_agreement":null},{"id":"W4405054281","doi":"10.1182/blood-2024-193412","title":"Toxicities and Financial Costs Associated with CNS Prophylaxis in Diffuse Large B-Cell Lymphoma: A Retrospective Analysis in Nova Scotia, Canada","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Nova scotia; Diffuse large B-cell lymphoma; Medicine; Retrospective cohort study; Lymphoma; Internal medicine; Geography","score_opus":0.0043218550418726125,"score_gpt":0.20316452600366472,"score_spread":0.19884267096179212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405054281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966263,0.0020317351,0.0000014194288,0.00014933554,0.00004786234,0.00035818553,0.00019459521,0.000026899917,0.00056366477],"genre_scores_gemma":[0.9995079,0.000036544167,0.00002001611,0.00010646418,0.000028988685,0.00003756607,0.00006381144,0.000019915073,0.00017876575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987704,0.0000347756,0.00021688185,0.00038145218,0.00028103605,0.0003154251],"domain_scores_gemma":[0.999571,0.00009446154,0.000039760616,0.00015901016,0.00004544922,0.00009028178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001078486,0.00018856952,0.00047342005,0.00034280852,0.0000299728,0.000038548293,0.000037078225,0.00008607969,0.000022679138],"category_scores_gemma":[0.0000962144,0.0001470871,0.00006259502,0.0014129982,0.00003619024,0.000047424543,0.00003044211,0.0001006297,0.0000023631549],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050567956,0.008539816,0.9862011,0.00004960626,0.0005445594,0.0031747916,0.00059903204,8.713741e-7,0.000045273973,0.00007193414,0.00012363955,0.0005987751],"study_design_scores_gemma":[0.018719926,0.000488308,0.97774845,0.00030206805,0.0009578468,0.000017405844,0.00018512075,0.00009977838,0.0012801884,0.000009696756,0.000035228735,0.00015597999],"about_ca_topic_score_codex":0.44940165,"about_ca_topic_score_gemma":0.98228806,"teacher_disagreement_score":0.53288645,"about_ca_system_score_codex":0.0011948961,"about_ca_system_score_gemma":0.0008002665,"threshold_uncertainty_score":0.5998038},"labels":[],"label_agreement":null},{"id":"W4405054344","doi":"10.1182/blood-2024-206600","title":"Pyruvate Kinase Activators in Sickle Cell Anemia: A Systematic Review and Single-Arm Meta-Analysis","year":2024,"lang":"en","type":"review","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Pyruvate kinase; Medicine; Meta-analysis; Sickle cell anemia; Internal medicine; Glycolysis; Disease; Metabolism","score_opus":0.04600964297127218,"score_gpt":0.30333121229423116,"score_spread":0.25732156932295897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405054344","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000020582554,0.99488646,9.673547e-7,0.00017756312,0.00004494237,0.0033601697,0.000053922817,0.00007637224,0.0013790244],"genre_scores_gemma":[0.00010129539,0.9970296,0.000042571395,0.00028705073,0.000022923063,0.00041745737,0.0001064662,0.00009367243,0.0018989475],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99666756,0.00034630208,0.0015103994,0.00075193145,0.0003413158,0.0003824825],"domain_scores_gemma":[0.99821967,0.00016248178,0.000507403,0.0008332969,0.000051456052,0.00022568861],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006914585,0.00072746474,0.010634303,0.0007102202,0.00003938351,0.00005239467,0.00017309772,0.00055191485,0.00018825135],"category_scores_gemma":[0.00019304689,0.00041173902,0.0032263484,0.0025513899,0.00005958897,0.000043730673,0.000111937115,0.0009798076,0.00014554517],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[8.9591157e-7,0.0007163631,4.375995e-7,0.9362614,0.061578203,0.0005345873,0.00004369073,1.156735e-7,0.000001034603,0.000007297329,0.00019664051,0.00065933645],"study_design_scores_gemma":[0.0002865632,0.000099483506,3.233065e-8,0.17297642,0.79865104,0.0001062032,0.000035972396,7.268617e-7,0.0000034446336,0.0000050413396,0.027533162,0.00030192104],"about_ca_topic_score_codex":0.000040527084,"about_ca_topic_score_gemma":0.000009430125,"teacher_disagreement_score":0.763285,"about_ca_system_score_codex":0.00008085249,"about_ca_system_score_gemma":0.00019862386,"threshold_uncertainty_score":0.99983346},"labels":[],"label_agreement":null},{"id":"W4405054375","doi":"10.1182/blood-2024-203534","title":"Exploring Physician-Related Transfusion Errors Reported to the Transfusion Error Surveillance System (TESS) from 2016-2023: A Single Centre Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Blood Services; University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Blood transfusion; Transfusion reaction; Emergency medicine; Surgery","score_opus":0.05544102885155802,"score_gpt":0.25874631995069564,"score_spread":0.2033052910991376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405054375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98415,0.0010942931,0.0004070212,0.0046849796,0.0017264351,0.003471296,0.00005471809,0.00090519886,0.0035060693],"genre_scores_gemma":[0.9974856,0.00022990926,0.00008417482,0.00025221732,0.00029775707,0.00021575784,0.00006756297,0.00009353178,0.0012735387],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9968897,0.00020445995,0.00074459595,0.00093959563,0.0007524168,0.00046924586],"domain_scores_gemma":[0.99865454,0.00010598507,0.00006901133,0.0008330844,0.00009832849,0.00023903573],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005539855,0.0003932933,0.0005743718,0.00020373812,0.00024756495,0.00009079453,0.00022358065,0.00009879681,0.00017861283],"category_scores_gemma":[0.000022765063,0.00027466327,0.00028890063,0.0010640342,0.000031308682,0.00016449271,0.00005548744,0.00040777895,0.0003828894],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028251652,0.039659515,0.028781818,0.0041193888,0.014255488,0.014625219,0.14464135,0.0006651895,0.55495113,0.00079635263,0.013805925,0.18087347],"study_design_scores_gemma":[0.06994138,0.008674201,0.41386536,0.024253722,0.024747942,0.00049763435,0.20818825,0.005925074,0.081625454,0.00008880388,0.15696481,0.005227383],"about_ca_topic_score_codex":0.0011222949,"about_ca_topic_score_gemma":0.0014008061,"teacher_disagreement_score":0.47332567,"about_ca_system_score_codex":0.00008147886,"about_ca_system_score_gemma":0.000069699076,"threshold_uncertainty_score":0.99997056},"labels":[],"label_agreement":null},{"id":"W4405054422","doi":"10.1182/blood-2024-209506","title":"Decoding Transcriptomic Landscape and Molecular Pathways in DNAJC21 Deficiency","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Transcriptome; Biology; Computational biology; Genetics; Gene; Gene expression","score_opus":0.007205983887128249,"score_gpt":0.21282890910023755,"score_spread":0.2056229252131093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405054422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98325104,0.013722767,0.00089913595,0.000039639737,0.000095758005,0.000094476025,0.000008399071,0.0000335107,0.0018552517],"genre_scores_gemma":[0.998729,0.00023501719,0.00082477916,0.000078283934,0.00003567419,0.000015356194,0.000016157748,0.000020714155,0.000045002165],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99928695,0.00002367635,0.0001166877,0.0003202689,0.00006735761,0.00018505969],"domain_scores_gemma":[0.99978,0.000005303029,0.000009898381,0.00015199356,0.000008110362,0.000044718065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013568549,0.000102182355,0.00008069513,0.000060216717,0.00001990469,0.000037472026,0.00008412704,0.00009380403,0.000008585192],"category_scores_gemma":[0.00001764184,0.000100163365,0.000049638522,0.00008808024,0.000016962664,0.0000031324996,0.00003899878,0.00006745396,0.0000069969087],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000048705374,0.000052306572,0.0008994211,0.000044327895,0.000014172294,0.000079010635,0.00008460401,0.0000036278914,0.9967064,0.0012808739,0.00003861971,0.0007917458],"study_design_scores_gemma":[0.00060836767,0.00013946158,0.00036827603,0.00004294512,0.000032036955,0.000087828645,0.00007039466,0.000387871,0.9963747,0.00066474907,0.0010527071,0.00017065405],"about_ca_topic_score_codex":0.0000032139849,"about_ca_topic_score_gemma":0.000015242675,"teacher_disagreement_score":0.015477954,"about_ca_system_score_codex":0.0000034089562,"about_ca_system_score_gemma":0.000037371323,"threshold_uncertainty_score":0.40845436},"labels":[],"label_agreement":null},{"id":"W4405054563","doi":"10.1182/blood-2024-211783","title":"Clinical Relevance of NPM1 Quantitative PCR As Standard of Care with Different Cut-Off Values on Treatment Outcomes in NPM1-Mutated Acute Myeloid Leukemia Patients","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"NPM1; Myeloid leukemia; Medicine; Clinical significance; Internal medicine; Oncology; Immunology; Biology; Genetics; Gene; Karyotype","score_opus":0.027230533196165852,"score_gpt":0.3658810064137878,"score_spread":0.33865047321762193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405054563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99596226,0.0009929758,0.000012982976,0.00023861561,0.00014219634,0.0012333068,0.0004412486,0.000070392096,0.0009060229],"genre_scores_gemma":[0.9961958,0.0017592317,0.0009087151,0.000052965926,0.000035631307,0.00007412944,0.00020060723,0.00006999611,0.00070295634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968789,0.00022769863,0.00088005525,0.00062613626,0.00096873974,0.00041847277],"domain_scores_gemma":[0.99766517,0.0009945611,0.00018963453,0.00054958975,0.000410406,0.00019064458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002179578,0.00038938125,0.00133908,0.00034298724,0.00003591991,0.00001682413,0.00018252028,0.00017994047,0.000034134682],"category_scores_gemma":[0.00038336727,0.00023385572,0.00026539637,0.00044663265,0.00029591357,0.000082753075,0.000082765575,0.0005012421,0.000027215949],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0156551,0.0038702644,0.93897223,0.0011943347,0.0046731886,0.0012843728,0.0084553845,0.00004221829,0.0014656448,0.00062949397,0.00028719663,0.023470579],"study_design_scores_gemma":[0.059987254,0.11279876,0.64562905,0.005763866,0.0029782264,0.0000345544,0.0036282465,0.0004264398,0.16667697,0.00031122068,0.0010247185,0.0007407028],"about_ca_topic_score_codex":0.00019469587,"about_ca_topic_score_gemma":0.00017478851,"teacher_disagreement_score":0.2933432,"about_ca_system_score_codex":0.00122912,"about_ca_system_score_gemma":0.0011363932,"threshold_uncertainty_score":0.953636},"labels":[],"label_agreement":null},{"id":"W4405054578","doi":"10.1182/blood-2024-209898","title":"Race and Ethnicity As a Category Poses Challenges in Global Registries: Experience from the Waustim Project of the Worldwide Network for Blood and Marrow Transplantation, WBMT","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre; McMaster University","funders":"","keywords":"Ethnic group; Race (biology); Medicine; Transplantation; Bone marrow transplantation; Gerontology; Intensive care medicine; Internal medicine; Political science; Sociology; Gender studies","score_opus":0.04027168034174183,"score_gpt":0.31806732044687624,"score_spread":0.2777956401051344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405054578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9663821,0.029775763,0.000054327025,0.0024204608,0.00007897074,0.0007389937,0.00017945096,0.000021500664,0.00034843534],"genre_scores_gemma":[0.9849076,0.014253343,0.00042046432,0.000116744355,0.000057253397,0.00008414733,0.000025916706,0.000008748989,0.0001257296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99923617,0.000053241612,0.00019717692,0.00023705879,0.00013817352,0.0001381617],"domain_scores_gemma":[0.9993169,0.00042808783,0.000045666387,0.00015218569,0.000025006544,0.000032177588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011425915,0.00012221064,0.00019642217,0.000016398886,0.000065736785,0.000022073913,0.00006889224,0.00005239024,0.000004194327],"category_scores_gemma":[0.000036059428,0.00006575205,0.000051644467,0.0001716507,0.00011467414,0.000054412867,0.000010439587,0.00008175092,3.400246e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001717525,0.0007922735,0.9276011,0.0033603131,0.0014884367,0.00045651846,0.048767358,0.00003990862,0.001313864,0.0064900466,0.0001976499,0.0077749765],"study_design_scores_gemma":[0.010141457,0.0005626432,0.9659088,0.0036385225,0.0028196208,0.0007062451,0.0040548053,0.0000894886,0.0073993267,0.0034511036,0.0009777517,0.0002502318],"about_ca_topic_score_codex":0.00085954904,"about_ca_topic_score_gemma":0.0010610446,"teacher_disagreement_score":0.044712555,"about_ca_system_score_codex":0.000008205423,"about_ca_system_score_gemma":0.00008509125,"threshold_uncertainty_score":0.26812908},"labels":[],"label_agreement":null},{"id":"W4405054612","doi":"10.1182/blood-2024-211127","title":"Type 2 Diabetes Mellitus Increases the Risk for Developing Monoclonal Gammopathy of Undetermined Significance in Asian Populations","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"","keywords":"Monoclonal gammopathy of undetermined significance; Medicine; Hazard ratio; Internal medicine; Multiple myeloma; Epidemiology; Type 2 Diabetes Mellitus; Diabetes mellitus; Immunology; Endocrinology; Monoclonal; Confidence interval; Antibody","score_opus":0.03979018242069634,"score_gpt":0.3232370056004411,"score_spread":0.2834468231797448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405054612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99306846,0.0053262697,0.00012538696,0.00044644886,0.00009561958,0.0005764312,0.000041268446,0.000031167318,0.00028898023],"genre_scores_gemma":[0.99692845,0.00021121989,0.0024081382,0.000023613482,0.00013615863,0.000088301495,0.000030204901,0.00002096888,0.00015294412],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99906397,0.000049055187,0.00024439025,0.0002031503,0.00019959785,0.00023981837],"domain_scores_gemma":[0.99905545,0.00046508788,0.00005438475,0.00030119243,0.00007711636,0.000046745066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037076804,0.000094613875,0.00020000736,0.00010569175,0.00007326917,0.000031335258,0.00014108526,0.000055215613,0.000011718897],"category_scores_gemma":[0.00087186066,0.00006595467,0.00007143908,0.0002490439,0.000096732474,0.00005066212,0.00004450089,0.00012246324,0.000007282645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021938016,0.0046577817,0.5291777,0.014593686,0.0033887706,0.0013471873,0.0073960987,0.00040663066,0.041670643,0.04568802,0.0038171026,0.34566253],"study_design_scores_gemma":[0.05065835,0.0015351779,0.64014876,0.0056371856,0.0021793728,0.00023685576,0.00087334635,0.1256349,0.13559707,0.025908446,0.0105427485,0.0010477775],"about_ca_topic_score_codex":0.00077332807,"about_ca_topic_score_gemma":0.0003096579,"teacher_disagreement_score":0.34461474,"about_ca_system_score_codex":0.00073396915,"about_ca_system_score_gemma":0.003432686,"threshold_uncertainty_score":0.60894376},"labels":[],"label_agreement":null},{"id":"W4405054655","doi":"10.1182/blood-2024-204112","title":"Health-Related Quality-of-Life Improvements after Exagamglogene Autotemcel in Patients with Severe Sickle Cell Disease","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Disease; Medicine; Quality of life (healthcare); Sickle cell anemia; Pediatrics; Intensive care medicine; Internal medicine","score_opus":0.007597886805489323,"score_gpt":0.23644219039796543,"score_spread":0.22884430359247612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405054655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910208,0.006413771,0.000006136672,0.00064099097,0.00015147397,0.00074679416,0.00007983753,0.00007950746,0.00086068007],"genre_scores_gemma":[0.9984014,0.000085120206,0.00008361466,0.00048369216,0.000017939401,0.000033056487,0.00010656527,0.000040714487,0.0007479084],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982828,0.000084126405,0.0006057266,0.00034325957,0.0003478885,0.00033620207],"domain_scores_gemma":[0.99917996,0.000031489813,0.00010268464,0.00029083976,0.00005111587,0.00034390125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023075877,0.00018845787,0.00039508528,0.00013978247,0.000030182386,0.000012366377,0.00006190464,0.00011347708,0.00014401846],"category_scores_gemma":[0.00003707375,0.00013898857,0.00009148143,0.00037055006,0.00005186074,0.0000646475,0.000041115847,0.0002643219,0.000050850107],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002096495,0.0061471276,0.97820354,0.0043952544,0.00037073708,0.00018684797,0.0012174201,0.000041903484,0.0002827274,0.000052523003,0.00043355132,0.0065718573],"study_design_scores_gemma":[0.021023225,0.0015663903,0.9740653,0.0013459179,0.00032425608,0.0000030869703,0.0001839367,0.00013494965,0.00025446102,0.00007645733,0.0006382203,0.00038376948],"about_ca_topic_score_codex":0.00027293575,"about_ca_topic_score_gemma":0.000016717151,"teacher_disagreement_score":0.01892673,"about_ca_system_score_codex":0.000053718864,"about_ca_system_score_gemma":0.00049799023,"threshold_uncertainty_score":0.56677896},"labels":[],"label_agreement":null},{"id":"W4405054674","doi":"10.1182/blood-2024-207949","title":"Pharmacokinetics of Plasminogen, Human-Tvmh in Subjects with Plasminogen Deficiency Type 1","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Medicine; Pharmacokinetics; Internal medicine","score_opus":0.012225510787651129,"score_gpt":0.25308323069250677,"score_spread":0.24085771990485563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405054674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938069,0.0035289468,0.00006782151,0.000011206408,0.00011242428,0.00016796785,0.00001915647,0.000016968277,0.0022686312],"genre_scores_gemma":[0.99901134,0.00012628552,0.0004026557,0.00003723105,0.00012400918,0.000014580815,0.00004095111,0.000024174695,0.00021879023],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99919677,0.000022439823,0.00016924381,0.0002807319,0.00012858423,0.00020222247],"domain_scores_gemma":[0.9996798,0.0000063899383,0.000033171917,0.0001907734,0.000043293683,0.000046584366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009032831,0.00012968088,0.00011428789,0.000074145995,0.000024122075,0.000013746096,0.00013522214,0.00009561845,0.000027888145],"category_scores_gemma":[0.000013686782,0.000111036374,0.00004066348,0.00019088443,0.000040473955,0.0000037529896,0.000057671987,0.00008604519,0.000012761455],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004250852,0.00019126778,0.0010599415,0.00008180576,0.000036526766,0.000047947524,0.000048403705,0.000015766756,0.9977468,0.0002883815,0.0002742142,0.00016641409],"study_design_scores_gemma":[0.00078948436,0.0007931119,0.00016455668,0.00007039062,0.000056900666,0.000038478684,0.000020227908,0.000029712193,0.99619716,0.00009546776,0.0015948642,0.00014963187],"about_ca_topic_score_codex":0.000013481651,"about_ca_topic_score_gemma":0.000022259232,"teacher_disagreement_score":0.0052044443,"about_ca_system_score_codex":0.0000051387096,"about_ca_system_score_gemma":0.00009977254,"threshold_uncertainty_score":0.45279318},"labels":[],"label_agreement":null},{"id":"W4405054702","doi":"10.1182/blood-2024-210641","title":"Diagnostic Test Accuracy of Fat Pad Sampling and Bone Marrow Biopsies in the Diagnosis of AL Amyloidosis: A Systematic Review and Meta-Analysis","year":2024,"lang":"en","type":"review","venue":"Blood","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Biopsy; Amyloidosis; AL amyloidosis; Gold standard (test); Grading (engineering); Pathology; Radiology","score_opus":0.06069720206845373,"score_gpt":0.34884577880292644,"score_spread":0.2881485767344727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405054702","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012179301,0.9946303,0.0000023722555,0.00032092302,0.000017079461,0.0028785777,0.0009149249,0.000009983651,0.000007906157],"genre_scores_gemma":[0.0120742,0.98251116,0.00016632526,0.00031513686,0.00002252315,0.004613073,0.00021176372,0.000059763548,0.0000260773],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99623394,0.00060811377,0.0017380241,0.00080969225,0.00030595472,0.0003042885],"domain_scores_gemma":[0.9922807,0.005255029,0.001206871,0.0010889217,0.0000893497,0.000079122336],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008684501,0.0007528839,0.006431136,0.00034053143,0.00004845244,0.00006316874,0.0004633359,0.00028476334,0.00001882984],"category_scores_gemma":[0.007020197,0.00042190132,0.0021016153,0.0009500737,0.00018296807,0.000009246239,0.0003592833,0.00021884622,0.000003960217],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000014007715,0.00071127247,0.004056172,0.8692518,0.12471694,0.000031462943,0.00008917605,4.2474278e-7,0.000021706199,0.000015608128,0.0002506392,0.00085343764],"study_design_scores_gemma":[0.00024025772,0.00016543949,0.00014375798,0.039771724,0.95509416,0.00007606142,0.000080551785,2.55805e-7,0.00011648689,0.000009041084,0.0038984348,0.00040384734],"about_ca_topic_score_codex":0.000079953716,"about_ca_topic_score_gemma":0.0001219552,"teacher_disagreement_score":0.8303772,"about_ca_system_score_codex":0.000014772106,"about_ca_system_score_gemma":0.00006725757,"threshold_uncertainty_score":0.9998233},"labels":[],"label_agreement":null},{"id":"W4405054865","doi":"10.1182/blood-2024-201793","title":"Intravenous Albumin Utilization: A Multi-Center Audit of 607,304 Admissions at 16 Hospitals","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Clinical Laboratory Practices and Quality Control","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; Queen's University; McMaster University; Canadian Blood Services; University of Calgary; Impact; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Audit; Emergency medicine; Center (category theory); Utilization management; Internal medicine; Business; Chemistry; Health care; Political science; Accounting","score_opus":0.07516182199893771,"score_gpt":0.38196395641944114,"score_spread":0.3068021344205034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405054865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97502977,0.008988194,0.00046802947,0.010936169,0.00064267794,0.000720505,0.00023730924,0.00017964556,0.0027976802],"genre_scores_gemma":[0.9939498,0.00041586618,0.0005286305,0.0010396783,0.00029213776,0.000016044336,0.000056840327,0.000026566027,0.003674455],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987615,0.00008047587,0.0004737183,0.0002808077,0.00022201918,0.0001815045],"domain_scores_gemma":[0.9987654,0.0003869908,0.000108596025,0.00032942317,0.00013418852,0.00027537456],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032274978,0.00012645195,0.0003281244,0.000043813357,0.00005006909,0.00002346959,0.000074264084,0.00012327518,0.0017791295],"category_scores_gemma":[0.0015237564,0.000098226876,0.00014568429,0.00021960225,0.000046771398,0.00008591324,0.00006210599,0.00019608733,0.00018260902],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046035475,0.114301845,0.2563078,0.012561903,0.012092572,0.0054703434,0.012013757,0.000012817721,0.17633276,0.028870808,0.17540942,0.20202242],"study_design_scores_gemma":[0.019861076,0.0020646637,0.022665149,0.0017503819,0.0022848307,0.00018530159,0.00039076098,0.0009894785,0.021290567,0.0001547004,0.9278996,0.00046350257],"about_ca_topic_score_codex":0.000015810343,"about_ca_topic_score_gemma":0.00003384331,"teacher_disagreement_score":0.75249016,"about_ca_system_score_codex":0.00003383369,"about_ca_system_score_gemma":0.00023976609,"threshold_uncertainty_score":0.9991334},"labels":[],"label_agreement":null},{"id":"W4405054868","doi":"10.1182/blood-2024-211689","title":"Monocytic Leukemia Cell Resistance to Ferroptosis Is Overcome By Iron Chelation","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"","keywords":"Leukemia; Deferiprone; Acquired resistance; Cancer research; Medicine; Resistance (ecology); Biology; Immunology; Deferoxamine; Internal medicine; Cancer","score_opus":0.008363419407690418,"score_gpt":0.24440411026741962,"score_spread":0.2360406908597292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405054868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94257015,0.012211591,0.00026650657,0.0020338842,0.00019399666,0.00028483244,0.00005829421,0.00014295494,0.042237785],"genre_scores_gemma":[0.96033174,0.00024406583,0.00080436206,0.0011624757,0.00012459382,0.000016956188,0.000042223706,0.000029360985,0.0372442],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990949,0.000014058537,0.00018179967,0.0002949844,0.00021281309,0.00020143861],"domain_scores_gemma":[0.9995494,0.000026447686,0.000020470148,0.00026088333,0.000020270018,0.00012256888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000087341905,0.00012449581,0.00016091093,0.00008543948,0.000039634713,0.000034762328,0.00005969921,0.00007989484,0.00016528995],"category_scores_gemma":[0.000029667364,0.000113538495,0.00006685169,0.00025446445,0.000015766076,0.000076705925,0.00002156529,0.000120816236,0.00059447123],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005517632,0.0007912602,0.004852282,0.0027461878,0.00008154569,0.00009674259,0.004838637,0.00003705708,0.27342913,0.0013148931,0.7062673,0.0049931975],"study_design_scores_gemma":[0.009345621,0.00033290844,0.025192795,0.0004097915,0.0014506534,0.000012643434,0.00053475174,0.00024215716,0.31029686,0.000522506,0.6509205,0.00073881197],"about_ca_topic_score_codex":0.000045971123,"about_ca_topic_score_gemma":0.0000055975647,"teacher_disagreement_score":0.055346806,"about_ca_system_score_codex":0.000073119176,"about_ca_system_score_gemma":0.000097281,"threshold_uncertainty_score":0.7640924},"labels":[],"label_agreement":null},{"id":"W4405054871","doi":"10.1182/blood-2024-207258","title":"Mondoa Promotes Resistance to Asparaginase Treatment in B-ALL By Inducing Asparagine Synthesis","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Plant tissue culture and regeneration","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Asparaginase; Asparagine; Biology; Chemistry; Cancer research; Medicine; Biochemistry; Leukemia; Genetics; Enzyme; Lymphoblastic Leukemia","score_opus":0.014199752098867958,"score_gpt":0.25273245167802727,"score_spread":0.23853269957915932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405054871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9790489,0.018470513,0.000104305946,0.001228217,0.00006810124,0.00022259628,0.000057436595,0.000024252147,0.0007756506],"genre_scores_gemma":[0.99290234,0.0002624823,0.0003998885,0.000078917175,0.00016342531,0.00013042788,0.00015833459,0.000015283107,0.0058889166],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993231,0.00002814944,0.00011251985,0.00031733996,0.000060186154,0.00015865546],"domain_scores_gemma":[0.9997508,0.000010539906,0.000013485861,0.00015450004,0.000012860967,0.00005780975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000059571732,0.0001234476,0.000103713355,0.00004009714,0.00002576269,0.000038237034,0.00006743833,0.000086444394,0.000006248775],"category_scores_gemma":[0.000031969546,0.00009756742,0.000033068703,0.00009341246,0.000010033544,0.0000036965905,0.000017609322,0.000038642364,0.000022902315],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016575055,0.00017071317,0.00023958752,0.000023299002,0.000070238566,0.000065917506,0.00014360447,0.000022792707,0.9875987,0.000023723582,0.01035746,0.001267348],"study_design_scores_gemma":[0.00018733302,0.00009268417,0.00009614646,0.000055852197,0.000039171206,0.000015108561,0.000009466189,0.00001179995,0.83279467,0.0000071381755,0.16657628,0.00011432646],"about_ca_topic_score_codex":0.00013078388,"about_ca_topic_score_gemma":0.0014895424,"teacher_disagreement_score":0.15621883,"about_ca_system_score_codex":0.000020142688,"about_ca_system_score_gemma":0.00005197946,"threshold_uncertainty_score":0.3978684},"labels":[],"label_agreement":null},{"id":"W4405054898","doi":"10.1182/blood-2024-200922","title":"An Investigation of Potential Treatment Effect Modifiers in Multiple Myeloma from Published Randomized Controlled Trials","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Multiple myeloma; Randomized controlled trial; Medicine; Pomalidomide; Oncology; Internal medicine; Lenalidomide","score_opus":0.028807039254962724,"score_gpt":0.31619278271171614,"score_spread":0.2873857434567534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405054898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910395,0.0023666327,0.00009999427,0.00029408434,0.00019478562,0.005635712,0.000105304745,0.00009378916,0.00017020688],"genre_scores_gemma":[0.99695945,0.00013823238,0.000712391,0.000014219582,0.00021387704,0.0011247881,0.00069108687,0.000028789762,0.00011719476],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9955061,0.002227993,0.0010667205,0.0004333076,0.0004744444,0.0002914162],"domain_scores_gemma":[0.994868,0.0042338893,0.00017894447,0.00035687108,0.000077162345,0.00028513104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030827788,0.00028150604,0.003329787,0.00049454044,0.0000354115,0.0001086163,0.000083105566,0.00015129846,0.00019182244],"category_scores_gemma":[0.0041329097,0.00015259776,0.00086615153,0.00025711817,0.00012438068,0.00021133888,0.000015262545,0.00013634274,0.000018774988],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.61992866,0.0026046117,0.076243415,0.00025208807,0.013154321,0.0013099712,0.0013506522,0.00007114957,0.26341733,0.00008232953,0.00006797349,0.021517511],"study_design_scores_gemma":[0.85007066,0.0013302085,0.017722309,0.00024136773,0.0028908583,0.00000891806,0.0000404517,0.028874438,0.09833158,0.00037267213,0.00000385465,0.00011267949],"about_ca_topic_score_codex":0.002301253,"about_ca_topic_score_gemma":0.00009345726,"teacher_disagreement_score":0.23014203,"about_ca_system_score_codex":0.000101270314,"about_ca_system_score_gemma":0.00027074717,"threshold_uncertainty_score":0.6222756},"labels":[],"label_agreement":null},{"id":"W4405054908","doi":"10.1182/blood-2024-204241","title":"Ability of Coagulation Tests to Assess Hemotherapeutic Agent Response Testing","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Clinical Laboratory Practices and Quality Control","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Coagulation testing; Coagulation; Internal medicine","score_opus":0.20069764224238876,"score_gpt":0.4428928880269864,"score_spread":0.24219524578459764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405054908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944242,0.00031454372,0.00027204116,0.004117061,0.00010803114,0.00033897668,0.000014197876,0.00008352216,0.00032741143],"genre_scores_gemma":[0.99651116,0.0000022013646,0.0022904107,0.00094999734,0.000116323776,0.000009637873,0.0000022957236,0.000013324933,0.0001046411],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998864,0.00023015469,0.00036789797,0.00021701456,0.00020718512,0.00011372795],"domain_scores_gemma":[0.9954592,0.0039078775,0.00006289787,0.00028374928,0.00017519841,0.000111074994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018536792,0.000076312,0.00021457412,0.00005278335,0.00002354144,0.000025882826,0.00004252533,0.00005775158,0.00007114668],"category_scores_gemma":[0.0059539997,0.000063322856,0.000059852304,0.00037215822,0.000024237534,0.00006281332,0.000019651769,0.00013505138,0.000040354655],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015186334,0.0013055485,0.106162995,0.0005327455,0.0002007763,0.000069697155,0.000436394,0.000020499618,0.86302304,0.00032470838,0.00008803365,0.02631695],"study_design_scores_gemma":[0.0019481498,0.0012545182,0.96764725,0.0004311355,0.00046469446,0.00002463178,0.00008036566,0.0016483237,0.011667287,0.00024071938,0.014459391,0.00013354051],"about_ca_topic_score_codex":0.000020035935,"about_ca_topic_score_gemma":0.0000058516957,"teacher_disagreement_score":0.8614842,"about_ca_system_score_codex":0.000023496996,"about_ca_system_score_gemma":0.00019726375,"threshold_uncertainty_score":0.7127924},"labels":[],"label_agreement":null},{"id":"W4405054916","doi":"10.1182/blood-2024-209033","title":"Substantial Variability in Platelet Transfusion Practice in a Patient-Level Audit of 56,204 Transfusions across 22 Hospitals","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto; Canadian Blood Services; McMaster University; Queen's University","funders":"","keywords":"Medicine; Audit; Platelet transfusion; Emergency medicine; Blood transfusion; Platelet; Internal medicine; Intensive care medicine; Pediatrics","score_opus":0.013065918398488004,"score_gpt":0.28522593909013666,"score_spread":0.27216002069164863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405054916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888772,0.0009254236,0.00074988103,0.0025065478,0.00039058784,0.0016238245,0.00016085367,0.00010104252,0.0046646358],"genre_scores_gemma":[0.99586797,0.0026148255,0.0010147835,0.00023206361,0.00005466352,0.000076584976,0.000028691551,0.000037343318,0.00007309143],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99743885,0.00020820792,0.00079954515,0.00059862074,0.0005146508,0.0004401015],"domain_scores_gemma":[0.9989107,0.00040539366,0.00005709695,0.0004081722,0.00008543233,0.0001332036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012319664,0.00024719437,0.0005119623,0.0002592481,0.000050888022,0.000027357315,0.00012702626,0.00020986679,0.00041753877],"category_scores_gemma":[0.0002813478,0.00022370476,0.00023175598,0.0010476037,0.00008950332,0.00024161483,0.00003969029,0.0005348802,0.000017455302],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056819017,0.052005395,0.02670862,0.0070448183,0.0019952226,0.0129683595,0.14598516,0.00013525508,0.2164145,0.011676072,0.0010335376,0.51835114],"study_design_scores_gemma":[0.11256976,0.00963462,0.43962345,0.010579623,0.0053349477,0.0013955394,0.029915288,0.0014553674,0.24501526,0.0024142948,0.13867767,0.0033841694],"about_ca_topic_score_codex":0.001082034,"about_ca_topic_score_gemma":0.0015514687,"teacher_disagreement_score":0.51496696,"about_ca_system_score_codex":0.000050800198,"about_ca_system_score_gemma":0.00021641472,"threshold_uncertainty_score":0.9122415},"labels":[],"label_agreement":null},{"id":"W4405054980","doi":"10.1182/blood-2024-206087","title":"Unveiling Mysteries: Novel Germline Mutations in Children with Bone Marrow Failure Syndrome and Hematologic Malignancy of Arab Ancestry","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hematologic malignancy; Germline; Bone marrow; Hematologic Neoplasms; Malignancy; Germline mutation; Medicine; Bone marrow failure; Mutation; Internal medicine; Cancer research; Genetics; Haematopoiesis; Biology; Cancer; Stem cell; Gene","score_opus":0.014302581647321694,"score_gpt":0.26423956382936464,"score_spread":0.24993698218204294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405054980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99584496,0.002531097,0.00046826503,0.0004698808,0.000016852064,0.0004137619,0.000054272343,0.00006186251,0.00013905982],"genre_scores_gemma":[0.99435097,0.000045902583,0.005213444,0.00003172083,0.00002958856,0.000042453205,0.000047635516,0.000027399277,0.0002109017],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998841,0.000016934882,0.00030183635,0.00031987962,0.00026494343,0.00025544318],"domain_scores_gemma":[0.9994912,0.00010510241,0.000050721676,0.00020974567,0.000052556697,0.00009068851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012936689,0.000150205,0.00036878165,0.00021609546,0.000027250213,0.00002332781,0.0000677969,0.0001062669,0.00004198679],"category_scores_gemma":[0.0000647774,0.00011136749,0.00003341514,0.0005053598,0.0001771413,0.00010158798,0.000051319443,0.00021763254,0.000009977827],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039520048,0.002722978,0.8474577,0.0076950938,0.0017743373,0.010899613,0.0027591751,0.00011331326,0.123058975,0.0019474756,0.00028403453,0.0008920761],"study_design_scores_gemma":[0.042140316,0.0037106185,0.6778692,0.01573385,0.0017864672,0.20605725,0.0024822282,0.007147408,0.041105222,0.00061099115,0.00016881182,0.0011876237],"about_ca_topic_score_codex":0.000050601113,"about_ca_topic_score_gemma":0.000020714378,"teacher_disagreement_score":0.19515765,"about_ca_system_score_codex":0.00005514642,"about_ca_system_score_gemma":0.00038836498,"threshold_uncertainty_score":0.45414343},"labels":[],"label_agreement":null},{"id":"W4405054996","doi":"10.1182/blood-2024-211186","title":"High-Dimensional Single-Cell Analysis of Clinical-Grade Flow Cytometry Explains the Unpredictable Complex Shifts of Patient-Specific Immunophenotypes during B-ALL Relapse Progression","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Flow cytometry; Immunophenotyping; Medicine; Immunology","score_opus":0.03589947275361183,"score_gpt":0.3035207173792604,"score_spread":0.26762124462564857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405054996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901196,0.0083228415,0.000019939585,0.00015006268,0.0003384008,0.00048088437,0.00014695748,0.000101479265,0.00031983],"genre_scores_gemma":[0.9934856,0.0002635151,0.0054589207,0.00003251764,0.00013307373,0.000024898101,0.00038901894,0.000047542293,0.00016487786],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99692655,0.00017308335,0.0012097228,0.0005296756,0.00081412354,0.00034682945],"domain_scores_gemma":[0.997958,0.0005772027,0.0003577432,0.00084377907,0.00012198428,0.00014130109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004003707,0.0002707824,0.0009152496,0.00047121634,0.00009303913,0.000021346814,0.00020046285,0.00017298524,0.00042172562],"category_scores_gemma":[0.00010604712,0.00017724001,0.00053262524,0.001502693,0.00021486687,0.00008393826,0.00018171174,0.0003808323,0.00002626274],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031073035,0.032329913,0.1563946,0.002610843,0.037074905,0.0013709413,0.00521628,0.003221176,0.7245601,0.00038976767,0.003030887,0.030693278],"study_design_scores_gemma":[0.036846418,0.0050248345,0.48124138,0.0036666046,0.032990094,0.00011881936,0.000855153,0.015871488,0.41814533,0.00016160068,0.004112423,0.0009658512],"about_ca_topic_score_codex":0.00006520124,"about_ca_topic_score_gemma":0.000008215532,"teacher_disagreement_score":0.32484677,"about_ca_system_score_codex":0.00017598734,"about_ca_system_score_gemma":0.0002062952,"threshold_uncertainty_score":0.72276384},"labels":[],"label_agreement":null},{"id":"W4405092569","doi":"10.1182/blood-2024-211475","title":"Comparative Real-World Outcomes of Commercial CD19-Directed CAR T-Cell Therapies in Large B-Cell Lymphoma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Lymphoma; Medicine; CD19; Immunology; Cancer research; Internal medicine; Antibody","score_opus":0.036435702091213884,"score_gpt":0.3426034512495697,"score_spread":0.3061677491583558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405092569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9288317,0.0026910794,0.0000025045117,0.00035515748,0.00015639912,0.0005927751,0.00006650263,0.00016759761,0.0671363],"genre_scores_gemma":[0.9766642,0.00037695424,0.00018089681,0.00012232007,0.00012040874,0.00004225964,0.00004808174,0.000048574402,0.022396348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998152,0.00018791853,0.00041918436,0.00034188802,0.00046566856,0.00043330068],"domain_scores_gemma":[0.9989744,0.0003361148,0.00005689269,0.0004088133,0.0001070585,0.00011672115],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003858505,0.00023684649,0.000769212,0.00047725116,0.00004232076,0.000029662338,0.00017615464,0.000102855636,0.0010866458],"category_scores_gemma":[0.000017167118,0.00019386664,0.00020323717,0.00084001024,0.00011442354,0.0000595148,0.00007564095,0.00028117053,0.00008361639],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088150264,0.01358926,0.5005364,0.0008681015,0.0010310782,0.0006299902,0.017040143,0.0000015811147,0.45609275,0.00062888477,0.0048084585,0.0038918755],"study_design_scores_gemma":[0.028767966,0.0006982319,0.56538236,0.0003005729,0.0003314378,0.000018527926,0.0012221216,0.00034754476,0.37556365,0.00014065317,0.02679979,0.00042710762],"about_ca_topic_score_codex":0.0011247743,"about_ca_topic_score_gemma":0.002394035,"teacher_disagreement_score":0.08052909,"about_ca_system_score_codex":0.00009840507,"about_ca_system_score_gemma":0.00025501067,"threshold_uncertainty_score":0.9998265},"labels":[],"label_agreement":null},{"id":"W4405092599","doi":"10.1182/blood-2024-211183","title":"Impact of Frailty in a Prospective Cohort of Patients with MDS Treated with Hypomethylating Agents","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; University of Saskatchewan; Queen Elizabeth II Health Sciences Centre; McMaster University; Juravinski Cancer Centre; University of Manitoba; Dr. Georges-L.-Dumont University Hospital Centre; St. Paul's Hospital; University of British Columbia; Sunnybrook Health Science Centre; Jewish General Hospital; University of Alberta; McGill University Health Centre; McGill University; Vancouver General Hospital; Princess Margaret Cancer Centre; University of Calgary; Saskatchewan Cancer Agency; CancerCare Manitoba; Ottawa Hospital; University Health Network; Health Sciences Centre","funders":"","keywords":"Medicine; Hypomethylating agent; Prospective cohort study; Myelodysplastic syndromes; Decitabine; Azacitidine; Cohort; Internal medicine; Oncology; Bone marrow; DNA methylation","score_opus":0.049922493830513934,"score_gpt":0.3743076205833573,"score_spread":0.32438512675284337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405092599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962107,0.0004941595,0.000012525194,0.0000032119196,0.000007875249,0.00043150227,0.000063668514,0.000017753995,0.0027585882],"genre_scores_gemma":[0.9991594,0.000027556278,0.00067316147,0.00000271598,0.000012756508,0.000014346715,0.00003320776,0.000017588649,0.000059269016],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99921143,0.000021298074,0.0002224818,0.00016596417,0.00025330842,0.00012553905],"domain_scores_gemma":[0.99946386,0.00006917781,0.000095513635,0.0001349443,0.00019154404,0.000044937926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007052448,0.000117229065,0.00038620242,0.00015795844,0.000006456146,0.0000026758883,0.000035660818,0.00004372063,0.00003482524],"category_scores_gemma":[0.00008808272,0.00007020728,0.000059683814,0.0005498418,0.00006352167,0.000051422146,0.0000127012845,0.00009631264,9.76027e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037973197,0.00073722046,0.9943894,0.000201539,0.0008453179,0.000030704712,0.0019171294,0.000008615691,0.0010111246,0.000005114177,0.00001055935,0.00046351826],"study_design_scores_gemma":[0.0037485484,0.0026004286,0.97036666,0.0019281061,0.0003204202,0.0000013473331,0.00011251838,0.000029601704,0.020805761,0.000009897698,0.000008154167,0.00006858837],"about_ca_topic_score_codex":0.0006950628,"about_ca_topic_score_gemma":0.000034258923,"teacher_disagreement_score":0.024022797,"about_ca_system_score_codex":0.00004817817,"about_ca_system_score_gemma":0.00010742425,"threshold_uncertainty_score":0.286297},"labels":[],"label_agreement":null},{"id":"W4405092600","doi":"10.1182/blood-2024-202435","title":"Patient Decision Aid for Extended Duration Thromboprophylaxis for Major Abdominopelvic Cancer Surgery: A Usability Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Manitoba; CancerCare Manitoba; University of Ottawa","funders":"","keywords":"Medicine; Usability; Surgery; Cancer; Duration (music); General surgery; Internal medicine; Computer science; Human–computer interaction","score_opus":0.022864974440103276,"score_gpt":0.3138670059016789,"score_spread":0.2910020314615756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405092600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98842305,0.0014044532,0.0015754877,0.00064165937,0.001030148,0.006624786,0.00009529903,0.00012593249,0.000079157915],"genre_scores_gemma":[0.9925858,0.00012722606,0.002580771,0.00020518083,0.0003307334,0.0039808266,0.000045579065,0.000049546517,0.000094358875],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981734,0.000033328324,0.0005424773,0.0006014389,0.00032836752,0.00032098827],"domain_scores_gemma":[0.9987329,0.0005026089,0.00008132806,0.00040957722,0.00016804818,0.00010550897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005672949,0.00020922918,0.0005894964,0.00015279869,0.00014694322,0.00008397003,0.00006560122,0.000068918605,0.00014051732],"category_scores_gemma":[0.00030267835,0.00016266962,0.000287915,0.0002324836,0.0000288808,0.00011355848,0.00005247366,0.00007479446,0.000016540633],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023272142,0.042576928,0.054624528,0.0052166,0.003738883,0.00011987743,0.0058511198,0.000024093775,0.006313977,0.0014744506,0.05963861,0.8180937],"study_design_scores_gemma":[0.027157007,0.016204963,0.75809836,0.0021506425,0.010293851,0.000032995184,0.0036105844,0.0021322216,0.035097416,0.008184641,0.13551357,0.0015237352],"about_ca_topic_score_codex":0.00019970274,"about_ca_topic_score_gemma":0.00027451443,"teacher_disagreement_score":0.81657,"about_ca_system_score_codex":0.000112821195,"about_ca_system_score_gemma":0.00015984147,"threshold_uncertainty_score":0.6633474},"labels":[],"label_agreement":null},{"id":"W4405092621","doi":"10.1182/blood-2024-207200","title":"Poisoning of Healthy Hematopoiesis Is an Unanticipated Mechanism Driving Clonal Dominance in Vexas Syndrome","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Ophthalmology and Eye Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Mechanism (biology); Dominance (genetics); Medicine; Biology; Genetics; Immunology; Gene","score_opus":0.02212913061203493,"score_gpt":0.3132396620583512,"score_spread":0.29111053144631627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405092621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970605,0.0013747432,0.000032830387,0.0007430664,0.00016558931,0.0001727263,0.000005599085,0.000053168336,0.00039180153],"genre_scores_gemma":[0.99886256,0.00004983436,0.00073574285,0.0001704742,0.00001893968,0.000015156925,0.000010301134,0.000023236402,0.00011376722],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998955,0.00004382523,0.00030083835,0.00027627609,0.00014099984,0.00028307026],"domain_scores_gemma":[0.99958533,0.00006819026,0.000046359117,0.00019769216,0.000026875252,0.0000755796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002728291,0.00012244622,0.00034725526,0.00019595727,0.000038850692,0.000007703309,0.000074599164,0.00013629609,0.00018505094],"category_scores_gemma":[0.000054407217,0.00011546653,0.000067121415,0.00036074195,0.000051377367,0.00009012634,0.000027610175,0.0002178202,0.000030452335],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009952316,0.007455095,0.85178894,0.0070526595,0.0011294286,0.022500442,0.022462435,0.000024328874,0.055601146,0.028904779,0.00024700802,0.0018384903],"study_design_scores_gemma":[0.009468888,0.004691715,0.8790549,0.005838702,0.0008054333,0.01197088,0.0032118624,0.002750353,0.07083364,0.010500059,0.0001150383,0.00075852236],"about_ca_topic_score_codex":0.00013640906,"about_ca_topic_score_gemma":0.000019289664,"teacher_disagreement_score":0.027265955,"about_ca_system_score_codex":0.00001684518,"about_ca_system_score_gemma":0.000118656775,"threshold_uncertainty_score":0.47085884},"labels":[],"label_agreement":null},{"id":"W4405092869","doi":"10.1182/blood-2024-199206","title":"Expanding the Donor Pool, the Number of Antigen Mismatches Has No Impact in the Outcomes of Haploidentical Stem Cell Transplantation with Peripheral Blood Stem Cells and Dual T Cell Depletion","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Stem cell; Peripheral Blood Stem Cells; Transplantation; Immunology; Antigen; Peripheral blood; Biology; Medicine; Hematopoietic stem cell transplantation; Cell biology; Internal medicine","score_opus":0.017842165140226473,"score_gpt":0.265294940780204,"score_spread":0.24745277563997753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405092869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972328,0.00063412054,0.00041969036,0.0003178621,0.00007584834,0.0007598991,0.000047088088,0.000025824518,0.00048689617],"genre_scores_gemma":[0.9990715,0.00043699495,0.00019082453,0.000039997285,0.0000454364,0.000029387591,0.000014205511,0.00003115627,0.00014054643],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99838316,0.00020053587,0.0004686332,0.00024336834,0.0004731404,0.00023116026],"domain_scores_gemma":[0.99888945,0.0006346836,0.00010998652,0.00026222266,0.000054712367,0.000048976024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005884474,0.00021430601,0.00034762378,0.0000632017,0.000086722954,0.00008351834,0.00012725833,0.000093145274,0.000038060098],"category_scores_gemma":[0.0000023409416,0.00009654448,0.00012643157,0.00023207461,0.00018629801,0.000110111,0.000009415714,0.00022654959,0.00000883713],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050291803,0.0010510987,0.63752526,0.004063691,0.00058082247,0.0003119138,0.06203156,0.00004401041,0.29351568,0.00011602046,0.000038064118,0.00021896388],"study_design_scores_gemma":[0.0055042207,0.0005083272,0.28756717,0.0007955143,0.0028364784,0.0010893916,0.010019281,0.00020157403,0.6912065,0.000022131608,0.000019523299,0.00022986851],"about_ca_topic_score_codex":0.00022380767,"about_ca_topic_score_gemma":0.000044910237,"teacher_disagreement_score":0.3976908,"about_ca_system_score_codex":0.000014205695,"about_ca_system_score_gemma":0.00010078978,"threshold_uncertainty_score":0.39369696},"labels":[],"label_agreement":null},{"id":"W4405095992","doi":"10.1182/blood-2024-211434","title":"Multiparameter Flow Cytometry-Based Measurable Residual Disease Assessment in the Patients with CCAAT Enhancer-Binding Protein a Gene (CEBPA) Mutated Acute Myeloid Leukemia","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"CEBPA; Ccaat-enhancer-binding proteins; Flow cytometry; Myeloid leukemia; Cancer research; Molecular biology; Myeloid; Minimal residual disease; Biology; Gene; Leukemia; Mutation; Medicine; Immunology; Genetics; Nuclear protein; Transcription factor","score_opus":0.015972281502590245,"score_gpt":0.28703491048645136,"score_spread":0.27106262898386113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405095992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99360293,0.0002308739,0.00051684753,0.0010854516,0.00007646521,0.0036995148,0.00021354403,0.00019349043,0.0003808785],"genre_scores_gemma":[0.9844346,0.000016279993,0.012699863,0.00014150205,0.00014464463,0.0012131593,0.00057075225,0.0001180665,0.0006611192],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99566597,0.00036200442,0.0004966656,0.0008640679,0.0017120384,0.0008992413],"domain_scores_gemma":[0.99817693,0.0003018708,0.00008883553,0.0008340146,0.00023399026,0.00036434198],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009960022,0.00043720478,0.00049698184,0.0006773798,0.00017352654,0.00023843496,0.00041318705,0.00016051247,0.00013241851],"category_scores_gemma":[0.00028178055,0.00027548932,0.0001441441,0.0018076755,0.00016825294,0.00023998324,0.000104086525,0.0012553445,0.00012616407],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011975734,0.007036989,0.09594963,0.0028201598,0.0040538386,0.01826078,0.0021430175,0.0010301796,0.8437009,0.00005678818,0.0032391371,0.0097328685],"study_design_scores_gemma":[0.08141532,0.004272383,0.12614612,0.003991408,0.0034636876,0.0001544727,0.00042775125,0.05002103,0.7270311,0.00007268406,0.0012434428,0.0017606074],"about_ca_topic_score_codex":0.00011604254,"about_ca_topic_score_gemma":0.000030364343,"teacher_disagreement_score":0.1166698,"about_ca_system_score_codex":0.0013514322,"about_ca_system_score_gemma":0.0029098126,"threshold_uncertainty_score":0.9999697},"labels":[],"label_agreement":null},{"id":"W4405096023","doi":"10.1182/blood-2024-203181","title":"Golseek-2: A Phase 2 Randomized, Open-Label Study to Evaluate the Efficacy and Safety of Golcadomide in Combination with Rituximab in Participants with Newly Diagnosed Advanced Stage Follicular Lymphoma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Rituximab; Follicular lymphoma; Medicine; Open label; Oncology; Internal medicine; Phases of clinical research; Lymphoma; Randomized controlled trial; Clinical trial","score_opus":0.02673293755314466,"score_gpt":0.3393171476816203,"score_spread":0.31258421012847565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405096023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882049,0.0015811712,0.0000402334,0.0006294562,0.000026506168,0.009355617,0.000019781592,0.000025857184,0.00011649077],"genre_scores_gemma":[0.9972965,0.00015445735,0.00046065814,0.00011945522,0.000008101152,0.001865522,0.000015693504,0.000032452208,0.000047130008],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99791807,0.0003535175,0.00052904437,0.00047833193,0.00040616855,0.00031486285],"domain_scores_gemma":[0.9982549,0.0010716098,0.00008043275,0.00038438372,0.000074541465,0.00013414523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011997869,0.00025802173,0.0009707779,0.00016682238,0.000050840023,0.00007709269,0.00013428114,0.000034656674,0.0000108748245],"category_scores_gemma":[0.00032147064,0.00013662278,0.000035418365,0.00062355073,0.000090980284,0.00015147313,0.000095485804,0.00007432857,0.000005746349],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5225693,0.3218743,0.071171455,0.00034939966,0.003064722,0.006848347,0.018358033,0.00033733898,0.0007406518,0.0018992153,0.00002952043,0.0527577],"study_design_scores_gemma":[0.9315233,0.0059259306,0.05620587,0.001172021,0.0014475774,0.00002649062,0.0010189499,0.0009616596,0.0014698876,0.000051211973,0.000029252384,0.00016785544],"about_ca_topic_score_codex":0.00073168933,"about_ca_topic_score_gemma":0.0011104612,"teacher_disagreement_score":0.40895396,"about_ca_system_score_codex":0.00012668225,"about_ca_system_score_gemma":0.00025105508,"threshold_uncertainty_score":0.5571315},"labels":[],"label_agreement":null},{"id":"W4405096029","doi":"10.1182/blood-2024-206324","title":"Environmental Pollution Is Associated with Higher Risk MDS in a Diverse Urban Cohort and Triggers Inflammation in a Murine Models","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Air Quality and Health Impacts","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Inflammation; Cohort; Environmental health; Medicine; Immunology; Internal medicine","score_opus":0.015273913393153007,"score_gpt":0.2296539446636315,"score_spread":0.2143800312704785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405096029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981505,0.00013452429,0.000029388482,0.00053349655,0.000020405025,0.00028168288,0.000042423642,0.000028843702,0.0007786799],"genre_scores_gemma":[0.99926746,0.00017209483,0.00008393618,0.00020268018,0.000016036805,0.000017066455,0.000012554616,0.000008792848,0.00021938689],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905664,0.000089280766,0.00018102048,0.00023350652,0.00022163626,0.0002179278],"domain_scores_gemma":[0.99975574,0.000029281211,0.000049209848,0.00008141551,6.324375e-7,0.000083722975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004114869,0.0000983992,0.000118094234,0.00006424699,0.00005414969,0.000021410759,0.000041877953,0.00008146003,0.00030796844],"category_scores_gemma":[0.000011401671,0.000086939945,0.000014686137,0.00020461107,0.00008272973,0.00038351922,0.000046071145,0.00016229371,0.000042196458],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005549891,0.0002744141,0.98883045,0.000022945102,0.000031565985,0.000053885127,0.005134423,0.0014165991,0.00040191892,0.00007363465,0.00039513363,0.0033095586],"study_design_scores_gemma":[0.0014715941,0.00011252942,0.9864668,0.00006661484,0.000039901384,0.0000028298116,0.000099752746,0.010607942,0.00018245194,0.0005294471,0.00029658378,0.00012350094],"about_ca_topic_score_codex":0.0016638035,"about_ca_topic_score_gemma":0.0006592194,"teacher_disagreement_score":0.009191343,"about_ca_system_score_codex":0.00029492116,"about_ca_system_score_gemma":0.0000126581845,"threshold_uncertainty_score":0.3545308},"labels":[],"label_agreement":null},{"id":"W4405096030","doi":"10.1182/blood-2024-198042","title":"Virtual Care Use for Patients with Hematologic Malignancies - a Natural Policy Experiment","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Hematologic Neoplasms; Medicine; Ibrutinib; Intensive care medicine; Cancer; Internal medicine; Leukemia; Chronic lymphocytic leukemia","score_opus":0.011553561257041876,"score_gpt":0.26629970522404495,"score_spread":0.25474614396700307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405096030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949101,0.003748229,0.00002473699,0.00015214685,0.0003309459,0.0004599835,0.00007581763,0.00012105513,0.00017696856],"genre_scores_gemma":[0.9985063,0.000012539556,0.00017390856,0.00027685764,0.00018960994,0.0001570276,0.00010745385,0.000023894816,0.0005524142],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993164,0.000007989144,0.0000967464,0.0002116893,0.00017449984,0.00019268495],"domain_scores_gemma":[0.9996193,0.000039608043,0.00001560311,0.0001556233,0.00010515899,0.000064718624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000015183091,0.00012179537,0.00016410834,0.0000756946,0.000040045947,0.000045953715,0.000041672723,0.000046212364,0.000014174981],"category_scores_gemma":[0.00003079798,0.00008126161,0.000080126054,0.00013992951,0.000031836404,0.00007020395,0.000022912096,0.00006956454,0.0000066676976],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005330563,0.0053738616,0.6816385,0.008777613,0.00327733,0.0012398945,0.16644648,0.000006776548,0.018945424,0.06695558,0.013568821,0.028439177],"study_design_scores_gemma":[0.057329513,0.029323153,0.19835737,0.007983097,0.00426822,0.00067341665,0.07353455,0.00011383425,0.32175073,0.00039642438,0.30262443,0.0036452718],"about_ca_topic_score_codex":0.00017693757,"about_ca_topic_score_gemma":0.00015096077,"teacher_disagreement_score":0.4832811,"about_ca_system_score_codex":0.00006090101,"about_ca_system_score_gemma":0.00013566088,"threshold_uncertainty_score":0.33137524},"labels":[],"label_agreement":null},{"id":"W4405096042","doi":"10.1182/blood-2024-200319","title":"HOPE-PMF: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Assess Efficacy and Safety of Ropeginterferon Alfa-2b in Patients with Early/Lower-Risk Primary Myelofibrosis","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Daiichi Sankyo Europe; Chugai Pharmaceutical; Genentech; Swedish Orphan Biovitrum; Eisai; Sierra Oncology; CTI Biopharma; Incyte; Novartis Pharma; Otsuka Pharmaceutical; Astellas Pharma; Ariad Pharmaceuticals; MorphoSys; Celgene; Gilead Sciences; Meiji Seika Pharma; AOP Orphan; Torii Pharmaceutical; Bristol-Myers Squibb","keywords":"Myelofibrosis; Medicine; Placebo; Internal medicine; Randomized controlled trial; Phases of clinical research; Double blind; Clinical trial; Oncology; Alternative medicine; Pathology; Bone marrow","score_opus":0.01651577286164992,"score_gpt":0.2874387472039899,"score_spread":0.27092297434234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405096042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848089,0.0005559139,0.000079625446,0.00018820835,0.0001157382,0.013485694,0.000064570944,0.0000481821,0.0006531171],"genre_scores_gemma":[0.99763274,0.00013248214,0.00042496828,0.000060417555,0.000062516156,0.0013549865,0.000047429432,0.000057310805,0.0002271542],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9973477,0.0003403497,0.0007327262,0.0006945982,0.0005434944,0.00034114695],"domain_scores_gemma":[0.99816924,0.0008437096,0.00016985176,0.00040093798,0.00016927168,0.00024696154],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007974536,0.00043163483,0.0018414714,0.0003850612,0.00007103582,0.000093373295,0.00009869089,0.00007852823,0.000081386046],"category_scores_gemma":[0.0001333064,0.00026771773,0.00017528744,0.00040204742,0.00007796815,0.00013833947,0.000098623794,0.00027165472,0.000025671956],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7478186,0.019397719,0.22595686,0.00011995767,0.0025256332,0.000118733995,0.0016512455,0.0000116061265,0.000058988368,0.000018281318,0.000034080862,0.0022882903],"study_design_scores_gemma":[0.8401021,0.012320053,0.14256577,0.00076143065,0.0029889036,0.0000052456703,0.000077231605,0.00002547485,0.00088123884,0.0000017154307,0.000043688648,0.00022718613],"about_ca_topic_score_codex":0.00022112983,"about_ca_topic_score_gemma":0.00013497107,"teacher_disagreement_score":0.09228345,"about_ca_system_score_codex":0.00009659545,"about_ca_system_score_gemma":0.0001450496,"threshold_uncertainty_score":0.9999775},"labels":[],"label_agreement":null},{"id":"W4405096057","doi":"10.1182/blood-2024-202516","title":"CTEP 10590, NORM: Nodular Lymphocyte Predominant Hodgkin Lymphoma Patients Treated in a Randomized Phase II Trial with Either Rituximab or Mosunetuzumab","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rituximab; Medicine; Lymphoma; Randomized controlled trial; Internal medicine; Oncology","score_opus":0.010354968366270884,"score_gpt":0.26413868819023817,"score_spread":0.2537837198239673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405096057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99020636,0.0031458065,0.000010881756,0.00020523272,0.00027181912,0.004808675,0.00010825875,0.00021738192,0.0010256121],"genre_scores_gemma":[0.995034,0.00043129103,0.00043007467,0.00015427578,0.00023793317,0.001806553,0.00026652368,0.00010917745,0.0015302044],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9968506,0.00022730106,0.00086556835,0.00083601155,0.00060849363,0.0006120391],"domain_scores_gemma":[0.9985731,0.00031606294,0.00016031261,0.0005799592,0.00011667136,0.00025385883],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003876201,0.0005814079,0.0017645078,0.00038090814,0.000121089375,0.00009891612,0.00014105237,0.00021546775,0.00046161012],"category_scores_gemma":[0.00018068471,0.00032702024,0.0004098497,0.00069594034,0.0001496711,0.00015942726,0.000076432334,0.0000918473,0.00014455919],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87408334,0.0627343,0.0023662061,0.00017378673,0.002206216,0.005134848,0.0009567408,0.000001941207,0.00010763804,0.00005533137,0.0004210582,0.051758576],"study_design_scores_gemma":[0.96845776,0.012156836,0.00093148265,0.0010200886,0.0033097796,0.00024440762,0.000033036053,0.0007994271,0.009271874,0.000015267431,0.0033552751,0.00040476493],"about_ca_topic_score_codex":0.0010665202,"about_ca_topic_score_gemma":0.00015838337,"teacher_disagreement_score":0.0943744,"about_ca_system_score_codex":0.0005827499,"about_ca_system_score_gemma":0.00071764976,"threshold_uncertainty_score":0.99991816},"labels":[],"label_agreement":null},{"id":"W4405096067","doi":"10.1182/blood-2024-207223","title":"A Comparison of the Timing of Treatment Initiation for Older Versus Younger Patients with Follicular Lymphoma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Follicular lymphoma; Medicine; Lymphoma; Internal medicine; Oncology","score_opus":0.03317416899513719,"score_gpt":0.30665910596451434,"score_spread":0.27348493696937715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405096067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978065,0.00082567317,0.000014648884,0.00008337218,0.00011872987,0.00071205775,0.00003905557,0.000013214297,0.00038675376],"genre_scores_gemma":[0.9994207,0.000010133154,0.00030805336,0.000013313412,0.000027144231,0.00012459035,0.00005313811,0.000012352375,0.000030577525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994768,0.0000102087115,0.00016056836,0.00012256338,0.00014522282,0.000084675565],"domain_scores_gemma":[0.999595,0.00008755281,0.000064715336,0.00015910793,0.0000690432,0.000024623176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000021375712,0.00008953954,0.00020317586,0.000034279306,0.000026764657,0.000006250119,0.000025641215,0.00003245114,0.000011416817],"category_scores_gemma":[0.000011856342,0.000046092715,0.00011514341,0.0000956176,0.000020767206,0.00003215229,0.000008947523,0.000008814719,0.000001677998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063697714,0.009109822,0.9640501,0.00032077936,0.0021291745,0.000007172229,0.00202493,0.000011433143,0.000326528,0.00042682013,0.0002319658,0.020724261],"study_design_scores_gemma":[0.035425074,0.0038733634,0.8477429,0.0005483348,0.003660781,0.0000030432084,0.00013315163,0.00029539023,0.107134506,0.000008777671,0.0010920546,0.00008258625],"about_ca_topic_score_codex":0.000043141594,"about_ca_topic_score_gemma":0.000007658641,"teacher_disagreement_score":0.11630721,"about_ca_system_score_codex":0.00010941583,"about_ca_system_score_gemma":0.00010081318,"threshold_uncertainty_score":0.18796064},"labels":[],"label_agreement":null},{"id":"W4405096070","doi":"10.1182/blood-2024-203060","title":"PRIMAVERA: A Modular Phase I/II Study to Evaluate the Safety, Tolerability, and Efficacy of AZD3470, a Protein Arginine Methyltransferase 5 (PRMT5) Inhibitor, in Participants with Relapsed/Refractory Hematologic Malignancies","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Tolerability; Protein arginine methyltransferase 5; Medicine; Hematologic Neoplasms; Refractory (planetary science); Internal medicine; Phases of clinical research; Methyltransferase; Pharmacology; Oncology; Adverse effect; Clinical trial; Chemistry; Transplantation; Methylation; Biology; Biochemistry","score_opus":0.016452092021642495,"score_gpt":0.29117312068523027,"score_spread":0.2747210286635878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405096070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940923,0.002857602,0.00030163626,0.00040323468,0.00005271226,0.002222183,0.00002553193,0.000024728499,0.000020071564],"genre_scores_gemma":[0.9993859,0.000047290247,0.00019015558,0.000023628652,0.000058364923,0.00019734075,0.000019316974,0.000029376895,0.000048635084],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99817073,0.00024778373,0.00045625522,0.00056545,0.00026751854,0.0002922555],"domain_scores_gemma":[0.9992692,0.00004273819,0.000049880713,0.0004666585,0.00008603184,0.000085526495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080351165,0.00022948351,0.00032792173,0.00008948355,0.00007774065,0.000026577447,0.00013524575,0.00010032843,0.00000961884],"category_scores_gemma":[0.00013364026,0.00015779656,0.000061131956,0.00034242883,0.00011452735,0.000010395026,0.00012790489,0.00015883545,0.000001692406],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014095161,0.0039701695,0.0019750928,0.00013473231,0.00028272002,0.000034072767,0.0021899762,0.0007048708,0.9872801,0.000054697088,0.000015643272,0.001948416],"study_design_scores_gemma":[0.012878926,0.012935545,0.012457625,0.0003804509,0.00041272468,0.00004255486,0.00039629271,0.00032468326,0.9592832,0.00014087405,0.00037251913,0.00037462075],"about_ca_topic_score_codex":0.00004912233,"about_ca_topic_score_gemma":0.00021387528,"teacher_disagreement_score":0.027996909,"about_ca_system_score_codex":0.000027458662,"about_ca_system_score_gemma":0.00020733017,"threshold_uncertainty_score":0.64347565},"labels":[],"label_agreement":null},{"id":"W4405096087","doi":"10.1182/blood-2024-197902","title":"Mosunetuzumab Monotherapy Demonstrates Encouraging Activity and a Manageable Safety Profile in Patients with Heavily Pre-Treated Relapsed or Refractory Mantle Cell Lymphoma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Jewish General Hospital; Spinal Cord Injury BC; University of British Columbia","funders":"Pharmacyclics; Genentech; F. Hoffmann-La Roche; Incyte; Constellation Pharmaceuticals; BeiGene; Eli Lilly and Company; AstraZeneca; MorphoSys; Celgene; Gilead Sciences; Agios Pharmaceuticals; Astellas Pharma; TG Therapeutics; Takeda Oncology; Fundació Institut de Recerca Hospital Universitari Vall d’Hebron; Amgen","keywords":"Mantle cell lymphoma; Refractory (planetary science); Medicine; Safety profile; Lymphoma; Internal medicine; Oncology; Cancer research; Adverse effect; Biology","score_opus":0.005187459901947161,"score_gpt":0.21742126831108918,"score_spread":0.21223380840914202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405096087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99535024,0.0013510349,0.000006764308,0.000113733724,0.000037347854,0.0009775163,0.00004779725,0.00012403402,0.0019915225],"genre_scores_gemma":[0.9974421,0.00040551426,0.0005888766,0.000047968977,0.000023388775,0.00013255182,0.00005166206,0.000045158595,0.0012627454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987512,0.000046513298,0.00020935822,0.00046984848,0.0002187858,0.0003042938],"domain_scores_gemma":[0.9994342,0.00010500631,0.000056208788,0.00025768284,0.000031992844,0.000114923154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000080741695,0.0002537383,0.00033750298,0.00014140487,0.00007359061,0.000063497464,0.00004776098,0.00009793371,0.00006938465],"category_scores_gemma":[0.000006821629,0.00016369997,0.000044786106,0.00029227784,0.000046732697,0.00019529367,0.000025217503,0.00008843082,0.000015556909],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036099444,0.008820885,0.9382145,0.00043423238,0.0004316685,0.0011116959,0.0005294097,0.000004458076,0.0010836704,0.000014142645,0.00020015644,0.045545273],"study_design_scores_gemma":[0.025128884,0.0018972238,0.94647217,0.0007050413,0.0003322609,0.00003881735,0.00006915946,0.00045109366,0.024136158,0.000010412169,0.0005304748,0.00022833173],"about_ca_topic_score_codex":0.00062516873,"about_ca_topic_score_gemma":0.00010989531,"teacher_disagreement_score":0.04531694,"about_ca_system_score_codex":0.00021701597,"about_ca_system_score_gemma":0.00019004573,"threshold_uncertainty_score":0.6675491},"labels":[],"label_agreement":null},{"id":"W4405096089","doi":"10.1182/blood-2024-205727","title":"Topic Modeling of Genotyping of Transcriptomes Reveals Collaboration between BTKC481S-Mutant and Wild Type Cells in Btki-Resistant Chronic Lymphocytic Leukemia","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Chronic lymphocytic leukemia; Genotyping; Mutant; Biology; Transcriptome; Leukemia; Genetics; Cancer research; Molecular biology; Genotype; Gene; Gene expression","score_opus":0.02120031658623975,"score_gpt":0.2911469645347938,"score_spread":0.269946647948554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405096089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98060775,0.018202145,0.00012735887,0.00007138086,0.00009778598,0.0005465622,0.000031736716,0.000041214866,0.00027407063],"genre_scores_gemma":[0.99782014,0.0013258384,0.00046941603,0.000014426157,0.00014991843,0.000012459152,0.00001758617,0.000037272184,0.00015291822],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980922,0.00006702864,0.0006865685,0.0003692331,0.00044238468,0.00034263762],"domain_scores_gemma":[0.99906945,0.00016949288,0.00007148779,0.00041874236,0.00016275876,0.00010804069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004823094,0.00018026867,0.0005946414,0.0003433617,0.000029542696,0.00002640078,0.00015036957,0.0001664247,0.000025094689],"category_scores_gemma":[0.00012486866,0.00016364429,0.000071117865,0.000891115,0.00010030411,0.00011412976,0.0000619895,0.0001837943,0.0000052935366],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00027063923,0.00007081235,0.00068295404,0.006763574,0.00034804165,0.00018384674,0.0021620742,0.0031495634,0.98432845,0.00038272393,0.000038994167,0.0016183063],"study_design_scores_gemma":[0.032956038,0.0012025294,0.0013048494,0.006389508,0.0011634075,0.00009842247,0.0006705291,0.4730138,0.48144352,0.00093181786,0.00036230008,0.00046328903],"about_ca_topic_score_codex":0.0009248823,"about_ca_topic_score_gemma":0.000116724244,"teacher_disagreement_score":0.5028849,"about_ca_system_score_codex":0.011922604,"about_ca_system_score_gemma":0.017218389,"threshold_uncertainty_score":0.99187046},"labels":[],"label_agreement":null},{"id":"W4405096090","doi":"10.1182/blood-2024-204249","title":"The Effect of Smoking and Pre-Transplant Pulmonary Comorbidity on the Incidence of Lung Graft Versus Host Disease and Post Transplant Outcomes","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Transplantation: Methods and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Comorbidity; Incidence (geometry); Medicine; Graft-versus-host disease; Lung; Internal medicine; Disease; Lung transplantation; Pulmonary disease; Intensive care medicine","score_opus":0.013434540890290886,"score_gpt":0.30043989921661335,"score_spread":0.28700535832632246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405096090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99265474,0.004823733,0.000055968103,0.001402031,0.0002012625,0.00048965454,0.00026578622,0.00003053875,0.00007630874],"genre_scores_gemma":[0.9978733,0.0019168775,0.000049145827,0.00005041202,0.00003223427,0.00002000264,0.000018131645,0.000014466856,0.000025393265],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892896,0.00018085638,0.00024472622,0.00020260489,0.00028964074,0.0001532241],"domain_scores_gemma":[0.9956371,0.003982614,0.00004834741,0.00021962814,0.00002187037,0.000090425754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059460086,0.00016654932,0.00029454668,0.000051257415,0.00011958969,0.00002303293,0.00009340897,0.00004723088,0.000006045203],"category_scores_gemma":[0.00008529519,0.00007828199,0.0001108442,0.00009491272,0.00019769899,0.000050129565,0.000012509981,0.00019588463,3.1618092e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027242585,0.000073194366,0.9824654,0.0020809239,0.0005112734,0.00033598702,0.0008951548,0.0000011224455,0.008899169,0.0008924318,0.000004308575,0.0011168194],"study_design_scores_gemma":[0.001710061,0.0005287397,0.9800374,0.0011286727,0.0024235945,0.00008342357,0.000036510442,0.00013347548,0.013779865,0.000030551008,0.00001946662,0.00008824741],"about_ca_topic_score_codex":0.00011228955,"about_ca_topic_score_gemma":0.000032476386,"teacher_disagreement_score":0.005218619,"about_ca_system_score_codex":0.0000061465257,"about_ca_system_score_gemma":0.000037218593,"threshold_uncertainty_score":0.31922472},"labels":[],"label_agreement":null},{"id":"W4405096106","doi":"10.1182/blood-2024-205767","title":"Odyssey: A Phase 2 Open-Label Study of Momelotinib in Combination with Luspatercept in Patients with Transfusion-Dependent Myelofibrosis","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Myelofibrosis; Medicine; Open label; Phases of clinical research; Ruxolitinib; Surgery; Internal medicine; Clinical trial; Bone marrow","score_opus":0.02033822022441533,"score_gpt":0.29750628624004904,"score_spread":0.2771680660156337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405096106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99586195,0.000064390115,0.000010838991,0.00015791375,0.00003456434,0.0034385857,0.000030957377,0.000020596332,0.00038019096],"genre_scores_gemma":[0.9989643,0.000033344997,0.00023734153,0.000030350473,0.000008460356,0.00054161064,0.00006633487,0.00003350927,0.00008472607],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847454,0.00007861659,0.00037017683,0.00043570352,0.00044364872,0.00019729172],"domain_scores_gemma":[0.9994806,0.0000619668,0.000057433066,0.00022248134,0.00009903379,0.000078476376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015205685,0.00021486702,0.0004678797,0.00029843653,0.0000323899,0.00004644644,0.00009402551,0.0000518543,0.00009924308],"category_scores_gemma":[0.000009927926,0.00013989343,0.00001719276,0.0005371919,0.000025858788,0.00016471608,0.000039030598,0.00015247498,0.000009044213],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019092065,0.12564565,0.8630315,0.00013273688,0.00025555876,0.00022885976,0.0046271603,0.0000065702843,0.00023100372,0.000049788676,0.0000084596495,0.0038734963],"study_design_scores_gemma":[0.15977271,0.028509082,0.80568683,0.0009391488,0.0003461992,0.0000069191906,0.0006313322,0.00006742562,0.0038605835,0.000010574455,0.000009708373,0.00015950855],"about_ca_topic_score_codex":0.0007540432,"about_ca_topic_score_gemma":0.0032784438,"teacher_disagreement_score":0.1578635,"about_ca_system_score_codex":0.00007656544,"about_ca_system_score_gemma":0.00010843732,"threshold_uncertainty_score":0.5704688},"labels":[],"label_agreement":null},{"id":"W4405096139","doi":"10.1182/blood-2024-211811","title":"Management of Upper Extremity Superficial Vein Thrombosis in Patients with Cancer: A Retrospective Observational Cohort Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Retrospective cohort study; Thrombosis; Observational study; Cancer; Surgery; Cohort study; Internal medicine","score_opus":0.017745364946328106,"score_gpt":0.276733361878753,"score_spread":0.2589879969324249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405096139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949101,0.00020828356,0.0000056697104,0.0001900803,0.00015660605,0.0019380451,0.000033495762,0.00004505827,0.0025126378],"genre_scores_gemma":[0.9990153,0.00015269028,0.00020659776,0.000057443587,0.00006322356,0.00031862254,0.000037700258,0.000024884252,0.00012354447],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985281,0.000026289179,0.00027794405,0.00039277526,0.0005785274,0.00019631218],"domain_scores_gemma":[0.9995526,0.000015937392,0.000041766874,0.0002429344,0.0001015791,0.00004515831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019847305,0.00015131065,0.00043464272,0.00013579066,0.000034299417,0.00001914864,0.00008042406,0.000036537283,0.00028083584],"category_scores_gemma":[0.0000068362433,0.00012060784,0.000056158406,0.0004483692,0.00003396906,0.00008814134,0.00007501906,0.00012045918,0.000006957311],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052451072,0.009018682,0.9866694,0.00022596151,0.0014437735,0.00004198513,0.0006409989,0.000008496693,0.0000091913425,0.0010022245,0.00038463314,0.0005021751],"study_design_scores_gemma":[0.0031813304,0.0006924941,0.9936056,0.0005108042,0.0012277038,2.2793375e-7,0.0004239059,0.000017210305,0.00006732251,0.000045154393,0.00010652504,0.00012167877],"about_ca_topic_score_codex":0.00061034947,"about_ca_topic_score_gemma":0.00017277418,"teacher_disagreement_score":0.008326188,"about_ca_system_score_codex":0.00015524913,"about_ca_system_score_gemma":0.000055145036,"threshold_uncertainty_score":0.49182448},"labels":[],"label_agreement":null},{"id":"W4405096159","doi":"10.1182/blood-2024-212166","title":"Thrombolytic Therapy for Venous Thromboembolism in the Pediatric Population: A Systematic Review and Meta-Analysis","year":2024,"lang":"en","type":"review","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster Children's Hospital; SickKids Foundation; Hospital for Sick Children; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Venous thromboembolism; Meta-analysis; Intensive care medicine; Population; Pulmonary embolism; Internal medicine; Thrombosis","score_opus":0.12764480115913884,"score_gpt":0.384071168400804,"score_spread":0.2564263672416652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405096159","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000010732389,0.9883166,0.000016502963,0.00035987003,0.00006496064,0.011017815,0.00008362894,0.00006670511,0.000063214546],"genre_scores_gemma":[0.00060716947,0.99405336,0.0001348795,0.0012265171,0.00015492919,0.0033827848,0.00022094253,0.00008403497,0.00013536957],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9966267,0.0004951072,0.0014422759,0.0006662129,0.0004727396,0.00029701798],"domain_scores_gemma":[0.9978911,0.00038896824,0.000549656,0.0010048709,0.000079246165,0.00008613795],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014715218,0.00062861224,0.011528338,0.0006007059,0.0000879544,0.000102935715,0.00028956757,0.0002959656,0.0000865614],"category_scores_gemma":[0.00011533801,0.0003075663,0.003549462,0.0021641843,0.000021113883,0.000052106127,0.00004398479,0.0003960112,0.000036139183],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[6.236582e-7,0.0004800045,0.000001916544,0.8669293,0.13090755,0.0000133255535,0.00011479529,4.49349e-8,2.13379e-8,0.0011976152,0.00006787794,0.00028695285],"study_design_scores_gemma":[0.00038805685,0.00016947387,0.000023822022,0.015082114,0.9818172,0.00020460406,0.00001792473,0.0000028102106,6.069616e-8,0.00034783152,0.0016658605,0.00028027754],"about_ca_topic_score_codex":0.000017803357,"about_ca_topic_score_gemma":0.000008401375,"teacher_disagreement_score":0.8518472,"about_ca_system_score_codex":0.00002870985,"about_ca_system_score_gemma":0.00013006906,"threshold_uncertainty_score":0.99993765},"labels":[],"label_agreement":null},{"id":"W4405096174","doi":"10.1182/blood-2024-199274","title":"Household Material Hardship and Inpatient Days in Dana-Farber Cancer Institute (DFCI) Acute Lymphoblastic Leukemia (ALL) Consortium Trial 16-001","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Lymphoblastic Leukemia; Internal medicine; Cancer; Pediatrics; Leukemia; Oncology","score_opus":0.0480106809097155,"score_gpt":0.3491408628114922,"score_spread":0.3011301819017767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405096174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98099,0.0003631831,0.000043948225,0.0003564192,0.014283322,0.0011902753,0.00054457865,0.00032490687,0.0019033814],"genre_scores_gemma":[0.99526596,0.00030638804,0.00014647974,0.0006457487,0.0017471678,0.00043485052,0.0001310001,0.00008897837,0.0012334354],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9968906,0.00023327263,0.00092675944,0.000664967,0.00038764245,0.00089674327],"domain_scores_gemma":[0.99860287,0.00055575115,0.0001766827,0.0003519832,0.00006299282,0.00024974067],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00060911814,0.00035942098,0.00055543525,0.00030025025,0.00026468502,0.00008742701,0.00022515713,0.000354976,0.00039738245],"category_scores_gemma":[0.0002997798,0.00031565232,0.000069298265,0.00031488182,0.00016633769,0.00027324297,0.00026883208,0.0006123952,0.00016172862],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14296584,0.012449271,0.37505963,0.02038438,0.0110726915,0.011874224,0.05385733,0.0014332044,0.053906318,0.033466328,0.2629787,0.020552075],"study_design_scores_gemma":[0.57526773,0.0025646724,0.069576494,0.013244517,0.006377155,0.00025818968,0.0015679464,0.003268514,0.008205999,0.0020115476,0.31315744,0.0044998075],"about_ca_topic_score_codex":0.0033309571,"about_ca_topic_score_gemma":0.0024239398,"teacher_disagreement_score":0.43230188,"about_ca_system_score_codex":0.0005026424,"about_ca_system_score_gemma":0.002385118,"threshold_uncertainty_score":0.99992955},"labels":[],"label_agreement":null},{"id":"W4405096216","doi":"10.1182/blood-2024-193907","title":"Monocytosis Is an Independent Risk Factor for Survival in Essential Thrombocythemia - a Revised Triple-a Prognostic Score (AAA+A) Based on Age and Absolute Monocyte, Neutrophil, and Lymphocyte Counts","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Monocytosis; Medicine; Internal medicine; Essential thrombocythemia; Absolute neutrophil count; Lymphocyte; Immunology; Gastroenterology; Platelet; Neutropenia","score_opus":0.03477717518231871,"score_gpt":0.29505890667816126,"score_spread":0.26028173149584255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405096216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950589,0.0021069525,0.000054078628,0.00019504516,0.00015864683,0.0015145545,0.00058493216,0.000060545623,0.00026632397],"genre_scores_gemma":[0.9972611,0.0015432023,0.0003975861,0.00014970651,0.00015369365,0.00027371617,0.00006072095,0.000048176295,0.000112088426],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985885,0.000059491027,0.0002658189,0.0005710703,0.00024958418,0.00026554853],"domain_scores_gemma":[0.9992623,0.0002289399,0.0000616326,0.00023247319,0.000042054748,0.00017264072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014445397,0.00027091222,0.00045310776,0.00016953918,0.000078934936,0.000115114985,0.00005068781,0.00012735397,0.00009246233],"category_scores_gemma":[0.00006746881,0.00021519708,0.00008513698,0.00014265368,0.00005289068,0.00008012067,0.000026828504,0.00015541141,0.000012074441],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006590087,0.010860181,0.82039046,0.0053468673,0.003420828,0.004837129,0.0049829655,0.000055496588,0.008061858,0.0014702929,0.0016298447,0.132354],"study_design_scores_gemma":[0.030672822,0.003763719,0.92373383,0.0016617266,0.0018788854,0.00006948475,0.000074116506,0.017820325,0.01753459,0.00024977696,0.0018902019,0.0006504992],"about_ca_topic_score_codex":0.00007485178,"about_ca_topic_score_gemma":0.00006922,"teacher_disagreement_score":0.1317035,"about_ca_system_score_codex":0.00009902229,"about_ca_system_score_gemma":0.00016983155,"threshold_uncertainty_score":0.8775483},"labels":[],"label_agreement":null},{"id":"W4405107401","doi":"10.1182/blood-2024-212973","title":"Lack of Benefit of Autologous Hematopoietic Cell Transplantation (auto-HCT) in Mantle Cell Lymphoma (MCL) Patients (pts) in First Complete Remission (CR) with Undetectable Minimal Residual Disease (uMRD): Initial Report from the ECOG-ACRIN EA4151 Phase 3 Randomized Trial","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Mantle cell lymphoma; Medicine; Minimal residual disease; Hematopoietic stem cell transplantation; Transplantation; Hematopoietic cell; Lymphoma; Internal medicine; Complete remission; Oncology; Surgery; Gastroenterology; Cancer research; Haematopoiesis; Stem cell; Chemotherapy; Leukemia; Biology","score_opus":0.02012098563730711,"score_gpt":0.27635723759576747,"score_spread":0.25623625195846034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405107401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953637,0.001242765,0.000010856667,0.00018524304,0.00013396115,0.0020273477,0.000508224,0.000033705426,0.00049420184],"genre_scores_gemma":[0.9985346,0.0002096622,0.0002082876,0.0000286094,0.000056436907,0.0002109474,0.0006663291,0.00003498647,0.000050131082],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9975987,0.00016210487,0.0010375541,0.0004678269,0.0004659695,0.00026781714],"domain_scores_gemma":[0.99833804,0.00081911235,0.00029652458,0.00037411108,0.000060533035,0.000111652866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031684968,0.00027187192,0.0009061529,0.00015476035,0.000046727255,0.000022792332,0.000110394096,0.00010802716,0.00010279716],"category_scores_gemma":[0.00008157303,0.00017459888,0.00019196472,0.0002607171,0.00011946157,0.00007772328,0.000031335887,0.00009264013,0.000006134816],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9216839,0.025708001,0.035171583,0.0017367286,0.00037667836,0.0074183578,0.0035477595,0.00007213247,0.0024074,0.000030525985,0.00012684302,0.0017200668],"study_design_scores_gemma":[0.9012567,0.0015106668,0.034593992,0.0014668077,0.0017539904,0.00006291082,0.00014532688,0.00036016258,0.05843949,0.00012618517,0.00007967501,0.00020412868],"about_ca_topic_score_codex":0.0014646733,"about_ca_topic_score_gemma":0.00028342975,"teacher_disagreement_score":0.056032088,"about_ca_system_score_codex":0.000102182734,"about_ca_system_score_gemma":0.00034225686,"threshold_uncertainty_score":0.7119936},"labels":[],"label_agreement":null},{"id":"W4405107409","doi":"10.1182/blood-2024-212970","title":"Tafasitamab Plus Lenalidomide and Rituximab for Relapsed or Refractory Follicular Lymphoma: Results from a Phase 3 Study (inMIND)","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Lenalidomide; Rituximab; Follicular lymphoma; Medicine; Refractory (planetary science); Oncology; Internal medicine; Phases of clinical research; Lymphoma; Clinical trial; Multiple myeloma; Biology","score_opus":0.02853263491178453,"score_gpt":0.3116804466416099,"score_spread":0.28314781172982534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405107409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98784965,0.007904722,0.000027421886,0.00069759425,0.00026077675,0.0019801245,0.0008119501,0.00017586719,0.00029191395],"genre_scores_gemma":[0.99626255,0.00021849627,0.0010921522,0.00016578013,0.00040100864,0.0005257145,0.00032577445,0.000058204718,0.00095034426],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99804986,0.000056940826,0.0004841772,0.0007711308,0.00031610212,0.00032178476],"domain_scores_gemma":[0.9984646,0.0006465389,0.00008004917,0.00051267893,0.00006945474,0.00022670797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002590441,0.00030917773,0.00061440817,0.00013185706,0.00012469679,0.00011315387,0.00008199651,0.00013440762,0.00003925469],"category_scores_gemma":[0.0002951046,0.00021070852,0.00018727824,0.00018220615,0.000044989152,0.00011743492,0.00005640775,0.00007369474,0.000053644482],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11759083,0.3771654,0.011457626,0.0015197555,0.027154187,0.073288694,0.028541774,0.0000027971919,0.010525257,0.0006162856,0.048515376,0.30362204],"study_design_scores_gemma":[0.8891872,0.012598484,0.0125034675,0.0009626861,0.009532977,0.00043259986,0.0019782002,0.0005406212,0.016862113,0.0002026581,0.05459074,0.0006082607],"about_ca_topic_score_codex":0.0004183304,"about_ca_topic_score_gemma":0.000081343496,"teacher_disagreement_score":0.7715964,"about_ca_system_score_codex":0.00020192,"about_ca_system_score_gemma":0.0003809215,"threshold_uncertainty_score":0.8592444},"labels":[],"label_agreement":null},{"id":"W4405126086","doi":"10.1182/blood-2024-203888","title":"SUVR (SUVmax Lymphoma/SUVmax Liver) Vs Deauville Score for Predicting Relapse in Hodgkin Lymphoma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal; Jewish General Hospital","funders":"","keywords":"Medicine; Lymphoma; Internal medicine; Hodgkin lymphoma; Oncology; Nuclear medicine","score_opus":0.015505536817918024,"score_gpt":0.29043364945214545,"score_spread":0.27492811263422745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405126086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812342,0.0091790315,0.00026631576,0.00069495826,0.000558849,0.0011849641,0.00012981793,0.00030560186,0.006446269],"genre_scores_gemma":[0.99330926,0.00031087274,0.0023122416,0.0002661058,0.00043907302,0.00038204275,0.00015257587,0.0000721447,0.002755702],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99861753,0.00002368914,0.00031965855,0.00044647563,0.00021367255,0.00037898208],"domain_scores_gemma":[0.99928635,0.00017508534,0.000048927468,0.00027891225,0.00006792592,0.00014281573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015755554,0.00020889021,0.00029567603,0.00021606666,0.000112988375,0.000059811027,0.00008611719,0.00012819137,0.00006798135],"category_scores_gemma":[0.00011378758,0.00017786051,0.00015313775,0.00035108638,0.000042531425,0.00013782264,0.000040211053,0.00006732082,0.00006367562],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016742114,0.010598917,0.4118795,0.0051019713,0.0045775883,0.007502471,0.01951514,0.00010079277,0.0044105905,0.0106620295,0.024798788,0.499178],"study_design_scores_gemma":[0.121910535,0.0076922,0.48590258,0.010637106,0.012161718,0.0034579495,0.003771852,0.015051926,0.02762837,0.0029647804,0.30662486,0.0021961206],"about_ca_topic_score_codex":0.0004608234,"about_ca_topic_score_gemma":0.0002142824,"teacher_disagreement_score":0.4969819,"about_ca_system_score_codex":0.0002895609,"about_ca_system_score_gemma":0.00053173094,"threshold_uncertainty_score":0.7252941},"labels":[],"label_agreement":null},{"id":"W4405126092","doi":"10.1182/blood-2024-208880","title":"Biological and Prognostic Subgroups of Plasmablastic Lymphoma Defined By EBV Status and <i>MYC</i> Rearrangement- an L.L.M.P.P. Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Canada's Michael Smith Genome Sciences Centre; University of Toronto; Spinal Cord Injury BC","funders":"","keywords":"Plasmablastic lymphoma; Lymphoma; Medicine; Internal medicine; Gene rearrangement; Cancer research; Oncology; Biology; Gene","score_opus":0.01328440150005027,"score_gpt":0.2489757335195145,"score_spread":0.2356913320194642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405126092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990346,0.00838058,0.000006615031,0.00011583371,0.00006264936,0.00050996925,0.00006046079,0.00006926139,0.00044863322],"genre_scores_gemma":[0.99898505,0.00067719934,0.00006635189,0.00006902604,0.000034388828,0.000035130848,0.00004470483,0.000019103178,0.00006903787],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989631,0.000051484887,0.00021215377,0.00033594074,0.0001699097,0.00026742232],"domain_scores_gemma":[0.99954104,0.00010702331,0.000041048646,0.00012037116,0.00003079409,0.0001597068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014609683,0.00015050451,0.00028527685,0.000065767585,0.00004847345,0.00003626636,0.00003529059,0.00008177664,0.00003436291],"category_scores_gemma":[0.000099269986,0.0001135147,0.000030929416,0.00017846865,0.00009584555,0.000059408205,0.000037964168,0.000073109135,0.000003889279],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039658093,0.0038076832,0.9677255,0.00024949253,0.000519583,0.00012279663,0.0013742816,4.2541032e-7,0.014617664,0.000098450284,0.0010743552,0.0100131845],"study_design_scores_gemma":[0.038733136,0.023170393,0.92041934,0.00043252358,0.002943091,0.000108119966,0.0070699663,0.00037483568,0.0018870328,0.0007036106,0.0035107778,0.0006471662],"about_ca_topic_score_codex":0.00012784362,"about_ca_topic_score_gemma":0.00005108633,"teacher_disagreement_score":0.047306154,"about_ca_system_score_codex":0.000020252332,"about_ca_system_score_gemma":0.00006617735,"threshold_uncertainty_score":0.4628995},"labels":[],"label_agreement":null},{"id":"W4405126133","doi":"10.1182/blood-2024-205641","title":"A CD33-Deleted Allograft (Trem-cel) Enables Post-Hematopoietic Cell Transplant (HCT) Maintenance Dosing of Gemtuzumab Ozogamicin (GO) with Therapeutic Levels of Drug Exposure and Low Hematologic and Hepatic Toxicity in Patients with High-Risk Acute Myeloid Leukemia (AML)","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Gemtuzumab ozogamicin; Calicheamicin; Dosing; Medicine; Toxicity; CD33; Pharmacology; Hematopoietic cell; Hematopoietic stem cell transplantation; Drug; Haematopoiesis; Internal medicine; Transplantation; Stem cell; Myeloid leukemia; Biology; CD34","score_opus":0.0047083901957352845,"score_gpt":0.19473791786580147,"score_spread":0.19002952767006617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405126133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994651,0.0035298613,0.00009228146,0.00007273488,0.000030281986,0.0012719752,0.00023641824,0.00007753273,0.0000379099],"genre_scores_gemma":[0.99768746,0.0006503815,0.0013340639,0.00006100389,0.00001047991,0.00004462385,0.000060970295,0.00007465963,0.00007635198],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974648,0.00013112827,0.00067456916,0.0007046389,0.0004934132,0.00053145795],"domain_scores_gemma":[0.9986888,0.00025782333,0.00029048033,0.0004736421,0.00014188871,0.00014735253],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020709369,0.00051504234,0.0010887128,0.00028816346,0.00006398545,0.000028585291,0.00013961007,0.00017654356,0.00002066482],"category_scores_gemma":[0.000017113021,0.00033934155,0.00008609163,0.00045877576,0.00033106864,0.00015085851,0.000050059465,0.00039003792,0.0000013950876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030667204,0.0027638276,0.87729806,0.008340555,0.0024311098,0.0013133923,0.010129052,0.00008332601,0.09225197,0.00008906209,0.000009725759,0.0022232025],"study_design_scores_gemma":[0.055661716,0.007144388,0.6133929,0.010109494,0.005759753,0.00090498535,0.00086452084,0.00092776254,0.30418122,0.0001972148,0.0000059051863,0.0008501868],"about_ca_topic_score_codex":0.00059578405,"about_ca_topic_score_gemma":0.00038145066,"teacher_disagreement_score":0.2639052,"about_ca_system_score_codex":0.00033586915,"about_ca_system_score_gemma":0.0005452356,"threshold_uncertainty_score":0.9999059},"labels":[],"label_agreement":null},{"id":"W4405126143","doi":"10.1182/blood-2024-200290","title":"High-Risk Subgroups and MRD: An Updated Analysis of the Phase 3 ECHO Trial of Acalabrutinib with Bendamustine/Rituximab in Previously Untreated Mantle Cell Lymphoma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Cilag; Pharmacyclics; Swedish Orphan Biovitrum; F. Hoffmann-La Roche; Incyte; BeiGene; Regeneron Pharmaceuticals; Gilead Sciences; MorphoSys; Celgene; AstraZeneca; Eli Lilly and Company; GlaxoSmithKline; Amgen","keywords":"Bendamustine; Mantle cell lymphoma; Medicine; Internal medicine; Rituximab; Oncology; Phases of clinical research; Lymphoma; Clinical trial","score_opus":0.007631377048258434,"score_gpt":0.2546233731632256,"score_spread":0.24699199611496714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405126143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99759555,0.0009374748,0.000002775269,0.00008230878,0.0000482636,0.0008022585,0.00027935058,0.000038922506,0.0002130747],"genre_scores_gemma":[0.99904865,0.00025680085,0.00020794109,0.000020061812,0.000038496197,0.00004114118,0.00029546808,0.00002360358,0.000067838984],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9985438,0.000115489835,0.00045989492,0.00038729727,0.0002770761,0.00021646821],"domain_scores_gemma":[0.99909043,0.0000994413,0.0001714329,0.00046838913,0.000066679706,0.00010364378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020396129,0.00021335714,0.0007162765,0.00031470307,0.000035542023,0.000022729211,0.000096780685,0.00010303693,0.000075547396],"category_scores_gemma":[0.000022914935,0.000121749275,0.00015334402,0.001366021,0.00009874687,0.000064589694,0.000041796437,0.000074043186,0.0000023241216],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042761516,0.14083709,0.7465192,0.0007271971,0.015533099,0.001382349,0.004231038,0.00008590054,0.0058923787,0.00043947893,0.00028058843,0.04131015],"study_design_scores_gemma":[0.6040331,0.0071342257,0.2212021,0.00037527573,0.039050397,0.000051586678,0.00026416575,0.0018529227,0.12552968,0.00002563762,0.00020308391,0.00027782586],"about_ca_topic_score_codex":0.0020840194,"about_ca_topic_score_gemma":0.00055918976,"teacher_disagreement_score":0.5612716,"about_ca_system_score_codex":0.000049404163,"about_ca_system_score_gemma":0.00016484411,"threshold_uncertainty_score":0.49647912},"labels":[],"label_agreement":null},{"id":"W4405126145","doi":"10.1182/blood-2024-205666","title":"A Phase 3 Randomized Trial for Patients with De Novo AML Comparing Standard Therapy Including Gemtuzumab Ozogamicin (GO) to CPX-351 with GO - a Report from the Children's Oncology Group","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Servier; Astellas Pharma; Syndax Pharmaceuticals; Incyte; Jazz Pharmaceuticals; Celgene","keywords":"Gemtuzumab ozogamicin; Medicine; Oncology; Internal medicine; Randomized controlled trial","score_opus":0.017494706870459512,"score_gpt":0.3249208257903451,"score_spread":0.3074261189198856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405126145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989258,0.0005032618,0.0057632406,0.00025058712,0.00015707493,0.0036108356,0.0002101797,0.000041615083,0.00020520831],"genre_scores_gemma":[0.99517405,0.000041252566,0.0023361363,0.00016073568,0.00069879583,0.0007088343,0.00071306154,0.000070236034,0.000096898744],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99788755,0.0002600228,0.00040540379,0.0006398998,0.0003671105,0.00044002745],"domain_scores_gemma":[0.9988404,0.00026221006,0.00012678932,0.0004801326,0.00015341496,0.00013707507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009393611,0.00026138892,0.00055653154,0.00007505627,0.00020716422,0.00010123269,0.00027676922,0.00015035464,0.000011259092],"category_scores_gemma":[0.00032965525,0.00016027164,0.00017021479,0.00017876623,0.00017085586,0.0000083065015,0.00012659603,0.00023215407,0.000003982005],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93411165,0.001931737,0.001651019,0.000017436318,0.0015207367,0.00014511953,0.0007390055,0.000024605732,0.054093316,0.000018576175,0.0023344918,0.003412301],"study_design_scores_gemma":[0.88950044,0.008848115,0.0000902946,0.00010785392,0.00023596268,0.000090396374,0.000032564607,0.000055077606,0.08168086,0.000019154928,0.019034717,0.00030454385],"about_ca_topic_score_codex":0.00014493847,"about_ca_topic_score_gemma":0.0002736997,"teacher_disagreement_score":0.04461119,"about_ca_system_score_codex":0.00012810697,"about_ca_system_score_gemma":0.00052225514,"threshold_uncertainty_score":0.65356874},"labels":[],"label_agreement":null},{"id":"W4405126155","doi":"10.1182/blood-2024-211780","title":"Diagnostic Test Accuracy of Serum and Urine Immunofixation and Free Light Chains in the Diagnosis of Light Chain Amyloidosis: A Systematic Review and Meta-Analysis","year":2024,"lang":"en","type":"review","venue":"Blood","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; University of British Columbia; Princess Margaret Cancer Centre","funders":"","keywords":"Immunoglobulin light chain; Immunofixation; Amyloidosis; AL amyloidosis; Medicine; Meta-analysis; Multiple myeloma; Monoclonal gammopathy of undetermined significance; Internal medicine; Pathology; Monoclonal; Immunology; Antibody","score_opus":0.026486862851039097,"score_gpt":0.3044857645176502,"score_spread":0.2779989016666111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405126155","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010974834,0.9933315,0.0000013391802,0.0012670174,0.000016865506,0.0033935425,0.0008618656,0.000009764675,0.000020651749],"genre_scores_gemma":[0.019747714,0.97579277,0.000047054098,0.00017374913,0.000028875242,0.003946419,0.0001331451,0.00005542579,0.00007485865],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9965028,0.0006322486,0.0015545484,0.0007654112,0.0002765663,0.00026840155],"domain_scores_gemma":[0.9950494,0.00222145,0.0012389444,0.001322457,0.00008963981,0.00007808166],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009523808,0.0007104549,0.0050328807,0.00036048453,0.000054111268,0.000058924776,0.00050021824,0.00031286015,0.000016630725],"category_scores_gemma":[0.0051735006,0.00040438515,0.0011992978,0.00085125124,0.00010550783,0.0000126623845,0.00044745073,0.00019567624,0.0000020550945],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000018102771,0.0009090197,0.0024691564,0.88067317,0.114091545,0.00002848318,0.00021962795,1.40152e-7,0.000022641052,0.000075466414,0.00029312272,0.0012158315],"study_design_scores_gemma":[0.00049554044,0.00029085664,0.00043729128,0.033411838,0.96002465,0.00007570236,0.00006138776,5.4633534e-7,0.00048046518,0.000014568708,0.004260181,0.00044698027],"about_ca_topic_score_codex":0.00005366492,"about_ca_topic_score_gemma":0.00016604346,"teacher_disagreement_score":0.8472613,"about_ca_system_score_codex":0.000016075202,"about_ca_system_score_gemma":0.00006830649,"threshold_uncertainty_score":0.9998408},"labels":[],"label_agreement":null},{"id":"W4405126172","doi":"10.1182/blood-2024-201784","title":"CD19-CAR T Cells As Definitive Consolidation for Older Adults with B-Cell Acute Lymphoblastic Leukemia in First Complete Remission: A Pilot Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lymphoblastic Leukemia; Medicine; Acute lymphocytic leukemia; CD19; Leukemia; Immunology; Internal medicine; Cancer research; Flow cytometry","score_opus":0.02819512710747323,"score_gpt":0.2907933705097839,"score_spread":0.26259824340231064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405126172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99140185,0.00027303057,0.00012108882,0.00018523246,0.00010732651,0.0034182717,0.00007352233,0.0001073087,0.00431238],"genre_scores_gemma":[0.9954591,0.00009450784,0.000355759,0.00014063006,0.00015066461,0.00043443777,0.00009546203,0.000081228645,0.0031882217],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998081,0.00007605781,0.00033092155,0.0006025021,0.00048527878,0.0004241883],"domain_scores_gemma":[0.99855036,0.00066895375,0.000053065312,0.00035911563,0.00017661313,0.0001919062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002884434,0.00025459353,0.00039494244,0.00025656525,0.00009141464,0.000071306305,0.00012762722,0.00006809237,0.00063090195],"category_scores_gemma":[0.000060216844,0.00020273993,0.000068948255,0.00046276956,0.0000769092,0.00007520414,0.00005930255,0.0002742361,0.00016168765],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043095954,0.019293092,0.010068947,0.0049675023,0.003081113,0.0086798165,0.028925197,0.00010642647,0.87126225,0.00019901032,0.005816833,0.0045038587],"study_design_scores_gemma":[0.2722165,0.10032233,0.01598238,0.0121048195,0.0048934943,0.0012892049,0.014599139,0.010748796,0.5522407,0.0002936507,0.013177503,0.0021314868],"about_ca_topic_score_codex":0.00022499532,"about_ca_topic_score_gemma":0.00022272201,"teacher_disagreement_score":0.31902155,"about_ca_system_score_codex":0.00034845824,"about_ca_system_score_gemma":0.000744996,"threshold_uncertainty_score":0.82674944},"labels":[],"label_agreement":null},{"id":"W4405177404","doi":"10.1182/blood.2024025897","title":"Efficacy and safety of daratumumab in intermediate/high-risk smoldering multiple myeloma: final analysis of CENTAURUS","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Daratumumab; Multiple myeloma; Medicine; Oncology; Internal medicine; Lenalidomide","score_opus":0.019100284888633426,"score_gpt":0.2904791316358852,"score_spread":0.27137884674725177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405177404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973594,0.0018466148,0.00004213873,0.000029392591,0.00004188467,0.0003167162,0.00016095524,0.000023422688,0.00017946474],"genre_scores_gemma":[0.9986915,0.0005779797,0.000514701,0.0000032556763,0.000026268646,0.000013523955,0.00011270844,0.000014826489,0.00004522493],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987671,0.000057172634,0.000384369,0.00028547968,0.0002663369,0.00023953589],"domain_scores_gemma":[0.9992113,0.00031008144,0.00006445672,0.0002480609,0.000040589843,0.00012551881],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017914726,0.00013573999,0.0005013164,0.0006410834,0.00002633568,0.000011597193,0.00006806878,0.00006458322,0.00006777592],"category_scores_gemma":[0.00024394252,0.00010945681,0.00012562398,0.00082050555,0.0000988102,0.00005300919,0.000082355364,0.00019165731,0.000004290552],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012120777,0.0012630117,0.94557893,0.0003798308,0.0038353093,0.0005100003,0.00065824366,0.000038146754,0.0051984205,0.000041397187,0.000008069571,0.04127656],"study_design_scores_gemma":[0.011641334,0.00038742338,0.96871537,0.00031040685,0.001839458,0.000012499552,0.00008144113,0.0036637676,0.013224104,0.000009559589,0.000038538616,0.00007608955],"about_ca_topic_score_codex":0.00089675264,"about_ca_topic_score_gemma":0.00046707902,"teacher_disagreement_score":0.04120047,"about_ca_system_score_codex":0.000035497153,"about_ca_system_score_gemma":0.00006315884,"threshold_uncertainty_score":0.44635192},"labels":[],"label_agreement":null},{"id":"W4405177856","doi":"10.1182/blood.2024024965","title":"Tumor burden quantified by soluble B-cell maturation antigen and metabolic tumor volume determines myeloma CAR-T outcomes","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Medicine; Multiple myeloma; Oncology; Chimeric antigen receptor; Cohort; Internal medicine; Bone marrow; Immunology; Cancer; Immunotherapy","score_opus":0.017851523879817328,"score_gpt":0.28673564636660515,"score_spread":0.26888412248678784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405177856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833004,0.012795927,0.00002022468,0.0010229372,0.0003180713,0.00064830395,0.00003663082,0.00021565505,0.0016418379],"genre_scores_gemma":[0.9431105,0.00036510223,0.00037760017,0.0001457241,0.00040724388,0.00006016,0.00006750824,0.00008230987,0.055383798],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982155,0.00006463963,0.00032850145,0.0005018809,0.00045391012,0.00043557704],"domain_scores_gemma":[0.9991526,0.00009845741,0.000049859635,0.00040809665,0.000092235874,0.00019872218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029227373,0.00025563833,0.00048897986,0.00020919325,0.00009886698,0.00022853122,0.00013617439,0.00007582872,0.00090329495],"category_scores_gemma":[0.00006192769,0.00020778396,0.00014407828,0.0002570373,0.00009210691,0.00016546977,0.000086745,0.00026502484,0.00023637636],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012271144,0.00020101047,0.018123414,0.00038128614,0.0002668069,0.00047957417,0.00047234423,4.0380186e-7,0.969147,0.000038701,0.0056513697,0.0051153647],"study_design_scores_gemma":[0.0062921597,0.0005132386,0.06286906,0.00018576124,0.00082284416,0.0009374244,0.00034403676,0.0031056895,0.71397513,0.00012008972,0.21016274,0.0006718233],"about_ca_topic_score_codex":0.0003056692,"about_ca_topic_score_gemma":0.000028641249,"teacher_disagreement_score":0.2551719,"about_ca_system_score_codex":0.000019581294,"about_ca_system_score_gemma":0.00013019009,"threshold_uncertainty_score":0.9890446},"labels":[],"label_agreement":null},{"id":"W4405177945","doi":"10.1182/blood.2024025673","title":"Anti-CD19 antibody cotreatment enhances serial killing activity of anti-CD19 CAR-T/-NK cells and reduces trogocytosis","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"CD19; Chimeric antigen receptor; Antibody; Antigen; Effector; Monoclonal antibody; Biology; Cancer research; Immunology; Chemistry; Cell biology; T cell; Immune system","score_opus":0.022774162309239055,"score_gpt":0.32420242912402375,"score_spread":0.3014282668147847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405177945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99497384,0.0026635765,0.000021379452,0.00026687852,0.00052306213,0.0006589409,0.00008663055,0.000111364505,0.00069434126],"genre_scores_gemma":[0.9919318,0.0059031807,0.0002998871,0.000015229576,0.00056069053,0.000021963002,0.00002815974,0.000054992302,0.0011841097],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99798065,0.00011019187,0.00032106426,0.0005966183,0.00053962274,0.0004518711],"domain_scores_gemma":[0.99903965,0.00022097278,0.00008129426,0.0003738501,0.00009512895,0.00018909447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034267156,0.00028803205,0.0007195982,0.00023119328,0.00009354339,0.00009313994,0.00012358768,0.00015713592,0.00042869555],"category_scores_gemma":[0.000028252924,0.00023659864,0.00019886368,0.00038407298,0.00020956315,0.0001539248,0.00009071943,0.0002763867,0.000022125905],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023136007,0.00091409625,0.002798098,0.0005690934,0.0007550048,0.00017981247,0.0006586921,0.000002558791,0.9886509,0.000013066198,0.000066811386,0.0051604835],"study_design_scores_gemma":[0.0025710633,0.00087490503,0.003729173,0.00045117814,0.00054259604,0.00008387851,0.00015622804,0.000120092445,0.9903296,0.000016790296,0.00092448393,0.00019999534],"about_ca_topic_score_codex":0.00031239956,"about_ca_topic_score_gemma":0.000011531285,"teacher_disagreement_score":0.0049604885,"about_ca_system_score_codex":0.000055769746,"about_ca_system_score_gemma":0.00023213141,"threshold_uncertainty_score":0.9648213},"labels":[],"label_agreement":null},{"id":"W4405239574","doi":"10.1182/blood.2024025846","title":"An erythroid-specific lentiviral vector improves anemia and iron metabolism in a new model of XLSA","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Porphyrin Metabolism and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Acuitas Therapeutics (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Institutes of Health","keywords":"Biology; Erythropoiesis; Haematopoiesis; Bone marrow; Internal medicine; Transferrin saturation; Transplantation; Stem cell; Endocrinology; Anemia; Cancer research; Immunology; Medicine; Cell biology; Iron deficiency","score_opus":0.007896087228199811,"score_gpt":0.22933650265625263,"score_spread":0.22144041542805282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405239574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9613071,0.03747916,0.00043636956,0.000042901902,0.0000942812,0.0001000378,0.00002827544,0.000013364701,0.0004984963],"genre_scores_gemma":[0.99616176,0.0020617296,0.0012458734,0.000038425176,0.00016744019,0.000005914435,0.00004162537,0.000019791503,0.00025745542],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992203,0.000025663627,0.00016187792,0.00033319774,0.00008122912,0.00017771013],"domain_scores_gemma":[0.99965245,0.000004082224,0.000026818952,0.00023298273,0.000012667583,0.00007102484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009411314,0.00012988057,0.00015554937,0.00006357524,0.00001586543,0.000030337851,0.00011089238,0.0001105031,0.00000563891],"category_scores_gemma":[0.000010076039,0.00012120134,0.000053330776,0.00008491725,0.0000602309,0.000012197429,0.000051819385,0.00007424703,0.0000017786729],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030976025,0.00013490941,0.0003744527,0.000047798214,0.000015385473,0.0000027467838,0.00015523643,0.000028499744,0.9912941,0.0011563478,0.00028639354,0.0064731846],"study_design_scores_gemma":[0.0038029912,0.0002997523,0.02521548,0.000041427917,0.00017145622,0.000017385988,0.00021656588,0.0017771965,0.9528753,0.003032727,0.011973428,0.00057624467],"about_ca_topic_score_codex":0.000055146753,"about_ca_topic_score_gemma":0.000058884012,"teacher_disagreement_score":0.038418725,"about_ca_system_score_codex":0.0000015096458,"about_ca_system_score_gemma":0.00010825758,"threshold_uncertainty_score":0.4942447},"labels":[],"label_agreement":null},{"id":"W4405317049","doi":"10.1182/blood.2024026548","title":"FL molecular subgroups come of age","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Carbohydrate Chemistry and Synthesis","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine","score_opus":0.008898206175448242,"score_gpt":0.21590567699366078,"score_spread":0.20700747081821255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405317049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90971065,0.0012957811,0.00001096719,0.000042785872,0.000033644126,0.000012785305,0.000035848538,0.00009482536,0.0887627],"genre_scores_gemma":[0.9981759,0.000021885016,0.00007133379,0.000011069528,0.00008310401,0.0000071062595,0.000022825916,0.000019362247,0.0015874213],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99940056,0.00000486941,0.00015393236,0.0001800528,0.0001289839,0.00013161956],"domain_scores_gemma":[0.9995793,0.00006016942,0.000020859392,0.00027719207,0.000013713761,0.000048748894],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00004913064,0.00009839464,0.00014303034,0.000019501213,0.000014739249,0.000027250966,0.0001382683,0.00009035536,0.0010732689],"category_scores_gemma":[0.000030435453,0.00009661995,0.00012894606,0.000101352685,0.000044019984,0.000025537196,0.000038249986,0.00010568041,0.000031730906],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000030637775,0.000103619794,0.00015037668,0.0005261585,0.00010091817,0.0005311635,0.00008021092,0.0000012769268,0.9977013,0.00041317492,0.0000844926,0.0003042467],"study_design_scores_gemma":[0.00016876377,0.0000038213216,0.000016492078,0.00010415236,0.000109431836,0.000026696296,0.00003762094,0.000030259942,0.9958617,0.00036767955,0.0031669647,0.00010642465],"about_ca_topic_score_codex":0.000010704189,"about_ca_topic_score_gemma":8.3487487e-7,"teacher_disagreement_score":0.08846523,"about_ca_system_score_codex":0.000008898373,"about_ca_system_score_gemma":0.000020229405,"threshold_uncertainty_score":0.9998399},"labels":[],"label_agreement":null},{"id":"W4405537000","doi":"10.1182/blood.2024025690","title":"Heme promotes venetoclax resistance in multiple myeloma through MEK-ERK signaling and purine biosynthesis","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of Neurological Disorders and Stroke; National Institute of General Medical Sciences; National Eye Institute; Pfizer; National Heart, Lung, and Blood Institute; Genentech; National Institutes of Health; Regeneron Pharmaceuticals; National Cancer Institute; Emory University; Amgen; Georgia Institute of Technology; Cancer Prevention and Research Institute of Texas; GlaxoSmithKline","keywords":"Heme; Biochemistry; Hemin; Biology; Globin; Chemistry; Cancer research; Enzyme; Hemoglobin","score_opus":0.03149116940997665,"score_gpt":0.2897438552208521,"score_spread":0.25825268581087546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405537000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830041,0.013918305,0.000022341463,0.00077622203,0.00003847139,0.00064241985,0.00003426453,0.00012320244,0.0014406671],"genre_scores_gemma":[0.99095213,0.00033001194,0.0076798433,0.00003599313,0.00012581074,0.00010094124,0.000025169118,0.00003838803,0.00071173086],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985698,0.000051843574,0.00023963538,0.00044370143,0.00029493286,0.00040011437],"domain_scores_gemma":[0.9992448,0.00029703474,0.000024602474,0.00025423543,0.000035975074,0.00014335375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017696542,0.0001878783,0.0002909901,0.00014186041,0.00007158305,0.00006094356,0.00007215504,0.000081672464,0.00008335709],"category_scores_gemma":[0.0003278176,0.00015081266,0.00006583252,0.0003305378,0.00007965763,0.000121237324,0.00005981757,0.00018668034,0.000050945848],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019327312,0.003048183,0.41883096,0.006063876,0.0023491362,0.017356925,0.0050412985,0.0000052543446,0.5107247,0.0016301685,0.00069026445,0.032326482],"study_design_scores_gemma":[0.011894546,0.00069797883,0.1533757,0.0037569045,0.00041710722,0.00023629038,0.00026290247,0.0013446423,0.8151835,0.0023286494,0.009937133,0.0005645993],"about_ca_topic_score_codex":0.00013425655,"about_ca_topic_score_gemma":0.0002604911,"teacher_disagreement_score":0.30445883,"about_ca_system_score_codex":0.00008559061,"about_ca_system_score_gemma":0.00013557462,"threshold_uncertainty_score":0.6149962},"labels":[],"label_agreement":null},{"id":"W4405537904","doi":"10.1182/blood.2024026476","title":"Deficiency of neutrophil gelatinase-associated lipocalin elicits a hemophilia-like bleeding and clotting disorder in mice","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"Canadian Institutes of Health Research; Natural Science Foundation of Shandong Province; Qingdao University; National Natural Science Foundation of China; Qingdao Key Health Discipline Development Fund; National Science Foundation","keywords":"Hemostasis; Medicine; Immunology; Coagulation; Thrombus; Platelet activation; Platelet; Internal medicine","score_opus":0.015633271218215162,"score_gpt":0.2584613749854385,"score_spread":0.2428281037672233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405537904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99426055,0.0034345358,0.000066692824,0.0005196037,0.0001418687,0.0002478972,0.000006667811,0.00010658863,0.001215608],"genre_scores_gemma":[0.99907374,0.000134643,0.00041412353,0.00015283252,0.000049787086,0.00001053292,0.000010667188,0.00003018897,0.00012349142],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988075,0.00004102115,0.0003819595,0.00030055188,0.00022696595,0.00024199925],"domain_scores_gemma":[0.9995599,0.00011667398,0.00007151823,0.00011643098,0.000056069763,0.00007940665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031865694,0.00014644982,0.00030934694,0.0002202592,0.000047653426,0.000024338779,0.00005256774,0.00012490372,0.000029009556],"category_scores_gemma":[0.00012931171,0.00013701129,0.000066415654,0.0006126274,0.000036775742,0.0000764308,0.000051727573,0.00021924477,0.000008094883],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000716719,0.0037093195,0.109967045,0.001553916,0.00036004258,0.00021434332,0.004327613,0.00008255132,0.8512628,0.018710537,0.00008077897,0.009659354],"study_design_scores_gemma":[0.040169973,0.0045873877,0.6012182,0.010133729,0.0052669304,0.00078105193,0.004451082,0.08625622,0.22968769,0.013504323,0.0015105796,0.0024327931],"about_ca_topic_score_codex":0.000098627395,"about_ca_topic_score_gemma":0.000041236322,"teacher_disagreement_score":0.6215751,"about_ca_system_score_codex":0.000020268577,"about_ca_system_score_gemma":0.00005622438,"threshold_uncertainty_score":0.5587158},"labels":[],"label_agreement":null},{"id":"W4405589202","doi":"10.1182/blood.2024026299","title":"Long-term efficacy and safety of danicopan as add-on therapy to ravulizumab or eculizumab in PNH with significant EVH","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Samsung; Novo Nordisk; Argenx; Incyte; Regeneron Pharmaceuticals; Alexion Pharmaceuticals; Swedish Orphan Biovitrum; Apellis Pharmaceuticals; BioCryst; Janssen Pharmaceuticals; Gilead Sciences; Sanofi; Celgene; Universität Ulm; Bristol-Myers Squibb; AstraZeneca; Amgen; Pfizer; Chugai Pharmaceutical; Agios Pharmaceuticals","keywords":"Eculizumab; Medicine; Term (time); Intensive care medicine; Pediatrics; Immunology; Antibody; Complement system; Physics","score_opus":0.01853142794094673,"score_gpt":0.28125842139029833,"score_spread":0.2627269934493516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405589202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99387944,0.0040419325,0.000013263766,0.00015425599,0.0001486501,0.0009738776,0.000090399,0.00007578672,0.00062241557],"genre_scores_gemma":[0.999117,0.00013537805,0.000018731305,0.000075594064,0.000024241806,0.00006706119,0.000054447704,0.000026849706,0.0004806711],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987196,0.00017012982,0.00034256183,0.00042661052,0.000061812745,0.00027929698],"domain_scores_gemma":[0.99921906,0.00029667155,0.000057093162,0.0003585952,0.000027949969,0.000040632254],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013726806,0.00020951538,0.00033716916,0.00017432997,0.000053401458,0.000023488697,0.00020343819,0.00008248157,0.0011537507],"category_scores_gemma":[0.00004171269,0.00014218608,0.000045330653,0.00022843634,0.000089757305,0.000040822004,0.00007012877,0.0001347033,0.00018378826],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051592633,0.008981476,0.12194814,0.0012772129,0.0038405,0.0016134748,0.007408874,0.000060243445,0.7131317,0.0062041464,0.004748914,0.07919265],"study_design_scores_gemma":[0.041976847,0.011960465,0.6927798,0.0034413114,0.00036697686,0.00054878276,0.0006098414,0.0000026513578,0.23532179,0.00006365569,0.011996546,0.00093137275],"about_ca_topic_score_codex":0.00006812985,"about_ca_topic_score_gemma":0.00012451512,"teacher_disagreement_score":0.5708316,"about_ca_system_score_codex":0.000029785217,"about_ca_system_score_gemma":0.00014790714,"threshold_uncertainty_score":0.9997593},"labels":[],"label_agreement":null},{"id":"W4406120286","doi":"10.1182/blood.2024025402","title":"Selenoprotein-mediated redox regulation shapes the cell fate of HSCs and mature lineages","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Selenium in Biological Systems","field":"Nursing","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Research Foundation","funders":"","keywords":"Selenoprotein; Biology; Haematopoiesis; Cell biology; Stem cell; Downregulation and upregulation; Myeloid; Hematopoietic stem cell; Immunology; Genetics; Oxidative stress; Biochemistry; Gene; Glutathione peroxidase; Superoxide dismutase","score_opus":0.007130117976179345,"score_gpt":0.22260327084490317,"score_spread":0.21547315286872382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406120286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935586,0.0024866262,0.000028822415,0.0013151306,0.00019517697,0.00042158726,0.000013412955,0.00008152219,0.0018991344],"genre_scores_gemma":[0.99898726,0.000025393332,0.000328758,0.00014371653,0.000109324166,0.000014918007,0.000013066754,0.000007860125,0.0003696974],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99918723,0.00013381499,0.00023711027,0.00019126775,0.0001098681,0.00014070059],"domain_scores_gemma":[0.9993627,0.00025598245,0.0001242307,0.00017148249,0.00006376575,0.000021842254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023208736,0.00010429146,0.00016968756,0.000038740698,0.00008176578,0.0000251754,0.00013835623,0.00018290183,0.000016759415],"category_scores_gemma":[0.00016790097,0.00006302245,0.000034200537,0.00023533328,0.000096369986,0.00003213332,0.000043441425,0.0001407157,0.00000614973],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009409341,0.00014941108,0.012232068,0.0002077448,0.00003813761,6.4422863e-7,0.00030776803,0.0000117072605,0.9846527,0.0002564489,0.000979083,0.0010701896],"study_design_scores_gemma":[0.001210495,0.00015452395,0.1581135,0.00016247378,0.00012269578,0.0000050186054,0.0001840084,0.00042726964,0.8332033,0.0010772782,0.005198718,0.00014070181],"about_ca_topic_score_codex":0.000039324463,"about_ca_topic_score_gemma":0.000005831757,"teacher_disagreement_score":0.15144938,"about_ca_system_score_codex":0.000008040254,"about_ca_system_score_gemma":0.000006502637,"threshold_uncertainty_score":0.25699812},"labels":[],"label_agreement":null},{"id":"W4406158698","doi":"10.1182/blood.2024026515","title":"Introduction to a series of reflections on a quarter century of TKIs for CML","year":2025,"lang":"en","type":"review","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Series (stratigraphy); History; Medicine; Biology","score_opus":0.034431397373121723,"score_gpt":0.3589982414632105,"score_spread":0.3245668440900888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406158698","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000061457526,0.99433726,0.00003935956,0.000491097,0.0005295015,0.002715292,0.00026725064,0.000036404945,0.0015223792],"genre_scores_gemma":[0.000017244301,0.9919932,0.002256131,0.000026863645,0.00083655067,0.0005624294,0.00026430303,0.000029194865,0.0040140953],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988343,0.000039815422,0.0004989472,0.00032952253,0.00014615494,0.00015125549],"domain_scores_gemma":[0.99896485,0.00010735863,0.00022118574,0.0005342328,0.000118817145,0.00005354466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008256627,0.00022211256,0.0012565759,0.0003358921,0.000026482889,0.0000030276753,0.00006915914,0.0001721408,0.00006007032],"category_scores_gemma":[0.00023430276,0.00017531535,0.00040875486,0.0004067973,0.000023982973,0.000020118741,0.0000232544,0.00013345352,0.000013945594],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047462608,0.0036351322,0.000008449329,0.19611463,0.004381111,0.000010941759,0.0005770975,7.3540787e-7,0.00023184987,0.0010728562,0.037983425,0.75550914],"study_design_scores_gemma":[0.001547701,0.0015720538,0.000004501352,0.014355369,0.005184474,0.000058348294,0.000037948343,5.127779e-8,0.00043720426,0.000013132627,0.97669274,0.00009649103],"about_ca_topic_score_codex":0.000021793294,"about_ca_topic_score_gemma":0.000016427826,"teacher_disagreement_score":0.9387093,"about_ca_system_score_codex":0.00029552003,"about_ca_system_score_gemma":0.0007533571,"threshold_uncertainty_score":0.7149152},"labels":[],"label_agreement":null},{"id":"W4406213558","doi":"10.1182/blood.2024027362","title":"Doubling down on GPRC5D in multiple myeloma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Multiple myeloma; Doubling time; Lenalidomide; Medicine; Internal medicine; Biology; Genetics","score_opus":0.031297875336970093,"score_gpt":0.3166248728459736,"score_spread":0.28532699750900353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406213558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96969664,0.0002678946,0.0000130992885,0.0008167164,0.00006528347,0.00045982195,0.000007048121,0.000057178502,0.028616304],"genre_scores_gemma":[0.9966636,0.000037120004,0.0005894806,0.00027163868,0.00005381042,0.00006609964,0.000029395887,0.000010639256,0.0022782441],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990074,0.000030589406,0.00017079493,0.00025491646,0.00021718828,0.00031912085],"domain_scores_gemma":[0.99938756,0.00014743075,0.000018734796,0.00029382008,0.000039020393,0.00011342601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011552182,0.00011695359,0.0002047178,0.00031569874,0.000056957786,0.000019406507,0.000076165845,0.00007029264,0.000086338376],"category_scores_gemma":[0.00031300733,0.00009365146,0.00006353652,0.0003494309,0.000029008797,0.000035454796,0.00004401992,0.00019906499,0.00016715155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000791082,0.0028911454,0.95787597,0.00010746581,0.00021654014,0.000806246,0.00009283773,0.0000065958397,0.0067644226,0.0005473,0.00042701713,0.029473359],"study_design_scores_gemma":[0.028562702,0.0003815246,0.90946764,0.00040507596,0.00006569965,0.000016811819,0.000063837266,0.00044454186,0.056826927,0.00014297041,0.0035068807,0.00011541842],"about_ca_topic_score_codex":0.00017776225,"about_ca_topic_score_gemma":0.00013413084,"teacher_disagreement_score":0.050062504,"about_ca_system_score_codex":0.00005654085,"about_ca_system_score_gemma":0.00010585374,"threshold_uncertainty_score":0.38189957},"labels":[],"label_agreement":null},{"id":"W4406364656","doi":"10.1182/blood.2023022416","title":"How I diagnose and treat systemic mastocytosis with an associated hematologic neoplasm","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Systemic mastocytosis; Medicine; Myeloproliferative neoplasm; Hematologic Neoplasms; Internal medicine; Quality of life (healthcare); Systemic therapy; Clinical trial; Oncology; Intensive care medicine; Bone marrow; Cancer; Myelofibrosis","score_opus":0.00576380637186202,"score_gpt":0.1898144024530972,"score_spread":0.18405059608123517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406364656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99180984,0.004980251,0.000027739983,0.0002485194,0.00008505834,0.00020118337,0.000027946675,0.000093794355,0.0025256723],"genre_scores_gemma":[0.98209476,0.0001281025,0.00004034987,0.00006821799,0.0000058024825,0.000041381372,0.00006610473,0.000008825554,0.017546467],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999304,0.00007645075,0.00011363416,0.0002629454,0.00001733271,0.00022563501],"domain_scores_gemma":[0.99958366,0.00009586352,0.00006840065,0.00019588637,0.000036304005,0.000019870813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006433833,0.00014946726,0.00029761254,0.00007749203,0.00014874546,0.000035856632,0.00009475343,0.00019764788,0.00004056998],"category_scores_gemma":[0.000031162323,0.00010967485,0.000027729391,0.00011579194,0.00011081362,0.00005388755,0.000038731032,0.0001223202,0.000016510761],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006243788,0.0051781395,0.48994336,0.0008380213,0.0024409753,0.0003998958,0.0015362309,0.000002936516,0.47032055,0.01687473,0.0038652634,0.0079755215],"study_design_scores_gemma":[0.08329652,0.008279627,0.19162141,0.002436813,0.0060048182,0.0053804843,0.0073070694,0.000034959186,0.6382728,0.0014026508,0.052880757,0.0030821026],"about_ca_topic_score_codex":0.00007159905,"about_ca_topic_score_gemma":0.0002361273,"teacher_disagreement_score":0.29832196,"about_ca_system_score_codex":0.000014498763,"about_ca_system_score_gemma":0.00002511451,"threshold_uncertainty_score":0.44724107},"labels":[],"label_agreement":null},{"id":"W4406364705","doi":"10.1182/blood.2024026598","title":"Precision medicine for high-risk gene fusions in pediatric AML: a focus on <i>KMT2A</i>, <i>NUP98</i>, and <i>GLIS2</i> rearrangements","year":2025,"lang":"en","type":"review","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute","keywords":"Oncology; Medicine; Bioinformatics; Fusion gene; Cancer research; Gene; Biology; Internal medicine; Genetics","score_opus":0.02961268909233812,"score_gpt":0.3402455250403277,"score_spread":0.31063283594798957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406364705","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009574238,0.98776466,0.00006998671,0.00059153244,0.0003778456,0.007014273,0.00057789683,0.00012349838,0.0025228674],"genre_scores_gemma":[0.00011224307,0.99181384,0.0015967264,0.00027244075,0.0016086051,0.001423006,0.00065358606,0.00015912857,0.0023604238],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99490285,0.00044449331,0.0013979141,0.001408733,0.0009556901,0.0008903117],"domain_scores_gemma":[0.99498993,0.0025793903,0.0005079611,0.0012649472,0.00022386386,0.00043393322],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016755617,0.00085810776,0.0032302712,0.0017808111,0.00019646599,0.000035068308,0.0005252658,0.0008100675,0.0000636642],"category_scores_gemma":[0.0025445395,0.00062439044,0.00040040133,0.0018167427,0.0001276985,0.00006817564,0.00046775964,0.0015160282,0.000049865204],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003314423,0.0010562597,0.0004776822,0.03069244,0.00044901858,0.0002452802,0.00010285068,2.5581411e-7,0.000017863247,0.00010934621,0.03468421,0.9318333],"study_design_scores_gemma":[0.027185984,0.0033340065,0.0005581188,0.038418088,0.016172286,0.00015568253,0.000027649696,0.0000066816137,0.00007719101,0.00063426216,0.91249615,0.0009339207],"about_ca_topic_score_codex":0.00035449996,"about_ca_topic_score_gemma":0.00008508188,"teacher_disagreement_score":0.93089944,"about_ca_system_score_codex":0.00032424135,"about_ca_system_score_gemma":0.0011571464,"threshold_uncertainty_score":0.99962074},"labels":[],"label_agreement":null},{"id":"W4406697636","doi":"10.1182/blood.2024025886","title":"FLT3 is genetically essential for ITD-mutated leukemic stem cells but dispensable for human hematopoietic stem cells","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada); Ontario Institute for Cancer Research; University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Stem cell; Haematopoiesis; Cancer research; Bone marrow; Biology; Leukemia; Hematopoietic stem cell; Immunology; Medicine; Cell biology","score_opus":0.020021129057359803,"score_gpt":0.300367644487132,"score_spread":0.2803465154297722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406697636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820902,0.000515859,0.009578261,0.001040475,0.0003433314,0.0043420307,0.00028158718,0.00018843258,0.0016198341],"genre_scores_gemma":[0.9130765,0.00008013451,0.0035011566,0.0007894294,0.00039481008,0.00065271417,0.00009409053,0.00014783975,0.08126332],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99684197,0.00007058179,0.00073098217,0.0008474684,0.0004790326,0.0010299573],"domain_scores_gemma":[0.9978109,0.0004201584,0.00013241865,0.0008643901,0.0004500404,0.00032207396],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043769975,0.00039846762,0.0007860569,0.0002559387,0.00030484732,0.00010778427,0.0004716702,0.00033459297,0.00017598865],"category_scores_gemma":[0.000023136909,0.00037081892,0.0003724258,0.0003903657,0.00019447325,0.00006631614,0.00020680965,0.00036178454,0.00015113648],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045178545,0.0007136441,0.0002175269,0.002055945,0.00060466904,0.00005955696,0.00027852113,0.000013819319,0.96542656,0.0011362903,0.028088108,0.0009535709],"study_design_scores_gemma":[0.014113074,0.0006153968,0.000057506382,0.00026869684,0.0009861109,0.00003236621,0.0003690967,0.001795535,0.97405946,0.0005066243,0.006863341,0.00033278167],"about_ca_topic_score_codex":0.000061292434,"about_ca_topic_score_gemma":0.0000140782395,"teacher_disagreement_score":0.07964349,"about_ca_system_score_codex":0.00032564867,"about_ca_system_score_gemma":0.000935039,"threshold_uncertainty_score":0.99987435},"labels":[],"label_agreement":null},{"id":"W4406854667","doi":"10.1182/blood.2024025355","title":"Integrative genomic analysis of DLBCL identifies immune environments associated with bispecific antibody response","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Spinal Cord Injury BC; BC Cancer Agency","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute","keywords":"Diffuse large B-cell lymphoma; Immune system; Germinal center; CD19; Immunotherapy; Chimeric antigen receptor; B cell; T cell; Cancer research; Lymphoma; CD20; Biology; Immunology; Antibody","score_opus":0.013690929479762403,"score_gpt":0.3065875653718829,"score_spread":0.2928966358921205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406854667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99611723,0.00074364647,0.000116850606,0.00014970949,0.000031022693,0.00035241028,0.000042217813,0.000022056965,0.0024248578],"genre_scores_gemma":[0.9545522,0.00021659525,0.00004759072,0.00002739039,0.000009151558,0.00001548705,0.00015007149,0.000017724293,0.044963833],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998475,0.00026922268,0.00034145458,0.0002964731,0.00038426646,0.00023359075],"domain_scores_gemma":[0.99885744,0.0003453571,0.00013105603,0.00053212856,0.00007896298,0.00005502711],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00069557823,0.00015658367,0.00059987506,0.0008836432,0.00006108574,0.000021828931,0.00016054919,0.000086777036,0.0009879472],"category_scores_gemma":[0.00024410212,0.00011963633,0.0002204625,0.0016147194,0.00022086948,0.00004018406,0.00007499688,0.00022061025,0.000015911088],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002504886,0.0012243821,0.09892147,0.000012013121,0.010085155,0.000049497117,0.0005685263,0.000007043159,0.886305,0.000017757058,0.000037046077,0.00026724208],"study_design_scores_gemma":[0.0037911267,0.0003138241,0.7470417,0.00011621666,0.0028381418,0.0000019408117,0.00050740386,0.000058636895,0.24485502,0.0000134859765,0.00037943755,0.00008304028],"about_ca_topic_score_codex":0.000085723346,"about_ca_topic_score_gemma":0.000059263348,"teacher_disagreement_score":0.6481202,"about_ca_system_score_codex":0.00014104263,"about_ca_system_score_gemma":0.00013486574,"threshold_uncertainty_score":0.99992526},"labels":[],"label_agreement":null},{"id":"W4406973106","doi":"10.1182/blood.2024026899","title":"Sickle cell trait does not cause “sickle cell crisis” leading to exertion-related death: a systematic review","year":2025,"lang":"en","type":"review","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Sickle cell trait; Sickle cell anemia; Disease; Population; Vaso-occlusive crisis; Acute chest syndrome; Cause of death; Exertion; Internal medicine; Intensive care medicine; Physical therapy","score_opus":0.02036048465167106,"score_gpt":0.2958700887147489,"score_spread":0.27550960406307784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406973106","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000034199504,0.9828226,0.000015753305,0.00047011807,0.00047210924,0.008344123,0.0001183905,0.0002730007,0.007449718],"genre_scores_gemma":[0.000106973384,0.9738628,0.00016058444,0.0014710716,0.00008434579,0.0008171663,0.00021632537,0.00015371644,0.023126967],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99475235,0.0004181279,0.0024316008,0.0010159167,0.00060224626,0.00077974703],"domain_scores_gemma":[0.99686074,0.00037148118,0.00073871965,0.0013483992,0.0001899312,0.00049070525],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007299305,0.000985775,0.006106811,0.0005146108,0.00018962882,0.000064885775,0.0004952189,0.0009136064,0.00025630996],"category_scores_gemma":[0.0004818879,0.00063988793,0.0015908207,0.0012924572,0.000036262605,0.00007006334,0.00015429838,0.0011136043,0.0013924803],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000049059895,0.0007291856,8.421223e-7,0.98990715,0.00075242517,0.0002575121,0.00020624838,5.7091574e-7,0.000015193551,0.000033249158,0.0048514972,0.0032412286],"study_design_scores_gemma":[0.0013211587,0.00017611134,1.6545675e-7,0.8201141,0.058547415,0.00017819433,0.000157295,0.0000014491442,0.00009719238,0.0000085280435,0.118682794,0.0007156451],"about_ca_topic_score_codex":0.00005763972,"about_ca_topic_score_gemma":0.000005731964,"teacher_disagreement_score":0.16979308,"about_ca_system_score_codex":0.00017512441,"about_ca_system_score_gemma":0.0007234394,"threshold_uncertainty_score":0.99960524},"labels":[],"label_agreement":null},{"id":"W4407232257","doi":"10.1182/blood.2024027322","title":"No exit: targeting RNA export in T-cell malignancy","year":2025,"lang":"en","type":"letter","venue":"Blood","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Cancer Institute","keywords":"RNA; Cancer research; Malignancy; Medicine; Biology; Internal medicine; Genetics; Gene","score_opus":0.00835345472972341,"score_gpt":0.22615501824538198,"score_spread":0.21780156351565857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407232257","genre_codex":"other","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15530118,0.044674225,0.00059720053,0.13926795,0.003446387,0.0020982698,0.0006436124,0.00012429319,0.65384686],"genre_scores_gemma":[0.07008064,0.01233005,0.0032460405,0.57178617,0.016212728,0.00096888206,0.0082680825,0.0002468325,0.31686056],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987234,0.000043399996,0.00029565857,0.000512846,0.00012203311,0.00030268496],"domain_scores_gemma":[0.9992498,0.0000068550253,0.00012281931,0.0005161288,0.00007950272,0.000024854036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009957287,0.00022321928,0.0002007272,0.00012242101,0.00004257977,0.000026008745,0.0003036256,0.0006337855,0.000080073405],"category_scores_gemma":[0.000028967894,0.00023069064,0.00012093273,0.00014055395,0.000027450742,0.0000016655503,0.00009371653,0.00042384275,0.000042739117],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000038029466,0.000087199754,0.0002950547,0.00011910481,0.000029982975,0.000061843275,0.000005084574,0.0000013109708,0.091009766,0.0000033662457,0.9081556,0.00022784728],"study_design_scores_gemma":[0.0005419647,0.000040863382,0.00007200439,0.00006844024,0.000038291593,0.0000028910938,0.0000047771673,0.0000014558964,0.06921789,0.000014468131,0.9297435,0.0002534472],"about_ca_topic_score_codex":0.000034567085,"about_ca_topic_score_gemma":0.0000041747417,"teacher_disagreement_score":0.43251824,"about_ca_system_score_codex":0.00000972492,"about_ca_system_score_gemma":0.00016529976,"threshold_uncertainty_score":0.9407291},"labels":[],"label_agreement":null},{"id":"W4407396455","doi":"10.1182/blood.2024027347","title":"Three-year follow-up analysis of first-line axicabtagene ciloleucel for high-risk large B-cell lymphoma: the ZUMA-12 study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Internal medicine; Lymphoma; Leukapheresis; Fludarabine; Phases of clinical research; Gastroenterology; Chimeric antigen receptor; Surgery; Chemotherapy; Immunotherapy; Cancer; Cyclophosphamide","score_opus":0.021148801557246615,"score_gpt":0.2961322123846648,"score_spread":0.2749834108274182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407396455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99244624,0.00087578,0.0016593904,0.00051303685,0.00017056869,0.0020160489,0.0002222848,0.000056357556,0.0020402747],"genre_scores_gemma":[0.9873912,0.00021549358,0.00022207134,0.0001115949,0.00016843683,0.00022670726,0.00007941822,0.000040465915,0.011544628],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99777037,0.00010629885,0.000524047,0.0004995344,0.0006104996,0.00048925186],"domain_scores_gemma":[0.9975732,0.00057813164,0.0001629136,0.0012764739,0.00029904372,0.000110269735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001226889,0.00024564643,0.00081570336,0.00049228565,0.00024402433,0.000029550773,0.00041777274,0.00012571109,0.0007429613],"category_scores_gemma":[0.0002597333,0.00017252762,0.0005804468,0.0016119655,0.00007996856,0.00003259927,0.00019555211,0.00018996086,0.000013723801],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004335172,0.03721049,0.8986417,0.000394677,0.02654219,0.000057215544,0.0016469293,0.000036649253,0.0146891065,0.0005061699,0.004065826,0.011873864],"study_design_scores_gemma":[0.2922968,0.007924117,0.48669502,0.00015193703,0.06986938,0.000005512267,0.0033856842,0.0061599505,0.1101553,0.0013848413,0.021137875,0.0008335848],"about_ca_topic_score_codex":0.00090825616,"about_ca_topic_score_gemma":0.0057392824,"teacher_disagreement_score":0.41194668,"about_ca_system_score_codex":0.00006597576,"about_ca_system_score_gemma":0.00017202251,"threshold_uncertainty_score":0.8134905},"labels":[],"label_agreement":null},{"id":"W4407511940","doi":"10.1182/blood.2024027136","title":"QTLs unlock RBC storage hemolysis secrets","year":2025,"lang":"en","type":"letter","venue":"Blood","topic":"Advanced Glycation End Products research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre","funders":"","keywords":"Hemolysis; Biology; Medicine; Chemistry; Immunology","score_opus":0.01078355525185559,"score_gpt":0.27529716130594917,"score_spread":0.2645136060540936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407511940","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013439209,0.015081438,0.0064109117,0.89705306,0.0016828488,0.002104093,0.0011849863,0.00022496739,0.062818505],"genre_scores_gemma":[0.010669466,0.0017510904,0.0038162365,0.584028,0.013630235,0.0002550434,0.011897878,0.00021031508,0.37374172],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980211,0.00013579558,0.00024142998,0.00082196953,0.00033474283,0.00044490822],"domain_scores_gemma":[0.9983917,0.000030267747,0.00011255661,0.0011917256,0.00021428078,0.000059477774],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013011227,0.0003024822,0.00027565905,0.00013644744,0.00009237308,0.00003888096,0.0005465211,0.0007884322,0.00016806202],"category_scores_gemma":[0.00028482286,0.00030920637,0.00015890483,0.00022550886,0.00007611402,0.0000026890425,0.0002981596,0.00084168854,0.00007613876],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011666877,0.000064936656,0.00003268305,0.00019733277,0.00026782427,0.00011960436,0.000009935165,0.00001989529,0.034685425,0.000004917359,0.9635956,0.0009901734],"study_design_scores_gemma":[0.00044461683,0.00006477835,0.000011765677,0.000026469981,0.00008203436,0.000023413622,0.0000041058124,0.000001714265,0.13280837,0.00007506046,0.86618006,0.0002775837],"about_ca_topic_score_codex":0.000009404698,"about_ca_topic_score_gemma":0.000003018389,"teacher_disagreement_score":0.31302503,"about_ca_system_score_codex":0.000020503881,"about_ca_system_score_gemma":0.00029418457,"threshold_uncertainty_score":0.999936},"labels":[],"label_agreement":null},{"id":"W4407734882","doi":"10.1182/blood.2023022883","title":"How I treat patients who are refractory to platelet transfusions","year":2025,"lang":"en","type":"review","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada); University of Alberta","funders":"","keywords":"Medicine; Intensive care medicine; Human leukocyte antigen; Immunology; Platelet transfusion; Immune system; Etiology; Platelet; Clinical significance; Culprit; Internal medicine; Antigen; Myocardial infarction","score_opus":0.022262264824856645,"score_gpt":0.28952821882546415,"score_spread":0.2672659540006075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407734882","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019551693,0.9885903,0.0000024675994,0.00015898138,0.00015978386,0.002091,0.0007581719,0.00007828846,0.0062058587],"genre_scores_gemma":[0.000087991786,0.984619,0.000059751674,0.00016410367,0.00007894905,0.0002563325,0.0007931112,0.00006253717,0.013878181],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983762,0.000055949222,0.00034123604,0.0005776478,0.00028011602,0.00036884856],"domain_scores_gemma":[0.9988605,0.000104284496,0.00014145057,0.00055484334,0.00006387802,0.00027507872],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00003185583,0.00054030446,0.0024435392,0.00034224318,0.00010158937,0.000040101404,0.00015373268,0.00041563238,0.000045054418],"category_scores_gemma":[0.00010325418,0.00038916364,0.0006047274,0.00042855082,0.00001907892,0.00004808554,0.000046945017,0.00033755953,0.000092711256],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018624607,0.0025689816,0.00020818629,0.012144719,0.0007533018,0.0008862411,0.0000409594,7.3355415e-9,1.5095216e-7,0.0000039853157,0.0062450757,0.97712976],"study_design_scores_gemma":[0.003524556,0.00040654125,0.00018608762,0.030030685,0.0048966506,0.000049384216,0.000012761751,2.2417703e-8,0.0000058923238,0.00000447336,0.96059334,0.00028961428],"about_ca_topic_score_codex":0.000020151412,"about_ca_topic_score_gemma":0.000030993982,"teacher_disagreement_score":0.97684014,"about_ca_system_score_codex":0.000084374384,"about_ca_system_score_gemma":0.00023695482,"threshold_uncertainty_score":0.99985605},"labels":[],"label_agreement":null},{"id":"W4407761773","doi":"10.1182/blood.2024027182","title":"Blastoid variant of double-hit lymphoma masquerading as acute lymphoblastic leukemia","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Blastoid; Medicine; Lymphoblastic Leukemia; Lymphoblastic lymphoma; Lymphoma; Leukemia; Oncology; Internal medicine; Immunology; Mantle cell lymphoma","score_opus":0.008223069084560474,"score_gpt":0.2527310163647831,"score_spread":0.24450794728022265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407761773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9559675,0.0008620673,0.00009884367,0.00045294798,0.0002514405,0.00043884345,0.000014040425,0.000088203335,0.041826125],"genre_scores_gemma":[0.99580824,0.00020833708,0.00070447725,0.00044155432,0.00008161468,0.000091763446,0.00002396234,0.000024159779,0.0026158672],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985727,0.00002353779,0.0004106026,0.00037665054,0.00028254904,0.00033393828],"domain_scores_gemma":[0.9990319,0.00012940766,0.00011783023,0.000474928,0.000097277465,0.00014866784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009672983,0.00024778213,0.0005469532,0.00021699195,0.000087778026,0.000025696985,0.0001322404,0.00013425363,0.00014121289],"category_scores_gemma":[0.00004227624,0.00020405545,0.00020296428,0.00038807304,0.00007015673,0.00005976782,0.00009023624,0.000045315777,0.00011632327],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009477635,0.040171746,0.3840525,0.0028024286,0.036138397,0.02005728,0.0032786727,0.00016611406,0.117669515,0.27333203,0.014387995,0.09846571],"study_design_scores_gemma":[0.1397856,0.0021877661,0.17621697,0.0022294899,0.010996137,0.0027073028,0.00024042962,0.0004538559,0.65112597,0.0014500819,0.011934088,0.00067228614],"about_ca_topic_score_codex":0.0003070368,"about_ca_topic_score_gemma":0.000009120356,"teacher_disagreement_score":0.53345644,"about_ca_system_score_codex":0.0004634334,"about_ca_system_score_gemma":0.0009914803,"threshold_uncertainty_score":0.832114},"labels":[],"label_agreement":null},{"id":"W4407953766","doi":"10.1182/blood.2024025525","title":"The MURANO study: final analysis and retreatment/crossover substudy results of VenR for patients with relapsed/refractory CLL","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Occupational Cancer Research Centre; University of Calgary","funders":"Genentech; F. Hoffmann-La Roche","keywords":"Medicine; Rituximab; Bendamustine; Internal medicine; Refractory (planetary science); Gastroenterology; Progression-free survival; Tolerability; Neutropenia; Surgery; Overall survival; Chemotherapy; Lymphoma; Adverse effect","score_opus":0.012659531314095663,"score_gpt":0.29446798302515886,"score_spread":0.2818084517110632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407953766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99733585,0.00041147837,0.00000778018,0.00007470397,0.000032908512,0.0015002321,0.000064813394,0.00001467226,0.0005575312],"genre_scores_gemma":[0.99727917,0.000050565184,0.00010435873,0.000020306554,0.00001930808,0.00009030665,0.000044639455,0.000012824171,0.0023785443],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853224,0.00006194313,0.0003354543,0.00034207568,0.000467335,0.00026097824],"domain_scores_gemma":[0.99824494,0.00068551255,0.000120375036,0.0006105638,0.00027081702,0.00006776537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040327106,0.00013952453,0.00036769037,0.00015247776,0.00017292926,0.000028387027,0.00012780189,0.000057436748,0.000004192168],"category_scores_gemma":[0.0004292424,0.00008071294,0.00009539419,0.0006631082,0.00015513088,0.000038963008,0.000076676864,0.00011372278,0.0000013549345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017370794,0.009813896,0.95936376,0.00014251657,0.008427494,0.000050889557,0.0011622255,0.0000037155864,0.000054886186,0.000030130825,0.000632065,0.002947633],"study_design_scores_gemma":[0.1797594,0.0034346133,0.8104532,0.00006142749,0.004509834,0.0000019919785,0.0003592942,0.0000971805,0.00057836005,0.000018747318,0.0006458581,0.00008013409],"about_ca_topic_score_codex":0.00042246733,"about_ca_topic_score_gemma":0.00047574867,"teacher_disagreement_score":0.16238861,"about_ca_system_score_codex":0.00073302176,"about_ca_system_score_gemma":0.0011338477,"threshold_uncertainty_score":0.3291378},"labels":[],"label_agreement":null},{"id":"W4407953821","doi":"10.1182/blood.2024027020","title":"NOTCH1 dimeric signaling is essential for T-cell leukemogenesis and leukemia maintenance","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; BC Cancer Agency","funders":"","keywords":"Biology; Notch signaling pathway; Progenitor cell; Haematopoiesis; Cancer research; Leukemia; Cell biology; Signal transduction; Stem cell; Genetics","score_opus":0.008653717296840897,"score_gpt":0.2670722429610097,"score_spread":0.2584185256641688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407953821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97693443,0.0012984563,0.016134463,0.0010934802,0.00018915812,0.0008189066,0.000025209927,0.000082411425,0.0034234659],"genre_scores_gemma":[0.9785403,0.00018534344,0.0068090716,0.0014598159,0.00022299489,0.00010636548,0.00001725681,0.00003974493,0.012619114],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984796,0.000024537612,0.00028012777,0.0004647282,0.00026537804,0.0004855957],"domain_scores_gemma":[0.9989565,0.0003164915,0.00006147102,0.00033284473,0.00017775205,0.00015494639],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020275629,0.00019729549,0.000356411,0.0001663908,0.00014262485,0.000038758015,0.0001457691,0.00014377423,0.00005635293],"category_scores_gemma":[0.0001973054,0.00017325323,0.00012171021,0.0003439671,0.0001329349,0.00005309083,0.0001240686,0.0001483792,0.000023225639],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013726974,0.00084109977,0.010242934,0.0025272677,0.00088393263,0.00023804703,0.00059017807,0.000024524166,0.9178087,0.000749285,0.05359342,0.011127931],"study_design_scores_gemma":[0.028896807,0.000464917,0.0025640517,0.00042980033,0.0013044585,0.00012944573,0.0002770393,0.0069033243,0.9431024,0.000440494,0.015108465,0.000378749],"about_ca_topic_score_codex":0.00011328407,"about_ca_topic_score_gemma":0.0000031564073,"teacher_disagreement_score":0.038484957,"about_ca_system_score_codex":0.00033117048,"about_ca_system_score_gemma":0.0012963807,"threshold_uncertainty_score":0.7065062},"labels":[],"label_agreement":null},{"id":"W4408020336","doi":"10.1182/blood.2024027928","title":"Hypercalcemia in MGUS: keep the differential diagnosis broad","year":2025,"lang":"en","type":"letter","venue":"Blood","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Monoclonal gammopathy of undetermined significance; Intensive care medicine; Immunology; Monoclonal","score_opus":0.01685601885561885,"score_gpt":0.2760506092722667,"score_spread":0.2591945904166479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408020336","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12748873,0.0026687996,0.0000014100415,0.86000496,0.0007956356,0.0013114553,0.00010669318,0.00007989582,0.0075424407],"genre_scores_gemma":[0.07945886,0.0010063632,0.000054500597,0.90194446,0.0021997846,0.00092218706,0.0007294562,0.000058994334,0.013625412],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99839705,0.000091478476,0.0003378722,0.000388118,0.0003072803,0.0004781776],"domain_scores_gemma":[0.9989913,0.000258426,0.00007443655,0.00056519517,0.00003219846,0.00007840614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000047879552,0.00029313305,0.0005522737,0.00016290981,0.00007330673,0.000020495496,0.00015637827,0.0006945826,0.0002996175],"category_scores_gemma":[0.000080582875,0.00018474154,0.00018197176,0.0001961623,0.00005132449,0.000016572563,0.00006702953,0.0016347485,0.00012824929],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004780198,0.00085937756,0.107217096,0.00060077227,0.00034126436,0.0017409908,0.000075709075,1.9182252e-8,0.0000027688243,0.0000050139893,0.87871104,0.010398168],"study_design_scores_gemma":[0.009366079,0.00026346563,0.14511423,0.0011550727,0.0020194177,0.00009651185,0.000009352917,0.0000028767968,0.0002133319,0.00015108289,0.84133554,0.00027302012],"about_ca_topic_score_codex":0.0009873519,"about_ca_topic_score_gemma":0.00013542795,"teacher_disagreement_score":0.048029877,"about_ca_system_score_codex":0.00007732113,"about_ca_system_score_gemma":0.00024572725,"threshold_uncertainty_score":0.75335413},"labels":[],"label_agreement":null},{"id":"W4408053851","doi":"10.1182/blood.2024026455","title":"The bone marrow NK-cell profile predicts MRD negativity in patients with multiple myeloma treated with daratumumab-based therapy","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Janssen Pharmaceuticals; Vrije Universiteit Amsterdam","keywords":"Daratumumab; Bone marrow; Multiple myeloma; Medicine; Immunology; Granzyme; Antibody; Cytotoxic T cell; Bortezomib; Immune system; Cancer research; Oncology; Biology; Perforin; CD8","score_opus":0.008667859743753462,"score_gpt":0.23548157536982306,"score_spread":0.2268137156260696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408053851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99311936,0.00036221923,0.000016484326,0.00027096446,0.000020622709,0.0028014865,0.000069817565,0.00008992049,0.0032491426],"genre_scores_gemma":[0.9968382,0.000031634932,0.000594093,0.00008776763,0.000018961513,0.0004659211,0.00023477229,0.00003587325,0.0016927564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99803925,0.00015635767,0.00024602722,0.0004390355,0.00056385953,0.0005554573],"domain_scores_gemma":[0.9986358,0.00027858227,0.00009284907,0.0006067811,0.0002069726,0.0001789658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001588363,0.0002953018,0.00036310023,0.000172949,0.00025422432,0.00005109236,0.0001409781,0.0000920244,0.00003104439],"category_scores_gemma":[0.000102940976,0.0001529025,0.000056622725,0.00064888474,0.00018147941,0.00008488348,0.000033111726,0.00028983376,0.000016280599],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009461454,0.005497319,0.9762416,0.00008013883,0.00027076763,0.0001691566,0.000052161962,0.000004751077,0.00077156204,0.000004113148,0.00020647248,0.0072405394],"study_design_scores_gemma":[0.074123554,0.0027159704,0.8719914,0.00025324855,0.00008711885,0.000002126108,0.000029260613,0.0005007728,0.04981663,0.0000040321415,0.0003378794,0.00013798433],"about_ca_topic_score_codex":0.00032384176,"about_ca_topic_score_gemma":0.0006003442,"teacher_disagreement_score":0.10425014,"about_ca_system_score_codex":0.00008799368,"about_ca_system_score_gemma":0.00035327632,"threshold_uncertainty_score":0.6235183},"labels":[],"label_agreement":null},{"id":"W4408492440","doi":"10.1182/blood.2024027336","title":"Safety and efficacy of rilzabrutinib vs placebo in adults with immune thrombocytopenia: the phase 3 LUNA3 study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Placebo; Adverse effect; Internal medicine; Clinical endpoint; Gastroenterology; Platelet; Immune thrombocytopenia; Clinical trial; Surgery; Pathology","score_opus":0.010349923133356365,"score_gpt":0.3138072653652863,"score_spread":0.30345734223192994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408492440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916739,0.00093247736,0.000008999087,0.00048089674,0.000029533141,0.0023773408,0.0000065313016,0.00002270886,0.004467641],"genre_scores_gemma":[0.9990608,0.000121912926,0.00006484135,0.000053059626,0.000028943989,0.000045300603,0.0000071446216,0.000016090677,0.0006018733],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99848074,0.00013154872,0.00040946619,0.00032114852,0.00036464483,0.00029243084],"domain_scores_gemma":[0.9985734,0.0005605924,0.000072969255,0.0006435066,0.000085011365,0.000064524334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066252815,0.00015821002,0.0005498401,0.00012758633,0.000072823714,0.00001410767,0.0002010533,0.0000639528,0.000045947054],"category_scores_gemma":[0.00030873722,0.00009373965,0.000040728093,0.0005491975,0.00023717646,0.000039741648,0.00019403367,0.000290034,0.0000054842653],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48918378,0.13958013,0.20166811,0.0061148303,0.008358137,0.0050909827,0.07130001,0.00012399934,0.010686357,0.0026320994,0.0013827084,0.06387886],"study_design_scores_gemma":[0.7873942,0.0035777898,0.19262469,0.0013658132,0.000614045,0.00017105213,0.0035233044,0.0007626599,0.009281117,0.000014574322,0.00049750257,0.00017324214],"about_ca_topic_score_codex":0.0010151388,"about_ca_topic_score_gemma":0.00031857545,"teacher_disagreement_score":0.29821044,"about_ca_system_score_codex":0.00058307825,"about_ca_system_score_gemma":0.0023373642,"threshold_uncertainty_score":0.4146384},"labels":[],"label_agreement":null},{"id":"W4408560952","doi":"10.1182/blood.2024026003","title":"Prognostic biomarkers in MCL: insights from the SHINE trial on the impact of MCL35 score and <i>TP53</i> mutation status","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Bendamustine; Ibrutinib; Medicine; Oncology; Internal medicine; Rituximab; Risk stratification; Clinical trial; Bioinformatics; Lymphoma; Leukemia; Biology; Chronic lymphocytic leukemia","score_opus":0.022847027365117036,"score_gpt":0.3161680054450819,"score_spread":0.2933209780799649,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408560952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99507236,0.0013122226,0.0000033100685,0.0006589686,0.00006274221,0.0015531763,0.00002559007,0.000015263748,0.0012963599],"genre_scores_gemma":[0.99954414,0.000083742,0.000019436011,0.00013205007,0.000078182355,0.000058231646,0.000035653316,0.000011667601,0.000036905767],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9987976,0.00016394503,0.0002696378,0.00021838996,0.0003167833,0.00023365606],"domain_scores_gemma":[0.9974376,0.0020062358,0.00006376326,0.0003719544,0.00005646243,0.00006399688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027570478,0.00012556772,0.00022922778,0.00010764636,0.00005340086,0.0000260929,0.0001211645,0.00007624724,0.000026812077],"category_scores_gemma":[0.0016772834,0.00005933278,0.00007436164,0.00047474747,0.00017890013,0.000032384363,0.00006423172,0.0002014756,0.000004149491],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.30306625,0.022203334,0.4651642,0.0015293079,0.014870547,0.0021201442,0.029181853,0.00035225757,0.06914532,0.00876444,0.02107173,0.06253058],"study_design_scores_gemma":[0.55364954,0.0028853586,0.41330415,0.0015036423,0.0006812766,0.000034154356,0.00089829846,0.0057222024,0.017453155,0.0034486698,0.00020012818,0.00021942524],"about_ca_topic_score_codex":0.006241354,"about_ca_topic_score_gemma":0.00037896543,"teacher_disagreement_score":0.25058326,"about_ca_system_score_codex":0.00091034506,"about_ca_system_score_gemma":0.0033920957,"threshold_uncertainty_score":0.94351023},"labels":[],"label_agreement":null},{"id":"W4408669628","doi":"10.1182/blood.2024027590","title":"Megakaryocyte mitotic figures in de novo AML, myelodysplasia related, with STAG2, SRSF2, and ASXL1 comutations","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Megakaryocyte; Mitosis; Biology; Medicine; Haematopoiesis; Genetics; Stem cell","score_opus":0.007324978713799938,"score_gpt":0.27099811916155075,"score_spread":0.2636731404477508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408669628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97718173,0.0011082485,0.00009033442,0.0029880723,0.00002765981,0.00050778047,0.000010910779,0.0000719813,0.018013299],"genre_scores_gemma":[0.9887478,0.00023284378,0.0026609935,0.00043001358,0.00003098927,0.00005592678,0.000030788917,0.000026397578,0.0077842413],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998727,0.00007884623,0.00025074533,0.0003082034,0.00024006369,0.00039510612],"domain_scores_gemma":[0.9991735,0.00024696652,0.000039737926,0.00030533195,0.00008524222,0.00014918108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023882653,0.00016021614,0.00028520072,0.00036965753,0.00009089276,0.00003437319,0.00011240959,0.00014335579,0.00007155109],"category_scores_gemma":[0.00025269084,0.00013337174,0.000031926527,0.0006845079,0.00016447749,0.0000835993,0.00006731797,0.0005484266,0.000033199743],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016839228,0.002436594,0.92684656,0.0015432087,0.001735176,0.008662039,0.0038544876,0.00027328037,0.030137826,0.008568439,0.0085711,0.005687384],"study_design_scores_gemma":[0.049916282,0.0012498228,0.899646,0.001971834,0.0012150609,0.0028934206,0.0019735564,0.0023089324,0.02831178,0.0016923958,0.008218703,0.0006021995],"about_ca_topic_score_codex":0.00019072361,"about_ca_topic_score_gemma":0.00023261886,"teacher_disagreement_score":0.048232358,"about_ca_system_score_codex":0.00016985708,"about_ca_system_score_gemma":0.0007871376,"threshold_uncertainty_score":0.54387414},"labels":[],"label_agreement":null},{"id":"W4408781448","doi":"10.1182/blood.2024027620","title":"Daratumumab-bortezomib-thalidomide-dexamethasone for newly diagnosed myeloma: CASSIOPEIA minimal residual disease results","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Celgene; National Cancer Institute; Kite Pharma; Yale University; Sanofi; Servier; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Daratumumab; Medicine; Internal medicine; Bortezomib; Minimal residual disease; Multiple myeloma; Thalidomide; Oncology; Surgery; Gastroenterology; Bone marrow","score_opus":0.028714405923374372,"score_gpt":0.3321263116093556,"score_spread":0.3034119056859812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408781448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820449,0.0021105867,0.00012278355,0.0041875695,0.00025040246,0.0026377311,0.0010269696,0.00018547408,0.0074335863],"genre_scores_gemma":[0.9822316,0.00012238038,0.0056526274,0.00032170885,0.00040709827,0.0006746593,0.00071104034,0.00005284357,0.009826005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997129,0.00013270472,0.00058921374,0.0008125694,0.00053325156,0.0008032622],"domain_scores_gemma":[0.99692404,0.0010267966,0.0001619892,0.00086960936,0.0002680569,0.0007495099],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042627906,0.0003608267,0.00059864274,0.0003098459,0.00030078104,0.000083394865,0.00023909868,0.00015956972,0.00005897658],"category_scores_gemma":[0.0047943513,0.00029743245,0.00026035774,0.00044003027,0.00015885911,0.00012209643,0.0001405436,0.00026343775,0.00006794062],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13918172,0.027089419,0.4607629,0.0029987404,0.0077698594,0.024194978,0.0010282367,0.000018766941,0.026289841,0.002758053,0.21312931,0.09477819],"study_design_scores_gemma":[0.13015404,0.0014320719,0.8185326,0.0006392383,0.0017888652,0.000044403114,0.00018797896,0.00027412848,0.026336215,0.00033808936,0.01981499,0.00045739493],"about_ca_topic_score_codex":0.00021824538,"about_ca_topic_score_gemma":0.00012289741,"teacher_disagreement_score":0.3577697,"about_ca_system_score_codex":0.000100707475,"about_ca_system_score_gemma":0.00079997967,"threshold_uncertainty_score":0.9999478},"labels":[],"label_agreement":null},{"id":"W4408823907","doi":"10.1182/blood.2024025653","title":"Destabilization of PF4-antigenic complexes in heparin-induced thrombocytopenia","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Heparin; Heparin-induced thrombocytopenia; Platelet factor 4; Chemistry; Antigen; Antithrombin; Platelet activation; Antibody; Monoclonal antibody; Platelet; Immune system; Immunology; Cell biology; Pharmacology; Biochemistry; Medicine; Biology","score_opus":0.029616784631947703,"score_gpt":0.3151513983916784,"score_spread":0.28553461375973066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408823907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97933334,0.00017755415,0.000057181634,0.00033782117,0.00015796552,0.000753271,0.0000061762466,0.00007597735,0.019100735],"genre_scores_gemma":[0.998578,0.00009312981,0.000833128,0.00017257704,0.000034200173,0.000034186483,0.000032184722,0.000027821081,0.00019476723],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981592,0.00009915312,0.0006866988,0.0004354499,0.0002422579,0.0003771894],"domain_scores_gemma":[0.9988819,0.000115893825,0.00012995361,0.00061663106,0.00015195554,0.00010371126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029665712,0.0002418103,0.00092480634,0.0003978032,0.00006983575,0.000020842977,0.00021669727,0.00019892662,0.00019504834],"category_scores_gemma":[0.00020809226,0.0002315349,0.00015335408,0.0010520192,0.00009598767,0.00013062898,0.0001351707,0.00025193993,0.000041833136],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052129682,0.0010669394,0.3597836,0.00019429407,0.000112901565,0.000013133829,0.00021673995,0.0000021152296,0.633854,0.0041245692,0.00003584505,0.00054380595],"study_design_scores_gemma":[0.003691294,0.00017992049,0.5069224,0.00027985813,0.00026979795,0.000014751452,0.00012353844,0.000033203447,0.48756507,0.00057843036,0.0001956811,0.00014602135],"about_ca_topic_score_codex":0.00039708195,"about_ca_topic_score_gemma":0.0005796669,"teacher_disagreement_score":0.14713885,"about_ca_system_score_codex":0.00008240184,"about_ca_system_score_gemma":0.00040680944,"threshold_uncertainty_score":0.9441719},"labels":[],"label_agreement":null},{"id":"W4408905115","doi":"10.1182/blood.2023023717","title":"Reducing clinical trial eligibility barriers for patients with MDS: an icMDS position statement","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Clinical trial; Medicine; Population; Intensive care medicine; Family medicine; Internal medicine","score_opus":0.032838014213156644,"score_gpt":0.41168558814440365,"score_spread":0.378847573931247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408905115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99494,0.00002124876,0.0006109908,0.0007205847,0.00020928126,0.002807786,0.000050189923,0.000056909892,0.00058303087],"genre_scores_gemma":[0.9939047,0.00001271665,0.004677277,0.00042263587,0.00025832583,0.00018212978,0.00026647098,0.000018897521,0.0002568365],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982065,0.00015604934,0.00053794804,0.0004610332,0.0003307003,0.00030776628],"domain_scores_gemma":[0.9986379,0.00020359203,0.00009082054,0.0004878986,0.00031236385,0.00026739432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012477598,0.00012517563,0.0003121188,0.00009823659,0.000120802186,0.00002776771,0.00010840117,0.00011527681,0.00003877337],"category_scores_gemma":[0.0010483835,0.0000961784,0.00009497312,0.00018404207,0.00009198929,0.00010216026,0.000046206635,0.0002453946,0.000004249108],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.38481352,0.015858091,0.53270066,0.0007840502,0.0019626364,0.000049103986,0.0007822268,0.0000137536645,0.0013020084,0.00052041997,0.018292187,0.042921323],"study_design_scores_gemma":[0.7784974,0.037320897,0.16471101,0.000478297,0.0017156437,0.000004846793,0.0005273505,0.00075138104,0.007893546,0.0006638429,0.006980205,0.00045555478],"about_ca_topic_score_codex":0.000058296457,"about_ca_topic_score_gemma":0.000010303609,"teacher_disagreement_score":0.3936839,"about_ca_system_score_codex":0.00023173283,"about_ca_system_score_gemma":0.0011375061,"threshold_uncertainty_score":0.39220414},"labels":[],"label_agreement":null},{"id":"W4409140497","doi":"10.1182/blood.2024027782","title":"The immunotherapy real estate of Hodgkin lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Hodgkin lymphoma; Medicine; Lymphoma; Immunotherapy; Immunology; Internal medicine; Immune system","score_opus":0.006475643344723708,"score_gpt":0.26360044880184796,"score_spread":0.25712480545712424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409140497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9292016,0.0011905471,0.0000026872956,0.00093850016,0.00008269224,0.00019058074,0.0000045218685,0.000023429671,0.06836546],"genre_scores_gemma":[0.9880076,0.010250611,0.0001844882,0.00014429179,0.000023404411,0.00004312038,0.0000047566314,0.00000702122,0.0013347077],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9994943,0.000020953805,0.00016012182,0.000100587626,0.00010218647,0.00012181779],"domain_scores_gemma":[0.9994681,0.00012500217,0.00004404208,0.00029834322,0.000040383184,0.000024152936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008327675,0.000074251824,0.0001512715,0.000030765037,0.00006725598,0.000010170851,0.00006372122,0.000031039417,0.000012781474],"category_scores_gemma":[0.000016420789,0.000042534426,0.000084559426,0.00011581091,0.00005372483,0.000011794124,0.000017727885,0.00001591973,0.000009865739],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031925674,0.0029764185,0.20780136,0.000039960923,0.0010871866,0.000071938455,0.00030904738,3.7655832e-7,0.0055059157,0.00471721,0.001541419,0.77562994],"study_design_scores_gemma":[0.013424695,0.00035138568,0.8354858,0.00009439758,0.0002773779,0.000022287313,0.00009256751,0.0000064684455,0.11603296,0.0003321827,0.033821262,0.00005860229],"about_ca_topic_score_codex":0.0004164346,"about_ca_topic_score_gemma":0.000026778398,"teacher_disagreement_score":0.7755713,"about_ca_system_score_codex":0.000030443163,"about_ca_system_score_gemma":0.00013098927,"threshold_uncertainty_score":0.17345035},"labels":[],"label_agreement":null},{"id":"W4409149760","doi":"10.1182/blood.2024027244","title":"Blood-based proteomic profiling identifies OSMR as a novel biomarker of AML outcomes","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center; National Institutes of Health; Cancer Prevention and Research Institute of Texas; GlaxoSmithKline","keywords":"Medicine; Oncology; Internal medicine; Myeloid leukemia; Concordance; Biomarker; Leukemia; Proportional hazards model; Bioinformatics; Immunology; Biology","score_opus":0.023986059074822264,"score_gpt":0.32406385723277453,"score_spread":0.30007779815795227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409149760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910903,0.00028641854,0.00025556728,0.0017253556,0.00009746652,0.0015206885,0.000027468563,0.00010484501,0.004891908],"genre_scores_gemma":[0.98639596,0.00001198706,0.0065108337,0.00043518664,0.00004043516,0.00019494246,0.000033889457,0.000034534096,0.006342215],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982506,0.000049753944,0.00046174365,0.0003834887,0.0004673181,0.0003870892],"domain_scores_gemma":[0.9987157,0.00018458262,0.00011504,0.00062448747,0.0002544594,0.00010571794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004711045,0.00020794063,0.00049694505,0.00046651936,0.00007308156,0.000029726072,0.0002539618,0.00015568074,0.00008774595],"category_scores_gemma":[0.0010068122,0.00016928965,0.00019992706,0.00058838824,0.00018051325,0.000064497326,0.00014342232,0.00029513286,0.00005325409],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024251192,0.001468306,0.19103552,0.0009274746,0.000955504,0.00007784594,0.000057009915,0.0000018181977,0.80414736,0.00046201536,0.00031847315,0.0003061833],"study_design_scores_gemma":[0.01169216,0.00017013041,0.08207368,0.0003685456,0.00077581237,0.000021182163,0.000079134086,0.00024683826,0.9041217,0.00013078045,0.00017963085,0.00014042782],"about_ca_topic_score_codex":0.00024579494,"about_ca_topic_score_gemma":0.000009602852,"teacher_disagreement_score":0.10896184,"about_ca_system_score_codex":0.000063054475,"about_ca_system_score_gemma":0.0011251481,"threshold_uncertainty_score":0.69034314},"labels":[],"label_agreement":null},{"id":"W4409255592","doi":"10.1182/blood.2024024476","title":"Acalabrutinib-obinutuzumab improves survival vs chemoimmunotherapy in treatment-naive CLL in the 6-year follow-up of ELEVATE-TN","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"National Comprehensive Cancer Network; Gilead Sciences; AstraZeneca; National Cancer Institute; National Institutes of Health; Pfizer","keywords":"Obinutuzumab; Chlorambucil; Medicine; Internal medicine; Chronic lymphocytic leukemia; Oncology; Leukemia; Chemotherapy; Cyclophosphamide","score_opus":0.018054785244153278,"score_gpt":0.30619122712006674,"score_spread":0.2881364418759135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409255592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989553,0.00091287325,0.0000026480807,0.00051597087,0.00013920332,0.0010037221,0.000011516498,0.000025363388,0.00783572],"genre_scores_gemma":[0.995971,0.00055745046,0.000090525304,0.00017552737,0.000066284796,0.000119617514,0.000022942675,0.000026181428,0.0029704627],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980724,0.00016686268,0.00048790796,0.00035952238,0.00042218989,0.00049112434],"domain_scores_gemma":[0.9986015,0.0004669623,0.00007978028,0.0007258291,0.0000786278,0.000047275153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000623467,0.00022341732,0.0005715891,0.00026363047,0.00003571603,0.000020269095,0.00033872898,0.00017918149,0.00007356896],"category_scores_gemma":[0.00024075429,0.00015094304,0.00016231906,0.0008277,0.0001489389,0.00005242565,0.00006740963,0.00028446168,0.000022223885],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.04712302,0.029385474,0.24273577,0.003360962,0.0059132683,0.0026262316,0.04765188,0.000040081322,0.51384526,0.016579233,0.0035114437,0.08722736],"study_design_scores_gemma":[0.5850374,0.0033469372,0.12124173,0.00097483303,0.00046997846,0.000086571126,0.0057503455,0.0010652961,0.27323774,0.0010334642,0.007223819,0.0005319063],"about_ca_topic_score_codex":0.0044300444,"about_ca_topic_score_gemma":0.0006388999,"teacher_disagreement_score":0.5379144,"about_ca_system_score_codex":0.0047138855,"about_ca_system_score_gemma":0.005902901,"threshold_uncertainty_score":0.99973273},"labels":[],"label_agreement":null},{"id":"W4409256027","doi":"10.1182/blood.2024026216","title":"Standard-of-care idecabtagene vicleucel for relapsed/refractory multiple myeloma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Stanford Cancer Institute; National Institute of Allergy and Infectious Diseases; Office of Naval Research; Legend Biotech; Pharmacyclics; Takeda Oncology; Health Resources and Services Administration; MorphoSys; Seagen; Astellas Pharma; Adaptive Biotechnologies; Pfizer; Incyte; Kiadis Pharma; bluebird bio; Medac; Jazz Pharmaceuticals; BeiGene; HistoGenetics; Atara Biotherapeutics; National Cancer Institute; Gilead Sciences; Sanofi; GlaxoSmithKline; CSL Behring; Bristol-Myers Squibb; AstraZeneca; Gateway for Cancer Research; Doris Duke Charitable Foundation; Amgen; CareDx; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Swedish Orphan Biovitrum; Omeros Corporation; Vertex Pharmaceuticals; Alexion Pharmaceuticals; Mallinckrodt Pharmaceuticals; Astellas Pharma US","keywords":"Medicine; Internal medicine; Multiple myeloma; Clinical trial; Refractory (planetary science); Cohort; Surgery; Oncology","score_opus":0.022124320350807025,"score_gpt":0.3219916211097771,"score_spread":0.29986730075897006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409256027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96768916,0.0045469212,0.0005546059,0.00046785502,0.00021040476,0.0014318293,0.0001503856,0.00009921954,0.024849616],"genre_scores_gemma":[0.9856678,0.00016909954,0.0029475756,0.00019211698,0.00013227967,0.00010455502,0.000054927666,0.0000412391,0.0106903855],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987107,0.000038181814,0.00029865967,0.00029457491,0.0003473112,0.000310604],"domain_scores_gemma":[0.9986029,0.00032238095,0.00005978963,0.0005278457,0.00037778364,0.00010927653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024905542,0.00014351822,0.0003983055,0.00019678785,0.000076501085,0.000013519345,0.0001536614,0.0001350909,0.0005123136],"category_scores_gemma":[0.00038510084,0.00013202227,0.0002077102,0.000282824,0.00008042822,0.000041551728,0.00006843314,0.00019433109,0.000012013157],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005043667,0.00075711525,0.024235236,0.0012393858,0.00052767695,0.000039551924,0.00067213294,0.000002502124,0.8680174,0.0004300478,0.0026681337,0.09636718],"study_design_scores_gemma":[0.0185486,0.0017728969,0.010603782,0.0002642373,0.00024628258,0.000007491953,0.00051410415,0.000032238022,0.77984643,0.00019100923,0.18783285,0.00014006576],"about_ca_topic_score_codex":0.000018463721,"about_ca_topic_score_gemma":0.000039415358,"teacher_disagreement_score":0.18516472,"about_ca_system_score_codex":0.00009009559,"about_ca_system_score_gemma":0.0003881763,"threshold_uncertainty_score":0.5609475},"labels":[],"label_agreement":null},{"id":"W4409324133","doi":"10.1182/blood.2024027742","title":"An unbiased genomewide screen uncovers 7 genes that drive hematopoietic stem cell fate from mouse embryonic stem cells","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Biology; Stem cell; Embryonic stem cell; Embryoid body; Cell biology; Haematopoiesis; Induced pluripotent stem cell; Progenitor cell; Hemangioblast; Genetics; Gene","score_opus":0.012486683907715741,"score_gpt":0.23817058518844406,"score_spread":0.22568390128072832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409324133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923201,0.0038951058,0.0015081369,0.00006981846,0.00014247857,0.0005260259,0.00033948445,0.000054921686,0.001143931],"genre_scores_gemma":[0.98765177,0.00070165796,0.00032002342,0.00023505872,0.000103180115,0.000040007853,0.0003061287,0.000060600218,0.010581553],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975531,0.00025302244,0.00029906761,0.00090313295,0.00036504405,0.0006266506],"domain_scores_gemma":[0.9982846,0.00005078188,0.00012773038,0.0011932515,0.000099288496,0.0002443456],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021440531,0.00035620612,0.0003451558,0.00012677524,0.0001571992,0.000118742304,0.0007985124,0.0003074598,0.000034723045],"category_scores_gemma":[0.0000028189145,0.00035523568,0.00018961763,0.00020278519,0.00010494828,0.000012713357,0.0003463714,0.00019776597,0.00011258443],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008091541,0.0003932518,0.0048186043,0.000086019245,0.00023364315,0.000040336123,0.00008124958,0.00044674968,0.99270564,0.000007236984,0.0005916023,0.00051476544],"study_design_scores_gemma":[0.0022050429,0.00021298206,0.00033580922,0.000032022126,0.00012862933,0.000002767256,0.00056396314,0.00010260989,0.9911823,0.000018294728,0.0048581106,0.00035746433],"about_ca_topic_score_codex":0.00018677332,"about_ca_topic_score_gemma":0.00009309452,"teacher_disagreement_score":0.0094376225,"about_ca_system_score_codex":0.00004385057,"about_ca_system_score_gemma":0.00026237426,"threshold_uncertainty_score":0.99988997},"labels":[],"label_agreement":null},{"id":"W4409487608","doi":"10.1182/blood.2024026332","title":"Genotype-specific immune responses at the intestinal barrier predispose to colitis in mouse models of chronic granulomatous disease","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Institute of Infection and Immunity; Université de Montréal; Montreal Clinical Research Institute","funders":"National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Chronic granulomatous disease; Colitis; Immunology; Immune system; Inflammatory bowel disease; NADPH oxidase; Dysbiosis; Primary immunodeficiency; Biology; Inflammasome; Inflammation; Gut flora; Disease; Medicine; Reactive oxygen species; Genetics; Pathology","score_opus":0.012057900537088974,"score_gpt":0.22980684908295887,"score_spread":0.2177489485458699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409487608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825909,0.015301309,0.00033931542,0.00031765594,0.00019217565,0.00061795407,0.00031088296,0.000042290554,0.00028750396],"genre_scores_gemma":[0.99087834,0.0003873935,0.00005963201,0.00014819835,0.000018796442,0.00013897182,0.000061100036,0.000018996492,0.00828856],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984839,0.00034717933,0.000389765,0.0003564308,0.000049088885,0.00037366318],"domain_scores_gemma":[0.99898845,0.00022144771,0.00007506699,0.00058234757,0.000090389716,0.00004231633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024986823,0.00020591568,0.00030983458,0.00021922732,0.00017262378,0.000012332786,0.0003832028,0.00009967045,0.00023810181],"category_scores_gemma":[0.000104094834,0.00015596795,0.00010494673,0.0003467604,0.00021800812,0.00006767343,0.00032198118,0.00021334509,0.00013754166],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021278902,0.00043022152,0.00055140984,0.000048634087,0.000098587036,0.000061944396,0.00037572265,0.000074232325,0.98611593,0.008951436,0.0003529125,0.00081106246],"study_design_scores_gemma":[0.0025972452,0.00027793075,0.013750027,0.00022525704,0.00006876678,0.00002759535,0.00009489932,0.000008455599,0.97840124,0.0018162496,0.0025535636,0.00017875494],"about_ca_topic_score_codex":0.00006380202,"about_ca_topic_score_gemma":0.00013514994,"teacher_disagreement_score":0.014913916,"about_ca_system_score_codex":0.00008590512,"about_ca_system_score_gemma":0.00018875649,"threshold_uncertainty_score":0.6360188},"labels":[],"label_agreement":null},{"id":"W4409487670","doi":"10.1182/blood.2024028064","title":"International consensus statement on diagnosis, evaluation, and research of Richter transformation: the ERIC recommendations","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Genentech; Eli Lilly and Company; AstraZeneca; American Society of Clinical Oncology; Conquer Cancer Foundation; Gilead Sciences; BeiGene; Sanofi; Deutsche Forschungsgemeinschaft; Amgen; National Institutes of Health; Incyte","keywords":"Statement (logic); Consensus conference; Medicine; Family medicine; Political science; Law; Internal medicine","score_opus":0.10050846989220998,"score_gpt":0.4492966184956321,"score_spread":0.34878814860342217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409487670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8769447,0.0006179792,0.000041072497,0.083526626,0.00019448301,0.0014372442,0.000032362263,0.00001531632,0.037190218],"genre_scores_gemma":[0.99765015,0.0008415121,0.0002826891,0.0002537983,0.00004637193,0.00031555528,0.000045351433,0.00000528648,0.00055928],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99844104,0.0002156057,0.00030002455,0.00014234825,0.00075333787,0.00014765709],"domain_scores_gemma":[0.9981878,0.00085654063,0.000038342918,0.00023686676,0.0006406231,0.00003986552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020609212,0.00005913282,0.000101270234,0.00022084719,0.00011602639,0.000024178113,0.000106162996,0.00003513476,0.00040921159],"category_scores_gemma":[0.00060734263,0.00004055713,0.000028188542,0.0003612915,0.00015602863,0.00003045184,0.00004862076,0.00017249324,0.000014127495],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019580894,0.010486996,0.013831318,0.0013961421,0.0041214293,0.000055864115,0.023800422,0.0001222441,0.0029082783,0.052149165,0.4740372,0.41513285],"study_design_scores_gemma":[0.14786683,0.0015057673,0.046765845,0.0021052037,0.0011226247,0.00017497776,0.006688962,0.02730171,0.08273986,0.011657849,0.67172104,0.0003493266],"about_ca_topic_score_codex":0.00008653394,"about_ca_topic_score_gemma":0.000019955472,"teacher_disagreement_score":0.41478354,"about_ca_system_score_codex":0.0011369587,"about_ca_system_score_gemma":0.0019543204,"threshold_uncertainty_score":0.44805798},"labels":[],"label_agreement":null},{"id":"W4409631033","doi":"10.1182/blood.2024026936","title":"Coordinated regulation of self-renewal and cell cycle during human lympho-myeloid lineage restriction","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"","keywords":"Biology; Myeloid; Transcriptome; Lineage (genetic); Cell biology; Cellular differentiation; Stem cell; Genetics; Immunology; Gene; Gene expression","score_opus":0.0033076496785729324,"score_gpt":0.20569021861603692,"score_spread":0.20238256893746398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409631033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912774,0.0026942473,0.0000143909865,0.000019838924,0.0003495467,0.00013336509,0.0000056905756,0.00008218455,0.005423325],"genre_scores_gemma":[0.9958558,0.00016678715,0.000077439756,0.000010657117,0.000017822387,0.000008798525,0.000041666557,0.000009204891,0.0038118334],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99932814,0.00007589912,0.00023900614,0.00018844403,0.000018319806,0.00015020423],"domain_scores_gemma":[0.99958616,0.000038557806,0.000111020934,0.00020252075,0.000055327808,0.0000064122905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000096119526,0.00009796123,0.00015739942,0.00012810016,0.00016358135,0.0000063618168,0.00008559146,0.0001954224,0.0000627239],"category_scores_gemma":[0.000014288356,0.00010386422,0.000033669112,0.00017501648,0.0000720945,0.000044487144,0.00007447575,0.0001032013,0.000011399439],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039385006,0.00021616204,0.007807285,0.00008513463,0.00009990523,8.7774674e-7,0.00012736858,0.000013580605,0.99112976,0.00024355673,0.00013335666,0.00010362099],"study_design_scores_gemma":[0.003515312,0.000054698114,0.07552666,0.00004219633,0.00011926819,0.000007322561,0.000040843992,0.0000032126534,0.9199506,0.0001346393,0.0005224203,0.000082814106],"about_ca_topic_score_codex":0.00013346756,"about_ca_topic_score_gemma":0.000007916288,"teacher_disagreement_score":0.07117916,"about_ca_system_score_codex":0.00003380737,"about_ca_system_score_gemma":0.00003772814,"threshold_uncertainty_score":0.42354602},"labels":[],"label_agreement":null},{"id":"W4409737326","doi":"10.1182/blood.2025028490","title":"17(<i>R</i>)-Resolvin D1: a novel approach for SCD cardiomyopathy","year":2025,"lang":"en","type":"letter","venue":"Blood","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cardiomyopathy; Medicine; Internal medicine; Cardiology; Intensive care medicine; Heart failure","score_opus":0.01792687174140022,"score_gpt":0.2949763618183134,"score_spread":0.27704949007691315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409737326","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007700951,0.04937441,0.016402597,0.47062927,0.0053898674,0.030708456,0.041514706,0.0017807429,0.376499],"genre_scores_gemma":[0.0055432054,0.00021377724,0.013129651,0.8689747,0.017627837,0.0038571898,0.026274728,0.0003495172,0.064029396],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977865,0.000026976444,0.0003317442,0.00081687514,0.00045969716,0.000578187],"domain_scores_gemma":[0.99851024,0.00010699676,0.00011811654,0.00093000557,0.00018995437,0.00014466998],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009388088,0.0005161668,0.0010975096,0.00023244941,0.00010120763,0.000055670655,0.00017020079,0.0006630563,0.000026414871],"category_scores_gemma":[0.00008198992,0.00045268028,0.003585231,0.00020331406,0.00005086689,0.000029067594,0.000097572054,0.000620499,0.00001699753],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010559722,0.0011562476,0.004152181,0.0016359923,0.006831781,0.00020766174,0.000019180792,0.0000015429473,0.000025447816,0.000015725287,0.985454,0.00039459782],"study_design_scores_gemma":[0.014516743,0.0002814612,0.0038258173,0.00036557147,0.02566508,0.00008982808,0.000019423058,0.000022279912,0.000083784245,0.000027824404,0.9545908,0.0005113957],"about_ca_topic_score_codex":0.00006138034,"about_ca_topic_score_gemma":2.7211647e-7,"teacher_disagreement_score":0.39834544,"about_ca_system_score_codex":0.00008551542,"about_ca_system_score_gemma":0.0004073146,"threshold_uncertainty_score":0.9997925},"labels":[],"label_agreement":null},{"id":"W4409785662","doi":"10.1182/blood.2024028035","title":"Clinical phenotype and pathophysiological mechanisms underlying qualitative low VWF","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Institutes of Health; Amgen; ZonMw; LEO Pharma; Bristol-Myers Squibb; CSL Behring; Science Foundation Ireland; Swedish Orphan Biovitrum; Novo Nordisk; Daiichi Sankyo Europe; Sanofi; Alexion Pharmaceuticals; National Heart, Lung, and Blood Institute; Pfizer","keywords":"Phenotype; Pathophysiology; Medicine; Biology; Immunology; Genetics; Internal medicine","score_opus":0.060433437085463546,"score_gpt":0.4016269543555995,"score_spread":0.3411935172701359,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409785662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940687,0.00041150794,0.0008684687,0.00037580027,0.000073104165,0.00019460994,0.0000057179163,0.000043274875,0.0039588073],"genre_scores_gemma":[0.9951336,0.00013891522,0.0035033254,0.0008885288,0.000011525614,0.000011520561,0.000016579203,0.0000057933144,0.0002902223],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9992899,0.000083332096,0.00018314776,0.00023296343,0.00007314904,0.0001375539],"domain_scores_gemma":[0.9995501,0.00020279261,0.000033538887,0.000118943186,0.000028514349,0.00006608893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015034227,0.00009410787,0.00030101548,0.000031903746,0.00006290345,0.00000885439,0.000030400373,0.000100265745,0.000019088946],"category_scores_gemma":[0.00013083278,0.00006924858,0.00006441135,0.00008631697,0.000060312424,0.000021750628,0.00003717604,0.0001212393,0.000021586384],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032760368,0.036569845,0.041958336,0.0012748296,0.007800652,0.006219957,0.008256429,0.0000025708202,0.1049962,0.55157083,0.0014509876,0.23662333],"study_design_scores_gemma":[0.039413936,0.004750839,0.3710427,0.00066354364,0.002003264,0.00008077445,0.006236992,0.00018843588,0.0028061897,0.5716237,0.0006063258,0.00058332627],"about_ca_topic_score_codex":0.000010180125,"about_ca_topic_score_gemma":0.000003937004,"teacher_disagreement_score":0.32908437,"about_ca_system_score_codex":0.0000055000855,"about_ca_system_score_gemma":0.000052273546,"threshold_uncertainty_score":0.2823875},"labels":[],"label_agreement":null},{"id":"W4409785682","doi":"10.1182/blood.2024027873","title":"A phase 2 randomized study of modakafusp alfa as a single agent for patients with relapsed/refractory multiple myeloma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Active Biotech; Regeneron Pharmaceuticals; BeiGene; Sanofi; Genentech; Celgene; AstraZeneca; Takeda Pharmaceuticals U.S.A.; Amgen; Pfizer; GlaxoSmithKline","keywords":"Medicine; Neutropenia; Adverse effect; Internal medicine; Refractory (planetary science); Multiple myeloma; Febrile neutropenia; Gastroenterology; Phases of clinical research; Progressive disease; Surgery; Clinical trial; Toxicity; Chemotherapy","score_opus":0.02022512990478543,"score_gpt":0.3084402270575456,"score_spread":0.28821509715276017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409785682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99105173,0.00022623737,0.00015827357,0.000051490304,0.000060941504,0.0072663375,0.00006178976,0.000046224075,0.0010769955],"genre_scores_gemma":[0.9965349,0.0000117750815,0.001056672,0.000055553377,0.00002585759,0.0009800888,0.00014042435,0.000029398529,0.0011653746],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998267,0.00013915119,0.00042610947,0.00037241814,0.00046123736,0.00033407792],"domain_scores_gemma":[0.9982872,0.0006271608,0.00015282705,0.0004517452,0.00032608878,0.00015495597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000223604,0.00022269267,0.0007957654,0.00023998137,0.00009649025,0.00001545552,0.000104712286,0.000068144676,0.000048463102],"category_scores_gemma":[0.00114219,0.00015064109,0.00017798792,0.00023327005,0.00008826355,0.00006328031,0.000053995012,0.0001163041,0.000008595394],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.52458066,0.278753,0.15642883,0.00041786567,0.0060718735,0.00016839332,0.0013776672,0.0000030659378,0.0032296516,0.0000329906,0.00025493375,0.028681051],"study_design_scores_gemma":[0.9583481,0.017132351,0.015408722,0.0002160188,0.0014201985,0.000002525307,0.00029704702,0.0002215424,0.006420392,0.000035779187,0.00036808,0.00012925614],"about_ca_topic_score_codex":0.00018476791,"about_ca_topic_score_gemma":0.0000572056,"teacher_disagreement_score":0.4337674,"about_ca_system_score_codex":0.000058031797,"about_ca_system_score_gemma":0.00016367168,"threshold_uncertainty_score":0.61429656},"labels":[],"label_agreement":null},{"id":"W4409908090","doi":"10.1182/blood.2025029042","title":"Counterpoint: the design and interpretation of blood transfusion randomized clinical trials","year":2025,"lang":"en","type":"review","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bruyère; University of Ottawa","funders":"","keywords":"Counterpoint; Medicine; Blood transfusion; Interpretation (philosophy); Randomized controlled trial; Intensive care medicine; Internal medicine; Computer science; Psychology","score_opus":0.09430663565613648,"score_gpt":0.4234981704247062,"score_spread":0.32919153476856977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409908090","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000011059134,0.9630885,0.024524057,0.0002764641,0.0003908577,0.010078273,0.00001994656,0.000046410205,0.0015644447],"genre_scores_gemma":[0.0001559038,0.9974007,0.0011045081,0.0002836398,0.00012443539,0.00046811625,0.00004258571,0.00003110412,0.00038899409],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9893333,0.0067318385,0.002951606,0.0004754633,0.00033314017,0.00017470775],"domain_scores_gemma":[0.98638743,0.012136648,0.00075196783,0.00052225427,0.00010386854,0.00009783277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019116255,0.00039335262,0.006299636,0.0002538338,0.00006011016,0.00002849464,0.00019824023,0.00038008543,0.00012071763],"category_scores_gemma":[0.0032838753,0.00020196044,0.0019957868,0.00027127314,0.00024567664,0.000029414416,0.0000589161,0.0005089579,0.000005311555],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008084349,0.0011927005,9.857338e-7,0.028260164,0.005348483,0.000019559315,0.00017575624,1.6298695e-7,0.0000026945306,0.0005600461,0.0003444637,0.95601064],"study_design_scores_gemma":[0.38268188,0.00080530706,0.00000216208,0.08175087,0.2912982,0.00014722925,0.00009037143,0.0002028596,0.000050603026,0.000244194,0.24231507,0.0004112388],"about_ca_topic_score_codex":0.0000149564175,"about_ca_topic_score_gemma":0.0000029934242,"teacher_disagreement_score":0.95559937,"about_ca_system_score_codex":0.000005948322,"about_ca_system_score_gemma":0.0003230436,"threshold_uncertainty_score":0.8235708},"labels":[],"label_agreement":null},{"id":"W4409994769","doi":"10.1182/blood.2024028067","title":"NET self-renewal: vascular Groundhog Day","year":2025,"lang":"en","type":"letter","venue":"Blood","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine","score_opus":0.008315079730072625,"score_gpt":0.20485029912864597,"score_spread":0.19653521939857335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409994769","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03904232,0.053759925,0.0014432598,0.79538876,0.02585746,0.0054317494,0.0021049073,0.0046927524,0.07227884],"genre_scores_gemma":[0.003392962,0.0014789683,0.0007323368,0.8916531,0.0037593946,0.00033215294,0.007749764,0.00023340505,0.09066792],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99696463,0.0006592905,0.00047042628,0.0009559182,0.000098190656,0.00085156184],"domain_scores_gemma":[0.9983485,0.00022599688,0.00020282915,0.0010798395,0.00011758399,0.000025247182],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0002635728,0.00068453595,0.000878162,0.00031952007,0.00026892466,0.000057820223,0.00084006053,0.0021343967,0.0011984218],"category_scores_gemma":[0.000039195653,0.0006138545,0.00044665445,0.00025525846,0.00012112382,0.00007931658,0.00032188868,0.0023315754,0.0021824844],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007278524,0.0002876388,0.000026197658,0.00015548654,0.002877047,0.00046351712,0.00009242411,1.4279854e-7,0.052899607,0.0007410494,0.94213164,0.00031796066],"study_design_scores_gemma":[0.0020814915,0.00015954774,0.000027856193,0.000127948,0.0011949063,0.000066329514,0.000010989407,4.39915e-8,0.10439176,0.0008532352,0.8905115,0.0005743831],"about_ca_topic_score_codex":0.00008080367,"about_ca_topic_score_gemma":0.0000093692,"teacher_disagreement_score":0.09626431,"about_ca_system_score_codex":0.000049336068,"about_ca_system_score_gemma":0.00020957613,"threshold_uncertainty_score":0.9999701},"labels":[],"label_agreement":null},{"id":"W4410158978","doi":"10.1182/blood.2025028357","title":"Menin inhibition with revumenib for <i>NPM1</i>-mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Swedish Orphan Biovitrum; Daiichi Sankyo Europe; National Cancer Institute; Foghorn Therapeutics; Gilead Sciences; Servier; Astellas Pharma; Genentech; Y-mAbs Therapeutics; MacroGenics; Syndax Pharmaceuticals; Pfizer; Incyte; Agios Pharmaceuticals; American Society of Pediatric Hematology/Oncology; Astex Pharmaceuticals; Jazz Pharmaceuticals; Alexion Pharmaceuticals; Kite Pharma; Sanofi; Celgene; Bristol-Myers Squibb; AstraZeneca; Amgen; GlaxoSmithKline","keywords":"Medicine; Internal medicine; Discontinuation; Myeloid leukemia; Tolerability; Population; Adverse effect; Refractory (planetary science); Phases of clinical research; Oncology; Gastroenterology; Clinical trial","score_opus":0.017444601370284602,"score_gpt":0.300949740871285,"score_spread":0.2835051395010004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410158978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98557913,0.00032890297,0.00042903368,0.003886882,0.00014453827,0.0056873565,0.000056317807,0.00025213987,0.0036357136],"genre_scores_gemma":[0.9640224,0.00019699612,0.0017992746,0.0015132078,0.00028059667,0.0015800399,0.00020031615,0.000097234464,0.030309912],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997272,0.00020941679,0.0005383121,0.0006810669,0.0006544634,0.00064472755],"domain_scores_gemma":[0.9978902,0.00045965673,0.00017279487,0.00093504053,0.0003682282,0.00017407804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000902392,0.00036441055,0.00056383363,0.00027072494,0.00039611722,0.000074828735,0.00028803482,0.00020859716,0.00009770668],"category_scores_gemma":[0.00028888715,0.00020774931,0.00015332749,0.0009990117,0.00017696647,0.00017037542,0.00016847365,0.0008145853,0.00004014464],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.068162106,0.015605262,0.015069944,0.0016916399,0.022017622,0.00573178,0.0085305115,0.000041949836,0.5129881,0.0008459885,0.32869118,0.020623941],"study_design_scores_gemma":[0.30897194,0.040621404,0.019927373,0.0027931398,0.021631127,0.001316702,0.015641026,0.00076057564,0.44746554,0.0005450999,0.13827518,0.002050909],"about_ca_topic_score_codex":0.000116086914,"about_ca_topic_score_gemma":0.00012234645,"teacher_disagreement_score":0.24080984,"about_ca_system_score_codex":0.0008754378,"about_ca_system_score_gemma":0.0019188055,"threshold_uncertainty_score":0.84717715},"labels":[],"label_agreement":null},{"id":"W4411141965","doi":"10.1182/blood.2024027949","title":"Eliminating The Need for Sequential Confirmation of Response in Multiple Myeloma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Multiple myeloma; Medicine; Internal medicine; Oncology; Clinical trial; Monoclonal gammopathy of undetermined significance; Surrogate endpoint; Progression-free survival; Disease; Serum protein electrophoresis; Monoclonal; Antibody; Immunology; Chemotherapy; Monoclonal antibody","score_opus":0.036461286842071255,"score_gpt":0.3341772016959929,"score_spread":0.2977159148539217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411141965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967574,0.00011558333,0.00038997416,0.001286669,0.000032765263,0.0009162622,0.000019555202,0.000013055214,0.00046872417],"genre_scores_gemma":[0.998093,0.0000051236,0.0013143097,0.00006406001,0.000019207735,0.00012467711,0.00002680969,0.000005566054,0.00034726574],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99932337,0.00009673884,0.00019789881,0.000099505916,0.00013030226,0.0001521893],"domain_scores_gemma":[0.9989808,0.0006876595,0.000045337576,0.00016241557,0.00009500165,0.00002876039],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043587494,0.000060563816,0.00013641796,0.00013734895,0.000054067565,0.000007821077,0.000057852274,0.000040117862,0.000011707141],"category_scores_gemma":[0.0015332161,0.00004180526,0.00005560872,0.00018017077,0.000043385062,0.000027702055,0.00002563614,0.00006716773,0.0000026728403],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026624547,0.0025155675,0.3429022,0.0007682579,0.00064927054,0.00008422533,0.001944818,0.000027952568,0.5678051,0.0010761933,0.00030177203,0.055300087],"study_design_scores_gemma":[0.023121554,0.00049086683,0.66525006,0.00022092935,0.00012089674,0.00000913075,0.0006008167,0.0048954682,0.30463725,0.00016131722,0.00043865808,0.000053059764],"about_ca_topic_score_codex":0.00009484739,"about_ca_topic_score_gemma":0.00004116054,"teacher_disagreement_score":0.32234782,"about_ca_system_score_codex":0.000026441006,"about_ca_system_score_gemma":0.0001273578,"threshold_uncertainty_score":0.18355137},"labels":[],"label_agreement":null},{"id":"W4411170038","doi":"10.1182/blood.2024028107","title":"Biallelic antigen escape is a mechanism of resistance to anti-CD38 antibodies in multiple myeloma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"National Cancer Institute","keywords":"Multiple myeloma; Antibody; Antigen; Immunology; Mechanism (biology); CD38; Medicine; Virology; Biology; Cancer research; Genetics","score_opus":0.023945573857095715,"score_gpt":0.3022157461441357,"score_spread":0.27827017228704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411170038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99298805,0.0008009139,0.00009787158,0.0012556033,0.000054579727,0.0008202983,0.00005479588,0.000040722225,0.0038871497],"genre_scores_gemma":[0.99342394,0.00039132067,0.0034795608,0.00027591607,0.00002778477,0.00004250922,0.000018434,0.000017324455,0.0023232289],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850774,0.000049717157,0.0003419343,0.0003713245,0.00032696605,0.0004023302],"domain_scores_gemma":[0.999091,0.000098997116,0.000052499752,0.0004537182,0.00016184161,0.00014191719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016855107,0.00017407512,0.00047084945,0.00047152923,0.000062075305,0.000013888386,0.00015453485,0.000090057154,0.00007505945],"category_scores_gemma":[0.00041736595,0.0001533494,0.00009253529,0.00078691996,0.000049142505,0.000046986144,0.000113200505,0.00012062835,0.00005131643],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005853684,0.002092007,0.7761155,0.00048590204,0.000483032,0.00042721137,0.00072812015,8.3871674e-7,0.21463744,0.0008812132,0.0012555411,0.0023078234],"study_design_scores_gemma":[0.007013317,0.00016477128,0.58297527,0.00054670026,0.00005691443,0.0000043792265,0.00013034171,0.000050990493,0.40764531,0.00026337072,0.0010395296,0.00010910917],"about_ca_topic_score_codex":0.00022558826,"about_ca_topic_score_gemma":0.00049627695,"teacher_disagreement_score":0.19314024,"about_ca_system_score_codex":0.000034061144,"about_ca_system_score_gemma":0.00017988145,"threshold_uncertainty_score":0.62534076},"labels":[],"label_agreement":null},{"id":"W4411201262","doi":"10.1182/blood.2025028902","title":"Array genotyping of transfusion-relevant blood cell antigens in 6946 ancestrally diverse study participants","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services","funders":"NIHR Cambridge Biomedical Research Centre; Department of Health and Social Care; Stichting Sanquin Bloedvoorziening; Syöpäsäätiö; Cambridge University Hospitals; NIHR BioResource; University of Cambridge; Business Finland; British Heart Foundation; National Institute for Health and Care Research; Australian Government; NHS Blood and Transplant","keywords":"Genotyping; Antigen; Medicine; Biology; Immunology; Genetics; Genotype; Gene","score_opus":0.023578853760456153,"score_gpt":0.28199664676544284,"score_spread":0.2584177930049867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411201262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99558604,0.00077986886,0.000116060444,0.00014598138,0.00016404277,0.0010586388,0.000014217813,0.00004698431,0.002088143],"genre_scores_gemma":[0.9985629,0.00055839634,0.00050828763,0.000075087795,0.000044049415,0.000026143614,0.0000061286846,0.000018925979,0.00020013067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99818987,0.00007351287,0.0005709782,0.00042525717,0.00029801394,0.00044236978],"domain_scores_gemma":[0.9992816,0.00006195867,0.00007274066,0.0003851571,0.00007879423,0.00011976405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003307404,0.00021362891,0.0005451898,0.00023910304,0.00008474984,0.000010706009,0.0001413344,0.00011424836,0.00007372208],"category_scores_gemma":[0.000028658651,0.00018719512,0.00013452285,0.0005651221,0.00006217815,0.0000686336,0.000027940194,0.0002772051,0.000007784867],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020128615,0.012461068,0.5702652,0.0002988892,0.00023254243,0.00023864934,0.0025888586,0.000016284363,0.41283232,0.000046644473,0.000005917665,0.000812378],"study_design_scores_gemma":[0.017768832,0.0010947112,0.7115038,0.00047571582,0.0018496065,0.000009114428,0.0017607294,0.000016864682,0.26522937,0.000059109425,0.000046615736,0.00018554351],"about_ca_topic_score_codex":0.0005474788,"about_ca_topic_score_gemma":0.0007142383,"teacher_disagreement_score":0.14760295,"about_ca_system_score_codex":0.00001027557,"about_ca_system_score_gemma":0.0001600398,"threshold_uncertainty_score":0.7633596},"labels":[],"label_agreement":null},{"id":"W4411474622","doi":"10.1182/blood.2025028412","title":"Somatic <i>IRF4</i> mutations and thymic tropism in primary mediastinal large B-cell lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Princess Margaret Cancer Centre; Simon Fraser University; BC Cancer Agency; University of British Columbia; Spinal Cord Injury BC","funders":"Eisai; Michael Smith Health Research BC; Veracyte; Canadian Institutes of Health Research; Regeneron Pharmaceuticals; Genome Canada; Seagen; Gilead Sciences; AstraZeneca; Deutsche Forschungsgemeinschaft; Bristol-Myers Squibb","keywords":"IRF4; Biology; Phenotype; Cancer research; Lymphoma; Transcription factor; Genetics; Immunology; Gene","score_opus":0.004425606108904823,"score_gpt":0.22436540302452654,"score_spread":0.2199397969156217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411474622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98128027,0.0029628768,0.000018224528,0.0008148435,0.000064682434,0.00033769698,0.000014597432,0.000039232753,0.014467563],"genre_scores_gemma":[0.99739444,0.00021992532,0.0008135417,0.00087404076,0.000033422577,0.00010718726,0.000053660886,0.000009877051,0.00049392803],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99920386,0.000027164147,0.00021928656,0.00020968058,0.00012818916,0.00021183275],"domain_scores_gemma":[0.9995593,0.00013307355,0.000038711984,0.0001718056,0.000021416474,0.00007573715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006727319,0.0001255076,0.00024902239,0.00013894703,0.000055631546,0.000016490376,0.000040411625,0.00005793009,0.000018561966],"category_scores_gemma":[0.0000329103,0.00010411141,0.000049445236,0.00018947324,0.000033807723,0.000042754455,0.000041515596,0.00004092671,0.00002603192],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006751003,0.019394951,0.96038836,0.0006484053,0.00020490494,0.0007341571,0.00077263755,5.888332e-7,0.003703491,0.0011385231,0.0006289531,0.012317521],"study_design_scores_gemma":[0.037056506,0.00015597118,0.953002,0.00028636883,0.0004484439,0.000084048595,0.00013352458,0.00004440463,0.0074887495,0.00035163382,0.00085103593,0.00009732769],"about_ca_topic_score_codex":0.000034748176,"about_ca_topic_score_gemma":0.000027141894,"teacher_disagreement_score":0.036988996,"about_ca_system_score_codex":0.000084631545,"about_ca_system_score_gemma":0.00020980001,"threshold_uncertainty_score":0.424554},"labels":[],"label_agreement":null},{"id":"W4411639056","doi":"10.1182/blood.2025028560","title":"Transposable elements as novel therapeutic targets for PARPi-induced synthetic lethality in PcG-mutated blood cancer","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; Blood Cancer UK; National Institutes of Health; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Cancer Research UK","keywords":"Synthetic lethality; Biology; Loss function; Cancer research; DNA damage; Reverse transcriptase; Epigenetics; Homologous recombination; DNA repair; Genetics; Phenotype; DNA; RNA; Gene","score_opus":0.015514838116578623,"score_gpt":0.2890300698712648,"score_spread":0.27351523175468617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411639056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958093,0.0013831988,0.00075922976,0.00021977953,0.0002073259,0.00080787606,0.0000997422,0.000032851116,0.00068070577],"genre_scores_gemma":[0.9969949,0.00009690596,0.001001539,0.0005464242,0.000046493573,0.0004681035,0.000102163496,0.00003223793,0.00071119075],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985403,0.000055508077,0.00032546296,0.00053092954,0.00012300855,0.00042483732],"domain_scores_gemma":[0.9993773,0.000021843956,0.00007422386,0.0003911585,0.000076303775,0.000059136382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028516466,0.00021852717,0.00023261765,0.00006501193,0.000066333276,0.000019944253,0.000257436,0.00021205709,0.00004082311],"category_scores_gemma":[0.00005433446,0.00022096021,0.00012692733,0.00016259406,0.000027209286,0.000004415094,0.00004471355,0.00009855179,0.0000036450517],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001132358,0.0010602255,0.0023121077,0.00008404631,0.00038308738,0.0000040170257,0.0000571706,0.000017302042,0.994615,0.00038292748,0.000022957678,0.00094792445],"study_design_scores_gemma":[0.005018724,0.00029497486,0.00043488253,0.000059459195,0.0002761741,0.000004666406,0.000048150578,0.00011321154,0.9903418,0.000842869,0.0023298098,0.00023526972],"about_ca_topic_score_codex":0.00011298806,"about_ca_topic_score_gemma":0.00033029777,"teacher_disagreement_score":0.0049054883,"about_ca_system_score_codex":0.000017564553,"about_ca_system_score_gemma":0.00020860588,"threshold_uncertainty_score":0.9010496},"labels":[],"label_agreement":null},{"id":"W4411639549","doi":"10.1182/blood.2024026735","title":"Clinical and molecular features of immunodeficiency in patients with telomere biology disorders","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute","funders":"","keywords":"Neutropenia; Immunodeficiency; Telomere; Cohort; Internal medicine; Immunology; Medicine; Lymphocyte; Biomarker; Gastroenterology; Biology; Immune system; Chemotherapy; Genetics","score_opus":0.004240536297145078,"score_gpt":0.2663074713435084,"score_spread":0.2620669350463633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411639549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99514705,0.0025298703,0.000024523073,0.00020413472,0.000053931763,0.00024752377,0.000006067864,0.000015085548,0.0017718353],"genre_scores_gemma":[0.99902797,0.00022939726,0.00046654546,0.00020104571,0.000005155679,0.0000051586444,0.000011779424,0.0000072027415,0.000045718574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991778,0.000048645954,0.00027411804,0.00024194349,0.0000902401,0.00016725501],"domain_scores_gemma":[0.99956715,0.00005979327,0.000054843993,0.00023062486,0.000049314593,0.000038258793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000107564854,0.000105543935,0.00031715483,0.00014961873,0.000021446625,0.0000034623797,0.00007469726,0.00009949726,0.000006298225],"category_scores_gemma":[0.00012470529,0.00007753416,0.000040733525,0.00029493796,0.00026280453,0.0000215704,0.000041746483,0.00016878595,7.679983e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018988707,0.0010707304,0.9796828,0.00006873968,0.00005545362,0.000004743014,0.00006298887,2.0756158e-7,0.00069546804,0.00088385824,0.000013925008,0.017271204],"study_design_scores_gemma":[0.0057402807,0.000560399,0.99189174,0.00012778636,0.00008081959,0.0000015381015,0.00006395466,0.0000012305044,0.0010546887,0.0002365614,0.00016370692,0.00007727541],"about_ca_topic_score_codex":0.00008721671,"about_ca_topic_score_gemma":0.000026891537,"teacher_disagreement_score":0.01719393,"about_ca_system_score_codex":0.000004136512,"about_ca_system_score_gemma":0.00007198064,"threshold_uncertainty_score":0.31617513},"labels":[],"label_agreement":null},{"id":"W4411639581","doi":"10.1182/blood.2025029250","title":"Clinical significance of preleukemic somatic <i>GATA1</i> mutations in children with Down syndrome","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Blood Cancer UK; Fondation ARC pour la Recherche sur le Cancer; University of Oxford; Imperial College Healthcare NHS Trust; Imperial College London; Kay Kendall Leukaemia Fund; University of Cambridge; Birmingham Women's and Children's NHS Foundation Trust; Hospital for Sick Children; National Institute for Health and Care Research; University Hospitals Birmingham NHS Foundation Trust; Middlesex University","keywords":"GATA1; Medicine; Mutation; Down syndrome; Internal medicine; Biology; Anemia; Genetics; Gene; Erythropoiesis","score_opus":0.012319172612852694,"score_gpt":0.3070535380022427,"score_spread":0.29473436538939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411639581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961626,0.00021819783,0.0001740683,0.00041962296,0.000019144065,0.0010490039,0.000019204965,0.00004344008,0.0018947036],"genre_scores_gemma":[0.9952061,0.00005206201,0.003542563,0.00018060004,0.000023814227,0.000097155,0.00004176619,0.000017277898,0.00083864725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985326,0.00009992841,0.0005260644,0.00030757737,0.00027136705,0.0002624872],"domain_scores_gemma":[0.9989463,0.00029492972,0.00009520047,0.00048503798,0.00008618711,0.000092308714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003745982,0.00012439454,0.00044278213,0.00022784647,0.000029662066,0.000008093936,0.00019628346,0.00011164896,0.00003341993],"category_scores_gemma":[0.00030805517,0.00009944404,0.00006941868,0.0007480194,0.00023055369,0.00005810547,0.00006120816,0.00044424008,0.000028677989],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011410751,0.0010046151,0.99501747,0.00019030532,0.000391611,0.00009154192,0.00006876966,0.000023984485,0.0014905374,0.00015404215,0.00027227178,0.001180718],"study_design_scores_gemma":[0.009338654,0.00050618383,0.9851599,0.0004988183,0.00033390583,0.00029890766,0.00006248053,0.00017119526,0.0032928342,0.00019461485,0.000041057017,0.000101484016],"about_ca_topic_score_codex":0.00017681626,"about_ca_topic_score_gemma":0.000027131275,"teacher_disagreement_score":0.00985763,"about_ca_system_score_codex":0.00010582025,"about_ca_system_score_gemma":0.0013404128,"threshold_uncertainty_score":0.40552104},"labels":[],"label_agreement":null},{"id":"W4411994968","doi":"10.1182/blood.2024027468","title":"Marstacimab prophylaxis in hemophilia A/B without inhibitors: results from the phase 3 BASIS trial","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"Grifols; Regeneron Pharmaceuticals; Novo Nordisk; Sanofi; Chugai Pharmaceutical; Amgen; Pfizer; Swedish Orphan Biovitrum; BioMarin Pharmaceutical; CSL Behring; F. Hoffmann-La Roche","keywords":"Medicine; Factor IX; Hemostasis; Internal medicine; Clinical trial; Clinical endpoint; Phases of clinical research; Gastroenterology; Adverse effect; Surgery","score_opus":0.02719290802489917,"score_gpt":0.3274449486869177,"score_spread":0.30025204066201855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411994968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98177135,0.0005330574,0.0000019455977,0.008725831,0.00024664213,0.0016989252,0.000107604625,0.000052744927,0.006861888],"genre_scores_gemma":[0.9935545,0.000071623974,0.00018262028,0.00019747001,0.00061289273,0.00010893193,0.00011767905,0.00001675728,0.0051375753],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982426,0.00014910697,0.00044404465,0.00042178264,0.00040586168,0.00033658143],"domain_scores_gemma":[0.9988153,0.00035994835,0.000052683936,0.00060639565,0.00007005076,0.000095610354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004876459,0.00018338664,0.00035547934,0.0001679785,0.000103120045,0.00004229758,0.00016992635,0.00015840704,0.00007496781],"category_scores_gemma":[0.0008080988,0.0001068221,0.00013386279,0.00062772236,0.00011658746,0.000054719385,0.0000891209,0.00040174072,0.00008695194],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4765221,0.050913148,0.19345514,0.0003613053,0.0023915283,0.0028117525,0.005253303,0.0000018316987,0.04363883,0.00031618823,0.03931734,0.18501754],"study_design_scores_gemma":[0.8572126,0.0031850298,0.009269817,0.0007913892,0.0005272987,0.000011941184,0.00045704274,0.000077567725,0.10750757,0.00076599844,0.019891823,0.00030194016],"about_ca_topic_score_codex":0.00039593512,"about_ca_topic_score_gemma":0.00008466601,"teacher_disagreement_score":0.3806905,"about_ca_system_score_codex":0.00007175105,"about_ca_system_score_gemma":0.0003470126,"threshold_uncertainty_score":0.4356079},"labels":[],"label_agreement":null},{"id":"W4412003093","doi":"10.1182/blood.2025029269","title":"<i>SRSF2</i>-mutated MDS: bortezomib STAT?","year":2025,"lang":"en","type":"letter","venue":"Blood","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Celgene; Sanofi; Pfizer; Bristol-Myers Squibb; Amgen","keywords":"stat; Bortezomib; Medicine; Multiple myeloma; Internal medicine; Biology; Genetics; Signal transduction; STAT3","score_opus":0.005929705792180534,"score_gpt":0.20492764085124973,"score_spread":0.1989979350590692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412003093","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016202386,0.32081667,0.000152571,0.5218131,0.012918362,0.0022733444,0.0019727605,0.0018817919,0.12196904],"genre_scores_gemma":[0.031587925,0.0011960297,0.000030483932,0.7933427,0.00015039543,0.0001962939,0.0138194915,0.00014720467,0.15952948],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99715334,0.00030222884,0.0006635632,0.00076624873,0.00008296192,0.0010316607],"domain_scores_gemma":[0.9984226,0.00021557233,0.00028504455,0.0009509019,0.00012074849,0.0000051377306],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.00019682052,0.000630869,0.0008110859,0.00032004516,0.00037585365,0.00005330217,0.00091787946,0.0020509176,0.0012473084],"category_scores_gemma":[0.000092403236,0.0005998685,0.00038281555,0.0003637145,0.00034649175,0.00008490099,0.00021234328,0.0031804994,0.0017918602],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031277166,0.0003939628,0.00002757802,0.00017591458,0.001061736,0.00022753885,0.00019805442,0.0000013437095,0.012358203,0.00005402725,0.98287237,0.002597982],"study_design_scores_gemma":[0.0030340282,0.000099320976,0.00009858581,0.00019424735,0.00058062474,0.00009079701,0.00009267127,2.9051003e-7,0.01480792,0.00018405303,0.9801742,0.00064327987],"about_ca_topic_score_codex":0.00026560036,"about_ca_topic_score_gemma":0.0000022303063,"teacher_disagreement_score":0.31962064,"about_ca_system_score_codex":0.000029902973,"about_ca_system_score_gemma":0.0003717278,"threshold_uncertainty_score":0.9996657},"labels":[],"label_agreement":null},{"id":"W4412162065","doi":"10.1182/blood.2025028865","title":"Silence of the myeloma clones: GPRC5D epigenetic regulation","year":2025,"lang":"en","type":"letter","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Multiple myeloma; Epigenetics; Biology; Cancer research; Medicine; Genetics; Immunology; Gene","score_opus":0.018503326395002823,"score_gpt":0.2751283451659038,"score_spread":0.25662501877090094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412162065","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2512476,0.0046803528,0.000089806585,0.7142122,0.0008834833,0.004552927,0.00037663692,0.00013771995,0.023819275],"genre_scores_gemma":[0.7620527,0.00051494734,0.0012431345,0.15401156,0.003144544,0.00029843085,0.00090257777,0.0001029372,0.077729136],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9983462,0.000111140194,0.00029239454,0.00031662616,0.0006333915,0.00030022394],"domain_scores_gemma":[0.99863243,0.00016272205,0.00014454429,0.0008597134,0.00015075096,0.00004980915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000775748,0.00020582514,0.00037260275,0.00013374165,0.00006796784,0.00001098735,0.00023894625,0.0003763655,0.00018005472],"category_scores_gemma":[0.00021916162,0.00013138543,0.00021862965,0.0002648298,0.000116498035,0.000017886874,0.00010430903,0.0006137216,0.000036500634],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016804054,0.0010492095,0.10152445,0.003985826,0.0018833849,0.0007053276,0.0002115263,0.0000029265057,0.0059622903,0.000038850947,0.8643114,0.020156765],"study_design_scores_gemma":[0.007947364,0.00052921346,0.6714846,0.0031501604,0.0019953083,0.0001352141,0.00002671583,0.000060472,0.08624444,0.000515273,0.22755156,0.0003596897],"about_ca_topic_score_codex":0.000090152105,"about_ca_topic_score_gemma":0.0000061189485,"teacher_disagreement_score":0.6367598,"about_ca_system_score_codex":0.000040561707,"about_ca_system_score_gemma":0.00032877148,"threshold_uncertainty_score":0.53577423},"labels":[],"label_agreement":null},{"id":"W4412489258","doi":"10.1182/blood.2024027935","title":"A novel cause of type 1 von Willebrand disease: impaired exocytosis of Weibel-Palade bodies due to biallelic <i>MADD</i> variants","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"Erasmus Medisch Centrum; RIKEN; Company of Biologists; Stichting de Drie Lichten","keywords":"Von Willebrand factor; Exocytosis; Secretion; Von Willebrand disease; Rab; Cell biology; Immunology; Hemostasis; Degranulation; Biology; Medicine; Bleeding diathesis; Internal medicine; Platelet; GTPase; Receptor","score_opus":0.0163985224513464,"score_gpt":0.26212263088171744,"score_spread":0.24572410843037104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412489258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995632,0.0015766012,0.000048878162,0.00070385286,0.00009933359,0.00045245778,0.00015213537,0.00003166945,0.0013030639],"genre_scores_gemma":[0.9979483,0.00019861886,0.00058478274,0.00028370318,0.000021054168,0.000023561794,0.000040747585,0.000016353677,0.00088287157],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990712,0.000015957814,0.00028865036,0.0002321053,0.00018628422,0.00020581235],"domain_scores_gemma":[0.9992819,0.00005137817,0.00007649942,0.00033419483,0.000109498156,0.00014653376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000054784534,0.00016072077,0.00051203155,0.00016905644,0.000039217528,0.000006016589,0.00008494673,0.00006732164,0.000035813693],"category_scores_gemma":[0.00014791737,0.00013423286,0.000100862664,0.00032323386,0.000044792665,0.000039242976,0.00006093837,0.00005594443,0.000010437858],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009701417,0.0303312,0.63559407,0.0032373774,0.011572183,0.0026016952,0.002740098,0.000056549205,0.28486115,0.0011422458,0.01208905,0.00607293],"study_design_scores_gemma":[0.031564515,0.0016621856,0.89880013,0.0017303828,0.0049504307,0.000107004205,0.00015302449,0.000077335186,0.058202453,0.00045164026,0.0018882743,0.00041263955],"about_ca_topic_score_codex":0.00016812525,"about_ca_topic_score_gemma":0.00007586283,"teacher_disagreement_score":0.26320603,"about_ca_system_score_codex":0.000015972211,"about_ca_system_score_gemma":0.00020081083,"threshold_uncertainty_score":0.5473857},"labels":[],"label_agreement":null},{"id":"W4412746936","doi":"10.1182/blood.2024028205","title":"Final analysis of the RESONATE-2 study: up to 10 years of follow-up of first-line ibrutinib treatment for CLL/SLL","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"Incyte; Pharmacyclics; BeiGene; TG Therapeutics; Gilead Sciences; Genentech; AstraZeneca; Eli Lilly and Company","keywords":"Ibrutinib; Chlorambucil; Medicine; Internal medicine; Chronic lymphocytic leukemia; IGHV@; Peripheral edema; Nausea; Neutropenia; Gastroenterology; Adverse effect; Oncology; Surgery; Leukemia; Toxicity; Chemotherapy; Cyclophosphamide","score_opus":0.04988792393192714,"score_gpt":0.3568477804765986,"score_spread":0.30695985654467145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412746936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973241,0.0003096488,0.000024514926,0.00034357773,0.000075947246,0.0013456297,0.00011448842,0.000008805977,0.00045327994],"genre_scores_gemma":[0.9892482,0.000037039714,0.00018573835,0.000026958633,0.000025995565,0.00009069523,0.000017933136,0.000012317665,0.010355085],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99852544,0.000052259777,0.00048918184,0.0002652612,0.00044120816,0.00022663215],"domain_scores_gemma":[0.99831694,0.00043969098,0.00012892095,0.000787623,0.0002608164,0.00006599568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035617867,0.00012093295,0.00066807406,0.00034196358,0.000032766355,0.0000036537879,0.00023996517,0.00006819621,0.00010664217],"category_scores_gemma":[0.00059946335,0.000084998916,0.0004147135,0.0014031586,0.00007757459,0.0000120198965,0.0001378848,0.00005274862,0.0000025540373],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.053970598,0.06679656,0.48659736,0.005870264,0.13483639,0.00026956247,0.043418165,0.0032986088,0.025998302,0.0020514547,0.021972844,0.15491988],"study_design_scores_gemma":[0.39260656,0.013163964,0.2385961,0.0009359337,0.04330678,0.000010654897,0.0031880117,0.008476017,0.27296382,0.00014956483,0.026187703,0.00041488014],"about_ca_topic_score_codex":0.0014859871,"about_ca_topic_score_gemma":0.0016057905,"teacher_disagreement_score":0.33863595,"about_ca_system_score_codex":0.0008841399,"about_ca_system_score_gemma":0.001976109,"threshold_uncertainty_score":0.35055324},"labels":[],"label_agreement":null},{"id":"W4413138673","doi":"10.1182/blood.2024026018","title":"Treatment of relapsed and refractory follicular lymphoma: which treatment for which patient for which line of therapy?","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Agency","funders":"","keywords":"Follicular lymphoma; Chimeric antigen receptor; Lymphoma; Medicine; Immunotherapy; Tumor microenvironment; Immunology; Oncology; Immune system; Cancer research; Bioinformatics; Biology","score_opus":0.018947519111163633,"score_gpt":0.28078744849761056,"score_spread":0.2618399293864469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413138673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829696,0.011302373,0.00004529026,0.0011107102,0.00013010354,0.0035715448,0.00025825584,0.000032469383,0.0005796604],"genre_scores_gemma":[0.99016774,0.005100709,0.0020186938,0.000056766796,0.00006542524,0.0018869068,0.00023557506,0.000034380835,0.00043380196],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984339,0.00003894229,0.0005826329,0.00046866594,0.00018615079,0.0002897365],"domain_scores_gemma":[0.998094,0.0003891192,0.00023789889,0.00053398864,0.0006296852,0.00011529819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007705582,0.00034415978,0.0008872001,0.00016139774,0.000088127024,0.000010250783,0.00005367381,0.00017674491,0.000008328942],"category_scores_gemma":[0.00009376058,0.00023159762,0.000262428,0.00034560738,0.00003310856,0.000038463157,0.000017746343,0.000016275244,8.019124e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012262133,0.17235863,0.23210691,0.0015650316,0.01875363,0.00005205107,0.004615666,0.000032969332,0.03333466,0.003243886,0.0010693441,0.5206051],"study_design_scores_gemma":[0.17107233,0.056249037,0.0647122,0.00048033768,0.00503718,0.00003075059,0.00035269567,0.00025944956,0.6627602,0.00026825131,0.038424455,0.00035310106],"about_ca_topic_score_codex":0.00025385208,"about_ca_topic_score_gemma":0.00017277611,"teacher_disagreement_score":0.6294255,"about_ca_system_score_codex":0.00027476277,"about_ca_system_score_gemma":0.00046822373,"threshold_uncertainty_score":0.94442767},"labels":[],"label_agreement":null},{"id":"W4413139273","doi":"10.1182/blood.2024027879","title":"Molecular determinants of thrombosis recurrence risk across venous thromboembolism subtypes","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Public Health Ontario; University of Toronto","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; National Institutes of Health; University of Toronto; School of Medicine, Boston University; Fondation pour la Recherche Médicale; Agence Nationale de la Recherche; Université de Bordeaux","keywords":"Medicine; Mendelian randomization; Pulmonary embolism; Internal medicine; Hazard ratio; Deep vein; Von Willebrand factor; Thrombosis; Gastroenterology; Incidence (geometry); Venous thrombosis; Genotype; Confidence interval; Gene; Genetics; Genetic variants","score_opus":0.012983979336316695,"score_gpt":0.3093731028120288,"score_spread":0.2963891234757121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413139273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914646,0.0019706981,0.00012330708,0.00014048252,0.00033876466,0.00059744465,0.00004865931,0.00007470512,0.0052413247],"genre_scores_gemma":[0.99704546,0.0018678188,0.00053332496,0.00033848156,0.000046721838,0.00005595441,0.000009124231,0.000025754951,0.000077362434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99828404,0.000064126165,0.00046311572,0.00043181118,0.00030388628,0.00045303677],"domain_scores_gemma":[0.99875855,0.00007152598,0.0002169623,0.00070229184,0.00015281221,0.00009787504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031739907,0.0002361203,0.0009728118,0.00012321204,0.00014022001,0.000025089465,0.0002523323,0.00013404388,0.00005160845],"category_scores_gemma":[0.00020266608,0.00021586358,0.00021128404,0.0004361848,0.00015930254,0.00006690784,0.00020377332,0.00019759774,0.000033210235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010631314,0.021644088,0.86996067,0.0024856715,0.0031910203,0.00027919322,0.0037489333,0.000053893687,0.020623434,0.0053189015,0.003130188,0.06945768],"study_design_scores_gemma":[0.002211331,0.00053696375,0.8606668,0.00066557206,0.001719748,0.000009327802,0.00027401838,0.000045238874,0.13151543,0.0009446609,0.0011941994,0.00021672942],"about_ca_topic_score_codex":0.00040040773,"about_ca_topic_score_gemma":0.00006563781,"teacher_disagreement_score":0.11089199,"about_ca_system_score_codex":0.000027155615,"about_ca_system_score_gemma":0.00011312355,"threshold_uncertainty_score":0.88026613},"labels":[],"label_agreement":null},{"id":"W4413419002","doi":"10.1182/blood.2025029876","title":"Artificial intelligence in hematology","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"AI in cancer detection","field":"Computer Science","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"U.S. Food and Drug Administration; National Cancer Institute; National Institutes of Health; Incyte; Swedish Orphan Biovitrum; CSL Behring; Novo Nordisk; Sanofi; Genentech; AstraZeneca","keywords":"Workflow; Artificial intelligence; Personalized medicine; Pace; Medical physics; Computer science; Medicine; Data science; Bioinformatics","score_opus":0.017645548277878977,"score_gpt":0.27660179170183574,"score_spread":0.2589562434239568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413419002","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.034047194,0.00021739496,0.9580234,0.0012651839,0.0006119553,0.000078235666,1.4780363e-7,0.000103251674,0.0056531886],"genre_scores_gemma":[0.98752177,0.000007134016,0.0121946605,0.00018331241,0.000021115444,0.000016863922,8.747816e-8,0.0000016176317,0.000053457283],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99945325,0.000026386311,0.000144658,0.00019483008,0.000056902223,0.00012395404],"domain_scores_gemma":[0.99965197,0.000050456016,0.00002132246,0.00024734344,0.000015954736,0.00001296547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000111564645,0.000044852688,0.00007227618,0.00012799054,0.000026343525,0.00002608301,0.00035396207,0.000042653024,0.000006515582],"category_scores_gemma":[0.00003340672,0.00004757706,0.00001659273,0.00055058947,0.000021270822,0.000094150164,0.00011297442,0.00008433528,0.000043637196],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000003621824,0.00017636867,0.002260966,0.000014309765,0.000008447787,0.00002486415,0.00021020719,0.000084494415,0.00078442245,0.7788781,0.0000973249,0.21745688],"study_design_scores_gemma":[0.00014516692,0.00007411396,0.0028822229,0.000057154746,0.000007668015,0.000040907104,0.000044801338,0.026929094,0.48434246,0.4839346,0.001365823,0.00017600048],"about_ca_topic_score_codex":0.000026615044,"about_ca_topic_score_gemma":0.000107054315,"teacher_disagreement_score":0.9534746,"about_ca_system_score_codex":0.000020427644,"about_ca_system_score_gemma":0.000054484768,"threshold_uncertainty_score":0.19401363},"labels":[],"label_agreement":null},{"id":"W4413425553","doi":"10.1182/blood.2025028794","title":"Mitochondrial DNA via recipient TLR9 acts as a potent first hit in murine transfusion-related acute lung injury","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Lunds Universitet","keywords":"Transfusion-related acute lung injury; Immunology; TLR9; Pulmonary edema; Biology; Medicine; Lung; Internal medicine; Gene","score_opus":0.004432223814849291,"score_gpt":0.2443935923353478,"score_spread":0.2399613685204985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413425553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94253856,0.00037484468,0.00033933503,0.015994897,0.0014022898,0.0024784247,0.000015287993,0.00023447146,0.036621906],"genre_scores_gemma":[0.98808914,0.0014495525,0.00057856145,0.0019621733,0.00013081326,0.00017440328,0.000061648316,0.000041017967,0.0075126686],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.997894,0.000056406792,0.0006079436,0.0005708773,0.0004154579,0.00045534654],"domain_scores_gemma":[0.9991101,0.000041541047,0.00006121867,0.0005129733,0.00006502182,0.00020911553],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017011334,0.00029960505,0.00049975177,0.0004996269,0.00012335974,0.00002531181,0.00018785718,0.00022533246,0.0006181413],"category_scores_gemma":[0.00004337561,0.0002701351,0.00022518297,0.0008225638,0.00004948797,0.000073406525,0.00009710183,0.00043654937,0.000099055],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01819846,0.061330866,0.030225951,0.00368052,0.014386997,0.010531955,0.010183142,0.0001243529,0.6702928,0.016355857,0.060129482,0.10455965],"study_design_scores_gemma":[0.18549544,0.0047732797,0.16239935,0.0065557705,0.015320277,0.0005045441,0.00068210124,0.0010713425,0.3047019,0.0020341417,0.31406486,0.0023969787],"about_ca_topic_score_codex":0.00031868814,"about_ca_topic_score_gemma":0.00043095025,"teacher_disagreement_score":0.36559087,"about_ca_system_score_codex":0.00009112332,"about_ca_system_score_gemma":0.00012577513,"threshold_uncertainty_score":0.9999751},"labels":[],"label_agreement":null},{"id":"W4413637702","doi":"10.1182/blood.2025029132","title":"Plasma lipid levels predict chemotherapy response and survival in acute myeloid leukemia","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; National Institutes of Health; Cancer Center, University of Colorado; Leukemia and Lymphoma Society; Princess Margaret Cancer Foundation; Rally Foundation; V Foundation for Cancer Research; Elsa U. Pardee Foundation","keywords":"Myeloid leukemia; Oncology; Internal medicine; Metabolome; Medicine; Proportional hazards model; Metabolomics; Biomarker; Chemotherapy regimen; Leukemia; Survival analysis; Chemotherapy; Bioinformatics; Biology; Immunology; Metabolite; Genetics","score_opus":0.015998662678743437,"score_gpt":0.29272969806333893,"score_spread":0.2767310353845955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413637702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898492,0.00024947917,0.000049444112,0.0039633126,0.00013064526,0.00061057846,0.000037519272,0.00010813536,0.005001691],"genre_scores_gemma":[0.98515266,0.0004267952,0.0011415168,0.00087658485,0.00016950356,0.000060633865,0.000014712465,0.0000445947,0.0121130245],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980457,0.00021578284,0.0003549756,0.000492132,0.00037446298,0.0005169399],"domain_scores_gemma":[0.99867755,0.0004959286,0.00004663538,0.0005078802,0.00008446889,0.00018751531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001054583,0.00023901291,0.0005191021,0.00045554695,0.000073432726,0.00003831131,0.00020928726,0.00024803315,0.000096401214],"category_scores_gemma":[0.00040471926,0.0002158401,0.0000722349,0.0006598695,0.00017206285,0.00009331896,0.00015569536,0.00060289126,0.00003221175],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031479966,0.0013586904,0.37307683,0.0005708692,0.0021266907,0.0018706077,0.002498908,0.000010986919,0.5328966,0.00063481816,0.014058366,0.039416716],"study_design_scores_gemma":[0.0366262,0.000696076,0.84275395,0.00034884465,0.00023693226,0.0002378378,0.00026335928,0.00093171373,0.0994703,0.000107635155,0.0180218,0.00030537354],"about_ca_topic_score_codex":0.000097506476,"about_ca_topic_score_gemma":0.00003790032,"teacher_disagreement_score":0.4696771,"about_ca_system_score_codex":0.0004147283,"about_ca_system_score_gemma":0.0014656652,"threshold_uncertainty_score":0.8801704},"labels":[],"label_agreement":null},{"id":"W4413921737","doi":"10.1182/blood.2025029163","title":"The origin, diagnosis, and prognosis of oligomannose-type diffuse large B-cell lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Simon Fraser University; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Diffuse large B-cell lymphoma; Biology; Germinal center; Cancer research; Lymphoma; Glycosylation; Immunology; Antibody; B cell; Genetics","score_opus":0.009062110927720239,"score_gpt":0.2710406355717131,"score_spread":0.26197852464399285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413921737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911068,0.0058822827,0.000019222996,0.00025125218,0.000054210923,0.00026783635,0.00001254574,0.00000756414,0.002398249],"genre_scores_gemma":[0.9947612,0.0030004957,0.00009511369,0.00009429395,0.000035309342,0.00007405308,0.000019805933,0.000008096354,0.0019115917],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993283,0.000048291928,0.00013746867,0.00018629793,0.00010654025,0.00019306588],"domain_scores_gemma":[0.99951506,0.000032003984,0.00003845468,0.0002550769,0.000115436414,0.000043994973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015066705,0.000084696025,0.00008493917,0.00003524608,0.00013160949,0.000029933633,0.00015832657,0.00008355937,0.000005829184],"category_scores_gemma":[0.00012748971,0.000061681036,0.000039857998,0.00015283351,0.00007806606,0.000001975739,0.00014820564,0.000038474325,0.0000045898423],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037012625,0.011912517,0.4832785,0.00035757935,0.00044036703,0.000014289456,0.000120376455,0.0000010207405,0.4539465,0.0065649073,0.018658508,0.024335317],"study_design_scores_gemma":[0.0043103765,0.00018934018,0.017352695,0.000016396154,0.000027669157,0.0000020428258,0.000036948924,0.000014147134,0.68719864,0.00007114265,0.29070133,0.00007925295],"about_ca_topic_score_codex":0.0000183978,"about_ca_topic_score_gemma":0.000042495172,"teacher_disagreement_score":0.4659258,"about_ca_system_score_codex":0.0000030465785,"about_ca_system_score_gemma":0.000077633325,"threshold_uncertainty_score":0.25152797},"labels":[],"label_agreement":null},{"id":"W4414161460","doi":"10.1182/blood.2025028823","title":"Impact of immunochemotherapy regimens on outcomes of patients with primary mediastinal B-cell lymphoma in the IELSG37 trial","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Chemotherapy; Logistic regression; Lymphoma; Radiation therapy; Chemotherapy regimen; Performance status; Clinical trial; Salvage therapy","score_opus":0.0073887445773075915,"score_gpt":0.26097553912508514,"score_spread":0.25358679454777755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414161460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99492973,0.00019839077,4.911037e-7,0.00016090237,0.000041161824,0.0007638887,0.000021354488,0.0000061722303,0.0038779113],"genre_scores_gemma":[0.9994793,0.000039853403,0.00009653269,0.00021869622,0.000015360043,0.000044007462,0.000029792121,0.000008155291,0.00006833139],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991294,0.000047330435,0.0002685585,0.0001391628,0.0002826412,0.0001329],"domain_scores_gemma":[0.9991907,0.00025214118,0.00013580605,0.00034249263,0.000054691423,0.000024164388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010388763,0.00013787551,0.00039843208,0.000107046115,0.000015950167,0.0000039086044,0.000094580224,0.00004714144,0.000015825344],"category_scores_gemma":[0.00003084906,0.00006623864,0.00015442968,0.00018667003,0.00004956353,0.0000178998,0.000012517726,0.00003671563,0.0000013495148],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01626303,0.029897382,0.9489802,0.000041652966,0.00050236675,0.000014823272,0.000342304,6.930861e-7,0.00013051619,0.00003587285,0.00016457943,0.0036265648],"study_design_scores_gemma":[0.21191256,0.00438113,0.77888733,0.00010476109,0.0002207563,0.0000010890922,0.000026999565,3.1382464e-7,0.0043941387,0.000010664712,0.000019330138,0.000040908573],"about_ca_topic_score_codex":0.0001480577,"about_ca_topic_score_gemma":0.000003904139,"teacher_disagreement_score":0.19564953,"about_ca_system_score_codex":0.00008058896,"about_ca_system_score_gemma":0.00025236837,"threshold_uncertainty_score":0.27011335},"labels":[],"label_agreement":null},{"id":"W4414397582","doi":"10.1182/blood.2025029640","title":"Hematopoietic stem cell transplantation for purine nucleoside phosphorylase deficiency: an EBMT-IEWP retrospective study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"Vlaamse regering; Fonds Wetenschappelijk Onderzoek","keywords":"Retrospective cohort study; Hematopoietic stem cell transplantation; Transplantation; Purine nucleoside phosphorylase; Disease; Stem cell; Haematopoiesis; Immunodeficiency","score_opus":0.018667862918208284,"score_gpt":0.3058258094760101,"score_spread":0.28715794655780186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414397582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915362,0.00078071904,0.00035126548,0.00018384305,0.00007730134,0.0021438417,0.00006275851,0.00009995407,0.0047641066],"genre_scores_gemma":[0.99694693,0.00013085215,0.00026072346,0.00011070843,0.000060668393,0.00022501571,0.000025057583,0.00003164358,0.0022084126],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998409,0.000049818915,0.00032518522,0.00047595115,0.00036698638,0.0003730823],"domain_scores_gemma":[0.9991364,0.00006326304,0.000054352,0.00040800814,0.00018267412,0.00015533762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040058795,0.0001846934,0.0003699982,0.00020949573,0.00020647321,0.000054469885,0.00015151966,0.00008758592,0.00009333109],"category_scores_gemma":[0.00001783188,0.00016484996,0.00011397035,0.00042634993,0.000049601942,0.00009830318,0.000028029013,0.0002274308,0.000036178477],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009732789,0.07797103,0.6694108,0.0076106405,0.0011303866,0.0016104599,0.034882993,0.000032357635,0.15195206,0.010115477,0.0029823822,0.0325686],"study_design_scores_gemma":[0.040388077,0.008691388,0.52325785,0.00034189687,0.0024873486,0.000098482866,0.008222743,0.00033408403,0.41129595,0.0012590562,0.0029185084,0.00070459605],"about_ca_topic_score_codex":0.00016312425,"about_ca_topic_score_gemma":0.00021803977,"teacher_disagreement_score":0.2593439,"about_ca_system_score_codex":0.00008145528,"about_ca_system_score_gemma":0.00020751539,"threshold_uncertainty_score":0.67223865},"labels":[],"label_agreement":null},{"id":"W4414398065","doi":"10.1182/blood.2025029360","title":"Talquetamab plus daratumumab for the treatment of relapsed or refractory multiple myeloma in the TRIMM-2 study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Bone and Joint Health Institute; University of Calgary; Princess Margaret Cancer Centre","funders":"Chugai Pharmaceutical; Servier; Onyx Pharmaceuticals; Prothena; Regeneron Pharmaceuticals; Genentech; Celgene; Adaptive Biotechnologies; Kite Pharma; Gilead Sciences; Sanofi; Pfizer; Amgen","keywords":"Daratumumab; Multiple myeloma; Adverse effect; Refractory (planetary science); Clinical endpoint; Proteasome inhibitor; Phases of clinical research; Cohort","score_opus":0.04932490908800263,"score_gpt":0.3540793614770588,"score_spread":0.3047544523890562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414398065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897628,0.002229829,0.000033146913,0.00070370216,0.00009429347,0.0060899025,0.000050559207,0.000024959783,0.0010108273],"genre_scores_gemma":[0.99485165,0.00029597155,0.00020029575,0.00006559009,0.000067477944,0.0015069911,0.000035365843,0.000017026725,0.0029596272],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850166,0.00017144691,0.00036839003,0.00029790515,0.00033456218,0.00032605988],"domain_scores_gemma":[0.9972933,0.001724225,0.00007937981,0.0007599058,0.00008749422,0.000055691908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032438114,0.00020080918,0.00042809398,0.00015565882,0.00017627336,0.000021509799,0.00022500676,0.000071286435,0.000026794381],"category_scores_gemma":[0.0004545439,0.0000862579,0.00017209734,0.00041042257,0.00008312948,0.000038017133,0.000028130904,0.00013187763,0.0000070264805],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05453869,0.14494322,0.52395296,0.00056994177,0.009209589,0.00200853,0.02278477,0.000023716157,0.0050440365,0.00032890218,0.0026393158,0.2339563],"study_design_scores_gemma":[0.18140343,0.01918762,0.7579329,0.00015114495,0.0016820449,0.000034326433,0.00854242,0.0008694595,0.008940676,0.00004592561,0.021030204,0.00017982139],"about_ca_topic_score_codex":0.0005159782,"about_ca_topic_score_gemma":0.0012621529,"teacher_disagreement_score":0.23397994,"about_ca_system_score_codex":0.0001499637,"about_ca_system_score_gemma":0.00036225817,"threshold_uncertainty_score":0.3517495},"labels":[],"label_agreement":null},{"id":"W4414459627","doi":"10.1182/blood.2025028954","title":"CEBPA repression by MECOM blocks differentiation to drive aggressive leukemias","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Edward P. Evans Foundation; Dana-Farber Cancer Institute; Alex's Lemonade Stand Foundation for Childhood Cancer; National Cancer Institute; National Institutes of Health; National Science Foundation","keywords":"CEBPA; Psychological repression; Transcription factor; Myeloid leukemia; Stem cell; Myeloid; Leukemia; Regulator; Regulation of gene expression; Gene","score_opus":0.0033325632654960754,"score_gpt":0.23128592784267404,"score_spread":0.22795336457717796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414459627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99165636,0.0007470073,0.0030168486,0.0004780027,0.00021996029,0.000257856,0.000022396775,0.000023746828,0.0035778093],"genre_scores_gemma":[0.9922752,0.00006779138,0.0002709316,0.00055642315,0.00010591478,0.000052798798,0.00025142852,0.0000093633025,0.006410167],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99924713,0.000042676194,0.00015816068,0.00031892172,0.00009152976,0.0001416025],"domain_scores_gemma":[0.9994674,0.0000070557758,0.00009378528,0.0003047561,0.00006372813,0.000063290536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000053456773,0.000110828,0.000095185154,0.00004792172,0.00008478306,0.000024932246,0.00014029718,0.00013422752,0.000034657165],"category_scores_gemma":[0.00017796407,0.00010194252,0.000054302123,0.00009501402,0.000018073832,0.000003000853,0.00013224427,0.00006588411,0.000012193068],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025314243,0.00012408466,0.0019520925,0.000006350263,0.00004668689,0.0000012040566,0.000024622126,0.0000043489504,0.89903563,0.000054437784,0.09641122,0.002314034],"study_design_scores_gemma":[0.0008537974,0.00008328152,0.0012484998,0.000050121555,0.000028181817,0.0000017900906,0.000020179608,0.000014544928,0.9589037,0.00006979938,0.038612157,0.000113993345],"about_ca_topic_score_codex":0.000012687569,"about_ca_topic_score_gemma":0.000008916924,"teacher_disagreement_score":0.05986805,"about_ca_system_score_codex":0.000012086955,"about_ca_system_score_gemma":0.00004471212,"threshold_uncertainty_score":0.41570953},"labels":[],"label_agreement":null},{"id":"W4414497874","doi":"10.1182/blood.2025028848","title":"PROs vs clinician-reported adverse events in a large clinical trial: findings from the phase 3 POLARIX study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; Roche (Canada)","funders":"Wake Forest School of Medicine; University of Texas MD Anderson Cancer Center; Samsung; Genentech; Tianjin Medical University; Daiichi-Sankyo; University of Rochester; Sungkyunkwan University; University of Alberta; Université de Lille; Regeneron Pharmaceuticals; Yuhan; Univerzita Karlova v Praze; Memorial Sloan-Kettering Cancer Center; AstraZeneca; F. Hoffmann-La Roche; lékařská fakulta Univerzity Karlovy; Amgen","keywords":"Adverse effect; Tolerability; Quality of life (healthcare); Hematology; Incidence (geometry); Prednisone; Clinical trial","score_opus":0.06259727055660541,"score_gpt":0.4278840482358637,"score_spread":0.36528677767925827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414497874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937842,0.00022045764,0.0000020155587,0.0012891233,0.0005300535,0.0038161867,0.00005284607,0.000050581406,0.00025452557],"genre_scores_gemma":[0.9974683,0.000045152105,0.00005517603,0.0014008619,0.00019760417,0.0003450533,0.000077064746,0.000014879137,0.0003959003],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99767137,0.00025404862,0.001042215,0.00047680637,0.00027797342,0.00027759586],"domain_scores_gemma":[0.9983844,0.0006472846,0.00017432598,0.0006414162,0.00005610158,0.000096427226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011997462,0.00018492276,0.00058993313,0.00007625328,0.0000884251,0.000008475132,0.00014211793,0.00014122305,0.00007860505],"category_scores_gemma":[0.001303538,0.00011672586,0.0002625145,0.00031922615,0.00002935999,0.000043661923,0.00010410373,0.00024217596,0.0000615057],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010057556,0.077058956,0.90942156,0.0000056703143,0.00093150965,0.00051385787,0.00034234516,3.0987405e-8,0.000009546707,0.000021457176,0.00058037223,0.0010571592],"study_design_scores_gemma":[0.33627734,0.0020787835,0.65811276,0.00013772953,0.0013907219,0.0000026105733,0.00033415738,0.000006788259,0.00009734186,0.000048547696,0.0014461937,0.00006699818],"about_ca_topic_score_codex":0.00052702246,"about_ca_topic_score_gemma":0.00041347882,"teacher_disagreement_score":0.3262198,"about_ca_system_score_codex":0.0000582493,"about_ca_system_score_gemma":0.00032060244,"threshold_uncertainty_score":0.47599426},"labels":[],"label_agreement":null},{"id":"W4414696710","doi":"10.1182/blood.2025028960","title":"A single-cell atlas of bone marrow B cells reveals defective central B-cell tolerance in immune thrombocytopenia","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Natural Science Foundation of Shandong Province; Postdoctoral Innovation Project of Shandong Province; South China University of Technology; China Postdoctoral Science Foundation; Key Technologies Research and Development Program; National Natural Science Foundation of China","keywords":"Autoantibody; Bone marrow; Antibody; Immune system; Receptor; Immune tolerance; Bruton's tyrosine kinase; Peripheral tolerance; Central tolerance","score_opus":0.008113688650390171,"score_gpt":0.22676161619805818,"score_spread":0.21864792754766801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414696710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9679971,0.0044359565,0.000009984289,0.00009688793,0.00010014231,0.0006002448,0.0000212795,0.000021512331,0.026716925],"genre_scores_gemma":[0.99641144,0.0001856941,0.00060257164,0.00010588241,0.000013673632,0.000020280524,0.000020647016,0.000016784408,0.0026230093],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99879205,0.00004479913,0.0003821029,0.00028565733,0.00014369843,0.00035167378],"domain_scores_gemma":[0.9994182,0.00006561491,0.000118545424,0.00028481305,0.000049403818,0.00006343634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000083245424,0.00018372279,0.0007129526,0.00012277695,0.000030221552,0.000008945565,0.0000760555,0.00010668958,0.000053012074],"category_scores_gemma":[0.000020023743,0.00016693103,0.00013972855,0.00033255064,0.000049014987,0.000051276973,0.000044527715,0.00015347617,0.000026669548],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031940063,0.009600512,0.062832855,0.00041505342,0.00013396857,0.0006335128,0.00041129295,0.000012333029,0.9248322,0.000033881817,0.0003668876,0.00040808762],"study_design_scores_gemma":[0.018354317,0.00046376055,0.06257567,0.00045336233,0.00034446956,0.000022711276,0.00011225887,0.000018135006,0.9169491,0.00023775753,0.0003171591,0.0001513351],"about_ca_topic_score_codex":0.00020471093,"about_ca_topic_score_gemma":0.000052620908,"teacher_disagreement_score":0.028414391,"about_ca_system_score_codex":0.000058133908,"about_ca_system_score_gemma":0.00009363761,"threshold_uncertainty_score":0.680725},"labels":[],"label_agreement":null},{"id":"W4414756626","doi":"10.1182/blood.2025030114","title":"In low-risk myelodysplastic syndrome, don’t shoot the <i>STAG2</i>","year":2025,"lang":"en","type":"letter","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Shoot; Bone marrow; Chromosomal translocation; Transplantation; Chromosome abnormality","score_opus":0.008616782781362499,"score_gpt":0.25219025573659154,"score_spread":0.24357347295522905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414756626","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.052664135,0.0016342995,0.000040430696,0.9235246,0.0008961847,0.002312642,0.00032996878,0.00016854335,0.018429188],"genre_scores_gemma":[0.016442843,0.0011716436,0.00024292657,0.8871658,0.0046391063,0.00049656915,0.0005566064,0.00021545537,0.08906907],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99598044,0.00033874813,0.0006470794,0.00085771905,0.0010745133,0.0011014692],"domain_scores_gemma":[0.9966728,0.0013283374,0.00018206034,0.0015530782,0.00013643717,0.00012729976],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0005979721,0.00057354406,0.0009731634,0.0006233419,0.00013701066,0.00007518405,0.00088458863,0.0012046805,0.00064132706],"category_scores_gemma":[0.00078806176,0.00039272907,0.000288329,0.0009682212,0.00025913026,0.000072640854,0.0004238199,0.008275332,0.0005837144],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005908846,0.00020711032,0.0023267514,0.0010971834,0.00044811302,0.018448738,0.000077122844,0.000003515796,0.00004348248,0.000010647427,0.977114,0.00016424368],"study_design_scores_gemma":[0.006574074,0.00031029893,0.0032529337,0.0016945305,0.0013345884,0.0018469468,0.00005053366,0.0000545718,0.0003339161,0.00015246964,0.98389196,0.00050319405],"about_ca_topic_score_codex":0.0005162708,"about_ca_topic_score_gemma":0.000067745415,"teacher_disagreement_score":0.070639886,"about_ca_system_score_codex":0.00041193055,"about_ca_system_score_gemma":0.0015356876,"threshold_uncertainty_score":0.9998525},"labels":[],"label_agreement":null},{"id":"W4414756633","doi":"10.1182/blood.2025029483","title":"AML with mutated TP53, therapy-related, with basophilic differentiation, partial CD22, and ring sideroblasts","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Mutation; Basophilic; Chromosome abnormality; Bone marrow; Chromosomal translocation","score_opus":0.008580515217785429,"score_gpt":0.24612998866464728,"score_spread":0.23754947344686184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414756633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948944,0.00056535046,0.0002280857,0.0015893447,0.000023036328,0.0005784315,0.0000033068013,0.0001292852,0.0019887828],"genre_scores_gemma":[0.9978918,0.000148151,0.00033585992,0.00023534145,0.00005003351,0.00005245836,0.00002693414,0.00003411052,0.001225341],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987431,0.0000576649,0.00020878813,0.00035860934,0.00029491298,0.0003369319],"domain_scores_gemma":[0.99927616,0.00008808212,0.000058048056,0.0003111907,0.00013081118,0.00013572296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001168508,0.00019527372,0.0002880835,0.00018076674,0.00012521658,0.000048026388,0.0000813076,0.00010047332,0.00008997603],"category_scores_gemma":[0.000041093765,0.00012818453,0.000028902736,0.0004452987,0.00014248645,0.00008410004,0.000052614763,0.0003356359,0.000014971768],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006026127,0.0033600642,0.86182445,0.0007992169,0.0070005753,0.0015433447,0.0032903838,0.00017688026,0.09162523,0.0026654445,0.0011426987,0.020545596],"study_design_scores_gemma":[0.08226767,0.003042915,0.6887787,0.0014847149,0.0013109165,0.00097269757,0.00050271803,0.004230356,0.21494278,0.0004996617,0.0012611,0.0007057557],"about_ca_topic_score_codex":0.00006560586,"about_ca_topic_score_gemma":0.000039318344,"teacher_disagreement_score":0.17304572,"about_ca_system_score_codex":0.000049273836,"about_ca_system_score_gemma":0.0002529073,"threshold_uncertainty_score":0.52272135},"labels":[],"label_agreement":null},{"id":"W4414756755","doi":"10.1182/blood.2025030281","title":"Foxo1 unlocks the liver endothelial code to iron sensing","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Biomarkers in Disease Mechanisms","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Hemochromatosis; Endothelium; FOXO1; Hepatocellular carcinoma; Code (set theory)","score_opus":0.008001327940296555,"score_gpt":0.22502052172147835,"score_spread":0.21701919378118179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414756755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95821565,0.006392224,0.0055277087,0.0033052852,0.0034719913,0.0009016813,0.00020507992,0.00029961177,0.02168077],"genre_scores_gemma":[0.9919736,0.000022498174,0.00047974294,0.0019018127,0.000042620017,0.000009112543,0.000013083374,0.00001134898,0.0055461945],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99922234,0.00014256794,0.00012880588,0.00022522945,0.00002374468,0.0002573166],"domain_scores_gemma":[0.9994449,0.00012267291,0.000028886545,0.00035820782,0.000029080324,0.000016224227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014809772,0.00011600952,0.00012015219,0.000059197366,0.00021043532,0.000015620186,0.00023023435,0.00014756818,0.00019353195],"category_scores_gemma":[0.00007845699,0.000085541105,0.00006819745,0.00012287244,0.00009132103,0.000016048125,0.00017183078,0.0001496,0.000557923],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015721582,0.00020207172,0.0002164014,0.000018873146,0.0002962918,0.000024329873,0.000323638,0.0000016567072,0.9568857,0.003735715,0.019102482,0.019035643],"study_design_scores_gemma":[0.0017865995,0.00006484978,0.0012271208,0.00004913367,0.000254076,0.000043370677,0.00018334105,0.0000051052493,0.9104895,0.0008601392,0.084888905,0.00014787001],"about_ca_topic_score_codex":0.000049537874,"about_ca_topic_score_gemma":0.00004888695,"teacher_disagreement_score":0.06578642,"about_ca_system_score_codex":0.000016007318,"about_ca_system_score_gemma":0.000049233513,"threshold_uncertainty_score":0.7171157},"labels":[],"label_agreement":null},{"id":"W4414958520","doi":"10.1182/blood.2025029513","title":"Inflammation perturbs hematopoiesis by remodeling specific compartments of the bone marrow niche","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Cancer Research UK; National Institutes of Health; York University; New York State Stem Cell Science; Irving Medical Center, Columbia University; Damon Runyon Cancer Research Foundation","keywords":"Stromal cell; Haematopoiesis; Inflammation; Bone marrow; Mesenchymal stem cell; Progenitor cell; Chemokine; Stem cell; Monocyte; Flow cytometry","score_opus":0.008395897374400125,"score_gpt":0.218045152965436,"score_spread":0.20964925559103587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414958520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96890503,0.022782728,0.00012484305,0.00060278067,0.00102172,0.00024823617,0.000017200902,0.000032142885,0.006265306],"genre_scores_gemma":[0.9905809,0.00018271783,0.00010840887,0.00010136616,0.000013368752,0.000014591441,0.000033713128,0.000008311341,0.008956598],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992368,0.000111612164,0.00029961698,0.00015593943,0.000034019107,0.00016198648],"domain_scores_gemma":[0.99933684,0.00008098614,0.00012451071,0.00039893945,0.000054569995,0.0000041620224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015847763,0.000102796264,0.0001939528,0.000040886574,0.00012390806,0.000006803977,0.00023779902,0.00013081031,0.0001903375],"category_scores_gemma":[0.000035286503,0.0000782624,0.00007883262,0.00013697102,0.0001218833,0.000034597095,0.00011406796,0.00016458968,0.00005965],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032492306,0.00012153714,0.0019820603,0.000038872255,0.00013894645,2.2832985e-7,0.00018895385,0.000011921367,0.9747279,0.0004912962,0.021241684,0.0010240938],"study_design_scores_gemma":[0.001363181,0.000011370447,0.0009745416,0.00008463345,0.000067732115,0.0000069519183,0.000085110194,0.000006168806,0.91688794,0.00024807395,0.08019287,0.00007143634],"about_ca_topic_score_codex":0.000015597776,"about_ca_topic_score_gemma":0.0000036222202,"teacher_disagreement_score":0.058951188,"about_ca_system_score_codex":0.000026445838,"about_ca_system_score_gemma":0.00003805617,"threshold_uncertainty_score":0.31914482},"labels":[],"label_agreement":null},{"id":"W4414958876","doi":"10.1182/blood.2025028625","title":"Distinct biological subtypes of chronic GVHD after pediatric hematopoietic cell transplantation","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Hospital for Sick Children; Alberta Children's Hospital; Centre Hospitalier Universitaire Sainte-Justine; Montreal Children's Hospital; CancerCare Manitoba; BC Children's Hospital","funders":"Canadian Institutes of Health Research; National Cancer Institute; National Institutes of Health; Incyte; Sanofi; Pfizer","keywords":"Hematopoietic stem cell transplantation; Cohort; Transplantation; Stem cell; Hematology; Graft-versus-host disease; Cancer; Haematopoiesis","score_opus":0.009755702808552789,"score_gpt":0.243029164127143,"score_spread":0.23327346131859023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414958876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879335,0.001981388,0.0019486385,0.000091349655,0.00012585946,0.00038956842,0.000028519236,0.000062581974,0.0074385717],"genre_scores_gemma":[0.99832386,0.0006520415,0.00050495827,0.000042880485,0.00007948056,0.00004933764,0.00006798773,0.00001221774,0.000267266],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989311,0.000047944097,0.00038951612,0.0002534647,0.00017604847,0.00020192837],"domain_scores_gemma":[0.9994344,0.00015750164,0.00007396538,0.00021136097,0.00006022145,0.00006254007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012793994,0.00014950568,0.00030501204,0.0001514816,0.000028047192,0.0000063822868,0.00007347126,0.00014222745,0.0003730584],"category_scores_gemma":[0.000017659106,0.00012181265,0.00011232197,0.0003195971,0.000055256452,0.00003014296,0.000008701299,0.00011656002,0.00004806714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000323295,0.0014736429,0.9665882,0.007933958,0.0000792092,0.00024242644,0.00057121564,0.0000019659992,0.021863371,0.00037584594,0.000052804393,0.0004940833],"study_design_scores_gemma":[0.0042221434,0.0003394515,0.8058247,0.00017615466,0.0012956109,0.00009601836,0.0000423622,0.000010695655,0.18761998,0.00015994263,0.00006356363,0.00014939325],"about_ca_topic_score_codex":0.00000849174,"about_ca_topic_score_gemma":0.0000058077117,"teacher_disagreement_score":0.16575661,"about_ca_system_score_codex":0.000022724294,"about_ca_system_score_gemma":0.000144574,"threshold_uncertainty_score":0.49673757},"labels":[],"label_agreement":null},{"id":"W4414987352","doi":"10.1182/blood.2025030044","title":"A rare case of epithelioid hemangioendothelioma involving bone marrow","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Vascular Tumors and Angiosarcomas","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Bone marrow; Epithelioid hemangioendothelioma; Hemangioendothelioma; Epithelioid cell; Biopsy","score_opus":0.008898369564768013,"score_gpt":0.24617835797433052,"score_spread":0.2372799884095625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414987352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98518,0.0103011895,0.00006222739,0.0005876352,0.00005779321,0.00022111705,0.000012938729,0.000054919637,0.0035221667],"genre_scores_gemma":[0.9964908,0.00006344892,0.001261725,0.0002906979,0.00007213562,0.000012856224,0.000007804133,0.000017146443,0.0017834372],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99923134,0.000027916518,0.0002452297,0.00018605939,0.00011895793,0.00019047993],"domain_scores_gemma":[0.9993849,0.000038038823,0.00005735766,0.00036892685,0.00007667624,0.00007410666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013610268,0.00011725189,0.00032018428,0.0002352299,0.000052945994,0.000008208408,0.000058094847,0.000051873583,0.00008994722],"category_scores_gemma":[0.00010440677,0.00009957457,0.00024955274,0.00036667252,0.000046877394,0.00003183409,0.000059751623,0.000093048926,0.000013621685],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019799337,0.003841136,0.13098699,0.0028199973,0.0013789684,0.07462585,0.0011524626,0.000002484509,0.7599479,0.011620554,0.004411449,0.009014228],"study_design_scores_gemma":[0.018255752,0.00054483005,0.013923662,0.0023323316,0.0022497948,0.038316723,0.0013978034,0.00020129251,0.9152376,0.0016965969,0.00537584,0.00046778598],"about_ca_topic_score_codex":0.00008827442,"about_ca_topic_score_gemma":0.000024177707,"teacher_disagreement_score":0.15528971,"about_ca_system_score_codex":0.000009913269,"about_ca_system_score_gemma":0.00007152147,"threshold_uncertainty_score":0.40605333},"labels":[],"label_agreement":null},{"id":"W4414987375","doi":"10.1182/blood.2025030399","title":"Mel200 or BuMel conditioning in myeloma: is there a winner?","year":2025,"lang":"en","type":"letter","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Conditioning; Central air conditioning; Quality (philosophy); MEDLINE","score_opus":0.02818191209263476,"score_gpt":0.31031070148034307,"score_spread":0.2821287893877083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414987375","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06875969,0.0037808972,0.000013392165,0.8635499,0.00033119248,0.0028102773,0.0009901914,0.00024871138,0.05951575],"genre_scores_gemma":[0.07806649,0.000674229,0.001304989,0.6957999,0.0037403582,0.00076362427,0.003929359,0.00017471868,0.21554635],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978594,0.00009271522,0.00033884513,0.0005417236,0.00054370816,0.00062361785],"domain_scores_gemma":[0.99892336,0.00022709915,0.000084637824,0.00055536855,0.000098176635,0.00011136745],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009769989,0.0003538692,0.00064998824,0.00042835358,0.00007970029,0.00004784492,0.00018444858,0.0006341732,0.002311252],"category_scores_gemma":[0.00018150911,0.00025806692,0.00017233446,0.00036521693,0.0000688727,0.00005190795,0.000086801345,0.0014901303,0.00030167552],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001863477,0.0005866672,0.018449213,0.00091452384,0.0010258404,0.0278827,0.00012858277,6.451546e-8,0.000057797297,0.000008214309,0.9484338,0.0023262487],"study_design_scores_gemma":[0.02430099,0.00065078074,0.04106163,0.0032572532,0.0008951217,0.00044151983,0.00008062652,0.00002743382,0.0029771763,0.00017282215,0.9256069,0.000527736],"about_ca_topic_score_codex":0.00038846847,"about_ca_topic_score_gemma":0.00008378908,"teacher_disagreement_score":0.16775003,"about_ca_system_score_codex":0.00012261058,"about_ca_system_score_gemma":0.0005903267,"threshold_uncertainty_score":0.9999872},"labels":[],"label_agreement":null},{"id":"W4415286785","doi":"10.1182/blood.2024027904","title":"Diagnosis and management of AML in pediatric patients: consensus recommendations from an international expert panel","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"National Cancer Institute; National Institutes of Health; Incyte; bluebird bio; Jazz Pharmaceuticals; Daiichi Sankyo Europe; U.S. Department of Defense; Sanofi; Pennsylvania Department of Health; Syndax Pharmaceuticals; BeiGene; Swedish Orphan Biovitrum; Children's Hospital of Philadelphia; AstraZeneca; Pfizer; Amgen; Seattle Children's Research Institute","keywords":"MEDLINE; Myeloid leukemia; Consensus conference; Genetic testing; Disease; Disease management","score_opus":0.03217994557747656,"score_gpt":0.33346294873077303,"score_spread":0.3012830031532965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415286785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99293226,0.0002756259,0.000010305829,0.003764399,0.00009852053,0.000313541,0.00006112687,0.000013400313,0.0025308405],"genre_scores_gemma":[0.9900423,0.0056750067,0.0034021726,0.00034784857,0.000053754095,0.000107577194,0.00019669767,0.0000073773977,0.00016725292],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993222,0.00003741873,0.00021089388,0.00018397535,0.0001436533,0.00010187247],"domain_scores_gemma":[0.9995363,0.00013007151,0.000037265007,0.00017301833,0.00007536467,0.00004801566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008326041,0.00006401375,0.00012367488,0.00023103452,0.000018510911,0.000008577886,0.00008948623,0.00004033939,0.00010184706],"category_scores_gemma":[0.00007868735,0.00006158154,0.000018815505,0.00020128027,0.000028361328,0.00004030065,0.0001077834,0.000092016715,0.000003737829],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057288165,0.0013712815,0.9738688,0.00005619951,0.00013437904,0.00002505389,0.00022779875,3.4284466e-7,0.000035822413,0.00018737823,0.0034743825,0.020561296],"study_design_scores_gemma":[0.0062499368,0.000076872486,0.98955023,0.00011225535,0.0001051041,6.333232e-7,0.0003451743,0.000066548055,0.00063883176,0.00009532903,0.0027049235,0.000054169832],"about_ca_topic_score_codex":0.0002810492,"about_ca_topic_score_gemma":0.000037158337,"teacher_disagreement_score":0.020507127,"about_ca_system_score_codex":0.000060853254,"about_ca_system_score_gemma":0.000041328847,"threshold_uncertainty_score":0.25112224},"labels":[],"label_agreement":null},{"id":"W4415675833","doi":"10.1182/blood.2025031086","title":"High-grade/large B-cell lymphoma-11q has a very good prognosis in children and young people without a predisposition","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Genetic predisposition; Lymphoma; Prospective cohort study; Survival rate; MEDLINE; Young adult","score_opus":0.0050455531586384925,"score_gpt":0.21703668836330425,"score_spread":0.21199113520466575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415675833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949718,0.0020125823,0.000008822744,0.0007330536,0.00008926845,0.0011310503,0.000063877385,0.00008459345,0.0009049115],"genre_scores_gemma":[0.99822545,0.00025882298,0.00043976077,0.00015089204,0.00007033712,0.00039651923,0.00018553874,0.000021186142,0.00025149758],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987418,0.00004256747,0.0002645566,0.00042732788,0.00019676879,0.00032700077],"domain_scores_gemma":[0.9995239,0.000034966262,0.00006380971,0.00023590095,0.000034586643,0.00010687114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010238589,0.00022409426,0.00039616047,0.00019142653,0.00011157754,0.00006821862,0.000062097075,0.0001281548,0.000011379924],"category_scores_gemma":[0.000019267505,0.00019195539,0.0000860669,0.00033132994,0.000036441466,0.000094473944,0.00007152212,0.0000622129,0.000012950167],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010500458,0.014473936,0.9829918,0.000092507486,0.00027588572,0.000041455063,0.00036483648,2.0924428e-7,0.0003116405,0.00027356352,0.00032375174,0.00074537913],"study_design_scores_gemma":[0.03951584,0.00038393663,0.94266415,0.00031027952,0.0009511929,0.00015054591,0.00006492489,0.00002842543,0.015659954,0.000061091174,0.000060573548,0.00014908047],"about_ca_topic_score_codex":0.0009341172,"about_ca_topic_score_gemma":0.00046407618,"teacher_disagreement_score":0.040327676,"about_ca_system_score_codex":0.000110792236,"about_ca_system_score_gemma":0.00016375926,"threshold_uncertainty_score":0.7827714},"labels":[],"label_agreement":null},{"id":"W4415933155","doi":"10.1182/blood.2025029359","title":"Multinational assessment of absolute neutrophil counts and white blood cell counts among healthy Duffy-null adults","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Reference values; Ethnic group; Biobank; White blood cell; Population; Confidence interval; Complete blood count; Absolute neutrophil count; Blood count","score_opus":0.0027673667753712306,"score_gpt":0.23608221205907268,"score_spread":0.23331484528370144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415933155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96324116,0.001454532,0.000029267547,0.00007130605,0.000086839376,0.00011997753,0.000058431484,0.0000054947973,0.03493297],"genre_scores_gemma":[0.9974934,0.00036757567,0.00037090463,0.00014847296,0.000026141133,0.000010672325,0.000080139005,0.000006630413,0.0014961065],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99957633,0.00001184656,0.000100506455,0.00015351102,0.000068158,0.00008963495],"domain_scores_gemma":[0.999759,0.000005521451,0.00004682103,0.00011186999,0.000049285743,0.000027501977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003101185,0.00007149085,0.00007811186,0.000024741434,0.0000313208,0.0000066075786,0.000047916274,0.00006484903,0.000027281782],"category_scores_gemma":[0.0000051424067,0.00006894579,0.00002749717,0.000038702074,0.000030585474,0.0000018468962,0.000036558773,0.000034214812,0.00000433329],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014220964,0.0071931113,0.95076436,0.0005710834,0.0010212426,0.00002386218,0.000072094386,0.000022886477,0.012595915,0.0014191724,0.02119706,0.00497703],"study_design_scores_gemma":[0.016630102,0.0009457578,0.9287091,0.00011257359,0.00052527577,0.000008589375,0.000050483966,0.00026421112,0.019062215,0.00024466417,0.03302942,0.00041759253],"about_ca_topic_score_codex":0.000013905335,"about_ca_topic_score_gemma":0.000012919113,"teacher_disagreement_score":0.034252178,"about_ca_system_score_codex":0.0000024348644,"about_ca_system_score_gemma":0.0000619279,"threshold_uncertainty_score":0.28115276},"labels":[],"label_agreement":null},{"id":"W4415933175","doi":"10.1182/blood.2025030061","title":"PIKfyve inhibition in MM disrupts autophagy and lysosome function, increasing MHC expression and cholesterol metabolism","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Evonik (Canada); Systems, Applications & Products in Data Processing (Canada); Hospital for Sick Children; Princess Margaret Cancer Centre","funders":"National Cancer Institute; National Science Council; Regeneron Pharmaceuticals; Sanofi; Genentech; AstraZeneca; Amgen; Pfizer; Bristol-Myers Squibb; GlaxoSmithKline","keywords":"Autophagy; Downregulation and upregulation; Lysosome; Regulator; Cytotoxicity; Myeloid; Major histocompatibility complex; Cell culture","score_opus":0.0058201903199480735,"score_gpt":0.25002383291733354,"score_spread":0.24420364259738547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415933175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99217856,0.006449435,0.000085704145,0.00024299625,0.000088796456,0.00027369446,0.000005188415,0.00005995224,0.00061567023],"genre_scores_gemma":[0.99827033,0.00035647556,0.00011292325,0.0009155795,0.000103933126,0.000033095555,0.00001953182,0.000012877656,0.00017523798],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99917257,0.00007360756,0.00020695805,0.00027010762,0.00011751389,0.00015926968],"domain_scores_gemma":[0.9996093,0.000046679852,0.00004635867,0.00017086642,0.000029701276,0.00009710568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015361632,0.00013584213,0.00024280882,0.00019354768,0.00007913045,0.000030655854,0.000018995217,0.00010182477,0.00002561885],"category_scores_gemma":[0.000049970517,0.00011726029,0.0000317056,0.00017527484,0.000056936307,0.00016158479,0.000047361744,0.0001348342,0.000002998784],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012835608,0.0018059134,0.12001064,0.00047658305,0.00026088,0.00023957105,0.0012556938,0.000002056957,0.8510318,0.0016950662,0.00018785273,0.02175041],"study_design_scores_gemma":[0.008112361,0.00006366758,0.87313485,0.00045358363,0.00025941525,0.00006558544,0.00009550929,0.000030841875,0.115178734,0.0019958834,0.00050539675,0.0001041761],"about_ca_topic_score_codex":0.000042601303,"about_ca_topic_score_gemma":0.0000052304276,"teacher_disagreement_score":0.7531242,"about_ca_system_score_codex":0.000011876321,"about_ca_system_score_gemma":0.000039347535,"threshold_uncertainty_score":0.4781736},"labels":[],"label_agreement":null},{"id":"W4415966100","doi":"10.1182/blood.2025029949","title":"Classic Hodgkin lymphoma with signet ring cell morphology mimicking adenocarcinoma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Signet ring cell; Adenocarcinoma; Hodgkin lymphoma; Morphology (biology); Lymphoma; Signet ring cell carcinoma","score_opus":0.009167817723630267,"score_gpt":0.2274746615911367,"score_spread":0.21830684386750643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415966100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9722034,0.0030030853,0.000070134876,0.0006443724,0.000098214936,0.00033435467,0.000005178044,0.00009447005,0.023546807],"genre_scores_gemma":[0.99582636,0.00006082025,0.0014522643,0.0008646198,0.00008330247,0.00008786949,0.000020514011,0.000023696724,0.0015805726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988788,0.000034856843,0.00020283108,0.0003912091,0.00015322925,0.00033908396],"domain_scores_gemma":[0.99930984,0.00009255773,0.000065353976,0.00038302483,0.000045825407,0.00010339289],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006082667,0.00020821558,0.0003430535,0.00015062727,0.00009119755,0.00002507893,0.00009107761,0.00010792144,0.00006639809],"category_scores_gemma":[0.000013160496,0.00015719933,0.000084801315,0.00023742167,0.00006332584,0.000037775786,0.000058829602,0.00006163193,0.00006594398],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001802861,0.0031333086,0.97619987,0.00013910186,0.00043815494,0.0021108778,0.00017024226,0.000005588555,0.008010768,0.0005881561,0.0012710548,0.0077525824],"study_design_scores_gemma":[0.022008764,0.00092653465,0.79165024,0.00027145646,0.0012731506,0.00046640256,0.00012554698,0.000034088785,0.1805998,0.000058090904,0.0023837215,0.0002022099],"about_ca_topic_score_codex":0.00010694023,"about_ca_topic_score_gemma":0.000018480589,"teacher_disagreement_score":0.18454964,"about_ca_system_score_codex":0.000113874776,"about_ca_system_score_gemma":0.00021479835,"threshold_uncertainty_score":0.6410403},"labels":[],"label_agreement":null},{"id":"W4416186528","doi":"10.1182/blood.2025030290","title":"Decoding RNA modifications to unlock new treatments for AML","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"RNA regulation and disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Sierra Oncology; Incyte; CTI Biopharma; Pfizer","keywords":"RNA; Leukemia; Mutation; Bone marrow; Myeloid leukemia; Decoding methods","score_opus":0.017083350442017194,"score_gpt":0.29584898285063194,"score_spread":0.27876563240861474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416186528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9602208,0.00044351886,0.031501938,0.0009578959,0.0000855383,0.00039223963,0.00003574069,0.000018327599,0.0063439915],"genre_scores_gemma":[0.9744188,0.000017307319,0.003938771,0.00051911396,0.00008027777,0.000059697122,0.00009344725,0.000006315535,0.020866267],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99965245,0.000005660528,0.000075205775,0.00015170126,0.000027270378,0.00008770424],"domain_scores_gemma":[0.9996843,0.000004707346,0.000015257097,0.00017960969,0.000029312507,0.00008686746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00001566304,0.00005494024,0.00004445884,0.000030384173,0.000057488636,0.000015710839,0.00006658702,0.000036836816,0.000008339259],"category_scores_gemma":[0.000047048434,0.000054288263,0.0000511151,0.000060880455,0.0000053987415,0.0000010802607,0.000020695908,0.000007713435,0.000009581663],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010322168,0.00052812975,0.0075762533,0.00001495938,0.00026757224,6.560548e-7,0.000038826045,0.0002906457,0.9271045,0.0039250012,0.042814855,0.017335404],"study_design_scores_gemma":[0.005087047,0.00017299865,0.025000956,0.0000193596,0.00032144276,0.0000013310181,0.00004882266,0.00021961553,0.86090535,0.0012704151,0.10672084,0.00023184581],"about_ca_topic_score_codex":0.000006784599,"about_ca_topic_score_gemma":0.000007857067,"teacher_disagreement_score":0.06619915,"about_ca_system_score_codex":0.0000050211424,"about_ca_system_score_gemma":0.000086334716,"threshold_uncertainty_score":0.22138111},"labels":[],"label_agreement":null},{"id":"W4416216601","doi":"10.1182/blood.2025028933","title":"Glutaredoxin 2 is essential for AML survival through mitochondrial permeability transition pore regulation","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Redox biology and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Amgen (Canada); University of Toronto; University Health Network; Princess Margaret Cancer Centre; McMaster University","funders":"Princess Margaret Cancer Foundation; Cancer Center, University of Colorado; Genome Canada; University of Cincinnati; National Institutes of Health; Cincinnati Children's Hospital Medical Center; Celgene; Rally Foundation; V Foundation for Cancer Research; Elsa U. Pardee Foundation","keywords":"Mitochondrial permeability transition pore; Mitochondrion; Glutaredoxin; Oxidative phosphorylation; Myeloid leukemia; Haematopoiesis; Inner mitochondrial membrane; Glutathione; ATP synthase; mitochondrial fusion","score_opus":0.008244670536948372,"score_gpt":0.27217984674043094,"score_spread":0.26393517620348256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416216601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95615184,0.0002760847,0.04028559,0.0007307709,0.0006164212,0.00044731467,0.00024551936,0.000017793145,0.0012286631],"genre_scores_gemma":[0.99546933,0.000038549042,0.0016847996,0.00022908313,0.00056762574,0.000056542973,0.0013957944,0.000009228436,0.00054905895],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990758,0.00008580426,0.00018995669,0.00040549788,0.000063490545,0.00017946512],"domain_scores_gemma":[0.9995289,0.000020479512,0.000052102998,0.00026249338,0.00011285639,0.000023162016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008745284,0.00013311357,0.00014600475,0.000020108517,0.00013126916,0.000014343133,0.00011630143,0.0002681296,0.00003786368],"category_scores_gemma":[0.00006662671,0.0001276567,0.00015100809,0.00006769239,0.00012661307,0.0000063214598,0.000030145995,0.000059235175,0.0000016094951],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057199306,0.0002591465,0.0010996341,0.00005155362,0.00017188236,7.729226e-7,0.0001612598,0.000015456262,0.9940889,0.00084376533,0.0021310893,0.0006045701],"study_design_scores_gemma":[0.0026794088,0.00021149123,0.0066552046,0.00001471695,0.00011272335,0.000002900728,0.00008691635,0.000032622367,0.9745604,0.003001867,0.012483779,0.00015798688],"about_ca_topic_score_codex":0.000015340522,"about_ca_topic_score_gemma":0.00003689846,"teacher_disagreement_score":0.039317477,"about_ca_system_score_codex":0.000006301126,"about_ca_system_score_gemma":0.00006488898,"threshold_uncertainty_score":0.52056897},"labels":[],"label_agreement":null},{"id":"W4416892702","doi":"10.1182/blood.2025029676","title":"NLRP3 inflammasome blockade treats intestinal inflammation associated with chronic granulomatous disease","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Diet and metabolism studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Institute of Infection and Immunity; Université de Montréal; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research; McGill University","keywords":"Inflammasome; Chronic granulomatous disease; Inflammation; Inflammatory bowel disease; Colitis; Nicotinamide adenine dinucleotide phosphate; Immune system; Blockade","score_opus":0.0075478479379957305,"score_gpt":0.2367927156625917,"score_spread":0.22924486772459596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416892702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98821145,0.0022856465,0.000027096874,0.0010676349,0.000114993316,0.00044151314,0.0000076099063,0.00023266044,0.0076113837],"genre_scores_gemma":[0.99545056,0.00014588388,0.000104701,0.00007817486,0.00026448924,0.00009670399,0.000062467756,0.000018972638,0.0037780674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989558,0.000031960142,0.0002424933,0.00024118199,0.00023591227,0.0002926725],"domain_scores_gemma":[0.9992948,0.00007530393,0.00009033859,0.0002439184,0.00015477465,0.00014083259],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010148133,0.0002014616,0.00034743524,0.00016246003,0.00011712297,0.000024647503,0.000071676586,0.00005548809,0.000022643697],"category_scores_gemma":[0.00045575807,0.00015209791,0.000082788676,0.00039397454,0.000095843294,0.00007733288,0.00004856253,0.00014716625,0.000023561992],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073624984,0.0014860025,0.9612493,0.00060650235,0.0016316007,0.00066012895,0.0005759952,0.000016279526,0.014194244,0.0020593675,0.0010220904,0.015762227],"study_design_scores_gemma":[0.008174194,0.00025448838,0.97812146,0.0009133122,0.0023418278,0.000008931436,0.000040930994,0.000052772673,0.0065171565,0.00035757944,0.0030307537,0.00018658313],"about_ca_topic_score_codex":0.000015182124,"about_ca_topic_score_gemma":0.00009229661,"teacher_disagreement_score":0.016872156,"about_ca_system_score_codex":0.000062552404,"about_ca_system_score_gemma":0.00032660295,"threshold_uncertainty_score":0.6202373},"labels":[],"label_agreement":null},{"id":"W4416926257","doi":"10.1182/blood.2024027700","title":"Gene expression profiling reveals 2 overarching types of ALCL with distinct targetable biology: an LLMPP study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Toronto; University Health Network; Spinal Cord Injury BC","funders":"","keywords":"Subtyping; Gene expression profiling; Anaplastic large-cell lymphoma; Anaplastic lymphoma kinase; EZH2; Epigenetics","score_opus":0.014035150953222714,"score_gpt":0.29543626886569024,"score_spread":0.2814011179124675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416926257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963762,0.00091493275,0.00005422725,0.000038686325,0.00003506624,0.00059552805,0.000014758895,0.00003432057,0.0019362355],"genre_scores_gemma":[0.99367756,0.000015269175,0.0059201326,0.00003894862,0.000042177937,0.00007222431,0.000048513095,0.000009657631,0.00017554007],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99927,0.000060551673,0.00018211242,0.00024433355,0.00009711133,0.00014587755],"domain_scores_gemma":[0.999485,0.000056732708,0.000067555055,0.0002884898,0.000050357696,0.00005184365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013245222,0.00011135114,0.0002922193,0.00006798508,0.000066657296,0.000008228102,0.000056593908,0.000036119054,0.000019715388],"category_scores_gemma":[0.000042558637,0.000068234556,0.000033136734,0.00011969731,0.000020638805,0.00004141741,0.000045710745,0.000047077516,0.0000023280006],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001308131,0.004570063,0.9168826,0.000058110945,0.00022810795,0.00003576056,0.00016580017,0.0000031976485,0.07691511,0.00018434227,0.000021054735,0.000805066],"study_design_scores_gemma":[0.006434057,0.0015328113,0.4556387,0.00030112738,0.00055482326,0.000008160059,0.00014357315,0.000011692754,0.5350595,0.00018348201,0.00005199041,0.00008005797],"about_ca_topic_score_codex":0.000082737955,"about_ca_topic_score_gemma":0.000008201601,"teacher_disagreement_score":0.46124384,"about_ca_system_score_codex":0.000018002429,"about_ca_system_score_gemma":0.00007431058,"threshold_uncertainty_score":0.27825242},"labels":[],"label_agreement":null},{"id":"W4417001549","doi":"10.1182/blood-2025-2851","title":"Impact of pre-transplant anxiety and depression on outcomes of AML patients after allogeneic transplantation","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Anxiety; Depression (economics); Transplantation; Cognition; Myeloid leukemia; Retrospective cohort study; Montreal Cognitive Assessment; Leukemia","score_opus":0.005429563745104125,"score_gpt":0.26591150416886256,"score_spread":0.26048194042375844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417001549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99891907,0.00029293486,0.000032868713,0.000012216746,0.00006990684,0.00019337269,0.00015844616,0.00000869655,0.0003125055],"genre_scores_gemma":[0.99950737,0.00032503807,0.000016459595,0.000047727302,0.000007876364,0.000012584545,0.000046409787,0.000005415499,0.000031093787],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995017,0.000018582805,0.00015608591,0.000119379874,0.00012745438,0.00007678389],"domain_scores_gemma":[0.9997265,0.000027240574,0.00004017663,0.00012370171,0.00004834282,0.00003406093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000033974873,0.00008209441,0.00019526517,0.00006785882,0.0000096481435,0.0000018037924,0.000026239672,0.000056977704,0.000017307273],"category_scores_gemma":[0.0000062641616,0.000056662502,0.00009470845,0.000068729685,0.000019501387,0.000021451686,0.000004874142,0.00004650268,2.1779023e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011746957,0.0004270837,0.99117726,0.00036236862,0.00015140181,0.0000027853614,0.0009301965,0.0000016748364,0.0034794006,0.000003052795,0.0000067849182,0.0022833056],"study_design_scores_gemma":[0.002839893,0.00026861584,0.96321917,0.0003405631,0.0003972063,0.0000015759215,0.00001253475,0.0000017990734,0.032859255,0.000010406117,0.0000052842147,0.000043695425],"about_ca_topic_score_codex":0.0002948313,"about_ca_topic_score_gemma":0.00017676687,"teacher_disagreement_score":0.029379856,"about_ca_system_score_codex":0.000008560387,"about_ca_system_score_gemma":0.000029523255,"threshold_uncertainty_score":0.23106298},"labels":[],"label_agreement":null},{"id":"W4417001562","doi":"10.1182/blood-2025-2845","title":"Management of chronic myeloid leukaemia (CML) during pregnancy: A systematic review of maternal and foetal outcomes","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Observational study; Pregnancy; Watchful waiting; Systematic review; Disease; Evidence-based practice; Fetus; Evidence-based medicine","score_opus":0.007551844088013685,"score_gpt":0.258552774803317,"score_spread":0.2510009307153033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417001562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7802462,0.21532463,0.000009248177,0.00009289658,0.000056322217,0.0018609766,0.000009872092,0.000031239273,0.0023686378],"genre_scores_gemma":[0.9640744,0.03195895,0.00040389644,0.000029900317,0.000009855768,0.00016078373,0.0000058198452,0.000017293065,0.0033391574],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99863064,0.00003530387,0.0006545324,0.0002269483,0.00026395376,0.00018860478],"domain_scores_gemma":[0.99912184,0.000032802927,0.00024748233,0.000502661,0.000045919478,0.000049282673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009719657,0.0001814172,0.0009350757,0.00009648429,0.00002384515,0.000004500441,0.0001105435,0.000047095276,0.000043853455],"category_scores_gemma":[0.00003380233,0.0001367599,0.00014152782,0.00015291691,0.000048457503,0.000038141465,0.0001325879,0.000073521944,0.000006062838],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014040424,0.00025046142,0.02535684,0.9706752,0.0021558648,0.00019273009,0.000029822882,1.9406345e-7,0.0005991876,0.00031296775,0.0000071603868,0.00040557745],"study_design_scores_gemma":[0.008444144,0.0001435213,0.093317494,0.8689299,0.0064130723,0.00016448446,0.000026122076,0.000009280627,0.022417942,0.000027576541,0.0000043337272,0.00010208018],"about_ca_topic_score_codex":0.000023318547,"about_ca_topic_score_gemma":0.0000033029714,"teacher_disagreement_score":0.18382816,"about_ca_system_score_codex":0.00026519466,"about_ca_system_score_gemma":0.00013471585,"threshold_uncertainty_score":0.5576907},"labels":[],"label_agreement":null},{"id":"W4417001634","doi":"10.1182/blood-2025-6532","title":"Improvement of sickle cell disease care mitigates the healthcare utilization induced by increased prevalence: Experience of a tertiary pediatric center","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; Ste. Anne's Hospital; Hospital for Sick Children","funders":"","keywords":"Disease; Health care; Epidemiology; Population; Anemia; Sickle cell anemia; Emergency department; Quality management","score_opus":0.007134598359362567,"score_gpt":0.25326242093089396,"score_spread":0.2461278225715314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417001634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98316526,0.0151796285,0.0000066078583,0.0005955455,0.00006370595,0.0006771697,0.00009086443,0.000018046185,0.00020315537],"genre_scores_gemma":[0.99804676,0.0013381512,0.00000976192,0.00037075885,0.000016623177,0.00004873725,0.000056561777,0.000008399375,0.000104235645],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99912477,0.000041501422,0.0002995943,0.00018155007,0.00019902589,0.0001535462],"domain_scores_gemma":[0.9993418,0.00002810469,0.00011429646,0.0002774732,0.00014254448,0.00009577694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000052066873,0.000105278945,0.0001558851,0.000060942868,0.000056633682,0.000004141172,0.00010446422,0.00007213848,0.000023516264],"category_scores_gemma":[0.000053597654,0.00007112683,0.00007313758,0.00026050932,0.00005770597,0.000029962648,0.000049528495,0.00010393737,6.9348806e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015631641,0.0016683278,0.90766287,0.007509031,0.000048218033,0.000005751161,0.005080291,0.0000011577165,0.07567312,0.000018104172,0.00041896183,0.0017578696],"study_design_scores_gemma":[0.011111774,0.000899851,0.3336285,0.0011600653,0.001338096,0.00000228706,0.02054896,0.00011897412,0.63048726,0.000054175725,0.0003633284,0.00028670134],"about_ca_topic_score_codex":0.00020977494,"about_ca_topic_score_gemma":0.000002783217,"teacher_disagreement_score":0.57403433,"about_ca_system_score_codex":0.000016939428,"about_ca_system_score_gemma":0.000227592,"threshold_uncertainty_score":0.29004678},"labels":[],"label_agreement":null},{"id":"W4417001677","doi":"10.1182/blood-2025-80","title":"Efficacy and safety results from the primary analysis of the pivotal summit trial: Bezuclastinib in adults with non-advanced systemic mastocytosis","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Calgary; University of Alberta","funders":"","keywords":"Systemic mastocytosis; Clinical endpoint; Placebo; Randomized controlled trial; Summit; Quality of life (healthcare); Bone marrow; Roche Diagnostics","score_opus":0.004579965691352419,"score_gpt":0.19651660680087615,"score_spread":0.19193664110952374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417001677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948505,0.001813739,0.00001815332,0.00021301582,0.00015392694,0.00071710604,0.00035221735,0.000012417514,0.0018689089],"genre_scores_gemma":[0.9987278,0.000129342,0.00003678404,0.000057299276,0.000011762709,0.000024687712,0.00016397546,0.000006730869,0.0008415957],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9988253,0.00017966697,0.00046386084,0.0003157905,0.000041908806,0.0001734584],"domain_scores_gemma":[0.9985471,0.0007098555,0.00021885756,0.00047458065,0.000040135652,0.0000094972775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002229212,0.00014442892,0.00046226464,0.00010416033,0.00012811394,0.000007752935,0.00025331575,0.00012241385,0.000023647111],"category_scores_gemma":[0.00009625638,0.0000774886,0.000092350136,0.00063851906,0.00021236743,0.000022831471,0.000117733,0.00021073742,0.0000028459092],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.55433583,0.0052342885,0.1640135,0.00051996147,0.016840164,0.000023805485,0.009577514,0.00090871984,0.22805533,0.00074137683,0.0013055207,0.018444015],"study_design_scores_gemma":[0.25257578,0.00057136035,0.72848094,0.0012024741,0.0038523464,0.000004151625,0.00082998484,0.000024772307,0.009342868,0.000007061529,0.0028601815,0.0002481125],"about_ca_topic_score_codex":0.00057969533,"about_ca_topic_score_gemma":0.0019768097,"teacher_disagreement_score":0.56446743,"about_ca_system_score_codex":0.000018522369,"about_ca_system_score_gemma":0.000066910674,"threshold_uncertainty_score":0.31598932},"labels":[],"label_agreement":null},{"id":"W4417001683","doi":"10.1182/blood-2025-81","title":"Rusfertide or placebo plus current standard-of-care therapy for polycythemia vera: Durability of response and safety results through week 52 from the randomized controlled phase 3 VERIFY study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Phlebotomy; Placebo; Randomized controlled trial; Hematocrit; Randomization; Polycythemia vera","score_opus":0.02675687638169033,"score_gpt":0.3520523992182334,"score_spread":0.32529552283654306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417001683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9715349,0.009551756,0.0001606691,0.0019461002,0.00017964681,0.014755681,0.001706085,0.000025324427,0.00013982884],"genre_scores_gemma":[0.9957735,0.0017676045,0.00042976238,0.000110473586,0.000058109457,0.00171884,0.000076740136,0.000017622448,0.000047338337],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99671143,0.0010875778,0.0011392487,0.00046548614,0.0003841715,0.00021210803],"domain_scores_gemma":[0.9850714,0.0135951815,0.00027567684,0.00058857596,0.00040298735,0.00006617956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018746234,0.0003158533,0.0023833218,0.000053345473,0.00017086096,0.000020372812,0.00011515604,0.00008229327,0.000038328875],"category_scores_gemma":[0.0043884204,0.00015388402,0.00039544617,0.00015451384,0.00023460109,0.000042672164,0.0000491997,0.00017801899,4.2191218e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97421825,0.0055954126,0.0033844712,0.000095215655,0.003177018,0.0000113334,0.009533219,0.0000022899978,0.0005286999,0.000088601875,0.00022210964,0.003143399],"study_design_scores_gemma":[0.9373734,0.0072630206,0.010359274,0.0004302739,0.002423666,0.0000016235907,0.0030051197,0.000033262553,0.037867766,0.00011631224,0.0010042688,0.00012198739],"about_ca_topic_score_codex":0.0001313231,"about_ca_topic_score_gemma":0.000097188095,"teacher_disagreement_score":0.037339065,"about_ca_system_score_codex":0.000097211916,"about_ca_system_score_gemma":0.000771162,"threshold_uncertainty_score":0.6275208},"labels":[],"label_agreement":null},{"id":"W4417001687","doi":"10.1182/blood-2025-62","title":"Fixed treatment duration subcutaneous mosunetuzumab monotherapy in elderly/unfit patients with previously untreated diffuse large B-cell lymphoma: Interim results from the Phase II MorningSun study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Atlantic Cancer Research Institute","funders":"","keywords":"Chemoimmunotherapy; Interim analysis; Clinical endpoint; Phases of clinical research; Follicular lymphoma; Cohort; Lymphoma; Regimen; Pharmacokinetics","score_opus":0.013817240001792937,"score_gpt":0.2851206098193621,"score_spread":0.27130336981756914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417001687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940216,0.0003799589,0.000014036233,0.0003051274,0.000062561754,0.004121486,0.00018728647,0.00010863786,0.0007992862],"genre_scores_gemma":[0.99315995,0.00016369845,0.000051752264,0.00013359498,0.000057209316,0.00028441573,0.0006210462,0.000057242105,0.005471074],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99740624,0.00028876588,0.00064080924,0.0006846868,0.00047391292,0.00050559983],"domain_scores_gemma":[0.9983024,0.00029893065,0.00018010665,0.0009444785,0.00016025179,0.000113837465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023252136,0.00038911615,0.0005492281,0.00018860292,0.00021721967,0.00007704821,0.00023403796,0.00012101784,0.00017940835],"category_scores_gemma":[0.000076772994,0.00024371277,0.000101956626,0.000580527,0.000058555113,0.00007244386,0.00007617151,0.00019353593,0.000014418362],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12673539,0.45534316,0.22045071,0.00005712117,0.0030574773,0.0018460343,0.04727868,0.00001634242,0.026380388,0.0000076773695,0.0005264359,0.11830058],"study_design_scores_gemma":[0.8586064,0.060199,0.0494408,0.00036424526,0.0009743892,0.000023233826,0.0019474176,0.0006046054,0.02372316,0.000025768963,0.0036029883,0.00048798425],"about_ca_topic_score_codex":0.0024975585,"about_ca_topic_score_gemma":0.0022831277,"teacher_disagreement_score":0.731871,"about_ca_system_score_codex":0.00042542786,"about_ca_system_score_gemma":0.00024750974,"threshold_uncertainty_score":0.9938318},"labels":[],"label_agreement":null},{"id":"W4417001699","doi":"10.1182/blood-2025-75","title":"Somatic mutations at diagnosis in patients with chronic Phase CML receiving frontline imatinib are associated with a higher rate of treatment failure: First analysis from the international CML foundation (iCMLf) genomics alliance on the harmony platform","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Imatinib; Exome sequencing; Genomics; DNA sequencing; Precision medicine; Exome; Cohort; Germline mutation","score_opus":0.018647265839945644,"score_gpt":0.2530596419954415,"score_spread":0.23441237615549587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417001699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944806,0.0001267009,0.000051724488,0.0036149789,0.000053106614,0.0012385873,0.0003131013,0.000028684726,0.00009251224],"genre_scores_gemma":[0.996369,0.00010125076,0.00033667602,0.00020888585,0.00003862316,0.00056596415,0.0020589728,0.000024869998,0.00029577626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998627,0.00006616464,0.00044859565,0.00035095736,0.00029289862,0.00021438523],"domain_scores_gemma":[0.9978328,0.001002806,0.0005152738,0.00047407384,0.00013258363,0.00004250318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014060487,0.0002602268,0.00044232744,0.00012151933,0.0001815104,0.00004386653,0.00018643879,0.00006836759,0.00044271292],"category_scores_gemma":[0.00016336051,0.00014135518,0.000113273294,0.0005893253,0.00007697497,0.00010221057,0.000043632048,0.00013439705,0.000014571323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005559468,0.0032980726,0.98345184,0.000022151415,0.00875586,0.00001216195,0.0009831856,0.0018128933,0.00007603907,0.000020713009,0.00021718358,0.000793957],"study_design_scores_gemma":[0.034840196,0.00083291566,0.95073426,0.0008824581,0.004715355,3.8210524e-7,0.00012996107,0.0055346293,0.0018375322,0.000049068665,0.00029434654,0.00014891203],"about_ca_topic_score_codex":0.000807597,"about_ca_topic_score_gemma":0.022457635,"teacher_disagreement_score":0.034284253,"about_ca_system_score_codex":0.004524577,"about_ca_system_score_gemma":0.0003438656,"threshold_uncertainty_score":0.9992969},"labels":[],"label_agreement":null},{"id":"W4417001702","doi":"10.1182/blood-2025-82","title":"Evaluation of the novel TMPRSS6 antisense inhibitor sapablursen for treatment of polycythemia vera: Results of the imprssion clinical trial","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"","keywords":"Phlebotomy; Polycythemia vera; Hematocrit; Cohort; TMPRSS6; Ferritin; Clinical trial; Clinical endpoint","score_opus":0.09594355595731972,"score_gpt":0.4079281348573382,"score_spread":0.31198457890001846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417001702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932447,0.00039675715,0.000009319197,0.0014313005,0.0006648147,0.0033820206,0.00022652758,0.0000052997157,0.00063925405],"genre_scores_gemma":[0.99886453,0.00010485667,0.00032051923,0.00003767464,0.00021300961,0.00016075533,0.000016557655,0.000009099548,0.00027302516],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981002,0.00020041071,0.00082745415,0.00024202759,0.00050934625,0.00012055656],"domain_scores_gemma":[0.9978815,0.0006303764,0.00045237434,0.0005410041,0.0004603439,0.000034407305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000926443,0.0001414035,0.00051516335,0.00004537533,0.000063054365,0.0000032105652,0.000077300065,0.00012041277,0.0000067544247],"category_scores_gemma":[0.0013114741,0.00006716941,0.00043272687,0.00018936548,0.00011487675,0.000016510465,0.000038325445,0.00004876542,4.013311e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14703742,0.089022234,0.18827282,0.00051097537,0.0073032314,0.000003648298,0.0021633732,0.000048669404,0.4089701,0.002323973,0.004462327,0.14988124],"study_design_scores_gemma":[0.2053284,0.0031095142,0.08820522,0.0003785512,0.0033366738,0.0000023816406,0.000045644658,0.00014502495,0.69872934,0.00007992216,0.0005942047,0.000045139313],"about_ca_topic_score_codex":0.000056793673,"about_ca_topic_score_gemma":0.000040093273,"teacher_disagreement_score":0.28975922,"about_ca_system_score_codex":0.00007434546,"about_ca_system_score_gemma":0.00070787285,"threshold_uncertainty_score":0.27390888},"labels":[],"label_agreement":null},{"id":"W4417001753","doi":"10.1182/blood-2025-316","title":"Clinically relevant bleeding and heavy menstrual bleeding among patients &amp;lt;21 years old with provoked VTE: Findings from the multinational kids-DOTT trial","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Interquartile range; Randomized controlled trial; Adverse effect; Clinical trial; Anticoagulant; Major bleeding; Antithrombotic","score_opus":0.013368558855543956,"score_gpt":0.2666841565025532,"score_spread":0.2533155976470093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417001753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954267,0.00009028006,0.000036885845,0.0012149652,0.0004163778,0.0015337856,0.000025734897,0.000066678,0.0011885556],"genre_scores_gemma":[0.9958755,0.000120251294,0.0019835723,0.0009242259,0.0003319532,0.00011836152,0.00007916385,0.000027979098,0.0005389886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981127,0.000051389405,0.00052489963,0.00047839174,0.00050999783,0.00032262283],"domain_scores_gemma":[0.9987753,0.00052983983,0.00016918422,0.00027397732,0.00013509125,0.00011659145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000544778,0.0002104453,0.0004631782,0.00010271623,0.000215328,0.000104814266,0.00015726425,0.00011534955,0.000049417125],"category_scores_gemma":[0.00066379004,0.00014801402,0.000088018765,0.00022169854,0.00015744468,0.00011213291,0.00018908425,0.00029747764,0.0000098257315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071400274,0.005208383,0.96041733,0.00014785847,0.0021876919,0.000037776314,0.0029770613,0.0000091883685,0.0006566559,0.0022981593,0.011270355,0.0076495144],"study_design_scores_gemma":[0.06571648,0.0011083937,0.92600006,0.00066046714,0.0016323848,0.0000018499692,0.0002990389,0.000084133,0.0002691651,0.00015961652,0.0038342897,0.00023409758],"about_ca_topic_score_codex":0.00024850963,"about_ca_topic_score_gemma":0.00008919187,"teacher_disagreement_score":0.058576457,"about_ca_system_score_codex":0.000045935143,"about_ca_system_score_gemma":0.00009359128,"threshold_uncertainty_score":0.6035837},"labels":[],"label_agreement":null},{"id":"W4417001771","doi":"10.1182/blood-2025-109","title":"Superior long-term outcomes with fludarabine and melphalan reduced intensity regimen in older AML/MDS patients undergoing allogeneic stem cell transplantation: An analysis of CIBMTR data","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Fludarabine; Melphalan; Busulfan; Regimen; Cohort; Transplantation; Hematopoietic stem cell transplantation","score_opus":0.026670916817568342,"score_gpt":0.3027017942571621,"score_spread":0.27603087743959376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417001771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99863684,0.00018518325,0.00008869772,0.00029019726,0.000021541568,0.00052041246,0.00010459623,0.000025095256,0.00012744062],"genre_scores_gemma":[0.99769086,0.00022426118,0.00046632558,0.00012465489,0.000011031065,0.000012013328,0.0011974612,0.000019143154,0.0002542349],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99834174,0.0001010978,0.00039277194,0.00055875286,0.0003393518,0.00026628122],"domain_scores_gemma":[0.99859047,0.00012258375,0.000085968444,0.00090205343,0.00017427851,0.00012463178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028730466,0.00019317947,0.0006811537,0.0006144867,0.0000537675,0.000022893028,0.00027354466,0.000099596255,0.000018133242],"category_scores_gemma":[0.000027008478,0.00015132771,0.000050755825,0.0009014719,0.00010072919,0.00018163737,0.00012631623,0.00020070432,7.5224705e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005105487,0.00073969207,0.9904212,0.00042668742,0.0012299349,0.00014408905,0.00081592746,0.00000775414,0.0051129577,0.0000037589198,0.000011627487,0.00057583814],"study_design_scores_gemma":[0.009946658,0.00034690346,0.96891594,0.00018286258,0.0034205345,0.0000133423355,0.00038528544,0.0002567581,0.01639948,9.412378e-7,0.0000010869973,0.00013017913],"about_ca_topic_score_codex":0.00022650958,"about_ca_topic_score_gemma":0.0012533428,"teacher_disagreement_score":0.021505218,"about_ca_system_score_codex":0.000083755236,"about_ca_system_score_gemma":0.00029250229,"threshold_uncertainty_score":0.6170965},"labels":[],"label_agreement":null},{"id":"W4417001819","doi":"10.1182/blood-2025-762","title":"Factors associated with central nervous system relapse after b-acute lymphoblastic leukemia: A Children's oncology group report","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Cumulative incidence; Proportional hazards model; Bone marrow; Incidence (geometry); Hazard ratio; Central nervous system; Acute lymphocytic leukemia; Clinical trial; Disease","score_opus":0.009933234459681617,"score_gpt":0.25172405592037045,"score_spread":0.24179082146068884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417001819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99180424,0.00018251257,0.0007899223,0.00021004197,0.0003681265,0.0010857393,0.0000751682,0.0004617075,0.0050225575],"genre_scores_gemma":[0.99583024,0.0000134509455,0.00024331023,0.00027255458,0.00018278824,0.00018864575,0.00035840727,0.00008594941,0.0028246476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962444,0.0001886428,0.0007358274,0.00085588516,0.0008056969,0.0011695522],"domain_scores_gemma":[0.99771154,0.00042883068,0.00028543946,0.0008292533,0.00026428723,0.00048067185],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033160014,0.00049592846,0.0010082291,0.00035498224,0.00017031618,0.00005564661,0.00027782613,0.00058107986,0.00005531099],"category_scores_gemma":[0.00062987575,0.0003589021,0.00023181326,0.00091623265,0.0002761471,0.00011572065,0.00021385957,0.0006174533,0.000028599417],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028627429,0.0029990007,0.9210205,0.0005377601,0.011218712,0.05231595,0.00070723135,0.00004049493,0.0020342178,0.0005445791,0.004893495,0.00082529633],"study_design_scores_gemma":[0.022320384,0.0017796927,0.9618042,0.0013065132,0.0046492713,0.0048690094,0.00029958683,0.00041457237,0.0015811097,0.0000118902635,0.0004931601,0.0004705987],"about_ca_topic_score_codex":0.00028521547,"about_ca_topic_score_gemma":0.00009969264,"teacher_disagreement_score":0.04744694,"about_ca_system_score_codex":0.0065835956,"about_ca_system_score_gemma":0.004340037,"threshold_uncertainty_score":0.9998863},"labels":[],"label_agreement":null},{"id":"W4417001845","doi":"10.1182/blood-2025-761","title":"Clinical characteristics and outcomes of children with T-cell acute lymphoblastic leukemia harboring ABL-class fusions: A report from the ponte di legno consortium","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Cohort; PDGFRB; Retrospective cohort study; Lymphoblastic Leukemia; Acute lymphocytic leukemia; Dasatinib; White blood cell; Tyrosine kinase; ETV6","score_opus":0.012235771763407486,"score_gpt":0.2900034489522792,"score_spread":0.2777676771888717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417001845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99582165,0.00033744067,0.00049025816,0.000753639,0.00019087706,0.00076836464,0.0001611325,0.0000718549,0.0014047966],"genre_scores_gemma":[0.99598145,0.0004110623,0.0009491127,0.00061407924,0.00018801758,0.00004609516,0.00009397293,0.000043227585,0.0016729727],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972107,0.00012095489,0.0010295814,0.00062144815,0.00057729695,0.00044003976],"domain_scores_gemma":[0.9963604,0.0017491848,0.0003924816,0.0010252872,0.00024512922,0.0002274876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005368891,0.00031873237,0.0009345206,0.00011169262,0.00014925112,0.000048988248,0.0003141868,0.00021727815,0.000030875028],"category_scores_gemma":[0.0013207707,0.0001930916,0.00015701834,0.0003092661,0.00056877267,0.00007112024,0.0003854885,0.00048254975,0.000011284616],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045262743,0.0004938443,0.9917024,0.000052677842,0.0019275242,0.00081619085,0.00008542766,7.3257604e-7,0.0028802736,0.000058443176,0.000685315,0.00084455917],"study_design_scores_gemma":[0.012516964,0.00030676005,0.9799224,0.00042737593,0.0028445553,0.0005075302,0.000076562974,0.00047158528,0.0024116056,0.000020224617,0.00030397976,0.00019042456],"about_ca_topic_score_codex":0.0005276364,"about_ca_topic_score_gemma":0.00002846351,"teacher_disagreement_score":0.012064337,"about_ca_system_score_codex":0.00019289146,"about_ca_system_score_gemma":0.0023099163,"threshold_uncertainty_score":0.7874047},"labels":[],"label_agreement":null},{"id":"W4417001848","doi":"10.1182/blood-2025-325","title":"Lipid uptake via FATP2 enhances CAR-t therapy resistance in B-cell acute lymphoblastic leukemia","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Leukemia; Chemotherapy regimen; Acute lymphocytic leukemia; Chemotherapy; Antigen; T-cell leukemia; Perforin; T cell; Immunotherapy","score_opus":0.012976977087274388,"score_gpt":0.28214832654264144,"score_spread":0.269171349455367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417001848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92931426,0.0046206787,0.00014093569,0.00045786644,0.00024615435,0.00079876254,0.000008780609,0.000098004624,0.06431458],"genre_scores_gemma":[0.9227185,0.0032241335,0.00061903655,0.0006428006,0.0002601846,0.00015445962,0.000016240781,0.000047104542,0.072317496],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99793774,0.00010376508,0.00042106395,0.0005149739,0.00046443954,0.00055800984],"domain_scores_gemma":[0.9987749,0.00026193392,0.00006848624,0.0006476317,0.000116437644,0.0001306151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035312396,0.00025711718,0.00051360414,0.00030934723,0.00007736226,0.000040354833,0.00029480786,0.00017289007,0.00077315164],"category_scores_gemma":[0.00007103228,0.00022577804,0.00015197023,0.0008431884,0.00012110234,0.00006873115,0.00006231669,0.0003582161,0.00008704924],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013191943,0.00081239856,0.0037433677,0.00017928932,0.0002933871,0.00022768522,0.00044859573,0.0000024717497,0.9792841,0.000102068305,0.0014966177,0.012090837],"study_design_scores_gemma":[0.020249631,0.00047687502,0.020751288,0.00039436328,0.00016218149,0.000022863242,0.00010469541,0.000074534946,0.8642041,0.0005463367,0.09267859,0.00033455485],"about_ca_topic_score_codex":0.00012526552,"about_ca_topic_score_gemma":0.00038751605,"teacher_disagreement_score":0.11508001,"about_ca_system_score_codex":0.00031661327,"about_ca_system_score_gemma":0.00072153343,"threshold_uncertainty_score":0.92069614},"labels":[],"label_agreement":null},{"id":"W4417001860","doi":"10.1182/blood-2025-7971","title":"Qualitative interviews exploring the patient experience of fatigue in individuals with sickle cell disease (SCD), thalassemia, and pyruvate kinase (PK) deficiency","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"The Scarborough Hospital; University of Toronto","funders":"","keywords":"Interim; Quality of life (healthcare); Disease; Pyruvate kinase deficiency; Qualitative research; Interim analysis; Pyruvate kinase; Patient experience","score_opus":0.03179361046200808,"score_gpt":0.30227038053087824,"score_spread":0.27047677006887016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417001860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922128,0.0047691916,0.00005548691,0.00042252082,0.000044833898,0.00050540594,0.000010947982,0.000015433507,0.0019634305],"genre_scores_gemma":[0.99894834,0.00049148983,0.00015674115,0.00016784399,0.0000038035894,0.00015496783,0.0000050196454,0.00000929266,0.000062534615],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9989048,0.00012172643,0.0003304536,0.00024141152,0.00019730348,0.00020426085],"domain_scores_gemma":[0.99937284,0.00013244925,0.00010198446,0.00025849856,0.000047743324,0.00008651367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020946788,0.00014327149,0.00024043002,0.0001152122,0.000064618376,0.000012852148,0.00009682785,0.000036448808,0.000011427099],"category_scores_gemma":[0.00011239129,0.0000834834,0.000043111602,0.0004269869,0.00019391191,0.0000841269,0.000086344604,0.00017725326,0.0000012037218],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027064254,0.0039357105,0.37096184,0.001381808,0.00012397875,0.00013302617,0.60123336,0.000104665145,0.0064327144,0.0013709741,0.0001225093,0.013928746],"study_design_scores_gemma":[0.013274484,0.0019046422,0.22165227,0.005647672,0.0007877503,0.000009814846,0.6429765,0.00018249964,0.11099623,0.00081721146,0.0010918698,0.0006590157],"about_ca_topic_score_codex":0.00014268792,"about_ca_topic_score_gemma":0.000020167348,"teacher_disagreement_score":0.14930958,"about_ca_system_score_codex":0.000014666744,"about_ca_system_score_gemma":0.00009190246,"threshold_uncertainty_score":0.34043542},"labels":[],"label_agreement":null},{"id":"W4417001866","doi":"10.1182/blood-2025-763","title":"Monotherapy update from Phase 1 portion in Phase1/2 trial of the menin-MLL inhibitor enzomenib (DSP-5336) in patients with relapsed or refractory acute leukemia","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Tolerability; Refractory (planetary science); Regimen; Phases of clinical research; Acute leukemia; Leukemia; Adverse effect","score_opus":0.01024731356587494,"score_gpt":0.2959461322324716,"score_spread":0.2856988186665967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417001866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963525,0.00010417442,0.000027975359,0.00051436375,0.00022284652,0.002213645,0.0002256636,0.000027219588,0.00031163835],"genre_scores_gemma":[0.9975256,0.00012105664,0.00035784265,0.0004419583,0.00012625472,0.00014333992,0.00024850425,0.00004126642,0.0009941907],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9975204,0.0002185378,0.0007640616,0.00046723854,0.0006413031,0.00038846926],"domain_scores_gemma":[0.99860626,0.0001707536,0.00027894595,0.0007154238,0.00013285836,0.00009575192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003930797,0.0002579832,0.00061509653,0.00041874024,0.000047408656,0.000016307687,0.0002825812,0.00022908322,0.00014130051],"category_scores_gemma":[0.00021691372,0.00016058068,0.00009658077,0.0010284282,0.0001246347,0.00016504605,0.0000875787,0.00069292134,0.000007157393],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.73219347,0.02020836,0.11964235,0.00014310156,0.0015897583,0.0005259118,0.0015650073,0.000013790277,0.09739558,0.000038119768,0.0074517406,0.019232808],"study_design_scores_gemma":[0.8268505,0.004782841,0.038329158,0.00071798475,0.00043501105,0.0000024880344,0.000148367,0.00012840437,0.125274,0.00008355408,0.002975558,0.00027213764],"about_ca_topic_score_codex":0.00066080136,"about_ca_topic_score_gemma":0.00028677614,"teacher_disagreement_score":0.09465702,"about_ca_system_score_codex":0.00076966675,"about_ca_system_score_gemma":0.0016448249,"threshold_uncertainty_score":0.65482897},"labels":[],"label_agreement":null},{"id":"W4417001876","doi":"10.1182/blood-2025-8120","title":"Quality initiative in first-line multiple myeloma assessing the use of anti-CD38 agents and quadruplet therapy","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada)","funders":"","keywords":"Multiple myeloma; Carfilzomib; Bortezomib; Guideline; Daratumumab; Cancer; Thalidomide; Transplantation; Ixazomib","score_opus":0.17238568986395333,"score_gpt":0.40849723795789805,"score_spread":0.23611154809394472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417001876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972219,0.00047939856,0.00008194759,0.0011984353,0.000029797313,0.000667186,0.000040658688,0.000017912433,0.00026278893],"genre_scores_gemma":[0.9981207,0.0006509781,0.00065275107,0.00036717852,0.000021019354,0.000039480645,0.000036211553,0.000010715931,0.00010094494],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871624,0.00022562277,0.0003310584,0.0002351424,0.00025264523,0.00023928021],"domain_scores_gemma":[0.9984284,0.0009914944,0.00009307721,0.00031357317,0.00010315121,0.000070293165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032574087,0.00013981723,0.00034173534,0.0001435038,0.00010016203,0.000038996,0.00007846227,0.00006708616,0.000024737545],"category_scores_gemma":[0.00087363855,0.00008929845,0.00006315485,0.00032367586,0.00013082949,0.0001366016,0.000073232826,0.00017463627,0.0000023625726],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018347634,0.0014738786,0.9840841,0.00009338291,0.000294393,0.00006641253,0.0004963152,0.000005537587,0.0019101443,0.000033408163,0.00007023042,0.011288666],"study_design_scores_gemma":[0.0121554155,0.00013519502,0.97550505,0.00019346784,0.000037488524,0.000005036432,0.00018149811,0.0007900639,0.010118645,0.000056276807,0.00075466075,0.000067212095],"about_ca_topic_score_codex":0.0008748169,"about_ca_topic_score_gemma":0.00031479978,"teacher_disagreement_score":0.011971939,"about_ca_system_score_codex":0.000025876148,"about_ca_system_score_gemma":0.00010879427,"threshold_uncertainty_score":0.36414853},"labels":[],"label_agreement":null},{"id":"W4417001881","doi":"10.1182/blood-2025-100","title":"Safety and efficacy of elranatamab in combination with iberdomide in patients with relapsed or refractory multiple myeloma: Results from the phase 1b MagnetisMM-30 trial","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dr. Everett Chalmers Regional Hospital; Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Refractory (planetary science); Regimen; Multiple myeloma; Phases of clinical research; Bone marrow; Neutropenia; Bortezomib; Lenalidomide; Proteasome inhibitor; Progressive disease","score_opus":0.012640389278778093,"score_gpt":0.275946361885988,"score_spread":0.2633059726072099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417001881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964321,0.00014778391,0.000009845825,0.0003276126,0.00003077644,0.0024449248,0.00021895628,0.00001566487,0.0003722872],"genre_scores_gemma":[0.9986968,0.000060392795,0.00045988584,0.000037237816,0.00001793724,0.00004930452,0.00048553623,0.000015454998,0.00017743072],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9983541,0.00019330642,0.00047035152,0.0003553316,0.00038867843,0.0002382495],"domain_scores_gemma":[0.9979972,0.0012782369,0.00014073208,0.00040291212,0.00009901403,0.000081864746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002875196,0.00017187445,0.0004019444,0.0001793144,0.00005626361,0.000013642131,0.00009927222,0.00008786725,0.000024219658],"category_scores_gemma":[0.001181455,0.00009398063,0.000027123051,0.00040458186,0.00012313804,0.0000842886,0.00004597926,0.00026124215,0.0000023456073],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.71271354,0.019310351,0.24033058,0.000041039104,0.00025935253,0.00015948892,0.00051539444,0.0000023259174,0.000104171624,0.000013305481,0.000051379026,0.026499096],"study_design_scores_gemma":[0.48994708,0.0037629928,0.505293,0.0002871253,0.00009288458,6.2414296e-7,0.000054681575,0.00006832223,0.00034154498,0.0000057977013,0.00009287707,0.00005307569],"about_ca_topic_score_codex":0.0013203309,"about_ca_topic_score_gemma":0.0013982567,"teacher_disagreement_score":0.2649624,"about_ca_system_score_codex":0.000070763665,"about_ca_system_score_gemma":0.00021595284,"threshold_uncertainty_score":0.38324186},"labels":[],"label_agreement":null},{"id":"W4417001889","doi":"10.1182/blood-2025-94","title":"Long-term progression-free survival benefit with ciltacabtagene autoleucel in standard-risk relapsed / refractory multiple myeloma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Multiple myeloma; Cyclophosphamide; Cytogenetics; Population; Dexamethasone; Minimal residual disease; Progression-free survival; Chemotherapy","score_opus":0.015546457846614998,"score_gpt":0.29866513852176224,"score_spread":0.2831186806751472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417001889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927738,0.0017145518,0.000108638866,0.00031697602,0.00011690921,0.0013165544,0.0001690526,0.00016729027,0.0033162346],"genre_scores_gemma":[0.9939573,0.0003127265,0.0027644804,0.000045115,0.00007885829,0.00021261741,0.00015862174,0.000051367166,0.0024189549],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972023,0.00012276061,0.0004215995,0.0006409813,0.0009193965,0.00069300085],"domain_scores_gemma":[0.99795717,0.00029558488,0.0001326064,0.0010856781,0.00020369876,0.00032526528],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039012486,0.00034361487,0.00059815403,0.00038402734,0.00017422254,0.000049323786,0.00029553732,0.00019963247,0.00012165799],"category_scores_gemma":[0.00068613974,0.0002507383,0.00011498452,0.00058081053,0.0001327223,0.00012501903,0.00021029131,0.0005613349,0.00002960182],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004021891,0.0023143962,0.94630754,0.00021145986,0.0005344735,0.0019309453,0.000102819526,0.000003570007,0.001602007,0.00003568028,0.000120010336,0.042815223],"study_design_scores_gemma":[0.046008054,0.0013710302,0.93739563,0.0009603464,0.00025584718,0.00003124576,0.00004789454,0.00007854561,0.013166783,0.00006674089,0.00039737238,0.00022050123],"about_ca_topic_score_codex":0.00020311345,"about_ca_topic_score_gemma":0.0017167275,"teacher_disagreement_score":0.042594723,"about_ca_system_score_codex":0.00020917234,"about_ca_system_score_gemma":0.0005078316,"threshold_uncertainty_score":0.99999446},"labels":[],"label_agreement":null},{"id":"W4417001907","doi":"10.1182/blood-2025-758","title":"Blinatumomab mitigates the impact of traditional adverse prognosticators among children with standard risk b-acute lymphoblastic leukemia: Updated results of the Children's oncology group (COG) Trial AALL1731","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; BC Children's Hospital; University of Toronto","funders":"","keywords":"Blinatumomab; Minimal residual disease; Chemotherapy; Acute lymphocytic leukemia; Adverse effect; Leukemia; Randomized controlled trial; Bone marrow","score_opus":0.008009611273946893,"score_gpt":0.26424181340837577,"score_spread":0.2562322021344289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417001907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919607,0.000101277066,0.00007891803,0.00029048006,0.00012181794,0.0036723835,0.0027211404,0.00006649497,0.0009868116],"genre_scores_gemma":[0.99854195,0.000062154715,0.0003612902,0.00004433265,0.00020702992,0.00014298198,0.00049713836,0.000047975438,0.000095134135],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963094,0.00046758508,0.00096771924,0.0005937202,0.0010478261,0.0006137239],"domain_scores_gemma":[0.9963678,0.0013198127,0.0007343202,0.00093918224,0.00042287915,0.00021600163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076229125,0.00042515717,0.00088945974,0.00030652471,0.00025151938,0.00002172346,0.00070507516,0.00033763755,0.000051548886],"category_scores_gemma":[0.001591441,0.00021579384,0.0004903673,0.0014069851,0.001791363,0.00011434106,0.00022611361,0.0007901144,0.0000042574543],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22396396,0.0076650083,0.7216454,0.00012154743,0.026323007,0.00018111146,0.001043692,0.0007106553,0.0020574809,0.00091618963,0.014023656,0.0013482588],"study_design_scores_gemma":[0.18538955,0.007944218,0.7929975,0.00034731394,0.0045719896,0.00029444342,0.0000837031,0.00038514222,0.007579059,0.00019263939,0.000016851163,0.00019763263],"about_ca_topic_score_codex":0.0012556888,"about_ca_topic_score_gemma":0.000076996505,"teacher_disagreement_score":0.07135203,"about_ca_system_score_codex":0.0012217675,"about_ca_system_score_gemma":0.0069413525,"threshold_uncertainty_score":0.99868834},"labels":[],"label_agreement":null},{"id":"W4417001913","doi":"10.1182/blood-2025-2253","title":"A clinical overview of infection in patients receiving elranatamab (ELRA) in combination with daratumumab (DARA) and lenalidomide (R) for newly diagnosed multiple myeloma in the MagnetisMM-6 trial","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Daratumumab; Multiple myeloma; Lenalidomide; Adverse effect; Regimen; Pomalidomide; Bortezomib; Bristol-Myers; Hematology","score_opus":0.04015539964167918,"score_gpt":0.3531118143982857,"score_spread":0.3129564147566065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417001913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99543065,0.00042664827,0.000028912595,0.00025675175,0.000070399125,0.0035699944,0.000014057256,0.000008987969,0.00019361441],"genre_scores_gemma":[0.99849135,0.00049938547,0.0003937723,0.00006673959,0.000022348715,0.00041769617,0.00007776523,0.000010790819,0.00002018467],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998268,0.00035718238,0.0005720999,0.00029259728,0.0002709745,0.00023914673],"domain_scores_gemma":[0.998346,0.0011770864,0.0001203039,0.00022290146,0.000087458175,0.00004630837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093310507,0.00013799882,0.00044221562,0.00034245866,0.00004048773,0.00001932479,0.0000698046,0.00011077543,0.000003822208],"category_scores_gemma":[0.0017617071,0.00009763548,0.00006638567,0.00053255033,0.00006660932,0.00010702697,0.000035677804,0.00024616867,5.862481e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024992473,0.005246821,0.932617,0.0002506063,0.00005924218,0.00003065173,0.0001689515,0.0000021244648,0.000012836934,0.00005444944,0.000027013484,0.036537796],"study_design_scores_gemma":[0.29649752,0.0025160024,0.6997446,0.00054581044,0.000059995902,0.0000014470166,0.000031304393,0.00030351672,0.0001138224,0.00007964381,0.000052046737,0.00005427324],"about_ca_topic_score_codex":0.0011756964,"about_ca_topic_score_gemma":0.007858567,"teacher_disagreement_score":0.27150506,"about_ca_system_score_codex":0.00005925757,"about_ca_system_score_gemma":0.00013155729,"threshold_uncertainty_score":0.43852645},"labels":[],"label_agreement":null},{"id":"W4417001949","doi":"10.1182/blood-2025-1094","title":"Changes in complete blood count (CBC) and white blood cell (WBC) differential associated with overweight and obesity: A patient-level meta-analysis of randomized trials","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Overweight; Body mass index; Obesity; Leukocytosis; Complete blood count; White blood cell; Confounding; Clinical trial","score_opus":0.05102489204692627,"score_gpt":0.26968855399820757,"score_spread":0.21866366195128129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417001949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99122304,0.005155097,0.000043616958,0.00027987966,0.000039950144,0.0021207319,0.0007753714,0.000042026302,0.00032027697],"genre_scores_gemma":[0.9982,0.00033309948,0.0005297986,0.00023649534,0.000019122914,0.0003339516,0.00017326676,0.00002699497,0.00014728827],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99589646,0.001303393,0.0012181309,0.00060828956,0.00060919026,0.0003645151],"domain_scores_gemma":[0.99663186,0.0016294151,0.00084343,0.00044009215,0.0002932653,0.00016190765],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001804883,0.00043272637,0.005338192,0.0009782735,0.00008547281,0.000056741166,0.00011840424,0.00021131115,0.0002447407],"category_scores_gemma":[0.0011511847,0.0003002541,0.0009298779,0.000989284,0.00029784252,0.00005885683,0.00015123568,0.00018509943,3.967613e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017718406,0.0052001663,0.49388075,0.0005651619,0.47648332,0.00014610033,0.00072586397,0.0000011283539,0.005069643,0.00008112814,0.00004387014,0.000084466425],"study_design_scores_gemma":[0.18344192,0.00025819504,0.10477274,0.0001423398,0.6976713,0.0000045083884,0.00011701156,0.00017729065,0.013094417,0.00005514888,0.000009309389,0.00025581385],"about_ca_topic_score_codex":0.00007365367,"about_ca_topic_score_gemma":0.0008349363,"teacher_disagreement_score":0.389108,"about_ca_system_score_codex":0.000021186292,"about_ca_system_score_gemma":0.00011325778,"threshold_uncertainty_score":0.999945},"labels":[],"label_agreement":null},{"id":"W4417001966","doi":"10.1182/blood-2025-2738","title":"The influence of age on patient-reported outcomes (PROs) endpoints on the S1826 cross-network Phase III trial of advanced-stage, classic Hodgkin lymphoma (cHL)","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; McGill University","funders":"","keywords":"Brentuximab vedotin; Randomization; Dacarbazine; Quality of life (healthcare); Clinical endpoint; Surrogate endpoint; Hodgkin lymphoma; Chemotherapy regimen; Phases of clinical research; Clinical trial","score_opus":0.01630886923820037,"score_gpt":0.3165869747371246,"score_spread":0.30027810549892425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417001966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993582,0.0002732835,0.0000010531733,0.0004953924,0.00034859835,0.0017605542,0.000041331477,0.00003542567,0.0034623516],"genre_scores_gemma":[0.9977999,0.0001543257,0.000040626277,0.00063965673,0.000056845798,0.00032577716,0.000016379467,0.000017885775,0.0009486098],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978542,0.00010798667,0.0008494033,0.0003446754,0.0005172284,0.000326515],"domain_scores_gemma":[0.9970908,0.0011560892,0.0005620294,0.0009811039,0.00013723336,0.00007269783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033081495,0.0002651391,0.00058417354,0.00006775446,0.00021787624,0.000030070658,0.00020491991,0.00009840471,0.000021536513],"category_scores_gemma":[0.0006774046,0.00013363131,0.00028380103,0.00033700297,0.0002544684,0.000042823107,0.000079561505,0.00009800404,0.0000075803746],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19306864,0.08092823,0.42856422,0.00037078888,0.00836331,0.0015538459,0.0014769526,0.0019503483,0.0067109996,0.029467527,0.004115146,0.24342999],"study_design_scores_gemma":[0.37637255,0.006562297,0.50109017,0.00084319414,0.00091089937,0.000008668254,0.00016168592,0.000015161209,0.105630875,0.00052101625,0.0076586395,0.0002248262],"about_ca_topic_score_codex":0.00006763237,"about_ca_topic_score_gemma":0.000024356172,"teacher_disagreement_score":0.24320516,"about_ca_system_score_codex":0.00008972651,"about_ca_system_score_gemma":0.00023156508,"threshold_uncertainty_score":0.5449327},"labels":[],"label_agreement":null},{"id":"W4417001967","doi":"10.1182/blood-2025-797","title":"Genomic assessment of acquired mutations in participants with CLL/SLL treated with nemtabrutinib in the Phase 2 bellwave-003 study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Jewish General Hospital; Montreal General Hospital","funders":"","keywords":"Bruton's tyrosine kinase; Ibrutinib; Mutation; Gene; Mutant; Tyrosine kinase; Kinase; Phases of clinical research","score_opus":0.0389420738251895,"score_gpt":0.3898912402730499,"score_spread":0.3509491664478604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417001967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951746,0.00008785753,0.000019374032,0.00021689119,0.000009011198,0.002093346,0.000010505229,0.000017761577,0.0023706746],"genre_scores_gemma":[0.99913234,0.000010760061,0.00021621163,0.000072042,0.000013863415,0.00030062732,0.00002575245,0.000017222603,0.0002111781],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821216,0.00022460942,0.00041151993,0.00030779562,0.0004315438,0.00041238553],"domain_scores_gemma":[0.9989564,0.00027684894,0.00008209425,0.0005418438,0.0000756364,0.000067193636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000622543,0.00015704577,0.00039430443,0.00026998797,0.00004819224,0.000018048031,0.00017945132,0.0000483284,0.000032942167],"category_scores_gemma":[0.00007166396,0.00009306119,0.000028550103,0.0011110251,0.00014025348,0.000043173983,0.00004831406,0.00012704311,0.0000030025462],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023771736,0.0390012,0.9377506,0.00025429777,0.00090731616,0.0023953877,0.008988068,0.00048931764,0.0063648494,0.00021758006,0.000056440775,0.0011977886],"study_design_scores_gemma":[0.26589286,0.003967045,0.7091045,0.0004020824,0.0009150933,0.00007388593,0.009222085,0.00544658,0.004748246,0.000018949519,0.00004589567,0.00016278605],"about_ca_topic_score_codex":0.0017403825,"about_ca_topic_score_gemma":0.0025830888,"teacher_disagreement_score":0.26351568,"about_ca_system_score_codex":0.0012918258,"about_ca_system_score_gemma":0.005318402,"threshold_uncertainty_score":0.94346166},"labels":[],"label_agreement":null},{"id":"W4417001971","doi":"10.1182/blood-2025-1097","title":"Impact of optimizing the serum ferritin threshold for diagnosis of iron deficiency: A pre- and post-intervention study using EHR data","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Ferritin; Anemia; Confidence interval; Retrospective cohort study; Hematocrit; Biomarker; Iron deficiency; Serum ferritin; Interquartile range","score_opus":0.035304341082342004,"score_gpt":0.35434098014898746,"score_spread":0.3190366390666455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417001971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943864,0.004059558,0.0002001182,0.00008513072,0.000039219627,0.00094620057,0.000161048,0.000008223288,0.00011411624],"genre_scores_gemma":[0.9991613,0.00006905708,0.0006526356,0.000023911021,0.000014837639,0.00001961932,0.000024941477,0.00000831495,0.000025382431],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99929297,0.00003246348,0.00024956503,0.00018494844,0.00011184279,0.00012820389],"domain_scores_gemma":[0.9993058,0.000075680866,0.000096742995,0.0004313367,0.000067560446,0.000022911936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036778432,0.00008687996,0.00022628825,0.00008191797,0.000056855697,0.000011750593,0.00014529526,0.000032124222,0.000010076143],"category_scores_gemma":[0.00017434826,0.00005800498,0.00008642452,0.00013083238,0.000049220063,0.00007932951,0.00015161485,0.00005340111,6.38995e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002649358,0.0037436455,0.98733,0.00071403617,0.00009886032,0.0000011892514,0.00097330206,0.00009125574,0.0034736635,0.00009999014,0.000063773536,0.0031453401],"study_design_scores_gemma":[0.0070141046,0.0010455201,0.9836657,0.00024713515,0.0018321896,0.0000043289774,0.0034249842,0.0006478144,0.0019900266,0.00005680097,0.0000036250017,0.0000677873],"about_ca_topic_score_codex":0.00068264344,"about_ca_topic_score_gemma":0.00006249579,"teacher_disagreement_score":0.006749169,"about_ca_system_score_codex":0.0000067879355,"about_ca_system_score_gemma":0.000065191656,"threshold_uncertainty_score":0.23653744},"labels":[],"label_agreement":null},{"id":"W4417001993","doi":"10.1182/blood-2025-1092","title":"Humanistic and economic burden among caregivers of adults and children with sickle cell disease and recurrent vaso-occlusive crises","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Disease; Quality of life (healthcare); Activities of daily living; Blood Disorder; Disease burden; Mental health; Caregiver burden; Health care","score_opus":0.002658355485236239,"score_gpt":0.1982028994077334,"score_spread":0.19554454392249715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417001993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898642,0.008336343,0.0000028357092,0.00015945263,0.000027364475,0.00038351273,0.000042345542,0.000015486132,0.0011684962],"genre_scores_gemma":[0.9975389,0.0022163184,0.000036012025,0.000025015266,0.000021485475,0.0000058092533,0.000018256585,0.000009129858,0.00012903348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994582,0.000012941126,0.0001202802,0.0002357624,0.00005337281,0.00011943931],"domain_scores_gemma":[0.9996297,0.000027062795,0.000054211487,0.00012444725,0.000026708905,0.00013787029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000025689335,0.00011848741,0.00020428014,0.00006681859,0.00008071649,0.000012721138,0.000029321143,0.00004898213,0.000011892396],"category_scores_gemma":[0.0000150812375,0.00009343641,0.000021659365,0.000037938273,0.0002224903,0.00003321747,0.000056684574,0.00008824963,6.1608864e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064976624,0.00033907132,0.99115056,0.001046579,0.00049742893,0.000054350843,0.0029329185,0.000018614679,0.00010690609,0.00019630052,0.0004679362,0.00253959],"study_design_scores_gemma":[0.01451094,0.0008231343,0.9758664,0.0011651794,0.0028358402,0.000026206983,0.003469267,0.00020650894,0.00062015763,0.00009826482,0.00012867029,0.00024944294],"about_ca_topic_score_codex":0.00040491796,"about_ca_topic_score_gemma":0.00007469373,"teacher_disagreement_score":0.01528415,"about_ca_system_score_codex":0.000010810214,"about_ca_system_score_gemma":0.00007375131,"threshold_uncertainty_score":0.3810226},"labels":[],"label_agreement":null},{"id":"W4417002049","doi":"10.1182/blood-2025-1101","title":"Comparative efficacy of complement inhibitors in complement Inhibitor–Naïve PNH: A network meta-analysis of randomized trials","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of New Brunswick","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Randomized controlled trial; Eculizumab; Complement (music); Clinical trial; Randomization; Complement component 5","score_opus":0.1363188031666678,"score_gpt":0.3771899923326464,"score_spread":0.24087118916597858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417002049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94386387,0.043252345,0.0006685033,0.00038521094,0.00077023526,0.0076959324,0.0012957167,0.00006595441,0.002002246],"genre_scores_gemma":[0.9984089,0.000028366738,0.00028204918,0.00006514175,0.000028305729,0.00048670813,0.000569456,0.000009503445,0.00012156853],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98886114,0.005840066,0.004176274,0.00050184486,0.00017145838,0.00044918683],"domain_scores_gemma":[0.98936385,0.007973912,0.0017359037,0.00065037736,0.00024592289,0.000030024254],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.006191024,0.00038054844,0.00918364,0.00093272794,0.00009268363,0.00001280081,0.0004095927,0.0001138687,0.0028330314],"category_scores_gemma":[0.0007127084,0.0002931808,0.003477223,0.0015401894,0.00035232416,0.00004094405,0.00030547616,0.00016346938,0.000013930247],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019637197,0.0057645864,0.016628692,0.00020818858,0.9055187,0.0000037626921,0.0018392162,0.0034766486,0.019147674,0.014260619,0.013432727,0.00008199927],"study_design_scores_gemma":[0.28358644,0.00024107956,0.011821963,0.00018993973,0.61772484,9.319647e-7,0.0011803609,0.0000631153,0.08150605,0.0006105254,0.0026414096,0.00043335458],"about_ca_topic_score_codex":0.00055068464,"about_ca_topic_score_gemma":0.0006592583,"teacher_disagreement_score":0.28779387,"about_ca_system_score_codex":0.000047419027,"about_ca_system_score_gemma":0.00013222855,"threshold_uncertainty_score":0.999952},"labels":[],"label_agreement":null},{"id":"W4417002052","doi":"10.1182/blood-2025-1845","title":"External validation of the early-stage classic Hodgkin lymphoma (cHL) international prognostication index (E-HIPI) in the german Hodgkin study group (GHSG) unfavorable clinical trials","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency; Canadian Cancer Society; University of Toronto","funders":"","keywords":"ABVD; Clinical trial; Hodgkin lymphoma; Brentuximab vedotin; International Prognostic Index; Lymphoma; Cohort; Chemotherapy regimen","score_opus":0.06479326219693014,"score_gpt":0.4040638090016049,"score_spread":0.3392705468046747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417002052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942425,0.0001523926,0.00012304138,0.0013182048,0.0004787502,0.0024070172,0.000021741245,0.000024207564,0.0012321535],"genre_scores_gemma":[0.9985657,0.00006780671,0.000109805114,0.0003095358,0.00021447685,0.00041048718,0.00003204812,0.000013037009,0.0002771204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99623865,0.0013680926,0.0011982756,0.000375729,0.00062213646,0.00019712244],"domain_scores_gemma":[0.9973866,0.0013490665,0.00048731733,0.00060390437,0.00012506863,0.00004807405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037010182,0.00018791015,0.0005078891,0.0001680947,0.00008736712,0.00007858815,0.000401575,0.00012799528,0.000051255938],"category_scores_gemma":[0.0014027725,0.00010614726,0.00025915666,0.000435837,0.0000956242,0.00010510405,0.000115276634,0.00015587121,0.000014079787],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002757352,0.012577929,0.9714917,0.000023757872,0.00039920953,0.000028688828,0.0006358675,0.000003206284,0.00033707469,0.0017872994,0.00015503439,0.012284526],"study_design_scores_gemma":[0.01627881,0.00053866266,0.9765489,0.00023317545,0.0006920901,0.000009806199,0.00035817438,0.000106954285,0.004072298,0.0005033122,0.0005730314,0.00008478453],"about_ca_topic_score_codex":0.00037559675,"about_ca_topic_score_gemma":0.00010011418,"teacher_disagreement_score":0.016003076,"about_ca_system_score_codex":0.00011324789,"about_ca_system_score_gemma":0.00023029494,"threshold_uncertainty_score":0.43285596},"labels":[],"label_agreement":null},{"id":"W4417002067","doi":"10.1182/blood-2025-3123","title":"Safety and effectiveness of standard versus extended duration of anticoagulation in children with acute lymphoblastic leukemia and venous thrombo-embolism","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Hôtel-Dieu de Québec; Université de Sherbrooke; Centre hospitalier universitaire de Québec","funders":"","keywords":"Interquartile range; Cohort; Retrospective cohort study; Hazard ratio; Regimen; Proportional hazards model; Cohort study; Asparaginase; Acute lymphocytic leukemia","score_opus":0.004909475955274624,"score_gpt":0.24698191051090937,"score_spread":0.24207243455563474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417002067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99788874,0.000404661,0.0005088156,0.00002645354,0.00003979451,0.0007435695,0.00001552883,0.000013074165,0.00035934543],"genre_scores_gemma":[0.9990195,0.0006472867,0.00026400774,0.000009983597,0.000010104597,0.000012886688,0.000023590781,0.000009346375,0.0000032667456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992404,0.000053507014,0.0002423336,0.00019946559,0.0001497004,0.00011461853],"domain_scores_gemma":[0.9995596,0.00009845915,0.00009831011,0.00014935136,0.00006440751,0.000029871959],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021464669,0.00011177906,0.00052119413,0.00015393819,0.00003377751,0.000007428412,0.00002991951,0.000056640965,0.0000026527648],"category_scores_gemma":[0.00003921546,0.000094403964,0.000021503463,0.00019970279,0.00009183979,0.00006204119,0.000040155268,0.00004921269,1.3565409e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015142328,0.0042963834,0.8833759,0.0031767841,0.006035832,0.00004983847,0.001448267,0.0005156322,0.047312934,0.022521807,0.000016572274,0.016107766],"study_design_scores_gemma":[0.015814804,0.0013529788,0.9612582,0.00064417516,0.0013753403,0.000013751686,0.000050863833,0.00008953846,0.01913325,0.00018977787,0.00000311676,0.00007420613],"about_ca_topic_score_codex":0.00015151648,"about_ca_topic_score_gemma":0.000029492057,"teacher_disagreement_score":0.07788234,"about_ca_system_score_codex":0.00006339654,"about_ca_system_score_gemma":0.00012969201,"threshold_uncertainty_score":0.3849682},"labels":[],"label_agreement":null},{"id":"W4417002069","doi":"10.1182/blood-2025-2730","title":"Patient journey with axicabtagene ciloleucel for relapsed or refractory large B cell lymphoma in Canada: Manufacturing experience and impact of patient location to treatment centre","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; Hôtel-Dieu de Québec; Hôpital Maisonneuve-Rosemont; Princess Margaret Cancer Centre","funders":"","keywords":"Chimeric antigen receptor; Real world data; Lymphoma; CAR T-cell therapy; Follicular lymphoma; Rituximab; Refractory (planetary science); Apheresis","score_opus":0.01346666025648666,"score_gpt":0.2753726718758079,"score_spread":0.2619060116193212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417002069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981139,0.00030955832,0.000033092907,0.000098499375,0.00003117428,0.0011464246,0.000035923305,0.0000066847347,0.00022478736],"genre_scores_gemma":[0.9987487,0.00008613793,0.00025386357,0.000081920436,0.000011355554,0.00010155264,0.000015349471,0.000015956863,0.00068516546],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989021,0.000033872373,0.00025895413,0.0002547715,0.00024225582,0.0003080931],"domain_scores_gemma":[0.9993231,0.00007586938,0.00007389139,0.0002626157,0.000094553114,0.00016994613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005533438,0.00014888734,0.00026934966,0.00014696049,0.000042771713,0.000008738458,0.00004587911,0.000039272098,0.000094428586],"category_scores_gemma":[0.000026190406,0.00009880371,0.00003890908,0.0001822789,0.00001566685,0.00003275424,0.00002986119,0.000048349633,3.7892482e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027456215,0.01978594,0.35032558,0.0012258949,0.0010382178,0.00066992396,0.041327592,0.0005848504,0.19123262,0.000015047224,0.0009709271,0.3653672],"study_design_scores_gemma":[0.0203982,0.005556685,0.11819387,0.00037442017,0.0000877502,0.000015726842,0.0039587594,0.00009505777,0.84710896,0.0000024204073,0.0040409425,0.0001671763],"about_ca_topic_score_codex":0.15006334,"about_ca_topic_score_gemma":0.19343495,"teacher_disagreement_score":0.6558764,"about_ca_system_score_codex":0.0013250281,"about_ca_system_score_gemma":0.0019036012,"threshold_uncertainty_score":0.8555965},"labels":[],"label_agreement":null},{"id":"W4417002078","doi":"10.1182/blood-2025-2250","title":"Sensitive peripheral residual disease (PRD) detection using clonotypic mass spectrometry (EasyM) in patients with newly diagnosed multiple myeloma (NDMM)","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Multiple myeloma; Minimal residual disease; Transplantation; Bone marrow; Flow cytometry; Surrogate endpoint; Monoclonal gammopathy of undetermined significance; Autologous stem-cell transplantation","score_opus":0.009968163287180221,"score_gpt":0.25441198149699135,"score_spread":0.24444381820981112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417002078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973586,0.00013058235,0.00076098996,0.000103223785,0.000081179634,0.0011746171,0.000057763224,0.00006916093,0.0002638831],"genre_scores_gemma":[0.9955484,0.000012888612,0.003886312,0.00008780784,0.00010114767,0.0000529791,0.00011008296,0.000034410965,0.00016593025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981204,0.0001362838,0.0002588479,0.0004962401,0.0004518409,0.0005363892],"domain_scores_gemma":[0.9989707,0.0001403632,0.00006677618,0.0003565445,0.0001582305,0.00030742126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009742569,0.0002615667,0.00034864346,0.00044099594,0.00014304864,0.000042247666,0.00006985602,0.000092617884,0.000029261273],"category_scores_gemma":[0.000348579,0.00021914323,0.00008146139,0.00067966955,0.00007946107,0.0001351764,0.00005254272,0.000286078,0.000012075959],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006462409,0.0018173405,0.984148,0.000086501124,0.00032909756,0.0009241126,0.0000797934,0.00004174679,0.0032687853,0.000006286799,0.000005808598,0.0028300695],"study_design_scores_gemma":[0.032736793,0.0005977057,0.95017815,0.00024463082,0.00025659436,0.000004853143,0.000104444305,0.0012693243,0.014392307,0.000023729273,0.000012474254,0.00017897668],"about_ca_topic_score_codex":0.00039306236,"about_ca_topic_score_gemma":0.00047145277,"teacher_disagreement_score":0.03396988,"about_ca_system_score_codex":0.00033799603,"about_ca_system_score_gemma":0.0002787198,"threshold_uncertainty_score":0.89364016},"labels":[],"label_agreement":null},{"id":"W4417002079","doi":"10.1182/blood-2025-2238","title":"Head-to-head longitudinal comparison of two mass spectrometry-based methods for monitoring monoclonal proteins in multiple myeloma: Analytical and clinical insights from the GEM-CESAR trial","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Isotype; Immunoglobulin light chain; Kappa; Multiple myeloma; Monoclonal; Monoclonal antibody; Bone marrow; Minimal residual disease","score_opus":0.15392628887993035,"score_gpt":0.4986896564270345,"score_spread":0.3447633675471041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417002079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9726174,0.00072826346,0.02253834,0.0008179062,0.00015317279,0.0029906556,0.0000454021,0.00002451887,0.000084374005],"genre_scores_gemma":[0.79561037,0.000008928612,0.20375124,0.000025426038,0.0003146829,0.00021305427,0.000029076013,0.000015323281,0.00003192715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974479,0.00042361408,0.0008137682,0.00055641617,0.0003557576,0.00040252737],"domain_scores_gemma":[0.9952922,0.0037652082,0.00011684757,0.00043791998,0.0001290155,0.00025884467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000750857,0.00023192227,0.0009069958,0.0002997767,0.00011532158,0.000036317255,0.00019224506,0.00014287264,0.000015860945],"category_scores_gemma":[0.0022378773,0.00015891899,0.00023591393,0.00057432224,0.00015927461,0.00004311243,0.00009192077,0.000436235,0.0000043588007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025698131,0.0037284412,0.9511695,0.000073013,0.00072456006,0.00003397216,0.000053775675,0.000009554749,0.006776171,0.000091537484,0.000014635861,0.011626688],"study_design_scores_gemma":[0.14486401,0.0025129772,0.79404306,0.00027090524,0.00052717346,0.0000012244222,0.000055059987,0.019775787,0.037343293,0.00036929044,0.000109130946,0.0001280598],"about_ca_topic_score_codex":0.00066633575,"about_ca_topic_score_gemma":0.00037401056,"teacher_disagreement_score":0.18121289,"about_ca_system_score_codex":0.00007660652,"about_ca_system_score_gemma":0.00028665244,"threshold_uncertainty_score":0.6480528},"labels":[],"label_agreement":null},{"id":"W4417002179","doi":"10.1182/blood-2025-4419","title":"Consensus on cytokine release syndrome (CRS) monitoring practices: A Delphi approach","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Agfa-Gevaert (Canada)","funders":"","keywords":"Delphi method; Cytokine release syndrome; Delphi; MEDLINE; Patient safety; Chimeric antigen receptor; Grading (engineering); Health care","score_opus":0.062168909495097215,"score_gpt":0.35368419703172876,"score_spread":0.29151528753663153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417002179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9087038,0.000637774,0.00003484889,0.0013365225,0.00016225474,0.000700562,0.000008431879,0.00014318994,0.088272594],"genre_scores_gemma":[0.9796056,0.0001279839,0.0027226722,0.00021344637,0.00024841222,0.00008834339,0.000013694802,0.000038939947,0.01694091],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983209,0.00010900971,0.00026018254,0.0004277505,0.0004942158,0.000387944],"domain_scores_gemma":[0.9984688,0.0004100652,0.00012475715,0.00067777134,0.00013516331,0.00018343411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040615426,0.00018334214,0.00033429373,0.00027095745,0.00009862427,0.00004273288,0.00015326744,0.00013218354,0.0002164494],"category_scores_gemma":[0.00096674607,0.0001640423,0.00010860021,0.000528166,0.00007761014,0.000035191173,0.000057328216,0.0005710246,0.00008852402],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059121554,0.013509969,0.059340145,0.0020960828,0.0031324653,0.00818036,0.0010562423,0.00006840705,0.8820441,0.001261918,0.0032807773,0.020117376],"study_design_scores_gemma":[0.07967964,0.0076726065,0.07771299,0.0041688033,0.004284592,0.011563945,0.005907352,0.0011738534,0.58177507,0.0006114649,0.22348592,0.0019637838],"about_ca_topic_score_codex":0.00012463584,"about_ca_topic_score_gemma":0.0000018706256,"teacher_disagreement_score":0.30026904,"about_ca_system_score_codex":0.000090621084,"about_ca_system_score_gemma":0.00026298114,"threshold_uncertainty_score":0.6689451},"labels":[],"label_agreement":null},{"id":"W4417002206","doi":"10.1182/blood-2025-3547","title":"Evaluating targeted long-read sequencing as a diagnostic tool for burkitt lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Spinal Cord Injury BC; Simon Fraser University","funders":"","keywords":"Germline; DNA sequencing; Epigenetics; Lymphoma; Somatic cell; DNA methylation; Germline mutation; Mutation; KRAS","score_opus":0.015831481033634003,"score_gpt":0.3013910919382883,"score_spread":0.28555961090465426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417002206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908151,0.0033674808,0.0036957094,0.00012724855,0.0003098787,0.00052543415,0.000066300585,0.000020222127,0.0010726049],"genre_scores_gemma":[0.99381816,0.00027126115,0.003146008,0.0009566181,0.00036210514,0.00025600003,0.00021890897,0.000027594228,0.0009433667],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989643,0.000026553751,0.00023774864,0.00038297696,0.00009454568,0.0002938949],"domain_scores_gemma":[0.999103,0.0002734641,0.00007278842,0.00034969597,0.00014784442,0.00005320848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021995886,0.00016116937,0.00015682216,0.000045796936,0.00012647493,0.000051319457,0.00017572976,0.00013334896,0.000017916249],"category_scores_gemma":[0.0031709233,0.00017359764,0.00011766531,0.0001020101,0.000034863766,0.0000024536962,0.00011818012,0.000036069232,0.000009846808],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021207702,0.00049677765,0.01567829,0.00022745655,0.00053654535,0.000032165182,0.00011000423,0.000991236,0.9228277,0.0018607122,0.0037929357,0.053234074],"study_design_scores_gemma":[0.007975125,0.001081133,0.0089152865,0.00017008312,0.00054659776,0.00003834425,0.000089712325,0.00069956033,0.95484585,0.0025023178,0.022526471,0.00060954614],"about_ca_topic_score_codex":0.00007332417,"about_ca_topic_score_gemma":0.000054672542,"teacher_disagreement_score":0.052624527,"about_ca_system_score_codex":0.00004327329,"about_ca_system_score_gemma":0.0005714003,"threshold_uncertainty_score":0.70791066},"labels":[],"label_agreement":null},{"id":"W4417002262","doi":"10.1182/blood-2025-4434","title":"Animated Patient's guide to Acute Myeloid Leukemia: Assessing patient understanding, shared decision-making, and health outcomes.","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Health Literacy and Information Accessibility","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"March of Dimes Canada","funders":"","keywords":"Health literacy; Patient education; Health communication; Literacy; Comprehension; Health care; Patient portal; Health education; MEDLINE","score_opus":0.05863145950254125,"score_gpt":0.46356482947508876,"score_spread":0.40493336997254753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417002262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9204524,0.00032868207,0.043294113,0.004560561,0.001387935,0.0030635328,0.00022855864,0.00040655653,0.026277626],"genre_scores_gemma":[0.9269462,0.00006268122,0.023211243,0.049256124,0.000036337544,0.00017019965,0.000064632666,0.000026221916,0.0002263446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99537593,0.00036965194,0.0025144613,0.0004904377,0.00041292535,0.0008366104],"domain_scores_gemma":[0.9972252,0.0007153501,0.00079034874,0.0005749237,0.00029461124,0.00039955205],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0014898767,0.0002818932,0.000571119,0.00039459803,0.0018773497,0.0001539878,0.0002344026,0.00024667574,0.0002898383],"category_scores_gemma":[0.00090785377,0.00023393097,0.00007074155,0.0007126927,0.000038320846,0.0010382829,0.00043945538,0.00064304186,0.00008348922],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002069273,0.00050332444,0.6890706,0.0016568733,0.00021900354,0.00001578326,0.024957228,0.000017474813,0.000032615048,0.0063055814,0.1718384,0.105176196],"study_design_scores_gemma":[0.0071758586,0.00067110994,0.7763175,0.0074228984,0.00013771027,0.000009103219,0.02193114,0.0019149348,0.00006250508,0.005176265,0.17830382,0.0008771847],"about_ca_topic_score_codex":0.00024284396,"about_ca_topic_score_gemma":0.00016958146,"teacher_disagreement_score":0.10429901,"about_ca_system_score_codex":0.0015853272,"about_ca_system_score_gemma":0.0018442124,"threshold_uncertainty_score":0.9994221},"labels":[],"label_agreement":null},{"id":"W4417002264","doi":"10.1182/blood-2025-4425","title":"A multinational study to explore patient preferences for chronic myeloid leukaemia treatments","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tolerability; Logistic regression; Logit; Risk assessment; Myeloid leukaemia; Toxicity; Clinical trial; Mixed logit","score_opus":0.03774920091659433,"score_gpt":0.3201063048281047,"score_spread":0.28235710391151037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417002264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928325,0.00042483985,0.000069327776,0.000238075,0.00017038945,0.0041404776,0.000038833678,0.000098409095,0.0019871644],"genre_scores_gemma":[0.9923551,0.000016050259,0.0019441259,0.00019538708,0.000107467706,0.0022181352,0.00012247227,0.000022683707,0.0030185909],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984976,0.000033616103,0.00032864255,0.0005003091,0.00030865116,0.00033114944],"domain_scores_gemma":[0.99914515,0.000121415476,0.0000679284,0.0003863038,0.00014316222,0.00013602419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000072364426,0.0002430294,0.00034010728,0.00018795172,0.00012532824,0.000021512291,0.00011820888,0.00005819481,0.00009074742],"category_scores_gemma":[0.00013917727,0.00019714111,0.00011082758,0.00026055082,0.000021775082,0.000054646913,0.00009294773,0.00008656636,0.000060635055],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016192372,0.048598297,0.71907765,0.0006125086,0.0071266023,0.00018306369,0.015079229,0.000089721114,0.0058348416,0.00025631321,0.0069917575,0.19453079],"study_design_scores_gemma":[0.09908282,0.021510733,0.80598146,0.00087435526,0.0040795016,0.000038128866,0.0053661396,0.00026762523,0.051953737,0.00043142418,0.009754063,0.00066000427],"about_ca_topic_score_codex":0.00008334127,"about_ca_topic_score_gemma":0.00008274088,"teacher_disagreement_score":0.19387078,"about_ca_system_score_codex":0.0011717264,"about_ca_system_score_gemma":0.0008878778,"threshold_uncertainty_score":0.8039181},"labels":[],"label_agreement":null},{"id":"W4417002266","doi":"10.1182/blood-2025-4430","title":"Frailty as a prognostic factor in younger adult patients with Acute Myeloid Leukemia undergoing allogeneic stem cell transplantation","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Frailty in Older Adults","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cumulative incidence; Hazard ratio; Proportional hazards model; Hematopoietic stem cell transplantation; Transplantation; Myeloid leukemia; Incidence (geometry); Confidence interval","score_opus":0.008854953563090974,"score_gpt":0.2337839820334662,"score_spread":0.22492902847037524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417002266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950287,0.00011674345,0.0002164544,0.00018162707,0.00010232786,0.0011486397,0.000060764134,0.000099708726,0.003045039],"genre_scores_gemma":[0.99675786,0.00010806891,0.00070522,0.0005118469,0.000026994332,0.00009017549,0.00018406825,0.00003449753,0.0015812699],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985096,0.000048013142,0.00032847238,0.00040907695,0.0003573453,0.00034748708],"domain_scores_gemma":[0.99922425,0.00015226996,0.00008507113,0.0002795357,0.0001564049,0.00010250122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000040388746,0.00024515556,0.00029777788,0.00020141367,0.000051728384,0.000025953215,0.00011826407,0.0001518131,0.000030937725],"category_scores_gemma":[0.00003773969,0.00020478852,0.000056866655,0.0003700587,0.000037813166,0.00015625914,0.00002018903,0.0002623748,0.00004929968],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005504902,0.00092624896,0.988562,0.000854291,0.00033099268,0.0003240332,0.0013824949,0.000020303993,0.004726498,0.00006848023,0.00006638624,0.0021877966],"study_design_scores_gemma":[0.019216169,0.00077284826,0.94572717,0.0013576852,0.0008687393,0.000037393373,0.00015671129,0.000024836318,0.03146797,0.00005002636,0.000059595503,0.00026083097],"about_ca_topic_score_codex":0.000107510365,"about_ca_topic_score_gemma":0.00038214555,"teacher_disagreement_score":0.04283479,"about_ca_system_score_codex":0.00017889035,"about_ca_system_score_gemma":0.00055108656,"threshold_uncertainty_score":0.83510333},"labels":[],"label_agreement":null},{"id":"W4417002342","doi":"10.1182/blood-2025-5823","title":"Patient-reported outcomes from dreamm-7 and dreamm-8 using the EQ-5D-3L, patient global impression of severity, and patient global impression of change","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Clinical Global Impression; Visual analogue scale; Global health; Multiple myeloma; Bortezomib; Hazard ratio; Scale (ratio)","score_opus":0.06096495421358535,"score_gpt":0.32421268082549365,"score_spread":0.2632477266119083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417002342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99464244,0.0028871186,0.000016793889,0.00019657178,0.00014800279,0.0011941763,0.0005779962,0.000025110015,0.00031179603],"genre_scores_gemma":[0.9988853,0.00015564279,0.0006922951,0.000121104196,0.000020404867,0.00003825807,0.000070635324,0.000010705721,0.000005692964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979413,0.00012595279,0.00057095336,0.00040748232,0.000612603,0.000341679],"domain_scores_gemma":[0.99865323,0.00010657514,0.000340129,0.0004928424,0.00019916499,0.00020807657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007921679,0.0002630177,0.0005375083,0.00006376139,0.00013515541,0.000022417193,0.00008771623,0.00014222853,0.000027473281],"category_scores_gemma":[0.00020283768,0.00016172027,0.000110666406,0.00024485897,0.00016994169,0.00010163669,0.00053425436,0.00012134012,4.98399e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055879966,0.0013315653,0.84564465,0.00012077707,0.00055460475,0.0000735149,0.00062279153,5.46457e-7,0.005206505,0.000010832864,0.00006139638,0.14581403],"study_design_scores_gemma":[0.007196246,0.00078765576,0.96373206,0.0007144788,0.0005905275,0.00003954446,0.0006329234,0.00038701112,0.025463682,0.00022195661,0.00009494186,0.0001389523],"about_ca_topic_score_codex":0.0064771087,"about_ca_topic_score_gemma":0.00010395524,"teacher_disagreement_score":0.14567508,"about_ca_system_score_codex":0.000083739855,"about_ca_system_score_gemma":0.00011345887,"threshold_uncertainty_score":0.9791494},"labels":[],"label_agreement":null},{"id":"W4417002349","doi":"10.1182/blood-2025-5820","title":"Functional high-risk Relapsed/Refractory multiple myeloma (RRMM) outcomes with belantamab mafodotin (belamaf): Dreamm-7 and dreamm-8 subgroup analysis","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Subgroup analysis; Clinical endpoint; Hazard ratio; Dexamethasone; Adverse effect; Multiple myeloma; Clinical trial; Randomized controlled trial","score_opus":0.00996949051566891,"score_gpt":0.2462573102883356,"score_spread":0.2362878197726667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417002349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99554193,0.0008795993,0.0005619561,0.00051656313,0.00009266064,0.0007141602,0.00019881931,0.00016751362,0.0013267949],"genre_scores_gemma":[0.9896258,0.00032961596,0.0022760688,0.00017360483,0.00008930873,0.00012683273,0.0005942887,0.000042788073,0.00674168],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972505,0.00015286579,0.0004429543,0.00079858577,0.000716201,0.000638874],"domain_scores_gemma":[0.99786764,0.0006348415,0.00016686606,0.00072714343,0.00019639364,0.00040710304],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002829505,0.00043579933,0.0008606086,0.00079574296,0.00035571482,0.000071289185,0.00014024622,0.00020815773,0.00031691903],"category_scores_gemma":[0.00033729844,0.00031167158,0.00027068902,0.001061737,0.00020516272,0.00015098062,0.0001338587,0.0005056223,0.00007663734],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014136536,0.002007383,0.977438,0.00010244863,0.01033243,0.00041042783,0.00007526258,0.0000104508335,0.00056063524,0.00017606672,0.000408178,0.0070650647],"study_design_scores_gemma":[0.026067624,0.00071360293,0.96326286,0.00008842337,0.0061578564,0.00005677688,0.00013425683,0.00021049991,0.0024262972,0.000071102935,0.00054448145,0.0002662438],"about_ca_topic_score_codex":0.0020520964,"about_ca_topic_score_gemma":0.0018707702,"teacher_disagreement_score":0.02465397,"about_ca_system_score_codex":0.00010901888,"about_ca_system_score_gemma":0.00022888422,"threshold_uncertainty_score":0.99993354},"labels":[],"label_agreement":null},{"id":"W4417002382","doi":"10.1182/blood-2025-5840","title":"Belantamab mafodotin (belamaf) in combination with bortezomib, lenalidomide, and dexamethasone (VRd) for patients (pts) with transplant-ineligible (TI) newly diagnosed multiple myeloma (NDMM): A focus on treatment efficacy and management/resolution of ocular events in the Phase 1 dreamm-9 study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Visual acuity; Multiple myeloma; Clinical endpoint; Dexamethasone; Dosing; Proportional hazards model; Hazard ratio; Logistic regression","score_opus":0.015564423951555112,"score_gpt":0.29107672760683256,"score_spread":0.27551230365527746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417002382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99066174,0.00023244826,0.00014454625,0.00020529963,0.000010768937,0.008569856,0.00007876789,0.000017920966,0.00007865061],"genre_scores_gemma":[0.997569,0.0003272077,0.00065146846,0.000031839765,0.0000071807535,0.0011379914,0.00020910945,0.000023640756,0.00004255341],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998158,0.0002059823,0.0003765935,0.00048711983,0.00040425605,0.00036805202],"domain_scores_gemma":[0.9988874,0.0005223812,0.00011189621,0.00031590334,0.00007077781,0.00009163564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031258498,0.0003030975,0.0005028574,0.00047907702,0.00009721612,0.000019322355,0.00009414225,0.000058845966,0.0000017624261],"category_scores_gemma":[0.00007184878,0.00018251583,0.00004440413,0.00045397444,0.00006310593,0.000083720355,0.000023873534,0.00011559225,6.1277956e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026655491,0.048699804,0.90014535,0.00025971778,0.00091368286,0.00033201682,0.0015062755,0.000014918764,0.00011560015,0.000046494843,0.000007385829,0.02130326],"study_design_scores_gemma":[0.30201682,0.013969622,0.6796248,0.00060732494,0.00070599024,0.000009618603,0.0005108446,0.00036986617,0.0020243349,0.000028638395,0.00001286071,0.00011928035],"about_ca_topic_score_codex":0.0010988673,"about_ca_topic_score_gemma":0.0021471537,"teacher_disagreement_score":0.27536133,"about_ca_system_score_codex":0.00010905417,"about_ca_system_score_gemma":0.00005153628,"threshold_uncertainty_score":0.74427795},"labels":[],"label_agreement":null},{"id":"W4417002423","doi":"10.1182/blood-2025-6434","title":"Diagnosis, management, and outcomes of tumor-associated erythrocytosis: A systematic review","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Systematic review; Renal cell carcinoma; Cohort; Retrospective cohort study; MEDLINE; Clear cell; Cohort study","score_opus":0.010060352941037883,"score_gpt":0.27333480496208185,"score_spread":0.26327445202104394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417002423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76954895,0.21555522,0.0000073195974,0.0031547432,0.00008330153,0.005464294,0.000042005533,0.0000987321,0.0060454123],"genre_scores_gemma":[0.94822747,0.04607679,0.00027291002,0.0027839637,0.0000055499236,0.0017967515,0.00001642944,0.000013438641,0.0008066894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988612,0.000075241296,0.0004875172,0.00022797906,0.00019452952,0.00015354181],"domain_scores_gemma":[0.9991739,0.00021420605,0.0001761467,0.00029440966,0.0000820187,0.000059350114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019589298,0.00016913262,0.0010782406,0.000105098974,0.00004650658,0.000010791405,0.00005786763,0.00003478806,0.000029420966],"category_scores_gemma":[0.00032817727,0.000121275596,0.00013070476,0.00025186114,0.00003229002,0.000029119976,0.000058948277,0.000058447586,0.000009505761],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000067616784,0.0022277914,0.72111094,0.26997814,0.0035071883,0.00007943045,0.000037931815,2.5942407e-8,0.000006043782,0.001601234,0.0013440057,0.0001005081],"study_design_scores_gemma":[0.0064052097,0.00027421792,0.67071116,0.3004013,0.018528974,0.000024687804,0.000096698146,0.0000022522286,0.00310602,0.0001670728,0.00011081021,0.00017158686],"about_ca_topic_score_codex":0.000014322515,"about_ca_topic_score_gemma":0.0000130881745,"teacher_disagreement_score":0.17867851,"about_ca_system_score_codex":0.000031578675,"about_ca_system_score_gemma":0.000026730655,"threshold_uncertainty_score":0.49454755},"labels":[],"label_agreement":null},{"id":"W4417002431","doi":"10.1182/blood-2025-6426","title":"Evaluation of the American society of hematology quality improvement training institute: Impact on learner quality improvement knowledge, confidence, and satisfaction","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Radiology practices and education","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Likert scale; Quality management; Scale (ratio); Multidisciplinary approach; Baseline (sea); Program evaluation; Quality (philosophy); Qualitative property","score_opus":0.09910246595239296,"score_gpt":0.45090347512502743,"score_spread":0.35180100917263446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417002431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965732,0.0002537986,0.00009212365,0.001280316,0.0002239924,0.00052482146,0.000005448713,0.0000088926945,0.0010373897],"genre_scores_gemma":[0.9993317,0.00010031069,0.00015606402,0.00025873457,0.000038095957,0.00003587212,0.0000059730482,0.000004040239,0.000069211084],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986331,0.00031183296,0.00044206198,0.00021133255,0.00027497832,0.0001266824],"domain_scores_gemma":[0.9985467,0.00021838088,0.0005821743,0.00029261457,0.00032500195,0.000035082285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027537039,0.00010366169,0.0003632311,0.000048792135,0.000076361976,0.000005289196,0.00004796065,0.00006506677,0.00001798069],"category_scores_gemma":[0.00052090635,0.00006910862,0.00012023442,0.00020709365,0.0002925554,0.00007229923,0.000027535856,0.00016627971,5.446818e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003264291,0.0013214459,0.3432912,0.00048431073,0.0012491001,9.721467e-8,0.0041732197,0.00006004732,0.21059583,0.0048311353,0.00042448068,0.4332427],"study_design_scores_gemma":[0.0022122087,0.0006735249,0.9673139,0.000089338144,0.00069777394,0.0000046795967,0.00386356,0.0002926665,0.024103507,0.0005939317,0.00009261127,0.00006230473],"about_ca_topic_score_codex":0.0019212394,"about_ca_topic_score_gemma":0.00017676225,"teacher_disagreement_score":0.62402266,"about_ca_system_score_codex":0.000109519715,"about_ca_system_score_gemma":0.00069816445,"threshold_uncertainty_score":0.29043522},"labels":[],"label_agreement":null},{"id":"W4417002464","doi":"10.1182/blood-2025-8027","title":"Test characteristics of end-of-treatment PET scans in diffuse large b-cell lymphoma in a population-level cohort","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Chemoimmunotherapy; Diffuse large B-cell lymphoma; Biopsy; Cohort; Lymphoma; False positive paradox; Retrospective cohort study","score_opus":0.011718566527138896,"score_gpt":0.2585494978111685,"score_spread":0.24683093128402958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417002464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974023,0.00024691486,0.000002513971,0.00009358163,0.00004874618,0.00053505664,0.00030535556,0.000010725904,0.0013548138],"genre_scores_gemma":[0.99877137,0.00026151934,0.00024197476,0.00005075708,0.000015371674,0.00011425809,0.00021749912,0.000011119765,0.00031611955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899286,0.000022725008,0.00045642682,0.00020758316,0.00012737274,0.00019305466],"domain_scores_gemma":[0.99935097,0.00016544673,0.00011338096,0.00027986223,0.000041502062,0.00004886633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007790263,0.00015050112,0.0004887833,0.00022193372,0.000015671376,0.0000045246993,0.000049745977,0.000053963668,0.00002131693],"category_scores_gemma":[0.00007744674,0.00012497931,0.00008221503,0.00026432326,0.000022242026,0.00002364082,0.00002940565,0.000024281146,0.0000041649914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004495561,0.05605414,0.9404172,0.00011480423,0.000098710996,0.00017111706,0.00013961972,2.5899794e-7,0.00036660294,0.00023083684,0.000012831812,0.002348933],"study_design_scores_gemma":[0.0420367,0.00036721348,0.94902676,0.00032112695,0.00032861557,0.000011895254,0.000035823945,0.000058898,0.0075842845,0.000023385863,0.00013066934,0.00007462941],"about_ca_topic_score_codex":0.0025626132,"about_ca_topic_score_gemma":0.0009254041,"teacher_disagreement_score":0.05568693,"about_ca_system_score_codex":0.00029076054,"about_ca_system_score_gemma":0.00023405103,"threshold_uncertainty_score":0.5096508},"labels":[],"label_agreement":null},{"id":"W4417002476","doi":"10.1182/blood-2025-8036","title":"Extranodal involvement of the gastrointestinal tract in post transplant lymphoproliferative disorders: Stomach or small bowel involvement increases mortality risk","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Alberta Cancer Foundation; University of Alberta","funders":"","keywords":"Post-transplant lymphoproliferative disorder; Gastrointestinal tract; Complication; Stomach; Transplantation; Stage (stratigraphy); Proportional hazards model; Lymphoproliferative disorders","score_opus":0.015263353679762528,"score_gpt":0.25936423781546075,"score_spread":0.24410088413569822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417002476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99630636,0.00071399246,0.00011542968,0.0005369442,0.000059326943,0.0010304681,0.00026512993,0.00003480464,0.00093754893],"genre_scores_gemma":[0.9984605,0.00037101517,0.00017842362,0.0006676743,0.000025096611,0.00010790349,0.00005760606,0.000016846463,0.000114979695],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981905,0.00017859972,0.0005555563,0.00035617987,0.00035130468,0.0003678182],"domain_scores_gemma":[0.9991546,0.000102188635,0.00020737585,0.0003431578,0.000100814876,0.00009181549],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003759948,0.00026021886,0.00042013053,0.00013040811,0.000108657085,0.000016289277,0.000196301,0.00007699729,0.00007562282],"category_scores_gemma":[0.00017029206,0.00017282543,0.00021780859,0.00041348286,0.00014430718,0.00005695273,0.000043012093,0.0002761825,0.0000011035828],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009771788,0.0055354196,0.989359,0.0002449948,0.0002191876,0.000035575962,0.0009014728,0.000045290537,0.0019000642,0.00009398301,0.000060264858,0.00062756304],"study_design_scores_gemma":[0.014284309,0.0009212687,0.97700554,0.00086826924,0.00084311544,0.00001571527,0.0024406966,0.00014997351,0.003001154,0.0002786135,0.000027285654,0.00016408639],"about_ca_topic_score_codex":0.0112902,"about_ca_topic_score_gemma":0.041279294,"teacher_disagreement_score":0.029989092,"about_ca_system_score_codex":0.0001568899,"about_ca_system_score_gemma":0.00085805164,"threshold_uncertainty_score":0.9952937},"labels":[],"label_agreement":null},{"id":"W4417002560","doi":"10.1182/blood-2025-519","title":"WM-voice: An international discrete choice experiment on treatment preferences in 1,455 patients with Waldenström macroglobulinemia","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; Mining Association of Canada","funders":"","keywords":"Logit; Preference; Mixed logit; Choice set; Discrete choice; Set (abstract data type); Duration (music); Logistic regression","score_opus":0.016147797973792538,"score_gpt":0.33228748791516205,"score_spread":0.31613968994136954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417002560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886148,0.00009746001,0.0000041125627,0.00026640313,0.00012071121,0.0006853575,0.00002449113,0.000040786737,0.010145897],"genre_scores_gemma":[0.9972606,0.00005129911,0.0003550834,0.00013375086,0.00010528902,0.00016584017,0.00016645162,0.000015630392,0.0017460726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844944,0.000043454318,0.00024199947,0.00043468288,0.00052637706,0.00030406064],"domain_scores_gemma":[0.9992262,0.00008757076,0.00004793295,0.00041719284,0.00009170375,0.00012936699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006440256,0.00020193713,0.00024715482,0.00017377087,0.000042313408,0.000039015635,0.00019602058,0.00007847042,0.0001284619],"category_scores_gemma":[0.000064865824,0.00013161341,0.000043107266,0.00019491378,0.000068461835,0.00009367067,0.000065604356,0.00013397222,0.00003263659],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038380024,0.01786398,0.9288389,0.00014478693,0.0011296138,0.00042711143,0.001833384,0.00011068641,0.00097030395,0.00047021272,0.0002934235,0.044079583],"study_design_scores_gemma":[0.20650907,0.0062556644,0.7188283,0.0012240747,0.0003075152,0.000029109384,0.00046491105,0.0016784365,0.05666615,0.0000723534,0.0074946526,0.0004697517],"about_ca_topic_score_codex":0.0011198232,"about_ca_topic_score_gemma":0.0004230183,"teacher_disagreement_score":0.2100106,"about_ca_system_score_codex":0.0048048794,"about_ca_system_score_gemma":0.0016074061,"threshold_uncertainty_score":0.9990155},"labels":[],"label_agreement":null},{"id":"W4417002683","doi":"10.1182/blood-2025-6872","title":"“upfront use of blinatumomab in adolescents and adults with Philadelphia Chromosome–Negative B-cell acute lymphoblastic leukemia: A systematic review and proportional meta-analysis”","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Blinatumomab; Minimal residual disease; Acute lymphocytic leukemia; Meta-analysis; Lymphoblastic Leukemia; Randomized controlled trial; Clinical trial; Young adult","score_opus":0.018786508668547593,"score_gpt":0.27137321041589235,"score_spread":0.25258670174734477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417002683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9057483,0.08196325,0.0006409553,0.0017444284,0.000024993466,0.009408882,0.00023375888,0.0000733157,0.0001621381],"genre_scores_gemma":[0.99660254,0.0014059093,0.00076749333,0.00043896574,0.000008360799,0.000349624,0.000031182237,0.00002450937,0.0003714237],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99713844,0.0002109902,0.0009664,0.00063053047,0.00070085016,0.00035281145],"domain_scores_gemma":[0.99817723,0.00027315938,0.0003971615,0.0005356105,0.00042943915,0.00018740188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040563446,0.00035568577,0.0026526093,0.0006201598,0.000048793674,0.00002976876,0.0001430475,0.00013626805,0.000024151066],"category_scores_gemma":[0.00053205097,0.00022861514,0.00027668738,0.0015140922,0.00027323441,0.00016474431,0.00016279718,0.0002756585,0.0000034100644],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001537559,0.003437737,0.013851858,0.8023488,0.1755623,0.0013166426,0.000503874,0.000038715152,0.00092943205,0.00016500818,0.00029754304,0.0000105181725],"study_design_scores_gemma":[0.023453828,0.0009168162,0.0146726,0.061686322,0.8928775,0.0005521947,0.0001585215,0.0026611255,0.002570724,0.00003848678,0.000002102559,0.00040974354],"about_ca_topic_score_codex":0.00014832521,"about_ca_topic_score_gemma":0.00009410058,"teacher_disagreement_score":0.74066246,"about_ca_system_score_codex":0.000360802,"about_ca_system_score_gemma":0.0012113806,"threshold_uncertainty_score":0.93226546},"labels":[],"label_agreement":null},{"id":"W4417002713","doi":"10.1182/blood-2025-7363","title":"Artificial intelligence‑driven virtual tumor board enhances precision care in myelodysplastic syndromes (MDS)","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Myelodysplastic syndromes; Context (archaeology); Clinical trial; Multidisciplinary approach; Domain (mathematical analysis); Disease; Clinical decision support system; Clinical decision making","score_opus":0.017872736738031067,"score_gpt":0.3092670765136607,"score_spread":0.2913943397756296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417002713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99354815,0.0007821933,0.000750622,0.0004440203,0.0002942936,0.00066488853,0.000014292375,0.00008584841,0.0034157024],"genre_scores_gemma":[0.99758583,0.00011573118,0.0010036585,0.00013173284,0.00015747912,0.00008779225,0.000026189926,0.000023926274,0.00086764945],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979271,0.000099866105,0.0004987462,0.00051044323,0.00048437814,0.00047944344],"domain_scores_gemma":[0.9988234,0.0004214045,0.000057469893,0.00040570193,0.0001542921,0.00013774175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022128371,0.00021880449,0.00045088906,0.00055235514,0.00008794594,0.00004543106,0.00029933726,0.0001401279,0.00019888562],"category_scores_gemma":[0.000825498,0.00019075809,0.00010076457,0.0008314732,0.00015194734,0.00009627809,0.00020757572,0.00053436885,0.00029380753],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056425747,0.0050052158,0.08123598,0.0022297134,0.0010939076,0.0073497505,0.010206406,0.0008257103,0.21652827,0.010735539,0.0033294677,0.65581745],"study_design_scores_gemma":[0.0050462442,0.004374626,0.07325631,0.004243064,0.00078369345,0.00033161844,0.016297935,0.0043535284,0.88178444,0.003389235,0.0050755227,0.0010638018],"about_ca_topic_score_codex":0.00009621009,"about_ca_topic_score_gemma":0.00022247525,"teacher_disagreement_score":0.66525614,"about_ca_system_score_codex":0.0002648343,"about_ca_system_score_gemma":0.00075582805,"threshold_uncertainty_score":0.7778889},"labels":[],"label_agreement":null},{"id":"W4417002787","doi":"10.1182/blood-2025-1420","title":"Efficacy and safety of pozelimab plus cemdisiran versus ravulizumab in patients with paroxysmal nocturnal hemoglobinuria who received prior C5 therapy","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Phases of clinical research; Monoclonal antibody; Clinical trial; Lactate dehydrogenase; Drug holiday","score_opus":0.009386905569112081,"score_gpt":0.2368386501938044,"score_spread":0.2274517446246923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417002787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99506116,0.0029162373,0.000006344475,0.00007567628,0.00029122733,0.0008692129,0.00007258646,0.000029050909,0.0006784914],"genre_scores_gemma":[0.99955755,0.00007606041,0.000043010463,0.000032736956,0.000010688839,0.000021690636,0.000089129644,0.000012224289,0.00015692487],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870986,0.00021323141,0.00041265355,0.00031639432,0.00005968498,0.0002881537],"domain_scores_gemma":[0.99921525,0.00021615757,0.00015653596,0.00031399596,0.00007466396,0.000023426763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000114888244,0.00020316557,0.00042456374,0.00013153082,0.00010066821,0.000011514488,0.00020929928,0.00011402326,0.00020128912],"category_scores_gemma":[0.000059251208,0.00016327399,0.000051100902,0.0001875686,0.00014518888,0.00005338512,0.00008402341,0.00014934545,0.000008626432],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1017516,0.0038157785,0.86577976,0.00021878249,0.00214459,0.000011568865,0.0014713816,0.000029447934,0.0075443806,0.0003609144,0.00085313624,0.016018678],"study_design_scores_gemma":[0.11950689,0.0008825641,0.87318665,0.00023994537,0.00011911149,0.0000023374187,0.000115981224,0.0000010191719,0.0043842327,0.000015045753,0.0013793578,0.0001668844],"about_ca_topic_score_codex":0.00006969198,"about_ca_topic_score_gemma":0.000051166244,"teacher_disagreement_score":0.017755287,"about_ca_system_score_codex":0.00005024762,"about_ca_system_score_gemma":0.00013891199,"threshold_uncertainty_score":0.665812},"labels":[],"label_agreement":null},{"id":"W4417002867","doi":"10.1182/blood-2025-2537","title":"Long-term follow-up demonstrates durable clinical benefits of exagamglogene autotemcel for sickle cell disease with recurrent vaso-occlusive crises: Final results of climb SCD-121","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Clinical endpoint; Climb; Clinical trial; Sickle cell anemia; Phases of clinical research; Anemia; Disease","score_opus":0.027980406615791185,"score_gpt":0.3024700431906813,"score_spread":0.2744896365748901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417002867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98785484,0.007222699,0.00012541204,0.00058490987,0.00039396138,0.0012562667,0.00044312509,0.000044609806,0.0020741695],"genre_scores_gemma":[0.9950083,0.0019741026,0.000840768,0.00012734336,0.00008337395,0.00004829662,0.0001995177,0.000030402707,0.0016878801],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975897,0.00007498959,0.0010805783,0.0005395183,0.00029768236,0.00041755234],"domain_scores_gemma":[0.9979349,0.00037744574,0.00041615174,0.00054633484,0.00043675175,0.00028846148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039574705,0.00028368278,0.0007556922,0.00015357567,0.00011113733,0.000012301765,0.00019359785,0.0002463633,0.000022629838],"category_scores_gemma":[0.00045052072,0.00021600082,0.00037403213,0.00038079903,0.00025846297,0.000056062865,0.000084009,0.0002724486,0.0000043321534],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04495659,0.026808007,0.8774557,0.009823326,0.002631939,0.00031086634,0.0007990561,0.000573547,0.006308925,0.0007333538,0.0080990605,0.021499606],"study_design_scores_gemma":[0.1615269,0.013603635,0.6848567,0.010881258,0.013469413,0.00005495626,0.001431181,0.0006192597,0.110792466,0.00039856377,0.0012223731,0.0011432648],"about_ca_topic_score_codex":0.0000321612,"about_ca_topic_score_gemma":0.00004860519,"teacher_disagreement_score":0.192599,"about_ca_system_score_codex":0.00002206841,"about_ca_system_score_gemma":0.00088758697,"threshold_uncertainty_score":0.88082576},"labels":[],"label_agreement":null},{"id":"W4417002922","doi":"10.1182/blood-2025-3069","title":"Perioperative use of efanesoctocog alfa in Hemophilia A: A dual-center real-world study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Perioperative; Hemostasis; Dosing; Factor IX; Von Willebrand disease; Clinical trial; Von Willebrand factor","score_opus":0.042575186475233874,"score_gpt":0.3526610773152532,"score_spread":0.3100858908400193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417002922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881372,0.00009032331,3.5880382e-7,0.000864128,0.000045402005,0.0017620034,0.000011049013,0.00002413332,0.009065429],"genre_scores_gemma":[0.9654956,0.00006790474,0.000110868794,0.00008186583,0.00003902501,0.00013276922,0.000017697612,0.000013310975,0.034040976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987477,0.00011036267,0.00032434246,0.00028927837,0.00027234794,0.0002559798],"domain_scores_gemma":[0.9993122,0.00010773215,0.00003193051,0.0003519492,0.00011858843,0.00007758787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001738086,0.00015245365,0.00041810097,0.000401938,0.000044137832,0.000018246155,0.0000607815,0.00005693908,0.000118208],"category_scores_gemma":[0.00009875137,0.00011098976,0.000082714876,0.0006646689,0.000079648744,0.000068159534,0.00008821186,0.00020393364,0.000027530656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002819991,0.009386443,0.98380816,0.000092264694,0.00031760172,0.00063784607,0.0013058917,8.3676275e-7,0.0031052553,0.00026769371,0.0002233708,0.0005726515],"study_design_scores_gemma":[0.021138102,0.0008731823,0.96017003,0.0003652577,0.00026314813,0.000015388669,0.00070924486,0.00003328797,0.013427801,0.000022539476,0.0028439697,0.0001380568],"about_ca_topic_score_codex":0.00081272714,"about_ca_topic_score_gemma":0.0011082067,"teacher_disagreement_score":0.024975548,"about_ca_system_score_codex":0.00007345728,"about_ca_system_score_gemma":0.00016106437,"threshold_uncertainty_score":0.4526031},"labels":[],"label_agreement":null},{"id":"W4417003224","doi":"10.1182/blood-2025-852","title":"Clinical outcomes associated with serological subsets of heparin-induced thrombocytopenia","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"","keywords":"Heparin-induced thrombocytopenia; Platelet; Serology; Platelet factor 4; Heparin; Platelet activation; Retrospective cohort study; Thrombosis; Venous thrombosis","score_opus":0.05612397568639335,"score_gpt":0.3560546389737495,"score_spread":0.2999306632873562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417003224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97699434,0.00003779517,0.000018099132,0.000955929,0.00022938187,0.0007219652,0.000013797124,0.00018018585,0.020848492],"genre_scores_gemma":[0.99737734,0.000038661903,0.00059053005,0.0009850285,0.000046775865,0.000035629673,0.000040139887,0.000034973993,0.0008509179],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971477,0.00024811755,0.0009993423,0.0006461967,0.00041715184,0.00054151716],"domain_scores_gemma":[0.9977599,0.0006053868,0.0002863923,0.00080892915,0.00028679005,0.00025262043],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007399398,0.0003753849,0.0019489102,0.0001764179,0.000116918556,0.000025834552,0.00032694545,0.0005155774,0.0002017127],"category_scores_gemma":[0.0009694614,0.00026284694,0.00039031968,0.0006743285,0.0002469251,0.00010199412,0.00019497698,0.00063971436,0.0000622144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019923924,0.0035746475,0.98006153,0.00005011867,0.0022272305,0.00008553674,0.000053111686,2.999549e-7,0.011407156,0.0015892957,0.00015131565,0.00060049817],"study_design_scores_gemma":[0.010461973,0.001219279,0.9654172,0.00024897052,0.0016645589,0.0000226527,0.000047429578,0.0000095443,0.020239433,0.0002231238,0.00019829278,0.0002475657],"about_ca_topic_score_codex":0.00012402257,"about_ca_topic_score_gemma":0.00022684265,"teacher_disagreement_score":0.020382987,"about_ca_system_score_codex":0.000056967136,"about_ca_system_score_gemma":0.00047879972,"threshold_uncertainty_score":0.99998236},"labels":[],"label_agreement":null},{"id":"W4417003774","doi":"10.1182/blood-2025-3078","title":"Acquired hemophilia a results from a provincial registry highlight the need for improvement of clinical outcomes and bypassing agent use","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Providence Health Care; University of Toronto; University of British Columbia","funders":"","keywords":"Bleed; Medical record; Patient registry; Hemarthrosis; Hemostasis; Thrombosis; Disease; Concomitant","score_opus":0.06070205851508116,"score_gpt":0.3653962882053567,"score_spread":0.30469422969027554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417003774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98380244,0.00016494324,0.000023509354,0.013885251,0.00019504625,0.0013777451,0.00018241256,0.000027630744,0.00034104846],"genre_scores_gemma":[0.99136215,0.000072629344,0.0010260162,0.00037319012,0.00022460188,0.00007334674,0.00007069717,0.000012383011,0.0067850016],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984516,0.000050002196,0.0006612105,0.00034759514,0.0002597,0.00022988136],"domain_scores_gemma":[0.99815786,0.00096782425,0.00015362089,0.0005028455,0.00011564145,0.00010220382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049850804,0.00014340585,0.00045884834,0.00006132203,0.00011603893,0.000038518217,0.00011392403,0.00013851095,0.0000047563226],"category_scores_gemma":[0.0015258751,0.00007880961,0.00017661392,0.00011202992,0.00018198817,0.00004270046,0.00011913859,0.000108845205,0.0000012332014],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009344725,0.005441425,0.8590442,0.00050163147,0.003433589,0.000143257,0.00078453287,3.018216e-7,0.067001216,0.0006286707,0.009912456,0.04376399],"study_design_scores_gemma":[0.05088795,0.0015386991,0.86738396,0.00040611206,0.0017069023,0.0000040688406,0.0002602573,0.00016279776,0.06716506,0.000505248,0.009789915,0.00018903032],"about_ca_topic_score_codex":0.00033130185,"about_ca_topic_score_gemma":0.00004994544,"teacher_disagreement_score":0.04357496,"about_ca_system_score_codex":0.0000241882,"about_ca_system_score_gemma":0.00031650258,"threshold_uncertainty_score":0.32137626},"labels":[],"label_agreement":null},{"id":"W4417004071","doi":"10.1182/blood-2025-1800","title":"Promising response rates and manageable safety with mosunetuzumab plus lenalidomide (Mosun-Len) in patients with relapsed/refractory (R/R) follicular lymphoma (FL): US extension cohort from the Phase III CELESTIMO study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Lenalidomide; Follicular lymphoma; Cohort; Adverse effect; Rituximab; Common Terminology Criteria for Adverse Events; Cytokine release syndrome; Phases of clinical research","score_opus":0.006508503620268719,"score_gpt":0.241098801781042,"score_spread":0.2345902981607733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417004071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942157,0.0016144754,0.000023734505,0.0002933168,0.000052691088,0.003559151,0.000031574986,0.000059496717,0.00014982288],"genre_scores_gemma":[0.9984251,0.00009675519,0.00040718575,0.00032543796,0.00002474194,0.00025270082,0.0001047771,0.000041476877,0.00032180655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99763715,0.0003081316,0.0004659818,0.0007442606,0.00047667735,0.00036782344],"domain_scores_gemma":[0.99827164,0.00050947716,0.00017353964,0.00077477645,0.0001377432,0.00013284468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048900064,0.0003915401,0.0007017374,0.00013895117,0.00029085917,0.00007865665,0.00012269654,0.000100064164,0.00001526921],"category_scores_gemma":[0.00011421617,0.00022237109,0.00005816291,0.00041357032,0.00011855891,0.00015774505,0.00010452345,0.00013123927,0.0000043169625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050918855,0.012355743,0.9292165,0.000029200119,0.0012124605,0.0012714145,0.0006610646,0.000046421108,0.00012711226,0.0000086516575,0.00012741466,0.0040251575],"study_design_scores_gemma":[0.18280922,0.0029739393,0.8091445,0.00079208094,0.0017970826,0.000017513908,0.00048630993,0.00010741944,0.001233422,0.000008722096,0.00042205706,0.00020771529],"about_ca_topic_score_codex":0.0023444619,"about_ca_topic_score_gemma":0.00038752804,"teacher_disagreement_score":0.13189036,"about_ca_system_score_codex":0.0003961586,"about_ca_system_score_gemma":0.0004278731,"threshold_uncertainty_score":0.90680295},"labels":[],"label_agreement":null},{"id":"W4417004073","doi":"10.1182/blood-2025-1801","title":"Phase 2 bellwave-003 cohort f: Updated clinical outcomes of nemtabrutinib in participants with relapsed or refractory marginal zone lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Ibrutinib; Chronic lymphocytic leukemia; Mantle cell lymphoma; Cohort; Bruton's tyrosine kinase; Idelalisib; Refractory (planetary science); Phases of clinical research; Bendamustine; Follicular lymphoma","score_opus":0.036017164921138274,"score_gpt":0.3636572974253188,"score_spread":0.32764013250418056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417004073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961944,0.00031117478,0.0000085589045,0.0004998148,0.00013585975,0.0007455088,0.000034928693,0.000050964438,0.0020187541],"genre_scores_gemma":[0.9968127,0.00020887393,0.0006885018,0.0005208919,0.00003230381,0.000104309715,0.000090064765,0.000021776515,0.0015205962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978287,0.00012169675,0.00088216877,0.0004427513,0.00031182656,0.00041280666],"domain_scores_gemma":[0.99859023,0.0003558617,0.00020892639,0.00056254707,0.00008969633,0.00019273252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042776432,0.00024908638,0.0009762894,0.00017201647,0.000042825737,0.000010427479,0.00010384074,0.00016414227,0.00018840651],"category_scores_gemma":[0.0002466068,0.00015742838,0.00014180891,0.00044469652,0.00015187073,0.00005809133,0.00005379973,0.00011191397,0.000024778548],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035331564,0.03685952,0.9479028,0.00005353287,0.0014107575,0.0011640262,0.00006319599,4.2321935e-7,0.00013170038,0.00010412748,0.000851362,0.00792542],"study_design_scores_gemma":[0.10013978,0.0028423064,0.88667154,0.0002890221,0.0017410853,0.000032197677,0.00007636312,0.00002273535,0.0051090284,0.0000077450595,0.0029259517,0.00014223429],"about_ca_topic_score_codex":0.00025225006,"about_ca_topic_score_gemma":0.00020979157,"teacher_disagreement_score":0.09660663,"about_ca_system_score_codex":0.00009252902,"about_ca_system_score_gemma":0.00068027887,"threshold_uncertainty_score":0.6419743},"labels":[],"label_agreement":null},{"id":"W4417004100","doi":"10.1182/blood-2025-3066","title":"Management of breakthrough bleeds in participants with hemophilia Α or Β without inhibitors receiving marstacimab prophylaxis in the phase 3 BASIS study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Bleed; Concomitant; Observational study; Breakthrough bleeding; Phases of clinical research; Adverse effect; Clinical trial; Hemarthrosis","score_opus":0.038624657115432455,"score_gpt":0.35639151807174957,"score_spread":0.3177668609563171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417004100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931991,0.00016366693,0.000002786065,0.0007676321,0.00003065061,0.0027249234,0.0000037457883,0.00001975018,0.0030877423],"genre_scores_gemma":[0.9975708,0.00006699079,0.00026902868,0.000038876333,0.000023026492,0.00034479215,0.0000044763797,0.000016762893,0.0016652598],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980736,0.00017978175,0.00043072438,0.00035236657,0.000531019,0.0004325308],"domain_scores_gemma":[0.9992322,0.00009859838,0.00005802056,0.0004997924,0.00005500948,0.000056419558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077086996,0.00019221121,0.00043391183,0.0003313553,0.000056839035,0.000021099606,0.00017687991,0.000060476745,0.00004138368],"category_scores_gemma":[0.00003385229,0.00009990824,0.00004646347,0.0016098191,0.00010086857,0.00007065545,0.00008755402,0.00024968915,0.000004996914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022793193,0.02252873,0.95215714,0.0006238301,0.0006775775,0.00210997,0.004718512,0.0000027058484,0.00035537957,0.000025895266,0.00002848894,0.014492431],"study_design_scores_gemma":[0.11471391,0.016512636,0.7928748,0.0044829566,0.0021375534,0.000057964768,0.041757416,0.000116289986,0.026540732,0.00010751027,0.00025275373,0.0004454509],"about_ca_topic_score_codex":0.00022377247,"about_ca_topic_score_gemma":0.0004671306,"teacher_disagreement_score":0.15928234,"about_ca_system_score_codex":0.000069699025,"about_ca_system_score_gemma":0.00014365988,"threshold_uncertainty_score":0.40741396},"labels":[],"label_agreement":null},{"id":"W4417004116","doi":"10.1182/blood-2025-1805","title":"Long-term outcomes of patients with hairy cell leukemia treated with first-line cladribine in British Columbia","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Cladribine; Hairy cell leukemia; Purine analogue; Rituximab; Cancer; Leukemia; Alemtuzumab; Monoclonal","score_opus":0.008816306317654938,"score_gpt":0.24396355938512118,"score_spread":0.23514725306746626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417004116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99727184,0.00022217486,0.000014265996,0.000045066172,0.000023671806,0.001020599,0.000044848315,0.000054776356,0.0013027893],"genre_scores_gemma":[0.9924702,0.00007002121,0.00022518584,0.000091189984,0.00001816775,0.000058538382,0.0001659709,0.00003907781,0.0068616304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981733,0.000034209148,0.00042155376,0.00041981786,0.00051701686,0.00043412118],"domain_scores_gemma":[0.998831,0.00015214251,0.00010522775,0.000530222,0.00025073378,0.00013069637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010367584,0.0001718263,0.0006280836,0.00014363907,0.00005190076,0.00004852196,0.00017382292,0.00013924476,0.00015221981],"category_scores_gemma":[0.0000917553,0.00017760847,0.000064233216,0.0006892738,0.00018382262,0.00007157197,0.000092066184,0.00023960417,0.0000068948625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040564474,0.0025741553,0.99382085,0.0008031069,0.00023908554,0.00070542004,0.000041386116,0.000017482409,0.000024302217,5.858061e-7,0.00037137675,0.0009965913],"study_design_scores_gemma":[0.1154414,0.0008555987,0.8807279,0.0010985533,0.00028604822,0.000030164445,0.000016252932,0.000084851505,0.0012712167,0.0000025703675,0.000033807017,0.00015166274],"about_ca_topic_score_codex":0.02895307,"about_ca_topic_score_gemma":0.21156837,"teacher_disagreement_score":0.1826153,"about_ca_system_score_codex":0.002833739,"about_ca_system_score_gemma":0.0042074225,"threshold_uncertainty_score":0.9775132},"labels":[],"label_agreement":null},{"id":"W4417004176","doi":"10.1182/blood-2025-3338","title":"Comparison of simulated exposure of inotuzumab ozogamicin with and without dose capping in overweight and obese patients with relapsed/refractory acute lymphoblastic leukemia","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Body surface area; Regimen; Dosing; Pharmacokinetics; Phases of clinical research; Population; Antibody-drug conjugate; Acute lymphocytic leukemia; Antibody","score_opus":0.008184380537076581,"score_gpt":0.2727083277999659,"score_spread":0.2645239472628893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417004176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99809307,0.0005996502,0.00009604233,0.000019437446,0.000021437323,0.0007420535,0.00002294364,0.000026302847,0.00037907352],"genre_scores_gemma":[0.9990108,0.00006578798,0.00067708746,0.000039497027,0.0000109127695,0.000009721164,0.00003057383,0.000034866825,0.000120729674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980285,0.00007796506,0.0005733144,0.00043700822,0.0005309621,0.00035223347],"domain_scores_gemma":[0.9986256,0.00029784712,0.0002502528,0.0003979713,0.00028518258,0.0001431885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014063672,0.00028683714,0.000914538,0.00045856193,0.000047221125,0.000013017122,0.000117293705,0.00019687899,0.0000081573235],"category_scores_gemma":[0.00014926083,0.00020604047,0.000029091569,0.0006441052,0.00038346133,0.00012939557,0.00013558331,0.00031895275,7.052295e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004454223,0.0011899535,0.9829204,0.00081010157,0.0006132717,0.000050774674,0.0012455453,0.00019568135,0.007848919,0.000030391846,0.000023558152,0.00061719306],"study_design_scores_gemma":[0.07237857,0.004173816,0.8976741,0.0033403456,0.0010209657,0.000034607896,0.00041478177,0.005535115,0.015125852,0.000019198045,0.000024089633,0.00025860424],"about_ca_topic_score_codex":0.0003150308,"about_ca_topic_score_gemma":0.00009809909,"teacher_disagreement_score":0.08524633,"about_ca_system_score_codex":0.0004158958,"about_ca_system_score_gemma":0.0011517053,"threshold_uncertainty_score":0.84020865},"labels":[],"label_agreement":null},{"id":"W4417004318","doi":"10.1182/blood-2025-5410","title":"Impact of DUSP22 and TP63 rearrangements in patients with ALK-negative ALCL treated with frontline BV-CH(E)P","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Population; Chemotherapy; Chemotherapy regimen; Retrospective cohort study; Lymphoma; Survival analysis; Gene rearrangement; Progression-free survival; Disease; Stage (stratigraphy)","score_opus":0.004704925180450714,"score_gpt":0.24157327475217577,"score_spread":0.23686834957172506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417004318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959486,0.00018148306,0.0000017004319,0.000073148,0.0000067303727,0.00064946595,0.000049715967,0.000015297454,0.0030738576],"genre_scores_gemma":[0.9992184,0.000035286306,0.00036350248,0.00004226642,0.000006728831,0.000046767276,0.000067409004,0.000012248541,0.00020740555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99923956,0.000024034533,0.00017535269,0.00023019865,0.00016615997,0.00016469196],"domain_scores_gemma":[0.9995121,0.000040704217,0.000074990654,0.00020335276,0.00009975362,0.00006913626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000036223766,0.00016474664,0.00035228935,0.00013664142,0.00002286578,0.0000075632474,0.000030709198,0.000044764143,0.0000337259],"category_scores_gemma":[0.000021468144,0.00009370827,0.000037366055,0.00025060383,0.000053591626,0.000048605976,0.000020665693,0.000044906516,0.0000019078027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013848079,0.005005022,0.98984903,0.00003333673,0.0010287893,0.000048180907,0.00017815611,0.0000019703502,0.00004947556,0.000009761998,0.00013338147,0.0022780758],"study_design_scores_gemma":[0.042820286,0.003533155,0.9498562,0.00048198714,0.00059844926,0.0000026067962,0.00003337903,0.000006646114,0.0025604258,0.000011005694,0.00001555009,0.00008027768],"about_ca_topic_score_codex":0.0011289549,"about_ca_topic_score_gemma":0.00014389121,"teacher_disagreement_score":0.041435476,"about_ca_system_score_codex":0.000084214465,"about_ca_system_score_gemma":0.00007466561,"threshold_uncertainty_score":0.38213125},"labels":[],"label_agreement":null},{"id":"W4417004439","doi":"10.1182/blood-2025-630","title":"Germline genetic testing uncovers a high frequency of inborn error of immunity diagnoses in children with single and multi-lineage immune cytopenias in a large US cohort","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Autoimmune hemolytic anemia; Genetic testing; Newborn screening; Primary immunodeficiency; Immune system; Neutropenia; Autoimmunity; Common variable immunodeficiency","score_opus":0.0070472739724126605,"score_gpt":0.2287768962772888,"score_spread":0.22172962230487614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417004439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941033,0.0053099114,0.00003416844,0.000007493344,0.000010156574,0.00038213033,0.00008078714,0.0000038473013,0.000068212736],"genre_scores_gemma":[0.99562424,0.00014615382,0.004045321,0.000021427986,0.000005127776,0.000033661712,0.00009704788,0.000012012449,0.000015003917],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991788,0.000054235028,0.00029885035,0.00023430724,0.000061373394,0.00017238688],"domain_scores_gemma":[0.9995284,0.000026047195,0.00011678782,0.0002539787,0.000052449926,0.000022329703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009633363,0.00014268674,0.00027490416,0.00008437464,0.000024919858,0.000005719166,0.0001080512,0.00009228622,0.0000022774527],"category_scores_gemma":[0.00013429254,0.00012727384,0.000030318495,0.00025576534,0.000072284936,0.0000044867274,0.000111154266,0.00007596508,1.3228805e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034127475,0.0024928688,0.92654,0.000032939493,0.00020670204,0.000008803711,0.000028842705,0.000031407944,0.07021619,0.0000040315317,4.5553685e-7,0.00040361632],"study_design_scores_gemma":[0.006595263,0.00033077167,0.8221801,0.000093380775,0.00010304503,0.0000063428784,0.000030811774,0.000012595348,0.17054273,0.000010626592,9.945836e-7,0.000093368304],"about_ca_topic_score_codex":0.004164773,"about_ca_topic_score_gemma":0.0031388702,"teacher_disagreement_score":0.104359955,"about_ca_system_score_codex":0.000006659984,"about_ca_system_score_gemma":0.00008358707,"threshold_uncertainty_score":0.6295919},"labels":[],"label_agreement":null},{"id":"W4417004453","doi":"10.1182/blood-2025-6299","title":"PET imaging biomarkers predict survival in peripheral T-cell lymphoma: A systematic review and meta-analysis.","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Hazard ratio; Interim; Meta-analysis; Prospective cohort study; Positron emission tomography; Lymphoma; Pet imaging; Clinical trial; Imaging biomarker","score_opus":0.014393939488430254,"score_gpt":0.26696360743330244,"score_spread":0.2525696679448722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417004453","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17649707,0.80484223,0.000022457109,0.004609121,0.00006201405,0.003199018,0.000060395007,0.0000910727,0.010616602],"genre_scores_gemma":[0.9944869,0.0027740165,0.0002310374,0.0012021761,0.00000650708,0.0004531843,0.000028497247,0.000011331927,0.00080629456],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9985269,0.00017824695,0.0005161542,0.00035940556,0.00020735967,0.00021196298],"domain_scores_gemma":[0.9991935,0.00012534439,0.000108368244,0.00043297966,0.00004968455,0.00009012981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046590937,0.0002199679,0.0019934056,0.00022385606,0.000040019593,0.000033714354,0.00007400866,0.000025594647,0.00008164042],"category_scores_gemma":[0.00008742121,0.00014473163,0.0006007652,0.00067710783,0.000036547408,0.00004760805,0.000049896717,0.000032538926,0.000005876445],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004250568,0.007042478,0.31533322,0.27340636,0.40117523,0.0017236385,0.0001536173,0.0000012676165,0.000060293853,0.0001962096,0.0008099435,0.000055236516],"study_design_scores_gemma":[0.0063445102,0.000042149073,0.030356908,0.001925594,0.96075773,0.00008806386,0.00009241084,0.000092004295,0.00012660668,0.0000115498,0.000030524316,0.00013194245],"about_ca_topic_score_codex":0.00022717504,"about_ca_topic_score_gemma":0.00006036977,"teacher_disagreement_score":0.8179899,"about_ca_system_score_codex":0.000086411965,"about_ca_system_score_gemma":0.000096274845,"threshold_uncertainty_score":0.59019846},"labels":[],"label_agreement":null},{"id":"W4417004462","doi":"10.1182/blood-2025-738","title":"End-of-study results from the ICON3 pines trial, a phase 3, randomized trial of eltrombopag vs. standard first-line treatment for newly diagnosed immune thrombocytopenia in children","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Eltrombopag; Rituximab; Clinical endpoint; Randomized controlled trial; Romiplostim; Immune thrombocytopenia; Intention-to-treat analysis; Randomization","score_opus":0.02170483454182572,"score_gpt":0.32504948372879,"score_spread":0.3033446491869643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417004462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97615117,0.0020773092,0.00002416347,0.00094217854,0.00021601403,0.018810205,0.001620991,0.000025410165,0.00013253164],"genre_scores_gemma":[0.99603873,0.0014178732,0.00024227651,0.000040908697,0.00012035494,0.0012986613,0.0007220274,0.000022635577,0.00009653578],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9974425,0.0002441346,0.0013609376,0.00042398262,0.00026933654,0.0002591396],"domain_scores_gemma":[0.9964648,0.0023050338,0.00043973824,0.00064342323,0.00009515524,0.00005184211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072919694,0.00032268366,0.002635001,0.00014002302,0.00008794887,0.00001927045,0.00017924658,0.00010518637,0.000032548316],"category_scores_gemma":[0.0013618928,0.0001879504,0.00052074285,0.00028340184,0.00012211548,0.00004692362,0.000044205102,0.000093295246,0.0000011786527],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9542892,0.03448644,0.0020977936,0.000014040388,0.004106205,0.000047536534,0.0008292419,0.000003324316,0.00020133721,0.000017804481,0.000107119915,0.003799948],"study_design_scores_gemma":[0.96688217,0.01807239,0.0028994395,0.00020310355,0.0045293286,0.0000021886349,0.000136988,0.000019068939,0.0066948417,0.00024665776,0.00018875941,0.00012507332],"about_ca_topic_score_codex":0.0051825168,"about_ca_topic_score_gemma":0.0010046737,"teacher_disagreement_score":0.019887531,"about_ca_system_score_codex":0.000055284952,"about_ca_system_score_gemma":0.00033079146,"threshold_uncertainty_score":0.783445},"labels":[],"label_agreement":null},{"id":"W4417004472","doi":"10.1182/blood-2025-1141","title":"High morbidity in adults with non-transfusion-dependent thalassemia referred to u.S. specialty centers","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Thalassemia; Specialty; Referral; Splenectomy; Blood transfusion; Hemoglobinopathy","score_opus":0.005005289355613819,"score_gpt":0.2291504231281121,"score_spread":0.22414513377249828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417004472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802937,0.0001260905,0.00007466982,0.0026414157,0.0003158571,0.0007636465,0.000012872083,0.000054313194,0.015717437],"genre_scores_gemma":[0.99749637,0.00047188616,0.00033937476,0.0006790011,0.000068861744,0.000030471634,0.000024975658,0.00001793747,0.00087115075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877656,0.000023881408,0.00026035457,0.00036413054,0.00025527325,0.00031982842],"domain_scores_gemma":[0.9994176,0.000020132564,0.000031115607,0.00031703696,0.000056048928,0.00015805941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010573699,0.00017445021,0.00030920713,0.00019456237,0.00005450289,0.000012585618,0.0001052911,0.0001572961,0.000083570136],"category_scores_gemma":[0.000034407614,0.00013162369,0.000057697784,0.00048150044,0.00003169844,0.00003672096,0.000041681174,0.00032601826,0.000038852006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061859903,0.006903722,0.94584185,0.0010353447,0.00057473005,0.002069257,0.0033561385,0.00026823324,0.014624316,0.00041707788,0.010461691,0.008261647],"study_design_scores_gemma":[0.033672266,0.0009911577,0.9311944,0.0038880708,0.00037985467,0.000069800124,0.0017388787,0.000039174753,0.024729628,0.000079299105,0.0027906797,0.00042674752],"about_ca_topic_score_codex":0.0017885251,"about_ca_topic_score_gemma":0.00260983,"teacher_disagreement_score":0.027486278,"about_ca_system_score_codex":0.000072240495,"about_ca_system_score_gemma":0.00015785322,"threshold_uncertainty_score":0.53674585},"labels":[],"label_agreement":null},{"id":"W4417004473","doi":"10.1182/blood-2025-1139","title":"Revisiting erythroid response in the phase 3 BELIEVE trial of luspatercept in patients with transfusion-dependent β-thalassemia using real-world criteria","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"The Scarborough Hospital; University of Toronto","funders":"","keywords":"Placebo; Cohort; Anemia; Clinical trial; Post-hoc analysis; Phases of clinical research; Retrospective cohort study; Hemoglobin","score_opus":0.011663473528916375,"score_gpt":0.302026060889941,"score_spread":0.2903625873610246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417004473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967708,0.00011264173,0.000018753359,0.00052671233,0.000099076075,0.001226495,0.000012340662,0.000014333887,0.0012188251],"genre_scores_gemma":[0.99941945,0.00011837897,0.00015929647,0.00015146131,0.000034960784,0.000017329989,0.000017262004,0.000015835876,0.00006601705],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99828285,0.00035921216,0.0005535879,0.00025285775,0.00030281147,0.00024868062],"domain_scores_gemma":[0.99932855,0.00015889737,0.000101399084,0.00030481454,0.00006685812,0.000039465092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008894317,0.0001578676,0.000389675,0.0003465037,0.000057203586,0.000014986305,0.00010841603,0.000111263,0.000037394784],"category_scores_gemma":[0.00014467772,0.00010331469,0.000068110676,0.0007414899,0.000056387154,0.000055077497,0.000026577074,0.0003175306,9.3451916e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48642236,0.016628763,0.4275362,0.00085026043,0.00029634224,0.000575091,0.011927676,0.00008077227,0.045828037,0.00006678349,0.00008417405,0.009703565],"study_design_scores_gemma":[0.6059406,0.004640111,0.37315136,0.00570364,0.00082388514,0.000020434702,0.0036683085,0.00027578138,0.005181684,0.000059432445,0.00015503376,0.00037972565],"about_ca_topic_score_codex":0.00055073085,"about_ca_topic_score_gemma":0.0001336735,"teacher_disagreement_score":0.119518235,"about_ca_system_score_codex":0.00006318723,"about_ca_system_score_gemma":0.00020831091,"threshold_uncertainty_score":0.4213051},"labels":[],"label_agreement":null},{"id":"W4417004489","doi":"10.1182/blood-2025-741","title":"Impact of concurrent antiplatelet/NSAID use on the safety and efficacy of thromboprophylaxis with apixaban in patients with cancer: A post-hoc analysis of the AVERT trial","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Western University; London Health Sciences Centre; Jewish General Hospital; University of Ottawa; Sault Area Hospital; Ottawa Hospital","funders":"","keywords":"Apixaban; Ambulatory; Randomized controlled trial; Anticoagulant; Placebo; Thrombosis; Clinical trial; Hazard ratio; Major bleeding","score_opus":0.008784172246037353,"score_gpt":0.26341153992565447,"score_spread":0.25462736767961713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417004489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99793583,0.0001201188,0.0000025513762,0.00013733382,0.000042212476,0.0014984868,0.00014910048,0.0000043661807,0.0001100052],"genre_scores_gemma":[0.99965113,0.00021283407,0.0000097535185,0.00006196069,0.000007867639,0.00001678078,0.000018280118,0.000009095928,0.000012279589],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988701,0.00007545846,0.00036753708,0.0002078641,0.00033075342,0.00014832363],"domain_scores_gemma":[0.99891025,0.00018436852,0.00027295356,0.00043793564,0.00016259578,0.00003188129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014776041,0.00015287899,0.0007991359,0.00021815294,0.000037232847,0.0000074416403,0.00011755625,0.00003826823,0.000038954593],"category_scores_gemma":[0.00007072297,0.0000665056,0.00017156758,0.0009616629,0.00016287954,0.000031761898,0.0000616317,0.000109882385,1.277186e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025780331,0.007572354,0.95319504,0.00013258241,0.008283253,0.000002108302,0.00084827055,0.0003106427,0.00020028626,0.0002900386,0.000048468308,0.0033366284],"study_design_scores_gemma":[0.04439879,0.0068656467,0.9438655,0.0004743858,0.003462994,1.2296869e-7,0.000052274314,0.00002560846,0.0007718408,0.0000011496312,0.000016993961,0.0000647329],"about_ca_topic_score_codex":0.0019848933,"about_ca_topic_score_gemma":0.00047325017,"teacher_disagreement_score":0.018618459,"about_ca_system_score_codex":0.000040074432,"about_ca_system_score_gemma":0.00013821445,"threshold_uncertainty_score":0.30005783},"labels":[],"label_agreement":null},{"id":"W4417004501","doi":"10.1182/blood-2025-1114","title":"Switching between complement inhibitors in patients with PNH: A real-world analysis of strategy, efficacy, and safety.","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Associated Medical Services","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Hemolysis; Eculizumab; Thrombosis; Clinical trial; Cohort; Off-label use","score_opus":0.011056364937215181,"score_gpt":0.2628794024825541,"score_spread":0.2518230375453389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417004501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99832124,0.0002320519,0.000026597281,0.000028105575,0.000034997563,0.00046455223,0.00016642436,0.000022172664,0.0007038384],"genre_scores_gemma":[0.99948895,0.000005502724,0.000023618271,0.000010653927,0.0000050705785,0.00001337252,0.0003831539,0.0000059357008,0.00006374415],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882793,0.00015397738,0.00050115056,0.0002594388,0.000049421968,0.0002080933],"domain_scores_gemma":[0.9993124,0.00021794664,0.00016102684,0.00024640915,0.00004529232,0.00001695278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017398078,0.00013868234,0.0004695149,0.00063319865,0.00007160484,0.0000093402095,0.00012704254,0.000042431133,0.00009999377],"category_scores_gemma":[0.000014943338,0.000118271186,0.00005386048,0.00078839314,0.000053694963,0.00003418062,0.000119284705,0.0000935337,0.0000024395401],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014314675,0.000555122,0.99413997,0.000042021296,0.0025809882,7.031273e-7,0.00013139899,0.000037100905,0.00058019126,0.00034686193,0.000068600726,0.0013738864],"study_design_scores_gemma":[0.0063952757,0.00015790875,0.9897794,0.00017219463,0.0017961045,5.455488e-8,0.00014512746,0.0000014652886,0.0011877296,0.00001483108,0.00024338994,0.0001065208],"about_ca_topic_score_codex":0.0010310112,"about_ca_topic_score_gemma":0.0025707951,"teacher_disagreement_score":0.006252129,"about_ca_system_score_codex":0.000028374156,"about_ca_system_score_gemma":0.000044341265,"threshold_uncertainty_score":0.4822959},"labels":[],"label_agreement":null},{"id":"W4417004586","doi":"10.1182/blood-2025-4616","title":"Assessment of real-world treatment patterns and outcomes of olutasidenib in patients with mutated isocitrate dehydrogenase 1 Acute Myeloid Leukemia previously treated with venetoclax using electronic health record data","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Systems, Applications & Products in Data Processing (Canada)","funders":"","keywords":"Venetoclax; Regimen; IDH1; Context (archaeology); Myeloid leukemia; Cohort; Clinical trial; Retrospective cohort study; Refractory (planetary science)","score_opus":0.021230467722185117,"score_gpt":0.33693358236623355,"score_spread":0.31570311464404843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417004586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970706,0.00014901118,0.000059735954,0.00010040189,0.0000074321165,0.0021896863,0.00029723477,0.0000341032,0.00009178009],"genre_scores_gemma":[0.99603087,0.0009411277,0.0019108993,0.000069608235,0.000007970551,0.000056150657,0.0007710431,0.00004990469,0.0001624407],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973663,0.00020111138,0.0006966869,0.0006406048,0.0004206883,0.0006745863],"domain_scores_gemma":[0.9981889,0.00011038354,0.00039251146,0.0009770547,0.00015902772,0.00017209105],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003206711,0.0003518477,0.0011122975,0.00048368424,0.000061984756,0.000015128436,0.00022890216,0.000082471495,0.000010377355],"category_scores_gemma":[0.000017377904,0.00024550545,0.000049887403,0.0008579635,0.00011604906,0.00013329677,0.00013542516,0.00029979282,2.8999034e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009468276,0.000812849,0.9930626,0.00032393573,0.0022431794,0.0000804825,0.0001303397,0.00009261868,0.000510564,0.000015510477,0.000009198528,0.0017718937],"study_design_scores_gemma":[0.023999006,0.0045178086,0.9612143,0.00079101877,0.0012348,0.000014738061,0.00006492286,0.0021685148,0.005789487,0.0000065397885,0.0000117754635,0.00018710374],"about_ca_topic_score_codex":0.03039682,"about_ca_topic_score_gemma":0.016049584,"teacher_disagreement_score":0.031848315,"about_ca_system_score_codex":0.0033500977,"about_ca_system_score_gemma":0.006512211,"threshold_uncertainty_score":0.9999997},"labels":[],"label_agreement":null},{"id":"W4417004589","doi":"10.1182/blood-2025-6987","title":"CPX-351 versus venetoclax plus hypomethylating agents for newly diagnosed acute myeloid leukemia: A systematic review and meta-analysis","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Venetoclax; Azacitidine; Hypomethylating agent; Regimen; Observational study; Systematic review; Randomized controlled trial; Clinical trial; Myeloid leukemia","score_opus":0.06132397024247202,"score_gpt":0.35514183984024283,"score_spread":0.2938178695977708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417004589","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15517288,0.77215725,0.007145241,0.013083071,0.00043570148,0.04160172,0.0008300428,0.0007375031,0.008836561],"genre_scores_gemma":[0.7230334,0.061306506,0.056978635,0.03625346,0.00063346117,0.027351145,0.001476629,0.0006184301,0.0923483],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99694276,0.0002721504,0.000943263,0.0006977213,0.00055014726,0.0005939435],"domain_scores_gemma":[0.99644685,0.0016103382,0.00030796372,0.0010416621,0.00032302702,0.0002701822],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013318707,0.00040163123,0.0035804647,0.0005463159,0.00019565652,0.00007553393,0.00033963687,0.00020200657,0.00012786349],"category_scores_gemma":[0.0028515293,0.00030204142,0.0012833627,0.0018688915,0.00008127351,0.00010671011,0.00023037108,0.0004023408,0.00002868581],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037541226,0.00013218344,0.00011733096,0.25876194,0.7324202,0.00034429613,0.00028421177,0.000076403376,0.0006955514,0.00029324228,0.006393644,0.00010559706],"study_design_scores_gemma":[0.010498498,0.0002827968,0.00013117136,0.0014266352,0.9847453,0.000026348303,0.00010692662,0.0014181456,0.0007054674,0.000036243844,0.00036357678,0.0002588428],"about_ca_topic_score_codex":0.00015676036,"about_ca_topic_score_gemma":0.00003492854,"teacher_disagreement_score":0.7108508,"about_ca_system_score_codex":0.0012135695,"about_ca_system_score_gemma":0.0013177799,"threshold_uncertainty_score":0.9999432},"labels":[],"label_agreement":null},{"id":"W4417004592","doi":"10.1182/blood-2025-6990","title":"Time burden of treatment with parenteral hypomethylating agents in combination with venetoclax among patients with newly diagnosed Acute Myeloid Leukemia","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Venetoclax; Azacitidine; Hypomethylating agent; Regimen; Myeloid leukemia; Off-label use; Chemotherapy regimen; Chemotherapy; Retrospective cohort study","score_opus":0.010706470629511458,"score_gpt":0.2622389418092833,"score_spread":0.25153247117977184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417004592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968027,0.000044522494,0.000043065334,0.00008365527,0.000015568423,0.0016303728,0.000026162563,0.000045896748,0.0013080765],"genre_scores_gemma":[0.9965439,0.000029292436,0.0016080993,0.000042957126,0.000025268437,0.00019098577,0.000282811,0.000044897944,0.0012318073],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981883,0.00009053679,0.0003538702,0.000424348,0.0005157163,0.00042721158],"domain_scores_gemma":[0.9988919,0.00013603143,0.000185162,0.0004127058,0.00024101837,0.000133196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011766984,0.00029450827,0.0005696596,0.00041755,0.00006417916,0.00002445761,0.00015293619,0.00010247682,0.000034208675],"category_scores_gemma":[0.00003860762,0.00019456034,0.000048002268,0.0008266052,0.00017431972,0.00015344482,0.00006242389,0.00024401034,0.00000849466],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021799959,0.0009186411,0.98724854,0.000113424605,0.0011824929,0.00029895766,0.0012555989,0.00085457886,0.0010029386,0.000007157872,0.00008037315,0.0048572943],"study_design_scores_gemma":[0.081125826,0.010333937,0.8948901,0.0014200098,0.00085642654,0.000012186024,0.00025647148,0.0037982885,0.0069104997,0.000009637335,0.000108426786,0.00027815814],"about_ca_topic_score_codex":0.0015543753,"about_ca_topic_score_gemma":0.00015541991,"teacher_disagreement_score":0.09235842,"about_ca_system_score_codex":0.001797102,"about_ca_system_score_gemma":0.0011778562,"threshold_uncertainty_score":0.7933941},"labels":[],"label_agreement":null},{"id":"W4417004613","doi":"10.1182/blood-2025-2611","title":"The first characterization of disease burden and healthcare resource utilization for the recent definition of severe von Willebrand disease using a large United States real-world dataset","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Von Willebrand disease; Disease; Retrospective cohort study; Health care; Disease burden; Severity of illness; Von Willebrand factor","score_opus":0.03400030868725258,"score_gpt":0.3007537542784189,"score_spread":0.2667534455911663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417004613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98083067,0.0011493932,0.000128192,0.0070131808,0.000023016724,0.0009691717,0.009861434,0.000010802895,0.00001416658],"genre_scores_gemma":[0.95703954,0.0068159783,0.00002746639,0.00036899597,0.00001985438,0.000040903156,0.035644714,0.000011146106,0.000031390588],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994093,0.00003913986,0.0002013698,0.00012949965,0.000107071464,0.000113598806],"domain_scores_gemma":[0.99934685,0.00014655259,0.0001275948,0.00021472225,0.00010249002,0.000061793566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010660759,0.000083429746,0.00013699787,0.00007768856,0.0002403779,0.000013533562,0.00004020843,0.000020890659,0.0000033584947],"category_scores_gemma":[0.00009033158,0.000052286076,0.00002574225,0.00028706164,0.000044211083,0.00004186214,0.00002815815,0.000033604414,8.61991e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0252324,0.004349336,0.91633314,0.009633904,0.002228133,0.00007772587,0.0024595275,0.00023989458,0.0012623369,0.010254943,0.003898779,0.024029886],"study_design_scores_gemma":[0.019079886,0.000338975,0.77993333,0.0021552555,0.004189481,0.0000052012356,0.00079826266,0.017168827,0.00065918494,0.002662474,0.1727539,0.0002552169],"about_ca_topic_score_codex":0.00014507177,"about_ca_topic_score_gemma":0.00015530677,"teacher_disagreement_score":0.16885513,"about_ca_system_score_codex":0.000015540565,"about_ca_system_score_gemma":0.00007502197,"threshold_uncertainty_score":0.21321644},"labels":[],"label_agreement":null},{"id":"W4417004621","doi":"10.1182/blood-2025-2867","title":"A Canadian national needs assessment for an immunology curriculum for hematology residents","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Innovations in Medical Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; St. Paul's Hospital; Université Laval; St. Michael's Hospital; University Health Network; University of Toronto; University of British Columbia Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Curriculum; Hematology; Clinical immunology; MEDLINE; Clinical Practice; Scholarship; Needs assessment","score_opus":0.013375282220381585,"score_gpt":0.36925152635161707,"score_spread":0.3558762441312355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417004621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93367505,0.00022110566,0.011363892,0.038048804,0.0019257531,0.002254296,0.00005004513,0.00007045696,0.012390598],"genre_scores_gemma":[0.9477257,0.0000040809746,0.04343505,0.005156705,0.00025460415,0.0010748059,0.0006946293,0.000013766989,0.0016406361],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.99925816,0.00001768999,0.0002364202,0.00014892085,0.00011417804,0.0002246213],"domain_scores_gemma":[0.99903965,0.00005945989,0.000047914273,0.00015641349,0.0006443149,0.000052264637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033424833,0.000071019116,0.00015394248,0.0005346138,0.00014013084,0.000010436354,0.00009597924,0.00013938436,0.000041224586],"category_scores_gemma":[0.0009662013,0.000070628455,0.000036985624,0.0003819638,0.00003921083,0.000042868527,0.000010517135,0.0001100317,0.000003621439],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004347607,0.0017282474,0.06950601,0.0002736679,0.00043226185,0.0000025358652,0.00024000506,0.0000015174232,0.0011251566,0.7907226,0.13025293,0.0056715696],"study_design_scores_gemma":[0.036642473,0.003063642,0.4135865,0.0007007313,0.0015174717,0.00043388558,0.0062260604,0.007377279,0.0076395217,0.12476002,0.3972424,0.00081001787],"about_ca_topic_score_codex":0.004332104,"about_ca_topic_score_gemma":0.005151744,"teacher_disagreement_score":0.6659626,"about_ca_system_score_codex":0.0002660689,"about_ca_system_score_gemma":0.0023411347,"threshold_uncertainty_score":0.6548875},"labels":[],"label_agreement":null},{"id":"W4417004679","doi":"10.1182/blood-2025-4608","title":"CPX-351 is a feasible bridge to allogeneic hematopoietic stem cell transplantation in TP53 mutated acute myeloid leukemia with  myelodisplastic related changes or therapy related without del(17p): Sub-analysis from a large italian real world retrospective study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Myeloid leukemia; Context (archaeology); Hematology; Hematopoietic stem cell transplantation; Transplantation; Leukemia; Population; Myeloid","score_opus":0.01610269223968738,"score_gpt":0.2906916307746867,"score_spread":0.2745889385349993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417004679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925825,0.0003514838,0.00020930146,0.0008722277,0.000070416834,0.0042283973,0.0004452138,0.0003082099,0.0009322426],"genre_scores_gemma":[0.9904563,0.00078633515,0.00028252392,0.00042701678,0.000035337016,0.000545715,0.00052713626,0.00014332043,0.0067963563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994559,0.0005142507,0.001049467,0.0016475251,0.0010945799,0.0011351692],"domain_scores_gemma":[0.99750096,0.00025431425,0.0003110484,0.0011102412,0.00038529804,0.0004381531],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007524855,0.0007701102,0.0017442618,0.0025096785,0.00024433443,0.00011105502,0.00047932853,0.00037486668,0.00026221733],"category_scores_gemma":[0.000035826713,0.0006015286,0.0002528096,0.010051553,0.00011376888,0.00017962523,0.00010679552,0.001101675,0.00009596181],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011249565,0.0029127924,0.9106654,0.00019258374,0.014856669,0.005107828,0.025168207,0.00012158822,0.029198185,0.000026870377,0.00021450844,0.00028582936],"study_design_scores_gemma":[0.03644923,0.0025038605,0.9093099,0.0005416952,0.011358525,0.00010086095,0.002301579,0.0008317156,0.035841703,0.000038244896,0.00002479107,0.0006978948],"about_ca_topic_score_codex":0.0038634606,"about_ca_topic_score_gemma":0.027411597,"teacher_disagreement_score":0.025199667,"about_ca_system_score_codex":0.0015660245,"about_ca_system_score_gemma":0.0012360162,"threshold_uncertainty_score":0.9996436},"labels":[],"label_agreement":null},{"id":"W4417004801","doi":"10.1182/blood-2025-7294","title":"Feasibility of the edmonton symptom assessment system (ESAS) score as patient-reported outcomes (PROs) assessment in chronic myeloid leukemia patients receiving tyrosine kinase inhibitor therapy: A pilot Study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Discontinuation; Myeloid leukemia; Context (archaeology); Clinical trial; Cancer; Medical record; Palliative care; Tyrosine-kinase inhibitor","score_opus":0.02364250898800571,"score_gpt":0.30918438888542793,"score_spread":0.2855418798974222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417004801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98793423,0.000513206,0.0000057148936,0.00013121788,0.0006723171,0.008736565,0.000032154403,0.00014985933,0.0018247298],"genre_scores_gemma":[0.9984436,0.000042181542,0.00016732578,0.000108596374,0.00006417244,0.0007738886,0.00006490519,0.00006645304,0.0002688722],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99455917,0.0005395834,0.0017802682,0.0010893994,0.0013695242,0.00066205615],"domain_scores_gemma":[0.99628985,0.00023160999,0.0008472441,0.0019995545,0.00045994436,0.00017181692],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00079478504,0.0006516411,0.0012810065,0.00031673737,0.00021370116,0.000055833483,0.00039681094,0.00015910188,0.000039394003],"category_scores_gemma":[0.0002985676,0.00044901366,0.00024890975,0.0011149521,0.00012250723,0.0001656923,0.00041432623,0.0007064226,0.00000480776],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00040973647,0.0147052035,0.97383416,0.00055109424,0.00094455265,0.00008805556,0.00041133273,0.000034754838,0.0063607637,0.000050876595,0.000044940145,0.002564525],"study_design_scores_gemma":[0.047452305,0.0059509547,0.9363637,0.002095421,0.0007165602,0.000011296284,0.00070101564,0.00012125351,0.006259637,0.000014099219,0.000020875732,0.00029289615],"about_ca_topic_score_codex":0.00293632,"about_ca_topic_score_gemma":0.0009740458,"teacher_disagreement_score":0.047042567,"about_ca_system_score_codex":0.015661156,"about_ca_system_score_gemma":0.006859575,"threshold_uncertainty_score":0.99979615},"labels":[],"label_agreement":null},{"id":"W4417004835","doi":"10.1182/blood-2025-5697","title":"Pharmacodynamic activity and clinical benefits of mezigdomide in high-risk biomarker subgroups from the CC-92480-MM-001 study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Princess Margaret Cancer Centre","funders":"","keywords":"Biomarker; Pomalidomide; Pharmacodynamics; Multiple myeloma; Bone marrow; Clinical trial; Whole blood","score_opus":0.033714665266651574,"score_gpt":0.36313672704094896,"score_spread":0.3294220617742974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417004835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99715084,0.0009152122,0.0000047719564,0.00035615073,0.00009405799,0.0010887058,0.00016224942,0.000020765183,0.00020726353],"genre_scores_gemma":[0.9987603,0.0008474285,0.00010281851,0.00004823709,0.000048596597,0.000046331952,0.000031773972,0.000012592611,0.00010194333],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983093,0.00043097424,0.00036232005,0.00037061202,0.00027436632,0.0002523861],"domain_scores_gemma":[0.9980074,0.0013154186,0.00009863296,0.00040776265,0.00005377023,0.000116987445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067545404,0.00015790133,0.00045016894,0.000108891276,0.00006823806,0.000014612356,0.00013578878,0.000082276325,0.000031107957],"category_scores_gemma":[0.0004153069,0.00010054614,0.00008085274,0.00028116722,0.000120135366,0.000052492753,0.00016684589,0.0003286021,0.0000089750765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014106021,0.019634025,0.9163762,0.00001891931,0.0013442629,0.00007194449,0.00006369013,2.7466055e-7,0.00071288546,0.000009902913,0.000054758457,0.06030259],"study_design_scores_gemma":[0.0768889,0.00039395125,0.9199889,0.00007575854,0.0007804826,0.0000020652913,0.000087358865,0.0003855722,0.0012531992,0.00005687711,0.000022246184,0.00006474441],"about_ca_topic_score_codex":0.012406488,"about_ca_topic_score_gemma":0.007016862,"teacher_disagreement_score":0.07547829,"about_ca_system_score_codex":0.000028541914,"about_ca_system_score_gemma":0.00008527671,"threshold_uncertainty_score":0.99417},"labels":[],"label_agreement":null},{"id":"W4417004843","doi":"10.1182/blood-2025-644","title":"Outcome of children and adolescents with newly diagnosed T-cell acute lymphoblastic leukemia: Results of DFCI ALL consortium protocol 16-001","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Centre Hospitalier de l’Université de Montréal; Centre hospitalier universitaire de Québec","funders":"","keywords":"Adverse effect; Cohort; Induction chemotherapy; Acute lymphocytic leukemia; Minimal residual disease; Chemotherapy; Lymphoblastic Leukemia; Induction therapy; Cohort study","score_opus":0.009981563563284097,"score_gpt":0.28065600326016915,"score_spread":0.27067443969688504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417004843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96249497,0.000045620127,0.00017861756,0.00014656041,0.000033751247,0.034097455,0.00019333726,0.00006620399,0.0027434644],"genre_scores_gemma":[0.99327475,0.000021604366,0.00082417426,0.0002532685,0.00004748197,0.004190607,0.0000610916,0.00004490193,0.0012821157],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972215,0.00008865304,0.000936708,0.0005676476,0.0006714245,0.0005140451],"domain_scores_gemma":[0.9980938,0.0002535315,0.00035517788,0.00072037056,0.00031958462,0.00025753753],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002855358,0.00033691092,0.00083000597,0.00031394127,0.000046457997,0.00001754964,0.00028980797,0.00023233834,0.000016295306],"category_scores_gemma":[0.0004062173,0.00025282448,0.0000958577,0.00047331597,0.00043020144,0.000074163065,0.00024304529,0.00030431987,0.000010954003],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015818274,0.0075739827,0.94121104,0.0041506044,0.0019209475,0.0005648434,0.0002599832,0.000026716154,0.01963555,0.00006178974,0.007526951,0.0012492907],"study_design_scores_gemma":[0.3819688,0.0037164062,0.46718368,0.0034588156,0.002967372,0.00038278967,0.0000831951,0.00028954208,0.13896084,0.000034361736,0.00043591633,0.0005182951],"about_ca_topic_score_codex":0.00072500046,"about_ca_topic_score_gemma":0.000047477068,"teacher_disagreement_score":0.4740274,"about_ca_system_score_codex":0.0003577381,"about_ca_system_score_gemma":0.0014544994,"threshold_uncertainty_score":0.9999924},"labels":[],"label_agreement":null},{"id":"W4417004848","doi":"10.1182/blood-2025-7753","title":"Investigating belumosudil in children with refractory moderate-to-severe chronic graft-versus-host disease: Design of a phase 1/2 study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Refractory (planetary science); Clinical trial; Systemic therapy; Hematopoietic stem cell transplantation; Transplantation; Disease; Complication; Adverse effect","score_opus":0.022293264580268427,"score_gpt":0.2926293551418031,"score_spread":0.2703360905615347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417004848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953982,0.000358515,0.0016716492,0.000100755184,0.000029830091,0.002135204,0.000019887555,0.000051787083,0.0002341297],"genre_scores_gemma":[0.99794126,0.000018339595,0.0016610952,0.0000739687,0.000030177718,0.00013936496,0.00003377207,0.000025911286,0.00007609133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985969,0.000119789074,0.00037289056,0.00035802997,0.00031492114,0.00023745028],"domain_scores_gemma":[0.99917585,0.0001327787,0.000084553016,0.00035451725,0.00007411261,0.00017821597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024042011,0.00018754171,0.00035986718,0.00021732156,0.000051207677,0.00001203604,0.00010387573,0.00005233748,0.000026034253],"category_scores_gemma":[0.00009410884,0.00016564183,0.0000322887,0.0005000896,0.000053911546,0.00006971093,0.000022465796,0.00017503428,0.0000077436425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035258532,0.008995197,0.95678794,0.00081200904,0.0010248547,0.00016412904,0.0030494698,0.0013704891,0.023354223,0.000085272884,0.000053568503,0.00077697943],"study_design_scores_gemma":[0.1301941,0.0068261875,0.82465184,0.0033386694,0.0029880756,0.00004288339,0.00092248287,0.001530712,0.028917754,0.000056110686,0.000009895774,0.0005212942],"about_ca_topic_score_codex":0.00009297105,"about_ca_topic_score_gemma":0.00005762876,"teacher_disagreement_score":0.13213612,"about_ca_system_score_codex":0.00008067534,"about_ca_system_score_gemma":0.0007054217,"threshold_uncertainty_score":0.6754678},"labels":[],"label_agreement":null},{"id":"W4417004858","doi":"10.1182/blood-2025-657","title":"A rapid gene expression profiler predicts tumor responsiveness and patient outcome for standard-of-care therapies in acute myeloid leukemia","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada); Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Myeloid leukemia; Decitabine; Leukemia; Ex vivo; Azacitidine; Gene signature; NPM1; Myeloid; Gene expression profiling","score_opus":0.017291609927974398,"score_gpt":0.3012204746034046,"score_spread":0.2839288646754302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417004858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903423,0.005897257,0.00015221149,0.00055912434,0.00009165194,0.0023642895,0.0002745698,0.00004795031,0.0002706039],"genre_scores_gemma":[0.9898223,0.00036096337,0.008498216,0.00032180367,0.00004192791,0.00056621083,0.000060450213,0.00003919615,0.00028891538],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981801,0.00012346862,0.0004992522,0.00042993054,0.00038603164,0.00038123815],"domain_scores_gemma":[0.99868286,0.0002818576,0.00011430018,0.00044061156,0.0003702202,0.00011018115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030745534,0.00022136242,0.0006327221,0.00040393032,0.0000839917,0.000019323246,0.00014824301,0.0001391847,0.000022889359],"category_scores_gemma":[0.00040400375,0.0001720396,0.0000990753,0.0003372929,0.00013342628,0.000083388535,0.00019161959,0.00026905598,0.0000011243189],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03191497,0.0005234981,0.21377985,0.003322048,0.00073535554,0.00041245314,0.008260368,0.000008232847,0.70211524,0.00022027662,0.0018467901,0.036860906],"study_design_scores_gemma":[0.01799003,0.002350267,0.057714134,0.0010228738,0.00024697563,0.00003735007,0.0021091653,0.000049163566,0.9120611,0.00010387434,0.006120293,0.00019475195],"about_ca_topic_score_codex":0.000014504648,"about_ca_topic_score_gemma":0.000005196042,"teacher_disagreement_score":0.20994587,"about_ca_system_score_codex":0.00032229017,"about_ca_system_score_gemma":0.0010904053,"threshold_uncertainty_score":0.7015571},"labels":[],"label_agreement":null},{"id":"W4417004860","doi":"10.1182/blood-2025-635","title":"Ivosidenib leads to durable responses in IDH1 mutated clonal cytopenias of undetermined significance: A phase II decentralized clinical trial","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Covenant Health","funders":"","keywords":"Cytopenia; Myeloid leukemia; Myelodysplastic syndromes; Clinical trial; Phases of clinical research; Adverse effect; IDH1; Myeloid; Haematopoiesis","score_opus":0.0680078998807573,"score_gpt":0.43629458244645214,"score_spread":0.36828668256569486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417004860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931367,0.00018519833,0.00007256686,0.003048225,0.00020315654,0.002405879,0.000048462167,0.000060287635,0.0008394969],"genre_scores_gemma":[0.9920864,0.00011942283,0.0016448979,0.00065941556,0.00013445831,0.0001733661,0.000034916127,0.00002867978,0.0051184036],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.996448,0.00056880806,0.0013047388,0.00056656334,0.0005173004,0.000594591],"domain_scores_gemma":[0.9975187,0.0011952961,0.00014718533,0.0006002118,0.00023068122,0.00030793535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017438453,0.00022900585,0.0009826701,0.0005321798,0.00007798905,0.000023252958,0.0003433215,0.00025199656,0.00028820755],"category_scores_gemma":[0.0053024674,0.00020538445,0.00022406862,0.0012537772,0.0002091976,0.00007515866,0.00020322393,0.0005660452,0.00003447979],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5140801,0.009359349,0.01569742,0.00017534736,0.0003447124,0.0013010196,0.0003168972,0.0000049759424,0.4471795,0.00018003485,0.0064792237,0.0048814],"study_design_scores_gemma":[0.61054015,0.010771304,0.012094985,0.00050120906,0.00045652554,0.000058001344,0.00014259732,0.00019506991,0.36016,0.00012450622,0.004660708,0.0002949403],"about_ca_topic_score_codex":0.00023511284,"about_ca_topic_score_gemma":0.0001245855,"teacher_disagreement_score":0.09646003,"about_ca_system_score_codex":0.00020430898,"about_ca_system_score_gemma":0.0028247228,"threshold_uncertainty_score":0.8375335},"labels":[],"label_agreement":null},{"id":"W4417004861","doi":"10.1182/blood-2025-652","title":"γ9δ2 T-cell (γ9δ2TC) activation with ICT01 and azacitidine-venetoclax (Aza-Ven) induces high rates of remission and overall survival in patients with newly diagnosed (ND) acute myeloid leukemia (AML): Results from the phase 1/2 study eviction","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Bone marrow; Immunosurveillance; Cohort; Myeloid leukemia; Interim analysis; Phases of clinical research; Chemotherapy; Dosing; Chemotherapy regimen; Cancer","score_opus":0.01582501349393114,"score_gpt":0.28506090680109153,"score_spread":0.2692358933071604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417004861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973867,0.000117351774,0.000012012764,0.00022321589,0.00004640877,0.0018539954,0.00007002617,0.00002727804,0.00026300465],"genre_scores_gemma":[0.9987838,0.0002014532,0.0001237804,0.000056595207,0.00006512652,0.00005546425,0.00023432342,0.000028634651,0.0004507835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980631,0.00023000281,0.000398453,0.00051455095,0.0005519122,0.00024201538],"domain_scores_gemma":[0.9984671,0.0006050139,0.00019937995,0.0004309812,0.0002015592,0.0000959853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040785287,0.0002484677,0.0004322942,0.00018329825,0.00010683762,0.000050000486,0.00011475149,0.00011762009,0.000022390152],"category_scores_gemma":[0.0001360706,0.00015652289,0.000025005815,0.00048350325,0.000106385545,0.00020173928,0.00007752192,0.0003703436,4.4429274e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038671862,0.004045439,0.5457393,0.00011361963,0.0007949795,0.000045040346,0.0038887083,0.000046619694,0.39482534,0.000009182999,0.0001943404,0.011625543],"study_design_scores_gemma":[0.09279776,0.004228128,0.71380204,0.00060691725,0.00031124993,0.0000012175726,0.00068020856,0.000055044417,0.18723246,0.00003509476,0.0000842067,0.0001656745],"about_ca_topic_score_codex":0.004045345,"about_ca_topic_score_gemma":0.00026529198,"teacher_disagreement_score":0.20759289,"about_ca_system_score_codex":0.00016154961,"about_ca_system_score_gemma":0.0003611709,"threshold_uncertainty_score":0.63828176},"labels":[],"label_agreement":null},{"id":"W4417004874","doi":"10.1182/blood-2025-1016","title":"Pembrolizumab (Pembro) plus R-CHOP is efficacious as first-line therapy for primary mediastinal B-cell lymphoma (PMBL) with high rates of ctdna negativity – interim efficacy analysis of the ALLG-Pacific (NHL35) trial","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nutrasource","funders":"","keywords":"Pembrolizumab; Interim analysis; Discontinuation; Clinical endpoint; Clinical trial; Lung cancer; Chemoimmunotherapy; Regimen; Lymphoma; Surrogate endpoint","score_opus":0.01613233198756853,"score_gpt":0.28237400725371653,"score_spread":0.266241675266148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417004874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937182,0.0010882071,0.00007936345,0.0012055289,0.00019827813,0.002494804,0.00018960836,0.000042624015,0.0009833847],"genre_scores_gemma":[0.99772346,0.00043774323,0.00043464662,0.0003148317,0.00010793791,0.0003315548,0.000115875766,0.00003642292,0.0004975395],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9976022,0.00012938373,0.0007668029,0.0005923366,0.0005408262,0.00036843185],"domain_scores_gemma":[0.99688554,0.0012249941,0.0005304705,0.00091774965,0.00031655474,0.00012468628],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002546388,0.0004300772,0.0014413161,0.00035548297,0.00014184111,0.000027425363,0.00031947342,0.00015591783,0.000069311514],"category_scores_gemma":[0.00018826214,0.0002556281,0.0007908319,0.0012150962,0.000262019,0.000053658125,0.00009980012,0.00009725849,0.0000032453622],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5760361,0.14570321,0.106898606,0.002283364,0.057851166,0.00019024918,0.0063493657,0.0004238961,0.016787218,0.00070362963,0.0022799773,0.08449321],"study_design_scores_gemma":[0.45413372,0.0072264853,0.3168891,0.00042632685,0.012532807,0.000019178331,0.00012523866,0.00024155335,0.20729776,0.00006584378,0.00074767694,0.00029431467],"about_ca_topic_score_codex":0.00038460418,"about_ca_topic_score_gemma":0.000082377235,"teacher_disagreement_score":0.2099905,"about_ca_system_score_codex":0.0001970025,"about_ca_system_score_gemma":0.00081302394,"threshold_uncertainty_score":0.99998957},"labels":[],"label_agreement":null},{"id":"W4417004880","doi":"10.1182/blood-2025-661","title":"Integrated clinico-biological profiling identifies a high-risk epigenetic signature in Mantle Cell Lymphoma: A lysa study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Mantle cell lymphoma; Epigenetics; DNA methylation; Transcriptome; Multivariate analysis; Gene expression profiling; Survival analysis; CDKN2A","score_opus":0.014292622670228959,"score_gpt":0.2740520551911256,"score_spread":0.2597594325208966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417004880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943446,0.0031393017,0.000008561561,0.00011506029,0.00021277073,0.0013118369,0.000024335339,0.00008858016,0.0007549709],"genre_scores_gemma":[0.9980812,0.00039204516,0.00042570438,0.00013983165,0.000050803123,0.0002873118,0.000057480105,0.000014572843,0.00055103307],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983424,0.0001819259,0.00047769162,0.0005263624,0.00017075452,0.0003008712],"domain_scores_gemma":[0.9991338,0.00023748791,0.00010031167,0.00037605382,0.000076127,0.00007617786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028388,0.00024151745,0.0005239094,0.00019262805,0.00007595408,0.000036909965,0.0001294911,0.00020519996,0.00004170996],"category_scores_gemma":[0.00018345835,0.00016414869,0.00012823413,0.00047073493,0.000048986025,0.000027984448,0.00009588809,0.00016967408,0.000051336854],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018992601,0.022729592,0.96940815,0.000052463205,0.0003047964,0.00071698637,0.0002637611,0.0000032188277,0.002142909,0.000054646185,0.00013659892,0.0039969534],"study_design_scores_gemma":[0.026331283,0.0012295182,0.8915151,0.00018390312,0.0008386853,0.000009727285,0.0016125325,0.00002718948,0.07763953,0.0003212148,0.00012159758,0.00016977389],"about_ca_topic_score_codex":0.0005400989,"about_ca_topic_score_gemma":0.00020815083,"teacher_disagreement_score":0.0778931,"about_ca_system_score_codex":0.00009978186,"about_ca_system_score_gemma":0.00018881123,"threshold_uncertainty_score":0.66937894},"labels":[],"label_agreement":null},{"id":"W4417004887","doi":"10.1182/blood-2025-1026","title":"Cytoreductive therapy reduces recurrent thrombosis in patients with myeloproliferative neoplasm-associated splanchnic vein thrombosis: A global abdominal/splanchnic thrombosis retrospective observational study (GASTRO-MPN) study of 757 patients","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"","keywords":"Thrombosis; Discontinuation; Retrospective cohort study; Hazard ratio; Portal vein thrombosis; Transjugular intrahepatic portosystemic shunt; Proportional hazards model; Asymptomatic","score_opus":0.033037452227772754,"score_gpt":0.31220677108044764,"score_spread":0.2791693188526749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417004887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988964,0.00016026667,0.0000030541528,0.00017835839,0.00038250408,0.009151321,0.0005596505,0.00009847092,0.0005023826],"genre_scores_gemma":[0.9969078,0.00013332423,0.00027271116,0.00012150607,0.00007985623,0.0019587504,0.000445701,0.00006070408,0.000019695923],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9939185,0.0006681423,0.0014086151,0.0015320904,0.0016709433,0.00080170843],"domain_scores_gemma":[0.99626696,0.00026320366,0.00087174756,0.000731544,0.0016581108,0.0002084257],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044702092,0.0009704962,0.0021510983,0.0004193086,0.00032567096,0.00007822998,0.0003630844,0.00024832602,0.000063694104],"category_scores_gemma":[0.00032897334,0.0007537377,0.00022966902,0.00222707,0.00020808597,0.0003896248,0.0001739827,0.00057767215,0.00000860991],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002124295,0.12260455,0.8629024,0.000040024355,0.0057536815,0.000009826483,0.0058227675,0.00001386502,0.00005670066,0.00006474304,0.00020452774,0.00040262955],"study_design_scores_gemma":[0.052652013,0.027134618,0.9120693,0.00088428747,0.0015710795,8.855429e-7,0.0040760916,0.000009719471,0.0010048747,0.00010366223,0.000003420035,0.00049000414],"about_ca_topic_score_codex":0.00043899784,"about_ca_topic_score_gemma":0.0012886563,"teacher_disagreement_score":0.09546994,"about_ca_system_score_codex":0.0013811277,"about_ca_system_score_gemma":0.00063125347,"threshold_uncertainty_score":0.99949133},"labels":[],"label_agreement":null},{"id":"W4417004896","doi":"10.1182/blood-2025-8057","title":"The association between neighbourhood walkability and diffuse large B-cell lymphoma: A population-based Study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Urban Transport and Accessibility","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; St. Michael's Hospital; University of Toronto","funders":"","keywords":"Walkability; Neighbourhood (mathematics); Population; Diffuse large B-cell lymphoma; Incidence (geometry); Built environment; Proxy (statistics)","score_opus":0.008525112032051209,"score_gpt":0.27003319606874493,"score_spread":0.26150808403669373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417004896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944268,0.00013207263,0.00001647308,0.000637797,0.00010230254,0.00052024954,0.000023229488,0.00007368397,0.0040674326],"genre_scores_gemma":[0.9990088,0.000003693239,0.000014185161,0.000050439594,0.00009160275,0.000025264113,0.000010249681,0.000004435637,0.0007913585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867624,0.00022239985,0.00024803128,0.0002558385,0.00031943092,0.00027808067],"domain_scores_gemma":[0.99887794,0.000667864,0.00011394065,0.00019276697,0.00008627557,0.00006123956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015576839,0.000091656875,0.00015474792,0.000030438958,0.0012417892,0.00018328695,0.00020428326,0.00009457281,0.000013352076],"category_scores_gemma":[0.00030202154,0.00007054042,0.00005978621,0.00031756476,0.00003634893,0.0001280279,0.000024825085,0.00007842936,0.0000024041074],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005810552,0.0034528081,0.9945372,0.00000868696,0.000035312285,3.23736e-7,0.00078130374,4.3205798e-8,0.0000022331033,0.00031375093,0.000014258019,0.00084831123],"study_design_scores_gemma":[0.004852726,0.000020763942,0.9917196,0.00000427386,0.00018363426,1.4942906e-9,0.0008856309,0.0000036297245,0.000034232402,0.0016662943,0.0005531561,0.00007605869],"about_ca_topic_score_codex":0.0036785698,"about_ca_topic_score_gemma":0.01652423,"teacher_disagreement_score":0.01284566,"about_ca_system_score_codex":0.00012292246,"about_ca_system_score_gemma":0.00014436946,"threshold_uncertainty_score":0.9550964},"labels":[],"label_agreement":null},{"id":"W4417004908","doi":"10.1182/blood-2025-7923","title":"Evaluating patient preferences for chronic lymphocytic leukemia (CLL) in Korea: A discrete choice experiment","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovative Research Group (Canada); Group for Research in Decision Analysis","funders":"","keywords":"Chronic lymphocytic leukemia; Adverse effect; Quality of life (healthcare); Dosing; Logistic regression; Atrial fibrillation; Preference","score_opus":0.04822927713616006,"score_gpt":0.3880623121763555,"score_spread":0.33983303504019546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417004908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883669,0.0049716216,0.00008264583,0.00009022275,0.00016751056,0.0022463074,0.00001067197,0.00008173898,0.0039823973],"genre_scores_gemma":[0.9956384,0.00010151143,0.0014068654,0.0001572052,0.00017074305,0.0014271997,0.000040849838,0.000032666354,0.0010245648],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973852,0.000093522525,0.0005772131,0.00063019275,0.0005980702,0.00071579113],"domain_scores_gemma":[0.9984373,0.0005637842,0.00010118568,0.00060456793,0.00014294536,0.0001502559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044615407,0.00026462655,0.00047770338,0.00026253532,0.00010702549,0.00004665879,0.00024057944,0.00015300396,0.00007400277],"category_scores_gemma":[0.0008599764,0.00022162509,0.0001437382,0.0004730151,0.00011066289,0.00008550978,0.0002077377,0.00019857011,0.000021489475],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.009606895,0.006704439,0.022909664,0.023161966,0.0061291177,0.0009835672,0.022871707,0.01718917,0.3288974,0.005456443,0.008717862,0.5473718],"study_design_scores_gemma":[0.2666448,0.0054498124,0.0064236843,0.0048897658,0.0009879109,0.00013431392,0.0014380045,0.312621,0.39443257,0.0012294576,0.004829701,0.0009189913],"about_ca_topic_score_codex":0.0023960466,"about_ca_topic_score_gemma":0.00039352366,"teacher_disagreement_score":0.5464528,"about_ca_system_score_codex":0.06725929,"about_ca_system_score_gemma":0.042401396,"threshold_uncertainty_score":0.9630273},"labels":[],"label_agreement":null},{"id":"W4417004910","doi":"10.1182/blood-2025-1031","title":"Evidence for pre-existing myeloma cells with a gene expression pattern associated with resistance to BCMA CAR T cells.","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"CD19; Cell culture; Multiple myeloma; Gene expression; Antigen; Annexin A5; Gene; Chimeric antigen receptor","score_opus":0.04496808679528664,"score_gpt":0.3337368869448775,"score_spread":0.2887688001495909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417004910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99070287,0.0006652641,0.0039344723,0.0004914587,0.0000628971,0.0020040877,0.000036977468,0.00011493339,0.0019870615],"genre_scores_gemma":[0.94610876,0.00004717632,0.006126968,0.00043970728,0.0001362553,0.00035891458,0.000019227704,0.00006574896,0.046697233],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979889,0.000089589914,0.00026265462,0.00057864335,0.0005624685,0.0005177826],"domain_scores_gemma":[0.99813485,0.0005930353,0.00010707913,0.0005933847,0.00037963077,0.00019202493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043636697,0.00022915055,0.00038694168,0.00014310014,0.00015456327,0.000054923505,0.00022404606,0.00010681604,0.00009990066],"category_scores_gemma":[0.00028265512,0.00017279673,0.00006993292,0.0005298738,0.000058990317,0.000067529,0.000082023806,0.00023527109,0.0000075812827],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023519457,0.00032686838,0.012796762,0.00038062804,0.00019307916,0.00010739236,0.00060269004,0.000020384778,0.979674,0.000001890025,0.0016348242,0.0019095244],"study_design_scores_gemma":[0.0048726965,0.0009611205,0.0116771655,0.005744915,0.00023677111,0.0000052546643,0.000074456686,0.00005189306,0.9746357,0.000009474719,0.001520326,0.00021018245],"about_ca_topic_score_codex":0.000042694086,"about_ca_topic_score_gemma":0.00024739737,"teacher_disagreement_score":0.04471017,"about_ca_system_score_codex":0.00014308374,"about_ca_system_score_gemma":0.00029321594,"threshold_uncertainty_score":0.7046446},"labels":[],"label_agreement":null},{"id":"W4417004913","doi":"10.1182/blood-2025-1814","title":"Efficacy and tolerability of bendamustine, rituximab and acalabutinib in elderly treatment naïve Waldenström's macroglobulinemia","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Queen Elizabeth II Health Sciences Centre; Occupational Cancer Research Centre; Health Canada; Spinal Cord Injury BC; Health Sciences North; University of Toronto; University Health Network; McGill University Health Centre; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Tolerability; Rituximab; Clinical trial; Clinical endpoint; Toxicity; Surrogate endpoint; Adverse effect; Bone marrow","score_opus":0.012779166908002154,"score_gpt":0.3115764928566705,"score_spread":0.29879732594866837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417004913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946992,0.0021283138,0.0000047192193,0.00064482685,0.000029983454,0.00070910266,0.000019547588,0.00002728784,0.0017370498],"genre_scores_gemma":[0.9983161,0.0003403305,0.00074150774,0.000044977667,0.000035538815,0.000027920998,0.000013015239,0.000010790309,0.00046979534],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99861276,0.000051723957,0.00040843512,0.00040856062,0.00020197964,0.00031655483],"domain_scores_gemma":[0.999043,0.00032707374,0.00005015876,0.00037124014,0.00007705648,0.00013148575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021408671,0.00017622608,0.00054780755,0.00013932929,0.00003635046,0.000014864436,0.000068908674,0.00014269112,0.00003656057],"category_scores_gemma":[0.00033936682,0.00014404563,0.00004637309,0.0002879064,0.00023999234,0.000031082785,0.000109748806,0.00017013091,0.0000031307231],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051757204,0.023686485,0.27847043,0.0040139337,0.0010937039,0.0015925808,0.0024756715,0.000011122012,0.019781198,0.0013378965,0.00043386678,0.6619274],"study_design_scores_gemma":[0.47097385,0.0031598487,0.44596976,0.0012259654,0.00087726343,0.0007552753,0.0003873594,0.002348962,0.07110087,0.00040825194,0.0023971796,0.00039542932],"about_ca_topic_score_codex":0.0009938679,"about_ca_topic_score_gemma":0.00018376399,"teacher_disagreement_score":0.661532,"about_ca_system_score_codex":0.0010489217,"about_ca_system_score_gemma":0.0018056018,"threshold_uncertainty_score":0.58740103},"labels":[],"label_agreement":null},{"id":"W4417004914","doi":"10.1182/blood-2025-1048","title":"Lipid nanoparticle-mediated epitope editing in human HSPCs enables resistance to CD45-directed CAR-T cell therapy","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"WSP (Canada)","funders":"","keywords":"Epitope; Electroporation; Haematopoiesis; Ex vivo; Stem cell; Genome editing; Progenitor cell","score_opus":0.004866321082779813,"score_gpt":0.25680457486220243,"score_spread":0.25193825377942264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417004914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99435556,0.0033407223,0.0001605803,0.00016230131,0.00019767834,0.00019400558,0.000008644219,0.000045122353,0.0015354019],"genre_scores_gemma":[0.99752945,0.00020706288,0.000511168,0.00020170952,0.00024709766,0.000045407513,0.000032705135,0.000018668934,0.001206751],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99907094,0.000036308185,0.00021321012,0.0003082402,0.0000785101,0.00029276148],"domain_scores_gemma":[0.9995632,0.000014409307,0.000027673374,0.00028246467,0.000048919068,0.00006330852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001256757,0.00013842274,0.0001390329,0.00007474512,0.0000612721,0.000025032168,0.00017359604,0.000096004085,0.000008897893],"category_scores_gemma":[0.00008132772,0.0001459174,0.000041385945,0.00027265673,0.000017914033,0.0000023267928,0.00007062758,0.0000761366,0.0000039691904],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002160112,0.00013136202,0.0065182145,0.00002379826,0.0000196352,0.0000048470356,0.00008036104,0.00015383835,0.99082255,0.000012048565,0.0019083867,0.0003033296],"study_design_scores_gemma":[0.0012011045,0.00006698552,0.0072797355,0.000040698716,0.0000095116675,4.6511659e-7,0.000057071167,0.000017742115,0.9667122,0.000013305724,0.02445,0.00015122641],"about_ca_topic_score_codex":0.00004129303,"about_ca_topic_score_gemma":0.00037151598,"teacher_disagreement_score":0.024110425,"about_ca_system_score_codex":0.000009097874,"about_ca_system_score_gemma":0.00003599855,"threshold_uncertainty_score":0.5950339},"labels":[],"label_agreement":null},{"id":"W4417004940","doi":"10.1182/blood-2025-1020","title":"Long-term follow-up with sustained progression-free survival (PFS) benefit after subcutaneous (SC) mosunetuzumab in combination with polatuzumab vedotin compared with rituximab plus polatuzumab vedotin in patients with relapsed or refractory (R/R) B-cell non-Hodgkin lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Jewish General Hospital","funders":"","keywords":"Rituximab; Follicular lymphoma; Refractory (planetary science); Clinical endpoint; Phases of clinical research; Cytokine release syndrome; Lymphoma; Cohort","score_opus":0.004965107923882109,"score_gpt":0.22528995639170812,"score_spread":0.22032484846782602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417004940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99326974,0.00074951904,0.00003486764,0.00022691528,0.00015953975,0.0045108586,0.000068328154,0.00018327808,0.0007969739],"genre_scores_gemma":[0.99572575,0.000039889972,0.001443299,0.00014476322,0.000043008407,0.0008722851,0.0006765649,0.00019648304,0.00085793453],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945153,0.00018992959,0.001019785,0.0014934237,0.0015568477,0.001224739],"domain_scores_gemma":[0.9965486,0.00033993038,0.0005554934,0.0015668297,0.0006083508,0.00038082458],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002100149,0.0011416752,0.0017966073,0.00094424,0.00021789428,0.00015761465,0.00048773925,0.00039573072,0.000050963816],"category_scores_gemma":[0.00006910628,0.0007207279,0.0001317588,0.0018415253,0.0002807792,0.00037894447,0.00021118898,0.0004754089,0.000013512578],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11418805,0.026243273,0.8467384,0.00053284096,0.00065573305,0.00752126,0.001169128,0.000050075538,0.000021129463,0.00004325946,0.00003617847,0.0028006837],"study_design_scores_gemma":[0.2792925,0.016258704,0.69765073,0.0036422163,0.00091389177,0.00014527312,0.00045896386,0.00014944446,0.0007076303,0.000014647063,0.000025826954,0.0007401809],"about_ca_topic_score_codex":0.001037675,"about_ca_topic_score_gemma":0.011320151,"teacher_disagreement_score":0.16510445,"about_ca_system_score_codex":0.002458933,"about_ca_system_score_gemma":0.0024165628,"threshold_uncertainty_score":0.99952435},"labels":[],"label_agreement":null},{"id":"W4417004955","doi":"10.1182/blood-2025-1024","title":"Safety and efficacy of INCA033989, a novel first in class mutant calreticulin-specific monoclonal antibody, in patients with essential thrombocythemia","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Princess Margaret Cancer Centre","funders":"","keywords":"Essential thrombocythemia; Anagrelide; Myelofibrosis; Calreticulin; Hematology; Thrombocytosis; Thrombopoietin receptor; Polycythemia vera; Platelet","score_opus":0.006471341317987652,"score_gpt":0.2467173859262837,"score_spread":0.24024604460829604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417004955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977315,0.00024191684,0.000062161715,0.00042255636,0.000037473237,0.00079083786,0.00004490303,0.000010559199,0.00065806095],"genre_scores_gemma":[0.9988459,0.00026608264,0.00068208,0.00005156942,0.000020344112,0.000026590096,0.000079381796,0.000013119127,0.00001493016],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987607,0.000024090472,0.00041376994,0.00035542238,0.00022770897,0.0002183315],"domain_scores_gemma":[0.99939096,0.00016905055,0.00008578746,0.00020821695,0.00007938375,0.00006658319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008848557,0.00019691099,0.0005249244,0.00018118213,0.00004107265,0.000010671665,0.000053517797,0.000095074574,0.000033150678],"category_scores_gemma":[0.00003936814,0.0001451298,0.000043170854,0.00034434666,0.000119087716,0.00003872714,0.000060637183,0.00017171552,0.0000018075802],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015157425,0.007344115,0.98747253,0.00010343984,0.00017565615,0.0000557537,0.0003694021,0.000019313518,0.0013073909,0.0012323688,0.000011708009,0.00039255977],"study_design_scores_gemma":[0.03750247,0.00054030283,0.9488088,0.0007560367,0.00012808885,0.000006948431,0.00003815744,0.00006970302,0.011775582,0.00001144096,0.0002470085,0.00011547593],"about_ca_topic_score_codex":0.00009445202,"about_ca_topic_score_gemma":0.0002713423,"teacher_disagreement_score":0.038663764,"about_ca_system_score_codex":0.00007138048,"about_ca_system_score_gemma":0.00011441353,"threshold_uncertainty_score":0.59182215},"labels":[],"label_agreement":null},{"id":"W4417004958","doi":"10.1182/blood-2025-1030","title":"Antigen-dependent clonal sweep with sequential or combinatory anti-myeloma T cell engagers","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Antigen; Mutation; Bone marrow; Flow cytometry; T cell; Chimeric antigen receptor; Multiple myeloma; Immune system","score_opus":0.019741545579833257,"score_gpt":0.29060074867316643,"score_spread":0.27085920309333317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417004958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847394,0.0005383394,0.00007996976,0.00024493606,0.00012627986,0.0006587184,0.000028246068,0.00010368766,0.013480424],"genre_scores_gemma":[0.9922581,0.00013890442,0.0007453287,0.00019941929,0.00006452712,0.000046811685,0.000066882996,0.000028399625,0.00645167],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824405,0.000104297906,0.00021778882,0.00040421216,0.0005374025,0.00049227977],"domain_scores_gemma":[0.9990721,0.000094841336,0.00005326753,0.00039920118,0.000118052034,0.0002625667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018503265,0.0002252335,0.00034392762,0.00020703809,0.00019964455,0.000040258168,0.00014504213,0.00010442343,0.00041013994],"category_scores_gemma":[0.000054232765,0.00015490886,0.00009505822,0.00027671808,0.00012214614,0.00006861519,0.00008542598,0.00035968778,0.00012136912],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003191052,0.009552703,0.88911265,0.0006445727,0.0024356602,0.01359306,0.00029357136,0.0000064425294,0.070857376,0.00047324251,0.0016620527,0.008177645],"study_design_scores_gemma":[0.04287973,0.0014355207,0.53654736,0.00027959055,0.00047579466,0.00036729887,0.00029112864,0.00007823766,0.41391703,0.000046920883,0.0033528272,0.0003285482],"about_ca_topic_score_codex":0.0001341757,"about_ca_topic_score_gemma":0.000039644325,"teacher_disagreement_score":0.35256526,"about_ca_system_score_codex":0.0000669469,"about_ca_system_score_gemma":0.00063421245,"threshold_uncertainty_score":0.63170004},"labels":[],"label_agreement":null},{"id":"W4417005015","doi":"10.1182/blood-2025-1819","title":"Phase 3 study (inMIND) of tafasitamab plus lenalidomide and rituximab for relapsed or refractory follicular lymphoma: Clinical characteristics and outcomes of patients receiving second-line treatment","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Lenalidomide; Rituximab; Chemoimmunotherapy; Follicular lymphoma; Refractory (planetary science); Population; Phases of clinical research; Neutropenia; Placebo; Maintenance therapy","score_opus":0.03145136658565763,"score_gpt":0.3478430245550208,"score_spread":0.3163916579693632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417005015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996837,0.0006582714,0.0000105508,0.00009084224,0.00014212207,0.0018975683,0.00030176603,0.000016569638,0.00004529049],"genre_scores_gemma":[0.99822783,0.0003481443,0.00064907875,0.00007853754,0.000036072423,0.00017719339,0.00009734325,0.0000203529,0.00036545718],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982147,0.0000828252,0.0009407327,0.00039958823,0.0001717852,0.00019031849],"domain_scores_gemma":[0.998218,0.00076571415,0.00036174228,0.0003622928,0.00017315564,0.00011910164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025931408,0.00025716948,0.0012839468,0.00012549506,0.00006488522,0.000012474538,0.000053265347,0.00012158125,0.000013705313],"category_scores_gemma":[0.0004788317,0.00017102748,0.00018192484,0.00009705924,0.00008613999,0.000051285715,0.000058043148,0.000038946797,5.8550455e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004264364,0.09624566,0.84219307,0.00027012383,0.0023925619,0.00006616371,0.00041076695,2.311342e-8,0.00009173918,0.000015157978,0.000042222484,0.054008164],"study_design_scores_gemma":[0.2815731,0.012592491,0.6987502,0.00015915066,0.0031085347,0.0000047406247,0.00020755624,0.00001937125,0.0031055682,0.000009178185,0.00036507688,0.00010504196],"about_ca_topic_score_codex":0.0000405224,"about_ca_topic_score_gemma":0.00004253275,"teacher_disagreement_score":0.27730873,"about_ca_system_score_codex":0.000108140084,"about_ca_system_score_gemma":0.00023663549,"threshold_uncertainty_score":0.69742984},"labels":[],"label_agreement":null},{"id":"W4417005033","doi":"10.1182/blood-2025-3139","title":"Title: Role of primary VTE prophylaxis in pediatric leukemia, lymphoma, and solid tumors: A systematic review and meta-analysis.","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; McMaster University Medical Centre; Centre hospitalier universitaire de Québec; McMaster Children's Hospital; University of Toronto","funders":"","keywords":"Systematic review; MEDLINE; Grading (engineering); Meta-analysis; Population; Randomized controlled trial; Guideline; Thrombosis","score_opus":0.017208985670912804,"score_gpt":0.2623257423482366,"score_spread":0.24511675667732377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417005033","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17908804,0.79097676,0.00006540443,0.00043316136,0.00002793132,0.002942904,0.000020491298,0.00006591024,0.026379379],"genre_scores_gemma":[0.9965661,0.0016570509,0.00025545908,0.0004812408,0.000007438079,0.00005238915,0.000005157201,0.0000060944985,0.0009690475],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99929464,0.000053576892,0.00032902823,0.00014286547,0.00011079096,0.000069093265],"domain_scores_gemma":[0.9995983,0.00003135029,0.00010096771,0.00019747789,0.000038618782,0.000033273594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024015177,0.00008269555,0.0011385812,0.00020561335,0.000011255205,0.000005674056,0.00003509551,0.000041705633,0.00008566941],"category_scores_gemma":[0.000054905104,0.000059408234,0.00013088848,0.00050931313,0.000013031976,0.000019781806,0.000030844134,0.000039361763,0.000006943425],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002109254,0.0016012556,0.008107068,0.8987967,0.08129009,0.000037650334,0.0003569337,0.0000012247898,0.003314707,0.005477628,0.0005087776,0.00048689617],"study_design_scores_gemma":[0.0017329109,0.0001527828,0.024869239,0.001733505,0.9683628,0.000026809048,0.00003938571,0.000088957466,0.0021306244,0.00067279214,0.000022959966,0.00016720276],"about_ca_topic_score_codex":0.000012913255,"about_ca_topic_score_gemma":0.000005632027,"teacher_disagreement_score":0.8970632,"about_ca_system_score_codex":0.000014054865,"about_ca_system_score_gemma":0.00008660102,"threshold_uncertainty_score":0.24225974},"labels":[],"label_agreement":null},{"id":"W4417005037","doi":"10.1182/blood-2025-3137","title":"Role in of primary VTE prophylaxis in pediatric patients in hospitalized and critically ill settings: A systematic review and meta-analysis","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Centre hospitalier universitaire de Québec; McMaster Children's Hospital; Public Health Ontario","funders":"","keywords":"Randomized controlled trial; Critically ill; MEDLINE; Guideline; Population; Meta-analysis; Systematic review; Anticoagulant","score_opus":0.011380418368609401,"score_gpt":0.25703738294052536,"score_spread":0.24565696457191596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417005037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9505495,0.046483234,0.000009744022,0.00063532504,0.000006533647,0.0019534105,0.000009280782,0.000010662435,0.00034231498],"genre_scores_gemma":[0.9965456,0.00096089795,0.00064241345,0.0016494789,0.000001894906,0.0001457855,0.000009761385,0.0000069869016,0.00003713929],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998436,0.00022379075,0.0007612451,0.00025543905,0.00019165724,0.00013188929],"domain_scores_gemma":[0.9993339,0.00010385795,0.00012557383,0.00021922473,0.00017191369,0.00004553626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006551079,0.00012912894,0.0018358898,0.00057021866,0.000010671759,0.000008215995,0.000050203646,0.00007190593,0.000015708787],"category_scores_gemma":[0.0008867431,0.00009945501,0.00014544632,0.0012625057,0.00001902362,0.000049467297,0.000052444917,0.00012386515,6.240994e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029587714,0.00329022,0.55436575,0.42965347,0.011265395,0.00001852439,0.00060531806,7.473408e-7,0.00020620457,0.00050626055,0.000008411342,0.000050072747],"study_design_scores_gemma":[0.0045717834,0.00027995388,0.6720517,0.0030044196,0.319169,0.0000015161336,0.00009116948,0.000040644605,0.00015344155,0.0004782268,5.7814344e-7,0.00015750655],"about_ca_topic_score_codex":0.000040204843,"about_ca_topic_score_gemma":0.00005062436,"teacher_disagreement_score":0.42664906,"about_ca_system_score_codex":0.000016689732,"about_ca_system_score_gemma":0.000039365463,"threshold_uncertainty_score":0.40556574},"labels":[],"label_agreement":null},{"id":"W4417005078","doi":"10.1182/blood-2025-3240","title":"PKM2 modulation regulates leukemia cell survival.","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Guelph","funders":"","keywords":"PKM2; Pyruvate kinase; Glycolysis; Anaerobic glycolysis; Warburg effect; Anabolism; Cell growth; Phosphoenolpyruvate carboxykinase; Pentose phosphate pathway","score_opus":0.013561899101615685,"score_gpt":0.27701741164042076,"score_spread":0.26345551253880506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417005078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9105119,0.00036337017,0.00028156795,0.001017452,0.00013308386,0.00034346408,0.0000039116953,0.00013020345,0.08721506],"genre_scores_gemma":[0.96229076,0.00006766416,0.0012099977,0.00024408022,0.00015994372,0.00001945268,0.00004592496,0.000021359336,0.035940815],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988737,0.00005069805,0.00021072004,0.00028661318,0.00028489289,0.00029335753],"domain_scores_gemma":[0.99914813,0.00010533085,0.00003694657,0.00047296466,0.0001378441,0.00009878989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026057742,0.00012809112,0.0002325948,0.00019084757,0.00007746969,0.000023407498,0.00012822417,0.00014120064,0.00013725438],"category_scores_gemma":[0.00014084388,0.00011503098,0.00007938439,0.00044294843,0.000056126475,0.000060725357,0.000091061345,0.00026349587,0.00015554676],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005334723,0.0013730092,0.14948945,0.0011655929,0.0006413712,0.0003109124,0.00043059647,0.00028453497,0.7701832,0.005776675,0.050042413,0.019768752],"study_design_scores_gemma":[0.014313389,0.00024780506,0.3086785,0.00022921311,0.0004408479,0.000035666733,0.00020231407,0.0074221985,0.6437215,0.0017815125,0.022599313,0.0003277099],"about_ca_topic_score_codex":0.0001062339,"about_ca_topic_score_gemma":0.000008251689,"teacher_disagreement_score":0.15918908,"about_ca_system_score_codex":0.000263413,"about_ca_system_score_gemma":0.0005535183,"threshold_uncertainty_score":0.46908274},"labels":[],"label_agreement":null},{"id":"W4417005099","doi":"10.1182/blood-2025-3669","title":"Sex-and-ethnicity-related differences in primary central nervous system lymphoma based on the SEER database","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Primary central nervous system lymphoma; Proportional hazards model; Concordance; Cohort; Retrospective cohort study; Lymphoma; Survival analysis; Cancer registry; Stage (stratigraphy)","score_opus":0.011405916670863851,"score_gpt":0.22148560164780484,"score_spread":0.210079684976941,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417005099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99043185,0.0008489696,0.000007836086,0.0018338207,0.00010291851,0.00055072946,0.00003649284,0.000068121204,0.0061192457],"genre_scores_gemma":[0.99837047,0.000064779975,0.00004744064,0.0010013382,0.00002457748,0.00009888667,0.0000567093,0.0000116252095,0.00032419967],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998869,0.00011589751,0.00024710235,0.00029957877,0.00020641148,0.00026200133],"domain_scores_gemma":[0.9990765,0.00038063378,0.000046587462,0.00039640666,0.000018328094,0.000081548234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016835229,0.00017675414,0.0003329144,0.00011066406,0.000080437814,0.000025548814,0.00008658153,0.00007759936,0.000024902647],"category_scores_gemma":[0.000048453196,0.000104681545,0.000071157454,0.00024128884,0.000055658707,0.000023754517,0.000052280055,0.00008587716,0.000011400206],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021265821,0.0050281407,0.95718426,0.00044815024,0.00040468125,0.000824331,0.00028351895,0.000007713936,0.0005566551,0.0033118622,0.00056584366,0.031172162],"study_design_scores_gemma":[0.0067911376,0.00014392045,0.98744065,0.00094541034,0.00036353638,0.00003209407,0.00017416949,0.0013083989,0.0025802439,0.000012197496,0.000112362744,0.00009585659],"about_ca_topic_score_codex":0.00035081667,"about_ca_topic_score_gemma":0.000029870202,"teacher_disagreement_score":0.031076306,"about_ca_system_score_codex":0.00017053349,"about_ca_system_score_gemma":0.00017608964,"threshold_uncertainty_score":0.42687896},"labels":[],"label_agreement":null},{"id":"W4417005124","doi":"10.1182/blood-2025-4513","title":"Real-world selection of fixed-duration versus continuous therapies for treatment-naïve chronic lymphocytic leukemia/small lymphocytic lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Cancer Foundation; University of Calgary; Alberta Health Services","funders":"","keywords":"IGHV@; Chemoimmunotherapy; Chronic lymphocytic leukemia; Rituximab; Ibrutinib; Clinical trial; Bendamustine; Venetoclax; Lymphoma","score_opus":0.02508001714647555,"score_gpt":0.3109438261423497,"score_spread":0.28586380899587416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417005124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98706436,0.0020643887,0.00032410063,0.000097349046,0.00050919526,0.002480087,0.00003846897,0.0002834193,0.0071386513],"genre_scores_gemma":[0.9837237,0.0012875077,0.0012952617,0.000066917986,0.00047738134,0.00062971446,0.00016022264,0.00008692286,0.012272397],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996965,0.00011623579,0.0008904469,0.00074567745,0.000452189,0.0008304385],"domain_scores_gemma":[0.9973189,0.00094172126,0.00031181282,0.00076010416,0.00048299343,0.00018443812],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034648972,0.0004848795,0.0009911737,0.00064842735,0.00022996984,0.0000627772,0.00025739073,0.0002935509,0.00008702829],"category_scores_gemma":[0.00033193867,0.00043185215,0.0004172934,0.0010923734,0.00024201535,0.00013348235,0.0000728048,0.00007371119,0.000035679554],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.070623584,0.0075178607,0.009429202,0.01350801,0.028418016,0.00067526486,0.005088867,0.0030618839,0.40242693,0.02529421,0.007931518,0.42602465],"study_design_scores_gemma":[0.38101986,0.0053313,0.0026036317,0.00080551225,0.0031460505,0.00019757672,0.0003878528,0.06358427,0.53465194,0.0003013283,0.00736708,0.0006035885],"about_ca_topic_score_codex":0.0078537995,"about_ca_topic_score_gemma":0.0030394853,"teacher_disagreement_score":0.42542106,"about_ca_system_score_codex":0.17819849,"about_ca_system_score_gemma":0.078953385,"threshold_uncertainty_score":0.9998133},"labels":[],"label_agreement":null},{"id":"W4417005135","doi":"10.1182/blood-2025-4517","title":"The impact of distance to CAR-T centre on CAR-T delivery and CAR-T outcomes: A single centre retrospective cohort study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Juravinski Cancer Centre; McMaster University Medical Centre","funders":"","keywords":"Retrospective cohort study; Cohort; Cohort study; Young adult; Systemic therapy; Propensity score matching; Log-rank test","score_opus":0.01285999277351518,"score_gpt":0.3074315453285909,"score_spread":0.2945715525550757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417005135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892918,0.00043462642,0.0000039883103,0.0006449555,0.00010442954,0.0023860047,0.0000857597,0.00004280712,0.007005638],"genre_scores_gemma":[0.9885461,0.000074026815,0.000016317641,0.00008256679,0.000056108747,0.000029287483,0.000007993654,0.000031445696,0.011156187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978677,0.00015156872,0.00033457845,0.0005109644,0.00064562156,0.00048956095],"domain_scores_gemma":[0.998194,0.00033859967,0.00007912863,0.0008255945,0.00035210283,0.00021061112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038778211,0.00027037057,0.0006404975,0.00014600951,0.00016800924,0.000053072305,0.00020190711,0.000078755766,0.00014174159],"category_scores_gemma":[0.00036962592,0.00017446314,0.00021223674,0.00053909665,0.000121813166,0.000035688146,0.00014063364,0.00031602348,0.000008440688],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007838725,0.0019632275,0.9798797,0.00003106387,0.0013792971,0.00006798997,0.0018133575,0.0000042606785,0.011662844,0.000055318647,0.0009615442,0.0013975388],"study_design_scores_gemma":[0.004486222,0.0014694027,0.98553437,0.00013775156,0.00033559097,0.000004723784,0.0024480037,0.000012661568,0.004862934,0.000039486717,0.00052078225,0.00014808048],"about_ca_topic_score_codex":0.0016242862,"about_ca_topic_score_gemma":0.0015328372,"teacher_disagreement_score":0.0067999098,"about_ca_system_score_codex":0.0005135434,"about_ca_system_score_gemma":0.0002025557,"threshold_uncertainty_score":0.71144},"labels":[],"label_agreement":null},{"id":"W4417005160","doi":"10.1182/blood-2025-4530","title":"Longitudinal assessments of simple frailty tools can help predict outcomes of patients undergoing chimeric antigen receptor T-cell (CAR-T) therapy: A prospective pilot study at Princess Margaret Cancer Centre","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Frailty in Older Adults","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Proportional hazards model; Prospective cohort study; Cohort; Comorbidity; Follicular lymphoma; Cancer; Clinical trial","score_opus":0.0343280497823988,"score_gpt":0.3173034602643677,"score_spread":0.2829754104819689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417005160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99458206,0.00026955857,0.000011295341,0.00016764933,0.00027968112,0.0032331708,0.0005480679,0.0000654431,0.0008430684],"genre_scores_gemma":[0.99785995,0.00020397178,0.00022584238,0.00009161342,0.00004142701,0.000132952,0.00016147949,0.000044484197,0.00123827],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974498,0.00012809083,0.00067196845,0.0005962777,0.0007357698,0.00041810566],"domain_scores_gemma":[0.9981753,0.00022119953,0.00043492345,0.0005883582,0.00046096309,0.000119251556],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014637808,0.000351752,0.00086687796,0.00016426778,0.00010597642,0.000019556643,0.00028454632,0.000071751914,0.00025983126],"category_scores_gemma":[0.00019320198,0.00029347575,0.00012045137,0.0005015275,0.00009041613,0.00011840795,0.00024643177,0.00021111967,0.0000025598047],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006124819,0.011388977,0.981893,0.00036979013,0.0017224711,0.000006696188,0.00079237774,0.0000068039444,0.0016179092,0.0000043789496,0.00045077087,0.00113435],"study_design_scores_gemma":[0.017649904,0.0041194777,0.95317686,0.00033442862,0.0004089996,5.091444e-7,0.00057820714,0.0000058110018,0.023438707,0.000016998503,0.000067244524,0.00020286744],"about_ca_topic_score_codex":0.0022192656,"about_ca_topic_score_gemma":0.0031014264,"teacher_disagreement_score":0.028716149,"about_ca_system_score_codex":0.0003087158,"about_ca_system_score_gemma":0.00042575048,"threshold_uncertainty_score":0.9999517},"labels":[],"label_agreement":null},{"id":"W4417005181","doi":"10.1182/blood-2025-7274","title":"DNA methylation instability as a biomarker to predict resistance or progression to advanced disease Phase following tyrosine kinase inhibitor therapy in chronic myeloid leukemia","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"DNA methylation; Myeloid leukemia; Epigenetics; Methylation; Biomarker; CpG site; Genome instability; Myeloid","score_opus":0.016375076702198548,"score_gpt":0.33585564430109904,"score_spread":0.3194805675989005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417005181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98880285,0.004272023,0.00014432697,0.0013402677,0.00025125637,0.004407957,0.000050120772,0.00019869099,0.0005324956],"genre_scores_gemma":[0.9943171,0.00012309717,0.0024661392,0.0004895914,0.00012008921,0.0011357986,0.000120593155,0.00005173962,0.0011758384],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971267,0.00015312845,0.0006572484,0.00094790076,0.0005445712,0.00057042553],"domain_scores_gemma":[0.99818695,0.00015323922,0.000108187975,0.0009239904,0.00010832884,0.00051929534],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000429156,0.00040551194,0.0005812084,0.00042467943,0.00013300958,0.000039044517,0.00018180624,0.0001415023,0.00010027589],"category_scores_gemma":[0.0011189743,0.00032317016,0.00017662584,0.0016407499,0.000047707224,0.00022100894,0.00012700773,0.00021688531,0.000030749638],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033857808,0.0049549714,0.023354832,0.0007277499,0.00040525975,0.0011231783,0.0006547487,0.000047167443,0.6964357,0.000036132245,0.0007973076,0.23760517],"study_design_scores_gemma":[0.13520217,0.004304907,0.2306791,0.008118958,0.000658131,0.000007578042,0.00013052447,0.0004143482,0.5971207,0.00018363546,0.022354525,0.00082543393],"about_ca_topic_score_codex":0.000062034684,"about_ca_topic_score_gemma":0.00034735026,"teacher_disagreement_score":0.23677973,"about_ca_system_score_codex":0.005142279,"about_ca_system_score_gemma":0.003991757,"threshold_uncertainty_score":0.99992204},"labels":[],"label_agreement":null},{"id":"W4417005194","doi":"10.1182/blood-2025-7480","title":"Title: Hacs1 is a myeloma immunosuppressor driving pro-tumorigenic myelopoiesis and myeloid cell differentiation through MS4A3/IL3/GM-CSF signaling","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Discovery Centre; University of Toronto","funders":"","keywords":"Myelopoiesis; Myeloid; Haematopoiesis; Bone marrow; Progenitor cell; Immune system; Cytokine; Cellular differentiation","score_opus":0.006969279992262762,"score_gpt":0.22431780829738182,"score_spread":0.21734852830511905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417005194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9238532,0.03414326,0.0005336442,0.0004523056,0.0024246657,0.0005213929,0.00003372759,0.00019523076,0.03784258],"genre_scores_gemma":[0.9732985,0.000567537,0.00042869092,0.00027107747,0.000055022825,0.00005217117,0.000050991715,0.000028839868,0.025247209],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99885947,0.00009277509,0.00030017327,0.00035955376,0.000046578367,0.00034143776],"domain_scores_gemma":[0.999329,0.00011228761,0.00012058438,0.00035835183,0.00006866838,0.000011111287],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00010923839,0.00021463966,0.0002711552,0.000093943,0.00025202363,0.000045924528,0.00023209667,0.0002471493,0.0025088352],"category_scores_gemma":[0.000039410508,0.00020684459,0.00008653553,0.00017434102,0.00012910899,0.00013857946,0.00017726346,0.0002889628,0.0005111721],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003050515,0.00020332434,0.0019315085,0.00014466453,0.00039308143,0.0000036854158,0.0009283177,6.01946e-7,0.9810988,0.000555197,0.011585328,0.0031250387],"study_design_scores_gemma":[0.0014464981,0.000044139942,0.0046648444,0.00012080277,0.00024693867,0.0000120974255,0.000119457705,0.0000049663117,0.92678726,0.0006018022,0.06571531,0.00023586414],"about_ca_topic_score_codex":0.000030250609,"about_ca_topic_score_gemma":0.0000037010047,"teacher_disagreement_score":0.054311473,"about_ca_system_score_codex":0.000037506365,"about_ca_system_score_gemma":0.00010209642,"threshold_uncertainty_score":0.998403},"labels":[],"label_agreement":null},{"id":"W4417005305","doi":"10.1182/blood-2025-7565","title":"Anti-CD38-based quadruplet versus triplet induction regimens in transplant-ineligible newly diagnosed multiple myeloma: A systematic review and meta-analysis","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Dexamethasone; Induction therapy; Multiple myeloma; Neutropenia; Adverse effect; Meta-analysis; Induction chemotherapy; Minimal residual disease; Randomized controlled trial","score_opus":0.05244011514780706,"score_gpt":0.32639834790211963,"score_spread":0.2739582327543126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417005305","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8294305,0.15150666,0.00038946405,0.0074228854,0.00010565776,0.00995028,0.0003841066,0.00021747865,0.00059292215],"genre_scores_gemma":[0.99484795,0.002543392,0.000538086,0.00046849676,0.000013091365,0.0008816471,0.00026731184,0.000020142794,0.00041987162],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99751747,0.00036669665,0.00071934384,0.00055363047,0.00041985486,0.0004230097],"domain_scores_gemma":[0.9981925,0.0006629004,0.00015657656,0.00067167514,0.00011501921,0.00020131822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061339757,0.00032445134,0.0025986505,0.0007979193,0.00008843894,0.00003764525,0.0001266106,0.00012546657,0.000097602475],"category_scores_gemma":[0.00074838096,0.00023300156,0.0006565505,0.0017515392,0.000054815984,0.00008738422,0.00002435154,0.00023610928,0.000019498217],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023772698,0.00806476,0.12665135,0.37329188,0.4832592,0.0029152946,0.00044140412,0.00008640497,0.0017401341,0.00012338578,0.00095135585,0.00009758301],"study_design_scores_gemma":[0.040421188,0.00036137702,0.02716712,0.003806278,0.9236042,0.000027518561,0.00009673101,0.0006750183,0.0034600375,0.000007951538,0.000045549135,0.0003270142],"about_ca_topic_score_codex":0.00070050027,"about_ca_topic_score_gemma":0.00076550024,"teacher_disagreement_score":0.44034502,"about_ca_system_score_codex":0.00006954979,"about_ca_system_score_gemma":0.00016343854,"threshold_uncertainty_score":0.95015275},"labels":[],"label_agreement":null},{"id":"W4417005790","doi":"10.1182/blood-2025-6309","title":"Risk of hepatitis B virus reactivaton in HBsAg-negative, anti-hbc-positive patients receiving rituximab: A systematic review","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Thornhill Medical (Canada); University of Ottawa; McMaster University; McMaster University Medical Centre","funders":"","keywords":"Rituximab; Serostatus; Hepatitis B virus; Systematic review; Hepatitis B; Randomized controlled trial; Clinical trial; Serology; MEDLINE","score_opus":0.00740457531327772,"score_gpt":0.2574769778598469,"score_spread":0.2500724025465692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417005790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97743464,0.014493814,0.000022162565,0.000157933,0.00010486451,0.0028727155,0.00013612103,0.00005183482,0.004725949],"genre_scores_gemma":[0.95477575,0.043926302,0.00045860652,0.00043858247,0.000015560661,0.00022018731,0.000019111065,0.00002518703,0.00012072005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974377,0.00046458846,0.0010234573,0.00037410442,0.00039393993,0.00030619866],"domain_scores_gemma":[0.99791247,0.00064502936,0.000505255,0.00048629503,0.0003836176,0.00006731914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005590321,0.00025617264,0.0017127529,0.00027395762,0.00008248995,0.000009600426,0.00012984226,0.00009741083,0.000019383835],"category_scores_gemma":[0.0066883727,0.00022803975,0.0001716826,0.00082315266,0.00009413217,0.00012742126,0.0001231353,0.00030952884,0.00003341351],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000267189,0.0018567564,0.8871029,0.10870659,0.00066553056,0.000039572362,0.00051299937,1.271531e-7,0.00048241843,0.00004190168,0.00024084582,0.00032366],"study_design_scores_gemma":[0.003471032,0.00020296934,0.7330862,0.250401,0.0019559155,0.0000043754617,0.000023066681,0.000010855406,0.010603234,0.00007161076,0.000010766591,0.00015897723],"about_ca_topic_score_codex":0.010434112,"about_ca_topic_score_gemma":0.004037422,"teacher_disagreement_score":0.15401666,"about_ca_system_score_codex":0.00014421689,"about_ca_system_score_gemma":0.00011048167,"threshold_uncertainty_score":0.9961555},"labels":[],"label_agreement":null},{"id":"W4417005838","doi":"10.1182/blood-2025-6317","title":"Real-world treatment patterns and patient characteristics of venetoclax combination time-limited therapy for chronic lymphocytic leukemia","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada)","funders":"","keywords":"Venetoclax; Obinutuzumab; Regimen; Chronic lymphocytic leukemia; Rituximab; IGHV@; Bendamustine; Neutropenia; Cohort","score_opus":0.014401138527520327,"score_gpt":0.2891758793130606,"score_spread":0.27477474078554026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417005838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969298,0.00047693143,0.000028235183,0.000078264966,0.000063682935,0.0016612692,0.00007408169,0.000050652376,0.000637058],"genre_scores_gemma":[0.99577355,0.001766098,0.00013499505,0.00008843148,0.00006405271,0.0002510953,0.00018580079,0.000029972996,0.0017059972],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99870765,0.00004294318,0.00039813085,0.0003127205,0.00023140639,0.00030717227],"domain_scores_gemma":[0.99898726,0.00026391234,0.00013338406,0.00034813024,0.00017126116,0.000096074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000100869824,0.00019682449,0.0004702899,0.00024291642,0.00006483204,0.000018560822,0.00007878504,0.00009740521,0.00003925958],"category_scores_gemma":[0.00005457653,0.00016492422,0.00010092178,0.00024069723,0.00008106083,0.00003419768,0.000044997953,0.00006597156,0.0000062246845],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.008069029,0.005264606,0.037180234,0.006150108,0.00571358,0.00031512504,0.0033352647,0.00013710897,0.10058648,0.0031538429,0.0022540933,0.8278405],"study_design_scores_gemma":[0.28580567,0.010957761,0.2408469,0.0017950973,0.0012572106,0.000085545755,0.000097171716,0.09775875,0.35393643,0.00030517814,0.0065943133,0.0005599567],"about_ca_topic_score_codex":0.0024330071,"about_ca_topic_score_gemma":0.000092256036,"teacher_disagreement_score":0.8272806,"about_ca_system_score_codex":0.046107814,"about_ca_system_score_gemma":0.017788647,"threshold_uncertainty_score":0.98777956},"labels":[],"label_agreement":null},{"id":"W4417005998","doi":"10.1182/blood-2025-3199","title":"Maternal and fetal pharmacokinetics (PK) of pegcetacoplan in paroxysmal nocturnal hemoglobinuria (PNH): A case report of use in pregnancy","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; London Health Sciences Centre; Western University","funders":"","keywords":"Eculizumab; Pregnancy; Paroxysmal nocturnal hemoglobinuria; Anemia; Gestation; Hemolytic anemia; Gestational age; Hematologic disease; Erythropoietin","score_opus":0.015203421549507646,"score_gpt":0.27125878773852724,"score_spread":0.2560553661890196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417005998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954461,0.0036153088,0.000007116528,0.000018174713,0.00022763677,0.00032760104,0.00012961123,0.000010085913,0.00021837518],"genre_scores_gemma":[0.999492,0.00003152749,0.000093794435,0.000008405532,0.000006827957,0.000019160789,0.000021776135,0.0000062430595,0.00032025296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877256,0.00013788056,0.00064937375,0.00021098003,0.000033458124,0.00019576917],"domain_scores_gemma":[0.9994323,0.000091244074,0.00021183446,0.00020882777,0.000040125495,0.000015635485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001357247,0.00012715333,0.00033039134,0.00019383228,0.000019611969,0.000006861227,0.00010627928,0.00008128447,0.00011385707],"category_scores_gemma":[0.000062865336,0.000122053,0.00004846595,0.00013638007,0.000100074125,0.000055064025,0.0001179527,0.00012199803,0.0000016699806],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016500862,0.00050282484,0.91804177,0.00027830922,0.00015541977,0.008359188,0.0001288074,0.0000068011677,0.0718968,0.000066639186,0.00011710572,0.00028135514],"study_design_scores_gemma":[0.011681794,0.00014291366,0.6510372,0.0012797475,0.00026722185,0.024653744,0.00014666861,0.000011455755,0.3103085,0.00007972225,0.00020907902,0.00018193372],"about_ca_topic_score_codex":0.0008008154,"about_ca_topic_score_gemma":0.0005607613,"teacher_disagreement_score":0.26700452,"about_ca_system_score_codex":0.000014940639,"about_ca_system_score_gemma":0.00007386291,"threshold_uncertainty_score":0.4977177},"labels":[],"label_agreement":null},{"id":"W4417006002","doi":"10.1182/blood-2025-2592","title":"Pediatric sickle cell outpatient pain management: A quality improvement initiative","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Quality management; Emergency department; PDCA; Pain management; MEDLINE; Quality of life (healthcare); Vaso-occlusive crisis; Patient satisfaction; Outpatient clinic","score_opus":0.00905258345653699,"score_gpt":0.24915598746667933,"score_spread":0.24010340401014235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417006002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8505047,0.0015318164,0.0007109169,0.00079185964,0.00020961044,0.00096241455,0.000011977906,0.00010872986,0.14516799],"genre_scores_gemma":[0.99324495,0.000565253,0.00039509195,0.002632198,0.000049445112,0.00006561211,0.000027180682,0.000012416134,0.003007844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988468,0.00009066987,0.000332825,0.00026419325,0.00020606881,0.00025944185],"domain_scores_gemma":[0.9994418,0.0000605896,0.00008380811,0.00026969137,0.00006059642,0.00008352247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044614525,0.00014216192,0.00021227151,0.00014608137,0.00008203251,0.0000125270135,0.00007397558,0.000102633,0.00006276992],"category_scores_gemma":[0.000059061007,0.000118895776,0.00010518815,0.00037761126,0.000025749652,0.000027075203,0.00008417324,0.0001933798,0.00005158628],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011402627,0.073628694,0.49068174,0.021104328,0.004001309,0.0010543076,0.011308201,0.00005532303,0.004727287,0.01615325,0.0704419,0.3057034],"study_design_scores_gemma":[0.23598072,0.016761087,0.35985515,0.0019629155,0.020595253,0.000019029821,0.071538635,0.0009395604,0.069551215,0.011895964,0.20632139,0.0045790877],"about_ca_topic_score_codex":0.000031678213,"about_ca_topic_score_gemma":0.0000026668083,"teacher_disagreement_score":0.3011243,"about_ca_system_score_codex":0.000039716488,"about_ca_system_score_gemma":0.00006677794,"threshold_uncertainty_score":0.4848429},"labels":[],"label_agreement":null},{"id":"W4417006069","doi":"10.1182/blood-2025-7051","title":"Prognostic relevance of multiparameter flow cytometry-based MRD assessment in patients with FLT3-ITD mutated AML considering concomitant mutations including DNMT3A/NPM1/WT1 mutation","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"NPM1; Myeloid leukemia; Cumulative incidence; Hazard ratio; Concomitant; Proportional hazards model; Minimal residual disease; Incidence (geometry); Overall survival","score_opus":0.019316080134565886,"score_gpt":0.3159474065810198,"score_spread":0.2966313264464539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417006069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898416,0.000063061,0.00734293,0.00030675894,0.000064795626,0.0018969484,0.000056752517,0.000085030864,0.00034214882],"genre_scores_gemma":[0.9330033,0.0000044318945,0.066284806,0.0001423621,0.000013315019,0.00020433974,0.00026891177,0.000039267128,0.000039248484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975846,0.00016221764,0.0006968712,0.00047251448,0.00063625275,0.00044755515],"domain_scores_gemma":[0.99722004,0.001423011,0.00022168076,0.00039480743,0.000617331,0.00012312797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040393454,0.00025835045,0.00055765,0.0008737827,0.00010211763,0.00003448151,0.0001392705,0.00013380524,0.000027789081],"category_scores_gemma":[0.0018408461,0.00022909444,0.0000718896,0.001583171,0.00019891081,0.00015000098,0.000084663916,0.0005556905,0.0000072045395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006203237,0.0018444057,0.980684,0.00063360267,0.0003864197,0.00028469195,0.00039496797,0.0038688919,0.008285796,0.000042117485,0.00003125427,0.0029235673],"study_design_scores_gemma":[0.036779646,0.0012009196,0.8277742,0.0018144841,0.00052409247,0.00001513457,0.00046187398,0.08177049,0.049219277,0.00008781126,0.000028896857,0.0003231703],"about_ca_topic_score_codex":0.00010477163,"about_ca_topic_score_gemma":0.00006855223,"teacher_disagreement_score":0.15290976,"about_ca_system_score_codex":0.000512948,"about_ca_system_score_gemma":0.0011798189,"threshold_uncertainty_score":0.93422},"labels":[],"label_agreement":null},{"id":"W4417006141","doi":"10.1182/blood-2025-3293","title":"LSD1 inhibition enhances venetoclax efficacy in Acute Myeloid Leukemia via metabolic rewiring","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Population Health Research Institute; McMaster University; Hamilton Health Sciences","funders":"","keywords":"Venetoclax; Myeloid leukemia; Azacitidine; Clofarabine; NPM1; Leukemia; In vivo; Myeloid; Cytarabine","score_opus":0.01175402913000026,"score_gpt":0.2939082699760667,"score_spread":0.28215424084606644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417006141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877179,0.0022064473,0.00021765861,0.00070653745,0.00013288327,0.0007068731,0.0000060613047,0.00013274877,0.008172865],"genre_scores_gemma":[0.9948516,0.00087147194,0.0010476211,0.00056672713,0.0002370087,0.00011782042,0.000052519033,0.000035002206,0.002220217],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99799526,0.00009992712,0.00044373923,0.0005004882,0.00038474833,0.0005758504],"domain_scores_gemma":[0.9990307,0.00014273037,0.000074739255,0.00050907803,0.000100626086,0.00014214513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004328665,0.00023569664,0.00051139743,0.00057730306,0.00009374531,0.000037591115,0.00018362363,0.00020345309,0.000075156124],"category_scores_gemma":[0.0002285549,0.00022280261,0.0001256117,0.0011635169,0.00010564011,0.00015240614,0.00017603407,0.0006763743,0.00016778952],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003946905,0.0004588949,0.006857503,0.00021436028,0.00051775016,0.00063567667,0.00043482767,0.000044469605,0.9653486,0.00072570285,0.0011817333,0.023185804],"study_design_scores_gemma":[0.0114054615,0.00017910068,0.10123531,0.0005633895,0.00048701884,0.000117119154,0.0000672789,0.00051324494,0.8773251,0.00034031676,0.0075062267,0.00026043374],"about_ca_topic_score_codex":0.00024502006,"about_ca_topic_score_gemma":0.000057826604,"teacher_disagreement_score":0.0943778,"about_ca_system_score_codex":0.0007172441,"about_ca_system_score_gemma":0.0012074778,"threshold_uncertainty_score":0.90856266},"labels":[],"label_agreement":null},{"id":"W4417006144","doi":"10.1182/blood-2025-4319","title":"First in human prime edited autologous hematopoietic stem cell therapy for the treatment of p47phox CGD: Initial results of PRIME-0101","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Chronic granulomatous disease; Severe combined immunodeficiency; Genetic enhancement; Haematopoiesis; Stem cell; NADPH oxidase; Innate immune system; Nicotinamide adenine dinucleotide phosphate; Immune system","score_opus":0.018538445056820542,"score_gpt":0.26562462451111635,"score_spread":0.2470861794542958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417006144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934049,0.004010229,0.00015255003,0.00025103614,0.00035691692,0.0011923587,0.00015270534,0.000029915793,0.0004493544],"genre_scores_gemma":[0.9980325,0.0003692501,0.00007270533,0.000047256908,0.00003224927,0.00015920732,0.00007168918,0.00001427081,0.0012008416],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987302,0.0001457759,0.0005297754,0.0002919722,0.000034033965,0.00026827332],"domain_scores_gemma":[0.9987813,0.0004696571,0.00022639248,0.00043188513,0.00008011117,0.000010643156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017830025,0.00020538025,0.0004700568,0.00015467255,0.00014079829,0.000005196256,0.00025585954,0.00020966721,0.000034234457],"category_scores_gemma":[0.00001048558,0.00013583478,0.00014895138,0.00019807767,0.0001781518,0.000025662936,0.00003826933,0.00010560557,0.000007917138],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010402086,0.0036025522,0.00017750128,0.000055317407,0.000422483,0.000006861953,0.0020549495,0.000004253801,0.9879601,0.0014012465,0.00020083397,0.0030736974],"study_design_scores_gemma":[0.015261647,0.0022261941,0.0013778858,0.0000675053,0.00012691798,0.0000051248658,0.00026751633,0.0000015836617,0.9737905,0.00028741642,0.006476692,0.00011099654],"about_ca_topic_score_codex":0.00013142476,"about_ca_topic_score_gemma":0.0000666528,"teacher_disagreement_score":0.014221439,"about_ca_system_score_codex":0.00002714839,"about_ca_system_score_gemma":0.00008732026,"threshold_uncertainty_score":0.5539181},"labels":[],"label_agreement":null},{"id":"W4417006155","doi":"10.1182/blood-2025-4295","title":"Post-transplant monitoring of multiparameter flow-cytometry (MFC)-based measurable residual disease (MRD) assessment combined with T-cell chimerism following allogeneic stem cell transplantation (HCT) in Acute Myeloid Leukemia (AML) and myelodysplastic syndrome (MDS)","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Minimal residual disease; Transplantation; Hematopoietic stem cell transplantation; Myeloid leukemia; Stem cell; Risk stratification; Myelodysplastic syndromes; Leukemia","score_opus":0.009019765977009887,"score_gpt":0.2543601898744024,"score_spread":0.24534042389739252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417006155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954087,0.00077861146,0.001464589,0.00015274565,0.00015835326,0.0015462784,0.00020663881,0.00009679342,0.00018726784],"genre_scores_gemma":[0.9906405,0.00030586089,0.008085644,0.00007449981,0.000026999802,0.0002002311,0.0002509814,0.000086491455,0.0003287623],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99626523,0.00027565807,0.00079936016,0.00084918033,0.0010197699,0.0007907829],"domain_scores_gemma":[0.998018,0.00060804596,0.00017640511,0.00059531286,0.00017349244,0.00042874058],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006096485,0.0005446397,0.00096846384,0.0010324508,0.00016283563,0.0000628796,0.00029496828,0.00024810128,0.000010791175],"category_scores_gemma":[0.000028449882,0.0004788235,0.00018520557,0.0009704079,0.00013527606,0.00022450603,0.00005328011,0.00078306685,0.000004856522],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056328215,0.0011484198,0.568015,0.0030951104,0.000820844,0.005498872,0.0004432381,0.001380247,0.41359985,0.0000036051576,0.0000058758633,0.00035613307],"study_design_scores_gemma":[0.034709033,0.0017475577,0.65888155,0.0024648635,0.0036822497,0.00013147725,0.00035072071,0.0027984323,0.29467753,0.000005829769,0.0000036579902,0.0005471293],"about_ca_topic_score_codex":0.0002282569,"about_ca_topic_score_gemma":0.000029899069,"teacher_disagreement_score":0.11892231,"about_ca_system_score_codex":0.0005144506,"about_ca_system_score_gemma":0.0019679274,"threshold_uncertainty_score":0.99976635},"labels":[],"label_agreement":null},{"id":"W4417006170","doi":"10.1182/blood-2025-4314","title":"CRISPR-Cas12a gene editing of the HBG1/2 promoters leads to sustained normalization of total hemoglobin and increased fetal hemoglobin in patients with severe sickle cell disease: Updated Results from the RUBY trial","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Fetal hemoglobin; Stem cell; Haematopoiesis; Progenitor cell; Hematopoietic stem cell transplantation; Sickle cell anemia; Anemia; Hemoglobin","score_opus":0.002875867535686232,"score_gpt":0.19585329009471378,"score_spread":0.19297742255902756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417006170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955586,0.00015494793,0.00002432605,0.0011212258,0.00014614293,0.0021563112,0.0004164066,0.000023619223,0.00039842023],"genre_scores_gemma":[0.9989088,0.000008602006,0.00015459416,0.00022759991,0.00005607942,0.000018815645,0.0004574796,0.00002037731,0.00014761534],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982221,0.00016098542,0.00060295925,0.00034450652,0.000391632,0.00027781905],"domain_scores_gemma":[0.99888355,0.00009946742,0.00024720083,0.00044151198,0.00020868913,0.000119612945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025265964,0.00021671689,0.00037345674,0.00009826284,0.00010282748,0.000017935998,0.00014939062,0.00012967511,0.000011732092],"category_scores_gemma":[0.00042984216,0.0001287747,0.000080668455,0.00076720247,0.0001272442,0.000074084855,0.00014553253,0.00021249917,7.4218616e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17039768,0.007769144,0.7957853,0.0006998253,0.0006309819,0.00006577212,0.0038656555,0.001027755,0.014143137,0.000065126515,0.0037791987,0.0017703921],"study_design_scores_gemma":[0.32142457,0.001709458,0.60903704,0.0013264951,0.0016167539,0.0000063676243,0.0024677548,0.00088127947,0.060899347,0.00004066714,0.00013494871,0.00045528848],"about_ca_topic_score_codex":0.00067873625,"about_ca_topic_score_gemma":0.00005293498,"teacher_disagreement_score":0.18674825,"about_ca_system_score_codex":0.00004774264,"about_ca_system_score_gemma":0.0003084711,"threshold_uncertainty_score":0.525128},"labels":[],"label_agreement":null},{"id":"W4417006201","doi":"10.1182/blood-2025-4309","title":"Decoding the role of inflammatory signaling in shaping HSC heterogeneity and engraftment in gene therapy-treated β-thalassemia pediatric patients","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada); University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Haematopoiesis; Stem cell; Bone marrow; Progenitor cell; Hematopoietic stem cell; Erythropoiesis; CXCR4; Ineffective erythropoiesis","score_opus":0.0073984211209639225,"score_gpt":0.22939581221406394,"score_spread":0.22199739109310002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417006201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98764384,0.01161806,0.000001150942,0.000040777584,0.000026909962,0.00042498973,0.0000017393755,0.000013986552,0.00022852884],"genre_scores_gemma":[0.9980311,0.0018034602,0.00004486185,0.000067197136,0.000014062959,0.000020852614,0.000005587104,0.000009045506,0.0000038427665],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991481,0.00006167406,0.00032186467,0.00017100375,0.00011481476,0.00018254365],"domain_scores_gemma":[0.9996663,0.00006475218,0.000069295835,0.00012989981,0.0000349996,0.000034784814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020856236,0.00011197783,0.00020193146,0.00020259368,0.00004319613,0.000007893079,0.000056796955,0.00010516953,0.0000035517432],"category_scores_gemma":[0.00004361228,0.00007927596,0.00004249323,0.00033628015,0.00002564445,0.000028484405,0.000043290427,0.00017274005,6.262546e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047608108,0.0003933359,0.9744161,0.000053894037,0.000052505417,0.000009548991,0.0004107661,0.000042623,0.021317068,0.000009414162,0.0000013541892,0.0032458135],"study_design_scores_gemma":[0.0070594694,0.0001194136,0.82434815,0.00021063804,0.00011255263,0.0000023800278,0.00039230703,0.00034705614,0.1671898,0.00007167946,0.000042698397,0.00010384435],"about_ca_topic_score_codex":0.00006937958,"about_ca_topic_score_gemma":0.000031397263,"teacher_disagreement_score":0.15006791,"about_ca_system_score_codex":0.000031697848,"about_ca_system_score_gemma":0.000055115397,"threshold_uncertainty_score":0.323278},"labels":[],"label_agreement":null},{"id":"W4417006214","doi":"10.1182/blood-2025-1328","title":"Splenectomy as a treatment for relapsed or refractory immune thrombotic thrombocytopenic purpura: A systematic review","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; Hamilton Health Sciences; McMaster University Medical Centre","funders":"","keywords":"Splenectomy; Rituximab; Thrombotic microangiopathy; ADAMTS13; Thrombotic thrombocytopenic purpura; Refractory (planetary science); Hematology; Cohort","score_opus":0.02627460998196584,"score_gpt":0.3150770005373853,"score_spread":0.28880239055541945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417006214","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17686017,0.79398733,0.00011701154,0.0011807882,0.0016543599,0.022019219,0.000278974,0.0005292508,0.0033729149],"genre_scores_gemma":[0.9668296,0.0072906855,0.00011933865,0.00065692863,0.000032456788,0.0059489855,0.0003551082,0.00005098407,0.018715918],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9975229,0.0004628204,0.0010001871,0.0004983884,0.000057697558,0.00045799796],"domain_scores_gemma":[0.997599,0.0008221096,0.00035949232,0.0010771224,0.000111941816,0.00003034786],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035758095,0.00035631048,0.0015539461,0.00012941568,0.0002589023,0.000027880928,0.00045915684,0.00014754591,0.0011519348],"category_scores_gemma":[0.00073568,0.00025185963,0.00044061118,0.000259061,0.00007754394,0.000082984756,0.00011373799,0.00010190102,0.00077172945],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001169192,0.010655821,0.00091359613,0.8129691,0.020819906,0.00011025235,0.0006135717,0.0000010127145,0.1214602,0.009356,0.021249585,0.00068179367],"study_design_scores_gemma":[0.08121045,0.011298806,0.005740174,0.67897654,0.06306228,0.0010929604,0.0018062539,0.0000060694697,0.10546109,0.0017302623,0.04684079,0.0027743452],"about_ca_topic_score_codex":0.00009418616,"about_ca_topic_score_gemma":0.0000590553,"teacher_disagreement_score":0.78996944,"about_ca_system_score_codex":0.00017783078,"about_ca_system_score_gemma":0.0003946113,"threshold_uncertainty_score":0.9999934},"labels":[],"label_agreement":null},{"id":"W4417006218","doi":"10.1182/blood-2025-7600","title":"Real-world treatment landscape after anti-BCMA CAR T-cell therapy in relapsed/refractory multiple myeloma: An international Study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Cohort; Multiple myeloma; CAR T-cell therapy; Second line; Overall survival; Second-line therapy; First line therapy","score_opus":0.02281320235758821,"score_gpt":0.32365944172801614,"score_spread":0.3008462393704279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417006218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97653925,0.00052085915,6.370218e-7,0.00018820398,0.00021461543,0.0011958705,0.000016709446,0.00006970147,0.021254173],"genre_scores_gemma":[0.977092,0.0009899768,0.00007646516,0.00009906114,0.00021776097,0.0002645232,0.000044146025,0.00003710634,0.021178912],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836993,0.00015333421,0.0003128306,0.0004717131,0.00037905658,0.00031315105],"domain_scores_gemma":[0.9990018,0.00012970949,0.000045743105,0.0006127772,0.000094007315,0.00011594973],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025725074,0.0002212101,0.00036368493,0.000544168,0.00004241685,0.000037885995,0.00018927015,0.000084772655,0.0013231995],"category_scores_gemma":[0.000021536029,0.00017871092,0.00010648487,0.00038975014,0.000037441274,0.00007913341,0.000052212545,0.00025467516,0.000034374785],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015879608,0.014146708,0.93479526,0.000014877118,0.00032261436,0.0004969815,0.0013457617,0.0000031393793,0.036592413,0.0000047844205,0.00007569063,0.010613787],"study_design_scores_gemma":[0.032066327,0.0022793266,0.9378508,0.000049723883,0.00007316111,0.0000043576433,0.0005059608,0.000097233096,0.017742055,0.000007961671,0.00917171,0.00015139152],"about_ca_topic_score_codex":0.0009691479,"about_ca_topic_score_gemma":0.002486723,"teacher_disagreement_score":0.030478364,"about_ca_system_score_codex":0.0001911038,"about_ca_system_score_gemma":0.00019172057,"threshold_uncertainty_score":0.99958974},"labels":[],"label_agreement":null},{"id":"W4417006291","doi":"10.1182/blood-2025-2590","title":"Cost-effectiveness of hydroxyurea for children with sickle cell disease in sub-saharan Africa: A discrete event simulation model to inform policy and government planning","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Providence Health Care","funders":"","keywords":"Disease; Government (linguistics); Population; Clinical trial; Disease burden; Developed country; Public health; Cost effectiveness","score_opus":0.012991920109573733,"score_gpt":0.2848333626393113,"score_spread":0.2718414425297376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417006291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878731,0.0007134296,0.008260974,0.00017039315,0.000007498929,0.002264836,0.00008565619,0.0000136415965,0.00061049],"genre_scores_gemma":[0.99948114,0.000038516337,0.0001418317,0.00006690899,0.000009191815,0.00014228412,0.00003313248,0.000011381893,0.00007561485],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9993149,0.000014167366,0.0001691494,0.00016261831,0.00016466658,0.00017449712],"domain_scores_gemma":[0.99961287,0.00007669187,0.000045176974,0.0001267842,0.000025849698,0.000112628164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001216328,0.00011397936,0.00020747076,0.000092792085,0.000041160427,0.000006819158,0.000035184305,0.00005144332,4.1942192e-7],"category_scores_gemma":[0.00006875957,0.00008735802,0.00003912224,0.00024272369,0.000022957996,0.000045016797,0.00003381825,0.00006971043,3.0144727e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037666862,0.0010199143,0.163665,0.00096368813,0.00020282072,0.000006611166,0.001062813,0.8245327,0.0024551153,0.0002521829,0.000031276195,0.0020412232],"study_design_scores_gemma":[0.030200494,0.0012111041,0.6582425,0.0028051394,0.0009251589,0.000002230181,0.0001950341,0.29423374,0.011046822,0.000445878,0.00031476194,0.00037709984],"about_ca_topic_score_codex":0.000038781403,"about_ca_topic_score_gemma":0.000004099602,"teacher_disagreement_score":0.53029895,"about_ca_system_score_codex":0.00007250988,"about_ca_system_score_gemma":0.00012736679,"threshold_uncertainty_score":0.35623568},"labels":[],"label_agreement":null},{"id":"W4417006327","doi":"10.1182/blood-2025-4337","title":"Comprehensive and rapid detection of genomic alterations in pediatric leukemias using whole-genome sequencing with adaptive sampling","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal; Ontario Genomics","funders":"","keywords":"Exome sequencing; Genomic sequencing; DNA sequencing; Nanopore sequencing; Genomics; Exome; Sampling (signal processing); Workflow","score_opus":0.039560214955137576,"score_gpt":0.2855337754025537,"score_spread":0.24597356044741614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417006327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98306364,0.0010798624,0.015116475,0.00003062145,0.000023922452,0.00043831198,0.000012525794,0.000018978368,0.00021566644],"genre_scores_gemma":[0.99255514,0.00010008219,0.007141919,0.000052268395,0.000081195416,0.000013822524,0.000009578881,0.000016044465,0.000029935205],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99904114,0.000049952065,0.0002677145,0.0002573982,0.00016443004,0.00021935225],"domain_scores_gemma":[0.99932015,0.00019918913,0.00007856004,0.00016932943,0.00017056159,0.0000621843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011397415,0.00012395225,0.00027444237,0.0004743046,0.00008167063,0.000015053935,0.000050183306,0.00007647637,0.0000037116279],"category_scores_gemma":[0.000050835682,0.00011223035,0.000027448286,0.000502421,0.000078215664,0.00007513697,0.000064721666,0.00021319502,0.000001782321],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033365644,0.00008575004,0.008094188,0.000307531,0.00012470227,0.000053861073,0.0007933818,0.0029128136,0.9866752,0.00003186136,8.333727e-7,0.00058623886],"study_design_scores_gemma":[0.059649933,0.0033676096,0.60346127,0.0015128447,0.0032015485,0.0016851278,0.008222336,0.12656818,0.19071381,0.00037780532,0.00020757627,0.0010319217],"about_ca_topic_score_codex":0.0003300764,"about_ca_topic_score_gemma":0.000057005855,"teacher_disagreement_score":0.7959614,"about_ca_system_score_codex":0.0007249577,"about_ca_system_score_gemma":0.0011629439,"threshold_uncertainty_score":0.4576621},"labels":[],"label_agreement":null},{"id":"W4417006357","doi":"10.1182/blood-2025-5728","title":"Pomalidomide promotes activation induced cell death of pre-activated, memory BCMA CAR-T cells in a model of high, but not low, tumor burden multiple myeloma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; Spinal Cord Injury BC","funders":"","keywords":"Pomalidomide; Multiple myeloma; Cancer; Flow cytometry; Cancer cell; T cell; Tumor microenvironment; Bortezomib","score_opus":0.024890221459246457,"score_gpt":0.2771451017268084,"score_spread":0.25225488026756193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417006357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961673,0.00003217087,0.000096713076,0.00015443245,0.000048787635,0.0016884168,0.00004651823,0.000046522582,0.0017191462],"genre_scores_gemma":[0.9955997,0.000015606713,0.0012713603,0.00005548498,0.00006279807,0.00010796934,0.000025466477,0.000049115628,0.0028125388],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99787486,0.00012905966,0.00061999244,0.00044063583,0.0005439543,0.0003915138],"domain_scores_gemma":[0.9984379,0.00031336586,0.00023387141,0.0006196441,0.0002898818,0.00010537284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036406127,0.0002529201,0.0006854282,0.00052746054,0.00003402729,0.000012201598,0.00024164791,0.0001944672,0.000105408144],"category_scores_gemma":[0.00026827276,0.00024266384,0.00013947008,0.0005224788,0.00007102071,0.00011497812,0.00013430936,0.00041350414,0.0000034741045],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025988417,0.0015229164,0.0019874508,0.000838408,0.0001526552,0.000023763481,0.0009125248,0.0006338719,0.9902077,0.000020172178,0.000011240654,0.0010904896],"study_design_scores_gemma":[0.011345712,0.00038260067,0.011010267,0.0004900893,0.00010407386,0.0000046884443,0.00022399393,0.00758284,0.96858305,0.00010232717,0.000004355845,0.00016603434],"about_ca_topic_score_codex":0.003320921,"about_ca_topic_score_gemma":0.00003505524,"teacher_disagreement_score":0.021624647,"about_ca_system_score_codex":0.00013256582,"about_ca_system_score_gemma":0.00058254134,"threshold_uncertainty_score":0.9895544},"labels":[],"label_agreement":null},{"id":"W4417006557","doi":"10.1182/blood-2025-7490","title":"Priming of bone marrow stromal cells with the epigenetic modifier decitabine overcomes stroma-mediated resistance to bortezomib in multiple myeloma cells.","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Decitabine; Bortezomib; Bone marrow; Multiple myeloma; Stromal cell; Priming (agriculture); Cancer cell","score_opus":0.013338281209722866,"score_gpt":0.2520764960907462,"score_spread":0.23873821488102337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417006557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99555683,0.0009878945,0.00014100842,0.0007453074,0.00004298387,0.0013324749,0.00009403524,0.000031601317,0.001067838],"genre_scores_gemma":[0.992121,0.000067641355,0.004888093,0.00011391788,0.00002936929,0.00013335024,0.000034761564,0.000030165045,0.0025817472],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9979736,0.00009754983,0.00041462068,0.00042465737,0.00052600895,0.00056357105],"domain_scores_gemma":[0.99850184,0.0004272856,0.000099880024,0.00062255387,0.00013644299,0.00021202404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024045735,0.0002519621,0.0005168259,0.00030431157,0.000086159795,0.000022379516,0.00019257271,0.00008866464,0.00003774803],"category_scores_gemma":[0.00018739994,0.00016883199,0.00008821935,0.00069843,0.00012006179,0.000049208815,0.00010354966,0.00023345157,0.000016391125],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035229868,0.0024679098,0.3089872,0.00045343614,0.00060208177,0.00072487385,0.000616086,0.0001409445,0.6796651,0.000047267113,0.0008713698,0.0019007473],"study_design_scores_gemma":[0.013487397,0.00050494814,0.6529232,0.00047155656,0.0001817682,0.000005265478,0.00028047693,0.00023924277,0.33121806,0.000013380444,0.00051825505,0.00015643123],"about_ca_topic_score_codex":0.00023491262,"about_ca_topic_score_gemma":0.001134996,"teacher_disagreement_score":0.34844705,"about_ca_system_score_codex":0.00008504714,"about_ca_system_score_gemma":0.00029726245,"threshold_uncertainty_score":0.68847686},"labels":[],"label_agreement":null},{"id":"W4417006583","doi":"10.1182/blood-2025-5703","title":"Zip-code drug conjugates (ZDCs): Ctdna-guided therapy shows strong efficacy and low toxicity in vitro and In Vivo","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"In vivo; In vitro; Drug; In vitro toxicology; Conjugate; Cytokine","score_opus":0.01084755981043633,"score_gpt":0.25677914161589854,"score_spread":0.2459315818054622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417006583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98641,0.011934071,0.000004562054,0.00031579245,0.00014604452,0.000300604,0.000028004491,0.000033104232,0.0008278103],"genre_scores_gemma":[0.9964023,0.00070156367,0.00002379761,0.00033357856,0.000007250608,0.000021041398,0.000009447172,0.000010022984,0.0024909566],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987763,0.00030251304,0.0002955769,0.00029422896,0.000018262479,0.00031308617],"domain_scores_gemma":[0.9994204,0.00031410015,0.00004476635,0.00018664984,0.000019730642,0.000014361254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002714234,0.0001812479,0.00033640632,0.00020510094,0.00007215009,0.000026178233,0.0001316137,0.00016640684,0.00012472311],"category_scores_gemma":[0.00009371331,0.00015965327,0.000034038407,0.000111721565,0.00019353766,0.00006735607,0.000095707,0.00027518795,0.0000105272375],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014686593,0.00048449583,0.006803109,0.00001924665,0.00009322026,0.000008699331,0.0005383215,7.298926e-7,0.9881742,0.00016911532,0.00038596283,0.0018542366],"study_design_scores_gemma":[0.008979711,0.00010294883,0.024074826,0.000097794924,0.000015263706,0.00002325379,0.00025084775,0.000007531042,0.96383846,0.000050823146,0.0024090644,0.00014947676],"about_ca_topic_score_codex":0.00019977055,"about_ca_topic_score_gemma":0.00025986333,"teacher_disagreement_score":0.024335746,"about_ca_system_score_codex":0.00001823436,"about_ca_system_score_gemma":0.000052751333,"threshold_uncertainty_score":0.6510471},"labels":[],"label_agreement":null},{"id":"W4417006596","doi":"10.1182/blood-2025-5717","title":"P300/CBP acetyltransferase inhibition and degradation disrupt oncogenic transcriptional programs and reveal epigenetic vulnerabilities in multiple myeloma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"","keywords":"Epigenetics; Bromodomain; Acetylation; Transcriptional regulation; Histone; Chromatin; Demethylase; BRD4; Histone acetyltransferase; P300-CBP Transcription Factors","score_opus":0.010192958283912663,"score_gpt":0.22986703122328855,"score_spread":0.21967407293937588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417006596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958283,0.002108896,0.0009059665,0.0004924949,0.000055054174,0.00045653322,0.000026203425,0.000016806987,0.000109799556],"genre_scores_gemma":[0.99759644,0.0002694863,0.001041634,0.00012891121,0.000056870755,0.00012700452,0.0004163927,0.0000105303225,0.00035274745],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990534,0.00009141378,0.00024383975,0.0003381017,0.00009125279,0.00018196378],"domain_scores_gemma":[0.99972177,0.000016518014,0.000028113629,0.0001334775,0.000040220766,0.000059907445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018222068,0.00014045346,0.00012431137,0.000083353065,0.00009370226,0.000039071816,0.000043512686,0.00011462567,0.0000053631875],"category_scores_gemma":[0.000071187394,0.00014244253,0.000042862568,0.000121791105,0.00012533953,0.000014582484,0.000025465737,0.00009152294,6.8350266e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009312787,0.00033059664,0.07013991,0.00008644918,0.0000334025,0.0000023058894,0.00012075566,0.0000032386558,0.9051225,0.00028446145,0.00007055568,0.02371267],"study_design_scores_gemma":[0.0038994087,0.00033308435,0.081828624,0.000098424316,0.00004737751,0.000021732641,0.00019114591,0.000074873344,0.91046757,0.0006878909,0.0021013096,0.0002485635],"about_ca_topic_score_codex":0.000047744357,"about_ca_topic_score_gemma":0.0005028928,"teacher_disagreement_score":0.023464106,"about_ca_system_score_codex":0.000011521809,"about_ca_system_score_gemma":0.00006008805,"threshold_uncertainty_score":0.5808638},"labels":[],"label_agreement":null},{"id":"W4417006712","doi":"10.1182/blood-2025-8005","title":"Feasibility assessment of indirect treatment comparison between off-label rituximab and novel treatments in patients with warm autoimmune hemolytic anemia","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Rituximab; Autoimmune hemolytic anemia; Clinical trial; Systematic review; MEDLINE; Anemia","score_opus":0.022584107686845368,"score_gpt":0.3070448051932109,"score_spread":0.28446069750636555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417006712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973032,0.0004238138,0.000053074677,0.0000956807,0.000028106871,0.0013085555,0.00006465906,0.000030050076,0.000692893],"genre_scores_gemma":[0.9978079,0.000037697217,0.0018399642,0.000019524277,0.000008326787,0.000034269255,0.00014743472,0.000014950604,0.000089930785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865836,0.000037322665,0.00043874877,0.0003852346,0.0002505946,0.00022975686],"domain_scores_gemma":[0.9993332,0.000071667426,0.00010544556,0.00034816333,0.0000641802,0.00007736106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011346869,0.00024021072,0.000830695,0.00016702122,0.000055189073,0.000009893572,0.000054870015,0.000109310095,0.000007919568],"category_scores_gemma":[0.000008692224,0.00017198775,0.000051394218,0.0003076569,0.00007237247,0.000050383303,0.00003134777,0.00014081062,6.6424326e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002946287,0.029116554,0.954495,0.00017181436,0.0004612247,0.0000065085665,0.00015607444,6.7480823e-7,0.0005773266,0.000019416357,0.0000016208941,0.014699125],"study_design_scores_gemma":[0.08581705,0.0027746633,0.9050923,0.00033645472,0.0016242627,0.0000017355161,0.000029969064,0.00006829769,0.004114389,0.000013835601,0.000014014502,0.00011300289],"about_ca_topic_score_codex":0.00034335614,"about_ca_topic_score_gemma":0.00009523425,"teacher_disagreement_score":0.08552242,"about_ca_system_score_codex":0.00017602117,"about_ca_system_score_gemma":0.0001657017,"threshold_uncertainty_score":0.7013457},"labels":[],"label_agreement":null},{"id":"W4417006713","doi":"10.1182/blood-2025-306","title":"Marstacimab prophylaxis in participants with Hemophilia A or B with inhibitors: Results from the Phase 3 BASIS trial","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Clinical endpoint; Adverse effect; Incidence (geometry); Hemostasis; Bleed; Factor IX; Observational study; Phases of clinical research","score_opus":0.044304473164452816,"score_gpt":0.33316710143358913,"score_spread":0.28886262826913633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417006713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990561,0.00017126357,0.0000029273738,0.005499388,0.000058321195,0.002036134,0.00008891265,0.000045576013,0.0015364483],"genre_scores_gemma":[0.9955245,0.000032258726,0.00029814575,0.00015012494,0.0002599186,0.00024962853,0.0000593518,0.000020688873,0.0034053826],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99811417,0.00012804833,0.00036358347,0.00045122326,0.00047602959,0.0004669662],"domain_scores_gemma":[0.9987256,0.00041413057,0.00006088866,0.0005819989,0.00008447063,0.00013291217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003682691,0.000209714,0.0003886341,0.00013328997,0.00010465726,0.000045972218,0.00013746,0.000105048064,0.00006634034],"category_scores_gemma":[0.00043575055,0.000088033456,0.000055588043,0.0008768475,0.00016856389,0.000065396285,0.000052638912,0.00032828707,0.000022140954],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.879997,0.01879952,0.06741154,0.00014444775,0.001385776,0.0042625368,0.0026772295,0.0000023311652,0.0024548129,0.000029357823,0.0022153747,0.020620042],"study_design_scores_gemma":[0.8996038,0.019560466,0.011326932,0.0016489058,0.0009494911,0.000030350757,0.0010065062,0.00006512359,0.061791737,0.00008124825,0.0036273536,0.00030809085],"about_ca_topic_score_codex":0.00039951052,"about_ca_topic_score_gemma":0.00072120683,"teacher_disagreement_score":0.059336923,"about_ca_system_score_codex":0.00005946437,"about_ca_system_score_gemma":0.0007136589,"threshold_uncertainty_score":0.35899},"labels":[],"label_agreement":null},{"id":"W4417006717","doi":"10.1182/blood-2025-300","title":"Full assessment of clinical transfusion support (FACTS): A prospective Study to determine the burden of sickle cell anemia on pediatric blood transfusion use in a malaria-endemic region in Africa","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Anemia; Blood transfusion; Sickle cell anemia; Malaria; Malnutrition; Prospective cohort study; Plasmodium falciparum; Referral","score_opus":0.02374128683891528,"score_gpt":0.3038537920657533,"score_spread":0.280112505226838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417006717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936546,0.000111897534,0.000043412896,0.00065105804,0.00010732944,0.003327067,0.0000095454325,0.00002287111,0.002072216],"genre_scores_gemma":[0.99857193,0.00076157606,0.00016594744,0.000055881523,0.000054568955,0.000073214556,0.000005090425,0.000021475358,0.00029029616],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997238,0.00030206892,0.0012020266,0.00052179355,0.0004170242,0.00031910912],"domain_scores_gemma":[0.99875796,0.00037068926,0.00017911568,0.00048464653,0.000106637846,0.00010096037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010050415,0.00023355307,0.00074514496,0.00047332703,0.000041995874,0.000007863165,0.00018260315,0.00024884465,0.00002753018],"category_scores_gemma":[0.00018593007,0.00016319171,0.00018560007,0.0011710926,0.00005404533,0.00005235955,0.000054463704,0.00076623587,0.0000016716903],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026343039,0.022718133,0.95329064,0.00043250038,0.00009722113,0.0003795805,0.009397043,0.00028398304,0.009737398,0.00002799587,0.0000806707,0.00092050823],"study_design_scores_gemma":[0.03964652,0.018332671,0.9270823,0.00056219613,0.0019340658,0.0000336243,0.007548085,0.00034512125,0.0041045905,0.00004713658,0.00007625746,0.00028745615],"about_ca_topic_score_codex":0.00084355485,"about_ca_topic_score_gemma":0.00037673028,"teacher_disagreement_score":0.037012216,"about_ca_system_score_codex":0.000043212214,"about_ca_system_score_gemma":0.0004213358,"threshold_uncertainty_score":0.6654765},"labels":[],"label_agreement":null},{"id":"W4417006725","doi":"10.1182/blood-2025-302","title":"NXT007 prophylaxis in people with hemophilia A with or without FVIII inhibitors: A global Phase I/II multiple-ascending-dose study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McMaster University","funders":"","keywords":"Cohort; Adverse effect; Phases of clinical research; Potency; Clinical endpoint; Coagulopathy; Incidence (geometry); Cohort study","score_opus":0.018073253183915304,"score_gpt":0.33123102042749614,"score_spread":0.31315776724358085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417006725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99328375,0.00017012644,0.000010414846,0.0006870528,0.000059099,0.004149421,0.00002089326,0.00013860814,0.0014806315],"genre_scores_gemma":[0.9947538,0.000011617452,0.0007119343,0.00006478787,0.00012784696,0.00042596422,0.000024633402,0.000037988524,0.0038414227],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973675,0.000101789126,0.00039471744,0.0007364549,0.00073012715,0.0006694322],"domain_scores_gemma":[0.99878883,0.0000718513,0.00007472722,0.0006196206,0.00016812516,0.0002768431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028921023,0.00040606738,0.00074764114,0.00035019033,0.00021745612,0.000050982893,0.00018275346,0.00013584681,0.00005894462],"category_scores_gemma":[0.00015516406,0.00022731617,0.000074083735,0.0020868713,0.00014837293,0.00012128319,0.00015389445,0.00040278008,0.000021242195],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0110945115,0.032920245,0.9475232,0.00025796524,0.0005729129,0.0021069378,0.0017152133,0.0000015727645,0.0006913966,0.000015838265,0.00009456143,0.0030056762],"study_design_scores_gemma":[0.39192218,0.12377484,0.4540188,0.003147356,0.0018625078,0.0007981467,0.008800912,0.0005486656,0.0128544755,0.000028023418,0.0010957454,0.0011483593],"about_ca_topic_score_codex":0.00065000623,"about_ca_topic_score_gemma":0.0052937125,"teacher_disagreement_score":0.49350438,"about_ca_system_score_codex":0.00022637227,"about_ca_system_score_gemma":0.0008881603,"threshold_uncertainty_score":0.92696846},"labels":[],"label_agreement":null},{"id":"W4417006732","doi":"10.1182/blood-2025-305","title":"Emicizumab prophylaxis in pups and mtps with severe haemophilia: The pednet real world experience in 80 infants","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Concomitant; Haemophilia A; Adverse effect; Observational study; Haemophilia; Clinical endpoint; Clinical trial; Incidence (geometry)","score_opus":0.020072840726868418,"score_gpt":0.30762975029401857,"score_spread":0.28755690956715013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417006732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835491,0.00064091344,2.8811624e-7,0.0017784409,0.000024275925,0.0007298868,0.0000032102253,0.000020572941,0.013253277],"genre_scores_gemma":[0.9942932,0.0002635514,0.00008457982,0.00010638987,0.00003617154,0.00011571047,0.000005575046,0.000010343561,0.0050844727],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988845,0.00006061429,0.00019156406,0.00030154624,0.00024789508,0.00031386083],"domain_scores_gemma":[0.9994545,0.000101586105,0.000023486198,0.0003146642,0.00003503344,0.00007076062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001745437,0.00014017557,0.00024540268,0.00026863476,0.00006534681,0.00002386719,0.00011435021,0.00007125389,0.000031818545],"category_scores_gemma":[0.00006834868,0.00007761859,0.000021224374,0.00085771363,0.00017842694,0.000063280764,0.000087060194,0.0003428642,0.0000055616374],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041412568,0.00048765301,0.9891296,0.00009486548,0.00004015769,0.0005647156,0.0028481956,0.0000010451789,0.0004998549,0.000104731844,0.00009196552,0.005723107],"study_design_scores_gemma":[0.0088908,0.00055322424,0.98299617,0.0006328795,0.000046932677,0.00010815811,0.0014783464,0.000046670604,0.0042528375,0.00018951877,0.0006547015,0.00014976908],"about_ca_topic_score_codex":0.0006658727,"about_ca_topic_score_gemma":0.0027881942,"teacher_disagreement_score":0.010744072,"about_ca_system_score_codex":0.000053962765,"about_ca_system_score_gemma":0.00021230629,"threshold_uncertainty_score":0.31651944},"labels":[],"label_agreement":null},{"id":"W4417006971","doi":"10.1182/blood-2025-682","title":"Long-term immune reconstitution and final 1-year follow-up after fixed-duration venetoclax-obinutuzumab (VenO) in first-line (1L) chronic lymphocytic leukemia (CLL): Results from the Phase III CRISTALLO trial","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Immune system; Chronic lymphocytic leukemia; Clinical endpoint; Antibody; Lymphocyte; Minimal residual disease; Surrogate endpoint; Cytokine release syndrome","score_opus":0.023856536462730945,"score_gpt":0.30188347942102073,"score_spread":0.2780269429582898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417006971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908021,0.004822142,0.00014008193,0.0003231593,0.000696616,0.0022997165,0.00012338905,0.00008336561,0.00070939993],"genre_scores_gemma":[0.99545115,0.0010422656,0.00007153858,0.00012696772,0.0007535621,0.00032493897,0.0005797314,0.000034390723,0.0016154253],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9966953,0.00017656179,0.0011608189,0.0008065342,0.0005327389,0.00062807335],"domain_scores_gemma":[0.99787796,0.0006037696,0.00021936842,0.0010122657,0.00013432748,0.00015234202],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00079187786,0.00037550274,0.0006573921,0.00023432224,0.00023981016,0.00012717217,0.00029665173,0.00034549367,0.00013609485],"category_scores_gemma":[0.00091968314,0.00030292876,0.00019437607,0.00055480114,0.00037425727,0.0002153186,0.00023062926,0.0005050953,0.00005286251],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.9282796,0.0018651137,0.0020225325,0.0015692622,0.0022091058,0.0044449456,0.004051294,0.0011425015,0.011377632,0.00047854133,0.0033743184,0.03918516],"study_design_scores_gemma":[0.96500057,0.0014820938,0.0056885215,0.001877805,0.000750002,0.00017125743,0.000083768056,0.015346451,0.007704625,0.00014988316,0.0013744625,0.00037056606],"about_ca_topic_score_codex":0.0072611836,"about_ca_topic_score_gemma":0.0063499943,"teacher_disagreement_score":0.038814593,"about_ca_system_score_codex":0.06449599,"about_ca_system_score_gemma":0.043315593,"threshold_uncertainty_score":0.9999423},"labels":[],"label_agreement":null},{"id":"W4417006974","doi":"10.1182/blood-2025-863","title":"IFN-γ drives long-term bone marrow niche dysfunction following chemotherapy","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Ottawa Hospital; University Health Network","funders":"","keywords":"Haematopoiesis; Bone marrow; Stem cell; Stromal cell; Mesenchymal stem cell; CD34; Ex vivo; Hematopoietic stem cell; Progenitor cell","score_opus":0.009882015868977204,"score_gpt":0.2637104617858673,"score_spread":0.25382844591689013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417006974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98049605,0.000647172,0.0045417794,0.0009356407,0.00039833927,0.0004135555,0.0000017248944,0.0001528577,0.012412907],"genre_scores_gemma":[0.9923083,0.00012197711,0.0009366141,0.0006322018,0.000104477826,0.00003125489,0.000042810676,0.000023765715,0.0057986025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990818,0.000028607643,0.00025049786,0.00025760516,0.00017939533,0.00020208526],"domain_scores_gemma":[0.99951226,0.00006787183,0.000043951364,0.0002753181,0.000033761775,0.00006686796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014762883,0.00014240936,0.00025914118,0.00012536097,0.000064185646,0.000020172312,0.000055213324,0.00011683385,0.0001748989],"category_scores_gemma":[0.000026576194,0.00013248289,0.00014157376,0.00023263911,0.000023667393,0.000059033555,0.000008686228,0.00012608709,0.000055130076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001943186,0.00088385236,0.71880573,0.00086149015,0.00066135306,0.00025931478,0.00075527857,0.0000012281295,0.26934412,0.00021546351,0.00063021126,0.007387636],"study_design_scores_gemma":[0.013338336,0.00018313312,0.6875126,0.0010417609,0.0011512573,0.00015579998,0.00010617368,0.00003367175,0.295422,0.00011803658,0.00071868976,0.00021857981],"about_ca_topic_score_codex":0.0000073205288,"about_ca_topic_score_gemma":0.0000082649385,"teacher_disagreement_score":0.031293172,"about_ca_system_score_codex":0.000027829074,"about_ca_system_score_gemma":0.00007376523,"threshold_uncertainty_score":0.5402495},"labels":[],"label_agreement":null},{"id":"W4417007055","doi":"10.1182/blood-2025-1452","title":"Ribosome biogenesis and its regulation by the exportin, CSE1L, are targetable vulnerabilities in childhood and young adult Acute Myeloid Leukemia","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children; University Health Network","funders":"","keywords":"Myeloid leukemia; Young adult; Downregulation and upregulation; Myeloid; Leukemia; Gene expression; Cell culture; Mutation","score_opus":0.0025214532898115783,"score_gpt":0.18856104519174396,"score_spread":0.1860395919019324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417007055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945182,0.004517197,0.000019144749,0.00024542375,0.00009427536,0.00015307721,0.000035666108,0.000009750407,0.00040723028],"genre_scores_gemma":[0.9977077,0.0007212588,0.000071597744,0.00023198583,0.00007755078,0.000018472118,0.000082794955,0.000010044123,0.0010785891],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993752,0.00003503617,0.0001466657,0.00025315635,0.000056285087,0.00013364026],"domain_scores_gemma":[0.9997076,0.0000064901296,0.000058345046,0.00015862893,0.000044675777,0.00002425443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000077837976,0.00010951271,0.000109143475,0.00003291653,0.000113979215,0.000030616236,0.000056473353,0.000118583004,0.0000066190837],"category_scores_gemma":[0.000047941885,0.0000851286,0.000024748078,0.00008784564,0.000039979757,0.000008087762,0.000060967828,0.00006454297,6.4724384e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006171766,0.0000610252,0.101835854,0.00004336349,0.00015635662,0.0000015231849,0.00020207511,0.000007579839,0.89192337,0.00028494632,0.0032901461,0.0021320232],"study_design_scores_gemma":[0.0015552787,0.00012343843,0.48073864,0.0000296146,0.00013440504,0.000036954396,0.00040487177,0.000056309713,0.511915,0.0005740152,0.004225714,0.00020572418],"about_ca_topic_score_codex":0.000058610334,"about_ca_topic_score_gemma":0.00012591171,"teacher_disagreement_score":0.38000837,"about_ca_system_score_codex":0.000008112801,"about_ca_system_score_gemma":0.000026449465,"threshold_uncertainty_score":0.34714437},"labels":[],"label_agreement":null},{"id":"W4417007088","doi":"10.1182/blood-2025-2046","title":"Clonal persistence and early cooperative mutations shape transformation in myelofibrosis","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Myelofibrosis; Loss of heterozygosity; Mutation; Point mutation; Somatic cell; Myeloid; Gene; Copy-number variation; Somatic evolution in cancer","score_opus":0.016289167920287062,"score_gpt":0.2623000399633939,"score_spread":0.24601087204310684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417007088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908276,0.0004101032,0.000051566385,0.0017351509,0.000021308253,0.00042983258,0.0000149547495,0.000013840709,0.0064956225],"genre_scores_gemma":[0.9985218,0.00014448616,0.0006455386,0.00024227763,0.000011966249,0.00014654377,0.000022125483,0.000004244128,0.00026098377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99943215,0.00002018909,0.00017392753,0.00016332993,0.00009766464,0.000112744994],"domain_scores_gemma":[0.99971515,0.00007759363,0.000019785624,0.00006617768,0.00007273642,0.000048586346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000055322973,0.00009603292,0.0001736655,0.00012115575,0.000083585546,0.000023268869,0.000021019086,0.000046664107,0.00007575491],"category_scores_gemma":[0.00003316315,0.000079784244,0.00003628446,0.0002213678,0.0000483552,0.00009872788,0.000007929987,0.00007964097,0.000012526441],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009529678,0.0010256935,0.97927094,0.00009278201,0.00018780028,0.000026300151,0.0046807015,0.000008453794,0.0020485972,0.0078994725,0.00003990262,0.00462404],"study_design_scores_gemma":[0.004246346,0.0003700098,0.9784923,0.00020023607,0.00019471424,0.000017056143,0.00042610275,0.00027421024,0.015421609,0.00010591937,0.0001770086,0.00007448575],"about_ca_topic_score_codex":0.000044017488,"about_ca_topic_score_gemma":0.00011810894,"teacher_disagreement_score":0.013373012,"about_ca_system_score_codex":0.000028946892,"about_ca_system_score_gemma":0.00008295867,"threshold_uncertainty_score":0.3253507},"labels":[],"label_agreement":null},{"id":"W4417007123","doi":"10.1182/blood-2025-2024","title":"Avapritinib achieves deep and durable symptom control with a well-tolerated safety profile in ism: Long-term outcomes from pioneer","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Calgary","funders":"","keywords":"Systemic mastocytosis; Disease; Distress; Adverse effect; Neutropenia; Maintenance therapy; Clinical trial; Mast cell","score_opus":0.00450742105113864,"score_gpt":0.20009075347201447,"score_spread":0.19558333242087583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417007123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881239,0.0035235398,0.0002012268,0.0005558721,0.00014057403,0.0004111513,0.0001053138,0.000058319485,0.0068801274],"genre_scores_gemma":[0.9875274,0.00009237753,0.000097504315,0.00030445578,0.000010161613,0.00004297823,0.00023352209,0.00001293485,0.011678706],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898374,0.00010127762,0.00027771966,0.00032407415,0.000025848005,0.00028736945],"domain_scores_gemma":[0.999499,0.00015739529,0.00006677308,0.00021700555,0.000038911432,0.000020887284],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009215239,0.00019222147,0.00041500828,0.00009937521,0.00012994211,0.00002521808,0.000114688504,0.00019330297,0.0013922339],"category_scores_gemma":[0.00001845997,0.00014787096,0.000035174366,0.00011685566,0.00013560826,0.000056022585,0.0000457151,0.0002360529,0.00012201286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006850087,0.0008426015,0.93670785,0.000065698936,0.00062160764,0.000055435365,0.00031160543,0.0000033853275,0.05883671,0.00072569435,0.00029499532,0.0008494295],"study_design_scores_gemma":[0.019550035,0.00014945457,0.9640082,0.00014396066,0.00022909668,0.000021643418,0.00011229302,0.000014576051,0.012943357,0.00003388671,0.0025430752,0.00025043037],"about_ca_topic_score_codex":0.0002442195,"about_ca_topic_score_gemma":0.0006717401,"teacher_disagreement_score":0.045893352,"about_ca_system_score_codex":0.00001163846,"about_ca_system_score_gemma":0.000046904523,"threshold_uncertainty_score":0.9995206},"labels":[],"label_agreement":null},{"id":"W4417007141","doi":"10.1182/blood-2025-2204","title":"Correlative biomarker analyses of etentamig in patients with Relapsed/Refractory multiple myeloma (RRMM) at optimal dose support its potential to maximize T-cell activity with rapid and transient proinflammatory cytokine responses","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"","keywords":"Multiple myeloma; Cytokine release syndrome; Cytokine; Proinflammatory cytokine; Biomarker; Dexamethasone; Immune system; Flow cytometry; Pharmacodynamics","score_opus":0.02138638260249365,"score_gpt":0.2825917297231733,"score_spread":0.26120534712067967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417007141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967088,0.00016984693,0.0000843408,0.000096720585,0.00003284142,0.0021771782,0.00020571526,0.0000337432,0.0004908208],"genre_scores_gemma":[0.9974515,0.000034703065,0.001250518,0.000029888963,0.000008796852,0.00012498492,0.000102999315,0.000035940837,0.0009606562],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976813,0.00022432697,0.00038522083,0.0006046224,0.0006292697,0.00047524355],"domain_scores_gemma":[0.9986553,0.00021339393,0.00016234559,0.00039506136,0.00025558512,0.00031830042],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021026078,0.00035113355,0.0006244527,0.00061700365,0.000114712275,0.000015573592,0.000099838384,0.0001253012,0.00006288216],"category_scores_gemma":[0.00014453789,0.0002466796,0.000091879025,0.0005282982,0.00019384298,0.00016833765,0.000109853114,0.00024219572,0.000008111039],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10309881,0.0059707887,0.7240543,0.00029394496,0.0010303449,0.0007314564,0.00043667748,0.000030339634,0.15964858,4.6667336e-7,0.000060359365,0.0046439585],"study_design_scores_gemma":[0.04854276,0.0038884925,0.8094165,0.00025615783,0.0004658915,0.000017846382,0.00008475062,0.00014300057,0.13693835,1.922249e-7,0.000060592753,0.00018550096],"about_ca_topic_score_codex":0.0001163338,"about_ca_topic_score_gemma":0.0001169363,"teacher_disagreement_score":0.085362196,"about_ca_system_score_codex":0.00014947854,"about_ca_system_score_gemma":0.00036172496,"threshold_uncertainty_score":0.99999857},"labels":[],"label_agreement":null},{"id":"W4417007157","doi":"10.1182/blood-2025-2623","title":"Parental perspectives on financial distress during treatment for childhood acute lymphoblastic leukemia: A qualitative report from Children's oncology group (COG) study ACCL20N1CD","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Distress; Qualitative research; Pediatric cancer; Exploratory research; Longitudinal study; Ethnic group; Cancer; Childhood cancer; Cog","score_opus":0.019470261279182978,"score_gpt":0.35785061430218124,"score_spread":0.33838035302299824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417007157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99227387,0.00078819203,0.00013371832,0.0007466677,0.00045728867,0.0037766632,0.0010985017,0.00020890632,0.0005161768],"genre_scores_gemma":[0.9959841,0.00006512829,0.00066448684,0.00023502667,0.00092284573,0.0010969604,0.00066765974,0.00005962683,0.00030416547],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.9963912,0.00033439498,0.00090189854,0.0013345868,0.0004800156,0.0005579011],"domain_scores_gemma":[0.99766773,0.00077240303,0.0004018576,0.0008062012,0.00013099823,0.00022079867],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003386785,0.00056894106,0.0012347347,0.0002307023,0.00036568276,0.000046665395,0.00023540416,0.00023328114,0.000033099866],"category_scores_gemma":[0.0008143336,0.00051102386,0.0004524241,0.00030571054,0.00015729439,0.00010131507,0.00013487494,0.0003013159,0.000012708717],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015236298,0.12644184,0.2645594,0.00029210563,0.032825503,0.0038176167,0.54598826,0.000026833179,0.001897563,0.0012108206,0.0011650303,0.006538754],"study_design_scores_gemma":[0.045253452,0.008229496,0.88287085,0.0004074939,0.0050443127,0.00018756744,0.055042468,0.0000034941722,0.0020333538,0.00032883868,0.000120022065,0.00047863062],"about_ca_topic_score_codex":0.0021334642,"about_ca_topic_score_gemma":0.0013001803,"teacher_disagreement_score":0.61831146,"about_ca_system_score_codex":0.0013942102,"about_ca_system_score_gemma":0.0010007974,"threshold_uncertainty_score":0.99973416},"labels":[],"label_agreement":null},{"id":"W4417007176","doi":"10.1182/blood-2025-2217","title":"Novel method of minimal residual disease testing in myeloma: Liquid biopsies to enumerate and 3D telomere-profiling of circulating tumor cells","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Ontario Genomics","funders":"","keywords":"Minimal residual disease; Circulating tumor cell; Liquid biopsy; Immunophenotyping; Bone marrow; Biopsy; Multiple myeloma; Disease","score_opus":0.034749612833538474,"score_gpt":0.3303466241274335,"score_spread":0.29559701129389504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417007176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979593,0.0004154669,0.00029026967,0.000102846134,0.000020380066,0.0005190667,0.000089471396,0.000017214896,0.000585952],"genre_scores_gemma":[0.8210199,0.0000035205426,0.17883123,0.000030679697,0.000025023131,0.000027627844,0.000008833886,0.000012349841,0.000040823124],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998686,0.00006516681,0.0004177276,0.00030384917,0.00023589615,0.000291325],"domain_scores_gemma":[0.9988523,0.000507764,0.00009580711,0.00021085548,0.00014789528,0.00018536515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036379177,0.00014485067,0.0003948427,0.0003460986,0.000043246007,0.000009744986,0.000068153844,0.00003632169,0.000006112976],"category_scores_gemma":[0.0017196679,0.000129107,0.000040751827,0.00055724476,0.000058378435,0.000041758944,0.00013222026,0.000115995244,0.0000012745242],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006482512,0.0005252604,0.22110839,0.0006840404,0.000108010645,0.00015482161,0.00018094844,0.00003177245,0.77377015,0.000037784666,0.0000014239648,0.0027491546],"study_design_scores_gemma":[0.004252459,0.0003661799,0.33582225,0.00074225024,0.00016036908,0.000020703512,0.00020372422,0.001146107,0.65718156,0.000014419161,0.0000024645424,0.00008750985],"about_ca_topic_score_codex":0.00027971744,"about_ca_topic_score_gemma":0.000011946593,"teacher_disagreement_score":0.17854096,"about_ca_system_score_codex":0.000021271604,"about_ca_system_score_gemma":0.00025541347,"threshold_uncertainty_score":0.526483},"labels":[],"label_agreement":null},{"id":"W4417007208","doi":"10.1182/blood-2025-2815","title":"Who participates in myeloma trials? clinical and geographic predictors of access and outcomes in British Columbia, Canada.","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Leukemia & Lymphoma Society of Canada; BC Cancer Agency; University of British Columbia","funders":"","keywords":"Cohort; Proportional hazards model; Socioeconomic status; Marital status; Retrospective cohort study; Multivariate analysis; Univariate; Observational study; Univariate analysis","score_opus":0.2550267600153635,"score_gpt":0.5230802003486432,"score_spread":0.2680534403332797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417007208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961965,0.00095936714,3.808245e-7,0.0018493115,0.000121708836,0.0005048324,0.00003309462,0.00000825094,0.00032653008],"genre_scores_gemma":[0.99633294,0.0026157305,0.000037488848,0.00040092756,0.000031548097,0.00003703718,0.0000028952968,0.000007993175,0.0005334606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997277,0.00041202368,0.0012817981,0.00034515362,0.00041831686,0.0002656948],"domain_scores_gemma":[0.98400384,0.015344493,0.00010747777,0.00024157875,0.00013537082,0.00016723243],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.007163585,0.000070863825,0.00096304936,0.0001161265,0.00002879342,0.00007946145,0.00015713206,0.0002925658,0.000026871636],"category_scores_gemma":[0.05604141,0.00008772988,0.000060694456,0.0003913718,0.00050886715,0.0000511544,0.00024785675,0.00091749296,7.402079e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048541544,0.00046451908,0.99637264,0.0003131582,0.0001296109,0.000105303654,0.00002133966,1.0944145e-7,0.000005585569,0.00005552981,0.00015755944,0.0023261157],"study_design_scores_gemma":[0.006867571,0.00016712087,0.9881418,0.00088133826,0.000120237535,0.000002766707,0.00006982322,0.000014458339,0.0000444616,0.0035588832,0.00006994642,0.00006159565],"about_ca_topic_score_codex":0.746912,"about_ca_topic_score_gemma":0.99650306,"teacher_disagreement_score":0.24959108,"about_ca_system_score_codex":0.000013344403,"about_ca_system_score_gemma":0.0011364416,"threshold_uncertainty_score":0.95190996},"labels":[],"label_agreement":null},{"id":"W4417007255","doi":"10.1182/blood-2025-3169","title":"IDH1/2-mutant clonal hematopoiesis: A novel driver of autoinflammatory disease","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Otitis Media and Relapsing Polychondritis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Covenant Health","funders":"","keywords":"Polymyalgia rheumatica; Autoimmune disease; Myeloid; Microchimerism; Immune dysregulation; Hematopoietic stem cell transplantation; Giant cell arteritis; Bone marrow","score_opus":0.006362573512152025,"score_gpt":0.24027465452408767,"score_spread":0.23391208101193564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417007255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865334,0.003103666,0.00022190236,0.0015716478,0.0030112995,0.00031268268,0.000047698235,0.000115181916,0.0050825085],"genre_scores_gemma":[0.9889801,0.00012602746,0.0014762203,0.00041787323,0.00015753407,0.000023923716,0.000018003313,0.000022006734,0.008778275],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99899805,0.000014457544,0.00030287442,0.00021247595,0.00026174748,0.00021041668],"domain_scores_gemma":[0.99930495,0.000050166796,0.00007108961,0.00031307407,0.000072060815,0.00018866922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006650669,0.00013052279,0.00031103133,0.00015153471,0.00004828257,0.00000774858,0.00008701524,0.00009048106,0.00011501081],"category_scores_gemma":[0.00013983993,0.00011302821,0.00016103203,0.00019354837,0.00015885131,0.00003814906,0.000047944213,0.00014951815,0.000027487089],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000388948,0.0053526172,0.21027467,0.0024703941,0.00112327,0.001436351,0.0007417912,0.0000027362564,0.73099893,0.025942143,0.01991755,0.0013505779],"study_design_scores_gemma":[0.03616589,0.00045591107,0.40007326,0.009025248,0.0050487677,0.0006171741,0.00042308026,0.00020329653,0.4342728,0.0021301194,0.110744104,0.00084035535],"about_ca_topic_score_codex":0.000008345797,"about_ca_topic_score_gemma":0.000003925036,"teacher_disagreement_score":0.29672617,"about_ca_system_score_codex":0.000018735727,"about_ca_system_score_gemma":0.00039751607,"threshold_uncertainty_score":0.46091565},"labels":[],"label_agreement":null},{"id":"W4417007331","doi":"10.1182/blood-2025-3862","title":"A comparison of overall survival and quality of life in MDS patients treated with azacytidine vs decitabine: A propensity matched registry Study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St Mary's Hospital Centre; HEC Montréal; Queen Elizabeth II Health Sciences Centre; Centre de Développement du Porc du Québec; Dr. Georges-L.-Dumont University Hospital Centre; St. Paul's Hospital; McMaster University; Saskatchewan Cancer Agency; Ottawa Hospital; University of Alberta Hospital; CancerCare Manitoba; Alberta Hospital Edmonton; Vancouver General Hospital; Princess Margaret Cancer Centre; Jewish General Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Decitabine; Myelodysplastic syndromes; Azacitidine; Clinical trial; Comorbidity; Cohort; Quality of life (healthcare); Disease registry; Hypomethylating agent; Randomized controlled trial","score_opus":0.05131948358538161,"score_gpt":0.3510928731173265,"score_spread":0.2997733895319449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417007331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99771607,0.000079721445,0.000006327248,0.00012955704,0.000009763418,0.0013409711,0.000017841363,0.000017893784,0.0006818703],"genre_scores_gemma":[0.99948734,0.000008892555,0.0001871814,0.000024369318,0.000008533875,0.000023618573,0.0000261564,0.000012310619,0.0002215755],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981502,0.00024686172,0.0006412713,0.00029839223,0.00046205832,0.00020121384],"domain_scores_gemma":[0.9987326,0.00017252457,0.00020714532,0.00044927603,0.0003384955,0.000099934245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005973243,0.00015158106,0.0010571389,0.00015916467,0.000022951588,0.000007158711,0.00011612775,0.000081002,0.000008723611],"category_scores_gemma":[0.00071053015,0.00011236965,0.00003418952,0.00048074283,0.00012552754,0.000043085816,0.0001480592,0.00025585896,5.755554e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060063805,0.007727476,0.9816902,0.000540877,0.00030170512,0.00001309506,0.0005717625,0.0000013954177,0.0029551687,0.000027175522,0.00009121798,0.00007350854],"study_design_scores_gemma":[0.032989204,0.0017406112,0.95804346,0.00020403328,0.00015490055,8.090184e-7,0.000757461,0.000040826493,0.005974299,0.0000035471094,0.000005966313,0.00008486744],"about_ca_topic_score_codex":0.0042375727,"about_ca_topic_score_gemma":0.00084570056,"teacher_disagreement_score":0.026982823,"about_ca_system_score_codex":0.000076955606,"about_ca_system_score_gemma":0.00040501237,"threshold_uncertainty_score":0.64059705},"labels":[],"label_agreement":null},{"id":"W4417007345","doi":"10.1182/blood-2025-3852","title":"Wide variability and inconsistency in reporting of results of Myelodysplastic Syndromes/neoplasms (MDS) clinical trials: An icMDS systematic review of published manuscripts","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Clinical trial; Myelodysplastic syndromes; Disease; MEDLINE; Myeloid leukemia; International Prognostic Scoring System; Systematic review; Clinical endpoint","score_opus":0.0915657376142063,"score_gpt":0.4157354921939886,"score_spread":0.32416975457978225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417007345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874359,0.0054015606,0.00007923381,0.0007584496,0.00016727229,0.0033513007,0.000050200975,0.000028018405,0.0027281055],"genre_scores_gemma":[0.99581593,0.0017209556,0.0020372358,0.00012641322,0.000022835626,0.00007528534,0.000035952566,0.000016990585,0.00014837229],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.978622,0.0051245713,0.014406201,0.000747669,0.000752544,0.00034700424],"domain_scores_gemma":[0.961046,0.023841966,0.010238765,0.002908771,0.0016040589,0.0003604658],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.082059234,0.00022515481,0.004618682,0.0004441343,0.00002322045,0.000013647501,0.0002888127,0.00027169415,0.000020955602],"category_scores_gemma":[0.54815674,0.00016973706,0.00031667238,0.0010426439,0.00031422035,0.00016928908,0.0002306729,0.0005534368,8.1723914e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008612027,0.0020968553,0.14259419,0.8508874,0.00077651447,0.0002033284,0.0001776289,7.582849e-7,0.0013818551,0.0003018451,0.00036688577,0.00035151778],"study_design_scores_gemma":[0.026707157,0.0021792066,0.22644319,0.7295274,0.007674841,0.00055982807,0.00054190704,0.0007622482,0.003963017,0.0012517446,0.000017348028,0.00037212716],"about_ca_topic_score_codex":0.00027715787,"about_ca_topic_score_gemma":0.000038698556,"teacher_disagreement_score":0.4660975,"about_ca_system_score_codex":0.00008849178,"about_ca_system_score_gemma":0.0015327082,"threshold_uncertainty_score":0.9452132},"labels":[],"label_agreement":null},{"id":"W4417007456","doi":"10.1182/blood-2025-3885","title":"Evaluation of ventoclax initiation prophylaxis and monitoring outcomes at each dose level and time point in patients with chronic lymphocytic leukemia: A real-world experience","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Ven; Tumor lysis syndrome; Obinutuzumab; Interim analysis; Observational study; Clinical endpoint; Intention-to-treat analysis; Population","score_opus":0.03227503016688986,"score_gpt":0.3235667561014786,"score_spread":0.29129172593458874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417007456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975541,0.00051874795,0.00000272566,0.000016306445,0.00003575753,0.0012297926,0.0000051933494,0.000020365313,0.00061698933],"genre_scores_gemma":[0.9992138,0.00005573156,0.00014831737,0.000009171486,0.000024465764,0.00016499597,0.000015042874,0.000016309752,0.0003521732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980265,0.000110670364,0.00034355372,0.00035489624,0.0009051883,0.0002592304],"domain_scores_gemma":[0.9990637,0.00013277325,0.000106820924,0.00031333286,0.00030383555,0.00007955322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006335865,0.00016100603,0.00033363045,0.0003332211,0.000059067497,0.00001758573,0.000068869245,0.00008566394,0.00001843705],"category_scores_gemma":[0.00034379764,0.00013077511,0.000024837671,0.00044646693,0.00013450944,0.00014432753,0.00014140313,0.00012012381,0.0000033705826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0005365184,0.00024726035,0.98688185,0.0005377884,0.00014820725,0.000017375776,0.0016254253,0.00010956003,0.0020330285,0.000021417623,0.0000064223336,0.007835144],"study_design_scores_gemma":[0.06614214,0.0005141976,0.9128425,0.0006918455,0.0002384576,0.000008040208,0.00006658804,0.007884655,0.011454227,0.0000400391,0.0000025678426,0.00011473335],"about_ca_topic_score_codex":0.0014417589,"about_ca_topic_score_gemma":0.00029256573,"teacher_disagreement_score":0.07403935,"about_ca_system_score_codex":0.04386009,"about_ca_system_score_gemma":0.0107376985,"threshold_uncertainty_score":0.9948705},"labels":[],"label_agreement":null},{"id":"W4417007631","doi":"10.1182/blood-2025-5153","title":"A dynamic comprehensive geriatric assessment demonstrates improvement in patient fitness after induction and predicts survival and treatment tolerability among older adults with newly diagnosed acute myeloid leukemia","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Memorial University of Newfoundland","funders":"","keywords":"Tolerability; Myeloid leukemia; Observational study; Sarcopenia; Induction chemotherapy; Clinical trial; Leukemia; Randomized controlled trial","score_opus":0.0059729783990127355,"score_gpt":0.253874380423955,"score_spread":0.24790140202494226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417007631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995685,0.0005167218,0.00006789953,0.00031324945,0.000088723864,0.0030899222,0.000048401052,0.00005274308,0.00013732885],"genre_scores_gemma":[0.99683434,0.0007546941,0.0011047758,0.00006405607,0.00002694941,0.0010210129,0.00007775456,0.000025939882,0.000090509326],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978543,0.00012901949,0.000447949,0.0007586425,0.00035936647,0.00045070078],"domain_scores_gemma":[0.9989403,0.00017405525,0.000109988294,0.00038118125,0.00018443179,0.00021008163],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013372434,0.00036327535,0.0005943319,0.0002943112,0.000092050956,0.000061149236,0.0000630439,0.00017600833,0.000013377207],"category_scores_gemma":[0.000022576292,0.00027223869,0.000049525544,0.00044657823,0.00023367454,0.00016220697,0.00013654989,0.0003527926,6.498057e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019843767,0.0017560286,0.9283146,0.00048144994,0.0009044524,0.0007769406,0.0014310619,0.000035046425,0.0031974942,0.0000073661176,0.000014848627,0.06109628],"study_design_scores_gemma":[0.024914915,0.0024892387,0.965339,0.00047438234,0.0005720296,0.00004903343,0.0018822568,0.002305468,0.0017267226,0.000013421856,0.000013163745,0.0002203571],"about_ca_topic_score_codex":0.0012838626,"about_ca_topic_score_gemma":0.0012512839,"teacher_disagreement_score":0.060875926,"about_ca_system_score_codex":0.0012055124,"about_ca_system_score_gemma":0.0007830487,"threshold_uncertainty_score":0.999973},"labels":[],"label_agreement":null},{"id":"W4417007812","doi":"10.1182/blood-2025-4200","title":"Impact of early bacteremia on clinical outcomes following allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide-based gvhd prophylaxis","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"","keywords":"Bacteremia; Neutropenia; Transplantation; Total body irradiation; Proportional hazards model; Cohort; Hematopoietic stem cell transplantation; Myeloid leukemia; Absolute neutrophil count; Acute lymphocytic leukemia","score_opus":0.012690902011191581,"score_gpt":0.30789133661846263,"score_spread":0.295200434607271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417007812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99706984,0.00008343965,0.00028367026,0.00010037321,0.00017378923,0.0006060049,0.000053494678,0.000062083134,0.0015673237],"genre_scores_gemma":[0.99919283,0.0000355488,0.00026858528,0.00021747597,0.000019343031,0.000042828953,0.00004711535,0.000024961577,0.0001512888],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998708,0.00006303709,0.00045161278,0.0003089816,0.00023777339,0.00023058796],"domain_scores_gemma":[0.99918145,0.00018368539,0.00010457721,0.00032794458,0.000088897235,0.00011345007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013177305,0.00021666968,0.0004983785,0.00014986358,0.00006447001,0.000015013792,0.00009094728,0.00012953303,0.00006701787],"category_scores_gemma":[0.0000134082675,0.00014655163,0.0005196121,0.00027627498,0.000052952186,0.000047563026,0.0000044415574,0.00026317436,0.000011860209],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009984459,0.0014386033,0.9889639,0.0002923335,0.0005389803,0.00016953336,0.0001180213,0.00003363638,0.006990841,0.000015972844,0.0000050340186,0.00043467007],"study_design_scores_gemma":[0.006627814,0.0049599903,0.96388763,0.0003021638,0.0012835409,0.000016346272,0.000010545313,6.826096e-8,0.022759499,0.0000072165544,0.000006809979,0.00013837688],"about_ca_topic_score_codex":0.00025213536,"about_ca_topic_score_gemma":0.0000486933,"teacher_disagreement_score":0.0250763,"about_ca_system_score_codex":0.00003875052,"about_ca_system_score_gemma":0.00049850764,"threshold_uncertainty_score":0.5976202},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"agree"},{"id":"W4417008277","doi":"10.1182/blood-2025-7880","title":"Assessing quality metrics in sickle cell disease: A multicenter review of community hospitals in southwestern Ontario from 2017-2024.","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Windsor; Windsor Regional Hospital; Western University","funders":"","keywords":"Logistic regression; Health care; Emergency department; Descriptive statistics; Quality management; MEDLINE; Retrospective cohort study; Community hospital; Disease; Community health","score_opus":0.02890644442978044,"score_gpt":0.3250526864681385,"score_spread":0.29614624203835804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417008277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9535583,0.041281626,0.000017225906,0.00047231867,0.00011597258,0.00046975672,0.000026304155,0.00001488201,0.0040435814],"genre_scores_gemma":[0.9952141,0.0030344627,0.00021248833,0.0009588511,0.0000069605253,0.000013217959,0.00007988191,0.000009691354,0.00047034706],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984761,0.00034446985,0.000623747,0.00015923873,0.00019974177,0.00019669179],"domain_scores_gemma":[0.99894387,0.00024368544,0.00015053505,0.0005027537,0.00006916203,0.00008999743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069842406,0.0001425422,0.0005391062,0.00018337798,0.000036135705,0.000017201908,0.00014330848,0.00011105068,0.000103996346],"category_scores_gemma":[0.00043052703,0.00012313324,0.00012321076,0.0005512671,0.00004960801,0.00008938649,0.00011451268,0.00066575024,0.0000086281],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003526185,0.002946353,0.98931897,0.0048378105,0.0000539838,0.000040580144,0.0012951675,0.0000015434027,0.00020118925,0.0000046681494,0.00020147486,0.0010630037],"study_design_scores_gemma":[0.0050238604,0.000038580132,0.9795814,0.01264939,0.00038709774,3.2266192e-7,0.0013058966,0.000010934043,0.00023287728,0.00006534344,0.00058449403,0.00011979349],"about_ca_topic_score_codex":0.064170346,"about_ca_topic_score_gemma":0.016931947,"teacher_disagreement_score":0.0472384,"about_ca_system_score_codex":0.0001032648,"about_ca_system_score_gemma":0.0003301161,"threshold_uncertainty_score":0.94484246},"labels":[],"label_agreement":null},{"id":"W4417008302","doi":"10.1182/blood-2025-1851","title":"Interim and end-of-treatment FDG-PET demonstrate limited ability to predict 3-year progression-free survival with nivolumab-AVD in first-line treatment of advanced stage Hodgkin lymphoma: Imaging sub-analysis of Phase 3 S1826 study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University","funders":"","keywords":"Dacarbazine; ABVD; Stage (stratigraphy); Regimen; Interim analysis; Phases of clinical research; Brentuximab vedotin; Chemotherapy regimen; Progression-free survival","score_opus":0.016185490822117392,"score_gpt":0.3174914110932512,"score_spread":0.3013059202711338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417008302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995872,0.00084508373,0.000026076868,0.00018156851,0.000034968092,0.0024746773,0.00041221073,0.000031631036,0.00012178068],"genre_scores_gemma":[0.9978916,0.0002707502,0.0012312008,0.000007505809,0.0000093694725,0.00044004526,0.00009980564,0.000020046908,0.000029669667],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977877,0.00013657103,0.0008171326,0.0006233485,0.00034271556,0.00029252892],"domain_scores_gemma":[0.99817497,0.00028136556,0.00029528094,0.0008981255,0.00019140058,0.00015887828],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021327175,0.00037568648,0.0014031817,0.00058860925,0.00004654324,0.0000127156845,0.00011593004,0.00004234135,0.000020205372],"category_scores_gemma":[0.00009378959,0.00025550203,0.00021107089,0.0011125337,0.00014226115,0.00006591365,0.000091306196,0.000029965533,3.3827288e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032087013,0.061505932,0.87662405,0.00014991993,0.004789836,0.00028447894,0.0009525903,0.00009704898,0.0019928862,0.000009173816,0.0000018534923,0.050383527],"study_design_scores_gemma":[0.092915885,0.020927444,0.800842,0.0004771605,0.010228187,0.000008170831,0.0018802416,0.0005019695,0.07201067,0.0000070043043,0.000021216549,0.00018008378],"about_ca_topic_score_codex":0.0016604563,"about_ca_topic_score_gemma":0.0035301733,"teacher_disagreement_score":0.08970718,"about_ca_system_score_codex":0.00043634285,"about_ca_system_score_gemma":0.0003258442,"threshold_uncertainty_score":0.99998975},"labels":[],"label_agreement":null},{"id":"W4417008341","doi":"10.1182/blood-2025-7342","title":"Real-world hematologic response and treatment patterns among patients with polycythemia vera (PV) treated with ropeginterferon alfa-2b (ropeg)","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Forming Technologies (Canada)","funders":"","keywords":"Polycythemia vera; Hematocrit; Hematology; Medical prescription; Retrospective cohort study; Observational study; Clinical trial; Myeloproliferative neoplasm; Guideline","score_opus":0.008347005931708583,"score_gpt":0.23960370287153207,"score_spread":0.23125669693982348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417008341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99535114,0.00012738952,0.000010628494,0.0007255213,0.000023720842,0.0012909686,0.00005823113,0.00010820741,0.0023041817],"genre_scores_gemma":[0.9949541,0.00025446506,0.0002758246,0.00014029612,0.000021410631,0.0003536726,0.00011949107,0.000040565545,0.0038401762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99838644,0.00013163143,0.0002816252,0.00060197397,0.00023375593,0.00036454995],"domain_scores_gemma":[0.9989367,0.00017150085,0.000115836505,0.00046338252,0.000115648996,0.00019690843],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00006977485,0.0004458318,0.00064635265,0.00023597814,0.00014245205,0.000052360683,0.00006380266,0.00008179438,0.000080576436],"category_scores_gemma":[0.000017214365,0.00024753052,0.00006465161,0.00024631905,0.000118339034,0.00007582053,0.000041778552,0.000117531636,0.000010655653],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008110803,0.003352812,0.9849966,0.000049296475,0.0011325342,0.0005982788,0.00020946862,0.0000014263635,0.00010036278,0.000073678195,0.00010232925,0.0012723852],"study_design_scores_gemma":[0.021046456,0.0069174515,0.9421382,0.0007856556,0.0012173248,0.00003548569,0.00007438594,0.000009948777,0.02718782,0.0000035519117,0.00035242003,0.0002313066],"about_ca_topic_score_codex":0.00082764943,"about_ca_topic_score_gemma":0.0012027678,"teacher_disagreement_score":0.042858433,"about_ca_system_score_codex":0.00023044532,"about_ca_system_score_gemma":0.00012127009,"threshold_uncertainty_score":0.9999977},"labels":[],"label_agreement":null},{"id":"W4417008372","doi":"10.1182/blood-2025-340","title":"Identifying fusions in AML/MDS: An experience from first 400 patients enrolled into myelomatch","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Fredericton","funders":"","keywords":"Concordance; Fluorescence in situ hybridization; Fusion gene; Chromosomal translocation; RNA; Karyotype; DNA sequencing; DNA","score_opus":0.017139624342320435,"score_gpt":0.3199701753135895,"score_spread":0.3028305509712691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417008372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956194,0.00024453993,0.000091270536,0.0005947942,0.00017410789,0.0006087663,0.0000105441095,0.0000893403,0.0025672263],"genre_scores_gemma":[0.9958864,0.00011062539,0.0023662166,0.00042198866,0.000089919915,0.00017431844,0.00009413309,0.000024408391,0.0008319969],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99815387,0.00008576218,0.0004068584,0.0005079691,0.0004389652,0.0004065744],"domain_scores_gemma":[0.9988005,0.0001693934,0.0000547654,0.00065515423,0.00012407475,0.0001961017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017472438,0.00018325013,0.0003612096,0.00034020562,0.0001926952,0.00005540931,0.00035408215,0.00015590948,0.0004242559],"category_scores_gemma":[0.0004749923,0.00016888576,0.000071104434,0.00075081957,0.0000922944,0.00021006969,0.00033090776,0.00038526856,0.000098208024],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003251243,0.002331767,0.9494488,0.00012407408,0.00012071284,0.00023144059,0.018583937,0.0000024388237,0.020754261,0.00007973804,0.001074684,0.006923013],"study_design_scores_gemma":[0.018802917,0.00024255765,0.9514589,0.00071635086,0.00011499001,0.0000046413084,0.0047447323,0.0005150101,0.01953509,0.00072883244,0.0028392763,0.00029674906],"about_ca_topic_score_codex":0.0034169627,"about_ca_topic_score_gemma":0.001355917,"teacher_disagreement_score":0.018477792,"about_ca_system_score_codex":0.00023585078,"about_ca_system_score_gemma":0.0002685497,"threshold_uncertainty_score":0.6886961},"labels":[],"label_agreement":null},{"id":"W4417008388","doi":"10.1182/blood-2025-884","title":"Acalabrutinib plus venetoclax and rituximab in patients with treatment-naive (TN) mantle cell lymphoma (MCL): Results from the Phase 2 TrAVeRse study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; Princess Margaret Cancer Centre; BC Cancer Agency; Ontario Institute for Cancer Research","funders":"","keywords":"Chemoimmunotherapy; Mantle cell lymphoma; Rituximab; Phases of clinical research; Progressive disease; Clinical endpoint; Minimal residual disease; Lymphoma; Ibrutinib","score_opus":0.009038424887865857,"score_gpt":0.2500816424486637,"score_spread":0.24104321756079786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417008388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99529135,0.00052956503,4.827626e-7,0.00017486591,0.000057706224,0.0018153335,0.0003358616,0.000028177483,0.0017666795],"genre_scores_gemma":[0.9989093,0.000081217506,0.0000701391,0.00016983468,0.000030813568,0.00015621156,0.00021936392,0.00001663884,0.00034649408],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986884,0.00007724913,0.00029243663,0.00047449494,0.00021532098,0.00025207453],"domain_scores_gemma":[0.9990934,0.00023554468,0.00008391717,0.00046521524,0.00004197515,0.000079921716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006792053,0.00025479493,0.0004124168,0.000070943075,0.00010485644,0.000033779692,0.000081068014,0.000069436705,0.000015282636],"category_scores_gemma":[0.000025117226,0.0001458093,0.0000538212,0.0002002579,0.00006154038,0.0000448252,0.0000455672,0.000050380786,0.000022488573],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076842783,0.10533146,0.8560788,0.000017994353,0.0009611272,0.0005174851,0.0046237735,0.000002567787,0.000015314517,0.000014163435,0.00032567015,0.024427371],"study_design_scores_gemma":[0.38537252,0.0033121589,0.6062618,0.00010350388,0.0010491833,0.0000019685167,0.0009348543,0.00002126647,0.0019030132,0.000008406649,0.0009269606,0.00010439266],"about_ca_topic_score_codex":0.0022090042,"about_ca_topic_score_gemma":0.00029854858,"teacher_disagreement_score":0.37768823,"about_ca_system_score_codex":0.00035303962,"about_ca_system_score_gemma":0.00027722373,"threshold_uncertainty_score":0.5945931},"labels":[],"label_agreement":null},{"id":"W4417008392","doi":"10.1182/blood-2025-7884","title":"Patient satisfaction with outpatient management of sickle cell pain crisis","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Hemoglobinopathy; Patient satisfaction; Emergency department; Population; Outpatient clinic; Disease; Health care; Chest pain; Sickle cell anemia","score_opus":0.0031018044359082497,"score_gpt":0.19775415467844126,"score_spread":0.19465235024253302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417008392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9735174,0.00062733254,0.0005624977,0.00041012623,0.00007156334,0.00042245362,0.0000032926193,0.000034082732,0.024351204],"genre_scores_gemma":[0.99802625,0.00017413803,0.0008861903,0.00029301614,0.0000042082106,0.000019918078,0.000005599602,0.000008213706,0.000582464],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993531,0.000029641827,0.00018455934,0.00014520556,0.00016368373,0.00012382184],"domain_scores_gemma":[0.9996461,0.0000122864385,0.000058964095,0.00019321675,0.000048829803,0.00004057013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008206053,0.00008675732,0.00014538855,0.000073715826,0.000033881428,0.0000036623317,0.000020168109,0.000057293266,0.00004389035],"category_scores_gemma":[0.000003962866,0.00006302222,0.000046921126,0.00019855738,0.000020670053,0.000015805288,0.000022687567,0.000086439584,0.000006987807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001721119,0.01620682,0.4881679,0.010336604,0.0037364142,0.00047915342,0.006288111,0.00059041666,0.005955617,0.0033726643,0.031280648,0.4318645],"study_design_scores_gemma":[0.07051961,0.022058228,0.447879,0.007493244,0.010905564,0.000051253777,0.114396155,0.00074150687,0.25424722,0.0009925624,0.068999074,0.0017165687],"about_ca_topic_score_codex":0.00013577398,"about_ca_topic_score_gemma":0.000008228347,"teacher_disagreement_score":0.43014795,"about_ca_system_score_codex":0.00001987839,"about_ca_system_score_gemma":0.000022996384,"threshold_uncertainty_score":0.25699717},"labels":[],"label_agreement":null},{"id":"W4417008400","doi":"10.1182/blood-2025-206","title":"Garp/LRRC32 defines the erythroid-megakaryocyte fate decision and enables β-globin program activation","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Erythropoietin receptor; Erythropoietin; Haematopoiesis; Transferrin receptor; Progenitor cell; Erythropoiesis; Downregulation and upregulation; Stem cell; Bone marrow","score_opus":0.006611409777154193,"score_gpt":0.25619330855556943,"score_spread":0.24958189877841525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417008400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829635,0.0037433465,0.00019915265,0.0040271957,0.00013344234,0.0007765828,0.0000022330921,0.00014258797,0.008011936],"genre_scores_gemma":[0.99457926,0.0019329444,0.0012719362,0.0008574031,0.00005788788,0.00006468081,0.000017792367,0.000016347092,0.0012017807],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991026,0.000031067,0.00021958034,0.000245283,0.00016907758,0.00023238827],"domain_scores_gemma":[0.9994169,0.00012631975,0.00005246014,0.00026712168,0.00007549845,0.0000617065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001621574,0.00014938603,0.0001967719,0.00009527374,0.00021147552,0.000053816722,0.00007684439,0.00014805187,0.00002018443],"category_scores_gemma":[0.00020044747,0.000088861,0.00006611775,0.00039410277,0.00011115194,0.000066678775,0.00007061892,0.00020375027,0.000012182023],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091162353,0.0034970213,0.06298764,0.00062393403,0.0008811648,0.00009133483,0.0010622725,0.000048715377,0.038231347,0.005024676,0.018749181,0.8678911],"study_design_scores_gemma":[0.03525475,0.0021904525,0.3341159,0.003953072,0.0027812482,0.00052393164,0.0045418586,0.0019721389,0.10863731,0.0131381815,0.49179843,0.0010927303],"about_ca_topic_score_codex":0.00006991295,"about_ca_topic_score_gemma":0.000014768751,"teacher_disagreement_score":0.86679834,"about_ca_system_score_codex":0.00001690762,"about_ca_system_score_gemma":0.00008938676,"threshold_uncertainty_score":0.36236465},"labels":[],"label_agreement":null},{"id":"W4417008411","doi":"10.1182/blood-2025-204","title":"Anti-PF4 antibodies are a potential mediator of antisense oligonucleotide (ASO)-induced thrombocytopenia.","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"DNA and Nucleic Acid Chemistry","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Lethbridge","funders":"","keywords":"Oligonucleotide; RNase P; Antibody; RNA; Mediator; Nucleic acid; RNase H; Mechanism of action; Gene","score_opus":0.005274219201199513,"score_gpt":0.2348420998560513,"score_spread":0.22956788065485179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417008411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947895,0.0007597463,0.000047131423,0.00015207424,0.00023557783,0.00011594103,0.00005431848,0.000025369382,0.003820338],"genre_scores_gemma":[0.99854547,0.0002956988,0.00037726975,0.00012906986,0.00018507379,0.000004877308,0.000054264066,0.000022274107,0.00038599042],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99888664,0.0000304479,0.0002885021,0.00038007397,0.00014411639,0.00027023748],"domain_scores_gemma":[0.99917275,0.000008977066,0.0001518414,0.00048806914,0.00010792636,0.000070418566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008823303,0.00020192203,0.0003571442,0.000047843027,0.000077213015,0.000020230575,0.0002880028,0.00021631103,0.000029543327],"category_scores_gemma":[0.00010194701,0.00019752666,0.00016101473,0.00012247833,0.00012021191,0.000004831262,0.00023087286,0.00009975481,0.000008751427],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033087643,0.0002851916,0.015288569,0.000101554324,0.00022823078,0.00003054051,0.000017169987,0.0000015800633,0.982313,0.000028388444,0.0014699844,0.0002027267],"study_design_scores_gemma":[0.0014241737,0.00006619018,0.025369138,0.000057239093,0.00015410458,0.000023636658,0.00014041437,0.000005600443,0.97145814,0.000033404893,0.0010742664,0.00019370747],"about_ca_topic_score_codex":0.000013531037,"about_ca_topic_score_gemma":0.0000061163314,"teacher_disagreement_score":0.010854852,"about_ca_system_score_codex":0.000004661043,"about_ca_system_score_gemma":0.00008989051,"threshold_uncertainty_score":0.8054904},"labels":[],"label_agreement":null},{"id":"W4417008450","doi":"10.1182/blood-2025-885","title":"Time to third-line treatment after bendamustine-rituximab with or without acalabrutinib in patients with previously untreated mantle cell lymphoma: Updated analysis of the phase 3 ECHO trial after 50 months of follow-up","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; BC Cancer Agency","funders":"","keywords":"Bendamustine; Hazard ratio; Clinical endpoint; Discontinuation; Rituximab; Randomization; Confidence interval; Phases of clinical research; Mantle cell lymphoma","score_opus":0.006260741455784101,"score_gpt":0.24771047819589428,"score_spread":0.2414497367401102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417008450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953303,0.00018831168,0.0000038980825,0.0001219702,0.000036514113,0.0034026382,0.00041521297,0.00003225196,0.0004689387],"genre_scores_gemma":[0.9959122,0.000015469814,0.00036014535,0.000140858,0.000018214194,0.0006663258,0.0002662594,0.00003419822,0.0025863545],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9978361,0.000101616,0.00069441897,0.00055131665,0.00044534437,0.00037118982],"domain_scores_gemma":[0.99846655,0.00007757767,0.0002635474,0.00081737345,0.00023066837,0.00014427204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009746631,0.00043129743,0.0013505885,0.00045974564,0.00003811443,0.000016050491,0.00014220522,0.00012845451,0.0003619568],"category_scores_gemma":[0.00002856272,0.00020768202,0.00027566316,0.0018059191,0.00009213946,0.00005588416,0.00007061188,0.000053598145,0.000016145787],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22792321,0.05846908,0.7049768,0.00007958115,0.005678543,0.000116374424,0.0006667744,0.000030214956,0.00007137393,6.178495e-7,0.000095041985,0.0018923801],"study_design_scores_gemma":[0.60270923,0.011953185,0.33817193,0.00053502806,0.025332725,0.0000023997625,0.000059230624,0.00015127477,0.020607589,6.212642e-7,0.00023501378,0.00024173758],"about_ca_topic_score_codex":0.00049201923,"about_ca_topic_score_gemma":0.0009219943,"teacher_disagreement_score":0.37478605,"about_ca_system_score_codex":0.00022599798,"about_ca_system_score_gemma":0.0003923565,"threshold_uncertainty_score":0.8469027},"labels":[],"label_agreement":null},{"id":"W4417008552","doi":"10.1182/blood-2025-2567","title":"Polygenic scores as a clinical diagnosis tool for abnormal hematological values","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Mean corpuscular volume; Percentile; Abnormality; Complete blood count; Hemoglobin; Hematology; Mean corpuscular hemoglobin concentration; Microcytosis; Mean corpuscular hemoglobin","score_opus":0.021422690655288935,"score_gpt":0.3391182193947339,"score_spread":0.31769552873944495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417008552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948545,0.0015558233,0.0012437799,0.0007875031,0.0002231009,0.00027052514,0.000023482924,0.000017665774,0.0010235849],"genre_scores_gemma":[0.9922559,0.00065397477,0.0037466118,0.0014677205,0.00024009291,0.00022030149,0.00007249441,0.000008981746,0.0013339256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987916,0.00013143045,0.00040361594,0.00034935542,0.000048813494,0.00027523303],"domain_scores_gemma":[0.9992888,0.00023206136,0.00008987952,0.0002661243,0.00007340457,0.00004974595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005071488,0.00012004034,0.0002635926,0.000028769513,0.000108617074,0.000013451178,0.00018531943,0.0003127074,0.000020941685],"category_scores_gemma":[0.0019707305,0.000103795166,0.0002485152,0.00006301114,0.0000871901,0.0000013629232,0.00012471809,0.00007363007,0.000016516022],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007887092,0.0005051217,0.97899294,0.00001886428,0.00030445526,0.0000020710202,0.000010463973,0.000007020409,0.0019012166,0.0011632253,0.01533737,0.0016783607],"study_design_scores_gemma":[0.0043302877,0.0014323409,0.9247436,0.00002943849,0.0004044951,0.000031155894,0.00009468444,0.00007303462,0.018902918,0.0056258896,0.043914955,0.0004171943],"about_ca_topic_score_codex":0.000013073073,"about_ca_topic_score_gemma":0.000009882347,"teacher_disagreement_score":0.05424935,"about_ca_system_score_codex":0.000004045284,"about_ca_system_score_gemma":0.00009605516,"threshold_uncertainty_score":0.42326438},"labels":[],"label_agreement":null},{"id":"W4417008688","doi":"10.1182/blood-2025-2945","title":"Cardiopulmonary complications during pregnancy as a risk factor for cesarean delivery in a two center, sickle cell disease pregnancy cohort","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Pregnancy; Cohort; Gestational age; Risk factor; Anemia; Cohort study; Sickle cell anemia","score_opus":0.007662294948840269,"score_gpt":0.25408384963426345,"score_spread":0.24642155468542318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417008688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9706795,0.017944118,0.00007647175,0.00029028312,0.0001150079,0.002277794,0.00050811266,0.00011359803,0.007995081],"genre_scores_gemma":[0.99511546,0.0028559552,0.00016800317,0.00006674413,0.000025437052,0.0004091551,0.00010781457,0.000030021836,0.0012213828],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986757,0.000045736415,0.00033688595,0.00043286604,0.00014912081,0.00035970367],"domain_scores_gemma":[0.9991028,0.000055213404,0.000084870975,0.0004785768,0.0000823286,0.00019622446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000030495716,0.00020335961,0.00031870443,0.00016821818,0.00017256712,0.000016718055,0.0001281514,0.00007807099,0.000021351663],"category_scores_gemma":[0.00006845541,0.00018881327,0.00022212154,0.00026912618,0.00004891085,0.00006660591,0.0000732607,0.00022925358,0.00001855439],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018811565,0.0029114927,0.9894765,0.0010803449,0.00024778425,0.0002107332,0.0003070373,0.00003618475,0.0011463851,0.000066503904,0.00005984071,0.004269073],"study_design_scores_gemma":[0.017369192,0.00012812483,0.97077733,0.0061368295,0.001145203,0.00002989189,0.00030116912,0.00032159933,0.0021536374,0.00033574607,0.0009624635,0.00033883698],"about_ca_topic_score_codex":0.00021946568,"about_ca_topic_score_gemma":0.00003669575,"teacher_disagreement_score":0.024435954,"about_ca_system_score_codex":0.00006179197,"about_ca_system_score_gemma":0.00019719441,"threshold_uncertainty_score":0.76995814},"labels":[],"label_agreement":null},{"id":"W4417008718","doi":"10.1182/blood-2025-2947","title":"Venous thromboembolism and bleeding rates in pregnant and postpartum patients with sickle cell disease","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Public Health; University of Ottawa","funders":"","keywords":"Interquartile range; Pregnancy; Odds ratio; Incidence (geometry); Aspirin; Retrospective cohort study; Low molecular weight heparin; Venous thromboembolism; Acute chest syndrome; Cohort","score_opus":0.0032195652086245696,"score_gpt":0.20456473823479923,"score_spread":0.20134517302617466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417008718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99101806,0.006307073,0.000001403646,0.0004186647,0.000039716484,0.00034965904,0.0000055470705,0.000020535514,0.0018393216],"genre_scores_gemma":[0.9987683,0.0008048383,0.00004448673,0.00017843081,0.000008781655,0.000008744166,0.000011519559,0.000009764901,0.00016509497],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99944955,0.000011572031,0.00010667398,0.00018286056,0.00007935902,0.0001699569],"domain_scores_gemma":[0.9997251,0.000020279691,0.000023654426,0.000094413255,0.000028047227,0.000108515254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003474467,0.00009925139,0.00019166962,0.00007319883,0.000053752487,0.000016051716,0.000022305376,0.00004971018,0.000004776056],"category_scores_gemma":[0.00002030709,0.000069972455,0.0000126825935,0.00012572625,0.00006161397,0.000042025807,0.000035292727,0.00010949907,0.0000013141912],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016113416,0.0018655116,0.9950567,0.0004773568,0.000061460574,0.000071615665,0.0005827651,0.0000021234043,0.00037401967,0.00012014346,0.000062705294,0.0011644958],"study_design_scores_gemma":[0.008710738,0.00044016214,0.98737156,0.0012722124,0.0004190396,0.00000346061,0.00036375414,0.0000653598,0.00084539363,0.00017764974,0.00020361508,0.00012702319],"about_ca_topic_score_codex":0.000029697243,"about_ca_topic_score_gemma":0.000005204066,"teacher_disagreement_score":0.008549604,"about_ca_system_score_codex":0.0000069524945,"about_ca_system_score_gemma":0.000061841434,"threshold_uncertainty_score":0.2853394},"labels":[],"label_agreement":null},{"id":"W4417008757","doi":"10.1182/blood-2025-2950","title":"Shear wave elastography as a screening modality for hepatic fibrosis in a comprehensive sickle cell disease clinic","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Blood Services; University of Calgary","funders":"","keywords":"Hepatic fibrosis; Transient elastography; Fibrosis; Retrospective cohort study; Elastography; Chronic liver disease; Cohort; Liver disease; Magnetic resonance elastography","score_opus":0.015241279701467582,"score_gpt":0.2742178751573036,"score_spread":0.258976595455836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417008757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924699,0.0021912928,0.0007864651,0.0012570192,0.000086273285,0.0011027097,0.00003424456,0.00006702873,0.0020050725],"genre_scores_gemma":[0.99555546,0.0002191157,0.0022738462,0.0011433602,0.000027954307,0.000101597514,0.000048725436,0.000020710779,0.00060921995],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876374,0.000057034067,0.00036401022,0.00034200738,0.00014663913,0.0003265685],"domain_scores_gemma":[0.9991558,0.0002065857,0.00006323803,0.0003030546,0.000085109314,0.00018616494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000116261195,0.00017189037,0.00036899306,0.0002140223,0.000090915135,0.000014720136,0.00006334481,0.0001345412,0.00004889616],"category_scores_gemma":[0.00011823315,0.00015482213,0.0002942384,0.00047961777,0.00008228805,0.000037796315,0.000050964492,0.00023697819,0.000018375807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0081223985,0.014461762,0.93603164,0.008354967,0.0015590197,0.00050050847,0.0025855703,0.0004304333,0.0110559575,0.00056069583,0.0038078297,0.012529222],"study_design_scores_gemma":[0.077129826,0.0029689572,0.8603231,0.004876514,0.00523836,0.00002318417,0.0052405703,0.015131857,0.008159938,0.007622701,0.012023192,0.0012618067],"about_ca_topic_score_codex":0.0001771566,"about_ca_topic_score_gemma":0.0000082409215,"teacher_disagreement_score":0.07570854,"about_ca_system_score_codex":0.000015441783,"about_ca_system_score_gemma":0.00015818888,"threshold_uncertainty_score":0.63134634},"labels":[],"label_agreement":null},{"id":"W4417008779","doi":"10.1182/blood-2025-2954","title":"Lived experience of pregnant patients with sickle cell disease: A qualitative study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; University of Toronto; Hamilton Health Sciences; University Health Network; St. Michael's Hospital; Mount Sinai Hospital","funders":"","keywords":"Qualitative research; Pregnancy; Thematic analysis; Lived experience; Coding (social sciences); Disease; Indigenous; Health care; Grounded theory","score_opus":0.009928316603387733,"score_gpt":0.2852672045203847,"score_spread":0.27533888791699695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417008779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99619246,0.0009115648,0.000022745282,0.000050188046,0.000033072054,0.0008045834,0.000008069217,0.000023550632,0.00195375],"genre_scores_gemma":[0.9989418,0.000025070947,0.000089543566,0.000052481828,0.0000036062738,0.00005006949,0.000008623006,0.000007806713,0.0008210457],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.999237,0.000059889575,0.00018038943,0.00018551655,0.00020540266,0.00013178126],"domain_scores_gemma":[0.9994734,0.000039017625,0.00006197184,0.00022479866,0.00011777065,0.000083047904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000051338848,0.000097008786,0.00019401847,0.000054281372,0.00004144568,0.000004042416,0.000059634676,0.000029683239,0.000027153275],"category_scores_gemma":[0.00005011585,0.00006323425,0.00003716184,0.00022248064,0.00008220893,0.000027849548,0.000033186312,0.000078048535,0.0000041069716],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010218222,0.0294572,0.62204856,0.00046643234,0.00037517215,0.00006238956,0.34508815,0.000005420756,0.00054872903,0.00006266753,0.0001408873,0.0007225809],"study_design_scores_gemma":[0.035176728,0.0044812835,0.45613593,0.0017487635,0.0015498959,6.036549e-7,0.4946181,0.000023233499,0.0056166374,0.00006777246,0.000267773,0.00031327567],"about_ca_topic_score_codex":0.00003952474,"about_ca_topic_score_gemma":0.0000025072222,"teacher_disagreement_score":0.1659126,"about_ca_system_score_codex":0.000008414444,"about_ca_system_score_gemma":0.00010867323,"threshold_uncertainty_score":0.25786176},"labels":[],"label_agreement":null},{"id":"W4417008787","doi":"10.1182/blood-2025-2956","title":"Subclinical neurovascular injury and cognitive outcomes in adults with sickle cell disease: Prevalence and imaging correlates","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"","keywords":"Hyperintensity; Stroke (engine); Magnetic resonance imaging; Leukoaraiosis; Neuroradiology; Neurovascular bundle; Magnetic resonance angiography; Neurology; White matter; Subclinical infection","score_opus":0.0028791192099883864,"score_gpt":0.23224923370976008,"score_spread":0.2293701144997717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417008787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869883,0.011093947,0.000011421859,0.00077971927,0.00003743838,0.00041929982,0.000010125268,0.000032298,0.00062745064],"genre_scores_gemma":[0.99693096,0.002146909,0.000035703724,0.0005269375,0.000006778248,0.00001495582,0.000005850023,0.000011216306,0.0003206975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992022,0.000039192342,0.00017898087,0.00030320536,0.000105219544,0.00017122769],"domain_scores_gemma":[0.99952924,0.00015457542,0.000032721076,0.00012362709,0.00003924759,0.00012059452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008934619,0.00012884276,0.000233397,0.00007855979,0.000044237415,0.000014325904,0.000030889045,0.0000530765,0.000007632003],"category_scores_gemma":[0.00018260708,0.000093253555,0.000036668647,0.00013972401,0.00017089321,0.000052373758,0.000054257882,0.0002444246,0.0000023990488],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039413854,0.00052356033,0.9958927,0.00057362195,0.000050744686,0.00019464493,0.00016981382,4.2092614e-7,0.00002708459,0.000014097849,0.000015971773,0.0021432023],"study_design_scores_gemma":[0.00938455,0.00019765143,0.98697793,0.0016123623,0.00084949716,0.00001765176,0.00037993022,0.0002566479,0.000110662346,0.00005507113,0.000034375345,0.00012365296],"about_ca_topic_score_codex":0.000020510364,"about_ca_topic_score_gemma":0.00000420799,"teacher_disagreement_score":0.009942653,"about_ca_system_score_codex":0.0000035911837,"about_ca_system_score_gemma":0.00006764667,"threshold_uncertainty_score":0.38027695},"labels":[],"label_agreement":null},{"id":"W4417008804","doi":"10.1182/blood-2025-2961","title":"Systematic intensification of red cell exchange with hydroxyurea decreased the transfusion burden in patients with sickle cell disease: A single-center retrospective cohort study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Fetal hemoglobin; Retrospective cohort study; Hemoglobinopathy; Red Cell; Hemoglobin; Exchange transfusion; Cohort; Cohort study; Red blood cell; Sickle cell anemia","score_opus":0.0037605680266271234,"score_gpt":0.18760138945640184,"score_spread":0.1838408214297747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417008804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915759,0.00037713812,0.00004320997,0.00019703014,0.000030943167,0.0056036585,0.0000098970195,0.000028981516,0.0021332593],"genre_scores_gemma":[0.9994101,0.000029809205,0.000019928792,0.00005189729,0.000007835046,0.00018469922,0.00004299234,0.000020673084,0.00023205997],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986544,0.00012854364,0.0003520784,0.0002972716,0.00039589428,0.0001718092],"domain_scores_gemma":[0.9990237,0.000040591294,0.000151389,0.00045764158,0.00025116373,0.00007551782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020922275,0.0001727374,0.00043490867,0.0001369006,0.00005890901,0.000011099586,0.00009319812,0.0000623385,0.000012082326],"category_scores_gemma":[0.000052797728,0.00009367792,0.00005208208,0.00051100884,0.00006558399,0.000036474714,0.000018528857,0.00016882941,0.000001822543],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011967608,0.008421485,0.9844272,0.0032693434,0.00020441785,0.000018938583,0.00188804,0.00000836541,0.00052287197,0.0000023782045,0.000026231734,0.000013929551],"study_design_scores_gemma":[0.020151926,0.0017629045,0.9671678,0.004600376,0.0020664195,0.0000014567432,0.0033686429,0.000117202144,0.0006193244,0.000005570252,0.000005003234,0.00013335736],"about_ca_topic_score_codex":0.0001785804,"about_ca_topic_score_gemma":0.000069709,"teacher_disagreement_score":0.018955166,"about_ca_system_score_codex":0.00007700944,"about_ca_system_score_gemma":0.00007735308,"threshold_uncertainty_score":0.38200745},"labels":[],"label_agreement":null},{"id":"W4417008854","doi":"10.1182/blood-2025-2971","title":"Splenomegaly patterns and clinical impact in African children with sickle cell anemia on hydroxyurea treatment","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario","funders":"","keywords":"Sickle cell anemia; Splenectomy; Anemia; Malaria; Splenic infarction; Clinical trial; Fetal hemoglobin; Hemoglobinopathy; Complication","score_opus":0.006527622502699283,"score_gpt":0.26887719039912145,"score_spread":0.26234956789642216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417008854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869857,0.0004392492,0.0000026082005,0.0005197335,0.0000220576,0.0004208646,0.000019719366,0.000030596555,0.011559492],"genre_scores_gemma":[0.99847084,0.0006826737,0.000036615555,0.0002108196,0.000034297675,0.000009107,0.000030683947,0.000014123021,0.00051085785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914545,0.000033550496,0.00022022516,0.00027724498,0.00009714955,0.00022638787],"domain_scores_gemma":[0.99953437,0.00004672609,0.0000427068,0.00023534265,0.000012454589,0.00012837404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008345488,0.00016602919,0.00031877824,0.00011722404,0.000032785414,0.0000122297715,0.000040730665,0.00013792058,0.000030427143],"category_scores_gemma":[0.000011611398,0.00010083922,0.00007920737,0.00017330013,0.00005243467,0.000017802864,0.000017073877,0.00022983049,0.000009597643],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020794656,0.002393483,0.9921998,0.000020388961,0.00020176396,0.000084656676,0.000143844,0.000012360939,0.00003814641,0.000008946342,0.00007395453,0.0046147155],"study_design_scores_gemma":[0.013261113,0.0038659102,0.9812967,0.00014210293,0.0004579174,0.000030424819,0.00014354815,0.000026877977,0.00044275532,0.000010989938,0.00020468913,0.00011693389],"about_ca_topic_score_codex":0.0010539757,"about_ca_topic_score_gemma":0.00018806724,"teacher_disagreement_score":0.013053167,"about_ca_system_score_codex":0.000051389747,"about_ca_system_score_gemma":0.00013613605,"threshold_uncertainty_score":0.41121042},"labels":[],"label_agreement":null},{"id":"W4417008866","doi":"10.1182/blood-2025-3582","title":"Phase 3 study (inMIND) of tafasitamab plus lenalidomide and rituximab for relapsed or refractory follicular lymphoma: Clinical characteristics and outcomes by age","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Lenalidomide; Rituximab; Follicular lymphoma; Refractory (planetary science); Population; Phases of clinical research; Placebo; Post-hoc analysis; Neutropenia; Progression-free survival","score_opus":0.028369455627643467,"score_gpt":0.355005242533406,"score_spread":0.3266357869057625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417008866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99618006,0.001510933,0.000028859331,0.00035711593,0.00013330892,0.0014957311,0.0001897169,0.00002857218,0.00007567747],"genre_scores_gemma":[0.99759597,0.00038052368,0.00056436344,0.00036695975,0.00004253907,0.00018301561,0.000077297074,0.000020940322,0.0007684123],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984404,0.00007329373,0.0006891257,0.00041480514,0.00017396953,0.00020840066],"domain_scores_gemma":[0.9985502,0.0006825523,0.00019347026,0.00035543053,0.00007484566,0.00014354734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033533937,0.00023215606,0.0010474023,0.00008542918,0.000083025974,0.000027035414,0.00006532497,0.00013870774,0.000007615127],"category_scores_gemma":[0.00049369654,0.0001603658,0.00014963775,0.00008993229,0.000110861816,0.000047754853,0.00006962612,0.000059471324,0.0000013809108],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064832317,0.12483262,0.8117068,0.0004522553,0.0036146685,0.0010362085,0.00051093585,8.792721e-9,0.00072233204,0.00012015773,0.0027161401,0.04780466],"study_design_scores_gemma":[0.48054373,0.007654055,0.49709436,0.00022330694,0.004964482,0.000038975613,0.0004643358,0.00002239982,0.0027663663,0.000035198478,0.0059675816,0.00022518844],"about_ca_topic_score_codex":0.000045832363,"about_ca_topic_score_gemma":0.000012710032,"teacher_disagreement_score":0.4740605,"about_ca_system_score_codex":0.000054406257,"about_ca_system_score_gemma":0.00018833908,"threshold_uncertainty_score":0.6539528},"labels":[],"label_agreement":null},{"id":"W4417008902","doi":"10.1182/blood-2025-2976","title":"Hibiscus 2 (Trial-in-Progress): A global, Phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of etavopivat in adolescents and adults with sickle cell disease","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hibiscus Plant Research Studies","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hemolysis; Sickle cell anemia; Red blood cell; Dosing; Haemolysis; Hemolytic anemia; Anemia; Hemoglobin","score_opus":0.06632244761578317,"score_gpt":0.4549998098580316,"score_spread":0.38867736224224847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417008902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9751123,0.007129998,0.0000026693904,0.0005940607,0.0001094059,0.016560454,0.000052489348,0.000025100282,0.0004134812],"genre_scores_gemma":[0.9979882,0.00056399597,0.000022072016,0.00007742839,0.00004307317,0.0012040115,0.000008224,0.000011205816,0.000081782215],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99527377,0.0025209768,0.0007806594,0.00053277065,0.00037567044,0.000516143],"domain_scores_gemma":[0.997325,0.0018610066,0.00024453268,0.00027602416,0.000115495684,0.00017795061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041634017,0.00033087126,0.0010993187,0.00018656088,0.00025259133,0.000039098006,0.00025980306,0.00011850464,0.000019419229],"category_scores_gemma":[0.00062716554,0.00019313961,0.0000867982,0.0004944162,0.00059574586,0.000073204064,0.0002803346,0.0006321954,0.0000022118675],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8912134,0.01040284,0.09375924,0.00032882878,0.00068055553,0.00011920273,0.0013111366,0.00009196263,0.00009096699,0.00004790145,0.000024009885,0.0019299306],"study_design_scores_gemma":[0.9896001,0.0014057895,0.0044173608,0.00041051235,0.0015995133,0.0000026895377,0.00075862097,0.0013517968,0.00021614363,0.000031332558,0.000020686957,0.00018543629],"about_ca_topic_score_codex":0.00007783684,"about_ca_topic_score_gemma":0.00038679043,"teacher_disagreement_score":0.09838669,"about_ca_system_score_codex":0.000040787796,"about_ca_system_score_gemma":0.00024826202,"threshold_uncertainty_score":0.7876005},"labels":[],"label_agreement":null},{"id":"W4417008940","doi":"10.1182/blood-2025-3581","title":"Prognostic impact of Mantle Cell Lymphoma frontline induction response assessments in the ECOG-ACRIN E1411 study of bendamustine-rituximab +/- bortezomib and maintenance with rituximab +/- lenalidomide","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Moncton Hospital","funders":"","keywords":"Lenalidomide; Mantle cell lymphoma; Rituximab; Bortezomib; Chemoimmunotherapy; Maintenance therapy; Diffuse large B-cell lymphoma; Induction chemotherapy; Phases of clinical research; Follicular lymphoma","score_opus":0.012168514822884483,"score_gpt":0.30387745695810225,"score_spread":0.29170894213521775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417008940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971866,0.00056166365,0.000012238363,0.0002233667,0.000035903264,0.001574187,0.000044538323,0.000015582718,0.00034591425],"genre_scores_gemma":[0.9991074,0.000067300774,0.00043486225,0.000047507077,0.000019085568,0.00018280161,0.000017680515,0.000017824883,0.00010551255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983335,0.00023540479,0.00049779454,0.00035904394,0.00030927465,0.0002649495],"domain_scores_gemma":[0.99882436,0.0003039293,0.00022819053,0.00044677593,0.00013834196,0.000058409732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050682307,0.00024683692,0.000630329,0.00023412073,0.00005272314,0.00001985924,0.00011986825,0.000068696376,0.000014322499],"category_scores_gemma":[0.00012806534,0.00014450293,0.00008498286,0.00042050052,0.00008642999,0.00008420668,0.000057367743,0.0000944924,0.0000018327612],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007927745,0.064520635,0.92043585,0.00020973323,0.00062130566,0.00040765153,0.0009971781,0.000011305882,0.0021143383,0.00001938543,0.0002041191,0.0025307387],"study_design_scores_gemma":[0.087438986,0.0057429904,0.89703465,0.0004273189,0.0010238668,0.000114884606,0.0023538815,0.0000581609,0.0056522936,0.00001956111,0.00002342569,0.00010997255],"about_ca_topic_score_codex":0.0013532358,"about_ca_topic_score_gemma":0.00023775546,"teacher_disagreement_score":0.07951124,"about_ca_system_score_codex":0.00013279915,"about_ca_system_score_gemma":0.00037358757,"threshold_uncertainty_score":0.5892658},"labels":[],"label_agreement":null},{"id":"W4417008991","doi":"10.1182/blood-2025-3601","title":"Prognostic impact of diagnosis-to-treatment interval in follicular lymphoma patients treated with immunochemotherapy: Evidence from an international cohort with independent validation","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Follicular lymphoma; Cohort; Clinical endpoint; Confidence interval; Lymphoma; Clinical trial; Epidemiology; Proportional hazards model; Cohort study","score_opus":0.011164805391691509,"score_gpt":0.28778310082296477,"score_spread":0.27661829543127325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417008991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99765384,0.00021838408,0.000020578427,0.0001244407,0.000032955304,0.0017540195,0.0000641953,0.000031916312,0.00009965895],"genre_scores_gemma":[0.99796987,0.00020582347,0.00042872687,0.000055798813,0.000019610245,0.00086811517,0.00040811868,0.000022042133,0.00002186999],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985801,0.00006334936,0.0003345263,0.00044517798,0.00038076963,0.00019609612],"domain_scores_gemma":[0.99900997,0.00012440028,0.00013195955,0.00040240178,0.00022121794,0.00011004387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006851338,0.00027022985,0.0004311689,0.00024759167,0.000027184902,0.000038735263,0.00012975973,0.00007107746,0.000057375746],"category_scores_gemma":[0.000053649244,0.00016716587,0.00010546471,0.00033062883,0.00003239139,0.0001868835,0.000029224382,0.000033179105,0.000005508755],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016666608,0.013542185,0.9718362,0.000013189475,0.0025368205,0.00010890518,0.00036944705,0.000055088352,0.00033841273,0.000003919676,0.0000048646352,0.009524322],"study_design_scores_gemma":[0.017659897,0.006755447,0.9171069,0.0016286374,0.0008760793,0.000008322245,0.000028882614,0.00004068979,0.055745445,0.000004248216,0.000010548117,0.00013487495],"about_ca_topic_score_codex":0.006400493,"about_ca_topic_score_gemma":0.00031995127,"teacher_disagreement_score":0.055407032,"about_ca_system_score_codex":0.0007958949,"about_ca_system_score_gemma":0.00027662938,"threshold_uncertainty_score":0.9675674},"labels":[],"label_agreement":null},{"id":"W4417008999","doi":"10.1182/blood-2025-4598","title":"Short survival with BCMA and GPRC5D dual antigen exposed relapsed myeloma- an international myeloma working group immunotherapy database analysis","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Multiple myeloma; Lenalidomide; Immunotherapy; Cart; Expanded access; Progression-free survival; Retrospective cohort study","score_opus":0.02916013662651603,"score_gpt":0.3099720713084753,"score_spread":0.2808119346819593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417008999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99523926,0.0004583733,0.0007826873,0.0001823387,0.00010137775,0.00046954074,0.00006463735,0.00009544052,0.002606359],"genre_scores_gemma":[0.99308324,0.00040984328,0.0046177777,0.00009726283,0.00012424406,0.00005292581,0.0011247688,0.000030023988,0.0004599038],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797773,0.00011980783,0.00030950006,0.0006007838,0.0005931884,0.0003989636],"domain_scores_gemma":[0.99883777,0.000114213406,0.000058242276,0.0006411441,0.00011782684,0.00023077958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034262048,0.00026126095,0.00046406846,0.0005816542,0.00017910301,0.00011166914,0.00018471493,0.0000901184,0.0001256722],"category_scores_gemma":[0.000053404998,0.00020539755,0.00011522049,0.00081201625,0.00011903318,0.00023401425,0.00009893769,0.00022774635,0.000005761505],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017893047,0.0013332793,0.9385193,0.00002140138,0.0074745785,0.0009434441,0.0001605427,0.0000019984802,0.01771931,0.00021208612,0.000013034592,0.031811725],"study_design_scores_gemma":[0.010418095,0.00047219027,0.981038,0.00011417706,0.0009150391,0.000051613242,0.00019607207,0.00057558244,0.005500622,0.000012415762,0.00050913077,0.00019711323],"about_ca_topic_score_codex":0.00014294106,"about_ca_topic_score_gemma":0.0003319514,"teacher_disagreement_score":0.042518653,"about_ca_system_score_codex":0.0000526009,"about_ca_system_score_gemma":0.000098611265,"threshold_uncertainty_score":0.8375869},"labels":[],"label_agreement":null},{"id":"W4417009029","doi":"10.1182/blood-2025-5178","title":"Performance of the ELN 2022 risk stratification in a real-world Canadian AML patient population","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Leukemia & Lymphoma Society of Canada; University of British Columbia","funders":"","keywords":"Myeloid leukemia; Cohort; CEBPA; Risk stratification; Population; Cohort study; Leukemia; Framingham Risk Score; Survival analysis","score_opus":0.010887565442296888,"score_gpt":0.27104532913407403,"score_spread":0.2601577636917771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417009029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98394203,0.000047391357,5.5609524e-7,0.00074215035,0.000048359132,0.0004731159,0.0000149890575,0.000007619731,0.014723791],"genre_scores_gemma":[0.9986063,0.00008501351,0.000082768966,0.000075308635,0.000018243769,0.000031626878,0.000035656813,0.0000053521962,0.0010596833],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99925154,0.000065514534,0.00021726765,0.000127265,0.00018191314,0.00015649795],"domain_scores_gemma":[0.99945587,0.000028889584,0.00006673898,0.00033210363,0.000063943444,0.000052427305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019918845,0.00005619187,0.00010605516,0.00027618546,0.00006452488,0.000005266635,0.00009079333,0.00004317662,0.000031790376],"category_scores_gemma":[0.000106781765,0.000042461623,0.000028043165,0.0007694251,0.000026196327,0.00003556576,0.000022884216,0.00022870218,0.0000045286056],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030930893,0.00008846273,0.9901648,0.000048479276,0.00002157326,0.0000019505806,0.00017287597,0.0000480003,0.0011919035,0.00035106836,0.0005183817,0.007361554],"study_design_scores_gemma":[0.00076419476,0.00006143522,0.9901513,0.00009500461,0.000050218165,0.0000011835969,0.00006586142,0.0025718499,0.0058345017,0.00004731966,0.00032335633,0.00003378729],"about_ca_topic_score_codex":0.27333927,"about_ca_topic_score_gemma":0.41203916,"teacher_disagreement_score":0.1386999,"about_ca_system_score_codex":0.00031204647,"about_ca_system_score_gemma":0.0006569649,"threshold_uncertainty_score":0.7314996},"labels":[],"label_agreement":null},{"id":"W4417009100","doi":"10.1182/blood-2025-5183","title":"Establishing contemporary benchmarks for Acute Myeloid Leukemia outcomes and measurable residual disease: Real-world data utilization from the ELN-david MRD international working group","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Myeloid leukemia; Clinical trial; Real world data; Minimal residual disease; Leukemia; Disease; Myeloid","score_opus":0.09294386827485815,"score_gpt":0.3616713012801106,"score_spread":0.2687274330052525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417009100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85102415,0.015354243,0.003120688,0.073437855,0.0017951688,0.005236941,0.0034713673,0.00046992433,0.046089694],"genre_scores_gemma":[0.977435,0.0022683155,0.003479715,0.0017103539,0.0007559113,0.00014851692,0.010570352,0.00005794677,0.0035738724],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976073,0.00015164111,0.0004700238,0.00075911655,0.00063905725,0.00037286375],"domain_scores_gemma":[0.99654,0.0017587609,0.00016597439,0.0011583725,0.00019048335,0.00018640127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011955106,0.00025333342,0.00042222356,0.00023169504,0.00030169706,0.00031174574,0.00090711826,0.000094031755,0.00003734892],"category_scores_gemma":[0.0017642451,0.00018915323,0.00007611483,0.00042478117,0.00017466613,0.0005913653,0.00082986173,0.0004473702,0.0000022898864],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014565029,0.00022141909,0.88578117,0.00010436796,0.0021441148,0.00010601672,0.0002860074,0.0000032673731,0.0008767014,0.0034575078,0.086428575,0.019134365],"study_design_scores_gemma":[0.009629955,0.00007399013,0.88955206,0.0008537486,0.0014294722,0.000007730898,0.00055130944,0.0034965153,0.0006027883,0.0016401277,0.091838695,0.00032364143],"about_ca_topic_score_codex":0.0019529691,"about_ca_topic_score_gemma":0.0011246975,"teacher_disagreement_score":0.1264109,"about_ca_system_score_codex":0.00031464925,"about_ca_system_score_gemma":0.0010644465,"threshold_uncertainty_score":0.7713445},"labels":[],"label_agreement":null},{"id":"W4417009115","doi":"10.1182/blood-2025-3578","title":"Analysis of predictive factors for POD24 in patients with previously untreated mantle cell lymphoma receiving bendamustine-rituximab with or without acalabrutinib in the phase 3 ECHO trial","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Mantle cell lymphoma; Logistic regression; Hazard ratio; Confidence interval; Placebo; Rituximab; Proportional hazards model; Phases of clinical research; Odds ratio","score_opus":0.012089763459884453,"score_gpt":0.2813415108521616,"score_spread":0.26925174739227714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417009115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956974,0.00007492702,0.000026500502,0.00005184755,0.000026769332,0.0033925134,0.00020946254,0.000023329154,0.00049727893],"genre_scores_gemma":[0.9987617,0.000018778364,0.00026585738,0.000055905737,0.000016772397,0.00040052275,0.00035981482,0.000019627943,0.00010101864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840605,0.00009306709,0.00046443348,0.00041110662,0.0003161974,0.00030916423],"domain_scores_gemma":[0.99875706,0.0004514049,0.00021558571,0.0003751655,0.00013983076,0.000060931467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019110742,0.00026573948,0.0008537716,0.000488388,0.000052617357,0.000020766793,0.00012889771,0.000098687335,0.000021444916],"category_scores_gemma":[0.00013449631,0.00013072879,0.00012651307,0.0015711237,0.00005931679,0.0000659403,0.000023788232,0.000068901114,4.5453783e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05128425,0.030808477,0.9129177,0.000102380654,0.0017163394,0.00002934828,0.0016819352,0.000017965733,0.000006183274,0.000004331111,0.000021028247,0.001410105],"study_design_scores_gemma":[0.4034396,0.0069441716,0.5785276,0.00036923442,0.0076715895,0.0000010389867,0.0006883042,0.000261329,0.001960069,0.0000020946077,0.000022583186,0.00011234024],"about_ca_topic_score_codex":0.0004107068,"about_ca_topic_score_gemma":0.00085539813,"teacher_disagreement_score":0.35215536,"about_ca_system_score_codex":0.00014406512,"about_ca_system_score_gemma":0.0003129508,"threshold_uncertainty_score":0.53309655},"labels":[],"label_agreement":null},{"id":"W4417009140","doi":"10.1182/blood-2025-5193","title":"First-in-human trial of siltuximab in combination with standard induction chemotherapy in patients with acute myeloid leukemia: The Phase 1 siltuxilam study.","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Cytarabine; Myeloid leukemia; Induction chemotherapy; Adverse effect; Toxicity; Chemotherapy; Myeloid; Clinical trial","score_opus":0.010405047148600584,"score_gpt":0.29732188756943495,"score_spread":0.2869168404208344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417009140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940331,0.000022490793,0.000026785941,0.0008761691,0.000044971304,0.0044954554,0.000010267568,0.000023120983,0.00046764934],"genre_scores_gemma":[0.99925655,0.00002370287,0.00011047413,0.00007138549,0.000032681637,0.00024268132,0.00004157815,0.000028615466,0.00019232536],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99789375,0.00015714896,0.00052197184,0.0003847955,0.0007172374,0.00032510204],"domain_scores_gemma":[0.99901986,0.0000846991,0.00015812252,0.00047986148,0.00021162393,0.000045809313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007002508,0.00021913371,0.0005594696,0.0005928382,0.000073946176,0.000022099706,0.00021111088,0.00013094961,0.000017616112],"category_scores_gemma":[0.00008079707,0.00014043186,0.000037935944,0.0014521229,0.00013817259,0.00015128872,0.00005169848,0.00066560146,9.2781295e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27821827,0.041120272,0.6631993,0.00020381199,0.00077359064,0.00020984827,0.006891769,0.00008784177,0.0013595831,0.0001926142,0.00023127017,0.007511807],"study_design_scores_gemma":[0.6597314,0.015917808,0.317907,0.0002945284,0.0001672551,0.0000033457343,0.0009902583,0.000060339207,0.0046121553,0.00007377612,0.00010044072,0.00014172599],"about_ca_topic_score_codex":0.00055123353,"about_ca_topic_score_gemma":0.0013057307,"teacher_disagreement_score":0.3815131,"about_ca_system_score_codex":0.0011189828,"about_ca_system_score_gemma":0.0007370804,"threshold_uncertainty_score":0.5726645},"labels":[],"label_agreement":null},{"id":"W4417009147","doi":"10.1182/blood-2025-3508","title":"Morphologic leukemia-free state (MLFS) is associated with inferior outcomes in patients with Acute Myeloid Leukemia (AML) treated with front-line azacitidine plus venetoclax","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Venetoclax; Azacitidine; Myeloid leukemia; Bone marrow; Leukemia; Myeloid; Cancer; Complete remission","score_opus":0.010224258869297675,"score_gpt":0.2512293891688022,"score_spread":0.24100513029950454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417009147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939685,0.00011232429,0.000112021,0.0005757943,0.00003877685,0.002645017,0.00056492625,0.00033879877,0.001643835],"genre_scores_gemma":[0.98433346,0.00008558778,0.0013430294,0.001494031,0.00003643351,0.0003548707,0.0009213973,0.00016001897,0.011271202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951391,0.00019097363,0.0008114853,0.0011657816,0.0012491731,0.0014434794],"domain_scores_gemma":[0.9967573,0.000267866,0.00036725024,0.0015035969,0.00070695474,0.000397001],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039771342,0.00088636996,0.0017513616,0.00079834956,0.0001872354,0.00009066846,0.0006833146,0.00040558717,0.00017085063],"category_scores_gemma":[0.00036158893,0.0005697767,0.00013381768,0.001704411,0.00041916015,0.00029367785,0.0003405346,0.0012978816,0.000052245214],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009116802,0.0008273783,0.97956765,0.00011783308,0.00377034,0.0028547964,0.00038800473,0.0004700787,0.0008442057,0.0000105316085,0.0014969003,0.00053549226],"study_design_scores_gemma":[0.10834945,0.0059987195,0.87071,0.00091786875,0.0016553767,0.0000732202,0.00012063401,0.0006774631,0.010459267,0.000045872417,0.00020106278,0.00079106225],"about_ca_topic_score_codex":0.0019740018,"about_ca_topic_score_gemma":0.0014232117,"teacher_disagreement_score":0.10885763,"about_ca_system_score_codex":0.006894172,"about_ca_system_score_gemma":0.005519088,"threshold_uncertainty_score":0.9996754},"labels":[],"label_agreement":null},{"id":"W4417009162","doi":"10.1182/blood-2025-3500","title":"Dogs with acute leukemia have shared and unique genetic mutations compared to human acute leukemia","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Veterinary Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Acute leukemia; Myeloid leukemia; Bone marrow; Leukemia; Myeloid; Germline mutation; Germline; Haematopoiesis","score_opus":0.0275841834578867,"score_gpt":0.351421855987036,"score_spread":0.3238376725291493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417009162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915906,0.000089701505,0.0004697188,0.0013025154,0.000027170392,0.0009886116,0.000042546195,0.00010116191,0.0053879675],"genre_scores_gemma":[0.9769219,0.000020853506,0.014580408,0.0007093029,0.000046512792,0.00022902965,0.000117263895,0.00003000313,0.0073446953],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99868566,0.000072339455,0.00023952784,0.00042243415,0.00020967827,0.00037035326],"domain_scores_gemma":[0.99907035,0.00007037702,0.0000418455,0.000436971,0.00012960828,0.00025085532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000103549624,0.00019268386,0.00040434094,0.0002875839,0.00021393623,0.000045207333,0.00017616992,0.00012902686,0.00007391279],"category_scores_gemma":[0.000028050914,0.00016872166,0.000040866307,0.00034124212,0.00018841255,0.00005907494,0.00017696571,0.0003201345,0.000029701658],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020401499,0.00087818824,0.28195345,0.0003665045,0.005253836,0.012689242,0.0041808737,0.00008535891,0.67736757,0.00041600832,0.013274617,0.0014941854],"study_design_scores_gemma":[0.021642338,0.0056055016,0.9420746,0.000541364,0.0031360446,0.007374483,0.00050998584,0.0009007492,0.0131907035,0.00037659335,0.004117909,0.00052972196],"about_ca_topic_score_codex":0.0002392619,"about_ca_topic_score_gemma":0.00035184078,"teacher_disagreement_score":0.6641769,"about_ca_system_score_codex":0.0003087895,"about_ca_system_score_gemma":0.0008995666,"threshold_uncertainty_score":0.68802696},"labels":[],"label_agreement":null},{"id":"W4417009446","doi":"10.1182/blood-2025-2792","title":"The impact of frailty on real world outcomes for multiple myeloma patients in England – a cohort study from the uncover study group and ukmra frailty group.","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Multiple myeloma; Proportional hazards model; Poisson regression; Cancer; Incidence (geometry); Cohort study; Cohort; Survival analysis; Relative survival","score_opus":0.028052626219121427,"score_gpt":0.34211614534862733,"score_spread":0.3140635191295059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417009446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992412,0.000070234375,0.000002383899,0.00007397824,0.00007196766,0.0067542302,0.00027738092,0.000020336944,0.00031753656],"genre_scores_gemma":[0.9988593,0.000032585715,0.000036481313,0.000035599554,0.000042413525,0.0006085234,0.000104959705,0.000021152027,0.00025901664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998026,0.0002603706,0.00041706895,0.000432448,0.00049174053,0.00037233724],"domain_scores_gemma":[0.9963041,0.0027336306,0.00010609276,0.00065991783,0.000086469074,0.000109771434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050608674,0.00026408042,0.00054160954,0.00013047276,0.00022285104,0.000047363756,0.00020552023,0.000054233446,0.000011629644],"category_scores_gemma":[0.0007800922,0.0001244123,0.00014847355,0.00030751698,0.00007899791,0.00005418377,0.00014574312,0.0002423067,0.0000019995339],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025830863,0.013368284,0.97410846,0.000011459647,0.0022148555,0.000022643273,0.0010182043,0.0000012320664,0.000025084923,0.000008256371,0.00009564688,0.0065427986],"study_design_scores_gemma":[0.05043144,0.0038425645,0.9444739,0.00005042234,0.00031311382,1.9082661e-7,0.00053750776,0.00007571098,0.000029183027,0.00007364986,0.00008007327,0.00009219595],"about_ca_topic_score_codex":0.024771564,"about_ca_topic_score_gemma":0.056674752,"teacher_disagreement_score":0.047848355,"about_ca_system_score_codex":0.00010478613,"about_ca_system_score_gemma":0.000070343965,"threshold_uncertainty_score":0.9817226},"labels":[],"label_agreement":null},{"id":"W4417009447","doi":"10.1182/blood-2025-3418","title":"Revumenib for patients with relapsed or refractory (R/R) Nucleophosmin 1–Mutated (NPM1m) Acute Myeloid Leukemia (AML): Outcomes by prior treatment in the phase 2 AUGMENT-101 study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Venetoclax; Myeloid leukemia; Refractory (planetary science); Azacitidine; Salvage therapy; Hematopoietic stem cell transplantation; Phases of clinical research; Complete remission; Leukemia","score_opus":0.015226456477174697,"score_gpt":0.32337671257225864,"score_spread":0.30815025609508395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417009447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879789,0.00017130497,0.000021398626,0.0013820049,0.00010646716,0.009507266,0.000262729,0.00010708363,0.00046284648],"genre_scores_gemma":[0.98143,0.00011399413,0.00079041655,0.0010262784,0.000049301932,0.0022338282,0.00049592514,0.00009223675,0.013768016],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99675614,0.0002512055,0.00071250356,0.0007910929,0.0007345884,0.0007544574],"domain_scores_gemma":[0.99768424,0.000644088,0.0001997097,0.0010738883,0.00021247278,0.00018559559],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00050885754,0.00051795633,0.0008688131,0.00034784002,0.00024841435,0.000071562215,0.00045566994,0.00017920883,0.0000816672],"category_scores_gemma":[0.00029560915,0.00027846295,0.00018938568,0.0008323386,0.00011715206,0.00015333568,0.00009648484,0.00045623572,0.000025873442],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06391738,0.12839262,0.65292144,0.0005070232,0.013595163,0.0023668993,0.014286468,0.000003274278,0.00943934,0.00003528333,0.062307492,0.052227598],"study_design_scores_gemma":[0.63940567,0.06759241,0.19615702,0.00052953715,0.007860079,0.00004372867,0.0069298767,0.00012128161,0.010934443,0.000035051296,0.06923171,0.0011591685],"about_ca_topic_score_codex":0.00030027798,"about_ca_topic_score_gemma":0.00015888155,"teacher_disagreement_score":0.5754883,"about_ca_system_score_codex":0.0018082772,"about_ca_system_score_gemma":0.0014205402,"threshold_uncertainty_score":0.99996674},"labels":[],"label_agreement":null},{"id":"W4417009454","doi":"10.1182/blood-2025-2798","title":"Real-world experience with first-line regimens in transplant-ineligible patients with multiple myeloma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"William Osler Health System; Newfoundland and Labrador Centre for Applied Health Research; St. John’s Health Sciences Centre; Jewish General Hospital; BC Cancer Agency; Saint John Regional Hospital; Hôpital Maisonneuve-Rosemont; Dr. Georges-L.-Dumont University Hospital Centre; Juravinski Cancer Centre; Institute of Cancer Research; McGill University; Ottawa Hospital; CancerCare Manitoba; Occupational Cancer Research Centre; Saskatchewan Cancer Agency; University of Saskatchewan; University of Alberta; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Lenalidomide; Multiple myeloma; Bortezomib; Regimen; Context (archaeology); Retrospective cohort study; Observational study; Chemotherapy regimen; Clinical trial","score_opus":0.01380753445270157,"score_gpt":0.27822076164989135,"score_spread":0.2644132271971898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417009454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99317235,0.000072820985,0.00005603016,0.00031649406,0.000022291204,0.0009712906,0.00003594088,0.000073681265,0.0052790893],"genre_scores_gemma":[0.99575144,0.0001342092,0.0014892069,0.00007949965,0.000022350094,0.00023796382,0.00013962577,0.000024688512,0.0021209922],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842525,0.000028151911,0.00023958478,0.00042799432,0.00039435423,0.00048468378],"domain_scores_gemma":[0.9990927,0.00013406566,0.000046426372,0.00042884168,0.00010726653,0.0001907138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000055234643,0.00022778193,0.0003423499,0.000332509,0.00009588273,0.000019534762,0.00011640075,0.000053450523,0.00004578107],"category_scores_gemma":[0.00004593442,0.00014987226,0.000038640614,0.0007399858,0.000092376926,0.0000945068,0.00002683677,0.0001733377,0.000016484406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023718548,0.0023074243,0.9932328,0.00014229811,0.00017204898,0.00049692224,0.0004567271,0.0000110155515,0.00014774388,0.000033484193,0.000067159366,0.0005605088],"study_design_scores_gemma":[0.03251808,0.00078111456,0.95576483,0.00084747805,0.00010991351,0.0000096324975,0.0000563639,0.000088436806,0.009234227,0.0000073852834,0.00042869506,0.00015387201],"about_ca_topic_score_codex":0.0013011054,"about_ca_topic_score_gemma":0.011964691,"teacher_disagreement_score":0.037468012,"about_ca_system_score_codex":0.00007267817,"about_ca_system_score_gemma":0.0001771129,"threshold_uncertainty_score":0.6676578},"labels":[],"label_agreement":null},{"id":"W4417009462","doi":"10.1182/blood-2025-3440","title":"CYP3A4 inhibitors (CYP3A4i) and myelosuppression in patients (Pts) with newly diagnosed mutant isocitrate dehydrogenase 1 (mIDH1) Acute Myeloid Leukemia (AML) in the phase 3 AGILE study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Neutropenia; Febrile neutropenia; Adverse effect; Concomitant; CYP3A4; Venetoclax; Placebo; Pharmacokinetics; Myeloid leukemia","score_opus":0.008985298497670649,"score_gpt":0.28161595335693446,"score_spread":0.2726306548592638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417009462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944044,0.0002891831,0.000008475239,0.00061957614,0.00007254007,0.0035801646,0.00005198874,0.00006498646,0.0009087169],"genre_scores_gemma":[0.99815714,0.00016819389,0.00016143106,0.00064961246,0.000083114006,0.0004238611,0.000089469875,0.000055761855,0.00021139279],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963755,0.00045583854,0.0006979673,0.0008300599,0.0008593558,0.00078126974],"domain_scores_gemma":[0.9983204,0.00036135394,0.00014661491,0.00079380895,0.00014723619,0.000230574],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008342239,0.0004606544,0.00068192824,0.0006027455,0.00019306061,0.00009597341,0.00040846245,0.00021909356,0.000032213553],"category_scores_gemma":[0.00028093037,0.00029997234,0.00008311544,0.0015628504,0.00021341219,0.00024071438,0.00026183514,0.0010810449,0.000016253569],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005445018,0.01894816,0.90176725,0.0002671717,0.0008294839,0.007352338,0.01123467,0.000047671092,0.038523477,0.000041356005,0.0022779575,0.013265455],"study_design_scores_gemma":[0.35801655,0.012073855,0.49328884,0.0020472228,0.0018705078,0.00017685456,0.012535635,0.0013336275,0.115461566,0.00015736515,0.0017613502,0.0012766311],"about_ca_topic_score_codex":0.0006841901,"about_ca_topic_score_gemma":0.0005981831,"teacher_disagreement_score":0.4084784,"about_ca_system_score_codex":0.00052717834,"about_ca_system_score_gemma":0.00084271166,"threshold_uncertainty_score":0.9999452},"labels":[],"label_agreement":null},{"id":"W4417009494","doi":"10.1182/blood-2025-4058","title":"Safety and efficacy of elranatamab + nirogacestat in patients with relapsed or refractory multiple myeloma: Results from the Phase 1b MagnetisMM-4 study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Ottawa Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Refractory (planetary science); Multiple myeloma; Phases of clinical research; Bone marrow; Bortezomib; Progressive disease; Logistic regression","score_opus":0.014471959261729653,"score_gpt":0.2906162230157695,"score_spread":0.27614426375403983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417009494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963391,0.0003224516,0.0000040343193,0.0002253505,0.000032640946,0.002207657,0.00047548872,0.000025214307,0.0003680643],"genre_scores_gemma":[0.9987454,0.00008739877,0.00037213427,0.000041912335,0.00001813279,0.000034377816,0.00030321997,0.000017821447,0.00037961805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99818933,0.00019282442,0.00046152808,0.00043735266,0.00043766544,0.00028127627],"domain_scores_gemma":[0.9977741,0.0012528673,0.00011808483,0.00062303455,0.00010881611,0.00012308868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002450305,0.0002006724,0.00041185072,0.00013367514,0.00009596967,0.000016576314,0.00014185657,0.00006846261,0.000029451321],"category_scores_gemma":[0.0011519965,0.00010974646,0.00003575489,0.00038470625,0.00012598297,0.00007378379,0.00010038026,0.00025757813,0.0000045702504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07691248,0.03369005,0.85244226,0.000037591668,0.0005873574,0.0003090083,0.0014361053,9.968392e-7,0.0001221072,0.0000022148026,0.000119524346,0.03434029],"study_design_scores_gemma":[0.28463137,0.0040250705,0.7097787,0.00018244745,0.00024201647,9.79986e-7,0.00046047464,0.000032823194,0.00027157992,0.0000019986162,0.00030222256,0.00007028314],"about_ca_topic_score_codex":0.0012781327,"about_ca_topic_score_gemma":0.0013818162,"teacher_disagreement_score":0.20771891,"about_ca_system_score_codex":0.00004490425,"about_ca_system_score_gemma":0.00016326329,"threshold_uncertainty_score":0.44753307},"labels":[],"label_agreement":null},{"id":"W4417009510","doi":"10.1182/blood-2025-4039","title":"Primary analysis of the phase 3 randomized trial of selinexor and lenalidomide versus lenalidomide alone as maintenance therapy post autologous stem cell transplant for patients with newly diagnosed multiple myeloma (ALLG MM23; SEALAND)","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nutrasource","funders":"","keywords":"Lenalidomide; Multiple myeloma; Maintenance therapy; Thalidomide; Randomized controlled trial; Nausea; Dexamethasone; Autologous stem-cell transplantation","score_opus":0.012472698615939415,"score_gpt":0.27401167501488016,"score_spread":0.26153897639894075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417009510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991568,0.00068777957,0.00023090727,0.00035483533,0.000097990174,0.0060350928,0.0008714851,0.000024743507,0.00012914639],"genre_scores_gemma":[0.9973394,0.00064852764,0.0006949639,0.00013576285,0.000028983939,0.00044754945,0.00042884884,0.000025740586,0.0002501889],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99760246,0.00034263247,0.00073373155,0.00042767572,0.0004982892,0.00039522935],"domain_scores_gemma":[0.99568594,0.0028309878,0.00038478512,0.0005026561,0.00044277357,0.00015283287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052209076,0.00030839918,0.001641178,0.0003120472,0.00010508927,0.00001639874,0.00019602085,0.00011768324,0.0000125921],"category_scores_gemma":[0.00034939245,0.00016713935,0.0005822072,0.00055059383,0.00027189965,0.000058230165,0.00003442691,0.00014649385,5.449566e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.945599,0.0068782447,0.027725719,0.00025622552,0.010083702,0.00004036763,0.00037738157,0.000016517919,0.0031452083,0.000013338965,0.000036270038,0.0058279852],"study_design_scores_gemma":[0.935953,0.003654137,0.02611027,0.00018982662,0.0071433596,0.0000021722105,0.000072675764,0.00063927716,0.026044281,0.000008944205,0.00004222664,0.00013978514],"about_ca_topic_score_codex":0.00051140285,"about_ca_topic_score_gemma":0.00017911458,"teacher_disagreement_score":0.022899073,"about_ca_system_score_codex":0.00004485104,"about_ca_system_score_gemma":0.00038061567,"threshold_uncertainty_score":0.6815745},"labels":[],"label_agreement":null},{"id":"W4417009515","doi":"10.1182/blood-2025-4688","title":"Total effect of gestational hypertension on neonatal iron deficiency in very-preterm infants.","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Odds ratio; Iron deficiency; Anemia; Pregnancy; Gestational age; Gestational hypertension; Hepcidin; Small for gestational age; Gestation","score_opus":0.005036158076918604,"score_gpt":0.23848556607374843,"score_spread":0.23344940799682984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417009515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99222696,0.00091123336,0.000010084443,0.000096534306,0.00013735506,0.00021681873,0.000008496294,0.000014637331,0.006377853],"genre_scores_gemma":[0.9994984,0.00002693556,0.00010081009,0.00016701112,0.000017210275,0.000008158348,0.000029067589,0.0000059488366,0.00014640304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993267,0.00003591797,0.00016332311,0.0001581413,0.00018495592,0.00013096178],"domain_scores_gemma":[0.9996383,0.00012440045,0.000029906168,0.00015711854,0.000021710674,0.000028526838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011370803,0.00009172934,0.00020434274,0.00017208296,0.000020205563,0.0000031397724,0.000044053773,0.000060808637,0.000028642044],"category_scores_gemma":[0.00020630444,0.00007290685,0.000051712457,0.00017312496,0.000041207604,0.000034381927,0.000025182126,0.00009973531,0.000011966942],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042355717,0.0027387913,0.8239798,0.0021895622,0.000035358968,0.00029662746,0.00080466503,0.0002326668,0.07696884,0.0047075674,0.00083024846,0.08298032],"study_design_scores_gemma":[0.010774099,0.0006702325,0.96231437,0.00018274455,0.00015408747,0.000027384918,0.000045687495,0.00006533087,0.02554733,0.000064551255,0.000064314976,0.00008984187],"about_ca_topic_score_codex":0.00005187418,"about_ca_topic_score_gemma":0.000005927188,"teacher_disagreement_score":0.13833462,"about_ca_system_score_codex":0.000007769037,"about_ca_system_score_gemma":0.000058453537,"threshold_uncertainty_score":0.2973055},"labels":[],"label_agreement":null},{"id":"W4417009527","doi":"10.1182/blood-2025-4079","title":"Trial in progress: QUINTESSENTIAL—a phase 2 study of arlocabtagene autoleucel (arlo-cel) in patients with relapsed/refractory multiple myeloma (RRMM)","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute of Cancer Research; Juravinski Cancer Centre","funders":"","keywords":"Multiple myeloma; Chimeric antigen receptor; Clinical trial; Phases of clinical research; Carfilzomib; Bortezomib; Antigen; Overall survival","score_opus":0.016579407795935888,"score_gpt":0.3164352646403779,"score_spread":0.29985585684444205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417009527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99413544,0.00028828654,0.000005367467,0.000065883134,0.00016936769,0.004634768,0.000012144932,0.000047114696,0.000641656],"genre_scores_gemma":[0.9984102,0.000012291376,0.00012974147,0.000027401473,0.00007332747,0.0003010906,0.000039501574,0.000042889602,0.00096351845],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99729156,0.0002481281,0.0007338684,0.00052791,0.000753327,0.00044522647],"domain_scores_gemma":[0.9986538,0.00017524466,0.00016472103,0.0006852576,0.00020752242,0.00011343805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004967456,0.00025525497,0.0007016512,0.00073233526,0.000037274967,0.000020737694,0.00023437987,0.0001412879,0.00023028065],"category_scores_gemma":[0.00024109462,0.00021513428,0.000084953106,0.0010201595,0.00013782813,0.00009865181,0.00011732058,0.00051687646,0.0000053975546],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12550978,0.10233653,0.7380933,0.0001964389,0.00040484135,0.000233351,0.0017662214,0.0000053062768,0.010746754,0.000004325544,0.0000809346,0.02062217],"study_design_scores_gemma":[0.7016144,0.018093254,0.26337567,0.0004980147,0.00021485756,0.000001751451,0.00083902176,0.00009290645,0.0146675315,0.000010450313,0.00037014115,0.0002220411],"about_ca_topic_score_codex":0.00032733133,"about_ca_topic_score_gemma":0.0006492464,"teacher_disagreement_score":0.5761046,"about_ca_system_score_codex":0.00012810856,"about_ca_system_score_gemma":0.0003877305,"threshold_uncertainty_score":0.8772921},"labels":[],"label_agreement":null},{"id":"W4417009529","doi":"10.1182/blood-2025-4685","title":"Congenital dyserythropoietic anemia type I: Updated report from the congenital dyserythropoietic anemia registry of North America","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children’s Health Research Institute; Hôpital Fleurimont","funders":"","keywords":"Ineffective erythropoiesis; Anemia; Jaundice; Blood transfusion; Natural history; Deferasirox; Thalassemia","score_opus":0.011484726472058482,"score_gpt":0.25472866799885974,"score_spread":0.24324394152680126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417009529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886355,0.0013910355,0.00006876929,0.0013417578,0.0011282662,0.00048983475,0.00013381551,0.00015176355,0.006659294],"genre_scores_gemma":[0.99231863,0.00025322862,0.0005449644,0.0013568794,0.0003431647,0.000019497287,0.00140761,0.000039769573,0.00371625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99780566,0.00012801963,0.000741482,0.0006063363,0.00032919427,0.00038928707],"domain_scores_gemma":[0.99746555,0.00024170718,0.00035241662,0.0013278885,0.0004592206,0.0001532174],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000105044295,0.00033836073,0.00067309674,0.000095524265,0.00016778563,0.000022621776,0.00028803677,0.00024071851,0.0011585484],"category_scores_gemma":[0.00043579948,0.0002559558,0.00020586267,0.00080628943,0.00073728414,0.000064001906,0.0001476629,0.0005428574,0.0001808354],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033674927,0.0036086529,0.69011277,0.00038820147,0.0034269805,0.005156548,0.0013103426,0.000033597247,0.1281003,0.00029466112,0.16002303,0.004177405],"study_design_scores_gemma":[0.011874304,0.0022225205,0.85169584,0.0002511623,0.0053800936,0.0023300208,0.002340394,0.00007636238,0.02522462,0.0002827507,0.097411215,0.0009106975],"about_ca_topic_score_codex":0.0006484919,"about_ca_topic_score_gemma":0.00028907033,"teacher_disagreement_score":0.16158308,"about_ca_system_score_codex":0.000046885438,"about_ca_system_score_gemma":0.00058604334,"threshold_uncertainty_score":0.9999893},"labels":[],"label_agreement":null},{"id":"W4417009574","doi":"10.1182/blood-2025-4678","title":"Functional inactivation of duodenal ferroportin by hepcidin drives iron-dependent degradation of DMT1 in lysosomes","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal","funders":"","keywords":"Hepcidin; Ferroportin; DMT1; Transporter; Intracellular; Iron deficiency; Hemochromatosis","score_opus":0.00900013596517934,"score_gpt":0.2460595586681397,"score_spread":0.23705942270296035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417009574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99540967,0.0008193379,0.0007679787,0.00036229237,0.000081175276,0.00017629845,0.000010508715,0.00001101451,0.0023617125],"genre_scores_gemma":[0.9976945,0.000092723996,0.00030485555,0.00006132352,0.000018335933,0.0000109362945,0.0001131155,0.0000058309142,0.0016983562],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991429,0.00003197582,0.00035180154,0.00014106989,0.00023518287,0.000097104195],"domain_scores_gemma":[0.99960613,0.000035911664,0.00014085407,0.00012554124,0.000067995046,0.000023562954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013423842,0.00008021263,0.00021980076,0.00020909484,0.000017104665,0.0000026757032,0.00003952746,0.00006482764,0.000101881735],"category_scores_gemma":[0.00013078681,0.00007374149,0.000046314493,0.00023415335,0.000045407407,0.00007966905,0.000018442655,0.00007788349,0.0000022563086],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028843674,0.0018347501,0.5122162,0.0003054589,0.000033106306,0.0000022023269,0.00017848989,0.00003304565,0.47679135,0.003970129,0.0013198744,0.0030269339],"study_design_scores_gemma":[0.0042248867,0.000070068985,0.5950136,0.00006446982,0.00012009793,0.0000020997832,0.0006285408,0.000017734927,0.39938635,0.00031844593,0.00009627615,0.000057394136],"about_ca_topic_score_codex":0.00017151776,"about_ca_topic_score_gemma":0.000036545793,"teacher_disagreement_score":0.08279741,"about_ca_system_score_codex":0.000017641207,"about_ca_system_score_gemma":0.00011507835,"threshold_uncertainty_score":0.30070904},"labels":[],"label_agreement":null},{"id":"W4417009577","doi":"10.1182/blood-2025-4679","title":"Transferrin receptor 2 (Tfr2) is necessary for hepcidin induction in mice with hepatocyte-specific transferrin receptor 1 (Tfr1) deficiency","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"HAMP; Hepcidin; Transferrin receptor; Hereditary hemochromatosis; Hemochromatosis; Transferrin; Receptor; Ferroportin","score_opus":0.016682084791167666,"score_gpt":0.25012526369487215,"score_spread":0.23344317890370447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417009577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98219126,0.0046064775,0.0025949103,0.0030553336,0.00047487998,0.0018761373,0.00009833935,0.00014910319,0.004953565],"genre_scores_gemma":[0.99070776,0.0016617305,0.004069334,0.00088743767,0.0001984475,0.0004195439,0.00015164999,0.00006899877,0.0018350877],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977434,0.000080327125,0.0005567745,0.0007177511,0.00033176143,0.00056997297],"domain_scores_gemma":[0.99922013,0.00007793669,0.000050678562,0.00039093674,0.000115905,0.00014443947],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034561887,0.00036336025,0.000581645,0.00045310208,0.00014038806,0.000034541234,0.00020995566,0.00027227108,0.00037465678],"category_scores_gemma":[0.000037824724,0.00031975962,0.00017750025,0.0010029112,0.000121428915,0.00021008484,0.000013736594,0.00037279865,0.000039419858],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016594464,0.017190972,0.10930079,0.005148799,0.00041984103,0.00006309837,0.014463019,0.000060108512,0.67650706,0.022455573,0.054691684,0.08310458],"study_design_scores_gemma":[0.054603245,0.0021737367,0.03259526,0.0009903874,0.0010137516,0.00005150693,0.0072418014,0.00004067619,0.67340803,0.00045986514,0.22607516,0.0013465625],"about_ca_topic_score_codex":0.000235522,"about_ca_topic_score_gemma":0.00018985482,"teacher_disagreement_score":0.17138347,"about_ca_system_score_codex":0.000065274406,"about_ca_system_score_gemma":0.00030113434,"threshold_uncertainty_score":0.99992543},"labels":[],"label_agreement":null},{"id":"W4417009579","doi":"10.1182/blood-2025-4673","title":"DNA methylation episignature as a novel diagnostic tool for diamond-blackfan anemia","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Epigenetics; DNA methylation; Methylation; Clinical significance; Genotype; Human genetics; Genetic testing; Differentially methylated regions","score_opus":0.006973656063672742,"score_gpt":0.26303706474386546,"score_spread":0.25606340868019273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417009579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9666099,0.0025880449,0.027259063,0.000537966,0.00017130484,0.00050525746,0.00008546874,0.00001814586,0.0022248332],"genre_scores_gemma":[0.9946452,0.00016907013,0.0014885745,0.00045240685,0.0001763636,0.00025298123,0.00024546203,0.000012625551,0.002557353],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99939674,0.000013611366,0.00013187173,0.00026130019,0.000056148183,0.00014032767],"domain_scores_gemma":[0.99949384,0.000060794064,0.000045062156,0.000285236,0.000087582026,0.000027491762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009453965,0.000098180215,0.00008556024,0.000034130928,0.00007887481,0.000024691812,0.0001233095,0.00015800189,0.00001260351],"category_scores_gemma":[0.00040249983,0.000094465424,0.000075950535,0.000099211946,0.000025736423,0.0000030718134,0.000031643795,0.00005361672,0.000005030403],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030043366,0.00019878268,0.000909623,0.00003506957,0.00006747011,4.4839808e-7,0.000019409823,0.00003667788,0.98720473,0.0029772506,0.0039939983,0.004526475],"study_design_scores_gemma":[0.0019224883,0.00014443323,0.010559788,0.000025220905,0.00014774935,0.0000028875802,0.000024063744,0.000031619795,0.9010112,0.0011696793,0.08476636,0.0001945046],"about_ca_topic_score_codex":0.000007300987,"about_ca_topic_score_gemma":0.000010009651,"teacher_disagreement_score":0.08619355,"about_ca_system_score_codex":0.000007945638,"about_ca_system_score_gemma":0.00009898182,"threshold_uncertainty_score":0.38521883},"labels":[],"label_agreement":null},{"id":"W4417009636","doi":"10.1182/blood-2025-5330","title":"Non-invasive classification &amp; molecular subtyping of mature lymphoid neoplasms by cell-free DNA profiling","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Subtyping; Liquid biopsy; Gene expression profiling; DNA methylation; Cell-free fetal DNA; Biopsy; Immunohistochemistry; Circulating tumor cell; Gene","score_opus":0.007938541094122937,"score_gpt":0.23966449549946628,"score_spread":0.23172595440534335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417009636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98764837,0.0021777393,0.00024460614,0.00074726326,0.00009256896,0.00053504884,0.00004373508,0.000041809217,0.00846884],"genre_scores_gemma":[0.9952833,0.00020064799,0.0032587673,0.00031755044,0.00002711107,0.00009792167,0.00023475039,0.000017136668,0.0005627989],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990554,0.000019198225,0.000258703,0.00028793135,0.00019072657,0.00018803176],"domain_scores_gemma":[0.999076,0.0000716902,0.00011885215,0.0005570754,0.00010738381,0.00006899711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000068601155,0.00015813259,0.00027535376,0.00009454511,0.00005017313,0.000014977686,0.000119383556,0.00013610187,0.000013717105],"category_scores_gemma":[0.000086923545,0.00013637227,0.00011688553,0.00023943406,0.000034644247,0.000034244546,0.000052981555,0.000063736574,0.000018325592],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000071657996,0.002167794,0.1352501,0.0004952893,0.00026165627,0.00003808262,0.00013490481,0.0000029420476,0.85504514,0.0006942142,0.00527332,0.0005648724],"study_design_scores_gemma":[0.006670048,0.00009245326,0.0137682175,0.0003223794,0.0006031091,0.000020993353,0.00009401511,0.000023041073,0.9773658,0.00012906308,0.0008088851,0.00010199612],"about_ca_topic_score_codex":0.000043897722,"about_ca_topic_score_gemma":0.000009073179,"teacher_disagreement_score":0.122320645,"about_ca_system_score_codex":0.000081403974,"about_ca_system_score_gemma":0.00026381214,"threshold_uncertainty_score":0.55610996},"labels":[],"label_agreement":null},{"id":"W4417009642","doi":"10.1182/blood-2025-4718","title":"Baseline data from the prioritizing utilization and safety of hydroxyurea using precision in Africa (PUSHUP) trial","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Providence Health Care","funders":"","keywords":"Dosing; Clinical trial; Anemia; Sickle cell anemia; Adverse effect; Randomized controlled trial; Data monitoring committee; Clinical endpoint","score_opus":0.06048723993788494,"score_gpt":0.31162738520738026,"score_spread":0.2511401452694953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417009642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866588,0.009017059,0.0010447562,0.0006805306,0.00015216733,0.00065043377,0.00006345992,0.000015452819,0.0017173341],"genre_scores_gemma":[0.9971894,0.001506457,0.0009902662,0.000075072596,0.00006269341,0.0000016422083,0.00012897517,0.000006977329,0.00003848637],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9991852,0.00008247766,0.00030978076,0.00019509518,0.00012532684,0.00010208854],"domain_scores_gemma":[0.99923897,0.00026963418,0.000058129353,0.00037945143,0.000029678877,0.000024158022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051450805,0.00007111722,0.00018811863,0.00005768485,0.000052081905,0.000008739258,0.000097697244,0.00010089622,0.000013767922],"category_scores_gemma":[0.00069184473,0.000047709105,0.000021289623,0.00029407372,0.000040505438,0.000052132797,0.00013191663,0.00013327997,5.106418e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10267956,0.013275643,0.22246975,0.0012839267,0.00195751,0.00024780104,0.011813406,0.0004361521,0.10972253,0.002133581,0.006753366,0.52722675],"study_design_scores_gemma":[0.54385155,0.0011107819,0.059426248,0.009408243,0.0048922454,0.0000466063,0.006063934,0.28724718,0.007985038,0.0035049708,0.075703755,0.0007594396],"about_ca_topic_score_codex":0.00022570172,"about_ca_topic_score_gemma":0.00004577982,"teacher_disagreement_score":0.5264673,"about_ca_system_score_codex":0.000010311833,"about_ca_system_score_gemma":0.000100372854,"threshold_uncertainty_score":0.19455208},"labels":[],"label_agreement":null},{"id":"W4417009647","doi":"10.1182/blood-2025-4722","title":"The psychometric properties of the stoplight pain scale in children with sickle cell disease","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Pediatric Pain Management Techniques","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Observational study; Pain scale; Rating scale; Pain assessment; Disease; Scale (ratio); Prospective cohort study; Randomized controlled trial; Intervention (counseling); Emergency department","score_opus":0.0049116789656675,"score_gpt":0.20466777473198305,"score_spread":0.19975609576631556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417009647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899458,0.0035145332,0.00014013624,0.0014766388,0.0000172637,0.0010595827,0.0000020112088,0.00006313847,0.0037808549],"genre_scores_gemma":[0.99714273,0.00022791393,0.0001599522,0.00034550403,0.000029389646,0.00009117666,0.0000011938818,0.000008824675,0.001993328],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991858,0.00012484094,0.00016252932,0.0001526306,0.00022047888,0.00015369429],"domain_scores_gemma":[0.9993202,0.00004903822,0.00006031834,0.00050596875,0.000031243926,0.000033192566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058287784,0.00008937084,0.00012759578,0.00019411961,0.0000637823,0.000011765936,0.00024974972,0.000025418183,0.0000026343307],"category_scores_gemma":[0.00016719772,0.00004136563,0.000048179158,0.0012241735,0.00009430279,0.00002439701,0.000078649355,0.000118452444,0.0000013765916],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005167024,0.00054906704,0.9956856,0.000086144755,0.000038811773,6.7074745e-7,0.000027939717,8.540057e-7,0.00038754276,0.000036587313,0.0019181948,0.0012169211],"study_design_scores_gemma":[0.0012699018,0.000069969356,0.9911625,0.00014584578,0.00024404017,5.031759e-7,0.000037892343,0.000022739461,0.0061741015,0.00012363744,0.0006903312,0.000058539157],"about_ca_topic_score_codex":0.00003394129,"about_ca_topic_score_gemma":0.00001499969,"teacher_disagreement_score":0.007196876,"about_ca_system_score_codex":0.000017914008,"about_ca_system_score_gemma":0.000081500286,"threshold_uncertainty_score":0.16868414},"labels":[],"label_agreement":null},{"id":"W4417009678","doi":"10.1182/blood-2025-5339","title":"Stepwise engineering of human germinal center B cells to model dark zone high-grade B cell lymphoma driven by sequential BCL2 and MYC deregulation","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Optech (Canada)","funders":"","keywords":"Germinal center; Gene silencing; Lymphoma; Follicular lymphoma; B cell; Gene; Phenotype; Gene rearrangement; B-cell receptor","score_opus":0.011601034071110537,"score_gpt":0.2662502802555481,"score_spread":0.25464924618443757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417009678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958064,0.00016024445,0.0025697523,0.0001891576,0.000056499564,0.00047320724,0.000040237483,0.000036951194,0.00066755054],"genre_scores_gemma":[0.9926689,0.000022208462,0.0018335753,0.000061289065,0.000077355,0.000019053588,0.00004883384,0.000029670593,0.0052391123],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99888045,0.00002566258,0.00025380144,0.00027748305,0.00029419115,0.00026842678],"domain_scores_gemma":[0.9994337,0.00002593298,0.000041442585,0.00028663018,0.00006774396,0.0001445598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000105666055,0.00015195356,0.00027622553,0.00021008358,0.000044746987,0.000021679612,0.00009729626,0.000093941635,0.00006673165],"category_scores_gemma":[0.0000051304733,0.00015763962,0.00006361172,0.00017826846,0.000033697397,0.000047490405,0.00009418508,0.00009521171,0.0000035930298],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000105825864,0.00074815535,0.0011322626,0.0002479817,0.00009318864,0.00001545964,0.00024168863,0.00047839124,0.9946922,0.000046326244,0.0010063052,0.0011922201],"study_design_scores_gemma":[0.008997939,0.00025482583,0.0032950938,0.0001497596,0.00018571058,0.000010808169,0.00003142284,0.009900659,0.9765407,0.000034838376,0.00044879297,0.0001494803],"about_ca_topic_score_codex":0.000086008484,"about_ca_topic_score_gemma":0.0000075552184,"teacher_disagreement_score":0.018151525,"about_ca_system_score_codex":0.00006417304,"about_ca_system_score_gemma":0.00006863837,"threshold_uncertainty_score":0.64283574},"labels":[],"label_agreement":null},{"id":"W4417009708","doi":"10.1182/blood-2025-5367","title":"Phase 3 study (inMIND) of tafasitamab plus lenalidomide and rituximab for relapsed or refractory follicular lymphoma: Clinical characteristics and outcomes of high-risk patients","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Rituximab; Lenalidomide; Follicular lymphoma; Refractory (planetary science); Phases of clinical research; Neutropenia; Placebo; Post-hoc analysis; Dosing; Progression-free survival","score_opus":0.019422702537377132,"score_gpt":0.3272506070412496,"score_spread":0.30782790450387243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417009708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973699,0.0004581769,0.000018455812,0.000074324336,0.0001616508,0.001544564,0.00033977098,0.000015153173,0.000018042452],"genre_scores_gemma":[0.9985041,0.00035369888,0.00073058734,0.00007852018,0.00003151747,0.00011248374,0.00006272791,0.000017545002,0.000108801185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983319,0.00009177675,0.0008451726,0.00035698322,0.00020513388,0.00016903834],"domain_scores_gemma":[0.99820244,0.00074080174,0.0003981586,0.0003590702,0.00019116604,0.000108362154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030524394,0.00020847122,0.0011460567,0.0001113893,0.00006366251,0.000010742827,0.00006205414,0.00012462473,0.0000050385897],"category_scores_gemma":[0.00086047774,0.00014214139,0.00014673814,0.00009747699,0.000106025516,0.000045480017,0.000075534765,0.000053359337,7.2842965e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037608892,0.07013372,0.8919483,0.00021455146,0.0018066027,0.000048923117,0.00020877617,1.6527826e-8,0.00002380617,0.000046433255,0.00008925318,0.031718723],"study_design_scores_gemma":[0.27535537,0.0065581156,0.71277463,0.00011817121,0.0036252555,0.0000029003816,0.00013976365,0.000010308503,0.0011613024,0.000026648944,0.00014087498,0.00008669211],"about_ca_topic_score_codex":0.00014087785,"about_ca_topic_score_gemma":0.000017148559,"teacher_disagreement_score":0.27159446,"about_ca_system_score_codex":0.000045106186,"about_ca_system_score_gemma":0.00018144342,"threshold_uncertainty_score":0.5796358},"labels":[],"label_agreement":null},{"id":"W4417009721","doi":"10.1182/blood-2025-5962","title":"Individualizing apheresis processing volumes using a predictive algorithm: Analysis of the CAR T-cell collection protocol utilized in ACIT001/EXC002, a phase lb/ll trial of decentralized production of CAR T-cells for treatment of relapsed/refractory aggressive NHL and ALL","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Alberta","funders":"","keywords":"Apheresis; Leukapheresis; Blood collection; Plateletpheresis; Data collection; Chimeric antigen receptor","score_opus":0.04184067357787266,"score_gpt":0.3720435590733941,"score_spread":0.33020288549552146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417009721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93969727,0.00061212364,0.00021790685,0.000017715927,0.00007372459,0.05921386,0.000108760214,0.000011130986,0.00004749718],"genre_scores_gemma":[0.97868776,0.0002768012,0.002912449,0.000004320011,0.00005161161,0.017508868,0.000031005053,0.00003577167,0.00049139967],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974982,0.0003692779,0.00093850645,0.00043063474,0.0004966219,0.00026672243],"domain_scores_gemma":[0.99761754,0.0002200321,0.0011538488,0.0003637205,0.0005847825,0.00006006844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000544367,0.00022988975,0.0011476659,0.000847537,0.00007196208,0.000010312085,0.00010902368,0.00017693426,0.000027662809],"category_scores_gemma":[0.00035047813,0.00017551664,0.00036031156,0.0020574864,0.00025103876,0.00008871331,0.00004165915,0.000108115855,1.4273183e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.061379157,0.010768828,0.004474235,0.0016219056,0.0044715707,0.000004028087,0.0067349775,0.00013050865,0.8845173,7.929328e-7,0.000016081922,0.025880605],"study_design_scores_gemma":[0.16174679,0.0036765863,0.00039412043,0.0007819489,0.0075637978,0.0000030273516,0.0011185375,0.011831347,0.8126183,0.000014520671,0.00014843777,0.0001025681],"about_ca_topic_score_codex":0.00049386756,"about_ca_topic_score_gemma":0.0001019018,"teacher_disagreement_score":0.100367635,"about_ca_system_score_codex":0.00022458713,"about_ca_system_score_gemma":0.0008009906,"threshold_uncertainty_score":0.7157361},"labels":[],"label_agreement":null},{"id":"W4417009738","doi":"10.1182/blood-2025-5352","title":"Fixed treatment duration mosunetuzumab continues to demonstrate clinically meaningful outcomes in patients with relapsed/refractory (R/R) follicular lymphoma (FL) after ≥2 prior therapies: 5-year follow-up of a pivotal Phase II study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Jewish General Hospital; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Follicular lymphoma; Adverse effect; Tolerability; Dosing; Incidence (geometry); Progressive disease; Phases of clinical research; Lymphoma","score_opus":0.013852790504268511,"score_gpt":0.30590820073459446,"score_spread":0.29205541023032594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417009738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954867,0.00012842934,0.000014090295,0.00015547706,0.00009999071,0.0036390298,0.00003130492,0.00005091148,0.00039409593],"genre_scores_gemma":[0.99520814,0.000023091441,0.00046461797,0.00010525923,0.000027883485,0.00041569103,0.000030467763,0.000043758755,0.0036810937],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99734443,0.00022164668,0.0008879841,0.0005414454,0.0006294701,0.00037499005],"domain_scores_gemma":[0.99852467,0.00020025567,0.00018880256,0.0006506093,0.00028401503,0.00015162597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040734076,0.00033055965,0.00086760934,0.00033035286,0.00008046061,0.000031979816,0.00015169456,0.00013179076,0.00017558639],"category_scores_gemma":[0.00020999805,0.00023645611,0.000209204,0.00045952306,0.000077437864,0.000102687794,0.00007675966,0.00014365258,0.000008219728],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024005271,0.029787682,0.90900373,0.00003477488,0.0017532135,0.00010874128,0.005477026,9.1750996e-7,0.0045954213,0.0000045798943,0.000016770584,0.025211869],"study_design_scores_gemma":[0.1879177,0.044910073,0.75988674,0.00025624296,0.000631984,0.0000018401647,0.0012393153,0.000010795878,0.00455756,0.000011833679,0.00033437033,0.00024153624],"about_ca_topic_score_codex":0.00015412213,"about_ca_topic_score_gemma":0.00042148397,"teacher_disagreement_score":0.16391242,"about_ca_system_score_codex":0.00022038948,"about_ca_system_score_gemma":0.00037883534,"threshold_uncertainty_score":0.96424},"labels":[],"label_agreement":null},{"id":"W4417009748","doi":"10.1182/blood-2025-5353","title":"Fixed-duration subcutaneous mosunetuzumab continues to demonstrate high rates of durable responses in patients with relapsed/refractory follicular lymphoma after ≥2 prior therapies: 3-year follow-up from a pivotal Phase II study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Spinal Cord Injury BC; University of British Columbia; Jewish General Hospital","funders":"","keywords":"Follicular lymphoma; Refractory (planetary science); Dosing; Complete response; Phases of clinical research; Progressive disease; Follicular phase; Lymphoma","score_opus":0.008669991846502094,"score_gpt":0.2697400038793466,"score_spread":0.2610700120328445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417009748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99625397,0.00047629973,0.000010215051,0.00013814865,0.00011011621,0.0027015642,0.00011177691,0.00005433684,0.00014360041],"genre_scores_gemma":[0.9952738,0.00003114545,0.00031993416,0.00008750123,0.000037926162,0.0002569819,0.00006694504,0.000050735376,0.0038750242],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974633,0.00031475685,0.0006227124,0.0005578136,0.0006392273,0.00040221302],"domain_scores_gemma":[0.99843496,0.0003105438,0.000148701,0.00063844834,0.00033618623,0.00013113616],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003260136,0.00031056226,0.0006639345,0.00040379915,0.00010665686,0.000051321156,0.00018130594,0.00013925252,0.00038430243],"category_scores_gemma":[0.00023550811,0.00025227413,0.00010696487,0.00065504154,0.00009445592,0.00014048516,0.00008556595,0.00019280461,0.000010398807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13951607,0.018051282,0.7074319,0.000073731826,0.0014957509,0.0007654167,0.0058516753,0.0000029987377,0.1132653,0.000006766785,0.00011620773,0.013422899],"study_design_scores_gemma":[0.14456281,0.03236981,0.7322958,0.00070463616,0.00061395834,0.000012240209,0.0023500572,0.000020713149,0.08604454,0.000059592425,0.00052038376,0.00044542656],"about_ca_topic_score_codex":0.0008617866,"about_ca_topic_score_gemma":0.00076854747,"teacher_disagreement_score":0.027220756,"about_ca_system_score_codex":0.00014690091,"about_ca_system_score_gemma":0.00040637745,"threshold_uncertainty_score":0.99999297},"labels":[],"label_agreement":null},{"id":"W4417009769","doi":"10.1182/blood-2025-2772","title":"Reassessing bone marrow staging practices in limited-stage follicular lymphoma in the PET era","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of Calgary","funders":"","keywords":"Follicular lymphoma; Positron emission tomography; Bone marrow; Biopsy; Lymphoma; Retrospective cohort study; Fine-needle aspiration","score_opus":0.021897750399162138,"score_gpt":0.30707894741033204,"score_spread":0.2851811970111699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417009769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97542286,0.0029183384,0.0000030062056,0.0061528133,0.000058758884,0.00042577644,0.0000044265944,0.00003208115,0.014981914],"genre_scores_gemma":[0.9969652,0.0002937878,0.000687178,0.0013848521,0.000042792315,0.0001225465,0.000021666378,0.0000120587865,0.00046991138],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876666,0.00014488006,0.000282436,0.00029227123,0.00024325892,0.0002704733],"domain_scores_gemma":[0.9990241,0.0003522769,0.00015373797,0.00039882737,0.000029872996,0.000041194984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004807592,0.00015458722,0.0002755942,0.00022160851,0.000071058115,0.000094968775,0.00010080184,0.000049715392,0.000020037653],"category_scores_gemma":[0.0003313289,0.00010550144,0.00007480128,0.00054851174,0.000026263586,0.0001468886,0.000045692104,0.00010927872,0.000009477674],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007963924,0.005086258,0.9742531,0.00014786566,0.00014561477,0.007409551,0.0006518737,0.0000049090845,0.00095713534,0.0013691371,0.0003386186,0.009556273],"study_design_scores_gemma":[0.012266565,0.00010127296,0.97223747,0.0007257405,0.00036871954,0.00019379717,0.0017288573,0.00015675944,0.003114151,0.0001026051,0.008874122,0.00012992977],"about_ca_topic_score_codex":0.0009355881,"about_ca_topic_score_gemma":0.000299618,"teacher_disagreement_score":0.021542322,"about_ca_system_score_codex":0.00013724259,"about_ca_system_score_gemma":0.00025130154,"threshold_uncertainty_score":0.4302224},"labels":[],"label_agreement":null},{"id":"W4417009796","doi":"10.1182/blood-2025-2748","title":"Real world population-based outcome analysis of small lymphocytic lymphoma (SLL) in British Columbia (BC)","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Leukemia & Lymphoma Society of Canada; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Chronic lymphocytic leukemia; Lymphoma; Epidemiology; Cohort; Somatic evolution in cancer; Natural history; Survival analysis; Bone marrow; Leukemia; Incidence (geometry)","score_opus":0.01871223548760332,"score_gpt":0.29803873841165396,"score_spread":0.27932650292405065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417009796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950334,0.00018091551,0.000020514737,0.000060255985,0.00007446376,0.00049933884,0.000034938726,0.00006901013,0.004027169],"genre_scores_gemma":[0.9916881,0.000028295939,0.0007800582,0.00021088184,0.000033388704,0.000055569988,0.00019058783,0.000026687168,0.0069864844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975025,0.00010425715,0.0009042104,0.0004946375,0.0005155223,0.00047883886],"domain_scores_gemma":[0.9983818,0.00043424708,0.00014304476,0.0007196036,0.00017020965,0.00015112892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045788745,0.00014842699,0.0009341094,0.0010307619,0.0000611742,0.000086620166,0.00024696343,0.00015316802,0.0003301894],"category_scores_gemma":[0.00044024666,0.00022275616,0.00033916414,0.0045838235,0.000094957046,0.00004168194,0.00009127277,0.00011329377,0.000010067353],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00009850004,0.0009597908,0.9925611,0.00038027763,0.0009191618,0.00040588435,0.000027556242,0.00040808148,0.000065796485,0.00003364497,0.000106752144,0.0040334496],"study_design_scores_gemma":[0.041062146,0.00006520215,0.9131462,0.00032665403,0.0021880746,0.000012282981,0.00003223696,0.04271357,0.00018039372,0.00005108903,0.00006668317,0.00015547762],"about_ca_topic_score_codex":0.65191823,"about_ca_topic_score_gemma":0.7743412,"teacher_disagreement_score":0.12242302,"about_ca_system_score_codex":0.012734064,"about_ca_system_score_gemma":0.008558228,"threshold_uncertainty_score":0.9970623},"labels":[],"label_agreement":null},{"id":"W4417009797","doi":"10.1182/blood-2025-2761","title":"Outcomes of autologous stem cell transplantation using busulfan-melphalan conditioning with pharmacokinetic monitoring for relapsed diffuse large B-cell lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Busulfan; Melphalan; Rituximab; Autologous stem-cell transplantation; Carmustine; Diffuse large B-cell lymphoma; Transplantation; Lymphoma","score_opus":0.01424451056297561,"score_gpt":0.27704321430655765,"score_spread":0.26279870374358205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417009797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99696505,0.00066271645,0.0007801984,0.000056841815,0.00014304832,0.0006958284,0.00012557382,0.000062317464,0.0005084185],"genre_scores_gemma":[0.9972272,0.000102490005,0.0021284872,0.000052286796,0.000034213044,0.00011078731,0.00008404624,0.0000233797,0.00023711014],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99903446,0.000026219417,0.00029324697,0.00024196223,0.0001603334,0.00024376974],"domain_scores_gemma":[0.9993535,0.00018577688,0.00013886769,0.00017186113,0.00008569541,0.000064275984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006593293,0.0001837406,0.00038036174,0.00013378476,0.000109666915,0.000014753152,0.00005524525,0.00007095658,0.000004472768],"category_scores_gemma":[0.0000042710635,0.00014416274,0.000107070664,0.00014760537,0.000025495174,0.000054856235,0.000009520044,0.00003547463,0.0000013573691],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046590864,0.013041338,0.9404372,0.001313741,0.0006488344,0.00021700603,0.00073186535,0.000050164468,0.04052198,0.00010099668,0.00002411512,0.0024468345],"study_design_scores_gemma":[0.07450683,0.00033359448,0.36511993,0.00033735717,0.0027739163,0.000035507463,0.00023072503,0.00020031101,0.55628717,0.0000075933967,0.000049331033,0.00011774809],"about_ca_topic_score_codex":0.00005105825,"about_ca_topic_score_gemma":0.000003262882,"teacher_disagreement_score":0.57531726,"about_ca_system_score_codex":0.00007200107,"about_ca_system_score_gemma":0.00011164296,"threshold_uncertainty_score":0.5878786},"labels":[],"label_agreement":null},{"id":"W4417009812","doi":"10.1182/blood-2025-2769","title":"Limited-stage Mantle Cell Lymphoma: Real-world outcomes according to nodal vs. extranodal presentation","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Mantle cell lymphoma; Stage (stratigraphy); Radiation therapy; Chemotherapy; Proportional hazards model; Retrospective cohort study; Chemotherapy regimen; Survival analysis; Transplantation; Disease","score_opus":0.015790387473181844,"score_gpt":0.29953035294808844,"score_spread":0.2837399654749066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417009812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.928968,0.0001627735,0.00004470454,0.002106708,0.00027070797,0.00065063674,0.000028294115,0.0001285077,0.06763966],"genre_scores_gemma":[0.9702047,0.00008219171,0.0011103079,0.0011092403,0.00009195072,0.00013955327,0.000055351993,0.000024088178,0.027182614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987175,0.00003029926,0.00030069592,0.00037628593,0.00025593606,0.00031928023],"domain_scores_gemma":[0.9991757,0.00015375856,0.0000600075,0.00039148523,0.000060192437,0.00015883587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008156558,0.00021483397,0.0003699326,0.00029149986,0.00010709104,0.000054791682,0.000105049316,0.000066881774,0.000082099315],"category_scores_gemma":[0.00003979394,0.00017736809,0.00016052379,0.00040933752,0.000019809793,0.00008202416,0.00007973418,0.00004562361,0.00015463203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014592637,0.0034937842,0.98577684,0.00012651089,0.00022920634,0.00024304456,0.00015964407,0.000005597497,0.0019541185,0.00085242226,0.002618432,0.0043944595],"study_design_scores_gemma":[0.013320626,0.00018910291,0.90222245,0.000114829236,0.0005843265,0.000007122831,0.00024087449,0.000026837877,0.075174324,0.000028013243,0.007930601,0.00016086093],"about_ca_topic_score_codex":0.00088918005,"about_ca_topic_score_gemma":0.00020069092,"teacher_disagreement_score":0.08355437,"about_ca_system_score_codex":0.00015362854,"about_ca_system_score_gemma":0.00013511609,"threshold_uncertainty_score":0.72328603},"labels":[],"label_agreement":null},{"id":"W4417009848","doi":"10.1182/blood-2025-5959","title":"Expanding access to haploidentical transplantation : Clinical feasibility of a centralized nationwide distribution model for fresh TCRα/β-depleted grafts in France","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Transplantation; Apheresis; Stem cell; CD19; Hematopoietic stem cell transplantation; Immune system; Interim","score_opus":0.09580000145381803,"score_gpt":0.44903173316484646,"score_spread":0.3532317317110284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417009848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8999519,0.000049934337,0.097175226,0.0007977736,0.00007597506,0.0016520417,0.0001685683,0.000031308646,0.000097301185],"genre_scores_gemma":[0.9982041,0.000077529,0.0008981322,0.0001449551,0.00003657268,0.00014323286,0.00022020169,0.000011210635,0.00026406086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837726,0.00010216877,0.00061482645,0.00033632753,0.00030639413,0.00026303725],"domain_scores_gemma":[0.99899155,0.0003847236,0.000057895086,0.00023919197,0.00021922542,0.000107436004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080564443,0.00010164167,0.00036043042,0.00014412265,0.000040898452,0.000025927966,0.0001482924,0.00012573515,0.000047622874],"category_scores_gemma":[0.00089076645,0.00010076787,0.00015234337,0.00048653182,0.000057746758,0.000106880485,0.000028485823,0.00018025955,0.0000010051973],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035237742,0.0023115408,0.892685,0.0006868567,0.00011340033,0.000010207237,0.00031107,0.00015226117,0.09718634,0.00053163216,0.0002085428,0.0022793843],"study_design_scores_gemma":[0.021497529,0.00021914615,0.866702,0.00044405082,0.00021788044,0.000003333887,0.000023263616,0.028245332,0.08012203,0.002345009,0.000052522708,0.00012788907],"about_ca_topic_score_codex":0.000058751484,"about_ca_topic_score_gemma":0.00021680849,"teacher_disagreement_score":0.09825224,"about_ca_system_score_codex":0.00007231813,"about_ca_system_score_gemma":0.00018406379,"threshold_uncertainty_score":0.41091946},"labels":[],"label_agreement":null},{"id":"W4417009855","doi":"10.1182/blood-2025-6006","title":"Immune and DNA-damage responses in the intestinal stroma of patients presenting with lower gastro-intestinal symptoms after allogeneic stem cell transplantation","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Immune system; Stem cell; CD68; Inflammation; Stromal cell; CD3; Stem cell marker; Acquired immune system; Transplantation; Stroma","score_opus":0.006512448977178549,"score_gpt":0.22011851281623065,"score_spread":0.21360606383905212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417009855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989072,0.00021893611,0.000097446704,0.000078047175,0.000028484616,0.0003740593,0.000015193992,0.000018088478,0.0002625634],"genre_scores_gemma":[0.99903476,0.00001736112,0.0006058796,0.00006415428,0.000016221851,0.000029592527,0.00001733555,0.000011115613,0.00020354983],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99889815,0.00012568895,0.00030693103,0.00022429162,0.00022979954,0.00021514375],"domain_scores_gemma":[0.99934757,0.0002086467,0.00009329502,0.00021712846,0.00009421007,0.000039139624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019363826,0.00014950789,0.00021806464,0.00015396513,0.000041203013,0.000018987706,0.000106201594,0.000038040045,0.00001057032],"category_scores_gemma":[0.00003807551,0.00010128652,0.000037515965,0.00024627594,0.000117044474,0.00006481886,0.000023286166,0.00016461697,8.986772e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002208215,0.000711589,0.9761145,0.00036382282,0.000028530747,0.00023732639,0.0009081888,0.0000012768514,0.019041922,0.000010831072,0.000003067635,0.00037071583],"study_design_scores_gemma":[0.0034624715,0.0007664736,0.9689716,0.00056138524,0.0002285719,0.000081766455,0.00040051897,0.000024380419,0.025402658,0.0000050006656,0.000011889859,0.000083274565],"about_ca_topic_score_codex":0.00004160551,"about_ca_topic_score_gemma":0.000037177888,"teacher_disagreement_score":0.0071429056,"about_ca_system_score_codex":0.000009855053,"about_ca_system_score_gemma":0.00007041763,"threshold_uncertainty_score":0.41303444},"labels":[],"label_agreement":null},{"id":"W4417009913","doi":"10.1182/blood-2025-6620","title":"Management of acute coronary syndrome and surgical revascularization in a patient with severe Hemophilia A on emicizumab","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Winnipeg; University of Manitoba; University of British Columbia","funders":"","keywords":"Partial thromboplastin time; Acute coronary syndrome; Antithrombotic; Myocardial infarction; Population; Perioperative; Aspirin; Revascularization","score_opus":0.008038524527140746,"score_gpt":0.25484035170447994,"score_spread":0.2468018271773392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417009913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942836,0.00027063093,0.0000022630106,0.00046423316,0.000010182784,0.0006507042,0.000005314998,0.000012339417,0.004300727],"genre_scores_gemma":[0.99786276,0.0003890976,0.00026448042,0.00002772759,0.0000025322622,0.000033382537,0.00003146874,0.000006980197,0.0013815571],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992752,0.000027372316,0.00014433304,0.00019393381,0.0002275926,0.00013155791],"domain_scores_gemma":[0.9997091,0.000020372721,0.00002108236,0.00017728993,0.000027707114,0.000044399698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006248479,0.000088478715,0.00020505855,0.00014153472,0.000021856576,0.0000039103884,0.000030819316,0.000050566316,0.000018093384],"category_scores_gemma":[0.0000024548672,0.000060535727,0.000030923322,0.00027495236,0.00003973131,0.000019473508,0.000045568053,0.00008895933,0.0000027635463],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005829815,0.009466624,0.8318472,0.0029109872,0.0057311933,0.1066753,0.0005904903,0.000021847572,0.0006586261,0.0038429478,0.00010588737,0.032319106],"study_design_scores_gemma":[0.03526313,0.0050161346,0.9435754,0.004380228,0.0015157596,0.005185626,0.00022448164,0.000111868234,0.0039553326,0.00027513906,0.00027335773,0.00022357193],"about_ca_topic_score_codex":0.000007439968,"about_ca_topic_score_gemma":0.0000011859461,"teacher_disagreement_score":0.11172819,"about_ca_system_score_codex":0.00003382734,"about_ca_system_score_gemma":0.00003637752,"threshold_uncertainty_score":0.24685752},"labels":[],"label_agreement":null},{"id":"W4417009920","doi":"10.1182/blood-2025-6599","title":"Partial splenic embolization to manage thrombocytopenia in cancer patients: Case series and review of the literature","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute; McMaster University Medical Centre","funders":"","keywords":"Cancer; Embolization; Complication; Colorectal cancer; Chemotherapy; Interventional radiology","score_opus":0.007997392503483882,"score_gpt":0.2907620195688594,"score_spread":0.28276462706537553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417009920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98050743,0.015516656,0.0000021234582,0.0019463662,0.00014716065,0.00065165426,0.000026036003,0.000007976403,0.0011946212],"genre_scores_gemma":[0.98758256,0.0096888775,0.000021652731,0.0020544806,0.000032359305,0.00009590731,0.0000063783464,0.0000050919434,0.0005126916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99958646,0.000029538143,0.00014575948,0.00010943017,0.000059656828,0.000069176676],"domain_scores_gemma":[0.9997177,0.000006604857,0.000030773,0.00015242417,0.00006943199,0.000023039243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000040305782,0.000058316673,0.00016812436,0.000042109983,0.000036999532,0.000008901403,0.000031002128,0.00002564864,0.000047083224],"category_scores_gemma":[0.00003716478,0.000039172788,0.000028041328,0.0004981777,0.00001907978,0.000056116452,0.00004427678,0.000069923335,7.69774e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024245033,0.0014017693,0.9484219,0.022487517,0.0002601049,0.00025802324,0.0024922201,0.000011108351,0.0032210783,0.0037622687,0.006406784,0.011034759],"study_design_scores_gemma":[0.00909808,0.0007515511,0.77907217,0.075168766,0.0021684933,0.00076502335,0.00017404807,0.000003990686,0.035983045,0.00023996155,0.09621501,0.00035986368],"about_ca_topic_score_codex":0.00009447082,"about_ca_topic_score_gemma":0.0005359054,"teacher_disagreement_score":0.16934974,"about_ca_system_score_codex":0.000019737323,"about_ca_system_score_gemma":0.000043294265,"threshold_uncertainty_score":0.159742},"labels":[],"label_agreement":null},{"id":"W4417010065","doi":"10.1182/blood-2025-7540","title":"Safety and efficacy of the use of anabolic bone agents in patients with underlying plasma cell dyscrasias: A case series.","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Multiple myeloma; Osteoporosis; Plasma cell dyscrasia; Monoclonal gammopathy of undetermined significance; Dyscrasia; Adverse effect; Population; Occult; Retrospective cohort study; Cancer","score_opus":0.03887787072356657,"score_gpt":0.2868829622134642,"score_spread":0.24800509148989763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417010065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99889505,0.00008289711,0.000002911509,0.00005671497,0.0000120455,0.0006844574,0.000043671134,0.0000054255647,0.00021681956],"genre_scores_gemma":[0.99929833,0.000035807556,0.0003503452,0.000020305053,0.0000021785079,0.0000068104764,0.000010292292,0.000008340714,0.00026760067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99924463,0.000051388757,0.00020837739,0.00014591088,0.00018869452,0.00016097455],"domain_scores_gemma":[0.9994587,0.00010025766,0.000068003734,0.0002567285,0.000061703075,0.000054660894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000048164293,0.00009397111,0.0002318891,0.00011289353,0.00004277995,0.0000062231957,0.000038734583,0.00003841395,0.000008383046],"category_scores_gemma":[0.00013856412,0.000058282854,0.000030203568,0.00030739015,0.000085781154,0.00005546208,0.00006649944,0.00009135428,4.5801252e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015515261,0.0021121558,0.9912059,0.00020750366,0.00017128329,0.0003875677,0.00029122637,0.000009372406,0.0002154273,0.00001831605,0.000013140565,0.0038166163],"study_design_scores_gemma":[0.024375027,0.0003764532,0.97086376,0.00030679425,0.0001497136,0.000053787277,0.00008015078,0.000054113912,0.0036024349,0.0000026014761,0.00009222339,0.000042937078],"about_ca_topic_score_codex":0.0003686219,"about_ca_topic_score_gemma":0.0002756251,"teacher_disagreement_score":0.0228235,"about_ca_system_score_codex":0.000025281975,"about_ca_system_score_gemma":0.00009628066,"threshold_uncertainty_score":0.23767059},"labels":[],"label_agreement":null},{"id":"W4417010092","doi":"10.1182/blood-2025-7849","title":"Inhibitors of RAD51 as potential novel therapies in Acute Myeloid Leukemia","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Lawson Health Research Institute; McMaster University; McMaster University Medical Centre","funders":"","keywords":"RAD51; Myeloid leukemia; Homologous recombination; Synthetic lethality; DNA repair; Cancer cell; Myeloid; Cancer; Cell culture","score_opus":0.009361340339531064,"score_gpt":0.2795919969100128,"score_spread":0.27023065657048173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417010092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98826486,0.0009136538,0.00012451959,0.0017761717,0.00015170782,0.00046022178,0.000013606581,0.000050518967,0.00824473],"genre_scores_gemma":[0.9935972,0.00033049134,0.0014439615,0.00041480115,0.00013205038,0.000030191006,0.000020152313,0.000025871037,0.0040052654],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998479,0.00004142562,0.00040442045,0.0003110654,0.00039565106,0.0003684353],"domain_scores_gemma":[0.9992256,0.00007675865,0.00007134436,0.00041537973,0.00012170937,0.00008918408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028719622,0.00017694983,0.00043909793,0.00047929017,0.000041571147,0.000015228952,0.00021784828,0.00018909285,0.00009930236],"category_scores_gemma":[0.00014830445,0.00015343391,0.00013300305,0.0007183523,0.00016594277,0.00007801108,0.00016004356,0.0004504598,0.0000354036],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006801559,0.00085954764,0.019599207,0.00020814127,0.00086935755,0.00032247422,0.00066631724,0.000011710785,0.96705425,0.0014752396,0.002074722,0.006178896],"study_design_scores_gemma":[0.029612362,0.0006546507,0.100368686,0.0005865913,0.0006210267,0.0002625173,0.00092034356,0.00027590053,0.8597714,0.00077510026,0.0058248444,0.00032658892],"about_ca_topic_score_codex":0.00046832126,"about_ca_topic_score_gemma":0.000022506922,"teacher_disagreement_score":0.10728284,"about_ca_system_score_codex":0.00025330042,"about_ca_system_score_gemma":0.0012654269,"threshold_uncertainty_score":0.62568533},"labels":[],"label_agreement":null},{"id":"W4417010141","doi":"10.1182/blood-2025-8202","title":"Estimating incidence and prevalence of polycythemia vera and associated eligibility for cytoreductive therapies in major US health plans","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Theratechnologies (Canada); Forming Technologies (Canada)","funders":"","keywords":"Polycythemia vera; Incidence (geometry); Cumulative incidence; Myeloproliferative neoplasm; Epidemiology; Myelofibrosis; Cancer","score_opus":0.013651752186808237,"score_gpt":0.3255977372001084,"score_spread":0.3119459850133001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417010141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949265,0.0030301805,0.000057265835,0.000981526,0.000026318936,0.000816204,0.00010375206,0.000012149634,0.000046113164],"genre_scores_gemma":[0.99479425,0.00028613882,0.0045883595,0.00015080908,0.000013022863,0.00011711394,0.0000079683305,0.000005110834,0.000037232785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99925303,0.000046458314,0.00023503968,0.00024008425,0.00008513465,0.00014026012],"domain_scores_gemma":[0.9993429,0.00034514582,0.00010118122,0.000106654166,0.00005977779,0.000044295484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027427744,0.00010233197,0.0003142229,0.000057787787,0.000059561607,0.000008114477,0.000026600519,0.000044605487,0.0000030303502],"category_scores_gemma":[0.00037995982,0.000082630315,0.000023102995,0.00009377349,0.00007341643,0.000040228388,0.000023996483,0.00006832092,8.998847e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013574741,0.0005659121,0.9940493,0.0006649688,0.00014248428,0.0000025262968,0.0018003243,0.000001417434,0.00089983316,0.00020295658,0.00002009428,0.0015144323],"study_design_scores_gemma":[0.004149714,0.0005644006,0.9791706,0.00089794165,0.00011793697,0.0000073788806,0.0001436049,0.00024270447,0.013884078,0.00076287845,0.0000036605804,0.000055059543],"about_ca_topic_score_codex":0.00026369403,"about_ca_topic_score_gemma":0.00018825219,"teacher_disagreement_score":0.01487866,"about_ca_system_score_codex":0.000058782218,"about_ca_system_score_gemma":0.00016474878,"threshold_uncertainty_score":0.33695665},"labels":[],"label_agreement":null},{"id":"W4417010147","doi":"10.1182/blood-2025-8013","title":"A genomic analysis of patients with chronic lymphocytic leukemia treated with fixed duration therapy in a first-line setting in alberta, Canada","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Venetoclax; Ibrutinib; Chemoimmunotherapy; Obinutuzumab; Chronic lymphocytic leukemia; IGHV@; Rituximab; Bruton's tyrosine kinase; Leukemia","score_opus":0.005497961082703836,"score_gpt":0.22826581225323983,"score_spread":0.222767851170536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417010147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985772,0.00022902586,0.00000983454,0.00007927533,0.0000088924135,0.0008465589,0.0000150657,0.000011930407,0.00022222743],"genre_scores_gemma":[0.9991167,0.00006718179,0.000065394706,0.00008448979,0.000012855362,0.00008647006,0.00022309362,0.000022719361,0.00032106639],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982236,0.000062996696,0.000515618,0.00038718607,0.0004121014,0.00039848802],"domain_scores_gemma":[0.9989376,0.00026311525,0.0001471499,0.0004342155,0.00014263521,0.00007527474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013446997,0.00020975008,0.00060002174,0.0006965516,0.00003751978,0.000011499289,0.00012937425,0.00008745487,0.00004219746],"category_scores_gemma":[0.000090833964,0.00015489952,0.000052285875,0.0026593732,0.00005992967,0.000052418898,0.00003236577,0.00014730508,9.1235484e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0019647735,0.0003221529,0.9766269,0.00021913176,0.0016389341,0.000133263,0.0002884907,0.017442022,0.00027949142,0.000004892553,0.00002233651,0.0010576294],"study_design_scores_gemma":[0.102731206,0.00055560004,0.8125186,0.00044055545,0.00078735093,0.000005724675,0.0000417136,0.07903043,0.0036743295,0.0000013805635,0.00005018424,0.00016293216],"about_ca_topic_score_codex":0.90337443,"about_ca_topic_score_gemma":0.98255485,"teacher_disagreement_score":0.16410829,"about_ca_system_score_codex":0.06538948,"about_ca_system_score_gemma":0.055470448,"threshold_uncertainty_score":0.9498842},"labels":[],"label_agreement":null},{"id":"W4417010151","doi":"10.1182/blood-2025-8199","title":"Estimating incident and prevalent essential thrombocythemia patients eligible for cytoreductive therapies in the US and Canada","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Theratechnologies (Canada); Forming Technologies (Canada)","funders":"","keywords":"Essential thrombocythemia; Epidemiology; Medical prescription; Anagrelide; Population; Incidence (geometry); MEDLINE; Myelofibrosis","score_opus":0.006760433327555526,"score_gpt":0.266591384883312,"score_spread":0.2598309515557565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417010151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99683493,0.0009460744,0.000020265803,0.0008848182,0.00007860804,0.0010076308,0.000020614807,0.00000550887,0.00020154983],"genre_scores_gemma":[0.99808264,0.000099565965,0.0010883261,0.0003371732,0.00004677653,0.00029331027,0.000015656617,0.0000060817883,0.000030455461],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999358,0.000030014367,0.00015000779,0.00019163,0.00013582992,0.0001345312],"domain_scores_gemma":[0.99959695,0.00016656937,0.000044173656,0.00010237839,0.000059219463,0.00003070885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000090288944,0.00011116,0.00019012057,0.00003470892,0.00010360451,0.000026843094,0.000033936984,0.000027594413,0.0000038832472],"category_scores_gemma":[0.00007884576,0.000069534515,0.000019356945,0.00005229389,0.00003796892,0.00003046952,0.000028146365,0.00005923517,1.09138504e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000066155335,0.00062879635,0.9944941,0.00016835611,0.00022588306,0.000008881726,0.0019320052,0.0000053142076,0.00019490262,0.00041613088,0.0004925966,0.0013668721],"study_design_scores_gemma":[0.0058218976,0.00030789236,0.98091316,0.0002290531,0.00032193243,0.000011073354,0.00050057116,0.00012483314,0.011003438,0.0004305982,0.0002512049,0.00008432782],"about_ca_topic_score_codex":0.03315535,"about_ca_topic_score_gemma":0.06300976,"teacher_disagreement_score":0.029854413,"about_ca_system_score_codex":0.000057256253,"about_ca_system_score_gemma":0.00018475427,"threshold_uncertainty_score":0.97328293},"labels":[],"label_agreement":null},{"id":"W4417010179","doi":"10.1182/blood-2025-8206","title":"Identifying educational and resource needs of general internal medicine physicians in sickle cell disease management.","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Ottawa; University of Calgary","funders":"","keywords":"Multidisciplinary approach; Disease; Likert scale; Chronic pain; Educational resources; Acute chest syndrome; MEDLINE; Alternative medicine; Chest pain","score_opus":0.00591056361977307,"score_gpt":0.2487573720853052,"score_spread":0.24284680846553214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417010179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9148006,0.0033687213,0.00007018545,0.0035092523,0.000088730536,0.0001667184,0.0000025112802,0.000010093567,0.077983215],"genre_scores_gemma":[0.98301387,0.00032489593,0.000162869,0.00064426096,0.000069251735,0.000007888187,0.000019136745,0.0000072759894,0.015750548],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994505,0.00001758468,0.00019261155,0.00010878543,0.000114206276,0.00011629333],"domain_scores_gemma":[0.9997349,0.000022736573,0.000042280513,0.00012532703,0.000020061896,0.00005474396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007207372,0.000075527605,0.00015038425,0.00025461192,0.000025739238,0.000004516275,0.000054747707,0.000030765397,0.0000436378],"category_scores_gemma":[0.000017606482,0.00006536425,0.000031693733,0.00030220408,0.00008488841,0.00002410379,0.000049813065,0.00010231693,0.0000020667046],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081935216,0.0074701323,0.8279999,0.006474966,0.0009509606,0.00027619576,0.01022759,0.000120929,0.03720977,0.03127001,0.04515308,0.032027148],"study_design_scores_gemma":[0.024965422,0.00026856494,0.9242682,0.005734654,0.002110223,0.000019318111,0.015578292,0.00061526446,0.005182526,0.0054234467,0.015468422,0.00036566294],"about_ca_topic_score_codex":0.000086997265,"about_ca_topic_score_gemma":0.0000040469877,"teacher_disagreement_score":0.09626834,"about_ca_system_score_codex":0.000012062176,"about_ca_system_score_gemma":0.00003323883,"threshold_uncertainty_score":0.26654765},"labels":[],"label_agreement":null},{"id":"W4417010180","doi":"10.1182/blood-2025-8213","title":"Tracking fellowship competitiveness in hematology-oncology: Insights from nrmp match data (2014–2025)","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Global Health Workforce Issues","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Matching (statistics); Tracking (education); Statistical analysis; Propensity score matching; Trend analysis; Annual growth %","score_opus":0.08903290261811425,"score_gpt":0.4538836796959307,"score_spread":0.36485077707781643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417010180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9214731,0.007163348,0.00014192285,0.0036184397,0.0020136419,0.0012884686,0.00015940124,0.00024294968,0.06389877],"genre_scores_gemma":[0.9920854,0.00043611292,0.0016227873,0.003227859,0.000241936,0.00012198109,0.00051427714,0.000032340347,0.0017173236],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956846,0.0013776411,0.0010358501,0.00081503845,0.0002220637,0.00086480414],"domain_scores_gemma":[0.99561185,0.0024587384,0.0002734184,0.0013418208,0.00014697487,0.00016720206],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007350508,0.00027483274,0.00082651,0.0002265992,0.0004892489,0.000015170801,0.0010915265,0.0006842862,0.0008841435],"category_scores_gemma":[0.00040280036,0.00026472626,0.00004373619,0.0005782707,0.00012823055,0.00021994076,0.00087227894,0.001176441,0.0011755443],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018327884,0.0011198712,0.94765943,0.00079876726,0.00011744921,0.0003107084,0.003944702,0.0000058174624,0.0002631921,0.03078893,0.012888692,0.0019191651],"study_design_scores_gemma":[0.011461168,0.0001264813,0.38030455,0.007758976,0.00026429206,0.000008700501,0.019015621,0.0002943371,0.0008917647,0.022167081,0.55702645,0.0006805618],"about_ca_topic_score_codex":0.0037006785,"about_ca_topic_score_gemma":0.014701522,"teacher_disagreement_score":0.56735486,"about_ca_system_score_codex":0.00023782025,"about_ca_system_score_gemma":0.0010058659,"threshold_uncertainty_score":0.9999805},"labels":[],"label_agreement":null},{"id":"W4417010229","doi":"10.1182/blood-2025-235","title":"Subgroup analyses from the randomized, Phase 3 VERONA study of venetoclax with azacitidine (Ven+Aza) versus placebo with azacitidine (Pbo+Aza) in patients with treatment-naïve, intermediate and higher-risk Myelodysplastic Syndromes (HR MDS)","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital de l'Enfant-Jésus","funders":"","keywords":"Azacitidine; Clinical endpoint; Myelodysplastic syndromes; Subgroup analysis; International Prognostic Scoring System; Placebo; Neutropenia; Phases of clinical research; Surrogate endpoint; Eltrombopag","score_opus":0.02219161213324807,"score_gpt":0.30959028125290716,"score_spread":0.2873986691196591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417010229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99425226,0.00065840926,0.000056137582,0.00011724037,0.00008516279,0.004260314,0.00025199208,0.000060860864,0.0002576161],"genre_scores_gemma":[0.9982029,0.00026679097,0.00030978225,0.000034227145,0.000074881544,0.0005420962,0.0002826194,0.00007332765,0.00021333346],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99642044,0.0005733533,0.00068198476,0.00083827635,0.0008803803,0.0006055673],"domain_scores_gemma":[0.9956448,0.002653977,0.00037018966,0.0008481693,0.00025514074,0.0002277057],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039677985,0.00063165225,0.0017586257,0.00047644737,0.00016180544,0.000059784856,0.00030420494,0.00013058173,0.000073350326],"category_scores_gemma":[0.00028623315,0.0003326145,0.00010546157,0.0010679233,0.00069167063,0.00017649011,0.00014492088,0.00052142696,0.0000057214606],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5810567,0.005985756,0.3997457,0.00011694027,0.009079373,0.0005909611,0.0014060665,0.00012637982,0.00024831668,0.000016465261,0.00007549586,0.0015518118],"study_design_scores_gemma":[0.7191542,0.019399974,0.2507901,0.000656902,0.006630881,0.000012485265,0.001269189,0.0002859186,0.0014573741,0.000009882161,0.000026610187,0.00030648688],"about_ca_topic_score_codex":0.0033013474,"about_ca_topic_score_gemma":0.0022733733,"teacher_disagreement_score":0.1489556,"about_ca_system_score_codex":0.00044558474,"about_ca_system_score_gemma":0.0006061325,"threshold_uncertainty_score":0.99991256},"labels":[],"label_agreement":null},{"id":"W4417010242","doi":"10.1182/blood-2025-545","title":"Next generation platelet storage bags for better and safer transfusions","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Polymer Surface Interaction Studies","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Platelet; Platelet transfusion; Sepsis; Shelf life; SAFER; Off the shelf; Blood transfusion","score_opus":0.03256149669763752,"score_gpt":0.277591479030227,"score_spread":0.2450299823325895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417010242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919512,0.0008343064,0.0039565023,0.0017406669,0.0006101376,0.00017687515,0.00004324759,0.00004553884,0.0006415091],"genre_scores_gemma":[0.99597806,0.000042625008,0.0019652755,0.0007263643,0.000095586416,0.00006848237,0.000004082078,0.000006585672,0.0011129326],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99946797,0.00002295119,0.00013203055,0.0001866347,0.00006272298,0.00012769569],"domain_scores_gemma":[0.9997258,0.00008744302,0.000023081862,0.00010709768,0.00003351756,0.00002305453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009266436,0.000076890006,0.00010969301,0.000044558285,0.00018771316,0.00007435532,0.000052648775,0.000036388996,0.00014854202],"category_scores_gemma":[0.00002795966,0.000068487745,0.000027888278,0.000051004987,0.000032471948,0.00016952652,0.000027043528,0.00003759062,0.000023651599],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011654164,0.0000518775,0.0002150967,0.000011342754,0.000020882333,0.0000011229625,0.00024801606,0.000002713632,0.99431854,0.00014244836,0.003105418,0.001870871],"study_design_scores_gemma":[0.00086279155,0.000029851142,0.0013023177,0.000015981417,0.000054249085,0.0000039894758,0.00007893846,0.00018282025,0.97812337,0.000098150565,0.019155905,0.00009164955],"about_ca_topic_score_codex":0.000034748395,"about_ca_topic_score_gemma":0.00007404816,"teacher_disagreement_score":0.0161952,"about_ca_system_score_codex":0.000008021954,"about_ca_system_score_gemma":0.000016735201,"threshold_uncertainty_score":0.27928492},"labels":[],"label_agreement":null},{"id":"W4417010243","doi":"10.1182/blood-2025-548","title":"Outcomes after relapse for adolescent and young adult patients with ALL: Results from the Children's oncology group","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Young adult; Clinical trial; Proportional hazards model; Minimal residual disease; Multivariate analysis; Disease; Hazard ratio; Acute lymphocytic leukemia; Chemotherapy regimen","score_opus":0.006582918573300854,"score_gpt":0.25808040771797863,"score_spread":0.2514974891446778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417010243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930581,0.00013799529,0.0001551083,0.004460207,0.00011636516,0.0013331004,0.000315685,0.00003483394,0.00038861166],"genre_scores_gemma":[0.99364936,0.00004435684,0.0016513743,0.0036612207,0.00009575445,0.00014983771,0.00025594357,0.00002221336,0.00046995815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987678,0.000054016677,0.00024938103,0.00036456744,0.00026968046,0.00029458807],"domain_scores_gemma":[0.99879485,0.00047934047,0.00006425619,0.00039779616,0.00016436701,0.00009939347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013503204,0.00015743445,0.0002751679,0.000051080606,0.00007195468,0.00002046628,0.0001275866,0.00012211963,0.000005758422],"category_scores_gemma":[0.0005905941,0.000085217835,0.00005277756,0.00009846481,0.00012514471,0.00003845056,0.00012479734,0.00021300542,0.000006354074],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004542466,0.00089018006,0.9868464,0.000027881162,0.0005074281,0.000023354994,0.00036072568,9.975175e-8,0.000013763324,0.00006234026,0.0049166786,0.0018086941],"study_design_scores_gemma":[0.046410684,0.0005821364,0.95051396,0.00019588346,0.0005686591,0.000008119485,0.00006584311,0.000022686354,0.000074230986,0.00004594581,0.0014223565,0.00008948594],"about_ca_topic_score_codex":0.0004093324,"about_ca_topic_score_gemma":0.00032898615,"teacher_disagreement_score":0.041868217,"about_ca_system_score_codex":0.00015189781,"about_ca_system_score_gemma":0.00019900347,"threshold_uncertainty_score":0.34750825},"labels":[],"label_agreement":null},{"id":"W4417010245","doi":"10.1182/blood-2025-547","title":"Outcomes in children and adolescents with down syndrome and B-lymphoblastic leukemia: A report from Children's oncology group study AALL1731","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; BC Children's Hospital; University of British Columbia","funders":"","keywords":"Blinatumomab; Chemotherapy; Cohort; Chemotherapy regimen; Regimen; Induction chemotherapy; Anthracycline; Minimal residual disease; Methotrexate; Down syndrome","score_opus":0.005139833589903941,"score_gpt":0.2584940298031257,"score_spread":0.25335419621322175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417010245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969883,0.00037873516,0.000057384816,0.00021555173,0.000049700004,0.0019843352,0.00002525609,0.00008200207,0.0002187461],"genre_scores_gemma":[0.9988324,0.00005710005,0.00038839236,0.00026142196,0.000044705663,0.000101785,0.000059517417,0.000039919756,0.00021477243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99736744,0.00013323678,0.0005536502,0.0009220401,0.0004994899,0.0005241119],"domain_scores_gemma":[0.9987371,0.00020443561,0.00013246913,0.0006024714,0.000064281805,0.00025922986],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003257517,0.0003652785,0.00095044123,0.00042456543,0.00009458165,0.000048258175,0.000186356,0.00024147108,0.000013514774],"category_scores_gemma":[0.0002957908,0.00027551927,0.000046927144,0.00044682587,0.00025577671,0.000100402845,0.0003838391,0.000499281,0.000008514541],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004541147,0.002666239,0.9896377,0.000047314308,0.0009573246,0.005101928,0.00019850557,0.0000011864655,0.00010422223,0.000008216673,0.00006261351,0.0007606364],"study_design_scores_gemma":[0.040735923,0.0016752336,0.9487559,0.0004363338,0.0008826805,0.0070083686,0.00016105163,0.000030538497,0.000036037047,0.000044514065,0.0000067102965,0.0002267151],"about_ca_topic_score_codex":0.0035130365,"about_ca_topic_score_gemma":0.00055213267,"teacher_disagreement_score":0.040881805,"about_ca_system_score_codex":0.00067706447,"about_ca_system_score_gemma":0.0010098186,"threshold_uncertainty_score":0.9999697},"labels":[],"label_agreement":null},{"id":"W4417010252","doi":"10.1182/blood-2025-537","title":"Mim8 prophylaxis in adults and adolescents with hemophilia A: 52-week efficacy and safety outcomes from the phase 3 FRONTIER2 study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster Children's Hospital","funders":"","keywords":"Randomized controlled trial; Immunogenicity; Factor IX; Confidence interval; Clotting factor; Clinical trial; Clinical endpoint","score_opus":0.014555641049072744,"score_gpt":0.2917125177482265,"score_spread":0.27715687669915373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417010252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99450475,0.0014301164,0.0000025668662,0.0017081382,0.000040252224,0.0020873756,0.000020670454,0.000025363543,0.0001807399],"genre_scores_gemma":[0.9990227,0.0001324654,0.000085368556,0.00010912066,0.000041543324,0.00004386072,0.000013781629,0.000013683832,0.0005374594],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987785,0.000094960786,0.00022031141,0.00039113086,0.00026995965,0.0002451116],"domain_scores_gemma":[0.9993632,0.00011395098,0.00003033397,0.00034016816,0.00004522616,0.000107111475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001648867,0.00018903015,0.00037438032,0.00009797118,0.00011611198,0.000029638462,0.00009224381,0.00006627476,0.000011307413],"category_scores_gemma":[0.00010468721,0.000096684824,0.000028621886,0.00024339529,0.00013110883,0.000042371852,0.00009585391,0.00026688047,0.0000044800204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003310367,0.009407914,0.97024435,0.000103292645,0.00028966388,0.0002463216,0.0013986432,6.272428e-8,0.00008417383,0.0000023648347,0.000053866726,0.014859002],"study_design_scores_gemma":[0.070633024,0.0023138525,0.9246674,0.0007343452,0.00024144241,0.0000049801333,0.00095024466,0.000011173069,0.00024297288,0.000016489386,0.00009216629,0.00009187655],"about_ca_topic_score_codex":0.0003100368,"about_ca_topic_score_gemma":0.00022127463,"teacher_disagreement_score":0.06732266,"about_ca_system_score_codex":0.000023169236,"about_ca_system_score_gemma":0.000077946075,"threshold_uncertainty_score":0.39426926},"labels":[],"label_agreement":null},{"id":"W4417010261","doi":"10.1182/blood-2025-539","title":"Clinical outcomes up to 4 years of once-weekly efanesoctocog alfa prophylaxis in previously treated adults, adolescents, and children with severe hemophilia A: Interim analysis of the Phase 3 XTEND-ed long-term extension study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster Children's Hospital","funders":"","keywords":"Interim analysis; Bleed; Clinical endpoint; Hemarthrosis; Cumulative incidence; Interim; Intention-to-treat analysis; Incidence (geometry); Clinical trial","score_opus":0.023067172148241902,"score_gpt":0.36273678494840494,"score_spread":0.33966961280016306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417010261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958787,0.00021124448,0.0000010416121,0.00014860355,0.000029597299,0.0036696668,0.000027637763,0.000017340933,0.000016161735],"genre_scores_gemma":[0.99921423,0.00010238012,0.000033913893,0.000042308584,0.00001458101,0.000055801953,0.000027890464,0.000016507604,0.00049238023],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978793,0.00022746563,0.0006643139,0.00050935464,0.00046729558,0.00025225754],"domain_scores_gemma":[0.99877036,0.00008360862,0.00014805845,0.00068967877,0.0001747859,0.00013351048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034784983,0.00021479318,0.0009900952,0.00045892026,0.000035945057,0.0000105939425,0.00020059152,0.0001113839,0.000015746273],"category_scores_gemma":[0.00020675217,0.00012364447,0.00023113065,0.0014030148,0.00015937047,0.0000353466,0.0001832551,0.0002576488,0.000001301185],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025412568,0.01014375,0.9561946,0.0001471126,0.0027067696,0.00007900797,0.00071336736,0.0000011219889,0.00020066013,4.831736e-7,0.000009968783,0.027261924],"study_design_scores_gemma":[0.023719238,0.0041661784,0.9668665,0.0011349287,0.0031795192,0.00000938402,0.00019591996,0.000014833888,0.0006071116,6.674533e-7,7.7565494e-7,0.00010492921],"about_ca_topic_score_codex":0.00024452587,"about_ca_topic_score_gemma":0.0003223739,"teacher_disagreement_score":0.027156994,"about_ca_system_score_codex":0.000033679284,"about_ca_system_score_gemma":0.00012374551,"threshold_uncertainty_score":0.5042075},"labels":[],"label_agreement":null},{"id":"W4417010329","doi":"10.1182/blood-2025-925","title":"Initial results of a CRUK phase I/II, first in human trial of the CAR t-cell engager protein aleta-001 in patients who have received anti-CD19 CAR t-cell therapy for the treatment of b-cell malignancies","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Drug Research and Development","funders":"","keywords":"Tolerability; CD20; CD19; Phases of clinical research; Adverse effect; Refractory (planetary science); Cytokine release syndrome; Antigen; Chimeric antigen receptor","score_opus":0.04077552201564379,"score_gpt":0.3264877264865539,"score_spread":0.2857122044709101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417010329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866212,0.00063280755,0.0000012117995,0.00020502435,0.00010187165,0.009993084,0.00037046964,0.000008699722,0.0020656316],"genre_scores_gemma":[0.9916183,0.0005196129,0.000035047928,0.000033156357,0.00008632778,0.00065392215,0.00007428392,0.0000385072,0.006940854],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99713254,0.00044489017,0.0010758421,0.00038378395,0.0005540179,0.0004089367],"domain_scores_gemma":[0.9977138,0.0005819754,0.00041641173,0.00092927454,0.00030346095,0.000055064935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000873035,0.00030239546,0.00089826854,0.00029714996,0.00014179845,0.0000108315535,0.00036881774,0.00018865927,0.000073520234],"category_scores_gemma":[0.00017259012,0.0001839482,0.00038025685,0.00045117282,0.0002737491,0.000043660275,0.00007329644,0.00028148858,4.8976057e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.060293023,0.050808273,0.0036400964,0.00036301423,0.00023927739,0.000010627675,0.008761378,0.000013216309,0.87381184,0.0000057920506,0.0002890534,0.0017643938],"study_design_scores_gemma":[0.3223266,0.0116880005,0.0013543684,0.00024865652,0.0001279124,2.0355574e-7,0.0003885876,0.000022801612,0.6612291,0.000016629958,0.0025000726,0.000097094606],"about_ca_topic_score_codex":0.0013331787,"about_ca_topic_score_gemma":0.00040564727,"teacher_disagreement_score":0.26203358,"about_ca_system_score_codex":0.00011127531,"about_ca_system_score_gemma":0.00033534452,"threshold_uncertainty_score":0.750119},"labels":[],"label_agreement":null},{"id":"W4417010331","doi":"10.1182/blood-2025-934","title":"Outcomes after bone marrow versus peripheral blood mismatched unrelated donor hematopoietic cell transplantation using posttransplant cyclophosphamide-based GVHD prophylaxis","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"","keywords":"Hazard ratio; Proportional hazards model; Hematopoietic stem cell transplantation; Bone marrow; Transplantation; Cyclophosphamide; Retrospective cohort study; Myelodysplastic syndromes; Myeloid leukemia; Comorbidity","score_opus":0.012225790633043465,"score_gpt":0.25163366013768573,"score_spread":0.23940786950464227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417010331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99069136,0.0011463913,0.0032976079,0.00037361783,0.0006056707,0.0015507437,0.00017245399,0.00030739,0.0018547775],"genre_scores_gemma":[0.9910887,0.00013280365,0.007319486,0.0003650378,0.000042097843,0.00015279933,0.00038663327,0.000093041876,0.00041940867],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967743,0.00014863122,0.0009944685,0.00076032494,0.0006323167,0.0006899527],"domain_scores_gemma":[0.99845886,0.00030597695,0.0001845631,0.00060651323,0.0001805777,0.0002634961],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027201028,0.00061153696,0.0008798395,0.0003671627,0.00017030843,0.00006661089,0.00017647012,0.000473748,0.00044672293],"category_scores_gemma":[0.000029651585,0.0005656951,0.00038537622,0.0006727492,0.00012774774,0.0001409789,0.000012266882,0.00046332288,0.000037572376],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009923328,0.0050371676,0.70433974,0.014002938,0.0014378342,0.0061711636,0.0039199954,0.00038890395,0.25434035,0.00011168654,0.000021038217,0.0003058327],"study_design_scores_gemma":[0.06816377,0.0009794076,0.23879477,0.0018363793,0.010822062,0.00064151175,0.00036767783,0.00024561197,0.67690235,0.00006871548,0.000052441756,0.0011252948],"about_ca_topic_score_codex":0.00020646134,"about_ca_topic_score_gemma":0.000042176638,"teacher_disagreement_score":0.46554497,"about_ca_system_score_codex":0.000102527905,"about_ca_system_score_gemma":0.00044659886,"threshold_uncertainty_score":0.99967945},"labels":[],"label_agreement":null},{"id":"W4417010346","doi":"10.1182/blood-2025-944","title":"The ASH consa consortium on newborn screening in Africa for sickle cell disease: Interim updates of progress in screening, follow-up and supporting initiatives","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Newborn screening; Interim; Interim analysis; Incidence (geometry); Intervention (counseling); Health care; Sickle cell anemia; Disease; Clinical trial","score_opus":0.015370372655321868,"score_gpt":0.28676698425489516,"score_spread":0.2713966115995733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417010346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98638713,0.006764185,0.00025112886,0.0017030274,0.000072024064,0.0009649574,0.000031635023,0.00002898993,0.003796896],"genre_scores_gemma":[0.99797606,0.00018927648,0.0012911008,0.00012239112,0.0000135848995,0.00007719935,0.000022174456,0.000015097427,0.00029308622],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881095,0.00006239423,0.00044268297,0.00023974528,0.00011557691,0.00032866278],"domain_scores_gemma":[0.99918866,0.00034854875,0.00015482372,0.00016593025,0.0000625056,0.00007951334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036490886,0.00014391307,0.00029651774,0.00015825438,0.00008860214,0.000023704619,0.00008619045,0.00008186024,0.0000072898165],"category_scores_gemma":[0.00037093495,0.00010439564,0.000072034636,0.00026122923,0.00023149226,0.0000518161,0.00007109263,0.00020612327,4.7025972e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016923782,0.0009158335,0.95702434,0.00055396825,0.00018066207,0.000065524015,0.0018137541,0.000008125645,0.0005866774,0.0009945385,0.00047904465,0.035685185],"study_design_scores_gemma":[0.07124176,0.0024971468,0.78994197,0.009081001,0.0013433751,0.000013878688,0.044668492,0.004202459,0.047827724,0.0016026837,0.026672533,0.0009069966],"about_ca_topic_score_codex":0.000014937504,"about_ca_topic_score_gemma":0.00002948473,"teacher_disagreement_score":0.16708235,"about_ca_system_score_codex":0.0000068459813,"about_ca_system_score_gemma":0.00012224611,"threshold_uncertainty_score":0.4257131},"labels":[],"label_agreement":null},{"id":"W4417010366","doi":"10.1182/blood-2025-946","title":"Point of care hemoglobin measurement to streamline clinical decision-making: A single center experience","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network","funders":"","keywords":"Phlebotomy; Single Center; Hemoglobin; Blood transfusion; Point of care; Hematocrit; Anemia; Hematology; Prospective cohort study","score_opus":0.020502462352916865,"score_gpt":0.32430524634720326,"score_spread":0.3038027839942864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417010366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874099,0.0017730602,0.001092589,0.0007720068,0.00037771545,0.0005125162,0.000010461654,0.00004960083,0.008002135],"genre_scores_gemma":[0.9949443,0.000059769747,0.003848238,0.001000148,0.000044244312,0.000014917374,0.000004151562,0.000012603692,0.00007167978],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983518,0.000037390193,0.00062004745,0.00033434478,0.0004170433,0.00023938154],"domain_scores_gemma":[0.9989008,0.0000746111,0.00007530832,0.00043868565,0.00036613073,0.00014447473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022742616,0.00014543833,0.00039093397,0.000121426,0.00004664102,0.00001014799,0.00013469222,0.00014239077,0.000068530106],"category_scores_gemma":[0.0009840822,0.00011426395,0.00018759126,0.00034729304,0.00006705277,0.000024599229,0.00011708487,0.00016449613,0.000016840404],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034621195,0.022519868,0.48702258,0.0010008786,0.0010157668,0.00041913785,0.009586824,0.000076768854,0.027036501,0.00053022936,0.012004925,0.4353244],"study_design_scores_gemma":[0.118887484,0.022499306,0.19893256,0.05347304,0.0043930532,0.00058690005,0.08992205,0.00035084493,0.25554022,0.001484685,0.2509915,0.002938359],"about_ca_topic_score_codex":0.000014124601,"about_ca_topic_score_gemma":0.000026050991,"teacher_disagreement_score":0.43238604,"about_ca_system_score_codex":0.000066782195,"about_ca_system_score_gemma":0.00017191972,"threshold_uncertainty_score":0.46595487},"labels":[],"label_agreement":null},{"id":"W4417010430","doi":"10.1182/blood-2025-949","title":"Danicopan add-on therapy demonstrates positive efficacy and safety outcomes in advanced age adults with paroxysmal nocturnal hemoglobinuria and clinically significant extravascular hemolysis: A sub-analysis of the phase 3 ALPHA trial","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Eculizumab; Adverse effect; Hemoglobinuria; Placebo; Randomized controlled trial; Clinical trial","score_opus":0.009219941720847717,"score_gpt":0.2798795399384012,"score_spread":0.2706595982175535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417010430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955851,0.0023543648,0.000023970375,0.00011224637,0.00008698894,0.0015363641,0.00022333955,0.00001996093,0.000057677815],"genre_scores_gemma":[0.99949443,0.00017322521,0.000042545154,0.00009596998,0.000008317949,0.00006898444,0.000071009585,0.000010134717,0.000035394805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976589,0.0006663942,0.00081003684,0.0005074317,0.00008727817,0.00026993276],"domain_scores_gemma":[0.99817044,0.0009588348,0.00032169124,0.00045155166,0.000062335544,0.000035130008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040954805,0.00027424545,0.00090608065,0.00019846112,0.00013211386,0.000022700835,0.00024745535,0.00012253529,0.0000485236],"category_scores_gemma":[0.00016638979,0.00016850804,0.00025968772,0.0004673249,0.00032194974,0.00004446816,0.00007320767,0.00021391286,9.036224e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23416917,0.012704533,0.52144516,0.00009885281,0.028468631,0.00008114638,0.0013408693,0.00008454938,0.18211101,0.00032856152,0.000034757242,0.019132735],"study_design_scores_gemma":[0.24920015,0.0025893468,0.7012378,0.0003290398,0.004344406,0.000007670946,0.0006202624,0.0000141798,0.041317828,0.000030783965,0.00003565651,0.00027289928],"about_ca_topic_score_codex":0.00006374928,"about_ca_topic_score_gemma":0.00016832855,"teacher_disagreement_score":0.17979261,"about_ca_system_score_codex":0.000017833063,"about_ca_system_score_gemma":0.000106924126,"threshold_uncertainty_score":0.68715584},"labels":[],"label_agreement":null},{"id":"W4417010464","doi":"10.1182/blood-2025-1467","title":"Enhanced FLI1 accessibility mediates STAG2-mutant leukemogenesis","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Chromatin; Stem cell; Progenitor cell; Myeloid; Haematopoiesis; Hematopoietic stem cell; Population; Transcription factor","score_opus":0.01654294357995502,"score_gpt":0.316675972511159,"score_spread":0.30013302893120397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417010464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97918177,0.00081353885,0.00047495237,0.0013928224,0.00014871576,0.00057574915,0.000020689897,0.00017924981,0.017212527],"genre_scores_gemma":[0.99383044,0.00025921132,0.0009378837,0.00065250293,0.00017647025,0.00008299307,0.000030430203,0.000024892075,0.004005184],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981012,0.0000854007,0.00037226672,0.00052204635,0.0004294467,0.0004896349],"domain_scores_gemma":[0.99848515,0.00024147963,0.000059635615,0.000777135,0.0002335807,0.00020300211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045879773,0.00020077464,0.00042002677,0.00021692645,0.00011096264,0.000037650687,0.000311734,0.00016770369,0.0004412173],"category_scores_gemma":[0.00082957704,0.00016307681,0.00012965522,0.00070942164,0.00013747826,0.00009734462,0.00023143632,0.0003234728,0.00014861513],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004380429,0.0011025385,0.053444,0.0005224251,0.0005531188,0.0001814565,0.00025002845,0.0000016800279,0.92382157,0.00037743826,0.0019448607,0.01736284],"study_design_scores_gemma":[0.005228283,0.00012781956,0.08215949,0.00010236937,0.0002735379,0.000013320724,0.00014018541,0.000087085115,0.90977675,0.0003518099,0.0015904363,0.00014891403],"about_ca_topic_score_codex":0.00008781883,"about_ca_topic_score_gemma":0.0000299203,"teacher_disagreement_score":0.028715484,"about_ca_system_score_codex":0.000292076,"about_ca_system_score_gemma":0.0012449995,"threshold_uncertainty_score":0.6650079},"labels":[],"label_agreement":null},{"id":"W4417010673","doi":"10.1182/blood-2025-1486","title":"SMARCD1 subunit of SWI/SNF chromatin remodeling complexes collaborates with p53 to exert an oncogenic role in B-ALL by maintaining high metabolic activity","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer","funders":"","keywords":"Chromatin remodeling; Context (archaeology); Haematopoiesis; Genome instability; Protein subunit; Chromatin; Cancer; Myeloid; Carcinogenesis","score_opus":0.009003650922588086,"score_gpt":0.26572128215049284,"score_spread":0.25671763122790475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417010673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964884,0.0017497505,0.0010219922,0.00010261741,0.000031628435,0.00024039786,0.00006791501,0.00001916857,0.00027811772],"genre_scores_gemma":[0.99503225,0.00012120443,0.0043326975,0.00019458919,0.000049109218,0.00003784481,0.00009750193,0.00002699554,0.0001078242],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987761,0.000099050325,0.0002754168,0.00041105744,0.00014631986,0.00029209215],"domain_scores_gemma":[0.9992456,0.000019645495,0.000103266626,0.00040970615,0.000138449,0.00008331977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002481962,0.00020127562,0.00034014106,0.00009351739,0.000058928297,0.000028256323,0.00023797601,0.00012221544,0.000008480515],"category_scores_gemma":[0.000042564057,0.00019112138,0.00004594064,0.0003705624,0.000043853535,0.0000070538595,0.00010025114,0.000104122395,0.0000011691703],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018061567,0.00030285944,0.0022665295,0.000032764285,0.0001069409,0.0000013089626,0.00012696741,0.003926085,0.9897252,0.00004779718,0.00006427208,0.0032186909],"study_design_scores_gemma":[0.0018464404,0.00033992925,0.002081612,0.000113572096,0.000095370306,0.000004703887,0.0003099518,0.0026834211,0.99104726,0.000104297935,0.0011248888,0.00024852567],"about_ca_topic_score_codex":0.0010571816,"about_ca_topic_score_gemma":0.0010375851,"teacher_disagreement_score":0.0033107055,"about_ca_system_score_codex":0.000021158434,"about_ca_system_score_gemma":0.00025029853,"threshold_uncertainty_score":0.77937037},"labels":[],"label_agreement":null},{"id":"W4417011029","doi":"10.1182/blood-2025-269","title":"Safety and efficacy of AZD0120, a BCMA/CD19 dual-targeting CAR T-cell therapy, in relapsed/refractory multiple myeloma: Preliminary Results from the DURGA-1 Phase 1b/2 study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Multiple myeloma; Clinical trial; Adverse effect; Phases of clinical research; Lenalidomide; Progressive disease; Safety profile","score_opus":0.02062231640243224,"score_gpt":0.30420295861852553,"score_spread":0.2835806422160933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417011029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989489,0.0050952532,0.0000031301604,0.00061663636,0.00012334986,0.0025012689,0.00012505511,0.00005816286,0.0019881297],"genre_scores_gemma":[0.99662423,0.0009662846,0.00011676361,0.00012072245,0.00016816509,0.000049740018,0.00009064255,0.000048739224,0.0018146854],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99692875,0.0005616004,0.0008711592,0.00066769554,0.00053169095,0.00043909272],"domain_scores_gemma":[0.9954496,0.003140746,0.00019512343,0.0009456077,0.00014231323,0.00012660393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014662836,0.00030094857,0.00063449517,0.00021836524,0.00015361737,0.000025780597,0.00025488916,0.00016940341,0.000127417],"category_scores_gemma":[0.0011654687,0.00022095972,0.00013501282,0.0005834772,0.00017917145,0.00005823019,0.00022572718,0.00074753386,0.0000070116953],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07597603,0.043819595,0.10807712,0.00012261319,0.00091173203,0.0006068554,0.022688186,0.000020135092,0.71185845,0.0000048038046,0.0010275368,0.03488696],"study_design_scores_gemma":[0.40401012,0.011054579,0.45158297,0.0005885728,0.0005340716,0.000019994539,0.008428671,0.0004403971,0.11530091,0.000031754622,0.0075273775,0.00048059123],"about_ca_topic_score_codex":0.0013463425,"about_ca_topic_score_gemma":0.00010702818,"teacher_disagreement_score":0.59655756,"about_ca_system_score_codex":0.000066948414,"about_ca_system_score_gemma":0.00025925622,"threshold_uncertainty_score":0.9010476},"labels":[],"label_agreement":null},{"id":"W4417011092","doi":"10.1182/blood-2025-1091","title":"Development of a prediction model for maternal pregnancy complications in sickle cell disease","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pregnancy; Disease; Cohort; Retrospective cohort study; Anemia; Advanced maternal age; Blood transfusion; Clinical trial; Cohort study","score_opus":0.011751000614723372,"score_gpt":0.24928338697840954,"score_spread":0.23753238636368618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417011092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97481394,0.0008818896,0.019863695,0.00030829565,0.000034009092,0.0007092436,0.00004900858,0.000028878503,0.0033110606],"genre_scores_gemma":[0.99016356,0.000047993268,0.008570024,0.00004672851,0.0000034128736,0.00014059944,0.000041214083,0.000005399439,0.0009810383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99954957,0.0000034307643,0.00020019112,0.0001013418,0.000056600882,0.00008888447],"domain_scores_gemma":[0.9997766,0.000007277787,0.000030566593,0.0001059055,0.000037309008,0.000042364238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000028849938,0.000049250677,0.00008880253,0.00006865581,0.000032048854,0.000002213357,0.000033789394,0.000036600843,0.0000033168474],"category_scores_gemma":[0.000010191244,0.000043541608,0.000031142015,0.000086432425,0.000014002639,0.000015519547,0.000014458672,0.00004166499,0.0000015940161],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001024961,0.02217523,0.81591564,0.010686177,0.0005442511,0.000022334127,0.007871434,0.006707284,0.086084306,0.008632226,0.0019371293,0.038399003],"study_design_scores_gemma":[0.025790973,0.00015138413,0.5909044,0.0056226216,0.0009009135,0.0000042511783,0.0004922727,0.323926,0.04660226,0.0030768684,0.0022351271,0.0002929039],"about_ca_topic_score_codex":0.0000036011068,"about_ca_topic_score_gemma":0.0000047516346,"teacher_disagreement_score":0.31721872,"about_ca_system_score_codex":0.000015676642,"about_ca_system_score_gemma":0.00021675872,"threshold_uncertainty_score":0.17755751},"labels":[],"label_agreement":null},{"id":"W4417011103","doi":"10.1182/blood-2025-1991","title":"Immune deconvolution from whole transcriptomic data suggests expansion of exhausted T-cells and natural killer cells following tyrosine kinase inhibitor therapy in chronic myeloid leukemia patients","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Immune system; Myeloid leukemia; Natural killer cell; Myeloid; Cell; Bone marrow; T cell; Mass cytometry","score_opus":0.010890297946859624,"score_gpt":0.24786212162729712,"score_spread":0.2369718236804375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417011103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810759,0.016445963,0.0000104036635,0.00005722392,0.00115067,0.0010627348,0.000114141,0.000050900875,0.000032104494],"genre_scores_gemma":[0.9962963,0.0011263395,0.00043115093,0.00007546414,0.00008597435,0.000028589726,0.0015173634,0.000042433247,0.00039639772],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977938,0.00008881982,0.00068800634,0.00070757046,0.00032365616,0.00039817198],"domain_scores_gemma":[0.99860626,0.000108054315,0.00015759053,0.0009647049,0.00006786801,0.000095516705],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017781078,0.00035094758,0.00066829595,0.00026370227,0.000068899135,0.00002145781,0.0002561029,0.00023030177,0.000035232286],"category_scores_gemma":[0.00003905741,0.00031781418,0.00012327808,0.00037813105,0.00008194721,0.00027420386,0.00015407041,0.00033789116,0.000011220583],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004688918,0.0007130751,0.022581343,0.00013789818,0.00032344673,0.000042062446,0.000306394,0.000009732726,0.9665637,0.0000013511516,0.00040251485,0.008449598],"study_design_scores_gemma":[0.05685184,0.00044362491,0.23995417,0.0014466346,0.00041789332,0.0000021779285,0.00008128207,0.0010526624,0.6988921,0.000011035458,0.0005860982,0.00026044494],"about_ca_topic_score_codex":0.0017495478,"about_ca_topic_score_gemma":0.0002802022,"teacher_disagreement_score":0.26767156,"about_ca_system_score_codex":0.0013151271,"about_ca_system_score_gemma":0.0009579384,"threshold_uncertainty_score":0.9999274},"labels":[],"label_agreement":null},{"id":"W4417011124","doi":"10.1182/blood-2025-1993","title":"ASC4OPT 96-week results: Asciminib once or twice daily continues to be highly efficacious and demonstrates favorable safety in patients with chronic myeloid leukemia and suboptimal response, resistance or intolerance to two or more tyrosine kinase inhibitors","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Discontinuation; Dosing; Cohort; Adverse effect; Clinical endpoint; Myeloid leukemia; Clinical trial; Cohort study; Tolerability","score_opus":0.009452666292112995,"score_gpt":0.2560672023998395,"score_spread":0.2466145361077265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417011124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920874,0.001305746,0.00002598479,0.003250329,0.00009443647,0.0024499872,0.0003230444,0.00013446776,0.00032858035],"genre_scores_gemma":[0.9812446,0.00019254311,0.008520233,0.0009952615,0.00008772753,0.00019668993,0.00008980756,0.00007353179,0.008599592],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9961862,0.00019106866,0.00094700104,0.001301854,0.0005436462,0.00083024916],"domain_scores_gemma":[0.99733734,0.0008971037,0.00022735991,0.00080257363,0.0002722627,0.00046333752],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005750697,0.0006242177,0.0009990467,0.00040744693,0.00023436919,0.00011204749,0.00024046119,0.00019382752,0.00001582431],"category_scores_gemma":[0.0014650964,0.00043948274,0.000045455636,0.0015179571,0.00028771893,0.00025193495,0.00021367034,0.00042951482,0.0000075357307],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8061994,0.0039663524,0.13766952,0.0015710776,0.0008550639,0.0030764889,0.0067193727,0.00052984327,0.014962586,0.00005759218,0.006014582,0.018378168],"study_design_scores_gemma":[0.14679575,0.013583345,0.7690399,0.008323448,0.00073754566,0.00010471961,0.0009495342,0.00009901895,0.041814327,0.000004450879,0.017403454,0.0011445006],"about_ca_topic_score_codex":0.0005407875,"about_ca_topic_score_gemma":0.008810838,"teacher_disagreement_score":0.6594036,"about_ca_system_score_codex":0.0018870292,"about_ca_system_score_gemma":0.0026466092,"threshold_uncertainty_score":0.9998057},"labels":[],"label_agreement":null},{"id":"W4417011144","doi":"10.1182/blood-2025-1997","title":"Asciminib (ASC) demonstrates continued improvement in patient-reported outcomes (PROs) vs investigator-selected tyrosine kinase inhibitors (IS-TKIs) in newly diagnosed chronic myeloid leukemia (CML): ASC4FIRST week 96 analysis","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Adverse effect; Quality of life (healthcare); Clinical trial; Randomized controlled trial; Nilotinib; Myeloid leukemia; Clinical endpoint; Tyrosine-kinase inhibitor","score_opus":0.009302172277035474,"score_gpt":0.24516943866969315,"score_spread":0.23586726639265768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417011144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99288946,0.0020560743,0.000009513074,0.0014431826,0.00027676334,0.002637382,0.00006685286,0.000234058,0.00038673164],"genre_scores_gemma":[0.99622965,0.00025019774,0.00050270546,0.0010610366,0.00008919329,0.00069655967,0.00051029114,0.00008265377,0.00057770876],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9940906,0.00018521414,0.0022088254,0.0014674949,0.00081371516,0.0012341355],"domain_scores_gemma":[0.99680644,0.00039190837,0.00066875224,0.0012624674,0.00032777598,0.0005426735],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004405765,0.0008918439,0.0019276917,0.0017835895,0.00014519165,0.000102373546,0.00032801388,0.0004931075,0.00017168997],"category_scores_gemma":[0.0016682016,0.0008366787,0.0004750924,0.0058264583,0.00027147835,0.0002523118,0.00020874453,0.0008207255,0.000031643558],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00030487435,0.0028510038,0.95157796,0.00027249227,0.0031668565,0.0016103601,0.00068999914,0.000099437166,0.033014167,0.000022637474,0.0009854551,0.005404732],"study_design_scores_gemma":[0.049041953,0.0013098887,0.7507973,0.0008579047,0.0041450686,0.00002184386,0.00031376965,0.00092918985,0.191318,0.00006773391,0.0005027723,0.0006946108],"about_ca_topic_score_codex":0.0064908895,"about_ca_topic_score_gemma":0.008498489,"teacher_disagreement_score":0.20078073,"about_ca_system_score_codex":0.0048015127,"about_ca_system_score_gemma":0.0057762773,"threshold_uncertainty_score":0.99986005},"labels":[],"label_agreement":null},{"id":"W4417011174","doi":"10.1182/blood-2025-1905","title":"Efficacy of brentuximab vedotin combination treatment in patients with relapsed or refractory diffuse large B-cell lymphoma with CD30 &amp;lt;1% expression","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Brentuximab vedotin; CD30; Lymphoma; Diffuse large B-cell lymphoma; Immunohistochemistry; Rituximab; Refractory (planetary science); Clinical endpoint","score_opus":0.007496286780307536,"score_gpt":0.23599997250196073,"score_spread":0.2285036857216532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417011174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997331,0.00028833593,0.000008815859,0.00006742369,0.000046335306,0.0011740528,0.000029148907,0.0000431153,0.0010117381],"genre_scores_gemma":[0.998011,0.00006497411,0.00049213145,0.00005624703,0.000010780168,0.00015433606,0.0002857176,0.000026259906,0.00089857075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986397,0.00006714672,0.0003300292,0.00037180466,0.000331807,0.00025948335],"domain_scores_gemma":[0.998995,0.0001522863,0.00018097089,0.00047852122,0.00010354286,0.0000896652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000056586196,0.00025954033,0.0004649712,0.0002065198,0.000059059388,0.000012442585,0.000067406676,0.00009904427,0.000025843812],"category_scores_gemma":[0.00003577038,0.00014648857,0.00006659957,0.00031298603,0.00003896062,0.00007067291,0.00003297488,0.00004569547,0.000010312991],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057878816,0.25482166,0.73336554,0.000117714575,0.00024684178,0.00006593319,0.0004497321,9.3126505e-7,0.0005331856,0.000042563872,0.00012859463,0.004439445],"study_design_scores_gemma":[0.29300034,0.00414741,0.68102324,0.0007193731,0.00051466987,0.0000022985325,0.000034989698,0.0000036895058,0.01937293,0.0000028769055,0.0010641292,0.00011404104],"about_ca_topic_score_codex":0.00009069045,"about_ca_topic_score_gemma":0.00011120951,"teacher_disagreement_score":0.28721246,"about_ca_system_score_codex":0.0003099714,"about_ca_system_score_gemma":0.00026038932,"threshold_uncertainty_score":0.59736305},"labels":[],"label_agreement":null},{"id":"W4417011270","doi":"10.1182/blood-2025-620","title":"Protac-mediated degradation of neutrophil elastase as a potential therapeutic strategy for ELANE-related neutropenia","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neutrophil elastase; Haematopoiesis; Myeloid; Bone marrow; Congenital Neutropenia; Neutropenia; Elastase; Progenitor cell","score_opus":0.00673999174391346,"score_gpt":0.2480394293661432,"score_spread":0.24129943762222975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417011270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99538654,0.0022621031,0.0003932177,0.00012775278,0.00007284293,0.0008295133,0.000090409,0.000015240923,0.0008223679],"genre_scores_gemma":[0.9977382,0.00011502971,0.0001197712,0.00008947222,0.000021438014,0.00012606902,0.0008446335,0.000017237779,0.00092815],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99919575,0.000049669645,0.0002298798,0.0002681863,0.00007145237,0.00018507156],"domain_scores_gemma":[0.9995359,0.000010873588,0.00009852842,0.00022378787,0.00009179553,0.00003910929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005940155,0.00014680052,0.00015491105,0.00005073557,0.000074386575,0.000017013996,0.00011820621,0.00014926899,0.0000140901175],"category_scores_gemma":[0.000022296163,0.00013077287,0.00010564101,0.00011842343,0.000042964217,0.000004066042,0.000033121618,0.000059418602,0.000005793156],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006905336,0.002488003,0.003940406,0.000095431424,0.0014325,0.000010845289,0.000016950271,0.00020709679,0.9811004,0.0013386562,0.00030865363,0.008370525],"study_design_scores_gemma":[0.024245713,0.003348118,0.0077681127,0.00004550955,0.0012629406,0.000028220727,0.00013874414,0.0002445179,0.9572749,0.0023836915,0.0028477667,0.00041176227],"about_ca_topic_score_codex":0.000035385143,"about_ca_topic_score_gemma":0.000024073815,"teacher_disagreement_score":0.023825495,"about_ca_system_score_codex":0.0000035736457,"about_ca_system_score_gemma":0.00013847092,"threshold_uncertainty_score":0.5332763},"labels":[],"label_agreement":null},{"id":"W4417011284","doi":"10.1182/blood-2025-626","title":"Integrating thymic expression patterns into tumor antigen selection enhances immunotherapy design and stratifies clinical responses to immunotherapies","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Institute of Infection and Immunity","funders":"","keywords":"CD8; Immunotherapy; Immunogenicity; T cell; Antigen; Immune system; T-cell receptor; Cancer immunotherapy; Cytotoxic T cell","score_opus":0.016412963641211715,"score_gpt":0.3079391022192009,"score_spread":0.2915261385779892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417011284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9443479,0.033675347,0.02014319,0.00027475928,0.0006522311,0.0006554274,0.000008173715,0.00017222579,0.0000707112],"genre_scores_gemma":[0.9882746,0.0040448266,0.0044533163,0.0006679797,0.0000401947,0.00013997874,0.000012944365,0.000036362217,0.0023298298],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964774,0.0016989892,0.00078594976,0.0005476839,0.000059006077,0.0004309691],"domain_scores_gemma":[0.99797064,0.0012870979,0.00020746968,0.0003995336,0.0001130007,0.000022249415],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012165948,0.00037000742,0.0005428932,0.0003473532,0.0006942481,0.0001316679,0.00037064092,0.00027956933,0.00021209993],"category_scores_gemma":[0.0003126559,0.0003035434,0.00014740096,0.00029462436,0.0002654856,0.00022807842,0.0000967294,0.0004593461,0.000049798186],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039764545,0.00037435867,0.018287197,0.000023936826,0.0005213478,0.0000028462052,0.002163678,0.0000015518311,0.9453466,0.00012383642,0.00020700025,0.028971212],"study_design_scores_gemma":[0.0027539968,0.0010932096,0.058372054,0.000438556,0.000039147915,0.000041836905,0.0013968749,0.0000031271813,0.92646134,0.00028547004,0.00878675,0.000327643],"about_ca_topic_score_codex":0.00022050066,"about_ca_topic_score_gemma":0.000029597146,"teacher_disagreement_score":0.043926634,"about_ca_system_score_codex":0.000026444855,"about_ca_system_score_gemma":0.0002134128,"threshold_uncertainty_score":0.99994165},"labels":[],"label_agreement":null},{"id":"W4417011298","doi":"10.1182/blood-2025-2369","title":"INO-transit: Inotuzumab ozogamicin treatment prior to chimeric antigen receptor T-cell therapy in Relapsed/Refractory B-cell acute lymphoblastic leukemia: Real-world patient characteristics and outcomes in Spain, the UK and US","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Société de Protection des Forêts contre les Insectes et Maladies","funders":"","keywords":"Blinatumomab; Chimeric antigen receptor; Gemtuzumab ozogamicin; Minimal residual disease; Salvage therapy; Acute lymphocytic leukemia; Cytokine release syndrome; Hematopoietic stem cell transplantation","score_opus":0.011148621871947857,"score_gpt":0.2673398979002521,"score_spread":0.2561912760283042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417011298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944978,0.0010672869,0.0000041172893,0.00068234245,0.00014115943,0.0021749807,0.000047875103,0.000036963214,0.001347474],"genre_scores_gemma":[0.9839186,0.011054668,0.0001596355,0.00084069173,0.00004769183,0.00014638357,0.000031791373,0.000051510753,0.003748992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977281,0.00021517747,0.00058798934,0.000596257,0.00032689143,0.0005455834],"domain_scores_gemma":[0.99863863,0.00042613692,0.00011177113,0.000572244,0.00006464225,0.0001865792],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000287161,0.00040726288,0.0007781313,0.0006114206,0.00010346617,0.00005172118,0.00015735893,0.0001584071,0.00012698978],"category_scores_gemma":[0.000044532102,0.0002839564,0.00009225598,0.00072850374,0.00012920565,0.00004032022,0.00009281337,0.00038563737,0.000013687],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00199737,0.0022939255,0.70779055,0.00010111146,0.00028369523,0.00019290039,0.003855434,0.000005302856,0.22656545,0.000008186931,0.000071240924,0.056834854],"study_design_scores_gemma":[0.022174807,0.0031766517,0.9215983,0.00021793444,0.00017605825,0.00001474178,0.00027786635,0.00006937729,0.04821357,0.0000103945895,0.0037434148,0.00032685956],"about_ca_topic_score_codex":0.0020399024,"about_ca_topic_score_gemma":0.0010670617,"teacher_disagreement_score":0.21380779,"about_ca_system_score_codex":0.00074270274,"about_ca_system_score_gemma":0.00052459294,"threshold_uncertainty_score":0.99996126},"labels":[],"label_agreement":null},{"id":"W4417011372","doi":"10.1182/blood-2025-2903","title":"Morbidity and mortality in 128 otherwise healthy Canadian children with severe iron deficiency anemia in the setting of ongoing bottle use and excessive cow's milk intake: A massive preventable problem demanding action","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital; Hospital for Sick Children","funders":"","keywords":"Anemia; Iron deficiency; Transferrin saturation; Ferritin; Malnutrition; Iron-deficiency anemia; Incidence (geometry); Soluble transferrin receptor","score_opus":0.015171982222464353,"score_gpt":0.2701675664033033,"score_spread":0.25499558418083895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417011372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972404,0.0010230307,0.000018287745,0.00030416204,0.000014622462,0.0008342101,0.000020115851,0.000007267296,0.0005378556],"genre_scores_gemma":[0.9990718,0.00021692658,0.00039733812,0.00023134133,0.000011811836,0.000028439863,0.000016026854,0.000008340129,0.000017971939],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990641,0.00010614258,0.00021496587,0.00023654164,0.00012749562,0.00025074376],"domain_scores_gemma":[0.99958974,0.000059304104,0.000103908176,0.00015194362,0.000023650004,0.000071480456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035337562,0.00011783889,0.00022629618,0.00017594127,0.00009938956,0.000025914012,0.00005165953,0.00006975919,0.0000048121838],"category_scores_gemma":[0.00006848853,0.000088156026,0.000013965818,0.0003299805,0.00005937184,0.00016554691,0.000021675141,0.00019815286,1.2900766e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005481584,0.0001335362,0.9964774,0.0004688529,0.000007070138,0.000008641292,0.001922124,0.000049718732,0.00020548409,0.00012883841,0.000018164843,0.0005253138],"study_design_scores_gemma":[0.0032301492,0.00008726717,0.9930143,0.00027628252,0.00014525485,0.000035879075,0.002743713,0.000028545395,0.00022035511,0.00012823535,0.0000048218585,0.00008521465],"about_ca_topic_score_codex":0.16599289,"about_ca_topic_score_gemma":0.3840933,"teacher_disagreement_score":0.21810044,"about_ca_system_score_codex":0.00006340463,"about_ca_system_score_gemma":0.00037440515,"threshold_uncertainty_score":0.8395608},"labels":[],"label_agreement":null},{"id":"W4417011385","doi":"10.1182/blood-2025-2908","title":"Ferroportin Q248H mutation is associated with the less weight loss in persons with HIV-1","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"","keywords":"Ferroportin; Hepcidin; Mutation; Peripheral blood mononuclear cell; Anemia; Mutant; Genotype; Cohort","score_opus":0.007861554269142375,"score_gpt":0.2378294425197631,"score_spread":0.22996788825062073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417011385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98038477,0.0004409549,0.00014928721,0.007559931,0.000026298349,0.00027914165,0.000012096814,0.00003562434,0.011111928],"genre_scores_gemma":[0.99342626,0.000016325805,0.00009119824,0.0013702132,0.000023881676,0.000027707298,0.00004420506,0.0000131298475,0.004987057],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992703,0.000040923987,0.00012401753,0.00017661853,0.00019902198,0.00018910684],"domain_scores_gemma":[0.9996251,0.000037488575,0.0000670363,0.00018052188,0.000055880515,0.00003399777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013404372,0.0001106858,0.00019007595,0.00008677924,0.00007021775,0.000012959629,0.00006473127,0.000057515685,0.000057972273],"category_scores_gemma":[0.000044788245,0.000061939005,0.00002886163,0.0004375007,0.0000876301,0.000041489322,0.000011566434,0.00016045824,0.000010064213],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039855446,0.0014108537,0.97994626,0.000096411786,0.00021257735,0.0004046316,0.0060577593,0.000018124934,0.00023341605,0.0011210222,0.008952426,0.0011479437],"study_design_scores_gemma":[0.016559927,0.00018308818,0.9702307,0.00025561982,0.0009881877,0.000040848015,0.0066207713,0.00006039163,0.0024901384,0.00009617248,0.002273884,0.00020028024],"about_ca_topic_score_codex":0.00011708139,"about_ca_topic_score_gemma":0.0005240233,"teacher_disagreement_score":0.016161373,"about_ca_system_score_codex":0.000016131246,"about_ca_system_score_gemma":0.00015957977,"threshold_uncertainty_score":0.25257993},"labels":[],"label_agreement":null},{"id":"W4417011392","doi":"10.1182/blood-2025-2910","title":"Iron deficiency at neonatal intensive care unit discharge in very preterm infants","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Neonatal intensive care unit; Incidence (geometry); Iron deficiency; Retrospective cohort study; Cohort; Cohort study; Intensive care; Iron supplementation","score_opus":0.008906312504602132,"score_gpt":0.25783642164998155,"score_spread":0.2489301091453794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417011392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97697896,0.009163899,0.0000074132813,0.00018333003,0.00022527724,0.0002987797,0.000025679077,0.000033459222,0.013083208],"genre_scores_gemma":[0.99748874,0.0001438654,0.000044476332,0.00088866265,0.000028180713,0.000016422453,0.00007776409,0.000011131377,0.0013007789],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991617,0.000023983346,0.00017807874,0.00023673808,0.00014501077,0.00025444484],"domain_scores_gemma":[0.99949795,0.000027208924,0.00003063797,0.0002710094,0.00011477702,0.00005841778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000044195873,0.00012850572,0.00021260898,0.00017047675,0.00005302626,0.000008514492,0.00009162016,0.00008322923,0.00007811339],"category_scores_gemma":[0.0002141133,0.00011168171,0.000056113447,0.00024617574,0.00006146423,0.00006257076,0.000118938835,0.00014857526,0.0000496383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026000582,0.00014430567,0.9852325,0.0005526412,0.000009380431,0.00009238908,0.006627156,0.0000024747922,0.0020638476,0.0006189954,0.00038037807,0.0040159663],"study_design_scores_gemma":[0.011326246,0.00015106428,0.96040606,0.000292316,0.00031358318,0.00003053836,0.0146002835,0.000007954007,0.009083809,0.00008658423,0.0034518125,0.00024974113],"about_ca_topic_score_codex":0.00010687752,"about_ca_topic_score_gemma":0.00016726909,"teacher_disagreement_score":0.024826393,"about_ca_system_score_codex":0.000022333566,"about_ca_system_score_gemma":0.0001022669,"threshold_uncertainty_score":0.4554248},"labels":[],"label_agreement":null},{"id":"W4417011416","doi":"10.1182/blood-2025-2917","title":"Multimodal evaluation of brain injury and cerebral iron deposition in thalassemia patients: A combined human-imaging and murine model study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Globus pallidus; Ferritin; Deferiprone; Subthalamic nucleus; Susceptibility weighted imaging; Magnetic resonance imaging; Deferasirox; Thalassemia; Montreal Cognitive Assessment","score_opus":0.00861742214584264,"score_gpt":0.2871903643479998,"score_spread":0.27857294220215717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417011416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979508,0.0002646529,0.000020730371,0.00028418138,0.000021405722,0.0008937181,0.000003876771,0.000015421265,0.0005451988],"genre_scores_gemma":[0.99972624,0.000011592424,0.00009796378,0.000079622245,0.000004468579,0.000025553729,0.000027619983,0.000007781285,0.000019168432],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99919295,0.00007719011,0.00023936966,0.00018753209,0.00019618993,0.00010679452],"domain_scores_gemma":[0.99969536,0.000018292707,0.00005279549,0.00010983927,0.00009106353,0.000032674736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002902292,0.0000932647,0.00017988254,0.00016341035,0.000047174886,0.000008272556,0.000022491546,0.0000568025,0.000002833191],"category_scores_gemma":[0.00007961527,0.00008437082,0.00001741638,0.00013051115,0.00003195686,0.0000633932,0.000046186142,0.00011992118,1.5606896e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014138385,0.0029773584,0.983094,0.00013094019,0.000046736637,0.0000028107893,0.0010267621,0.000107088286,0.0067761545,0.000041523588,0.000027747832,0.0056275227],"study_design_scores_gemma":[0.030289927,0.00058235,0.8549786,0.00027714678,0.0004980869,0.0000021124504,0.0014087899,0.11034688,0.0012237546,0.00029920254,2.925134e-7,0.00009281109],"about_ca_topic_score_codex":0.0001662811,"about_ca_topic_score_gemma":0.000053327316,"teacher_disagreement_score":0.12811533,"about_ca_system_score_codex":0.000028260558,"about_ca_system_score_gemma":0.00004351997,"threshold_uncertainty_score":0.3440542},"labels":[],"label_agreement":null},{"id":"W4417011492","doi":"10.1182/blood-2025-4734","title":"Standard transcranial doppler as a resource-efficient first step to screen for MRA-defined cerebral vasculopathy in adults with sickle cell disease","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hatch (Canada); HEC Montréal; Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Transcranial Doppler; Neurovascular bundle; Middle cerebral artery; Stroke (engine); Magnetic resonance imaging; Magnetic resonance angiography; Cerebral arteries; Stenosis; Disease","score_opus":0.003460592539347515,"score_gpt":0.20938871880918983,"score_spread":0.2059281262698423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417011492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98294365,0.0007885466,0.001626913,0.0050925645,0.00006756899,0.0026921132,0.00022499061,0.00010105573,0.0064625777],"genre_scores_gemma":[0.99630034,0.000030011715,0.0013425228,0.0009999432,0.00006625196,0.00019230912,0.0000879068,0.000045086003,0.00093563844],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99827784,0.00003256684,0.00033710658,0.0005034985,0.00035430214,0.00049468665],"domain_scores_gemma":[0.9990591,0.00006445805,0.000041879324,0.0003763426,0.00009504034,0.0003631744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017867259,0.00025722777,0.00040673462,0.0002231327,0.00013597951,0.000025421703,0.00013005719,0.0001303692,0.00007772445],"category_scores_gemma":[0.00007918683,0.00019655953,0.0001792537,0.0005460331,0.00005921779,0.000023507362,0.00003425838,0.00021406153,0.000020704227],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4189841,0.05426894,0.29762098,0.019927224,0.0030771818,0.004133584,0.05025796,0.026887244,0.002782707,0.0070227487,0.08223622,0.032801133],"study_design_scores_gemma":[0.48318958,0.02168468,0.112813644,0.015432218,0.0070213648,0.00010512241,0.015285717,0.008048484,0.006542496,0.0002877228,0.3263059,0.0032830746],"about_ca_topic_score_codex":0.00023963948,"about_ca_topic_score_gemma":0.00039212563,"teacher_disagreement_score":0.24406968,"about_ca_system_score_codex":0.00005998585,"about_ca_system_score_gemma":0.0003477813,"threshold_uncertainty_score":0.8015465},"labels":[],"label_agreement":null},{"id":"W4417011606","doi":"10.1182/blood-2025-5806","title":"Incidence and characteristics of infections in patients with multiple myeloma treated with BCMA bispecific antibodies in British Columbia","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lions Gate Hospital; St. Paul's Hospital; Vancouver General Hospital; Hôtel-Dieu de Québec; BC Cancer Agency","funders":"","keywords":"Incidence (geometry); Multiple myeloma; Moxifloxacin; Expanded access; Cumulative incidence; Adverse effect; Refractory (planetary science); Neutropenia; Logistic regression","score_opus":0.0064101776179931605,"score_gpt":0.23432131241062235,"score_spread":0.22791113479262917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417011606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99897367,0.00012854206,0.0000019032449,0.000042441272,0.0000107145015,0.00037234472,0.00006365016,0.000011957743,0.00039477897],"genre_scores_gemma":[0.99880236,0.00019823387,0.0001539114,0.00002293401,0.000009398309,0.000018126597,0.00005026796,0.000008053585,0.0007367361],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992061,0.000028941757,0.00021854184,0.00019238783,0.0001736858,0.00018032723],"domain_scores_gemma":[0.99955785,0.00009365909,0.00004650148,0.00010956697,0.00014262376,0.0000497736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006171271,0.00007736072,0.00029620784,0.00014514543,0.00005036955,0.000035717025,0.000041719988,0.000048334397,0.000023742456],"category_scores_gemma":[0.00007958617,0.00008102516,0.000015712412,0.00046809966,0.00017862367,0.000055613058,0.000043248947,0.00015515125,9.71064e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002847962,0.0011788834,0.9941998,0.00018756402,0.000053188025,0.00010617689,0.0000609999,2.675651e-7,0.00027475663,0.000004613372,0.000029784125,0.0036191563],"study_design_scores_gemma":[0.0049911025,0.0007067305,0.99275094,0.0009845109,0.00003620952,0.00002567081,0.000043222062,0.000020183199,0.00023712753,0.0000062316135,0.00011683004,0.000081264305],"about_ca_topic_score_codex":0.02001182,"about_ca_topic_score_gemma":0.10698915,"teacher_disagreement_score":0.08697733,"about_ca_system_score_codex":0.000017770224,"about_ca_system_score_gemma":0.00007717865,"threshold_uncertainty_score":0.98651403},"labels":[],"label_agreement":null},{"id":"W4417011616","doi":"10.1182/blood-2025-5807","title":"Trial in progress: A phase 1 study to evaluate the safety and preliminary efficacy of arlocabtagene autoleucel (arlo-cel), a GPRC5D-targeted chimeric antigen receptor (CAR) T cell therapy, in combination with mezigdomide (MEZI) in patients (pts) with relapsed/refractory multiple myeloma (RRMM)","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Chimeric antigen receptor; T cell; Clinical trial; Phases of clinical research; Cytotoxicity; Hematopoietic stem cell transplantation; Antigen; Stem cell","score_opus":0.016471332803316262,"score_gpt":0.3027173890597998,"score_spread":0.2862460562564835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417011616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849818,0.0008220645,0.000009004537,0.00023938807,0.00006951997,0.013693961,0.000016497108,0.00003814225,0.00012965231],"genre_scores_gemma":[0.9984964,0.00015270866,0.00029928118,0.0000575273,0.000027407357,0.0006172351,0.000067166446,0.00006219841,0.00022008727],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9960425,0.0009771731,0.0008663608,0.00072086195,0.00088983367,0.0005032898],"domain_scores_gemma":[0.99825495,0.00048082237,0.00021599905,0.0006771697,0.00023943352,0.00013163553],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016150359,0.00038417036,0.0008587226,0.00082739483,0.00008395432,0.00003083022,0.0002862707,0.00012221921,0.000070101996],"category_scores_gemma":[0.00024172322,0.00025607474,0.00006877842,0.0019063413,0.00019019979,0.000121985635,0.00012700749,0.00057539286,0.0000025204884],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4532793,0.058246564,0.40816155,0.00009941815,0.000326558,0.00005584069,0.007947551,0.00006756978,0.02616641,0.0000012518409,0.00001744057,0.045630574],"study_design_scores_gemma":[0.44490728,0.038851548,0.49924603,0.0003836327,0.000112090136,0.0000016343514,0.0008510907,0.00042213761,0.0149330245,0.0000023791058,0.00008374503,0.0002054258],"about_ca_topic_score_codex":0.00041910348,"about_ca_topic_score_gemma":0.00037373995,"teacher_disagreement_score":0.09108449,"about_ca_system_score_codex":0.00020549311,"about_ca_system_score_gemma":0.00050102494,"threshold_uncertainty_score":0.99998915},"labels":[],"label_agreement":null},{"id":"W4417011663","doi":"10.1182/blood-2025-790","title":"Low-dose oral decitabine and cedazuridine among patients with low-risk myelodysplastic syndromes","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; London Health Sciences Centre","funders":"","keywords":"Decitabine; Cytopenia; Myelodysplastic syndromes; Azacitidine; Regimen; Clinical endpoint; Phases of clinical research; Dosing; Pharmacodynamics; Neutropenia","score_opus":0.005410488145994367,"score_gpt":0.23866160926690638,"score_spread":0.233251121120912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417011663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973722,0.00022432007,0.00010259933,0.00020977526,0.000077216,0.0007310782,0.000039211813,0.000094473486,0.0011491037],"genre_scores_gemma":[0.99700046,0.000105436324,0.00084713765,0.00012858571,0.000052315132,0.000047691286,0.00006910753,0.000041290114,0.0017079747],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825734,0.000063742926,0.0002776421,0.00046622055,0.00044533034,0.0004897537],"domain_scores_gemma":[0.9987502,0.00022865426,0.00007825317,0.0004443608,0.00022711727,0.00027138653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019041197,0.00026236908,0.00045512925,0.00031480147,0.0001340712,0.000043374992,0.00014475903,0.00012250002,0.00009226084],"category_scores_gemma":[0.0005391,0.00019278452,0.000051221345,0.0005903736,0.00025217645,0.00013241777,0.00018040997,0.00044719776,0.00004213728],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062763836,0.0010588963,0.9931798,0.0003381615,0.00046486192,0.0002740876,0.000080136575,0.0000057874545,0.0003559287,0.000051733987,0.0011073622,0.0024556024],"study_design_scores_gemma":[0.019979062,0.00085952843,0.97391343,0.00059075124,0.00061813276,0.00004030884,0.00004674747,0.00024788946,0.0032178129,0.00004283377,0.0002378064,0.00020571855],"about_ca_topic_score_codex":0.00008407011,"about_ca_topic_score_gemma":0.000048362752,"teacher_disagreement_score":0.019351423,"about_ca_system_score_codex":0.00009518493,"about_ca_system_score_gemma":0.0002928628,"threshold_uncertainty_score":0.7861524},"labels":[],"label_agreement":null},{"id":"W4417011691","doi":"10.1182/blood-2025-910","title":"Durable efficacy and long-term safety with pelabresib plus ruxolitinib in JAK Inhibitor–Naive myelofibrosis: 96-week Results from the Phase III MANIFEST-2 study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ruxolitinib; Discontinuation; Clinical endpoint; Adverse effect; Phases of clinical research; Myelofibrosis; Placebo; Clinical trial","score_opus":0.017388750860584338,"score_gpt":0.2848147305685922,"score_spread":0.26742597970800785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417011691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99054974,0.0012778194,0.0000068618738,0.0026127035,0.00008854081,0.0030008256,0.00021478868,0.00006316918,0.0021855645],"genre_scores_gemma":[0.9977132,0.00031675826,0.00013728102,0.00045548752,0.00017903667,0.00029729016,0.0001962667,0.000030125208,0.0006745281],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99760437,0.00019513314,0.0006479357,0.00076867477,0.00037251145,0.00041134536],"domain_scores_gemma":[0.998015,0.0009139109,0.00015763329,0.0006329847,0.00011631072,0.00016416116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031234897,0.0003892605,0.0006813431,0.00012185427,0.0002632019,0.00009455174,0.00014054884,0.00010615935,0.00004429692],"category_scores_gemma":[0.00017711452,0.00024011369,0.00006235475,0.0003724981,0.00012344318,0.00010068806,0.00012516772,0.00033344634,0.000017560575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019283723,0.02503329,0.9396165,0.000088043496,0.0015527142,0.0018492813,0.008262033,0.00000917552,0.00043969112,0.00021918905,0.0008870233,0.0027593537],"study_design_scores_gemma":[0.14745498,0.0033875143,0.84089935,0.0010943322,0.0010705041,0.0000440629,0.0017512962,0.000012928168,0.0038289777,0.000018107348,0.0002270197,0.0002109507],"about_ca_topic_score_codex":0.0011541845,"about_ca_topic_score_gemma":0.0018542326,"teacher_disagreement_score":0.12817125,"about_ca_system_score_codex":0.00011085637,"about_ca_system_score_gemma":0.00029182222,"threshold_uncertainty_score":0.97915524},"labels":[],"label_agreement":null},{"id":"W4417011724","doi":"10.1182/blood-2025-914","title":"Enhanced efficacy of TRAIL or TRAIL-CD28 chimera armored anti-BCMA CAR T cells in multiple myeloma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Chimeric antigen receptor; Chimera (genetics); CD28; T cell; Multiple myeloma; Immunotherapy; Jurkat cells; Cell culture; Receptor","score_opus":0.025723857366887964,"score_gpt":0.3050658594412568,"score_spread":0.2793420020743688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417011724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99221873,0.0003302192,0.00004462091,0.00026436558,0.00013647765,0.0010852573,0.000028314522,0.000062189436,0.0058298125],"genre_scores_gemma":[0.98991627,0.00018334034,0.00049712963,0.00013608043,0.00010852132,0.000046948982,0.000023701698,0.0000393549,0.00904864],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980505,0.00010843586,0.00051610084,0.00043840497,0.00040266383,0.0004838626],"domain_scores_gemma":[0.99871343,0.00040152407,0.00007702371,0.00056662614,0.000102010184,0.00013940538],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003050137,0.00022661845,0.00067577756,0.00038197314,0.00004228019,0.000014560709,0.00023785513,0.00016812666,0.0013280525],"category_scores_gemma":[0.00026187737,0.00019117602,0.00019372298,0.00088262715,0.00014864726,0.000043400978,0.000057938974,0.00038077208,0.000032063974],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013330152,0.002061101,0.0028298695,0.00023798287,0.0002366363,0.00011461987,0.0011584916,0.000008600941,0.9656354,0.000013255288,0.00017904349,0.026191978],"study_design_scores_gemma":[0.020002425,0.00038962855,0.123646714,0.0002483172,0.00011395339,0.00001124246,0.00016648161,0.000102629274,0.8538312,0.000009408604,0.0013340991,0.00014395769],"about_ca_topic_score_codex":0.00012115806,"about_ca_topic_score_gemma":0.00012536548,"teacher_disagreement_score":0.12081684,"about_ca_system_score_codex":0.00004798582,"about_ca_system_score_gemma":0.00036659924,"threshold_uncertainty_score":0.99958485},"labels":[],"label_agreement":null},{"id":"W4417011761","doi":"10.1182/blood-2025-1549","title":"Impact of therapy delays on outcomes in adults with BCR::ABL1 negative b-lineage acute lymphoblastic leukemia (ALL) in the ECOG-ACRIN E1910 trial randomized to conventional chemotherapy +/- blinatumomab","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Blinatumomab; Chemotherapy; Randomized controlled trial; Minimal residual disease; Lymphoblastic Leukemia; Maintenance therapy; Induction chemotherapy; Chemotherapy regimen","score_opus":0.015167490870442765,"score_gpt":0.3304657498964627,"score_spread":0.31529825902601993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417011761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99168396,0.00007098844,0.00021473582,0.001178807,0.000100325036,0.0055056512,0.000065671775,0.000034763696,0.0011451218],"genre_scores_gemma":[0.9965611,0.0001770552,0.0005849481,0.0013752768,0.000093419985,0.0007090423,0.000048437225,0.000047423146,0.00040330473],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9964359,0.00054307247,0.00094747636,0.0005737738,0.0008863499,0.00061341946],"domain_scores_gemma":[0.9955008,0.003272817,0.00023534553,0.00061438413,0.0002310652,0.00014556614],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012809325,0.00046048214,0.0015343314,0.0007965568,0.000051241237,0.000037918653,0.00047864715,0.00020577198,0.0001349099],"category_scores_gemma":[0.0010372521,0.00025266997,0.00048151703,0.0011908744,0.0002761518,0.000092354996,0.00006248103,0.0004951744,0.00001875419],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97995883,0.0040421793,0.008511643,0.00007308818,0.0024725918,0.00033665533,0.0020349503,0.00020415931,0.0008413809,0.0003388449,0.000388768,0.0007968829],"study_design_scores_gemma":[0.9366369,0.0053544156,0.05010351,0.00064573763,0.00024907006,0.00004677178,0.00022481313,0.0018295597,0.004480827,0.00017265182,0.00002211072,0.0002335775],"about_ca_topic_score_codex":0.0009039448,"about_ca_topic_score_gemma":0.00015872833,"teacher_disagreement_score":0.043321904,"about_ca_system_score_codex":0.0011276657,"about_ca_system_score_gemma":0.0026570417,"threshold_uncertainty_score":0.99999255},"labels":[],"label_agreement":null},{"id":"W4417011959","doi":"10.1182/blood-2025-2168","title":"Characterization of the plasma proteome of multiple myeloma and its precursor conditions and identification of a prognostic high-risk signature of progression","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Multiple myeloma; Monoclonal gammopathy of undetermined significance; Proteome; Bone marrow; Disease; Plasma cell; Plasma cell neoplasm; Myeloma protein; Waldenstrom macroglobulinemia","score_opus":0.008905233685841098,"score_gpt":0.27248066089474854,"score_spread":0.2635754272089074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417011959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996966,0.00023417271,0.000019058447,0.00009462096,0.00002034506,0.0022147056,0.0004297841,0.00000695999,0.0000143310335],"genre_scores_gemma":[0.9993832,0.0000831717,0.00017706424,0.0000014376625,0.000006566637,0.00013641824,0.00011417125,0.000006030022,0.00009195712],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99917984,0.0000749138,0.0003134786,0.00013866725,0.0002112012,0.00008188454],"domain_scores_gemma":[0.9990681,0.0001125462,0.00035830302,0.0001614902,0.00026482277,0.000034776273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011329125,0.00007588477,0.00021513655,0.00012262576,0.000041163385,0.0000035711935,0.000050709754,0.00007401855,0.00000449086],"category_scores_gemma":[0.0006830006,0.00005011144,0.0000328336,0.00025565582,0.00011949301,0.00005499714,0.000046560664,0.00007897996,1.8910949e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017496591,0.00069346296,0.30032623,0.000963379,0.00013974617,6.814667e-7,0.00017101364,3.2275122e-7,0.6958,0.000087340566,0.0000011329305,0.0016417402],"study_design_scores_gemma":[0.0020771676,0.00017690205,0.5014239,0.0004720387,0.00016604709,0.000001930597,0.000014695132,0.00027471117,0.49534276,0.000032692118,0.0000010746478,0.000016060636],"about_ca_topic_score_codex":0.000012351561,"about_ca_topic_score_gemma":0.0000056801,"teacher_disagreement_score":0.2010977,"about_ca_system_score_codex":0.000005234647,"about_ca_system_score_gemma":0.000073237476,"threshold_uncertainty_score":0.20434853},"labels":[],"label_agreement":null},{"id":"W4417011989","doi":"10.1182/blood-2025-2178","title":"Tumor intrinsic mechanisms leading to cevostamab resistance in multiple myeloma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Frameshift mutation; Transcriptome; Romidepsin; Multiple myeloma; Exome sequencing; Bone marrow; Exome; Mutation","score_opus":0.02039897027117914,"score_gpt":0.29339179084607436,"score_spread":0.2729928205748952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417011989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96970904,0.0005416795,0.00042467855,0.0019036396,0.00014631607,0.0008971521,0.000006408143,0.00009207794,0.02627899],"genre_scores_gemma":[0.96421427,0.000019703879,0.0045217243,0.0009271475,0.000078192905,0.000089128655,0.0000045091606,0.000027258617,0.030118056],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998627,0.000054217002,0.00024882104,0.0003585204,0.0002998032,0.00041162389],"domain_scores_gemma":[0.9991606,0.0001593818,0.000024997422,0.00044579178,0.00007919123,0.00013002135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003397911,0.00013494359,0.00030910934,0.00042606564,0.000055846005,0.00002646098,0.0001631949,0.00006034292,0.00035914977],"category_scores_gemma":[0.00046159467,0.00013462933,0.0000628484,0.00090361986,0.000029190998,0.000038576585,0.0001078118,0.0002800662,0.00013309724],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010710272,0.0006164791,0.009712164,0.00023336447,0.000090194386,0.00061905617,0.0005110237,0.0000019284757,0.96675617,0.004847397,0.0014491419,0.014092088],"study_design_scores_gemma":[0.012908372,0.00038058046,0.06767484,0.0009617627,0.000076909884,0.000030278235,0.00035165084,0.000031909563,0.8718037,0.003567234,0.041905142,0.00030764434],"about_ca_topic_score_codex":0.00005453825,"about_ca_topic_score_gemma":0.00088190817,"teacher_disagreement_score":0.09495246,"about_ca_system_score_codex":0.00014854355,"about_ca_system_score_gemma":0.00016761674,"threshold_uncertainty_score":0.54900247},"labels":[],"label_agreement":null},{"id":"W4417012025","doi":"10.1182/blood-2025-3037","title":"The platelet variability index tool to determine the likelihood of immune thrombocytopenia (ITP): User testing and tool refinement","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Thrombosis and Atherosclerosis Research Institute; University of British Columbia; McMaster University Medical Centre","funders":"","keywords":"Metric (unit); Usability; Immune thrombocytopenia; Cohort; Platelet; Likert scale; Workflow; Cohort study","score_opus":0.012558933395957282,"score_gpt":0.25475429507192926,"score_spread":0.24219536167597197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417012025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99325556,0.00043852304,0.00003905376,0.0020191115,0.00007103971,0.0009066149,0.000011017837,0.000025178382,0.0032339103],"genre_scores_gemma":[0.9981572,0.000048824993,0.000865573,0.00038442455,0.000025302332,0.00007826794,0.000004626881,0.00001097165,0.00042481415],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882084,0.00005298476,0.0004316213,0.00025566222,0.00018184702,0.0002570709],"domain_scores_gemma":[0.99856395,0.00062528846,0.0000949701,0.00057082647,0.00010455134,0.000040431907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005648457,0.00016755136,0.00039208116,0.00003919155,0.00022704856,0.000030338251,0.00015547115,0.00006180937,0.000028372175],"category_scores_gemma":[0.0009164917,0.00008694953,0.000053030435,0.00029648846,0.00009708965,0.000037456666,0.00018452416,0.0001362125,0.0000047784324],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094816444,0.0032067276,0.5716699,0.00043136688,0.0020506955,0.00023826852,0.00095581746,0.000008657179,0.062107347,0.0015282525,0.0014427609,0.35541207],"study_design_scores_gemma":[0.008762594,0.0007683947,0.96250314,0.00032940923,0.0005141168,0.00009090154,0.00014762151,0.00013423875,0.017195303,0.0025846146,0.006778054,0.00019160402],"about_ca_topic_score_codex":0.0003107759,"about_ca_topic_score_gemma":0.000065612316,"teacher_disagreement_score":0.39083326,"about_ca_system_score_codex":0.00002331596,"about_ca_system_score_gemma":0.000094144845,"threshold_uncertainty_score":0.35456988},"labels":[],"label_agreement":null},{"id":"W4417012034","doi":"10.1182/blood-2025-3041","title":"Shared decision making for immune thrombocytopenia (ITP) treatment: Data from the ITP natural history study registry","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"","keywords":"Immune thrombocytopenia; Hematologist; Natural history; Context (archaeology); Prospective cohort study; Public health; Clinical trial; MEDLINE","score_opus":0.09065338357536007,"score_gpt":0.35822138431268125,"score_spread":0.2675680007373212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417012034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98376304,0.0073286584,0.00012844929,0.0008511601,0.0013299433,0.0027590774,0.00030900486,0.00015226274,0.0033784125],"genre_scores_gemma":[0.99436164,0.000096652446,0.002320332,0.0005047578,0.00035066652,0.00018116896,0.0006665031,0.000055291075,0.0014629893],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974741,0.00011449719,0.0006314508,0.0010085455,0.00033715327,0.00043425855],"domain_scores_gemma":[0.9953517,0.00095738575,0.00020218886,0.0032762848,0.00012245092,0.00009003316],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040712132,0.00040643162,0.0010146181,0.00010169895,0.0003608879,0.0000971011,0.001161082,0.00017975476,0.00030028322],"category_scores_gemma":[0.000615442,0.0002753573,0.00022457163,0.0002570655,0.00010346002,0.00026152964,0.0006425272,0.0003443342,0.000071705996],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077735824,0.036849577,0.4358925,0.00050689245,0.025360022,0.0009623866,0.014454306,0.0000039976912,0.23604167,0.0021424273,0.12059641,0.11941624],"study_design_scores_gemma":[0.029862633,0.0012518207,0.87597257,0.0011806826,0.007123476,0.000045952274,0.002549369,0.00036873968,0.0052868905,0.0007463579,0.0749607,0.0006508395],"about_ca_topic_score_codex":0.00087708776,"about_ca_topic_score_gemma":0.00085511775,"teacher_disagreement_score":0.44008005,"about_ca_system_score_codex":0.0004919811,"about_ca_system_score_gemma":0.0005656836,"threshold_uncertainty_score":0.99996984},"labels":[],"label_agreement":null},{"id":"W4417012043","doi":"10.1182/blood-2025-1581","title":"Trial in progress: nutrition and exercise to optimize muscle and adiposity in adolescents and young adults with B-cell acute lymphocytic leukemia: The neoma ALL trial","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Memorial University of Newfoundland","funders":"","keywords":"Young adult; Obesity; Clinical trial; Acute lymphocytic leukemia; Metabolic syndrome; Randomized controlled trial","score_opus":0.009936649361070481,"score_gpt":0.26530638389400596,"score_spread":0.2553697345329355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417012043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99035454,0.00386713,0.0000051615452,0.0009937411,0.00014461007,0.0045333984,0.000011511804,0.000032888118,0.0000570291],"genre_scores_gemma":[0.99762243,0.00077853206,0.0005863681,0.000504056,0.0001439488,0.0003043792,0.000009807281,0.0000167472,0.000033724322],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99852103,0.00012862214,0.00037808352,0.00045405474,0.0002503088,0.00026788702],"domain_scores_gemma":[0.99941266,0.00006113201,0.00008259382,0.00026056473,0.00003761745,0.00014541407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042715628,0.0002021678,0.0004838492,0.00015972812,0.000059524737,0.000060806142,0.00008783712,0.00013225169,0.0000011795107],"category_scores_gemma":[0.00006144967,0.00015616053,0.000033036285,0.00028365996,0.00011175605,0.000095138705,0.000104741936,0.00022450589,6.2881924e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9233706,0.004584752,0.046159577,0.002478683,0.00024261954,0.000302539,0.011997661,0.000005324179,0.00022147669,0.0000116679585,0.00037818548,0.010246919],"study_design_scores_gemma":[0.9087806,0.002067628,0.08054141,0.0057884767,0.00076991203,0.000045296874,0.0008391,0.00017563882,0.0006602,0.000029109993,0.000074652264,0.00022802337],"about_ca_topic_score_codex":0.0013356532,"about_ca_topic_score_gemma":0.0017407192,"teacher_disagreement_score":0.034381833,"about_ca_system_score_codex":0.0001991858,"about_ca_system_score_gemma":0.0003251747,"threshold_uncertainty_score":0.63680416},"labels":[],"label_agreement":null},{"id":"W4417012067","doi":"10.1182/blood-2025-1584","title":"EZH2 inactivation cooperates with HOXA9 to induce leukemic transformation of human t-cell progenitors and sustain high-risk subsets of early t-cell precursor acute lymphoblastic leukemia (ETP-ALL)","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"EZH2; Haematopoiesis; Progenitor cell; Leukemia; Gene; Epigenetics; Cord blood; Flow cytometry; Malignant transformation; Transformation (genetics)","score_opus":0.006932369945181501,"score_gpt":0.25086558365015116,"score_spread":0.24393321370496965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417012067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99629515,0.00012017244,0.00070052943,0.00010242272,0.000041161617,0.0019350436,0.000070504495,0.000060348833,0.0006746529],"genre_scores_gemma":[0.9982057,0.00007814011,0.0008270719,0.00005079447,0.000042525262,0.00012677292,0.00009682132,0.000051339066,0.00052082055],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976156,0.000133471,0.0006853927,0.00046219872,0.0006236938,0.00047966282],"domain_scores_gemma":[0.9981867,0.00024340783,0.00028390094,0.00041809288,0.00064293575,0.00022496299],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033844914,0.00033426026,0.0006322463,0.0006246075,0.000120923636,0.00003792918,0.00022741144,0.00025879047,0.000010717615],"category_scores_gemma":[0.0001300493,0.00028710772,0.00006774803,0.0010624034,0.0002029114,0.00027134872,0.000079239595,0.0003211688,0.0000074584636],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002331921,0.00095480355,0.020535797,0.0016266407,0.0006198392,0.000028496532,0.003675816,0.0001092104,0.9681894,0.0003086916,0.00021447803,0.0014048658],"study_design_scores_gemma":[0.018020429,0.0037607013,0.03273268,0.0004972012,0.0013176284,0.000028704619,0.00071744516,0.0003016526,0.942278,0.000061247105,0.00002425706,0.00026001924],"about_ca_topic_score_codex":0.0012926107,"about_ca_topic_score_gemma":0.000048529524,"teacher_disagreement_score":0.025911406,"about_ca_system_score_codex":0.0009138152,"about_ca_system_score_gemma":0.0023097899,"threshold_uncertainty_score":0.9999581},"labels":[],"label_agreement":null},{"id":"W4417012091","doi":"10.1182/blood-2025-5479","title":"Zilovertamab vedotin plus R-CHP versus R-CHOP for first-line treatment of diffuse large B-cell lymphoma: The phase 3 waveline-010 study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rituximab; Brentuximab vedotin; Prednisone; Diffuse large B-cell lymphoma; International Prognostic Index; Phases of clinical research; Lymphoma; Neutropenia; Bendamustine","score_opus":0.027065021891596163,"score_gpt":0.3250178730099192,"score_spread":0.29795285111832304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417012091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912663,0.0024797902,0.000055133765,0.000996185,0.0004384344,0.003170985,0.00027219308,0.00005793689,0.0012630245],"genre_scores_gemma":[0.9963439,0.00045766166,0.00016577092,0.00016270432,0.00019442008,0.0008054211,0.00011479684,0.000033403205,0.0017218997],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99830633,0.000045295288,0.00051230704,0.00045699903,0.0002739872,0.00040508236],"domain_scores_gemma":[0.9981236,0.0006580215,0.0001554147,0.00080144155,0.00014002714,0.00012148188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013672895,0.00035629945,0.00067921693,0.000110825276,0.00020458606,0.000024534997,0.00015156933,0.00009937538,0.000035697896],"category_scores_gemma":[0.00011817169,0.00021571926,0.0003621388,0.00025300315,0.00004783573,0.000034478682,0.000063293424,0.000037577658,0.000021203887],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014070981,0.9132392,0.030443722,0.00036789704,0.0055159847,0.00042630447,0.003444339,0.000010523431,0.0006529899,0.0008357436,0.002693733,0.028298588],"study_design_scores_gemma":[0.890568,0.018149776,0.013330039,0.00011031614,0.0074452767,0.000011544947,0.0013068437,0.0006596217,0.03999556,0.000038596656,0.028121991,0.0002624117],"about_ca_topic_score_codex":0.00023465228,"about_ca_topic_score_gemma":0.00032317638,"teacher_disagreement_score":0.8950894,"about_ca_system_score_codex":0.00030670903,"about_ca_system_score_gemma":0.00032097384,"threshold_uncertainty_score":0.8796776},"labels":[],"label_agreement":null},{"id":"W4417012274","doi":"10.1182/blood-2025-3735","title":"Fixed-duration intravenous mosunetuzumab plus polatuzumab vedotin combination therapy continues to demonstrate durable responses in patients with large B-cell lymphoma: 3-year follow-up from a Phase Ib/II study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Saskatchewan Cancer Agency; University of Saskatchewan; McGill University; Jewish General Hospital","funders":"","keywords":"Clinical endpoint; Follicular lymphoma; Refractory (planetary science); Regimen; Phases of clinical research; Salvage therapy; Lymphoma; Combination therapy","score_opus":0.011221494668720168,"score_gpt":0.2776723305511716,"score_spread":0.2664508358824514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417012274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99420345,0.0002843477,0.00007268785,0.00022074254,0.000157355,0.0037345057,0.00010124832,0.00010285952,0.0011228136],"genre_scores_gemma":[0.9936492,0.000044187647,0.00018981728,0.00018376972,0.00004731155,0.0002039481,0.0002625251,0.000055616038,0.005363636],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9971466,0.00037710078,0.0005725939,0.0006233069,0.0006909392,0.00058945693],"domain_scores_gemma":[0.99851984,0.00021328677,0.00014146067,0.0005968226,0.00036638582,0.0001622129],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005348154,0.00032769766,0.00059775665,0.0005367846,0.00025629438,0.00010205149,0.00022385761,0.00015102814,0.0002065707],"category_scores_gemma":[0.000192365,0.00029083266,0.00008064299,0.0009504276,0.000050281127,0.00016411474,0.00009661626,0.00026470897,0.000023949015],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12420034,0.121953845,0.5925055,0.000097951204,0.0012418005,0.00034502562,0.016701119,0.000007998087,0.101412185,0.00013137975,0.0007315784,0.04067129],"study_design_scores_gemma":[0.4912271,0.020990498,0.41163337,0.0003053591,0.00027178775,0.0000039155825,0.002872377,0.00021589607,0.070672415,0.000117408315,0.001207299,0.0004826005],"about_ca_topic_score_codex":0.0009004711,"about_ca_topic_score_gemma":0.00088701275,"teacher_disagreement_score":0.36702675,"about_ca_system_score_codex":0.000390393,"about_ca_system_score_gemma":0.0007151118,"threshold_uncertainty_score":0.9999544},"labels":[],"label_agreement":null},{"id":"W4417012355","doi":"10.1182/blood-2025-4239","title":"Multicenter real-world experience of belumosudil treatment in heavily pretreated patients with steroid-refractory chronic graft-versus-host disease: Clinical outcomes and risk factor analysis for failure-free survival.","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Hôpital Maisonneuve-Rosemont; University Health Network; Saskatchewan Cancer Agency; Princess Margaret Cancer Centre; University of Calgary; McMaster University; University of Toronto; Hamilton Health Sciences; Université de Montréal; Université Laval; BC Cancer Agency","funders":"","keywords":"Clinical endpoint; Adverse effect; Retrospective cohort study; Clinical trial; Cohort; Risk factor; Randomized controlled trial; Cohort study; Disease","score_opus":0.022027986741953096,"score_gpt":0.3226872820268716,"score_spread":0.30065929528491847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417012355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972919,0.00014977602,0.0001908634,0.00006554572,0.00009309601,0.0014922812,0.0006224135,0.000032033447,0.00006206391],"genre_scores_gemma":[0.9984455,0.00038248865,0.0005646304,0.000012616456,0.000014016859,0.00016822791,0.00017283513,0.000020005898,0.0002196901],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981801,0.00013532327,0.0006603306,0.00048316186,0.00028786613,0.00025322486],"domain_scores_gemma":[0.9980794,0.00083354244,0.00021833282,0.00057051925,0.00012655975,0.00017160957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012339327,0.0002515052,0.00077199884,0.000311678,0.000046260073,0.0000129039745,0.00010207469,0.000069370704,0.00003401049],"category_scores_gemma":[0.00014078485,0.0001806332,0.00020355906,0.00043494842,0.00012157181,0.000080786485,0.000025819858,0.00009494448,9.048384e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024459762,0.0023058215,0.9916377,0.0002601104,0.002348576,0.000011328912,0.00055283983,0.000003775322,0.000041257874,0.000005351116,0.0000028412533,0.00038439585],"study_design_scores_gemma":[0.039897077,0.00097336445,0.95257527,0.00020791813,0.00525754,7.925093e-8,0.00014570908,0.00007618167,0.0006855587,0.0000013398677,0.000042870804,0.00013711696],"about_ca_topic_score_codex":0.0009850397,"about_ca_topic_score_gemma":0.014595352,"teacher_disagreement_score":0.039062485,"about_ca_system_score_codex":0.0001341627,"about_ca_system_score_gemma":0.00015257586,"threshold_uncertainty_score":0.8144549},"labels":[],"label_agreement":null},{"id":"W4417012460","doi":"10.1182/blood-2025-4641","title":"Using electronic consultations to identify hematology education needs in primary care","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Healthcare Systems and Technology","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University Medical Centre; McMaster University; University of Toronto; Hamilton Health Sciences; University of Ottawa","funders":"","keywords":"Primary care; Descriptive statistics; Continuing education; Continuing professional development; Service (business); Content analysis; MEDLINE; Continuing medical education","score_opus":0.014427168785493194,"score_gpt":0.30774346040205847,"score_spread":0.29331629161656525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417012460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98060966,0.0011125855,0.00035985908,0.0015043442,0.0003509745,0.00040700723,8.137704e-7,0.00009447566,0.0155602675],"genre_scores_gemma":[0.997691,0.000004120993,0.00019097584,0.0017952166,0.00010934279,0.00006763728,0.000024412675,0.000008973956,0.00010834545],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992724,0.0000107067835,0.00024666192,0.0001592817,0.00005531993,0.00025561178],"domain_scores_gemma":[0.99959487,0.0000180493,0.00006528834,0.0001618525,0.00015362604,0.0000062998865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001081494,0.00008057914,0.00015973028,0.0009202532,0.00008835169,0.000050129605,0.00012228344,0.00010320171,0.0000089798705],"category_scores_gemma":[0.000082002116,0.000089018635,0.000022460757,0.0013223375,0.000014957599,0.00015582694,0.00007211716,0.000120923534,0.00005165375],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009378049,0.00032370188,0.22734481,0.0015726621,0.000037746337,0.000006807221,0.00034570924,0.000015354644,0.0041649067,0.7414716,0.000689875,0.024017483],"study_design_scores_gemma":[0.0065673185,0.000064445805,0.42626885,0.0024509772,0.00045245982,0.00008077412,0.02734525,0.00028365693,0.0025767253,0.045306828,0.48729125,0.0013114781],"about_ca_topic_score_codex":0.0030675395,"about_ca_topic_score_gemma":0.0018784988,"teacher_disagreement_score":0.6961647,"about_ca_system_score_codex":0.00010241379,"about_ca_system_score_gemma":0.00042056228,"threshold_uncertainty_score":0.46372226},"labels":[],"label_agreement":null},{"id":"W4417012461","doi":"10.1182/blood-2025-4640","title":"Targeted online education in obstetric hematology significantly improves resident knowledge and addresses a critical training gap","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Maternal and fetal healthcare","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; McMaster University Medical Centre; University of Toronto; Sunnybrook Health Science Centre; Mount Sinai Hospital","funders":"","keywords":"Hematology; Computer-assisted web interviewing; MEDLINE; Likert scale; Obstetrics and gynaecology; Best practice; Continuing medical education; Distance education; Faculty development","score_opus":0.03886655597247223,"score_gpt":0.3702055174554615,"score_spread":0.33133896148298925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417012461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97089434,0.023983212,0.0000067663354,0.0016567233,0.0002335931,0.00024517206,0.000009623677,0.000031472297,0.002939083],"genre_scores_gemma":[0.9974333,0.00018486021,0.00045280234,0.0003240871,0.000082713814,0.0000256902,0.00001791117,0.000007575481,0.0014710773],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99921525,0.000050659608,0.00026457442,0.00021040172,0.000065188855,0.00019391353],"domain_scores_gemma":[0.99943227,0.00024017731,0.000025442743,0.00010805146,0.00009317332,0.00010089724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007872981,0.00009151769,0.00025726575,0.00025353755,0.00003489863,0.000009223658,0.00004134667,0.000088293884,0.00002381456],"category_scores_gemma":[0.0006565487,0.000078312914,0.000023359104,0.0002694274,0.00005161685,0.00003198821,0.000029556646,0.00016616423,0.0000041759017],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011545338,0.014830668,0.45960477,0.029426023,0.00026571742,0.00087972934,0.012911091,2.5086123e-7,0.07449088,0.06639068,0.0025644954,0.33748117],"study_design_scores_gemma":[0.00393157,0.00059270905,0.96631414,0.0024564296,0.00021936909,0.00033709194,0.006641888,0.00011966036,0.012552335,0.004892843,0.0017094477,0.00023254947],"about_ca_topic_score_codex":0.0001801822,"about_ca_topic_score_gemma":0.00022982822,"teacher_disagreement_score":0.50670934,"about_ca_system_score_codex":0.000019564086,"about_ca_system_score_gemma":0.0005719752,"threshold_uncertainty_score":0.3193508},"labels":[],"label_agreement":null},{"id":"W4417012482","doi":"10.1182/blood-2025-2265","title":"Patients with Relapsed/Refractory multiple myeloma who achieved sustained minimal residual disease negativity in the dreamm-7 trial","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Bortezomib; Multiple myeloma; Negativity effect; Interim analysis; Daratumumab; Dexamethasone; Minimal residual disease; Clinical endpoint","score_opus":0.012509134671503164,"score_gpt":0.27078280630996493,"score_spread":0.25827367163846177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417012482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99419993,0.00011896292,0.000006553995,0.0011666298,0.00005615478,0.0028053022,0.00008661785,0.000048607555,0.0015112482],"genre_scores_gemma":[0.99777573,0.00001120791,0.00017641415,0.00021145857,0.0001260037,0.0002980842,0.00024091003,0.00002357316,0.0011365906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99761105,0.00038491105,0.00032112605,0.0004472847,0.0006967355,0.00053886714],"domain_scores_gemma":[0.9982004,0.0006786923,0.00008491586,0.00063632184,0.00014734357,0.0002522831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032486542,0.00026037035,0.00037686073,0.00021736087,0.0001781253,0.000050368144,0.000216543,0.000095392315,0.000029712817],"category_scores_gemma":[0.001697441,0.00015667881,0.00010236698,0.0004758772,0.00015116575,0.00013500635,0.00008956573,0.00039829087,0.000013052702],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12352339,0.008845587,0.8626352,0.00009488498,0.0002744305,0.00055724086,0.00031026747,6.230489e-7,0.00004888988,0.00006439235,0.00059340673,0.0030516856],"study_design_scores_gemma":[0.2136214,0.0016514878,0.7833115,0.00012512675,0.00022812201,0.0000011677299,0.00020785164,0.0000320536,0.00018660507,0.000037966933,0.00048084187,0.00011589704],"about_ca_topic_score_codex":0.00018617648,"about_ca_topic_score_gemma":0.00028837437,"teacher_disagreement_score":0.09009799,"about_ca_system_score_codex":0.00009604406,"about_ca_system_score_gemma":0.0005641602,"threshold_uncertainty_score":0.6389176},"labels":[],"label_agreement":null},{"id":"W4417012485","doi":"10.1182/blood-2025-2269","title":"Prolonged elranatamab treatment interruption in patients with relapsed or refractory multiple myeloma (RRMM) is feasible: A retrospective analysis from MagnetisMM-3","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Refractory (planetary science); Clinical endpoint; Dosing; Progressive disease; Adverse effect; Multiple myeloma; Mallinckrodt; Proteasome inhibitor; Phases of clinical research","score_opus":0.018483087045418116,"score_gpt":0.2914891864335762,"score_spread":0.27300609938815806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417012485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996504,0.00026690715,0.00004020934,0.00025463547,0.00004211228,0.0017992991,0.00033487962,0.00007624351,0.0006816795],"genre_scores_gemma":[0.9951806,0.00009422666,0.0012980514,0.00009975357,0.000031249245,0.0003299052,0.0008454271,0.000028803073,0.0020919556],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977681,0.00013322911,0.00038446972,0.0007532068,0.0005139304,0.00044704438],"domain_scores_gemma":[0.9986628,0.00012899286,0.0001239141,0.0006865752,0.00020504081,0.00019263037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000088954366,0.00033576455,0.0007151356,0.0008343014,0.00009461876,0.000039095932,0.00012146328,0.00016658289,0.00048745202],"category_scores_gemma":[0.0002170887,0.00022302897,0.00017262618,0.0015947417,0.00007319818,0.00013745372,0.000055625667,0.0002552128,0.000036481117],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010320918,0.0067051593,0.96432465,0.000029063662,0.0046722046,0.00028722544,0.00050806237,0.0000011620139,0.00022057365,0.0000021968601,0.000068787514,0.012860015],"study_design_scores_gemma":[0.05869128,0.004392213,0.9314468,0.00019164897,0.002408008,0.0000014185625,0.000104055274,0.00031351167,0.0021178683,0.000016630926,0.00014335872,0.00017318757],"about_ca_topic_score_codex":0.0023788828,"about_ca_topic_score_gemma":0.0067580873,"teacher_disagreement_score":0.04837036,"about_ca_system_score_codex":0.00071580237,"about_ca_system_score_gemma":0.00026657674,"threshold_uncertainty_score":0.90948576},"labels":[],"label_agreement":null},{"id":"W4417012491","doi":"10.1182/blood-2025-2267","title":"Efficacy and safety of isa-vrd in elderly patients with or without frailty criteria: Pooled analysis of imroz and phase 1b studies in newly diagnosed multiple myeloma patients","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Lenalidomide; Multiple myeloma; Pooled analysis; Subgroup analysis; Post-hoc analysis; Phases of clinical research; Thalidomide; Dexamethasone; Bortezomib","score_opus":0.029862564288176782,"score_gpt":0.35612464121876275,"score_spread":0.32626207693058595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417012491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99782366,0.0005895719,0.000008150865,0.000037347152,0.000017483006,0.001299966,0.00016659927,0.000010110767,0.000047119327],"genre_scores_gemma":[0.9988222,0.0002447072,0.0006461379,0.000025645266,0.0000052830205,0.000063213134,0.00013891992,0.00001287173,0.00004103322],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983475,0.00012048061,0.0005525341,0.00038022632,0.00032011388,0.00027913987],"domain_scores_gemma":[0.9986734,0.000533406,0.00014721716,0.00027919016,0.00024655,0.00012022895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014527008,0.00021825338,0.0010041381,0.00073472253,0.000040284118,0.000008880314,0.00006774172,0.00007582445,0.000015524982],"category_scores_gemma":[0.000986206,0.00014797454,0.000052873733,0.0010525623,0.00019824899,0.000089628105,0.00009500943,0.00012037984,2.9871993e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012555883,0.011494824,0.949067,0.00030995585,0.0036487211,0.000060825376,0.0013010778,0.0000018135172,0.0002751079,0.0000011240147,0.000009069011,0.02127462],"study_design_scores_gemma":[0.15521473,0.0025345208,0.83795136,0.00052395783,0.0017269956,3.8782898e-7,0.00030493498,0.0002472586,0.0013895053,0.0000029211208,0.00000732554,0.000096122945],"about_ca_topic_score_codex":0.00055253616,"about_ca_topic_score_gemma":0.0023212251,"teacher_disagreement_score":0.14265884,"about_ca_system_score_codex":0.000042045274,"about_ca_system_score_gemma":0.00007998817,"threshold_uncertainty_score":0.60342264},"labels":[],"label_agreement":null},{"id":"W4417012576","doi":"10.1182/blood-2025-2283","title":"Impact of tumor burden on the risk of cytokine release syndrome (CRS) in patients with multiple myeloma treated with elranatamab (ELRA) in combination with daratumumab (DARA) and lenalidomide (R) in the MagnetisMM-6 trial","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Hotel Dieu Hospital","funders":"","keywords":"Daratumumab; Multiple myeloma; Lenalidomide; Bortezomib; Incidence (geometry); Disease; Proteasome inhibitor; Cohort; Overall survival","score_opus":0.008197257128600513,"score_gpt":0.25031424681673087,"score_spread":0.24211698968813036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417012576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961578,0.00008387294,0.000001914655,0.0001765654,0.000005375287,0.0032233195,0.00013332657,0.000009000306,0.00020879164],"genre_scores_gemma":[0.99957436,0.000027721098,0.00006526308,0.000013047395,0.0000056639956,0.00017199661,0.00009181149,0.000019682593,0.000030466634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980188,0.00039624827,0.00038912115,0.0003181753,0.00057172973,0.00030591607],"domain_scores_gemma":[0.9986311,0.0005199595,0.00020559698,0.0004556214,0.00012213638,0.000065590735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037834447,0.00024890114,0.0005484425,0.00046958192,0.00005222649,0.000017607732,0.00015203272,0.000059113867,0.000014081885],"category_scores_gemma":[0.0003410871,0.00011127364,0.000051073854,0.0009643907,0.0001850453,0.00008343098,0.000029690775,0.00035167692,8.067646e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.119599774,0.0044635907,0.8738511,0.00007333276,0.0003692782,0.0004088358,0.00025792414,0.00005985603,0.00008737192,0.000017399967,0.00000701352,0.0008045031],"study_design_scores_gemma":[0.24457504,0.013016254,0.7404166,0.00060809,0.00019246842,0.000020265496,0.00013644565,0.0002885588,0.0006534779,0.000011829939,0.0000012440429,0.00007975611],"about_ca_topic_score_codex":0.006089556,"about_ca_topic_score_gemma":0.0020429133,"teacher_disagreement_score":0.13343455,"about_ca_system_score_codex":0.00009533053,"about_ca_system_score_gemma":0.00019775447,"threshold_uncertainty_score":0.92056274},"labels":[],"label_agreement":null},{"id":"W4417012633","doi":"10.1182/blood-2025-3730","title":"First-line consolidation with cemacabtagene ansegedleucel (cema-cel) in patients with large B-cell lymphoma (LBCL) and minimal residual disease (MRD) after response to standard therapy: The pivotal, randomized, open‑label Phase 2 ALPHA3 study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Lymphoma; Minimal residual disease; Refractory (planetary science); Aggressive lymphoma; Rituximab; Phases of clinical research","score_opus":0.01633925364020866,"score_gpt":0.31334122923914537,"score_spread":0.2970019755989367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417012633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98548096,0.0010414148,0.00006618165,0.0017809926,0.00003736854,0.010900194,0.0004076898,0.000039366743,0.0002458507],"genre_scores_gemma":[0.99453145,0.0001442594,0.000249861,0.00095942,0.000049786904,0.0014440683,0.00008315282,0.00007523786,0.002462757],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9959766,0.0011049965,0.00058235397,0.00080373074,0.0009364865,0.0005957806],"domain_scores_gemma":[0.99741554,0.0008020855,0.00013233507,0.00091927283,0.0003635179,0.00036724214],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024902362,0.0004379218,0.0009298006,0.00039613564,0.00025467906,0.00022394552,0.00033586862,0.00008514284,0.0002941348],"category_scores_gemma":[0.0003223291,0.00026227834,0.000060290316,0.00079594506,0.00026425903,0.00018101858,0.00028820307,0.00024990138,0.0000060043885],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8773725,0.032055482,0.08497355,0.000078355355,0.0005243323,0.00045838032,0.0017594394,0.0000029012815,0.0010895121,0.000005048044,0.00021347847,0.0014670137],"study_design_scores_gemma":[0.8948574,0.0122529175,0.08591776,0.00029759126,0.00060190907,0.0000067716082,0.00043175774,0.000050674138,0.0036438804,0.00001441034,0.0015905395,0.0003343635],"about_ca_topic_score_codex":0.00009965959,"about_ca_topic_score_gemma":0.00036601015,"teacher_disagreement_score":0.019802563,"about_ca_system_score_codex":0.00011605134,"about_ca_system_score_gemma":0.00073710055,"threshold_uncertainty_score":0.99998295},"labels":[],"label_agreement":null},{"id":"W4417012652","doi":"10.1182/blood-2025-4970","title":"Real-world clinical characteristics and treatment outcomes in PNH patients prescribed pegcetacoplan across europe, the United States and Canada","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Eculizumab; Complement system; Disease; Hemolysis; Complement (music); Hemoglobinuria","score_opus":0.02074551540143868,"score_gpt":0.3025932183678071,"score_spread":0.2818477029663684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417012652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978969,0.00018228675,1.9742305e-7,0.00028614,0.0003022151,0.0003918433,0.00080301234,0.000017534567,0.00011988372],"genre_scores_gemma":[0.99681133,0.0004005672,0.00000265149,0.00023531818,0.000007551218,0.000029758852,0.00063846476,0.0000067764245,0.0018675876],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988425,0.0003103747,0.0003846354,0.00021453048,0.000025375517,0.00022262093],"domain_scores_gemma":[0.99907714,0.00053763646,0.00009063084,0.00022291018,0.000049131857,0.000022564736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012050206,0.0001379483,0.00028404102,0.00004854843,0.00013703182,0.000024121937,0.00011044368,0.000037284764,0.000018625862],"category_scores_gemma":[0.00011931737,0.000089696005,0.000020227779,0.00010897102,0.00011087288,0.000017718576,0.00013490782,0.00008797808,0.0000027386504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000061335515,0.0004174921,0.99703234,0.000015947735,0.0002495038,0.000007832861,0.00015301323,1.8904046e-7,0.000034282948,0.000047535057,0.0014361078,0.0005444298],"study_design_scores_gemma":[0.0035288658,0.00009733692,0.97159463,0.000033993976,0.00010360796,0.0000010064065,0.00016991867,0.000002331803,0.0000955661,0.0000054772927,0.024286898,0.000080346304],"about_ca_topic_score_codex":0.30960378,"about_ca_topic_score_gemma":0.6549025,"teacher_disagreement_score":0.34529874,"about_ca_system_score_codex":0.000028659928,"about_ca_system_score_gemma":0.0001077797,"threshold_uncertainty_score":0.6949936},"labels":[],"label_agreement":null},{"id":"W4417012694","doi":"10.1182/blood-2025-5596","title":"Aspirin therapy in myelofibrosis: Real-world clinical practice and outcomes in 215 consecutive patients","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; MPB Technologies & Communications (Canada); Université de Montréal","funders":"","keywords":"Thrombocytosis; Clinical Practice; Aspirin; Polycythemia vera; Anagrelide; Myelofibrosis; Medical record; Thrombosis","score_opus":0.02464276871906311,"score_gpt":0.37115303027883007,"score_spread":0.34651026155976694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417012694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815112,0.00048098754,7.159358e-7,0.0033033274,0.00010153824,0.0009351872,0.000012339444,0.000021068037,0.013633665],"genre_scores_gemma":[0.993194,0.0023471983,0.00086885487,0.0028839004,0.00002211515,0.00019212044,0.000018700355,0.000011682066,0.00046141684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847686,0.00021653667,0.00054622773,0.00037674262,0.00017238635,0.00021126895],"domain_scores_gemma":[0.9982901,0.0012050438,0.00010505146,0.00021091383,0.000105589934,0.00008328808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034852786,0.00018039066,0.000546324,0.00022933273,0.000032877873,0.00002035657,0.00004503835,0.00009476757,0.000019767607],"category_scores_gemma":[0.0006236431,0.00013560026,0.000065461056,0.00030883536,0.000073834446,0.00008414923,0.00004617324,0.00023491585,0.000010764007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004683161,0.0072268303,0.9811803,0.000023005834,0.0002825436,0.00009576207,0.0003089017,1.4495733e-7,0.000009630641,0.0009580867,0.00022942142,0.0092170555],"study_design_scores_gemma":[0.019494578,0.0009509746,0.9754012,0.00026708157,0.000122817,0.0000023249088,0.00016132773,0.0000032870767,0.00077142584,0.00012721021,0.0025957376,0.00010200804],"about_ca_topic_score_codex":0.00059128966,"about_ca_topic_score_gemma":0.0013427995,"teacher_disagreement_score":0.01902626,"about_ca_system_score_codex":0.000052760413,"about_ca_system_score_gemma":0.0001653914,"threshold_uncertainty_score":0.5529618},"labels":[],"label_agreement":null},{"id":"W4417012698","doi":"10.1182/blood-2025-6212","title":"Upfront comprehensive donor search overcomes the impact of poor search prognosis, irrespective of racial background","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; Leukemia & Lymphoma Society of Canada; University of British Columbia","funders":"","keywords":"Incidence (geometry); Cumulative incidence; Transplantation; Population; Retrospective cohort study; Clinical endpoint; Hematopoietic stem cell transplantation; Hematopoietic cell","score_opus":0.03671274093183594,"score_gpt":0.3546220392594531,"score_spread":0.31790929832761716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417012698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99344754,0.000667493,0.00019652586,0.00034015428,0.000053274587,0.0011003799,0.00006181281,0.000018645536,0.0041141477],"genre_scores_gemma":[0.9991844,0.000089105546,0.00038153515,0.000033717526,0.00004924105,0.000025087278,0.00002088176,0.000013447811,0.00020258158],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99862593,0.00016336207,0.00035233283,0.00021114305,0.00040488708,0.00024232389],"domain_scores_gemma":[0.9986582,0.0005274043,0.00006819049,0.0002743528,0.00040807482,0.000063782165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026068467,0.00014228314,0.00042716687,0.00016397792,0.000056486388,0.000011849728,0.00014336589,0.00008385508,0.00013752878],"category_scores_gemma":[0.000031595857,0.00009190649,0.00021068215,0.00039865077,0.00020827545,0.000043483917,0.00004349841,0.00021224286,0.000011488812],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002553208,0.004056433,0.650256,0.0027154747,0.0036583694,0.00007195407,0.012876367,0.00010263701,0.31821898,0.0025314172,0.00077687064,0.0021823375],"study_design_scores_gemma":[0.004261695,0.0005724339,0.72986776,0.00039521084,0.0003859629,0.000034095254,0.002231397,0.00011526664,0.26196092,0.00007114408,0.000029635745,0.000074462216],"about_ca_topic_score_codex":0.0009166128,"about_ca_topic_score_gemma":0.000027022614,"teacher_disagreement_score":0.07961181,"about_ca_system_score_codex":0.00006592812,"about_ca_system_score_gemma":0.0004928332,"threshold_uncertainty_score":0.3747838},"labels":[],"label_agreement":null},{"id":"W4417012721","doi":"10.1182/blood-2025-6220","title":"Transfer and integration into a young adult clinic for sickle cell disease: Stay with me","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Young adult; Hematologist; Adult care; Cohort; Sickle cell anemia; Disease; MEDLINE","score_opus":0.02454200458275859,"score_gpt":0.3788967763010113,"score_spread":0.35435477171825275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417012721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98366946,0.0010319281,0.008250556,0.0033413607,0.00030833448,0.0018947633,0.000082172664,0.000083855484,0.0013375973],"genre_scores_gemma":[0.992532,0.00029188397,0.0005935296,0.0010825177,0.000313297,0.00026100516,0.00007168165,0.000016885015,0.0048372],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896103,0.00014538136,0.00030317772,0.00022859569,0.00009603609,0.00026580124],"domain_scores_gemma":[0.9992035,0.00025905026,0.00004011376,0.00015685218,0.00018839096,0.00015209086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022740188,0.00011345711,0.00016813829,0.00006286604,0.00038320327,0.00000718935,0.00006296498,0.00010420436,0.000046041343],"category_scores_gemma":[0.00007143053,0.00008456819,0.000032129512,0.0001383113,0.000024566774,0.000083363244,0.000015773581,0.00028979668,0.000018277087],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013864583,0.0006035831,0.9712539,0.005244176,0.000044499448,0.0000047719323,0.007857131,2.5107445e-7,0.00026301623,0.0032770382,0.0070295343,0.0030356534],"study_design_scores_gemma":[0.09121455,0.00502806,0.7629259,0.007173918,0.00430369,0.0000022389456,0.05671937,0.001041794,0.0026973747,0.016918456,0.04959414,0.0023804593],"about_ca_topic_score_codex":0.00023257673,"about_ca_topic_score_gemma":0.0014675433,"teacher_disagreement_score":0.20832793,"about_ca_system_score_codex":0.000025177254,"about_ca_system_score_gemma":0.0004992218,"threshold_uncertainty_score":0.3448591},"labels":[],"label_agreement":null},{"id":"W4417012851","doi":"10.1182/blood-2025-7317","title":"Clinical characteristics and outcomes in patients with SH2B3-mutated erythrocytosis: A retrospective cohort study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Retrospective cohort study; Polycythemia vera; Myeloid; Cohort; Etiology; Phlebotomy; Cohort study; Hematology","score_opus":0.008668864416354465,"score_gpt":0.2928568483438678,"score_spread":0.2841879839275134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417012851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99721754,0.000031639185,0.000002379758,0.00020493442,0.00006919227,0.0019526111,0.000028085831,0.00003260937,0.00046100855],"genre_scores_gemma":[0.9991145,0.000045738474,0.00014542168,0.00026990115,0.000018174338,0.00022541085,0.000035152152,0.000013017387,0.0001326469],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987088,0.00007573005,0.00040531694,0.00041339544,0.00022568008,0.00017106498],"domain_scores_gemma":[0.9993247,0.00011997841,0.000086449494,0.0002321363,0.00015600119,0.000080782345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018231834,0.00018568788,0.0007488789,0.00010603161,0.000052435713,0.000021928057,0.000035378318,0.00006771153,0.000018701961],"category_scores_gemma":[0.00019964686,0.00012372353,0.000040170722,0.00019439761,0.000058487796,0.00003812594,0.00004601211,0.00018803625,0.0000053788885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036071203,0.014584792,0.9830474,0.000018099558,0.00121254,0.00007826458,0.00016762572,2.5985495e-8,6.7643833e-7,0.000041843476,0.000025470408,0.00046252194],"study_design_scores_gemma":[0.020585679,0.0029011504,0.9752029,0.0001274523,0.0009215612,0.0000014735161,0.00008534827,0.0000028540283,0.00004171405,0.000012538634,0.000012990569,0.00010432031],"about_ca_topic_score_codex":0.000039224116,"about_ca_topic_score_gemma":0.0000977676,"teacher_disagreement_score":0.020224968,"about_ca_system_score_codex":0.00006494687,"about_ca_system_score_gemma":0.000070558875,"threshold_uncertainty_score":0.5045299},"labels":[],"label_agreement":null},{"id":"W4417012866","doi":"10.1182/blood-2025-7369","title":"Impact of allogeneic transplant vs hypomethylating agents in high-risk myelodysplastic syndromes: A prisma-guided systematic review","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Myelodysplastic syndromes; Hypomethylating agent; Transplantation; Retrospective cohort study; Cumulative incidence; Azacitidine; Prospective cohort study; Hematopoietic stem cell transplantation; Overall survival","score_opus":0.0285742479294324,"score_gpt":0.33505561178929655,"score_spread":0.30648136385986413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417012866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800406,0.016283032,0.0001621097,0.00014288431,0.000048960752,0.0028834683,0.000055416403,0.00005144447,0.00033209432],"genre_scores_gemma":[0.9898242,0.008678377,0.0007540568,0.00013924717,0.000019426956,0.00020571923,0.000043769505,0.000037359365,0.00029788713],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.9966569,0.00047766356,0.0013461874,0.00042119995,0.00055842707,0.00053962326],"domain_scores_gemma":[0.99788177,0.00070395245,0.00034207365,0.0007386076,0.00015793397,0.00017564958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001421394,0.00030420546,0.0017586679,0.0006026397,0.000048669517,0.00001321634,0.00032867407,0.00016317432,0.00010020334],"category_scores_gemma":[0.0024992505,0.00022972419,0.00034212717,0.001283694,0.00006480582,0.000061815655,0.00007820044,0.0005096474,0.00005709209],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021653494,0.0014742014,0.2617207,0.7225221,0.0037474988,0.0012913554,0.00055018254,0.000078341705,0.0074867015,0.000057608617,0.0006107253,0.00024407005],"study_design_scores_gemma":[0.015014899,0.001444753,0.5017667,0.4684073,0.00869278,0.00090340787,0.000055648175,0.00073733286,0.0024239155,0.00009764723,0.0000047039216,0.00045091618],"about_ca_topic_score_codex":0.0005688337,"about_ca_topic_score_gemma":0.000014994464,"teacher_disagreement_score":0.25411478,"about_ca_system_score_codex":0.00037481615,"about_ca_system_score_gemma":0.0007728395,"threshold_uncertainty_score":0.936788},"labels":[],"label_agreement":null},{"id":"W4417012954","doi":"10.1182/blood-2025-4855","title":"Plasma-derived VWF/FVIII prophylaxis in children under 6 with VWD: First results from wil-33","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Tolerability; Von Willebrand disease; Clinical endpoint; Prospective cohort study; Adverse effect; Incidence (geometry); Clinical trial; Multicenter study","score_opus":0.01195064054402136,"score_gpt":0.2532123032218528,"score_spread":0.24126166267783142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417012954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853363,0.00019141793,0.000004518864,0.0034117787,0.000033840686,0.0008275129,0.0000918271,0.00006684278,0.010035979],"genre_scores_gemma":[0.9956259,0.00007546079,0.00043274392,0.00011169912,0.00010337557,0.000049490147,0.00021757704,0.000021314463,0.0033624545],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986078,0.000041711868,0.00024947117,0.0004427647,0.00031509303,0.00034312595],"domain_scores_gemma":[0.99921644,0.00013107802,0.000037487167,0.00044222595,0.000053342857,0.00011943949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010473399,0.0001833281,0.0003103108,0.00021337913,0.00009846939,0.000030824984,0.00012743117,0.00014752452,0.000050614195],"category_scores_gemma":[0.00008996412,0.00012503151,0.000055466462,0.00046917837,0.000110170826,0.00004962592,0.00006953552,0.000310119,0.00007863675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027261723,0.0036528923,0.9839397,0.00007767351,0.0012326933,0.00041656755,0.0006948031,0.000023108898,0.0038256461,0.0002177683,0.0007939743,0.0023989799],"study_design_scores_gemma":[0.03918807,0.0011669509,0.9226279,0.0006058489,0.0002506288,0.00002877362,0.00017508803,0.00003648825,0.034430336,0.00019663876,0.0010692552,0.00022397553],"about_ca_topic_score_codex":0.0009484934,"about_ca_topic_score_gemma":0.0007416624,"teacher_disagreement_score":0.061311774,"about_ca_system_score_codex":0.00005466571,"about_ca_system_score_gemma":0.00030381785,"threshold_uncertainty_score":0.50986373},"labels":[],"label_agreement":null},{"id":"W4417012988","doi":"10.1182/blood-2025-4988","title":"Study design of A phase 3, open-label trial for pozelimab and cemdisiran combination therapy in patients with paroxysmal nocturnal hemoglobinuria with inadequate control of intravascular hemolysis","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Eculizumab; Hemolysis; Combination therapy; Hemolytic anemia; Complement membrane attack complex; Phases of clinical research","score_opus":0.025176427646755716,"score_gpt":0.28880514435448645,"score_spread":0.26362871670773075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417012988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99003446,0.0005295598,0.0023940362,0.000024644552,0.000055266843,0.006846376,0.00010049565,0.000007863728,0.000007292829],"genre_scores_gemma":[0.99936247,0.0000048987577,0.00014762826,0.00001852192,0.0000035205396,0.00038069132,0.00005824952,0.000010367026,0.0000136320305],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9985959,0.00043138073,0.00046639674,0.00026100868,0.00006650164,0.00017880589],"domain_scores_gemma":[0.9990797,0.0002122899,0.00028106532,0.00023653038,0.00017610518,0.000014307575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044038246,0.0001645624,0.00056919723,0.00015743621,0.00006488259,0.000016766206,0.00022641552,0.0000584644,0.000016094542],"category_scores_gemma":[0.00004970043,0.00011960958,0.000029004315,0.00019535606,0.00009357281,0.00008103784,0.000040918676,0.000065869186,2.4403525e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.551148,0.10524206,0.31209758,0.00019988947,0.0069096917,0.000006740328,0.0013193935,0.000047061007,0.01382554,0.000405556,0.000059401376,0.008739076],"study_design_scores_gemma":[0.92275035,0.027594445,0.038473964,0.0001177366,0.0007417229,0.0000014361315,0.00035200425,0.000025140065,0.009703055,0.00008584135,0.000008854965,0.00014542905],"about_ca_topic_score_codex":0.00008721016,"about_ca_topic_score_gemma":0.000027648204,"teacher_disagreement_score":0.3716024,"about_ca_system_score_codex":0.000016767855,"about_ca_system_score_gemma":0.00011320166,"threshold_uncertainty_score":0.48775372},"labels":[],"label_agreement":null},{"id":"W4417013032","doi":"10.1182/blood-2025-5240","title":"Real-world evidence evaluation of the safety and efficacy of intensive chemotherapy with or without gemtuzumab ozogamicin (GO) in patients with newly diagnosed Acute Myeloid Leukemia (AML) and favorable or intermediate risk cytogenetics","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Gemtuzumab ozogamicin; Cytarabine; Myeloid leukemia; NPM1; Chemotherapy; Chemotherapy regimen; Cytogenetics; Induction chemotherapy","score_opus":0.020144692625386727,"score_gpt":0.3102496787177446,"score_spread":0.2901049860923579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417013032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966371,0.00021750116,0.00006529416,0.0002604614,0.00003016117,0.0026152423,0.00003487831,0.000015921756,0.00012343375],"genre_scores_gemma":[0.9947483,0.003039206,0.0014186504,0.00021931197,0.000021195969,0.000043291217,0.00001306796,0.000037974525,0.00045900917],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99757457,0.0003017348,0.00053682347,0.00046558923,0.00080975285,0.00031154288],"domain_scores_gemma":[0.996803,0.0007272228,0.00038708674,0.0006243123,0.0013617816,0.000096597585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080912054,0.00027341468,0.0007022311,0.00030319038,0.000070431044,0.000017830807,0.0002229208,0.00010621747,0.000020620038],"category_scores_gemma":[0.0015016001,0.00014428546,0.00004406313,0.0010205831,0.00050660403,0.00011138828,0.00017191873,0.00041366168,5.8922615e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025807522,0.00029752255,0.9572335,0.00024209746,0.00067993405,0.0000143772395,0.0016803888,0.000109763256,0.0016712106,0.000006001898,0.00007176183,0.012185936],"study_design_scores_gemma":[0.054494213,0.0022920694,0.9176723,0.0028485176,0.0016347476,0.000010486245,0.00050565496,0.0016164142,0.018738104,0.000013049567,0.000016265532,0.00015821819],"about_ca_topic_score_codex":0.0010705504,"about_ca_topic_score_gemma":0.002781636,"teacher_disagreement_score":0.039561223,"about_ca_system_score_codex":0.0005055153,"about_ca_system_score_gemma":0.002488942,"threshold_uncertainty_score":0.588379},"labels":[],"label_agreement":null},{"id":"W4417013071","doi":"10.1182/blood-2025-5247","title":"Validation of the FL/IL6 score, a new dynamic cytokine-based risk-model in adults with acute myeloid leukemia, a prospective multicentre filo study.","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Myeloid leukemia; Prospective cohort study; Cohort; Overall survival; Cohort study; Survival analysis; Proportional hazards model","score_opus":0.007577081449724317,"score_gpt":0.26532991793469274,"score_spread":0.25775283648496844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417013071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99312043,0.00008009518,0.000962568,0.0005039974,0.000034801003,0.004284824,0.00007161402,0.000062790765,0.0008788519],"genre_scores_gemma":[0.9952722,0.00003916909,0.0027384092,0.000104839295,0.000029027464,0.00019149827,0.000035207224,0.000039965667,0.0015496804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99773794,0.00016688637,0.00044725128,0.0005718698,0.0006575916,0.00041848383],"domain_scores_gemma":[0.99835193,0.00015529152,0.00023030568,0.0008414448,0.0003029816,0.000118025484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031102903,0.0002825206,0.0004826212,0.00034357153,0.000097951466,0.000022326849,0.00035884423,0.00013334824,0.000018341709],"category_scores_gemma":[0.0003757034,0.00018754079,0.00011185507,0.0013799302,0.00012390212,0.0001006038,0.00015651596,0.00073383236,0.000008281263],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009475705,0.0042288047,0.95622605,0.0004956768,0.001561645,0.00021934262,0.005427948,0.0067319986,0.012931986,0.00006708942,0.00039172792,0.002242015],"study_design_scores_gemma":[0.09027397,0.0015739712,0.6684823,0.0021871794,0.0023441385,0.000027693815,0.0020034087,0.13620324,0.0963244,0.00020602833,0.000010678506,0.0003629734],"about_ca_topic_score_codex":0.002065162,"about_ca_topic_score_gemma":0.0018553172,"teacher_disagreement_score":0.28774375,"about_ca_system_score_codex":0.0010027285,"about_ca_system_score_gemma":0.004253237,"threshold_uncertainty_score":0.76476914},"labels":[],"label_agreement":null},{"id":"W4417013082","doi":"10.1182/blood-2025-5746","title":"Effectiveness of second-line therapies following upfront daratumumab plus bortezomib, cyclophosphamide and dexamethasone: A new benchmark","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Daratumumab; AL amyloidosis; Bortezomib; Dexamethasone; Cyclophosphamide; Regimen; Cohort; Multiple myeloma","score_opus":0.005653437114811769,"score_gpt":0.25574856019675785,"score_spread":0.2500951230819461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417013082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9691415,0.028856574,0.00042789697,0.00007266096,0.00018686622,0.00041084707,0.00002623814,0.00001920046,0.00085826224],"genre_scores_gemma":[0.99678713,0.0007440019,0.0014616362,0.00012411608,0.000041089097,0.00007740877,0.000069292706,0.000024216604,0.00067110575],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987978,0.00012689023,0.0002606464,0.00045669367,0.00010758265,0.00025040767],"domain_scores_gemma":[0.9992097,0.0001596366,0.00010277589,0.0004066172,0.00004075024,0.000080531616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023469138,0.00025961926,0.0004230993,0.000066022345,0.00008187368,0.00002446901,0.00017030176,0.00017549391,0.000021063632],"category_scores_gemma":[0.0001420188,0.00023567928,0.00019069514,0.00014068765,0.00007084567,0.000007785847,0.00015354139,0.00008222701,0.0000013668468],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000504658,0.0006707061,0.4221373,0.00035378867,0.0034356688,0.00003256299,0.00021424211,0.000030047187,0.56682676,0.00033459679,0.0005826099,0.004877093],"study_design_scores_gemma":[0.007066617,0.00038208134,0.24309269,0.00016747697,0.00040835387,0.0000067081182,0.00010218527,0.000003378769,0.7464144,0.0003033011,0.0018104631,0.0002423502],"about_ca_topic_score_codex":0.000114404,"about_ca_topic_score_gemma":0.00011203986,"teacher_disagreement_score":0.17958766,"about_ca_system_score_codex":0.000025451032,"about_ca_system_score_gemma":0.00019369871,"threshold_uncertainty_score":0.9610722},"labels":[],"label_agreement":null},{"id":"W4417013127","doi":"10.1182/blood-2025-6265","title":"Patient characteristics and treatment outcomes with Pola-R-CHP: A real-world study of patients with previously untreated diffuse large B-cell lymphoma (DLBCL) in the United States (US)","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Prednisone; Rituximab; Vincristine; Lymphoma; Cancer; Clinical trial; Disease; Diffuse large B-cell lymphoma; Bendamustine","score_opus":0.006293172537444891,"score_gpt":0.2309704447356517,"score_spread":0.22467727219820682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417013127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968638,0.000075415,3.7713374e-7,0.000121553356,0.000016762013,0.0025162692,0.0001558747,0.0000328909,0.00021707348],"genre_scores_gemma":[0.99858004,0.00021411362,0.000036368107,0.0002712006,0.0000051915076,0.00029838432,0.00043536935,0.000023698356,0.00013562292],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850255,0.00012484725,0.0003982635,0.00034558543,0.0003149691,0.00031375256],"domain_scores_gemma":[0.99890476,0.00019433058,0.00019477325,0.0004872085,0.00012972522,0.00008917686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000065308006,0.00033418622,0.0006078427,0.00030561408,0.0000878192,0.000032146007,0.00007126644,0.000040571183,0.000004148401],"category_scores_gemma":[0.000013789936,0.00015817521,0.000043780707,0.0006428311,0.00005198821,0.000036825128,0.000042151933,0.000043994314,0.000001190939],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007472927,0.15707667,0.83509177,0.000056212873,0.000678992,0.00019027037,0.005043458,6.108269e-7,0.0000011603826,0.00002145007,0.000013252393,0.0010788324],"study_design_scores_gemma":[0.117789835,0.008350823,0.8700543,0.0001853667,0.0016023956,0.0000028601457,0.0014252868,0.000013721572,0.00015210251,0.0000017100473,0.00029277566,0.00012881226],"about_ca_topic_score_codex":0.0050504305,"about_ca_topic_score_gemma":0.0037488875,"teacher_disagreement_score":0.14872585,"about_ca_system_score_codex":0.00016062785,"about_ca_system_score_gemma":0.00010281433,"threshold_uncertainty_score":0.7634774},"labels":[],"label_agreement":null},{"id":"W4417013131","doi":"10.1182/blood-2025-6268","title":"Patterns of palliative care utilization across health sectors in patients with aggressive non-Hodgkin lymphoma.","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Institute for Clinical Evaluative Sciences; McMaster University Medical Centre","funders":"","keywords":"Palliative care; Retrospective cohort study; Cohort; Disease; Cancer; Health care; Lymphoma; Aggressive lymphoma","score_opus":0.01857700892609266,"score_gpt":0.26622779348622916,"score_spread":0.2476507845601365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417013131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945339,0.0016205533,0.0008516598,0.000052321,0.00017931935,0.00033833395,0.00074173545,0.000009766822,0.0016724404],"genre_scores_gemma":[0.99925524,0.00024734368,0.000084349536,0.00021281178,0.000022127506,0.000022340731,0.000067069755,0.00001577143,0.000072959476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988607,0.000008960867,0.0005222321,0.00029814543,0.00002731575,0.00028263693],"domain_scores_gemma":[0.9989447,0.00002122866,0.00070589187,0.00021163578,0.00006995724,0.00004655713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000102206075,0.00013859224,0.00044116622,0.00015868907,0.00005783823,0.000022647195,0.00014220008,0.000082969396,0.00002416354],"category_scores_gemma":[0.000049995655,0.00014941771,0.00004992797,0.00024101225,0.000030405194,0.0001505905,0.000042494157,0.00006126539,0.00000893906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048180667,0.00024842014,0.9893876,0.00011219513,0.00004380219,7.44591e-7,0.0028755965,0.00004958187,1.5701288e-7,0.0022279937,0.000027854496,0.0049778856],"study_design_scores_gemma":[0.0046654087,0.0002118342,0.99325925,0.00023117202,0.0000042570337,3.1159594e-8,0.0003971027,0.00002213472,0.00017345174,0.00041512056,0.00047945074,0.00014080982],"about_ca_topic_score_codex":0.0013809704,"about_ca_topic_score_gemma":0.0012216686,"teacher_disagreement_score":0.0048370757,"about_ca_system_score_codex":0.00020256134,"about_ca_system_score_gemma":0.00011133485,"threshold_uncertainty_score":0.60930777},"labels":[],"label_agreement":null},{"id":"W4417013140","doi":"10.1182/blood-2025-6197","title":"Cost-effectiveness of frontline blinatumomab in children with standard-risk B-cell acute lymphoblastic leukemia in Ontario, Canada","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Blinatumomab; Cohort; Ponatinib; Hazard ratio; Minimal residual disease; Acute lymphocytic leukemia; Hematopoietic stem cell transplantation; Chemotherapy","score_opus":0.006804404216793622,"score_gpt":0.2452258716070857,"score_spread":0.23842146739029207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417013140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953732,0.00025194907,0.0005287671,0.000030059224,0.00006552735,0.0018008938,0.00014225685,0.00002323385,0.0017841146],"genre_scores_gemma":[0.9983838,0.000032230404,0.0006025679,0.00006144436,0.000017676302,0.00013963642,0.00009740639,0.000037600454,0.0006275918],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974545,0.00020281112,0.0005068806,0.0005337986,0.00070327247,0.0005987172],"domain_scores_gemma":[0.9984829,0.00049130066,0.00013312526,0.0005216527,0.00020750189,0.00016353736],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005504017,0.0003091194,0.0008450846,0.00047351763,0.000042800886,0.000013676422,0.00026909838,0.00016927597,0.000056737947],"category_scores_gemma":[0.00021176366,0.00025765933,0.000060470786,0.00091336406,0.00012594664,0.00007021888,0.00014008634,0.000670132,0.0000025632253],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.004131552,0.000626494,0.99123096,0.00022038074,0.00053252664,0.0006380191,0.00014018214,0.0007975523,0.0010282992,0.000027266908,0.00029390134,0.00033283795],"study_design_scores_gemma":[0.065165766,0.00076952146,0.89516646,0.000982099,0.00059398555,0.00012763715,0.000074837015,0.0005162616,0.036218293,0.00004144004,0.000114383634,0.0002293168],"about_ca_topic_score_codex":0.9612474,"about_ca_topic_score_gemma":0.9766915,"teacher_disagreement_score":0.09606452,"about_ca_system_score_codex":0.015554473,"about_ca_system_score_gemma":0.037000388,"threshold_uncertainty_score":0.99998754},"labels":[],"label_agreement":null},{"id":"W4417013218","doi":"10.1182/blood-2025-7401","title":"Predictive value of red cell distribution width for SF3B1 mutation status in myelodysplastic neoplasms","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Red blood cell distribution width; Mutation; Myeloid; Complete blood count; Myelodysplastic syndromes; Platelet; Red Cell; Predictive value","score_opus":0.005139296015883385,"score_gpt":0.2423474959411186,"score_spread":0.2372081999252352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417013218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893771,0.00020574399,0.0072365273,0.0000976466,0.00017876357,0.0011859995,0.0003759122,0.000047548678,0.0012947486],"genre_scores_gemma":[0.9974028,0.000016604212,0.0016821957,0.000029654313,0.000029631647,0.00021909029,0.0005342124,0.000011853629,0.000073945834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989723,0.000049181537,0.00034890824,0.00022633781,0.00016839083,0.00023491445],"domain_scores_gemma":[0.9992467,0.00022714991,0.00011761615,0.0001739245,0.00016408424,0.00007050041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017642633,0.000117323245,0.00022183874,0.00013990421,0.000036165024,0.0000065350887,0.000044542863,0.00010494393,0.000009888691],"category_scores_gemma":[0.00052316184,0.00011850347,0.00008090813,0.00031589065,0.00006393354,0.00005588881,0.000026266795,0.00007705418,0.0000019670558],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008085082,0.0043443264,0.9381186,0.004395001,0.0007397588,0.0001284077,0.00065127795,0.00042864302,0.033677664,0.0024411404,0.0023897144,0.0046004145],"study_design_scores_gemma":[0.014819323,0.0006187992,0.8292041,0.0006326491,0.0012220464,0.000006407994,0.00025247454,0.008203926,0.142952,0.0015827642,0.00035419184,0.00015136355],"about_ca_topic_score_codex":0.000012608816,"about_ca_topic_score_gemma":0.0000045372685,"teacher_disagreement_score":0.109274335,"about_ca_system_score_codex":0.000107095504,"about_ca_system_score_gemma":0.00029073108,"threshold_uncertainty_score":0.4832431},"labels":[],"label_agreement":null},{"id":"W4417013233","doi":"10.1182/blood-2025-7498","title":"Artificial intelligence for predicting transformation of monoclonal gammopathy of undetermined significance to multiple myeloma: A systematic review and meta-analysis","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Monoclonal gammopathy of undetermined significance; Discriminative model; Multiple myeloma; Monoclonal gammopathy; Feature selection; Transformation (genetics)","score_opus":0.07449027410429242,"score_gpt":0.35039119347410735,"score_spread":0.2759009193698149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417013233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7035126,0.054108985,0.2114614,0.0026152616,0.000041458326,0.026510758,0.0012595737,0.00008546188,0.000404502],"genre_scores_gemma":[0.9948615,0.00013859599,0.0041326135,0.00006087658,0.0000045186794,0.00071063964,0.000029505545,0.0000057565935,0.000055981487],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9985512,0.000072864415,0.0008049545,0.00019561886,0.00022546173,0.0001499198],"domain_scores_gemma":[0.9988434,0.00041944993,0.00017608255,0.00024571683,0.00023083168,0.00008454217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050792814,0.000121090736,0.0013544005,0.0002479247,0.000035720397,0.0000070276387,0.000075198426,0.000035671885,0.00001371864],"category_scores_gemma":[0.00084422354,0.00008657149,0.00042695363,0.00058316585,0.000034069508,0.000045934696,0.00001656931,0.00004428216,8.2683533e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091120566,0.0022330864,0.006716893,0.758558,0.21176602,0.000015269437,0.0014313284,0.000083868385,0.015475982,0.0009108017,0.000010142803,0.0018874599],"study_design_scores_gemma":[0.000986223,0.00071952125,0.0019685072,0.0035703366,0.79539275,0.000007674771,0.0002751496,0.008793754,0.18791142,0.00023977192,0.0000014701212,0.00013342395],"about_ca_topic_score_codex":0.00005544984,"about_ca_topic_score_gemma":0.00006424726,"teacher_disagreement_score":0.7549876,"about_ca_system_score_codex":0.000015562158,"about_ca_system_score_gemma":0.00006410498,"threshold_uncertainty_score":0.3530283},"labels":[],"label_agreement":null},{"id":"W4417013234","doi":"10.1182/blood-2025-7442","title":"Tonsillar hypertrophy as a rare presentation of chronic lymphocytic leukemia/small lymphocytic lymphoma: A mini-review","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Chronic lymphocytic leukemia; Asymptomatic; Lymphocytosis; Histopathology; Tonsil; Respiratory distress; Leukemia","score_opus":0.014967083852141384,"score_gpt":0.29419546848224193,"score_spread":0.2792283846301005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417013234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85611326,0.124789335,0.00007479849,0.00037157495,0.00029100812,0.0024303114,0.00002422133,0.00021190029,0.015693605],"genre_scores_gemma":[0.96534073,0.023057595,0.00075990724,0.001957587,0.00031494864,0.00040610184,0.00013204732,0.0001100189,0.0079210885],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99580926,0.00021689065,0.0011566482,0.0008918015,0.0010082475,0.00091715023],"domain_scores_gemma":[0.9967248,0.00050335814,0.00029604975,0.0015819955,0.0005369739,0.0003568111],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000470972,0.00050949136,0.0013196653,0.0005096723,0.00014096934,0.00004109885,0.00056082325,0.00032677443,0.0002665155],"category_scores_gemma":[0.0012057143,0.00047691958,0.00050741935,0.0016301556,0.0003709551,0.0001359465,0.0003547995,0.00018162563,0.00032952375],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.008482975,0.012443752,0.0021455977,0.29474986,0.01667773,0.01688842,0.0027234268,0.0017363757,0.14695208,0.01119138,0.059070557,0.42693785],"study_design_scores_gemma":[0.45271087,0.004460747,0.0022349993,0.048339546,0.011987259,0.011622497,0.00056755234,0.05440673,0.35712463,0.00102483,0.053322736,0.0021976219],"about_ca_topic_score_codex":0.0031156505,"about_ca_topic_score_gemma":0.000068237125,"teacher_disagreement_score":0.4442279,"about_ca_system_score_codex":0.08416069,"about_ca_system_score_gemma":0.13829994,"threshold_uncertainty_score":0.99976826},"labels":[],"label_agreement":null},{"id":"W4417013308","doi":"10.1182/blood-2025-372","title":"Daratumumab monotherapy versus active monitoring in patients with high-risk smoldering multiple myeloma: Aquila outcomes based on mayo 2018/IMWG 2020 risk stratification, IMWG 2020 plus cytogenetic criteria, and age","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital; Alberta Cancer Foundation","funders":"","keywords":"Daratumumab; Multiple myeloma; Clinical endpoint; Lenalidomide; Asymptomatic; Data monitoring committee; Surrogate endpoint; Progression-free survival; Pomalidomide","score_opus":0.01578562255723771,"score_gpt":0.2875565832478632,"score_spread":0.2717709606906255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417013308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973871,0.00022244775,0.00009323285,0.00014029606,0.00022302059,0.0014811342,0.00021581745,0.000060499824,0.00017645999],"genre_scores_gemma":[0.99630857,0.00019712854,0.002840158,0.000025812291,0.00007459749,0.00023154264,0.00016930849,0.000047415047,0.00010546314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99781805,0.00017729116,0.0003666571,0.0006857449,0.00047798676,0.00047427186],"domain_scores_gemma":[0.99851775,0.00039090388,0.00015846705,0.00059588195,0.00011330773,0.00022367899],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012854747,0.0003780172,0.0005241981,0.00023962249,0.00023082938,0.00008683778,0.00014749875,0.00013209452,0.000027796677],"category_scores_gemma":[0.00027400735,0.0003083099,0.00007039006,0.00037672397,0.000093245646,0.00011951943,0.00005258085,0.0003743991,0.0000112611615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007817452,0.001327188,0.97825193,0.00006789099,0.000608798,0.00015550545,0.00028477103,0.0001159048,0.00077932404,0.0000025339818,0.000029137444,0.010559534],"study_design_scores_gemma":[0.06307705,0.0014158125,0.9204879,0.00019858286,0.00025951458,7.2892215e-7,0.000145557,0.00087332644,0.013281132,0.000013917416,0.000023154413,0.00022335513],"about_ca_topic_score_codex":0.0012310838,"about_ca_topic_score_gemma":0.00035621773,"teacher_disagreement_score":0.057764094,"about_ca_system_score_codex":0.00022378092,"about_ca_system_score_gemma":0.00016393757,"threshold_uncertainty_score":0.9999369},"labels":[],"label_agreement":null},{"id":"W4417013395","doi":"10.1182/blood-2025-1738","title":"Outcomes following MRD relapse in AML patients monitored by droplet digital PCR","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Leukemia & Lymphoma Society of Canada; University of British Columbia","funders":"","keywords":"Myeloid leukemia; Minimal residual disease; Leukemia; Induction chemotherapy; Bone marrow; NPM1; Chemotherapy; Chemotherapy regimen; Cancer","score_opus":0.00768189524713023,"score_gpt":0.2748417843216409,"score_spread":0.26715988907451066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417013395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99051213,0.00017858995,0.000010984844,0.0008370898,0.00019531739,0.0004500148,0.000036061854,0.000071774215,0.007708029],"genre_scores_gemma":[0.99229413,0.00001107167,0.00015238416,0.000314057,0.000027452203,0.0000401332,0.00013716113,0.000026239362,0.0069973413],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855375,0.000031679014,0.00030823715,0.00030667905,0.000402092,0.00039758458],"domain_scores_gemma":[0.99929535,0.00013323643,0.00003490614,0.00036360117,0.000052086427,0.00012080706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011918266,0.00016406445,0.00035247192,0.00023073606,0.00004991043,0.00005003417,0.00017434101,0.0001275594,0.000013966767],"category_scores_gemma":[0.00066209515,0.00014065843,0.00013685382,0.0004336487,0.00003812974,0.00015964235,0.00015678647,0.00035586147,0.00008130878],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045945642,0.0008262376,0.9881902,0.00003419259,0.00016473675,0.0001302784,0.00010430932,1.909559e-7,0.0006965556,0.000015625634,0.007628398,0.0021633334],"study_design_scores_gemma":[0.019055359,0.00021234028,0.97116673,0.00018412503,0.00013159547,0.0000024464787,0.00017031083,0.00002707468,0.0034505262,0.000087641885,0.00531975,0.00019210407],"about_ca_topic_score_codex":0.00009541237,"about_ca_topic_score_gemma":0.0000047238473,"teacher_disagreement_score":0.019009415,"about_ca_system_score_codex":0.00020447694,"about_ca_system_score_gemma":0.0001739936,"threshold_uncertainty_score":0.5735885},"labels":[],"label_agreement":null},{"id":"W4417013416","doi":"10.1182/blood-2025-2264","title":"Deep responses and durable outcomes in patients treated with belantamab mafodotin plus pomalidomide and dexamethasone from long-term follow-up of the Phase 3 dreamm-8 study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pomalidomide; Lenalidomide; Dexamethasone; Clinical endpoint; Hazard ratio; Randomization; Multiple myeloma; Intention-to-treat analysis; Randomized controlled trial","score_opus":0.0169290117943093,"score_gpt":0.3025473535185282,"score_spread":0.2856183417242189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417013416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977824,0.00030994,0.0000035473033,0.000098477496,0.000020334119,0.0016272597,0.00007288522,0.000016690445,0.00006842858],"genre_scores_gemma":[0.99866426,0.000033133725,0.00012624197,0.000027692122,0.000004893496,0.000061885105,0.000037262038,0.000015356603,0.0010292804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986562,0.0002161927,0.00026835618,0.00032159055,0.0002896396,0.0002480014],"domain_scores_gemma":[0.99900407,0.00038069522,0.00007929756,0.0003608651,0.0000689507,0.00010609788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013953247,0.00019163058,0.0005078622,0.00017636173,0.000079131045,0.000022650593,0.00008687994,0.000055503187,0.00001864421],"category_scores_gemma":[0.00033802004,0.00010081224,0.000040952655,0.00026095114,0.000103211576,0.000054117074,0.00010686465,0.00012924272,0.0000010380276],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011209982,0.005129097,0.9789064,0.000046916084,0.00094812125,0.00019249383,0.0004793686,1.6795788e-7,0.00053064286,0.0000010185001,0.0000028562467,0.0025529303],"study_design_scores_gemma":[0.13870682,0.0015670414,0.85191447,0.00018336502,0.0005691175,0.0000061134724,0.00023303235,0.000018876555,0.0067208568,0.000004760732,6.6261896e-7,0.000074914955],"about_ca_topic_score_codex":0.002119703,"about_ca_topic_score_gemma":0.0022781254,"teacher_disagreement_score":0.12749684,"about_ca_system_score_codex":0.000042454172,"about_ca_system_score_gemma":0.00009137394,"threshold_uncertainty_score":0.4111004},"labels":[],"label_agreement":null},{"id":"W4417013459","doi":"10.1182/blood-2025-379","title":"First results of exagamglogene autotemcel in pediatric patients aged 5-11 years with transfusion-dependent β-thalassemia or sickle cell disease with recurrent severe vaso-occlusive crises","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Fetal hemoglobin; Clinical endpoint; Climb; Adverse effect; Incidence (geometry); Hematopoietic stem cell transplantation; Sickle cell anemia; Hemoglobin","score_opus":0.005603497155184701,"score_gpt":0.2152376291367709,"score_spread":0.2096341319815862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417013459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961817,0.00091365504,0.000013042558,0.00024387897,0.00011399584,0.0011089212,0.00014822363,0.000046474666,0.0012300914],"genre_scores_gemma":[0.9972287,0.0014827751,0.0001972013,0.000075155505,0.000030257634,0.000042104413,0.00008944476,0.00003128016,0.000823095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99817777,0.00006439749,0.0004748289,0.00047950482,0.00046055438,0.0003429731],"domain_scores_gemma":[0.9989773,0.00011384988,0.00015975878,0.00039321504,0.00013724322,0.00021861804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001186217,0.0002617029,0.00041806034,0.00027071618,0.00008469203,0.000011175389,0.00013900784,0.00014853866,0.00004129872],"category_scores_gemma":[0.00009848158,0.00017555582,0.000081600185,0.00076272455,0.000063360414,0.000056136694,0.000054329383,0.00029452695,0.000005329121],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011057868,0.0095969355,0.971246,0.0016993536,0.00016041283,0.0010024173,0.0021660055,0.0006900257,0.00013150882,0.00000452691,0.0014655882,0.00077934336],"study_design_scores_gemma":[0.04692868,0.001951362,0.9456153,0.0012077397,0.0016911662,0.000011286838,0.0008395573,0.00004505989,0.0009839948,0.000010058844,0.00035593146,0.0003598878],"about_ca_topic_score_codex":0.00022182046,"about_ca_topic_score_gemma":0.00096995337,"teacher_disagreement_score":0.035870813,"about_ca_system_score_codex":0.00006414584,"about_ca_system_score_gemma":0.00062242796,"threshold_uncertainty_score":0.7158959},"labels":[],"label_agreement":null},{"id":"W4417013564","doi":"10.1182/blood-2025-4834","title":"Evaluation of the combined effects of emicizumab and marstacimab in plasma from Hemophilia A patients using thrombin generation assay","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; Hamilton Health Sciences","funders":"","keywords":"Coagulation; Thromboplastin; Thrombin; Monoclonal antibody; Antibody; Tissue factor; Thrombin generation; Monoclonal; Factor V","score_opus":0.029040488645062788,"score_gpt":0.30520964031510994,"score_spread":0.27616915167004713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417013564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99830216,0.0002963337,0.00000371583,0.000107586144,0.00009470811,0.00097023614,0.000007677537,0.000003825237,0.0002137325],"genre_scores_gemma":[0.9997394,0.000018768009,0.0001349758,0.000011870624,0.000013196413,0.000014850115,0.00002951551,0.000005741321,0.000031662454],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987993,0.00026095836,0.00021191179,0.00014413056,0.0004881167,0.00009554306],"domain_scores_gemma":[0.9993905,0.00012753632,0.000066227236,0.00018962247,0.00020625677,0.000019877114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042853414,0.000077284145,0.00021037231,0.00010621618,0.00003239868,0.000004780305,0.00004456137,0.000074819494,0.000008546533],"category_scores_gemma":[0.00046413307,0.000052607033,0.00003741754,0.00023613754,0.000053710573,0.000032917633,0.00004822808,0.00007962811,3.7640484e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000113376904,0.0016929627,0.6057998,0.00018849342,0.00021277853,0.0000022815434,0.0003304899,0.000013837769,0.38481164,0.000042021013,0.000025854653,0.0067664715],"study_design_scores_gemma":[0.017944178,0.00021788353,0.44224373,0.0004139773,0.0006805368,6.911864e-7,0.000018649727,0.017040579,0.52070117,0.0006998331,5.6488193e-7,0.000038233735],"about_ca_topic_score_codex":0.00011102084,"about_ca_topic_score_gemma":0.000034904875,"teacher_disagreement_score":0.16355605,"about_ca_system_score_codex":0.00007737344,"about_ca_system_score_gemma":0.00019379427,"threshold_uncertainty_score":0.21452525},"labels":[],"label_agreement":null},{"id":"W4417013566","doi":"10.1182/blood-2025-4842","title":"Self-reported prophylaxis treatment experience among persons living with hemophilia A in the US: A cross-sectional analysis of survey results combined with medical records","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Medical record; Cohort; Anxiety; Cohort study; Patient satisfaction; Health care; MEDLINE; Incidence (geometry)","score_opus":0.031986799002854636,"score_gpt":0.3276332865609868,"score_spread":0.29564648755813216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417013566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974827,0.00005458796,0.000006101273,0.00021846541,0.0000205263,0.00077488116,0.000035161218,0.000032016844,0.0013755622],"genre_scores_gemma":[0.99807364,0.000041508058,0.00017915247,0.000024329967,0.000021523263,0.00021877777,0.00010731729,0.000010750316,0.0013230266],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99748695,0.00028653568,0.00047244134,0.00047629926,0.0009686004,0.00030917348],"domain_scores_gemma":[0.9981673,0.00080128317,0.00012740173,0.0005299805,0.00024198154,0.00013205857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011151107,0.0002019839,0.0005064251,0.00048941054,0.00013585435,0.00003868611,0.0001685475,0.00013763839,0.00005983235],"category_scores_gemma":[0.000840331,0.00009893611,0.00012905075,0.002963944,0.00034626655,0.00004561397,0.000035122674,0.00023274789,9.3345983e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014018067,0.004224511,0.98652536,0.00004127133,0.004116153,0.00047060283,0.0030494654,0.000008812131,0.00003229887,0.0000035558337,0.0000051934917,0.00012095628],"study_design_scores_gemma":[0.006703541,0.0036219214,0.9868275,0.00019289642,0.0010229511,0.00004763965,0.0004335968,0.0006569628,0.00038562884,7.4961724e-7,0.000011734368,0.00009490187],"about_ca_topic_score_codex":0.003807087,"about_ca_topic_score_gemma":0.010014953,"teacher_disagreement_score":0.006207866,"about_ca_system_score_codex":0.00012702632,"about_ca_system_score_gemma":0.00079878466,"threshold_uncertainty_score":0.5755202},"labels":[],"label_agreement":null},{"id":"W4417013567","doi":"10.1182/blood-2025-4836","title":"Phosphatidylserine-rich platelet blebs enhance hemostasis after mucous membrane injury but not after skin or vascular injury: Studies with ANO6-deficient mice","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Platelet; Hemostasis; Bleeding diathesis; Annexin A5; Thrombin; Phosphatidylserine; Transmembrane protein; Prothrombinase; Congenic; Annexin","score_opus":0.012764841737296143,"score_gpt":0.2825302134482722,"score_spread":0.2697653717109761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417013567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933724,0.0033352107,0.0002082432,0.00092063827,0.00030415208,0.0010454787,0.0000742733,0.00020358412,0.0005360572],"genre_scores_gemma":[0.9874049,0.0008799374,0.0035143804,0.0045534014,0.00010726497,0.0005445957,0.000020613588,0.000068340334,0.0029065982],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972849,0.00007980492,0.0005776593,0.00080303964,0.0006846802,0.0005699233],"domain_scores_gemma":[0.9983889,0.00008990554,0.00014846471,0.0008139266,0.00038618763,0.00017265466],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000316538,0.0005089152,0.0009348103,0.00027107185,0.00014366266,0.000057714038,0.00018513911,0.00019739398,0.00039893616],"category_scores_gemma":[0.00009971799,0.0003698266,0.00016972661,0.0009208664,0.0001321325,0.00015104174,0.00018855304,0.00030518923,0.000096458505],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07237331,0.038893253,0.025495121,0.014695767,0.04375221,0.0041789603,0.014512534,0.00009958824,0.70783794,0.0025415255,0.008480574,0.06713919],"study_design_scores_gemma":[0.0045947153,0.0011925513,0.0051438655,0.0007510174,0.0018457174,0.000037481168,0.0005760761,0.000025097215,0.98061764,0.000040059633,0.0047020786,0.00047367494],"about_ca_topic_score_codex":0.00004694233,"about_ca_topic_score_gemma":0.00007020077,"teacher_disagreement_score":0.2727797,"about_ca_system_score_codex":0.00007354395,"about_ca_system_score_gemma":0.00021057439,"threshold_uncertainty_score":0.99987537},"labels":[],"label_agreement":null},{"id":"W4417013575","doi":"10.1182/blood-2025-4841","title":"Pharmacodynamic biomarkers in people with hemophilia A receiving multiple ascending doses of NXT007","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Pharmacodynamics; Partial thromboplastin time; Thromboplastin; In vivo; Pharmacokinetics; Biomarker; Thrombin; Thrombin time; Antibody","score_opus":0.013517471440130087,"score_gpt":0.30530579159672705,"score_spread":0.29178832015659695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417013575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99286413,0.00050202425,0.000015213196,0.00066502544,0.00004994455,0.00049082196,0.0000058590804,0.000037738573,0.0053692465],"genre_scores_gemma":[0.99801624,0.00015471572,0.00071907387,0.000030671406,0.000023111976,0.00003106346,0.000015977239,0.000015051071,0.0009940753],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989908,0.000041615356,0.00021904611,0.00023777343,0.00022343907,0.00028733048],"domain_scores_gemma":[0.99943584,0.00019084202,0.000040879117,0.0002029456,0.00005373761,0.00007575498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002171257,0.00012805981,0.00029963814,0.0004243156,0.00004513032,0.000008125705,0.00008493529,0.000060853326,0.00005719535],"category_scores_gemma":[0.00013546129,0.00009435215,0.00006224302,0.0008493704,0.0000651835,0.0000502429,0.00004663661,0.00015246564,0.0000060187267],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038693033,0.0009093539,0.8920676,0.00035813756,0.0004213606,0.00011157874,0.00022206262,0.0000033320464,0.102600284,0.000016841494,0.00005260164,0.002849911],"study_design_scores_gemma":[0.021608528,0.00038895322,0.7685455,0.0016358539,0.00042421123,0.000053765496,0.00054241787,0.0016959477,0.20468895,0.00003376098,0.00019152787,0.00019060238],"about_ca_topic_score_codex":0.00022359611,"about_ca_topic_score_gemma":0.00028273783,"teacher_disagreement_score":0.12352212,"about_ca_system_score_codex":0.000065592474,"about_ca_system_score_gemma":0.00017482848,"threshold_uncertainty_score":0.3847569},"labels":[],"label_agreement":null},{"id":"W4417013582","doi":"10.1182/blood-2025-4845","title":"Outcomes of marstacimab treatment in adolescent participants with Hemophilia A or B without inhibitors compared with prior routine prophylaxis: Results from the phase 3 BASIS trial","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster Children's Hospital","funders":"","keywords":"Adverse effect; Bleed; Incidence (geometry); Observational study; Factor IX; Clinical trial; Hemarthrosis; Risk factor; Population","score_opus":0.06530562784369948,"score_gpt":0.3549754596585926,"score_spread":0.28966983181489314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417013582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99251896,0.00017244453,0.0000037204327,0.002539607,0.000059006077,0.0042322786,0.00017539189,0.00004478325,0.00025382882],"genre_scores_gemma":[0.9969988,0.000041230272,0.0004600365,0.00007374834,0.0000956248,0.0003172868,0.00008492399,0.00002699625,0.0019013876],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9975027,0.00017235876,0.00070211146,0.0005235258,0.0005899225,0.00050936907],"domain_scores_gemma":[0.9984747,0.000331328,0.00017765498,0.00072853075,0.00012493314,0.0001628075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029986046,0.00035207302,0.0009643253,0.000177324,0.00009706673,0.000028773025,0.00015516001,0.00010015579,0.000029330587],"category_scores_gemma":[0.00023153315,0.00014314624,0.00011404793,0.00067364605,0.00022408032,0.000051965726,0.000054371565,0.00022457067,0.0000049843616],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29030725,0.01912654,0.6830212,0.00007529686,0.0012324719,0.00037388058,0.0014891183,0.0000034700038,0.0005055887,0.0000026192515,0.00007078831,0.0037917641],"study_design_scores_gemma":[0.699566,0.016144512,0.22619854,0.0015187616,0.0013724986,0.000010493595,0.0011193695,0.00009932024,0.05350105,0.000006485645,0.00022223746,0.00024069601],"about_ca_topic_score_codex":0.00083389244,"about_ca_topic_score_gemma":0.0014765512,"teacher_disagreement_score":0.45682266,"about_ca_system_score_codex":0.00016479398,"about_ca_system_score_gemma":0.00085576414,"threshold_uncertainty_score":0.58373344},"labels":[],"label_agreement":null},{"id":"W4417013583","doi":"10.1182/blood-2025-4838","title":"Characterization of participants with elevated bleeding rates responding to prophylactic marstacimab treatment in the phase 3 BASIS trial","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Observational study; Phases of clinical research; Clinical trial; Coagulation; Adverse effect; Factor X","score_opus":0.05673042641417225,"score_gpt":0.37222101777339955,"score_spread":0.3154905913592273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417013583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99582237,0.000022420292,0.000010818962,0.0017193663,0.000029039222,0.0019953533,0.000008190692,0.000014526579,0.0003779144],"genre_scores_gemma":[0.9982872,0.000017737124,0.00006673757,0.000045780827,0.0000446698,0.00027994963,0.000033338423,0.000008729759,0.0012158814],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990134,0.000112698806,0.00022830215,0.00017963134,0.00021781318,0.0002481182],"domain_scores_gemma":[0.99952567,0.00012045978,0.000046476525,0.00019385396,0.000060742546,0.000052772757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031111276,0.000108784036,0.00024703896,0.0004924403,0.000056397657,0.000022880291,0.00005783617,0.00004032653,0.000026777336],"category_scores_gemma":[0.00014499704,0.000056587032,0.000036020636,0.0013114002,0.000026690836,0.000051455456,0.000012704843,0.00006676511,0.0000050511276],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05717153,0.0067718215,0.042932536,0.00011271124,0.00028696947,0.00017609741,0.0018165859,6.388622e-7,0.88685465,0.00007787392,0.0000033881686,0.003795218],"study_design_scores_gemma":[0.124092646,0.007538356,0.016839819,0.00028291388,0.0005488683,0.0000053304625,0.00042966648,0.00006881952,0.8499327,0.000008718471,0.00017692562,0.00007525864],"about_ca_topic_score_codex":0.00001930618,"about_ca_topic_score_gemma":0.000007387188,"teacher_disagreement_score":0.066921115,"about_ca_system_score_codex":0.00007016937,"about_ca_system_score_gemma":0.00020385567,"threshold_uncertainty_score":0.23075522},"labels":[],"label_agreement":null},{"id":"W4417013642","doi":"10.1182/blood-2025-4846","title":"Quality of life and functional improvements with efanesoctocog alfa in patients with moderate-to-severe Hemophilia A: A real-world survey","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Haemophilia; Quality of life (healthcare); McNemar's test; Clotting factor; Factor IX; Body mass index; Coagulopathy; EQ-5D","score_opus":0.03127709822247501,"score_gpt":0.3043001428059295,"score_spread":0.2730230445834545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417013642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965668,0.000031774747,0.000008659475,0.00027814013,0.000017774953,0.0011738129,0.00005536333,0.000014319508,0.0018533665],"genre_scores_gemma":[0.9965276,0.000009215279,0.00017291383,0.00015196325,0.00001539009,0.00007409115,0.00014177777,0.000013492855,0.0028935622],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998597,0.000099279256,0.00029045178,0.00032718753,0.00044675273,0.00023929181],"domain_scores_gemma":[0.9991463,0.00011918141,0.000057287954,0.00024776466,0.00026616987,0.00016331415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035446067,0.00015660634,0.00040102575,0.00024129219,0.000050489736,0.000012085555,0.000045360513,0.00005575033,0.000033591616],"category_scores_gemma":[0.000096041156,0.00010158394,0.000023492892,0.0005802423,0.000069840375,0.00005242588,0.00005526672,0.00013919393,0.000003021727],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073718424,0.0019488044,0.98934966,0.00020346459,0.00029876514,0.0000067688616,0.00004875058,0.0000062024583,0.0001574003,0.000050386087,0.00010801715,0.00044991355],"study_design_scores_gemma":[0.020786159,0.00074698345,0.97755086,0.00014400578,0.00004650938,4.3028504e-7,0.000018858653,0.000011191118,0.0005502497,0.000030792835,0.000013343848,0.00010058507],"about_ca_topic_score_codex":0.0014857545,"about_ca_topic_score_gemma":0.0027685054,"teacher_disagreement_score":0.013414317,"about_ca_system_score_codex":0.000044788,"about_ca_system_score_gemma":0.0003238367,"threshold_uncertainty_score":0.41424727},"labels":[],"label_agreement":null},{"id":"W4417013798","doi":"10.1182/blood-2025-4349","title":"Evaluating large language models in real-world hematologic clinical decision-making: Performance, limitations, and clinical implications","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Subspecialty; Hematology; Hematologic Neoplasms; Test (biology); MEDLINE; Diagnostic test; Set (abstract data type); Scale (ratio); Specialty","score_opus":0.3906290804132259,"score_gpt":0.5832482353174215,"score_spread":0.19261915490419562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417013798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99007434,0.0005868968,0.00085644255,0.0026233462,0.00022073853,0.00046221763,0.000002941774,0.000053133135,0.005119963],"genre_scores_gemma":[0.986708,0.0021639192,0.009753412,0.0009774235,0.00013243232,0.00006255248,0.000016246131,0.000008434499,0.00017761829],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980956,0.00014567198,0.0010819493,0.00032935533,0.00012291857,0.00022454186],"domain_scores_gemma":[0.9964331,0.0028423013,0.00012488497,0.00034583887,0.00016656691,0.00008733428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002010263,0.00009262581,0.00030072132,0.0002337731,0.00013869627,0.000019013705,0.00008195771,0.00014441951,0.000015348129],"category_scores_gemma":[0.002519488,0.00008264909,0.0000707623,0.00045773102,0.00006539042,0.00009768677,0.0000544392,0.0003326453,0.000019502266],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053475498,0.00079173484,0.7292049,0.00004779647,0.000020378602,0.0000035496914,0.0002842571,0.000015001559,0.000006624012,0.0055333017,0.00023172301,0.26380727],"study_design_scores_gemma":[0.0005742489,0.0003268991,0.94721955,0.000735928,0.00020692847,0.000015809379,0.0016412686,0.02860151,0.000077685625,0.020225694,0.00024601482,0.0001284714],"about_ca_topic_score_codex":0.000064529246,"about_ca_topic_score_gemma":0.0007468599,"teacher_disagreement_score":0.26367882,"about_ca_system_score_codex":0.000033858945,"about_ca_system_score_gemma":0.00037613953,"threshold_uncertainty_score":0.33703318},"labels":[],"label_agreement":null},{"id":"W4417013934","doi":"10.1182/blood-2025-1345","title":"Undiagnosed patent foramen ovale with bi-atrial thrombus in transit: A case of pulmonary embolism and refractory hypoxia","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Cardiovascular and Diving-Related Complications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Windsor; Windsor Regional Hospital; Western University","funders":"","keywords":"Patent foramen ovale; Thrombus; Pulmonary embolism; Pulmonary hypertension; Thrombosis; Transesophageal echocardiogram; Transthoracic echocardiogram; Foramen secundum; Venous thrombosis; Thrombophilia","score_opus":0.016608581248432168,"score_gpt":0.24723578333977023,"score_spread":0.23062720209133805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417013934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916081,0.004416818,0.00022406402,0.00022943868,0.00004013521,0.0004944433,0.000015710939,0.00003009724,0.0029412343],"genre_scores_gemma":[0.9993037,0.00029024447,0.00021645548,0.000053739703,0.000035650886,0.000020475016,0.000015156564,0.000011102152,0.000053467425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99930155,0.000038756894,0.00020741411,0.00021008714,0.000108655186,0.0001335466],"domain_scores_gemma":[0.9994486,0.000083656065,0.000036444864,0.00031887533,0.000051636624,0.00006077973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012833002,0.00010132635,0.00032174707,0.00017295581,0.00003891561,0.000008424416,0.000037726262,0.00008760369,0.00000924598],"category_scores_gemma":[0.000035481557,0.00008534673,0.0001370063,0.0003196099,0.000060217146,0.00003686776,0.000021357091,0.00014680755,0.0000012970521],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010474028,0.027685035,0.55507326,0.004776174,0.02052839,0.07282658,0.01194064,0.0012275623,0.08340968,0.011707599,0.0009075366,0.19944349],"study_design_scores_gemma":[0.06573921,0.00096016406,0.90184176,0.0014948996,0.007505206,0.012153486,0.0014971518,0.00055579,0.0045529325,0.001300196,0.0018364516,0.00056276214],"about_ca_topic_score_codex":0.0004984859,"about_ca_topic_score_gemma":0.00009206092,"teacher_disagreement_score":0.34676847,"about_ca_system_score_codex":0.000018153105,"about_ca_system_score_gemma":0.00011097215,"threshold_uncertainty_score":0.34803385},"labels":[],"label_agreement":null},{"id":"W4417013939","doi":"10.1182/blood-2025-1348","title":"The score settles it? maybe not: Navigating postpartum VTE prophylaxis","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Incidence (geometry); Pregnancy; Medical history; Risk factor; Family history; Cohort; Gestation; Postpartum period","score_opus":0.012531900361532965,"score_gpt":0.2800650428315624,"score_spread":0.26753314247002946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417013939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9461514,0.0013209685,0.000017813663,0.029845456,0.00039211125,0.00082655775,0.000009061931,0.00010614637,0.021330524],"genre_scores_gemma":[0.9920021,0.0004969883,0.0003138921,0.0040064617,0.00017397854,0.00010546641,0.000014080555,0.000018305378,0.002868677],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989391,0.0000335346,0.00024307791,0.00024621506,0.00023423032,0.0003038317],"domain_scores_gemma":[0.9992559,0.000109062465,0.0000641808,0.00043009676,0.00007716799,0.00006360587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026422358,0.00013962362,0.00025585256,0.000034840745,0.00032923458,0.00007049994,0.00015916108,0.00005820171,0.00002693972],"category_scores_gemma":[0.00016690574,0.00009195467,0.00009910765,0.00021615467,0.00008070485,0.00003701396,0.0001431633,0.00023348563,0.00006770815],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044240316,0.011000054,0.14217821,0.0045851357,0.005377499,0.0009297857,0.0086739,0.000027064229,0.028475178,0.09978912,0.3476672,0.3508545],"study_design_scores_gemma":[0.007626711,0.0018415311,0.64254814,0.0051106415,0.002372364,0.00006161337,0.0038048367,0.00011480852,0.08462698,0.002341469,0.24881965,0.0007312806],"about_ca_topic_score_codex":0.000065019165,"about_ca_topic_score_gemma":0.00002151894,"teacher_disagreement_score":0.5003699,"about_ca_system_score_codex":0.000022797312,"about_ca_system_score_gemma":0.00007833504,"threshold_uncertainty_score":0.37498027},"labels":[],"label_agreement":null},{"id":"W4417013954","doi":"10.1182/blood-2025-1353","title":"Catheter-related risk factors for neonatal venous thrombo-embolism: A systematic review of the literature","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval","funders":"","keywords":"Retrospective cohort study; Prospective cohort study; Gestational age; Cohort study; Incidence (geometry); Intensive care; Risk factor; Cohort","score_opus":0.009852654513982689,"score_gpt":0.25860443623021484,"score_spread":0.24875178171623216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417013954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.803707,0.18217365,0.00046807746,0.0015432511,0.0011777715,0.009126636,0.00031898188,0.00018630642,0.0012983402],"genre_scores_gemma":[0.99633324,0.0018675517,0.00021709097,0.00073096436,0.000022952187,0.00010493474,0.000050906554,0.000020917154,0.00065143534],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99882436,0.00011625327,0.00050021365,0.00019572269,0.00020860056,0.00015487632],"domain_scores_gemma":[0.99875987,0.00014148005,0.00028717375,0.0005839096,0.00018121095,0.000046372614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002709768,0.00016527792,0.00077564776,0.0000718835,0.00009490645,0.000013935317,0.00017295528,0.00013408774,0.000024178586],"category_scores_gemma":[0.0005705669,0.000095712094,0.0003912317,0.00045456426,0.000032497723,0.000034646855,0.00004467601,0.00018588816,0.000003828203],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002859618,0.002859929,0.0013468481,0.9705447,0.0030135906,0.0000056462477,0.0043426696,0.0000019939487,0.0031681112,0.0139649315,0.0005438438,0.00017914522],"study_design_scores_gemma":[0.008013724,0.00094962766,0.0065500033,0.8880937,0.025051896,0.000104832776,0.00054324494,0.000136886,0.06438264,0.0053892466,0.00036917275,0.0004149948],"about_ca_topic_score_codex":0.000008810858,"about_ca_topic_score_gemma":0.0000014853616,"teacher_disagreement_score":0.19262627,"about_ca_system_score_codex":0.000015219894,"about_ca_system_score_gemma":0.00008823244,"threshold_uncertainty_score":0.3903026},"labels":[],"label_agreement":null},{"id":"W4417013955","doi":"10.1182/blood-2025-1346","title":"Safety of prothrombin complex concentrate for emergency surgery according to the oral factor xa inhibitor level","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"Moderna; Regeneron Pharmaceuticals; Sanofi","keywords":"Rivaroxaban; Apixaban; Edoxaban; Emergency surgery; Incidence (geometry); Prothrombin complex concentrate; PROTHROMBIN COMPLEX; Venous thromboembolism; Dabigatran","score_opus":0.1833951177774287,"score_gpt":0.37523866712843396,"score_spread":0.19184354935100525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417013955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801466,0.00011584574,0.004594271,0.009993324,0.0009611038,0.0029570684,0.00010027199,0.00005511965,0.0010764304],"genre_scores_gemma":[0.9963967,0.00002239186,0.00066496996,0.00020641116,0.0003363376,0.000015732883,0.00003345356,0.000010298105,0.0023137035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99912715,0.000029479977,0.00039272913,0.00014605404,0.00013296315,0.00017164773],"domain_scores_gemma":[0.99941707,0.00017194511,0.000096027485,0.00017558658,0.00009898227,0.000040389765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022423857,0.00009862407,0.00032204812,0.00007678292,0.00008704957,0.000009097794,0.00006805657,0.000035047775,0.00014951009],"category_scores_gemma":[0.00030911894,0.00006831933,0.0001801196,0.00027354612,0.000019017569,0.000042385258,0.000053073458,0.000038009453,0.000008316038],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047433795,0.000056690762,0.95116895,0.0003537286,0.00040567882,0.000001093247,0.00018599744,0.000008471999,0.019660149,0.0035691615,0.017719371,0.006396382],"study_design_scores_gemma":[0.0039355285,0.000119087585,0.8712306,0.00015348398,0.00040197198,7.061115e-7,0.0004638726,0.000094252406,0.027330816,0.00021130347,0.09589054,0.00016781517],"about_ca_topic_score_codex":0.000018503413,"about_ca_topic_score_gemma":0.000015174969,"teacher_disagreement_score":0.07993831,"about_ca_system_score_codex":0.000015325933,"about_ca_system_score_gemma":0.00006898674,"threshold_uncertainty_score":0.27859813},"labels":[],"label_agreement":null},{"id":"W4417013956","doi":"10.1182/blood-2025-1350","title":"VTE management in primary central nervous system neoplasms : A retrospective cohort study in a Canadian tertiary center between 2013 and 2023","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Retrospective cohort study; Thrombosis; Deep vein; Pulmonary embolism; Cancer; Venous thrombosis; Inferior vena cava; Low molecular weight heparin; Cohort","score_opus":0.0047316946852846604,"score_gpt":0.2251316653505591,"score_spread":0.22039997066527442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417013956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96775085,0.00026425542,0.000002854351,0.0007215771,0.00016822237,0.003613272,0.000023113429,0.000037517602,0.02741836],"genre_scores_gemma":[0.99840015,0.0001712023,0.000058919934,0.00042103583,0.000052397136,0.00032957943,0.00003680058,0.000019068233,0.0005108492],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981768,0.00007377337,0.00038547197,0.0005002148,0.00023060665,0.0006331374],"domain_scores_gemma":[0.99935293,0.00001897935,0.000046889298,0.00033722035,0.000023571596,0.00022038586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037093452,0.00020445511,0.0006331059,0.00059478753,0.00005878486,0.000038244685,0.000114788854,0.00007209647,0.000016151009],"category_scores_gemma":[0.000008376128,0.0001981635,0.00004572738,0.000404948,0.000025925414,0.000060444327,0.00015668383,0.00019763374,0.000012331403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016038655,0.0013649914,0.9929387,0.00036786566,0.00065696525,0.0011722025,0.00042098202,0.000003014272,0.000002418348,0.00019521154,0.0016293454,0.0012322535],"study_design_scores_gemma":[0.004848669,0.00016274946,0.9921449,0.000538424,0.00060741004,0.000008111727,0.00092171476,0.00002312779,0.000005937705,0.00001572187,0.00057300186,0.0001502598],"about_ca_topic_score_codex":0.2560472,"about_ca_topic_score_gemma":0.3220073,"teacher_disagreement_score":0.06596013,"about_ca_system_score_codex":0.00085989194,"about_ca_system_score_gemma":0.000112824404,"threshold_uncertainty_score":0.8080873},"labels":[],"label_agreement":null},{"id":"W4417014103","doi":"10.1182/blood-2025-8","title":"Sickle cell disease is associated with early-onset clonal hematopoiesis involving DNA damage response pathway mutations","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Leukemia; Myeloid; Disease; Myeloid leukemia; Haematopoiesis; Somatic cell; Germline mutation; Hematopoietic stem cell transplantation; Somatic evolution in cancer; Allele","score_opus":0.005879899633752663,"score_gpt":0.21920294099830265,"score_spread":0.21332304136455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417014103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99267465,0.00082534575,0.000024445497,0.0029885585,0.0000582239,0.00038317946,0.00015594791,0.00015555813,0.0027340949],"genre_scores_gemma":[0.9914995,0.000029488567,0.00014479659,0.0015243827,0.000015521493,0.000036907175,0.000115881005,0.000030405407,0.006603127],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986514,0.000142928,0.00026801863,0.0003133364,0.0002913763,0.00033297736],"domain_scores_gemma":[0.99886656,0.00029422579,0.00008910002,0.000360137,0.00014409187,0.00024590807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025659014,0.00019963473,0.0002817606,0.00018742049,0.00025354186,0.00004223442,0.00009924908,0.00014545045,0.00014149568],"category_scores_gemma":[0.0004980999,0.0001635139,0.00012162888,0.0006270898,0.00013143056,0.00007629224,0.000052316944,0.00027672874,0.00004848184],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010478072,0.019129321,0.8430479,0.0014413439,0.0036023692,0.0074624657,0.015893385,0.00008826192,0.06144581,0.0010475151,0.03590586,0.00045768937],"study_design_scores_gemma":[0.025670763,0.0010207088,0.8971271,0.002459322,0.0036514257,0.000050064955,0.0045660515,0.00052332773,0.05891142,0.0011241502,0.0039506326,0.0009450357],"about_ca_topic_score_codex":0.000040027306,"about_ca_topic_score_gemma":0.00001368545,"teacher_disagreement_score":0.05407919,"about_ca_system_score_codex":0.000051331757,"about_ca_system_score_gemma":0.00067211606,"threshold_uncertainty_score":0.6667903},"labels":[],"label_agreement":null},{"id":"W4417014157","doi":"10.1182/blood-2025-878","title":"Optimized treatment for pediatric patients with low-risk Acute Myeloid Leukemia: A report from the Children's oncology group study AAML1831","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Astellas Pharma; Jazz Pharmaceuticals","keywords":"Cytarabine; Anthracycline; Induction chemotherapy; Myeloid leukemia; Chemotherapy; Cumulative incidence; Chemotherapy regimen; Minimal residual disease; Idarubicin; Group B","score_opus":0.008218902604893885,"score_gpt":0.28099442078964765,"score_spread":0.27277551818475376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417014157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898702,0.0003359513,0.00054925214,0.0006084368,0.00017024524,0.007505113,0.00027119648,0.00012455978,0.0005650515],"genre_scores_gemma":[0.986139,0.0004678847,0.007342743,0.00043156068,0.0007471015,0.0020140896,0.0011361842,0.000086042324,0.0016354066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971709,0.00023771607,0.0006078713,0.0008577334,0.00052558375,0.0006001663],"domain_scores_gemma":[0.9971141,0.0008925777,0.00032051274,0.0011835074,0.0002985558,0.00019074812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047273134,0.00040437022,0.0008420165,0.00019445285,0.00034238017,0.000045843397,0.00035282536,0.0002264237,0.000039622733],"category_scores_gemma":[0.0003740852,0.00022877114,0.00022612335,0.00059607334,0.000104243976,0.00007367755,0.00019288776,0.00051755767,0.000020852904],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004342222,0.0076609617,0.9721093,0.000017403718,0.0050968872,0.0005682879,0.00059213926,0.000017817274,0.000025285533,0.000006882347,0.004336171,0.0052266414],"study_design_scores_gemma":[0.106965505,0.008743107,0.87030786,0.00003067129,0.0117126,0.000059897615,0.00034362412,0.000067623834,0.00025295193,0.000039661903,0.0012079219,0.0002685733],"about_ca_topic_score_codex":0.0013103612,"about_ca_topic_score_gemma":0.00012875452,"teacher_disagreement_score":0.102623284,"about_ca_system_score_codex":0.001203797,"about_ca_system_score_gemma":0.0019015494,"threshold_uncertainty_score":0.9329016},"labels":[],"label_agreement":null},{"id":"W4417014232","doi":"10.1182/blood-2025-2470","title":"Clinically meaningful improvement of the modified lee symptom score in patients treated with belumosudil for steroid-refractory chronic GVHD: Evidence from Canadian real-world outcomes","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Saskatchewan Cancer Agency; University of British Columbia; University Health Network; University of Toronto; Hamilton Health Sciences; Princess Margaret Cancer Centre; BC Cancer Agency","funders":"","keywords":"Clinical trial; Swallowing; Quality of life (healthcare); Disease; Confidence interval; Clinical endpoint; Standard score","score_opus":0.020195290881365284,"score_gpt":0.2892546838035123,"score_spread":0.26905939292214703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417014232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99636364,0.00080617255,0.000008130938,0.0005802024,0.00007436566,0.0014888076,0.00008128603,0.00001890897,0.00057847536],"genre_scores_gemma":[0.9982843,0.00074018125,0.000072834206,0.00019661264,0.000017737919,0.0001429976,0.000034787347,0.000020344087,0.0004902269],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983755,0.00006229652,0.0005150562,0.00031691557,0.00033526582,0.00039498106],"domain_scores_gemma":[0.9986132,0.00035738017,0.00014250314,0.0005238184,0.00020110207,0.00016201661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024005063,0.00017404996,0.0004439528,0.00019938222,0.00009346004,0.000022765073,0.00025391317,0.00006851363,0.000047586964],"category_scores_gemma":[0.00029017657,0.000110472785,0.00010681089,0.00026842815,0.00012807662,0.00008581951,0.000057393623,0.00020789503,0.0000021195046],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003966343,0.000440504,0.98773885,0.000070177965,0.00035241042,0.000004934171,0.00023562888,0.0000032838318,0.0009718078,0.000057244666,0.000058521666,0.009669999],"study_design_scores_gemma":[0.01219538,0.0016049035,0.9801469,0.0014434445,0.000050377646,1.5641696e-7,0.000053564123,0.00004496866,0.0041579045,0.00006545157,0.00013183463,0.000105137784],"about_ca_topic_score_codex":0.13315904,"about_ca_topic_score_gemma":0.47071445,"teacher_disagreement_score":0.3375554,"about_ca_system_score_codex":0.00025744192,"about_ca_system_score_gemma":0.0011712243,"threshold_uncertainty_score":0.8726133},"labels":[],"label_agreement":null},{"id":"W4417014291","doi":"10.1182/blood-2025-3903","title":"Real-world (RW) use of fixed-duration (FD) ibrutinib+venetoclax (Ibr+Ven) in patients (pts) with previously untreated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): Pooled analysis of REALITY-worldwide (WW) and REALITY-2 prospective cohort studies","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tolerability; Clinical trial; Clinical endpoint; Prospective cohort study; Adverse effect; Cohort study; Cohort; Discontinuation","score_opus":0.02364489091999106,"score_gpt":0.3028390251495863,"score_spread":0.27919413422959527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417014291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928368,0.0014666095,0.000026266547,0.00006482864,0.000059939626,0.004013818,0.0001420086,0.00013922832,0.0012505503],"genre_scores_gemma":[0.9940924,0.0027814857,0.00048428949,0.00007347182,0.000049880822,0.0005172678,0.00044256126,0.00008943271,0.001469211],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9931682,0.00063375983,0.002339386,0.001517071,0.00125802,0.0010835648],"domain_scores_gemma":[0.99401957,0.0015358827,0.0010294879,0.0017157875,0.0013804497,0.0003188098],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001290848,0.00080035446,0.0029936621,0.0022833862,0.00017122639,0.00006878122,0.0003874229,0.00033877185,0.00002930371],"category_scores_gemma":[0.0013825783,0.0006833214,0.00036178905,0.0064855134,0.00090215885,0.00032751882,0.00040965684,0.0002710102,0.000004830228],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.008977199,0.0016469593,0.93283737,0.0052679908,0.034205917,0.000339673,0.0019947076,0.00919574,0.0009111867,0.00092670316,0.0003125874,0.003383942],"study_design_scores_gemma":[0.09922389,0.0017188237,0.81364733,0.0037772602,0.024375472,0.000039180686,0.00030116973,0.037881833,0.018153794,0.000112483445,0.000071498325,0.0006972545],"about_ca_topic_score_codex":0.061686765,"about_ca_topic_score_gemma":0.03852064,"teacher_disagreement_score":0.119190045,"about_ca_system_score_codex":0.13238186,"about_ca_system_score_gemma":0.043905906,"threshold_uncertainty_score":0.9995618},"labels":[],"label_agreement":null},{"id":"W4417014418","doi":"10.1182/blood-2025-5773","title":"Do chip mutations predict frailty and toxicity in transplant-eligible patients with multiple myeloma?","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Ontario Institute for Cancer Research; Windsor Regional Hospital; Alberta Cancer Foundation; Princess Margaret Cancer Centre","funders":"","keywords":"Toxicity; Multiple myeloma; Clinical trial; Prospective cohort study; Comorbidity; Hematopoietic stem cell transplantation; Performance status; Stem cell","score_opus":0.015005603728760511,"score_gpt":0.27564382316848773,"score_spread":0.2606382194397272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417014418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958013,0.00021344396,0.000059182545,0.00014483223,0.000018345012,0.000801231,0.00013837594,0.000043013584,0.002780219],"genre_scores_gemma":[0.9986818,0.000045240562,0.00071961246,0.000058880225,0.000013896918,0.000088142646,0.00018464726,0.000010939383,0.00019685198],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901164,0.000035250094,0.00016801173,0.00027308936,0.00023724337,0.0002747628],"domain_scores_gemma":[0.9994658,0.000112912036,0.000023674998,0.00019403287,0.000057388963,0.00014618879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000064306485,0.0001344327,0.00021405533,0.00019677225,0.00008069029,0.000021280212,0.000053042506,0.000065935084,0.000028950231],"category_scores_gemma":[0.000093505834,0.00009922499,0.000029727267,0.0002782812,0.000066642926,0.00007070086,0.000021018483,0.00014935878,0.000007213933],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045482238,0.0016794213,0.9933231,0.000104502695,0.0001757079,0.000073225834,0.00021546279,0.0000023797822,0.00061974727,0.000026085614,0.000026593221,0.003298966],"study_design_scores_gemma":[0.021506967,0.00037619102,0.96918166,0.00025559336,0.00012377763,0.0000066316907,0.000031693682,0.00013448483,0.00816793,0.00006226038,0.0000734082,0.000079376136],"about_ca_topic_score_codex":0.00017668723,"about_ca_topic_score_gemma":0.00036203663,"teacher_disagreement_score":0.0241414,"about_ca_system_score_codex":0.00002680806,"about_ca_system_score_gemma":0.00010298526,"threshold_uncertainty_score":0.40462777},"labels":[],"label_agreement":null},{"id":"W4417014643","doi":"10.1182/blood-2025-2451","title":"Vorinostat for GVHD prophylaxis in children, adolescents, and young adults (AYA) shows low incidence of acute GVHD and relapse with encouraging overall survival after allogeneic hematopoietic cell transplantation (HCT): A multisite, nonrandomized clinical trial","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children’s Health Research Institute","funders":"","keywords":"Vorinostat; Clinical endpoint; Incidence (geometry); Transplantation; Cumulative incidence; Immunosuppression; Hazard ratio; Hematopoietic stem cell transplantation","score_opus":0.007155817751968099,"score_gpt":0.2641225151575087,"score_spread":0.25696669740554057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417014643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913024,0.00053111755,0.0030591325,0.000034239365,0.00020677551,0.0046811686,0.000106899155,0.000030835618,0.000047479723],"genre_scores_gemma":[0.99452126,0.0009711391,0.0039593107,0.0000534208,0.00004913608,0.00028388828,0.00008555873,0.000033172608,0.000043094366],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974556,0.00022236854,0.0010159271,0.0006338612,0.00034968008,0.0003225775],"domain_scores_gemma":[0.9988073,0.00041958236,0.00023161464,0.00027018564,0.00013346253,0.00013783907],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00075951807,0.00030757708,0.0009058208,0.00022367433,0.000052108076,0.00002744304,0.0000903633,0.00022808656,0.000010155951],"category_scores_gemma":[0.00007526388,0.0002576693,0.00013483541,0.0001975518,0.00014176093,0.00013461022,0.000021727077,0.00027934628,7.016866e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13726649,0.0011592174,0.85392964,0.0030387805,0.0002590766,0.00014969127,0.0015531842,0.0000021076378,0.001388138,0.000007733927,0.000001222079,0.0012446995],"study_design_scores_gemma":[0.328188,0.0012636735,0.6578086,0.0016576656,0.0015387629,0.00017435056,0.00008758638,0.00006978322,0.008975242,0.000016414528,4.1303323e-7,0.00021949923],"about_ca_topic_score_codex":0.00011718163,"about_ca_topic_score_gemma":0.00021385298,"teacher_disagreement_score":0.19612107,"about_ca_system_score_codex":0.00001913703,"about_ca_system_score_gemma":0.00014380926,"threshold_uncertainty_score":0.99998754},"labels":[],"label_agreement":null},{"id":"W4417014679","doi":"10.1182/blood-2025-3921","title":"Spatial proteomics of the bone marrow reveals distinct Tumor–Immune niches in smoldering and relapsed myeloma and their remodeling in response to bispecific antibody and CAR-T therapy","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Integrity Testing Laboratory (Canada)","funders":"","keywords":"Multiple myeloma; Bone marrow; Hematologic malignancy; Tumor microenvironment; Immunotherapy; Immunophenotyping; Flow cytometry","score_opus":0.018818863979529792,"score_gpt":0.28286349146779455,"score_spread":0.26404462748826474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417014679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931485,0.0037343525,0.000037523158,0.0013771884,0.000034084005,0.0015271034,0.000008381846,0.000013880835,0.000118952354],"genre_scores_gemma":[0.9985113,0.00057840935,0.0003707021,0.00007139804,0.000025119207,0.00004097719,0.000002268728,0.00002623901,0.0003735463],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984812,0.00029564727,0.00042885225,0.000357861,0.00017116535,0.00026526616],"domain_scores_gemma":[0.9990542,0.00032608752,0.0000711157,0.00043086536,0.000052543575,0.00006520033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014839617,0.00017876065,0.000469947,0.00031697477,0.00006379713,0.000030166379,0.00010709366,0.00008292764,0.000009896268],"category_scores_gemma":[0.00042299056,0.0001279286,0.000041472875,0.00047879445,0.00014710851,0.00003795861,0.00018603702,0.0003287984,1.3860164e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037769454,0.000116819436,0.22912654,0.000101070196,0.000025109197,0.000023941313,0.0012041286,0.000002416426,0.75894916,0.000006634395,0.0000017421158,0.006665479],"study_design_scores_gemma":[0.0062138527,0.00028921026,0.79367054,0.0008687344,0.0000137337465,0.000059539387,0.0003503747,0.00034553374,0.19778593,0.00020392537,0.000084286556,0.000114335824],"about_ca_topic_score_codex":0.00047764258,"about_ca_topic_score_gemma":0.00027542008,"teacher_disagreement_score":0.564544,"about_ca_system_score_codex":0.00004201356,"about_ca_system_score_gemma":0.00011847137,"threshold_uncertainty_score":0.5216777},"labels":[],"label_agreement":null},{"id":"W4417014706","doi":"10.1182/blood-2025-3924","title":"Enhancing immunotherapy efficacy in myeloma with a novel dual-action mitochondrial toxic peptide that overcomes resistance and induces immunogenic cell death.","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Granzyme; Cell culture; Immunotherapy; T cell; Cytotoxicity; Granzyme B; Viability assay; Immune system","score_opus":0.01343776296809729,"score_gpt":0.24510225371513497,"score_spread":0.23166449074703768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417014706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9543176,0.043452945,0.00017305068,0.0001236995,0.00052679743,0.00049693516,0.000015805688,0.0000816025,0.0008115071],"genre_scores_gemma":[0.9880158,0.002104034,0.0005953392,0.00016031011,0.000027701311,0.00007779781,0.0000264333,0.00003283883,0.00895979],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982354,0.00026362055,0.000437093,0.00048977946,0.000065163666,0.00050893985],"domain_scores_gemma":[0.99882126,0.0004531392,0.00018960761,0.00047694746,0.00004466868,0.0000143775505],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023954519,0.00036383464,0.0004926394,0.00034547693,0.00032030922,0.00006922528,0.00022946253,0.0003345635,0.000086393404],"category_scores_gemma":[0.00004821003,0.00031695378,0.00010963599,0.00035469895,0.00019093811,0.00024878886,0.00006756601,0.00047515403,0.000019393436],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045118434,0.0009164541,0.0013345858,0.000047733076,0.00043040558,0.000009957971,0.0010014543,0.0000012454091,0.9902893,0.00019265084,0.000039320716,0.0012250863],"study_design_scores_gemma":[0.015393837,0.00028483663,0.1116441,0.0003440319,0.000073678864,0.00007346944,0.0005691635,1.393108e-7,0.86185575,0.000030268071,0.009404233,0.0003264712],"about_ca_topic_score_codex":0.00020547827,"about_ca_topic_score_gemma":0.00030088372,"teacher_disagreement_score":0.1284335,"about_ca_system_score_codex":0.00006653925,"about_ca_system_score_gemma":0.0002059379,"threshold_uncertainty_score":0.99992824},"labels":[],"label_agreement":null},{"id":"W4417014736","doi":"10.1182/blood-2025-3895","title":"Preliminary efficacy and safety of the Bruton tyrosine kinase degrader BGB-16673 in patients with relapsed/refractory Richter transformation: Results from the ongoing phase 1 CaDAnCe-101 study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Bruton's tyrosine kinase; Ibrutinib; Chemoimmunotherapy; Tolerability; Chronic lymphocytic leukemia; Phases of clinical research; Lymphoma","score_opus":0.01228521462498295,"score_gpt":0.2723958621389367,"score_spread":0.26011064751395374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417014736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955574,0.00071223354,0.000012460512,0.0007703197,0.00006322199,0.0021159325,0.000072401366,0.0000186671,0.00067731756],"genre_scores_gemma":[0.9994457,0.00004785058,0.000050092713,0.00013760792,0.000039854902,0.000033494714,0.000044290027,0.000017495055,0.00018362899],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981492,0.00019499673,0.0005299268,0.00031789733,0.000557427,0.00025053544],"domain_scores_gemma":[0.99836797,0.0006463391,0.0001228747,0.00068926835,0.00011181022,0.00006175493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039167385,0.00018007099,0.00030213883,0.00008446068,0.00013126664,0.000017580915,0.0002102524,0.00008336972,0.00001038835],"category_scores_gemma":[0.00030439757,0.000095000796,0.000044225377,0.00050906016,0.00017609308,0.00011459548,0.00009747891,0.00038422534,0.000001754616],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19179237,0.09660656,0.51842624,0.0011696569,0.0028754123,0.0004182898,0.10711997,0.0002834767,0.0024260532,0.00016075929,0.0022871885,0.07643403],"study_design_scores_gemma":[0.27296618,0.0017648762,0.7200611,0.0009225012,0.00040607475,0.0000051873694,0.00073103176,0.00023926113,0.0023766533,0.0000067894243,0.00041697832,0.00010333919],"about_ca_topic_score_codex":0.0008541336,"about_ca_topic_score_gemma":0.0001815231,"teacher_disagreement_score":0.2016349,"about_ca_system_score_codex":0.0007345931,"about_ca_system_score_gemma":0.0012800993,"threshold_uncertainty_score":0.387402},"labels":[],"label_agreement":null},{"id":"W4417014747","doi":"10.1182/blood-2025-4454","title":"Disease monitoring and management among pediatric patients with pyruvate kinase deficiency: Real-world practices from pyruvate kinase deficiency registries prior to 2024 international expert guidelines","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Pyruvate kinase deficiency; Guideline; Disease registry; Retrospective cohort study; Disease; Observational study; Pyruvate kinase","score_opus":0.02344018227242279,"score_gpt":0.3090486865424654,"score_spread":0.28560850427004264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417014747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99275637,0.0013410909,0.00010401071,0.0014492109,0.0011523,0.00065768097,0.00005509172,0.000093982744,0.00239024],"genre_scores_gemma":[0.98698235,0.0020879616,0.0041396236,0.00060769933,0.0005870356,0.0001638819,0.00012419462,0.000029100685,0.005278149],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820054,0.00003646433,0.00043201496,0.0006443714,0.00039999775,0.00028662456],"domain_scores_gemma":[0.9986204,0.00010117323,0.00028759186,0.00041741919,0.00033355414,0.00023984196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001271075,0.0002576306,0.00026632746,0.00041967243,0.0001900566,0.00007941905,0.00016737662,0.00004804802,0.000044664765],"category_scores_gemma":[0.0003897433,0.00020736287,0.000054971944,0.00061325205,0.00007971696,0.0002062463,0.000207564,0.00014810119,0.000016940072],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009232367,0.00087614084,0.99095273,0.00018855695,0.0000906494,0.0001578986,0.0001860463,0.00002498848,0.0005274897,0.000161947,0.002621753,0.0032885761],"study_design_scores_gemma":[0.0031877456,0.00021711386,0.9882642,0.00034762264,0.0006157656,3.5579214e-7,0.00027594867,0.000037240054,0.0006065546,0.000106348765,0.0061032986,0.00023778259],"about_ca_topic_score_codex":0.00038416026,"about_ca_topic_score_gemma":0.00007961054,"teacher_disagreement_score":0.0057740384,"about_ca_system_score_codex":0.00006078949,"about_ca_system_score_gemma":0.00010490556,"threshold_uncertainty_score":0.8456012},"labels":[],"label_agreement":null},{"id":"W4417014766","doi":"10.1182/blood-2025-3898","title":"Impact of prognostic mutations on outcomes with fixed-duration acalabrutinib-venetoclax combinations versus chemoimmunotherapy: An exploratory analysis from AMPLIFY","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; Amorfix (Canada); University of British Columbia Hospital","funders":"","keywords":"Chemoimmunotherapy; Obinutuzumab; Fludarabine; IGHV@; Bendamustine; Rituximab; Chronic lymphocytic leukemia; Exploratory analysis; Cyclophosphamide","score_opus":0.02722216714397908,"score_gpt":0.35542961506980825,"score_spread":0.3282074479258292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417014766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979091,0.00008896456,0.00041581623,0.00012070939,0.00004079881,0.00063733425,0.000093138355,0.00007389411,0.0006201979],"genre_scores_gemma":[0.99826294,0.000015345922,0.00048897846,0.00004774391,0.000022288952,0.00013547919,0.000843137,0.000022664142,0.00016140274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853027,0.00009820436,0.00036622534,0.0003241015,0.00044663996,0.00023458207],"domain_scores_gemma":[0.9980714,0.00071923307,0.00013764318,0.00067446526,0.00029163176,0.00010563923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014288524,0.00018764271,0.0004488898,0.0004977006,0.00010155122,0.000035742913,0.00015444224,0.00012030948,0.00014454973],"category_scores_gemma":[0.00035348197,0.00014141531,0.00018913855,0.0013681238,0.00013297338,0.00012305859,0.000026567219,0.00020115824,0.00001503147],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061000837,0.014196553,0.9115022,0.00018625545,0.038474437,0.00010041024,0.0040519163,0.0034905388,0.016088353,0.0017302684,0.0002781342,0.0038008865],"study_design_scores_gemma":[0.083067976,0.0023712767,0.8928807,0.00013715016,0.004614689,0.0000029479843,0.000609381,0.005514833,0.010423049,0.00013883795,0.000022906916,0.00021630376],"about_ca_topic_score_codex":0.0011241438,"about_ca_topic_score_gemma":0.00036215314,"teacher_disagreement_score":0.07696789,"about_ca_system_score_codex":0.0025797398,"about_ca_system_score_gemma":0.005541795,"threshold_uncertainty_score":0.9830906},"labels":[],"label_agreement":null},{"id":"W4417014819","doi":"10.1182/blood-2025-4254","title":"Factors associated with acute and chronic graft-versus-host disease after unrelated donor hematopoietic cell transplantation using posttransplant cyclophosphamide-based GVHD prophylaxis","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"","keywords":"Hematopoietic stem cell transplantation; Odds ratio; Myeloid leukemia; Transplantation; Retrospective cohort study; Cyclophosphamide; Complication; Chronic leukemia; Cohort","score_opus":0.014803223178246503,"score_gpt":0.24392775536744343,"score_spread":0.22912453218919693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417014819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938163,0.001095876,0.0025736303,0.00011213715,0.00016374206,0.0013542383,0.00044912897,0.00019435032,0.00024057811],"genre_scores_gemma":[0.9983448,0.00018679095,0.00028145046,0.00008882256,0.000017909482,0.00007911032,0.00084864965,0.00006586059,0.00008660771],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978558,0.00010400344,0.000494225,0.0006049098,0.0004487576,0.00049235084],"domain_scores_gemma":[0.99878216,0.0002830497,0.0001450003,0.0003338292,0.00013553156,0.00032045334],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000131446,0.00047303463,0.0005276608,0.00027754004,0.00016509292,0.000054955002,0.00009637936,0.00025158422,0.00009107421],"category_scores_gemma":[0.000020033338,0.0003806087,0.0001387385,0.00061702094,0.0001551732,0.00013966525,0.000008426733,0.00031627816,0.0000044126023],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009469787,0.0023653768,0.9043587,0.008034569,0.0021723572,0.0039553205,0.0020457527,0.00021514081,0.0672113,0.00006711924,0.000006103004,0.00009850565],"study_design_scores_gemma":[0.02759343,0.0010791627,0.738823,0.0027543504,0.011948009,0.000045832872,0.0001027799,0.00026800187,0.21671359,0.000019515359,0.000008841165,0.0006435106],"about_ca_topic_score_codex":0.00005136614,"about_ca_topic_score_gemma":0.000066416076,"teacher_disagreement_score":0.16553569,"about_ca_system_score_codex":0.0001705556,"about_ca_system_score_gemma":0.0006699183,"threshold_uncertainty_score":0.9998646},"labels":[],"label_agreement":null},{"id":"W4417014835","doi":"10.1182/blood-2025-4921","title":"Perioperative anemia and transfusion thresholds in vascular surgery procedures – a systematic review","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; University of Toronto; McMaster University; McMaster University Medical Centre","funders":"","keywords":"Perioperative; Vascular surgery; Anemia; Blood management; Population; Adverse effect; Blood transfusion; Randomized controlled trial; Cohort","score_opus":0.008723635391885535,"score_gpt":0.24972686977026526,"score_spread":0.24100323437837973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417014835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7436432,0.23659195,0.00010992301,0.0056554093,0.00008953296,0.0066031395,0.0000025031839,0.00010938506,0.0071949037],"genre_scores_gemma":[0.87033606,0.12351079,0.000111618385,0.0048409267,0.000014429924,0.00047919044,0.000009287281,0.000014878285,0.00068284414],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9990005,0.00007155629,0.00036322526,0.00024760293,0.00017297106,0.0001441748],"domain_scores_gemma":[0.99959564,0.000052359097,0.000026675376,0.0002284338,0.00004216643,0.000054701926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044498706,0.0001310029,0.0006587123,0.00016672285,0.000045399316,0.000015048897,0.00004260981,0.0000566531,0.00003717764],"category_scores_gemma":[0.00014873654,0.000099788434,0.00010454121,0.00034780227,0.000028659895,0.000041548985,0.000018461726,0.000114857416,0.000003876832],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031732667,0.00087836594,0.010051439,0.98468953,0.0002614624,0.0001419961,0.00058006076,2.6696978e-7,0.0014767195,0.0010364266,0.00050232676,0.00034968086],"study_design_scores_gemma":[0.010704805,0.00023836792,0.06558351,0.9084382,0.009277141,0.00018674669,0.0010137409,0.00003187795,0.0029164697,0.00008260283,0.001000308,0.00052623166],"about_ca_topic_score_codex":0.000033080047,"about_ca_topic_score_gemma":0.00013910049,"teacher_disagreement_score":0.12669277,"about_ca_system_score_codex":0.000011558323,"about_ca_system_score_gemma":0.000104202445,"threshold_uncertainty_score":0.40692544},"labels":[],"label_agreement":null},{"id":"W4417014884","doi":"10.1182/blood-2025-4906","title":"Anticoagulation management and outcomes in cancer-associated ovarian and renal vein thrombosis: A multicenter retrospective cohort study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Retrospective cohort study; Cumulative incidence; Incidence (geometry); Cohort study; Population; Cohort; Prognostic variable; Confidence interval","score_opus":0.011946847262050076,"score_gpt":0.2973493045923643,"score_spread":0.2854024573303142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417014884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947406,0.00020657739,0.000011119388,0.0007744669,0.00009088182,0.0021170052,0.000005376521,0.000040961342,0.0020129913],"genre_scores_gemma":[0.99850285,0.00042532908,0.00012587484,0.00031677788,0.000013454004,0.0002403661,0.000007106159,0.000011210077,0.00035705994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989365,0.000051677507,0.00025089612,0.00036624583,0.00020007083,0.00019461782],"domain_scores_gemma":[0.99964535,0.0000231356,0.00006449051,0.00018171391,0.000041536525,0.00004374797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028389462,0.00014492766,0.0005178752,0.00020454668,0.000073370866,0.00003921445,0.000041043924,0.000048063775,0.000018722903],"category_scores_gemma":[0.0000377869,0.00012812215,0.000029018085,0.00022611114,0.000030835425,0.00006060167,0.000119014905,0.00009825155,0.0000010244105],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020163225,0.005412457,0.99111617,0.00007368427,0.0016370858,0.000030545136,0.00063294003,0.0000019355487,0.00008577072,0.0004899908,0.0001394119,0.00035983117],"study_design_scores_gemma":[0.00848295,0.0002471154,0.9883436,0.00027634104,0.0016507014,2.9827382e-7,0.00057225896,0.000105176514,0.0000750267,0.00011341816,0.000028617857,0.000104507584],"about_ca_topic_score_codex":0.0012097666,"about_ca_topic_score_gemma":0.0012139869,"teacher_disagreement_score":0.008462787,"about_ca_system_score_codex":0.000110428,"about_ca_system_score_gemma":0.000013548426,"threshold_uncertainty_score":0.52246696},"labels":[],"label_agreement":null},{"id":"W4417014934","doi":"10.1182/blood-2025-6511","title":"Digital cognitive behavioral therapy vs. education intervention in population with sickle cell disease experiencing pain: A systematic review","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cognitive behavioral therapy; Psychological intervention; Randomized controlled trial; Intervention (counseling); Chronic pain; Population; Mood; Disease; Cognition","score_opus":0.008055549034868091,"score_gpt":0.278968870922235,"score_spread":0.2709133218873669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417014934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9555676,0.041419737,0.000101381425,0.0002061326,0.000046758974,0.001959013,0.0000031338798,0.00003627568,0.0006599425],"genre_scores_gemma":[0.9977017,0.0008204837,0.000013568726,0.00052962644,0.000009478031,0.00031202496,0.00016881738,0.0000104833025,0.00043382385],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9992226,0.000082178776,0.00029908502,0.0001647015,0.00012425488,0.0001072252],"domain_scores_gemma":[0.9996203,0.000024192306,0.00009430566,0.00012878276,0.00007356146,0.00005886371],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016098924,0.00010241436,0.0002608195,0.00009846914,0.00003370569,0.00002566272,0.00003146955,0.000040389576,0.000014108581],"category_scores_gemma":[0.000106180785,0.0000767582,0.00007691848,0.00027038815,0.000017055972,0.00012001308,0.000009153282,0.000090127745,0.0000044667],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093584583,0.025817329,0.44723788,0.47242114,0.0002265066,0.00011940195,0.0036663518,0.0000028561276,0.00015364107,0.00008256868,0.00020154721,0.049134925],"study_design_scores_gemma":[0.012689768,0.0016576329,0.07747362,0.89032286,0.0025926437,0.000028414415,0.014016704,0.00014328104,0.00047752913,0.00007838585,0.00004472822,0.00047442951],"about_ca_topic_score_codex":0.00007044558,"about_ca_topic_score_gemma":0.000008915978,"teacher_disagreement_score":0.41790172,"about_ca_system_score_codex":0.000042048003,"about_ca_system_score_gemma":0.00010858794,"threshold_uncertainty_score":0.31301084},"labels":[],"label_agreement":null},{"id":"W4417014954","doi":"10.1182/blood-2025-7547","title":"An open-label rollover study to assess the long-term safety of ixazomib","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ixazomib; Adverse effect; Common Terminology Criteria for Adverse Events; Proteasome inhibitor; Clinical endpoint","score_opus":0.07319296200780288,"score_gpt":0.4131517652719811,"score_spread":0.3399588032641782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417014954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990603,0.000094086994,0.00005759845,0.0004520565,0.000049652022,0.0023279558,0.000022503107,0.000017879207,0.0063752616],"genre_scores_gemma":[0.99695647,0.0000123464415,0.00028180704,0.00022752244,0.00003328838,0.00008104643,0.000017751747,0.000011644757,0.0023781364],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988923,0.00012409779,0.00020818667,0.00024997123,0.00030231476,0.0002231083],"domain_scores_gemma":[0.99888474,0.00010829716,0.000034351346,0.0007123678,0.000110478075,0.00014975901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034025987,0.0001118371,0.00027554805,0.00007891831,0.00009358711,0.00005184014,0.00041368156,0.000028289081,0.00010762114],"category_scores_gemma":[0.00013205953,0.00006724637,0.000025897327,0.0002869308,0.000029788971,0.00008168258,0.00027667554,0.00011253497,0.000033596458],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011475068,0.02098774,0.9641935,0.000039043032,0.0008168294,0.00015716667,0.00027247024,7.837755e-7,0.004843426,0.00010728621,0.00017340627,0.0072608036],"study_design_scores_gemma":[0.022215158,0.002064803,0.96791124,0.00007275327,0.00028980302,0.000005700588,0.00019764928,0.000016565982,0.0070788073,0.000014018471,0.000077904595,0.00005561124],"about_ca_topic_score_codex":0.00022834894,"about_ca_topic_score_gemma":0.00030472016,"teacher_disagreement_score":0.021067651,"about_ca_system_score_codex":0.000029455392,"about_ca_system_score_gemma":0.00016975337,"threshold_uncertainty_score":0.27422273},"labels":[],"label_agreement":null},{"id":"W4417014962","doi":"10.1182/blood-2025-5505","title":"Late immune effector cell-associated hematotoxicity (ICAHT) in patients with relapsed refractory large B-cell lymphoma receiving anti-CD19 chimeric antigen receptor T-cell therapy","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cytopenia; Neutropenia; Rituximab; Febrile neutropenia; Lymphoma; Leukopenia; Salvage therapy; Anemia; Refractory (planetary science)","score_opus":0.006640684584130754,"score_gpt":0.23728001324453102,"score_spread":0.23063932866040027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417014962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900732,0.0018489915,0.000006484777,0.00007833979,0.00023962927,0.0023240875,0.000051113824,0.00021198724,0.0051661823],"genre_scores_gemma":[0.989285,0.0014007341,0.00015200448,0.00023643275,0.000058623587,0.000086837514,0.00025823902,0.00014431016,0.008377799],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99592215,0.00057944295,0.0007336484,0.00084189343,0.00084519474,0.0010776838],"domain_scores_gemma":[0.9977964,0.0003865144,0.00034729604,0.0009913042,0.00025306822,0.00022540358],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001027698,0.00053960166,0.0010855473,0.0005315188,0.0002143057,0.00006129717,0.00040311,0.0004005752,0.0008165135],"category_scores_gemma":[0.00014524002,0.00045985202,0.00025661805,0.0016332645,0.00010352842,0.00015284766,0.00014848734,0.0007067066,0.00014351681],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013424985,0.018352423,0.44659084,0.00022035874,0.00023854547,0.00004272632,0.00036082556,0.0000010936467,0.5317518,6.576986e-7,0.00035059277,0.00074762694],"study_design_scores_gemma":[0.06961717,0.0013385165,0.5271156,0.0004813363,0.000076935125,0.0000011471333,0.00003980004,0.000027215561,0.3993811,0.0000033167073,0.0015390809,0.0003788254],"about_ca_topic_score_codex":0.0002069275,"about_ca_topic_score_gemma":0.000019320103,"teacher_disagreement_score":0.1323707,"about_ca_system_score_codex":0.00036508398,"about_ca_system_score_gemma":0.00041897962,"threshold_uncertainty_score":0.9997853},"labels":[],"label_agreement":null},{"id":"W4417015030","doi":"10.1182/blood-2025-7213","title":"Ruxolitinib in malignancy-associated hemophagocytic lymphohistiocytosis (M-HLH): A systematic literature review","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ruxolitinib; Systematic review; Macrophage activation syndrome; Cytokine storm; Adverse effect; Hemophagocytic lymphohistiocytosis; Cytokine release syndrome; Meta-analysis","score_opus":0.009706681709632166,"score_gpt":0.28541229293492865,"score_spread":0.27570561122529647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417015030","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17480229,0.8008074,0.000008478332,0.0014889694,0.000102601356,0.002848641,0.000016871236,0.0001498938,0.019774875],"genre_scores_gemma":[0.9117843,0.07007947,0.00007153883,0.0039141183,0.000032890995,0.0007081522,0.00011988164,0.000042417596,0.01324724],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99789447,0.0002264421,0.0008097624,0.00030849446,0.00034717048,0.00041368575],"domain_scores_gemma":[0.9989311,0.000114564464,0.00013771723,0.0005402503,0.00019778703,0.00007854963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007068789,0.00020446883,0.0010158919,0.0003223573,0.00006945613,0.00003784202,0.00018845,0.00017395255,0.00008242863],"category_scores_gemma":[0.0015055818,0.00017735758,0.00019651274,0.0014279974,0.000044590855,0.0000836212,0.000071798,0.00029144617,0.00009710948],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011073025,0.0029760322,0.02046501,0.9608546,0.00085907837,0.002047853,0.0005952042,8.8981955e-7,0.0020275197,0.0025764431,0.0064341244,0.0010524949],"study_design_scores_gemma":[0.011879817,0.00020044434,0.023991095,0.9585096,0.0011611513,0.00019656819,0.0001762358,0.00012926036,0.0019974916,0.00022031492,0.001172528,0.00036545563],"about_ca_topic_score_codex":0.000015320009,"about_ca_topic_score_gemma":0.0000066373336,"teacher_disagreement_score":0.736982,"about_ca_system_score_codex":0.00018704229,"about_ca_system_score_gemma":0.0004929013,"threshold_uncertainty_score":0.7232432},"labels":[],"label_agreement":null},{"id":"W4417015040","doi":"10.1182/blood-2025-6473","title":"Evaluating efficacy and safety of hydroxyurea and thalidomide for beta-thalassemia: A systematic review andmeta-analysis.","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Thalidomide; Regimen; Adverse effect; Observational study; Confidence interval; Anemia","score_opus":0.025455130092827318,"score_gpt":0.33911273117506274,"score_spread":0.31365760108223545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417015040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5875277,0.40231434,0.0004883586,0.0024003754,0.000037722344,0.0049900976,0.000027372336,0.00003895979,0.002175096],"genre_scores_gemma":[0.9841133,0.012933814,0.0014871812,0.00065325096,0.000012401821,0.00012900797,0.000033621902,0.000015079168,0.00062237465],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99854445,0.000120279255,0.0007368926,0.00025835552,0.00018415568,0.00015585325],"domain_scores_gemma":[0.9987321,0.0005091364,0.0002365517,0.00032652612,0.00012358735,0.000072128096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013159632,0.00015270279,0.0014974425,0.00014672831,0.00007049822,0.000010673089,0.00005259112,0.00010942682,0.00001100618],"category_scores_gemma":[0.001299305,0.000101544145,0.00026443836,0.00048188795,0.00005620232,0.000025064614,0.00004020884,0.000112533315,7.031394e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026354773,0.0008814679,0.008927145,0.95003086,0.032073654,0.000017011096,0.00043478515,0.000028125423,0.004490985,0.0012307562,0.0004436577,0.0011779788],"study_design_scores_gemma":[0.033015046,0.0011097351,0.007707108,0.18343548,0.7659105,0.00013391467,0.0005766666,0.0035045503,0.0034912096,0.00034366507,0.00022977803,0.0005423548],"about_ca_topic_score_codex":0.0000104920455,"about_ca_topic_score_gemma":0.000002895927,"teacher_disagreement_score":0.7665954,"about_ca_system_score_codex":0.000009012297,"about_ca_system_score_gemma":0.0000619622,"threshold_uncertainty_score":0.414085},"labels":[],"label_agreement":null},{"id":"W4417015180","doi":"10.1182/blood-2025-7797","title":"The role of pentamidine for pneumocystis jirovecii prophylaxis in allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Pneumocystis jirovecii pneumonia detection and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pentamidine; Pneumocystis jirovecii; Discontinuation; Adverse effect; Hematopoietic stem cell transplantation; Observational study; Incidence (geometry); Cohort; Cohort study","score_opus":0.012409874326534289,"score_gpt":0.25432607981724165,"score_spread":0.24191620549070736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417015180","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27387547,0.7106771,0.00037837427,0.0024369876,0.00005361849,0.011369722,0.00020203736,0.00007419305,0.0009325058],"genre_scores_gemma":[0.99119824,0.0057677072,0.000082111605,0.00014990746,0.0000035141563,0.0013875412,0.000012466693,0.00001299769,0.0013854927],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9983414,0.00014508075,0.000786137,0.00032023818,0.00021733015,0.00018981488],"domain_scores_gemma":[0.99879843,0.00036273818,0.00023475375,0.0004433444,0.00009481389,0.00006593724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039518447,0.00021776292,0.0016949266,0.0002108313,0.00009158108,0.000019480947,0.00010658145,0.000062803636,0.000012740936],"category_scores_gemma":[0.000030328441,0.00012885168,0.00064576144,0.00069937867,0.000045266825,0.000029146848,0.000019308374,0.00008767478,0.0000024780538],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029467014,0.0027208012,0.004717129,0.79039615,0.1714694,0.000122266,0.0007930281,0.000015597727,0.02716512,0.002034171,0.0000120082605,0.0002596393],"study_design_scores_gemma":[0.0024783076,0.00051868067,0.002595982,0.0016215793,0.9647968,0.0001685242,0.00033345039,0.000058590143,0.027067747,0.00014991402,0.000042854048,0.00016761888],"about_ca_topic_score_codex":0.00002229431,"about_ca_topic_score_gemma":0.000087410095,"teacher_disagreement_score":0.79332733,"about_ca_system_score_codex":0.000031659052,"about_ca_system_score_gemma":0.000051675073,"threshold_uncertainty_score":0.5254419},"labels":[],"label_agreement":null},{"id":"W4417015203","doi":"10.1182/blood-2025-7963","title":"Evaluating the efficacy of brief neurocognitive assessments in adults and adolescents with sickle cell disease","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neurocognitive; Stroke (engine); Disease; Referral; Sickle cell anemia; Transcranial Doppler; Huntington's disease; Population","score_opus":0.010329084298528246,"score_gpt":0.30163489053767745,"score_spread":0.2913058062391492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417015203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963622,0.00067433086,0.000010041623,0.00023005091,0.000023101364,0.0006338676,0.000003939644,0.000010762162,0.0020516927],"genre_scores_gemma":[0.99938726,0.00008964866,0.000053986892,0.0003275893,0.000008533097,0.000012905731,0.0000046266005,0.000008105332,0.00010734002],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993227,0.000058599937,0.00015084322,0.0001750165,0.00016255981,0.00013025712],"domain_scores_gemma":[0.9996359,0.000055016404,0.000052135205,0.00013721923,0.000060051832,0.000059698526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000101508194,0.0000862836,0.00013612858,0.000051021052,0.00004031905,0.000006590588,0.00004320815,0.000032764976,0.0000039131514],"category_scores_gemma":[0.000110961984,0.00005300684,0.000025235127,0.00021366242,0.00007053289,0.000022295208,0.00003909513,0.00016402802,0.0000010398201],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029541359,0.0037804053,0.9740027,0.001224542,0.00008301812,0.00009618855,0.0006547099,0.000039513132,0.0013901613,0.00002471009,0.000026104695,0.015723802],"study_design_scores_gemma":[0.022089012,0.0006046274,0.9707874,0.0036204832,0.0004843094,0.0000034029647,0.0005739026,0.0007843786,0.00094504457,0.00002253601,0.000014239473,0.0000706454],"about_ca_topic_score_codex":0.000042211803,"about_ca_topic_score_gemma":0.000005481888,"teacher_disagreement_score":0.019134877,"about_ca_system_score_codex":0.0000060917982,"about_ca_system_score_gemma":0.00013849666,"threshold_uncertainty_score":0.21615562},"labels":[],"label_agreement":null},{"id":"W4417015225","doi":"10.1182/blood-2025-8041","title":"Real-world zanubrutinib treatment patterns in CLL/SLL among a curated sample of US community oncology patients with prior acalabrutinib therapy","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada)","funders":"","keywords":"Ibrutinib; Discontinuation; Adverse effect; Hazard ratio; Confidence interval; Retrospective cohort study; Bruton's tyrosine kinase","score_opus":0.030243247330094272,"score_gpt":0.3427940132156911,"score_spread":0.3125507658855968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417015225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99481416,0.000055451022,0.0000060955226,0.00014857504,0.000049822327,0.0016142424,0.00008391722,0.00005183887,0.0031758724],"genre_scores_gemma":[0.99830693,0.00030514537,0.00027298857,0.00013744891,0.000024216679,0.00014359961,0.00023371643,0.000030144543,0.0005458262],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99783045,0.00048218702,0.00054423854,0.00030092653,0.00035486757,0.00048734562],"domain_scores_gemma":[0.9976363,0.0009999264,0.00017516785,0.0008209827,0.00022832726,0.00013925385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037387887,0.0002526137,0.00070754526,0.0003597325,0.0000940751,0.000010948669,0.0002391984,0.00016351692,0.000121039404],"category_scores_gemma":[0.00019197863,0.00018091407,0.00008624546,0.00078938354,0.00023014871,0.0000535408,0.00011988272,0.00043911196,0.0000049689925],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019216662,0.0108427955,0.9731076,0.00014055647,0.00040377586,0.000066590444,0.001347936,0.0000044613694,0.0001502379,0.00003571213,0.000050011102,0.011928683],"study_design_scores_gemma":[0.12044344,0.002869208,0.8660646,0.00038893064,0.00013745573,0.0000043249597,0.00020669778,0.0001283632,0.008709291,0.000023945631,0.00089569204,0.00012801729],"about_ca_topic_score_codex":0.13368252,"about_ca_topic_score_gemma":0.04391953,"teacher_disagreement_score":0.11852177,"about_ca_system_score_codex":0.00507025,"about_ca_system_score_gemma":0.0049725706,"threshold_uncertainty_score":0.99874914},"labels":[],"label_agreement":null},{"id":"W4417015232","doi":"10.1182/blood-2025-8040","title":"National trends in acute lymphocytic leukemia (ALL) incidence (1999–2021): A longitudinal outcome study using joinpoint analysis of age, sex, and regional disparities","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Selkirk College","funders":"","keywords":"Incidence (geometry); Confidence interval; Epidemiology; Acute lymphocytic leukemia; Hematologic Neoplasms; Disease control; Leukemia","score_opus":0.0527547306640745,"score_gpt":0.3651986732154616,"score_spread":0.31244394255138713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417015232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983828,0.00026053993,0.0002156641,0.0002400824,0.000035609213,0.00026732168,0.000033691555,0.000021585565,0.00054272456],"genre_scores_gemma":[0.99741334,0.00004683685,0.00091973477,0.00023696134,0.000041187544,0.00003639926,0.000060385548,0.000015717183,0.0012294578],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971826,0.00011962739,0.0007386916,0.0005401605,0.0010423084,0.0003766101],"domain_scores_gemma":[0.99877834,0.00038915576,0.00014432282,0.0003479242,0.00021285043,0.0001274285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067060586,0.00024121364,0.0008892494,0.0023649402,0.000076739256,0.000042565294,0.000189923,0.00012148194,0.000057044017],"category_scores_gemma":[0.00028919076,0.00021824807,0.00017927366,0.0028221363,0.00025720402,0.00013561023,0.00029191934,0.00024460547,0.0000016174639],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035540527,0.00071243034,0.98874235,0.00011201299,0.0056629525,0.0011112121,0.00064253865,0.00075220276,0.0009806507,0.00037834237,0.00020522065,0.0003446803],"study_design_scores_gemma":[0.010305057,0.00023670652,0.9384225,0.00014429638,0.0057363533,0.00016043882,0.00042097742,0.044017714,0.00021832496,0.00013756164,0.000016948983,0.00018311868],"about_ca_topic_score_codex":0.0039093117,"about_ca_topic_score_gemma":0.001260469,"teacher_disagreement_score":0.05031985,"about_ca_system_score_codex":0.0032936833,"about_ca_system_score_gemma":0.0022176546,"threshold_uncertainty_score":0.8899898},"labels":[],"label_agreement":null},{"id":"W4417015358","doi":"10.1182/blood-2025-8236","title":"ALACRITY: A phase 1b/2 study of AZD0120 (BCMA/CD19 CAR-T cell therapy) in participants with relapsed or refractory light chain amyloidosis (AL)","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"AL amyloidosis; Immunoglobulin light chain; Multiple myeloma; Population; Minimal residual disease; Amyloidosis; Bone marrow; Monoclonal; Refractory (planetary science); CD19","score_opus":0.04004829720196012,"score_gpt":0.3470153644016904,"score_spread":0.30696706719973027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417015358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99574125,0.0006259454,0.0000030328436,0.0004982326,0.00004145657,0.0019432012,0.000020805383,0.000048006605,0.001078071],"genre_scores_gemma":[0.9972391,0.00029632886,0.00013211834,0.0001857045,0.000025316927,0.00034986515,0.000017354734,0.000032185584,0.0017220424],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99778813,0.00022535033,0.00044224726,0.00046538992,0.0005118208,0.00056704896],"domain_scores_gemma":[0.9987175,0.00016356225,0.000104325685,0.00064908876,0.00012422755,0.00024133852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003123252,0.000259008,0.00062333216,0.00037757706,0.00006859823,0.000016277621,0.00015148269,0.00009035628,0.0001066209],"category_scores_gemma":[0.00015341678,0.00016733537,0.0000707882,0.0007420147,0.00005728642,0.00007703587,0.000059799764,0.00030101978,0.00001297193],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015978688,0.14159165,0.7484496,0.00026382835,0.0015833562,0.002635511,0.005360623,0.000001300287,0.07365419,0.0000054284774,0.00046444996,0.010011337],"study_design_scores_gemma":[0.39450097,0.03775652,0.27449444,0.00077739044,0.0010412019,0.000019339368,0.0055033215,0.00018994456,0.28281754,0.000015326079,0.0024175164,0.00046648172],"about_ca_topic_score_codex":0.0009793337,"about_ca_topic_score_gemma":0.0010332642,"teacher_disagreement_score":0.4739552,"about_ca_system_score_codex":0.00007691121,"about_ca_system_score_gemma":0.00037209335,"threshold_uncertainty_score":0.6823738},"labels":[],"label_agreement":null},{"id":"W4417015458","doi":"10.1182/blood-2025-628","title":"Molecular profiling of lupus b cells reveals expansion of somatic mutations in lymphoma-related pathways","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Institute of Cancer Research; Princess Margaret Cancer Centre","funders":"","keywords":"Somatic cell; Germline; Germline mutation; B cell; Immune dysregulation; Population; Autoimmune disease; Systemic lupus erythematosus","score_opus":0.013691631434828709,"score_gpt":0.2740189450058738,"score_spread":0.2603273135710451,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417015458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948586,0.0011688063,0.00013318722,0.000045716,0.000097671065,0.00092456955,0.000007849645,0.000027367436,0.0027362339],"genre_scores_gemma":[0.9980138,0.000030048293,0.0015830058,0.000012240692,0.00000479686,0.000048563594,0.000014238609,0.000016617232,0.00027667405],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984211,0.00012524899,0.00071136135,0.00019264569,0.00034964737,0.00020001085],"domain_scores_gemma":[0.9990475,0.00018873274,0.00015251299,0.00040306876,0.00015762744,0.000050544837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004283618,0.00010576226,0.00044891844,0.0004241321,0.000017538567,0.0000034181974,0.000109483815,0.00011866857,0.000016098065],"category_scores_gemma":[0.00033406581,0.00009378153,0.000091808724,0.0006540015,0.000060165617,0.000029779047,0.000053859778,0.00008222536,0.000010148443],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024716926,0.0005346897,0.08190196,0.0029732392,0.0001019336,0.00008128433,0.0011350999,0.00003851426,0.91234106,0.00063056464,0.000015186671,0.00022176642],"study_design_scores_gemma":[0.005841678,0.0000940289,0.0017366383,0.0036121646,0.00014108482,0.00032907494,0.0013672871,0.0006712497,0.9850063,0.0011336877,0.0000011805139,0.000065664106],"about_ca_topic_score_codex":0.000034238023,"about_ca_topic_score_gemma":0.0000017218025,"teacher_disagreement_score":0.08016533,"about_ca_system_score_codex":0.0000521105,"about_ca_system_score_gemma":0.0003694095,"threshold_uncertainty_score":0.38242996},"labels":[],"label_agreement":null},{"id":"W4417015461","doi":"10.1182/blood-2025-950","title":"Outcomes and resource utilization during and after oral anticoagulant-related bleeding in chronic kidney disease (ORACLE-CKD): A population-based cohort study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Public Health; McMaster University; North Pacific Marine Science Organization; McMaster University Medical Centre; Institute for Work & Health; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Kidney disease; Medical prescription; Atrial fibrillation; Cohort study; Emergency department; Cohort; Hemodialysis; Pharmacy; Propensity score matching","score_opus":0.02337311335912712,"score_gpt":0.3115098098987708,"score_spread":0.2881366965396437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417015461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973059,0.00034056397,0.000019312287,0.00091377634,0.000050152303,0.0011676785,0.0000034894492,0.000075541495,0.00012356417],"genre_scores_gemma":[0.99904096,0.000018801938,0.00004394059,0.00013681319,0.000040969884,0.000012999796,0.000053988082,0.0000144560445,0.0006370966],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989971,0.000055944565,0.00032109718,0.00029039296,0.00017564135,0.00015983298],"domain_scores_gemma":[0.99957645,0.00005964092,0.00006207819,0.00016474813,0.00002198532,0.00011508889],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020511774,0.00014146893,0.00030627102,0.00032539538,0.00008457171,0.00004414881,0.000027980112,0.000048901933,0.000033350087],"category_scores_gemma":[0.00020216532,0.00012655035,0.000040521358,0.00031830408,0.000022413047,0.000093931434,0.000058657195,0.0000747535,0.0000014981579],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020854751,0.000061449544,0.998935,0.00021234511,0.00013034813,0.000037058217,0.0000642107,0.000047567723,0.000052692074,0.000053441916,0.00000536481,0.00019197643],"study_design_scores_gemma":[0.009474838,0.00004424767,0.9867601,0.00021031681,0.0007093588,7.2706416e-7,0.00006473125,0.0024990977,0.000026615584,0.000025685293,0.00007135838,0.00011296752],"about_ca_topic_score_codex":0.000081432045,"about_ca_topic_score_gemma":0.000047053203,"teacher_disagreement_score":0.012174942,"about_ca_system_score_codex":0.000057620517,"about_ca_system_score_gemma":0.00005678941,"threshold_uncertainty_score":0.5160573},"labels":[],"label_agreement":null},{"id":"W4417015464","doi":"10.1182/blood-2025-410","title":"Real-world effectiveness and safety of hydroxyurea in adults with hemoglobin SC disease: A retrospective cohort study in Quebec, Canada","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"","keywords":"Retrospective cohort study; Adverse effect; Acute chest syndrome; Clinical endpoint; Clinical trial; Cohort study; Medical prescription; Cohort; Hematologist; Hematologic disease","score_opus":0.002052362374961546,"score_gpt":0.21414510266397205,"score_spread":0.2120927402890105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417015464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927321,0.00053003797,0.000001426428,0.00027511577,0.000041999185,0.002188289,0.000017490382,0.000017123584,0.0041964203],"genre_scores_gemma":[0.99930245,0.00017233251,0.000009396091,0.000045247332,0.0000069622015,0.00008725799,0.000013406616,0.000013841629,0.00034909477],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867886,0.00012341062,0.00031111474,0.00038657468,0.0002673093,0.00023273028],"domain_scores_gemma":[0.99939024,0.00008933278,0.00006380147,0.00027248616,0.00007334091,0.0001108012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002575691,0.00017895637,0.0005595459,0.00022326745,0.000035060926,0.000005691023,0.000060629154,0.00005947896,0.00000806843],"category_scores_gemma":[0.00009107014,0.00014116391,0.000026537282,0.00095299457,0.00008179354,0.000039790906,0.000044691817,0.00025827246,1.9566076e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026400103,0.0014279507,0.99415684,0.0003933008,0.00020535056,0.00048204555,0.0002914873,0.000032611435,0.000032704815,0.00009523376,0.00004008261,0.00020239264],"study_design_scores_gemma":[0.015953084,0.00021000746,0.9803704,0.0021266825,0.00025412324,0.0000022862982,0.0007233228,0.00003730467,0.00014375249,0.00002596848,0.000022859609,0.00013022151],"about_ca_topic_score_codex":0.8912371,"about_ca_topic_score_gemma":0.9887148,"teacher_disagreement_score":0.0974777,"about_ca_system_score_codex":0.00038856475,"about_ca_system_score_gemma":0.001047536,"threshold_uncertainty_score":0.5756497},"labels":[],"label_agreement":null},{"id":"W4417015475","doi":"10.1182/blood-2025-412","title":"Safety and efficacy of ten years of hydroxyurea treatment for young children with sickle cell anemia in Uganda","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Fetal hemoglobin; Adverse effect; Sickle cell anemia; Anemia; Hydroxycarbamide; Clinical trial; Dosing; Clinical endpoint; Placebo","score_opus":0.0035611242395975316,"score_gpt":0.21761104205791046,"score_spread":0.21404991781831292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417015475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953647,0.0011878033,0.000012930875,0.00008592198,0.00001148507,0.0005568813,0.000019858544,0.000008200938,0.002752208],"genre_scores_gemma":[0.99883884,0.00044042207,0.00028836756,0.000016211521,0.0000068254494,0.000006307677,0.000024391706,0.000007796411,0.00037081726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995428,0.000007575946,0.00016752518,0.00012041401,0.00005781167,0.000103922415],"domain_scores_gemma":[0.99974394,0.00003766967,0.00004584493,0.00012366114,0.000018612547,0.000030262381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000045978453,0.000073776246,0.00024280947,0.00007157991,0.000013054114,0.0000015920714,0.000025982403,0.00006958779,0.0000040697555],"category_scores_gemma":[0.000014155508,0.000053276624,0.000037692716,0.00013286788,0.000050132552,0.000010252558,0.000010312585,0.00004662855,2.878317e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013548548,0.0029401327,0.9730225,0.00028942185,0.00041090674,0.000014575302,0.0014430193,0.00009031377,0.005209421,0.00008623494,0.00006813354,0.015070458],"study_design_scores_gemma":[0.04351219,0.0017593561,0.923953,0.00032799097,0.00087977195,0.00001857192,0.0002916736,0.000039906066,0.028821887,0.000019451478,0.00027492578,0.000101251186],"about_ca_topic_score_codex":0.00025499883,"about_ca_topic_score_gemma":0.000036922393,"teacher_disagreement_score":0.049069505,"about_ca_system_score_codex":0.0000130919025,"about_ca_system_score_gemma":0.000078132754,"threshold_uncertainty_score":0.21725576},"labels":[],"label_agreement":null},{"id":"W4417015501","doi":"10.1182/blood-2025-954","title":"Association between increased Patients' out-of-pocket costs for apixaban and oral anticoagulant discontinuation in high-risk patients with atrial fibrillation - a retrospective Medicare claims study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Apixaban; Discontinuation; Atrial fibrillation; Retrospective cohort study; Stroke (engine); Medical prescription; Medicare Part D; Cohort","score_opus":0.014448227677960317,"score_gpt":0.28807425347437043,"score_spread":0.2736260257964101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417015501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959072,0.00002240677,0.00017174442,0.00019819332,0.00018494201,0.003286734,0.0001673665,0.000029190793,0.00003225732],"genre_scores_gemma":[0.9984427,0.000009726946,0.0002871956,0.000011925766,0.00029051685,0.0000059034232,0.00088056567,0.000013782059,0.000057696503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984632,0.00016284469,0.00047867396,0.0002842881,0.00044747198,0.00016352817],"domain_scores_gemma":[0.99868727,0.00037023152,0.00044974813,0.00014300518,0.0003035709,0.000046181518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005280968,0.00015068486,0.00052474067,0.0002437241,0.0000774181,0.000024994526,0.000038226834,0.000102316764,0.0000053793],"category_scores_gemma":[0.0010991177,0.00012210746,0.00007913688,0.00030041864,0.000021470843,0.00014848962,0.000041175565,0.0000845631,6.078741e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006959398,0.00010265475,0.99435335,0.000033454955,0.00070996134,3.2550247e-7,0.00042846162,0.0000027055958,0.0000037127836,0.00004226131,0.00005202281,0.0035751574],"study_design_scores_gemma":[0.037278462,0.0014526349,0.95847964,0.00010866585,0.0021265354,1.0491061e-8,0.000173266,0.00004798923,0.000049198363,0.00012879519,0.000043534747,0.0001112629],"about_ca_topic_score_codex":0.00032109654,"about_ca_topic_score_gemma":0.00033817952,"teacher_disagreement_score":0.036582522,"about_ca_system_score_codex":0.00017163555,"about_ca_system_score_gemma":0.00004452781,"threshold_uncertainty_score":0.4979398},"labels":[],"label_agreement":null},{"id":"W4417015538","doi":"10.1182/blood-2025-964","title":"Grip strength predicts overall survival of patients with myelodysplastic syndrome in a multivariable model","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Leukemia & Lymphoma Society of Canada; University of Winnipeg; University of Manitoba; McMaster University; Providence Health Care; University of Alberta; Dr. Georges-L.-Dumont University Hospital Centre; Saskatchewan Cancer Agency; Ottawa Hospital; McGill University; Princess Margaret Cancer Centre; University of Calgary; Sunnybrook Hospital; Dalhousie University; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Grip strength; Logistic regression; Hand strength; Cohort; Survival analysis; Myelodysplastic syndromes; Cohort study; Prospective cohort study; Disease","score_opus":0.009447378572110457,"score_gpt":0.24505071694679414,"score_spread":0.2356033383746837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417015538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993409,0.00003766218,0.0004489372,0.00007766752,0.000044394088,0.00060981594,0.00007335653,0.000036382273,0.005262797],"genre_scores_gemma":[0.99597454,0.000011153506,0.002299876,0.000045414246,0.000012119912,0.000038336162,0.000070233196,0.000023068424,0.0015252595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99846655,0.000048083915,0.00031637275,0.00031277657,0.0004831923,0.0003730336],"domain_scores_gemma":[0.99907506,0.00018259781,0.000064754255,0.00037161124,0.00019398009,0.00011200645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001768064,0.00016743015,0.00042196087,0.00030456705,0.000026289517,0.000009079741,0.00015722777,0.00011807226,0.000032966076],"category_scores_gemma":[0.00034938793,0.00013226314,0.000038740243,0.0004641374,0.00008051707,0.0000946956,0.00011460776,0.00034638026,0.000005745693],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014441726,0.0039610947,0.98827946,0.0006950873,0.0004253864,0.00017625054,0.00018958985,0.001969396,0.00096335914,0.0013869823,0.00028864166,0.00022056923],"study_design_scores_gemma":[0.033998188,0.0007867588,0.9248525,0.0008033469,0.00025380697,0.000009415572,0.000031579766,0.03773434,0.0011047228,0.0002120485,0.00004547072,0.00016780799],"about_ca_topic_score_codex":0.00014840593,"about_ca_topic_score_gemma":0.000031538795,"teacher_disagreement_score":0.06342696,"about_ca_system_score_codex":0.00013004741,"about_ca_system_score_gemma":0.0006969453,"threshold_uncertainty_score":0.5393535},"labels":[],"label_agreement":null},{"id":"W4417015698","doi":"10.1182/blood-2025-1658","title":"Real life study of ivosidenib in either monotherapy or combined with azacytidine for first line mutant IDH1 AML: A study from the french AML intergroup ALFA/filo","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"IDH1; Adverse effect; Myeloid leukemia; Refractory (planetary science); Azacitidine; First line; Absolute neutrophil count; Retrospective cohort study; Myeloid","score_opus":0.025633408944226988,"score_gpt":0.31354692187287564,"score_spread":0.28791351292864864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417015698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902413,0.00018142875,0.00015171415,0.002296506,0.00006926821,0.0067503294,0.00007769489,0.00006652205,0.00016527061],"genre_scores_gemma":[0.9973411,0.00011257917,0.00033586804,0.0003835724,0.00017243285,0.0007825945,0.00003154782,0.00007377443,0.0007665383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99743056,0.00021932379,0.0007607341,0.0006069196,0.00054681057,0.00043563676],"domain_scores_gemma":[0.9972983,0.0010899446,0.00018338002,0.0010514335,0.000246755,0.00013018622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006525441,0.00034634068,0.00090341177,0.00026426106,0.00011378707,0.00003822611,0.00055391714,0.00011310915,0.00013957392],"category_scores_gemma":[0.00040344795,0.00019303923,0.00009202144,0.0009240206,0.000115044495,0.00006674573,0.0001980253,0.00048248458,0.000005125524],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030485215,0.040115494,0.88956094,0.00017792768,0.0052332343,0.000480051,0.022000615,0.000036171998,0.007231842,0.000048845417,0.0029998343,0.00162986],"study_design_scores_gemma":[0.2095065,0.052955084,0.6965757,0.00088349613,0.0017544501,0.000015354182,0.026004478,0.0017260492,0.009352415,0.00015529126,0.0005819044,0.00048929633],"about_ca_topic_score_codex":0.011497473,"about_ca_topic_score_gemma":0.05410486,"teacher_disagreement_score":0.19298522,"about_ca_system_score_codex":0.00015863543,"about_ca_system_score_gemma":0.0005993417,"threshold_uncertainty_score":0.99508506},"labels":[],"label_agreement":null},{"id":"W4417015726","doi":"10.1182/blood-2025-1672","title":"FLT3 inhibition with midostaurin offsets poor prognosis in NPM1/FLT3/DNMT3a triple-mutated AML","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Midostaurin; NPM1; Survival analysis; Retrospective cohort study; Cytarabine; Induction chemotherapy; Chemotherapy; Cancer; Chemotherapy regimen","score_opus":0.011272230175628567,"score_gpt":0.27750763342586476,"score_spread":0.2662354032502362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417015726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98550284,0.00029540985,0.0000473704,0.005923389,0.00005548449,0.0016635535,0.000026111209,0.00016446898,0.006321393],"genre_scores_gemma":[0.9951552,0.00006797848,0.000945363,0.000498259,0.00008470325,0.00030760327,0.00018810353,0.00004134532,0.0027114486],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99790454,0.00012212318,0.0004185123,0.0005154987,0.00048202102,0.0005572873],"domain_scores_gemma":[0.99911433,0.00010247197,0.00007578391,0.00032655697,0.00021064766,0.00017022187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038004652,0.00024495507,0.0004367563,0.0006464591,0.000077489014,0.00004001478,0.00012930662,0.00019720495,0.00013034753],"category_scores_gemma":[0.00026513278,0.00019832543,0.00007722282,0.0015587632,0.00012624924,0.00012686191,0.00010294696,0.00058505655,0.00008897278],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050327615,0.009935851,0.7083984,0.0019738304,0.0012280842,0.0062453905,0.0015712219,0.000014962907,0.21163994,0.0008306213,0.028324258,0.02480471],"study_design_scores_gemma":[0.05174612,0.0018566438,0.23465432,0.0019481604,0.0005732948,0.00039727247,0.0007375597,0.0006899843,0.7028754,0.00021117301,0.00379236,0.00051771785],"about_ca_topic_score_codex":0.00035460488,"about_ca_topic_score_gemma":0.00024169855,"teacher_disagreement_score":0.49123546,"about_ca_system_score_codex":0.00029880926,"about_ca_system_score_gemma":0.00079610647,"threshold_uncertainty_score":0.80874765},"labels":[],"label_agreement":null},{"id":"W4417015853","doi":"10.1182/blood-2025-4370","title":"Community health worker training for sickle cell disease education in the consortium for newborn screening in Africa","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Global Maternal and Child Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Newborn screening; Community health workers; Disease; Intervention (counseling); Hemoglobinopathy; Community health; Health care; Public health; Sickle cell anemia","score_opus":0.04400949118487114,"score_gpt":0.33888416266956506,"score_spread":0.29487467148469393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417015853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97459435,0.0014173388,0.0012848931,0.016829105,0.0000965907,0.0016597271,0.000036823243,0.000019775549,0.0040614177],"genre_scores_gemma":[0.9894592,0.000018733808,0.003239163,0.006518302,0.00007768055,0.00015903384,0.00004458152,0.000006403466,0.00047689863],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992498,0.00011285388,0.00022177232,0.0000993511,0.00006577445,0.00025044684],"domain_scores_gemma":[0.99945927,0.00019303325,0.000053506854,0.00018046462,0.00003096549,0.00008274807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061085285,0.00007160913,0.00016725654,0.00006803463,0.00013606226,0.000011550614,0.000096586715,0.000027505252,0.0000024760607],"category_scores_gemma":[0.00010463379,0.00005372968,0.00004416636,0.00015492225,0.000017917808,0.00002275488,0.000015566455,0.00019017982,6.604568e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025775335,0.011414421,0.7686366,0.004384569,0.00006448677,0.000007695452,0.022605686,0.000055030978,0.0001278914,0.0074496083,0.026826732,0.15584974],"study_design_scores_gemma":[0.006018799,0.0002541079,0.93207264,0.0010324524,0.00007733633,0.0000023704424,0.010565441,0.00012490798,0.000042477073,0.0039853505,0.045744084,0.0000800249],"about_ca_topic_score_codex":0.0007963369,"about_ca_topic_score_gemma":0.0005926773,"teacher_disagreement_score":0.16343604,"about_ca_system_score_codex":0.000027990664,"about_ca_system_score_gemma":0.0007839783,"threshold_uncertainty_score":0.21910328},"labels":[],"label_agreement":null},{"id":"W4417015862","doi":"10.1182/blood-2025-5549","title":"Improved long-term tolerability with asciminib (ASC) vs investigator-selected (IS) tyrosine kinase inhibitors (TKIs) in patients (pts) with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP): Week 96 exploratory analysis of the phase 3 ASC4FIRST trial","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Tolerability; Discontinuation; Adverse effect; Randomized controlled trial; Regimen; Multivariate analysis; Exploratory analysis","score_opus":0.012970421291537181,"score_gpt":0.26331847505347356,"score_spread":0.25034805376193636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417015862","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927673,0.0010031511,0.000021643813,0.00024056886,0.00021171929,0.005419162,0.00018102783,0.00011095558,0.000044484055],"genre_scores_gemma":[0.9976933,0.000109818095,0.00012925296,0.00027294568,0.00015889714,0.0008846742,0.00057388924,0.00009836715,0.00007886498],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9941127,0.0004718494,0.0017906466,0.0015367277,0.0010198808,0.0010682307],"domain_scores_gemma":[0.99582595,0.0003426556,0.00082472566,0.002059448,0.0004584324,0.00048876874],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00056674954,0.0009378734,0.002091211,0.0012294834,0.00017072832,0.000060937,0.00056871335,0.00041548256,0.00013168126],"category_scores_gemma":[0.0007304598,0.00067389716,0.0003972215,0.0077269175,0.0007024951,0.0003968842,0.00021628324,0.0010021077,0.0000053819244],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0602896,0.028727638,0.8762137,0.0011215147,0.0052481606,0.00037782965,0.0018364138,0.00066034397,0.017477421,0.0000071818095,0.0002722749,0.007767878],"study_design_scores_gemma":[0.6002503,0.014740609,0.25981167,0.0017972743,0.006552719,0.000004752005,0.00008806891,0.0016845491,0.11435849,0.0000046449413,0.000056061835,0.0006508471],"about_ca_topic_score_codex":0.0017165468,"about_ca_topic_score_gemma":0.013864325,"teacher_disagreement_score":0.6164021,"about_ca_system_score_codex":0.011931536,"about_ca_system_score_gemma":0.016903117,"threshold_uncertainty_score":0.9995712},"labels":[],"label_agreement":null},{"id":"W4417015865","doi":"10.1182/blood-2025-5548","title":"Beyond survival in chronic myeloid leukemia: A systematic review of secondary malignancies in the era of tyrosine kinase inhibitors","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Myeloid leukemia; Incidence (geometry); Systematic review; MEDLINE; Tyrosine kinase; Medical record; Concomitant; Tyrosine-kinase inhibitor; Nilotinib","score_opus":0.00854823276166846,"score_gpt":0.25125108441659944,"score_spread":0.24270285165493097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417015865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76078403,0.23312238,0.0000014476801,0.00048740595,0.00010148043,0.0021187002,0.000028203764,0.000014684398,0.0033416746],"genre_scores_gemma":[0.9891327,0.009778492,0.00007739146,0.0004481797,0.0000434577,0.0002253532,0.000039487946,0.000018430495,0.00023649623],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9976235,0.00026469995,0.0011630759,0.00027026123,0.00039966585,0.00027877573],"domain_scores_gemma":[0.99851066,0.00032226287,0.00030477342,0.00073199504,0.00009350383,0.00003681324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010504844,0.00023252219,0.0012606118,0.00020200788,0.000020912536,0.000005577685,0.00023584637,0.00011606404,0.00005700602],"category_scores_gemma":[0.0004893945,0.00015824605,0.00017491131,0.0009735271,0.000113941,0.000060558377,0.000080765894,0.0004171649,0.000006384774],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005828101,0.0010134421,0.008679114,0.9756633,0.00033312838,0.0002934308,0.00075024075,0.000005242695,0.01128121,0.0009817585,0.00048794452,0.00045292746],"study_design_scores_gemma":[0.02016935,0.00069606834,0.03357384,0.8779988,0.002470724,0.00013213106,0.0007923468,0.000032862245,0.06355199,0.00020734876,0.00008493124,0.00028954784],"about_ca_topic_score_codex":0.0004540394,"about_ca_topic_score_gemma":0.0004080528,"teacher_disagreement_score":0.22834869,"about_ca_system_score_codex":0.0011428751,"about_ca_system_score_gemma":0.002679212,"threshold_uncertainty_score":0.6453087},"labels":[],"label_agreement":null},{"id":"W4417015871","doi":"10.1182/blood-2025-4366","title":"A pilot study evaluating the feasibility and usability of an mHealth application: SCD warrior","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"","keywords":"mHealth; Usability; Life expectancy; Disease; Digital health; Disease management; Chronic disease; MEDLINE","score_opus":0.054443619643781686,"score_gpt":0.3794797546980037,"score_spread":0.325036135054222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417015871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955444,0.00095342856,0.000035349407,0.0008270188,0.00003567776,0.0017401105,0.0000029777104,0.000029491339,0.00083154766],"genre_scores_gemma":[0.99946064,0.000024197141,0.00022722782,0.00016701657,0.000019190365,0.000051577616,0.0000024343492,0.0000046886025,0.000043035576],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989731,0.00017589856,0.00029152926,0.00026365896,0.00017651675,0.00011930305],"domain_scores_gemma":[0.99911666,0.00010842325,0.00006700005,0.00053988997,0.000104433726,0.0000635959],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001364451,0.00007893214,0.00020175989,0.000026807134,0.00014248789,0.000007247138,0.000077395496,0.000028216753,0.000011089936],"category_scores_gemma":[0.00032919637,0.000049053917,0.000024399751,0.00024138653,0.00013077882,0.000024889281,0.000048186816,0.00016498273,0.0000011682257],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042944434,0.010289244,0.9497035,0.00038225218,0.000114932496,0.0000013118114,0.0012719088,0.0000067658148,0.005141309,0.00016208758,0.00001394324,0.032483313],"study_design_scores_gemma":[0.006890041,0.009928033,0.9759551,0.00006551265,0.0006347004,0.000010517009,0.00404322,0.0010531333,0.00047452626,0.0008525805,0.000022827347,0.00006980645],"about_ca_topic_score_codex":0.00043514607,"about_ca_topic_score_gemma":0.00014337325,"teacher_disagreement_score":0.03241351,"about_ca_system_score_codex":0.000021421281,"about_ca_system_score_gemma":0.00020304575,"threshold_uncertainty_score":0.20003606},"labels":[],"label_agreement":null},{"id":"W4417015925","doi":"10.1182/blood-2025-6165","title":"Utility of diagnostic bone marrow examinations for cytopenias and impact on clinical management: A practice audit","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hematological disorders and diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Cytopenia; Malignancy; Retrospective cohort study; Hematologic malignancy; Clinical significance; Cohort; Logistic regression; Kidney disease; Bone marrow examination; Bone marrow","score_opus":0.03848633367547988,"score_gpt":0.3912177251960742,"score_spread":0.3527313915205943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417015925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9505689,0.0010871108,0.001522885,0.0038255427,0.000070782844,0.0014603783,0.000070177775,0.00003511946,0.041359074],"genre_scores_gemma":[0.9952402,0.00077762327,0.002624592,0.0008883346,0.000019629557,0.00005882917,0.000020408703,0.0000059224467,0.0003644437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99912196,0.00006299041,0.00034504768,0.0002169801,0.00010970048,0.00014332586],"domain_scores_gemma":[0.9899563,0.009525024,0.000089929476,0.0002316386,0.000111241316,0.00008586663],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00042085347,0.00009693969,0.00033111687,0.000065452456,0.000045302793,0.0000105634235,0.000046481156,0.00008956829,0.00005698442],"category_scores_gemma":[0.021187395,0.00007168936,0.000102111626,0.00014974536,0.00008633089,0.000036595673,0.00005002315,0.00010466888,0.000006496766],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002048714,0.027864827,0.75973326,0.0022832009,0.0015861291,0.00045707406,0.00012005499,0.0000027620779,0.000046815057,0.08831746,0.05505004,0.062489647],"study_design_scores_gemma":[0.0072206086,0.0017406147,0.97640485,0.00033123823,0.0015926958,0.000020072344,0.0001776657,0.00013358898,0.00019494716,0.0038598583,0.00822744,0.00009643096],"about_ca_topic_score_codex":0.000009588708,"about_ca_topic_score_gemma":0.000004663651,"teacher_disagreement_score":0.21667157,"about_ca_system_score_codex":0.000004479794,"about_ca_system_score_gemma":0.00004996393,"threshold_uncertainty_score":0.98705757},"labels":[],"label_agreement":null},{"id":"W4417015928","doi":"10.1182/blood-2025-6162","title":"Current clinical concerns for patients with hereditary hemochromatosis – a Delphi consensus study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Phlebotomy; Hereditary hemochromatosis; Hemochromatosis; Hepcidin; Delphi method; Transferrin saturation; Biobank","score_opus":0.027291208101619672,"score_gpt":0.34866728875650066,"score_spread":0.321376080654881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417015928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951781,0.0013507315,0.000072199815,0.00022969514,0.000649437,0.0017850159,0.000054398683,0.000059046295,0.00062135136],"genre_scores_gemma":[0.99850154,0.000026559936,0.000676554,0.00033214586,0.00017926103,0.00010450988,0.00005142405,0.000016257949,0.00011176594],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998891,0.00005085722,0.00035291904,0.0003017714,0.00019475588,0.00020870447],"domain_scores_gemma":[0.9992111,0.00015310771,0.00006907147,0.00029171098,0.00017123383,0.000103784936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015691621,0.00014227745,0.00037859104,0.00006181351,0.00006929125,0.000009205458,0.00007343795,0.00005492781,0.000022575063],"category_scores_gemma":[0.00022447704,0.000105433326,0.00009736545,0.00013830735,0.000090944166,0.000017159131,0.000036115063,0.00012225905,0.000008320019],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073457556,0.0110933175,0.973221,0.00016910002,0.00019050713,0.000013136162,0.00013869627,2.5856838e-7,0.0000021369144,0.00009408155,0.008741385,0.0056017777],"study_design_scores_gemma":[0.063602656,0.0023825662,0.92152977,0.00014886363,0.002353542,0.000003355274,0.0011281244,0.000009916281,0.00004307179,0.00007256868,0.008533688,0.00019187962],"about_ca_topic_score_codex":0.000016507234,"about_ca_topic_score_gemma":0.000019325791,"teacher_disagreement_score":0.06286808,"about_ca_system_score_codex":0.0000068652607,"about_ca_system_score_gemma":0.00020470246,"threshold_uncertainty_score":0.42994463},"labels":[],"label_agreement":null},{"id":"W4417015948","doi":"10.1182/blood-2025-6172","title":"Systematic review on the diagnostic evaluation of pediatric evans syndrome","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Children's Hospital of Western Ontario; Centre Hospitalier Universitaire Sainte-Justine; Western University","funders":"","keywords":"Evans syndrome; Etiology; Systematic review; Autoimmune lymphoproliferative syndrome; Retrospective cohort study; MEDLINE; Critical appraisal","score_opus":0.011010775875703906,"score_gpt":0.26814720824914595,"score_spread":0.257136432373442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417015948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8220606,0.17407638,0.000013920045,0.00026162676,0.00006147277,0.0014194282,0.000011864941,0.000004689246,0.0020900138],"genre_scores_gemma":[0.9920935,0.0071293744,0.000005881807,0.00033674613,0.000012784101,0.00027418183,0.000023897517,0.000005320611,0.00011830272],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9992503,0.00016248494,0.00019505445,0.00013832863,0.00017553856,0.000078315425],"domain_scores_gemma":[0.9993513,0.00009444768,0.000087959685,0.00036030283,0.00009242832,0.000013517539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041472752,0.00008310687,0.00016835816,0.000023588185,0.000035547397,0.000004922495,0.00011813223,0.000041026236,0.0000133510675],"category_scores_gemma":[0.0011848556,0.00005129674,0.00007931724,0.00012865684,0.000013136826,8.357953e-7,0.00002767374,0.000027341257,0.0000144137975],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009692882,0.023042222,0.065322086,0.84489655,0.015363882,0.00006935996,0.00022383106,0.00025584016,0.00709922,0.008378105,0.03281781,0.002434129],"study_design_scores_gemma":[0.043704886,0.009055879,0.10827284,0.31821537,0.26469216,0.00031752657,0.0006653579,0.00032724687,0.23820871,0.0126580885,0.00064473395,0.0032372125],"about_ca_topic_score_codex":0.0000031806142,"about_ca_topic_score_gemma":0.000003616124,"teacher_disagreement_score":0.52668124,"about_ca_system_score_codex":0.00000385438,"about_ca_system_score_gemma":0.000065611326,"threshold_uncertainty_score":0.20918205},"labels":[],"label_agreement":null},{"id":"W4417015986","doi":"10.1182/blood-2025-1748","title":"Non-invasive detection and classification of lymphoma via cell-free DNA methylation profiling","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vector Institute; Ontario Institute for Cancer Research; University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"DNA methylation; Lymphoma; CpG site; Methylation; Follicular lymphoma; Diffuse large B-cell lymphoma; DNA; Predictive value","score_opus":0.006133005915640979,"score_gpt":0.2202393451451168,"score_spread":0.21410633922947583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417015986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98800397,0.00067194935,0.009657091,0.000029877514,0.000085616804,0.00014695145,0.000011513567,0.000003841781,0.0013891801],"genre_scores_gemma":[0.99872744,0.00029544096,0.000776394,0.000032323427,0.000058663478,0.00001867453,0.00003249854,0.0000060701077,0.000052507305],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99959856,0.000010500622,0.00012484276,0.00016127636,0.00003832968,0.00006651704],"domain_scores_gemma":[0.9996175,0.000020144336,0.0000713468,0.00020249552,0.000069716276,0.000018786508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006525644,0.000060327446,0.00006714741,0.000039165527,0.000036800753,0.000008854694,0.000059541548,0.00008460739,6.063179e-7],"category_scores_gemma":[0.00008282813,0.00006581853,0.000027538545,0.000065533604,0.00002544843,0.0000018453624,0.00005529942,0.00001741508,5.536932e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022703687,0.00007324236,0.002905721,0.00004681982,0.000023287463,1.8095928e-7,0.000014548379,0.00001003645,0.99094564,0.000063668034,0.000028038856,0.0058661075],"study_design_scores_gemma":[0.0010857579,0.00010011997,0.025108986,0.0000090369,0.000059809885,0.0000012631109,0.000032776406,0.00018795022,0.97269154,0.00038712783,0.00027565152,0.00005999959],"about_ca_topic_score_codex":0.000016679436,"about_ca_topic_score_gemma":0.00006115985,"teacher_disagreement_score":0.022203265,"about_ca_system_score_codex":0.000008147668,"about_ca_system_score_gemma":0.00007018056,"threshold_uncertainty_score":0.2684002},"labels":[],"label_agreement":null},{"id":"W4417016030","doi":"10.1182/blood-2025-1644","title":"Post-transplant maintenance with sorafenib is safe and effective in pediatric patients with har FLT3/ITD AML: A report from the Children's oncology group protocol AAML1031","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Sorafenib; Cohort; Tolerability; Chemotherapy; Hematopoietic stem cell transplantation; Chemotherapy regimen; Transplantation; Induction chemotherapy","score_opus":0.0032854587040255633,"score_gpt":0.24945933932135128,"score_spread":0.24617388061732573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417016030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9339451,0.000051093728,0.00007541268,0.0015782809,0.000021011434,0.06301428,0.0001232022,0.000040756124,0.0011508458],"genre_scores_gemma":[0.9584544,0.000025790585,0.0009736887,0.0012050385,0.0001360089,0.038767703,0.00016518685,0.000042924836,0.0002292648],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997915,0.00019166133,0.00035247402,0.0006483763,0.00042582868,0.00046660315],"domain_scores_gemma":[0.99859774,0.00036161512,0.00016166276,0.0005235139,0.00023109968,0.00012435559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037585167,0.00027464028,0.00048158612,0.0001744465,0.00010625996,0.000026211063,0.00019481515,0.00016635805,0.000025564212],"category_scores_gemma":[0.00015892167,0.00015005976,0.000046314282,0.00056278805,0.0002001875,0.000086484855,0.00009520929,0.0007092417,0.000008552656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048511634,0.001107591,0.989318,0.0001336711,0.00031055367,0.0011649488,0.00063436216,4.2826238e-7,0.00010957281,0.00002325132,0.0006953758,0.0016510927],"study_design_scores_gemma":[0.028085241,0.0024587149,0.96659636,0.00033752737,0.0004616951,0.00022917577,0.000064157444,0.000006370066,0.0006198876,0.000027179465,0.00093835883,0.00017531982],"about_ca_topic_score_codex":0.0012450806,"about_ca_topic_score_gemma":0.00058248115,"teacher_disagreement_score":0.024509277,"about_ca_system_score_codex":0.00020089315,"about_ca_system_score_gemma":0.00067205576,"threshold_uncertainty_score":0.61192596},"labels":[],"label_agreement":null},{"id":"W4417016053","doi":"10.1182/blood-2025-723","title":"Sex-based disparities in MPN treatment patterns: A study of 1167 patients from the Quebec MPN registry","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Louisiana-Pacific (Canada); Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Polycythemia vera; Medical record; Demographics; Essential thrombocythemia; Disease; Myelofibrosis; Epidemiology","score_opus":0.013023588258969057,"score_gpt":0.2639429333610009,"score_spread":0.25091934510203184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417016053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99679357,0.00032124016,0.0000046462433,0.00086934044,0.00007023807,0.0014419563,0.00013781569,0.0000195109,0.00034168255],"genre_scores_gemma":[0.9981804,0.000052404946,0.000036780115,0.00039162557,0.000037008584,0.0006272495,0.00013453346,0.000012039797,0.0005279713],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880326,0.00012404795,0.0003506693,0.00030953577,0.00023597646,0.00017651348],"domain_scores_gemma":[0.998938,0.00035712522,0.00009671008,0.00050138275,0.00006038978,0.000046367666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005819239,0.00020759481,0.00044781843,0.000067146764,0.00006025998,0.000021341997,0.00009164549,0.000058605125,0.000048639387],"category_scores_gemma":[0.00006013163,0.00012391883,0.000085283056,0.00013361532,0.000039388477,0.00002561306,0.000033511158,0.0000908097,0.0000039393353],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014574997,0.023198424,0.9721275,0.00004129496,0.0005208071,0.00005486849,0.0014033259,0.0000054256557,0.000012683215,0.00003603271,0.00019023557,0.00226363],"study_design_scores_gemma":[0.019784478,0.001557534,0.9689848,0.00035115177,0.0005705928,3.4420873e-7,0.001294667,0.0000147117735,0.007146966,0.000023857983,0.00018559986,0.00008528861],"about_ca_topic_score_codex":0.068867415,"about_ca_topic_score_gemma":0.0704983,"teacher_disagreement_score":0.02164089,"about_ca_system_score_codex":0.00012959307,"about_ca_system_score_gemma":0.0001658112,"threshold_uncertainty_score":0.9464627},"labels":[],"label_agreement":null},{"id":"W4417016071","doi":"10.1182/blood-2025-724","title":"A comparison of real-world outcomes of asciminib versus ATP-competitive tyrosine kinase inhibitors as second-line treatment in patients with chronic myeloid leukemia in chronic phase","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Nilotinib; Myeloid leukemia; Comorbidity; Dasatinib; Tyrosine-kinase inhibitor; Retrospective cohort study; Sorafenib; Imatinib mesylate","score_opus":0.018380191646538056,"score_gpt":0.32513581636332595,"score_spread":0.3067556247167879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417016071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99278593,0.001189055,0.0000012224548,0.000089601104,0.00018443158,0.0019396461,0.00012991989,0.0000428598,0.003637352],"genre_scores_gemma":[0.9980325,0.0001180162,0.00018378491,0.000025028949,0.00005870711,0.00016539074,0.0003687338,0.00004828158,0.0009995286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99704766,0.00009296532,0.0011813868,0.0006444555,0.000478719,0.0005548176],"domain_scores_gemma":[0.99821156,0.00030782112,0.0004597326,0.00072845427,0.00014891173,0.0001435468],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013355777,0.0005261125,0.0016395659,0.0008656854,0.000038391852,0.0000084836165,0.00017085618,0.00016472321,0.00025518125],"category_scores_gemma":[0.000078550336,0.00042514337,0.00018914661,0.0011407305,0.00022653455,0.000109376044,0.000092316324,0.0003098088,0.000013703765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00653083,0.01224992,0.96872103,0.0006149002,0.0012545891,0.00013313856,0.0010197497,0.0002394991,0.0029076978,0.0003052594,0.00003974961,0.0059836083],"study_design_scores_gemma":[0.22748171,0.014757953,0.57489973,0.0015797465,0.0009146515,0.0000014971843,0.00020270771,0.00018602065,0.17913365,0.000007584783,0.00053775747,0.00029697688],"about_ca_topic_score_codex":0.0043434775,"about_ca_topic_score_gemma":0.025698442,"teacher_disagreement_score":0.39382133,"about_ca_system_score_codex":0.013465719,"about_ca_system_score_gemma":0.005097665,"threshold_uncertainty_score":0.99982005},"labels":[],"label_agreement":null},{"id":"W4417016097","doi":"10.1182/blood-2025-1155","title":"Innate immune dysregulation in monocytes in sickle cell disease","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"CD14; Cytokine; Innate immune system; Peripheral blood mononuclear cell; Monocyte; Immune system; Lipoteichoic acid; Receptor","score_opus":0.004360453565424826,"score_gpt":0.22645604519200474,"score_spread":0.2220955916265799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417016097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826464,0.005501574,0.000009896603,0.0013305405,0.000064014304,0.00026384945,0.0000015097478,0.000029687286,0.010152532],"genre_scores_gemma":[0.9978889,0.0002828136,0.00006336158,0.00017776409,0.000010282812,0.000015126333,0.000019410272,0.0000076199512,0.001534686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99939287,0.000023248711,0.0002118862,0.00014421035,0.00007147557,0.00015628904],"domain_scores_gemma":[0.9997284,0.000019881414,0.000024590503,0.00016308062,0.000016681193,0.00004737591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000086756816,0.0000788104,0.00014778705,0.00020337143,0.000018663664,0.00000666136,0.000041019106,0.00007504858,0.000027950146],"category_scores_gemma":[0.000046888545,0.00007043511,0.000038789047,0.0004197024,0.000023800007,0.000037237423,0.000027390557,0.00014699699,0.000018566927],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005221603,0.0043537724,0.9568068,0.0006387702,0.00006115778,0.00041538468,0.00085714227,0.0008292938,0.023277465,0.0012968796,0.00032122998,0.01061997],"study_design_scores_gemma":[0.010401448,0.000059140384,0.97147745,0.00046685094,0.000119896475,0.0000016708134,0.00032662487,0.0021179854,0.01246324,0.0012406311,0.0011897217,0.0001353139],"about_ca_topic_score_codex":0.00012548926,"about_ca_topic_score_gemma":0.000024557214,"teacher_disagreement_score":0.015242539,"about_ca_system_score_codex":0.000027852731,"about_ca_system_score_gemma":0.00009346849,"threshold_uncertainty_score":0.28722605},"labels":[],"label_agreement":null},{"id":"W4417016145","doi":"10.1182/blood-2025-1440","title":"ANKRD26-related thrombocytopenia: Hematologic malignancy characteristics, clinical outcomes, and precursor states","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Malignancy; Myeloid leukemia; Germline; Hematologic malignancy; Germline mutation; Myeloproliferative neoplasm; Family history; Myeloid; Hematology","score_opus":0.017475598691765706,"score_gpt":0.3171696861970766,"score_spread":0.2996940875053109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417016145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930782,0.0015182769,0.0000075112566,0.0010972808,0.00018633506,0.0004590818,0.00003723278,0.00009140777,0.0035246941],"genre_scores_gemma":[0.9953267,0.0011939148,0.00037032756,0.00063057384,0.000009850917,0.00001997534,0.00011889432,0.0000129756145,0.002316795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884915,0.00004214299,0.0004535407,0.00032612708,0.00009408211,0.00023497696],"domain_scores_gemma":[0.9993766,0.00013843113,0.00009435959,0.0002443654,0.000046297733,0.00009996452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012270016,0.00018046417,0.00076991855,0.000061483945,0.00006670802,0.00002277899,0.00006214039,0.0001655255,0.00007683867],"category_scores_gemma":[0.00016563895,0.00013048116,0.00010115282,0.00011365492,0.00009698522,0.00004493929,0.000063795174,0.00017278941,0.0000696642],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056011646,0.001760086,0.99264777,0.000093124465,0.00081559626,0.000868531,0.000049747352,1.4971071e-8,0.00003868322,0.00066209404,0.0005867343,0.0024216368],"study_design_scores_gemma":[0.009028186,0.0003175433,0.98600763,0.00018010041,0.0008721114,0.00017021365,0.00003242791,0.000013672649,0.00029693535,0.0021403614,0.0008110789,0.00012971871],"about_ca_topic_score_codex":0.000024191937,"about_ca_topic_score_gemma":0.0000091985185,"teacher_disagreement_score":0.008972174,"about_ca_system_score_codex":0.000009894508,"about_ca_system_score_gemma":0.00006493256,"threshold_uncertainty_score":0.53208673},"labels":[],"label_agreement":null},{"id":"W4417016148","doi":"10.1182/blood-2025-1438","title":"A zebrafish model of parn deficiency identifies altered lipid metabolism as a novel therapeutic target for restoring hematopoiesis in dyskeratosis congenita","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; AGADA Biosciences; Hospital for Sick Children; University of Ottawa; Agricultural Research Institute of Ontario","funders":"","keywords":"Dyskeratosis congenita; Zebrafish; Cytopenia; Bone marrow failure; Hematopoietic stem cell; Bone marrow; Myeloid","score_opus":0.013255674690880181,"score_gpt":0.2475588306561665,"score_spread":0.2343031559652863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417016148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99026376,0.0016518731,0.006724358,0.00006350533,0.00025538224,0.00024263964,0.000027046175,0.000009966716,0.0007614703],"genre_scores_gemma":[0.9969317,0.00005145695,0.0023636585,0.00012975467,0.000078519304,0.00005168342,0.0000212148,0.000015029022,0.00035702394],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992519,0.000017215702,0.00022727647,0.00025805758,0.0000772192,0.00016835073],"domain_scores_gemma":[0.9995624,0.000013865361,0.00006754382,0.00025405292,0.000080109734,0.000022066239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000116125244,0.00011605279,0.00018457591,0.000081679194,0.00005365624,0.000020298907,0.00013313694,0.00011590114,0.0000038906396],"category_scores_gemma":[0.0000751008,0.00011257876,0.00009774865,0.00012463501,0.00003554253,0.000006329649,0.000055764354,0.00005168976,5.6424415e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009259235,0.0001583302,0.00074027455,0.00007205227,0.000100599216,1.3907504e-7,0.00011247844,0.00014039893,0.99550414,0.0027454211,0.00010659864,0.0002269466],"study_design_scores_gemma":[0.0019919996,0.000107587126,0.0014948355,0.000026271095,0.00016760067,0.000003485567,0.00014232297,0.00065212155,0.99017084,0.0031055417,0.0019774963,0.00015992485],"about_ca_topic_score_codex":0.000021513068,"about_ca_topic_score_gemma":0.000039222963,"teacher_disagreement_score":0.006667901,"about_ca_system_score_codex":0.000004854062,"about_ca_system_score_gemma":0.0000684294,"threshold_uncertainty_score":0.45908287},"labels":[],"label_agreement":null},{"id":"W4417016184","doi":"10.1182/blood-2025-710","title":"Cumulative incidence of household material hardship and income loss as measures of financial toxicity during pediatric acute lymphoblastic leukemia (ALL) treatment: A report from the DFCI ALL 16-001 Trial","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Centre hospitalier universitaire de Québec","funders":"","keywords":"Context (archaeology); Clinical endpoint; Clinical trial; Cumulative incidence; Incidence (geometry); Pediatric cancer; Cancer; Household income","score_opus":0.03221315360874016,"score_gpt":0.24469305411182568,"score_spread":0.21247990050308552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417016184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945727,0.0013017872,0.00005459152,0.00006712017,0.00065437605,0.00049359124,0.001387662,0.000023929864,0.001444228],"genre_scores_gemma":[0.9977957,0.0012019796,0.00006567067,0.00009030323,0.0005006891,0.000047396952,0.000028361557,0.000022323124,0.00024759964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979019,0.00003387864,0.0011854639,0.0004899358,0.0000718543,0.00031696755],"domain_scores_gemma":[0.99816835,0.00021564192,0.0010227588,0.00046016256,0.000053121283,0.00007999207],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004230404,0.00026822017,0.00086622755,0.0001752953,0.00010230421,0.00006104607,0.00029902675,0.00021380042,0.00005505391],"category_scores_gemma":[0.00063998887,0.00024582358,0.00017351007,0.00019544577,0.00015860963,0.0002738191,0.0001469739,0.0001140584,0.000008751443],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019940177,0.001551269,0.9490206,0.00024639757,0.0019626496,0.00025656848,0.0017905821,0.00029259367,0.0011884713,0.0225638,0.00043243577,0.0007544218],"study_design_scores_gemma":[0.052009236,0.0009059556,0.8917855,0.000112425725,0.00081995304,0.000044431657,0.000032061267,0.000051065934,0.017976172,0.034327205,0.0013083967,0.00062759634],"about_ca_topic_score_codex":0.0073569403,"about_ca_topic_score_gemma":0.0004055287,"teacher_disagreement_score":0.057235133,"about_ca_system_score_codex":0.0004442584,"about_ca_system_score_gemma":0.00036671266,"threshold_uncertainty_score":0.9999994},"labels":[],"label_agreement":null},{"id":"W4417016277","doi":"10.1182/blood-2025-6761","title":"A case of co-mutation of SF3B1 and BCR::ABL1 demonstrating an MDS-phenotype","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Concordia University; McGill University","funders":"","keywords":"Bone marrow; Myeloid leukemia; Missense mutation; Myeloid; Haematopoiesis; DNA sequencing; Myelodysplastic syndromes; Mutation; Germline mutation","score_opus":0.015709284618118984,"score_gpt":0.30291417144742494,"score_spread":0.28720488682930595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417016277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952724,0.0004570979,0.000067853856,0.000032240598,0.000020018535,0.0002253717,0.000013496496,0.00001835731,0.0038931787],"genre_scores_gemma":[0.9963317,0.000013377162,0.0034716018,0.000028873405,0.000018291503,0.000006370377,0.000022084587,0.0000071577088,0.0001005229],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994296,0.000027673215,0.00022824561,0.00014025148,0.000080815254,0.0000934434],"domain_scores_gemma":[0.99953914,0.00007727347,0.000091471775,0.0001818339,0.00006304005,0.000047237965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000098406934,0.000077151526,0.00020588412,0.00007440762,0.000029737255,0.000003627604,0.000023705568,0.000055741006,0.000025852012],"category_scores_gemma":[0.000103892235,0.000070454684,0.000026086576,0.00012569275,0.00005867479,0.00004397328,0.000013506115,0.00006079976,0.0000012899027],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058116706,0.0046996,0.5171173,0.0031869954,0.0018423762,0.0059951097,0.0052325716,0.00002990439,0.34030765,0.005081805,0.0001910121,0.11573451],"study_design_scores_gemma":[0.048925895,0.003477049,0.14042301,0.0014053419,0.0042275675,0.0083533665,0.003888359,0.0033364263,0.7842239,0.0012454551,0.000105293635,0.0003883334],"about_ca_topic_score_codex":0.0003484426,"about_ca_topic_score_gemma":0.00008415876,"teacher_disagreement_score":0.44391626,"about_ca_system_score_codex":0.0000391827,"about_ca_system_score_gemma":0.00025759137,"threshold_uncertainty_score":0.28730586},"labels":[],"label_agreement":null},{"id":"W4417016281","doi":"10.1182/blood-2025-6765","title":"The mitochondrial protease YME1L regulates type 1 interferon signaling via the cgas-sting pathway in AML","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Gene knockdown; Downregulation and upregulation; Myeloid leukemia; Haematopoiesis; Signal transduction; Myeloid; Interferon; Cell growth; RNA interference","score_opus":0.01538632082903093,"score_gpt":0.2779810156672474,"score_spread":0.2625946948382165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417016281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905273,0.0009992722,0.00012539884,0.0044701365,0.00030502488,0.0013402697,0.0000022721704,0.000064010135,0.0021663662],"genre_scores_gemma":[0.9951797,0.000021446976,0.00056243327,0.0002850491,0.00047762183,0.000118445256,0.000008547734,0.00002484863,0.0033218914],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99850684,0.00019077965,0.00032414598,0.00027793285,0.00028468,0.00041560302],"domain_scores_gemma":[0.9986612,0.0005457891,0.00006440469,0.0005259373,0.00013522293,0.00006739627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006350276,0.00015099703,0.0002047706,0.00010143916,0.00024692275,0.00006997865,0.00033309826,0.000104926636,0.000034304474],"category_scores_gemma":[0.0012541757,0.00008276124,0.00007220764,0.0005517502,0.00013927018,0.000044580294,0.00021035683,0.000667435,0.00004298903],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022414504,0.0004528131,0.008691418,0.00020477727,0.00032245793,0.00024315866,0.0012864036,0.000040141713,0.9528039,0.0006837089,0.0027927288,0.030237043],"study_design_scores_gemma":[0.011717112,0.0009831373,0.005620674,0.0014124482,0.000234345,0.00009437025,0.0013239254,0.0034190894,0.95117277,0.0028157919,0.020853305,0.00035303453],"about_ca_topic_score_codex":0.00016663597,"about_ca_topic_score_gemma":0.00006677624,"teacher_disagreement_score":0.029884009,"about_ca_system_score_codex":0.00013585367,"about_ca_system_score_gemma":0.00045800058,"threshold_uncertainty_score":0.33749053},"labels":[],"label_agreement":null},{"id":"W4417016321","doi":"10.1182/blood-2025-8246","title":"Trial in progress: A phase 1b/2a study to evaluate mezigdomide in combination with elranatamab in patients with relapsed/refractory multiple myeloma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Tolerability; Multiple myeloma; Phases of clinical research; Pharmacokinetics; Pharmacodynamics; Bortezomib; Drug","score_opus":0.019260332922885086,"score_gpt":0.3344037877665396,"score_spread":0.3151434548436545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417016321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894705,0.00008877837,0.000005036676,0.00025593888,0.00004672752,0.009890156,0.000016259846,0.000034798442,0.00019184897],"genre_scores_gemma":[0.9979209,0.000004092535,0.00045905958,0.0000445897,0.000015619882,0.0012909562,0.0001123096,0.000029428853,0.00012308851],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973212,0.0003352048,0.00049804547,0.0005602854,0.0007963834,0.0004888964],"domain_scores_gemma":[0.9989562,0.00016834577,0.000091008274,0.00043623423,0.00017788443,0.00017033887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006036414,0.00026352922,0.00054995046,0.00101348,0.000046907513,0.00003093797,0.0001427034,0.000071984025,0.000020047737],"category_scores_gemma":[0.0005099282,0.00018965831,0.000034336215,0.0012269347,0.00005347884,0.00016402974,0.0000695365,0.00035526266,0.000013309026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16456665,0.092414536,0.73098344,0.00004899709,0.00021467594,0.00048503434,0.0007618449,0.0000052114965,0.00001926033,0.0000028450659,0.000016951635,0.010480552],"study_design_scores_gemma":[0.47073305,0.012835951,0.51531184,0.0003266653,0.000091619186,7.567849e-7,0.0002474824,0.00013182608,0.00019873292,0.0000062203558,0.00001703601,0.0000988466],"about_ca_topic_score_codex":0.000556641,"about_ca_topic_score_gemma":0.005765033,"teacher_disagreement_score":0.30616638,"about_ca_system_score_codex":0.00029899122,"about_ca_system_score_gemma":0.0003536565,"threshold_uncertainty_score":0.7734041},"labels":[],"label_agreement":null},{"id":"W4417016329","doi":"10.1182/blood-2025-505","title":"Impact of conditioning intensity on outcomes after unrelated donor hematopoietic cell transplantation using posttransplant cyclophosphamide-based GVHD prophylaxis","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"","keywords":"Hazard ratio; Proportional hazards model; Transplantation; Hematopoietic stem cell transplantation; Cyclophosphamide; Retrospective cohort study; Cohort; Hematopoietic cell; Graft-versus-host disease","score_opus":0.011960863919973747,"score_gpt":0.2750931875893866,"score_spread":0.26313232366941286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417016329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929516,0.00012685829,0.004440033,0.00006420163,0.00015132326,0.00090517814,0.0002404922,0.000100109726,0.0010202556],"genre_scores_gemma":[0.99794084,0.000030378253,0.0014070098,0.00017827857,0.000011484518,0.000034003995,0.0003108808,0.000035678968,0.00005146588],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981557,0.00007801886,0.0006790709,0.00039356216,0.00036589772,0.0003277252],"domain_scores_gemma":[0.9988551,0.00025759038,0.00017590768,0.00035781335,0.00022939901,0.00012419347],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018432814,0.0003357259,0.00065366103,0.00038716287,0.000083369596,0.000019180452,0.00008883244,0.00024039786,0.00018720503],"category_scores_gemma":[0.000029225268,0.00027784857,0.00036032277,0.00045745587,0.00009814729,0.000076467004,0.0000054206407,0.00029413588,0.00001591776],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002027019,0.00143336,0.9354437,0.0027683836,0.00039647828,0.00049072277,0.00078954373,0.00066891743,0.055858593,0.000042859316,0.000005318033,0.000075099095],"study_design_scores_gemma":[0.0063321386,0.0005403803,0.68616366,0.0011834386,0.0012631194,0.000105945415,0.000041837964,0.00010440693,0.3040278,0.000043995315,6.360665e-7,0.00019263093],"about_ca_topic_score_codex":0.00027028055,"about_ca_topic_score_gemma":0.000006572327,"teacher_disagreement_score":0.24928004,"about_ca_system_score_codex":0.00010665883,"about_ca_system_score_gemma":0.00033176484,"threshold_uncertainty_score":0.9999674},"labels":[],"label_agreement":null},{"id":"W4417016379","doi":"10.1182/blood-2025-2648","title":"Inclusive practices for safe and equitable donor assessment","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services","funders":"","keywords":"Donation; Deferral; Health equity; Equity (law); Health care; Best practice; Transplantation","score_opus":0.020018853150817244,"score_gpt":0.3621489414667816,"score_spread":0.34213008831596436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417016379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7686279,0.001437236,0.01962987,0.008374106,0.00025321185,0.0020604946,0.00003427099,0.00008036124,0.19950254],"genre_scores_gemma":[0.9630334,0.0001863681,0.03182936,0.0006240519,0.00006987099,0.00013593867,0.00003628426,0.000010404591,0.0040743113],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99945235,0.000016452826,0.00014220453,0.00015450432,0.00009359319,0.00014088457],"domain_scores_gemma":[0.99936116,0.00033071713,0.00008534053,0.000114351824,0.0000655676,0.000042882188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024367003,0.000066161876,0.00014712731,0.000054737833,0.00008181761,0.00001941988,0.000030279889,0.000048656595,0.00003095097],"category_scores_gemma":[0.00011651294,0.000057813544,0.000023946257,0.00007492355,0.000017454819,0.00006233718,0.00002673328,0.000056327834,0.0000035787382],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013781592,0.0056333407,0.38498294,0.01997909,0.002935218,0.0002443952,0.004296255,0.0000079931315,0.4240169,0.11133997,0.008793413,0.03639232],"study_design_scores_gemma":[0.07027516,0.0026303486,0.18542352,0.003854557,0.011414319,0.0005941094,0.0054058684,0.0015117193,0.51039386,0.009944207,0.19766273,0.00088959804],"about_ca_topic_score_codex":0.00002527114,"about_ca_topic_score_gemma":0.000016454353,"teacher_disagreement_score":0.19955942,"about_ca_system_score_codex":0.000019127305,"about_ca_system_score_gemma":0.00017069568,"threshold_uncertainty_score":0.23575678},"labels":[],"label_agreement":null},{"id":"W4417016390","doi":"10.1182/blood-2025-2518","title":"Blastic plasmacytoid dendritic cell neoplasm (BPDCN) international registry: Assessment of the allo-HCT outcomes","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Leukocytosis; Chemotherapy; Leukopenia; Hematopoietic stem cell transplantation; Bone marrow; Hematology; Plasmacytoid dendritic cell; Transplantation; Interleukin-3 receptor","score_opus":0.009436705971283918,"score_gpt":0.319752060105991,"score_spread":0.31031535413470707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417016390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9387597,0.00012551129,0.0002182641,0.003163659,0.00036719404,0.00051760586,0.00003693658,0.00003239866,0.056778725],"genre_scores_gemma":[0.9826703,0.000038240047,0.00052341557,0.00041612927,0.00003529899,0.000041077048,0.000016616967,0.000017045155,0.01624187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998475,0.00007256933,0.00031732657,0.00026796473,0.0006205227,0.00024661733],"domain_scores_gemma":[0.9988085,0.00031715218,0.000088090776,0.00049258035,0.00022622166,0.00006743524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013232639,0.00015791338,0.00030052618,0.00014274985,0.00008271668,0.000032019987,0.0003832859,0.00007416118,0.00020146012],"category_scores_gemma":[0.00054928503,0.00011165996,0.0001708847,0.00025360816,0.00015954736,0.000030897812,0.00020824766,0.00025529644,0.000015837191],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006868714,0.0017691201,0.9683734,0.00025537063,0.0005254138,0.000094172625,0.000110583576,0.000048936625,0.025398366,0.0013495011,0.0017464506,0.00025997273],"study_design_scores_gemma":[0.018668111,0.00044445807,0.8482583,0.00063344097,0.0008663484,0.0006967192,0.00087335927,0.0038280692,0.11632318,0.0008847637,0.008139875,0.00038333226],"about_ca_topic_score_codex":0.00006182358,"about_ca_topic_score_gemma":0.00008571301,"teacher_disagreement_score":0.12011509,"about_ca_system_score_codex":0.00011382776,"about_ca_system_score_gemma":0.00074723415,"threshold_uncertainty_score":0.4553361},"labels":[],"label_agreement":null},{"id":"W4417016409","doi":"10.1182/blood-2025-2657","title":"Aromatherapy oil during bone marrow biopsy procedure and association with anxiety and pain: An interim analysis","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hematological disorders and diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Aromatherapy; Lavender oil; Anxiety; Visual analogue scale; Adverse effect; Placebo; Interim analysis","score_opus":0.006308267858314823,"score_gpt":0.2411268918525495,"score_spread":0.2348186239942347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417016409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99718446,0.0008630264,0.000117632495,0.0011507253,0.0000060509424,0.00007597558,0.0000043714317,0.000046560996,0.0005511854],"genre_scores_gemma":[0.9978209,0.00055328896,0.0007815511,0.00046039713,0.00001380264,0.000015599939,0.000016389095,0.000005718516,0.00033236848],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99942154,0.000031917963,0.000121555495,0.00020046528,0.00009739467,0.00012713039],"domain_scores_gemma":[0.99966127,0.000064554544,0.00004991595,0.00010261791,0.000046678764,0.00007494304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016743029,0.000092224705,0.00026000728,0.00008522171,0.000058940008,0.000031104148,0.00001967457,0.00009584737,0.000013536819],"category_scores_gemma":[0.00026672153,0.000065759305,0.000030639163,0.00032511514,0.000025563728,0.000039098424,0.00001477683,0.000079834375,4.023174e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007648608,0.0004894009,0.99476737,0.00021807366,0.00045855215,0.000032178814,0.0001734951,5.138183e-7,0.0024329857,0.000069998925,0.000044314664,0.0012366163],"study_design_scores_gemma":[0.0034314774,0.0003471201,0.99164414,0.000170987,0.0014340625,0.00007196347,0.00043903277,0.00034512096,0.0016888683,0.00015547406,0.00013405856,0.00013768881],"about_ca_topic_score_codex":0.000013847701,"about_ca_topic_score_gemma":0.000042930227,"teacher_disagreement_score":0.0033549913,"about_ca_system_score_codex":0.000011401939,"about_ca_system_score_gemma":0.0000220757,"threshold_uncertainty_score":0.26815864},"labels":[],"label_agreement":null},{"id":"W4417016416","doi":"10.1182/blood-2025-2652","title":"Frailty assessed by HCT-FS predicts survival and non-relapse mortality across hematologic disorders undergoing allo-HCT: A multicenter Study of 992 patients","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Frailty in Older Adults","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Myelodysplastic syndromes; Transplantation; Hematopoietic stem cell transplantation; Multicenter study; Observational study; Myeloid leukemia; Acute leukemia; Disease; Hematopoietic cell","score_opus":0.01717700284647161,"score_gpt":0.31005844314226977,"score_spread":0.29288144029579816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417016416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99625283,0.00016949432,0.00019028563,0.00022778487,0.00034473458,0.001692366,0.00010979247,0.000093525865,0.00091918284],"genre_scores_gemma":[0.99915427,0.000058363148,0.00017789255,0.00012456668,0.000018002693,0.0000698401,0.00009052222,0.000029944105,0.00027659396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99764186,0.00013124196,0.00063888717,0.00059538684,0.0005394709,0.00045317752],"domain_scores_gemma":[0.9984476,0.00036665233,0.00020595026,0.0006295306,0.00019375591,0.00015650288],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027690752,0.0003184402,0.00068586954,0.00007589975,0.00013010816,0.000034743975,0.00020486774,0.00018302005,0.000017497941],"category_scores_gemma":[0.00087544345,0.00028040624,0.00008412474,0.00033928672,0.00016252616,0.00013847611,0.0002814058,0.0002959487,0.0000041903977],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013391001,0.012366528,0.9823196,0.00070483005,0.00073090545,0.00001878419,0.0021812536,0.000006103511,0.00070272386,0.0000062053655,0.00060172216,0.00022741251],"study_design_scores_gemma":[0.032573745,0.0010543965,0.9601261,0.00040319408,0.00058919133,0.0000015704803,0.0032633431,0.00022052231,0.0014519383,0.000039386745,0.000059963557,0.00021663652],"about_ca_topic_score_codex":0.0008640038,"about_ca_topic_score_gemma":0.003565733,"teacher_disagreement_score":0.032439835,"about_ca_system_score_codex":0.000040438194,"about_ca_system_score_gemma":0.0000970516,"threshold_uncertainty_score":0.99996483},"labels":[],"label_agreement":null},{"id":"W4417016420","doi":"10.1182/blood-2025-2660","title":"External validation of an online predictive model for myelodysplastic syndrome","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Cytopenia; Cohort; Myelodysplastic syndromes; Predictive value; Gold standard (test); Anemia; Predictive value of tests; Bone marrow; Retrospective cohort study","score_opus":0.029526592938433526,"score_gpt":0.317789488804225,"score_spread":0.28826289586579146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417016420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90402734,0.00006040615,0.09461571,0.00015501147,0.000040158404,0.00058733096,0.00016724122,0.000038628823,0.00030818913],"genre_scores_gemma":[0.97873574,0.000012021573,0.019070426,0.00007360191,0.000060698327,0.00006009028,0.0001560936,0.00001669342,0.0018146039],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9991047,0.000024043653,0.00023380159,0.00021968277,0.0002282019,0.0001895679],"domain_scores_gemma":[0.99924946,0.00011813463,0.00005477125,0.000262739,0.00022897613,0.000085941545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017028567,0.000095211144,0.00023436536,0.0001908181,0.000036032452,0.0000071214636,0.00012071146,0.00008693993,0.000016826632],"category_scores_gemma":[0.00027249436,0.0000853764,0.000062337735,0.00017711708,0.000054035798,0.0000874732,0.000047163707,0.00014550563,0.000003097134],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01581665,0.03006067,0.046211343,0.007241651,0.0043782145,0.00064584374,0.0031409068,0.03641015,0.82156926,0.008710484,0.0025128732,0.023301944],"study_design_scores_gemma":[0.0117530925,0.0018701869,0.043672796,0.00046739314,0.0008343744,0.00016302138,0.00009910326,0.8502035,0.08831573,0.0024664411,0.000030138299,0.00012417806],"about_ca_topic_score_codex":0.0000122363135,"about_ca_topic_score_gemma":0.0000030203778,"teacher_disagreement_score":0.8137934,"about_ca_system_score_codex":0.000071624534,"about_ca_system_score_gemma":0.00046133035,"threshold_uncertainty_score":0.34815487},"labels":[],"label_agreement":null},{"id":"W4417016543","doi":"10.1182/blood-2025-5524","title":"A first-in-human Phase 1 trial of LY4152199, a B-cell activation factor receptor (BAFF-R) T-cell engager bispecific antibody, in patients with previously treated B-cell malignancies (BAF_FRontier-1 Trial in Progress)","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Lymphoma; Follicular lymphoma; Dosing; Macroglobulinemia; In vivo; Antibody; Waldenstrom macroglobulinemia; Chronic lymphocytic leukemia; Toxicity","score_opus":0.019152295503091648,"score_gpt":0.30541245797784644,"score_spread":0.2862601624747548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417016543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885959,0.00031677904,0.000007934139,0.000075394586,0.00017341574,0.008969468,0.00004662863,0.000054446646,0.0017600427],"genre_scores_gemma":[0.99495804,0.00011798174,0.00022072058,0.000016220578,0.00012297012,0.00047849352,0.00030511103,0.00006995521,0.003710534],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9961399,0.00046678042,0.0011206232,0.0007567606,0.00080392504,0.0007120504],"domain_scores_gemma":[0.9983826,0.00022641233,0.00036247453,0.0006758293,0.0002155753,0.00013710004],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000678773,0.0004390757,0.0010839683,0.0013347844,0.000075153825,0.000051865085,0.00028600887,0.00031428676,0.0005390599],"category_scores_gemma":[0.00013964677,0.00037276943,0.0001915553,0.00165367,0.00016893592,0.00019891562,0.00007812075,0.00068281085,0.000007689779],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4685816,0.070693344,0.24770664,0.0009112355,0.00012658648,0.000055339046,0.0016893339,0.0000053135823,0.20770977,0.0000045849138,0.0003436475,0.002172615],"study_design_scores_gemma":[0.73561156,0.010549262,0.012150013,0.0007631242,0.000108434266,3.2553353e-7,0.00014959634,0.000024614008,0.23910409,0.000005791381,0.0012368544,0.00029633206],"about_ca_topic_score_codex":0.0003432296,"about_ca_topic_score_gemma":0.0001924609,"teacher_disagreement_score":0.26702997,"about_ca_system_score_codex":0.00031881707,"about_ca_system_score_gemma":0.00041411974,"threshold_uncertainty_score":0.99987245},"labels":[],"label_agreement":null},{"id":"W4417016546","doi":"10.1182/blood-2025-5523","title":"Odronextamab treatment for patients with rare subtypes of relapsed/refractory (R/R) aggressive B-cell non-Hodgkin lymphoma (B-NHL): Updated efficacy and safety analyses from a dedicated cohort of the ELM-2 study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Aggressive lymphoma; Follicular lymphoma; Lymphoma; Cohort; Dosing; Mantle cell lymphoma; Prospective cohort study; Adverse effect","score_opus":0.01020518810993391,"score_gpt":0.2701855490575468,"score_spread":0.2599803609476129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417016546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947073,0.0013121967,0.0000064848914,0.000060569793,0.000053585973,0.0032328416,0.00038471722,0.000021952641,0.00022036546],"genre_scores_gemma":[0.9987851,0.0001877765,0.00022608972,0.000036451103,0.000015703397,0.0002078062,0.00038671753,0.000023446106,0.00013092464],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848235,0.00008879588,0.0004889325,0.0004358464,0.0003054228,0.0001986438],"domain_scores_gemma":[0.9982077,0.00034580924,0.00051372027,0.0005953596,0.00024995988,0.00008749098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006520823,0.00028967252,0.00075255526,0.00011979605,0.000108361106,0.000009928471,0.00012173625,0.00010094953,0.000020411067],"category_scores_gemma":[0.00007159964,0.00015787268,0.00013997368,0.00033052274,0.00012362075,0.000039140923,0.00006626847,0.00003910867,0.0000011071016],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033052058,0.03848477,0.94827396,0.000055017746,0.0043527526,0.00002655376,0.00047658477,0.0000037948666,0.00068628776,0.0000026665246,0.00014757953,0.004184848],"study_design_scores_gemma":[0.089969955,0.0046307337,0.8488796,0.00038052964,0.007065408,0.0000014378758,0.00021744093,0.0000147206265,0.048610754,0.0000048012876,0.00011266739,0.0001119588],"about_ca_topic_score_codex":0.00086851517,"about_ca_topic_score_gemma":0.000092384944,"teacher_disagreement_score":0.099394344,"about_ca_system_score_codex":0.00013260181,"about_ca_system_score_gemma":0.00031585293,"threshold_uncertainty_score":0.64378613},"labels":[],"label_agreement":null},{"id":"W4417016598","doi":"10.1182/blood-2025-6388","title":"The humanistic burden of patients with chronic myeloid leukemia (CML) treated with first line (1L) tyrosine kinase inhibitors (TKIs)","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Discontinuation; Myeloid leukemia; Adverse effect; Quality of life (healthcare); First line; Bosutinib; Cohort; Nilotinib; Population","score_opus":0.0057912680990299245,"score_gpt":0.21777353540926295,"score_spread":0.21198226731023304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417016598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99424505,0.0019707896,0.000022706912,0.00033573838,0.00007732706,0.0013025869,0.000054455577,0.00011421615,0.0018771155],"genre_scores_gemma":[0.99587166,0.00025404044,0.00015559238,0.00004635671,0.00019828243,0.00012088962,0.00025448916,0.00006426843,0.0030344354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979369,0.000041732605,0.000507045,0.0004981324,0.0005165298,0.0004996404],"domain_scores_gemma":[0.9981564,0.00023142352,0.00025690682,0.0009049961,0.00030615806,0.000144087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000101170685,0.00041877606,0.0005526993,0.00015712235,0.00031727206,0.00003446824,0.00022286142,0.00013664993,0.00007278378],"category_scores_gemma":[0.00011831078,0.00024045055,0.000096759504,0.0006488937,0.00033960812,0.000069291134,0.000093927105,0.00028481198,0.000024378118],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009276186,0.007717084,0.939174,0.0035090626,0.007981665,0.0008329876,0.0011333446,0.0012202639,0.005588727,0.001046029,0.005053712,0.017466927],"study_design_scores_gemma":[0.18758354,0.01916198,0.6048338,0.008666056,0.010537299,0.00009293859,0.00024355309,0.0006588963,0.13379784,0.00008388601,0.03294199,0.0013982472],"about_ca_topic_score_codex":0.0008664544,"about_ca_topic_score_gemma":0.001211078,"teacher_disagreement_score":0.33434024,"about_ca_system_score_codex":0.0015634595,"about_ca_system_score_gemma":0.0015738755,"threshold_uncertainty_score":0.98052883},"labels":[],"label_agreement":null},{"id":"W4417016607","doi":"10.1182/blood-2025-6151","title":"Healthcare costs associated with hematopoietic cell transplant for sickle cell disease in the United States and Canada: A comparative analysis","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Children's Hospital","funders":"","keywords":"Health care; Disease; Transplantation; Hematopoietic cell; Hematopoietic stem cell transplantation; Regimen; Cost effectiveness; Disease management; Clinical trial","score_opus":0.007778416605189874,"score_gpt":0.23676113567316737,"score_spread":0.22898271906797749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417016607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931173,0.0016449057,0.000038708993,0.0039993017,0.000010991796,0.0006793407,0.00022508444,0.0000129155715,0.00027146155],"genre_scores_gemma":[0.9976175,0.0002227327,0.000012193971,0.0012758904,0.0000028531297,0.000046920355,0.0006772738,0.000005240322,0.00013942186],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992239,0.000083015846,0.00017079843,0.00017141373,0.00014087502,0.00021000576],"domain_scores_gemma":[0.99941576,0.0002233841,0.000048976235,0.00012815169,0.00007579948,0.0001079555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010394166,0.00011868953,0.0002980713,0.00013762242,0.00009522287,0.000011903899,0.000052199837,0.000046707864,0.0000029326625],"category_scores_gemma":[0.00001098523,0.00007220439,0.00004363712,0.0008076429,0.000044705917,0.000010889116,0.000005187604,0.00014706084,1.3629614e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010342766,0.0029501703,0.97440195,0.0013481231,0.0018372288,0.00042653127,0.013962011,0.0014728326,0.00009593423,0.00027792863,0.0021668791,0.0000261446],"study_design_scores_gemma":[0.060121153,0.0019673551,0.78169966,0.0025387632,0.03449292,0.000016278067,0.0844785,0.025408858,0.0045057023,0.00028808857,0.0033321995,0.0011505324],"about_ca_topic_score_codex":0.22913322,"about_ca_topic_score_gemma":0.5582428,"teacher_disagreement_score":0.32910958,"about_ca_system_score_codex":0.000056982106,"about_ca_system_score_gemma":0.00045706492,"threshold_uncertainty_score":0.776},"labels":[],"label_agreement":null},{"id":"W4417016636","doi":"10.1182/blood-2025-7934","title":"Quality initiative in first-line chronic lymphocytic leukemia /small lymphocytic lymphoma assessing the use of 2nd generation BTKi therapy and impact on cardiac medical conditions patients experience on treatment","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada)","funders":"","keywords":"Ibrutinib; Chronic lymphocytic leukemia; Population; Acute lymphocytic leukemia; Clinical trial; Venetoclax; Randomized controlled trial","score_opus":0.11686154192662304,"score_gpt":0.39647440940937034,"score_spread":0.2796128674827473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417016636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99710363,0.00086957484,0.000028997816,0.0001340086,0.00015095195,0.0013245896,0.00007775329,0.000037010825,0.00027345467],"genre_scores_gemma":[0.99663997,0.00202685,0.000045101,0.00050585065,0.00014986645,0.0003151173,0.00020422167,0.000031214156,0.00008180881],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9968037,0.0005008096,0.00073481764,0.00059282046,0.00086624234,0.00050159707],"domain_scores_gemma":[0.996613,0.002025221,0.00020515769,0.00073869835,0.00020066866,0.0002172551],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046581973,0.00039675363,0.00073100335,0.00030831568,0.00023712257,0.00008826022,0.00018190387,0.000246131,0.00006027763],"category_scores_gemma":[0.0010007545,0.00024559928,0.00020997219,0.0005912293,0.0004440855,0.00017546497,0.000084938285,0.00015719203,0.0000060854372],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.011875617,0.02709898,0.3947614,0.0023071235,0.010092116,0.0016655846,0.03936607,0.04500064,0.013713991,0.003816987,0.0021293873,0.4481721],"study_design_scores_gemma":[0.21111387,0.005411021,0.5721274,0.0021252374,0.00037333756,0.00006563451,0.0005353499,0.14763454,0.05924962,0.000101023776,0.0006269317,0.00063601835],"about_ca_topic_score_codex":0.005985941,"about_ca_topic_score_gemma":0.00043726785,"teacher_disagreement_score":0.44753605,"about_ca_system_score_codex":0.09243325,"about_ca_system_score_gemma":0.03837262,"threshold_uncertainty_score":0.99999964},"labels":[],"label_agreement":null},{"id":"W4417016669","doi":"10.1182/blood-2025-8082","title":"Real-world use of Pola-R-CHP for untreated diffuse large B-cell lymphoma (DLBCL): A systematic literature review","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Systematic review; MEDLINE; Prednisone; Lymphoma; Meta-analysis; Clinical trial; Cochrane Library; Adverse effect","score_opus":0.0130026048439279,"score_gpt":0.2741083363861438,"score_spread":0.2611057315422159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417016669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6239722,0.3562328,0.000034125856,0.0019435632,0.00032413178,0.010950995,0.0009487742,0.00026253593,0.0053309184],"genre_scores_gemma":[0.91861486,0.062248636,0.0011678374,0.0025898474,0.000081692255,0.0011987858,0.0005054012,0.00005763494,0.013535311],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9984281,0.00008664518,0.0006348913,0.00033472423,0.00020636822,0.0003092727],"domain_scores_gemma":[0.99831194,0.00037729865,0.00022877417,0.00071680284,0.00024144021,0.00012372958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000179312,0.00026348088,0.0010591534,0.00021309666,0.00006381496,0.000040762796,0.00009992182,0.00010232833,0.000011243752],"category_scores_gemma":[0.00023562467,0.00018532903,0.00036937502,0.000707354,0.000022099664,0.000073898096,0.000045411347,0.000041956257,0.0000131925535],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030550582,0.09022738,0.06201429,0.8077908,0.0028915482,0.00064976944,0.0003647285,9.777508e-8,0.001146518,0.008022381,0.025720263,0.00086669764],"study_design_scores_gemma":[0.173564,0.001101479,0.03950526,0.71380675,0.023640402,0.00018234523,0.000054335822,0.00010183541,0.02886748,0.000096900796,0.018461013,0.00061817665],"about_ca_topic_score_codex":0.00007991182,"about_ca_topic_score_gemma":0.000046673213,"teacher_disagreement_score":0.2946427,"about_ca_system_score_codex":0.00010681005,"about_ca_system_score_gemma":0.0001606329,"threshold_uncertainty_score":0.7557499},"labels":[],"label_agreement":null},{"id":"W4417016685","doi":"10.1182/blood-2025-37","title":"Therapy-related core binding factor Acute Myeloid Leukemia – a Study of the french acute leukemia intergroup","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child, Adolescent and Family Mental Health","funders":"","keywords":"Acute leukemia; Myeloid leukemia; Radiation therapy; Chemotherapy; White blood cell; Complete remission; Retrospective cohort study; Chemotherapy regimen","score_opus":0.02244930580480628,"score_gpt":0.3026765162435691,"score_spread":0.28022721043876286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417016685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99256885,0.00036944478,0.000017645818,0.0003966559,0.00044046927,0.0022546474,0.00008240744,0.00016203054,0.0037078345],"genre_scores_gemma":[0.9860582,0.00027425075,0.0001240803,0.00026913677,0.00008140044,0.0001232579,0.000036467347,0.0000674356,0.012965818],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99679506,0.00018729016,0.0008171263,0.000689692,0.0008279632,0.0006828733],"domain_scores_gemma":[0.99762964,0.00021307183,0.0002758466,0.0014253559,0.0002782056,0.00017789687],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035973583,0.00045189398,0.00083190046,0.0004886761,0.00026046787,0.000049541013,0.0009964298,0.00034629335,0.00025329227],"category_scores_gemma":[0.00017096747,0.0002964091,0.00033626912,0.0018399789,0.000247473,0.00012704842,0.0006467409,0.001335741,0.000056622623],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095867034,0.0031438894,0.31838882,0.00020235326,0.017176816,0.0006575364,0.009581482,0.0000104712935,0.62684494,0.00027464618,0.011227207,0.011533142],"study_design_scores_gemma":[0.06311631,0.0042700297,0.6362048,0.0011321419,0.004135671,0.00039062946,0.003022721,0.0007215352,0.28280795,0.00025729556,0.003075286,0.0008656448],"about_ca_topic_score_codex":0.0006474528,"about_ca_topic_score_gemma":0.000081762235,"teacher_disagreement_score":0.34403703,"about_ca_system_score_codex":0.001237234,"about_ca_system_score_gemma":0.001908334,"threshold_uncertainty_score":0.9999488},"labels":[],"label_agreement":null},{"id":"W4417016692","doi":"10.1182/blood-2025-31","title":"Genomic determinants of treatment outcome and identification of a new genomic subset of adult acute lymphoblastic leukemia from the ECOG-ACRIN E1910 randomized phase III trial","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Exome sequencing; Transcriptome; Exome; Epigenetics; Single-nucleotide polymorphism; Gene expression profiling; Gene; Whole genome sequencing; Copy number analysis","score_opus":0.020393141851440564,"score_gpt":0.32053431929469306,"score_spread":0.30014117744325247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417016692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958278,0.00048132296,0.00047918886,0.00010027761,0.00017405313,0.0025254407,0.00034013944,0.000015957728,0.000055809924],"genre_scores_gemma":[0.9978837,0.0005703758,0.0003893272,0.00004278983,0.000111144946,0.000107457694,0.0000731763,0.000026141457,0.000795937],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.997227,0.00019717733,0.0016069442,0.0003926415,0.00030314224,0.00027308462],"domain_scores_gemma":[0.9969944,0.0013102978,0.00067608646,0.0007160455,0.00017749173,0.0001256883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004554366,0.00026464887,0.0015325613,0.00019951741,0.000053000058,0.00001649539,0.0002811819,0.00014472607,0.000043748474],"category_scores_gemma":[0.0007208661,0.00017389478,0.00031978468,0.0002292805,0.00036612066,0.000049344708,0.00012748622,0.00009351565,0.0000067388546],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6096135,0.001347841,0.010928767,0.00023856254,0.0032628344,0.000042396812,0.0016587924,0.000010317307,0.3666029,0.00007698983,0.00020449345,0.006012629],"study_design_scores_gemma":[0.8541822,0.0008806967,0.0073962593,0.00016244389,0.0049579157,0.000025322963,0.00014386087,0.0033411887,0.12865044,0.00013106593,0.000017762304,0.00011085312],"about_ca_topic_score_codex":0.0029231769,"about_ca_topic_score_gemma":0.00012732578,"teacher_disagreement_score":0.24456874,"about_ca_system_score_codex":0.0006084833,"about_ca_system_score_gemma":0.0024324893,"threshold_uncertainty_score":0.7091223},"labels":[],"label_agreement":null},{"id":"W4417016716","doi":"10.1182/blood-2025-52","title":"EZH2 and CREBBP mutation status identify a subset of patients who benefit from bendamustine- over CHOP/CVP-based immunochemotherapies in follicular lymphoma: Findings from the GALLIUM trial and validation in a large international cohort","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Bendamustine; Obinutuzumab; Cohort; Rituximab; Follicular lymphoma; Chemoimmunotherapy; Clinical trial; Proportional hazards model","score_opus":0.005904439077180711,"score_gpt":0.25681821949520606,"score_spread":0.25091378041802537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417016716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99735546,0.0009065378,0.000010738447,0.00024059278,0.00012320389,0.0008040278,0.00052630366,0.000008555913,0.000024555626],"genre_scores_gemma":[0.99789673,0.0002755551,0.00011994751,0.00016107033,0.00003087099,0.00011077555,0.0013833418,0.00001004947,0.000011635203],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989158,0.000043856853,0.00036738097,0.0002715702,0.0002581703,0.00014324431],"domain_scores_gemma":[0.9993602,0.0002676681,0.00011663766,0.00015591443,0.000069113536,0.000030456917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015177547,0.00014036169,0.00028289718,0.00014561138,0.000035920322,0.000047142406,0.000056603876,0.00008620731,0.00004985784],"category_scores_gemma":[0.0001389791,0.00011018292,0.00005346253,0.00015910366,0.00003284165,0.000091550435,0.000039638388,0.00004592515,6.3353264e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025847265,0.0018808271,0.9931964,0.000015976519,0.0003356256,0.000011824428,0.0006537648,0.000002489348,0.0004178936,0.000041880325,0.000036515255,0.00082201895],"study_design_scores_gemma":[0.13118249,0.00011750016,0.8609036,0.00025458747,0.0002544797,2.9856838e-7,0.000097234515,0.00020283433,0.006686273,0.00015403345,0.000075847085,0.000070768714],"about_ca_topic_score_codex":0.0044797393,"about_ca_topic_score_gemma":0.0005832737,"teacher_disagreement_score":0.1322928,"about_ca_system_score_codex":0.000113440816,"about_ca_system_score_gemma":0.00007397856,"threshold_uncertainty_score":0.67720556},"labels":[],"label_agreement":null},{"id":"W4417016745","doi":"10.1182/blood-2025-7188","title":"Radiotherapy consolidation post-autologous stem cell transplant in Relapsed/Refractory aggressive non-Hodgkin lymphoma improves progression-free and overall survival in patients with partial but not complete metabolic response pre-transplant","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Aggressive lymphoma; Radiation therapy; Proportional hazards model; Lymphoma; Autologous stem-cell transplantation; Chemotherapy; Salvage therapy; Stem cell; Cohort; Prognostic variable","score_opus":0.006319775147884242,"score_gpt":0.2346033067782472,"score_spread":0.22828353163036297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417016745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99505913,0.002072553,0.000018321853,0.00044082513,0.00013496178,0.0017571935,0.00043257096,0.00004658998,0.000037854777],"genre_scores_gemma":[0.9984987,0.00042576581,0.0002867263,0.00027992117,0.000025340512,0.0002682491,0.0001389658,0.00003286619,0.000043487787],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977024,0.00034994353,0.0005420862,0.0005816835,0.00038788616,0.00043596982],"domain_scores_gemma":[0.9986451,0.00042699504,0.00025411687,0.00044906788,0.00008430583,0.00014041422],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002777838,0.00037653735,0.00074987044,0.00033069626,0.0000804909,0.000038418522,0.00014462684,0.00019599524,0.0000066846496],"category_scores_gemma":[0.000024433908,0.00027344597,0.00007884231,0.00020300475,0.00012485548,0.00010484266,0.000029612294,0.00014381848,0.0000016284843],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045097563,0.007857392,0.9107889,0.000217188,0.0004038492,0.0011990183,0.0023729128,0.000008365231,0.020463651,0.00007198369,0.000010527222,0.011508668],"study_design_scores_gemma":[0.074028194,0.0024379452,0.8887418,0.0009671295,0.00037970446,0.000032086824,0.00006327535,0.00009712336,0.032917317,0.000009839381,0.00007528002,0.00025029847],"about_ca_topic_score_codex":0.00043927584,"about_ca_topic_score_gemma":0.00017113925,"teacher_disagreement_score":0.028930634,"about_ca_system_score_codex":0.00014801424,"about_ca_system_score_gemma":0.0004104559,"threshold_uncertainty_score":0.99997175},"labels":[],"label_agreement":null},{"id":"W4417016748","doi":"10.1182/blood-2025-7596","title":"Real-world outcomes of teclistamab for multiple myeloma in Canada: Multi-institutional report from the Canadian myeloma research group (CMRG) database","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Dr. Georges-L.-Dumont University Hospital Centre; St. John’s Health Sciences Centre; William Osler Health System; Ontario Institute for Cancer Research; McGill University; Jewish General Hospital; Newfoundland and Labrador Centre for Applied Health Research; Dalhousie University; Juravinski Cancer Centre; Université de Montréal; University of Saskatchewan; Queen Elizabeth II Health Sciences Centre; University of Alberta; CancerCare Manitoba; Ottawa Hospital; Occupational Cancer Research Centre; University of Calgary; Princess Margaret Cancer Centre; Vancouver General Hospital; Saint John Regional Hospital; BC Cancer Agency","funders":"","keywords":"Multiple myeloma; Observational study; Clinical trial; Overall survival; Retrospective cohort study; Outcomes research; Melphalan; Lenalidomide","score_opus":0.07502390516473915,"score_gpt":0.365392429111874,"score_spread":0.2903685239471348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417016748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856145,0.00043151123,0.0000564442,0.00446457,0.00021868262,0.0026941616,0.0031352027,0.000024034596,0.0033609078],"genre_scores_gemma":[0.9914446,0.000033866745,0.004268491,0.00018497872,0.000076274766,0.0004535914,0.001883504,0.000023076289,0.0016316582],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968984,0.000160759,0.000648111,0.0005657293,0.0008931179,0.0008338466],"domain_scores_gemma":[0.99659777,0.00147004,0.000095547715,0.0009957058,0.0004237431,0.00041719596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010069015,0.00023857909,0.0005346379,0.00053462974,0.00046659057,0.000031834476,0.00037357208,0.000090317924,0.000063097534],"category_scores_gemma":[0.0033964987,0.00016325674,0.00012394831,0.0008381377,0.0002583595,0.000085980006,0.00015324737,0.00046989464,0.0000058318506],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003105183,0.0006326789,0.9894519,0.0000885908,0.000490535,0.0023045647,0.00005576555,0.0000027729677,0.00092662184,0.0009269119,0.0028745336,0.0019346079],"study_design_scores_gemma":[0.0109288925,0.000050630457,0.97773206,0.00022917466,0.00010424223,0.000020122563,0.00022126497,0.0005562868,0.0027478538,0.000074766525,0.0072123716,0.00012235242],"about_ca_topic_score_codex":0.99921083,"about_ca_topic_score_gemma":0.9999685,"teacher_disagreement_score":0.013645398,"about_ca_system_score_codex":0.0018104551,"about_ca_system_score_gemma":0.015455854,"threshold_uncertainty_score":0.9901256},"labels":[],"label_agreement":null},{"id":"W4417016749","doi":"10.1182/blood-2025-7744","title":"FluMel100 with post-transplant cyclophosphamide: A safe and effective regimen for patients aged ≥75 years with MDS and AML","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Regimen; Tolerability; Transplantation; Graft-versus-host disease; Hematopoietic stem cell transplantation; Myelodysplastic syndromes; Myeloid leukemia; Conditioning regimen; Young adult","score_opus":0.003318610541880248,"score_gpt":0.2337407390668709,"score_spread":0.23042212852499067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417016749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99604577,0.00036041348,0.00008792945,0.0003439057,0.000017897224,0.0021226148,0.000063102125,0.000038230133,0.0009201229],"genre_scores_gemma":[0.99608296,0.00013034727,0.002181534,0.0003423879,0.00002590804,0.00022185879,0.00007015176,0.000030346857,0.0009144946],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989849,0.000039283696,0.00012318582,0.00036175552,0.00019278433,0.0002981056],"domain_scores_gemma":[0.99923825,0.00022222717,0.00003811248,0.00021660658,0.00014469279,0.00014010038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014782608,0.00016799346,0.00030306456,0.00012277221,0.00008759036,0.000024916466,0.000061705745,0.000086483335,0.0000055014066],"category_scores_gemma":[0.00006894721,0.00011891412,0.000023937831,0.0002040579,0.00015129286,0.000060849496,0.000037961763,0.00021350876,0.0000020703371],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009122254,0.00066602917,0.97086453,0.00080391165,0.0010478596,0.0002490168,0.0016301667,6.0606317e-7,0.0029665427,0.00011020142,0.0007252303,0.011813666],"study_design_scores_gemma":[0.025639014,0.0041878335,0.96313554,0.00056026346,0.00059090636,0.00007315418,0.000133464,0.000010267295,0.0045887306,0.000027169237,0.00088834105,0.00016531242],"about_ca_topic_score_codex":0.000121559206,"about_ca_topic_score_gemma":0.00004577665,"teacher_disagreement_score":0.01651676,"about_ca_system_score_codex":0.00005933651,"about_ca_system_score_gemma":0.0001734179,"threshold_uncertainty_score":0.4849177},"labels":[],"label_agreement":null},{"id":"W4417016774","doi":"10.1182/blood-2025-7930","title":"Assessing the cost &amp; cost-effectiveness of next-generation sequencing for the diagnosis of hematological malignancies in children, adolescence &amp; young-adults: A systematic literature review","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster Children's Hospital; McMaster University","funders":"","keywords":"Modalities; Systematic review; MEDLINE; Hematologic Neoplasms; Cancer; Treatment modality; Therapeutic modalities","score_opus":0.03858986085473442,"score_gpt":0.30526174714659543,"score_spread":0.266671886291861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417016774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8054004,0.18989553,0.0019774197,0.000063866115,0.000053373053,0.0025349068,0.000064637046,0.0000030316492,0.000006838949],"genre_scores_gemma":[0.9817622,0.016595976,0.00017867866,0.00014551281,0.000029093553,0.0010971428,0.00017761752,0.0000071555405,0.0000066446596],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989296,0.00027433244,0.00035397007,0.00021920011,0.00008372306,0.00013917735],"domain_scores_gemma":[0.9990416,0.0001841151,0.00019476017,0.00036078252,0.0002015188,0.000017215038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006819821,0.00012511223,0.0003071554,0.000028337354,0.00009143092,0.00005245141,0.00023295575,0.000088787536,7.470356e-7],"category_scores_gemma":[0.0008367787,0.00007201749,0.00014460365,0.00019995631,0.00006859186,0.0000077977475,0.00007086125,0.000064145155,2.102095e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012194678,0.0010463013,0.2611778,0.19954497,0.0006450126,0.0000048224674,0.00030814589,0.00034964966,0.5343511,0.0010870601,0.00042717543,0.0009359973],"study_design_scores_gemma":[0.004368645,0.00024137029,0.1798558,0.39681786,0.0023401193,0.00034608043,0.0006897575,0.00029776673,0.41376114,0.00020285229,0.00029475047,0.0007838765],"about_ca_topic_score_codex":0.000015271282,"about_ca_topic_score_gemma":0.000059585793,"teacher_disagreement_score":0.1972729,"about_ca_system_score_codex":0.000013063651,"about_ca_system_score_gemma":0.000096394935,"threshold_uncertainty_score":0.2936788},"labels":[],"label_agreement":null},{"id":"W4417016883","doi":"10.1182/blood-2025-4373","title":"How should fever be managed in adults with sickle cell disease? a quality metrics study and mapping of essential elements to improve care delivery","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Triage; Emergency department; Etiology; Febrile neutropenia; Population; Disease; Young adult; Retrospective cohort study; Health care","score_opus":0.01039536209782402,"score_gpt":0.2568916299567277,"score_spread":0.2464962678589037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417016883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99632055,0.0013142236,0.00006805497,0.0004573797,0.0000471178,0.0013014672,0.000030599167,0.000018238647,0.00044234708],"genre_scores_gemma":[0.9990481,0.000075739736,0.0002713918,0.00022158965,0.0000111043,0.00003213308,0.000016945194,0.0000109875355,0.0003120058],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989282,0.000057819412,0.00024370341,0.0003069806,0.00026825178,0.00019506393],"domain_scores_gemma":[0.99943936,0.00003252687,0.00006687993,0.00023937343,0.00010713082,0.000114714836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014491528,0.00013502594,0.0002844623,0.0002815489,0.000043144548,0.000017817098,0.00006623294,0.000061251965,0.0000036110773],"category_scores_gemma":[0.00007699085,0.00010712773,0.000040210252,0.0006726052,0.000028225244,0.000043985383,0.00010295133,0.00012853488,3.4673616e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009293279,0.0032473807,0.9798518,0.0026050499,0.0003377077,0.00017022307,0.006099345,0.0000070687793,0.002207464,0.000015895392,0.000087749715,0.004440981],"study_design_scores_gemma":[0.043184422,0.0012800929,0.7927523,0.0010335492,0.0015915055,0.0000012024308,0.15388037,0.000114410665,0.005387328,0.000015047507,0.00034865414,0.00041106157],"about_ca_topic_score_codex":0.00043074155,"about_ca_topic_score_gemma":0.00026601172,"teacher_disagreement_score":0.18709946,"about_ca_system_score_codex":0.0000273566,"about_ca_system_score_gemma":0.00008298738,"threshold_uncertainty_score":0.4368542},"labels":[],"label_agreement":null},{"id":"W4417016887","doi":"10.1182/blood-2025-4378","title":"Provider practices and preparedness for gene therapy in pediatric sickle cell disease: A national survey of pediatric hematologists","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Preparedness; Hematology; Referral; Interim; Transplantation; Sickle cell anemia; Clinical trial; Hematopoietic stem cell transplantation","score_opus":0.03739586278135313,"score_gpt":0.3497950808475565,"score_spread":0.31239921806620335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417016887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98000115,0.01905104,0.000041767886,0.000066289926,0.000032684682,0.0005982455,0.00011897708,0.0000058019464,0.00008405009],"genre_scores_gemma":[0.9956547,0.0034930618,0.00019996676,0.00005395771,0.00009726346,0.00018139929,0.00014115445,0.000013243964,0.00016524683],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998938,0.00016493462,0.00021132646,0.000340009,0.00016273923,0.00018298977],"domain_scores_gemma":[0.99913174,0.00016381199,0.0001757011,0.00019963083,0.00027917605,0.000049925875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006530812,0.0001114181,0.00014059327,0.00012315848,0.0000379165,0.000017656352,0.00016914649,0.00008767411,0.000003817824],"category_scores_gemma":[0.00067989505,0.00010481571,0.00003947692,0.00026834724,0.000039141836,0.0000062253753,0.0000688369,0.00005265871,5.0106723e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004173486,0.0016294202,0.9136663,0.00046281595,0.000075942604,0.000002935338,0.000057634137,0.000046725472,0.078662395,0.000012288141,0.0008788285,0.0003312216],"study_design_scores_gemma":[0.009091302,0.0019397159,0.45869657,0.000007655919,0.000104435625,0.0000026415037,0.000030582876,0.00011380868,0.5290004,0.00031772745,0.0003381865,0.0003569997],"about_ca_topic_score_codex":0.000045869027,"about_ca_topic_score_gemma":0.00026978078,"teacher_disagreement_score":0.45496973,"about_ca_system_score_codex":0.00000759747,"about_ca_system_score_gemma":0.0007769682,"threshold_uncertainty_score":0.42742604},"labels":[],"label_agreement":null},{"id":"W4417016892","doi":"10.1182/blood-2025-4754","title":"A phase 2 open-label study of epeleuton in patients with sickle cell disease","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sickle cell anemia; Hemolysis; Acute chest syndrome; Disease; Hemolytic anemia; Vaso-occlusive crisis; Thalassemia; Hemoglobin; Fetal hemoglobin","score_opus":0.008645175477801645,"score_gpt":0.2730849272981144,"score_spread":0.26443975182031276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417016892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936565,0.00023813442,0.0000024790086,0.00008741864,0.00003065254,0.0012982626,0.00000887058,0.000012954706,0.004664701],"genre_scores_gemma":[0.99909323,0.000011289095,0.000045627323,0.00012665745,0.0000035803146,0.000027218188,0.000017964689,0.000009892951,0.0006645385],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993008,0.000027999246,0.00019935542,0.00018657882,0.00014633466,0.00013895011],"domain_scores_gemma":[0.99954003,0.000013254747,0.00004888887,0.00025523794,0.000056948404,0.00008565837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005783586,0.00009488845,0.00022523882,0.00009959881,0.000027025297,0.00000819815,0.00010390444,0.000037369155,0.000018892402],"category_scores_gemma":[0.000023234334,0.00006827933,0.000013553718,0.00034675995,0.000024857687,0.000041146646,0.00007268277,0.000115480914,0.00000429851],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024447027,0.26705614,0.7265688,0.00020571268,0.00013025977,0.00009624798,0.00066183734,0.0000065894164,0.00015173206,0.00002370313,0.00023636654,0.0024179025],"study_design_scores_gemma":[0.6369553,0.014130502,0.34221384,0.0007808381,0.0013942793,5.3182055e-7,0.0022627679,0.00010607824,0.0013050473,0.000047522633,0.0005423859,0.00026086209],"about_ca_topic_score_codex":0.00011223401,"about_ca_topic_score_gemma":0.000021848091,"teacher_disagreement_score":0.63451064,"about_ca_system_score_codex":0.000012027489,"about_ca_system_score_gemma":0.00013653353,"threshold_uncertainty_score":0.27843502},"labels":[],"label_agreement":null},{"id":"W4417016903","doi":"10.1182/blood-2025-4375","title":"Feasibility and acceptability of point of care lung ultrasound for identification of acute chest syndrome in an inpatient pediatric hematology unit","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Ultrasound in Clinical Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children’s Health Research Institute","funders":"","keywords":"Acute chest syndrome; Hematology; Prospective cohort study; Intensive care unit; Cohort; Complication; Disease; Point of care","score_opus":0.02724041266737812,"score_gpt":0.3580590075460171,"score_spread":0.33081859487863896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417016903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974293,0.00036151,0.00039389034,0.00008280564,0.000030404863,0.0013541718,0.00027795462,0.000010929036,0.00005904447],"genre_scores_gemma":[0.99759084,0.00007260971,0.0020695303,0.000011077011,0.000006573339,0.00010531933,0.00013143344,0.0000064724422,0.000006132701],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984983,0.000057478566,0.00093787635,0.00029215924,0.00010938588,0.00010477545],"domain_scores_gemma":[0.99778765,0.0009166991,0.00031359505,0.00055266015,0.00038130276,0.000048088506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040122523,0.00008728113,0.00046100563,0.00013263023,0.000020030715,0.0000027729002,0.00011671652,0.00012403609,0.000023765337],"category_scores_gemma":[0.00094017666,0.000083538864,0.00007712756,0.00041973696,0.00018455971,0.000058302503,0.000034648387,0.00010109825,1.990518e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000106153886,0.0019978296,0.9879357,0.0020623284,0.000055514738,2.2856153e-7,0.0004643179,9.126626e-7,0.006379745,0.0008807514,0.0000022322254,0.000114255454],"study_design_scores_gemma":[0.0021722561,0.00037293066,0.97070205,0.000025574416,0.0007067591,0.000009592226,0.00042515388,0.000014271916,0.023711512,0.0018078806,0.000002340159,0.000049684084],"about_ca_topic_score_codex":0.00003958774,"about_ca_topic_score_gemma":0.00006854387,"teacher_disagreement_score":0.017331766,"about_ca_system_score_codex":0.000030291447,"about_ca_system_score_gemma":0.00012982781,"threshold_uncertainty_score":0.3406616},"labels":[],"label_agreement":null},{"id":"W4417016911","doi":"10.1182/blood-2025-4382","title":"Developing expert consensus for specialist e-consult response: A delphi study to inform graduate medical education","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Healthcare Systems and Technology","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Graduate medical education; Specialty; Accreditation; Delphi method; Subspecialty; Curriculum; Delphi; Interpersonal communication","score_opus":0.0651467725066665,"score_gpt":0.3661971726090868,"score_spread":0.3010504001024203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417016911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9279233,0.00007635959,0.00046960614,0.06649899,0.0010758082,0.001578291,0.0000019612337,0.00019277452,0.002182876],"genre_scores_gemma":[0.98807293,0.0000022728664,0.0009481227,0.009297643,0.0007338192,0.00044982246,0.000010061018,0.000015447396,0.00046985413],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987311,0.000021916907,0.00045994073,0.0002649339,0.00024106109,0.00028107822],"domain_scores_gemma":[0.99905115,0.00013429271,0.00010679843,0.0002538333,0.000428429,0.000025511832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001078187,0.0001377558,0.00023362043,0.0004713694,0.00028467123,0.00010987776,0.00024875483,0.00010512702,0.000020565592],"category_scores_gemma":[0.0038323028,0.00012889887,0.000038915223,0.00080923236,0.000031881846,0.00008889827,0.00015872976,0.00010783126,0.000060261613],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001879192,0.0032065376,0.027197463,0.0010066985,0.0003695533,0.00007048027,0.0023333775,5.032494e-7,0.00018920947,0.5337596,0.13669066,0.29329672],"study_design_scores_gemma":[0.0038052495,0.0000706175,0.02277527,0.00032516997,0.00005211071,0.000010832802,0.007962887,0.000036480676,0.000106601095,0.0030133284,0.96153754,0.00030388279],"about_ca_topic_score_codex":0.0026317963,"about_ca_topic_score_gemma":0.0030114776,"teacher_disagreement_score":0.8248469,"about_ca_system_score_codex":0.00005592068,"about_ca_system_score_gemma":0.0009728999,"threshold_uncertainty_score":0.52563435},"labels":[],"label_agreement":null},{"id":"W4417016928","doi":"10.1182/blood-2025-4388","title":"Sustainability and cost-avoidance of reduced inappropriate red cell transfusion at community hospitals in niagara region: A follow-up analysis on a quality improvement initiative.","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Brock University; McMaster University","funders":"","keywords":"Quality management; Psychological intervention; Activity-based costing; Health care; Sustainability; Unit (ring theory); Quality (philosophy); Cost driver; Overhead (engineering)","score_opus":0.021150031195834935,"score_gpt":0.2919446664233047,"score_spread":0.27079463522746977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417016928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897867,0.00015983309,0.00026921317,0.003292186,0.000052741005,0.0024454745,0.000014262566,0.000043050015,0.0039365278],"genre_scores_gemma":[0.9979073,0.0005082752,0.00009417285,0.0005437391,0.0000065122995,0.00018218109,0.000030114006,0.000011331524,0.0007163975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977019,0.0005888329,0.00070793024,0.00043461818,0.0002976843,0.00026905624],"domain_scores_gemma":[0.998478,0.00017952968,0.00017760051,0.0008263569,0.00023443266,0.00010410703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013150005,0.00023197106,0.0007830663,0.00041663824,0.00015982642,0.000011158465,0.00014181896,0.00013656981,0.000017046235],"category_scores_gemma":[0.00021524576,0.00021043106,0.00022709608,0.0012024408,0.00013499006,0.000056224748,0.00013422863,0.0004167345,4.867246e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016793652,0.046754,0.69095874,0.0139617855,0.005871198,0.00024110684,0.030526565,0.00006580485,0.13722505,0.0028033254,0.00075660174,0.054042175],"study_design_scores_gemma":[0.033785984,0.0018784103,0.81439316,0.00033568565,0.0028828706,0.0000016149484,0.004192394,0.00004817674,0.14068699,0.0011775268,0.00030319009,0.00031396098],"about_ca_topic_score_codex":0.0010655059,"about_ca_topic_score_gemma":0.0009849584,"teacher_disagreement_score":0.12343445,"about_ca_system_score_codex":0.00017981752,"about_ca_system_score_gemma":0.00011273111,"threshold_uncertainty_score":0.85811293},"labels":[],"label_agreement":null},{"id":"W4417016977","doi":"10.1182/blood-2025-3315","title":"Identification of XPO1 interactors and modulation by selinexor in diffuse large B cell lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Biotinylation; Diffuse large B-cell lymphoma; Lymphoma; Proteomics; Venetoclax; Mitochondrion; Biotin; Identification (biology); Cell","score_opus":0.001851523853129403,"score_gpt":0.20217127084410683,"score_spread":0.20031974699097743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417016977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99869925,0.00029918432,0.00066578976,0.00002458529,0.000075983924,0.000058089725,0.000013489415,0.000003196514,0.00016045738],"genre_scores_gemma":[0.9994144,0.000061964354,0.000042535605,0.000043380584,0.00002050597,0.0000026659868,0.000078752564,0.0000043431132,0.00033146868],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996559,0.000015541164,0.0001269366,0.00012121408,0.00002810054,0.000052311058],"domain_scores_gemma":[0.9998137,0.0000033250099,0.00004508115,0.00010572505,0.000022090238,0.000010103296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000046665315,0.00004470141,0.000049898117,0.000034304074,0.000013721989,0.000007053742,0.000033234275,0.00006355929,0.0000018355169],"category_scores_gemma":[0.000018184059,0.00004403291,0.0000157343,0.00005348773,0.000009508255,0.000002993933,0.00002476229,0.00001706042,6.0251614e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002165926,0.00047006505,0.013403511,0.000021178377,0.0000098758155,1.1634036e-7,0.000033756507,0.0000010537356,0.984048,0.000032611184,0.00037410238,0.0015840906],"study_design_scores_gemma":[0.0037708792,0.000048094855,0.083954096,0.000009117902,0.000022738388,9.4267665e-7,0.00005402884,0.0003109987,0.90766436,0.000088894296,0.0040124897,0.000063361644],"about_ca_topic_score_codex":0.000010641531,"about_ca_topic_score_gemma":0.000015729995,"teacher_disagreement_score":0.07638362,"about_ca_system_score_codex":0.0000028668544,"about_ca_system_score_gemma":0.00000787628,"threshold_uncertainty_score":0.17956099},"labels":[],"label_agreement":null},{"id":"W4417016989","doi":"10.1182/blood-2025-3316","title":"Autophagy/lysosome disruption via pikfyve inhibition in multiple myeloma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Systems, Applications & Products in Data Processing (Canada); Hospital for Sick Children; Princess Margaret Cancer Centre","funders":"","keywords":"Autophagy; Downregulation and upregulation; Cell culture; Proteasome; Ex vivo; Multiple myeloma; Phenotype; Ubiquitin","score_opus":0.010004865590765384,"score_gpt":0.2660244296044689,"score_spread":0.2560195640137035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417016989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949285,0.0009006797,0.00054267625,0.00039617365,0.00013521862,0.00037628453,0.000007225951,0.000121817575,0.0025914633],"genre_scores_gemma":[0.99788445,0.000061317005,0.00018493552,0.00080663385,0.00011640664,0.00006359613,0.00007187741,0.000013926108,0.00079684815],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99914783,0.00003491081,0.0002373425,0.00023549417,0.00014351726,0.0002008749],"domain_scores_gemma":[0.99956584,0.000040557898,0.000041976895,0.0002460521,0.000035546327,0.00007000925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000921844,0.00012530935,0.00020631669,0.0002055728,0.000051964485,0.00001176505,0.000034936555,0.00010950511,0.00012504088],"category_scores_gemma":[0.00004850533,0.00011764039,0.00008759127,0.00033788817,0.000040153158,0.00009102143,0.00002542206,0.00014377903,0.00008885854],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010575943,0.00860601,0.23412336,0.0005413651,0.00048702426,0.0017541572,0.0010482724,0.000026775067,0.70202327,0.004361292,0.0006637871,0.045307122],"study_design_scores_gemma":[0.009925933,0.00015023214,0.6948363,0.00026788673,0.00015821791,0.000036894573,0.000056135155,0.0006505156,0.29009452,0.0030617844,0.0006170022,0.00014456676],"about_ca_topic_score_codex":0.000036224148,"about_ca_topic_score_gemma":0.000021364185,"teacher_disagreement_score":0.46071294,"about_ca_system_score_codex":0.00004829767,"about_ca_system_score_gemma":0.00006941104,"threshold_uncertainty_score":0.47972357},"labels":[],"label_agreement":null},{"id":"W4417017085","doi":"10.1182/blood-2025-2680","title":"Relationship of sociodemographic factors to presentation and natural history of provoked venous thromboembolism in u.s. children: A secondary analysis of the multinational kids-DOTT trial","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Interquartile range; Socioeconomic status; Randomized controlled trial; Venous thrombosis; Natural history; Deep vein; Venous thromboembolism; Thrombosis","score_opus":0.016177703304367012,"score_gpt":0.27095287165404897,"score_spread":0.25477516834968195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417017085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980875,0.00045767534,0.000024679652,0.00016973619,0.00015878258,0.0008450282,0.000025288695,0.000009306258,0.00022196415],"genre_scores_gemma":[0.9994555,0.000004561852,0.00025593778,0.000062483174,0.000012801188,0.00001768908,0.000057736986,0.00000584679,0.00012744212],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989373,0.00010954586,0.0004440169,0.00016710759,0.0002599166,0.00008208928],"domain_scores_gemma":[0.99926937,0.00014340079,0.00023588545,0.00019347528,0.00012919898,0.000028699464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021188024,0.000091389484,0.00045227175,0.00070061546,0.000028114793,0.0000022056445,0.000077943936,0.00009049268,0.000024278606],"category_scores_gemma":[0.00023945989,0.00007338473,0.00017681625,0.0009581535,0.000102577505,0.00005003686,0.000038368882,0.00015604575,8.8345026e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040601657,0.0013571924,0.9773743,0.00009561731,0.001214762,1.2141479e-7,0.0027435585,0.000028552357,0.012238383,0.0041833236,0.000027437614,0.00033074254],"study_design_scores_gemma":[0.013116648,0.00013999737,0.97811383,0.000052632688,0.0018820212,4.826063e-7,0.00014011496,0.00016896546,0.005927991,0.00039977694,0.0000045517922,0.000053012187],"about_ca_topic_score_codex":0.00013225195,"about_ca_topic_score_gemma":0.00007701427,"teacher_disagreement_score":0.012710632,"about_ca_system_score_codex":0.00004022635,"about_ca_system_score_gemma":0.00026141416,"threshold_uncertainty_score":0.29925424},"labels":[],"label_agreement":null},{"id":"W4417017113","doi":"10.1182/blood-2025-2694","title":"Mortality associated with warm autoimmune hemolytic anemia among Medicare beneficiaries","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Autoimmune hemolytic anemia; Cohort; Anemia; Cohort study; Evans syndrome; Rituximab","score_opus":0.007940404878125591,"score_gpt":0.23726964242286194,"score_spread":0.22932923754473636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417017113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907514,0.00087797875,0.00006344981,0.00077839615,0.00010471866,0.00034967365,0.000015202424,0.00020940254,0.006849794],"genre_scores_gemma":[0.99869996,0.0000464046,0.00007497869,0.00031433257,0.000040917304,0.000022429489,0.00011829148,0.00002000254,0.0006627063],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987703,0.000030116724,0.000266917,0.0002929941,0.00035486446,0.00028483785],"domain_scores_gemma":[0.99927026,0.00007209525,0.00006464967,0.00037390724,0.00012219496,0.00009691355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020430014,0.00018279484,0.00039941238,0.00008443218,0.00014564891,0.000022125774,0.00009781324,0.00018884531,0.00009153384],"category_scores_gemma":[0.00012617807,0.00013717897,0.00008617469,0.00042985132,0.00012164346,0.0000544044,0.000034534925,0.0003152044,0.0000045699558],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007528362,0.0015588147,0.99220574,0.00022573664,0.0009160695,0.00030183836,0.00035157066,0.000004030228,0.0019836235,0.0007430557,0.00015222162,0.001482043],"study_design_scores_gemma":[0.0060714637,0.00023933074,0.98171306,0.0008001129,0.0021815798,0.000016245533,0.00016348818,0.000082135375,0.008250645,0.0001782334,0.00015223761,0.00015147947],"about_ca_topic_score_codex":0.00046119437,"about_ca_topic_score_gemma":0.0009657108,"teacher_disagreement_score":0.010492665,"about_ca_system_score_codex":0.000031799213,"about_ca_system_score_gemma":0.00018661846,"threshold_uncertainty_score":0.5593996},"labels":[],"label_agreement":null},{"id":"W4417017123","doi":"10.1182/blood-2025-2719","title":"Prehabilitation prior to CAR T-cell therapy in non-Hodgkin lymphoma: Baseline physical function and toxicity outcomes","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Prehabilitation; Logistic regression; Rehabilitation; Retrospective cohort study; Prospective cohort study; Minimal clinically important difference; Adverse effect","score_opus":0.012517721578787345,"score_gpt":0.3067540450047023,"score_spread":0.294236323425915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417017123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99550897,0.00015340677,0.00028182968,0.0014227841,0.00007190895,0.001128394,0.0000044548397,0.00003836143,0.001389878],"genre_scores_gemma":[0.9959769,0.000037767764,0.00043235166,0.00063607417,0.00009370547,0.00011172436,0.000008512096,0.000016983324,0.0026859834],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99890965,0.00010228556,0.00019728966,0.00032966243,0.0002451109,0.00021600374],"domain_scores_gemma":[0.9991809,0.00032438265,0.00002269906,0.000290891,0.000086724685,0.000094411575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041386014,0.00013735391,0.0002996443,0.00022271513,0.00003978625,0.000018716473,0.000058850346,0.00007264919,0.00007723316],"category_scores_gemma":[0.00016430074,0.000114566225,0.0000739125,0.000409041,0.0000390918,0.000051196253,0.000040037514,0.00011168538,0.0000139139265],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089593214,0.0027945777,0.17320843,0.00010149856,0.000060456943,0.0000055586706,0.00072185136,0.0000054851157,0.73214394,0.000025998672,0.00014439385,0.089891896],"study_design_scores_gemma":[0.014111023,0.0014546525,0.8160831,0.000058648016,0.000055095796,0.0000017838414,0.00014409809,0.00037242824,0.16651346,0.0002525117,0.0008347548,0.00011848505],"about_ca_topic_score_codex":0.00012655246,"about_ca_topic_score_gemma":0.000039124603,"teacher_disagreement_score":0.64287466,"about_ca_system_score_codex":0.00007942358,"about_ca_system_score_gemma":0.00010640866,"threshold_uncertainty_score":0.46718752},"labels":[],"label_agreement":null},{"id":"W4417017164","doi":"10.1182/blood-2025-3230","title":"Ectopic BCL11B disrupts the activity of early hematopoietic transcription factors to skew lineage commitment","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Ectopic expression; Progenitor cell; Haematopoiesis; Transcription factor; Myeloid; Stem cell; Immunophenotyping; Hematopoietic stem cell","score_opus":0.024415668953041758,"score_gpt":0.3122934303938841,"score_spread":0.2878777614408423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417017164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931327,0.00014168827,0.0007068846,0.0028966425,0.00009561518,0.0009060613,0.000014516956,0.000041760508,0.0020641054],"genre_scores_gemma":[0.9973062,0.000025486761,0.0001957033,0.00021777954,0.000049273538,0.000048118847,0.0000062868176,0.000013577114,0.0021375243],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989115,0.00009045916,0.00020893305,0.00021561867,0.0003227628,0.00025071038],"domain_scores_gemma":[0.9991038,0.00015638056,0.000040225954,0.000517806,0.00007622044,0.00010556527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021635857,0.00013886743,0.00030053814,0.00012428287,0.00008069325,0.000017507282,0.00019519802,0.000084468775,0.000061025283],"category_scores_gemma":[0.000099142075,0.00008945474,0.0001307761,0.0003926313,0.00007312612,0.000042368763,0.00006799088,0.00029629152,0.000021533346],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006861699,0.0037565168,0.16123506,0.001210916,0.0010430889,0.00007534837,0.008193669,0.0000051599322,0.80765927,0.0030425817,0.002257731,0.010834468],"study_design_scores_gemma":[0.0028651797,0.00053090014,0.4527656,0.00018896941,0.00031048863,0.000008292299,0.00022492169,0.000022262024,0.54091656,0.000085004125,0.0019839352,0.000097885226],"about_ca_topic_score_codex":0.00032130847,"about_ca_topic_score_gemma":0.000043682692,"teacher_disagreement_score":0.29153055,"about_ca_system_score_codex":0.00009963248,"about_ca_system_score_gemma":0.00017298634,"threshold_uncertainty_score":0.36478585},"labels":[],"label_agreement":null},{"id":"W4417017305","doi":"10.1182/blood-2025-1340","title":"Impact of race on the incidence, diagnosis and outcomes of pregnancy-associated venous thromboembolism: A nested case-control study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; University of Calgary; University of Ottawa; McGill University; Ottawa Hospital","funders":"","keywords":"Body mass index; Gestational age; Cohort; Incidence (geometry); Medical diagnosis; Retrospective cohort study; Emergency department; Comorbidity; Cohort study","score_opus":0.015335625875013118,"score_gpt":0.30073194958661514,"score_spread":0.285396323711602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417017305","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948287,0.0011083724,0.0000040174996,0.00048230504,0.00007343789,0.002667858,0.000057079116,0.000037932557,0.0007402711],"genre_scores_gemma":[0.99907786,0.00029332875,0.000012396571,0.00022519489,0.000012501087,0.00028635754,0.000002144493,0.000019488405,0.000070720074],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984783,0.00019323528,0.00047812148,0.00028585672,0.00030009748,0.00026441112],"domain_scores_gemma":[0.9980312,0.00090692815,0.00027702397,0.0005536696,0.00016544967,0.0000657417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041793508,0.00023497368,0.0012481089,0.0001964144,0.000112786576,0.000017757484,0.00014849374,0.000084781255,0.000058622274],"category_scores_gemma":[0.0007599001,0.00014401088,0.00021510273,0.0004509614,0.0000969928,0.000048416605,0.00009744627,0.00015922771,0.0000020101718],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047038484,0.021461666,0.96848005,0.00011383292,0.00483545,0.00033115174,0.001858693,0.000015499261,0.00012588465,0.00043081414,0.00043545815,0.0018644485],"study_design_scores_gemma":[0.006061207,0.0032952281,0.9846978,0.00072306057,0.0037091947,0.000019737998,0.0008694176,0.000020942418,0.00037815698,0.000114952505,0.0000035895857,0.00010669336],"about_ca_topic_score_codex":0.0014942017,"about_ca_topic_score_gemma":0.00027022074,"teacher_disagreement_score":0.018166438,"about_ca_system_score_codex":0.00004497054,"about_ca_system_score_gemma":0.00011172209,"threshold_uncertainty_score":0.5872593},"labels":[],"label_agreement":null},{"id":"W4417017310","doi":"10.1182/blood-2025-1343","title":"Predictors of clinically relevant bleeding during extended anticoagulation for cancer-associated venous thromboembolism, including by cancer site: Post-hoc analysis of the API-CAT randomised trial","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Apixaban; Pulmonary embolism; Cancer; Randomized controlled trial; Population; Venous thrombosis; Deep vein; Thrombosis","score_opus":0.018601218201108324,"score_gpt":0.3214214964980368,"score_spread":0.3028202782969285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417017310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994111,0.0010732207,0.000046679634,0.000656569,0.0007320621,0.0029412527,0.00025963286,0.000051329655,0.00012826564],"genre_scores_gemma":[0.997288,0.0016842966,0.000094088646,0.00017678268,0.00015823852,0.00035599605,0.00008752219,0.000030403531,0.00012470844],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99730575,0.000119880904,0.0013365068,0.00041701386,0.00046303627,0.00035781355],"domain_scores_gemma":[0.9976973,0.00040689317,0.00097653246,0.00041593178,0.0004306911,0.0000726708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008798928,0.00023295484,0.0017760533,0.00034571602,0.00021794513,0.000019837136,0.00022532078,0.00018281124,0.000045827914],"category_scores_gemma":[0.0009117122,0.00017884238,0.00071548414,0.001162218,0.00009723599,0.0000691017,0.00015054028,0.00013507866,2.3241208e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09048664,0.022047516,0.18375768,0.0026262484,0.07907197,0.0000060102525,0.0062251585,0.0024473828,0.607497,0.00034944437,0.0016052999,0.0038796766],"study_design_scores_gemma":[0.28053188,0.0016588512,0.59634197,0.0014553185,0.06945293,4.2293024e-7,0.0003821246,0.002465623,0.047233846,0.0000662978,0.00009761185,0.00031309322],"about_ca_topic_score_codex":0.0009619167,"about_ca_topic_score_gemma":0.00032373983,"teacher_disagreement_score":0.56026316,"about_ca_system_score_codex":0.00017265917,"about_ca_system_score_gemma":0.00029780157,"threshold_uncertainty_score":0.72929806},"labels":[],"label_agreement":null},{"id":"W4417017469","doi":"10.1182/blood-2025-7006","title":"Impact of c-KIT and FLT3 mutations on survival outcomes in core-binding factor acute myeloid leukemia: A systematic review and meta-analysis","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Hazard ratio; Myeloid leukemia; Meta-analysis; Observational study; Mutation; Incidence (geometry); Concomitant; Cumulative incidence; Survival analysis","score_opus":0.05972190516308384,"score_gpt":0.38115925115752547,"score_spread":0.3214373459944416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417017469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98607266,0.010870463,0.000022934686,0.00066063437,0.00000985942,0.0016989465,0.00023885632,0.000023126013,0.00040251322],"genre_scores_gemma":[0.9961717,0.0015430097,0.0002056696,0.00017305487,0.0000041876388,0.00013436527,0.000042188385,0.000016714348,0.001709114],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9981279,0.00019667184,0.0006981325,0.00034523787,0.0003671156,0.0002649712],"domain_scores_gemma":[0.99827725,0.00076801825,0.00019689422,0.0004987143,0.00013045825,0.00012864778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006281363,0.00024861025,0.003118844,0.00078416493,0.000051165185,0.000025047859,0.0001266416,0.00010167448,0.00010399399],"category_scores_gemma":[0.00093010115,0.00015519533,0.0006552189,0.0012800652,0.000082192084,0.000069579866,0.00009091304,0.00031014837,0.000006514231],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000091494854,0.0006007816,0.30531707,0.11686836,0.5731065,0.00020519675,0.0006051017,0.000011846189,0.0026945816,0.00036516707,0.00010685626,0.000027000793],"study_design_scores_gemma":[0.0032997439,0.00032226855,0.18312491,0.0019669926,0.8102902,0.000035203695,0.00013947327,0.00012913733,0.0004579793,0.000035626443,9.548365e-7,0.00019747858],"about_ca_topic_score_codex":0.00031951294,"about_ca_topic_score_gemma":0.00007974687,"teacher_disagreement_score":0.2371837,"about_ca_system_score_codex":0.00028588384,"about_ca_system_score_gemma":0.0003403933,"threshold_uncertainty_score":0.6328682},"labels":[],"label_agreement":null},{"id":"W4417017570","doi":"10.1182/blood-2025-7684","title":"Sociodemographic and patient-related determinants of outcomes after unrelated donor hematopoietic cell transplantation using posttransplant cyclophosphamide-based GVHD prophylaxis","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"","keywords":"Hazard ratio; Hematopoietic stem cell transplantation; Proportional hazards model; Transplantation; Graft-versus-host disease; Confidence interval; Retrospective cohort study; Comorbidity; Cyclophosphamide","score_opus":0.007511737726127206,"score_gpt":0.24051333380514536,"score_spread":0.23300159607901816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417017570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963785,0.0012732557,0.0005523674,0.000066732806,0.00014339855,0.0010925432,0.00012932396,0.00008649614,0.00027741407],"genre_scores_gemma":[0.99764746,0.00020298679,0.0018256444,0.00013338713,0.0000032186558,0.000047397076,0.00007056296,0.000039062248,0.00003027883],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978704,0.00010155552,0.00090746663,0.00043498573,0.00034535062,0.0003402735],"domain_scores_gemma":[0.9990146,0.00021227787,0.00021574619,0.0002992691,0.00013121047,0.00012686559],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015518712,0.00033697466,0.0006531613,0.00041052522,0.00009072164,0.00001653617,0.000079225785,0.0003403905,0.000060062895],"category_scores_gemma":[0.00001577956,0.00029600313,0.00020166798,0.0005401924,0.00017274344,0.00008550239,0.000008802804,0.0002412447,0.0000038325325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048768785,0.0007738453,0.9712034,0.0047999653,0.00018156694,0.000395058,0.0017868974,0.000024426317,0.019661186,0.000016617274,8.7854704e-7,0.0006684935],"study_design_scores_gemma":[0.009146813,0.0003807268,0.712462,0.0014937595,0.0023156737,0.0001930917,0.00015639246,0.00016650393,0.273274,0.00010797433,0.0000024207272,0.0003006123],"about_ca_topic_score_codex":0.000110545,"about_ca_topic_score_gemma":0.000015133007,"teacher_disagreement_score":0.25874135,"about_ca_system_score_codex":0.000024956787,"about_ca_system_score_gemma":0.00018222061,"threshold_uncertainty_score":0.9999492},"labels":[],"label_agreement":null},{"id":"W4417017728","doi":"10.1182/blood-2025-8088","title":"Genetic predispositions in children with primary immunodeficiency and lymphoma: Experience from king hussein cancer center","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Primary immunodeficiency; Immunodeficiency; Lymphoma; Immune dysregulation; Cancer; Genetic predisposition; Common variable immunodeficiency; Pediatric cancer","score_opus":0.0031017374639578203,"score_gpt":0.2023771431259596,"score_spread":0.1992754056620018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417017728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90668523,0.09168577,0.00008625648,0.00005403575,0.0001464776,0.00024663607,0.00005644153,0.000044379496,0.0009947532],"genre_scores_gemma":[0.9987177,0.0005838993,0.00005689298,0.00021569662,0.0000022790896,0.00011956389,0.00008972456,0.000010862233,0.00020334906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989222,0.00006798704,0.00025161367,0.00037754516,0.00003378931,0.00034682476],"domain_scores_gemma":[0.9996042,0.00003350698,0.000061761864,0.00027380334,0.000022164984,0.000004559163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000046217476,0.00018201387,0.00022033167,0.00012762226,0.00025650905,0.000027743778,0.00023850777,0.00012410223,0.00006900186],"category_scores_gemma":[0.0000083097875,0.00015883657,0.000036099616,0.00026639467,0.00027802135,0.000108156026,0.000113566566,0.00014165351,0.000010573504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008171997,0.0013432497,0.8407282,0.000012732373,0.0002129637,0.000003916876,0.0024230732,0.000023658205,0.1392228,0.00014836418,0.00000822195,0.01579109],"study_design_scores_gemma":[0.004818543,0.00004482315,0.9840448,0.00016946296,0.00007601924,0.000030714258,0.000419637,0.000003650453,0.009738455,0.000054680128,0.00040785698,0.00019135608],"about_ca_topic_score_codex":0.0023051566,"about_ca_topic_score_gemma":0.000044454522,"teacher_disagreement_score":0.1433166,"about_ca_system_score_codex":0.000029941393,"about_ca_system_score_gemma":0.00010331948,"threshold_uncertainty_score":0.6477167},"labels":[],"label_agreement":null},{"id":"W4417017790","doi":"10.1182/blood-2025-125","title":"Reclaiming the clinical social work role: A call for reform in sickle cell disease psychosocial care","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Providence Health Care","funders":"","keywords":"Psychosocial; Social work; Thematic analysis; Staffing; Biopsychosocial model; Psychological intervention; Social support; Health care; Clinical social work","score_opus":0.013672725993248395,"score_gpt":0.3146719213810545,"score_spread":0.3009991953878061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417017790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9328495,0.005467996,0.000029806626,0.022187049,0.0006115671,0.001283609,0.000024336561,0.000070914095,0.03747521],"genre_scores_gemma":[0.99617654,0.0001476033,0.00011978723,0.0015238468,0.00039130915,0.000090953115,0.00002966435,0.000018022252,0.0015022623],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989688,0.00005152213,0.00034037503,0.00023720783,0.00012368639,0.00027845093],"domain_scores_gemma":[0.99952483,0.00008472486,0.000056084802,0.00018431475,0.000060508894,0.00008954576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023079754,0.00011606748,0.00024208824,0.00004640514,0.00028974187,0.000014876988,0.00011410009,0.00022250126,0.000011088507],"category_scores_gemma":[0.00010900035,0.000078393175,0.0002385282,0.00034805603,0.000087044595,0.000018245171,0.000039676936,0.00038899627,0.000008311819],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00853677,0.009030728,0.5285763,0.0019359641,0.0007906959,0.0002129734,0.0232964,0.000011509093,0.00022494663,0.0043525216,0.052919295,0.37011188],"study_design_scores_gemma":[0.06146283,0.0007981995,0.4106395,0.0013685563,0.0035957722,0.000004260452,0.036714587,0.00015866604,0.0003008842,0.0040944656,0.4799935,0.0008687974],"about_ca_topic_score_codex":0.0000467941,"about_ca_topic_score_gemma":0.0000634408,"teacher_disagreement_score":0.4270742,"about_ca_system_score_codex":0.000076034565,"about_ca_system_score_gemma":0.00029509634,"threshold_uncertainty_score":0.3196781},"labels":[],"label_agreement":null},{"id":"W4417017792","doi":"10.1182/blood-2025-133","title":"Efficacy and safety of frail adults treated with ciltacabtagene autoleucel in the real-world: A CIBMTR analysis","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Cytopenia; Comorbidity; Retrospective cohort study; Transplantation; Cohort; Cohort study; Multiple myeloma; Multivariate analysis","score_opus":0.013317002783837507,"score_gpt":0.30222040276787254,"score_spread":0.288903399984035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417017792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9740128,0.00031077513,0.000011710901,0.00062554923,0.000004383897,0.00058812543,0.0000110462615,0.000024621286,0.024411023],"genre_scores_gemma":[0.9932822,0.00036250227,0.00013237914,0.00010791343,0.000020838454,0.000029477458,0.00003330469,0.000011277806,0.006020135],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987741,0.00012980447,0.00027242067,0.00028096398,0.0003246367,0.00021803779],"domain_scores_gemma":[0.99899036,0.00027609142,0.000054647375,0.00053212506,0.00008808428,0.000058692465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039234894,0.0001307601,0.0004389137,0.00063459703,0.000041389307,0.000013131356,0.0001322397,0.000060095255,0.00030069877],"category_scores_gemma":[0.00005558212,0.0000802558,0.00008299085,0.0031478174,0.000112198584,0.0000202694,0.000038318864,0.00021035761,0.0000017221602],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064440514,0.0018258335,0.9445138,0.00020093052,0.0030889339,0.0001702999,0.0014623633,0.0000190396,0.020740107,0.00018161238,0.00009773884,0.021255318],"study_design_scores_gemma":[0.01472972,0.0003912193,0.9727964,0.00020735971,0.0015959126,0.0000061180162,0.00015705053,0.00017331056,0.0091621885,0.0000082709275,0.0006933306,0.000079139805],"about_ca_topic_score_codex":0.0014849169,"about_ca_topic_score_gemma":0.0023042557,"teacher_disagreement_score":0.028282609,"about_ca_system_score_codex":0.000030949454,"about_ca_system_score_gemma":0.000120272765,"threshold_uncertainty_score":0.32924408},"labels":[],"label_agreement":null},{"id":"W4417017803","doi":"10.1182/blood-2025-129","title":"PET-adaptive beacopp- versus ABVD-based therapies for advanced-stage (AS) classic Hodgkin lymphoma (cHL): Survival comparisons leveraging a multi-state model and analyzing the impact of a-hipi scores across the disease course","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"ABVD; Hodgkin lymphoma; Clinical trial; Disease; Proportional hazards model; Stage (stratigraphy); Lymphoma; International Prognostic Index; Interim analysis","score_opus":0.04745001400502891,"score_gpt":0.3630787663845383,"score_spread":0.3156287523795094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417017803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98846215,0.0059634396,0.0027486815,0.0008205152,0.00008827139,0.001188792,0.0006403865,0.00004332961,0.000044461915],"genre_scores_gemma":[0.99828833,0.00023777259,0.00083086506,0.00010251966,0.000025589114,0.0002714924,0.00004194917,0.000029665913,0.00017183177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985681,0.00009685702,0.00030026335,0.00038582276,0.00022518895,0.0004237633],"domain_scores_gemma":[0.99808615,0.0009177796,0.00019194276,0.0005031463,0.00015613306,0.00014482821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026366184,0.00032135533,0.00048936903,0.000061946084,0.0004308846,0.00008947241,0.00017448018,0.0000342744,0.0000033016618],"category_scores_gemma":[0.00010458854,0.00017395029,0.00035531254,0.00021286105,0.00032757394,0.000106526924,0.00007444812,0.00008307309,7.9561084e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017337648,0.009303574,0.8981662,0.00029487142,0.0071836333,0.00015844124,0.004403758,0.04150233,0.0016959228,0.0011722905,0.0003401592,0.018441182],"study_design_scores_gemma":[0.051932726,0.00074459385,0.76711655,0.00040686544,0.0018862226,0.0000043004084,0.0024568802,0.17226972,0.0027267633,0.00014909015,0.000043406544,0.00026288934],"about_ca_topic_score_codex":0.0005716173,"about_ca_topic_score_gemma":0.00032628104,"teacher_disagreement_score":0.13104963,"about_ca_system_score_codex":0.00014715706,"about_ca_system_score_gemma":0.0007425196,"threshold_uncertainty_score":0.7093487},"labels":[],"label_agreement":null},{"id":"W4417017805","doi":"10.1182/blood-2025-132","title":"Inadequate social support and household material hardship among children with pediatric acute lymphoblastic leukemia: A report from the Children's oncology group Trial AALL1731","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Psychosocial; Psychological intervention; Poverty; Social support; Pediatric cancer; Distress; Neurocognitive","score_opus":0.014928334601396812,"score_gpt":0.26614475365756285,"score_spread":0.25121641905616604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417017805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937697,0.00014709479,0.00005619255,0.0021724743,0.00081686536,0.001881452,0.0003672143,0.00025104888,0.0005379291],"genre_scores_gemma":[0.99141616,0.00010627017,0.00021949828,0.0017135206,0.005431963,0.00015866384,0.0006999547,0.00007650542,0.00017744703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965227,0.00032121286,0.00093079684,0.00089788757,0.00067403703,0.0006533657],"domain_scores_gemma":[0.99816984,0.00032138845,0.00054637773,0.0006707779,0.00007118431,0.00022043589],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009640184,0.00046756404,0.0010368482,0.00016368231,0.00039904943,0.00013521784,0.0003437665,0.00043463687,0.00005896725],"category_scores_gemma":[0.00024316704,0.00034588343,0.00019864428,0.00043860523,0.00036311822,0.00014765267,0.00029644623,0.00058491883,0.00000798004],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017945675,0.0012492763,0.9636586,0.00006458587,0.0034605577,0.00076305424,0.001450062,9.93659e-7,0.000099278135,0.00015386222,0.010360556,0.00079352874],"study_design_scores_gemma":[0.07961437,0.0014030337,0.91129535,0.000053500593,0.0058692787,0.00069078646,0.000094654155,0.0000010177382,0.00024298792,0.00013145008,0.00025396587,0.00034957274],"about_ca_topic_score_codex":0.0038589605,"about_ca_topic_score_gemma":0.0008822193,"teacher_disagreement_score":0.061668698,"about_ca_system_score_codex":0.00025000112,"about_ca_system_score_gemma":0.0016743698,"threshold_uncertainty_score":0.9998993},"labels":[],"label_agreement":null},{"id":"W4417017817","doi":"10.1182/blood-2025-140","title":"Spen loss drives extra-follicular diffuse large B cell lymphoma with female-specific lethality and TLR pathway therapeutic vulnerabilities","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Germinal center; Somatic hypermutation; Pathogenesis; BCL6; B cell; Mutation; Phenocopy","score_opus":0.012964988583459906,"score_gpt":0.237054735305634,"score_spread":0.2240897467221741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417017817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98006123,0.0133348955,0.00006455667,0.00053309364,0.00006852624,0.00064639683,0.0000438329,0.000086242726,0.0051611983],"genre_scores_gemma":[0.99669105,0.00091880717,0.00040616433,0.0004051827,0.00007296271,0.00013075401,0.000030866086,0.000027119373,0.0013171041],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845177,0.00010145601,0.0002652276,0.0005333865,0.00025990602,0.00038822563],"domain_scores_gemma":[0.99893725,0.00017837196,0.0000679628,0.00060186395,0.00006743849,0.00014713581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016732689,0.00030906024,0.0004816455,0.000086677115,0.00019303715,0.000074278185,0.00009563581,0.00011251582,0.000066751076],"category_scores_gemma":[0.000011271018,0.0002090987,0.000120860495,0.00017572423,0.00017755861,0.00007728327,0.000062451385,0.00007672244,0.00001940138],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026560313,0.023278184,0.95794374,0.00037709225,0.0006712655,0.000821281,0.0015302174,3.395727e-7,0.0026126239,0.006105798,0.000085380074,0.0063085053],"study_design_scores_gemma":[0.051336925,0.00069211726,0.8363877,0.00028736747,0.00074726675,0.00014885413,0.0011491657,0.00000843083,0.091014214,0.00047323602,0.017407121,0.0003475864],"about_ca_topic_score_codex":0.000054134176,"about_ca_topic_score_gemma":0.000037195066,"teacher_disagreement_score":0.121556,"about_ca_system_score_codex":0.000080772756,"about_ca_system_score_gemma":0.00014149737,"threshold_uncertainty_score":0.8526797},"labels":[],"label_agreement":null},{"id":"W4417017876","doi":"10.1182/blood-2025-383","title":"Development of a JAK2V617F-targeting lipid nanoparticle-siRNA as a novel gene therapy for myeloproliferative neoplasms","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"iCo Therapeutics (Canada)","funders":"","keywords":"Bone marrow; Myelofibrosis; Myeloproliferative neoplasm; Essential thrombocythemia; Gene knockdown; Polycythemia vera; In vivo; Genetic enhancement","score_opus":0.022917169300661098,"score_gpt":0.2934784122967103,"score_spread":0.27056124299604917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417017876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931434,0.0011645665,0.001066431,0.0010704729,0.00016465224,0.0020250347,0.00002972828,0.000065567656,0.0012701805],"genre_scores_gemma":[0.90711296,0.000162835,0.08976667,0.00092386623,0.00013767782,0.0012590238,0.00006323966,0.000035345987,0.0005383663],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99804205,0.000030282637,0.0006984427,0.0004988127,0.00030135922,0.00042906325],"domain_scores_gemma":[0.9987333,0.0002641275,0.0001888247,0.00028193957,0.00038258836,0.0001492095],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003081619,0.00032828932,0.0006394694,0.0001641224,0.00024029972,0.000029453062,0.00011360631,0.00012156305,0.000062959625],"category_scores_gemma":[0.00024330031,0.00025695103,0.00018338775,0.0003289436,0.00006112528,0.000064991014,0.000058250476,0.00011795048,0.000017719642],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017463055,0.00959887,0.052807022,0.0003013417,0.0028468736,0.000021526399,0.005243096,0.000013155572,0.9024855,0.006738601,0.0006178753,0.01757987],"study_design_scores_gemma":[0.015936105,0.00086711865,0.011220611,0.00024141185,0.00026188188,0.00002099663,0.00028734482,0.000117091746,0.96215737,0.00014617053,0.00852907,0.00021485187],"about_ca_topic_score_codex":0.000014772115,"about_ca_topic_score_gemma":0.000023956381,"teacher_disagreement_score":0.088700235,"about_ca_system_score_codex":0.00007667253,"about_ca_system_score_gemma":0.0008437235,"threshold_uncertainty_score":0.99998826},"labels":[],"label_agreement":null},{"id":"W4417017886","doi":"10.1182/blood-2025-698","title":"Efficacy and safety of talquetamab + teclistamab in patients with Relapsed/Refractory multiple myeloma and extramedullary disease: Updated Phase 2 results from the redirectt-1 study with extended follow-up","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Alberta Health; Alberta Health Services","funders":"","keywords":"Multiple myeloma; Cohort; Phases of clinical research; Plasmacytoma; Progressive disease; Cancer; Soft tissue; Bone marrow","score_opus":0.009697505005120908,"score_gpt":0.26703960228675483,"score_spread":0.25734209728163393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417017886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99472666,0.0010429008,0.000006131849,0.00020511796,0.00003193141,0.0030413114,0.0007015902,0.000048284743,0.00019606708],"genre_scores_gemma":[0.99839,0.000094959316,0.00032565155,0.000038875092,0.000018927114,0.000081759405,0.0008004321,0.00003046593,0.00021893665],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99776435,0.00022561508,0.00047301766,0.0006442672,0.0005482126,0.00034452972],"domain_scores_gemma":[0.9980463,0.0006409187,0.00015388834,0.00072051707,0.00016723225,0.00027115224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024438367,0.0003023541,0.00051520026,0.00016654634,0.00014281207,0.00003178864,0.00013002007,0.00007792737,0.000012751827],"category_scores_gemma":[0.00071666733,0.00017507987,0.00003754,0.0004492394,0.00025814015,0.00011227222,0.00011153137,0.0003188007,0.000001030889],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14205314,0.014905061,0.8229028,0.000049943363,0.0010797807,0.00043292544,0.00058900786,8.8551553e-7,0.00021534658,0.0000041008425,0.00008732119,0.017679662],"study_design_scores_gemma":[0.23984034,0.0028364686,0.75541925,0.00042143013,0.0006078296,0.0000022373636,0.00029807966,0.00005102977,0.00024753116,0.000006663143,0.00014254541,0.00012656857],"about_ca_topic_score_codex":0.0004533737,"about_ca_topic_score_gemma":0.0005131194,"teacher_disagreement_score":0.097787194,"about_ca_system_score_codex":0.000047514714,"about_ca_system_score_gemma":0.00021383731,"threshold_uncertainty_score":0.713955},"labels":[],"label_agreement":null},{"id":"W4417017894","doi":"10.1182/blood-2025-701","title":"Safety and efficacy of talquetamab + teclistamab in patients with Relapsed/Refractory multiple myeloma from Phase 1b of redirectt-1: Results with an extended median follow-up of 3 years","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health; Alberta Health Services; McGill University","funders":"","keywords":"Multiple myeloma; Phases of clinical research; Regimen; Safety profile; Adverse effect; Plasmacytoma; Progressive disease","score_opus":0.010249553946417508,"score_gpt":0.2699321107751611,"score_spread":0.2596825568287436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417017894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972557,0.00025086908,0.000010441121,0.000036570254,0.00003343109,0.00096366444,0.0009194758,0.000022252552,0.000507599],"genre_scores_gemma":[0.99668676,0.00006103921,0.0024016863,0.000008622249,0.00001441698,0.000016648535,0.00067727314,0.000026769974,0.00010677822],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99796736,0.00012215835,0.0006238046,0.00044369508,0.0005596652,0.00028331426],"domain_scores_gemma":[0.99825686,0.00038792464,0.0002858002,0.00062241475,0.00024247749,0.00020453855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020872935,0.00021694324,0.00070849195,0.00035531857,0.00002861469,0.000005472292,0.00013021434,0.0001243896,0.000016552982],"category_scores_gemma":[0.0006667051,0.00016180209,0.000060160386,0.00045772392,0.00027053026,0.00011361256,0.000055707445,0.00020868442,6.9332947e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1552176,0.028628703,0.73789275,0.00027546386,0.0013534575,0.00024794062,0.0015974041,0.0000016457087,0.0067179636,0.000017877312,0.00002827186,0.068020925],"study_design_scores_gemma":[0.23791921,0.0047907117,0.7395124,0.0006820926,0.00026819232,0.0000014117396,0.000137014,0.00004032634,0.016482359,0.000012126173,0.000054039767,0.00010015525],"about_ca_topic_score_codex":0.0012573273,"about_ca_topic_score_gemma":0.0009839172,"teacher_disagreement_score":0.08270161,"about_ca_system_score_codex":0.0000464573,"about_ca_system_score_gemma":0.0002777711,"threshold_uncertainty_score":0.65980977},"labels":[],"label_agreement":null},{"id":"W4417017913","doi":"10.1182/blood-2025-704","title":"Symptom burden in patients with cancer and thromboembolism: A population-based matched cohort study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Ontario; Toronto Public Health; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Cancer; Emergency department; Retrospective cohort study; Cohort; Cohort study; Stage (stratigraphy); Lung cancer; Diagnosis code","score_opus":0.005241787396047053,"score_gpt":0.25155509468682663,"score_spread":0.24631330729077958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417017913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99620175,0.00012517671,0.0000049999117,0.0005196201,0.00007099242,0.0021866919,0.0000063522193,0.00004572341,0.00083871465],"genre_scores_gemma":[0.9988828,0.000022605669,0.000097882774,0.0004839489,0.00003186239,0.00032329772,0.00003577939,0.00001734029,0.00010449717],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989852,0.00002679637,0.00021822493,0.00032243217,0.00025155087,0.000195846],"domain_scores_gemma":[0.9995267,0.000028968474,0.000053919866,0.000269504,0.00006433247,0.00005657008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011575353,0.00015045058,0.00052069675,0.00017874717,0.000054744727,0.000025233647,0.00005759835,0.00004519712,0.00005751572],"category_scores_gemma":[0.00001761806,0.000119657736,0.000023055312,0.00027977547,0.00001980459,0.00004309336,0.00004273937,0.00008880551,0.0000024562091],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049550603,0.0036577433,0.9946782,0.00009981472,0.000387233,0.000008914846,0.00026960962,0.000050527407,0.000004637841,0.00008821342,0.00013825022,0.0005672763],"study_design_scores_gemma":[0.010433595,0.00031735812,0.98758656,0.00026495097,0.000970849,1.2072769e-7,0.00016977634,0.000035447683,0.000023213124,0.000028782444,0.000050654304,0.00011867175],"about_ca_topic_score_codex":0.004888838,"about_ca_topic_score_gemma":0.00082421966,"teacher_disagreement_score":0.010384045,"about_ca_system_score_codex":0.000056175748,"about_ca_system_score_gemma":0.00006926685,"threshold_uncertainty_score":0.7390494},"labels":[],"label_agreement":null},{"id":"W4417017914","doi":"10.1182/blood-2025-706","title":"Thromboembolism and event-free survival in children with extracranial solid tumors: A report from CYP-c.","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôtel-Dieu de Québec; Stollery Children's Hospital; Greenfield Research (Canada); SickKids Foundation; Capital District Health Authority; McMaster Children's Hospital; Centre hospitalier universitaire de Québec; Université Laval","funders":"","keywords":"Cohort; Common Terminology Criteria for Adverse Events; Retrospective cohort study; Malignancy; Medical record; Cancer; Proportional hazards model; Univariate analysis; Adverse effect","score_opus":0.006771467263125358,"score_gpt":0.2566053518336112,"score_spread":0.24983388457048586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417017914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904593,0.0007640793,0.0001384755,0.0010668513,0.00014004447,0.0008748369,0.00002626612,0.00008330581,0.0064468174],"genre_scores_gemma":[0.9974952,0.00019081,0.0011237006,0.0004714433,0.00025190262,0.00008059533,0.00007253242,0.000029948522,0.00028386698],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982969,0.000043335054,0.00043714384,0.0005496563,0.0003232105,0.0003497503],"domain_scores_gemma":[0.99894047,0.000044840803,0.000109959976,0.0007420547,0.00004891376,0.00011374538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026962374,0.00024196829,0.0008096193,0.00017368748,0.00007229542,0.00004707019,0.00017678134,0.00009683236,0.000076586526],"category_scores_gemma":[0.00010943732,0.00020148417,0.000065805616,0.00026061,0.00008531032,0.00009075242,0.00020972022,0.00022008995,0.0000074115214],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009481166,0.0036929054,0.9860763,0.00007648356,0.0012302839,0.0012561645,0.00039967097,0.0000047504627,0.0011097323,0.0014432177,0.0026110942,0.0020046136],"study_design_scores_gemma":[0.007939583,0.00020384445,0.9873143,0.00042727435,0.0008103315,0.00017661275,0.00014667379,0.000010349844,0.0010511171,0.0012901968,0.00042625007,0.00020347931],"about_ca_topic_score_codex":0.0021153472,"about_ca_topic_score_gemma":0.0007767008,"teacher_disagreement_score":0.00784477,"about_ca_system_score_codex":0.000028217064,"about_ca_system_score_gemma":0.0001466386,"threshold_uncertainty_score":0.82162863},"labels":[],"label_agreement":null},{"id":"W4417017939","doi":"10.1182/blood-2025-803","title":"Deletion of TRAF3 and CYLD and NIK amplification activates NF-kb signalling and drives resistance to T cell based therapies in multiple myeloma by suppressing T cell activity","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"CRISPR; Cas9; Chimeric antigen receptor; T cell; HEK 293 cells; Gene; Genome editing; Multiple myeloma; Cell","score_opus":0.015826011956377666,"score_gpt":0.2684716832338972,"score_spread":0.2526456712775195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417017939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953967,0.0022134297,0.0010136692,0.00050191354,0.000008304522,0.00046936542,0.000013590944,0.000017267828,0.00036580217],"genre_scores_gemma":[0.99752915,0.00032453402,0.0014938854,0.000045247434,0.000012324015,0.000023402028,0.000008651787,0.00001435944,0.0005484654],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99912584,0.00009899096,0.00015987658,0.0002973713,0.00014963018,0.00016829756],"domain_scores_gemma":[0.9992253,0.00044744546,0.000058330155,0.0001516874,0.00005078415,0.00006641517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024121517,0.00011858081,0.00023041523,0.00017074082,0.00006867781,0.000037092195,0.000044127497,0.00007616446,0.000012760739],"category_scores_gemma":[0.000054372304,0.00011373035,0.000020204496,0.00019200458,0.000097634256,0.000081198006,0.000025603598,0.00014286503,1.5263733e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000678132,0.00033647867,0.041597087,0.00038752015,0.000019118892,0.0000016402108,0.0008961759,0.000004103094,0.94741124,0.0000036473646,0.000024144572,0.008640712],"study_design_scores_gemma":[0.0030616673,0.00011319297,0.08722563,0.0002224879,0.00003091745,7.1240027e-7,0.00024114944,0.00041967013,0.9082854,0.000055161672,0.0002595726,0.00008446539],"about_ca_topic_score_codex":0.00006693287,"about_ca_topic_score_gemma":0.00008744001,"teacher_disagreement_score":0.045628548,"about_ca_system_score_codex":0.00002117045,"about_ca_system_score_gemma":0.000050550327,"threshold_uncertainty_score":0.46377888},"labels":[],"label_agreement":null},{"id":"W4417018128","doi":"10.1182/blood-2025-4556","title":"Long-term risk and racial disparities in second primary malignancies among diffuse large B-cell lymphoma survivors: A SEER-based analysis MP-SIR analysis (2000–2022)","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Myeloid leukemia; Incidence (geometry); Leukemia; Lymphoma; Esophagus; Cancer; Epidemiology; Odds ratio","score_opus":0.004949746950262819,"score_gpt":0.22296740879869786,"score_spread":0.21801766184843505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417018128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913688,0.00500536,0.0006021782,0.000071699935,0.00009613373,0.00043584808,0.0006217027,0.000080424645,0.0017178662],"genre_scores_gemma":[0.99428684,0.00050998415,0.00016698269,0.00094023166,0.00006662091,0.00008234379,0.0009244613,0.00002793757,0.0029945967],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99732137,0.0002245894,0.00068162265,0.0007733605,0.00037624728,0.00062283664],"domain_scores_gemma":[0.9984743,0.0002915863,0.00022571516,0.00069387007,0.000097125834,0.0002174276],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005259193,0.0004029676,0.0013137116,0.0017634687,0.00019144411,0.0001035222,0.00019592926,0.00024088894,0.0005736412],"category_scores_gemma":[0.00007541346,0.00038739553,0.00053157535,0.003112243,0.0002043094,0.00021649642,0.00012765786,0.00028029844,0.0000038847675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003382922,0.0033189731,0.9890786,0.00059554033,0.0041200975,0.00023589036,0.0006224081,0.000030520423,0.00049001095,0.000008385655,0.000080522506,0.0010807595],"study_design_scores_gemma":[0.021321628,0.00009591109,0.9605608,0.000067425404,0.013935213,0.0000019991933,0.00013957953,0.0014140144,0.0017486132,0.000008500659,0.0003522182,0.0003540752],"about_ca_topic_score_codex":0.0021656929,"about_ca_topic_score_gemma":0.044692397,"teacher_disagreement_score":0.042526703,"about_ca_system_score_codex":0.0002289044,"about_ca_system_score_gemma":0.00055878673,"threshold_uncertainty_score":0.9998578},"labels":[],"label_agreement":null},{"id":"W4417018218","doi":"10.1182/blood-2025-3998","title":"Tracking peripheral residual disease in myeloma: Clonotypic sequencing and mass spectrometry in the teclistamab era","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Monoclonal; Minimal residual disease; Monoclonal antibody; Immunofixation; Serum protein electrophoresis; clone (Java method); Selected reaction monitoring; Multiple myeloma","score_opus":0.019750617200870017,"score_gpt":0.29717043670788545,"score_spread":0.27741981950701544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417018218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99328375,0.0024728884,0.000019628449,0.001576152,0.000022345048,0.00048370377,0.000010326484,0.000021352756,0.002109855],"genre_scores_gemma":[0.99842227,0.00009278347,0.00091489824,0.00020001187,0.00006409082,0.000053975575,0.000018542225,0.000010209306,0.00022321193],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881214,0.00011557029,0.00020220912,0.0002754519,0.00024159595,0.00035302856],"domain_scores_gemma":[0.9994607,0.00013800024,0.000022274226,0.00025605396,0.000021428119,0.00010151903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029550798,0.00013040857,0.00020504706,0.0002869826,0.00007074588,0.00005625776,0.00009668524,0.000050370913,0.000028047552],"category_scores_gemma":[0.00028907266,0.00009260535,0.00003888865,0.00049126253,0.00006247513,0.00007628028,0.000035880315,0.00035125317,0.0000030762726],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004165214,0.00043567887,0.9877881,0.00014640202,0.00006322533,0.0024230818,0.00044065018,0.0000029319363,0.005018781,0.0004026996,0.000020674146,0.0028412961],"study_design_scores_gemma":[0.007147231,0.0001025935,0.989663,0.00019720948,0.000068707355,0.00002208717,0.00048024172,0.00019608522,0.0013350452,0.0006634384,0.000048331327,0.00007601262],"about_ca_topic_score_codex":0.00022938884,"about_ca_topic_score_gemma":0.00023749548,"teacher_disagreement_score":0.0067307097,"about_ca_system_score_codex":0.00015361814,"about_ca_system_score_gemma":0.00025963908,"threshold_uncertainty_score":0.37763366},"labels":[],"label_agreement":null},{"id":"W4417018263","doi":"10.1182/blood-2025-5138","title":"Tumor-induced dendritic cell dysfunction impairs T-cell proliferation and confers poor prognosis in high-risk acute lymphoblastic leukemia","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Dendritic cell; Flow cytometry; Bone marrow; Immune system; Myeloid; Peripheral blood mononuclear cell; Population; T cell","score_opus":0.004692772084027252,"score_gpt":0.20178749708457344,"score_spread":0.1970947250005462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417018263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99496585,0.003274991,0.00010589391,0.00007779795,0.0005361828,0.00062190386,0.000019741958,0.00008699878,0.00031066284],"genre_scores_gemma":[0.9973685,0.00040443035,0.000055149467,0.00017103172,0.00001445447,0.00015677247,0.000056554774,0.000021385971,0.0017517186],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99840266,0.0004066014,0.00038955105,0.0003745293,0.000037615715,0.00038906262],"domain_scores_gemma":[0.99936074,0.00024028007,0.00013236149,0.00018668079,0.00006247741,0.00001744171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024876624,0.00025073928,0.00034142454,0.00032365278,0.00024636934,0.000049236034,0.00013442156,0.0002676666,0.000062996354],"category_scores_gemma":[0.00007354594,0.00023760786,0.00007008083,0.00027063623,0.00010726008,0.0001456742,0.00005297915,0.00032162885,0.00008233218],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001090977,0.00062608,0.02207835,0.00008031082,0.00027782464,0.0000193251,0.00033133052,0.00000563272,0.9727701,0.00009088021,0.00019846542,0.0024307575],"study_design_scores_gemma":[0.012594102,0.0008044596,0.046173926,0.0000971906,0.00040166132,0.000078345765,0.00036907615,0.00003504579,0.938816,0.000073298754,0.0003055774,0.00025131198],"about_ca_topic_score_codex":0.0003974421,"about_ca_topic_score_gemma":0.00004591994,"teacher_disagreement_score":0.033954065,"about_ca_system_score_codex":0.00010860767,"about_ca_system_score_gemma":0.0003596921,"threshold_uncertainty_score":0.96893674},"labels":[],"label_agreement":null},{"id":"W4417018334","doi":"10.1182/blood-2025-4810","title":"Effectiveness of sirolimus for pediatric autoimmune cytopenias and factors associated with clinical response","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital; Hospital for Sick Children","funders":"","keywords":"Sirolimus; Eltrombopag; Thrombopoietin receptor; Tacrolimus; Immune system; Immunosuppression; Mycophenolic acid; Everolimus","score_opus":0.015367294538938965,"score_gpt":0.2764192470858835,"score_spread":0.2610519525469445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417018334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98426634,0.01457984,0.00014801093,0.000028040098,0.00025094673,0.000510869,0.000047209163,0.000051869047,0.000116895186],"genre_scores_gemma":[0.9993908,0.00006983366,0.0000074116265,0.000016366777,0.0000010337077,0.000035948025,0.000066714296,0.000012645439,0.0003992819],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982286,0.0007955934,0.00039822506,0.00027981427,0.000026288506,0.00027148903],"domain_scores_gemma":[0.99585617,0.0036247645,0.0001761765,0.00023679355,0.00010137387,0.000004728584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015655585,0.00017126689,0.0004997734,0.00014160087,0.00019218649,0.000008875288,0.00018408164,0.0002779296,0.000010341154],"category_scores_gemma":[0.0012314062,0.00013429624,0.00012264152,0.00027699684,0.00027421195,0.000049905953,0.00007001235,0.0002091039,0.0000026211383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017197713,0.0056682527,0.5417009,0.00063635927,0.0026501985,0.000004933457,0.0008628995,0.000022386452,0.4272312,0.0014435655,0.000048178696,0.0025334284],"study_design_scores_gemma":[0.010981274,0.00081896945,0.9516338,0.00010878454,0.00048360755,0.0000019465338,0.00016512684,0.0000022842962,0.034926843,0.00010399256,0.000614608,0.0001587586],"about_ca_topic_score_codex":0.00001938241,"about_ca_topic_score_gemma":8.715004e-7,"teacher_disagreement_score":0.4099329,"about_ca_system_score_codex":0.000010119019,"about_ca_system_score_gemma":0.0001680356,"threshold_uncertainty_score":0.54764414},"labels":[],"label_agreement":null},{"id":"W4417018347","doi":"10.1182/blood-2025-4905","title":"Elucidating the chronological relationship between central venous line dysfunction, infection and thrombosis in children with cancer: A preliminary analysis","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Central Venous Catheters and Hemodialysis","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Children's Hospital of Eastern Ontario; University of Ottawa; Kingston Health Sciences Centre; McMaster University Medical Centre; Hospital for Sick Children; Public Health Ontario; University of Toronto; London Health Sciences Centre; Queen's University; McMaster Children's Hospital","funders":"","keywords":"Prospective cohort study; Cancer; Venous thrombosis; Thrombosis; Central line; Cohort; Thrombus; Cohort study; Pediatric cancer","score_opus":0.0371839434744499,"score_gpt":0.3412873545897604,"score_spread":0.3041034111153105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417018347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962862,0.00041831905,0.0012645103,0.0010973604,0.00004885685,0.0006084797,0.000024504046,0.00005713629,0.00019459582],"genre_scores_gemma":[0.9990299,0.000240765,0.00009367319,0.00014560927,0.0001683822,0.00015036113,0.00008426444,0.000008636639,0.00007843298],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859107,0.00029024706,0.00034541558,0.0002882763,0.00010860464,0.00037636558],"domain_scores_gemma":[0.9991284,0.00040522427,0.00014849748,0.0002177412,0.00004656662,0.00005354638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031740728,0.00012948032,0.00031980616,0.0002174682,0.00085799105,0.000016857532,0.00007820807,0.00016540335,0.00005802539],"category_scores_gemma":[0.00010417042,0.00008495578,0.00007541999,0.0011888599,0.00006604105,0.00007120507,0.00006810656,0.0005348149,0.0000034593209],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002742177,0.00024018953,0.99606264,0.000027188986,0.0007320988,3.382124e-7,0.0011634305,0.0003121897,0.000007274733,0.00011648781,0.00002986958,0.0012808522],"study_design_scores_gemma":[0.0011346505,0.00020450269,0.99504584,0.000080946,0.0028911764,6.4967867e-7,0.00017839314,0.00016532822,0.00002105291,0.00015003598,0.000034899516,0.00009254478],"about_ca_topic_score_codex":0.0047102626,"about_ca_topic_score_gemma":0.0037734052,"teacher_disagreement_score":0.0027436377,"about_ca_system_score_codex":0.0001266746,"about_ca_system_score_gemma":0.0001481542,"threshold_uncertainty_score":0.7120539},"labels":[],"label_agreement":null},{"id":"W4417018394","doi":"10.1182/blood-2025-5918","title":"Lipid nanoparticle-mediated mRNA transfection enables efficient and safe generation of CAR macrophages.","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Transfection; Chimeric antigen receptor; Genetic enhancement; Carcinogenesis; Cytokine; Immune system; Cancer cell; Cancer; Immunotherapy","score_opus":0.01825271170035706,"score_gpt":0.272377285400817,"score_spread":0.25412457370045993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417018394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962539,0.001216824,0.00011344516,0.00037282886,0.00010942649,0.0004062074,0.00000760922,0.00003037723,0.0014893764],"genre_scores_gemma":[0.9978937,0.00032095183,0.00008251296,0.000065314205,0.000118803626,0.000020237769,0.000016410693,0.000010491895,0.0014715834],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99919724,0.00005885144,0.00019444058,0.00018300602,0.00020068446,0.00016574997],"domain_scores_gemma":[0.99959284,0.000056289435,0.000022197975,0.00016660347,0.00009668231,0.00006537478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000234283,0.0000822284,0.00018086964,0.00013576733,0.00005367369,0.000012622749,0.000032767344,0.00006587044,0.00025456405],"category_scores_gemma":[0.00006634304,0.00007293428,0.000045038225,0.0003108775,0.00006879567,0.000019642786,0.000014610293,0.00009647356,0.0000057973693],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013520248,0.00043020258,0.0032944134,0.0001337546,0.00009171273,0.000009380919,0.00022651513,0.000043930406,0.98930323,0.000052168405,0.000112023175,0.006167458],"study_design_scores_gemma":[0.0041118315,0.00030381588,0.006944208,0.000051139556,0.00014158059,0.00001517578,0.000040077673,0.0022411083,0.98497653,0.0000064216238,0.0011142008,0.000053897205],"about_ca_topic_score_codex":0.0000814593,"about_ca_topic_score_gemma":0.000025598594,"teacher_disagreement_score":0.0061135604,"about_ca_system_score_codex":0.000027300839,"about_ca_system_score_gemma":0.0000806235,"threshold_uncertainty_score":0.29741734},"labels":[],"label_agreement":null},{"id":"W4417018408","doi":"10.1182/blood-2025-4550","title":"Outcomes and treatment strategies following CD20/CD3 bispecific antibody failure in non-Hodgkin's lymphoma: A retrospective single-center study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Mantle cell lymphoma; Retrospective cohort study; Refractory (planetary science); Clinical trial; Rituximab; Lymphoma; Cancer; Antibody; Progressive disease","score_opus":0.012643894072925854,"score_gpt":0.2913683519374613,"score_spread":0.2787244578645354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417018408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99316704,0.00047376324,0.0000046452565,0.00051908166,0.00017666844,0.001588193,0.000015515698,0.00007018562,0.0039849174],"genre_scores_gemma":[0.9989484,0.00007265046,0.00021622427,0.0000778278,0.000042114956,0.00023713407,0.000028361892,0.000024163914,0.0003531274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983848,0.000053419142,0.0003584267,0.00060132437,0.00024157095,0.00036049503],"domain_scores_gemma":[0.9993002,0.00009171055,0.00006784097,0.00040267612,0.000043131888,0.00009445755],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009571172,0.00036664127,0.0007706713,0.0003008421,0.00011514487,0.00013363548,0.000070045266,0.000099308454,0.00001336682],"category_scores_gemma":[0.000025243417,0.00026441575,0.00019831255,0.0003693293,0.000043631913,0.0001441773,0.000067367495,0.00005679981,0.000009788587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009325017,0.024888085,0.9675925,0.000022823117,0.0013950899,0.0013986945,0.0013500861,3.9781676e-7,0.0007643318,0.00016735349,0.000038782706,0.0022886086],"study_design_scores_gemma":[0.04691411,0.0021858292,0.9432124,0.00021394072,0.00079332327,0.000028627917,0.0052254642,0.0000040620494,0.00090405287,0.00006251548,0.00027293805,0.0001827407],"about_ca_topic_score_codex":0.00046520482,"about_ca_topic_score_gemma":0.0012722132,"teacher_disagreement_score":0.04682086,"about_ca_system_score_codex":0.0005111786,"about_ca_system_score_gemma":0.00015330446,"threshold_uncertainty_score":0.9999808},"labels":[],"label_agreement":null},{"id":"W4417018484","doi":"10.1182/blood-2025-4207","title":"Comparison of alemtuzumab and ATG-based conditioning in adult recipients of allogeneic hematopoietic cell transplantation (HCT) for severe aplastic anemia: A retrospective study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Alemtuzumab; Fludarabine; Retrospective cohort study; Total body irradiation; Regimen; Cyclophosphamide; Transplantation; Cohort","score_opus":0.013205785198259955,"score_gpt":0.29720354767582063,"score_spread":0.2839977624775607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417018484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99397427,0.00011089437,0.003649381,0.00003137586,0.000058188405,0.0016739268,0.00009456624,0.000019425317,0.00038795234],"genre_scores_gemma":[0.9980771,0.000018342902,0.0015823087,0.000021950224,0.000007355287,0.00011779814,0.0001305445,0.000015697626,0.00002888562],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985604,0.000068428446,0.0006559039,0.0003020555,0.00024544107,0.00016772348],"domain_scores_gemma":[0.99903667,0.00033628472,0.0002048189,0.0001662625,0.00021009638,0.000045874436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001909749,0.00015720312,0.00057645765,0.00025620716,0.000040737927,0.000005528984,0.000056993682,0.00011464672,0.000016786504],"category_scores_gemma":[0.000069632224,0.0001607394,0.0000615004,0.00028430458,0.00006105659,0.00003842957,0.0000057357483,0.0001228161,8.972427e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077847514,0.002507228,0.96735823,0.004687576,0.000085549116,0.00001831073,0.0041524535,0.0001665795,0.020074822,0.00012614421,0.0000093783965,0.000035226676],"study_design_scores_gemma":[0.025504969,0.0015213805,0.70683414,0.001787794,0.0014416465,0.00002822844,0.0022825587,0.0005052087,0.25984523,0.000104695006,4.7454682e-7,0.00014370283],"about_ca_topic_score_codex":0.000039475053,"about_ca_topic_score_gemma":0.000102302874,"teacher_disagreement_score":0.26052415,"about_ca_system_score_codex":0.000049912698,"about_ca_system_score_gemma":0.00013008848,"threshold_uncertainty_score":0.6554762},"labels":[],"label_agreement":null},{"id":"W4417018487","doi":"10.1182/blood-2025-4900","title":"Risk factors for thrombo-embolism in neonates: A systematic review of the literature and call to action","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec; Centre hospitalier universitaire de Québec","funders":"","keywords":"Odds ratio; Confidence interval; Prospective cohort study; Risk factor; Cohort study; Retrospective cohort study; Psychological intervention; Gestational age; Risk assessment; MEDLINE","score_opus":0.01720482816386877,"score_gpt":0.29696367418977004,"score_spread":0.2797588460259013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417018487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96721506,0.025987132,0.00025476137,0.0016328729,0.00024379528,0.0043088193,0.00003736388,0.00003042102,0.00028976268],"genre_scores_gemma":[0.99600714,0.002026833,0.00025430063,0.0013284426,0.000014287121,0.00010457207,0.0000073011156,0.000007967483,0.00024917081],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99931574,0.00007118073,0.00028199938,0.00013725663,0.00010749734,0.000086320004],"domain_scores_gemma":[0.99943036,0.00010509726,0.00010132237,0.00024162821,0.00008656103,0.000035010224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022707699,0.00009142102,0.0004498717,0.00008280626,0.000033886023,0.0000098659175,0.000058624406,0.0000701006,0.000004068912],"category_scores_gemma":[0.0005726117,0.00005419018,0.000084301944,0.0003588974,0.000009882771,0.00002819611,0.000026366708,0.0000967738,6.008521e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003802587,0.0007567466,0.009738123,0.96455324,0.0005546924,0.0000015233694,0.004177579,0.0000016840781,0.011265712,0.007998331,0.0005369592,0.0003773917],"study_design_scores_gemma":[0.005438138,0.00032691142,0.1037095,0.8275821,0.0052061435,0.0000182334,0.0006637599,0.00009951967,0.052767877,0.0036749984,0.0002701266,0.00024266305],"about_ca_topic_score_codex":0.000020050105,"about_ca_topic_score_gemma":0.000018415432,"teacher_disagreement_score":0.1369711,"about_ca_system_score_codex":0.000012026814,"about_ca_system_score_gemma":0.00003290793,"threshold_uncertainty_score":0.22098114},"labels":[],"label_agreement":null},{"id":"W4417018511","doi":"10.1182/blood-2025-4904","title":"Arterial thrombotic events in lymphoma patients: Systematic review and meta-analysis","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Funnel plot; Study heterogeneity; Meta-analysis; Publication bias; Confidence interval; Univariate analysis; Univariate; Lymphoma","score_opus":0.018779793640537324,"score_gpt":0.27925182834978884,"score_spread":0.2604720347092515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417018511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89782333,0.09763348,0.000005528875,0.0012906302,0.0000458373,0.00270188,0.000028141532,0.000027426673,0.00044371613],"genre_scores_gemma":[0.99678713,0.0011886315,0.000060377708,0.0012832046,0.0000047149783,0.00042771306,0.000035704245,0.000006930538,0.00020558735],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99891144,0.00009551171,0.00045634896,0.00024653244,0.00015792847,0.00013222714],"domain_scores_gemma":[0.9993821,0.00006261269,0.00009365498,0.00036086107,0.00004771098,0.00005309922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014757519,0.00015310988,0.0018379594,0.00017616544,0.000024899793,0.000008834421,0.000047401332,0.00003936334,0.000094241725],"category_scores_gemma":[0.00011222028,0.0000992001,0.00044096497,0.00050577987,0.000011213922,0.000032042713,0.00003452653,0.000019305979,0.000017079257],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028192442,0.01324093,0.24878925,0.19462125,0.54244524,0.00008119438,0.00011800214,6.9328576e-7,0.000010230156,0.00027221636,0.00029007441,0.00010269716],"study_design_scores_gemma":[0.002906282,0.000054946166,0.29819593,0.0017214181,0.69697946,0.0000040631976,0.000008784664,0.0000020570903,0.00003648445,0.000029405786,0.0000033384265,0.00005783161],"about_ca_topic_score_codex":0.000060732884,"about_ca_topic_score_gemma":0.000042196563,"teacher_disagreement_score":0.19289984,"about_ca_system_score_codex":0.00005348509,"about_ca_system_score_gemma":0.000032955755,"threshold_uncertainty_score":0.4045263},"labels":[],"label_agreement":null},{"id":"W4417018553","doi":"10.1182/blood-2025-6411","title":"High response rates and early treatment patterns with venetoclax and azacitidine from the prospective liven study: Real-world AML care in Canada","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Espace pour la vie; Juravinski Cancer Centre; Centre Hospitalier Universitaire de Sherbrooke; Occupational Cancer Research Centre; London Health Sciences Centre; Thunder Bay Regional Research Institute; Research Institute in Oncology and Hematology","funders":"","keywords":"Azacitidine; Venetoclax; Myeloid leukemia; Adverse effect; Concomitant; Clinical endpoint; Interim analysis; Population; Chemotherapy regimen","score_opus":0.008598570720924043,"score_gpt":0.26382870674471093,"score_spread":0.25523013602378686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417018553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99642235,0.00060545624,3.9301756e-7,0.0010732139,0.000015872465,0.0016232062,0.00011847764,0.000013858606,0.0001271854],"genre_scores_gemma":[0.99885887,0.00015145376,0.000049637594,0.00008869855,0.000044476335,0.00022691854,0.000016552733,0.000016712498,0.00054669735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890286,0.0001900495,0.00014445177,0.00034087052,0.00019960046,0.00022218018],"domain_scores_gemma":[0.99903136,0.000476021,0.000031958323,0.00030223178,0.000074078846,0.000084350424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011465291,0.00016077053,0.00030289692,0.00009097703,0.000083811865,0.00003058567,0.000071174,0.000027165406,0.000010200084],"category_scores_gemma":[0.000044973734,0.00009601816,0.000011939936,0.00025519356,0.0000565968,0.000029263652,0.00007365783,0.00018885706,5.222707e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030603977,0.00011510225,0.9904611,0.000018849212,0.0003194706,0.00075479865,0.0042486405,0.0000017214325,0.00020328707,0.000009290684,0.000046039626,0.0007613092],"study_design_scores_gemma":[0.010605137,0.0017797108,0.9757529,0.00018749198,0.00023383685,0.0000064573787,0.007446013,0.0000059900376,0.0037783454,0.0000125459355,0.00010662565,0.0000849573],"about_ca_topic_score_codex":0.9719682,"about_ca_topic_score_gemma":0.98315173,"teacher_disagreement_score":0.014708204,"about_ca_system_score_codex":0.0016743117,"about_ca_system_score_gemma":0.002666991,"threshold_uncertainty_score":0.47311273},"labels":[],"label_agreement":null},{"id":"W4417018574","doi":"10.1182/blood-2025-5661","title":"Multiomic correlates of ex vivo αCD19 chimeric antigen receptor T-cell (CART) cytotoxicity in venetoclax-treated patients with chronic lymphocytic leukemia (CLL)","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University","funders":"","keywords":"Cytotoxicity; CD19; Peripheral blood mononuclear cell; Ex vivo; Chronic lymphocytic leukemia; Immune system; Flow cytometry; Immunotherapy; CD20","score_opus":0.007096418163613456,"score_gpt":0.2436032348991928,"score_spread":0.23650681673557936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417018574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99444085,0.00087172864,0.0000072717667,0.000008244976,0.00008379858,0.001510625,0.000032605432,0.00006986057,0.0029750234],"genre_scores_gemma":[0.99590695,0.0003598755,0.00013239526,0.000031858348,0.000042633124,0.00005361086,0.00009595677,0.000051501975,0.003325196],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980221,0.00010881623,0.00045842945,0.00046900215,0.0004397384,0.0005019496],"domain_scores_gemma":[0.99887234,0.0001274118,0.0001442591,0.00056097656,0.00016764953,0.00012735717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001749797,0.00027876356,0.0005906989,0.0004049934,0.000053239793,0.000016201839,0.00023240177,0.00019169677,0.0008275444],"category_scores_gemma":[0.00005594413,0.00024046104,0.00011232295,0.0010291386,0.000178331,0.000065709515,0.000092910384,0.0003032172,0.00006596724],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009845201,0.000491937,0.5369294,0.00026146212,0.00022718566,0.000020301815,0.0001355587,0.00030923012,0.45963675,0.0000027347985,0.00012762078,0.0008732961],"study_design_scores_gemma":[0.030065136,0.0013105954,0.29971877,0.0006165916,0.00017263091,0.000005564278,0.000034722656,0.0024387124,0.6650935,0.00000592784,0.0003148422,0.00022303048],"about_ca_topic_score_codex":0.0017247429,"about_ca_topic_score_gemma":0.00018217781,"teacher_disagreement_score":0.23721066,"about_ca_system_score_codex":0.0040139793,"about_ca_system_score_gemma":0.0030057833,"threshold_uncertainty_score":0.99980944},"labels":[],"label_agreement":null},{"id":"W4417018661","doi":"10.1182/blood-2025-5146","title":"Comparison of paired bone marrow and peripheral blood measurable residual disease in pediatric acute lymphoblastic leukemia by next-generation sequencing: A report from the dana farber ALL consortium protocol 16-001.","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Centre hospitalier universitaire de Québec","funders":"","keywords":"Minimal residual disease; Bone marrow; Leukemia; Acute lymphocytic leukemia; White blood cell; Clinical trial; Lymphoblastic Leukemia; Hematology","score_opus":0.04680415808880678,"score_gpt":0.31270643538709386,"score_spread":0.2659022772982871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417018661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9782509,0.0010278212,0.0001372686,0.00085066096,0.00007185662,0.018972246,0.00012121802,0.000073294534,0.00049472396],"genre_scores_gemma":[0.9864951,0.000051282153,0.00045504508,0.00031853156,0.00026350567,0.01067432,0.00048753098,0.000047975722,0.001206729],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99619734,0.00033074175,0.0011777425,0.0007789198,0.0009327433,0.00058251835],"domain_scores_gemma":[0.99778265,0.00043670845,0.00037545542,0.0008073742,0.00027745016,0.0003203925],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00069937034,0.0003769234,0.00077097904,0.00018816289,0.00015025058,0.000100708596,0.0002488059,0.00022542116,0.00008039141],"category_scores_gemma":[0.0011435787,0.00029000305,0.00010100105,0.00059255055,0.00025072994,0.00017869487,0.00018901307,0.00040543076,0.000004090833],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024412877,0.0028130468,0.76786417,0.0007374025,0.001080711,0.0020813134,0.0007240937,0.0001388496,0.1667539,0.000041755695,0.05494947,0.00037403035],"study_design_scores_gemma":[0.25445735,0.0033829778,0.36544874,0.002258755,0.026443977,0.00169094,0.0018643785,0.124372736,0.20815071,0.00074512407,0.008105703,0.0030785992],"about_ca_topic_score_codex":0.0028486908,"about_ca_topic_score_gemma":0.00042114584,"teacher_disagreement_score":0.4024154,"about_ca_system_score_codex":0.001056048,"about_ca_system_score_gemma":0.0043489393,"threshold_uncertainty_score":0.99995524},"labels":[],"label_agreement":null},{"id":"W4417018678","doi":"10.1182/blood-2025-1389","title":"Asxl1 mutant cells suppress Dnmt3a mutant clonal expansion.","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre","funders":"","keywords":"clone (Java method); Mutant; Haematopoiesis; Mutation; Stem cell; Cell; Logistic regression; Cell culture","score_opus":0.01246813572426497,"score_gpt":0.2834808857184379,"score_spread":0.2710127499941729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417018678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9734708,0.0005990405,0.00016550344,0.0026451314,0.00034601748,0.0006530658,0.00005682123,0.00016092657,0.021902679],"genre_scores_gemma":[0.987909,0.00018507289,0.001354225,0.0013565796,0.0002911439,0.000060274368,0.00004259304,0.000040269562,0.008760828],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99787694,0.00008118529,0.0003661336,0.0004906927,0.000587102,0.0005979289],"domain_scores_gemma":[0.9985877,0.00019870487,0.000050256684,0.00071894197,0.00018578426,0.00025859804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003112123,0.00023139812,0.00041622363,0.00025577855,0.0001247298,0.000039714843,0.00030097665,0.00019971734,0.0007054637],"category_scores_gemma":[0.00018677211,0.0001902499,0.0001560902,0.0004991914,0.00014022565,0.00006937445,0.0002537775,0.0005810242,0.0003504335],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029676192,0.0010699728,0.002026246,0.00023158056,0.00033758924,0.001528152,0.00021472343,0.0000045134652,0.97564906,0.00074846693,0.015169997,0.002722915],"study_design_scores_gemma":[0.0075283144,0.00025376212,0.004818549,0.00023260343,0.0003334168,0.00022557215,0.0002435288,0.00038791352,0.9420334,0.0002092654,0.04351804,0.00021559783],"about_ca_topic_score_codex":0.00008201311,"about_ca_topic_score_gemma":0.000007656551,"teacher_disagreement_score":0.03361565,"about_ca_system_score_codex":0.00014497072,"about_ca_system_score_gemma":0.0008261609,"threshold_uncertainty_score":0.7758166},"labels":[],"label_agreement":null},{"id":"W4417018713","doi":"10.1182/blood-2025-6285","title":"Initial performance of pirtobrutinib: Real-world outcomes among CLL patients after prior covalent-BTKi and BCL2i use","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada)","funders":"","keywords":"Retrospective cohort study; Chronic lymphocytic leukemia; Proportional hazards model; Cohort; Dosing; Cancer; Cohort study; Medical record; Survival analysis","score_opus":0.016122677369151454,"score_gpt":0.30544765046374334,"score_spread":0.2893249730945919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417018713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959928,0.0000809529,0.0000013668183,0.000056653098,0.00012298649,0.00060833,0.00002176837,0.000040018196,0.0030751657],"genre_scores_gemma":[0.99476576,0.00015760913,0.00020235576,0.00020301096,0.00004561509,0.000049131202,0.000018055205,0.000022650684,0.004535832],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998436,0.000044383065,0.0004203325,0.00030568722,0.00044028304,0.0003533346],"domain_scores_gemma":[0.9989078,0.0002332972,0.00008832884,0.0004526216,0.00018453544,0.00013340182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018190999,0.00017524263,0.00041138427,0.00026159917,0.000052915602,0.000024830684,0.000112143156,0.00009546213,0.000077685014],"category_scores_gemma":[0.00027411178,0.00014318553,0.00008216734,0.0002997243,0.00025091547,0.000158335,0.00021409792,0.00019705444,0.00001584371],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005277054,0.0006786274,0.9954895,0.00059119635,0.0001669546,0.000045856556,0.00016106218,4.808665e-7,0.0000356329,0.00002919378,0.00021518202,0.0020586113],"study_design_scores_gemma":[0.032746844,0.0002444307,0.9605439,0.00042491173,0.00024836522,0.0000038957537,0.00001739152,0.000297867,0.004925025,0.00000610676,0.00042707627,0.000114234084],"about_ca_topic_score_codex":0.00091810524,"about_ca_topic_score_gemma":0.00029074776,"teacher_disagreement_score":0.034945644,"about_ca_system_score_codex":0.0006738931,"about_ca_system_score_gemma":0.0013618116,"threshold_uncertainty_score":0.58389366},"labels":[],"label_agreement":null},{"id":"W4417018866","doi":"10.1182/blood-2025-6286","title":"Evaluation of real-world outcomes among CLL patients based on sequencing of BTKi and BCL2i therapies","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada)","funders":"","keywords":"Regimen; Chronic lymphocytic leukemia; Refractory (planetary science); Population; Ibrutinib; Venetoclax; Clinical trial; Dosing; Disease","score_opus":0.03675936140701149,"score_gpt":0.3451197157795975,"score_spread":0.308360354372586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417018866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98732936,0.00010942994,0.000005812439,0.000073869,0.000037550275,0.00051244406,0.000005795711,0.000013366656,0.011912374],"genre_scores_gemma":[0.999397,0.00002646921,0.00016057708,0.000066911394,0.000010635712,0.000021238311,0.00001078071,0.000009331244,0.00029707648],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99846613,0.000120038574,0.0002681586,0.00016634085,0.00084605574,0.00013328668],"domain_scores_gemma":[0.9988482,0.00028680835,0.000094887444,0.0003080937,0.0004228122,0.00003920315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009016374,0.000089133915,0.00026678928,0.00025374137,0.000023918183,0.0000047882445,0.000059419544,0.00004880227,0.00004201215],"category_scores_gemma":[0.0005775226,0.00006873065,0.000051510797,0.00024795558,0.000106283915,0.00003207419,0.000030796087,0.00007710061,0.0000010429297],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013530623,0.00068571087,0.98588043,0.0004467887,0.00030042737,0.000003450581,0.00044523343,0.000083598534,0.0014648166,0.00016261627,0.00006784813,0.010323745],"study_design_scores_gemma":[0.042760935,0.00026399104,0.90459347,0.0005764299,0.0005808032,3.4437355e-7,0.00011350893,0.018083401,0.032724556,0.00022595176,0.00001204678,0.00006458657],"about_ca_topic_score_codex":0.0016537021,"about_ca_topic_score_gemma":0.0002860213,"teacher_disagreement_score":0.08128701,"about_ca_system_score_codex":0.0016269819,"about_ca_system_score_gemma":0.0030323698,"threshold_uncertainty_score":0.5379294},"labels":[],"label_agreement":null},{"id":"W4417018929","doi":"10.1182/blood-2025-1387","title":"Prevalence and significance of cytoses in clonal hematpoiesis","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Basophilia; Cytopenia; Context (archaeology); Exome; Myelodysplastic syndromes; Cohort; Thrombocytosis; Myeloid; Exome sequencing","score_opus":0.013611903210886,"score_gpt":0.29340170006537514,"score_spread":0.2797897968544891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417018929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924284,0.0017508956,0.000020412546,0.00061614934,0.000010761175,0.00025295748,0.000007292145,0.00001328004,0.0048998436],"genre_scores_gemma":[0.99653804,0.00041795024,0.0010100213,0.00009957848,0.000016451819,0.0000252926,0.0000010504255,0.0000050022422,0.0018866104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993882,0.000026297394,0.00015414343,0.00015540257,0.00014314131,0.00013279147],"domain_scores_gemma":[0.9995619,0.00016176785,0.000023644172,0.00016758086,0.00004809522,0.000036977024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017106088,0.000057601057,0.00017127456,0.00012171652,0.000013093599,0.0000037668133,0.00006982291,0.000045012028,0.000035519563],"category_scores_gemma":[0.0002721205,0.00005053037,0.00002053715,0.0002492544,0.00011090262,0.00002810087,0.00006033663,0.00012033609,0.0000032208748],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016084914,0.00044178663,0.9061198,0.0021236232,0.0000696632,0.000066015,0.00015873417,6.913989e-7,0.087237865,0.0013568408,0.0006257625,0.0016383751],"study_design_scores_gemma":[0.00324357,0.00013538789,0.7859275,0.00054976746,0.00008676292,0.000023439341,0.000080029575,0.00004949699,0.20921464,0.0003014568,0.00032592684,0.00006203713],"about_ca_topic_score_codex":0.000054803113,"about_ca_topic_score_gemma":0.000008182921,"teacher_disagreement_score":0.121976785,"about_ca_system_score_codex":0.00002714458,"about_ca_system_score_gemma":0.00023369915,"threshold_uncertainty_score":0.20605686},"labels":[],"label_agreement":null},{"id":"W4417018938","doi":"10.1182/blood-2025-1386","title":"A pre-NGS screening strategy to identify populations with high-risk clonal hematopoiesis","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Overdiagnosis; Haematopoiesis; Population; Cohort; Myeloid; Bone marrow; Malignancy; Clinical trial; Mutation","score_opus":0.022725663312884153,"score_gpt":0.3222930530622046,"score_spread":0.29956738974932046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417018938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932398,0.00021191122,0.0026250877,0.001359681,0.000046936486,0.0007027715,0.000048997266,0.00007706609,0.0016877152],"genre_scores_gemma":[0.9807896,0.000018581584,0.017310686,0.00030554022,0.00007187027,0.00026774235,0.00006387772,0.000017375036,0.0011547544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890894,0.00003740545,0.00024029744,0.00033341735,0.00025314957,0.00022679151],"domain_scores_gemma":[0.99930817,0.00007584415,0.0000651468,0.0002824493,0.00012247721,0.00014589421],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000846574,0.00018052106,0.00031126157,0.00015834536,0.00018808397,0.000056470242,0.000060505834,0.00006201122,0.00015369472],"category_scores_gemma":[0.000063892134,0.00013466069,0.00007083925,0.0003659396,0.000025641995,0.000065755725,0.000040124996,0.00012862925,0.0000346979],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020745855,0.0012906203,0.9812043,0.00006862236,0.0007969404,0.00010116794,0.00018419864,0.00018904683,0.00037327854,0.010992748,0.0016712238,0.0029204122],"study_design_scores_gemma":[0.0040382766,0.0009365337,0.97998405,0.0003573844,0.0010649844,0.000039710394,0.0001151018,0.000024748535,0.012438335,0.0004606112,0.00040450584,0.00013574757],"about_ca_topic_score_codex":0.00066152774,"about_ca_topic_score_gemma":0.0005630743,"teacher_disagreement_score":0.014685598,"about_ca_system_score_codex":0.000028969018,"about_ca_system_score_gemma":0.000107488726,"threshold_uncertainty_score":0.5491303},"labels":[],"label_agreement":null},{"id":"W4417018940","doi":"10.1182/blood-2025-443","title":"CD19-CAR T cell therapy as a definitive consolidation in older adults with b-ALL in CR1 is safe and induces durable MRD- remission","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Fludarabine; Minimal residual disease; Chimeric antigen receptor; Tolerability; Cohort; Toxicity; Discontinuation; CAR T-cell therapy; Maintenance therapy","score_opus":0.023340242369378365,"score_gpt":0.3057704639602916,"score_spread":0.28243022159091324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417018940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96541584,0.0013460711,0.0000021983903,0.0012829206,0.000018230056,0.00088647724,0.000004149504,0.00001920861,0.031024912],"genre_scores_gemma":[0.99289423,0.0022277802,0.00015204164,0.0009723409,0.00002141464,0.000064367,0.000019829507,0.00001960095,0.0036283964],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99880147,0.00010016346,0.00022168788,0.0003547056,0.0002543647,0.00026762678],"domain_scores_gemma":[0.99937516,0.00017157031,0.000048885136,0.00022157897,0.00009839054,0.00008443439],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026707142,0.00014989366,0.00026678538,0.00031984798,0.00003477635,0.000027211818,0.00006650886,0.00013943121,0.0005986475],"category_scores_gemma":[0.000063118445,0.00011876594,0.00002630195,0.00046210198,0.00006828225,0.00007819356,0.000032261378,0.00033084519,0.000012349915],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008051482,0.0038503828,0.28200158,0.0005123462,0.00021564806,0.00043778445,0.018249985,0.000001885824,0.66261446,0.00011655384,0.00071823393,0.02322963],"study_design_scores_gemma":[0.037294537,0.0009639725,0.13988508,0.001788762,0.00004994326,0.000034969846,0.0030509362,0.000044751625,0.8146272,0.00030093003,0.0017370903,0.0002218878],"about_ca_topic_score_codex":0.0006202319,"about_ca_topic_score_gemma":0.0001669213,"teacher_disagreement_score":0.15201266,"about_ca_system_score_codex":0.000052754818,"about_ca_system_score_gemma":0.00025860715,"threshold_uncertainty_score":0.65547705},"labels":[],"label_agreement":null},{"id":"W4417018967","doi":"10.1182/blood-2025-1860","title":"Favorable safety and efficacy in a phase II trial using duvelisib maintenance after autologous stem cell transplant in T-cell and B-cell non-Hodgkin lymphomas","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Cancer Society","funders":"","keywords":"Maintenance therapy; Lymphoma; Phases of clinical research; Clinical trial; Adverse effect; Dosing; Stem cell; Safety profile","score_opus":0.009838374246912229,"score_gpt":0.2522366914532227,"score_spread":0.24239831720631047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417018967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99250674,0.0039733225,0.00002996501,0.00016859261,0.00011305901,0.001295194,0.00004919906,0.000024489014,0.0018394153],"genre_scores_gemma":[0.99771583,0.0009547027,0.00042265933,0.0001943619,0.000031787775,0.00008269054,0.00001312531,0.000020660613,0.00056420354],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983272,0.000073271796,0.0005177042,0.00052034867,0.00013985981,0.0004216037],"domain_scores_gemma":[0.9993609,0.00015049544,0.00008324447,0.0002553685,0.000022560444,0.00012743408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002352514,0.0002809254,0.00064979075,0.00023043266,0.00007730203,0.000029033967,0.000061483566,0.00016576855,0.0000133994845],"category_scores_gemma":[0.0000074171294,0.00023118481,0.00007735539,0.0002748631,0.000063063795,0.00006369416,0.000057219422,0.00012394416,0.000002803493],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23507127,0.23576409,0.3591297,0.003904401,0.00062239886,0.024449965,0.017573886,0.00014701094,0.057472177,0.00018484924,0.00040136767,0.06527889],"study_design_scores_gemma":[0.8710412,0.0033558055,0.05470221,0.0013510633,0.0008704751,0.00015005631,0.000313497,0.0013705052,0.06536159,0.00001954007,0.0010359456,0.00042812835],"about_ca_topic_score_codex":0.00045219227,"about_ca_topic_score_gemma":0.00012275706,"teacher_disagreement_score":0.63596994,"about_ca_system_score_codex":0.0001576106,"about_ca_system_score_gemma":0.00027065683,"threshold_uncertainty_score":0.94274426},"labels":[],"label_agreement":null},{"id":"W4417018998","doi":"10.1182/blood-2025-2013","title":"CSF3R-mutated chronic neutrophilic leukemia: A two-center study of 44 consecutive patients","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Leukocytosis; White blood cell; Retrospective cohort study; Medical record; Blood count; Institutional review board; Chronic lymphocytic leukemia; Myeloid; Stem cell","score_opus":0.011027947161160043,"score_gpt":0.2955251322044318,"score_spread":0.2844971850432717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417018998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916577,0.00020631432,0.0000060738503,0.00017021077,0.00010965615,0.0017551801,0.000031528507,0.0000687052,0.005994645],"genre_scores_gemma":[0.9985167,0.000034859466,0.00003440026,0.00023796243,0.0000692025,0.00008842661,0.000056330016,0.000029316456,0.0009328457],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99807334,0.00015230416,0.00045625714,0.0004324669,0.00044379072,0.0004418684],"domain_scores_gemma":[0.998686,0.00012043531,0.000110243695,0.00058672874,0.00036326237,0.00013330035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016085987,0.00021936209,0.0005137473,0.0003397044,0.000076563694,0.000013042054,0.00023117496,0.00010735651,0.00008750116],"category_scores_gemma":[0.00016454424,0.00018829636,0.00010158068,0.0006962442,0.00015324667,0.000054916563,0.00025316313,0.00050823524,0.000051602503],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001758349,0.020327395,0.93684524,0.0006073014,0.0030961034,0.00063825503,0.0027246766,0.00002838826,0.024354203,0.00021499315,0.0059674005,0.003437664],"study_design_scores_gemma":[0.25241417,0.01210617,0.67453,0.0008498418,0.0020469478,0.00007787321,0.0024649897,0.00060825225,0.052337702,0.00011771289,0.0018716406,0.00057467463],"about_ca_topic_score_codex":0.00037855117,"about_ca_topic_score_gemma":0.00008081648,"teacher_disagreement_score":0.26231524,"about_ca_system_score_codex":0.0007803181,"about_ca_system_score_gemma":0.0013261895,"threshold_uncertainty_score":0.7678503},"labels":[],"label_agreement":null},{"id":"W4417019033","doi":"10.1182/blood-2025-6789","title":"Mass spectrometry-based molecular investigation identifies key proteins involved in synergistic AXL and BCL-2 dual inhibition for Acute Myeloid Leukemia","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SignalChem (Canada); Canada's Michael Smith Genome Sciences Centre; Terry Fox Research Institute","funders":"","keywords":"Downregulation and upregulation; Myeloid leukemia; Gene knockdown; Cell culture; Venetoclax; Leukemia; Myeloid; Cytarabine; In vitro; Receptor tyrosine kinase","score_opus":0.008642149014913884,"score_gpt":0.23044568961831138,"score_spread":0.2218035406033975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417019033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871527,0.001927711,0.00950231,0.00034652822,0.0001567674,0.00072033517,0.000038775743,0.000051553823,0.0001033298],"genre_scores_gemma":[0.9974118,0.000036334437,0.0012194078,0.00012100799,0.000013616601,0.0002091768,0.00063502166,0.000013045701,0.00034062914],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99898225,0.000119735465,0.00032688925,0.00030060142,0.000036624602,0.00023389477],"domain_scores_gemma":[0.99955493,0.000075484866,0.000114397786,0.00017824408,0.00006226846,0.000014662605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023353756,0.00015938154,0.00025599322,0.00034233934,0.00012334528,0.000039943672,0.000061008745,0.00022019159,0.00001099259],"category_scores_gemma":[0.000121755096,0.0001620561,0.00006085095,0.0003075442,0.00013923977,0.00012858139,0.000033870176,0.00014551745,0.000008091686],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000833081,0.000082436556,0.0013773759,0.000087528264,0.0001657521,0.0000042834668,0.000066774206,0.000022502962,0.99403197,0.0038271244,0.00011666809,0.00013426092],"study_design_scores_gemma":[0.004474799,0.00014265972,0.011897912,0.00017556942,0.00022402381,0.0000034678756,0.00005178241,0.0001307234,0.9761379,0.0064850277,0.00011996382,0.00015622303],"about_ca_topic_score_codex":0.000066496614,"about_ca_topic_score_gemma":0.0000507894,"teacher_disagreement_score":0.017894138,"about_ca_system_score_codex":0.00009277547,"about_ca_system_score_gemma":0.00015568102,"threshold_uncertainty_score":0.6608456},"labels":[],"label_agreement":null},{"id":"W4417019045","doi":"10.1182/blood-2025-6793","title":"Curcumin and resveratrol sensitizes TP53 mutant acute myeloid leukemia (AML) cell lines to venetoclax-induced apoptosis","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Curcumin's Biomedical Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cegep de Saint Jerome","funders":"","keywords":"Venetoclax; Curcumin; Resveratrol; Apoptosis; Myeloid leukemia; Leukemia; Cell culture; Cell","score_opus":0.005374864747735158,"score_gpt":0.2420844383525985,"score_spread":0.23670957360486333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417019045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959407,0.00029773227,0.0012736691,0.00095169566,0.00009918873,0.00038030438,0.000076435375,0.000034447407,0.00094584987],"genre_scores_gemma":[0.99596053,0.00011627271,0.0015024296,0.00086374674,0.00025828843,0.00010539247,0.00011381714,0.000022041731,0.0010574528],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987819,0.000035097044,0.00024372719,0.0005253677,0.00012755397,0.0002863383],"domain_scores_gemma":[0.9991819,0.000024600015,0.000053266456,0.00047642752,0.000083479514,0.00018027444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009924601,0.00020121047,0.00019470254,0.00007656093,0.00012392587,0.000039571496,0.00020145271,0.00022033586,0.0000070167166],"category_scores_gemma":[0.000057587982,0.00019502241,0.000071916744,0.00026787163,0.00007627867,0.0000028457182,0.0002520833,0.00010893378,0.000021831967],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040536102,0.00007253363,0.00024016922,0.000024405821,0.00010560492,0.0000041050976,0.00005273862,0.0000030020208,0.9960481,0.000056726763,0.001963713,0.001388388],"study_design_scores_gemma":[0.0010391108,0.00015868036,0.0008049264,0.000019776935,0.00017513966,0.000014638624,0.00006332273,0.000027265629,0.97190726,0.000077542034,0.025506113,0.0002062538],"about_ca_topic_score_codex":0.00006533662,"about_ca_topic_score_gemma":0.000025483541,"teacher_disagreement_score":0.024140846,"about_ca_system_score_codex":0.000037313715,"about_ca_system_score_gemma":0.0002401718,"threshold_uncertainty_score":0.7952783},"labels":[],"label_agreement":null},{"id":"W4417019046","doi":"10.1182/blood-2025-3079","title":"Peripartum FXI replacement supports safe neuraxial anesthesia in FXI-deficient parturients","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Factor XI; Tranexamic acid; Fresh frozen plasma; Hypovolemia; Coagulopathy; Partial thromboplastin time; Risk factor; Pregnancy; Blood collection","score_opus":0.008564319609293247,"score_gpt":0.26117517036578464,"score_spread":0.25261085075649137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417019046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899361,0.0010556191,0.0000138380465,0.0028391974,0.00032403527,0.0005607426,0.000003576044,0.0000845491,0.0051823067],"genre_scores_gemma":[0.99214464,0.000057589623,0.00010440036,0.0012306918,0.00013203567,0.00005732181,0.000074723575,0.000020796238,0.006177815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981956,0.000050386643,0.0005044879,0.000468374,0.0003490529,0.00043210102],"domain_scores_gemma":[0.9991729,0.00004928648,0.00009485176,0.0004741911,0.000064935106,0.0001438343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000281374,0.0002187729,0.00036832792,0.00020782821,0.00009950931,0.00003392425,0.0001010243,0.00010861952,0.00033815354],"category_scores_gemma":[0.00008500845,0.0002038256,0.00013096155,0.0003639195,0.00006284737,0.000068884874,0.00005048559,0.00014041066,0.000047176443],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049662986,0.0028858013,0.9798727,0.00018567232,0.00010153073,0.00081054674,0.0011912511,0.000024534644,0.0010729557,0.0022245136,0.0086682085,0.0024656476],"study_design_scores_gemma":[0.007329846,0.00060966803,0.87026525,0.00043917703,0.000368789,0.00036798712,0.0003398837,0.00032341902,0.01715921,0.00024308974,0.10217343,0.0003802271],"about_ca_topic_score_codex":0.00008958661,"about_ca_topic_score_gemma":0.000035233414,"teacher_disagreement_score":0.10960744,"about_ca_system_score_codex":0.00005522236,"about_ca_system_score_gemma":0.00025323886,"threshold_uncertainty_score":0.8311767},"labels":[],"label_agreement":null},{"id":"W4417019060","doi":"10.1182/blood-2025-4284","title":"Risk factor analysis of relapse risk during FLT3-inhibitor post-transplant maintenance therapy following allogeneic hematopoietic stem cell transplantation in Acute Myeloid Leukemia with FLT3-ITD","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; Université Laval; Princess Margaret Cancer Centre","funders":"","keywords":"Cumulative incidence; Sorafenib; Clinical endpoint; Hematopoietic stem cell transplantation; Transplantation; Incidence (geometry); Maintenance therapy; Myeloid leukemia; Multivariate analysis","score_opus":0.006184717852742649,"score_gpt":0.23821660759694768,"score_spread":0.23203188974420502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417019060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959021,0.0011054329,0.0007861039,0.0001292067,0.000078388744,0.001060375,0.00061335694,0.000098467084,0.00022657138],"genre_scores_gemma":[0.99090296,0.007301429,0.00079906743,0.00006506166,0.0000340374,0.00009118848,0.0001442664,0.0000664284,0.0005955495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965448,0.00030534543,0.00087511743,0.00080007507,0.0007341753,0.0007404789],"domain_scores_gemma":[0.9982205,0.00030959872,0.00032533106,0.00075747963,0.00018938298,0.00019771098],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00050401036,0.00046694168,0.0011550054,0.0012874899,0.00016663592,0.000033370663,0.0003406836,0.00028941085,0.000040833515],"category_scores_gemma":[0.00002534396,0.00036512475,0.0005577879,0.002349191,0.00010488665,0.00017166935,0.000035065677,0.0008688843,0.000011739272],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035452389,0.00047981704,0.6950773,0.000548904,0.006481028,0.0014418487,0.004600393,0.000528624,0.28649905,0.00000941305,0.000008936098,0.0007794592],"study_design_scores_gemma":[0.015669156,0.0003677508,0.5810085,0.00063280016,0.007753355,0.00006648125,0.0006616479,0.00028365012,0.39320272,0.0000066444845,0.000011771828,0.00033556143],"about_ca_topic_score_codex":0.0008987311,"about_ca_topic_score_gemma":0.0006817457,"teacher_disagreement_score":0.11406882,"about_ca_system_score_codex":0.0004831034,"about_ca_system_score_gemma":0.0007060145,"threshold_uncertainty_score":0.9998801},"labels":[],"label_agreement":null},{"id":"W4417019114","doi":"10.1182/blood-2025-3118","title":"Antithrombin deficiency, venous thromboembolism risk, and peripartum antithrombin supplementation: A real-world analysis of delivery encounters from 2015–2024","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Comorbidity; Retrospective cohort study; Venous thromboembolism; Population; Antithrombin; Cohort; Pregnancy; Cohort study; Pulmonary embolism","score_opus":0.013340754343561492,"score_gpt":0.2919911108081794,"score_spread":0.27865035646461794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417019114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926863,0.0010469912,0.0006602733,0.00032046498,0.00041053613,0.0004345096,0.00030151114,0.00007742362,0.0040620365],"genre_scores_gemma":[0.9951382,0.001537196,0.0021954495,0.0002768557,0.000044258522,0.000020841208,0.0002845453,0.00002231464,0.00048030805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99795204,0.00011755841,0.0006262367,0.0005702679,0.00042439933,0.000309501],"domain_scores_gemma":[0.99875504,0.00013194737,0.00026638407,0.0005409944,0.0001794819,0.00012617696],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003048662,0.00026782684,0.0010476985,0.00093836477,0.00017883313,0.00005414041,0.00014741493,0.000118824835,0.0009511879],"category_scores_gemma":[0.000039447677,0.0002624944,0.00024562047,0.0019119412,0.00017497971,0.00014321762,0.0001066931,0.00020609803,0.000013037137],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019148023,0.0068100225,0.8553475,0.0003503393,0.01259462,0.0000613206,0.0036178434,0.000079760284,0.10218367,0.01273643,0.0042430228,0.0017839881],"study_design_scores_gemma":[0.0053112586,0.00047506965,0.92798316,0.00023398046,0.021763809,0.0000048328607,0.0013269242,0.0014064388,0.039688323,0.0011728798,0.00033105921,0.00030228446],"about_ca_topic_score_codex":0.0051027434,"about_ca_topic_score_gemma":0.0023681335,"teacher_disagreement_score":0.072635636,"about_ca_system_score_codex":0.000043626595,"about_ca_system_score_gemma":0.00018202233,"threshold_uncertainty_score":0.9999827},"labels":[],"label_agreement":null},{"id":"W4417019141","doi":"10.1182/blood-2025-6808","title":"Inhibition of telomerase and ALT pathways in MDS/AML cell lines","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Telomerase; Telomere; Cancer cell; Viability assay; Cell growth; Cell culture; Programmed cell death; Cell","score_opus":0.011793465069355838,"score_gpt":0.23821131433171266,"score_spread":0.22641784926235684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417019141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933124,0.002142392,0.000019402833,0.00030540317,0.000067941946,0.00023472548,0.000014822922,0.000036368678,0.0038665107],"genre_scores_gemma":[0.99799705,0.000572726,0.00055415585,0.00034026243,0.000056145174,0.000011599956,0.000019712545,0.000010162979,0.00043821504],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991296,0.000028217095,0.00030680143,0.00022763503,0.0001313226,0.00017645792],"domain_scores_gemma":[0.9995319,0.000067210145,0.000060106886,0.00020520457,0.00006494234,0.00007060951],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012889109,0.00012125594,0.00028705856,0.00026171116,0.00002857808,0.000007437886,0.000038571412,0.000092321075,0.000027086291],"category_scores_gemma":[0.00009354647,0.00010991649,0.000042139396,0.0003690735,0.000073094314,0.000052867632,0.000037669648,0.00013439382,0.0000059191975],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016722867,0.0020507101,0.21118692,0.0012017477,0.000037905877,0.00022377582,0.0011117944,0.0000016539135,0.76997393,0.00051254145,0.00054420956,0.012987576],"study_design_scores_gemma":[0.0057898643,0.00022372566,0.13209435,0.00057611504,0.00011710785,0.00002310795,0.00041500878,0.000046349298,0.8593441,0.00038461378,0.0008385611,0.00014705987],"about_ca_topic_score_codex":0.00012234008,"about_ca_topic_score_gemma":0.000057462537,"teacher_disagreement_score":0.08937018,"about_ca_system_score_codex":0.00001127111,"about_ca_system_score_gemma":0.000099771605,"threshold_uncertainty_score":0.44822642},"labels":[],"label_agreement":null},{"id":"W4417019190","doi":"10.1182/blood-2025-3330","title":"Mixed phenotype acute leukemia: Clinical characteristics and real-world outcomes","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Retrospective cohort study; Myeloid; Surrogate endpoint; White blood cell; Bristol-Myers; Disease; Clinical trial","score_opus":0.032126018793984315,"score_gpt":0.35222214458584344,"score_spread":0.32009612579185914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417019190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9781188,0.00008357406,0.00017485922,0.002082968,0.00042519943,0.0003812947,0.000032716634,0.0001266748,0.018573966],"genre_scores_gemma":[0.97092104,0.000688489,0.002732263,0.001711695,0.00030114438,0.00002651939,0.00005518247,0.000034994093,0.023528691],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982468,0.0000807238,0.00055721676,0.00041771107,0.00030890387,0.00038863902],"domain_scores_gemma":[0.9983286,0.0006697864,0.000088238776,0.0005253904,0.00014280528,0.00024515693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040912905,0.00020316106,0.0006629841,0.00019962508,0.00008806876,0.00003759779,0.00015979237,0.0001965069,0.00006175329],"category_scores_gemma":[0.0006945624,0.0001606402,0.00011997386,0.0003462783,0.00022389869,0.00004857506,0.00025035383,0.0004431548,0.000092462295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003967556,0.0005577747,0.968104,0.00018471328,0.0013924135,0.0005739013,0.000049226277,3.8047382e-8,0.0011186857,0.0037767082,0.01181008,0.012035693],"study_design_scores_gemma":[0.009682379,0.00020763722,0.9812298,0.00011801424,0.0012231531,0.000034704884,0.000021821106,0.00018805063,0.00074686273,0.00022846293,0.006168163,0.00015096359],"about_ca_topic_score_codex":0.00014656138,"about_ca_topic_score_gemma":0.00005331073,"teacher_disagreement_score":0.013125778,"about_ca_system_score_codex":0.00023701011,"about_ca_system_score_gemma":0.0012803312,"threshold_uncertainty_score":0.6550717},"labels":[],"label_agreement":null},{"id":"W4417019203","doi":"10.1182/blood-2025-351","title":"Circulating tumor DNA analyses of molecular tumor burden are superior to PET-assessed responses in patients with advanced stage classic Hodgkin lymphoma treated on SWOG S1826","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Somatic hypermutation; Circulating tumor DNA; Germline; Circulating tumor cell; Stage (stratigraphy); Digital polymerase chain reaction; Lymphoma; Nivolumab; Hodgkin lymphoma","score_opus":0.0136591892245383,"score_gpt":0.28789300236431237,"score_spread":0.2742338131397741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417019203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979577,0.00016581692,0.000003741381,0.0001782521,0.00002716673,0.0010572356,0.00008977392,0.000058246627,0.0004620415],"genre_scores_gemma":[0.9986442,0.000004306981,0.0006036253,0.00032285287,0.0000124307,0.00019268534,0.000057923422,0.000038683353,0.00012332258],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980636,0.00013234731,0.00048075223,0.0005413891,0.00042736626,0.0003545166],"domain_scores_gemma":[0.99872315,0.00020081713,0.00019297247,0.0005501576,0.00018998446,0.00014293952],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000087597975,0.00033252838,0.0007527973,0.0005228967,0.000059399346,0.00002753485,0.00011657641,0.000040125113,0.000027138938],"category_scores_gemma":[0.00033547965,0.00025406125,0.00012808817,0.0009210613,0.000044183475,0.00006387518,0.000050124083,0.00005998323,0.000007237565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028537195,0.005089839,0.9148373,0.00018333641,0.0005168024,0.003437042,0.00014601406,0.00021147208,0.070515305,0.000027432183,0.0000086004975,0.0021731546],"study_design_scores_gemma":[0.019584186,0.0014911362,0.71716,0.0012259412,0.00042810527,0.000009868486,0.000266635,0.000020845575,0.25961444,0.0000020260575,0.000028742572,0.00016806085],"about_ca_topic_score_codex":0.00031681717,"about_ca_topic_score_gemma":0.00005018793,"teacher_disagreement_score":0.19767727,"about_ca_system_score_codex":0.00027339198,"about_ca_system_score_gemma":0.0003102665,"threshold_uncertainty_score":0.9999912},"labels":[],"label_agreement":null},{"id":"W4417019206","doi":"10.1182/blood-2025-3332","title":"Severe toxicities in survivors of pediatric and adolescent acute lymphoblastic lymphoma: A population-based study in Ontario, Canada","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research; Occupational Cancer Research Centre; Hospital for Sick Children","funders":"","keywords":"Incidence (geometry); Hazard ratio; Emergency department; Pediatric cancer; Cumulative incidence; Population; Health care; Proxy (statistics); Childhood cancer; Heart failure","score_opus":0.00912411932315417,"score_gpt":0.2430897919791872,"score_spread":0.23396567265603302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417019206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985444,0.00015198906,0.000009686018,0.00010401586,0.000086750166,0.00078610354,0.000017643013,0.000013459509,0.00028598728],"genre_scores_gemma":[0.99920946,0.000009354399,0.00007338064,0.00017260142,0.000022600681,0.000043210308,0.000020232643,0.000015815987,0.0004333145],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982308,0.00009318234,0.0005036017,0.00033275053,0.0004931743,0.00034645715],"domain_scores_gemma":[0.99914503,0.00032038838,0.00007515367,0.00027417677,0.000081438004,0.000103814156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021066483,0.00019066919,0.00048000796,0.00055130455,0.000033296223,0.000011305977,0.000121411176,0.00008755595,0.000031309315],"category_scores_gemma":[0.00018147532,0.0001800952,0.00003261982,0.00073562417,0.000027102245,0.000039933144,0.00008855197,0.00014702375,5.844224e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033272625,0.0016817381,0.9965572,0.00026394828,0.00008497986,0.0004113328,0.0002590621,0.00011512627,0.000028430224,0.000009750967,0.00014197204,0.00011375299],"study_design_scores_gemma":[0.019589351,0.000215314,0.9784364,0.00019433913,0.0002719757,0.000013965419,0.00050462905,0.00048883626,0.0001258581,0.000016663173,0.000007946862,0.00013468401],"about_ca_topic_score_codex":0.971408,"about_ca_topic_score_gemma":0.9959306,"teacher_disagreement_score":0.024522599,"about_ca_system_score_codex":0.002524832,"about_ca_system_score_gemma":0.009561011,"threshold_uncertainty_score":0.9960539},"labels":[],"label_agreement":null},{"id":"W4417019216","doi":"10.1182/blood-2025-352","title":"Novel immune gene expression signature risk-stratifies Mantle Cell Lymphoma outcomes independent of TP53 status","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Mantle cell lymphoma; Gene signature; Proportional hazards model; Hazard ratio; Lymphoma; Gene; Cancer; Gene expression profiling; DNA sequencing","score_opus":0.007545335341883648,"score_gpt":0.24144168625415277,"score_spread":0.23389635091226912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417019216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887604,0.006154192,0.00006847157,0.00013740185,0.00019139975,0.00040860893,0.00014515729,0.000044638466,0.004089737],"genre_scores_gemma":[0.99469656,0.0006162472,0.0028346577,0.00009290397,0.000028275617,0.000053382282,0.000066773464,0.000016189295,0.0015949996],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99873656,0.000028462679,0.0003717674,0.00029253575,0.00030419236,0.00026645485],"domain_scores_gemma":[0.9990548,0.00011625956,0.00018560431,0.0004674993,0.00008417957,0.000091660404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008266422,0.00021516094,0.00045219186,0.00012236107,0.00007786351,0.000017455934,0.00010044745,0.00016753715,0.00006914389],"category_scores_gemma":[0.00004849824,0.00015180698,0.00018998688,0.00014196146,0.000040949075,0.000046775673,0.0000910084,0.00008748882,0.000013405563],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013045006,0.010140345,0.5883404,0.00017809449,0.00047367535,0.00007957037,0.00026855688,0.0000064346164,0.3972715,0.00012340526,0.00040238677,0.0025851803],"study_design_scores_gemma":[0.010163578,0.000121467216,0.44093224,0.00010504523,0.00042445093,0.000006531757,0.00012870955,0.000003234256,0.5477501,0.000033632725,0.00025990064,0.00007110821],"about_ca_topic_score_codex":0.0003228073,"about_ca_topic_score_gemma":0.00001858707,"teacher_disagreement_score":0.15047859,"about_ca_system_score_codex":0.00006613463,"about_ca_system_score_gemma":0.00020308905,"threshold_uncertainty_score":0.61905086},"labels":[],"label_agreement":null},{"id":"W4417019252","doi":"10.1182/blood-2025-2742","title":"Feasibility of collecting social determinants of health data in the frontline pediatric acute lymphoblastic leukemia (ALL) trial AALL1731: A report from the Children's oncology group","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute of Cancer Research; SickKids Foundation","funders":"","keywords":"Neurocognitive; Clinical trial; Proxy (statistics); Meta-analysis; Cog; Distress; MEDLINE; Lymphoblastic Leukemia; Pediatric cancer","score_opus":0.0793264659031629,"score_gpt":0.4020699858665053,"score_spread":0.3227435199633424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417019252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928841,0.0010024363,0.000075923366,0.0030566936,0.0004492382,0.0019970157,0.00036858013,0.000026037138,0.00013999673],"genre_scores_gemma":[0.9967737,0.00010373311,0.0006115947,0.0012002008,0.0009456158,0.0000356337,0.00029082852,0.000017702276,0.000020946596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99520546,0.0012636879,0.0019221844,0.0006254615,0.00062480464,0.00035838655],"domain_scores_gemma":[0.9949982,0.0021351,0.0012753431,0.00144821,0.00008837155,0.000054769203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005883892,0.00021706446,0.0011922022,0.000117872616,0.00016735829,0.000013566906,0.00084852823,0.00018479062,0.000012970344],"category_scores_gemma":[0.0031244063,0.00014830638,0.00017454011,0.0007330375,0.00016655831,0.0000672176,0.00040028244,0.00041320815,8.3025355e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007717999,0.0031522415,0.9770096,0.00022726144,0.0005304053,0.00007879443,0.0054730107,6.772027e-7,0.00006544638,0.000019300262,0.0034602943,0.0022649586],"study_design_scores_gemma":[0.06098017,0.00082309823,0.9349612,0.00013960562,0.0014743191,0.000081119906,0.00094607286,0.000040049326,0.000062514686,0.00026767052,0.00010131664,0.00012286675],"about_ca_topic_score_codex":0.015417189,"about_ca_topic_score_gemma":0.012086589,"teacher_disagreement_score":0.05326217,"about_ca_system_score_codex":0.00034872876,"about_ca_system_score_gemma":0.0040153,"threshold_uncertainty_score":0.99113923},"labels":[],"label_agreement":null},{"id":"W4417019321","doi":"10.1182/blood-2025-343","title":"Validation of measurable residual disease as a surrogate endpoint in acute myeloid leukemia: A HARMONY Alliance study of European randomized trials","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Surrogate endpoint; Clinical endpoint; Clinical trial; Minimal residual disease; Myeloid leukemia; Randomization; Randomized controlled trial; Disease; Cytarabine","score_opus":0.04702181082971312,"score_gpt":0.3392658178401871,"score_spread":0.292244007010474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417019321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904219,0.0008547771,0.000046036905,0.0008330848,0.00006734055,0.0039669033,0.000044161487,0.000045563418,0.003720258],"genre_scores_gemma":[0.9967476,0.0005948571,0.00034362343,0.0000988704,0.0000612959,0.00019057372,0.00004812916,0.000035588975,0.001879423],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99258834,0.004000773,0.0017193783,0.00049780315,0.0008293115,0.00036437993],"domain_scores_gemma":[0.9967261,0.0014533899,0.00050674815,0.00073126046,0.0004009677,0.00018152135],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.010690735,0.0002492165,0.0019704183,0.00041952395,0.000046607107,0.0000223244,0.0003132104,0.00007575292,0.00007738009],"category_scores_gemma":[0.010850158,0.000201279,0.00029270194,0.0008104733,0.0001576899,0.000114732145,0.00018570214,0.00040318663,0.000022369619],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.65044814,0.012362914,0.03181522,0.0017724645,0.008166672,0.0027601642,0.0053762533,0.00033674532,0.28057095,0.00063152914,0.0033303602,0.002428613],"study_design_scores_gemma":[0.68302935,0.0007530878,0.03373615,0.0008760461,0.004371137,0.0000106179405,0.00084883,0.00016627209,0.2754672,0.0003923032,0.000113334645,0.00023569896],"about_ca_topic_score_codex":0.00052843365,"about_ca_topic_score_gemma":0.000023655744,"teacher_disagreement_score":0.03258121,"about_ca_system_score_codex":0.0002328108,"about_ca_system_score_gemma":0.0014744711,"threshold_uncertainty_score":0.9974819},"labels":[],"label_agreement":null},{"id":"W4417019334","doi":"10.1182/blood-2025-784","title":"Real-world outcomes of frontline polatuzumab-rchp and impact of frailty in older adults with diffuse large B-cell lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Clinical endpoint; Diffuse large B-cell lymphoma; Clinical trial; Retrospective cohort study; Geriatric oncology; Surrogate endpoint; Activities of daily living; Survival analysis; Subgroup analysis","score_opus":0.006616230252781837,"score_gpt":0.27263158721558056,"score_spread":0.2660153569627987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417019334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955024,0.0012774493,0.0000022189772,0.00011264828,0.00001864346,0.00044304435,0.000082984734,0.000017159982,0.0025434413],"genre_scores_gemma":[0.9986896,0.0002884261,0.00032854613,0.000060536368,0.000010195089,0.000026084466,0.000032506887,0.0000148504105,0.00054923724],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990478,0.000025366386,0.00032325287,0.00023293817,0.00016030717,0.00021032],"domain_scores_gemma":[0.9992837,0.00011986464,0.00011596076,0.0003337638,0.000060014525,0.00008673722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000058291964,0.00018583718,0.0006033899,0.000240098,0.000018212617,0.0000048815027,0.00005405513,0.00006540913,0.000024392479],"category_scores_gemma":[0.000027642429,0.00011563113,0.00011540642,0.00026384168,0.00004626936,0.000038334172,0.000047121852,0.000043198128,0.0000012017646],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047558185,0.023058947,0.9736276,0.00019730125,0.00040867363,0.00006467973,0.0004941974,2.9192435e-7,0.00020578963,0.00011031315,0.00012271905,0.0012338797],"study_design_scores_gemma":[0.09519089,0.000546766,0.89575636,0.00051317684,0.00038646595,0.0000042905904,0.00012409086,0.000027667653,0.0073302267,0.000014960755,0.000023964449,0.00008112681],"about_ca_topic_score_codex":0.0048770313,"about_ca_topic_score_gemma":0.0016836092,"teacher_disagreement_score":0.094715305,"about_ca_system_score_codex":0.00009325302,"about_ca_system_score_gemma":0.00019959852,"threshold_uncertainty_score":0.7372645},"labels":[],"label_agreement":null},{"id":"W4417019353","doi":"10.1182/blood-2025-789","title":"Luspatercept initiated at the maximum-approved dose in transfusion-dependent lower-risk myelodysplastic syndromes: Interim analysis from maxilus","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Interim analysis; Cohort; Anemia; Clinical endpoint; Myelodysplastic syndromes; Population; Discontinuation; Hemoglobin","score_opus":0.022150532401733404,"score_gpt":0.29191408717674594,"score_spread":0.2697635547750125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417019353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99202126,0.00053527625,0.0008755202,0.0014808966,0.00020938193,0.0009657925,0.00021202196,0.000110940426,0.003588924],"genre_scores_gemma":[0.9956658,0.00090942974,0.00019808431,0.00044552327,0.00005498821,0.00014830595,0.00027500343,0.00004385381,0.0022590111],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969473,0.00037926572,0.0006246896,0.0008015759,0.00061861856,0.00062858616],"domain_scores_gemma":[0.99789053,0.0005809891,0.000115185256,0.0010892843,0.00012701226,0.00019696752],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005749385,0.00037447416,0.0008065796,0.00085560593,0.00018130115,0.00006726676,0.0005089287,0.00028399535,0.0022670683],"category_scores_gemma":[0.00039395082,0.00026185095,0.00034975223,0.0022153645,0.00020278807,0.00008233308,0.00039465123,0.0009696735,0.0002822725],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014110932,0.010600218,0.6826328,0.00077088695,0.032564588,0.014373498,0.011228665,0.0008397164,0.18272507,0.00008300429,0.0041367146,0.045933913],"study_design_scores_gemma":[0.042037304,0.0013453732,0.8945371,0.00085157703,0.016013088,0.00023371956,0.003052738,0.008934316,0.02939881,0.00089927996,0.0017194856,0.0009771904],"about_ca_topic_score_codex":0.0051756143,"about_ca_topic_score_gemma":0.006709065,"teacher_disagreement_score":0.21190432,"about_ca_system_score_codex":0.00055824313,"about_ca_system_score_gemma":0.00037568138,"threshold_uncertainty_score":0.9999834},"labels":[],"label_agreement":null},{"id":"W4417019424","doi":"10.1182/blood-2025-353","title":"Integrated multi-omic profiling reveals two biologically distinct subgroups of splenic marginal zone lymphoma with prognostic relevance","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"","keywords":"Splenic marginal zone lymphoma; Malignancy; Epigenetics; DNA methylation; CDKN2A; CpG site; Proportional hazards model; Cohort; Survival analysis","score_opus":0.015311901334553112,"score_gpt":0.26673766939455806,"score_spread":0.25142576806000494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417019424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956948,0.0016682791,0.0005124759,0.0002465604,0.000054259315,0.0010962556,0.00004846881,0.00010110083,0.00057776505],"genre_scores_gemma":[0.9790595,0.00011144752,0.019818462,0.00011259903,0.00003480339,0.00022935451,0.000129511,0.000018661567,0.00048563658],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985508,0.00006826825,0.00043141254,0.00044787154,0.00017728982,0.0003243941],"domain_scores_gemma":[0.9988704,0.00029959064,0.00016868138,0.0003663258,0.00019830588,0.000096711185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001604852,0.00026435076,0.0005700316,0.000108476255,0.00006366792,0.000015225975,0.00012087772,0.00008866471,0.000026430627],"category_scores_gemma":[0.00037156444,0.00016224952,0.000107898544,0.00042797517,0.00012589582,0.00003588462,0.00005330208,0.00008314349,0.000016825144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006620682,0.004781377,0.9716629,0.00026186506,0.00046212407,0.00030167302,0.000028175979,0.0000018709012,0.012997997,0.0008332308,0.000039064613,0.007967669],"study_design_scores_gemma":[0.021521455,0.0014231371,0.9243156,0.0014995026,0.0010457512,0.00016353943,0.000052336116,0.00017525758,0.049377564,0.00006594608,0.00017288172,0.00018705733],"about_ca_topic_score_codex":0.00013276712,"about_ca_topic_score_gemma":0.00006532643,"teacher_disagreement_score":0.04734731,"about_ca_system_score_codex":0.00011324907,"about_ca_system_score_gemma":0.00028913186,"threshold_uncertainty_score":0.6616343},"labels":[],"label_agreement":null},{"id":"W4417019432","doi":"10.1182/blood-2025-3552","title":"Multimodal single-cell and spatial analyses reveal a distinct immune ecosystem in pediatric classic Hodgkin lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children; Princess Margaret Cancer Centre; Spinal Cord Injury BC; University Health Network","funders":"","keywords":"Immune system; Lymphoma; Transcriptome; Population; Nodular sclerosis; Hodgkin lymphoma; Gene expression","score_opus":0.013600290981729631,"score_gpt":0.23950089930797058,"score_spread":0.22590060832624095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417019432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99410605,0.0028301172,0.0011666833,0.000039377286,0.00019888132,0.00019042077,0.00003277243,0.000017970406,0.001417695],"genre_scores_gemma":[0.99883074,0.00014370191,0.00033423858,0.000040951098,0.00022807617,0.000017915328,0.00007431552,0.00002009055,0.00030999145],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99874645,0.000097159034,0.0003608768,0.00042927347,0.00009380964,0.00027240964],"domain_scores_gemma":[0.9995122,0.000030869993,0.00008594452,0.00026842393,0.000040872812,0.000061701474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013331261,0.00020968483,0.00026877693,0.0001291129,0.00006989033,0.000043587374,0.00016565542,0.0002000085,0.00000386433],"category_scores_gemma":[0.00005468962,0.0002042135,0.00010462964,0.00020015794,0.00003757172,0.000003930417,0.00008865201,0.00007890957,0.0000028672375],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014144326,0.0011089765,0.19159362,0.0001817339,0.000055489087,0.00002103381,0.000039432158,0.000015067355,0.80136156,0.000004800685,0.000057584475,0.0054192655],"study_design_scores_gemma":[0.011298469,0.00053029077,0.27090782,0.00007847787,0.00040513082,0.00002298265,0.000061017243,0.0011195403,0.7137307,0.000039801238,0.0012210521,0.00058475626],"about_ca_topic_score_codex":0.00040073093,"about_ca_topic_score_gemma":0.0014020881,"teacher_disagreement_score":0.0876309,"about_ca_system_score_codex":0.000019036412,"about_ca_system_score_gemma":0.000098307275,"threshold_uncertainty_score":0.8327585},"labels":[],"label_agreement":null},{"id":"W4417019462","doi":"10.1182/blood-2025-3559","title":"Spatial profiling of the bone marrow microenvironment in patients with IgM gammopathies reveals a T cell–Enriched tumor niche associated with asymptomatic waldenstrom macroglobulinemia progression","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Integrity Testing Laboratory (Canada)","funders":"","keywords":"Waldenstrom macroglobulinemia; Monoclonal gammopathy of undetermined significance; Multiple myeloma; Bone marrow; Asymptomatic; Macroglobulinemia; Immunoglobulin M; Monoclonal","score_opus":0.004096862065782521,"score_gpt":0.22378071027191812,"score_spread":0.2196838482061356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417019462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99673706,0.00035196322,0.000014601,0.00017934208,0.00003716755,0.0023406353,0.000019168534,0.000035483423,0.0002845931],"genre_scores_gemma":[0.9975744,0.000008594327,0.0017130906,0.00008721187,0.000020137019,0.00014621684,0.000047227786,0.00003800649,0.00036513983],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973108,0.00020275256,0.00057724863,0.00042908062,0.0009698386,0.0005102492],"domain_scores_gemma":[0.99863166,0.00014842063,0.00035860037,0.0006227511,0.00014505725,0.00009349063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043972133,0.0002732002,0.0005717155,0.00014597343,0.0000790087,0.000023339482,0.00023315006,0.00012072593,0.000021594402],"category_scores_gemma":[0.00034698818,0.00015807307,0.00007733833,0.00061527075,0.00024032593,0.0000521267,0.00021731248,0.00039529457,0.0000036666065],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012071426,0.0037791254,0.9645076,0.0009765444,0.00020734794,0.00014334307,0.0003007695,0.00002216497,0.028229995,0.0000037923596,0.000074744836,0.000547461],"study_design_scores_gemma":[0.0784837,0.0010534249,0.75928205,0.004757959,0.0005745468,0.00003347702,0.00016833328,0.0008047087,0.15458028,0.000022478152,0.000005557949,0.00023350702],"about_ca_topic_score_codex":0.00011063723,"about_ca_topic_score_gemma":0.00005598142,"teacher_disagreement_score":0.20522554,"about_ca_system_score_codex":0.0024069515,"about_ca_system_score_gemma":0.0020876469,"threshold_uncertainty_score":0.64460325},"labels":[],"label_agreement":null},{"id":"W4417019469","doi":"10.1182/blood-2025-1288","title":"Concizumab efficacy in patients with Hemophilia A/B without inhibitors from the Phase 3 explorer8 study: A post-hoc sensitivity analysis for the intra-patient comparison of concizumab with previous prophylaxis","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster Children's Hospital","funders":"","keywords":"Confidence interval; Antibody; Phases of clinical research; Pooled analysis; Incidence (geometry); Monoclonal antibody; Monoclonal","score_opus":0.019505544576688426,"score_gpt":0.312663162758121,"score_spread":0.2931576181814326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417019469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912531,0.00040817578,0.000060677954,0.0005466394,0.00004428915,0.0074806684,0.00014233557,0.000034122324,0.000030035984],"genre_scores_gemma":[0.99909043,0.000007862222,0.00020072934,0.00007255791,0.00004554277,0.0003531879,0.00016912598,0.000028844044,0.00003170447],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974124,0.0002909118,0.0005794677,0.00054784195,0.0007844885,0.00038491236],"domain_scores_gemma":[0.9971187,0.0011033681,0.00023511091,0.00083295477,0.00060464157,0.000105193176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037190015,0.0003338357,0.0009771753,0.00023870001,0.00021075965,0.000037909977,0.00017202066,0.00009298031,0.000012250963],"category_scores_gemma":[0.00028114635,0.0001489011,0.00018153497,0.0013280428,0.00033874463,0.000064830965,0.00009059472,0.00036828042,0.0000018231128],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0141312,0.020693008,0.93520164,0.00006717856,0.005080185,0.00004029585,0.0077598183,0.00006953812,0.00022255037,0.0000035379173,0.000031032683,0.016699998],"study_design_scores_gemma":[0.078090005,0.030621901,0.86507297,0.00039094783,0.0071002976,0.0000021391359,0.0062395493,0.00047298134,0.01168463,0.0000038943617,0.00006132976,0.00025939013],"about_ca_topic_score_codex":0.00062041957,"about_ca_topic_score_gemma":0.0012890534,"teacher_disagreement_score":0.070128724,"about_ca_system_score_codex":0.00011049894,"about_ca_system_score_gemma":0.00036953643,"threshold_uncertainty_score":0.6072011},"labels":[],"label_agreement":null},{"id":"W4417019505","doi":"10.1182/blood-2025-1289","title":"Cost comparison of prophylactic vs. on-demand use of a 1:1 ratio pdVWF/FVIII concentrate in type 3 von willebrand disease with severe bleeding phenotype in the United States: A payer and societal perspective","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Von Willebrand disease; Population; Von Willebrand factor; Bleed; Indirect costs; Prophylactic treatment; Breakthrough bleeding; Hemarthrosis; Health care","score_opus":0.026689689022365685,"score_gpt":0.29652156909495053,"score_spread":0.26983188007258485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417019505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979569,0.0006268459,0.000009074833,0.00034492908,0.000011299133,0.0008077542,0.000022909186,0.0000054110974,0.00021490383],"genre_scores_gemma":[0.99958664,0.00012281812,0.000036415237,0.00016457782,0.0000037534528,0.000016127708,0.000033221237,0.0000073043375,0.00002911432],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993293,0.00005878111,0.00017675296,0.00016505082,0.00013857654,0.00013148942],"domain_scores_gemma":[0.99952763,0.00013913924,0.000081701095,0.00011108707,0.00010325817,0.000037154914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000668022,0.000116865645,0.00031334467,0.00010064488,0.000032179967,0.000015372869,0.00003370955,0.00003499715,0.0000047909525],"category_scores_gemma":[0.00006764321,0.0000716682,0.00002201662,0.0004627929,0.00010237227,0.00006494528,0.0000119997,0.00013093224,4.03657e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005215387,0.0032754403,0.97545505,0.00029667674,0.00036667607,0.00016604413,0.013924185,0.0003979694,0.00023383956,0.0004994343,0.00005514729,0.00011417297],"study_design_scores_gemma":[0.054047823,0.0032852064,0.8860847,0.001915503,0.0018424785,0.000022519072,0.037475437,0.012283063,0.0019014903,0.0006873999,0.00010658851,0.00034783388],"about_ca_topic_score_codex":0.00031093654,"about_ca_topic_score_gemma":0.00012547408,"teacher_disagreement_score":0.08937037,"about_ca_system_score_codex":0.000034231325,"about_ca_system_score_gemma":0.0001344754,"threshold_uncertainty_score":0.29225442},"labels":[],"label_agreement":null},{"id":"W4417019591","doi":"10.1182/blood-2025-3567","title":"Single-cell metabolic profiling of T cells identifies a fitness signature associated with early CAR T failure in large B cell lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada; Princess Margaret Cancer Centre","funders":"","keywords":"Metabolic pathway; Peripheral blood mononuclear cell; Pentose phosphate pathway; Citric acid cycle; Metabolism; T cell; Leukapheresis; Glycolysis; Lymphoma","score_opus":0.010410907551201793,"score_gpt":0.24733133903413448,"score_spread":0.23692043148293268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417019591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99161935,0.00239254,0.000019225174,0.000084537925,0.00008135619,0.0008941748,0.000055489512,0.000062212435,0.004791119],"genre_scores_gemma":[0.9857123,0.000044130644,0.0002611998,0.00006527292,0.000044391974,0.000045831057,0.000048800495,0.000048632082,0.013729446],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979134,0.00016654826,0.00038657288,0.00041810394,0.00057006575,0.00054531224],"domain_scores_gemma":[0.9987922,0.0001896143,0.00014585277,0.0004532468,0.0003230697,0.00009604529],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048389472,0.00024920344,0.00065361935,0.00044385428,0.00005716443,0.000044466862,0.0002314605,0.00025357786,0.00015277148],"category_scores_gemma":[0.00009144351,0.00021200016,0.00014203844,0.0013135675,0.00008801203,0.000090756,0.00009444683,0.00039959283,0.000008196767],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002562693,0.004463262,0.04469784,0.00041291857,0.00024676687,0.0001817687,0.00080581283,0.0000062074687,0.9486363,0.00003339248,0.00010436075,0.00015512205],"study_design_scores_gemma":[0.01763393,0.00027742775,0.012450848,0.00039584603,0.00035917485,0.0000044629296,0.0005422284,0.000035125064,0.967606,0.000031422634,0.000483986,0.00017956912],"about_ca_topic_score_codex":0.00012664901,"about_ca_topic_score_gemma":0.00031354686,"teacher_disagreement_score":0.032246992,"about_ca_system_score_codex":0.00007137907,"about_ca_system_score_gemma":0.0003659109,"threshold_uncertainty_score":0.86451155},"labels":[],"label_agreement":null},{"id":"W4417019600","doi":"10.1182/blood-2025-3570","title":"Nemtabrutinib in participants with relapsed or refractory follicular lymphoma: Updated efficacy and safety from cohort g of the phase 2 bellwave-003 study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Ibrutinib; Chemoimmunotherapy; Idelalisib; Follicular lymphoma; Cohort; Mantle cell lymphoma; Refractory (planetary science); Bruton's tyrosine kinase; Phases of clinical research","score_opus":0.02038115090320793,"score_gpt":0.32389404522471726,"score_spread":0.30351289432150935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417019600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99631274,0.00052943616,0.000005658933,0.00014866487,0.000056638884,0.0022229082,0.000025993058,0.000033508346,0.0006644543],"genre_scores_gemma":[0.9989378,0.00006784865,0.00007970671,0.00010760314,0.00002902828,0.00006120063,0.000028969891,0.000026242758,0.0006616371],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977235,0.0002545377,0.0005514651,0.0004855155,0.0005524718,0.00043251424],"domain_scores_gemma":[0.9982881,0.0004215101,0.00012389463,0.00093374104,0.00009061383,0.00014216473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005867421,0.00021182152,0.00060241617,0.000121332225,0.000090283545,0.000015274387,0.00021481821,0.00012143457,0.00008365207],"category_scores_gemma":[0.00056024606,0.000122018595,0.000049400216,0.0008371172,0.0002192285,0.000049897466,0.00020660821,0.00021226371,0.000004735441],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047598153,0.073360935,0.83430254,0.0004105619,0.0060479287,0.0037711156,0.0058425684,0.000033572225,0.015536392,0.00008556271,0.0010993271,0.011911357],"study_design_scores_gemma":[0.4287263,0.0014409212,0.5501552,0.0005922431,0.0016082685,0.000040613424,0.00084598205,0.0006611297,0.014616117,0.000013339218,0.0011170934,0.00018277476],"about_ca_topic_score_codex":0.0020247526,"about_ca_topic_score_gemma":0.0006635498,"teacher_disagreement_score":0.38112813,"about_ca_system_score_codex":0.0010712215,"about_ca_system_score_gemma":0.0048341667,"threshold_uncertainty_score":0.85756046},"labels":[],"label_agreement":null},{"id":"W4417019619","doi":"10.1182/blood-2025-1310","title":"Treatment of type 1 plasminogen deficiency in women and girls with reproductive tract lesions: Pharmacokinetics and clinical outcomes with plasminogen therapy","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Vagina; Cervix; Pharmacokinetics; Uterus; Genitourinary system","score_opus":0.01886448920654249,"score_gpt":0.2965068923847659,"score_spread":0.2776424031782234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417019619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99615574,0.0031822573,0.000014517826,0.0000635986,0.000027273963,0.0003696488,0.0000123444115,0.00000472382,0.00016987613],"genre_scores_gemma":[0.9960847,0.003015555,0.0006010261,0.00006297938,0.000028498242,0.000039840925,0.000006458469,0.00000931295,0.00015162646],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99921054,0.000043985554,0.00018203074,0.0003558792,0.000063455824,0.00014412515],"domain_scores_gemma":[0.9996182,0.00002412884,0.00006302524,0.0002081619,0.000041813557,0.000044720207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009532531,0.0001333095,0.00020828577,0.000043730342,0.000028656183,0.000006842693,0.000050949588,0.00007488542,0.000002377506],"category_scores_gemma":[0.000022637956,0.00008575218,0.0000219051,0.00008564663,0.00009057377,0.000003829792,0.000025485751,0.000041338797,2.3155543e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001948722,0.0028173786,0.70313704,0.00002672919,0.0004114836,0.000026065301,0.00035428087,0.0000054246543,0.27934015,0.000049076054,0.000023884857,0.011859761],"study_design_scores_gemma":[0.0076087373,0.007080273,0.09606052,0.000024198678,0.000086055225,0.000026666865,0.0001373685,0.0000050343324,0.88792413,0.00007684684,0.0008136403,0.0001565268],"about_ca_topic_score_codex":0.000014323849,"about_ca_topic_score_gemma":0.0000080008695,"teacher_disagreement_score":0.608584,"about_ca_system_score_codex":0.0000070743868,"about_ca_system_score_gemma":0.000092480375,"threshold_uncertainty_score":0.34968725},"labels":[],"label_agreement":null},{"id":"W4417019669","doi":"10.1182/blood-2025-4596","title":"Real-world incidence and management of non-icans neurologic events following ciltacabtagene autoleucel in multiple myeloma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis; Innovative Research Group (Canada)","funders":"","keywords":"Incidence (geometry); Multiple myeloma; Lenalidomide; Medical record; Cohort; Retrospective cohort study; Interim analysis; Chart; Medical diagnosis","score_opus":0.02433128109997328,"score_gpt":0.3200725747195481,"score_spread":0.2957412936195748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417019669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869422,0.00021383008,0.00003138891,0.00041110095,0.000067521636,0.0006790205,0.0000024429985,0.000028417478,0.011624127],"genre_scores_gemma":[0.99137324,0.00047998264,0.0011223723,0.000142627,0.000016050042,0.000058228772,0.0000047524154,0.0000137154,0.0067890207],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877,0.000056361598,0.00028417396,0.0003165493,0.00029600845,0.00027692018],"domain_scores_gemma":[0.9993936,0.00011150902,0.00004434793,0.00035426283,0.000031351286,0.000064955995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003628728,0.00012320624,0.00030669218,0.00032003783,0.00003763487,0.000006990475,0.00014832469,0.00005431342,0.00005449404],"category_scores_gemma":[0.000049631446,0.00011686389,0.000068584246,0.000707823,0.000044580185,0.000038619153,0.00021131786,0.0001840157,0.0000038714397],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023175558,0.0004900385,0.790232,0.00050673814,0.00019287835,0.0006067035,0.00011299063,0.000008576833,0.19744499,0.00005568176,0.00004179404,0.010075824],"study_design_scores_gemma":[0.005533821,0.00018436497,0.9643162,0.00032776606,0.0001315029,0.000005373903,0.000049598366,0.0005809887,0.028395902,0.00008576012,0.00030626412,0.0000824643],"about_ca_topic_score_codex":0.00046567892,"about_ca_topic_score_gemma":0.00030372373,"teacher_disagreement_score":0.17408417,"about_ca_system_score_codex":0.000041854768,"about_ca_system_score_gemma":0.000066322995,"threshold_uncertainty_score":0.4765571},"labels":[],"label_agreement":null},{"id":"W4417019670","doi":"10.1182/blood-2025-4588","title":"Real world efficacy and safety of elranatamab, a BCMA bispecific antibody for patients with relapsed and refractory multiple myeloma: An international myeloma working group immunotherapy database analysis","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Multiple myeloma; Refractory (planetary science); Immunotherapy; Progression-free survival; Progressive disease; Hematology; Phases of clinical research; Pembrolizumab","score_opus":0.016038977654783414,"score_gpt":0.3084764834002524,"score_spread":0.292437505745469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417019670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99710953,0.0003443183,0.0004970872,0.000058189984,0.000053688982,0.0011146757,0.00031770742,0.000039995884,0.0004647926],"genre_scores_gemma":[0.9883179,0.00079204503,0.0079000555,0.000024706707,0.00004721521,0.00005235719,0.0026611215,0.000028377977,0.00017620866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99828863,0.000076737204,0.00040593513,0.00054914545,0.00038163277,0.0002979053],"domain_scores_gemma":[0.998518,0.00043276238,0.0001646666,0.00052646233,0.00019108418,0.0001670257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024141952,0.00023270413,0.00050897815,0.0008090042,0.00015860714,0.000045122382,0.00014612645,0.000069076,0.000031671752],"category_scores_gemma":[0.00012847078,0.00018281167,0.00008977446,0.0007315835,0.00015148146,0.00020739289,0.00007740699,0.00016173246,5.417091e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012457121,0.0031960395,0.9439934,0.00008488061,0.00406701,0.000035562996,0.00014029485,0.0000010442162,0.0053704414,0.00015851874,0.000009572879,0.030486109],"study_design_scores_gemma":[0.045194585,0.00085128826,0.9506449,0.00025271732,0.0008725871,0.0000021462897,0.00005408341,0.0005152327,0.00060066243,0.000007705672,0.00085709203,0.00014701678],"about_ca_topic_score_codex":0.00021875561,"about_ca_topic_score_gemma":0.00041535287,"teacher_disagreement_score":0.032737464,"about_ca_system_score_codex":0.000057020883,"about_ca_system_score_gemma":0.00006522353,"threshold_uncertainty_score":0.74548435},"labels":[],"label_agreement":null},{"id":"W4417019727","doi":"10.1182/blood-2025-2304","title":"Murine regulatory NK cells restrict allogeneic CD4⁺ T cell-driven gvhd without compromising cytotoxic function","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Cytotoxic T cell; Interleukin 21; Flow cytometry; Interleukin 12; Immune system; T cell; Cell; IL-2 receptor; Cytotoxicity","score_opus":0.007795031634183232,"score_gpt":0.21404269196718595,"score_spread":0.2062476603330027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417019727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9698285,0.0022714527,0.001019394,0.000072293275,0.00654902,0.00038771128,0.0000039475713,0.0002475104,0.019620169],"genre_scores_gemma":[0.94256294,0.000119652825,0.000086145126,0.00033387687,0.0000672159,0.000026627944,0.00012818529,0.000023154544,0.056652173],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985998,0.00020506483,0.00039649976,0.00041484804,0.000046159097,0.00033762644],"domain_scores_gemma":[0.9991931,0.000070230264,0.00016943741,0.00044779183,0.0000963811,0.00002311548],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00014912833,0.00023871154,0.00028672683,0.00026112937,0.00032737295,0.000031312742,0.00017617995,0.00031673626,0.0013144359],"category_scores_gemma":[0.000023029206,0.00023265815,0.00014772282,0.00023824105,0.00009526705,0.00012450802,0.000087741835,0.00042149576,0.0009985751],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024074761,0.00050177623,0.0029841242,0.000045545457,0.00027698433,0.0000032623002,0.000051670853,0.000064963664,0.9818082,0.00010783324,0.013285441,0.0006294451],"study_design_scores_gemma":[0.0036278272,0.00025235105,0.020544617,0.000050594856,0.00030092592,0.000025407802,0.00010789569,0.000018576398,0.8977183,0.000026565796,0.07710056,0.00022638256],"about_ca_topic_score_codex":0.000048237584,"about_ca_topic_score_gemma":0.0000074638,"teacher_disagreement_score":0.084089905,"about_ca_system_score_codex":0.00006686644,"about_ca_system_score_gemma":0.000085243635,"threshold_uncertainty_score":0.9997793},"labels":[],"label_agreement":null},{"id":"W4417019768","doi":"10.1182/blood-2025-2302","title":"Trial in progress: QUINTESSENTIAL-2—a phase 3 study of arlocabtagene autoleucel versus standard of care in adult patients with relapsed and refractory multiple myeloma (RRMM) exposed to lenalidomide","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Lenalidomide; Multiple myeloma; Clinical trial; Refractory (planetary science); Phases of clinical research; Pomalidomide; Adverse effect; Standard of care","score_opus":0.015609160564724936,"score_gpt":0.31740208740408565,"score_spread":0.3017929268393607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417019768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948764,0.00030388575,0.000003353278,0.00003536578,0.0000810607,0.004489898,0.00010407351,0.000018089755,0.000087912726],"genre_scores_gemma":[0.9990277,0.000015479465,0.00054966164,0.000007295196,0.00001732224,0.00027328442,0.000067575755,0.000021451762,0.00002021831],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9979224,0.0001654006,0.00060161133,0.00041708793,0.0005823249,0.00031114946],"domain_scores_gemma":[0.9987184,0.00018793101,0.00015084984,0.0003951236,0.00039489177,0.00015283341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001592474,0.00021590825,0.00071819045,0.0005383058,0.00003172365,0.000010969011,0.000106407206,0.0000820858,0.000009082409],"category_scores_gemma":[0.00059458945,0.00017174639,0.00005113647,0.00049524906,0.000086981745,0.00007068844,0.000087125416,0.00018082872,6.3336853e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5369012,0.015895478,0.43074644,0.00031565013,0.0003835782,0.00017454832,0.0027618574,0.0000029778691,0.0013575889,0.0000021578317,0.0000087437,0.011449788],"study_design_scores_gemma":[0.74603504,0.05223576,0.16316293,0.0008076784,0.00023815082,4.52713e-7,0.0038687352,0.000021599373,0.03348468,9.75483e-7,0.000020608983,0.00012340894],"about_ca_topic_score_codex":0.00031370798,"about_ca_topic_score_gemma":0.0034186041,"teacher_disagreement_score":0.2675835,"about_ca_system_score_codex":0.0001285348,"about_ca_system_score_gemma":0.0003184021,"threshold_uncertainty_score":0.70036143},"labels":[],"label_agreement":null},{"id":"W4417019771","doi":"10.1182/blood-2025-5199","title":"Bleximenib in combination with intensive chemotherapy: A phase 1b study in newly diagnosed Acute Myeloid Leukemia with KMT2A or NPM1 alterations","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cytarabine; Idarubicin; Regimen; Myeloid leukemia; Daunorubicin; Phases of clinical research; Chemotherapy; Chemotherapy regimen; Leukemia","score_opus":0.01699114744651654,"score_gpt":0.3255138417467192,"score_spread":0.3085226943002027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417019771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915246,0.00006970979,0.00045565772,0.0032051727,0.000030333118,0.003542934,0.000011795897,0.000082633436,0.0010771852],"genre_scores_gemma":[0.99347514,0.00008628507,0.00148434,0.0017253668,0.000042426786,0.00070535694,0.00008288945,0.00005115525,0.0023470486],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99791706,0.00014260295,0.00043948137,0.00057040615,0.00045720875,0.00047321912],"domain_scores_gemma":[0.9985226,0.00024892573,0.000096638905,0.0005378199,0.00046380283,0.00013024238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032845535,0.00030521106,0.00058850873,0.0007920412,0.00008885285,0.00006578554,0.000206251,0.00011641287,0.0000663559],"category_scores_gemma":[0.000210759,0.00021373967,0.000038082362,0.0019212713,0.00012633503,0.00021093861,0.00006761938,0.0006576525,0.0000144626065],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.067773014,0.09994953,0.65500015,0.0006331305,0.0067148795,0.032118145,0.045810547,0.0003163974,0.049237028,0.0011125613,0.00806919,0.033265404],"study_design_scores_gemma":[0.7302478,0.025711093,0.1780146,0.0017441665,0.0013104536,0.00042145533,0.016551448,0.0052591837,0.03872428,0.00016827218,0.0009521926,0.00089508016],"about_ca_topic_score_codex":0.00082573836,"about_ca_topic_score_gemma":0.0037406215,"teacher_disagreement_score":0.66247475,"about_ca_system_score_codex":0.0008395997,"about_ca_system_score_gemma":0.002179166,"threshold_uncertainty_score":0.87160504},"labels":[],"label_agreement":null},{"id":"W4417019814","doi":"10.1182/blood-2025-2639","title":"Evaluating the implementation of an electronic patient-reported outcome system supporting self-management of treatment-related impairments among patients with lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; University of Calgary; University of British Columbia; McMaster University Medical Centre; University of Toronto; Hamilton Health Sciences; Saint John Regional Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Referral; Activities of daily living; Quality of life (healthcare); Patient-reported outcome; MEDLINE; Rehabilitation","score_opus":0.010617076082437192,"score_gpt":0.31589591256624766,"score_spread":0.3052788364838105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417019814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975,0.00006657991,0.000007658007,0.000012510001,0.00010140603,0.0016810779,0.000016076594,0.00007078799,0.0005439217],"genre_scores_gemma":[0.99950933,0.000004340478,0.00009543972,0.000014149052,0.000006547789,0.00014621497,0.000150825,0.000019788105,0.000053349548],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980503,0.00010344533,0.00085500645,0.00026947042,0.00041803662,0.00030374053],"domain_scores_gemma":[0.99856055,0.00002613231,0.0007150761,0.00042377907,0.00022480801,0.000049638977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031149675,0.00017858772,0.00034147722,0.00011106242,0.000085843,0.000010116488,0.0000834155,0.000045934492,0.0000216099],"category_scores_gemma":[0.0000056977024,0.000116813855,0.00010389915,0.0004146875,0.000028460687,0.000079491336,0.000036903508,0.000047202684,5.0483624e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018586137,0.0009963206,0.9726391,0.00047323713,0.0021770995,0.000013390868,0.0023235295,0.00001218656,0.00012929125,0.00009006539,0.000001117966,0.020958835],"study_design_scores_gemma":[0.018848708,0.005787895,0.95004535,0.00037170842,0.004306674,0.000008700891,0.014509553,0.0002392827,0.005737769,0.000008970191,0.000008864063,0.00012653445],"about_ca_topic_score_codex":0.0014452393,"about_ca_topic_score_gemma":0.00035741765,"teacher_disagreement_score":0.022593725,"about_ca_system_score_codex":0.0004058585,"about_ca_system_score_gemma":0.00025046075,"threshold_uncertainty_score":0.47635305},"labels":[],"label_agreement":null},{"id":"W4417020046","doi":"10.1182/blood-2025-5222","title":"Survival outcomes with the use of gemtuzumab-ozogamycin in patients with acute myeloid leukemia receiving intensive chemotherapy stratified by molecular risk category","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada; University of Toronto; University of British Columbia","funders":"","keywords":"Cytarabine; Myeloid leukemia; Induction chemotherapy; Retrospective cohort study; Transplantation; Cohort; Gemtuzumab ozogamicin; Hematology; Chemotherapy","score_opus":0.011263189126661174,"score_gpt":0.2525757062351514,"score_spread":0.24131251710849022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417020046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99635667,0.000085821135,0.00048379754,0.0013224039,0.000033823995,0.0012108246,0.000058500435,0.000040590443,0.00040755988],"genre_scores_gemma":[0.9965782,0.00011201626,0.00095822936,0.0010873633,0.000010988628,0.00005646948,0.00007819786,0.000056745794,0.0010617566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978567,0.00020927518,0.00037959786,0.00046248594,0.00063481904,0.00045714658],"domain_scores_gemma":[0.9979204,0.00037411466,0.00020958917,0.00077341846,0.00062517123,0.00009729511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002911157,0.00032418076,0.00067564443,0.00022602327,0.000079652214,0.000040403553,0.00028589752,0.00014593835,0.000022025733],"category_scores_gemma":[0.0002804773,0.00018693112,0.000084756,0.00071843405,0.0002778909,0.00013297319,0.00009352267,0.00075314584,0.0000036465237],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00302899,0.00052406563,0.97882825,0.00008891928,0.0024948108,0.00013896247,0.00094093423,0.000082755796,0.008403163,0.00006889199,0.0030772227,0.002323058],"study_design_scores_gemma":[0.02662567,0.0010717101,0.92692506,0.00024298781,0.00072404236,0.000008340506,0.0008369789,0.00013761748,0.04266467,0.000025150544,0.0004365427,0.0003012398],"about_ca_topic_score_codex":0.0017048576,"about_ca_topic_score_gemma":0.00031388836,"teacher_disagreement_score":0.051903177,"about_ca_system_score_codex":0.0003538952,"about_ca_system_score_gemma":0.00090336613,"threshold_uncertainty_score":0.76228297},"labels":[],"label_agreement":null},{"id":"W4417020065","doi":"10.1182/blood-2025-2647","title":"Healthcare resource utilization with prophylactic intravenous anakinra following anti-CD19 CAR-T therapy in B-cell lymphoma: A Canadian single-center quality improvement experience.","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Anakinra; Population; Cytokine release syndrome; Incidence (geometry); Retrospective cohort study; Adverse effect; Quality management","score_opus":0.041472522109953135,"score_gpt":0.3212215139428803,"score_spread":0.2797489918329272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417020065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927546,0.00067030167,0.000021156855,0.0011335156,0.00009302135,0.0018873453,0.0000096356125,0.0000505628,0.003379873],"genre_scores_gemma":[0.9973362,0.00005961593,0.0000933174,0.0013149309,0.000058638034,0.00016876087,0.000044562345,0.0000422211,0.0008817434],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976095,0.0001912422,0.00042441158,0.0005534177,0.000514643,0.00070677226],"domain_scores_gemma":[0.99885446,0.00004977836,0.00008445502,0.000582057,0.0001342007,0.0002950593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039733914,0.00024253142,0.00042498432,0.0004522541,0.00016144494,0.000071413175,0.00017756938,0.00014360978,0.00008264183],"category_scores_gemma":[0.00004802192,0.00020904772,0.0000958357,0.00093281805,0.00007369162,0.00007913228,0.000035711073,0.00022164888,0.000003008318],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015319597,0.008254624,0.4517922,0.00069734507,0.0002654371,0.0008268065,0.012506713,0.0000053658414,0.40790117,0.00006952055,0.000037152004,0.11611169],"study_design_scores_gemma":[0.115114756,0.012185327,0.23740424,0.0015758509,0.0002170839,0.00015578695,0.018168725,0.00019057849,0.58381623,0.00007919959,0.029642355,0.0014498747],"about_ca_topic_score_codex":0.09357223,"about_ca_topic_score_gemma":0.07759377,"teacher_disagreement_score":0.21438798,"about_ca_system_score_codex":0.000835088,"about_ca_system_score_gemma":0.0014210306,"threshold_uncertainty_score":0.9392377},"labels":[],"label_agreement":null},{"id":"W4417020112","doi":"10.1182/blood-2025-3619","title":"Inflammatory and oxidative stress biomarkers associated with cognitive function in patients with Hodgkin lymphoma treated with chemotherapy","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Biomarker; Oxidative stress; Lymphoma; Cognition; Inflammation; Malondialdehyde; Cancer; Neuropsychology","score_opus":0.004198924201401348,"score_gpt":0.21154994970781268,"score_spread":0.20735102550641132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417020112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99657553,0.00014977583,0.000036170015,0.00010142016,0.000015815322,0.0013599204,0.000058193866,0.000087947796,0.0016152521],"genre_scores_gemma":[0.99916685,0.00003288236,0.000024357554,0.00023959059,0.000010757561,0.00013732855,0.00015323612,0.000031910822,0.0002030849],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99883676,0.000071382136,0.00018287076,0.00038088998,0.0002635741,0.00026455193],"domain_scores_gemma":[0.9991539,0.00014132226,0.00014731594,0.00010333574,0.00038955454,0.00006454581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000076796416,0.00027473766,0.00036716353,0.00028147973,0.00009134835,0.00001789878,0.00002746057,0.000096404736,0.000014665331],"category_scores_gemma":[0.000066265675,0.00018867917,0.000020538202,0.0007347557,0.00025932433,0.0001149168,0.000019399291,0.00011705087,0.0000012861799],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013516087,0.0017743479,0.9747865,0.00004829419,0.0047155926,0.000038074064,0.00037734036,5.772015e-7,0.00007105504,0.0000025887775,0.00002576356,0.004643738],"study_design_scores_gemma":[0.07048642,0.004078652,0.915791,0.0026375793,0.0014504316,0.0000026435087,0.0010075691,0.0000061645314,0.0043178797,0.0000035942987,0.000009012965,0.00020905308],"about_ca_topic_score_codex":0.000070827344,"about_ca_topic_score_gemma":0.0003392141,"teacher_disagreement_score":0.05899554,"about_ca_system_score_codex":0.00014781827,"about_ca_system_score_gemma":0.00015522278,"threshold_uncertainty_score":0.7694113},"labels":[],"label_agreement":null},{"id":"W4417020225","doi":"10.1182/blood-2025-3462","title":"Thioguanine and decitabine can overcome hypomethylating agent resistance in patients with advanced myeloid malignancies","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Forming Technologies (Canada)","funders":"","keywords":"Decitabine; Hypomethylating agent; Azacitidine; Regimen; Myeloid leukemia; Myeloid; Venetoclax; Bone marrow; Progressive disease","score_opus":0.006979252920071475,"score_gpt":0.24323017042918862,"score_spread":0.23625091750911714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417020225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99330705,0.0015185637,0.000037824164,0.00086349447,0.000030167788,0.0006148238,0.000018374478,0.00004378054,0.0035658951],"genre_scores_gemma":[0.98951894,0.00011546994,0.0076494142,0.00037287353,0.000022514474,0.000047736256,0.000026976075,0.000024618004,0.0022214348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985339,0.000045739038,0.00028230433,0.00037102922,0.00036682212,0.00040021725],"domain_scores_gemma":[0.9991738,0.00014479086,0.00006427585,0.0003398378,0.00016060923,0.00011667885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022311669,0.00018231034,0.0003577794,0.00029098208,0.0000767598,0.000021423515,0.00010326725,0.00007182268,0.000016876385],"category_scores_gemma":[0.00036841648,0.000145478,0.000026760994,0.00077377376,0.00009089052,0.00008481108,0.00011919146,0.0002896203,0.0000025283302],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009644702,0.00052748487,0.983562,0.0003594129,0.00013080759,0.000126146,0.00051590084,0.0000073923043,0.008830208,0.000458561,0.00018569709,0.0043319426],"study_design_scores_gemma":[0.0150612425,0.00035284305,0.9766841,0.00069639774,0.00007222666,0.000003225833,0.00015874702,0.00001580202,0.0057844208,0.00012264898,0.000887181,0.00016115657],"about_ca_topic_score_codex":0.000062893785,"about_ca_topic_score_gemma":0.0003406601,"teacher_disagreement_score":0.014096772,"about_ca_system_score_codex":0.00020468766,"about_ca_system_score_gemma":0.00023896509,"threshold_uncertainty_score":0.59324205},"labels":[],"label_agreement":null},{"id":"W4417020247","doi":"10.1182/blood-2025-6526","title":"Adrenal insufficiency in sickle cell disease: A  Case series of a potentially underrecognized complication","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Adrenal Hormones and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Adrenal insufficiency; Acute chest syndrome; Complication; Nausea; Presyncope; Sickle cell anemia; Adrenal crisis; Vomiting; Disease","score_opus":0.010467731690182749,"score_gpt":0.2544684788131598,"score_spread":0.24400074712297706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417020247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917839,0.0014534828,0.0010996462,0.00043787947,0.000024082858,0.0003076074,0.0000148471345,0.000025250178,0.0048532872],"genre_scores_gemma":[0.9986716,0.00004862214,0.0006871646,0.0001072739,0.000010178564,0.00001762027,0.00002972335,0.0000062015424,0.00042163802],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99938256,0.000014771544,0.00022520412,0.00015502695,0.00009988939,0.00012256486],"domain_scores_gemma":[0.9996223,0.000023939818,0.00005453794,0.0001716445,0.00006204738,0.000065570406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005662406,0.00008055112,0.0001720753,0.00012274238,0.00003276656,0.000004880541,0.00004613389,0.00003512708,0.000035381327],"category_scores_gemma":[0.000044728873,0.000073034345,0.000060338614,0.0003202275,0.000056832385,0.000040577896,0.000032564356,0.00006667459,0.000004649133],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013872014,0.11685299,0.5944745,0.007965909,0.00080839155,0.022276407,0.0042157867,0.00055452506,0.14726213,0.03729841,0.0033561364,0.05106279],"study_design_scores_gemma":[0.07958331,0.003486925,0.8471031,0.0016580059,0.0035609351,0.00447179,0.006879283,0.0033521699,0.032635465,0.013969799,0.0020343855,0.0012648279],"about_ca_topic_score_codex":0.0001280587,"about_ca_topic_score_gemma":0.00011155464,"teacher_disagreement_score":0.2526286,"about_ca_system_score_codex":0.000010053631,"about_ca_system_score_gemma":0.00018088394,"threshold_uncertainty_score":0.29782543},"labels":[],"label_agreement":null},{"id":"W4417020279","doi":"10.1182/blood-2025-3612","title":"A retrospective population-based study of long-term treatments and outcomes inwaldenstrom macroglobulinemia in Ontario, Canada","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; McMaster University; University of Toronto","funders":"","keywords":"Waldenstrom macroglobulinemia; Rituximab; Lymphoplasmacytic Lymphoma; Macroglobulinemia; Retrospective cohort study; Ibrutinib; Lymphoma; Chemotherapy regimen; Survival analysis; Cohort","score_opus":0.010375265890168154,"score_gpt":0.2864919621207499,"score_spread":0.27611669623058177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417020279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986785,0.00006463024,7.978133e-7,0.000077229386,0.0000440443,0.00083266146,0.000010854036,0.000010171978,0.0002811258],"genre_scores_gemma":[0.9987121,0.0000012951097,0.000059645266,0.000057666726,0.0000065058402,0.000036355876,0.00003097539,0.000008739486,0.0010867148],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988615,0.00003288509,0.0002893684,0.00026555272,0.0003503207,0.00020039386],"domain_scores_gemma":[0.99943966,0.000076635,0.000054795637,0.0002938744,0.00006497947,0.000070078124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007132279,0.0001299759,0.00040005465,0.00013886018,0.000030819716,0.000008100862,0.00006653247,0.000052112497,0.000032950375],"category_scores_gemma":[0.00009378222,0.00010992208,0.000029161154,0.00021533905,0.000020138948,0.000019954054,0.000048942507,0.00014876088,6.4279124e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00012773277,0.0016592125,0.99692774,0.00005821644,0.0002844179,0.0005254591,0.00017283674,0.000006908158,0.00002618042,0.000004980467,0.000016941003,0.00018940603],"study_design_scores_gemma":[0.056097783,0.00026779348,0.9427925,0.000116305906,0.00023267136,0.000009750772,0.00009728902,0.000060263563,0.00025460165,0.000008277178,7.420756e-7,0.00006206355],"about_ca_topic_score_codex":0.99352914,"about_ca_topic_score_gemma":0.9983411,"teacher_disagreement_score":0.05597005,"about_ca_system_score_codex":0.013745254,"about_ca_system_score_gemma":0.010082948,"threshold_uncertainty_score":0.99552894},"labels":[],"label_agreement":null},{"id":"W4417020547","doi":"10.1182/blood-2025-6959","title":"Oral n-myristoyltransferase inhibitor zelenirstat for adults with Relapsed/Refractory Acute Myeloid Leukemia (AML): A phase 1 trial in progress","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Achieve Life Sciences (Canada)","funders":"","keywords":"Venetoclax; Pharmacokinetics; Pharmacodynamics; Myeloid leukemia; Clinical trial; Leukemia; CYP3A; Adverse effect","score_opus":0.013537435268961647,"score_gpt":0.31105341883320853,"score_spread":0.29751598356424686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417020547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895572,0.00070752203,0.0004564936,0.0014999417,0.0002672486,0.0064085233,0.00018989273,0.0001939192,0.00071924616],"genre_scores_gemma":[0.9899652,0.00019124089,0.0046393047,0.00043404385,0.00048247117,0.0019992306,0.00034454846,0.00010693563,0.0018370465],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99667656,0.00013342123,0.00073094876,0.0008801457,0.0006238732,0.0009550416],"domain_scores_gemma":[0.99823225,0.0002951406,0.000110801826,0.00070791837,0.00031044657,0.0003434387],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00057032437,0.0004632242,0.000886178,0.00064246677,0.00015229915,0.000061845305,0.0003187935,0.00036515517,0.00004496114],"category_scores_gemma":[0.00025734,0.0003736013,0.00022615684,0.0009537994,0.00032893117,0.00024186778,0.000073879375,0.0009787233,0.000019890656],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9005347,0.011910519,0.0030879981,0.0016133969,0.0016531663,0.0027969948,0.0021185102,0.0000031455706,0.020451251,0.0003210107,0.013607046,0.04190225],"study_design_scores_gemma":[0.897135,0.016109006,0.00041218338,0.0013445122,0.0013148384,0.00014356952,0.0005382429,0.00036186268,0.06309017,0.000077027435,0.018893147,0.0005804337],"about_ca_topic_score_codex":0.00012809184,"about_ca_topic_score_gemma":0.00020001862,"teacher_disagreement_score":0.042638917,"about_ca_system_score_codex":0.00089362595,"about_ca_system_score_gemma":0.0033597446,"threshold_uncertainty_score":0.9998716},"labels":[],"label_agreement":null},{"id":"W4417020585","doi":"10.1182/blood-2025-6963","title":"Ivosidenib with or without hypomethylating agent in IDH1-mutated AML: Real-world evidence to inform frontline therapy","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Azacitidine; Hypomethylating agent; Decitabine; Clinical endpoint; Myeloid leukemia; Performance status; Phases of clinical research; Clinical trial; Cohort; Hematology","score_opus":0.05831651651262254,"score_gpt":0.3771656489118306,"score_spread":0.31884913239920804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417020585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98562205,0.0005344203,0.00023295778,0.0067448122,0.000049221057,0.0017328007,0.000004148404,0.00015319155,0.004926372],"genre_scores_gemma":[0.9752818,0.0005565434,0.010745072,0.0026605679,0.000112917005,0.00023745006,0.000013579826,0.00005094565,0.010341124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977353,0.000083560175,0.0005306295,0.00045708218,0.0006043588,0.00058904756],"domain_scores_gemma":[0.9983582,0.00042425664,0.00009475252,0.0006247241,0.00024998633,0.00024810852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007326452,0.00026883144,0.0005967524,0.0008261752,0.00009618117,0.000055195535,0.00028869664,0.00009735975,0.00015160668],"category_scores_gemma":[0.00079560943,0.000180177,0.0000551581,0.002915636,0.00007403179,0.00019430443,0.0001531737,0.00054762745,0.00006051931],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014024317,0.0010237431,0.8280531,0.00043909255,0.00069893117,0.0012706871,0.0034030834,0.00014281225,0.09937469,0.00012039293,0.005027991,0.046421148],"study_design_scores_gemma":[0.050405867,0.006775715,0.57927215,0.008459002,0.00045474307,0.00017650245,0.0017119179,0.002904393,0.3326743,0.0001269262,0.015912933,0.0011255805],"about_ca_topic_score_codex":0.0030263974,"about_ca_topic_score_gemma":0.005920971,"teacher_disagreement_score":0.24878098,"about_ca_system_score_codex":0.00045851764,"about_ca_system_score_gemma":0.0010014764,"threshold_uncertainty_score":0.7347405},"labels":[],"label_agreement":null},{"id":"W4417020688","doi":"10.1182/blood-2025-4868","title":"Prothrombin complex concentrate in managing direct oral anticoagulant (DOAC)-associated bleeding and real-world use in vitamin k antagonist (VKA)-associated bleeding: The ongoing lex-210 and lex-212 studies","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"","keywords":"Prothrombin complex concentrate; Vitamin K antagonist; Interim analysis; Dosing; Vitamin k; Oral anticoagulant; Coagulation; Warfarin; Major bleeding","score_opus":0.11302549075377316,"score_gpt":0.3639758706257219,"score_spread":0.25095037987194874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417020688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903051,0.0007513136,0.0000040177183,0.0039701764,0.00016497413,0.0013980848,0.000009053388,0.00012991254,0.003267318],"genre_scores_gemma":[0.9958762,0.0018398047,0.000090752146,0.00026192525,0.000066557135,0.000014402418,0.000034527875,0.000028837992,0.0017869989],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977919,0.00024506604,0.00065985305,0.00047955077,0.000279476,0.00054418703],"domain_scores_gemma":[0.99855137,0.0008622889,0.00024639224,0.00018470064,0.000086928725,0.00006834971],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013373034,0.00031549434,0.0009249429,0.00045592533,0.0003066784,0.00022098921,0.00010073369,0.000093092014,0.000006062815],"category_scores_gemma":[0.00079294475,0.00025302608,0.00007523012,0.0011356969,0.0002274484,0.0002560964,0.00024216044,0.00025472298,0.0000012063327],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012258752,0.000095114345,0.9883669,0.00016669462,0.00068107765,0.000083708735,0.00091470225,0.00001636763,0.0071102115,0.0018652547,0.0002475574,0.00032984914],"study_design_scores_gemma":[0.009085032,0.0000948388,0.98320043,0.0009964218,0.0005957724,0.0000035630112,0.002138133,0.002238735,0.0007345741,0.00031694627,0.0003176568,0.00027787322],"about_ca_topic_score_codex":0.001392778,"about_ca_topic_score_gemma":0.0052430276,"teacher_disagreement_score":0.008962445,"about_ca_system_score_codex":0.00020397676,"about_ca_system_score_gemma":0.000053474967,"threshold_uncertainty_score":0.9999922},"labels":[],"label_agreement":null},{"id":"W4417020705","doi":"10.1182/blood-2025-7910","title":"Less plasma, less drama: A quality improvement initiative to reduce inappropriate plasmatransfusions across community hospitals in the niagara region.","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Sleep Society; McMaster University; Niagara Health System","funders":"","keywords":"Audit; Quality management; Transfusion medicine; Health care; Community hospital; Blood transfusion; Resource use; Clinical audit","score_opus":0.05310106145238635,"score_gpt":0.3359664151112736,"score_spread":0.28286535365888726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417020705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96907115,0.00008383386,0.0006151524,0.016299069,0.0002281624,0.002763212,0.000045387285,0.00010229244,0.0107917385],"genre_scores_gemma":[0.99208117,0.00017702674,0.00026470024,0.006281358,0.000042289248,0.0005953351,0.000027920192,0.000022218925,0.0005079981],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.9973614,0.00058743055,0.0006711536,0.00042122326,0.00044039072,0.00051837217],"domain_scores_gemma":[0.99824965,0.00031015184,0.00009999538,0.0010536934,0.00014497124,0.00014153145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015973028,0.00030489653,0.000542169,0.0001783407,0.0005563174,0.000081802806,0.00054511754,0.00015594119,0.0000085813535],"category_scores_gemma":[0.00018222994,0.0002287448,0.00016791056,0.0009108983,0.0001479677,0.00009482863,0.000258052,0.00095776754,0.000014138889],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059823436,0.085944265,0.0737944,0.006329209,0.0043597515,0.0013132968,0.36322725,0.00011725192,0.040071074,0.05216756,0.017538937,0.34915465],"study_design_scores_gemma":[0.052456416,0.002693668,0.53571033,0.0020851218,0.0013397491,0.00006709469,0.31642982,0.000032188073,0.07573105,0.0024129723,0.009885108,0.0011564784],"about_ca_topic_score_codex":0.0019067286,"about_ca_topic_score_gemma":0.0033272041,"teacher_disagreement_score":0.46191594,"about_ca_system_score_codex":0.00007363644,"about_ca_system_score_gemma":0.00014611788,"threshold_uncertainty_score":0.9327942},"labels":[],"label_agreement":null},{"id":"W4417020718","doi":"10.1182/blood-2025-4273","title":"Relapse with post-transplant tyrosine kinase inhibitor (TKI) maintenance therapy in phliladelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL) after allogeneic hematopoietic stem cell transplantation: Incidence and risk factor analysis","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Saskatchewan Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"Cumulative incidence; Maintenance therapy; Hematopoietic stem cell transplantation; Incidence (geometry); Clinical endpoint; Acute lymphocytic leukemia; Transplantation; Tyrosine-kinase inhibitor; Retrospective cohort study; Stem cell","score_opus":0.005103187444848837,"score_gpt":0.21940240336575145,"score_spread":0.21429921592090262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417020718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932151,0.0041345954,0.00030537412,0.00024974556,0.0000546451,0.0010203851,0.00088060426,0.000074899595,0.00006466764],"genre_scores_gemma":[0.9902522,0.008177859,0.00043556094,0.00040124374,0.000036776546,0.00020364011,0.00019571738,0.000048482703,0.00024850597],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99742055,0.00013624527,0.0005860576,0.00087479287,0.00042274524,0.00055959984],"domain_scores_gemma":[0.9986815,0.00021331127,0.00019404883,0.0005327669,0.00014908848,0.0002292929],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012411692,0.00054271304,0.00085638446,0.0004986638,0.00009339158,0.000047542373,0.00015580913,0.00022651376,0.000069753354],"category_scores_gemma":[0.0000072863386,0.0004137021,0.00019078379,0.0010610052,0.00017213546,0.0001860564,0.0000310187,0.00035009033,0.000013458104],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009166304,0.0016124782,0.88151824,0.0008241196,0.007509936,0.012492575,0.007503129,0.00016628626,0.07825983,0.000027824904,0.000012520011,0.0009067256],"study_design_scores_gemma":[0.027633557,0.0015410446,0.82458186,0.0016138576,0.011179907,0.00081704964,0.00020412014,0.00014936822,0.13172337,0.000013379278,0.000011481412,0.0005310017],"about_ca_topic_score_codex":0.00054471416,"about_ca_topic_score_gemma":0.00092995464,"teacher_disagreement_score":0.056936413,"about_ca_system_score_codex":0.00087284524,"about_ca_system_score_gemma":0.00074274366,"threshold_uncertainty_score":0.9998315},"labels":[],"label_agreement":null},{"id":"W4417020755","doi":"10.1182/blood-2025-4278","title":"Children and adolescents with sickle cell disease demonstrate improved health-related quality of life and low decisional regret after hematopoietic cell transplantation: A sickle cell transplant advocacy and research alliance (STAR) study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba; University of Calgary","funders":"","keywords":"Quality of life (healthcare); Regret; Observational study; Interim; Hematopoietic cell; Disease; Transplantation; Interim analysis; Clinical trial; Exploratory research","score_opus":0.010515623601807612,"score_gpt":0.2751639913052921,"score_spread":0.2646483677034845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417020755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810733,0.0162168,0.00003582655,0.0005992943,0.000023080931,0.0018276937,0.00012137814,0.000028459699,0.00007411864],"genre_scores_gemma":[0.99549127,0.003919665,0.00017604516,0.00016446265,0.000012228901,0.000038824186,0.00004199638,0.00002567767,0.00012982042],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974969,0.0003071537,0.00069667184,0.00061578286,0.00046458296,0.00041888183],"domain_scores_gemma":[0.9987438,0.00012563038,0.00014652936,0.0003175724,0.00012808693,0.00053838297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006729301,0.00027273435,0.00057585875,0.00012927511,0.00018047362,0.000032838412,0.000092203954,0.00013702975,0.000011037859],"category_scores_gemma":[0.000020311862,0.00021020626,0.0000554908,0.00034960735,0.0003310134,0.00007585948,0.00003621598,0.0004923983,0.0000016976801],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009117661,0.006653446,0.96903837,0.006516015,0.00016718936,0.00020858283,0.0055448203,0.000006219528,0.0022113156,0.0000049056503,0.00005567631,0.00047582958],"study_design_scores_gemma":[0.027727824,0.0012719581,0.96482015,0.0020507802,0.00048458524,0.00003592986,0.0016393033,0.0001056574,0.0015258563,0.000072312505,0.0000030216697,0.00026259807],"about_ca_topic_score_codex":0.00037021708,"about_ca_topic_score_gemma":0.0000885139,"teacher_disagreement_score":0.01861016,"about_ca_system_score_codex":0.000014386505,"about_ca_system_score_gemma":0.0006861842,"threshold_uncertainty_score":0.8571963},"labels":[],"label_agreement":null},{"id":"W4417020775","doi":"10.1182/blood-2025-8178","title":"Real-world analysis of asciminib as first-line therapy in patients with newly diagnosed chronic myeloid leukemia in chronic phase: A chart review Study in the United States","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Discontinuation; Interim; Clinical trial; Myeloid leukemia; Interim analysis; Concordance; Nilotinib; Medical record","score_opus":0.017885212387219577,"score_gpt":0.3186096871335428,"score_spread":0.30072447474632324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417020775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98599935,0.008444695,0.0000014106564,0.000542181,0.000024720975,0.004643597,0.000039065606,0.000031199488,0.00027376632],"genre_scores_gemma":[0.96193916,0.03552762,0.000021029737,0.00061645167,0.000028686729,0.00067537423,0.0009975018,0.000033750912,0.0001604041],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967147,0.0003824292,0.0010959394,0.0006391987,0.0006372767,0.00053047104],"domain_scores_gemma":[0.9978356,0.00051114266,0.0003183145,0.0011220364,0.00013657901,0.00007635651],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007812913,0.00042847803,0.0013883444,0.0019195797,0.00004962792,0.000016664244,0.00038487522,0.00008894771,0.00021667386],"category_scores_gemma":[0.00014152587,0.00028435714,0.00016168633,0.009717399,0.000096190306,0.00008983163,0.00006634398,0.0004681674,0.0000074689915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009824235,0.011817371,0.97226745,0.0008602318,0.0028099853,0.00033091655,0.0020435296,0.0015880677,0.000026135072,0.000015494097,0.00018242351,0.0070760017],"study_design_scores_gemma":[0.110737786,0.0057206294,0.8735072,0.0043583047,0.0029241461,0.000001175592,0.00027001312,0.0010557852,0.00016910813,0.000008335405,0.0010061015,0.00024141403],"about_ca_topic_score_codex":0.017952312,"about_ca_topic_score_gemma":0.080293566,"teacher_disagreement_score":0.10975537,"about_ca_system_score_codex":0.0052809888,"about_ca_system_score_gemma":0.0025357157,"threshold_uncertainty_score":0.99996084},"labels":[],"label_agreement":null},{"id":"W4417020800","doi":"10.1182/blood-2025-897","title":"Machine learning-based body composition analysis for risk stratification in newly diagnosed diffuse large B cell lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"","keywords":"Diffuse large B-cell lymphoma; Risk stratification; International Prognostic Index; Interim analysis; Lymphoma; Computed tomography; Interim","score_opus":0.012976482273886026,"score_gpt":0.29619792289279234,"score_spread":0.2832214406189063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417020800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9643107,0.0005890349,0.031960025,0.0015701632,0.000053171992,0.0007637187,0.00009179685,0.000096849595,0.0005645118],"genre_scores_gemma":[0.99574083,0.00012398897,0.0019456635,0.0007558293,0.000040273204,0.00012728012,0.0010569468,0.00001043931,0.00019874897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99902636,0.00010406958,0.0003211302,0.00023304352,0.00011500138,0.000200416],"domain_scores_gemma":[0.99933386,0.00020508448,0.00012160746,0.0001870851,0.00007715111,0.00007518519],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003107418,0.00010057382,0.00026898368,0.0004697099,0.0001478349,0.000021409358,0.000046426863,0.000079312835,0.000030639152],"category_scores_gemma":[0.00007206141,0.00010199464,0.00011855645,0.0006543367,0.000013352412,0.00003025407,0.0000070328542,0.00013174495,0.0000058465453],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037714487,0.016768957,0.97452354,0.00060464477,0.00017130341,0.000017531656,0.00015166872,0.00023716174,0.0056038825,0.00048604643,0.0001687629,0.00088934624],"study_design_scores_gemma":[0.09043795,0.00032045238,0.7306913,0.00018997521,0.0020981722,9.873734e-7,0.000113756156,0.15485446,0.017687732,0.00023952585,0.0031916513,0.00017402826],"about_ca_topic_score_codex":0.0001723324,"about_ca_topic_score_gemma":0.0002265239,"teacher_disagreement_score":0.24383225,"about_ca_system_score_codex":0.00005996226,"about_ca_system_score_gemma":0.000089025,"threshold_uncertainty_score":0.4159221},"labels":[],"label_agreement":null},{"id":"W4417020817","doi":"10.1182/blood-2025-5281","title":"Targeting ABCD1 inhibits peroxisomal fatty acid oxidation to selectively eliminate Acute Myeloid Leukemia cells","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Peroxisome Proliferator-Activated Receptors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Public Health; University of Guelph","funders":"","keywords":"Peroxisome; Myeloid leukemia; Peroxisomal disorder; Leukemia; Myeloid; Haematopoiesis; Clonogenic assay; Beta oxidation; Mitochondrion","score_opus":0.004530318547914138,"score_gpt":0.22742686479672491,"score_spread":0.22289654624881078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417020817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943258,0.00033283985,0.003489867,0.00016217439,0.0002621551,0.00041187712,0.000033161952,0.000068525114,0.000913563],"genre_scores_gemma":[0.9941927,0.00013853716,0.0039254855,0.0005804953,0.00022836306,0.00009293923,0.00015924548,0.000041538402,0.0006406951],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99826133,0.00009787435,0.00031215133,0.0006694537,0.0001758939,0.00048327592],"domain_scores_gemma":[0.99924994,0.000011977215,0.000101492464,0.0003002958,0.00019343822,0.00014283878],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018425188,0.00030337114,0.00023172148,0.0001472427,0.00019512272,0.000064331885,0.0002884637,0.00031459949,0.000021270254],"category_scores_gemma":[0.00013262773,0.00031307584,0.00009969446,0.00041862566,0.000044519486,0.0000145270715,0.00025430805,0.00022224268,0.000058023303],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011829029,0.00013531762,0.0015191121,0.00002445923,0.00024167603,0.0000034800667,0.00010846194,0.00006773395,0.99537367,0.00001570553,0.0014431131,0.0009489996],"study_design_scores_gemma":[0.0011127443,0.00025151458,0.0008259443,0.000032762724,0.0000889192,0.000007645598,0.000074510746,0.00002329192,0.9934781,0.0000149339685,0.003758547,0.00033108908],"about_ca_topic_score_codex":0.000011111981,"about_ca_topic_score_gemma":0.0000058338383,"teacher_disagreement_score":0.002315434,"about_ca_system_score_codex":0.00009038941,"about_ca_system_score_gemma":0.00028583716,"threshold_uncertainty_score":0.9999321},"labels":[],"label_agreement":null},{"id":"W4417020824","doi":"10.1182/blood-2025-907","title":"Safety and efficacy of bromodomain and extra-terminal protein inhibitor INCB057643 monotherapy in patients with relapsed or refractory myelofibrosis and other advanced myeloid neoplasms: A phase 1 study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University; Bell (Canada); Princess Margaret Cancer Centre","funders":"","keywords":"Myelofibrosis; Bone marrow; Phases of clinical research; Myeloproliferative neoplasm; Anemia; Clinical endpoint; Bromodomain; Refractory (planetary science); Myeloid; Hypomethylating agent","score_opus":0.006054009545463277,"score_gpt":0.24358246718733412,"score_spread":0.23752845764187083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417020824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99763983,0.001062288,0.00005332108,0.000019510311,0.000021440455,0.001115818,0.000045501787,0.000013984126,0.000028326553],"genre_scores_gemma":[0.998697,0.00007866476,0.0009325133,0.000029540966,0.00003561491,0.000059025493,0.000018126831,0.00003181436,0.000117725984],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989591,0.000086361455,0.0002726572,0.00041288632,0.00012605592,0.00014292313],"domain_scores_gemma":[0.99962246,0.000023706963,0.00007694626,0.00017990904,0.000026753396,0.000070223585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014382337,0.0001826766,0.00020122656,0.00008356876,0.00004247825,0.000031661748,0.000052400195,0.000098319506,0.000008651281],"category_scores_gemma":[0.00003775272,0.00013709677,0.000019235147,0.00011698324,0.000106049425,0.000018394208,0.00006135527,0.00009490365,2.886783e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016039796,0.004500914,0.04134114,0.0002441782,0.00023866404,0.000031281867,0.0014412437,0.0000013693749,0.834993,0.000021231197,0.000022309947,0.101124875],"study_design_scores_gemma":[0.12352381,0.036381382,0.1019502,0.0011633795,0.0001824096,0.000043552314,0.0007971961,0.000059284448,0.72600746,0.000045364442,0.008744492,0.0011014442],"about_ca_topic_score_codex":0.00001541824,"about_ca_topic_score_gemma":0.000036128764,"teacher_disagreement_score":0.108985506,"about_ca_system_score_codex":0.000007819801,"about_ca_system_score_gemma":0.00005339941,"threshold_uncertainty_score":0.5590644},"labels":[],"label_agreement":null},{"id":"W4417020907","doi":"10.1182/blood-2025-5279","title":"Myeloid malignancies molecular analysis for therapy choice (myeloMATCH): Rapid availability of clinical, pathologic and molecular features for treatment assignment in the first 550 patients.","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; Ottawa Hospital","funders":"","keywords":"Clinical trial; Myeloid leukemia; Cohort; Adverse effect; Disease; Myeloid; Minimal residual disease; Randomized controlled trial; Myelodysplastic syndromes","score_opus":0.032458749086411644,"score_gpt":0.3461586820832257,"score_spread":0.31369993299681403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417020907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891197,0.0032247459,0.0009956487,0.0025887373,0.000031296695,0.0036667713,0.0001080192,0.000020124315,0.00024493504],"genre_scores_gemma":[0.99353147,0.0011345762,0.0027069924,0.0013451494,0.000024913665,0.0010432464,0.00010052456,0.000018150859,0.00009499245],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99787253,0.00020729954,0.00069593266,0.00056610024,0.0003104867,0.00034765922],"domain_scores_gemma":[0.9976038,0.0011674819,0.0001859247,0.0007355808,0.00023647814,0.00007076611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001233821,0.00025179767,0.00085254974,0.00023317552,0.000100620804,0.000026604646,0.00023505733,0.0001955207,0.000014075798],"category_scores_gemma":[0.0008471599,0.00015417738,0.00052100484,0.00054203795,0.00021641643,0.000031533687,0.00006102005,0.00012539873,5.638326e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021731858,0.008685974,0.92396045,0.0005929477,0.0051999805,0.00009876157,0.0008849442,0.00006682691,0.016665913,0.0007291869,0.0008456465,0.04009619],"study_design_scores_gemma":[0.027680878,0.005413231,0.88034105,0.000086634536,0.00271471,0.000004878274,0.00033667203,0.0001874475,0.07305221,0.0005197746,0.0094096,0.0002528853],"about_ca_topic_score_codex":0.00009537436,"about_ca_topic_score_gemma":0.000051149065,"teacher_disagreement_score":0.0563863,"about_ca_system_score_codex":0.00009268692,"about_ca_system_score_gemma":0.00017399857,"threshold_uncertainty_score":0.6287171},"labels":[],"label_agreement":null},{"id":"W4417020971","doi":"10.1182/blood-2025-4856","title":"Real-world study of population pharmacokinetic-guided pdVWF/FVIII (1:1) prophylaxis in people with severe von Willebrand disease: The PopPK-WILPROPHY study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Von Willebrand disease; Dosing; Population; Clinical trial; Von Willebrand factor; Disease; Clinical research; Antibiotic prophylaxis","score_opus":0.01801113167397286,"score_gpt":0.32348484105047076,"score_spread":0.3054737093764979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417020971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99198115,0.00016669728,3.2520632e-7,0.00068372895,0.0000439933,0.005208936,0.0000067075384,0.00004110823,0.0018673816],"genre_scores_gemma":[0.9956096,0.000036228746,0.00001782178,0.000027009017,0.00006692339,0.00030445342,0.00003245713,0.000024863924,0.0038806403],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979973,0.00024989076,0.00040281497,0.00040569017,0.000665267,0.00027905768],"domain_scores_gemma":[0.99900436,0.000099755525,0.000082533974,0.0005595377,0.00013981268,0.0001140171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031117923,0.00021699516,0.00043376305,0.0003880919,0.00013139272,0.000021422513,0.00016413939,0.00003775233,0.000047223104],"category_scores_gemma":[0.000059837115,0.00012032683,0.00005758103,0.0014783833,0.000047444053,0.000064195156,0.00008915693,0.0002616019,0.000004094007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014023128,0.013418561,0.98076224,0.00019074438,0.00043579694,0.00017484467,0.0019986376,0.00008003955,0.0003203083,0.00001527797,0.00011393782,0.001087269],"study_design_scores_gemma":[0.020041307,0.0025652894,0.9743103,0.00016067545,0.0007793786,0.0000044353733,0.0015041459,0.00007298576,0.00038007324,0.000029603578,0.00003226108,0.00011954236],"about_ca_topic_score_codex":0.0024659687,"about_ca_topic_score_gemma":0.0035284488,"teacher_disagreement_score":0.018638995,"about_ca_system_score_codex":0.000065563676,"about_ca_system_score_gemma":0.0001562227,"threshold_uncertainty_score":0.49067858},"labels":[],"label_agreement":null},{"id":"W4417020974","doi":"10.1182/blood-2025-4858","title":"Systematic literature review and meta-analysis on the safety of fibrinogen concentrate versus cryoprecipitate in bleeding surgical patients","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Trauma, Hemostasis, Coagulopathy, Resuscitation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Global Affairs Canada","funders":"","keywords":"Cryoprecipitate; Systematic review; Adverse effect; Pulmonary embolism; Incidence (geometry); Randomized controlled trial; Population","score_opus":0.029722510053750185,"score_gpt":0.29581548682621894,"score_spread":0.26609297677246874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417020974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7748554,0.21541502,0.0000071682252,0.0027609512,0.00010795649,0.0031040395,0.00013040226,0.000031446503,0.003587674],"genre_scores_gemma":[0.9927082,0.0066910153,0.00007063318,0.0002674538,0.000008455889,0.00006681845,0.000046081088,0.0000081811595,0.00013317663],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9983447,0.00030775537,0.00064507185,0.0002543804,0.00028909097,0.00015896515],"domain_scores_gemma":[0.99850714,0.00071625825,0.00020305459,0.00034059543,0.00018295208,0.00004999449],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006799148,0.00016012686,0.0012355975,0.00017516098,0.000038226783,0.000022186954,0.00008925473,0.00006337145,0.00003627911],"category_scores_gemma":[0.0005047193,0.0000933008,0.0003504451,0.0012121926,0.00004043783,0.00005131404,0.000033869845,0.0001579328,0.000002703973],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037388382,0.0032995383,0.09039638,0.4164683,0.46476826,0.00039246507,0.0053570755,0.000116122785,0.00047097108,0.013584012,0.00059219997,0.0008158601],"study_design_scores_gemma":[0.011093472,0.00046583792,0.059291806,0.021586297,0.90455955,0.000009314154,0.0003017964,0.000091080925,0.00212025,0.00006883202,0.00012189285,0.0002898969],"about_ca_topic_score_codex":0.0000043513373,"about_ca_topic_score_gemma":0.000009424284,"teacher_disagreement_score":0.43979126,"about_ca_system_score_codex":0.000031322837,"about_ca_system_score_gemma":0.000029701434,"threshold_uncertainty_score":0.3804696},"labels":[],"label_agreement":null},{"id":"W4417020989","doi":"10.1182/blood-2025-4857","title":"Comparative analysis of prophylaxis with 1:1 ratio pdVWF/FVIII concentrate vs. recombinant VWF in type 3 von willebrand disease adults in the United States: Clinical and economic perspective","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Von Willebrand disease; Von Willebrand factor; Dosing; Clinical trial; Cost effectiveness; Disease","score_opus":0.014553412844420997,"score_gpt":0.3068797716427972,"score_spread":0.2923263587983762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417020989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99790466,0.00055993535,0.000002375823,0.00047094826,0.000021800683,0.0006327209,0.000035530687,0.000005272222,0.00036674738],"genre_scores_gemma":[0.99903035,0.0006073291,0.000018095801,0.00016261906,0.0000034244893,0.000021381415,0.00012696,0.000003632849,0.000026221247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99910545,0.00014495941,0.00029944952,0.000256153,0.000067771005,0.00012623076],"domain_scores_gemma":[0.9994575,0.000160942,0.00008752541,0.00016645825,0.00007703587,0.000050543964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014012815,0.00011702216,0.0005444669,0.00026388635,0.00002843198,0.000012239774,0.000049818213,0.00003947895,0.000009079815],"category_scores_gemma":[0.000039777446,0.000072225215,0.000050199924,0.00078351126,0.00016315874,0.000041442134,0.000012955811,0.00012940417,0.0000013844382],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005095998,0.0020850035,0.9863952,0.000034912213,0.0015569886,0.00018582412,0.0036041546,0.00018766854,0.0000021263506,0.00075785944,0.000023469798,0.00007082142],"study_design_scores_gemma":[0.016315652,0.0014435687,0.9696785,0.00018829248,0.001603013,0.0000022707698,0.005338269,0.0050057103,0.000046878904,0.00023293514,0.000052962077,0.000091948496],"about_ca_topic_score_codex":0.0012393399,"about_ca_topic_score_gemma":0.0035459278,"teacher_disagreement_score":0.016716676,"about_ca_system_score_codex":0.00003430329,"about_ca_system_score_gemma":0.00020867192,"threshold_uncertainty_score":0.2945259},"labels":[],"label_agreement":null},{"id":"W4417021010","doi":"10.1182/blood-2025-4860","title":"Fibrinogen concentrate versus cryoprecipitate for bleeding in cardiac surgery patients stratified by surgery risk in the phase 3 fibres Study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Trauma, Hemostasis, Coagulopathy, Resuscitation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Kingston Health Sciences Centre; University Health Network; Queen's University","funders":"","keywords":"Cryoprecipitate; Cardiac surgery; Cardiopulmonary bypass; Fibrinogen; Blood transfusion; Extracorporeal circulation; Hemodynamics; Complication","score_opus":0.03385373783729232,"score_gpt":0.3149016801170462,"score_spread":0.2810479422797539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417021010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951595,0.0007530744,0.000012719215,0.00016502144,0.00080705027,0.0024500506,0.00033637852,0.000043672047,0.0002725377],"genre_scores_gemma":[0.9989564,0.00015380158,0.000041666506,0.00005842755,0.00008030134,0.0003271624,0.000332013,0.000023987115,0.000026284297],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975956,0.00042429788,0.0007065532,0.0004385356,0.00036620544,0.0004688025],"domain_scores_gemma":[0.99538934,0.0038742186,0.00018986207,0.00034627432,0.00012879979,0.00007150389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015561344,0.00023425938,0.0006328025,0.00029711524,0.00010288051,0.0000666596,0.00011933566,0.00009351981,0.0000059747167],"category_scores_gemma":[0.0013128907,0.00019952939,0.0001976843,0.0006804389,0.000047778238,0.00015755545,0.000027632555,0.00022033315,0.0000033515144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00226123,0.003251364,0.9676495,0.00014873924,0.0002908484,0.000028783576,0.002114294,0.000007760528,0.0010840591,0.000009174918,0.0046183327,0.0185359],"study_design_scores_gemma":[0.025817035,0.00080315897,0.9451466,0.00036869664,0.0007864264,6.179194e-7,0.007352862,0.00007560088,0.018611806,0.0000741225,0.0006164191,0.00034662048],"about_ca_topic_score_codex":0.00023075491,"about_ca_topic_score_gemma":0.00016272,"teacher_disagreement_score":0.023555804,"about_ca_system_score_codex":0.000084602136,"about_ca_system_score_gemma":0.00024069831,"threshold_uncertainty_score":0.8136572},"labels":[],"label_agreement":null},{"id":"W4417021048","doi":"10.1182/blood-2025-5780","title":"Low skeletal muscle mass and cancer cachexia among patients with multiple myeloma undergoing CAR-T cell therapy","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; Simon Fraser University","funders":"","keywords":"Multiple myeloma; Cachexia; Cancer; Lymphoma; Skeletal muscle; Diffuse large B-cell lymphoma; Chimeric antigen receptor; Rituximab","score_opus":0.008883666690951208,"score_gpt":0.2497956715004315,"score_spread":0.2409120048094803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417021048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963,0.001204588,0.000040421495,0.00009422169,0.000048672737,0.0007823422,0.000035996625,0.00005143453,0.0014423147],"genre_scores_gemma":[0.9975697,0.00038003188,0.00050070207,0.00009184847,0.00004115864,0.000113414295,0.000055879493,0.000028193916,0.0012190868],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879557,0.000039454204,0.0001466395,0.0003471728,0.0002915097,0.0003796445],"domain_scores_gemma":[0.9992843,0.00011048442,0.000047854446,0.00025837077,0.00010489256,0.00019409366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004862323,0.00019751553,0.00024567716,0.00011064945,0.00013545407,0.000033149154,0.00006802165,0.00007682783,0.000055586515],"category_scores_gemma":[0.000037355545,0.00014214385,0.000052024498,0.00019171165,0.000097241405,0.00008567745,0.00003916147,0.0001591493,0.000006371908],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018280026,0.0010030189,0.97360754,0.00014572442,0.00034149754,0.000064595966,0.000112676724,0.0000030898466,0.0032417965,0.000002917522,0.00005351218,0.02124085],"study_design_scores_gemma":[0.024784673,0.00042379732,0.9527444,0.00019379568,0.000113485155,9.895865e-7,0.000069137284,0.00012629597,0.02112901,0.00000836661,0.0002763722,0.00012965947],"about_ca_topic_score_codex":0.0007565913,"about_ca_topic_score_gemma":0.00057644874,"teacher_disagreement_score":0.024601873,"about_ca_system_score_codex":0.000060756607,"about_ca_system_score_gemma":0.00018881529,"threshold_uncertainty_score":0.5796458},"labels":[],"label_agreement":null},{"id":"W4417021106","doi":"10.1182/blood-2025-5794","title":"Tumor flare pain reaction during teclistamab step-up dosing with tocilizumab prophylaxis: An underrecognized toxicity in the outpatient setting","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Dosing; Tocilizumab; Acetaminophen; Toxicity; Adverse effect; Pegfilgrastim; Bone pain; Neutropenia","score_opus":0.017129156851388126,"score_gpt":0.2838537990957559,"score_spread":0.2667246422443678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417021106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99705875,0.00012259993,0.00013569318,0.0003007418,0.000039647413,0.0015493236,0.0000098505325,0.00007421944,0.00070914737],"genre_scores_gemma":[0.99856067,0.0000050699505,0.00079220126,0.00013883805,0.000051238494,0.00020233801,0.000057561618,0.000017834,0.00017427887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99811953,0.00042622,0.00026341708,0.0003677183,0.00043128795,0.00039179396],"domain_scores_gemma":[0.99918264,0.00016217312,0.000079639896,0.0003843761,0.00009725284,0.00009392007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006784199,0.00018315972,0.00024282387,0.00018846325,0.00022796424,0.00006813867,0.00011223024,0.00006574461,0.00000985981],"category_scores_gemma":[0.00047331004,0.000114373484,0.00005376598,0.00042833106,0.000043478718,0.00012999933,0.00003975748,0.00038515372,0.0000045686447],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009660625,0.010346432,0.6435395,0.0020811947,0.00084189686,0.0026938014,0.0053740414,0.0000083617615,0.05569816,0.00007242554,0.00006848869,0.2696151],"study_design_scores_gemma":[0.0435466,0.0038028539,0.8943554,0.0017775028,0.00028925476,0.00021166526,0.010678853,0.001166596,0.043645438,0.00007850768,0.00010364478,0.00034366318],"about_ca_topic_score_codex":0.0004164334,"about_ca_topic_score_gemma":0.0009612289,"teacher_disagreement_score":0.26927143,"about_ca_system_score_codex":0.00021760428,"about_ca_system_score_gemma":0.00021267832,"threshold_uncertainty_score":0.46640152},"labels":[],"label_agreement":null},{"id":"W4417021202","doi":"10.1182/blood-2025-1077","title":"National landscape of real-world pediatric blinatumomab care delivery in the United States: A report from the Children's Oncology Group","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Blinatumomab; Pharmacy; Likert scale; Descriptive statistics; Pharmacist; Pediatric oncology; Lymphoblastic Leukemia","score_opus":0.01199108443506775,"score_gpt":0.29927349704255574,"score_spread":0.287282412607488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417021202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98776597,0.00073511957,0.00001533791,0.0019964424,0.000066246794,0.0005203011,0.00010282494,0.000024465107,0.0087733045],"genre_scores_gemma":[0.9964849,0.00046610035,0.0001890066,0.00089392945,0.0002863198,0.000053592637,0.0014286186,0.000011900707,0.00018568565],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982712,0.00022701352,0.00040332208,0.00025502278,0.0006169563,0.00022646706],"domain_scores_gemma":[0.9972522,0.0018170344,0.00013255824,0.0003875235,0.00037142055,0.0000392384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005797814,0.00012021907,0.0002518452,0.00045619017,0.0000697138,0.000013131538,0.0003181897,0.000103683305,0.000039447583],"category_scores_gemma":[0.00060049497,0.000069695416,0.000071958995,0.001766834,0.00008992999,0.000028976527,0.00012648015,0.00039871776,0.0000062974964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034150505,0.0009909786,0.9679526,0.00007526011,0.00026849238,0.0009045061,0.0020837693,0.000049471542,0.000043062242,0.0006348852,0.02628848,0.00036696089],"study_design_scores_gemma":[0.009049912,0.00023742871,0.98422354,0.000073495314,0.00047129468,0.0001573896,0.0020488165,0.0004334458,0.00008470888,0.0003419442,0.002791064,0.00008694175],"about_ca_topic_score_codex":0.005538966,"about_ca_topic_score_gemma":0.0015616893,"teacher_disagreement_score":0.023497416,"about_ca_system_score_codex":0.00025936254,"about_ca_system_score_gemma":0.0018462689,"threshold_uncertainty_score":0.8373297},"labels":[],"label_agreement":null},{"id":"W4417021249","doi":"10.1182/blood-2025-5785","title":"The evolution to hepta-refractory myeloma involves sequential loss of CD38, BCMA and GPRC5D","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Deutsche Krebshilfe; Bundesministerium für Bildung und Forschung","keywords":"Multiple myeloma; Malignancy; Carfilzomib; Proteasome inhibitor; Bortezomib; Hematologic malignancy; Proteasome; Immunohistochemistry; Antibody","score_opus":0.016163841067426375,"score_gpt":0.3010828026486136,"score_spread":0.28491896158118724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417021249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934771,0.002145684,0.00007590772,0.00091687264,0.000080806814,0.00033192185,0.000013831609,0.000023934283,0.0029339627],"genre_scores_gemma":[0.9967978,0.00014651522,0.00025441332,0.00007219726,0.00006580719,0.000036654237,0.00001109096,0.000007823453,0.0026077116],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99912024,0.00005354465,0.00017404443,0.00018245462,0.0002397496,0.00022999423],"domain_scores_gemma":[0.99933517,0.00011904026,0.00003461683,0.00027339376,0.000105745006,0.0001320063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015428803,0.00009871319,0.00017113241,0.00010835653,0.00012903832,0.000018517345,0.000079820646,0.000055567307,0.000020009324],"category_scores_gemma":[0.00024542323,0.00006430843,0.000056903504,0.00019094464,0.00012318388,0.000042391912,0.000092780174,0.00010121607,0.0000189947],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014463965,0.0017548958,0.8224489,0.0003851222,0.001449768,0.00018325588,0.0005043283,0.0000013345996,0.10974258,0.004336405,0.0019103779,0.055836614],"study_design_scores_gemma":[0.0067192125,0.00070005516,0.93741566,0.00020825949,0.00026787035,0.00002704146,0.00028126317,0.00005278998,0.04585218,0.00048806253,0.007888422,0.00009917184],"about_ca_topic_score_codex":0.00031122947,"about_ca_topic_score_gemma":0.0001661013,"teacher_disagreement_score":0.11496676,"about_ca_system_score_codex":0.00005997711,"about_ca_system_score_gemma":0.00018438818,"threshold_uncertainty_score":0.26224214},"labels":[],"label_agreement":null},{"id":"W4417021412","doi":"10.1182/blood-2025-3803","title":"Preliminary experience from the ODYSSEY trial: Efficacy and safety of momelotinib in combination with luspatercept in patients with transfusion-dependent myelofibrosis","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ruxolitinib; Myelofibrosis; Anemia; Phases of clinical research; Clinical trial; Randomized controlled trial; Deferasirox","score_opus":0.00808731145729626,"score_gpt":0.23912464614956824,"score_spread":0.23103733469227197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417021412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99692434,0.0001147924,0.000021732356,0.0004990293,0.000029979119,0.00218592,0.00001925174,0.000008638398,0.00019633313],"genre_scores_gemma":[0.9992188,0.00014736244,0.00021252857,0.00007394919,0.0000069574194,0.00025649322,0.000045092485,0.000010175566,0.00002861243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892694,0.00008855291,0.00030822874,0.00028987136,0.0002545595,0.00013182749],"domain_scores_gemma":[0.9993218,0.0002938206,0.000072371666,0.00021136134,0.00006263052,0.00003802609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009597619,0.00015152359,0.0003304634,0.00009107358,0.000047852598,0.000011328613,0.000061031653,0.00005566691,0.00003465352],"category_scores_gemma":[0.000039070663,0.00008470865,0.000020555814,0.00025358607,0.00007368798,0.000059553568,0.000026815054,0.00010476389,7.547309e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03810086,0.006090945,0.94781405,0.000029674988,0.000084430634,0.000009526088,0.0046267286,0.000008708074,0.00010910917,0.000050400893,0.000003924027,0.0030716439],"study_design_scores_gemma":[0.14560635,0.003969344,0.8442994,0.0006753395,0.000133863,7.3962906e-7,0.0003642213,0.000009117872,0.0048532216,0.000010695907,0.000007672098,0.00007005103],"about_ca_topic_score_codex":0.00060980074,"about_ca_topic_score_gemma":0.00063252676,"teacher_disagreement_score":0.10750549,"about_ca_system_score_codex":0.000035330566,"about_ca_system_score_gemma":0.00006486683,"threshold_uncertainty_score":0.34543186},"labels":[],"label_agreement":null},{"id":"W4417021452","doi":"10.1182/blood-2025-3767","title":"Emergence of new somatic mutations in CML patients optimally responding to tyrosine kinase inhibitor therapy: Proposal of long-term genomic monitoring","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Somatic cell; Germline mutation; Epigenetics; RUNX1; Myeloid leukemia; Somatic evolution in cancer; Trisomy 8; Spliceosome; Myeloid; Imatinib mesylate","score_opus":0.016867897445763384,"score_gpt":0.29805066500865546,"score_spread":0.28118276756289207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417021452","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979259,0.00061739696,0.000050245086,0.0001122787,0.00016173536,0.00096600066,0.000008575568,0.000020852598,0.00013705599],"genre_scores_gemma":[0.9926669,0.000051611507,0.006696557,0.000013957422,0.000058225465,0.000040081104,0.000019288183,0.000019815758,0.00043356474],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881107,0.000032850527,0.0005055631,0.00022919061,0.00021861288,0.00020272216],"domain_scores_gemma":[0.99934876,0.000048077265,0.00013039735,0.00029832913,0.00008443901,0.00008998836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000919042,0.0001461466,0.0003164477,0.0005607933,0.0000275243,0.0000058874407,0.000113578855,0.00005785878,0.000054266293],"category_scores_gemma":[0.00011982538,0.00013667012,0.00006240131,0.0006912135,0.000027028002,0.00006225414,0.00006197846,0.00008869886,0.00000793427],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002512891,0.001138041,0.7626321,0.00021635284,0.000118193566,0.00002597929,0.0010441267,0.000056020213,0.22936428,0.000016533797,0.000022947934,0.0051141954],"study_design_scores_gemma":[0.00723975,0.00041403878,0.62765074,0.0009800077,0.00011013688,0.0000019065901,0.00007624205,0.000019162397,0.36341962,0.000016709088,0.0000021914861,0.000069491485],"about_ca_topic_score_codex":0.00010129234,"about_ca_topic_score_gemma":0.000016124059,"teacher_disagreement_score":0.13498132,"about_ca_system_score_codex":0.00017673074,"about_ca_system_score_gemma":0.0007749255,"threshold_uncertainty_score":0.5573246},"labels":[],"label_agreement":null},{"id":"W4417021539","doi":"10.1182/blood-2025-3809","title":"Impact of new or worsening anemia and thrombocytopenia on clinical outcomes in JAK inhibitor–naive myelofibrosis patients treated with ruxolitinib","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ruxolitinib; Myelofibrosis; Anemia; Platelet; Post-hoc analysis; Spleen; Hemoglobin; Subgroup analysis","score_opus":0.03194674096498619,"score_gpt":0.3559187528937559,"score_spread":0.32397201192876973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417021539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976697,0.000054111682,7.5585615e-7,0.00020127099,0.000031798478,0.0007681467,0.000035490775,0.000023182467,0.0012155275],"genre_scores_gemma":[0.9985255,0.000085503816,0.000546815,0.00018047872,0.000035257126,0.00003571082,0.000039921008,0.00001807653,0.0005327186],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857706,0.000073137155,0.000520039,0.00038162674,0.00020088941,0.0002472257],"domain_scores_gemma":[0.9989146,0.000436671,0.0001420283,0.0002424296,0.000091498,0.00017274737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000093849405,0.00026243587,0.0008885447,0.00017573981,0.000040851435,0.00001882051,0.000046748366,0.00012753466,0.0000686058],"category_scores_gemma":[0.00023479386,0.00014643207,0.00012778903,0.00029838228,0.000073808464,0.000055869674,0.000041070725,0.00017882996,0.000005304324],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00195072,0.003471696,0.9905149,0.000041535495,0.00058741774,0.000060714883,0.00023092983,0.0000011538649,0.000049750273,0.00004003447,0.00035222902,0.002698943],"study_design_scores_gemma":[0.02386281,0.007838487,0.9629698,0.0007861129,0.00043572666,0.0000054798934,0.00004958874,0.0000026950374,0.0038864538,0.000010723189,0.000028536691,0.00012361577],"about_ca_topic_score_codex":0.0006814097,"about_ca_topic_score_gemma":0.00020179684,"teacher_disagreement_score":0.027545106,"about_ca_system_score_codex":0.00007170634,"about_ca_system_score_gemma":0.000308612,"threshold_uncertainty_score":0.5971327},"labels":[],"label_agreement":null},{"id":"W4417021621","doi":"10.1182/blood-2025-3127","title":"Plasma protein biomarkers associated with venous thromboembolism (VTE) and mortality in patients with cancer: A substudy of the avert trial","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Proportional hazards model; Hazard ratio; Biomarker; Population; Randomized controlled trial; Prospective cohort study; Apixaban; Placebo; Venous thromboembolism; Troponin T","score_opus":0.00758977856126162,"score_gpt":0.2369712596571165,"score_spread":0.22938148109585488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417021621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958353,0.00010611853,3.1505192e-7,0.00006685666,0.00007992745,0.003427543,0.000049834627,0.000028208498,0.00040586607],"genre_scores_gemma":[0.9995494,0.0000039434844,0.00003283664,0.000042210577,0.000011663493,0.00030746014,0.0000111383215,0.000016592141,0.000024785757],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867857,0.00013342242,0.00029461156,0.00027564858,0.00039593663,0.00022184192],"domain_scores_gemma":[0.99925464,0.000043534295,0.00018604875,0.0003239655,0.00013479136,0.000057026366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024254956,0.00017302035,0.00044046214,0.000095383526,0.000070020316,0.000011160448,0.000114841976,0.00009676653,0.000010245786],"category_scores_gemma":[0.0001531945,0.00010636355,0.000049956194,0.00052245555,0.00022971568,0.000043327844,0.00006237338,0.00013169237,2.0805255e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013952418,0.0036402086,0.97958803,0.00015125815,0.0019168023,0.000014323209,0.00022434459,3.832429e-7,0.0001237706,0.0000128400025,0.000021113965,0.0003545012],"study_design_scores_gemma":[0.091126494,0.00060768257,0.9024475,0.00094731024,0.0010596325,4.2992386e-7,0.00005524847,0.000011172821,0.003615254,0.000018378967,0.000004162338,0.00010672744],"about_ca_topic_score_codex":0.00024613927,"about_ca_topic_score_gemma":0.0005728846,"teacher_disagreement_score":0.077174075,"about_ca_system_score_codex":0.00007836511,"about_ca_system_score_gemma":0.0003920489,"threshold_uncertainty_score":0.43373796},"labels":[],"label_agreement":null},{"id":"W4417021721","doi":"10.1182/blood-2025-3795","title":"The activin receptor-like kinase-2 inhibitor zilurgisertib (INCB000928) as monotherapy or with ruxolitinib in patients with anemia due to myelofibrosis: Phase 1/2 study final results","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Ruxolitinib; Myelofibrosis; Anemia; Pharmacokinetics; Hepcidin; Phases of clinical research; Regimen; Toxicity","score_opus":0.012428506558766855,"score_gpt":0.2869146319855738,"score_spread":0.27448612542680695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417021721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911201,0.00009506327,0.0000044234666,0.0022541166,0.00010713295,0.0053857057,0.00007091484,0.00006781231,0.00089470757],"genre_scores_gemma":[0.99453217,0.000030184961,0.00049916544,0.0007745034,0.000096478914,0.0018372926,0.000064067666,0.000049157876,0.002116965],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99739367,0.00017642126,0.00056160847,0.00075704535,0.00058621424,0.00052506325],"domain_scores_gemma":[0.9982998,0.00035799405,0.00015888002,0.0007167108,0.00023399624,0.00023263115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002639513,0.00044433412,0.00061329175,0.00020747326,0.0002881799,0.00010538539,0.00017510557,0.00009805049,0.000058894748],"category_scores_gemma":[0.0001507529,0.00023192953,0.000059074406,0.0007679521,0.00006896711,0.0001094124,0.00005753775,0.00027891513,0.000037661554],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5238595,0.060480975,0.38947764,0.00007753276,0.0010364424,0.00054805074,0.0031110859,0.000010117287,0.0002565592,0.000075412194,0.0031558005,0.017910877],"study_design_scores_gemma":[0.45736033,0.06844202,0.43740416,0.001218277,0.00047211387,0.000013626586,0.0013424882,0.0000038593594,0.02440432,0.000012372793,0.008861136,0.00046532534],"about_ca_topic_score_codex":0.00028930654,"about_ca_topic_score_gemma":0.0011017915,"teacher_disagreement_score":0.066499196,"about_ca_system_score_codex":0.00020470678,"about_ca_system_score_gemma":0.00053057575,"threshold_uncertainty_score":0.9457812},"labels":[],"label_agreement":null},{"id":"W4417021874","doi":"10.1182/blood-2025-1608","title":"Clinical, cytogenetic and molecular characteriszation of Mecom- rearranged pediatric de novo Acute Myeloid Leukemia (AML): A retrospective cohort study of the international-berlin-frankfurt-Münster (I-BFM) AML-study group","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Retrospective cohort study; Myeloid leukemia; Leukemia; Acute promyelocytic leukemia; Chemotherapy regimen; Cohort; Myeloid; Myeloid sarcoma; Chemotherapy","score_opus":0.012258294986843186,"score_gpt":0.3076906259428016,"score_spread":0.29543233095595844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417021874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995301,0.00016088021,0.000106934494,0.00031731994,0.00022319217,0.0031581332,0.000038998456,0.000032388336,0.0006611231],"genre_scores_gemma":[0.9984399,0.0003556361,0.00028465726,0.00023065567,0.00016192776,0.00015899591,0.000021492351,0.000038729828,0.00030801943],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968138,0.0004279221,0.0009812706,0.00062364445,0.0008534121,0.00029994725],"domain_scores_gemma":[0.9978941,0.00019252714,0.00039433516,0.00088413997,0.00052035163,0.00011454668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001464279,0.00025194293,0.00076393003,0.0003424562,0.00009278377,0.000030764582,0.00050188054,0.00017970662,0.000038323873],"category_scores_gemma":[0.0005757577,0.00019816923,0.00017643918,0.0008136951,0.00014905269,0.000074411095,0.0004611774,0.0005776792,0.0000036690426],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005319024,0.0029155961,0.95721567,0.000073182215,0.0019328305,0.00009196609,0.0009933877,0.0000018071818,0.035798945,0.000014929602,0.00010697946,0.00032279704],"study_design_scores_gemma":[0.0127442395,0.0014871452,0.9768261,0.00006199052,0.002671651,0.000040430732,0.00060202484,0.00009462118,0.0052585322,0.000040975247,0.000035455032,0.00013687953],"about_ca_topic_score_codex":0.0002886231,"about_ca_topic_score_gemma":0.00017487239,"teacher_disagreement_score":0.030540412,"about_ca_system_score_codex":0.00035789932,"about_ca_system_score_gemma":0.00052625156,"threshold_uncertainty_score":0.80811065},"labels":[],"label_agreement":null},{"id":"W4417021970","doi":"10.1182/blood-2025-4119","title":"Identifying splice variants of cell surface proteins for chimeric antigen receptor T cell therapy of Acute Myeloid Leukemia","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute","funders":"","keywords":"Gene isoform; Alternative splicing; Myeloid leukemia; Transcriptome; Protein isoform; Exon; Intron; Chimeric antigen receptor; RNA splicing","score_opus":0.025361823637314998,"score_gpt":0.3108893188318013,"score_spread":0.28552749519448634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417021970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98718315,0.0020723238,0.0012260305,0.00009480699,0.00014488447,0.0024010208,0.00007853165,0.000039645245,0.006759629],"genre_scores_gemma":[0.94430065,0.0057151266,0.026248157,0.00009577798,0.000116989526,0.00009373717,0.00005552492,0.0000769146,0.023297137],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983067,0.00007627817,0.00046333135,0.00037869462,0.00038949755,0.0003855008],"domain_scores_gemma":[0.9986789,0.00013898454,0.00020987153,0.0006080864,0.0002720938,0.00009201372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047920813,0.00020220975,0.00057189504,0.00017903428,0.00006772396,0.000012672249,0.0003013726,0.0001454942,0.0005261588],"category_scores_gemma":[0.00002776898,0.00018475525,0.00023368513,0.00063915603,0.00009050582,0.00006566244,0.00008005007,0.00021607727,0.000012785585],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086025044,0.000893412,0.0038911328,0.00063416426,0.0005505676,0.000004672079,0.0005049056,0.000003300095,0.9907766,0.000015220445,0.00044306734,0.0014227347],"study_design_scores_gemma":[0.008123314,0.0006595023,0.0067126467,0.00017128076,0.00017286744,0.0000035875776,0.00010382391,0.000054617136,0.9814745,0.000053141575,0.0023369952,0.00013368287],"about_ca_topic_score_codex":0.00025778063,"about_ca_topic_score_gemma":0.0000045569464,"teacher_disagreement_score":0.04288249,"about_ca_system_score_codex":0.00006419231,"about_ca_system_score_gemma":0.0005974539,"threshold_uncertainty_score":0.75341004},"labels":[],"label_agreement":null},{"id":"W4417022292","doi":"10.1182/blood-2025-4654","title":"Efficacy and safety of mitapivat in pediatric patients with pyruvate kinase deficiency who are not regularly transfused: Results from the Phase 3, global, randomized, double-blind, placebo-controlled ACTIVATE-Kids trial","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Pyruvate kinase deficiency; Pyruvate kinase; Hemolytic anemia; Anemia; Glucose-6-phosphate dehydrogenase deficiency; Splenectomy; Placebo; Deferasirox; Clinical trial","score_opus":0.015483998674833433,"score_gpt":0.2656738063171086,"score_spread":0.25018980764227516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417022292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912464,0.0005697579,0.00009945744,0.0008725661,0.00028444378,0.0058865803,0.00022824512,0.000039781116,0.00077274116],"genre_scores_gemma":[0.9986012,0.00042534675,0.00007737919,0.000291797,0.00017345326,0.00016346188,0.00014723132,0.000015801037,0.00010435821],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9973925,0.0004551766,0.0009617004,0.0005500056,0.00034425998,0.00029635415],"domain_scores_gemma":[0.99715585,0.0016614305,0.00039859084,0.00049861707,0.00018191642,0.0001035744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007147904,0.00030699867,0.0014668417,0.00016994437,0.00012221625,0.00002394957,0.00015035324,0.0002146761,0.000017221048],"category_scores_gemma":[0.0008883724,0.00018057438,0.00021016817,0.0007059797,0.00021401336,0.00008999558,0.000035964167,0.00031829128,0.0000024029612],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9894536,0.0041222163,0.0045182994,0.00006050774,0.00029383978,0.000015245949,0.00033923401,0.000016070928,0.0004787513,0.00009698587,0.00009529767,0.0005099454],"study_design_scores_gemma":[0.9767034,0.0015667145,0.01832568,0.00022667836,0.0018570285,8.7179933e-7,0.00010543298,0.000024955416,0.0009189069,0.000044004428,0.000057877085,0.00016847024],"about_ca_topic_score_codex":0.0001823598,"about_ca_topic_score_gemma":0.000093994124,"teacher_disagreement_score":0.0138073815,"about_ca_system_score_codex":0.00003732133,"about_ca_system_score_gemma":0.00023106807,"threshold_uncertainty_score":0.73636097},"labels":[],"label_agreement":null},{"id":"W4417022293","doi":"10.1182/blood-2025-4649","title":"Assessing the impact of an OSCE-style workshop on internal medicine residents' ability to manage hematologic emergencies: An iterative pilot study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Simulation-Based Education in Healthcare","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; McMaster University Medical Centre; University Health Network","funders":"","keywords":"Competence (human resources); Hematology; Curriculum; Debriefing; Hematologic Neoplasms; Autoimmune hemolytic anemia; Psychological intervention; Medical school","score_opus":0.09246436778503898,"score_gpt":0.4828306487294628,"score_spread":0.3903662809444238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417022293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952858,0.00008971364,0.00012026134,0.0019081507,0.00028582383,0.0013761456,0.0000052826686,0.000055932047,0.00087289757],"genre_scores_gemma":[0.9988498,0.000001934794,0.00017284509,0.00055107917,0.00016947433,0.00007643864,0.000020511854,0.000014375302,0.00014354957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979046,0.00049685786,0.00060641137,0.00040444933,0.00037172996,0.00021595544],"domain_scores_gemma":[0.9973122,0.0010044057,0.00017121548,0.00090699684,0.00042770387,0.00017746523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009301188,0.00018548108,0.00038103142,0.00026244344,0.00017010588,0.000035096207,0.00024736914,0.000044735112,0.0003698493],"category_scores_gemma":[0.0014297777,0.00011396783,0.00005243923,0.00069772,0.00008772506,0.00016199116,0.000046734032,0.00027301486,0.0000052170967],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003567072,0.005664581,0.97297496,0.00012674608,0.00012314935,0.000013122493,0.018697256,0.00050117687,0.0008297772,0.00006142608,0.0002635019,0.00038762548],"study_design_scores_gemma":[0.0016848777,0.005505237,0.95334256,0.0004901473,0.00014419346,0.000004815188,0.03767637,0.00046122685,0.00038871446,0.0002199215,0.0000016455527,0.00008029682],"about_ca_topic_score_codex":0.0031984567,"about_ca_topic_score_gemma":0.00023452085,"teacher_disagreement_score":0.019632379,"about_ca_system_score_codex":0.00017702949,"about_ca_system_score_gemma":0.00022327922,"threshold_uncertainty_score":0.48351312},"labels":[],"label_agreement":null},{"id":"W4417022354","doi":"10.1182/blood-2025-5488","title":"Subgroup analysis in pediatric patients from the Phase 3 study of tabelecleucel for allogeneic or solid organ transplant recipients with Epstein–Barr virus-driven post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE)","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Rituximab; Population; Subgroup analysis; Lymphoproliferative disorders; Hazard ratio; Phases of clinical research; Transplantation; Salvage therapy; Clinical trial","score_opus":0.0060490942018682995,"score_gpt":0.25234412472186746,"score_spread":0.24629503051999915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417022354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99441725,0.0006139432,0.00012244633,0.0002778533,0.000024252104,0.00220607,0.0023172288,0.000016721398,0.000004250751],"genre_scores_gemma":[0.9978787,0.000697065,0.00014052533,0.0004247158,0.000030142071,0.00030405243,0.00045768853,0.000034144352,0.000033021188],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980391,0.00011323507,0.0006037868,0.00052129064,0.00038832644,0.00033424204],"domain_scores_gemma":[0.99888414,0.00014069544,0.00024003044,0.00034838342,0.00025006232,0.00013668423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012579147,0.00032744874,0.0009540093,0.00029568005,0.00008781943,0.000018096063,0.00017689406,0.000116049414,0.00006218563],"category_scores_gemma":[0.000040273208,0.00019252537,0.00015749918,0.0010535745,0.00007734452,0.000085730615,0.000018911265,0.00013367155,3.723447e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047248114,0.023014776,0.9189206,0.00017136453,0.0027213513,0.000054676162,0.006757274,0.00001520288,0.000700338,0.0000011338378,0.000024352988,0.00037082547],"study_design_scores_gemma":[0.18780132,0.0052099396,0.79082346,0.00020344817,0.012522301,8.716176e-7,0.0013539551,0.00014832233,0.0016401367,0.000010663102,0.000012190809,0.00027342033],"about_ca_topic_score_codex":0.0006573811,"about_ca_topic_score_gemma":0.013555198,"teacher_disagreement_score":0.1405532,"about_ca_system_score_codex":0.00005623831,"about_ca_system_score_gemma":0.0003757575,"threshold_uncertainty_score":0.7850957},"labels":[],"label_agreement":null},{"id":"W4417022382","doi":"10.1182/blood-2025-4143","title":"First-in-human study of CTX130, a CD70-directed allogeneic CAR T therapy, in adult T-cell leukemia/lymphoma: Clinical and genomics findings from a long-term follow-up of subgroup analysis from the cobalt-LYM Phase 1 trial","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and Retrovirus Studies","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Fludarabine; Cyclophosphamide; Clinical endpoint; Clinical trial; Survival analysis; Malignancy; Subgroup analysis; Lenalidomide; Dosing","score_opus":0.0184909170257456,"score_gpt":0.2819544354967021,"score_spread":0.2634635184709565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417022382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99002343,0.008284792,0.0000036124,0.000024477551,0.00041822385,0.0009387649,0.00024436353,0.00002576916,0.00003657385],"genre_scores_gemma":[0.99787337,0.0016793646,0.000014215338,0.00004866212,0.000038535705,0.000057595007,0.0001352052,0.00001466201,0.00013836852],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973027,0.00058798486,0.001141141,0.00058905804,0.00006529102,0.00031382998],"domain_scores_gemma":[0.9981401,0.0009240213,0.00032596724,0.000505492,0.00008217557,0.000022244478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041162354,0.0002918199,0.0012560413,0.00026036863,0.0001731247,0.000012825789,0.00042628564,0.0003754131,0.000040833063],"category_scores_gemma":[0.00011419663,0.00020992299,0.00032789574,0.0005993397,0.00038892313,0.000028929964,0.00023161898,0.00027943202,0.000002680913],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01152614,0.007727223,0.89715296,0.000014798221,0.0057757315,0.000020694732,0.0045689265,0.0000034341872,0.072458856,0.000007070082,0.00005675694,0.0006873845],"study_design_scores_gemma":[0.27272418,0.0017599234,0.703162,0.00004942821,0.0025285485,6.354227e-7,0.0014574588,0.000007645571,0.018026302,0.000034214725,0.000036786398,0.00021289896],"about_ca_topic_score_codex":0.016626421,"about_ca_topic_score_gemma":0.04968617,"teacher_disagreement_score":0.261198,"about_ca_system_score_codex":0.00005341479,"about_ca_system_score_gemma":0.00013175215,"threshold_uncertainty_score":0.9899219},"labels":[],"label_agreement":null},{"id":"W4417022450","doi":"10.1182/blood-2025-4653","title":"Adapting the American society of hematology crti-la model to build clinical research capacity in Mexico: Results from the ameh-I3 course","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Health and Medical Research Impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Clinical research; Clinical trial; Latin Americans; MEDLINE; Capacity building; Research ethics; Alternative medicine","score_opus":0.4536585827864832,"score_gpt":0.5527332373745935,"score_spread":0.09907465458811027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417022450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8072,0.00024207176,0.00037557006,0.18941277,0.00003522088,0.0006455151,0.000052318464,0.000016726548,0.0020197756],"genre_scores_gemma":[0.97666657,0.00047721452,0.0028821786,0.019575505,0.00014257095,0.000044796867,0.000006303644,0.000011953831,0.00019290831],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99543303,0.001361618,0.0008176801,0.00038828832,0.000973163,0.0010262001],"domain_scores_gemma":[0.9794288,0.017139403,0.00017129748,0.0011054615,0.00043049786,0.0017245378],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.015687993,0.00011759194,0.0005543832,0.0000686321,0.00015319166,0.0000145459535,0.00043297745,0.00016049792,0.0000065052222],"category_scores_gemma":[0.08519902,0.0000643893,0.00014273211,0.00098071,0.0013630617,0.00002447096,0.00025873166,0.002035813,0.000011201101],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058390154,0.0065285484,0.23972999,0.00038418328,0.0006633133,0.00014308239,0.009368911,0.00013982752,0.0037396646,0.0044333064,0.6446379,0.08439231],"study_design_scores_gemma":[0.035692982,0.00491243,0.73980933,0.0052052215,0.0005197249,0.000068189554,0.018554477,0.08251731,0.012768435,0.008980292,0.09038316,0.0005884642],"about_ca_topic_score_codex":0.004513079,"about_ca_topic_score_gemma":0.0006428412,"teacher_disagreement_score":0.5542547,"about_ca_system_score_codex":0.00006692815,"about_ca_system_score_gemma":0.0052488633,"threshold_uncertainty_score":0.9311258},"labels":[],"label_agreement":null},{"id":"W4417022496","doi":"10.1182/blood-2025-6146","title":"Financial and clinical implications of xromi as a new commercial liquid formulation of hydroxyurea","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Providence Health Care","funders":"","keywords":"Hydroxycarbamide; Pharmacy; Authorization; Product (mathematics); Disease; Sickle cell anemia","score_opus":0.014081976569092356,"score_gpt":0.317073671816487,"score_spread":0.3029916952473946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417022496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882409,0.00044054902,0.00018576987,0.004304866,0.00005570991,0.00022707229,0.0000058133696,0.0000123253685,0.0065269945],"genre_scores_gemma":[0.9987343,0.00028023645,0.0003018812,0.0004067629,0.000044696186,0.0000022680194,0.000012491077,0.0000041172884,0.00021324531],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993975,0.000014651451,0.0003521823,0.00009948949,0.000058674068,0.000077474724],"domain_scores_gemma":[0.9995873,0.00006349259,0.000082824736,0.00014965607,0.000056315865,0.000060424416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009889639,0.000054987442,0.00022260968,0.000059646314,0.000029328568,0.0000016349898,0.000036325084,0.00015332257,0.000012924645],"category_scores_gemma":[0.0003840831,0.000047422633,0.00007959804,0.00016144957,0.000056059132,0.00002027288,0.000029217907,0.00010565204,0.0000018621716],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025534572,0.005884556,0.7184467,0.0006581321,0.00078932213,0.000008469361,0.001049282,0.000008769072,0.025171265,0.121237084,0.015922198,0.10827078],"study_design_scores_gemma":[0.015108399,0.0023636005,0.95144206,0.0004296821,0.0014464785,0.000023397733,0.00006804909,0.00007481301,0.01206643,0.008464253,0.008367994,0.0001448152],"about_ca_topic_score_codex":0.00013625753,"about_ca_topic_score_gemma":0.000026832688,"teacher_disagreement_score":0.2329954,"about_ca_system_score_codex":0.000004064561,"about_ca_system_score_gemma":0.00035574767,"threshold_uncertainty_score":0.19338387},"labels":[],"label_agreement":null},{"id":"W4417023440","doi":"10.1182/blood-2025-5579","title":"Survival outcomes in ruxolitinib-treated patients with myelofibrosis following crossover to momelotinib: Application of the response to ruxolitinib at 6 months (RR6) prognostic model to SIMPLIFY-1","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ruxolitinib; Myelofibrosis; Discontinuation; Post-hoc analysis; Survival analysis; Population; Clinical trial; Phases of clinical research","score_opus":0.009425352301015117,"score_gpt":0.27461878846563686,"score_spread":0.26519343616462177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417023440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908307,0.000018320417,0.00016820473,0.0026584552,0.00007471166,0.005173594,0.00025659305,0.000060167964,0.0007592474],"genre_scores_gemma":[0.99461854,0.0000012473377,0.0013130719,0.0010724562,0.000017604645,0.0018922961,0.000049649236,0.000048701168,0.0009864566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974402,0.00014572735,0.0006196568,0.0006624309,0.00060838356,0.00052356475],"domain_scores_gemma":[0.9979142,0.0006262465,0.00012087636,0.0007696862,0.00027871015,0.0002902773],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029230828,0.0003799233,0.0007824617,0.00029393766,0.00015948586,0.000033570068,0.00022160883,0.00011374905,0.000009743424],"category_scores_gemma":[0.0009497441,0.0002526423,0.00018104113,0.0009977886,0.000035162535,0.000058800997,0.00026161625,0.00012410092,0.000035239624],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003749411,0.002369738,0.98881245,0.000055373315,0.0002664074,0.000007125499,0.0008838013,0.0007994009,0.0023117773,0.00026102562,0.00009041462,0.0003930559],"study_design_scores_gemma":[0.009022432,0.0008257077,0.96316564,0.0004382428,0.00036641324,5.732134e-7,0.00009468453,0.00010609274,0.025505155,0.000032110176,0.00021610066,0.0002268618],"about_ca_topic_score_codex":0.00025577482,"about_ca_topic_score_gemma":0.0004640652,"teacher_disagreement_score":0.025646843,"about_ca_system_score_codex":0.00026241504,"about_ca_system_score_gemma":0.00019069725,"threshold_uncertainty_score":0.9999926},"labels":[],"label_agreement":null},{"id":"W4417023442","doi":"10.1182/blood-2025-5581","title":"Impact of hemoglobin improvement with momelotinib on survival in patients with myelofibrosis and anemia: Post hoc analyses of the simplify-1 and momentum trials","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Post-hoc analysis; Ruxolitinib; Myelofibrosis; Anemia; Hazard ratio; Survival analysis; Clinical trial; Clinical endpoint","score_opus":0.018701950883845655,"score_gpt":0.312995108099779,"score_spread":0.29429315721593335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417023442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979888,0.00018116231,0.0000011614273,0.00023701864,0.000017421095,0.0012227184,0.0001642377,0.000005274292,0.00018219018],"genre_scores_gemma":[0.9996578,0.00007834509,0.00008819771,0.00005200145,0.00000807991,0.000050543775,0.000023660636,0.000010893041,0.00003046358],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987602,0.00009760305,0.00041765423,0.0002699221,0.00028645637,0.00016815911],"domain_scores_gemma":[0.9990028,0.00027084432,0.0002473329,0.0002605379,0.00015241586,0.00006607083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021899382,0.00021360158,0.00077664683,0.00015253537,0.00003864823,0.000012410699,0.00004738165,0.000054610744,0.000013260764],"category_scores_gemma":[0.00011060105,0.00009863601,0.000080312195,0.00032065235,0.00009603417,0.000033943168,0.000048725822,0.000084385065,1.366897e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028862301,0.0027215139,0.98584914,0.00015092366,0.0008720435,0.0000028734225,0.00012882614,0.000010238315,0.0055989437,0.000047618603,0.00001795514,0.0017136954],"study_design_scores_gemma":[0.01972156,0.010087106,0.8922783,0.00046277736,0.0007435166,0.000001033343,0.00008906619,0.0000025545257,0.07652548,0.000009960407,0.0000017608581,0.000076847],"about_ca_topic_score_codex":0.00032709658,"about_ca_topic_score_gemma":0.00007971286,"teacher_disagreement_score":0.0935708,"about_ca_system_score_codex":0.000049675553,"about_ca_system_score_gemma":0.00013667838,"threshold_uncertainty_score":0.40222597},"labels":[],"label_agreement":null},{"id":"W4417023476","doi":"10.1182/blood-2025-5574","title":"INCB057643, a bromodomain and extra-terminal protein inhibitor, in combination with ruxolitinib in patients with myelofibrosis: A phase 1 study of safety and efficacy","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ruxolitinib; Myelofibrosis; Tolerability; Anemia; Myeloproliferative neoplasm; Bromodomain; Phases of clinical research; Phlebotomy; Adverse effect","score_opus":0.0070089788861592605,"score_gpt":0.2553300017353423,"score_spread":0.24832102284918306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417023476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99628496,0.00010145407,0.000006582773,0.000094931085,0.0000053493873,0.00334463,0.0000136563485,0.000010453272,0.00013799687],"genre_scores_gemma":[0.9992476,0.000008822907,0.00037414112,0.000021643335,0.000005192998,0.00028537647,0.0000230449,0.000011651036,0.000022487051],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988628,0.00009895285,0.00033596827,0.00032212865,0.00021835728,0.00016177619],"domain_scores_gemma":[0.99953866,0.00007946256,0.00009481686,0.00014929286,0.00007422472,0.000063519874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013713507,0.00017972122,0.00042525772,0.00023325454,0.0000403924,0.000014812662,0.000027036833,0.000049918584,0.000004053653],"category_scores_gemma":[0.00004002342,0.00012739419,0.0000117192585,0.00030649005,0.000068537396,0.000073506526,0.00003229633,0.00011663759,1.833958e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005656309,0.039668404,0.94621277,0.00017902986,0.00011536149,0.000089897214,0.0017749219,6.361507e-7,0.0001933971,0.00017645846,0.0000011719385,0.0059316745],"study_design_scores_gemma":[0.13982998,0.014055015,0.84077,0.0014717191,0.00016898436,0.0000070600277,0.00041588146,0.000011926443,0.0031467052,0.000019425974,0.0000057619873,0.000097539116],"about_ca_topic_score_codex":0.00012372462,"about_ca_topic_score_gemma":0.00029921852,"teacher_disagreement_score":0.13417368,"about_ca_system_score_codex":0.000039160615,"about_ca_system_score_gemma":0.0000839982,"threshold_uncertainty_score":0.51949847},"labels":[],"label_agreement":null},{"id":"W4417023485","doi":"10.1182/blood-2025-5588","title":"Comprehensive analyses of patient-reported outcomes from the phase 3 VERIFY study of rusfertide or placebo plus current standard of care for polycythemia vera","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Phlebotomy; Polycythemia vera; Placebo; Clinical endpoint; Myeloproliferative neoplasm; Hematocrit; Ruxolitinib; Clinical trial","score_opus":0.06118410426330739,"score_gpt":0.3977018425519126,"score_spread":0.3365177382886052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417023485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938312,0.002491434,0.000031356587,0.00010259104,0.00013740864,0.0024792226,0.0008560758,0.000012089752,0.000058591108],"genre_scores_gemma":[0.99923146,0.000082665705,0.00025047245,0.00004680044,0.00001798704,0.00023123974,0.00011771321,0.00001222641,0.0000094286215],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984436,0.00007272774,0.0007090313,0.00025503128,0.00038111184,0.00013850104],"domain_scores_gemma":[0.99771005,0.00088697905,0.00028630006,0.0004569138,0.00061015104,0.00004958939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004732774,0.00020515647,0.0010073157,0.00008845267,0.000062254694,0.0000054486254,0.00008964684,0.000043934288,0.000048077072],"category_scores_gemma":[0.00026392832,0.00011260929,0.00020731988,0.00019367982,0.00006749274,0.000020740401,0.000056887402,0.00009335805,2.5620074e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03399708,0.017483234,0.8952089,0.00091985223,0.012898062,0.000059191916,0.019073118,0.00006737415,0.0071060415,0.000049290265,0.00069760554,0.012440231],"study_design_scores_gemma":[0.09821758,0.011915304,0.18353033,0.0007875155,0.008359785,0.0000022682186,0.024330698,0.000027572418,0.6718777,0.00001862037,0.0007692418,0.00016343904],"about_ca_topic_score_codex":0.0004692516,"about_ca_topic_score_gemma":0.00018329007,"teacher_disagreement_score":0.7116786,"about_ca_system_score_codex":0.0000532889,"about_ca_system_score_gemma":0.000354897,"threshold_uncertainty_score":0.45920736},"labels":[],"label_agreement":null},{"id":"W4417023492","doi":"10.1182/blood-2025-5580","title":"Association between momelotinib exposure and hemoglobin improvement in patients with myelofibrosis and anemia: An exposure-response and time-to-event analysis","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Anemia; Myelofibrosis; Post-hoc analysis; Randomized controlled trial; Hemoglobin; Ruxolitinib; Prospective cohort study; Clinical trial","score_opus":0.003761307535390847,"score_gpt":0.22601530291703,"score_spread":0.22225399538163917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417023492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99759084,0.00019610187,0.000011123815,0.0010605262,0.000009122677,0.0009629997,0.00008785696,0.00002317849,0.000058251488],"genre_scores_gemma":[0.9984222,0.00003362086,0.00055863475,0.00024051167,0.000018888975,0.00013043698,0.000103538885,0.000013634983,0.00047855324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853605,0.00012999188,0.0003217096,0.000487574,0.00028035717,0.00024430986],"domain_scores_gemma":[0.9991516,0.00021260759,0.000110129506,0.00020937536,0.00011357776,0.0002027068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038955305,0.00022826121,0.00054826506,0.00036207587,0.00008738646,0.000057264606,0.000034153683,0.00012204283,0.00002648303],"category_scores_gemma":[0.000099982804,0.00018032223,0.00003705295,0.0005202493,0.000024919946,0.00008569052,0.00006309337,0.00010658991,0.0000026884882],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000793881,0.0010020215,0.98880816,0.000048739344,0.0012378489,0.0000072119087,0.00038316887,0.0000035036567,0.0006797908,0.0000046055347,0.000039750725,0.006991313],"study_design_scores_gemma":[0.010468464,0.0042128344,0.9770407,0.00010851505,0.002736922,6.246485e-7,0.000065112195,0.000014306248,0.0051294994,0.000008418287,0.00005876083,0.00015585138],"about_ca_topic_score_codex":0.000058130925,"about_ca_topic_score_gemma":0.00006857281,"teacher_disagreement_score":0.011767473,"about_ca_system_score_codex":0.00012291293,"about_ca_system_score_gemma":0.000052582946,"threshold_uncertainty_score":0.73533267},"labels":[],"label_agreement":null},{"id":"W4417023493","doi":"10.1182/blood-2025-5587","title":"Should dermatologic examinations become routine standard of care in patients with polycythemia vera? Observations from the phase 3 VERIFY study prior to rusfertide exposure","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Phlebotomy; Randomization; Placebo; Hematocrit; Polycythemia vera; Stage (stratigraphy); Randomized controlled trial","score_opus":0.02118794865231098,"score_gpt":0.29643712669220745,"score_spread":0.27524917803989646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417023493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949848,0.00028028453,0.000022644663,0.0020521893,0.000041573086,0.0020911316,0.0003713309,0.000023906377,0.00013214268],"genre_scores_gemma":[0.9981329,0.0000076134565,0.0006843241,0.0005389371,0.000014119782,0.00037655677,0.00020126828,0.00001191114,0.000032375174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886334,0.000077771554,0.0003424522,0.0002605244,0.0002954796,0.00016044038],"domain_scores_gemma":[0.99900347,0.00023260257,0.00006997552,0.00038437647,0.00024991788,0.00005967202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006685631,0.00017033437,0.00039536293,0.00009599259,0.00011615175,0.000017103786,0.000106756765,0.00005383543,0.00003765045],"category_scores_gemma":[0.0001654045,0.000104024984,0.000042958323,0.0004181219,0.000028700879,0.00004621344,0.000053544667,0.00013721811,0.0000023076489],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00103071,0.0053871064,0.9886731,0.000021891909,0.00028501512,0.000018931752,0.0035174799,0.000006881045,0.000038254126,0.00008839026,0.000106602674,0.0008256571],"study_design_scores_gemma":[0.023749685,0.0045114793,0.9630494,0.00021045914,0.00050528167,5.1000166e-7,0.001941991,0.0000021138471,0.005676145,0.000009442581,0.000257834,0.00008562873],"about_ca_topic_score_codex":0.00017425207,"about_ca_topic_score_gemma":0.0015120504,"teacher_disagreement_score":0.025623651,"about_ca_system_score_codex":0.000091431706,"about_ca_system_score_gemma":0.00016612012,"threshold_uncertainty_score":0.42420155},"labels":[],"label_agreement":null},{"id":"W4417042033","doi":"10.1182/blood-2025-lba-5","title":"A hospital policy of tranexamic acid to reduce transfusion in major non-cardiac surgery: The traction trial","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; NOSM University; University of Sudbury; Queen's University; Humber River Regional Hospital; University of Manitoba; Ottawa Hospital; University of Ottawa; CancerCare Manitoba","funders":"","keywords":"Tranexamic acid; Pulmonary embolism; Odds ratio; Venous thrombosis; Deep vein; Randomized controlled trial; Confidence interval; Thrombosis; Blood transfusion","score_opus":0.0099439565260468,"score_gpt":0.272496018651528,"score_spread":0.2625520621254812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417042033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9732188,0.0001549538,0.00017425045,0.017847076,0.0006066451,0.0029890505,0.000010336039,0.00003406584,0.0049647987],"genre_scores_gemma":[0.9980473,0.00042300986,0.00006554157,0.0005366238,0.000199093,0.00018563657,0.000010102882,0.000014384362,0.0005183145],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99879193,0.00008091238,0.00040012985,0.00025696223,0.00024695654,0.00022310278],"domain_scores_gemma":[0.9994359,0.000093617586,0.00004277288,0.0003191696,0.000037675247,0.00007087943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051405677,0.00014055085,0.00044227025,0.00045785413,0.000047571226,0.000010666256,0.00009618499,0.00009380007,0.000035987385],"category_scores_gemma":[0.0000858252,0.00010507049,0.00027225207,0.00093161565,0.000033451815,0.00004534573,0.000014822374,0.00018819717,0.000008569342],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04447654,0.016801184,0.0059017115,0.0010955206,0.0014189834,0.000094207695,0.007461562,0.0000070117144,0.68555313,0.0017610468,0.009787779,0.22564133],"study_design_scores_gemma":[0.14370844,0.002306975,0.2956663,0.0010106676,0.0023610515,0.000012426759,0.0020157925,0.00001844159,0.53810024,0.00019276497,0.014152854,0.00045405718],"about_ca_topic_score_codex":0.00074146123,"about_ca_topic_score_gemma":0.000103931896,"teacher_disagreement_score":0.28976458,"about_ca_system_score_codex":0.000030262563,"about_ca_system_score_gemma":0.00020655563,"threshold_uncertainty_score":0.428465},"labels":[],"label_agreement":null},{"id":"W4417042055","doi":"10.1182/blood-2025-lba-6","title":"Phase 3 randomized study of teclistamab plus daratumumab versus investigator’s choice of daratumumab and dexamethasone with either pomalidomide or Bortezomib (DPd/DVd) in patients (Pts) with relapsed refractory multiple myeloma (RRMM): Results of majestec-3","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Calgary","funders":"","keywords":"Daratumumab; Pomalidomide; Lenalidomide; Multiple myeloma; Bortezomib; Dexamethasone; Refractory (planetary science); Dosing; Regimen","score_opus":0.0275454128551027,"score_gpt":0.31831427676072543,"score_spread":0.29076886390562273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417042055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930545,0.00053268013,0.000010551306,0.000049152248,0.00006052794,0.005012631,0.00020411758,0.000037759444,0.0010380789],"genre_scores_gemma":[0.99732435,0.000048477443,0.0018137174,0.000018254563,0.000017470302,0.00025175817,0.000115638046,0.000059263126,0.00035108736],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9956862,0.00063771725,0.0013918406,0.0007730449,0.0010059044,0.0005052929],"domain_scores_gemma":[0.99507815,0.0020781222,0.00083793816,0.0010673156,0.0005771769,0.00036129527],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00079377653,0.00050347345,0.0021545903,0.00071303797,0.000089793175,0.000018371915,0.00024866738,0.00019824777,0.000014836645],"category_scores_gemma":[0.0052356212,0.00032454642,0.00011276567,0.0011083167,0.00072815246,0.00018873745,0.0001389671,0.00044835842,9.767657e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8112195,0.023628285,0.15624586,0.00055278925,0.0027460894,0.00028128113,0.0014711353,0.00000897226,0.0018703104,0.00001018585,0.00006039149,0.0019051977],"study_design_scores_gemma":[0.84573793,0.020633837,0.11435081,0.001136952,0.0014114159,0.000006452607,0.00095509744,0.0001506449,0.015314954,0.0000037654115,0.00005603363,0.00024210317],"about_ca_topic_score_codex":0.0024673236,"about_ca_topic_score_gemma":0.0035344572,"teacher_disagreement_score":0.04189505,"about_ca_system_score_codex":0.00015069479,"about_ca_system_score_gemma":0.00095911487,"threshold_uncertainty_score":0.99992067},"labels":[],"label_agreement":null},{"id":"W4417069280","doi":"10.1182/blood-2025-599","title":"From lab to field: Evaluation of a rapid, low-cost, point-of-care ferritin assay for detection of iron deficiency","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Biosensors and Analytical Detection","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Providence Health Care","funders":"","keywords":"Ferritin; Iron deficiency; Hemoglobin; Anemia; Iron-deficiency anemia; Antibody; Immunoassay; Thalassemia","score_opus":0.011083163856734317,"score_gpt":0.25439777985365647,"score_spread":0.24331461599692214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417069280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96134853,0.0004160501,0.03664052,0.000033161603,0.00016419947,0.00034003129,0.000044739194,0.00002691635,0.0009858345],"genre_scores_gemma":[0.9993379,0.000008618318,0.00056587625,0.000009183075,0.000031620602,0.00002424179,0.0000064480273,0.000006261015,0.000009855557],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99944633,0.00002655409,0.00021464675,0.000100040495,0.00013296801,0.00007946962],"domain_scores_gemma":[0.99956256,0.00009889077,0.000032503118,0.000119376266,0.000168731,0.000017909751],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020554633,0.00006116043,0.00013417754,0.000098447614,0.000014974733,0.000004061874,0.000047704798,0.00008323608,0.000021507614],"category_scores_gemma":[0.00023111372,0.00006232987,0.000070662245,0.00019389068,0.0000073256124,0.000027092381,0.000009829935,0.00004628152,0.0000010762707],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005130434,0.000116073425,0.00014868735,0.000605836,0.000036092533,9.721579e-8,0.00026064538,0.003314746,0.7611483,0.00008638006,0.00005762188,0.23417425],"study_design_scores_gemma":[0.0008193091,0.00015427536,0.0020072693,0.00013196254,0.00019870102,1.2502687e-7,0.00021861061,0.023146268,0.97280467,0.0004068138,0.000052692307,0.00005932165],"about_ca_topic_score_codex":0.000072068004,"about_ca_topic_score_gemma":0.000064942345,"teacher_disagreement_score":0.23411493,"about_ca_system_score_codex":0.000021087024,"about_ca_system_score_gemma":0.00001328567,"threshold_uncertainty_score":0.25417382},"labels":[],"label_agreement":null},{"id":"W4417069316","doi":"10.1182/blood-2025-7300","title":"Real-world data comparison of asciminib 40 mg twice daily vs. 80 mg once daily in chronic myeloid leukemia patients","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Discontinuation; Myeloid leukemia; Adverse effect; Tyrosine-kinase inhibitor; Survival analysis; Leukemia; Nilotinib; Myeloid; Clinical trial","score_opus":0.03434395425559256,"score_gpt":0.3315944448529916,"score_spread":0.29725049059739905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417069316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98083776,0.001251544,0.000013593036,0.00025076003,0.00029551753,0.0010361209,0.00018799912,0.00011002687,0.01601669],"genre_scores_gemma":[0.99415946,0.00038736113,0.0014124124,0.00021586753,0.00016160205,0.00005459004,0.0013073529,0.000057736517,0.002243627],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99622035,0.00013661798,0.0011682893,0.0010442788,0.00070810324,0.0007223325],"domain_scores_gemma":[0.99636984,0.00032817613,0.00045028995,0.002505117,0.00015371169,0.00019289555],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039655555,0.00045140568,0.0011950094,0.00050124835,0.000092671966,0.000029103008,0.000919216,0.00017936369,0.00010857339],"category_scores_gemma":[0.00031131686,0.00043980585,0.0001171224,0.0012964776,0.00022329218,0.00025840473,0.00073926576,0.0006104637,0.00009591601],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011266504,0.0032118035,0.9592624,0.00096108014,0.0006889829,0.00009517525,0.0006856537,0.000058079022,0.005145003,0.00021575238,0.010888894,0.017660582],"study_design_scores_gemma":[0.037159644,0.0011022681,0.9261214,0.0018256272,0.0011233458,0.0000062675563,0.000186367,0.002780099,0.014705061,0.000035024077,0.014525909,0.00042894532],"about_ca_topic_score_codex":0.0057060495,"about_ca_topic_score_gemma":0.0076867724,"teacher_disagreement_score":0.036032993,"about_ca_system_score_codex":0.0038735198,"about_ca_system_score_gemma":0.0034966178,"threshold_uncertainty_score":0.9999504},"labels":[],"label_agreement":null},{"id":"W4417085276","doi":"10.1182/blood.2025031065","title":"Efficacy and safety of marstacimab prophylaxis in hemophilia A/B with inhibitors: results from the phase 3 BASIS trial","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"Swedish Orphan Biovitrum; CSL Behring; Sanofi; Novo Nordisk; Regeneron Pharmaceuticals; Pfizer","keywords":"Rash; Adverse effect; Observational study; Confidence interval; Factor IX; Clinical trial; Phases of clinical research; Quality of life (healthcare)","score_opus":0.018544172306117223,"score_gpt":0.29942627263689625,"score_spread":0.28088210033077904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417085276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923808,0.00050669856,0.0000016569602,0.0035637945,0.00004446225,0.0015076882,0.00009506557,0.000015728612,0.0018840841],"genre_scores_gemma":[0.9987622,0.00011665296,0.0001837742,0.0000390797,0.00013912248,0.000028816517,0.00005567138,0.000009428438,0.00066524517],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9988159,0.000093771305,0.00034781068,0.0002828346,0.00027337088,0.00018631],"domain_scores_gemma":[0.99894357,0.00051744154,0.00005408864,0.0003656051,0.000057586567,0.00006172571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032831277,0.00012768201,0.0003151362,0.00011265734,0.000057131663,0.00001357005,0.00008101211,0.000089437664,0.000019664694],"category_scores_gemma":[0.0004064459,0.00006690899,0.000046686047,0.00045274865,0.00016510377,0.000032934342,0.00005630273,0.0002181876,0.0000037287941],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.82358354,0.01834986,0.043883152,0.00026496948,0.0011716605,0.0005384166,0.0026250558,0.0000014457993,0.014300698,0.0001307717,0.0014217917,0.093728654],"study_design_scores_gemma":[0.88968956,0.0053013773,0.031787183,0.0009834445,0.00042395166,0.000008644526,0.00029637085,0.000019648189,0.06890371,0.000112228336,0.0023284175,0.00014544188],"about_ca_topic_score_codex":0.000219892,"about_ca_topic_score_gemma":0.000046803685,"teacher_disagreement_score":0.09358321,"about_ca_system_score_codex":0.00002604605,"about_ca_system_score_gemma":0.0002127321,"threshold_uncertainty_score":0.27284697},"labels":[],"label_agreement":null},{"id":"W4417130084","doi":"10.1182/blood.2025030898","title":"Increased prevalence of clonal hematopoiesis in children with sickle cell disease","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Sickle cell anemia; Disease; Cell; Allele; Haematopoiesis; Allele frequency","score_opus":0.0026263014782030164,"score_gpt":0.20238357573227192,"score_spread":0.19975727425406892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417130084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99308914,0.002506493,0.000010568374,0.0002989029,0.000010152313,0.0003350573,0.000018936824,0.0000229277,0.0037078052],"genre_scores_gemma":[0.998693,0.00018399923,0.00016548848,0.00015577527,0.000008590776,0.000013752795,0.000012069295,0.000007904441,0.0007594076],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993644,0.000021848713,0.0001672328,0.0001650778,0.00014024085,0.00014121497],"domain_scores_gemma":[0.99960184,0.000022782891,0.000040467054,0.00021257544,0.00003257401,0.000089754176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000063960775,0.00009151534,0.00017847477,0.00009710697,0.000020719875,0.000003008681,0.00006602855,0.00005308134,0.00006644265],"category_scores_gemma":[0.000038067123,0.00006807451,0.000047053603,0.00027433672,0.00007299247,0.000023514844,0.000026624632,0.000110978246,0.000005082918],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018585243,0.0014996843,0.9962142,0.0006837935,0.00007736909,0.000024186606,0.000051739164,0.000008311279,0.00088061334,0.00012868183,0.00016129059,0.000084275416],"study_design_scores_gemma":[0.0060528903,0.000120269455,0.9814388,0.00056804117,0.0005718451,0.000012260938,0.00005853118,0.00002670301,0.01094173,0.00007764145,0.000045431723,0.00008582129],"about_ca_topic_score_codex":0.00010433549,"about_ca_topic_score_gemma":0.000004192199,"teacher_disagreement_score":0.014775367,"about_ca_system_score_codex":0.000009000112,"about_ca_system_score_gemma":0.00021896798,"threshold_uncertainty_score":0.27759978},"labels":[],"label_agreement":null},{"id":"W4417246418","doi":"10.1182/blood.2025031149","title":"Neutrophils fine-tune the NET effects of activation","year":2025,"lang":"en","type":"letter","venue":"Blood","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University of Calgary","funders":"","keywords":"Neutrophil extracellular traps; Neutrophile; Granulocyte; Inflammation; N-Formylmethionine leucyl-phenylalanine","score_opus":0.007276421097047532,"score_gpt":0.20619252327419457,"score_spread":0.19891610217714703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417246418","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14458306,0.0061625657,0.0006659091,0.8343697,0.004866772,0.003288381,0.00044119466,0.00029062683,0.005331749],"genre_scores_gemma":[0.15707777,0.00046392373,0.00016831499,0.7615963,0.0032999916,0.00054124405,0.0045020757,0.00016696987,0.07218337],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99833554,0.00041701054,0.00035870748,0.00042531695,0.0000667696,0.00039663457],"domain_scores_gemma":[0.9981426,0.00074579706,0.0003023205,0.000693563,0.00010747176,0.000008263252],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011047265,0.00037751897,0.0005753784,0.00018050797,0.00016032453,0.000015188078,0.00055563415,0.000976615,0.00022295052],"category_scores_gemma":[0.00009722971,0.00025459242,0.00021930491,0.0002317908,0.00017453688,0.000051717114,0.00016861995,0.0015775118,0.00017343965],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002091739,0.00010377235,0.0000076060473,0.00021668863,0.0005020212,0.000039060542,0.00004421505,3.9023394e-7,0.47753164,0.00035573554,0.5207834,0.0003944871],"study_design_scores_gemma":[0.001194376,0.00014811779,0.000110127694,0.00022153124,0.00033966685,0.0000131488,0.0000044650337,4.4377042e-8,0.6272981,0.00033363007,0.37017924,0.0001575341],"about_ca_topic_score_codex":0.000035088367,"about_ca_topic_score_gemma":0.0000017728307,"teacher_disagreement_score":0.15060422,"about_ca_system_score_codex":0.000016867833,"about_ca_system_score_gemma":0.00010081583,"threshold_uncertainty_score":0.99999064},"labels":[],"label_agreement":null},{"id":"W4417342517","doi":"10.1182/blood.2025031480","title":"2025 update on MRD in acute myeloid leukemia: a consensus document from the ELN-DAVID MRD Working Party","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Servier; Amgen; José Carreras Leukämie-Stiftung; Astellas Pharma; Jazz Pharmaceuticals; Ascentage Pharma; Syndax Pharmaceuticals; BeiGene; Deutsche Krebshilfe; Daiichi Sankyo Europe; European Commission; Pfizer; Bristol-Myers Squibb","keywords":"Minimal residual disease; Blinatumomab; Guideline; Myeloid leukemia; Disease; Hematopoietic cell; Delphi method; Hematopoietic stem cell transplantation","score_opus":0.01933422933977684,"score_gpt":0.2980073833926368,"score_spread":0.27867315405286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417342517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9525184,0.0014385615,0.000023331619,0.029897626,0.00031541745,0.0011107153,0.000044558063,0.000119683136,0.014531675],"genre_scores_gemma":[0.9823069,0.0010377737,0.001000836,0.008498166,0.00037748856,0.00017812836,0.00011663656,0.000047508853,0.0064365854],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99704397,0.0002733176,0.0005681174,0.0007008454,0.0006316081,0.0007821232],"domain_scores_gemma":[0.9976125,0.00095998985,0.00010900326,0.0010450227,0.000093366696,0.00018015168],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007144909,0.00035031643,0.000578077,0.0002523229,0.00018638607,0.000093644136,0.0004974154,0.00026887763,0.00025434434],"category_scores_gemma":[0.0003603868,0.0002459015,0.00016697802,0.00091077987,0.00020213451,0.000042805605,0.00037781906,0.0014298611,0.00043045692],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009277446,0.0029891469,0.28449318,0.00033057196,0.008170712,0.011540663,0.0038733657,0.00018574517,0.07413857,0.011120362,0.50140446,0.09247577],"study_design_scores_gemma":[0.07064015,0.0011616718,0.25150213,0.0048892265,0.003478169,0.00022567129,0.0019763906,0.0009939673,0.16362083,0.007866354,0.49211502,0.0015304404],"about_ca_topic_score_codex":0.0010477847,"about_ca_topic_score_gemma":0.00032032645,"teacher_disagreement_score":0.09094533,"about_ca_system_score_codex":0.00091095513,"about_ca_system_score_gemma":0.001366969,"threshold_uncertainty_score":0.99999934},"labels":[],"label_agreement":null},{"id":"W4417342747","doi":"10.1182/blood.2025029210","title":"Asciminib demonstrates superior efficacy and safety in newly diagnosed chronic myeloid leukemia in the ASC4FIRST trial","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Novartis Pharma; EUSA Pharma; Astellas Pharma; Incyte; Syndax Pharmaceuticals; BeiGene; Gilead Sciences; Celgene; Bristol-Myers Squibb; AstraZeneca; Amgen; Pfizer","keywords":"Discontinuation; Imatinib; Tolerability; Myeloid leukemia; Imatinib mesylate; Adverse effect; Hazard ratio; Clinical trial","score_opus":0.012407773810649187,"score_gpt":0.2700160286641859,"score_spread":0.2576082548535367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417342747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98942626,0.0035541249,0.000002843124,0.0012229705,0.0001537359,0.002168498,0.000010908607,0.00004624459,0.0034144057],"genre_scores_gemma":[0.9976895,0.0010997258,0.00014871127,0.00032062383,0.00020954316,0.00021475014,0.00004319024,0.000021484455,0.00025248426],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99806404,0.0001646243,0.00055502146,0.00048772714,0.00025684683,0.00047174512],"domain_scores_gemma":[0.9983913,0.0009259879,0.00006274177,0.000513388,0.000021655966,0.0000849583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000493701,0.00028277538,0.0005327779,0.00022625767,0.000095631316,0.00004845571,0.00021249858,0.00020215349,0.00006432444],"category_scores_gemma":[0.00045713063,0.00020610937,0.00008915122,0.000626098,0.0001616722,0.00008416207,0.00007739894,0.00047273946,0.000021448388],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06950366,0.013518281,0.66941357,0.0017384454,0.0019791485,0.007732013,0.012702587,0.00030430572,0.016471613,0.0026909073,0.0025032393,0.20144226],"study_design_scores_gemma":[0.4590309,0.0011942912,0.532043,0.00065194804,0.0004415583,0.00010466673,0.00051833317,0.00017678543,0.0022152187,0.00007313637,0.0033061747,0.00024403333],"about_ca_topic_score_codex":0.00078751164,"about_ca_topic_score_gemma":0.0016880088,"teacher_disagreement_score":0.38952723,"about_ca_system_score_codex":0.0014805009,"about_ca_system_score_gemma":0.002561342,"threshold_uncertainty_score":0.8404896},"labels":[],"label_agreement":null},{"id":"W4417414240","doi":"10.1182/blood.2024028196","title":"Methylation-based lineage tracing in cancer","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vector Institute; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto; University Health Network","funders":"","keywords":"Lineage (genetic); Cancer; Epigenetics; DNA methylation; Genomics; DNA sequencing; Genome; Cell lineage; Epigenomics","score_opus":0.008287232837571129,"score_gpt":0.27294575337536336,"score_spread":0.26465852053779226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417414240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919023,0.002987047,0.0023145631,0.00025332853,0.0001357334,0.00009277278,0.000022489961,0.0000050503254,0.0022867275],"genre_scores_gemma":[0.9984401,0.00019796084,0.0003717061,0.00059798814,0.000099693294,0.000031458007,0.000031401734,0.0000061304822,0.00022355195],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99961054,0.000011272619,0.00010430285,0.00014690246,0.000029638593,0.000097335615],"domain_scores_gemma":[0.9997806,0.000022739188,0.00002138353,0.00013240518,0.000024576133,0.000018324832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006382087,0.000057122663,0.000064681306,0.000042270116,0.00002097904,0.000010826052,0.000061870385,0.0000616994,0.000011739744],"category_scores_gemma":[0.000068112575,0.00006154449,0.000032361793,0.00009138971,0.000012325201,6.064206e-7,0.000020947959,0.000040374754,0.0000011830442],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006607664,0.00054485595,0.16560127,0.00007343446,0.00008633636,0.000008888869,0.0000495571,0.012201291,0.8105856,0.00042155207,0.0013716199,0.008989489],"study_design_scores_gemma":[0.0017919332,0.000046663095,0.017395617,0.000036294972,0.000035536577,2.5140935e-7,0.000013523198,0.0007115022,0.96295595,0.000068191075,0.016824972,0.00011956198],"about_ca_topic_score_codex":0.00016544902,"about_ca_topic_score_gemma":0.00082543265,"teacher_disagreement_score":0.15237033,"about_ca_system_score_codex":0.000009687386,"about_ca_system_score_gemma":0.00015895562,"threshold_uncertainty_score":0.25097114},"labels":[],"label_agreement":null},{"id":"W4417424232","doi":"10.1182/blood-2025-482","title":"Preliminary data from the Phase I/II study of nuvisertib, an oral investigational selective PIM1 inhibitor, in combination with momelotinib showed clinical responses in patients with relapsed/refractory myelofibrosis","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ruxolitinib; Myelofibrosis; PIM1; Phases of clinical research; Bone marrow; Combination therapy; Janus kinase inhibitor","score_opus":0.04823130709713899,"score_gpt":0.34450074179795664,"score_spread":0.2962694347008177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417424232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971156,0.000057908255,0.0000034848006,0.00041755443,0.00004562185,0.002125543,0.00017365019,0.000017757176,0.00004286987],"genre_scores_gemma":[0.997956,0.000009622776,0.0006182712,0.00019967719,0.000026686403,0.00019875048,0.0009362231,0.000020295352,0.000034491877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973982,0.00070431345,0.0006392948,0.0006106164,0.00046973513,0.00017786674],"domain_scores_gemma":[0.9977762,0.0009930405,0.00021948769,0.0006661322,0.0002580206,0.00008713686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005165848,0.00022745092,0.0005031441,0.00018761944,0.00010818125,0.000018164063,0.0002034442,0.000100098325,0.000018888348],"category_scores_gemma":[0.00047844797,0.00014152576,0.000024929965,0.0006039409,0.0001544881,0.00028310675,0.00014167409,0.0003374236,0.0000015272008],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018514594,0.08679854,0.8908018,0.000014203804,0.00037763576,0.000022366414,0.0018914365,0.000007100571,0.000069315254,0.000025105986,0.00020383354,0.0012740579],"study_design_scores_gemma":[0.07297636,0.04685674,0.8771374,0.00042027442,0.00043654448,7.1518195e-7,0.0006932777,0.00011631741,0.0011819376,0.00004561803,0.000016014694,0.00011880803],"about_ca_topic_score_codex":0.00049657346,"about_ca_topic_score_gemma":0.0025644116,"teacher_disagreement_score":0.054461762,"about_ca_system_score_codex":0.00007102447,"about_ca_system_score_gemma":0.0005132631,"threshold_uncertainty_score":0.5771253},"labels":[],"label_agreement":null},{"id":"W4417466563","doi":"10.1182/blood.2025031063","title":"Outnumbered: T-cell dominance breaks BCMA-TCE resistance","year":2025,"lang":"en","type":"letter","venue":"Blood","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Resistance (ecology); Dominance (genetics); Population; Ectotherm","score_opus":0.0067638590663220925,"score_gpt":0.20150165903655068,"score_spread":0.19473779997022858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417466563","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018262781,0.13687278,0.00010541553,0.43837273,0.015180526,0.002019789,0.0016623929,0.0011545017,0.38636905],"genre_scores_gemma":[0.014783204,0.0011767083,0.00020366984,0.18896176,0.000933226,0.00015265224,0.0015770947,0.0001050449,0.7921066],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99601066,0.00048078145,0.00081036816,0.0013054124,0.00009141461,0.0013013595],"domain_scores_gemma":[0.99721843,0.0004641188,0.0005203026,0.0016124062,0.00016160794,0.000023126837],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0002087358,0.0008576909,0.0012306311,0.00027487273,0.00037736967,0.000047460995,0.0013832711,0.003851341,0.0010692293],"category_scores_gemma":[0.00007408383,0.00082906015,0.00044972953,0.00030127386,0.0005756041,0.00007748514,0.0003978421,0.004129352,0.004483611],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007582392,0.00035486172,0.000055407996,0.0002992955,0.00042130158,0.00039582443,0.000065227905,8.6936915e-8,0.25653023,0.00007531931,0.7415071,0.00021948245],"study_design_scores_gemma":[0.0037603327,0.000081748905,0.000022762284,0.00024170184,0.00048821076,0.00013460434,0.0000193461,2.607314e-8,0.18718764,0.00022343286,0.8071619,0.00067824393],"about_ca_topic_score_codex":0.00020222912,"about_ca_topic_score_gemma":0.00009701466,"teacher_disagreement_score":0.40573758,"about_ca_system_score_codex":0.000062801504,"about_ca_system_score_gemma":0.00033996312,"threshold_uncertainty_score":0.99984396},"labels":[],"label_agreement":null},{"id":"W46861897","doi":"10.1182/blood.v96.13.4185","title":"Human hematopoietic stem cells stimulated to proliferate in vitro lose engraftment potential during their S/G2/M transit and do not reenter G0","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":234,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Stem cell; Haematopoiesis; Biology; Stem cell factor; Cell biology; Cord blood; CD34; Homing (biology); Interleukin 3; Population; Progenitor cell; Molecular biology; Immunology; Cancer research; T cell; IL-2 receptor; Medicine; Immune system","score_opus":0.010435913374374824,"score_gpt":0.22987683555431213,"score_spread":0.2194409221799373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W46861897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997713,0.00011429154,0.0000641321,0.00030610274,0.00003777259,0.0013335195,0.000032485197,0.00008576288,0.0003129263],"genre_scores_gemma":[0.9987016,0.00003395939,0.00025104554,0.00020606628,0.00006280626,0.000059936385,0.000019291781,0.00004904614,0.0006162896],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982428,0.000082117185,0.0005046899,0.00046888745,0.0002994483,0.00040203842],"domain_scores_gemma":[0.99935615,0.000021891252,0.00004205107,0.00030277733,0.000036770038,0.0002403461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017795661,0.0002744622,0.00044174516,0.00016985956,0.00008418993,0.000045293276,0.00008224623,0.00012542687,0.00024297478],"category_scores_gemma":[0.000001107286,0.00024072861,0.000081028214,0.0001831383,0.00003260391,0.000064403044,0.000013386904,0.00019753288,0.00007279176],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089385046,0.0007936716,0.00084878126,0.0006233679,0.000108175154,0.00065907766,0.004837729,0.00017768351,0.99032825,0.0000042203033,0.0000051541892,0.0007200593],"study_design_scores_gemma":[0.01077113,0.00025566816,0.010822847,0.00052577205,0.0002434822,0.00038200096,0.00018227161,0.00013197376,0.97640157,0.000010695075,0.000027673166,0.00024489415],"about_ca_topic_score_codex":0.000019344137,"about_ca_topic_score_gemma":0.000005969992,"teacher_disagreement_score":0.013926637,"about_ca_system_score_codex":0.0000374947,"about_ca_system_score_gemma":0.000026359756,"threshold_uncertainty_score":0.9816628},"labels":[],"label_agreement":null},{"id":"W48554944","doi":"10.1182/blood.v122.21.2806.2806","title":"Thrombopoietin (TPO)-Receptor Agonists In Myelodysplastic Syndromes (MDS): A Systematic Review and Meta-Analysis","year":2013,"lang":"en","type":"review","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Eltrombopag; Romiplostim; Medicine; Myelodysplastic syndromes; Thrombopoietin receptor; Thrombopoietin; Lenalidomide; Internal medicine; Randomized controlled trial; Placebo; Oncology; Platelet; Bone marrow; Multiple myeloma","score_opus":0.06566835860055069,"score_gpt":0.33365578336069734,"score_spread":0.26798742476014664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W48554944","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000042608648,0.99343103,0.0000013577528,0.00010418546,0.000023547927,0.005922735,0.00014750398,0.000043420652,0.00028363112],"genre_scores_gemma":[0.00006241691,0.9949263,0.00023678574,0.00015046964,0.000010486773,0.0023631712,0.0004340893,0.00007111981,0.0017451637],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9965726,0.0003835484,0.001490992,0.000750542,0.000384841,0.00041748708],"domain_scores_gemma":[0.9978394,0.0003379027,0.000702785,0.0008315552,0.000066610184,0.00022175904],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038454967,0.00082881324,0.018436408,0.0005089135,0.00005162957,0.000059676913,0.00020217226,0.0003132019,0.0012591811],"category_scores_gemma":[0.00024544128,0.00047884232,0.0025938821,0.0011359481,0.00006221568,0.00006589755,0.00008637156,0.00035108466,0.00076171267],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[5.409571e-7,0.00047701137,0.000004465508,0.7322129,0.26643702,0.00033158073,0.000012288229,1.2468273e-8,3.72819e-8,0.000007851311,0.00013639584,0.0003799033],"study_design_scores_gemma":[0.0006053842,0.00009836145,0.0000041506546,0.08374485,0.90701514,0.00081354956,0.000006841914,4.0835053e-7,1.3164346e-7,0.0000064861347,0.0073657013,0.00033896725],"about_ca_topic_score_codex":0.00006730409,"about_ca_topic_score_gemma":0.000021448348,"teacher_disagreement_score":0.648468,"about_ca_system_score_codex":0.00005984895,"about_ca_system_score_gemma":0.00014202164,"threshold_uncertainty_score":0.99976635},"labels":[],"label_agreement":null},{"id":"W48601634","doi":"10.1182/blood.v122.21.168.168","title":"Effective Treatment Of Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma With Autologous T Cells Genetically-Engineered To Express An Anti-CD19 Chimeric Antigen Receptor","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; CD19; Antigen; Immunology; Cyclophosphamide; Chimeric antigen receptor; T cell; Internal medicine; Immune system; Chemotherapy","score_opus":0.007627921460208917,"score_gpt":0.2469499303169068,"score_spread":0.23932200885669788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W48601634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995311,0.0004849068,0.0002336524,0.00008328966,0.00007366472,0.0030663854,0.000043586042,0.000121090474,0.0005823829],"genre_scores_gemma":[0.9937548,0.00047891086,0.0032469041,0.00012117427,0.00019172873,0.00035269017,0.00003957156,0.00012488467,0.0016893287],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978492,0.00015380539,0.00030485948,0.0005762617,0.00045400273,0.0006618259],"domain_scores_gemma":[0.9982111,0.0001375831,0.000090604124,0.00086082163,0.00019624557,0.00050363253],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00011301977,0.0003866421,0.0007458694,0.00021374879,0.000061863895,0.000030361922,0.00020612108,0.00017117648,0.0015116751],"category_scores_gemma":[0.0000140019665,0.00028434227,0.00014454538,0.00033704445,0.00010166136,0.000077109675,0.00003800065,0.00010667184,0.0001817103],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005476073,0.026576353,0.0053864503,0.000076930024,0.00043568574,0.00003812104,0.0014547673,0.0000046317014,0.9406276,0.000001415323,0.0001259475,0.024724534],"study_design_scores_gemma":[0.0315844,0.0098839495,0.07051893,0.000048837734,0.00013091261,0.000026699581,0.000090121444,0.00009926903,0.88295436,0.0000020401922,0.004372175,0.00028830036],"about_ca_topic_score_codex":0.00022136167,"about_ca_topic_score_gemma":0.000005499131,"teacher_disagreement_score":0.065132484,"about_ca_system_score_codex":0.00011448019,"about_ca_system_score_gemma":0.00012942075,"threshold_uncertainty_score":0.9999609},"labels":[],"label_agreement":null},{"id":"W4916723","doi":"10.1182/blood.v122.21.1143.1143","title":"Analysis Of Warfarin Drug-Drug Interactions With Antibiotics In The Ambulatory Care Setting","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Antibiotic Use and Resistance","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; St. Joseph's Hospital","funders":"","keywords":"Medicine; Warfarin; Antibiotics; Internal medicine; Ambulatory; Retrospective cohort study; Population; Atrial fibrillation","score_opus":0.004395684512885719,"score_gpt":0.2121258367608825,"score_spread":0.2077301522479968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4916723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99657553,0.0013702643,0.000018314,0.0001603979,0.00006206644,0.00013496791,0.000012293357,0.00001419651,0.0016519881],"genre_scores_gemma":[0.99908197,0.000027784616,0.00012326983,0.000079181154,0.000008860442,7.8036123e-7,0.000039135957,0.000006280535,0.00063273765],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993553,0.00010981805,0.0001910529,0.00014956607,0.000030067858,0.00016417878],"domain_scores_gemma":[0.99945,0.000112542846,0.00010146487,0.00026661035,0.00006225126,0.000007086226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008869319,0.000090290574,0.00019786591,0.00014719961,0.00008611701,0.000009299598,0.00017050774,0.000042093216,0.00011350469],"category_scores_gemma":[0.000011760736,0.00005434586,0.00007551713,0.0003757873,0.000120962075,0.000051884792,0.00002903816,0.00019858779,0.000047292106],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017333574,0.00049797894,0.9439582,0.000067566754,0.0017412128,0.000009468325,0.012015888,0.00009063367,0.040127307,0.0002255241,0.000713416,0.0005354501],"study_design_scores_gemma":[0.0011135819,0.000039845825,0.89860255,0.00013446632,0.0017706424,0.000016899125,0.030385775,0.000020545935,0.066677,0.00001016817,0.0010418671,0.00018667796],"about_ca_topic_score_codex":0.0008168128,"about_ca_topic_score_gemma":0.0021857868,"teacher_disagreement_score":0.04535569,"about_ca_system_score_codex":0.0000075794605,"about_ca_system_score_gemma":0.00002595711,"threshold_uncertainty_score":0.22161599},"labels":[],"label_agreement":null},{"id":"W54712678","doi":"10.1182/blood.v95.4.1435.004k01_1435_1442","title":"Three differentially expressed survivin cDNA variants encode proteins with distinct antiapoptotic functions","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":173,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Survivin; Biology; Alternative splicing; Exon; Complementary DNA; Molecular biology; Messenger RNA; Gene; Gene isoform; Open reading frame; RNA splicing; Peptide sequence; Amino acid; Genetics; RNA","score_opus":0.006862111179382893,"score_gpt":0.19170575087951594,"score_spread":0.18484363970013304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W54712678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95209664,0.00010702281,0.04544809,0.000033868822,0.00006880261,0.0003125012,0.00003464439,0.000029467965,0.0018689886],"genre_scores_gemma":[0.9957813,0.00004210533,0.0012851885,0.000015070615,0.00022285199,0.000041952917,0.00025832042,0.00002787774,0.0023253132],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99911624,0.00003029217,0.0001418788,0.00035045386,0.00014248064,0.00021866843],"domain_scores_gemma":[0.9994654,0.0000048810216,0.00004712888,0.00036913116,0.000040858227,0.0000726048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006446883,0.00016052958,0.00012216027,0.000023644912,0.00013972902,0.000037730075,0.00011723466,0.000115112955,0.00045030972],"category_scores_gemma":[0.000008451686,0.00012445463,0.000058709225,0.00007435239,0.00003920873,0.0000045734478,0.00003128842,0.000060980037,0.000025532194],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011021982,0.000558673,0.0032471134,0.00001849454,0.000113670496,0.0000059887284,0.000018368813,0.00007862305,0.9895757,0.00006624703,0.00008268816,0.0061242394],"study_design_scores_gemma":[0.0060687796,0.0017142722,0.29347667,0.00009549178,0.00044733775,0.00009476343,0.000021963386,0.0006669122,0.6891317,0.0005884659,0.006791436,0.0009022604],"about_ca_topic_score_codex":0.00007454383,"about_ca_topic_score_gemma":0.0006717297,"teacher_disagreement_score":0.300444,"about_ca_system_score_codex":0.0000032660196,"about_ca_system_score_gemma":0.000046077417,"threshold_uncertainty_score":0.50751126},"labels":[],"label_agreement":null},{"id":"W56457892","doi":"10.1182/blood.v122.21.144.144","title":"Co-Administration Of Gene-Modified CD4+ T Cells Targeting HLA Class I-Restricted WT1 Epitope Diversely Enhances The Antitumor Effect Mediated By Redirected T-Cell Based Adoptive Immunotherapy Against Human Leukemia","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"CD8; Cytotoxic T cell; Biology; T cell; Immunotherapy; Adoptive cell transfer; Epitope; T-cell receptor; Interleukin 21; Cancer research; Immunology; Molecular biology; Antigen; Immune system; In vitro","score_opus":0.012433194291963979,"score_gpt":0.2701206179103804,"score_spread":0.2576874236184164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W56457892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923614,0.0007932254,0.000059152342,0.00013201547,0.00013425623,0.002374634,0.00010668832,0.00015585299,0.003882772],"genre_scores_gemma":[0.99679416,0.0006198038,0.00026438438,0.0001695491,0.00019008877,0.00018587474,0.0008696739,0.00007578058,0.0008306954],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996617,0.0006482951,0.00070109527,0.0005354892,0.000903567,0.00059455534],"domain_scores_gemma":[0.9974085,0.00087541697,0.000458732,0.0006102546,0.0004523,0.00019481494],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006442379,0.00040532296,0.000688147,0.00020123285,0.00029944745,0.00008617733,0.00042305165,0.00025699846,0.00072056917],"category_scores_gemma":[0.00019145866,0.00029817742,0.00022984175,0.0006510701,0.00035164296,0.00013761099,0.000028996257,0.00057989435,0.000070702525],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080617826,0.0006818377,0.0012987339,0.000105255094,0.0002626366,0.000043466807,0.00026491584,0.000018558541,0.9926673,0.000001301197,0.0031941158,0.00065566105],"study_design_scores_gemma":[0.010181792,0.0018459272,0.004113636,0.00008985004,0.00011844051,0.0000043667,0.0001389351,0.00089714886,0.9816241,0.0000022579384,0.0007034784,0.00028001424],"about_ca_topic_score_codex":0.00049102056,"about_ca_topic_score_gemma":0.000010144086,"teacher_disagreement_score":0.011043186,"about_ca_system_score_codex":0.00016643485,"about_ca_system_score_gemma":0.00047558692,"threshold_uncertainty_score":0.999947},"labels":[],"label_agreement":null},{"id":"W574761510","doi":"10.1182/blood.v122.21.1714.1714","title":"Acute Promyelocytic Leukemia In Canada: Poor Outcomes In Older Patients Remain","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; Queen Elizabeth II Health Sciences Centre; Université de Montréal; Hôpital Maisonneuve-Rosemont; McGill University; University of Calgary; Ottawa Hospital; University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Acute promyelocytic leukemia; Incidence (geometry); Relative survival; Population; Cancer registry; Leukemia; Mortality rate; Pediatrics; Referral; Myeloid leukemia; Internal medicine; Cancer; Retinoic acid","score_opus":0.0028258732893731,"score_gpt":0.18811513034767124,"score_spread":0.18528925705829816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W574761510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99843657,0.00017783057,0.000007116066,0.00007631745,0.0000769174,0.0003559532,0.000007525683,0.0000049030955,0.0008568453],"genre_scores_gemma":[0.9985967,0.0000460953,0.00018636104,0.00031261766,0.00003191855,0.00010872036,0.00006851674,0.000019956733,0.0006290946],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989028,0.000039592698,0.0002679874,0.00031027218,0.00015361974,0.0003257542],"domain_scores_gemma":[0.9995694,0.000010017566,0.000061300765,0.0002395598,0.00005384166,0.00006589244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000061243394,0.00016009953,0.00018685084,0.000042939515,0.000021918871,0.000016325046,0.00021548694,0.00011341487,0.000033909015],"category_scores_gemma":[0.00007554288,0.00014067696,0.00003534356,0.00010859616,0.00002444124,0.0000061773885,0.00008440541,0.00011970437,0.000012427121],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011322299,0.00014976943,0.95301986,0.000047064463,0.000051284303,0.000031765896,0.000041590563,0.000020965917,0.04491632,0.0000066887446,0.0009971752,0.0007061948],"study_design_scores_gemma":[0.005473898,0.00013215089,0.653188,0.000047638383,0.000033443186,0.000010071704,0.000114021095,0.00005973645,0.33968958,0.00008424493,0.0007425111,0.00042472812],"about_ca_topic_score_codex":0.16841233,"about_ca_topic_score_gemma":0.26035333,"teacher_disagreement_score":0.29983187,"about_ca_system_score_codex":0.0002708549,"about_ca_system_score_gemma":0.0014566345,"threshold_uncertainty_score":0.8371253},"labels":[],"label_agreement":null},{"id":"W577449728","doi":"10.1182/blood.v122.21.206.206","title":"Treatment Of Serious Bleeds With a B-Domain Deleted Recombinant Porcine Sequence Factor VIII (OBI-1) In Patients With Acquired Hemophilia A: A Prospective Clinical Trial","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Population; Clinical endpoint; Recombinant factor VIIa; Dosing; Clinical trial; Immunosuppression; Internal medicine; Hemostasis; Pediatrics; Surgery","score_opus":0.03547520650490885,"score_gpt":0.3157871477102192,"score_spread":0.28031194120531033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W577449728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99273986,0.0000639295,0.0000019151835,0.0005035228,0.00006372089,0.0063114692,0.000022959734,0.000044775585,0.0002478552],"genre_scores_gemma":[0.9974455,0.000055332843,0.0009689697,0.000020293408,0.00008269161,0.00049965136,0.00006687924,0.0000438296,0.00081684854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976041,0.00013826022,0.000654389,0.0005524636,0.0005415248,0.00050929125],"domain_scores_gemma":[0.9985808,0.00011055705,0.0001952497,0.0004993845,0.0003284551,0.00028551568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012925587,0.00033647812,0.0009473741,0.00019305112,0.000056687575,0.000017420558,0.00010555208,0.00016994071,0.00012094487],"category_scores_gemma":[0.00005107049,0.00018148131,0.0001276922,0.0005042887,0.00025441783,0.00012481317,0.00003122037,0.0001422879,0.000029327886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043035302,0.017548246,0.934252,0.000047784513,0.0007588777,0.00027865078,0.00042797043,2.5127204e-7,0.0008576243,0.000010322147,0.000009231767,0.0027736872],"study_design_scores_gemma":[0.28048578,0.055500384,0.6603778,0.0001612594,0.0002550497,0.000027605947,0.000065512504,0.0000104535275,0.0028658856,0.000051158524,0.000020604512,0.00017847745],"about_ca_topic_score_codex":0.00022029167,"about_ca_topic_score_gemma":0.00006208923,"teacher_disagreement_score":0.27387422,"about_ca_system_score_codex":0.00022316957,"about_ca_system_score_gemma":0.0004147187,"threshold_uncertainty_score":0.7400594},"labels":[],"label_agreement":null},{"id":"W591410430","doi":"10.1182/blood.v124.21.4986.4986","title":"Eculizumab Inhibits Thrombotic Microangiopathy and Improves Renal Function in Pediatric Patients with Atypical Hemolytic Uremic Syndrome: 1-Year Update","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Eculizumab; Thrombotic microangiopathy; Medicine; Atypical hemolytic uremic syndrome; Gastroenterology; Internal medicine; Renal function; Immunology; Complement system; Disease","score_opus":0.0033693324025400617,"score_gpt":0.17488637856978873,"score_spread":0.17151704616724867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W591410430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99822706,0.0009774277,0.00003362292,0.000029667912,0.00017515119,0.000419982,0.000022736003,0.000057348272,0.000056997345],"genre_scores_gemma":[0.9996014,0.000012214715,0.00005090731,0.00005697537,0.00003191736,0.000027576274,0.00016453661,0.000021534353,0.000032943302],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877125,0.00015635262,0.00029163316,0.00038898873,0.000058248137,0.0003335334],"domain_scores_gemma":[0.9994947,0.000060429178,0.000116554176,0.0002465912,0.000043801738,0.00003794623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001234554,0.00019775935,0.00028060976,0.00015624617,0.000086743035,0.000019669718,0.00011713286,0.00012253119,0.00008364546],"category_scores_gemma":[0.00004815148,0.00016505053,0.00004188796,0.00016952115,0.000078385056,0.00009364219,0.000099225945,0.00016294149,0.00018538011],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052653416,0.0009419947,0.98515826,0.00013493559,0.00012650642,0.000007911997,0.00007570713,0.0000022184745,0.011963681,0.0001757626,0.0005171317,0.00036936204],"study_design_scores_gemma":[0.008920755,0.00082274055,0.9877924,0.00007904017,0.00032882846,0.00006556289,0.000024112021,0.0000023416715,0.0014575218,0.00011956402,0.00014951467,0.00023765443],"about_ca_topic_score_codex":0.000011518382,"about_ca_topic_score_gemma":0.000027768407,"teacher_disagreement_score":0.01050616,"about_ca_system_score_codex":0.000023904095,"about_ca_system_score_gemma":0.000035588462,"threshold_uncertainty_score":0.6730565},"labels":[],"label_agreement":null},{"id":"W597837577","doi":"10.1182/blood.v106.11.1636.1636","title":"Incidence, Timing of Onset and Severity of Post-Thrombotic Syndrome after Acute Symptomatic Deep Vein Thrombosis: Two-Year Results from a Canadian Multicenter Prospective Cohort Study (The VETO Study).","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; McGill University; Université de Montréal; McMaster University; Jewish General Hospital","funders":"","keywords":"Medicine; Post-thrombotic syndrome; Cumulative incidence; Thrombosis; Cohort; Deep vein; Incidence (geometry); Prospective cohort study; Venous thrombosis; Surgery; Internal medicine; Pediatrics","score_opus":0.00890512545728796,"score_gpt":0.26162324572482804,"score_spread":0.2527181202675401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W597837577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99423784,0.000108852946,0.000001167772,0.00031808447,0.000067587665,0.0047581336,0.00015423923,0.000029826866,0.0003242606],"genre_scores_gemma":[0.99884725,0.00003314781,0.00043925463,0.00025701296,0.00004384024,0.00029869057,0.000024867039,0.000035192515,0.000020758403],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99771106,0.0001468927,0.00070187065,0.0005318459,0.0005345793,0.0003737394],"domain_scores_gemma":[0.9984392,0.00013186637,0.0002474827,0.00075793354,0.00020990222,0.00021360962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058366905,0.00027806044,0.0009400329,0.00020330278,0.00011733225,0.000033544115,0.0002140606,0.000063557076,0.00011666216],"category_scores_gemma":[0.00013307758,0.000215496,0.00009085506,0.00026171395,0.00013986336,0.00015240799,0.00018647527,0.00020116498,0.000026221693],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001554009,0.007292458,0.96954423,0.000056470017,0.0037642801,0.00017391623,0.018812027,0.000007946246,0.00006895848,0.0000037950383,0.000055596,0.00006491426],"study_design_scores_gemma":[0.007819815,0.0018272867,0.97530466,0.00028407396,0.0055094347,0.000025135889,0.008696607,0.00015175685,0.00017288367,0.000011877298,0.0000040494965,0.00019239316],"about_ca_topic_score_codex":0.06919524,"about_ca_topic_score_gemma":0.1480439,"teacher_disagreement_score":0.07884867,"about_ca_system_score_codex":0.00013429398,"about_ca_system_score_gemma":0.00013742295,"threshold_uncertainty_score":0.9370031},"labels":[],"label_agreement":null},{"id":"W599078627","doi":"10.1182/blood.v124.21.47.47","title":"Early CMV Reactivation Still Remains a Cause of Increased Transplant Related Mortality in the Current Era: A CIBMTR Analysis","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Serology; Cytomegalovirus; Transplantation; Internal medicine; Bone marrow; Incidence (geometry); Hematopoietic cell; Immunology; Cord blood; Haematopoiesis; Stem cell; Gastroenterology; Human immunodeficiency virus (HIV); Antibody; Viral disease; Herpesviridae; Biology","score_opus":0.03256778908597976,"score_gpt":0.3190012849076288,"score_spread":0.28643349582164906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W599078627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980339,0.00015201262,0.00006259378,0.0002178033,0.000014447363,0.00040597137,0.00004099109,0.000020051993,0.0010522545],"genre_scores_gemma":[0.9995975,0.0001425216,0.000025588502,0.00004389987,0.000043661676,0.000027834863,0.000089767476,0.000010780894,0.000018461258],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982838,0.00028612305,0.00042095286,0.0002435048,0.0005392196,0.0002263739],"domain_scores_gemma":[0.9990002,0.00019673143,0.00011094585,0.00049923826,0.000101114936,0.00009177743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012403942,0.000118831056,0.00039214568,0.0003713541,0.00003643118,0.000013976803,0.00012529433,0.00007879199,0.000052746756],"category_scores_gemma":[0.00020444646,0.00007995574,0.00016998214,0.0012780011,0.000077194556,0.000060603503,0.000013980152,0.0005046375,0.000008397634],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024773588,0.0017527442,0.980776,0.00012003031,0.0009558045,0.000048477024,0.0028939804,0.0000057029292,0.010083201,0.00044753388,0.000017293669,0.0026514805],"study_design_scores_gemma":[0.0028288304,0.00017234216,0.9922866,0.00009757971,0.0017658924,0.0000069411003,0.000030969688,0.000484,0.0018368163,0.00010066357,0.0003068981,0.00008242586],"about_ca_topic_score_codex":0.0039815116,"about_ca_topic_score_gemma":0.002382437,"teacher_disagreement_score":0.011510625,"about_ca_system_score_codex":0.00003125828,"about_ca_system_score_gemma":0.00011989051,"threshold_uncertainty_score":0.6018881},"labels":[],"label_agreement":null},{"id":"W60089101","doi":"10.1182/blood.v95.2.592","title":"VCAM-1 is more effective than MAdCAM-1 in supporting eosinophil rolling under conditions of shear flow","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Center for Research Resources; National Institute of Allergy and Infectious Diseases","keywords":"Addressin; VCAM-1; Eosinophil; Integrin; Monoclonal antibody; Cell adhesion; Cell adhesion molecule; Adhesion; Venule; Immunology; In vivo; Cell biology; Intravital microscopy; Chemistry; Biology; ICAM-1; Antibody; Endothelium; Cell; Biochemistry; Endocrinology","score_opus":0.013354898765747244,"score_gpt":0.3156996918783136,"score_spread":0.30234479311256635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W60089101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927118,0.00022131023,0.000034932422,0.00085084897,0.000017823055,0.00065013405,0.00003487405,0.000034556106,0.005443748],"genre_scores_gemma":[0.9971331,0.00005063439,0.000822677,0.00027811984,0.00006720457,0.000044526278,0.000048923794,0.000034613942,0.0015202494],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99843293,0.00008054978,0.0003614664,0.00030793797,0.00043838433,0.00037871447],"domain_scores_gemma":[0.9992131,0.00015984559,0.00005906069,0.00032464263,0.000091870395,0.00015145232],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026450207,0.00014477907,0.000337315,0.00023242692,0.00005855369,0.000011800979,0.00009846366,0.000115479634,0.003018324],"category_scores_gemma":[0.00009810864,0.00013631051,0.00012763869,0.0004284726,0.00010794363,0.00005461132,0.000037824397,0.00033039428,0.00015807584],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009771488,0.007134643,0.27560556,0.0011619178,0.0007680787,0.001844765,0.0068829674,0.0021843773,0.6777221,0.00017794182,0.003015536,0.022524975],"study_design_scores_gemma":[0.010944863,0.0009067068,0.5274906,0.00064340944,0.00028674418,0.00020728917,0.0008505073,0.0045600673,0.4525735,0.00070002826,0.00048285341,0.00035342955],"about_ca_topic_score_codex":0.00014081241,"about_ca_topic_score_gemma":0.000010709787,"teacher_disagreement_score":0.25188506,"about_ca_system_score_codex":0.000047350568,"about_ca_system_score_gemma":0.00011098008,"threshold_uncertainty_score":0.99789304},"labels":[],"label_agreement":null},{"id":"W610485528","doi":"10.1182/blood-2014-12-618678","title":"Microenvironmental interleukin-6 suppresses toll-like receptor signaling in human leukemia cells through miR-17/19A","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital; University of Toronto; Sunnybrook Hospital","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research","keywords":"Stromal cell; Toll-like receptor; Signal transduction; Immunology; Cancer research; Biology; Leukemia; Interleukin-1 receptor; Receptor; Cell biology; Interleukin 3; Cytokine; Interleukin; Immune system; Antigen-presenting cell; T cell; Innate immune system","score_opus":0.03197391298599731,"score_gpt":0.2929792186043396,"score_spread":0.2610053056183423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W610485528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921078,0.0007812321,0.000015420854,0.000120766745,0.00024008774,0.00063096575,0.000024448067,0.00008247194,0.005996792],"genre_scores_gemma":[0.9918947,0.00008337513,0.0023172526,0.00038710862,0.00038385918,0.000059921902,0.0001166285,0.000083388506,0.0046737595],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99722505,0.00011311552,0.00055411254,0.00062367466,0.0007214446,0.00076259614],"domain_scores_gemma":[0.99873805,0.00011867838,0.00010206172,0.0006476556,0.00004920324,0.00034432218],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003679319,0.00032629262,0.00052157574,0.00015174608,0.00007260471,0.000053417098,0.00036273038,0.00022083322,0.00068667595],"category_scores_gemma":[0.000069374604,0.00030605312,0.00013842196,0.00024078158,0.00025346305,0.00020531955,0.0003135398,0.00048173207,0.00043201662],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032470314,0.001370279,0.0018975589,0.00019605462,0.00016932267,0.00079773297,0.0030602068,0.00007768158,0.96048576,0.000019081452,0.031435456,0.00016617693],"study_design_scores_gemma":[0.0472951,0.00056637207,0.0001722164,0.00035924447,0.0001346131,0.00039330803,0.0014915576,0.0001091729,0.9127701,0.000074716794,0.036259014,0.00037456726],"about_ca_topic_score_codex":0.0012899637,"about_ca_topic_score_gemma":0.00009611933,"teacher_disagreement_score":0.047715634,"about_ca_system_score_codex":0.010337586,"about_ca_system_score_gemma":0.002390327,"threshold_uncertainty_score":0.99993914},"labels":[],"label_agreement":null},{"id":"W612583348","doi":"10.1182/blood.v124.21.3094.3094","title":"A Phase I Study of 177 lu-DOTA-HH1 (Betalutin) Radioimmunotherapy for Patients with Relapsed CD37+ Non-Hodgkin's B Cell Lymphoma","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Radioimmunotherapy; Medicine; B cell; DOTA; Lymphoma; Non-Hodgkin's lymphoma; Mantle cell lymphoma; Bone marrow; Cancer research; In vivo; Internal medicine; Antibody; Monoclonal antibody; Immunology; Biology","score_opus":0.011030105382614917,"score_gpt":0.28664447928972,"score_spread":0.2756143739071051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W612583348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960432,0.0000663565,0.0005102622,0.000071860195,0.000030453044,0.0015736236,0.00003111701,0.000043007738,0.0016301132],"genre_scores_gemma":[0.99775153,0.000007540004,0.0012586777,0.00012209323,0.00011446666,0.0002762605,0.000060900722,0.000040005216,0.00036853892],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988381,0.000025524616,0.00033064,0.00031678332,0.0002447736,0.00024417555],"domain_scores_gemma":[0.998923,0.00012123111,0.00015675576,0.00051412295,0.0001363037,0.00014860234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013953015,0.00018869802,0.0003797171,0.000037443893,0.000093199014,0.000009836218,0.00013684323,0.00006902827,0.000039664003],"category_scores_gemma":[0.000032014843,0.00014824294,0.000093761315,0.00018337378,0.00007067859,0.000038662667,0.000014212095,0.00008902348,0.0000060511247],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0104304105,0.39425996,0.07959219,0.0012987368,0.0019222448,0.000025783658,0.0025506173,0.0000185802,0.4700841,0.00014636388,0.0014237629,0.038247276],"study_design_scores_gemma":[0.3879928,0.017770763,0.02224577,0.00012129059,0.0020267083,0.000020189824,0.00039016173,0.0006895714,0.55529153,0.00004693648,0.01289674,0.00050751824],"about_ca_topic_score_codex":0.000006046848,"about_ca_topic_score_gemma":3.2401869e-7,"teacher_disagreement_score":0.3775624,"about_ca_system_score_codex":0.00001906043,"about_ca_system_score_gemma":0.000049141676,"threshold_uncertainty_score":0.60451716},"labels":[],"label_agreement":null},{"id":"W613303972","doi":"10.1182/blood.v124.21.409.409","title":"Efficacy and Safety of Lenalidomide (LEN) Versus Placebo (PBO) in RBC-Transfusion Dependent (TD) Patients (Pts) with IPSS Low/Intermediate (Int-1)-Risk Myelodysplastic Syndromes (MDS) without Del(5q) and Unresponsive or Refractory to Erythropoiesis-Stimulating Agents (ESAs): Results from a Randomized Phase 3 Study (CC-5013-MDS-005)","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Lenalidomide; Anemia; Internal medicine; Myelodysplastic syndromes; Placebo; Clinical endpoint; Randomization; Refractory (planetary science); Neutropenia; Gastroenterology; Randomized controlled trial; Surgery; Toxicity; Bone marrow; Multiple myeloma","score_opus":0.018595255429268674,"score_gpt":0.3049827407129871,"score_spread":0.28638748528371843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W613303972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99185544,0.0001585091,0.00047214137,0.00008649701,0.00019422523,0.0067345207,0.00035983283,0.00007451493,0.000064326545],"genre_scores_gemma":[0.9976507,0.00057694514,0.001037171,0.000057590158,0.000108441134,0.00019127926,0.00014614903,0.000116880845,0.00011488085],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9930263,0.0019157635,0.0016086625,0.0013138435,0.001335745,0.0007996498],"domain_scores_gemma":[0.98799646,0.009539032,0.00061492936,0.0008238313,0.00035993176,0.0006658441],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025320724,0.00069819106,0.0021474797,0.00069879973,0.00023186099,0.00006843416,0.00030162427,0.00025431757,0.000053543798],"category_scores_gemma":[0.0120810885,0.0005020236,0.000120790806,0.0004961753,0.00037977943,0.0002516061,0.00036999755,0.00085196015,0.000015730046],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9505178,0.008091315,0.02246811,0.00018712108,0.0014878621,0.00048969034,0.008691019,0.00018698827,0.0014203145,9.681869e-7,0.000033392113,0.0064254715],"study_design_scores_gemma":[0.9154546,0.0117964465,0.06145773,0.0018493168,0.0020730596,0.00003383217,0.0017686827,0.003744428,0.0012658974,0.0000045432184,0.000022554677,0.0005288925],"about_ca_topic_score_codex":0.0023590329,"about_ca_topic_score_gemma":0.0019648613,"teacher_disagreement_score":0.03898962,"about_ca_system_score_codex":0.00033325923,"about_ca_system_score_gemma":0.00040408145,"threshold_uncertainty_score":0.99974316},"labels":[],"label_agreement":null},{"id":"W643910028","doi":"10.1182/blood.v124.21.684.684","title":"Outcomes after Intermediate-Risk Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL) and the Role of Allogeneic Stem Cell Transplantation (SCT): A Report from Children's Oncology Group (COG) AALL0433","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Minimal residual disease; Internal medicine; Transplantation; Oncology; Cog; Bone marrow; Stem cell; Acute lymphocytic leukemia; Chemotherapy; Leukemia; Lymphoblastic Leukemia","score_opus":0.003859167319566137,"score_gpt":0.21913084607560213,"score_spread":0.21527167875603598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W643910028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99652135,0.0010146595,0.00041296575,0.00008241072,0.00010230491,0.00093947165,0.00014589557,0.000042659234,0.00073828426],"genre_scores_gemma":[0.99792963,0.0006086412,0.0007565784,0.00016089731,0.0001458532,0.00011849178,0.00014935351,0.00005837587,0.000072153416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970285,0.0004066898,0.0009922051,0.00055058836,0.00061559223,0.00040639483],"domain_scores_gemma":[0.9968562,0.0014661624,0.0006155799,0.00072233204,0.0001265274,0.0002131709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077546766,0.0003286424,0.0009754392,0.00017684404,0.000053468128,0.000013751147,0.00028434364,0.00031229825,0.000050026418],"category_scores_gemma":[0.0002620904,0.00021445932,0.00024443868,0.00015284175,0.00054539274,0.000080762125,0.00013689649,0.0003857622,0.000018260753],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049576536,0.0016661513,0.9592103,0.0002883316,0.002111979,0.00042676358,0.0064236955,0.000024569488,0.011788022,0.00012645635,0.000050326023,0.012925749],"study_design_scores_gemma":[0.03740206,0.0010853867,0.93827784,0.00018003331,0.003583608,0.00082706613,0.00028120726,0.00037353704,0.017193925,0.00046243504,0.0000994984,0.00023337973],"about_ca_topic_score_codex":0.001064286,"about_ca_topic_score_gemma":0.00013757117,"teacher_disagreement_score":0.03244441,"about_ca_system_score_codex":0.00017980777,"about_ca_system_score_gemma":0.000520374,"threshold_uncertainty_score":0.87453973},"labels":[],"label_agreement":null},{"id":"W651362905","doi":"10.1182/blood.v116.21.1533.1533","title":"Changes In Health Status and Quality of Life In Adults with Thalassemia: Year 1 Report of the Thalassemia Longitudinal Cohort Study.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Thalassemia; Life expectancy; Quality of life (healthcare); Cohort; Longitudinal study; Cohort study; Pediatrics; Gerontology; Demography; Population; Internal medicine; Environmental health; Pathology","score_opus":0.012790013563933241,"score_gpt":0.27801369989523245,"score_spread":0.2652236863312992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W651362905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997448,0.00033994354,2.3333938e-7,0.00066365703,0.000056882403,0.0008983966,0.000007149891,0.000008785829,0.0005769512],"genre_scores_gemma":[0.9995032,0.00030265824,0.00006387126,0.000033543893,0.000016852684,0.00001797275,0.000004638025,0.000011742072,0.000045500263],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99862915,0.00008813212,0.00049434527,0.0002460521,0.00031793636,0.00022435762],"domain_scores_gemma":[0.99906814,0.000055799617,0.00031745894,0.00038527817,0.000068280926,0.00010502849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090864516,0.00011030591,0.00047692342,0.00008288961,0.000021844464,0.0000028587513,0.000059666523,0.00011347255,0.000012353535],"category_scores_gemma":[0.0003246288,0.00006667916,0.00002760452,0.0003034516,0.00012216478,0.000024385767,0.000048666137,0.00044260753,2.5600212e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001874426,0.0012497813,0.99610764,0.00038216726,0.00006366352,0.00003615251,0.0013931709,9.122892e-7,0.0004544115,0.000033058248,0.000015584905,0.00007600665],"study_design_scores_gemma":[0.005438754,0.00050218904,0.98997706,0.0003908257,0.00004126869,0.000039806837,0.003095766,0.0000020640937,0.00042452646,0.000005828492,0.000018445466,0.00006348644],"about_ca_topic_score_codex":0.0059794104,"about_ca_topic_score_gemma":0.029987775,"teacher_disagreement_score":0.024008363,"about_ca_system_score_codex":0.000015437356,"about_ca_system_score_gemma":0.0003429733,"threshold_uncertainty_score":0.98771244},"labels":[],"label_agreement":null},{"id":"W653522987","doi":"10.1182/blood.v124.21.5285.5285","title":"FLAG-IDA Has Significant Activity As Frontline Induction or Salvage Therapy for Patients with High Risk and/or Relapsed or Refractory Acute Myeloid Leukemia (AML)","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Leukemia & Lymphoma Society of Canada; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Flag (linear algebra); Medicine; Salvage therapy; Cytarabine; Internal medicine; Refractory (planetary science); Fludarabine; Surgery; Idarubicin; Transplantation; Myeloid leukemia; Oncology; Chemotherapy; Gastroenterology; Cyclophosphamide","score_opus":0.01957236013626043,"score_gpt":0.2685598724542179,"score_spread":0.2489875123179575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W653522987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99512297,0.00033039442,0.0009530378,0.00032998243,0.00014927567,0.0027273858,0.00012633107,0.00019382355,0.00006677976],"genre_scores_gemma":[0.9824831,0.0072084987,0.006116897,0.00026997193,0.00060079043,0.00042465812,0.00018196645,0.00017435767,0.002539761],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.997109,0.00029285075,0.0004297865,0.0008440552,0.000660619,0.00066368206],"domain_scores_gemma":[0.9973615,0.0007714898,0.0003597814,0.0008075353,0.00030193207,0.0003977815],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006256944,0.00047422666,0.0008766327,0.00024966107,0.00037504215,0.00008341211,0.00023450996,0.00038638516,0.0001852512],"category_scores_gemma":[0.000915759,0.0002604735,0.00011299421,0.0004034509,0.00026928508,0.00033718438,0.00008755968,0.0008405889,0.000042291023],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17106147,0.0062552597,0.017823864,0.000758169,0.003727295,0.00032550955,0.0014194773,0.0000047164917,0.057076983,0.000042720883,0.0045884144,0.7369161],"study_design_scores_gemma":[0.26485306,0.11094281,0.26888537,0.0012165557,0.0055883885,0.0004293706,0.0005252614,0.000762205,0.11723799,0.00023448758,0.22658652,0.0027379969],"about_ca_topic_score_codex":0.0007031073,"about_ca_topic_score_gemma":0.00012056647,"teacher_disagreement_score":0.7341781,"about_ca_system_score_codex":0.00050647877,"about_ca_system_score_gemma":0.0014674877,"threshold_uncertainty_score":0.99998474},"labels":[],"label_agreement":null},{"id":"W655017083","doi":"10.1182/blood.v124.21.3197.3197","title":"Safety and Efficacy of Ruxolitinib in an Open-Label, Multicenter, Single-Arm, Expanded-Access Study in Patients with Myelofibrosis (MF): An 1144-Patient Update","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Ruxolitinib; Medicine; Myelofibrosis; Internal medicine; Clinical endpoint; Tolerability; Discontinuation; Clinical trial; Phases of clinical research; Placebo; Surgery; Adverse effect; Bone marrow; Pathology","score_opus":0.03038952331248791,"score_gpt":0.30902278592985855,"score_spread":0.27863326261737065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W655017083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99668616,0.000036341906,0.000003819058,0.000059338756,0.00004340042,0.00289886,0.000041899115,0.00002042636,0.000209757],"genre_scores_gemma":[0.99847776,0.000020984462,0.0009666088,0.00016454191,0.000020966434,0.0001554006,0.00015034243,0.000038541708,0.00000483366],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977984,0.0002819056,0.000614721,0.0006205426,0.00035107287,0.00033335394],"domain_scores_gemma":[0.9987937,0.00010686524,0.00021304975,0.00049759896,0.00014873395,0.00024005043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002261075,0.00029835355,0.0006983979,0.00018886189,0.00006637697,0.00008894416,0.00020963902,0.00006694511,0.00003744672],"category_scores_gemma":[0.00007459806,0.00022358946,0.00001642713,0.0002477009,0.00006583097,0.00043213431,0.00021146087,0.00013384757,0.0000024236022],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003384125,0.113624915,0.8694467,0.00004280733,0.00008974813,0.000019559604,0.001811371,0.000006225536,0.00013716416,0.000028718488,0.0000022602874,0.011406406],"study_design_scores_gemma":[0.08599223,0.028401453,0.88066167,0.000339679,0.00017665299,0.0000019849017,0.00029624414,0.00005703443,0.0038251902,0.000005361042,0.00003518673,0.00020729615],"about_ca_topic_score_codex":0.00036868895,"about_ca_topic_score_gemma":0.0012793136,"teacher_disagreement_score":0.08522346,"about_ca_system_score_codex":0.000057605463,"about_ca_system_score_gemma":0.000043914417,"threshold_uncertainty_score":0.91177136},"labels":[],"label_agreement":null},{"id":"W65840692","doi":"10.1182/blood.v108.11.2153.2153","title":"Abnormally Small BCR-ABL Transcripts in CML Patients before and during Imatinib Treatment.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Biology; Exon; Imatinib mesylate; Fusion gene; Amplicon; ABL; Imatinib; Tyrosine kinase; Alternative splicing; breakpoint cluster region; Cancer research; Fusion transcript; Molecular biology; Genetics; Gene; Polymerase chain reaction; Myeloid leukemia; Receptor","score_opus":0.007286936200778216,"score_gpt":0.2101842660553204,"score_spread":0.20289732985454217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W65840692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99349827,0.0003788016,0.0000012443337,0.00007119228,0.00004853801,0.0006724896,0.000031146992,0.00007163013,0.0052266954],"genre_scores_gemma":[0.9975626,0.0000721267,0.00084180094,0.000040490355,0.000096700474,0.000069936796,0.00014565636,0.00003823189,0.0011324706],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99872273,0.000024861316,0.00034328032,0.00034101898,0.00017134503,0.00039678474],"domain_scores_gemma":[0.99951226,0.00001892826,0.00006651318,0.00025771835,0.00003119424,0.000113384325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004237386,0.00025407202,0.00035000383,0.00014713137,0.00006165168,0.000018223158,0.000052987503,0.000105857136,0.00005184489],"category_scores_gemma":[0.000013063691,0.00021153674,0.00007779918,0.0001469483,0.00004113741,0.00008548532,0.000019276646,0.00010459464,0.0000211783],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012204974,0.0026484667,0.98996526,0.00014148197,0.00011396029,0.00032299556,0.0006194091,0.0000029580633,0.0018551414,0.000025906815,0.000011325205,0.0041710245],"study_design_scores_gemma":[0.040058736,0.00081069797,0.9489115,0.00015113401,0.0002856539,0.00010358921,0.00002935911,0.000023435743,0.009166579,0.00004163647,0.0002652428,0.00015247142],"about_ca_topic_score_codex":0.0014068389,"about_ca_topic_score_gemma":0.0023536088,"teacher_disagreement_score":0.041053817,"about_ca_system_score_codex":0.00036919958,"about_ca_system_score_gemma":0.00010665253,"threshold_uncertainty_score":0.8626218},"labels":[],"label_agreement":null},{"id":"W68963654","doi":"10.1182/blood.v96.10.3310.h8003310_3310_3321","title":"Hypersensitivity of circulating progenitor cells to megakaryocyte growth and development factor (PEG-rHu MGDF) in essential thrombocythemia","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Thrombopoietin; Megakaryocyte; Progenitor cell; Immunology; Biology; Haematopoiesis; Myeloid; Interleukin 3; Stem cell factor; Stem cell; Cell biology; T cell; Antigen-presenting cell","score_opus":0.014273951780636278,"score_gpt":0.24738974098751318,"score_spread":0.2331157892068769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W68963654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99789697,0.00014780722,0.00000922443,0.00011032328,0.00003597701,0.00071509084,0.000017696806,0.000024679366,0.0010422196],"genre_scores_gemma":[0.99537575,0.00005274842,0.0042850254,0.00008878279,0.000064028645,0.000058191847,0.000012329652,0.000021214877,0.000041937565],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987597,0.000044079254,0.00032797514,0.00034765198,0.0002598989,0.00026073612],"domain_scores_gemma":[0.9995213,0.00007745531,0.000056617973,0.00014739709,0.00005728562,0.00013992867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008083058,0.00020233201,0.00044397326,0.0000926131,0.0000590772,0.000014031561,0.000034727007,0.00007691533,0.00013367762],"category_scores_gemma":[0.000031276148,0.00016998708,0.000049232964,0.00014878441,0.000037406204,0.000052126245,0.000032575233,0.00010223475,0.000026039399],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026490074,0.003340748,0.4634095,0.00038879277,0.0004977873,0.00046858983,0.005677756,0.000008696604,0.5019795,0.000040631698,0.000016251211,0.023906851],"study_design_scores_gemma":[0.0028331818,0.00016883478,0.27231845,0.000153895,0.000075776494,0.000059589354,0.00007205035,0.000010406578,0.72407377,0.0000033942638,0.00009945719,0.00013116012],"about_ca_topic_score_codex":0.00008637706,"about_ca_topic_score_gemma":0.00003862599,"teacher_disagreement_score":0.2220943,"about_ca_system_score_codex":0.000048061764,"about_ca_system_score_gemma":0.00014035558,"threshold_uncertainty_score":0.6931872},"labels":[],"label_agreement":null},{"id":"W70976452","doi":"10.1182/blood.v122.21.70.70","title":"A Phase 1/2 Study Of Blinatumomab In Pediatric Patients With Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Blinatumomab; Medicine; Refractory (planetary science); Cytokine release syndrome; Internal medicine; Acute lymphocytic leukemia; Hematopoietic stem cell transplantation; Bone marrow; Toxicity; Phases of clinical research; Clinical endpoint; Gastroenterology; Leukemia; Oncology; Transplantation; Clinical trial; Lymphoblastic Leukemia; Immunotherapy; Cancer","score_opus":0.00788388270475319,"score_gpt":0.25223030621074166,"score_spread":0.24434642350598848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W70976452","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955455,0.00013131154,0.000019757437,0.000018844868,0.00007520089,0.0028216117,0.000021818327,0.00006383621,0.0013020978],"genre_scores_gemma":[0.99839675,0.000028644741,0.00037608956,0.000041666954,0.00010596448,0.00028265532,0.000039653823,0.0000840613,0.0006445366],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968173,0.00012830111,0.00067552703,0.000604634,0.0011200627,0.0006541962],"domain_scores_gemma":[0.9978715,0.0003188559,0.00028162356,0.0007161879,0.00046795275,0.00034385023],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018036024,0.0003577724,0.0006853685,0.0006602505,0.000051530893,0.000025590303,0.0003208828,0.00018521032,0.00014571592],"category_scores_gemma":[0.00022915598,0.0002714287,0.00007430659,0.0010829249,0.00009549173,0.00025936755,0.00016044042,0.00045396053,0.00020429959],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035320306,0.13288778,0.85280454,0.0006706708,0.0005358438,0.00080262194,0.0025707816,0.000021871432,0.0023708565,0.0000039865013,0.002132936,0.0016660849],"study_design_scores_gemma":[0.42481858,0.04689233,0.5198528,0.0002042504,0.0024141816,0.00005552925,0.00064107607,0.0007902566,0.003655793,0.000019148036,0.000047164085,0.0006088914],"about_ca_topic_score_codex":0.00023708596,"about_ca_topic_score_gemma":0.000022534297,"teacher_disagreement_score":0.42128655,"about_ca_system_score_codex":0.00066700956,"about_ca_system_score_gemma":0.0014990346,"threshold_uncertainty_score":0.9999738},"labels":[],"label_agreement":null},{"id":"W7108439879","doi":"10.1182/blood-2025-3386","title":"Differences in outcomes with intensive chemotherapy in AML patients according to mutational status – recent real-world results","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cytarabine; Gemtuzumab ozogamicin; Midostaurin; Adverse effect; Chemotherapy; Induction chemotherapy; Retrospective cohort study; Hematopoietic stem cell transplantation","score_opus":0.02230570188941118,"score_gpt":0.32235179589054935,"score_spread":0.3000460940011382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108439879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873373,0.000018795366,0.0000089661535,0.006786808,0.000055935605,0.00077807636,0.000026280495,0.000025623242,0.0049622003],"genre_scores_gemma":[0.99545753,0.00015941383,0.0009974936,0.0020819916,0.000019714107,0.00007577444,0.00007597753,0.000015503578,0.0011165964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99846643,0.000057490834,0.00035574622,0.00035362813,0.00037148094,0.00039522647],"domain_scores_gemma":[0.99895275,0.00028532778,0.000057835678,0.00022339761,0.00036767605,0.000112994414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017550787,0.00015259393,0.0003721904,0.0007085173,0.000028262524,0.000020660746,0.000114074595,0.00005116904,0.000020252735],"category_scores_gemma":[0.00085547485,0.00011172271,0.000025669155,0.0011501191,0.000043757595,0.00005732526,0.00006797341,0.0002961956,0.000010033265],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018201793,0.00045782077,0.9894195,0.000025740343,0.00007985116,0.00007159078,0.0010205403,0.0000033654842,0.00012352254,0.00006815325,0.0004173688,0.006492339],"study_design_scores_gemma":[0.017313981,0.00029889267,0.97894937,0.0003311634,0.000018433726,0.0000011547254,0.0012594,0.00002998078,0.0012349705,0.000055310138,0.00040214328,0.00010519235],"about_ca_topic_score_codex":0.0015221655,"about_ca_topic_score_gemma":0.002713543,"teacher_disagreement_score":0.015493801,"about_ca_system_score_codex":0.00044101544,"about_ca_system_score_gemma":0.00046528876,"threshold_uncertainty_score":0.45559198},"labels":[],"label_agreement":null},{"id":"W7108440027","doi":"10.1182/blood-2025-822","title":"FOXP3 and helios expressing CD4+ T conventional cells are a regulatory-like subset that is induced after orca-T allogeneic immunotherapy","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"FOXP3; Haematopoiesis; Hematopoietic stem cell transplantation; Immunotherapy; Stem cell; Peripheral blood mononuclear cell; Transplantation; T cell; Transcriptome","score_opus":0.016849724356206082,"score_gpt":0.2567816822357881,"score_spread":0.23993195787958205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108440027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956447,0.0024407515,0.00027001393,0.00042874462,0.00020266672,0.00044206955,0.00003467896,0.000054676875,0.00048168757],"genre_scores_gemma":[0.9961532,0.00018043505,0.00074533204,0.0016024193,0.000051836625,0.00007264126,0.00003001505,0.000027296186,0.0011368432],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99884754,0.00005530787,0.00026486898,0.00033628993,0.0002733315,0.00022266527],"domain_scores_gemma":[0.9993886,0.00006377829,0.000088727014,0.00031367017,0.00006402529,0.00008121416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014997054,0.00018689728,0.00029530228,0.00014774123,0.000073971656,0.00003934781,0.00006712791,0.00016476256,0.0003442915],"category_scores_gemma":[0.000004635362,0.0001744786,0.000095778276,0.00014008267,0.000058579008,0.00006864569,0.00001930785,0.00013143753,0.000021571559],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030009952,0.0003559167,0.14393447,0.00065427914,0.00041340632,0.00012028369,0.0010382477,2.3160915e-7,0.8520107,0.000047884845,0.0005600774,0.00056435977],"study_design_scores_gemma":[0.006500124,0.000063486244,0.21876661,0.001142537,0.00036725894,0.00009713987,0.00022694973,0.000010981256,0.7713765,0.00011383983,0.0011546743,0.0001799141],"about_ca_topic_score_codex":0.000010601238,"about_ca_topic_score_gemma":0.0000053785775,"teacher_disagreement_score":0.08063426,"about_ca_system_score_codex":0.000021899397,"about_ca_system_score_gemma":0.00009093658,"threshold_uncertainty_score":0.7115031},"labels":[],"label_agreement":null},{"id":"W7108440548","doi":"10.1182/blood-2025-1240","title":"Favorable safety and therapeutic efficacy of a novel humanized anti-ADAMTS13 antibody in acquired von willebrand syndrome: A preclinical study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"","keywords":"Von Willebrand factor; Antibody; Tolerability; In vivo; Von Willebrand disease; Therapeutic effect; Toxicity; Humanized antibody; Safety pharmacology","score_opus":0.022524237328508813,"score_gpt":0.3315419361617272,"score_spread":0.3090176988332184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108440548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961378,0.0016532816,0.000025140303,0.000146246,0.000045398152,0.0013328965,0.0000116437695,0.000029692443,0.0006179107],"genre_scores_gemma":[0.9992751,0.00021007904,0.00011435274,0.00008360011,0.00000544989,0.00001376796,0.000020318968,0.000015174955,0.0002621813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873656,0.00005696546,0.0004715688,0.0003489155,0.00016689794,0.00021910857],"domain_scores_gemma":[0.9993358,0.00019316934,0.00008578225,0.00029250677,0.000038034446,0.00005470419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024677697,0.00017605796,0.0007983938,0.00016712587,0.00005799108,0.000013098038,0.000077986726,0.00009776859,0.000020716801],"category_scores_gemma":[0.00008689828,0.00014096328,0.00007211035,0.00035966872,0.000074376265,0.00003980308,0.000058224865,0.00010364506,0.0000021027865],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015221542,0.035315003,0.94847566,0.00017207119,0.0014595459,0.0005257228,0.0007086521,0.0000036023287,0.009907037,0.000073374016,0.000005519775,0.0018316337],"study_design_scores_gemma":[0.07894118,0.0011703015,0.9177924,0.00031014142,0.000781782,0.000085149775,0.00022709809,0.000103122555,0.0003871038,0.000038403352,0.000054924887,0.00010842981],"about_ca_topic_score_codex":0.000109026405,"about_ca_topic_score_gemma":0.0000454212,"teacher_disagreement_score":0.07741903,"about_ca_system_score_codex":0.000013579637,"about_ca_system_score_gemma":0.000095562405,"threshold_uncertainty_score":0.5748316},"labels":[],"label_agreement":null},{"id":"W7108441195","doi":"10.1182/blood-2025-252","title":"Tumor clearance, T-cell fitness, and minimal residual disease (MRD) outcomes in patients with relapsed/refractory multiple myeloma (RRMM) treated with cevostamab plus pomalidomide and dexamethasone: Biomarker analyses from CAMMA 1 Arm B","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Alberta Cancer Foundation; McMaster University","funders":"","keywords":"Pomalidomide; Multiple myeloma; Biomarker; Dexamethasone; Randomized controlled trial; Clinical endpoint; Lenalidomide; Minimal residual disease","score_opus":0.017667836661984015,"score_gpt":0.2774876403507092,"score_spread":0.2598198036887252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108441195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960336,0.0017485282,0.0000053513954,0.00013735352,0.000022315291,0.0012358079,0.00049054663,0.000065504515,0.00026095856],"genre_scores_gemma":[0.9971988,0.00006760611,0.0014088255,0.000095269235,0.000020106716,0.00011915081,0.00037549066,0.00005344908,0.00066128623],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99750674,0.0001814447,0.00039916034,0.00082161854,0.00052639126,0.0005646563],"domain_scores_gemma":[0.99816227,0.0005349609,0.00014288138,0.0005157607,0.00014661512,0.0004975309],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001039138,0.00046416768,0.00080459693,0.00044496157,0.00016261973,0.00007102591,0.000109156244,0.00010620374,0.00003649863],"category_scores_gemma":[0.00032086388,0.00031041392,0.0000652598,0.00048249384,0.00034097218,0.00019045369,0.00011000408,0.0002647258,0.00000528464],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031204306,0.003524694,0.9600773,0.0001679467,0.0009045724,0.0014147033,0.000086163,0.0000021623748,0.0006749962,0.0000014098998,0.00006101814,0.0018807318],"study_design_scores_gemma":[0.09033097,0.001140831,0.90364534,0.00039476407,0.0009084385,0.0000051165266,0.00015639637,0.0001597866,0.0029253757,0.00000682042,0.000038370912,0.00028781107],"about_ca_topic_score_codex":0.0019442519,"about_ca_topic_score_gemma":0.00081478106,"teacher_disagreement_score":0.059126668,"about_ca_system_score_codex":0.000100296355,"about_ca_system_score_gemma":0.00032600356,"threshold_uncertainty_score":0.9999348},"labels":[],"label_agreement":null},{"id":"W7108441632","doi":"10.1182/blood-2025-1761","title":"Genomic and transcriptomic landscape of extranodal marginal zone lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Transcriptome; Lymphoma; Exome sequencing; BCL10; Copy number analysis; Missense mutation; Mutation; Exome","score_opus":0.006672173479129042,"score_gpt":0.22576154697001088,"score_spread":0.21908937349088184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108441632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98701215,0.0066815875,0.000023961717,0.00042473825,0.00005566752,0.00018789252,0.000016761074,0.000021346053,0.0055758827],"genre_scores_gemma":[0.9983758,0.0004033016,0.00043640158,0.00014108892,0.000030457108,0.000019029369,0.000011391761,0.000007503468,0.00057504425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99945617,0.000011587906,0.00016082317,0.00016463088,0.00007862944,0.00012816848],"domain_scores_gemma":[0.9997166,0.00002839207,0.000026049453,0.0001507496,0.000021115075,0.00005708951],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000044226374,0.00009986921,0.00024819796,0.000086753396,0.000027474209,0.0000071793856,0.000035335026,0.000050682986,0.000065631386],"category_scores_gemma":[0.0000043598898,0.000080922386,0.000069347414,0.00008258231,0.00004199399,0.000018039935,0.000012312908,0.0000202747,0.0000065378945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032667277,0.0025032926,0.91890574,0.00024581532,0.00055694307,0.00012508382,0.00019254486,3.0956542e-7,0.05345322,0.0014120404,0.00047449258,0.021803848],"study_design_scores_gemma":[0.017767178,0.00022823,0.9414542,0.00011069319,0.0007419903,0.00011426896,0.000051454477,0.000018403038,0.037152987,0.0000491103,0.002247678,0.000063826956],"about_ca_topic_score_codex":0.000054350603,"about_ca_topic_score_gemma":0.00001313105,"teacher_disagreement_score":0.022548443,"about_ca_system_score_codex":0.000019766288,"about_ca_system_score_gemma":0.00010231209,"threshold_uncertainty_score":0.32999194},"labels":[],"label_agreement":null},{"id":"W7108443597","doi":"10.1182/blood-2025-4506","title":"Real-world incidence of treatment-emergent cardiovascular events among chronic lymphocytic leukemia/small lymphocytic lymphoma patients receiving acalabrutinib or zanubrutinib monotherapy","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada)","funders":"","keywords":"Ibrutinib; Propensity score matching; Incidence (geometry); Logistic regression; Cohort; Adverse effect; Retrospective cohort study; Progression-free survival","score_opus":0.02127202425802453,"score_gpt":0.29344711897257236,"score_spread":0.2721750947145478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108443597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98812985,0.0033438194,0.00007139521,0.00002074406,0.00055403804,0.0028173937,0.00003566595,0.00026969257,0.0047573815],"genre_scores_gemma":[0.9800646,0.008468172,0.00062071736,0.0001014464,0.00030175364,0.00045221983,0.00011573102,0.00016719515,0.009708185],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9934005,0.00041769107,0.0017076902,0.0015083827,0.0013982006,0.001567531],"domain_scores_gemma":[0.9951613,0.0006049544,0.0004792452,0.0025647453,0.0006442233,0.00054552616],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008626288,0.00092059094,0.0019899784,0.0009738784,0.0002820767,0.000049107377,0.00083818496,0.00046941705,0.0001807038],"category_scores_gemma":[0.000720363,0.0007601615,0.0010820992,0.0025918006,0.00041734567,0.00022163897,0.00041003322,0.00023728378,0.000087917266],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.01316538,0.007982744,0.5053894,0.010426116,0.03729895,0.002646262,0.0031019896,0.0095377965,0.008324735,0.00042644836,0.001472623,0.40022758],"study_design_scores_gemma":[0.47593185,0.0047391984,0.31469363,0.0066231973,0.007302143,0.0002942492,0.0003459433,0.03612402,0.14401275,0.00011116457,0.007840854,0.0019809904],"about_ca_topic_score_codex":0.028207067,"about_ca_topic_score_gemma":0.00196954,"teacher_disagreement_score":0.46276647,"about_ca_system_score_codex":0.22473405,"about_ca_system_score_gemma":0.10273575,"threshold_uncertainty_score":0.99948496},"labels":[],"label_agreement":null},{"id":"W7108444082","doi":"10.1182/blood-2025-2288","title":"A Phase 2/3, multicenter, randomized, open-label study evaluating the efficacy and safety of etentamig and daratumumab compared to daratumumab, lenalidomide, and dexamethasone in frailer transplant-ineligible patients with newly diagnosed multiple myeloma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Daratumumab; Multiple myeloma; Dexamethasone; Monoclonal antibody; Monoclonal; Phases of clinical research; Antibody; Clinical trial","score_opus":0.04428676901334626,"score_gpt":0.3690392358046509,"score_spread":0.32475246679130465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108444082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98670226,0.0010615517,0.00009860258,0.0001806221,0.00003340929,0.011654074,0.00013270673,0.000018862886,0.000117890944],"genre_scores_gemma":[0.99612856,0.0001867174,0.0028322106,0.00011160857,0.000011926116,0.0005696259,0.000083680316,0.000026971413,0.00004871151],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.997107,0.0006526153,0.0006921743,0.00063359475,0.00049044116,0.00042414776],"domain_scores_gemma":[0.99651414,0.002459219,0.0001532162,0.00042235843,0.00019127164,0.00025979354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010936017,0.00034893368,0.0011868296,0.00027051353,0.00025437918,0.000103456274,0.00020072062,0.00006689525,0.000008366691],"category_scores_gemma":[0.0010565885,0.00021454254,0.00003602491,0.00044968355,0.00024465343,0.0001468793,0.00024893542,0.0002713527,0.0000011542631],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.39092278,0.023024049,0.56489897,0.00018013568,0.0011770498,0.000099430494,0.0035843612,0.0000069716375,0.0011278334,0.0000060546618,0.000017991795,0.0149543695],"study_design_scores_gemma":[0.6838287,0.0029751223,0.3078618,0.0007246942,0.0007399374,0.0000059773856,0.00053074665,0.0025963243,0.0005842415,0.0000035138514,0.000008474728,0.00014041807],"about_ca_topic_score_codex":0.0014232325,"about_ca_topic_score_gemma":0.0011831895,"teacher_disagreement_score":0.29290596,"about_ca_system_score_codex":0.00003357053,"about_ca_system_score_gemma":0.000101764104,"threshold_uncertainty_score":0.87487906},"labels":[],"label_agreement":null},{"id":"W7108444735","doi":"10.1182/blood-2025-3390","title":"Comparable remission rates in therapy-related and myelodysplasia-related Acute Myeloid Leukemia (AML) versus de novo AML treated with azacitidine and venetoclax: A contemporary real-world study.","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Azacitidine; Venetoclax; Myeloid leukemia; Complete remission; Hematology; Myeloid; Leukemia; Retrospective cohort study; Cancer","score_opus":0.02262684375554143,"score_gpt":0.3085555877238291,"score_spread":0.28592874396828766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108444735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788453,0.0023796733,0.000002414036,0.00056933577,0.000041526233,0.0021737327,0.000016034528,0.00020658081,0.015765388],"genre_scores_gemma":[0.99044335,0.0019615365,0.00021981412,0.00010521729,0.000026665606,0.00013330279,0.00011312,0.00007236323,0.006924604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971023,0.00032327662,0.00068185583,0.00082784845,0.0003831772,0.0006814971],"domain_scores_gemma":[0.9983351,0.00043481865,0.00016210038,0.00055123575,0.00016238088,0.00035436737],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006576413,0.0004977088,0.0009771915,0.0007714243,0.00021050307,0.000076950695,0.00019576054,0.00029344743,0.00005834348],"category_scores_gemma":[0.00008842788,0.0003895533,0.000057477446,0.0018296879,0.00031846057,0.0001890732,0.00015219675,0.00096737704,0.000007877014],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023742104,0.0012662751,0.8790856,0.00019441365,0.0035359107,0.0044649746,0.0019438083,0.00004961525,0.081912845,0.00016099079,0.0012907273,0.0023527548],"study_design_scores_gemma":[0.22963507,0.007251128,0.66802365,0.0022811536,0.0014158518,0.0007027012,0.0021983227,0.004061097,0.08118467,0.00017428419,0.0020528978,0.0010191422],"about_ca_topic_score_codex":0.0026380515,"about_ca_topic_score_gemma":0.0004770134,"teacher_disagreement_score":0.21106191,"about_ca_system_score_codex":0.00089659495,"about_ca_system_score_gemma":0.0019571113,"threshold_uncertainty_score":0.99985564},"labels":[],"label_agreement":null},{"id":"W7108445722","doi":"10.1182/blood-2025-6670","title":"When pregnancy, HIT, and stroke collide: Navigating complex thrombotic care in a community-based setting","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor; Windsor Regional Hospital; Western University","funders":"","keywords":"Fondaparinux; Heparin-induced thrombocytopenia; Argatroban; Rivaroxaban; Stroke (engine); Thrombosis; Heparin; Pregnancy; Complication","score_opus":0.03193843379076074,"score_gpt":0.31677439502743004,"score_spread":0.2848359612366693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108445722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98956907,0.0007803645,0.000033193883,0.0009741209,0.00006302324,0.00078882865,0.000036563448,0.0001097025,0.0076451465],"genre_scores_gemma":[0.9932777,0.000021752248,0.005594083,0.0008089982,0.000024781964,0.000058827176,0.00011150008,0.000030218347,0.00007213181],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983664,0.00030611432,0.00042970054,0.00030454915,0.00018780405,0.0004053937],"domain_scores_gemma":[0.99879766,0.00034907545,0.00009447253,0.000529989,0.00010516157,0.00012366436],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028159382,0.00024642228,0.0006474554,0.0001374603,0.00034389732,0.00005869989,0.00017847394,0.00015658641,0.00003370541],"category_scores_gemma":[0.00017041196,0.0002472949,0.00008067498,0.00032460756,0.00012521185,0.00007958906,0.00018533129,0.0009131991,0.0000071918466],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044921562,0.0014426244,0.8964083,0.0029316773,0.000307654,0.00010732623,0.008595209,0.000013090133,0.082562014,0.00035885695,0.00008001434,0.0071483026],"study_design_scores_gemma":[0.021266015,0.0008831455,0.8915267,0.016094092,0.0010932779,0.000050584807,0.010710589,0.0006995982,0.055807285,0.0005372495,0.00071980065,0.0006116645],"about_ca_topic_score_codex":0.00087797723,"about_ca_topic_score_gemma":0.00091951113,"teacher_disagreement_score":0.026754728,"about_ca_system_score_codex":0.00010979354,"about_ca_system_score_gemma":0.00029903653,"threshold_uncertainty_score":0.9999979},"labels":[],"label_agreement":null},{"id":"W7108446632","doi":"10.1182/blood-2025-7816","title":"Outcomes of haploidentical hematopoietic stem cell transplantation in low- and middle-income countries: A systematic review and meta-analysis.","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hematopoietic stem cell transplantation; Transplantation; Disease; Stem cell; Systematic review; Hematopoietic cell; MEDLINE; Graft-versus-host disease","score_opus":0.02094165106994374,"score_gpt":0.27749686819740077,"score_spread":0.25655521712745705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108446632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88885444,0.104444586,0.0013211042,0.0012311818,0.00002465555,0.0034459832,0.00007170173,0.00004911689,0.00055724283],"genre_scores_gemma":[0.9936718,0.004994284,0.00027685228,0.0004270638,0.0000013773428,0.0001384223,0.0000127030435,0.000012047219,0.00046547284],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99793726,0.00016457205,0.0011129229,0.00030155643,0.00031451994,0.00016914593],"domain_scores_gemma":[0.9988207,0.0005084674,0.00018986552,0.00031743405,0.00008434334,0.00007919174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000656283,0.00021149147,0.0025938249,0.00035713188,0.000025128447,0.000018239427,0.00006975066,0.000094437004,0.000042842337],"category_scores_gemma":[0.000028710625,0.00015515037,0.00030664733,0.000551025,0.000071380535,0.00006606671,0.000011549225,0.00010230873,0.000004873111],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001812603,0.00020694915,0.035771966,0.9436454,0.018706063,0.00006685724,0.00089063536,8.63228e-7,0.00005026577,0.0006422034,5.2799606e-7,1.5074535e-7],"study_design_scores_gemma":[0.0026353851,0.000056709112,0.026430458,0.0280869,0.93785805,0.00012395033,0.0002712212,0.000031523516,0.0042773406,0.00006486136,2.361948e-7,0.00016338253],"about_ca_topic_score_codex":0.000024257832,"about_ca_topic_score_gemma":0.000035362304,"teacher_disagreement_score":0.91915196,"about_ca_system_score_codex":0.000013845739,"about_ca_system_score_gemma":0.000046726218,"threshold_uncertainty_score":0.6326848},"labels":[],"label_agreement":null},{"id":"W7108446833","doi":"10.1182/blood-2025-831","title":"Burnout in sickle cell disease-focused hematology-oncology trained providers: A national cross-sectional study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Healthcare professionals’ stress and burnout","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Providence Health Care","funders":"","keywords":"Burnout; Logistic regression; Emotional exhaustion; Affect (linguistics); Pride; Psychological resilience; Depersonalization; Disease","score_opus":0.058637191402548194,"score_gpt":0.44542414903411687,"score_spread":0.3867869576315687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108446833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97437197,0.0013038258,0.000045316687,0.004587039,0.001203847,0.0029975204,0.000118834185,0.00016352918,0.01520813],"genre_scores_gemma":[0.99091464,0.0000234663,0.00024984797,0.002072039,0.00032722842,0.0016810738,0.00006732183,0.000027129518,0.0046372744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952604,0.0013537001,0.0013152298,0.0006907948,0.00057277107,0.0008071091],"domain_scores_gemma":[0.9969952,0.001574284,0.00030766355,0.00032044514,0.00053283473,0.00026956902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017010607,0.00027159535,0.000541471,0.0004431192,0.0009140609,0.000025007621,0.0003428411,0.000461895,0.0006372203],"category_scores_gemma":[0.0008879442,0.00023757377,0.000119195945,0.00054348103,0.00011559784,0.00017321529,0.00023038349,0.0012172331,0.00018962857],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038396457,0.0049859434,0.98756486,0.0005727989,0.000057889767,0.00009525654,0.0018432967,0.000009286303,0.000085673215,0.0027856152,0.0012054855,0.00040993496],"study_design_scores_gemma":[0.012504508,0.0002248144,0.97498536,0.00055184733,0.00003939778,0.000002429389,0.0027033822,0.00011124541,0.00003679614,0.005208376,0.0033946177,0.00023720945],"about_ca_topic_score_codex":0.00050715555,"about_ca_topic_score_gemma":0.0013489649,"teacher_disagreement_score":0.01654266,"about_ca_system_score_codex":0.00035884502,"about_ca_system_score_gemma":0.0055486835,"threshold_uncertainty_score":0.98431265},"labels":[],"label_agreement":null},{"id":"W7108449712","doi":"10.1182/blood-2025-7823","title":"Factors influencing outcomes in therapy-related myeloid neoplasms following allogeneic hematopoietic stem cell transplantation","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Cumulative incidence; Myeloid leukemia; Hematopoietic stem cell transplantation; Transplantation; Myelodysplastic syndromes; Chromosome abnormality; Myeloid; Malignancy; Cytogenetics; Leukemia","score_opus":0.017828690572918377,"score_gpt":0.2770430339639212,"score_spread":0.25921434339100285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108449712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960239,0.00077792635,0.000041548956,0.00031052853,0.00013643438,0.0006900574,0.0000052410865,0.00012142834,0.0018929641],"genre_scores_gemma":[0.9976777,0.00022529931,0.0001282517,0.00025193434,0.000009894069,0.00004084832,0.000031402582,0.00003486773,0.0015997944],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982342,0.00010179608,0.00049086707,0.00036942342,0.00035754748,0.00044617627],"domain_scores_gemma":[0.99918604,0.00027761742,0.000064053,0.00032569194,0.0000401182,0.000106455256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028456052,0.00025671814,0.0005081564,0.0004698305,0.00008318013,0.000029468989,0.00018243324,0.00022152494,0.000035019497],"category_scores_gemma":[0.000024996569,0.0002029254,0.00021423792,0.0006728506,0.000033194647,0.00011269635,0.00003192728,0.00044254033,0.000026048436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067291425,0.00034779237,0.89309835,0.00022228848,0.0003053495,0.0002560608,0.0042632464,0.000038304366,0.10043716,0.00004228419,0.000013902008,0.00090798805],"study_design_scores_gemma":[0.014025796,0.00018015133,0.6578617,0.00035933315,0.00030920038,0.000024681358,0.002006773,0.000051916457,0.3247415,0.00008745692,0.00007571747,0.00027578956],"about_ca_topic_score_codex":0.0001441775,"about_ca_topic_score_gemma":0.000043840846,"teacher_disagreement_score":0.23523666,"about_ca_system_score_codex":0.00018566879,"about_ca_system_score_gemma":0.0003699901,"threshold_uncertainty_score":0.8275057},"labels":[],"label_agreement":null},{"id":"W7108450376","doi":"10.1182/blood-2025-6296","title":"Pre-existing cognitive impairment is associated with reduced long-term survival following chimeric antigen receptor T-cell therapy for non-Hodgkin's lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cohort; Proportional hazards model; Lymphoma; Retrospective cohort study; Survival analysis; Cohort study; Chimeric antigen receptor; Surrogate endpoint; CAR T-cell therapy","score_opus":0.025455255169864653,"score_gpt":0.3288733749213329,"score_spread":0.30341811975146826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108450376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890854,0.00054086786,0.00022592743,0.00019634179,0.00034296533,0.0032616262,0.000054933495,0.00013982499,0.0061521353],"genre_scores_gemma":[0.98558295,0.00021992139,0.0003791722,0.00033248734,0.00022502466,0.00034922318,0.0002376797,0.00010352477,0.012570032],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974816,0.00014085436,0.00038632494,0.00065917714,0.000589282,0.0007427763],"domain_scores_gemma":[0.99840325,0.00054384023,0.00017268823,0.00037600743,0.00032524066,0.00017899724],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007009345,0.00036190875,0.00067771884,0.00021898684,0.0002681857,0.000078273944,0.00020314608,0.00017439392,0.00034709083],"category_scores_gemma":[0.00017291014,0.00030781497,0.00034635086,0.00072529295,0.000083703584,0.00007715534,0.00006821038,0.00020164838,0.000012132918],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059920643,0.0059266393,0.38881618,0.0002345778,0.005490682,0.00014915608,0.0023134893,4.509192e-7,0.5521762,0.0000024228993,0.00044107763,0.03845709],"study_design_scores_gemma":[0.04991319,0.0037959118,0.41931957,0.0013476833,0.0006100223,0.0000100755815,0.00032527794,0.000057385863,0.5239371,0.000011338998,0.00022683412,0.0004455925],"about_ca_topic_score_codex":0.000069610134,"about_ca_topic_score_gemma":0.00001312391,"teacher_disagreement_score":0.043921128,"about_ca_system_score_codex":0.00019283789,"about_ca_system_score_gemma":0.0006335949,"threshold_uncertainty_score":0.9999374},"labels":[],"label_agreement":null},{"id":"W7108450771","doi":"10.1182/blood-2025-3340","title":"Outcome after relapse in older patients with Philadelphia Chromosome–Negative B-cell ALL treated with inotuzumab ozogamicin and low-dose chemotherapy in first-line therapy: A graall study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Chemotherapy; Gemtuzumab ozogamicin; Blinatumomab; Transplantation; Chemotherapy regimen; Lymphoblastic Leukemia; Acute lymphocytic leukemia; Induction chemotherapy; Hematopoietic stem cell transplantation","score_opus":0.009541283168434021,"score_gpt":0.2626484433560594,"score_spread":0.2531071601876254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108450771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949492,0.00019196137,0.000007950809,0.0008756589,0.000016105521,0.0036913904,0.000020547457,0.000054127107,0.00019303958],"genre_scores_gemma":[0.99790514,0.0001028575,0.00014906787,0.0009022264,0.00002462273,0.00039188578,0.000034271725,0.00007778517,0.00041215707],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99748653,0.00012324184,0.00054035196,0.0007461462,0.0005416731,0.00056208455],"domain_scores_gemma":[0.9988165,0.00020699341,0.000108450025,0.00054503814,0.00016828501,0.00015476704],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020382725,0.00045990656,0.0007569462,0.0006063092,0.000042877367,0.000033947992,0.00017247876,0.00017262611,0.000058325862],"category_scores_gemma":[0.000048818256,0.00030329838,0.000043547243,0.0011033362,0.00016962676,0.00013942526,0.000087598666,0.00050690916,0.0000072498137],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011509746,0.015157874,0.96754634,0.0001726737,0.00034622024,0.0007964181,0.0039495267,0.000010093466,0.00021119814,0.0000013808024,0.000027171685,0.00027135154],"study_design_scores_gemma":[0.18748139,0.004172091,0.8052209,0.00044747314,0.00015211503,0.000011504426,0.00034987586,0.00017522273,0.0016811355,0.000010530163,0.000023015513,0.0002747705],"about_ca_topic_score_codex":0.0007148162,"about_ca_topic_score_gemma":0.0012247267,"teacher_disagreement_score":0.17597164,"about_ca_system_score_codex":0.0005134733,"about_ca_system_score_gemma":0.0003692234,"threshold_uncertainty_score":0.9999419},"labels":[],"label_agreement":null},{"id":"W7108451088","doi":"10.1182/blood-2025-73","title":"Distinct patterns of mutant ASXL1 over time and their implications for treatment failure (TF) and BCR::ABL1 mutation development in newly diagnosed patients with chronic myeloid leukemia in chronic phase (CML-CP) treated with asciminib (ASC) vs investigator-selected tyrosine kinase inhibitors (IS-TKI) in the ASC4FIRST study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Proportional hazards model; Myeloid leukemia; Mutation; Allele; Multivariate analysis; Genotype; Allele frequency; Survival analysis","score_opus":0.009043509721543675,"score_gpt":0.24678857015356734,"score_spread":0.23774506043202367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108451088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925463,0.00039995133,0.000011824551,0.00027669157,0.000010490905,0.0064599547,0.00024699685,0.000037389244,0.000010398129],"genre_scores_gemma":[0.99677724,0.00004803538,0.00016336484,0.000063181986,0.000023315828,0.0018803431,0.00096479163,0.00005180607,0.000027929147],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976259,0.00014583408,0.0007423425,0.0007655624,0.00023335908,0.00048699998],"domain_scores_gemma":[0.99857223,0.0003595034,0.00027490073,0.0004975351,0.00014270986,0.00015312844],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019790024,0.0005468475,0.00076593476,0.00044951492,0.00012650026,0.00004206561,0.00013222838,0.00013878837,0.000010628662],"category_scores_gemma":[0.00011150718,0.0003434796,0.000042161908,0.0011133172,0.00013756163,0.00014582569,0.00005050309,0.00018548514,8.718085e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096984184,0.0052775354,0.97745514,0.0002488835,0.00047527847,0.00006729601,0.005223218,0.000039178365,0.0031818035,0.0000061664323,0.000018780109,0.0070369067],"study_design_scores_gemma":[0.11102009,0.0065826722,0.8627882,0.00097028306,0.00047180057,0.00001638069,0.00031566946,0.00032864185,0.01714522,0.000009963444,0.00006774991,0.00028335018],"about_ca_topic_score_codex":0.0024425494,"about_ca_topic_score_gemma":0.027515769,"teacher_disagreement_score":0.11466693,"about_ca_system_score_codex":0.0046096435,"about_ca_system_score_gemma":0.0034184044,"threshold_uncertainty_score":0.9999017},"labels":[],"label_agreement":null},{"id":"W7108451665","doi":"10.1182/blood-2025-8152","title":"The role of palliative care in the multidisciplinary treatment of immunoglobulin light chain amyloidosis","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"AL amyloidosis; Amyloidosis; Palliative care; Quality of life (healthcare); Daratumumab; Immunoglobulin light chain; Psychological intervention; Cardiac amyloidosis","score_opus":0.006120119194831603,"score_gpt":0.26615436217385074,"score_spread":0.2600342429790191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108451665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9529292,0.044298127,0.0000032722637,0.0006815009,0.00004545715,0.0005147296,0.000060566832,0.0000047681106,0.0014623716],"genre_scores_gemma":[0.9943542,0.004951409,0.00012540222,0.000030371248,0.000028162713,0.000295808,0.000050263145,0.000010881391,0.00015349442],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990005,0.0001384887,0.00030513958,0.00024451836,0.00011458702,0.00019679719],"domain_scores_gemma":[0.9990815,0.00012336065,0.0001451888,0.0005643022,0.00006729351,0.000018391365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009219165,0.00018386223,0.0002307326,0.000044189364,0.000106657164,0.000009777653,0.00032002886,0.00010741706,0.000002825488],"category_scores_gemma":[0.000046133275,0.00010361402,0.0001925735,0.00017895593,0.000099650766,0.0000019451618,0.00010630213,0.00004305936,0.0000018371993],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022869167,0.0024487248,0.85280085,0.000041074072,0.0008245224,0.0000053434646,0.0046181893,0.00002672668,0.129217,0.00043923932,0.0000621991,0.009287418],"study_design_scores_gemma":[0.0022037248,0.0007536917,0.21164615,0.000039044116,0.00017521933,5.134912e-7,0.0071390765,0.000003610703,0.77306414,0.000099707104,0.004781551,0.0000935611],"about_ca_topic_score_codex":0.00015952677,"about_ca_topic_score_gemma":0.00036161253,"teacher_disagreement_score":0.64384717,"about_ca_system_score_codex":0.000035176006,"about_ca_system_score_gemma":0.00008666734,"threshold_uncertainty_score":0.4225257},"labels":[],"label_agreement":null},{"id":"W7108452450","doi":"10.1182/blood-2025-2395","title":"Ultra-low-dose IL-10-expressing CAR-T cells achieve high efficacy in R/R DLBCL: An update analysis","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"","keywords":"Cytokine release syndrome; Tolerability; Fludarabine; Adverse effect; Clinical trial; Chimeric antigen receptor; Lymphoma; Immunotherapy","score_opus":0.014438933948381607,"score_gpt":0.30784283175018984,"score_spread":0.29340389780180826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108452450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914431,0.000256071,0.00004971442,0.00055137515,0.00010448326,0.00053377455,0.00003816643,0.00011042832,0.00691286],"genre_scores_gemma":[0.9893602,0.00015671323,0.0005192731,0.0003551094,0.00016132752,0.000033073782,0.00018233054,0.000043603344,0.009188332],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974734,0.00025954135,0.00047193083,0.0006632394,0.00051784783,0.000614049],"domain_scores_gemma":[0.99826,0.00020998614,0.00007785989,0.0010685554,0.00012818792,0.0002553932],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005867993,0.00027177212,0.0006955898,0.00095999404,0.00010029641,0.000096634125,0.00033186082,0.00019017298,0.0020749709],"category_scores_gemma":[0.000099715726,0.00025437062,0.00027545416,0.0022486453,0.000114446426,0.00011924498,0.00007603076,0.00051365356,0.00007359626],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068935315,0.004241093,0.012436289,0.000103865415,0.0012539638,0.00026447128,0.0004740574,0.00019148938,0.9697076,0.000048684622,0.00034977024,0.010239358],"study_design_scores_gemma":[0.019620534,0.00042917358,0.10458818,0.0002607114,0.0025804283,0.000010970646,0.00023767477,0.0005881628,0.8643677,0.00011535749,0.006742557,0.00045850873],"about_ca_topic_score_codex":0.00052443624,"about_ca_topic_score_gemma":0.00019286825,"teacher_disagreement_score":0.10533986,"about_ca_system_score_codex":0.00009953828,"about_ca_system_score_gemma":0.00022649522,"threshold_uncertainty_score":0.9999909},"labels":[],"label_agreement":null},{"id":"W7108452504","doi":"10.1182/blood-2025-2287","title":"Real-world sequencing of anti-BCMA CAR T-cells and bispecific T-cell engagers in Relapsed/Refractory multiple myeloma: A multi-country analysis","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Clinical Practice; CAR T-cell therapy; Clinical trial; Multiple myeloma; Real world data; Daratumumab; Bispecific antibody; Hematologic Neoplasms","score_opus":0.02518383271107581,"score_gpt":0.2919276031433316,"score_spread":0.2667437704322558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108452504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99132454,0.0010854012,0.000031440988,0.000045667763,0.000089606925,0.0005901712,0.000040500778,0.000055267094,0.0067374003],"genre_scores_gemma":[0.99020565,0.0011764114,0.0011599269,0.000056084344,0.000050461895,0.00002508454,0.00003453714,0.00003939478,0.0072524454],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99765116,0.00024059827,0.0006102908,0.0005942056,0.00043144662,0.0004722944],"domain_scores_gemma":[0.9982277,0.00059674843,0.00014599493,0.00072253397,0.00014653326,0.00016047219],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008967571,0.00026252744,0.0008472687,0.0017754588,0.000085707434,0.000026578045,0.00017834698,0.00018531004,0.00022657355],"category_scores_gemma":[0.00016112223,0.00025636522,0.00021241805,0.0028481823,0.00019718087,0.00006374164,0.00010181203,0.0007237885,0.000007525745],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014559628,0.0007440055,0.28167927,0.000257959,0.00051627075,0.00016681156,0.000685169,0.00006381428,0.7152208,0.000009546637,0.0000621322,0.000448623],"study_design_scores_gemma":[0.01883377,0.00023013832,0.22542886,0.00032282266,0.0016124664,0.000007884879,0.0017718801,0.0034145927,0.74650013,0.000008975427,0.0015045556,0.0003639247],"about_ca_topic_score_codex":0.0027966576,"about_ca_topic_score_gemma":0.0023125987,"teacher_disagreement_score":0.056250405,"about_ca_system_score_codex":0.0002481711,"about_ca_system_score_gemma":0.00036757175,"threshold_uncertainty_score":0.99998885},"labels":[],"label_agreement":null},{"id":"W7108453570","doi":"10.1182/blood-2025-250","title":"Phase 1 study of ktx-1001, a first-in-class oral MMSET/NSD2 inhibitor, demonstrates clinical activity in relapsed/refractory multiple myeloma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Multiple myeloma; Panobinostat; Phases of clinical research; Clinical endpoint; Cereblon; Pharmacodynamics; Proteasome inhibitor; Clinical trial; Carfilzomib; Ubiquitin ligase","score_opus":0.04703664611367812,"score_gpt":0.37922288353181416,"score_spread":0.332186237418136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108453570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967214,0.00027935955,0.000004849345,0.00020994795,0.00014792045,0.0017353725,0.00003691048,0.000047433754,0.00081683055],"genre_scores_gemma":[0.99916345,0.00007484343,0.00023145271,0.00003278748,0.00006212501,0.0001570489,0.00002176822,0.000024233708,0.0002323161],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971701,0.00039533083,0.0008288403,0.0006148107,0.00045081825,0.0005401258],"domain_scores_gemma":[0.9978942,0.0010063682,0.00015281411,0.00059304264,0.000107463784,0.00024605743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007107621,0.00028288402,0.0008719297,0.00048838754,0.00007004778,0.00001763731,0.00017852668,0.00023266532,0.00004363002],"category_scores_gemma":[0.0012870603,0.00024418332,0.00016552526,0.0007156694,0.00015944461,0.000113431546,0.00014544754,0.0007193019,0.000022064556],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003470308,0.092888206,0.8726115,0.0001337054,0.00037346437,0.0011100798,0.00024068271,0.0000025820473,0.002424625,0.000005046185,0.00012135394,0.026618425],"study_design_scores_gemma":[0.12737127,0.0059019495,0.8551342,0.00034985313,0.00019093289,0.000009464096,0.00055968104,0.0010627151,0.009020049,0.000020384554,0.00021446652,0.00016503678],"about_ca_topic_score_codex":0.001470118,"about_ca_topic_score_gemma":0.008953293,"teacher_disagreement_score":0.12390096,"about_ca_system_score_codex":0.00012204984,"about_ca_system_score_gemma":0.00040409437,"threshold_uncertainty_score":0.9957506},"labels":[],"label_agreement":null},{"id":"W7108454742","doi":"10.1182/blood-2025-3388","title":"Extramedullary disease in AML: A high-risk feature beyond ELN 2022 classification","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Bone marrow; Retrospective cohort study; Multivariate analysis; Myeloid leukemia; Leukemia; Cohort; Propensity score matching; Myeloid; Induction chemotherapy","score_opus":0.009285117213352853,"score_gpt":0.27869146000297274,"score_spread":0.2694063427896199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108454742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800541,0.004141657,0.00007763872,0.010809299,0.00011873484,0.00067829806,0.00005643741,0.00008790901,0.0039759576],"genre_scores_gemma":[0.98839885,0.0011260018,0.0009572044,0.0007803109,0.00017600082,0.00014181122,0.00020389193,0.00002582881,0.0081900805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859565,0.00011817079,0.0002036539,0.00040029877,0.0003478893,0.0003343355],"domain_scores_gemma":[0.9989109,0.00012449529,0.000052702722,0.00060896744,0.00008397666,0.00021894168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028846925,0.00014921067,0.0002340385,0.00035199046,0.0000729147,0.00002628276,0.00018013085,0.0001652838,0.0001209791],"category_scores_gemma":[0.0005288905,0.00013487779,0.000076300494,0.00083335006,0.000081504884,0.00006882641,0.000092604874,0.0008026318,0.00006870684],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009905761,0.0022171112,0.88305455,0.00041810292,0.00026803015,0.0009799558,0.00021662663,0.0000084304365,0.01510781,0.004822897,0.06570143,0.02621448],"study_design_scores_gemma":[0.0065410202,0.000101927166,0.97524124,0.0001608509,0.00034282336,0.000011171174,0.00013734707,0.0008084055,0.0019431175,0.0014268548,0.013138174,0.00014704885],"about_ca_topic_score_codex":0.00017423935,"about_ca_topic_score_gemma":0.000057967532,"teacher_disagreement_score":0.09218671,"about_ca_system_score_codex":0.00023616673,"about_ca_system_score_gemma":0.00074611185,"threshold_uncertainty_score":0.5500156},"labels":[],"label_agreement":null},{"id":"W7108455829","doi":"10.1182/blood-2025-3988","title":"Factors impacting treatment choice with a CD38 antibody, immunomodulator, proteasome inhibitor, and dexamethasone in first line multiple myeloma patients: A real-world US study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada)","funders":"","keywords":"Bortezomib; Lenalidomide; Multiple myeloma; Dexamethasone; Regimen; Thalidomide; Pomalidomide; Performance status; Carfilzomib","score_opus":0.026256291101218618,"score_gpt":0.32518897360278337,"score_spread":0.29893268250156474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108455829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99420667,0.00033042885,0.0000054115108,0.000078454024,0.000044943074,0.004890343,0.000044666973,0.0000922517,0.0003068515],"genre_scores_gemma":[0.99854,0.00008477126,0.00028614845,0.000016531214,0.000056084486,0.0003926734,0.00013780803,0.000047698923,0.0004383009],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976454,0.00012913553,0.00047042212,0.00067961,0.00042794927,0.00064747606],"domain_scores_gemma":[0.9984214,0.0004488578,0.00014054075,0.0005493428,0.00014546074,0.00029442488],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016400547,0.00047204373,0.00075195805,0.00060827646,0.0002201117,0.00007144708,0.00009818421,0.000089718924,0.00001651762],"category_scores_gemma":[0.00047916183,0.00031300177,0.00008785548,0.00087544345,0.000082184306,0.000184253,0.00011863831,0.00027259366,0.0000040902455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011326916,0.014614793,0.97686464,0.00013354511,0.0010307969,0.00024533315,0.0008646246,0.0000033100719,0.00080692157,0.0000017252742,0.000002323317,0.00429928],"study_design_scores_gemma":[0.052706927,0.0056958925,0.9351079,0.00051775906,0.00034036397,0.000006097285,0.00032157457,0.000144276,0.0048372922,0.0000030729777,0.000092352835,0.00022652654],"about_ca_topic_score_codex":0.01738804,"about_ca_topic_score_gemma":0.020261172,"teacher_disagreement_score":0.051574234,"about_ca_system_score_codex":0.00039517228,"about_ca_system_score_gemma":0.00021571374,"threshold_uncertainty_score":0.9999322},"labels":[],"label_agreement":null},{"id":"W7108456461","doi":"10.1182/blood-2025-8151","title":"Elranatamab real-world step-up dosing patterns in relapsed-refractory multiple myeloma patients: Interim analysis Results of the AMbreLA study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cascades (Canada); Hotel Dieu Hospital","funders":"","keywords":"Interim analysis; Adverse effect; Dosing; Interim; Observational study; Mallinckrodt; Multiple myeloma","score_opus":0.020402476598391978,"score_gpt":0.31573424057809496,"score_spread":0.29533176397970295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108456461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962002,0.00007612823,0.000019167494,0.00012918403,0.0001620262,0.0013788817,0.00020014255,0.000035443685,0.0017988392],"genre_scores_gemma":[0.99810654,0.000034734567,0.00008240038,0.000054070697,0.0000243563,0.00007431935,0.00012809574,0.000021613982,0.0014738732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99727637,0.0003597133,0.00080692215,0.0005360377,0.00061793556,0.00040304047],"domain_scores_gemma":[0.9979787,0.00036626018,0.00023202418,0.0010903116,0.00021220626,0.00012048875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039669062,0.00024881217,0.00063172344,0.0009522256,0.000102240156,0.000024368142,0.00030777048,0.000085682856,0.000033919885],"category_scores_gemma":[0.00073166477,0.00017096318,0.00027987795,0.0020363447,0.0000763643,0.00007195624,0.00027119185,0.00039887114,0.0000071532845],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016716737,0.00818728,0.97720504,0.00008652972,0.0023521634,0.00007311869,0.00072050176,0.0000046719906,0.00036108057,0.000006102421,0.00010779577,0.009224038],"study_design_scores_gemma":[0.03842734,0.00059442676,0.95566475,0.00036772757,0.0014828547,5.943933e-7,0.0007477072,0.00032270336,0.002174681,0.0000029795194,0.00010017554,0.00011402477],"about_ca_topic_score_codex":0.008402142,"about_ca_topic_score_gemma":0.023865145,"teacher_disagreement_score":0.03675567,"about_ca_system_score_codex":0.00019120376,"about_ca_system_score_gemma":0.00013621499,"threshold_uncertainty_score":0.998201},"labels":[],"label_agreement":null},{"id":"W7108456604","doi":"10.1182/blood-2025-4505","title":"Real-world comparison of treatment outcomes between BCL2i and 2nd generation BTKi therapy in first-line CLL patients","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada)","funders":"","keywords":"Chronic lymphocytic leukemia; Cancer; Venetoclax; Proportional hazards model; Prostate cancer; Clinical trial; Leukemia; Population","score_opus":0.06249190916898607,"score_gpt":0.379948571791648,"score_spread":0.3174566626226619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108456604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974624,0.0003641282,0.0000070959327,0.0003341117,0.00004190666,0.00067161996,0.0000142614335,0.000016471262,0.0010880004],"genre_scores_gemma":[0.9978795,0.00061815686,0.00018905058,0.00003902833,0.00006378865,0.000037948208,0.00010664135,0.000011578542,0.0010543235],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989401,0.000043937995,0.0003906885,0.00022785198,0.00020689497,0.00019051859],"domain_scores_gemma":[0.9993428,0.00018190691,0.00006843996,0.00027440203,0.00006967527,0.00006278453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011404219,0.00013302121,0.00047208284,0.00023055795,0.000037619982,0.000009985811,0.000056677734,0.00006991186,0.000018311104],"category_scores_gemma":[0.00005211343,0.000098916375,0.000050103503,0.00026048056,0.000051492763,0.000031820502,0.00003753684,0.000077621415,0.0000027218264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000081256076,0.0014891812,0.98131835,0.00006457689,0.00018511649,0.000004164048,0.0003713435,0.000011925835,0.00019906693,0.000037715516,0.00014583074,0.01609144],"study_design_scores_gemma":[0.06899457,0.0011459034,0.9039664,0.00010029082,0.0001343432,4.81481e-7,0.000026037309,0.0016132434,0.022902872,0.000037226662,0.0009922864,0.00008631883],"about_ca_topic_score_codex":0.0046507022,"about_ca_topic_score_gemma":0.002743463,"teacher_disagreement_score":0.07735196,"about_ca_system_score_codex":0.0020222059,"about_ca_system_score_gemma":0.00083492335,"threshold_uncertainty_score":0.70305014},"labels":[],"label_agreement":null},{"id":"W7108456815","doi":"10.1182/blood-2025-3443","title":"ALIDHE: An ongoing open-label phase 3b study investigating ivosidenib with azacitidine in clinical practice in adult patients with newly diagnosed mutant isocitrate dehydrogenase 1 (mIDH1) Acute Myeloid Leukemia (AML) ineligible for intensive induction chemotherapy (IC)","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"FPInnovations; University of Toronto; Western University","funders":"","keywords":"Azacitidine; Phases of clinical research; Adverse effect; Clinical endpoint; Myeloid leukemia; Clinical trial; Refractory (planetary science); Isocitrate dehydrogenase; Clinical Practice","score_opus":0.04281600314779762,"score_gpt":0.3916544753235229,"score_spread":0.3488384721757253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108456815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886583,0.000058413694,0.00020451042,0.0019766276,0.000086205604,0.008703439,0.000052091527,0.000097206546,0.00016319395],"genre_scores_gemma":[0.97295386,0.00015919309,0.019010484,0.0058656572,0.00016803834,0.0013265144,0.00028099454,0.00013906944,0.00009620926],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99495286,0.0005656177,0.0014957482,0.0013391962,0.0007500971,0.00089645357],"domain_scores_gemma":[0.99498963,0.0010293057,0.0006114135,0.00084163423,0.0020848494,0.00044314223],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018675153,0.0005815954,0.0012040836,0.0006386392,0.00021839519,0.00021675776,0.00054792786,0.0003189692,0.000007779951],"category_scores_gemma":[0.005194093,0.00047049273,0.000067097135,0.0021431558,0.00027499528,0.0012987809,0.00023492116,0.0014933104,0.000004873804],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05973951,0.06531058,0.73544955,0.00057365827,0.005117289,0.0047150836,0.018749155,0.0001976889,0.0755686,0.00018494095,0.001218814,0.033175144],"study_design_scores_gemma":[0.7612785,0.03876308,0.05241652,0.0034848016,0.002503422,0.0002719837,0.028660284,0.0055577387,0.10511132,0.00018454049,0.00025373622,0.0015140533],"about_ca_topic_score_codex":0.0026575502,"about_ca_topic_score_gemma":0.0023975763,"teacher_disagreement_score":0.701539,"about_ca_system_score_codex":0.000896292,"about_ca_system_score_gemma":0.0032030363,"threshold_uncertainty_score":0.9997747},"labels":[],"label_agreement":null},{"id":"W7108457678","doi":"10.1182/blood-2025-6683","title":"Maternal anti-αIIb antibodies target fetal hematopoietic stem cells disrupting hematopoiesis and causing pregnancy loss in a murine model of fnait","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Neonatal alloimmune thrombocytopenia; Pregnancy; Fetus; Miscarriage; Antibody; Haematopoiesis; Stem cell","score_opus":0.01189538339068592,"score_gpt":0.2531985445003396,"score_spread":0.24130316110965366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108457678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995065,0.0035132328,0.00019809279,0.00009159556,0.000037363905,0.00031961294,0.000031037962,0.000029845163,0.000714259],"genre_scores_gemma":[0.9973706,0.0002988224,0.001853898,0.000022628608,0.0000063792186,0.00001131834,0.0000059734634,0.000018324403,0.0004120521],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99889815,0.000017410477,0.00037360066,0.00027659672,0.00015584852,0.00027841813],"domain_scores_gemma":[0.9995848,0.000030766263,0.000102383645,0.00018996415,0.00003717026,0.000054908603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006431044,0.0001977929,0.00059630186,0.00016998015,0.000055980618,0.000018278124,0.000047644964,0.00007508657,0.000008554426],"category_scores_gemma":[0.0000064593055,0.0001699132,0.00007066953,0.00016436924,0.000074077245,0.00008608294,0.00009522108,0.00009642143,0.0000019829733],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008413289,0.0020863644,0.9417044,0.004170215,0.0004971122,0.002583713,0.0013757589,0.00020108285,0.04645255,0.00034521022,0.000013874305,0.00048557288],"study_design_scores_gemma":[0.019715084,0.00022934268,0.076477945,0.012488968,0.0010869644,0.0009898266,0.00088344293,0.01478113,0.870687,0.0021079103,0.000006447679,0.0005459497],"about_ca_topic_score_codex":0.000097688535,"about_ca_topic_score_gemma":0.000016950664,"teacher_disagreement_score":0.86522645,"about_ca_system_score_codex":0.000016373884,"about_ca_system_score_gemma":0.000051975057,"threshold_uncertainty_score":0.69288594},"labels":[],"label_agreement":null},{"id":"W7108461223","doi":"10.1182/blood-2025-7647","title":"BCMA-targeted CAR-NK cell therapy using lipid nanoparticle mRNA delivery for multiple myeloma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Alberta","funders":"","keywords":"Chimeric antigen receptor; Multiple myeloma; Genetic enhancement; Immunogenicity; Cancer; Cell therapy; Cytokine release syndrome; Immunotherapy","score_opus":0.03345951169619087,"score_gpt":0.3009155936766589,"score_spread":0.267456081980468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108461223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993729,0.0026178372,0.00015003086,0.0002909971,0.00025116222,0.0012887468,0.000022182348,0.000119776756,0.001530246],"genre_scores_gemma":[0.9906669,0.00028745676,0.0024708526,0.0005668934,0.00033713324,0.000091685164,0.000022959872,0.000055098477,0.0055010137],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99837655,0.00007196843,0.0003016827,0.00039280657,0.000296683,0.00056029443],"domain_scores_gemma":[0.99876523,0.00026952053,0.00005501514,0.0005064175,0.00024450917,0.00015930156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029715255,0.0002025511,0.00035257498,0.00018204005,0.00017700717,0.000043407304,0.00017278979,0.0001328533,0.00047385407],"category_scores_gemma":[0.0001058088,0.0001849353,0.0002128983,0.00042956762,0.00007505149,0.00007263102,0.000064669905,0.00019622139,0.000025453763],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009931449,0.00091039215,0.021149885,0.00012611534,0.00020868274,0.000021422053,0.00024296282,0.000015464424,0.9647585,0.000010347447,0.0005986369,0.010964407],"study_design_scores_gemma":[0.014248091,0.00047834805,0.0034210826,0.000073231706,0.0001317829,0.00001253443,0.00012731482,0.0032299147,0.96079236,0.000040870098,0.017274218,0.00017026495],"about_ca_topic_score_codex":0.00014793949,"about_ca_topic_score_gemma":0.000024861667,"teacher_disagreement_score":0.017728802,"about_ca_system_score_codex":0.00008323802,"about_ca_system_score_gemma":0.00030570177,"threshold_uncertainty_score":0.7541443},"labels":[],"label_agreement":null},{"id":"W7108463524","doi":"10.1182/blood-2025-4507","title":"The impact of marginalization on outcomes in patients with Hodgkin lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Oakville-Trafalgar Memorial Hospital; University of Toronto","funders":"","keywords":"Socioeconomic status; Hodgkin lymphoma; Census; Immigration; Retrospective cohort study; Proportional hazards model; Health care; Population; Ethnic group","score_opus":0.004784470550882652,"score_gpt":0.25990299224498525,"score_spread":0.2551185216941026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108463524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971427,0.00007626496,0.0000013812955,0.00016541028,0.000018295177,0.0002804571,0.0000058683377,0.000007002227,0.0023026688],"genre_scores_gemma":[0.99969375,0.000018174505,0.00002275437,0.000053194726,0.0000035680184,0.00002360778,0.000013911032,0.0000044088733,0.00016663327],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99958456,0.000016942962,0.00011080021,0.000083945015,0.00011504973,0.00008872952],"domain_scores_gemma":[0.99965584,0.00007426956,0.000040568313,0.00017068363,0.000039510374,0.000019111658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003594353,0.00007211141,0.00014498421,0.000060839062,0.000024846213,0.000006457997,0.00003141577,0.000022210128,0.0000069097346],"category_scores_gemma":[0.000033795877,0.00003259403,0.00004882325,0.00014410626,0.000018110048,0.000014075843,0.0000090875055,0.000012159274,0.0000031231837],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025259415,0.0036748154,0.99004084,0.000008240946,0.00022372378,0.0000050750473,0.00002967013,0.0000065508116,0.000002813817,0.00037161843,0.00011353734,0.005270535],"study_design_scores_gemma":[0.014056128,0.0009305768,0.9837794,0.00010700861,0.000093015165,4.1543268e-7,0.000008704659,0.0000054097704,0.00091026333,0.00003686118,0.00004404494,0.000028218876],"about_ca_topic_score_codex":0.00017445786,"about_ca_topic_score_gemma":0.000019158475,"teacher_disagreement_score":0.013803534,"about_ca_system_score_codex":0.00008552965,"about_ca_system_score_gemma":0.000080649355,"threshold_uncertainty_score":0.13291459},"labels":[],"label_agreement":null},{"id":"W7108463527","doi":"10.1182/blood-2025-6686","title":"Blood product transfusions for pediatric Jehovah's witness patients: Management recommendations and considerations","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children’s Health Research Institute","funders":"","keywords":"Erythropoietin; Anemia; Blood transfusion; Blood product; Platelet transfusion; Plateletpheresis; Clinical trial; Bone marrow; Hematinic","score_opus":0.012267023840282179,"score_gpt":0.26161198629436655,"score_spread":0.24934496245408438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108463527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88807833,0.0016274728,0.01016444,0.054419782,0.0010882983,0.010746197,0.0001966943,0.00043950518,0.03323928],"genre_scores_gemma":[0.9755968,0.0031584245,0.013251646,0.0025038137,0.00013266236,0.0009799808,0.0001673875,0.000030278488,0.004179023],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.99881345,0.000030117248,0.00034680564,0.0004325616,0.00014474984,0.00023232744],"domain_scores_gemma":[0.99926966,0.00009147804,0.00004309323,0.00032825457,0.00016610921,0.00010141422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015726314,0.00017343632,0.00024287235,0.00032944573,0.00036025487,0.000040444644,0.00005446199,0.000050216844,0.00012387008],"category_scores_gemma":[0.000063736305,0.00016279491,0.00008852169,0.0003677987,0.00004466121,0.00007782412,0.000044843717,0.00011018124,0.000004302486],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047195217,0.05461818,0.2596728,0.008359581,0.006698181,0.00010275352,0.0018555782,0.000013912164,0.0017241114,0.46722624,0.121764034,0.077492684],"study_design_scores_gemma":[0.15890603,0.0024116347,0.54789513,0.0011712279,0.06036726,0.00009433286,0.0019703994,0.00008843298,0.010348797,0.021953104,0.19293132,0.0018623444],"about_ca_topic_score_codex":0.000013022358,"about_ca_topic_score_gemma":0.00004611359,"teacher_disagreement_score":0.44527316,"about_ca_system_score_codex":0.000009984244,"about_ca_system_score_gemma":0.000055570523,"threshold_uncertainty_score":0.6638584},"labels":[],"label_agreement":null},{"id":"W7108464033","doi":"10.1182/blood-2025-1231","title":"Evolutionarily divergent notch regulation underpins the initiation of human T-cell development","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Notch signaling pathway; Priming (agriculture); Epigenetics; Progenitor cell; Lineage (genetic); Myeloid; T cell; Cellular differentiation; Cell fate determination; Haematopoiesis","score_opus":0.013531654796093714,"score_gpt":0.22990738840101851,"score_spread":0.2163757336049248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108464033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99070716,0.0002873591,0.0053092614,0.000070965754,0.00010969093,0.00011654849,0.0000039355127,0.0000062361846,0.003388834],"genre_scores_gemma":[0.99883276,0.000016342661,0.00036760408,0.00008298418,0.0000454548,0.000008943327,0.00010594026,0.000004944903,0.0005349971],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99951726,0.00002689328,0.00016535225,0.00012748913,0.000081988226,0.0000810388],"domain_scores_gemma":[0.9997041,0.0000056211074,0.000055248667,0.00015121665,0.00007018898,0.000013587066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008325391,0.00006540412,0.000057821624,0.000026361724,0.00013015048,0.000007058914,0.000101608,0.00006983654,0.000009654806],"category_scores_gemma":[0.000010984201,0.00005450857,0.00003991717,0.00007059619,0.000033142318,0.0000017338492,0.000037158858,0.000034662837,0.0000018846891],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013331864,0.00024878874,0.020010743,0.00002257876,0.000043779073,1.4107178e-7,0.00015746613,0.000059328395,0.9783158,0.0006423312,0.00025570195,0.00023005749],"study_design_scores_gemma":[0.0007096523,0.000048364902,0.0861061,0.000013366525,0.000036083788,4.2149514e-7,0.00004477556,0.000020524427,0.9103728,0.00020913685,0.002373561,0.0000651978],"about_ca_topic_score_codex":0.000013652306,"about_ca_topic_score_gemma":0.00004443041,"teacher_disagreement_score":0.06794293,"about_ca_system_score_codex":0.000010603197,"about_ca_system_score_gemma":0.00009279684,"threshold_uncertainty_score":0.2222795},"labels":[],"label_agreement":null},{"id":"W7108464563","doi":"10.1182/blood-2025-7390","title":"PARP inhibitors and the rising incidence of secondary myelodysplastic syndrome and acute myeloid leukemia: A comprehensive meta-analysis","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Incidence (geometry); Hazard ratio; Myelodysplastic syndromes; Myeloid leukemia; Cohort study; Cohort; Proportional hazards model; Confidence interval","score_opus":0.01997014474744769,"score_gpt":0.28439712214805485,"score_spread":0.26442697740060717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108464563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791509,0.017958509,0.00038171082,0.0013594321,0.00006187044,0.00040698738,0.00004915317,0.000030043104,0.0006014144],"genre_scores_gemma":[0.9972589,0.00070435455,0.00062684744,0.0010704579,0.000023392597,0.000057226247,0.000008541029,0.000011293683,0.00023895572],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9986273,0.00014421165,0.00045914124,0.0003369599,0.00025794294,0.00017444542],"domain_scores_gemma":[0.9984883,0.00071801926,0.0002041213,0.0003618459,0.00015211638,0.00007561935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002935495,0.00019642283,0.0011660397,0.00029009167,0.00012261506,0.000027547405,0.000084319945,0.00009451292,0.00008667116],"category_scores_gemma":[0.00006405651,0.000129525,0.00035283633,0.00074394094,0.0005817602,0.00008641457,0.00010222697,0.00028933826,0.000001924657],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024430803,0.0005177656,0.026663743,0.0015872504,0.8915266,0.00083817943,0.0046186456,0.00025830907,0.06434638,0.0035879049,0.0015479035,0.00206426],"study_design_scores_gemma":[0.024652557,0.0004469454,0.0975486,0.0002752826,0.81908166,0.001480761,0.00085947453,0.000535486,0.050664358,0.0031703429,0.0008321415,0.00045240548],"about_ca_topic_score_codex":0.00011701555,"about_ca_topic_score_gemma":0.000021346863,"teacher_disagreement_score":0.07244493,"about_ca_system_score_codex":0.000039570754,"about_ca_system_score_gemma":0.00019982614,"threshold_uncertainty_score":0.52818763},"labels":[],"label_agreement":null},{"id":"W7108465232","doi":"10.1182/blood-2025-5094","title":"Polyunsaturated fatty acids control lipid membrane dynamics and ferroptosis sensitivity in B-cell lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer","funders":"","keywords":"GPX4; Polyunsaturated fatty acid; Cancer cell; Programmed cell death; Cell culture; Arachidonic acid; Lymphoma; Metabolomics","score_opus":0.006059158868055167,"score_gpt":0.22735048648102546,"score_spread":0.2212913276129703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108465232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919589,0.0007706118,0.00019489705,0.0023426565,0.00013810267,0.00043197957,0.00003659175,0.0000815059,0.004044727],"genre_scores_gemma":[0.9976127,0.00030728747,0.0002394507,0.0012774727,0.00006219655,0.000037463582,0.00002775889,0.000021031728,0.00041461733],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99874526,0.00008708088,0.0002823545,0.00038785714,0.00017112576,0.0003263039],"domain_scores_gemma":[0.9993687,0.000086616834,0.000059298236,0.00027937343,0.000089885885,0.00011610229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022923788,0.00022037803,0.00050041423,0.00018531032,0.00006890679,0.000037474572,0.000051880892,0.00018441882,0.000020652216],"category_scores_gemma":[0.00005411071,0.00019776526,0.000088395536,0.00047950228,0.00008658343,0.00006792447,0.000046600973,0.00016645546,0.000005775134],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086584693,0.0037417763,0.8614682,0.0005249862,0.0003342781,0.00015705041,0.00018566282,0.0000072623648,0.1074696,0.00041394116,0.00014642121,0.024684973],"study_design_scores_gemma":[0.033842668,0.00031351246,0.7315008,0.00038501032,0.00083669624,0.000074422045,0.0002901637,0.008334007,0.22367199,0.000016591817,0.000388747,0.00034541026],"about_ca_topic_score_codex":0.00028820836,"about_ca_topic_score_gemma":0.0003719912,"teacher_disagreement_score":0.12996742,"about_ca_system_score_codex":0.000105244995,"about_ca_system_score_gemma":0.00014764283,"threshold_uncertainty_score":0.8064633},"labels":[],"label_agreement":null},{"id":"W7108465574","doi":"10.1182/blood-2025-6089","title":"Correction of ineffective erythropoiesis and durable clinical benefit with exagamglogene autotemcel for transfusion-dependent β-thalassemia","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of British Columbia; BC Children's Hospital; University of Toronto","funders":"","keywords":"Erythropoiesis; Anemia; Clinical endpoint; Clinical trial; Blood transfusion; Hemoglobin; Ineffective erythropoiesis; Hepcidin","score_opus":0.00737162448813724,"score_gpt":0.26952857088073856,"score_spread":0.26215694639260134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108465574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99214536,0.001100088,0.0013800951,0.000502616,0.00041830816,0.0008757095,0.000011782812,0.000043843986,0.0035221863],"genre_scores_gemma":[0.9958318,0.0014682127,0.00053860946,0.00009626885,0.000037442347,0.000053963508,0.0000115297435,0.000016433047,0.0019457755],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990778,0.000029190025,0.00032572294,0.0002810714,0.00012036313,0.00016585305],"domain_scores_gemma":[0.9992642,0.0002687783,0.000076538796,0.00016956298,0.00014701267,0.000073929856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024308637,0.00013159969,0.00039280375,0.00009733809,0.00009129953,0.000006907749,0.000035871337,0.00021684963,0.000018531586],"category_scores_gemma":[0.00013802623,0.000096145886,0.00009834505,0.00020774416,0.000111390545,0.000032036525,0.000016547045,0.00018369337,0.000001007922],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063469135,0.008280838,0.76289314,0.002394659,0.003987361,0.000073759875,0.0011478879,0.00026252342,0.06288035,0.00071273156,0.0038475816,0.14717226],"study_design_scores_gemma":[0.0701118,0.012738136,0.63712656,0.0035980954,0.008233252,0.00041644493,0.004297398,0.00334563,0.2550928,0.00072198664,0.003569227,0.0007486724],"about_ca_topic_score_codex":0.00014582103,"about_ca_topic_score_gemma":0.00009500826,"teacher_disagreement_score":0.19221243,"about_ca_system_score_codex":0.000019859699,"about_ca_system_score_gemma":0.00013190947,"threshold_uncertainty_score":0.39207155},"labels":[],"label_agreement":null},{"id":"W7108466202","doi":"10.1182/blood-2025-495","title":"Ultra-deep whole-genome sequencing of cell-free DNA recovers most bone marrow-derived mutations in newly diagnosed multiple myeloma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Alberta Cancer Foundation; University of Alberta; Queen Elizabeth II Health Sciences Centre; University of Toronto; University of New Brunswick; Dalhousie University; Vancouver General Hospital; Saint John Regional Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Multiple myeloma; Germline; Deep sequencing; DNA sequencing; Somatic cell; Copy number analysis; Whole genome sequencing; Structural variation; Bone marrow","score_opus":0.016730283328497627,"score_gpt":0.260427158636545,"score_spread":0.24369687530804734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108466202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990977,0.0005954288,0.0001244196,0.00053270505,0.00006853081,0.001051969,0.0002475656,0.00006132993,0.006341077],"genre_scores_gemma":[0.99449664,0.00012751626,0.0037304878,0.00013393286,0.00003640807,0.00014398145,0.00044410204,0.000031112388,0.00085581123],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99813116,0.00009931808,0.0005030933,0.00040800826,0.0003603779,0.0004980351],"domain_scores_gemma":[0.99839705,0.00048416518,0.00012227702,0.0006380594,0.00014540055,0.00021302397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018254304,0.00023261673,0.0004789238,0.00047471226,0.00009436257,0.000022253655,0.00020448146,0.00012856243,0.000095824056],"category_scores_gemma":[0.001255523,0.0002239331,0.00013218609,0.000773744,0.00011104408,0.00011471047,0.00007057869,0.00024847235,0.000037178823],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034177894,0.0013323167,0.10547581,0.0002900758,0.0002482677,0.0009048241,0.00079537166,0.00009567556,0.88836616,0.000013787807,0.000077131204,0.002058805],"study_design_scores_gemma":[0.048701167,0.0004893162,0.3804505,0.0003950977,0.00032614009,0.00003330295,0.0019352719,0.00060384086,0.5662706,0.00020783841,0.00030514481,0.00028179493],"about_ca_topic_score_codex":0.0010760451,"about_ca_topic_score_gemma":0.0012136608,"teacher_disagreement_score":0.32209554,"about_ca_system_score_codex":0.0002178395,"about_ca_system_score_gemma":0.00045288666,"threshold_uncertainty_score":0.91317266},"labels":[],"label_agreement":null},{"id":"W7108467868","doi":"10.1182/blood-2025-3439","title":"Analysis of hematologic improvement (HI) by time to response in Relapsed/Refractory Acute Myeloid Leukemia (AML) patients treated with olutasidenib","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Tolerability; Hemoglobin; Platelet; Cohort; Refractory (planetary science); Myeloid; Adverse effect","score_opus":0.006107269524519951,"score_gpt":0.25704375083346315,"score_spread":0.2509364813089432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108467868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99700344,0.00012440087,0.000017357987,0.0004620105,0.00000992987,0.0010990242,0.00015051191,0.00006642797,0.001066888],"genre_scores_gemma":[0.991024,0.000027317301,0.00031786604,0.00051894743,0.0000071222144,0.00013912338,0.00023145329,0.000032836768,0.0077013355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973518,0.0002158421,0.00066190644,0.0006275585,0.0006021931,0.00054068794],"domain_scores_gemma":[0.9981856,0.0003207891,0.00017114071,0.0008135274,0.00028230977,0.00022664691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005362603,0.00030404015,0.0009921163,0.0015804749,0.00005280394,0.000015654741,0.00029394383,0.00021835096,0.00023644726],"category_scores_gemma":[0.00041745958,0.00023778094,0.00016353237,0.003598591,0.00010389052,0.00006403535,0.00017992046,0.0003954733,0.00009695502],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02598311,0.0033052452,0.50466424,0.00015252508,0.008805988,0.00053023844,0.00041450848,0.00010416095,0.4455905,0.00000628757,0.008264997,0.0021781765],"study_design_scores_gemma":[0.027772658,0.0075754994,0.7068703,0.00037743233,0.007486381,0.000014484172,0.00013215044,0.000588896,0.24730912,0.000006256289,0.0013842663,0.0004825243],"about_ca_topic_score_codex":0.0003843171,"about_ca_topic_score_gemma":0.0000402763,"teacher_disagreement_score":0.20220608,"about_ca_system_score_codex":0.00115066,"about_ca_system_score_gemma":0.0007944779,"threshold_uncertainty_score":0.9696425},"labels":[],"label_agreement":null},{"id":"W7108468115","doi":"10.1182/blood-2025-5102","title":"First report of the GIMEMA INO-first multicenter observational study analyzing infective and non-infective complications in patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with inotuzumab ozogamicin.","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Refractory (planetary science); Observational study; Adverse effect; Salvage therapy; Clinical trial; Lymphoblastic Leukemia; Bone marrow; Leukemia; Toxicity","score_opus":0.013347469233359907,"score_gpt":0.26629295778044504,"score_spread":0.25294548854708515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108468115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958831,0.000012380925,0.00029931916,0.00009620486,0.00002683456,0.0029068328,0.00004108077,0.000035357254,0.0006988559],"genre_scores_gemma":[0.99893713,0.0000085097545,0.00038860884,0.00007789695,0.000014790178,0.00023212026,0.00007179563,0.000039179416,0.0002299543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977199,0.00010762798,0.0006293754,0.0006280829,0.0005723388,0.00034267243],"domain_scores_gemma":[0.9971301,0.0008367779,0.000396924,0.0007505364,0.0007778812,0.00010778982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020479597,0.00032867023,0.0005844934,0.0004009529,0.00024297903,0.000026454816,0.00019303257,0.00012908572,0.000011077892],"category_scores_gemma":[0.00044265136,0.00019457401,0.000058498572,0.0015145079,0.00029739027,0.00017747248,0.0002158126,0.00036446808,0.000002829983],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025170618,0.00500162,0.98950547,0.00016794699,0.0010676415,0.0001641915,0.0010276574,0.00023176907,0.00023315674,0.0000059325375,0.00004566495,0.000031880278],"study_design_scores_gemma":[0.048754685,0.0022738501,0.94397897,0.00081141625,0.0012482076,0.0000470772,0.00030213944,0.0013960132,0.0009847101,0.0000033907945,0.000017134711,0.00018239937],"about_ca_topic_score_codex":0.0013978939,"about_ca_topic_score_gemma":0.0017218695,"teacher_disagreement_score":0.046237625,"about_ca_system_score_codex":0.0017916281,"about_ca_system_score_gemma":0.0019025626,"threshold_uncertainty_score":0.79344976},"labels":[],"label_agreement":null},{"id":"W7108469148","doi":"10.1182/blood-2025-3425","title":"Phase 1 study of revumenib in combination with intensive chemotherapy (IC) in patients (Pts) with newly diagnosed (ND) Acute Myeloid Leukemia (AML) harboring genetic alterations in KMT2A, NPM1, or NUP98: SNDX-5613-0708","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University","funders":"","keywords":"Daunorubicin; NPM1; Myeloid leukemia; Cohort; Phases of clinical research; Chemotherapy regimen; Chemotherapy; Leukemia","score_opus":0.014366117399019501,"score_gpt":0.29485977790026263,"score_spread":0.28049366050124314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108469148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99528617,0.000082319006,0.0001284693,0.00038755173,0.000047621146,0.0038415552,0.000014315434,0.000034920275,0.00017708707],"genre_scores_gemma":[0.9969862,0.00011848545,0.0014599715,0.00037714778,0.00003069675,0.00051178253,0.000068901725,0.000057662197,0.00038915113],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972806,0.00019441453,0.00078267406,0.00063313445,0.0006068301,0.0005023308],"domain_scores_gemma":[0.9982581,0.00021328621,0.00020180258,0.0006060534,0.00059909455,0.00012166068],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003024614,0.00034133054,0.0007542936,0.0011415179,0.00005917081,0.000038495982,0.00026406636,0.00013729958,0.000032324348],"category_scores_gemma":[0.00028398525,0.00026813964,0.000039612314,0.0021046414,0.000110519315,0.00022137807,0.000085242566,0.00063261884,0.0000043613163],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01265032,0.024534054,0.92859274,0.0002734012,0.0006628176,0.0013747643,0.012393352,0.00028193867,0.009692364,0.000032460455,0.00030791128,0.009203845],"study_design_scores_gemma":[0.27986634,0.0139496755,0.6807338,0.001637477,0.00031220412,0.000018386856,0.0040892,0.0012231477,0.017718477,0.00002616409,0.00004174571,0.00038335906],"about_ca_topic_score_codex":0.0018802378,"about_ca_topic_score_gemma":0.0032077364,"teacher_disagreement_score":0.26721603,"about_ca_system_score_codex":0.0011275816,"about_ca_system_score_gemma":0.0013294359,"threshold_uncertainty_score":0.99997705},"labels":[],"label_agreement":null},{"id":"W7108472195","doi":"10.1182/blood-2025-4496","title":"Incidence of thrombosis and bleeding in patients receiving CAR-T cell therapy: A multicentric retrospective analysis of the Canadian experience","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; Vancouver General Hospital; University of Calgary; Hôpital Maisonneuve-Rosemont; Juravinski Cancer Centre; Ottawa Hospital; Princess Margaret Cancer Centre; Université Laval","funders":"","keywords":"Thrombosis; Retrospective cohort study; Incidence (geometry); Population; Venous thrombosis; Deep vein; Cytokine release syndrome","score_opus":0.018863630296467995,"score_gpt":0.29893779854187236,"score_spread":0.2800741682454044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108472195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966547,0.00027447107,9.744479e-7,0.00008406837,0.000033348395,0.00040956872,0.0000071796226,0.000003776877,0.0025319078],"genre_scores_gemma":[0.99945706,0.00027549508,0.00005198254,0.000053552016,0.000005559429,0.0000139308395,0.000001420435,0.0000065448703,0.00013447332],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891865,0.00006821714,0.0002445749,0.00021998916,0.0003340725,0.00021451394],"domain_scores_gemma":[0.99921006,0.000108314096,0.00009055998,0.00030492485,0.00021482377,0.00007129736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025544883,0.0000874503,0.00033891006,0.0006394039,0.00006477157,0.000010907687,0.00015192914,0.00006429185,0.00010939734],"category_scores_gemma":[0.0002292273,0.000067002235,0.00008389909,0.0028548436,0.00012813284,0.000043984193,0.00006443617,0.00016830473,1.4810422e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026906391,0.00020657985,0.9568725,0.000027963073,0.00027507616,8.7693803e-7,0.0046303496,0.0000051764473,0.037443828,0.000010011645,0.0000029680884,0.0004977387],"study_design_scores_gemma":[0.0017789949,0.00008025237,0.9352744,0.00010703256,0.00027013186,1.1781061e-7,0.00047809348,0.00023695591,0.061712157,0.000007923119,0.000007674487,0.000046244568],"about_ca_topic_score_codex":0.089105666,"about_ca_topic_score_gemma":0.0846221,"teacher_disagreement_score":0.024268327,"about_ca_system_score_codex":0.00021469695,"about_ca_system_score_gemma":0.0002460633,"threshold_uncertainty_score":0.93208116},"labels":[],"label_agreement":null},{"id":"W7108475431","doi":"10.1182/blood-2025-3434","title":"Prognostic impact of cognitive and other impairments in older adults with acute myeloid leukemia (AML) participating in a geriatric assessment-guided treatment selection trial","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Comorbidity; Cognition; Clinical trial; Activities of daily living; Transplantation; Proportional hazards model; Randomized controlled trial; Adverse effect; Geriatrics","score_opus":0.013852291956163366,"score_gpt":0.33615884499002086,"score_spread":0.32230655303385747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108475431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99483055,0.00018213366,0.00003418605,0.000038170427,0.000040928335,0.004123137,0.00003466382,0.000035087563,0.00068117026],"genre_scores_gemma":[0.99750555,0.000089133166,0.00013355739,0.000040836338,0.000044415312,0.0020492973,0.000017161192,0.000023069391,0.00009698324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984653,0.000115563395,0.0004808435,0.000378834,0.00019204912,0.00036739913],"domain_scores_gemma":[0.9992662,0.00025162814,0.00019573483,0.000086928216,0.00013257595,0.000066953384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017326469,0.00026522562,0.0005609938,0.00044187406,0.000049408016,0.000013684885,0.000026455129,0.00009037187,0.00003827944],"category_scores_gemma":[0.00016815598,0.00019698554,0.00008332298,0.0008688271,0.000066616056,0.00007945519,0.000031040152,0.00017020537,9.2675253e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021528896,0.0031909898,0.9681117,0.0001031202,0.0017548267,0.00010419533,0.0020627503,0.000011398844,0.00034190752,0.0000012348218,0.000016563861,0.0027724172],"study_design_scores_gemma":[0.20417377,0.008352728,0.78153706,0.0019560931,0.001709351,0.000052346877,0.0006117743,0.00031451572,0.0011497273,0.00000777192,6.5641547e-7,0.00013421457],"about_ca_topic_score_codex":0.0016743212,"about_ca_topic_score_gemma":0.000523173,"teacher_disagreement_score":0.18657465,"about_ca_system_score_codex":0.0007736249,"about_ca_system_score_gemma":0.000796874,"threshold_uncertainty_score":0.8032837},"labels":[],"label_agreement":null},{"id":"W7108475458","doi":"10.1182/blood-2025-1207","title":"Home monitoring of neutrophil counts by patients with cyclic and congenital neutropenia","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Neutropenia; Congenital Neutropenia; Absolute neutrophil count; White blood cell; Blood count; Blood smear; Granulocyte colony-stimulating factor","score_opus":0.002130968739407607,"score_gpt":0.19038694886272553,"score_spread":0.18825598012331793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108475458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996444,0.001912515,0.000003843963,0.0000083961095,0.000041682688,0.00007119655,0.000030666273,0.0000030146423,0.0014847271],"genre_scores_gemma":[0.9994722,0.00011024185,0.000056498695,0.000015372574,0.000012354757,0.0000057429984,0.000038580565,0.00000615508,0.00028284997],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99971604,0.000005750455,0.000055139044,0.000113835966,0.00003897349,0.00007023233],"domain_scores_gemma":[0.99982977,0.0000019169513,0.000021830072,0.00009349755,0.0000333543,0.000019608782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000007054256,0.00006176484,0.00006678155,0.000012360699,0.000021573132,0.000006687112,0.00003925381,0.000037250138,0.0000022819206],"category_scores_gemma":[0.0000023764292,0.000050724997,0.000012000091,0.00003772925,0.000028621796,0.0000016737253,0.000027985263,0.000018933368,0.0000014620044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037447433,0.00037287676,0.98475057,0.000011174253,0.00020019471,9.073845e-7,0.000004727694,2.3602969e-7,0.013187215,0.000015952406,0.00031158671,0.0011070991],"study_design_scores_gemma":[0.011016228,0.0008373873,0.7648292,0.00003473694,0.00035121382,0.0000022811084,0.000028675846,6.4214447e-7,0.21704268,0.000045570407,0.0055657807,0.00024554934],"about_ca_topic_score_codex":0.00000979883,"about_ca_topic_score_gemma":0.0000016354705,"teacher_disagreement_score":0.21992134,"about_ca_system_score_codex":0.0000011237892,"about_ca_system_score_gemma":0.00001329108,"threshold_uncertainty_score":0.20685054},"labels":[],"label_agreement":null},{"id":"W7108475644","doi":"10.1182/blood-2025-3963","title":"MGUS like phenotype in patients with AL amyloidosis: Impact on clinical outcomes for patients treated with bortezomib-containing regimens (BCR).","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"AL amyloidosis; Monoclonal gammopathy of undetermined significance; Multiple myeloma; Amyloidosis; Log-rank test; Retrospective cohort study; Stage (stratigraphy); Survival analysis; Melphalan","score_opus":0.009326782519904504,"score_gpt":0.29350815824923776,"score_spread":0.2841813757293333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108475644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99787706,0.000094093324,0.000016839487,0.00013731234,0.00010693674,0.0012881847,0.0001484327,0.000039970615,0.00029116755],"genre_scores_gemma":[0.99678785,0.000044332963,0.00043793605,0.0014211044,0.000035335444,0.00034029066,0.0006566788,0.00006640355,0.00021008035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977777,0.00009507221,0.0005304227,0.0008149512,0.000229075,0.00055276504],"domain_scores_gemma":[0.9985895,0.00016335769,0.0002605089,0.00064820674,0.00019447718,0.00014394132],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015197087,0.00049186795,0.00062337006,0.00015046375,0.00010468804,0.00004066341,0.00024366006,0.0002453218,0.0000073870465],"category_scores_gemma":[0.00017310533,0.00032830518,0.00024883368,0.0002181293,0.00009053823,0.0000127959065,0.00008229832,0.0001599348,0.0000066551365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030335642,0.0047012186,0.98885274,0.00001217244,0.001434361,0.0000042550423,0.00002521491,0.000017514412,0.000034986555,0.000011061091,0.0009172378,0.00095569534],"study_design_scores_gemma":[0.027208503,0.009948127,0.9598595,0.00010122748,0.00042875556,2.9617837e-7,0.000030582698,0.0000025320953,0.0016131392,0.0000054737006,0.00043434455,0.0003675005],"about_ca_topic_score_codex":0.00011862753,"about_ca_topic_score_gemma":0.00016594914,"teacher_disagreement_score":0.0289932,"about_ca_system_score_codex":0.00007832563,"about_ca_system_score_gemma":0.00016152291,"threshold_uncertainty_score":0.9999169},"labels":[],"label_agreement":null},{"id":"W7108476531","doi":"10.1182/blood-2025-7975","title":"Delays in hydroxyurea initiation for patients with sickle cell disease in British Columbia","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Disease; Hemoglobinopathy; Quality of life (healthcare); Adverse effect; Anemia; Hydroxycarbamide","score_opus":0.0026513417410403786,"score_gpt":0.19250898148327517,"score_spread":0.1898576397422348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108476531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99636227,0.00032307746,0.000022743361,0.00011683029,0.00004157557,0.0008145903,0.000030085705,0.00001996606,0.0022688755],"genre_scores_gemma":[0.998796,0.000052759253,0.0001201669,0.00030431763,0.000009052354,0.000078319994,0.00015291778,0.000011026227,0.0004754829],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994043,0.000013176945,0.00016752238,0.00016160827,0.00008724651,0.00016612177],"domain_scores_gemma":[0.999738,0.000026031055,0.000028974035,0.000098359254,0.00004641961,0.00006223284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000048559727,0.0000535637,0.00013493648,0.000059376187,0.00003276332,0.000026521844,0.000032280415,0.00007098834,0.000019521447],"category_scores_gemma":[0.000060560895,0.0000707094,0.000028706667,0.00024979401,0.00002003247,0.00004514681,0.000012105146,0.0000987449,0.0000023688879],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008620651,0.0020983762,0.9960195,0.00017193216,0.00001300429,0.000043597684,0.000064244094,0.000024660152,0.000010402065,0.0000045645793,0.0005358908,0.00092765247],"study_design_scores_gemma":[0.018089667,0.00023381629,0.9798219,0.00047267287,0.0001321568,6.344852e-7,0.00008600021,0.00026704237,0.000026153397,0.00020736232,0.0005656741,0.00009689132],"about_ca_topic_score_codex":0.002273752,"about_ca_topic_score_gemma":0.012248769,"teacher_disagreement_score":0.01800346,"about_ca_system_score_codex":0.00002776905,"about_ca_system_score_gemma":0.00012616126,"threshold_uncertainty_score":0.6835101},"labels":[],"label_agreement":null},{"id":"W7108476913","doi":"10.1182/blood-2025-494","title":"Combined assessment of circulating tumor cells (CTCs) and measurable residual disease (MRD) for dynamic risk assessment of patients (Pts) with multiple myeloma (MM)","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Circulating tumor cell; Minimal residual disease; Bone marrow; Multiple myeloma; Immunophenotyping; Clinical trial; Flow cytometry","score_opus":0.01174581384605436,"score_gpt":0.2997749837798987,"score_spread":0.2880291699338443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108476913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955622,0.00010836138,0.00068060216,0.00006137771,0.000040901385,0.002272062,0.00074163853,0.000027208975,0.0005056263],"genre_scores_gemma":[0.9853182,0.000027285798,0.013971936,0.000018591447,0.000010172055,0.00022142082,0.00028681624,0.000029359015,0.00011621189],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979901,0.00012416986,0.00047708745,0.00042004458,0.0006154343,0.00037316504],"domain_scores_gemma":[0.9981331,0.00041314977,0.00029974678,0.00043550695,0.00045750762,0.0002609937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031683617,0.00023485979,0.00055852806,0.00019970145,0.0001431455,0.000021117017,0.00010366227,0.000047892845,0.000015545422],"category_scores_gemma":[0.0003121634,0.00018391783,0.00010295804,0.00022711638,0.00011461264,0.00008277663,0.00008706194,0.00015884696,3.9586695e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009418573,0.004117114,0.9842847,0.0012241069,0.00086828775,0.00003558511,0.00003587708,0.00006201114,0.0065184273,0.00006566444,0.000024641162,0.0018217145],"study_design_scores_gemma":[0.032056432,0.0015608569,0.93789434,0.00049075496,0.00092149683,0.0000010970938,0.000087934255,0.020307368,0.006449605,0.000085693915,0.000009571978,0.0001348732],"about_ca_topic_score_codex":0.00016727316,"about_ca_topic_score_gemma":0.000060886243,"teacher_disagreement_score":0.0463904,"about_ca_system_score_codex":0.000112467096,"about_ca_system_score_gemma":0.00055443944,"threshold_uncertainty_score":0.7499952},"labels":[],"label_agreement":null},{"id":"W7108479951","doi":"10.1182/blood-2025-484","title":"Safety and efficacy of the mutant calreticulin-specific monoclonal antibody INCA033989 as monotherapy or in combination with ruxolitinib in patients (pts) with myelofibrosis (MF): Preliminary results from dose escalation of two global Phase 1 studies","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ruxolitinib; Myelofibrosis; Anemia; Phases of clinical research; Monoclonal; Thrombopoietin; Clinical endpoint; Essential thrombocythemia","score_opus":0.015249921125697511,"score_gpt":0.3173373087987922,"score_spread":0.3020873876730947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108479951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99700046,0.00047523,0.000017894065,0.0005778311,0.000028867316,0.0014935646,0.00025468704,0.000009129307,0.0001423461],"genre_scores_gemma":[0.9983603,0.0005933502,0.00074872724,0.000045945122,0.000010993976,0.00004602702,0.00017293046,0.00000987534,0.000011861335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99846715,0.00013132127,0.00058681093,0.0003527906,0.0003115634,0.00015035391],"domain_scores_gemma":[0.9988381,0.00041996717,0.00025489036,0.0002489746,0.00019643163,0.000041593816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013995141,0.00020587503,0.00051334105,0.00009797165,0.00005235212,0.000008564663,0.000060243314,0.000062266445,0.0000059962517],"category_scores_gemma":[0.00010464699,0.0001138049,0.00003685809,0.00049340294,0.0001719932,0.0000623735,0.000043859498,0.00010072007,3.4993974e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.065340675,0.012960807,0.9086344,0.000068906396,0.00043228175,0.000029859171,0.00202299,0.00006830718,0.0005168244,0.00072561996,0.0000069486955,0.009192364],"study_design_scores_gemma":[0.1201049,0.0062360913,0.8549553,0.001525309,0.00021094481,0.0000034911957,0.00026885056,0.00013953022,0.016345458,0.00010021794,0.000016579737,0.000093310475],"about_ca_topic_score_codex":0.00032387124,"about_ca_topic_score_gemma":0.00022651804,"teacher_disagreement_score":0.054764226,"about_ca_system_score_codex":0.000112494796,"about_ca_system_score_gemma":0.00013545266,"threshold_uncertainty_score":0.4640829},"labels":[],"label_agreement":null},{"id":"W7108481922","doi":"10.1182/blood-2025-6551","title":"Association of duffy antigen receptor for chemokines with clinical conditions: A scoping review","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Ontario Tech University; St. Michael's Hospital","funders":"","keywords":"Chemokine receptor; Chemokine; Phenotype; CXC chemokine receptors; Asymptomatic; Absolute neutrophil count","score_opus":0.02506541097811515,"score_gpt":0.37746391605945956,"score_spread":0.3523985050813444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108481922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9623453,0.025142632,0.00077780883,0.006305184,0.00029445218,0.0029764127,0.00004604907,0.00008296896,0.0020291805],"genre_scores_gemma":[0.8646137,0.09072491,0.024754398,0.007525863,0.001947013,0.000795658,0.0009046212,0.00010631436,0.00862753],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990821,0.000027571656,0.0004640227,0.00016786832,0.00013743548,0.00012100787],"domain_scores_gemma":[0.998992,0.0003280625,0.00023139626,0.00014277865,0.00026785085,0.000037893027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005647628,0.00008006947,0.00048682804,0.00004452906,0.000038352453,0.0000054204315,0.000042025145,0.00008454132,0.000117471245],"category_scores_gemma":[0.0010208501,0.000065454966,0.00014867683,0.00021214172,0.000023533405,0.00002891683,0.000013093648,0.000085657324,0.0000027975339],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029152838,0.0022765172,0.8604125,0.04632874,0.00212464,0.0000035270652,0.00006746306,8.7970125e-7,0.026784766,0.00040776114,0.05372765,0.0075740386],"study_design_scores_gemma":[0.026348611,0.0013149483,0.031866275,0.43563086,0.005943422,0.000019298683,0.0000915288,0.00004536888,0.4711497,0.00023863415,0.0268192,0.0005321561],"about_ca_topic_score_codex":0.0000032603132,"about_ca_topic_score_gemma":0.0000040652712,"teacher_disagreement_score":0.8285462,"about_ca_system_score_codex":0.000021682496,"about_ca_system_score_gemma":0.00022168037,"threshold_uncertainty_score":0.2669176},"labels":[],"label_agreement":null},{"id":"W7108485025","doi":"10.1182/blood-2025-5097","title":"Real-world treatment patterns, outcomes, and unmet needs in patients with ph+ ALL receiving tyrosine kinase inhibitors in the United States: Emerging trends and the role of asciminib-based combinations","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Retrospective cohort study; Tyrosine-kinase inhibitor; Cohort; Dasatinib; Cohort study; Bristol-Myers; Nilotinib","score_opus":0.008571614611094965,"score_gpt":0.2713230086125489,"score_spread":0.2627513940014539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108485025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955671,0.00008673777,0.000006587054,0.0033634342,0.000014479748,0.0005188458,0.00003550222,0.000012293828,0.00039502353],"genre_scores_gemma":[0.99907815,0.00010697376,0.000060760263,0.00030400275,0.0000058940836,0.00007772483,0.00021845881,0.00001397876,0.00013402342],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877036,0.00020988341,0.00031379247,0.0001784527,0.00030324026,0.0002242749],"domain_scores_gemma":[0.9987752,0.00074518635,0.00008453948,0.0002788512,0.00006808864,0.00004816343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036748516,0.00016072411,0.00031639883,0.0010409636,0.000058639504,0.0000238405,0.00009145441,0.00003964947,0.0000055993014],"category_scores_gemma":[0.000094773764,0.00008315384,0.000028607197,0.001518589,0.0001502276,0.000040687195,0.0000482852,0.00014677031,1.4586392e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039455332,0.0014857671,0.99035984,0.00004880895,0.00012418184,0.000012885503,0.0029650058,0.00003774051,0.000017849767,0.00023790657,0.000035724144,0.0042797336],"study_design_scores_gemma":[0.05200088,0.0004991075,0.94141245,0.0003684698,0.00027084618,0.0000010040911,0.0019034061,0.0026268812,0.0005636598,0.000046533794,0.00022326015,0.00008351177],"about_ca_topic_score_codex":0.008197197,"about_ca_topic_score_gemma":0.0023010059,"teacher_disagreement_score":0.051606327,"about_ca_system_score_codex":0.00019689977,"about_ca_system_score_gemma":0.00013251105,"threshold_uncertainty_score":0.9984073},"labels":[],"label_agreement":null},{"id":"W7108505175","doi":"10.1182/blood-2025-490","title":"Correlation between treatment-emergent cytopenias and clinical response with imetelstat (IME) in patients (Pts) with lower-risk myelodysplastic syndromes (LR-MDS): Analysis from the imerge Trial","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Cytopenia; Myelodysplastic syndromes; Neutropenia; Post-hoc analysis; Anemia; Adverse effect; Exact test; Placebo; Univariate analysis","score_opus":0.020154153455477095,"score_gpt":0.31450893329800067,"score_spread":0.29435477984252356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108505175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996777,0.00019086909,0.00033944007,0.00055928587,0.000087542976,0.0017782939,0.000154666,0.000035733283,0.000077141165],"genre_scores_gemma":[0.9980303,0.0002386581,0.00041421555,0.000043813194,0.0001016712,0.000078069905,0.00027031364,0.000030937477,0.00079200434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967436,0.00097359536,0.00065649976,0.0006824473,0.0005488212,0.00039501104],"domain_scores_gemma":[0.9959177,0.0028163816,0.0002304649,0.00068955036,0.00014067139,0.00020523285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009448912,0.00031642526,0.0009068696,0.0004298917,0.00016128233,0.00004583663,0.0001538478,0.00018758018,0.00010848814],"category_scores_gemma":[0.0007989484,0.00017661348,0.00017644593,0.0015478948,0.00021640406,0.00009993381,0.00010326387,0.0005030885,0.000023931008],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13990472,0.0011510791,0.8495943,0.0000062053,0.0058772694,0.000120063516,0.00017536574,0.00003606588,0.0000062893387,0.0000019104334,0.000115179166,0.0030115757],"study_design_scores_gemma":[0.12378323,0.0083227055,0.8544476,0.00009003983,0.012034115,0.0000028221814,0.00013039299,0.00070233276,0.000045527497,0.000006571307,0.00027428326,0.00016040391],"about_ca_topic_score_codex":0.0013536427,"about_ca_topic_score_gemma":0.00083549786,"teacher_disagreement_score":0.01612149,"about_ca_system_score_codex":0.0002577375,"about_ca_system_score_gemma":0.00061682746,"threshold_uncertainty_score":0.7202089},"labels":[],"label_agreement":null},{"id":"W7108512155","doi":"10.1182/blood-2025-3431","title":"Trial in progress: A phase I study evaluating the safety of cirtuvivint (CIRT) as monotherapy and in combination with ASTX727 in patients with myelodysplastic syndromes (MDS) and Acute Myeloid Leukemia (AML)","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of New Brunswick","funders":"","keywords":"Venetoclax; Decitabine; Myelodysplastic syndromes; Combination therapy; Salvage therapy; Refractory (planetary science); Clinical trial; Cancer; Phases of clinical research","score_opus":0.014787416141106954,"score_gpt":0.3297274307720428,"score_spread":0.31494001463093585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108512155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937198,0.0002150412,0.000016555672,0.00029875268,0.00002248726,0.005622362,0.0000075873822,0.000015846192,0.00008152534],"genre_scores_gemma":[0.9991283,0.00006276564,0.00027284192,0.000043111973,0.000011112133,0.0003852183,0.0000164697,0.00002677775,0.000053423286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976621,0.00036266568,0.00056172954,0.0004554819,0.0006335721,0.00032443576],"domain_scores_gemma":[0.9988725,0.00043122453,0.00016686748,0.00031565328,0.00014738295,0.00006637478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011529558,0.00023876003,0.0005907186,0.00054937595,0.00006310746,0.000035037447,0.00014070475,0.00009073887,0.000008125293],"category_scores_gemma":[0.00027213362,0.00015199886,0.000019808453,0.000990329,0.00022650427,0.00013734424,0.000098149285,0.00048135375,5.327847e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14583774,0.006444377,0.8244336,0.00014121502,0.00047200584,0.0001340069,0.003401495,0.000031819156,0.00037084005,0.00005829452,0.000003364549,0.018671216],"study_design_scores_gemma":[0.3705671,0.020803973,0.60522056,0.00066517445,0.00021603995,0.000016261643,0.00095940696,0.0011555813,0.00022422947,0.000045904362,0.0000025377249,0.00012321015],"about_ca_topic_score_codex":0.00027741268,"about_ca_topic_score_gemma":0.00037511863,"teacher_disagreement_score":0.22472937,"about_ca_system_score_codex":0.00035544924,"about_ca_system_score_gemma":0.0008818141,"threshold_uncertainty_score":0.61983335},"labels":[],"label_agreement":null},{"id":"W7108514045","doi":"10.1182/blood-2025-5104","title":"Associations between serum asparaginase activity and asparaginase-associated toxicities in pediatric ALL patients receiving calaspargase: A report from the DFCI ALL consortium","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Centre hospitalier universitaire de Québec","funders":"","keywords":"Toxicity; Asparaginase; Clinical trial; Randomized controlled trial; Chemotherapy; Neutropenia; Leukemia; Acute lymphocytic leukemia","score_opus":0.02031177302584116,"score_gpt":0.293211464849776,"score_spread":0.27289969182393486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108514045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927522,0.00033604793,0.000036250472,0.0035167246,0.00013692497,0.0008641042,0.0005601961,0.00010897159,0.0016885663],"genre_scores_gemma":[0.9974061,0.00015498014,0.00011750522,0.0006350424,0.00017412378,0.00007656907,0.0005274456,0.00003487373,0.00087331946],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969651,0.00039345736,0.00062698347,0.0006180381,0.000703598,0.0006928325],"domain_scores_gemma":[0.99610394,0.002524097,0.00034461365,0.0005579258,0.00025916807,0.00021025025],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009480628,0.0003014679,0.0006670567,0.0002480545,0.00017725234,0.000089909285,0.00022951134,0.0003032513,0.000024974683],"category_scores_gemma":[0.0050326856,0.00025257687,0.00009679504,0.0007373551,0.00013291095,0.00017292958,0.00028653172,0.00072294095,0.000014358624],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051003477,0.0008085684,0.9921079,0.00003210337,0.0005233947,0.0003507122,0.0004377636,0.0000021345686,0.00014879931,0.000009599512,0.005093944,0.00043403773],"study_design_scores_gemma":[0.007664863,0.0001164662,0.98898417,0.000112751484,0.0011126043,0.000011047495,0.0000653454,0.00016577517,0.0011248444,0.00020307653,0.0002293696,0.00020971059],"about_ca_topic_score_codex":0.003915285,"about_ca_topic_score_gemma":0.0017671157,"teacher_disagreement_score":0.0076138596,"about_ca_system_score_codex":0.00082289876,"about_ca_system_score_gemma":0.0010098353,"threshold_uncertainty_score":0.99999267},"labels":[],"label_agreement":null},{"id":"W7108516095","doi":"10.1182/blood-2025-7650","title":"Pre-clinical characterization and process development of a BCMA-directed CAR NK-cell therapy product for relapsed/refractory multiple myeloma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Chimeric antigen receptor; Immune system; Cytokine release syndrome; Human leukocyte antigen; Multiple myeloma; Transplantation; Antigen; CAR T-cell therapy; Blood product","score_opus":0.033852035526264625,"score_gpt":0.3372780528990568,"score_spread":0.3034260173727922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108516095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960142,0.0007762705,0.00021047142,0.00013167788,0.0001143566,0.0023167387,0.000013834081,0.00008961163,0.00033283926],"genre_scores_gemma":[0.9879192,0.00049077434,0.00240698,0.000091501395,0.0001451955,0.0003048295,0.00015201054,0.000036615744,0.008452882],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985058,0.00007662593,0.0005203842,0.0004197836,0.00024500885,0.00023244829],"domain_scores_gemma":[0.99889904,0.00018352868,0.00013944457,0.00030538984,0.00038280862,0.00008976458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053409446,0.00015681097,0.000393183,0.0001472556,0.00007492184,0.000014305626,0.000103564875,0.00010506101,0.00007696875],"category_scores_gemma":[0.0003613398,0.00013408659,0.000068497924,0.0002758747,0.00008132337,0.000058345766,0.000034433506,0.00018976921,0.0000018725403],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020188454,0.002090862,0.07847154,0.00072201784,0.00024436731,0.0000027098986,0.001180916,1.0339766e-7,0.8204467,0.0000015606549,0.000055958484,0.0947644],"study_design_scores_gemma":[0.0120342905,0.0005425356,0.3057042,0.00018178445,0.000072303665,0.0000045122774,0.00004128853,0.00010752393,0.6660151,0.000008187538,0.015165387,0.00012291159],"about_ca_topic_score_codex":0.0000053766908,"about_ca_topic_score_gemma":0.0000072428443,"teacher_disagreement_score":0.22723268,"about_ca_system_score_codex":0.000026168498,"about_ca_system_score_gemma":0.0006167912,"threshold_uncertainty_score":0.5467892},"labels":[],"label_agreement":null},{"id":"W7108604932","doi":"10.1182/blood-2025-2262","title":"Long-term responders from the Phase 3 dreamm-7 study of belantamab mafodotin plus bortezomib and dexamethasone vs daratumumab plus bortezomib and dexamethasone in Relapsed/Refractory multiple myeloma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Dexamethasone; Daratumumab; Clinical endpoint; Multiple myeloma; Bortezomib; Phases of clinical research; Intention-to-treat analysis; Randomized controlled trial; Randomization","score_opus":0.026574681224570032,"score_gpt":0.322453296623898,"score_spread":0.29587861539932797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108604932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895744,0.0063093044,0.00004648013,0.0003569962,0.000110754896,0.003064481,0.00020554113,0.00006933934,0.0002627479],"genre_scores_gemma":[0.997658,0.0006153029,0.0006288658,0.00013884292,0.00008027565,0.00019064735,0.00016558838,0.00006233329,0.00046012356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99599105,0.00064780086,0.00086502626,0.0010242328,0.00073216273,0.00073971465],"domain_scores_gemma":[0.99584746,0.002239009,0.00026725276,0.0011211693,0.00014791025,0.00037721056],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008572986,0.0005370396,0.001206618,0.00050723733,0.00026797576,0.00007875998,0.00032947407,0.00027777388,0.0000654629],"category_scores_gemma":[0.0013156228,0.00040625926,0.00012072038,0.0007168525,0.0004079042,0.0001552954,0.00038098078,0.0008358159,0.0000072091193],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0176419,0.008185408,0.9396495,0.00017793037,0.0016872137,0.0016077177,0.0037065293,0.0000030884426,0.008456986,0.000010899366,0.00012397715,0.018748837],"study_design_scores_gemma":[0.14283322,0.0028192198,0.84475344,0.0004535517,0.00090473704,0.00006920961,0.0027347037,0.000441128,0.004630887,0.000025836303,0.000058489386,0.00027555795],"about_ca_topic_score_codex":0.004316983,"about_ca_topic_score_gemma":0.0060506384,"teacher_disagreement_score":0.12519132,"about_ca_system_score_codex":0.00022480873,"about_ca_system_score_gemma":0.00050444575,"threshold_uncertainty_score":0.99983895},"labels":[],"label_agreement":null},{"id":"W7108607412","doi":"10.1182/blood-2025-5117","title":"Efficacy of single-agent subcutaneous blinatumomab in adults with relapsed/refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL): Results from a phase 1/2 dose expansion study with extended follow-up","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Calgary","funders":"","keywords":"Blinatumomab; Clinical endpoint; Phases of clinical research; Pharmacokinetics; Refractory (planetary science); Minimal residual disease; Hematopoietic stem cell transplantation; Adverse effect; Acute lymphocytic leukemia","score_opus":0.012493653804542613,"score_gpt":0.27211653978171074,"score_spread":0.25962288597716815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108607412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99412465,0.00037296003,0.00021491107,0.00009898197,0.00019439793,0.0032684056,0.0002109211,0.00017568917,0.0013390717],"genre_scores_gemma":[0.99626976,0.00007015531,0.0014534965,0.00011457978,0.000084916224,0.00014149638,0.00035297233,0.0001252695,0.0013873669],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9943157,0.00029903746,0.0013189331,0.0015201044,0.0015840323,0.0009622077],"domain_scores_gemma":[0.9954709,0.0014734452,0.0004802596,0.0016793517,0.00046431812,0.00043172872],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041880456,0.0007248757,0.0012913843,0.00085089105,0.00011088795,0.000049000075,0.00055016845,0.00033990838,0.00003662152],"category_scores_gemma":[0.0006610478,0.00053802104,0.00016789124,0.00158217,0.0002917471,0.00017034852,0.0002762507,0.0007425305,0.000030243302],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.65325344,0.104218006,0.0034958587,0.00074655865,0.003671347,0.0561477,0.011211855,0.00031034392,0.15703306,0.000012247958,0.0009803497,0.008919227],"study_design_scores_gemma":[0.8366115,0.060843997,0.014723571,0.005443726,0.004974721,0.0007913372,0.0035778782,0.002197954,0.0697038,0.000024418496,0.00014304575,0.0009640441],"about_ca_topic_score_codex":0.0012518754,"about_ca_topic_score_gemma":0.0005506261,"teacher_disagreement_score":0.18335804,"about_ca_system_score_codex":0.001818276,"about_ca_system_score_gemma":0.0037710096,"threshold_uncertainty_score":0.9997071},"labels":[],"label_agreement":null},{"id":"W7108609160","doi":"10.1182/blood-2025-4483","title":"Real-world survival, cognitive and health-related quality of life outcomes of methotrexate/ifosfamide plus whole brain radiotherapy for newly diagnosed primary central nervous system lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Primary central nervous system lymphoma; Neurocognitive; Quality of life (healthcare); Radiation therapy; Lymphoma; Performance status; Wisconsin Card Sorting Test; Chemotherapy regimen","score_opus":0.03746126170329857,"score_gpt":0.3364075298734753,"score_spread":0.2989462681701767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108609160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98460233,0.0077254716,0.00023089872,0.0038193262,0.00020291,0.002217574,0.00042612918,0.000087778746,0.0006875779],"genre_scores_gemma":[0.9960451,0.00067307445,0.0014136801,0.0008479706,0.000038573577,0.0002007195,0.00020432346,0.000041115276,0.0005354427],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99722666,0.00038043366,0.0012341875,0.00044854658,0.00029832937,0.00041186807],"domain_scores_gemma":[0.9954013,0.003207457,0.0005888805,0.00036676796,0.00018160985,0.0002539673],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009114305,0.0003063984,0.0019083878,0.00024161312,0.00008834006,0.000015265987,0.00009120547,0.00012859146,0.000007908171],"category_scores_gemma":[0.00044483953,0.0002544514,0.00032764557,0.00038414478,0.00013355109,0.000048788872,0.000043116026,0.00005998208,6.925518e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015651478,0.0039038453,0.9190004,0.00352396,0.004689416,0.000048557056,0.0010334786,0.000010211628,0.0010897807,0.0029714366,0.00091262005,0.061251182],"study_design_scores_gemma":[0.04425338,0.00054502906,0.9504538,0.00091061176,0.00066339684,0.000005562002,0.0006470661,0.00006766065,0.002088855,0.00003493969,0.00016564122,0.00016403692],"about_ca_topic_score_codex":0.012391494,"about_ca_topic_score_gemma":0.0008373494,"teacher_disagreement_score":0.061087146,"about_ca_system_score_codex":0.00041516274,"about_ca_system_score_gemma":0.0009930596,"threshold_uncertainty_score":0.99999076},"labels":[],"label_agreement":null},{"id":"W7108620632","doi":"10.1182/blood-2025-5120","title":"Toxicities on the E1910 phase III randomized trial of blinatumomab plus chemotherapy in adults with BCR:ABL-1 negative acute lymphoblastic leukemia","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Blinatumomab; Chemotherapy; Minimal residual disease; Acute lymphocytic leukemia; Incidence (geometry); Toxicity; Randomized controlled trial","score_opus":0.008506622467973221,"score_gpt":0.281102103651251,"score_spread":0.27259548118327775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108620632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832397,0.00013243606,0.00045844715,0.0016227082,0.00013794424,0.004683292,0.000033033262,0.00006268377,0.009629773],"genre_scores_gemma":[0.9950991,0.00022837245,0.0002991133,0.0009007595,0.00016155808,0.0006051914,0.000020499478,0.000046779198,0.002638613],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9969961,0.00034260552,0.00080298434,0.00049383607,0.00083003106,0.0005344152],"domain_scores_gemma":[0.9950291,0.0036543068,0.00027166243,0.00066465035,0.000260583,0.00011970614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008710684,0.00038865313,0.001550737,0.0004781531,0.00009810334,0.000031852996,0.00037142783,0.00020482996,0.0001265633],"category_scores_gemma":[0.0013720606,0.00022140797,0.00024561695,0.0009900501,0.00077695353,0.00007871747,0.00008562552,0.00046768013,0.000012472532],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9898444,0.0017076993,0.000010236562,0.00015511978,0.0013687345,0.00021507323,0.0021697222,0.000028047452,0.0012207594,0.0018232506,0.0007500109,0.00070699025],"study_design_scores_gemma":[0.92980635,0.003209771,0.00003503551,0.0015499264,0.0006515692,0.00004183285,0.0008242115,0.005118135,0.058113564,0.0004225698,0.000041992338,0.00018501557],"about_ca_topic_score_codex":0.0003454997,"about_ca_topic_score_gemma":0.000042727752,"teacher_disagreement_score":0.06003798,"about_ca_system_score_codex":0.0009861708,"about_ca_system_score_gemma":0.003780163,"threshold_uncertainty_score":0.90287554},"labels":[],"label_agreement":null},{"id":"W7108628094","doi":"10.1182/blood-2025-3102","title":"An updated systematic review and meta-analysis of caplacizumab for immune thromboticthrombocytopenic purpura: Insights into efficacy and safety","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Observational study; Adverse effect; Placebo; Randomized controlled trial; Meta-analysis; Confidence interval; Clinical trial; Relative risk","score_opus":0.023055583571447626,"score_gpt":0.3026509015855126,"score_spread":0.279595318014065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108628094","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28222257,0.7116612,0.00027656692,0.00031673134,0.000070100905,0.005045677,0.00023049513,0.00006665944,0.00010996709],"genre_scores_gemma":[0.99756104,0.001171946,0.00009362231,0.00014408343,0.0000016865769,0.00024623235,0.0005431532,0.000010688802,0.00022756892],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9978531,0.0005353577,0.0009849883,0.00039991978,0.000040789197,0.00018585425],"domain_scores_gemma":[0.99837726,0.00035690548,0.0003498177,0.00074487564,0.0001445645,0.000026560378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040027796,0.00023814107,0.0029389556,0.00025109857,0.0001772976,0.000019520465,0.00027457345,0.00009902248,0.00037038155],"category_scores_gemma":[0.00014048791,0.00017220467,0.00039038248,0.0004588401,0.00014130816,0.00009279044,0.00012547548,0.000069634945,0.0000059097747],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014615127,0.0014466471,0.00026129917,0.122997165,0.81176335,0.0000024271349,0.0006698473,0.0000052760065,0.05466018,0.0075253765,0.00050637836,0.000015932417],"study_design_scores_gemma":[0.0029215969,0.0001905424,0.0034439696,0.0009507573,0.98545784,0.000007689328,0.00016647344,0.000008152411,0.006409998,0.00012129562,0.000120209894,0.00020150705],"about_ca_topic_score_codex":0.00007411754,"about_ca_topic_score_gemma":0.00009475009,"teacher_disagreement_score":0.71533847,"about_ca_system_score_codex":0.000016288535,"about_ca_system_score_gemma":0.00004569049,"threshold_uncertainty_score":0.7022303},"labels":[],"label_agreement":null},{"id":"W7108630260","doi":"10.1182/blood-2025-3046","title":"Treatment strategies and outcomes in pediatric patients with immune thrombocytopenia (ITP) undergoing surgical procedures: A multicenter study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; Children's Hospital of Eastern Ontario; University of Ottawa","funders":"","keywords":"Perioperative; Splenectomy; Immune thrombocytopenia; Retrospective cohort study; Cohort study; Cohort; Adenoidectomy; Tonsillectomy; Cytopenia","score_opus":0.008179084762856626,"score_gpt":0.26733779942475394,"score_spread":0.2591587146618973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108630260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969491,0.00066772406,6.151105e-7,0.0000909317,0.000022310003,0.0013482248,0.0000041549797,0.000029189838,0.0008877737],"genre_scores_gemma":[0.99938726,0.00019469012,0.000073638126,0.000015873096,0.000006890125,0.00008962574,0.000017019238,0.000011841355,0.00020316428],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913853,0.000026409347,0.0002148626,0.0002766928,0.00013759347,0.00020591708],"domain_scores_gemma":[0.9996437,0.0000825251,0.00004403648,0.00015292413,0.000029369085,0.00004747567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000027050117,0.00019655224,0.00048654692,0.00013617393,0.00005845626,0.000048709724,0.00003643574,0.00004319191,0.0000069912367],"category_scores_gemma":[0.000018070441,0.000119011514,0.000035838013,0.00017349055,0.000021679152,0.00011668834,0.000031405627,0.0000654979,0.0000033534852],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034873854,0.014768308,0.9828861,0.00008888672,0.00042123438,0.00064315874,0.0006062314,0.0000012210836,0.0000023068264,0.000019904199,8.8436144e-7,0.00021304858],"study_design_scores_gemma":[0.058060005,0.0018975507,0.93750876,0.000059285478,0.0006911114,0.000006751371,0.0016305676,0.0000033136466,0.000022433665,0.000019897578,0.0000054980173,0.00009482514],"about_ca_topic_score_codex":0.00011704352,"about_ca_topic_score_gemma":0.0012259878,"teacher_disagreement_score":0.057711266,"about_ca_system_score_codex":0.00004369529,"about_ca_system_score_gemma":0.00020385715,"threshold_uncertainty_score":0.48531488},"labels":[],"label_agreement":null},{"id":"W7108642827","doi":"10.1182/blood-2025-6190","title":"Title: Clinical trial availability and receipt of guideline concordant care among adolescents and young adults (AYAs) with acute lymphoblastic leukemia","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Young adult; Clinical trial; Concordance; Guideline; Cancer; Odds ratio; Receipt; Cohort","score_opus":0.01547298955550359,"score_gpt":0.3186961775283763,"score_spread":0.30322318797287273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108642827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962303,0.000700514,0.000055832767,0.000116806434,0.0003531305,0.0005203981,0.000033121712,0.00003265716,0.0019572387],"genre_scores_gemma":[0.99844635,0.00022557368,0.0006043331,0.00025629287,0.00023534666,0.00000748121,0.000019195268,0.000012569936,0.00019287025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986634,0.000084423984,0.0006111906,0.0003180092,0.00019852287,0.00012445702],"domain_scores_gemma":[0.99918157,0.00009182936,0.00014134908,0.00029520429,0.00017810479,0.00011192297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038479356,0.00012639539,0.00045458027,0.000042601998,0.000030220068,0.0000088412235,0.000060923143,0.00009977537,0.00003714285],"category_scores_gemma":[0.0004274547,0.000101590755,0.00005383408,0.00010365872,0.00022971138,0.000029061895,0.00006854071,0.00014244931,0.000003992978],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0132752955,0.00037919564,0.974346,0.00076228275,0.0003277887,0.00003444232,0.00056559866,1.1562669e-7,0.00003766047,0.000014719632,0.0042648655,0.005992024],"study_design_scores_gemma":[0.17080082,0.002354467,0.81726235,0.003193903,0.0018384113,0.00006385783,0.00082920253,0.00015005936,0.0006407604,0.000028302095,0.00255406,0.00028381913],"about_ca_topic_score_codex":0.00039510507,"about_ca_topic_score_gemma":0.0004304515,"teacher_disagreement_score":0.15752552,"about_ca_system_score_codex":0.000043256743,"about_ca_system_score_gemma":0.0004542256,"threshold_uncertainty_score":0.41427508},"labels":[],"label_agreement":null},{"id":"W7108643524","doi":"10.1182/blood-2025-2163","title":"Identify high-risk disease in multiple myeloma through single-cell transcriptomic detection of highly proliferative (PR) cells","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Multiple myeloma; Transcriptome; Bone marrow; Gene expression profiling; Disease; Beta-2 microglobulin; Chromothripsis","score_opus":0.01795868949242272,"score_gpt":0.2700083733081279,"score_spread":0.25204968381570514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108643524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963381,0.00080510776,0.00059221644,0.00011884255,0.00014515668,0.0013385884,0.00013001433,0.000057822832,0.00047415134],"genre_scores_gemma":[0.9982189,0.00012791643,0.00073625694,0.0000407981,0.000048588343,0.00014581364,0.00004894133,0.000024285619,0.00060850143],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983273,0.0001611663,0.00040982568,0.00040928012,0.00032964587,0.00036274365],"domain_scores_gemma":[0.99910223,0.00015056106,0.00010261875,0.0003609449,0.00011875147,0.00016487083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012083525,0.00021584719,0.0003914739,0.0002567539,0.00008679918,0.000022024537,0.000106242616,0.000102638005,0.000030847863],"category_scores_gemma":[0.00016804515,0.00018800065,0.00014913155,0.00044549047,0.0000952473,0.00013939329,0.000034827284,0.00025323627,0.000031854626],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018894918,0.0053150505,0.21523315,0.00044917324,0.00026775777,0.00023716471,0.00056864246,0.00001774329,0.7740466,0.000020265297,0.00003495569,0.0019200244],"study_design_scores_gemma":[0.014692248,0.00038148786,0.29016793,0.00016189246,0.00031077518,0.0000016922473,0.000089529494,0.00025807394,0.6935981,0.00019326915,0.000050785424,0.00009420544],"about_ca_topic_score_codex":0.0011598144,"about_ca_topic_score_gemma":0.0004531882,"teacher_disagreement_score":0.08044847,"about_ca_system_score_codex":0.00010689655,"about_ca_system_score_gemma":0.00017410131,"threshold_uncertainty_score":0.76664436},"labels":[],"label_agreement":null},{"id":"W7108647764","doi":"10.1182/blood-2025-3086","title":"A 10-year retrospective review of the effectiveness and safety of tranexamic acid in women with inherited bleeding disorders in the peripartum setting","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; St. Michael's Hospital","funders":"","keywords":"Tranexamic acid; Von Willebrand disease; Retrospective cohort study; Haemophilia; Coagulopathy; Bleeding diathesis; Clotting factor; Pregnancy; Platelet disorder; Hemarthrosis","score_opus":0.0068207904718092915,"score_gpt":0.2642159351798089,"score_spread":0.2573951447079996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108647764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99036616,0.0036736415,7.721045e-7,0.0010815318,0.000005568763,0.0011198116,0.000003510118,0.0000037272846,0.0037452548],"genre_scores_gemma":[0.99753606,0.0022725174,0.000014409057,0.00003726094,0.0000048173697,0.00007858776,0.0000011670298,0.0000054703155,0.000049708826],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911225,0.00026755116,0.00016526112,0.00013401358,0.00017457429,0.00014636508],"domain_scores_gemma":[0.99956995,0.00017979897,0.00003923785,0.0001577218,0.000037891154,0.000015420232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010814646,0.00007780057,0.00028748528,0.00007504913,0.00003002176,0.0000030318727,0.00007508186,0.000033942306,0.000022925462],"category_scores_gemma":[0.00023904057,0.000037920254,0.00002785669,0.00071705366,0.000117577896,0.000022950959,0.0000272838,0.00017090394,2.3423163e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014680822,0.00066051737,0.9741248,0.009350087,0.00018711736,0.000009229055,0.0026761417,5.851342e-7,0.0077882526,0.00009704075,0.000006832569,0.0036313015],"study_design_scores_gemma":[0.0050617917,0.00040358448,0.9768116,0.013608002,0.00007903857,0.000004903135,0.0010524588,0.0000057146844,0.002837606,0.000059934653,0.000037847687,0.00003754292],"about_ca_topic_score_codex":0.000026630414,"about_ca_topic_score_gemma":0.000034324094,"teacher_disagreement_score":0.007169879,"about_ca_system_score_codex":0.00005259593,"about_ca_system_score_gemma":0.00008140329,"threshold_uncertainty_score":0.1546343},"labels":[],"label_agreement":null},{"id":"W7108659049","doi":"10.1182/blood-2025-2118","title":"A post hoc safety analysis of fixed-duration acalabrutinib-venetoclax combinations vs chemoimmunotherapy: Results from the phase 3 AMPLIFY trial","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Obinutuzumab; Venetoclax; Fludarabine; Chemoimmunotherapy; Post-hoc analysis; Discontinuation; Adverse effect; Cyclophosphamide; Neutropenia","score_opus":0.018781331082540362,"score_gpt":0.3385754346485994,"score_spread":0.31979410356605903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108659049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911534,0.0004698369,0.00024320038,0.0034725147,0.00013080778,0.0012463438,0.0011471444,0.00005157937,0.002085173],"genre_scores_gemma":[0.99511963,0.00022026012,0.00020439766,0.00051472546,0.00012939642,0.0000619381,0.0024910597,0.000016219388,0.001242379],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99781644,0.00018414519,0.000842296,0.00036477845,0.00053546537,0.00025687434],"domain_scores_gemma":[0.9967685,0.0015841033,0.00023396291,0.0010033537,0.0003425655,0.00006752167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008004306,0.00016419959,0.0005472064,0.00027894,0.00016650859,0.000039740033,0.00030209462,0.00018383174,0.00022708943],"category_scores_gemma":[0.0014895867,0.00011906597,0.00029099933,0.0016888197,0.0001690967,0.00005637696,0.00008492104,0.00028176612,0.000014444859],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.76535416,0.022823837,0.00073931646,0.00022247467,0.042950295,0.000109111985,0.008530967,0.0002951128,0.09791398,0.0069000134,0.010039248,0.044121485],"study_design_scores_gemma":[0.94079626,0.0013006284,0.0066985046,0.00015491556,0.0059422,0.0000050148196,0.00033676808,0.013256577,0.020018095,0.00014962305,0.011164392,0.0001770138],"about_ca_topic_score_codex":0.002775362,"about_ca_topic_score_gemma":0.00030166737,"teacher_disagreement_score":0.17544211,"about_ca_system_score_codex":0.0019314983,"about_ca_system_score_gemma":0.005445373,"threshold_uncertainty_score":0.9659858},"labels":[],"label_agreement":null},{"id":"W7108662280","doi":"10.1182/blood-2025-2187","title":"Light-chain MGUS defined as per the revised definition of the istopmm study: Experience from the university of calgary MGUS clinic","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Monoclonal gammopathy of undetermined significance; Multiple myeloma; Monoclonal gammopathy; Confidence interval; Lymphoproliferative disorders; Population; Waldenstrom macroglobulinemia; Prospective cohort study","score_opus":0.031228438704084212,"score_gpt":0.2915604792796188,"score_spread":0.2603320405755346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108662280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864479,0.0010147176,0.00001564098,0.0015096776,0.000060018727,0.0008992232,0.000015493028,0.0000127443145,0.010024615],"genre_scores_gemma":[0.9986294,0.0001346521,0.0001528398,0.00018597014,0.000019093977,0.000010671805,0.000008371123,0.00000570726,0.0008533275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988448,0.0002978268,0.00019546042,0.0001932588,0.0003227483,0.00014592924],"domain_scores_gemma":[0.99859023,0.0004959664,0.00009931054,0.00066948147,0.00010059932,0.000044429133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024033246,0.000098940014,0.00021786573,0.000027940761,0.00022169524,0.0000062570916,0.00030518774,0.000048878486,0.0002537217],"category_scores_gemma":[0.00044305934,0.000048233625,0.0001380797,0.00022828889,0.00016015154,0.000022692851,0.0001567647,0.00017255715,0.000033039043],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016854916,0.0043522464,0.9653197,0.000083201194,0.0011217976,0.000120631434,0.011563996,2.2144204e-7,0.0092969015,0.0015117949,0.0011832777,0.0037607304],"study_design_scores_gemma":[0.008158661,0.0004421173,0.9752008,0.00021592253,0.0006142286,0.0000049996456,0.0087871365,0.0000165616,0.0051213093,0.00048297454,0.0008923996,0.00006293563],"about_ca_topic_score_codex":0.0027449785,"about_ca_topic_score_gemma":0.00031337797,"teacher_disagreement_score":0.012181496,"about_ca_system_score_codex":0.000036870384,"about_ca_system_score_gemma":0.00020553087,"threshold_uncertainty_score":0.41496047},"labels":[],"label_agreement":null},{"id":"W7108678797","doi":"10.1182/blood-2025-154","title":"Clinical prognostication in the SWOG 1826 randomized clinical trial of nivolumab-AVD versus brentuximab-AVD: Performance of the advanced-stage Hodgkin lymphoma international prognostic index (A-HIPI)","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; McGill University Health Centre; Institute of Cancer Research","funders":"","keywords":"Brentuximab vedotin; Dacarbazine; Randomized controlled trial; Nivolumab; International Prognostic Index; Hodgkin lymphoma; Clinical trial; ABVD; Nomogram","score_opus":0.031878883213405707,"score_gpt":0.3669264143961367,"score_spread":0.335047531182731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108678797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906074,0.00036690698,0.000023806364,0.0011540793,0.0016888307,0.0036791482,0.000022081063,0.00002053584,0.0024372258],"genre_scores_gemma":[0.9976501,0.00085207925,0.00026631806,0.00017817182,0.00023018042,0.0005849289,0.000039304865,0.000013020391,0.00018593467],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99615663,0.0008153376,0.0017799722,0.0004023971,0.00061158836,0.00023405634],"domain_scores_gemma":[0.9936103,0.00478199,0.00065359665,0.0006635669,0.00023417886,0.000056336816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026762486,0.00021486124,0.00093559053,0.00012858,0.000060742717,0.00001968885,0.00047436016,0.00018913891,0.000026422831],"category_scores_gemma":[0.006310817,0.00012217123,0.00057672407,0.00041780475,0.0004438074,0.00008252169,0.00014342356,0.000215105,0.000008263198],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2845056,0.012302998,0.64913666,0.000098993456,0.00073777116,0.000010718922,0.00016090713,0.000009059616,0.000008781684,0.0010267352,0.000113441296,0.051888335],"study_design_scores_gemma":[0.5833533,0.0011792891,0.4124195,0.00037019944,0.000823194,0.000004411916,0.00012313975,0.00077144074,0.00039687357,0.000038079947,0.00044864241,0.00007196581],"about_ca_topic_score_codex":0.000048819853,"about_ca_topic_score_gemma":0.000030776217,"teacher_disagreement_score":0.29884768,"about_ca_system_score_codex":0.00007416128,"about_ca_system_score_gemma":0.0005497094,"threshold_uncertainty_score":0.7555093},"labels":[],"label_agreement":null},{"id":"W7108682180","doi":"10.1182/blood-2025-3084","title":"Real-world treatment characteristics and outcomes in patients with von Willebrand disease treated prophylactically with plasma-derived or recombinant von Willebrand factor in europe: A multi-center, retrospective study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital; Group for Research in Decision Analysis","funders":"","keywords":"Von Willebrand disease; Retrospective cohort study; Von Willebrand factor; Medical record; Disease; Coagulopathy","score_opus":0.010486782382690083,"score_gpt":0.2530740349533118,"score_spread":0.24258725257062175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108682180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957311,0.00002022612,0.0000010497771,0.00012149463,0.000040953575,0.0037349917,0.00015596554,0.000052236213,0.00014196272],"genre_scores_gemma":[0.99804085,0.0001506071,0.00012139293,0.000033321867,0.0000044697226,0.00021502357,0.0001421595,0.00004901782,0.0012431594],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981096,0.00011015174,0.00043128853,0.0006903169,0.0002640959,0.00039454916],"domain_scores_gemma":[0.9991019,0.000060024406,0.00014465755,0.00034485076,0.00013429113,0.000214281],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000043182,0.0004849253,0.0010299315,0.00036188384,0.00008667849,0.00005091993,0.000062855455,0.00005812844,0.0000119110655],"category_scores_gemma":[0.000095542484,0.00026716822,0.00003948613,0.0006360721,0.00008069265,0.00012774038,0.000040256084,0.0001760767,0.000002578016],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018051509,0.0519605,0.92464423,0.000072736715,0.00081004505,0.0028414743,0.0005271718,2.0594125e-7,0.00001855611,0.0000025251447,0.0000013533621,0.0010696967],"study_design_scores_gemma":[0.13382824,0.00725723,0.8574927,0.0003666251,0.00062659057,0.000004856214,0.00008122234,0.000025108564,0.00006485706,0.0000017305914,0.000012816257,0.00023801748],"about_ca_topic_score_codex":0.00041700638,"about_ca_topic_score_gemma":0.0039272853,"teacher_disagreement_score":0.115776725,"about_ca_system_score_codex":0.00022988864,"about_ca_system_score_gemma":0.00019287303,"threshold_uncertainty_score":0.99997807},"labels":[],"label_agreement":null},{"id":"W7108684918","doi":"10.1182/blood-2025-6341","title":"Real-world outcomes of transplant-ineligible newly diagnosed multiple myeloma patients treated in the United States with contemporary regimens","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Discontinuation; Multiple myeloma; Observational study; Population; Retrospective cohort study; Melphalan; Charlson comorbidity index; Lenalidomide","score_opus":0.023729353248533203,"score_gpt":0.2908707777886225,"score_spread":0.2671414245400893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108684918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99376243,0.00009851128,0.000004236736,0.0006387718,0.00001565237,0.0013491741,0.00017119572,0.000051574134,0.0039084707],"genre_scores_gemma":[0.9970521,0.00018406492,0.00015071049,0.00022737685,0.0000071422487,0.00013769329,0.0013593759,0.000019930161,0.0008616227],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848264,0.00015734535,0.00037671925,0.0002694222,0.00037947073,0.00033442312],"domain_scores_gemma":[0.9985386,0.0006960587,0.00009199863,0.00042623165,0.00014426807,0.000102827405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014197733,0.00022599245,0.0004743919,0.0005757999,0.00006172853,0.000015666232,0.00016058494,0.00005748512,0.000013488297],"category_scores_gemma":[0.00009527397,0.00012517764,0.000079924255,0.0011074616,0.00009832893,0.000059177997,0.000019733172,0.00017099705,0.000005068462],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001872578,0.0034422805,0.9918074,0.000119176104,0.00060373126,0.00051072426,0.0006872402,0.000006229923,0.000114757044,0.000041601772,0.0005327129,0.00026159242],"study_design_scores_gemma":[0.03888459,0.00063167757,0.95276517,0.00033925023,0.0002018008,0.0000025493346,0.00025594386,0.00012292432,0.006322515,0.000016482587,0.00035412377,0.000102979546],"about_ca_topic_score_codex":0.015540947,"about_ca_topic_score_gemma":0.0038149261,"teacher_disagreement_score":0.039042216,"about_ca_system_score_codex":0.000036337526,"about_ca_system_score_gemma":0.00013403609,"threshold_uncertainty_score":0.99101466},"labels":[],"label_agreement":null},{"id":"W7108696894","doi":"10.1182/blood-2025-2410","title":"Development of multi-targeting CAR-double-negative T cells for allogeneic immunotherapy in B-cell leukemia","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Chimeric antigen receptor; Antigen; Leukemia; Immunotherapy; CD19; Myeloid leukemia; Cancer immunotherapy; Immune system; T cell","score_opus":0.03209382223099345,"score_gpt":0.3197897275302218,"score_spread":0.28769590529922834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108696894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926225,0.0014446544,0.0005580946,0.000050682444,0.00009535333,0.0015598475,0.0000071626205,0.000027048407,0.0036346372],"genre_scores_gemma":[0.9027005,0.00023279536,0.08486741,0.00015658369,0.00005231179,0.00032376294,0.0000291433,0.000051874424,0.011585615],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985609,0.000040808514,0.00049424416,0.0003046194,0.00022564462,0.00037380512],"domain_scores_gemma":[0.9992352,0.00018780745,0.000091203685,0.00026259795,0.00016623129,0.00005695787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005629897,0.00017109254,0.00041478532,0.00026216236,0.000058967453,0.000009966605,0.00016878363,0.00011971134,0.00018323361],"category_scores_gemma":[0.00003575725,0.00016020836,0.00011979674,0.00035353878,0.00005532886,0.000027095244,0.000056038047,0.00020192802,0.00000722374],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008806613,0.00083370274,0.0035307507,0.0002933488,0.00022243215,0.0000075330577,0.002210626,0.000023590004,0.98272824,0.000014668494,0.000070233225,0.009184213],"study_design_scores_gemma":[0.02677084,0.00011833804,0.0018979647,0.00013900785,0.000036997128,0.0000010552953,0.0004525452,0.00016734967,0.96289945,0.000017337148,0.00737238,0.00012671317],"about_ca_topic_score_codex":0.00014952502,"about_ca_topic_score_gemma":0.00012498209,"teacher_disagreement_score":0.08992202,"about_ca_system_score_codex":0.00026209134,"about_ca_system_score_gemma":0.0009789021,"threshold_uncertainty_score":0.6533107},"labels":[],"label_agreement":null},{"id":"W7108702916","doi":"10.1182/blood-2025-6193","title":"Access to diagnostics, therapies, and advanced care for lymphoma in Latin America: A multicenter, survey-based study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Health, Education, and Cultural Studies","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Latin Americans; Lymphoma; Hodgkin lymphoma; Hematology; MEDLINE; Cancer; Clinical trial","score_opus":0.03775547860869531,"score_gpt":0.38208235669768625,"score_spread":0.34432687808899093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108702916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938306,0.0024786938,0.00002263645,0.001647972,0.00019721707,0.0015055176,0.000033300323,0.000022833323,0.0002612312],"genre_scores_gemma":[0.99795926,0.00063024857,0.0003712868,0.0005609637,0.00004105651,0.00029835998,0.00000987263,0.0000042043735,0.00012477279],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991202,0.0002245473,0.00014644251,0.00020366335,0.00009806229,0.00020710137],"domain_scores_gemma":[0.9989562,0.00069341174,0.00003693067,0.0000817952,0.00017196323,0.000059671424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026714892,0.000076683806,0.00016129825,0.00004372672,0.0005075434,0.00007007602,0.00014161416,0.000028783983,0.0000038091414],"category_scores_gemma":[0.00096441637,0.000066583394,0.000015775624,0.00036428246,0.00004496032,0.000072487084,0.000018781957,0.000025802548,9.589616e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026703769,0.0006047093,0.8787932,0.00003078252,0.000017811617,3.2202703e-7,0.091671534,0.0000028341383,0.000001752905,0.000032803728,0.00017543338,0.02864211],"study_design_scores_gemma":[0.0017909816,0.000083831444,0.88441235,0.00003199979,0.000015130626,3.0324196e-9,0.09044162,0.0000011421128,0.000019167655,0.000017013721,0.023113718,0.00007301373],"about_ca_topic_score_codex":0.025955511,"about_ca_topic_score_gemma":0.38211605,"teacher_disagreement_score":0.35616055,"about_ca_system_score_codex":0.00006319048,"about_ca_system_score_gemma":0.00030030613,"threshold_uncertainty_score":0.98053074},"labels":[],"label_agreement":null},{"id":"W7108703181","doi":"10.1182/blood-2025-6031","title":"Propensity score matching analysis comparing the efficacy and treatment outcomes of belumosudil treatment with ruxolitinib therapy as second-line or beyond in chronic GVHD patients after steroid failure","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Hôpital Maisonneuve-Rosemont; University of Calgary; McMaster University; University Health Network; University of Toronto; Hamilton Health Sciences; Université de Montréal; Université Laval; BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"Propensity score matching; Ruxolitinib; Confounding; Population; Clinical trial; Randomized controlled trial; Statistical significance; Survival analysis","score_opus":0.024594940230590234,"score_gpt":0.28235146237778236,"score_spread":0.25775652214719214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108703181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947094,0.003413546,0.0000033817464,0.00034370695,0.000010913397,0.0012671221,0.000025061503,0.000017752292,0.00020912426],"genre_scores_gemma":[0.9968668,0.0023632972,0.0000809145,0.00007423966,0.000011798075,0.00015965932,0.00004371395,0.000014443736,0.00038510567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987829,0.00009631083,0.00031195392,0.00029673608,0.00022516066,0.00028694677],"domain_scores_gemma":[0.9992495,0.00015619998,0.000083899366,0.00035833797,0.00007066971,0.00008139375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010083647,0.00023515083,0.0007332217,0.00021271345,0.00009931416,0.0000447082,0.00007617943,0.000041657815,0.00017735703],"category_scores_gemma":[0.000013502608,0.000109385466,0.000103355436,0.00031653343,0.00012837315,0.0000685107,0.000044659064,0.00010273675,0.0000023443242],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016803757,0.0019316942,0.97414774,0.00003369787,0.0034409785,0.000045992332,0.0017895164,0.000010349295,0.0002167775,0.00001740892,0.0000014301625,0.016684053],"study_design_scores_gemma":[0.026819285,0.0043457053,0.9644316,0.00017716845,0.00022106968,0.0000062974705,0.00022061102,0.000013084355,0.0033887837,0.000024078669,0.00025090895,0.00010143332],"about_ca_topic_score_codex":0.00073080393,"about_ca_topic_score_gemma":0.013776735,"teacher_disagreement_score":0.025138909,"about_ca_system_score_codex":0.00012876009,"about_ca_system_score_gemma":0.00021982747,"threshold_uncertainty_score":0.7687742},"labels":[],"label_agreement":null},{"id":"W7108708946","doi":"10.1182/blood-2025-4776","title":"Prognostic impact of molecular genetic and cytogenetic alterations in newly diagnosed acute myeloid leukemia treated with azacitidine and venetoclax: A real-world cohort study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"NPM1; Azacitidine; Venetoclax; IDH1; Myeloid leukemia; IDH2; Proportional hazards model; Cohort; CEBPA; Survival analysis","score_opus":0.009547124342296088,"score_gpt":0.29582519012458325,"score_spread":0.28627806578228715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108708946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99510574,0.00061225396,0.000044088232,0.00006024413,0.0000060136276,0.0035406356,0.000028277276,0.000038737264,0.0005640097],"genre_scores_gemma":[0.99782115,0.0004837876,0.00087764015,0.00003697524,0.000019071724,0.00042527032,0.000048328282,0.000039190236,0.0002486087],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820805,0.00014866378,0.00042254696,0.0005267353,0.000304117,0.00038988944],"domain_scores_gemma":[0.9989024,0.00019253422,0.00008254165,0.0004658096,0.00015692027,0.00019983518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019139542,0.00028542956,0.0006230746,0.00062446186,0.00006194203,0.000039321374,0.00010519884,0.000081763435,0.000014753938],"category_scores_gemma":[0.00011516524,0.00022555559,0.000054197888,0.0011248079,0.00017437308,0.000048398746,0.00010075752,0.00026398903,0.0000013440621],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044751537,0.0004985363,0.95652735,0.00009280558,0.0011966826,0.0014261206,0.00022693646,0.00020275751,0.038626015,0.00001032531,0.000024836232,0.00072009716],"study_design_scores_gemma":[0.013617098,0.0027104367,0.9706697,0.00027044053,0.0016002117,0.00012323596,0.000072656214,0.0009944425,0.009750658,0.000018293342,0.0000026384412,0.000170201],"about_ca_topic_score_codex":0.0038674045,"about_ca_topic_score_gemma":0.001213177,"teacher_disagreement_score":0.028875357,"about_ca_system_score_codex":0.00045829502,"about_ca_system_score_gemma":0.0013603591,"threshold_uncertainty_score":0.91978896},"labels":[],"label_agreement":null},{"id":"W7108721199","doi":"10.1182/blood-2025-6025","title":"Propensity score matching analysis comparing the efficacy and long-term outcomes of belumosudil to the best available treatment as a historical control, used as second-line therapy or beyond for chronic GVHD after steroid failure.","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Hôpital Maisonneuve-Rosemont; University Health Network; Saskatchewan Cancer Agency; Princess Margaret Cancer Centre; University of Calgary; McMaster University; University of Toronto; Hamilton Health Sciences; Université de Montréal; Université Laval; BC Cancer Agency","funders":"","keywords":"Propensity score matching; Confounding; Randomized controlled trial; Clinical trial; Statistical significance; Sample size determination; Meta-analysis; Retrospective cohort study","score_opus":0.13267534313174487,"score_gpt":0.36915146620153577,"score_spread":0.2364761230697909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108721199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98411983,0.00082398,0.011349121,0.0009407201,0.000037844093,0.0025213896,0.000026697167,0.000084527885,0.00009586376],"genre_scores_gemma":[0.9936146,0.000053561518,0.0028431197,0.00026933252,0.000037899932,0.0006534583,0.0000067138317,0.000027951655,0.0024933647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851614,0.00010197501,0.00049526774,0.00037922323,0.00020520961,0.0003022015],"domain_scores_gemma":[0.9974922,0.00136378,0.00022644765,0.00072775886,0.00012536319,0.000064456464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036141058,0.00030754055,0.0009079876,0.00013006807,0.00020546601,0.00008056402,0.0003098512,0.00008180455,0.00015692269],"category_scores_gemma":[0.0001818846,0.00015336295,0.00019815746,0.0002918387,0.00007603409,0.000101746344,0.00012281866,0.00014745558,0.0000076179904],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035761322,0.0072837174,0.93211275,0.00071539223,0.016072473,0.00006955732,0.0066596535,0.00014566626,0.01771672,0.005555456,0.0006742517,0.009418221],"study_design_scores_gemma":[0.07699972,0.02509718,0.57346934,0.0014672879,0.036593217,0.00011412716,0.0009778296,0.0006556997,0.2223841,0.049961712,0.008715764,0.0035640087],"about_ca_topic_score_codex":0.0001390675,"about_ca_topic_score_gemma":0.0051270826,"teacher_disagreement_score":0.3586434,"about_ca_system_score_codex":0.00029138935,"about_ca_system_score_gemma":0.00013260933,"threshold_uncertainty_score":0.625396},"labels":[],"label_agreement":null},{"id":"W7108732077","doi":"10.1182/blood-2025-151","title":"3-year follow-up of the S1826 study confirms improved progression-free survival with nivolumab-AVD compared to brentuximab vedotin-AVD in advanced stage classic Hodgkin lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; McGill University; University of Toronto; Cargill (Canada)","funders":"","keywords":"Brentuximab vedotin; Nivolumab; Hodgkin lymphoma; Dacarbazine; Clinical endpoint; Stage (stratigraphy); Randomized controlled trial; Lymphoma","score_opus":0.011486390225167467,"score_gpt":0.2751201723404266,"score_spread":0.2636337821152592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108732077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930576,0.0002837078,0.000007894459,0.0006313522,0.00039038662,0.0035756328,0.00006780681,0.00006989826,0.0019157239],"genre_scores_gemma":[0.9975014,0.000010574611,0.0005197083,0.00014586818,0.000034023098,0.000509175,0.000019175555,0.000038214053,0.0012219006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976198,0.00015857806,0.00056057365,0.0005982806,0.000609964,0.0004527885],"domain_scores_gemma":[0.9980111,0.0001699735,0.0002152509,0.0012640415,0.00018648458,0.00015310787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025328484,0.0003546055,0.0008388661,0.00017538492,0.00011213344,0.000035900495,0.0004246621,0.00008934172,0.00003290572],"category_scores_gemma":[0.00017539147,0.00021871457,0.00015458297,0.00078838976,0.00010765886,0.000060874205,0.00030877182,0.000117241296,0.000008245461],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026200358,0.016487075,0.966211,0.00013333876,0.00064930087,0.00011171988,0.00092761277,0.000007806263,0.0023591125,0.00019218163,0.00027465442,0.010026139],"study_design_scores_gemma":[0.12220391,0.0025490576,0.85169303,0.000812103,0.0005675208,0.0000066415987,0.0027521881,0.000045654167,0.018438928,0.000021071664,0.0006842445,0.00022566524],"about_ca_topic_score_codex":0.0006686449,"about_ca_topic_score_gemma":0.0031927659,"teacher_disagreement_score":0.119583875,"about_ca_system_score_codex":0.00020500315,"about_ca_system_score_gemma":0.000551759,"threshold_uncertainty_score":0.8918922},"labels":[],"label_agreement":null},{"id":"W7108733746","doi":"10.1182/blood-2025-6182","title":"Understanding secondary immunodeficiency management in patients with hematological malignancies","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Hypogammaglobulinemia; Rituximab; Multiple myeloma; Chronic lymphocytic leukemia; Lymphoma; Disease; Acute lymphocytic leukemia; Antibody; Immunodeficiency","score_opus":0.012806393974195503,"score_gpt":0.2040480435896873,"score_spread":0.1912416496154918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108733746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9397469,0.009764983,0.00053792604,0.000075198,0.00026729034,0.00036936736,0.000007021027,0.00008098957,0.049150288],"genre_scores_gemma":[0.998671,0.000045875397,0.000040509847,0.0001403579,2.8819196e-7,0.00003209226,0.000051019808,0.000008369311,0.001010476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881244,0.0000739519,0.00030516644,0.00031823784,0.00004677809,0.0004434279],"domain_scores_gemma":[0.9995736,0.000046024787,0.000065903456,0.0002873415,0.000024171837,0.0000029642274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015900978,0.00018969055,0.00026326242,0.00024435722,0.0002477243,0.000021474249,0.00028307506,0.0001390418,0.00017132588],"category_scores_gemma":[0.000013065307,0.00015042818,0.00005628559,0.0004409992,0.00022897193,0.000093839146,0.00012765957,0.00026628032,0.000068202164],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014220914,0.015059174,0.4833313,0.0005455106,0.0017644196,0.0001088367,0.002124926,0.00009237169,0.011372879,0.47057498,0.0005663598,0.013037165],"study_design_scores_gemma":[0.023663135,0.00039654959,0.9532756,0.00043836323,0.00020862198,0.000014713176,0.00492637,0.0000020616535,0.00647563,0.0046269456,0.0053178407,0.00065412576],"about_ca_topic_score_codex":0.000015358231,"about_ca_topic_score_gemma":0.000002341253,"teacher_disagreement_score":0.46994436,"about_ca_system_score_codex":0.000049955743,"about_ca_system_score_gemma":0.000043637545,"threshold_uncertainty_score":0.61342835},"labels":[],"label_agreement":null},{"id":"W7108737773","doi":"10.1182/blood-2025-462","title":"Distinct blood endothelial cells shape spatial niches in angioimmunoblastic T-cell lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Angioimmunoblastic T-cell lymphoma; Lymphoma; Stromal cell; Follicular lymphoma; Immune system; Transcriptome; Bone marrow; Laser capture microdissection","score_opus":0.0064978798153001545,"score_gpt":0.22311145603833304,"score_spread":0.2166135762230329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108737773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98902035,0.0017359392,0.000017316672,0.0001844007,0.00027005505,0.00049177953,0.00006318658,0.00007561357,0.008141331],"genre_scores_gemma":[0.9981053,0.00014243742,0.00021871304,0.00019388899,0.00013979433,0.00012122239,0.00003894331,0.000029349665,0.0010103864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985587,0.000042385698,0.00038187293,0.00041908768,0.0002145052,0.00038343217],"domain_scores_gemma":[0.99915844,0.00022554913,0.00007078903,0.00040688278,0.000039180803,0.000099128985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008746215,0.00026841802,0.00043976036,0.00020889945,0.00006781052,0.00003483243,0.0001299504,0.000117906064,0.0001939752],"category_scores_gemma":[0.000064219596,0.00023265515,0.00019871973,0.00028422405,0.00006206801,0.00003408038,0.000091830756,0.000077548255,0.00013305037],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071281043,0.05902406,0.7025203,0.00052703876,0.0011300059,0.0030597083,0.00044663265,0.0000056355984,0.11873941,0.00028245343,0.0008479006,0.112704016],"study_design_scores_gemma":[0.033625364,0.0005252256,0.5700697,0.00032875035,0.0013933685,0.000058732716,0.00004431993,0.000114989256,0.391691,0.0000635169,0.0018613084,0.00022378082],"about_ca_topic_score_codex":0.00077589863,"about_ca_topic_score_gemma":0.00023373368,"teacher_disagreement_score":0.27295157,"about_ca_system_score_codex":0.00008729975,"about_ca_system_score_gemma":0.0002620181,"threshold_uncertainty_score":0.9487402},"labels":[],"label_agreement":null},{"id":"W7108740836","doi":"10.1182/blood-2025-5459","title":"Randomised Phase II study of acalabrutinib in combination with R-CHOP treatment for diffuse large B-cell lymphoma confirms safety and unimpaired treatment delivery","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Clinical endpoint; Diffuse large B-cell lymphoma; Chemotherapy regimen; Progression-free survival; International Prognostic Index; Phases of clinical research; Surrogate endpoint; Chemotherapy; Dasatinib; Clinical trial","score_opus":0.01761737825219514,"score_gpt":0.30622307886079697,"score_spread":0.28860570060860186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108740836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99289435,0.00047904806,0.000039925737,0.00009901766,0.00002391197,0.005887488,0.00005278409,0.00003103995,0.00049244304],"genre_scores_gemma":[0.99745303,0.00029538225,0.000079925805,0.000027567507,0.000014360879,0.00047868202,0.00007800551,0.000021621056,0.0015513976],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9985147,0.00010503546,0.0004421408,0.00037492265,0.00023345125,0.00032974835],"domain_scores_gemma":[0.9988247,0.00046441186,0.00010260361,0.00037165155,0.00012040912,0.00011620135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024622373,0.00023574162,0.00068243244,0.00023255283,0.00011408272,0.000011844357,0.0000653794,0.00009001965,0.000009166706],"category_scores_gemma":[0.00005535504,0.00016140201,0.0000780747,0.00027689355,0.00006896035,0.000042379503,0.00004603124,0.000037871687,6.7448474e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18588509,0.7434326,0.008165355,0.00052183284,0.002287279,0.00043332897,0.011526967,0.000007881192,0.00410634,0.00019961929,0.00004401385,0.04338972],"study_design_scores_gemma":[0.94475776,0.028706428,0.0028074398,0.00013475183,0.0010064016,0.00001807575,0.0018120756,0.0029229526,0.017207718,0.000007787707,0.0004997255,0.00011886677],"about_ca_topic_score_codex":0.00080295734,"about_ca_topic_score_gemma":0.00043559994,"teacher_disagreement_score":0.7588727,"about_ca_system_score_codex":0.0033713097,"about_ca_system_score_gemma":0.0023845604,"threshold_uncertainty_score":0.8815857},"labels":[],"label_agreement":null},{"id":"W7108742579","doi":"10.1182/blood-2025-2402","title":"Expansion, differentiation, and culture of hematopoietic stem &amp; progenitor cells using an ancillary GMP-compliant medium","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute; Stemcell Technologies","funders":"","keywords":"Progenitor cell; Haematopoiesis; Cord blood; Stem cell; Cell therapy; CD34; Induced pluripotent stem cell; Cell culture","score_opus":0.03631323697064287,"score_gpt":0.30975795947561624,"score_spread":0.27344472250497337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108742579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966501,0.0018628789,0.00030891987,0.00014346503,0.00013222214,0.0006001864,0.000012049149,0.000040828763,0.00024935274],"genre_scores_gemma":[0.99515665,0.00015630819,0.0012723648,0.0000796439,0.00014263064,0.00001655991,0.000026483789,0.000023596887,0.0031257365],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998742,0.00007511632,0.00029659172,0.0002823684,0.00037903222,0.00022493525],"domain_scores_gemma":[0.9990783,0.000035102188,0.00007158444,0.00041000842,0.00026191954,0.0001431312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017846886,0.0001476406,0.000339494,0.00012825278,0.00007785878,0.000022918288,0.00009627056,0.000120846205,0.00016705836],"category_scores_gemma":[0.000020811663,0.000117839874,0.00006525479,0.00026695558,0.00009037452,0.000054737542,0.000069352696,0.00016169855,0.0000036994822],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000077502744,0.00070067454,0.015172358,0.0006033026,0.00014033381,0.000012141042,0.0017651066,9.330332e-7,0.9806643,0.000016213631,0.00032867317,0.0005184619],"study_design_scores_gemma":[0.003144753,0.00019320809,0.009119368,0.00039510877,0.00032824514,0.00009619144,0.0006564336,0.00014393644,0.98412025,0.00015972719,0.0015019177,0.00014088834],"about_ca_topic_score_codex":0.00002273633,"about_ca_topic_score_gemma":0.000013253231,"teacher_disagreement_score":0.006052989,"about_ca_system_score_codex":0.000030091232,"about_ca_system_score_gemma":0.00017467188,"threshold_uncertainty_score":0.48053706},"labels":[],"label_agreement":null},{"id":"W7108743472","doi":"10.1182/blood-2025-3053","title":"Novel mechanisms of cell-based blood coagulation: Roles of integrin β3 psi domain and its L33P polymorphism","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Axon Guidance and Neuronal Signaling","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Toronto; Imperial College of Toronto; St. Michael's Hospital","funders":"","keywords":"Platelet; Clot retraction; Fibrin; Fibrinogen; Integrin; Platelet activation; Protein disulfide-isomerase; Thromboelastography; Coagulation; Chinese hamster ovary cell","score_opus":0.020759613316391572,"score_gpt":0.24397422996273216,"score_spread":0.2232146166463406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108743472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888439,0.00033794873,0.009173799,0.00018965648,0.00007946475,0.00020181137,0.000037848396,0.000032284464,0.0011032529],"genre_scores_gemma":[0.9981012,0.000018897943,0.0013288159,0.00036595474,0.000018978173,0.0000098380215,0.0000013345621,0.000012553307,0.0001424232],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99881047,0.000060836664,0.00035482226,0.00032809709,0.0002640219,0.00018177231],"domain_scores_gemma":[0.99926376,0.00025520308,0.00018969567,0.00019300134,0.00004913376,0.000049204333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015832686,0.00014652807,0.00024818466,0.0001438708,0.00007729516,0.000012615787,0.00021693621,0.000077837954,0.000028088924],"category_scores_gemma":[0.000096448275,0.00013885713,0.00007021367,0.00032335112,0.0000761789,0.0000749238,0.00008004427,0.000118019016,0.0000022545235],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038616592,0.000521281,0.0001754903,0.00008073556,0.000008595507,0.000007798565,0.00005845576,0.000058796013,0.97588074,0.023082107,0.00000431253,0.00008304383],"study_design_scores_gemma":[0.0023648683,0.0001585125,0.00049176207,0.00012557075,0.000083298226,0.000011902997,0.000036867306,0.0003878274,0.9937367,0.0024683469,0.000024516152,0.00010986173],"about_ca_topic_score_codex":0.000011213949,"about_ca_topic_score_gemma":0.0000051469738,"teacher_disagreement_score":0.02061376,"about_ca_system_score_codex":0.0000043483806,"about_ca_system_score_gemma":0.00008469389,"threshold_uncertainty_score":0.56624293},"labels":[],"label_agreement":null},{"id":"W7108746524","doi":"10.1182/blood-2025-6181","title":"Differences in patient-reported time toxicity between bispecific antibody (BsAb) options: Impact of treatment duration and dosing frequency on patient-reported time burden in relapsed/refractory (R/R) follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL)","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Dosing; Toxicity; Follicular lymphoma; Bispecific antibody; Diffuse large B-cell lymphoma; Clinical trial; Lymphoma","score_opus":0.017793661996298747,"score_gpt":0.28814354733105,"score_spread":0.2703498853347513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108746524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99575496,0.00220827,0.0000027508206,0.00012563755,0.000034129567,0.0010355263,0.00012688467,0.000037117446,0.00067474355],"genre_scores_gemma":[0.9981239,0.0009104977,0.000114793795,0.000021199006,0.000045760844,0.00004078274,0.0003362416,0.00002434395,0.0003824745],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99711657,0.00022558944,0.0011173392,0.0006146063,0.0004398733,0.00048601817],"domain_scores_gemma":[0.99859685,0.00030179226,0.0003824078,0.0003938826,0.00012018799,0.00020489642],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024788405,0.00039419936,0.0008418432,0.0006927274,0.00013695989,0.000045344612,0.00008599609,0.00023382036,0.000048162066],"category_scores_gemma":[0.00016750682,0.00029674204,0.00017241797,0.0005805657,0.00014142889,0.00012858139,0.00009071057,0.00014457073,0.000009180329],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006499929,0.011053408,0.8389503,0.00012027546,0.0005068143,0.0005494674,0.00084234506,0.0000013298063,0.13812572,0.000024342906,0.000016580949,0.009159452],"study_design_scores_gemma":[0.025510298,0.0036767074,0.9515339,0.0006805533,0.00028277276,0.00006848209,0.00012655719,0.0005366003,0.017089669,0.0001276012,0.00007509937,0.00029175315],"about_ca_topic_score_codex":0.0024853547,"about_ca_topic_score_gemma":0.00005339623,"teacher_disagreement_score":0.121036045,"about_ca_system_score_codex":0.0003504048,"about_ca_system_score_gemma":0.00034142603,"threshold_uncertainty_score":0.99994844},"labels":[],"label_agreement":null},{"id":"W7108839697","doi":"10.1182/blood-2025-6140","title":"Real-time multimodal AI outperforms conventional scores for early risk prediction in BCMA CAR-T–Treated myeloma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Overfitting; Multiple myeloma; Concordance; Pomalidomide; Logistic regression; Random forest; Framingham Risk Score; Clinical trial; Nomogram","score_opus":0.012459371308312156,"score_gpt":0.2928575631419537,"score_spread":0.28039819183364156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7108839697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928273,0.00007706338,0.00007017966,0.00026048237,0.00011487403,0.0014191341,0.00018233703,0.000120901874,0.0049277465],"genre_scores_gemma":[0.96694434,0.00009626151,0.00048742408,0.00004894524,0.00020611225,0.0002841271,0.00027504622,0.0000328318,0.031624895],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984881,0.00006416963,0.00036415225,0.0003691252,0.00033988507,0.0003745648],"domain_scores_gemma":[0.99917233,0.00012933889,0.000059603277,0.0003080255,0.00022161097,0.000109082204],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042104087,0.00016869284,0.00032126068,0.00036633326,0.00009982497,0.00003220856,0.00010649623,0.0001803315,0.0011072966],"category_scores_gemma":[0.00017452551,0.00014850666,0.00017066507,0.00036745757,0.00009098799,0.000095159434,0.000043098014,0.00030239744,0.00007262936],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018080893,0.0008752172,0.8533886,0.00012480028,0.0003635452,0.000025232051,0.00016500207,0.000009709361,0.13600753,0.00007959898,0.00114384,0.0060088304],"study_design_scores_gemma":[0.017855437,0.0008702658,0.9269986,0.0002419851,0.0002469614,0.000014868008,0.000032312797,0.004739487,0.047850754,0.00030940594,0.000711448,0.0001284618],"about_ca_topic_score_codex":0.0010544397,"about_ca_topic_score_gemma":0.00006485974,"teacher_disagreement_score":0.08815677,"about_ca_system_score_codex":0.00012255853,"about_ca_system_score_gemma":0.00022805709,"threshold_uncertainty_score":0.9998058},"labels":[],"label_agreement":null},{"id":"W7117236645","doi":"10.1182/blood.2025031180","title":"Babesiosis precipitating immune thrombotic thrombocytopenic purpura","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Vector-borne infectious diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Babesiosis; Thrombotic thrombocytopenic purpura; Immune system; Schistocyte; Antibody; Platelet; Thrombocytopenic purpura; Immunopathology","score_opus":0.009028028965649231,"score_gpt":0.2453137332581457,"score_spread":0.23628570429249648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117236645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97163916,0.011946303,0.00007335944,0.00021178434,0.0009920318,0.0003723845,0.000018551424,0.00031463796,0.014431796],"genre_scores_gemma":[0.99749446,0.00010736202,0.000100979,0.00022758833,0.000027350543,0.00007512125,0.000043496755,0.000022101944,0.0019015356],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99860936,0.0001941741,0.00035843457,0.00037809907,0.00003411654,0.00042580834],"domain_scores_gemma":[0.99902236,0.0002910568,0.000104270686,0.00048243624,0.00007939848,0.000020463545],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00015627201,0.00022049618,0.00039350046,0.00014014238,0.0003128931,0.00003910142,0.0003231642,0.00020172512,0.0011801717],"category_scores_gemma":[0.00033822842,0.0002082994,0.00017461844,0.00033100555,0.00015881748,0.00011930566,0.0001873568,0.00026495996,0.0011237286],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044538414,0.0018946422,0.08982484,0.000108525484,0.0020593824,0.000013156738,0.00032143612,0.000011064423,0.894023,0.005548987,0.0033170118,0.0028334016],"study_design_scores_gemma":[0.004973886,0.00031054375,0.54188555,0.0002284124,0.001046064,0.000071435825,0.0002781445,0.0000023287434,0.44592226,0.0014485178,0.003386633,0.000446266],"about_ca_topic_score_codex":0.00014409493,"about_ca_topic_score_gemma":0.000038764738,"teacher_disagreement_score":0.4520607,"about_ca_system_score_codex":0.000040478437,"about_ca_system_score_gemma":0.00013988485,"threshold_uncertainty_score":0.9997329},"labels":[],"label_agreement":null},{"id":"W7117484682","doi":"10.1182/blood.2024026928","title":"Comprehensive molecular and functional analysis of <i>NUTM1</i> -rearranged leukemia","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Research Foundation","funders":"","keywords":"Chromatin; Leukemia; Epigenetics; Functional analysis; Stem cell; DNA methylation; Lineage (genetic)","score_opus":0.00659793641159774,"score_gpt":0.2231921487800486,"score_spread":0.21659421236845086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117484682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946339,0.001355717,0.0015415188,0.00009966566,0.000026062897,0.000077603145,0.000012594695,0.0000053250606,0.0022476206],"genre_scores_gemma":[0.9984703,0.00005922554,0.00048119307,0.0004238943,0.000013805427,0.0000073836113,0.00014573151,0.0000035464884,0.00039490688],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995766,0.000021308288,0.00011230729,0.00016333025,0.000064816755,0.000061610226],"domain_scores_gemma":[0.9996866,0.0000051931293,0.00003533581,0.00015979324,0.00008686507,0.000026240416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00002982338,0.000064075255,0.00012934906,0.00010008667,0.000025447705,0.000006376848,0.00003221124,0.00006844654,0.000011798923],"category_scores_gemma":[0.000019738056,0.000063155734,0.00009157354,0.00025036256,0.000051478655,0.0000012783939,0.000043126274,0.000033341792,4.2953147e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032434353,0.000054226235,0.005173747,0.000017333698,0.0008906297,9.979053e-7,0.0000043503533,0.000045286506,0.99261874,0.0002516218,0.00051011774,0.00040054135],"study_design_scores_gemma":[0.0009083303,0.00005846465,0.025850976,0.000006912291,0.0005823666,0.0000024750684,0.000013643084,0.000056177112,0.9596018,0.00003531987,0.012817469,0.0000660578],"about_ca_topic_score_codex":0.000011199578,"about_ca_topic_score_gemma":0.000004311093,"teacher_disagreement_score":0.033016905,"about_ca_system_score_codex":0.0000036288939,"about_ca_system_score_gemma":0.00005410175,"threshold_uncertainty_score":0.25754163},"labels":[],"label_agreement":null},{"id":"W74426933","doi":"10.1182/blood.v95.3.894.003k15_894_902","title":"Platelet secretion induced by phorbol esters stimulation is mediated through phosphorylation of MARCKS: a MARCKS-derived peptide blocks MARCKS phosphorylation and serotonin release without affecting pleckstrin phosphorylation*","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Receptor Mechanisms and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"MARCKS; Phosphorylation; Protein kinase C; Biology; Pleckstrin homology domain; Cell biology; Biochemistry","score_opus":0.008919457842009702,"score_gpt":0.2299009571910334,"score_spread":0.2209814993490237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W74426933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99449897,0.0009545522,0.002684303,0.00007291997,0.00009361786,0.0011826605,0.00009316475,0.000067309644,0.0003524949],"genre_scores_gemma":[0.9950685,0.0006066267,0.002241081,0.00015201444,0.000118383825,0.00007946123,0.001357105,0.000085419946,0.0002913883],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973064,0.00018362766,0.00074763247,0.00083693373,0.00046538466,0.00046001014],"domain_scores_gemma":[0.99863505,0.00007016819,0.0004826382,0.00041527065,0.00022929652,0.00016758649],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045401682,0.00046818572,0.00044915194,0.00009380388,0.0002573547,0.00007801684,0.00017610399,0.0005314434,0.0007496442],"category_scores_gemma":[0.00014051353,0.0005077414,0.00013487534,0.00035832942,0.000085994885,0.00006530095,0.000070735434,0.00027981002,0.000010367205],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065943564,0.00021090676,0.006891774,0.000059405855,0.00016965452,0.0000025182126,0.0010633589,0.00060293067,0.98273706,0.000006471306,0.00018033368,0.007416117],"study_design_scores_gemma":[0.0045135007,0.0006435971,0.00417625,0.00013856107,0.00014575946,0.00001705095,0.0003222302,0.005682018,0.98298836,0.00012815189,0.0006846675,0.00055986806],"about_ca_topic_score_codex":0.00034448455,"about_ca_topic_score_gemma":0.000025683046,"teacher_disagreement_score":0.0068562487,"about_ca_system_score_codex":0.000049947495,"about_ca_system_score_gemma":0.000107772335,"threshold_uncertainty_score":0.99973744},"labels":[],"label_agreement":null},{"id":"W76243008","doi":"10.1182/blood.v124.21.5447.5447","title":"Safety and Efficacy of Dose Attentuated R-CHOP Chemotherapy for Treatment of Diffuse Large B Cell Lymphoma in the Very Elderly: A Cohort Study","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Hospital; Western University; London Health Sciences Centre","funders":"","keywords":"Medicine; Diffuse large B-cell lymphoma; Internal medicine; Tolerability; CHOP; Chemotherapy regimen; Oncology; Regimen; Lymphoma; Cancer; Adverse effect","score_opus":0.010482693665450514,"score_gpt":0.2578473889440864,"score_spread":0.24736469527863586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W76243008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965371,0.00044382256,0.000005645778,0.0001686852,0.000021294823,0.0025298386,0.000028509761,0.00001118393,0.0002539394],"genre_scores_gemma":[0.9990449,0.0004819209,0.00006687817,0.000078790574,0.000032082145,0.00020430781,0.000027460608,0.000017007866,0.00004668283],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990195,0.00007230126,0.00031843313,0.0002355017,0.00017493241,0.0001793312],"domain_scores_gemma":[0.9990488,0.00036367046,0.000114197406,0.0003831625,0.000040073886,0.00005009569],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002240073,0.00016604528,0.0005161189,0.000060577575,0.00003676652,0.000006530168,0.000058290538,0.00005065434,0.000007359521],"category_scores_gemma":[0.000025909776,0.00009619978,0.00011147896,0.00011022381,0.000033031207,0.000017351862,0.000011574521,0.0000118715925,0.0000012352244],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011686544,0.13745956,0.8432525,0.000052223248,0.00048737472,0.000015808513,0.0022911353,2.4368782e-7,0.0005863567,0.000032438053,0.000024011753,0.014629722],"study_design_scores_gemma":[0.19321632,0.0065301307,0.7926333,0.000033502027,0.000734721,0.0000071520562,0.00029016924,0.000028304932,0.0058357096,0.0000058932555,0.00061991275,0.00006487359],"about_ca_topic_score_codex":0.00018839746,"about_ca_topic_score_gemma":0.000047486945,"teacher_disagreement_score":0.19204767,"about_ca_system_score_codex":0.00004713816,"about_ca_system_score_gemma":0.000038844475,"threshold_uncertainty_score":0.3922913},"labels":[],"label_agreement":null},{"id":"W77107658","doi":"10.1182/blood.v96.1.188","title":"Morphological analysis of microparticle generation in heparin-induced thrombocytopenia","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":194,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services","funders":"Medical Research Council; Medical Research Council Canada; Heart and Stroke Foundation of Canada","keywords":"Platelet; Microparticle; Population; Chemistry; Heparin; Biophysics; Platelet activation; Vesicle; Neonatal alloimmune thrombocytopenia; Flow cytometry; Endocytosis; Cell biology; Immunology; Molecular biology; Biology; Membrane; Medicine; Biochemistry; Receptor","score_opus":0.05309423063431226,"score_gpt":0.30387122631090424,"score_spread":0.25077699567659195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W77107658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938369,0.00006363667,0.000005452281,0.00024537547,0.00003059238,0.0003419059,0.000009258388,0.000044642413,0.005422236],"genre_scores_gemma":[0.998611,0.000070852,0.000753934,0.00022663403,0.00006676381,0.000025652611,0.00007044221,0.000019432138,0.00015532704],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982204,0.000108553715,0.0006049022,0.0004497048,0.00024893723,0.0003674897],"domain_scores_gemma":[0.99912393,0.000038456776,0.00008396043,0.0005272716,0.00006754729,0.0001588347],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028145194,0.00019944635,0.00097185146,0.00031913092,0.000052594532,0.000020432042,0.00014415382,0.00018239008,0.0034298794],"category_scores_gemma":[0.00005013877,0.00017484372,0.00024517087,0.0015649105,0.00006776339,0.000110152556,0.000040389714,0.00020843623,0.00014907529],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005894022,0.0015687097,0.17582695,0.000010620167,0.00070737,0.000095817435,0.00022642633,0.000060594077,0.81944907,0.00009969638,0.000026410096,0.0018693887],"study_design_scores_gemma":[0.0024104107,0.0002802786,0.59541535,0.000012995689,0.0018516427,0.000040992047,0.000027190816,0.0011839294,0.39852455,0.000016833244,0.00008869288,0.00014713767],"about_ca_topic_score_codex":0.00056892453,"about_ca_topic_score_gemma":0.00040796027,"teacher_disagreement_score":0.4209245,"about_ca_system_score_codex":0.000050602408,"about_ca_system_score_gemma":0.000079726946,"threshold_uncertainty_score":0.9974811},"labels":[],"label_agreement":null},{"id":"W77452706","doi":"10.1182/blood.v96.12.3979","title":"High marrow seeding efficiency of human lymphomyeloid repopulating cells in irradiated NOD/SCID mice","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Heart, Lung, and Blood Institute","keywords":"Haematopoiesis; Nod; Stem cell; Biology; Bone marrow; Severe combined immunodeficiency; Myeloid; Immunology; Cord blood; Transplantation; Andrology; Molecular biology; In vivo; Internal medicine; Medicine; Cell biology; Genetics","score_opus":0.012207588025855757,"score_gpt":0.24422168806997252,"score_spread":0.23201410004411677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W77452706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99284536,0.000075412376,0.000008864073,0.000040705494,0.000064242246,0.0003104619,0.0000071948243,0.00005972495,0.006588067],"genre_scores_gemma":[0.99784946,0.000017809236,0.0015854972,0.000041320305,0.0000621698,0.000008237306,0.000044950208,0.000026757532,0.00036379969],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985261,0.00004373811,0.00060251774,0.00027642213,0.00028175887,0.0002694933],"domain_scores_gemma":[0.9994687,0.00006780298,0.00012177231,0.00021993609,0.000039326296,0.000082493476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028710693,0.00014249996,0.00034275584,0.0001603933,0.00005197858,0.000008670518,0.000085125044,0.00010685242,0.0005153522],"category_scores_gemma":[0.000023488394,0.00014310936,0.00006136482,0.0004007864,0.00003796367,0.000047687325,0.000007091222,0.00011221137,0.000059212052],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036826146,0.0004494126,0.053337995,0.00039159725,0.000023451135,0.00013829966,0.001406827,0.00008278093,0.9436881,0.00004292608,0.000009327326,0.00039247467],"study_design_scores_gemma":[0.0076995,0.00025129342,0.12332565,0.0010149826,0.0002343189,0.00024345596,0.00026096162,0.00042338006,0.8662476,0.00004276779,0.000021179607,0.00023492648],"about_ca_topic_score_codex":0.000557341,"about_ca_topic_score_gemma":0.000022955192,"teacher_disagreement_score":0.0774405,"about_ca_system_score_codex":0.000040064744,"about_ca_system_score_gemma":0.00004778267,"threshold_uncertainty_score":0.583583},"labels":[],"label_agreement":null},{"id":"W77500779","doi":"10.1182/blood.v95.1.102","title":"Expansion of human cord blood CD34+CD38−cells in ex vivo culture during retroviral transduction without a corresponding increase in SCID repopulating cell (SRC) frequency: dissociation of SRC phenotype and function","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":251,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Hospital for Sick Children; University of Toronto","funders":"","keywords":"CD38; Stem cell; Biology; Haematopoiesis; CD34; Cord blood; Cell biology; Molecular biology; Population; Ex vivo; Immunology; Medicine; In vitro; Biochemistry","score_opus":0.009587674266420888,"score_gpt":0.24348748602836945,"score_spread":0.23389981176194857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W77500779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99781156,0.00018164216,0.000035655212,0.000009934479,0.000067837216,0.00058755215,0.00001417571,0.000038199596,0.0012534444],"genre_scores_gemma":[0.99858046,0.0000854307,0.0009380442,0.000009289014,0.00006526891,0.000011636456,0.00006592238,0.000031257667,0.00021270553],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99801886,0.0001622558,0.0008348178,0.000375753,0.0003721452,0.000236162],"domain_scores_gemma":[0.9992825,0.00004444857,0.000319933,0.00020790212,0.0000699946,0.00007522801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044764119,0.00020083942,0.0004710236,0.0003196735,0.00007065138,0.000010977474,0.000048738424,0.00020976878,0.00008979867],"category_scores_gemma":[0.00004266532,0.00020451313,0.00006805798,0.0004996109,0.000049115475,0.000215567,0.0000068766453,0.00025195535,0.0000015353979],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006514143,0.00040125713,0.26935035,0.00074720755,0.000021171845,0.000028693561,0.004011569,0.000026292484,0.72449434,0.000013790729,6.5681115e-7,0.0002532512],"study_design_scores_gemma":[0.008548891,0.000766428,0.28630963,0.0013924224,0.00048819528,0.0000518729,0.0009981475,0.000118128126,0.7010279,0.00010965079,9.076686e-7,0.00018779204],"about_ca_topic_score_codex":0.00079267984,"about_ca_topic_score_gemma":0.00019036327,"teacher_disagreement_score":0.02346639,"about_ca_system_score_codex":0.00006502185,"about_ca_system_score_gemma":0.00005357269,"threshold_uncertainty_score":0.8339803},"labels":[],"label_agreement":null},{"id":"W78744612","doi":"10.1182/blood.v95.11.3489","title":"Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":882,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research & Development Corporation","funders":"","keywords":"Haematopoiesis; Biology; Progenitor cell; Myeloid; Bone marrow; Spleen; CD11c; CD8; Immunology; Lymphopoiesis; Stem cell; Dendritic cell; Cell biology; Antigen","score_opus":0.006408495738670238,"score_gpt":0.2070385583558723,"score_spread":0.20063006261720204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W78744612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856593,0.006603136,0.000018222227,0.00005656585,0.005661621,0.00039588145,0.0000033197766,0.00015021901,0.0014517109],"genre_scores_gemma":[0.97480345,0.00023748486,0.00012818379,0.00017292827,0.00009134599,0.000025254833,0.000030567204,0.000043180808,0.024467606],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982644,0.00020288584,0.00040756277,0.0005015854,0.00007750947,0.00054608507],"domain_scores_gemma":[0.9992868,0.0001895579,0.00012839212,0.00027616753,0.00007341447,0.00004569523],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0002332749,0.00032682545,0.0003582892,0.00012567922,0.0004692724,0.000100812395,0.00016577274,0.00026937723,0.0011556208],"category_scores_gemma":[0.000021999078,0.0003065073,0.00015420742,0.00012677988,0.00012940266,0.00016189355,0.000074136195,0.00049644517,0.0013375268],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006471812,0.00046899045,0.00019234378,0.00011364238,0.00018337579,0.000016971164,0.0012993417,0.000009224388,0.99330395,0.000012391591,0.0036162557,0.00071881467],"study_design_scores_gemma":[0.0017890595,0.0001343777,0.0001617253,0.00011937425,0.00021037727,0.0005580177,0.0014411309,0.000026173944,0.9746739,0.0000074804198,0.020523945,0.00035440281],"about_ca_topic_score_codex":0.000065395754,"about_ca_topic_score_gemma":0.000015501613,"teacher_disagreement_score":0.023015894,"about_ca_system_score_codex":0.00003816904,"about_ca_system_score_gemma":0.000028729259,"threshold_uncertainty_score":0.9999387},"labels":[],"label_agreement":null},{"id":"W802914929","doi":"10.1182/blood.v124.21.5704.5704","title":"A Systematic Literature Review on the Epidemiological Burden in Multiple Myeloma","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Epidemiology; MEDLINE; Incidence (geometry); Multiple myeloma; Systematic review; Family medicine; Demography; Internal medicine","score_opus":0.041439539561852465,"score_gpt":0.3162305012531897,"score_spread":0.2747909616913372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W802914929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8183595,0.14499393,0.00002689802,0.020687327,0.00007856225,0.00695036,0.0000200822,0.0001337976,0.008749573],"genre_scores_gemma":[0.98926896,0.007184679,0.00024305862,0.002285151,0.00013684176,0.00042883254,0.000028637403,0.000012918994,0.0004109463],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99810356,0.00072592,0.00035111816,0.0002458564,0.00027429004,0.00029922897],"domain_scores_gemma":[0.997472,0.0017427002,0.00007265249,0.0005236351,0.000051613275,0.00013741519],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0012598571,0.00016034754,0.0006042896,0.00006116292,0.000053838037,0.000016001797,0.00014084208,0.00008370958,0.00006163656],"category_scores_gemma":[0.010669913,0.00006971707,0.00013771273,0.00024774254,0.000038384707,0.000021786625,0.00003905231,0.00031067024,0.00028046896],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011255771,0.008042857,0.32725513,0.6101536,0.0023596953,0.005639193,0.0014370593,0.000008929752,0.0034547348,0.011844224,0.012660463,0.016018517],"study_design_scores_gemma":[0.016605565,0.0024267633,0.26247102,0.7090012,0.0007205995,0.0009346183,0.00008993569,0.0030371204,0.0009380534,0.00065865915,0.0026450425,0.00047142798],"about_ca_topic_score_codex":0.000011756066,"about_ca_topic_score_gemma":0.000006983551,"teacher_disagreement_score":0.17090946,"about_ca_system_score_codex":0.000025000363,"about_ca_system_score_gemma":0.000018182835,"threshold_uncertainty_score":0.9976636},"labels":[],"label_agreement":null},{"id":"W805386214","doi":"10.1182/blood.v124.21.2976.2976","title":"Single Cell Mass Cytometry for Phenotypic Analysis of Diffuse Large B-Cell Lymphoma","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diffuse large B-cell lymphoma; Biology; Population; Mass cytometry; Cancer research; Immunology; Lymphoma; Molecular biology; Pathology; Medicine; Phenotype; Genetics","score_opus":0.010772123293533314,"score_gpt":0.23540012164552687,"score_spread":0.22462799835199357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W805386214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915074,0.0006422573,0.0017987938,0.000060982577,0.000055465043,0.00029051377,0.00010143639,0.000038405175,0.0055047274],"genre_scores_gemma":[0.99601674,0.000029003784,0.0028319438,0.00020601315,0.00008428926,0.000053463442,0.00013545337,0.000024681753,0.00061838626],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998933,0.00002670894,0.00027419542,0.00027797502,0.00020730935,0.00028081812],"domain_scores_gemma":[0.9989915,0.00020699305,0.00013926122,0.00044210235,0.0000874979,0.00013263567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013379438,0.00016096521,0.00053938664,0.00030594133,0.000048241396,0.00001275624,0.00008291419,0.00008928277,0.00005936379],"category_scores_gemma":[0.000052124844,0.00012870817,0.00038426142,0.00054958946,0.000022454784,0.00002784816,0.000026058971,0.00001984985,0.000024711935],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028505304,0.1551593,0.7109794,0.0006261206,0.0046585747,0.000036588943,0.00040077884,0.000005082313,0.11915234,0.0006333564,0.00085231505,0.0072110924],"study_design_scores_gemma":[0.08850197,0.0015454098,0.17845498,0.000043948,0.021183128,0.0000037201958,0.00010450724,0.0010160068,0.7005221,0.00008433928,0.008270477,0.00026937498],"about_ca_topic_score_codex":0.00002486843,"about_ca_topic_score_gemma":0.000010073242,"teacher_disagreement_score":0.5813698,"about_ca_system_score_codex":0.000054416836,"about_ca_system_score_gemma":0.000035254696,"threshold_uncertainty_score":0.5248567},"labels":[],"label_agreement":null},{"id":"W82184047","doi":"10.1182/blood.v96.9.2951","title":"Mechanisms of HIV-associated lymphocyte apoptosis","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":304,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Immune system; Apoptosis; Cytotoxic T cell; Immunology; Biology; CD8; T cell; Lymphocyte; Virology; In vitro","score_opus":0.00874553566597122,"score_gpt":0.22195374780474517,"score_spread":0.21320821213877394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W82184047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876032,0.0007982559,0.000016911446,0.00007121519,0.00004246009,0.00012343258,0.0001948397,0.00004859028,0.011101088],"genre_scores_gemma":[0.98906463,0.00015411174,0.000080805585,0.000027488124,0.000003263403,0.000018733626,0.00023393208,0.000008093676,0.010408936],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993393,0.00008994814,0.00013481836,0.00013742779,0.000032868535,0.00026565764],"domain_scores_gemma":[0.99971014,0.000043178763,0.000032639025,0.00016433276,0.000028260198,0.000021445816],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000081912855,0.00008465203,0.00016615177,0.000041690222,0.000070064016,0.000003495544,0.000112809474,0.00011507014,0.0063126725],"category_scores_gemma":[0.000020924695,0.00007009738,0.00007184917,0.00009401424,0.00005780339,0.000023202174,0.000019067355,0.000063514264,0.0047638975],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022163587,0.0038311284,0.0025308395,0.000015065196,0.001835039,0.00001731071,0.00030481923,0.000002187222,0.9612085,0.0009727099,0.0034566342,0.025604099],"study_design_scores_gemma":[0.0064957268,0.00034672988,0.0040255655,0.000016938322,0.00010118968,0.00001404672,0.000030291203,3.7497426e-7,0.98344165,0.00037294423,0.0050657666,0.00008876611],"about_ca_topic_score_codex":0.000099130804,"about_ca_topic_score_gemma":0.000008694515,"teacher_disagreement_score":0.025515333,"about_ca_system_score_codex":0.000021347787,"about_ca_system_score_gemma":0.00005137116,"threshold_uncertainty_score":0.996011},"labels":[],"label_agreement":null},{"id":"W8239046","doi":"10.1182/blood.v95.3.1056.003k26_1056_1065","title":"Myeloma progenitors in the blood of patients with aggressive or minimal disease: engraftment and self-renewal of primary human myeloma in the bone marrow of NOD SCID mice","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; University of Alberta","funders":"","keywords":"Bone marrow; Progenitor cell; Multiple myeloma; Immunology; Medicine; Homing (biology); Stem cell; Pathology; Biology; Cell biology","score_opus":0.01016805378354015,"score_gpt":0.24858711608381864,"score_spread":0.23841906230027848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W8239046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99662143,0.0010102022,3.6976157e-8,0.000102563914,0.0000058340916,0.001820726,0.00013090903,0.000008099277,0.0003001886],"genre_scores_gemma":[0.999093,0.00009671695,0.00039733568,0.000030411908,0.000029704928,0.00016913273,0.00012079792,0.000019281566,0.000043646753],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99785566,0.00023413828,0.00045852107,0.00028621955,0.00083923654,0.0003262303],"domain_scores_gemma":[0.9989532,0.00017508953,0.0002459353,0.00039912728,0.00010727698,0.00011936213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002584055,0.00021585835,0.00043874604,0.00016930947,0.000057824498,0.000010033816,0.00021280866,0.000051884697,0.00006436585],"category_scores_gemma":[0.000069510344,0.00010787898,0.000071294984,0.00039125807,0.00023857532,0.000058842328,0.000046339155,0.00014878635,0.0000013026357],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003970411,0.01705586,0.9693484,0.00057137053,0.00047056618,0.0008430983,0.002413495,4.5172828e-7,0.0021230336,0.000010781169,0.000013164327,0.0031793735],"study_design_scores_gemma":[0.019888671,0.0028920604,0.9649182,0.0004139152,0.000549971,0.000045164143,0.00025311598,0.0000029809069,0.010901411,0.000012135754,0.000019897225,0.00010246455],"about_ca_topic_score_codex":0.00013920045,"about_ca_topic_score_gemma":0.00015098216,"teacher_disagreement_score":0.015918259,"about_ca_system_score_codex":0.000025476616,"about_ca_system_score_gemma":0.00021152622,"threshold_uncertainty_score":0.4399177},"labels":[],"label_agreement":null},{"id":"W824520190","doi":"10.1182/blood.v122.21.2948.2948","title":"Lupus Increases The Incidence Ratio Of Hematologic Malignancies: A Meta-Analysis Of Cohort Studies","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Multiple myeloma; Lymphoma; Incidence (geometry); Population; Confidence interval; Meta-analysis; Etiology; Cohort study; Oncology; Immunology; Environmental health","score_opus":0.06219536481522704,"score_gpt":0.3072800703527492,"score_spread":0.24508470553752215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W824520190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97531915,0.02348258,0.000003342558,0.00048064982,0.000013033408,0.00048352798,0.00001599216,0.000011364313,0.00019037373],"genre_scores_gemma":[0.99820966,0.00073282834,0.00029430824,0.0001825829,0.0000067166616,0.00039436048,0.000007535111,0.000004128968,0.00016785724],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9990199,0.00006635735,0.000374398,0.00016122338,0.00027036536,0.000107733584],"domain_scores_gemma":[0.9985146,0.00051075435,0.00022396394,0.0004188098,0.0002943033,0.00003756735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018599725,0.000119603814,0.0011399481,0.00008861538,0.000037239563,0.0000060860466,0.00008580026,0.000030465786,0.00029243593],"category_scores_gemma":[0.00033591615,0.000053957083,0.0005844706,0.00039920682,0.00014803531,0.000043037297,0.000056227964,0.000021971005,0.00001272607],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000064360343,0.0012149647,0.6749687,0.00006055404,0.32155243,0.000022704522,0.0003336416,0.0000067921883,0.00074579124,0.00045818381,0.0006117609,0.00001803516],"study_design_scores_gemma":[0.000815748,0.00020016158,0.35161412,0.000018495699,0.6055542,0.00005623308,0.00076379045,0.000025593034,0.04074096,0.0001342587,0.00001531045,0.00006109891],"about_ca_topic_score_codex":0.001361377,"about_ca_topic_score_gemma":0.0000908466,"teacher_disagreement_score":0.32335457,"about_ca_system_score_codex":0.000015715968,"about_ca_system_score_gemma":0.000046345063,"threshold_uncertainty_score":0.32019684},"labels":[],"label_agreement":null},{"id":"W83130955","doi":"10.1182/blood.v122.21.3535.3535","title":"Combination Of 4T’s Score and Rapid Gel Centrifugation Assay Excludes HIT In a Prospective Cohort Study","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; McMaster University","funders":"","keywords":"Medicine; Immunoassay; Prospective cohort study; Heparin-induced thrombocytopenia; Heparin; Platelet factor 4; Antibody; Internal medicine; Platelet; Gastroenterology; Surgery; Immunology","score_opus":0.020271590964658553,"score_gpt":0.26281461837625086,"score_spread":0.2425430274115923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W83130955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935429,0.00008098961,0.0000065431013,0.00016810071,0.00004839923,0.0028410172,0.0000021448013,0.000029558101,0.0032803244],"genre_scores_gemma":[0.9994936,0.00003885143,0.0001253838,0.000025697696,0.000027022972,0.00018227313,0.000014633635,0.000015297008,0.00007723186],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989118,0.000095749696,0.0003033734,0.00026916052,0.00024329193,0.00017659955],"domain_scores_gemma":[0.9993783,0.000059012553,0.00010593762,0.00020480396,0.00017465402,0.000077275756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003844344,0.00012533793,0.00040875064,0.00015657052,0.000040530274,0.000020384754,0.000051375828,0.00008130852,0.00011582728],"category_scores_gemma":[0.00016746929,0.00011095421,0.000031412015,0.0002572348,0.000052369865,0.00017062035,0.000042961736,0.00014170786,0.000018572106],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001887621,0.0030867762,0.97528577,0.00005172627,0.0001575817,0.000005812857,0.0012158601,1.5773279e-7,0.018967548,0.0002705335,0.000016941585,0.000922438],"study_design_scores_gemma":[0.0065920018,0.0007153359,0.96893555,0.00008835468,0.00022499968,0.000009783299,0.0005848325,0.00004249536,0.022298897,0.00040368072,0.000005177143,0.0000989074],"about_ca_topic_score_codex":0.00069228746,"about_ca_topic_score_gemma":0.00011080663,"teacher_disagreement_score":0.0065731257,"about_ca_system_score_codex":0.00005844799,"about_ca_system_score_gemma":0.00006033953,"threshold_uncertainty_score":0.45245814},"labels":[],"label_agreement":null},{"id":"W838111053","doi":"10.1182/blood.v124.21.10.10","title":"Azacitidine (AZA) Versus Conventional Care Regimens (CCR) in Older Patients with Newly Diagnosed Acute Myeloid Leukemia (&gt;30% Bone Marrow Blasts) with Morphologic Dysplastic Changes: A Subgroup Analysis of the AZA-AML-001 Trial","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre; CancerCare Manitoba","funders":"","keywords":"Medicine; Internal medicine; Cytarabine; Azacitidine; Chemotherapy regimen; Randomization; Gastroenterology; Febrile neutropenia; Regimen; Chemotherapy; Neutropenia; Oncology; Randomized controlled trial","score_opus":0.011056432322382596,"score_gpt":0.24185382794184385,"score_spread":0.23079739561946125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W838111053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965802,0.00012780543,0.000082005405,0.00029212103,0.00016716369,0.0020572993,0.00023807147,0.000058172947,0.00039716673],"genre_scores_gemma":[0.9974646,0.00006028032,0.00045386798,0.00016326254,0.00021809459,0.00033195212,0.0009855501,0.00007587972,0.00024652376],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9959406,0.00033543003,0.0005981872,0.0008268248,0.0015094832,0.0007894558],"domain_scores_gemma":[0.99701226,0.00064282,0.0004683934,0.0010037193,0.000591122,0.00028170322],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043902177,0.00048959756,0.0011757757,0.00077223993,0.00014066811,0.0000362435,0.00042851066,0.00027981863,0.00047638474],"category_scores_gemma":[0.00043820505,0.00031160054,0.0002534549,0.002278315,0.00046610853,0.00011144304,0.00019691318,0.00064732856,0.000029894354],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24758047,0.010679796,0.68840045,0.0010593545,0.025961738,0.0020374907,0.0039732032,0.0015518318,0.013135136,0.00052815763,0.003013018,0.002079336],"study_design_scores_gemma":[0.5405012,0.010613508,0.42885923,0.00049006817,0.013543822,0.00004520531,0.00065598846,0.0010977677,0.00308317,0.0000065071877,0.00042728867,0.0006762753],"about_ca_topic_score_codex":0.00031711295,"about_ca_topic_score_gemma":0.0014675222,"teacher_disagreement_score":0.2929207,"about_ca_system_score_codex":0.0006680472,"about_ca_system_score_gemma":0.0006510733,"threshold_uncertainty_score":0.9999336},"labels":[],"label_agreement":null},{"id":"W84221740","doi":"10.1182/blood.v122.21.661.661","title":"Efficacy and Safety Of Fedratinib (SAR302503/TG101348) In Patients With Intermediate- Or High-Risk Myelofibrosis (MF), Post-Polycythemia Vera (PV) MF, Or Post-Essential Thrombocythemia (ET) MF Previously Treated With Ruxolitinib: Interim Results From a Phase II Study (JAKARTA-2)","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ruxolitinib; Medicine; Myelofibrosis; Internal medicine; Clinical endpoint; Polycythemia vera; Essential thrombocythemia; Phases of clinical research; Gastroenterology; Clinical trial; Bone marrow","score_opus":0.00992980083170512,"score_gpt":0.2635124977117351,"score_spread":0.25358269688003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W84221740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99072635,0.00007249322,0.0000048395736,0.00030538175,0.00006311927,0.00645944,0.002161592,0.0001082814,0.00009850349],"genre_scores_gemma":[0.99585193,0.00013205143,0.00094304036,0.00020323879,0.000103841696,0.000636832,0.0018606271,0.0001232057,0.00014522551],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956284,0.0003575195,0.0013834337,0.0012187507,0.0007214174,0.0006904816],"domain_scores_gemma":[0.99635345,0.00087787124,0.0007670543,0.00089142274,0.0006691199,0.0004410962],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023229077,0.00086931133,0.0016741782,0.00027954957,0.0002185145,0.000113920774,0.0002341868,0.00021733358,0.0005571568],"category_scores_gemma":[0.00053789647,0.0004910501,0.000112888294,0.00046195177,0.00029038097,0.0003775269,0.00023112193,0.00047954643,0.000025670342],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19840413,0.060697276,0.7049523,0.00018345934,0.003913534,0.00039300957,0.021642003,0.0000060556154,0.002997325,0.000007889089,0.00019628783,0.006606725],"study_design_scores_gemma":[0.1791366,0.07592501,0.7161519,0.0013628935,0.0018420495,0.000026225951,0.0014674433,0.000019446607,0.023559805,0.0000028920942,0.000022395408,0.00048335906],"about_ca_topic_score_codex":0.0061759595,"about_ca_topic_score_gemma":0.002223491,"teacher_disagreement_score":0.020562481,"about_ca_system_score_codex":0.00013720528,"about_ca_system_score_gemma":0.00042853673,"threshold_uncertainty_score":0.99975413},"labels":[],"label_agreement":null},{"id":"W84591217","doi":"10.1182/blood.v122.21.2.2","title":"Initial Phase 3 Results Of The First (Frontline Investigation Of Lenalidomide + Dexamethasone Versus Standard Thalidomide) Trial (MM-020/IFM 07 01) In Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts) Ineligible For Stem Cell Transplantation (SCT)","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; University of Calgary; University of Alberta","funders":"","keywords":"Lenalidomide; Medicine; Multiple myeloma; Thalidomide; Internal medicine; Melphalan; Clinical endpoint; Adverse effect; Surgery; Dexamethasone; Phases of clinical research; Oncology; Gastroenterology; Randomized controlled trial; Clinical trial","score_opus":0.04326538170802355,"score_gpt":0.30895721281488925,"score_spread":0.2656918311068657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W84591217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99187547,0.00010121459,0.00013653039,0.00023882653,0.00025688024,0.005795672,0.00143256,0.000025420155,0.00013744863],"genre_scores_gemma":[0.9967542,0.000090516034,0.0015166228,0.00003579596,0.00015304209,0.0005542404,0.00079627155,0.00004141755,0.000057865822],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99705666,0.00023188742,0.0011180649,0.00041575948,0.0007473865,0.00043025086],"domain_scores_gemma":[0.9968377,0.0015499347,0.00052046304,0.00044598692,0.00043267946,0.00021325203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051783706,0.0002884059,0.00068461464,0.00024371935,0.00009653287,0.000030326051,0.00020523932,0.0001753016,0.000036506382],"category_scores_gemma":[0.00089879,0.00021167986,0.00022763842,0.00037145786,0.0001586065,0.00028591958,0.000041446132,0.00019987364,0.000009660803],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.82942325,0.007699247,0.12538041,0.0013935044,0.00055627147,0.000053999254,0.0035535211,0.00012235086,0.01875228,0.000013271895,0.00087088044,0.01218101],"study_design_scores_gemma":[0.58954185,0.005327838,0.037707247,0.00030670638,0.0003188695,0.0000015237913,0.00016141872,0.00037821426,0.36599678,0.00003146922,0.00008189421,0.00014617573],"about_ca_topic_score_codex":0.0018580665,"about_ca_topic_score_gemma":0.0014196604,"teacher_disagreement_score":0.3472445,"about_ca_system_score_codex":0.0001298974,"about_ca_system_score_gemma":0.0003270338,"threshold_uncertainty_score":0.8632054},"labels":[],"label_agreement":null},{"id":"W845942330","doi":"10.1182/blood.v122.21.1132.1132","title":"Predictive Value Of Markers Of Fibrinolysis and Endothelial Dysfunction In The Post Thrombotic Syndrome: A Systematic Review","year":2013,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Internal medicine; Post-thrombotic syndrome; Fibrinolysis; Biomarker; Deep vein; Von Willebrand factor; Thrombosis; Platelet","score_opus":0.016265364117644558,"score_gpt":0.26835426944110263,"score_spread":0.25208890532345807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W845942330","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008543423,0.989749,0.0000034528919,0.000052180007,0.00006610532,0.008622754,0.00005631994,0.000011805665,0.0005840157],"genre_scores_gemma":[0.002061811,0.9967381,0.000048448343,0.00010467846,0.000025656893,0.0009012108,0.000046118483,0.00003381108,0.00004016792],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9973221,0.0004991853,0.0012217521,0.00031382323,0.00044612313,0.00019704833],"domain_scores_gemma":[0.99794,0.00037314786,0.00087284134,0.0006690061,0.000095896234,0.000049093822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008261334,0.00032020538,0.0046246694,0.00023972156,0.000024211051,0.000010772451,0.00020832449,0.00013929443,0.000051521805],"category_scores_gemma":[0.00033628655,0.00018781655,0.00049470086,0.00039993812,0.00008983769,0.000049475406,0.00008898158,0.00020524288,0.000014436151],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000033472957,0.0007129829,0.000016284554,0.9915459,0.0020173935,0.000027116592,0.000101287726,1.4216324e-7,0.0000010295879,0.0001504815,0.00013291034,0.0052910787],"study_design_scores_gemma":[0.0007625594,0.0011429413,0.0013257852,0.92788947,0.0667106,0.0005261529,0.00016761721,0.000002923119,0.0000016261698,0.0000101709975,0.0012930355,0.00016715417],"about_ca_topic_score_codex":0.00017631258,"about_ca_topic_score_gemma":0.0000038274916,"teacher_disagreement_score":0.064693205,"about_ca_system_score_codex":0.000038710426,"about_ca_system_score_gemma":0.00010949428,"threshold_uncertainty_score":0.7658937},"labels":[],"label_agreement":null},{"id":"W873112638","doi":"10.1182/blood.v122.21.5540.5540","title":"Improved Survival In Adults With Mixed-Phenotype Acute Leukemia Following Stem Cell Transplantation (SCT): A Single Centre Experience","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Immunophenotyping; Transplantation; Internal medicine; Myeloid; Oncology; Population; Autologous stem-cell transplantation; Induction chemotherapy; Myeloid leukemia; Hematopoietic stem cell transplantation; Leukemia; Chemotherapy regimen; Chemotherapy; Gastroenterology; Immunology; Pathology; Antigen","score_opus":0.009394319172079155,"score_gpt":0.23273571348752412,"score_spread":0.22334139431544497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W873112638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99619985,0.00010722447,0.00019805419,0.00018396806,0.00010931662,0.0010863433,0.000010716964,0.000093383496,0.0020111403],"genre_scores_gemma":[0.9968404,0.000039880608,0.0017877498,0.000090225345,0.00007771282,0.00010500485,0.000061998886,0.000054323613,0.0009426973],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980428,0.00008327998,0.00031864352,0.00048395907,0.00046287006,0.00060845],"domain_scores_gemma":[0.99911726,0.0000957821,0.0000752564,0.0003633331,0.000114367205,0.00023399119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013406304,0.00024688986,0.00037267743,0.00014305455,0.00006768565,0.0000494813,0.0001895786,0.00014397682,0.000070766364],"category_scores_gemma":[0.0000140543825,0.00019787703,0.00008635452,0.0004227944,0.000057379944,0.0003005112,0.000036084224,0.00035102156,0.00007834238],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00318728,0.0018402033,0.13516906,0.0010528571,0.00046039274,0.0028731308,0.03786956,0.000018059249,0.80536485,0.000029052851,0.00026489713,0.011870634],"study_design_scores_gemma":[0.06667234,0.0027784545,0.13791524,0.0016524027,0.000868604,0.00023047118,0.020409936,0.0029458983,0.76515377,0.000017442342,0.00018225204,0.0011732138],"about_ca_topic_score_codex":0.001221341,"about_ca_topic_score_gemma":0.0003886704,"teacher_disagreement_score":0.06348506,"about_ca_system_score_codex":0.00032984326,"about_ca_system_score_gemma":0.00039054346,"threshold_uncertainty_score":0.8069191},"labels":[],"label_agreement":null},{"id":"W876997243","doi":"10.1182/blood.v124.21.757.757","title":"A Randomized Clinical Trial of Liberal Versus Restrictive Transfusion Strategy Evaluating Long Term Survival and Cause of Death: Results from the FOCUS Trial","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Blood transfusion and management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; University of Calgary; University of Alberta","funders":"","keywords":"Medicine; Blood transfusion; Randomized controlled trial; Diabetes mellitus; Stroke (engine); Heart failure; Coronary artery disease; Disease; Internal medicine; Intensive care medicine; Surgery","score_opus":0.133012101672498,"score_gpt":0.38952305036976625,"score_spread":0.25651094869726826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W876997243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920394,0.00014791082,0.0002895362,0.00046874373,0.0008072537,0.0036181665,0.000037061112,0.000027371507,0.0025645592],"genre_scores_gemma":[0.99806684,0.0007334834,0.00031587528,0.000023636278,0.00070319313,0.000050157818,0.00003313489,0.000018716091,0.0000549856],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9956767,0.001793751,0.0013535508,0.00040158513,0.0005820903,0.00019233862],"domain_scores_gemma":[0.9926521,0.006264001,0.00038126577,0.00045930283,0.0001263734,0.00011695527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005331789,0.00019054815,0.0010954883,0.00006506602,0.00006863959,0.000015945167,0.00013009476,0.00016810937,0.000022315411],"category_scores_gemma":[0.0030212435,0.00012013218,0.00037373786,0.00013911945,0.00019718191,0.00004585493,0.000047938312,0.00029653474,9.768032e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9726527,0.0016706442,0.00051396806,0.00002255215,0.0009435549,0.000009977626,0.00044617255,0.0000016282405,0.00033204132,0.00032782723,0.000013121187,0.02306586],"study_design_scores_gemma":[0.97037274,0.007983209,0.0151368845,0.00013499627,0.004751957,0.0000014734693,0.000114672024,0.00014721997,0.0010405553,0.000201439,0.0000081695625,0.0001066856],"about_ca_topic_score_codex":0.0009139101,"about_ca_topic_score_gemma":0.00033243536,"teacher_disagreement_score":0.022959173,"about_ca_system_score_codex":0.000006768307,"about_ca_system_score_gemma":0.00012541896,"threshold_uncertainty_score":0.4898848},"labels":[],"label_agreement":null},{"id":"W926934808","doi":"10.1182/blood.v122.21.4829.4829","title":"A Case Of Refractory Autoimmune Hemolytic Anemia In a Patient With Digeorge Syndrome Treated Successfully With Plasma Exchange","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Blood groups and transfusion","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Rituximab; Reticulocytosis; Pure red cell aplasia; Splenectomy; Autoimmune hemolytic anemia; Gastroenterology; Internal medicine; Immunology; Prednisone; Common variable immunodeficiency; Anemia; Pediatrics; Antibody","score_opus":0.006278394782372011,"score_gpt":0.19565427429659724,"score_spread":0.18937587951422521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W926934808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976101,0.00028502196,0.000003247079,0.00010095902,0.000014818826,0.0009620282,0.000012819395,0.000054905253,0.00095613266],"genre_scores_gemma":[0.99930906,0.00002822874,0.00027671098,0.000041358973,0.000009495006,0.000114159746,0.00002700581,0.000040508126,0.00015344379],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988388,0.000032786655,0.00030900436,0.00029064598,0.00022727,0.0003015386],"domain_scores_gemma":[0.99924904,0.00003997859,0.0001116843,0.0003673007,0.00010230663,0.000129697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005890884,0.00021789665,0.00046062146,0.00018635413,0.000039581304,0.00001155672,0.000056200206,0.00010990133,0.00024363442],"category_scores_gemma":[0.000007872964,0.00014114034,0.00004223509,0.00040585297,0.00008019977,0.00013089574,0.000020442434,0.0002204303,0.000013852038],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036870562,0.024242,0.548352,0.0036159288,0.0010114572,0.3323822,0.009028488,0.000016084725,0.055161014,0.00005574081,0.00007703402,0.022371018],"study_design_scores_gemma":[0.06548555,0.028769938,0.6150462,0.0033601758,0.0019429993,0.23796281,0.0014524095,0.00029039066,0.044510018,0.000017352324,0.00020538707,0.0009567357],"about_ca_topic_score_codex":0.0047409926,"about_ca_topic_score_gemma":0.0007545205,"teacher_disagreement_score":0.094419375,"about_ca_system_score_codex":0.000028551864,"about_ca_system_score_gemma":0.000076155346,"threshold_uncertainty_score":0.7166994},"labels":[],"label_agreement":null},{"id":"W929985516","doi":"10.1182/blood.v122.21.3032.3032","title":"Hepatosplenic T-Cell Lymphoma: Clinicopathological Features and Treatment Outcomes: Report From The North American Peripheral T-Cell Lymphoma Consortium","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"T-cell and Retrovirus Studies","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Lymphoma; Transplantation; Internal medicine; Peripheral T-cell lymphoma; Cohort; Oncology; Pathology; Immunology; T cell","score_opus":0.01179464637475592,"score_gpt":0.22613468428385478,"score_spread":0.21434003790909886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W929985516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860564,0.010509875,0.0000022795305,0.0005272913,0.000505,0.0005008371,0.00011967234,0.00013242145,0.0016462429],"genre_scores_gemma":[0.98916745,0.0018181112,0.0001323889,0.00064121577,0.000100361445,0.00016282682,0.00013900055,0.000028715565,0.007809953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978444,0.00028405304,0.0005340683,0.0006894652,0.00006776881,0.00058021914],"domain_scores_gemma":[0.99842495,0.0004761466,0.00034677453,0.00062196294,0.00006461155,0.00006557353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001042358,0.0004533752,0.00075817725,0.000032583874,0.00050617696,0.00005382572,0.00027353494,0.00020454377,0.00013267472],"category_scores_gemma":[0.00006550047,0.00023880677,0.00026630037,0.000116043404,0.001056008,0.00005633788,0.00021597507,0.00015282846,0.0003692922],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062500854,0.002789112,0.97470343,0.0000047314156,0.00033108823,0.00019455823,0.00067738316,1.7648162e-7,0.010691915,0.0000046590753,0.0037904424,0.006750027],"study_design_scores_gemma":[0.008385585,0.00076316757,0.971923,0.0000051367897,0.0003906669,0.00045862873,0.0009862493,4.8607893e-7,0.0057708323,0.000019597255,0.010952684,0.0003439475],"about_ca_topic_score_codex":0.005559557,"about_ca_topic_score_gemma":0.0010299707,"teacher_disagreement_score":0.0086917635,"about_ca_system_score_codex":0.00004759082,"about_ca_system_score_gemma":0.000090438036,"threshold_uncertainty_score":0.97382575},"labels":[],"label_agreement":null},{"id":"W945635311","doi":"10.1182/blood.v122.21.4382.4382","title":"Three-Year Follow-Up Data and Characterization Of Long-Term Remissions From An Ongoing Phase 2 Study Of Brentuximab Vedotin In Patients With Relapsed Or Refractory Hodgkin Lymphoma","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Brentuximab vedotin; Medicine; Internal medicine; Population; Oncology; Refractory (planetary science); Chemotherapy regimen; Phases of clinical research; CD30; Lymphoma; Surgery; Chemotherapy","score_opus":0.023484202020987745,"score_gpt":0.27857208762072533,"score_spread":0.2550878855997376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W945635311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99856836,0.000035133544,0.0000051903476,0.000021007261,0.000041493542,0.0011184069,0.00018306576,0.00001590826,0.000011464768],"genre_scores_gemma":[0.99817646,0.000025433297,0.00020286813,0.000015727452,0.000026076383,0.000039383758,0.0014791997,0.00002409397,0.000010780958],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987787,0.000051545496,0.00037603773,0.000377683,0.0002771257,0.00013891481],"domain_scores_gemma":[0.9987301,0.000061176186,0.00024779045,0.00075162476,0.00009155115,0.00011775238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000711646,0.00015719935,0.00039684962,0.00010213177,0.00003366356,0.000015239476,0.00012335503,0.00006203961,0.00008656032],"category_scores_gemma":[0.000055567787,0.00010605797,0.000017800414,0.00014612249,0.000030866275,0.0002746416,0.00009888335,0.000041213,0.0000023808182],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001092313,0.036696978,0.93050444,0.000035337976,0.00020269952,0.00003436322,0.0007655808,2.2365517e-8,0.0048213038,4.231778e-7,0.0000076530305,0.025838895],"study_design_scores_gemma":[0.09362195,0.005087467,0.8979053,0.00040102497,0.00044241495,0.0000020728428,0.00014717305,0.00003326942,0.0022592586,0.00000125514,0.0000029671164,0.00009585854],"about_ca_topic_score_codex":0.0007638972,"about_ca_topic_score_gemma":0.00040366215,"teacher_disagreement_score":0.09252963,"about_ca_system_score_codex":0.000033140353,"about_ca_system_score_gemma":0.00009555745,"threshold_uncertainty_score":0.43249184},"labels":[],"label_agreement":null},{"id":"W947311794","doi":"10.1182/blood.v124.21.3432.3432","title":"IMiDs® Immunomodulatory Agents Regulate Interferon-Stimulated Genes through Cereblon-Mediated Aiolos Destruction in Multiple Myeloma (MM) Cells: Identification of a Novel Mechanism of Action and Pathway for Resistance","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Gene knockdown; Cereblon; Downregulation and upregulation; Pomalidomide; Biology; Cell biology; Panobinostat; Cell growth; Cancer research; Cell culture; Ubiquitin ligase; Molecular biology; Lenalidomide; Immunology; Histone deacetylase; Histone; Ubiquitin; Multiple myeloma; Gene; Biochemistry","score_opus":0.020278363857289622,"score_gpt":0.2407211620336887,"score_spread":0.22044279817639909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W947311794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9776357,0.00023476184,0.021479584,0.000011125633,0.00015409778,0.00040595033,0.000056096782,0.000010185373,0.000012544236],"genre_scores_gemma":[0.99647725,0.00009660226,0.00305412,0.000010702342,0.000042505562,0.000040873212,0.00019559557,0.00001792098,0.000064428954],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999043,0.000054792854,0.0004236821,0.00027577713,0.000085091575,0.00011764602],"domain_scores_gemma":[0.9992522,0.000021058864,0.0003296409,0.000245882,0.00012741206,0.000023780978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020869669,0.00011844781,0.00016232922,0.000062428815,0.00004114445,0.000007977327,0.00008815512,0.00016635798,0.0000015829427],"category_scores_gemma":[0.000119398974,0.00012397565,0.000051247123,0.000085480606,0.000060447182,0.000017117984,0.00003628107,0.000042822296,3.868197e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022870896,0.00017760808,0.00029127538,0.00009765979,0.00003765252,6.397967e-8,0.000058182697,0.000077748286,0.99801767,0.00013687616,0.000008630649,0.00086794124],"study_design_scores_gemma":[0.0027068944,0.0002225493,0.0032886679,0.00005433686,0.000021545055,0.0000017410339,0.000042523126,0.003280876,0.9897725,0.00023148091,0.00026081863,0.00011607417],"about_ca_topic_score_codex":0.000024667057,"about_ca_topic_score_gemma":0.00004953296,"teacher_disagreement_score":0.018841596,"about_ca_system_score_codex":0.000011690538,"about_ca_system_score_gemma":0.000024287476,"threshold_uncertainty_score":0.5055581},"labels":[],"label_agreement":null},{"id":"W950248854","doi":"10.1182/blood.v122.21.5541.5541","title":"Pre-Transplant Remission Status and Peripheral Blood Stem Cell Graft Contribute To Long-Term Outcome After Myeloablative Sibling-Donor Allogeneic Transplant For Multiple Myeloma","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Internal medicine; Multiple myeloma; Hematopoietic stem cell transplantation; Transplantation; Proportional hazards model; Graft-versus-host disease; Single Center; Oncology; Retrospective cohort study; Cohort; Cumulative incidence; Surgery","score_opus":0.019077501586503575,"score_gpt":0.2809743732923201,"score_spread":0.26189687170581655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W950248854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909845,0.0016264631,0.0009622134,0.00031202132,0.00008263339,0.0047856527,0.0010880011,0.00011095085,0.000047590118],"genre_scores_gemma":[0.9938611,0.000320758,0.0021618952,0.00021496863,0.00013568296,0.0013074345,0.00041831715,0.000081501545,0.0014983546],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99681485,0.000096287426,0.0006062271,0.0007928859,0.00048288688,0.0012068538],"domain_scores_gemma":[0.9976484,0.000284809,0.00010700693,0.00044412728,0.00024290908,0.0012727071],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018359747,0.00050844037,0.0007288926,0.00021676102,0.00021150698,0.00010578947,0.00015182159,0.00021911954,0.00019992099],"category_scores_gemma":[0.00004168497,0.0003814571,0.00023044385,0.00016773271,0.00008001572,0.00018737605,0.000055213073,0.0002545264,0.000037411213],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002821647,0.0013894561,0.9327618,0.00080264243,0.00057870976,0.00048802415,0.0010992344,0.0000037895215,0.05726132,0.000001737167,0.000017978426,0.002773677],"study_design_scores_gemma":[0.026188187,0.001946676,0.87870455,0.0003178485,0.0010726172,0.000101712874,0.00005038996,0.0001931088,0.0909139,0.000007084907,0.00009781068,0.00040608714],"about_ca_topic_score_codex":0.00020504424,"about_ca_topic_score_gemma":0.00021943919,"teacher_disagreement_score":0.054057207,"about_ca_system_score_codex":0.00007114208,"about_ca_system_score_gemma":0.00012246514,"threshold_uncertainty_score":0.99986374},"labels":[],"label_agreement":null},{"id":"W950652435","doi":"10.1182/blood.v122.21.3639.3639","title":"A Systematic Review On Different Prothrombin Complex Concentrate Strategies To Reverse Vitamin K Antagonist Therapy","year":2013,"lang":"en","type":"review","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Vitamin K antagonist; Prothrombin complex concentrate; Dosing; MEDLINE; Retrospective cohort study; Prospective cohort study; Internal medicine; Clinical trial; Vitamin k; Cohort study; Pediatrics; Intensive care medicine; Warfarin","score_opus":0.0641474204123761,"score_gpt":0.34509267134564875,"score_spread":0.28094525093327266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W950652435","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000047912337,0.96337026,0.0000054834386,0.00047959626,0.00017270235,0.03399303,0.000056885503,0.00013134166,0.0017427673],"genre_scores_gemma":[0.000034560417,0.98684454,0.00008842656,0.0034679319,0.00015559218,0.008419725,0.00026093223,0.0001298286,0.0005984543],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99609125,0.000443464,0.0014746937,0.0007843956,0.00061419606,0.0005919772],"domain_scores_gemma":[0.9973597,0.00012899622,0.00071112585,0.0013476595,0.00011480399,0.0003377502],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034985336,0.00095209695,0.0075574433,0.00017548726,0.00011702136,0.00018384676,0.00043805593,0.00019496068,0.0005788914],"category_scores_gemma":[0.0000774618,0.0005745824,0.00083605695,0.0003158532,0.000067844594,0.00006337227,0.00011005593,0.00036968922,0.0012775369],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000003928087,0.002674129,3.269462e-7,0.95840603,0.0020215258,0.000089920744,0.000065213026,3.327203e-8,0.000009191107,0.0011037536,0.024302468,0.011323461],"study_design_scores_gemma":[0.00092737924,0.0009133705,0.000013770057,0.65165263,0.007272696,0.000050417475,0.00006020796,2.2747952e-7,0.000008343954,0.00000887396,0.33865166,0.00044042946],"about_ca_topic_score_codex":0.000054893746,"about_ca_topic_score_gemma":0.0000056827953,"teacher_disagreement_score":0.3143492,"about_ca_system_score_codex":0.00016103635,"about_ca_system_score_gemma":0.0002299138,"threshold_uncertainty_score":0.99967057},"labels":[],"label_agreement":null},{"id":"W951605309","doi":"10.1182/blood.v122.21.487.487","title":"DNMT3a Mutations Define a Pre-Leukemic Stem Cell Reservoir In Human Acute Myeloid Leukemia","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Myeloid leukemia; NPM1; Sanger sequencing; Leukemia; Biology; Mutation; Cancer research; Haematopoiesis; Stem cell; Myeloid; Molecular biology; Immunology; Gene; Genetics; Karyotype; Chromosome","score_opus":0.01779519455919561,"score_gpt":0.28025473613626883,"score_spread":0.26245954157707324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W951605309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97823745,0.00040039723,0.00003257039,0.00091456145,0.000052488598,0.0016759832,0.000028379838,0.00020396741,0.018454196],"genre_scores_gemma":[0.97525483,0.000120127006,0.0016593357,0.0003591504,0.00020413223,0.00056597154,0.00017945279,0.00010450226,0.021552475],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9968813,0.00015053229,0.00069483824,0.0006686328,0.0006671324,0.0009375591],"domain_scores_gemma":[0.9979667,0.0001858446,0.00014203899,0.0010067349,0.00026755861,0.00043113396],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003853923,0.00035926356,0.00059623056,0.0005628689,0.00018478495,0.00008549207,0.00048119234,0.00030511458,0.0006369191],"category_scores_gemma":[0.00007009173,0.0003293448,0.00016102492,0.0009152959,0.0001759878,0.00032039123,0.00028087376,0.0010620867,0.0011296626],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024816822,0.0017656481,0.05632719,0.00064834516,0.0005394018,0.0012726383,0.003857259,0.00012854028,0.9048677,0.00059972185,0.027435148,0.002310208],"study_design_scores_gemma":[0.062152747,0.002997167,0.48305354,0.000896338,0.0014909955,0.0014049836,0.0030070718,0.0041015055,0.42896235,0.0028289815,0.007141586,0.0019627423],"about_ca_topic_score_codex":0.0020324406,"about_ca_topic_score_gemma":0.00018085547,"teacher_disagreement_score":0.4759054,"about_ca_system_score_codex":0.0011760148,"about_ca_system_score_gemma":0.0011804295,"threshold_uncertainty_score":0.99991584},"labels":[],"label_agreement":null},{"id":"W966185508","doi":"10.1182/blood.v122.21.1139.1139","title":"Performance Of The Simplified Pesi Score In Patients With Pulmonary Embolism Treated With Rivaroxaban Or Standard Therapy","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Rivaroxaban; Pulmonary embolism; Warfarin; Vitamin K antagonist; Deep vein; Anesthesia; Thrombosis; Surgery; Internal medicine; Atrial fibrillation","score_opus":0.009484894000251107,"score_gpt":0.20564393736017325,"score_spread":0.19615904335992215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W966185508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99614286,0.00003666476,6.030063e-7,0.00019113431,0.000021159143,0.0017582548,0.0000104988085,0.00002695132,0.0018118706],"genre_scores_gemma":[0.99914986,0.00012223593,0.00007820319,0.0002586926,0.000027329226,0.00011375239,0.00002011685,0.0000322018,0.00019758152],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888414,0.000028339844,0.00021947655,0.00022194983,0.00038973967,0.00025633627],"domain_scores_gemma":[0.9992046,0.000018555373,0.00011804113,0.00041901867,0.00017423416,0.00006557981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006152062,0.0001842809,0.00041390854,0.000079250356,0.00006193625,0.000013865959,0.00014463962,0.000049050093,0.00015063136],"category_scores_gemma":[0.000008677435,0.00008365958,0.000037991962,0.0003074852,0.000086000226,0.000107284824,0.00004015183,0.000112652466,0.0000063843345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083915354,0.0029413654,0.99109596,0.000082779734,0.00014311694,0.000005183635,0.00020731536,0.0000083405275,0.00006998398,0.000020710164,0.00019135265,0.004394754],"study_design_scores_gemma":[0.009673412,0.0026817285,0.98452234,0.00031768938,0.00014003665,0.000002158006,0.000049029422,0.000014615601,0.0022845352,0.0000041958933,0.00018248406,0.00012777744],"about_ca_topic_score_codex":0.0002088751,"about_ca_topic_score_gemma":0.00003493874,"teacher_disagreement_score":0.008834259,"about_ca_system_score_codex":0.000026386611,"about_ca_system_score_gemma":0.00006837962,"threshold_uncertainty_score":0.34115386},"labels":[],"label_agreement":null},{"id":"W97160107","doi":"10.1182/blood.v116.21.3397.3397","title":"Analysis of BCR-ABL1 Tyrosine Kinase Domain Mutations In Primitive Chronic Myeloid Leukemia Cells Identifies a Unique Mutator Phenotype.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Imatinib mesylate; Myeloid leukemia; Biology; Mutation; Cancer research; Phenotype; Tyrosine kinase; Leukemia; Molecular biology; ABL; Imatinib; Genetics; Gene; Receptor","score_opus":0.007657762070300278,"score_gpt":0.2521590659268038,"score_spread":0.24450130385650354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W97160107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972042,0.00042751315,0.000092599905,0.00009303289,0.00015279496,0.0006513264,0.00016373981,0.00006992732,0.0011448914],"genre_scores_gemma":[0.996457,0.000076320706,0.0023657705,0.00005672225,0.000114988354,0.00009165017,0.000388242,0.000046078327,0.00040325432],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979477,0.000088889596,0.0006341772,0.0005155583,0.00038353464,0.00043014862],"domain_scores_gemma":[0.99835354,0.00026759994,0.00026575872,0.0007320065,0.00019224247,0.00018885378],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028636682,0.00030267125,0.0007698078,0.00083421636,0.00007141156,0.000024593419,0.00017972548,0.00022458196,0.0005832822],"category_scores_gemma":[0.00019522212,0.00028804192,0.00028041014,0.0017164735,0.00026185665,0.00013203756,0.00007591613,0.00046863576,0.00005645042],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012789336,0.0015973754,0.02331757,0.00018302516,0.0024636313,0.00041878098,0.002501282,0.00023342049,0.96747065,0.0006392285,0.00006070354,0.0009864714],"study_design_scores_gemma":[0.014097742,0.00029774633,0.32647026,0.00020369302,0.006968372,0.000039346483,0.0005543276,0.0006709261,0.64980257,0.00027731658,0.00024427936,0.00037343102],"about_ca_topic_score_codex":0.0012344761,"about_ca_topic_score_gemma":0.005454045,"teacher_disagreement_score":0.31766805,"about_ca_system_score_codex":0.0010000337,"about_ca_system_score_gemma":0.0016836683,"threshold_uncertainty_score":0.99995714},"labels":[],"label_agreement":null},{"id":"W983430947","doi":"10.1182/blood.v124.21.5930.5930","title":"Serum Albumin Level &lt; 32 g/l on Day 30 Can Predicts Higher Risk of Non-Relapse Mortality in Acute Lymphoblastic Leukemia Following Allogeneic Stem Cell Transplantation","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Gastroenterology; Hematopoietic stem cell transplantation; Albumin; Transplantation; Acute lymphocytic leukemia; Serum albumin; Leukemia; Surgery; Immunology; Lymphoblastic Leukemia","score_opus":0.01721256107787829,"score_gpt":0.25888154278952097,"score_spread":0.2416689817116427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W983430947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99488544,0.000062260355,0.0013099281,0.00006617741,0.00032751006,0.00082388,0.00038841984,0.00007148862,0.0020648853],"genre_scores_gemma":[0.99770206,0.00013767845,0.0003861708,0.00016190378,0.00017420409,0.00007676073,0.00012782474,0.000093033035,0.0011403682],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961827,0.00035142942,0.0008214775,0.00072788534,0.0011476898,0.00076885475],"domain_scores_gemma":[0.99784386,0.00061841815,0.00027700505,0.0007855215,0.00010563883,0.0003695723],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010275939,0.00043722542,0.000805705,0.00034615558,0.00009274773,0.000021641255,0.00034720244,0.00037935813,0.000061218816],"category_scores_gemma":[0.00009101921,0.0003855854,0.00025888495,0.0004824971,0.0001173614,0.000106342224,0.000070563765,0.00043926013,0.000070999486],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012928587,0.0024656334,0.7392162,0.0018489046,0.0026002515,0.0022480544,0.003659526,0.0024456903,0.23906045,0.00009864324,0.000773188,0.0042905826],"study_design_scores_gemma":[0.026372854,0.0010575058,0.8142293,0.0006489837,0.0024103068,0.000045773617,0.000060423314,0.003998652,0.1507043,0.000032739583,0.00006315039,0.00037598537],"about_ca_topic_score_codex":0.0009675973,"about_ca_topic_score_gemma":0.00033564275,"teacher_disagreement_score":0.08835616,"about_ca_system_score_codex":0.0009010565,"about_ca_system_score_gemma":0.0011677372,"threshold_uncertainty_score":0.99985963},"labels":[],"label_agreement":null},{"id":"W986273956","doi":"10.1182/blood.v124.21.3659.3659","title":"Dietary Intake of Zinc and Severity of Infection during Prophase/Induction in Children with Acute Lymphoblastic Leukemia","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pediatrics; Malnutrition; Incidence (geometry); Cohort; Prospective cohort study; Internal medicine; Gerontology","score_opus":0.007715472074841221,"score_gpt":0.23713497626997954,"score_spread":0.22941950419513832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W986273956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999186,0.00002915727,0.000106700034,0.000027790911,0.000021092159,0.00043084635,0.000007328287,0.000027508993,0.0001635987],"genre_scores_gemma":[0.99914324,0.000058817943,0.00060859264,0.000009560179,0.00008111582,0.000018140283,0.000016640404,0.000022006481,0.000041908723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886733,0.000056581677,0.00028956853,0.00026047288,0.00031322872,0.0002127905],"domain_scores_gemma":[0.9994204,0.000038278184,0.00012770777,0.00022483079,0.000095878815,0.00009290217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017931641,0.00014282207,0.00036016785,0.0002296632,0.00003381145,0.0000052666674,0.000047703095,0.000109792345,0.000009262399],"category_scores_gemma":[0.00011396725,0.000103081074,0.0000353864,0.0003536589,0.00018524677,0.00011499342,0.00006560252,0.00017239383,0.000001943423],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082938565,0.0005235852,0.8890454,0.00041366738,0.00040427534,0.000021662787,0.00021449957,0.000045973753,0.10581941,0.000011118548,0.0000058722335,0.0026651146],"study_design_scores_gemma":[0.009882213,0.00096346193,0.8549402,0.0002283944,0.0003116829,0.0010810798,0.000012370305,0.00049686484,0.13196664,0.000022264074,0.000001922835,0.00009291548],"about_ca_topic_score_codex":0.0008244122,"about_ca_topic_score_gemma":0.000068874826,"teacher_disagreement_score":0.03410523,"about_ca_system_score_codex":0.00024883915,"about_ca_system_score_gemma":0.00034691393,"threshold_uncertainty_score":0.42035243},"labels":[],"label_agreement":null},{"id":"W986955076","doi":"10.1182/blood.v122.21.1246.1246","title":"Somatic Mutations and Loss-Of-Heterozygosity Impair The DNA Repair Functions Of CUX1 in Myelodysplastic Syndromes (MDS)","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Genetics; Biology; Sanger sequencing; Loss of heterozygosity; Nonsense mutation; Mutation; Exome sequencing; Compound heterozygosity; Haploinsufficiency; Molecular biology; Chromosome 7 (human); Missense mutation; Gene; Chromosome; Allele; Phenotype","score_opus":0.015017851937639765,"score_gpt":0.2625885613126934,"score_spread":0.24757070937505365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W986955076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99782765,0.00020044475,0.000055985096,0.0006568286,0.00003439387,0.00066144,0.000015072396,0.00004621092,0.0005019813],"genre_scores_gemma":[0.9988226,0.000032995504,0.0006015629,0.000033515767,0.00002706292,0.000087202054,0.000011886657,0.000015584355,0.00036756706],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998888,0.00008694761,0.00036311414,0.00018065968,0.00025693828,0.0002243435],"domain_scores_gemma":[0.99878925,0.0005161492,0.00009254054,0.00038790394,0.00011878253,0.0000953504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023503618,0.00011353015,0.0002959219,0.0001941413,0.000068257315,0.000009885816,0.00010083277,0.000073641175,0.00018712842],"category_scores_gemma":[0.00041672407,0.0000773498,0.0000842725,0.0003402237,0.00030302635,0.00010646715,0.00008558036,0.0002288204,0.000059072496],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000061719,0.0014418409,0.96089053,0.0011453991,0.0005699797,0.00009350064,0.0020852962,0.000032808708,0.031692762,0.00021947203,0.0010462439,0.0007204315],"study_design_scores_gemma":[0.0027784563,0.00042637798,0.9903723,0.00019138707,0.00028650757,0.00040246022,0.0008563299,0.0015625983,0.0026166113,0.00038159295,0.000035779023,0.000089579786],"about_ca_topic_score_codex":0.0004052078,"about_ca_topic_score_gemma":0.000046347475,"teacher_disagreement_score":0.029481774,"about_ca_system_score_codex":0.000043623408,"about_ca_system_score_gemma":0.00017886626,"threshold_uncertainty_score":0.31542334},"labels":[],"label_agreement":null},{"id":"W992317070","doi":"10.1182/blood-2015-03-635151","title":"Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 study","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":168,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Association Histiocytose France","keywords":"Cladribine; Medicine; Cytarabine; Internal medicine; Gastroenterology; Cytopenia; Refractory (planetary science); Langerhans cell histiocytosis; Toxicity; Surgery; Chemotherapy; Disease; Bone marrow","score_opus":0.03326927811821148,"score_gpt":0.3170181235733548,"score_spread":0.28374884545514334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W992317070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945344,0.00031351572,0.0000034157367,0.000055393964,0.00008816581,0.00040748107,0.000080436614,0.000021561034,0.0044956678],"genre_scores_gemma":[0.9988085,0.00002105116,0.00032968126,0.000017052504,0.000047410285,0.000022813016,0.00012485479,0.00001206445,0.00061658485],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9991058,0.000043752756,0.00030587154,0.00022187966,0.00022214631,0.00010053689],"domain_scores_gemma":[0.99944866,0.000019876947,0.000095321404,0.00021975908,0.00008653626,0.00012984317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018970271,0.000101684665,0.00024280956,0.00012534145,0.000012390766,0.0000060500206,0.000057202265,0.000043971184,0.000008709281],"category_scores_gemma":[0.00008810948,0.00008611467,0.000019861767,0.00008227645,0.000026161428,0.000078725665,0.000021547217,0.000069149915,0.0000064353367],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0110439975,0.23214725,0.68711734,0.00034064276,0.0009893576,0.003866801,0.025582004,0.00002983416,0.01243689,0.0000399568,0.0010416118,0.025364337],"study_design_scores_gemma":[0.7119953,0.028004456,0.22507752,0.0005521086,0.001495065,0.00019634725,0.010632333,0.0018191403,0.009184344,0.00003528195,0.010406445,0.0006016254],"about_ca_topic_score_codex":0.0006411762,"about_ca_topic_score_gemma":0.00022801314,"teacher_disagreement_score":0.70095134,"about_ca_system_score_codex":0.00006315835,"about_ca_system_score_gemma":0.000068385176,"threshold_uncertainty_score":0.35116544},"labels":[],"label_agreement":null},{"id":"W99729840","doi":"10.1182/blood.v122.21.3935.3935","title":"Blockade Of CD47 Using SIRPαFc: Role Of The Fc Region In Anti-Leukemic Activity and Tolerability","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Princess Margaret Cancer Centre; University Health Network; Trillium Therapeutics (Canada)","funders":"","keywords":"CD47; Fusion protein; Effector; Cancer research; Biology; Immunology; Blockade; Myeloid; Antibody-dependent cell-mediated cytotoxicity; Phagocytosis; Cell biology; Antibody; Receptor; Monoclonal antibody; Recombinant DNA; Biochemistry","score_opus":0.011393151082342599,"score_gpt":0.2098492353476612,"score_spread":0.1984560842653186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W99729840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982007,0.0014079044,0.0000040619225,0.000045611152,0.000049022907,0.00019677558,0.000003151041,0.000005182393,0.00008757531],"genre_scores_gemma":[0.9999141,0.000024274217,0.000016256306,0.000004431228,0.0000045112793,0.0000035463602,0.0000016703291,0.000004223898,0.000026954718],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993968,0.0001449922,0.00020007492,0.00012386829,0.000019782288,0.00011449325],"domain_scores_gemma":[0.9995222,0.00004560469,0.000159981,0.00023233058,0.000034555098,0.000005305112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000106035644,0.00007145688,0.00021581551,0.000036829035,0.000041664738,0.0000028915179,0.00008857117,0.00012126768,0.000018203276],"category_scores_gemma":[0.000035756293,0.000052171054,0.000046946945,0.000090478025,0.00016134045,0.00009092127,0.00007312322,0.00010627611,0.0000018956383],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011460979,0.0001995684,0.15996453,0.000014961739,0.00002273197,3.9054736e-8,0.00016949858,0.000008313957,0.83793294,0.000019968456,0.000002682687,0.0016532823],"study_design_scores_gemma":[0.00050625857,0.000024637951,0.49078813,0.000025557672,0.000017196671,0.000008379795,0.000036597303,0.000046317957,0.5083834,0.00012341242,0.000011000828,0.000029116114],"about_ca_topic_score_codex":0.0009401061,"about_ca_topic_score_gemma":0.000023858393,"teacher_disagreement_score":0.3308236,"about_ca_system_score_codex":0.000014641126,"about_ca_system_score_gemma":0.000032657917,"threshold_uncertainty_score":0.21274738},"labels":[],"label_agreement":null},{"id":"W999976674","doi":"10.1182/blood.v124.21.1529.1529","title":"Epidural Analgesia Use in Women with Von Willebrand Disease","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Von Willebrand disease; Population; Pregnancy; Confidence interval; Von Willebrand factor; Pediatrics; Obstetrics; Disease; Internal medicine; Platelet","score_opus":0.006646339297653731,"score_gpt":0.20238396479751272,"score_spread":0.19573762549985899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W999976674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983503,0.000881495,0.00009805659,0.00014161428,0.000015469004,0.00018376729,0.000004554285,0.000045190383,0.00027950155],"genre_scores_gemma":[0.99888307,0.00012219606,0.00008516234,0.00059072225,0.000103912935,0.000028908464,0.000013340976,0.000019857329,0.00015281697],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991797,0.00006700617,0.000110384026,0.00020243687,0.0002016076,0.00023881809],"domain_scores_gemma":[0.9993538,0.000028108043,0.000023534016,0.00030381285,0.000023452196,0.00026726697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014000593,0.00011675538,0.00025545966,0.0000669117,0.000031783402,0.000018820425,0.000045844547,0.00003286708,0.00007143021],"category_scores_gemma":[0.00004782019,0.00008470702,0.000087245615,0.0001406428,0.000052355994,0.00009904235,0.000010547907,0.00007858243,0.00001577448],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031302369,0.00066733203,0.98598266,0.00009158036,0.00048060762,0.00057268864,0.000155208,0.000025982616,0.00024411033,0.00011170665,0.00009119777,0.008446692],"study_design_scores_gemma":[0.009334198,0.00026298832,0.9852807,0.000124562,0.00029713838,0.000046317033,0.000052204312,0.000032835876,0.00024793672,0.00006818271,0.0041094595,0.00014349753],"about_ca_topic_score_codex":0.000010519672,"about_ca_topic_score_gemma":0.000005652806,"teacher_disagreement_score":0.008303194,"about_ca_system_score_codex":0.000014303659,"about_ca_system_score_gemma":0.000044747874,"threshold_uncertainty_score":0.3454252},"labels":[],"label_agreement":null}]}